PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhou, GK; Wang, T; Zha, XM				Zhou, Guokun; Wang, Tao; Zha, Xiang-ming			RNA-Seq analysis of knocking out the neuroprotective proton-sensitive GPR68 on basal and acute ischemia-induced transcriptome changes and signaling in mouse brain	FASEB JOURNAL			English	Article						GPR68; ischemia; neuroprotection; OGR1; proton receptor; transcriptome	SYNAPTIC PLASTICITY; CEREBRAL-ISCHEMIA; CORTICAL-NEURONS; RECEPTOR; EXPRESSION; RAT; HEMOGLOBIN; CHANNEL; MICE; NEUROGLOBIN	Brain acid signaling plays important roles in both physiological and disease conditions. One key neuronal metabotropic proton receptor in the brain is GPR68, which contributes to hippocampal long-term potentiation (LTP) and mediates neuroprotection in acidotic and ischemic conditions. Here, to gain greater understanding of GPR68 function in the brain, we performed mRNA-Seq analysis in mice. First, we studied sham-operated animals to determine baseline expression. Compared to wild type (WT), GPR68-/- (KO) brain downregulated genes that are enriched in Gene Ontology (GO) terms of misfolding protein binding, response to organic cyclic compounds, and endoplasmic reticulum chaperone complex. Next, we examined the expression profile following transient middle cerebral artery occlusion (tMCAO). tMCAO-upregulated genes cluster to cytokine/chemokine-related functions and immune responses, while tMCAO-downregulated genes cluster to channel activities and synaptic signaling. For proton-sensitive receptors, tMCAO downregulated ASIC1a and upregulated GPR4 and GPR65, but had no effect on ASIC2, PAC, or GPR68. GPR68 deletion did not alter the expression of these proton receptors, either at baseline or after ischemia. Lastly, we performed GeneVenn analysis of differential genes at baseline and post-tMCAO. Ischemia upregulated the expression of three hemoglobin genes, along with H2-Aa, Ppbp, Siglece, and Tagln, in WT but not in KO. Immunostaining showed that tMCAO-induced hemoglobin localized to neurons. Western blot analysis further showed that hemoglobin induction is GPR68-dependent. Together, these data suggest that GPR68 deletion at baseline disrupts chaperone functions and cellular signaling responses and imply a contribution of hemoglobin-mediated antioxidant mechanism to GPR68-dependent neuroprotection in ischemia.	[Zhou, Guokun; Wang, Tao; Zha, Xiang-ming] Univ S Alabama, Dept Physiol & Cell Biol, Coll Med, 5851 USA Dr N,MSB3074, Mobile, AL 36688 USA; [Zhou, Guokun] Nantong Univ, Inst Special Environm Med, Nantong, Peoples R China	University of South Alabama; Nantong University	Zha, XM (corresponding author), Univ S Alabama, Dept Physiol & Cell Biol, Coll Med, 5851 USA Dr N,MSB3074, Mobile, AL 36688 USA.	zha@southalabama.edu	Wang, Tao/ABB-7736-2021	Wang, Tao/0000-0002-3725-4050; Zha, Xiangming/0000-0001-9490-2731; Zhou, Guokun/0000-0002-5755-507X	NIH/NINDS [R01NS102495]; University of South Alabama College of Medicine [1341]; NIH/ARRA [S10RR027535]	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of South Alabama College of Medicine; NIH/ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was supported by NIH/NINDS grant R01NS102495 and an intramural grant #1341 from University of South Alabama College of Medicine (to XMZ). The Nikon A1 microscope was funded by an NIH/ARRA equipment grant #S10RR027535.	Alcazar O, 2007, INVEST OPHTH VIS SCI, V48, P5662, DOI 10.1167/iovs.07-0392; Amri F, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00067; Anea CB, 2009, CIRCULATION, V119, P1510, DOI 10.1161/CIRCULATIONAHA.108.827477; Bot PTG, 2009, STROKE, V40, P439, DOI 10.1161/STROKEAHA.108.522284; Brown IR, 2007, ANN NY ACAD SCI, V1113, P147, DOI 10.1196/annals.1391.032; Buga AM, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/fnagi.2014.00044, 10.3389/fnagi.2014.00130]; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Clarke J, 2014, J CEREBR BLOOD F MET, V34, P630, DOI 10.1038/jcbfm.2013.237; Claude J, 2013, J NEUROSCI, V33, P18270, DOI 10.1523/JNEUROSCI.2211-13.2013; Codrich M, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.458; Deng XT, 2017, COMPUT BIOL CHEM, V68, P1, DOI 10.1016/j.compbiolchem.2017.01.015; Dergunova LV, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5039-5; Devis-Jauregui L, 2021, AUTOPHAGY, V17, P1077, DOI 10.1080/15548627.2020.1752548; Du JY, 2017, ELIFE, V6, DOI 10.7554/eLife.22564; Du JY, 2014, P NATL ACAD SCI USA, V111, P8961, DOI 10.1073/pnas.1407018111; Duclot F, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00035; Enogieru AB, 2019, ADV PHARMACOL SCI, V2019, DOI 10.1155/2019/2706783; Fischer M, 2005, J MOL DIAGN, V7, P89, DOI 10.1016/S1525-1578(10)60013-X; Fury W, 2020, STROKE, V51, P2514, DOI 10.1161/STROKEAHA.120.029440; Glitsch M, 2019, CELL CALCIUM, V80, P38, DOI 10.1016/j.ceca.2019.03.010; Guo SZ, 2018, J CEREBR BLOOD F MET, V38, P2236, DOI 10.1177/0271678X18795986; Hanafusa K, 2019, J BIOL CHEM, V294, P19335, DOI 10.1074/jbc.RA119.009603; He YD, 2010, TRANSL STROKE RES, V1, P48, DOI 10.1007/s12975-009-0004-x; He YD, 2009, J CEREBR BLOOD F MET, V29, P596, DOI 10.1038/jcbfm.2008.145; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Highstein SM, 2014, P NATL ACAD SCI USA, V111, P5421, DOI 10.1073/pnas.1319561111; Huang Y, 2015, NEUROPHARMACOLOGY, V94, P42, DOI 10.1016/j.neuropharm.2014.12.010; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jiang N, 2017, J CEREBR BLOOD F MET, V37, P528, DOI 10.1177/0271678X16630558; Kang PF, 2020, FREE RADICAL BIO MED, V146, P198, DOI 10.1016/j.freeradbiomed.2019.10.416; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; KILMARTIN JV, 1973, P NATL ACAD SCI USA, V70, P1246, DOI 10.1073/pnas.70.4.1246; Kopec AM, 2017, J NEUROSCI METH, V280, P64, DOI 10.1016/j.jneumeth.2017.02.002; Kori A, 2019, BRAIN DEV-JPN, V41, P803, DOI 10.1016/j.braindev.2019.05.006; Kosmachevskaya OV, 2018, BIOCHEMISTRY-MOSCOW+, V83, P1575, DOI 10.1134/S0006297918120155; Kumar NN, 2015, SCIENCE, V348, P1255, DOI 10.1126/science.aaa0922; Lam TI, 2013, P NATL ACAD SCI USA, V110, pE4362, DOI 10.1073/pnas.1313029110; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005705; Mezuki S, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-1001-4; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Musiek ES, 2013, J CLIN INVEST, V123, P5389, DOI 10.1172/JCI70317; Nakano T, 2019, THROMB HAEMOSTASIS, V119, P467, DOI 10.1055/s-0038-1677532; Nestler EJ, 2015, EUR J PHARMACOL, V753, P66, DOI [10.1016/j.ejphar.2014.1.0.034, 10.1016/j.ejphar.2014.10.034]; Ouyang Yi-Bing, 2012, Int J Cell Biol, V2012, P493934, DOI 10.1155/2012/493934; Patterson JR, 2016, BRAIN RES, V1649, P53, DOI 10.1016/j.brainres.2016.08.030; Pera T, 2018, FASEB J, V32, P862, DOI 10.1096/fj.201700555R; PERUTZ MF, 1987, COLD SPRING HARB SYM, V52, P555, DOI 10.1101/SQB.1987.052.01.063; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; Rajdev S, 2000, ANN NEUROL, V47, P782, DOI 10.1002/1531-8249(200006)47:6<782::AID-ANA11>3.0.CO;2-3; Rajput PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024467; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; REISBERG PI, 1980, J BIOL CHEM, V255, P4159; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; Sato K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74372-7; Schaffner A, 2004, J LEUKOCYTE BIOL, V76, P1010, DOI 10.1189/jlb.0404261; Scheich B, 2017, NEUROSCIENCE, V346, P320, DOI 10.1016/j.neuroscience.2017.01.039; Schelshorn DW, 2009, J CEREBR BLOOD F MET, V29, P585, DOI 10.1038/jcbfm.2008.152; Secondo A, 2019, STROKE, V50, P1240, DOI 10.1161/STROKEAHA.118.024115; Siddiqui SS, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101125; Siesjo B K, 1982, Ciba Found Symp, V87, P77, DOI 10.1002/9780470720691.ch5; SILVER IA, 1992, J CEREBR BLOOD F MET, V12, P759, DOI 10.1038/jcbfm.1992.107; Simoes AES, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-181; Singhal NK, 2018, MOL NEUROBIOL, V55, P8051, DOI 10.1007/s12035-018-0971-6; Stetler RA, 2010, PROG NEUROBIOL, V92, P184, DOI 10.1016/j.pneurobio.2010.05.002; Su YC, 2016, INT J NEUROSCI, V126, P681, DOI 10.3109/00207454.2015.1059836; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Ting SM, 2020, STROKE, V51, P958, DOI 10.1161/STROKEAHA.119.027315; TOMBAUGH GC, 1993, J NEUROCHEM, V61, P793, DOI 10.1111/j.1471-4159.1993.tb03589.x; Turrin NP, 2006, MOL NEUROBIOL, V34, P221, DOI 10.1385/MN:34:3:221; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang P, 2015, J NEUROSCI RES, V93, P1756, DOI 10.1002/jnr.23637; Wang T., 2020, BRAIN HEMORRHAGES, V1, p185; Wang T, 2020, STROKE, V51, P3690, DOI 10.1161/STROKEAHA.120.031479; Wang XY, 2002, STROKE, V33, P1882, DOI 10.1161/01.STR.0000020121.41527.5D; Watanabe-Kusunoki K, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.575890; Wei WC, 2018, CURR BIOL, V28, P3815, DOI 10.1016/j.cub.2018.10.046; Wei WC, 2015, P NATL ACAD SCI USA, V112, P10738, DOI 10.1073/pnas.1506085112; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wiley SZ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030559; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xu YY, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-020-00672-8; Xu YY, 2018, FASEB J, V32, P3832, DOI 10.1096/fj.201701367R; Yonetani T, 2008, BBA-PROTEINS PROTEOM, V1784, P1146, DOI 10.1016/j.bbapap.2008.04.025; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103; Zha XM, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-1; Zhang CJ, 2018, AGING DIS, V9, P249, DOI 10.14336/AD.2017.0424; Zhang WT, 2019, CNS NEUROSCI THER, V25, P1329, DOI 10.1111/cns.13256; Zhao XR, 2009, J NEUROSCI, V29, P15819, DOI 10.1523/JNEUROSCI.3776-09.2009; Zhong WL, 2018, EBIOMEDICINE, V37, P246, DOI 10.1016/j.ebiom.2018.10.041	92	6	6	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21461	10.1096/fj.202002511R	http://dx.doi.org/10.1096/fj.202002511R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33724568	Green Accepted			2022-12-26	WOS:000635216100093
J	Abdu, M; Ali, Y; Anteneh, S; Yesuf, M; Birhanu, A; Mohamed, S; Hussien, A				Abdu, Mehd; Ali, Yeshimebet; Anteneh, Samuel; Yesuf, Mohammed; Birhanu, Adane; Mohamed, Salih; Hussien, Adem			Determinant factors for the occurrence of tuberculosis after initiation of antiretroviral treatment among adult patients living with HIV at Dessie Referral Hospital, South Wollo, Northeast Ethiopia, 2020. A case-control study	PLOS ONE			English	Article								Introduction Globally, tuberculosis takes the first rank for the ill-health of people living with HIV/AIDS. Despite the favorable outcome of antiretroviral therapy, the risk of tuberculosis remains higher among HIV patients. This obliges to identify factors for its occurrence and further prevention of drug-resistant tuberculosis. There is a contradiction between different studies and studies conducted in Ethiopia studied poorly the association between adherence to antiretroviral therapy and viral load with tuberculosis. Studies conducted in the study area were limited to cross-sectional study design. Therefore, this study claimed to identify factors determining the occurrence of tuberculosis after initiation of antiretroviral therapy. Methods This study was conducted at Dessie Referral Hospital by using a case-control study design on a sample of 565 with a control: case ratio of 3:1. Participants from controls were selected by systematic random sampling and from cases by consecutive random sampling. The data were collected by interviewing through structured questionnaires and from the medical record. The data were entered into Epi data version 3.1. In the multivariable analysis, variables with a P-value of <= 0.05 were anticipated as independent determinant factors. Result Patients without separate kitchen (AOR: 3.547, 95% CI: 2.137, 5.888), having opportunistic infection (AOR: 3.728, 95% CI: 2.058, 6.753), CD4 count of <350 cells/mm3 (AOR: 3.383, 95% CI: 1.520, 7.528), baseline WHO stage III (AOR: 3.321, 95% CI: 1.688, 6.534) or IV (AOR: 2.900, 95% CI: 1.251, 6.722), don't taking IPT (AOR: 3.701, 95% CI: 2.228, 6.147) and those who were poorly adherent (AOR: 2.626, 95% CI: 1.272, 5.423) or moderately adherent (AOR: 3.455, 95% CI: 1.885, 6.335) to anti-retroviral therapy were more likely to develop tuberculosis after anti-retroviral therapy initiation. Conclusion Poor housing conditions, having an opportunistic infection, low CD4 count, starting ART at the advanced HIV stage, don't take IPT, and being poorly adherent to antiretroviral therapy were associated with the occurrence of TB after initiation of ART. The institution should screen for TB as early as possible and strictly follow their drug adherence.	[Abdu, Mehd; Yesuf, Mohammed] Mizan Tepi Univ, Coll Med & Hlth Sci, Dept Nursing, Mizan Teferi, Ethiopia; [Ali, Yeshimebet] Wollo Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Dessie, Ethiopia; [Anteneh, Samuel; Hussien, Adem] Wollo Univ, Coll Med & Hlth Sci, Dept Adult Hlth Nursing, Dessie, Ethiopia; [Birhanu, Adane] Debre Tabor Univ, Coll Med & Hlth Sci, Dept Nursing, Debre Tabor, Ethiopia; [Mohamed, Salih] Wollo Univ, Coll Med & Hlth Sci, Dept Anesthesia, Dessie, Ethiopia	University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar	Abdu, M (corresponding author), Mizan Tepi Univ, Coll Med & Hlth Sci, Dept Nursing, Mizan Teferi, Ethiopia.	mehdabdu@gmail.com	Abdu, Mehd/AAW-6969-2021; Nigat, Adane Birhanu/AAA-4723-2022	Abdu, Mehd/0000-0003-4078-5757; 				Adeoti AO, 2019, PAN AFR MED J, V33, DOI 10.11604/pamj.2019.33.277.18711; Ahmed A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-016961; Belew H., 2017, RES SQ; Dravid A, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4361-0; Fauci AS, 2012, HARRISONS PRINCIPLES; Federal Ministry of Health, 2017, NATL GUIDELINES COMP; Federal Ministry of Health, 2017, NATL COMPREHENSIVE H; Federal Ministry of Health, 2014, NATL GUIDELINES COMP; Federal Ministry of Health, 2016, NATL COMPREHENSIVE T; Federal Ministry of Health, 2018, NATL COMPREHENSIVE H; Federal Ministry of Health, 2017, NATL COMPREHENSIVE T; Fitzpatrick ME, 2018, AIDS, V32, P277, DOI 10.1097/QAD.0000000000001712; Global Adult Tobacco Survey Collaborative Group, 2011, TOBACCO QUESTIONS SU, V2nd ed; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Ismail I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073250; Kibret KT., 2013, PLOS ONE, V8; Liu EJ, 2015, AIDS, V29, P1391, DOI 10.1097/QAD.0000000000000705; Mama Mohammedaman, 2018, Open Microbiol J, V12, P163, DOI 10.2174/1874285801812010163; Melkamu H, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/279876; Meriki HD., 2019, INT J HIVAIDS PREV E, V5, P82; Mesfin EA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197737; Mitku AA, 2016, AFR HEALTH SCI, V16, P588, DOI 10.4314/ahs.v16i2.29; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Siika AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053022; Singh Y. K., 2006, FUNDAMENTALS RES MET; Temesgen B, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7912-9; Teni FS, 2015, ANN MED HEALTH SCI R, V5, P454, DOI 10.4103/2141-9248.177992; Tesfaye B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203986; WHO, 2020, GLOB TUB REP; World Health Organization, 2016, CONS GUID US ANT DRU; World Health Organization, 2021, 10 THREATS GLOB HLTH; Yirdaw KD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211688	32	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0248490	10.1371/journal.pone.0248490	http://dx.doi.org/10.1371/journal.pone.0248490			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY1VJ	33724992	Green Published, gold			2022-12-26	WOS:000629833700012
J	Ma, RF; Huang, B; Chen, JL; Huang, ZN; Yu, PY; Ruan, SY; Zhang, ZJ				Ma, Ruifang; Huang, Bin; Chen, Jialu; Huang, Zhinuo; Yu, Peiyao; Ruan, Shiyu; Zhang, Zhijun			Genome-wide identification and expression analysis of dirigent-jacalin genes from plant chimeric lectins in Moso bamboo (Phyllostachys edulis)	PLOS ONE			English	Article							GLUCOSIDASE-AGGREGATING FACTOR; MANNOSE-BINDING LECTIN; FUNCTIONAL-ANALYSIS; MOLECULAR-CLONING; FAMILY GENES; WHEAT; PROTEINS; DEFENSE; DOMAIN; REVEALS	Dirigent-jacalin (D-J) genes belong to the plant chimeric lectin family, and play vital roles in plant growth and resistance to abiotic and biotic stresses. To explore the functions of the D-J family in the growth and development of Moso bamboo (Phyllostachys edulis), their physicochemical properties, phylogenetic relationships, gene and protein structures, and expression patterns were analyzed in detail. Four putative PeD-J genes were identified in the Moso bamboo genome, and microsynteny and phylogenetic analyses indicated that they represent a new branch in the evolution of plant lectins. PeD-J proteins were found to be composed of a dirigent domain and a jacalin-related lectin domain, each of which contained two different motifs. Multiple sequence alignment and homologous modeling analysis indicated that the three-dimensional structure of the PeD-J proteins was significantly different compared to other plant lectins, primarily due to the tandem dirigent and jacalin domains. We surveyed the upstream putative promoter regions of the PeD-Js and found that they mainly contained cis-acting elements related to hormone and abiotic stress response. An analysis of the expression patterns of root, leaf, rhizome and panicle revealed that four PeD-J genes were highly expressed in the panicle, indicating that they may be required during the formation and development of several different tissue types in Moso bamboo. Moreover, PeD-J genes were shown to be involved in the rapid growth and development of bamboo shoots. Quantitative Real-time PCR (qRT PCR) assays further verified that D-J family genes were responsive to hormones and stresses. The results of this study will help to elucidate the biological functions of PeD-Js during bamboo growth, development and stress response.	[Ma, Ruifang; Huang, Bin; Chen, Jialu; Huang, Zhinuo; Yu, Peiyao; Ruan, Shiyu; Zhang, Zhijun] Zhejiang A&F Univ, State Key Lab Subtrop Forest Cultivat, Hangzhou, Zhejiang, Peoples R China; [Ma, Ruifang; Huang, Bin; Chen, Jialu; Huang, Zhinuo; Yu, Peiyao; Ruan, Shiyu; Zhang, Zhijun] Zhejiang A&F Univ, Sch Forestry & Biotechnol, Hangzhou, Zhejiang, Peoples R China	Zhejiang A&F University; Zhejiang A&F University	Zhang, ZJ (corresponding author), Zhejiang A&F Univ, State Key Lab Subtrop Forest Cultivat, Hangzhou, Zhejiang, Peoples R China.; Zhang, ZJ (corresponding author), Zhejiang A&F Univ, Sch Forestry & Biotechnol, Hangzhou, Zhejiang, Peoples R China.	zjzhang@zafu.edu.cn			National Natural Science Foundation of China (NSFC) [31770721]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (NSFC, Project grant: 31770721). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe T, 2005, PLANTA, V221, P170, DOI 10.1007/s00425-004-1429-9; Andrade LM, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00065; Azarkan M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29439-x; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Balciunaite G, 2020, TOXINS, V12, DOI 10.3390/toxins12020088; Bourne Y, 1999, STRUCTURE, V7, P1473, DOI 10.1016/S0969-2126(00)88338-0; Chang WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040618; Chen CJ, 2020, MOL PLANT, V13, P1194, DOI 10.1016/j.molp.2020.06.009; Chen Y, 2002, FASEB J, V16, P905, DOI 10.1096/fj.01-0598fje; Cheng X, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00136; Cheng YQ, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01465; Chronopoulou L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54852-1; del Sol FG, 2005, J MOL BIOL, V353, P574, DOI 10.1016/j.jmb.2005.08.055; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eggermont L, 2018, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02218; Esch L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071592; Esen A, 2000, PLANT PHYSIOL, V122, P563, DOI 10.1104/pp.122.2.563; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020; Hu ZJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00469; Jia F, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24563; Jia XY, 2008, J EXP BOT, V59, P739, DOI 10.1093/jxb/erm369; Jiang B, 2019, POLYMERS-BASEL, V11, DOI 10.3390/polym11050785; Jiang JF, 2006, TOXICON, V47, P133, DOI 10.1016/j.toxicon.2005.10.010; Jiang SY, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-79; Jung IJ, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-2056-8; Khan Fauzia, 2002, Med Sci Monit, V8, pRA293; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kittur FS, 2010, PLANT PHYSIOL BIOCH, V48, P731, DOI 10.1016/j.plaphy.2010.03.007; Kulahoglu C, 2014, METHODS MOL BIOL, V1158, P71, DOI 10.1007/978-1-4939-0700-7_5; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lannoo N, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00397; Lannoo N, 2010, BBA-GEN SUBJECTS, V1800, P190, DOI 10.1016/j.bbagen.2009.07.021; Lee X, 1998, J BIOL CHEM, V273, P6312, DOI 10.1074/jbc.273.11.6312; Leng F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082300; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li F, 2018, PLANT PHYSIOL BIOCH, V130, P431, DOI 10.1016/j.plaphy.2018.07.033; Li F, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00582; Li HJM, 2005, PLANT PHYSIOL, V138, P2386, DOI 10.1104/pp.105.063297; Li L, 2018, PLANT BIOTECHNOL J, V16, P72, DOI 10.1111/pbi.12750; Liu WZ, 2015, BIOINFORMATICS, V31, P3359, DOI 10.1093/bioinformatics/btv362; Ma QH, 2014, CRIT REV BIOTECHNOL, V34, P300, DOI 10.3109/07388551.2013.793650; Ma QH, 2013, BIOCHIMIE, V95, P359, DOI 10.1016/j.biochi.2012.10.014; Ma QH, 2010, BIOCHIMIE, V92, P187, DOI 10.1016/j.biochi.2009.11.008; Meagher JL, 2005, GLYCOBIOLOGY, V15, P1033, DOI 10.1093/glycob/cwi088; Nagano AJ, 2008, PLANT CELL PHYSIOL, V49, P969, DOI 10.1093/pcp/pcn075; Nobile PM, 2017, MOL GENET GENOMICS, V292, P1323, DOI 10.1007/s00438-017-1349-6; Pan F, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3882-4; Peng ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078944; Peng ZH, 2013, NAT GENET, V45, P456, DOI 10.1038/ng.2569; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; Peumans WJ, 2000, FEBS LETT, V477, P186, DOI 10.1016/S0014-5793(00)01801-9; Pickel B, 2012, FEBS J, V279, P1980, DOI 10.1111/j.1742-4658.2012.08580.x; Ralph S, 2006, PLANT MOL BIOL, V60, P21, DOI 10.1007/s11103-005-2226-y; Ramakrishnan M, 2020, FOOD ENERGY SECUR, V9, DOI 10.1002/fes3.229; Rauf I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41833-7; Raval S, 2004, GLYCOBIOLOGY, V14, P1247, DOI 10.1093/glycob/cwh140; Rouge P, 2003, BIOCHEM BIOPH RES CO, V304, P91, DOI 10.1016/S0006-291X(03)00538-2; Sankaranarayanan R, 1996, NAT STRUCT BIOL, V3, P596, DOI 10.1038/nsb0796-596; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Song M, 2014, PLANT MOL BIOL, V84, P95, DOI 10.1007/s11103-013-0121-5; Subramanyam S, 2006, PLANT SCI, V170, P90, DOI 10.1016/j.plantsci.2005.08.006; Subramanyam S, 2008, PLANT PHYSIOL, V147, P1412, DOI 10.1104/pp.108.116145; Tan CM, 2013, INT J MOL SCI, V14, P20204, DOI 10.3390/ijms141020204; Tao GY, 2020, TREE PHYSIOL, V40, P1487, DOI 10.1093/treephys/tpaa090; Tateno H, 2003, J BIOL CHEM, V278, P10891, DOI 10.1074/jbc.M211840200; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Van Damme EJM, 1998, CRIT REV PLANT SCI, V17, P575, DOI 10.1016/S0735-2689(98)00365-7; Van Damme EJM, 2002, PLANT PHYSIOL, V130, P757, DOI 10.1104/pp.005892; Van Damme EJM, 2008, ADV BOT RES, V48, P107, DOI 10.1016/S0065-2296(08)00403-5; Van Holle S, 2018, BIOCHEM SOC T, V46, P217, DOI 10.1042/BST20170371; Van Holle S, 2015, MOLECULES, V20, P2868, DOI 10.3390/molecules20022868; Vandenborre G, 2010, J EXP BOT, V61, P1003, DOI 10.1093/jxb/erp365; Wang TT, 2017, PLANT J, V91, P684, DOI 10.1111/tpj.13597; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wang YS, 2019, PLANT CELL PHYSIOL, V60, P1354, DOI 10.1093/pcp/pcz043; Wang YJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192382; Wang ZM, 2013, INT J MOL SCI, V14, P20299, DOI 10.3390/ijms141020299; Wei H, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00106; Weidenbach D, 2016, MOL PLANT, V9, P514, DOI 10.1016/j.molp.2015.12.009; Wilkins MR, 1999, METH MOL B, V112, P531; Wu RH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174309; Xiang Y, 2011, J EXP BOT, V62, P5471, DOI 10.1093/jxb/err226; Xing LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004854; Xu WW, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112436; Yang KB, 2019, PEERJ, V6, DOI 10.7717/peerj.6242; Zhang WL, 2000, PLANTA, V210, P970, DOI 10.1007/s004250050705; Zhang YT, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1394-2; Zhao HS, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy115; Zhou AM, 2018, HORTIC RES-ENGLAND, V5, DOI 10.1038/s41438-018-0044-z	90	3	3	7	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0248318	10.1371/journal.pone.0248318	http://dx.doi.org/10.1371/journal.pone.0248318			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY1VJ	33724993	gold, Green Published			2022-12-26	WOS:000629833700001
J	Park, I; Kim, SJ; Shin, D; Shim, SR; Chang, HK; Kim, CH				Park, Il Woo; Kim, Su Jin; Shin, Dongseong; Shim, Sung Ryul; Chang, Hyun Kyung; Kim, Chang Hee			Radiation exposure to the urology surgeon during retrograde intrarenal surgery	PLOS ONE			English	Article								Retrograde intrarenal surgery is a common procedure that carries a risk of radiation exposure for urologists. This study aimed to measure the amount of radiation that urologists are exposed to during surgery, and to estimate how many procedures can be safely performed by one urologist per year. Variables that affect radiation exposure were also identified. Radiation exposure doses were measured for the eye, neck, chest, arms, and hands of a urologist who performed 226 retrograde intrarenal surgeries. To determine how many procedures could be safely performed per year, the Annual Permissible Occupational Exposure Radiation Dose Guidelines of the National Council on Radiation Protection and Measurements were consulted. Correlations between radiation exposure dose and the patient's age, sex, body mass index, stone number/burden/laterality/location/Hounsfield unit, and their renal calculi were calculated. The mean surgery and fluoroscopy durations were 83.2 and 5.13 min; the mean tube voltage and current were 68.88 kV and 2.48 mA, respectively. Cumulative radiation doses for the eye, neck, chest, right upper arm, left hand, and right hand were 65.53, 69.95, 131.79, 124.43, 165.66, and 126.64 mSv, respectively. Radiation reduction rates for lead collars and aprons were 97% and 98%, respectively. If the urologists wear only radiation shields and lead apron but do not wear safety glasses during RIRS, the recommended by the ICRP publication 103 is taken into consideration, our results showed that 517 RIRS can be performed per year safely. However, if no protective measures are taken, this number decreases to only 85 RIRS per year. At all measurement sites, significant correlations were observed between the radiation exposure dose and stone numbers and Hounsfield unit values. In conclusion, it is imperative that urologists wear protective gear. Greater effort should be made to reduce radiation exposure when renal calculi have a large number of stones or large Hounsfield unit values.	[Park, Il Woo; Kim, Chang Hee] Gachon Univ, Gil Med Ctr, Dept Urol, Coll Med, Incheon, South Korea; [Kim, Su Jin] Yonsei Univ, Dept Urol, Wonju Coll Med, Wonju, South Korea; [Shin, Dongseong] Gachon Univ, Dept Pharmacol, Coll Med, Incheon, South Korea; [Shin, Dongseong] Gachon Univ, Gil Med Ctr, Clin Trials Ctr, Incheon, South Korea; [Shim, Sung Ryul] Korea Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Chang, Hyun Kyung] Catholic Kwandong Univ, Int St Marys Hosp, Dept Urol, Incheon, South Korea	Gachon University; Yonsei University; Gachon University; Gachon University; Korea University; Korea University Medicine (KU Medicine); Catholic Kwandong University	Kim, CH (corresponding author), Gachon Univ, Gil Med Ctr, Dept Urol, Coll Med, Incheon, South Korea.	budee@gilhospital.com	shim, sungryul/D-3792-2016	shim, sungryul/0000-0003-4143-7383	Gachon University Gil Medical Center [FRD2018-01]	Gachon University Gil Medical Center	This work was supported by the Gachon University Gil Medical Center (Grant number: FRD2018-01). The funders had no role in our study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboumarzouk OM, 2012, J ENDOUROL, V26, P1257, DOI 10.1089/end.2012.0217; AGARWAL SK, 1978, RADIOLOGY, V129, P810, DOI 10.1148/129.3.810; Beir V., 1990, HLTH EFFECTS EXPOSUR, P22; Bindal RK, 2008, J NEUROSURG-SPINE, V9, P570, DOI 10.3171/SPI.2008.4.08182; Cho SY, 2016, J KOREAN MED ASSOC, V59, P459, DOI 10.5124/jkma.2016.59.6.459; Chubak B, 2014, CUAJ-CAN UROL ASSOC, V8, pE862, DOI 10.5489/cuaj.2154; Compagnone G, 2005, J APPL CLIN MED PHYS, V6, P101, DOI 10.1120/jacmp.2023.25326; Do K-H, 2011, TAEHAN UIHAK HYOPHOE, V54; Fabrizio MD, 1998, J UROLOGY, V159, P1139, DOI 10.1016/S0022-5347(01)63531-6; FAULKNER K, 1993, HEALTH PHYS, V64, P502, DOI 10.1097/00004032-199305000-00007; Finkelstein MM, 1998, CAN J CARDIOL, V14, P1385; Foti C, 2008, RADIAT PROT DOSIM, V129, P100, DOI 10.1093/rpd/ncn038; Hellawell GO, 2005, J UROLOGY, V174, P948, DOI 10.1097/01.ju.0000170232.58930.8f; ICRP, 2012, Ann ICRP, V41 Suppl 1, P1, DOI 10.1016/j.icrp.2012.06.038; Jensen K, 2011, CARDIOVASC INTER RAD, V34, P717, DOI 10.1007/s00270-010-0017-6; Jornet N., 2004, DETERMINATION ENTRAN; Jung JW, 2014, UROLITHIASIS, V42, P335, DOI 10.1007/s00240-014-0650-7; Klein LW, 2009, RADIOLOGY, V250, P538, DOI 10.1148/radiol.2502082558; Kuroda S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192597; Lim SH, 2010, KOREAN J UROL, V51, P777, DOI 10.4111/kju.2010.51.11.777; Manchikanti Laxmaiah, 2003, BMC Anesthesiol, V3, P2; MATANOSKI GM, 1975, AM J EPIDEMIOL, V101, P199, DOI 10.1093/oxfordjournals.aje.a112087; NIKLASON LT, 1994, HEALTH PHYS, V67, P611, DOI 10.1097/00004032-199412000-00003; Olvera-Posada D, 2015, J UROLOGY, V194, P1646, DOI 10.1016/j.juro.2015.06.095; Padovani R, 2001, RADIAT PROT DOSIM, V94, P193, DOI 10.1093/oxfordjournals.rpd.a006471; Rana RS, 2020, INT UROL NEPHROL, V52, P1637, DOI 10.1007/s11255-020-02442-w; Resorlu B, 2012, UROLOGY, V80, P512, DOI 10.1016/j.urology.2012.02.072; Schauer DA, 2009, HEALTH PHYS, V97, P1, DOI 10.1097/01.HP.0000356672.44380.b7; Schueler BA, 2010, TECH VASC INTERV RAD, V13, P167, DOI 10.1053/j.tvir.2010.03.005; Shabon M., 2013, J NUCL RAD PHYS, V8, P35; Sont WN, 2001, AM J EPIDEMIOL, V153, P309, DOI 10.1093/aje/153.4.309; Stoeckelhuber BM, 2005, CARDIOVASC INTER RAD, V28, P589, DOI 10.1007/s00270-005-0104-2; Thurston J, 2010, PHYS MED BIOL, V55; Tung Chuan-Jong, 1999, Proceedings of the National Science Council Republic of China Part B Life Sciences, V23, P107; Wang JX, 2002, HEALTH PHYS, V82, P455, DOI 10.1097/00004032-200204000-00004; Williams JR, 1997, BRIT J RADIOL, V70, P498, DOI 10.1259/bjr.70.833.9227232; Wrixon AD, 2008, J RADIOL PROT, V28, P161, DOI 10.1088/0952-4746/28/2/R02; Xiao YL, 2017, BMC UROL, V17, DOI 10.1186/s12894-017-0297-0; Xu Y, 2018, UROLITHIASIS, V46, P197, DOI 10.1007/s00240-017-0961-6; Zablotska LB, 2004, RADIAT RES, V161, P633, DOI 10.1667/RR3170; Zablotska LB, 2003, ANAL MORTALITY EXPER, DOI [10.1002/cncr.11214, DOI 10.1002/CNCR.11214]; 박진성, 2006, Investigative and Clinical Urology, V47, P1315	42	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0247833	10.1371/journal.pone.0247833	http://dx.doi.org/10.1371/journal.pone.0247833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720938	Green Published, gold			2022-12-26	WOS:000629667400015
J	Chalard, K; Szabo, V; Pavillard, F; Djanikian, F; Dargazanli, C; Molinari, N; Manna, F; Costalat, V; Chanques, G; Perrigault, PF				Chalard, Kevin; Szabo, Vivien; Pavillard, Frederique; Djanikian, Flora; Dargazanli, Cyril; Molinari, Nicolas; Manna, Federico; Costalat, Vincent; Chanques, Gerald; Perrigault, Pierre-Francois			Long-term outcome in patients with aneurysmal subarachnoid hemorrhage requiring mechanical ventilation	PLOS ONE			English	Article								Background Patients affected with aneurysmal subarachnoid hemorrhage (aSAH) often require intensive care, and then present distinctive outcome from less severe patients. We aimed to specify their long-term outcome and to identify factors associated with poor outcome. Methods We conducted a retrospective study in a French university hospital intensive care unit. Patients with aSAH requiring mechanical ventilation hospitalized between 2010 and 2015 were included. At least one year after initial bleeding, survival and degree of disability were assessed using the modified Rankin Scale (mRS) via telephone interviews. A multivariable logistic regression analysis was performed to determine independent factors associated with poor outcome defined as mRS >= 3. Results Two-hundred thirty-six patients were included. Among them, 7 were lost to follow-up, and 229 were analyzed: 73 patients (32%) had a good outcome (mRS<3), and 156 (68%) had a poor outcome (mRS >= 3). The estimated 1-year survival rate was 63%. One-hundred sixty-three patients patients (71%) suffered from early brain injuries (EBI), 33 (14%) from rebleeding, 80 (35%) from vasospasm and 63 (27%) from delayed cerebral ischemia (DCI). Multivariable logistic regression identified independent factors associated with poor outcome including delay between aSAH diagnosis and mRS assessment (OR, 0.96; 95% CI, 0.95-0.98; p<.0001), age (OR per 10 points, 1.57; 95% CI, 1.12-2.19; p = 0.008), WFNS V versus WFNS III (OR, 5.71; 95% CI 1.51-21.61; p = 0.004), subarachnoid rebleeding (OR, 6.47; 95% CI 1.16-36.06; p = 0.033), EBI (OR, 4.52; 95% CI 1.81-11.29; p = 0.001) and DCI (OR, 4.73; 95% CI, 1.66-13.49; p = 0.004). Conclusion Among aSAH patients requiring assisted ventilation, two-third of them survived at one year, and one-third showed good long-term outcome. As it appears as an independant factor associated with poor outcome, DCI shoud retain particular attention in future studies beyond angiographic vasospasm.	[Chalard, Kevin; Szabo, Vivien; Pavillard, Frederique; Djanikian, Flora; Perrigault, Pierre-Francois] Gui Chauliac Univ Hosp Montpellier, Dept Crit Care Med & Anesthesiol DAR C, Montpellier, France; [Chalard, Kevin; Szabo, Vivien] Univ Montpellier, INSERM, CNRS, IGF, Montpellier, France; [Dargazanli, Cyril; Costalat, Vincent] Gui Chauliac Univ Hosp Montpellier, Dept Neuroradiol, Montpellier, France; [Molinari, Nicolas] Univ Montpellier, CHU Montpellier, CNRS, IMAG, Montpellier, France; [Manna, Federico] Univ Hosp Montpellier, Epidemiol & Clin Res Dept, Montpellier, France; [Chanques, Gerald] St Eloi Univ Hosp Montpellier, Dept Crit Care Med & Anesthesiol DAR B, Montpellier, France; [Chanques, Gerald] Univ Montpellier, CNRS, INSERM, PhyMedExp, Montpellier, France	Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Chalard, K (corresponding author), Gui Chauliac Univ Hosp Montpellier, Dept Crit Care Med & Anesthesiol DAR C, Montpellier, France.; Chalard, K (corresponding author), Univ Montpellier, INSERM, CNRS, IGF, Montpellier, France.	k-chalard@chu-montpellier.fr		Szabo, Vivien/0000-0002-0079-7596; Chalard, Kevin/0000-0002-0727-064X				Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Ayling OGS, 2016, STROKE, V47, P2945, DOI 10.1161/STROKEAHA.116.014794; Bashir A, 2016, NEURORADIOL J, V29, P72, DOI 10.1177/1971400915626429; Bruno A, 2011, STROKE, V42, P2276, DOI 10.1161/STROKEAHA.111.613273; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Cinotti R, 2019, ANAESTH CRIT CARE PA, V38, P251, DOI 10.1016/j.accpm.2018.10.002; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; D'Andrea A, 2016, J CARDIOVASC ECHOGR, V26, P28, DOI 10.4103/2211-4122.183746; de Oliveira Manoel AL, 2016, NEUROCRIT CARE, V25, P338, DOI 10.1007/s12028-016-0305-3; Fraticelli AT, 2008, STROKE, V39, P893, DOI 10.1161/STROKEAHA.107.492447; Friedrich B, 2012, J CEREBR BLOOD F MET, V32, P447, DOI 10.1038/jcbfm.2011.154; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; Galea JP, 2017, STROKE, V48, P2958, DOI 10.1161/STROKEAHA.117.017777; Goncalves B, 2018, WORLD NEUROSURG, V115, pE292, DOI 10.1016/j.wneu.2018.04.037; Hoh BL, 2005, NEUROSURG CLIN N AM, V16, P501, DOI 10.1016/j.nec.2005.04.004; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Inamasu J, 2016, J CLIN NEUROSCI, V33, P142, DOI 10.1016/j.jocn.2016.03.035; Lindegaard K F, 1988, Acta Neurochir Suppl (Wien), V42, P81; Macdonald RL, 2014, NAT REV NEUROL, V10, P44, DOI 10.1038/nrneurol.2013.246; Manoel ALD, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1193-9; Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Ostergaard L, 2013, J CEREBR BLOOD F MET, V33, P1825, DOI 10.1038/jcbfm.2013.173; RANKIN J, 1957, Scott Med J, V2, P200; Rowland MJ, 2012, BRIT J ANAESTH, V109, P315, DOI 10.1093/bja/aes264; Schmidt JM, 2007, NEUROCRIT CARE, V7, P10, DOI 10.1007/s12028-007-0003-2; Schwartz C, 2017, NEUROSURGERY, V80, P967, DOI 10.1093/neuros/nyw138; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Terpolilli NA, 2015, STROKE, V46, P3014, DOI 10.1161/STROKEAHA.115.006353; Toulouse E, 2018, ANAESTH CRIT CARE PA, V37, P607, DOI 10.1016/j.accpm.2018.10.013; Udy AA, 2017, CRIT CARE MED, V45, pE138, DOI 10.1097/CCM.0000000000002059; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275	34	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0247942	10.1371/journal.pone.0247942	http://dx.doi.org/10.1371/journal.pone.0247942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711023	Green Published, gold			2022-12-26	WOS:000629591800001
J	Baldwin, SL; Reese, VA; Larsen, SE; Beebe, E; Guderian, J; Orr, MT; Fox, CB; Reed, SG; Coler, RN				Baldwin, Susan L.; Reese, Valerie A.; Larsen, Sasha E.; Beebe, Elyse; Guderian, Jeff; Orr, Mark T.; Fox, Christopher B.; Reed, Steven G.; Coler, Rhea N.			Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model	PLOS ONE			English	Article								An estimated 10 million people developed tuberculosis (TB) disease in 2019 which underscores the need for a vaccine that prevents disease and reduces transmission. The aim of our current studies is to characterize and test a prophylactic tuberculosis vaccine comprised of ID93, a polyprotein fusion antigen, and a liposomal formulation [including a synthetic TLR4 agonist (glucopyranosyl lipid adjuvant, GLA) and QS-21] in a preclinical mouse model of TB disease. Comparisons of the ID93+GLA-LSQ vaccines are also made to the highly characterized ID93+GLA-SE oil-in-water emulsion adjuvant, which are also included these studies. The recent success of vaccine candidate M72 combined with adjuvant AS01(E) (GlaxoSmithKline Biologicals) in reducing progression to active disease is promising and has renewed excitement for experimental vaccines currently in the TB vaccine pipeline. The AS01(E) adjuvant contains monophosphoryl lipid A (MPL) and QS-21 (a saponin) in a liposomal formulation. While AS01(E) has demonstrated potent adjuvant activity as a component of both approved and experimental vaccines, developing alternatives to this adjuvant system will become important to fill the high demand envisioned for future vaccine needs. Furthermore, replacement sources of potent adjuvants will help to supply the demand of a TB vaccine [almost one-quarter of the world's population are estimated to have latent Mycobacterium tuberculosis (Mtb) according to the WHO 2019 global TB report], addressing (a) cost of goods, (b) supply of goods, and (c) improved efficacy of subunit vaccines against Mtb. We show that both ID93+GLA-SE (containing an emulsion adjuvant) and ID93+GLA-LSQ (containing a liposomal adjuvant) induce ID93-specific TH1 cellular immunity including CD4+CD44+ T cells expressing IFN gamma, TNF, and IL-2 (using flow cytometry and intracellular cytokine staining) and vaccine-specific IgG2 antibody responses (using an ELISA). In addition, both ID93+GLA-SE and ID93+GLA-LSQ effectively decrease the bacterial load within the lungs of mice infected with Mtb. Formulations based on this liposomal adjuvant formulation may provide an alternative to AS01 adjuvant systems.	[Baldwin, Susan L.; Reese, Valerie A.; Larsen, Sasha E.; Coler, Rhea N.] Seattle Childrens Res Inst, Seattle, WA 98101 USA; [Beebe, Elyse; Guderian, Jeff; Orr, Mark T.; Fox, Christopher B.; Reed, Steven G.] Infect Dis Res Inst, Seattle, WA USA; [Fox, Christopher B.; Coler, Rhea N.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Beebe, Elyse] Umoja Biopharma, Seattle, WA USA; [Orr, Mark T.] Bristol Myers Squibb, Seattle, WA USA; [Reed, Steven G.] HDT Bio Corp, Seattle, WA USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; Bristol-Myers Squibb	Baldwin, SL (corresponding author), Seattle Childrens Res Inst, Seattle, WA 98101 USA.	Susan.Baldwin@seattlechildrens.org		Reese, Valerie/0000-0003-0847-7447	National Institute of Allergy and Infectious Diseases [R01AI125160, HHSN272200800045C]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the National Institute of Allergy and Infectious Diseases to SLB and RNC (R01AI125160) and RNC (HHSN272200800045C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar I, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17370; Achkar JM, 2015, IMMUNOL REV, V264, P167, DOI 10.1111/imr.12276; Alving CR, 2012, CURR OPIN IMMUNOL, V24, P310, DOI 10.1016/j.coi.2012.03.008; Baldwin SL, 2016, CLIN VACCINE IMMUNOL, V23, P137, DOI 10.1128/CVI.00458-15; Baldwin SL, 2012, J IMMUNOL, V188, P2189, DOI 10.4049/jimmunol.1102696; Barnes VL, 2017, AAPS PHARMSCITECH, V18, P2077, DOI 10.1208/s12249-016-0688-7; Bertholet S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001094; Carter D, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aas9930; Cauwelaert ND, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146372; Chan J, 2014, SEMIN IMMUNOL, V26, P588, DOI 10.1016/j.smim.2014.10.005; Choreno-Parra JA, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00226; Coccia M, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0027-3; Coer RN, 2015, J IMMUNOL, V195, P3190, DOI 10.4049/jimmunol.1501118; Coler RN, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0057-5; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Day CL, 2013, AM J RESP CRIT CARE, V188, P492, DOI 10.1164/rccm.201208-1385OC; Didierlaurent AM, 2017, EXPERT REV VACCINES, V16, P55, DOI 10.1080/14760584.2016.1213632; Didierlaurent AM, 2014, J IMMUNOL, V193, P1920, DOI 10.4049/jimmunol.1400948; Fox CB, 2017, IMMUNOPOTENTIATORS IN MODERN VACCINES, 2ND EDITION, P105, DOI 10.1016/B978-0-12-804019-5.00006-2; Ginsberg AM, 2019, EXPERT REV VACCINES, V18, P423, DOI 10.1080/14760584.2019.1593143; Hesseling AC, 2009, B WORLD HEALTH ORGAN, V87, P505, DOI 10.2471/BLT.08.055657; Jellison ER, 2005, J IMMUNOL, V174, P614, DOI 10.4049/jimmunol.174.2.614; JOUVINMARCHE E, 1989, IMMUNOGENETICS, V29, P92, DOI 10.1007/BF00395856; Kwon KW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52146-0; Lacaille-Dubois MA, 2019, PHYTOMEDICINE, V60, DOI 10.1016/j.phymed.2019.152905; Lu LL, 2016, CELL, V167, P433, DOI 10.1016/j.cell.2016.08.072; Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5; Misquith A, 2014, COLLOID SURFACE B, V113, P312, DOI 10.1016/j.colsurfb.2013.09.006; Mordmuller B, 2019, CLIN INFECT DIS, V69, P1509, DOI 10.1093/cid/ciy1140; Morrison C, 2015, NAT BIOTECHNOL, V33, P1015, DOI 10.1038/nbt1015-1015; Orr MT, 2014, J CONTROL RELEASE, V177, P20, DOI 10.1016/j.jconrel.2013.12.025; Orr MT, 2013, J CONTROL RELEASE, V172, P190, DOI 10.1016/j.jconrel.2013.07.030; Penn-Nicholson A, 2018, LANCET RESP MED, V6, P287, DOI [10.1016/S2213-2600(18)30077-8, 10.1016/s2213-2600(18)30077-8]; Qi YZ, 2021, J CHROMATOGR A, V1635, DOI 10.1016/j.chroma.2020.461705; Santini-Oliveira M, 2016, VACCINE, V34, P586, DOI 10.1016/j.vaccine.2015.10.027; Shanmugasundaram U, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.137858; Tait DR, 2019, NEW ENGL J MED, V381, P2429, DOI 10.1056/NEJMoa1909953; Talbot EA, 1997, CLIN INFECT DIS, V24, P1139, DOI 10.1086/513642; van den Berg RA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00564; Van der Meeren O, 2018, NEW ENGL J MED, V379, P1621, DOI 10.1056/NEJMoa1803484	40	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0247990	10.1371/journal.pone.0247990	http://dx.doi.org/10.1371/journal.pone.0247990			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705411	Green Published, gold			2022-12-26	WOS:000629590400020
J	Comins, J; Siersma, V; Couppe, C; Svensson, RB; Johansen, F; Malmgaard-Clausen, NM; Magnusson, SP				Comins, Jonathan; Siersma, Volkert; Couppe, Christian; Svensson, Rene B.; Johansen, Finn; Malmgaard-Clausen, Nikolaj M.; Magnusson, S. Peter			Assessment of content validity and psychometric properties of VISA-A for Achilles tendinopathy	PLOS ONE			English	Article								A recent COSMIN review found that the Victorian Institute of Sports Assessment-Achilles tendinopathy questionnaire (VISA-A) has flawed construct validity. The objective of the current study was to assess specifically the process of how VISA-A was constructed and validated, and whether the Danish version of VISA-A is a valid patient-reported outcome measure (PROM) for measuring the perceived impact of Achilles tendinopathy. The original item generation strategy for content validity and the process for confirming the scaling properties (construct validity) were examined. In addition, construct validity was evaluated directly using several psychometric methods (Rasch analysis, confirmatory factor analysis (CFA), and multivariable linear regression) in a cohort of 318 persons with Achilles tendinopathy with symptom duration groups ranging from less than 3 months to more than 1 year of chronicity, and a group of 120 healthy persons. We found that the item generation and item reduction in the original construction of VISA-A was based on literature review and clinician consensus with little or no patient involvement. We determined that 1) VISA-A consists of ambiguous conceptual item themes and thus lacks content validity, 2) there was no thorough investigation of the psychometric properties of the original version of VISA-A, which thus lacks construct validity, and 3) rigorous direct assessment of the psychometric properties of the Danish VISA-A revealed inadequate psychometric properties. In agreement with the COSMIN study, we conclude that when used as a single score, VISA-A is not an adequate scale for measuring self-reported impact of Achilles tendinopathy.	[Comins, Jonathan; Siersma, Volkert] Univ Copenhagen, Dept Publ Hlth, Res Unit Gen Practice, Copenhagen, Denmark; [Comins, Jonathan; Siersma, Volkert] Univ Copenhagen, Dept Publ Hlth, Sect Gen Practice, Copenhagen, Denmark; [Comins, Jonathan] Univ Copenhagen, Bispebjerg & Frederiksberg Hosp, Sect Sports Traumatol M51, Copenhagen, Denmark; [Couppe, Christian; Svensson, Rene B.; Johansen, Finn; Malmgaard-Clausen, Nikolaj M.; Magnusson, S. Peter] Univ Copenhagen, Bispebjerg Hosp, Inst Sports Med Copenhagen, Copenhagen, Denmark; [Couppe, Christian; Svensson, Rene B.; Johansen, Finn; Malmgaard-Clausen, Nikolaj M.; Magnusson, S. Peter] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark; [Couppe, Christian; Magnusson, S. Peter] Bispebjerg Hosp, Dept Phys & Occupat Therapy, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Magnusson, SP (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Inst Sports Med Copenhagen, Copenhagen, Denmark.; Magnusson, SP (corresponding author), Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark.; Magnusson, SP (corresponding author), Bispebjerg Hosp, Dept Phys & Occupat Therapy, Copenhagen, Denmark.	p.magnusson@sund.ku.dk	Magnusson, S. Peter/AAD-5903-2022; Svensson, Rene B./AGZ-3181-2022; Magnusson, Peter/AAN-1631-2020; Siersma, Volkert/G-6867-2016	Magnusson, S. Peter/0000-0002-4308-5484; Svensson, Rene B./0000-0002-1607-5379; Siersma, Volkert/0000-0003-1941-2681				ANDERSEN EB, 1973, PSYCHOMETRIKA, V38, P123, DOI 10.1007/BF02291180; Andrich D, 2004, DETECTION DIFFERENTI; Andrich D, 1988, RASCH MODELS MEASURE, DOI [10.1016/0005-2736(88)90260-x, DOI 10.1016/0005-2736(88)90260-X3337808]; Andrich D, 2011, J EDUC BEHAV STAT, V0, P1; Ortega-Avila AB, 2021, DISABIL REHABIL, V43, P1056, DOI 10.1080/09638288.2019.1652701; Beyer R, 2015, AM J SPORT MED, V43, P1704, DOI 10.1177/0363546515584760; Bjorner JB, 1998, J CLIN EPIDEMIOL, V51, P1189, DOI 10.1016/S0895-4356(98)00111-5; Borsboom D., 2005, MEASURING MIND, V2005; Brodersen J., 2007, J MED ECON, V10, P309, DOI [10.3111/13696990701557048, DOI 10.3111/13696990701557048]; Brodersen JD L., 2013, WRITING HLTH RELATED; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; Comins JD, 2013, SCAND J MED SCI SPOR, V23, pE293, DOI 10.1111/sms.12079; Hambleton RK, 2006, MED CARE, V44, pS182, DOI 10.1097/01.mlr.0000245443.86671.c4; Hernandez-Sanchez S, 2018, J ORTHOP SPORT PHYS, V48, P111, DOI 10.2519/jospt.2018.7402; Hjerrild JN, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061409; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iversen JV, 2016, SCAND J MED SCI SPOR, V26, P1423, DOI 10.1111/sms.12576; Iversen JV, 2012, INT J SPORTS PHYS TH, V7, P76; Luce RD, 1996, J MATH PSYCHOL, V40, P78, DOI 10.1006/jmps.1996.0005; Mallows A, 2018, BRIT J SPORT MED, V52, P1221, DOI 10.1136/bjsports-2017-097531; MESSICK S, 1980, AM PSYCHOL, V35, P1012, DOI 10.1037/0003-066X.35.11.1012; Murphy M, 2018, INT J SPORTS PHYS TH, V13, P283, DOI 10.26603/ijspt20180283; Muthen B, 2006, TWIN RES HUM GENET, V9, P313, DOI 10.1375/183242706777591317; Pallant JF, 2007, BRIT J CLIN PSYCHOL, V46, P1, DOI 10.1348/014466506X96931; Rasch G., 1960, PROBABILISTIC MODELS; Robinson JM, 2001, BRIT J SPORT MED, V35, P335, DOI 10.1136/bjsm.35.5.335; Robinson M, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0680-5; SB AndrichD, 2010, RASCH MODELS MEASURE; Silbernagel KG, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-12; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]	30	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0247152	10.1371/journal.pone.0247152	http://dx.doi.org/10.1371/journal.pone.0247152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8JZ	33705412	Green Published, gold			2022-12-26	WOS:000629590400076
J	Dahl, TM; Reed, M; Gerstner, CD; Ying, GX; Baehr, W				Dahl, Tiffanie M.; Reed, Michelle; Gerstner, Cecilia D.; Ying, Guoxin; Baehr, Wolfgang			Effect of conditional deletion of cytoplasmic dynein heavy chain DYNC1H1 on postnatal photoreceptors	PLOS ONE			English	Article								Cytoplasmic dynein (dynein 1), a major retrograde motor of eukaryotic cells, is a 1.4 MDa protein complex consisting of a pair of heavy chains (DYNC1H1) and a set of heterodimeric noncatalytic accessory components termed intermediate, light intermediate and light chains. DYNC1H1 (4644 amino acids) is the dynein backbone encoded by a gene consisting of 77 exons. We generated a floxed Dync1h1 allele that excises exons 24 and 25 and truncates DYNC1H1 during Six3Cre-induced homologous recombination. Truncation results in loss of the motor and microtubule-binding domain. Dync1h1(F/F);Six3Cre photoreceptors degenerated rapidly within two postnatal weeks. In the postnatal day 6 (P6) Dync1h1(F/F);Six3Cre central retina, outer and inner nuclear layers were severely disorganized and lacked a recognizable outer plexiform layer (OPL). Although the gene was effectively silenced by P6, DYNC1H1 remnants persisted and aggregated together with rhodopsin, PDE6 and centrin-2-positive centrosomes in the outer nuclear layer. As photoreceptor degeneration is delayed in the Dync1h1(F/F);Six3Cre retina periphery, retinal lamination and outer segment elongation are in part preserved. DYNC1H1 strongly persisted in the inner plexiform layer (IPL) beyond P16 suggesting lack of clearance of the DYNC1H1 polypeptide. This persistence of DYNC1H1 allows horizontal, rod bipolar, amacrine and ganglion cells to survive past P12. The results show that cytoplasmic dynein is essential for retina lamination, nuclear positioning, vesicular trafficking of photoreceptor membrane proteins and inner/outer segment elaboration.	[Dahl, Tiffanie M.; Reed, Michelle; Gerstner, Cecilia D.; Ying, Guoxin; Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA; [Baehr, Wolfgang] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Dahl, Tiffanie M.; Reed, Michelle] Univ Utah, Neurosci Grad Program, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Baehr, W (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA.; Baehr, W (corresponding author), Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA.; Baehr, W (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	wbaehr@hsc.utah.edu		Dahl, Tiffanie/0000-0002-7088-2788; Baehr, Wolfgang/0000-0001-5003-9550	National Eye Institute [RO1EY08123]; Vision Research Training Grant at the University of Utah National Eye Institute [5T32 EY024234-06]; National Eye Institute, Core Vision Research Grant at the University of Utah National Eye Institute [P30 EY014800-16]; Retina Research Foundation , Houston; Research to Prevent Blindness (RPB; New York)	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Vision Research Training Grant at the University of Utah National Eye Institute; National Eye Institute, Core Vision Research Grant at the University of Utah National Eye Institute; Retina Research Foundation , Houston; Research to Prevent Blindness (RPB; New York)(Research to Prevent Blindness (RPB))	Funding Sources: WB RO1EY08123 National Eye Institute https://www.nei.nih.gov/WB 5T32 EY024234-06 Vision Research Training Grant at the University of Utah National Eye Institute https://www.nei.nih.gov/WB P30 EY014800-16. National Eye Institute, Core Vision Research Grant at the University of Utah National Eye Institute https://www.nei.nih.gov/WB Retina Research Foundation (Alice McPherson, MD), Houston. Unrestricted grants to the University of Utah Department of Ophthalmology from Research to Prevent Blindness (RPB; New York). The funders provided support in the form of author salaries [TMD, MR, CDG, GY, WB], but had no additional role in study design, data collection and analysis, decision to publish, or manuscript preparation. Specific roles of each author are articulated in the `author contributions' section.	Allan VJ, 2011, BIOCHEM SOC T, V39, P1169, DOI 10.1042/BST0391169; ANANT JS, 1992, J BIOL CHEM, V267, P687; Avasthi P, 2009, J NEUROSCI, V29, P14287, DOI 10.1523/JNEUROSCI.3976-09.2009; Barlowe CK, 2013, GENETICS, V193, P383, DOI 10.1534/genetics.112.142810; Baye LM, 2008, BRAIN RES, V1192, P29, DOI 10.1016/j.brainres.2007.05.021; Carter AP, 2016, CURR OPIN STRUC BIOL, V37, P62, DOI 10.1016/j.sbi.2015.12.003; Courchesne Stephanie L, 2011, PLoS One, V6, pe16753, DOI 10.1371/journal.pone.0016753; Diacou R, 2018, CELL REP, V25, P2510, DOI 10.1016/j.celrep.2018.10.106; Eschbach J, 2011, PHARMACOL THERAPEUT, V130, P348, DOI 10.1016/j.pharmthera.2011.03.004; Fei YJ, 2003, MOL VIS, V9, P31; Fogerty J, 2016, ADV EXP MED BIOL, V854, P209, DOI 10.1007/978-3-319-17121-0_28; Frederick JM, 2001, INVEST OPHTH VIS SCI, V42, P826; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Grotjahn DA, 2019, J BIOL CHEM, V294, P13202, DOI 10.1074/jbc.REV119.003095; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Hafezparast M, 2003, AMYOTROPH LATERAL SC, V4, P249, DOI 10.1080/14660820310016084; Hanke-Gogokhia C, 2018, MOL VIS, V24, P834; Hanke-Gogokhia C, 2017, J BIOL CHEM, V292, P21442, DOI 10.1074/jbc.RA117.000141; Hanke-Gogokhia C, 2016, J BIOL CHEM, V291, P7142, DOI 10.1074/jbc.M115.710954; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; HArgrave PA, 1982, PROGR RET RES, V1, P1; Harms MB, 2012, NEUROLOGY, V78, P1714, DOI 10.1212/WNL.0b013e3182556c05; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Insinna C, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-12; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Kong SS, 2013, CELL RES, V23, P835, DOI 10.1038/cr.2013.59; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Lewis TR, 2018, MOL BIOL CELL, V29, P180, DOI 10.1091/mbc.E17-08-0525; LI T, 1990, P NATL ACAD SCI USA, V87, P293, DOI 10.1073/pnas.87.1.293; Malicki J, 2004, CURR OPIN NEUROBIOL, V14, P15, DOI 10.1016/j.conb.2004.01.015; Masai I, 2003, DEVELOPMENT, V130, P2479, DOI 10.1242/dev.00465; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mitchell CK, 1995, EXP EYE RES, V61, P691, DOI 10.1016/S0014-4835(05)80020-X; Nandini S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48431-7; Nemet I, 2015, PROG MOL BIOL TRANSL, V132, P39, DOI 10.1016/bs.pmbts.2015.02.007; Ori-McKenney KM, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-26; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; QIN N, 1992, J BIOL CHEM, V267, P8458; Razafsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047180; Rich KA, 1997, J COMP NEUROL, V388, P47; Sabblah TT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20081-1; Schiavo G, 2013, TRENDS NEUROSCI, V36, P641, DOI 10.1016/j.tins.2013.08.001; Scoto M, 2015, NEUROLOGY, V84, P668, DOI 10.1212/WNL.0000000000001269; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Song H, 2014, INVEST OPHTH VIS SCI, V55, P2659, DOI 10.1167/iovs.13-13649; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Torisawa T, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00022; Tsujikawa M, 2007, P NATL ACAD SCI USA, V104, P14819, DOI 10.1073/pnas.0700178104; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; van Vliet C, 2003, PROG BIOPHYS MOL BIO, V83, P1, DOI 10.1016/S0079-6107(03)00019-1; Vecino E, 2016, PROG RETIN EYE RES, V51, P1, DOI 10.1016/j.preteyeres.2015.06.003; Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Wei XY, 2002, NAT GENET, V31, P150, DOI 10.1038/ng883; Wu CH, 2016, DEV BIOL, V420, P79, DOI 10.1016/j.ydbio.2016.10.007; Ying GX, 2019, J BIOL CHEM, V294, P3957, DOI 10.1074/jbc.RA118.006371; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1976, INVEST OPHTH VISUAL, V15, P700; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Yu JH, 2011, HUM MOL GENET, V20, P1061, DOI 10.1093/hmg/ddq549; Zhang H, 2007, P NATL ACAD SCI USA, V104, P8857, DOI 10.1073/pnas.0701681104; Zhang HB, 2015, FASEB J, V29, P932, DOI 10.1096/fj.14-257915	63	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248354	10.1371/journal.pone.0248354	http://dx.doi.org/10.1371/journal.pone.0248354			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705456	gold, Green Published			2022-12-26	WOS:000629590400058
J	Lukesova, G; Voslarova, E; Vecerek, V; Vucinic, M				Lukesova, Gabriela; Voslarova, Eva; Vecerek, Vladimir; Vucinic, Marijana			Trends in intake and outcomes for European hedgehog (Erinaceus europaeus) in the Czech rescue centers	PLOS ONE			English	Article								The European hedgehog (Erinaceus europaeus) is a species found in abundance throughout Europe. Nevertheless, it has seen a decline in some regions. This study aimed to analyze trends in intake and outcomes for hedgehogs admitted into rescue centers in the Czech Republic. In the period from 2010 to 2019, 16,967 European hedgehogs were admitted in 34 rescue centers in the Czech Republic. Most hedgehogs were admitted in September (25.30%) and October (22.14%), the fewest in March (0.96%). Most admitted hedgehogs were hoglets (59.49%). The treatment was successful in 44.39% of admitted hedgehogs; those were subsequently released into the wild. On average, they stayed in rescue centers for 48.77 days (median of 30 days). Death or euthanasia was an outcome for 25.27% and 3.15% of admitted hedgehogs, respectively. Only 0.59% of the hedgehogs remained in captivity with a permanent handicap. The highest release rate was achieved in hedgehogs admitted after falls into pits and other openings (83.19%), whereas the least success was achieved in poisoned hedgehogs (13.21%). An increasing trend (rSp = 0.9273, p < 0.01) was found in the number of hedgehogs admitted to rescue centers during the monitored period. Furthermore, not all of them required human care. Given the fact that less than a half of the admitted hedgehogs could be released, raising public awareness of this issue could help to avoid unnecessary interventions (especially in hoglets).	[Lukesova, Gabriela; Voslarova, Eva; Vecerek, Vladimir] Univ Vet & Pharmaceut Sci Brno, Fac Vet Hyg & Ecol, Dept Anim Protect & Welf & Vet Publ Hlth, Brno, Czech Republic; [Vucinic, Marijana] Univ Belgrade, Fac Vet Med, Dept Anim Hyg, Belgrade, Serbia	University of Veterinary Sciences Brno; University of Belgrade	Lukesova, G (corresponding author), Univ Vet & Pharmaceut Sci Brno, Fac Vet Hyg & Ecol, Dept Anim Protect & Welf & Vet Publ Hlth, Brno, Czech Republic.	lukesovag@vfu.cz	Vucinic, Marijana/U-1299-2017	Vucinic, Marijana/0000-0002-3299-1107	Internal Creative Agency of the University of Veterinary and Pharmaceutical Sciences Brno [FVHE/Vecerek/ITA2020]	Internal Creative Agency of the University of Veterinary and Pharmaceutical Sciences Brno	This study was supported by the Internal Creative Agency of the University of Veterinary and Pharmaceutical Sciences Brno (Project No. FVHE/Vecerek/ITA2020).	Amori G, 2020, IUCN RED LIST THREAT; Molina-Lopez RA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181331; Bearman-Brown LE, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10091449; Bolfikova B, 2012, HEREDITY, V108, P248, DOI 10.1038/hdy.2011.67; BROEKHUIZEN S, 1980, J ZOOL, V191, P487, DOI 10.1111/j.1469-7998.1980.tb01480.x; Brown JD, 2002, J WILDLIFE DIS, V38, P699, DOI 10.7589/0090-3558-38.4.699; Bunnell T, 2002, J WILDLIFE REHABIL, V25, P11; Bunnell Toni, 2009, Lutra, V52, P15; Martinez JC, 2014, HYSTRIX, V25, P107, DOI 10.4404/hystrix-25.2-10248; Dowding CV, 2010, ANIM BEHAV, V80, P13, DOI 10.1016/j.anbehav.2010.04.007; Dowding CV, 2010, ENVIRON POLLUT, V158, P161, DOI 10.1016/j.envpol.2009.07.017; FOWLER PA, 1990, J COMP PHYSIOL B, V160, P299, DOI 10.1007/BF00302596; Gaglio G, 2010, EUR J WILDLIFE RES, V56, P839, DOI 10.1007/s10344-010-0381-1; Garces A, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10081305; Gazzard A, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10081344; Grogan A, 2013, VET REC, V172, P211, DOI 10.1136/vr.101139; Haigh A, 2014, ACTA THERIOL, V59, P165, DOI 10.1007/s13364-013-0142-0; Haigh A, 2012, ACTA THERIOL, V57, P321, DOI 10.1007/s13364-012-0080-2; Harris S, 2005, PRACTICAL WILDLIFE CARE, 2ND EDITION, P200; Harrison S, 1999, ECOGRAPHY, V22, P225, DOI 10.1111/j.1600-0587.1999.tb00496.x; Hof AR, 2016, EUR J WILDLIFE RES, V62, P407, DOI 10.1007/s10344-016-1013-1; Jackson DB, 2006, J ZOOL, V268, P303, DOI 10.1111/j.1469-7998.2005.00035.x; Jackson DB, 2000, BIOL CONSERV, V93, P333, DOI 10.1016/S0006-3207(99)00135-4; Jensen AB, 2004, ACTA THERIOL, V49, P145, DOI 10.1007/BF03192516; Jones C, 2005, NEW ZEAL J ECOL, V29, P29; Jones SA, 2020, J APPL ANIM WELF SCI, V23, P467, DOI 10.1080/10888705.2019.1672553; Kandir E. H., 2020, KOCATEPE VET J, DOI [10.30607/kvj.766330, DOI 10.30607/KVJ.766330]; Kirkwood J, 1998, IN PRACTICE, V20, P214; Lande R, 1998, RES POPUL ECOL, V40, P259, DOI 10.1007/BF02763457; Molony SE, 2006, BIOL CONSERV, V130, P530, DOI 10.1016/j.biocon.2006.01.015; MORRIS PA, 1993, ANIM WELFARE, V2, P53; MORRIS PA, 1988, J ZOOL, V214, P433, DOI 10.1111/j.1469-7998.1988.tb03751.x; Morris PA, 1998, VET REC, V143, P633; MORRIS PA, 1994, ANIM WELFARE, V3, P163; Morris PA, 1997, ANIM WELFARE, V6, P317; Mullineaux E., 2016, BSAVA MANUAL WILDLIF, V2nd; Naem S, 2015, VET RES FORUM, V6, P149; Orlowski G, 2004, POL J ECOL, V52, P377; Pettett CE, 2017, EUR J WILDLIFE RES, V63, DOI 10.1007/s10344-017-1113-6; Rasmussen SL, 2019, ECOL EVOL, V9, P13174, DOI 10.1002/ece3.5764; Rautio A, 2016, MAMMAL RES, V61, P161, DOI 10.1007/s13364-015-0256-7; Reeve N. J., 1999, Lutra, V42, P7; Republic C., 1992, COLLECTION LAW, V50, P1284; Robinson I, 1999, IN PRACTICE, V21, P128; Rondinini C, 2002, FUNCT ECOL, V16, P504, DOI 10.1046/j.1365-2435.2002.00651.x; SABOUREAU M, 1981, REPROD NUTR DEV, V21, P109, DOI 10.1051/rnd:19810110; Sainsbury AW, 1996, VET REC, V138, P61, DOI 10.1136/vr.138.3.61; Schenk AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093517; Sheriff MJ, 2011, P ROY SOC B-BIOL SCI, V278, P2369, DOI 10.1098/rspb.2010.2482; Vallefuoco R, 2013, J ZOO WILDLIFE MED, V44, P491, DOI 10.1638/2012-0193R1.1; van de Poel JL, 2015, WILDLIFE BIOL, V21, P51, DOI 10.2981/wlb.00072; Williams B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30130-4; Williams CT, 2014, J ZOOL, V292, P112, DOI 10.1111/jzo.12103; Woods M, 2003, MAMMAL REV, V33, P174, DOI 10.1046/j.1365-2907.2003.00017.x; YANES M, 1995, BIOL CONSERV, V71, P217, DOI 10.1016/0006-3207(94)00028-O	55	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248422	10.1371/journal.pone.0248422	http://dx.doi.org/10.1371/journal.pone.0248422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705491	Green Published, gold			2022-12-26	WOS:000629590400050
J	Shao, HW; Moller, M; Cai, L; Prokupets, R; Yang, CX; Costa, C; Yu, K; Le, N; Liu, ZJ				Shao, Hongwei; Moller, Mecker; Cai, Long; Prokupets, Rochelle; Yang, Cuixia; Costa, Connor; Yu, Kerstin; Le, Nga; Liu, Zhao-Jun			Converting melanoma-associated fibroblasts into a tumor-suppressive phenotype by increasing intracellular Notch1 pathway activity	PLOS ONE			English	Article							STROMAL FIBROBLASTS; METASTASIS; ACTIVATION; CANCER; INHIBITORS; THERAPY	Cancer-associated fibroblasts (CAFs) play a crucial role in cancer progression, drug resistance and tumor recurrence. We have recently shown that the Notch pathway determines the tumor-regulatory role of experimentally created 'CAFs'. Here, we examined the status of Notch signaling in human melanoma-associated fibroblasts (MAFs) versus their normal counterparts and tested whether manipulation of the Notch pathway activity in MAFs alters their tumor-regulatory function. Using tissue microarrays, we found that MAFs exhibit decreased Notch pathway activity compared with normal fibroblasts in adjacent and non-adjacent skin. Consistently, MAFs isolated from human metastatic melanoma exhibited lower Notch activity than did normal human fibroblasts, demonstrating that Notch pathway activity is low in MAFs. We then investigated the effect of increasing Notch pathway activity in MAF on melanoma growth in co-cultures and in a mouse co-graft model. We found that activation of the Notch pathway in MAFs significantly restricted melanoma cell growth in vitro and suppressed melanoma skin growth and tumor angiogenesis in vivo. Our study demonstrates that the Notch signaling is inhibited in MAFs. Increase of Notch pathway activity can confer tumor-suppressive function on MAFs. Thus, targeting melanoma by activating Notch signaling in MAF may represent a novel therapeutic approach.	[Shao, Hongwei; Moller, Mecker; Cai, Long; Prokupets, Rochelle; Yang, Cuixia; Costa, Connor; Yu, Kerstin; Le, Nga; Liu, Zhao-Jun] Univ Miami, Sch Med, Dept Surg, Miami, FL 33101 USA; [Cai, Long] Hangzhou Red Cross Hosp, Hangzhou, Zhejiang, Peoples R China; [Yang, Cuixia] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Mol Biol Lab, Shanghai, Peoples R China	University of Miami; Shanghai Jiao Tong University	Liu, ZJ (corresponding author), Univ Miami, Sch Med, Dept Surg, Miami, FL 33101 USA.	zliu@med.miami.edu		Costa, Connor/0000-0003-0916-8726; Liu, zhao-jun/0000-0002-2301-0768; Le, Nga/0000-0001-8142-6035; Shao, Hongwei/0000-0001-9770-4132	Bankhead-Coley Cancer Research Program [09BN-11]; Women's Cancer Association; University of Miami	Bankhead-Coley Cancer Research Program; Women's Cancer Association; University of Miami	This study was supported by Bankhead-Coley Cancer Research Program (Award#09BN-11), Women's Cancer Association and internal funds from the University of Miami to Z-J L.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; Ishikawa Y, 2008, ONCOGENE, V27, P6164, DOI 10.1038/onc.2008.216; Jessurun CAC, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00233; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Kudchadkar R, 2012, CANCER J, V18, P124, DOI 10.1097/PPO.0b013e31824b436e; Li G, 2001, CANCER RES, V61, P3819; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Liu ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038811; Liu ZJ, 2010, ANN SURG, V252, P625, DOI 10.1097/SLA.0b013e3181f5a079; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Meier F, 2000, AM J PATHOL, V156, P193, DOI 10.1016/S0002-9440(10)64719-0; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Pinchot SN, 2011, CANCER-AM CANCER SOC, V117, P1386, DOI 10.1002/cncr.25652; Pinnix CC, 2009, CANCER RES, V69, P5312, DOI 10.1158/0008-5472.CAN-08-3767; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Price J E, 2001, Methods Mol Med, V58, P205, DOI 10.1385/1-59259-137-X:205; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Shao H, 2011, ONCOGENE, V30, P4316, DOI 10.1038/onc.2011.142; Shao HW, 2016, ONCOTARGET, V7, P79248, DOI 10.18632/oncotarget.13021; Shao HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142815; Shao HW, 2012, ADV PHARMACOL, V65, P191, DOI 10.1016/B978-0-12-397927-8.00007-5; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sullivan RJ, 2014, BRIT J DERMATOL, V170, P36, DOI 10.1111/bjd.12698; Sullivan Ryan, 2015, Am Soc Clin Oncol Educ Book, P177, DOI 10.14694/EdBook_AM.2015.35.177; Sullivan RJ, 2013, CLIN CANCER RES, V19, P5283, DOI 10.1158/1078-0432.CCR-13-2151; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211; Zhang XHF, 2013, CELL, V154, P1060, DOI 10.1016/j.cell.2013.07.036	32	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248260	10.1371/journal.pone.0248260	http://dx.doi.org/10.1371/journal.pone.0248260			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705467	Green Published, gold			2022-12-26	WOS:000629590400054
J	Ruyani, A; Kartika, E; Parlindungan, D; Putra, RJ; Sundaryono, A; Susanta, A				Ruyani, Aceng; Kartika, Eda; Parlindungan, Deni; Putra, Riza Julian; Sundaryono, Agus; Susanta, Agus			Leaf ethanolic extract of Etlingera hemesphaerica Blume mitigates defects in fetal anatomy and endochondral ossification due to mercuric chloride during the post-implantation period in Mus musculus	PLOS ONE			English	Article								This study aimed to investigate the effectiveness of leaf ethanolic extract of Etlingera hemisphaerica (LE3H) in reducing defects in fetal anatomy and endochondral ossification in mice induced by HgCl2 during the post-implantation period. Pregnant mice were divided into four groups, each consisting of 10 dams, and received drink and food ad libitum. The first group was administered LE3H (E1), the second one HgCl2 (E2), the third one HgCl2+LE3H (E3), and the fourth was control (E0), administered double-distilled water only. HgCl2 (5 mg/kg bw) was administrated by injection intraperitoneally on gestation day (GD)9 and LE3H (0.39 mg/g bw) was administered by gavage on GD10. The treated and control animals were killed by cervical dislocation on GD18, dissected, and the morphologically normal living fetuses (MNLF) were collected. The MNLF of E0, E1, E2, and E3 from 5 dams were fixed with Bouin solution, and observed using the free hand razor blade technique for soft tissue examination. The remaining MNLF were fixed with 96% ethanol, and then stained with Alizarin Red S and Alcian Blue for ossification examination. Index of length of ossified part (ILOP) of humerus, index of width of ossified part (IWOP) of humerus, ILOP of femur, and IWOP of femur were calculated. E2 had higher cases of anatomical defects (74,6%) than E3 (48.9%), E1 (15.0%), and E0 (0%). E2 had humerus IWOP of 0.82 +/- 0.03, which was significantly lower than that of E0 (0.89 +/- 0.04) and E1 (0.89 +/- 0.03), while that of E1 and E0 was not significantly different from each other. Meanwhile, IWOP in E3 (0.88 +/- 0.03) was significantly higher than that in E2, but not different from that in E1 and E0. Thus, LE3H mitigated defects in fetal anatomy and endochondral ossification induced by HgCl2 in mice.	[Ruyani, Aceng; Kartika, Eda; Sundaryono, Agus; Susanta, Agus] Bengkulu Univ, Grad Sch Sci Educ, Bengkulu, Indonesia; [Ruyani, Aceng] Bengkulu Univ, Dept Biol Educ, Bengkulu, Indonesia; [Parlindungan, Deni] Bengkulu Univ, Dept Sci Educ, Bengkulu, Indonesia; [Sundaryono, Agus] Bengkulu Univ, Dept Chem Educ, Bengkulu, Indonesia; [Putra, Riza Julian] State Islamic Inst Kerinci, Dept Biol Educ, Sungai Penuh, Jambi, Indonesia	Universitas Bengkulu; Universitas Bengkulu; Universitas Bengkulu; Universitas Bengkulu	Ruyani, A (corresponding author), Bengkulu Univ, Grad Sch Sci Educ, Bengkulu, Indonesia.; Ruyani, A (corresponding author), Bengkulu Univ, Dept Biol Educ, Bengkulu, Indonesia.	ruyani@unib.ac.id	Susanta, Agus/GNH-6399-2022	Susanta, Agus/0000-0002-5008-4383	Directorate of Higher education, Ministry of Education and Culture, Republic of Indonesia	Directorate of Higher education, Ministry of Education and Culture, Republic of Indonesia	This research was funded by Directorate of Higher education, Ministry of Education and Culture, Republic of Indonesia.	Abd El-Aziz GS, 2012, ANAT REC, V295, P939, DOI 10.1002/ar.22485; Ali S, 2019, ENVIRON SCI POLLUT R, V26, P3909, DOI 10.1007/s11356-018-3819-8; Beasley DMG, 2014, J MED TOXICOL, V10, P40, DOI 10.1007/s13181-013-0311-1; Bhattacharya Sanjib, 2018, Interdiscip Toxicol, V11, P247, DOI 10.2478/intox-2018-0024; Burdan Franciszek, 2005, Folia Morphol (Warsz), V64, P1; Cappelletti S, 2019, CRIT REV TOXICOL, V49, P329, DOI 10.1080/10408444.2019.1621262; Cunha FAB, 2019, ARAB J CHEM, V12, P4197, DOI 10.1016/j.arabjc.2016.04.018; CURLE DC, 1987, ANAT REC, V219, P286, DOI 10.1002/ar.1092190309; El-Desoky GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059177; Elseady Y, 2013, FISH PHYSIOL BIOCHEM, V39, P1031, DOI 10.1007/s10695-012-9760-8; Fadda LM, 2020, J BIOCHEM MOL TOXIC, V34, DOI 10.1002/jbt.22481; Franco JL, 2007, CHEM RES TOXICOL, V20, P1919, DOI 10.1021/tx7002323; Ghosh A, 2008, BIOL PHARM BULL, V31, P1651, DOI 10.1248/bpb.31.1651; Hallett SA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236009; Jahan S, 2019, ENVIRON HEALTH PREV, V24, DOI 10.1186/s12199-019-0820-x; Karapehlivan M, 2014, J TRACE ELEM MED BIO, V28, P94, DOI 10.1016/j.jtemb.2013.08.004; Kumar A, 2019, CURR ALZHEIMER RES, V16, P116, DOI 10.2174/1567205016666181212155147; Lakshmi B V S, 2014, Indian J Physiol Pharmacol, V58, P423; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Mohamed NE, 2018, BIOL TRACE ELEM RES, V182, P49, DOI 10.1007/s12011-017-1067-2; Mumtaz S, 2019, ENVIRON SCI POLLUT R, V26, P14087, DOI 10.1007/s11356-019-04620-5; Oliveira CS, 2015, TOXICOLOGY, V335, P62, DOI 10.1016/j.tox.2015.07.006; Park EJ, 2007, TOXICOL IN VITRO, V21, P789, DOI 10.1016/j.tiv.2007.01.019; Pinho AI, 2017, J TOXICOL ENV HEAL A, V80, P1301, DOI 10.1080/15287394.2017.1382408; Rafipay A, 2018, DEV DYNAM, V247, P1217, DOI 10.1002/dvdy.24671; Ridwan E., 2013, J INDON MED ASS, V63, P112; Ruyani A, 2005, BIRTH DEFECTS RES A, V73, P517, DOI 10.1002/bdra.20146; Ruyani A, 2003, TOXICOL SCI, V75, P148, DOI 10.1093/toxsci/kfg159; Ruyani A, 2014, INT J SCI, V01, P70; Ruyani A, 1997, JURNAL KEDOKTERAN DA, V23, P883; Ruyani A, 1991, P ITB, V24, P1; Ruyani A, 2017, PROSIDING SEMINAR NA; Ruyani A, 2020, TOXICOL RES-GER, V36, P131, DOI 10.1007/s43188-019-00010-8; Ruyani A, 2019, J TRADIT COMPL MED, V9, P285, DOI 10.1016/j.jtcme.2017.08.005; Ruyani A, 2019, J DIET SUPPL, V16, P51, DOI 10.1080/19390211.2018.1429516; Sanders AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031354; Shi GJ, 2019, BIOMED PHARMACOTHER, V109, P1085, DOI 10.1016/j.biopha.2018.10.130; Shin YJ, 2015, J MED FOOD, V18, P524, DOI 10.1089/jmf.2014.3242; Sobral-Souza CE, 2019, J HAZARD MATER, V370, P54, DOI 10.1016/j.jhazmat.2018.03.039; Sobral-Souza CE, 2014, ARAB J CHEM, V7, P165, DOI 10.1016/j.arabjc.2013.10.003; Sopi RB, 2013, PHARMACOGN RES, V5, P169, DOI 10.4103/0974-8490.112422; Steel RGD, 1981, PRINCIPLES PROCEDURE; Sun BB, 2018, J PERIPHER NERV SYST, V23, P17, DOI 10.1111/jns.12246; Uzunhisarcikli M, 2016, TOXICOL IND HEALTH, V32, P1651, DOI 10.1177/0748233715572561; Vejrup K, 2018, ENVIRON INT, V110, P71, DOI 10.1016/j.envint.2017.10.008; Vigeh M, 2018, REPROD TOXICOL, V76, P78, DOI 10.1016/j.reprotox.2018.01.002; WANEK N, 1989, J EXP ZOOL, V249, P41, DOI 10.1002/jez.1402490109; Wildemann TM, 2016, TOXICOLOGY, V339, P1, DOI 10.1016/j.tox.2015.11.004; Wilson JG, 1965, TERATOLOGY PRINCIPLE; Zhang YB, 2013, TOXICOL SCI, V133, P101, DOI 10.1093/toxsci/kft023	50	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0247467	10.1371/journal.pone.0247467	http://dx.doi.org/10.1371/journal.pone.0247467			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690696	Green Published, gold			2022-12-26	WOS:000627854700011
J	Goddard, R; Steed, A; Scheeren, PL; Maciel, JLN; Caierao, E; Torres, GAM; Consoli, L; Santana, FM; Fernandes, JMC; Simmonds, J; Uauy, C; Cockram, J; Nicholson, P				Goddard, Rachel; Steed, Andrew; Scheeren, Pedro Luiz; Nunes Maciel, Joao Leodato; Caierao, Eduardo; Montan Torres, Gisele Abigail; Consoli, Luciano; Santana, Flavio Martins; Cunha Fernandes, Jose Mauricio; Simmonds, James; Uauy, Cristobal; Cockram, James; Nicholson, Paul			Identification of Fusarium head blight resistance loci in two Brazilian wheat mapping populations	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; UDP-GLUCOSYLTRANSFERASE; FIELD-RESISTANCE; DEOXYNIVALENOL ACCUMULATION; MOLECULAR CHARACTERIZATION; MYCOTOXIN DEOXYNIVALENOL; BARLEY; QTL; FHB1; GRAMINEARUM	Fusarium head blight (FHB) is a disease of wheat (Triticum aestivum L.) that causes major yield losses in South America, as well as many other wheat growing regions around the world. FHB results in low quality, contaminated grain due to the production of mycotoxins such as deoxynivalenol (DON). In Brazil, FHB outbreaks are increasing in frequency and are currently controlled by fungicides which are costly and potentially harmful to the wider environment. To identify the genetic basis of resistance to FHB in Brazilian wheat, two mapping populations (Anahuac 75 x BR 18-Terena and BR 18-Terena x BRS 179) segregating for FHB resistance were phenotyped and quantitative trait loci (QTL) analysis was undertaken to identify genomic regions associated with FHB-related traits. A total of 14 QTL associated with FHB visual symptoms were identified, each of which explained 3.7-17.3% of the phenotypic variance. Two of these QTL were stable across environments. This suggests FHB resistance in Anahuac 75, BR 18-Terena and BRS 179 is controlled by multiple genetic loci that confer relatively minor differences in resistance. A major, novel QTL associated with DON accumulation was also identified on chromosome 4B (17.8% of the phenotypic variance), as well as a major QTL associated with thousand-grain weight on chromosome 6B (16.8% phenotypic variance). These QTL could be useful breeding targets, when pyramided with major sources of resistance such as Fhb1, to improve grain quality and reduce the reliance on fungicides in Brazil and other countries affected by FHB.	[Goddard, Rachel; Steed, Andrew; Simmonds, James; Uauy, Cristobal; Nicholson, Paul] John Innes Ctr, Dept Crop Genet, Norwich, Norfolk, England; [Scheeren, Pedro Luiz; Nunes Maciel, Joao Leodato; Caierao, Eduardo; Montan Torres, Gisele Abigail; Consoli, Luciano; Santana, Flavio Martins; Cunha Fernandes, Jose Mauricio] Embrapa Trigo, Passo Fundo, RS, Brazil; [Cockram, James] NIAB, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Goddard, R; Nicholson, P (corresponding author), John Innes Ctr, Dept Crop Genet, Norwich, Norfolk, England.	rachel.goddard@jic.ac.uk; paul.nicholson@jic.ac.uk	consoli, luciano/K-2454-2016	consoli, luciano/0000-0003-3744-4732; Cockram, James/0000-0002-1014-6463; Fernandes, Jose Mauricio/0000-0003-4965-2432; Goddard, Rachel/0000-0001-7553-3889	Bilateral Biotechnology and Biological Sciences Research Council BBSRC-Embrapa project [BB/N019113/1]; BBSRC [BB/N004442/1, BB/J019992/1]	Bilateral Biotechnology and Biological Sciences Research Council BBSRC-Embrapa project; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	RG was funded by a Bilateral Biotechnology and Biological Sciences Research Council BBSRC-Embrapa project (BB/N019113/1). We also gratefully acknowledge funding awards BB/N004442/1 and BB/J019992/1 from BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate ZA, 2008, CROP SCI, V48, P1408, DOI 10.2135/cropsci2007.07.0411; Agencia Nacional de Vigilancia Sanitaria (ANVISA), 2011, RES DIR COL RDC 07; [Anonymous], 2019, VSN INT, V20th; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Bonnin I, 2008, THEOR APPL GENET, V116, P383, DOI 10.1007/s00122-007-0676-0; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Buerstmayr M, 2020, PLANT BREEDING, V139, P429, DOI 10.1111/pbr.12797; Buerstmayr M, 2016, PHYTOPATHOLOGY, V106, P1544, DOI 10.1094/PHYTO-05-16-0200-R; Ceresini PC, 2019, MOL PLANT PATHOL, V20, P155, DOI 10.1111/mpp.12747; Ceresini PC, 2018, ANNU REV PHYTOPATHOL, V56, P427, DOI 10.1146/annurev-phyto-080417-050036; Chandler PM, 2002, PLANT PHYSIOL, V129, P181, DOI 10.1104/pp.010917; Cruz CD, 2016, CROP SCI, V56, P990, DOI 10.2135/cropsci2015.07.0410; Cruz CD, 2017, TROP PLANT PATHOL, V42, P210, DOI 10.1007/s40858-017-0159-z; Cruz MFA, 2010, TROP PLANT PATHOL, V35, P24, DOI 10.1590/S1982-56762010000100004; Cuthbert PA, 2007, THEOR APPL GENET, V114, P429, DOI 10.1007/s00122-006-0439-3; Cuthbert PA, 2006, THEOR APPL GENET, V112, P1465, DOI 10.1007/s00122-006-0249-7; Del Ponte EM, 2009, J PHYTOPATHOL, V157, P675, DOI 10.1111/j.1439-0434.2009.01559.x; Dhokane D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155851; dos Santos JS, 2013, FOOD CHEM, V138, P90, DOI 10.1016/j.foodchem.2012.09.100; Draeger R, 2007, THEOR APPL GENET, V115, P617, DOI 10.1007/s00122-007-0592-3; Flintham JE, 1997, J AGR SCI-CAMBRIDGE, V128, P11, DOI 10.1017/S0021859696003942; Fradgley N, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000071; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Gatti Miriam, 2018, Front Plant Sci, V9, P1853, DOI 10.3389/fpls.2018.01853; Goddard R, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-02592-0; Gruner K, 2020, GENES-BASEL, V11, DOI 10.3390/genes11050517; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020; Guenther JC, 2005, MYCOLOGIA, V97, P229, DOI 10.3852/mycologia.97.1.229; Gunupuru LR, 2017, TROP PLANT PATHOL, V42, P175, DOI 10.1007/s40858-017-0147-3; Ha X, 2016, PHYTOPATHOLOGY, V106, P270, DOI 10.1094/PHYTO-09-15-0202-R; He XY, 2019, THEOR APPL GENET, V132, P2401, DOI 10.1007/s00122-019-03362-9; He XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162499; Jayatilake D, 2011, THEOR APPL GENET, V122, P1189, DOI 10.1007/s00122-010-1523-2; Klahr A, 2007, EUPHYTICA, V154, P17, DOI 10.1007/s10681-006-9264-7; Kollers S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057500; Langevin F, 2004, EUR J PLANT PATHOL, V110, P735, DOI 10.1023/B:EJPP.0000041568.31778.ad; Lemmens M, 2005, MOL PLANT MICROBE IN, V18, P1318, DOI 10.1094/MPMI-18-1318; Li GQ, 2019, NAT GENET, V51, P1106, DOI 10.1038/s41588-019-0426-7; Li X, 2015, MOL PLANT MICROBE IN, V28, P1237, DOI 10.1094/MPMI-03-15-0062-R; Lima Maria I. P. M., 2002, Fitopatologia Brasileira, V27, P104, DOI 10.1590/S0100-41582002000100019; Liu SY, 2013, THEOR APPL GENET, V126, P2485, DOI 10.1007/s00122-013-2149-y; Liu SY, 2012, CROP SCI, V52, P2283, DOI 10.2135/cropsci2012.03.0144; Liu SX, 2008, CEREAL RES COMMUN, V36, P195, DOI 10.1556/CRC.36.2008.Suppl.B.15; Lu QX, 2013, THEOR APPL GENET, V126, P317, DOI 10.1007/s00122-012-1981-9; Ma HX, 2006, PLANT PATHOL, V55, P739, DOI 10.1111/j.1365-3059.2006.01447.x; Ma ZQ, 2020, THEOR APPL GENET, V133, P1541, DOI 10.1007/s00122-019-03525-8; Mallmann CA, 2017, TROP PLANT PATHOL, V42, P146, DOI 10.1007/s40858-017-0152-6; McMullen M, 2012, PLANT DIS, V96, P1712, DOI 10.1094/PDIS-03-12-0291-FE; Mehta YR, 2014, WHEAT DISEASES AND THEIR MANAGEMENT, P65, DOI 10.1007/978-3-319-06465-9_3; Mellers G, 2020, G3-GENES GENOM GENET, V10, P2229, DOI 10.1534/g3.120.401234; Menke J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063077; Miedaner T, 2008, CROP SCI, V48, P2115, DOI 10.2135/cropsci2008.02.0107; Ollier M, 2020, THEOR APPL GENET, V133, P457, DOI 10.1007/s00122-019-03476-0; Paillard S, 2004, THEOR APPL GENET, V109, P323, DOI 10.1007/s00122-004-1628-6; Peraldi A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-100; Petersen S, 2016, CROP SCI, V56, P1473, DOI 10.2135/cropsci2015.05.0312; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Rawat N, 2016, NAT GENET, V48, P1576, DOI 10.1038/ng.3706; Ruan YF, 2012, GENOME, V55, P853, DOI 10.1139/gen-2012-0110; Scheeren PL, 2016, EMBRAPA TRIGO; Schmolke M, 2008, PLANT BREEDING, V127, P459, DOI 10.1111/j.1439-0523.2007.01486.x; Schweiger W, 2013, MOL PLANT MICROBE IN, V26, P781, DOI 10.1094/MPMI-08-12-0205-R; Schweiger W, 2010, MOL PLANT MICROBE IN, V23, P977, DOI 10.1094/MPMI-23-7-0977; Somers DJ, 2003, GENOME, V46, P555, DOI 10.1139/G03-033; Sousa C.N.A., 2014, CULTIVARES TRIGO IND; Srinivasachary, 2008, THEOR APPL GENET, V116, P1145, DOI 10.1007/s00122-008-0742-2; Srinivasachary, 2009, THEOR APPL GENET, V118, P695, DOI 10.1007/s00122-008-0930-0; Steiner B, 2004, THEOR APPL GENET, V109, P215, DOI 10.1007/s00122-004-1620-1; Steiner B, 2017, TROP PLANT PATHOL, V42, P165, DOI 10.1007/s40858-017-0127-7; Su ZQ, 2019, NAT GENET, V51, P1099, DOI 10.1038/s41588-019-0425-8; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Szabo-Hever A, 2014, EUPHYTICA, V200, P9, DOI [10.1007/s10681-014-1124-2, 10.1007/s10681-014-1229-7]; Tessmann EW, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8050068; Trail F, 2009, PLANT PHYSIOL, V149, P103, DOI 10.1104/pp.108.129684; Urashima A. S., 2004, Fitopatologia Brasileira, V29, P511, DOI 10.1590/S0100-41582004000500007; Val-Moraes SP, 2017, MANAGEMENT WHEAT BAR, DOI 10.1590/S1984-29612017069; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang R, 2017, PHYTOPATHOLOGY, V107, P1486, DOI [10.1094/PHYTO-02-17-0073-R, 10.1094/phyto-02-17-0073-r]; Xu XM, 2009, ANNU REV PHYTOPATHOL, V47, P83, DOI 10.1146/annurev-phyto-080508-081737; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yu JB, 2008, PHYTOPATHOLOGY, V98, P87, DOI 10.1094/PHYTO-98-1-0087; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang M, 2010, MOL BIOL REP, V37, P1031, DOI 10.1007/s11033-009-9809-7; Zhao MX, 2018, THEOR APPL GENET, V131, P1939, DOI 10.1007/s00122-018-3124-4; Zhu ZW, 2019, CROP J, V7, P730, DOI 10.1016/j.cj.2019.06.003	86	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0248184	10.1371/journal.pone.0248184	http://dx.doi.org/10.1371/journal.pone.0248184			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU3OZ	33684152	gold, Green Published			2022-12-26	WOS:000627193500049
J	Liu, QL				Liu, Qiaoling			Impact of different dietary fat sources on blood pressure in Chinese adults	PLOS ONE			English	Article							TO-POTASSIUM RATIO; NUTRITION SURVEY; HYPERTENSION; SODIUM; METAANALYSIS; POPULATION; HEALTH; FRUIT; MEN	Objectives To investigate the association between the source of dietary fat and blood pressure for Chinese people aged between 30-59 with the aim of elucidating methods of hypertension prevention. Design Prospective cohort study using national survey data. Participants 1,104 adults aged between 30-59 with normal blood pressures in 2006 were included in the study. Adults with history of prehypertension, hypertension, or were taking hypertension drugs in 2006 were excluded. Participants with implausibly high or low daily total energy intakes (<600 kcal/d or >5000 kcal/d) were excluded. Pregnant women, breastfeeding women, and people with motor impairment were excluded. Results People with abnormal blood pressure ingested a lower percent of dietary fat taken from seafood (P < 0.001) and a higher percent of dietary fat taken from fast food (P < 0.001). Dietary fat obtained from seafood and dairy products can be protective against abnormal blood pressure with a RR = 0.01 (95% CI: 0.001 to 0.25; P= 0.004) for seafood, and RR = 0.14 (95% CI: 0.04 to 0.44; P= 0.001) for egg, milk, and dairy products. Conclusion Seafood, egg, milk, and dairy products can be recommended as sources of dietary fat to reduce the incidence of hypertension and prehypertension while fast food should be avoided.	[Liu, Qiaoling] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine	Liu, QL (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.	Qiaoling.Liu1@student.lshtm.ac.uk	Liu, Qiaoling/HHZ-6537-2022; Liu, Qiaoling/ABA-3562-2021	Liu, Qiaoling/0000-0003-2109-3974; Liu, Qiaoling/0000-0003-2109-3974	National Institute for Nutrition and Health, China Center for Disease Control and Prevention, Carolina Population Center [P2C HD050924, T32 HD007168]; University of North Carolina at Chapel Hill, the NIH [R01HD30880, DK056350, R24 HD050924, R01HD38700]; NIH Fogarty International Center [D43 TW009077, D43 TW007709]; China-Japan Friendship Hospital, Ministry of Health; Chinese National Human Genome Center at Shanghai; Beijing Municipal Center for Disease Prevention and Control	National Institute for Nutrition and Health, China Center for Disease Control and Prevention, Carolina Population Center; University of North Carolina at Chapel Hill, the NIH; NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); China-Japan Friendship Hospital, Ministry of Health; Chinese National Human Genome Center at Shanghai; Beijing Municipal Center for Disease Prevention and Control	The original database is available from: http://www.cpc.unc.edu/projects/china/.We used the following dataset: mast_pub_12.sas7bdat, nutr3_00.sas7bdat, pexam_pub_12.sas7bdat, rst_12.sas7bdat. This research uses data from China Health and Nutrition Survey (CHNS). We thank the National Institute for Nutrition and Health, China Center for Disease Control and Prevention, Carolina Population Center (P2C HD050924, T32 HD007168), the University of North Carolina at Chapel Hill, the NIH (R01HD30880, DK056350, R24 HD050924, and R01HD38700) and the NIH Fogarty International Center (D43 TW009077, D43 TW007709) for financial support for the CHNS data collection and analysis files from 1989 to 2015 and future surveys, and the China-Japan Friendship Hospital, Ministry of Health for support for CHNS 2009, Chinese National Human Genome Center at Shanghai since 2009, and Beijing Municipal Center for Disease Prevention and Control since 2011.	Alter DA, 2005, CAN J PUBLIC HEALTH, V96, P173, DOI 10.1007/BF03403684; Appleby PN, 2002, PUBLIC HEALTH NUTR, V5, P645, DOI 10.1079/PHN2002332; Binia A, 2015, J HYPERTENS, V33, P1509, DOI 10.1097/HJH.0000000000000611; Borgi L, 2016, HYPERTENSION, V67, P288, DOI 10.1161/HYPERTENSIONAHA.115.06497; Bray GA, 2004, AM J CARDIOL, V94, P222, DOI 10.1016/j.amjcard.2004.03.070; ChinaCDC, 2006, CHIN HLTH NUTR SURV; Czernichow S, 2011, OBES REV, V12, P680, DOI 10.1111/j.1467-789X.2011.00879.x; Engberink MF, 2009, AM J CLIN NUTR, V89, P1877, DOI 10.3945/ajcn.2008.27064; FAO, 2018, DIET ASS RES GUID ME; Jalal DI, 2010, J AM SOC NEPHROL, V21, P1543, DOI 10.1681/ASN.2009111111; Kar Sumit, 2015, J Nat Sci Biol Med, V6, P356, DOI 10.4103/0976-9668.160004; Lee SA, 2010, BRIT J NUTR, V104, P265, DOI 10.1017/S0007114510000383; Liu AG, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0271-4; Liu LS, 2019, J GERIATR CARDIOL, V16, P182, DOI 10.11909/j.issn.1671-5411.2019.03.014; Liu ZQ, 2009, AM J HYPERTENS, V22, P929, DOI 10.1038/ajh.2009.134; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lu JP, 2017, LANCET, V390, P2549, DOI [10.1016/S0140-6736(17)32478-9, 10.1016/s0140-6736(17)32478-9]; Ma LY, 2020, J GERIATR CARDIOL, V17, P1, DOI 10.11909/j.issn.1671-5411.2020.01.001; Perez V, 2014, ADV NUTR, V5, P712, DOI 10.3945/an.114.006783; Poslusna K, 2009, BRIT J NUTR, V101, pS73, DOI 10.1017/S0007114509990602; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Shah M, 2007, AM J CLIN NUTR, V85, P1251, DOI 10.1093/ajcn/85.5.1251; Shen X, 2017, PUBLIC HEALTH NUTR, V20, P2927, DOI [10.1017/S1368980017001781, 10.1017/s1368980017001781]; Singh S, 2017, INT J HYPERTENS, V2017, DOI 10.1155/2017/5491838; Stamler J, 2002, HYPERTENSION, V39, P1000, DOI 10.1161/01.HYP.0000016178.80811.D9; Therapy DcoCcooomn, 2016, CHIN J DIABETES MELL, V08, P525, DOI DOI 10.3760/cma.j.issn.1674-5809.2016.09.004; Wang L, 2012, AM J HYPERTENS, V25, P180, DOI 10.1038/ajh.2011.186; Wang SS, 2016, J ZHEJIANG UNIV-SC B, V17, P649, DOI 10.1631/jzus.B1600341; Wang YF, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111112; Wang ZW, 2018, CIRCULATION, V137, P2344, DOI 10.1161/CIRCULATIONAHA.117.032380; Xu HW, 2013, J EPIDEMIOL COMMUN H, V67, P271, DOI 10.1136/jech-2012-201157; Yang Y, 2002, CHINESE FOOD COMPOSI; Yang YX., 2004, CHINESE FOOD COMPOSI; Zhai FY, 2014, OBES REV, V15, P16, DOI 10.1111/obr.12124; Zhang B, 2014, OBES REV, V15, P2, DOI 10.1111/obr.12119	35	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0247116	10.1371/journal.pone.0247116	http://dx.doi.org/10.1371/journal.pone.0247116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU3OZ	33684108	gold, Green Published			2022-12-26	WOS:000627193500023
J	Hoffmann, DB; Fraccarollo, D; Galuppo, P; Frantz, S; Bauersachs, J; Tillmanns, J				Hoffmann, Daniel B.; Fraccarollo, Daniela; Galuppo, Paolo; Frantz, Stefan; Bauersachs, Johann; Tillmanns, Jochen			Genetic ablation of fibroblast activation protein alpha attenuates left ventricular dilation after myocardial infarction	PLOS ONE			English	Article							REMODELING INTERFACE; GROWTH-FACTOR; COLLAGEN; TISSUE; CELLS; DISRUPTION; EXPRESSION; TARGET; BETA; MICE	Introduction Regulating excessive activation of fibroblasts may be a promising target to optimize extracellular matrix deposition and myocardial stiffness. Fibroblast activation protein alpha (FAP) is upregulated in activated fibroblasts after myocardial infarction (MI), and alters fibroblast migration in vitro. We hypothesized that FAP depletion may have a protective effect on left ventricular (LV) remodeling after MI. Materials and methods We used the model of chronic MI in homozygous FAP deficient mice (FAP-KO, n = 51) and wild type mice (WT, n = 55) to analyze wound healing by monocyte and myofibroblast infiltration. Heart function and remodeling was studied by echocardiography, morphometric analyses including capillary density and myocyte size, collagen content and in vivo cell-proliferation. In non-operated healthy mice up to 6 months of age, morphometric analyses and collagen content was assessed (WT n = 10, FAP-KO n = 19). Results Healthy FAP-deficient mice did not show changes in LV structure or differences in collagen content or cardiac morphology. Infarct size, survival and cardiac function were not different between FAP-KO and wildtype mice. FAP-KO animals showed less LV-dilation and a thicker scar, accompanied by a trend towards lower collagen content. Wound healing, assessed by infiltration with inflammatory cells and myofibroblasts were not different between groups. Conclusion We show that genetic ablation of FAP does not impair cardiac wound healing, and attenuates LV dilation after MI in mice. FAP seems dispensable for normal cardiac function and homeostasis.	[Hoffmann, Daniel B.] Univ Med Ctr Gottingen, Dept Trauma Orthopaed & Plast Surg, Gottingen, Germany; [Hoffmann, Daniel B.; Fraccarollo, Daniela; Galuppo, Paolo; Bauersachs, Johann; Tillmanns, Jochen] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany; [Frantz, Stefan] Univ Hosp Wurzburg, Dept Med, Wurzburg, Germany	University of Gottingen; Hannover Medical School; University of Wurzburg	Tillmanns, J (corresponding author), Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany.	tillmanns.jochen@mh-hannover.de	Frantz, Stefan/G-1723-2012	Tillmanns, Jochen/0000-0001-9429-5484	Interdisciplinary Clinical Research Center Wurzburg [JB: IZKF E-140]	Interdisciplinary Clinical Research Center Wurzburg	This work was initially supported by grants from the Interdisciplinary Clinical Research Center Wurzburg (to JT, JB: IZKF E-140). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya PS, 2006, HUM PATHOL, V37, P352, DOI 10.1016/j.humpath.2005.11.020; Aghajanian H, 2019, NATURE, V573, P430, DOI 10.1038/s41586-019-1546-z; Brokopp CE, 2011, EUR HEART J, V32, P2713, DOI 10.1093/eurheartj/ehq519; Cleutjens JPM, 1999, CARDIOVASC RES, V44, P232, DOI 10.1016/S0008-6363(99)00212-6; Cohen SJ, 2008, PANCREAS, V37, P154, DOI 10.1097/MPA.0b013e31816618ce; Dean RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1245, DOI 10.1369/jhc.4A6560.2005; Dienus K, 2010, ARCH DERMATOL RES, V302, P725, DOI 10.1007/s00403-010-1084-x; Dolznig Helmut, 2005, Cancer Immun, V5, P10; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Fomovsky GM, 2010, AM J PHYSIOL-HEART C, V298, pH221, DOI 10.1152/ajpheart.00495.2009; Fraccarollo D, 2012, CARDIOVASC RES, V94, P293, DOI 10.1093/cvr/cvs109; Fraccarollo D, 2011, CIRCULATION, V123, P400, DOI 10.1161/CIRCULATIONAHA.110.983023; Frantz S, 2004, BRIT J PHARMACOL, V141, P9, DOI 10.1038/sj.bjp.0705585; Frantz S, 2008, BASIC RES CARDIOL, V103, P485, DOI 10.1007/s00395-008-0739-7; Frantz S, 2013, FASEB J, V27, P871, DOI 10.1096/fj.12-214049; GARINCHESA P, 1990, P NATL ACAD SCI USA, V87, P7235, DOI 10.1073/pnas.87.18.7235; Goldsmith EC, 2014, J MOL CELL CARDIOL, V70, P92, DOI 10.1016/j.yjmcc.2014.01.008; Heckmann MB, 2020, CIRC-CARDIOVASC IMAG, V13, DOI 10.1161/CIRCIMAGING.120.010628; Jugdutt BI, 1996, CIRCULATION, V94, P94, DOI 10.1161/01.CIR.94.1.94; Kimura T, 2019, AM J PHYSIOL-LUNG C, V317, pL271, DOI 10.1152/ajplung.00071.2019; Levy MT, 1999, HEPATOLOGY, V29, P1768, DOI 10.1002/hep.510290631; Lindsey ML, 2018, NAT REV CARDIOL, V15, P471, DOI 10.1038/s41569-018-0022-z; Monslow J, 2020, AM J PATHOL, V190, P1118, DOI 10.1016/j.ajpath.2020.01.004; Niedermeyer J, 2000, MOL CELL BIOL, V20, P1089, DOI 10.1128/MCB.20.3.1089-1094.2000; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pure E, 2018, ONCOGENE, V37, P4343, DOI 10.1038/s41388-018-0275-3; RETTIG WJ, 1993, CANCER RES, V53, P3327; Riehle C, 2019, CARDIOVASC RES, V115, P1838, DOI 10.1093/cvr/cvz161; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Spinale FG, 2010, J BIOL CHEM, V285, P30316, DOI 10.1074/jbc.M110.158196; Stein S, 2021, CARDIOVASC RES, V117, P1060, DOI 10.1093/cvr/cvaa142; Tillmanns J, 2015, J MOL CELL CARDIOL, V87, P194, DOI 10.1016/j.yjmcc.2015.08.016; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Varasteh Z, 2019, J NUCL MED, V60, P1743, DOI 10.2967/jnumed.119.226993; Virag JI, 2003, AM J PATHOL, V163, P2433, DOI 10.1016/S0002-9440(10)63598-5; Vogel B, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0472-y	36	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0248196	10.1371/journal.pone.0248196	http://dx.doi.org/10.1371/journal.pone.0248196			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667270	gold, Green Published			2022-12-26	WOS:000626604300012
J	Mohamed, RI; Bargal, SA; Mekawy, AS; El-Shiekh, I; Tuncbag, N; Ahmed, AS; Badr, E; Elserafy, M				Mohamed, Ruwaa, I; Bargal, Salma A.; Mekawy, Asmaa S.; El-Shiekh, Iman; Tuncbag, Nurcan; Ahmed, Alaa S.; Badr, Eman; Elserafy, Menattallah			The overexpression of DNA repair genes in invasive ductal and lobular breast carcinomas: Insights on individual variations and precision medicine	PLOS ONE			English	Article							BASE EXCISION-REPAIR; ATAXIA-TELANGIECTASIA; PROGNOSTIC VALUE; CANCER-RISK; EXPRESSION; POLYMORPHISMS; FORM; IDENTIFICATION; ASSOCIATION; SIGNATURE	In the era of precision medicine, analyzing the transcriptomic profile of patients is essential to tailor the appropriate therapy. In this study, we explored transcriptional differences between two invasive breast cancer subtypes; infiltrating ductal carcinoma (IDC) and lobular carcinoma (LC) using RNA-Seq data deposited in the TCGA-BRCA project. We revealed 3854 differentially expressed genes between normal ductal tissues and IDC. In addition, IDC to LC comparison resulted in 663 differentially expressed genes. We then focused on DNA repair genes because of their known effects on patients' response to therapy and resistance. We here report that 36 DNA repair genes are overexpressed in a significant number of both IDC and LC patients' samples. Despite the upregulation in a significant number of samples, we observed a noticeable variation in the expression levels of the repair genes across patients of the same cancer subtype. The same trend is valid for the expression of miRNAs, where remarkable variations between patients' samples of the same cancer subtype are also observed. These individual variations could lie behind the differential response of patients to treatment. The future of cancer diagnostics and therapy will inevitably depend on high-throughput genomic and transcriptomic data analysis. However, we propose that performing analysis on individual patients rather than a big set of patients' samples will be necessary to ensure that the best treatment is determined, and therapy resistance is reduced.	[Mohamed, Ruwaa, I] Nile Univ, Ctr Informat Sci CIS, Giza, Egypt; [Bargal, Salma A.; Mekawy, Asmaa S.; El-Shiekh, Iman; Ahmed, Alaa S.; Elserafy, Menattallah] Zewail City Sci & Technol, Helmy Inst Med Sci, Ctr Genom, Giza, Egypt; [Mekawy, Asmaa S.; El-Shiekh, Iman; Ahmed, Alaa S.; Badr, Eman; Elserafy, Menattallah] Univ Sci & Technol, Zewail City Sci & Technol, Giza, Egypt; [Tuncbag, Nurcan] Middle East Tech Univ, Grad Sch Informat, Dept Hlth Informat, Ankara, Turkey; [Badr, Eman] Cairo Univ, Fac Comp & Artificial Intelligence, Giza, Egypt	Egyptian Knowledge Bank (EKB); Nile University; Egyptian Knowledge Bank (EKB); Zewail City of Science & Technology; Egyptian Knowledge Bank (EKB); Misr University for Science & Technology; Zewail City of Science & Technology; Middle East Technical University; Egyptian Knowledge Bank (EKB); Cairo University	Elserafy, M (corresponding author), Zewail City Sci & Technol, Helmy Inst Med Sci, Ctr Genom, Giza, Egypt.; Badr, E; Elserafy, M (corresponding author), Univ Sci & Technol, Zewail City Sci & Technol, Giza, Egypt.; Badr, E (corresponding author), Cairo Univ, Fac Comp & Artificial Intelligence, Giza, Egypt.	emostafa@zewailcity.edu.eg; melserafy@zewailcity.edu.eg	Elserafy, Menattallah/U-4761-2017; Tuncbag, Nurcan/ABA-2355-2020	Elserafy, Menattallah/0000-0002-0272-8498; Tuncbag, Nurcan/0000-0002-0389-9459; El-Shiekh, Iman/0000-0003-4828-2310; Badr, Eman M./0000-0001-9531-2266; Ahmed, Alaa/0000-0003-3261-3517; Mekawy, Asmaa/0000-0002-7238-386X	International Centre for Genetic Engineering and Biotechnology (ICGEB) [CRP/EGY18-05_EC]	International Centre for Genetic Engineering and Biotechnology (ICGEB)	The study is funded by a grant from International Centre for Genetic Engineering and Biotechnology (ICGEB) 'CRP/EGY18-05_EC' to ME. https://www.icgeb.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abugable AA, 2017, ADV EXP MED BIOL, V1007, P157, DOI 10.1007/978-3-319-60733-7_9; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Akashi-Tanaka S, 2015, CLIN BREAST CANCER, V15, P80, DOI 10.1016/j.clbc.2014.08.003; Al-Kaabi MM, 2015, BRIT J CANCER, V112, P901, DOI 10.1038/bjc.2014.576; [Anonymous], 2019, INT AGENCY RES CANC, V399, P2018; [Anonymous], P PYTH SCI C SCIPY; Arora A, 2015, MOL CANCER THER, V14, P1057, DOI 10.1158/1535-7163.MCT-14-0939; Bao SN, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.577150; Barroso-Sousa R, 2016, THER ADV MED ONCOL, V8, P261, DOI 10.1177/1758834016644156; Bashir N, 2014, FAM CANCER, V13, P611, DOI 10.1007/s10689-014-9745-0; Bechtel PE, 1998, CANCER RES, V58, P3264; Bektas N, 2008, BREAST CANCER RES, V10; Benson M, 2016, J INTERN MED, V279, P229, DOI 10.1111/joim.12412; Bertucci F, 2008, ONCOGENE, V27, P5359, DOI 10.1038/onc.2008.158; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; BORST MJ, 1993, SURGERY, V114, P637; Bridges AE, 2020, CANCER RES, V80, P3855, DOI 10.1158/0008-5472.CAN-19-3713; Broberg K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-140; Campone M, 2008, BREAST CANCER RES TR, V109, P491, DOI 10.1007/s10549-007-9673-x; Cavaciuti E, 2005, GENE CHROMOSOME CANC, V42, P1, DOI 10.1002/gcc.20101; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Chi LM, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0838-1; Choi SH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-211; Chudasama D, 2018, CARCINOGENESIS, V39, P407, DOI 10.1093/carcin/bgx122; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Coradini D, 2002, BRIT J CANCER, V87, P1105, DOI 10.1038/sj.bjc.6600556; Cuchra M, 2016, MOL CARCINOGEN, V55, P1899, DOI 10.1002/mc.22436; Cui X, 2020, ANALYSES DNA METHYLA, DOI [10.2147/CMAR.S261290, DOI 10.2147/CMAR.S261290]; Dahl E, 2006, CLIN CANCER RES, V12, P3950, DOI 10.1158/1078-0432.CCR-05-2090; Dankof A, 2007, VIRCHOWS ARCH, V451, P877, DOI 10.1007/s00428-007-0513-5; Davies H, 2017, CANCER RES, V77, P4755, DOI 10.1158/0008-5472.CAN-17-1083; Davis JD, 2011, WORLD J CLIN ONCOL, V2, P329, DOI 10.5306/wjco.v2.i9.329; Desmedt C, 2016, J CLIN ONCOL, V34, P1872, DOI 10.1200/JCO.2015.64.0334; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Erdal E, 2017, GENE DEV, V31, P353, DOI 10.1101/gad.289769.116; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Fang CB, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00160; Gao T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091771; Geradts J, 2000, MODERN PATHOL, V13, P945, DOI 10.1038/modpathol.3880172; Gilmore E, 2019, J ONCOL, V2019, DOI 10.1155/2019/4325105; Gluz O, 2008, INT J CANCER, V123, P1433, DOI 10.1002/ijc.23628; Goswami S, 2020, NAT MED, V26, P39, DOI 10.1038/s41591-019-0694-x; Guo E, 2020, P NATL ACAD SCI USA, V117, P19415, DOI 10.1073/pnas.2009237117; Gupta I, 2018, ENDOCR CONNECT, V7, P65, DOI 10.1530/EC-17-0173; Gustafsson M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad2722; He LF, 2016, EBIOMEDICINE, V14, P32, DOI 10.1016/j.ebiom.2016.11.012; Hildrestrand GA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-45; Hong S, 2014, NEOPLASIA, V16, P279, DOI 10.1016/j.neo.2014.03.010; Huang HY, 2020, NUCLEIC ACIDS RES, V48, pD148, DOI 10.1093/nar/gkz896; Huszno J, 2019, ONCOL LETT, V17, P1986, DOI 10.3892/ol.2018.9770; JAIN SJ, 1993, EUR J CANCER, V29A, P2155, DOI 10.1016/0959-8049(93)90053-I; Keung MY, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040940; Kluzniak W, 2019, BREAST CANCER RES TR, V178, P657, DOI 10.1007/s10549-019-05415-5; Korkola JE, 2003, CANCER RES, V63, P7167; Kutomi G, 2017, ONCOL LETT, V13, P1491, DOI 10.3892/ol.2017.5609; Latimer JJ, 2010, P NATL ACAD SCI USA, V107, P21725, DOI 10.1073/pnas.0914772107; Li XH, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6502-7; Lin YZ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2353-z; Litton JK, 2018, NEW ENGL J MED, V379, P753, DOI 10.1056/NEJMoa1802905; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo DY, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-57; Maacke H, 2000, INT J CANCER, V88, P907, DOI 10.1002/1097-0215(20001215)88:6<907::AID-IJC11>3.0.CO;2-4; Mackintosh C, 2012, ONCOGENE, V31, P1287, DOI 10.1038/onc.2011.317; Mani C, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1192-2; Matta Jaime, 2013, Mol Cancer Biol, V1, P54; Matta J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-490; McAlpine K. E., 2020, INT J MOL SCI, V101; McCann Kelly E, 2018, Drugs Context, V7, P212540, DOI 10.7573/dic.212540; Mechanic LE, 2006, CARCINOGENESIS, V27, P1377, DOI 10.1093/carcin/bgi330; Michailidou K, 2015, NAT GENET, V47, P373, DOI 10.1038/ng.3242; Munagala R, 2013, CANCER LETT, V339, P175, DOI 10.1016/j.canlet.2013.06.012; Newman LA, 2002, ANN SURG ONCOL, V9, P228, DOI 10.1245/aso.2002.9.3.228; O'Brien J, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00402; Olsen JH, 2001, JNCI-J NATL CANCER I, V93, P121, DOI 10.1093/jnci/93.2.121; Oughtred R, 2019, NUCLEIC ACIDS RES, V47, pD529, DOI 10.1093/nar/gky1079; Patrono C, 2014, WORLD J CLIN ONCOL, V5, P874, DOI 10.5306/wjco.v5.i5.874; Peng G, 2012, CANCER RES, V72, P2802, DOI 10.1158/0008-5472.CAN-11-3152; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Phillips KA, 1999, J NATL CANCER I, V91, P469, DOI 10.1093/jnci/91.5.469; Pommier Y, 2012, EUR J CANCER, V48, P87, DOI 10.1016/S0959-8049(12)72082-8; Post AEM, 2020, ONCOL RES, V28, P33, DOI 10.3727/096504019X15555794826018; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; RCore Team, 2020, R LANG ENV STAT COMP; Richard M, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007869; Roberts ME, 2018, GENET MED, V20, P1167, DOI 10.1038/gim.2017.254; Robson M, 2017, NEW ENGL J MED, V377, P523, DOI 10.1056/NEJMoa1706450; RochaSimonini PDS, 2010, CANCER RES, DOI [10.1158/0008-5472.CAN-10-1318, DOI 10.1158/0008-5472.CAN-10-1318]; Rose M, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.564601; Schonborn I, 1994, BREAST, V3, P97, DOI DOI 10.1016/0960-9776(94)90007-8; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shinmura K, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1546392; Si HY, 2013, J CANCER RES CLIN, V139, P223, DOI 10.1007/s00432-012-1315-y; Singh P, 2008, MOL CANCER RES, V6, P1710, DOI 10.1158/1541-7786.MCR-08-0269; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Siraj Abdul Khalid, 2018, Oncotarget, V9, P37319, DOI 10.18632/oncotarget.26470; Smith PD, 1999, ONCOGENE, V18, P2451, DOI 10.1038/sj.onc.1202565; Song K-H, 2019, MOL SCI INHIBITION K, DOI [10.3390/ijms20112843, DOI 10.3390/IJMS20112843]; Soslow RA, 2000, BREAST CANCER RES TR, V61, P161, DOI 10.1023/A:1006479113769; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; Tachibana C., 2015, SCIENCE, DOI 10.1126/science.349.6247.544; Thompson R, 2013, BRIT J CLIN PHARMACO, V76, P358, DOI 10.1111/bcp.12139; Tomoda Y, 2009, INT J CANCER, V124, P2997, DOI 10.1002/ijc.24268; Toziu-Kara S, 2007, J MOL ENDOCRINOL, V39, P305, DOI 10.1677/JME-07-0001; Tran Oanh Tn, 2020, Tumour Biol, V42, p1010428320918404, DOI 10.1177/1010428320918404; Turashvili G, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00227; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Ueki T, 2008, ONCOGENE, V27, P5672, DOI 10.1038/onc.2008.186; Ueki T, 2009, CANCER RES, V69, P8752, DOI 10.1158/0008-5472.CAN-09-1809; Urquidi V, CLIN CANCER RES, V8; van der Groep P, 2008, BREAST CANCER RES TR, V107, P41, DOI 10.1007/s10549-007-9534-7; Vasudevan S, 2012, WIRES RNA, V3, P311, DOI 10.1002/wrna.121; Verlinden L, 2007, CANCER RES, V67, P6574, DOI 10.1158/0008-5472.CAN-06-3545; Vitali F, 2019, BRIEF BIOINFORM, V20, P789, DOI 10.1093/bib/bbx149; Wang B, 2008, CELL RES, V18, P974, DOI 10.1038/cr.2008.274; Wang HW, 2015, BIOINFORMATICS, V31, P62, DOI 10.1093/bioinformatics/btu522; Wang HC, 2009, ANTICANCER RES, V29, P3897; Wang JW, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1043-1; Wang X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10633; Wang YH, 2019, EUR REV MED PHARMACO, V23, P9566, DOI 10.26355/eurrev_201911_19451; World Health Organization, 2014, COMP HDB WHO GUID PR, P11, DOI DOI 10.3989/MC.2010.49909; Wu M, 2019, INT J CLIN EXP PATHO, V12, P1; Xie WT, 2019, EXP THER MED, V18, P4893, DOI 10.3892/etm.2019.8131; Yan ZJ, 2010, MOL CELL, V37, P865, DOI 10.1016/j.molcel.2010.01.039; Yin CG, 2018, THORAC CANCER, V9, P472, DOI 10.1111/1759-7714.12612; Zaim SR, 2019, BMC MED GENOMICS, V12, DOI 10.1186/s12920-019-0513-8; Zhan WX, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00295-4; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786; Zhao JW, 2013, J BIOMED RES, V27, P193, DOI 10.7555/JBR.27.20130013; Zhao XG, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1705-z; Zhou Q, 2008, CANCER GENOM PROTEOM; Zhou ZR, 2017, ACTA PHARMACOL SIN, V38, P513, DOI 10.1038/aps.2016.136; Zou Jiao, 2018, Oncotarget, V9, P11268, DOI 10.18632/oncotarget.24109	132	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0247837	10.1371/journal.pone.0247837	http://dx.doi.org/10.1371/journal.pone.0247837			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33662042	gold, Green Published			2022-12-26	WOS:000626604100090
J	Zhang, XC; Pawlikowski, M; Olivo-Marston, S; Williams, KP; Bower, JK; Felix, AS				Zhang, Xiaochen; Pawlikowski, Meghan; Olivo-Marston, Susan; Williams, Karen Patricia; Bower, Julie K.; Felix, Ashley S.			Ten-year cardiovascular risk among cancer survivors: The National Health and Nutrition Examination Survey	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; LONG-TERM SURVIVORS; BREAST-CANCER; ADULT SURVIVORS; DISEASE; MORTALITY; PREVALENCE; CARDIOTOXICITY; CHEMOTHERAPY; MORBIDITY	Background Cancer survivors have a higher risk of developing and dying from cardiovascular disease (CVD) compared to the general population. We sought to determine whether 10-year risk of atherosclerotic CVD (ASCVD) is elevated among those with vs. without a cancer history in a nationally representative U.S. sample. Methods Participants aged 40-79 years with no CVD history were included from the 2007-2016 National Health and Nutrition Examination Survey. Cancer history was self-reported and 10-year risk of ASCVD was estimated using Pooled Cohort Equations. We used logistic regression to estimate associations between cancer history and odds of elevated (>= 7.5%) vs. low (< 7.5%) 10-year ASCVD risk. An interaction between age and cancer history was examined. Results A total of 15,095 participants were included (mean age = 55.2 years) with 12.3% (n = 1,604) reporting a cancer history. Individuals with vs. without a cancer history had increased odds of elevated 10-year ASCVD risk (OR = 3.42, 95% CI: 2.51-4.66). Specifically, those with bladder/kidney, prostate, colorectal, lung, melanoma, or testicular cancer had a 2.72-10.47 higher odds of elevated 10-year ASCVD risk. Additionally, age was an effect modifier: a cancer history was associated with 1.24 (95% CI: 1.19-4.21) times higher odds of elevated 10-year ASCVD risk among those aged 60-69, but not with other age groups. Conclusions Adults with a history of self-reported cancer had higher 10-year ASCVD risk. ASCVD risk assessment and clinical surveillance of cardiovascular health following a cancer diagnosis could potentially reduce disease burden and prolong survival, especially for patients with specific cancers and high ASCVD risk.	[Zhang, Xiaochen; Pawlikowski, Meghan; Olivo-Marston, Susan; Bower, Julie K.; Felix, Ashley S.] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA; [Zhang, Xiaochen] Ohio State Univ, Div Populat Sci, Comprehens Canc Ctr, Columbus, OH USA; [Williams, Karen Patricia] Ohio State Univ, Coll Nursing, Martha S Pitzer Ctr Women Children & Youth, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Felix, AS (corresponding author), Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA.	Felix.20@osu.edu		Zhang, Xiaochen/0000-0003-3086-1285	National Cancer Institute [F99CA25374501, K01CA21845701A1]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (F99CA25374501 to XZ and K01CA21845701A1 to ASF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2018, CANCER-AM CANCER SOC, V124, P4512, DOI 10.1002/cncr.31775; [Anonymous], 2016, NHANES 2015 2016 PUB; Armenian SH, 2017, J CLIN ONCOL, V35, P893, DOI 10.1200/JCO.2016.70.5400; Armenian SH, 2016, J CLIN ONCOL, V34, P1122, DOI 10.1200/JCO.2015.64.0409; Armstrong GT, 2013, J CLIN ONCOL, V31, P3673, DOI 10.1200/JCO.2013.49.3205; Azim HA, 2011, ANN ONCOL, V22, P1939, DOI 10.1093/annonc/mdq683; Bhatia N, 2016, CIRCULATION, V133, P537, DOI 10.1161/CIRCULATIONAHA.115.012519; Bluethmann SM, 2016, CANCER EPIDEM BIOMAR, V25, P1029, DOI 10.1158/1055-9965.EPI-16-0133; Boerma M, 2012, RADIAT RES, V178, P1, DOI 10.1667/RR2933.1; Bouillon K, 2011, J AM COLL CARDIOL, V57, P445, DOI 10.1016/j.jacc.2010.08.638; Bradshaw PT, 2016, EPIDEMIOLOGY, V27, P6, DOI 10.1097/EDE.0000000000000394; Brown JC, 2016, J GERIATR ONCOL, V7, P108, DOI 10.1016/j.jgo.2016.01.009; Calvillo-Arguelles O, 2019, JAMA CARDIOL, V4, P380, DOI 10.1001/jamacardio.2019.0302; Chen MH, 2011, CIRC RES, V108, P619, DOI 10.1161/CIRCRESAHA.110.224519; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; de Moor JS, 2013, CANCER EPIDEM BIOMAR, V22, P561, DOI 10.1158/1055-9965.EPI-12-1356; Doyle JJ, 2005, J CLIN ONCOL, V23, P8597, DOI 10.1200/JCO.2005.02.5841; Feldman DR, 2018, CLIN GENITOURIN CANC, V16, pE761, DOI 10.1016/j.clgc.2018.01.011; Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2; Florido R, 2022, AM J EPIDEMIOL, V191, P369, DOI 10.1093/aje/kwz124; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Greenland S, 1983, Stat Med, V2, P243, DOI 10.1002/sim.4780020219; Haddy N, 2016, CIRCULATION, V133, P31, DOI 10.1161/CIRCULATIONAHA.115.016686; Haugnes HS, 2010, J CLIN ONCOL, V28, P4649, DOI 10.1200/JCO.2010.29.9362; Heinzerling L, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0152-y; Hequet O, 2004, J CLIN ONCOL, V22, P1864, DOI 10.1200/JCO.2004.06.033; Kero AE, 2014, INT J CANCER, V134, P664, DOI 10.1002/ijc.28385; Koene RJ, 2016, CIRCULATION, V133, P1104, DOI 10.1161/CIRCULATIONAHA.115.020406; KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Landy DC, 2012, AM HEART J, V163, P295, DOI 10.1016/j.ahj.2011.11.008; Lenihan DJ, 2012, J CLIN ONCOL, V30, P3657, DOI 10.1200/JCO.2012.45.2938; Levine GN, 2010, CIRCULATION, V121, P833, DOI 10.1161/CIRCULATIONAHA.109.192695; Liavaag AH, 2009, INT J GYNECOL CANCER, V19, P634, DOI 10.1111/IGC.0b013e3181a13058; Libby P, 2018, CIRCULATION, V138, P666, DOI 10.1161/CIRCULATIONAHA.118.034392; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Loprinzi PD, 2016, INT J CLIN PRACT, V70, P691, DOI 10.1111/ijcp.12840; Mehta LS, 2018, CIRCULATION, V137, pE30, DOI 10.1161/CIR.0000000000000556; Miller KD, 2019, CA-CANCER J CLIN, V69, P363, DOI 10.3322/caac.21565; Ng AK, 2011, J CLIN ONCOL, V29, P1885, DOI 10.1200/JCO.2010.32.8427; Okwuosa TM, 2017, POSTGRAD MED J, V93, P82, DOI 10.1136/postgradmedj-2016-134417; Rugbjerg K, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju110; Schoormans D, 2018, CANCER MED-US, V7, P4952, DOI 10.1002/cam4.1754; Siegel Rebecca L, 2019, CA Cancer J Clin, V69, P7, DOI 10.3322/caac.21551; So JH, 2016, KOREAN J FAM MED, V37, P235, DOI 10.4082/kjfm.2016.37.4.235; Strongman H, 2019, LANCET, V394, P1041, DOI 10.1016/S0140-6736(19)31674-5; Sturgeon KM, 2019, EUR HEART J, V40, P3889, DOI 10.1093/eurheartj/ehz766; van den Belt-Dusebout AW, 2006, J CLIN ONCOL, V24, P467, DOI 10.1200/JCO.2005.02.7193; van Laar M, 2014, BRIT J CANCER, V110, P1338, DOI 10.1038/bjc.2014.37; Zamorano JL, 2016, EUR HEART J, V37, P2768, DOI 10.1093/eurheartj/ehw211; Zaorsky NG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13120-6	53	10	10	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0247919	10.1371/journal.pone.0247919	http://dx.doi.org/10.1371/journal.pone.0247919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33661978	gold, Green Published			2022-12-26	WOS:000626604100114
J	Du, N; Li, H; Sun, CS; He, BQ; Yang, T; Song, HH; Wang, YJ; Wang, YJ				Du, Nan; Li, Hui; Sun, Chunshuai; He, Bingqiang; Yang, Ting; Song, Honghua; Wang, Yingjie; Wang, Yongjun			Adult astrocytes from reptiles are resistant to proinflammatory activation via sustaining Vav1 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIGRATION-INHIBITORY FACTOR; SPINAL-CORD REGENERATION; FIBRILLARY ACIDIC PROTEIN; KEY REGULATORS; CELLS; PHAGOCYTOSIS; ENVIRONMENT; PROGENITOR; MICROGLIA; PATHOLOGY	Adult mammalian astrocytes are sensitive to inflammatory stimuli in the context of neuropathology or mechanical injury, thereby affecting functional outcomes of the central nervous system (CNS). In contrast, glial cells residing in the spinal cord of regenerative vertebrates exhibit a weak astroglial reaction similar to those of mammals in embryonic stages. Macrophage migration inhibitory factor (MIF) participates in multiple neurological disorders by activation of glial and immune cells. However, the mechanism of astrocytes from regenerative species, such as gecko astrocytes (gAS), in resistance to MIF-mediated inflammation in the severed cords remains unclear. Here, we compared neural stem cell markers among gAS, as well as adult (rAS) and embryonic (eAS) rat astrocytes. We observed that gAS retained an immature phenotype resembling rat eAS. Proinflammatory activation of gAS with gecko (gMIF) or rat (rMIF) recombinant protein was unable to induce the production of inflammatory cytokines, despite its interaction with membrane CD74 receptor. Using cross-species screening of inflammation-related mediators from models of gMIF- and rMIF-induced gAS and rAS, we identified Vav1 as a key regulator in suppressing the inflammatory activation of gAS. The gAS with Vav1 deficiency displayed significantly restored sensitivity to inflammatory stimuli. Meanwhile, gMIF acts to promote the migration of gAS through regulation of CXCL8 following cord lesion. Taken together, our results suggest that Vav1 contributes to the regulation of astrocyte-mediated inflammation, which might be beneficial for the therapeutic development of neurological diseases.	[Wang, Yingjie; Wang, Yongjun] Nantong Univ, Key Lab Neuroregenerat Jiangsu, Nantong, Peoples R China; Nantong Univ, Coinnovat Ctr Neuroregenerat, Minist Educ, Nantong, Peoples R China	Nantong University; Nantong University	Wang, YJ; Wang, YJ (corresponding author), Nantong Univ, Key Lab Neuroregenerat Jiangsu, Nantong, Peoples R China.	wyj2010@ntu.edu.cn; wyjbs@ntu.edu.cn		Wang, Yongjun/0000-0001-5040-8926	National Natural Science Foundation of China [31871211, 31702022]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	We are grateful to Prof. Mei Liu for providing the original data about the comparison of stem cell marker among gAS, eAS, and rAS. This study was supported by the National Natural Science Foundation of China (No. 31871211; 31702022) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Ahboucha S, 2003, J COMP NEUROL, V464, P159, DOI 10.1002/cne.10781; Alibardi L, 2020, J MORPHOL, V281, P95, DOI 10.1002/jmor.21082; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Bradbury EJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11707-7; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Colombo E, 2016, TRENDS IMMUNOL, V37, P608, DOI 10.1016/j.it.2016.06.006; Cox GM, 2013, J IMMUNOL, V191, P1043, DOI 10.4049/jimmunol.1200485; Davies Jeannette E, 2006, J Biol, V5, P7, DOI 10.1186/jbiol35; Diaz Quiroz JF, 2013, BIOCHEM J, V451, P353, DOI 10.1042/BJ20121807; Dong YY, 2013, J BIOL CHEM, V288, P18204, DOI 10.1074/jbc.M113.463810; Farago M, 2020, CELL SIGNAL, V65, DOI 10.1016/j.cellsig.2019.109438; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Flynn G, 2003, J NEUROIMMUNOL, V136, P84, DOI 10.1016/S0165-5728(03)00009-2; Fry AL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6579; Fujimoto Y, 2006, EUR SPINE J, V15, P223, DOI 10.1007/s00586-005-0933-3; Goldshmit Y, 2012, J NEUROSCI, V32, P7477, DOI 10.1523/JNEUROSCI.0758-12.2012; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Grommes C, 2008, J NEUROIMMUNE PHARM, V3, P130, DOI 10.1007/s11481-007-9090-2; Gu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127663; Haas C, 2012, EXP NEUROL, V233, P717, DOI 10.1016/j.expneurol.2011.11.002; Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015; Hill CE, 2004, EXP NEUROL, V190, P289, DOI 10.1016/j.expneurol.2004.05.043; Rehermann MI, 2009, J COMP NEUROL, V515, P197, DOI 10.1002/cne.22061; Kang ZH, 2013, NAT NEUROSCI, V16, P1401, DOI 10.1038/nn.3505; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Kassem S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006185; Khalaf H, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-26; Koda M, 2004, ACTA NEUROPATHOL, V108, P31, DOI 10.1007/s00401-004-0853-z; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kuegler PB, 2010, ALTEX-ALTERN ANIM EX, V27, P17; Leyton-Jaimes MF, 2018, EXP NEUROL, V301, P83, DOI 10.1016/j.expneurol.2017.06.021; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Lue HQ, 2002, MICROBES INFECT, V4, P449, DOI 10.1016/S1286-4579(02)01560-5; Mamik MK, 2016, CURR DRUG TARGETS, V17, P111, DOI 10.2174/1389450116666150626124544; Mayo L, 2014, NAT MED, V20, P1147, DOI 10.1038/nm.3681; McLean KE, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-50; MONZONMAYOR M, 1990, J COMP NEUROL, V295, P569, DOI 10.1002/cne.902950406; Nicholls J, 1996, TRENDS NEUROSCI, V19, P229, DOI 10.1016/0166-2236(96)10021-7; Nishio Y, 2009, ACTA NEUROPATHOL, V117, P321, DOI 10.1007/s00401-008-0476-x; Oikonomidi A, 2017, J ALZHEIMERS DIS, V60, P273, DOI 10.3233/JAD-170335; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Ramjeesingh R, 2003, FASEB J, V17, P1292, DOI 10.1096/fj.02-0560fje; Rasmussen JP, 2017, EXP NEUROL, V287, P318, DOI 10.1016/j.expneurol.2016.02.022; Roth S, 2016, CELL REP, V17, P2572, DOI 10.1016/j.celrep.2016.11.018; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Shah VB, 2009, MOL IMMUNOL, V46, P1845, DOI 10.1016/j.molimm.2009.01.014; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Spurrell DR, 2009, J IMMUNOL, V183, P310, DOI 10.4049/jimmunol.0802096; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Tazaki A, 2017, DEV BIOL, V432, P63, DOI 10.1016/j.ydbio.2017.09.034; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Vandenbark AA, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-018-1393-0; WANG JJ, 1995, NEUROSCIENCE, V65, P973, DOI 10.1016/0306-4522(94)00519-B; Wang YJ, 2019, FASEB J, V33, P14798, DOI 10.1096/fj.201801966RRR; Wheeler MA, 2019, CELL, V176, P581, DOI 10.1016/j.cell.2018.12.012; Wilsbacher Julie L, 2006, Cell Commun Signal, V4, P5, DOI 10.1186/1478-811X-4-5; Zenker S, 2014, J IMMUNOL, V192, P2830, DOI 10.4049/jimmunol.1300157; Zhang XJ, 2020, NEUROSCI BULL, V36, P778, DOI 10.1007/s12264-020-00493-8; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang YX, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1468-6; Zhou Y, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1297-z; Zukor KA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-1	65	5	5	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100527	10.1016/j.jbc.2021.100527	http://dx.doi.org/10.1016/j.jbc.2021.100527			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33705794	Green Published, gold			2022-12-26	WOS:000672866400501
J	York, NJ; Lockart, MM; Sardar, S; Khadka, N; Shi, WX; Stenkamp, RE; Zhang, JY; Kiser, PD; Pierce, BS				York, Nicholas J.; Lockart, Molly M.; Sardar, Sinjinee; Khadka, Nimesh; Shi, Wuxian; Stenkamp, Ronald E.; Zhang, Jianye; Kiser, Philip D.; Pierce, Brad S.			Structure of 3-mercaptopropionic acid dioxygenase with a substrate analog reveals bidentate substrate binding at the iron center	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYR CROSS-LINK; CYSTEINE DIOXYGENASE; THIOL DIOXYGENASE; ACTIVE-SITE; AZOTOBACTER-VINELANDII; ELECTRONIC-STRUCTURE; REACTION CYCLE; COMPLEXES; OXIDATION; ENZYME	Thiol dioxygenases are a subset of nonheme iron oxygenases that catalyze the formation of sulfinic acids from sulfhydryl-containing substrates and dioxygen. Among this class, cysteine dioxygenases (CDOs) and 3-mercaptopropionic acid dioxygenases (3MDOs) are the best characterized, and the mode of substrate binding for CDOs is well understood. However, the manner in which 3-mercaptopropionic acid (3MPA) coordinates to the nonheme iron site in 3MDO remains a matter of debate. A model for bidentate 3MPA coordination at the 3MDO Fe-site has been proposed on the basis of computational docking, whereas steady-state kinetics and EPR spectroscopic measurements suggest a thiolate-only coordination of the substrate. To address this gap in knowledge, we determined the structure of Azobacter vinelandii 3MDO (Av3MDO) in complex with the substrate analog and competitive inhibitor, 3-hydroxypropionic acid (3HPA). The structure together with DFT computational modeling demonstrates that 3HPA and 3MPA associate with iron as chelate complexes with the substrate-carboxylate group forming an additional interaction with Arg168 and the thiol bound at the same position as in CDO. A chloride ligand was bound to iron in the coordination site assigned as the O-2-binding site. Supporting HYS-CORE spectroscopic experiments were performed on the (3MPA/NO)-bound Av3MDO iron nitrosyl (S = 3/2) site. In combination with spectroscopic simulations and optimized DFT models, this work provides an experimentally verified model of the Av3MDO enzyme-substrate complex, effectively resolving a debate in the literature regarding the preferred substrate-binding denticity. These results elegantly explain the observed 3MDO substrate specificity, but leave unanswered questions regarding the mechanism of substrate-gated reactivity with dioxygen.	[York, Nicholas J.; Lockart, Molly M.; Pierce, Brad S.] Univ Alabama, Dept Chem & Biochem, Tuscaloosa, AL 35487 USA; [Sardar, Sinjinee] Univ Texas Arlington, Dept Chem & Biochem, Arlington, TX 76019 USA; [Khadka, Nimesh] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Shi, Wuxian] Brookhaven Natl Lab, Natl Synchrotron Light Source 2, Upton, NY 11973 USA; [Stenkamp, Ronald E.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Stenkamp, Ronald E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Zhang, Jianye; Kiser, Philip D.] Univ Calif Irvine, Sch Med, Dept Ophthalmol, Irvine, CA 92717 USA; [Kiser, Philip D.] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Kiser, Philip D.] VA Long Beach Healthcare Syst, Res Serv, Long Beach, CA 90822 USA	University of Alabama System; University of Alabama Tuscaloosa; University of Texas System; University of Texas Arlington; Case Western Reserve University; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Irvine; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System	Pierce, BS (corresponding author), Univ Alabama, Dept Chem & Biochem, Tuscaloosa, AL 35487 USA.; Kiser, PD (corresponding author), Univ Calif Irvine, Sch Med, Dept Ophthalmol, Irvine, CA 92717 USA.; Kiser, PD (corresponding author), Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92717 USA.; Kiser, PD (corresponding author), VA Long Beach Healthcare Syst, Res Serv, Long Beach, CA 90822 USA.	pkiser@uci.edu; bspierce1@ua.edu		Stenkamp, Ronald/0000-0003-4151-1336; York, Nicholas/0000-0001-7054-8336	Department of Veterans Affairs [I01BX004939]; National Institutes of Health [R01EY009339, 2 R15 GM117511-01]; Research to Prevent Blindness	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was supported by grants from the Department of Veterans Affairs (I01BX004939 to P. D. K.) and the National Institutes of Health (R01EY009339 to P. D. K.) and (2 R15 GM117511-01 to B. S. P.). P. D. K. acknowledges an unrestricted grant to the UC Irvine Department of Ophthalmology from Research to Prevent Blindness.	Aloi S, 2019, BIOCHEMISTRY-US, V58, P2398, DOI 10.1021/acs.biochem.9b00079; ARCIERO DM, 1983, J BIOL CHEM, V258, P4981; BECKE AD, 1986, J CHEM PHYS, V84, P4524, DOI 10.1063/1.450025; Bhave Devayani P., 2007, Infectious Disorders - Drug Targets, V7, P140; Blaesi EJ, 2015, BIOCHEMISTRY-US, V54, P2874, DOI 10.1021/acs.biochem.5b00171; Brandt U, 2014, J BIOL CHEM, V289, P30800, DOI 10.1074/jbc.M114.579730; Brines LM, 2015, J AM CHEM SOC, V137, P2253, DOI 10.1021/ja5068405; Brown CD, 2007, J AM CHEM SOC, V129, P7427, DOI 10.1021/ja071364v; Buhl M, 2006, J CHEM THEORY COMPUT, V2, P1282, DOI 10.1021/ct6001187; Bykov D, 2014, J BIOL INORG CHEM, V19, P97, DOI 10.1007/s00775-013-1065-6; Crowell JK, 2016, ARCH BIOCHEM BIOPHYS, V604, P86, DOI 10.1016/j.abb.2016.06.009; Crowell JK, 2014, BIOCHEMISTRY-US, V53, P7541, DOI 10.1021/bi501241d; Dajnowicz S, 2017, J BIOL CHEM, V292, P5970, DOI 10.1074/jbc.M116.774588; Davies CG, 2014, BIOCHEMISTRY-US, V53, P7961, DOI 10.1021/bi501277a; Deth R, 2008, NEUROTOXICOLOGY, V29, P190, DOI 10.1016/j.neuro.2007.09.010; Dikanov SA, 1998, J AM CHEM SOC, V120, P6797, DOI 10.1021/ja9742343; Dominy JE, 2008, J BIOL CHEM, V283, P12188, DOI 10.1074/jbc.M800044200; Dominy JE, 2006, J BACTERIOL, V188, P5561, DOI 10.1128/JB.00291-06; Driggers C. M., 2015, ENCY INORGANIC BIOIN; Driggers CM, 2016, J MOL BIOL, V428, P3999, DOI 10.1016/j.jmb.2016.07.012; Driggers CM, 2015, PROTEIN SCI, V24, P154, DOI 10.1002/pro.2587; Driggers CM, 2013, J MOL BIOL, V425, P3121, DOI 10.1016/j.jmb.2013.05.028; Dominy J, 2007, J BIOL CHEM, V282, P25189, DOI 10.1074/jbc.M703089200; Easson LH, 1933, BIOCHEM J, V27, P1257, DOI 10.1042/bj0271257; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENEMARK JH, 1974, COORDIN CHEM REV, V13, P339, DOI 10.1016/S0010-8545(00)80259-3; EWETZ L, 1966, BIOCHIM BIOPHYS ACTA, V128, P296, DOI 10.1016/0926-6593(66)90176-7; Fellner M, 2016, J BIOL INORG CHEM, V21, P501, DOI 10.1007/s00775-016-1360-0; Fellner M, 2016, BIOCHEMISTRY-US, V55, P1362, DOI 10.1021/acs.biochem.5b01203; Fernandez RL, 2020, BIOCHEMISTRY-US, V59, P2450, DOI 10.1021/acs.biochem.0c00267; Fischer AA, 2019, INORG CHEM, V58, P16487, DOI 10.1021/acs.inorgchem.9b02432; Fischer AA, 2016, INORG CHEM, V55, P11839, DOI 10.1021/acs.inorgchem.6b01931; GORDON C, 1992, LANCET, V339, P25, DOI 10.1016/0140-6736(92)90144-R; Gordon JB, 2018, J AM CHEM SOC, V140, P14807, DOI 10.1021/jacs.8b08349; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; HEAFIELD MT, 1990, NEUROSCI LETT, V110, P216, DOI 10.1016/0304-3940(90)90814-P; HENDRICH MP, 1992, J BIOL CHEM, V267, P261; James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611; Jers C, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00124; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kampa M, 2012, J BIOL INORG CHEM, V17, P1269, DOI 10.1007/s00775-012-0941-9; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar V, 2013, BIOTECHNOL ADV, V31, P945, DOI 10.1016/j.biotechadv.2013.02.008; Lebedev AA, 2006, ACTA CRYSTALLOGR D, V62, P83, DOI 10.1107/S0907444905036759; Lebedev AA, 2014, ACTA CRYSTALLOGR D, V70, P2430, DOI 10.1107/S1399004714014795; Li W, 2015, ARCH BIOCHEM BIOPHYS, V565, P49, DOI 10.1016/j.abb.2014.11.004; Li W, 2013, BIOCHEMISTRY-US, V52, P9104, DOI 10.1021/bi4010232; LOMBARDINI JB, 1969, J BIOL CHEM, V244, P1172; Martinie RJ, 2015, J AM CHEM SOC, V137, P6912, DOI 10.1021/jacs.5b03370; Masson N, 2019, SCIENCE, V365, P65, DOI 10.1126/science.aaw0112; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy JG, 2006, P NATL ACAD SCI USA, V103, P3084, DOI 10.1073/pnas.0509262103; McCracken J, 2021, APPL MAGN RESON, V52, P971, DOI 10.1007/s00723-020-01288-w; McCracken J, 2015, BIOCHEMISTRY-US, V54, P3759, DOI 10.1021/acs.biochem.5b00363; Mitchell AJ, 2017, J AM CHEM SOC, V139, P13830, DOI 10.1021/jacs.7b07374; Morrow WP, 2017, ARCH BIOCHEM BIOPHYS, V631, P66, DOI 10.1016/j.abb.2017.08.013; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neese F, 2018, WIRES COMPUT MOL SCI, V8, DOI 10.1002/wcms.1327; Neese F, 2009, CHEM PHYS, V356, P98, DOI 10.1016/j.chemphys.2008.10.036; Njeri CW, 2014, ARCH BIOCHEM BIOPHYS, V558, P61, DOI 10.1016/j.abb.2014.06.001; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce BS, 2007, BIOCHEMISTRY-US, V46, P8569, DOI 10.1021/bi700662d; Pierce BS, 2015, BIOCHEMISTRY-US, V54, P7477, DOI 10.1021/acs.biochem.5b00636; Poon BK, 2010, ACTA CRYSTALLOGR D, V66, P503, DOI 10.1107/S0907444910001502; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Romelt M, 2009, INORG CHEM, V48, P784, DOI 10.1021/ic801535v; Salaudeen AA, 2008, POLYHEDRON, V27, P2569, DOI 10.1016/j.poly.2008.05.013; Sardar S, 2019, BIOCHEMISTRY-US, V58, P5135, DOI 10.1021/acs.biochem.9b00674; Silva AMN, 2009, BIOMETALS, V22, P771, DOI 10.1007/s10534-009-9224-5; Simmons CR, 2006, J BIOL CHEM, V281, P18723, DOI 10.1074/jbc.M601555200; SORBO B, 1965, BIOCHEM BIOPH RES CO, V18, P359, DOI 10.1016/0006-291X(65)90714-X; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Tchesnokov EP, 2015, J BIOL CHEM, V290, P24424, DOI 10.1074/jbc.M114.635672; Todd AE, 2002, TRENDS BIOCHEM SCI, V27, P419, DOI 10.1016/S0968-0004(02)02158-8; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tyler LA, 2003, INORG CHEM, V42, P5751, DOI 10.1021/ic030088s; VAHTRAS O, 1993, CHEM PHYS LETT, V213, P514, DOI 10.1016/0009-2614(93)89151-7; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; Weits DA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4425; White MD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14690; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winyard PG, 2005, TRENDS BIOCHEM SCI, V30, P453, DOI 10.1016/j.tibs.2005.06.001; Ye S, 2007, J BIOL CHEM, V282, P3391, DOI 10.1074/jbc.M609337200; Ye SF, 2010, J AM CHEM SOC, V132, P4739, DOI 10.1021/ja909715g; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3; Yu CP, 2018, J AM CHEM SOC, V140, P15190, DOI 10.1021/jacs.8b10077; Zwart PH, 2008, ACTA CRYSTALLOGR D, V64, P99, DOI 10.1107/S090744490705531X	92	7	7	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100492	10.1016/j.jbc.2021.100492	http://dx.doi.org/10.1016/j.jbc.2021.100492			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33662397	Green Published, gold, Green Submitted			2022-12-26	WOS:000672866400466
J	Cui, YX; Yang, MM; Wang, YL; Ren, JN; Lin, P; Cui, C; Song, J; He, Q; Hu, HQ; Wang, KX; Sun, Y				Cui, Yixin; Yang, Mengmeng; Wang, Yilin; Ren, Jianmin; Lin, Peng; Cui, Chen; Song, Jia; He, Qin; Hu, Huiqing; Wang, Kexin; Sun, Yu			Melatonin prevents diabetes-associated cognitive dysfunction from microglia-mediated neuroinflammation by activating autophagy via TLR4/Akt/mTOR pathway	FASEB JOURNAL			English	Article						apoptosis; autophagy; cognition; melatonin; neuroinflammation	NF-KAPPA-B; METABOLIC-DISORDERS; OXIDATIVE STRESS; INFLAMMATION; IMPAIRMENT; EXPRESSION; APOPTOSIS; HIPPOCAMPUS; SEX	Cognitive dysfunction often occurs in diabetes mellitus patients. This study aimed to investigate the efficacy of melatonin (MLT) in improving diabetes-associated cognitive decline and the underlying mechanism involved. Type 2 diabetic mice and palmitic acid (PA)-stimulated BV-2 cells were treated by MLT, and the potential mechanisms among MLT, cognition, and autophagy were explored. The results showed that type 2 diabetic mice showed obvious learning and memory impairments in the Morris water maze test compared with normal controls, which could be ameliorated by MLT treatment. Meanwhile, MLT administration significantly improved neuroinflammation and regulated microglial apoptosis. Furthermore, autophagy inhibitor 3-methyladenine (3-MA) increased the microglial inflammation and apoptosis, indicating that the treatment effect of MLT was mediated by autophagy. Lastly, MLT treatment significantly decreased the levels of toll-like receptors 4 (TLR4), phosphorylated-protein kinase B (Akt), and phosphorylated-mechanistic target of rapamycin (mTOR), indicating that blocking TLR4/Akt/mTOR pathway might be an underlying basis for the anti-inflammatory and anti-apoptosis effects of MLT. Collectively, our study suggested that MLT could improve learning and memory in type 2 diabetic mice by activating autophagy via the TLR4/Akt/mTOR pathway, thereby inhibiting neuroinflammation and microglial apoptosis.	[Cui, Yixin; Yang, Mengmeng; Ren, Jianmin; Lin, Peng; Cui, Chen; Song, Jia; He, Qin; Hu, Huiqing; Sun, Yu] Shandong Univ, Qilu Hosp, Dept Endocrinol, Jinan, Peoples R China; [Cui, Yixin; Yang, Mengmeng; Ren, Jianmin; Lin, Peng; Cui, Chen; Song, Jia; He, Qin; Hu, Huiqing; Sun, Yu] Shandong Univ, Inst Endocrine & Metab Dis, Jinan, Peoples R China; [Wang, Yilin] Peking Univ, Dept Traumat Orthoped, Peoples Hosp, Beijing, Peoples R China; [Ren, Jianmin; Lin, Peng; He, Qin; Sun, Yu] Shandong Prov Med & Hlth, Key Lab Endocrine & Metab Dis, Jinan, Peoples R China; [Ren, Jianmin; Lin, Peng; He, Qin; Sun, Yu] Jinan Clin Res Ctr Endocrine & Metab Dis, Jinan, Peoples R China; [Wang, Kexin] Shandong Univ, Qilu Hosp, Dept Gen Surg, Jinan 250012, Shandong, Peoples R China	Shandong University; Shandong University; Peking University; Shandong University	Wang, KX (corresponding author), Shandong Univ, Qilu Hosp, Dept Gen Surg, Jinan 250012, Shandong, Peoples R China.; Sun, Y (corresponding author), Shandong Univ, Qilu Hosp, Dept Endocrinol, Inst Endocrinol & Metab, Jinan 250012, Shandong, Peoples R China.	wkx3726@163.com; 18560083995@163.com			National Natural Science Foundation of China [82070852, 81873650, 82070799]; Natural Science Foundation of Shandong Province [ZR2020MH105]; Fundamental research funds of Shandong University [2018JC015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Fundamental research funds of Shandong University	National Natural Science Foundation of China, Grant/Award Number: 82070852, 81873650 and 82070799; Natural Science Foundation of Shandong Province, Grant/Award Number: ZR2020MH105; Fundamental research funds of Shandong University, Grant/Award Number: 2018JC015	Baydas G, 2002, NEUROSCI LETT, V326, P109, DOI 10.1016/S0304-3940(02)00328-2; Benloucif S, 2008, J CLIN SLEEP MED, V4, P66; Chang CP, 2013, CELL DEATH DIFFER, V20, P515, DOI 10.1038/cdd.2012.146; Cho MH, 2014, AUTOPHAGY, V10, P1761, DOI 10.4161/auto.29647; Corpas R, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12515; Espeland MA, 2018, ALZHEIMERS DEMENT, V14, P1184, DOI 10.1016/j.jalz.2018.05.015; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Fernandez-Gil BI, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7187128; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Han HE, 2013, BIOMOL THER, V21, P21, DOI 10.4062/biomolther.2012.089; Hu Y, 2016, AUTOPHAGY, V12, P2286, DOI 10.1080/15548627.2016.1230584; Kahya MC, 2017, MOL NEUROBIOL, V54, P2345, DOI 10.1007/s12035-016-9727-3; Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-1137; Kim J, 2011, BRAIN RES, V1418, P42, DOI 10.1016/j.brainres.2011.08.059; Kliosnky D, 2016, AUTOPHAGY, V12, P443, DOI 10.1080/15548627.2016.1147886; Lee JW, 2019, AUTOPHAGY, V15, P753, DOI 10.1080/15548627.2018.1556946; Lo CC, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111187; Luengo E, 2019, J PINEAL RES, V67, DOI 10.1111/jpi.12578; Machado I, 2015, BRAIN BEHAV IMMUN, V46, P137, DOI 10.1016/j.bbi.2015.01.012; Matsuzawa-Ishimoto Y, 2018, ANNU REV IMMUNOL, V36, P73, DOI 10.1146/annurev-immunol-042617-053253; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Obayashi K, 2018, CLIN ENDOCRINOL, V89, P750, DOI 10.1111/cen.13842; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Qiao JT, 2018, METABOLISM, V81, P13, DOI 10.1016/j.metabol.2017.09.010; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Rawlings AM, 2019, DIABETES CARE, V42, P1248, DOI 10.2337/dc19-0120; Rawlings AM, 2014, ANN INTERN MED, V161, P785, DOI 10.7326/M14-0737; Robert G, 2012, AUTOPHAGY, V8, P637, DOI 10.4161/auto.19084; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanchez A, 2015, INT J MOL SCI, V16, P16981, DOI 10.3390/ijms160816981; Srinivasan M, 2015, EXPERT OPIN THER TAR, V19, P471, DOI 10.1517/14728222.2014.989834; Tuzcu M, 2006, EUR J PHARMACOL, V537, P106, DOI 10.1016/j.ejphar.2006.03.024; Wang KW, 2015, CELL CYCLE, V14, P1631, DOI 10.1080/15384101.2015.1038685; Wang KX, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/1567179; Wang SJ, 2018, J CELL MOL MED, V22, P5132, DOI 10.1111/jcmm.13802; Wei J, 2020, AM J TRANSL RES, V12, P1584; Wu X, 2018, BRAIN BEHAV IMMUN, V73, P533, DOI 10.1016/j.bbi.2018.06.018; Xia MZ, 2012, J PINEAL RES, V53, P325, DOI 10.1111/j.1600-079X.2012.01002.x; Xu JQ, 2019, J PINEAL RES, V67, DOI 10.1111/jpi.12584; Yang L, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190225; Yang L, 2018, CELL STRESS CHAPERON, V23, P1283, DOI 10.1007/s12192-018-0936-8; Yang YJ, 2019, NEUROPSYCHOPHARMACOL, V44, P2054, DOI 10.1038/s41386-019-0437-1; Yates KF, 2012, ARTERIOSCL THROM VAS, V32, P2060, DOI 10.1161/ATVBAHA.112.252759; Zemdegs J, 2016, BRIT J PHARMACOL, V173, P2095, DOI 10.1111/bph.13343; Zhai ME, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12419; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zhao LC, 2018, MOL CELL PROTEOMICS, V17, P2335, DOI 10.1074/mcp.RA118.000690; Zonis S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0281-0	49	9	9	4	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21485	10.1096/fj.202002247RR	http://dx.doi.org/10.1096/fj.202002247RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33709562	hybrid			2022-12-26	WOS:000635216100025
J	Almeida, CF; Bitoun, M; Vainzof, M				F. Almeida, Camila; Bitoun, Marc; Vainzof, Mariz			Satellite cells deficiency and defective regeneration in dynamin 2-related centronuclear myopathy	FASEB JOURNAL			English	Article						congenital; GTPase; injury; muscle; stem cell		Dynamin 2 (DNM2) is a ubiquitously expressed protein involved in many functions related to trafficking and remodeling of membranes and cytoskeleton dynamics. Mutations in the DNM2 gene cause the autosomal dominant centronuclear myopathy (AD-CNM), characterized mainly by muscle weakness and central nuclei. Several defects have been identified in the KI-Dnm2(R465W/+) mouse model of the disease to explain the muscle phenotype, including reduction of the satellite cell pool in muscle, but the functional consequences of this depletion have not been characterized until now. Satellite cells (SC) are the main source for muscle growth and regeneration of mature tissue. Here, we investigated muscle regeneration in the KI-Dnm2(R465W/+) mouse model for AD-CNM. We found a reduced number of Pax7-positive SCs, which were also less activated after induced muscle injury. The muscles of the KI-Dnm2(R465W/+) mouse regenerated more slowly and less efficiently than wild-type ones, formed fewer new myofibers, and did not recover its normal mass 15 days after injury. Altogether, our data provide evidence that the muscle regeneration is impaired in the KI-Dnm2(R465W/+) mouse and contribute with one more layer to the comprehension of the disease, by identifying a new pathomechanism linked to DNM2 mutations which may be involved in the muscle-specific impact occurring in AD-CNM.	[F. Almeida, Camila; Vainzof, Mariz] Univ Sao Paulo, Lab Muscle Prot & Comparat Histopathol, Human Genome & Stem Cell Res Ctr, Biosci Inst, Sao Paulo, Brazil; [F. Almeida, Camila; Bitoun, Marc] Sorbonne Univ, INSERM, Inst Myol, Ctr Res Myol,UMRS 974, Paris, France; [F. Almeida, Camila] Ohio State Univ, Dept Pediat, Ctr Gene Therapy, Nationwide Childrens Hosp, Columbus, OH 43210 USA	Universidade de Sao Paulo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Vainzof, M (corresponding author), IBUSP, Human Genome & Stem Cell Res Ctr, Rua Matao,106 Cidade Univ, BR-05508900 Sao Paulo, SP, Brazil.	mvainzof@usp.br	Vainzof, Mariz/J-7150-2012; Bitoun, Marc/M-4720-2017; de Freitas Almeida, Camila/L-6601-2013	Vainzof, Mariz/0000-0002-2797-0782; Bitoun, Marc/0000-0002-4188-7918; de Freitas Almeida, Camila/0000-0003-2652-2205	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Centro de Pesquisa, Inovacao e Difusao (FAPESP-CEPID) [2013/08028-1, 2015/18914-4, 2017/07376-7]; MCTI | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [456522/2014-0]; MCTI | Financiadora de Estudos e Projetos (FINEP) [01.08.0579.00]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Centro de Pesquisa, Inovacao e Difusao (FAPESP-CEPID)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); MCTI | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MCTI | Financiadora de Estudos e Projetos (FINEP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Centro de Pesquisa, Inovacao e Difusao (FAPESP-CEPID grants 2013/08028-1, 2015/18914-4, and 2017/07376-7); MCTI | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Grant/Award Number: 456522/2014-0; MCTI | Financiadora de Estudos e Projetos (FINEP), Grant/Award Number: 01.08.0579.00	Abou-Khalil R, 2010, CELL CYCLE, V9, P2575, DOI 10.4161/cc.9.13.12149; Almeida CF, 2020, METHODS MOL BIOL, V2063, P157, DOI 10.1007/978-1-0716-0138-9_12; Almeida CF, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1078686; Bachman JF, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.167197; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Bitoun M, 2007, ANN NEUROL, V62, P666, DOI 10.1002/ana.21235; Bitoun M, 2009, HUM MUTAT, V30, P1419, DOI 10.1002/humu.21086; Bohm J, 2012, HUM MUTAT, V33, P949, DOI 10.1002/humu.22067; Castets P, 2011, HUM MOL GENET, V20, P694, DOI 10.1093/hmg/ddq515; Dumont NA, 2015, NAT MED, V21, P1455, DOI 10.1038/nm.3990; Durieux AC, 2010, HUM MOL GENET, V19, P4820, DOI 10.1093/hmg/ddq413; Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4; Feichtinger RG, 2019, GENET MED, V21, P2521, DOI 10.1038/s41436-019-0532-z; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Fischer D, 2006, BRAIN, V129, P1463, DOI 10.1093/brain/awl071; Fongy A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38184-0; Franck A, 2019, MOL BIOL CELL, V30, P579, DOI 10.1091/mbc.E18-11-0718; Fraysse B, 2016, BIOL OPEN, V5, P1691, DOI 10.1242/bio.020263; Garry GA, 2016, METHODS MOL BIOL, V1460, P61, DOI 10.1007/978-1-4939-3810-0_6; Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059; Gonzalez-Jamett AM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04418-w; Hanisch F, 2011, J NEUROL, V258, P1085, DOI 10.1007/s00415-010-5889-5; Hardy D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147198; Heslop L, 2000, J CELL SCI, V113, P2299; Keefe AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8087; Kenniston JA, 2010, EMBO J, V29, P3054, DOI 10.1038/emboj.2010.187; Kudryashova E, 2012, J CLIN INVEST, V122, P1764, DOI 10.1172/JCI59581; Kutchukian C, 2017, J PHYSIOL-LONDON, V595, P7369, DOI 10.1113/JP274990; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lawlor MW, 2012, AM J PATHOL, V181, P961, DOI 10.1016/j.ajpath.2012.05.016; Leikina E, 2013, J CELL BIOL, V200, P109, DOI 10.1083/jcb.201207012; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Ribeiro AF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48156-7; Romero NB, 2011, SEMIN PEDIATR NEUROL, V18, P250, DOI 10.1016/j.spen.2011.10.006; ROSE DSC, 1994, J CLIN PATHOL, V47, P1010, DOI 10.1136/jcp.47.11.1010; Ross J, 2012, STEM CELLS, V30, P2330, DOI 10.1002/stem.1197; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Sambuughin N, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0481-3; Schiaffino S, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0046-6; Schultz E, 1996, DEV BIOL, V175, P84, DOI 10.1006/dbio.1996.0097; Sewry CA, 2017, NEUROPATH APPL NEURO, V43, P5, DOI 10.1111/nan.12369; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Sidiropoulos PNM, 2012, BRAIN, V135, P1395, DOI 10.1093/brain/aws061; Soleimani VD, 2012, DEV CELL, V22, P1208, DOI 10.1016/j.devcel.2012.03.014; Warnock DE, 1997, MOL BIOL CELL, V8, P2553, DOI 10.1091/mbc.8.12.2553; Zammit PS, 2017, SEMIN CELL DEV BIOL, V72, P19, DOI 10.1016/j.semcdb.2017.11.011	51	4	4	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21346	10.1096/fj.202001313RRR	http://dx.doi.org/10.1096/fj.202001313RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715228	Green Submitted			2022-12-26	WOS:000635216100090
J	Zapata-Perez, R; Tammaro, A; Schomakers, BV; Scantlebery, AML; Denis, S; Elfrink, HL; Giroud-Gerbetant, J; Canto, C; Lopez-Leonardo, C; McIntyre, RL; van Weeghel, M; Sanchez-Ferrer, A; Houtkooper, RH				Zapata-Perez, Ruben; Tammaro, Alessandra; Schomakers, Bauke V.; Scantlebery, Angelique M. L.; Denis, Simone; Elfrink, Hyung L.; Giroud-Gerbetant, Judith; Canto, Carles; Lopez-Leonardo, Carmen; McIntyre, Rebecca L.; van Weeghel, Michel; Sanchez-Ferrer, Alvaro; Houtkooper, Riekelt H.			Reduced nicotinamide mononucleotide is a new and potent NAD(+) precursor in mammalian cells and mice	FASEB JOURNAL			English	Article						metabolism; NAD(+); NMNH; nicotinamide mononucleotide		Nicotinamide adenine dinucleotide (NAD(+)) homeostasis is constantly compromised due to degradation by NAD(+)-dependent enzymes. NAD(+) replenishment by supplementation with the NAD(+) precursors nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) can alleviate this imbalance. However, NMN and NR are limited by their mild effect on the cellular NAD(+) pool and the need of high doses. Here, we report a synthesis method of a reduced form of NMN (NMNH), and identify this molecule as a new NAD(+) precursor for the first time. We show that NMNH increases NAD(+) levels to a much higher extent and faster than NMN or NR, and that it is metabolized through a different, NRK and NAMPT-independent, pathway. We also demonstrate that NMNH reduces damage and accelerates repair in renal tubular epithelial cells upon hypoxia/reoxygenation injury. Finally, we find that NMNH administration in mice causes a rapid and sustained NAD(+) surge in whole blood, which is accompanied by increased NAD(+) levels in liver, kidney, muscle, brain, brown adipose tissue, and heart, but not in white adipose tissue. Together, our data highlight NMNH as a new NAD(+) precursor with therapeutic potential for acute kidney injury, confirm the existence of a novel pathway for the recycling of reduced NAD(+) precursors and establish NMNH as a member of the new family of reduced NAD(+) precursors.	[Zapata-Perez, Ruben; Schomakers, Bauke V.; Scantlebery, Angelique M. L.; Denis, Simone; Elfrink, Hyung L.; McIntyre, Rebecca L.; van Weeghel, Michel; Houtkooper, Riekelt H.] Univ Amsterdam, Amsterdam UMC, Amsterdam Gastroenterol Endocrinol & Metab, Lab Genet Metab Dis,Amsterdam Cardiovasc Sci, Meibergdreef 9, Amsterdam, Netherlands; [Tammaro, Alessandra] Univ Amsterdam, Amsterdam UMC, Pathol Dept, Amsterdam, Netherlands; [Schomakers, Bauke V.; Elfrink, Hyung L.; van Weeghel, Michel] Univ Amsterdam, Amsterdam UMC, Core Facil Metabol, Amsterdam, Netherlands; [Giroud-Gerbetant, Judith; Canto, Carles] Nestle Res, Nestle Inst Hlth Sci, Lausanne, Switzerland; [Lopez-Leonardo, Carmen] Univ Murcia, Dept Organ Chem, Murcia, Spain; [Sanchez-Ferrer, Alvaro] Univ Murcia, Dept Biochem & Mol Biol A, Murcia, Spain	University of Amsterdam; University of Amsterdam; University of Amsterdam; Nestle SA; University of Murcia; University of Murcia	Zapata-Perez, R; Houtkooper, RH (corresponding author), Univ Amsterdam, Amsterdam UMC, Amsterdam Gastroenterol Endocrinol & Metab, Lab Genet Metab Dis,Amsterdam Cardiovasc Sci, Meibergdreef 9, Amsterdam, Netherlands.	r.zapataperez@amsterdamumc.nl; r.h.houtkooper@amsterdamumc.nl	Houtkooper, Riekelt/P-5001-2019; Zapata-Perez, Ruben/AAA-9782-2020; Sanchez-Ferrer, Alvaro/M-1631-2014	Zapata-Perez, Ruben/0000-0003-4432-9652; Canto, Carles/0000-0002-5167-7922; Giroud-Gerbetant, Judith/0000-0001-6847-5721; Tammaro, Alessandra/0000-0003-3128-5259; Sanchez-Ferrer, Alvaro/0000-0001-7266-4402; Houtkooper, Riekelt/0000-0001-9961-0842	NWO-FAPESP [457002002]; European Union's Horizon 2020; ERC Starting grant [638290]; ZonMw [91715305]; Velux Stiftung [1063]; MINECO-FEDER [BIO2013-45336-R]; Ayudas a los Grupos y Unidades de Excelencia Cientifica de la Region de Murcia; Fundacion Seneca-Agencia de Ciencia y Tecnologia de la Region de Murcia [19893/GERM/15];  [840110]	NWO-FAPESP; European Union's Horizon 2020; ERC Starting grant(European Research Council (ERC)); ZonMw(Netherlands Organization for Health Research and Development); Velux Stiftung; MINECO-FEDER; Ayudas a los Grupos y Unidades de Excelencia Cientifica de la Region de Murcia; Fundacion Seneca-Agencia de Ciencia y Tecnologia de la Region de Murcia(Fundacion Seneca); 	NWO-FAPESP, Grant/Award Number: 457002002; European Union's Horizon 2020; Marie Sklodowska-Curie, Grant/Award Number: 840110; ERC Starting grant, Grant/Award Number: 638290; ZonMw, Grant/Award Number: 91715305; Velux Stiftung, Grant/Award Number: 1063; MINECO-FEDER, Grant/Award Number: BIO2013-45336-R; Ayudas a los Grupos y Unidades de Excelencia Cientifica de la Region de Murcia, Fundacion Seneca-Agencia de Ciencia y Tecnologia de la Region de Murcia, Grant/Award Number: 19893/GERM/15	Abdelraheim SR, 2017, PROTEIN J, V36, P425, DOI 10.1007/s10930-017-9734-x; Abdelraheim SR, 2003, BIOCHEM J, V374, P329, DOI 10.1042/BJ20030441; Ago T, 2010, CIRC RES, V106, P1253, DOI 10.1161/CIRCRESAHA.109.213116; Airhart SE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186459; Ansari HR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-160; ASH SR, 1970, AM J PATHOL, V60, P385; Benyo Z, 2005, J CLIN INVEST, V115, P3634, DOI 10.1172/JCI23626; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Bonventre Joseph V, 2014, Trans Am Clin Climatol Assoc, V125, P293; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Cao LJ, 2017, FREE RADICAL BIO MED, V112, P433, DOI 10.1016/j.freeradbiomed.2017.08.011; Chung KW, 2019, CELL METAB, V30, P784, DOI 10.1016/j.cmet.2019.08.003; Connell NJ, 2019, DIABETOLOGIA, V62, P888, DOI 10.1007/s00125-019-4831-3; Conze D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46120-z; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Dollerup OL, 2018, AM J CLIN NUTR, V108, P343, DOI 10.1093/ajcn/nqy132; Elena-Real CA, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0408-1; Elhassan YS, 2019, CELL REP, V28, P1717, DOI 10.1016/j.celrep.2019.07.043; FRICK DN, 1995, J BIOL CHEM, V270, P1529, DOI 10.1074/jbc.270.4.1529; Garavaglia S, 2012, BIOCHEM J, V441, P131, DOI 10.1042/BJ20111263; Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245; Giroud-Gerbetant J, 2019, MOL METAB, V30, P192, DOI 10.1016/j.molmet.2019.09.013; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Goodman RP, 2020, NATURE, V583, P122, DOI 10.1038/s41586-020-2337-2; Grozio A, 2019, NAT METAB, V1, P47, DOI 10.1038/s42255-018-0009-4; Grozio A, 2013, J BIOL CHEM, V288, P25938, DOI 10.1074/jbc.M113.470435; Guan Y, 2017, J AM SOC NEPHROL, V28, P2337, DOI 10.1681/ASN.2016040385; Hosios AM, 2018, J BIOL CHEM, V293, P7490, DOI 10.1074/jbc.TM117.000239; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Huang SZ, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005233; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Ishibashi N, 1999, J IMMUNOL, V163, P5666; KATO T, 1973, ANAL BIOCHEM, V53, P86, DOI 10.1016/0003-2697(73)90409-0; Khamchun S, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0123-9; Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943; Kim J, 2015, AM J PHYSIOL-RENAL, V308, pF298, DOI 10.1152/ajprenal.00459.2014; Lan RP, 2016, J AM SOC NEPHROL, V27, P3356, DOI 10.1681/ASN.2015020177; Langley B, 2013, NEUROTHERAPEUTICS, V10, P605, DOI 10.1007/s13311-013-0214-5; Leung AKL, 2017, CURR BIOL, V27, pR1256, DOI 10.1016/j.cub.2017.09.054; Love NR, 2015, P NATL ACAD SCI USA, V112, P1386, DOI 10.1073/pnas.1417290112; MANDEL LJ, 1990, J CLIN INVEST, V85, P316, DOI 10.1172/JCI114440; Martens CR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03421-7; Martin DR, 2000, AM J PHYSIOL-REG I, V279, pR1834, DOI 10.1152/ajpregu.2000.279.5.R1834; Mills KF, 2016, CELL METAB, V24, P795, DOI 10.1016/j.cmet.2016.09.013; Mouchiroud L, 2013, CRIT REV BIOCHEM MOL, V48, P397, DOI 10.3109/10409238.2013.789479; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Mukherjee S, 2017, HEPATOLOGY, V65, P616, DOI 10.1002/hep.28912; Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698; PALLER MS, 1992, J AM SOC NEPHROL, V2, P1338; Pulskens WP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003596; Ralto KM, 2020, NAT REV NEPHROL, V16, P99, DOI 10.1038/s41581-019-0216-6; Ratajczak J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13103; Remie CME, 2020, AM J CLIN NUTR, V112, P413, DOI 10.1093/ajcn/nqaa072; Ren HL, 2018, MED SCI MONITOR, V24, P1132, DOI 10.12659/MSM.908954; Riss TL, 2004, CELL VIABILITY ASSAY; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ryu D, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5504; Scantlebery AML, 2021, J PATHOL, V253, P404, DOI 10.1002/path.5605; Stokman G, 2011, J AM SOC NEPHROL, V22, P859, DOI 10.1681/ASN.2010040423; Stokman G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014386; Tammaro A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01346; Trammell SAJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12948; Wei Wenjie, 2014, World J Biol Chem, V5, P58, DOI 10.4331/wjbc.v5.i1.58; Xiao WS, 2018, ANTIOXID REDOX SIGN, V28, P251, DOI 10.1089/ars.2017.7216; Yang B, 2001, J AM SOC NEPHROL, V12, P275, DOI 10.1681/ASN.V122275; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yang Y, 2019, J BIOL CHEM, V294, P9295, DOI 10.1074/jbc.RA118.005772; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zennaro MC, 1998, J CLIN INVEST, V101, P1254, DOI 10.1172/JCI1915; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693; Zhou HL, 2019, NATURE, V565, P96, DOI 10.1038/s41586-018-0749-z	73	20	21	8	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21456	10.1096/fj.202001826R	http://dx.doi.org/10.1096/fj.202001826R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33724555	hybrid			2022-12-26	WOS:000635216100078
J	Pu, J; Mei, H; Lei, L; Li, DW; Zhao, JK; Li, B; Wang, HY; Ma, Y; Du, XB				Pu, Jing; Mei, He; Lei, Li; Li, Daiwen; Zhao, Jiekun; Li, Bin; Wang, Haiyan; Ma, Ying; Du, Xiao Bo			Knowledge of medical professionals, their practices, and their attitudes toward traditional Chinese medicine for the prevention and treatment of coronavirus disease 2019: A survey in Sichuan, China	PLOS ONE			English	Article							WECHAT	This study aimed to investigate the knowledge, practices, and attitudes of medical professionals toward Traditional Chinese Medicine (TCM) for the prevention and treatment of coronavirus disease 2019 (COVID-19). All 401 medical professionals were surveyed using an anonymous with an investigator using the Questionnaire star APP. The participants answered 14 questions; of the 401 participants, 55.2% agreed with the statement "TCM can be used for the prevention and treatment of COVID-19," 40.4% remained neutral, and 4.4% disagreed. Moreover, 75.3% agreed with the statement "There is no specific drug for COVID-19," 67% agreed with the statement "TCM can develop immunity to COVID-19" and 62.1% agreed with "TCM can alleviate the symptoms of patients with COVID-19." Meanwhile, 69.1% were aware that TCM has been recommended for COVID-19 by the National Health Commission of the People's Republic of China. Regarding the selection of sources of knowledge on whether "TCM can be used for the prevention and treatment of COVID-19," There were 277, 123, 82, 369, and 17 participants selected sources from "Hospital training," "Academic journals," "Academic Conferences," "Social media platforms (such as WeChat)" and "Others," respectively. Further, 358 participants will take TCM for the prevention of COVID-19. Multiple logistic regression analysis showed that age, major and received TCM treatment within the last five years were independent factors affecting the participants' attitudes. In the absence of specific drugs for COVID-19, more than half of the participants agreed that TCM could be used for the prevention and treatment of COVID-19 and most participants are willing to take TCM to prevent COVID-19, although unsure about its effectiveness. The main information sources on TCM for the treatment and prevention of COVID-19 were social platforms and hospital training.	[Pu, Jing; Lei, Li; Li, Daiwen; Zhao, Jiekun; Li, Bin] Mianyang Cent Hosp, Dept Tradit Chinese Med, Mianyang, Sichuan, Peoples R China; [Mei, He; Wang, Haiyan] Mianyang Cent Hosp, Dept Nursing, Mianyang, Sichuan, Peoples R China; [Ma, Ying] Mianyang Cent Hosp, Sci Res & Educ Dept, Mianyang, Sichuan, Peoples R China; [Du, Xiao Bo] Mianyang Cent Hosp, Dept Oncol, Mianyang, Sichuan, Peoples R China		Ma, Y (corresponding author), Mianyang Cent Hosp, Sci Res & Educ Dept, Mianyang, Sichuan, Peoples R China.; Du, XB (corresponding author), Mianyang Cent Hosp, Dept Oncol, Mianyang, Sichuan, Peoples R China.	1099435982@qq.com; duxiaobo2005@126.com		Du, Xiao-bo/0000-0001-6348-0636				Cao JL, 2020, CLIN INFECT DIS, V71, P748, DOI 10.1093/cid/ciaa243; Cao JL, 2020, INTENS CARE MED, V46, P851, DOI 10.1007/s00134-020-05987-7; Chinese Medical Association, NOT POSTP AC M CHIN; Chu CM, 2004, THORAX, V59, P252, DOI 10.1136/thorax.2003.012658; Fan LL, 2018, J INT MED RES, V46, P1709, DOI 10.1177/0300060518756244; Harmsworth K, 2001, SOC SCI MED, V52, P149, DOI 10.1016/S0277-9536(00)00124-6; Hon KLE, 2006, J NURS EDUC, V45, P182, DOI 10.3928/01484834-20060501-08; Hon KLE, 2005, AM J CHINESE MED, V33, P269, DOI 10.1142/S0192415X05002904; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Liu ZD, 2017, J TRADIT CHIN MED, V37, P261; Long XB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181895; Luo H, 2020, CHIN J INTEGR MED, V26, P243, DOI 10.1007/s11655-020-3192-6; Montag C, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02247; National Health Commission of the People's Republic of China, NOTICE PRINTING DIST; Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6; Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653; Shen LN, 2019, J MED INTERNET RES, V21, DOI 10.2196/13025; Wang J, 2017, BIOCHEM MOL BIOL EDU, V45, P421, DOI 10.1002/bmb.21065; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; Wang ZR, 2019, INT J NURS STUD, V98, P19, DOI 10.1016/j.ijnurstu.2019.06.001; Zhang W, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9607; Zhang XT, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0470-0; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	24	6	6	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0234855	10.1371/journal.pone.0234855	http://dx.doi.org/10.1371/journal.pone.0234855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY1VJ	33725021	gold, Green Published			2022-12-26	WOS:000629833700013
J	Wang, K; Yang, JC; Jang, YJ; Chen, GY; Zhang, YJ; Dai, YH; Zhang, DY; Wu, YC				Wang, Ke; Yang, Juan-Cheng; Jang, Yeong-Jiunn; Chen, Guan-Yu; Zhang, Ya-Jing; Dai, Yun-Hao; Zhang, Da-Yong; Wu, Yang-Chang			19-(Benzyloxy)-19-oxojolkinolide B (19-BJB), an ent-abietane diterpene diepoxide, inhibits the growth of bladder cancer T24 cells through DNA damage	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; JOLKINOLIDE-B; IN-VITRO; KAPPA-B; ACTIVATION; KINASE; REPAIR; CISPLATIN; APOPTOSIS; BINDING	Diterpenoids jolkinolide A and B, were first isolated from Euphorbia fischeriana. In our previous research, 19-(Benzyloxy)-19-oxojolkinolide B (19-BJB), a derivative of jolkinolides, was synthesized as a novel ent -abietane diterpene diepoxide. In this study, 19-BJB showed strong in vitro activity against bladder cancer cell lines. DNA damage which was observed through the interaction of 19-BJB with nucleotide chains and affected DNA repair resulted in the activation of checkpoint kinase 1 (Chk1) and checkpoint kinase 2 (Chk2) in bladder cancer cell lines. In vivo testing in nude mice also proved that 19-BJB revealed a potential inhibitory effect on tumor growth. Additionally, the 3D-QSAR models of jolkinolides were established. Briefly, we proved that 19-BJB could potentially be used as a drug to inhibit the growth of bladder tumor.	[Wang, Ke; Zhang, Ya-Jing; Zhang, Da-Yong] China Pharmaceut Univ, Dept Med Chem, Nanjing, Peoples R China; [Wang, Ke; Zhang, Ya-Jing; Zhang, Da-Yong] China Pharmaceut Univ, Ctr Drug Discovery, Nanjing, Peoples R China; [Wang, Ke; Wu, Yang-Chang] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Yang, Juan-Cheng; Jang, Yeong-Jiunn; Chen, Guan-Yu; Dai, Yun-Hao; Wu, Yang-Chang] China Med Univ Hosp, Chinese Med Res & Dev Ctr, Taichung, Taiwan; [Wu, Yang-Chang] Asia Univ, Coll Med & Hlth Sci, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan	China Pharmaceutical University; China Pharmaceutical University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Zhang, DY (corresponding author), China Pharmaceut Univ, Dept Med Chem, Nanjing, Peoples R China.; Zhang, DY (corresponding author), China Pharmaceut Univ, Ctr Drug Discovery, Nanjing, Peoples R China.; Wu, YC (corresponding author), China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan.; Wu, YC (corresponding author), China Med Univ Hosp, Chinese Med Res & Dev Ctr, Taichung, Taiwan.; Wu, YC (corresponding author), Asia Univ, Coll Med & Hlth Sci, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan.	zhangdayong@cpu.edu.cn; yachwu@gmail.com		Chen, Guan-Yu/0000-0002-2773-8748	National Natural Science Foundation of China [30973607, 81172934]; Ministry of Science and Technology of Taiwan [MOST 103-2911-I-002-303, MOST 104-2911-I-002-302, MOST 107-2320-B-037-001]; National Health Research Institutes of Taiwan [NHRI-EX104-10241BI]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan)	This research was funded by the National Natural Science Foundation of China (No. 30973607; No. 81172934); Ministry of Science and Technology of Taiwan (MOST 103-2911-I-002-303; MOST 104-2911-I-002-302; MOST 107-2320-B-037-001), National Health Research Institutes of Taiwan (NHRI-EX104-10241BI).	Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Caffo O, 2011, CANCER-AM CANCER SOC, V117, P1190, DOI 10.1002/cncr.25667; Canals A, 2005, ACTA CRYSTALLOGR D, V61, P1009, DOI 10.1107/S0907444905015404; CHENG KC, 1992, J BIOL CHEM, V267, P166; Dean N, 1996, CANCER RES, V56, P3499; Dominici L., 2011, International Journal of Probiotics and Prebiotics, V6, P179; Freitas RF, 2009, BIOORGAN MED CHEM, V17, P2476, DOI 10.1016/j.bmc.2009.01.079; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; GOVARDHAN C, 1984, PHYTOCHEMISTRY, V23, P411, DOI 10.1016/S0031-9422(00)80342-8; GRAY GD, 1993, CANCER RES, V53, P577; Hanson JR, 2015, NAT PROD REP, V32, P76, DOI 10.1039/c4np00108g; Huang TY, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13122; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Ji XH, 1997, BIOCHEMISTRY-US, V36, P9690, DOI 10.1021/bi970805s; Kanvah S, 2010, ACCOUNTS CHEM RES, V43, P280, DOI 10.1021/ar900175a; Karsten R., 1997, BIF FUTURA, V12, P20; Lee HP, 2019, J FUNCT FOODS, V52, P537, DOI 10.1016/j.jff.2018.11.040; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lenis AT, 2020, JAMA-J AM MED ASSOC, V324, P1980, DOI [10.1001/jama.2020.17598, 10.1001/jama.2020.17601]; Liu SC, 2017, SCI REP-UK, V7, DOI 10.1038/srep43205; Liu WK, 2002, BIOCHEM PHARMACOL, V63, P951, DOI 10.1016/S0006-2952(01)00938-8; Luo HY, 2006, CAN J PHYSIOL PHARM, V84, P959, DOI 10.1139/Y06-045; Ma XJ, 2014, BIOCHEM BIOPH RES CO, V445, P282, DOI 10.1016/j.bbrc.2014.01.145; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Man SL, 2012, PHYTOTHER RES, V26, P1449, DOI 10.1002/ptr.4609; McNeely S, 2014, PHARMACOL THERAPEUT, V142, P1, DOI 10.1016/j.pharmthera.2013.10.005; Moretti M, 2013, FOOD CHEM, V140, P660, DOI 10.1016/j.foodchem.2012.10.022; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Pascal JM, 2018, DNA REPAIR, V71, P177, DOI 10.1016/j.dnarep.2018.08.022; Prevost Gregoire Pierre, 2003, Prog Cell Cycle Res, V5, P225; Pu YS, 2001, J UROLOGY, V165, P2082, DOI 10.1016/S0022-5347(05)66298-2; Richters A, 2020, WORLD J UROL, V38, P1895, DOI 10.1007/s00345-019-02984-4; Rothkamm K, 2015, ENVIRON MOL MUTAGEN, V56, P491, DOI 10.1002/em.21944; Samanta SK, 2013, J MED CHEM, V56, P5709, DOI 10.1021/jm400290q; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Scully R, 2013, MUTAT RES-FUND MOL M, V750, P5, DOI 10.1016/j.mrfmmm.2013.07.007; Shi HM, 2005, PLANTA MED, V71, P349, DOI 10.1055/s-2005-864102; Shi LY, 2011, SYNTHESIS-STUTTGART, P3807, DOI 10.1055/s-0031-1289293; Shi QW, 2008, CHEM REV, V108, P4295, DOI 10.1021/cr078350s; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Thoh M, 2011, J BIOL CHEM, V286, P4690, DOI 10.1074/jbc.M110.169334; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Tichy A., 2012, MIL MED SCI LETT, V81, P176, DOI [10.31482/mmsl.2012.025, DOI 10.31482/MMSL.2012.025]; Uto T, 2012, INT IMMUNOPHARMACOL, V12, P101, DOI 10.1016/j.intimp.2011.10.020; Wang JH, 2011, MOL CELLS, V32, P451, DOI 10.1007/s10059-011-0137-0; Wang K, 2016, SYNTHESIS-STUTTGART, V48, P2245, DOI 10.1055/s-0035-1561598; Wang Y, 2009, CANCER RES, V69, P7302, DOI 10.1158/0008-5472.CAN-09-0462; Wu QC, 2009, MOLECULES, V14, P4454, DOI 10.3390/molecules14114454; Yan SS, 2008, MOL CANCER THER, V7, P1523, DOI 10.1158/1535-7163.MCT-08-0263; Yang HL, 2015, INT IMMUNOPHARMACOL, V26, P119, DOI 10.1016/j.intimp.2015.03.021; Yu Hong-Jeng, 1992, Journal of the Formosan Medical Association, V91, P608; Zhu CZ, 2014, SYNTHESIS-STUTTGART, V46, P2574, DOI 10.1055/s-0034-1378317	56	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0248468	10.1371/journal.pone.0248468	http://dx.doi.org/10.1371/journal.pone.0248468			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY1VJ	33724994	Green Published, gold			2022-12-26	WOS:000629833700029
J	Bernardo, L; Corallo, L; Caterini, J; Su, J; Gisonni-Lex, L; Gajewska, B				Bernardo, Lidice; Corallo, Lucas; Caterini, Judy; Su, Jin; Gisonni-Lex, Lucy; Gajewska, Beata			Application of xCELLigence real-time cell analysis to the microplate assay for pertussis toxin induced clustering in CHO cells	PLOS ONE			English	Article								The microplate assay with Chinese Hamster Ovary (CHO) cells is currently used as a safety test to monitor the residual pertussis toxin (PT) amount in acellular pertussis antigens prior to vaccine formulation. The assay is based on the findings that the exposure of CHO cells to PT results in a concentration-dependent clustering response which can be used to estimate the amount of PT in a sample preparation. A major challenge with the current CHO cell assay methodology is that scoring of PT-induced clustering is dependent on subjective operator visual assessment using light microscopy. In this work, we have explored the feasibility of replacing the microscopy readout for the CHO cell assay with the xCELLigence Real-Time Cell Analysis system (ACEA BioSciences, a part of Agilent). The xCELLigence equipment is designed to monitor cell adhesion and growth. The electrical impedance generated from cell attachment and proliferation is quantified via gold electrodes at the bottom of the cell culture plate wells, which is then translated into a unitless readout called cell index. Results showed significant decrease in the cell index readouts of CHO cells exposed to PT compared to the cell index of unexposed CHO cells. Similar endpoint concentrations were obtained when the PT reference standard was titrated with either xCELLigence or microscopy. Testing genetically detoxified pertussis samples unspiked or spiked with PT further supported the sensitivity and reproducibility of the xCELLigence assay in comparison with the conventional microscopy assay. In conclusion, the xCELLigence RTCA system offers an alternative automated and higher throughput method for evaluating PT-induced clustering in CHO cells.	[Bernardo, Lidice; Corallo, Lucas; Caterini, Judy; Su, Jin; Gisonni-Lex, Lucy; Gajewska, Beata] Sanofi Pasteur, Dept Analyt Sci, Toronto, ON, Canada	Sanofi-Aventis	Bernardo, L (corresponding author), Sanofi Pasteur, Dept Analyt Sci, Toronto, ON, Canada.	Lidice.bernardo-reyes@sanofi.com						Agilent Technologies I, 2021, INF DIS APPL 2019; Agilent Technologies I, 2021, REAL TIM DYN MON CEL; Agilent Technologies I, 2021, XCELLIGENCE REAL TIM; Agilent Technologies I, 2021, DYN MON CELL ADH SPR; Agilent Technologies I, 2021, VACC VIR APPL 2019; [Anonymous], 2020, EUROPEAN PHARMACOPOE; Atienza JM, 2006, ASSAY DRUG DEV TECHN, V4, P597, DOI 10.1089/adt.2006.4.597; Ausar SF, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01153-3; Bache C, 2012, BIOLOGICALS, V40, P309, DOI 10.1016/j.biologicals.2012.04.002; BRENNAN MJ, 1988, J BIOL CHEM, V263, P4895; BURNS DL, 1987, INFECT IMMUN, V55, P24, DOI 10.1128/IAI.55.1.24-28.1987; Carbonetti NH, 2010, FUTURE MICROBIOL, V5, P455, DOI 10.2217/FMB.09.133; Cerignoli F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193498; Charretier C, 2018, J VIROL METHODS, V252, P57, DOI 10.1016/j.jviromet.2017.11.002; Corbel Michael J, 2004, Expert Rev Vaccines, V3, P89, DOI 10.1586/14760584.3.1.89; Zamith HPD, 2021, TOXICOL IN VITRO, V70, DOI 10.1016/j.tiv.2020.105029; Dorji D, 2018, MED MICROBIOL IMMUN, V207, P3, DOI 10.1007/s00430-017-0524-z; Ebersohn K, 2014, J VIROL METHODS, V199, P25, DOI 10.1016/j.jviromet.2013.12.023; elBaya A, 1997, EUR J CELL BIOL, V73, P40; GILLENIUS P, 1985, J BIOL STAND, V13, P61, DOI 10.1016/S0092-1157(85)80034-2; Glamann J, 2006, ASSAY DRUG DEV TECHN, V4, P555, DOI 10.1089/adt.2006.4.555; HEWLETT EL, 1983, INFECT IMMUN, V40, P1198, DOI 10.1128/IAI.40.3.1198-1203.1983; Hou XQ, 2014, INT J MOL MED, V33, P543, DOI 10.3892/ijmm.2013.1608; Housley DM, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040617; HSIA JA, 1985, J BIOL CHEM, V260, P6187; Huang B, 2014, J CLIN MICROBIOL, V52, P1105, DOI 10.1128/JCM.02601-13; Isbrucker R, 2016, Pharmeur Bio Sci Notes, V2015, P97; Isbrucker R, 2014, BIOLOGICALS, V42, P114, DOI 10.1016/j.biologicals.2013.11.011; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Lebourgeois S, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00335; Limame R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046536; Locht C, 2011, FEBS J, V278, P4668, DOI 10.1111/j.1742-4658.2011.08237.x; LOOSMORE SM, 1990, INFECT IMMUN, V58, P3653, DOI 10.1128/IAI.58.11.3653-3662.1990; Lv DD, 2020, EXP CELL RES, V394, DOI 10.1016/j.yexcr.2020.112101; Mangmool S, 2011, TOXINS, V3, P884, DOI 10.3390/toxins3070884; Markey K, 2018, Pharmeur Bio Sci Notes, V2018, P112; Markey K, 2019, TOXINS, V11, DOI 10.3390/toxins11070417; Marlina S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1104-y; More GK, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63491-w; Pan TH, 2013, COMPUT BIOL CHEM, V47, P113, DOI 10.1016/j.compbiolchem.2013.08.008; Peper JK, 2014, J IMMUNOL METHODS, V405, P192, DOI 10.1016/j.jim.2014.01.012; Pham PV, 2014, ONCOTARGETS THER, V7, P1455, DOI 10.2147/OTT.S67057; Plaut RD, 2008, CELL MICROBIOL, V10, P1130, DOI 10.1111/j.1462-5822.2007.01115.x; Pollock NR, 2016, J CLIN MICROBIOL, V54, P259, DOI 10.1128/JCM.02419-15; Quereda JJ, 2010, TRANSPL P, V42, P3239, DOI 10.1016/j.transproceed.2010.05.059; Ramis G, 2013, BIOMED MICRODEVICES, V15, P985, DOI 10.1007/s10544-013-9790-8; Ryder AB, 2010, J CLIN MICROBIOL, V48, P4129, DOI 10.1128/JCM.01104-10; Single A, 2015, J BIOMOL SCREEN, V20, P1286, DOI 10.1177/1087057115605765; Smout MJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000885; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; TAMURA M, 1983, J BIOL CHEM, V258, P6756; Teng Z, 2013, J VIROL METHODS, V193, P364, DOI 10.1016/j.jviromet.2013.06.034; Valdes L, 2015, J MICROBIOL METH, V119, P66, DOI 10.1016/j.mimet.2015.09.022; vanStraatenvandeKappelle I, 1997, BIOLOGICALS, V25, P41, DOI 10.1006/biol.1996.0059; Wagner L, 2016, Pharmeur Bio Sci Notes, V2016, P151; Wagner LD, 2017, VACCINE, V35, P7160, DOI 10.1016/j.vaccine.2017.10.082; Witzel F, 2015, BIOINFORMATICS, V31, P2705, DOI 10.1093/bioinformatics/btv216; Xing D, 2010, Pharmeur Bio Sci Notes, V2010, P51; Xing D, 2002, VACCINE, V20, P3535, DOI 10.1016/S0264-410X(02)00338-9; XU YR, 1995, INFECT IMMUN, V63, P825, DOI 10.1128/IAI.63.3.825-832.1995; Ye JL, 2015, CURR MICROBIOL, V70, P536, DOI 10.1007/s00284-014-0752-z	61	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0248491	10.1371/journal.pone.0248491	http://dx.doi.org/10.1371/journal.pone.0248491			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720984	Green Published, gold			2022-12-26	WOS:000629667400037
J	Karlsen, ST; Vesth, TC; Oregaard, G; Poulsen, VK; Lund, O; Henderson, G; Baelum, J				Karlsen, Signe Tang; Vesth, Tammi Camilla; Oregaard, Gunnar; Poulsen, Vera Kuzina; Lund, Ole; Henderson, Gemma; Baelum, Jacob			Machine learning predicts and provides insights into milk acidification rates of Lactococcus lactis	PLOS ONE			English	Article							PH HOMEOSTASIS; MEMBRANE; RESISTANCE; BACTERIA	Lactococcus lactis strains are important components in industrial starter cultures for cheese manufacturing. They have many strain-dependent properties, which affect the final product. Here, we explored the use of machine learning to create systematic, high-throughput screening methods for these properties. Fast acidification of milk is such a strain-dependent property. To predict the maximum hourly acidification rate (V-max), we trained Random Forest (RF) models on four different genomic representations: Presence/absence of gene families, counts of Pfam domains, the 8 nucleotide long subsequences of their DNA (8-mers), and the 9 nucleotide long subsequences of their DNA (9-mers). V-max was measured at different temperatures, volumes, and in the presence or absence of yeast extract. These conditions were added as features in each RF model. The four models were trained on 257 strains, and the correlation between the measured V-max and the predicted V-max was evaluated with Pearson Correlation Coefficients (PC) on a separate dataset of 85 strains. The models all had high PC scores: 0.83 (gene presence/absence model), 0.84 (Pfam domain model), 0.76 (8-mer model), and 0.85 (9-mer model). The models all based their predictions on relevant genetic features and showed consensus on systems for lactose metabolism, degradation of casein, and pH stress response. Each model also predicted a set of features not found by the other models.	[Karlsen, Signe Tang; Vesth, Tammi Camilla; Oregaard, Gunnar; Poulsen, Vera Kuzina; Henderson, Gemma; Baelum, Jacob] Chr Hansen AS, Horsholm, Denmark; [Karlsen, Signe Tang; Lund, Ole] Tech Univ Denmark, Natl Food Inst, Lyngby, Denmark; [Henderson, Gemma] Bacthera Denmark AS, Horsholm, Denmark	Chr Hansen; Technical University of Denmark	Karlsen, ST (corresponding author), Chr Hansen AS, Horsholm, Denmark.; Karlsen, ST (corresponding author), Tech Univ Denmark, Natl Food Inst, Lyngby, Denmark.	DKSIKA@chr-hansen.com	Lund, Ole/F-4437-2014; Poulsen, Vera Kuzina/A-8329-2011	Lund, Ole/0000-0003-1108-0491; Karlsen, Signe/0000-0002-9779-2475; Poulsen, Vera Kuzina/0000-0003-3340-3634	Innovation Fund Denmark (IFD) [703800250B]	Innovation Fund Denmark (IFD)	SK acknowledges financial support from Innovation Fund Denmark (IFD), case no. 703800250B, www.innovationsfonden.dk.IFD had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Chr. Hansen A/S provided support in the form of salaries for authors SK, TV, GO, VP, GH, and JB and provided a pre-existing dataset, but did not have any additional role in the study design, analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Aun E, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006434; Bayjanov JR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-68; Booth IR, 1999, NOVART FDN SYMP, V221, P19; Boulesteix AL, 2012, WIRES DATA MIN KNOWL, V2, P493, DOI 10.1002/widm.1072; Breiman L., 2001, MACH LEARN, V45, P5; Castaneda-Garcia A, 2011, J ANTIMICROB CHEMOTH, V66, P1489, DOI 10.1093/jac/dkr165; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chen ML, 2019, EBIOMEDICINE, V43, P356, DOI 10.1016/j.ebiom.2019.04.016; Clausen PTLC, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2336-6; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Davis JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep27930; DEVOS WM, 1990, J BIOL CHEM, V265, P22554; Drouin A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40561-2; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Gregorutti B, 2017, STAT COMPUT, V27, P659, DOI 10.1007/s11222-016-9646-1; HUTKINS RW, 1993, J DAIRY SCI, V76, P2354, DOI 10.3168/jds.S0022-0302(93)77573-6; KASHKET ER, 1977, J BACTERIOL, V130, P1017, DOI 10.1128/JB.130.3.1017-1023.1977; Koebmann BJ, 2000, J BACTERIOL, V182, P4738, DOI 10.1128/JB.182.17.4738-4743.2000; Kunji ERS, 1996, ANTON LEEUW INT J G, V70, P187, DOI 10.1007/BF00395933; Laroute V, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01050; Larsen MV, 2014, J CLIN MICROBIOL, V52, P1529, DOI 10.1128/JCM.02981-13; Larsen N, 2015, J DAIRY SCI, V98, P1640, DOI 10.3168/jds.2014-8971; Lundberg S.M., 2019, CONSISTENT FEATURE A; Mahe P, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2403-z; Moradigaravand D, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006258; Nguyen M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18972-w; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Parente E., 2004, CHEESE CHEM PHYS MIC, V3rd ed., P123, DOI DOI 10.1016/S1874-558X(04)80065-4; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Poulsen VK, 2019, FEMS MICROBIOL LETT, V366, DOI 10.1093/femsle/fnz001; Sanders JW, 1999, FEMS MICROBIOL REV, V23, P483, DOI 10.1111/j.1574-6976.1999.tb00409.x; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; VANROOIJEN RJ, 1991, J BIOL CHEM, V266, P7176; VOS P, 1989, J BACTERIOL, V171, P2795, DOI 10.1128/jb.171.5.2795-2802.1989; Weimann A, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00101-16; Wels M, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00004; Zankari E, 2013, J ANTIMICROB CHEMOTH, V68, P771, DOI 10.1093/jac/dks496	38	1	1	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0246287	10.1371/journal.pone.0246287	http://dx.doi.org/10.1371/journal.pone.0246287			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720959	gold, Green Published			2022-12-26	WOS:000629667400046
J	Du, QJ; Xiao, HJ; Li, JQ; Zhang, JX; Zhou, LY; Wang, JQ				Du, Qing-Jie; Xiao, Huai-Juan; Li, Juan-Qi; Zhang, Jia-Xin; Zhou, Lu-Yao; Wang, Ji-Qing			Effects of different fertilization rates on growth, yield, quality and partial factor productivity of tomato under non-pressure gravity irrigation	PLOS ONE			English	Article								To select the optimum fertilizer application under specific irrigation levels and to provide a reliable fertigation system for tomato plants, an experiment was conducted by using a microporous membrane for water-fertilizer integration under non-pressure gravity. A compound fertilizer (N:P2O5:K2O, 18:7:20) was adopted for topdressing at four levels, 1290 kg/ha, 1140 kg/ha, 990 kg/ha, and 840 kg/ha, and the locally recommended level of 1875 kg/ha was used as the control to explore the effects of different fertilizer application rates on growth, nutrient distribution, quality, yield, and partial factor of productivity (PFP) in tomato. The new regime of microporous membrane water-fertilizer integration under non-pressure gravity irrigation reduced the fertilizer application rate while promoting plant growth in the early and intermediate stages. Except for the 990 kg/ha fertilizer treatment, yields per plant and per plot for each fertilizer application rate were higher than or equal to those of the control. The new regime could effectively improve PFP and reduce soil nutrient enrichment. Fertilizer at 840 kg/ha showed the optimum results by increasing PFP by 75.72% as compared to control. In conclusion, the fertilizer rate at 840 kg/ha has not only maintained the productivity of soil but also tomato growth and quality of fruit which makes the non-pressure gravity irrigation a potential and cost-effective way for fertilizer application.	[Du, Qing-Jie; Xiao, Huai-Juan; Li, Juan-Qi; Zhang, Jia-Xin; Zhou, Lu-Yao; Wang, Ji-Qing] Henan Agr Univ, Coll Hort, Zhengzhou, Henan, Peoples R China	Henan Agricultural University	Wang, JQ (corresponding author), Henan Agr Univ, Coll Hort, Zhengzhou, Henan, Peoples R China.	wjq16@sina.com			Special Support Project for the Construction of Technology Systems for the Bulk Vegetable Industry in Henan Province [CZ2015S003]	Special Support Project for the Construction of Technology Systems for the Bulk Vegetable Industry in Henan Province	The work was supported by the Special Support Project for the Construction of Technology Systems for the Bulk Vegetable Industry in Henan Province (CZ2015S003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai SS, 2020, AGR WATER MANAGE, V228, DOI 10.1016/j.agwat.2019.105885; Bilalis D, 2018, FOLIA HORTIC, V30, P321, DOI 10.2478/fhort-2018-0027; BREMNER J. M., 1960, JOUR AGRIC SCI, V55, P11, DOI 10.1017/S0021859600021572; Cao J, 2015, PLANT SOIL, V396, P45, DOI 10.1007/s11104-015-2588-0; Carreira JA, 2006, J ARID ENVIRON, V64, P460, DOI 10.1016/j.jaridenv.2005.06.003; Castellanos MT, 2012, SPAN J AGRIC RES, V10, P756, DOI 10.5424/sjar/2012103-437-11; Chen JY, 2004, HYDROL PROCESS, V18, P3133, DOI 10.1002/hyp.5753; Chen YH, 2016, BIOL RES, V49, DOI 10.1186/s40659-016-0069-4; Chen ZK, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00173; Diaz-Perez JC, 2017, HORTSCIENCE, V52, P774, DOI 10.21273/HORTSCI11830-17; Dubos B, 2017, EXP AGR, V53, P255, DOI 10.1017/S0014479716000363; Gholamhoseini M, 2013, AGR WATER MANAGE, V126, P9, DOI 10.1016/j.agwat.2013.05.002; Harmon X, 2017, J PLANT NUTR, V40, P1547, DOI 10.1080/01904167.2016.1263321; Hebbar SS, 2004, EUR J AGRON, V21, P117, DOI 10.1016/S1161-0301(03)00091-1; Hu XH, 2019, PLANT SOIL ENVIRON, V65, P328, DOI [10.17221/186/2019-pse, 10.17221/186/2019-PSE]; Hu XF, 2016, FIELD CROP RES, V196, P33, DOI 10.1016/j.fcr.2016.06.004; Jarvis NJ, 2007, EUR J SOIL SCI, V58, P523, DOI 10.1111/j.1365-2389.2007.00915.x; Jones JB., 1991, PLANT ANAL HDB PRACT, P127; Kolahchi Z, 2007, J ARID ENVIRON, V68, P624, DOI 10.1016/j.jaridenv.2006.06.010; Kumar PS, 2015, SCI HORTIC-AMSTERDAM, V197, P261, DOI 10.1016/j.scienta.2015.09.054; Lamont WJ., 2017, GUIDE MANUFACTURE PE, P45, DOI DOI 10.1016/B978-0-08-102170-5.00003-8; Li JA, 2018, AGR WATER MANAGE, V210, P354, DOI 10.1016/j.agwat.2018.08.036; Li YK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38695-4; Ma CX., 2020, China Patent, Patent No. [2017 1 0751922.X, 201710751922]; Mahajan G, 2006, AGR WATER MANAGE, V84, P202, DOI 10.1016/j.agwat.2006.03.003; Ozores-Hampton M, 2015, HORTSCIENCE, V50, P1636, DOI 10.21273/HORTSCI.50.11.1636; Rahi AA, 2016, SOIL ENVRON, V35, P187; Rajput TBS, 2006, AGR WATER MANAGE, V79, P293, DOI 10.1016/j.agwat.2005.03.009; Sperling O, 2019, PLANT PHYSIOL BIOCH, V143, P265, DOI 10.1016/j.plaphy.2019.08.030; Studer C, 2007, FUNCT PLANT BIOL, V34, P228, DOI 10.1071/FP06294; Tudor-Radu M, 2016, NOT BOT HORTI AGROBO, V44, P477, DOI 10.15835/nbha44210332; Wang JW, 2018, APPL SOIL ECOL, V124, P240, DOI 10.1016/j.apsoil.2017.11.014; Zhang BG, 2018, J SCI FOOD AGR, V98, P2681, DOI 10.1002/jsfa.8762; Zhang Y, 2014, ENVIRON MONIT ASSESS, V186, P5185, DOI 10.1007/s10661-014-3768-8; Zotarelli L, 2009, AGR WATER MANAGE, V96, P1247, DOI 10.1016/j.agwat.2009.03.019	35	1	1	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0247578	10.1371/journal.pone.0247578	http://dx.doi.org/10.1371/journal.pone.0247578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711032	gold, Green Published			2022-12-26	WOS:000629591800055
J	Hodges-Simeon, CR; Albert, G; Richardson, GB; McHale, TS; Weinberg, SM; Gurven, M; Gaulin, SJC				Hodges-Simeon, Carolyn R.; Albert, Graham; Richardson, George B.; McHale, Timothy S.; Weinberg, Seth M.; Gurven, Michael; Gaulin, Steven J. C.			Was facial width-to-height ratio subject to sexual selection pressures? A life course approach	PLOS ONE			English	Article								Sexual selection researchers have traditionally focused on adult sex differences; however, the schedule and pattern of sex-specific ontogeny can provide insights unobtainable from an exclusive focus on adults. Recently, it has been debated whether facial width-to-height ratio (fWHR; bi-zygomatic breadth divided by midface height) is a human secondary sexual characteristic (SSC). Here, we review current evidence, then address this debate using ontogenetic evidence, which has been under-explored in fWHR research. Facial measurements were collected from 3D surface images of males and females aged 3 to 40 (Study 1; US European-descent, n = 2449), and from 2D photographs of males and females aged 7 to 21 (Study 2; Bolivian Tsimane, n = 179), which were used to calculate three fWHR variants (which we call fWHRnasion, fWHRstomion, and fWHRbrow) and two other common facial masculinity ratios (facial width-to-lower-face-height ratio, fWHRlower, and cheekbone prominence). We test whether the observed pattern of facial development exhibits patterns indicative of SSCs, i.e., differential adolescent growth in either male or female facial morphology leading to an adult sex difference. Results showed that only fWHRlower exhibited both adult sex differences as well as the classic pattern of ontogeny for SSCs-greater lower-face growth in male adolescents relative to females. fWHRbrow was significantly wider among both pre- and post-pubertal males in the Bolivian Tsimane sample; post-hoc analyses revealed that the effect was driven by large sex differences in brow height, with females having higher placed brows than males across ages. In both samples, all fWHR measures were inversely associated with age; that is, human facial growth is characterized by greater relative elongation in the mid-face and lower face relative to facial width. This trend continues even into middle adulthood. BMI was also a positive predictor of most of the ratios across ages, with greater BMI associated with wider faces. Researchers collecting data on fWHR should target fWHRlower and fWHRbrow and should control for both age and BMI. Researchers should also compare ratio approaches with multivariate techniques, such as geometric morphometrics, to examine whether the latter have greater utility for understanding the evolution of facial sexual dimorphism.	[Hodges-Simeon, Carolyn R.; Albert, Graham; McHale, Timothy S.] Boston Univ, Dept Anthropol, Boston, MA 02215 USA; [Richardson, George B.] Univ Cincinnati, Sch Human Serv, Cincinnati, OH USA; [McHale, Timothy S.] Cent Washington Univ, Dept Anthropol & Museum Studies, Ellensburg, WA USA; [Weinberg, Seth M.] Univ Pittsburgh, Dept Oral Biol, Sch Dent Med, Ctr Craniofacial & Dent Genet, Pittsburgh, PA USA; [Weinberg, Seth M.] Univ Pittsburgh, Dept Anthropol, Dietrich Sch Arts & Sci, Pittsburgh, PA 15260 USA; [Gurven, Michael; Gaulin, Steven J. C.] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA	Boston University; University System of Ohio; University of Cincinnati; Central Washington University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Santa Barbara	Hodges-Simeon, CR (corresponding author), Boston Univ, Dept Anthropol, Boston, MA 02215 USA.	crhodges@bu.edu		Weinberg, Seth/0000-0001-9467-4556	Wenner-Gren dissertation fieldwork grant; NSF [BCS-0136761]; NIH/NIA [R01AG024119-01, R56AG024119-06, R01AG024119-07]; National Institute of Dental and Craniofacial Research [U01-DE020078, R01-DE016148, R01-DE027023]	Wenner-Gren dissertation fieldwork grant; NSF(National Science Foundation (NSF)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a Wenner-Gren dissertation fieldwork grant (C.R.H.; www.wennergren.org).The Tsimane Health and Life History project (M.G.) is supported by grants from NSF (BCS-0136761; www.nsf.gov) and NIH/NIA (R01AG024119-01, R56AG024119-06, R01AG024119-07; www.nih.gov).The 3D Norms Facial Database (S.M.W.) was funded by the National Institute of Dental and Craniofacial Research (U01-DE020078, R01-DE016148, and R01-DE027023; www.https://www.nidcr.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2019, PERS INDIV DIFFER, V138, P133, DOI 10.1016/j.paid.2018.09.029; Aldridge K, 2005, AM J MED GENET A, V138A, P247, DOI 10.1002/ajmg.a.30959; Alrajih S, 2014, BRIT J PSYCHOL, V105, P153, DOI 10.1111/bjop.12035; Altschul D.M., 2019, INT J PRIMATOL, P1, DOI [10.1159/000500007, DOI 10.1159/000500007]; Amstislavskaya TG, 2004, HORM BEHAV, V46, P544, DOI 10.1016/j.yhbeh.2004.05.010; Anderl C, 2016, PERS INDIV DIFFER, V88, P99, DOI 10.1016/j.paid.2015.08.057; Andersson Malte, 1994; Apicella CL, 2007, BIOL LETTERS, V3, P682, DOI 10.1098/rsbl.2007.0410; Arnocky S, 2018, EVOL HUM BEHAV, V39, P602, DOI 10.1016/j.evolhumbehav.2018.06.003; Arnocky S, 2018, ARCH SEX BEHAV, V47, P1375, DOI 10.1007/s10508-017-1070-x; Badyaev AV, 2002, TRENDS ECOL EVOL, V17, P369, DOI 10.1016/S0169-5347(02)02569-7; Bird BM, 2016, EVOL HUM BEHAV, V37, P392, DOI 10.1016/j.evolhumbehav.2016.03.004; Bogin B., 1999, PATTERNS HUMAN GROWT, V88; Borgi M, 2016, PEERJ, V4, DOI 10.7717/peerj.1775; Brooks RC, 2015, EVOL HUM BEHAV, V36, P351, DOI 10.1016/j.evolhumbehav.2015.02.001; Bulygina E, 2006, AM J PHYS ANTHROPOL, V131, P432, DOI 10.1002/ajpa.20317; Burger DK, 2013, BEHAV BRAIN RES, V236, P131, DOI 10.1016/j.bbr.2012.08.044; Burton CM, 2013, SOC COGNITION, V31, P672, DOI 10.1521/soco.2013.31.6.672; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; BUSS DM, 1988, J PERS SOC PSYCHOL, V54, P616, DOI 10.1037/0022-3514.54.4.616; BUTLER GE, 1989, CLIN ENDOCRINOL, V30, P587, DOI 10.1111/j.1365-2265.1989.tb01431.x; Campbell B, 2011, AM J HUM BIOL, V23, P44, DOI 10.1002/ajhb.21111; Carre JM, 2013, SOC COGN AFFECT NEUR, V8, P224, DOI 10.1093/scan/nsr096; Carre JM, 2009, PSYCHOL SCI, V20, P1194, DOI 10.1111/j.1467-9280.2009.02423.x; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Chan K.H., 2020, MACBETH FACTOR DARK; Claes P, 2012, J ANAT, V221, P97, DOI 10.1111/j.1469-7580.2012.01528.x; Cleary S, 2020, J BUS FINAN ACCOUNT, V47, P949, DOI 10.1111/jbfa.12441; Coetzee V, 2010, PERCEPTION, V39, P51, DOI 10.1068/p6560; Conroy-Beam D, 2015, PERS SOC PSYCHOL B, V41, P1082, DOI 10.1177/0146167215590987; Costa M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172739; Craig BM, 2019, PSYCHOL SCI, V30, P728, DOI 10.1177/0956797619834876; CUNNINGHAM MR, 1990, J PERS SOC PSYCHOL, V59, P61, DOI 10.1037/0022-3514.59.1.61; Darwin C., 1871, P423; Deaner RO, 2012, J RES PERS, V46, P235, DOI 10.1016/j.jrp.2012.01.005; Deska JC, 2018, J PERS SOC PSYCHOL, V114, P75, DOI 10.1037/pspi0000110; Deska JC, 2018, EMOTION, V18, P453, DOI 10.1037/emo0000328; Dixson A, 2005, ANN REV SEX RES, V16, P1; Dixson BJ, 2012, BEHAV ECOL, V23, P481, DOI 10.1093/beheco/arr214; Dixson BJW, 2018, ARCH SEX BEHAV, V47, P827, DOI 10.1007/s10508-018-1184-9; Dixson BJW, 2017, EVOL HUM BEHAV, V38, P164, DOI 10.1016/j.evolhumbehav.2016.08.004; Efferson C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01047; Eisenbruch AB, 2018, ADAPT HUM BEHAV PHYS, V4, P138, DOI 10.1007/s40750-017-0084-x; Ellison P., 2001, FERTILE GROUND NATUR; Elmlinger MW, 2005, CLIN LAB, V51, P625; Fawcett TW, 2019, BEHAV ECOL, V30, P1436, DOI 10.1093/beheco/arz097; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Fitch WT, 1999, J ACOUST SOC AM, V106, P1511, DOI 10.1121/1.427148; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Fouquet M, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160395; Franklin D, 2008, S AFR J SCI, V104, P101; Fuji T., 2016, LETT EVOL BEHAV SCI, V7, P37, DOI DOI 10.5178/LEBS.2016.49; GALEA LAM, 1994, BRAIN RES, V635, P18, DOI 10.1016/0006-8993(94)91419-2; Garvin HM, 2012, AM J PHYS ANTHROPOL, V147, P661, DOI 10.1002/ajpa.22036; Geniole SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132726; Geniole SN, 2015, EVOL HUM BEHAV, V36, P279, DOI 10.1016/j.evolhumbehav.2014.12.005; Geniole SN, 2014, PERS INDIV DIFFER, V57, P59, DOI 10.1016/j.paid.2013.09.023; German A, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00387; Gomez-Valdes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052317; Gontard-Danek MC, 1999, BEHAV ECOL, V10, P476, DOI 10.1093/beheco/10.5.476; Gould S. J., 1977, ONTOGENY PHYLOGENY; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; Grueter CC, 2015, EVOL HUM BEHAV, V36, P398, DOI 10.1016/j.evolhumbehav.2015.03.003; Gurven M, 2008, J GERONTOL A-BIOL, V63, P196, DOI 10.1093/gerona/63.2.196; Gurven M, 2007, AM J HUM BIOL, V19, P376, DOI 10.1002/ajhb.20600; Hahn T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187957; Harries MLL, 1997, ARCH DIS CHILD, V77, P445, DOI 10.1136/adc.77.5.445; Haselhuhn MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122637; Haselhuhn MP, 2014, LEADERSHIP QUART, V25, P835, DOI 10.1016/j.leaqua.2013.12.003; Haselhuhn MP, 2012, P ROY SOC B-BIOL SCI, V279, P571, DOI 10.1098/rspb.2011.1193; Hauspie R, 2012, HUMAN GROWTH AND DEVELOPMENT, 2ND EDITION, P57, DOI 10.1016/B978-0-12-383882-7.00003-9; He XJ, 2019, J ACCOUNT RES, V57, P1013, DOI 10.1111/1475-679X.12259; Hehman E, 2015, J EXP SOC PSYCHOL, V59, P51, DOI 10.1016/j.jesp.2015.03.007; Hehman E, 2014, PERS SOC PSYCHOL B, V40, P1624, DOI 10.1177/0146167214552791; Hehman E, 2013, J EXP SOC PSYCHOL, V49, P747, DOI 10.1016/j.jesp.2013.02.015; Hill AK, 2013, EVOL HUM BEHAV, V34, P334, DOI 10.1016/j.evolhumbehav.2013.05.004; Hochberg Z., 2011, EVO DEVO CHILD GROWT; Hodges-Simeon CR, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00160; Hodges-Simeon CR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153083; Hodges-Simeon CR, 2015, EVOL HUM BEHAV, V36, P294, DOI 10.1016/j.evolhumbehav.2015.01.002; Hodges-Simeon CR, 2014, BEHAV ECOL, V25, P984, DOI 10.1093/beheco/aru081; Hodges-Simeon CR, 2013, ANN HUM BIOL, V40, P209, DOI 10.3109/03014460.2012.759622; Hughes SM, 2004, EVOL HUM BEHAV, V25, P295, DOI 10.1016/j.evolhumbehav.2004.06.001; Huh H, 2014, PERS INDIV DIFFER, V68, P43, DOI 10.1016/j.paid.2014.03.044; Janson KT, 2018, ADAPT HUM BEHAV PHYS, V4, P21, DOI 10.1007/s40750-017-0075-y; JARVI T, 1987, BEHAV ECOL SOCIOBIOL, V20, P161, DOI 10.1007/BF00299729; Jia YP, 2014, J ACCOUNT RES, V52, P1195, DOI 10.1111/1475-679X.12065; Jones BC, 2010, ANIM BEHAV, V79, P57, DOI 10.1016/j.anbehav.2009.10.003; Kajonius Petri., 2020, INT J PSYCHOL BRAIN, V5, P1; Kakkar H, 2020, ACAD MANAGE J, V63, P530, DOI 10.5465/amj.2017.0729; Kamiya S, 2019, EUR FINANC MANAG, V25, P239, DOI 10.1111/eufm.12175; Kesterke MJ, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0076-8; Koehler N, 2004, P ROY SOC B-BIOL SCI, V271, pS233, DOI 10.1098/rsbl.2003.0146; Kolar JC., 1997, CRANIOFACIAL ANTHROP; Koo WWK, 2000, J NUTR, V130, P2188, DOI 10.1093/jn/130.9.2188; Kordsmeyer TL, 2019, ADAPT HUM BEHAV PHYS, V5, P117, DOI 10.1007/s40750-018-0105-4; Kosinski M, 2017, PSYCHOL SCI, V28, P1675, DOI 10.1177/0956797617716929; Koudelova J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212618; Kramer RSS, 2017, EVOL HUM BEHAV, V38, P414, DOI 10.1016/j.evolhumbehav.2016.12.002; Kramer RSS, 2015, EVOL PSYCHOL-US, V13, P197, DOI 10.1177/147470491501300112; Kramer RSS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042705; Krenn B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224472; Krenn B, 2018, EVOL PSYCHOL-US, V16, DOI 10.1177/1474704918818590; Landry N, 2019, J ENVIRON PSYCHOL, V64, P107, DOI 10.1016/j.jenvp.2019.05.007; Lassek WD, 2009, EVOL HUM BEHAV, V30, P322, DOI 10.1016/j.evolhumbehav.2009.04.002; Lebuda I, 2016, CREATIVITY RES J, V28, P207, DOI 10.1080/10400419.2016.1162572; Lee AJ, 2017, ADAPT HUM BEHAV PHYS, V3, P351, DOI 10.1007/s40750-017-0073-0; Lefevre CE, 2013, EVOL HUM BEHAV, V34, P273, DOI 10.1016/j.evolhumbehav.2013.03.005; Lefevre CE, 2012, EVOL HUM BEHAV, V33, P623, DOI 10.1016/j.evolhumbehav.2012.03.002; Lefevre CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093369; LEIGH SR, 1995, AM J PRIMATOL, V36, P37, DOI 10.1002/ajp.1350360104; Lewis GJ, 2012, PERS INDIV DIFFER, V52, P855, DOI 10.1016/j.paid.2011.12.030; Lieberz KA, 2017, AGGRESSIVE BEHAV, V43, P460, DOI 10.1002/ab.21704; Lindenfors P, 2011, ADV GENET, V75, P7, DOI 10.1016/B978-0-12-380858-5.00009-5; Lippa RA, 2009, ARCH SEX BEHAV, V38, P631, DOI 10.1007/s10508-007-9242-8; Little AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002106; Little AC, 2013, PSYCHONEUROENDOCRINO, V38, P1777, DOI 10.1016/j.psyneuen.2013.02.014; Loehr J, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0049; Lohman T.G., 1988, HUMAN KINETICS BOOKS, V177, P3, DOI DOI 10.1080/00140138808966796; LUNDSTROM ANDERS, 1953, ACTA ODONTOL SCAND, V11, P111, DOI 10.3109/00016355308993918; MacDonell ET, 2018, AGGRESSIVE BEHAV, V44, P512, DOI 10.1002/ab.21771; Mank JE, 2010, MOL BIOL EVOL, V27, P1570, DOI 10.1093/molbev/msq042; Mareckova K, 2011, HORM BEHAV, V60, P681, DOI 10.1016/j.yhbeh.2011.09.004; Martin JS, 2019, BIOL LETTERS, V15, DOI 10.1098/rsbl.2019.0232; Martin MA, 2012, MATERN CHILD NUTR, V8, P404, DOI 10.1111/j.1740-8709.2012.00412.x; Matthews HS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22752-5; Mayew WJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0538; McHale TS, 2020, ADAPT HUM BEHAV PHYS, V6, P413, DOI 10.1007/s40750-020-00146-0; McHale TS, 2020, J SPORT SCI, V38, P2688, DOI 10.1080/02640414.2020.1796164; Mileva VR, 2014, PERS INDIV DIFFER, V69, P115, DOI 10.1016/j.paid.2014.05.019; Mogilski JK, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02428; Munoz-Reyes JA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57259-0; Noser E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207333; Ormiston ME, 2017, PERS INDIV DIFFER, V105, P40, DOI 10.1016/j.paid.2016.09.017; Ozener B, 2012, EVOL HUM BEHAV, V33, P169, DOI 10.1016/j.evolhumbehav.2011.08.001; Palmer-Hague JL, 2018, AGGRESSIVE BEHAV, V44, P553, DOI 10.1002/ab.21774; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; Penton-Voak IS, 2001, P ROY SOC B-BIOL SCI, V268, P1617, DOI 10.1098/rspb.2001.1703; Pisanski K, 2014, ANIM BEHAV, V95, P89, DOI 10.1016/j.anbehav.2014.06.011; Plavcan JM, 2012, HUM NATURE-INT BIOS, V23, P45, DOI 10.1007/s12110-012-9130-3; Polo P, 2019, AM J HUM BIOL, V31, DOI 10.1002/ajhb.23235; Price ME, 2017, EVOL HUM BEHAV, V38, P626, DOI 10.1016/j.evolhumbehav.2017.04.001; Puts DA, 2012, P ROY SOC B-BIOL SCI, V279, P601, DOI 10.1098/rspb.2011.0829; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Pyter LM, 2006, EUR J NEUROSCI, V23, P3056, DOI 10.1111/j.1460-9568.2006.04821.x; Pyter LM, 2005, J NEUROSCI, V25, P4521, DOI 10.1523/JNEUROSCI.0795-05.2005; Quist MC, 2011, PERS INDIV DIFFER, V50, P1089, DOI 10.1016/j.paid.2011.01.032; Robertson JM, 2017, EVOL PSYCHOL-US, V15, DOI 10.1177/1474704917730640; Roney JR, 2007, HORM BEHAV, V52, P326, DOI 10.1016/j.yhbeh.2007.05.008; Roosenboom J, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00497; Rostovtseva VV, 2021, AM J HUM BIOL, V33, DOI 10.1002/ajhb.23458; Saini V, 2011, J FORENSIC SCI, V56, pS13, DOI 10.1111/j.1556-4029.2010.01599.x; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Schutz Y, 2002, INT J OBESITY, V26, P953, DOI 10.1038/sj.ijo.0802037; Sell A, 2017, EVOL HUM BEHAV, V38, P334, DOI 10.1016/j.evolhumbehav.2016.11.002; Sell A, 2014, EVOL HUM BEHAV, V35, P425, DOI 10.1016/j.evolhumbehav.2014.05.008; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Shaw RB, 2011, PLAST RECONSTR SURG, V127, P374, DOI 10.1097/PRS.0b013e3181f95b2d; Smith GT, 1997, J COMP NEUROL, V381, P253, DOI 10.1002/(SICI)1096-9861(19970512)381:3<253::AID-CNE1>3.0.CO;2-1; SNODELL SF, 1993, AM J ORTHOD DENTOFAC, V104, P471, DOI 10.1016/0889-5406(93)70073-W; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Stirrat M, 2012, EVOL HUM BEHAV, V33, P551, DOI 10.1016/j.evolhumbehav.2012.02.002; Taylor AB, 1997, AM J PRIMATOL, V43, P1, DOI 10.1002/(SICI)1098-2345(1997)43:1<1::AID-AJP1>3.0.CO;2-0; Valentine KA, 2014, PSYCHOL SCI, V25, P806, DOI 10.1177/0956797613511823; Vasunilashorn S, 2010, AM J HUM BIOL, V22, P731, DOI 10.1002/ajhb.21074; Verdonck A, 1999, EUR J ORTHODONT, V21, P137, DOI 10.1093/ejo/21.2.137; Vogel AP, 2009, BEHAV RES METHODS, V41, P318, DOI 10.3758/BRM.41.2.318; Wade T.J, 2016, EVOS J J EVOLUTIONAR, V22; Wang DW, 2019, PSYCHOL SCI, V30, P1074, DOI 10.1177/0956797619849928; Weinberg SM, 2015, ORTHOD CRANIOFAC RES, V18, P21, DOI 10.1111/ocr.12055; Weinberg SM, 2016, CLEFT PALATE-CRAN J, V53, pE185, DOI 10.1597/15-199; Welker KM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01745; Welker KM, 2015, EVOL HUM BEHAV, V36, P423, DOI 10.1016/j.evolhumbehav.2015.03.006; Welker KM, 2015, ADAPT HUM BEHAV PHYS, V1, P17, DOI 10.1007/s40750-014-0003-3; Wen GJ, 2020, PERS INDIV DIFFER, V157, DOI 10.1016/j.paid.2020.109832; Weston EM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000710; Whitehouse AJO, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1351; Wong A, 2016, AUST ORTHOD J, V32, P2; Yang Y, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00214; Yasui T, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.3.031108; Zebrowitz LA, 2015, PERS INDIV DIFFER, V86, P312, DOI 10.1016/j.paid.2015.06.036; Zelazniewicz A, 2020, BMC EVOL BIOL, V20, DOI 10.1186/s12862-020-01670-z; Zhang DY, 2020, PERCEPTION, V49, P422, DOI 10.1177/0301006620909286; Zhang J., 2020, **DROPPED REF**, DOI [10.1016/j.evolhumbehav.2020.04.001, DOI 10.1016/J.EVOLHUMBEHAV.2020.04.001]; Zhang JG, 2017, EVOL HUM BEHAV, V38, P513, DOI 10.1016/j.evolhumbehav.2017.02.005; Zhang WQ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200308; Zilioli S, 2015, AGGRESSIVE BEHAV, V41, P322, DOI 10.1002/ab.21544	188	8	8	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0240284	10.1371/journal.pone.0240284	http://dx.doi.org/10.1371/journal.pone.0240284			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8KN	33711068	Green Submitted, gold, Green Published			2022-12-26	WOS:000629591800018
J	Jeong, JU; Nam, TK; Song, JY; Yoon, MS; Ahn, SJ; Chung, WK; Cho, IJ; Kim, YH; Cho, SH; Jung, SI; Kang, TW; Kwon, DD				Jeong, Jae-Uk; Nam, Taek-Keun; Song, Ju-Young; Yoon, Mee Sun; Ahn, Sung-Ja; Chung, Woong-Ki; Cho, Ick Joon; Kim, Yong-Hyub; Cho, Shin Haeng; Jung, Seung Il; Kang, Taek Won; Kwon, Dong Deuk			Favorable prognosis of patients who received adjuvant androgen deprivation therapy after radiotherapy achieving undetectable levels of prostate-specific antigen in high- or very high-risk prostate cancer	PLOS ONE			English	Article								Introduction To determine the prognostic significance of long-term adjuvant androgen deprivation therapy (A-ADT) over 1 year in achieving undetectable levels of prostate-specific antigen (PSA) less than 0.001 ng/mL in prostate cancer patients with high- or very high-risk prostate cancer who underwent radiotherapy (RT). Materials and methods A total of 197 patients with prostate cancer received RT, with a follow-up of >= 12 months. Biochemical failure was defined as PSA >= nadir + 2 ng/mL after RT. We analyzed clinical outcomes, including survival, failure patterns, and prognostic factors affecting outcomes. Results Biochemical failure-free survival (BCFFS), clinical failure-free survival, distant metastasis-free survival, cancer-specific survival, and overall survival (OS) rates at 5 years were 91.1%, 95.4%, 96.9%, 99.5%, and 89.1%, respectively. Administration of long-term A-ADT significantly predicted favorable BCFFS (p = 0.027) and OS (p < 0.001) in multivariate analysis. Nadir PSA <= 0.001 ng/mL was an independent prognostic factor for BCFFS (p = 0.006) and OS (p = 0.021). The use of long-term A-ADT significantly affected nadir PSA <= 0.001 ng/mL (p < 0.001). The patients with A-ADT for 1 year or longer had better BCFFS or OS than those for less than 1 year or those without A-ADT (p < 0.001). The best prognosis was demonstrated in patients treated with long-term A-ADT and nadir PSA <= 0.001 ng/mL in BCFFS (p < 0.001). Conclusion The addition of long-term A-ADT over 1 year to RT demonstrated good treatment outcomes in patients with locally advanced prostate cancer. Achieving a nadir PSA value <= 0.001 ng/mL using combination therapy with RT and A-ADT is a powerful clinical predictor of treatment outcomes.	[Jeong, Jae-Uk; Nam, Taek-Keun; Song, Ju-Young; Yoon, Mee Sun; Ahn, Sung-Ja; Chung, Woong-Ki; Cho, Ick Joon; Kim, Yong-Hyub; Cho, Shin Haeng] Chonnam Natl Univ, Coll Med, Dept Radiat Oncol, Hwasun Hosp, Hwasun, South Korea; [Jung, Seung Il; Kang, Taek Won; Kwon, Dong Deuk] Chonnam Natl Univ, Coll Med, Dept Urol, Hwasun Hosp, Hwasun, South Korea	Chonnam National University; Chonnam National University	Nam, TK (corresponding author), Chonnam Natl Univ, Coll Med, Dept Radiat Oncol, Hwasun Hosp, Hwasun, South Korea.	tknam@jnu.ac.kr			Chonnam National University [2017-0227]	Chonnam National University	This study was financially supported by Chonnam National University (Grant number: 2017-0227).	Albertsen PC, 2014, EUR UROL, V65, P565, DOI 10.1016/j.eururo.2013.10.032; Amit U, 2019, RADIAT ONCOL, V14, DOI 10.1186/s13014-019-1298-9; [Anonymous], 2019, NATL COMPREHENSIVE C; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; Bolla M, 2010, LANCET ONCOL, V11, P1066, DOI 10.1016/S1470-2045(10)70223-0; Bolla M, 2009, NEW ENGL J MED, V360, P2516, DOI 10.1056/NEJMoa0810095; Bosco C, 2015, EUR UROL, V68, P386, DOI 10.1016/j.eururo.2014.11.039; Chow PM, 2013, UROL SCI, V24, P120, DOI 10.1016/j.urols.2013.08.001; Crook J, 2009, INT J RADIAT ONCOL, V73, P327, DOI 10.1016/j.ijrobp.2008.04.075; D'Amico AV, 2012, LANCET ONCOL, V13, P189, DOI 10.1016/S1470-2045(11)70295-9; Denham JW, 2005, LANCET ONCOL, V6, P841, DOI 10.1016/S1470-2045(05)70348-X; Geara FB, 2017, RADIAT ONCOL, V12, DOI 10.1186/s13014-017-0884-y; Hallemeier CL, 2019, INT J RADIAT ONCOL, V104, P1057, DOI 10.1016/j.ijrobp.2019.03.049; Hong SK, 2010, UROLOGY, V76, P723, DOI 10.1016/j.urology.2010.03.081; Johnson SB, 2015, AM J CLIN ONCOL-CANC, V38, P465, DOI 10.1097/COC.0b013e3182a468b2; Jung KW., 2019, CANCER RES TREAT, V51, P17; Kishan AU, 2019, JAMA ONCOL, V5, P91, DOI 10.1001/jamaoncol.2018.3732; Klayton TL, 2011, RADIOTHER ONCOL, V101, P508, DOI 10.1016/j.radonc.2011.07.022; Lee DH, 2013, YONSEI MED J, V54, P87, DOI 10.3349/ymj.2013.54.1.87; LEE WR, 1995, J CLIN ONCOL, V13, P464, DOI 10.1200/JCO.1995.13.2.464; Pierorazio PM, 2013, BJU INT, V111, P753, DOI 10.1111/j.1464-410X.2012.11611.x; Pilepich MV, 2005, INT J RADIAT ONCOL, V61, P1285, DOI 10.1016/j.ijrobp.2004.08.047; ROACH M, 1994, INT J RADIAT ONCOL, V28, P33, DOI 10.1016/0360-3016(94)90138-4; Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029; Rosser CJ, 2002, J UROLOGY, V168, P536, DOI 10.1016/S0022-5347(05)64674-5; Schwandt A, 2009, CURR OPIN UROL, V19, P322, DOI 10.1097/MOU.0b013e32832a082c; See WA, 2006, J CANCER RES CLIN, V132, pS7, DOI 10.1007/s00432-006-0132-6; Son CH, 2017, AM J CLIN ONCOL-CANC, V40, P348, DOI 10.1097/COC.0000000000000161; Tsumura H, 2015, WORLD J RADIOL, V7, P494, DOI 10.4329/wjr.v7.i12.494; ZIETMAN AL, 1994, J UROLOGY, V151, P640, DOI 10.1016/S0022-5347(17)35036-X	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0248461	10.1371/journal.pone.0248461	http://dx.doi.org/10.1371/journal.pone.0248461			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711055	gold, Green Published			2022-12-26	WOS:000629591800059
J	Qiao, LY; Madar, J				Qiao, Liya Y.; Madar, Jonathan			An objective approach to assess colonic pain in mice using colonometry	PLOS ONE			English	Article								The present study presents a non-surgical approach to assess colonic mechanical sensitivity in mice using colonometry, a technique in which colonic stretch-reflex contractions are measured by recording intracolonic pressures during saline infusion into the distal colon in a constant rate. Colonometrical recording has been used to assess colonic function in healthy individuals and patients with neurological disorders. Here we found that colonometry can also be implemented in mice, with an optimal saline infusion rate of 1.2 mL/h. Colonometrograms showed intermittent pressure rises that was caused by periodical colonic contractions. In the sceneries of colonic hypersensitivity that was generated post 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colonic inflammation, following chemogenetic activation of primary afferent neurons, or immediately after noxious stimulation of the colon by colorectal distension (CRD), the amplitude of intracolonic pressure (A(ICP)) was markedly elevated which was accompanied by a faster pressure rising (Delta P/Delta t). Colonic hypersensitivity-associated A(ICP) elevation was a result of the enhanced strength of colonic stretch-reflex contraction which reflected the heightened activity of the colonic sensory reflex pathways. The increased value of Delta P/Delta t in colonic hypersensitivity indicated a lower threshold of colonic mechanical sensation by which colonic stretch-reflex contraction was elicited by a smaller saline infusion volume during a shorter period of infusion time. Chemogenetic inhibition of primary afferent pathway that was governed by Nav1.8-expressing cells attenuated TNBS-induced up-regulations of A(ICP), Delta P/Delta t, and colonic pain behavior in response to CRD. These findings support that colonometrograms can be used for analysis of colonic pain in mice.	[Qiao, Liya Y.; Madar, Jonathan] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23284 USA; [Qiao, Liya Y.] Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Richmond, VA 23284 USA	Virginia Commonwealth University; Virginia Commonwealth University	Qiao, LY (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23284 USA.; Qiao, LY (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Richmond, VA 23284 USA.	liya.qiao@vcuhealth.org			National Institute of Health [NIH R01 DK118137, P30 DA033934]; Commonwealth Health Research Board [CHRB 236-06-18]; VCU Institutional Career Development Core [CTSA 5KL2TR002648]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth Health Research Board; VCU Institutional Career Development Core	This work is supported by grants listed below: 1. NIH R01 DK118137 (LYQ) from National Institute of Health 2. CHRB 236-06-18 (LYQ) from Commonwealth Health Research Board 3. CTSA 5KL2TR002648 (LYQ) from VCU Institutional Career Development Core 4. P30 DA033934 (Sub to LYQ) from National Institute of Health. The sponsors or funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chaer ED, 2000, GASTROENTEROLOGY, V119, P1276, DOI 10.1053/gast.2000.19576; Antoniou E, 2016, ANN MED SURG, V11, P9, DOI 10.1016/j.amsu.2016.07.019; Arvidsson S, 2006, J PAIN, V7, P108, DOI 10.1016/j.jpain.2005.09.003; Beyak MJ, 2004, AM J PHYSIOL-GASTR L, V287, pG845, DOI 10.1152/ajpgi.00154.2004; Cameron DM, 2008, J PAIN, V9, P246, DOI 10.1016/j.jpain.2007.10.017; Castro J, 2013, GASTROENTEROLOGY, V145, P1334, DOI 10.1053/j.gastro.2013.08.017; CHAUVE A, 1976, GASTROENTEROLOGY, V70, P336; Chen LB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22216-w; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Christianson JA, 2007, NAT PROTOC, V2, P2624, DOI 10.1038/nprot.2007.392; Coppini R, 2018, CARDIOVASC RES, V114, P1691, DOI 10.1093/cvr/cvy210; Daou I, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0140-15.2016; Delafoy L, 2006, GUT, V55, P940, DOI 10.1136/gut.2005.064063; Erickson A, 2018, J PHYSIOL-LONDON, V596, P785, DOI 10.1113/JP273461; Feng B, 2012, AM J PHYSIOL-GASTR L, V303, pG817, DOI 10.1152/ajpgi.00257.2012; HALDEMAN S, 1982, ARCH NEUROL-CHICAGO, V39, P698, DOI 10.1001/archneur.1982.00510230024008; Harrington AM, 2019, AM J PHYSIOL-GASTR L, V317, pG285, DOI 10.1152/ajpgi.00013.2019; HOLDSTOCK DJ, 1969, GUT, V10, P19, DOI 10.1136/gut.10.1.19; Hughes PA, 2009, GUT, V58, P1333, DOI 10.1136/gut.2008.170811; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Ji Y, 2008, NEUROSCIENCE, V154, P1562, DOI 10.1016/j.neuroscience.2008.04.070; Kay JC, 2013, EXP NEUROL, V250, P366, DOI 10.1016/j.expneurol.2013.10.015; King DE, 2009, NEUROGASTROENT MOTIL, V21, P880, DOI 10.1111/j.1365-2982.2009.01279.x; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Larauche M, 2010, STRESS, V13, P344, DOI 10.3109/10253891003664166; Larauche M, 2009, AM J PHYSIOL-GASTR L, V297, pG215, DOI 10.1152/ajpgi.00072.2009; Larsson M, 2003, NEUROGASTROENT MOTIL, V15, P371, DOI 10.1046/j.1365-2982.2003.00418.x; Liu M, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0371-z; Mahler SV, 2018, NEUROPSYCHOPHARMACOL, V43, P934, DOI 10.1038/npp.2017.299; Mujagic Z, 2015, ALIMENT PHARM THER, V42, P1064, DOI 10.1111/apt.13378; O'Mahony Siobhain M, 2012, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0940s61; Payne CE, 2015, BRIT J PHARMACOL, V172, P2654, DOI 10.1111/bph.13092; Rose DK, 1927, J UROLOGY, V17, P0487, DOI 10.1016/S0022-5347(17)73369-1; Shen SW, 2017, EXP NEUROL, V295, P104, DOI 10.1016/j.expneurol.2017.06.007; Shields SD, 2012, PAIN, V153, P2017, DOI 10.1016/j.pain.2012.04.022; Simren M, 2001, GUT, V48, P20, DOI 10.1136/gut.48.1.20; STANLEY NN, 1975, J CLIN INVEST, V55, P1195, DOI 10.1172/JCI108037; White JC, 1940, ANN SURG, V112, P1042, DOI 10.1097/00000658-194012000-00004; Xia CM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-30; Xia CM, 2016, EXP NEUROL, V285, P126, DOI 10.1016/j.expneurol.2015.12.006	40	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0245410	10.1371/journal.pone.0245410	http://dx.doi.org/10.1371/journal.pone.0245410			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711031	Green Submitted, gold, Green Published			2022-12-26	WOS:000629591800028
J	Defar, A; Molla, G; Abdella, S; Tessema, M; Ahmed, M; Tadele, A; Getachew, F; Hailegiorgis, B; Tigabu, E; Ababor, S; Bizuwork, K; Deressa, A; Tasaw, G; Kebede, A; Melese, D; Gashu, A; Eshetu, K; Tayachew, A; Wossen, M; Hassen, A; Habebe, S; Assefa, Z; Abayneh, A; Abate, E; Tollera, G				Defar, Atkure; Molla, Gebeyaw; Abdella, Saro; Tessema, Masresha; Ahmed, Muhammed; Tadele, Ashenif; Getachew, Fikresilassie; Hailegiorgis, Bezawit; Tigabu, Eyasu; Ababor, Sabit; Bizuwork, Ketema; Deressa, Asefa; Tasaw, Geremew; Kebede, Adisu; Melese, Daniel; Gashu, Andargachew; Eshetu, Kirubel; Tayachew, Adamu; Wossen, Mesfin; Hassen, Abduilhafiz; Habebe, Shambel; Assefa, Zewdu; Abayneh, Aschalew; Abate, Ebba; Tollera, Getachew			Knowledge, practice and associated factors towards the prevention of COVID-19 among high-risk groups: A cross-sectional study in Addis Ababa, Ethiopia	PLOS ONE			English	Article								Background Coronavirus disease (COVID-19) is a highly transmittable virus that continues to disrupt livelihoods, particularly those of low-income segments of society, around the world. In Ethiopia, more specifically in the capital city of Addis Ababa, a sudden increase in the number of confirmed positive cases in high-risk groups of the community has been observed over the last few weeks of the first case. Therefore, this study aims to assess knowledge, practice and associated factors that can contribute to the prevention of COVID-19 among high-risk groups in Addis Ababa. Methods A cross-sectional in person survey (n = 6007) was conducted from 14-30 April, 2020 following a prioritization within high-risk groups in Addis Ababa. The study area targeted bus stations, public transport drivers, air transport infrastructure, health facilities, public and private pharmacies, hotels, government-owned and private banks, telecom centers, trade centers, orphanages, elderly centers, prison, prisons and selected slum areas where the people live in a crowded areas. A questionnaire comprised of four sections (demographics, knowledge, practice and reported symptoms) was used for data collection. The outcomes (knowledge on the transmission and prevention of COVID-19 and practice) were measured using four items. A multi variable logistic regression was applied with adjustment for potential confounding. Results About half (48%, 95% CI: 46-49) of the study participants had poor knowledge on the transmission mode of COVID-19 whereas six out of ten (60%, 95% CI: 58-61) had good knowledge on prevention methods for COVID-19. The practice of preventive measures towards COVID-19 was found to be low (49%, 95% CI: 48-50). Factors that influence knowledge on COVID-19 transmission mechanisms were female gender, older age, occupation (health care and grocery worker), lower income and the use of the 8335 free call centre. Older age, occupation (being a health worker), middle income, experience of respiratory illness and religion were significantly associated with being knowledgeable about the prevention methods for COVID-19. The study found that occupation, religion, income, knowledge on the transmission and prevention of COVID-19 were associated with the practice of precautionary measures towards COVID-19. Conclusion The study highlighted that there was moderate knowledge about transmission modes and prevention mechanisms. Similarly, there was moderate practice of measures that contribute towards the prevention of COVID-19 among these priority and high-risk communities of Addis Ababa. There is an urgent need to fill the knowledge gap in terms of transmission mode and prevention methods of COVID-19 to improve prevention practices and control the spread of COVID-19. Use of female public figures and religious leaders could support the effort towards the increase in awareness.	[Defar, Atkure; Molla, Gebeyaw; Abdella, Saro; Tessema, Masresha; Ahmed, Muhammed; Tadele, Ashenif; Getachew, Fikresilassie; Hailegiorgis, Bezawit; Tigabu, Eyasu; Ababor, Sabit; Bizuwork, Ketema; Deressa, Asefa; Tasaw, Geremew; Kebede, Adisu; Melese, Daniel; Gashu, Andargachew; Eshetu, Kirubel; Tayachew, Adamu; Wossen, Mesfin; Hassen, Abduilhafiz; Habebe, Shambel; Assefa, Zewdu; Abayneh, Aschalew; Abate, Ebba; Tollera, Getachew] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Defar, Atkure] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Paediat & Child Hlth, Gondar, Ethiopia; [Bizuwork, Ketema] Addis Ababa Univ, Sch Nursing & Midwifery, Coll Hlth Sci, Addis Ababa, Ethiopia	University of Gondar; Addis Ababa University	Defar, A (corresponding author), Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia.; Defar, A (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Paediat & Child Hlth, Gondar, Ethiopia.	atkuredefar@gmail.com		Tessema, Masresha/0000-0002-7155-4815; Tasew, Geremew/0000-0002-2797-824X	EPHI	EPHI	The authors would like to thank the EPHI for the support provided to the large-scale screening program. We also would like to thanks Albab Seifu and Hileena Eshetu Chole for proofreading the manuscript. Special thanks to all field staff for their excellent data collection and the study participants for their kind cooperation in interviews and data collection.	Bhagavathula Akshaya Srikanth, 2020, JMIR Public Health Surveill, V6, pe19160, DOI 10.2196/19160; Cao JL, 2020, CLIN INFECT DIS, V71, P748, DOI 10.1093/cid/ciaa243; Federal Mnistry of Health (FMOH) and Ethiopian Public Health Institute (EPHI), 2020, NOTIFICATION NOTE; FMOH, 2020, NAT COMPR COVID 19 M, VFirst, P1; Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396; Kebede Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233744; Mohd S., 2020, KNOWLEDGE ATTITUDE P, DOI [10.1101/2020.04.21.20074757v1.full.pdf+html, DOI 10.1101/2020.04.21.20074757V1.FULL.PDF+HTML]; Ngwewondo A, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008700; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Qian X, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00650-1; Saqlain M., 2020, KNOWLEDGE ATTITUDE P, DOI [10.1101/2020.04.13.20063198v1.full.pdf, DOI 10.1101/2020.04.13.20063198V1.FULL.PDF]; Srichan P., 2020, KNOWLEDGE ATTITUDE P; UN World Urbanization Prospects, 2020, ADDIS ABABA POPULATI; Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239; World Health Organization 2020, 2020, PREP PREV CONTR COVI; Worldmeter report, 2020, COVID 19 CORONAVIRUS; Wu YC, 2020, J CHIN MED ASSOC, V83, P217, DOI 10.1097/JCMA.0000000000000270; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	18	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248420	10.1371/journal.pone.0248420	http://dx.doi.org/10.1371/journal.pone.0248420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705480	Green Published, gold, Green Submitted			2022-12-26	WOS:000629590400046
J	Eder, SJ; Steyrl, D; Stefanczyk, MM; Pieniak, M; Molina, JM; Pesout, O; Binter, J; Smela, P; Scharnowski, F; Nicholson, AA				Eder, Stephanie Josephine; Steyrl, David; Stefanczyk, Michal Mikolaj; Pieniak, Michal; Martinez Molina, Judit; Pesout, Ondra; Binter, Jakub; Smela, Patrick; Scharnowski, Frank; Nicholson, Andrew A.			Predicting fear and perceived health during the COVID-19 pandemic using machine learning: A cross-national longitudinal study	PLOS ONE			English	Article							ATTACHMENT STYLE; DISPOSITIONAL MINDFULNESS; ADULT ATTACHMENT; STRESS; VULNERABILITY; METAANALYSIS; ASSOCIATION; POPULATION; MOTIVATION; SELECTION	During medical pandemics, protective behaviors need to be motivated by effective communication, where finding predictors of fear and perceived health is of critical importance. The varying trajectories of the COVID-19 pandemic in different countries afford the opportunity to assess the unique influence of 'macro-level' environmental factors and 'micro-level' psychological variables on both fear and perceived health. Here, we investigate predictors of fear and perceived health using machine learning as lockdown restrictions in response to the COVID-19 pandemic were introduced in Austria, Spain, Poland and Czech Republic. Over a seven-week period, 533 participants completed weekly self-report surveys which measured the target variables subjective fear of the virus and perceived health, in addition to potential predictive variables related to psychological factors, social factors, perceived vulnerability to disease (PVD), and economic circumstances. Viral spread, mortality and governmental responses were further included in the analysis as potential environmental predictors. Results revealed that our models could accurately predict fear of the virus (accounting for approximately 23% of the variance) using predictive factors such as worrying about shortages in food supplies and perceived vulnerability to disease (PVD), where interestingly, environmental factors such as spread of the virus and governmental restrictions did not contribute to this prediction. Furthermore, our results revealed that perceived health could be predicted using PVD, physical exercise, attachment anxiety and age as input features, albeit with smaller effect sizes. Taken together, our results emphasize the importance of 'micro-level' psychological factors, as opposed to 'macro-level' environmental factors, when predicting fear and perceived health, and offer a starting point for more extensive research on the influences of pathogen threat and governmental restrictions on the psychology of fear and health.	[Eder, Stephanie Josephine; Steyrl, David; Smela, Patrick; Scharnowski, Frank; Nicholson, Andrew A.] Univ Vienna, Fac Psychol, Dept Cognit Emot & Methods Psychol, Vienna, Austria; [Steyrl, David; Scharnowski, Frank] Univ Zurich, Psychiat Hosp, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland; [Stefanczyk, Michal Mikolaj; Pieniak, Michal] Univ Wroclaw, Inst Psychol, Wroclaw, Poland; [Martinez Molina, Judit] Univ Barcelona, Fac Psychol, Barcelona, Spain; [Pesout, Ondra] Univ JE Purkyne, Dept Psychol, Usti Nad Labem, Czech Republic; [Binter, Jakub] Charles Univ Prague, Fac Humanities, Dept Anthropol, Prague, Czech Republic; [Scharnowski, Frank] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; [Scharnowski, Frank] Swiss Fed Inst Technol, Zurich, Switzerland; [Scharnowski, Frank] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Nicholson, Andrew A.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Nicholson, Andrew A.] Homewood Res Inst, Guelph, ON, Canada	University of Vienna; University of Zurich; University of Wroclaw; University of Barcelona; University of Jan Evangelista Purkyne; Charles University Prague; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); McMaster University	Eder, SJ (corresponding author), Univ Vienna, Fac Psychol, Dept Cognit Emot & Methods Psychol, Vienna, Austria.	Stephanie.eder@univie.ac.at	Pieniak, Michał/ABE-3188-2021; Binter, Jakub/GNM-5833-2022; Eder, Stephanie J./AAN-9684-2021	Pieniak, Michał/0000-0002-2991-7109; Binter, Jakub/0000-0001-5304-2130; Eder, Stephanie J./0000-0002-2061-5382; Scharnowski, Frank/0000-0002-9973-2521; Steyrl, David/0000-0002-3215-8115; Pesout, Ondra/0000-0003-2997-8312	European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie Individual Fellowship [897709]; Swiss National Science Foundation [BSSG10_155915, 100014_178841, 32003B_166566]; Foundation for Research in Science and the Humanities at the University of Zurich [STWF-17-012]; Baugarten Stiftung; University of Vienna	European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie Individual Fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Foundation for Research in Science and the Humanities at the University of Zurich; Baugarten Stiftung; University of Vienna	AAN has received funding support from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie Individual Fellowship (grant agreement No. 897709). FS was supported by the Swiss National Science Foundation (BSSG10_155915, 100014_178841, 32003B_166566), the Foundation for Research in Science and the Humanities at the University of Zurich (STWF-17-012), and the Baugarten Stiftung. Open access funding provided by University of Vienna.	Ahn S., 2020, CHANGES HEALTHCARE U; AINSWORTH MDS, 1991, AM PSYCHOL, V46, P333, DOI 10.1037/0003-066X.46.4.333; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; Boyraz G, 2020, J ANXIETY DISORD, V76, DOI 10.1016/j.janxdis.2020.102307; Branstrom R, 2011, BRIT J HEALTH PSYCH, V16, P300, DOI 10.1348/135910710X501683; Breiman L., 2001, MACH LEARN, V45, P5; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Capraro V, 2020, J BEHAV EC POLICY, V4, P45, DOI [DOI 10.31234/OSF.IO/TG7VZ, 10.31234/osf.io/tg7vz]; Carmichael CL, 2021, SOC PSYCHOL PERS SCI, V12, P550, DOI 10.1177/1948550620929164; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Champion VL., 2008, HLTH BEHAV HLTH ED T, P45; Cigler H., 2019, E PSYCHOL, V13, P57, DOI [10.29364/epsy.359, DOI 10.29364/EPSY.359]; Dickert S., 2015, SAGE HDB RISK COMMUN, P41; Ditzen B, 2007, PSYCHONEUROENDOCRINO, V32, P565, DOI 10.1016/j.psyneuen.2007.03.011; Duncan LA, 2009, PERS INDIV DIFFER, V47, P541, DOI 10.1016/j.paid.2009.05.001; Dwyer DB, 2018, ANNU REV CLIN PSYCHO, V14, P91, DOI [10.1146/annurev-clinpsy-032816045037, 10.1146/annurev-clinpsy-032816-045037]; Elran-Barak R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155403; Eurostat, 2020, POP 1 JAN; Fernandez-Fuertes AA, 2011, AN PSICOL-SPAIN, V27, P827; Field T, 2010, DEV REV, V30, P367, DOI 10.1016/j.dr.2011.01.001; Flesia L, 2020, J CLIN MED, V9, DOI 10.3390/jcm9103350; Fraley RC, 2000, J PERS SOC PSYCHOL, V78, P350, DOI 10.1037/0022-3514.78.2.350; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Gotz FM, 2021, AM PSYCHOL, V76, P39, DOI 10.1037/amp0000740; Goodall K, 2012, PERS INDIV DIFFER, V52, P622, DOI 10.1016/j.paid.2011.12.008; Govan F., 2020, THE LOCAL; Green EC, 2006, J HEALTH COMMUN, V11, P245, DOI 10.1080/10810730600613807; Hale T., 2020, OXFORD COVID 19 GOVT; Hastie T., 2009, UNSUPERVISED LEARNIN; Hexel M, 2003, PERS INDIV DIFFER, V35, P1261, DOI 10.1016/S0191-8869(02)00333-1; Ho SMY, 2005, J CONSULT CLIN PSYCH, V73, P344, DOI 10.1037/0022-006X.73.2.344; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Holt-Lunstad J, 2008, PSYCHOSOM MED, V70, P976, DOI 10.1097/PSY.0b013e318187aef7; Hornstein EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175891; Howard MS, 2004, PSYCHOL SCHOOLS, V41, P391, DOI 10.1002/pits.10167; Inbar L, 2021, PSYCHOL HEALTH MED, V26, P75, DOI 10.1080/13548506.2020.1858490; Jamison J, COMP IMPACT COVID 19, DOI [10.1101/2020.08.02.20166793v1, DOI 10.1101/2020.08.02.20166793V1]; Kowalski RM, 2021, HEALTH COMMUN, V36, P15, DOI 10.1080/10410236.2020.1847448; Kushlev K, 2020, PSYCHOL SCI, V31, P807, DOI 10.1177/0956797620919673; Lawler EJ., 1993, Sociological Theory, P268, DOI [DOI 10.2307/201971, 10.2307/201971]; Lindau ST, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c810; Lubiewska K., 2016, PSYCHOL ROZWOJOWA, V21, P49, DOI [DOI 10.4467/20843879PR.16.004.4793, 10.4467/20843879PR.16.004.4793]; Marganska A, 2013, AM J ORTHOPSYCHIAT, V83, P131, DOI 10.1111/ajop.12001; Mazza C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093165; Mckay D, 2020, J ANXIETY DISORD, V73, DOI 10.1016/j.janxdis.2020.102233; McWilliams LA, 2010, HEALTH PSYCHOL, V29, P446, DOI 10.1037/a0020061; MIKULINCER M, 1990, J PERS SOC PSYCHOL, V58, P273, DOI 10.1037/0022-3514.58.2.273; Morman MT, 2000, J APPL COMMUN RES, V28, P91, DOI 10.1080/00909880009365558; Norman P., 2005, PREDICTING HLTH BEHA, P81; Ohlbrecht H, 2021, EUR SOC, V23, pS905, DOI 10.1080/14616696.2020.1852440; Orru G, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02970; Pai C., 2017, INT J COMPUT APPL, V175, P7, DOI DOI 10.5120/IJCA2017915495; Pakpour A.H., 2020, J CONCURR DISORD, V2, P58, DOI [10.54127/WCIC8036, DOI 10.54127/WCIC8036]; Pappas G, 2009, CLIN MICROBIOL INFEC, V15, P743, DOI 10.1111/j.1469-0691.2009.02947.x; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Pennycook G, 2020, PSYCHOL SCI, V31, P770, DOI 10.1177/0956797620939054; Piko B, 2000, J COMMUN HEALTH, V25, P125, DOI 10.1023/A:1005129707550; R Core Team, 2021, R LANGUAGE ENV STAT; Reissman DB, 2006, J HOMEL SECUR EMERG, V3; Roberts KC, 2011, J AM COLL HEALTH, V59, P165, DOI 10.1080/07448481.2010.484452; Roddenberry A, 2010, CHILD PSYCHIAT HUM D, V41, P353, DOI 10.1007/s10578-010-0173-6; Roma P, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197252; Schaller M, 2011, CURR DIR PSYCHOL SCI, V20, P99, DOI 10.1177/0963721411402596; Shultz JM, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0741-y; Szabo A, 2020, PSYCHOL TRAUMA-US, V12, P572, DOI 10.1037/tra0000665; Tannenbaum MB, 2015, PSYCHOL BULL, V141, P1178, DOI 10.1037/a0039729; Thewes B, 2012, SUPPORT CARE CANCER, V20, P2651, DOI 10.1007/s00520-011-1371-x; Thomas Hale, 2020, VARIATION GOVT RESPO; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Prasetyo YT, 2020, INT J INFECT DIS, V99, P312, DOI 10.1016/j.ijid.2020.07.074; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Watt MC, 2005, J PSYCHOPATHOL BEHAV, V27, P191, DOI 10.1007/s10862-005-0635-5; Weinstein ND, 2000, HEALTH PSYCHOL, V19, P65, DOI 10.1037/0278-6133.19.1.65; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; Wong LP, 2020, HUM VACC IMMUNOTHER, V16, P2204, DOI 10.1080/21645515.2020.1790279; Yarkoni T, 2017, PERSPECT PSYCHOL SCI, V12, P1100, DOI 10.1177/1745691617693393; Zakin G, 2003, PERS INDIV DIFFER, V34, P819, DOI 10.1016/S0191-8869(02)00073-9	77	23	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0247997	10.1371/journal.pone.0247997	http://dx.doi.org/10.1371/journal.pone.0247997			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8JZ	33705439	gold, Green Published, Green Submitted			2022-12-26	WOS:000629590400017
J	Edwards, CE; Tessier, BC; Swift, JF; Bassuner, B; Linan, AG; Albrecht, MA; Yatskievych, GA				Edwards, Christine E.; Tessier, Brooke C.; Swift, Joel F.; Bassuner, Burgund; Linan, Alexander G.; Albrecht, Matthew A.; Yatskievych, George A.			Conservation genetics of the threatened plant species Physaria filiformis (Missouri bladderpod) reveals strong genetic structure and a possible cryptic species	PLOS ONE			English	Article							POPULATION-SIZE; SEED DISPERSAL; DIVERSITY; DIFFERENTIATION; PATTERNS; HISTORY; RARE; CONSEQUENCES; SOFTWARE; PROGRAM	Understanding genetic diversity and structure in a rare species is critical for prioritizing both in situ and ex situ conservation efforts. One such rare species is Physaria filiformis (Brassicaceae), a threatened, winter annual plant species. The species has a naturally fragmented distribution, occupying three different soil types spread across four disjunct geographical locations in Missouri and Arkansas. The goals of this study were to understand: (1) whether factors associated with fragmentation and small population size (i.e., inbreeding, genetic drift or genetic bottlenecks) have reduced levels of genetic diversity, (2) how genetic variation is structured and which factors have influenced genetic structure, and (3) how much extant genetic variation of P. filiformis is currently publicly protected and the implications for the development of conservation strategies to protect its genetic diversity. Using 16 microsatellite markers, we genotyped individuals from 20 populations of P. filiformis from across its geographical range and one population of Physaria gracilis for comparison and analyzed genetic diversity and structure. Populations of P. filiformis showed comparable levels of genetic diversity to its congener, except a single population in northwest Arkansas showed evidence of a genetic bottleneck and two populations in the Ouachita Mountains of Arkansas showed lower genetic variation, consistent with genetic drift. Populations showed isolation by distance, indicating that migration is geographically limited, and analyses of genetic structure grouped individuals into seven geographically structured genetic clusters, with geographic location/spatial separation showing a strong influence on genetic structure. At least one population is protected for all genetic clusters except one in north-central Arkansas, which should therefore be prioritized for protection. Populations in the Ouachita Mountains were genetically divergent from the rest of P. filiformis; future morphological analyses are needed to identify whether it merits recognition as a new, extremely rare species.	[Edwards, Christine E.; Tessier, Brooke C.; Swift, Joel F.; Bassuner, Burgund; Linan, Alexander G.; Albrecht, Matthew A.; Yatskievych, George A.] Missouri Bot Garden, Ctr Conservat & Sustainable Dev, St Louis, MO 63110 USA; [Tessier, Brooke C.] Winona State Univ, Dept Cellular & Mol Biol, Winona, MN 55987 USA; [Swift, Joel F.; Linan, Alexander G.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Yatskievych, George A.] Univ Texas Austin, Plant Resources Ctr, Austin, TX 78712 USA	Missouri Botanical Gardens; Minnesota State Colleges & Universities; Winona State University; Saint Louis University; University of Texas System; University of Texas Austin	Edwards, CE (corresponding author), Missouri Bot Garden, Ctr Conservat & Sustainable Dev, St Louis, MO 63110 USA.	Christine.edwards@mobot.org	Edwards, Christine/P-1324-2014	Edwards, Christine/0000-0001-8837-4872	USFWS [F16AP00374]; Missouri Department of Conservation [366]; Arkansas Natural History Commission [1000738077]; Research Experiences for Undergraduates Program of National Science Foundation [DBI-1157030]	USFWS(US Fish & Wildlife Service); Missouri Department of Conservation; Arkansas Natural History Commission; Research Experiences for Undergraduates Program of National Science Foundation	Funding was provided by the USFWS (Grant Agreement F16AP00374) to CEE, MAA and GAY, Missouri Department of Conservation (Cooperative Agreement 366) to CEE, MAA and GAY, Arkansas Natural History Commission (Purchase Order 1000738077) to CEE, MAA and GAY, and the Research Experiences for Undergraduates Program of National Science Foundation (Grant number DBI-1157030) to the Missouri Botanical Garden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbogast BS, 2017, J MAMMAL, V98, P1027, DOI 10.1093/jmammal/gyx055; Barrett SCH, 2017, ANNU REV ECOL EVOL S, V48, P135, DOI 10.1146/annurev-ecolsys-110316-023021; Schuler SBM, 2017, BOT J LINN SOC, V183, P94; Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24, DOI 10.2144/01311bm02; Casacci LP, 2014, ITAL J ZOOL, V81, P182, DOI 10.1080/11250003.2013.870240; Diaz S, 2019, SCIENCE, V366, P1327, DOI 10.1126/science.aax3100; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Duminil J, 2007, AM NAT, V169, P662, DOI 10.1086/513490; Dutcher KE, 2020, CONSERV GENET, V21, P289, DOI 10.1007/s10592-020-01251-z; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edens-Meier R, 2011, J TORREY BOT SOC, V138, P287, DOI 10.3159/TORREY-D-11-00024.1; Edh K, 2007, MOL ECOL, V16, P4972, DOI 10.1111/j.1365-294X.2007.03585.x; Edwards CE, 2008, MOL ECOL, V17, P5157, DOI 10.1111/j.1365-294X.2008.03985.x; Edwards CE, 2019, CONSERV GENET, V20, P1437, DOI 10.1007/s10592-019-01226-9; Edwards CE, 2014, CONSERV GENET, V15, P419, DOI 10.1007/s10592-013-0549-9; Edwards CE, 2009, SYST BOT, V34, P747, DOI 10.1600/036364409790139664; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Ersts PJAo, 2020, GEOGRAPHIC DISTANCE; Escudero A, 2003, BIOL CONSERV, V113, P351, DOI 10.1016/S0006-3207(03)00122-8; Ewedje EEBK, 2020, CONSERV GENET, V21, P501, DOI 10.1007/s10592-020-01265-7; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; FARRIS JS, 1989, SYST ZOOL, V38, P406, DOI 10.2307/2992406; Fay MF, 2019, BOT J LINN SOC, V191, P299, DOI 10.1093/botlinnean/boz076; Feng L, 2019, CONSERV GENET, V20, P315, DOI 10.1007/s10592-018-1133-0; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Funk WC, 2012, TRENDS ECOL EVOL, V27, P489, DOI 10.1016/j.tree.2012.05.012; Gelmi-Candusso TA, 2017, MOL ECOL, V26, P5896, DOI 10.1111/mec.14351; Gilbert KJ, 2012, MOL ECOL, V21, P4925, DOI 10.1111/j.1365-294X.2012.05754.x; Gitzendanner MA, 2000, AM J BOT, V87, P783, DOI 10.2307/2656886; Glemin S, 2005, GENETICS, V171, P279, DOI 10.1534/genetics.104.035915; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Graham M, 1994, THESIS NO MISSOURI S; HAMRICK JL, 1993, VEGETATIO, V108, P281; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Holsinger KE, 2000, P NATL ACAD SCI USA, V97, P7037, DOI 10.1073/pnas.97.13.7037; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Karron JD, 2012, ANN BOT-LONDON, V109, P493, DOI 10.1093/aob/mcr319; Keene J, 2009, THESIS MISSOURI STAT; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kothera L, 2007, CONSERV GENET, V8, P1043, DOI 10.1007/s10592-006-9252-4; Kramer AT, 2011, AM J BOT, V98, P109, DOI 10.3732/ajb.1000229; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; Lindsay DL, 2018, BOT J LINN SOC, V186, P361, DOI 10.1093/botlinnean/box099; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; MANTEL N, 1967, CANCER RES, V27, P209; Martin SD, 2016, J BIOGEOGR, V43, P410, DOI 10.1111/jbi.12625; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; Neel MC, 2008, BIOL CONSERV, V141, P938, DOI 10.1016/j.biocon.2007.12.031; NEI M, 1978, GENETICS, V89, P583; Newbold T, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006841; Paschke M, 2002, CONSERV GENET, V3, P131, DOI 10.1023/A:1015293530776; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Ren MX, 2017, BOT J LINN SOC, V183, P429, DOI 10.1093/botlinnean/bow017; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Sgro CM, 2011, EVOL APPL, V4, P326, DOI 10.1111/j.1752-4571.2010.00157.x; Swift JF., 2016, CONSERV GENET, P1; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Thomas LP, 1996, NAT AREA J, V16, P216; USFWS, 1988, MISS BLADD LESQ FIL; USFWS, 2015, MISS BLADD PHYS FIL; USFWS, 2003, FED REG, V68, P59337; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Westrich JL, 1997, THESIS TRUMAN STATE; Whitehead MR, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00038; Whitsell T., 2008, MANAGEMENT PLAN MISS; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wright S, 1943, GENETICS, V28, P114; Yatskievych G., 2006, STEYERMARKS FLORA MI; Young CC., 2013, ANN STATUS REPORT MI; Young CC, 2008, NAT AREA J, V28, P370, DOI 10.3375/0885-8608(2008)28[370:MLFRMB]2.0.CO;2; Young CC, 2009, J TORREY BOT SOC, V136, P233, DOI 10.3159/08-RA-105.1	84	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0247586	10.1371/journal.pone.0247586	http://dx.doi.org/10.1371/journal.pone.0247586			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705416	gold, Green Published			2022-12-26	WOS:000629590400005
J	Gunarathna, N; Amarasinghe, A; Wijesundara, S; Iddawela, D; Wickramasinghe, S				Gunarathna, Nuwan; Amarasinghe, Anjalie; Wijesundara, Sunil; Iddawela, Devika; Wickramasinghe, Susiji			Isolation, molecular characterization and phylogeny of Naegleria species in water bodies of North-Western Province, Sri Lanka	PLOS ONE			English	Article								Background The inland freshwater bodies in the North-Western Province of Sri Lanka have ideal environmental conditions for the Naegleria species. Therefore, the presence and prevalence of Naegleria species in the water bodies of North-Western Province were determined by molecular characterization and phylogenetic analysis in this study. Methods A total of 104 water bodies were selected from Kurunegala and Puttalam districts in the North-Western Province of Sri Lanka. Mean turbidity, pH, and temperature were recorded in each water body from three selected site. Centrifuged samples were cultured on non-nutrient agar plates with Escherichia coli. Enflagellation test positive isolates were subjected to DNA extraction and polymerase chain reaction using genus and species-specific primers targeting the internal transcribed spacer region (ITS) and Mp2CL5 gene. Phylogenetic analysis was performed using Bayesian and maximum likelihood (ML) methods. Results The prevalence of Naegleria species and N. fowleri in the study area were 23.07% and 1.92%. The prevalence of Naegleria species and the physicochemical parameters of the water bodies showed no significant correlation. Bayesian analysis of the ITS region revealed the Naegleria Sri Lankan (SL) isolates 1, 3, and 4 in a single clade separated from the 2 and 5. Furthermore, Bayesian analysis identified isolates 2 and 5 in the same clade with Naegleria sp. samples and N. Philippinensis forming a sister clade. However, in the ML tree, all isolates were in the same clade with Naegleria sp. samples and N. Philippinensis. Conclusions The present study reports the first isolation of pathogenic N. fowleri from Sri Lanka. Based on Bayesian analysis, SL isolates 2 and 5 form a separate clade from 1, 3, and 4. However, in ML analysis, all isolates are grouped in one clade with Naegleria sp. samples and N. philippinensis. Further investigations are required to confirm these findings.	[Gunarathna, Nuwan; Amarasinghe, Anjalie; Wijesundara, Sunil; Iddawela, Devika; Wickramasinghe, Susiji] Univ Peradeniya, Dept Parasitol, Fac Med, Peradeniya, Sri Lanka; [Gunarathna, Nuwan] Minist Hlth, Colombo, Sri Lanka	University of Peradeniya	Iddawela, D; Wickramasinghe, S (corresponding author), Univ Peradeniya, Dept Parasitol, Fac Med, Peradeniya, Sri Lanka.	devikaiddawela@yahoo.com; susijij@pdn.ac.lk		Gunarathna, J.A. Nuwan Shantha/0000-0002-4461-4288; Wickramasinghe, Susiji/0000-0003-2046-1093				[Anonymous], 2016, ANN HLTH B; [Anonymous], 2010, MIN 17 STAT SOFTW; Ash LR, 1987, GUIDE LAB PROCEDURES; Bartrand TA, 2014, J AM WATER WORKS ASS, V106, pE418, DOI 10.5942/jawwa.2014.106.0140; Benterki MS, 2016, PARASITE, V23, DOI 10.1051/parasite/2016011; Blair B, 2008, EMERG INFECT DIS, V14, P1499, DOI 10.3201/eid1409.071076; Bright KR, 2017, HYDROGEOL J, V25, P953, DOI 10.1007/s10040-017-1582-4; CABLE BL, 1986, J PROTOZOOL, V33, P467, DOI 10.1111/j.1550-7408.1986.tb05643.x; Cheesbrough M, 1981, MED LAB MANUAL TROPI, V1; De Jonckheere JF, 2001, PROTIST, V152, P115, DOI 10.1078/1434-4610-00049; De Jonckheere JF, 2014, EXP PARASITOL, V145, pS2, DOI 10.1016/j.exppara.2014.07.011; De Jonckheere JF, 2011, INFECT GENET EVOL, V11, P1520, DOI 10.1016/j.meegid.2011.07.023; Department of Census and Statistics-Sri Lanka, 2012, POP SRI LANKA; Department of Metrology-Sri Lanka, 2006, ANN RAINF SRI LANKA; Foot NC, 1933, STAIN TECHNOL, V8, P101, DOI 10.3109/10520293309116112; Ghadar-ghadr Sh, 2012, J JAHROM U MED SCI, V10, P26; Gharpure R, 2021, CLIN INFECT DIS, V73, pE19, DOI 10.1093/cid/ciaa520; Gunarathna J.A.N.S., 2018, SRI LANKAN J INFECT, V8, P74; Gunarathna JANS., 2009, P KANDY SOC MED, V31, P40; Gupta N, 2009, BRAZ J INFECT DIS, V13, P236, DOI 10.1590/S1413-86702009000300016; Hall T., 2011, GERF B BIOSCI, V2, P60; Hikal WM, 2015, PUBLIC HLTH PREV MED, V1, P73; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Izumiyama S, 2003, J EUKARYOT MICROBIOL, V50, P514, DOI 10.1111/j.1550-7408.2003.tb00614.x; Kao PM, 2013, PARASITOL RES, V112, P1467, DOI 10.1007/s00436-013-3290-x; KINGSTON D, 1969, J MED MICROBIOL, V2, P27, DOI 10.1099/00222615-2-1-27; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; KYLE DE, 1985, J PROTOZOOL, V32, P99, DOI 10.1111/j.1550-7408.1985.tb03022.x; KYLE DE, 1986, J PROTOZOOL, V33, P422, DOI 10.1111/j.1550-7408.1986.tb05634.x; Lachenbruch PA., 1991, J AM STAT ASSOC, V86, P1149, DOI [DOI 10.2307/2290547, 10.2307/2290547]; Maciver SK, 2020, TRENDS PARASITOL, V36, P19, DOI 10.1016/j.pt.2019.10.008; Marciano-Cabral F, 2003, APPL ENVIRON MICROB, V69, P5864, DOI 10.1128/AEM.69.10.5864-5869.2003; MARCIANOCABRAL F, 1988, MICROBIOL REV, V52, P114, DOI 10.1128/MMBR.52.1.114-133.1988; MARTINEZ AJ, 1985, FREE LIVING AMOEBAS; Montalbano Di Filippo M, 2017, EXP PARASITOL, V183, P143, DOI 10.1016/j.exppara.2017.08.008; Moussa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054414; Phu NH, 2013, LANCET, V381, P176, DOI 10.1016/S0140-6736(12)61730-9; Niyyati M, 2015, IRAN J PARASITOL, V10, P523; Panabokke CR., EVOLUTION PRESENT ST, DOI [10.1023/a%3A1014459100736, DOI 10.1023/A%3A1014459100736]; Panda A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137736; Pelandakis M, 2002, APPL ENVIRON MICROB, V68, P2061, DOI 10.1128/AEM.68.4.2061-2065.2002; Reveiller FL, 2002, PARASITOL RES, V88, P443, DOI 10.1007/s00436-002-0591-x; Saberi R, 2020, TRANSBOUND EMERG DIS, V67, P2389, DOI 10.1111/tbed.13635; Shoff ME, 2008, J WATER HEALTH, V6, P99, DOI 10.2166/wh.2007.014; Sifuentes LY, 2014, J ENVIRON SCI HEAL A, V49, P1322, DOI 10.1080/10934529.2014.910342; Thilakasiri K. R., 2015, Tropical Agricultural Research, V26, P684; Thomas V, 2006, APPL ENVIRON MICROB, V72, P2428, DOI 10.1128/AEM.72.4.2428-2438.2006; Wijesundera NLS., 1996, P SRI LANKA COLL MIC, V6, P11; Zhang LL, 2018, INT J INFECT DIS, V72, P28, DOI 10.1016/j.ijid.2018.05.001	49	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248510	10.1371/journal.pone.0248510	http://dx.doi.org/10.1371/journal.pone.0248510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705485	gold, Green Published			2022-12-26	WOS:000629590400062
J	Ortolano, NA; Romero-Morales, AI; Rasmussen, ML; Bodnya, C; Kline, LA; Joshi, P; Connelly, JP; Rose, KL; Pruett-Miller, SM; Gama, V				Ortolano, Natalya A.; Romero-Morales, Alejandra, I; Rasmussen, Megan L.; Bodnya, Caroline; Kline, Leigh A.; Joshi, Piyush; Connelly, Jon P.; Rose, Kristie L.; Pruett-Miller, Shondra M.; Gama, Vivian			A proteomics approach for the identification of cullin-9 (CUL9) related signaling pathways in induced pluripotent stem cell models	PLOS ONE			English	Article								CUL9 is a non-canonical and poorly characterized member of the largest family of E3 ubiquitin ligases known as the Cullin RING ligases (CRLs). Most CRLs play a critical role in developmental processes, however, the role of CUL9 in neuronal development remains elusive. We determined that deletion or depletion of CUL9 protein causes aberrant formation of neural rosettes, an in vitro model of early neuralization. In this study, we applied mass spectrometric approaches in human pluripotent stem cells (hPSCs) and neural progenitor cells (hNPCs) to identify CUL9 related signaling pathways that may contribute to this phenotype. Through LC-MS/MS analysis of immunoprecipitated endogenous CUL9, we identified several subunits of the APC/C, a major cell cycle regulator, as potential CUL9 interacting proteins. Knockdown of the APC/C adapter protein FZR1 resulted in a significant increase in CUL9 protein levels, however, CUL9 does not appear to affect protein abundance of APC/C subunits and adapters or alter cell cycle progression. Quantitative proteomic analysis of CUL9 KO hPSCs and hNPCs identified protein networks related to metabolic, ubiquitin degradation, and transcriptional regulation pathways that are disrupted by CUL9 deletion in both hPSCs. No significant changes in oxygen consumption rates or ATP production were detected in either cell type. The results of our study build on current evidence that CUL9 may have unique functions in different cell types and that compensatory mechanisms may contribute to the difficulty of identifying CUL9 substrates.	[Ortolano, Natalya A.; Romero-Morales, Alejandra, I; Rasmussen, Megan L.; Bodnya, Caroline; Kline, Leigh A.; Joshi, Piyush; Gama, Vivian] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37235 USA; [Connelly, Jon P.; Pruett-Miller, Shondra M.] St Jude Childrens Res Hosp, Dept Cell & Mol Biol, Memphis, TN USA; [Connelly, Jon P.; Pruett-Miller, Shondra M.] St Jude Childrens Res Hosp, Ctr Adv Genome Engn, 332 N Lauderdale St, Memphis, TN 38105 USA; [Rose, Kristie L.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Rose, Kristie L.] Vanderbilt MSRC Prote Core, Nashville, TN USA; [Gama, Vivian] Vanderbilt Ctr Stem Cell Biol, Nashville, TN 37232 USA; [Gama, Vivian] Vanderbilt Brain Inst, Nashville, TN 37232 USA	Vanderbilt University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Vanderbilt University; Vanderbilt University	Gama, V (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37235 USA.; Gama, V (corresponding author), Vanderbilt Ctr Stem Cell Biol, Nashville, TN 37232 USA.; Gama, V (corresponding author), Vanderbilt Brain Inst, Nashville, TN 37232 USA.	vivian.gama@vanderbilt.edu		Gama, Vivian/0000-0002-1201-1394; Romero Morales, Alejandra/0000-0001-9087-1907	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [1R35GM128915-01]; HHS \ National Institutes of Health (NIH) [1R21CA227483-01A1]; HHS \ NIH \ National Institute of Neurological Disorders and Stroke (NINDS) [F31NS10858]; HHS \ NIH \ Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [5T32HD7502-20]	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHS \ NIH \ National Institute of Neurological Disorders and Stroke (NINDS); HHS \ NIH \ Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS):Vivian Gama 1R35GM128915-01; HHS vertical bar National Institutes of Health (NIH):Vivian Gama 1R21CA227483-01A1; HHS vertical bar NIH vertical bar National Institute of Neurological Disorders and Stroke (NINDS):Natalya Ortolano F31NS10858; HHS vertical bar NIH vertical bar Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD):Natalya Ortolano 5T32HD7502-20 https://www.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2003, P NATL ACAD SCI USA, V100, P9855, DOI 10.1073/pnas.1733908100; Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bennati AM, 2006, BBA-MOL CELL BIOL L, V1761, P677, DOI 10.1016/j.bbalip.2006.05.004; Cao R, 2012, J PROTEOME RES, V11, P829, DOI 10.1021/pr200677z; Chandrasekaran A, 2017, STEM CELL RES, V25, P139, DOI 10.1016/j.scr.2017.10.010; Chen YH, 2018, STEM CELL RES, V31, P186, DOI 10.1016/j.scr.2018.08.003; Ciechanover A, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.117; Connelly JP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40896-w; Cubelos B, 2010, NEURON, V66, P523, DOI 10.1016/j.neuron.2010.04.038; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Dee CT, 2008, DEV BIOL, V320, P289, DOI 10.1016/j.ydbio.2008.05.542; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Dumitru R, 2012, MOL CELL, V46, P573, DOI 10.1016/j.molcel.2012.04.002; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Franceschini A, 2016, BIOINFORMATICS, V32, P1085, DOI 10.1093/bioinformatics/btv696; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Gama V, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005309; Georgala PA, 2011, CEREB CORTEX, V21, P81, DOI 10.1093/cercor/bhq061; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hamasaki T, 2004, NEURON, V43, P359, DOI 10.1016/j.neuron.2004.07.016; Haremaki T, 2019, NAT BIOTECHNOL, V37, P1198, DOI 10.1038/s41587-019-0237-5; He J, 2013, MOL CELL, V50, P649, DOI 10.1016/j.molcel.2013.04.024; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jehl P, 2016, NUCLEIC ACIDS RES, V44, pW11, DOI 10.1093/nar/gkw265; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Konze SA, 2017, J PROTEOME RES, V16, P1133, DOI 10.1021/acs.jproteome.6b00534; Li BH, 2002, MOL CELL BIOL, V22, P4997, DOI 10.1128/MCB.22.14.4997-5005.2002; Li ZJ, 2014, MOL CELL, V54, P805, DOI 10.1016/j.molcel.2014.03.046; Manuel M, 2007, DEVELOPMENT, V134, P545, DOI 10.1242/dev.02764; Medelnik JP, 2018, STEM CELL REP, V10, P1751, DOI 10.1016/j.stemcr.2018.04.018; Molina H, 2009, J PROTEOME RES, V8, P48, DOI 10.1021/pr800650r; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Nikolaev AY, 2003, CELL CYCLE, V2, P169, DOI 10.4161/cc.2.3.346; Ordureau A, 2015, MOL CELL, V58, P660, DOI 10.1016/j.molcel.2015.02.020; Pei XH, 2011, CANCER RES, V71, P2969, DOI 10.1158/0008-5472.CAN-10-4300; Poirier K, 2010, HUM MOL GENET, V19, P4462, DOI 10.1093/hmg/ddq377; Potenza E, 2015, NUCLEIC ACIDS RES, V43, pD315, DOI 10.1093/nar/gku982; Qiao RP, 2016, P NATL ACAD SCI USA, V113, pE2570, DOI 10.1073/pnas.1604929113; Rajalingam K, 2016, CELL, V164, DOI 10.1016/j.cell.2016.02.019; Sackton KL, 2014, NATURE, V514, P646, DOI 10.1038/nature13660; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Skaar JR, 2007, CANCER RES, V67, P2006, DOI 10.1158/0008-5472.CAN-06-3241; Skaar JR, 2005, MOL CELL BIOL, V25, P5579, DOI 10.1128/mcb.25.13.5579-5589.2005; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; van de Leemput J, 2014, NEURON, V83, P51, DOI 10.1016/j.neuron.2014.05.013; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Volpato V, 2018, STEM CELL REP, V11, P897, DOI 10.1016/j.stemcr.2018.08.013; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wang YS, 1999, CURR BIOL, V9, P1191, DOI 10.1016/S0960-9822(00)80024-X; Wiese S, 2007, PROTEOMICS, V7, P340, DOI 10.1002/pmic.200600422; Wild T, 2018, CELL REP, V25, P2317, DOI 10.1016/j.celrep.2018.10.104; Wilson PG, 2006, STEM CELL REV, V2, P67, DOI 10.1385/SCR:2:1:67; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Yan J, 2014, MOL CELL, V54, P791, DOI 10.1016/j.molcel.2014.03.047; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zhang SY, 2016, NATURE, V533, P260, DOI 10.1038/nature17973	72	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248000	10.1371/journal.pone.0248000	http://dx.doi.org/10.1371/journal.pone.0248000			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705438	gold, Green Published			2022-12-26	WOS:000629590400070
J	Berdiel-Acer, M; Maia, A; Hristova, Z; Borgoni, S; Vetter, M; Burmester, S; Becki, C; Michels, B; Abnaof, K; Binenbaum, I; Bethmann, D; Chatziioannou, A; Hasmann, M; Thomssen, C; Espinet, E; Wiemann, S				Berdiel-Acer, Mireia; Maia, Ana; Hristova, Zhivka; Borgoni, Simone; Vetter, Martina; Burmester, Sara; Becki, Corinna; Michels, Birgitta; Abnaof, Khalid; Binenbaum, Ilona; Bethmann, Daniel; Chatziioannou, Aristotelis; Hasmann, Max; Thomssen, Christoph; Espinet, Elisa; Wiemann, Stefan			Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts	ONCOGENE			English	Article							INTRACELLULAR DOMAIN; ERBB RECEPTORS; GENE ONTOLOGY; EXPRESSION; HER3; SUBTYPES; ANTIBODY; HETEROGENEITY; METASTASIS; DISCOVERY	HER3 is highly expressed in luminal breast cancer subtypes. Its activation by NRG1 promotes activation of AKT and ERK1/2, contributing to tumour progression and therapy resistance. HER3-targeting agents that block this activation, are currently under phase 1/2 clinical studies, and although they have shown favorable tolerability, their activity as a single agent has proven to be limited. Here we show that phosphorylation and activation of HER3 in luminal breast cancer cells occurs in a paracrine manner and is mediated by NRG1 expressed by cancer-associated fibroblasts (CAFs). Moreover, we uncover a HER3-independent NRG1 signaling in CAFs that results in the induction of a strong migratory and pro-fibrotic phenotype, describing a subtype of CAFs with elevated expression of NRG1 and an associated transcriptomic profile that determines their functional properties. Finally, we identified Hyaluronan Synthase 2 (HAS2), a targetable molecule strongly correlated with NRG1, as an attractive player supporting NRG1 signaling in CAFs.	[Berdiel-Acer, Mireia; Maia, Ana; Hristova, Zhivka; Borgoni, Simone; Burmester, Sara; Becki, Corinna; Michels, Birgitta; Abnaof, Khalid; Wiemann, Stefan] German Canc Res Ctr, Div Mol Genome Anal, Heidelberg, Germany; [Maia, Ana; Hristova, Zhivka; Borgoni, Simone] Ruprecht Karls Univ Heidelberg, Fac Biosci, Heidelberg, Germany; [Vetter, Martina; Thomssen, Christoph] Martin Luther Univ Halle Wittenberg, Dept Gynecol, Halle, Germany; [Binenbaum, Ilona] German Canc Res Ctr, Div Med Informat Translat Oncol, Heidelberg, Germany; [Binenbaum, Ilona] Univ Patras, Dept Biol, Patras, Greece; [Binenbaum, Ilona; Chatziioannou, Aristotelis] Natl Hellen Res Fdn, Inst Chem Biol, Athens, Greece; [Bethmann, Daniel] Martin Luther Univ Halle Wittenberg, Inst Pathol, Halle, Germany; [Chatziioannou, Aristotelis] E NIOS Pc, Kallithea Athens, Greece; [Hasmann, Max] Roche Diagnostics, Penzberg, Germany; [Espinet, Elisa] German Canc Res Ctr, Div Stem Cells & Canc, Heidelberg, Germany; [Espinet, Elisa] Heidelberg Inst Stem Cell Technol & Expt Med HI S, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Martin Luther University Halle Wittenberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Patras; National Hellenic Research Foundation; Martin Luther University Halle Wittenberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Berdiel-Acer, M; Wiemann, S (corresponding author), German Canc Res Ctr, Div Mol Genome Anal, Heidelberg, Germany.	mireia.berdiel@gmail.com; s.wiemann@dkfz-heidelberg.de	Wiemann, Stefan/E-4424-2013; Thomssen, Christoph/ABC-3102-2021	Wiemann, Stefan/0000-0003-4683-3174; Maia, Ana/0000-0003-1261-7211; Berdiel-Acer, Mireia/0000-0002-9777-9457; Hristova, Zhivka/0000-0003-2609-3623; Espinet, Elisa/0000-0002-0690-9878; Michels, Birgitta E./0000-0001-9948-4567	Projekt DEAL	Projekt DEAL	Open Access funding enabled and organized by Projekt DEAL.	Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Augsten M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00062; Balko JM, 2012, P NATL ACAD SCI USA, V109, P221, DOI 10.1073/pnas.1115802109; Berdiel-Acer M, 2014, MOL ONCOL, V8, P1290, DOI 10.1016/j.molonc.2014.04.006; Casey T, 2009, BREAST CANCER RES TR, V114, P47, DOI 10.1007/s10549-008-9982-8; Cejalvo JM, 2017, CANCER RES, V77, P2213, DOI 10.1158/0008-5472.CAN-16-2717; Chua YL, 2009, ONCOGENE, V28, P4041, DOI 10.1038/onc.2009.259; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cortez E, 2014, SEMIN CANCER BIOL, V25, P3, DOI 10.1016/j.semcancer.2013.12.010; Costea DE, 2013, CANCER RES, V73, P3888, DOI 10.1158/0008-5472.CAN-12-4150; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Fujiwara S, 2014, BREAST CANCER-TOKYO, V21, P472, DOI 10.1007/s12282-012-0415-5; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jacob W, 2018, CANCER TREAT REV, V68, P111, DOI 10.1016/j.ctrv.2018.06.011; Karachaliou N, 2017, BIODRUGS, V31, P63, DOI 10.1007/s40259-016-0205-2; Karagiannis GS, 2012, MOL CANCER RES, V10, P1403, DOI 10.1158/1541-7786.MCR-12-0307; Kim J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-383; Kim YH, 2019, CANCER SCI, V110, P2226, DOI 10.1111/cas.14070; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kolb A, 2007, INT J CANCER, V120, P514, DOI 10.1002/ijc.22360; Koutsandreas Theodoros, 2016, International Journal of Monitoring and Surveillance Technologies Research, V4, P30, DOI 10.4018/IJMSTR.2016040103; Kudo D, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030600; Ledonne A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010275; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lisanti MP, 2014, CELL CYCLE, V13, P580, DOI 10.4161/cc.27379; Liu HY, 2017, DEV CELL, V41, P392, DOI 10.1016/j.devcel.2017.04.024; Liu XL, 2019, BIOL PROCED ONLINE, V21, DOI 10.1186/s12575-019-0093-1; Loeb JA, 1998, MOL CELL NEUROSCI, V11, P77, DOI 10.1006/mcne.1998.0676; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Mei L, 2014, NEURON, V83, P27, DOI 10.1016/j.neuron.2014.06.007; Meulendijks D, 2017, CLIN CANCER RES, V23, P5406, DOI 10.1158/1078-0432.CCR-17-0812; Meulendijks D, 2016, CLIN CANCER RES, V22, P877, DOI 10.1158/1078-0432.CCR-15-1683; Mirschberger C, 2013, CANCER RES, V73, P5183, DOI 10.1158/0008-5472.CAN-13-0099; Mishra R, 2018, ONCOL REV, V12, P45, DOI 10.4081/oncol.2018.355; Montero JC, 2008, CLIN CANCER RES, V14, P3237, DOI 10.1158/1078-0432.CCR-07-5133; Morrison MM, 2013, J CLIN INVEST, V123, P4329, DOI 10.1172/JCI66764; Morsing M, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0769-2; Ocana A, 2016, ONCOTARGET, V7, P45042, DOI 10.18632/oncotarget.8648; Ogier C, 2018, CANCER LETT, V432, P227, DOI 10.1016/j.canlet.2018.06.023; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Orimo A, 2007, CANCER BIOL THER, V6, P618, DOI 10.4161/cbt.6.4.4255; Parra LM, 2015, MOL CELL BIOL, V35, P3381, DOI 10.1128/MCB.00500-15; Patel AK, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0087-x; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Qian GQ, 2015, CANCER-AM CANCER SOC, V121, P3600, DOI 10.1002/cncr.29549; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Saadi A, 2010, P NATL ACAD SCI USA, V107, P2177, DOI 10.1073/pnas.0909797107; Sadlonova A, 2009, CANCER MICROENVIRON, V2, P9, DOI 10.1007/s12307-008-0017-0; Sahai E, 2020, NAT REV CANCER, V20, P174, DOI 10.1038/s41568-019-0238-1; Sahin O, 2007, P NATL ACAD SCI USA, V104, P6579, DOI 10.1073/pnas.0606827104; Schneeweiss A, 2018, INVEST NEW DRUG, V36, P848, DOI 10.1007/s10637-018-0562-4; Shee K, 2018, J EXP MED, V215, P895, DOI 10.1084/jem.20171818; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Sonntag J, 2014, EXPERT REV PROTEOMIC, V11, P757, DOI 10.1586/14789450.2014.971113; Sorlie T, 2004, EUR J CANCER, V40, P2667, DOI 10.1016/j.ejca.2004.08.021; Su SC, 2018, CELL, V172, P841, DOI 10.1016/j.cell.2018.01.009; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Tsai MS, 2003, ONCOGENE, V22, P761, DOI 10.1038/sj.onc.1206130; Vargas AC, 2012, BREAST CANCER RES TR, V135, P153, DOI 10.1007/s10549-012-2123-4; Walker RA, 2001, BREAST CANCER RES, V3, P143, DOI 10.1186/bcr287; Weinstein IB, 1997, CLIN CANCER RES, V3, P2696; Wernig G, 2017, P NATL ACAD SCI USA, V114, P4757, DOI 10.1073/pnas.1621375114; Willem M, 2016, BRAIN RES BULL, V126, P178, DOI 10.1016/j.brainresbull.2016.07.003; Wilson TR, 2011, CANCER CELL, V20, P158, DOI 10.1016/j.ccr.2011.07.011; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoshida E, 2018, ANTICANCER RES, V38, P5799, DOI 10.21873/anticanres.12919; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Yun S, 2018, GASTRIC CANCER, V21, P225, DOI 10.1007/s10120-017-0732-7; Zhang K, 2012, ONCOGENE, V31, P4609, DOI 10.1038/onc.2011.606; Zhang ZW, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0458-0	76	7	7	2	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 15	2021	40	15					2651	2666		10.1038/s41388-021-01719-3	http://dx.doi.org/10.1038/s41388-021-01719-3		MAR 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RN8NW	33692466	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000627285600003
J	Miller, ARV; Johnson, J; Makhortykh, S; Gerling, C; Litvinova, L; Andrukh, S; Toschev, G; Zech, J; le Roux, P; Makarewicz, C; Boivin, N; Roberts, P				Miller, Alicia R. Ventresca; Johnson, James; Makhortykh, Sergey; Gerling, Claudia; Litvinova, Ludmilla; Andrukh, Svetlana; Toschev, Gennady; Zech, Jana; le Roux, Petrus; Makarewicz, Cheryl; Boivin, Nicole; Roberts, Patrick			Re-evaluating Scythian lifeways: Isotopic analysis of diet and mobility in Iron Age Ukraine	PLOS ONE			English	Article							TOOTH ENAMEL; OXYGEN ISOTOPES; BONE PHOSPHATE; COPPER AGE; STRONTIUM; FRACTIONATION; SR-87/SR-86; RATIOS; PATTERNS; COLLAGEN	The Scythians are frequently presented, in popular and academic thought alike, as highly mobile warrior nomads who posed a great economic risk to growing Mediterranean empires from the Iron Age into the Classical period. Archaeological studies provide evidence of first millennium BCE urbanism in the steppe while historical texts reference steppe agriculture, challenging traditional characterizations of Scythians as nomads. However, there have been few direct studies of the diet and mobility of populations living in the Pontic steppe and forest-steppe during the Scythian era. Here, we analyse strontium, oxygen, and carbon isotope data from human tooth enamel samples, as well as nitrogen and carbon isotope data of bone collagen, at several Iron Age sites across Ukraine commonly associated with 'Scythian' era communities. Our multi-isotopic approach demonstrates generally low levels of human mobility in the vicinity of urban locales, where populations engaged in agro-pastoralism focused primarily on millet agriculture. Some individuals show evidence for long-distance mobility, likely associated with significant inter-regional connections. We argue that this pattern supports economic diversity of urban locales and complex trading networks, rather than a homogeneous nomadic population.	[Miller, Alicia R. Ventresca; Zech, Jana] Univ Michigan, Dept Anthropol, Ann Arbor, MI 48109 USA; [Miller, Alicia R. Ventresca; Zech, Jana] Univ Michigan, Museum Anthropol Archaeol, Ann Arbor, MI 48109 USA; [Miller, Alicia R. Ventresca; Boivin, Nicole; Roberts, Patrick] Max Planck Inst Sci Human Hist, Dept Archaeol, Stable Isotope Grp, Jena, Germany; [Miller, Alicia R. Ventresca; Makarewicz, Cheryl] Univ Kiel, Grad Sch Human Dev Landscapes, Kiel, Germany; [Miller, Alicia R. Ventresca; Makarewicz, Cheryl] Univ Kiel, Inst Prehist & Protohist Archaeol, Kiel, Germany; [Johnson, James] Univ Wyoming, Dept Anthropol, Laramie, WY 82071 USA; [Makhortykh, Sergey; Litvinova, Ludmilla] Natl Acad Sci Ukraine NUAS, Inst Archaeol, Kiev, Ukraine; [Gerling, Claudia] Univ Basel, Dept Environm Sci Integrat Prehist & Archaeol Sci, Basel, Switzerland; [Andrukh, Svetlana; Toschev, Gennady] Zaporizhzhya Natl Univ, Zaporizhzhya, Ukraine; [le Roux, Petrus] Univ Cape Town, Dept Geol Sci, Rondebosch, South Africa; [Boivin, Nicole; Roberts, Patrick] Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia; [Boivin, Nicole] Univ Calgary, Dept Archaeol, Calgary, AB, Canada; [Boivin, Nicole] Smithsonian Inst, New York, NY USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Kiel; University of Kiel; University of Wyoming; National Academy of Sciences Ukraine; Institute of Archaeology, National Academy of Sciences of Ukraine; University of Basel; Ministry of Education & Science of Ukraine; Zaporizhzhia National University; University of Cape Town; University of Queensland; University of Calgary; Smithsonian Institution	Miller, ARV (corresponding author), Univ Michigan, Dept Anthropol, Ann Arbor, MI 48109 USA.; Miller, ARV (corresponding author), Univ Michigan, Museum Anthropol Archaeol, Ann Arbor, MI 48109 USA.; Miller, ARV (corresponding author), Max Planck Inst Sci Human Hist, Dept Archaeol, Stable Isotope Grp, Jena, Germany.; Miller, ARV (corresponding author), Univ Kiel, Grad Sch Human Dev Landscapes, Kiel, Germany.; Miller, ARV (corresponding author), Univ Kiel, Inst Prehist & Protohist Archaeol, Kiel, Germany.	ventrescamiller@shh.mpg.de	le Roux, Petrus J./AAD-4755-2021	le Roux, Petrus J./0000-0002-5930-4995; BOIVIN, NICOLE/0000-0002-7783-4199; Gerling, Claudia/0000-0003-4619-7032; Roberts, Patrick/0000-0002-4403-7548; Ventresca Miller, Alicia R./0000-0003-4148-4016	National Geographic Society [9332-13]; Graduate School for Human Development in Landscapes under the Deutsche Forschungsgemeinschaft [GS 208]; Max Planck Society	National Geographic Society(National Geographic Society); Graduate School for Human Development in Landscapes under the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	Generous funding from the National Geographic Society (9332-13; PI -JJ) provided support for fieldwork at Bel'sk (SM, JJ, Tim Taylor) and the physical analysis of human remains at the Institute of Archaeology, Ukrainian Academy of Sciences in Kyiv (AVM, LL). Carbon, oxygen, and nitrogen isotopic analyses were funded by the National Geographic Society (9332-13) (JJ) and the Graduate School for Human Development in Landscapes under the Deutsche Forschungsgemeinschaft: GS 208 (AVM). Funding for strontium isotopic analyses was provided by the Max Planck Society. AVM, PR, and NB thank the Max Planck Society for funding.	ABERG G, 1995, WATER AIR SOIL POLL, V79, P309, DOI 10.1007/BF01100444; Acsadi G., 1970, HIST HUMAN LIFE SPAN; Alexeyev A., 2017, SCYTHIANS WARRIORS A, P16; Alt KW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110793; Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; Ambrose SH, 2003, J ANTHROPOL ARCHAEOL, V22, P217, DOI 10.1016/S0278-4165(03)00036-9; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Andrukh SI., 2009, MAMAI GORA METERY; Andrukh SI., 2004, MAMAI GORA METERY; Andrukh SI., 2012, PEREGRINATIONES ARCH, P485; Andrukh SI., 1999, MAMAI GORA METERY; Andrukh SI., 2001, MAMAI GORA CEMETERY; Anthony DW., 2007, HORSE WHEEL LANGUAGE; Beard BL, 2000, J FORENSIC SCI, V45, P1049; Beckwith CI., 2009, EMPIRES SILK ROAD HI; Bentley RA, 2005, ARCHAEOMETRY, V47, P629, DOI 10.1111/j.1475-4754.2005.00223.x; Buikstra J.E., 1994, STANDARDS DATA COLLE; Bunyatyan KP., 2003, PREHISTORIC STEPPE A, P269; Chenery C, 2010, J ARCHAEOL SCI, V37, P150, DOI 10.1016/j.jas.2009.09.025; Copeland SR, 2008, RAPID COMMUN MASS SP, V22, P3187, DOI 10.1002/rcm.3717; Crowley BE., 2017, BIOL REV, V92, P43, DOI [10.1111/brv.12217, DOI 10.1111/BRV.12217]; Cuney M, 2012, ORE GEOL REV, V44, P82, DOI 10.1016/j.oregeorev.2011.09.007; Cunliffe B., 2019, SCYTHIANS NOMAD WARR; Damgaard PD, 2018, NATURE, V557, P369, DOI 10.1038/s41586-018-0094-2; Daux V, 2008, J HUM EVOL, V55, P1138, DOI 10.1016/j.jhevol.2008.06.006; Dobrovol'skaya MV., 2016, STABLE ISOTOPE STUDI, V245, P172; Dolukhavnov PM., 2009, E EUROPEAN PLAIN EVE, P9; Dovatur AI., 1982, PEOPLES OUR COUNTRY; Eckardt H, 2009, J ARCHAEOL SCI, V36, P2816, DOI 10.1016/j.jas.2009.09.010; Ehleringer JR, 2008, P NATL ACAD SCI USA, V105, P2788, DOI 10.1073/pnas.0712228105; Emerson TE, 2020, AM ANTIQUITY, V85, P241, DOI 10.1017/aaq.2020.7; ERICSON JE, 1985, J HUM EVOL, V14, P503, DOI 10.1016/S0047-2484(85)80029-4; Evans JA, 2012, J ANAL ATOM SPECTROM, V27, P754, DOI 10.1039/c2ja10362a; Evans JA, 2006, ARCHAEOMETRY, V48, P309, DOI 10.1111/j.1475-4754.2006.00258.x; Fernandez-Gotz M, 2018, J ARCHAEOL RES, V26, P117, DOI 10.1007/s10814-017-9107-1; Gerling C., 2015, PREHISTORIC MOBILITY; Gerling C., 2014, J ANCIENT STUDIES; Gerling C, 2012, ANTIQUITY, V86, P1097, DOI 10.1017/S0003598X00048274; Giblin JI, 2013, J ARCHAEOL SCI, V40, P227, DOI 10.1016/j.jas.2012.08.024; Giblin JI, 2009, J ARCHAEOL SCI, V36, P491, DOI 10.1016/j.jas.2008.09.034; Gorbanenko SA., ARCHAEOLOGY ANCIENT, P456; Graustein W.C., 1989, STABLE ISOTOPES ECOL, P491; Grechko DS., 2017, ARCHAEOLOGICAL RES B, P80; Grene David., 1987, HISTORY; Haverkort CM, 2008, J ARCHAEOL SCI, V35, P1265, DOI 10.1016/j.jas.2007.09.002; Hildinger E., 1997, WARRIORS STEPPE MILI; Jarve M, 2019, CURR BIOL, V29, P2430, DOI 10.1016/j.cub.2019.06.019; Johnson J., ARXIV210212367; Julien MA, 2012, QUATERN INT, V271, P106, DOI 10.1016/j.quaint.2012.06.011; Juras A, 2017, SCI REP-UK, V7, DOI 10.1038/srep43950; Kaiser E., 2003, ARCHAEOLOGY EURASIA; KATZENBERG MA, 1995, AM ANTIQUITY, V60, P335, DOI 10.2307/282144; Kellner CM, 2007, AM J PHYS ANTHROPOL, V133, P1112, DOI 10.1002/ajpa.20618; Knudson KJ, 2009, INT J OSTEOARCHAEOL, V19, P171, DOI 10.1002/oa.1042; Knudson KJ, 2010, J ARCHAEOL SCI, V37, P2352, DOI 10.1016/j.jas.2010.04.009; Koryakova L, 2007, CAMB WOR ARCHAEOL, P1, DOI 10.1017/CBO9780511618451; Kovpanenko GT., 1977, SCYTHIANS SARMATIANS, P40; Levchenko BM., 2015, ARCHAEOLOGY ANCIENT, V2, P202; Levchenko BM., 2012, GRISHKOVSKY CEMETERY, P109; Levinson A.A., 1987, APPL GEOCHEM, V2, P367, DOI DOI 10.1016/0883-2927(87)90021-7; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Lightfoot E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153850; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; LUZ B, 1985, EARTH PLANET SC LETT, V75, P29, DOI 10.1016/0012-821X(85)90047-0; LUZ B, 1984, GEOCHIM COSMOCHIM AC, V48, P1689, DOI 10.1016/0016-7037(84)90338-7; Makarewicz CA., 2018, ISOTOPIC INVESTIGATI; Makhortykh S., 2013, STRATUM PLUS, V3, P223; Makhortykh S., 2009, EARLY IRON AGE, P268, DOI [10.1007/s10517-009-0512-4, DOI 10.1007/S10517-009-0512-4]; Makhortykh S., 2006, ARCHAEOLOGICAL CHRON, P2; Makhortykh SV., 2012, STRATUM PLUS J, P2012; Melyoukova A., 1995, NOMADS EURASIAN STEP, P27; Miller ARV, 2018, ENVIRON ARCHAEOL, V23, P352, DOI 10.1080/14614103.2017.1390031; Miller ARV, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-35758-w; Miller BK., J WORLD HIST; Motuzait Matuzeviit G., 2012, DOCUMENTA PRAEHISTOR, V39, P1, DOI [10.4312/dp.39.1, DOI 10.4312/DP.39.1]; Motuzaite-Matuzeviciute G, 2016, ARCHAEOL ANTHROP SCI, V8, P43, DOI 10.1007/s12520-013-0142-7; Motuzaite-Matuzeviciute G, 2013, ANTIQUITY, V87, P1073, DOI 10.1017/S0003598X00049875; Motuzaite-Matuzeviciute G, 2012, J FIELD ARCHAEOL, V37, P51, DOI 10.1179/0093469011Z.0000000004; Mozolevskiy BM., 2005, ETHNICAL GEOGRAPHY S; Nelson Soraya, 2014, NPR PARALLELS CULTUR; Nier AO, 1938, PHYS REV, V54, P275, DOI 10.1103/PhysRev.54.275; Nikitin AG., 2010, INTERDISCIPLINARIA A, V1, P9; Nikitin AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172952; Pashkevich GA., 2005, PALEOBOTANICAL STUDY, P90; PHENICE TW, 1969, AM J PHYS ANTHROPOL, V30, P297, DOI 10.1002/ajpa.1330300214; PIN C, 1994, ANAL CHIM ACTA, V298, P209, DOI 10.1016/0003-2670(94)00274-6; Rassamakin Y., 1999, LATE PREHISTORIC EXP, P59; Rolle R., 2014, BARBARIANS ANCIENT E, P107; Rolle R., 1996, HAMBURGER CONTRIBUTI, P57; Scheeres M, 2013, J ARCHAEOL SCI, V40, P3614, DOI 10.1016/j.jas.2013.05.003; Scherer AK., 2015, J ARCHAEOL SCI-REP, V2, P666; Shramko B., 1985, SOVIET ARCHAEOLOGY, V2, P27; Shramko B., 1987, BELSK ANCIENT SETTLE; Shramko IB., 2010, BELSK HILLFORT MAIN; Simpson S., 2017, UNIVERSAL COVERAGE P; Slovak NM, 2011, ADV ISOTOP GEOCHEM, P743, DOI 10.1007/978-3-642-10637-8_35; Sorokina L., 2014, UKRAINIAN GEOGRAPHIC, V3, P25; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; Suprunenko A., 1996, BELSK HILLFORT CONTE, P88; Suprunenko O., 2010, MOUNDS SCYTHIAN TIME; Team RDC, 2013, R LANG ENV STAT COMP; Unterlander M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14615; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; Ventresca Miller AR., 2019, ARCHAEOMETRY, V61, P1399; Ventresca Miller AR., 2018, ISOTOPIC INVESTIGATI, P41; Voerkelius S, 2010, FOOD CHEM, V118, P933, DOI 10.1016/j.foodchem.2009.04.125; White C, 2004, J ARCHAEOL SCI, V31, P233, DOI 10.1016/j.jas.2003.08.007; Wilkin S., IN PRESS; Zingerle M-C., 2010, SCYTHIANS UKRAINIAN	109	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0245996	10.1371/journal.pone.0245996	http://dx.doi.org/10.1371/journal.pone.0245996			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QV3DA	33690634	Green Published, gold			2022-12-26	WOS:000627854700058
J	Blouquy, L; Mottet, C; Olivares, J; Plantamp, C; Siegwart, M; Barres, B				Blouquy, Lucile; Mottet, Claire; Olivares, Jerome; Plantamp, Christophe; Siegwart, Myriam; Barres, Benoit			How varying parameters impact insecticide resistance bioassay: An example on the worldwide invasive pest Drosophila suzukii	PLOS ONE			English	Article							SPOTTED-WING DROSOPHILA; DIPTERA DROSOPHILIDAE; PYRETHROID RESISTANCE; MOLECULAR-BIOLOGY; MOTH LEPIDOPTERA; CODLING MOTH; SUSCEPTIBILITY; CHERRY; SEX; IMPLEMENTATION	Monitoring pesticide resistance is essential for effective and sustainable agricultural practices. Bioassays are the basis for pesticide-resistance testing, but devising a reliable and reproducible method can be challenging because these tests are carried out on living organisms. Here, we investigated five critical parameters and how they affected the evaluation of resistance to the organophosphate phosmet or the pyrethroid lambda-cyhalothrin using a tarsal-contact protocol on Drosophila suzukii, a worldwide invasive pest. Three of the parameters were related to insect biology: (i) sex, (ii) age of the imago (adult stage) and (iii) genetic diversity of the tested population. The two remaining parameters were linked to the experimental setup: (iv) the number of individuals tested per dose and (v) the duration of exposure to the active ingredient. Results showed that response to insecticide differed depending on sex, males being twice as susceptible to phosmet as females. Age principally affected young females' susceptibility to phosmet, because 0-24 hour-old flies were twice as susceptible as 24-48 hour-old and 72-96 hour-old females. Genetic diversity had no observable effect on resistance levels. The precision and accuracy of the median lethal dose (LD50) were greatly affected by the number of individuals tested per dose with a threshold effect. Finally, optimal duration of exposure to the active ingredient was 24 h, as we found an underestimation of mortality when assessed between 1 and 5 h after exposure to lambda-cyhalothrin. None of the main known point mutations on the para sodium channel gene associated with a knockdown effect were observed. Our study demonstrates the importance of calibrating the various parameters of a bioassay to develop a reliable method. It also provides a valuable and transferable protocol for monitoring D. suzukii resistance worldwide.	[Blouquy, Lucile; Mottet, Claire; Plantamp, Christophe; Barres, Benoit] Univ Lyon, USC CASPER, INRAE, Anses, Lyon, France; [Blouquy, Lucile; Olivares, Jerome; Siegwart, Myriam] INRAE, PSH Unite Rech Plantes & Syst Culture Hort, Avignon, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); INRAE; INRAE	Barres, B (corresponding author), Univ Lyon, USC CASPER, INRAE, Anses, Lyon, France.	benoit.barres@anses.fr	Barrès, Benoit/AAC-9053-2019	Barrès, Benoit/0000-0002-6777-0275; Plantamp, Christophe/0000-0003-2554-359X	ANSES	ANSES	BB received funding from ANSES via the tax on the sales of plant protection products. As stipulated in the French Act on the Future of Agriculture of 13 October 2014, the proceeds of this tax are allocated to ANSES to finance research on establishing a system for monitoring the adverse effects of plant protection products (`phytopharmacovigilance', PPV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agossa FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145207; Aguila JR, 2007, J EXP BIOL, V210, P956, DOI 10.1242/jeb.001586; Alnajjar G., 2017, INT J ENTOMOL NEMATO, V3, P51; Andreazza F, 2018, PEST MANAG SCI, V74, P861, DOI 10.1002/ps.4772; Asplen MK, 2015, J PEST SCI, V88, P469, DOI 10.1007/s10340-015-0681-z; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Barres B, 2016, TRENDS PLANT SCI, V21, P834, DOI 10.1016/j.tplants.2016.06.006; Beers EH, 2011, PEST MANAG SCI, V67, P1386, DOI 10.1002/ps.2279; Bijlsma R, 2000, J EVOLUTION BIOL, V13, P502, DOI 10.1046/j.1420-9101.2000.00177.x; Brogdon W., 2011, GUIDELINE EVALUATING; Bruck DJ, 2011, PEST MANAG SCI, V67, P1375, DOI 10.1002/ps.2242; Brun-Barale A, 2005, PEST MANAG SCI, V61, P549, DOI 10.1002/ps.1002; Cahenzli F, 2018, J APPL ENTOMOL, V142, P563, DOI 10.1111/jen.12510; Carriere Y, 2003, J ECON ENTOMOL, V96, P1626, DOI 10.1603/0022-0493-96.6.1626; Cattel J, 2018, J APPL ECOL, V55, P2408, DOI 10.1111/1365-2664.13101; Chen XT, 2018, PESTIC BIOCHEM PHYS, V148, P190, DOI 10.1016/j.pestbp.2018.04.014; Chouaibou MS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-214; Cini A, 2012, B INSECTOL, V65, P149; Colinet H, 2016, J GERONTOL A-BIOL, V71, P1574, DOI 10.1093/gerona/glv193; Cotter SC, 2011, FUNCT ECOL, V25, P186, DOI 10.1111/j.1365-2435.2010.01766.x; Cuthbertson Andrew G S, 2014, Insects, V5, P488, DOI 10.3390/insects5020488; Dam D, 2019, AGRON SUSTAIN DEV, V39, DOI 10.1007/s13593-019-0593-z; de Souza MT, 2020, ENVIRON SCI POLLUT R, V27, P13056, DOI 10.1007/s11356-020-07871-9; DiGiacomo G, 2019, J INTEGR PEST MANAG, V10, DOI 10.1093/jipm/pmz006; Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012; dos Santos LA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174318; Fanning PD, 2018, J APPL ENTOMOL, V142, P26, DOI 10.1111/jen.12462; Finetti L, 2020, PESTIC BIOCHEM PHYS, V165, DOI 10.1016/j.pestbp.2020.02.015; Finney D.J., 1971, PROBIT ANAL, V3rd; Foye S, 2020, J ECON ENTOMOL, V113, P1047, DOI 10.1093/jee/toz365; Fraimout A, 2018, BIOL INVASIONS, V20, P2963, DOI 10.1007/s10530-018-1750-z; Fraimout A, 2017, MOL BIOL EVOL, V34, P980, DOI 10.1093/molbev/msx050; Fraimout A, 2015, EUR J ENTOMOL, V112, P855, DOI 10.14411/eje.2015.079; Franck P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043543; Goodhue RE, 2011, PEST MANAG SCI, V67, P1396, DOI 10.1002/ps.2259; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Gress BE, 2019, PEST MANAG SCI, V75, P1270, DOI 10.1002/ps.5240; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamby KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068472; Hawkins NJ, 2019, BIOL REV, V94, P135, DOI 10.1111/brv.12440; Haye T, 2016, J PEST SCI, V89, P643, DOI 10.1007/s10340-016-0737-8; Hopkins BW, 2010, INSECT BIOCHEM MOLEC, V40, P385, DOI 10.1016/j.ibmb.2010.03.004; Kanzawa T., 1939, STUDIES DROSOPHILA S; KNIGHT AL, 1989, J ECON ENTOMOL, V82, P1019, DOI 10.1093/jee/82.4.1019; Knoll V, 2017, SCI REP-UK, V7, DOI 10.1038/srep40697; KOREN B, 1984, J ECON ENTOMOL, V77, P864, DOI 10.1093/jee/77.4.864; Kruger AP, 2018, J ECON ENTOMOL, V111, P741, DOI 10.1093/jee/tox349; Kulma K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058322; Larson NR, 2020, FRONT ECOL EVOL, V8, DOI 10.3389/fevo.2020.00045; Lee JC, 2011, PEST MANAG SCI, V67, P1349, DOI 10.1002/ps.2271; Lee KP, 2013, ANIM BEHAV, V86, P987, DOI 10.1016/j.anbehav.2013.08.018; MCDONALD PT, 1990, J ECON ENTOMOL, V83, P1718, DOI 10.1093/jee/83.5.1718; Mermer S, 2020, PEST MANAG SCI, V76, P1531, DOI 10.1002/ps.5672; Miller Audra L E, 2010, J Vis Exp, DOI 10.3791/2129; Mishra R, 2018, INSECT SCI, V25, P928, DOI 10.1111/1744-7917.12498; Nagy A., 2020, Bulletin OEPP, V50, DOI 10.1111/epp.12651; Navarro-Roldan MA, 2017, J ECON ENTOMOL, V110, P1740, DOI 10.1093/jee/tox113; Nei M., 1987, MOL EVOLUTIONARY GEN; Nikolouli K, 2020, J PEST SCI, V93, P647, DOI 10.1007/s10340-020-01199-6; Ong SQ, 2018, J INSECT SCI, V18, DOI 10.1093/jisesa/iey032; Owusu HF, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0971-6; Pavlova AK, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iew100; Perry T, 2011, INSECT BIOCHEM MOLEC, V41, P411, DOI 10.1016/j.ibmb.2011.03.003; PLUTHERO FG, 1981, J ECON ENTOMOL, V74, P736, DOI 10.1093/jee/74.6.736; Pruett JH, 2000, J ECON ENTOMOL, V93, P920, DOI 10.1603/0022-0493-93.3.920; R Core Team, 2021, R LANGUAGE ENV STAT; Rane RV, 2019, J HERED, V110, P80, DOI 10.1093/jhered/esy058; Revadi S, 2015, INSECTS, V6, P183, DOI 10.3390/insects6010183; Reyes M, 2008, PEST MANAG SCI, V64, P945, DOI 10.1002/ps.1588; Reyes PFM, 2007, MOL ECOL, V16, P3554, DOI 10.1111/j.1365-294X.2007.03410.x; RIEDL H, 1985, J ECON ENTOMOL, V78, P692, DOI 10.1093/jee/78.3.692; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Rota-Stabelli O, 2020, J PEST SCI, V93, P77, DOI 10.1007/s10340-019-01172-y; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saeed N, 2018, J ECON ENTOMOL, V111, P1306, DOI 10.1093/jee/toy080; Schetelig MF, 2018, J APPL ENTOMOL, V142, P3, DOI 10.1111/jen.12469; Schoneberg T, 2020, AGR ECOSYST ENVIRON, V294, DOI 10.1016/j.agee.2020.106860; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shaw B, 2019, CROP PROT, V121, P182, DOI 10.1016/j.cropro.2019.04.006; Shawer R, 2018, CROP PROT, V103, P73, DOI 10.1016/j.cropro.2017.09.010; Shearer PW, 2001, PEST MANAG SCI, V57, P822, DOI 10.1002/ps.367; Sial AA, 2019, J APPL ENTOMOL, V143, P593, DOI 10.1111/jen.12629; Smirle MJ, 2017, PEST MANAG SCI, V73, P130, DOI 10.1002/ps.4310; Soderlund DM, 2003, INSECT BIOCHEM MOLEC, V33, P563, DOI 10.1016/S0965-1748(03)00023-7; Spielman D, 2004, CONSERV GENET, V5, P439, DOI 10.1023/B:COGE.0000041030.76598.cd; Tochen S, 2014, ENVIRON ENTOMOL, V43, P501, DOI 10.1603/EN13200; Usherwood PNR, 2007, FEBS LETT, V581, P5485, DOI 10.1016/j.febslet.2007.10.057; Valtierra-de-Luis D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210545; Van Timmeren S, 2019, PEST MANAG SCI, V75, P1782, DOI 10.1002/ps.5341; Van Timmeren S, 2018, PEST MANAG SCI, V74, P78, DOI 10.1002/ps.4702; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wheeler D., 1996, ANNU REV ENTOMOL, V41, P345, DOI [10.1146/annurev.en.41.010196.002203, DOI 10.1146/ANNUREV.EN.41.010196.002203]; Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204; Wilson TG, 2005, INTEGR COMP BIOL, V45, P127, DOI 10.1093/icb/45.1.127; Wilson TG, 2001, ANNU REV ENTOMOL, V46, P545, DOI 10.1146/annurev.ento.46.1.545; Wise JC, 2015, CAN ENTOMOL, V147, P109, DOI 10.4039/tce.2014.36	96	4	4	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0247756	10.1371/journal.pone.0247756	http://dx.doi.org/10.1371/journal.pone.0247756			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667239	Green Published, gold			2022-12-26	WOS:000626604300018
J	Iwasaki, N; Terawaki, S; Shimizu, K; Oikawa, D; Sakamoto, H; Sunami, K; Tokunaga, F				Iwasaki, Naruhito; Terawaki, Seigo; Shimizu, Kouhei; Oikawa, Daisuke; Sakamoto, Hirokazu; Sunami, Kishiko; Tokunaga, Fuminori			Th2 cells and macrophages cooperatively induce allergic inflammation through histamine signaling	PLOS ONE			English	Article							H-4 RECEPTOR; HISTIDINE-DECARBOXYLASE; AIRWAY INFLAMMATION; BONE-MARROW; ACTIVATION; EXPRESSION; EFFECTOR; MEMORY; LYMPHOCYTES; ANTAGONISM	Histamine, which is mainly produced by mast cells and basophils, participates in various allergic symptoms, and some studies have reported that macrophages also produce histamine. Moreover, recent studies have revealed that macrophages, especially alternatively activated macrophages (M2) induced by T helper 2 (Th2) cytokines, such as interleukin (IL)-4 and IL-13, participate in the pathogenesis of allergic diseases. The major source of Th2 cytokines is antigen-specific Th2 cells. To elucidate the relationship between histamine, macrophages, and Th2 cells in allergic inflammation, we established a macrophage-Th2 cell co-culture model in vitro and an antigen-specific Th2 cell transfer mouse model of rhinitis. In vitro analyses indicated that macrophages produce histamine by interacting with antigen-specific Th2 cells through the antigen. Furthermore, Th2 cells and macrophages cooperatively elicited rhinitis in the mouse model. We determined that histamine induces Th2- and macrophage-elicited sneezing responses through H1 receptor signaling, whereas it induces nasal eosinophil infiltrations through H4 receptor signaling. Collectively, these results indicate a novel histamine production mechanism by macrophages, in which Th2 cells and macrophages cooperatively induce nasal allergic inflammation through histamine signaling.	[Iwasaki, Naruhito; Terawaki, Seigo; Shimizu, Kouhei; Oikawa, Daisuke; Tokunaga, Fuminori] Osaka City Univ, Grad Sch Med, Dept Pathobiochem, Osaka, Japan; [Iwasaki, Naruhito; Sakamoto, Hirokazu; Sunami, Kishiko] Osaka City Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Osaka, Japan	Osaka Metropolitan University; Osaka Metropolitan University	Iwasaki, N (corresponding author), Osaka City Univ, Grad Sch Med, Dept Pathobiochem, Osaka, Japan.; Iwasaki, N (corresponding author), Osaka City Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Osaka, Japan.	m2071288@med.osaka-cu.ac.jp		Tokunaga, Fuminori/0000-0003-3626-9119; Shimizu, Kouhei/0000-0001-9523-4296	Japan Society for the Promotion of Science KAKENHI [19K17912]; GlaxoSmithKline Japan	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); GlaxoSmithKline Japan(GlaxoSmithKline)	NI received a Japan Society for the Promotion of Science (https://www.jsps.go.jp/) KAKENHI Grant-in-Aid for Young Scientists (Grant Number 19K17912) and a GlaxoSmithKline Japan (https://jp.gsk.com/jp/) Research Grant 2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOI R, 1989, IMMUNOLOGY, V66, P219; Cowden JM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-86; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Dunford PJ, 2006, J IMMUNOL, V176, P7062, DOI 10.4049/jimmunol.176.11.7062; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Guerriero JL, 2019, INT REV CEL MOL BIO, V342, P73, DOI 10.1016/bs.ircmb.2018.07.001; Hirasawa N, 2006, LIFE SCI, V80, P36, DOI 10.1016/j.lfs.2006.08.019; Hirasawa N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020376; Iwasaki N, 2017, J ALLERGY CLIN IMMUN, V139, P258, DOI 10.1016/j.jaci.2016.03.023; Ling P, 2004, BRIT J PHARMACOL, V142, P161, DOI 10.1038/sj.bjp.0705729; Mahapatra S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087296; Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13; Murata Y, 2005, ARTERIOSCL THROM VAS, V25, P430, DOI 10.1161/01.ATV.0000148705.13411.65; Ohsawa Y, 2012, ALLERGY, V67, P1014, DOI 10.1111/j.1398-9995.2012.02854.x; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Okubo K, 2017, ALLERGOL INT, V66, P205, DOI 10.1016/j.alit.2016.11.001; Onodera A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02929; Rossbach K, 2016, ALLERGY, V71, P189, DOI 10.1111/all.12779; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Takabayashi T, 2013, J ALLERGY CLIN IMMUN, V132, P584, DOI 10.1016/j.jaci.2013.02.003; Takahashi Y, 2009, INT IMMUNOPHARMACOL, V9, P734, DOI 10.1016/j.intimp.2009.02.011; Takamatsu S, 1996, J IMMUNOL, V156, P778; TAKAMATSU S, 1995, BIOSCI BIOTECH BIOCH, V59, P1493, DOI 10.1271/bbb.59.1493; Tatarkiewicz J, 2019, ARCH MED SCI, V15, P537, DOI 10.5114/aoms.2017.68534; UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.iy.02.040184.002143; Yamauchi K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071733; Yeon SM, 2019, ARCH PHARM RES, V42, P754, DOI 10.1007/s12272-019-01159-4; Zampeli E, 2009, BRIT J PHARMACOL, V157, P24, DOI 10.1111/j.1476-5381.2009.00151.x	30	11	11	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0248158	10.1371/journal.pone.0248158	http://dx.doi.org/10.1371/journal.pone.0248158			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33662037	Green Published, gold			2022-12-26	WOS:000626604100011
J	Perera, SJ; Herbert, DG; Proches, S; Ramdhani, S				Perera, Sandun J.; Herbert, David G.; Proches, Serban; Ramdhani, Syd			Land snail biogeography and endemism in south-eastern Africa: Implications for the Maputaland-Pondoland-Albany biodiversity hotspot	PLOS ONE			English	Article							BIOTIC ELEMENT ANALYSIS; CANNIBAL SNAILS; PARSIMONY ANALYSIS; GENUS PRESTONELLA; CONSERVATION; REGIONS; AREAS; GASTROPODA; DIVERSITY; MOLLUSCA	Invertebrates in general have long been underrepresented in studies on biodiversity, biogeography and conservation. Boundaries of biodiversity hotspots are often delimited intuitively based on floristic endemism and have seldom been empirically tested using actual species distributions, and especially invertebrates. Here we analyse the zoogeography of terrestrial malacofauna from south-eastern Africa (SEA), proposing the first mollusc-based numerical regionalisation for the area. We also discuss patterns and centres of land snail endemism, thence assessing the importance and the delimitation of the Maputaland-Pondoland-Albany (MPA) biodiversity hotspot for their conservation. An incidence matrix compiled for relatively well-collected lineages of land snails and slugs (73 taxa in twelve genera) in 40 a priori operational geographic units was subjected to (a) phenetic agglomerative hierarchical clustering using unweighted pair-group method with arithmetic means (UPGMA), (b) parsimony analysis of endemicity (PAE) and biotic element analysis (BEA). Fulfilling the primary objective of our study, the UPGMA dendrogram provided a hierarchical regionalisation and identified five centres of molluscan endemism for SEA, while the PAE confirmed six areas of endemism, also supported by the BEA. The regionalisation recovers a zoogeographic province similar to the MPA hotspot, but with a conspicuous westward extension into Knysna (towards the Cape). The MPA province, centres and areas of endemism, biotic elements as well as the spatial patterns of species richness and endemism, support the MPA hotspot, but suggest further extensions resulting in a greater MPA region of land snail endemism (also with a northward extension into sky islands-Soutpansberg and Wolkberg), similar to that noted for vertebrates. The greater MPA region provides a more robustly defined region of conservation concern, with centres of endemism serving as local conservation priorities.	[Perera, Sandun J.; Proches, Serban] Univ KwaZulu Natal, Sch Agr Earth & Environm Sci, Durban, South Africa; [Herbert, David G.] KwaZulu Natal Museum, Pietermaritzburg, South Africa; [Ramdhani, Syd] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa; [Perera, Sandun J.] Sabaragamuwa Univ, Dept Nat Resources, Belhuloya, Sri Lanka; [Herbert, David G.] Natl Museum Wales, Dept Nat Sci, Cardiff, Wales	University of Kwazulu Natal; University of Kwazulu Natal; Sabaragamuwa University of Sri Lanka	Perera, SJ (corresponding author), Univ KwaZulu Natal, Sch Agr Earth & Environm Sci, Durban, South Africa.; Perera, SJ (corresponding author), Sabaragamuwa Univ, Dept Nat Resources, Belhuloya, Sri Lanka.	sandun.perera@appsc.sab.ac.lk	Perera, Sandun J./D-1750-2010; Procheş, Şerban/A-2044-2008; Ramdhani, Syd/AFQ-0706-2022	Perera, Sandun J./0000-0002-4241-0062; Procheş, Şerban/0000-0002-3415-6930; Ramdhani, Syd/0000-0003-1988-5438	South African National Research Foundation (NRF); University of KwaZuluNatal (UKZN); Gay Langmuir bursaries for Conservation Biology; UKZpost-doctoral scholarship (2013); University Grants Commission; Sabaragamuwa University of Sri Lanka; Unitas Malacologica; NRF (South African Biosystematics Initiative) [GUN 61261]; UKZN	South African National Research Foundation (NRF)(National Research Foundation - South Africa); University of KwaZuluNatal (UKZN); Gay Langmuir bursaries for Conservation Biology; UKZpost-doctoral scholarship (2013); University Grants Commission(University Grants Commission, India); Sabaragamuwa University of Sri Lanka; Unitas Malacologica; NRF (South African Biosystematics Initiative); UKZN	SJP was funded by the South African National Research Foundation (NRF; https://www.nrf.ac.za/) grants through SP (African Origins platform doctoral bursary, and incentive funding for rated researchers), a University of KwaZuluNatal (UKZN; https://www.ukzn.ac.za/) doctoral research grant, Gay Langmuir bursaries for Conservation Biology (2010, 2012) and a UKZpost-doctoral scholarship (2013). SJP received study leave and a travel grant from the University Grants Commission and the Sabaragamuwa University of Sri Lanka to conduct this study in South Africa and a travel grant from Unitas Malacologica to attend the World Congress of Malacology 2013 in Azores, where an early version of this work was presented. DGH's work on the terrestrial molluscs of South Africa was funded by the NRF (South African Biosystematics Initiative GUN 61261; http://www.sassb.co.za/sabi.htm).SR acknowledges the UKZN for research support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander G, 2004, SI MAB SERIES, P31; [Anonymous], 2004, HOTSPOTS REVISITED E; Baillie JEM, 2004, 2004 IUCN RED LIST T; Born J, 2007, J BIOGEOGR, V34, P147, DOI 10.1111/j.1365-2699.2006.01595.x; Breuke ASH, 2012, ARCH MOLLUSKENKD, V141, P1, DOI 10.1127/arch.moll/1869-0963/141/001-020; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Chen YH, 2013, CURR ZOOL, V59, P449, DOI 10.1093/czoolo/59.4.449; Clark JA, 2002, SCIENCE, V297, P191; Clark VR, 2009, S AFR J BOT, V75, P196, DOI 10.1016/j.sajb.2008.10.010; Clark VR, 2012, SPRINGERPLUS, V1, DOI 10.1186/2193-1801-1-56; Cole ML, 2019, EUR J TAXON, V569, P1, DOI 10.5852/ejt.2019.569; Colville JF, 2014, FYNBOS: ECOLOGY, EVOLUTION, AND CONSERVATION OF A MEGADIVERSE REGION, P73; Connolly M., 1939, Annals of the South African Museum, V33, P1; Coppolino ML, 2009, LAND SNAIL ABUNDANCE; Crisp MD, 2001, J BIOGEOGR, V28, P183, DOI 10.1046/j.1365-2699.2001.00524.x; Crowe T.M., 1990, P145; CROWE TM, 1982, J ZOOL, V198, P417, DOI 10.1111/jzo.1982.198.4.417; D'Amen M, 2013, ANIM CONSERV, V16, P383, DOI 10.1111/acv.12071; Daru BH, 2015, DIVERS DISTRIB, V21, P769, DOI 10.1111/ddi.12290; De Klerk HM, 2002, DIVERS DISTRIB, V8, P147, DOI 10.1046/j.1472-4642.2002.00142.x; Department of Environmental Affairs Forestry and Fisheries, 2020, S AFRICA PROTECTED A; Ebach MC, 2008, J BIOGEOGR, V35, P1153, DOI 10.1111/j.1365-2699.2008.01920.x; Eeley HAC, 1999, J BIOGEOGR, V26, P595, DOI 10.1046/j.1365-2699.1999.00307.x; Escalante T, 2017, BIOL J LINN SOC, V120, P349; Escalante T, 2015, SYST BIODIVERS, V13, P413, DOI 10.1080/14772000.2015.1046966; Escalante T, 2013, BIOL J LINN SOC, V110, P485, DOI 10.1111/bij.12142; ESRI, 2012, ARCGIS DESKTOP SOFWA; Fjeldsa J, 1997, BIODIVERS CONSERV, V6, P401, DOI 10.1023/A:1018364708207; Geldenhuys CJ, 1989, THESIS U CAPE TOWN; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hamer ML, 2002, AFR ENTOMOL, V10, P29; Hamer ML, 1997, ENTOMOL SCAND, P209; Hamilton A., 1976, Palaeoecology Afr, V9, P63; Hausdorf B, 2003, SYST BIOL, V52, P717, DOI 10.1080/10635150390235584; Hennig C, 2006, SYST BIOL, V55, P170, DOI 10.1080/10635150500481523; Hennig C, 2004, COMPUT STAT DATA AN, V45, P875, DOI 10.1016/S0167-9473(03)00091-4; Herbert D, 2004, FIELD GUIDE LAND SNA; Herbert DG, 2010, AFR INVERTEBR, V51, P1; Herbert DG, 2007, AFR INVERTEBR, V48, P1; Herbert DG, 2020, EUR J TAXON, V629, P1, DOI 10.5852/ejt.2020.629; Herbert DG, 2017, EUR J TAXON, V309, P1, DOI 10.5852/ejt.2017.309; Herbert DG, 2016, EUR J TAXON, V236, P1, DOI 10.5852/ejt.2016.236; Herbert DG, 2016, ZOOTAXA, V4094, P1, DOI 10.11646/zootaxa.4094.1.1; Herbert DG, 2009, BIOL J LINN SOC, V96, P203, DOI 10.1111/j.1095-8312.2008.01109.x; Herbert DG, 1998, J CONCHOL, P61; Hoffman M, 2016, **DATA OBJECT**, DOI [10.5281/zenodo.3261807, DOI 10.5281/ZENODO.3261807]; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; KREMEN C, 1993, CONSERV BIOL, V7, P796, DOI 10.1046/j.1523-1739.1993.740796.x; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Lawes MJ, 2007, J BIOGEOGR, V34, P1246, DOI 10.1111/j.1365-2699.2007.01696.x; Leather SR, 2013, ANIM CONSERV, V16, P379, DOI 10.1111/acv.12068; Linder H. P., 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P229; Linder HP, 2012, J BIOGEOGR, V39, P1189, DOI 10.1111/j.1365-2699.2012.02728.x; Linder HP, 2001, SYST BIOL, V50, P892, DOI 10.1080/106351501753462867; Lydeard C, 2004, BIOSCIENCE, V54, P321, DOI 10.1641/0006-3568(2004)054[0321:TGDONM]2.0.CO;2; Mast AR, 2003, SYST BIOL, V52, P271, DOI 10.1080/10635150390192799; Milewski AV, 2015, S AFR J BOT, V101, P98, DOI 10.1016/j.sajb.2015.05.019; Moline PM, 2006, J BIOGEOGR, V33, P47, DOI 10.1111/j.1365-2699.2005.01369.x; MolluscaBase, 2020, MOLLUSCABASE; Moritz C, 2001, P ROY SOC B-BIOL SCI, V268, P1875, DOI 10.1098/rspb.2001.1713; MORRONE JJ, 1994, SYST BIOL, V43, P438, DOI 10.2307/2413679; Morrone JJ, 2017, REV MEX BIODIVERS, V88, P710, DOI 10.1016/j.rmb.2017.07.012; Morrone JJ, 2015, AUST SYST BOT, V28, P81, DOI 10.1071/SB14042; Morrone JJ, 2014, J BIOGEOGR, V41, P842, DOI 10.1111/jbi.12251; Morrone JJ, 2014, ZOOTAXA, V 3782, P1, DOI 10.11646/zootaxa.3782.1.1; Mouillot D, 2013, J BIOGEOGR, V40, P2228, DOI 10.1111/jbi.12194; Moussalli A, 2009, 10 ANN C S AFR SOC S; Moussalli A, 2016, MOL PHYLOGENET EVOL, V95, P100, DOI 10.1016/j.ympev.2015.11.003; Moussalli A, 2009, MOL PHYLOGENET EVOL, V52, P167, DOI 10.1016/j.ympev.2009.02.018; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naggs Fred, 2005, Records of the Western Australian Museum Supplement, V68, P11; Nelson G., 1981, SYSTEMATICS BIOGEORA; NEW TR, 1993, AM ZOOL, V33, P623; Open Knowledge Foundation, 2020, S AFRICA BIOMES OPEN; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Patten MA, 2008, J BIOGEOGR, V35, P407, DOI 10.1111/j.1365-2699.2007.01831.x; Pavlicek A, 1999, FOLIA BIOL-PRAGUE, V45, P97; Perera SJ, 2018, ZOOTAXA, V4382, P56, DOI 10.11646/zootaxa.4382.1.2; Perera SJ, 2011, S AFR J SCI, V107, P49, DOI 10.4102/sajs.v107i7/8.462; Perera SJ, 2013, THESIS U KWAZULU NAT; Proches S, 2020, PHYTOTAXA, V442, P20, DOI 10.11646/phytotaxa.442.1.3; Proches S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15457; Proches S, 2012, BIOSCIENCE, V62, P260, DOI 10.1525/bio.2012.62.3.7; R Core Team, 2021, R LANGUAGE ENV STAT; Riddle W.A., 1983, P431; Rosenberg G, 2014, AM MALACOL BULL, V32, P308, DOI 10.4003/006.032.0204; Rovito SM, 2004, J BIOGEOGR, V31, P1623, DOI 10.1111/j.1365-2699.2004.01100.x; Sallam A, 2012, INTEGRATED PEST MANAGEMENT AND PEST CONTROL - CURRENT AND FUTURE TACTICS, P413; SAMWAYS MJ, 1990, CONSERV BIOL, V4, P375, DOI 10.1111/j.1523-1739.1990.tb00311.x; Seymour CL, 2001, BIODIVERS CONSERV, V10, P2045, DOI 10.1023/A:1013137409896; Sfenthourakis S, 2001, BIODIVERS CONSERV, V10, P1387, DOI 10.1023/A:1016672415953; SNEATH PHA, 1962, NATURE, V193, P855, DOI 10.1038/193855a0; SOKAL ROBERT R., 1962, TAXON, V11, P33, DOI 10.2307/1217208; Solem A.C., 1984, P6; Steenkamp Y., 2004, HOTSPOTS REVISITED E; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Szumik CA, 2002, SYST BIOL, V51, P806, DOI 10.1080/10635150290102483; Tattersfield P, 1998, J CONCHOL, P77; Van Bruggen AC, 2016, ZOOTAXA, V4084, P590, DOI 10.11646/zootaxa.4084.4.9; van Bruggen A.C., 1977, Malacologia, V16, P75; van Rooy J, 2000, THESIS U PRETORIA; Van Rooy J, 2010, J BRYOL, V32, P80, DOI 10.1179/037366810X12578498136039; van Wyk AE, 2001, REGIONS FLORISTIC EN; VANBRUGGEN AC, 1978, BIOGEOGRAPHY ECOLOGY, P877; Vernon C.J., 1999, P57, DOI 10.1017/CBO9780511541988.008; Williams P, 1996, CONSERV BIOL, V10, P155, DOI 10.1046/j.1523-1739.1996.10010155.x; Wilson E.O., 1987, Conservation Biology, V1, P344, DOI 10.1111/j.1523-1739.1987.tb00055.x; Wronski T, 2010, J MOLLUS STUD, V76, P87, DOI 10.1093/mollus/eyp048	109	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0248040	10.1371/journal.pone.0248040	http://dx.doi.org/10.1371/journal.pone.0248040			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33662026	gold, Green Published			2022-12-26	WOS:000626604100034
J	Young, GH; Lin, JT; Cheng, YF; Ho, CF; Kuok, QY; Hsu, RC; Liao, WR; Chen, CC; Chen, HM				Young, Guang-Huar; Lin, Jiun-Tsai; Cheng, Yi-Fang; Ho, Chia-Fang; Kuok, Qian-Yu; Hsu, Ru-Chun; Liao, Wan-Rou; Chen, Chin-Chen; Chen, Han-Min			Modulation of adenine phosphoribosyltransferase-mediated salvage pathway to accelerate diabetic wound healing	FASEB JOURNAL			English	Article						adenine; adenylate energy charge; AMPK; APRT; diabetic wound healing		Adenine phosphoribosyltransferase (APRT) is the key enzyme involved in purine salvage by the incorporation of adenine and phosphoribosyl pyrophosphate to provide adenylate nucleotides. To evaluate the role of APRT in the repair processes of cutaneous wounds in healthy skin and in diabetic patients, a diabetic mouse model (db/db) and age-matched wild-type mice were used. Moreover, the topical application of adenine was assessed. In vitro studies, analytical, histological, and immunohistochemical methods were used. Diabetic mice treated with adenine exhibited elevated ATP levels in organismic skin and accelerated wound healing. In vitro studies showed that APRT utilized adenine to rescue cellular ATP levels and proliferation from hydrogen peroxide-induced oxidative damage. HPLC-ESI-MS/MS-based analysis of total adenylate nucleotides in NIH-3T3 fibroblasts demonstrated that adenine addition enlarged the cellular adenylate pool, reduced the adenylate energy charge, and provided additional AMP for the further generation of ATP. These data indicate an upregulation of APRT in skin wounds, highlighting its role during the healing of diabetic wounds through regulation of the nucleotide pool after injury. Furthermore, topical adenine supplementation resulted in an enlargement of the adenylate pool needed for the generation of ATP, an important molecule for wound repair.	[Young, Guang-Huar; Lin, Jiun-Tsai; Cheng, Yi-Fang; Ho, Chia-Fang; Kuok, Qian-Yu; Hsu, Ru-Chun; Liao, Wan-Rou; Chen, Chin-Chen; Chen, Han-Min] Energenesis Biomed Co Ltd, Taipei, Taiwan; [Chen, Han-Min] Catholic Fu Jen Univ, Inst Appl Sci & Engn, Dept Life Sci, 510 Zhongzheng Rd, New Taipei 24205, Taiwan	Fu Jen Catholic University	Chen, HM (corresponding author), Catholic Fu Jen Univ, Inst Appl Sci & Engn, Dept Life Sci, 510 Zhongzheng Rd, New Taipei 24205, Taiwan.	steven@energenesis-biomedical.com			Energenesis-Biomedical	Energenesis-Biomedical	Energenesis-Biomedical	Andreea SI, 2008, EXP DIABETES RES, DOI 10.1155/2008/473603; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Baranowska-Bosiacka I, 2009, TOXICOLOGY, V259, P77, DOI 10.1016/j.tox.2009.02.005; Bhagavan NV., 2011, NUCLEOTIDE METABOLIS, pCH25; Burnstock G, 2012, J INVEST DERMATOL, V132, P526, DOI 10.1038/jid.2011.344; Sanchez MC, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7080098; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; CARTIER PH, 1980, J BIOL CHEM, V255, P4574; Chen Y, 2017, INT J CLIN EXP MED, V10, P14904; Cheng YF, 2016, EXP DERMATOL, V25, P162, DOI 10.1111/exd.12881; Cheng YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142283; Dunn L, 2013, JOVE-J VIS EXP, DOI 10.3791/50265; Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Foker JE., 1988, GOOGLE PATENTS; Frenguelli BG, 2019, NEUROCHEM RES, V44, P661, DOI 10.1007/s11064-017-2386-6; Gassmann MG, 1999, ONCOGENE, V18, P6667, DOI 10.1038/sj.onc.1203120; Gough W, 2011, J BIOMOL SCREEN, V16, P155, DOI 10.1177/1087057110393340; Gupta A, 2005, MOL CELL BIOCHEM, V270, P71, DOI 10.1007/s11010-005-5258-3; Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004; Hardie DG, 2014, J INTERN MED, V276, P543, DOI 10.1111/joim.12268; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Howard JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091787; IM MJC, 1970, J SURG RES, V10, P459, DOI 10.1016/0022-4804(70)90070-3; IM MJC, 1970, J SURG RES, V10, P173; Jin CE, 2015, GENET MOL RES, V14, P8883, DOI 10.4238/2015.August.3.11; KAMATANI N, 1981, BIOCHIM BIOPHYS ACTA, V675, P344, DOI 10.1016/0304-4165(81)90024-6; Kiernan J.A., 2015, HISTOLOGICAL HISTOCH, P454; LANAHAN A, 1992, MOL CELL BIOL, V12, P3919, DOI 10.1128/MCB.12.9.3919; Lee DH, 2014, INT J MOL MED, V33, P1147, DOI 10.3892/ijmm.2014.1698; Lelli JL, 1998, FREE RADICAL BIO MED, V25, P694, DOI 10.1016/S0891-5849(98)00107-5; Leu JG, 2018, EUR J PHARMACOL, V818, P569, DOI 10.1016/j.ejphar.2017.11.027; Li HC, 2015, J BIOL CHEM, V290, P24592, DOI 10.1074/jbc.M115.680074; Liao WR, 2020, J FOOD DRUG ANAL, V28, P365, DOI 10.38212/2224-6614.1007; Lin JT, 2014, EXPERT OPIN INV DRUG, V23, P1253, DOI 10.1517/13543784.2014.922951; Mansbridge JN, 1999, DIABETES OBES METAB, V1, P265, DOI 10.1046/j.1463-1326.1999.00032.x; MAZOR D, 1994, VOX SANG, V66, P264, DOI 10.1111/j.1423-0410.1994.tb00327.x; Muller WEG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188977; MURRAY AW, 1971, ANNU REV BIOCHEM, V40, P811, DOI 10.1146/annurev.bi.40.070171.004115; Nouvong A, 2016, PHYSIOL GENOMICS, V48, P889, DOI 10.1152/physiolgenomics.00066.2016; Paglia G, 2016, TRANSFUSION, V56, P2538, DOI 10.1111/trf.13740; PAKKENBERG H, 1965, ACTA NEUROL SCAND, V41, P497, DOI 10.1111/j.1600-0404.1965.tb04740.x; Papanas N, 2010, DRUG SAFETY, V33, P455, DOI 10.2165/11534570-000000000-00000; Park SA, 2014, WOUND REPAIR REGEN, V22, P368, DOI 10.1111/wrr.12172; Pastar I, 2014, ADV WOUND CARE, V3, P445, DOI 10.1089/wound.2013.0473; ROSSOMANDO EF, 1983, J SURG RES, V35, P259, DOI 10.1016/S0022-4804(83)80012-2; Sarojini H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174899; Smith DG, 1999, FOOT ANKLE INT, V20, P258, DOI 10.1177/107110079902000409; STUART MJ, 1977, AM J HEMATOL, V2, P53, DOI 10.1002/ajh.2830020108; Sun CY, 2015, J AM SOC NEPHROL, V26, P281, DOI 10.1681/ASN.2014010021; Thimm D, 2015, ACTA PHYSIOL, V213, P808, DOI 10.1111/apha.12452; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vande Berg JS, 2003, SURG CLIN N AM, V83, P509, DOI 10.1016/S0039-6109(02)00195-0; Wang JP, 2010, AM J SURG, V199, P823, DOI 10.1016/j.amjsurg.2009.05.040; Wang XY, 2016, J BIOTECHNOL, V231, P115, DOI 10.1016/j.jbiotec.2016.05.032; Wojtowicz AM, 2014, WOUND REPAIR REGEN, V22, P246, DOI 10.1111/wrr.12154; Wu VC, 2013, ANGIOGENESIS, V16, P609, DOI 10.1007/s10456-013-9339-8; Yin J, 2007, J CELL SCI, V120, P815, DOI 10.1242/jcs.03389; Young G-H., 2015, HONG KONG J NEPHROL, V2, pS19; Young GH, 2006, PLANTA, V223, P468, DOI 10.1007/s00425-005-0103-1; Young GH, 2020, J CEREBR BLOOD F MET, V40, P1316, DOI 10.1177/0271678X19861448; Young GH, 2015, J PROTEOMICS, V120, P204, DOI 10.1016/j.jprot.2015.03.012; Young GH, 2014, ANTIOXID REDOX SIGN, V20, P1181, DOI 10.1089/ars.2013.5366	64	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21296	10.1096/fj.202001736RR	http://dx.doi.org/10.1096/fj.202001736RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33675115				2022-12-26	WOS:000629576700019
J	Du, Y; Wang, TZ; Guo, J; Li, WT; Yang, TH; Szendrey, M; Zhang, ST				Du, Yuan; Wang, Tingzhong; Guo, Jun; Li, Wentao; Yang, Tonghua; Szendrey, Mark; Zhang, Shetuan			Kv1.5 channels are regulated by PKC-mediated endocytic degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RECTIFIER K+ CURRENT; SURFACE EXPRESSION; K(V)1.5 CHANNELS; TYROSINE KINASE; I-KUR; UBIQUITIN; PHOSPHORYLATION; TRANSPORTER; MODULATION	The voltage-gated potassium channel Kv1.5 plays important roles in the repolarization of atrial action potentials and regulation of the vascular tone. While the modulation of Kv1.5 function has been well studied, less is known about how the protein levels of Kv1.5 on the cell membrane are regulated. Here, through electrophysiological and biochemical analyses of Kv1.5 channels heterologously expressed in HEK293 cells and neonatal rat ventricular myocytes, as well as native Kv1.5 in human induced pluripotent stem cell (iPSC)-derived atrial cardiomyocytes, we found that activation of protein kinase C (PKC) with phorbol 12-myristate 13-acetate (PMA, 10 nM) diminished Kv1.5 current (I-Kv1.5) and protein levels of Kv1.5 in the plasma membrane. Mechanistically, PKC activation led to monoubiquitination and degradation of the mature Kv1.5 proteins. Overexpression of Vps24, a protein that sorts transmembrane proteins into lysosomes via the multivesicular body (MVB) pathway, accelerated, whereas the lysosome inhibitor bafilomycin A1 completely prevented PKC-mediated Kv1.5 degradation. Kv1.5, but not Kv1.1, Kv1.2, Kv1.3, or Kv1.4, was uniquely sensitive to PMA treatment. Sequence alignments suggested that residues within the N terminus of Kv1.5 are essential for PKC-mediated Kv1.5 reduction. UsingN-terminal truncation as well as site-directedmutagenesis, we identified that Thr15 is the target site for PKC that mediates endocytic degradation of Kv1.5 channels. These findings indicate that alteration of protein levels in the plasma membrane represents an important regulatory mechanism of Kv1.5 channel function under PKC activation conditions.	[Du, Yuan; Wang, Tingzhong] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Xian, Peoples R China; [Du, Yuan; Wang, Tingzhong; Guo, Jun; Li, Wentao; Yang, Tonghua; Szendrey, Mark; Zhang, Shetuan] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Xi'an Jiaotong University; Queens University - Canada	Zhang, ST (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	shetuan.zhang@queensu.ca		Zhang, Shetuan/0000-0002-2297-0193	Canadian Institutes of Health Research [MOP 72911]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (Grant MOP 72911) to S. Z.	Aimond F, 2005, CIRC RES, V96, P451, DOI 10.1161/01.RES.0000156890.25876.63; Andersen MN, 2015, CHANNELS, V9, P121, DOI 10.1080/19336950.2015.1036205; Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Boehmer C, 2008, CELL PHYSIOL BIOCHEM, V22, P591, DOI 10.1159/000185543; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bowling N, 1999, CIRCULATION, V99, P384, DOI 10.1161/01.CIR.99.3.384; Brandt DT, 2003, J BIOL CHEM, V278, P34073, DOI 10.1074/jbc.M211650200; Chen R, 2018, BIOCHEMISTRY-US, V57, P2704, DOI 10.1021/acs.biochem.8b00268; Choi BH, 2000, J PHARMACOL EXP THER, V293, P634; Choi WS, 2005, CIRC RES, V97, P363, DOI 10.1161/01.RES.0000179535.06458.f8; Christophersen IE, 2013, EUR HEART J, V34, P1517, DOI 10.1093/eurheartj/ehs442; Churchill E, 2008, ANNU REV PHARMACOL, V48, P569, DOI 10.1146/annurev.pharmtox.48.121806.154902; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; David M, 2012, J BIOL CHEM, V287, P21416, DOI 10.1074/jbc.M111.328278; Eldstrom J, 2003, FEBS LETT, V547, P205, DOI 10.1016/S0014-5793(03)00668-9; FEDIDA D, 1993, CIRC RES, V73, P210, DOI 10.1161/01.RES.73.1.210; Fischer F, 2014, N-S ARCH PHARMACOL, V387, P469, DOI 10.1007/s00210-014-0965-5; Ford J, 2016, HEART RHYTHM, V13, P555, DOI 10.1016/j.hrthm.2015.10.003; Frankel EB, 2018, SEMIN CELL DEV BIOL, V74, P4, DOI 10.1016/j.semcdb.2017.08.020; Garcia-Tardon N, 2012, J BIOL CHEM, V287, P19177, DOI 10.1074/jbc.M112.355909; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Guo W, 1997, PFLUG ARCH EUR J PHY, V434, P206, DOI 10.1007/s004240050385; Hanson PI, 2009, CURR OPIN CELL BIOL, V21, P568, DOI 10.1016/j.ceb.2009.06.002; Harmati G, 2011, N-S ARCH PHARMACOL, V383, P141, DOI 10.1007/s00210-010-0584-8; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Kanda VA, 2011, HEART RHYTHM, V8, P1641, DOI 10.1016/j.hrthm.2011.04.034; Kidd M, 2017, J PHYSIOL-LONDON, V595, P1607, DOI 10.1113/JP272893; Kwak YG, 1999, J BIOL CHEM, V274, P25355, DOI 10.1074/jbc.274.36.25355; Lamothe SM, 2018, J BIOL CHEM, V293, P15347, DOI 10.1074/jbc.RA118.004065; Lata S, 2009, BIOCHEM SOC T, V37, P156, DOI 10.1042/BST0370156; Li GR, 1996, CIRC RES, V78, P903, DOI 10.1161/01.RES.78.5.903; Li HL, 2005, J MOL CELL CARDIOL, V39, P121, DOI 10.1016/j.yjmcc.2005.03.013; Li PL, 2015, J MOL CELL CARDIOL, V86, P138, DOI 10.1016/j.yjmcc.2015.07.018; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lin DH, 2005, P NATL ACAD SCI USA, V102, P4306, DOI 10.1073/pnas.0409767102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald PE, 2003, DIABETOLOGIA, V46, P1046, DOI 10.1007/s00125-003-1159-8; Manna PT, 2010, J BIOL CHEM, V285, P5963, DOI 10.1074/jbc.M109.066902; Mathur R, 2006, BIOCHEM BIOPH RES CO, V342, P1, DOI 10.1016/j.bbrc.2006.01.110; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Nitabach MN, 2001, P NATL ACAD SCI USA, V98, P705, DOI 10.1073/pnas.031446198; Ohanyan V, 2015, CIRC RES, V117, P612, DOI 10.1161/CIRCRESAHA.115.306642; Olson TM, 2006, HUM MOL GENET, V15, P2185, DOI 10.1093/hmg/ddl143; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Schumacher SM, 2009, CIRC RES, V104, P1390, DOI 10.1161/CIRCRESAHA.108.192773; Singh RM, 2017, HEART FAIL REV, V22, P843, DOI 10.1007/s10741-017-9634-3; Sun T, 2011, J BIOL CHEM, V286, P6751, DOI 10.1074/jbc.M110.198408; Sutherland-Deveen ME, 2019, MOL PHARMACOL, V96, P1, DOI 10.1124/mol.118.115188; Takeishi Y, 1999, AM J PHYSIOL-HEART C, V276, pH53, DOI 10.1152/ajpheart.1999.276.1.H53; Tschirhart JN, 2019, MOL PHARMACOL, V95, P386, DOI 10.1124/mol.118.114751; Voigt N, 2007, CARDIOVASC RES, V74, P426, DOI 10.1016/j.cardiores.2007.02.009; WANG ZG, 1993, CIRC RES, V73, P1061, DOI 10.1161/01.RES.73.6.1061; Williams CP, 2002, J PHARMACOL EXP THER, V302, P545, DOI 10.1124/jpet.102.033357; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Yang T, 2010, HEART RHYTHM, V7, P1246, DOI 10.1016/j.hrthm.2010.05.032; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	61	3	3	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100514	10.1016/j.jbc.2021.100514	http://dx.doi.org/10.1016/j.jbc.2021.100514			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33676894	Green Published, gold			2022-12-26	WOS:000672866400488
J	Estevan, I; Sardi, R; Tejera, AC; Silva, A; Tassino, B				Estevan, Ignacio; Sardi, Romina; Tejera, Ana Clara; Silva, Ana; Tassino, Bettina			Should I study or should I go (to sleep)? The influence of test schedule on the sleep behavior of undergraduates and its association with performance	PLOS ONE			English	Article							ACADEMIC-PERFORMANCE; COLLEGE-STUDENTS; UNIVERSITY-STUDENTS; WAKE CYCLE; QUALITY; PREVALENCE; DURATION; ANXIETY; IMPACT; DISORDERS	Sleep is crucial for college students' well-being. Although recommended sleep duration is between 7-9 hours per day, many students do not sleep that much. Scholar demands are among the causes of observed sleep deprivation in youth. We explored the influence of having a school test on previous night sleep in first-year students and the association of sleep duration and test performance. We ran two surveys in freshman students of the Universidad de la Republica, Montevideo, Uruguay: 1) 97 students of the School of Sciences who took the test at the same time; and 2) 252 School of Psychology students who took the test in four successive shifts. More than 1/2 of the participants (survey #1) and almost 1/3 (survey #2) reported short regular sleep duration (< 7h). In both samples, the sleep duration of the night before the test was reduced with respect to regular nights (survey #1: 2.1 +/- 0.2 h, p < 0.001; survey #2: between 1.7 +/- 0.4 h and 3.6 +/- 0.3 h, all p < 0.001), with more than 10% of the students who did not sleep at all. In survey 2, sleep duration increased in later shifts (F (3,248) = 4.6, p = 0.004). Using logit regressions, we confirmed that sleep duration was positively related to test scores in both samples (survey #1: exp B = 1.15, p < 0.001; pseudo-R-2 = 0.38; survey #2: exp B = 1.03, p < 0.001; pseudo-R-2 = 0.25). Delaying test start time may prevent the reduction in sleep duration, which may also improve school performance. In addition, educational policies should include information for students about the impact of sleep on learning and of the consequences of reduced sleep duration.	[Estevan, Ignacio; Sardi, Romina; Tejera, Ana Clara] Univ Republica, Fac Psicol, Programa Neuropsicol & Neurobiol, Montevideo, Uruguay; [Silva, Ana] Univ Republica, Fac Ciencias, Lab Neurociencias, Montevideo, Uruguay; [Tassino, Bettina] Univ Republica, Fac Ciencias, Secc Etol, Montevideo, Uruguay	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Estevan, I (corresponding author), Univ Republica, Fac Psicol, Programa Neuropsicol & Neurobiol, Montevideo, Uruguay.	iestevan@psico.edu.uy	Estevan, Ignacio/AAQ-7783-2021	Estevan, Ignacio/0000-0003-4743-1310; Silva, Ana/0000-0003-2890-0353	Comision Academica de Posgrado, Universidad de la Republica, Uruguay [2020-2023]	Comision Academica de Posgrado, Universidad de la Republica, Uruguay	IE was supported by a 2020-2023 Scholarship from Comision Academica de Posgrado, Universidad de la Republica, Uruguay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrona-Palacios A, 2018, BRIT J EDUC PSYCHOL, V88, P480, DOI 10.1111/bjep.12196; Astill RG, 2013, J SLEEP RES, V22, P373, DOI 10.1111/jsr.12032; Becker SP, 2018, SLEEP HEALTH, V4, P174, DOI 10.1016/j.sleh.2018.01.001; Boehm MA, 2016, J AM COLL HEALTH, V64, P565, DOI 10.1080/07448481.2016.1205073; Borisenkov MF, 2010, CHRONOBIOL INT, V27, P1259, DOI 10.3109/07420528.2010.487624; Bray M, 2008, DOUBLE SHIFT SCH DES, V3rd ed.; Carskadon MA, 2011, PEDIATR CLIN N AM, V58, P637, DOI 10.1016/j.pcl.2011.03.003; Crowley SJ, 2018, J ADOLESCENCE, V67, P55, DOI 10.1016/j.adolescence.2018.06.001; Eliasson AH, 2010, SLEEP BREATH, V14, P71, DOI 10.1007/s11325-009-0282-2; Engle-Friedman M., 2004, SLEEP HYPNOSIS, V6, P155; Estevan I, 2018, CHRONOBIOL INT, V35, P1753, DOI 10.1080/07420528.2018.1504785; Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x; Gaultney JF, 2010, J AM COLL HEALTH, V59, P91, DOI 10.1080/07448481.2010.483708; Gilbert SP, 2010, J COLL STUD PSYCHOTH, V24, P295, DOI 10.1080/87568225.2010.509245; Goldin AP, 2020, NAT HUM BEHAV, V4, P387, DOI 10.1038/s41562-020-0820-2; Gomes AA, 2011, CHRONOBIOL INT, V28, P786, DOI 10.3109/07420528.2011.606518; Fonseca AG, 2020, CURR OPIN BEHAV SCI, V33, P65, DOI 10.1016/j.cobeha.2019.12.008; Gradisar M, 2011, SLEEP MED, V12, P110, DOI 10.1016/j.sleep.2010.11.008; Hartmann ME, 2018, SLEEP HEALTH, V4, P463, DOI 10.1016/j.sleh.2018.07.002; Hartwig MK, 2012, PSYCHON B REV, V19, P126, DOI 10.3758/s13423-011-0181-y; Hershner S, 2020, CURR OPIN BEHAV SCI, V33, P51, DOI 10.1016/j.cobeha.2019.11.009; Hershner SD, 2014, NAT SCI SLEEP, V6, P73, DOI 10.2147/NSS.S62907; Itani O, 2017, SLEEP MED, V32, P246, DOI 10.1016/j.sleep.2016.08.006; Jahrami H, 2020, J PUBLIC HEALTH-HEID, V28, P605, DOI 10.1007/s10389-019-01064-6; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Lemma S, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-237; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; Machado ERS, 1998, BIOL RHYTHM RES, V29, P578, DOI 10.1076/brhm.29.5.578.4827; Medeiros ALD, 2001, BIOL RHYTHM RES, V32, P263, DOI 10.1076/brhm.32.2.263.1359; Mesquita G, 2010, AN ACAD BRAS CIENC, V82, P545, DOI 10.1590/S0001-37652010000200029; Norbury R, 2019, PSYCHIAT RES, V271, P214, DOI 10.1016/j.psychres.2018.11.054; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Okano K, 2019, NPJ SCI LEARN, V4, DOI 10.1038/s41539-019-0055-z; Orzech KM, 2011, J AM COLL HEALTH, V59, P612, DOI 10.1080/07448481.2010.520051; Owens J, 2014, PEDIATRICS, V134, pE921, DOI 10.1542/peds.2014-1696; Papadimitriou GN, 2005, INT REV PSYCHIATR, V17, P229, DOI 10.1080/09540260500104524; Piro RS, 2018, SLEEP BIOL RHYTHMS, V16, P125, DOI 10.1007/s41105-017-0134-6; Prichard JR, 2020, SLEEP MED CLIN, V15, P59, DOI 10.1016/j.jsmc.2019.10.003; Prichard JR, 2019, SLEEP HEALTH, V5, P320, DOI 10.1016/j.sleh.2019.01.006; PRORREN, 2020, LICENCIATURA PSICOLO; R Core Team, 2019, R LANG ENV STAT COMP; Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039; Rstudio Team, 2019, RSTUDIO INTEGRATED D; Scullin MK, 2019, TEACH PSYCHOL, V46, P55, DOI 10.1177/0098628318816142; Seun-Fadipe CT, 2017, SLEEP HEALTH, V3, P190, DOI 10.1016/j.sleh.2017.02.004; Tarokh L, 2019, CURR SLEEP MED REP, V5, P181, DOI 10.1007/s40675-019-00155-w; Tassino B, 2016, SLEEP SCI, V9, P20, DOI 10.1016/j.slsci.2016.01.002; Taylor DJ, 2013, BEHAV SLEEP MED, V11, P159, DOI 10.1080/15402002.2011.602776; Thacher PV, 2008, BEHAV SLEEP MED, V6, P16, DOI 10.1080/15402000701796114; Watson MS., 1990, ANXIETY RES, V3, P193; Watson NF, 2015, J CLIN SLEEP MED, V11, P591, DOI 10.5664/jcsm.4758; Watson NF, 2015, SLEEP, V38, P1161, DOI 10.5665/sleep.4886; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zunhammer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109490	54	1	1	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0247104	10.1371/journal.pone.0247104	http://dx.doi.org/10.1371/journal.pone.0247104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QV3DA	33690625	Green Submitted, gold, Green Published			2022-12-26	WOS:000627854700010
J	Hammer, Y; Talmor-Barkan, Y; Abelow, A; Orvin, K; Aviv, Y; Bar, N; Levi, A; Landes, U; Shafir, G; Barsheshet, A; Vaknin-Assa, H; Sagie, A; Kornowski, R; Hamdan, A				Hammer, Yoav; Talmor-Barkan, Yeela; Abelow, Aryeh; Orvin, Katia; Aviv, Yaron; Bar, Noam; Levi, Amos; Landes, Uri; Shafir, Gideon; Barsheshet, Alon; Vaknin-Assa, Hana; Sagie, Alexander; Kornowski, Ran; Hamdan, Ashraf			Myocardial extracellular volume quantification by computed tomography predicts outcomes in patients with severe aortic stenosis	PLOS ONE			English	Article							CARDIAC CT; FRACTION; FIBROSIS	Background The extent of myocardial fibrosis in patients with severe aortic stenosis might have an important prognostic value. Non-invasive imaging to quantify myocardial fibrosis by measuring extracellular volume fraction might have an important clinical utility prior to aortic valve intervention. Methods Seventy-five consecutive patients with severe aortic stenosis, and 19 normal subjects were prospectively recruited and underwent pre- and post-contrast computed tomography for estimating myocardial extracellular volume fraction. Serum level of galectin-3 was measured and 2-dimensional echocardiography was performed to characterize the extent of cardiac damage using a recently published aortic stenosis staging classification. Results Extracellular volume fraction was higher in patients with aortic stenosis compared to normal subjects (40.0 +/- 11% vs. 21.6 +/- 5.6%; respectively, p<0.001). In patients with aortic stenosis, extracellular volume fraction correlated with markers of left ventricular decompensation including New York Heart Association functional class, left atrial volume, staging classification of aortic stenosis and lower left ventricular ejection fraction. Out of 75 patients in the AS group, 49 underwent TAVI, 6 surgical AVR, 2 balloon valvuloplasty, and 18 did not undergo any type of intervention. At 12-months after aortic valve intervention, extracellular volume fraction predicted the combined outcomes of stroke and hospitalization for heart failure with an area under the curve of 0.77 (95% confidence interval: 0.65-0.88). A trend for correlation between serum galectin-3 and extracellular volume was noted. Conclusion In patients with severe aortic stenosis undergoing computed tomography before aortic valve intervention, quantification of extracellular volume fraction correlated with functional status and markers of left ventricular decompensation, and predicted the 12-months composite adverse clinical outcomes. Implementation of this novel technique might aid in the risk stratification process before aortic valve interventions.	[Hammer, Yoav; Talmor-Barkan, Yeela; Abelow, Aryeh; Orvin, Katia; Aviv, Yaron; Levi, Amos; Landes, Uri; Shafir, Gideon; Barsheshet, Alon; Vaknin-Assa, Hana; Sagie, Alexander; Kornowski, Ran; Hamdan, Ashraf] Rabin Med Ctr, Dept Cardiol, Beilinson Hosp, Petah Tiqwa, Israel; [Hammer, Yoav; Talmor-Barkan, Yeela; Abelow, Aryeh; Orvin, Katia; Aviv, Yaron; Levi, Amos; Landes, Uri; Shafir, Gideon; Barsheshet, Alon; Vaknin-Assa, Hana; Sagie, Alexander; Kornowski, Ran; Hamdan, Ashraf] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Talmor-Barkan, Yeela; Bar, Noam] Weizmann Inst Sci, Dept Comp Sci & Appl Math, Rehovot, Israel	Rabin Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science	Hamdan, A (corresponding author), Rabin Med Ctr, Dept Cardiol, Beilinson Hosp, Petah Tiqwa, Israel.; Hamdan, A (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	hamdashraf@gmail.com						Barone-Rochette G, 2014, J AM COLL CARDIOL, V64, P144, DOI 10.1016/j.jacc.2014.02.612; Chikwe J, 2015, J AM COLL CARDIOL, V65, P1931, DOI 10.1016/j.jacc.2015.01.059; Chin CWL, 2017, JACC-CARDIOVASC IMAG, V10, P1320, DOI 10.1016/j.jcmg.2016.10.007; Everett RJ, 2020, J AM COLL CARDIOL, V75, P304, DOI 10.1016/j.jacc.2019.11.032; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Genereux P, 2017, EUR HEART J, V38, P3351, DOI 10.1093/eurheartj/ehx381; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; Kumar V, 2019, J CARDIOVASC COMPUT, V13, P315, DOI 10.1016/j.jcct.2018.12.004; Kurita Y, 2016, J CARDIOVASC COMPUT, V10, P237, DOI 10.1016/j.jcct.2016.02.001; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Li LC, 2014, J PHARMACOL EXP THER, V351, P336, DOI 10.1124/jpet.114.218370; Musa TA, 2018, CIRCULATION, V138, P1935, DOI 10.1161/CIRCULATIONAHA.117.032839; Nacif MS, 2013, J CARDIOVASC COMPUT, V7, P51, DOI 10.1016/j.jcct.2012.10.010; Nacif MS, 2012, RADIOLOGY, V264, P876, DOI 10.1148/radiol.12112458; Oda S, 2020, CIRC-CARDIOVASC IMAG, V13, DOI 10.1161/CIRCIMAGING.119.010358; Puls M, 2020, EUR HEART J, V41, P1903, DOI 10.1093/eurheartj/ehaa033; Sado DM, 2011, FUTUR CARDIOL, V7, P643, DOI [10.2217/FCA.11.45, 10.2217/fca.11.45]; Scully PR, 2020, JACC-CARDIOVASC IMAG, V13, P2177, DOI 10.1016/j.jcmg.2020.05.029; Tamarappoo B, 2020, JACC-CARDIOVASC IMAG, V13, P2591, DOI 10.1016/j.jcmg.2020.07.045; Treibel TA, 2020, JACC-CARDIOVASC IMAG, V13, P44, DOI 10.1016/j.jcmg.2019.03.017; Treibel TA, 2018, EUR HEART J, V39, P699, DOI 10.1093/eurheartj/ehx353; Wu KC, 2008, J AM COLL CARDIOL, V51, P2414, DOI 10.1016/j.jacc.2008.03.018	22	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0248306	10.1371/journal.pone.0248306	http://dx.doi.org/10.1371/journal.pone.0248306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690718	gold, Green Published			2022-12-26	WOS:000627854700061
J	Jung, J; Lee, YJ; Kim, CH; Ahn, S				Jung, Jiyoon; Lee, Yoo Jin; Kim, Chul Hwan; Ahn, Sangjeong			Landscape of epigenetically regulated lncRNAs and DNA methylation in smokers with lung adenocarcinoma	PLOS ONE			English	Article								In this study, we identified long non-coding RNAs (lncRNAs) associated with DNA methylation in lung adenocarcinoma (LUAD) using clinical and methylation/expression data from 184 qualified LUAD tissue samples and 21 normal lung-tissue samples from The Cancer Genome Atlas (TCGA). We identified 1865 differentially expressed genes that correlated negatively with the methylation profiles of normal lung tissues, never-smoker LUAD tissues and smoker LUAD tissues, while 1079 differentially expressed lncRNAs were identified using the same criteria. These transcripts were integrated using ingenuity pathway analysis to determine significant pathways directly related to cancer, suggesting that lncRNAs play a crucial role in carcinogenesis. When comparing normal lung tissues and smoker LUAD tissues, 86 candidate genes were identified, including six lncRNAs. Of the 43 candidate genes revealed by comparing never-smoker LUAD tissues and smoker LUAD tissues, 13 were also different when compared to normal lung tissues. We then investigated the expression of these genes using the Gene Expression of Normal and Tumor Tissues (GENT) and Methylation and Expression Database of Normal and Tumor Tissues (MENT) databases. We observed an inverse correlation between the expression of 13 genes in normal lung tissues and smoker LUAD tissues, and the expression of five genes between the never-smoker and smoker LUAD tissues. These findings were further validated in clinical specimens using bisulfite sequencing, revealing that AGR2, AURKB, FOXP3, and HMGA1 displayed borderline differences in methylation. Finally, we explored the functional connections between DNA methylation, lncRNAs, and gene expression to identify possible targets that may contribute toward the pathogenesis of cigarette smoking-associated LUAD. Together, our findings suggested that differentially expressed lncRNAs and their target transcripts could serve as potential biomarkers for LUAD.	[Jung, Jiyoon; Ahn, Sangjeong] Catholic Kwandong Univ, Dept Pathol, Coll Med, Int St Marys Hosp, Incheon, South Korea; [Lee, Yoo Jin; Kim, Chul Hwan] Korea Univ, Anam Hosp, Dept Pathol, Coll Med, Seoul, South Korea	Catholic Kwandong University; Korea University; Korea University Medicine (KU Medicine)	Ahn, S (corresponding author), Catholic Kwandong Univ, Dept Pathol, Coll Med, Int St Marys Hosp, Incheon, South Korea.; Kim, CH (corresponding author), Korea Univ, Anam Hosp, Dept Pathol, Coll Med, Seoul, South Korea.	chkap@korea.ac.kr; vanitasahn@gmail.com		Jung, Jiyoon/0000-0001-9553-5283; Lee, Yoo Jin/0000-0003-3830-7051	National Research Foundation of Korea [NRF-2019R1G1A1004267]	National Research Foundation of Korea(National Research Foundation of Korea)	Sangjeong Ahn(SA) received support from National Research Foundation of Korea (https://www.nrf.re.kr)(NRF-2019R1G1A1004267).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03265-1; Baek SJ, 2013, GENE, V518, P194, DOI 10.1016/j.gene.2012.11.032; Banovich NE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004663; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bryant A, 2007, CHEST, V132, P185, DOI 10.1378/chest.07-0442; Buro-Auriemma LJ, 2013, HUM MOL GENET, V22, P4726, DOI 10.1093/hmg/ddt326; Chen J, 2014, J CELL MOL MED, V18, P2425, DOI 10.1111/jcmm.12431; Chen X, 2015, SCI REP-UK, V5, DOI 10.1038/srep13186; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Choi SW, 2019, BRIEF BIOINFORM, V20, P1853, DOI 10.1093/bib/bby055; Consonni D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203539; Corner BS, 2015, PHARMACOL THERAPEUT, V147, P91, DOI 10.1016/j.pharmthera.2014.11.006; Dammann R, 2005, EUR J CANCER, V41, P1223, DOI 10.1016/j.ejca.2005.02.020; Gan L, 2018, BIOMARK RES, V6, DOI 10.1186/s40364-018-0122-2; Gudas LJ, 2013, SEMIN CELL DEV BIOL, V24, P701, DOI 10.1016/j.semcdb.2013.08.002; Guo WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-774; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hou ZB, 2014, INT J BIOCHEM CELL B, V53, P380, DOI 10.1016/j.biocel.2014.06.004; Huang T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08897; Hubner RH, 2009, MOL MED, V15, P203, DOI 10.2119/molmed.2008.00130; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Jin ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102685; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kaplan R, 2003, CANCER RES, V63, P1475; Lamichhane DK, 2017, YONSEI MED J, V58, P1111, DOI [10.3349/ymj.2017.5, 10.3349/ymj.2017.58.6.1111]; Lara OD, 2020, CANCER-AM CANCER SOC, V126, P800, DOI 10.1002/cncr.32598; Lee SM, 2010, CANCER GENET CYTOGEN, V197, P39, DOI 10.1016/j.cancergencyto.2009.10.008; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; Liu F, 2010, ONCOGENE, V29, P3650, DOI 10.1038/onc.2010.129; Liu XH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-464; Liu Y, 2016, TOXICOL LETT, V240, P60, DOI 10.1016/j.toxlet.2015.10.016; Liu Y, 2015, TOXICOL APPL PHARM, V282, P9, DOI 10.1016/j.taap.2014.10.022; Liu ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077293; Lu L, 2015, TOXICOL APPL PHARM, V289, P276, DOI 10.1016/j.taap.2015.09.016; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Nakagawa T, 2013, BIOCHEM BIOPH RES CO, V436, P319, DOI 10.1016/j.bbrc.2013.05.101; Ono H, 2014, CANCER MED-US, V3, P632, DOI 10.1002/cam4.220; Proctor RN, 2001, NAT REV CANCER, V1, P82, DOI 10.1038/35094091; Ren J, 2018, CELL CYCLE, V17, P1372, DOI 10.1080/15384101.2018.1482137; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Saba R, 2017, ONCOLOGY-BASEL, V93, P347, DOI 10.1159/000479796; Schmidt LH, 2011, J THORAC ONCOL, V6, P1984, DOI 10.1097/JTO.0b013e3182307eac; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shin G, 2011, CANCER INFORM, V10, P149, DOI 10.4137/CIN.S7226; Slack FJ, 2019, CELL, V179, P1033, DOI 10.1016/j.cell.2019.10.017; Song MA, 2020, CANCER EPIDEM BIOMAR, V29, P443, DOI 10.1158/1055-9965.EPI-19-1245; Sui J, 2016, INT J ONCOL, V49, P2023, DOI 10.3892/ijo.2016.3716; Sun M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.256; Sundar IK, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0335-5; SWISSHELM K, 1994, CELL GROWTH DIFFER, V5, P133; Terry MB, 2008, CANCER EPIDEM BIOMAR, V17, P2306, DOI 10.1158/1055-9965.EPI-08-0312; Thai P, 2013, AM J RESP CELL MOL, V49, P204, DOI 10.1165/rcmb.2013-0159RC; Volkel P, 2015, AM J TRANSL RES, V7, P175; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Zhang EB, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.201; Zhang EB, 2016, TUMOR BIOL, V37, P4007, DOI 10.1007/s13277-015-4185-5; Zhang RY, 2019, MOL ONCOL, V13, P1235, DOI 10.1002/1878-0261.12482; Zhao W, 2014, EUR REV MED PHARMACO, V18, P1930; Zhou Y, 2017, CANCER GENE THER, V24, P317, DOI 10.1038/cgt.2017.20; Zhuang Y, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-35; Zong DD, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-019-0311-8	65	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0247928	10.1371/journal.pone.0247928	http://dx.doi.org/10.1371/journal.pone.0247928			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU3OZ	33684161	gold, Green Published			2022-12-26	WOS:000627193500051
J	Takeda, S; Terazawa, S; Shimoda, H; Imokawa, G				Takeda, Shogo; Terazawa, Shuko; Shimoda, Hiroshi; Imokawa, Genji			beta-Sitosterol 3-O-D-glucoside increases ceramide levels in the stratum corneum via the up-regulated expression of ceramide synthase-3 and glucosylceramide synthase in a reconstructed human epidermal keratinization model	PLOS ONE			English	Article								beta-Sitosterol 3-O-D-glucoside (BSG) is known to act as an agonist by binding to estrogen receptors, and estrogen has been reported to enhance the activity of beta-glucocerebrosidase, an epidermal ceramide metabolizing enzyme. In this study, we determined whether BSG up-regulates ceramide levels in the stratum corneum (SC) of a reconstructed human epidermal keratinization (RHEK) model. Treatment with BSG significantly increased the total ceramide content by 1.2-fold compared to that in the control in the SC of the RHEK model, accompanied by a significant increase of the ceramide species, Cer[EOS] by 2.1-fold compared to that in the control. RT-PCR analysis demonstrated that BSG significantly up-regulated the mRNA expression levels of serine palmitoyltransferase (SPT)2, ceramide synthase (CerS)3, glucosylceramide synthase (GCS) and acid sphingomyelinase by 1.41-1.89, 1.35-1.44, 1.19 and 2.06-fold, respectively, compared to that in the control in the RHEK model. Meanwhile, BSG significantly down-regulated the mRNA expression levels of sphingomyelin synthase (SMS)2 by 0.87-0.89-fold. RT-PCR analysis also demonstrated that BSG significantly up-regulated the mRNA expression levels of CerS3 and GCS by 1.19-1.55 and 1.20-fold, respectively, but not of SPT2 and significantly down-regulated that of SMS2 by 0.74-fold in HaCaT keratinocytes. Western blotting analysis revealed that BSG significantly increased the protein expression levels of CerS3 and GCS by 1.78 and 1.28-1.32-fold, respectively, compared to that in the control in HaCaT cells. These findings indicate that BSG stimulates ceramide synthesis via the up-regulated expression levels of CerS3 and GCS in the glucosylceramide pathway, which results in a significantly increased level of total ceramides in the SC accompanied by significantly increased levels of acylceramide species such as Cer[EOS].	[Takeda, Shogo; Shimoda, Hiroshi] Oryza Oil & Fat Chem Co Ltd, Res & Dev Div, Ichinomiya, Aichi, Japan; [Terazawa, Shuko; Imokawa, Genji] Utsunomiya Univ, Ctr Biosci Res & Educ, Utsunomiya, Tochigi, Japan	Utsunomiya University	Imokawa, G (corresponding author), Utsunomiya Univ, Ctr Biosci Res & Educ, Utsunomiya, Tochigi, Japan.	imokawag@dream.ocn.ne.jp			6th Ogaki Kyoritsu Bank (OKB) [2015-85]	6th Ogaki Kyoritsu Bank (OKB)	This work was supported by 6th Ogaki Kyoritsu Bank (OKB) in the form of an agribusiness subsidy awarded to HS (2015-85) and Oryza Oil & Fat Chemical Co., Ltd. in the form of salaries for ST and HS. The specific roles of these authors are articulated in the `author contributions' section.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto Kayoko, 1993, Journal of Dermatology (Tokyo), V20, P1; Arikawa J, 2002, J INVEST DERMATOL, V119, P433, DOI 10.1046/j.1523-1747.2002.01846.x; AYLWARD F, 1958, NATURE, V181, P1064, DOI 10.1038/1811064a0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chung IM, 2005, J CHEM ECOL, V31, P1339, DOI 10.1007/s10886-005-5290-5; Dolai N, 2016, NAT PROD RES, V30, P482, DOI 10.1080/14786419.2015.1023201; GREEN H, 1978, CELL, V15, P801, DOI 10.1016/0092-8674(78)90265-9; Gutendorf B, 2001, TOXICOLOGY, V166, P79, DOI 10.1016/S0300-483X(01)00437-1; Hamanaka S, 2002, J INVEST DERMATOL, V119, P416, DOI 10.1046/j.1523-1747.2002.01836.x; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hanley K, 1997, J LIPID RES, V38, P576; Higurashi S, 2015, J DAIRY SCI, V98, P6706, DOI 10.3168/jds.2015-9529; Huang HC, 2008, INT J DERMATOL, V47, P812, DOI 10.1111/j.1365-4632.2008.03687.x; IMOKAWA G, 1994, J CLIN INVEST, V94, P89, DOI 10.1172/JCI117352; IMOKAWA G, 1991, J INVEST DERMATOL, V96, P523, DOI 10.1111/1523-1747.ep12470233; IVORRA MD, 1988, ARCH INT PHARMACOD T, V296, P224; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Ju YH, 2004, J NUTR, V134, P1145, DOI 10.1093/jn/134.5.1145; 김태수, 2012, [Korean Journal of Food Science and Technology, 한국식품과학회지], V44, P434; Kessner D, 2008, EUR BIOPHYS J BIOPHY, V37, P989, DOI 10.1007/s00249-008-0328-6; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; MALINI T, 1992, J ETHNOPHARMACOL, V36, P51, DOI 10.1016/0378-8741(92)90060-5; Masukawa Y, 2008, J LIPID RES, V49, P1466, DOI 10.1194/jlr.M800014-JLR200; MELTON JL, 1987, BIOCHIM BIOPHYS ACTA, V921, P191, DOI 10.1016/0005-2760(87)90018-X; Mustarichie R, 2014, MED J INDONES, V23, P15, DOI 10.13181/mji.v23i1.684; Njinga NS, 2016, NITTE UNIV J HEALTH, V6, P4; Nojiri H, 2018, ARCH DERMATOL RES, V310, P495, DOI 10.1007/s00403-018-1833-9; Peshin T, 2017, BRIT J PHARM RES, V16, DOI 10.9734/BJPR/2017/33160; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; ROSENBLUM ER, 1993, ALCOHOL CLIN EXP RES, V17, P1207, DOI 10.1111/j.1530-0277.1993.tb05230.x; Sawada E, 2012, J DERMATOL SCI, V68, P25, DOI 10.1016/j.jdermsci.2012.07.004; Schroter A, 2009, BIOPHYS J, V97, P1104, DOI 10.1016/j.bpj.2009.05.041; Shi C, 2013, BBA-GEN SUBJECTS, V1830, P2538, DOI 10.1016/j.bbagen.2012.12.012; Shimoda H, 2012, J MED FOOD, V15, P1064, DOI 10.1089/jmf.2011.2137; SVOBODA J. A., 1967, LIFE SCI, V6, P395, DOI 10.1016/0024-3205(67)90009-4; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Takagi Y, 1999, J LIPID RES, V40, P861; Takagi Y, 2004, J INVEST DERMATOL, V122, P722, DOI 10.1111/j.0022-202X.2004.22307.x; Takeda S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205061; Teles YCF, 2015, REV BRAS FARMACOGN, V25, P363, DOI 10.1016/j.bjp.2015.02.002; Tsuji K, 2006, J DERMATOL SCI, V44, P101, DOI 10.1016/j.jdermsci.2006.08.005; Uchida Y, 2000, J LIPID RES, V41, P2071; Villasenor IM, 2002, PHYTOTHER RES, V16, P417, DOI 10.1002/ptr.910; WERBIN H, 1960, J BIOL CHEM, V235, P1629; Wu JQ, 2011, INT J COSMETIC SCI, V33, P257, DOI 10.1111/j.1468-2494.2010.00627.x; Yoshida N, 2012, ARCH DERMATOL RES, V304, P563, DOI 10.1007/s00403-012-1232-6	46	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0248150	10.1371/journal.pone.0248150	http://dx.doi.org/10.1371/journal.pone.0248150			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU3OZ	33684145	Green Published, gold			2022-12-26	WOS:000627193500014
J	Dutta, SD; Patel, DK; Ganguly, K; Lim, KT				Dutta, Sayan Deb; Patel, Dinesh K.; Ganguly, Keya; Lim, Ki-Taek			Effects of GABA/beta-glucan supplements on melatonin and serotonin content extracted from natural resources	PLOS ONE			English	Article							RICE BRAN; STEM-CELLS; SLEEP; SYSTEM	Objective This study aimed to monitor the secretion of serotonin and melatonin in the blood serum of rats in the presence of rice bran (RB), and Sarcodon aspratus (S) extracts for sleep promotion. Background Sleep is a natural physiological phenomenon, and sleep disorders may cause severe mental hazards leading to excessive daytime sleepiness (EDS). The gamma-aminobutyric acid (GABA) and beta-glucan are the essential active ingredients of RB and mushroom, respectively, exhibited stress-reduction and nerve stabilizing potential through regulation of melatonin and serotonin hormones. Methods Cytotoxicity of the extracts (RBS) was evaluated through WST-1 assay. The melatonin and serotonin concentrations in the blood serum were measured through ELISA kits. The Ig ELISA kit measured the immunoglobulin's (IgG, IgM, and IgA) concentrations. Results Improved cell viability was observed in RBS treated groups than control, indicating their biocompatibility. The melatonin and serotonin levels were high in RBS (5:5 and 7:3) treated groups compared to the control. Enhanced expression of immunoglobulin (Ig) A and G level was observed in RBS treated rats. The serotonergic genes (5-HTT, 5-HT 1B, and MAO-A) expression levels were upregulated in RBS treated groups vis-a-vis the control. Conclusion Based on these results, we anticipated that RBS supplements could promote the sleep phenomenon by elevating the serotonin/melatonin level in the blood through the serotonergic system. Therefore, RBS supplements can be utilized as functional food material for sleep promotion.	[Dutta, Sayan Deb; Patel, Dinesh K.; Ganguly, Keya; Lim, Ki-Taek] Kangwon Natl Univ, Inst Forest Sci, Dept Biosyst Engn, Interdisciplinary Program Smart Agr, Chunchon, South Korea	Kangwon National University	Lim, KT (corresponding author), Kangwon Natl Univ, Inst Forest Sci, Dept Biosyst Engn, Interdisciplinary Program Smart Agr, Chunchon, South Korea.	ktlim@kangwon.ac.kr	Lim, Ki-Taek/AAI-9518-2021	Lim, Ki-Taek/0000-0003-2091-788X; Deb Dutta, Sayan/0000-0001-9397-3140; Ganguly, Keya/0000-0002-0235-6313	'Cooperative Research Program for Agriculture Science and Technology Development', Rural Development Administration, Republic of Korea [PJ012854012019]; 'Basic Science Research Program' through the 'National Research Foundation of Korea (NRF)' - 'Ministry of Education' [2018R1A6A1A03025582]; National Research Foundation of Korea [NRF2019R1D1A3A03103828]	'Cooperative Research Program for Agriculture Science and Technology Development', Rural Development Administration, Republic of Korea; 'Basic Science Research Program' through the 'National Research Foundation of Korea (NRF)' - 'Ministry of Education'(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by 'Cooperative Research Program for Agriculture Science and Technology Development (No. PJ012854012019)', Rural Development Administration, Republic of Korea and 'Basic Science Research Program' through the 'National Research Foundation of Korea (NRF)' funded by the 'Ministry of Education' (No. 2018R1A6A1A03025582) and the `National Research Foundation of Korea' (NRF2019R1D1A3A03103828).	Adrien J., 1995, HANDB EXP PHARMACOL, P91; Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; [Anonymous], 2018, J SLEEP RES, DOI [10.1111/jsr.12722, DOI 10.1111/jsr.12722]; Bathory E, 2017, CURR PROB PEDIATR AD, V47, P29, DOI 10.1016/j.cppeds.2016.12.001; Bhat A, 2008, EXPERT OPIN PHARMACO, V9, P351, DOI [10.1517/14656566.9.3.351, 10.1517/14656566.9.3.351 ]; Brancaccio A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63933-5; Cespuglio R, 1998, J NEURAL TRANSM, V105, P205, DOI 10.1007/s007020050049; Costa HFB, 2019, FLOWER EXTRACT; de Taeye SW, 2019, ANTIBODIES, V8, DOI 10.3390/antib8020030; Dutta SD, 2019, J NANOMATER, V2019, DOI 10.1155/2019/2061545; Francis AJP, 2002, PHYTOMEDICINE, V9, P273, DOI 10.1078/0944-7113-00110; Gandhi AV, 2015, NEURON, V85, P1193, DOI 10.1016/j.neuron.2015.02.016; Gunja N, 2013, J MED TOXICOL, V9, P155, DOI 10.1007/s13181-013-0292-0; Guo YX, 2012, EUR FOOD RES TECHNOL, V234, P679, DOI 10.1007/s00217-012-1678-y; Hu ZZ, 2018, BIOMOL THER, V26, P343, DOI 10.4062/biomolther.2018.099; Jin B, 2016, TISSUE ENG PT A, V22, P721, DOI 10.1089/ten.tea.2015.0273; KAHLON TS, 1993, CEREAL CHEM, V70, P435; Kim JY, 2013, FOOD SCI BIOTECHNOL, V22, P121, DOI 10.1007/s10068-013-0057-1; Lim Kitaek, 2014, Journal of Biosystems Engineering, V39, P235; Lorton D, 2006, NEUROIMMUNOMODULAT, V13, P357, DOI 10.1159/000104864; Masson J, 2012, WIRES COMPUT STAT, V1, P685, DOI DOI 10.1002/WMTS.50; Park HY, 2017, FOOD FUNCT, V8, P935, DOI 10.1039/c6fo01763k; Patel DK, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/8193971; Patel DK, 2019, RSC ADV, V9, P36040, DOI 10.1039/c9ra06260b; Sakashita Maya, 2019, J Clin Med Res, V11, P428, DOI 10.14740/jocmr3817; Seonwoo H, 2018, NANOMATERIALS-BASEL, V8, DOI 10.3390/nano8070554; Sheldon SH, 2005, PRINCIPLES PRACTISE, V1st, P11; Taranu I, 2019, WASTE BIOMASS VALORI, V10, P3373, DOI 10.1007/s12649-018-0341-7; Urrutia M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163735; Vermetten E., 2018, SLEEP COMBAT RELATED; Woof JM, 2016, BIOCHEM SOC T, V44, P1651, DOI 10.1042/BST20160246; Yang H, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050512; Yulira Y., 2019, PHARMACOGNOSY J, V11; Zhang GJ, 1997, PHYTOCHEMISTRY, V44, P1007, DOI 10.1016/S0031-9422(96)00626-7	34	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0247890	10.1371/journal.pone.0247890	http://dx.doi.org/10.1371/journal.pone.0247890			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667254	gold, Green Published			2022-12-26	WOS:000626604300054
J	Shabannejad, M; Bihamta, MR; Majidi-Hervan, E; Alipour, H; Ebrahimi, A				Shabannejad, Morteza; Bihamta, Mohammad-Reza; Majidi-Hervan, Eslam; Alipour, Hadi; Ebrahimi, Asa			A classic approach for determining genomic prediction accuracy under terminal drought stress and well-watered conditions in wheat landraces and cultivars	PLOS ONE			English	Article							POPULATION-STRUCTURE; WIDE ASSOCIATION; BREEDING VALUES; SELECTION; TRAITS; REGRESSION; SOFTWARE; PACKAGE; IMPACT; PLANT	The present study aimed to improve the accuracy of genomic prediction of 16 agronomic traits in a diverse bread wheat (Triticum aestivum L.) germplasm under terminal drought stress and well-watered conditions in semi-arid environments. An association panel including 87 bread wheat cultivars and 199 landraces from Iran bread wheat germplasm was planted under two irrigation systems in semi-arid climate zones. The whole association panel was genotyped with 9047 single nucleotide polymorphism markers using the genotyping-by-sequencing method. A number of 23 marker-trait associations were selected for traits under each condition, whereas 17 marker-trait associations were common between terminal drought stress and well-watered conditions. The identified marker-trait associations were mostly single nucleotide polymorphisms with minor allele effects. This study examined the effect of population structure, genomic selection method (ridge regression-best linear unbiased prediction, genomic best-linear unbiased predictions, and Bayesian ridge regression), training set size, and type of marker set on genomic prediction accuracy. The prediction accuracies were low (-0.32) to moderate (0.52). A marker set including 93 significant markers identified through genome-wide association studies with P values <= 0.001 increased the genomic prediction accuracy for all traits under both conditions. This study concluded that obtaining the highest genomic prediction accuracy depends on the extent of linkage disequilibrium, the genetic architecture of trait, genetic diversity of the population, and the genomic selection method. The results encouraged the integration of genome-wide association study and genomic selection to enhance genomic prediction accuracy in applied breeding programs.	[Shabannejad, Morteza; Majidi-Hervan, Eslam; Ebrahimi, Asa] Islamic Azad Univ, Fac Agr Sci & Food Ind, Dept Plant Breeding & Biotechnol, Sci & Res Branch, Tehran, Iran; [Bihamta, Mohammad-Reza] Univ Tehran, Coll Agr & Nat Resources, Fac Agr Sci & Engn, Dept Agron & Plant Breeding, Tehran, Iran; [Alipour, Hadi] Urmia Univ, Fac Agr & Nat Resources, Dept Plant Prod & Genet, Orumiyeh, Iran	Islamic Azad University; University of Tehran; Urmia University	Bihamta, MR (corresponding author), Univ Tehran, Coll Agr & Nat Resources, Fac Agr Sci & Engn, Dept Agron & Plant Breeding, Tehran, Iran.	mrghanad@ut.ac.ir	ebrahimi, asa/AAT-9741-2021; Shabannejad, Morteza/ABD-5547-2020	Shabannejad, Morteza/0000-0002-2816-2541; Bihamta, Mohammad Reza/0000-0003-0614-0963	 [31191]		This is contribution number 31191 between UT and SRBIAU. This research was funded by SRBIAU and granted to the first author. Funders had no role in the study design, data collection and analysis, decision to publication, or manuscript preparation.	Alipour H, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01293; [Anonymous], 2013, FAO Food Nutr Pap, V92, P1; [Anonymous], 1988, **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Asoro FG, 2011, PLANT GENOME-US, V4, P132, DOI 10.3835/plantgenome2011.02.0007; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Chen CPJ, 2018, BIOINFORMATICS, V34, P1925, DOI 10.1093/bioinformatics/bty015; Clark Samuel A, 2013, Methods Mol Biol, V1019, P321, DOI 10.1007/978-1-62703-447-0_13; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Crain J, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00319; Daetwyler HD, 2010, ANIM PROD SCI, V50, P1004, DOI 10.1071/AN10096; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; de Roos APW, 2009, GENETICS, V183, P1545, DOI 10.1534/genetics.109.104935; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Hayes BJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-51; Howard R, 2014, G3-GENES GENOM GENET, V4, P1027, DOI 10.1534/g3.114.010298; Institute S., 2017, BASE SAS 9; Isidro J, 2015, THEOR APPL GENET, V128, P145, DOI 10.1007/s00122-014-2418-4; Juliana P, 2017, PLANT GENOME-US, V10, DOI 10.3835/plantgenome2016.08.0082; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Lipka AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112227; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Lorenz AJ, 2011, ADV AGRON, V110, P77, DOI 10.1016/B978-0-12-385531-2.00002-5; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Massman JM, 2013, CROP SCI, V53, P58, DOI 10.2135/cropsci2012.02.0112; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-35; Michaletti A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24012-y; Muleta KT, 2017, PLANT GENOME-US, V10, DOI 10.3835/plantgenome2016.12.0124; Nuttonson MY., 1995, WHEAT CLIMATE RELATI; Pask A., 2012, PHYSIOLOGICAL BREEDI; Perez P, 2014, GENETICS, V198, P483, DOI 10.1534/genetics.114.164442; Perez P, 2010, PLANT GENOME-US, V3, P106, DOI 10.3835/plantgenome2010.04.0005; Pinheiro C, 2011, J EXP BOT, V62, P869, DOI 10.1093/jxb/erq340; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Pritchard JK, 2000, GENETICS, V155, P945; Rahimi Y, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-2165-4; Resende MFR, 2012, GENETICS, V190, P1503, DOI 10.1534/genetics.111.137026; Rutkoski J, 2015, PLANT GENOME-US, V8, DOI [10.3835/plantgenome2014.09.0046, 10.3835/plantgenome2014.10.0074]; Sallam AH, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.05.0020; Sehgal A, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01705; Shabannejad M, 2020, PLANT METHODS, V16, DOI 10.1186/s13007-020-00686-2; Sievert C., 2017, PLOTLY CREATE INTERA; Singmann H, **DATA OBJECT**; Spindel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004982; Sukumaran S, 2015, THEOR APPL GENET, V128, P353, DOI 10.1007/s00122-014-2435-3; Tayeh N, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00941; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Weir BS, 1996, SINAUER ASS SUNDERL; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; Zhang JP, 2016, THEOR APPL GENET, V129, P117, DOI 10.1007/s00122-015-2614-x; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao YS, 2012, THEOR APPL GENET, V124, P769, DOI 10.1007/s00122-011-1745-y; Zhong SQ, 2009, GENETICS, V182, P355, DOI 10.1534/genetics.108.098277	61	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0247824	10.1371/journal.pone.0247824	http://dx.doi.org/10.1371/journal.pone.0247824			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667255	gold, Green Published			2022-12-26	WOS:000626604300002
J	Iadarola, DM; Joshi, A; Caldwell, CB; Gohil, VM				Iadarola, Donna M.; Joshi, Alaumy; Caldwell, Cameron B.; Gohil, Vishal M.			Choline restores respiration in Psd1-deficient yeast by replenishing mitochondrial phosphatidylethanolamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLSERINE DECARBOXYLASE; SACCHAROMYCES-CEREVISIAE; BIOSYNTHETIC PATHWAYS; CARDIOLIPIN; PHOSPHATIDYLCHOLINE; CLONING; GENE; METHYLTRANSFERASE; METHYLATION; STABILITY	Phosphatidylethanolamine (PE) is essential for mitochondrial respiration in yeast, Saccharomyces cerevisiae, whereas the most abundant mitochondrial phospholipid, phosphatidylcholine (PC), is largely dispensable. Surprisingly, choline (Cho), which is a biosynthetic precursor of PC, has been shown to rescue the respiratory growth of mitochondrial PE-deficient yeast; however, the mechanism underlying this rescue has remained unknown. Using a combination of yeast genetics, lipid biochemistry, and cell biological approaches, we uncover the mechanism by showing that Cho rescues mitochondrial respiration by partially replenishing mitochondrial PE levels in yeast cells lacking the mitochondrial PE-biosynthetic enzyme Psd1. This rescue is dependent on the conversion of Cho to PC via the Kennedy pathway as well as on Psd2, an enzyme catalyzing PE biosynthesis in the endosome. Metabolic labeling experiments reveal that in the absence of exogenously supplied Cho, PE biosynthesized via Psd2 is mostly directed to the methylation pathway for PC biosynthesis and is unavailable for replenishing mitochondrial PE in Psd1-deleted cells. In this setting, stimulating the Kennedy pathway for PC biosynthesis by Cho spares Psd2-synthesized PE from the methylation pathway and redirects it to the mitochondria. Cho-mediated elevation in mitochondrial PE is dependent on Vps39, which has been recently implicated in PE trafficking to the mitochondria. Accordingly, epistasis experiments placed Vps39 downstream of Psd2 in Cho-based rescue. Our work, thus, provides a mechanism of Cho-based rescue of mitochondrial PE deficiency and uncovers an intricate interorganelle phospholipid regulatory network that maintains mitochondrial PE homeostasis.	[Iadarola, Donna M.; Joshi, Alaumy; Caldwell, Cameron B.; Gohil, Vishal M.] Texas A&M Univ, Dept Biochem & Biophys, MS 3474, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Gohil, VM (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, MS 3474, College Stn, TX 77843 USA.	vgohil@tamu.edu		Joshi, Alaumy/0000-0002-4637-5639; Gohil, Vishal/0000-0002-9920-2563; Caldwell, Cameron/0000-0002-4144-093X	Welch Foundation [A-1810]; NIH [R01GM111672]	Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by The Welch Foundation Grant (A-1810) and the NIH award R01GM111672 to V. M. G. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amberg DC., 2005, METHODS YEAST GENETI; Baker CD, 2016, MOL BIOL CELL, V27, P2161, DOI 10.1091/mbc.E15-12-0865; Ball WB, 2018, FEBS LETT, V592, P1273, DOI 10.1002/1873-3468.12887; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; Bottinger L, 2012, J MOL BIOL, V423, P677, DOI 10.1016/j.jmb.2012.09.001; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P161, DOI 10.1016/j.bbalip.2004.09.007; Calzada E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09425-1; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Chan EYL, 2012, J BIOL CHEM, V287, P40131, DOI 10.1074/jbc.M112.399428; CLANCEY CJ, 1993, J BIOL CHEM, V268, P24580; FOLCH J, 1957, J BIOL CHEM, V226, P497; GAYNOR PM, 1990, BIOCHIM BIOPHYS ACTA, V1045, P156, DOI 10.1016/0005-2760(90)90145-N; Ghosh S, 2020, P NATL ACAD SCI USA, V117, P16383, DOI 10.1073/pnas.2000640117; Girisha KM, 2019, HUM MUTAT, V40, P299, DOI 10.1002/humu.23693; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Gulshan K, 2010, MOL BIOL CELL, V21, P443, DOI 10.1091/mbc.E09-06-0519; Henneberry AL, 2001, MOL BIOL CELL, V12, P511, DOI 10.1091/mbc.12.3.511; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Iadarola DM, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158655; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Janssen MJFW, 2002, FEBS LETT, V513, P197, DOI 10.1016/S0014-5793(02)02298-6; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Kim KS, 1999, J BIOL CHEM, V274, P14857, DOI 10.1074/jbc.274.21.14857; KODAKI T, 1987, J BIOL CHEM, V262, P15428; MCGEE TP, 1994, J BACTERIOL, V176, P6861, DOI 10.1128/JB.176.22.6861-6868.1994; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Mejia EM, 2016, J BIOENERG BIOMEMBR, V48, P99, DOI 10.1007/s10863-015-9601-4; Peter VG, 2019, GENET MED, V21, P2734, DOI 10.1038/s41436-019-0595-x; Schuler MH, 2016, J BIOL CHEM, V291, P18718, DOI 10.1074/jbc.M116.722694; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Vance DE, 2014, BBA-BIOMEMBRANES, V1838, P1477, DOI 10.1016/j.bbamem.2013.10.018; Zhao T, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900353	36	0	0	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100539	10.1016/j.jbc.2021.100539	http://dx.doi.org/10.1016/j.jbc.2021.100539			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33722607	gold, Green Published			2022-12-26	WOS:000672866400512
J	Levitin, F; Lee, SCES; Hulme, S; Rumantir, RA; Wong, AS; Meester, MR; Koritzinsky, M				Levitin, Fiana; Lee, Sandy Che-Eun S.; Hulme, Stephanie; Rumantir, Ryan A.; Wong, Amy S.; Meester, Marmendia R.; Koritzinsky, Marianne			Oxygen-independent disulfide bond formation in VEGF-A and CA9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENE-EXPRESSION; PROTEIN; HYPOXIA; ISOMERASE; METABOLISM; SURVIVAL; HISTONE; PATHWAY; CELLS	Low levels of oxygen (hypoxia) occurs in many (patho) physiological situations. Adaptation to hypoxia is in part mediated by proteins expressed in the extracellular space that mature in the endoplasmic reticulum (ER) prior to traversing the secretory pathway. The majority of such ER cargo proteins require disulfide bonds for structural stability. Disulfide bonds are formed co- and posttranslationally in a redox relay that requires a terminal electron acceptor such as oxygen. We have previously demonstrated that some ER cargo proteins such as low-density lipoprotein receptor (LDLR) and influenza hemagglutinin (Flu-HA) are unable to complete disulfide bond formation in the absence of oxygen, limiting their ability to pass ER quality control and their ultimate expression. Here, using radioactive pulse-chase immunoprecipitation analysis, we demonstrate that hypoxia-induced ER cargo proteins such as carbonic anhydrase 9 (CA9) and vascular endothelial growth factor A (VEGF-A) complete disulfide bond formation and mature with similar kinetics under hypoxia and normoxia. A global in silico analysis of ER cargo revealed that hypoxia-induced proteins on average contain fewer free cysteines and shorter-range disulfide bonds in comparison to other ER cargo proteins. These data demonstrate the existence of alternative electron acceptors to oxygen for disulfide bond formation in cellulo. However, the ability of different proteins to utilize an oxygen-independent pathway for disulfide bond formation varies widely, contributing to differential gene expression in hypoxia. The superior ability of hypoxia-induced proteins such as VEGF-A and CA9 to mature in hypoxia may be conferred by a simpler disulfide architecture.	[Levitin, Fiana; Lee, Sandy Che-Eun S.; Hulme, Stephanie; Rumantir, Ryan A.; Wong, Amy S.; Meester, Marmendia R.; Koritzinsky, Marianne] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Lee, Sandy Che-Eun S.; Hulme, Stephanie; Rumantir, Ryan A.; Wong, Amy S.; Meester, Marmendia R.; Koritzinsky, Marianne] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Koritzinsky, Marianne] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Koritzinsky, Marianne] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto	Koritzinsky, M (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.; Koritzinsky, M (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.; Koritzinsky, M (corresponding author), Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada.; Koritzinsky, M (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	Marianne.Koritzinsky@uhnresearch.ca		Koritzinsky, Marianne/0000-0003-0547-2480; Lee, Sandy Che-Eun/0000-0002-7691-8104	Terry Fox Research Institute [PPG14-1036, 1090]; Strategic Training Initiative for Excellence in Radiation Research for the 21st Century (EIRR21/STARS21); Canadian Graduate Scholarship-Masters Awards; Vanier Canadian Graduate Scholarship; Princess Margaret Cancer Centre; Princess Margaret Cancer Foundation; Ontario Ministry of Health	Terry Fox Research Institute; Strategic Training Initiative for Excellence in Radiation Research for the 21st Century (EIRR21/STARS21); Canadian Graduate Scholarship-Masters Awards; Vanier Canadian Graduate Scholarship; Princess Margaret Cancer Centre(University of Toronto); Princess Margaret Cancer Foundation(University of Toronto); Ontario Ministry of Health(Ministry of Health and Long-Term Care, Ontario)	This work was financially supported by the Terry Fox Research Institute (New Investigator Award and New Frontiers Project Program Grant PPG14-1036 and PPG#1090 to M. K.), Strategic Training Initiative for Excellence in Radiation Research for the 21st Century (EIRR21/STARS21 to F. L. and S. C.-E. S. L.), Canadian Graduate Scholarship-Masters Awards (to S. C.-E. S. L., S. H., A. S. W.), Vanier Canadian Graduate Scholarship (to S. C.-E. S. L.), Princess Margaret Cancer Centre, The Princess Margaret Cancer Foundation, and Ontario Ministry of Health.	Alterio V, 2009, P NATL ACAD SCI USA, V106, P16233, DOI 10.1073/pnas.0908301106; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Braakman Ineke, 2017, Curr Protoc Protein Sci, V90, DOI 10.1002/cpps.43; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Chakraborty AA, 2019, SCIENCE, V363, P1217, DOI 10.1126/science.aaw1026; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Gent J, 2004, CELL MOL LIFE SCI, V61, P2461, DOI 10.1007/s00018-004-4090-3; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hilvo M, 2008, J BIOL CHEM, V283, P27799, DOI 10.1074/jbc.M800938200; Iyer S, 2011, FEBS J, V278, P4304, DOI 10.1111/j.1742-4658.2011.08350.x; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Koritzinsky M, 2013, J CELL BIOL, V203, P615, DOI 10.1083/jcb.201307185; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Muller YA, 2002, J BIOL CHEM, V277, P43410, DOI 10.1074/jbc.M206438200; Oka OBV, 2013, MOL CELL, V50, P793, DOI 10.1016/j.molcel.2013.05.014; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; POTGENS AJG, 1994, J BIOL CHEM, V269, P32879; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Rouschop KM, 2013, P NATL ACAD SCI USA, V110, P4622, DOI 10.1073/pnas.1210633110; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Sarris M, 2014, ONCOGENE, V33, P1207, DOI 10.1038/onc.2013.87; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Sullivan DC, 2003, J BIOL CHEM, V278, P47079, DOI 10.1074/jbc.M308124200; Tanaka T, 2016, BRIT J CANCER, V114, P1227, DOI 10.1038/bjc.2016.105; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Wouters BG, 2005, SEMIN CELL DEV BIOL, V16, P487, DOI 10.1016/j.semcdb.2005.03.009; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Wykoff CC, 2000, CANCER RES, V60, P7075	39	2	2	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100505	10.1016/j.jbc.2021.100505	http://dx.doi.org/10.1016/j.jbc.2021.100505			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33675747	Green Published, gold			2022-12-26	WOS:000672866400479
J	Liu, LX; Zhang, YY; Liu, T; Ke, CR; Huang, JZ; Fu, YJ; Lin, Z; Chen, FJ; Wu, XQ; Chen, Q				Liu, Lixia; Zhang, Yingyong; Liu, Tao; Ke, Chongrong; Huang, Jianzhong; Fu, Yajuan; Lin, Zhang; Chen, Fengjuan; Wu, Xiuqin; Chen, Qi			Pyrroloquinoline quinone protects against exercise-induced fatigue and oxidative damage via improving mitochondrial function in mice	FASEB JOURNAL			English	Article						damage; exercise; fatigue; mitochondria; PQQ		Pyrroloquinoline quinone (PQQ) has a variety of biological functions. However, rare attention has been paid to its effects on exercise-induced damage. Here, we assessed the potential protective effects of PQQ against the fatigue and oxidative damage caused by repeated exhaustive exercise, and studied the underlying mechanism. The models for exercise-induced fatigue were established, and the parameters were measured, including the time to exhaustion (TTE), biochemical indicators, the expression of nuclear factor kappa B (NF-kappa B) and inflammatory cytokines and so on. Besides, the mitochondrial function was evaluated by the morphology, membrane potential, respiratory function, adenosine triphosphate (ATP) levels, and the application of the mitochondrial complex I inhibitor. The results demonstrate that PQQ prolongs TTE, causes the decrease in the activity of serum creatine kinase and lactate dehydrogenase, increases the activity of antioxidant enzymes, inhibits the production of reactive oxygen species (ROS) and malondialdehyde (MDA), and diminishes the over expression of NF-kappa B (p65) and inflammatory mediators. Furthermore, PQQ preserves normal mitochondrial function. Particularly, PQQ reduces the accumulation of ROS triggered by the mitochondrial complex I inhibitor. These data suggest that PQQ can significantly protect mice from exercise-induced fatigue and oxidative damage by improving mitochondrial function. These data also suggest that PQQ controls mitochondrial activity through directly affecting the NADH dehydrogenase.	[Liu, Lixia; Fu, Yajuan; Lin, Zhang; Chen, Qi] Fujian Normal Univ, Biomed Res Ctr South China, Fujian Key Lab Innate Immune Biol, Fuzhou, Funjian, Peoples R China; [Liu, Lixia; Zhang, Yingyong; Liu, Tao; Chen, Fengjuan; Wu, Xiuqin] Fujian Normal Univ, Sch Phys Educ & Sport Sci, Fuzhou, Fujian, Peoples R China; [Liu, Lixia; Wu, Xiuqin] Fujian Normal Univ, Key Lab Gen Adm Sport China, Fuzhou, Fujian, Peoples R China; [Liu, Lixia] Fujian Normal Univ, Fujian Key Lab Sports & Hlth, Fuzhou, Fujian, Peoples R China; [Ke, Chongrong; Huang, Jianzhong; Fu, Yajuan; Lin, Zhang; Chen, Qi] Fujian Normal Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China; [Ke, Chongrong; Huang, Jianzhong] Fujian Normal Univ, Natl Engn Res Ctr Ind Microbiol & Fermentat Techn, Fuzhou, Fujian, Peoples R China	Fujian Normal University; Fujian Normal University; Fujian Normal University; Fujian Normal University; Fujian Normal University; Fujian Normal University	Wu, XQ (corresponding author), Fujian Normal Univ, Sch Phys Educ & Sport Sci, Fuzhou, Fujian, Peoples R China.; Chen, Q (corresponding author), Fujian Normal Univ, Biomed Res Ctr South China, Qishan Campus,Keji Rd 1, Fuzhou 350117, Fujian, Peoples R China.	616331350@qq.com; chenqi@fjnu.edu.cn		Ke, ChongRong/0000-0002-2111-4627	Fujian Provincial Health and Education Alliance Funds [WKJ-FJ-28]; Fujian Key Laboratories Funds; Fujian Provincial Lingjun Scholarship	Fujian Provincial Health and Education Alliance Funds; Fujian Key Laboratories Funds; Fujian Provincial Lingjun Scholarship	Fujian Provincial Health and Education Alliance Funds, Grant/Award Number: WKJ-FJ-28; Fujian Key Laboratories Funds; Fujian Provincial Lingjun Scholarship to QC	Aydin C, 2007, CELL BIOCHEM FUNCT, V25, P129, DOI 10.1002/cbf.1279; Basham SA, 2020, J DIET SUPPL, V17, P401, DOI 10.1080/19390211.2019.1604604; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bishop A, 1998, NUTR REV, V56, P287, DOI 10.1111/j.1753-4887.1998.tb01661.x; Breuer ME, 2013, NEUROBIOL DIS, V51, P27, DOI 10.1016/j.nbd.2012.03.007; Das S, 2008, PHARM RES-DORDR, V25, P2593, DOI 10.1007/s11095-008-9677-1; DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1; Feldkamp T, 2005, AM J PHYSIOL-RENAL, V288, pF1092, DOI 10.1152/ajprenal.00443.2004; Fu X, 2010, J MED FOOD, V13, P211, DOI 10.1089/jmf.2009.0049; Hamidie RDR, 2017, IOP CONF SER-MAT SCI, V180, DOI 10.1088/1757-899X/180/1/012202; Harris CB, 2013, J NUTR BIOCHEM, V24, P2076, DOI 10.1016/j.jnutbio.2013.07.008; Hou LJ, 2017, J AM COLL CARDIOL, V70, pC64, DOI 10.1016/j.jacc.2017.07.218; Huang WC, 2015, NUTRIENTS, V7, P905, DOI 10.3390/nu7020905; Jonscher KR, 2017, FASEB J, V31, P1434, DOI 10.1096/fj.201600906R; Kasahara T, 2003, NATURE, V422, P832, DOI 10.1038/422832a; Kinoshita S, 2003, ACTA PHYSIOL SCAND, V178, P225, DOI 10.1046/j.1365-201X.2003.01135.x; Kramer HF, 2007, J APPL PHYSIOL, V103, P388, DOI 10.1152/japplphysiol.00085.2007; Liu LX, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1333390; Liu ZG, 2016, J SPORT HEALTH SCI, V5, P424, DOI 10.1016/j.jshs.2015.09.005; Liu ZB, 2016, INFLAMMATION, V39, P248, DOI 10.1007/s10753-015-0245-7; Mankowski RT, 2015, MED SCI SPORT EXER, V47, P1857, DOI 10.1249/MSS.0000000000000620; Matsushita K, 2002, APPL MICROBIOL BIOT, V58, P13, DOI 10.1007/s00253-001-0851-1; McFarlin BK, 2016, BBA CLIN, V5, P72, DOI 10.1016/j.bbacli.2016.02.003; Nieman DC, 2018, INT J SPORT NUTR EXE, V28, P266, DOI 10.1123/ijsnem.2017-0272; Nybo L, 2003, MED SCI SPORT EXER, V35, P589, DOI 10.1249/01.MSS.0000058433.85789.66; Ohwada K, 2008, J CLIN BIOCHEM NUTR, V42, P29, DOI 10.3164/jcbn.2008005; Pan HY, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/145418; Purkayastha S, 2013, MOL METAB, V2, P356, DOI 10.1016/j.molmet.2013.09.005; Rasbach KA, 2008, J PHARMACOL EXP THER, V325, P536, DOI 10.1124/jpet.107.134882; Singh AK, 2015, EXP GERONTOL, V66, P1, DOI 10.1016/j.exger.2015.04.001; SMIDT CR, 1991, BIOFACTORS, V3, P53; Steckling FM, 2020, SCAND J MED SCI SPOR, V30, P264, DOI 10.1111/sms.13579; Stevanovic J, 2020, MOL METAB, V32, P1, DOI 10.1016/j.molmet.2019.11.015; Suhett LG, 2021, CRIT REV FOOD SCI, V61, P946, DOI 10.1080/10408398.2020.1749025; Sun M, 2012, SCAND J MED SCI SPOR, V22, P764, DOI 10.1111/j.1600-0838.2011.01314.x; THOMAS DP, 1988, INT J SPORTS MED, V9, P257, DOI 10.1055/s-2007-1025017; Tsukakoshi K, 2018, ACS CHEM NEUROSCI, V9, P2898, DOI 10.1021/acschemneuro.8b00355; Wan JJ, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.194; Xu MH, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1334485; Zhang YH, 2006, BRAIN RES, V1094, P200, DOI 10.1016/j.brainres.2006.03.111; Zhu BQ, 2006, J CARDIOVASC PHARM T, V11, P119, DOI 10.1177/1074248406288757	41	6	7	11	37	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21394	10.1096/fj.202001977RR	http://dx.doi.org/10.1096/fj.202001977RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710654				2022-12-26	WOS:000635216100056
J	Leulseged, TW; Hassen, IS; Ayele, BT; Tsegay, YG; Abebe, DS; Edo, MG; Maru, EH; Zewde, WC; Naylor, LK; Semane, DF; Dresse, MT; Tezera, BB				Leulseged, Tigist W.; Hassen, Ishmael S.; Ayele, Birhanu T.; Tsegay, Yakob G.; Abebe, Daniel S.; Edo, Mesay G.; Maru, Endalkachew H.; Zewde, Wuletaw C.; Naylor, Lydia K.; Semane, Dejene F.; Dresse, Menayit T.; Tezera, Bereket B.			Laboratory biomarkers of COVID-19 disease severity and outcome: Findings from a developing country	PLOS ONE			English	Article							RATIO	Aim To identify laboratory biomarkers that predict disease severity and outcome among COVID-19 patients admitted to the Millennium COVID-19 Care Center in Ethiopia. Methods A retrospective cohort study was conducted among 429 COVID-19 patients who were on follow up from July to October 2020. Data was described using frequency tables. Robust Poisson regression model was used to identify predictors of COVID-19 severity where adjusted relative risk (ARR), P-value and 95 CI for ARR were used to test significance. Binary Logistic regression model was used to assess the presence of statistically significant association between the explanatory variables and COVID-19 outcome where adjusted odds ratio (AOR), P-value and 95%CI for AOR were used for testing significance. Results Among the 429 patients studied, 182 (42.4%) had Severe disease at admission and the rest 247 (57.6%) had Non-severe disease. Regarding disease outcome, 45 (10.5%) died and 384 (89.5%) were discharged alive. Age group (ARR = 1.779, 95%CI = 1.405-2.252, p-value <0.0001), Neutrophil to Lymphocyte ratio (NLR) (ARR = 4.769, 95%CI = 2.419-9.402 p-value <0.0001), Serum glutamic oxaloacetic transaminase (SGOT) (ARR = 1.358, 95%CI = 1.109-1.662 p-value = 0.003), Sodium (ARR = 1.321, 95%CI = 1.091-1.600 p-value = 0.004) and Potassium (ARR = 1.269, 95%CI = 1.059-1.521 p-value = 0.010) were found to be significant predictors of COVID-19 severity. The following factors were significantly associated with COVID-19 outcome; age group (AOR = 2.767, 95%CI = 1.099-6.067, p-value = 0.031), white blood cell count (WBC) (AOR = 4.253, 95%CI = 1.918-9.429, p-value = 0.0001) and sodium level (AOR = 3.435, 95%CI = 1.439-8.198, p-value = 0.005). Conclusions Assessing and monitoring the laboratory markers of WBC, NLR, SGOT, sodium and potassium levels at the earliest stage of the disease could have a considerable role in halting disease progression and death.	[Leulseged, Tigist W.; Hassen, Ishmael S.; Tsegay, Yakob G.; Abebe, Daniel S.; Edo, Mesay G.; Maru, Endalkachew H.; Zewde, Wuletaw C.; Naylor, Lydia K.; Semane, Dejene F.; Dresse, Menayit T.; Tezera, Bereket B.] St Pauls Hosp, Millennium COVID 19 Care Ctr, Millennium Med Coll, Addis Ababa, Ethiopia; [Ayele, Birhanu T.] Stellenbosch Univ, Fac Med & Hlth Sci, Div Epidemiol & Biostat, Cape Town, South Africa	Stellenbosch University	Leulseged, TW (corresponding author), St Pauls Hosp, Millennium COVID 19 Care Ctr, Millennium Med Coll, Addis Ababa, Ethiopia.	tigdolly@gmail.com		Leulseged, Tigist/0000-0002-5767-1417				Ahmed M., 2020, AUSTIN HEPATOL, V5, P1; [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; Bertolini A, 2020, HEPATOLOGY, V72, P1864, DOI 10.1002/hep.31480; Bi XJ, 2020, PLATELETS, V31, P674, DOI 10.1080/09537104.2020.1760230; Cai QX, 2020, J HEPATOL, V73, P566, DOI 10.1016/j.jhep.2020.04.006; Chen D, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.11122; Du RH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00524-2020; Ethiopian Federal Ministry of Health, 2020, COVID19 MANAGEMENT H; Ethiopian Federal Ministry of Health, 2020, NATL COVID 19 DAILY; Guan G W, 2020, Zhonghua Gan Zang Bing Za Zhi, V28, P100, DOI 10.3760/cma.j.issn.1007-3418.2020.02.002; Gupta S, 2020, JAMA INTERN MED, V180, P1436, DOI 10.1001/jamainternmed.2020.3596; Kumar A, 2020, DIABETES METAB SYND, V14, P1951, DOI 10.1016/j.dsx.2020.10.001; Lenti MV, 2020, INTERN EMERG MED, V15, P1399, DOI 10.1007/s11739-020-02425-w; Leulseged T.W., 2020, MEDRXIV; Leulseged TW., 2020, MEDRXIV 202010092020; Leulseged TW., MEDRXIV 202010092020; Li X, 2020, CRIT CARE, V24, P647, DOI [DOI 10.1186/S13054-020-03374-8, 10.1186/s13054-020-03374-8]; Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006; Li YL, 2020, LAB INVEST, V100, P794, DOI 10.1038/s41374-020-0431-6; Lippi G, 2020, ANN CLIN BIOCHEM, V57, P262, DOI 10.1177/0004563220922255; Liu F, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104370; Liu JY, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02374-0; Nalbant A, 2020, REV ASSOC MED BRAS, V66, P746, DOI 10.1590/1806-9282.66.6.746; Saini RK, 2022, POSTGRAD MED J, V98, P91, DOI 10.1136/postgradmedj-2020-138930; Shi S, 2021, J CLIN LAB ANAL, V35, DOI 10.1002/jcla.23598; Tan CC, 2020, J MED VIROL, V92, P856, DOI 10.1002/jmv.25871; Tezcan ME, 2020, NEW MICROB NEW INFEC, V37, DOI 10.1016/j.nmni.2020.100753; Wang SJ, 2021, J INFECTION, V82, pE16, DOI 10.1016/j.jinf.2020.09.022; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Yang Y, 2020, J ALLERGY CLIN IMMUN, V146, P119, DOI 10.1016/j.jaci.2020.04.027; Zheng YFF, 2020, CLIN CHEM LAB MED, V58, P1106, DOI 10.1515/cclm-2020-0377	31	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0246087	10.1371/journal.pone.0246087	http://dx.doi.org/10.1371/journal.pone.0246087			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720944	gold, Green Published, Green Submitted			2022-12-26	WOS:000629667400042
J	Shavit-Stein, E; Mindel, E; Gofrit, SG; Chapman, J; Maggio, N				Shavit-Stein, Efrat; Mindel, Ekaterina; Gofrit, Shany Guly; Chapman, Joab; Maggio, Nicola			Ischemic stroke in PAR1 KO mice: Decreased brain plasmin and thrombin activity along with decreased infarct volume	PLOS ONE			English	Article								Background Ischemic stroke is a common and debilitating disease with limited treatment options. Protease activated receptor 1 (PAR1) is a fundamental cell signaling mediator in the central nervous system (CNS). It can be activated by many proteases including thrombin and plasmin, with various down-stream effects, following brain ischemia. Methods A permanent middle cerebral artery occlusion (PMCAo) model was used in PAR1 KO and WT C57BL/6J male mice. Mice were evaluated for neurological deficits (neurological severity score, NSS), infarct volume (Tetrazolium Chloride, TTC), and for plasmin and thrombin activity in brain slices. Results Significantly low levels of plasmin and thrombin activities were found in PAR1 KO compared to WT (1.6 +/- 0.4 vs. 3.2 +/- 0.6 ng/mu l, p<0.05 and 17.2 +/- 1.0 vs. 21.2 +/- 1.0 mu/ml, p<0.01, respectively) along with a decreased infarct volume (178.9 +/- 14.3, 134.4 +/- 13.3 mm(3), p<0.05). Conclusions PAR1 KO mice have smaller infarcts, with lower thrombin and plasmin activity levels. These findings may suggest that modulation of PAR1 is a potential target for future pharmacological treatment of ischemic stroke.	[Shavit-Stein, Efrat; Mindel, Ekaterina; Chapman, Joab; Maggio, Nicola] Tel Aviv Univ, Sackler Fac Med, Dept Neurol, Tel Aviv, Israel; [Shavit-Stein, Efrat; Gofrit, Shany Guly; Chapman, Joab; Maggio, Nicola] Chaim Sheba Med Ctr, Dept Neurol, Ramat Gan, Israel; [Mindel, Ekaterina; Chapman, Joab] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Tel Aviv, Israel; [Chapman, Joab] Tel Aviv Univ, Sackler Fac Med, Robert & Martha Harden Chair Mental & Neurol Dis, Tel Aviv, Israel; [Maggio, Nicola] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Shavit-Stein, E (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Neurol, Tel Aviv, Israel.; Shavit-Stein, E (corresponding author), Chaim Sheba Med Ctr, Dept Neurol, Ramat Gan, Israel.	efrat.shavit.stein@gmail.com	Chapman, Joab/E-4598-2010	Chapman, Joab/0000-0002-2161-9764				Bao Xuhui, 2018, Cond Med, V1, P57; Basham ME, 2001, J NEUROCHEM, V77, P318, DOI 10.1046/j.1471-4159.2001.t01-1-00239.x; Bushi D, 2018, J NEUROSCI RES, V96, P1406, DOI 10.1002/jnr.24253; Bushi D, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00138; Bushi D, 2015, J NEUROCHEM, V135, P1140, DOI 10.1111/jnc.13372; Bushi D, 2013, J MOL NEUROSCI, V51, P844, DOI 10.1007/s12031-013-0072-y; Campbell BCV, 2015, LANCET NEUROL, V14, P846, DOI 10.1016/S1474-4422(15)00140-4; Chapman J, 2013, SEMIN THROMB HEMOST, V39, P876, DOI 10.1055/s-0033-1357482; Chen B, 2012, J NEUROSCI, V32, P7622, DOI 10.1523/JNEUROSCI.0369-12.2012; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Draxler DF, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00591; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Feigin VL, 2018, NEW ENGL J MED, V379, P2429, DOI 10.1056/NEJMoa1804492; Festoff BW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00059; Gofrit SG, 2019, NEURAL REGEN RES, V14, P2043, DOI 10.4103/1673-5374.262568; Guzik Amy, 2017, Continuum (Minneap Minn), V23, P15, DOI 10.1212/CON.0000000000000416; Junge CE, 2004, EXP NEUROL, V188, P94, DOI 10.1016/j.expneurol.2004.02.018; Junge CE, 2003, P NATL ACAD SCI USA, V100, P13019, DOI 10.1073/pnas.2235594100; KATO H, 1980, J BIOCHEM-TOKYO, V88, P183; Katzan IL, 2004, ARCH NEUROL-CHICAGO, V61, P346, DOI 10.1001/archneur.61.3.346; Krinke G.J., 2000, LAB RAT, P463; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Loew D, 2000, BIOCHEMISTRY-US, V39, P10812, DOI 10.1021/bi0003341; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Mannaioni G, 2008, J BIOL CHEM, V283, P20600, DOI 10.1074/jbc.M803015200; Masada T, 2000, BRAIN RES, V867, P173, DOI 10.1016/S0006-8993(00)02302-7; Mindel E, 2021, J NEUROSCI RES, V99, P966, DOI 10.1002/jnr.24764; Morrow DA, 2013, STROKE, V44, P691, DOI 10.1161/STROKEAHA.111.000433; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Niego B, 2012, BLOOD, V119, P4752, DOI 10.1182/blood-2011-07-369512; Peterson EA, 2003, J CELL SCI, V116, P2399, DOI 10.1242/jcs.00434; Pontecorvi P, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1657-3; Radulovic M, 2016, NEUROBIOL DIS, V93, P226, DOI 10.1016/j.nbd.2016.04.010; Rajput PS, 2014, NEUROSCIENCE, V281, P229, DOI 10.1016/j.neuroscience.2014.09.038; Sheehan JJ, 2007, J NEUROSCI, V27, P1738, DOI 10.1523/JNEUROSCI.4987-06.2007; Siao CJ, 2002, J NEUROSCI, V22, P3352; Stein ES, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/7692182; Stein ES, 2015, SCI REP-UK, V5, DOI 10.1038/srep07912; Suo ZM, 2002, J NEUROCHEM, V80, P655, DOI 10.1046/j.0022-3042.2001.00745.x; Wang JH, 2012, STROKE, V43, P2476, DOI 10.1161/STROKEAHA.112.661819; Wu L, 2014, BRAIN RES BULL, V101, P12, DOI 10.1016/j.brainresbull.2013.12.003; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; Zhang F., 2012, ANIMAL MODELS ACUTE, V9, P93, DOI [10.1007/978-1-61779-782-8_9, DOI 10.1007/978-1-61779-782-8_9]	43	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0248431	10.1371/journal.pone.0248431	http://dx.doi.org/10.1371/journal.pone.0248431			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720950	gold, Green Published			2022-12-26	WOS:000629667400005
J	Kumar, P; Sharma, D; Verma, SK; Halterman, D; Kumar, A				Kumar, Pankaj; Sharma, Dixit; Verma, Shailender Kumar; Halterman, Dennis; Kumar, Arun			Genome-wide identification and expression profiling of basic leucine zipper transcription factors following abiotic stresses in potato (Solanum tuberosum L.)	PLOS ONE			English	Article							FACTOR FAMILY; FUNCTIONAL-ANALYSIS; RESPONSIVE GENES; BZIP; TOLERANCE; DROUGHT; PROTEINS; PLANTS; DNA; EVOLUTIONARY	Potato (Solanum tuberosum L.) is an important food crop that is grown and consumed worldwide. The growth and productivity of this crop are severely affected by various abiotic stresses. Basic leucine zipper (bZIP) transcription factors (TFs) in plants are well known for their function during growth and development. However, systematic and in-depth identification and functional characterization of the bZIP gene family of potato is lacking. In the current study, we identified a total of 90 bZIPs (StbZIP) distributed on 12 linkage groups of potato. Based on the previous functional annotation and classification of bZIPs in Arabidopsis, wheat, and rice, a phylogenetic tree of potato bZIPs was constructed and genes were categorized into various functional groups (A to I, S, and U) as previously annotated in Arabidopsis thaliana. Analyses of the transcript sequence (RNA-seq) data led to identifying a total of 18 candidate StbZIPs [four in roots, eight in the tuber, six in mesocarp and endocarp] that were expressed in a tissue-specific manner. Differential expression analysis under the various abiotic conditions (salt, mannitol, water, and heat stress) and treatment with phytohormones (ABA, GA, IAA, and BAP) led to the identification of forty-two [thirteen under salt stress, two under mannitol stress, ten under water stress, and eighteen under heat stress], and eleven [eight and three StbZIPs upon treatment with ABA, and IAA, respectively] candidate StbZIPs, respectively. Using sequence information of candidate StbZIPs, a total of 22 SSR markers were also identified in this study. In conclusion, the genome-wide identification analysis coupled with RNA-Seq expression data led to identifying candidate StbZIPs, which are dysregulated, and may play a pivotal role under various abiotic stress conditions. This study will pave the way for future functional studies using forward and reverse genetics to improve abiotic stress tolerance in potato.	[Kumar, Pankaj] Punjab Agr Univ, Sch Agr Biotechnol, Ludhiana, Punjab, India; [Kumar, Pankaj; Kumar, Arun] CSIR Inst Himalayan Bioresource Technol, Biotechnol Div, Palampur, Himachal Prades, India; [Sharma, Dixit; Verma, Shailender Kumar] Cent Univ Himachal Pradesh, Ctr Computat Biol & Bioinformat, Sch Life Sci, Kangra, Himachal Prades, India; [Halterman, Dennis] USDA ARS, Madison, WI USA; [Kumar, Arun] Acad Sci & Innovat Res, Ghaziabad, Uttar Pradesh, India	Punjab Agricultural University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT); Central University of Himachal Pradesh; United States Department of Agriculture (USDA); Academy of Scientific & Innovative Research (AcSIR)	Kumar, A (corresponding author), CSIR Inst Himalayan Bioresource Technol, Biotechnol Div, Palampur, Himachal Prades, India.; Kumar, A (corresponding author), Acad Sci & Innovat Res, Ghaziabad, Uttar Pradesh, India.	arunkumar@ihbt.res.in	Kumar, Pankaj/AAQ-8181-2021; Sharma, Dixit/D-5463-2018; Verma, Shailender/K-3457-2016	Kumar, Pankaj/0000-0002-2275-9144; Kumar, Pankaj/0000-0002-6022-2962; Sharma, Dixit/0000-0002-9911-9364; Kumar, Arun/0000-0002-0106-2735; Verma, Shailender/0000-0002-4192-933X				Ajithkumar IP, 2014, CELL BIOCHEM BIOPHYS, V68, P587, DOI 10.1007/s12013-013-9746-x; Alves MS, 2013, INT J MOL SCI, V14, P7815, DOI 10.3390/ijms14047815; Assuncao AGL, 2010, P NATL ACAD SCI USA, V107, P10296, DOI 10.1073/pnas.1004788107; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Banerjee A, 2017, PROTOPLASMA, V254, P3, DOI 10.1007/s00709-015-0920-4; Chae MJ, 2007, PLANT MOL BIOL, V63, P151, DOI 10.1007/s11103-006-9079-x; Chakraborty M, 2019, PLANT J, V99, P1080, DOI 10.1111/tpj.14381; Chattopadhyay S, 1998, PLANT CELL, V10, P673, DOI 10.1105/tpc.10.5.673; Davies P. J., 1987, Plant hormones and their role in plant growth and development., P1; Devaux A, 2014, POTATO RES, V57, P185, DOI 10.1007/s11540-014-9265-1; EWING EE, 1981, AM POTATO J, V58, P31, DOI 10.1007/BF02855378; FELDBRUGGE M, 1994, PLANT CELL, V6, P1607, DOI 10.1105/tpc.6.11.1607; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gai WX, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00139; Gibson SI, 2004, J EXP BOT, V55, P253, DOI 10.1093/jxb/erh048; Gong L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128041; Correa LGG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002944; Guilfoyle TJ, 2015, PLANT CELL, V27, P33, DOI 10.1105/tpc.114.132753; Gupta P. K., 2012, Plant Breeding Reviews, V36, P85; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Hauser F, 2011, CURR BIOL, V21, pR346, DOI 10.1016/j.cub.2011.03.015; He ZL, 2016, NUCLEIC ACIDS RES, V44, pW236, DOI 10.1093/nar/gkw370; Henriquez-Valencia C, 2015, J CELL BIOCHEM, V116, P1638, DOI 10.1002/jcb.25121; Hirsch CD, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.12.0042; Hsieh TH, 2010, PLANTA, V231, P1459, DOI 10.1007/s00425-010-1147-4; Hwang I, 2014, GENOMICS, V104, P194, DOI 10.1016/j.ygeno.2014.07.008; Iven T, 2010, PLANT J, V63, P155, DOI 10.1111/j.1365-313X.2010.04230.x; Jain P., 2017, SCI REP-UK, V7, P1; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Joshi R, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01029; Kolachevskaya OO, 2019, PLANT CELL REP, V38, P681, DOI 10.1007/s00299-019-02395-0; Kolachevskaya OO, 2017, PLANT CELL REP, V36, P419, DOI 10.1007/s00299-016-2091-y; Kumar A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00387; Kumar P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35366-8; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lambrecht M, 2000, TRENDS MICROBIOL, V8, P298, DOI 10.1016/S0966-842X(00)01732-7; Liang CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep23657; Liu CT, 2012, PLANTA, V235, P1157, DOI 10.1007/s00425-011-1564-z; Massa AN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026801; Mazzucotelli E, 2008, PLANT SCI, V174, P420, DOI 10.1016/j.plantsci.2008.02.005; Garcia MNM, 2012, PLANTA, V235, P761, DOI 10.1007/s00425-011-1540-7; Nakashima K, 2006, PLANT MOL BIOL, V60, P51, DOI 10.1007/s11103-005-2418-5; Nijhawan A, 2008, PLANT PHYSIOL, V146, P333, DOI 10.1104/pp.107.112821; Noctor G, 2018, SEMIN CELL DEV BIOL, V80, P3, DOI 10.1016/j.semcdb.2017.07.013; Orellana S, 2010, PLANT CELL ENVIRON, V33, P2191, DOI 10.1111/j.1365-3040.2010.02220.x; Park JE, 2007, J BIOL CHEM, V282, P10036, DOI 10.1074/jbc.M610524200; Peivastegan B, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1875-y; Pieterse CM, 2004, CURR OPIN PLANT BIOL, V7, P456, DOI 10.1016/j.pbi.2004.05.006; Pourabed E, 2015, MOL BIOTECHNOL, V57, P12, DOI 10.1007/s12033-014-9797-2; Rahman MM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00155; Sarkar D, 2010, PLANT GROWTH REGUL, V62, P117, DOI 10.1007/s10725-010-9502-9; Schutze K, 2008, TRENDS PLANT SCI, V13, P247, DOI 10.1016/j.tplants.2008.03.002; Shaikhali J, 2012, J BIOL CHEM, V287, P27510, DOI 10.1074/jbc.M112.361394; Shan JW, 2013, GENOMICS, V102, P388, DOI 10.1016/j.ygeno.2013.07.001; Sharma H, 2020, GENE, V756, DOI 10.1016/j.gene.2020.144912; Siberil Y, 2001, EUR J BIOCHEM, V268, P5655, DOI 10.1046/j.0014-2956.2001.02552.x; Thompson AL, 2008, AM J POTATO RES, V85, P375, DOI 10.1007/s12230-008-9034-2; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Wang JZ, 2011, J INTEGR PLANT BIOL, V53, P212, DOI 10.1111/j.1744-7909.2010.01017.x; Wang ZH, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5434-6; Wei KF, 2012, DNA RES, V19, P463, DOI 10.1093/dnares/dss026; Xiang CB, 1997, PLANT MOL BIOL, V34, P403, DOI 10.1023/A:1005873500238; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Yanez M, 2009, PLANT CELL REP, V28, P1497, DOI 10.1007/s00299-009-0749-4; Yang ZM, 2019, BMC GENET, V20, DOI 10.1186/s12863-019-0743-y; Yu SM, 2015, TRENDS PLANT SCI, V20, P844, DOI 10.1016/j.tplants.2015.10.009; Zhang H, 2018, NAT PLANTS, V4, P989, DOI 10.1038/s41477-018-0309-4; Zhang M, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4511-6; Zhang ZS, 2015, BIOCHEM SYST ECOL, V61, P218, DOI 10.1016/j.bse.2015.06.025; Zhao P, 2020, INT J BIOL MACROMOL, V161, P155, DOI 10.1016/j.ijbiomac.2020.06.032; Zhu F, 2020, FOOD BIOSCI, V33, DOI 10.1016/j.fbio.2019.100488	73	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0247864	10.1371/journal.pone.0247864	http://dx.doi.org/10.1371/journal.pone.0247864			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711039	gold, Green Published			2022-12-26	WOS:000629591800010
J	Mihara, K; Matsuda, S; Nakamura, Y; Aiura, K; Kuwahata, A; Chikaki, S; Sekino, M; Kusakabe, M; Suzuki, S; Fuchimoto, D; Onishi, A; Kuramoto, J; Kameyama, K; Itano, O; Yagi, H; Abe, Y; Kitago, M; Shinoda, M; Kitagawa, Y; Xu, B				Mihara, Kisyo; Matsuda, Sachiko; Nakamura, Yuki; Aiura, Koichi; Kuwahata, Akihiro; Chikaki, Shinichi; Sekino, Masaki; Kusakabe, Moriaki; Suzuki, Shunichi; Fuchimoto, Daiichiro; Onishi, Akira; Kuramoto, Junko; Kameyama, Kaori; Itano, Osamu; Yagi, Hiroshi; Abe, Yuta; Kitago, Minoru; Shinoda, Masahiro; Kitagawa, Yuko; Xu, Bing			Intraoperative laparoscopic detection of sentinel lymph nodes with indocyanine green and superparamagnetic iron oxide in a swine gallbladder cancer model	PLOS ONE			English	Article								Mapping of sentinel lymph nodes (SLNs) can enable less invasive surgery. However, mapping is challenging for cancers of difficult-to-access visceral organs, such as the gallbladder, because the standard method using radioisotopes (RIs) requires preoperative tracer injection. Indocyanine green (ICG) and superparamagnetic iron oxide (SPIO) have also been used as alternative tracers. In this study, we modified a previously reported magnetic probe for laparoscopic use and evaluated the feasibility of detecting SLNs of the gallbladder using a laparoscopic dual tracer method by injecting ICG and SPIO into five swine and one cancer-bearing swine. The laparoscopic probe identified SPIO nanoparticles in the nodes of 4/5 swine in situ, the magnetic field counts were 2.5-15.9 mu T, and fluorescence was detected in SLNs in all five swine. ICG showed a visual lymph flow map, and SPIO more accurately identified each SLN with a measurable magnetic field quite similar to the RI. We then developed an advanced gallbladder cancer model with lymph node metastasis using recombination activating gene 2-knockout swine. We identified an SLN in the laparoscopic investigation, and the magnetic field count was 3.5 mu T. The SLN was histologically determined to be one of the two metastatic lymph nodes. In conclusion, detecting the SLNs of gallbladder cancer in situ using a dual tracer laparoscopic technique with ICG and SPIO was feasible in a swine model.	[Mihara, Kisyo; Aiura, Koichi] Kawasaki Municipal Kawasaki Hosp, Dept Surg, Kawasaki Ku, Kawasaki, Kanagawa, Japan; [Mihara, Kisyo; Matsuda, Sachiko; Nakamura, Yuki; Yagi, Hiroshi; Abe, Yuta; Kitago, Minoru; Shinoda, Masahiro; Kitagawa, Yuko] Keio Univ, Dept Surg, Sch Med, Shinjuku Ku, Tokyo, Japan; [Kuwahata, Akihiro; Chikaki, Shinichi; Sekino, Masaki] Univ Tokyo, Grad Sch Engn, Bunkyo Ku, Tokyo, Japan; [Kusakabe, Moriaki] Univ Tokyo, Res Ctr Food Safety, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Kusakabe, Moriaki] Matrix Cell Res Inst Inc, Ushi Ku, Ibaraki, Japan; [Suzuki, Shunichi; Fuchimoto, Daiichiro] Natl Agr & Food Res Org NARO, Div Anim Sci, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Onishi, Akira] Nihon Univ, Coll Bioresource Sci, Dept Anim Sci & Resources, Lab Anim Reprod, Fujisawa, Kanagawa, Japan; [Kuramoto, Junko] Keio Univ, Dept Pathol, Sch Med, Shinjuku Ku, Tokyo, Japan; [Kameyama, Kaori] Keio Univ Hosp, Dept Diagnost Pathol, Shinjuku Ku, Tokyo, Japan; [Itano, Osamu] Int Univ Hlth & Welf, Dept Gastrointestinal Surg, Chiba, Japan	Keio University; University of Tokyo; University of Tokyo; National Agriculture & Food Research Organization - Japan; Nihon University; Keio University; Keio University; International University of Health & Welfare	Matsuda, S (corresponding author), Keio Univ, Dept Surg, Sch Med, Shinjuku Ku, Tokyo, Japan.	matsuda-sa@umin.ac.jp		Matsuda, Sachiko/0000-0003-4797-1149	Project for Medical Device Development from the Japan Agency for Medical Research and Development (AMED) [JP18he0902010h0004]	Project for Medical Device Development from the Japan Agency for Medical Research and Development (AMED)	This study was supported by the Project for Medical Device Development from the Japan Agency for Medical Research and Development (AMED) (Grant Number JP18he0902010h0004 to YK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anninga B, 2016, ANN SURG ONCOL, V23, P2070, DOI 10.1245/s10434-016-5113-7; Birnbaum DJ, 2015, ANN SURG ONCOL, V22, P811, DOI 10.1245/s10434-014-4044-4; Chen DX, 2009, J APPL PHYS, V106, DOI 10.1063/1.3211307; Cousins A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10842; Currie AC, 2017, EJSO-EUR J SURG ONC, V43, P2044, DOI 10.1016/j.ejso.2017.05.026; Douek M, 2014, ANN SURG ONCOL, V21, P1237, DOI 10.1245/s10434-013-3379-6; Feng JW, 2019, J SURG RES, V234, P269, DOI 10.1016/j.jss.2018.09.025; Gasparri ML, 2019, J CANCER RES CLIN, V145, P213, DOI 10.1007/s00432-018-2792-4; GIULIANO AE, 1994, ANN SURG, V220, P391, DOI 10.1097/00000658-199409000-00015; He MF, 2018, J SURG ONCOL, V118, P1243, DOI 10.1002/jso.25285; Johnson L, 2013, HISTOPATHOLOGY, V62, P481, DOI 10.1111/his.12019; Karo H, 2017, AIP ADV, V7, DOI 10.1063/1.4975655; Kitagawa Y, 2013, J CLIN ONCOL, V31, P3704, DOI 10.1200/JCO.2013.50.3789; Kurihara T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44171-w; Kuwahata A, 2018, AIP ADV, V8, DOI 10.1063/1.5006668; Lee SE, 2014, ANN SURG ONCOL, V21, P3654, DOI 10.1245/s10434-014-3527-7; Lee SE, 2011, WORLD J GASTROENTERO, V17, P174, DOI 10.3748/wjg.v17.i2.174; Liberale G, 2018, EJSO-EUR J SURG ONC, V44, P1301, DOI 10.1016/j.ejso.2018.05.034; Miyazaki M, 2015, J HEPATO-BIL-PAN SCI, V22, P181, DOI 10.1002/jhbp.211; Mok CW, 2019, BJS OPEN, V3, P445, DOI 10.1002/bjs5.50157; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; Pouw JJ, 2015, INT J NANOMED, V10, DOI 10.2147/IJN.S76962; Reimer P, 2003, EUR RADIOL, V13, P1266, DOI 10.1007/s00330-002-1721-7; Schneebaum S, 1998, EUR J SURG ONCOL, V24, P515, DOI 10.1016/S0748-7983(98)93392-3; Sekino M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19480-1; Suzuki S, 2016, VET IMMUNOL IMMUNOP, V178, P37, DOI 10.1016/j.vetimm.2016.06.011; Tajima Y, 2010, ANN SURG ONCOL, V17, P1787, DOI 10.1245/s10434-010-0944-0; Takeuchi H, 2019, ANN GASTROENT SURG, V3, P7, DOI 10.1002/ags3.12206; Taruno K, 2019, J SURG ONCOL, V120, P1391, DOI 10.1002/jso.25747; Tsioulias GJ, 2000, ARCH SURG-CHICAGO, V135, P926, DOI 10.1001/archsurg.135.8.926; Vidal-Sicart S, 2019, INT J COMPUT ASS RAD, V14, P409, DOI 10.1007/s11548-018-1816-5; Visscher M, 2014, J MAGN MAGN MATER, V365, P31, DOI 10.1016/j.jmmm.2014.04.044; Waanders S, 2016, PHYS MED BIOL, V61, DOI 10.1088/0031-9155/61/22/8120; Wang YXJ, 2017, QUANT IMAG MED SURG, V7, P88, DOI 10.21037/qims.2017.02.09; Xu W, 2015, GUT LIVER, V9, P353, DOI 10.5009/gnl13419	35	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248531	10.1371/journal.pone.0248531	http://dx.doi.org/10.1371/journal.pone.0248531			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705492	Green Published, gold			2022-12-26	WOS:000629590400032
J	Saegerman, C; Gilbert, A; Donneau, AF; Gangolf, M; Diep, AN; Meex, C; Bontems, S; Hayette, MP; D'Orio, V; Ghuysen, A				Saegerman, Claude; Gilbert, Allison; Donneau, Anne-Francoise; Gangolf, Marjorie; Anh Nguvet Diep; Meex, Cecile; Bontems, Sebastien; Hayette, Marie-Pierre; D'Orio, Vincent; Ghuysen, Alexandre			Clinical decision support tool for diagnosis of COVID-19 in hospitals	PLOS ONE			English	Article							CLASSIFICATION; SARS-COV-2; DISEASE	Background The coronavirus infectious disease 19 (COVID-19) pandemic has resulted in significant morbidities, severe acute respiratory failures and subsequently emergency departments' (EDs) overcrowding in a context of insufficient laboratory testing capacities. The development of decision support tools for real-time clinical diagnosis of COVID-19 is of prime importance to assist patients' triage and allocate resources for patients at risk. Methods and principal findings From March 2 to June 15, 2020, clinical patterns of COVID-19 suspected patients at admission to the EDs of Liege University Hospital, consisting in the recording of eleven symptoms (i.e. dyspnoea, chest pain, rhinorrhoea, sore throat, dry cough, wet cough, diarrhoea, headache, myalgia, fever and anosmia) plus age and gender, were investigated during the first COVID-19 pandemic wave. Indeed, 573 SARS-CoV-2 cases confirmed by qRT-PCR before mid-June 2020, and 1579 suspected cases that were subsequently determined to be qRT-PCR negative for the detection of SARS-CoV-2 were enrolled in this study. Using multivariate binary logistic regression, two most relevant symptoms of COVID-19 were identified in addition of the age of the patient, i.e. fever (odds ratio [OR] = 3.66; 95% CI: 2.97-4.50), dry cough (OR = 1.71; 95% CI: 1.39-2.12), and patients older than 56.5 y (OR = 2.07; 95% CI: 1.67-2.58). Two additional symptoms (chest pain and sore throat) appeared significantly less associated to the confirmed COVID-19 cases with the same OR = 0.73 (95% CI: 0.56-0.94). An overall pondered (by OR) score (OPS) was calculated using all significant predictors. A receiver operating characteristic (ROC) curve was generated and the area under the ROC curve was 0.71 (95% CI: 0.68-0.73) rendering the use of the OPS to discriminate COVID-19 confirmed and unconfirmed patients. The main predictors were confirmed using both sensitivity analysis and classification tree analysis. Interestingly, a significant negative correlation was observed between the OPS and the cycle threshold (Ct values) of the qRT-PCR. Conclusion and main significance The proposed approach allows for the use of an interactive and adaptive clinical decision support tool. Using the clinical algorithm developed, a web-based user-interface was created to help nurses and clinicians from EDs with the triage of patients during the second COVID-19 wave.	[Saegerman, Claude] Univ Liege, Fundamental & Appl Res Anim & Hlth FARAH Ctr, Liege, Belgium; [Gilbert, Allison; D'Orio, Vincent; Ghuysen, Alexandre] Univ Hosp Ctr Liege, Emergency Dept, Liege, Belgium; [Donneau, Anne-Francoise; Anh Nguvet Diep] Univ Liege, Biostat Unit, Liege, Belgium; [Donneau, Anne-Francoise; Anh Nguvet Diep] Univ Liege, Publ Hlth Dept, Liege, Belgium; [Gangolf, Marjorie] Univ Hosp Ctr Liege, Dept Medicoecon Informat, Liege, Belgium; [Meex, Cecile; Bontems, Sebastien; Hayette, Marie-Pierre] Univ Hosp Liege, Ctr Interdisciplinary Res Med CIRM, Lab Clin Microbiol, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege; University of Liege; University of Liege	Saegerman, C (corresponding author), Univ Liege, Fundamental & Appl Res Anim & Hlth FARAH Ctr, Liege, Belgium.; Ghuysen, A (corresponding author), Univ Hosp Ctr Liege, Emergency Dept, Liege, Belgium.	claude.saegerman@uliege.be; A.Ghuysen@chuliege.be	Gilbert, Allison/AAV-9595-2021	Gilbert, Allison/0000-0003-1492-7424; Saegerman, Claude/0000-0001-9087-7436; Diep, Anh Nguyet/0000-0001-5134-3220	Liege University Hospital	Liege University Hospital(University of Liege)	This study was funded by the Liege University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, SCIENSANO; Artesi M, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01598-20; Breiman I., 1984, CLASSIFICATION REGRE; Burke RM, 2020, MMWR-MORBID MORTAL W, V69, P245, DOI 10.15585/mmwr.mm6909e1; Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; Chung NC, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3118-5; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Federation of European Heating Ventilation and Air Conditioning Associations, 2020, COVID 19 GUID; Gilbert A, 2022, ACTA CLIN BELG, V77, P30, DOI 10.1080/17843286.2020.1778348; Giri B, 2021, ANAL BIOANAL CHEM, V413, P35, DOI 10.1007/s00216-020-02889-x; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hausmann JS, 2018, J GEN INTERN MED, V33, P2046, DOI 10.1007/s11606-018-4610-8; Iaccarino G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237297; Ibrahim OR, 2020, AM J TROP MED HYG, V103, P2376, DOI 10.4269/ajtmh.20-0759; ISARIC International Severe Acute Respiratory and Emerging Infections Consortium, 2020, COVID 19 REPORT 19 M; Iserson KV, 2007, ANN EMERG MED, V49, P275, DOI 10.1016/j.annemergmed.2006.05.019; Lechien JR, 2020, J INTERN MED, V288, P335, DOI 10.1111/joim.13089; McRae MP, 2020, J MED INTERNET RES, V22, DOI 10.2196/22033; Mei S, 2020, Lancet Infect Dis, V20, P911; Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2; Nations United., 1982, STESASTATSEAM74 NAT; Petrie A., 2013, STAT VET ANIMAL SCI; Porter RS, 2011, TRANSBOUND EMERG DIS, V58, P197, DOI 10.1111/j.1865-1682.2010.01196.x; Preux PM, 2005, REV MAL RESPIR, V22, P159, DOI 10.1016/S0761-8425(05)85450-6; Saegerman C, 2015, TRANSBOUND EMERG DIS, V62, P46, DOI 10.1111/tbed.12070; Saegerman C, 2004, J CLIN MICROBIOL, V42, P172, DOI 10.1128/JCM.42.1.172-178.2004; Saegerman C, 2011, REV SCI TECH OIE, V30, P555; Saegerman C, 2021, TRANSBOUND EMERG DIS, V68, P626, DOI 10.1111/tbed.13724; Saegerman C, 2012, VET CLIN N AM-FOOD A, V28, P121, DOI 10.1016/j.cvfa.2012.01.001; Speybroeck N, 2004, AGR SYST, V80, P133, DOI 10.1016/j.agsy.2003.06.006; Steinberg D., 1997, CART CLASSIFICATION; Struyf T, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013665; Sun YXH, 2020, CLIN INFECT DIS, V71, P786, DOI 10.1093/cid/ciaa322; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Ueyama Hiroki, 2020, Crit Care Explor, V2, pe0148, DOI 10.1097/CCE.0000000000000148; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786; Wu YJ, 2020, LANCET GASTROENTEROL, V5, P434, DOI 10.1016/S2468-1253(20)30083-2; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328; Zanella G, 2013, TRANSBOUND EMERG DIS, V60, P231, DOI 10.1111/j.1865-1682.2012.01334.x; Zhang RY, 2020, P NATL ACAD SCI USA, V117, P14857, DOI 10.1073/pnas.2009637117	44	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0247773	10.1371/journal.pone.0247773	http://dx.doi.org/10.1371/journal.pone.0247773			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705435	Green Published, gold			2022-12-26	WOS:000629590400094
J	Vaz, E; Cusimano, MD; Bacao, F; Damasio, B; Penfound, E				Vaz, Eric; Cusimano, Michael D.; Bacao, Fernando; Damasio, Bruno; Penfound, Elissa			Open data and injuries in urban areas-A spatial analytical framework of Toronto using machine learning and spatial regressions	PLOS ONE			English	Article							UNINTENTIONAL INJURIES; PEDESTRIAN INJURY; CHILD; RISK; TRAUMA; HEALTH; LEVEL; EPIDEMIOLOGY; ASSOCIATION; EXPLORATION	Injuries have become devastating and often under-recognized public health concerns. In Canada, injuries are the leading cause of potential years of life lost before the age of 65. The geographical patterns of injury, however, are evident both over space and time, suggesting the possibility of spatial optimization of policies at the neighborhood scale to mitigate injury risk, foster prevention, and control within metropolitan regions. In this paper, Canada's National Ambulatory Care Reporting System is used to assess unintentional and intentional injuries for Toronto between 2004 and 2010, exploring the spatial relations of injury throughout the city, together with Wellbeing Toronto data. Corroborating with these findings, spatial autocorrelations at global and local levels are performed for the reported over 1.7 million injuries. The sub-categorization for Toronto's neighborhood further distills the most vulnerable communities throughout the city, registering a robust spatial profile throughout. Individual neighborhoods pave the need for distinct policy profiles for injury prevention. This brings one of the main novelties of this contribution. A comparison of the three regression models is carried out. The findings suggest that the performance of spatial regression models is significantly stronger, showing evidence that spatial regressions should be used for injury research. Wellbeing Toronto data performs reasonably well in assessing unintentional injuries, morbidity, and falls. Less so to understand the dynamics of intentional injuries. The results enable a framework to allow tailor-made injury prevention initiatives at the neighborhood level as a vital source for planning and participatory decision making in the medical field in developed cities such as Toronto.	[Vaz, Eric] Ryerson Univ, Dept Geog & Environm Studies, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Bacao, Fernando; Damasio, Bruno] Univ Nova Lisboa, NOVA IMS Informat Management Sch, Lisbon, Portugal; [Penfound, Elissa] Ryerson Univ, Yeates Sch Grad Studies, Toronto, ON, Canada	Toronto Metropolitan University; University of Toronto; Universidade Nova de Lisboa	Damasio, B (corresponding author), Univ Nova Lisboa, NOVA IMS Informat Management Sch, Lisbon, Portugal.	bdamasio@novaims.unl.pt	Cusimano, Michael/GWR-1025-2022; Bacao, Fernando/E-2912-2010	Bacao, Fernando/0000-0002-0834-0275; Damasio, Bruno/0000-0002-2289-3087	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research [TIR103946]	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research(Canadian Institutes of Health Research (CIHR))	This research is supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research #TIR103946.	Anselin L, 2002, AGR ECON-BLACKWELL, V27, P247, DOI 10.1111/j.1574-0862.2002.tb00120.x; Ardalan A, 2014, INT J PREVENTIVE MED, V5, P241; BAMZAR R, 2014, GEOJOURNAL, P279; Barber K, 2019, J URBAN TECHNOL, V26, P107, DOI 10.1080/10630732.2018.1558573; Bilette J-M., 2011, STAT CANADA CATALOGU, P82; BRADDOCK M, 1994, AM J PUBLIC HEALTH, V84, P1158, DOI 10.2105/AJPH.84.7.1158; CIHI, 2003, NAT TRAUM REG 2003 R; Cohen DA, 2003, AM J PUBLIC HEALTH, V93, P467, DOI 10.2105/AJPH.93.3.467; Cubbin C, 2000, J EPIDEMIOL COMMUN H, V54, P517, DOI 10.1136/jech.54.7.517; Cusimano M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008669; Deal LW, 2000, FUTURE CHILD, V10, P4, DOI 10.2307/1602823; Ernst JS, 2000, CHILD WELFARE, V79, P555; Fabio A, 2009, AM J PUBLIC HEALTH, V99, P748, DOI 10.2105/AJPH.2008.139576; Faelker T, 2000, Inj Prev, V6, P203, DOI 10.1136/ip.6.3.203; FAGHRI A, 1995, J ADV TRANSPORT, V29, P321, DOI 10.1002/atr.5670290305; Falk H, 2011, AM J EPIDEMIOL, V174, pS65, DOI 10.1093/aje/kwr313; Fischer M. M., 2009, HDB APPL SPATIAL ANA; Gable S, 1998, J PEDIATR PSYCHOL, V23, P323, DOI 10.1093/jpepsy/23.5.323; Garbarini C, 1988, NURSING, P5; Gattrell A., 1998, GIS HLTH GISDATA; George M.A., 2016, SPRINGERPLUS, V5, P1; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Grise E, 2018, J TRANSP GEOGR, V66, P321, DOI 10.1016/j.jtrangeo.2017.10.003; HC, 2003, INJURY SURVEILLANCE; Keeves J, 2019, INJURY, V50, P1826, DOI 10.1016/j.injury.2019.07.013; Kivell P, 1999, HEALTH PLACE, V5, P99, DOI 10.1016/S1353-8292(98)00042-2; Kristiansen T, 2014, INJURY, V45, P23, DOI 10.1016/j.injury.2013.07.007; LaScala E A, 2001, Prev Sci, V2, P123, DOI 10.1023/A:1011547831475; Latkin C, 1998, DRUG ALCOHOL DEPEN, V50, P167, DOI 10.1016/S0376-8716(98)00025-8; Lightstone A S, 2001, Inj Prev, V7, P155, DOI 10.1136/ip.7.2.155; Link BG, 1996, AM J PUBLIC HEALTH, V86, P471, DOI 10.2105/AJPH.86.4.471; Logan R., 2010, OCCUPATIONAL INJURIE; Midford R, 1998, AUST NZ J PUBL HEAL, V22, P80, DOI 10.1111/j.1467-842X.1998.tb01149.x; Mitchell RJ, 2018, AUST J RURAL HEALTH, V26, P165, DOI 10.1111/ajr.12408; Morassaei S, 2013, ANN EPIDEMIOL, V23, P260, DOI 10.1016/j.annepidem.2013.03.008; Morency P, 2012, CAN J PUBLIC HEALTH, V103, P218, DOI 10.1007/BF03403816; Ng KS, 2002, J SAFETY RES, V33, P387, DOI 10.1016/S0022-4375(02)00033-6; NIH, 2007, FOG INT COLL TRAUM I; Pickett W, 2002, SOC SCI MED, V55, P1055, DOI 10.1016/S0277-9536(01)00224-6; Raatiniemi L, 2016, ACTA ANAESTH SCAND, V60, P668, DOI 10.1111/aas.12682; Ramsay LJ, 2003, PUBLIC HEALTH, V117, P404, DOI 10.1016/S0033-3506(03)00072-6; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Rockett Ian R H, 2012, Am J Public Health, V102, pe84, DOI 10.2105/AJPH.2012.300960; Rothman L, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2012-040701; Runyan CW, 2005, AM J PREV MED, V28, P73, DOI 10.1016/j.amepre.2004.09.010; Sherriff B, 2015, INT J INJ CONTROL SA, V22, P75, DOI 10.1080/17457300.2013.870580; SMITH GS, 1991, EPIDEMIOL REV, V13, P228, DOI 10.1093/oxfordjournals.epirev.a036070; Tracy M, 2014, SOC PSYCH PSYCH EPID, V49, P1769, DOI 10.1007/s00127-014-0884-2; Vaz E, 2015, J ENVIRON INFORM, V25, P71, DOI 10.3808/jei.201500299; Vaz E, 2017, J SPAT ORGAN DYN, V5, P37; Vaz E, 2016, HABITAT INT, V56, P52, DOI 10.1016/j.habitatint.2016.04.006; Vaz E, 2015, LAND USE POLICY, V46, P232, DOI 10.1016/j.landusepol.2015.02.014; Vaz E, 2013, LAND, V2, P595, DOI 10.3390/land2040595; Ward M.D., 2008, SPATIAL REGRESSION M; Welton RE, 2017, INTERN MED J, V47, P170, DOI 10.1111/imj.13297; Zavoski R W, 1999, Inj Prev, V5, P65; Zebib L, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4086-1; ZY M, HEALTH PROMOT CHRON, V39, P35, DOI DOI 10.24095/HPCDP.39.2.01	58	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248285	10.1371/journal.pone.0248285	http://dx.doi.org/10.1371/journal.pone.0248285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8JZ	33705490	Green Published, gold			2022-12-26	WOS:000629590400024
J	Dookeran, KA; Groh, JM; Ritacco, DG; Marcus, LR; Wang, Y; Khan, JY				Dookeran, Keith A.; Groh, James M.; Ritacco, David G.; Marcus, Lydia R.; Wang, Yang; Khan, Janine Y.			An assessment of prevalence and expenditure associated with discharge brain MRI in preterm infants	PLOS ONE			English	Article							NEURODEVELOPMENTAL OUTCOMES; UNITED-STATES; HEALTH-CARE; WASTE; COSTS	To assess national expenditure associated with preterm-infant brain MRI and potential impact of reduction per Choosing Wisely campaign 2015 recommendation to "avoid routine screening term-equivalent or discharge brain MRIs in preterm-infants". Cross-sectional U.S. trend data from the Agency for Healthcare Research and Quality (AHRQ), Healthcare Cost and Utilization Project (HCUP) Kids' Inpatient Database (KID) database (2006, 2009, 2012, 2016) was used to estimate overall national expenditure associated with brain MRI among infants with gestational age (GA) <= 36 weeks, and also when classified as 'not indicated' (NI-MRI) i.e., equivalent to routine use without clinical indications and regarded as low-value service (LVS). Associated cost was determined by querying CMS-database for physician-fee-schedules to find the highest global procedure-cost per cycle, then adjusting for inflation. Sensitivity-analyses were conducted to account for additional clinical charges associated with NI-MRI. 3,768 (0.26%) of 1,472,236 preterm-infants had brain MRI across all cycles (inflation-adjusted total $3,690,088). Overall proportion of brain MRIs increased across 2006-2012 from 0.25%-0.33% but decreased in 2016 to 0.16% (P<0.001). Inflation-adjusted overall expenditure by cycle was: 2006, $1,299,130 (95% CI: $987,505, $1,610,755); 2009, $1,194,208 (95% CI: $873,487, $1,516,154); 2012, $931,836 (95% CI: $666,114, $1,197,156); and 2016, $264,648 (95% CI: $172,061, $357,280). Prevalence for NI-MRI in 2006, 2009, 2012 and 2016 was 86% (n = 809), 88% (n = 940), 89% (n = 1028) and 50% (n = 299), respectively; and 70% were in infants 35-36 weeks GA. NI-MRI prevalence was not different over time by payer-type (Medicaid, private), sex or race/ethnicity (white, black, Hispanic); larger hospital size was significantly associated across 2006-2012 but this declined for all sizes in 2016, with most decline in larger hospitals (P for interaction <0.05). NI-MRI expenditure sensitivity-analysis with addition of cycle median total-admission-charge to inflation-adjusted CMS-fee was $1,190,919/$518,343, for 2012/2016 cycles respectively. National MRI prevalence in preterm infants (both overall and LVS) and associated expenditure decreased substantially post recommendation; however, annual savings are modest and unlikely to be >$1.2 million.	[Dookeran, Keith A.; Marcus, Lydia R.; Wang, Yang] Univ Wisconsin, Joseph J Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA; [Dookeran, Keith A.] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60607 USA; [Dookeran, Keith A.] Canc Fdn Minor & Underserved Populat, Chicago, IL 60614 USA; [Groh, James M.] Marion Cty Publ Hlth Dept, Epidemiol, Indianapolis, IN USA; [Ritacco, David G.] Northwestern Univ, Dept Pediat, Div Neurol, Ann & Robert H Lurie Childrens Hosp, Chicago, IL 60611 USA; [Khan, Janine Y.] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp, Dept Pediat, Div Neonatol, Chicago, IL 60611 USA; [Dookeran, Keith A.] Univ Wisconsin, Joseph J Zilber Sch Publ Hlth, Epidemiol, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; University of Wisconsin System; University of Wisconsin Milwaukee	Dookeran, KA (corresponding author), Univ Wisconsin, Joseph J Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA.; Dookeran, KA (corresponding author), Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60607 USA.; Dookeran, KA (corresponding author), Canc Fdn Minor & Underserved Populat, Chicago, IL 60614 USA.; Dookeran, KA (corresponding author), Univ Wisconsin, Joseph J Zilber Sch Publ Hlth, Epidemiol, Milwaukee, WI 53201 USA.	dookeran@uwm.edu	Dookeran, Keith Anthony/AAD-2885-2019	Dookeran, Keith Anthony/0000-0003-3695-9873				AHRQ, 2020, INTRO HCUP KIDSINPAT; AHRQ, 2020, NIS DESCRIPTION DATA; Anderson PJ, 2015, SEMIN PERINATOL, V39, P147, DOI 10.1053/j.semperi.2015.01.008; [Anonymous], ICD 9 900 DIAGNOSIS; [Anonymous], 2020, PHYS FEE SCHED SEARC; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Buchiboyina A, 2019, NEONATOLOGY, V115, P1, DOI 10.1159/000492419; Bui AL, 2017, JAMA PEDIATR, V171, P181, DOI 10.1001/jamapediatrics.2016.4086; CMS, 2020, NAT HLTH EXP DAT; CMS, 2020, USE SEARCHABLE MEDIC; CoinNews.net, 2020, US INFLATION CALCULA; Cuckler GA, 2018, HEALTH AFFAIR, V37, P482, DOI 10.1377/hlthaff.2017.1655; Cutler DM, 2011, J ECON PERSPECT, V25, P3, DOI 10.1257/jep.25.2.3; Edwards AD, 2018, ARCH DIS CHILD-FETAL, V103, pF15, DOI 10.1136/archdischild-2017-313102; El-Dib M, 2020, NEUROIMAGING PRETERM; Fisher PG, 2017, J PEDIATR-US, V184, P44, DOI 10.1016/j.jpeds.2017.06.029; HCUP, 2020, KID DESCRIPTION DATA; HCUP Kids' Inpatient Database (KID), **DATA OBJECT**; Ho T, 2018, J PEDIATR-US, V196, P330, DOI 10.1016/j.jpeds.2018.01.016; Ho T, 2015, PEDIATRICS, V136, pE482, DOI 10.1542/peds.2015-0737; Jha AK, 2009, HEALTH AFFAIR, V28, P897, DOI 10.1377/hlthaff.28.3.897; Kerr EA, 2017, HEALTH AFFAIR, V36, P2012, DOI 10.1377/hlthaff.2017.0953; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Malova M, 2017, ARCH DIS CHILD-FETAL, V102, pF73, DOI 10.1136/archdischild-2015-310333; Martin Joyce A, 2018, NCHS Data Brief, P1; Martin Joyce A, 2017, Natl Vital Stat Rep, V66, P1; Parikh NA, 2016, SEMIN PERINATOL, V40, P530, DOI 10.1053/j.semperi.2016.09.005; Shrank WH, 2019, JAMA-J AM MED ASSOC, V322, P1501, DOI 10.1001/jama.2019.13978; Smyser CD, 2012, J PAEDIATR CHILD H, V48, P794, DOI 10.1111/j.1440-1754.2012.02535.x; Statistics USBoL, 2019, CONS PRIC IND; Tolia VN, 2020, J PERINATOL, V40, P1389, DOI 10.1038/s41372-020-0667-4; Wolfson D, 2014, ACAD MED, V89, P990, DOI 10.1097/ACM.0000000000000270; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Woolhandler S, 2003, NEW ENGL J MED, V349, P768, DOI 10.1056/NEJMsa022033	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0247857	10.1371/journal.pone.0247857	http://dx.doi.org/10.1371/journal.pone.0247857			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QT5CA	33667251	Green Published, gold			2022-12-26	WOS:000626604300051
J	Akbor, MM; Kurosawa, N; Nakayama, H; Nakatani, A; Tomobe, K; Chiba, Y; Ueno, M; Tanaka, M; Nomura, Y; Isobe, M				Akbor, Maruf Mohammad; Kurosawa, Nobuyuki; Nakayama, Hiroki; Nakatani, Ayumi; Tomobe, Koji; Chiba, Yoichi; Ueno, Masaki; Tanaka, Masashi; Nomura, Yasuyuki; Isobe, Masaharu			Polymorphic SERPINA3 prolongs oligomeric state of amyloid beta	PLOS ONE			English	Article								Molecular chaperon SERPINA3 colocalizes with accumulated amyloid peptide in Alzheimer's disease (AD) patient's brain. From the QTL analysis, we narrowed down Serpina3 with two SNPs in senescence-accelerated mouse prone (SAMP) 8 strain. Our study showed SAMP8 type Serpina3 prolonged retention of oligomeric A beta 42 for longer duration (72 hr) while observing under transmission electron microscope (TEM). From Western blot results, we confirmed presence of A beta 42 oligomeric forms (trimers, tetramers) were maintained for longer duration only in the presences of SAMP8 type Serpina3. Using SH-SY5Y neuroblastoma cell line, we observed until 36 hr preincubated A beta 42 with SAMP8 type Serpina3 caused neuronal cell death compared to 12 hr preincubated A beta 42 with SAMR1 or JF1 type Serpina3 proteins. Similar results were found by extending this study to analyze the effect of polymorphism of SERPINA3 gene of the Japanese SNP database for geriatric research (JG-SNP). We observed that polymorphic SERPINA3 I308T (rs142398813) prolonged toxic oligomeric A beta 42 forms till 48 hr in comparison to the presence wild type SERPINA3 protein, resulting neuronal cell death. From this study, we first clarified pathogenic regulatory role of polymorphic SERPINA3 in neurodegeneration.	[Akbor, Maruf Mohammad; Kurosawa, Nobuyuki; Nakayama, Hiroki; Nakatani, Ayumi; Isobe, Masaharu] Univ Toyama, Fac Engn, Dept Life Sci & Bioengn, Lab Mol & Cellular Biol, Toyama, Japan; [Tomobe, Koji] Yokohama Univ Pharm, Dept Pathophysiol, Yokohama, Kanagawa, Japan; [Chiba, Yoichi; Ueno, Masaki] Kagawa Univ, Fac Med, Dept Pathol & Host Def, Miki, Kagawa, Japan; [Tanaka, Masashi] Natl Inst Biomed Innovat Hlth & Nutr, Dept Hlth & Longev Res, Shinjuku Ku, Tokyo, Japan; [Nomura, Yasuyuki] Kurume Univ, Sch Med, Dept Pharmacol, Kurume, Fukuoka, Japan	University of Toyama; Kagawa University; Kurume University	Isobe, M (corresponding author), Univ Toyama, Fac Engn, Dept Life Sci & Bioengn, Lab Mol & Cellular Biol, Toyama, Japan.	isobe@eng.u-toyama.ac.jp		Kurosawa, Nobuyuki/0000-0002-1548-4541	Japan Agency for Medical Research and Development (AMED) Grant [07805510, 15657579, 19187977, 20333128]	Japan Agency for Medical Research and Development (AMED) Grant(Japan Agency for Medical Research and Development (AMED))	This study was supported by the following grants: -The Grant-in-Aid for Scientific Research (KAKENHI) Grant number: 07805510 to MI -The Basic Science and Platform Technology Program for Innovative Biological Medicine from Japan Agency for Medical Research and Development (AMED) Grant number: 15657579 to MI -The Research Program on Emerging and Reemerging Infectious Diseases from Japan Agency for Medical Research and Development (AMED) Grant number: 19187977 and 20333128 to MI -The Toyama Pharmaceutical Valley Development Consortium (to MI; no grant number assigned) -The Hokuriku Life Science Cluster (to MI; no grant number assigned)	Abraham CR, 2001, NEUROBIOL AGING, V22, P931, DOI 10.1016/S0197-4580(01)00302-5; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Akbor MM, 2013, BIOCHEM BIOPH RES CO, V441, P25, DOI 10.1016/j.bbrc.2013.09.145; Akiguchi I, 2017, NEUROPATHOLOGY, V37, P293, DOI 10.1111/neup.12373; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Budowle B, 1996, INT J LEGAL MED, V108, P173, DOI 10.1007/BF01369786; Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007; Chen JA, 2015, JAMA NEUROL, V72, P414, DOI 10.1001/jamaneurol.2014.4040; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Edwards GA, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00146; Forsyth S, 2003, GENOMICS, V81, P336, DOI 10.1016/S0888-7543(02)00041-1; Grinan-Ferre C, 2018, J ALZHEIMERS DIS, V62, P943, DOI 10.3233/JAD-170664; Isobe M, 2004, INT CONGR SER, V1260, P29, DOI 10.1016/S0531-5131(03)01563-2; Janciauskiene S, 1998, J BIOL CHEM, V273, P28360, DOI 10.1074/jbc.273.43.28360; Janssen L, 2015, METHODSX, V2, P112, DOI 10.1016/j.mex.2015.02.011; Kamboh MI, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.45; Kamboh MI, 2004, ANN HUM GENET, V68, P381, DOI 10.1046/j.1529-8817.2004.00110.x; Kamnasaran D, 2001, CLIN INVEST MED, V24, P138; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Ki CS, 2001, NEUROSCI LETT, V302, P69, DOI 10.1016/S0304-3940(01)01660-3; Kodis EJ, 2018, ALZHEIMERS DEMENT, V14, P1302, DOI 10.1016/j.jalz.2018.05.017; Koide T, 1998, MAMM GENOME, V9, P15, DOI 10.1007/s003359900672; Kurosawa N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055147; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lesne S, 2008, NEUROSCIENCE, V151, P745, DOI 10.1016/j.neuroscience.2007.10.054; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; Licastro F, 2005, NEUROBIOL AGING, V26, P449, DOI 10.1016/j.neurobiolaging.2004.05.001; Liu B, 2020, J ALZHEIMERS DIS, V75, P385, DOI 10.3233/JAD-200063; Liu P, 2015, CELL REP, V11, P1760, DOI 10.1016/j.celrep.2015.05.021; Louche A, 2017, METHODS MOL BIOL, V1615, P247, DOI 10.1007/978-1-4939-7033-9_20; Lublin AL, 2010, MT SINAI J MED, V77, P43, DOI 10.1002/msj.20160; Maeda Y, 2016, J GERIATR CARDIOL, V13, P960, DOI 10.11909/j.issn.1671-5411.2016.12.003; Medway C, 2014, NEUROPATH APPL NEURO, V40, P97, DOI 10.1111/nan.12101; MIYAMOTO M, 1986, PHYSIOL BEHAV, V38, P399, DOI 10.1016/0031-9384(86)90112-5; Morgan K, 2001, HUM GENET, V109, P303, DOI 10.1007/s004390100575; Morley JE, 2012, CURR PHARM DESIGN, V18, P1123; Mucke L, 2000, AM J PATHOL, V157, P2003, DOI 10.1016/S0002-9440(10)64839-0; Ono K, 2018, NEUROCHEM INT, V119, P57, DOI 10.1016/j.neuint.2017.08.010; Padmanabhan J, 2006, BRAIN, V129, P3020, DOI 10.1093/brain/awl255; Pall?s M., 2012, ISRN CELL BIOL, V2012, DOI 10.5402/2012/917167; Pallas M, 2008, J ALZHEIMERS DIS, V15, P615; POTEMPA J, 1991, J BIOL CHEM, V266, P21482; Rosenberg RN, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0441-4; Ryan TM, 2013, PEERJ, V1, DOI 10.7717/peerj.73; Saetre P, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-46; Sakono M, 2008, FEBS J, V275, P5982, DOI 10.1111/j.1742-4658.2008.06727.x; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Shigemitsu Y, 2016, ANAL BIOCHEM, V498, P59, DOI 10.1016/j.ab.2015.12.021; Takeda Toshio, 1997, ILAR J, V38, P109; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Tomobe K, 2005, PHYSIOL BEHAV, V84, P505, DOI 10.1016/j.physbeh.2004.12.012; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Tu SC, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-48; Vanni S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15778-8; Wang JH, 2016, ONCOTARGET, V7, P22988, DOI 10.18632/oncotarget.8453; Xia X, 2018, AGING CELL, V17, DOI 10.1111/acel.12802; Yanai S, 2016, BEHAV BRAIN RES, V308, P187, DOI 10.1016/j.bbr.2016.04.026; Young JE, 2012, HUM MOL GENET, V21, pR82, DOI 10.1093/hmg/dds319; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zolochevska O, 2018, J ALZHEIMERS DIS, V65, P659, DOI 10.3233/JAD-180179	63	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0248027	10.1371/journal.pone.0248027	http://dx.doi.org/10.1371/journal.pone.0248027			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33662018	gold, Green Published			2022-12-26	WOS:000626604100064
J	Motta-Romero, H; Niyongira, F; Boehm, JD; Rose, DJ				Motta-Romero, Hollman; Niyongira, Ferdinand; Boehm, Jeffrey D., Jr.; Rose, Devin J.			Effects of foliar fungicide on yield, micronutrients, and cadmium in grains from historical and modern hard winter wheat genotypes	PLOS ONE			English	Article							GENETIC-IMPROVEMENT; BREAD WHEAT; DURUM-WHEAT; RHT GENES; REGISTRATION; CULTIVARS; PLAINS; CEREALS; PHYTATE; TRENDS	Plant breeding and disease management practices have increased the grain yield of hard winter wheat (Triticum aestivum L.) adapted to the Great Plains of the United States during the last century. However, the effect of genetic gains for seed yield and the application of fungicide on the micronutrient and cadmium (Cd) concentration in wheat grains is still unclear. The objectives of this study were to evaluate the effects of fungicide application on the productivity and nutritional quality of wheat cultivars representing 80 years of plant breeding efforts. Field experiments were conducted over two crop years (2017 and 2018) with eighteen hard winter wheat genotypes released between 1933 and 2013 in the presence or absence of fungicide application. For each growing season, the treatments were arranged in a split-plot design with the fungicide levels (treated and untreated) as the whole plot treatments and the genotypes as split-plot treatments in triplicate. The effects on seed yield, grain protein concentration (GPC), micronutrients, phytic acid, and Cd in grains were measured. While the yield of wheat was found to increase at annualized rates of 26.5 and 13.0 kg ha(-1) yr(-1) in the presence and absence of fungicide (P < 0.001), respectively, GPC (-190 and -180 mg kg(-1) yr(-1), P < 0.001), Fe (-35.0 and -44.0 mu g kg(-1) yr(-1), P < 0.05), and Zn (-68.0 and -57.0 mu g kg(-1) yr(-1), P < 0.01) significantly decreased during the period studied. In contrast to the other mineral elements, grain Cd significantly increased over time (0.4 mu g kg(-1) yr(-1), P < 0.01) in the absence of fungicide. The results from this study are of great concern, as many mineral elements essential for human nutrition have decreased over time while the toxic heavy metal, Cd, has increased, indicating modern wheats are becoming a better vector of dietary Cd.	[Motta-Romero, Hollman; Niyongira, Ferdinand; Rose, Devin J.] Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68583 USA; [Boehm, Jeffrey D., Jr.] USDA ARS, Wheat Sorghum & Forage Res Unit, Lincoln, NE USA; [Rose, Devin J.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln	Rose, DJ (corresponding author), Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68583 USA.; Rose, DJ (corresponding author), Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA.	drose3@unl.edu		Boehm, Jr, Jeffrey/0000-0003-2255-5181; Motta Romero, Hollman/0000-0002-2915-2732	Nebraska Agricultural Experiment Station from the Hatch Multistate Research capacity funding program from the USDA National Institute of Food and Agriculture [224073]; USDA [3042-210000-33-00D]	Nebraska Agricultural Experiment Station from the Hatch Multistate Research capacity funding program from the USDA National Institute of Food and Agriculture; USDA(United States Department of Agriculture (USDA))	This project was supported by the Nebraska Agricultural Experiment Station with funding from the Hatch Multistate Research capacity funding program (Accession Number 224073) from the USDA National Institute of Food and Agriculture. This project was also funded through USDA in-house funds appropriated to USDA-ARS CRIS project number 3042-210000-33-00D (Improved Winter Wheat Disease Resistance and Quality through Molecular Biology, Genetics, and Breeding). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arduini I, 2014, PLANT SOIL ENVIRON, V60, P43, DOI 10.17221/416/2013-PSE; Atkins I, 1967, CROP SCI, V7, P406; Azeke MA, 2011, J FOOD SCI TECH MYS, V48, P724, DOI 10.1007/s13197-010-0186-y; Baenziger PS, 2014, J PLANT REGIST, V8, P279, DOI 10.3198/jpr2014.02.0009crc; Baenziger PS, 2011, J PLANT REGIST, V5, P75, DOI 10.3198/jpr2010.02.0084crc; Baenziger PS, 2008, J PLANT REGIST, V2, P36, DOI 10.3198/jpr2007.06.0327crc; Bancal MO, 2012, ANN BOT-LONDON, V110, P113, DOI 10.1093/aob/mcs094; Battenfield SD, 2013, CROP SCI, V53, P946, DOI 10.2135/cropsci2012.03.0158; Bhatta M, 2018, AGRON J, V110, P602, DOI 10.2134/agronj2017.07.0383; Bilal HM, 2019, ARCH AGRON SOIL SCI, V65, P727, DOI 10.1080/03650340.2018.1521957; Bockus WW, 2001, PLANT DIS, V85, P453, DOI 10.1094/PDIS.2001.85.5.453; Calderini DF, 2003, CROP SCI, V43, P141, DOI 10.2135/cropsci2003.0141; Cao SH, 2010, THEOR APPL GENET, V121, P385, DOI 10.1007/s00122-010-1317-6; Ceylan Y, 2016, PLANT SOIL, V406, P145, DOI 10.1007/s11104-016-2871-8; Chen WP, 2008, J ENVIRON QUAL, V37, P689, DOI 10.2134/jeq2007.0444; COX TS, 1988, CROP SCI, V28, P756, DOI 10.2135/cropsci1988.0011183X002800050006x; De Brier N, 2015, J AGR FOOD CHEM, V63, P1276, DOI 10.1021/jf5055485; Deng FL, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00322; Doblado-Maldonado AF, 2013, J CEREAL SCI, V58, P420, DOI 10.1016/j.jcs.2013.08.006; Eagles HA, 2014, CROP PASTURE SCI, V65, P854, DOI 10.1071/CP14106; EFSA, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.243r; Fan MS, 2008, J TRACE ELEM MED BIO, V22, P315, DOI 10.1016/j.jtemb.2008.07.002; Fufa H, 2005, EUPHYTICA, V144, P187, DOI 10.1007/s10681-005-5811-x; Garvin DF, 2006, J SCI FOOD AGR, V86, P2213, DOI 10.1002/jsfa.2601; Graybosch RA, 2012, CROP SCI, V52, P631, DOI 10.2135/cropsci2011.08.0412; Graybosch RA, 2011, J PLANT REGIST, V5, P339, DOI 10.3198/jpr2010.08.0481crc; Graybosch RA, 2010, CROP SCI, V50, P1882, DOI 10.2135/cropsci2009.11.0685; Gruter R, 2019, SCI TOTAL ENVIRON, V669, P608, DOI 10.1016/j.scitotenv.2019.03.112; Guedira M, 2010, CROP SCI, V50, P1811; Gulati P, 2018, FOOD CHEM, V269, P118, DOI 10.1016/j.foodchem.2018.06.124; Gupta RK, 2015, J FOOD SCI TECH MYS, V52, P676, DOI 10.1007/s13197-013-0978-y; Guttieri M, 2015, J AGR FOOD CHEM, V63, P10681; Guttieri MJ, 2006, CROP SCI, V46, P2692, DOI 10.2135/cropsci2006.01.0054; Guttieri MJ, 2015, CROP SCI, V55, P1712, DOI 10.2135/cropsci2014.08.0559; Guttieri MJ, 2015, CROP SCI, V55, P1035, DOI 10.2135/cropsci2014.07.0506; Harris NS, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-103; HAUG W, 1983, J SCI FOOD AGR, V34, P1423, DOI 10.1002/jsfa.2740341217; IARC, 1993, IARC MONOGRAPHS, V58; Igamberdiev AU, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00010; Iwai T, 2012, PLANT PHYSIOL, V160, P2007, DOI 10.1104/pp.112.206573; Johnson V, 1981, CROP SCI, V21, P989; Kelley KW, 2001, AGRON J, V93, P380, DOI 10.2134/agronj2001.932380x; Khalil IH, 2002, CROP SCI, V42, P710, DOI 10.2135/cropsci2002.0710; Khan MA, 2017, SCI TOTAL ENVIRON, V601, P1591, DOI 10.1016/j.scitotenv.2017.06.030; KIBITE S, 1984, EUPHYTICA, V33, P801, DOI 10.1007/BF00021906; Knopf C, 2008, CEREAL RES COMMUN, V36, P553, DOI 10.1556/CRC.36.2008.4.4; Knox RE, 2009, GENOME, V52, P741, DOI [10.1139/G09-042, 10.1139/g09-042]; Korzun V, 1998, THEOR APPL GENET, V96, P1104, DOI 10.1007/s001220050845; Kubo K, 2008, PLANT SOIL ENVIRON, V11, P243; Liu CX, 2019, CROP SCI, V59, P945, DOI 10.2135/cropsci2018.08.0484; Liu CX, 2018, PLANT SOIL, V430, P127, DOI 10.1007/s11104-018-3712-8; Lonnerdal B, 2002, INT J FOOD SCI TECH, V37, P749, DOI 10.1046/j.1365-2621.2002.00640.x; Lott J, 2006, CAN J BOT, V83, P1599; Maeoka RE, 2020, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01786; MARCAR NE, 1986, PLANT SOIL, V96, P165, DOI 10.1007/BF02374761; Marles R., 2017, J FOOD COMPOS ANAL, V56, P93; Martens G, 2014, CAN J PLANT SCI, V94, P371, DOI [10.4141/CJPS2013-193, 10.4141/cjps2013-193]; MCGRATH SP, 1985, J SCI FOOD AGR, V36, P1073, DOI 10.1002/jsfa.2740361108; Mondal S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00991; Mueller N, 2017, RECAP 2017 E NEBRASK; Mueller N, 2018, RECAP 2017 2018 E NE; Nordberg GF, 2009, TOXICOL APPL PHARM, V238, P192, DOI 10.1016/j.taap.2009.03.015; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Perrier F, 2016, PLANT SOIL, V404, P307, DOI 10.1007/s11104-016-2847-8; Peterson CJ, 2001, CROP SCI, V41, P260, DOI 10.2135/cropsci2001.411260-ax; PORTER KB, 1987, CROP SCI, V27, P818, DOI 10.2135/cropsci1987.0011183X002700040050x; Rife TW, 2019, CROP SCI, V59, P905, DOI 10.2135/cropsci2018.01.0073; Salmon S, HARD RED WINTER WHEA; Satarug S, 2003, TOXICOL LETT, V137, P65, DOI 10.1016/S0378-4274(02)00381-8; Schlehuber A, 1965, CROP SCI, V5, P605; Schmidt J, 1965, CROP SCI, V5, P485; Schmidt J, 1971, CROP SCI, V11, P138; Schmidt J, 1963, CROP SCI, V3, P372; SCHMIDT JW, 1985, CROP SCI, V25, P574; Sharma S, 2019, BMC MOL BIOL, V20, DOI 10.1186/s12867-019-0139-6; Shewry PR, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.97, 10.1038/nplants.2016.97]; Simon MR, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.569401; Stoltzfus Rebecca J., 2003, Food and Nutrition Bulletin, V24, pS99; Tabbita F, 2017, J CEREAL SCI, V73, P183, DOI 10.1016/j.jcs.2017.01.003; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; USDA, 2018, NAT NUTR DAT STAND R; USDA, 1982, PI476305 USDA; Venegas JP, 2018, CROP SCI, V58, P1942, DOI 10.2135/cropsci2018.03.0175; Vishwakarma MK, 2014, CURR PLANT BIOL, V1, P60, DOI 10.1016/j.cpb.2014.09.003; Voss-Fels KP, 2019, NAT PLANTS, V5, P706, DOI 10.1038/s41477-019-0445-5; Wegulo S., 2018, WHEAT UPTADE DIS INC; Wegulo S., 2017, WHEAT DIS UPTADE STR; Wegulo SN, 2011, CROP PROT, V30, P685, DOI 10.1016/j.cropro.2011.02.002; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050568; Wu YX, 2001, PESTIC BIOCHEM PHYS, V71, P1, DOI 10.1006/pest.2001.2561	91	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0247809	10.1371/journal.pone.0247809	http://dx.doi.org/10.1371/journal.pone.0247809			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33662021	Green Published, gold			2022-12-26	WOS:000626604100131
J	Kmezik, C; Mazurkewich, S; Meents, T; McKee, LS; Idstrom, A; Armeni, M; Savolainen, O; Branden, G; Larsbrink, J				Kmezik, Cathleen; Mazurkewich, Scott; Meents, Tomke; McKee, Lauren Sara; Idstrom, Alexander; Armeni, Marina; Savolainen, Otto; Branden, Gisela; Larsbrink, Johan			A polysaccharide utilization locus from the gut bacterium Dysgonomonas mossii encodes functionally distinct carbohydrate esterases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN FATTY-ACIDS; FERULOYL ESTERASE; SUBSTRATE-SPECIFICITY; MOLECULAR REPLACEMENT; ENZYMATIC DEGRADATION; AUTOMATED REFINEMENT; STRUCTURAL BASIS; MICROBIOTA; LIGNIN; STARCH	The gut microbiota plays a central role in human health by enzymatically degrading dietary fiber and concomitantly excreting short chain fatty acids that are associated with manifold health benefits. The polysaccharide xylan is abundant in dietary fiber but noncarbohydrate decorations hinder efficient cleavage by glycoside hydrolases (GHs) and need to be addressed by carbohydrate esterases (CEs). Enzymes from carbohydrate esterase families 1 and 6 (CE1 and 6) perform key roles in xylan degradation by removing feruloyl and acetate decorations, yet little is known about these enzyme families especially with regard to their diversity in activity. Bacteroidetes bacteria are dominant members of the microbiota and often encode their carbohydrate-active enzymes in multigene polysaccharide utilization loci (PULs). Here we present the characterization of three CEs found in a PUL encoded by the gut Bacteroidete Dysgonomonas mossii. We demonstrate that the CEs are functionally distinct, with one highly efficient CE6 acetyl esterase and two CE1 enzymes with feruloyl esterase activities. One multidomain CE1 enzyme contains two CE1 domains: an N-terminal domain feruloyl esterase, and a C-terminal domain with minimal activity on model substrates. We present the structure of the C-terminal CE1 domain with the carbohydrate-binding module that bridges the two CE1 domains, as well as a complex of the same protein fragment with methyl ferulate. The investment of D. mossii in producing multiple CEs suggests that improved accessibility of xylan for GHs and cleavage of covalent polysaccharide-polysaccharide and lignin-polysaccharide bonds are important enzyme activities in the gut environment.	[Kmezik, Cathleen; Mazurkewich, Scott; Meents, Tomke; Larsbrink, Johan] Chalmers Univ Technol, Dept Biol & Biol Engn, Div Ind Biotechnol, Gothenburg, Sweden; [McKee, Lauren Sara] Royal Inst Technol KTH, AlbaNova Univ Ctr, Dept Chem, Div Glycosci, Stockholm, Sweden; [McKee, Lauren Sara; Larsbrink, Johan] Wallenberg Wood Sci Ctr, Stockholm, Sweden; [Idstrom, Alexander] Chalmers Univ Technol, Dept Chem & Chem Engn, Gothenburg, Sweden; [Armeni, Marina; Savolainen, Otto] Chalmers Univ Technol, Chalmers Mass Spectrometry Infrastruct, Dept Biol & Biol Engn, Gothenburg, Sweden; [Savolainen, Otto] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Dept Clin Nutr, Kuopio, Finland; [Branden, Gisela] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Meents, Tomke] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmaceut Biol, Mendelssohnstr 1, D-38106 Braunschweig, Germany	Chalmers University of Technology; Royal Institute of Technology; Chalmers University of Technology; Chalmers University of Technology; University of Eastern Finland; University of Gothenburg; Braunschweig University of Technology	Larsbrink, J (corresponding author), Chalmers Univ Technol, Dept Biol & Biol Engn, Div Ind Biotechnol, Gothenburg, Sweden.; Larsbrink, J (corresponding author), Wallenberg Wood Sci Ctr, Stockholm, Sweden.	johan.larsbrink@chalmers.se	Larsbrink, Johan/A-3053-2013	Larsbrink, Johan/0000-0001-8386-2914; Mazurkewich, Scott/0000-0002-9238-0615; /0000-0002-3372-8773	Swedish Research Council [Dnr 2016-03931]; Novo Nordisk Foundation [NNF17OC0027648]; Knut and Alice Wallenberg Foundation through the Wallenberg Wood Science Center	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Knut and Alice Wallenberg Foundation through the Wallenberg Wood Science Center(Knut & Alice Wallenberg Foundation)	The work was supported by a Starting Grant (Dnr 2016-03931) from the Swedish Research Council and a Research project grant from the Novo Nordisk Foundation (Grant number NNF17OC0027648), respectively, awarded to J. L., as well as the Knut and Alice Wallenberg Foundation through the Wallenberg Wood Science Center (J. L. and L. S. M.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Baath JA, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1115-y; Barapatre A, 2016, INT J BIOL MACROMOL, V86, P443, DOI 10.1016/j.ijbiomac.2016.01.109; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BIELY P, 1986, BIO-TECHNOL, V4, P731, DOI 10.1038/nbt0886-731; Blum DL, 1999, APPL ENVIRON MICROB, V65, P3990; Bocker S, 2016, J CHEMINFORMATICS, V8, DOI 10.1186/s13321-016-0116-8; Brunecky R, 2013, SCIENCE, V342, P1513, DOI 10.1126/science.1244273; Buanafina MMD, 2009, MOL PLANT, V2, P861, DOI 10.1093/mp/ssp067; Busse-Wicher M, 2016, PLANT PHYSIOL, V171, P2418, DOI 10.1104/pp.16.00539; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; D?hrkop K., 2020, BIORXIV, DOI [10.1101/2020.04.17.046672, DOI 10.1101/2020.04.17.046672]; De Rosso M, 2018, J MASS SPECTROM, V53, P763, DOI 10.1002/jms.4263; Della JN, 1996, J BACTERIOL, V178, P7180; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Dilokpimol A, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0651-6; Djoumbou Feunang Yannick, 2016, J Cheminform, V8, P61; Duhrkop K, 2015, P NATL ACAD SCI USA, V112, P12580, DOI 10.1073/pnas.1509788112; Duhrkop K, 2019, NAT METHODS, V16, P299, DOI 10.1038/s41592-019-0344-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faulds CB, 2005, FEBS J, V272, P4362, DOI 10.1111/j.1742-4658.2005.04849.x; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Foley MH, 2016, CELL MOL LIFE SCI, V73, P2603, DOI 10.1007/s00018-016-2242-x; Freelove ACJ, 2001, J BIOL CHEM, V276, P43010, DOI 10.1074/jbc.M107143200; Galisteo M, 2008, J NUTR BIOCHEM, V19, P71, DOI 10.1016/j.jnutbio.2007.02.009; GILBERT HJ, 1992, MOL MICROBIOL, V6, P2065, DOI 10.1111/j.1365-2958.1992.tb01379.x; Gille S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00012; Grabber JH, 1998, J SCI FOOD AGR, V77, P193, DOI 10.1002/(SICI)1097-0010(199806)77:2<193::AID-JSFA25>3.0.CO;2-A; Grondin JM, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00860-16; Gruninger RJ, 2016, BIOCHEM J, V473, P839, DOI 10.1042/BJ20151153; Holck J, 2019, J BIOL CHEM, V294, P17339, DOI 10.1074/jbc.RA119.009523; Kabel MA, 2003, CARBOHYD RES, V338, P69, DOI 10.1016/S0008-6215(02)00351-8; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KATO Y, 1985, CARBOHYD RES, V137, P139, DOI 10.1016/0008-6215(85)85155-7; Kelle S, 2016, BIOTECHNOL APPL BIOC, V63, P852, DOI 10.1002/bab.1430; Kmezik C, 2020, BIOTECHNOL BIOFUELS, V13, DOI 10.1186/s13068-020-01698-9; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krska D, 2020, BIOTECHNOL BIOFUELS, V13, DOI 10.1186/s13068-020-01709-9; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Larsbrink J, 2020, ADV APPL MICROBIOL, V110, P63, DOI 10.1016/bs.aambs.2019.11.001; Larsbrink J, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0674-z; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Lawson PA, 2002, SYST APPL MICROBIOL, V25, P194, DOI 10.1078/0723-2020-00107; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Linke D, 2013, APPL MICROBIOL BIOT, V97, P7241, DOI 10.1007/s00253-012-4598-7; Ludwig M., 2019, ZODIAC DATABASE INDE, DOI [10.1101/842740, DOI 10.1101/842740]; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Munir RI, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0711-x; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Niemi P, 2013, J AGR FOOD CHEM, V61, P6754, DOI 10.1021/jf401738x; Nishimura H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24328-9; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Vinardell MP, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061219; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Rogowski A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8481; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Schubot FD, 2001, BIOCHEMISTRY-US, V40, P12524, DOI 10.1021/bi011391c; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; SHAO WL, 1995, APPL ENVIRON MICROB, V61, P729, DOI 10.1128/AEM.61.2.729-733.1995; Sheridan PO, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000043; Tan J, 2014, ADV IMMUNOL, V121, P91, DOI 10.1016/B978-0-12-800100-4.00003-9; TANCULA E, 1992, J BACTERIOL, V174, P5609, DOI 10.1128/JB.174.17.5609-5616.1992; Tauzin AS, 2016, MBIO, V7, DOI 10.1128/mBio.02134-15; Terrapon N, 2018, NUCLEIC ACIDS RES, V46, pD677, DOI 10.1093/nar/gkx1022; Terrett OM, 2019, CURR OPIN BIOTECH, V56, P97, DOI 10.1016/j.copbio.2018.10.010; Timell T. E., 1967, Wood Science and Technology, V1, P45, DOI 10.1007/BF00592255; Vagin A, 2015, ACTA CRYSTALLOGR A, V71, pS19, DOI 10.1107/S2053273315099672; Wang L, 2014, APPL BIOCHEM BIOTECH, V172, P993, DOI 10.1007/s12010-013-0536-0; Wefers D, 2017, J MOL BIOL, V429, P2509, DOI 10.1016/j.jmb.2017.06.017; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015	81	8	8	3	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100500	10.1016/j.jbc.2021.100500	http://dx.doi.org/10.1016/j.jbc.2021.100500			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33667545	Green Published, gold			2022-12-26	WOS:000672866400474
J	Lin, CSH; Chan, ACK; Vermeulen, J; Brockerman, J; Soni, AS; Tanner, ME; Gaynor, EC; McIntosh, LP; Simorre, JP; Murphy, MEP				Lin, Chang Sheng-Huei; Chan, Anson C. K.; Vermeulen, Jenny; Brockerman, Jacob; Soni, Arvind S.; Tanner, Martin E.; Gaynor, Erin C.; McIntosh, Lawrence P.; Simorre, Jean-Pierre; Murphy, Michael E. P.			Peptidoglycan binding by a pocket on the accessory NTF2-domain of Pgp2 directs helical cell shape of Campylobacter jejuni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; PROTEIN; RESISTANCE; CRYSTALLOGRAPHY; EPIDEMIOLOGY; ORGANIZATION; PATHOGENESIS; EXPRESSION; SYSTEM; FAMILY	The helical morphology of Campylobacter jejuni, a bacterium involved in host gut colonization and pathogenesis in humans, is determined by the structure of the peptidoglycan (PG) layer. This structure is dictated by trimming of peptide stems by the LD-carboxypeptidase Pgp2 within the periplasm. The interaction interface between Pgp2 and PG to select sites for peptide trimming is unknown. We determined a 1.6 angstrom resolution crystal structure of Pgp2, which contains a conserved LD-carboxypeptidase domain and a previously uncharacterized domain with an NTF2-like fold (NTF2). We identified a pocket in the NTF2 domain formed by conserved residues and located similar to 40 angstrom from the LD-carboxypeptidase active site. Expression of pgp2 in trans with substitutions of charged (Lys257, Lys307, Glu324) and hydrophobic residues (Phe242 and Tyr233) within the pocket did not restore helical morphology to a pgp2 deletion strain. Muropeptide analysis indicated a decrease of murotripeptides in the deletion strain expressing these mutants, suggesting reduced Pgp2 catalytic activity. Pgp2 but not the K307A mutant was pulled down by C. jejuni Delta pgp2 PG sacculi, supporting a role for the pocket in PG binding. NMR spectroscopy was used to define the interaction interfaces of Pgp2 with several PG fragments, which bound to the active site within the LD-carboxypeptidase domain and the pocket of the NTF2 domain. We propose a model for Pgp2 binding to PG strands involving both the LD-carboxypeptidase domain and the accessory NTF2 domain to induce a helical cell shape.	[Lin, Chang Sheng-Huei; Chan, Anson C. K.; Vermeulen, Jenny; Gaynor, Erin C.; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada; [Brockerman, Jacob; McIntosh, Lawrence P.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Soni, Arvind S.; Tanner, Martin E.; McIntosh, Lawrence P.] Univ British Columbia, Dept Chem, Vancouver, BC, Canada; [Simorre, Jean-Pierre] Univ Grenoble Alpes, IBS, CEA, CNRS, Grenoble, France	University of British Columbia; University of British Columbia; University of British Columbia; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Murphy, MEP (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada.	michael.murphy@ubc.ca		Lin, Chang Sheng-Huei/0000-0002-6966-4417; simorre, jean-pierre/0000-0002-7943-1342	Canadian Institutes of Health Research (CIHR) [MOP-142176]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was funded by Canadian Institutes of Health Research (CIHR) grants MOP-142176 to M. E. P. M. and M. E. T. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Asakura H, 2010, MOL MICROBIOL, V78, P1130, DOI 10.1111/j.1365-2958.2010.07393.x; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Bartlett TM, 2017, CELL, V168, P172, DOI 10.1016/j.cell.2016.12.019; Beeby M, 2016, P NATL ACAD SCI USA, V113, pE1917, DOI 10.1073/pnas.1518952113; Bielnicki J, 2006, PROTEINS, V62, P144, DOI 10.1002/prot.20702; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Blair KM, 2018, MOL MICROBIOL, V110, P114, DOI 10.1111/mmi.14087; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cabeen MT, 2009, EMBO J, V28, P1208, DOI 10.1038/emboj.2009.61; Cai ML, 2016, J BIOMOL NMR, V66, P85, DOI 10.1007/s10858-016-0052-y; Chou S, 2012, CELL REP, V1, P656, DOI 10.1016/j.celrep.2012.05.016; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eberhardt RY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-327; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esson D, 2016, SCI REP-UK, V6, DOI 10.1038/srep38303; Frirdich E, 2014, J BIOL CHEM, V289, P8007, DOI 10.1074/jbc.M113.491829; Frirdich E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002602; Gan L, 2008, P NATL ACAD SCI USA, V105, P18953, DOI 10.1073/pnas.0808035105; GOODWIN SD, 1975, ARCH BIOCHEM BIOPHYS, V170, P23, DOI 10.1016/0003-9861(75)90094-6; Gumbart JC, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003475; Ha R, 2016, J BIOL CHEM, V291, P22686, DOI 10.1074/jbc.M116.746404; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Holm L, 2020, PROTEIN SCI, V29, P128, DOI 10.1002/pro.3749; Huang KC, 2008, P NATL ACAD SCI USA, V105, P19282, DOI 10.1073/pnas.0805309105; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karlyshev AV, 2005, APPL ENVIRON MICROB, V71, P4004, DOI 10.1128/AEM.71.7.4004-4013.2005; Kim HS, 2015, J BIOL CHEM, V290, P25103, DOI 10.1074/jbc.M115.658781; Kim SJ, 2015, BBA-BIOMEMBRANES, V1848, P350, DOI 10.1016/j.bbamem.2014.05.031; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lecoq L, 2012, STRUCTURE, V20, P850, DOI 10.1016/j.str.2012.03.015; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Liu YJ, 2016, ACS CHEM BIOL, V11, P981, DOI 10.1021/acschembio.5b01039; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; Magnet S, 2007, J BIOL CHEM, V282, P13151, DOI 10.1074/jbc.M610911200; Margolin W, 2009, CURR BIOL, V19, pR812, DOI 10.1016/j.cub.2009.06.033; Maya-Martine R, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03223; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; Mesnage S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5269; Min K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13934-4; Moore JE, 2006, MICROBES INFECT, V8, P1955, DOI 10.1016/j.micinf.2005.12.030; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pincus Z, 2007, J MICROSC-OXFORD, V227, P140, DOI 10.1111/j.1365-2818.2007.01799.x; Rocaboy M, 2013, MOL MICROBIOL, V90, P267, DOI 10.1111/mmi.12361; Schanda P, 2014, J AM CHEM SOC, V136, P17852, DOI 10.1021/ja5105987; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Soni AS, 2019, CHEMBIOCHEM, V20, P1591, DOI 10.1002/cbic.201900011; Stahl M, 2016, INFECT IMMUN, V84, P3399, DOI 10.1128/IAI.00751-16; Sycuro LK, 2013, MOL MICROBIOL, V90, P869, DOI 10.1111/mmi.12405; Sycuro LK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002603; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Taylor JA, 2020, ELIFE, V9, DOI 10.7554/eLife.52482; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolgemuth CW, 2005, PHYS BIOL, V2, P189, DOI 10.1088/1478-3975/2/3/006; Yang DC, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00724-18; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200	65	3	3	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100528	10.1016/j.jbc.2021.100528	http://dx.doi.org/10.1016/j.jbc.2021.100528			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33711341	Green Published, gold			2022-12-26	WOS:000672866400502
J	Muller, M; Calvert, M; Hottmann, I; Kluj, RM; Teufel, T; Balbuchta, K; Engelbrecht, A; Selim, KA; Xu, QP; Borisova, M; Titz, A; Mayer, C				Mueller, Maraike; Calvert, Matthew; Hottmann, Isabel; Kluj, Robert Maria; Teufel, Tim; Balbuchta, Katja; Engelbrecht, Alicia; Selim, Khaled A.; Xu, Qingping; Borisova, Marina; Titz, Alexander; Mayer, Christoph			The exo-beta-N-acetylmuramidase NamZ from Bacillus subtilis is the founding member of a family of exo-lytic peptidoglycan hexosaminidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC-ANALYSIS; ACETYLGLUCOSAMINIDASE; HYDROLYSIS; MECHANISM; HYDROLASE; ENZYMES; TRANSGLYCOSYLASES; IDENTIFICATION; PURIFICATION; SUBSTRATE	Endo-beta-N-acetylmuramidases, commonly known as lysozymes, are well-characterized antimicrobial enzymes that catalyze an endo-lytic cleavage of peptidoglycan; i.e., they hydrolyze the beta-1,4-glycosidic bonds connecting N-acetylmuramic acid (MurNAc) and N-acetylglucosamine (GlcNAc). In contrast, little is known about exo-beta-N-acetylmuramidases, which catalyze an exo-lytic cleavage of beta-1,4-MurNAc entities from the non-reducing ends of peptidoglycan chains. Such an enzyme was identified earlier in the bacterium Bacillus subtilis, but the corresponding gene has remained unknown so far. We now report that ybbC of B. subtilis, renamed namZ, encodes the reported exo-beta-N-acetylmuramidase. A Delta namZ mutant accumulated specific cell wall fragments and showed growth defects under starvation conditions, indicating a role of NamZ in cell wall turnover and recycling. Recombinant NamZ protein specifically hydrolyzed the artificial substrate para-nitrophenyl beta-MurNAc and the peptidoglycan-derived disaccharide MurNAc-beta-1,4-GlcNAc. Together with the exo-beta-N-acetylglucosaminidase NagZ and the exo-muramoyl-L-alanine amidase AmiE, NamZ degraded intact peptidoglycan by sequential hydrolysis from the non-reducing ends. A structure model of NamZ, built on the basis of two crystal structures of putative orthologs from Bacteroides fragilis, revealed a two-domain structure including a Rossmann-fold-like domain that constitutes a unique glycosidase fold. Thus, NamZ, a member of the DUF1343 protein family of unknown function, is now classified as the founding member of a new family of glycosidases (CAZy GH171; www.cazy.org/GH171.html). NamZ-like peptidoglycan hexosaminidases are mainly present in the phylum Bacteroidetes and less frequently found in individual genomes within Firmicutes (Bacilli, Clostridia), Actinobacteria, and gamma-proteobacteria.	[Mueller, Maraike; Hottmann, Isabel; Kluj, Robert Maria; Teufel, Tim; Balbuchta, Katja; Engelbrecht, Alicia; Selim, Khaled A.; Borisova, Marina; Mayer, Christoph] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany; [Calvert, Matthew; Titz, Alexander] Helmholtz Ctr Infect Res HZI, Helmholtz Inst Pharmaceut Res Saarland HIPS, Chem Biol Carbohydrates, Saarbrucken, Germany; [Calvert, Matthew; Titz, Alexander] Deutsch Zentrum Infekt Forsch DZIF, Standort Hannover Brauns, Germany; [Calvert, Matthew; Titz, Alexander] Saarland Univ, Dept Chem, Saarbrucken, Germany; [Selim, Khaled A.] Natl Res Ctr, Chem Nat & Microbial Prod Dept, Pharmaceut & Drug Ind Res Div, Giza, Egypt; [Xu, Qingping] Argonne Natl Lab, GM CA APS, Lemont, IL USA; [Calvert, Matthew] Univ Auckland, Dept Chem, Auckland, New Zealand	Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center for Infection Research; German Center for Infection Research; Saarland University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); United States Department of Energy (DOE); Argonne National Laboratory; University of Auckland	Mayer, C (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany.	christoph.mayer@uni-tuebingen.de	Titz, Alexander/E-6701-2010; Mayer, Christoph/S-8666-2017; Selim, Khaled/AAC-9733-2021	Titz, Alexander/0000-0001-7408-5084; Mayer, Christoph/0000-0003-4731-4851; Selim, Khaled/0000-0002-2974-9483	Ministry of Science, Research and Art of the state Baden-Wurttemberg (programme glycobiology/glycobiotechnology); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [SFB766, 398967434-TRR 261, 174858087-GRK1708]	Ministry of Science, Research and Art of the state Baden-Wurttemberg (programme glycobiology/glycobiotechnology); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	C. M. acknowledges funding by the Ministry of Science, Research and Art of the state Baden-Wurttemberg (programme glycobiology/glycobiotechnology) and by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), grants SFB766, Project-ID 398967434-TRR 261, and Project-ID 174858087-GRK1708.	Acebron I, 2017, J AM CHEM SOC, V139, P6795, DOI 10.1021/jacs.7b01626; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Bacik JP, 2012, CHEM BIOL, V19, P1471, DOI 10.1016/j.chembiol.2012.09.016; BERKELEY RC, 1973, BIOCHIM BIOPHYS ACTA, V309, P157, DOI 10.1016/0005-2744(73)90327-6; Borisova M, 2016, MBIO, V7, DOI 10.1128/mBio.00923-16; Dahl U, 2004, J BACTERIOL, V186, P2385, DOI 10.1128/JB.186.8.2385-2392.2004; DELRIO LA, 1975, ANAL BIOCHEM, V66, P405, DOI 10.1016/0003-2697(75)90608-9; DELRIO LA, 1976, EUR J BIOCHEM, V65, P3; DELRIO LA, 1973, FEBS LETT, V37, P7, DOI 10.1016/0014-5793(73)80414-4; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Fumeaux C, 2017, MBIO, V8, DOI 10.1128/mBio.00102-17; Gisin J, 2013, NAT CHEM BIOL, V9, P491, DOI 10.1038/nchembio.1289; HAYASHI K, 1975, ANAL BIOCHEM, V67, P503, DOI 10.1016/0003-2697(75)90324-3; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Horsburgh GJ, 2003, BIOCHEMISTRY-US, V42, P257, DOI 10.1021/bi020498c; Itoh T, 2019, ADV EXP MED BIOL, V1142, P131, DOI 10.1007/978-981-13-7318-3_7; Jaeger T, 2005, J BIOL CHEM, V280, P30100, DOI 10.1074/jbc.M502208200; Jaeger T, 2008, J BACTERIOL, V190, P6598, DOI 10.1128/JB.00642-08; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; JEANLOZ RW, 1968, CARBOHYD RES, V6, P184, DOI 10.1016/S0008-6215(00)81509-8; Kluj RM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02725; Koo BM, 2017, CELL SYST, V4, P291, DOI 10.1016/j.cels.2016.12.013; Laurino P, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002396; Lee M, 2013, J AM CHEM SOC, V135, P3311, DOI 10.1021/ja309036q; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Litzinger S, 2010, J BIOL CHEM, V285, P35675, DOI 10.1074/jbc.M110.131037; Litzinger S, 2010, J BACTERIOL, V192, P3132, DOI 10.1128/JB.01256-09; Liu QYP, 2007, NAT BIOTECHNOL, V25, P454, DOI 10.1038/nbt1298; Mayer, 2019, EXTRACELLULAR SUGAR, P237, DOI DOI 10.1007/978-3-030-12919-4_6; Mayer C, 2019, INT J MED MICROBIOL, V309, DOI 10.1016/j.ijmm.2019.06.006; Medema MH, 2013, MOL BIOL EVOL, V30, P1218, DOI 10.1093/molbev/mst025; Miller J. H., 1972, ASSAY BETA GALACTOSI, V1972, P352; MSADEK T, 1990, J BACTERIOL, V172, P824, DOI 10.1128/jb.172.2.824-834.1990; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; ORTIZ JM, 1972, BIOCHIM BIOPHYS ACTA, V289, P174, DOI 10.1016/0005-2744(72)90120-9; Ragland SA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006512; Rajan SS, 2004, STRUCTURE, V12, P1619, DOI 10.1016/j.str.2004.06.020; Reith J, 2011, APPL MICROBIOL BIOT, V92, P1, DOI 10.1007/s00253-011-3486-x; Schaub RE, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2438; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Selim KA, 2020, FEBS J, V287, P465, DOI 10.1111/febs.14989; Strynadka N C, 1996, EXS, V75, P185; Sudiarta IP, 2010, BIOCHEM BIOPH RES CO, V398, P606, DOI 10.1016/j.bbrc.2010.07.001; SUGAI M, 1995, J BACTERIOL, V177, P1491, DOI 10.1128/jb.177.6.1491-1496.1995; Walter A, 2021, MICROB PHYSIOL, V31, P178, DOI 10.1159/000515178; Wang JP, 2013, LANGMUIR, V29, P14997, DOI 10.1021/la403401c; Warren RAJ, 1996, ANNU REV MICROBIOL, V50, P183, DOI 10.1146/annurev.micro.50.1.183; Wheeler R, 2015, MBIO, V6, DOI 10.1128/mBio.00660-15; Yip VLY, 2007, BIOCHEMISTRY-US, V46, P9840, DOI 10.1021/bi700536p; Yip VLY, 2004, J AM CHEM SOC, V126, P8354, DOI 10.1021/ja047632w	50	4	4	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100519	10.1016/j.jbc.2021.100519	http://dx.doi.org/10.1016/j.jbc.2021.100519			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33684445	Green Submitted, gold, Green Published			2022-12-26	WOS:000672866400493
J	Ito, M; Kudo, K; Higuchi, H; Otsuka, H; Tanaka, M; Fukunishi, N; Araki, T; Takamatsu, M; Ino, Y; Kimura, Y; Kotani, A				Ito, Masatoshi; Kudo, Kai; Higuchi, Hiroshi; Otsuka, Hiroko; Tanaka, Masayuki; Fukunishi, Nahoko; Araki, Takuma; Takamatsu, Masako; Ino, Yoko; Kimura, Yayoi; Kotani, Ai			Proteomic and phospholipidomic characterization of extracellular vesicles inducing tumor microenvironment in Epstein-Barr virus-associated lymphomas	FASEB JOURNAL			English	Article						Epstein&#8208; Barr virus; extracellular vesicle; tumor microenvironment; proteomics; phospholipids		Epstein-Barr virus (EBV) causes malignant carcinomas including B cell lymphomas accompanied by the systemic inflammation. Previously, we observed that phosphatidylserine (PS)-exposing subset of extracellular vesicles (EVs) secreted from an EBV strain Akata-transformed lymphoma (Akata EVs) convert surrounding phagocytes into tumor-associated macrophages (TAMs) via induction of inflammatory response, which is in part mediated by EBV-derived micro RNAs. However, it is still unclear about EV-carried other potential inflammatory factors associated with TAM formation in EBV lymphomas. To this end, we sought to explore proteomic and phospholipidomic profiles of PS-exposing EVs derived from EBV-transformed lymphomas. Mass spectrometric analysis revealed that several immunomodulatory proteins including integrin alpha L beta 2 and fibroblast growth factor 2 (FGF2) were highly expressed in PS-exposing Akata EVs compared with another EBV strain B95-8-transformed lymphoma-derived counterparts which significantly lack TAM-inducing ability. Pharmacological inhibition of either integrin alpha L beta 2 or FGF2 hampered cytokine induction in monocytic cultured cells elicited by PS-exposing Akata EVs, suggesting the involvement of these proteins in EV-mediated TAM induction in EBV lymphomas. In addition, phospholipids containing precursors of immunomodulatory lipid mediators were also enriched in PS-exposing Akata EVs compared with B95-8 counterparts. Phospholipidomic analysis of fractionated Akata EVs by density gradient centrifugation further demonstrated that PS-exposing Akata EVs might be identical to certain Akata EVs in low density fractions containing exosomes. Therefore, we concluded that a variety of immunomodulatory cargo molecules in a certain EV subtype are presumably conducive to the development of EBV lymphomas.	[Ito, Masatoshi; Tanaka, Masayuki; Fukunishi, Nahoko; Araki, Takuma] Tokai Univ, Support Ctr Med Res & Educ, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan; [Kudo, Kai; Higuchi, Hiroshi; Otsuka, Hiroko; Takamatsu, Masako; Kotani, Ai] Tokai Univ, Dept Hematol Malignancy, Isehara, Kanagawa, Japan; [Kudo, Kai; Takamatsu, Masako; Kotani, Ai] Tokai Univ, Inst Med Sci, Dept Innovat Med Sci, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan; [Ino, Yoko; Kimura, Yayoi] Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa, Japan; [Kotani, Ai] Japan Agcy Med Res & Dev, AMED PRIME, Tokyo, Japan	Tokai University; Tokai University; Tokai University; Yokohama City University	Ito, M (corresponding author), Tokai Univ, Support Ctr Med Res & Educ, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.; Kotani, A (corresponding author), Tokai Univ, Inst Med Sci, Dept Innovat Med Sci, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	masa104-ito@tokai-u.jp; aikotani@k-lab.jp		Ito, Masatoshi/0000-0003-2665-0020; Kudo, Kai/0000-0002-5410-3334; Tanaka, Masayuki/0000-0002-8682-8719	Japan Agency for Medical Research and Development (AMED); MEXT | JST | Core Research for Evolutional Science and Technology (CREST); Research Program on Hepatitis from Japan Agency for Medical Research and Development [16fk0210114h0001]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT | JST | Core Research for Evolutional Science and Technology (CREST); Research Program on Hepatitis from Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	Japan Agency for Medical Research and Development (AMED), Grant/Award Number: AMED--PRIME; MEXT | JST | Core Research for Evolutional Science and Technology (CREST); Research Program on Hepatitis from Japan Agency for Medical Research and Development, Grant/Award Number: 16fk0210114h0001	Ariza ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069827; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Chen ZZ, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0863-7; Cianciaruso C, 2019, CELL REP, V27, P3062, DOI 10.1016/j.celrep.2019.05.008; Dang VD, 2017, FASEB J, V31, P5399, DOI 10.1096/fj.201700417R; De Re V, 2019, J CLIN MED, V8, DOI 10.3390/jcm8101596; Duchez AC, 2015, P NATL ACAD SCI USA, V112, pE3564, DOI 10.1073/pnas.1507905112; Ferrucci L, 2006, J CLIN ENDOCR METAB, V91, P439, DOI 10.1210/jc.2005-1303; Hamidi H, 2018, NAT REV CANCER, V18, P532, DOI 10.1038/s41568-018-0038-z; Haraszti RA, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.32570; Harayama T, 2018, NAT REV MOL CELL BIO, V19, P281, DOI 10.1038/nrm.2017.138; Higuchi H, 2018, BLOOD, V131, P2552, DOI 10.1182/blood-2017-07-794529; Innes JK, 2018, PROSTAG LEUKOTR ESS, V132, P41, DOI 10.1016/j.plefa.2018.03.004; Jeppesen DK, 2019, CELL, V177, P428, DOI 10.1016/j.cell.2019.02.029; Jiao YJ, 2019, J CELL BIOCHEM, V120, P988, DOI 10.1002/jcb.27465; Kakizaki M, 2020, J BIOL CHEM, V295, P12449, DOI 10.1074/jbc.RA120.014317; Kakizaki M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205886; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Lai RC, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.29828; Laulagnier K, 2004, BIOCHEM J, V380, P161, DOI 10.1042/BJ20031594; Llorente A, 2013, BBA-MOL CELL BIOL L, V1831, P1302, DOI 10.1016/j.bbalip.2013.04.011; Ludwig S, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1593808; Lydic TA, 2015, METHODS, V87, P83, DOI 10.1016/j.ymeth.2015.04.014; Maas SLN, 2017, TRENDS CELL BIOL, V27, P172, DOI 10.1016/j.tcb.2016.11.003; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Marimpietri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075054; Masoodi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076532; Matsumura S, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1579541; Nakai W, 2016, SCI REP-UK, V6, DOI 10.1038/srep33935; Nakamura S, 2008, WHO CLASSIFICATION T, V94, P243; Nishiumi S, 2018, DIGEST DIS SCI, V63, P1485, DOI 10.1007/s10620-018-5025-4; Onodi Z, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01479; Pathan M, 2015, PROTEOMICS, V15, P2597, DOI 10.1002/pmic.201400515; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Sato H, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107579; Shannon-Lowe C, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00713; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Takase N, 2016, CANCER LETT, V380, P47, DOI 10.1016/j.canlet.2016.06.009; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Teow SY, 2017, INT J BIOL SCI, V13, P1276, DOI 10.7150/ijbs.19531; Triebl A, 2014, J CHROMATOGR A, V1347, P104, DOI 10.1016/j.chroma.2014.04.070; Valkonen S, 2019, BBA-MOL CELL BIOL L, V1864, P1168, DOI 10.1016/j.bbalip.2019.03.011; Van Deun J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24858; Witwer KW, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1648167; Wortzel I, 2019, DEV CELL, V49, P347, DOI 10.1016/j.devcel.2019.04.011; Yang CJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/842849; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	47	5	5	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21505	10.1096/fj.202002730R	http://dx.doi.org/10.1096/fj.202002730R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33723887				2022-12-26	WOS:000635216100011
J	Xiang, JN; Zhang, SY; Xu, RY; Chu, HS; Biswas, S; Yu, SX; Miao, DS; Li, WD; Li, ST; Brown, AJ; Yang, HY; Xu, YH; Li, BJ; Liu, HJ				Xiang, Jinnan; Zhang, Shaoyang; Xu, Ruiyao; Chu, Hongshang; Biswas, Soma; Yu, Shuxiang; Miao, Dengshun; Li, Weidong; Li, Shentian; Brown, Andrew J.; Yang, Hongyuan; Xu, Yuhong; Li, Baojie; Liu, Huijuan			Elevated HB-EGF expression in neural stem cells causes middle age obesity by suppressing Hypocretin/Orexin expression	FASEB JOURNAL			English	Article						HB&#8208; EGF; midlife obesity; Nestin; neuron; Orexin		Obesity is common in the middle aged population and it increases the risks of diabetes, cardiovascular diseases, certain cancers, and dementia. Yet, its etiology remains incompletely understood. Here, we show that ectopic expression of HB-EGF, an important regulator of neurogenesis, in Nestin(+) neuroepithelial progenitors with the Cre-LoxP system leads to development of spontaneous middle age obesity in male mice accompanied by hyperglycemia and insulin resistance. The Nestin-HB-EGF mice show decreases in food uptake, energy expenditure, and physical activity, suggesting that reduced energy expenditure underlies the pathogenesis of this obesity model. However, HB-EGF expression in appetite-controlling POMC or AgRP neurons or adipocytes fails to induce obesity. Mechanistically, HB-EGF suppresses expression of Hypocretin/Orexin, an orexigenic neuropeptide hormone, in the hypothalamus of middle aged Nestin-HB-EGF mice. Hypothalamus Orexin administration alleviates the obese and hyperglycemic phenotypes in Nestin-HB-EGF mice. This study uncovers an important role for HB-EGF in regulating Orexin expression and energy expenditure and establishes a midlife obesity model whose pathogenesis involves age-dependent changes in hypothalamus neurons.	[Xiang, Jinnan; Li, Baojie] Shanghai Jiao Tong Univ, Sch Med, Bio X Renji Hosp Res Ctr, Renji Hosp, Shanghai, Peoples R China; [Xiang, Jinnan; Zhang, Shaoyang; Xu, Ruiyao; Chu, Hongshang; Biswas, Soma; Yu, Shuxiang; Li, Weidong; Li, Shentian; Li, Baojie; Liu, Huijuan] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai, Peoples R China; [Miao, Dengshun] Nanjing Med Univ, State Key Lab Reprod Med, Dept Anat Histol & Embryol, Res Ctr Bone & Stem Cells, Nanjing, Peoples R China; [Brown, Andrew J.; Yang, Hongyuan] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Xu, Yuhong] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai, Peoples R China; [Li, Baojie] Chengdu Univ Tradit Chinese Med, Ctr Tradit Chinese Med & Stem Cell Res, Chengdu, Sichuan, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Nanjing Medical University; University of New South Wales Sydney; Shanghai Jiao Tong University; Chengdu University of Traditional Chinese Medicine	Li, BJ; Liu, HJ (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai, Peoples R China.	libj@sjtu.edu.cn; liuhj@sjtu.edu.cn	zhang, shaoyang/GPX-2651-2022	Li, Weidong/0000-0001-5384-4838	National Key Research and Development Program of China [2018YFA0800803]; NSFC | National Natural Science Foundation of ChinaYunnan Joint Fund (NSFC-Yunnan Joint Fund) [81520108012, 91749201]	National Key Research and Development Program of China; NSFC | National Natural Science Foundation of ChinaYunnan Joint Fund (NSFC-Yunnan Joint Fund)	National Key Research and Development Program of China, Grant/Award Number: 2018YFA0800803; NSFC | National Natural Science Foundation of ChinaYunnan Joint Fund (NSFC-Yunnan Joint Fund), Grant/Award Number: 81520108012 and 91749201	Adam JA, 2002, INT J OBESITY, V26, P274, DOI 10.1038/sj.ijo.0801868; Adeghate E, 2012, VITAM HORM, V89, P111, DOI 10.1016/B978-0-12-394623-2.00007-X; Andermann ML, 2017, NEURON, V95, P757, DOI 10.1016/j.neuron.2017.06.014; Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Cavalcanti-de-Albuquerque JP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08239-x; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Deng Q, 2019, ELIFE, V8, DOI 10.7554/eLife.50208; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gao XB, 2014, ANNU REV NEUROSCI, V37, P101, DOI 10.1146/annurev-neuro-071013-013855; Goodarzi MO, 2018, LANCET DIABETES ENDO, V6, P223, DOI 10.1016/S2213-8587(17)30200-0; Hara J, 2005, NEUROSCI LETT, V380, P239, DOI 10.1016/j.neulet.2005.01.046; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Hirano A, 2018, P NATL ACAD SCI USA, V115, P3434, DOI 10.1073/pnas.1801693115; Hoshino H, 2007, MOL BIOL CELL, V18, P1143, DOI 10.1091/mbc.E06-08-0733; Hunt NJ, 2015, NEUROBIOL AGING, V36, P292, DOI 10.1016/j.neurobiolaging.2014.08.010; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Jin KL, 2002, J NEUROSCI, V22, P5365; Johren O, 2001, ENDOCRINOLOGY, V142, P3324, DOI 10.1210/en.142.8.3324; Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-1137; Kivipelto M, 2018, NAT REV NEUROL, V14, P653, DOI 10.1038/s41582-018-0070-3; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602; Lemus MB, 2015, ENDOCRINOLOGY, V156, P1701, DOI 10.1210/en.2014-1961; Li P, 2019, J BONE MINER RES, V34, P295, DOI 10.1002/jbmr.3596; Mahler SV, 2014, NAT NEUROSCI, V17, P1298, DOI 10.1038/nn.3810; Manceau R, 2020, DIABETOLOGIA, V63, P673, DOI 10.1007/s00125-020-05104-9; Martins LB, 2019, NUTRITION, V66, P16, DOI 10.1016/j.nut.2019.03.017; Matsumoto S, 2002, BIOCHEM BIOPH RES CO, V292, P781, DOI 10.1006/bbrc.2002.6720; Morello G, 2016, P NATL ACAD SCI USA, V113, P4759, DOI 10.1073/pnas.1521304113; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; Nakagawa T, 1998, DEV BRAIN RES, V108, P263, DOI 10.1016/S0165-3806(98)00057-1; Nevarez N, 2018, F1000RESEARCH, V7; Opanashuk LA, 1999, J NEUROSCI, V19, P133, DOI 10.1523/JNEUROSCI.19-01-00133.1999; Oyagi A, 2011, NEUROSCIENCE, V185, P116, DOI 10.1016/j.neuroscience.2011.04.034; Oyagi A, 2012, CNS NEUROSCI THER, V18, P803, DOI 10.1111/j.1755-5949.2012.00371.x; Oyagi A, 2011, BRAIN RES, V1419, P97, DOI 10.1016/j.brainres.2011.09.003; Pulver A, 2020, BRAIN RES, V1746, DOI 10.1016/j.brainres.2020.147013; Ronan L, 2016, NEUROBIOL AGING, V47, P63, DOI 10.1016/j.neurobiolaging.2016.07.010; Sanchez-Gurmaches J, 2015, STEM CELL REP, V4, P541, DOI 10.1016/j.stemcr.2015.02.008; Sasaki K, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0176-0; Sawai N, 2010, NEUROSCI LETT, V468, P51, DOI 10.1016/j.neulet.2009.10.061; Sellayah D, 2011, CELL METAB, V14, P478, DOI 10.1016/j.cmet.2011.08.010; Shi YC, 2013, CELL METAB, V17, P236, DOI 10.1016/j.cmet.2013.01.006; Shiuchi T, 2009, CELL METAB, V10, P466, DOI 10.1016/j.cmet.2009.09.013; Silva JP, 2009, NATURE, V462, P646, DOI 10.1038/nature08589; Sternson SM, 2017, ANNU REV PHYSIOL, V79, P401, DOI 10.1146/annurev-physiol-021115-104948; Sugiura S, 2005, STROKE, V36, P859, DOI 10.1161/01.STR.0000158905.22871.95; Taylor SR, 2014, SEMIN CELL DEV BIOL, V28, P22, DOI 10.1016/j.semcdb.2014.03.004; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Tsuneki H, 2008, DIABETOLOGIA, V51, P657, DOI 10.1007/s00125-008-0929-8; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Yamazaki S, 2003, J CELL BIOL, V163, P469, DOI 10.1083/jcb.200307035; Yang LY, 2013, J NEUROSCI, V33, P5275, DOI 10.1523/JNEUROSCI.3200-12.2013; Yang SB, 2012, NEURON, V75, P425, DOI 10.1016/j.neuron.2012.03.043; Yelin-Bekerman L, 2015, ELIFE, V4, DOI [10.7554/eLife.08633, 10.7554/eLife.08638]	59	0	0	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21345	10.1096/fj.202001945R	http://dx.doi.org/10.1096/fj.202001945R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715219				2022-12-26	WOS:000635216100091
J	Huebner, R; Mugabi, R; Hetesy, G; Fox, L; De Vliegher, S; De Visscher, A; Barlow, JW; Sensabaugh, G				Huebner, Rebeca; Mugabi, Robert; Hetesy, Gabriella; Fox, Lawrence; De Vliegher, Sarne; De Visscher, Anneleen; Barlow, John W.; Sensabaugh, George			Characterization of genetic diversity and population structure within Staphylococcus chromogenes by multilocus sequence typing	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; INTRAMAMMARY INFECTIONS; IDENTIFICATION; CLONES	Staphylococcus chromogenes is a common skin commensal in cattle and has been identified as a frequent cause of bovine mastitis and intramammary infections. We have developed a seven locus Multilocus Sequence Typing (MLST) scheme for typing S. chromogenes. Sequence-based typing systems, such as MLST, have application in studies of genetic diversity, population structure, and epidemiology, including studies of strain variation as a factor in pathogenicity or host adaptation. The S. chromogenes scheme was tested on 120 isolates collected from three geographic locations, Vermont and Washington State in the United States and Belgium. A total of 46 sequence types (STs) were identified with most of the STs being location specific. The utility of the typing scheme is indicated by a discrimination power of 95.6% for all isolates and greater than 90% for isolates from each of the three locations. Phylogenetic analysis placed 39 of the 46 STs into single core group consistent with a common genetic lineage; the STs in this group differ by less than 0.5% at the nucleotide sequence level. Most of the diversification in this lineage group can be attributed to mutation; recombination plays a limited role. This lineage group includes two clusters of single nucleotide variants in starburst configurations indicative of recent clonal expansion; nearly 50% of the isolates sampled in this study are in these two clusters. The remaining seven STs were set apart from the core group by having alleles with highly variable sequences at one or more loci. Recombination had a higher impact than mutation in the diversification of these outlier STs. Alleles with hypervariable sequences were detected at five of the seven loci used in the MLST scheme; the average sequence distances between the hypervariable alleles and the common core alleles ranged from 12 to 34 nucleotides. The extent of these sequence differences suggests the hypervariable alleles may be remnants of an ancestral genotype.	[Huebner, Rebeca; Sensabaugh, George] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Mugabi, Robert; Hetesy, Gabriella; Barlow, John W.] Univ Vermont, Dept Anim & Vet Sci, Burlington, VT 05405 USA; [Fox, Lawrence] Washington State Univ, Coll Vet Med, Pullman, WA 99164 USA; [De Vliegher, Sarne; De Visscher, Anneleen] Univ Ghent, Fac Vet Med, Dept Reprod Obstet & Herd Hlth, M Team & Mastitis & Milk Qual Res Unit, Merelbeke, Belgium; [Mugabi, Robert] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA; [Hetesy, Gabriella] Royal Vet Coll, Camden Campus, London, England; [De Vliegher, Sarne] Flanders Res Inst Agr Fisheries & Food ILVO Techo, Merelbeke, Belgium	University of California System; University of California Berkeley; University of Vermont; Washington State University; Ghent University; Iowa State University; University of London; University of London Royal Veterinary College	Barlow, JW (corresponding author), Univ Vermont, Dept Anim & Vet Sci, Burlington, VT 05405 USA.	john.barlow@uvm.edu	Barlow, John/C-4876-2013	Barlow, John/0000-0002-7815-9383	University of Vermont College of Agriculture and Life Sciences competitive USDA HATCH experiment station multi-state project [NE1748, NEVT-H01920MS]; USDA Animal Health and Disease Research award [VT-AH02703]; University of Vermont Cancer Center; UVM Larner College of Medicine; Lake Champlain Cancer Research Organization	University of Vermont College of Agriculture and Life Sciences competitive USDA HATCH experiment station multi-state project; USDA Animal Health and Disease Research award; University of Vermont Cancer Center; UVM Larner College of Medicine; Lake Champlain Cancer Research Organization	This study was supported by a University of Vermont College of Agriculture and Life Sciences competitive USDA HATCH experiment station multi-state project (NE1748) award (NEVT-H01920MS) and USDA Animal Health and Disease Research award (VT-AH02703) received by JB. The automated DNA sequencing was performed in Vermont Integrative Genomics Resource DNA Facility, which is supported by University of Vermont Cancer Center, Lake Champlain Cancer Research Organization, and the UVM Larner College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins PRF, 2018, J DAIRY SCI, V101, P5388, DOI 10.3168/jds.2017-13910; Andresen LO, 2005, VET MICROBIOL, V105, P291, DOI 10.1016/j.vetmic.2004.12.006; Gosselin VB, 2018, J DAIRY SCI, V101, P6262, DOI 10.3168/jds.2017-14224; Bexiga R, 2014, J DAIRY RES, V81, P208, DOI 10.1017/S0022029914000041; Bouchami O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156653; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Capurro A, 2009, VET MICROBIOL, V134, P327, DOI 10.1016/j.vetmic.2008.08.028; Chassain B, 2012, J CLIN MICROBIOL, V50, P3003, DOI 10.1128/JCM.00988-12; De Visscher A, 2016, J DAIRY SCI, V99, P6457, DOI 10.3168/jds.2015-10458; De Visscher A, 2016, J DAIRY SCI, V99, P1427, DOI 10.3168/jds.2015-10326; De Vliegher S, 2004, VET MICROBIOL, V101, P215, DOI 10.1016/j.vetmic.2004.03.020; DEVRIESE LA, 1978, INT J SYST BACTERIOL, V28, P482, DOI 10.1099/00207713-28-4-482; Drancourt M, 2002, J CLIN MICROBIOL, V40, P1333, DOI 10.1128/JCM.40.4.1333-1338.2002; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; FEIL E, 2004, BIOINFORMATICS, V186, P1518, DOI DOI 10.1128/JB.186.5.1518-1530.2004; FEIL E, 2003, VET MICROBIOL, V185, P3307, DOI DOI 10.1128/JB.185.11.3307-3316.2003; Feil EJ, 2000, RES MICROBIOL, V151, P465, DOI 10.1016/S0923-2508(00)00168-6; Foster AP, 2012, VET DERMATOL, V23, P342, DOI 10.1111/j.1365-3164.2012.01093.x; FRANCISCO A, 2009, J CLIN MICROBIOL, V10, P152, DOI DOI 10.1186/1471-2105-10-152; Fry Pamela R, 2014, Genome Announc, V2, DOI 10.1128/genomeA.00835-14; GILLESPIE B, 2009, GENETICS, V134, P65, DOI DOI 10.1016/J.VETMIC.2008.09.007; HAJEK V, 1986, SYST APPL MICROBIOL, V8, P169, DOI 10.1016/S0723-2020(86)80071-6; HUDSON RR, 1985, BMC BIOINFORMATICS, V111, P147; HUNTER P, 1988, MOL BIOL EVOL, V26, P2465, DOI DOI 10.1128/JCM.26.11.2465-2466.1988; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jenkins SN, 2019, PEERJ, V7, DOI 10.7717/peerj.6749; Lamers RP, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-171; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; MATTHEWS KR, 1990, J DAIRY SCI, V73, P3457, DOI 10.3168/jds.S0022-0302(90)79044-3; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; Mork T, 2012, VET MICROBIOL, V159, P171, DOI 10.1016/j.vetmic.2012.03.034; Muller ABN, 2017, SYST APPL MICROBIOL, V40, P34, DOI 10.1016/j.syapm.2016.11.005; Naushad S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01990; Park JY, 2011, VET MICROBIOL, V147, P142, DOI 10.1016/j.vetmic.2010.06.020; Pate M, 2012, J DAIRY RES, V79, P129, DOI 10.1017/S0022029911000811; PEREZLOSADA M, 2018, VET MICROBIOL, V63, P346, DOI DOI 10.1016/J.MEEGID.2017.09.022; Piessens V, 2012, VET MICROBIOL, V155, P62, DOI 10.1016/j.vetmic.2011.08.005; Piessens V, 2011, J DAIRY SCI, V94, P2933, DOI 10.3168/jds.2010-3956; RAJALASCHULTZ P, 2009, J DAIRY RES, V134, P55, DOI DOI 10.1016/J.VETMIC.2008.09.008; ROCHA E, 2006, INFECT GENET EVOL, V239, P226, DOI DOI 10.1016/J.JTBI.2005.08.037; Ruiz-Romero RA, 2018, POL J MICROBIOL, V67, P171, DOI 10.21307/pjm-2018-019; Schmidt T, 2015, J DAIRY SCI, V98, P6256, DOI 10.3168/jds.2015-9715; Solyman SM, 2013, J CLIN MICROBIOL, V51, P306, DOI 10.1128/JCM.02421-12; Supre K, 2011, J DAIRY SCI, V94, P2329, DOI 10.3168/jds.2010-3741; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taponen S, 2008, J DAIRY RES, V75, P422, DOI 10.1017/S0022029908003312; Vanderhaeghen W, 2015, VET J, V203, P44, DOI 10.1016/j.tvjl.2014.11.001; WHITE DG, 1989, J DAIRY SCI, V72, P1886, DOI 10.3168/jds.S0022-0302(89)79307-3; Wuytack A, 2020, VET RES, V51, DOI 10.1186/s13567-020-00761-5; Zhang L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058440, 10.1371/journal.pone.0066496]	51	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0243688	10.1371/journal.pone.0243688	http://dx.doi.org/10.1371/journal.pone.0243688			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720932	Green Submitted, Green Published, gold			2022-12-26	WOS:000629667400027
J	Chuang, A; Nguyen, MT; Khan, E; Jones, D; Horsfall, M; Lehman, S; Smilowitz, NR; Lambrakis, K; Than, M; Vaile, J; Sinhal, A; French, JK; Chew, DP				Chuang, Anthony (Ming-yu); Nguyen, Mau T.; Khan, Ehsan; Jones, Dylan; Horsfall, Matthew; Lehman, Sam; Smilowitz, Nathaniel R.; Lambrakis, Kristina; Than, Martin; Vaile, Julian; Sinhal, Ajay; French, John K.; Chew, Derek P.			Troponin elevation pattern and subsequent cardiac and non-cardiac outcomes: Implementing the Fourth Universal Definition of Myocardial Infarction and high-sensitivity troponin at a population level	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; RULE-OUT; RANDOMIZED-TRIAL; TYPE-2; ALGORITHM; SURVIVAL; MODELS; IMPACT; INJURY	Background The Fourth Universal Definition of Myocardial Infarction (MI) differentiates MI from myocardial injury. We characterised the temporal course of cardiac and non-cardiac outcomes associated with MI, acute and chronic myocardial injury. Methods We included all patients presenting to public emergency departments in South Australia between June 2011-Sept 2019. Episodes of care (EOCs) were classified into 5 groups based on high-sensitivity troponin-T (hs-cTnT) and diagnostic codes: 1) Acute MI [rise/fall in hs-cTnT and primary diagnosis of acute coronary syndrome], 2) Acute myocardial injury with coronary artery disease (CAD) [rise/fall in hs-cTnT and diagnosis of CAD], 3) Acute myocardial injury without CAD [rise/fall in hs-cTnT without diagnosis of CAD], 4) Chronic myocardial injury [elevated hs-cTnT without rise/fall], and 5) No myocardial injury. Multivariable flexible parametric models were used to characterize the temporal hazard of death, MI, heart failure (HF), and ventricular arrhythmia. Results 372,310 EOCs (218,878 individuals) were included: acute MI (19,052 [5.12%]), acute myocardial injury with CAD (6,928 [1.86%]), acute myocardial injury without CAD (32,231 [8.66%]), chronic myocardial injury (55,056 [14.79%]), and no myocardial injury (259,043 [69.58%]). We observed an early hazard of MI and HF after acute MI and acute myocardial injury with CAD. In contrast, subsequent MI risk was lower and more constant in patients with acute injury without CAD or chronic injury. All patterns of myocardial injury were associated with significantly higher risk of all-cause mortality and ventricular arrhythmia. Conclusions Different patterns of myocardial injury were associated with divergent profiles of subsequent cardiac and non-cardiac risk. The therapeutic approach and modifiability of such excess risks require further research.	[Chuang, Anthony (Ming-yu); Nguyen, Mau T.; Khan, Ehsan; Jones, Dylan; Horsfall, Matthew; Lehman, Sam; Lambrakis, Kristina; Vaile, Julian; Sinhal, Ajay; Chew, Derek P.] Flinders Univ South Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia; [Chuang, Anthony (Ming-yu); Nguyen, Mau T.; Khan, Ehsan; Jones, Dylan; Lehman, Sam; Lambrakis, Kristina; Vaile, Julian; Sinhal, Ajay; Chew, Derek P.] Southern Adelaide Local Hlth Network, Dept Cardiovasc Med, Adelaide, SA, Australia; [Smilowitz, Nathaniel R.] NYU, Sch Med, Dept Med, Div Cardiol, New York, NY USA; [Than, Martin] Christchurch Hosp, Dept Emergency Med, Christchurch, New Zealand; [French, John K.] Univ New South Wales, South Western Sydney Clin Sch, Sydney, NSW, Australia; [French, John K.] Western Sydney Univ, Sydney, NSW, Australia	Flinders University South Australia; New York University; Christchurch Hospital New Zealand; University of New South Wales Sydney; Western Sydney University	Chuang, A (corresponding author), Flinders Univ South Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia.; Chuang, A (corresponding author), Southern Adelaide Local Hlth Network, Dept Cardiovasc Med, Adelaide, SA, Australia.	anthonychuang4@gmail.com		Chew, Derek/0000-0003-3593-296X; Lambrakis, Kristina/0000-0002-6221-0244; chuang, ming-yu/0000-0001-9898-9782	Royal Australasian College of Physicians' Fellows Research Entry grant	Royal Australasian College of Physicians' Fellows Research Entry grant	Dr Anthony (Ming-yu) Chuang is supported by the Royal Australasian College of Physicians' Fellows Research Entry grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Samkari H, 2020, BLOOD, V136, P489, DOI 10.1182/blood.2020006520; Alatassi A, 2018, BMC ANESTHESIOL, V18, DOI 10.1186/s12871-018-0515-7; Alpert JS, 2014, AM J MED, V127, P105, DOI 10.1016/j.amjmed.2013.09.031; Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI [10.1161/CIR.0000000000000134, 10.1161/CIR.0000000000000151]; Baron T, 2015, HEART, V101, P101, DOI 10.1136/heartjnl-2014-306093; Cediel G, 2017, HEART, V103, P616, DOI 10.1136/heartjnl-2016-310243; Chapman AR, 2020, CIRCULATION, V141, P1733, DOI 10.1161/CIRCULATIONAHA.120.047008; Chapman AR, 2018, CIRCULATION, V137, P1236, DOI 10.1161/CIRCULATIONAHA.117.031806; Chew DP, 2015, EUR HEART J-ACUTE CA, V4, P419, DOI 10.1177/2048872614564083; Chuang A, 2016, INT J CARDIOL, V204, P106, DOI 10.1016/j.ijcard.2015.11.132; Eggers KM, 2019, J AM COLL CARDIOL, V73, P1, DOI 10.1016/j.jacc.2018.09.082; Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017; Gupta S, 2017, CARDIOVASC DIAGN THE, V7, P348, DOI 10.21037/cdt.2017.03.21; Lambrakis K, 2019, AM HEART J, V208, P11, DOI 10.1016/j.ahj.2018.09.016; McFalls EO, 2011, AM J MED, V124, P630, DOI 10.1016/j.amjmed.2011.02.024; Mueller C, 2016, ANN EMERG MED, V68, P76, DOI 10.1016/j.annemergmed.2015.11.013; Nelson CP, 2007, STAT MED, V26, P5486, DOI 10.1002/sim.3064; Papendick C, 2017, AM HEART J, V190, P25, DOI 10.1016/j.ahj.2017.05.004; Putot A, 2018, AM J MED, V131, P1209, DOI 10.1016/j.amjmed.2018.04.032; Reichlin T, 2015, CAN MED ASSOC J, V187, pE243, DOI 10.1503/cmaj.141349; Reichlin T, 2015, AM J MED, V128, P369, DOI 10.1016/j.amjmed.2014.10.032; Reichlin T, 2012, AM J MED, V125, P1205, DOI 10.1016/j.amjmed.2012.07.015; Reichlin T, 2012, ARCH INTERN MED, V172, P1211, DOI 10.1001/archinternmed.2012.3698; Roffi M, 2016, G ITAL CARDIOL, V17, P831, DOI [10.1093/eurheartj/ehv320, 10.1714/2464.25804]; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Sandoval Y, 2019, AM J MED, V132, P869, DOI 10.1016/j.amjmed.2019.01.043; Sandoval Y, 2017, AM J MED, V130, P1431, DOI 10.1016/j.amjmed.2017.05.049; Sarkisian L, 2016, AM J MED, V129, P506, DOI 10.1016/j.amjmed.2015.12.009; Sarkisian L, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2015.11.006; Shah ASV, 2018, LANCET, V392, P919, DOI 10.1016/S0140-6736(18)31923-8; Shah ASV, 2015, AM J MED, V128, P493, DOI 10.1016/j.amjmed.2014.10.056; Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950; Thygesen K., 2018, GLOB HEART, V72, P2231, DOI 10.1016/j.jacc.2018.08.1038; Thygesen K, 2012, EUR HEART J, V33, P2252, DOI 10.1093/eurheartj/ehs154; Thygesen K, 2010, EUR HEART J, V31, P2197, DOI 10.1093/eurheartj/ehq251; Vallet H, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006169; Webb IG, 2015, HEART LUNG CIRC, V24, P142, DOI 10.1016/j.hlc.2014.07.071	37	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0248289	10.1371/journal.pone.0248289	http://dx.doi.org/10.1371/journal.pone.0248289			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711079	Green Published, gold			2022-12-26	WOS:000629591800026
J	Arciuolo, R; Leggieri, MC; Chiusa, G; Castello, G; Genova, G; Spigolon, N; Battilani, P				Arciuolo, Roberta; Leggieri, Marco Camardo; Chiusa, Giorgio; Castello, Giuseppe; Genova, Giuseppe; Spigolon, Nicola; Battilani, Paola			Ecology of Diaporthe eres, the causal agent of hazelnut defects	PLOS ONE			English	Article							ASPERGILLUS-FLAVUS; WATER ACTIVITY; WOOD CANKERS; TEMPERATURE; GRAPE; INFECTION; CONIDIA; CONTAMINATION; SPORULATION; GERMINATION	Diaporthe eres has been recently reported as the causal agent of hazelnut defects, with characteristic brown spots on the kernels surface and internal fruit discoloration. Knowledge regarding the ecology of this fungus is poor but, is critical to support a rationale and effective hazelnut crop protection strategy. Therefore, a study was performed to describe and model the effect of different abiotic factors such as temperature (T, 5-35 degrees C, step 5 degrees C) and water activity (a(w) 0.83-0.99, step 0.03) regimes on D. eres mycelial growth, pycnidial conidiomata development and asexual spore production during a 60-day incubation period. Alpha conidia germination was tested in the same T range and at different relative humidities (RH = 94, 97 and 100%) over 48 h incubation period. Fungal growth was observed from the first visual observation; regarding pycnidia and cirrhi, their development started after 8 and 19 days of incubation, respectively and increased over time. The optimum T for growth was 20-25 degrees C and for pycnidia and cirrhi development was 30 degrees C; a(w) >= 0.98 was optimal for the tested steps of the fungal cycle. The best condition for conidial germination of D. eres was at 25 degrees C with RH = 100%. Quantitative data obtained were fitted using non- linear regression functions (Bete, logistic and polynomial), which provided a very good fit of the biological process (R-2 = 0.793-0.987). These functions could be the basis for the development of a predictive model for the infection of D. eres of hazelnuts.	[Arciuolo, Roberta; Leggieri, Marco Camardo; Chiusa, Giorgio; Battilani, Paola] Univ Cattolica Sacro Cuore, Dept Sustainable Crop Prod, Piacenza, PC, Italy; [Castello, Giuseppe; Genova, Giuseppe; Spigolon, Nicola] SOREMARTEC ITALIA Srl, Piazzale Pietro Ferrero 1, Alba, CN, Italy	Catholic University of the Sacred Heart	Battilani, P (corresponding author), Univ Cattolica Sacro Cuore, Dept Sustainable Crop Prod, Piacenza, PC, Italy.	paola.battilani@unicatt.it		Camardo Leggieri, Marco/0000-0002-6547-7702; Battilani, Paola/0000-0003-1287-1711	Fondazione Romeo ed Enrica Invernizzi	Fondazione Romeo ed Enrica Invernizzi	SOREMARTEC ITALIA S.r.l provided support in the form of salary for authors Giuseppe Castello, Giuseppe Genova and Nicola Spigolon, and provided support in the form of research materials. Fondazione Romeo ed Enrica Invernizzi provided partial support in the form of scholarship for Roberta Arciuolo. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agrios GN., 2005, PLANT PATHOL, VVth Edition, DOI [10.1094/PD-89-1013A, DOI 10.1094/PD-89-1013A]; Aldwinkle HS, 1990, COMPENDIUM APPLE PEA, P38; Anagnostakis SL, 2007, PLANT DIS, V91, P1198, DOI 10.1094/PDIS-91-9-1198C; ANALYTIS S, 1977, PHYTOPATHOL Z, V90, P64; Anco DJ, 2012, PLANT DIS, V96, P1297, DOI 10.1094/PDIS-09-11-0806-RE; Arciuolo R, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.611655; Arsenijevic M., 2005, Acta Agriculturae Slovenica, V85, P107; Bai Q, 2015, PLANT DIS, V99, P1704, DOI 10.1094/PDIS-03-15-0259-RE; Banihashemi Z, 2009, PHYTOPATHOL MEDITERR, V48, P454; Battilani P, 2013, COMPUT ELECTRON AGR, V94, P38, DOI 10.1016/j.compag.2013.03.005; Battilani P, 2018, PHYTOPATHOL MEDITERR, V57, P320, DOI 10.14601/Phytopathol_Mediterr-22872; Battilani P, 2016, CURR OPIN FOOD SCI, V11, P10, DOI 10.1016/j.cofs.2016.08.009; Baumgartner K, 2013, PLANT DIS, V97, P912, DOI 10.1094/PDIS-04-12-0357-RE; BEUCHAT LR, 1978, J FOOD SCI, V43, P754, DOI 10.1111/j.1365-2621.1978.tb02410.x; Leggieri MC, 2014, FUNGAL BIOL-UK, V118, P996, DOI 10.1016/j.funbio.2014.09.005; CHRISTENSEN CM, 1965, ANNU REV PHYTOPATHOL, V3, P69, DOI 10.1146/annurev.py.03.090165.000441; Ciliberti N, 2015, PHYTOPATHOLOGY, V105, P325, DOI 10.1094/PHYTO-05-14-0152-R; Dallyn H., 1980, MICROBIAL GROWTH SUR, P129; Duthie JA, 1997, PHYTOPATHOLOGY, V87, P1088, DOI 10.1094/PHYTO.1997.87.11.1088; Fedele G, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10020222; Fleurat-Lessard F, 2017, J STORED PROD RES, V71, P22, DOI 10.1016/j.jspr.2016.10.002; Ghali R, 2008, FOOD CONTROL, V19, P921, DOI 10.1016/j.foodcont.2007.09.003; Ghirardello D, 2013, POSTHARVEST BIOL TEC, V81, P37, DOI 10.1016/j.postharvbio.2013.02.014; GILLIGAN CA, 1990, NEW PHYTOL, V115, P223, DOI 10.1111/j.1469-8137.1990.tb00448.x; Gonzalez-Dominguez E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107547; Guarnaccia V, 2018, PERSOONIA, V40, P135, DOI 10.3767/persoonia.2018.40.06; Contreras JG, 2020, PLANT DIS, V104, P975, DOI 10.1094/PDIS-06-19-1166-PDN; Huang ChiaoWen, 2016, Journal of Taiwan Agricultural Research, V65, P45; Ji ZhaoLin, 2014, Journal of Yangzhou University, Agricultural and Life Sciences Edition, V35, P104; Karaoglanidis GS, 2006, PLANT DIS, V90, P375, DOI 10.1094/PD-90-0375C; Lawrence DP, 2015, MYCOLOGIA, V107, P926, DOI 10.3852/14-353; Leggieri MC, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02653; Li BH, 2005, PLANT PATHOL, V54, P357, DOI 10.1111/j.1365-3059.2005.01207.x; Liu Chao, 2011, Journal of Northwest A & F University - Natural Science Edition, V39, P203; Liu ZhiHeng, 2008, Journal of Shenyang Agricultural University, V39, P301; Lombard L, 2014, PHYTOPATHOL MEDITERR, V53, P287; Madden L. V., 1988, Experimental techniques in plant disease epidemiology., P191; Madden L.V., 2007, STUDY PLANT DIS EPID; MAGAN N, 1985, T BRIT MYCOL SOC, V85, P29, DOI 10.1016/S0007-1536(85)80153-4; Manstretta V, 2016, APPL ENVIRON MICROB, V82, P184, DOI 10.1128/AEM.02436-15; Mathew F., 2018, PLANT HLTH INSTRUCTO; Moschini RC, 2019, AUSTRALAS PLANT PATH, V48, P519, DOI 10.1007/s13313-019-00655-x; Mousa W, 2016, J STORED PROD RES, V67, P49, DOI 10.1016/j.jspr.2016.01.003; Nabetani K, 2017, CAN J PLANT PATHOL, V39, P405, DOI 10.1080/07060661.2017.1375995; Nakatami F., 1990, COMPENDIUM APPLE PEA, P38; Nazari L, 2016, FUNGAL BIOL-UK, V120, P562, DOI 10.1016/j.funbio.2016.01.010; Onesti G, 2018, AUST J GRAPE WINE R, V24, P136, DOI 10.1111/ajgw.12321; Patil P. D., 2016, Plant Archives, V16, P275; Pearson R.C., 1994, COMPENDIUM GRAPE DIS, P17; Pezet R, 1974, J PHYTOPATHOL, V79, P67, DOI DOI 10.1111/J.1439-0434.1974.TB02690.X; Pscheidt JW, 2019, PLANT DIS, V103, P922, DOI 10.1094/PDIS-09-18-1520-RE; Pscheidt JW., 1991, DIS IDENTIFICATION, V6; Rossi V, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9110710; Rossman AY, 2015, IMA FUNGUS, V6, P145, DOI 10.5598/imafungus.2015.06.01.09; Samson R., 2004, INTRO FOOD AIRBORNE; Sergeeva V, 2003, AUSTRALAS PLANT PATH, V32, P105, DOI 10.1071/AP02072; Thomidis T, 2009, PLANT DIS, V93, P1293, DOI 10.1094/PDIS-93-12-1293; Trecate L, 2019, PLANT PATHOL, V68, P1165, DOI 10.1111/ppa.13038; Udayanga D, 2014, FUNGAL DIVERS, V67, P203, DOI 10.1007/s13225-014-0297-2; Vrandecic K, 2011, PLANT DIS, V95, P612, DOI 10.1094/PDIS-11-10-0860; Wiman NG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223500; Yang Q, 2018, MYCOKEYS, P97, DOI 10.3897/mycokeys.39.26914; Yi RunHua, 2018, Scientia Silvae Sinicae, V54, P80; Zehr EI., 1995, COMPENDIUM STONE FRU, P30; Zheng HuaYing, 2011, Journal of Jiangsu Forestry Science & Technology, V38, P11	65	6	6	7	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0247563	10.1371/journal.pone.0247563	http://dx.doi.org/10.1371/journal.pone.0247563			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690684	Green Published, gold			2022-12-26	WOS:000627854700037
J	Bitarakwate, E; Ashburn, K; Kazooba, P; Khamasi, R; Natumanya, E; Herrera, N; Owomugisha, B; Malkin, RA; Kisaakye, L				Bitarakwate, Edward; Ashburn, Kim; Kazooba, Patrick; Khamasi, Ronald; Natumanya, Eliab; Herrera, Nicole; Owomugisha, Boaz; Malkin, Robert A.; Kisaakye, Linda			Effects of the Pratt pouch model of dispensing nevirapine prophylaxis on HIV exposed infant completion of 6 weeks of prophylaxis in Uganda	PLOS ONE			English	Article								Introduction The innovative Pratt pouch could optimize dispensing nevirapine prophylaxis to HIV-exposed infants in pre-measured single dose pouches to increase completion of the full 6 week infant nevirapine regimen. Materials and methods Nineteen health facilities with highest HIV positivity rates among pregnant women across 9 districts in southwest and central Uganda were assigned to control and intervention groups. HIV-positive women enrolled at intervention facilities received pouches filled with premeasured single doses of nevirapine using Uganda national guidelines, which were integrated into the existing drug distribution system. During antenatal care (ANC) women received 14 pouches to cover time until the 6 day postpartum visit, with an additional 8 pouches if women were delayed in returning to the facility, and 28 pouches after delivery. Women enrolled at control facilities received standard nevirapine syrup following delivery for postnatal infant prophylaxis. In a select number of intervention facilities, during ANC, women received all 42 pouches needed to complete the 6 weeks regimen. Medical record data from enrolled women were extracted; interviews with HIV-positive women during postnatal care visits were conducted. Data were collected January to August 2018 (control sites) and October 2019 to February 2020 (intervention sites). Unadjusted and adjusted logistic regression models were used to identify factors associated with facility delivery, postnatal care follow-up visit, and completion of the full 6 weeks infant nevirapine regimen. Results Significantly more women in the intervention (n = 320) versus control (n = 340) group had facility delivery (292/316, 92.4% versus 169/340, 49.7%, p<0.0001), postnatal visits within 2 weeks postpartum (295/297, 99.3% versus 133/340, 39.1%, p<0.0001) and reported their infants completing the full 6 weeks infant prophylaxis regimen (299/313, 95.5% versus 210/242, 86.8%, p = 0.0002). Dispensing 42 versus 14 pouches during ANC did not have negative effects on these outcomes. Among out-of-facility deliveries, a higher proportion of infants received nevirapine within 72 hours of birth in the intervention versus control group, 95.8% versus 77.9%. In multivariate models, the intervention group was the only significant factor associated with facility delivery or completion of the full 6 weeks infant prophylaxis. Conclusions Use of the Pratt pouch resulted in an increase in HIV-exposed infants completing the full 6weeks prophylaxis regimen and associated benefits including increasing facility delivery and women's adherence to postnatal care services.	[Bitarakwate, Edward; Kazooba, Patrick; Khamasi, Ronald; Natumanya, Eliab; Owomugisha, Boaz] Elizabeth Glaser Pediat AIDS fdn EGPAF, Kampala, Uganda; [Ashburn, Kim; Herrera, Nicole] Elizabeth Glaser Pediat AIDS Fdn, Washington, DC 20036 USA; [Malkin, Robert A.] Duke Univ, Biomed Engn, Durham, NC USA; [Kisaakye, Linda] Uganda Minist Hlth, Kampala, Uganda	Duke University	Ashburn, K (corresponding author), Elizabeth Glaser Pediat AIDS Fdn, Washington, DC 20036 USA.	kimberly.ashburn@gmail.com			United States Agency for International Development USAID [AID-OAA-A-16-00010]	United States Agency for International Development USAID(United States Agency for International Development (USAID)CGIAR)	This study was made possible by the generous support of the United States Agency for International Development USAID Cooperative Agreement AID-OAA-A-16-00010 (March 16, 2016 to March 15, 2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, HIV DRUG RESISTANCE; [Anonymous], 2020, **DROPPED REF**; [Anonymous], 2019, UG MIN HLTH DHIS2 DA; [Anonymous], SAS SOFTWARE VERSION; Choy A, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001030; Dahinten AP, 2016, PEDIATR INFECT DIS J, V35, P987, DOI 10.1097/INF.0000000000001224; Dahinten Alexander P, 2016, Open Biomed Eng J, V10, P12, DOI 10.2174/1874120701610010012; Joint United Nations Programme for HIV/AIDS, 2019, START FREE STAY FREE; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2014, GAP REP; Malkin RA., 2013, J BIOMED ENG RES, V2, P66; Malkin Robert, 2012, Open Biomed Eng J, V6, P92, DOI 10.2174/1874120701206010092; Ministry of Health Uganda, UG AIDS COUNTR PROGR; Spiegel GJ, 2013, ANN BIOMED ENG, V41, P1860, DOI 10.1007/s10439-013-0780-z; Uganda Ministry of Health, 2016, SPECTR EST 2015 16	14	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0247507	10.1371/journal.pone.0247507	http://dx.doi.org/10.1371/journal.pone.0247507			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690610	gold, Green Published			2022-12-26	WOS:000627854700006
J	Prause, N; Siegle, GJ; Coan, J				Prause, Nicole; Siegle, Greg J.; Coan, James			Partner intimate touch is associated with increased interpersonal closeness, especially in non-romantic partners	PLOS ONE			English	Article							SEXUAL FREQUENCY; SOCIAL REGULATION; DATING RELATIONSHIPS; ADULT ATTACHMENT; SELF-EXPANSION; CASUAL SEX; SATISFACTION; EXPERIENCES; VALIDITY; WOMEN	Relationship closeness promotes desirable health outcomes. Most interventions to increase relationship closeness are verbal, which may not suit all couples. We consider whether Orgasmic Meditation (OM), a structured, partnered, largely non-verbal practice that includes genital touch, also increases relationship closeness. We hypothesized that OM would increase feelings of closeness for both romantic and non-romantic partners. This is important, because intimate touch with non-romantic partners is commonly considered deleterious by clinicians, which may inadvertently increase feelings of shame. Dyads (n = 125) reported their feelings of closeness before and after OM. Approximately half of the participants were romantic partners, while the other half only engaged in OM together (non-romantic). Closeness after OM increased on average across participants. Non-romantic dyads increased self-other overlap more than romantic dyads. These data support that a partnered, largely non-verbal practice is associated with increased feelings of closeness in the moment, including for individuals who are not in a romantic relationship.	[Prause, Nicole] Liberos, Los Angeles, CA 90028 USA; [Siegle, Greg J.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Coan, James] Univ Virginia, Dept Psychol, Charlottesville, NC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Virginia	Prause, N (corresponding author), Liberos, Los Angeles, CA 90028 USA.	Nicole.Prause@gmail.com		Prause, Nicole/0000-0002-1420-9177	OM Free	OM Free	This study was supported by OM Free, a 501(c)3 nonprofit URL: http://www.iomfoundation.org/.	Aron A, 1997, PERS SOC PSYCHOL B, V23, P363, DOI 10.1177/0146167297234003; ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Aron A., 2013, OXFORD HDB CLOSE REL, DOI 10.1093/oxfordhb/9780195398694.013.0005; Bancroft J, 2003, ARCH SEX BEHAV, V32, P193, DOI 10.1023/A:1023420431760; Beckes L, 2013, SOC COGN AFFECT NEUR, V8, P670, DOI 10.1093/scan/nss046; Blair KL, 2018, J SEX RES, V55, P719, DOI 10.1080/00224499.2017.1303437; Bohns VK, 2013, SOC COGNITION, V31, P1; Bradshaw C, 2010, SEX ROLES, V62, P661, DOI 10.1007/s11199-010-9765-7; Branand B, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02399; Brennan K.AC.C.L., 1998, ATTACHMENT THEORY CL, P46, DOI DOI 10.1037/T03763-000; Bretz MN., 2008, PSYCEXTRA DATASET, DOI [10.1037/e626972012-179, DOI 10.1037/E626972012-179]; Brisini KS, 2019, COMMUN Q, V67, P424, DOI 10.1080/01463373.2019.1605398; Campbell L, 2008, PERS RELATIONSHIP, V15, P41, DOI 10.1111/j.1475-6811.2007.00183.x; Carlisle M, 2012, HEALTH PSYCHOL, V31, P217, DOI 10.1037/a0025187; Carson JW, 2004, BEHAV THER, V35, P471, DOI 10.1016/S0005-7894(04)80028-5; Chivers ML, 2010, ARCH SEX BEHAV, V39, P5, DOI 10.1007/s10508-009-9556-9; Cialdini RB, 1997, J PERS SOC PSYCHOL, V73, P481, DOI 10.1037/0022-3514.73.3.481; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; Coan JA, 2017, SOC COGN AFFECT NEUR, V12, P1574, DOI 10.1093/scan/nsx091; Coan JA, 2015, CURR OPIN PSYCHOL, V1, P87, DOI 10.1016/j.copsyc.2014.12.021; Collins NL, 2004, HANDBOOK OF CLOSENESS AND INTIMACY, P163; Conley TD, 2013, PSYCHOL WOMEN QUART, V37, P392, DOI 10.1177/0361684312467169; COOPER J, 1978, J PERS SOC PSYCHOL, V36, P1101, DOI 10.1037/0022-3514.36.10.1101; Cooper ML, 1998, J PERS SOC PSYCHOL, V75, P1528, DOI 10.1037/0022-3514.75.6.1528; Crocker J, 2017, J PERS SOC PSYCHOL, V112, P58, DOI 10.1037/pspi0000076; Cundiff JM, 2015, PERS SOC PSYCHOL B, V41, P35, DOI 10.1177/0146167214557002; Cwir D, 2011, J EXP SOC PSYCHOL, V47, P661, DOI 10.1016/j.jesp.2011.01.009; Davis D, 2004, PERS SOC PSYCHOL B, V30, P1076, DOI 10.1177/0146167204264794; Davis MH, 1996, J PERS SOC PSYCHOL, V70, P713, DOI 10.1037/0022-3514.70.4.713; Dibble JL, 2012, PSYCHOL ASSESSMENT, V24, P565, DOI 10.1037/a0026265; Dube S, 2017, J SEX RES, V54, P1006, DOI 10.1080/00224499.2016.1255874; Edmond M., 2004, JOY PARTNER YOGA; Egan PM, 2012, J EXP SOC PSYCHOL, V48, P457, DOI 10.1016/j.jesp.2011.10.019; Farvid P, 2017, J SEX RES, V54, P73, DOI 10.1080/00224499.2016.1143442; Fischer N, 2020, EUR J AGEING, V17, P151, DOI 10.1007/s10433-019-00541-x; Forsythe KE, 2015, COMMUN STUD, V66, P321, DOI 10.1080/10510974.2015.1018444; Fraley RC, 2011, PSYCHOL ASSESSMENT, V23, P615, DOI 10.1037/a0022898; Galecki A, 2013, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-1-4614-3900-4; Garcia JR., 2018, J RELATIONSHIPS RES, V9, DOI [10.1017/jrr.2018.19, DOI 10.1017/JRR.2018.19]; Garcia JR., 2008, J SOC EVOL CULT PSYC, V2, DOI [10.1037/h0099345, DOI 10.1037/H0099345]; Gazzola V, 2012, P NATL ACAD SCI USA, V109, pE1657, DOI 10.1073/pnas.1113211109; Gillespie BJ, 2017, J SEX MARITAL THER, V43, P403, DOI 10.1080/0092623X.2016.1176608; Gordon CL, 2011, PERS INDIV DIFFER, V51, P89, DOI 10.1016/j.paid.2011.03.015; Graham JM, 2008, J PERS SOC PSYCHOL, V95, P679, DOI 10.1037/0022-3514.95.3.679; Haupert ML, 2017, J SEX MARITAL THER, V43, P424, DOI 10.1080/0092623X.2016.1178675; HEIMAN JR, 1983, J PSYCHOSOM RES, V27, P105, DOI 10.1016/0022-3999(83)90086-7; Herbenick D., 2018, J SEX MARITAL THER, P1, DOI [10.1080/0092623X.2017.1305029, DOI 10.1080/0092623X.2017.1305029]; Hook JN, 2008, SEX ADDICT COMPULS, V15, P217, DOI 10.1080/10720160802288829; Hudson NW, 2017, PERS RELATIONSHIP, V24, P17, DOI 10.1111/pere.12166; Janssen E, 2000, J SEX RES, V37, P8, DOI 10.1080/00224490009552016; Jonsson EH, 2015, J SEX MED, V12, P1338, DOI 10.1111/jsm.12905; Johnson SM, 2011, BAS PRINCIPLE PRACT, P1; JOHNSON SM, 1985, J MARITAL FAM THER, V11, P313, DOI 10.1111/j.1752-0606.1985.tb00624.x; Kang SK, 2010, J EXP SOC PSYCHOL, V46, P229, DOI 10.1016/j.jesp.2009.09.012; Kashdan TB, 2018, EMOTION, V18, P563, DOI 10.1037/emo0000324; Kohut T, 2018, J SOC PERS RELAT, V35, P655, DOI 10.1177/0265407517743096; Laan E, 2008, J SEX MED, V5, P1424, DOI 10.1111/j.1743-6109.2008.00827.x; Lambert TA, 2003, J SEX RES, V40, P129, DOI 10.1080/00224490309552174; Larson CM, 2013, HORM BEHAV, V63, P128, DOI 10.1016/j.yhbeh.2012.10.005; Lefcheck J., 2018, PIECEWISE STRUCTURAL; Lehmiller JJ, 2014, J SEX RES, V51, P74, DOI 10.1080/00224499.2012.719167; LEIGH BC, 1989, J SEX RES, V26, P199, DOI 10.1080/00224498909551506; Lewandowski GW, 2004, SOC BEHAV PERSONAL, V32, P361, DOI 10.2224/sbp.2004.32.4.361; Loewenstein G, 2015, J ECON BEHAV ORGAN, V116, P206, DOI 10.1016/j.jebo.2015.04.021; Manne S, 2008, CANCER-AM CANCER SOC, V112, P2541, DOI 10.1002/cncr.23450; Mashek D, 2007, J COMMUNITY PSYCHOL, V35, P257, DOI 10.1002/jcop.20146; Masters W.H., 1980, HUMAN SEXUAL RESPONS; Mattingly BA, 2014, SOC PERSONAL PSYCHOL, V8, P30, DOI 10.1111/spc3.12080; Mattingly BA, 2012, PERS RELATIONSHIP, V19, P113, DOI 10.1111/j.1475-6811.2010.01343.x; Meltzer AL, 2010, J FAM PSYCHOL, V24, P156, DOI 10.1037/a0019063; Mendle J, 2013, J ABNORM PSYCHOL, V122, P51, DOI 10.1037/a0029816; Morry MM, 2010, J SOC PSYCHOL, V150, P369, DOI 10.1080/00224540903365471; Muise A, 2019, J PERS SOC PSYCHOL, V116, P237, DOI 10.1037/pspi0000148; Muise A, 2016, SOC PSYCHOL PERS SCI, V7, P295, DOI 10.1177/1948550615616462; Myers MW, 2014, MOTIV EMOTION, V38, P224, DOI 10.1007/s11031-013-9377-y; Neuberg SL, 1997, J PERS SOC PSYCHOL, V73, P510; Oveis C, 2010, J PERS SOC PSYCHOL, V98, P618, DOI 10.1037/a0017628; Owen J, 2011, ARCH SEX BEHAV, V40, P331, DOI 10.1007/s10508-010-9697-x; Pallesen S, 2020, SLEEP BIOL RHYTHMS, V18, P65, DOI 10.1007/s41105-019-00246-9; Paolucci EO, 2001, J PSYCHOL, V135, P17, DOI 10.1080/00223980109603677; Parks MR, 1996, J SOC PERS RELAT, V13, P85, DOI 10.1177/0265407596131005; Peterson ZD, 2007, ARCH SEX BEHAV, V36, P793, DOI 10.1007/s10508-006-9145-0; Picardi A, 2005, PSYCHOL PSYCHOTHER-T, V78, P327, DOI 10.1348/147608305X26882; Postmes T, 2013, BRIT J SOC PSYCHOL, V52, P597, DOI 10.1111/bjso.12006; Ramsey MA, 2015, DEV REV, V36, P58, DOI 10.1016/j.dr.2015.01.003; Richters J, 2003, AUST NZ J PUBL HEAL, V27, P171, DOI 10.1111/j.1467-842X.2003.tb00805.x; Rise MB, 2014, INT J SOC PSYCHIATR, V60, P134, DOI 10.1177/0020764012471278; Rubin H, 2012, SOC PSYCHOL PERS SCI, V3, P224, DOI 10.1177/1948550611416520; Sanders SA, 1999, JAMA-J AM MED ASSOC, V281, P275, DOI 10.1001/jama.281.3.275; Santtila P, 2008, J SEX MARITAL THER, V34, P29, DOI 10.1080/00926230701620548; Schermuly-Haupt ML, 2018, COGNITIVE THER RES, V42, P219, DOI 10.1007/s10608-018-9904-y; Schmiedeberg C, 2017, ARCH SEX BEHAV, V46, P465, DOI 10.1007/s10508-016-0843-y; Schober JM, 2004, BJU INT, V94, P589, DOI 10.1111/j.1464-410X.2004.05006.x; Schoenfeld EA, 2017, ARCH SEX BEHAV, V46, P489, DOI 10.1007/s10508-015-0672-4; Shadish WR, 2003, J MARITAL FAM THER, V29, P547, DOI 10.1111/j.1752-0606.2003.tb01694.x; Sibley CG, 2005, PERS SOC PSYCHOL B, V31, P1524, DOI 10.1177/0146167205276865; SIMON W, 1986, ARCH SEX BEHAV, V15, P97, DOI 10.1007/BF01542219; Staley C, 2013, ARCH SEX BEHAV, V42, P615, DOI 10.1007/s10508-012-0034-4; Sutton TE, 2015, J CHILD FAM STUD, V24, P2827, DOI 10.1007/s10826-014-0087-1; Tan ESN, 2010, PSYCHOTHERAPY, V47, P500, DOI 10.1037/a0022081; Tan QB, 2015, PERS INDIV DIFFER, V73, P7, DOI 10.1016/j.paid.2014.08.038; Testa M, 1999, J INTERPERS VIOLENCE, V14, P548, DOI 10.1177/088626099014005006; Tholander M, 2020, SEX CULT, V24, P1397, DOI 10.1007/s12119-019-09690-8; VAUX A, 1988, J SOC CLIN PSYCHOL, V6, P462, DOI 10.1521/jscp.1988.6.3-4.462; Ven TV, 2009, SOCIOL SPECTRUM, V29, P626, DOI 10.1080/02732170903051417; Waugh Christian E, 2006, J Posit Psychol, V1, P93, DOI 10.1080/17439760500510569; Wei MF, 2005, J COUNS PSYCHOL, V52, P591, DOI 10.1037/0022-0167.52.4.591; Wesche R, 2021, J SEX RES, V58, P1069, DOI 10.1080/00224499.2020.1821163; Wrzus C, 2012, PERS RELATIONSHIP, V19, P465, DOI 10.1111/j.1475-6811.2011.01373.x; Yabiku ST, 2009, J MARRIAGE FAM, V71, P983, DOI 10.1111/j.1741-3737.2009.00648.x	110	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0246065	10.1371/journal.pone.0246065	http://dx.doi.org/10.1371/journal.pone.0246065			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QV3DA	33690603	Green Published, gold			2022-12-26	WOS:000627854700021
J	Fruehwirth, JC; Biswas, S; Perreira, KM				Fruehwirth, Jane Cooley; Biswas, Siddhartha; Perreira, Krista M.			The Covid-19 pandemic and mental health of first-year college students: Examining the effect of Covid-19 stressors using longitudinal data	PLOS ONE			English	Article							DEPRESSION; ANXIETY; SCALE	Purpose The Covid-19 pandemic has brought unprecedented stress to students and educational institutions across the world. We aimed to estimate the effect of the pandemic on the mental health of college students. Methods We used data on 419 first-year students (ages 18-20) at a large public university in North Carolina both before (October 2019-February 2020) and after (June/July 2020) the start of the Covid-19 pandemic. After evaluating descriptive data on mental health and stressors by students' demographic characteristics, we estimated the associations between Covid-19 stressors (including work reductions, health, distanced learning difficulties and social isolation) and mental health symptoms and severity controlling for students' pre-pandemic mental health, psychosocial resources, and demographic characteristics. Results We found that the prevalence of moderate-severe anxiety increased from 18.1% before the pandemic to 25.3% within four months after the pandemic began; and the prevalence of moderate-severe depression increased from 21.5% to 31.7%. White, female and sexual/gender minority (SGM) students were at highest risk of increases in anxiety symptoms. Non-Hispanic (NH) Black, female, and SGM students were at highest risk of increases in depression symptoms. General difficulties associated with distanced learning and social isolation contributed to the increases in both depression and anxiety symptoms. However, work reductions as well as Covid-19 diagnosis and hospitalization of oneself, family members or friends were not associated with increases in depression or anxiety symptoms. Conclusion Colleges may be able to reduce the mental health consequences of Covid-19 by investing in resources to reduce difficulties with distance learning and reduce social isolation during the pandemic.	[Fruehwirth, Jane Cooley; Biswas, Siddhartha] Univ North Carolina Chapel Hill, Dept Econ, Chapel Hill, NC 27599 USA; [Perreira, Krista M.] Univ North Carolina Chapel Hill, Dept Social Med, Sch Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Fruehwirth, JC (corresponding author), Univ North Carolina Chapel Hill, Dept Econ, Chapel Hill, NC 27599 USA.	jane_fruehwirth@unc.edu		Biswas, Siddhartha/0000-0003-1765-8696; Gorman, Benjamin/0000-0001-9800-8921	Carolina Population Center; National Institutes of Health (NIH)/National Institute of Child Health and Human Development (NICHD) [P2C HD50924]; Integrating Special Populations/North Carolina Translational and Clinical Sciences Institute [ILITR002489]; Economics department and Office of Undergraduate Research at UNC-Chapel Hill	Carolina Population Center; National Institutes of Health (NIH)/National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Integrating Special Populations/North Carolina Translational and Clinical Sciences Institute; Economics department and Office of Undergraduate Research at UNC-Chapel Hill	This research was supported by the Carolina Population Center and its National Institutes of Health (NIH)/National Institute of Child Health and Human Development (NICHD) Grant Award Number P2C HD50924 (JF), the Integrating Special Populations/North Carolina Translational and Clinical Sciences Institute through Grant Award Number ILITR002489 (KP). We also thank the Economics department and Office of Undergraduate Research at UNC-Chapel Hill for funding (JF). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2019, ANN ONCOL, V30, P397, DOI 10.1093/annonc/mdy517; Akdeniz G, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00695; [Anonymous], NC DHHS COVID-19: COVID-19 North Carolina Dashboard; Barbot O, 2020, AM J PUBLIC HEALTH, V110, P1253, DOI 10.2105/AJPH.2020.305850; Bledsoe C., 2020, PSYARXIV; Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934; Chi XL, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00803; Cleary Michelle, 2011, Issues Ment Health Nurs, V32, P250, DOI 10.3109/01612840.2010.548906; Copeland WE., 2020, J AM ACAD CHILD ADOL; D'Amato P., 2020, HECHINGER REPORT; Eisenberg D, 2009, BE J ECON ANAL POLI, V9, DOI 10.2202/1935-1682.2191; Farmer PE, 2006, PLOS MED, V3, P1686, DOI 10.1371/journal.pmed.0030449; Fletcher J, 2013, SOUTH ECON J, V80, P26, DOI 10.4284/0038-4038-2011.193; Geller LL, 2009, SOC WORK MENT HEALTH, V8, P92, DOI 10.1080/15332980902932466; Gonzales G, 2020, J ADOLESCENT HEALTH, V67, P645, DOI 10.1016/j.jadohealth.2020.08.006; Hahn EA, 2014, HEALTH PSYCHOL, V33, P490, DOI 10.1037/hea0000055; Healthy-Minds-Network ACHA-NCHA., 2020, IMPACT COVID 19 COLL; Hefner J, 2009, AM J ORTHOPSYCHIAT, V79, P491, DOI 10.1037/a0016918; Hollander JE, 2020, NEW ENGL J MED, V382, P1679, DOI 10.1056/NEJMp2003539; Huckins JF, 2020, J MED INTERNET RES, V22, DOI 10.2196/20185; Husky MM, 2020, COMPR PSYCHIAT, V102, DOI 10.1016/j.comppsych.2020.152191; Kecojevic A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239696; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Kumaraswamy N., 2013, INT REV SOCIAL SCI H, V5, P135, DOI DOI 10.24941/IJCR.33132.12.2018; Lederman D., 2020, INSIDE HIGHER ED; Lepine Jean-Pierre, 2011, Neuropsychiatr Dis Treat, V7, P3, DOI 10.2147/NDT.S19617; LeViness P., 2018, ASS U COLL COUNSELIN, P73; Lipson SK, 2019, PSYCHIAT SERV, V70, P60, DOI 10.1176/appi.ps.201800332; Liu X., REPRESENTATION LEARN; Matthews T, 2016, SOC PSYCH PSYCH EPID, V51, P339, DOI 10.1007/s00127-016-1178-7; Mckenzie SK, 2014, J EPIDEMIOL COMMUN H, V68, P253, DOI 10.1136/jech-2013-203013; Mood C, 2010, EUR SOCIOL REV, V26, P67, DOI 10.1093/esr/jcp006; Nathiya D., 2020, SOC HLTH BEHAV, V3, P83, DOI DOI 10.4103/SHB.SHB_32_20; Norton EC, 2018, HEALTH SERV RES, V53, P859, DOI 10.1111/1475-6773.12712; Nulty DD, 2008, ASSESS EVAL HIGH EDU, V33, P301, DOI 10.1080/02602930701293231; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017; Pramukti I, 2020, J MED INTERNET RES, V22, DOI 10.2196/24487; Sinclair VG, 2004, ASSESSMENT, V11, P94, DOI 10.1177/1073191103258144; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; SON C, 2020, J MED INTERNET RES, V22, DOI [10.2196/21279, DOI 10.2196/21279]; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; The JED Foundation, 2020, SURVEY COLL STUDENT; Toledo L., 2020, AM POLIT SCI ASS PRE; Twenge JM, 2019, J ABNORM PSYCHOL, V128, P185, DOI 10.1037/abn0000410; Wang XM, 2020, J MED INTERNET RES, V22, DOI 10.2196/22817; Williams PG, 2002, J CONSULT CLIN PSYCH, V70, P828, DOI 10.1037//0022-006X.70.3.828; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	48	119	121	23	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0247999	10.1371/journal.pone.0247999	http://dx.doi.org/10.1371/journal.pone.0247999			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QT5CA	33667243	Green Published, gold			2022-12-26	WOS:000626604300015
J	Pontelo, TP; Franco, MM; Kawamoto, TS; Caixeta, FMC; Leme, LD; Kussano, NR; Zangeronimo, MG; Dode, MAN				Pontelo, Thais Preisser; Franco, Mauricio Machaim; Kawamoto, Taynan Stonoga; Costa Caixeta, Felippe Manoel; Leme, Ligiane de Oliveira; Kussano, Nayara Ribeiro; Zangeronimo, Marcio Gilberto; Nunes Dode, Margot Alves			Histone deacetylase inhibitor during in vitro maturation decreases developmental capacity of bovine oocytes	PLOS ONE			English	Article							INNER CELL MASS; MESSENGER-RNA EXPRESSION; MEIOTIC RESUMPTION; FOLLICLE SIZE; EMBRYONIC-DEVELOPMENT; MEIOSIS PROGRESSION; VALPROIC ACID; ACETYLATION; CHROMATIN; COMPETENCE	This study aimed to evaluate the effect of scriptaid during pre-maturation (PIVM) and/or maturation (IVM) on developmental competence of bovine oocytes. Cumulus-oocyte complexes (COCs) were submitted to PIVM for 6 h in the presence or absence of scriptaid. COCs were distributed into five groups: T1-IVM for 22 h, T2-PIVM for 6 h and IVM for 22 h, T3-PIVM with scriptaid for 6 h and IVM for 22 h, T4-PIVM for 6 h and IVM with scriptaid for 22 h, and T5-PIVM with scriptaid for 6 h and IVM with scriptaid for 22 h. Nuclear maturation, gene expression, cumulus cells (CCs) expansion, and embryo development and quality were evaluated. At the end of maturation, all groups presented the majority of oocytes in MII (P>0.05). Only HAT1 gene was differentially expressed (P<0.01) in oocytes with different treatments. Regarding embryo development at D7, T4 (23%) and T5 (18%) had lower blastocyst rate (P<0.05) than the other treatments (T1 = 35%, T2 = 37% and T3 = 32%). No effect was observed when scriptaid in PIVM was used in less competent oocytes (P>0.05). In conclusion, presence of scriptaid in PIVM and/or IVM did not improve developmental competence or embryo quality.	[Pontelo, Thais Preisser; Zangeronimo, Marcio Gilberto] Univ Fed Lavras, Vet Sci, Lavras, MG, Brazil; [Franco, Mauricio Machaim; Kawamoto, Taynan Stonoga] Univ Fed Uberlandia, Anim Sci, Uberlandia, MG, Brazil; [Franco, Mauricio Machaim] Univ Uberlandia, Inst Genet & Biochem Fed, Uberlandia, MG, Brazil; [Franco, Mauricio Machaim; Nunes Dode, Margot Alves] Embrapa Genet Resources & Biotechnol, Brasilia, DF, Brazil; [Costa Caixeta, Felippe Manoel; Nunes Dode, Margot Alves] Univ Brasilia, Anim Sci, Brasilia, DF, Brazil; [Leme, Ligiane de Oliveira] Univ Fed Espirito Santo, Anim Sci, Vitoria, ES, Brazil; [Kussano, Nayara Ribeiro; Nunes Dode, Margot Alves] Univ Brasilia, Inst Biol, Brasilia, DF, Brazil	Universidade Federal de Lavras; Universidade Federal de Uberlandia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia; Universidade Federal do Espirito Santo; Universidade de Brasilia	Dode, MAN (corresponding author), Embrapa Genet Resources & Biotechnol, Brasilia, DF, Brazil.; Dode, MAN (corresponding author), Univ Brasilia, Anim Sci, Brasilia, DF, Brazil.; Dode, MAN (corresponding author), Univ Brasilia, Inst Biol, Brasilia, DF, Brazil.	margot.dode@embrapa.br	dode, margot alves nunes/S-6524-2019; Franco, Maurício M/B-6204-2013	dode, margot alves nunes/0000-0002-1096-0457; Franco, Maurício M/0000-0003-4105-9079	EMBRAPA [01.03.14.011.00.00]; Coordination for the Improvement of Higher Education Personnel (CAPES)	EMBRAPA(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by EMBRAPA (MP1 Project n. 01.03.14.011.00.00) and Coordination for the Improvement of Higher Education Personnel (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghani MA, 2018, J REPROD DEVELOP, V64, P365, DOI 10.1262/jrd.2018-004; Adona PR, 2006, ARQ BRAS MED VET ZOO, V58, P354, DOI 10.1590/S0102-09352006000300011; Adona PR, 2004, ZYGOTE, V12, P197, DOI 10.1017/S0967199404002771; Akiyama T, 2004, MOL REPROD DEV, V69, P222, DOI 10.1002/mrd.20121; Akiyama T, 2006, P NATL ACAD SCI USA, V103, P7339, DOI 10.1073/pnas.0510946103; Albuz FK, 2010, HUM REPROD, V25, P2999, DOI 10.1093/humrep/deq246; Azari-Dolatabad N, 2016, THERIOGENOLOGY, V85, P1483, DOI 10.1016/j.theriogenology.2016.01.008; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bouniol-Baly C, 1999, BIOL REPROD, V60, P580, DOI 10.1095/biolreprod60.3.580; Caixeta ES, 2009, REPROD FERT DEVELOP, V21, P655, DOI 10.1071/RD08201; Caixeta FMC, 2017, ZYGOTE, V25, P32, DOI 10.1017/S0967199416000289; Castillo Josefa, 2017, Adv Exp Med Biol, V966, P65, DOI 10.1007/5584_2017_58; De Cesaro MP, 2015, ANIM REPROD SCI, V159, P52, DOI 10.1016/j.anireprosci.2015.05.012; De La Fuente R, 2004, DEV BIOL, V275, P447, DOI 10.1016/j.ydbio.2004.08.028; Dieci C, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110577; Diogenes MN, 2017, J ASSIST REPROD GEN, V34, P383, DOI 10.1007/s10815-016-0852-8; Endo T, 2005, MOL REPROD DEV, V71, P123, DOI 10.1002/mrd.20288; Farghaly T, 2015, IN VITRO CELL DEV-AN, V51, P662, DOI 10.1007/s11626-015-9878-y; Franciosi F, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.118869; Gao HX, 2014, CYTOTECHNOLOGY, V66, P525, DOI 10.1007/s10616-013-9603-1; Ge ZJ, 2015, REPRODUCTION, V149, pR103, DOI 10.1530/REP-14-0242; Gharibi S, 2013, THERIOGENOLOGY, V80, P302, DOI 10.1016/j.theriogenology.2013.04.012; Gu L, 2010, CELL CYCLE, V9, P1942, DOI 10.4161/cc.9.10.11599; Guimaraes ALS, 2016, ZYGOTE, V24, P219, DOI 10.1017/S0967199415000064; Hales BF, 2011, BIRTH DEFECTS RES A, V91, P652, DOI 10.1002/bdra.20781; Hezroni H, 2011, J BIOL CHEM, V286, P35977, DOI 10.1074/jbc.M111.266254; Holm P, 1999, THERIOGENOLOGY, V52, P683, DOI 10.1016/S0093-691X(99)00162-4; Hou LM, 2014, CELL REPROGRAM, V16, P253, DOI 10.1089/cell.2013.0058; Hyndman KA, 2017, AM J PHYSIOL-RENAL, V313, pF842, DOI 10.1152/ajprenal.00313.2017; Iacobuzio-Donahue CA, 2009, ANNU REV PATHOL-MECH, V4, P229, DOI 10.1146/annurev.pathol.3.121806.151442; Ikeda S, 2009, ZYGOTE, V17, P209, DOI 10.1017/S0967199409005279; Jin JX, 2017, CELL PHYSIOL BIOCHEM, V41, P1255, DOI 10.1159/000464389; Jin YX, 2014, REPROD FERT DEVELOP, V26, P806, DOI 10.1071/RD13013; Kim JM, 2003, J CELL BIOL, V162, P37, DOI 10.1083/jcb.200303047; Kocyigit A, 2015, CRYOBIOLOGY, V71, P64, DOI 10.1016/j.cryobiol.2015.05.068; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Laguna-Barraza R, 2018, THERIOGENOLOGY, V110, P79, DOI 10.1016/j.theriogenology.2017.12.043; Lequarre AS, 2005, THERIOGENOLOGY, V63, P841, DOI 10.1016/j.theriogenology.2004.05.015; Liang S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134567; Liu LM, 2012, CELL BIOL INT, V36, P483, DOI 10.1042/CBI20110220; Lodde V, 2007, MOL REPROD DEV, V74, P740, DOI 10.1002/mrd.20639; LONERGAN P, 1994, MOL REPROD DEV, V37, P48, DOI 10.1002/mrd.1080370107; Luciano AM, 2012, EUR J HISTOCHEM, V56, P231, DOI 10.4081/ejh.2012.e37; Luciano AM, 2011, BIOL REPROD, V85, P1252, DOI 10.1095/biolreprod.111.092858; Ma P, 2016, CELL DEATH DIFFER, V23, P1119, DOI 10.1038/cdd.2016.31; McGraw S, 2003, BIOL REPROD, V68, P383, DOI 10.1095/biolreprod.102.005991; Mehnert JM, 2007, CANCER J, V13, P23, DOI 10.1097/PPO.0b013e31803c72ba; Nunes M., 2017, THERIOGENOLOGY; Ochota M, 2016, REPROD DOMEST ANIM, V51, P339, DOI 10.1111/rda.12684; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Racedo SE, 2009, REPROD FERT DEVELOP, V21, P738, DOI 10.1071/RD09039; Barretto LSS, 2011, ZYGOTE, V19, P107, DOI 10.1017/S096719941000016X; Sasseville M, 2009, BIOL REPROD, V81, P415, DOI 10.1095/biolreprod.108.074450; Seto E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018713; Shu YM, 2008, HUM REPROD, V23, P504, DOI 10.1093/humrep/dem344; Smitz JEJ, 2011, SEMIN REPROD MED, V29, P24, DOI 10.1055/s-0030-1268701; Su GH, 2000, CANCER RES, V60, P3137; Sugimura S, 2018, J REPROD DEVELOP, V64, P233, DOI 10.1262/jrd.2018-009; Sun HL, 2015, THERIOGENOLOGY, V83, P1219, DOI 10.1016/j.theriogenology.2015.01.003; Tram N., 2017, HISTONE DEACETYLASE, P883; Van Thuan N, 2009, REPRODUCTION, V138, P309, DOI 10.1530/REP-08-0299; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varago F. C., 2008, Revista Brasileira de Reproducao Animal, V32, P100; Velazquez MA, 2012, THERIOGENOLOGY, V78, P517, DOI 10.1016/j.theriogenology.2012.02.034; Verdone L, 2005, BIOCHEM CELL BIOL, V83, P344, DOI 10.1139/o05-041; Wang LJ, 2011, CELL REPROGRAM, V13, P431, DOI 10.1089/cell.2011.0024; Wang Q, 2006, CELL CYCLE, V5, P766, DOI 10.4161/cc.5.7.2627; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Zhang T, 2017, IN VITRO CELL DEV-AN, V53, P199, DOI 10.1007/s11626-016-0101-6	69	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0247518	10.1371/journal.pone.0247518	http://dx.doi.org/10.1371/journal.pone.0247518			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667248	gold, Green Published			2022-12-26	WOS:000626604300019
J	Desai, AA; Smith, MD; Zhang, YL; Makowski, EK; Gerson, JE; Ionescu, E; Starr, CG; Zupancic, JM; Moore, SJ; Sutter, AB; Ivanova, MI; Murphy, GG; Paulson, HL; Tessier, PM				Desai, Alec A.; Smith, Matthew D.; Zhang, Yulei; Makowski, Emily K.; Gerson, Julia E.; Ionescu, Edward; Starr, Charles G.; Zupancic, Jennifer M.; Moore, Shannon J.; Sutter, Alexandra B.; Ivanova, Magdalena I.; Murphy, Geoffrey G.; Paulson, Henry L.; Tessier, Peter M.			Rational affinity maturation of anti-amyloid antibodies with high conformational and sequence specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; PROTEIN-A CHROMATOGRAPHY; ALZHEIMERS-DISEASE; MONOCLONAL-ANTIBODIES; IN-VITRO; IMAGING ABNORMALITIES; TRANSFERRIN RECEPTOR; NONSPECIFIC-BINDING; IMMUNOGLOBULIN-G; CELLULAR UPTAKE	The aggregation of amyloidogenic polypeptides is strongly linked to several neurodegenerative disorders, including Alzheimer's and Parkinson's diseases. Conformational antibodies that selectively recognize protein aggregates are leading therapeutic agents for selectively neutralizing toxic aggregates, diagnostic and imaging agents for detecting disease, and biomedical reagents for elucidating disease mechanisms. Despite their importance, it is challenging to generate high-quality conformational antibodies in a systematic and site-specific manner due to the properties of protein aggregates (hydrophobic, multivalent, and heterogeneous) and limitations of immunization (uncontrolled antigen presentation and immunodominant epitopes). Toward addressing these challenges, we have developed a systematic directed evolution procedure for affinity maturing antibodies against Alzheimer's A beta fibrils and selecting variants with strict conformational and sequence specificity. We first designed a library based on a lead conformational antibody by sampling combinations of amino acids in the antigen-binding site predicted to mediate high antibody specificity. Next, we displayed this library on the surface of yeast, sorted it against A beta 42 aggregates, and identified promising clones using deep sequencing. The resulting antibodies displayed similar or higher affinities than clinical-stage A beta antibodies (aducanumab and crenezumab). Moreover, the affinity-matured antibodies retained high conformational specificity for A beta aggregates, as observed for aducanumab and unlike crenezumab. Notably, the affinity-maturated antibodies displayed extremely low levels of nonspecific interactions, as observed for crenezumab and unlike aducanumab. We expect that our systematic methods for generating antibodies with unique combinations of desirable properties will improve the generation of high-quality conformational antibodies specific for diverse types of aggregated conformers.	[Desai, Alec A.; Smith, Matthew D.; Zhang, Yulei; Ionescu, Edward; Starr, Charles G.; Zupancic, Jennifer M.; Tessier, Peter M.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Desai, Alec A.; Smith, Matthew D.; Zhang, Yulei; Makowski, Emily K.; Ionescu, Edward; Starr, Charles G.; Zupancic, Jennifer M.; Tessier, Peter M.] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA; [Makowski, Emily K.; Starr, Charles G.; Tessier, Peter M.] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA; [Gerson, Julia E.; Sutter, Alexandra B.; Ivanova, Magdalena I.; Paulson, Henry L.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Moore, Shannon J.; Murphy, Geoffrey G.; Paulson, Henry L.; Tessier, Peter M.] Univ Michigan, Prot Folding Dis Initiat, Ann Arbor, MI 48109 USA; [Moore, Shannon J.; Murphy, Geoffrey G.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Sutter, Alexandra B.; Ivanova, Magdalena I.] Univ Michigan, Biophys Program, Ann Arbor, MI USA; [Paulson, Henry L.] Univ Michigan, Michigan Alzheimers Dis Ctr, Ann Arbor, MI USA; [Tessier, Peter M.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Starr, Charles G.] Sanofi Genzyme, Biol Res, Framingham, MA 01701 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Sanofi-Aventis; Genzyme Corporation	Tessier, PM (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.; Tessier, PM (corresponding author), Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA.; Tessier, PM (corresponding author), Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA.; Tessier, PM (corresponding author), Univ Michigan, Prot Folding Dis Initiat, Ann Arbor, MI 48109 USA.; Tessier, PM (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	ptessier@umich.edu	Tessier, Peter/GPP-3396-2022	Ionescu, Edward/0000-0001-7187-7094	National Institutes of Health [R01GM104130, RF1AG059723, R01AG050598, R35GM136300]; National Science Foundation [CBET 1159943, 1605266, 1813963]; Albert M. Mattocks Chair; American Parkinson Disease Association (APDA); Babcox; University of Michigan M-cubed	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Albert M. Mattocks Chair; American Parkinson Disease Association (APDA); Babcox; University of Michigan M-cubed(University of Michigan System)	This work was supported by the National Institutes of Health [R01GM104130, RF1AG059723, R01AG050598, and R35GM136300 to P. M. T.], National Science Foundation [CBET 1159943, 1605266, and 1813963 to P. M. T., Graduate Research Fellowship to M. D. S.], the Albert M. Mattocks Chair (to P. M. T.), American Parkinson Disease Association (APDA; to M. I. I.), Babcox (to M. I. I.) and University of Michigan M-cubed (to M. I. I.).	Alam ME, 2020, J PHARM SCI-US, V109, P656, DOI 10.1016/j.xphs.2019.10.051; Aprile FA, 2020, P NATL ACAD SCI USA, V117, P13509, DOI 10.1073/pnas.1919464117; Arndt JW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24501-0; Barkhof F, 2013, AM J NEURORADIOL, V34, P1550, DOI 10.3174/ajnr.A3475; Benatuil L, 2010, PROTEIN ENG DES SEL, V23, P155, DOI 10.1093/protein/gzq002; Birtalan S, 2008, J MOL BIOL, V377, P1518, DOI 10.1016/j.jmb.2008.01.093; Birtalan S, 2010, MOL BIOSYST, V6, P1186, DOI 10.1039/b927393j; Bodani RU, 2015, ACS CHEM NEUROSCI, V6, P1981, DOI 10.1021/acschemneuro.5b00231; Bonito-Oliva A, 2019, J CELL MOL MED, V23, P2103, DOI 10.1111/jcmm.14119; Boswell CA, 2010, BIOCONJUGATE CHEM, V21, P2153, DOI 10.1021/bc100261d; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Bushnell B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185056; Castillo-Carranza DL, 2014, J NEUROSCI, V34, P4260, DOI 10.1523/JNEUROSCI.3192-13.2014; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Chung S, 2019, MABS-AUSTIN, V11, P942, DOI 10.1080/19420862.2019.1605270; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Combs B, 2016, NEUROBIOL DIS, V94, P18, DOI 10.1016/j.nbd.2016.05.016; Covell DJ, 2017, NEUROPATH APPL NEURO, V43, P604, DOI 10.1111/nan.12402; Cromwell MEM, 2006, AAPS J, V8, pE572, DOI 10.1208/aapsj080366; Datta-Mannan A, 2015, MABS-AUSTIN, V7, P1084, DOI 10.1080/19420862.2015.1075109; Datta-Mannan A, 2015, MABS-AUSTIN, V7, P483, DOI 10.1080/19420862.2015.1016696; Droste P, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0146-8; Ejima D, 2007, PROTEINS, V66, P954, DOI 10.1002/prot.21243; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Gibbons GS, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0687-5; Gibbons GS, 2018, J NEUROPATH EXP NEUR, V77, P216, DOI 10.1093/jnen/nly010; Gibbs E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46306-5; Glabe CG, 2004, TRENDS BIOCHEM SCI, V29, P542, DOI 10.1016/j.tibs.2004.08.009; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Hari SB, 2010, BIOCHEMISTRY-US, V49, P9328, DOI 10.1021/bi100841u; Hatami A, 2014, J BIOL CHEM, V289, P32131, DOI 10.1074/jbc.M114.594846; Hober S, 2007, J CHROMATOGR B, V848, P40, DOI 10.1016/j.jchromb.2006.09.030; Hong GY, 2000, J DRUG TARGET, V8, P67, DOI 10.3109/10611860008996853; Jain T, 2017, P NATL ACAD SCI USA, V114, P944, DOI 10.1073/pnas.1616408114; Jones AR, 2007, PHARM RES-DORDR, V24, P1759, DOI 10.1007/s11095-007-9379-0; Julian MC, 2019, J BIOL CHEM, V294, P8438, DOI 10.1074/jbc.RA118.004731; Julian MC, 2017, SCI REP-UK, V7, DOI 10.1038/srep45259; Julian MC, 2015, PROTEIN ENG DES SEL, V28, P339, DOI 10.1093/protein/gzv050; Kanaan NM, 2016, J NEUROPATH EXP NEUR, V75, P19, DOI 10.1093/jnen/nlv001; Kanaan NM, 2011, J NEUROSCI, V31, P9858, DOI 10.1523/JNEUROSCI.0560-11.2011; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kelly RL, 2015, MABS-AUSTIN, V7, P770, DOI 10.1080/19420862.2015.1043503; Kulenkampff K, 2020, BIOPHYS J, V118, p370A; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lee CC, 2016, J BIOL CHEM, V291, P2858, DOI 10.1074/jbc.M115.682336; Munke A, 2017, P NATL ACAD SCI USA, V114, P6444, DOI 10.1073/pnas.1700407114; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Nilvebrant J, 2016, CURR PHARM DESIGN, V22, P6527, DOI 10.2174/1381612822666160921143011; Pardridge WM, 2017, BIODRUGS, V31, P503, DOI 10.1007/s40259-017-0248-z; Pardridge WM, 2016, EXPERT OPIN BIOL TH, V16, P1455, DOI 10.1080/14712598.2016.1230195; Pardridge WM, 2015, EXPERT OPIN DRUG DEL, V12, P207, DOI 10.1517/17425247.2014.952627; PARDRIDGE WM, 1994, IMMUNOL LETT, V42, P191, DOI 10.1016/0165-2478(94)90085-X; Perchiacca JM, 2012, P NATL ACAD SCI USA, V109, P84, DOI 10.1073/pnas.1111232108; Rabia LA, 2018, PROTEIN ENG DES SEL, V31, P409, DOI 10.1093/protein/gzz002; Rabia LA, 2018, BIOCHEM ENG J, V137, P365, DOI 10.1016/j.bej.2018.06.003; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sebollela A, 2017, J NEUROCHEM, V142, P934, DOI 10.1111/jnc.14118; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Shukla AA, 2007, J CHROMATOGR A, V1171, P22, DOI 10.1016/j.chroma.2007.09.040; Silverman JM, 2018, ACS CHEM NEUROSCI, V9, P1591, DOI 10.1021/acschemneuro.7b00469; Spencer S, 2012, MABS-AUSTIN, V4, P319, DOI 10.4161/mabs.19869; Sperling R, 2012, LANCET NEUROL, V11, P241, DOI 10.1016/S1474-4422(12)70015-7; Starr CG, 2019, CURR OPIN BIOTECH, V60, P119, DOI 10.1016/j.copbio.2019.01.008; Stimple SD, 2019, BIOTECHNOL BIOENG, V116, P1868, DOI 10.1002/bit.26994; Sumbria RK, 2013, MOL PHARMACEUT, V10, P3507, DOI 10.1021/mp400348n; Swindells MB, 2017, J MOL BIOL, V429, P356, DOI 10.1016/j.jmb.2016.08.019; Tiller KE, 2017, J BIOL CHEM, V292, P16638, DOI 10.1074/jbc.M117.783837; Tiller KE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00986; TRIGUERO D, 1989, P NATL ACAD SCI USA, V86, P4761, DOI 10.1073/pnas.86.12.4761; Vaikath NN, 2015, NEUROBIOL DIS, V79, P81, DOI 10.1016/j.nbd.2015.04.009; van Dyck CH, 2018, BIOL PSYCHIAT, V83, P311, DOI 10.1016/j.biopsych.2017.08.010; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Weihofen A, 2019, NEUROBIOL DIS, V124, P276, DOI 10.1016/j.nbd.2018.10.016; Xu YD, 2013, PROTEIN ENG DES SEL, V26, P663, DOI 10.1093/protein/gzt047; Zago Wagner, 2013, Alzheimers Dement, V9, pS105, DOI 10.1016/j.jalz.2012.11.010; Zhang YL, 2020, MOL PHARMACEUT, V17, P2555, DOI 10.1021/acs.molpharmaceut.0c00257; Zuchero YJY, 2016, NEURON, V89, P70, DOI 10.1016/j.neuron.2015.11.024	80	3	3	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100508	10.1016/j.jbc.2021.100508	http://dx.doi.org/10.1016/j.jbc.2021.100508			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33675750	gold, Green Published			2022-12-26	WOS:000672866400482
J	Bivona, JJ; Crymble, HM; Guigni, BA; Stapleton, RD; Files, DC; Toth, MJ; Poynter, ME; Suratt, BT				Bivona, Joseph J., III; Crymble, Hanna M.; Guigni, Blas A.; Stapleton, Renee D.; Files, D. Clark; Toth, Michael J.; Poynter, Matthew E.; Suratt, Benjamin T.			Macrophages augment the skeletal muscle proinflammatory response through TNF alpha following LPS-induced acute lung injury	FASEB JOURNAL			English	Article						acute lung injury; cytokines; inflammation; macrophage; skeletal muscle		Muscle may contribute to the systemic inflammatory environment during critical illness, but leukocyte interaction and cytokine influence on muscle and its response has not been fully explored in this context. Using an in vivo model of intratracheal lipopolysaccharide (IT LPS)-induced acute lung injury, we show that skeletal muscle rapidly responds with expression of proinflammatory genes, which may be explained by migration of LPS into the circulation. Treatment of mature C2C12 myotubes with LPS at a level achieved in the circulation following IT LPS elicited a proinflammatory cytokine expression profile similar to that of in vivo murine muscle following IT LPS. Stimulation with toll-like receptor (TLR) 2 and 3 agonists provoked comparable responses in C2C12 myotubes. Additionally, co-cultures of C2C12 myotubes and bone marrow-derived macrophages (BMDM) identified the capacity of macrophages to increase myotube proinflammatory gene expression, with tumor necrosis factor-alpha (TNF alpha) gene and protein expression largely attributable to BMDM. To investigate the contribution of TNF alpha in the synergy of the co-culture environment, C2C12 myotubes were treated with recombinant TNF alpha, co-cultures were established using TNF-deficient BMDM, and co-cultures were also depleted of TNF alpha using antibodies. To determine whether the in vitro observations were relevant in vivo, mice received intramuscular administration of LPS +/- TNF alpha or TNF alpha-neutralizing antibodies and showed that TNF alpha is both sufficient and necessary to induce synergistic cytokine release from muscle. Taken together, these data demonstrate how skeletal muscle tissue may contribute proinflammatory cytokines following acute endotoxin injury and the potential of leukocytes to augment this response via TNF alpha secretion.	[Bivona, Joseph J., III; Crymble, Hanna M.; Stapleton, Renee D.; Toth, Michael J.; Poynter, Matthew E.; Suratt, Benjamin T.] Univ Vermont, Dept Med, Larner Coll Med, Burlington, VT USA; [Bivona, Joseph J., III; Guigni, Blas A.] Univ Vermont, Cellular Mol & Biomed Sci Doctoral Program, Burlington, VT USA; [Guigni, Blas A.; Toth, Michael J.] Univ Vermont, Dept Mol Physiol & Biophys, Larner Coll Med, Burlington, VT USA; [Files, D. Clark] Wake Forest Sch Med, Dept Internal Med, Sect Pulm Crit Care Allergy & Immunol, Winston Salem, NC 27101 USA	University of Vermont; University of Vermont; University of Vermont; Wake Forest University	Poynter, ME (corresponding author), Univ Vermont, Pulm Dis & Crit Care Med, Given E410A,89 Beaumont Ave, Burlington, VT 05405 USA.	matthew.poynter@uvm.edu		Files, Daniel Clark/0000-0002-1595-4080	NIH NHLBI [R01HL143452, T32HL076122]	NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded through NIH NHLBI R01HL143452 and T32HL076122.	Armstrong Lawrence E, 2018, J Sports Med (Hindawi Publ Corp), V2018, P5724575, DOI 10.1155/2018/5724575; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bercker S, 2005, CRIT CARE MED, V33, P711, DOI 10.1097/01.CCM.0000157969.46388.A2; Borge BAS, 2009, AM J PHYSIOL-HEART C, V296, pH735, DOI 10.1152/ajpheart.01309.2008; Brown SM, 2019, ANN AM THORAC SOC, V16, P947, DOI 10.1513/AnnalsATS.201812-913FR; De Letter MACJ, 2000, J NEUROIMMUNOL, V106, P206, DOI 10.1016/S0165-5728(99)00252-0; De Rossi M, 2000, INT IMMUNOL, V12, P1329, DOI 10.1093/intimm/12.9.1329; DEITCH EA, 1990, SURGERY, V107, P411; Dirajlal-Fargo S, 2020, CLIN INFECT DIS, V70, P2413, DOI 10.1093/cid/ciz561; Dokladny K, 2006, AM J PHYSIOL-GASTR L, V290, pG204, DOI 10.1152/ajpgi.00401.2005; Dort J, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/4761427; Dumont NA, 2013, AM J PATHOL, V182, P505, DOI 10.1016/j.ajpath.2012.10.010; Fan E, 2014, CRIT CARE MED, V42, P849, DOI 10.1097/CCM.0000000000000040; Faries PL, 1998, J TRAUMA, V44, P1031, DOI 10.1097/00005373-199806000-00016; Files DC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010283; Frontera WR, 2015, CALCIFIED TISSUE INT, V96, P183, DOI 10.1007/s00223-014-9915-y; Frost RA, 2003, AM J PHYSIOL-REG I, V285, pR1153, DOI 10.1152/ajpregu.00164.2003; Gong WY, 2016, J PAIN, V17, P1081, DOI 10.1016/j.jpain.2016.06.010; Guigni BA, 2019, AM J PHYSIOL-CELL PH, V317, pC1213, DOI 10.1152/ajpcell.00148.2019; Hermans G, 2014, AM J RESP CRIT CARE, V190, P410, DOI 10.1164/rccm.201312-2257OC; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Jin RM, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121549; Kompan L, 1999, INTENS CARE MED, V25, P157, DOI 10.1007/s001340050809; Laitano O, 2021, SHOCK, V55, P676, DOI 10.1097/SHK.0000000000001641; Langen RCJ, 2012, AM J RESP CELL MOL, V47, P288, DOI 10.1165/rcmb.2011-0119OC; Latroche C, 2017, STEM CELL REP, V9, P2018, DOI 10.1016/j.stemcr.2017.10.027; Lee C, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00077; Lemos DR, 2015, NAT MED, V21, P786, DOI 10.1038/nm.3869; LIM SG, 1993, SCAND J GASTROENTERO, V28, P573, DOI 10.3109/00365529309096090; Marshall JC, 2004, J INFECT DIS, V190, P527, DOI 10.1086/422254; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; McNicol FJ, 2010, BRIT J SURG, V97, P434, DOI 10.1002/bjs.6868; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Peake JM, 2015, EXERC IMMUNOL REV, V21, P8; Puthucheary ZA, 2018, THORAX, V73, P926, DOI 10.1136/thoraxjnl-2017-211073; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Raza A, 2017, J LEUKOCYTE BIOL, V102, P1219, DOI 10.1189/jlb.2AB0116-009RR; Reidy PT, 2019, AM J PHYSIOL-ENDOC M, V317, pE85, DOI 10.1152/ajpendo.00422.2018; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sands KE, 1997, JAMA-J AM MED ASSOC, V278, P234, DOI 10.1001/jama.278.3.234; Schaefer L, 2014, J BIOL CHEM, V289, P35237, DOI 10.1074/jbc.R114.619304; Scheler M, 2013, AM J PHYSIOL-CELL PH, V305, pC877, DOI 10.1152/ajpcell.00043.2013; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Suzuki K, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7010017; Pham T, 2017, AM J RESP CRIT CARE, V195, P860, DOI 10.1164/rccm.201609-1773CP; Tidball JG, 2017, NAT REV IMMUNOL, V17, P165, DOI 10.1038/nri.2016.150; Tkalcevic VI, 2006, EUR J PHARMACOL, V539, P131, DOI 10.1016/j.ejphar.2006.03.074; Tseng WP, 2010, J CELL PHYSIOL, V223, P389, DOI 10.1002/jcp.22047; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; Wang HZ, 2014, AM J PATHOL, V184, P1167, DOI 10.1016/j.ajpath.2013.12.020; Wilairatana P, 1997, CLIN INFECT DIS, V24, P430, DOI 10.1093/clinids/24.3.430	51	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21462	10.1096/fj.202002275RR	http://dx.doi.org/10.1096/fj.202002275RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33724561	Green Accepted			2022-12-26	WOS:000635216100096
J	Goulding, J; Kondrashov, A; Mistry, SJ; Melarangi, T; Vo, NTN; Hoang, DM; White, CW; Denning, C; Briddon, SJ; Hill, SJ				Goulding, Joelle; Kondrashov, Alexander; Mistry, Sarah J.; Melarangi, Tony; Vo, Nguyen T. N.; Hoang, Duc M.; White, Carl W.; Denning, Chris; Briddon, Stephen J.; Hill, Stephen J.			The use of fluorescence correlation spectroscopy to monitor cell surface beta 2-adrenoceptors at low expression levels in human embryonic stem cell-derived cardiomyocytes and fibroblasts	FASEB JOURNAL			English	Article						cardiomyocytes; differentiation; embryonic stem cells; fibroblasts; fluorescence correlation spectroscopy; haplotype; receptor internalization; single&#8208; nucleotide polymorphisms; &#946; 2&#8208; adrenoceptors		The importance of cell phenotype in determining the molecular mechanisms underlying beta(2)-adrenoceptor (beta 2AR) function has been noted previously when comparing responses in primary cells and recombinant model cell lines. Here, we have generated haplotype-specific SNAP-tagged beta 2AR human embryonic stem (ES) cell lines and applied fluorescence correlation spectroscopy (FCS) to study cell surface receptors in progenitor cells and in differentiated fibroblasts and cardiomyocytes. FCS was able to quantify SNAP-tagged beta 2AR number and diffusion in both ES-derived cardiomyocytes and CRISPR/Cas9 genome-edited HEK293T cells, where the expression level was too low to detect using standard confocal microscopy. These studies demonstrate the power of FCS in investigating cell surface beta 2ARs at the very low expression levels often seen in endogenously expressing cells. Furthermore, the use of ES cell technology in combination with FCS allowed us to demonstrate that cell surface beta 2ARs internalize in response to formoterol-stimulation in ES progenitor cells but not following their differentiation into ES-derived fibroblasts. This indicates that the process of agonist-induced receptor internalization is strongly influenced by cell phenotype and this may have important implications for drug treatment with long-acting beta 2AR agonists.	[Goulding, Joelle; Kondrashov, Alexander; Mistry, Sarah J.; White, Carl W.; Denning, Chris; Briddon, Stephen J.; Hill, Stephen J.] Univ Nottingham, Ctr Membrane Proteins & Receptors COMPARE, Nottingham, England; [Goulding, Joelle; White, Carl W.; Briddon, Stephen J.; Hill, Stephen J.] Univ Nottingham, Sch Life Sci, Div Physiol Pharmacol & Neurosci, Nottingham, England; [Kondrashov, Alexander; Melarangi, Tony; Vo, Nguyen T. N.; Hoang, Duc M.; Denning, Chris] Univ Nottingham, Div Canc & Stem Cells, Biodiscovery Inst, Univ Pk, Nottingham, England; [Mistry, Sarah J.] Univ Nottingham, Sch Pharm, Nottingham, England; [Hoang, Duc M.] Vinmec Res Inst Stem Cell & Gene Technol, Dept Cellular Mfg, Hanoi, Vietnam; [White, Carl W.] Univ Western Australia, Harry Perkins Inst Med Res, QEII Med Ctr, Nedlands, WA, Australia; [White, Carl W.] Univ Western Australia, Ctr Med Res, QEII Med Ctr, Nedlands, WA, Australia; [White, Carl W.] Australian Res Council, Ctr Personalised Therapeut Technol, Melbourne, Vic, Australia	University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham; Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia	Briddon, SJ; Hill, SJ (corresponding author), Univ Nottingham, Ctr Membrane Proteins & Receptors COMPARE, Nottingham, England.	stephen.briddon@nottingham.ac.uk; stephen.hill@nottingham.ac.uk	Goulding, Joelle/AAI-1362-2021; Hill, Stephen/N-6753-2013	Goulding, Joelle/0000-0002-6227-4483; Hill, Stephen/0000-0002-4424-239X; Mistry, Sarah Jane/0000-0003-1409-0097; Hoang, Duc M./0000-0001-5444-561X; Kondrashov, Alexander/0000-0003-3428-5975; White, Carl/0000-0002-4975-6189	RCUK | Medical Research Council (MRC) [MR/N020081/1]; British Heart Foundation (BHF) [RG/14/1/30588]; Department of Health | National Health and Medical Research Council (NHMRC) [1088334]	RCUK | Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation (BHF)(British Heart Foundation); Department of Health | National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	RCUK | Medical Research Council (MRC), Grant/Award Number: MR/N020081/1; British Heart Foundation (BHF), Grant/Award Number: RG/14/1/30588; Department of Health | National Health and Medical Research Council (NHMRC), Grant/Award Number: 1088334	Ayling LJ, 2012, J CELL SCI, V125, P869, DOI 10.1242/jcs.091090; Briddon SJ, 2004, P NATL ACAD SCI USA, V101, P4673, DOI 10.1073/pnas.0400420101; Briddon SJ, 2018, TRENDS PHARMACOL SCI, V39, P158, DOI 10.1016/j.tips.2017.11.004; Bruck H, 2005, CLIN PHARMACOL THER, V78, P232, DOI 10.1016/j.clpt.2005.06.002; Bruck H, 2003, PHARMACOGENETICS, V13, P59, DOI 10.1097/00008571-200302000-00001; Calebiro D, 2020, ANNU REV PHARMACOL, V60, P73, DOI 10.1146/annurev-pharmtox-010919-023348; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Chiantia S, 2009, BBA-BIOMEMBRANES, V1788, P225, DOI 10.1016/j.bbamem.2008.08.013; Corriden R, 2014, FASEB J, V28, P4211, DOI 10.1096/fj.13-247270; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Denning C, 2006, INT J DEV BIOL, V50, P27, DOI 10.1387/ijdb.052107cd; Dewar JC, 1998, CLIN EXP ALLERGY, V28, P442; Dick E, 2011, STEM CELL RES, V6, P158, DOI 10.1016/j.scr.2010.10.002; Dishy V, 2001, NEW ENGL J MED, V345, P1030, DOI 10.1056/NEJMoa010819; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Gherbi K, 2015, FASEB J, V29, P2859, DOI 10.1096/fj.14-265199; Ghosh E, 2019, CELL REP, V28, P3287, DOI 10.1016/j.celrep.2019.08.053; Gondin AB, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00104; GREEN SA, 1994, BIOCHEMISTRY-US, V33, P9414, DOI 10.1021/bi00198a006; GREEN SA, 1993, J BIOL CHEM, V268, P23116; GREEN SA, 1995, AM J RESP CELL MOL, V13, P25, DOI 10.1165/ajrcmb.13.1.7598936; Gregorio GG, 2017, NATURE, V547, P68, DOI 10.1038/nature22354; Grime RL, 2020, NANOSCALE, V12, P11518, DOI 10.1039/d0nr01060j; Hawkins GA, 2006, AM J RESP CRIT CARE, V174, P1101, DOI 10.1164/rccm.200509-1405OC; Herrick-Davis K, 2013, MOL PHARMACOL, V84, P630, DOI 10.1124/mol.113.087072; Hilger D, 2018, NAT STRUCT MOL BIOL, V25, P4, DOI 10.1038/s41594-017-0011-7; Huang B, 2004, CHEMPHYSCHEM, V5, P1523, DOI 10.1002/cphc.200400176; Huang SXL, 2014, NAT BIOTECHNOL, V32, P84, DOI 10.1038/nbt.2754; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Isbilir A, 2020, P NATL ACAD SCI USA, V117, P29144, DOI 10.1073/pnas.2013319117; Jacobson GA, 2018, DRUG SAFETY, V41, P441, DOI 10.1007/s40264-017-0631-1; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kilpatrick LE, 2019, CELL CHEM BIOL, V26, P830, DOI 10.1016/j.chembiol.2019.02.014; KOBILKA B, 1992, ANNU REV NEUROSCI, V15, P87, DOI 10.1146/annurev.ne.15.030192.000511; KOBILKA BK, 1987, P NATL ACAD SCI USA, V84, P46, DOI 10.1073/pnas.84.1.46; Kondrashov A, 2018, STEM CELLS DEV, V27, P391, DOI 10.1089/scd.2017.0268; Kondrashov AV, 2005, J MOL BIOL, V353, P88, DOI 10.1016/j.jmb.2005.07.049; Koryakina Y, 2012, CELL BIOL INT, V36, P1171, DOI 10.1042/CBI20120134; Lamichhane R, 2015, P NATL ACAD SCI USA, V112, P14254, DOI 10.1073/pnas.1519626112; Masureel M, 2018, NAT CHEM BIOL, V14, P1059, DOI 10.1038/s41589-018-0145-x; Matsa E, 2011, EUR HEART J, V32, P952, DOI 10.1093/eurheartj/ehr073; MOORE RH, 1995, J CELL SCI, V108, P2983; Murphy L, 2014, DRUGS, V74, P1635, DOI 10.1007/s40265-014-0284-7; Nesbeth D, 2006, MOL THER, V13, P814, DOI 10.1016/j.ymthe.2005.09.016; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; REIHSAUS E, 1993, AM J RESP CELL MOL, V8, P334, DOI 10.1165/ajrcmb/8.3.334; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Rose RH, 2012, BRIT J PHARMACOL, V165, P1789, DOI 10.1111/j.1476-5381.2011.01640.x; Rosethorne EM, 2010, N-S ARCH PHARMACOL, V382, P255, DOI 10.1007/s00210-010-0533-6; Scarselli M, 2012, J BIOL CHEM, V287, P16768, DOI 10.1074/jbc.M111.329912; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Stallaert W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029420; Sun YH, 2016, CHEM COMMUN, V52, P7086, DOI 10.1039/c6cc00628k; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; White CW, 2020, CELL CHEM BIOL, V27, P499, DOI 10.1016/j.chembiol.2020.01.010; White CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03486-2; Wingler LM, 2020, TRENDS CELL BIOL, V30, P736, DOI 10.1016/j.tcb.2020.06.002	64	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21398	10.1096/fj.202002268R	http://dx.doi.org/10.1096/fj.202002268R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710675	Green Published			2022-12-26	WOS:000635216100052
J	Liu, XY; Lin, L; Tang, LC; Xie, HH; Gu, LK; Lv, XJ; Liu, CB; Zhao, JZ; Deng, RZ; Liu, Y; Qu, J; Gu, F				Liu, Xiaoyu; Lin, Li; Tang, Lianchao; Xie, Haihua; Gu, Lingkai; Lv, Xiujuan; Liu, Changbao; Zhao, Junzhao; Deng, Ruzhi; Liu, Yong; Qu, Jia; Gu, Feng			Lb2Cas12a and its engineered variants mediate genome editing in human cells	FASEB JOURNAL			English	Article						PAM; activity; fidelity; RS1		Cas12a-mediated targeted genome engineering strategies have enabled a broad range of research and clinical applications. However, the limited target-selection spectrum and low activity/fidelity remain a bottleneck for its widespread application in precision site-specific human genome editing. Therefore, there exists an acute need to identify novel Cas12a nucleases with improved features for genome editing. By screening a range of candidate Cas12a nucleases, here we demonstrate that Lb2Cas12a possesses genome editing activity in human cells and it has greater flexibility in PAM (5MODIFIER LETTER PRIME-BYYV-3MODIFIER LETTER PRIME) selection. Furthermore, we engineered Lb2Cas12a to generate variants (Lb2Cas12a-RVR and Lb2Cas12a-RR), which greatly expands the target-selection spectrum. Our study illustrated that Lb2Cas12a could be harnessed as additional genome editing tool for the manipulation of human genome.	[Liu, Xiaoyu; Lin, Li; Tang, Lianchao; Xie, Haihua; Gu, Lingkai; Lv, Xiujuan; Deng, Ruzhi; Liu, Yong; Qu, Jia; Gu, Feng] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Eye Hosp, State Key Lab, Wenzhou, Peoples R China; [Liu, Xiaoyu; Lin, Li; Tang, Lianchao; Xie, Haihua; Gu, Lingkai; Lv, Xiujuan; Deng, Ruzhi; Liu, Yong; Qu, Jia; Gu, Feng] Wenzhou Med Univ, Key Lab Vis Sci, Minist Hlth, Wenzhou, Peoples R China; [Liu, Xiaoyu; Lin, Li; Tang, Lianchao; Xie, Haihua; Gu, Lingkai; Lv, Xiujuan; Deng, Ruzhi; Liu, Yong; Qu, Jia; Gu, Feng] Wenzhou Med Univ, Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Peoples R China; [Liu, Changbao; Zhao, Junzhao] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Peoples R China; [Liu, Changbao; Zhao, Junzhao] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Gu, F (corresponding author), Wenzhou Med Univ, 270 Xueyuan West Rd, Wenzhou 325027, Zhejiang, Peoples R China.	gufenguw@gmail.com		Gu, Feng/0000-0002-9600-8407; Gu, Feng/0000-0002-9019-2960	National Natural Science Foundation of China [81201181, 82000861]; National Key R&D Program of China [2018YFA0107304]; Natural Science Foundation of Zhejiang Province [2017C37176]; Zhejiang Provincial & Ministry of Health Research Fund for Medical Sciences [WKJ-ZJ-1828]; Zhejiang Provincial Fund for Collegiate Technological Innovation Program [2017R413001]; Project of State Key Laboratory of Ophthalmology, Optometry and Visual Science, Wenzhou Medical University [J01-20190201]; Wenzhou City Grant [C20170007]; Lin He's Academician Workstation of New Medicine and Clinical Translation [17331209, 18331105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial & Ministry of Health Research Fund for Medical Sciences; Zhejiang Provincial Fund for Collegiate Technological Innovation Program; Project of State Key Laboratory of Ophthalmology, Optometry and Visual Science, Wenzhou Medical University; Wenzhou City Grant; Lin He's Academician Workstation of New Medicine and Clinical Translation	National Natural Science Foundation of China, Grant/Award Number: 81201181 and 82000861; National Key R&D Program of China, Grant/Award Number: 2018YFA0107304; Natural Science Foundation of Zhejiang Province, Grant/Award Number: 2017C37176; Zhejiang Provincial & Ministry of Health Research Fund for Medical Sciences, Grant/Award Number: WKJ-ZJ-1828; Zhejiang Provincial Fund for Collegiate Technological Innovation Program, Grant/Award Number: 2017R413001; Project of State Key Laboratory of Ophthalmology, Optometry and Visual Science, Wenzhou Medical University, Grant/Award Number: J01-20190201; Wenzhou City Grant, Grant/Award Number: C20170007; Lin He's Academician Workstation of New Medicine and Clinical Translation, Grant/Award Number: 17331209 and 18331105	Anzalone AV, 2019, NATURE, V576, P149, DOI 10.1038/s41586-019-1711-4; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen D, 2018, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00453; Chen P, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-01989-2; Gao LY, 2017, NAT BIOTECHNOL, V35, P789, DOI 10.1038/nbt.3900; He XB, 2019, J BIOL CHEM, V294, P9308, DOI 10.1074/jbc.RA119.007791; Hong W, 2018, ACS SYNTH BIOL, V7, P1588, DOI 10.1021/acssynbio.8b00087; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kleinstiver BP, 2019, NAT BIOTECHNOL, V37, P276, DOI 10.1038/s41587-018-0011-0; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Komor AC, 2017, CELL, V169, P559, DOI 10.1016/j.cell.2017.04.005; Li XS, 2018, NAT BIOTECHNOL, V36, P324, DOI 10.1038/nbt.4102; Lin L, 2018, MOL THER, V26, P2650, DOI 10.1016/j.ymthe.2018.08.021; Liu YC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02265-x; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2018, SCIENCE, V361, P1259, DOI 10.1126/science.aas9129; Sun HH, 2018, MOL THER, V26, P2070, DOI 10.1016/j.ymthe.2018.05.021; Tang Lianchao, 2019, Cell Regen, V8, P44, DOI 10.1016/j.cr.2019.08.002; Teng F, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1620-8; Teng F, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0069-3; Toth E, 2018, NUCLEIC ACIDS RES, V46, P10272, DOI 10.1093/nar/gky815; Tu MJ, 2017, NUCLEIC ACIDS RES, V45, P11295, DOI 10.1093/nar/gkx783; Walton RT, 2020, SCIENCE, V368, P290, DOI 10.1126/science.aba8853; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang XC, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.18; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05405; Zhang Y, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602814	30	4	4	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21270	10.1096/fj.202001013RR	http://dx.doi.org/10.1096/fj.202001013RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715215				2022-12-26	WOS:000635216100049
J	Yokoyama, J; Miyagawa, S; Akagi, T; Akashi, M; Sawa, Y				Yokoyama, Junya; Miyagawa, Shigeru; Akagi, Takami; Akashi, Mitsuru; Sawa, Yoshiki			Human induced pluripotent stem cell-derived three-dimensional cardiomyocyte tissues ameliorate the rat ischemic myocardium by remodeling the extracellular matrix and cardiac protein phenotype	PLOS ONE			English	Article								The extracellular matrix (ECM) plays a key role in the viability and survival of implanted human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). We hypothesized that coating of three-dimensional (3D) cardiac tissue-derived hiPSC-CMs with the ECM protein fibronectin (FN) would improve the survival of transplanted cells in the heart and improve heart function in a rat model of ischemic heart failure. To test this hypothesis, we first explored the tolerance of FN-coated hiPSC-CMs to hypoxia in an in vitro study. For in vivo assessments, we constructed 3D-hiPSC cardiac tissues (3D-hiPSC-CTs) using a layer-by-layer technique, and then the cells were implanted in the hearts of a myocardial infarction rat model (3D-hiPSC-CTs, n = 10; sham surgery control group (without implant), n = 10). Heart function and histology were analyzed 4 weeks after transplantation. In the in vitro assessment, cell viability and lactate dehydrogenase assays showed that FN-coated hiPSC-CMs had improved tolerance to hypoxia compared with the control cells. In vivo, the left ventricular ejection fraction of hearts implanted with 3D-hiPSC-CT was significantly better than that of the sham control hearts. Histological analysis showed clear expression of collagen type IV and plasma membrane markers such as desmin and dystrophin in vivo after implantation of 3D-hiPSC-CT, which were not detected in 3D-hiPSC-CMs in vitro. Overall, these results indicated that FN-coated 3D-hiPSC-CT could improve distressed heart function in a rat myocardial infarction model with a well-expressed cytoskeletal or basement membrane matrix. Therefore, FN-coated 3D-hiPSC-CT may serve as a promising replacement for heart transplantation and left ventricular assist devices and has the potential to improve survivability and therapeutic efficacy in cases of ischemic heart disease.	[Yokoyama, Junya; Miyagawa, Shigeru; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Osaka, Japan; [Akagi, Takami; Akashi, Mitsuru] Osaka Univ, Grad Sch Frontier Biosci, Bldg Block Sci Joint Res, Osaka, Japan	Osaka University; Osaka University	Sawa, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Osaka, Japan.	sawa-p@surg1.med.osaka-u.ac.jp		Miyagawa, Shigeru/0000-0003-0015-6569; YOKOYAMA, JUNYA/0000-0001-6700-8937	JSPS KAKENHI [JP18K16391]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was partially funded by JSPS KAKENHI Grant Number JP18K16391. https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT18K16391/No additional external funding was received for this study.	Abraham WT, 2013, NAT REV CARDIOL, V10, P98, DOI 10.1038/nrcardio.2012.178; Alford AI, 2001, AM J PHYSIOL-LUNG C, V280, pL680, DOI 10.1152/ajplung.2001.280.4.L680; Amano Y, 2016, ACTA BIOMATER, V33, P110, DOI 10.1016/j.actbio.2016.01.033; Imbeault S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-13; Konstandin MH, 2013, CIRC RES, V113, P115, DOI 10.1161/CIRCRESAHA.113.301152; Lauten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092833; Longnus SL, 2014, NAT REV CARDIOL, V11, P354, DOI 10.1038/nrcardio.2014.45; Machaj F, 2019, THER CLIN RISK MANAG, V15, P147, DOI 10.2147/TCRM.S179302; Masumoto H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29933; Matsusaki M, 2014, ADV DRUG DELIVER REV, V74, P95, DOI 10.1016/j.addr.2014.01.003; Nishiguchi A, 2015, ADV HEALTHC MATER, V4, P1164, DOI 10.1002/adhm.201500065; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Omairi S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39532-4; Sakaguchi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01316; Samura T, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.015841; Sasse P, 2008, CARDIOVASC RES, V80, P435, DOI 10.1093/cvr/cvn225; Sato-Nishiuchi R, 2018, MATRIX BIOL, V65, P75, DOI 10.1016/j.matbio.2017.08.001; Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje; Sougawa N, 2019, TRANSPLANTATION, V103, pE119, DOI 10.1097/TP.0000000000002653; Takeda M, 2018, TISSUE ENG PART C-ME, V24, P56, DOI [10.1089/ten.tec.2017.0247, 10.1089/ten.TEC.2017.0247]; Wu X, 2010, AM J PHYSIOL-HEART C, V298, pH2071, DOI 10.1152/ajpheart.01156.2009	21	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0245571	10.1371/journal.pone.0245571	http://dx.doi.org/10.1371/journal.pone.0245571			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720933	Green Submitted, Green Published, gold			2022-12-26	WOS:000629667400020
J	Solorzano, S; Kim, J; Chen, JC; Feng, XM; Young, NS				Solorzano, Sabrina; Kim, Jisoo; Chen, Jichun; Feng, Xingmin; Young, Neal S.			Minimal role of interleukin 6 and toll-like receptor 2 and 4 in murine models of immune-mediated bone marrow failure	PLOS ONE			English	Article								Immune aplastic anemia (AA) results from T cell attack on hematopoietic cells, resulting in bone marrow hypocellularity and pancytopenia. Animal models have been successfully developed to study pathophysiological mechanisms in AA. While we have systemically defined the critical components of the adaptive immune response in the pathogenesis of immune marrow failure using this model, the role of innate immunity has not been fully investigated. Here, we demonstrate that lymph node (LN) cells from B6-based donor mice carrying IL-6, TLR2, or TLR4 gene deletions were fully functional in inducing severe pancytopenia and bone marrow failure (BMF) when infused into MHC-mismatched CByB6F1 recipients. Conversely, B6-based recipient mice with IL-6, TLR2, and TLR4 deletion backgrounds were all susceptible to immune-mediated BMF relative to wild-type B6 recipients following infusion of MHC-mismatched LN cells from FVB donors, but the disease appeared more severe in IL-6 deficient mice. We conclude that IL-6, TLR2, and TLR4, molecular elements important in maintenance of normal innate immunity, have limited roles in a murine model of immune-mediated BMF. Rather, adaptive immunity appears to be the major contributor to the animal disease.	[Solorzano, Sabrina; Kim, Jisoo; Chen, Jichun; Feng, Xingmin; Young, Neal S.] NHLBI, Hematol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Solorzano, Sabrina] Childrens Natl Med Ctr, Ctr Canc & Blood Disorders, Washington, DC 20010 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Children's National Health System	Feng, XM (corresponding author), NHLBI, Hematol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	fengx2@nhlbi.nih.gov		feng, xingmin/0000-0001-8018-2366	National Heart, Lung, and Blood Institute Intramural Research Program	National Heart, Lung, and Blood Institute Intramural Research Program	This study was supported by National Heart, Lung, and Blood Institute Intramural Research Program.	Abdollahi-Roodsaz S, 2007, ARTHRITIS RHEUM, V56, P2957, DOI 10.1002/art.22848; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; Barcellini W, 2017, EXPERT REV HEMATOL, V10, P649, DOI 10.1080/17474086.2017.1339597; Billiau A, 1996, ADV IMMUNOL, V62, P61, DOI 10.1016/S0065-2776(08)60428-9; BIONDILLO DE, 1994, AM J PHYSIOL-LUNG C, V267, pL564, DOI 10.1152/ajplung.1994.267.5.L564; Bloom ML, 2004, EXP HEMATOL, V32, P1163, DOI 10.1016/j.exphem.2004.08.006; Capitano ML, 2019, CURR OPIN HEMATOL, V26, P207, DOI 10.1097/MOH.0000000000000511; Carey A, 2017, CELL REP, V18, P3204, DOI 10.1016/j.celrep.2017.03.018; Chen J, 2004, BLOOD, V104, P1671, DOI 10.1182/blood-2004-03-1115; Chen JC, 2007, J IMMUNOL, V178, P4159, DOI 10.4049/jimmunol.178.7.4159; Chen JC, 2015, BLOOD, V126, P2621, DOI 10.1182/blood-2015-06-652453; Danilova N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23561-6; de Latour RP, 2010, BLOOD, V116, P4175, DOI 10.1182/blood-2010-01-266098; Duarte D, 2018, CELL STEM CELL, V22, P64, DOI 10.1016/j.stem.2017.11.006; Duffy L, 2016, IMMUNOTARGETS THER, V5, P69, DOI 10.2147/ITT.S89795; Esplin BL, 2011, J IMMUNOL, V186, P5367, DOI 10.4049/jimmunol.1003438; Fujimoto M, 2008, ARTHRITIS RHEUM-US, V58, P3710, DOI 10.1002/art.24126; Haruta H, 2011, INVEST OPHTH VIS SCI, V52, P3264, DOI 10.1167/iovs.10-6272; Hemmati S, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00265; Hosokawa K, 2016, J IMMUNOL, V196, P1568, DOI 10.4049/jimmunol.1501739; Kitaba S, 2012, AM J PATHOL, V180, P165, DOI 10.1016/j.ajpath.2011.09.013; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kordasti S, 2016, BLOOD, V128, P1193, DOI 10.1182/blood-2016-03-703702; Korniotis S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02007; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Liu CY, 2014, GENET MOL RES, V13, P4083, DOI 10.4238/2014.May.30.3; McCabe A, 2018, HAEMATOLOGICA, V103, P1451, DOI 10.3324/haematol.2018.189449; McCranor BJ, 2014, BLOOD CELL MOL DIS, V52, P126, DOI 10.1016/j.bcmd.2013.09.004; Megias J, 2012, STEM CELLS, V30, P1486, DOI 10.1002/stem.1110; Mihara M, 1998, CLIN EXP IMMUNOL, V112, P397; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Omokaro SO, 2009, J IMMUNOL, V182, P3414, DOI 10.4049/jimmunol.0801430; Radstake TRDJ, 2004, ARTHRITIS RHEUM-US, V50, P3856, DOI 10.1002/art.20678; Sarcon AK, 2009, EXP HEMATOL, V37, P477, DOI 10.1016/j.exphem.2008.12.001; Schneider RK, 2016, NAT MED, V22, P288, DOI 10.1038/nm.4047; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; Smith JNP, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00330; Solomou EE, 2005, BLOOD, V106, p245A; Solomou EE, 2007, BLOOD, V110, P1603, DOI 10.1182/blood-2007-01-066258; Sun WL, 2018, BLOOD, V132, P2730, DOI 10.1182/blood-2018-05-844928; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Tanaka T, 2013, CLIN MED INSIGHTS-TH, V5, P33, DOI 10.4137/CMT.S9282; Tang Y, 2010, BLOOD, V115, P541, DOI 10.1182/blood-2009-03-211383; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wang Y, 2016, LEUKEMIA, V30, P1897, DOI 10.1038/leu.2016.81; Wei Y, 2018, BLOOD ADV, V2, P2491, DOI 10.1182/bloodadvances.2018024166; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Wu ZJ, 2019, EXP HEMATOL, V69, P54, DOI 10.1016/j.exphem.2018.10.003; Young NS, 2018, NEW ENGL J MED, V379, P1643, DOI 10.1056/NEJMra1413485; Zhang TY, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax5104; Zhao JL, 2014, CELL STEM CELL, V14, P445, DOI 10.1016/j.stem.2014.01.007; Zhao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055552	54	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0248343	10.1371/journal.pone.0248343	http://dx.doi.org/10.1371/journal.pone.0248343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711076	Green Published, gold			2022-12-26	WOS:000629591800050
J	Boecking, B; Rose, M; Brueggemann, P; Mazurek, B				Boecking, Benjamin; Rose, Matthias; Brueggemann, Petra; Mazurek, Birgit			Two birds with one stone.-Addressing depressive symptoms, emotional tension and worry improves tinnitus-related distress and affective pain perceptions in patients with chronic tinnitus	PLOS ONE			English	Article							STRESS QUESTIONNAIRE PSQ; LOW-BACK-PAIN; PERCEIVED STRESS; ICD-10-SYMPTOM-RATING ISR; PSYCHOMETRIC PROPERTIES; PSYCHOLOGICAL TREATMENT; RISK-FACTORS; PSYCHOPATHOLOGY; VALIDATION; OPTIMISM	Background Psychological factors link the co-occurrence of tinnitus-related distress and pain perceptions in patients with chronic tinnitus. Objective This study examines, if treatment-related changes in these factors ameliorate both tinnitus-related distress and pain perceptions in a sample of patients with chronic tinnitus. Methods N = 1238 patients with chronic tinnitus provided pre- and post-treatment ratings of tinnitus-related distress and affective or sensory pain perceptions alongside measures of depressive symptoms and perceived stress. Treatment comprised an intensive tinnitus-specific multimodal treatment program. Using serial indirect-effects analyses, we examined association patterns between baseline values and change rates of those variables that were found to respond to treatment. Results Small effect sizes emerged for changes in tinnitus-related distress, affective (but not sensory) pain perceptions, depressive symptoms, emotional tension and worry. At pre- or post-treatment respectively, baseline values and change rates intercorrelated. Across timepoints, (1) baseline tinnitus-related distress and affective pain perceptions were positively associated with improvements in tinnitus-related distress, affective pain perceptions and depressive symptoms. (2) Baseline depressive symptoms or emotional tension mediated positive associations between baseline tinnitus-related distress and improvement in affective pain perceptions. (3) Change in depressive symptoms mediated the effect of baseline tinnitus-related distress on change in affective pain perceptions-partly through associated change in emotional tension or worry. Mood-independent aspects of emotional tension were negatively associated with improvement in affective pain perceptions. Conclusions Depressive symptoms, emotional tension and worry emerge as key predictors of treatment response and transdiagnostic treatment targets for alleviating tinnitus-related distress and functionally associated affective pain perceptions.	[Boecking, Benjamin; Brueggemann, Petra; Mazurek, Birgit] Charite Univ Med Berlin, Tinnitus Ctr, Berlin, Germany; [Rose, Matthias] Charite Univ Med Berlin, Med Dept, Div Psychosomat Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Mazurek, B (corresponding author), Charite Univ Med Berlin, Tinnitus Ctr, Berlin, Germany.	birgit.mazurek@charite.de			German Research Foundation (DFG); Open Access Publication Fund of Charite' Universitatsmedizin Berlin	German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of Charite' Universitatsmedizin Berlin	We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Fund of Charite' Universitatsmedizin Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler JM, 2013, J CONSULT CLIN PSYCH, V81, P839, DOI 10.1037/a0033774; Affleck G., 2001, OPTIMISM PESSIMISM D; Akbari M, 2018, PERS INDIV DIFFER, V135, P166, DOI 10.1016/j.paid.2018.07.011; Andersson G, 2002, CLIN PSYCHOL REV, V22, P977, DOI 10.1016/S0272-7358(01)00124-6; Andersson G, 1996, PSYCHOL HEALTH, V11, P697, DOI 10.1080/08870449608404998; Andersson G, 1999, BRIT J AUDIOL, V33, P201, DOI 10.3109/03005369909090101; Andersson G, 1995, ANN BEHAV MED, V17, P357, DOI 10.1007/BF02888601; Angst J, 2001, J AFFECT DISORDERS, V62, P7, DOI 10.1016/S0165-0327(00)00346-3; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Bauch Christopher D, 2003, J Am Acad Audiol, V14, P181; Baumeister RF, 2007, SOC PERSONAL PSYCHOL, V1, P115, DOI 10.1111/j.1751-9004.2007.00001.x; Bhatt JM, 2017, LARYNGOSCOPE, V127, P466, DOI 10.1002/lary.26107; Biehl R, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.03093; Boecking B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234807; BORKOVEC TD, 1995, J BEHAV THER EXP PSY, V26, P25, DOI 10.1016/0005-7916(94)00064-S; Borkovec TD, 1998, COGNITIVE THER RES, V22, P561, DOI 10.1023/A:1018790003416; Boudoukha AH, 2017, PSYCHOL TRAUMA-US, V9, P561, DOI 10.1037/tra0000243; Bradford A, 2011, AM J GERIAT PSYCHIAT, V19, P347, DOI 10.1097/JGP.0b013e3181f18061; Brandt WA, 2015, J AFFECT DISORDERS, V173, P143, DOI 10.1016/j.jad.2014.10.070; Buscemi V, 2019, J PAIN, V20, P1127, DOI 10.1016/j.jpain.2019.02.008; Chalder T, 2017, J MENT HEALTH, V26, P187, DOI 10.1080/09638237.2017.1322187; Cima RFF, 2014, J AM ACAD AUDIOL, V25, P29, DOI 10.3766/jaaa.25.1.4; CLARK DA, 1986, COGNITIVE THER RES, V10, P607, DOI 10.1007/BF01173749; Conard MA, 2008, PERS INDIV DIFFER, V44, P171, DOI 10.1016/j.paid.2007.07.023; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Dauman Nicolas, 2012, Int J Qual Stud Health Well-being, V7, P1, DOI 10.3402/qhw.v7i0.19540; DEWE P, 1992, ANXIETY STRESS COPIN, V5, P95, DOI 10.1080/10615809208250490; Dobie RA, 2003, OTOLARYNG CLIN N AM, V36, P383, DOI 10.1016/S0030-6665(02)00168-8; Dozois DJA, 2009, J COGN PSYCHOTHER, V23, P44, DOI 10.1891/0889-8391.23.1.44; Erlandsson SIM, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00136; FERNANDEZ E, 1992, PSYCHOL BULL, V112, P205, DOI 10.1037/0033-2909.112.2.205; Fischer HF, 2011, PSYCHOTHER PSYCH MED, V61, P162, DOI 10.1055/s-0030-1249683; Fischer HF, 2010, PSYCHOTHER PSYCH MED, V60, P307, DOI 10.1055/s-0029-1214419; Fishbain DA, 1997, CLIN J PAIN, V13, P116, DOI 10.1097/00002508-199706000-00006; Fliege H, 2005, PSYCHOSOM MED, V67, P78, DOI 10.1097/01.psy.0000151491.80178.78; Fliege H, 2001, DIAGNOSTICA, V47, P142, DOI 10.1026//0012-1924.47.3.142; Folmer RL, 2001, OTOLARYNG HEAD NECK, V124, P394, DOI 10.1067/mhn.2001.114673; Forbes MK, 2016, DEV PSYCHOPATHOL, V28, P971, DOI 10.1017/S0954579416000651; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Geissner E, 1996, GOTT GER HOGREFE; GOEBEL G, 1992, TINNITUS 91, P465; Goebel G., 1998, TINNITUS FRAGEBOGEN, DOI [10.1007/s00106-013-2798-9, DOI 10.1007/S00106-013-2798-9]; Graul Joachim, 2008, Int Tinnitus J, V14, P73; Guzman J, 2002, COCHRANE DB SYST REV, V1, P1, DOI [10.1002/14651858.CD000963, DOI 10.1002/14651858.CD000963]; Hahn Ales, 2008, Int Tinnitus J, V14, P69; Hasson D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052945; Hautzinger M., 2012, PSYCHIAT PRAX, V2nd, DOI DOI 10.1055/S-0032-1326702; Hayes A. F., 2012, PROCESS VERSATILE CO; Hayes AF, 2017, BEHAV RES THER, V98, P39, DOI 10.1016/j.brat.2016.11.001; Hesser H, 2011, CLIN PSYCHOL REV, V31, P545, DOI 10.1016/j.cpr.2010.12.006; HILLER W, 1994, BRIT J CLIN PSYCHOL, V33, P231, DOI 10.1111/j.2044-8260.1994.tb01117.x; Hofmann SG, 2016, PERSPECT PSYCHOL SCI, V11, P597, DOI 10.1177/1745691616639283; Horner KC, 2003, NEUROSCI BIOBEHAV R, V27, P437, DOI 10.1016/S0149-7634(03)00071-X; Hundt NE, 2014, J ANXIETY DISORD, V28, P845, DOI 10.1016/j.janxdis.2014.09.012; Jacobson E, 1959, PROGR RELAXATION, P1959; Kaaria S, 2012, EUR J PAIN, V16, P911, DOI 10.1002/j.1532-2149.2011.00065.x; Kerns RD, 2011, ANNU REV CLIN PSYCHO, V7, P411, DOI 10.1146/annurev-clinpsy-090310-120430; Kim HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127578; Koechlin H, 2018, J PSYCHOSOM RES, V107, P38, DOI 10.1016/j.jpsychores.2018.02.002; Kotov R, 2017, J ABNORM PSYCHOL, V126, P454, DOI 10.1037/abn0000258; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; Krueger RF, 2016, J ABNORM PSYCHOL, V125, P1023, DOI 10.1037/abn0000223; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Langguth B, 2011, WORLD J BIOL PSYCHIA, V12, P489, DOI 10.3109/15622975.2011.575178; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Linton SJ, 2013, J APPL BIOBEHAV RES, V18, P82, DOI 10.1111/jabr.12007; Loeser JD, 1999, LANCET, V353, P1607, DOI 10.1016/S0140-6736(99)01311-2; Lowe B, 2008, GEN HOSP PSYCHIAT, V30, P191, DOI 10.1016/j.genhosppsych.2008.01.001; Lumley MA, 2011, J CLIN PSYCHOL, V67, P942, DOI 10.1002/jclp.20816; Maddux J. E., 2002, HDB POSITIVE PSYCHOL, P277, DOI 10.1093/oxfordhb/9780195187243.013.0031; Marek RJ., 2019, J ABNORM PSYCHOL; Marks R, 2005, HEALTH PROMOT PRACT, V6, P148, DOI 10.1177/1524839904266792; McEvoy PM, 2013, J AFFECT DISORDERS, V151, P313, DOI 10.1016/j.jad.2013.06.014; McEwen BS, 2010, METABOLISM, V59, pS9, DOI 10.1016/j.metabol.2010.07.012; Moller AR, 1997, AM J OTOL, V18, P577; Morley S, 1999, PAIN, V80, P1, DOI 10.1016/S0304-3959(98)00255-3; Neimeyer R. A., 2000, CONSTRUCTIONS DISORD; Obbarius A, 2020, J PAIN RES, V13, P1023, DOI 10.2147/JPR.S223092; Oltmanns JR, 2018, CLIN PSYCHOL SCI, V6, P581, DOI 10.1177/2167702617750150; Peerdeman KJ, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01270; Pincus T, 2001, PSYCHOL BULL, V127, P599, DOI 10.1037//0033-2909.127.5.599; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; PRICE DD, 1987, PAIN, V28, P297, DOI 10.1016/0304-3959(87)90065-0; Pryce H, 2018, INT J AUDIOL, V57, P801, DOI 10.1080/14992027.2018.1500041; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Renna ME, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00098; Riley KE, 2014, J SOC CLIN PSYCHOL, V33, P587, DOI 10.1521/jscp.2014.33.7.587; Rosen HE., 1996, CONSTRUCTING REALITI; Rosenbaum DL, 2012, J HEALTH PSYCHOL, V17, P1183, DOI 10.1177/1359105311433906; SCHEIER MF, 1992, COGNITIVE THER RES, V16, P201, DOI 10.1007/BF01173489; Scheier MF., 2001, OPTIMISM PESSIMISM P; SCHNEIDER WR, 1994, HNO, V42, P22; Scholler G, 1999, PSYCHOTHER PSYCH MED, V49, P275; Seydel C, 2010, AUDIOL NEURO-OTOL, V15, P69, DOI 10.1159/000231632; Shaver PR, 1991, MEASURES PERSONALITY, V1st, P195, DOI DOI 10.1016/B978-0-12-590241-0.50010-1; Singer JA, 2013, J PERS, V81, P569, DOI 10.1111/jopy.12005; Thombs BD, 2010, BRIT J PSYCHIAT, V197, P61, DOI 10.1192/bjp.bp.109.076596; TONNDORF J, 1987, HEARING RES, V28, P271, DOI 10.1016/0378-5955(87)90054-2; Trevis KJ, 2018, CLIN PSYCHOL REV, V60, P62, DOI 10.1016/j.cpr.2017.12.006; TURK DC, 1994, BEHAV RES THER, V32, P9, DOI 10.1016/0005-7967(94)90078-7; Turk DC, 2010, MAYO CLIN PROC, V85, pS42, DOI 10.4065/mcp.2009.0648; Urits I, 2019, CURR PAIN HEADACHE R, V23, DOI 10.1007/s11916-019-0757-1; van Tulder MW, 2000, SPINE, V25, P2688, DOI 10.1097/00007632-200010150-00024; Vollmann M, 2014, PSYCHOL HEALTH, V29, P81, DOI 10.1080/08870446.2013.828294; Wells A., 2002, J COGN PSYCHOTHER, V16, P179; White RS, 2014, J AM GERIATR SOC, V62, P2350, DOI 10.1111/jgs.13135; WHO, 2012, ICD 10 CLASS MENT BE; Widiger TA, 2005, J ABNORM PSYCHOL, V114, P494, DOI 10.1037/0021-843X.114.4.494; Zeman F, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-128	109	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0246747	10.1371/journal.pone.0246747	http://dx.doi.org/10.1371/journal.pone.0246747			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8JZ	33705407	gold, Green Published			2022-12-26	WOS:000629590400065
J	Williams, K; Eggett, D; Patten, EV				Williams, Karla; Eggett, Dennis; Patten, Emily Vaterlaus			How work and family caregiving responsibilities interplay and affect registered dietitian nutritionists and their work: A national survey	PLOS ONE			English	Article							JOB-SATISFACTION; PSYCHOSOCIAL IMPLICATIONS; MARITAL SATISFACTION; NEW-ZEALAND; CONFLICT; HEALTH; CARE; VALIDATION; ENRICHMENT; TEACHERS	Healthcare professionals provide paid care at work and potentially have caregiving responsibilities outside of work; work responsibilities in addition to child and/or elder care is considered double- or triple-duty care. Employees may experience conflict and/or enrichment as their work and family responsibilities interface. This study's purpose is to explore the work and family interface of Registered Dietitian Nutritionists (RDNs), determine the prevalence of work-family conflict and enrichment, and identify characteristics associated with higher work-family conflict and enrichment scores. A survey instrument assessing caregiving responsibilities and work-family conflict and enrichment was distributed electronically to 4,900 RDNs throughout the United States. Frequencies, means, correlative relationships, and ANCOVA were calculated using SAS software 9.04. Of 1,233 usable responses, nearly two-thirds of RDNs (65.5%) reported providing either double-duty or triple-duty care. About half of RDNs (47.2%) reported work-family conflict and fewer (14.8%) reported family-work conflict. Additionally, most RDNs (79.4%) reported work-family enrichment and even more (85.2%) reported family-work enrichment. Higher work-family conflict scores had correlative relationships with higher levels of burnout, lower life satisfaction, and higher intent to quit. Higher work-family enrichment scores had correlative relationships with lower burnout, higher job satisfaction, higher career satisfaction, higher life satisfaction, and lower intent to quit. Understanding the unpaid caregiving responsibilities of RDNs and the interface of work/family responsibilities may provide insight into career planning for RDNs and guide managers of RDNs in efforts to amplify the contribution of RDNs.	[Williams, Karla; Patten, Emily Vaterlaus] Brigham Young Univ, Dept Nutr Dietet & Food Sci, Provo, UT 84602 USA; [Eggett, Dennis] Brigham Young Univ, Dept Stat, Provo, UT 84602 USA	Brigham Young University; Brigham Young University	Patten, EV (corresponding author), Brigham Young Univ, Dept Nutr Dietet & Food Sci, Provo, UT 84602 USA.	emily_patten@byu.edu		Patten, Emily/0000-0003-0161-383X				Akutsu RD, 2008, REV NUTR, V21, P7, DOI 10.1590/S1415-52732008000100002; AlAzzam M, 2017, NURS FORUM, V52, P278, DOI 10.1111/nuf.12199; [Anonymous], 2011, DIET CAN; [Anonymous], 2020, CLIN RES WELL BEING; BEGLEY TM, 1993, J APPL PSYCHOL, V78, P552, DOI 10.1037/0021-9010.78.4.552; Bruschini M, 2018, WORK, V59, P121, DOI 10.3233/WOR-172657; Cabrera EF, 2007, CAREER DEV INT; Carlson DS, 2000, J VOCAT BEHAV, V56, P249, DOI 10.1006/jvbe.1999.1713; Carmichael F, 2003, J HEALTH ECON, V22, P781, DOI 10.1016/S0167-6296(03)00044-4; Cinamon RG, 2007, CAREER DEV Q, V55, P249, DOI 10.1002/j.2161-0045.2007.tb00081.x; Clancy RL, 2020, J BUS PSYCHOL, V35, P9, DOI 10.1007/s10869-018-9612-3; DePasquale N, 2018, J APPL GERONTOL, V37, P464, DOI 10.1177/0733464816641391; DePasquale N, 2017, J FAM ISSUES, V38, P1495, DOI 10.1177/0192513X15584680; DePasquale N, 2016, J GERONTOL B-PSYCHOL, V71, P201, DOI 10.1093/geronb/gbu139; Erdamar G, 2014, PROCD SOC BEHV, V116, P4919, DOI 10.1016/j.sbspro.2014.01.1050; Feinberg L, 2011, WASHINGTON DC AARP P, V32, P2011; Geiger A. W., 2019, 6 FACTS US MOMS; Gingras J, 2010, J HUM NUTR DIET, V23, P238, DOI 10.1111/j.1365-277X.2010.01062.x; Grace-Farfaglia PM, 2018, J PREV MED, V3, P1, DOI [10.21767/2572-5483.100027, DOI 10.21767/2572-5483.100027]; Greenhaus JH, 2006, ACAD MANAGE REV, V31, P72, DOI 10.5465/amr.2006.19379625; GREENHAUS JH, 1985, ACAD MANAGE REV, V10, P76, DOI 10.5465/AMR.1985.4277352; Grzywacz JG, 2006, RES NURS HEALTH, V29, P414, DOI 10.1002/nur.20133; Hasselhorn H.-M., 2003, WORKING CONDITIONS I; Health Workforce Australia, 2014, AUSTR HLTH WORKF SER; HOBFOLL SE, 1989, AM PSYCHOL, V44, P513, DOI 10.1037/0003-066X.44.3.513; Hooker RS, 2012, J ACAD NUTR DIET, V112, pS75, DOI 10.1016/j.jand.2011.12.024; Johnson CY, 2017, ANN EPIDEMIOL, V27, P558, DOI 10.1016/j.annepidem.2017.08.017; Kacmar KM, 2014, J OCCUP HEALTH PSYCH, V19, P32, DOI 10.1037/a0035123; Killien MG, 2004, NURS CLIN N AM, V39, P19, DOI 10.1016/j.cnur.2003.11.002; Lapierre LM, 2018, J ORGAN BEHAV, V39, P385, DOI 10.1002/job.2234; Laschinger HKS, 2006, J NURS ADMIN, V36, P259; Mackison D, 2010, EUR J CLIN NUTR, V64, P210, DOI 10.1038/ejcn.2009.126; McNall LA, 2015, J OCCUP HEALTH PSYCH, V20, P93, DOI 10.1037/a0038165; McNall LA, 2010, J BUS PSYCHOL, V25, P381, DOI 10.1007/s10869-009-9141-1; Milosavljevic M, 2015, NUTR DIET, V72, P101, DOI 10.1111/1747-0080.12109; Nadine H, 2017, SWISS MED WKLY, V147, DOI 10.4414/smw.2017.14552; National Research Council, 2010, ROLE HUMAN FACTORS H; Navaie-Waliser M, 2002, MED CARE, V40, P1249, DOI 10.1097/00005650-200212000-00012; Netemeyer RG, 1996, J APPL PSYCHOL, V81, P400, DOI 10.1037/0021-9010.81.4.400; Palmer M, 2012, TEACH TEACH EDUC, V28, P1049, DOI 10.1016/j.tate.2012.05.002; Phillips W, 2015, J ACAD NUTR DIET, V115, P1054, DOI 10.1016/j.jand.2015.03.020; Rogers D, 2018, J ACAD NUTR DIET, V118, P499, DOI 10.1016/j.jand.2017.11.016; Rutman D, 1996, QUAL HEALTH RES, V6, P90, DOI 10.1177/104973239600600106; SCARPELLO V, 1983, PERS PSYCHOL, V36, P577, DOI 10.1111/j.1744-6570.1983.tb02236.x; SCHUMM WR, 1986, J MARRIAGE FAM, V48, P381, DOI 10.2307/352405; Schwartz SP, 2019, BMJ QUAL SAF, V28, P142, DOI 10.1136/bmjqs-2018-007933; Starmer AJ, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3183; Stewart LM, 2013, J FAM ISSUES, V34, P113, DOI 10.1177/0192513X12437708; Touger-Decker R., 2006, Topics in Clinical Nutrition, V21, P190; United Nations, 2015, WORLDS WOM 2015 TREN; van Exel NJA, 2004, CLIN REHABIL, V18, P683, DOI 10.1191/0269215504cr743oa; Walker L, 2018, INT NURS REV, V65, P33, DOI 10.1111/inr.12411; Ward-Griffin C, 2005, CAN J AGING, V24, P379, DOI 10.1353/cja.2006.0015; Yucel D, 2017, SOC MENT HEALTH, V7, P175, DOI 10.1177/2156869317713069; Zhang YC, 2018, J VOCAT BEHAV, V104, P210, DOI 10.1016/j.jvb.2017.11.003	55	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0248109	10.1371/journal.pone.0248109	http://dx.doi.org/10.1371/journal.pone.0248109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QV3DA	33690670	Green Published, gold			2022-12-26	WOS:000627854700057
J	Daubert, E; Weber, KM; French, AL; Seidman, D; Michel, K; Gustafson, D; Murphy, K; Muzny, CA; Alcaide, M; Sheth, A; Adimora, AA; Spear, GT				Daubert, Elizabeth; Weber, Kathleen M.; French, Audrey L.; Seidman, Dominika; Michel, Katherine; Gustafson, Deborah; Murphy, Kerry; Muzny, Christina A.; Alcaide, Maria; Sheth, Anandi; Adimora, Adaora A.; Spear, Gregory T.			Obesity is associated with lower bacterial vaginosis prevalence in menopausal but not pre-menopausal women in a retrospective analysis of the Women's Interagency HIV Study	PLOS ONE			English	Article							VAGINAL MICROBIOTA; COHORT; HEALTH; TRACT	The vaginal microbiota is known to impact women's health, but the biological factors that influence the composition of the microbiota are not fully understood. We previously observed that levels of glycogen in the lumen of the vagina were higher in women that had a high body mass index (BMI). Vaginal glycogen is thought to impact the composition of the vaginal microbiota. We therefore sought to determine if BMI was associated having or not having bacterial vaginosis (BV), as determined by the Amsel criteria. We also hypothesized that increased blood glucose levels could lead to the previously-observed higher vaginal glycogen levels and therefore investigated if hemoglobin A1c levels were associated with BV. We analyzed data from the Women's Interagency HIV Study using multiple multivariable (GEE) logistic regression models to assess the relationship between BMI, BV and blood glucose. Women with a BMI >30 kg/m(2) (obese) had a lower rate (multivariable adjusted OR 0.87 (0.79-0.97), p = 0.009) of BV compared to the reference group (BMI 18.5-24.9 kg/m(2)). There was a significantly lower rate of BV in post-menopausal obese women compared to the post-menopausal reference group, but not in pre-menopausal women. HIV- post-menopausal obese women had a significantly lower rate of BV, but this was not seen in HIV+ post-menopausal obese women. Pre-menopausal women with a higher hemoglobin A1c (>= 6.5%) had a significantly lower rate (multivariable adjusted OR 0.66 (0.49-0.91), p = 0.010) of BV compared to pre-menopausal women with normal hemoglobin A1c levels (<5.7%), but there was no difference in post-menopausal women. This study shows inverse association of BMI with BV in post-menopausal women and hemoglobin A1c with BV in pre-menopausal women. Further studies are needed to confirm these relationships in other cohorts across different reproductive stages and to identify underlying mechanisms for these observed associations.	[Daubert, Elizabeth; Weber, Kathleen M.] Cook Cty Hlth Hektoen Inst Med, Chicago, IL USA; [French, Audrey L.] John H Stroger Jr Hosp Cook Cty, Dept Med, Chicago, IL USA; [Seidman, Dominika] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Michel, Katherine] Georgetown Univ, Sch Med, Dept Infect Dis, Washington, DC USA; [Gustafson, Deborah] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Murphy, Kerry] Montefiore AECOM, Dept Med, Bronx, NY USA; [Muzny, Christina A.] Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL USA; [Alcaide, Maria] Univ Miami, Miller Sch Med, Div Infect Dis, Miami, FL 33136 USA; [Sheth, Anandi] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Adimora, Adaora A.] Univ North Carolina Chapel Hill, Dept Med, Div Infect Dis, Chapel Hill, NC USA; [Spear, Gregory T.] Hektoen Inst Med, Chicago, IL 60608 USA	John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California San Francisco; Georgetown University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Alabama System; University of Alabama Birmingham; University of Miami; Emory University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Spear, GT (corresponding author), Hektoen Inst Med, Chicago, IL 60608 USA.	gsgspear@gmail.com		Sheth, Anandi/0000-0002-6305-2727; Alcaide, Maria/0000-0003-4648-0145				Adimora AA, 2018, INT J EPIDEMIOL, V47, P393, DOI 10.1093/ije/dyy021; Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Alcaide ML, 2017, AIDS RES HUM RETROV, V33, P309, DOI [10.1089/aid.2016.0187, 10.1089/AID.2016.0187]; Anahtar MN, 2018, CELL HOST MICROBE, V23, P159, DOI 10.1016/j.chom.2018.01.013; Bacon MC, 2005, CLIN DIAGN LAB IMMUN, V12, P1013, DOI 10.1128/CDLI.12.9.1013-1019.2005; Bailin SS, 2020, CURR HIV-AIDS REP, V17, P138, DOI 10.1007/s11904-020-00483-5; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Brookheart RT, 2019, AM J OBSTET GYNECOL, V220, DOI 10.1016/j.ajog.2019.01.229; Brotman RM, 2018, MENOPAUSE, V25, P1321, DOI 10.1097/GME.0000000000001236; Chalvon-Demersay T, 2017, FRONT NUTR, V4, DOI 10.3389/fnut.2017.00005; Cruickshank R SA, 1934, J OBSTET GYN BR COMM, V41, P208, DOI DOI 10.1111/J.1471-0528; Dela F, 2019, ACTA PHYSIOL, V226, DOI 10.1111/apha.13245; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Gallagher EJ, 2009, J DIABETES, V1, P9, DOI 10.1111/j.1753-0407.2009.00009.x; HAARBO J, 1991, METABOLISM, V40, P1323, DOI 10.1016/0026-0495(91)90037-W; Hearris MA, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030298; Herold BC, 2013, JAIDS-J ACQ IMM DEF, V63, P485, DOI 10.1097/QAI.0b013e3182961cfc; Jamieson DJ, 2001, OBSTET GYNECOL, V98, P656, DOI 10.1016/S0029-7844(01)01525-3; Landolt NK, 2018, AIDS CARE, V30, P1351, DOI 10.1080/09540121.2018.1450479; Levy ME, 2017, HIV MED, V18, P724, DOI 10.1111/hiv.12516; Lokken EM, 2019, SEX TRANSM DIS, V46, P31, DOI 10.1097/OLQ.0000000000000905; Marschalek J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155182; Massad LS, 2017, AIDS RES HUM RETROV, V33, P432, DOI [10.1089/aid.2016.0213, 10.1089/AID.2016.0213]; Mastrobattista JM, 2008, AM J PERINAT, V25, P233, DOI 10.1055/s-2008-1066875; McKinnon LR, 2019, AIDS RES HUM RETROV, V35, P219, DOI [10.1089/aid.2018.0304, 10.1089/AID.2018.0304]; Mirmonsef P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153553; Mirmonsef P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102467; Mitchell CM, 2017, MENOPAUSE, V24, P1160, DOI 10.1097/GME.0000000000000904; Murphy K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216049; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Obry-Roguet V, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010956; Peipert JF, 2008, SEX TRANSM DIS, V35, P363, DOI 10.1097/OLQ.0b013e31815e4179; Phipps AI, 2010, MATURITAS, V67, P60, DOI 10.1016/j.maturitas.2010.04.015; Schellenberg JJ, 2012, AIDS, V26, P387, DOI 10.1097/QAD.0b013e32834ed7f0; Spear GT, 2014, J INFECT DIS, V210, P1019, DOI 10.1093/infdis/jiu231; Svare JA, 2006, BJOG-INT J OBSTET GY, V113, P1419, DOI 10.1111/j.1471-0528.2006.01087.x; Xu GF, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k1497	37	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0248136	10.1371/journal.pone.0248136	http://dx.doi.org/10.1371/journal.pone.0248136			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU3OZ	33684141	gold, Green Published			2022-12-26	WOS:000627193500034
J	Angeles, MA; Martinez-Gomez, C; Del, M; Migliorelli, F; Daix, M; Provendier, A; Picard, M; Ruiz, J; Chantalat, E; Leray, H; Martinez, A; Gladieff, L; Ferron, G				Angeles, Martina Aida; Martinez-Gomez, Carlos; Del, Mathilde; Migliorelli, Federico; Daix, Manon; Provendier, Anais; Picard, Muriel; Ruiz, Jean; Chantalat, Elodie; Leray, Helene; Martinez, Alejandra; Gladieff, Laurence; Ferron, Gwenael			Risk factors for gastric perforation after cytoreductive surgery in patients with peritoneal carcinomatosis: Splenectomy and increased body mass index	PLOS ONE			English	Article								Background Gastric perforation after cytoreductive surgery (CRS) is an infrequent complication. There is lack of evidence regarding the risk factors for this postoperative complication. The aim of this study was to assess the prevalence of postoperative gastric perforation in patients undergoing CRS for peritoneal carcinomatosis (PC) and to evaluate risk factors predisposing to this complication. Methods We designed a unicentric retrospective study to identify all patients who underwent an open upfront or interval CRS after a primary diagnosis of PC of different origins between March 2007 and December 2018 at a French Comprehensive Cancer Center. The main outcome was the occurrence of postoperative gastric perforation. Results Five hundred thirty-three patients underwent a CRS for PC during the study period and 13 (2.4%) presented a postoperative gastric perforation with a mortality rate of 23% (3/13). Neoadjuvant chemotherapy was administered in 283 (53.1%) patients and 99 (18.6%) received hyperthermic intraperitoneal chemotherapy (HIPEC). In the univariate analysis, body mass index (BMI), peritoneal cancer index, splenectomy, distal pancreatectomy, and histology were significantly associated with postoperative gastric perforation. After multivariate analysis, BMI (OR [95%CI] = 1.13 [1.05-1.22], p = 0.002) and splenectomy (OR [95% CI] = 26.65 [1.39-509.67], p = 0.029) remained significantly related to the primary outcome. Conclusions Gastric perforation after CRS is a rare event with a high rate of mortality. While splenectomy and increased BMI are risk factors associated with this complication, HIPEC does not seem to be related. Gastric perforation is probably an ischemic complication due to a multifactorial process. Preventive measures such as preservation of the gastroepiploic arcade and prophylactic suture of the greater gastric curvature require further assessment.	[Angeles, Martina Aida; Martinez-Gomez, Carlos; Del, Mathilde; Daix, Manon; Provendier, Anais; Chantalat, Elodie; Leray, Helene; Martinez, Alejandra; Ferron, Gwenael] Inst Univ Canc Toulouse, Dept Surg Oncol, Inst Claudius Regaud, Oncopole, Toulouse, France; [Martinez-Gomez, Carlos; Martinez, Alejandra] INSERM, Tumor Immunol & Immunotherapy, CRCT Team 1, Toulouse, France; [Migliorelli, Federico] Ctr Hosp Intercommunal Vallees Ariege, Dept Gynecol & Obstet, St Jean De Verges, France; [Picard, Muriel; Ruiz, Jean] Inst Univ Canc Toulouse, Intens Care Unit, Inst Claudius Regaud, Oncopole, Toulouse, France; [Gladieff, Laurence] Inst Univ Canc Toulouse, Dept Med Oncol, Inst Claudius Regaud, Oncopole, Toulouse, France; [Ferron, Gwenael] INSERM, CRCT Team 19, ONCOSARC Oncogenesis Sarcomas, Toulouse, France	UNICANCER; Institut Claudius Regaud; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Claudius Regaud; UNICANCER; Institut Claudius Regaud; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ferron, G (corresponding author), Inst Univ Canc Toulouse, Dept Surg Oncol, Inst Claudius Regaud, Oncopole, Toulouse, France.; Ferron, G (corresponding author), INSERM, CRCT Team 19, ONCOSARC Oncogenesis Sarcomas, Toulouse, France.	Ferron.Gwenael@iuct.oncopole.fr	Martinez, Alejandra/A-4097-2015; Chantalat, Elodie/AAN-9430-2020; Migliorelli, Federico/HHM-2182-2022	Martinez, Alejandra/0000-0002-7633-3536; Del, Mathilde/0000-0003-2199-6188; Angeles, Martina Aida/0000-0003-4401-3084				Angeles MA, 2020, INT J GYNECOL CANCER, V30, P556, DOI 10.1136/ijgc-2019-000997; Angeles MA, 2019, INT J GYNECOL CANCER, V29, P382, DOI 10.1136/ijgc-2018-000099; Angeles MA, 2019, GYNECOL ONCOL, V153, P209, DOI 10.1016/j.ygyno.2018.12.006; Ayhan A, 2005, GYNECOL ONCOL, V98, P235, DOI 10.1016/j.ygyno.2005.05.028; Bhagwandin SB, 2015, J SURG ONCOL, V111, P324, DOI 10.1002/jso.23834; Ceelen WP, 2008, ANN SURG ONCOL, V15, P535, DOI 10.1245/s10434-007-9648-5; Chang SJ, 2013, GYNECOL ONCOL, V130, P493, DOI 10.1016/j.ygyno.2013.05.040; Chi DS, 2010, GYNECOL ONCOL, V119, P38, DOI 10.1016/j.ygyno.2010.05.031; Chua TC, 2012, J CLIN ONCOL, V30, P2449, DOI 10.1200/JCO.2011.39.7166; CROFTS TJ, 1989, NEW ENGL J MED, V320, P970, DOI 10.1056/NEJM198904133201504; Gerestein CG, 2009, GYNECOL ONCOL, V114, P523, DOI 10.1016/j.ygyno.2009.03.011; Gilly FN, 2006, EJSO-EUR J SURG ONC, V32, P597, DOI 10.1016/j.ejso.2006.03.002; Glehen O, 2003, J CLIN ONCOL, V21, P799, DOI 10.1200/JCO.2003.06.139; Kim J, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.03.96; Kusamura S, 2006, CANCER-AM CANCER SOC, V106, P1144, DOI 10.1002/cncr.21708; Kyang LS, 2017, WORLD J SURG ONCOL, V15, DOI 10.1186/s12957-017-1114-7; Martin AS, 2016, ANN SURG ONCOL, V23, P1941, DOI 10.1245/s10434-016-5109-3; Mikula-Pietrasik J, 2018, CELL MOL LIFE SCI, V75, P509, DOI 10.1007/s00018-017-2663-1; Moller MH, 2013, SCAND J GASTROENTERO, V48, P168, DOI 10.3109/00365521.2012.746393; Munoz-Casares FC, 2016, EJSO-EUR J SURG ONC, V42, P224, DOI 10.1016/j.ejso.2015.11.006; Pierpont Yvonne N, 2014, ISRN Obes, V2014, P638936, DOI 10.1155/2014/638936; Prudius V, 2017, SURG RADIOL ANAT, V39, P433, DOI 10.1007/s00276-016-1746-2; Schmidt U, 2005, EJSO-EUR J SURG ONC, V31, P53, DOI 10.1016/j.ejso.2004.09.011; Sugarbaker Paul H., 1994, Journal of Surgical Oncology, V56, P246, DOI 10.1002/jso.2930560409; Sugarbaker PH, 2006, LANCET ONCOL, V7, P69, DOI 10.1016/S1470-2045(05)70539-8; SUGARBAKER PH, 1995, ANN SURG, V221, P29, DOI 10.1097/00000658-199501000-00004; van Driel WJ, 2018, NEW ENGL J MED, V378, P230, DOI 10.1056/NEJMoa1708618; Yan TD, 2009, J CLIN ONCOL, V27, P6237, DOI 10.1200/JCO.2009.23.9640; Zappa L, 2010, J SURG ONCOL, V101, P634, DOI 10.1002/jso.21546	29	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0248205	10.1371/journal.pone.0248205	http://dx.doi.org/10.1371/journal.pone.0248205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33661999	Green Published, gold			2022-12-26	WOS:000626604100027
J	Bauer, NC; Yang, AL; Wang, X; Zhou, YL; Klibanski, A; Soberman, RJ				Bauer, Nicholas C.; Yang, Anli; Wang, Xin; Zhou, Yunli; Klibanski, Anne; Soberman, Roy J.			A cross-nearest neighbor/Monte Carlo algorithm for single-molecule localization microscopy defines interactions between p53, Mdm2, and MEG3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG NONCODING RNA; PROLYL ISOMERASE PIN1; GENE-EXPRESSION; EXPLOITING NANOBODIES; HYPERMETHYLATION; IDENTIFICATION; ACTIVATION; LOCUS; SUPPRESSOR; PATHWAY	The functions of long noncoding (lnc)RNAs, such as MEG3, are defined by their interactions with other RNAs and proteins. These interactions, in turn, are shaped by their subcellular localization and temporal context. Therefore, it is important to be able to analyze the relationships of lncRNAs while preserving cellular architecture. The ability of MEG3 to suppress cell proliferation led to its recognition as a tumor suppressor. MEG3 has been proposed to activate p53 by disrupting the interaction of p53 with mouse double minute 2 homolog (Mdm2). To test this mechanism in the native cellular context, we employed two-color direct stochastic optical reconstruction microscopy, a single-molecule localization microscopy technique, to detect and quantify the localizations of p53, Mdm2, and MEG3 in U2OS cells. We developed a new cross-nearest neighbor/Monte Carlo algorithm to quantify the association of these molecules. Proof of concept for our method was obtained by examining the association between FKBP1A and mTOR, MEG3 and p53, and Mdm2 and p53. In contrast to previous models, our data support a model in which MEG3 modulates p53 independently of the interaction with Mdm2.	[Bauer, Nicholas C.; Soberman, Roy J.] Massachusetts Gen Hosp, Div Nephrol, Dept Med, Charlestown, MA 02129 USA; [Bauer, Nicholas C.; Soberman, Roy J.] Harvard Med Sch, Charlestown, MA 02129 USA; [Yang, Anli; Wang, Xin; Zhou, Yunli; Klibanski, Anne] Massachusetts Gen Hosp, Dept Med, Neuroendocrine Unit, Boston, MA 02114 USA; [Yang, Anli; Wang, Xin; Zhou, Yunli; Klibanski, Anne] Harvard Med Sch, Boston, MA 02115 USA; [Yang, Anli] Sun Yat Sen Univ Canc Ctr, Dept Breast Oncol, Guangzhou, Guangdong, Peoples R China; [Wang, Xin] Guangdong Pharmaceut Univ, Dept Histol & Embryol, Guangzhou, Guangdong, Peoples R China; [Klibanski, Anne] Mass Gen Brigham, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Sun Yat Sen University; Guangdong Pharmaceutical University	Soberman, RJ (corresponding author), Massachusetts Gen Hosp, Div Nephrol, Dept Med, Charlestown, MA 02129 USA.; Soberman, RJ (corresponding author), Harvard Med Sch, Charlestown, MA 02129 USA.	soberman@helix.mgh.harvard.edu		Bauer, Nicholas/0000-0002-8513-4467; Zhou, Yunli/0000-0003-4831-209X	Jarislowsky Foundation [R01CA193520, R01DK062472, S10RR027931, T32DK007540]	Jarislowsky Foundation	R. J. S. obtained grants R01CA193520, R01DK062472, S10RR027931; N. C. B.: T32DK007540; A. K. and Y. Z. obtained grants R01CA193520 and from the Jarislowsky Foundation. Stochastic optical reconstruction microscopy experiments were conducted at the MGH Molecular Imaging Core. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Annibale P, 2011, NAT METHODS, V8, P527, DOI 10.1038/nmeth.1627; Bauer NC, 2015, TRAFFIC, V16, P1039, DOI 10.1111/tra.12310; Bezanson J, 2017, SIAM REV, V59, P65, DOI 10.1137/141000671; Carrington G, 2019, MOL BIOL CELL, V30, P2737, DOI 10.1091/mbc.E18-11-0694; Chen XZ, 2018, CELL RES, V28, P518, DOI 10.1038/s41422-018-0029-3; Cheunsuchon P, 2011, AM J PATHOL, V179, P2120, DOI 10.1016/j.ajpath.2011.07.002; Das AT, 2004, J BIOL CHEM, V279, P18776, DOI 10.1074/jbc.M313895200; Das PP, 2015, CELL REP, V12, P1456, DOI 10.1016/j.celrep.2015.07.053; Eliscovich C, 2017, P NATL ACAD SCI USA, V114, pE1875, DOI 10.1073/pnas.1621440114; Feher K, 2019, CURR OPIN CHEM BIOL, V51, P130, DOI 10.1016/j.cbpa.2019.05.019; Gejman R, 2008, J CLIN ENDOCR METAB, V93, P4119, DOI 10.1210/jc.2007-2633; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Herce HD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3660; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Ingram JR, 2018, ANNU REV IMMUNOL, V36, P695, DOI 10.1146/annurev-immunol-042617-053327; Jia LF, 2014, INT J CANCER, V135, P2282, DOI 10.1002/ijc.28667; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Landre V, 2017, CELL DEATH DIFFER, V24, P903, DOI 10.1038/cdd.2017.42; Levet F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10007-4; Li LL, 2010, CLIN CANCER RES, V16, P2949, DOI 10.1158/1078-0432.CCR-09-3178; Li RP, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao2387; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81; Lu KH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-461; Miyoshi N, 2000, GENES CELLS, V5, P211, DOI 10.1046/j.1365-2443.2000.00320.x; Mondal T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8743; Pageon SV, 2016, MOL BIOL CELL, V27, P3627, DOI 10.1091/mbc.E16-07-0478; Perry ME, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000968; Qu CS, 2013, GENE EXPR PATTERNS, V13, P51, DOI 10.1016/j.gep.2012.11.003; Riley KJL, 2007, RNA, V13, P1825, DOI 10.1261/rna.673407; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Savchenko A, 2009, MOL BIOTECHNOL, V41, P270, DOI 10.1007/s12033-008-9116-x; Schmider AB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211943; Sheng XJ, 2014, ONCOL REP, V32, P277, DOI 10.3892/or.2014.3208; Sloan KE, 2013, CELL REP, V5, P237, DOI 10.1016/j.celrep.2013.08.049; Sograte-Idrissi S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010048; Sun M, 2014, TUMOR BIOL, V35, P1065, DOI 10.1007/s13277-013-1142-z; Swoboda M, 2012, ACS NANO, V6, P6364, DOI 10.1021/nn301895c; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Uroda T, 2019, MOL CELL, V75, P982, DOI 10.1016/j.molcel.2019.07.025; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wawrzynow B, 2009, J BIOL CHEM, V284, P11517, DOI 10.1074/jbc.M809294200; Yan HL, 2016, NEUROSCIENCE, V337, P191, DOI 10.1016/j.neuroscience.2016.09.017; Young RM, 2019, METHODS MOL BIOL, V1956, P363, DOI 10.1007/978-1-4939-9151-8_18; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zhang X, 2003, J CLIN ENDOCR METAB, V88, P5119, DOI 10.1210/jc.2003-030222; Zhang X, 2010, CANCER RES, V70, P2350, DOI 10.1158/0008-5472.CAN-09-3885; Zhao J, 2005, J CLIN ENDOCR METAB, V90, P2179, DOI 10.1210/jc.2004-1848; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200; Zhu JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139790	56	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100540	10.1016/j.jbc.2021.100540	http://dx.doi.org/10.1016/j.jbc.2021.100540			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33722609	gold, Green Published			2022-12-26	WOS:000672866400513
J	Kido, K; Egawa, T; Fujiyoshi, H; Suzuki, H; Kawanaka, K; Hayashi, T				Kido, Kohei; Egawa, Tatsuro; Fujiyoshi, Haruna; Suzuki, Hikari; Kawanaka, Kentaro; Hayashi, Tatsuya			AMPK is indispensable for overload-induced muscle glucose uptake and glycogenesis but dispensable for inducing hypertrophy in mice	FASEB JOURNAL			English	Article						AMP-activated protein kinase; functional overload; glucose uptake; hypertrophy; skeletal muscle		Chronic muscle loading (overload) induces skeletal muscles to undergo hypertrophy and to increase glucose uptake. Although AMP-activated protein kinase (AMPK) reportedly serves as a negative regulator of hypertrophy and a positive regulator of glucose uptake, its role in overload-induced skeletal muscle hypertrophy and glucose uptake is unclear. This study aimed to determine whether AMPK regulates overload-induced hypertrophy and glucose uptake in skeletal muscles. To this end, skeletal muscle overload was induced through unilateral synergist ablations in wild-type (WT) and transgenic mice, expressing the dominant-negative mutation of AMPK (AMPK-DN). After 14 days, parameters, including muscle fiber cross-sectional area (CSA), glycogen level, and in vivo CHJ-2-deoxy-D-glucose uptake, were assessed. No significant difference was observed in body weight or blood glucose level between the WT and AMPK-DN mice. However, the 14-day muscle overload activated the AMPK pathway in WT mice skeletal muscle, whereas this response was impaired in the AMPK-DN mice. Despite a normal CSA gain in each fiber type, the AMPK-DN mice demonstrated a significant impairment of overload-induced muscle glucose uptake and glycogenesis, compared to WT mice. Moreover, 14-day overload-induced changes in GLUT4 and HKII expression levels were reduced in AMPK-DN mice, compared to WT mice. This study demonstrated that AMPK activation is indispensable for overload-induced muscle glucose uptake and glycogenesis; however, it is dispensable for the induction of hypertrophy in AMPK-DN mice. Furthermore, the AMPK/GLUT4 and HKII axes may regulate overload-induced muscle glucose uptake and glycogenesis.	[Kido, Kohei; Egawa, Tatsuro; Fujiyoshi, Haruna; Suzuki, Hikari; Hayashi, Tatsuya] Kyoto Univ, Grad Sch Human & Environm Studies, Lab Sports & Exercise Med, Kyoto, Japan; [Kido, Kohei; Kawanaka, Kentaro] Fukuoka Univ, Fac Sports & Hlth Sci, Fukuoka, Japan; [Kido, Kohei; Kawanaka, Kentaro] Fukuoka Univ, Inst Phys Act, Fukuoka, Japan	Kyoto University; Fukuoka University; Fukuoka University	Kido, K (corresponding author), Grad Sch Human & Environm Studies, Lab Sports & Exercise Med, Sakyo Ku, Yoshida Nihonmatsu Cho, Kyoto 6068501, Japan.	kohei.kido110@gmail.com		hayashi, Tatsuya/0000-0001-7600-4735; Kido, Kohei/0000-0003-0665-6572	MEXT \ Japan Society for the Promotion of Science (JSPS) [18J01392, 19K20007, 18H03148, 19K22806, 19K11520]	MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 18J01392, 19K20007, 18H03148, 19K22806 and 19K11520	Al-Khalili L, 2003, CELL MOL LIFE SCI, V60, P991, DOI 10.1007/s00018-003-3001-3; AUGERT G, 1985, DIABETOLOGIA, V28, P295, DOI 10.1007/BF00271689; Bacchi E, 2012, DIABETES CARE, V35, P676, DOI 10.2337/dc11-1655; BALDWIN KM, 1981, J APPL PHYSIOL, V50, P1272, DOI 10.1152/jappl.1981.50.6.1272; Bodine SC, 2012, METHODS MOL BIOL, V798, P213, DOI 10.1007/978-1-61779-343-1_12; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Croymans DM, 2013, J APPL PHYSIOL, V115, P1245, DOI 10.1152/japplphysiol.00485.2013; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Dreyer HC, 2006, J PHYSIOL-LONDON, V576, P613, DOI 10.1113/jphysiol.2006.113175; Egawa T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102954; Egawa T, 2015, AM J PHYSIOL-ENDOC M, V309, pE651, DOI 10.1152/ajpendo.00165.2015; Fang SH, 2011, MOL CELL BIOCHEM, V347, P175, DOI 10.1007/s11010-010-0626-z; Fentz J, 2015, AM J PHYSIOL-ENDOC M, V309, pE900, DOI 10.1152/ajpendo.00157.2015; Fryer LGD, 2002, BIOCHEM J, V363, P167, DOI 10.1042/0264-6021:3630167; Fu X, 2013, AM J PHYSIOL-CELL PH, V305, pC887, DOI 10.1152/ajpcell.00124.2013; Fueger PT, 2004, J BIOL CHEM, V279, P50956, DOI 10.1074/jbc.M408312200; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Hingst JR, 2020, MOL METAB, V40, DOI 10.1016/j.molmet.2020.101028; Holten MK, 2004, DIABETES, V53, P294, DOI 10.2337/diabetes.53.2.294; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kido K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65397-z; Kjobsted R, 2019, DIABETES, V68, P1427, DOI 10.2337/db19-0050; Kjobsted R, 2017, DIABETES, V66, P598, DOI 10.2337/db16-0530; KONG XM, 1994, J BIOL CHEM, V269, P12963; Lantier L, 2010, FASEB J, V24, P3555, DOI 10.1096/fj.10-155994; Larkin LM, 2000, J APPL PHYSIOL, V89, P1469, DOI 10.1152/jappl.2000.89.4.1469; Mcgee SL, 2008, J PHYSIOL-LONDON, V586, P1731, DOI 10.1113/jphysiol.2007.143685; Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843; McMillin SL, 2017, DIABETES, V66, P1491, DOI 10.2337/db16-1075; MEGENEY LA, 1993, AM J PHYSIOL, V264, pE583, DOI 10.1152/ajpendo.1993.264.4.E583; Miura S, 2009, AM J PHYSIOL-ENDOC M, V296, pE47, DOI 10.1152/ajpendo.90690.2008; Moller LLV, 2020, J PHYSIOL-LONDON, V598, P5351, DOI 10.1113/JP280294; Moller LLV, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14460; Moore DR, 2009, J PHYSIOL-LONDON, V587, P897, DOI 10.1113/jphysiol.2008.164087; Mounier R, 2009, FASEB J, V23, P2264, DOI 10.1096/fj.08-119057; Nakano M, 2006, METABOLISM, V55, P300, DOI 10.1016/j.metabol.2005.09.003; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Riedl I, 2016, AM J PHYSIOL-ENDOC M, V310, pE461, DOI 10.1152/ajpendo.00387.2015; Ryder JW, 1999, FASEB J, V13, P2246, DOI 10.1096/fasebj.13.15.2246; Schwingshackl L, 2014, DIABETOLOGIA, V57, P1789, DOI 10.1007/s00125-014-3303-z; Thomson DM, 2008, J APPL PHYSIOL, V104, P429, DOI 10.1152/japplphysiol.00900.2007; Toyoda T, 2004, AM J PHYSIOL-ENDOC M, V287, pE166, DOI 10.1152/ajpendo.00487.2003; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; You JS, 2019, FASEB J, V33, P4021, DOI 10.1096/fj.201801653RR; Zheng DH, 2001, J APPL PHYSIOL, V91, P1073, DOI 10.1152/jappl.2001.91.3.1073	50	2	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21459	10.1096/fj.202002164R	http://dx.doi.org/10.1096/fj.202002164R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710687	Green Submitted			2022-12-26	WOS:000635216100103
J	Kirkwood, PM; Gibson, DA; Smith, JR; Wilson-Kanamori, JR; Kelepouri, O; Esnal-Zufiaurre, A; Dobie, R; Henderson, NC; Saunders, PTK				Kirkwood, Phoebe M.; Gibson, Douglas A.; Smith, James R.; Wilson-Kanamori, John R.; Kelepouri, Olympia; Esnal-Zufiaurre, Arantza; Dobie, Ross; Henderson, Neil C.; Saunders, Philippa T. K.			Single-cell RNA sequencing redefines the mesenchymal cell landscape of mouse endometrium	FASEB JOURNAL			English	Article						CD146; chondroitin sulfate proteoglycan 4; endometrium; fibroblast; pericyte; platelet&#8208; derived growth factor beta	STEM-CELLS; PERIVASCULAR CELLS; STROMAL CELLS; KIDNEY INJURY; R PACKAGE; EXPRESSION; IDENTIFICATION; DECIDUALIZATION; PERICYTES; MARKERS	The endometrium is a dynamic tissue that exhibits remarkable resilience to repeated episodes of differentiation, breakdown, regeneration, and remodeling. Endometrial physiology relies on a complex interplay between the stromal and epithelial compartments with the former containing a mixture of fibroblasts, vascular, and immune cells. There is evidence for rare populations of putative mesenchymal progenitor cells located in the perivascular niche of human endometrium, but the existence of an equivalent cell population in mouse is unclear. We used the Pdgfrb-BAC-eGFP transgenic reporter mouse in combination with bulk and single-cell RNA sequencing to redefine the endometrial mesenchyme. In contrast to previous reports we show that CD146 is expressed in both PDGFR beta + perivascular cells and CD31 + endothelial cells. Bulk RNAseq revealed cells in the perivascular niche which express the high levels of Pdgfrb as well as genes previously identified in pericytes and/or vascular smooth muscle cells (Acta2, Myh11, Olfr78, Cspg4, Rgs4, Rgs5, Kcnj8, and Abcc9). scRNA-seq identified five subpopulations of cells including closely related pericytes/vascular smooth muscle cells and three subpopulations of fibroblasts. All three fibroblast populations were PDGFR alpha+/CD34 + but were distinct in their expression of Ngfr/Spon2/Angptl7 (F1), Cxcl14/Smoc2/Rgs2 (F2), and Clec3b/Col14a1/Mmp3 (F3), with potential functions in the regulation of immune responses, response to wounding, and organization of extracellular matrix, respectively. Immunohistochemistry was used to investigate the spatial distribution of these populations revealing F1/NGFR + cells in most abundance beside epithelial cells. We provide the first definitive analysis of mesenchymal cells in the adult mouse endometrium identifying five subpopulations providing a platform for comparisons between mesenchymal cells in endometrium and other adult tissues which are prone to fibrosis.	[Kirkwood, Phoebe M.; Gibson, Douglas A.; Smith, James R.; Wilson-Kanamori, John R.; Kelepouri, Olympia; Esnal-Zufiaurre, Arantza; Dobie, Ross; Henderson, Neil C.; Saunders, Philippa T. K.] Univ Edinburgh, Ctr Inflammat Res, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland; [Henderson, Neil C.] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Saunders, PTK (corresponding author), Univ Edinburgh, Ctr Inflammat Res, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	p.saunders@ed.ac.uk	Saunders, Philippa/C-7489-2013	Saunders, Philippa/0000-0001-9051-9380; Gibson, Douglas/0000-0002-9949-1983; Smith, James/0000-0002-8120-8289	RCUK | Medical Research Council (MRC) [MR/N024524/1]; RCUK | MRC | Medical Research Foundation [MR/N013166/1]; Wellcome Trust (Wellcome) [219542/Z/19/Z]	RCUK | Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RCUK | MRC | Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust (Wellcome)	RCUK | Medical Research Council (MRC), Grant/Award Number: MR/N024524/1; RCUK | MRC | Medical Research Foundation, Grant/Award Number: MR/N013166/1; Wellcome Trust (Wellcome), Grant/Award Number: 219542/Z/19/Z	Andersson E, 2015, INT J MOL MED, V35, P433, DOI 10.3892/ijmm.2014.2035; Ansell DM, 2015, EXP DERMATOL, V24, P833, DOI 10.1111/exd.12782; Bellofiore N, 2018, HUM REPROD, V33, P1715, DOI 10.1093/humrep/dey247; Bellofiore N, 2018, J MOL ENDOCRINOL, V61, pR25, DOI 10.1530/JME-17-0278; Bodnar RJ, 2016, WOUND REPAIR REGEN, V24, P204, DOI 10.1111/wrr.12415; Caligioni CS, 2009, CURR PROTOC NEUROSCI, V4, p4I, DOI DOI 10.1002/0471142301.NSA04IS48; Cervello I, 2007, HUM REPROD, V22, P45, DOI 10.1093/humrep/del332; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109; Cheng Y, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/4794827; Conway JR, 2017, BIOINFORMATICS, V33, P2938, DOI 10.1093/bioinformatics/btx364; Cousins FL, 2016, SCI REP-UK, V6, DOI 10.1038/srep36748; Cousins FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086378; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Crisan M, 2012, J CELL MOL MED, V16, P2851, DOI 10.1111/j.1582-4934.2012.01617.x; Dobie R, 2019, CELL REP, V29, P1832, DOI 10.1016/j.celrep.2019.10.024; Gaafar T, 2014, MOL CELL BIOCHEM, V395, P29, DOI 10.1007/s11010-014-2109-0; Gargett CE, 2016, HUM REPROD UPDATE, V22, P137, DOI 10.1093/humupd/dmv051; Gargett CE, 2010, MOL HUM REPROD, V16, P818, DOI 10.1093/molehr/gaq061; Gargett CE, 2009, BIOL REPROD, V80, P1136, DOI 10.1095/biolreprod.108.075226; Garry R, 2009, HUM REPROD, V24, P1393, DOI 10.1093/humrep/dep036; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Guimaraes-Camboa N, 2017, CELL STEM CELL, V20, P345, DOI 10.1016/j.stem.2016.12.006; Han XP, 2018, CELL, V173, P1307, DOI 10.1016/j.cell.2018.05.012; He LQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35108; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Kaitu'u-Lino TJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.099309; Kirita Y, 2020, P NATL ACAD SCI USA, V117, P15874, DOI 10.1073/pnas.2005477117; Kirita Y, 2019, NEPHRON, V143, P162, DOI 10.1159/000500638; Kitaya K, 2005, J CLIN ENDOCR METAB, V90, P2932, DOI 10.1210/jc.2004-2447; Krausgruber T, 2020, NATURE, V583, P296, DOI 10.1038/s41586-020-2424-4; Krjutskov K, 2016, HUM REPROD, V31, P844, DOI 10.1093/humrep/dew008; Letouzey V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127531; Lucas ES, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0763-1; Masuda H, 2012, CELL TRANSPLANT, V21, P2201, DOI 10.3727/096368911X637362; Matsumoto H, 2017, J REPROD DEVELOP, V63, P445, DOI 10.1262/jrd.2017-047; Maybin JA, 2015, HUM REPROD UPDATE, V21, P748, DOI 10.1093/humupd/dmv038; Mills Stuart J, 2013, Cells, V2, P621, DOI 10.3390/cells2030621; Papatheodorou I, 2020, NUCLEIC ACIDS RES, V48, pD77, DOI 10.1093/nar/gkz947; Parasar P, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0273-2; Peyser R, 2019, AM J RESP CELL MOL, V61, P74, DOI 10.1165/rcmb.2018-0313OC; Queckborner S, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-019-1496-2; Ramachandran P, 2020, NAT REV GASTRO HEPAT, V17, P457, DOI 10.1038/s41575-020-0304-x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saatcioglu HD, 2019, ELIFE, V8, DOI 10.7554/eLife.46349; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Schwab KE, 2005, FERTIL STERIL, V84, P1124, DOI 10.1016/j.fertnstert.2005.02.056; Spitzer TLB, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095885; Tempest N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103240; Wang WX, 2020, NAT MED, V26, P1644, DOI 10.1038/s41591-020-1040-z; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	52	18	18	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21285	10.1096/fj.202002123R	http://dx.doi.org/10.1096/fj.202002123R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710643	Green Published, Green Submitted			2022-12-26	WOS:000635216100067
J	Stoddart, LA; Kilpatrick, LE; Corriden, R; Kellam, B; Briddon, SJ; Hill, SJ				Stoddart, Leigh A.; Kilpatrick, Laura E.; Corriden, Ross; Kellam, Barrie; Briddon, Stephen J.; Hill, Stephen J.			Efficient G protein coupling is not required for agonist-mediated internalization and membrane reorganization of the adenosine A(3) receptor	FASEB JOURNAL			English	Article						&#946; &#8208; arrestin; adenosine A(3) receptor; fluorescence correlation spectroscopy; G protein&#8208; coupled receptor; internalization; membrane organization	BETA(2)-ADRENERGIC RECEPTOR; TERNARY COMPLEX; IONIC LOCK; DRY MOTIF; CONSTITUTIVE ACTIVATION; MICRODOMAINS; ARRESTIN; BINDING; PHOSPHORYLATION; DESENSITIZATION	Organization of G protein-coupled receptors at the plasma membrane has been the focus of much recent attention. Advanced microscopy techniques have shown that these receptors can be localized to discrete microdomains and reorganization upon ligand activation is crucial in orchestrating their signaling. Here, we have compared the membrane organization and downstream signaling of a mutant (R108A, R3.50A) of the adenosine A(3) receptor (A(3)AR) to that of the wild-type receptor. Fluorescence Correlation Spectroscopy (FCS) studies with a fluorescent agonist (ABEA-X-BY630) demonstrated that both wild-type and mutant receptors bind agonist with high affinity but in subsequent downstream signaling assays the R108A mutation abolished agonist-mediated inhibition of cAMP production and ERK phosphorylation. In further FCS studies, both A(3)AR and A(3)AR R108A underwent similar agonist-induced increases in receptor density and molecular brightness which were accompanied by a decrease in membrane diffusion after agonist treatment. Using bimolecular fluorescence complementation, experiments showed that the R108A mutant retained the ability to recruit beta-arrestin and these receptor/arrestin complexes displayed similar membrane diffusion and organization to that observed with wild-type receptors. These data demonstrate that effective G protein signaling is not a prerequisite for agonist-stimulated beta-arrestin recruitment and membrane reorganization of the A(3)AR.	[Stoddart, Leigh A.; Kilpatrick, Laura E.; Corriden, Ross; Briddon, Stephen J.; Hill, Stephen J.] Univ Nottingham, Cell Signalling & Pharmacol Res Grp, Div Physiol Pharmacol & Neurosci, Sch Life Sci, Nottingham, England; [Stoddart, Leigh A.; Kilpatrick, Laura E.; Corriden, Ross; Kellam, Barrie; Briddon, Stephen J.; Hill, Stephen J.] Univ Birmingham, Ctr Membrane Prot & Receptors COMPARE, Birmingham, Midlands, England; [Stoddart, Leigh A.; Kilpatrick, Laura E.; Corriden, Ross; Kellam, Barrie; Briddon, Stephen J.; Hill, Stephen J.] Univ Nottingham, Nottingham, England; [Kilpatrick, Laura E.; Kellam, Barrie] Biodiscovery Inst, Sch Pharm, Univ Pk Nottingham, Nottingham, England	University of Nottingham; University of Birmingham; University of Nottingham; University of Nottingham	Briddon, SJ; Hill, SJ (corresponding author), Univ Nottingham, Cell Signalling & Pharmacol Res Grp, Div Physiol Pharmacol & Neurosci, Sch Life Sci, Nottingham, England.	stephen.briddon@nottingham.ac.uk; Stephen.hill@nottingham.ac.uk	Hill, Stephen/N-6753-2013	Hill, Stephen/0000-0002-4424-239X; Stoddart, Leigh/0000-0002-4469-0600; Kilpatrick, Laura/0000-0001-6331-5606	Medical Research Council (MRC) [G0800006, MR/N020081/1]	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Medical Research Council (MRC), Grant/Award Number: G0800006 and MR/N020081/1	Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Borea PA, 2015, PHARMACOL REV, V67, P74, DOI 10.1124/pr.113.008540; Briddon SJ, 2018, TRENDS PHARMACOL SCI, V39, P158, DOI 10.1016/j.tips.2017.11.004; Burnstock G, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00661; Calebiro D, 2019, CURR OPIN CELL BIOL, V57, P57, DOI 10.1016/j.ceb.2018.11.003; Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; Chen A, 2001, BIOCHEM BIOPH RES CO, V284, P596, DOI 10.1006/bbrc.2001.5027; Cordeaux Y, 2008, FASEB J, V22, P850, DOI 10.1096/fj.07-8180com; Corriden R, 2014, FASEB J, V28, P4211, DOI 10.1096/fj.13-247270; Dawaliby R, 2016, NAT CHEM BIOL, V12, P35, DOI [10.1038/NCHEMBIO.1960, 10.1038/nchembio.1960]; DELEAN A, 1980, J BIOL CHEM, V255, P7108; DeVree BT, 2016, NATURE, V535, P182, DOI 10.1038/nature18324; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; DONALDSON J, 1988, BIOCHEM PHARMACOL, V37, P715, DOI 10.1016/0006-2952(88)90146-3; Feng WK, 2003, BIOCHEM PHARMACOL, V65, P1077, DOI 10.1016/S0006-2952(03)00005-4; Ferguson G, 2002, BIOCHEMISTRY-US, V41, P14748, DOI 10.1021/bi0262911; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Ganguly S, 2010, BIOPHYS J, V99, P1397, DOI 10.1016/j.bpj.2010.06.031; Gondin AB, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00104; Grundmann M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02661-3; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Kara E, 2006, MOL ENDOCRINOL, V20, P3014, DOI 10.1210/me.2006-0098; Kazemi MH, 2018, J CELL PHYSIOL, V233, P2032, DOI 10.1002/jcp.25873; Kilpatrick LE, 2010, BRIT J PHARMACOL, V160, P892, DOI 10.1111/j.1476-5381.2010.00676.x; Latorraca NR, 2017, CHEM REV, V117, P139, DOI 10.1021/acs.chemrev.6b00177; Leschner J, 2013, J PHARMACOL EXP THER, V344, P85, DOI 10.1124/jpet.112.199190; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Middleton RJ, 2007, J MED CHEM, V50, P782, DOI 10.1021/jm061279i; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PALMER TM, 1995, J BIOL CHEM, V270, P29607, DOI 10.1074/jbc.270.49.29607; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; Perkovska S, 2018, TRAFFIC, V19, P58, DOI 10.1111/tra.12535; Rose RH, 2010, BRIT J PHARMACOL, V159, P738, DOI 10.1111/j.1476-5381.2009.00480.x; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Scheer A, 1997, P NATL ACAD SCI USA, V94, P808, DOI 10.1073/pnas.94.3.808; Schneider EH, 2010, J PHARMACOL EXP THER, V333, P382, DOI 10.1124/jpet.109.163220; Stoddart LA, 2014, BRIT J PHARMACOL, V171, P3827, DOI 10.1111/bph.12739; Sungkaworn T, 2017, NATURE, V550, P543, DOI 10.1038/nature24264; Tao YX, 2008, PHARMACOL THERAPEUT, V120, P129, DOI 10.1016/j.pharmthera.2008.07.005; Valentin-Hansen L, 2012, J BIOL CHEM, V287, P31973, DOI 10.1074/jbc.M112.348565; Yanagawa M, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao1917	45	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21211	10.1096/fj.202001729RR	http://dx.doi.org/10.1096/fj.202001729RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710641	Green Published			2022-12-26	WOS:000635216100076
J	Tafere, C; Yilma, Z; Abrha, S; Yehualaw, A				Tafere, Chernet; Yilma, Zewdu; Abrha, Solomon; Yehualaw, Adane			Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression	PLOS ONE			English	Article								Introduction Orally disintegrating tablet (ODT) is a dosage form that overcomes the problem of swallowing which is prevalent in about 35% of the general population. Co-trimoxazole (CTX) is given for patients with HIV for the prophylaxis of opportunistic infection (OI), commonly for pneumocystis carinii pneumonia. It was reported that CTX was associated with a 25-46% reduction in mortality among individuals infected with HIV in sub-Saharan Africa. Esophageal candidiasis which usually comes along with HIV/AIDS is one of AIDS defining illness affecting up to 1 in 5 of people with AIDS. This opportunistic illness is manifested by painful or difficulty of swallowing. In this respect, CTX ODT offer the advantages of both liquid dosage forms in terms of easy swallowing thereby improve patient compliance and solid dosage forms in terms of dose uniformity, stability, lower production, and transportation costs. The objective of this study was to formulate, characterize and optimize CTX ODT which could overcome swallowing problem and improve patient compliance. Co-trimoxazole ODTs were prepared by direct compression technique using a semi synthetic super disintegrant (crospovidone) along with other excipients. Two taste masking techniques were employed, addition of sweetening agent, and solid dispersion by using a pH sensitive polymer, Eudragit E-100 at different ratios (1:1, 1:2 and 1:3). Taste masking was determined by comparing taste threshold value and in vitro drug release. Preliminary study was used to investigate the effect of crospovidone, compression force (CF) and Hydroxypropyl cellulose (HPC) on disintegration time, friability and wetting time (WT). Factorial design was used as it enables simultaneous evaluation of formulation variables and their interaction effect. From the preliminary study, the factors that were found significant were further optimized using central composite design. Design-Expert 8.0.7.1 software was employed to carry out the experimental design. The bitterness threshold concentration of Trimethoprim was found to be 150 mu g/ml and the in vitro drug release of the three batches of drug to polymer ratio (F1:1, 1:2 and 1:3) was 2.80 +/- 0.05, 2.77 +/- 0.00 and 2.63 +/- 0.00 respectively. From the optimization study, the optimal concentration for the superdisintegrant was 8.60% w/w and a CF of 11.25 KN which gave a rapid disintegration and WT of 13.79 and 23.19 seconds respectively and a friability of 0.666%. Conclusion In this study, co-trimoxazole ODT was formulated successfully. Central composite design was effectively used to model and optimize friability, DT and WT. The method was found effective for estimating the effect of independent variables on the dependent variables by using polynomial equation and surface plots. Optimization of the response variables was possible by using both numerical and graphical optimization and the predicted optimal conditions were confirmed experimentally and were found to be in good agreement within 5% of the predicted responses. The results of the study showed that CTX ODT had significantly rapid disintegration, less than 1% friability and enhanced dissolution profiles. The successful formulation of CTX ODT can solve difficulty of swallowing of conventional tablets for some group of patients which are unable to swallow solid oral dosage form.	[Tafere, Chernet; Yilma, Zewdu; Yehualaw, Adane] Bahir Dar Univ, Coll Hlth Sci, Dept Pharm, Bahir Dar, Ethiopia; [Abrha, Solomon] Mekelle Univ, Coll Hlth Sci, Sch Pharm, Dept Pharmaceut, Mekelle, Ethiopia	Bahir Dar University; Mekelle University	Tafere, C (corresponding author), Bahir Dar Univ, Coll Hlth Sci, Dept Pharm, Bahir Dar, Ethiopia.	cheru004@gmail.com		, Chernet Tafere Negesse/0000-0001-7792-5704; yehualaw, adane/0000-0002-3207-8369; Abrha, Solomon/0000-0002-8192-6985	Adigrat University, Adigrat, Ethiopia	Adigrat University, Adigrat, Ethiopia	This research was financially funded by Adigrat University, Adigrat, Ethiopia, for the partial fulfillment of a master's degree in pharmaceutics at Mekelle University. In addition to Adigrat University, Addis Pharmaceutical Factory provided the materials including the active pharmaceutical ingredients and excipients freely. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No authors received any salary from the funders.	Ahmed JA., 2015, INT J PHARM PHARM RE, V2, P1; Ameen SM, 2014, J ANTIMICROB CHEMOTH, V69, P757, DOI 10.1093/jac/dkt400; [Anonymous], 2008, GUID IND OR DIS TABL; [Anonymous], 2007, USP30NF25; Azad K., 2011, J APPL PHARM SCI, V1, P35; Benyounis KY, 2008, OPT LASER TECHNOL, V40, P76, DOI 10.1016/j.optlastec.2007.03.009; Berthoumieu D., 2010, TABLETTING STUDY ODT; Bharadwaj N., 2014, INT J PHARM RES APPL, V4, P78; Bhupendra G. P., 2010, INT J PHARM TECH RES, V2, P1893; Date AA, 2010, B WORLD HEALTH ORGAN, V88, P253, DOI 10.2471/BLT.09.066522; Ramirez DG, 2015, BRAZ J PHARM SCI, V51, P155, DOI 10.1590/S1984-82502015000100016; Ghafari S, 2009, J HAZARD MATER, V163, P650, DOI 10.1016/j.jhazmat.2008.07.090; Ghosh T., 2011, INT J PHARM PHARM SC, V3, P1; Hesari Z, 2016, IRAN J PHARM RES, V15, P677; Inform Project, 2011, OR CAND HIV DIS; Jadhav A., 2016, CJPS, V5, P27; Jafari E., 2013, J APPL PHARM SCI, V3, P167; Karthik V, 2016, J CHEM-NY, V5, P143; Kolhe S., 2013, LOSR J PHARM, V3, P1; Kulkarni AP., 2012, DEV ORAL DISINTEGRAT, V7, P47; Kumar MV., 2016, IJPSR, V2, P53; Li YM, 2008, MATH COMPUT SIMULAT, V79, P1165, DOI 10.1016/j.matcom.2007.11.002; Liew KB, 2013, IJPPS, V5, P4; Lundstedt T, 1998, CHEMOMETR INTELL LAB, V42, P3, DOI 10.1016/S0169-7439(98)00065-3; Maheswarappa MK, 2011, ASIAN J PHARM, V5, P107, DOI 10.4103/0973-8398.84551; Malpure PS., 2018, WJPPS, V7, P428; Maniruzzaman M, 2012, EUR J PHARM BIOPHARM, V80, P433, DOI 10.1016/j.ejpb.2011.10.019; Mehdi ZS, 2015, J CHEM-NY, V3, P63; Mekonnin D., 2015, IJPTP, V6, P1598; Mohajeri L, 2010, BIORESOURCE TECHNOL, V101, P893, DOI 10.1016/j.biortech.2009.09.013; Molla F., 2014, INT J PHARM PHARM SC, V6, P827; Mukesh PR, 2012, INT J DRUG DEV RES, V4, P374; Nutan MTH, 2005, INT J PHARMACEUT, V294, P89, DOI 10.1016/j.ijpharm.2005.01.013; Olmez SS., 2009, FABAD J PHARM SCI, V34, P167; Ordu JI., 2018, J PHARM INNOV, V7, P682; Oyejola BA., 2015, INT J STAT APPL, V5, P21, DOI DOI 10.5923/J.STATISTICS.20150501.04; Pabari RM, 2012, J YOUNG PHARM, V4, P157, DOI 10.4103/0975-1483.100021; Pabari RM, 2012, INT J PHARMACEUT, V430, P18, DOI 10.1016/j.ijpharm.2012.03.021; Pahwa R, 2010, ARCH APPL SCI RES, V2, P35; Pandey P, 2016, INT J PHARMA RES REV, V5, P50; Paula Nersesian, 2011, COTRIMOXAZOLE MANAGE; Picker-Freyer KM, 2007, AAPS PHARMSCITECH, V8; Poojan P., 2013, JPSBR, V3, P68; Preis M, 2015, AAPS PHARMSCITECH, V16, P234, DOI 10.1208/s12249-015-0313-1; Rahane R, 2018, J DRUG DEL THERAP, V8, P50; Rajakumar S, 2011, MATER DESIGN, V32, P2878, DOI 10.1016/j.matdes.2010.12.025; Rajakumar S., 2011, J MANUF ENG, V6, P191; Rowe R.C., 2012, HDB PHARM EXCIPIENTS; Saffoon N, 2011, J APPL PHARM SCI, V1, P13; Sandeep DS, 2015, NITTE UNIV J HEALTH, V5, P40; Santhanakumar M, 2015, INT J CHEMTECH RES, V7, P2625; Sayar E, 2008, FABAD J PHARM SCI, V33, P87; Schiermeier S, 2002, EUR J PHARM SCI, V15, P295, DOI 10.1016/S0928-0987(02)00011-8; Shahtalebi MA., 2015, J HERBMED PHARM, V4, P102; Singh KP, 2010, CHEM ENG J, V165, P151, DOI 10.1016/j.cej.2010.09.010; Singh S., 2015, INT J PHARM PHARM SC, V7, P89; SINGH SK, 1995, INT J PHARM, V125, P243, DOI 10.1016/0378-5173(95)00135-6; Tabbakhian M., 2014, J HERBMED PHARM, V3, P21; Taymaz I, 2011, ENERGY, V36, P1155, DOI 10.1016/j.energy.2010.11.034; Velmurugan S, 2010, INT J CHEM PHARM SCI, V1, P1; WHO, 2010, DISP TABL; World Health Organization, 2008, INF EXP M DOS FORMS; World Health Organization (WHO), 2006, GUID COTR PROPH HIV; Yilma Z, 2015, INT J PHARM SCI RES, V6, P1877, DOI 10.13040/IJPSR.0975-8232.6(5).1877-92; Zohdi-Fasaei H, 2017, ENERGY, V128, P496, DOI 10.1016/j.energy.2017.03.122	65	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0246648	10.1371/journal.pone.0246648	http://dx.doi.org/10.1371/journal.pone.0246648			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY1VJ	33725014	gold, Green Published			2022-12-26	WOS:000629833700023
J	Martinez-Ordonez, A; Seoane, S; Avila, L; Eiro, N; Macia, M; Arias, E; Pereira, F; Garcia-Caballero, T; Gomez-Lado, N; Aguiar, P; Vizoso, F; Perez-Fernandez, R				Martinez-Ordonez, Anxo; Seoane, Samuel; Avila, Leandro; Eiro, Noemi; Macia, Manuel; Arias, Efigenia; Pereira, Fabio; Garcia-Caballero, Tomas; Gomez-Lado, Noemi; Aguiar, Pablo; Vizoso, Francisco; Perez-Fernandez, Roman			POU1F1 transcription factor induces metabolic reprogramming and breast cancer progression via LDHA regulation	ONCOGENE			English	Article								Metabolic reprogramming is considered hallmarks of cancer. Aerobic glycolysis in tumors cells has been well-known for almost a century, but specific factors that regulate lactate generation and the effects of lactate in both cancer cells and stroma are not yet well understood. In the present study using breast cancer cell lines, human primary cultures of breast tumors, and immune deficient murine models, we demonstrate that the POU1F1 transcription factor is functionally and clinically related to both metabolic reprogramming in breast cancer cells and fibroblasts activation. Mechanistically, we demonstrate that POU1F1 transcriptionally regulates the lactate dehydrogenase A (LDHA) gene. LDHA catalyzes pyruvate into lactate instead of leading into the tricarboxylic acid cycle. Lactate increases breast cancer cell proliferation, migration, and invasion. In addition, it activates normal-associated fibroblasts (NAFs) into cancer-associated fibroblasts (CAFs). Conversely, LDHA knockdown in breast cancer cells that overexpress POU1F1 decreases tumor volume and [F-18]FDG uptake in tumor xenografts of mice. Clinically, POU1F1 and LDHA expression correlate with relapse- and metastasis-free survival. Our data indicate that POU1F1 induces a metabolic reprogramming through LDHA regulation in human breast tumor cells, modifying the phenotype of both cancer cells and fibroblasts to promote cancer progression.	[Martinez-Ordonez, Anxo; Seoane, Samuel; Avila, Leandro; Perez-Fernandez, Roman] Univ Santiago de Compostela, Dept Physiol, Ctr Res Mol Med & Chron Dis CIMUS, Santiago De Compostela, Spain; [Eiro, Noemi; Vizoso, Francisco] Hosp Fdn Jove, Res Unit, Gijon, Spain; [Macia, Manuel; Arias, Efigenia] Univ Santiago de Compostela, Dept Obstet & Gynecol, Hlth Res Inst Santiago de Compostela IDIS, Santiago De Compostela, Spain; [Pereira, Fabio] Univ Santiago de Compostela, Dept Radiat Oncol, Hlth Res Inst Santiago de Compostela IDIS, Santiago De Compostela, Spain; [Garcia-Caballero, Tomas] Univ Santiago de Compostela, Dept Morphol Sci, Hlth Res Inst Santiago de Compostela IDIS, Santiago De Compostela, Spain; [Gomez-Lado, Noemi; Aguiar, Pablo] Univ Santiago de Compostela, Mol Imaging Grp, Dept Psychiat Radiol Publ Hlth Nursing & Med, Santiago De Compostela, Spain; [Gomez-Lado, Noemi; Aguiar, Pablo] Univ Santiago de Compostela, Hlth Res Inst Santiago de Compostela IDIS, Santiago De Compostela, Spain; [Martinez-Ordonez, Anxo] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA	Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Cornell University	Perez-Fernandez, R (corresponding author), Univ Santiago de Compostela, Dept Physiol, Ctr Res Mol Med & Chron Dis CIMUS, Santiago De Compostela, Spain.	roman.perez.fernandez@usc.es	Fernández, Pablo Aguiar/ABD-9169-2022; Gómez-Lado, Noemí/AAR-2538-2021; Seoane Ruzo, Samuel/H-6299-2015; Perez-Fernandez, Roman/L-6342-2014; Eiro, Noemi/C-9510-2018	Gómez-Lado, Noemí/0000-0003-2362-3051; Pires Pereira, Fabio/0000-0002-9991-2805; Avila Concepcion, Leandro/0000-0003-4027-4578; Seoane Ruzo, Samuel/0000-0002-9178-0887; Perez-Fernandez, Roman/0000-0002-5894-0615; Arias, Maria Efigenia/0000-0001-8744-9502; Eiro, Noemi/0000-0001-5840-4807	FEDER/Ministerio de Ciencia, Innovacion y Universidades-Agencia Estatal de Investigacion [PGC2018-100776-B-I00]; Conselleria de Cultura, Educacion e Ordenacion Universitaria [GPC2014/001]; FPU grant (Ministerio de Educacion) [FPU14/00548]; BioBank Complejo Hospitalario Universitario de Santiago (CHUS) [PT17/0015/0002]	FEDER/Ministerio de Ciencia, Innovacion y Universidades-Agencia Estatal de Investigacion; Conselleria de Cultura, Educacion e Ordenacion Universitaria; FPU grant (Ministerio de Educacion)(German Research Foundation (DFG)); BioBank Complejo Hospitalario Universitario de Santiago (CHUS)	This study was supported by FEDER/Ministerio de Ciencia, Innovacion y Universidades-Agencia Estatal de Investigacion-PGC2018-100776-B-I00 and from Conselleria de Cultura, Educacion e Ordenacion Universitaria (GPC2014/001), AM-O was supported by an FPU grant (Ministerio de Educacion-FPU14/00548). We are grateful to Dr. M. Fidalgo and Dr. D. Guallar for helping us to design some experiments, to MJ Otero Fraga for IHC analysis, and the BioBank Complejo Hospitalario Universitario de Santiago (CHUS)(PT17/0015/0002) for their collaboration.	An JY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04366-5; Andersen B, 2001, ENDOCR REV, V22, P2, DOI 10.1210/er.22.1.2; Baek G, 2014, CELL REP, V9, P2233, DOI 10.1016/j.celrep.2014.11.025; Ben-Batalla I, 2010, ENDOCR-RELAT CANCER, V17, P73, DOI 10.1677/ERC-09-0100; Ben-Batalla I, 2010, J CLIN INVEST, V120, P4289, DOI 10.1172/JCI42015; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bhagat TD, 2019, ELIFE, V8, DOI 10.7554/eLife.50663; Brown TP, 2020, ONCOGENE, V39, P3292, DOI 10.1038/s41388-020-1216-5; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Davis RT, 2020, NAT CELL BIOL, V22, P310, DOI 10.1038/s41556-020-0477-0; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DOLLE P, 1990, CELL, V60, P809, DOI 10.1016/0092-8674(90)90095-V; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; FIRTH JD, 1995, J BIOL CHEM, V270, P21021, DOI 10.1074/jbc.270.36.21021; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Gao ZC, 2016, MED SCI MONITOR, V22, P4121, DOI 10.12659/MSM.896107; Gascard P, 2016, GENE DEV, V30, P1002, DOI 10.1101/gad.279737.116; Gil-Puig C, 2005, EUR J ENDOCRINOL, V153, P335, DOI 10.1530/eje.1.01962; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang XJ, 2016, BREAST, V30, P39, DOI 10.1016/j.breast.2016.08.014; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; Husain Z, 2013, J IMMUNOL, V191, P1486, DOI 10.4049/jimmunol.1202702; Ko YH, 2016, J BIOL CHEM, V291, P26291, DOI 10.1074/jbc.M116.740209; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee YJ, 2016, ONCOTARGET, V7, P70898, DOI 10.18632/oncotarget.12286; LEFEVRE C, 1987, EMBO J, V6, P971, DOI 10.1002/j.1460-2075.1987.tb04847.x; Lehuede C, 2016, CANCER RES, V76, P5201, DOI 10.1158/0008-5472.CAN-16-0266; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Luo HJ, 2015, CANCER LETT, V361, P155, DOI 10.1016/j.canlet.2015.02.018; Martinez-Ordonez A, 2018, ONCOGENE, V37, P1430, DOI 10.1038/s41388-017-0036-8; Martinez-Outschoorn UE, 2014, SEMIN CANCER BIOL, V25, P47, DOI 10.1016/j.semcancer.2014.01.005; Martinez-Outschoorn UE, 2011, CELL CYCLE, V10, P1271, DOI 10.4161/cc.10.8.15330; McGuirk S, 2020, TRENDS CANCER, V6, P49, DOI 10.1016/j.trecan.2019.11.009; NELSON C, 1988, SCIENCE, V239, P1400, DOI 10.1126/science.2831625; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Roland CL, 2014, CANCER RES, V74, P5301, DOI 10.1158/0008-5472.CAN-14-0319; Sahai E, 2020, NAT REV CANCER, V20, P174, DOI 10.1038/s41568-019-0238-1; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Seoane S, 2006, MOL ENDOCRINOL, V20, P735, DOI 10.1210/me.2005-0253; Seoane S, 2019, J PATHOL, V249, P381, DOI 10.1002/path.5324; Seoane S, 2015, ONCOTARGET, V6, P14456, DOI 10.18632/oncotarget.3894; Sherman MH, 2014, CELL, V159, P80, DOI 10.1016/j.cell.2014.08.007; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Xie H, 2014, CELL METAB, V19, P795, DOI 10.1016/j.cmet.2014.03.003; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x; Zhu JJ, 2019, NAT REV MOL CELL BIO, V20, P436, DOI 10.1038/s41580-019-0123-5	49	10	11	4	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 15	2021	40	15					2725	2740		10.1038/s41388-021-01740-6	http://dx.doi.org/10.1038/s41388-021-01740-6		MAR 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RN8NW	33714987	hybrid, Green Published			2022-12-26	WOS:000628485300001
J	Kimanya, ME; Routledge, MN; Mpolya, E; Ezekiel, CN; Shirima, CP; Gong, YY				Kimanya, Martin E.; Routledge, Michael N.; Mpolya, Emmanuel; Ezekiel, Chibundu N.; Shirima, Candida P.; Gong, Yun Yun			Estimating the risk of aflatoxin-induced liver cancer in Tanzania based on biomarker data	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; ALBUMIN ADDUCTS; EXPOSURE; GROWTH; AFRICA; CARCINOGENESIS; EPIDEMIOLOGY; MYCOTOXINS; REDUCTION; FUMONISIN	Evidence about the magnitude of the aflatoxin menace can help policy makers appreciate the importance of the problem and strengthen policies to support aflatoxin mitigation measures. In this study, we estimated aflatoxin-induced liver cancer risk in 2016 for Tanzania and used the information to estimate the health burden due to the aflatoxin exposure in the country. The burden of aflatoxin-induced liver cancer was assessed based on available aflatoxin biomarker data from a previous epidemiology study, hepatitis B virus infection prevalence and population size of Tanzania in 2016. The health burden due to aflatoxin-induced liver cancer was estimated using disability adjusted life years (DALYs). The aflatoxin exposures ranged from 15.0-10,926.0 ng/kg bw/day (median, 105.5 ng/kg bw/day). We estimated that in 2016 there were about 1,480 (2.95 per 100,000 persons) new cases of aflatoxin-induced liver cancer in Tanzania and assumed all of them would die within a year. These morbidity and mortality rates led to a total loss of about 56,247.63 DALYs. These results show, quantitatively, the cases of liver cancer and related deaths that could be avoided, and the healthy life years that could be saved, annually, by strengthening measures to control aflatoxin contamination in Tanzania.	[Kimanya, Martin E.; Mpolya, Emmanuel] Nelson Mandela African Inst Sci & Technol, Sch Life Sci & Bioengn, Arusha, Arusha Region, Tanzania; [Routledge, Michael N.] Univ Leeds, Sch Med, Leeds, W Yorkshire, England; [Routledge, Michael N.] Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang, Jiangsu, Peoples R China; [Ezekiel, Chibundu N.] Babcock Univ, Dept Microbiol, Ilishan Remo, Ogun State, Nigeria; [Shirima, Candida P.] Tanzania Bur Stand, Dar Es Salaam, Dar Es Salaam R, Tanzania; [Gong, Yun Yun] Univ Leeds, Sch Food Sci & Nutr, Leeds, W Yorkshire, England	Nelson Mandela African Institution of Science & Technology; University of Leeds; Jiangsu University; University of Leeds	Gong, YY (corresponding author), Univ Leeds, Sch Food Sci & Nutr, Leeds, W Yorkshire, England.	Y.Gong@leeds.ac.uk	Kimanya, Martin/AAX-3199-2020; Gong, Yun Yun/L-7094-2016	Kimanya, Martin/0000-0002-8320-2841; Gong, Yun Yun/0000-0003-4927-5526; Mpolya, Emmanuel/0000-0002-6210-9445	University of Leeds QR GCRF Research England [95522719 (2017-18)]	University of Leeds QR GCRF Research England	YG "Aflatoxin risk assessment and capacity building in Tanzania" from the University of Leeds QR GCRF Research England account number 95522719 (2017-18) www.leeds.ac.uk The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abt Associates Inc, 2013, COUNTRY EC ASSESSMEN; Akinyemiju T, 2017, JAMA ONCOL, V3, P1683, DOI 10.1001/jamaoncol.2017.3055; [Anonymous], 1998, WHO FOOD ADDITIVES S; Asiki G, 2014, TROP MED INT HEALTH, V19, P592, DOI 10.1111/tmi.12283; Bandyopadhyay R, 2016, WORLD MYCOTOXIN J, V9, P771, DOI 10.3920/WMJ2016.2130; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chapot B., 1991, TECHNIQUES DIAGNOSTI, P135; Chen C, 2018, ENVIRON INT, V115, P29, DOI 10.1016/j.envint.2018.03.001; GAN LS, 1988, CARCINOGENESIS, V9, P1323, DOI 10.1093/carcin/9.7.1323; Gong Yun Yun, 2016, Food Saf (Tokyo), V4, P14, DOI 10.14252/foodsafetyfscj.2015026; Gong YY, 2004, ENVIRON HEALTH PERSP, V112, P1334, DOI 10.1289/ehp.6954; Gong YY, 2002, BRIT MED J, V325, P20, DOI 10.1136/bmj.325.7354.20; Ingenbleek L, 2020, LANCET PLANET HEALTH, V4, pE292, DOI 10.1016/S2542-5196(20)30104-2; Institute for Health Metrics and Evaluation (IHME), 2016, GLOBAL HLTH DATA EXC; Kamala A, 2017, J AGR FOOD CHEM, V65, P7106, DOI 10.1021/acs.jafc.6b03429; Kew MC, 2013, ANN HEPATOL, V12, P173, DOI 10.1016/S1665-2681(19)31354-7; Kilonzo SB, 2018, J TROP MED-US, V2018, DOI 10.1155/2018/4239646; Kimanya ME, 2008, FOOD ADDIT CONTAM A, V25, P1353, DOI 10.1080/02652030802112601; Kimanya ME, 2015, CURR OPIN FOOD SCI, V6, P7, DOI 10.1016/j.cofs.2015.11.005; Liu Y, 2010, ENVIRON HEALTH PERSP, V118, P818, DOI 10.1289/ehp.0901388; Makori N, 2019, WORLD MYCOTOXIN J, V12, P67, DOI 10.3920/WMJ2018.2354; Pierron A, 2016, ANIM NUTR, V2, P63, DOI 10.1016/j.aninu.2016.03.001; Routledge MN, 2011, WOODHEAD PUBL FOOD S, P225; Routledge MN, 2014, BIOMARKERS, V19, P430, DOI 10.3109/1354750X.2014.924998; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Shephard GS, 2008, FOOD ADDIT CONTAM A, V25, P1246, DOI 10.1080/02652030802036222; Shephard GS, 2003, J TOXICOL-TOXIN REV, V22, P267, DOI 10.1081/TXR-120024094; Shirima CP, 2015, ENVIRON HEALTH PERSP, V123, P173, DOI 10.1289/ehp.1408097; Subandoro A, 2007, FOOD SECURITY PRACTI; Turner PC, 2007, INT J EPIDEMIOL, V36, P1119, DOI 10.1093/ije/dym122; Turner PC, 2005, LANCET, V365, P1950, DOI 10.1016/S0140-6736(05)66661-5; Watson S, 2015, WORLD MYCOTOXIN J, V8, P525, DOI 10.3920/WMJ2014.1824; WHO (World Health Organization), 2020, EVALUATIONS JOINT FA; Wild CP, 1996, CANCER EPIDEM BIOMAR, V5, P179; Wild CP, 2016, IARC WORKING GROUP R; Wu F, 2010, FOOD ADDIT CONTAM A, V27, P496, DOI 10.1080/19440040903437865; Yang JD, 2017, LANCET GASTROENTEROL, V2, P103, DOI 10.1016/S2468-1253(16)30161-3	37	10	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0247281	10.1371/journal.pone.0247281	http://dx.doi.org/10.1371/journal.pone.0247281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705417	Green Published, gold			2022-12-26	WOS:000629590400042
J	Kim, H; Son, S; Ko, Y; Shin, I				Kim, Hyungjoo; Son, Seogho; Ko, Yunhyo; Shin, Incheol			CTGF regulates cell proliferation, migration, and glucose metabolism through activation of FAK signaling in triple-negative breast cancer	ONCOGENE			English	Article								Connective tissue growth factor (CTGF), also known as CCN2, is a member of the CCN protein family of secreted proteins with roles in diverse biological processes. CTGF regulates biological functions such as cell proliferation, migration, adhesion, wound healing, and angiogenesis. In this study, we demonstrate a mechanistic link between CTGF and enhanced aerobic glycolysis in triple-negative breast cancer (TNBC). We found that CTGF is overexpressed in TNBC and high CTGF expression is correlated with a poor prognosis. Also, CTGF was required for in vivo tumorigenesis and in vitro proliferation, migration, invasion, and adhesion of TNBC cells. Our results indicate that extracellular CTGF binds directly to integrin alpha v beta 3, activating the FAK/Src/NF-kappa B p65 signaling axis, which results in transcriptional upregulation of Glut3. Neutralization of CTGF decreased cell proliferation, migration, and invasion through downregulation of Glut3-mediated glycolytic phenotypes. Overall, our work suggests a novel function for CTGF as a modulator of cancer metabolism, indicating that CTGF is a potential therapeutic target in TNBC.	[Kim, Hyungjoo; Son, Seogho; Ko, Yunhyo; Shin, Incheol] Hanyang Univ, Dept Life Sci, Seoul 04763, South Korea; [Shin, Incheol] Hanyang Univ, Inst Nat Sci, Seoul 04763, South Korea	Hanyang University; Hanyang University	Shin, I (corresponding author), Hanyang Univ, Dept Life Sci, Seoul 04763, South Korea.; Shin, I (corresponding author), Hanyang Univ, Inst Nat Sci, Seoul 04763, South Korea.	incheol@hanyang.ac.kr		Kim, Hyungjoo/0000-0003-1627-4797	National Research Foundation of Korea (NRF) [2019R1H1A2079999, 2020R1F1A1048616, 2020R1A6A3A13074546]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	Grant source, National Research Foundation of Korea (NRF); Grant numbers (grant recipient), 2019R1H1A2079999 (Incheol Shin), 2020R1F1A1048616 (Incheol Shin), 2020R1A6A3A13074546 (Hyungjoo Kim).	Adekola K, 2012, CURR OPIN ONCOL, V24, P650, DOI 10.1097/CCO.0b013e328356da72; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Ancey PB, 2018, FEBS J, V285, P2926, DOI 10.1111/febs.14577; Aysola K, 2013, HEREDITARY GENET, V2013; Bennewith KL, 2009, CANCER RES, V69, P775, DOI 10.1158/0008-5472.CAN-08-0987; Bosch A, 2010, CANCER TREAT REV, V36, P206, DOI 10.1016/j.ctrv.2009.12.002; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Braig S, 2011, BRIT J CANCER, V105, P231, DOI 10.1038/bjc.2011.226; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen PS, 2007, J CELL SCI, V120, P2053, DOI 10.1242/jcs.03460; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; Chien WW, 2011, INT J ONCOL, V38, P1741, DOI 10.3892/ijo.2011.985; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dornhofer N, 2006, CANCER RES, V66, P5816, DOI 10.1158/0008-5472.CAN-06-0081; Garcia P, 2013, INT J EXP PATHOL, V94, P195, DOI 10.1111/iep.12023; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Hall-Glenn F, 2011, CELL MOL LIFE SCI, V68, P3209, DOI 10.1007/s00018-011-0782-7; Han DF, 2015, ONCOTARGET, V6, P26119, DOI 10.18632/oncotarget.4444; Han TY, 2013, CELL ADHES MIGR, V7, P395, DOI 10.4161/cam.26345; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kikuchi R, 2007, CANCER RES, V67, P7095, DOI 10.1158/0008-5472.CAN-06-4567; Kim H, 2018, BMB REP, V51, P486, DOI 10.5483/BMBRep.2018.51.10.192; Krzeslak A, 2012, PATHOL ONCOL RES, V18, P721, DOI 10.1007/s12253-012-9500-5; Kuo MH, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121568; Ladwa R, 2011, J CLIN PATHOL, V64, P58, DOI 10.1136/jcp.2010.082768; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Lee HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054652; Lee HS, 2007, J IMMUNOL, V179, P7001, DOI 10.4049/jimmunol.179.10.7001; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Lipson KE, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S24; Lluis JM, 2007, CANCER RES, V67, P7368, DOI 10.1158/0008-5472.CAN-07-0515; Londhe P, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00104; Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324; Neesse A, 2013, P NATL ACAD SCI USA, V110, P12325, DOI 10.1073/pnas.1300415110; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; Shakunaga T, 2000, CANCER, V89, P1466, DOI 10.1002/1097-0142(20001001)89:7<1466::AID-CNCR8>3.0.CO;2-G; Shimo T, 2001, ONCOLOGY-BASEL, V61, P315, DOI 10.1159/000055339; Shimo T, 2006, J BONE MINER RES, V21, P1045, DOI 10.1359/JBMR.060416; Sun XY, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00428; Tai YL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/690690; Wang GM, 2013, J INT MED RES, V41, P1214, DOI 10.1177/0300060513476595; Wang MY, 2009, CANCER RES, V69, P3482, DOI 10.1158/0008-5472.CAN-08-2524; Wang XJ, 2019, MOL CELL, V76, P148, DOI 10.1016/j.molcel.2019.07.007; Watanabe M, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.21; Welch MD, 2013, BRIT J HAEMATOL, V162, P537, DOI 10.1111/bjh.12417; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Xie D, 2001, CANCER RES, V61, P8917; Yang F, 2005, CANCER RES, V65, P8887, DOI 10.1158/0008-5472.CAN-05-1702; Yin D, 2010, INT J CANCER, V127, P2257, DOI 10.1002/ijc.25257; Yoshida T, 2010, MOL CANCER THER, V9, P1657, DOI 10.1158/1535-7163.MCT-09-0906; Zha XJ, 2015, CANCER LETT, V359, P97, DOI 10.1016/j.canlet.2015.01.001	53	14	14	0	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 15	2021	40	15					2667	2681		10.1038/s41388-021-01731-7	http://dx.doi.org/10.1038/s41388-021-01731-7		MAR 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RN8NW	33692467				2022-12-26	WOS:000627285600002
J	Yanagi, N; Kamiya, K; Hamazaki, N; Matsuzawa, R; Nozaki, K; Ichikawa, T; Valley, TS; Nakamura, T; Yamashita, M; Maekawa, E; Koike, T; Yamaoka-Tojo, M; Arai, M; Matsunaga, A; Ako, J				Yanagi, Naoya; Kamiya, Kentaro; Hamazaki, Nobuaki; Matsuzawa, Ryota; Nozaki, Kohei; Ichikawa, Takafumi; Valley, Thomas S.; Nakamura, Takeshi; Yamashita, Masashi; Maekawa, Emi; Koike, Tomotaka; Yamaoka-Tojo, Minako; Arai, Masayasu; Matsunaga, Atsuhiko; Ako, Junya			Post-intensive care syndrome as a predictor of mortality in patients with critical illness: A cohort study	PLOS ONE			English	Article							MECHANICALLY VENTILATED PATIENTS; TERM COGNITIVE IMPAIRMENT; ICU-ACQUIRED WEAKNESS; MISSING DATA; GAIT SPEED; MINI-COG; SURVIVORS; DEPRESSION; UNIT; VALIDITY	Introduction The post-intensive care syndrome (PICS) encompasses multiple, diverse conditions, such as physical disability, cognitive impairment, and depression. We sought to evaluate whether conditions within PICS have similar associations with mortality among survivors of critical illness. Materials and methods In this retrospective cohort study, we identified 248 critically ill patients with intensive care unit stay >= 72 hours, who underwent PICS evaluation. Patients with disability in activities of daily living, cognitive impairment, or depression before hospitalization were excluded. We defined PICS using established measures of physical disability (usual gait speed), cognitive impairment (Mini-Cog test), and depression (Patient Health Questionnaire-2) at hospital discharge. The endpoint was all-cause mortality. Results Patients had a median age of 69 years and Acute Physiology and Chronic Health Evaluation (APACHE) II score of 16. One hundred thirty-two patients were classified as having PICS, and 19 patients died. 81/248 (34%) patients had physical disability, 42/248 (19%) had cognitive impairment, and 44/248 (23%) had depression. After adjusting for covariates on multivariable Cox regression analyses, PICS was significantly associated with all-cause mortality (hazard ratio [HR] 3.78, 95% confidence interval [CI] 1.02 - 13.95; P = 0.046). However, the association between PICS and all-cause mortality was related to physical disability and cognitive impairment (P = 0.001 and P = 0.027, respectively), while depression was not (P = 0.623). Conclusion While PICS as a syndrome has been useful in gaining attention to the sequelae of critical illness, its relationship with long-term mortality is driven largely by physical disability and cognitive impairment and not depression.	[Yanagi, Naoya; Kamiya, Kentaro; Nakamura, Takeshi; Yamashita, Masashi; Matsunaga, Atsuhiko] Kitasato Univ, Grad Sch Med Sci, Dept Rehabil Sci, Sagamihara, Kanagawa, Japan; [Kamiya, Kentaro; Yamaoka-Tojo, Minako; Matsunaga, Atsuhiko] Kitasato Univ, Sch Allied Hlth Sci, Dept Rehabil, Sagamihara, Kanagawa, Japan; [Hamazaki, Nobuaki; Nozaki, Kohei; Ichikawa, Takafumi] Kitasato Univ Hosp, Dept Rehabil, Sagamihara, Kanagawa, Japan; [Matsuzawa, Ryota] Hyogo Univ Hlth Sci, Sch Rehabil, Dept Phys Therapy, Kobe, Hyogo, Japan; [Valley, Thomas S.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Valley, Thomas S.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Valley, Thomas S.] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA; [Nakamura, Takeshi] Juntendo Univ Hosp, Dept Rehabil, Tokyo, Japan; [Maekawa, Emi; Ako, Junya] Kitasato Univ, Sch Med, Dept Cardiovasc Med, Sagamihara, Kanagawa, Japan; [Koike, Tomotaka] Kitasato Univ Hosp, Dept Intens Care Ctr, Sagamihara, Kanagawa, Japan; [Yamaoka-Tojo, Minako; Ako, Junya] Kitasato Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Sagamihara, Kanagawa, Japan; [Arai, Masayasu] Kitasato Univ, Dept Res, Sch Med, Div Intens Care Med, Sagamihara, Kanagawa, Japan; [Arai, Masayasu] Kitasato Univ, Dev Ctr New Med Frontiers, Sch Med, Sagamihara, Kanagawa, Japan	Kitasato University; Kitasato University; Kitasato University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Juntendo University; Kitasato University; Kitasato University; Kitasato University; Kitasato University; Kitasato University	Kamiya, K (corresponding author), Kitasato Univ, Grad Sch Med Sci, Dept Rehabil Sci, Sagamihara, Kanagawa, Japan.; Kamiya, K (corresponding author), Kitasato Univ, Sch Allied Hlth Sci, Dept Rehabil, Sagamihara, Kanagawa, Japan.	k-kamiya@kitasato-u.ac.jp	Valley, Thomas/ABC-7960-2020; Yamashita, Masashi/ABD-3109-2021	Valley, Thomas/0000-0002-5766-4970; Yamashita, Masashi/0000-0003-4680-1068				Ali NA, 2008, AM J RESP CRIT CARE, V178, P261, DOI 10.1164/rccm.200712-1829OC; Beenakker KGM, 2010, AGEING RES REV, V9, P431, DOI 10.1016/j.arr.2010.05.005; Bemis-Dougherty AR, 2013, PHYS THER, V93, P179, DOI 10.2522/ptj.20110429; Bodner TE, 2008, STRUCT EQU MODELING, V15, P651, DOI 10.1080/10705510802339072; Borson S, 2005, J AM GERIATR SOC, V53, P871, DOI 10.1111/j.1532-5415.2005.53269.x; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Chan KS, 2016, CRIT CARE MED, V44, P859, DOI 10.1097/CCM.0000000000001760; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, DOI 10.1093/ageing/afz046; Culley DJ, 2017, ANESTHESIOLOGY, V127, P765, DOI 10.1097/ALN.0000000000001859; De Jonghe B, 2004, INTENS CARE MED, V30, P1117, DOI 10.1007/s00134-004-2174-z; De Jonghe B, 2007, CRIT CARE MED, V35, P2007, DOI 10.1097/01.ccm.0000281450.01881.d8; Deveney TK, 2016, GEN HOSP PSYCHIAT, V42, P9, DOI 10.1016/j.genhosppsych.2016.06.005; Elliott D, 2014, CRIT CARE MED, V42, P2518, DOI 10.1097/CCM.0000000000000525; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Fetterplace K, 2019, J HUM NUTR DIET, V32, P702, DOI 10.1111/jhn.12659; Forman DE, 2016, CAN J CARDIOL, V32, P1082, DOI 10.1016/j.cjca.2016.05.015; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Guerra C, 2015, ANESTHESIOLOGY, V123, P1105, DOI 10.1097/ALN.0000000000000821; Hatch R, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2223-6; Hermans G, 2014, AM J RESP CRIT CARE, V190, P410, DOI 10.1164/rccm.201312-2257OC; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Kamiya K, 2018, EUR J PREV CARDIOL, V25, P212, DOI 10.1177/2047487317735715; Kamiya K, 2017, AM J CARDIOL, V119, P186, DOI 10.1016/j.amjcard.2016.09.040; Kamiya K, 2016, JACC-HEART FAIL, V4, P265, DOI 10.1016/j.jchf.2015.11.010; Kamiya K, 2015, AM J MED, V128, P1212, DOI 10.1016/j.amjmed.2015.06.035; Kayambu G, 2013, CRIT CARE MED, V41, P1543, DOI 10.1097/CCM.0b013e31827ca637; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Marra A, 2018, CRIT CARE MED, V46, P1393, DOI 10.1097/CCM.0000000000003218; Myhren H, 2010, CRIT CARE, V14, DOI 10.1186/cc8870; Nakamura T, 2018, NUTR METAB CARDIOVAS, V28, P743, DOI 10.1016/j.numecd.2018.02.015; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Needham DM, 2010, ARCH PHYS MED REHAB, V91, P536, DOI 10.1016/j.apmr.2010.01.002; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Pedersen AB, 2017, CLIN EPIDEMIOL, V9, P157, DOI 10.2147/CLEP.S129785; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Sharshar T, 2009, CRIT CARE MED, V37, P3047, DOI 10.1097/CCM.0b013e3181b027e9; Tanaka S, 2019, CIRC J, V83, P1860, DOI 10.1253/circj.CJ-19-0136; van Wagenberg L, 2020, J INTENSIVE CARE MED, V35, P293, DOI 10.1177/0885066617745818; Vincent JL, 2010, LANCET, V376, P1354, DOI 10.1016/S0140-6736(10)60575-2; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vlake JH, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-019-0422-0; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Wieske L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0937-2; Wintermann GB, 2015, CRIT CARE MED, V43, P1213, DOI 10.1097/CCM.0000000000000936; Witteveen E, 2017, CRIT CARE MED, V45, P972, DOI 10.1097/CCM.0000000000002408	50	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0244564	10.1371/journal.pone.0244564	http://dx.doi.org/10.1371/journal.pone.0244564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QV3DA	33690614	Green Published, gold			2022-12-26	WOS:000627854700027
J	De la Guardia-Hidrogo, VM; Paz, HA				De la Guardia-Hidrogo, Vanessa M.; Paz, Henry A.			Influence of industry standard feeding frequencies on behavioral patterns and rumen and fecal bacterial communities in Holstein and Jersey cows	PLOS ONE			English	Article							DAIRY-COWS; MILK-YIELD; GASTROINTESTINAL-TRACT; RUMINAL FERMENTATION; EATING BEHAVIOR; ACID PRODUCTION; CORN-SILAGE; DRY-MATTER; DIGESTIBILITY; MICROBIOME	This study aimed to evaluate the effects of feeding frequency on behavioral patterns and on diurnal fermentation and bacteriome profiles of the rumen and feces in Holstein and Jersey cows. Ten Holstein and 10 Jersey cows were offered a TMR (53:47 forage-to-concentrate ratio dry matter basis) for ad libitum consumption and were randomly allocated within breed to one of the following feeding frequencies: (1) TMR delivered 1x/d (at 0600 h) or (2) TMR delivered 2x/d (at 0600 and 1800 h). The experiment lasted for 28 d with the first 14 d for cow adaptation to the Calan gates and the next 14 d for data collection. On d 23 and 24, an observer manually recorded the time budget (time spent lying, eating, drinking, standing, and milking), rumination activity, and number of visits to the feeding gate from each animal. On d 28, 5 concomitant collections of rumen and fecal samples were performed at intervals of 6 h via esophageal tubing and fecal grab, respectively. The bacteriome composition from these samples was determined through sequencing of the V4 region of the 16S rRNA gene. Feeding frequency did not affect behavioral patterns; however, Holstein cows spend more time lying (15.4 vs. 13.5 +/- 0.8 h) and ruminating (401 vs. 331 +/- 17.5 min) than Jersey cows. Fermentation profiles were similar by feeding frequency in both breeds. While no major diurnal fluctuations were observed in the fecal bacterial community from both breeds, diurnal fluctuations were identified in the rumen bacterial community from Holstein cows which appeared to follow pH responses. Overall, the bacterial community composition was not differentiated by industry standard feeding frequencies but was differentiated by breed and sample type.	[De la Guardia-Hidrogo, Vanessa M.; Paz, Henry A.] Mississippi State Univ, Dept Anim & Dairy Sci, Mississippi State, MS 39762 USA	Mississippi State University	Paz, HA (corresponding author), Mississippi State Univ, Dept Anim & Dairy Sci, Mississippi State, MS 39762 USA.	hap151@msstate.edu		Paz, Henry A/0000-0002-2231-9368				Abbas W, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72011-9; Allen MS, 1996, J ANIM SCI, V74, P3063; Allen MS, 1997, J DAIRY SCI, V80, P1447, DOI 10.3168/jds.S0022-0302(97)76074-0; Amir A, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00191-16; Aschenbach JR, 2011, J ANIM SCI, V89, P1092, DOI 10.2527/jas.2010-3301; Bainbridge ML, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw059; Beecher M, 2014, J DAIRY SCI, V97, P3906, DOI 10.3168/jds.2013-7708; Ben Shabat SK, 2016, ISME J, V10, P2958, DOI 10.1038/ismej.2016.62; Benchaar C, 2020, J DAIRY SCI, V103, P7094, DOI 10.3168/jds.2020-18199; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Britt JH, 2018, J DAIRY SCI, V101, P3722, DOI 10.3168/jds.2017-14025; Britt JS, 2003, J DAIRY SCI, V86, P3796, DOI 10.3168/jds.S0022-0302(03)73987-3; Cholewinska P, 2020, ANIM HEALTH RES REV, V21, P3, DOI 10.1017/S1466252319000069; DeVries TJ, 2005, J DAIRY SCI, V88, P3553, DOI 10.3168/jds.S0022-0302(05)73040-X; Dieho K, 2016, J DAIRY SCI, V99, P5370, DOI 10.3168/jds.2015-10819; Dong RL, 2018, J ANIM SCI, V96, P783, DOI 10.1093/jas/skx073; ERDMAN RA, 1995, J DAIRY SCI, V78, P1199, DOI 10.3168/jds.S0022-0302(95)76738-8; Fan PX, 2020, ISME J, V14, P302, DOI 10.1038/s41396-019-0529-2; Foster ZSL, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005404; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Grainger C, 2010, J DAIRY SCI, V93, P2612, DOI 10.3168/jds.2009-2888; Hart KD, 2014, J DAIRY SCI, V97, P1713, DOI 10.3168/jds.2013-7504; HOOVER WH, 1978, J ANIM SCI, V46, P1789, DOI 10.2527/jas1978.4661789x; Jones B. W., 2017, Professional Animal Scientist, V33, P140, DOI 10.15232/pas.2016-01548; King EE, 2011, APPL ENVIRON MICROB, V77, P5682, DOI 10.1128/AEM.05130-11; Kononoff PJ, 2003, J DAIRY SCI, V86, P3343, DOI 10.3168/jds.S0022-0302(03)73937-X; Lengowski MB, 2016, ANAEROBE, V42, P6, DOI 10.1016/j.anaerobe.2016.07.004; Li F., 2019, MICROBIOME, P7, DOI [10.1186/s40168-019-0621-x, DOI 10.1186/S40168-019-0621-X]; Li FY, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0618-5; Luan S, 2016, J DAIRY SCI, V99, P2190, DOI 10.3168/jds.2015-9671; Macmillan K, 2017, J DAIRY SCI, V100, P1045, DOI 10.3168/jds.2016-11337; Mao SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16116; Mattachini G, 2013, J ANIM SCI, V91, P4899, DOI 10.2527/jas.2012-5554; Maulfair DD, 2010, J DAIRY SCI, V93, P4791, DOI 10.3168/jds.2010-3278; McGlinn D, 2016, **DATA OBJECT**; Munksgaard L, 2020, J DAIRY SCI, V103, P4643, DOI 10.3168/jds.2019-17565; Myer PR, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1201-6; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; NOCEK JE, 1985, J DAIRY SCI, V68, P2238, DOI 10.3168/jds.S0022-0302(85)81096-1; Norring M, 2012, J DAIRY SCI, V95, P102, DOI 10.3168/jds.2010-3458; Paz HA, 2018, J ANIM SCI, V96, P1045, DOI 10.1093/jas/skx081; Paz HA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01206; Pitta DW, 2018, J DAIRY SCI, V101, P7661, DOI 10.3168/jds.2017-13858; Plaizier JC, 2008, VET J, V176, P21, DOI 10.1016/j.tvjl.2007.12.016; R Core Team, 2020, R LANG ENV STAT COMP; Robles V, 2007, J ANIM SCI, V85, P2538, DOI 10.2527/jas.2006-739; Schirmann K, 2012, J DAIRY SCI, V95, P3212, DOI 10.3168/jds.2011-4741; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shaani Y, 2018, ISME J, V12, P2446, DOI 10.1038/s41396-018-0203-0; Shabi Z, 1999, J DAIRY SCI, V82, P1252, DOI 10.3168/jds.S0022-0302(99)75348-8; Shabi Z, 1998, J DAIRY SCI, V81, P1991, DOI 10.3168/jds.S0022-0302(98)75773-X; Sova AD, 2013, J DAIRY SCI, V96, P4759, DOI 10.3168/jds.2013-6679; Thaiss CA, 2015, GUT MICROBES, V6, P137, DOI 10.1080/19490976.2015.1016690; Tong JJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198225; de Oliveira MNV, 2013, VET MICROBIOL, V164, P307, DOI 10.1016/j.vetmic.2013.02.013; von Keyserlingk MAG, 2012, J DAIRY SCI, V95, P7399, DOI 10.3168/jds.2012-5807; Welkie DG, 2010, ANAEROBE, V16, P94, DOI 10.1016/j.anaerobe.2009.07.002	58	2	2	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0248147	10.1371/journal.pone.0248147	http://dx.doi.org/10.1371/journal.pone.0248147			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667259	Green Published, gold			2022-12-26	WOS:000626604300057
J	Medina, MS; Bretzing, KO; Aviles, RA; Chong, KM; Espinoza, A; Garcia, CNG; Katz, BB; Kharwa, RN; Hernandez, A; Lee, JL; Lee, TM; Lo Verde, C; Strul, MW; Wong, EY; Owens, CP				Medina, Michael S.; Bretzing, Kevin O.; Aviles, Richard A.; Chong, Kiersten M.; Espinoza, Alejandro; Garcia, Chloe Nicole G.; Katz, Benjamin B.; Kharwa, Ruchita N.; Hernandez, Andrea; Lee, Justin L.; Lee, Terrence M.; Lo Verde, Christine; Strul, Max W.; Wong, Emily Y.; Owens, Cedric P.			CowN sustains nitrogenase turnover in the presence of the inhibitor carbon monoxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; GLUCONACETOBACTER-DIAZOTROPHICUS; GENE-EXPRESSION; FEMO-COFACTOR; BINDING; PROTEIN; FIXATION; PROTECTION; MECHANISM; IDENTIFICATION	Nitrogenase is the only enzyme capable of catalyzing nitrogen fixation, the reduction of dinitrogen gas (N-2) to ammonia (NH3). Nitrogenase is tightly inhibited by the environmental gas carbon monoxide (CO). Nitrogen-fixing bacteria rely on the protein CowN to grow in the presence of CO. However, the mechanism by which CowN operates is unknown. Here, we present the biochemical characterization of CowN and examine how CowN protects nitrogenase from CO. We determine that CowN interacts directly with nitrogenase and that CowN protection observes hyperbolic kinetics with respect to CowN concentration. At a CO concentration of 0.001 atm, CowN restores nearly full nitrogenase activity. Our results further indicate that CowN's protection mechanism involves decreasing the binding affinity of CO to nitrogenase's active site approximately tenfold without interrupting substrate turnover. Taken together, our work suggests CowN is an important auxiliary protein in nitrogen fixation that engenders CO tolerance to nitrogenase.	[Medina, Michael S.; Bretzing, Kevin O.; Aviles, Richard A.; Chong, Kiersten M.; Espinoza, Alejandro; Garcia, Chloe Nicole G.; Kharwa, Ruchita N.; Hernandez, Andrea; Lee, Terrence M.; Lo Verde, Christine; Strul, Max W.; Wong, Emily Y.; Owens, Cedric P.] Chapman Univ, Schmid Coll Sci & Technol, Orange, CA 92866 USA; [Katz, Benjamin B.; Lee, Justin L.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA	Chapman University System; Chapman University; University of California System; University of California Irvine	Owens, CP (corresponding author), Chapman Univ, Schmid Coll Sci & Technol, Orange, CA 92866 USA.	cpowens@chapman.edu		Lee, Justin/0000-0001-8207-1272	USDA-NIFA [2015-67012-26563]; NSF-CLP grant [1905399]; Research Corporation for Science Advancement Cottrell Scholar Award; Chapman University Faculty Opportunity Fund grant; Chapman Center for Undergraduate Excellence grants; Schmid College's Capstone funds	USDA-NIFA(United States Department of Agriculture (USDA)); NSF-CLP grant; Research Corporation for Science Advancement Cottrell Scholar Award; Chapman University Faculty Opportunity Fund grant; Chapman Center for Undergraduate Excellence grants; Schmid College's Capstone funds	This work was supported by USDA-NIFA grant 2015-67012-26563, NSF-CLP grant 1905399, a Research Corporation for Science Advancement Cottrell Scholar Award, and a Chapman University Faculty Opportunity Fund grant to C. P. O, through Chapman Center for Undergraduate Excellence grants to K. O. B., K. M. C., C. N. G. G., T. M. L., and C. L. V., and Schmid College's Capstone funds.	Buscagan TM, 2021, ANGEW CHEM INT EDIT, V60, P5704, DOI 10.1002/anie.202015751; Christiansen J, 2000, J BIOL CHEM, V275, P36104, DOI 10.1074/jbc.M004889200; CONRAD R, 1982, GEOPHYS RES LETT, V9, P1353, DOI 10.1029/GL009i012p01353; Danyal K, 2011, METHODS MOL BIOL, V766, P191, DOI 10.1007/978-1-61779-194-9_13; DAVIS LC, 1979, BIOCHEMISTRY-US, V18, P4860, DOI 10.1021/bi00589a014; DAVIS LC, 1980, J BACTERIOL, V141, P1230, DOI 10.1128/JB.141.3.1230-1238.1980; FISCHER HM, 1994, MICROBIOL REV, V58, P352, DOI 10.1128/MMBR.58.3.352-386.1994; Fisher K, 2005, BBA-PROTEINS PROTEOM, V1750, P154, DOI 10.1016/j.bbapap.2005.04.010; Flores-Encarnacion M, 1999, J BACTERIOL, V181, P6987; Galisa PS, 2012, J MICROBIOL METH, V91, P1, DOI 10.1016/j.mimet.2012.07.005; Gee LB, 2015, BIOCHEMISTRY-US, V54, P3314, DOI 10.1021/acs.biochem.5b00216; George SJ, 1997, J AM CHEM SOC, V119, P6450, DOI 10.1021/ja971088s; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Guo K, 2008, J EXP BOT, V59, P3443, DOI 10.1093/jxb/ern194; Hoffmann MC, 2014, J BACTERIOL, V196, P3494, DOI 10.1128/JB.01754-14; Howard JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072751; Hsu YY, 2013, J PLANT PHYSIOL, V170, P1075, DOI 10.1016/j.jplph.2013.03.004; Igarashi RY, 2003, CRIT REV BIOCHEM MOL, V38, P351, DOI 10.1080/10409230390242380; Jasniewski AJ, 2020, CHEM REV, V120, P5107, DOI 10.1021/acs.chemrev.9b00704; Katz FEH, 2017, ANAL BIOCHEM, V520, P62, DOI 10.1016/j.ab.2016.12.012; Katz FEH, 2016, ISR J CHEM, V56, P682, DOI 10.1002/ijch.201600020; Kerby RL, 2011, J BACTERIOL, V193, P774, DOI 10.1128/JB.00794-10; King GM, 2002, APPL ENVIRON MICROB, V68, P4480, DOI 10.1128/AEM.68.9.4480-4485.2002; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Lee CC, 2018, CHEMBIOCHEM, V19, P649, DOI 10.1002/cbic.201800035; Lee CC, 2010, SCIENCE, V329, P642, DOI 10.1126/science.1191455; Lee CC, 2009, P NATL ACAD SCI USA, V106, P9209, DOI 10.1073/pnas.0904408106; Lee HI, 2005, J AM CHEM SOC, V127, P15880, DOI 10.1021/ja054078x; Lee HI, 1997, J AM CHEM SOC, V119, P10121, DOI 10.1021/ja9715096; LOWE DJ, 1990, BIOCHEM J, V272, P621, DOI 10.1042/bj2720621; Masepohl B, 2002, J MOL MICROB BIOTECH, V4, P243; Milligan P, 2000, FEMS MICROBIOL ECOL, V34, P157, DOI 10.1111/j.1574-6941.2000.tb00765.x; MORETT E, 1988, P NATL ACAD SCI USA, V85, P9401, DOI 10.1073/pnas.85.24.9401; Morrison CN, 2015, BIOCHEMISTRY-US, V54, P2052, DOI 10.1021/bi501313k; Owens CP, 2018, METHOD ENZYMOL, V599, P355, DOI 10.1016/bs.mie.2017.09.007; Owens CP, 2016, J AM CHEM SOC, V138, P10124, DOI 10.1021/jacs.6b06783; Owens CP, 2015, J AM CHEM SOC, V137, P12704, DOI 10.1021/jacs.5b08310; Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017; Rebelein JG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13641; Rees DC, 2005, PHILOS T R SOC A, V363, P971, DOI 10.1098/rsta.2004.1539; Rich JJ, 1999, FEMS MICROBIOL ECOL, V28, P215; RIVERAORTIZ JM, 1975, J BACTERIOL, V123, P537, DOI 10.1128/JB.123.2.537-545.1975; Rutledge HL, 2020, CHEM REV, V120, P5158, DOI 10.1021/acs.chemrev.9b00663; Schlesier J, 2016, J AM CHEM SOC, V138, P239, DOI 10.1021/jacs.5b10341; Scott AD, 2014, J AM CHEM SOC, V136, P15942, DOI 10.1021/ja505720m; Seefeldt LC, 2013, BBA-BIOENERGETICS, V1827, P1102, DOI 10.1016/j.bbabio.2013.04.003; Segal HM, 2017, PROTEIN SCI, V26, P1984, DOI 10.1002/pro.3236; Sippel D, 2018, SCIENCE, V359, P1484, DOI 10.1126/science.aar2765; Sippel D, 2017, NAT CHEM BIOL, V13, P956, DOI [10.1038/nchembio.2428, 10.1038/NCHEMBIO.2428]; Souza ALF, 2010, J MICROBIOL, V48, P77, DOI 10.1007/s12275-009-0077-y; Spatzal T, 2014, SCIENCE, V345, P1620, DOI 10.1126/science.1256679; Sun P, 2011, METHODS MOL BIOL, V705, P259, DOI 10.1007/978-1-61737-967-3_16; Tezcan FA, 2005, SCIENCE, V309, P1377, DOI 10.1126/science.1115653; Urbauer JL, 2015, PROTEINS, V83, P1137, DOI 10.1002/prot.24811; Ureta A, 2002, J BACTERIOL, V184, P5805, DOI 10.1128/JB.184.20.5805-5809.2002; Walsh I, 2012, BIOINFORMATICS, V28, P2189, DOI 10.1093/bioinformatics/bts343; Wareham LK, 2016, ANTIOXID REDOX SIGN, V24, P1013, DOI 10.1089/ars.2015.6501; Xuan W, 2008, PLANT SIGNAL BEHAV, V3, P381, DOI 10.4161/psb.3.6.5374; Yan LF, 2011, EUR J INORG CHEM, P2064, DOI 10.1002/ejic.201100029; Yang ZY, 2011, J BIOL CHEM, V286, P19417, DOI 10.1074/jbc.M111.229344; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	61	3	3	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100501	10.1016/j.jbc.2021.100501	http://dx.doi.org/10.1016/j.jbc.2021.100501			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33667548	Green Published, gold			2022-12-26	WOS:000672866400475
J	Liu, HB; Sun, ST; Liu, B				Liu, Haibin; Sun, Shengtao; Liu, Bing			Smurf2 exerts neuroprotective effects on cerebral ischemic injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-EDGED-SWORD; OXIDATIVE STRESS; APOPTOSIS; DEGRADATION; HIF-1-ALPHA; EXPRESSION; AUTOPHAGY; RECOVERY; NEURON; ROLES	The present study aimed to explore specific mechanisms involved in mediating the neuroprotective effects of Smad ubiquitination regulatory factor 2 (Smurf2) in cerebral ischemic injury. A middle cerebral artery occlusion (MCAO) mouse model and an oxygen-glucose deprivation (OGD)-treated neuron model were developed. The expression of Smurf2, Yin Yang 1 (YY1), hypoxia-inducible factor-1 alpha (HIF1 alpha), and DNA damage-inducible transcript 4 gene (DDIT4) was analyzed. Thereafter, the expression of Smurf2, YY1, HIF1 alpha, and DDIT4 was altered in the MCAO mice and OGD-treated neurons. Apoptosis in tissues and cerebral infarction were assessed. In neurons, the expression of apoptosis-related proteins, viability, and apoptosis were assessed, followed by evaluation of lactate dehydrogenase leakage rate. The interaction between Smurf2 and YY1 was analyzed by coimmunoprecipitation assay and that between YY1 ubiquitination by in vivo ubiquitination experiment. The results showed downregulation of Smurf2 and upregulation of YY1, HIF1 alpha, and DDIT4 in both MCAO mice and OGD-treated neurons. Smurf2 elevated YY1 ubiquitination and degradation, and YY1 increased HIF1 alpha expression to promote DDIT4 in neurons. Overexpressed Smurf2 or down-regulated YY1, HIF1 alpha, or DDIT4 reduced the volume of cerebral infarction and apoptosis in MCAO mice, while enhancing cell viability and reducing apoptosis and lactate dehydrogenase leakage in OGD-treated neurons. In summary, our findings elucidated a neuroprotective role of Smurf2 in cerebral ischemic injury via inactivation of the YY1/HIF1 alpha/DDIT4 axis.	[Liu, Haibin; Sun, Shengtao; Liu, Bing] Linyi Peoples Hosp, Dept Paediat, Linyi, Shandong, Peoples R China		Liu, B (corresponding author), Linyi Peoples Hosp, Dept Paediat, Linyi, Shandong, Peoples R China.	13562955239@163.com						Chae DK, 2019, MOL ONCOL, V13, P2663, DOI 10.1002/1878-0261.12581; Chen SD, 2011, INT J MOL SCI, V12, P7199, DOI 10.3390/ijms12107199; Chen SH, 2020, BRAIN RES, V1748, DOI 10.1016/j.brainres.2020.147075; Chen WQ, 2014, NEURAL REGEN RES, V9, P1210, DOI 10.4103/1673-5374.135329; Dong S, 2019, AM J PHYSIOL-CELL PH, V316, pC632, DOI 10.1152/ajpcell.00443.2018; Fu L, 2020, SEMIN CANCER BIOL, V67, P102, DOI 10.1016/j.semcancer.2019.12.023; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; He JT, 2012, MOLECULES, V17, P315, DOI 10.3390/molecules17010315; Jeong HM, 2014, BBA-MOL CELL RES, V1843, P2005, DOI 10.1016/j.bbamcr.2014.04.023; Jo DH, 2014, J MOL MED, V92, P1083, DOI 10.1007/s00109-014-1168-8; Koganti P, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00295; Koizumi S, 2018, NEUROCHEM INT, V119, P107, DOI 10.1016/j.neuint.2018.01.007; Liu W, 2018, BIOMED PHARMACOTHER, V108, P698, DOI 10.1016/j.biopha.2018.09.082; Lou Z, 2018, CELL PHYSIOL BIOCHEM, V46, P2103, DOI 10.1159/000489450; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Park KM, 2016, AM J PHYSIOL-HEART C, V311, pH371, DOI 10.1152/ajpheart.00807.2015; Radak D, 2017, CURR VASC PHARMACOL, V15, P115, DOI 10.2174/1570161115666161104095522; Ramkumar C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3598; Sarvagalla S, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01230; Singh N, 2012, CELL MOL NEUROBIOL, V32, P491, DOI 10.1007/s10571-012-9803-9; Su JY, 2019, NEUROCHEM INT, V128, P14, DOI 10.1016/j.neuint.2019.03.019; Sun JG, 2019, J CELL BIOCHEM, V120, P14771, DOI 10.1002/jcb.28737; Wang J, 2018, CELL PHYSIOL BIOCHEM, V51, P692, DOI 10.1159/000495327; Wang XW, 2016, EXP BIOL MED, V241, P177, DOI 10.1177/1535370215600548; Wei K, 2012, CNS NEUROSCI THER, V18, P879, DOI 10.1111/cns.12005; Wu SR, 2013, CANCER RES, V73, P1787, DOI 10.1158/0008-5472.CAN-12-0366; Yang XS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06088-0; Yao MH, 2010, J NEUROSCI, V30, P4062, DOI 10.1523/JNEUROSCI.2964-09.2010; Yu YL, 2013, EMBO MOL MED, V5, P531, DOI 10.1002/emmm.201201783; Zhang JB, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.03.144; Zhang XC, 2019, NEUROPHARMACOLOGY, V158, DOI 10.1016/j.neuropharm.2019.107682; Zong YH, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0235-6	32	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100537	10.1016/j.jbc.2021.100537	http://dx.doi.org/10.1016/j.jbc.2021.100537			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	33722608	gold, Green Published			2022-12-26	WOS:000690873500010
J	Wang, XF; Chang, XY; He, CY; Fan, ZY; Yu, ZJ; Yu, BQ; Wu, XY; Hou, JY; Li, JF; Su, LP; Liu, BY; Zhu, ZG				Wang, Xufeng; Chang, Xinyu; He, Changyu; Fan, Zhiyuan; Yu, Zhenjia; Yu, Beiqin; Wu, Xiongyan; Hou, Junyi; Li, Jianfang; Su, Liping; Liu, Bingya; Zhu, Zhenggang			ATP5B promotes the metastasis and growth of gastric cancer by activating the FAK/AKT/MMP2 pathway	FASEB JOURNAL			English	Article						ATP5B; gastric cancer; metastasis; proliferation		Adenosine triphosphate (ATP) in the tumor microenvironment serves a vital role during tumor progression. ATP synthase F1 beta subunit (ATP5B) is one of the most important subunits of ATP synthase and increases cellular ATP levels. ATP5B reportedly participates in carcinogenesis in several tumors. However, the regulatory mechanisms of ATP5B remain poorly understood in gastric cancer (GC). Here, we determined that high ATP5B expression in tumor tissues of GC is positively correlated with age, the tumor size, the TNM stage, lymph node metastasis, and patients' poor prognosis. The overexpression of ATP5B in GC cells elevated the cellular ATP content and promoted migration, invasion and proliferation. The levels of MMP2 expression, phosphorylated FAK, and phosphorylated AKT were increased after ATP5B overexpression in GC cells. Additionally, ATP5B overexpression increased the extracellular ATP level through the secretion of intracellular ATP and activated the FAK/AKT/MMP2 signaling pathway. ATP5B-induced downstream pathway activation was induced through the plasma membrane P2X7 receptor. Inhibitors of P2X7, FAK, AKT, and MMP2 suppressed the proliferative, migratory, and invasive capabilities of GC cells. In conclusion, our experiments indicate that ATP5B contributes to tumor progression of GC via FAK/AKT/MMP2 pathway. ATP5B, therefore, may be a biomarker of poor prognosis and a potential therapeutic target for GC.	[Wang, Xufeng; Chang, Xinyu; He, Changyu; Fan, Zhiyuan; Yu, Zhenjia; Yu, Beiqin; Wu, Xiongyan; Hou, Junyi; Li, Jianfang; Su, Liping; Liu, Bingya; Zhu, Zhenggang] Shanghai Jiao Tong Univ, Sch Med, Dept Surg,Ruijin Hosp, Shanghai Key Lab Gastr Neoplasms,Shanghai Inst Di, Shanghai, Peoples R China	Shanghai Jiao Tong University	Liu, BY; Zhu, ZG (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Surg, Shanghai Inst Digest Surg,Ruijin Hosp, Shanghai 200025, Peoples R China.; Liu, BY; Zhu, ZG (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Gastr Neoplasms, Ruijin Hosp, Shanghai 200025, Peoples R China.	liubingya@sjtu.edu.cn; zzg1954@hotmail.com	Liu, Bingya/GMW-5655-2022	Liu, Bingya/0000-0002-4406-3762	National Natural Science Foundation of China (NSFC) [81672822, 81871904, 81772509, 81871902, 81902393]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81672822, 81871904, 81772509, 81871902 and 81902393	Amoroso F, 2015, ONCOGENE, V34, P5240, DOI 10.1038/onc.2014.444; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Burnstock G, 2013, PURINERG SIGNAL, V9, P491, DOI 10.1007/s11302-013-9372-5; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Chen HY, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0837-9; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Gilbert SM, 2019, ONCOGENE, V38, P194, DOI 10.1038/s41388-018-0426-6; Hu LP, 2019, CLIN CANCER RES, V25, P1318, DOI 10.1158/1078-0432.CCR-18-2297; Leon D, 2007, ANAL BIOCHEM, V367, P140, DOI 10.1016/j.ab.2007.03.038; Li W, 2017, INT J ONCOL, V50, P1312, DOI 10.3892/ijo.2017.3878; Lu YX, 2018, CANCER RES, V78, P1972, DOI 10.1158/0008-5472.CAN-17-3155; McCarthy AE, 2019, CELL, V179, P659, DOI 10.1016/j.cell.2019.09.017; Mishra M, 2017, EXPERT REV PROTEOMIC, V14, P1037, DOI 10.1080/14789450.2017.1388167; Mittler R, 2017, TRENDS PLANT SCI, V22, P11, DOI 10.1016/j.tplants.2016.08.002; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pan JM, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1049-7; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ren T, 2017, ONCOGENE, V36, P5897, DOI 10.1038/onc.2017.167; Robinson AJ, 2020, CANCER RES, V80, P937, DOI 10.1158/0008-5472.CAN-19-1920; Schulien I, 2020, CANCER RES, V80, P699, DOI 10.1158/0008-5472.CAN-19-1909; Stagg J, 2010, ONCOGENE, V29, P5346, DOI 10.1038/onc.2010.292; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang LL, 2019, EXP BIOL MED, V244, P734, DOI 10.1177/1535370219846492; Weber GF, 2016, INT J CANCER, V138, P2061, DOI 10.1002/ijc.29839; White N, 2006, TRENDS PHARMACOL SCI, V27, P211, DOI 10.1016/j.tips.2006.02.004; Xu GY, 2016, J NEURO-ONCOL, V126, P405, DOI 10.1007/s11060-015-1984-x; Yang JC, 2006, DIABETES, V55, P193, DOI 10.2337/diabetes.55.01.06.db05-0938; Yang JC, 2004, J BIOL CHEM, V279, P53915, DOI 10.1074/jbc.M405309200; Zhang YC, 2019, INT J CANCER, V145, P1068, DOI 10.1002/ijc.32207	31	3	4	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e20649	10.1096/fj.202000608R	http://dx.doi.org/10.1096/fj.202000608R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715234	hybrid			2022-12-26	WOS:000635216100098
J	Thapamagar, SB; Ellstrom, K; Anholm, JD; Fargo, RA; Dandamudi, N				Thapamagar, Suman B.; Ellstrom, Kathleen; Anholm, James D.; Fargo, Ramiz A.; Dandamudi, Nagamani			Impact of pulmonary rehabilitation in sleep in COPD patients measured by actigraphy	PLOS ONE			English	Article							QUALITY-OF-LIFE; OLDER-ADULTS; SUBJECTIVE SLEEP; EXERCISE; VALIDITY; MODERATE; INDEX; RELIABILITY; PREVALENCE; DISORDERS	Introduction Chronic obstructive pulmonary disease (COPD) patients have poor sleep quality, longer time to sleep onset and frequent nocturnal awakenings. Poor sleep quality in COPD is associated with poor quality of life (QoL), increased exacerbations and increased mortality. Pulmonary rehabilitation (PR) improves functional status and QoL in COPD but effects on sleep are unclear. PR improves subjective sleep quality but there is paucity of objective actigraphy data. We hypothesized that actigraphy would demonstrate subjective and objective improvement in sleep following PR. Paired comparisons (t-test or Wilcoxon-signed-rank test) were performed before and after PR data on all variables. Methods This retrospective study of COPD patients undergoing PR utilized actigraphy watch recordings before and after 8-weeks of PR to assess changes in sleep variables including total time in bed (TBT), total sleep time (TST), sleep onset latency (SOL), sleep efficiency (SE), wakefulness after sleep onset (WASO) and total nocturnal awakenings. A change in Pittsburg Sleep Quality Index (PSQI) was a secondary outcome. PSQI was performed before and after PR. Results Sixty-nine patients were included in the final analysis. Most participants were male (97%), non-obese (median BMI 27.5, IQR 24.3 to 32.4 kg/m(2)) with an average age of 69 +/- 8 years and 71% had severe COPD (GOLD stage 3 or 4). Prevalence of poor sleep quality (PSQI >= 5) was 86%. Paired comparisons did not show improvement in actigraphic sleep parameters following 8-weeks PR despite improvements in 6-min-walk distance (6MWD, mean improvement 54 m, 95% CI 34 m to 74 m, p<0.0001) and St. George's Respiratory Questionnaire scores (SGRQ, mean improvement 7.7 points, 95% CI 5.2 to 10.2, p<0.0001). Stratified analysis of all sleep variables by severity of COPD, BMI, mood, mental status, 6-MWD and SGRQ did not show significant improvement after PR. In Veterans with poor sleep quality (PSQI >= 5), PR improved subjective sleep quality (PSQI, mean difference 0.79, 95% CI 0.07 to 1.40, p = 0.03). Conclusions Pulmonary rehabilitation improved subjective sleep quality in Veterans who had poor sleep quality at the beginning of the PR but did not improve objective sleep parameters by actigraphy. Our findings highlight the complex interactions among COPD, sleep and exercise.	[Thapamagar, Suman B.; Anholm, James D.; Fargo, Ramiz A.; Dandamudi, Nagamani] Loma Linda Univ, Sch Med Loma Linda, Div Pulm Crit Care Sleep Allergy & Hyperbar Med, Loma Linda, CA 92350 USA; [Thapamagar, Suman B.; Ellstrom, Kathleen; Anholm, James D.; Fargo, Ramiz A.; Dandamudi, Nagamani] VA Loma Linda Healthcare Syst, Pulm & Crit Care Sect, Med Serv, Loma Linda, CA 92357 USA; [Thapamagar, Suman B.; Fargo, Ramiz A.] Riverside Univ Hlth Syst, Div Pulm Crit Care & Hyperbar Med, Moreno Valley, CA 92555 USA	Loma Linda University	Thapamagar, SB (corresponding author), Loma Linda Univ, Sch Med Loma Linda, Div Pulm Crit Care Sleep Allergy & Hyperbar Med, Loma Linda, CA 92350 USA.; Thapamagar, SB (corresponding author), VA Loma Linda Healthcare Syst, Pulm & Crit Care Sect, Med Serv, Loma Linda, CA 92357 USA.; Thapamagar, SB (corresponding author), Riverside Univ Hlth Syst, Div Pulm Crit Care & Hyperbar Med, Moreno Valley, CA 92555 USA.	suman.thapamagar@ruhealth.org	Anholm, James/GRF-6796-2022; Lista-Paz, Ana/I-1170-2016	Anholm, James/0000-0002-5699-3481; Lista-Paz, Ana/0000-0002-8458-6285				Aili K, 2017, J CLIN SLEEP MED, V13, P39, DOI 10.5664/jcsm.6384; Alexander M, 2016, SLEEP, V39, P1399, DOI 10.5665/sleep.5972; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Ancoli-Israel S, 2006, J CLIN SLEEP MED, V2, P333; Aydin H.T, 2014, COPD CLIN PERSPECTIV; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Bonardi JMT, 2016, SLEEP MED, V25, P122, DOI 10.1016/j.sleep.2016.06.025; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chennaoui M, 2015, SLEEP MED REV, V20, P59, DOI 10.1016/j.smrv.2014.06.008; CORMICK W, 1986, THORAX, V41, P846, DOI 10.1136/thx.41.11.846; Coventry PA, 2007, J PSYCHOSOM RES, V63, P551, DOI 10.1016/j.jpsychores.2007.08.002; Cox NS, 2019, COPD, V16, P25, DOI 10.1080/15412555.2019.1567701; Dodd JW, 2011, THORAX, V66, P425, DOI 10.1136/thx.2010.156372; Ellstrom K., 2018, AM J RESP CRIT CARE; Goel N, 2005, CHRONOBIOL INT, V22, P905, DOI 10.1080/07420520500263235; Gordon CS, 2019, CHEST, V156, P80, DOI 10.1016/j.chest.2019.04.009; Hajiro T, 1998, AM J RESP CRIT CARE, V158, P1185, DOI 10.1164/ajrccm.158.4.9802091; HOCH CC, 1987, PSYCHOPHYSIOLOGY, V24, P293, DOI 10.1111/j.1469-8986.1987.tb00298.x; Irwin MR, 2008, SLEEP, V31, P1001; Jakubowski KP, 2017, BEHAV SLEEP MED, V15, P257, DOI 10.1080/15402002.2015.1126595; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; King AC, 1997, JAMA-J AM MED ASSOC, V277, P32, DOI 10.1001/jama.277.1.32; KLINK M, 1987, CHEST, V91, P540, DOI 10.1378/chest.91.4.540; Lan CC, 2014, RESP CARE, V59, P1569, DOI 10.4187/respcare.02912; LAREAU SC, 1994, HEART LUNG, V23, P242; Lewis CA, 2009, THORAX, V64, P133, DOI 10.1136/thx.2007.088930; Majde JA, 2005, J ALLERGY CLIN IMMUN, V116, P1188, DOI 10.1016/j.jaci.2005.08.005; McCarthy B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub3; McDonnell LM, 2014, NPJ PRIM CARE RESP M, V24, DOI 10.1038/npjpcrm.2014.28; Mcsharry DG, 2012, RESPIROLOGY, V17, P1119, DOI 10.1111/j.1440-1843.2012.02217.x; Melancon MO, 2015, PHYSIOL BEHAV, V140, P203, DOI 10.1016/j.physbeh.2014.12.031; Middelkoop HAM, 1996, J GERONTOL A-BIOL, V51, pM108, DOI 10.1093/gerona/51A.3.M108; Mollayeva T, 2016, SLEEP MED REV, V25, P52, DOI 10.1016/j.smrv.2015.01.009; Morgenthaler T, 2007, SLEEP, V30, P519, DOI 10.1093/sleep/30.4.519; Nunes DM, 2009, LUNG, V187, P159, DOI 10.1007/s00408-009-9147-5; Omachi TA, 2012, SLEEP MED, V13, P476, DOI 10.1016/j.sleep.2011.12.007; Ries AL, 2007, CHEST, V131, p4S, DOI 10.1378/chest.06-2418; Ryrso CK, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0718-1; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Singh SJ, 2014, EUR RESPIR J, V44, P1447, DOI 10.1183/09031936.00150414; Smith MT, 2018, J CLIN SLEEP MED, V14, P1231, DOI 10.5664/jcsm.7230; Soler X, 2013, COPD, V10, P156, DOI 10.3109/15412555.2012.729622; Spina G, 2017, THORAX, V72, P694, DOI 10.1136/thoraxjnl-2016-208900; Spruit MA, 2013, AM J RESP CRIT CARE, V188, pE13, DOI 10.1164/rccm.201309-1634ST; STEVENSON JS, 1990, RES NURS HEALTH, V13, P209, DOI 10.1002/nur.4770130403; Tariq SH, 2006, AM J GERIAT PSYCHIAT, V14, P900, DOI 10.1097/01.JGP.0000221510.33817.86; Tryon WW, 2004, SLEEP, V27, P158, DOI 10.1093/sleep/27.1.158; Vardar-Yagli N, 2015, EXPERT REV RESP MED, V9, P233, DOI 10.1586/17476348.2015.1009041; Yang PY, 2012, J PHYSIOTHER, V58, P157, DOI 10.1016/S1836-9553(12)70106-6; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	51	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0248466	10.1371/journal.pone.0248466	http://dx.doi.org/10.1371/journal.pone.0248466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY1VJ	33724995	gold, Green Published			2022-12-26	WOS:000629833700033
J	Garg, CC; Tshefu, A; Longombe, AL; Kila, JSN; Esamai, F; Gisore, P; Ayede, AI; Falade, AG; Adejuyigbe, EA; Anyabolu, CH; Wammanda, RD; Hyellashelni, JD; Yoshida, S; Gram, L; Bin Nisar, Y; Qazi, SA; Bahl, R				Garg, Charu C.; Tshefu, Antoinette; Longombe, Adrien Lokangaka; Kila, Jean-Serge Ngaima; Esamai, Fabian; Gisore, Peter; Ayede, Adejumoke Idowu; Falade, Adegoke Gbadegesin; Adejuyigbe, Ebunoluwa A.; Anyabolu, Chineme Henry; Wammanda, Robinson D.; Hyellashelni, Joshua Daba; Yoshida, Sachiyo; Gram, Lu; Bin Nisar, Yasir; Qazi, Shamim Ahmad; Bahl, Rajiv			Costs and cost-effectiveness of management of possible serious bacterial infections in young infants in outpatient settings when referral to a hospital was not possible: Results from randomized trials in Africa	PLOS ONE			English	Article								Introduction Serious bacterial neonatal infections are a major cause of global neonatal mortality. While hospitalized treatment is recommended, families cannot access inpatient treatment in low resource settings. Two parallel randomized control trials were conducted at five sites in three countries (Democratic Republic of Congo, Kenya, and Nigeria) to compare the effectiveness of treatment with experimental regimens requiring fewer injections with a reference regimen A (injection gentamicin plus injection procaine penicillin both once daily for 7 days) on the outpatient basis provided to young infants (0-59 days) with signs of possible serious bacterial infection (PSBI) when the referral was not feasible. Costs were estimated to quantify the financial implications of scaleup, and cost-effectiveness of these regimens. Methods Direct economic costs (including personnel, drugs and consumable costs) were estimated for identification, prenatal and postnatal visits, assessment, classification, treatment and follow-up. Data on time spent by providers on each activity was collected from 83% of providers. Indirect marginal financial costs were estimated for non-consumables/capital, training, transport, communication, administration and supervision by considering only a share of the total research and health system costs considered important for the program. Total economic costs (direct plus indirect) per young infant treated were estimated based on 39% of young infants enrolled in the trial during 2012 and the number of days each treated during one year. The incremental cost-effectiveness ratio was calculated using treatment failure after one week as the outcome indicator. Experimental regimens were compared to the reference regimen and pairwise comparisons were also made. Results The average costs of treating a young infant with clinical severe infection (a sub-category of PSBI) in 2012 was lowest with regimen D (injection gentamicin once daily for 2 days plus oral amoxicillin twice daily for 7 days) at US$ 20.9 (95% CI US$ 16.4-25.3) or US$ 32.5 (2018 prices). While all experimental regimens B (injection gentamicin once daily plus oral amoxicillin twice daily, both for 7 days), regimen C (once daily of injection gentamicin injection plus injection procaine penicillin for 2 days, thereafter oral amoxicillin twice daily for 5 days) and regimen D were found to be more cost-effective as compared with the reference regimen A; pairwise comparison showed regimen D was more cost-effective than B or C. For fast breathing, the average cost of treatment with regimen E (oral amoxicillin twice daily for 7 days) at US$ 18.3 (95% CI US$ 13.4-23.3) or US$ 29.0 (2018 prices) was more cost-effective than regimen A. Indirect costs were 32% of the total treatment costs. Conclusion Scaling up of outpatient treatment for PSBI when the referral is not feasible with fewer injections and oral antibiotics is cost-effective for young infants and can lead to increased access to treatment resulting in potential reductions in neonatal mortality.	[Garg, Charu C.; Qazi, Shamim Ahmad] World Hlth Org, Dept Maternal Newborn Child & Adolescent Hlth, Geneva, Switzerland; [Tshefu, Antoinette; Longombe, Adrien Lokangaka; Kila, Jean-Serge Ngaima] Kinshasa Sch Publ Hlth, Dept Community Hlth, Kinshasa, DEM REP CONGO; [Esamai, Fabian; Gisore, Peter] Moi Univ, Sch Med, Dept Child Hlth & Paediat, Eldoret, Kenya; [Ayede, Adejumoke Idowu; Falade, Adegoke Gbadegesin] Univ Ibadan, Coll Med, Dept Paediat, Ibadan, Nigeria; [Ayede, Adejumoke Idowu; Falade, Adegoke Gbadegesin] Univ Coll Hosp, Ibadan, Nigeria; [Adejuyigbe, Ebunoluwa A.; Anyabolu, Chineme Henry] Obafemi Awolowo Univ, Dept Paediat & Child Hlth, Ife, Nigeria; [Wammanda, Robinson D.; Hyellashelni, Joshua Daba] Ahmadu Bello Univ, Teaching Hosp, Dept Paediat, Zaria, Nigeria; [Yoshida, Sachiyo; Bin Nisar, Yasir; Bahl, Rajiv] World Hlth Org, Dept Maternal Newborn Child & Adolescent Hlth & A, Geneva, Switzerland; [Gram, Lu] UCL, London, England; [Garg, Charu C.] Ojas Consulting, Gurugram, India; [Garg, Charu C.] Inst Human Dev, New Delhi, India	World Health Organization; Moi University; University of Ibadan; University of Ibadan; University College Hospital, Ibadan; Obafemi Awolowo University; Ahmadu Bello University; World Health Organization; University of London; University College London	Garg, CC (corresponding author), World Hlth Org, Dept Maternal Newborn Child & Adolescent Hlth, Geneva, Switzerland.; Garg, CC (corresponding author), Ojas Consulting, Gurugram, India.; Garg, CC (corresponding author), Inst Human Dev, New Delhi, India.	charucgarg@gmail.com	Garg, Charu C/AAR-7434-2021; Nisar, Yasir Bin/AFO-2407-2022	Adejuyigbe, Ebunoluwa/0000-0002-8671-4965	Bill and Melinda Gates Foundation [OPPGH5299]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was funded by Bill and Melinda Gates Foundation (www.gatesfoundation.org) through a grant number OPPGH5299 to World Health Organization, Geneva, Switzerland. AT, FE, AIA, EAA, RDW, received awards from the same BMGF grant OPPGH5299 to conduct field work at 5 sites and collect data. CCG was awarded a consultant contract from WHO to conduct costing analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFRIcan NEonatal Sepsis Trial Group, 2013, Pediatr Infect Dis J, V32 Suppl 1, pS26, DOI 10.1097/INF.0b013e31829ff7d1; AFRIcan NEonatal Sepsis Trial Group, 2013, Pediatr Infect Dis J, V32 Suppl 1, pS33, DOI 10.1097/INF.0b013e31829ff7eb; [Anonymous], 2015, GUID MAN POSS SER BA; Applegate JA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231490; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Baqui AH, 2015, LANCET GLOB HEALTH, V3, pE279, DOI 10.1016/S2214-109X(14)70347-X; Haacker M, 2020, HEALTH POLICY PLANN, V35, P107, DOI 10.1093/heapol/czz127; Hailegebriel TD, 2017, GLOB HEALTH-SCI PRAC, V5, P202, DOI 10.9745/GHSP-D-16-00312; Hendrich Ann, 2008, Perm J, V12, P25; Kozuki N, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2330-0; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Mathewos B, 2017, HEALTH POLICY PLANN, V32, P21, DOI 10.1093/heapol/czx054; Mir F, 2017, LANCET GLOB HEALTH, V5, pE177, DOI [10.1016/s2214-109x(16)30335-7, 10.1016/S2214-109X(16)30335-7]; Munthali AC, 2014, MALAWI MED J, V26, P126; Owais A, 2011, J PERINATOL, V31, P586, DOI 10.1038/jp.2010.191; Ranjeva SL, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000347; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Tshefu A, 2015, LANCET, V385, P1767, DOI 10.1016/S0140-6736(14)62284-4; Tshefu A, 2015, LANCET, V385, P1758, DOI 10.1016/S0140-6736(14)62285-6; UNICEF; WHO and World Bank Group, 2019, LEVELS TRENDS CHILD; UNICEF WHO  World Bank  United Nations Population Division, 2018, ESTIMATES DEV UN INT; Wall Stephen N, 2013, Pediatr Infect Dis J, V32 Suppl 1, pS39, DOI 10.1097/INF.0b013e31829ff801; World Health Organization, 2019, MAN SICK YOUNG INF A; World Health Organization, 2013, POCK BOOK HOSP CAR C; Zaidi Anita K M, 2013, Pediatr Infect Dis J, V32 Suppl 1, pS7, DOI 10.1097/INF.0b013e31829ff5fc; Zaidi AKM, 2012, PEDIATR INFECT DIS J, V31, P667, DOI 10.1097/INF.0b013e318256f86c; Zhang SS, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010408	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0247977	10.1371/journal.pone.0247977	http://dx.doi.org/10.1371/journal.pone.0247977			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720960	Green Published, gold			2022-12-26	WOS:000629667400038
J	Blokzijl-Franke, S; Ponsioen, B; Schulte-Merker, S; Herbomel, P; Kissa, K; Choorapoikayil, S; den Hertog, J				Blokzijl-Franke, Sasja; Ponsioen, Bas; Schulte-Merker, Stefan; Herbomel, Philippe; Kissa, Karima; Choorapoikayil, Suma; den Hertog, Jeroen			Phosphatidylinositol-3 kinase signaling controls survival and stemness of hematopoietic stem and progenitor cells	ONCOGENE			English	Article								Hematopoietic stem and progenitor cells (HSPCs) are multipotent cells giving rise to all blood lineages during life. HSPCs emerge from the ventral wall of the dorsal aorta (VDA) during a specific timespan in embryonic development through endothelial hematopoietic transition (EHT). We investigated the ontogeny of HSPCs in mutant zebrafish embryos lacking functional pten, an important tumor suppressor with a central role in cell signaling. Through in vivo live imaging, we discovered that in pten mutant embryos a proportion of the HSPCs died upon emergence from the VDA, an effect rescued by inhibition of phosphatidylinositol-3 kinase (PI3K). Surprisingly, inhibition of PI3K in wild-type embryos also induced HSPC death. Surviving HSPCs colonized the caudal hematopoietic tissue (CHT) normally and committed to all blood lineages. Single-cell RNA sequencing indicated that inhibition of PI3K enhanced survival of multipotent progenitors, whereas the number of HSPCs with more stem-like properties was reduced. At the end of the definitive wave, loss of Pten caused a shift to more restricted progenitors at the expense of HSPCs. We conclude that PI3K signaling tightly controls HSPCs survival and both up- and downregulation of PI3K signaling reduces stemness of HSPCs.	[Blokzijl-Franke, Sasja; Ponsioen, Bas; Schulte-Merker, Stefan; Choorapoikayil, Suma; den Hertog, Jeroen] Hubrecht Inst KNAW, Utrecht, Netherlands; [Blokzijl-Franke, Sasja; Ponsioen, Bas; Schulte-Merker, Stefan; Choorapoikayil, Suma; den Hertog, Jeroen] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Ponsioen, Bas] Univ Utrecht, Univ Med Ctr Utrecht, Ctr Mol Med, Mol Canc Res, Utrecht, Netherlands; [Schulte-Merker, Stefan] WWU Munster, Inst Cardiovasc Organogenesis & Regenerat, Med Fac, Munster, Germany; [Herbomel, Philippe; Kissa, Karima] Inst Pasteur, Dept Dev & Stem Cell Biol, Paris, France; [Herbomel, Philippe; Kissa, Karima] CNRS, UMR 3738, Paris, France; [Kissa, Karima; Choorapoikayil, Suma] Univ Montpellier, CNRS, Lab Pathogen Host Interact, INSERM, Montpellier, France; [den Hertog, Jeroen] Leiden Univ, Inst Biol, Leiden, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Munster; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Leiden University; Leiden University - Excl LUMC	den Hertog, J (corresponding author), Hubrecht Inst KNAW, Utrecht, Netherlands.; den Hertog, J (corresponding author), Univ Med Ctr Utrecht, Utrecht, Netherlands.; den Hertog, J (corresponding author), Leiden Univ, Inst Biol, Leiden, Netherlands.	j.denhertog@hubrecht.eu	Kissa, Karima/N-6801-2018	Kissa, Karima/0000-0002-7683-3661	EU (FP7) grant, ZF-CANCER [HEALTH-F2-2008-201439]	EU (FP7) grant, ZF-CANCER	The authors would like to thank Mark Reijnen and animal caretakers for excellent management of the fish facility. Microscopy was done in the Hubrecht Imaging Centre. The authors would like to thank Stefan van der Elst and Reinier van der Linden for FACS-sorting. The authors would like to thank Jeroen Paardekooper Overman for statistical analysis, Laila Ritsma, Sylvain de Rossi, and Miriam Stumpf for technical support and Bas Castelijns for help with scRNA data analysis. This work was supported in part by an EU (FP7) grant, ZF-CANCER (HEALTH-F2-2008-201439).	Alestrom P, 2020, LAB ANIM-UK, V54, P213, DOI 10.1177/0023677219869037; Athanasiadis EI, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02305-6; Baron CS, 2019, CELL, V179, P527, DOI 10.1016/j.cell.2019.08.006; Baron CS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04893-3; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Blackburn JS, 2014, CANCER CELL, V25, P366, DOI 10.1016/j.ccr.2014.01.032; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Bolli N, 2011, BLOOD, V117, P3996, DOI 10.1182/blood-2010-08-304030; Buenrostro JD, 2018, CELL, V173, P1535, DOI 10.1016/j.cell.2018.03.074; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Choorapoikayil S, 2014, BLOOD, V123, P184, DOI 10.1182/blood-2013-05-501544; Choorapoikayil S, 2013, DIS MODEL MECH, V6, P1159, DOI 10.1242/dmm.012377; Choorapoikayil S, 2012, DIS MODEL MECH, V5, P241, DOI 10.1242/dmm.008326; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; Dixon Giles, 2012, ISRN Hematol, V2012, P915868, DOI 10.5402/2012/915868; Faucherre A, 2008, ONCOGENE, V27, P1079, DOI 10.1038/sj.onc.1210730; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Herman JS, 2018, NAT METHODS, V15, P379, DOI 10.1038/nmeth.4662; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Kartalaei PS, 2015, J EXP MED, V212, P93, DOI 10.1084/jem.20140767; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kissa K, 2008, BLOOD, V111, P1147, DOI 10.1182/blood-2007-07-099499; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kowalczyk MS, 2015, GENOME RES, V25, P1860, DOI 10.1101/gr.192237.115; Lai SJ, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0038-x; Lin HF, 2005, BLOOD, V106, P3803, DOI 10.1182/blood-2005-01-0179; Lin HT, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0334; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Muraro MJ, 2016, CELL SYST, V3, P385, DOI 10.1016/j.cels.2016.09.002; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Nestorowa S, 2016, BLOOD, V128, pE20, DOI 10.1182/blood-2016-05-716480; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Renaud O, 2011, NAT PROTOC, V6, P1897, DOI 10.1038/nprot.2011.408; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stachura DL, 2011, METHOD CELL BIOL, V101, P75, DOI 10.1016/B978-0-12-387036-0.00004-9; Stumpf M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154771; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Svoboda O, 2014, BLOOD, V124, P220, DOI 10.1182/blood-2014-03-564682; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tian Y, 2017, J EXP MED, V214, P3347, DOI 10.1084/jem.20170488; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; van den Brink SC, 2017, NAT METHODS, V14, P935, DOI 10.1038/nmeth.4437; Van Vlierberghe P, 2012, J CLIN INVEST, V122, P3398, DOI 10.1172/JCI61269; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Xue YY, 2019, CELL REP, V27, P1567, DOI 10.1016/j.celrep.2019.04.030; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	61	2	2	0	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 15	2021	40	15					2741	2755		10.1038/s41388-021-01733-5	http://dx.doi.org/10.1038/s41388-021-01733-5		MAR 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RN8NW	33714985	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000628485300003
J	Costa, PPC; Waller, SB; dos Santos, GR; Gondim, FD; Serra, DS; Cavalcante, FSA; Gouveia, FS; de Paula, VF; Sousa, EHS; Lopes, LGD; Ribeiro, WLC; Monteiro, HSA				Correia Costa, Paula Priscila; Waller, Stefanie Bressan; dos Santos, Gilvan Ribeiro; Gondim, Fladimir de Lima; Serra, Daniel Silveira; Avila Cavalcante, Francisco Sales; Gouveia Junior, Florencio Sousa; de Paula Junior, Valdir Ferreira; Silva Sousa, Eduardo Henrique; de Franca Lopes, Luiz Gonzaga; Correia Ribeiro, Wesley Lyeverton; Azul Monteiro, Helena Serra			Anti-asthmatic effect of nitric oxide metallo-donor FOR811A [cis-[Ru(bpy)(2)(2-MIM)(NO)](PF6)(3)] in the respiratory mechanics of Swiss mice	PLOS ONE			English	Article							AIRWAY INFLAMMATION; SMOOTH-MUSCLE; MOUSE MODEL; ASTHMA; ACTIVATION; RESPONSES; DOCKING; CYCLASE; BINDING; CELLS	We aimed at evaluating the anti-asthmatic effect of cis-[Ru(bpy)(2)(2-MIM)(NO)](PF6)(3) (FOR811A), a nitrosyl-ruthenium compound, in a murine model of allergic asthma. The anti-asthmatic effects were analyzed by measuring the mechanical lung and morphometrical parameters in female Swiss mice allocated in the following groups: untreated control (Ctl+Sal) and control treated with FOR811A (Ctl+FOR), along asthmatic groups untreated (Ast+Sal) and treated with FOR811A (Ast+FOR). The drug-protein interaction was evaluated by in-silico assay using molecular docking. The results showed that the use of FOR811A in experimental asthma (Ast+FOR) decreased the pressure-volume curve, hysteresis, tissue elastance, tissue resistance, and airway resistance, similar to the control groups (Ctl+Sal; Ctl+FOR). However, it differed from the untreated asthmatic group (Ast+Sal, p<0.05), indicating that FOR811A corrected the lung parenchyma and relaxed the smooth muscles of the bronchi. Similar to control groups (Ctl+Sal; Ctl+FOR), FOR811A increased the inspiratory capacity and static compliance in asthmatic animals (Ast+Sal, p<0.05), showing that this metallodrug improved the capacity of inspiration during asthma. The morphometric parameters showed that FOR811A decreased the alveolar collapse and kept the bronchoconstriction during asthma. Beyond that, the molecular docking using FOR811A showed a strong interaction in the distal portion of the heme group of the soluble guanylate cyclase, particularly with cysteine residue (Cys141). In summary, FOR811A relaxed bronchial smooth muscles and improved respiratory mechanics during asthma, providing a protective effect and promising use for the development of an anti-asthmatic drug.	[Correia Costa, Paula Priscila; Waller, Stefanie Bressan] Univ Fed Pelotas, Fac Vet, Dept Vet Clin, Pelotas, RS, Brazil; [Correia Costa, Paula Priscila; Correia Ribeiro, Wesley Lyeverton; Azul Monteiro, Helena Serra] Univ Fed Ceara, Fac Med, Dept Physiol & Pharmacol, Fortaleza, Ceara, Brazil; [dos Santos, Gilvan Ribeiro; Gondim, Fladimir de Lima; Serra, Daniel Silveira; Avila Cavalcante, Francisco Sales] Univ Estadual Ceara, Super Inst Biomed Sci, Lab Biophys Respirat, Fortaleza, Ceara, Brazil; [Gouveia Junior, Florencio Sousa; Silva Sousa, Eduardo Henrique; de Franca Lopes, Luiz Gonzaga] Univ Fed Ceara, Dept Organ & Inorgan Chem, Lab Bioinorgan, Fortaleza, Ceara, Brazil; [de Paula Junior, Valdir Ferreira] Univ Estadual Ceara, Super Inst Biomed Sci, Lab Biotechnol & Mol Biol, Fortaleza, Ceara, Brazil	Universidade Federal de Pelotas; Universidade Federal do Ceara; Universidade Estadual do Ceara; Universidade Federal do Ceara; Universidade Estadual do Ceara	Costa, PPC; Waller, SB (corresponding author), Univ Fed Pelotas, Fac Vet, Dept Vet Clin, Pelotas, RS, Brazil.; Costa, PPC (corresponding author), Univ Fed Ceara, Fac Med, Dept Physiol & Pharmacol, Fortaleza, Ceara, Brazil.	paulapriscilamv@yahoo.com.br; waller.stefanie@yahoo.com.br; wesleylyeverton@yahoo.com.br	Ribeiro, Wesley Lyeverton Correia/AAW-7285-2021; Lopes, Luiz G F/J-4385-2015; Sousa, Eduardo H S/J-8167-2014	Ribeiro, Wesley Lyeverton Correia/0000-0002-2784-0013; Lopes, Luiz G F/0000-0002-3641-1835; Sousa, Eduardo H S/0000-0002-0007-8452	Brazilian Institutes Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [CAPES/FUNCAP - 88881.166839/2018-01]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [CNPq - 303355/2018-2, 308383/2018-4]	Brazilian Institutes Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was financed by the Brazilian Institutes Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) under Grant CAPES/FUNCAP - 88881.166839/2018-01 (L.G.F. Lopes); and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) under Grant CNPq - 303355/2018-2 (L.G.F. Lopes) and 308383/2018-4 (E.H.S. Sousa).	Akinbami Lara J, 2012, NCHS Data Brief, P1; Aljebab F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170259; Alwarith J, 2020, NUTR REV, V78, P928, DOI 10.1093/nutrit/nuaa005; Barbara C., 2000, REV PORT PNEUMOL, V6, P297, DOI [10.1016/S0873-2159(15)30905-3, DOI 10.1016/S0873-2159(15)30905-3]; Bates JHT, 2009, LUNG MECHANICS: AN INVERSE MODELING APPROACH, P1, DOI 10.1017/CBO9780511627156; Blacquiere MJ, 2010, INT ARCH ALLERGY IMM, V153, P173, DOI 10.1159/000312635; Calciano L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177538; Carvalho IO, 2019, THESIS STATE U CEARA; Castro PFS, 2011, EUR J PHARM SCI, V43, P370, DOI 10.1016/j.ejps.2011.05.004; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Costa PPC, 2020, RES VET SCI, V130, P153, DOI 10.1016/j.rvsc.2020.03.014; Castro PFD, 2016, CLIN EXP PHARMACOL P, V43, P221, DOI 10.1111/1440-1681.12523; Deng YH, 2013, INT IMMUNOPHARMACOL, V17, P561, DOI 10.1016/j.intimp.2013.06.028; Marcelino AMFC, 2012, INT ARCH OTORHINOLAR, V16, P492, DOI 10.7162/S1809-97772012000400010; Fernhoff NB, 2009, P NATL ACAD SCI USA, V106, P21602, DOI 10.1073/pnas.0911083106; de Oliveira CMG, 2012, J BRAS PNEUMOL, V38, P308, DOI 10.1590/S1806-37132012000300005; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Global Initiative for Asthma, 2019, DIAGNOSIS MANAGEMENT; Gomes RFM, 2000, J APPL PHYSIOL, V89, P908, DOI 10.1152/jappl.2000.89.3.908; Gouveia FS, 2017, THESIS FEDERAL U CEA; Guyton A.C., 2016, TXB MED PHYSL; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Hekking PPW, 2015, J ALLERGY CLIN IMMUN, V135, P896, DOI 10.1016/j.jaci.2014.08.042; Horst BG, 2018, NITRIC OXIDE-BIOL CH, V77, P65, DOI 10.1016/j.niox.2018.04.011; IGNARRO LJ, 1982, P NATL ACAD SCI-BIOL, V79, P2870, DOI 10.1073/pnas.79.9.2870; Ishizawa K, 2004, FEBS LETT, V556, P249, DOI 10.1016/S0014-5793(03)01399-1; Karamaoun C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00255; Kim HR, 2004, AM J PHYSIOL-CELL PH, V287, pC1375, DOI 10.1152/ajpcell.00100.2004; King GG, 2019, EUR RESPIR REV, V28, DOI 10.1183/16000617.0111-2018; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Lancas T, 2006, J APPL PHYSIOL, V100, P1610, DOI 10.1152/japplphysiol.00828.2005; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Maniscalco M, 2007, INFLAMM RES, V56, P58, DOI 10.1007/s00011-006-6111-1; Misaka S, 2009, EUR J PHARM SCI, V37, P469, DOI 10.1016/j.ejps.2009.04.002; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Olson E., 2014, HDB PHARMACOGENOMICS, P73, DOI 10.1016/B978-0-12-386882-4.00005-0; SALAZAR E, 1964, J APPL PHYSIOL, V19, P97, DOI 10.1152/jappl.1964.19.1.97; Seabra AB, 2017, MINI-REV MED CHEM, V17, P216, DOI 10.2174/1389557516666160808124624; Serra DS, 2020, J ETHNOPHARMACOL, V252, DOI 10.1016/j.jep.2020.112633; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; Wagers S, 2004, J APPL PHYSIOL, V96, P2019, DOI 10.1152/japplphysiol.00924.2003; Yamashita AMS, 2017, AM J PHYSIOL-CELL PH, V313, pC11, DOI 10.1152/ajpcell.00140.2016	44	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0248394	10.1371/journal.pone.0248394	http://dx.doi.org/10.1371/journal.pone.0248394			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711054	gold, Green Published			2022-12-26	WOS:000629591800014
J	Ni, MD; Li, JJ; Zhao, HY; Xu, F; Cheng, JY; Yu, M; Ke, GH; Wu, XH				Ni, Mengdong; Li, Jiajia; Zhao, Haiyun; Xu, Fei; Cheng, Jingyi; Yu, Min; Ke, Guihao; Wu, Xiaohua			BRD4 inhibition sensitizes cervical cancer to radiotherapy by attenuating DNA repair	ONCOGENE			English	Article							PHASE-II; BINDING PROTEIN; STEM-CELLS; BROMODOMAIN; CARCINOMA; RADIORESISTANCE; EPIGENETICS; COMBINATION; VORINOSTAT; CHROMATIN	Cisplatin-based chemoradiotherapy is the recommended treatment for local advanced cervical cancer, but radioresistance remains one of the most important and unresolved clinical problems. Investigations have revealed aberrant epigenetic modifications as one of the chief culprits for the development of radioresistance. Here, we attempt to identify a radiosensitizer from an epigenetic drug synergy screen and explore the underlying mechanism. We integrated epigenetic inhibitors and radiotherapy in cervical cancer cell lines to identify potential radiosensitizers. We further verified the sensitization effect of the drug and the function of its target gene both in vitro and in vivo. Finally, we validated the clinical significance of its target gene in clinical cervical cancer specimens. We identified JQ1, a BRD4 inhibitor, as a potent radiosensitizer. Functional assays demonstrated that repressing BRD4 activity led to significant radiosensitization and potentiation of DNA damage in cervical cancer cell lines. By using RNA-seq to determine JQ1-mediated changes in transcription, we identified RAD51AP1 as a major BRD4 target gene involved in radiosensitivity. A dual-luciferase reporter assay and ChIP-qPCR showed that BRD4 binds to the promoter region of RAD51AP1 and promotes its transcription, whereas this activity was attenuated by BRD4 inhibition. The in vivo experiments also suggested a synergy between BRD4 inhibition and radiotherapy. High BRD4 expression was found to be related to a worse prognosis and radiation resistance. BRD4 inhibition sensitizes cervical cancer to radiotherapy by inhibiting RAD51AP1 transcription. The combination of JQ1 with radiotherapy merits further evaluation as a therapeutic strategy for improving local control in cervical cancer.	[Ni, Mengdong; Li, Jiajia; Zhao, Haiyun; Xu, Fei; Cheng, Jingyi; Yu, Min; Ke, Guihao; Wu, Xiaohua] Fudan Univ, Dept Gynecol Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China; [Ni, Mengdong; Li, Jiajia; Zhao, Haiyun; Xu, Fei; Cheng, Jingyi; Yu, Min; Ke, Guihao; Wu, Xiaohua] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China	Fudan University; Fudan University	Ke, GH; Wu, XH (corresponding author), Fudan Univ, Dept Gynecol Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China.; Ke, GH; Wu, XH (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.	kegh5734@126.com; wu.xh@fudan.edu.cn		Yu, Min/0000-0001-9197-2101	National Natural Science Foundation of China [81672569, 81902660]; Natural Science Foundation of Shanghai [19ZR1410700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This study was supported by grants from the National Natural Science Foundation of China to XW (No. 81672569), the Natural Science Foundation of Shanghai to GK (No. 19ZR1410700), and the National Natural Science Foundation of China to JL (No. 81902660).	Abramson JS, 2015, BLOOD, V126, P1491, DOI DOI 10.1182/BLOOD.V126.23.1491.1491; Aggarwal R, 2017, J CLIN ONCOL, V35, P1231, DOI 10.1200/JCO.2016.70.5350; Bagratuni T, 2020, EUR J CANCER, V126, P125, DOI 10.1016/j.ejca.2019.11.017; Balbous A, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2647-9; Barker HE, 2015, NAT REV CANCER, V15, P409, DOI 10.1038/nrc3958; Bates SE, 2020, NEW ENGL J MED, V383, P650, DOI 10.1056/NEJMra1805035; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Bitzer M, 2016, J HEPATOL, V65, P280, DOI 10.1016/j.jhep.2016.02.043; Cao LJ, 2019, INT J GYNECOL CANCER, V29, P1244, DOI 10.1136/ijgc-2019-000556; Chaidos A, 2014, BLOOD, V123, P697, DOI 10.1182/blood-2013-01-478420; Cheng ZX, 2013, CLIN CANCER RES, V19, P1748, DOI 10.1158/1078-0432.CCR-12-3066; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Easwaran H, 2014, MOL CELL, V54, P716, DOI 10.1016/j.molcel.2014.05.015; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Glasspool RM, 2014, BRIT J CANCER, V110, P1923, DOI 10.1038/bjc.2014.116; Harkenrider MM, 2020, JNCI-J NATL CANCER I, V112, P1081, DOI 10.1093/jnci/djaa041; Hatzi VI, 2015, CANCER LETT, V356, P34, DOI 10.1016/j.canlet.2013.11.018; HAYNES SR, 1992, NUCLEIC ACIDS RES, V20, P2603, DOI 10.1093/nar/20.10.2603; Jiang ZF, 2019, LANCET ONCOL, V20, P806, DOI 10.1016/S1470-2045(19)30164-0; Karakashev S, 2017, CELL REP, V21, P3398, DOI 10.1016/j.celrep.2017.11.095; Kovalenko OV, 1997, NUCLEIC ACIDS RES, V25, P4946, DOI 10.1093/nar/25.24.4946; Krause M, 2017, ADV DRUG DELIVER REV, V109, P63, DOI 10.1016/j.addr.2016.02.002; Kwon NH, 2008, J CLIN IMMUNOL, V28, P139, DOI 10.1007/s10875-007-9148-1; Lewin J, 2018, J CLIN ONCOL, V36, P3007, DOI 10.1200/JCO.2018.78.2292; Li N, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0789-1; Li XY, 2018, CELL REP, V22, P796, DOI 10.1016/j.celrep.2017.12.078; Lin LL, 2020, INT J GYNECOL CANCER, V30, P409, DOI 10.1136/ijgc-2020-001227; Marie-Egyptienne DT, 2013, CANCER LETT, V341, P63, DOI 10.1016/j.canlet.2012.11.019; Mizuta R, 1997, P NATL ACAD SCI USA, V94, P6927, DOI 10.1073/pnas.94.13.6927; Modesti M, 2007, MOL CELL, V28, P468, DOI 10.1016/j.molcel.2007.08.025; Munster PN, 2011, BRIT J CANCER, V104, P1828, DOI 10.1038/bjc.2011.156; Najafova Z, 2017, NUCLEIC ACIDS RES, V45, P127, DOI 10.1093/nar/gkw826; Postel-Vinay S, 2019, EUR J CANCER, V109, P103, DOI 10.1016/j.ejca.2018.12.020; Prabakaran PJ, 2017, CLIN CANCER RES, V23, P6044, DOI 10.1158/1078-0432.CCR-17-0969; Rashmi R, 2018, CANCER RES, V78, P1392, DOI 10.1158/0008-5472.CAN-17-2367; Rataj O, 2019, INT J CANCER, V144, P2330, DOI 10.1002/ijc.31986; Shaffer SM, 2017, NATURE, V546, P431, DOI 10.1038/nature22794; Stanlie A, 2014, MOL CELL, V55, P97, DOI 10.1016/j.molcel.2014.05.018; Stonestrom Aaron J, 2016, Drug Discov Today Technol, V19, P23, DOI 10.1016/j.ddtec.2016.05.004; Sun CY, 2018, CANCER CELL, V33, P401, DOI 10.1016/j.ccell.2018.01.019; Tsai CL, 2018, HEPATOLOGY, V67, P586, DOI 10.1002/hep.29328; Wang J, 2017, CANCER LETT, V391, P141, DOI 10.1016/j.canlet.2017.01.031; Wang ZW, 2014, CELL MOL BIOL LETT, V19, P233, DOI 10.2478/s11658-014-0191-7; Welti J, 2018, CLIN CANCER RES, V24, P3149, DOI 10.1158/1078-0432.CCR-17-3571; Williams KE, 2015, STEM CELLS, V33, P327, DOI 10.1002/stem.1843; Yang L, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal1645; Yardley DA, 2013, J CLIN ONCOL, V31, P2128, DOI 10.1200/JCO.2012.43.7251; Zhuang HQ, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0109-5; Zibelman M, 2015, INVEST NEW DRUG, V33, P1040, DOI 10.1007/s10637-015-0261-3	51	9	9	4	25	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 15	2021	40	15					2711	2724		10.1038/s41388-021-01735-3	http://dx.doi.org/10.1038/s41388-021-01735-3		MAR 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RN8NW	33712705				2022-12-26	WOS:000628201500002
J	Villatte, J; Taconnat, L; Bidet-Ildei, C; Toussaint, L				Villatte, Jeremy; Taconnat, Laurence; Bidet-Ildei, Christel; Toussaint, Lucette			Short-term upper limb immobilization and the embodied view of memory: A pilot study	PLOS ONE			English	Article								The present study aimed to explore the contribution of the manual sensorimotor system to the memory of graspable objects. Participants in the experimental group underwent a short-term upper limb immobilization design to decrease arousal to their dominant hand. Such designs are known to elicit updating of sensorimotor representations and to hardened use of implicit motor simulation, a process that occurs when observing graspable objects. Subsequently, a free recall and a recognition task of graspable and non-graspable objects took place. We found slower recognition for graspable than for non-graspable objects in the control group, while no differences appeared for the immobilized group. Moreover, the recognition latency for graspable objects tended to be slower for the control than for the immobilized group. These results suggest that a time demanding reactivation of motor simulation is elicited when a graspable object is correctly recognized by control participants. The effect of immobilization could prevent this reactivation, leading to faster recognition. Hence, immobilization selectively affects graspable object memory, showing a close relationship with the manual sphere of the sensorimotor system. We suggest that recognition accuracy would probably be affected in cases of stronger disruption of sensorimotor arousal.	[Villatte, Jeremy] Univ Poitiers, CNRS, Ctr Rech Cognit & Apprentissage UMR 7295, Dept Psychol, Poitiers, France; [Taconnat, Laurence] Univ Tours, CNRS, Ctr Rech Cognit & Apprentissage UMR, Dept Psychol, F-7295 Tours, France; [Bidet-Ildei, Christel; Toussaint, Lucette] Univ Poitiers, CNRS, Ctr Rech Cognit & Apprentissage UMR 7295, Dept Sci Sport, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Poitiers	Villatte, J (corresponding author), Univ Poitiers, CNRS, Ctr Rech Cognit & Apprentissage UMR 7295, Dept Psychol, Poitiers, France.	jeremy.villatte@univ-poitiers.fr	Toussaint, Lucette/GOH-0425-2022; Bidet-Ildei, christel/AAC-3502-2019	Toussaint, Lucette/0000-0003-3945-2146; Bidet-Ildei, christel/0000-0002-4699-179X; Villatte, Jeremy/0000-0002-4821-2091				Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bassolino M, 2014, CEREB CORTEX, V24, P3268, DOI 10.1093/cercor/bht190; Bidet-Ildei C, 2017, J EXP PSYCHOL LEARN, V43, P1129, DOI 10.1037/xlm0000373; Briglia J, 2018, J MATH PSYCHOL, V82, P97, DOI 10.1016/j.jmp.2017.12.002; Brouillet D, 2016, INT J PSYCHOL, V51, P397, DOI 10.1002/ijop.12210; Brunel L, 2009, J EXP PSYCHOL LEARN, V35, P1081, DOI 10.1037/a0015537; Bub DN, 2008, COGNITION, V106, P27, DOI 10.1016/j.cognition.2006.12.010; Canits I, 2018, ACTA PSYCHOL, V182, P65, DOI 10.1016/j.actpsy.2017.11.009; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Creem-Regehr SH, 2005, COGNITIVE BRAIN RES, V22, P457, DOI 10.1016/j.cogbrainres.2004.10.006; Danker JF, 2010, PSYCHOL BULL, V136, P87, DOI 10.1037/a0017937; Deltour J. J., 1993, ECHELLE VOCABULAIRE; Dutriaux L, 2021, AGING NEUROPSYCHOL C, V28, P26, DOI 10.1080/13825585.2019.1708252; Dutriaux L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159108; Elbert T, 1997, EXP BRAIN RES, V117, P161, DOI 10.1007/s002210050210; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Furlan L, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8176217; Gibson J.J., 1986, ECOLOGICAL APPROACH; Gibson J.J., 1977, PERCEIVING ACTING KN, P67; Glenberg AM, 1997, BEHAV BRAIN SCI, V20, P1, DOI 10.1017/S0140525X97470012; Grezes J, 2003, EUR J NEUROSCI, V17, P2735, DOI 10.1046/j.1460-9568.2003.02695.x; Guerard K, 2015, ACTA PSYCHOL, V162, P69, DOI 10.1016/j.actpsy.2015.10.008; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Lissek S, 2009, CURR BIOL, V19, P837, DOI 10.1016/j.cub.2009.03.065; McNair NA, 2017, J COGNITIVE NEUROSCI, V29, P1918, DOI 10.1162/jocn_a_01165; Meugnot A, 2014, EXP PSYCHOL, V61, P180, DOI 10.1027/1618-3169/a000237; New B, 2001, ANN PSYCHOL, V101, P447; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osiurak F, 2016, PSYCHOL REV, V123, P534, DOI 10.1037/rev0000027; Paulus M, 2009, Q J EXP PSYCHOL, V62, P2298, DOI 10.1080/17470210903108405; Pezzulo G, 2010, BRAIN COGNITION, V73, P68, DOI 10.1016/j.bandc.2010.03.002; Phillips JC, 2002, VIS COGN, V9, P540, DOI 10.1080/13506280143000575; Ruggiero G, 2021, BRIT J PSYCHOL, V112, DOI 10.1111/bjop.12467; Schneider W., 2002, E PRIME USERS GUIDE; Toussaint L, 2021, Q J EXP PSYCHOL, V74, P1096, DOI 10.1177/1747021820985523; Toussaint L, 2013, J EXP PSYCHOL LEARN, V39, P623, DOI 10.1037/a0028942; Tucker M, 2004, ACTA PSYCHOL, V116, P185, DOI 10.1016/j.actpsy.2004.01.004; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; van Dam WO, 2013, Q J EXP PSYCHOL, V66, P2310, DOI 10.1080/17470218.2013.777084; Versace R, 2014, J COGN PSYCHOL, V26, P280, DOI 10.1080/20445911.2014.892113; Zeelenberg R, 2020, EXP PSYCHOL, V67, P211, DOI 10.1027/1618-3169/a000490	43	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248239	10.1371/journal.pone.0248239	http://dx.doi.org/10.1371/journal.pone.0248239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8JZ	33705459	Green Published, gold			2022-12-26	WOS:000629590400057
J	Hwang, H; Cho, G; Jin, MJ; Ryoo, JH; Choi, Y; Lee, SH				Hwang, Heungsun; Cho, Gyeongcheol; Jin, Min Jin; Ryoo, Ji Hoon; Choi, Younyoung; Lee, Seung Hwan			A knowledge-based multivariate statistical method for examining gene-brain-behavioral/cognitive relationships: Imaging genetics generalized structured component analysis	PLOS ONE			English	Article							STRESSFUL LIFE EVENTS; CORTICAL THICKNESS; IMPROPER SOLUTIONS; CEREBRAL-CORTEX; DEPRESSION; REGRESSION; FMRI; POLYMORPHISMS; VULNERABILITY; ASSOCIATION	With advances in neuroimaging and genetics, imaging genetics is a naturally emerging field that combines genetic and neuroimaging data with behavioral or cognitive outcomes to examine genetic influence on altered brain functions associated with behavioral or cognitive variation. We propose a statistical approach, termed imaging genetics generalized structured component analysis (IG-GSCA), which allows researchers to investigate such gene-brain-behavior/cognitive associations, taking into account well-documented biological characteristics (e.g., genetic pathways, gene-environment interactions, etc.) and methodological complexities (e.g., multicollinearity) in imaging genetic studies. We begin by describing the conceptual and technical underpinnings of IG-GSCA. We then apply the approach for investigating how nine depression-related genes and their interactions with an environmental variable (experience of potentially traumatic events) influence the thickness variations of 53 brain regions, which in turn affect depression severity in a sample of Korean participants. Our analysis shows that a dopamine receptor gene and an interaction between a serotonin transporter gene and the environment variable have statistically significant effects on a few brain regions' variations that have statistically significant negative impacts on depression severity. These relationships are largely supported by previous studies. We also conduct a simulation study to safeguard whether IG-GSCA can recover parameters as expected in a similar situation.	[Hwang, Heungsun; Cho, Gyeongcheol] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Jin, Min Jin] Kongju Natl Univ, Inst Liberal Educ, Gongju, South Korea; [Ryoo, Ji Hoon] Yonsei Univ, Dept Educ, Seoul, South Korea; [Choi, Younyoung] Hanyang Cyber Univ, Dept Counseling Psychol, Seoul, South Korea; [Lee, Seung Hwan] Inje Univ, Dept Psychiat, Ilsan Paik Hosp, Goyang, South Korea; [Lee, Seung Hwan] Inje Univ, Goyang, South Korea	McGill University; Kongju National University; Yonsei University; Inje University; Inje University	Hwang, H (corresponding author), McGill Univ, Dept Psychol, Montreal, PQ, Canada.; Lee, SH (corresponding author), Inje Univ, Dept Psychiat, Ilsan Paik Hosp, Goyang, South Korea.; Lee, SH (corresponding author), Inje Univ, Goyang, South Korea.	heungsun.hwang@mcgill.ca; lshpss@paik.ac.kr	Cho, Gyeongcheol/C-2392-2019; Cho, Gyeongcheol/GZM-0792-2022; Jin, Min Jin/AAU-6731-2021	Cho, Gyeongcheol/0000-0002-9237-0388; Cho, Gyeongcheol/0000-0002-9237-0388; 	Ministry of Education; National Research Foundation of Korea [NRF-2019S1A5A2A03052192]; Brain Research Program through the National Research Foundation of Korea from the Ministry of Science, ICT & Future Planning [NRF-2015M3C7A1028252]; Korea Medical Device Development Fund grant - Korean government (Ministry of Science and ICT) [202013B10]; Korea Medical Device Development Fund grant - Korean government (Ministry of Trade, Industry and Energy) [202013B10]; Korea Medical Device Development Fund grant - Korean government (Ministry of Health & Welfare, Republic of Korea) [202013B10]; Korea Medical Device Development Fund grant - Korean government (Ministry of Food and Drug Safety) [202013B10]	Ministry of Education; National Research Foundation of Korea(National Research Foundation of Korea); Brain Research Program through the National Research Foundation of Korea from the Ministry of Science, ICT & Future Planning(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); Korea Medical Device Development Fund grant - Korean government (Ministry of Science and ICT)(Ministry of Science, ICT & Future Planning, Republic of Korea); Korea Medical Device Development Fund grant - Korean government (Ministry of Trade, Industry and Energy); Korea Medical Device Development Fund grant - Korean government (Ministry of Health & Welfare, Republic of Korea); Korea Medical Device Development Fund grant - Korean government (Ministry of Food and Drug Safety)	This work was partially supported by the Ministry of Education and the National Research Foundation of Korea (NRF-2019S1A5A2A03052192) to Heungsun Hwang and Younyoung Choi, and by the Brain Research Program through the National Research Foundation of Korea from the Ministry of Science, ICT & Future Planning (NRF-2015M3C7A1028252) and the Korea Medical Device Development Fund grant funded by the Korean government (the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, Republic of Korea, the Ministry of Food and Drug Safety) (Project Number: 202013B10) to Seung Hwan Lee.	Aberg E, 2011, J AFFECT DISORDERS, V129, P158, DOI 10.1016/j.jad.2010.08.009; Arslan A, 2018, PROG NEURO-PSYCHOPH, V80, P155, DOI 10.1016/j.pnpbp.2017.06.018; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bae H, 2008, PSYCHIAT INVEST, V5, P163, DOI 10.4306/pi.2008.5.3.163; Berk RA, 2016, SPRINGER TEXTS STAT, P1, DOI [10.1007/978-3-319-44048-4, 10.1007/978-3-319-44048-4_1]; Bertolino A, 2009, J NEUROSCI, V29, P1224, DOI 10.1523/JNEUROSCI.4858-08.2009; Birnbaum Rebecca, 2013, Dialogues Clin Neurosci, V15, P279; Boden JM, 2011, ADDICTION, V106, P906, DOI 10.1111/j.1360-0443.2010.03351.x; Bollen KA., 1989, STRUCTURAL EQUATIONS, DOI [10.1002/9781118619179, DOI 10.1002/9781118619179]; Bollen KA, 2011, PSYCHOL METHODS, V16, P265, DOI 10.1037/a0024448; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; BOOMSMA A, 1985, PSYCHOMETRIKA, V50, P229, DOI 10.1007/BF02294248; Borsboom D, 2004, PSYCHOL REV, V111, P1061, DOI 10.1037/0033-295x.111.4.1061; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Charney Dennis S, 2004, Sci STKE, V2004, pre5, DOI 10.1126/stke.2252004re5; Chen FN, 2001, SOCIOL METHOD RES, V29, P468, DOI 10.1177/0049124101029004003; Chou KL, 2001, INT J AGING HUM DEV, V52, P155, DOI 10.2190/9C97-LCA5-EWB7-XK2W; Corbo V, 2014, PSYCHIAT RES-NEUROIM, V223, P53, DOI 10.1016/j.pscychresns.2014.04.013; Corley J., 2020, BIORXIV, DOI [10.1101/2020.01.19.911420, DOI 10.1101/2020.01.19.911420]; Dahnke R, 2013, NEUROIMAGE, V65, P336, DOI 10.1016/j.neuroimage.2012.09.050; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Duncan T, 2006, INTRO LATENT VARIABL; Durazzo TC, 2011, ALCOHOL CLIN EXP RES, V35, P1187, DOI 10.1111/j.1530-0277.2011.01452.x; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Friston KJ, 1995, HUM BRAIN MAPP, V3, P56, DOI 10.1002/hbm.460030106; Frodl T, 2008, MOL PSYCHIATR, V13, P1093, DOI 10.1038/mp.2008.62; Galecka E, 2013, MOL BIOL REP, V40, P1693, DOI 10.1007/s11033-012-2220-9; Gatt JM, 2010, DEPRESS ANXIETY, V27, P752, DOI 10.1002/da.20726; Green AE, 2008, NAT REV NEUROSCI, V9, P710, DOI 10.1038/nrn2461; Grieve SM, 2013, NEUROIMAGE-CLIN, V3, P332, DOI 10.1016/j.nicl.2013.08.016; Hammen C, 2005, ANNU REV CLIN PSYCHO, V1, P293, DOI 10.1146/annurev.clinpsy.1.102803.143938; Hariri AR, 2003, GENES BRAIN BEHAV, V2, P341, DOI 10.1046/j.1601-1848.2003.00048.x; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Heim C, 2012, EXP NEUROL, V233, P102, DOI 10.1016/j.expneurol.2011.10.032; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Holmes AJ, 2010, NEUROPSYCHOPHARMACOL, V35, P1186, DOI 10.1038/npp.2009.223; Huisman Sjoerd M H, 2018, Brain Inform, V5, P13, DOI 10.1186/s40708-018-0091-0; Hwang H, 2014, GEN STRUCTURED COMPO; Hwang HS, 2007, PSYCHOMETRIKA, V72, P181, DOI 10.1007/s11336-005-1314-x; Hwang H, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02137; Hwang H, 2010, PSYCHOMETRIKA, V75, P228, DOI 10.1007/s11336-010-9157-5; Hwang H, 2009, PSYCHOMETRIKA, V74, P517, DOI 10.1007/s11336-009-9119-y; Hwang HS, 2004, PSYCHOMETRIKA, V69, P81, DOI 10.1007/BF02295841; Jaworska N, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0777-x; Joreskog KG., 1973, STRUCTURAL EQUATION, P255; Jung K, 2012, PSYCHOMETRIKA, V77, P827, DOI 10.1007/s11336-012-9284-2; Kaufman J, 2001, DEV PSYCHOPATHOL, V13, P451, DOI 10.1017/S0954579401003030; Kessler RC, 2010, PSYCHOL MED, V40, P225, DOI 10.1017/S0033291709990213; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; Kiers HAL, 1996, PSYCHOMETRIKA, V61, P601, DOI 10.1007/BF02294039; Kline R.B., 2011, PRINCIPLES PRACTICE; Kohncke Y., 2020, HIPPOCAMPAL PARAHIPP, DOI [10.1101/2020.02.07.936872, DOI 10.1101/2020.02.07.936872]; Le Floch E, 2012, NEUROIMAGE, V63, P11, DOI 10.1016/j.neuroimage.2012.06.061; Lee BO, 2000, J KOREAN ACAD ADDICT, V4, P85; Lee S, 2016, BIOINFORMATICS, V32, P586, DOI 10.1093/bioinformatics/btw425; Lim L, 2014, AM J PSYCHIAT, V171, P854, DOI 10.1176/appi.ajp.2014.13101427; Liu JY, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00029; Liu JY, 2009, HUM BRAIN MAPP, V30, P241, DOI 10.1002/hbm.20508; Lowe SR, 2015, J AFFECT DISORDERS, V187, P147, DOI 10.1016/j.jad.2015.08.002; Luo L, 2012, J COMPUT BIOL, V19, P731, DOI 10.1089/cmb.2012.0035; MCDONALD RP, 1979, PSYCHOL BULL, V86, P297, DOI 10.1037/0033-2909.86.2.297; McQuaid RJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00128; Meda SA, 2010, NEUROIMAGE, V53, P1007, DOI 10.1016/j.neuroimage.2009.11.052; MEREDITH W, 1990, PSYCHOMETRIKA, V55, P107, DOI 10.1007/BF02294746; Meyer-Lindenberg A, 2012, NEUROIMAGE, V62, P1286, DOI 10.1016/j.neuroimage.2011.10.063; Northoff G, 2013, CURR OPIN NEUROBIOL, V23, P133, DOI 10.1016/j.conb.2012.08.004; Oh SM, 1999, J KOREAN NEUROPSYCHI, V38, P289; Papagni SA, 2011, STRESS, V14, P227, DOI 10.3109/10253890.2010.522279; Park S, 2020, MATHEMATICS-BASEL, V8, DOI 10.3390/math8112076; Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398; Pezawas L, 2010, NEUROIMAGE, V53, P801, DOI 10.1016/j.neuroimage.2010.08.001; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ramsay J., 2005, FUNCTIONAL DATA ANAL, P147, DOI [10.1007/0-387-22751-2_8, DOI 10.1007/0-387-22751-2_8]; Rasetti R, 2011, CURR OPIN GENET DEV, V21, P340, DOI 10.1016/j.gde.2011.02.003; Romdhani H, 2015, GENET EPIDEMIOL, V39, P101, DOI 10.1002/gepi.21872; Ryoo JH, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12091514; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Sambataro F, 2013, SCHIZOPHRENIA BULL, V39, P206, DOI 10.1093/schbul/sbr128; Sen S, 2003, NEUROPSYCHOPHARMACOL, V28, P397, DOI 10.1038/sj.npp.1300053; Sheng R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5393; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; STEIGER JH, 1979, PSYCHOMETRIKA, V44, P157, DOI 10.1007/BF02293967; Suk HW, 2016, PSYCHOMETRIKA, V81, P940, DOI 10.1007/s11336-016-9521-1; Takahashi T, 2010, J AFFECT DISORDERS, V121, P231, DOI 10.1016/j.jad.2009.06.003; Takane Y, 2007, COMPUT STAT DATA AN, V52, P394, DOI 10.1016/j.csda.2007.02.014; Tan HY, 2007, P NATL ACAD SCI USA, V104, P12536, DOI 10.1073/pnas.0610125104; Tian PF, 2010, P NATL ACAD SCI USA, V107, P15246, DOI 10.1073/pnas.1006735107; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Tol MJ, 2014, PSYCHOL MED, V44, P2053, DOI 10.1017/S0033291713002742; Vaske J, 2009, J AFFECT DISORDERS, V112, P120, DOI 10.1016/j.jad.2008.03.027; Vounou M, 2010, NEUROIMAGE, V53, P1147, DOI 10.1016/j.neuroimage.2010.07.002; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xie B, 2013, BRAIN RES, V1490, P225, DOI 10.1016/j.brainres.2012.10.048; Yang HH, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00192; You S, 2009, J NERV MENT DIS, V197, P829, DOI 10.1097/NMD.0b013e3181be7841; Zhou LX, 2016, COMPUT STAT DATA AN, V101, P93, DOI 10.1016/j.csda.2016.03.001; Zobel A, 2010, INT J NEUROPSYCHOPH, V13, P649, DOI 10.1017/S1461145709991155	100	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0247592	10.1371/journal.pone.0247592	http://dx.doi.org/10.1371/journal.pone.0247592			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690643	gold, Green Published			2022-12-26	WOS:000627854700029
J	Spurnic, AR; Bukumiric, Z; Jevtovic, D; Brmbolic, B; Pekmezovic, T; Salemovic, D; Pavlovic, IP; Milosevic, I; Ranin, J; Korac, M				Spurnic, Aleksandra Radovanovic; Bukumiric, Zoran; Jevtovic, Djordje; Brmbolic, Branko; Pekmezovic, Tatijana; Salemovic, Dubravka; Pavlovic, Ivana Pesic; Milosevic, Ivana; Ranin, Jovan; Korac, Milos			Helicobacter pylori infection rates in dyspeptic Serbian HIV-infected patients compared to HIV-negative controls	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; PEPTIC-ULCER DISEASE; HIGH PREVALENCE; RESCUE THERAPY; AIDS; ENDOSCOPY; GASTRITIS; INITIATION	Helicobacter pylori infection does not belong to the spectrum of opportunistic infections in people living with HIV (PLHIV). To evaluate the Helicobacter pylori infection prevalence rate trends in HIV co-infected individuals in comparison to the HIV-negative population, we compared histopathological findings of H. pylori positive gastritis (gastritis topography and histopathology) between 303 PLHIV and 2642 HIV-negative patients who underwent esophagogastroduodenoscopy (EGD) between 1993 and 2014 due to dyspeptic symptoms. The prevalence of H. pylori infection was significantly higher in HIV-negative controls than in PLHIV (50.2% vs. 28.1%). A significantly positive linear trend of H. pylori co-infection in PLHIV was revealed in the observed period (b = 0.030, SE = 0.011, p = 0.013), while this trend was significantly negative in HIV-negative patients (b = - 0.027, SE = 0.003, p < 0.001). Patients with HIV/H. pylori co-infection had significantly higher CD4(+) T cell counts and more often had undetectable HIV viremia, due to successful anti-retroviral therapy (ART). Stomach histopathological findings differed between HIV co-infected and H. pylori mono-infected patients. Our findings confirm that the ART has changed the progression of HIV infection, leading to a significant increase in the prevalence of H. pylori infection in dyspeptic PLHIV over time. Our data also suggests that a functional immune system may be needed for H. pylori-induced human gastric mucosa inflammation.	[Spurnic, Aleksandra Radovanovic; Jevtovic, Djordje; Brmbolic, Branko; Salemovic, Dubravka; Milosevic, Ivana; Ranin, Jovan; Korac, Milos] Univ Belgrade, Fac Med, Clin Ctr Serbia, Clin Infect & Trop Dis, Belgrade, Serbia; [Bukumiric, Zoran] Univ Belgrade, Fac Med, Inst Med Stat & Informat, Belgrade, Serbia; [Pekmezovic, Tatijana] Univ Belgrade, Fac Med, Inst Epidemiol, Belgrade, Serbia; [Pavlovic, Ivana Pesic] Clin Ctr Serbia, Microbiol Dept, Belgrade, Serbia	Clinical Centre of Serbia; University of Belgrade; University of Belgrade; University of Belgrade; Clinical Centre of Serbia	Korac, M (corresponding author), Univ Belgrade, Fac Med, Clin Ctr Serbia, Clin Infect & Trop Dis, Belgrade, Serbia.	milos.korac@med.bg.ac.rs						Ahuja V, 2005, DIGEST DIS SCI, V50, P630, DOI 10.1007/s10620-005-2548-2; AliMohamed F, 2002, East Afr Med J, V79, P226; [Anonymous], 2017, LANCET GLOBAL HLTH, V5, pe428; Cacciarelli AG, 1996, AM J GASTROENTEROL, V91, P1783; Chey WD, 2017, AM J GASTROENTEROL, V112, P212, DOI 10.1038/ajg.2016.563; Chiu HM, 2004, J GASTROEN HEPATOL, V19, P423, DOI 10.1111/j.1440-1746.2003.03278.x; Cianci R, 2006, WORLD J GASTROENTERO, V12, P2313, DOI 10.3748/wjg.v12.i15.2313; DeSimone JA, 2000, ANN INTERN MED, V133, P447, DOI 10.7326/0003-4819-133-6-200009190-00013; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Fialho ABC, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-13; Gisbert JP, 2007, HELICOBACTER, V12, P50, DOI 10.1111/j.1523-5378.2007.00576.x; Goebel FD, 2005, INFECTION, V33, P43, DOI 10.1007/s15010-005-6105-x; Goedert J J, 1985, Eur J Epidemiol, V1, P155; GRAY SF, 1986, J CLIN PATHOL, V39, P1280, DOI 10.1136/jcp.39.11.1279-a; Hocker M, 2003, LANCET, V362, P1231, DOI 10.1016/S0140-6736(03)14547-3; Jevtovic DO, 2007, HIV MED, V8, P75, DOI 10.1111/j.1468-1293.2007.00429.x; Korac M, 2009, HEPATO-GASTROENTEROL, V56, P1675; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Logan RPH, 2001, BRIT MED J, V323, P920, DOI 10.1136/bmj.323.7318.920; Malaty HM, 1996, AM J EPIDEMIOL, V143, P257, DOI 10.1093/oxfordjournals.aje.a008736; Malfertheiner P, 2017, GUT, V66, P6, DOI 10.1136/gutjnl-2016-312288; MARANO BJ, 1993, AM J GASTROENTEROL, V88, P687; MARSHALL BJ, 1984, LANCET, V1, P1311; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; Nevin DT, 2014, HELICOBACTER, V19, P323, DOI 10.1111/hel.12131; Nkuize M, 2010, HIV MED, V11, P412, DOI 10.1111/j.1468-1293.2009.00807.x; Nkuize M, 2012, HELICOBACTER, V17, P153, DOI 10.1111/j.1523-5378.2011.00929.x; Romanelli F, 2007, AIDS PATIENT CARE ST, V21, P908, DOI 10.1089/apc.2006.0215; Sarfo FS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143388; Shepherd L, 2016, HIV MED, V17, P590, DOI 10.1111/hiv.12359; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Stevenson TH, 2000, APPL ENVIRON MICROB, V66, P723, DOI 10.1128/AEM.66.2.723-727.2000; Strnad Marija, 2002, Lijec Vjesn, V124 Suppl 1, P5; Vucic-Jankovic, 1996, J Travel Med, V3, P177, DOI 10.1111/j.1708-8305.1996.tb00736.x; Werneck-Silva AL, 2009, WORLD J GASTROENTERO, V15, P1050, DOI 10.3748/wjg.15.1050; Yamaoka Y, 2010, NAT REV GASTRO HEPAT, V7, P629, DOI 10.1038/nrgastro.2010.154	36	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0248041	10.1371/journal.pone.0248041	http://dx.doi.org/10.1371/journal.pone.0248041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690620	Green Published, gold			2022-12-26	WOS:000627854700030
J	Szojka, ARA; Moore, CN; Liang, Y; Andrews, SHJ; Kunze, M; Mulet-Sierra, A; Jomha, NM; Adesida, AB				Szojka, Alexander R. A.; Moore, Colleen N.; Liang, Yan; Andrews, Stephen H. J.; Kunze, Melanie; Mulet-Sierra, Aillette; Jomha, Nadr M.; Adesida, Adetola B.			Engineered human meniscus' matrix-forming phenotype is unaffected by low strain dynamic compression under hypoxic conditions	PLOS ONE			English	Article							FACTOR-BETA 3; OXYGEN-TENSION; HYDROSTATIC-PRESSURE; GENE-EXPRESSION; GROWTH-FACTOR; MECHANICAL STIMULATION; ARTICULAR-CARTILAGE; TRANSIENT EXPOSURE; KNEE; CELLS	Low oxygen and mechanical loading may play roles in regulating the fibrocartilaginous phenotype of the human inner meniscus, but their combination in engineered tissues remains unstudied. Here, we investigated how continuous low oxygen ("hypoxia") combined with dynamic compression would affect the fibrocartilaginous "inner meniscus-like" matrix-forming phenotype of human meniscus fibrochondrocytes (MFCs) in a porous type I collagen scaffold. Freshly-seeded MFC scaffolds were cultured for 4 weeks in either 3 or 20% O-2 or pre-cultured for 2 weeks in 3% O-2 and then dynamically compressed for 2 weeks (10% strain, 1 Hz, 1 h/day, 5 days/week), all with or without TGF-beta 3 supplementation. TGF-beta 3 supplementation was found necessary to induce matrix formation by MFCs in the collagen scaffold regardless of oxygen tension and application of the dynamic compression loading regime. Neither hypoxia under static culture nor hypoxia combined with dynamic compression had significant effects on expression of specific protein and mRNA markers for the fibrocartilaginous matrix-forming phenotype. Mechanical properties significantly increased over the two-week loading period but were not different between static and dynamic-loaded tissues after the loading period. These findings indicate that 3% O-2 applied immediately after scaffold seeding and dynamic compression to 10% strain do not affect the fibrocartilaginous matrix-forming phenotype of human MFCs in this type I collagen scaffold. It is possible that a delayed hypoxia treatment and an optimized pre-culture period and loading regime combination would have led to different outcomes.	[Szojka, Alexander R. A.; Moore, Colleen N.; Liang, Yan; Andrews, Stephen H. J.; Kunze, Melanie; Mulet-Sierra, Aillette; Jomha, Nadr M.; Adesida, Adetola B.] Univ Alberta, Fac Med & Dent, Dept Surg, Div Orthopaed Surg, Edmonton, AB, Canada; [Szojka, Alexander R. A.; Moore, Colleen N.; Liang, Yan; Andrews, Stephen H. J.; Kunze, Melanie; Mulet-Sierra, Aillette; Jomha, Nadr M.; Adesida, Adetola B.] Univ Alberta, Fac Med & Dent, Dept Surg, Div Surg Res, Edmonton, AB, Canada	University of Alberta; University of Alberta	Adesida, AB (corresponding author), Univ Alberta, Fac Med & Dent, Dept Surg, Div Orthopaed Surg, Edmonton, AB, Canada.	adesida@ualberta.ca	; Adesida, Adetola/H-3549-2011	Moore, Colleen/0000-0002-9766-6786; Adesida, Adetola/0000-0003-1798-6251; Liang, Yan/0000-0002-1847-1703	Natural Sciences and Engineering Research Council (NSERC) [RGPIN-2018-06290]; Canadian Institutes of Health Research (CIHR) [MOP 125921]; Edmonton Civic Employees Charitable Assistance Fund (ECECAF) [RES0036207]; Canada Foundation for Innovation (CFI) [33786]; University Hospital of Alberta Foundation (UHF) [RES0028185, RES0045921]; Edmonton Orthopaedic Research Committee; Integra Lifesciences (USA); Alberta Cancer Foundation-Mickleborough Interfacial Biosciences Research Program (ACF-MIBRP) [27128]	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Edmonton Civic Employees Charitable Assistance Fund (ECECAF); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); University Hospital of Alberta Foundation (UHF); Edmonton Orthopaedic Research Committee; Integra Lifesciences (USA); Alberta Cancer Foundation-Mickleborough Interfacial Biosciences Research Program (ACF-MIBRP)	Financial or material grant support for this study was provided by: Natural Sciences and Engineering Research Council (NSERC RGPIN-2018-06290 Adesida); Canadian Institutes of Health Research (CIHR MOP 125921 Adesida); Edmonton Civic Employees Charitable Assistance Fund (ECECAF RES0036207, Adesida); Canada Foundation for Innovation (CFI 33786, Adesida); University Hospital of Alberta Foundation (UHF RES0028185, RES0045921 Adesida); Edmonton Orthopaedic Research Committee; Integra Lifesciences (USA) (in-kind donation of the type I collagen scaffold). Salary support for this study was provided by: ARAS: Alexander Graham Bell Scholarship, NSERC (nserc-crsng.gc.ca); President's Doctoral Prize of Distinction, University of Alberta (ualberta.ca); Canadian Institutes of Health Research; Queen Elizabeth II Scholarship program, Alberta Government; Alberta Graduate Scholarship, Student Aid Alberta; CNM: Alberta Innovates Health Solutions (AIHS) Summer Studentship; YL: Li Ka Shing Sino-Canadian Exchange Program; SHJA and MK: Alberta Cancer Foundation-Mickleborough Interfacial Biosciences Research Program (ACF-MIBRP 27128 Adesida); AMS: Canadian Institutes of Health Research (CIHR MOP 125921 Adesida); NMJ and ABA: University of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesida AB, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1929; Adesida AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039339; Adesida AB, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2267; Allen KD, 2006, J BIOMECH, V39, P312, DOI 10.1016/j.jbiomech.2004.11.012; Anderson DE, 2017, FRONT BIOENG BIOTECH, V5, DOI 10.3389/fbioe.2017.00076; Andrews SHJ, 2017, CONNECT TISSUE RES, V58, P271, DOI 10.1080/03008207.2017.1303489; ARNOCZKY SP, 1982, AM J SPORT MED, V10, P90, DOI 10.1177/036354658201000205; Athanasiou K.A., 2009, SYNTH LECT TISSUE EN, V1, P1, DOI DOI 10.2200/S00212ED1V01Y200910TIS003; Aufderheide AC, 2007, TISSUE ENG, V13, P2195, DOI 10.1089/ten.2006.0291; Aufderheide AC, 2006, ANN BIOMED ENG, V34, P1463, DOI 10.1007/s10439-006-9157-x; Baker, 2010, 56 ANN M ORTH RES SO; Ballyns JJ, 2011, J BIOMECH, V44, P509, DOI 10.1016/j.jbiomech.2010.09.017; Benjamin M, 1998, J ANAT, V193, P481, DOI 10.1046/j.1469-7580.1998.19340481.x; Bursac P, 2009, BIORHEOLOGY, V46, P227, DOI 10.3233/BIR-2009-0537; Byers BA, 2008, TISSUE ENG PT A, V14, P1821, DOI 10.1089/ten.tea.2007.0222; CLARK CR, 1983, J BONE JOINT SURG AM, V65, P538, DOI 10.2106/00004623-198365040-00018; Clark CR., 1981, IOWA ORTHOP J, V1, P20; Coimbra IB, 2004, OSTEOARTHR CARTILAGE, V12, P336, DOI 10.1016/j.joca.2003.12.005; Croutze R, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-353; Egli RJ, 2011, INT REV CEL MOL BIO, V289, P37, DOI 10.1016/B978-0-12-386039-2.00002-X; Elkhenany HA, 2021, TISSUE ENG PT A, V27, P914, DOI [10.1089/ten.tea.2020.0183, 10.1089/ten.TEA.2020.0183]; Englund M, 2009, RHEUM DIS CLIN N AM, V35, P579, DOI 10.1016/j.rdc.2009.08.004; FITHIAN DC, 1990, CLIN ORTHOP RELAT R, P19; Fitzgerald JB, 2004, J BIOL CHEM, V279, P19502, DOI 10.1074/jbc.M400437200; Folkesson E, 2020, J ORTHOP RES, V38, P1735, DOI 10.1002/jor.24602; Furumatsu T, 2012, J ORTHOP RES, V30, P1738, DOI 10.1002/jor.22142; Gunja NJ, 2010, J TISSUE ENG REGEN M, V4, P115, DOI 10.1002/term.221; Gunja NJ, 2010, J BIOMED MATER RES A, V92A, P896, DOI 10.1002/jbm.a.32451; Gunja NJ, 2009, BIOMATERIALS, V30, P565, DOI 10.1016/j.biomaterials.2008.10.007; Huang AH, 2009, TISSUE ENG PT A, V15, P3461, DOI [10.1089/ten.tea.2009.0198, 10.1089/ten.TEA.2009.0198]; Huang CYC, 2004, STEM CELLS, V22, P313, DOI 10.1634/stemcells.22-3-313; Huey DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027857; Imler SM, 2004, OSTEOARTHR CARTILAGE, V12, P736, DOI 10.1016/j.joca.2004.05.007; Kanazawa T, 2012, J ORTHOP RES, V30, P468, DOI 10.1002/jor.21528; Lee CR, 2003, J BIOMED MATER RES A, V64A, P560, DOI 10.1002/jbm.a.10443; Liang Y, 2020, ANN BIOMED ENG, V48, P968, DOI 10.1007/s10439-019-02272-7; Liang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12096-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; LUNDOLESEN K, 1970, ARTHRITIS RHEUM-US, V13, P769, DOI 10.1002/art.1780130606; Makris EA, 2013, OSTEOARTHR CARTILAGE, V21, P634, DOI 10.1016/j.joca.2013.01.007; Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037; Matthies NF, 2013, J TISSUE ENG REGEN M, V7, P965, DOI 10.1002/term.1489; Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006; McMurray TP, 1942, BRIT J SURG, V29, P407, DOI 10.1002/bjs.18002911612; McNulty AL, 2015, J BIOMECH, V48, P1469, DOI 10.1016/j.jbiomech.2015.02.008; Meyer EG, 2010, J BIOMECH, V43, P2516, DOI 10.1016/j.jbiomech.2010.05.020; Namiki A, 1995, J BIOL CHEM, V270, P31189, DOI 10.1074/jbc.270.52.31189; Natsu-Ume T, 2005, J ORTHOP SCI, V10, P396, DOI 10.1007/s00776-005-0912-x; Paradowski PT, 2016, OSTEOARTHR CARTILAGE, V24, P794, DOI 10.1016/j.joca.2015.12.002; Pauwels F, 1982, J BIOMECH ENG, V104, P346; PETERSEN W, 1995, ACTA ORTHOP SCAND, V66, P308, DOI 10.3109/17453679508995550; Puetzer JL, 2016, TISSUE ENG PT A, V22, P907, DOI [10.1089/ten.TEA.2015.0519, 10.1089/ten.tea.2015.0519]; Puetzer JL, 2012, TISSUE ENG PT A, V18, P1365, DOI [10.1089/ten.tea.2011.0589, 10.1089/ten.TEA.2011.0589]; Pufe T, 2004, MATRIX BIOL, V23, P267, DOI 10.1016/j.matbio.2004.06.003; Schatti O, 2011, EUR CELLS MATER, V22, P214, DOI 10.22203/eCM.v022a17; Scholtes S, 2018, J CELL PHYSIOL, V233, P699, DOI 10.1002/jcp.25933; Shin SJ, 2003, J APPL PHYSIOL, V95, P308, DOI 10.1152/japplphysiol.00131.2003; Suzuki T, 2006, BIORHEOLOGY, V43, P611; Szojka ARA, 2019, TISSUE ENG PT A, V25, P446, DOI [10.1089/ten.tea.2018.0211, 10.1089/ten.TEA.2018.0211]; Tan GK, 2011, BIOMATERIALS, V32, P5600, DOI 10.1016/j.biomaterials.2011.04.033; Upton ML, 2003, J ORTHOPAED RES, V21, P963, DOI 10.1016/S0736-0266(03)00063-9; Verdonk PCM, 2005, OSTEOARTHR CARTILAGE, V13, P548, DOI 10.1016/j.joca.2005.01.010; Wendt D, 2003, BIOTECHNOL BIOENG, V84, P205, DOI 10.1002/bit.10759; Wernike E, 2008, CELL TISSUE RES, V331, P473, DOI 10.1007/s00441-007-0500-9; Zellner J, 2015, J BIOMECH, V48, P1479, DOI 10.1016/j.jbiomech.2015.02.003; Zielinska B, 2009, OSTEOARTHR CARTILAGE, V17, P754, DOI 10.1016/j.joca.2008.11.018	67	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0248292	10.1371/journal.pone.0248292	http://dx.doi.org/10.1371/journal.pone.0248292			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690647	gold, Green Published			2022-12-26	WOS:000627854700052
J	Zelazniewicz, A; Nowak-Kornicka, J; Zbyrowska, K; Pawlowski, B				Zelazniewicz, Agnieszka; Nowak-Kornicka, Judyta; Zbyrowska, Klaudia; Pawlowski, Boguslaw			Predicted reproductive longevity and women's facial attractiveness	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; NATURAL MENOPAUSE; OVARIAN RESERVE; MOTHERS AGE; LIFE-STYLE; INHIBIN-B; SERUM; ESTRADIOL; HERITABILITY; DAUGHTERS	Physical attractiveness has been shown to reflect women's current fecundity level, allowing a man to choose a potentially more fertile partner in mate choice context. However, women vary not only in terms of fecundity level at reproductive age but also in reproductive longevity, both influencing a couple's long-term reproductive success. Thus, men should choose their potential partner not only based on cues of current fecundity but also on cues of reproductive longevity, and both may be reflected in women's appearance. In this study, we investigated if a woman's facial attractiveness at reproductive age reflects anti-Mullerian hormone (AMH) level, a hormone predictor of age at menopause, similarly as it reflects current fecundity level, estimated with estradiol level (E2). Face photographs of 183 healthy women (M-age = 28.49, SDage = 2.38), recruited between 2(nd) - 4(th) day of the menstrual cycle, were assessed by men in terms of attractiveness. Women's health status was evaluated based on C-reactive protein level and biochemical blood test. Serum AMH and E2 were measured. The results showed that facial attractiveness was negatively correlated with AMH level, a hormone indicator of expected age at menopause, and positively with E2, indicator of current fecundity level, also when controlled for potential covariates (testosterone, BMI, age). This might result from biological trade-off between high fecundity and the length of reproductive lifespan in women and greater adaptive importance of high fecundity at reproductive age compared to the length of reproductive lifespan.	[Zelazniewicz, Agnieszka; Nowak-Kornicka, Judyta; Zbyrowska, Klaudia; Pawlowski, Boguslaw] Univ Wroclaw, Dept Human Biol, Wroclaw, Poland	University of Wroclaw	Zelazniewicz, A (corresponding author), Univ Wroclaw, Dept Human Biol, Wroclaw, Poland.	agnieszka.zelazniewicz@uwr.edu.pl	; Zelazniewicz, Agnieszka/X-9637-2018	Nowak-Kornicka, Judyta/0000-0002-3468-8128; Zelazniewicz, Agnieszka/0000-0002-8081-4922; Pawlowski, Boguslaw/0000-0002-7418-475X	Narodowe Centrum Nauki, Poland [2015/19/B/NZ8/02061]	Narodowe Centrum Nauki, Poland(National Science Centre, Poland)	BP is a grant holder. This work was supported by Narodowe Centrum Nauki, Poland; Contract grant number: 2015/19/B/NZ8/02061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CY, 2008, J CLIN ENDOCR METAB, V93, P2344, DOI 10.1210/jc.2007-2342; Andersen CY, 2006, J CLIN ENDOCR METAB, V91, P4064, DOI 10.1210/jc.2006-1066; Munoz-Reyes JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132979; Ash, 2001, EC EFFICIENCY LONG C, P1; Bentzen JG, 2013, HUM REPROD, V28, P247, DOI 10.1093/humrep/des356; Bentzen JG, 2012, REPROD BIOMED ONLINE, V25, P612, DOI 10.1016/j.rbmo.2012.09.001; Blackwell AD, 2015, SCIENCE, V350, P970, DOI 10.1126/science.aac7902; Bovet J, 2018, J EVOLUTION BIOL, V31, P229, DOI 10.1111/jeb.13214; Bragg JM, 2012, AM J HUM BIOL, V24, P739, DOI 10.1002/ajhb.22309; Briley DA, 2017, BEHAV GENET, V47, P36, DOI 10.1007/s10519-016-9805-3; Broekmans FJ, 2007, TRENDS ENDOCRIN MET, V18, P58, DOI 10.1016/j.tem.2007.01.004; Broer SL, 2014, HUM REPROD UPDATE, V20, P688, DOI 10.1093/humupd/dmu020; Chang Jeani, 2003, MMWR Surveill Summ, V52, P1; Chapais B, 2013, EVOL ANTHROPOL, V22, P52, DOI 10.1002/evan.21345; Christiansen SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146739; Coetzee V, 2009, PERCEPTION, V38, P1700, DOI 10.1068/p6423; de Bruin JP, 2001, HUM REPROD, V16, P2014, DOI 10.1093/humrep/16.9.2014; Depmann M, 2016, MENOPAUSE, V23, P224, DOI 10.1097/GME.0000000000000509; Dolleman M, 2014, HUM REPROD, V29, P584, DOI 10.1093/humrep/det446; Dolleman M, 2013, J CLIN ENDOCR METAB, V98, P2106, DOI [10.1210/jc.2012-3995, 10.1210/jc.2012-4228]; Dratva J, 2009, MENOPAUSE, V16, P385, DOI 10.1097/gme.0b013e31818aefef; Fanchin R, 2003, HUM REPROD, V18, P323, DOI 10.1093/humrep/deg042; Fong SL, 2012, J CLIN ENDOCR METAB, V97, P4650, DOI 10.1210/jc.2012-1440; Gold EB, 2001, AM J EPIDEMIOL, V153, P865, DOI 10.1093/aje/153.9.865; Grynberg M, 2012, J CLIN ENDOCR METAB, V97, pE1649, DOI 10.1210/jc.2011-3133; Han CY, 2016, AM J HUM BIOL, V28, P352, DOI 10.1002/ajhb.22792; Hidayet N M, 1999, East Mediterr Health J, V5, P307; Hill K, 2007, J HUM EVOL, V52, P443, DOI 10.1016/j.jhevol.2006.11.003; Huang L, 2008, CAN MED ASSOC J, V178, P165, DOI 10.1503/cmaj.070150; Jacobsen BK, 2003, AM J EPIDEMIOL, V157, P923, DOI 10.1093/aje/kwg066; Jasienska G, 2004, P ROY SOC B-BIOL SCI, V271, P1213, DOI 10.1098/rspb.2004.2712; Jasienska G., 2010, DEV HUM EVOL BIOL, P322; Jasienska G, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2395; Jensen TK, 1999, EPIDEMIOLOGY, V10, P422, DOI 10.1097/00001648-199907000-00014; Jokela M, 2009, EVOL HUM BEHAV, V30, P342, DOI 10.1016/j.evolhumbehav.2009.03.006; Jones BC, 2018, PSYCHONEUROENDOCRINO, V98, P1, DOI 10.1016/j.psyneuen.2018.07.026; Kelsey TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022024; La Marca A, 2012, EUR J OBSTET GYN R B, V163, P180, DOI 10.1016/j.ejogrb.2012.04.013; Lambert-Messerlian G, 2016, FERTIL STERIL, V105, P208, DOI 10.1016/j.fertnstert.2015.09.033; Law-Smith MJ, 2006, P ROY SOC B-BIOL SCI, V273, P135, DOI 10.1098/rspb.2005.3296; Lipson SF, 1996, HUM REPROD, V11, P2090; Maestripieri D, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00179; Melado L, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00686; Moini A, 2016, EUR J OBSTET GYN R B, V207, P184, DOI 10.1016/j.ejogrb.2016.10.024; Morris DH, 2012, AM J EPIDEMIOL, V175, P998, DOI 10.1093/aje/kwr447; Morris DH, 2011, MENOPAUSE, V18, P956, DOI 10.1097/gme.0b013e31820ed6d2; Murabito JM, 2005, J CLIN ENDOCR METAB, V90, P3427, DOI 10.1210/jc.2005-0181; Nikolaou D, 2003, HUM REPROD, V18, P1137, DOI 10.1093/humrep/deg245; Pakarinen M, 2010, MATURITAS, V66, P417, DOI 10.1016/j.maturitas.2010.04.005; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Pfluger LS, 2012, EVOL HUM BEHAV, V33, P708, DOI 10.1016/j.evolhumbehav.2012.05.005; Roberts SC, 2004, P ROY SOC B-BIOL SCI, V271, pS270, DOI 10.1098/rsbl.2004.0174; Rosen MP, 2011, FERTIL STERIL, V95, P1950, DOI 10.1016/j.fertnstert.2011.01.151; Sapre Shilpa, 2014, J Midlife Health, V5, P3, DOI 10.4103/0976-7800.127779; Schacht R, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00230; Snieder H, 1998, J CLIN ENDOCR METAB, V83, P1875, DOI 10.1210/jc.83.6.1875; Stearns S.C., 1992, pi; Stepaniak U, 2013, MATURITAS, V75, P87, DOI 10.1016/j.maturitas.2013.02.008; Stewart S, 2000, J SOC PERS RELAT, V17, P843, DOI 10.1177/0265407500176008; Sulikowski D, 2015, ETHOLOGY, V121, P1002, DOI 10.1111/eth.12412; te Velde ER, 1998, MATURITAS, V30, P103, DOI 10.1016/S0378-5122(98)00067-X; Tehrani FR, 2013, J CLIN ENDOCR METAB, V98, P729, DOI 10.1210/jc.2012-3176; Thomas F, 2001, HUM BIOL, V73, P271, DOI 10.1353/hub.2001.0029; Torgerson DJ, 1997, EUR J OBSTET GYN R B, V74, P63, DOI 10.1016/S0301-2115(97)00085-7; Towner MC, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0147; van Asselt KM, 2004, FERTIL STERIL, V82, P1348, DOI 10.1016/j.fertnstert.2004.04.047; van Rooij IAJ, 2002, HUM REPROD, V17, P3065, DOI 10.1093/humrep/17.12.3065; Velde ERT, 2002, HUM REPROD UPDATE, V8, P141, DOI 10.1093/humupd/8.2.141; Visser JA, 2006, REPRODUCTION, V131, P1, DOI 10.1530/rep.1.00529; Weeden J, 2005, PSYCHOL BULL, V131, P635, DOI 10.1037/0033-2909.131.5.635; Weenen C, 2004, MOL HUM REPROD, V10, P77, DOI 10.1093/molehr/gah015; WHELAN EA, 1990, AM J EPIDEMIOL, V131, P625, DOI 10.1093/oxfordjournals.aje.a115546; Whitworth KW, 2015, EPIDEMIOLOGY, V26, P429, DOI 10.1097/EDE.0000000000000265	73	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0248344	10.1371/journal.pone.0248344	http://dx.doi.org/10.1371/journal.pone.0248344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QV3DA	33690719	gold, Green Published			2022-12-26	WOS:000627854700063
J	Sun, YK; Chen, Y; Diaz-Sacco, JJ; Shi, K				Sun, Yakuan; Chen, Ying; Diaz-Sacco, Juan Jose; Shi, Kun			Assessing population structure and body condition to inform conservation strategies for a small isolated Asian elephant (Elephas maximus) population in southwest China	PLOS ONE			English	Article							CAPTURE-RECAPTURE MODELS; CAMERA TRAP; INDIVIDUAL IDENTIFICATION; DEMOGRAPHIC PARAMETERS; PREY POPULATIONS; INFRARED CAMERA; NATIONAL-PARK; DENSITY; FOREST; PRECISION	The Asian elephant (Elephas maximus) population in Nangunhe National Nature Reserve in China represents a unique evolutionary branch that has been isolated for more than twenty years from neighboring populations in Myanmar. The scarcity of information on population structure, sex ratio, and body condition makes it difficult to develop effective conservation measures for this elephant population. Twelve individuals were identified from 3,860 valid elephant images obtained from February to June 2018 (5,942 sampling effort nights) at 52 camera sites. Three adult females, three adult males, one subadult male, two juvenile females, two juvenile males and one male calf were identified. The ratio of adult females to adult males was 1:1, and the ratio of reproductive ability was 1:0.67, indicating the scarcity of reproductive females as an important limiting factor to population growth. A population density of 5.32 +/- 1.56 elephants/100 km(2) was estimated using Spatially Explicit Capture Recapture (SECR) models. The health condition of this elephant population was assessed using an 11-point scale of Body Condition Scoring (BCS). The average BCS was 5.75 (n = 12, range 2-9), with adult females scoring lower than adult males. This isolated population is extremely small and has an inverted pyramid age structure and therefore is at a high risk of extinction. We propose three plans to improve the survival of this population: improving the quality and quantity of food resources, removing fencing and establishing corridors between the east and wet parts of Nangunhe reserve.	[Sun, Yakuan; Diaz-Sacco, Juan Jose; Shi, Kun] Beijing Forestry Univ, Sch Ecol & Nat Conservat, Beijing, Peoples R China; [Chen, Ying] Univ Hong Kong, Sch Biol Sci, Hong Kong, Peoples R China; [Shi, Kun] Ecobridge Continental, Beijing, Peoples R China	Beijing Forestry University; University of Hong Kong	Shi, K (corresponding author), Beijing Forestry Univ, Sch Ecol & Nat Conservat, Beijing, Peoples R China.; Shi, K (corresponding author), Ecobridge Continental, Beijing, Peoples R China.	kunshi@bjfu.edu.cn		Shi, Kun/0000-0002-3731-8421; Yakuan, Sun/0000-0002-3317-0239; Chen, Ying/0000-0002-1206-2896	National Forest and Grassland Administration, China under the Project of Asian Elephant Habitat Assessment and Habitat Maintenance Pilot; Yunnan Forest and Grassland Administration	National Forest and Grassland Administration, China under the Project of Asian Elephant Habitat Assessment and Habitat Maintenance Pilot; Yunnan Forest and Grassland Administration	Funding for this work was provided by National Forest and Grassland Administration, http://www.forestry.gov.cn, China under the Project of Asian Elephant Habitat Assessment and Habitat Maintenance Pilot, with effective support by the Yunnan Forest and Grassland Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada JA, 2011, PHILOS T R SOC B, V366, P2703, DOI 10.1098/rstb.2011.0115; Alexer JS., 2015, THESIS BEIJING FORES; Alfred R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031400; Archie EA, 2012, MOL ECOL, V21, P765, DOI 10.1111/j.1365-294X.2011.05237.x; Barnes RFW, 2002, AFR J ECOL, V40, P179, DOI 10.1046/j.1365-2028.2002.00376.x; Bashir T, 2013, WILDLIFE BIOL, V19, P462, DOI 10.2981/12-098; Blanc L, 2013, J WILDLIFE MANAGE, V77, P372, DOI 10.1002/jwmg.453; BOEVER F, 1948, ARCH INT PHARMACOD T, V77, P1; Bohm T, 2018, AFR J ECOL, V56, P841, DOI 10.1111/aje.12520; Bohnett Eve, 2015, Journal of Resources and Ecology, V6, P331; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Borchers DL., 2002, ESTIMATING ANIMAL AB, DOI 10.1007/978-1-4471-3708-5; Bowen-Jones E, 2002, ORYX, V36, P189, DOI 10.1017/S0030605302000261; Broto B, 2019, MAMMAL REV, V49, P78, DOI 10.1111/mam.12141; Campos-Arceiz A, 2011, ACTA OECOL, V37, P542, DOI 10.1016/j.actao.2011.01.014; Chaiyarat R, 2015, ENDANGER SPECIES RES, V29, P95, DOI 10.3354/esr00706; Choudhury A., 2008, ELEPHAS MAXIMUS, DOI [10.2305/IUCN.UK.2008.RLTS.T7140A12828813., DOI 10.2305/IUCN.UK.2008.RLTS.T7140A12828813, DOI 10.2305/IUCN.UK.2008.RLTS.T7140A12828813.EN]; de Silva S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082788; de Silva S, 2011, BIOL CONSERV, V144, P1742, DOI 10.1016/j.biocon.2011.03.011; De Z, 2019, FORESTRY CONSTRUCTIO, P61; Efford MG, 2013, OIKOS, V122, P918, DOI 10.1111/j.1600-0706.2012.20440.x; Efford MG, 2011, ECOLOGY, V92, P2202, DOI 10.1890/11-0332.1; Eggert LS, 2003, MOL ECOL, V12, P1389, DOI 10.1046/j.1365-294X.2003.01822.x; Feng Limin, 2010, Acta Theriologica Sinica, V30, P1; Fernando P, 2008, MAMM BIOL, V73, P2, DOI 10.1016/j.mambio.2007.07.007; Fernando Prithiviraj, 2009, Gajah, V31, P29; Gardner B, 2010, ECOLOGY, V91, P3376, DOI 10.1890/09-0804.1; Goswami VR, 2012, ANIM CONSERV, V15, P174, DOI 10.1111/j.1469-1795.2011.00501.x; Goswami VR, 2007, ANIM CONSERV, V10, P391, DOI 10.1111/j.1469-1795.2007.00124.x; Guo B., 1999, CHINESE J WILDLIFE, P46; Guo B, 1989, YUNNAN FORESTRY; Gupta M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173609; Hedges S, 2013, BIOL CONSERV, V159, P101, DOI 10.1016/j.biocon.2012.12.010; Jiang Zhigang, 2016, Biodiversity Science, V24, P500, DOI 10.17520/biods.2016076; Kumara HN, 2012, TROP CONSERV SCI, V5, P163, DOI 10.1177/194008291200500206; Kurt F, 1995, ACTA THERIOL, P125; Leggett KEA, 2006, AFR ZOOL, V41, P17, DOI 10.3377/1562-7020(2006)41[17:HRASMO]2.0.CO;2; Li Z., 2018, RES ASIAN ELEPHAN CO; Li Zhilin, 2014, Biodiversity Science, V22, P725, DOI 10.3724/SP.J.1003.2014.14079; Lichao M., 2004, CONSERVATION GENETIC; Ling Q., 2007, HABITAT SELECTION AS; Liu P, 2016, BIOL CONSERV, V198, P113, DOI 10.1016/j.biocon.2016.04.005; Liu Xuehua, 2018, Biodiversity Science, V26, P850, DOI 10.17520/biods.2018053; Lopez-Bao JV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20675-9; Matsukawa A, 2019, MAMMALIA, V83, P23, DOI 10.1515/mammalia-2017-0104; McConkey KR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198960; Mills LS, 2000, ECOL APPL, V10, P283, DOI 10.2307/2641002; Mingyong C., 2006, ASIAN ELEPHANT RES C; Montalvo VH, 2019, J TROP ECOL, V35, P68, DOI 10.1017/S0266467418000457; Morfeld KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093802; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943003003172; Park Heebok, 2019, Journal of Ecology and Environment, V43, P39, DOI 10.1186/s41610-019-0138-z; Paulraj S., 2000, Indian Forester, V126, P1046; Platt SG, 2019, MAMMALIA, V83, P287, DOI 10.1515/mammalia-2017-0174; Pokharel SS, 2017, CONSERV PHYSIOL, V5, DOI 10.1093/conphys/cox039; Ramesh T., 2011, Wildlife Biology in Practice, V7, P47; Rich LN, 2019, BIOL CONSERV, V233, P12, DOI 10.1016/j.biocon.2019.02.018; Riddle Heidi S., 2010, Journal of Threatened Taxa, V2, P653; Royle JA, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P163, DOI 10.1007/978-4-431-99495-4_10; Royle JA, 2009, J APPL ECOL, V46, P118, DOI 10.1111/j.1365-2664.2008.01578.x; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Silveira L, 2003, BIOL CONSERV, V114, P351, DOI 10.1016/S0006-3207(03)00063-6; Sriniyasaiah N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45130-1; Sukumar R., 2006, International Zoo Yearbook, V40, P1, DOI 10.1111/j.1748-1090.2006.00001.x; SUKUMAR R, 1988, P INDIAN AS-ANIM SCI, V97, P561, DOI 10.1007/BF03179558; Sun G., 2015, INVESTIGATION REPORT; Sunarto S, 2015, J ZOOL, V296, P104, DOI 10.1111/jzo.12218; Tan A, 2015, PROTECTION FOREST SC, P89, DOI [10.13601/j.issn.1005-5215.2015.05.035, DOI 10.13601/J.ISSN.1005-5215.2015.05.035]; Varma S, 2006, CURR SCI INDIA, V91, P324; Vidya T.N.C., 2014, Gajah, V40, P3; Vidya TNC, 2005, CURR SCI INDIA, V89, P1200; Wearn OR, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.181748; Wijeyamohan S, 2015, ZOO BIOL, V34, P53, DOI 10.1002/zoo.21181; Xian-ming G., 2019, FORESTRY CONSTRUCTIO, P30; Xiao Wenhong, 2019, Biodiversity Science, V27, P257, DOI 10.17520/biods.2018194; Xiaolin H, 1986, FOREST INVENTORY PLA, P01; Yang Fan, 2012, Acta Theriologica Sinica, V32, P90; Yong-jing T., 2019, FORESTRY CONSTRUCTIO, V6, P101; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Yuan T., 2015, BIODIVERS SCI, V23, P109, DOI [10.17520/biods.2014128, DOI 10.17520/BIODS.2014128]; Yuming Y., 1982, FOREST INVENTORY PLA, P02; Zhang Chengcheng, 2018, Journal of Resources and Ecology, V9, P566; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124834; Zhang Lvbing, 2014, Biodiversity Science, V22, P696, DOI 10.3724/SP.J.1003.2014.14225; Zhao Yu, 2018, World Forestry Research, V31, P25; Zheng-ling L., 2019, FORESTRY CONSTRUCTIO, P79; Zhiqiang Y, 2006, ACTA THERIOL SIN, V26, P359, DOI [10.3969/j.issn.1000-1050.2006.04.007, DOI 10.3969/J.ISSN.1000-1050.2006.04.007]	87	2	2	18	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2021	16	3							e0248210	10.1371/journal.pone.0248210	http://dx.doi.org/10.1371/journal.pone.0248210			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DJ	33690688	gold, Green Published			2022-12-26	WOS:000627855600005
J	Atas, DB; Sunbul, EA; Velioglu, A; Tuglular, S				Atas, Dilek Barutcu; Sunbul, Esra Aydin; Velioglu, Arzu; Tuglular, Serhan			The association between perceived stress with sleep quality, insomnia, anxiety and depression in kidney transplant recipients during Covid-19 pandemic	PLOS ONE			English	Article							SEVERITY INDEX; RENAL-TRANSPLANTATION; IMMUNOSUPPRESSANTS; VALIDATION; DISORDERS; IMPACT	Background The psychological distress and sleep problems caused by current Covid-19 outbreak is not well known in kidney transplant recipients. In this study, we aimed to investigate the association between perceived stress with sleep quality, insomnia, anxiety, depression and kidney function in kidney transplant recipients during the Covid-19 pandemic. Material and methods A hundred-six kidney transplant recipients were enrolled. Questionnaire of "Socio-demographics", "Perceived Stress Scale (PSS)", "Pittsburgh Sleep Quality Index (PSQI)", "Insomnia Severity Index (ISO" and "Hospital Anxiety Depression Scale (HADS)" are performed. The laboratory data is recorded. The perceived stress related to Covid-19 pandemic and its associations were investigated. Results The mean age of patients was 44.2 +/- 13.3 years, and 65 of the patients (61.3%) were men. Forty-nine (46.2%) of the patients had high-perceived stress; 51 (48.1%) of the patients had poor sleep quality, 40 (37.7%) of the patients had insomnia, 25 (23.6%) of the patients had anxiety and 47 (44.3%) of the patients had depression. The patients having a history of Covid-19 infection in own or closed relatives (9.09 +/- 4.17 vs 6.49 +/- 4.16, p:0.014) and the patients who have a rejection episode any of time (8.24 +/- 5.16 vs 6.37 +/- 3.57, p:0.033) have had significantly higher anxiety scores, when they compared to others. The high PSS were positively correlated with PSQI, ISI, HAD-A and HAD-D. Regression analyses revealed that high-perceived stress is an independent predictor of anxiety and depression. There was not significant difference between kidney function with PSS, PSQI, ISI, HAD-A and HAD-D. Conclusions High PSS is positively correlated with poor sleep quality and insomnia and also an independent predictor of anxiety and depression in kidney transplant recipients during the outbreak of Covid-19. As the pandemic is still spreading worldwide quickly early identification and intervention of sleep disturbances and psychiatric disorders are essential to protect graft function with high compliance to treatment in transplantation patients.	[Atas, Dilek Barutcu; Velioglu, Arzu; Tuglular, Serhan] Marmara Univ, Sch Med, Dept Internal Med, Div Nephrol, Istanbul, Turkey; [Sunbul, Esra Aydin] Univ Hlth Sci, Dept Psychiat, Erenkoy Mental Hlth & Neurol Dis Training & Res H, Istanbul, Turkey	Marmara University; Erenkoy Mental & Neurological Disorders Education & Research Hospital; University of Health Sciences Turkey	Atas, DB (corresponding author), Marmara Univ, Sch Med, Dept Internal Med, Div Nephrol, Istanbul, Turkey.	drdilekb@gmail.com						Achille MA, 2006, CLIN TRANSPLANT, V20, P301, DOI 10.1111/j.1399-0012.2005.00478.x; Agargun M.Y., 1996, TURKISH J PSYCHIAT, V7, P107, DOI DOI 10.5606/ARCHRHEUMATOL.2018.6376; Aydemir O, 1997, T RK PSIKIYATR DERG, V8, P280; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Boysan M, 2010, ANADOLU PSIKIYATR DE, V11, P248; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Butler JA, 2004, TRANSPLANTATION, V77, P769, DOI 10.1097/01.TP.0000110408.83054.88; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COLLIS I, 1995, BRIT J PSYCHIAT, V166, P521, DOI 10.1192/bjp.166.4.521; De Pasquale C, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00106; Dew MA, 2016, TRANSPLANTATION, V100, P988, DOI 10.1097/TP.0000000000000901; Dobbels F, 2008, AM J KIDNEY DIS, V51, P819, DOI 10.1053/j.ajkd.2008.01.010; Eskin M., 2013, NEW S J, V51, P132; Fernandez-Ruiz M, 2020, AM J TRANSPLANT, V20, P1849, DOI 10.1111/ajt.15929; Gualano MR, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134779; Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954; Li LQ, 2020, J MED VIROL, V92, P1433, DOI 10.1002/jmv.25924; Merlino G, 2006, NEPHROL DIAL TRANSPL, V21, P184, DOI 10.1093/ndt/gfi144; Michaels MG, 2020, AM J TRANSPLANT, V20, P1768, DOI 10.1111/ajt.15832; Molnar MZ, 2009, INT UROL NEPHROL, V41, P373, DOI 10.1007/s11255-009-9527-z; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM, 2009, ARCH INTERN MED, V169, P447, DOI 10.1001/archinternmed.2008.610; Nacif LS, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e1983; Novak M, 2010, PSYCHOSOM MED, V72, P527, DOI 10.1097/PSY.0b013e3181dbbb7d; Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]; Diamanti AP, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8111818; Pieh C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238906; Umucu E, 2020, REHABIL PSYCHOL, V65, P193, DOI 10.1037/rep0000328; Umucu E, 2018, REHABIL RES POL EDUC, V32, P232, DOI 10.1891/0889-7018.32.4.232; World Health Organization (WHO), 2019, COR DIS COVID 19 PAN; Xiang YT, 2020, LANCET PSYCHIAT, V7, P228, DOI 10.1016/S2215-0366(20)30046-8; Xie J, 2018, TRANSPL P, V50, P3426, DOI 10.1016/j.transproceed.2018.06.030	34	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0248117	10.1371/journal.pone.0248117	http://dx.doi.org/10.1371/journal.pone.0248117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QU3OZ	33684159	Green Published, gold			2022-12-26	WOS:000627193500009
J	Cox, JC; Leeds, IL; Sadiraj, V; Schnier, KE; Sweeney, JF				Cox, James C.; Leeds, Ira L.; Sadiraj, Vjollca; Schnier, Kurt E.; Sweeney, John F.			Effects of patients' hospital discharge preferences on uptake of clinical decision support	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; LENGTH-OF-STAY; 30-DAY READMISSIONS; SURGERY; QUALITY; COST; PERFORMANCE; PREDICTION; OUTCOMES; SYSTEMS	The Centers for Medicare and Medicaid Services identified unplanned hospital readmissions as a critical healthcare quality and cost problem. Improvements in hospital discharge decision-making and post-discharge care are needed to address the problem. Utilization of clinical decision support (CDS) can improve discharge decision-making but little is known about the empirical significance of two opposing problems that can occur: (1) negligible uptake of CDS by providers or (2) over-reliance on CDS and underuse of other information. This paper reports an experiment where, in addition to electronic medical records (EMR), clinical decision-makers are provided subjective reports by standardized patients, or CDS information, or both. Subjective information, reports of being eager or reluctant for discharge, was obtained during examinations of standardized patients, who are regularly employed in medical education, and in our experiment had been given scripts for the experimental treatments. The CDS tool presents discharge recommendations obtained from econometric analysis of data from de-identified EMR of hospital patients. 38 clinical decision-makers in the experiment, who were third and fourth year medical students, discharged eight simulated patient encounters with an average length of stay 8.1 in the CDS supported group and 8.8 days in the control group. When the recommendation was "Discharge," CDS uptake of "Discharge" recommendation was 20% higher for eager than reluctant patients. Compared to discharge decisions in the absence of patient reports: (i) odds of discharging reluctant standardized patients were 67% lower in the CDS-assisted group and 40% lower in the control (no-CDS) group; whereas (ii) odds of discharging eager standardized patients were 75% higher in the control group and similar in CDS-assisted group. These findings indicate that participants were neither ignoring nor over-relying on CDS.	[Cox, James C.; Sadiraj, Vjollca] Georgia State Univ, Dept Econ, Atlanta, GA 30303 USA; [Cox, James C.; Sadiraj, Vjollca] Georgia State Univ, Expt Econ Ctr, Atlanta, GA 30303 USA; [Leeds, Ira L.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Schnier, Kurt E.] Univ Calif Merced, Dept Econ & Business Management, Merced, CA USA; [Sweeney, John F.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Johns Hopkins University; University of California System; University of California Merced; Emory University	Cox, JC (corresponding author), Georgia State Univ, Dept Econ, Atlanta, GA 30303 USA.; Cox, JC (corresponding author), Georgia State Univ, Expt Econ Ctr, Atlanta, GA 30303 USA.	jccox@gsu.edu	Leeds, Ira L./H-5520-2019	Leeds, Ira L./0000-0001-6572-8658	National Institutes of Health, National Institute on Aging [1RC4AG039071]	National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the National Institutes of Health, National Institutes of Health, National Institute on Aging (grant number 1RC4AG039071): John F. Sweeney (PI); James C. Cox (PI); Vjollca Sadiraj (Co-investigator), Kurt E. Schnier (Co-investigator).	Abdelnoor M, 2017, VASC HEALTH RISK MAN, V13, P101, DOI 10.2147/VHRM.S122951; Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; Carey K, 2014, MED CARE RES REV, V71, P99, DOI 10.1177/1077558713504998; Chau Anthony, 2011, Anesthesiol Clin, V29, P57, DOI 10.1016/j.anclin.2010.11.002; Chole RA, 2012, ARCH OTOLARYNGOL, V138, P707, DOI 10.1001/archoto.2012.1374; Comeau G, 2020, MUSIC MED; Cox JC, 2016, J ECON BEHAV ORGAN, V131, P24, DOI 10.1016/j.jebo.2015.03.014; Cox JC, 2016, J ECON BEHAV ORGAN, V131, P1, DOI 10.1016/j.jebo.2015.03.017; Croskerry Pat, 2009, Healthc Q, V12 Spec No Patient, pe171; Fiks AG, 2011, CURR PROB PEDIATR AD, V41, P60, DOI 10.1016/j.cppeds.2010.10.006; Fillmore CL, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-135; Fingar K.R., 2017, COMP ALL CAUSE 7 DAY; Hyslop B, 2021, AGE AGEING, V50, P358, DOI 10.1093/ageing/afaa238; Jaspers MWM, 2011, J AM MED INFORM ASSN, V18, P327, DOI 10.1136/amiajnl-2011-000094; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Kassin MT, 2012, J AM COLL SURGEONS, V215, P322, DOI 10.1016/j.jamcollsurg.2012.05.024; Khairat S, 2018, JMIR MED INF, V6, P25, DOI 10.2196/medinform.8912; Kim MO, 2017, J AM MED INFORM ASSN, V24, P246, DOI 10.1093/jamia/ocw154; Krumholz HM, 2013, JAMA-J AM MED ASSOC, V310, P151, DOI 10.1001/jama.2013.7835; Kwok CS, 2018, JACC-CARDIOVASC INTE, V11, P665, DOI 10.1016/j.jcin.2018.01.248; Leeds IL, 2017, AM J SURG, V213, P112, DOI 10.1016/j.amjsurg.2016.03.010; Leeds IL, 2013, J SURG RES, V184, P42, DOI 10.1016/j.jss.2013.03.064; Mayr FB, 2017, JAMA-J AM MED ASSOC, V317, P530, DOI 10.1001/jama.2016.20468; McIlvennan CK, 2015, CIRCULATION, V131, P1796, DOI 10.1161/CIRCULATIONAHA.114.010270; Meunier A, 2017, ACTA ORTHOP, V88, P466, DOI 10.1080/17453674.2017.1298353; Roshanov PS, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f657; Sheetz KH, 2019, JAMA SURG, V154, P510, DOI 10.1001/jamasurg.2019.0090; Simon HA, 1955, Q J ECON, V69, P99, DOI 10.2307/1884852; Wallis CJD, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4366; Wiswell J, 2013, AM J EMERG MED, V31, P1448, DOI 10.1016/j.ajem.2013.07.018	30	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0247270	10.1371/journal.pone.0247270	http://dx.doi.org/10.1371/journal.pone.0247270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QU3OZ	33684144	gold, Green Published			2022-12-26	WOS:000627193500027
J	Garner, SB; Olsen, AM; Caillouet, R; Campbell, MD; Patterson, WF				Garner, Steven B.; Olsen, Aaron M.; Caillouet, Ryan; Campbell, Matthew D.; Patterson, William F., III			Estimating reef fish size distributions with a mini remotely operated vehicle-integrated stereo camera system	PLOS ONE			English	Article							UNDERWATER VISUAL CENSUS; VIDEO SYSTEM; BODY-SIZE; SCUBA-DIVERS; CALIBRATION; HABITAT; LASER; INDICATORS; ORGANISMS; MEGAFAUNA	We tested the efficacy of a stereo camera (SC) system adapted for use with a remotely operated vehicle (ROV) to estimate fish length distributions at reef sites in the northern Gulf of Mexico. A pool experiment was conducted to test the effect of distance (1, 2, 3 or 5 m), angle of incidence (AOI; 0 degrees to 40 degrees at 5 degrees increments), and SC baseline distance (BD; BD1 = 406, BD2 = 610, and BD3 = 762 mm camera separation) on the accuracy and precision of fish model length (288, 552, or 890 mm fork length) estimates compared to a red laser scaler (RLS). A field experiment was then conducted at 20 reef sites with SCs positioned at BD1 to compare fish length distribution estimates between the SC and RLS systems under in situ conditions. In the pool experiment, mean percent errors were consistently within the a priori selected threshold of +/- 5% at AOIs <= 10 degrees at all distances with all four systems. However, SCs produced accurate estimates at AOIs up to 30 degrees at all distances tested; 2-3 m was optimal. During reef site surveys, SCs collected 10.4 times as many length estimates from 4.3 times as many species compared to the RLS. Study results demonstrate that, compared to laser scalers, ROV-based SC systems can substantially increase the number of available fish length estimates by producing accurate length estimates at a wider range of target orientations while also enabling measurements from a greater portion of the cameras' field of view.	[Garner, Steven B.; Patterson, William F., III] Univ Florida, Fisheries & Aquat Sci, Gainesville, FL 32610 USA; [Olsen, Aaron M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Caillouet, Ryan; Campbell, Matthew D.] Natl Marine Fisheries Serv, Mississippi Labs, Southeast Fisheries Sci Ctr, Pascagoula, MS USA	State University System of Florida; University of Florida; Brown University; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Garner, SB (corresponding author), Univ Florida, Fisheries & Aquat Sci, Gainesville, FL 32610 USA.	sgarner@ufl.edu			Sea Grant; National Marine Fisheries Service [NA16OAR4170181]; Florida Fish and Wildlife Research Institute [FWC16188]	Sea Grant; National Marine Fisheries Service; Florida Fish and Wildlife Research Institute	Funding for this work was provided by a grant from Sea Grant and the National Marine Fisheries Service (#NA16OAR4170181) and the Florida Fish and Wildlife Research Institute (#FWC16188) to WFP.	Abdo DA, 2006, J EXP MAR BIOL ECOL, V339, P120, DOI 10.1016/j.jembe.2006.07.015; Birkeland C, 2005, TRENDS ECOL EVOL, V20, P356, DOI 10.1016/j.tree.2005.03.015; Bohnsack JA, 1986, NOAA TECHNICAL REPOR; Boutros N, 2015, LIMNOL OCEANOGR-METH, V13, P224, DOI 10.1002/lom3.10020; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Dance MA, 2011, B MAR SCI, V87, P301, DOI 10.5343/bms.2010.1040; Davis T, 2015, MAR FRESHWATER RES, V66, P286, DOI 10.1071/MF14076; Delacy CR, 2017, MAR ECOL PROG SER, V574, P75, DOI 10.3354/meps12190; Dunlop KM, 2015, DEEP-SEA RES PT I, V96, P38, DOI 10.1016/j.dsr.2014.11.003; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; Fischer P, 2007, LIMNOL OCEANOGR-METH, V5, P250, DOI 10.4319/lom.2007.5.250; Fournier DA, 1998, CAN J FISH AQUAT SCI, V55, P2105, DOI 10.1139/cjfas-55-9-2105; Gislason H, 2010, FISH FISH, V11, P149, DOI 10.1111/j.1467-2979.2009.00350.x; Haddon M., 2011, MODELLING QUANTITATI, P381; Harvey E, 2004, MAR FRESHWATER RES, V55, P573, DOI 10.1071/MF03130; Harvey E, 2002, MAR TECHNOL SOC J, V36, P38, DOI 10.4031/002533202787914106; Harvey E, 1995, MAR TECHNOL SOC J, V29, P10; Harvey E, 2001, FISH B-NOAA, V99, P63; Harvey ES, 1998, MAR TECHNOL SOC J, V32, P3; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; HILBORN R, 1992; Hoare DJ, 2000, J FISH BIOL, V57, P1351, DOI 10.1006/jfbi.2000.1446; Istenic K, 2020, ISPRS J PHOTOGRAMM, V159, P13, DOI 10.1016/j.isprsjprs.2019.10.007; Jennings S, 2001, J ANIM ECOL, V70, P934, DOI 10.1046/j.0021-8790.2001.00552.x; KIRKPATRICK M, 1984, ECOLOGY, V65, P1874, DOI 10.2307/1937785; KLIMLEY AP, 1983, MAR BIOL, V74, P175, DOI 10.1007/BF00413921; Langlois TJ, 2012, ECOL INDIC, V23, P524, DOI 10.1016/j.ecolind.2012.04.030; Langlois TJ, 2010, AQUAT BIOL, V9, P155, DOI 10.3354/ab00235; Langlois TJ, 2015, FISH RES, V161, P145, DOI 10.1016/j.fishres.2014.06.008; Letessier TB, 2015, J EXP MAR BIOL ECOL, V466, P120, DOI 10.1016/j.jembe.2015.02.013; Liang CK, 2005, P SOC PHOTO-OPT INS, V5960, P1315, DOI 10.1117/12.632671; McLean DL, 2019, CONT SHELF RES, V179, P66, DOI 10.1016/j.csr.2019.04.006; Mittelbach GG, 1998, CAN J FISH AQUAT SCI, V55, P1454, DOI 10.1139/f98-041; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Olden JD, 2007, GLOBAL ECOL BIOGEOGR, V16, P694, DOI 10.1111/j.1466-8238.2007.00337.x; Olsen AM, 2015, METHODS ECOL EVOL, V6, P351, DOI 10.1111/2041-210X.12326; Olsen AM, 2017, **DATA OBJECT**; Parry DM, 2002, MAR ECOL PROG SER, V244, P89, DOI 10.3354/meps244089; Patterson III WF, 2009, P GULF CARIB FISH I, V61, P263; Patterson W. F. III, 2014, P 66 GULF CAR FISH I, P4; Pauly D, 1987, LENGTH BASED METHODS, V13; Pilgrim DA, 2000, UNDERWATER TECHNOL, V24, P93, DOI 10.3723/175605400783259684; R Core Team, 2020, R LANG ENV STAT COMP; Rizzo AA, 2017, N AM J FISH MANAGE, V37, P16, DOI 10.1080/02755947.2016.1235632; Santana-Garcon J, 2014, METHODS ECOL EVOL, V5, P824, DOI 10.1111/2041-210X.12216; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; Schmidt MB, 2006, FISH RES, V82, P131, DOI 10.1016/j.fishres.2006.08.014; Schramm KD, 2020, J EXP MAR BIOL ECOL, V524, DOI 10.1016/j.jembe.2019.151273; SeaGIS PhotoMeasure, 2008, SEAGIS PTY; SHAH S, 1994, IEEE INT CONF ROBOT, P3422, DOI 10.1109/ROBOT.1994.351044; Shin YJ, 2005, ICES J MAR SCI, V62, P384, DOI 10.1016/j.icesjms.2005.01.004; Shortis M.R., 1998, INT ARCH PHOTOGRAMM, V32, P792, DOI DOI 10.1017/CB09781107415324.004; Shortis M, 2015, SENSORS-BASEL, V15, P30810, DOI 10.3390/s151229831; Somerton DA, 2005, REPORT NATL MARINE F; Somerton DA, 2017, FISH B-NOAA, V115, P343, DOI 10.7755/FB.115.3.5; Szedlmayer ST, 2004, FISH B-NOAA, V102, P366; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; Wehkamp M, 2014, UNDERWATER TECHNOL, V32, P111, DOI 10.3723/ut.32.111; WERNER EE, 1988, ECOLOGY, V69, P1352, DOI 10.2307/1941633; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141	60	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0247985	10.1371/journal.pone.0247985	http://dx.doi.org/10.1371/journal.pone.0247985			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33662031	gold, Green Published			2022-12-26	WOS:000626604100010
J	Imasogie, N; Rose, RV; Wilson, A				Imasogie, Ngozi; Rose, Rhiannon, V; Wilson, Aze			High quantities: Evaluating the association between cannabis use and propofol anesthesia during endoscopy	PLOS ONE			English	Article								Background Endoscopy under propofol sedation has become a routine procedure. Given the number of Canadians undergoing an endoscopy annually, as well as the pervasive use of cannabis by many patients, understanding the effect of cannabis use on the propofol dose at endoscopy is highly relevant. We aimed to evaluate the association between cannabis exposure and the propofol dose needed to achieve adequate sedation at endoscopy. Methods A case-control study of individuals undergoing endoscopy was conducted at a single outpatient endoscopy clinic in London, Ontario between 2014 and 2017. Cases included all individuals with any self-reported cannabis exposure, while controls included all individuals without any self-reported history of cannabis use. Dose of propofol administered by a single anesthetist was collected on each subject as well as additional demographic and procedure-related covariates. Results Three hundred and eighteen participants were included (cases, n = 151; controls, n = 167). Cannabis exposure was associated with an increase in propofol dose (cases 0.33 mg/kg/minute +/- 0.24; controls, 0.18 mg/kg/minute +/- 0.11; p<0.0001). Cannabis exposure remained an independent predictor of propofol dose on multivariate linear regression accounting for other important covariates (p<0.0001). Daily cannabis users required a higher propofol dose than weekly or monthly users. Three procedural sedation-related complications occurred in the cannabis-exposed group, while none occurred in the unexposed group. Conclusion Our data suggest that cannabis use is significantly associated with the quantity of propofol needed for sedation at endoscopy. Further study is needed to better understand the molecular basis for this possible drug-drug interaction.	[Imasogie, Ngozi] Yorkton Reg Ctr, Dept Anesthesia, Yorkton, SK, Canada; [Rose, Rhiannon, V] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada; [Wilson, Aze] Western Univ, Dept Med, Div Clin Pharmacol, London, ON, Canada; [Wilson, Aze] Western Univ, Dept Med, Div Gastroenterol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Wilson, A (corresponding author), Western Univ, Dept Med, Div Clin Pharmacol, London, ON, Canada.; Wilson, A (corresponding author), Western Univ, Dept Med, Div Gastroenterol, London, ON, Canada.	awilson2008@meds.uwo.ca		Wilson, Aze Suzanne/0000-0001-6568-1714				Brand P., 2007, EUROPEAN J ANAESTHES, V24; Cote GA, 2010, CLIN GASTROENTEROL H, V8, P137, DOI 10.1016/j.cgh.2009.07.008; Crean RD, 2011, J ADDICT MED, V5, P1, DOI 10.1097/ADM.0b013e31820c23fa; Flisberg P, 2009, EUR J ANAESTH, V26, P192, DOI 10.1097/EJA.0b013e328319be59; Hauer D, 2011, ANESTHESIOLOGY, V114, P1380, DOI 10.1097/ALN.0b013e31821c120e; Morales P, 2017, PROG CHEM ORG NAT PR, V103, P103, DOI 10.1007/978-3-319-45541-9_4; Patel S, 2003, BRIT J PHARMACOL, V139, P1005, DOI 10.1038/sj.bjp.0705334; Richtig G, 2015, INT J CASE REP IMAGE, V6, P436, DOI [10.5348/ijcri-201573-CR-10534, DOI 10.5348/ijcri-201573-CR-10534, DOI 10.5348/IJCRI-201573-CR-10534]; Sheahan CG, 2014, BRIT J ANAESTH, V113, P37, DOI 10.1093/bja/aeu378; Symons IE, 2002, ANAESTHESIA, V57, P1142, DOI 10.1046/j.1365-2044.2002.288312.x; Twardowski MA, 2019, J AM OSTEOPATH ASSOC, V119, P307, DOI 10.7556/jaoa.2019.052; United Nations Office on Drugs and Crime (UNODC), 2015, WORLD DRUG REP	12	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0248062	10.1371/journal.pone.0248062	http://dx.doi.org/10.1371/journal.pone.0248062			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33661987	Green Published, gold			2022-12-26	WOS:000626604100130
J	Lugon, CC; Smit, M; Salamun, J; Abderrahmane, M; Braillard, O; Nehme, M; Bausch, FJ; Guessous, I; Spechbach, H				Lugon, Chloe Chevallier; Smit, Mikaela; Salamun, Julien; Abderrahmane, Meriem; Braillard, Olivia; Nehme, Mayssam; Bausch, Frederique Jacquerioz; Guessous, Idris; Spechbach, Herve			Novel outpatient management of mild to moderate COVID-19 spares hospital capacity and safeguards patient outcome: The Geneva PneumoCoV-Ambu study	PLOS ONE			English	Article								Background Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2), the novel coronavirus that causes coronavirus disease (COVID-19), is creating an unprecedented burden on health care systems across the world due to its high rate of pneumonia-related hospitalizations. This study presents recommendations for the outpatient management of moderate SARS-CoV-2 pneumonia implemented at the Geneva University Hospital, Switzerland, from April 4 to June 30, 2020 and evaluated the impact of these recommendations on patient safety, patient satisfaction, and overall hospital capacity. Methods Recommendations for the outpatient management of moderate pneumonia implemented in the Geneva University Hospital (PneumoCoV-Ambu) between April 4 and June 30, 2020, were evaluated prospectively. The primary endpoint was hospitalization. Secondary endpoints were: severity of COVID-19 disease based on a 7-points ordinal scale assessed at 1 and 2 months following SARS-CoV-2 infection; patient satisfaction using a satisfaction survey and the analysis of number of beds and costs potentially averted. Results A total of 36 patients with COVID-19-related pneumonia were followed between April 4 and May 5, 2020. Five patients (14%) were hospitalized and none died over a median of 30 days follow-up. The majority of patients (n = 31; 86%) were satisfied with the ambulatory care they received. These novel recommendations for outpatient management resulted in sparing an estimated potential 124 hospital bed-nights and CHF 6'826 per capita averted hospitalization costs over the three months period. Conclusions Recommendations developed for the outpatient management of COVID-19-related pneumonia were able to spare hospital capacity without increasing adverse patient outcomes. Widely implementing such recommendations is crucial in preserving hospital capacity during this pandemic.	[Lugon, Chloe Chevallier; Salamun, Julien; Abderrahmane, Meriem; Braillard, Olivia; Nehme, Mayssam; Bausch, Frederique Jacquerioz; Guessous, Idris; Spechbach, Herve] Geneva Univ Hosp, Dept Community Med Primary Care & Emergency Med, Div Primary Care Med, Geneva, Switzerland; [Smit, Mikaela] Geneva Univ Hosp, Dept Med, Div Infect Dis, Geneva, Switzerland; [Smit, Mikaela] Univ Geneva, Fac Med, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Lugon, CC (corresponding author), Geneva Univ Hosp, Dept Community Med Primary Care & Emergency Med, Div Primary Care Med, Geneva, Switzerland.	chloe.lugon@hcuge.ch		Chevallier Lugon, Chloe/0000-0002-8386-3447; Smit, Mikaela/0000-0001-8530-748X				Berlin DA, 2020, NEW ENGL J MED, V383, P2451, DOI 10.1056/NEJMcp2009575; CDC, COR DIS 2019 COVID 1; Chalfin DB, 2007, CRIT CARE MED, V35, P1477, DOI 10.1097/01.CCM.0000266585.74905.5A; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; Crooks CJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007974; Cummings Matthew J, 2020, medRxiv, DOI [10.1016/S0140-6736(20)31189-2, 10.1101/2020.04.15.20067157]; Dolgin M, 1994, NOMENCLATURE CRITERI; Jones BE, 2011, CHEST, V140, P156, DOI 10.1378/chest.10-1296; Liang WH, 2020, JAMA INTERN MED, V180, P1081, DOI 10.1001/jamainternmed.2020.2033; National Health Institute (NIH), WHATS NEW COR DIS CO; Nehme M, 2021, ANN INTERN MED, V174, P723, DOI 10.7326/M20-5926; Tan KS, 2020, US ICU RESOURCE AVAI; Tormey D, ECOG PERFORMANCE STA; Universite de Gen eve, UN INT GEN PED CRIT; World Health Organization, COR DIS COVID 19 DAS; Zillich AJ, 2014, HEALTH SERV RES, V49, P1537, DOI 10.1111/1475-6773.12176	16	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0247774	10.1371/journal.pone.0247774	http://dx.doi.org/10.1371/journal.pone.0247774			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33662012	Green Published, gold			2022-12-26	WOS:000626604100128
J	Ard, R; Maillet, JC; Daher, E; Phan, M; Zinoviev, R; Parks, RJ; Gee, SH				Ard, Ryan; Maillet, Jean-Christian; Daher, Elias; Phan, Michael; Zinoviev, Radoslav; Parks, Robin J.; Gee, Stephen H.			PKC alpha-mediated phosphorylation of the diacylglycerol kinase zeta MARCKS domain switches cell migration modes by regulating interactions with Rac1 and RhoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION; C-ALPHA; GTPASES; DISSOCIATION; ACTIVATION; PROTEINS; DYNAMICS; ADHESION; FAMILY; RHOGDI	Cells can switch between Rac1 (lamellipodia-based) and RhoA (blebbing-based) migration modes, but the molecular mechanisms regulating this shift are not fully understood. Diacylglycerol kinase zeta (DGK zeta), which phosphorylates diacylglycerol to yield phosphatidic acid, forms independent complexes with Rac1 and RhoA, selectively dissociating each from their common inhibitor RhoGDI. DGK zeta catalytic activity is required for Rac1 dissociation but is dispensable for RhoA dissociation; instead, DGK zeta stimulates RhoA release via a kinase-independent scaffolding mechanism. The molecular determinants that mediate the selective targeting of DGK zeta to Rac1 or RhoA signaling complexes are unknown. Here, we show that protein kinase C alpha (PKC alpha)-mediated phosphorylation of the DGK zeta MARCKS domain increased DGK. association with RhoA and decreased its interaction with Rac1. The same modification also enhanced DGK zeta interaction with the scaffold protein syntrophin. Expression of a phosphomimetic DGK zeta mutant stimulated membrane blebbing in mouse embryonic fibroblasts and C2C12 myoblasts, which was augmented by inhibition of endogenous Rac1. DGK zeta expression in differentiated C2 myotubes, which have low endogenous Rac1 levels, also induced substantial membrane blebbing via the RhoA-ROCK pathway. These events were independent of DGK zeta catalytic activity, but dependent upon a functional C-terminal PDZ-binding motif. Rescue of RhoA activity in DGK zeta-null cells also required the PDZ-binding motif, suggesting that syntrophin interaction is necessary for optimal RhoA activation. Collectively, our results define a switch-like mechanism whereby DGK zeta phosphorylation by PKC alpha plays a role in the interconversion between Rac1 and RhoA signaling pathways that underlie different cellular migration modes.	[Ard, Ryan; Maillet, Jean-Christian; Daher, Elias; Phan, Michael; Zinoviev, Radoslav; Gee, Stephen H.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Ard, Ryan; Maillet, Jean-Christian; Daher, Elias; Phan, Michael; Zinoviev, Radoslav; Parks, Robin J.; Gee, Stephen H.] Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON, Canada; [Parks, Robin J.] Ottawa Hlth Res Inst, Mol Med Program, Ottawa, ON, Canada; [Parks, Robin J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Ard, Ryan] Univ British Columbia Okanagan, Dept Biol, Kelowna, BC V1V 1V7, Canada	University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of British Columbia; University of British Columbia Okanagan	Gee, SH (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.; Gee, SH (corresponding author), Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON, Canada.	stevegee@uottawa.ca			Cancer Research Society [20457]	Cancer Research Society	This work was made possible by grant #20457 from the Cancer Research Society to S. G.	Abramovici H, 2003, MOL BIOL CELL, V14, P4499, DOI 10.1091/mbc.E03-03-0190; Abramovici H, 2009, MOL BIOL CELL, V20, P2049, DOI 10.1091/mbc.E07-12-1248; ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; Antonyak Marc A, 2012, Small GTPases, V3, P219, DOI 10.4161/sgtp.20755; Ard R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144942; Ard R, 2012, MOL BIOL CELL, V23, P4008, DOI 10.1091/mbc.E12-01-0026; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Byrne KM, 2016, CELL SYST, V2, P38, DOI 10.1016/j.cels.2016.01.003; Cai JJ, 2009, BBA-MOL CELL BIOL L, V1791, P942, DOI 10.1016/j.bbalip.2009.02.010; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Dovas A, 2010, J BIOL CHEM, V285, P23294, DOI 10.1074/jbc.M109.098129; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Froehner SC, 1997, SOC GEN PHY, V52, P197; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Heller H, 2001, J BIOL CHEM, V276, P37307, DOI 10.1074/jbc.M103195200; Hogan A, 2001, J BIOL CHEM, V276, P26526, DOI 10.1074/jbc.M104156200; Luo B, 2003, J CELL BIOL, V160, P929, DOI 10.1083/jcb.200208120; Luo B, 2003, J BIOL CHEM, V278, P39542, DOI 10.1074/jbc.M307153200; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Myat MM, 1997, CURR BIOL, V7, P611, DOI 10.1016/S0960-9822(06)00262-4; Nguyen Lan K, 2018, Small GTPases, V9, P316, DOI 10.1080/21541248.2016.1224399; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Santos T, 2002, J BIOL CHEM, V277, P30300, DOI 10.1074/jbc.M200999200; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Street M, 2006, J CELL SCI, V119, P1528, DOI 10.1242/jcs.02872; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Torgerson RR, 1998, J CELL SCI, V111, P2911; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Yakubchyk Y, 2005, MOL CELL BIOL, V25, P7289, DOI 10.1128/MCB.25.16.7289-7302.2005	35	1	2	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100516	10.1016/j.jbc.2021.100516	http://dx.doi.org/10.1016/j.jbc.2021.100516			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33676892	Green Published, gold			2022-12-26	WOS:000672866400490
J	Pedersen, MH; Pham, J; Mancebo, H; Inoue, A; Asher, WB; Javitch, JA				Pedersen, Maria Hauge; Pham, Jennifer; Mancebo, Helena; Inoue, Asuka; Asher, Wesley B.; Javitch, Jonathan A.			A novel luminescence-based beta-arrestin recruitment assay for unmodified receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; BETA-ARRESTIN2; REPORTER	G protein-coupled receptors (GPCRs) signal through activation of G proteins and subsequent modulation of downstream effectors. More recently, signaling mediated by beta-arrestin has also been implicated in important physiological functions. This has led to great interest in the identification of biased ligands that favor either G protein or beta-arrestin-signaling pathways. However, nearly all screening techniques for measuring beta-arrestin recruitment have required C-terminal receptor modifications that can in principle alter protein interactions and thus signaling. Here, we have developed a novel luminescence-based assay to measure beta-arrestin recruitment to the membrane or early endosomes by unmodified receptors. Our strategy uses NanoLuc, an engineered luciferase from Oplophorus gracilirostris (deep-sea shrimp) that is smaller and brighter than other well-established luciferases. Recently, several publications have explored functional NanoLuc split sites for use in complementation assays. We have identified a unique split site within NanoLuc and fused the corresponding N-terminal fragment to either a plasma membrane or early endosome tether and the C-terminal fragment to beta-arrestins, which form the basis for the MeNArC and EeNArC assays, respectively. Upon receptor activation, beta-arrestin is recruited to the membrane and subsequently internalized in an agonist concentration-dependent manner. This recruitment promotes complementation of the two NanoLuc fragments, thereby reconstituting functional NanoLuc, allowing for quantification of beta-arrestin recruitment with a single luminescence signal. Our assay avoids potential artifacts related to C-terminal receptor modification and has promise as a new generic assay for measuring beta-arrestin recruitment to diverse GPCR types in heterologous or native cells.	[Pedersen, Maria Hauge; Asher, Wesley B.; Javitch, Jonathan A.] Columbia Univ, Vagelos Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA; [Pedersen, Maria Hauge; Asher, Wesley B.; Javitch, Jonathan A.] Columbia Univ, Vagelos Coll Phys & Surg, Dept Mol Pharmacol & Therapeut, New York, NY 10027 USA; [Pedersen, Maria Hauge; Asher, Wesley B.; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Pedersen, Maria Hauge] Univ Copenhagen, Fac Hlth & Med Sci, NNF Ctr Basic Metab Res, Sect Metab Receptol, Copenhagen, Denmark; [Pham, Jennifer; Mancebo, Helena] Multispan Inc, Hayward, CA USA; [Inoue, Asuka] Tohoku Univ, Dept Pharmacol Sci, Sendai, Miyagi, Japan	Columbia University; Columbia University; New York State Psychiatry Institute; University of Copenhagen; Tohoku University	Javitch, JA (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA.; Javitch, JA (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, Dept Mol Pharmacol & Therapeut, New York, NY 10027 USA.; Javitch, JA (corresponding author), New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA.	javitch@nyspi.columbia.edu		Hauge Pedersen, Maria/0000-0003-0034-5837	National Institutes of Health [MH54137]; Novo Nordisk Foundation [NNF17OC0024830]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	Supported by National Institutes of Health grant MH54137 (J. A. J) and Novo Nordisk Foundation grant NNF17OC0024830 (M. H. P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2002, J NEUROSCI, V22, P10494; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; DeLano W. L, 2002, CCP4 NEWSLETTER PROT, V40, P44; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Donthamsetti P, 2020, MOL PSYCHIATR, V25, P2086, DOI 10.1038/s41380-018-0212-4; Donthamsetti Prashant, 2015, Curr Protoc Pharmacol, V70, DOI 10.1002/0471141755.ph0214s70; Ehrlich AT, 2019, ISCIENCE, V14, P47, DOI 10.1016/j.isci.2019.03.011; Eishingdrelo Haifeng, 2011, Curr Chem Genomics, V5, P122, DOI 10.2174/1875397301105010122; Grunberg R, 2013, NAT METHODS, V10, P1021, DOI [10.1038/nmeth.2625, 10.1038/NMETH.2625]; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Irannejad R, 2014, CURR OPIN CELL BIOL, V27, P109, DOI 10.1016/j.ceb.2013.10.003; Klewe IV, 2008, NEUROPHARMACOLOGY, V54, P1215, DOI 10.1016/j.neuropharm.2008.03.015; Kliewer A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08162-1; Kliewer A, 2020, BRIT J PHARMACOL, V177, P2923, DOI 10.1111/bph.15004; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Laschet C, 2019, J BIOL CHEM, V294, P4079, DOI 10.1074/jbc.RA118.006231; Lohse Martin J, 2014, Handb Exp Pharmacol, V219, P15, DOI 10.1007/978-3-642-41199-1_2; Miess E, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aas9609; Namkung Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12178; Oakley RH, 2002, ASSAY DRUG DEV TECHN, V1, P21, DOI 10.1089/154065802761001275; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Reyes-Alcaraz A, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0134-3; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Smith JS, 2016, J BIOL CHEM, V291, P8969, DOI 10.1074/jbc.R115.713313; Stivala A, 2011, BIOINFORMATICS, V27, P3315, DOI 10.1093/bioinformatics/btr575; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P199, DOI 10.1101/pdb.ip067876; Thompson GL, 2016, BIOCHEM PHARMACOL, V113, P70, DOI 10.1016/j.bcp.2016.05.014; Tomabechi Y, 2016, BIOCHEM BIOPH RES CO, V470, P88, DOI 10.1016/j.bbrc.2015.12.123; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Yano H, 2018, BIOTECHNIQUES, V65, P9, DOI 10.2144/btn-2018-0039; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao XN, 2008, J BIOMOL SCREEN, V13, P737, DOI 10.1177/1087057108321531	35	4	4	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100503	10.1016/j.jbc.2021.100503	http://dx.doi.org/10.1016/j.jbc.2021.100503			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33684444	Green Published, gold			2022-12-26	WOS:000672866400477
J	Sharif, AS; Gerstner, CD; Cady, MA; Arshavsky, VY; Mitchell, C; Ying, GX; Frederick, JM; Baehr, W				Sharif, Ali S.; Gerstner, Cecilia D.; Cady, Martha A.; Arshavsky, Vadim Y.; Mitchell, Christina; Ying, Guoxin; Frederick, Jeanne M.; Baehr, Wolfgang			Deletion of the phosphatase INPP5E in the murine retina impairs photoreceptor axoneme formation and prevents disc morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL POLYPHOSPHATE 5-PHOSPHATASES; JOUBERT SYNDROME; INTRAFLAGELLAR TRANSPORT; PROTEIN TRAFFICKING; TRANSITION ZONE; OUTER SEGMENTS; PHOSPHOINOSITIDES; CILIA; CILIOGENESIS; TRANSDUCIN	INPP5E, also known as pharbin, is a ubiquitously expressed phosphatidylinositol polyphosphate 5-phosphatase that is typically located in the primary cilia and modulates the phosphoinositide composition of membranes. Mutations to or loss of INPP5E is associated with ciliary dysfunction. INPP5E missense mutations of the phosphatase catalytic domain cause Joubert syndrome in humans-a syndromic ciliopathy affecting multiple tissues including the brain, liver, kidney, and retina. In contrast to other primary cilia, photoreceptor INPP5E is prominently expressed in the inner segment and connecting cilium and absent in the outer segment, which is a modified primary cilium dedicated to phototransduction. To investigate how loss of INPP5e causes retina degeneration, we generated mice with a retina-specific KO (Inpp5e(F/F);Six3Cre, abbreviated as (ret)Inpp5e(-/-)). These mice exhibit a rapidly progressing rod-cone degeneration resembling Leber congenital amaurosis that is nearly completed by postnatal day 21 (P21) in the central retina. Mutant cone outer segments contain vesicles instead of discs as early as P8. Although P10 mutant outer segments contain structural and phototransduction proteins, axonemal structure and disc membranes fail to form. Connecting cilia of (ret)Inpp5e(-/-) rods display accumulation of intraflagellar transport particles A and B at their distal ends, suggesting disrupted intraflagellar transport. Although INPP5E ablation may not prevent delivery of outer segment-specific proteins by means of the photoreceptor secretory pathway, its absence prevents the assembly of axonemal and disc components. Herein, we suggest a model for INPP5E-Leber congenital amaurosis, proposing how deletion of INPP5E may interrupt axoneme extension and disc membrane elaboration.	[Sharif, Ali S.; Gerstner, Cecilia D.; Ying, Guoxin; Frederick, Jeanne M.; Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA; [Cady, Martha A.; Arshavsky, Vadim Y.] Duke Univ, Dept Ophthalmol, Durham, NC USA; [Mitchell, Christina] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Baehr, Wolfgang] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Duke University; Monash University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Baehr, W (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA.; Baehr, W (corresponding author), Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA.; Baehr, W (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	wbaehr@hsc.utah.edu			NIH [EY08123, EY019298, EY012859, EY005722, EY014800-039003, 5T32 EY024234]; Research to Prevent Blindness (RPB; New York); Retina Research Foundation, Houston; RPB Senior Investigator award; RPB Nelson Trust award; NEI training grant	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (RPB; New York)(Research to Prevent Blindness (RPB)); Retina Research Foundation, Houston; RPB Senior Investigator award; RPB Nelson Trust award; NEI training grant	This work was supported by NIH Grants EY08123, EY019298 (to W. B.); EY012859 (to V. Y. A.); EY005722 (to V. Y. A.); EY014800-039003 (NEI core grant); 5T32 EY024234 (NEI training grant) by unrestricted grants to the University of Utah Department of Ophthalmology from Research to Prevent Blindness (RPB; New York) and by a grant from the Retina Research Foundation, Houston (Alice McPherson, MD). W. B. and V. Y. A. are recipients of the RPB Senior Investigator award and the RPB Nelson Trust award. A. S. S. is a fellow on the NEI training grant. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Avasthi P, 2009, J NEUROSCI, V29, P14287, DOI 10.1523/JNEUROSCI.3976-09.2009; Badgandi HB, 2017, J CELL BIOL, V216, P743, DOI 10.1083/jcb.201607095; Baehr W, 2014, INVEST OPHTH VIS SCI, V55, P8653, DOI 10.1167/iovs.14-16066; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Boldt K, 2011, J CLIN INVEST, V121, P2169, DOI 10.1172/JCI45627; CHAITIN MH, 1991, EXP EYE RES, V53, P107, DOI 10.1016/0014-4835(91)90152-5; Chavez M, 2015, DEV CELL, V34, P338, DOI 10.1016/j.devcel.2015.06.016; Conduit SE, 2012, FEBS LETT, V586, P2846, DOI 10.1016/j.febslet.2012.07.037; Dyson JM, 2017, J CELL BIOL, V216, P247, DOI 10.1083/jcb.201511055; Fansa EK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11366; Fei YJ, 2003, MOL VIS, V9, P31; Finkelstein S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061417; Frederick JM, 2001, INVEST OPHTH VIS SCI, V42, P826; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Garcia-Gonzalo FR, 2015, DEV CELL, V34, P400, DOI 10.1016/j.devcel.2015.08.001; Hagstrom SA, 2012, ADV EXP MED BIOL, V723, P783, DOI 10.1007/978-1-4614-0631-0_100; Hakim S, 2016, HUM MOL GENET, V25, P2295, DOI 10.1093/hmg/ddw097; Hanke-Gogokhia C, 2017, J BIOL CHEM, V292, P21442, DOI 10.1074/jbc.RA117.000141; Hanke-Gogokhia C, 2016, J BIOL CHEM, V291, P7142, DOI 10.1074/jbc.M115.710954; Hardee I, 2017, AM J MED GENET A, V173, P3231, DOI 10.1002/ajmg.a.38376; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Humbert MC, 2012, P NATL ACAD SCI USA, V109, P19691, DOI 10.1073/pnas.1210916109; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Ismail SA, 2012, EMBO J, V31, P4085, DOI 10.1038/emboj.2012.257; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Jiang L, 2015, J BIOL CHEM, V290, P12765, DOI 10.1074/jbc.M115.638437; Jiang ST, 2009, HUM MOL GENET, V18, P1566, DOI 10.1093/hmg/ddp068; Kisseleva MV, 2000, J BIOL CHEM, V275, P20110, DOI 10.1074/jbc.M910119199; Kosling SK, 2018, BIOL CHEM, V399, P277, DOI 10.1515/hsz-2017-0226; Kong AM, 2000, J BIOL CHEM, V275, P24052, DOI 10.1074/jbc.M000874200; Krock BL, 2009, INVEST OPHTH VIS SCI, V50, P5463, DOI 10.1167/iovs.09-3828; Lobanova ES, 2008, J NEUROSCI, V28, P3510, DOI 10.1523/JNEUROSCI.0338-08.2008; Louie CM, 2010, NAT GENET, V42, P175, DOI 10.1038/ng.519; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; Nachury MV, 2019, NAT REV MOL CELL BIO, V20, P389, DOI 10.1038/s41580-019-0116-4; Nasuhoglu C, 2002, ANAL BIOCHEM, V301, P243, DOI 10.1006/abio.2001.5489; Nozaki S, 2017, J CELL SCI, V130, P563, DOI 10.1242/jcs.197004; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Paquet-Durand F, 2011, HUM MOL GENET, V20, P941, DOI 10.1093/hmg/ddq539; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Plotnikova OV, 2015, J CELL SCI, V128, P364, DOI 10.1242/jcs.161323; Rao KN, 2016, HUM MOL GENET, V25, P4533, DOI 10.1093/hmg/ddw281; Roberson EC, 2015, J CELL BIOL, V209, P129, DOI 10.1083/jcb.201411087; Ronquillo CC, 2016, FASEB J, V30, P3400, DOI 10.1096/fj.201600511R; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Scholey JM, 2012, VISION RES, V75, P44, DOI 10.1016/j.visres.2012.06.015; Sokolov M, 2004, J BIOL CHEM, V279, P19149, DOI 10.1074/jbc.M311058200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Spencer WJ, 2020, TRENDS CELL BIOL, V30, P904, DOI 10.1016/j.tcb.2020.08.005; Spencer WJ, 2019, P NATL ACAD SCI USA, V116, P13087, DOI 10.1073/pnas.1906421116; Thomas S, 2014, HUM MUTAT, V35, P137, DOI 10.1002/humu.22470; Travaglini L, 2013, EUR J HUM GENET, V21, P1074, DOI 10.1038/ejhg.2012.305; Vig A, 2020, GENET MED, V22, P2041, DOI 10.1038/s41436-020-0915-1; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; Wensel TG, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040866; Xi QS, 2005, INVEST OPHTH VIS SCI, V46, P4754, DOI 10.1167/iovs.05-0693; Xu WY, 2017, J AM SOC NEPHROL, V28, P118, DOI 10.1681/ASN.2015080906; Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008; Zhang HB, 2015, FASEB J, V29, P932, DOI 10.1096/fj.14-257915; Zhang HB, 2012, VISION RES, V75, P19, DOI 10.1016/j.visres.2012.08.013	64	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100529	10.1016/j.jbc.2021.100529	http://dx.doi.org/10.1016/j.jbc.2021.100529			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33711342	Green Published, gold, Green Submitted			2022-12-26	WOS:000672866400503
J	Hung, CF; Holton, S; Chow, YH; Liles, WC; Gharib, SA; Altemeier, WA				Hung, Chi F.; Holton, Sarah; Chow, Yu-Hua; Liles, Wayne Conrad; Gharib, Sina A.; Altemeier, William A.			Pericyte-like cells undergo transcriptional reprogramming and distinct functional adaptations in acute lung injury	FASEB JOURNAL			English	Article						acute lung injury; angiogenesis; ANGPTL4; CCR2; lung; inflammation; lung immunity; pericytes; transcriptional profiling		We previously reported on the role of pericyte-like cells as functional sentinel immune cells in lung injury. However, much about the biological role of pericytes in lung injury remains unknown. Lung pericyte-like cells are well-positioned to sense disruption to the epithelial barrier and coordinate local inflammatory responses due to their anatomic niche within the alveoli. In this report, we characterized transcriptional responses and functional changes in pericyte-like cells following activation by alveolar components from injured and uninjured lungs in a mouse model of acute lung injury (ALI). Purified pericyte-like cells from lung digests using PDGFR beta as a selection marker were expanded in culture as previously described (1). We induced sterile acute lung injury in mice with recombinant human Fas ligand (rhFasL) instillation followed by mechanical ventilation (1). We then collected bronchoalveolar lavage fluid (BALF) from injured and uninjured mice. Purified pericyte-like cells in culture were exposed to growth media only (control), BALF from uninjured mice, and BALF from injured mice for 6 and 24 hours. RNA collected from these treatment conditions were processed for RNAseq. Targets of interest identified by pathway analysis were validated using in vitro and in vivo assays. We observed robust global transcriptional changes in pericyte-like cells following treatment with uninjured and injured BALF at 6 hours, but this response persisted for 24 hours only after exposure to injured BALF. Functional enrichment analysis of pericytes treated with injured BALF revealed the activation of pro-inflammatory, cell migration, and angiogenesis-related pathways, whereas processes associated with tissue development and cell differentiation were down-regulated. We validated select upregulated targets in the inflammatory, angiogenic, and cell migratory pathways using functional biological assays in vitro and in vivo. We conclude that lung pericyte-like cells are highly responsive to alveolar compartment content from both uninjured and injured lungs, but injured BALF elicits a more sustained response. The inflammatory, angiogenic, and migratory changes exhibited by activated pericyte-like cells underscore the phenotypic plasticity of these specialized stromal cells in the setting of acute lung injury.	[Hung, Chi F.; Holton, Sarah; Chow, Yu-Hua; Gharib, Sina A.; Altemeier, William A.] Univ Washington, Dept Med, Div Pulm Crit Care & Sleep Med, Seattle, WA USA; [Hung, Chi F.; Holton, Sarah; Chow, Yu-Hua; Liles, Wayne Conrad; Gharib, Sina A.; Altemeier, William A.] Univ Washington, Ctr Lung Biol, Seattle, WA 98195 USA; [Liles, Wayne Conrad] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hung, CF (corresponding author), Univ Washington, Ctr Lung Biol, Div Pulm & Crit Care, Box 358052,850 Republican St, Seattle, WA 98109 USA.	cfhung@uw.edu		Holton, Sarah/0000-0002-6373-3768	National Heart, Lung, and Blood Institute (NHLBI) [K08HL127075, R01HL122895]	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: K08HL127075 and R01HL122895	Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Arpino V, 2015, MATRIX BIOL, V44-46, P247, DOI 10.1016/j.matbio.2015.03.005; Babapoor-Farrokhran S, 2015, P NATL ACAD SCI USA, V112, pE3030, DOI 10.1073/pnas.1423765112; Coates BM, 2018, J IMMUNOL, V200, P2391, DOI 10.4049/jimmunol.1701543; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; Galaup A, 2012, CIRCULATION, V125, P140, DOI 10.1161/CIRCULATIONAHA.111.049072; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Huang RL, 2011, BLOOD, V118, P3990, DOI 10.1182/blood-2011-01-328716; Hung C, 2013, AM J RESP CRIT CARE, V188, P820, DOI 10.1164/rccm.201212-2297OC; Hung CF, 2017, AM J PHYSIOL-LUNG C, V312, pL556, DOI 10.1152/ajplung.00349.2016; Hung CF, 2017, AM J RESP CELL MOL, V56, P160, DOI 10.1165/rcmb.2016-0083MA; Ito Y, 2003, CANCER RES, V63, P6651; Leaf IA, 2017, J CLIN INVEST, V127, P321, DOI 10.1172/JCI87532; Lei X, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217638; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li L, 2019, MBIO, V10, DOI 10.1128/mBio.02469-18; Li L, 2015, CELL REP, V10, P654, DOI 10.1016/j.celrep.2015.01.011; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Perdiguero EG, 2016, J PATHOL, V240, P461, DOI 10.1002/path.4805; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Stapor PC, 2014, J VASC RES, V51, P163, DOI 10.1159/000362276; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wang J, 2017, NUCLEIC ACIDS RES, V45, pW130, DOI 10.1093/nar/gkx356; Xiao YL, 2013, J PATHOL, V229, P535, DOI 10.1002/path.4145; Xin XB, 2013, P NATL ACAD SCI USA, V110, pE3425, DOI 10.1073/pnas.1217091110	31	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21323	10.1096/fj.201903192RR	http://dx.doi.org/10.1096/fj.201903192RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710674	Green Submitted			2022-12-26	WOS:000635216100064
J	Lu, XP; Xu, M; Zhu, Q; Zhang, J; Liu, G; Bao, YT; Gu, L; Tian, Y; Wen, H; Zhu, WG				Lu, Xiaopeng; Xu, Min; Zhu, Qian; Zhang, Jun; Liu, Ge; Bao, Yantao; Gu, Luo; Tian, Yuan; Wen, He; Zhu, Wei-Guo			RNF8-ubiquitinated KMT5A is required for RNF168-induced H2A ubiquitination in response to DNA damage	FASEB JOURNAL			English	Article						DNA double&#8208; strand breaks; histone ubiquitination; KMT5A; RNF8; RNF168		Histone modifications play critical roles in DNA damage repair to safeguard genome integrity. However, how different histone modifiers coordinate to build appropriate chromatin context for DNA damage repair is largely unknown. Here, we report a novel interplay between the histone methyltransferase KMT5A and two E3 ligases RNF8 and RNF168 in establishing the histone modification status for DNA damage repair. KMT5A is a newly identified substrate of RNF8 in vitro and in vivo. In response to DNA double-strand breaks (DSBs), RNF8 promotes KMT5A recruitment onto damaged chromatin in a ubiquitination-dependent manner. RNF8-induced KMT5A ubiquitination increases the binding capacity of KMT5A to RNF168. Interestingly, KMT5A not only drives a local increase in H4K20 monomethylation at DSBs, but also promotes RNF168's activity in catalyzing H2A ubiquitination. We proved that the interaction between the H2A acidic patch and KMT5A R188/R189 residues is critical for KMT5A-mediated regulation of H2A ubiquitination. Taken together, our results highlight a new role for KMT5A in linking H4K20 methylation and H2A ubiquitination and provide insight into the histone modification network during DNA damage repair.	[Lu, Xiaopeng; Xu, Min; Zhu, Qian; Zhang, Jun; Liu, Ge; Bao, Yantao; Tian, Yuan; Wen, He; Zhu, Wei-Guo] Shenzhen Univ Sch Med, Dept Biochem & Mol Biol, Guangdong Key Lab Genome Instabil & Human Dis Pre, Shenzhen 518055, Peoples R China; [Gu, Luo] Nanjing Med Univ, Dept Physiol, Nanjing, Peoples R China; [Tian, Yuan; Zhu, Wei-Guo] Shenzhen Univ Sch Med, Shenzhen Bay Lab, Shenzhen, Peoples R China; [Zhu, Wei-Guo] Shenzhen Univ Sch Med, Int Canc Ctr, Shenzhen, Peoples R China	Nanjing Medical University; Shenzhen Bay Laboratory	Zhu, WG (corresponding author), Shenzhen Univ Sch Med, Dept Biochem & Mol Biol, Guangdong Key Lab Genome Instabil & Human Dis Pre, Shenzhen 518055, Peoples R China.	zhuweiguo@szu.edu.cn	Wen, He/GZL-8825-2022; Zhu, Wei-Guo/ABF-8373-2021; ZHANG, Jun/V-5275-2018	Zhu, Wei-Guo/0000-0001-8385-6581; ZHANG, Jun/0000-0002-6523-7573	National Key R&D Program of China [2017YFA0503900]; National Natural Science Foundation of China [81720108027, 81530074, 32090030, 82002988]; Science and Technology Program of Guangdong Province in China [2017B030301016]; Shenzhen Municipal Commission of Science and Technology Innovation [JCYJ20170818092450901, JCYJ20200109114214463]; China Postdoctoral Science Foundation [2019M653054]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangdong Province in China; Shenzhen Municipal Commission of Science and Technology Innovation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	National Key R&D Program of China, Grant/Award Number: 2017YFA0503900; National Natural Science Foundation of China, Grant/Award Number: 81720108027, 81530074, 32090030 and 82002988; Science and Technology Program of Guangdong Province in China, Grant/Award Number: 2017B030301016; Shenzhen Municipal Commission of Science and Technology Innovation, Grant/Award Number: JCYJ20170818092450901, JCYJ20200109114214463; China Postdoctoral Science Foundation, Grant/Award Number: 2019M653054	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Baldock RA, 2015, CELL REP, V13, P2081, DOI 10.1016/j.celrep.2015.10.074; Barbour H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19722-9; Beck DB, 2012, GENE DEV, V26, P325, DOI 10.1101/gad.177444.111; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Campbell S, 2013, CELL CYCLE, V12, P2675, DOI 10.4161/cc.25795; Cao LL, 2016, SCI CHINA LIFE SCI, V59, P257, DOI 10.1007/s11427-016-5011-z; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chen XS, 2020, SCI CHINA LIFE SCI, V63, P206, DOI 10.1007/s11427-019-1587-x; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Dhami GK, 2013, MOL CELL, V50, P565, DOI 10.1016/j.molcel.2013.04.028; Dulev S, 2020, CELL CYCLE, V19, P15, DOI 10.1080/15384101.2019.1690231; Dulev S, 2014, EMBO REP, V15, P1163, DOI 10.15252/embr.201439434; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Feng L, 2012, NAT STRUCT MOL BIOL, V19, P201, DOI 10.1038/nsmb.2211; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Gieni RS, 2011, CELL CYCLE, V10, P883, DOI 10.4161/cc.10.6.14907; Ginjala V, 2011, MOL CELL BIOL, V31, P1972, DOI 10.1128/MCB.00981-10; Girish TS, 2016, J MOL BIOL, V428, P1531, DOI 10.1016/j.jmb.2016.02.025; GOLDKNOPF IL, 1975, J BIOL CHEM, V250, P7182; Gong FD, 2019, MUTAT RES-REV MUTAT, V780, P37, DOI 10.1016/j.mrrev.2017.09.003; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Han J., 2020, GENOME INSTAB DIS, V1, P10, DOI [DOI 10.1007/S42764-019-00002-W, 10.1007/s42764-019-00002-w]; Hou LJ, 2016, MOL MED REP, V13, P1681, DOI 10.3892/mmr.2015.4733; Hsiao KY, 2013, J MOL CELL BIOL, V5, P157, DOI 10.1093/jmcb/mjs066; Huen MSY, 2008, J BIOL CHEM, V283, P11073, DOI 10.1074/jbc.C700242200; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Isono M, 2017, CELL REP, V18, P520, DOI 10.1016/j.celrep.2016.12.042; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Jorgensen S, 2011, J CELL BIOL, V192, P43, DOI 10.1083/jcb.201009076; Kim JJ, 2019, CRIT REV BIOCHEM MOL, V54, P208, DOI 10.1080/10409238.2019.1620676; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Leung JW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004178; Li L, 2010, J EXP MED, V207, P983, DOI 10.1084/jem.20092437; Liu B, 2016, CANCER LETT, V376, P259, DOI 10.1016/j.canlet.2016.04.008; Liu CH, 2020, THERANOSTICS, V10, P1758, DOI 10.7150/thno.39013; Lu CS, 2012, J BIOL CHEM, V287, P43984, DOI 10.1074/jbc.M112.421545; Lu XP, 2019, NUCLEIC ACIDS RES, V47, P10977, DOI 10.1093/nar/gkz897; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Mattiroli F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4291; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Nowsheen S, 2018, NAT CELL BIOL, V20, P455, DOI 10.1038/s41556-018-0071-x; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Ramachandran S, 2010, P NATL ACAD SCI USA, V107, P809, DOI 10.1073/pnas.0913790107; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Santos MA, 2010, J EXP MED, V207, P973, DOI 10.1084/jem.20092308; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Scully R, 2019, NAT REV MOL CELL BIO, V20, P698, DOI 10.1038/s41580-019-0152-0; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Sin HS, 2012, GENE DEV, V26, P2737, DOI 10.1101/gad.202713.112; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tamburri S, 2020, MOL CELL, V77, P840, DOI 10.1016/j.molcel.2019.11.021; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Thorslund T, 2015, NATURE, V527, P389, DOI 10.1038/nature15401; Tuzon CT, 2014, CELL REP, V8, P429, DOI 10.1016/j.celrep.2014.06.013; Uckelmann M, 2017, DNA REPAIR, V56, P92, DOI 10.1016/j.dnarep.2017.06.011; Vazquez BN, 2016, EMBO J, V35, P1488, DOI 10.15252/embj.201593499; Vissers JHA, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-8; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Wilson MD, 2016, NATURE, V536, P100, DOI 10.1038/nature18951; Yang F, 2012, EMBO J, V31, P110, DOI 10.1038/emboj.2011.364; Zhang HF, 2019, NUCLEIC ACIDS RES, V47, P9053, DOI 10.1093/nar/gkz626; Zimmerman M, 2014, TRENDS CELL BIOL, V24, P108, DOI 10.1016/j.tcb.2013.09.003; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	75	2	2	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21326	10.1096/fj.202002234R	http://dx.doi.org/10.1096/fj.202002234R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710666				2022-12-26	WOS:000635216100083
J	Aboshady, HM; Mandonnet, N; Johansson, AM; Jonas, E; Bambou, JC				Aboshady, Hadeer M.; Mandonnet, Nathalie; Johansson, Anna M.; Jonas, Elisabeth; Bambou, Jean-Christophe			Genomic variants from RNA-seq for goats resistant or susceptible to gastrointestinal nematode infection	PLOS ONE			English	Article							PROLACTIN RECEPTOR GENE; WIDE ASSOCIATION; CANDIDATE GENES; CAPRA-HIRCUS; TRAITS; SNP; IDENTIFICATION; TRANSCRIPTOME; MECHANISMS; SELECTION	Gastrointestinal nematodes (GIN) are an important constraint in small ruminant production. Genetic selection for resistant animals is a potential sustainable control strategy. Advances in molecular genetics have led to the identification of several molecular genetic markers associated with genes affecting economic relevant traits. In this study, the variants in the genome of Creole goats resistant or susceptible to GIN were discovered from RNA-sequencing. We identified SNPs, insertions and deletions that distinguish the two genotypes, resistant and susceptible and we characterized these variants through functional analysis. The T cell receptor signalling pathway was one of the top significant pathways that distinguish the resistant from the susceptible genotype with 78% of the genes involved in this pathway showing genomic variants. These genomic variants are expected to provide useful resources especially for molecular breeding for GIN resistance in goats.	[Aboshady, Hadeer M.] Cairo Univ, Fac Agr, Dept Anim Prod, Cairo, Egypt; [Aboshady, Hadeer M.] AgroParisTech, Paris, France; [Aboshady, Hadeer M.; Johansson, Anna M.; Jonas, Elisabeth] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Aboshady, Hadeer M.; Mandonnet, Nathalie; Bambou, Jean-Christophe] INRA, Unite Rech Zootech, URZ, Petit Bourg, Guadeloupe, France	Egyptian Knowledge Bank (EKB); Cairo University; AgroParisTech; Swedish University of Agricultural Sciences; INRAE	Bambou, JC (corresponding author), INRA, Unite Rech Zootech, URZ, Petit Bourg, Guadeloupe, France.	jean-christophe.bambou@inrae.fr	Jonas, Elisabeth/F-1764-2017	Jonas, Elisabeth/0000-0003-4950-2549; Johansson, Anna M/0000-0002-9762-0497; Aboshady, Hadeer/0000-0002-1514-8839	Project MALIN (La Region Guadeloupe); Project MALIN (Fonds Europeens FEDER); European Graduate School in Animal Breeding and Genetics	Project MALIN (La Region Guadeloupe); Project MALIN (Fonds Europeens FEDER); European Graduate School in Animal Breeding and Genetics	This study was funded by the Project MALIN (La Region Guadeloupe and Fonds Europeens FEDER). H.M.A was supported by a doctoral fellowship from the project European Graduate School in Animal Breeding and Genetics.	Aboshady HM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218719; Aboshady HM., 2020, VET RES, P1, DOI [10.1186/s13567-019-0731-2, DOI 10.1186/S13567-019-0731-2]; Ahmed AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124823; Alam MBB, 2019, J ANIM SCI BIOTECHNO, V10, DOI 10.1186/s40104-019-0327-8; An XP, 2016, ANIM GENET, V47, P499, DOI 10.1111/age.12425; Balic A, 2002, PARASITE IMMUNOL, V24, P39, DOI 10.1046/j.0141-9838.2001.00432.x; Bhuiyan AA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040751; Bressani FA, 2014, GENET MOL RES, V13, P8530, DOI 10.4238/2014.October.20.29; Canovas A, 2010, MAMM GENOME, V21, P592, DOI 10.1007/s00335-010-9297-z; Chen HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120170; Chitneedi PK, 2018, VET RES, V49, DOI 10.1186/s13567-018-0534-x; Cirulli ET, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r57; El-Ashram S, 2017, PARASITOL INT, V66, P681, DOI 10.1016/j.parint.2017.05.007; Geng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062704; Guo ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26200; Hou JX, 2013, GENE, V529, P276, DOI 10.1016/j.gene.2013.07.057; Huse M, 2009, J CELL SCI, V122, P1269, DOI 10.1242/jcs.042762; Jabbar A, 2006, LIFE SCI, V79, P2413, DOI 10.1016/j.lfs.2006.08.010; Karlsson LJE, 2006, AUST J EXP AGR, V46, P809, DOI 10.1071/EA05367; Kemper KE, 2010, VET PARASITOL, V171, P238, DOI 10.1016/j.vetpar.2010.04.005; Knights M, 1997, SMALL RUMINANT RES, V26, P203, DOI 10.1016/S0921-4488(96)00977-7; Lee S, 2020, NAR GENOM BIOINFORM, V2, DOI 10.1093/nargab/lqaa073; Li RW, 2012, VET PARASITOL, V190, P1, DOI 10.1016/j.vetpar.2012.06.021; Li RW, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-114; Li ZJ, 2010, MOL BIOL REP, V37, P563, DOI 10.1007/s11033-009-9810-1; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Ma L, 2017, ANN ANIM SCI, V17, P399, DOI 10.1515/aoas-2016-0066; Martinez-Montes AM, 2017, ANIM GENET, V48, P151, DOI 10.1111/age.12507; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mcrae KM, 2016, VET PARASITOL, V224, P96, DOI 10.1016/j.vetpar.2016.05.014; Minozzi G, 2017, ITAL J ANIM SCI, V16, P31, DOI [10.1080/1828051X.2016.1250610, 10.1080/1828051x.2016.1250610]; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Morris CA, 2005, NEW ZEAL J AGR RES, V48, P1, DOI 10.1080/00288233.2005.9513625; Pareek CS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172687; Piskol R, 2013, AM J HUM GENET, V93, P641, DOI 10.1016/j.ajhg.2013.08.008; Robinson N, 2010, VET RES, V41, DOI 10.1051/vetres/2010009; Silva FF, 2018, SMALL RUMINANT RES, V166, P109, DOI 10.1016/j.smallrumres.2018.06.004; Upasna Sharma, 2012, International Journal of Animal and Veterinary Advances, V4, P272; Wang L, 2015, ASIAN AUSTRAL J ANIM, V28, P1235, DOI 10.5713/ajas.15.0172; Wang X, 2012, MOL BIOL REP, V39, P10525, DOI 10.1007/s11033-012-1937-9; Xiong Q, 2016, LIVEST SCI, V193, P71, DOI 10.1016/j.livsci.2016.10.002; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087218; Zhang RQ, 2018, GENE, V643, P1, DOI 10.1016/j.gene.2017.12.002; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhou JP, 2011, GENET MOL RES, V10, P2511, DOI 10.4238/2011.October.13.8	46	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0248405	10.1371/journal.pone.0248405	http://dx.doi.org/10.1371/journal.pone.0248405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720948	Green Published, Green Submitted, gold			2022-12-26	WOS:000629667400016
J	Di Perna, G; Penner, F; Cofano, F; De Marco, R; Baldassarre, BM; Portonero, I; Garbossa, D; Ceroni, L; Pecorari, G; Zenga, F				Di Perna, Giuseppe; Penner, Federica; Cofano, Fabio; De Marco, Raffaele; Baldassarre, Bianca Maria; Portonero, Irene; Garbossa, Diego; Ceroni, Luca; Pecorari, Giancarlo; Zenga, Francesco			Skull base reconstruction: A question of flow? A critical analysis of 521 endoscopic endonasal surgeries	PLOS ONE			English	Article								Introduction Post-operative CSF leak still represents the main drawback of Endoscopic Endonasal Approach (EEA), and different reconstructive strategies have been proposed in order to decrease its rate. Objective To critically analyze the effectiveness of different adopted reconstruction strategies in patients that underwent EEA. Materials and methods Adult patients with skull base tumor surgically treated with EEA were retrospectively analyzed. Data recorded for each case concerned patient demographics, type of surgical approach, histotype, anatomical site of surgical approach, intra-operative CSF leak grade (no leak (INL), low flow (ILFL), high flow (IHFL)), reconstructive adopted strategy, Lumbar Drain positioning, post-operative CSF leak rate and intra/post-operative complications. Results A total number of 521 patients (January 2012-December 2019) was included. Intra-operative CSF leak grade showed to be associated with post-operative CSF leak rate. In particular, the risk to observe a post-operative CSF leak was higher when IHFL was encountered (25,5%; Exp(B) 16.25). In particular, vascularized multilayered reconstruction and fat use showed to be effective in lowering post-operative CSF leaks in IHFL (p 0.02). No differences were found considering INL and ILFL groups. Yearly post-operative CSF leak rate analysis showed a significative decreasing trend. Conclusion Intra-operative CSF leak grade strongly affected post-operative CSF leak rate. Multilayer reconstruction with fat and naso-septal flap could reduce the rate of CSF leak in high risk patients. Reconstructive strategies should be tailored according also to the type and the anatomical site of the approach.	[Di Perna, Giuseppe; Penner, Federica; Cofano, Fabio; De Marco, Raffaele; Baldassarre, Bianca Maria; Portonero, Irene; Garbossa, Diego; Zenga, Francesco] Univ Turin, Dept Neurosci Rita Levi Montalcini, Neurosurg Unit, Turin, Italy; [Cofano, Fabio] Humanitas Gradenigo Hosp, Spine Surg Unit, Turin, Italy; [Ceroni, Luca] Univ Turin, Psychol Dept, Psychol Sci & Tech, Turin, Italy; [Pecorari, Giancarlo] Univ Turin, Dept Surg Sci, ENT Surg Unit, Turin, Italy	University of Turin; Humanitas Hospital Gradenigo; University of Turin; University of Turin	Cofano, F (corresponding author), Univ Turin, Dept Neurosci Rita Levi Montalcini, Neurosurg Unit, Turin, Italy.; Cofano, F (corresponding author), Humanitas Gradenigo Hosp, Spine Surg Unit, Turin, Italy.	fabio.cofano@gmail.com	Cofano, Fabio/AAE-4223-2022	De Marco, Raffaele/0000-0001-5187-4689; Di Perna, Giuseppe/0000-0002-7381-9194				A M., 2012, J NEUROLOGICAL SURG; Banu MA, 2014, J NEUROSURG, V121, P961, DOI 10.3171/2014.5.JNS132028; Barazi SA, 2013, BRIT J NEUROSURG, V27, P374, DOI 10.3109/02688697.2012.741739; Cappabianca P, 2004, NEUROSURGERY, V55, P933, DOI 10.1227/01.NEU.0000137330.02549.0D; Cappabianca P, 2002, NEUROSURGERY, V51, P1365, DOI 10.1227/01.NEU.0000035904.77559.9F; Castelnuovo P, 2006, RHINOLOGY, V44, P2; Cavallo LM., 2005, NEUROSURG FOCUS, DOI [10.3171/foc.2005.19.1.3, DOI 10.3171/FOC.2005.19.1.3]; Cavallo LM, 2019, WORLD NEUROSURG, V126, P439, DOI 10.1016/j.wneu.2019.03.125; Cavallo LM, 2014, WORLD NEUROSURG, V82, pE479, DOI 10.1016/j.wneu.2013.01.017; Cavallo LM, 2007, J NEUROSURG, V107, P713, DOI 10.3171/JNS-07/10/0713; Conger A, 2019, J NEUROSURG, V130, P861, DOI 10.3171/2017.11.JNS172141; de Divitiis E, 2007, NEUROSURGERY, V60, P46, DOI 10.1227/01.NEU.0000249211.89096.25; Dehdashti AR, 2008, NEUROSURGERY, V62, P1006, DOI 10.1227/01.neu.0000325862.83961.12; Eloy JA, 2012, INT FORUM ALLERGY RH, V2, P397, DOI 10.1002/alr.21040; Esposito F, 2007, NEUROSURGERY, V60, P295, DOI 10.1227/01.NEU.0000255354.64077.66; Fernandez-Miranda JC, 2012, HEAD NECK-J SCI SPEC, V34, P1036, DOI 10.1002/hed.21771; Garcia-Navarro V, 2013, WORLD NEUROSURG, V80, P563, DOI 10.1016/j.wneu.2011.08.034; Gardner PA, 2008, NEUROSURGERY, V63, P36, DOI 10.1227/01.NEU.0000335069.30319.1E; H T, 2015, WORLD NEUROSURG; Hadad G, 2006, LARYNGOSCOPE, V116, P1882, DOI 10.1097/01.mlg.0000234933.37779.e4; Kassam Amin, 2005, Neurosurg Focus, V19, pE8; Kassam AB, 2008, NEUROSURGERY, V63, P44, DOI 10.1227/01.NEU.0000297074.13423.F5; Kassam AB, 2011, J NEUROSURG, V114, P1544, DOI 10.3171/2010.10.JNS09406; Koutourousiou M, 2012, NEUROSURGERY, V71, P614, DOI 10.1227/NEU.0b013e31825ea3e0; Koutourousiou M, 2011, OTOLARYNG CLIN N AM, V44, P1155, DOI 10.1016/j.otc.2011.06.002; Leng LZ, 2008, NEUROSURGERY, V62, P342, DOI [10.1227/01.NEU.0000312720.93685.17, 10.1227/01.neu.0000326017.84315.1f]; Li Z, 2018, J CRANIOFAC SURG, V29, P193, DOI 10.1097/SCS.0000000000004184; Mazzatenta D, 2020, WORLD NEUROSURG, V134, pE277, DOI 10.1016/j.wneu.2019.10.039; McCoul ED, 2014, WORLD NEUROSURG, V81, P136, DOI 10.1016/j.wneu.2012.08.011; Nishioka H, 2005, ACTA NEUROCHIR, V147, P1163, DOI 10.1007/s00701-005-0586-3; Ogiwara T, 2019, NEUROSURG REV, V42, P683, DOI 10.1007/s10143-018-1006-5; Patel MR, 2010, SKULL BASE-INTERD AP, V20, P397, DOI 10.1055/s-0030-1253573; Pennacchietti V, 2016, WORLD NEUROSURG, V89, P121, DOI 10.1016/j.wneu.2016.01.049; Scheithauer S, 2010, INFECTION, V38, P205, DOI 10.1007/s15010-010-0006-3; Sigler AC, 2017, OTOLARYNG CLIN N AM, V50, P643, DOI 10.1016/j.otc.2017.01.015; Snyderman CH, 2020, J NEURO-ONCOL, V150, P463, DOI 10.1007/s11060-020-03465-0; Snyderman CH, 2011, OTOLARYNG CLIN N AM, V44, P1223, DOI 10.1016/j.otc.2011.06.014; Snyderman CH., 2019, WORLD NEUROSURG, V135, P439, DOI [10.1016/j.wneu.2014.07.004, DOI 10.1016/J.WNEU.2014.07.004]; Tardivo V, 2020, PITUITARY, V23, P92, DOI 10.1007/s11102-019-01014-1; Turri-Zanoni M, 2018, WORLD NEUROSURG, V116, pE436, DOI 10.1016/j.wneu.2018.04.225; Villaret AB, 2011, SKULL BASE-INTERD AP, V21, P185, DOI 10.1055/s-0031-1275260; Wang EW, 2019, INT FORUM ALLERGY RH, V9, pS145, DOI 10.1002/alr.22326; Wormald PJ, 2003, AM J RHINOL, V17, P299, DOI 10.1177/194589240301700508; Zanation AM, 2009, AM J RHINOL ALLERGY, V23, P518, DOI 10.2500/ajra.2009.23.3378; Zenga F, 2016, J NEUROL SURG REP, V77, pE50, DOI 10.1055/s-0035-1570388; Zwagerman NT, 2019, J NEUROSURG, V131, P1172, DOI 10.3171/2018.4.JNS172447; Zwagerman NT, 2016, J NEURO-ONCOL, V130, P319, DOI 10.1007/s11060-016-2274-y	47	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0245119	10.1371/journal.pone.0245119	http://dx.doi.org/10.1371/journal.pone.0245119			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720937	Green Published, gold			2022-12-26	WOS:000629667400041
J	Ding, ZH; Xu, XP; Wang, TR; Liang, X; Ran, ZH; Lu, H				Ding, Zhao-Hui; Xu, Xiao-Ping; Wang, Tian-Rong; Liang, Xiao; Ran, Zhi-Hua; Lu, Hong			The prevalence of Helicobacter pylori infection in inflammatory bowel disease in China: A case-control study	PLOS ONE			English	Article								Background & aims Helicobacter pylori (H. pylori) infection remains high in China though the incidence of inflammatory bowel disease (IBD) has increased. Our aim was to investigate the relationship between the prevalence of H. pylori and inflammatory bowel disease. Methods Hospitalized IBD patients including Crohn's disease (CD) and ulcerative colitis (UC) who had tested H. pylori antibody were enrolled. Controls were chose from age- and sex- matched healthy physical examination people who had H. pylori antibody test in a 1:2 fashion (IBD patients:controls). IBD medical history was recorded. All patients were typed by the Montreal classification. Mayo Clinic score and the Harvey-Bradshaw Severity Index were used to evaluate their disease activity. Patients and controls that had H. pylori eradication therapy before were excluded. Results Two hundred and sixty IBD patients including 213 CD patients and 47 UC patients, and 520 controls were involved in this study. The prevalence of H. pylori infection in IBD patients (9.6%, 25/260) and IBD newly diagnosed patients (12.1%, 8/66), as well as CD patients (8.9%, 19/213) including CD newly diagnosed patients (10.6%, 5/47) and UC patients (12.8%, 6/47) was significantly lower than controls (29.8%, 155/520) (p = 2.796*10(-10), 0.007, 5.723*10(-9), 0.016, 0.014), while there was no statistically difference between UC newly diagnosed patients and the controls, and IBD patients with different disease type, disease activity and treatment history. Conclusions H. pylori infection had a negative association with IBD, especially CD.	[Ding, Zhao-Hui; Wang, Tian-Rong; Liang, Xiao; Ran, Zhi-Hua; Lu, Hong] Shanghai Jiao Tong Univ, Key Lab Gastroenterol & Hepatol, Div Gastroenterol & Hepatol, Minist Hlth,Sch Med,Shanghai Inst Digest Dis,RenJ, Shanghai, Peoples R China; [Xu, Xiao-Ping] Shanghai Jiao Tong Univ, RenJi Hosp, Sch Med, Clin Biochem Lab, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Lu, H (corresponding author), Shanghai Jiao Tong Univ, Key Lab Gastroenterol & Hepatol, Div Gastroenterol & Hepatol, Minist Hlth,Sch Med,Shanghai Inst Digest Dis,RenJ, Shanghai, Peoples R China.	hlu@sjtu.edu.cn			National Natural Science Foundation of China [81970497]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Hong Lu(HL) was funded by National Natural Science Foundation of China (81970497). URL: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell SJ, 2003, ALIMENT PHARM THER, V18, P481, DOI 10.1046/j.1365-2036.2003.01703.x; Castano-Rodriguez N, 2017, GUT, V66, P235, DOI 10.1136/gutjnl-2015-310545; Chinese Society of Inflammatory Bowel Disease, 2018, CHIN J DIG, V2, P173; D'Haens G, 2007, GASTROENTEROLOGY, V132, P763, DOI 10.1053/j.gastro.2006.12.038; Frost F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56631-4; HARVEY RF, 1980, LANCET, V1, P514; Higgins PDR, 2011, INFLAMM BOWEL DIS, V17, P1398, DOI 10.1002/ibd.21489; Hooi JKY, 2017, GASTROENTEROLOGY, V153, P420, DOI 10.1053/j.gastro.2017.04.022; Kaplan GG, 2017, GASTROENTEROLOGY, V152, P313, DOI 10.1053/j.gastro.2016.10.020; Leja M, 2019, HELICOBACTER, V24, DOI 10.1111/hel.12635; Liu WZ., 2017, CHIN J GASTROENTEROL, V22, P346, DOI [10.3760/cma.j.issn.0578-1426.2017.07.014, DOI 10.3760/CMA.J.ISSN.0578-1426.2017.07.014]; Luther J, 2011, GUT, V60, P1479, DOI 10.1136/gut.2010.220087; Luther J, 2010, INFLAMM BOWEL DIS, V16, P1077, DOI 10.1002/ibd.21116; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Rizzello F, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051033; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Smolka AJ, 2017, CURR TOP MICROBIOL, V400, P227, DOI 10.1007/978-3-319-50520-6_10; Sonnenberg A, 2020, DIGEST DIS SCI, V65, P2373, DOI 10.1007/s10620-019-05972-1; Tepler A, 2019, ALIMENT PHARM THER, V50, P121, DOI 10.1111/apt.15306; Van Limbergen J, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.27; Yang XiaoPing, 2018, Chinese Journal of Nosocomiology, V28, P3068; Zhang W., 2010, MOD DIG INTERVEN, V15, P265, DOI DOI 10.3969/J.ISSN.1672-2159.2010.05.001	23	6	6	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0248427	10.1371/journal.pone.0248427	http://dx.doi.org/10.1371/journal.pone.0248427			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711050	gold, Green Published			2022-12-26	WOS:000629591800049
J	Jia, ZL; Li, YY				Jia, Zelin; Li, Yinyun			A possible mechanism for neurofilament slowing down in myelinated axon: Phosphorylation-induced variation of NF kinetics	PLOS ONE			English	Article							TRANSPORT; SITES	Neurofilaments(NFs) are the most abundant intermediate filaments that make up the inner volume of axon, with possible phosphorylation on their side arms, and their slow axonal transport by molecular motors along microtubule tracks in a "stop-and-go" manner with rapid, intermittent and bidirectional motion. The kinetics of NFs and morphology of axon are dramatically different between myelinate internode and unmyelinated node of Ranvier. The NFs in the node transport as 7.6 times faster as in the internode, and the distribution of NFs population in the internode is 7.6 folds as much as in the node of Ranvier. We hypothesize that the phosphorylation of NFs could reduce the on-track rate and slow down their transport velocity in the internode. By modifying the '6-state' model with (a) an extra phosphorylation kinetics to each six state and (b) construction a new '8-state' model in which NFs at off-track can be phosphorylated and have smaller on-track rate, our model and simulation demonstrate that the phosphorylation-induced decrease of on-track rate could slow down the NFs average velocity and increase the axonal caliber. The degree of phosphorylation may indicate the extent of velocity reduction. The Continuity equation used in our paper predicts that the ratio of NFs population is inverse proportional to the ratios of average velocity of NFs between node of Ranvier and internode. We speculate that the myelination of axon could increase the level of phosphorylation of NF side arms, and decrease the possibility of NFs to get on-track of microtubules, therefore slow down their transport velocity. In summary, our work provides a potential mechanism for understanding the phosphorylation kinetics of NFs in regulating their transport and morphology of axon in myelinated axons, and the different kinetics of NFs between node and internode.	[Jia, Zelin; Li, Yinyun] Beijing Normal Univ, Sch Syst Sci, Beijing, Peoples R China	Beijing Normal University	Li, YY (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing, Peoples R China.	yinyun@bnu.edu.cn		Li, Yinyun/0000-0002-8286-160X	National Key R&D Program of China [2019 YFA0709503]; Beijing high-level discipline construction project -cognitive neuroscience; China National Science Foundation [31601145]	National Key R&D Program of China; Beijing high-level discipline construction project -cognitive neuroscience; China National Science Foundation(National Natural Science Foundation of China (NSFC))	This research is supported by National Key R&D Program of China (No. 2019 YFA0709503), Beijing high-level discipline construction project -cognitive neuroscience, and China National Science Foundation (No. 31601145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley S, 2003, J CELL BIOL, V161, P489, DOI 10.1083/jcb.200303138; Brown A, 2000, NAT REV MOL CELL BIO, V1, P153, DOI 10.1038/35040102; Brown A, 2005, MOL BIOL CELL, V16, P4243, DOI 10.1091/mbc.E05-02-0141; Brown A, 2003, J CELL BIOL, V160, P817, DOI 10.1083/jcb.200212017; Brown A, 2003, METHOD CELL BIOL, V71, P305, DOI 10.1016/S0091-679X(03)01014-8; Brown A, 2009, ENCY NEUROSCIENCE, V9, P1, DOI [10.1016/B978-008045046-9.02000-3, DOI 10.1016/B978-008045046-9.02000-3]; Craciun G, 2005, J THEOR BIOL, V237, P316, DOI 10.1016/j.jtbi.2005.04.018; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; HOFFMAN PN, 1984, J CELL BIOL, V99, P705, DOI 10.1083/jcb.99.2.705; HOFFMAN PN, 1985, J NEUROSCI, V5, P2920; Hoffman PN, 1995, NEUROSCIENTIST, V1, P76; JULIEN JP, 1982, J BIOL CHEM, V257, P467; JULIEN JP, 1983, BIOCHIM BIOPHYS ACTA, V755, P25, DOI 10.1016/0304-4165(83)90268-4; Jung C, 2000, BRAIN RES, V856, P12, DOI 10.1016/S0006-8993(99)02314-8; Jung CW, 1999, CELL MOTIL CYTOSKEL, V42, P230, DOI 10.1002/(SICI)1097-0169(1999)42:3<230::AID-CM6>3.3.CO;2-1; Jung P, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046002; Kushkuley J, 2009, J CELL SCI, V122, P3579, DOI 10.1242/jcs.051318; Lariviere RC, 2004, J NEUROBIOL, V58, P131, DOI 10.1002/neu.10270; Lee S, 2011, CYTOSKELETON, V68, P8, DOI 10.1002/cm.20488; Li YY, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/2/026001; Li YY, 2012, J NEUROSCI, V32, P746, DOI 10.1523/JNEUROSCI.4926-11.2012; Marszalek JR, 1996, J CELL BIOL, V135, P711, DOI 10.1083/jcb.135.3.711; MATA M, 1992, J NEUROCYTOL, V21, P199, DOI 10.1007/BF01194978; Monsma PC, 2014, J NEUROSCI, V34, P2979, DOI 10.1523/JNEUROSCI.4502-13.2014; NIXON RA, 1994, J CELL BIOL, V126, P1031, DOI 10.1083/jcb.126.4.1031; Rao MV, 2002, J CELL BIOL, V158, P681, DOI 10.1083/jcb.200202037; Rao MV, 2003, J CELL BIOL, V163, P1021, DOI 10.1083/jcb.200308076; Sanchez I, 2000, J CELL BIOL, V151, P1013, DOI 10.1083/jcb.151.5.1013; Sanchez I, 1996, J NEUROSCI, V16, P5095; Shea TB, 2003, TRENDS NEUROSCI, V26, P397, DOI 10.1016/S0166-2236(03)00199-1; Shea TB, 2008, EUR J NEUROSCI, V27, P1893, DOI 10.1111/j.1460-9568.2008.06165.x; Trivedi N, 2007, J NEUROSCI, V27, P507, DOI 10.1523/JNEUROSCI.4227-06.2007; Walker CL, 2019, J NEUROSCI, V39, P663, DOI 10.1523/JNEUROSCI.2272-18.2018; Wang L, 2000, NAT CELL BIOL, V2, P137, DOI 10.1038/35004008; Wang L, 2001, MOL BIOL CELL, V12, P3257, DOI 10.1091/mbc.12.10.3257; WEISS PA, 1971, P NATL ACAD SCI USA, V68, P846, DOI 10.1073/pnas.68.4.846; Xu ZS, 2000, BRAIN RES, V866, P326, DOI 10.1016/S0006-8993(00)02390-8; XU ZS, 1992, J BIOL CHEM, V267, P4467; Yabe JT, 2000, CELL MOTIL CYTOSKEL, V45, P249, DOI 10.1002/(SICI)1097-0169(200004)45:4<249::AID-CM1>3.0.CO;2-M; Yabe JT, 2001, J NEUROSCI, V21, P2195; Yan YP, 2005, J NEUROSCI, V25, P7014, DOI 10.1523/JNEUROSCI.2001-05.2005; Yin XH, 1998, J NEUROSCI, V18, P1953, DOI 10.1523/jneurosci.18-06-01953.1998; Yuan AD, 2006, NEUROSCI LETT, V393, P264, DOI 10.1016/j.neulet.2005.10.029; Yuan AD, 2012, J CELL SCI, V125, P3257, DOI 10.1242/jcs.104729	44	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0247656	10.1371/journal.pone.0247656	http://dx.doi.org/10.1371/journal.pone.0247656			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711034	gold, Green Published			2022-12-26	WOS:000629591800048
J	Thomsen, MS; Humle, N; Hede, E; Moos, T; Burkhart, A; Thomsen, LB				Thomsen, Maj Schneider; Humle, Nanna; Hede, Eva; Moos, Torben; Burkhart, Annette; Thomsen, Louiza Bohn			The blood-brain barrier studied in vitro across species	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; MODEL; PERICYTES; EXPRESSION; PROTEINS; ALPHA	The blood-brain barrier (BBB) is formed by brain capillary endothelial cells (BECs) supported by pericytes and astrocytes. The BBB maintains homeostasis and protects the brain against toxic substances circulating in the blood, meaning that only a few drugs can pass the BBB. Thus, for drug screening, understanding cell interactions, and pathology, in vitro BBB models have been developed using BECs from various animal sources. When comparing models of different species, differences exist especially in regards to the transendothelial electrical resistance (TEER). Thus, we compared primary mice, rat, and porcine BECs (mBECs, rBECs, and pBECs) cultured in mono- and co-culture with astrocytes, to identify species-dependent differences that could explain the variations in TEER and aid to the selection of models for future BBB studies. The BBB models based on primary mBECs, rBECs, and pBECs were evaluated and compared in regards to major BBB characteristics. The barrier integrity was evaluated by the expression of tight junction proteins and measurements of TEER and apparent permeability (Papp). Additionally, the cell size, the functionality of the P-glycoprotein (P-gp) efflux transporter, and the expression of the transferrin receptor were evaluated and compared. Expression and organization of tight junction proteins were in all three species influenced by co-culturing, supporting the findings, that TEER increases after co-culturing with astrocytes. All models had functional polarised P-gp efflux transporters and expressed the transferrin receptor. The most interesting discovery was that even though the pBECs had higher TEER than rBECs and mBECs, the Papp did not show the same variation between species, which could be explained by a significantly larger cell size of pBECs. In conclusion, our results imply that the choice of species for a given BBB study should be defined from its purpose, instead of aiming to reach the highest TEER, as the models studied here revealed similar BBB properties.	[Thomsen, Maj Schneider; Humle, Nanna; Hede, Eva; Moos, Torben; Burkhart, Annette; Thomsen, Louiza Bohn] Aalborg Univ, Dept Hlth Sci & Technol Neurobiol Res & Drug Deli, Aalborg, Denmark	Aalborg University	Burkhart, A (corresponding author), Aalborg Univ, Dept Hlth Sci & Technol Neurobiol Res & Drug Deli, Aalborg, Denmark.	abl@hst.aau.dk		Moos, Torben/0000-0001-9989-0207; Thomsen, Maj Schneider/0000-0002-8385-7039; Larsen, Annette Burkhart/0000-0003-2086-4693; Thomsen, Louiza Bohn/0000-0002-3144-7150	Fonden til Laegevidenskabens Fremme; Kong Christian d. X Fond; Fhv. Dir. Leo Nielsen og Hustru Karen Margrethe Nielsens Legat for Laegevidenskabelig Grundforskning; Augustinus fonden; Danielsens fond; Lundbeck Foundation Research Initiative on Brain Barriers and Drug Delivery [R155-2013-14113]	Fonden til Laegevidenskabens Fremme; Kong Christian d. X Fond; Fhv. Dir. Leo Nielsen og Hustru Karen Margrethe Nielsens Legat for Laegevidenskabelig Grundforskning; Augustinus fonden; Danielsens fond; Lundbeck Foundation Research Initiative on Brain Barriers and Drug Delivery	The work was supported by grants from Fonden til Laegevidenskabens Fremme (https://www.apmollerfonde.dk/ansoegning/laegefonden/) (MST, NH, AB, LBT), Kong Christian d. X Fond (http://kongehuset.dk/node/5556) (NH), Fhv. Dir. Leo Nielsen og Hustru Karen Margrethe Nielsens Legat for Laegevidenskabelig Grundforskning (https://www.njordlaw.com/da/om-njord/fonde-oglegater/fhv-dir-leo-nielsen-og-hustru-karen-margrethe-nielsens-legat-for-laegevidenskabeliggrundforskning/) (MST), Augustinus fonden (https://augustinusfonden.dk/) (AB, LBT), Danielsens fond (https://danielsensfond.dk/)(AB, LBT), the Lundbeck Foundation Research Initiative on Brain Barriers and Drug Delivery (Grant no. R155-2013-14113) (https://www.lundbeckfonden.com/) (TM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2013, J INHERIT METAB DIS, V36, P437, DOI 10.1007/s10545-013-9608-0; Abbott NJ, 2012, METHODS MOL BIOL, V814, P415, DOI 10.1007/978-1-61779-452-0_28; Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bernard-Patrzynski F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226302; Bernas MJ, 2010, NAT PROTOC, V5, P1265, DOI 10.1038/nprot.2010.76; Burkhart A, 2017, CELL MOL LIFE SCI, V74, P2467, DOI 10.1007/s00018-017-2501-5; Burkhart A, 2016, MOL NEUROBIOL, V53, P7237, DOI 10.1007/s12035-015-9582-7; Burkhart A, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/s12987-015-0015-9; Campisi M, 2018, BIOMATERIALS, V180, P117, DOI 10.1016/j.biomaterials.2018.07.014; Campos-Bedolla P, 2014, ARCH MED RES, V45, P610, DOI 10.1016/j.arcmed.2014.11.018; Carl SM, 2010, MOL PHARMACEUT, V7, P1057, DOI 10.1021/mp900178j; Czupalla CJ, 2014, METHODS MOL BIOL, V1135, P415, DOI 10.1007/978-1-4939-0320-7_34; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; DEHOUCK MP, 1990, J NEUROCHEM, V54, P1798, DOI 10.1111/j.1471-4159.1990.tb01236.x; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; DOROVINIZIS K, 1991, LAB INVEST, V64, P425; Fazakas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020758; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Galla HJ, 2018, J CONTROL RELEASE, V285, P172, DOI 10.1016/j.jconrel.2018.07.016; Greene C, 2019, FLUIDS BARRIERS CNS, V16, DOI 10.1186/s12987-019-0123-z; Gutmann H, 1999, DRUG METAB DISPOS, V27, P937; Haseloff RF, 2015, SEMIN CELL DEV BIOL, V38, P16, DOI 10.1016/j.semcdb.2014.11.004; Hatherell K, 2011, J NEUROSCI METH, V199, P223, DOI 10.1016/j.jneumeth.2011.05.012; Hayashi K, 2004, REGUL PEPTIDES, V123, P77, DOI 10.1016/j.regpep.2004.05.023; Hede E, 2021, J NEUROCHEM, V156, P290, DOI 10.1111/jnc.14982; Helgudottir SS, 2019, MOL NEUROBIOL, V56, P2362, DOI 10.1007/s12035-018-1241-3; Helms HC, 2016, J CEREBR BLOOD F MET, V36, P862, DOI 10.1177/0271678X16630991; Helms HC, 2014, AAPS J, V16, P1046, DOI 10.1208/s12248-014-9628-1; Helms HC, 2010, AAPS J, V12, P759, DOI 10.1208/s12248-010-9237-6; Heymans M, 2018, EUR J PHARM BIOPHARM, V127, P453, DOI 10.1016/j.ejpb.2018.03.007; Ishizaki T, 2003, EXP CELL RES, V290, P275, DOI 10.1016/S0014-4827(03)00354-9; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; Johnsen KB, 2019, PROG NEUROBIOL, V181, DOI 10.1016/j.pneurobio.2019.101665; Johnsen KB, 2018, THERANOSTICS, V8, P3416, DOI 10.7150/thno.25228; Johnsen KB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11220-1; Johnsen BKB, 2019, J CONTROL RELEASE, V295, P237, DOI 10.1016/j.jconrel.2019.01.005; Lelu S, 2017, IEEE T ULTRASON FERR, V64, P281, DOI 10.1109/TUFFC.2016.2597004; Lippmann ES, 2014, SCI REP-UK, V4, DOI 10.1038/srep04160; Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1602/neurorx.2.1.86; Markel SF, 2017, J NEUROCHEM, V140, P216, DOI 10.1111/jnc.13861; Mathiisen TM, 2010, GLIA, V58, P1094, DOI 10.1002/glia.20990; Miller DS, 2008, PHARMACOL REV, V60, P196, DOI 10.1124/pr.107.07109; Molino Y, 2014, JOVE-J VIS EXP, DOI 10.3791/51278; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Neuhaus W, 2017, NEURAL REGEN RES, V12, P1607, DOI 10.4103/1673-5374.217326; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Parran DK, 2005, NEUROTOXICOLOGY, V26, P77, DOI 10.1016/j.neuro.2004.07.003; Patabendige Adjanie, 2014, Curr Protoc Neurosci, V69, DOI 10.1002/0471142301.ns0327s69; Patabendige A, 2013, BRAIN RES, V1521, P1, DOI 10.1016/j.brainres.2012.06.057; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poller B, 2008, J NEUROCHEM, V107, P1358, DOI 10.1111/j.1471-4159.2008.05730.x; Qian TC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701679; Ribecco-Lutkiewicz M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19522-8; RUBIN LL, 1991, J CELL BIOL, V115, P1725, DOI 10.1083/jcb.115.6.1725; Ruck T, 2014, JOVE-J VIS EXP, DOI 10.3791/52204; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Saaby L, 2016, MOL PHARMACEUT, V13, P640, DOI 10.1021/acs.molpharmaceut.5b00874; Shayan G, 2011, EUR J PHARM SCI, V42, P148, DOI 10.1016/j.ejps.2010.11.005; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; Stamatovic SM, 2006, J BIOL CHEM, V281, P8379, DOI 10.1074/jbc.M513122200; TAOCHENG JH, 1987, J NEUROSCI, V7, P3293; Thomsen LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134765; Thomsen MS, 2017, J NEUROCHEM, V140, P741, DOI 10.1111/jnc.13747; Tietz S, 2015, J CELL BIOL, V209, P493, DOI 10.1083/jcb.201412147; Urich E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038149; Vandenhaute E, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-11; Veszelka S, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00166; Wang Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085234, 10.1371/journal.pone.0110024, 10.1371/journal.pone.0096339, 10.1371/journal.pone.0108223]; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Welser-Alves JV, 2014, METHODS MOL BIOL, V1135, P345, DOI 10.1007/978-1-4939-0320-7_28; Wilhelm I, 2011, ACTA NEUROBIOL EXP, V71, P113; Wuest DM, 2012, BIOTECHNOL J, V7, P409, DOI 10.1002/biot.201100189	79	8	9	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0236770	10.1371/journal.pone.0236770	http://dx.doi.org/10.1371/journal.pone.0236770			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711041	Green Published, Green Submitted, gold			2022-12-26	WOS:000629591800017
J	Alnajjar, S; Sitthicharoenchai, P; Gallup, J; Ackermann, M; Verhoeven, D				Alnajjar, Sarhad; Sitthicharoenchai, Panchan; Gallup, Jack; Ackermann, Mark; Verhoeven, David			Streptococcus pneumoniae serotype 22F infection in respiratory syncytial virus infected neonatal lambs enhances morbidity	PLOS ONE			English	Article								Respiratory syncytial virus (RSV) is the primary cause of viral bronchiolitis resulting in hospitalization and a frequent cause of secondary respiratory bacterial infection, especially by Streptococcus pneumoniae (Spn) in infants. While murine studies have demonstrated enhanced morbidity during a viral/bacterial co-infection, human meta-studies have conflicting results. Moreover, little knowledge about the pathogenesis of emerging Spn serotype 22F, especially the co-pathologies between RSV and Spn, is known. Here, colostrum-deprived neonate lambs were divided into four groups. Two of the groups were nebulized with RSV M37, and the other two groups were mock nebulized. At day three post-RSV infection, one RSV group (RSV/Spn) and one mock-nebulized group (Spn only) were inoculated with Spn intratracheally. At day six post-RSV infection, bacterial/viral loads were assessed along with histopathology and correlated with clinical symptoms. Lambs dually infected with RSV/Spn trended with higher RSV titers, but lower Spn. Additionally, lung lesions were observed to be more frequent in the RSV/Spn group characterized by increased interalveolar wall thickness accompanied by neutrophil and lymphocyte infiltration and higher myeloperoxidase. Despite lower Spn in lungs, co-infected lambs had more significant morbidity and histopathology, which correlated with a different cytokine response. Thus, enhanced disease severity during dual infection may be due to lesion development and altered immune responses rather than bacterial counts.	[Alnajjar, Sarhad; Sitthicharoenchai, Panchan; Gallup, Jack] Iowa State Univ, Coll Vet Med, Dept Vet Pathol, Ames, IA USA; [Alnajjar, Sarhad] Baghdad Univ, Coll Vet Med, Dept Vet Pathol, Baghdad, Iraq; [Alnajjar, Sarhad; Ackermann, Mark] Oregon State Univ, Carlson Coll Vet Med, Dept Biomed Sci, Corvallis, OR USA; [Verhoeven, David] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Preventat Med, Ames, IA 50011 USA	Iowa State University; University of Baghdad; Oregon State University; Iowa State University	Verhoeven, D (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Preventat Med, Ames, IA 50011 USA.	davidver@iastate.edu	Alnajjar, Sarhad/AAQ-2287-2021; Sitthicharoenchai, Panchan/AAW-8672-2021	Alnajjar, Sarhad/0000-0001-5060-8506; Sitthicharoenchai, Panchan/0000-0002-4412-7121; Verhoeven, David/0000-0002-0766-4606	Merck and Co.	Merck and Co.(Merck & Company)	DV received a investigator initiated grant from Merck and Co. for this study. Merck.com. They played no role in the design, evaluation, or writing of the study.	Aberle JH, 2004, CLIN EXP IMMUNOL, V137, P146, DOI 10.1111/j.1365-2249.2004.02504.x; Ackermann MR, 2014, ILAR J, V55, P4, DOI 10.1093/ilar/ilu003; Avadhanula V, 2007, J MED MICROBIOL, V56, P1133, DOI 10.1099/jmm.0.47086-0; Balsells E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177113; Basha S, 2017, J INFECT DIS, V215, P1321, DOI 10.1093/infdis/jix090; Bem RA, 2011, AM J PHYSIOL-LUNG C, V301, pL148, DOI 10.1152/ajplung.00065.2011; Berman-Rosa M, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2019-0377; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brealey JC, 2018, RESPIROLOGY, V23, P220, DOI 10.1111/resp.13179; Cui YDA, 2017, HUM VACC IMMUNOTHER, V13, P1229, DOI 10.1080/21645515.2016.1277300; de Roock S, 2013, J ALLERGY CLIN IMMUN, V132, P754, DOI 10.1016/j.jaci.2013.04.014; Demczuk WHB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178040; Deng Y, 2020, J VIROL, V94, DOI 10.1128/JVI.02161-19; Derscheid RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081472; Derscheid RJ, 2013, VIRUSES-BASEL, V5, P2881, DOI 10.3390/v5112881; Derscheid RJ, 2012, VIRUSES-BASEL, V4, P2359, DOI 10.3390/v4102359; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; Garedew L, 2010, AFR J MICROBIOL RES, V4, P14; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Griffiths C, 2017, CLIN MICROBIOL REV, V30, P277, DOI 10.1128/CMR.00010-16; Grosz Drew D, 2014, BMC Res Notes, V7, P158, DOI 10.1186/1756-0500-7-158; Halfhide CP, 2011, J INFECT DIS, V204, P451, DOI 10.1093/infdis/jir280; Hament JM, 2004, PEDIATR RES, V55, P972, DOI 10.1203/01.PDR.0000127431.11750.D9; Jacobs MR, 2008, CLIN INFECT DIS, V47, P1388, DOI 10.1086/592972; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Jaovisidha P, 1999, J IMMUNOL, V163, P2816; Altamirano-Lagos MJ, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00873; Kim YI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113100; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Kwon YS, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2897-4; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; MacIntyre CR, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3548-0; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Madhi SA, 2000, J PEDIATR-US, V137, P78, DOI 10.1067/mpd.2000.105350; McNamee LA, 2006, INFECT IMMUN, V74, P6707, DOI 10.1128/IAI.00789-06; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Moffitt KL, 2011, CELL HOST MICROBE, V9, P158, DOI 10.1016/j.chom.2011.01.007; Mora AL, 2018, MABS-AUSTIN, V10, P778, DOI 10.1080/19420862.2018.1470727; Mora AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143580; Moyes J, 2013, J INFECT DIS, V208, pS217, DOI 10.1093/infdis/jit479; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nguyen DT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127098; Carnalla-Barajas MN, 2017, INT J INFECT DIS, V58, P1, DOI 10.1016/j.ijid.2017.02.005; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Rijneveld AW, 2002, J INFECT DIS, V185, P91, DOI 10.1086/338122; Roymans D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00170-x; Rubins JB, 1997, INFECT IMMUN, V65, P2975, DOI 10.1128/IAI.65.7.2975-2977.1997; Rudd Jennifer M, 2016, J Infect Pulm Dis, V2, DOI 10.16966/2470-3176.114; Shibata T, 2020, J CLIN INVEST, V130, P3021, DOI 10.1172/JCI125505; Smith AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003238; Smith CM, 2014, AM J RESP CRIT CARE, V190, P196, DOI 10.1164/rccm.201311-2110OC; Taylor G, 2017, VACCINE, V35, P469, DOI 10.1016/j.vaccine.2016.11.054; Thorburn K, 2006, THORAX, V61, P611, DOI 10.1136/thx.2005.048397; van Schaik SM, 2000, J MED VIROL, V62, P257, DOI 10.1002/1096-9071(200010)62:2<257::AID-JMV19>3.0.CO;2-M; Verhoeven D, 2019, VIRAL IMMUNOL, V32, P76, DOI 10.1089/vim.2018.0121; Verhoeven D, 2019, J LEUKOCYTE BIOL, V106, P301, DOI 10.1002/JLB.MR0518-204RR; Verhoeven D, 2014, CLIN INFECT DIS, V59, P376, DOI 10.1093/cid/ciu303; Vissers M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1454-x; Watson M, 2006, CLIN INFECT DIS, V42, P211, DOI 10.1086/498897; Weinberger DM, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001776; Weinberger DM, 2014, CLIN INFECT DIS, V58, P188, DOI 10.1093/cid/cit721; Weiser JN, 2018, NAT REV MICROBIOL, V16, P354, DOI 10.1038/s41579-018-0001-8; Xiang Y, 2017, INNATE IMMUN-LONDON, V23, P296, DOI 10.1177/1753425917693907; Zaghawa AHH, 2010, MINUFIYA VET J, V7, P93; Zhou H, 2012, EMERG INFECT DIS, V18, P294, DOI 10.3201/eid1802.102025	65	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0235026	10.1371/journal.pone.0235026	http://dx.doi.org/10.1371/journal.pone.0235026			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705390	Green Published, gold, Green Submitted			2022-12-26	WOS:000629590400086
J	Campolina, JP; Coelho, SG; Belli, AL; Machado, FS; Pereira, LGR; Tomich, TR; Carvalho, WA; Silva, ROS; Voorsluys, AL; Jacob, DV; Campos, MM				Campolina, Joana Palhares; Coelho, Sandra Gesteira; Belli, Anna Luiza; Machado, Fernanda Samarini; Pereira, Luiz Gustavo R.; Tomich, Thierry R.; Carvalho, Wanessa A.; Silva, Rodrigo Otavio S.; Voorsluys, Alessandra L.; Jacob, David, V; Campos, Mariana Magalhaes			Effects of a blend of essential oils in milk replacer on performance, rumen fermentation, blood parameters, and health scores of dairy heifers	PLOS ONE			English	Article								The aim of this study was to evaluate how the inclusion of a blend of essential oils in milk replacer (MR) affects different outcomes of dairy heifers. The outcomes evaluated: feed intake, performance, body development, blood cells and metabolites, insulin-like growth factor-1 (IGF-1), rumen fermentation, fecal scores, and respiratory scores. All outcomes were evaluated during pre-weaning (4-60 d of age), and carry-over effects during post-weaning (61-90 d of age) periods. The experimental units utilized were 29 newborn Holstein x Gyr crossbred dairy heifers, with genetic composition of 5/8 or more Holstein and 3/8 or less Gyr and body weight (BW) at birth of 32.2 +/- 5.2 kg. Experimental units were assigned to either a control (CON, n = 15) or a blend of essential oil supplementation (BEO, n = 14) treatment, maintaining a balance of genetic composition. The BEO was supplemented in the MR with 1 g/d/calf of a blend of essential oils (Apex Calf, Adisseo, China) composed by plant extracts derived from anise, cinnamon, garlic, rosemary, and thyme. During the pre-weaning phase, all heifers were fed 5 L of MR/d reconstituted to 15% (dry matter basis), divided into two equal meals. Water and starter were provided ad libitum. During the post-weaning, animals received a maximum of 3 kg of starter/d, and ad libitum corn silage, divided into two meals. Feed intake, fecal and respiratory scores were evaluated daily. The BW was measured every three days, while body development was recorded weekly. Blood samples were collected on 0, 30, and 60 d of age for total blood cell count, weekly and on the weaning day to determinate ss-hydroxybutyrate, urea and glucose, and biweekly for IGF-1. Ruminal parameters (pH, volatile fatty acids, ammonia-N, and acetate:propionate proportion-C2:C3) were measured on days 14, 28, 42, 60, 74 and 90. A randomized complete block design with an interaction between treatment and week was the experimental method of choice to test the hypothesis of the BEO's effect on all outcomes. An ANOVA procedure was used for continuous outcomes, and a non-parametric test was used for the ordered categorical outcomes, both adopting a CI = 95%. Results indicated that there was not enough evidence to accept the alternative hypothesis of the effect of BEO in MR on feed intake, performance, body development, and blood metabolites during both pre-weaning and post-weaning periods. However, results indicated that the inclusion of BEO in MR significantly affects the proportion of C2:C3 during pre- and post-weaning (P = 0.05). Similarly, the effect was significant for basophil (P <= 0.001), and platelet (P = 0.04) counts pre-weaning. The interaction between week and treatment was also significant for lymphocytes (P <= 0.001), revealing a cumulative effect. Lastly, fecal scores were also significant (P = 0.04) during pre-weaning, with lower values for BEO. The BEO contributed to ruminal manipulation in pre-weaning and carry-over effects in post-weaning, immunity improvement, and decreased morbidity of neonatal diarrhea in the pre-weaning phase.	[Campolina, Joana Palhares; Coelho, Sandra Gesteira; Belli, Anna Luiza] Univ Fed Minas Gerais, Vet Sch, Dept Anim Sci, Belo Horizonte, MG, Brazil; [Machado, Fernanda Samarini; Pereira, Luiz Gustavo R.; Tomich, Thierry R.; Carvalho, Wanessa A.; Campos, Mariana Magalhaes] Brazilian Agr Res Corp EMBRAPA, Natl Ctr Res Dairy Cattle, Juiz De Fora, MG, Brazil; [Silva, Rodrigo Otavio S.] Univ Fed Minas Gerais, Vet Sch, Dept Vet Sci, Belo Horizonte, MG, Brazil; [Voorsluys, Alessandra L.; Jacob, David, V] Adisseo, Campinas, SP, Brazil	Universidade Federal de Minas Gerais; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Minas Gerais	Campos, MM (corresponding author), Brazilian Agr Res Corp EMBRAPA, Natl Ctr Res Dairy Cattle, Juiz De Fora, MG, Brazil.	mariana.campos@embrapa.br	Campos, Mariana Magalhães/CAA-0176-2022; Silva, Rodrigo/GXM-7197-2022	Campos, Mariana Magalhães/0000-0001-5332-6010; carvalho, wanessa/0000-0002-1346-5240; Palhares Campolina Diniz, Joana/0000-0002-7081-382X; Silva, Rodrigo Otavio Silveira/0000-0003-0074-2488	Brazilian Agricultural Research Corporation (EMBRAPA), Embrapa Dairy Cattle; Adisseo Company [20500.18/0005-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brasilia, Brazil); Instituto Nacional de Ciencia e Tecnologia Ciencia Animal (INCT, Vicosa, Brazil)	Brazilian Agricultural Research Corporation (EMBRAPA), Embrapa Dairy Cattle; Adisseo Company(Adisseo France S.A.S.); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brasilia, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia Ciencia Animal (INCT, Vicosa, Brazil)	This paper was financed by Brazilian Agricultural Research Corporation (EMBRAPA), Embrapa Dairy Cattle for funding this research and providing its facilities, and Adisseo Company for funding this research (project number: 20500.18/0005-2). Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brasilia, Brazil), Instituto Nacional de Ciencia e Tecnologia Ciencia Animal (INCT, Vicosa, Brazil) for granting the scholarship. Alessandra L. Voorsluys and David V. Jacob received salary from Adisseo Company. The specific roles of these authors are articulated in the 'author contributions' section. The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support.	Abd El-Hack ME, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9050210; Akbarian-Tefaghi M, 2018, J ANIM PHYSIOL AN N, V102, P630, DOI 10.1111/jpn.12842; AOAC, 2012, AOAC OFFICIAL ANAL M, V19th; Bacanli M, 2019, FOOD CHEM TOXICOL, V125, P462, DOI 10.1016/j.fct.2019.01.033; Bampidis VA, 2006, J VET MED A, V53, P154, DOI 10.1111/j.1439-0442.2006.00806.x; Barton MD, 2000, NUTR RES REV, V13, P279, DOI 10.1079/095442200108729106; Benchaar C, 2008, ANIM FEED SCI TECH, V145, P209, DOI 10.1016/j.anifeedsci.2007.04.014; Benesi FJ, 2012, PESQUI VET BRASIL, V32, P352, DOI 10.1590/S0100-736X2012000400013; Calsamiglia S, 2007, J DAIRY SCI, V90, P2580, DOI 10.3168/jds.2006-644; CHANEY AL, 1962, CLIN CHEM, V8, P130; Chapman CE, 2017, J DAIRY SCI, V100, P1712, DOI 10.3168/jds.2016-11893; Chapman CE, 2016, J DAIRY SCI, V99, P3607, DOI 10.3168/jds.2015-10582; Chase CCL, 2018, VET CLIN N AM-FOOD A, V34, P1, DOI 10.1016/j.cvfa.2017.10.006; Cobellis G, 2016, SCI TOTAL ENVIRON, V545, P556, DOI 10.1016/j.scitotenv.2015.12.103; Drackley JK, 2008, VET CLIN N AM-FOOD A, V24, P55, DOI 10.1016/j.cvfa.2008.01.001; Durmic Z, 2012, ANIM FEED SCI TECH, V176, P150, DOI 10.1016/j.anifeedsci.2012.07.018; Ebani VV, 2019, MOLECULES, V24, DOI 10.3390/molecules24050900; Edris AE, 2007, PHYTOTHER RES, V21, P308, DOI 10.1002/ptr.2072; Ferreira LS, 2011, ANIMAL, V5, P239, DOI 10.1017/S1751731110001965; Food and Drug Administration (FDA), 2015, VET FEED DIRECTIVE R; FRANK NA, 1993, J DAIRY SCI, V76, P1313, DOI 10.3168/jds.S0022-0302(93)77462-7; Gabbi A. M., 2009, Revista Brasileira de Saude e Producao Animal, V10, P917; Gomez-Garcia M, 2019, PORCINE HEALTH MANAG, V5, DOI 10.1186/s40813-019-0139-4; Ronquillo MG, 2017, FOOD CONTROL, V72, P255, DOI 10.1016/j.foodcont.2016.03.001; Greathead H, 2003, P NUTR SOC, V62, P279, DOI 10.1079/PNS2002197; Hao HH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00288; Heller MC, 2018, VET CLIN N AM-FOOD A, V34, P101, DOI 10.1016/j.cvfa.2017.08.001; Jeshari M, 2016, LIVEST SCI, V185, P117, DOI 10.1016/j.livsci.2015.12.011; Jouany JP, 2007, ANIMAL, V1, P1443, DOI 10.1017/S1751731107000742; Katsoulos PD, 2017, RES VET SCI, V115, P478, DOI 10.1016/j.rvsc.2017.07.029; Kazemi-Bonchenari M, 2018, J ANIM PHYSIOL AN N, V102, P652, DOI 10.1111/jpn.12867; Keeton STN, 2018, VET CLIN N AM-FOOD A, V34, P201, DOI 10.1016/j.cvfa.2017.10.009; KERR DE, 1991, CAN J ANIM SCI, V71, P695, DOI 10.4141/cjas91-085; Kertz AF, 2017, J DAIRY SCI, V100, P10151, DOI 10.3168/jds.2017-13062; Khan MA, 2007, J DAIRY SCI, V90, P5259, DOI 10.3168/jds.2007-0338; Khan MA, 2011, J DAIRY SCI, V94, P1071, DOI 10.3168/jds.2010-3733; Li SY, 2012, LIVEST SCI, V145, P119, DOI 10.1016/j.livsci.2012.01.005; Liu T, 2020, J DAIRY SCI, V103, P2315, DOI 10.3168/jds.2019-16647; McGuirk SM, 2008, VET CLIN N AM-FOOD A, V24, P139, DOI 10.1016/j.cvfa.2007.10.003; Meale SJ, 2017, J DAIRY SCI, V100, P5984, DOI 10.3168/jds.2016-12474; Mercati F, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10010149; Micciche A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01058; Miguel MG, 2010, MOLECULES, V15, P9252, DOI 10.3390/molecules15129252; Millet S, 2011, VET J, V187, P143, DOI 10.1016/j.tvjl.2010.05.001; Nazzaro F, 2013, PHARMACEUTICALS, V6, P1451, DOI 10.3390/ph6121451; Patra AK, 2012, APPL ENVIRON MICROB, V78, P4271, DOI 10.1128/AEM.00309-12; Perez-Roses R, 2015, J AGR FOOD CHEM, V63, P1496, DOI 10.1021/jf504761m; Puvaca N, 2019, WORLD POULTRY SCI J, V75, P235, DOI 10.1017/S0043933919000229; QUIGLEY JD, 1991, J DAIRY SCI, V74, P258, DOI 10.3168/jds.S0022-0302(91)78168-X; Ramos CP, 2019, CIENC RURAL, V49, DOI 10.1590/0103-8478cr20180788; Roland L, 2014, J VET DIAGN INVEST, V26, P592, DOI 10.1177/1040638714546490; Salazar LFL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216066; Salem AZM, 2012, ANIM FEED SCI TECH, V176, P1, DOI 10.1016/j.anifeedsci.2012.07.001; Santos FHR, 2015, ANIMAL, V9, P958, DOI 10.1017/S175173111500018X; Searcy GP., 2001, VET CLIN PATH, DOI [10.1016/B978-0-7216-6334-0.X5001-4, DOI 10.1016/B978-0-7216-6334-0.X5001-4]; Seirafy H, 2017, IRAN J APPL ANIM SCI, V7, P585; Simitzis Panagiotis E, 2017, Medicines (Basel), V4, DOI 10.3390/medicines4020035; Sneeringer S., 2015, USDA EC RES REP, V200; Arena JS, 2020, J PEST SCI, V93, P403, DOI 10.1007/s10340-019-01141-5; Sonmez Ozge, 2017, Porto Biomed J, V2, P311, DOI 10.1016/j.pbj.2017.05.005; Stamilla A, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10030442; Stevanovic ZD, 2018, MOLECULES, V23, DOI 10.3390/molecules23071717; Suarez-Mena FX, 2015, J DAIRY SCI, V98, P3417, DOI 10.3168/jds.2014-9193; Tian QY, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9100847; Vakili AR, 2013, ASIAN AUSTRAL J ANIM, V26, P935, DOI 10.5713/ajas.2012.12636; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Weiskopf K, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0031-2016; Wu JP, 2020, J DAIRY SCI, V103, P8119, DOI 10.3168/jds.2020-18211; Xiong WG, 2018, ENVIRON SCI POLLUT R, V25, P18377, DOI 10.1007/s11356-018-1852-2; Zeng ZK, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0004-5; Zhai H, 2020, ANIM FEED SCI TECH, V262, DOI 10.1016/j.anifeedsci.2020.114426; Zhai HX, 2018, ANIM NUTR, V4, P179, DOI 10.1016/j.aninu.2018.01.005	73	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0231068	10.1371/journal.pone.0231068	http://dx.doi.org/10.1371/journal.pone.0231068			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705410	gold, Green Published, Green Submitted			2022-12-26	WOS:000629590400083
J	McIntosh, AT; Wei, RHZ; Ahn, J; Aouizerat, BE; Kassaye, SG; Augenbraun, MH; Price, JC; French, AL; Gange, SJ; Anastos, KM; Goldman, R				McIntosh, Alec T.; Wei, Renhuizi; Ahn, Jaeil; Aouizerat, Brad E.; Kassaye, Seble G.; Augenbraun, Michael H.; Price, Jennifer C.; French, Audrey L.; Gange, Stephen J.; Anastos, Kathryn M.; Goldman, Radoslav			A genomic variant of ALPK2 is associated with increased liver fibrosis risk in HIV/HCV coinfected women	PLOS ONE			English	Article								HIV coinfection is associated with more rapid liver fibrosis progression in hepatitis C (HCV) infection. Recently, much work has been done to improve outcomes of liver disease and to identify targets for pharmacological intervention in coinfected patients. In this study, we analyzed clinical data of 1,858 participants from the Women's Interagency HIV Study (WIHS) to characterize risk factors associated with changes in the APRI and FIB-4 surrogate measurements for advanced fibrosis. We assessed 887 non-synonymous single nucleotide variants (nsSNV) in a subset of 661 coinfected participants for genetic associations with changes in liver fibrosis risk. The variants utilized produced amino acid substitutions that either altered an N-linked glycosylation (NxS/T) sequon or mapped to a gene related to glycosylation processes. Seven variants were associated with an increased likelihood of liver fibrosis. The most common variant, ALPK2 rs3809973, was associated with liver fibrosis in HIV/HCV coinfected patients; individuals homozygous for the rare C allele displayed elevated APRI (0.61, 95% CI, 0.334 to 0.875) and FIB-4 (0.74, 95% CI, 0.336 to 1.144) relative to those coinfected women without the variant. Although warranting replication, ALPK2 rs3809973 may show utility to detect individuals at increased risk for liver disease progression.	[McIntosh, Alec T.; Wei, Renhuizi; Goldman, Radoslav] Georgetown Univ, Dept Oncol, Washington, DC 20057 USA; [Ahn, Jaeil] Georgetown Univ, Med Ctr, Dept Biostat Bioinformat & Biomath, Washington, DC 20007 USA; [Aouizerat, Brad E.] NYU, Coll Dent, Bluestone Ctr Clin Res, New York, NY USA; [Kassaye, Seble G.] Georgetown Univ, Med Ctr, Dept Infect Dis, Washington, DC 20007 USA; [Augenbraun, Michael H.] Suny Downstate Med Ctr, Dept Med, Div Infect Dis, Brooklyn, NY 11203 USA; [Price, Jennifer C.] Univ Calif San Francisco, Dept Med, Div Liver Dis, San Francisco, CA 94143 USA; [French, Audrey L.] John H Stroger Jr Hosp Cook Cty, Dept Internal Med, Div Infect Dis, Chicago, IL USA; [Gange, Stephen J.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Anastos, Kathryn M.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Anastos, Kathryn M.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Goldman, Radoslav] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cell Biol, Washington, DC 20007 USA; [Goldman, Radoslav] Georgetown Univ, Med Ctr, Clin Translat Glycosci Res Ctr, Washington, DC 20007 USA	Georgetown University; Georgetown University; New York University; Georgetown University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of California System; University of California San Francisco; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Georgetown University; Georgetown University	Goldman, R (corresponding author), Georgetown Univ, Dept Oncol, Washington, DC 20057 USA.; Goldman, R (corresponding author), Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cell Biol, Washington, DC 20007 USA.; Goldman, R (corresponding author), Georgetown Univ, Med Ctr, Clin Translat Glycosci Res Ctr, Washington, DC 20007 USA.	rg26@georgetown.edu	Gange, Stephen/AGY-5004-2022	Gange, Stephen/0000-0001-7842-512X; Ahn, Jaeil/0000-0001-7998-4759; McIntosh, Alec/0000-0002-7764-3608	National Institutes of Health [R01CA135069, R01CA238455]; National Heart, Lung, and Blood Institute (NHLBI); Eunice Kennedy Shriver National Institute Of Child Health & Human Development (NICHD); National Human Genome Research Institute (NHGRI), National Institute On Aging (NIA); National Institute Of Dental & Craniofacial Research (NIDCR); National Institute Of Allergy And Infectious Diseases (NIAID); National Institute Of Neurological Disorders And Stroke (NINDS); National Institute Of Mental Health (NIMH); National Institute On Drug Abuse (NIDA); National Institute of Nursing Research (NINR); National Cancer Institute (NCI); National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute on Deafness and Other Communication Disorders (NIDCD); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); UCSF CTSA [UL1-TR000004]; Atlanta CFAR [P30-AI-050409]; UNC CFAR [P30-AI-050410]; UAB CFAR [P30-AI-027767]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Eunice Kennedy Shriver National Institute Of Child Health & Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Human Genome Research Institute (NHGRI), National Institute On Aging (NIA); National Institute Of Dental & Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute Of Allergy And Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute Of Neurological Disorders And Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute Of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute On Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Nursing Research (NINR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); UCSF CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Atlanta CFAR; UNC CFAR; UAB CFAR	Research reported in this publication was supported in part by the National Institutes of Health to RG (awards R01CA135069 and R01CA238455). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The MWCCS is funded primarily by the National Heart, Lung, and Blood Institute (NHLBI), with additional co-funding from the Eunice Kennedy Shriver National Institute Of Child Health & Human Development (NICHD), National Human Genome Research Institute (NHGRI), National Institute On Aging (NIA), National Institute Of Dental & Craniofacial Research (NIDCR), National Institute Of Allergy And Infectious Diseases (NIAID), National Institute Of Neurological Disorders And Stroke (NINDS), National Institute Of Mental Health (NIMH), National Institute On Drug Abuse (NIDA), National Institute of Nursing Research (NINR), National Cancer Institute (NCI), National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Deafness and Other Communication Disorders (NIDCD), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). MWCCS data collection is also supported by UL1-TR000004 (UCSF CTSA), P30-AI-050409 (Atlanta CFAR), P30-AI-050410 (UNC CFAR), and P30-AI-027767 (UAB CFAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avihingsanon A, 2014, J GASTROEN HEPATOL, V29, P1706, DOI 10.1111/jgh.12613; Bacon MC, 2005, CLIN DIAGN LAB IMMUN, V12, P1013, DOI 10.1128/CDLI.12.9.1013-1019.2005; Bouwman LH, 2005, GASTROENTEROLOGY, V129, P408, DOI 10.1053/j.gastro.2005.06.049; Brau N, 2006, J HEPATOL, V44, P47, DOI 10.1016/j.jhep.2005.07.006; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Cahill S, 2013, AM J PUBLIC HEALTH, V103, pE7, DOI 10.2105/AJPH.2012.301161; Chrysanthidis T, 2017, AIDS REV, V19, P148, DOI 10.24875/AIDSRev.M17000004; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Eisen S, 2008, FUTURE VIROL, V3, P225, DOI 10.2217/17460794.3.3.225; Fan Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22345-2; Frasco MA, 2012, AIDS, V26, P2097, DOI 10.1097/QAD.0b013e3283593602; French AL, 2017, JAIDS-J ACQ IMM DEF, V76, P438, DOI 10.1097/QAI.0000000000001524; Gupta P, 2014, VIROLOGY, V450, P336, DOI 10.1016/j.virol.2013.12.026; Hansen L, 2015, GLYCOBIOLOGY, V25, P211, DOI 10.1093/glycob/cwu104; Hayasaka H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117454; Henry Brandy, 2018, J Health Biomed Law, V14, P265; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Kuniholm MH, 2011, J INFECT DIS, V203, P1807, DOI 10.1093/infdis/jir192; Lee YA, 2015, GUT, V64, P830, DOI 10.1136/gutjnl-2014-306842; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Lledo GM, 2018, AIDS, V32, P2347, DOI 10.1097/QAD.0000000000001966; Mazumder R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036212; Mohsen AH, 2003, GUT, V52, P1035, DOI 10.1136/gut.52.7.1035; O'Rourke JM, 2018, WORLD J GASTROENTERO, V24, P4436, DOI 10.3748/wjg.v24.i39.4436; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Palmieri O, 2015, INFLAMM BOWEL DIS, V21, P1260, DOI 10.1097/MIB.0000000000000370; Papadopoulos N, 2019, ANN GASTROENTEROL, V32, P498, DOI 10.20524/aog.2019.0406; Rinkenberger N, 2018, MBIO, V9, DOI 10.1128/mBio.02314-17; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Ryazanov AG, 1999, CURR BIOL, V9, pR43, DOI 10.1016/S0960-9822(99)80006-2; Salmon-Ceron D, 2005, J HEPATOL, V42, P799, DOI 10.1016/j.jhep.2005.01.022; Sarkar M, 2015, J VIRAL HEPATITIS, V22, P1055, DOI 10.1111/jvh.12431; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Shendre A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188725; Sherman KE, 2017, HEPATOL COMMUN, V1, P987, DOI 10.1002/hep4.1112; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38; Urabe Y, 2013, J HEPATOL, V58, P875, DOI 10.1016/j.jhep.2012.12.024; Van Breedam W, 2014, FEMS MICROBIOL REV, V38, P598, DOI 10.1111/1574-6976.12052; Yoshida Y, 2012, ANTICANCER RES, V32, P2301; Yu Linda Chia-Hui, 2012, World J Gastrointest Pathophysiol, V3, P27, DOI 10.4291/wjgp.v3.i1.27; Zhan YT, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0040-3	43	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0247277	10.1371/journal.pone.0247277	http://dx.doi.org/10.1371/journal.pone.0247277			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705408	Green Published, Green Submitted, gold			2022-12-26	WOS:000629590400068
J	Shimoshige, H; Kobayashi, H; Shimamura, S; Mizuki, T; Inoue, A; Maekawa, T				Shimoshige, Hirokazu; Kobayashi, Hideki; Shimamura, Shigeru; Mizuki, Toru; Inoue, Akira; Maekawa, Toru			Isolation and cultivation of a novel sulfate-reducing magnetotactic bacterium belonging to the genus Desulfovibrio	PLOS ONE			English	Article								Magnetotactic bacteria (MTB) synthesize magnetosomes composed of membrane-enveloped magnetite (Fe3O4) and/or greigite (Fe3S4) nanoparticles in the cells. It is known that the magnetotactic Deltaproteobacteria are ubiquitous and inhabit worldwide in the sediments of freshwater and marine environments. Mostly known MTB belonging to the Deltaproteobacteria are dissimilatory sulfate-reducing bacteria that biomineralize bullet-shaped magnetite nanoparticles, but only a few axenic cultures have been obtained so far. Here, we report the isolation, cultivation and characterization of a dissimilatory sulfate-reducing magnetotactic bacterium, which we designate "strain FSS-1". We found that the strain FSS-1 is a strict anaerobe and uses casamino acids as electron donors and sulfate as an electron acceptor to reduce sulfate to hydrogen sulfide. The strain FSS-1 produced bullet-shaped magnetite nanoparticles in the cells and responded to external magnetic fields. On the basis of 16S rRNA gene sequence analysis, the strain FSS-1 is a member of the genus Desulfovibrio, showing a 96.7% sequence similarity to Desulfovibrio putealis strain B7-43(T). Futhermore, the magnetosome gene cluster of strain FSS-1 was different from that of Desulfovibrio magneticus strain RS-1. Thus, the strain FSS-1 is considered to be a novel sulfate-reducing magnetotactic bacterium belonging to the genus Desulfovibrio.	[Shimoshige, Hirokazu; Kobayashi, Hideki; Mizuki, Toru; Inoue, Akira; Maekawa, Toru] Toyo Univ, Bionano Elect Res Ctr, Kawagoe, Saitama, Japan; [Shimamura, Shigeru] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa, Japan; [Maekawa, Toru] Toyo Univ, Grad Sch Interdisciplinary New Sci, Kawagoe, Saitama, Japan	Toyo University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Toyo University	Shimoshige, H; Maekawa, T (corresponding author), Toyo Univ, Bionano Elect Res Ctr, Kawagoe, Saitama, Japan.; Maekawa, T (corresponding author), Toyo Univ, Grad Sch Interdisciplinary New Sci, Kawagoe, Saitama, Japan.	shimoshige552@toyo.jp; maekawa@toyo.jp		Shimoshige, Hirokazu/0000-0002-0583-6160				Abreu F, 2007, INT J SYST EVOL MICR, V57, P1318, DOI 10.1099/ijs.0.64857-0; Amann R, 2007, MAGNETORECEPTION MAG, P24; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; BAZYLINSKI DA, 1993, NATURE, V366, P218, DOI 10.1038/366218a0; Bazylinski DA, 2000, ENVIRON MICROBIOL, V2, P266, DOI 10.1046/j.1462-2920.2000.00096.x; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; Descamps ECT, 2017, SYST APPL MICROBIOL, V40, P280, DOI 10.1016/j.syapm.2017.05.001; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finster K, 2001, INT J SYST EVOL MICR, V51, P2055, DOI 10.1099/00207713-51-6-2055; Frankel RB, 1997, BIOPHYS J, V73, P994, DOI 10.1016/S0006-3495(97)78132-3; Hannon GJ, 2010, FASTX TOOLKIT FASTQ; Hanzlik M, 2002, J MAGN MAGN MATER, V248, P258, DOI 10.1016/S0304-8853(02)00353-0; Isambert A, 2007, AM MINERAL, V92, P621, DOI 10.2138/am.2007.2278; Ji BY, 2017, ENVIRON MICROBIOL, V19, P1103, DOI 10.1111/1462-2920.13637; Jogler C, 2011, P NATL ACAD SCI USA, V108, P1134, DOI 10.1073/pnas.1012694108; Jogler C, 2009, ANNU REV MICROBIOL, V63, P501, DOI 10.1146/annurev.micro.62.081307.162908; Jogler C, 2009, APPL ENVIRON MICROB, V75, P3972, DOI 10.1128/AEM.02701-08; Kolinko S, 2016, ENVIRON MICROBIOL, V18, P21, DOI 10.1111/1462-2920.12907; Kolinko S, 2012, ENVIRON MICROBIOL, V14, P1709, DOI 10.1111/j.1462-2920.2011.02609.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefevre CT, 2016, ENV MICROBIOL REP, V8, P1003, DOI 10.1111/1758-2229.12479; Lefevre CT, 2013, ENVIRON MICROBIOL, V15, P2712, DOI 10.1111/1462-2920.12128; Lefevre CT, 2011, EARTH PLANET SC LETT, V312, P194, DOI 10.1016/j.epsl.2011.10.003; Lefevre CT, 2011, SCIENCE, V334, P1720, DOI 10.1126/science.1212596; Lefevre CT, 2011, ENVIRON MICROBIOL, V13, P2342, DOI 10.1111/j.1462-2920.2011.02505.x; Li JH, 2020, J GEOPHYS RES-BIOGEO, V125, DOI 10.1029/2020JG005680; Li JH, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.00731-19; Li JH, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1288; Li JH, 2010, EARTH PLANET SC LETT, V293, P368, DOI 10.1016/j.epsl.2010.03.007; Lin W, 2018, ISME J, V12, P1508, DOI 10.1038/s41396-018-0098-9; Lin W, 2012, APPL ENVIRON MICROB, V78, P668, DOI 10.1128/AEM.06764-11; Lins U, 2007, GEOMICROBIOL J, V24, P43, DOI 10.1080/01490450601134317; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Liu PY, 2021, ENVIRON MICROBIOL, V23, P1115, DOI 10.1111/1462-2920.15254; MANN S, 1987, PROC R SOC SER B-BIO, V231, P477, DOI 10.1098/rspb.1987.0056; Miyazaki S, 2003, NUCLEIC ACIDS RES, V31, P13, DOI 10.1093/nar/gkg088; Monteil CL, 2019, NAT MICROBIOL, V4, P1088, DOI 10.1038/s41564-019-0432-7; Nakazawa H, 2009, GENOME RES, V19, P1801, DOI 10.1101/gr.088906.108; Pan YX, 2004, CHINESE SCI BULL, V49, P2563, DOI 10.1360/982004-153; Pan YX, 2005, EARTH PLANET SC LETT, V237, P311, DOI 10.1016/j.epsl.2005.06.029; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Pohl A, 2019, NANO LETT, V19, P8207, DOI 10.1021/acs.nanolett.9b03560; Posfai M, 2006, EARTH PLANET SC LETT, V249, P444, DOI 10.1016/j.epsl.2006.06.036; Qian XX, 2020, ENVIRON MICROBIOL, V22, P1481, DOI 10.1111/1462-2920.14710; Rabus R., 2013, PROKARYOTES PROKARYO, P309, DOI DOI 10.1007/978-3-642-30141-4_70; Rees GN, 1998, ARCH MICROBIOL, V169, P76; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAKAGUCHI T, 1993, NATURE, V365, P47, DOI 10.1038/365047a0; Sakaguchi T, 2002, INT J SYST EVOL MICR, V52, P215, DOI 10.1099/00207713-52-1-215; Sass A, 2002, ARCH MICROBIOL, V177, P468, DOI 10.1007/s00203-002-0415-5; Schueler D., 2002, International Microbiology, V5, P209; Schuler D, 2008, FEMS MICROBIOL REV, V32, P654, DOI 10.1111/j.1574-6976.2008.00116.x; Simmons SL, 2007, ENVIRON MICROBIOL, V9, P206, DOI 10.1111/j.1462-2920.2006.01129.x; SMITH RL, 1981, APPL ENVIRON MICROB, V42, P116, DOI 10.1128/AEM.42.1.116-121.1981; STAMS AJM, 1985, FEMS MICROBIOL ECOL, V31, P11, DOI 10.1016/0378-1097(85)90041-2; Takii S, 2003, J GEN APPL MICROBIOL, V49, P329, DOI 10.2323/jgam.49.329; Vali H., 1990, IRON BIOMINERALS, P97; Wang YZ, 2013, APPL ENVIRON MICROB, V79, P2813, DOI 10.1128/AEM.03635-12; Wenter R, 2009, ENVIRON MICROBIOL, V11, P1493, DOI 10.1111/j.1462-2920.2009.01877.x; WOLIN EA, 1963, J BIOL CHEM, V238, P2882; Zhou K, 2012, ENVIRON MICROBIOL, V14, P405, DOI 10.1111/j.1462-2920.2011.02590.x; Zhou K, 2011, CHIN J OCEANOL LIMN, V29, P246, DOI 10.1007/s00343-011-0032-8	66	4	4	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248313	10.1371/journal.pone.0248313	http://dx.doi.org/10.1371/journal.pone.0248313			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705469	Green Published, gold			2022-12-26	WOS:000629590400009
J	Goetz, SM; Steen, DA; Miller, MA; Guyer, C; Kottwitz, J; Roberts, JF; Blankenship, E; Pearson, PR; Warner, DA; Reed, RN				Goetz, Scott M.; Steen, David A.; Miller, Melissa A.; Guyer, Craig; Kottwitz, Jack; Roberts, John F.; Blankenship, Emmett; Pearson, Phillip R.; Warner, Daniel A.; Reed, Robert N.			Argentine Black and White Tegu (Salvator merianae) can survive the winter under semi-natural conditions well beyond their current invasive range	PLOS ONE			English	Article								The Argentine Black and White Tegu (Salvator merianae, formerly Tupinambis merianae) is a large lizard from South America. Now established and invasive in southern Florida, and it poses threats to populations of many native species. Models suggest much of the southern United States may contain suitable temperature regimes for this species, yet there is considerable uncertainty regarding either the potential for range expansion northward out of tropical and subtropical zones or the potential for the species establishing elsewhere following additional independent introductions. We evaluated survival, body temperature, duration and timing of winter dormancy, and health of wild-caught tegus from southern Florida held in semi-natural enclosures for over a year in Auburn, Alabama (> 900 km northwest of capture location). Nine of twelve lizards emerged from winter dormancy and seven survived the greater-than-one-year duration of the study. Average length of dormancy (176 d) was greater than that reported in the native range or for invasive populations in southern Florida and females remained dormant longer than males. Tegus grew rapidly throughout the study and the presence of sperm in the testes of males and previtellogenic or early vitellogenic follicles in female ovaries at the end of our study suggest the animals would have been capable of reproduction the following spring. The survival and overall health of the majority of adult tegus in our study suggests weather and climate patterns are unlikely to prevent survival following introduction in many areas of the United States far from their current invasive range.	[Goetz, Scott M.; Reed, Robert N.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA; [Steen, David A.] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, Gainesville, FL USA; [Miller, Melissa A.] Univ Florida, Ft Lauderdale Res & Educ Ctr, Dept Wildlife Ecol & Conservat, Davie, FL USA; [Guyer, Craig; Warner, Daniel A.] Auburn Univ, Coll Sci & Math, Dept Biol Sci, Auburn, AL 36849 USA; [Kottwitz, Jack] Auburn Univ, Coll Vet Med, Dept Anat Physiol & Pharmacol, Auburn, AL 36849 USA; [Roberts, John F.] Univ Florida, Coll Vet Med, Dept Comparat Diagnost & Populat Med, Gainesville, FL USA; [Blankenship, Emmett] All Pets Emergency & Referral Ctr, Alpharetta, GA USA; [Pearson, Phillip R.] Univ Canberra, Inst Appl Ecol, Ctr Conservat Ecol & Genet, Australian Capital City, Australia	United States Department of the Interior; United States Geological Survey; Florida Fish & Wildlife Conservation Commission; State University System of Florida; University of Florida; Auburn University System; Auburn University; Auburn University System; Auburn University; State University System of Florida; University of Florida; University of Canberra	Goetz, SM (corresponding author), US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA.	sgoetz@usgs.gov	Kottwitz, Jack/AIE-1039-2022	Pearson, Phillip/0000-0001-8109-7649; Miller, Melissa/0000-0002-6743-6808; Kottwitz, Jack/0000-0001-7227-8325; Goetz, Scott/0000-0002-8705-5316	U.S. Geological Survey (USGS) Greater Everglades Priority Ecosystem Science Program; USGS Invasive Species Program	U.S. Geological Survey (USGS) Greater Everglades Priority Ecosystem Science Program; USGS Invasive Species Program	Funding was provided by the U.S. Geological Survey (USGS) Greater Everglades Priority Ecosystem Science Program and USGS Invasive Species Program.	ABE AS, 1995, BRAZ J MED BIOL RES, V28, P1241; Abe AS., 1983, NATURALIA, V8, P135; Abrahao C.R., 2019, Occasional Papers of the IUCN Species Survival Commission, V62, P317; Andrade DV., 2004, OVERWINTERING TEGU L, P339; Ashfaq M, 2016, J GEOPHYS RES-ATMOS, V121, P9943, DOI 10.1002/2016JD025285; Barraco LA, THESIS FLORIDA ATLAN; Brito Simone P., 2001, Herpetological Review, V32, P260; Bull CM, 2002, J ZOOL, V256, P383, DOI 10.1017/S0952836902000420; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Byers JE, 2002, CONSERV BIOL, V16, P630, DOI 10.1046/j.1523-1739.2002.01057.x; Cardozo G, 2012, PERSPECTIVES NATURE, P161; Cotter SC, 2011, FUNCT ECOL, V25, P186, DOI 10.1111/j.1365-2435.2010.01766.x; Currylow AF., ECOSPHERE; Donadio OE., 1984, MAGAZINE ARGENTINE M, V13, P117; Dorcas ME, 2011, BIOL INVASIONS, V13, P793, DOI 10.1007/s10530-010-9869-6; DOUGHTY P, 1994, COPEIA, P537; Enge KM, FLORIDA FISH WILDLIF; Fitzgerald L.A., 1991, P303; FITZGERALD LA, 1994, AM ZOOL, V34, P371; FITZGERALD LA, 1993, J HERPETOL, V27, P70, DOI 10.2307/1564908; French SS, 2010, HORM BEHAV, V58, P792, DOI 10.1016/j.yhbeh.2010.08.001; Haro D, 2020, SOUTHEAST NAT, V19, P649, DOI 10.1656/058.019.0404; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Hoopes M.F., 2013, INVASION ECOLOGY, V2nd; Jarnevich CS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28468-w; Johnson FA, 2017, ECOL ECON, V137, P83, DOI 10.1016/j.ecolecon.2017.03.004; Klug PE, 2015, BIOL INVASIONS, V17, P1785, DOI 10.1007/s10530-014-0834-7; Krysko KL, 2011, ZOOTAXA, P1; Labra A, 2009, AM NAT, V174, P204, DOI 10.1086/600088; Lanfri S, 2013, AMPHIBIA-REPTILIA, V34, P551, DOI 10.1163/15685381-00002917; Ljungstrom G, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0476-0; Juri GL, 2015, S AM J HERPETOL, V10, P132, DOI 10.2994/SAJH-D-15-00002.1; Mack RN, 1992, MODELLING PREDICT FA, P739; Marketon JIW, 2008, CELL IMMUNOL, V252, P16, DOI 10.1016/j.cellimm.2007.09.006; Mazzotti FJ, 2015, BIOL INVASIONS, V17, P47, DOI 10.1007/s10530-014-0730-1; McConnachie S, 2007, J THERM BIOL, V32, P66, DOI 10.1016/j.jtherbio.2006.10.002; McEachern MA, 2015, SOUTHEAST NAT, V14, P319, DOI 10.1656/058.014.0207; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; MERCOLLI C, 1994, HERPETOL J, V4, P15; Meshaka WE., 2020, SOUTHEAST NAT, V18, P659; Mieres MM, 2006, J WILDLIFE MANAGE, V70, P1723, DOI 10.2193/0022-541X(2006)70[1723:MAMTHO]2.0.CO;2; Miller MA, 2020, ECOSPHERE, V11, DOI 10.1002/ecs2.3153; Miller MA, 2018, ECOL EVOL, V8, P830, DOI 10.1002/ece3.3557; Milsom William K., 2012, P317; MOODY ME, 1988, J APPL ECOL, V25, P1009, DOI 10.2307/2403762; Muscat Edelcio, 2016, Herpetological Bulletin, P36; National Oceanic and Atmospheric Administration National Centers for Environmental Information, DAIL SUMM; Pernas T, 2012, SOUTHEAST NAT, V11, P765, DOI 10.1656/058.011.0414; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pyron RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002931; R Studio Team, 2019, RSTUDIO INT DEV R; Reichard SH, 1997, CONSERV BIOL, V11, P193, DOI 10.1046/j.1523-1739.1997.95473.x; Cecchetto NR, 2015, J THERM BIOL, V53, P198, DOI 10.1016/j.jtherbio.2015.09.001; Rodda GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014670; Rodda GH, 2009, BIOL INVASIONS, V11, P241, DOI 10.1007/s10530-008-9228-z; Romagosa CM, 2009, CONSERV BIOL, V23, P1001, DOI 10.1111/j.1523-1739.2009.01194.x; Rubalcaba JG, 2020, J ANIM ECOL, V89, P1277, DOI 10.1111/1365-2656.13181; Sanders CE, 2015, J COMP PHYSIOL B, V185, P905, DOI 10.1007/s00360-015-0928-2; Sazima Ivan, 2013, Herpetology Notes, V6, P427; Schwanz LE, 2008, PHYSIOL BIOCHEM ZOOL, V81, P826, DOI 10.1086/590220; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Tattersall GJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500951; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Williamson M, 1999, ECOGRAPHY, V22, P5, DOI 10.1111/j.1600-0587.1999.tb00449.x; WILSON MA, 1987, COMP BIOCHEM PHYS A, V87, P757, DOI 10.1016/0300-9629(87)90395-1; Winck GR, 2008, J NAT HIST, V42, P239, DOI 10.1080/00222930701828667; Wood JP, 2018, GENETICA, V146, P443, DOI 10.1007/s10709-018-0040-0; Yang J, 2008, J COMP PHYSIOL B, V178, P343, DOI 10.1007/s00360-007-0227-7	68	4	4	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0245877	10.1371/journal.pone.0245877	http://dx.doi.org/10.1371/journal.pone.0245877			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690637	Green Published, gold			2022-12-26	WOS:000627854700060
J	Valverde, A; Castro-Morales, O; Madrigal-Valverde, M; Camacho, M; Barquero, V; Soler, C; Roldan, ERS				Valverde, Anthony; Castro-Morales, Olivier; Madrigal-Valverde, Monica; Camacho, Marlen; Barquero, Vinicio; Soler, Carles; Roldan, Eduardo R. S.			Sperm kinematic subpopulations of the American crocodile (Crocodylus acutus)	PLOS ONE			English	Article							POPULATION-STRUCTURE; MALE-FERTILITY; SEMEN; MORPHOMETRY; CASA; CRYOPRESERVATION; SPERMATOZOA; DESIGN; IDENTIFICATION; COLLECTION	There has been very limited use of computer assisted semen analysis (CASA) to evaluate reptile sperm. The aim of this study was to examine sperm kinematic variables in American crocodile (Crocodylus acutus) semen samples and to assess whether sperm subpopulations could be characterized. Eight ejaculates (two ejaculates/male) from four sexually mature captive crocodiles were obtained. An ISAS (R) v1 CASA-Mot system, with an image acquisition rate of 50 Hz, and ISAS (R) D4C20 counting chambers were used for sperm analyses. The percentages of motile and progressively motile spermatozoa did not differ among animals (P > 0.05) but there was a significant animal effect with regards to kinematic variables (P < 0.05). Principal component (PC) analysis revealed that kinematic variables grouped into three components: PC1, related to velocity; PC2 to progressiveness and PC3 to oscillation. Subpopulation structure analysis identified four groups (P < 0.05), which represented, on average, 9.8%, 32.1%, 26.8%, and 31.3% of the total sperm population. Males differed in the proportion of sperm in each of the kinematic subpopulations. This new approach for the analysis of reptile sperm kinematic subpopulations, reflecting quantifiable parameters generated by CASA system technology, opens up possibilities for future assessments of crocodile sperm and will be useful in the future development of assisted reproduction for these species.	[Valverde, Anthony; Castro-Morales, Olivier; Madrigal-Valverde, Monica; Camacho, Marlen; Barquero, Vinicio] Costa Rica Inst Technol, Sch Agron, Cartago, Alajuela, Costa Rica; [Valverde, Anthony; Soler, Carles] Univ Valencia, Dept Cellular Biol Funct Biol & Phys Anthropol, Burjassot, Spain; [Roldan, Eduardo R. S.] Museo Nacl Ciencias Nat CSIC, Dept Biodivers & Evolutionary Biol, Madrid, Spain	Instituto Tecnologico de Costa Rica; University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Roldan, ERS (corresponding author), Museo Nacl Ciencias Nat CSIC, Dept Biodivers & Evolutionary Biol, Madrid, Spain.	roldane@mncn.csic.es	Barquero, Vinicio/AAQ-8464-2021; Valverde, Anthony/GQO-7737-2022; Abarca, Anthony Valverde/AAF-6652-2019; Roldan, Eduardo/M-7947-2014	Barquero, Vinicio/0000-0003-0042-6178; Abarca, Anthony Valverde/0000-0002-3191-6965; Roldan, Eduardo/0000-0002-7545-4248	Costa Rica Institute of Technology [07-0336-01]; Vice-Chancellor's office of Research and Extension; Spanish Ministry of Science and Innovation [CGL2016-80577-P]; VIE; Agronomy School	Costa Rica Institute of Technology; Vice-Chancellor's office of Research and Extension; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); VIE; Agronomy School	This research was funded by the Costa Rica Institute of Technology (grant number 07-0336-01 to AV), Vice-Chancellor's office of Research and Extension; VIE, and Agronomy School, and by the Spanish Ministry of Science and Innovation (grant number CGL2016-80577-P to ERSR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann RP, 2014, THERIOGENOLOGY, V81, P5, DOI 10.1016/j.theriogenology.2013.09.004; Gutierrez-Reinoso MA, 2016, ASIAN J ANDROL, V18, P871, DOI 10.4103/1008-682X.187583; Assumpcao Teresinha I., 2017, Herpetology Notes, V10, P697; Bompart D, 2018, REPROD FERT DEVELOP, V30, P810, DOI 10.1071/RD17551; Boryshpolets S, 2018, REPROD FERT DEVELOP, V30, P833, DOI [10.1071/RD17478, 10.1071/rd17478]; Caldeira C, 2018, REPROD FERT DEVELOP, V30, P897, DOI [10.1071/RD17466, 10.1071/rd17466]; Ferguson M.W.J., 1985, Biology of Reptilia, V14, P329; Fitri WN, 2018, AQUACULTURE, V483, P169, DOI 10.1016/j.aquaculture.2017.10.026; Froman DP, 1999, BIOL REPROD, V61, P400, DOI 10.1095/biolreprod61.2.400; Gallego V, 2018, REPROD FERT DEVELOP, V30, P820, DOI [10.1071/rd17460, 10.1071/RD17460]; Gallego V, 2015, REPROD FERT DEVELOP, V27, P529, DOI 10.1071/RD13198; Garcia-Herreros M, 2014, ANDROLOGIA, V46, P820, DOI 10.1111/and.12141; Garcia-Molina A, 2020, ASIAN J ANDROL, V22, P118, DOI 10.4103/aja.aja_33_19; Gil MC, 2009, THERIOGENOLOGY, V71, P254, DOI 10.1016/j.theriogenology.2008.07.007; Holdridge LR., 1967, LIFE ZONE ECOLOGY EC, DOI [10.1016/0010-406x%2867%2990766-9, DOI 10.1016/0010-406X%2867%2990766-9]; Holt WV, 2018, REPROD FERT DEVELOP, V30, pIII, DOI 10.1071/RDv30n6_FO; Huchzermeyer FW., 2003, FW CROCODILES BIOLOG; Ibanescu I, 2020, ANIM REPROD SCI, V215, DOI 10.1016/j.anireprosci.2020.106329; International Union for Conservation of Nature and Natural Resources, 2017, IUCN RED LIST THREAT; Johnston SD, 2014, AQUACULTURE, V426, P213, DOI 10.1016/j.aquaculture.2014.02.014; Johnston SD, 2014, AQUACULTURE, V422, P25, DOI 10.1016/j.aquaculture.2013.11.002; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Kaufman L., 1990, FINDING GROUPS DATA, DOI [10.1002/9780470316801, DOI 10.1002/9780470316801]; Knox RV, 2015, REPROD DOMEST ANIM, V50, P90, DOI 10.1111/rda.12552; Larsen R. E., 1992, P 11 WORK M CROC SPE, P270; Larsen R. E., 1982, P 13 ANN C WORKSH IN, P45; LARSEN RE, 1984, AQUACULTURE, V42, P141, DOI 10.1016/0044-8486(84)90361-2; Lever J., 2014, DEV BREEDING TECHNIQ; Malo AF, 2006, BIOL LETTERS, V2, P246, DOI 10.1098/rsbl.2006.0449; Maroto-Morales A, 2015, THERIOGENOLOGY, V84, P1536, DOI 10.1016/j.theriogenology.2015.07.038; Marti JI, 2011, THERIOGENOLOGY, V75, P473, DOI 10.1016/j.theriogenology.2010.09.015; Martinez-Pastor F, 2011, THERIOGENOLOGY, V75, P783, DOI 10.1016/j.theriogenology.2010.11.034; Morrell J M, 2010, Vet Med Int, V2011, DOI 10.4061/2011/894767; Morrissiey F., 2014, P 23 WORK M CROC SPE, P144; Mortimer ST, 2000, J ANDROL, V21, P515; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Ortega-Ferrusola C, 2009, REPROD DOMEST ANIM, V44, P419, DOI 10.1111/j.1439-0531.2008.01097.x; Palacin I, 2013, SMALL RUMINANT RES, V112, P128, DOI 10.1016/j.smallrumres.2012.12.014; Piedra L, 2000, ESTADO POBLACIONES C; Pinto CRF, 1999, THERIOGENOLOGY, V52, P609, DOI 10.1016/S0093-691X(99)00156-9; Platt SG, 2013, J HERPETOL, V47, P1, DOI 10.1670/12-077; Ponce-Campos P., 2012, CROCODYLUS ACUTUS IU; Ramon M, 2014, REPROD DOMEST ANIM, V49, P30, DOI 10.1111/rda.12404; Ramon M, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.112110; Roldan ERS, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P539, DOI 10.1016/B978-0-12-372568-4.00014-8; Romero-Solorzano L., MEMORIAS CONFERENCIA, P6; Ross J. P., 1998, CROCODILES STATUS SU; Sadeghi S, 2016, ASIAN J ANDROL, V18, P835, DOI 10.4103/1008-682X.186875; Savage J.M., 2002, AMPHIBIANS REPTILES; Soler C, 2014, REPROD DOMEST ANIM, V49, P560, DOI 10.1111/rda.12310; Soler C, 2017, ASIAN J ANDROL, V19, P154, DOI 10.4103/1008-682X.188445; Soler C, 2016, ASIAN J ANDROL, V18, P895, DOI 10.4103/1008-682X.188451; Spencer N., 2013, ESSENTIALS MULTIVARI, DOI [10.1201/b16344, DOI 10.1201/B16344]; Thorbjarnarson J, 2006, BIOL CONSERV, V128, P25, DOI 10.1016/j.biocon.2005.09.013; Thurston LM, 2001, J ANDROL, V22, P382; Tourmente M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-12; Valle RR, 2013, ANIM REPROD SCI, V137, P93, DOI 10.1016/j.anireprosci.2012.12.007; Valverde Anthony, 2019, Revista de Biologia Tropical, V67, P1473; Valverde A, 2019, ANIM REPROD SCI, V207, P9, DOI 10.1016/j.anireprosci.2019.06.011; Valverde A, 2019, REPROD DOMEST ANIM, V54, P167, DOI 10.1111/rda.13320; Valverde A, 2016, ASIAN J ANDROL, V18, P851, DOI 10.4103/1008-682X.187579; van der Horst G, 2018, REPROD FERT DEVELOP, V30, P875, DOI 10.1071/RD17468; Vasquez F, 2016, ASIAN J ANDROL, V18, P824, DOI 10.4103/1008-682X.186873; Verstegen J, 2002, THERIOGENOLOGY, V57, P149, DOI 10.1016/S0093-691X(01)00664-1; Viquez L, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9060138; Wheatley PV, 2012, MAR ECOL PROG SER, V447, P211, DOI 10.3354/meps09503; Yaniz JL, 2018, REPROD FERT DEVELOP, V30, P919, DOI 10.1071/RD17441; Yaniz JL, 2018, REPROD FERT DEVELOP, V30, P799, DOI 10.1071/RD17432; Yaniz JL, 2015, ANIM REPROD SCI, V156, P128, DOI 10.1016/j.anireprosci.2015.03.012; Zimmerman DM, 2017, CONSERV PHYSIOL, V5, DOI 10.1093/conphys/cox062; Zimmerman DM, 2013, AM J VET RES, V74, P1536, DOI 10.2460/ajvr.74.12.1536	71	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2021	16	3							e0248270	10.1371/journal.pone.0248270	http://dx.doi.org/10.1371/journal.pone.0248270			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DJ	33690716	gold, Green Published			2022-12-26	WOS:000627855600011
J	Hasan, MM; Ragnarsson, L; Cardoso, FC; Lewis, RJ				Hasan, Md Mahadhi; Ragnarsson, Lotten; Cardoso, Fernanda C.; Lewis, Richard J.			Transfection methods for high-throughput cellular assays of voltage-gated calcium and sodium channels involved in pain	PLOS ONE			English	Article								Chemical transfection is broadly used to transiently transfect mammalian cells, although often associated with cellular stress and membrane instability, which imposes challenges for most cellular assays, including high-throughput (HT) assays. In the current study, we compared the effectiveness of calcium phosphate, FuGENE and Lipofectamine 3000 to transiently express two key voltage-gated ion channels critical in pain pathways, Ca(V)2.2 and Na(V)1.7. The expression and function of these channels were validated using two HT platforms, the Fluorescence Imaging Plate Reader FLIPRTetra and the automated patch clamp QPatch 16X. We found that all transfection methods tested demonstrated similar effectiveness when applied to FLIPRTetra assays. Lipofectamine 3000-mediated transfection produced the largest peak currents for automated patch clamp QPatch assays. However, the FuGENE-mediated transfection was the most effective for QPatch assays as indicated by the superior number of cells displaying G omega seal formation in whole-cell patch clamp configuration, medium to large peak currents, and higher rates of accomplished assays for both Ca(V)2.2 and Na(V)1.7 channels. Our findings can facilitate the development of HT automated patch clamp assays for the discovery and characterization of novel analgesics and modulators of pain pathways, as well as assisting studies examining the pharmacology of mutated channels.	[Hasan, Md Mahadhi; Ragnarsson, Lotten; Cardoso, Fernanda C.; Lewis, Richard J.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia	University of Queensland	Lewis, RJ (corresponding author), Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia.	f.caldascardoso@imb.uq.edu.au; r.lewis@imb.uq.edu.au	C Cardoso, Fernanda/J-7147-2013; Ragnarsson, Lotten/A-8632-2012; Lewis, Richard J./E-8674-2013	C Cardoso, Fernanda/0000-0002-0068-9974; Ragnarsson, Lotten/0000-0002-7137-1656; Lewis, Richard J./0000-0003-3470-923X	National Health and Medical Research Council [APP1072113, APP1119056]; Endeavour Foundation [5281_2016]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Endeavour Foundation	RJL received support from an National Health and Medical Research Council Program Grant (APP1072113) and Principal Research Fellowship (APP1119056). MH received scholarship support from the Endeavour Foundation (5281_2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AS, 2006, FUND CLIN PHARMACOL, V20, P81, DOI 10.1111/j.1472-8206.2005.00344.x; Black JA, 1996, MOL BRAIN RES, V43, P117, DOI 10.1016/S0169-328X(96)00163-5; Cardoso FC, 2018, BRIT J PHARMACOL, V175, P2138, DOI 10.1111/bph.13962; Cardoso FC, 2017, BRIT J PHARMACOL, V174, P2528, DOI 10.1111/bph.13865; Cardoso FC, 2015, MOL PHARMACOL, V88, P291, DOI 10.1124/mol.115.098178; Chang DS, 2015, CURR OPIN ANESTHESIO, V28, P379, DOI 10.1097/ACO.0000000000000216; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Day NC, 1996, NEUROSCIENCE, V71, P1013, DOI 10.1016/0306-4522(95)00514-5; Deer TR, 2019, PAIN MED, V20, P784, DOI 10.1093/pm/pny132; Du XN, 2013, CURR NEUROPHARMACOL, V11, P621, DOI 10.2174/1570159X113119990042; Emery EC, 2016, EXPERT OPIN THER TAR, V20, P975, DOI 10.1517/14728222.2016.1162295; Fan L, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-8; FRALEY R, 1980, BIOCHEMISTRY-US, V19, P6021, DOI 10.1021/bi00567a012; Fukuoka T, 2011, NEUROSCI RES, V70, P164, DOI 10.1016/j.neures.2011.01.020; Goncalves TC, 2019, BRIT J PHARMACOL, V176, P1298, DOI 10.1111/bph.14628; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hao YC, 2015, ASSAY DRUG DEV TECHN, V13, P174, DOI 10.1089/adt.2014.622; Henschke N, 2015, MAYO CLIN PROC, V90, P139, DOI 10.1016/j.mayocp.2014.09.010; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Inoue T, 2001, NAT NEUROSCI, V4, P1156, DOI 10.1038/nn1101-1156; Jacobsen LB, 2004, METHODS, V33, P104, DOI 10.1016/j.ymeth.2003.11.002; Kim HJ, 1996, HUM GENE THER, V7, P1339, DOI 10.1089/hum.1996.7.11-1339; Kim TK, 2010, ANAL BIOANAL CHEM, V397, P3173, DOI 10.1007/s00216-010-3821-6; Kisilevsky AE, 2008, CHANNELS, V2, P269, DOI 10.4161/chan.2.4.6402; Lewis RJ, 2000, J BIOL CHEM, V275, P35335, DOI 10.1074/jbc.M002252200; MARTINOU I, 1995, J CELL BIOL, V128, P201, DOI 10.1083/jcb.128.1.201; Marucci G, 2011, ANAL BIOCHEM, V414, P300, DOI 10.1016/j.ab.2011.02.028; Mathes C, 2009, COMB CHEM HIGH T SCR, V12, P78, DOI 10.2174/138620709787047948; MCCUTCHAN JH, 1968, JNCI-J NATL CANCER I, V41, P351; Mould J, 2004, J BIOL CHEM, V279, P34705, DOI 10.1074/jbc.M310848200; Neff RA, 2020, J BIOL CHEM, V295, P1315, DOI 10.1074/jbc.RA119.011318; O'Brien JA, 2006, NAT PROTOC, V1, P977, DOI 10.1038/nprot.2006.145; Pfeifer A, 2001, ANNU REV GENOM HUM G, V2, P177, DOI 10.1146/annurev.genom.2.1.177; Priest BT, 2004, ASSAY GUIDANCE MANUA; Tubio MR, 2010, J BIOL CHEM, V285, P14990, DOI 10.1074/jbc.M109.099689; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shirahata Y, 2001, J INVEST MED, V49, P184, DOI 10.2310/6650.2001.34045; Tay B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213751; Tsukamoto T, 2017, BRIT J PHARMACOL, V174, P3881, DOI 10.1111/bph.13985; VAHERI A, 1965, VIROLOGY, V27, P434, DOI 10.1016/0042-6822(65)90126-1; Vetter I, 2012, ADV EXP MED BIOL, V740, P45, DOI 10.1007/978-94-007-2888-2_3; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Westenbroek RE, 1998, J NEUROSCI, V18, P6319; Wiffen PJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005451.pub2; Zamponi GW, 2015, PHARMACOL REV, V67, P821, DOI 10.1124/pr.114.009654; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; ZINDER ND, 1952, J BACTERIOL, V64, P679, DOI 10.1002/path.1700640402	47	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0243645	10.1371/journal.pone.0243645	http://dx.doi.org/10.1371/journal.pone.0243645			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667217	gold, Green Published			2022-12-26	WOS:000626604300034
J	Matter, D; Potgieter, L				Matter, Dean; Potgieter, Linke			Allocating epidemic response teams and vaccine deliveries by drone in generic network structures, according to expected prevented exposures	PLOS ONE			English	Article								The tumultuous inception of an epidemic is usually accompanied by difficulty in determining how to respond best. In developing nations, this can be compounded by logistical challenges, such as vaccine shortages and poor road infrastructure. To provide guidance towards improved epidemic response, various resource allocation models, in conjunction with a network-based SEIRVD epidemic model, are proposed in this article. Further, the feasibility of using drones for vaccine delivery is evaluated, and assorted relevant parameters are discussed. For the sake of generality, these results are presented for multiple network structures, representing interconnected populations-upon which repeated epidemic simulations are performed. The resource allocation models formulated maximise expected prevented exposures on each day of a simulated epidemic, by allocating response teams and vaccine deliveries according to the solutions of two respective integer programming problems-thereby influencing the simulated epidemic through the SEIRVD model. These models, when compared with a range of alternative resource allocation strategies, were found to reduce both the number of cases per epidemic, and the number of vaccines required. Consequently, the recommendation is made that such models be used as decision support tools in epidemic response. In the absence thereof, prioritizing locations for vaccinations according to susceptible population, rather than total population or number of infections, is most effective for the majority of network types. In other results, fixed-wing drones are demonstrated to be a viable delivery method for vaccines in the context of an epidemic, if sufficient drones can be promptly procured; the detrimental effect of intervention delay was discovered to be significant. In addition, the importance of well-documented routine vaccination activities is highlighted, due to the benefits of increased pre-epidemic immunity rates, and targeted vaccination.	[Matter, Dean; Potgieter, Linke] Stellenbosch Univ, Dept Logist, Stellenbosch, Western Cape, South Africa	Stellenbosch University	Matter, D (corresponding author), Stellenbosch Univ, Dept Logist, Stellenbosch, Western Cape, South Africa.	deanmmatter@gmail.com	Potgieter, Linke/HFZ-9598-2022	Matter, Dean/0000-0001-6599-2811; Potgieter, Linke/0000-0001-6837-6037				Ackerman, 2019, IEEE SPECTRUM; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P205; Avis D., 2002, BRANCH BOUND KNAPSAC; Danet C, 2013, MEDECINS SANS FRONTI; Duijzer LE, 2018, PROD OPER MANAG, V27, P143, DOI 10.1111/poms.12788; Feldstein MS., 1973, B WORLD HEALTH ORGAN, V48, P79; Grais RF, 2008, J R SOC INTERFACE, V5, P67, DOI 10.1098/rsif.2007.1038; Grais RF, 2006, EPIDEMIOL INFECT, V134, P845, DOI 10.1017/S0950268805005716; Guerra FM, 2017, LANCET INFECT DIS, V17, pE420, DOI 10.1016/S1473-3099(17)30307-9; Gwilliam K., 2008, BURDEN MAINTENANCE R, V14, P4; Hethcote H.W., 1973, Mathematical Biosci, V18, P365, DOI 10.1016/0025-5564(73)90011-4; Juan A, 2018, MSF ACCESS CAMPAIGN; Kolesar P.J., 1967, MANAGE SCI, V13, P723, DOI [10.1287/mnsc.13.9.723, DOI 10.1287/MNSC.13.9.723]; Kraemer MUG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41192-3; Matrajt L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002964; Matrajt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013767; Mbah MLN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024577; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Moss WJ, 2007, PLOS MED, V4, P9, DOI 10.1371/journal.pmed.0040024; Murray CC, 2015, TRANSPORT RES C-EMER, V54, P86, DOI 10.1016/j.trc.2015.03.005; Mylius SD, 2008, VACCINE, V26, P3742, DOI 10.1016/j.vaccine.2008.04.043; Poikonen S, 2017, NETWORKS, V70, P34, DOI 10.1002/net.21746; Poncin M, 2018, B WORLD HEALTH ORGAN, V96, P86, DOI 10.2471/BLT.16.189241; Scott JE, 2017, PROCEEDINGS OF THE 50TH ANNUAL HAWAII INTERNATIONAL CONFERENCE ON SYSTEM SCIENCES, P3297; Sheppeard V, 2009, EFFECTIVENESS PROPHY; Teytelman A, 2013, SERV SCI, V5, P197, DOI 10.1287/serv.2013.0046; Vitoriano B, 2011, J GLOBAL OPTIM, V51, P189, DOI 10.1007/s10898-010-9603-z; Winston WL, 2004, OPERATIONS RES APPL; Wolfson LJ, 2009, INT J EPIDEMIOL, V38, P192, DOI 10.1093/ije/dyn224; Zaric GS, 2002, IMA J MATH APPL MED, V19, P235; Zaric GS, 2001, MATH BIOSCI, V171, P33, DOI 10.1016/S0025-5564(01)00050-5	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0248053	10.1371/journal.pone.0248053	http://dx.doi.org/10.1371/journal.pone.0248053			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667263	Green Published, gold			2022-12-26	WOS:000626604300042
J	Grabska, E; Socha, J				Grabska, Ewa; Socha, Jaroslaw			Evaluating the effect of stand properties and site conditions on the forest reflectance from Sentinel-2 time series	PLOS ONE			English	Article							FAGUS-SYLVATICA L.; LEAF-AREA INDEX; SPECIES CLASSIFICATION; SPECTRAL REFLECTANCE; CHLOROPHYLL CONTENT; SUCCESSIONAL STAGE; TREE GROWTH; LANDSAT TM; RED EDGE; VEGETATION	Forest stand reflectance at the canopy level results from various factors, such as vegetation chemical properties, leaf morphology, canopy structure, and tree sizes. These factors are dependent on the species, age, and health statuses of trees, as well as the site conditions. Sentinel-2 imagery with the high spatial, spectral, and temporal resolution, has enabled analysis of the relationships between vegetation properties and their spectral responses at large spatial scales. A comprehensive study of these relationships is needed to understand the drivers of vegetation spectral patterns and is essential from the point of view of remote sensing data interpretation. Our study aimed to quantify the site and forest parameters affecting forest stands reflectance. The analysis was conducted for common beech-, silver fir- and Scots pine-dominated stands in a mountainous area of the Polish Carpathians. The effect of stands and site properties on reflectance in different parts of the growing season was captured using the dense time series provided by Sentinel-2 from 2018-2019. The results indicate that the reflectance of common beech stands is mainly influenced by elevation, particularly during spring and autumn. Other factors influencing beech stand reflectance include the share of the broadleaved understory, aspect, and, during summer, the age of stands. The reflectance of coniferous species, i.e., Scots pine and silver fir, is mainly influenced by the age and stand properties, namely the crown closure and stand density. The age is a primary driver for silver fir stands reflectance changes, while the stand properties have a large impact on Scots pine stands reflectance. Also, the understory influences Scots pine stands reflectance, while there appears to be no impact on silver fir stands. The influence of the abovementioned factors is highly diverse, depending on the used band and time of the season.	[Grabska, Ewa] Jagiellonian Univ, Fac Geog & Geol, Inst Geog & Spatial Management, Krakow, Poland; [Grabska, Ewa; Socha, Jaroslaw] Agr Univ Krakow, Fac Forestry, Dept Forest Resources Management, Krakow, Poland	Jagiellonian University; Agricultural University Krakow	Grabska, E (corresponding author), Jagiellonian Univ, Fac Geog & Geol, Inst Geog & Spatial Management, Krakow, Poland.; Grabska, E (corresponding author), Agr Univ Krakow, Fac Forestry, Dept Forest Resources Management, Krakow, Poland.	ewa2.grabska@doctoral.uj.edu.pl	Grabska-Szwagrzyk, Ewa/AAC-5597-2020	Grabska-Szwagrzyk, Ewa/0000-0001-6783-3355	project I-MAESTRO; ForestValue ERA-NET Cofund by the National Science Centre, Poland; French Ministry of Agriculture, Agrifood, and Forestry; German Federal Ministry of Food and Agriculture (BMEL) via Agency for Renewable Resources (FNR); European Union's Horizon 2020 research and innovation programme [773324]; Ministry of Science and Higher Education of the Republic of Poland; French Ministry of Higher Education, Research and Innovation; Slovenian Ministry of Education, Science and Sport (MIZS)	project I-MAESTRO; ForestValue ERA-NET Cofund by the National Science Centre, Poland; French Ministry of Agriculture, Agrifood, and Forestry; German Federal Ministry of Food and Agriculture (BMEL) via Agency for Renewable Resources (FNR); European Union's Horizon 2020 research and innovation programme; Ministry of Science and Higher Education of the Republic of Poland(Ministry of Science and Higher Education, Poland); French Ministry of Higher Education, Research and Innovation; Slovenian Ministry of Education, Science and Sport (MIZS)	This research was supported by the project I-MAESTRO. Project Innovative forest MAnagEment STrategies for a Resilient biOeconomy under climate change and disturbances (I-MAESTRO) is supported under the umbrella of ForestValue ERA-NET Cofund by the National Science Centre, Poland and French Ministry of Agriculture, Agrifood, and Forestry; French Ministry of Higher Education, Research and Innovation, German Federal Ministry of Food and Agriculture (BMEL) via Agency for Renewable Resources (FNR), Slovenian Ministry of Education, Science and Sport (MIZS). ForestValue has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 773324. The APC was funded by the Ministry of Science and Higher Education of the Republic of Poland for the University of Agriculture in Krakow for 2020.	[Anonymous], 2010, WSKAZNIKOWA ANALIZA; Asner GP, 1998, REMOTE SENS ENVIRON, V64, P234, DOI 10.1016/S0034-4257(98)00014-5; Astola H, 2019, REMOTE SENS ENVIRON, V223, P257, DOI 10.1016/j.rse.2019.01.019; Bayer D, 2013, TREES-STRUCT FUNCT, V27, P1035, DOI 10.1007/s00468-013-0854-4; Bortolot Z. J., 2000, DETERMINING STAND AG; Care O, 2020, TREE GENET GENOMES, V16, DOI 10.1007/s11295-019-1394-x; Chen G, 2018, ISPRS J PHOTOGRAMM, V144, P94, DOI 10.1016/j.isprsjprs.2018.07.003; Christ B, 2014, J PLANT GROWTH REGUL, V33, P4, DOI 10.1007/s00344-013-9392-y; Chrysafis I, 2017, REMOTE SENS LETT, V8, P508, DOI [10.1080/2150704X.2017.1295479, 10.1080/2150704x.2017.1295479]; Chuine I, 2010, SCIENCE, V329, P277, DOI 10.1126/science.329.5989.277-e; Clevers JGPW, 2013, INT J APPL EARTH OBS, V23, P344, DOI 10.1016/j.jag.2012.10.008; COHEN WB, 1992, REMOTE SENS ENVIRON, V41, P1, DOI 10.1016/0034-4257(92)90056-P; Croft H, 2014, INT J APPL EARTH OBS, V33, P312, DOI 10.1016/j.jag.2014.06.005; Croft H., 2017, COMPREHENSIVE REMOTE, P1, DOI [10.1016/B978-0-12-409548-9.10547-0, DOI 10.1016/B978-0-12-409548-9.10547-0]; DANSON FM, 1993, REMOTE SENS ENVIRON, V43, P55, DOI 10.1016/0034-4257(93)90064-5; Delpierre N, 2016, ANN FOREST SCI, V73, P5, DOI 10.1007/s13595-015-0477-6; Dengel S, 2013, PLANT ECOL DIVERS, V6, P31, DOI 10.1080/17550874.2012.754512; Dittmar C, 2006, EUR J FOREST RES, V125, P181, DOI 10.1007/s10342-005-0099-x; Eklundh L, 2001, REMOTE SENS ENVIRON, V78, P239, DOI 10.1016/S0034-4257(01)00222-X; Eriksson HM, 2006, REMOTE SENS ENVIRON, V103, P408, DOI 10.1016/j.rse.2006.04.005; Fassnacht FE, 2016, REMOTE SENS ENVIRON, V186, P64, DOI 10.1016/j.rse.2016.08.013; FIORELLA M, 1993, PHOTOGRAMM ENG REM S, V59, P239; Fisher JI, 2006, REMOTE SENS ENVIRON, V100, P265, DOI 10.1016/j.rse.2005.10.022; Fraser RH, 2002, REMOTE SENS ENVIRON, V82, P95, DOI 10.1016/S0034-4257(02)00027-5; Gatti A., 2018, THALES ALENIA SP, P1; GEMMELL FM, 1995, REMOTE SENS ENVIRON, V51, P291, DOI 10.1016/0034-4257(94)00056-S; Gitelson AA, 1996, J PLANT PHYSIOL, V148, P501, DOI 10.1016/S0176-1617(96)80285-9; Godzik Barbara, 2008, Ekologia (Bratislava), V27, P300; Guyon D, 2011, REMOTE SENS ENVIRON, V115, P615, DOI 10.1016/j.rse.2010.10.006; Guyot G., 1989, GEOCARTO INT, V4, P3; Hale SE, 2009, FORESTRY, V82, P503, DOI 10.1093/forestry/cpp020; Hallik L, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11141717; Hastie T., 1986, STAT SCI, V1, P297; Heiskanen J, 2013, ISPRS J PHOTOGRAMM, V78, P1, DOI 10.1016/j.isprsjprs.2013.01.001; Hess M, 1965, PIETRA KLIMATYCZNE P; Hijmans RJ., 2019, **DATA OBJECT**, P9; Hovi A, 2017, SILVA FENN, V51, DOI 10.14214/sf.7753; Hubert M, 2018, WIRES COMPUT STAT, V10, DOI 10.1002/wics.1421; Humagain K, 2017, FORESTS, V8, DOI 10.3390/f8080287; Jakubauskas ME, 1997, PHOTOGRAMM ENG REM S, V63, P1375; Jensen JR, 1999, INT J REMOTE SENS, V20, P2805, DOI 10.1080/014311699211804; Joyce S., 2000, MONITORING FOREST GR, VXXXIII, P1081; Kahriman A, 2014, J INDIAN SOC REMOTE, V42, P559, DOI 10.1007/s12524-013-0355-3; Kattenborn T, 2019, REMOTE SENS ECOL CON, V5, P5, DOI 10.1002/rse2.86; Korhonen L, 2017, REMOTE SENS ENVIRON, V195, P259, DOI 10.1016/j.rse.2017.03.021; Kuusinen N, 2016, REMOTE SENS ENVIRON, V175, P43, DOI 10.1016/j.rse.2015.12.035; Kuusinen N, 2014, REMOTE SENS ENVIRON, V145, P145, DOI 10.1016/j.rse.2014.02.005; Larsen K., 2015, MULTITHREADED STITCH, V30, P196; Lausch A, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8121029; Leckie DG, 2005, CAN J REMOTE SENS, V31, P175, DOI 10.5589/m05-004; Leckie DG, 2017, CAN J REMOTE SENS, V43, P140, DOI 10.1080/07038992.2017.1286974; Lukasova V, 2019, FORESTS, V10, DOI 10.3390/f10010060; Makela A, 1997, FOREST SCI, V43, P7; Marien B, 2019, NEW PHYTOL, V224, P166, DOI 10.1111/nph.15991; Markiet V, 2020, REMOTE SENS ENVIRON, V249, DOI 10.1016/j.rse.2020.112018; Marx A, 2017, IFOREST, V10, P659, DOI 10.3832/ifor1727-010; Masaitis G, 2013, IFOREST, V6, P30, DOI 10.3832/ifor0709-006; MONSERUD RA, 1990, FOREST SCI, V36, P1; NIEMANN KO, 1995, PHOTOGRAMM ENG REM S, V61, P1119; Nilson T, 2008, INT J REMOTE SENS, V29, P5073, DOI 10.1080/01431160802167543; Nilson T., 2012, SEASONAL REFLECTANCE, DOI [10.1016/j.colsurfa.2011.12.014, DOI 10.1016/J.COLSURFA.2011.12.014]; Ollinger SV, 2011, NEW PHYTOL, V189, P375, DOI 10.1111/j.1469-8137.2010.03536.x; Persson H, 2013, CAN J REMOTE SENS, V39, P251, DOI 10.5589/m13-032; Puliti S, 2020, REMOTE SENS ENVIRON, V236, DOI 10.1016/j.rse.2019.111501; Raim O, 2012, PLANT BIOLOGY, V14, P306, DOI 10.1111/j.1438-8677.2011.00503.x; Ranghetii L., 2019, **DATA OBJECT**, DOI [10.5281/zenodo.1240384, DOI 10.5281/ZENODO.1240384]; Rautiainen M, 2004, REMOTE SENS ENVIRON, V89, P41, DOI 10.1016/j.rse.2003.10.001; Rautiainen M, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10020207; Rautiainen M, 2015, REMOTE SENS ENVIRON, V171, P98, DOI 10.1016/j.rse.2015.10.009; Rautiainen M, 2009, REMOTE SENS ENVIRON, V113, P805, DOI 10.1016/j.rse.2008.12.009; Remlein A., 2015, ANN WARSAW U LIFE SC, V92, P355; Richardson AD, 2003, TREE PHYSIOL, V23, P537, DOI 10.1093/treephys/23.8.537; Richardson AD, 2002, AM J BOT, V89, P88, DOI 10.3732/ajb.89.1.88; Roberts DA, 2004, ECOSYSTEMS, V7, P545, DOI 10.1007/s10021-004-0144-5; ROY PS, 1989, P INDIAN AS-PLANT SC, V99, P59; SADER SA, 1989, REMOTE SENS ENVIRON, V28, P143, DOI 10.1016/0034-4257(89)90112-0; Schieber B., 2009, Journal of Forest Science (Prague), V55, P15, DOI 10.17221/51/2008-JFS; Schieber B., 2013, Journal of Forest Science (Prague), V59, P176, DOI 10.17221/82/2012-JFS; Skoupy O., 2012, Journal of Forest Science (Prague), V58, P287, DOI 10.17221/86/2011-JFS; Song C, 2007, REMOTE SENS ENVIRON, V106, P228, DOI 10.1016/j.rse.2006.08.008; Sothe C, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9080838; Stoffels J, 2012, EUR J FOREST RES, V131, P1071, DOI 10.1007/s10342-011-0577-2; Testa S, 2018, INT J APPL EARTH OBS, V64, P132, DOI 10.1016/j.jag.2017.08.006; Treitz PM, 1999, PROG PHYS GEOG, V23, P359, DOI 10.1177/030913339902300303; Trepinska J., 2002, GORSKIE KLIMATY; TUCKER CJ, 1978, PHOTOGRAMM ENG REM S, V44, P1369; Valladares F., 2007, ARCHITECTURE PLANT C, DOI [10.1201/9781420007626.ch4, DOI 10.1201/9781420007626.CH4]; Van Doninck J, 2020, ECOGRAPHY, V43, P128, DOI 10.1111/ecog.04729; Vastaranta M, 2018, INT J REMOTE SENS, V39, P8766, DOI 10.1080/01431161.2018.1492176; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Vieira ICG, 2003, REMOTE SENS ENVIRON, V87, P470, DOI 10.1016/j.rse.2002.09.002; Vilhar U, 2013, DEV ENVIRONM SCI, V12, P169, DOI 10.1016/B978-0-08-098222-9.00009-1; Wood S., 2017, GEN ADDITIVE MODELS, V2nd Edn; Wu J, 2017, NEW PHYTOL, V214, P1033, DOI 10.1111/nph.14051; Wu QL, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10020262	95	8	8	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0248459	10.1371/journal.pone.0248459	http://dx.doi.org/10.1371/journal.pone.0248459			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720961	Green Published, gold			2022-12-26	WOS:000629667400026
J	Loubet, P; Koumar, Y; Lechiche, C; Cellier, N; Schuldiner, S; Kouyoumdjian, P; Lavigne, JP; Sotto, A				Loubet, Paul; Koumar, Yatrika; Lechiche, Catherine; Cellier, Nicolas; Schuldiner, Sophie; Kouyoumdjian, Pascal; Lavigne, Jean-Philippe; Sotto, Albert			Clinical features and outcome of Streptococcus agalactiae bone and joint infections over a 6-year period in a French university hospital	PLOS ONE			English	Article							GROUP-B; NONPREGNANT ADULTS; DISEASE; ARTHRITIS	Background Bone and joint infections (BJIs) due to Streptococcus agalactiae are rare but has been described to increase in the past few years. The objective of this study was to describe clinical features and outcomes of cases of S. BJIs. Methods We conducted a retrospective analysis of adult cases of S. agalactiae BJIs that occurred between January 2009 and June 2015 in a French university hospital. The treatment success was assessed until 24 months after the end of antibiotic treatment. Results Among the 26 patients included, 20 (77%) were male, mean age was 62 years +/- 13 and mean Charlson comorbidity index score was 4.9 +/- 3.2. Diabetes mellitus was the most common comorbidity (n = 14, 54%). Six had PJI (Prosthetic Joint Infections), five osteosynthesis-associated infections, 11 osteomyelitis and four native septic arthritis. Eleven patients had a delayed or late infection: six with a prosthetic joint infection and five with an internal fixation device infection. Sixteen patients (62%) had a polymicrobial BJI, most commonly with Gram-positive cocci (75%) notably Staphylococcus aureus (44%). Polymicrobial infections were more frequently found in foot infections (90% vs 44%, p = 0.0184). During the two-year follow-up, three patients died (3/25, 12%) and seven (7/25, 28%) had treatment failure. Conclusion Diabetes mellitus was the most common comorbidity. We observed an heterogenous management and a high rate of relapse.	[Loubet, Paul; Sotto, Albert] Univ Montpellier, Dept Infect & Trop Dis, CHU Nimes, INSERM U1407,VBMI, Nimes, France; [Koumar, Yatrika; Lechiche, Catherine] Univ Montpellier, Dept Infect & Trop Dis, CHU Nimes, Nimes, France; [Cellier, Nicolas; Kouyoumdjian, Pascal] Univ Montpellier, Dept Orthoped & Trauma Surg, CHU Nimes, Nimes, France; [Schuldiner, Sophie] Univ Montpellier, Dept Metab & Endocrine Dis, CHU Nimes, INSERM U1407,VBMI, Nimes, France; [Lavigne, Jean-Philippe] Univ Montpellier, Dept Microbiol & Hosp Hyg, CHU Nimes, INSERM U1407,VBMI, Nimes, France	Universite de Montpellier; CHU de Nimes; Universite de Montpellier; CHU de Nimes; Universite de Montpellier; CHU de Nimes; Universite de Montpellier; CHU de Nimes; Universite de Montpellier; CHU de Nimes	Loubet, P (corresponding author), Univ Montpellier, Dept Infect & Trop Dis, CHU Nimes, INSERM U1407,VBMI, Nimes, France.	paul.loubet@chu-nimes.fr	Sotto, Albert/AFJ-9023-2022; Lavigne, Jean-Philippe/E-1756-2014	Lavigne, Jean-Philippe/0000-0002-9484-0304; Sotto, Albert/0000-0002-6463-9386; Loubet, Paul/0000-0002-1218-9432				Camuset G, 2015, INT J INFECT DIS, V35, P46, DOI 10.1016/j.ijid.2015.04.006; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Fiaux E, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1889-0; Kerneis S, 2017, EUR J CLIN MICROBIOL, V36, P1679, DOI 10.1007/s10096-017-2983-y; Nolla JM, 2003, MEDICINE, V82, P119, DOI 10.1097/00005792-200303000-00006; Oppegaard O, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1874-7; Osmon DR, 2013, CLIN INFECT DIS, V56, DOI [10.1093/cid/cis803, 10.1093/cid/cis966]; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Rantz LA, 1940, ANN INTERN MED, V13, P1744, DOI 10.7326/0003-4819-13-9-1744; Seng P., 2016, New Microbes and New Infections, V12, P8, DOI 10.1016/j.nmni.2016.03.009; Skoff TH, 2009, CLIN INFECT DIS, V49, P85, DOI 10.1086/599369; Tazi A, 2011, CLIN MICROBIOL INFEC, V17, P1587, DOI 10.1111/j.1469-0691.2011.03628.x; Zeller V, 2009, JOINT BONE SPINE, V76, P491, DOI 10.1016/j.jbspin.2008.11.010; Zimmerli W, 2014, J INTERN MED, V276, P111, DOI 10.1111/joim.12233	15	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0248231	10.1371/journal.pone.0248231	http://dx.doi.org/10.1371/journal.pone.0248231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711071	Green Published, gold			2022-12-26	WOS:000629591800008
J	Castro, MYR; Orriols, L; Contrand, B; Dupuy, M; Sztal-Kutas, C; Avalos, M; Lagarde, E				Castro, Madelyn Yiseth Rojas; Orriols, Ludivine; Contrand, Benjamin; Dupuy, Marion; Sztal-Kutas, Catherine; Avalos, Marta; Lagarde, Emmanuel			Cohort profile: MAVIE a web-based prospective cohort study of home, leisure, and sports injuries in France	PLOS ONE			English	Article							RISK-FACTORS; FALLS	MAVIE is a web-based prospective cohort study of Home, Leisure, and Sports Injuries with a longitudinal follow-up of French general population volunteers. MAVIE participants are voluntary members of French households, including overseas territories. Participation in the cohort involves answering individual and household questionnaires and relevant exposures and prospectively reporting injury events during the follow-up. Recruitment and data collection have been in progress since 2014. The number of participants as of the end of the year 2019 was 12,419 from 9,483 households. A total of 8,640 participants provided data during follow-up. Respondents to follow-up were composed of 763 children aged 0-14, 655 teenagers and young adults aged 15-29, 6,845 adults, and 377 people aged 75 or more. At the end of the year 2019, 1,698 participants had reported 2,483 injury events. Children, people aged 50 and more, people with poor self-perceived physical and mental health, people who engage in sports activities, and people with a history of injury during the year before recruitment were more likely to report new injuries. An interactive mobile/web application (MAVIE-Lab) was developed to help volunteers decide on personalized measures to prevent their risks of HLIs. The available data provides an opportunity to analyse multiple exposures at both the individual and household levels that may be associated with an increased risk of trauma. The ongoing analysis includes HLI incidence estimates, the determination of health-related risk factors, a specific study on the risk of home injury, another on sports injuries, and an analysis of the role of cognitive skills and mind wandering. Volunteers form a community that constitutes a population laboratory for preventative initiatives.	[Castro, Madelyn Yiseth Rojas; Orriols, Ludivine; Contrand, Benjamin; Avalos, Marta; Lagarde, Emmanuel] Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, INSERM, UMR U1219, Bordeaux, France; [Dupuy, Marion; Sztal-Kutas, Catherine] Ctr Risk Expertise, Calyxis, Niort, France; [Avalos, Marta] SISTM Team Inria BSO, Talence, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Lagarde, E (corresponding author), Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, INSERM, UMR U1219, Bordeaux, France.	emmanuel.lagarde@u-bordeaux.fr	Lagarde, Emmanuel/F-7132-2013	Lagarde, Emmanuel/0000-0001-8031-7400	Institut de recherche en sante publique (IReSP) [CONV 067-00187II]; Agence nationale de securite du medicament et des produits de sante [2014S029]; Universite de Bordeaux; Re'gion Nouvelle Aquitaine as part of the Cassiopee project [2014-1R30504 -00003101]; Institut national de la santeet de la recherche medicale (INSERM); Region Nouvelle Aquitaine [2017-1R40301, 00013329]; Graduate Digital Public Health Program [17-EURE-0019]; MAIF; MAAF; MACIF; Decathlon [AD 13339, AD 15404]	Institut de recherche en sante publique (IReSP); Agence nationale de securite du medicament et des produits de sante(French National Research Agency (ANR)); Universite de Bordeaux; Re'gion Nouvelle Aquitaine as part of the Cassiopee project; Institut national de la santeet de la recherche medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Region Nouvelle Aquitaine(Region Nouvelle-Aquitaine); Graduate Digital Public Health Program; MAIF; MAAF; MACIF; Decathlon	This study was supported by the Institut de recherche en sante publique (IReSP) [CONV 067-00187II], the Agence nationale de securite du medicament et des produits de sante [conv 2014S029], the Universite de Bordeaux and the Re ' gion Nouvelle Aquitaine as part of the Cassiopee project [conv 2014-1R30504 -00003101]. MR is the recipient of an Institut national de la santeet de la recherche medicale (INSERM) and the Region Nouvelle Aquitaine doctoral grant (2017-1R40301 These 00013329) and is affiliated to the Graduate Digital Public Health Program supported within the framework of the PIA3 (Investment for the future) [17-EURE-0019]. The MAVIE observatory has the support of the mutual insurance companies MAIF, MAAF, MACIF and Decathlon [AD 13339, AD 15404].	Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; Christensen T, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.6716; Croutte P., 2019, BAROMETRE NATL PRATI; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Dionyssiotis Y, 2012, INT J GEN MED, V5, P805, DOI 10.2147/IJGM.S32651; EPAC, 2017, ENQ PERM ACC VIE COU; Eurosafe, 2016, INJ EUR UN SUMM INJ INJ EUR UN SUMM INJ; Euser AM, 2009, NEPHRON CLIN PRACT, V113, pC214, DOI 10.1159/000235241; Finch CF, 1997, SPORTS MED, V24, P157, DOI 10.2165/00007256-199724030-00002; Gielen AC, 2015, ANNU REV PUBL HEALTH, V36, P231, DOI 10.1146/annurev-publhealth-031914-122722; Gillespie LD, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000340.pub2; Guilbert P, 2018, BAROMETRE SANTE 2005; INSEE, 2003, ENQ TRANSV REP DEC S; IRDES, 2004, ENQ SANT PROT SOC 20; Keall MD, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-98; Keiding N, 2018, ANNU REV STAT APPL, V5, P25, DOI 10.1146/annurev-statistics-031017-100127; Meeuwisse WH, 1997, SPORTS MED, V24, P184, DOI 10.2165/00007256-199724030-00008; Mein G, 2012, SOC SCI MED, V75, P2345, DOI 10.1016/j.socscimed.2012.09.006; Mejean C, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3161; Palmer KT, 2008, OCCUP ENVIRON MED, V65, P757, DOI 10.1136/oem.2007.037440; Petridou E, 2004, EPIDEMIOLOGY, V15, P428, DOI 10.1097/01.ede.0000129519.76945.0d; Richiardi L, 2013, INT J EPIDEMIOL, V42, P1018, DOI 10.1093/ije/dyt103; Rojas-Castro MY., 2018, ASS COMPUTING MACHIN, P158; Ruppli N, 2012, ACCIDENTS AVEC HOSPI; Sante Publique France, 2020, BAR SANT PUBL FRANC; Schneider S, 2007, INT J SPORTS MED, V28, P247, DOI 10.1055/s-2006-924293; Shi XQ, 2015, DISABIL HEALTH J, V8, P153, DOI 10.1016/j.dhjo.2014.09.012; Talbot LA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-86; Tan N C, 2004, Asia Pac J Public Health, V16, P104, DOI 10.1177/101053950401600205; Thelot B., 2018, REV EPIDEMIOLOGIE SA, V66, pS338; Turner S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003600.pub3; van Gelder MMHJ, 2010, AM J EPIDEMIOL, V172, P1292, DOI 10.1093/aje/kwq291; World Health Organization, WHO HOUS HLTH GUID; World Health Organization, 2014, INJ VIOL FACTS 2014; Zambon F, 2014, INJURIES INEQUITIES, P1	36	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248162	10.1371/journal.pone.0248162	http://dx.doi.org/10.1371/journal.pone.0248162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705466	gold, Green Published			2022-12-26	WOS:000629590400026
J	Park, HJ; Lee, SY; Rho, MH; Jung, HL				Park, Hee Jin; Lee, So-Yeon; Rho, Myung Ho; Jung, Hye Lim			Ultrasound and MRI findings as predictors of propranolol therapy response in patients with infantile hemangioma	PLOS ONE			English	Article							ORAL PROPRANOLOL; CLINICAL CHARACTERISTICS; CLASSIFICATION; EFFICACY	Objectives To evaluate the prognostic value of ultrasound and MRI findings in patients with infantile hemangioma undergoing propranolol therapy. Methods This study was based on retrospective interpretation of prospectively acquired data. Thirty-eight consecutive patients (28 females and 10 males; mean age +/- standard deviation, 3.2 +/- 2.2 months) who underwent propranolol treatment for infantile hemangioma were included. Pre-treatment ultrasound images were assessed in terms of echogenicity, lesion height and vascularity. Presence of prominent intratumoral fat, non-fat septa, and enhancement pattern on MRI were retrospectively evaluated. Mann-Whitney test, chi-square, and Fisher's exact tests were used to compare imaging parameters between patients with treatment success and failure. Results All patients underwent ultrasound and 15 patients underwent MRI. A total of 24 patients showed successful treatment. Between patients with treatment success and failure, there were significant differences in increased vascularity on pre-treatment ultrasound (19/24 vs. 6/14, p = 0.025), decreased vascularity on post-treatment ultrasound (21/24 vs. 5/14, p = 0.001), and prominent intratumoral fat on MRI (1/8 vs. 5/7 p = 0.033). There were no significant differences in echogenicity, lesion height on ultrasound, non-fat septa and MR enhancement pattern. Conclusions Increased vascularity on pre-treatment ultrasound was significantly associated with successful treatment for propranolol therapy in patients with infantile hemangioma, whereas prominent fat component on MRI was significantly associated with treatment failure.	[Park, Hee Jin; Rho, Myung Ho] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Radiol, Sch Med, Seoul, South Korea; [Lee, So-Yeon] Catholic Univ Korea, Seoul St Marys Hosp, Dept Radiol, Sch Med, Seoul, South Korea; [Jung, Hye Lim] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Pediat, Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Korea; Seoul St. Mary's Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, SY (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Radiol, Sch Med, Seoul, South Korea.	capella27@gmail.com		Lee, So-Yeon/0000-0002-0109-0998				[Anonymous], CLIN PEDIAT HEMATOL, V2919, P6, DOI [10.15264/cpho.2019.26.1.6, DOI 10.15264/CPHO.2019.26.1.6]; Babiak-Choroszczak L, 2018, ADV CLIN EXP MED, V27, P723, DOI 10.17219/acem/84800; Chang LC, 2008, PEDIATRICS, V122, P360, DOI 10.1542/peds.2007-2767; Chinnadurai S, 2016, LASER SURG MED, V48, P221, DOI 10.1002/lsm.22455; EZEKOWITZ RAB, 1992, NEW ENGL J MED, V326, P1456, DOI 10.1056/NEJM199205283262203; Flors L, 2011, RADIOGRAPHICS, V31, P1321, DOI 10.1148/rg.315105213; Frieden Ilona J, 2005, Pediatr Dermatol, V22, P383, DOI 10.1111/j.1525-1470.2005.00102.x; Ginguerra MA, 2018, AM J OPHTHALMOL, V185, P48, DOI 10.1016/j.ajo.2017.10.021; Haggstrom AN, 2006, PEDIATRICS, V118, P882, DOI 10.1542/peds.2006-0413; Hogeling M, 2011, PEDIATRICS, V128, pE259, DOI 10.1542/peds.2010-0029; Ji Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22787-8; Johnson CM, 2017, PEDIATR RADIOL, V47, P1184, DOI 10.1007/s00247-017-3885-y; Kilcline C, 2008, PEDIATR DERMATOL, V25, P168, DOI 10.1111/j.1525-1470.2008.00626.x; Kim KM., 2016, PROPRANOLOL 1 LINE T, V23, P97, DOI [10.15264/cpho.2016.23.2.97, DOI 10.15264/CPHO.2016.23.2.97]; Kim KH, 2017, JAMA DERMATOL, V153, P529, DOI 10.1001/jamadermatol.2017.0250; Krowchuk DP, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-3475; Leaute-Labreze C, 2015, NEW ENGL J MED, V372, P735, DOI 10.1056/NEJMoa1404710; Leaute-Labreze C, 2013, BRIT J DERMATOL, V169, P181, DOI 10.1111/bjd.12217; Leaute-Labreze C, 2008, NEW ENGL J MED, V358, P2649, DOI 10.1056/NEJMc0708819; Munden A, 2014, BRIT J DERMATOL, V170, P907, DOI 10.1111/bjd.12804; Park M, 2020, PEDIATR RES, V88, P749, DOI 10.1038/s41390-020-0862-1; Rotter A, 2017, J DTSCH DERMATOL GES, V15, P1185, DOI 10.1111/ddg.13365; Schupp CJ, 2011, PEDIATR DERMATOL, V28, P640, DOI 10.1111/j.1525-1470.2011.01569.x; Shi HJ, 2014, ULTRASOUND MED BIOL, V40, P2622, DOI 10.1016/j.ultrasmedbio.2014.06.021; Watanabe T, 2019, ULTRASOUND MED BIOL, V45, P1367, DOI 10.1016/j.ultrasmedbio.2019.01.021; Wu YC, 2006, J MED ULTRASOUND, V14, P25, DOI 10.1016/S0929-6441(09)60087-4; Zvulunov A, 2011, PEDIATR DERMATOL, V28, P94, DOI 10.1111/j.1525-1470.2010.01379.x	27	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0247505	10.1371/journal.pone.0247505	http://dx.doi.org/10.1371/journal.pone.0247505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690675	gold, Green Published			2022-12-26	WOS:000627854700002
J	Tashiro, S; Kuroki, M; Okuyama, K; Oshima, O; Ogura, M; Hijikata, N; Nakamura, T; Oka, A; Kawakami, M; Tsuji, T; Liu, MG				Tashiro, Syoichi; Kuroki, Miho; Okuyama, Kohei; Oshima, Osamu; Ogura, Miho; Hijikata, Nanako; Nakamura, Takuya; Oka, Asako; Kawakami, Michiyuki; Tsuji, Tetsuya; Liu, Meigen			Factors related to daily use of the paretic upper limb in patients with chronic hemiparetic stroke-A retrospective cross-sectional study	PLOS ONE			English	Article								Aims The present study aimed to determine factors associated with the frequency of paralyzed upper extremity (UE) use in chronic stroke patients with severe UE functional deficiency. Methods We retrospectively reviewed the medical records of 138 consecutive patients, and 117 was analyzed (median age, 55 [range, 18-85] years; median stroke duration, 24.5 [range, 7-302] months) with chronic hemiparetic stroke who were admitted to our hospital for intensive upper extremity rehabilitation. The mean Fugl-Meyer Assessment (FMA) UE score was 28.6. All of them are independent in their activity of daily living (ADL) and without remarkable cognitive deficits. Amount-of-use score of Motor Activity Log-14 (MAL-AOU) was applied as the index of daily use of affected UE. The following parameters were examined as the explanatory variables: demographics, proximal and distal sub-scores of FMA UE, Modified Ashworth Scale (MAS), and sensory function scores in the Stroke Impairment Assessment Set (SIAS). Results The median MAL-AOU score was 0.57 [range, 0.28-0.80]. Ordinal regression analysis revealed that FMA proximal, FMA distal, and SIAS sensory function (touch) were associated with AOU score of MAL-14 (Pseudo R-square = 0.460). Conclusion Not only motor but also sensory function, especially tactile sensation, play a crucial role in the daily use of affected UE in chronic stroke patients with severe UE hemiparesis.	[Tashiro, Syoichi; Kuroki, Miho; Okuyama, Kohei; Oshima, Osamu; Ogura, Miho; Hijikata, Nanako; Nakamura, Takuya; Oka, Asako; Kawakami, Michiyuki; Tsuji, Tetsuya; Liu, Meigen] Keio Univ, Sch Med, Dept Rehabil Med, Shinju Ku, Tokyo, Japan; [Tashiro, Syoichi] Kyorin Univ, Sch Med, Dept Rehabil Med, Mitaka, Tokyo, Japan	Keio University; Kyorin University	Kawakami, M (corresponding author), Keio Univ, Sch Med, Dept Rehabil Med, Shinju Ku, Tokyo, Japan.	michiyukikawakami@hotmail.com	Kawakami, Michiyuki/AAY-6325-2020; Tashiro, Syoichi/I-5119-2019	Tashiro, Syoichi/0000-0002-1430-0552	JSPS KAKENHI(B) by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [18H03135]; KAKENHI (Wakate) by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [20K16467]	JSPS KAKENHI(B) by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; KAKENHI (Wakate) by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This study was partially supported by a JSPS KAKENHI (B) Grant (18H03135) and KAKENHI (Wakate) Grant (20K16467) by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The former one was applied throughout this study, and the latter one was applied in the revision process.	Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; Bailey RR, 2015, NEUROREHAB NEURAL RE, V29, P969, DOI 10.1177/1545968315583720; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Carey LM, 2018, AM J OCCUP THER, V72, DOI 10.5014/ajot.2018.025114; Carey LM, 2011, J REHABIL MED, V43, P257, DOI 10.2340/16501977-0662; Carlsson H, 2019, PM&R, V11, P821, DOI 10.1002/pmrj.12044; Chino N, 1994, JPN J REHABIL MED, V31, P119, DOI DOI 10.2490/JJRM1963.31.119; Engin S, 2010, J NUTR HEALTH AGING, V14, P483; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Hayward KS, 2016, BRAIN IMPAIR, V17, P16, DOI 10.1017/BrImp.2015.21; Kawakami M, 2016, RESTOR NEUROL NEUROS, V34, P789, DOI 10.3233/RNN-160652; Kidd L, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040985; Kong KH, 2011, NEUROREHABILITATION, V28, P105, DOI 10.3233/NRE-2011-0639; Kroll T., 2013, INT J STROKE, V3, DOI [10.1111/j.1747-4949.2012.00969.x, DOI 10.1111/J.1747-4949.2012.00969.X]; Lang CE, 2013, J HAND THER, V26, P104, DOI 10.1016/j.jht.2012.06.005; Liepert J, 2010, CURR OPIN NEUROL, V23, P678, DOI 10.1097/WCO.0b013e32833ff4c4; Meyer S, 2016, NEUROREHAB NEURAL RE, V30, P731, DOI 10.1177/1545968315624779; Meyer S, 2014, PHYS THER, V94, P1220, DOI 10.2522/ptj.20130271; Morris J., 2009, INT J STROKE, V4, P1; Morris JH, 2014, ARCH PHYS MED REHAB, V95, P956, DOI 10.1016/j.apmr.2013.12.016; Nowak DA, 2003, J NEUROL, V250, P850, DOI 10.1007/s00415-003-1095-z; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Ramage ER, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027416; Rand D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195043; Rand D, 2015, J STROKE CEREBROVASC, V24, P274, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.039; Schabrun SM, 2009, CLIN REHABIL, V23, P27, DOI 10.1177/0269215508098897; Shindo K, 2011, NEUROREHAB NEURAL RE, V25, P830, DOI 10.1177/1545968311408917; Smania N, 2003, ARCH PHYS MED REHAB, V84, P1692, DOI 10.1053/S0003-9993(03)00277-6; Stewart JC, 2013, STROKE, V44, P1111, DOI 10.1161/STROKEAHA.111.674671; Sullivan JE, 2007, CLIN REHABIL, V21, P142, DOI 10.1177/0269215506071252; Tsuji T, 2000, ARCH PHYS MED REHAB, V81, P863, DOI 10.1053/apmr.2000.6275; Turville M, 2017, AM J OCCUP THER, V71, DOI 10.5014/ajot.2017.024950; Uswatte G, 2006, NEUROLOGY, V67, P1189, DOI 10.1212/01.wnl.0000238164.90657.c2; Uswatte G, 2005, STROKE, V36, P2493, DOI 10.1161/01.STR.0000185928.90848.2e; Wagner AK, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0791-5; Wiratunga N., 2019, LEARNING SELF MANAGE, P60; Wondergem R, 2017, CEREBROVASC DIS, V43, P1, DOI 10.1159/000451034	37	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2021	16	3							e0247998	10.1371/journal.pone.0247998	http://dx.doi.org/10.1371/journal.pone.0247998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QV3DJ	33690690	gold, Green Published			2022-12-26	WOS:000627855600018
J	Huang, DL; Tang, AP; Liu, Q; Mu, DR; Ding, Y				Huang, Delong; Tang, Aiping; Liu, Qiang; Mu, Dianrui; Ding, Yan			Response analysis of the nodes of pipe networks under seismic load	PLOS ONE			English	Article							ARTIFICIAL EARTHQUAKE TEST; PIPELINES	Transient ground displacement (TGD) that is caused by earthquakes can damage underground pipes. This damage is especially critical for the joints, elbows and tees of the pipes which play an important role in the operation of a pipe network. In this study, a scale pipe network with both elbows and tees, as well as some components of the pipe network with only tees or elbows, has been investigated. The response of the nodes of a pipe network, when installed in non-uniform geology, was analyzed using the shaking table test and ABAQUS finite element simulation. This paper has firstly introduced the preparation of the test and the developed finite element model. Then the system response in terms of strain, the friction, the bending deformation, the node deformation amplification coefficient and the pipe-soil relative displacement along the pipe axis of the pipe network and two pipe network components have been analyzed explaining the correlation between these responses. Finally, the influence of elbows and tees on the pipe network was analyzed, and the conclusions that have been reached about how tees and elbows can change the response of a pipe network during an earthquake can provide theoretical support for the seismic design and layout of an underground pipe network.	[Huang, Delong; Tang, Aiping; Liu, Qiang; Mu, Dianrui] Harbin Inst Technol, Sch Civil Engn, Harbin, Heilongjiang, Peoples R China; [Ding, Yan] Harbin Engn Univ, Sch Mech & Elect Engn, Harbin, Heilongjiang, Peoples R China	Harbin Institute of Technology; Harbin Engineering University	Tang, AP (corresponding author), Harbin Inst Technol, Sch Civil Engn, Harbin, Heilongjiang, Peoples R China.	tangaipinghit@163.com	Huang, Delong/HGB-8118-2022		National Key Technology R&D Program of China [2016YFC0802407]	National Key Technology R&D Program of China(National Key Technology R&D Program)	Tang A. P. grant number 2016YFC0802407 National Key Technology R&D Program of China	Almahakeri M, 2017, J PIPELINE SYST ENG, V8, DOI 10.1061/(ASCE)PS.1949-1204.0000237; Berezin Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08934; Chakraborty D, 2014, J PIPELINE SYST ENG, V5, DOI 10.1061/(ASCE)PS.1949-1204.0000149; Daiyan N, 2011, CAN GEOTECH J, V48, P1683, DOI [10.1139/T11-061, 10.1139/t11-061]; [高乃辉 Gao Naihui], 2010, [灾害学, Journal of Catastrophology], V25, P71; [郭恩栋 Guo Endong], 2012, [世界地震工程, World Earthquake Engineering], V28, P8; Hall W., 1977, CURRENT STATE KNOWLE, P18; Hernandez-Fajardo I, 2013, RELIAB ENG SYST SAFE, V111, P260, DOI 10.1016/j.ress.2012.10.012; Honegger D.G., 2002, 2002 4 INT PIPELINE, P563, DOI [10.1115/IPC2002-27330, DOI 10.1115/IPC2002-27330]; Hu Y., 2006, EARTHQUAKE ENG; Huang DL, 2020, J PIPELINE SYST ENG, V11, DOI 10.1061/(ASCE)PS.1949-1204.0000457; Karimian H, 2006, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE ON OFFSHORE MECHANICS AND ARCTIC ENGINEERING, VOL 4, P73; [李杰 Li Jie], 2006, [地震工程与工程振动, Earthquake Engineering and Engineering Vibration], V26, P172; [李倩 Li Qian], 2019, [灾害学, Journal of Catastrophology], V34, P83; [刘晶波 LIU Jingbo], 2006, [岩土工程学报, Chinese Journal of Geotechnical Engineering], V28, P1070; Liu R, 2015, J COASTAL RES, P391, DOI 10.2112/SI73-069.1; Liu W, 2020, EARTHQ ENG ENG VIB, V19, P791, DOI 10.1007/s11803-020-0596-4; Liu W, 2018, SOIL DYN EARTHQ ENG, V106, P41, DOI 10.1016/j.soildyn.2017.12.014; Liu W, 2017, SOIL DYN EARTHQ ENG, V100, P113, DOI 10.1016/j.soildyn.2017.05.024; Liu XJ, 1990, SEISMIC HAZARD PREDI, P87; Meng H, 2008, CHIN J UNDERGROUND S, V4, P852; Mertz GE, 1993, AM SOC MECH ENG ASME, P25; Miao HQ, 2016, SOIL DYN EARTHQ ENG, V90, P510, DOI 10.1016/j.soildyn.2016.09.022; Ministry of Construction of the People's Republic of China, 2003, 500322003 GB; Ministry of Housing and Urban-Rural Development of the People's Republic of China, 2016, 500112010 GB; Nordberg C., 1992, NCEER920014 STAT U; O'Rourke TD., 2008, GEOTECHNICAL EARTHQU, P1; ORourke MJ, 2012, MCEER MONOGRAPH MCEE; Qu TJ, 2013, J PIPELINE SYST ENG, V4, DOI 10.1061/(ASCE)PS.1949-1204.0000144; Shinozuka M., 1979, PVP34 ASME, V34, P31; Shiro T., 1997, SPECIAL STRUCTURES, V4, P25; Sim WW, 2012, SOIL DYN EARTHQ ENG, V35, P59, DOI 10.1016/j.soildyn.2011.11.005; Tang AP, 2006, J HARBIN I TECHNOLOG, P398; Trautmann C.H., 1983, GEOTECHNICAL ENG REP, P83; Wang C, 2015, SOIL DYN EARTHQ ENG, V79, P171, DOI 10.1016/j.soildyn.2015.09.008; [王绍杰 WANG Shaojie], 2007, [世界地震工程, World Earthquake Engineering], V23, P47; Wang XJ, 2011, ADV MATER RES-SWITZ, V194-196, P1938, DOI 10.4028/www.scientific.net/AMR.194-196.1938; Wijewickreme D, 2009, CAN GEOTECH J, V46, P735, DOI 10.1139/T09-019; Wu BC, 2016, RELIAB ENG SYST SAFE, V147, P1, DOI 10.1016/j.ress.2015.10.019; Xiao Y, 1990, SPECIAL STRUCTURES, V7, P43; Yan KM, 2017, ROCK SOIL MECH, V38, P2621, DOI 10.16285/j.rsm.2017.09.020; [张波 ZHANG Bo], 2010, [世界地震工程, World Earthquake Engineering], V26, P153; Zhang J, 2016, J PRESS VESS-T ASME, V138, DOI 10.1115/1.4032991	43	1	1	16	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0247677	10.1371/journal.pone.0247677	http://dx.doi.org/10.1371/journal.pone.0247677			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU3OZ	33684122	Green Published, gold			2022-12-26	WOS:000627193500022
J	Kupriyanova, G; Rafalskiy, V; Mershiev, I; Moiseeva, E				Kupriyanova, Galina; Rafalskiy, Vladimir; Mershiev, Ivan; Moiseeva, Ekaterina			NMR spectroscopy reveals acetylsalicylic acid metabolites in the human urine for drug compliance monitoring	PLOS ONE			English	Article							QUANTITATIVE-DETERMINATION; ASPIRIN; IDENTIFICATION; ADHERENCE; SERUM	Cardiovascular disease is the leading cause of morbidity and mortality worldwide. Long-term use of antiplatelet drugs is a well-studied therapy for the prevention of cardiovascular death. Ensuring compliance with lifelong administration of antiplatelet drugs, in particular acetylsalicylic acid, is one of the challenges of such therapy. The aim of this study is to explore the possibility of using nuclear magnetic resonance spectroscopy to identify acetylsalicylic acid metabolites in urine and to search for characteristic markers that could be used to detect patient compliance with long-term acetylsalicylic acid treatment.	[Kupriyanova, Galina; Rafalskiy, Vladimir; Mershiev, Ivan; Moiseeva, Ekaterina] Immanuel Kant Baltic Fed Univ, Kaliningrad, Russia	Immanuel Kant Baltic Federal University	Rafalskiy, V (corresponding author), Immanuel Kant Baltic Fed Univ, Kaliningrad, Russia.	V.Rafalskiy@mail.ru	Rafalskiy, Vladimir V/G-3172-2013; Galina, Kupriyanova/ABA-8818-2021; Mershiev, Ivan/B-1227-2018	Rafalskiy, Vladimir V/0000-0002-2503-9580; Mershiev, Ivan/0000-0001-5677-9429; Moiseeva, Ekaterina/0000-0003-4052-1604	Russian Foundation of Fundamental research and government of Kaliningrad region [19415-390001]	Russian Foundation of Fundamental research and government of Kaliningrad region	The studies reported in this publication were supported by a grant from the Russian Foundation of Fundamental research and government of Kaliningrad region, project No. 19415-390001.	Baxter GJ, 2002, ANN CLIN BIOCHEM, V39, P50, DOI 10.1258/0004563021901739; BOCHNER F, 1989, THROMB HAEMOSTASIS, V61, P211; Emwas AH, 2019, METABOLITES, V9, DOI 10.3390/metabo9070123; HUTT AJ, 1986, XENOBIOTICA, V16, P239, DOI 10.3109/00498258609043527; Imbenotte M, 2003, FORENSIC SCI INT, V133, P132, DOI 10.1016/S0379-0738(03)00059-8; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; KMETEC V, 1992, J PHARMACEUT BIOMED, V10, P1073, DOI 10.1016/0731-7085(91)80122-P; Kolokolova TN, 2008, BIOCHEM MOSC-SUPPL S, V2, P418, DOI 10.1134/S1990750808040136; KONSTANTIANOS DG, 1992, ANALYST, V117, P877, DOI 10.1039/an9921700877; Lawrence JR, 2003, J CLIN PATHOL, V56, P651, DOI 10.1136/jcp.56.9.651; Li JP, 2017, J PHARMACEUT BIOMED, V138, P109, DOI 10.1016/j.jpba.2016.12.038; Liu JH, 1996, J CHROMATOGR B, V675, P61; MASCHKE S, 1995, NMR BIOMED, V8, P19, DOI 10.1002/nbm.1940080105; Navaratnam K., 2017, PLATELET FUNCTION RE, DOI [10.17638/03009774, DOI 10.17638/03009774]; Navaratnam K, 2017, EUR J OBSTET GYN R B, V219, P1, DOI 10.1016/j.ejogrb.2017.10.004; Navarro SL, 2011, J NUTRIGENET NUTRIGE, V4, P110, DOI 10.1159/000327782; Nicolescu A, 2012, REV ROUM CHIM, V57, P653; Packard KA, 2016, CARDIOVASC THER, V34, P415, DOI 10.1111/1755-5922.12211; Paterson JR, 1998, J CLIN PATHOL, V51, P502, DOI 10.1136/jcp.51.7.502; PEDERSEN AK, 1984, NEW ENGL J MED, V311, P1206, DOI 10.1056/NEJM198411083111902; VERMEERSCH G, 1988, CLIN CHEM, V34, P1003; Violi F, 2006, LANCET, V367, P2059, DOI 10.1016/S0140-6736(06)68924-1	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0247102	10.1371/journal.pone.0247102	http://dx.doi.org/10.1371/journal.pone.0247102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU3OZ	33684129	gold, Green Published			2022-12-26	WOS:000627193500010
J	Jakobsen, MD; Obstfelder, A; Braaten, T; Abelsen, B				Jakobsen, Monika Dybdahl; Obstfelder, Aud; Braaten, Tonje; Abelsen, Birgit			The self-management work of food hypersensitivity	PLOS ONE			English	Article								Background Food hypersensitivity (FH) has received considerable attention in the scientific community in recent years. However, little attention has been given to the efforts people make to manage their FH. We aimed to explore these efforts by using Normalization Process Theory, which is a conceptual framework formerly used to describe the self-management 'work' of long-term conditions. Methods We carried out qualitative individual interviews with 16 women with FH. Transcripts from recorded interviews were analyzed using template analysis. Results 16 women participated; some had diagnoses from conventional medicine (celiac disease, lactose intolerance, food allergies, irritable bowel syndrome) and some did not. Participants described carrying out several tasks, some of which were time-consuming, to manage their FH. Women who had clarified once and for all what food(s) caused symptoms, described that they could concentrate on carrying out a restricted diet, which could become routine. Conversely, participants who had not achieved such clarification described carrying out tasks to identify what food(s) caused symptoms, and to implement and evaluate a tentative diet. Participants' descriptions also revealed a heightened vigilance when they ate food that others had prepared, and some made efforts to conceal their FH. Conclusions Self-management of FH may, like the self-management of other long-term conditions, imply a large workload and burden of treatment. Efforts made to conceal FH may be considered part of this workload, while help in clarifying which food(s) cause symptoms has the potential to reduce the workload.	[Jakobsen, Monika Dybdahl] UiT Arctic Univ Norway, Ctr Care Res, Tromso, Norway; [Jakobsen, Monika Dybdahl; Braaten, Tonje] UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway; [Obstfelder, Aud] Norwegian Univ Sci & Technol NTNU, Ctr Care Res, Gjovik, Norway; [Abelsen, Birgit] UiT Arctic Univ Norway, Norwegian Ctr Rural Med, Dept Community Med, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso	Jakobsen, MD (corresponding author), UiT Arctic Univ Norway, Ctr Care Res, Tromso, Norway.; Jakobsen, MD (corresponding author), UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway.	monika.d.jakobsen@uit.no			Department of Community Medicine, UiT The Arctic University of Norway [4025]	Department of Community Medicine, UiT The Arctic University of Norway	MJ was supported by the Department of Community Medicine, UiT The Arctic University of Norway (https://en.uit.no/enhet/ism), grant agreement 4025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan G, 2004, DIGEST DIS SCI, V49, P680, DOI 10.1023/B:DDAS.0000026318.81635.3b; Begen FM, 2018, CLIN EXP ALLERGY, V48, P317, DOI 10.1111/cea.13072; Berstad A, 2012, SCAND J GASTROENTERO, V47, P914, DOI 10.3109/00365521.2012.690045; Birdi Gurkiran, 2016, J Allergy (Cairo), V2016, P1497375, DOI 10.1155/2016/1497375; Bolle R., 2012, HELSERADET RAPPORT S, P3; Brooks J, 2015, QUAL RES PSYCHOL, V12, P202, DOI 10.1080/14780887.2014.955224; Bugge A., 2006, SPISE MIDDAG MATSOSI; Bugge A. B., 2015, Journal of Food Research, V4, P89; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Casellas F, 2016, EUR J CLIN NUTR, V70, P1068, DOI 10.1038/ejcn.2016.80; Ch'ng CL, 2007, CLIN MED RES, V5, P184, DOI 10.3121/cmr.2007.738; Charmaz K, 1983, Sociol Health Illn, V5, P168, DOI 10.1111/1467-9566.ep10491512; Christensen BJ., 2015, MADSOCIOLOGI, P51; Corbin J., 1985, QUALITATIVE SOCIOLOG, V8, P224, DOI [10.1007/BF00989485, DOI 10.1007/BF00989485]; Cummings AJ, 2010, ALLERGY, V65, P933, DOI 10.1111/j.1398-9995.2010.02342.x; Diesen PS, 2015, SCAND J DISABIL RES, V17, P321, DOI 10.1080/15017419.2014.941003; Dobler CC, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4065; El-Serag HB, 2002, ALIMENT PHARM THER, V16, P1171, DOI 10.1046/j.1365-2036.2002.01290.x; Eton DT, 2012, PATIENT-RELAT OUTCOM, V3, P39, DOI 10.2147/PROM.S34681; FISCHLER C, 1988, SOC SCI INFORM, V27, P275, DOI 10.1177/053901888027002005; Fischler C., 2015, SELECTIVE EATING RIS, P15; Fischler C, 2011, SOC SCI INFORM, V50, P528, DOI 10.1177/0539018411413963; Fournier T, 2018, QUAL HEALTH RES, V28, P2195, DOI 10.1177/1049732318793417; Gallacher K, 2011, ANN FAM MED, V9, P235, DOI 10.1370/afm.1249; Gallacher KI, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-017-0691-4; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hallert C, 2003, SCAND J CARING SCI, V17, P301, DOI 10.1046/j.1471-6712.2003.00228.x; Jakobsen MD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168653; Johansson SGO, 2001, ALLERGY, V56, P813, DOI 10.1034/j.1398-9995.2001.t01-1-00001.x; Kahn LS, 2015, CHRONIC ILLN, V11, P171, DOI 10.1177/1742395314559751; King JA, 2019, J HUM NUTR DIET, V32, P72, DOI 10.1111/jhn.12597; King N., 2004, ESSENTIAL GUIDE QUAL, P256, DOI DOI 10.4135/9781446280119.N21; Lind R, 2005, DIGEST DIS SCI, V50, P1245, DOI 10.1007/s10620-005-2767-6; Ludvigsson JF, 2014, GUT, V63, P1210, DOI 10.1136/gutjnl-2013-306578; MacKenzie H, 2010, PEDIAT ALLERG IMM-UK, V21, P595, DOI 10.1111/j.1399-3038.2009.00938.x; Mair FS, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6680; Malterud K., 2011, KVALITATIVE METODER, V3; Marklund B, 2007, BMC NURS, V6, DOI 10.1186/1472-6955-6-8; Marklund B, 2007, CURR OPIN ALLERGY CL, V7, P279, DOI 10.1097/ACI.0b013e32814a569b; Maslin K, 2018, J HUM NUTR DIET, V31, P209, DOI 10.1111/jhn.12495; Mattar R, 2012, CLIN EXP GASTROENTER, V5, P113, DOI 10.2147/CEG.S32368; May C, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2803; May CR, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-281; Mielby H., 2015, MADSOCIOLOGI, P161; Nettleton S., 2013, SOCIOL HEALTH ILL; Nettleton S, 2009, HEALTH-LONDON, V13, P647, DOI 10.1177/1363459308341433; Olsson C, 2009, QUAL HEALTH RES, V19, P976, DOI 10.1177/1049732309338722; Rona RJ, 2007, J ALLERGY CLIN IMMUN, V120, P638, DOI 10.1016/j.jaci.2007.05.026; Sav A, 2015, HEALTH EXPECT, V18, P312, DOI 10.1111/hex.12046; Sav A, 2013, HEALTH SOC CARE COMM, V21, P665, DOI 10.1111/hsc.12052; Sayuk GS, 2015, AM J MED, V128, P817, DOI 10.1016/j.amjmed.2015.01.036; Skodje GI, 2018, GASTROENTEROLOGY, V154, P529, DOI 10.1053/j.gastro.2017.10.040; Sorensen M., 2017, THESIS UIT ARCTIC U; Strinnholm A, 2017, THESIS UMEA U, DOI [1078954/FULLTEXT01.pdf, DOI 1078954/FULLTEXT01.PDF]; Sutton Jane, 2015, Can J Hosp Pharm, V68, P226; Sverker A, 2005, J HUM NUTR DIET, V18, P171, DOI 10.1111/j.1365-277X.2005.00591.x; van der Velde JL, 2013, CURR ALLERGY ASTHM R, V13, P651, DOI 10.1007/s11882-013-0391-7; Wolf RL, 2018, DIGEST DIS SCI, V63, P1438, DOI 10.1007/s10620-018-4936-4	58	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0248181	10.1371/journal.pone.0248181	http://dx.doi.org/10.1371/journal.pone.0248181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667275	Green Published, gold			2022-12-26	WOS:000626604300059
J	Kim, KS; Jekarl, DW; Yoo, J; Lee, S; Kim, M; Kim, Y				Kim, Kyung Soo; Jekarl, Dong Wook; Yoo, Jaeeun; Lee, Seungok; Kim, Myungshin; Kim, Yonggoo			Immune gene expression networks in sepsis: A network biology approach	PLOS ONE			English	Article							INTERNATIONAL CONSENSUS DEFINITIONS; SEPTIC SHOCK PATIENTS; IMMUNOSUPPRESSION; PLATELETS; BACTERIAL; CYTOKINE; PROTEIN; BLOOD	To study the dysregulated host immune response to infection in sepsis, gene expression profiles from the Gene Expression Omnibus (GEO) datasets GSE54514, GSE57065, GSE64456, GSE95233, GSE66099 and GSE72829 were selected. From the Kyoto Encyclopedia of Genes and Genomes (KEGG) immune system pathways, 998 unique genes were selected, and genes were classified as follows based on gene annotation from KEGG, Gene Ontology, and Reactome: adaptive immunity, antigen presentation, cytokines and chemokines, complement, hematopoiesis, innate immunity, leukocyte migration, NK cell activity, platelet activity, and signaling. After correlation matrix formation, correlation coefficient of 0.8 was selected for network generation and network analysis. Total transcriptome was analyzed for differentially expressed genes (DEG), followed by gene set enrichment analysis. The network topological structure revealed that adaptive immunity tended to form a prominent and isolated cluster in sepsis. Common genes within the cluster from the 6 datasets included CD247, CD8A, ITK, LAT, and LCK. The clustering coefficient and modularity parameters were increased in 5/6 and 4/6 datasets in the sepsis group that seemed to be associated with functional aspect of the network. GSE95233 revealed that the nonsurvivor group showed a prominent and isolated adaptive immunity cluster, whereas the survivor group had isolated complement-coagulation and platelet-related clusters. T cell receptor signaling (TCR) pathway and antigen processing and presentation pathway were down-regulated in 5/6 and 4/6 datasets, respectively. Complement and coagulation, Fc gamma, epsilon related signaling pathways were up-regulated in 5/6 datasets. Altogether, network and gene set enrichment analysis showed that adaptive-immunity-related genes along with TCR pathway were down-regulated and isolated from immune the network that seemed to be associated with unfavorable prognosis. Prominence of platelet and complement-coagulation-related genes in the immune network was associated with survival in sepsis. Complement-coagulation pathway was up-regulated in the sepsis group that was associated with favorable prognosis. Network and gene set enrichment analysis supported elucidation of sepsis pathogenesis.	[Kim, Kyung Soo] Catholic Univ Korea, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul St Marys Hosp, Seoul, South Korea; [Jekarl, Dong Wook; Kim, Myungshin; Kim, Yonggoo] Catholic Univ Korea, Coll Med, Dept Lab Med, Seoul St Marys Hosp, Seoul, South Korea; [Jekarl, Dong Wook; Yoo, Jaeeun; Lee, Seungok; Kim, Myungshin; Kim, Yonggoo] Catholic Univ Korea, Coll Med, Lab Dev & Evaluat Ctr, Seoul St Marys Hosp, Seoul, South Korea; [Yoo, Jaeeun; Lee, Seungok] Catholic Univ Korea, Coll Med, Dept Lab Med, Incheon St Marys Hosp, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Jekarl, DW (corresponding author), Catholic Univ Korea, Coll Med, Dept Lab Med, Seoul St Marys Hosp, Seoul, South Korea.; Jekarl, DW (corresponding author), Catholic Univ Korea, Coll Med, Lab Dev & Evaluat Ctr, Seoul St Marys Hosp, Seoul, South Korea.	bonokarl@catholic.ac.kr		Kyung Soo, Kim/0000-0002-3680-9851	Seoul St. Mary's Hospital, The Catholic University of Korea	Seoul St. Mary's Hospital, The Catholic University of Korea	This study was funded by Seoul St. Mary's Hospital, The Catholic University of Korea to promote scientific work. This hosptial is affiliated to The Catholic University of Korea, Seoul, Korea. Six of the authors work at University. As following authors work at the hospital, they received a salary from Incheon St Mary's Hospital, which is affiliated to The Catholic University of Korea, Seoul, Korea.: Kyung Soo Kim, Dong Wook Jekarl, Myungshin Kim, Yonggoo Kim, Jaeeun Yoo and Seungok Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.281pe44; Alpert A, 2019, NAT MED, V25, P487, DOI 10.1038/s41591-019-0381-y; Barabasi A-L., 2016, NETW SCI, DOI [10.1017/nws.2016.2, DOI 10.1017/NWS.2016.2]; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bermejo-Martin JF, 2016, J INFECTION, V72, P525, DOI 10.1016/j.jinf.2016.01.010; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Carlson M., 2013, LUMIHUMANALL DB ILLU; CARLSON M, 2016, HGU133PLUS2 DB AFFYM; Cazalis MA, 2014, INTENS CARE MED EXP, V2, DOI 10.1186/s40635-014-0020-3; Delano MJ, 2016, IMMUNOL REV, V274, P330, DOI 10.1111/imr.12499; Dewitte A, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0337-7; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Draghici S, 2012, STATITICS DATA ANAL; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Falcon S., 2007, INTRO BIOCONDUCTORS; Galindo-Albarran AO, 2016, CELL REP, V17, P2151, DOI 10.1016/j.celrep.2016.10.056; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Herberg JA, 2016, JAMA-J AM MED ASSOC, V316, P835, DOI 10.1001/jama.2016.11236; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Jaksik R, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0077-2; Jekarl DW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224318; Jekarl DW, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/1089107; Jekarl DW, 2018, EUR CYTOKINE NETW, V29, P103, DOI 10.1684/ecn.2018.0414; Jekarl DW, 2015, CLIN CHEM LAB MED, V53, P575, DOI 10.1515/cclm-2014-0607; Jekarl DW, 2013, DIAGN MICR INFEC DIS, V75, P342, DOI 10.1016/j.diagmicrobio.2012.12.011; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Leligdowicz A, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2372-2; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Mahajan P, 2016, JAMA-J AM MED ASSOC, V316, P846, DOI 10.1001/jama.2016.9207; Matsumoto H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32275-8; Mitra K, 2013, NAT REV GENET, V14, P719, DOI 10.1038/nrg3552; Netanalyzer, 2017, GERM M PLANK I INF; Newman MEJ., 2010, NETWORKS ANTRODUCTIO, DOI DOI 10.1093/ACPROF:OSO/9780199206650.001.0001; Parnell GP, 2013, SHOCK, V40, P166, DOI 10.1097/SHK.0b013e31829ee604; Pavlopoulos GA, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-10; R Developoment Core Team, 2017, **DATA OBJECT**; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ritchie ME, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002276; Rogge L, 2000, NAT GENET, V25, P96, DOI 10.1038/75671; Rudd KE, 2020, LANCET, V395, P200, DOI 10.1016/S0140-6736(19)32989-7; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stocker TJ, 2017, THROMB HAEMOSTASIS, V117, P651, DOI 10.1160/TH16-12-0921; Sweeney TE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03078-2; Sweeney TE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5993; Venet F, 2017, HUM IMMUNOL, V78, P441, DOI 10.1016/j.humimm.2017.03.010; Wagner GP, 2007, NAT REV GENET, V8, P921, DOI 10.1038/nrg2267; Zhang ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005686; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	56	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0247669	10.1371/journal.pone.0247669	http://dx.doi.org/10.1371/journal.pone.0247669			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667236	gold, Green Published			2022-12-26	WOS:000626604300001
J	Rawat, V; Malvi, P; Della Manna, D; Yang, ES; Bugide, S; Zhang, XC; Gupta, R; Wajapeyee, N				Rawat, Vipin; Malvi, Parmanand; Della Manna, Deborah; Yang, Eddy S.; Bugide, Suresh; Zhang, Xuchen; Gupta, Romi; Wajapeyee, Narendra			PSPH promotes melanoma growth and metastasis by metabolic deregulation-mediated transcriptional activation of NR4A1	ONCOGENE			English	Article								Metabolic deregulation, a hallmark of cancer, fuels cancer cell growth and metastasis. Here, we show that phosphoserine phosphatase (PSPH), an enzyme of the serine metabolism pathway, is upregulated in patient-derived melanoma samples. PSPH knockdown using short hairpin RNAs (shRNAs) blocks melanoma tumor growth and metastasis in both cell culture and mice. To elucidate the mechanism underlying PSPH action, we evaluated PSPH shRNA-expressing melanoma cells using global metabolomics and targeted mRNA expression profiling. Metabolomics analysis showed an increase in 2-hydroxyglutarate (2-HG) levels in PSPH knockdown cells. 2-HG inhibits the TET family of DNA demethylases and the Jumonji family of histone demethylases (KDM and JMJD), which is known to impact gene expression. Consistent with these data, PSPH knockdown in melanoma cells showed reduced DNA 5-hydroxymethylcytosine (5hmC) and increased histone H3K4me3 modifications. 2-HG treatment also inhibited melanoma growth. The nCounter PanCancer Pathways Panel-based mRNA expression profiling revealed attenuation of a number of cancer-promoting pathways upon PSPH knockdown. In particular, PSPH was necessary for nuclear receptor NR4A1 expression. Ectopic NR4A1 expression partly rescued the growth of melanoma cells expressing PSPH shRNA. Collectively, these results link PSPH to the facilitation of melanoma growth and metastasis through suppression of 2-HG and thus activation of pro-oncogenic gene expression.	[Rawat, Vipin; Malvi, Parmanand; Bugide, Suresh; Gupta, Romi; Wajapeyee, Narendra] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Della Manna, Deborah; Yang, Eddy S.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL USA; [Zhang, Xuchen] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Yale University	Wajapeyee, N (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA.	nwajapey@uab.edu	Bugide, Suresh/AAD-6053-2022; zhang, xu/GYE-3558-2022; rawat, vipin/AAJ-3623-2021	rawat, vipin/0000-0003-2070-2299; Gupta, Romi/0000-0001-5108-5962; Wajapeyee, Narendra/0000-0003-3306-349X; Zhang, Xuchen/0000-0002-1484-4672	NCATS NIH HHS [UL1 TR001863] Funding Source: Medline; NCI NIH HHS [R21 CA229927, R01 CA218008, R01 CA200919, R01 CA196566] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Amelio I, 2014, TRENDS BIOCHEM SCI, V39, P191, DOI 10.1016/j.tibs.2014.02.004; Bachelor MA, 2011, J DERMATOL SCI, V63, P164, DOI 10.1016/j.jdermsci.2011.06.001; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Cao LX, 2019, MOL CANCER THER, V18, P3, DOI 10.1158/1535-7163.MCT-18-0863; Chen JY, 2013, ONCOTARGET, V4, P2502, DOI 10.18632/oncotarget.1540; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; DiNardo CD, 2018, NEW ENGL J MED, V378, P2386, DOI 10.1056/NEJMoa1716984; Fan J, 2015, ACS CHEM BIOL, V10, P510, DOI 10.1021/cb500683c; Fischer GM, 2018, PIGM CELL MELANOMA R, V31, P11, DOI 10.1111/pcmr.12661; Gao S, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0648-4; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; Jin HO, 2019, ANTICANCER RES, V39, P6723, DOI 10.21873/anticanres.13887; Kakadia S, 2018, ONCOTARGETS THER, V11, P7095, DOI 10.2147/OTT.S182721; Kampen KR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10508-2; Koo JS, 2015, AM J CLIN PATHOL, V143, P584, DOI 10.1309/AJCPXAYH10WENLTC; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Li SS, 2015, MOL CELL, V60, P408, DOI 10.1016/j.molcel.2015.09.024; Li XX, 2018, MOL CELL, V69, P480, DOI 10.1016/j.molcel.2018.01.001; Liao L, 2019, INT J BIOL SCI, V15, P183, DOI 10.7150/ijbs.29203; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Luke JJ, 2017, NAT REV CLIN ONCOL, V14, P463, DOI 10.1038/nrclinonc.2017.43; Mattaini KR, 2016, J CELL BIOL, V214, P248, DOI 10.1083/jcb.201604085; McCabe A, 2005, JNCI-J NATL CANCER I, V97, P1808, DOI 10.1093/jnci/dji427; Mullarky E, 2011, PIGM CELL MELANOMA R, V24, P1112, DOI 10.1111/j.1755-148X.2011.00919.x; Nowicki TS, 2018, CANCER J, V24, P47, DOI 10.1097/PPO.0000000000000303; Pacold ME, 2016, NAT CHEM BIOL, V12, P452, DOI [10.1038/NCHEMBIO.2070, 10.1038/nchembio.2070]; Park SM, 2019, MOL CELLS, V42, P604, DOI 10.14348/molcells.2019.0160; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Ratnikov BI, 2017, ONCOGENE, V36, P147, DOI 10.1038/onc.2016.198; Sato K, 2017, ANTICANCER RES, V37, P2365, DOI 10.21873/anticanres.11574; Song ZW, 2018, GENE, V642, P43, DOI 10.1016/j.gene.2017.11.014; Su R, 2018, CELL, V172, P90, DOI 10.1016/j.cell.2017.11.031; Sullivan MR, 2019, CELL METAB, V29, P1410, DOI 10.1016/j.cmet.2019.02.015; Tan EH, 2010, ANN ONCOL, V21, P217, DOI 10.1093/annonc/mdp520; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Wang CY, 2020, AM J CANCER RES, V10, P95; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Ye D, 2018, TRENDS CANCER, V4, P151, DOI 10.1016/j.trecan.2017.12.005; Zhan YY, 2012, NAT CHEM BIOL, V8, P897, DOI [10.1038/NCHEMBIO.1069, 10.1038/nchembio.1069]; Zhang BX, 2017, CELL REP, V19, P2289, DOI 10.1016/j.celrep.2017.05.067; Zhao GS, 1996, J BACTERIOL, V178, P232, DOI 10.1128/jb.178.1.232-239.1996	49	5	5	1	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 1	2021	40	13					2448	2462		10.1038/s41388-021-01683-y	http://dx.doi.org/10.1038/s41388-021-01683-y		MAR 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RH1BQ	33674745	Green Accepted			2022-12-26	WOS:000625607100002
J	Bengali, M; Goodman, S; Sun, XY; Dohil, MA; Dohil, R; Newbury, R; Lobry, T; Hernandez, L; Antignac, C; Jain, S; Cherqui, S				Bengali, Marya; Goodman, Spencer; Sun, Xiaoying; Dohil, Magdalene A.; Dohil, Ranjan; Newbury, Robert; Lobry, Tatiana; Hernandez, Laura; Antignac, Corinne; Jain, Sonia; Cherqui, Stephanie			Non-invasive intradermal imaging of cystine crystals in cystinosis	PLOS ONE			English	Article								Importance Development of noninvasive methodology to reproducibly measure tissue cystine crystal load to assess disease status and guide clinical care in cystinosis, an inherited lysosomal storage disorder characterized by widespread cystine crystal accumulation. Objective To develop an unbiased and semi-automated imaging methodology to quantify dermal cystine crystal accumulation in patients to correlate with disease status. Design, setting and participants 101 participants, 70 patients and 31 healthy controls, were enrolled at the University of California, San Diego, Cystinosis Clinics, Rady Children's Hospital, San Diego and at the annual Cystinosis Research Foundation family conference for an ongoing prospective longitudinal cohort study of cystinosis patients with potential yearly follow-up. Exposures Intradermal reflectance confocal microscopy (RCM) imaging, blood collection via standard venipuncture, medical record collection, and occasional skin punch biopsies. Main outcomes and measures The primary outcome was to establish an automated measure of normalized confocal crystal volume (nCCV) for each subject. Secondary analysis examined the association of nCCV with various clinical indicators to assess nCCV's possible predictive potential. Results Over 2 years, 57 patients diagnosed with cystinosis (median [range] age: 15.1 yrs [0.8, 54]; 41.4% female) were intradermally assessed by RCM to produce 84 image stacks. 27 healthy individuals (38.7 yrs [10, 85]; 53.1% female) were also imaged providing 37 control image stacks. Automated 2D crystal area quantification revealed that patients had significantly elevated crystal accumulation within the superficial dermis. 3D volumetric analysis of this region was significantly higher in patients compared to healthy controls (mean [SD]: 1934.0 mu m3 [1169.1] for patients vs. 363.1 mu m(3) [194.3] for controls, P<0.001). Medical outcome data was collected from 43 patients with infantile cystinosis (media [range] age: 11 yrs [0.8, 54]; 51% female). nCCV was positively associated with hypothyroidism (OR = 19.68, 95% CI: [1.60, 242.46], P = 0.02) and stage of chronic kidney disease (slope estimate = 0.53, 95%CI: [0.05, 1.00], P = 0.03). Conclusions and relevance This study used non-invasive RCM imaging to develop an intradermal cystine crystal quantification method. Results showed that cystinosis patients had increased nCCV compared to healthy controls. Level of patient nCCV correlated with several clinical outcomes suggesting nCCV may be used as a potential new biomarker for cystinosis to monitor long-term disease control and medication compliance.	[Bengali, Marya; Goodman, Spencer; Lobry, Tatiana; Hernandez, Laura; Cherqui, Stephanie] Univ Calif San Diego, Dept Pediat, Div Genet, La Jolla, CA 92093 USA; [Sun, Xiaoying; Jain, Sonia] Univ Calif San Diego, Biostat Res Ctr, Herbert Wertheim Sch Publ Hlth & Human Longev Sci, La Jolla, CA 92093 USA; [Dohil, Magdalene A.] Rady Childrens Hosp, Dept Dermatol, Div Pediat Dermatol, San Diego, CA USA; [Dohil, Ranjan] Univ Calif San Diego, Dept Gastroenterol, Rady Childrens Hosp, Div Pediat Gastroenterol, San Diego, CA USA; [Newbury, Robert] Univ Calif San Diego, Dept Pathol, Rady Childrens Hosp, San Diego, CA 92103 USA; [Antignac, Corinne] Univ Paris, Imagine Inst, Lab Hereditary Kidney Dis, Inserm UMR1163, Paris, France; [Antignac, Corinne] Hop Necker Enfants Malad, AP HP, Dept Mol Genet, Paris, France	University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Cherqui, S (corresponding author), Univ Calif San Diego, Dept Pediat, Div Genet, La Jolla, CA 92093 USA.	scherqui@ucsd.edu	ANTIGNAC, Corinne/H-8945-2017	ANTIGNAC, Corinne/0000-0002-9934-4940; Goodman, Spencer/0000-0001-5825-5055	National Institutes of Health (NIH) [R01-DK090058, R01-NS108965]; California Institute of Regenerative Medicine (CIRM) [CLIN-09230]; cystinosis Research Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); cystinosis Research Foundation	Stephanie Cherqui received the following funding sources to support this work. 1) National Institutes of Health (NIH), grant numbers R01-DK090058 and R01-NS108965. https://urldefense.com/v3/__http://www.nih.gov__;!!LLK065n_ VXAQ!0bgSNM3dVDb5-fgGwjiBhx71 bGSI2G9GR2oGYLXpURq4hXISFUlHgH5r8-uSxWqDYSo$. 2) California Institute of Regenerative Medicine (CIRM), grant number CLIN-09230. https://urldefense.com/v3/__https://www.cirm.ca.gov/__;!!LLK065n_VXAQ! 0bgSNM3dVDb5-fgGwjiBhx71bGSI2G9 GR2oGYLXpURq4hXISFUlHgH5r8-uSD78zFm4$. 3) The cystinosis Research Foundation https://www.cystinosisresearch.org/.	Ariceta G, 2015, NEPHROL DIAL TRANSPL, V30, P475, DOI 10.1093/ndt/gfu329; Baumner S, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00058; Belldina EB, 2003, BRIT J CLIN PHARMACO, V56, P520, DOI 10.1046/j.1365-2125.2003.01927.x; Brodin-Sartorius A, 2012, KIDNEY INT, V81, P179, DOI 10.1038/ki.2011.277; Brown T.M, 2020, HISTOLOGY DERMIS; Cherqui S, 2017, NAT REV NEPHROL, V13, P115, DOI 10.1038/nrneph.2016.182; Cherqui S, 2012, KIDNEY INT, V81, P127, DOI 10.1038/ki.2011.301; Chiaverini C, 2013, J AM ACAD DERMATOL, V68, pE111, DOI 10.1016/j.jaad.2011.08.010; Chiaverini C, 2012, FASEB J, V26, P3779, DOI 10.1096/fj.11-201376; Cichorek M, 2013, POSTEP DERM ALERGOL, V30, P30, DOI 10.5114/pdia.2013.33376; Dohil R, 2012, J PEDIATR-US, V161, P531, DOI 10.1016/j.jpeds.2012.03.011; Emma F, 2014, NEPHROL DIAL TRANSPL, V29, P87, DOI 10.1093/ndt/gfu090; Forestier L, 1999, AM J HUM GENET, V65, P353, DOI 10.1086/302509; Gahl WA, 2002, NEW ENGL J MED, V347, P111, DOI 10.1056/NEJMra020552; Gahl WA, 2007, ANN INTERN MED, V147, P242, DOI 10.7326/0003-4819-147-4-200708210-00006; Gertsman I, 2016, CLIN CHEM, V62, P766, DOI 10.1373/clinchem.2015.252494; Greco M, 2010, PEDIATR NEPHROL, V25, P2459, DOI 10.1007/s00467-010-1641-8; Guimaraes Luciana Pache de Faria, 2012, J Bras Nefrol, V34, P309; Haffner D, 1999, NEPHRON, V83, P250, DOI 10.1159/000045518; Ivanova E, 2014, PEDIATR ENDOCR REV P, V12, P176; Kalatzis V, 2001, EMBO J, V20, P5940, DOI 10.1093/emboj/20.21.5940; Kawasaki K, 2015, INT J DERMATOL, V54, P295, DOI 10.1111/ijd.12220; Levtchenko Elena, 2017, J Pediatr, V183S, pS5, DOI 10.1016/j.jpeds.2016.12.049; Lobry T, 2019, KIDNEY INT, V96, P350, DOI 10.1016/j.kint.2019.01.029; Maarouf M, 2019, ACTAS DERMO-SIFILOGR, V110, P626, DOI 10.1016/j.ad.2018.08.008; Navarrete-Dechent C, 2020, J EUR ACAD DERMATOL, V34, P74, DOI 10.1111/jdv.15819; Schwartz GJ, 2009, CLIN J AM SOC NEPHRO, V4, P1832, DOI 10.2215/CJN.01640309; Town M, 1998, NAT GENET, V18, P319, DOI 10.1038/ng0498-319; Wilmer MJ, 2011, PEDIATR NEPHROL, V26, P205, DOI 10.1007/s00467-010-1627-6	29	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0247846	10.1371/journal.pone.0247846	http://dx.doi.org/10.1371/journal.pone.0247846			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33661986	Green Published, gold			2022-12-26	WOS:000626604100036
J	He, HL; Miao, RY; Huang, LL; Jiang, HS; Cheng, YQ				He, Hongli; Miao, Runyu; Huang, Lilong; Jiang, Hongshan; Cheng, Yunqing			Vegetative cells may perform nitrogen fixation function under nitrogen deprivation in Anabaena sp. strain PCC 7120 based on genome-wide differential expression analysis	PLOS ONE			English	Article							HETEROCYST DIFFERENTIATION; GENE-EXPRESSION; OXYGENIC PHOTOSYNTHESIS; CULTURES; COMPONENTS; BUOYANCY; MUTANTS; LIGHT	Nitrogen assimilation is strictly regulated in cyanobacteria. In an inorganic nitrogen-deficient environment, some vegetative cells of the cyanobacterium Anabaena differentiate into heterocysts. We assessed the photosynthesis and nitrogen-fixing capacities of heterocysts and vegetative cells, respectively, at the transcriptome level. RNA extracted from nitrogen-replete vegetative cells (NVs), nitrogen-deprived vegetative cells (NDVs), and nitrogen-deprived heterocysts (NDHs) in Anabaena sp. strain PCC 7120 was evaluated by transcriptome sequencing. Paired comparisons of NVs vs. NDHs, NVs vs. NDVs, and NDVs vs. NDHs revealed 2,044 differentially expressed genes (DEGs). Kyoto Encyclopedia of Genes and Genomes enrichment analysis of the DEGs showed that carbon fixation in photosynthetic organisms and several nitrogen metabolism-related pathways were significantly enriched. Synthesis of Gvp (Gas vesicle synthesis protein gene) in NVs was blocked by nitrogen deprivation, which may cause Anabaena cells to sink and promote nitrogen fixation under anaerobic conditions; in contrast, heterocysts may perform photosynthesis under nitrogen deprivation conditions, whereas the nitrogen fixation capability of vegetative cells was promoted by nitrogen deprivation. Immunofluorescence analysis of nitrogenase iron protein suggested that the nitrogen fixation capability of vegetative cells was promoted by nitrogen deprivation. Our findings provide insight into the molecular mechanisms underlying nitrogen fixation and photosynthesis in vegetative cells and heterocysts at the transcriptome level. This study provides a foundation for further functional verification of heterocyst growth, differentiation, and water bloom control.	[He, Hongli; Miao, Runyu; Huang, Lilong; Jiang, Hongshan; Cheng, Yunqing] Jilin Normal Univ, Jilin Prov Key Lab Plant Resource Sci & Green Pro, Siping, Jilin, Peoples R China	Jilin Normal University	Cheng, YQ (corresponding author), Jilin Normal Univ, Jilin Prov Key Lab Plant Resource Sci & Green Pro, Siping, Jilin, Peoples R China.	chengyunqing1977@163.com			National Natural Science Foundation of China [31670681, 31770723]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (No. 31670681; 31770723).	Alexa A., 2019, TOPGO ENRICHMENT ANA; Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Black K, 2004, NEW PHYTOL, V162, P125, DOI 10.1111/j.1469-8137.2004.01008.x; Campbell EL, 2007, J BACTERIOL, V189, P5247, DOI 10.1128/JB.00360-07; Cardona T, 2009, BBA-BIOENERGETICS, V1787, P252, DOI 10.1016/j.bbabio.2009.01.015; Cheng YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122072; Chua JPS, 2012, NEW PHYTOL, V196, P862, DOI 10.1111/j.1469-8137.2012.04272.x; Ehira S, 2006, MOL MICROBIOL, V59, P1692, DOI 10.1111/j.1365-2958.2006.05049.x; Ekvall MK, 2013, FRESHWATER BIOL, V58, P2414, DOI 10.1111/fwb.12220; Ferimazova N, 2013, PHOTOSYNTH RES, V116, P79, DOI 10.1007/s11120-013-9897-z; Flaherty BL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-332; Flores E, 2019, BBA-GENE REGUL MECH, V1862, P673, DOI 10.1016/j.bbagrm.2018.04.006; Fredriksson C, 1998, NEW PHYTOL, V140, P531, DOI 10.1111/j.1469-8137.1998.00284.x; Geisler E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45505-4; GOLDEN JW, 1991, J BACTERIOL, V173, P7098, DOI 10.1128/jb.173.22.7098-7105.1991; Howard JB, 2006, P NATL ACAD SCI USA, V103, P17088, DOI 10.1073/pnas.0603978103; KLEMER AR, 1982, SCIENCE, V215, P1629, DOI 10.1126/science.215.4540.1629; KONOPKA A, 1987, J PHYCOL, V23, P70; Kumazaki S, 2013, PLANT PHYSIOL, V161, P1321, DOI 10.1104/pp.112.206680; LEVINE SN, 1987, FRESHWATER BIOL, V17, P265, DOI 10.1111/j.1365-2427.1987.tb01047.x; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; MARTINEZ L, 1983, SCIENCE, V221, P152, DOI 10.1126/science.221.4606.152; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P20130, DOI 10.1073/pnas.1112724108; Molot LA, 2017, ENVIRON REV, V25, P292, DOI 10.1139/er-2016-0107; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Muro-Pastor AM, 2012, TRENDS MICROBIOL, V20, P548, DOI 10.1016/j.tim.2012.07.005; Park JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-759; PETERSON RB, 1978, P NATL ACAD SCI USA, V75, P6271, DOI 10.1073/pnas.75.12.6271; Pfeifer F, 2012, NAT REV MICROBIOL, V10, P705, DOI 10.1038/nrmicro2834; Pratte BS, 2006, J BACTERIOL, V188, P5806, DOI 10.1128/JB.00618-06; PRIVALLE LS, 1983, J BACTERIOL, V155, P940, DOI 10.1128/JB.155.2.940-942.1983; REES DC, 1993, CURR PLANT SCI BIOT, V17, P83; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; SCHRAUTEMEIER B, 1995, MOL MICROBIOL, V18, P357, DOI 10.1111/j.1365-2958.1995.mmi_18020357.x; Soo RM, 2017, SCIENCE, V355, P1436, DOI 10.1126/science.aal3794; SPENCE DW, 1987, FEMS MICROBIOL LETT, V40, P119; Stal LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05715-0; TELOR E, 1977, PROC R SOC SER B-BIO, V198, P61, DOI 10.1098/rspb.1977.0086; THIEL T, 1995, P NATL ACAD SCI USA, V92, P9358, DOI 10.1073/pnas.92.20.9358; Thiel T, 2001, J BACTERIOL, V183, P280, DOI 10.1128/JB.183.1.280-286.2001; THOMAS J, 1972, J BACTERIOL, V110, P92, DOI 10.1128/JB.110.1.92-95.1972; WALSBY AE, 1994, MICROBIOL REV, V58, P94, DOI 10.1128/MMBR.58.1.94-144.1994; Wang YL, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00076-18; WEARE NM, 1973, ARCH MIKROBIOL, V90, P323, DOI 10.1007/BF00408927; Wolk CP, 2000, PROKARYOTIC DEVELOPMENT, P83; Wolk CP, 1996, ANNU REV GENET, V30, P59, DOI 10.1146/annurev.genet.30.1.59; Zhang H, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00707-17; Zheng ZG, 2017, P NATL ACAD SCI USA, V114, pE1405, DOI 10.1073/pnas.1621424114	48	3	3	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0248155	10.1371/journal.pone.0248155	http://dx.doi.org/10.1371/journal.pone.0248155			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33662009	Green Published, gold			2022-12-26	WOS:000626604100009
J	Mai, J; Peng, XD; Tang, J; Du, T; Chen, YH; Wang, ZF; Zhang, HL; Huang, JH; Zhong, ZY; Yang, D; Li, ZL; Huang, Y; Feng, GK; Zhu, XF; Deng, R				Mai, Jia; Peng, Xiao-Dan; Tang, Jun; Du, Tian; Chen, Yu-Hong; Wang, Zi-Feng; Zhang, Hai-Liang; Huang, Jun-Hao; Zhong, Zhuo-Yan; Yang, Dong; Li, Zhi-Ling; Huang, Yun; Feng, Gong-Kan; Zhu, Xiao-Feng; Deng, Rong			AKT-mediated regulation of chromatin ubiquitylation and tumorigenesis through Mel18 phosphorylation	ONCOGENE			English	Article							POLYCOMB GROUP GENE; HISTONE H2A UBIQUITINATION; BREAST-CANCER; GROUP PROTEIN; SELF-RENEWAL; MEL-18; PROLIFERATION; EXPRESSION; REPRESSION; COMPLEX	Polycomb repressor complex 1 (PRC1) is linked to the regulation of gene expression and histone ubiquitylation conformation, which contributes to carcinogenesis. However, the upstream regulators of PRC1 biogenesis machinery remain obscure. Here, we report that the polycomb group-related mammalian gene Mel18 is a target of the protein kinase AKT. AKT phosphorylates Mel18 at T334 to disrupt the interaction between Mel18 and other PRC1 members, leading to attenuated PRC1-dependent ubiquitylation of histone H2A at Lys119. As such, PRC1 target genes, many of which are known oncogenes, are derepressed upon T334-Mel18 phosphorylation, which promotes malignant behaviours, including cell proliferation, tumour formation, migration and invasion, bone and brain metastatic lesion formation. Notably, a positive correlation between AKT activity and pT334-Mel18 is observed, and prognostic models based on p-AKT and pT334-Mel18 that predicted overall survival and distant metastasis-free survival in breast cancer patients are established. These findings have implications for understanding the role of AKT and its associated proteins in chromatin ubiquitylation, and also indicate the AKT-Mel18-H2AK119ub axis as a novel prognostic biomarker and therapeutic target for cancer patients.	[Mai, Jia; Peng, Xiao-Dan; Tang, Jun; Du, Tian; Chen, Yu-Hong; Wang, Zi-Feng; Zhang, Hai-Liang; Huang, Jun-Hao; Zhong, Zhuo-Yan; Yang, Dong; Li, Zhi-Ling; Huang, Yun; Feng, Gong-Kan; Zhu, Xiao-Feng; Deng, Rong] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Guangdong Key Lab Nasopharyngeal Carcinoma Diag &, Canc Ctr,State Key Lab Oncol South China, Guangzhou, Peoples R China; [Mai, Jia] Sichuan Univ, West China Univ Hosp 2, Key Lab Birth Defects & Related Dis Women & Child, Minist Educ,Dept Lab Med, Chengdu, Sichuan, Peoples R China; [Tang, Jun; Du, Tian; Huang, Jun-Hao] Sun Yat Sen Univ, Dept Breast Oncol, Canc Ctr, Guangzhou, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sichuan University; Sun Yat Sen University	Zhu, XF; Deng, R (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Guangdong Key Lab Nasopharyngeal Carcinoma Diag &, Canc Ctr,State Key Lab Oncol South China, Guangzhou, Peoples R China.	zhuxfeng@mail.sysu.edu.cn; dengrong@sysucc.org.cn			Natural Science Foundation of China [81772624, 81572605, 81772835, 81972481, 81630079, 81972855]; Science and Technology Project of Guangzhou [201803010007]; China Postdoctoral Science Foundation [2020M683107]; Natural Science Foundation of Guangdong Province [2019A1515011209]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Guangzhou; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This study was supported by the Natural Science Foundation of China (81772624, 81572605, 81772835, 81972481, 81630079, and 81972855), the Science and Technology Project of Guangzhou (201803010007), China Postdoctoral Science Foundation (2020M683107) and the Natural Science Foundation of Guangdong Province (2019A1515011209).	Akasaka T, 1997, IMMUNITY, V7, P135, DOI 10.1016/S1074-7613(00)80516-6; Al-Zahrani KN, 2020, ONCOGENE, V39, P4592, DOI 10.1038/s41388-020-1315-3; Bhatnagar S, 2014, NATURE, V516, P116, DOI 10.1038/nature13955; Brown JS, 2017, PHARMACOL THERAPEUT, V172, P101, DOI 10.1016/j.pharmthera.2016.12.001; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chun TH, 2005, FEBS LETT, V579, P5275, DOI 10.1016/j.febslet.2005.08.050; Deng R, 2021, AUTOPHAGY, V17, P3011, DOI 10.1080/15548627.2020.1850609; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Fujisaki S, 2003, BIOCHEM BIOPH RES CO, V300, P135, DOI 10.1016/S0006-291X(02)02791-2; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Ghosh JC, 2019, ONCOGENE, V38, P6926, DOI 10.1038/s41388-019-0939-7; Guo BH, 2010, ANN ONCOL, V21, P2361, DOI 10.1093/annonc/mdq241; Guo WJ, 2007, MOL BIOL CELL, V18, P536, DOI 10.1091/mbc.E06-05-0447; Kajiume T, 2004, EXP HEMATOL, V32, P571, DOI 10.1016/j.exphem.2004.03.001; KANNO M, 1995, EMBO J, V14, P5672, DOI 10.1002/j.1460-2075.1995.tb00254.x; Kimura M, 2001, IMMUNITY, V15, P275, DOI 10.1016/S1074-7613(01)00182-0; Klauke K, 2013, NAT CELL BIOL, V15, P353, DOI 10.1038/ncb2701; Kummar S, 2010, NAT REV DRUG DISCOV, V9, P843, DOI 10.1038/nrd3216; Lempiainen JK, 2020, ONCOGENE, V39, P2391, DOI 10.1038/s41388-020-1153-3; Li QQ, 2019, CELL REP, V28, P3406, DOI 10.1016/j.celrep.2019.08.066; Li X, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01272-2; Li ZL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17395-y; Liao SY, 2019, ONCOGENE, V38, P6723, DOI 10.1038/s41388-019-0928-x; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Mai J, 2019, THERANOSTICS, V9, P3541, DOI 10.7150/thno.32908; Marchi S, 2019, EMBO J, V38, DOI 10.15252/embj.201899435; Meng X, 2017, ONCOTARGET, V8, P72847, DOI 10.18632/oncotarget.20457; Morey L, 2015, CELL STEM CELL, V17, P300, DOI 10.1016/j.stem.2015.08.009; Nitulescu GM, 2018, INT J ONCOL, V53, P2319, DOI 10.3892/ijo.2018.4597; Nitulescu GM, 2016, INT J ONCOL, V48, P869, DOI 10.3892/ijo.2015.3306; Park JH, 2011, ONCOGENE, V30, P4578, DOI 10.1038/onc.2011.174; Perkail S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16589-8; Pietila M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10275-0; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Su WJ, 2019, CANCER CELL, V36, P139, DOI 10.1016/j.ccell.2019.06.009; Tamburri S, 2020, MOL CELL, V77, P840, DOI 10.1016/j.molcel.2019.11.021; Uzawa K, 2013, CANCER MED-US, V2, P40, DOI 10.1002/cam4.56; Vidal M, 2017, EXP HEMATOL, V48, P12, DOI 10.1016/j.exphem.2016.12.006; Wan LX, 2018, MOL CELL, V69, P279, DOI 10.1016/j.molcel.2017.12.024; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang W, 2011, UROL ONCOL-SEMIN ORI, V29, P244, DOI 10.1016/j.urolonc.2009.02.004; Wang YN, 2016, MOL CELL, V63, P34, DOI 10.1016/j.molcel.2016.05.027; Won HY, 2012, FASEB J, V26, P5002, DOI 10.1096/fj.12-209247; Xing Y, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1154-8; Zhang XW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-40; Zhang YL, 2018, NAT CELL BIOL, V20, P1181, DOI 10.1038/s41556-018-0178-0; Zhang Z, 2017, P NATL ACAD SCI USA, V114, pE7949, DOI 10.1073/pnas.1711158114; Zhao ZB, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1870-5	48	3	3	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 1	2021	40	13					2422	2436		10.1038/s41388-020-01602-7	http://dx.doi.org/10.1038/s41388-020-01602-7		MAR 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RH1BQ	33664452				2022-12-26	WOS:000625833000003
J	Napoli, E; Bonsdorff, TB; Jorstad, IS; Bruland, OS; Larsen, RH; Westrom, S				Napoli, Elisa; Bonsdorff, Tina B.; Jorstad, Ida Sofie; Bruland, Oyvind S.; Larsen, Roy H.; Westrom, Sara			Radon-220 diffusion from Ra-224-labeled calcium carbonate microparticles: Some implications for radiotherapeutic use	PLOS ONE			English	Article							RADON EMANATION; ALPHA-EMITTERS; SOLID TUMORS; RELEASE; CANCER; TRIAL; MICE	Alpha-particle emitting radionuclides continue to be the subject of medical research because of their high energy and short range of action that facilitate effective cancer therapies. Radium-224 (Ra-224) is one such candidate that has been considered for use in combating micrometastatic disease. In our prior studies, a suspension of Ra-224-labeled calcium carbonate (CaCO3) microparticles was designed as a local therapy for disseminated cancers in the peritoneal cavity. The progenies of Ra-224, of which radon-220 (Rn-220) is the first, together contribute three of the four alpha particles in the decay chain. The proximity of the progenies to the delivery site at the time of decay of the Ra-224-CaCO3 microparticles can impact its therapeutic efficacy. In this study, we show that the diffusion of Rn-220 was reduced in labeled CaCO3 suspensions as compared with cationic Ra-224 solutions, both in air and liquid volumes. Furthermore, free-floating lead-212 (Pb-212), which is generated from released Rn-220, had the potential to be re-adsorbed onto CaCO3 microparticles. Under conditions mimicking an in vivo environment, more than 70% of the Pb-212 was adsorbed onto the CaCO3 at microparticle concentrations above 1 mg/mL. Further, the diffusion of Rn-220 seemed to occur whether the microparticles were labeled by the surface adsorption of Ra-224 or if the Ra-224 was incorporated into the bulk of the microparticles. The therapeutic benefit of differently labeled Ra-224-CaCO3 microparticles after intraperitoneal administration was similar when examined in mice bearing intraperitoneal ovarian cancer xenografts. In conclusion, both the release of Rn-220 and re-adsorption of Pb-212 are features that have implications for the radiotherapeutic use of Ra-224-labeled CaCO3 microparticles. The release of Rn-220 through diffusion may extend the effective range of alpha-particle dose deposition, and the re-adsorption of the longer lived Pb-212 onto the CaCO3 microparticles may enhance the retention of this nuclide in the peritoneal cavity.	[Napoli, Elisa; Bonsdorff, Tina B.; Jorstad, Ida Sofie; Larsen, Roy H.; Westrom, Sara] Oncoinvent AS, Oslo, Norway; [Napoli, Elisa; Bruland, Oyvind S.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Napoli, Elisa] Oslo Univ Hosp, Inst Canc Res, Dept Radiat Biol, Oslo, Norway; [Bruland, Oyvind S.] Oslo Univ Hosp, Dept Oncol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Westrom, S (corresponding author), Oncoinvent AS, Oslo, Norway.	westrom@oncoinvent.com	Napoli, Elisa/AAW-4515-2021	Westrom, Sara/0000-0001-9556-3807; Napoli, Elisa/0000-0002-1411-2690	Norwegian Research Council [259820, 282220]; Oncoinvent AS	Norwegian Research Council(Research Council of NorwayEuropean Commission); Oncoinvent AS	This study was funded by: The Norwegian Research Council (www.forskningsradet.no, grant numbers 259820 and 282220, Recipients: EN and TBB/Oncoinvent AS respectively) and Oncoinvent AS www.oncoinvent.com).RHL is a board member of Oncoinvent AS, i.e. one of the funding entities. The funders provided support in the form of salaries for authors EN, ISJ, TBB and SW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], CURR RADIOPHARM; Arazi L, 2007, PHYS MED BIOL, V52, P5025, DOI 10.1088/0031-9155/52/16/021; Arazi L, 2010, PHYS MED BIOL, V55, P1203, DOI 10.1088/0031-9155/55/4/020; Arazi L, 2020, PHYS MED BIOL, V65, DOI 10.1088/1361-6560/ab5b73; Barillon R, 2005, GEOCHIM COSMOCHIM AC, V69, P2735, DOI 10.1016/j.gca.2004.11.021; Browne E, 2004, MONOGRAPHIE BIPM, V2; ClinicalTrials.gov, 2000, STUDY RADSPHERIN COL; De Kruijff RM, 2015, PHARMACEUTICALS, V8, P321, DOI 10.3390/ph8020321; Decay Data Evaluation Project, ATOMIC NUCL DATA; Hassfjell S, 2001, APPL RADIAT ISOTOPES, V55, P433, DOI 10.1016/S0969-8043(00)00372-9; Ishimori Y., 2014, Measurement and Calculation of Radon Releases from NORM Residues; JAHNE B, 1987, J GEOPHYS RES-OCEANS, V92, P10767, DOI 10.1029/JC092iC10p10767; Juzeniene A, 2018, ANTICANCER RES, V38, P1947, DOI 10.21873/anticanres.12432; Keller G., 2000, P INT C INT RAD PROT; Larsen RH., 2016, Patent No. [9,433,690, 9433690, 9.433,690 B1]; Li RG, 2021, CURR RADIOPHARM, V14, P145, DOI 10.2174/1874471013666201201102056; Napoli E, 2020, APPL RADIAT ISOTOPES, V166, DOI 10.1016/j.apradiso.2020.109362; Oosterhof GON, 2003, EUR UROL, V44, P519, DOI 10.1016/S0302-2838(03)00364-6; Parker C, 2013, NEW ENGL J MED, V369, P213, DOI 10.1056/NEJMoa1213755; Parker C, 2018, JAMA ONCOL, V4, P1765, DOI 10.1001/jamaoncol.2018.4044; Popovtzer A, 2020, INT J RADIAT ONCOL, V106, P571, DOI 10.1016/j.ijrobp.2019.10.048; Resche I, 1997, EUR J CANCER, V33, P1583, DOI 10.1016/S0959-8049(97)00155-X; Rona E., 1918, PHYS CHEM N F, V92U, P213; Sakoda A, 2011, APPL RADIAT ISOTOPES, V69, P1422, DOI 10.1016/j.apradiso.2011.06.009; SEMKOW TM, 1990, GEOCHIM COSMOCHIM AC, V54, P425, DOI 10.1016/0016-7037(90)90331-E; Sgouros G, 2020, NAT REV DRUG DISCOV, V19, P589, DOI 10.1038/s41573-020-0073-9; Silker WB., 1983, REPORT NO NUREGCR 29; Srivastava S. C., 2013, THERAPEUTIC RADIONUC, P11; Strosberg J, 2017, NEW ENGL J MED, V376, P125, DOI 10.1056/NEJMoa1607427; Volodkin DV, 2004, LANGMUIR, V20, P3398, DOI 10.1021/la036177z; Westrom S, 2018, J LABELLED COMPD RAD, V61, P472, DOI 10.1002/jlcr.3610; Westrom S, 2018, TRANSL ONCOL, V11, P259, DOI 10.1016/j.tranon.2017.12.011; Witzig TE, 2002, J CLIN ONCOL, V20, P2453, DOI 10.1200/JCO.2002.11.076	34	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							0248133	10.1371/journal.pone.0248133	http://dx.doi.org/10.1371/journal.pone.0248133			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33662039	Green Submitted, Green Published, gold			2022-12-26	WOS:000626604100043
J	Ren, J; Yao, HW; Hu, WH; Perrett, S; Gong, WB; Feng, YG				Ren, Jie; Yao, Hongwei; Hu, Wanhui; Perrett, Sarah; Gong, Weibin; Feng, Yingang			Structural basis for the DNA-binding activity of human ARID4B Tudor domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEB SERVER; PROTEINS; IDENTIFICATION; RECOGNITION; PROGRAM; METHYLATION; SYSTEM	Human ARID4A and ARID4B are homologous proteins that are important in controlling gene expression and epigenetic regulation but have distinct functions. Previous studies have shown that the N-terminal domain of ARID4A is an unusual interdigitated double Tudor domain with DNA-binding activity. However, how the Tudor domain of ARID4B differs from that of ARID4A remains unknown. Here, we found that the ARID4B Tudor domain has significantly weaker DNA affinity than the ARID4A Tudor domain despite sharing more than 80% sequence identity. Structure determination and DNA titration analysis indicated that the ARID4B Tudor domain is also an interdigitated double Tudor domain with a DNA-binding surface similar to ARID4A. We identified a residue close to the DNA-binding site of the Tudor domain that differs between ARID4A and ARID4B. The Leu50 in ARID4A is Glu50 in ARID4B, and the latter forms salt bridges with two lysine residues at the DNA-binding surface. This causes a decrease in the strength of positive charge, thus reducing DNA-binding affinity while significantly increasing protein stability. We also found that a C-terminal extension region enhances the DNA-binding affinity of the ARID4B Tudor domain. This C-terminal extension is disordered and contains a positively charged RGR motif, providing an additional DNA-binding site. Finally, sequence and phylogenetic analyses indicated that the residue differences and the presence of the RGR extension region are conserved. These results provide new insight into the functional differences between ARID4A and ARID4B proteins, as well as elucidating the function of the disordered regions in these proteins.	[Ren, Jie; Hu, Wanhui; Perrett, Sarah; Gong, Weibin] Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China; [Ren, Jie; Hu, Wanhui; Perrett, Sarah; Feng, Yingang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yao, Hongwei] Soochow Univ, Sch Biol & Basic Med Sci, Inst Mol Enzymol, Suzhou, Peoples R China; [Feng, Yingang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, CAS Key Lab Biofuels, Qingdao, Peoples R China; [Feng, Yingang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Synthet Biol, Qingdao, Peoples R China; [Hu, Wanhui] Shanghai Henlius Biotech Inc, Bldg C,1289 Yishan Rd, Shanghai 200233, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Soochow University - China; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Gong, WB (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China.; Feng, YG (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Feng, YG (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, CAS Key Lab Biofuels, Qingdao, Peoples R China.; Feng, YG (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Synthet Biol, Qingdao, Peoples R China.	gongweibin@ibp.ac.cn; fengyg@qibebt.ac.cn	Feng, Yingang/B-6304-2008	Feng, Yingang/0000-0002-0879-1316; Gong, Weibin/0000-0001-7130-4093	National Key R&D Program of China [2017YFA0504000]; National Natural Science Foundation of China [31470747, 32070125, 31870735]; Beijing Natural Science Foundation [5172026]; CAS Center for Excellence in Biomacromolecules; Director Innovation Foundation of Qingdao Institute of Bioenergy and Bioprocess Technology, CAS; QIBEBT; Dalian National Laboratory for Clean Energy [QIBEBT I201804]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); CAS Center for Excellence in Biomacromolecules; Director Innovation Foundation of Qingdao Institute of Bioenergy and Bioprocess Technology, CAS; QIBEBT; Dalian National Laboratory for Clean Energy	This work was supported by National Key R&D Program of China [grant number 2017YFA0504000 to S. P.]; National Natural Science Foundation of China [grant numbers 31470747 to W. G., 32070125 to Y. F., 31870735 to H. Y.]; Beijing Natural Science Foundation [grant number 5172026 to W. G.]; the CAS Center for Excellence in Biomacromolecules; the Director Innovation Foundation of Qingdao Institute of Bioenergy and Bioprocess Technology, CAS [to Y. F.]; and QIBEBT and Dalian National Laboratory for Clean Energy [grant number QIBEBT I201804 to Y. F.].	Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; Binda O, 2006, MOL CELL BIOL, V26, P1917, DOI 10.1128/MCB.26.5.1917-1931.2006; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cajuso T, 2014, INT J CANCER, V135, P611, DOI 10.1002/ijc.28705; Crane-Robinson C, 2006, TRENDS BIOCHEM SCI, V31, P547, DOI 10.1016/j.tibs.2006.08.006; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Duggan BM, 2001, J BIOMOL NMR, V19, P321, DOI 10.1023/A:1011227824104; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Gong WB, 2018, J BIOL CHEM, V293, P17663, DOI 10.1074/jbc.RA118.002691; Gong WB, 2014, J BIOL CHEM, V289, P4882, DOI 10.1074/jbc.M113.501940; Gong WB, 2012, J BIOL CHEM, V287, P8531, DOI 10.1074/jbc.M111.299149; Gordon BRG, 2011, P NATL ACAD SCI USA, V108, P10690, DOI 10.1073/pnas.1102544108; Hafsa NE, 2015, NUCLEIC ACIDS RES, V43, pW370, DOI 10.1093/nar/gkv494; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Hurst DR, 2008, J BIOL CHEM, V283, P7438, DOI 10.1074/jbc.M709446200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lai A, 2001, MOL CELL BIOL, V21, P2918, DOI 10.1128/MCB.21.8.2918-2932.2001; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li SX, 2019, NUCLEIC ACIDS RES, V47, pW26, DOI 10.1093/nar/gkz394; Malovannaya A, 2010, P NATL ACAD SCI USA, V107, P2431, DOI 10.1073/pnas.0912599106; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Oughtred R, 2019, NUCLEIC ACIDS RES, V47, pD529, DOI 10.1093/nar/gky1079; Pek JW, 2012, DEVELOPMENT, V139, P2255, DOI 10.1242/dev.073304; Shen Y, 2015, METHODS MOL BIOL, V1260, P17, DOI 10.1007/978-1-4939-2239-0_2; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Wu MY, 2008, JNCI-J NATL CANCER I, V100, P1247, DOI 10.1093/jnci/djn253; Wu MY, 2006, GENE DEV, V20, P2859, DOI 10.1101/gad.1452206; Wu RC, 2017, STEM CELLS, V35, P1554, DOI 10.1002/stem.2597; Wu RC, 2015, MOL ENDOCRINOL, V29, P1334, DOI 10.1210/me.2015-1089; Wu RC, 2013, P NATL ACAD SCI USA, V110, P4616, DOI 10.1073/pnas.1218318110; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100	36	5	5	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100506	10.1016/j.jbc.2021.100506	http://dx.doi.org/10.1016/j.jbc.2021.100506			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33675746	Green Published, gold			2022-12-26	WOS:000672866400480
J	Wu, YL; Chanclon, B; Micallef, P; Stener-Victorin, E; Asterholm, IW; Benrick, A				Wu, Yanling; Chanclon, Belen; Micallef, Peter; Stener-Victorin, Elisabet; Wernstedt Asterholm, Ingrid; Benrick, Anna			Maternal adiponectin prevents visceral adiposity and adipocyte hypertrophy in prenatal androgenized female mice	FASEB JOURNAL			English	Article						adiponectin; adiposity; imprinting; PCOS; PNA		Hyperandrogenism is the main characteristic of polycystic ovary syndrome, which affects placental function and fetal growth, and leads to reproductive and metabolic dysfunction in female offspring. Adiponectin acts on the placenta and may exert endocrine effects on the developing fetus. This study aims to investigate if maternal and/or fetal adiponectin can prevent metabolic and reproductive dysfunction in prenatal androgenized (PNA) female offspring. Adiponectin transgenic (APNtg) and wild-type dams received dihydrotestosterone/vehicle injections between gestational days 16.5-18.5 to induce PNA offspring, which were followed for 4 months. Offspring from APNtg dams were smaller than offspring from wild-type dams, independent of genotype. Insulin sensitivity was higher in wild-type mice from APNtg dams compared to wild-types from wild-type dams, and insulin sensitivity correlated with fat mass and adipocyte size. PNA increased visceral fat% and adipocyte size in wild-type offspring from wild-type dams, while wild-type and APNtg offspring from APNtg dams were protected against this effect. APNtg mice had smaller adipocytes than wild-types and this morphology was associated with an increased expression of genes regulating adipogenesis (Ppard, Pparg, Cebpa, and Cebpb) and metabolism (Chrebp and Lpl). Anogenital distance was increased in all PNA-exposed wild-type offspring, but there was no increase in PNA APNtg offspring, suggesting that adiponectin overexpression protects against this effect. In conclusion, elevated adiponectin levels in utero improve insulin sensitivity, reduce body weight and fat mass gain in the adult offspring and protect against PNA-induced visceral adiposity. In conclusion, these data suggest that PNA offspring benefit from prenatal adiponectin supplementation.	[Wu, Yanling; Chanclon, Belen; Micallef, Peter; Wernstedt Asterholm, Ingrid; Benrick, Anna] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden; [Stener-Victorin, Elisabet] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Benrick, Anna] Univ Skovde, Sch Hlth Sci, Skovde, Sweden	University of Gothenburg; Karolinska Institutet; University of Skovde	Benrick, A (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Dept Physiol, Box 423, S-40530 Gothenburg, Sweden.	anna.benrick@gu.se	; Stener-Victorin, Elisabet/W-6322-2018	Chanclon Garcia, Belen/0000-0001-7170-9699; Wernstedt Asterholm, Ingrid/0000-0002-0755-5784; Stener-Victorin, Elisabet/0000-0002-3424-1502	Novo Nordisk Fonden (NNF) [NNF19OC0056601]; Diabetesfonden (Stiftelsen Svenska Diabetesforbundets Forskningsfond) [DIA2019-419]; Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation) [2017-02069]; Adlerbertska Stiftelserna (Adlerbertska Foundations) [GU2019/86]; Stiftelsen Handlanden Hjalmar Svenssons (Hjalmar Svensson Foundation) [HJSV2019056]; Kungl. Vetenskaps-och Vitterhets-Samhallet i Goteborg (KVVS) [2018-217]; Vetenskapsradet (VR) [2017-00792, 2018-02435, 2013-7107, 2020-02435]	Novo Nordisk Fonden (NNF); Diabetesfonden (Stiftelsen Svenska Diabetesforbundets Forskningsfond); Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation); Adlerbertska Stiftelserna (Adlerbertska Foundations); Stiftelsen Handlanden Hjalmar Svenssons (Hjalmar Svensson Foundation); Kungl. Vetenskaps-och Vitterhets-Samhallet i Goteborg (KVVS); Vetenskapsradet (VR)(Swedish Research Council)	Novo Nordisk Fonden (NNF), Grant/Award Number: NNF19OC0056601; Diabetesfonden (Stiftelsen Svenska Diabetesforbundets Forskningsfond), Grant/Award Number: DIA2019-419; Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation), Grant/Award Number: 2017-02069; Adlerbertska Stiftelserna (Adlerbertska Foundations), Grant/Award Number: GU2019/86; Stiftelsen Handlanden Hjalmar Svenssons (Hjalmar Svensson Foundation), Grant/Award Number: HJSV2019056; Kungl. Vetenskaps-och Vitterhets-Samhallet i Goteborg (KVVS), Grant/Award Number: 2018-217; Vetenskapsradet (VR), Grant/Award Number: 2017-00792, 2018-02435, 2013-7107 and 2020-02435	Abbott DH, 2019, EXPERT REV ENDOCRINO, V14, P131, DOI 10.1080/17446651.2019.1576522; Abbott DH, 2009, AM J PRIMATOL, V71, P776, DOI 10.1002/ajp.20679; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Astapova O, 2012, VITAM HORM, V90, P143, DOI 10.1016/B978-0-12-398313-8.00006-3; Asterholm IW, 2010, AM J PATHOL, V176, P1364, DOI 10.2353/ajpath.2010.090647; Aye ILMH, 2013, PLACENTA, V34, pS40, DOI 10.1016/j.placenta.2012.11.024; Aye ILMH, 2015, P NATL ACAD SCI USA, V112, P12858, DOI 10.1073/pnas.1515484112; Barbe A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071526; Benrick A, 2017, P NATL ACAD SCI USA, V114, pE7187, DOI 10.1073/pnas.1708854114; Caldwell ASL, 2015, ENDOCRINOLOGY, V156, P1441, DOI 10.1210/en.2014-1887; Caldwell ASL, 2014, ENDOCRINOLOGY, V155, P3146, DOI 10.1210/en.2014-1196; Chabrolle C, 2009, FERTIL STERIL, V92, P1988, DOI 10.1016/j.fertnstert.2008.09.008; Dobrzyn K, 2018, INT J ENDOCRINOL, V2018, DOI 10.1155/2018/7965071; Dulka EA, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqz038; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Jin ZX, 2015, ENDOCRINOLOGY, V156, P1504, DOI 10.1210/en.2014-1738; Kauffman AS, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131631; Lagaly DV, 2008, MOL CELL ENDOCRINOL, V284, P38, DOI 10.1016/j.mce.2008.01.007; Lizneva D, 2016, FERTIL STERIL, V106, P6, DOI 10.1016/j.fertnstert.2016.05.003; Luquet S, 2005, BBA-MOL BASIS DIS, V1740, P313, DOI 10.1016/j.bbadis.2004.11.011; Maleszka A, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/957076; Maliqueo M, 2015, HUM REPROD, V30, P692, DOI 10.1093/humrep/deu351; Maliqueo M, 2013, EUR J OBSTET GYN R B, V166, P151, DOI 10.1016/j.ejogrb.2012.10.015; Manneras-Holm L, 2011, J CLIN ENDOCR METAB, V96, pE304, DOI 10.1210/jc.2010-1290; Manno FAM, 2008, PHYSIOL BEHAV, V93, P364, DOI 10.1016/j.physbeh.2007.09.011; Manti M, 2018, FASEB J, V32, P4158, DOI 10.1096/fj.201701263RR; Mills G, 2020, HUM REPROD, V35, P1666, DOI 10.1093/humrep/deaa099; Moore AM, 2015, P NATL ACAD SCI USA, V112, P596, DOI 10.1073/pnas.1415038112; Moore AM, 2013, ENDOCRINOLOGY, V154, P796, DOI 10.1210/en.2012-1954; Nagy TR, 2000, OBES RES, V8, P392, DOI 10.1038/oby.2000.47; Palin MF, 2012, VITAM HORM, V90, P239, DOI 10.1016/B978-0-12-398313-8.00010-5; Qiao LP, 2017, DIABETES, V66, P1126, DOI 10.2337/db16-1096; Qiao LP, 2016, DIABETOLOGIA, V59, P2417, DOI 10.1007/s00125-016-4061-x; Richards JS, 2012, FERTIL STERIL, V98, P471, DOI 10.1016/j.fertnstert.2012.04.050; Risal S, 2019, NAT MED, V25, P1894, DOI 10.1038/s41591-019-0666-1; Roland AV, 2010, J ENDOCRINOL, V207, P213, DOI 10.1677/JOE-10-0217; Sir-Petermann T, 2002, HUM REPROD, V17, P2573, DOI 10.1093/humrep/17.10.2573; Sir-Petermann T, 2007, HUM REPROD, V22, P1830, DOI 10.1093/humrep/dem090; Stener-Victorin E, 2020, ENDOCR REV, V41, DOI 10.1210/endrev/bnaa010; Sullivan SD, 2004, P NATL ACAD SCI USA, V101, P7129, DOI 10.1073/pnas.0308058101; Takemura Y, 2006, ENDOCRINOLOGY, V147, P3203, DOI 10.1210/en.2005-1510; Wen JP, 2008, BIOCHEM BIOPH RES CO, V371, P756, DOI 10.1016/j.bbrc.2008.04.146; Witham EA, 2012, ENDOCRINOLOGY, V153, P4522, DOI 10.1210/en.2012-1283; Yang WK, 2018, MOL MED REP, V17, P428, DOI 10.3892/mmr.2017.7881	44	4	4	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21299	10.1096/fj.202002212R	http://dx.doi.org/10.1096/fj.202002212R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715227	Green Published			2022-12-26	WOS:000635216100077
J	Rimlinger, A; Avana, ML; Awono, A; Chakocha, A; Gakwavu, A; Lemoine, T; Marie, L; Mboujda, F; Vigouroux, Y; Johnson, V; Vinceti, B; Carriere, SM; Duminil, J				Rimlinger, Aurore; Avana, Marie-Louise; Awono, Abdon; Chakocha, Armel; Gakwavu, Alexis; Lemoine, Taina; Marie, Lison; Mboujda, Franca; Vigouroux, Yves; Johnson, Vincent; Vinceti, Barbara; Carriere, Stephanie M.; Duminil, Jerome			Trees and their seed networks: The social dynamics of urban fruit trees and implications for genetic diversity	PLOS ONE			English	Article							ECOSYSTEM SERVICES; DACRYODES-EDULIS; HOME GARDENS; BIODIVERSITY; CONSERVATION; CITY; STRATEGIES; MANAGEMENT; EXCHANGE; ECOLOGY	Trees are a traditional component of urban spaces where they provide ecosystem services critical to urban wellbeing. In the Tropics, urban trees' seed origins have rarely been characterized. Yet, understanding the social dynamics linked to tree planting is critical given their influence on the distribution of associated genetic diversity. This study examines elements of these dynamics (seed exchange networks) in an emblematic indigenous fruit tree species from Central Africa, the African plum tree (Dacryodes edulis, Burseraceae), within the urban context of Yaounde. We further evaluate the consequences of these social dynamics on the distribution of the genetic diversity of the species in the city. Urban trees were planted predominantly using seeds sourced from outside the city, resulting in a level of genetic diversity as high in Yaounde as in a whole region of production of the species. Debating the different drivers that foster the genetic diversity in planted urban trees, the study argues that cities and urban dwellers can unconsciously act as effective guardians of indigenous tree genetic diversity.	[Rimlinger, Aurore; Carriere, Stephanie M.] Univ Paul Valery Montpellier 3, Univ Montpellier, CIRAD, SENS,IRD, Montpellier, France; [Rimlinger, Aurore; Marie, Lison; Mboujda, Franca; Vigouroux, Yves; Duminil, Jerome] Univ Montpellier, DIADE, IRD, Montpellier, France; [Avana, Marie-Louise; Chakocha, Armel; Gakwavu, Alexis; Mboujda, Franca] Univ Dschang, Fac Agron & Agr Sci, Forestry Dept, Dschang, Cameroon; [Awono, Abdon] CIFOR, IITA Humid Forest Ecoreg Ctr, Yaounde, Cameroon; [Lemoine, Taina] Univ Montpellier, Montpellier, France; [Johnson, Vincent; Vinceti, Barbara; Duminil, Jerome] Alliance Biovers Int & CIAT, Fiumicino Rome, Italy	CIRAD; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite Paul-Valery; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CGIAR; Center for International Forestry Research (CIFOR); Universite de Montpellier	Rimlinger, A; Carriere, SM (corresponding author), Univ Paul Valery Montpellier 3, Univ Montpellier, CIRAD, SENS,IRD, Montpellier, France.; Rimlinger, A; Duminil, J (corresponding author), Univ Montpellier, DIADE, IRD, Montpellier, France.; Duminil, J (corresponding author), Alliance Biovers Int & CIAT, Fiumicino Rome, Italy.	aurore.rimlinger@ird.fr; stephanie.carriere@ird.fr; jerome.duminil@ird.fr		Duminil, Jerome/0000-0002-2500-824X; Rimlinger, Aurore/0000-0002-4297-1580	Agropolis Fondation [1605-042, Labex Agro: ANR-10-LABX0001-01, ANR16-IDEX-0006]; Agence Universitaire de la Francophonie (AUF)	Agropolis Fondation; Agence Universitaire de la Francophonie (AUF)	This project has been supported by Agropolis Fondation (https://www.agropolisfondation.fr/) under the reference ID 1605-042 awarded to J.D. through the "Investissements d'avenir" program (Labex Agro: ANR-10-LABX0001-01), under the frame of I-SITE MUSE (ANR16-IDEX-0006). We acknowledge the Agence Universitaire de la Francophonie (AUF) for funding the data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinnifesi Festus Kehinde, 2010, Urban Ecosystems, V13, P129, DOI 10.1007/s11252-009-0108-9; [Anonymous], 2002, URBAN ECOSYST, V6, P43, DOI [10.1023/A:1025914629492, DOI 10.1023/A:1025914629492]; Aronson MFJ, 2017, FRONT ECOL ENVIRON, V15, P189, DOI 10.1002/fee.1480; Aronson MFJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3330; Auffret AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062763; Ban N, 2004, GEOGR REV, V94, P348, DOI 10.1111/j.1931-0846.2004.tb00177.x; Bennett NJ, 2017, CONSERV BIOL, V31, P56, DOI 10.1111/cobi.12788; Bernholt H, 2009, AGROFOREST SYST, V77, P159, DOI 10.1007/s10457-009-9236-8; Bolanle-Ojo OT., 2020, NOT SCI BIOL, V12, P100, DOI [10.15835/nsb12110561, DOI 10.15835/NSB12110561]; Bopda A., 2003, YAOUND D FI CAMEROUN; Buchmann C, 2009, HUM ECOL, V37, P705, DOI 10.1007/s10745-009-9283-9; Bullock JM, 2018, TRENDS ECOL EVOL, V33, P958, DOI 10.1016/j.tree.2018.09.008; Callicott JB, 1999, CONSERV BIOL, V13, P22, DOI 10.1046/j.1523-1739.1999.97333.x; Chen WY, 2008, SPRINGER SER ENV MAN, P53, DOI 10.1007/978-0-387-71425-7_5; Chimaimba FB, 2020, URBAN FOR URBAN GREE, V54, DOI 10.1016/j.ufug.2020.126781; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Cilliers S, 2013, URBAN ECOSYST, V16, P681, DOI 10.1007/s11252-012-0254-3; Coomes OT, 2010, PROF GEOGR, V62, P323, DOI 10.1080/00330124.2010.483628; De Lacy P, 2017, URBAN ECOSYST, V20, P1169, DOI 10.1007/s11252-017-0669-y; Degrande A, 2013, SMALL-SCALE FOR, V12, P403, DOI 10.1007/s11842-012-9220-4; Deletre M, 2011, P NATL ACAD SCI USA, V108, P18249, DOI 10.1073/pnas.1106259108; Diaz-Reviriego I, 2016, ECOL SOC, V21, DOI 10.5751/ES-07944-210101; Ellen R, 2011, J ROY ANTHROPOL INST, V17, P563, DOI 10.1111/j.1467-9655.2011.01707.x; Endreny TA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03622-0; Etshekape PG, 2018, URBAN FOR URBAN GREE, V30, P12, DOI 10.1016/j.ufug.2017.12.015; Fonteh Florence A., 2005, Fruits, V60, P107, DOI 10.1051/fruits:2005021; Frison EA, 2011, SUSTAINABILITY-BASEL, V3, P238, DOI 10.3390/su3010238; Galluzzi G, 2010, BIODIVERS CONSERV, V19, P3635, DOI 10.1007/s10531-010-9919-5; Garrard GE, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12411; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Gonzalez-Garcia A, 2008, HUM ECOL, V36, P291, DOI 10.1007/s10745-007-9155-0; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Heraty JM, 2016, ECON BOT, V70, P37, DOI 10.1007/s12231-016-9333-3; Hyden G, 1983, NO SHORTCUTS PROGR A; Jika AKN, 2017, HEREDITY, V118, P491, DOI 10.1038/hdy.2016.128; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kengue J., 2002, FORESTS TREES LIVELI, V11, p73 , DOI DOI 10.1080/14728028.2002.9752411; Kirkpatrick JB, 2007, AUST J BOT, V55, P221, DOI 10.1071/BT06104; Kull CA, 2013, ENVIRONMENT, V55, P6, DOI 10.1080/00139157.2013.765307; Labeyrie V, 2016, P NATL ACAD SCI USA, V113, P98, DOI 10.1073/pnas.1513238112; Labeyrie V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092178; Leclerc C., 2011, DIVERSITY, V4, P1, DOI [DOI 10.3390/D4010001, 10.3390/d4010001]; Li DJ, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2020.0777; Lin BB, 2011, BIOSCIENCE, V61, P183, DOI 10.1525/bio.2011.61.3.4; Livesley SJ, 2016, J ENVIRON QUAL, V45, P119, DOI 10.2134/jeq2015.11.0567; Mainet H, 2017, GEOGR TIDSSKR-DEN, V117, P117, DOI 10.1080/00167223.2017.1354715; Mariac C, 2006, THEOR APPL GENET, V114, P49, DOI 10.1007/s00122-006-0409-9; McDonnell MJ, 2016, SCIENCE, V352, P936, DOI 10.1126/science.aaf3630; Nero BF, 2018, FORESTS, V9, DOI 10.3390/f9090519; Orsini F, 2013, AGRON SUSTAIN DEV, V33, P695, DOI 10.1007/s13593-013-0143-z; Peroni N, 2016, ETHNOBIOL CONSERV, V5, DOI 10.15451/ec2016-8-5.6-1-17; Pritchard JK, 2000, GENETICS, V155, P945; QGIS Development Team, 2019, OPEN SOURCE GEOSPATI; Rimlinger A, 2020, MOL BIOL REP, V47, P2391, DOI 10.1007/s11033-020-05270-4; Rimlinger A, 2019, ECON BOT, V73, P249, DOI 10.1007/s12231-019-09455-2; Sardeshpande M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230693; Seto KC, 2016, SCIENCE, V352, P943, DOI 10.1126/science.aaf7439; Sierra-Guerrero MC, 2017, URBAN FOR URBAN GREE, V28, P54, DOI 10.1016/j.ufug.2017.09.015; Stadlmayr B, 2013, J SCI FOOD AGR, V93, P2627, DOI 10.1002/jsfa.6196; Sthapit B, 2016, ISS AGRICULT BIODIV, P31; Tchuenguem Fohouo F. N., 2001, Fruits (Paris), V56, P179, DOI 10.1051/fruits:2001121; Temple Ludovic, 2001, Cahiers Agricultures, V10, P87; Thomas M, 2012, EVOL APPL, V5, P779, DOI 10.1111/j.1752-4571.2012.00257.x; Togolo JP, 2019, THESIS; Torres-Camacho K, 2017, URBAN ECOSYST, V20, P403, DOI 10.1007/s11252-016-0602-9; Turner-Skoff JB, 2019, PLANTS PEOPLE PLANET, V1, P323, DOI 10.1002/ppp3.39; United Nations Department of Economic and Social Affairs, 2019, POPULATION DIVISION; Vanden Broeck A, 2018, BIODIVERS CONSERV, V27, P3777, DOI 10.1007/s10531-018-1628-5; Waruhiu AN, 2004, J FOOD AGRIC ENVIRON, V2, P340; Youmbi E, 2010, FRUITS, V65, P355, DOI 10.1051/fruits/2010030	72	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0243017	10.1371/journal.pone.0243017	http://dx.doi.org/10.1371/journal.pone.0243017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY1VJ	33724989	Green Published, gold, Green Submitted			2022-12-26	WOS:000629833700020
J	Rivera, AL; Estanol, B; Macias-Gallardo, JJ; Delgado-Garcia, G; Fossion, R; Frank, A; Torres-Villalobos, GM				Leonor Rivera, Ana; Estanol, Bruno; Macias-Gallardo, Julio J.; Delgado-Garcia, Guillermo; Fossion, Ruben; Frank, Alejandro; Torres-Villalobos, Gonzalo M.			Cardiovascular dysautonomia in Achalasia Patients: Blood pressure and heart rate variability alterations	PLOS ONE			English	Article							GASTRIC-ACID SECRETION; AUTONOMIC DYSFUNCTION; DIABETES-MELLITUS; RELAXATION; ESOPHAGUS; SPECTRUM; BEAT	Achalasia is a disease characterized by the inability to relax the esophageal sphincter due to a degeneration of the parasympathetic ganglion cells located in the wall of the thoracic esophagus. Achalasia has been associated with extraesophageal dysmotility, suggesting alterations of the autonomic nervous system (ANS) that extend beyond the esophagus. The purpose of the present contribution is to investigate whether achalasia may be interpreted as the esophageal manifestation of a more generalized disturbance of the ANS which includes alterations of heart rate and/or blood pressure. Therefore simultaneous non-invasive records of the heart inter-beat intervals (IBI) and beat-to-beat systolic blood pressure (SBP) of 14 patients (9 female, 5 male) with achalasia were compared with the records of 34 rigorously screened healthy control subjects (17 female, 17 male) in three different conditions: supine, standing up, and controlled breathing at 0.1 Hz, using a variety of measures in the time and spectral domains. Significant differences in heart rate variability (HRV) and blood pressure variability (BPV) were observed which seem to be due to cardiovagal damage to the heart, i.e., a failure of the ANS, as expected according to our hypothesis. This non-invasive methodology can be employed as an auxiliary clinical protocol to study etiology and evolution of achalasia, and other pathologies that damage ANS.	[Leonor Rivera, Ana; Fossion, Ruben; Frank, Alejandro] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Ciudad Univ, Mexico City, DF, Mexico; [Leonor Rivera, Ana; Estanol, Bruno; Fossion, Ruben; Frank, Alejandro] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Ciudad Univ, Mexico City, DF, Mexico; [Estanol, Bruno; Macias-Gallardo, Julio J.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Neurol, Mexico City, DF, Mexico; [Estanol, Bruno; Macias-Gallardo, Julio J.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Psychiat & Clin Neurophysiol Lab, Mexico City, DF, Mexico; [Delgado-Garcia, Guillermo] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Frank, Alejandro] El Colegio Nacl, Ctr Hist, Mexico City, DF, Mexico; [Torres-Villalobos, Gonzalo M.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Expt Surg, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; University of Calgary; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Rivera, AL (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Ciudad Univ, Mexico City, DF, Mexico.; Rivera, AL (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Ciudad Univ, Mexico City, DF, Mexico.	ana.rivera@nucleares.unam.mx	Delgado-García, Guillermo/R-3050-2018; Rivera, Ana Leonor/L-4433-2019	Delgado-García, Guillermo/0000-0002-3123-5879; Rivera, Ana Leonor/0000-0002-0296-7966	CONACyT [FORDECYT-PRONACES 610285/2020, 263377/2020]; Universidad Nacional Autonoma de Mexico [DGAPA-PAPIIT IA100120, IN113619]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	This work was partially financially supported by CONACyT through grants FORDECYT-PRONACES 610285/2020, 263377/2020, the Universidad Nacional Autonoma de Mexico through grants DGAPA-PAPIIT IA100120 and IN113619.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; ALLGROVE J, 1978, LANCET, V1, P1284; ANNESE V, 1991, DIGEST DIS SCI, V36, P1116, DOI 10.1007/BF01297456; [Anonymous], 1995, DIABETES CARE S1, V18, P59, DOI [10.2337/diacare.18.1.S59, DOI 10.2337/DIACARE.18.1.S59]; APPEL ML, 1989, J AM COLL CARDIOL, V14, P1139, DOI 10.1016/0735-1097(89)90408-7; Ascaso JF, 2006, NEUROGASTROENT MOTIL, V18, P813, DOI 10.1111/j.1365-2982.2006.00799.x; ATKINSON M, 1987, Q J MED, V63, P297; Bauer A, 2006, LANCET, V367, P1674, DOI 10.1016/S0140-6736(06)68735-7; BENINI L, 1994, DIGEST DIS SCI, V39, P733, DOI 10.1007/BF02087415; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Bittinger M, 1998, EUR J GASTROEN HEPAT, V10, P741, DOI 10.1097/00042737-199809000-00003; CAMILLERI M, 1985, GASTROENTEROLOGY, V88, P1852, DOI 10.1016/0016-5085(85)90010-1; Camm AJ, 1996, EUR HEART J, V17, P354; Campos GM, 2009, ANN SURG, V249, P45, DOI 10.1097/SLA.0b013e31818e43ab; Carmena R., 1987, CIR ESP, V41, P237; CASSELLA RR, 1965, AM J PATHOL, V46, P279; CASSELLA RR, 1964, ANN SURG, V160, P474, DOI 10.1097/00000658-196409000-00010; Corrales MM, 2012, HEALTH-LONDON, V04, P377, DOI [10.4236/health.2012.47060, DOI 10.4236/OJAPPS.2022.127074, DOI 10.4236/health.2012.47060]; CSENDES A, 1992, GUT, V33, P150, DOI 10.1136/gut.33.2.150; DELAFUENTE A, 1977, REV ESP ENFERM APAR, V51, P659; des Varannes SB, 2006, GUT, V55, P319, DOI 10.1136/gut.2005.070011; DOOLEY CP, 1983, GASTROENTEROLOGY, V84, P809; ECKARDT VF, 1995, NEUROGASTROENT MOTIL, V7, P55, DOI 10.1111/j.1365-2982.1995.tb00209.x; ECKARDT VF, 1989, DIGEST DIS SCI, V34, P665, DOI 10.1007/BF01540335; Eckert S, 2002, BLOOD PRESS MONIT, V7, P179, DOI 10.1097/00126097-200206000-00006; Estanol B, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13053; FIROUZI M, 1994, AM J GASTROENTEROL, V89, P1585; Floras JS, 2013, CAN J CARDIOL, V29, P557, DOI 10.1016/j.cjca.2013.02.012; Fossion R., 2018, QUANTITATIVE MODELS, P87, DOI [10.1007/978-3-319-73975-5_5, DOI 10.1007/978-3-319-73975-5_5]; Fossion Ruben, 2020, Inter disciplina, V8, P55, DOI 10.22201/ceiich.24485705e.2020.20.71195; Fossion R, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aad8db; Franzini C., 1962, EL MICR 5 INT C EL M, P55; FREEMAN R, 1991, ARCH NEUROL-CHICAGO, V48, P185, DOI 10.1001/archneur.1991.00530140079020; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Furuzawa-Carballeda J, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/729217; Furuzawa-Carballeda J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201676; Ge F, 1994, Chin Med Sci J, V9, P194; Griffin MP, 2001, PEDIATRICS, V107, P97, DOI 10.1542/peds.107.1.97; Herreros B, 2007, NEUROGASTROENT MOTIL, V19, P646, DOI 10.1111/j.1365-2982.2007.00920.x; HOLLIS JB, 1977, GASTROENTEROLOGY, V73, P1098; HOPKINS A, 1974, LANCET, V1, P769; Houle MS, 1999, AM J PHYSIOL-HEART C, V276, pH215, DOI 10.1152/ajpheart.1999.276.1.H215; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Kellow JE., 1990, GASTROINTEST MOT, V2, P180; KITNEY R I, 1982, Automedica (London), V4, P155; Lavin-Perez R, 2018, THESIS U NACL AUTONO; Rivera AL, 2020, J PHYS CONF SER, V1612, DOI 10.1088/1742-6596/1612/1/012024; Rivera AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165904; Rivera AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148378; LEVY MN, 1971, CIRC RES, V29, P437, DOI 10.1161/01.RES.29.5.437; Lluch I, 1999, AM J GASTROENTEROL, V94, P919; MAAYAN C, 1990, AM J GASTROENTEROL, V85, P729; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; MANCIA G, 1983, CIRC RES, V53, P96, DOI 10.1161/01.RES.53.1.96; Mayberry J F, 2001, Gastrointest Endosc Clin N Am, V11, P235; MEARIN F, 1995, GUT, V36, P363, DOI 10.1136/gut.36.3.363; Michel-Chavez A, 2015, ARQ BRAS CARDIOL, V105, P276, DOI 10.5935/abc.20150073; Ohlsson B, 2004, SCAND J GASTROENTERO, V39, P527, DOI 10.1080/00365520410004460; Olk W, 1999, DIGEST DIS SCI, V44, P2088, DOI 10.1023/A:1026638822259; Pandolfino JE, 2008, GASTROENTEROLOGY, V135, P1526, DOI 10.1053/j.gastro.2008.07.022; Parati G, 2013, DIABETES CARE, V36, pS312, DOI 10.2337/dcS13-2043; Parati G, 2013, NAT REV CARDIOL, V10, P143, DOI 10.1038/nrcardio.2013.1; Petersen RP, 2012, DIS ESOPHAGUS, V25, P305, DOI 10.1111/j.1442-2050.2009.01030.x; Prokhorov MD, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041913; QUALMAN SJ, 1984, GASTROENTEROLOGY, V87, P848; del Paso GAR, 2013, PSYCHOPHYSIOLOGY, V50, P477, DOI 10.1111/psyp.12027; Rinaldi R, 2000, DIGEST DIS SCI, V45, P825, DOI 10.1023/A:1005472400263; Rivera A.L., 2018, QUANTITATIVE MODELS, P111, DOI [DOI 10.1007/978-3-319-73975-5_6, 10.1007/978-3-319-73975-5%5F6]; Robles-Cabrera A, 2014, REV NEUROLOGIA, V59, P508, DOI 10.33588/rn.5911.2014314; RUSSELL COH, 1983, DIGEST DIS SCI, V28, P289, DOI 10.1007/BF01324943; Shaffer F, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00258; SMITH B, 1970, GUT, V11, P388, DOI 10.1136/gut.11.5.388; STEWART IM, 1976, THORAX, V31, P278, DOI 10.1136/thx.31.3.278; STUCKEY BG, 1987, ANN INTERN MED, V106, P62, DOI 10.7326/0003-4819-106-1-62; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Trudgill NJ, 1999, EUR J GASTROEN HEPAT, V11, P1349, DOI 10.1097/00042737-199912000-00002; von Herbay A, 1998, NEUROGASTROENT MOTIL, V10, P387; Wienbeck M, 1983, Z GASTROENTEROLOGIE, V21, P249; Ziegler D, 2008, DIABETES CARE, V31, P556, DOI 10.2337/dc07-1615	79	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0248106	10.1371/journal.pone.0248106	http://dx.doi.org/10.1371/journal.pone.0248106			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720957	gold, Green Published			2022-12-26	WOS:000629667400049
J	Biermann, O; Kluppelberg, R; Lonnroth, K; Viney, K; Caws, M; Atkins, S				Biermann, Olivia; Kluppelberg, Raina; Lonnroth, Knut; Viney, Kerri; Caws, Maxine; Atkins, Salla			'A double-edged sword': Perceived benefits and harms of active case-finding for people with presumptive tuberculosis and communities-A qualitative study based on expert interviews	PLOS ONE			English	Article								Background Active case-finding (ACF), also referred to as community-based tuberculosis screening, is a component of the World Health Organization's End TB Strategy. ACF has potential benefits but also harms, which need to be carefully assessed when developing and implementing ACF policies. While empirical evidence on the benefits of ACF is still weak, evidence on the harms is even weaker. This study aimed to explore experts' views on the benefits and harms of ACF for people with presumptive TB and communities. Methods This was an exploratory study. Semi-structured interviews were conducted with a purposive sample of 39 experts from international, non-governmental/non-profit organizations, funders, government institutions, international societies, think tanks, universities and research institutions worldwide. Framework analysis was applied. Results Findings elaborated perceived benefits of ACF, including reaching vulnerable populations, reducing patient costs, helping raise awareness for tuberculosis among individuals and engaging communities, and reducing tuberculosis transmission. Perceived harms included increasing stigma and discrimination, causing false-positive diagnoses, as well as triggering other unintended consequences related to screening for tuberculosis patients, such as deportation of migrants once confirmed to have tuberculosis. Most of the perceived benefits of ACF could be linked to its objective of finding and treating persons with tuberculosis early (theme 1), while ACF was also perceived as a "double-edged sword" and could cause harms, if inappropriately designed and implemented (theme 2). The analysis underlined the importance of considering the benefits and harms of ACF throughout the screening pathway. The study provides new insights into the perceived benefits and harms of ACF from the perspectives of experts in the field. Conclusion This study highlights gaps in the evidence base surrounding ACF and can stimulate further research, debate and analysis regarding the benefits and harms of ACF to inform contextual optimization of design and implementation of ACF strategies.	[Biermann, Olivia; Kluppelberg, Raina; Lonnroth, Knut; Viney, Kerri; Atkins, Salla] Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden; [Viney, Kerri] Australian Natl Univ, Coll Hlth & Med, Res Sch Populat Hlth, Canberra, ACT, Australia; [Caws, Maxine] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England; [Caws, Maxine] Birat Nepal Med Trust, Kathmandu, Nepal; [Atkins, Salla] Tampere Univ, Fac Social Sci, New Social Res & Global Hlth & Dev, Tampere, Finland	Karolinska Institutet; Australian National University; Liverpool School of Tropical Medicine; Tampere University	Biermann, O (corresponding author), Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden.	olivia.biermann@ki.se	Atkins, Salla/ABH-1071-2021; Lonnroth, Knut/H-5470-2017	Lonnroth, Knut/0000-0001-6944-0256; Biermann, Olivia/0000-0002-5978-0211; Atkins, Salla/0000-0002-4116-893X	EU-Horizon 2020 [733174]	EU-Horizon 2020	OB, KL and MC are funded by the EUHorizon 2020-funded IMPACT-TB project (grant 733174). The grant was received by MC. URL: https://ec.europa.eu/programmes/horizon2020/en.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Coello P, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2016; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Barratt Alexandra L, 2006, Aust Fam Physician, V35, P39; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Beijer U, 2012, LANCET INFECT DIS, V12, P859, DOI 10.1016/S1473-3099(12)70177-9; Biermann O, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240696; Biermann O, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-036285; Biermann O, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031284; Blok L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119822; Bond M, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17130; Borgdorff MW, 2002, B WORLD HEALTH ORGAN, V80, P217; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Creswell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094465; Creswell J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-2; Deandrea S, 2016, PREV MED, V91, P250, DOI 10.1016/j.ypmed.2016.08.021; Dowdy DW, 2012, P NATL ACAD SCI USA, V109, P9557, DOI 10.1073/pnas.1203517109; Eang MT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-469; Fox GJ, 2018, NEW ENGL J MED, V378, P221, DOI 10.1056/NEJMoa1700209; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Furst T, 2018, ACTA TROP, V180, P26, DOI 10.1016/j.actatropica.2017.12.031; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Gurung SC, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0603-z; Ho J, 2016, INT J MYCOBACT, V5, P374, DOI 10.1016/j.ijmyco.2016.09.023; Hoffmann TC, 2017, JAMA INTERN MED, V177, P407, DOI 10.1001/jamainternmed.2016.8254; Holloway I., 2010, QUALITATIVE RES NURS; Hsiang MS, 2020, CLIN INFECT DIS, V70, P1316, DOI 10.1093/cid/ciz403; Jonas DE, 2018, JAMA-J AM MED ASSOC, V320, P485, DOI 10.1001/jama.2018.4190; Kane J, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0613-5; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Legrand J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002100; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444; Marks GB, 2019, NEW ENGL J MED, V381, P1347, DOI 10.1056/NEJMoa1902129; Marmot MG, 2013, BRIT J CANCER, V108, P2205, DOI 10.1038/bjc.2013.177; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Miller AC, 2010, INT J TUBERC LUNG D, V14, P720; Morishita F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162796; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Murray CJL, 1998, P NATL ACAD SCI USA, V95, P13881, DOI 10.1073/pnas.95.23.13881; Musa J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183924; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Petticrew MP., 2000, HLTH TECHNOL ASSESS, V4; Seedat F, 2014, INT COMP SCREENING P; Shewade HD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213345; Shewade HD, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1494897; SHICKLE D, 1994, J MED ETHICS, V20, P12, DOI 10.1136/jme.20.1.12; Szczepura A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-346; Talib Y., 2017, LANCET, V5, pPE565; The World Bank, CLASS COUNTR INC; Thorne S., 2004, INT J QUAL METH, V3, P1, DOI [DOI 10.1177/160940690400300101, 10.1177/160940690400300101]; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UN, 2015, UN TRANSF OUR WORLD, DOI [10.1201/b20466-7, DOI 10.1201/B20466-7]; Uplekar M, 2013, INT J TUBERC LUNG D, V17, P1248, DOI 10.5588/ijtld.13.0199; von Wagner C, 2011, INT J EPIDEMIOL, V40, P712, DOI 10.1093/ije/dyr008; WHO, 2020, GLOB TB REP 2020; *WHO, 2002, EXP DOTS FRAM EFF TU; WHO Europe, 2020, SCREEN PROGR SHORT G; WILSON JMG, 1968, B OFIC SANIT PANAM, V65, P281; World Health Organization, RAPID COMMUNICATION; World Health Organization, 2013, SYST SCREEN ACT TUB; World Health Organization, 2014, 67 WORLD HLTH ASS 20; World Health Organization, 2010, WHOHTMTB201016; World health Organization, 2015, SYSTEMATIC SCREENING	65	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0247568	10.1371/journal.pone.0247568	http://dx.doi.org/10.1371/journal.pone.0247568			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8JZ	33705422	Green Published, gold			2022-12-26	WOS:000629590400030
J	Karagianni, F; Piperi, C; Mpakou, V; Spathis, A; Foukas, PG; Dalamaga, M; Pappa, V; Papadavid, E				Karagianni, Fani; Piperi, Christina; Mpakou, Vassiliki; Spathis, Aris; Foukas, Periklis G.; Dalamaga, Maria; Pappa, Vasiliki; Papadavid, Evangelia			Ruxolitinib with resminostat exert synergistic antitumor effects in Cutaneous T-cell Lymphoma	PLOS ONE			English	Article								Background The combination of JAK/STAT and HDAC inhibitors exerted beneficial effects in haematological malignancies, presenting promising therapeutic CTCL targets. We aim to investigate the efficacy of JAK1/2i ruxolitinib in combination with HDACi resminostat in CTCL in vitro. Material & methods Non-toxic concentrations of ruxolitinib and/or resminostat were administered to MyLa (MF) and SeAx (SS) cells for 24h. Cytotoxicity, cell proliferation and apoptosis were estimated through MTT, BrdU/7AAD and Annexin V/PI assay. Multi-pathway analysis was performed to investigate the effect of JAK1/2i and/or HDACi on JAK/STAT, Akt/mTOR and MAPK signalling pathways. Results Both drugs and their combination were cytotoxic in MyLa (p<0.05) and in SeAx cell line (p<0.001), inhibited proliferation of MyLa (p<0.001) and SeAx (p<0.001) at 24h, compared to untreated cells. Moreover, combined drug treatment induced apoptosis after 24h (p<0.001) in MyLa, and SeAx (p<0.001). The combination of drugs had a strong synergistic effect with a CI<1. Importantly, the drugs' combination inhibited phosphorylation of STAT3 (p<0.001), Akt (p<0.05), ERK1/2 (p<0.001) and JNK (p<0.001) in MyLa, while it reduced activation of Akt (p<0.05) and JNK (p<0.001) in SeAx. Conclusion The JAKi/HDACi combination exhibited substantial anti-tumor effects in CTCL cell lines, and may represent a promising novel therapeutic modality for CTCL patients.	[Karagianni, Fani; Dalamaga, Maria; Papadavid, Evangelia] NKUA, Dept Dermatol & Venereal Dis 2, Athens, Greece; [Piperi, Christina; Dalamaga, Maria] NKUA, Dept Biol Chem, Athens, Greece; [Mpakou, Vassiliki; Pappa, Vasiliki] Attikon Univ Gen Hosp, Dept Internal Med 2, NKUA, Athens, Greece; [Mpakou, Vassiliki; Pappa, Vasiliki] Attikon Univ Gen Hosp, Res Inst, NKUA, Athens, Greece; [Spathis, Aris; Foukas, Periklis G.] Natl & Kapodistrian Univ Athens, Dept Pathol 2, Athens, Greece	University Hospital Attikon; University Hospital Attikon; National & Kapodistrian University of Athens	Karagianni, F (corresponding author), NKUA, Dept Dermatol & Venereal Dis 2, Athens, Greece.	karagiannifani@gmail.com		Karagianni, Fani/0000-0001-9514-2199; Dalamaga, Maria/0000-0002-7008-388X; Piperi, Christina/0000-0002-2701-0618				Barrio S, 2013, BRIT J HAEMATOL, V161, P667, DOI 10.1111/bjh.12308; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Benedetti R, 2015, ANTIOXID REDOX SIGN, V23, P99, DOI 10.1089/ars.2013.5776; Bradford PT, 2009, BLOOD, V113, P5064, DOI 10.1182/blood-2008-10-184168; Bretz AC, 2018, EUR J CANCER, V101, pS2, DOI 10.1016/j.ejca.2018.07.144; Campbell JJ, 2010, BLOOD, V116, P767, DOI 10.1182/blood-2009-11-251926; Cardoso BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143897; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Civallero M, 2017, ONCOTARGET, V8, P103797, DOI 10.18632/oncotarget.21951; Clark JD, 2014, J MED CHEM, V57, P5023, DOI 10.1021/jm401490p; Cristofoletti C, 2019, LEUKEMIA, V33, P1231, DOI 10.1038/s41375-018-0305-8; de Masson A, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar5894; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Devata S, 2016, AM J CLIN DERMATOL, V17, P225, DOI 10.1007/s40257-016-0177-5; Dulmage BO, 2013, BRIT J DERMATOL, V169, P1188, DOI 10.1111/bjd.12578; Dulmage BO, 2018, CURR DERMATOL REP, V7, P91, DOI 10.1007/s13671-018-0214-0; Haery Leila, 2015, Genes Cancer, V6, P184; Hull EE, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8797206; Kim YH, 2003, ARCH DERMATOL, V139, P857, DOI 10.1001/archderm.139.7.857; Klemke CD, 2009, CANCER RES, V69, P4175, DOI 10.1158/0008-5472.CAN-08-4631; Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006; Krejsgaard T, 2006, LEUKEMIA, V20, P1759, DOI 10.1038/sj.leu.2404350; Kremer M, 2010, EXP DERMATOL, V19, P800, DOI 10.1111/j.1600-0625.2010.01102.x; Levidou G, 2013, J AM ACAD DERMATOL, V69, P375, DOI 10.1016/j.jaad.2013.04.027; Li Janet Y, 2012, Cancer Manag Res, V4, P75, DOI 10.2147/CMAR.S9660; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Marquard L, 2009, HISTOPATHOLOGY, V54, P688, DOI 10.1111/j.1365-2559.2009.03290.x; Meyer SC, 2015, CANCER CELL, V28, P15, DOI 10.1016/j.ccell.2015.06.006; Mishra A, 2016, CANCER DISCOV, V6, P986, DOI 10.1158/2159-8290.CD-15-1297; Mullally A, 2012, J CLIN ONCOL, V30, P4168, DOI 10.1200/JCO.2012.44.0347; Nebbioso A, 2010, J MOL ENDOCRINOL, V45, P219, DOI 10.1677/JME-10-0043; Netchiporouk E, 2014, CELL CYCLE, V13, P3331, DOI 10.4161/15384101.2014.965061; Papadavid E, 2014, EXP DERMATOL, V23, P931, DOI 10.1111/exd.12547; Perez C, 2015, HAEMATOLOGICA, V100, pE450, DOI 10.3324/haematol.2015.132837; Ramelyte E, 2019, EXPERT OPIN INV DRUG, V28, P799, DOI 10.1080/13543784.2019.1654995; Scarisbrick JJ, 2014, BRIT J DERMATOL, V170, P1226, DOI 10.1111/bjd.12909; Schade AE, 2006, BLOOD, V107, P4834, DOI 10.1182/blood-2005-08-3076; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Torres ANB, 2018, SEMIN CUTAN MED SURG, V37, P81, DOI 10.12788/j.sder.2018.007; Trung LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055183; van Doorn R, 2009, BLOOD, V113, P127, DOI 10.1182/blood-2008-04-153031; Watanabe R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010302; Wernham AG, 2015, BRIT J DERMATOL, V173, P1295, DOI 10.1111/bjd.13939; Wilcox RA, 2017, AM J HEMATOL, V92, P1085, DOI 10.1002/ajh.24876; Yumeen S, 2020, YALE J BIOL MED, V93, P111	45	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248298	10.1371/journal.pone.0248298	http://dx.doi.org/10.1371/journal.pone.0248298			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705488	gold, Green Published			2022-12-26	WOS:000629590400081
J	Rajhi, M; Haddad-Boubaker, S; Chouikha, A; Bourquain, D; Michel, J; Hammami, W; Sadraoui, A; Touzi, H; Ghedira, K; Triki, H				Rajhi, Mouna; Haddad-Boubaker, Sondes; Chouikha, Anissa; Bourquain, Daniel; Michel, Janine; Hammami, Walid; Sadraoui, Amel; Touzi, Hinda; Ghedira, Kais; Triki, Henda			Identification of two novel hepatitis C virus subtype 2 from Tunisia (2v and 2w)	PLOS ONE			English	Article								Background Hepatitis C virus (HCV) has a high genetic diversity. Eight genotypes and 90 subtypes are currently described. Genotypes are clinically significant for therapeutic management and their determination is necessary for epidemiological studies. Methods Tunisian patients plasma samples (n = 6) with unassigned HCV-2 subtype using partial sequencing in the NS5B and Core/E1 regions were analyzed by realizing whole-genome sequencing analysis. Phylogenetic analyses were performed to assign subtypes. Results Phylogenetic analysis of the full genome sequences of Tunisian strains shows two subtypes within HCV-2. These later were genetically distinct from all previously established HCV-2 subtypes with nucleotide divergence greater than 15% (20% -31%). These two subtypes are proposed as new subtypes 2v and 2w. Conclusions The discovery of two new HCV-2 subtypes circulating in the Tunisian population confirms the great diversity of HCV-2 viruses and increases the total number of HCV-2 subtypes from 21 to 23.	[Rajhi, Mouna; Haddad-Boubaker, Sondes; Chouikha, Anissa; Hammami, Walid; Sadraoui, Amel; Touzi, Hinda; Triki, Henda] Pasteur Inst, Lab Clin Virol, WHO Reg Reference Lab Poliomyelitis & Measles, EMR, Tunis, Tunisia; [Rajhi, Mouna; Haddad-Boubaker, Sondes; Chouikha, Anissa; Hammami, Walid; Sadraoui, Amel; Touzi, Hinda; Ghedira, Kais; Triki, Henda] Univ Tunis El Manar, Tunis, Tunisia; [Rajhi, Mouna; Haddad-Boubaker, Sondes; Chouikha, Anissa; Hammami, Walid; Sadraoui, Amel; Touzi, Hinda; Triki, Henda] Pasteur Inst, Res Lab Virus Vector & Host LR20IPT10, Tunis, Tunisia; [Bourquain, Daniel; Michel, Janine] Robert Koch Inst, Ctr Biol Threats & Special Pathogens Highly Patho, Berlin, Germany; [Ghedira, Kais] Pasteur Inst, Lab Bioinformat Biomath & Biostat LR16IPT09, Tunis, Tunisia	Universite de Tunis-El-Manar; Robert Koch Institute	Rajhi, M (corresponding author), Pasteur Inst, Lab Clin Virol, WHO Reg Reference Lab Poliomyelitis & Measles, EMR, Tunis, Tunisia.; Rajhi, M (corresponding author), Univ Tunis El Manar, Tunis, Tunisia.; Rajhi, M (corresponding author), Pasteur Inst, Res Lab Virus Vector & Host LR20IPT10, Tunis, Tunisia.	rajhimouna@yahoo.fr	; CHOUIKHA, Anissa/AAO-9251-2020	Bourquain, Daniel/0000-0001-5075-8870; CHOUIKHA, Anissa/0000-0001-5616-0204	Ministry of High Education and Scientific research, Tunisia (Research Laboratory Virus, Vector and Host) [LR20IPT10]; Ministry of Health, Tunisia (Centre d'investigation Clinique (PRF-4)) [CIC2016IPT02]	Ministry of High Education and Scientific research, Tunisia (Research Laboratory Virus, Vector and Host); Ministry of Health, Tunisia (Centre d'investigation Clinique (PRF-4))	This study was funded by the Ministry of High Education and Scientific research, Tunisia (Research Laboratory Virus, Vector and Host (LR20IPT10)) and the Ministry of Health, Tunisia (Centre d'investigation Clinique (PRF-4; CIC2016IPT02)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayed K, 2003, TRANSPL P, V35, P2573, DOI 10.1016/j.transproceed.2003.09.005; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bellentani S, 2000, MICROBES INFECT, V2, P1757, DOI 10.1016/S1286-4579(00)01332-0; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borgia SM, 2018, J INFECT DIS, V218, P1722, DOI 10.1093/infdis/jiy401; Brahim I, 2012, ARCH VIROL, V157, P515, DOI 10.1007/s00705-011-1193-7; Candotti D, 2003, J VIROL, V77, P7914, DOI 10.1128/JVI.77.14.7914-7923.2003; Cantaloube JF, 2008, J MED VIROL, V80, P1732, DOI 10.1002/jmv.21285; CHOO QL, 1991, P NATL ACAD SCI USA, V88, P2451, DOI 10.1073/pnas.88.6.2451; Djebbi A, 2003, EPIDEMIOL INFECT, V130, P501, DOI 10.1017/S095026880300846X; Hedskog C, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz076; Jeannel D, 1998, J MED VIROL, V55, P92, DOI 10.1002/(SICI)1096-9071(199806)55:2&lt;92::AID-JMV2&gt;3.0.CO;2-I; Jordier F, 2013, J MED VIROL, V85, P1754, DOI 10.1002/jmv.23674; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kuiken C, 2006, HEPATOLOGY, V44, P1355, DOI 10.1002/hep.21377; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Maggi F, 1997, J CLIN MICROBIOL, V35, P161, DOI 10.1128/JCM.35.1.161-164.1997; Markov PV, 2012, J VIROL, V86, P7677, DOI 10.1128/JVI.06910-11; Markov PV, 2009, J GEN VIROL, V90, P2086, DOI 10.1099/vir.0.011569-0; Martial J, 2004, J CLIN MICROBIOL, V42, P784, DOI 10.1128/JCM.42.2.784-791.2004; Mejri S, 2005, J MED VIROL, V76, P185, DOI 10.1002/jmv.20342; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Njouom R, 2007, INFECT GENET EVOL, V7, P361, DOI 10.1016/j.meegid.2006.10.003; Pasquier C, 2005, J MED VIROL, V77, P390, DOI 10.1002/jmv.20468; Pouillot R, 2008, INFECT GENET EVOL, V8, P676, DOI 10.1016/j.meegid.2008.06.001; Rajhi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153761; Rajhi M, 2014, VIRUS GENES, V48, P209, DOI 10.1007/s11262-013-1010-3; Rouabhia S, 2013, WORLD J HEPATOL, V5, P393, DOI 10.4254/wjh.v5.i7.393; Ruggieri A, 1996, J GEN VIROL, V77, P2073, DOI 10.1099/0022-1317-77-9-2073; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Sulbaran MZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014315; Thomas F, 2007, J MED VIROL, V79, P26, DOI 10.1002/jmv.20765; Vilsker M, 2019, BIOINFORMATICS, V35, P871, DOI 10.1093/bioinformatics/bty695; Zaltron S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-S2-S2	36	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248249	10.1371/journal.pone.0248249	http://dx.doi.org/10.1371/journal.pone.0248249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705445	Green Published, gold			2022-12-26	WOS:000629590400072
J	Honigberg, MC; Patel, AP; Lahm, T; Wood, MJ; Ho, JE; Kohli, P; Natarajan, P				Honigberg, Michael C.; Patel, Aniruddh P.; Lahm, Tim; Wood, Malissa J.; Ho, Jennifer E.; Kohli, Puja; Natarajan, Pradeep			Association of premature menopause with incident pulmonary hypertension: A cohort study	PLOS ONE			English	Article								Background Several forms of pulmonary hypertension (PH) disproportionately affect women. Animal and human studies suggest that estradiol exerts mixed effects on the pulmonary vasculature. Whether premature menopause represents a risk factor for PH is unknown. Methods and findings In this cohort study, women in the UK Biobank aged 40-69 years who were postmenopausal and had complete data available on reproductive history were included. Premature menopause, defined as menopause occurring before age 40 years. Postmenopausal women without premature menopause served as the reference group. The primary outcome was incident PH, ascertained by appearance of a qualifying ICD code in the participant's UK Biobank study record. Of 136,715 postmenopausal women included, 5,201 (3.8%) had premature menopause. Participants were followed up for a median of 11.1 (interquartile range 10.5-11.8) years. The primary outcome occurred in 38 women (0.73%) with premature menopause and 409 (0.31%) without. After adjustment for age, race, ever-smoking, body-mass index, systolic blood pressure, antihypertensive medication use, non-high-density lipoprotein cholesterol, cholesterol-lowering medication use, C-reactive protein, prevalent type 2 diabetes, obstructive sleep apnea, heart failure, mitral regurgitation, aortic stenosis, venous thromboembolism, forced vital capacity (FVC), the forced expiratory volume in 1 second-to-FVC ratio, use of menopausal hormone therapy, and hysterectomy status, premature menopause was independently associated with PH (hazard ratio 2.13, 95% CI 1.31-3.23, P<0.001). In analyses of alternate menopausal age thresholds, risk of PH appeared to increase progressively with younger age at menopause (P-trend <0.001), with 4.8-fold risk in women with menopause before age 30 years (95% CI 1.82-12.74, P = 0.002). Use of menopausal hormone therapy did not modify the association of premature menopause with PH. Conclusions Premature menopause may represent an independent risk factor for PH in women. Further investigation of the role of sex hormones in PH is needed in animal and human studies to elucidate pathobiology and identify novel therapeutic targets.	[Honigberg, Michael C.; Patel, Aniruddh P.; Wood, Malissa J.; Ho, Jennifer E.; Natarajan, Pradeep] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Cardiol Div, Boston, MA 02115 USA; [Honigberg, Michael C.; Patel, Aniruddh P.; Natarajan, Pradeep] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Honigberg, Michael C.; Patel, Aniruddh P.; Ho, Jennifer E.; Natarajan, Pradeep] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Honigberg, Michael C.; Patel, Aniruddh P.; Ho, Jennifer E.; Natarajan, Pradeep] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Honigberg, Michael C.; Wood, Malissa J.] Massachusetts Gen Hosp, Cardiol Div, Corrigan Womens Heart Hlth Program, Boston, MA 02114 USA; [Lahm, Tim] Indiana Univ Sch Med, Div Pulm Allergy Crit Care & Sleep Med, Indianapolis, IN USA; [Lahm, Tim] Richard L Roudebush VA Med Ctr, Indianapolis, IN USA; [Kohli, Puja] Vertex Pharmaceut, Boston, MA USA; [Kohli, Puja] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Vertex Pharmaceuticals; Harvard University; Harvard Medical School; Massachusetts General Hospital	Natarajan, P (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Cardiol Div, Boston, MA 02115 USA.; Natarajan, P (corresponding author), Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Natarajan, P (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA.; Natarajan, P (corresponding author), Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA.	pnatarajan@mgh.harvard.edu	Honigberg, Michael/AAF-1381-2019; Natarajan, Pradeep/H-9764-2019	Honigberg, Michael/0000-0001-8630-5021; Natarajan, Pradeep/0000-0001-8402-7435	U.S. National Heart, Lung, and Blood Institute [R01HL1427, R01HL148565, R01HL148050, T32HL094301-07, T32HL007208, R01HL144727-01A1, R01HL134893, R01HL140224]; U.S. Department of Veterans Affairs [VA Merit Award] [1I01BX002042-07]; Fondation Leducq [TNE-18CVD04]; Massachusetts General Hospital	U.S. National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. Department of Veterans Affairs [VA Merit Award]; Fondation Leducq(Leducq Foundation); Massachusetts General Hospital(General Electric)	Dr. Honigberg is supported by the U.S. National Heart, Lung, and Blood Institute [T32HL094301-07]. Dr. Patel is supported by the U.S. National Heart, Lung, and Blood Institute [T32HL007208]. Dr. Lahm is supported by grants from the U.S. National Heart, Lung, and Blood Institute [R01HL144727-01A1] and the U.S. Department of Veterans Affairs [VA Merit Award 1I01BX002042-07]. Dr. Ho is supported by the U.S. National Heart, Lung, and Blood Institute [R01HL134893, R01HL140224]. Dr. Kohli reports employment by Vertex Pharmaceuticals, unrelated to this work. Dr. Natarajan is supported by grants from the U.S. National Heart, Lung, and Blood Institute [R01HL1427, R01HL148565, and R01HL148050], Fondation Leducq [TNE-18CVD04], and a Hassenfeld award from the Massachusetts General Hospital. The authors received no specific funding for this work.	Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Grundy SM, 2019, J AM COLL CARDIOL, V73, pE285, DOI 10.1016/j.jacc.2018.11.003; Hester J, 2020, COMPR PHYSIOL, V10, P125, DOI 10.1002/cphy.c190011; Honigberg MC, 2019, JAMA-J AM MED ASSOC, V322, P2411, DOI 10.1001/jama.2019.19191; Kawut SM, 2019, ANN AM THORAC SOC, V16, P1456, DOI 10.1513/AnnalsATS.201904-328RL; Lahm T, 2017, AM J RESP CRIT CARE, V195, P284, DOI 10.1164/rccm.201609-1906ED; Lahm T, 2012, AM J RESP CRIT CARE, V185, P965, DOI 10.1164/rccm.201107-1293OC; Mair KM, 2014, AM J RESP CRIT CARE, V190, P456, DOI 10.1164/rccm.201403-0483OC; Maron BA, 2016, CIRCULATION, V133, P1240, DOI 10.1161/CIRCULATIONAHA.115.020207; Scorza R, 2002, ANN NY ACAD SCI, V966, P238, DOI 10.1111/j.1749-6632.2002.tb04221.x; Simonneau G, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01913-2018; Ventetuolo CE, 2014, EUR RESPIR J, V43, P523, DOI 10.1183/09031936.00027613	12	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0247398	10.1371/journal.pone.0247398	http://dx.doi.org/10.1371/journal.pone.0247398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690615	Green Published, gold			2022-12-26	WOS:000627854700022
J	Ibarra-Nava, I; Flores-Rodriguez, KG; Ruiz-Herrera, V; Ochoa-Bayona, HC; Salinas-Zertuche, A; Padilla-Orozco, M; Salazar-Montalvo, RG				Ibarra-Nava, Ismael; Flores-Rodriguez, Kathia G.; Ruiz-Herrera, Violeta; Ochoa-Bayona, Hilda C.; Salinas-Zertuche, Alfonso; Padilla-Orozco, Magaly; Salazar-Montalvo, Raul G.			Ethnic disparities in COVID-19 mortality in Mexico: A cross-sectional study based on national data	PLOS ONE			English	Article							HEALTH-CARE; HYPERTENSION; PREVALENCE; BURDEN	Introduction Across the world, the COVID-19 pandemic has disproportionately affected racial and ethnic minorities. How ethnicity affects Indigenous peoples in Mexico is unclear. The aim of this cross-sectional study was to determine the mortality associated with ethnicity, particularly of Indigenous peoples, in a large sample of patients with COVID-19 in Mexico. Methods We used open access data from the Mexican Ministry of Health, which includes data of all confirmed COVID-19 cases in the country. We used descriptive statistics to compare differences among different groups of patients. Logistic regression was used to calculate odds ratios while adjusting for confounders. Results From February 28 to August 3, 2020, a total of 416546 adult patients were diagnosed with COVID-19. Among these, 4178 were Indigenous peoples. Among all patients with COVID-19, whether hospitalized or not, a higher proportion of Indigenous peoples died compared to non-Indigenous people (16.5% vs 11.1%, respectively). Among hospitalized patients, a higher proportion of Indigenous peoples died (37.1%) compared to non-Indigenous peoples (36.3%). Deaths outside the hospital were also higher among Indigenous peoples (3.7% vs 1.7%). A higher proportion of Indigenous peoples died in both the private and public health care sectors. The adjusted odds ratio for COVID-19 mortality among Indigenous peoples with COVID-19 was 1.13 (95% confidence interval 1.03 to 1.24). The adjusted odds ratio for COVID-19 mortality among Indigenous peoples with COVID-19 was higher among those who received only ambulatory care (1.55, 95% confidence interval 1.24 to 1.92). Discussion In this large sample of patients with COVID-19, the findings suggest that Indigenous peoples in Mexico have a higher risk of death from COVID-19, especially outside the hospital. These findings suggest Indigenous peoples lack access to care more so than non-Indigenous people during the COVID-19 pandemic in Mexico.	[Ibarra-Nava, Ismael; Flores-Rodriguez, Kathia G.; Ruiz-Herrera, Violeta; Ochoa-Bayona, Hilda C.; Salinas-Zertuche, Alfonso; Padilla-Orozco, Magaly; Salazar-Montalvo, Raul G.] Univ Autonoma Nuevo Leon, Fac Med, Dept Prevent Med & Publ Hlth, Monterrey, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon	Salazar-Montalvo, RG (corresponding author), Univ Autonoma Nuevo Leon, Fac Med, Dept Prevent Med & Publ Hlth, Monterrey, Nuevo Leon, Mexico.	raul.salazarm@uanl.mx		Ibarra-Nava, Ismael/0000-0002-8573-5959				Agudelo-Botero M, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035285; Baqui P, 2020, LANCET GLOB HEALTH, V8, P1018, DOI 10.1016/S2214-109X(20)30285-0; Campos-Nonato I, 2018, SALUD PUBLICA MEXICO, V60, P233, DOI 10.21149/8813; Carrillo-Balam G, 2020, PUBLIC HEALTH, V181, P8, DOI 10.1016/j.puhe.2019.11.017; de Leon-Martinez LD, 2020, SCI TOTAL ENVIRON, V733, DOI 10.1016/j.scitotenv.2020.139357; Giannouchos TV, 2020, MEDRXIV, DOI DOI 10.1101/2020.06.04.20122481; Gomez-Dantes H, 2016, LANCET, V388, P2386, DOI 10.1016/S0140-6736(16)31773-1; Hernandez-Vasquez Akram, 2020, J Prev Med Public Health, V53, P211, DOI 10.3961/jpmph.20.186; Kirby T, 2020, LANCET RESP MED, V8, P547, DOI 10.1016/S2213-2600(20)30228-9; Laurencin CT, 2020, J RACIAL ETHN HEALTH, V7, P398, DOI 10.1007/s40615-020-00756-0; Leyva-Flores R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102781; Mamo D., 2020, INDIGENOUS WORLD 202; Mendoza-Caamal EC, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8378-5; Meza R, 2015, PREV MED, V81, P445, DOI 10.1016/j.ypmed.2015.10.015; Ortiz-Hernandez L, 2020, LAT AM CARIBB ETHN S, V15, P70, DOI 10.1080/17442222.2020.1714846; Puig A, 2009, J AMBUL CARE MANAG, V32, P123, DOI 10.1097/JAC.0b013e31819942e5; Rizo Amezquita JN., POBLACI N IND GENA C; Hernandez-Galdamez DR, 2020, ARCH MED RES, V51, P683, DOI 10.1016/j.arcmed.2020.07.003; Saenz R., 2015, INT HDB DEMOGRAPHY R, V4, P73, DOI [10.1007/978-90-481-8891-8_4, DOI 10.1007/978-90-481-8891-8_4]; Servan-Mori E, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-21; Suarez V., 2020, REV 150 NICA ESP; Williamson EJ., 2020, NATURE INTERNET; World Health Organizatin, 2020, CORONAVIRUS DIS COVI; Zheng ZH, 2020, J INFECTION, V81, pE16, DOI 10.1016/j.jinf.2020.04.021; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	25	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0239168	10.1371/journal.pone.0239168	http://dx.doi.org/10.1371/journal.pone.0239168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690607	Green Published, Green Submitted, gold			2022-12-26	WOS:000627854700015
J	Li, JQ; Wang, QQ; Xuan, YT; Zhou, H				Li, Jinqiu; Wang, Qingqin; Xuan, Yitong; Zhou, Hao			User demands analysis of Eco-city based on the Kano model-An application to China case study	PLOS ONE			English	Article								Eco-cities have witnessed rapid growth in these years worldwide. As the Eco-cities entering operation stage gradually, more and more researchers have found that users (who are living or working in the Eco-cities) satisfaction is one of the most important factors to determine the success or failure of Eco-cities. Therefore, it is very important to investigate the user demands to attract more citizens willing to live or work in the Eco-cities, which will make the development of Eco-cities more sustainable and solid. The recent researches on user demands investigation and analysis in the Eco-cities mainly focused on understanding the user need itself, yet lack of research on the relationship between the user demand and user satisfaction. This paper initially introduced the Kano model analysis method to the research field of user demands in Eco-city, to explore the relationship between the user demand and user satisfaction. After proposing user demands library in Eco-city (including Land use, Ecological environment, Green building, Energy utilization, etc.), the user demands classification and importance analysis methods of Eco-city were proposed based on Kano model. The questionnaire survey for users of two Eco-cities in China as case study was conducted, consisted of user demand items questionnaire based on the Kano model and a questionnaire on the importance of the user demand items. By utilizing the integration of quantitative analysis methods based on the Kano model and Analytic Hierarchy Process (AHP) method, the final ranking of user demands importance was obtained. Comparing with the existing literatures in terms of user demands research for Eco-city, the user demands analysis method based on Kano model of this paper, is able to reveal the influence degree of user satisfaction towards the facilities and services provided in the Eco-city. The user demands analysis method can be used for other researchers worldwide to investigate and quantitively analyze user demands according to their local development situation and preference of Eco-city. The user demands analysis results obtained through this method, can benefit different stages of Eco-city.	[Li, Jinqiu; Wang, Qingqin; Xuan, Yitong] Chongqing Univ, Sch Civil Engn, Chongqing, Peoples R China; [Li, Jinqiu] Beijing Tsinghua Tongheng Urban Planning & Design, Beijing, Peoples R China; [Li, Jinqiu; Zhou, Hao] Tsinghua Univ, Minist Educ, Key Lab Eco Planning & Green Bldg, Beijing, Peoples R China; [Wang, Qingqin] China Acad Bldg Res, Beijing, Peoples R China; [Zhou, Hao] Tsinghua Univ, Think Tank Res Ctr, Beijing, Peoples R China	Chongqing University; Tsinghua University; Tsinghua University	Li, JQ (corresponding author), Chongqing Univ, Sch Civil Engn, Chongqing, Peoples R China.; Li, JQ (corresponding author), Beijing Tsinghua Tongheng Urban Planning & Design, Beijing, Peoples R China.; Li, JQ (corresponding author), Tsinghua Univ, Minist Educ, Key Lab Eco Planning & Green Bldg, Beijing, Peoples R China.	lijinqiu@thupdi.com			China National Key RD Program [2018YFC0704800, 2018YFF0215804]	China National Key RD Program	This study is supported by the China National Key R&D Program (Grant No.2018YFC0704800, Grant No.2018YFF0215804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyu R, 2019, J PHYS CONF SER, V1150, DOI 10.1088/1742-6596/1150/1/012025; [Anonymous], 2019, USER REQUIREMENTS AN; [Anonymous], 2019, IDENTIFICATION ANAL; AnthonyIkpong PACAB, CAN J CIVIL ENG; Berger C., 1993, CTR QUALITY MANAGEME, V2, P3; Caprotti F, 2017, HABITAT INT, V61, P45, DOI 10.1016/j.habitatint.2017.01.006; Chang ICC, 2017, ENVIRON PLANN A, V49, P1719, DOI 10.1177/0308518X16685092; Chen MC, 2020, J RETAIL CONSUM SERV, V57, DOI 10.1016/j.jretconser.2020.102231; China MoHaU-RDotPsRo, 2017, INT J IND ERGONOM; Chung Ruth H Gim, 2004, Cultur Divers Ethnic Minor Psychol, V10, P66; Daniel Wayne W, BUSINESS STAT MANAGE; Dominici G, 2013, BUS HORIZONS, V56, P87, DOI 10.1016/j.bushor.2012.09.011; Eisinga R, 2013, INT J PUBLIC HEALTH, V58, P637, DOI 10.1007/s00038-012-0416-3; El Ghorab HK, 2016, ALEX ENG J, V55, P495, DOI 10.1016/j.aej.2015.12.018; Enssle F, 2020, ENVIRON SCI POLICY, V109, P36, DOI 10.1016/j.envsci.2020.04.008; Fruth E, 2019, LAND USE POLICY, V89, DOI 10.1016/j.landusepol.2019.104237; Garibay C, 2010, J ACAD LIBR, V36, P125, DOI 10.1016/j.acalib.2010.01.002; Hoffken JI, 2019, LOCAL ENVIRON, V24, P646, DOI 10.1080/13549839.2019.1628730; Kano N, 1984, J JPN SOC QUAL CONTR, V14, P147, DOI [10.20684/quality.14.2_147, DOI 10.20684/QUALITY.14.2_147]; Li J, 2020, ENERGIES, V13; Li YF, 2011, ENRGY PROCED, V5, P1791, DOI 10.1016/j.egypro.2011.03.305; Lin ZJ, 2018, LANDSCAPE URBAN PLAN, V179, P90, DOI 10.1016/j.landurbplan.2018.07.008; Liu YX, 2018, ENRGY PROCED, V152, P366, DOI 10.1016/j.egypro.2018.09.150; Luor T, 2015, MATURITAS, V82, P377, DOI 10.1016/j.maturitas.2015.07.025; Ma MY, 2019, INT J IND ERGONOM, V69, P142, DOI 10.1016/j.ergon.2018.11.003; Matzler K, 1998, TECHNOVATION, V18, P25, DOI 10.1016/S0166-4972(97)00072-2; Mersal A, 2017, PROCEDIA ENVIRON SCI, V37, P22, DOI 10.1016/j.proenv.2017.03.010; Min SH, 2011, EXPERT SYST APPL, V38, P12923, DOI 10.1016/j.eswa.2011.04.087; Monteiro MV, 2020, FORESTRY, V93, P107, DOI 10.1093/forestry/cpz054; Ozdemir Z, 2018, LECT NOTES CIVIL ENG, V6, P584, DOI 10.1007/978-3-319-63709-9_47; Pow CP, 2018, ANN AM ASSOC GEOGR, V108, P864, DOI 10.1080/24694452.2017.1373626; Premalatha M, 2013, RENEW SUST ENERG REV, V25, P660, DOI 10.1016/j.rser.2013.05.011; Saaty T. L., 2004, Journal of Systems Science and Systems Engineering, V13, P1, DOI 10.1007/s11518-006-0151-5; Saaty TL, 2003, EUR J OPER RES, V145, P85, DOI 10.1016/S0377-2217(02)00227-8; Sun Y, 2020, URBAN FOR URBAN GREE, V53, DOI 10.1016/j.ufug.2020.126709; Tan KC., 1999, INT J INNOVATION MAN, V3; Wlodarczyk-Marciniak R, 2020, SUSTAIN CITIES SOC, V59, DOI 10.1016/j.scs.2020.102236; Wu GD, 2017, SUSTAINABILITY-BASEL, V9; Xu KD, 2019, DES J, V22, P1983, DOI 10.1080/14606925.2019.1594923; Yao ML, 2018, COMPUT SECUR, V78, P336, DOI 10.1016/j.cose.2018.07.008; Zabkar V, 2010, TOURISM MANAGE, V31, P537, DOI 10.1016/j.tourman.2009.06.005; Zhang YL, 2017, PROCEDIA ENGINEER, V174, P260, DOI 10.1016/j.proeng.2017.01.132	42	6	7	6	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0248187	10.1371/journal.pone.0248187	http://dx.doi.org/10.1371/journal.pone.0248187			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QV3DA	33690633	gold, Green Published			2022-12-26	WOS:000627854700068
J	Rey-Mermet, A; Gade, M; Steinhauser, M				Rey-Mermet, Alodie; Gade, Miriam; Steinhauser, Marco			Multiplicative priming of the correct response can explain the interaction between Simon and flanker congruency	PLOS ONE			English	Article							WITHIN-TRIAL ADAPTATION; CONFIDENCE-INTERVALS; STIMULUS-STIMULUS; COGNITIVE CONTROL; CONFLICT; INTERFERENCE; MODULATIONS; SELECTION; STROOP; NOISE	In the Simon task, participants perform a decision on non-spatial features (e.g., stimulus color) by responding with a left or right key-press to a stimulus presented on the left or right side of the screen. In the flanker task, they classify the central character while ignoring the flanking characters. In each task, there is a conflict between the response-relevant features and the response-irrelevant features (i.e., the location on the screen for the Simon task, and the flankers for the flanker task). Thus, in both tasks, resolving conflict requires to inhibit irrelevant features and to focus on relevant features. When both tasks were combined within the same trial (e.g., when the row of characters was presented on the left or right side of the screen), most previous research has shown an interaction. In the present study, we investigated whether this interaction is affected by a multiplicative priming of the correct response occurring when both Simon and flanker irrelevant features co-activate the correct response (Exp. 1), a spatial overlap between Simon and flanker features (Exp. 2), and the learning of stimulus-response pairings (Exp. 3). The results only show an impact of multiplicative priming.	[Rey-Mermet, Alodie; Gade, Miriam; Steinhauser, Marco] Catholic Univ Eichstatt Ingolstadt, Dept Psychol, Gen Psychol, Eichstatt, Germany; [Rey-Mermet, Alodie] Swiss Distance Univ Inst, Fac Psychol, Brig, Switzerland; [Gade, Miriam] Med Sch Berlin, Dept Sci, Berlin, Germany		Rey-Mermet, A (corresponding author), Catholic Univ Eichstatt Ingolstadt, Dept Psychol, Gen Psychol, Eichstatt, Germany.; Rey-Mermet, A (corresponding author), Swiss Distance Univ Inst, Fac Psychol, Brig, Switzerland.	alodie.rey-mermet@fernuni.ch	Gade, Miriam/AAP-2352-2021; Rey-Mermet, Alodie/AAF-6553-2021	Gade, Miriam/0000-0002-1537-0157; Rey-Mermet, Alodie/0000-0002-6385-9328	Swiss National Science Foundation [P300P1_164598]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a grant from the Swiss National Science Foundation (www.snf.ch) to ARM (Grant P300P1_164598). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisenberg D, 2012, Q J EXP PSYCHOL, V65, P295, DOI 10.1080/17470218.2010.507819; Akcay C, 2008, J EXP PSYCHOL HUMAN, V34, P958, DOI 10.1037/0096-1523.34.4.958; Akcay C, 2011, PSYCHON B REV, V18, P505, DOI 10.3758/s13423-011-0084-y; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Boy F, 2010, P NATL ACAD SCI USA, V107, P11134, DOI 10.1073/pnas.1001925107; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; de Bruin A, 2018, Q J EXP PSYCHOL, V71, P1219, DOI 10.1080/17470218.2017.1311352; Dreisbach G, 2007, PSYCHOL RES-PSYCH FO, V71, P383, DOI 10.1007/s00426-005-0041-3; Duthoo W, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01001; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; FLOWERS JH, 1982, PERCEPT PSYCHOPHYS, V32, P581, DOI 10.3758/BF03204214; FLOWERS JH, 1990, PERCEPT PSYCHOPHYS, V47, P135, DOI 10.3758/BF03205978; Fruhholz S, 2011, NEUROIMAGE, V54, P622, DOI 10.1016/j.neuroimage.2010.07.071; Hommel B, 1997, PSYCHOL RES-PSYCH FO, V59, P248, DOI 10.1007/BF00439302; Hommel B, 2011, ACTA PSYCHOL, V136, P189, DOI 10.1016/j.actpsy.2010.04.011; Hubner R, 2010, PSYCHOL REV, V117, P759, DOI 10.1037/a0019471; Kalamala P, 2020, CORTEX, V131, P151, DOI 10.1016/j.cortex.2020.07.012; Keye D, 2009, PSYCHOL RES-PSYCH FO, V73, P762, DOI 10.1007/s00426-008-0188-9; Klauer KC, 2010, Q J EXP PSYCHOL, V63, P595, DOI 10.1080/17470210903076826; Mittelstadt V, 2018, J EXP PSYCHOL HUMAN, V44, P1153, DOI 10.1037/xhp0000523; Morey RD., 2015, **DATA OBJECT**; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Paap KR, 2013, COGNITIVE PSYCHOL, V66, P232, DOI 10.1016/j.cogpsych.2012.12.002; Pratte MS, 2010, ATTEN PERCEPT PSYCHO, V72, P2013, DOI 10.3758/APP.72.7.2013; R Core Team, 2020, R LANG ENV STAT COMP; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Rey-Mermet A, 2019, J EXP PSYCHOL GEN, V148, P1335, DOI 10.1037/xge0000593; Rey-Mermet A, 2019, NEUROIMAGE, V188, P411, DOI 10.1016/j.neuroimage.2018.12.031; Rey-Mermet A, 2018, J EXP PSYCHOL LEARN, V44, P501, DOI 10.1037/xlm0000450; Rey-Mermet A, 2016, J EXP PSYCHOL HUMAN, V42, P1505, DOI 10.1037/xhp0000229; Rouder JN, 2017, PSYCHOL METHODS, V22, P304, DOI 10.1037/met0000057; SIMON JR, 1970, J EXP PSYCHOL, V86, P272, DOI 10.1037/h0029961; SIMON JR, 1969, J EXP PSYCHOL, V81, P174, DOI 10.1037/h0027448; SIMON JR, 1969, J APPL PSYCHOL, V53, P433, DOI 10.1037/h0028034; Steinhauser M, 2006, J EXP PSYCHOL HUMAN, V32, P517, DOI 10.1037/0096-1523.32.3.517; Steinhauser M, 2009, J EXP PSYCHOL HUMAN, V35, P1398, DOI 10.1037/a0016467; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Sternberg S., 1998, METHODS MODELS CONCE, P703; Stevens M, 2006, BEHAV RES METHODS, V38, P280, DOI 10.3758/BF03192779; STOFFELS EJ, 1988, PERCEPT PSYCHOPHYS, V44, P7, DOI 10.3758/BF03207468; Treccani B, 2018, PSYCHOL RES-PSYCH FO, V82, P771, DOI 10.1007/s00426-017-0863-9; Treccani B, 2012, J COGNITIVE NEUROSCI, V24, P854, DOI 10.1162/jocn_a_00185; Treccani B, 2009, Q J EXP PSYCHOL, V62, P1784, DOI 10.1080/17470210802557751; Umilta C, 1999, ARCH ITAL BIOL, V137, P139; von Bastian CC, 2016, J EXP PSYCHOL GEN, V145, P246, DOI 10.1037/xge0000120; Wendt M, 2006, J EXP PSYCHOL HUMAN, V32, P644, DOI 10.1037/0096-1523.32.3.644; Westfall J., 2018, **DATA OBJECT**; Wild-Wall N, 2008, BRAIN RES, V1211, P72, DOI 10.1016/j.brainres.2008.03.025; Wuhr P, 2005, Q J EXP PSYCHOL-A, V58, P705, DOI 10.1080/02724980443000269; YEH YY, 1984, PERCEPT PSYCHOPHYS, V36, P225, DOI 10.3758/BF03206363	53	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2021	16	3							e0248172	10.1371/journal.pone.0248172	http://dx.doi.org/10.1371/journal.pone.0248172			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QV3DJ	33690621	gold, Green Published			2022-12-26	WOS:000627855600012
J	Fujita, K; Norikura, T; Matsui-Yuasa, I; Kumazawa, S; Honda, S; Sonoda, T; Kojima-Yuasa, A				Fujita, Kasumi; Norikura, Toshio; Matsui-Yuasa, Isao; Kumazawa, Shigenori; Honda, Sari; Sonoda, Takumi; Kojima-Yuasa, Akiko			Carob pod polyphenols suppress the differentiation of adipocytes through posttranscriptional regulation of C/EBP beta	PLOS ONE			English	Article							ADIPOSE CONVERSION; SILIQUA L.; EXPRESSION	Obesity is a major risk factor for various chronic diseases such as diabetes, cardiovascular disease, and cancer; hence, there is an urgent need for an effective strategy to prevent this disorder. Currently, the anti-obesity effects of food ingredients are drawing attention. Therefore, we focused on carob, which has high antioxidant capacity and various physiological effects, and examined its anti-obesity effect. Carob is cultivated in the Mediterranean region, and its roasted powder is used as a substitute for cocoa powder. We investigated the effect of carob pod polyphenols (CPPs) on suppressing increases in adipose tissue weight and adipocyte hypertrophy in high fat diet-induced obesity model mice, and the mechanism by which CPPs inhibit the differentiation of 3T3-L1 preadipocytes into adipocytes in vitro. In an in vivo experimental system, we revealed that CPPs significantly suppressed the increase in adipose tissue weight and adipocyte hypertrophy. Moreover, in an in vitro experimental system, CPPs acted at the early stage of differentiation of 3T3-L1 preadipocytes and suppressed cell proliferation because of differentiation induction. They also suppressed the expression of transcription factors involved in adipocyte differentiation, thereby reducing triacylglycerol synthesis ability and triglycerol (TG) accumulation. Notably, CPPs regulated CCAAT/enhancer binding protein (C/EBP)beta, which is expressed at the early stage of differentiation, at the posttranscriptional level. These results demonstrate that CPPs suppress the differentiation of adipocytes through the posttranscriptional regulation of C/EBP beta and may serve as an effective anti-obesity compound.	[Fujita, Kasumi; Matsui-Yuasa, Isao; Kojima-Yuasa, Akiko] Osaka City Univ, Grad Sch Human Life Sci, Dept Food & Human Hlth Sci, Osaka, Japan; [Norikura, Toshio] Aomori Univ Hlth & Welf, Dept Nutr, Aomori, Japan; [Kumazawa, Shigenori; Honda, Sari] Univ Shizuoka, Dept Food & Nutr Sci, Shizuoka, Japan; [Sonoda, Takumi] TAISHO TECHNOS Co Ltd, Tokyo, Japan	Osaka Metropolitan University; Aomori University of Health & Welfare; University of Shizuoka	Kojima-Yuasa, A (corresponding author), Osaka City Univ, Grad Sch Human Life Sci, Dept Food & Human Hlth Sci, Osaka, Japan.	kojima@life.osaka-cu.ac.jp			JSPS KAKENHI [JP15K00832]; Carob pod polyphenols	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Carob pod polyphenols	This work was supported by JSPS KAKENHI (Grant Number JP15K00832). KAKENHI aims to significantly develop all "academic research" from basic to applied (research based on the free thinking of researchers). TAISHO TECHNOS, Co., Ltd. provided the Carob pod polyphenols, a part of the grant, and support in the form of salary for T.S., but did not have any additional role in the study design data collection and analysis decision to publish, or preparation of the manuscript. The specific role of T.S. is articulated in the "Author Contributions" section.	CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Kumazawa S, 2002, J AGR FOOD CHEM, V50, P373, DOI 10.1021/jf010938r; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Papagiannopoulos M, 2004, J AGR FOOD CHEM, V52, P3784, DOI 10.1021/jf030660y; Qasem MA, 2018, PEERJ, V6, DOI 10.7717/peerj.4788; RAGAZZI E, 1973, J CHROMATOGR, V77, P369, DOI 10.1016/S0021-9673(00)92204-0; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; RIDDELL RJ, 1986, FOOD CHEM TOXICOL, V24, P469, DOI 10.1016/0278-6915(86)90095-5; Rtibi K, 2013, TOXICOL IND HLTH; Rtibi K, 2017, J SCI FOOD AGR, V97, P2664, DOI 10.1002/jsfa.8091; Rtibi K, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0819-9; Stavrou IJ, 2018, FOOD CHEM, V269, P355, DOI 10.1016/j.foodchem.2018.06.152; Suzek H, 2017, INDIAN J PHARM EDUC, V51, P312, DOI 10.5530/ijper.51.2.37; Tanaka M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5982; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tripathy D, 2003, DIABETES, V52, P2882, DOI 10.2337/diabetes.52.12.2882; VASSEURCOGNET M, 1993, CURR OPIN GENET DEV, V3, P238, DOI 10.1016/0959-437X(93)90029-O; Watanabe Y, 2020, FASEB J, V34, P5827, DOI 10.1096/fj.201902575R; WISE LS, 1979, J BIOL CHEM, V254, P273; Woods SC, 2003, J NUTR, V133, P1081, DOI 10.1093/jn/133.4.1081; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Yousif AK, 2000, FOOD CHEM, V69, P283, DOI 10.1016/S0308-8146(99)00265-4	24	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0248073	10.1371/journal.pone.0248073	http://dx.doi.org/10.1371/journal.pone.0248073			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU3OZ	33684156	Green Published, gold			2022-12-26	WOS:000627193500015
J	Caetano, R; Correa, MCDV; Villardi, P; Rodrigues, PHA; Osorio-de-Castro, CGS				Caetano, Rosangela; Dias Villela Correa, Marilena Cordeiro; Villardi, Pedro; Almeida Rodrigues, Paulo Henrique; Serpa Osorio-de-Castro, Claudia Garcia			Dynamics of patents, orphan drug designation, licensing, and revenues from drugs for rare diseases: The market expansion of eculizumab	PLOS ONE			English	Article							MEDICINAL PRODUCTS; CHALLENGES; EUROPE; IMPACT	Background This study examines the dynamics of the eculizumab patenting, orphan designation, and marketing authorization process in different countries and regulatory systems and analyzes drug revenues since its first marketing authorization. Methods A retrospective case study was conducted. Multiple information sources were used to: determine the status of eculizumab patents; examine the designation of orphan drug status by US, European, Japanese, and Brazilian regulatory authorities to determine registration status and approved clinical indications; estimate the prevalence of associated clinical conditions; investigate the history of the drug manufacturer, Alexion Pharmaceuticals, Inc., and its financialized business model; and examine global eculizumab sales revenues since its first marketing authorization. Results Our search yielded 32 patent families divided into 98 applications. The first patent granted was filed in 1995 by Alexion Pharmaceuticals, Inc. in the US. Eculizumab has always been as an orphan drug, except in the Brazilian regulatory agency. All clinical indications approved thus far refer to rare diseases (e.g., paroxysmal nocturnal hemoglobinuria syndrome, atypical hemolytic-uremic syndrome, refractory and generalized myasthenia gravis, and neuromyelitis optica spectrum disorder). Alexion's revenues amounted to more than US$25 billion between 2007 and 2019, showing a growing trend. Eculizumab led sales from the beginning, being the only product in the company's portfolio until 2015. In 2019, the drug accounted for 79.1% of all revenues. Discussion Our findings show that a strategy focused on obtaining orphan drug designation, expanding therapeutic indications and the geographic range of marketing approvals, extending monopoly periods, and prioritizing public procurement niches has enhanced revenues and helped the company achieve leadership in a highly specific and profitable market.	[Caetano, Rosangela; Almeida Rodrigues, Paulo Henrique] Univ Estado Rio de Janeiro, Inst Med Social, Dept Polit Planejamento & Adm Saude, Rio De Janeiro, Brazil; [Dias Villela Correa, Marilena Cordeiro; Villardi, Pedro] Univ Estado Rio de Janeiro, Dept Polit & Inst Saude, Inst Med Social, Rio De Janeiro, Brazil; [Serpa Osorio-de-Castro, Claudia Garcia] Fundacao Oswaldo Cruz, Dept Polit Medicamentos & Assistencia Farmaceut, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz	Caetano, R (corresponding author), Univ Estado Rio de Janeiro, Inst Med Social, Dept Polit Planejamento & Adm Saude, Rio De Janeiro, Brazil.	caetano.r@gmail.com	de Castro, Claudia Garcia Serpa Osorio/H-1549-2012	de Castro, Claudia Garcia Serpa Osorio/0000-0003-4875-7216; Caetano, Rosangela/0000-0003-1480-2453	Brazilian National Council for Scientific and Technological Development (CNPq) [304975/2016-8]	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	CGSOC obtained a grant from the Brazilian National Council for Scientific and Technological Development (CNPq), #304975/2016-8, website http://cnpq.br/, which funded the manuscript translation. The authors RC, MCDVC, PV and PHAR received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexion, 2020, HISTORY; Alexion, 2020, PIPELINE; Alexion Pharmaceuticals, OUR HIST; Alexion Pharmaceuticals Inc, FIN ANN REP; America's Health Insurance Plans, 2016, HIGH PRIC DRUGS EST; Amin T, 2012, HEALTH AFFAIR, V31, P2286, DOI 10.1377/hlthaff.2012.0107; Andersson T., 2010, CRIT PERSPECT, V21, P631, DOI 10.1016/j.cpa.2010.06.006; [Anonymous], 2014, ORPHANET RARE DIS; Aronson JK, 2006, BRIT J CLIN PHARMACO, V61, P243, DOI 10.1111/j.1365-2125.2006.02617.x; Attwood MM, 2018, TRENDS PHARMACOL SCI, V39, P525, DOI 10.1016/j.tips.2018.03.003; Auvin S, 2018, VALUE HEALTH, V21, P501, DOI 10.1016/j.jval.2018.03.002; Barber Christopher, 2017, Nurs Stand, V31, P42, DOI 10.7748/ns.2017.e10434; Bell L, WALL STREET TRANSCRI; Berdud M, 2018, 1805 OHE; BOEVER F, 1948, ARCH INT PHARMACOD T, V77, P1; Brabers AEM, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-59; Brasil. Agencia Nacional de Vigilancia Sanitaria-ANVISA, CONS PROD REG CONS M; Brasil. Portal de Compras Governo Federal. SIASG, QUE SIST INT ADM SER; Brooks M, 2017, RARE DIS TREATMENTS; Caetano R, 2020, REV SAUDE PUBL, V54, DOI 10.11606/s1518-8787.2020054001693; Chaves GC., PATENT PARADOX BRAZI; Chow V, 2020, EUR J HAEMATOL, V105, P66, DOI 10.1111/ejh.13411; Cohan P.S, 2017, DISCIPLINED GROWTH S, P194; Crowe S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-100; Dear JW, 2006, BRIT J CLIN PHARMACO, V62, P264, DOI 10.1111/j.1365-2125.2006.02654.x; Ducimetiere C, 2019, 101 S CTR RES; European Commission, UN REG MED PROD; European Medicines Agency, MED; European Patent Office, ESP PAT SEARCH; EvaluatePharma, 2015, ORPHAN DRUG REPORT 2; EvaluatePharma, 2020, ORPH DRUG REP 2020; EvaluatePharma, 2019, EVALUATEPHARMA ORPH, V6th; Fierce Biotech, S SQUINTO ALEXION; Fierce Pharma, L BELL ALEXION PHARM; Gammie T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140002; Giannuzzi V, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0617-1; Government of Brazil. Ministerio da Saude Agencia Nacional de Vigilancia Sanitaria, 2019, CONS REG MED SOL; Griggs RC, 2009, MOL GENET METAB, V96, P20, DOI 10.1016/j.ymgme.2008.10.003; Herper M., 2010, FORBES; Herper M, 2012, FORBES; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Huda S, 2019, CLIN MED, V19, P169, DOI 10.7861/clinmedicine.19-2-169; Hughes DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164681; Instituto de Pesquisa Economica Aplicada. IPEAdata, TAX CAMB COM VEND RE; Instituto Nacional de Propriedade Intelectual, CONS BAS DAD INPI; Integrity Database, PATENTS; Japan Patent Office, JAP PLATF PAT INF J; Japan. Pharmaceuticals and Medical Devices Agency, ORPH DRUGS WA; Jayasundara K, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-018-0990-4; Kondo H, 3 IRDIRC C FEBR; Kulasekararaj AG, 2019, BLOOD, V133, P540, DOI 10.1182/blood-2018-09-876805; Lazonick W., 2019, FINANCIALIZATION US; Lazonick William., 2020, PREDATORY VALUE EXTR; Lazonick William., 2017, 62 I NEW EC THINK, DOI 10.2139/ssrn.3035529; Lee JW, 2020, EXPERT OPIN BIOL TH, V20, P227, DOI 10.1080/14712598.2020.1725468; Lee JW, 2019, BLOOD, V133, P530, DOI 10.1182/blood-2018-09-876136; Luzzatto L, 2018, LANCET, V392, P791, DOI 10.1016/S0140-6736(18)31069-9; MarketScreener Homepage, EQ NASD AL PHARM CO; Mastellos DC, 2019, NAT REV DRUG DISCOV, V18, P707, DOI 10.1038/s41573-019-0031-6; Meekings KN, 2012, DRUG DISCOV TODAY, V17, P660, DOI 10.1016/j.drudis.2012.02.005; Mehr S, 2020, DROPPING LITIGATION; Minghetti P, 2000, PHARMACOL RES, V42, P33, DOI 10.1006/phrs.1999.0644; Moorkens E, 2020, MABS-AUSTIN, V12, DOI 10.1080/19420862.2020.1743517; Moorkens E, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00193; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; OVANS A., 2015, HARVARD BUSINESS REV; Picavet E, 2011, APPL HEALTH ECON HEA, V9, P275, DOI 10.2165/11590170-000000000-00000; Reis ES, 2015, CLIN IMMUNOL, V161, P225, DOI 10.1016/j.clim.2015.08.009; Richter T, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0762-1; Richter T, 2015, VALUE HEALTH, V18, P906, DOI 10.1016/j.jval.2015.05.008; Ricklin D, 2018, NAT REV NEPHROL, V14, P26, DOI 10.1038/nrneph.2017.156; Roth A, 2018, EUR J HAEMATOL, V101, P3, DOI 10.1111/ejh.13059; Roos JCP, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6471; Sarpatwari A, 2018, HEALTH AFFAIR, V37, P732, DOI 10.1377/hlthaff.2017.1179; Simonov R, 2019, ECONOMIC & EDUCATION, V04, P39; Suh Joome, 2013, Yale Journal of Biology and Medicine, V86, P255; US Food and Drug Administration, DRUGS FDA FDA APPR D; US Food and Drug Administration, ORPH DRUG DES APPR; Vickers PJ, 2012, DRUG DISCOVERY WORLD, V14, P9; von der Schulenburg JMG, 2015, EUR J HEALTH ECON, V16, P113, DOI 10.1007/s10198-014-0639-8; Wellman-Labadie O, 2010, HEALTH POLICY, V95, P216, DOI 10.1016/j.healthpol.2009.12.001	81	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0247853	10.1371/journal.pone.0247853	http://dx.doi.org/10.1371/journal.pone.0247853			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QT5CA	33667235	gold, Green Published			2022-12-26	WOS:000626604300055
J	Riedel, M; Berthelsen, MF; Cai, HQ; Haldrup, J; Borre, M; Paludan, SR; Hager, H; Vendelbo, MH; Wagner, EF; Bakiri, L; Thomsen, MK				Riedel, Maria; Berthelsen, Martin F.; Cai, Huiqiang; Haldrup, Jakob; Borre, Michael; Paludan, Soren R.; Hager, Henrik; Vendelbo, Mikkel H.; Wagner, Erwin F.; Bakiri, Latifa; Thomsen, Martin K.			In vivo CRISPR inactivation of Fos promotes prostate cancer progression by altering the associated AP-1 subunit Jun	ONCOGENE			English	Article								Prostate cancer is a major global health concern with limited treatment options for advanced disease. Its heterogeneity challenges the identification of crucial driver genes implicated in disease progression. Activating protein-1 (AP-1) transcription factor is associated with cancer since the first identification of its subunits, the proto-oncogenes JUN and FOS. Whereas both JUN and FOS have been implicated in prostate cancer, this study provides the first functional evidence that FOS acts as a tumor suppressor during prostate cancer progression and invasion. Data mining revealed decreased FOS expression in prostate cancer and a further downregulation in metastatic disease, consistent with FOS expression in cell lines derived from different prostate cancer stages. FOS deficiency in prostate cancer cell lines increases cell proliferation and induces oncogenic pathway alterations. Importantly, in vivo CRISPR/Cas9-mediated Fos and Pten double mutation in murine prostate epithelium results in increased proliferation and invasiveness compared to the abrogation of Pten alone. Interestingly, enhanced Jun expression is observed in the murine prostatic intraepithelial neoplasia lacking Fos. CRISPR/Cas9-mediated knockout of Jun combined with Fos and Pten deficiency diminishes the increased proliferation rate in vivo but not the ability to form invasive disease. Overall, we demonstrate that loss of Fos promotes disease progression from clinical latent prostate cancer to advanced disease through accelerated proliferation and invasiveness, partly through Jun.	[Riedel, Maria; Berthelsen, Martin F.; Cai, Huiqiang; Haldrup, Jakob] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Borre, Michael] Aarhus Univ Hosp, Dept Clin Med & Urol, Aarhus, Denmark; [Paludan, Soren R.; Thomsen, Martin K.] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Hager, Henrik] South Denmark Hosp, Vejle, Denmark; [Vendelbo, Mikkel H.] Aarhus Univ Hosp, Dept Nucl Med & PET Ctr, Aarhus, Denmark; [Wagner, Erwin F.] Med Univ Vienna MUV, Dept Dermatol, Lab Genes & Dis, Vienna, Austria; [Wagner, Erwin F.; Bakiri, Latifa] Med Univ Vienna MUV, Dept Lab Med, Lab Genes & Dis, Vienna, Austria; [Thomsen, Martin K.] Aarhus Univ, Aarhus Inst Adv Studies AIAS, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Medical University of Vienna; Medical University of Vienna; Aarhus University	Thomsen, MK (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.; Thomsen, MK (corresponding author), Aarhus Univ, Aarhus Inst Adv Studies AIAS, Aarhus, Denmark.	mkt@biomed.au.dk	Thomsen, Martin/AAU-5014-2021	Thomsen, Martin/0000-0002-5055-7531; Vendelbo, Mikkel Holm/0000-0003-0431-2522; Paludan, Soren Riis/0000-0001-9180-4060; bakiri, latifa/0000-0002-6300-2420; Riedel, Maria/0000-0002-6545-0243; Wagner, Erwin F/0000-0001-7872-0196	Danish cancer society [R146-A9394, R204-A12490]; Ministry of health [4-1612-236/7]; AUFF NOVA [E-2o15-FLS-9-8]; Dagmar Marshalls Fond; Einar Willumsens Mindelegat; Harboefonden; Helge Peetz og Verner og hustru Vilma Peetz legat; Raimond og Dagmar Ringgaed-Bohns Fond; Aarhus University Research Foundation; Thora og Viggo Grove's Mindelegat; European Research Council [741888]; Medical University of Vienna	Danish cancer society(Danish Cancer Society); Ministry of health; AUFF NOVA; Dagmar Marshalls Fond; Einar Willumsens Mindelegat; Harboefonden; Helge Peetz og Verner og hustru Vilma Peetz legat; Raimond og Dagmar Ringgaed-Bohns Fond; Aarhus University Research Foundation; Thora og Viggo Grove's Mindelegat; European Research Council(European Research Council (ERC)European Commission); Medical University of Vienna	We thank Mette Simonsen for assistance with PET/MRI scanning. This work was funded by Danish cancer society (R146-A9394 and R204-A12490), Ministry of health (4-1612-236/7), AUFF NOVA (E-2o15-FLS-9-8), Dagmar Marshalls Fond, Einar Willumsens Mindelegat, Harboefonden, Helge Peetz og Verner og hustru Vilma Peetz legat, Raimond og Dagmar Ringgaed-Bohns Fond, The Aarhus University Research Foundation, and Thora og Viggo Grove's Mindelegat (all to MKT). EFW and LB are supported by the European Research Council (grant: ERC-AdG 2016 CSI-Fun-741888 to EFW) and the Medical University of Vienna.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chandran UR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-45; Edwards J, 2004, J PATHOL, V204, P153, DOI 10.1002/path.1605; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Evans AJ, 2018, MODERN PATHOL, V31, pS110, DOI 10.1038/modpathol.2017.158; Feng ZW, 1998, ONCOGENE, V17, P2593, DOI 10.1038/sj.onc.1202195; Fleischmann A, 2003, CANCER CELL, V4, P477, DOI 10.1016/S1535-6108(03)00280-0; Guo JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120332; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Hubner A, 2012, P NATL ACAD SCI USA, V109, P12046, DOI 10.1073/pnas.1209660109; Konishi N, 2008, CLIN CANCER RES, V14, P4408, DOI 10.1158/1078-0432.CCR-07-4120; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Millena AC, 2016, J BIOL CHEM, V291, P17964, DOI 10.1074/jbc.M116.714899; Min LH, 2012, NAT CELL BIOL, V14, P1203, DOI 10.1038/ncb2590; Ouyang X, 2008, CANCER RES, V68, P2132, DOI 10.1158/0008-5472.CAN-07-6055; Parisotto M, 2013, MOL ONCOL, V7, P190, DOI 10.1016/j.molonc.2013.02.005; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Riedel M, 2018, JOVE-J VIS EXP, DOI 10.3791/57525; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Thomsen MK, 2015, CELL DEATH DIFFER, V22, P574, DOI 10.1038/cdd.2014.213; Thomsen MK, 2010, CANCER RES, V70, P979, DOI 10.1158/0008-5472.CAN-09-2370; Wang GC, 2018, GENE DEV, V32, P1105, DOI 10.1101/gad.315739.118; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wenzel A, 2002, J NEUROCHEM, V80, P1089, DOI 10.1046/j.0022-3042.2002.00807.x; Xu RY, 2020, BIOMED PHARMACOTHER, V121, DOI 10.1016/j.biopha.2019.109679; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	32	9	10	1	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 1	2021	40	13					2437	2447		10.1038/s41388-021-01724-6	http://dx.doi.org/10.1038/s41388-021-01724-6		MAR 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RH1BQ	33674748	Green Accepted, Green Submitted			2022-12-26	WOS:000625607100006
J	Aski, MS; Rai, N; Reddy, VRP; Gayacharan; Dikshit, HK; Mishra, GP; Singh, D; Kumar, A; Pandey, R; Singh, MP; Pratap, A; Nair, RM; Schafleitner, R				Aski, Muraleedhar S.; Rai, Neha; Reddy, Venkata Ravi Prakash; Gayacharan; Dikshit, Harsh Kumar; Mishra, Gyan Prakash; Singh, Dharmendra; Kumar, Arun; Pandey, Renu; Singh, Madan Pal; Pratap, Aditya; Nair, Ramakrishnan M.; Schafleitner, Roland			Assessment of root phenotypes in mungbean mini-core collection (MMC) from the World Vegetable Center (AVRDC) Taiwan	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; RADIATA L. WILCZEK; CICER-ARIETINUM L.; DROUGHT STRESS; LUPINUS-ANGUSTIFOLIUS; ARCHITECTURAL TRAITS; GENOTYPIC VARIATION; PHOSPHORUS ACQUISITION; SYSTEM ARCHITECTURE; GENETIC-VARIATION	Mungbean (Vigna radiata L.) is an important food grain legume, but its production capacity is threatened by global warming, which can intensify plant stress and limit future production. Identifying new variation of key root traits in mungbean will provide the basis for breeding lines with effective root characteristics for improved water uptake to mitigate heat and drought stress. The AVRDC mungbean mini core collection consisting of 296 genotypes was screened under modified semi-hydroponic screening conditions to determine the variation for fourteen root-related traits. The AVRDC mungbean mini core collection displayed wide variations for the primary root length, total surface area, and total root length, and based on agglomerative hierarchical clustering eight homogeneous groups displaying different root traits could be identified. Germplasm with potentially favorable root traits has been identified for further studies to identify the donor genotypes for breeding cultivars with enhanced adaptation to water-deficit stress and other stress conditions.	[Aski, Muraleedhar S.; Rai, Neha; Reddy, Venkata Ravi Prakash; Dikshit, Harsh Kumar; Mishra, Gyan Prakash; Singh, Dharmendra] ICAR Indian Agr Res Inst, Div Genet, New Delhi, India; [Gayacharan] ICAR Natl Bur Plant Genet Resources, Germplasm Evaluat Div, New Delhi, India; [Kumar, Arun] ICAR Indian Agr Res Inst, Div Seed Sci & Technol, New Delhi, India; [Pandey, Renu; Singh, Madan Pal] ICAR Indian Agr Res Inst, Div Plant Physiol, New Delhi, India; [Pratap, Aditya] ICAR Indian Inst Pulses Res, Crop Improvement Div, Kanpur, Uttar Pradesh, India; [Nair, Ramakrishnan M.] South Asia Cent Asia, World Vegetable Ctr, Hyderabad, India; [Schafleitner, Roland] World Vegetable Ctr Taiwan, Vegetable Divers & Improvement Shanhua, Mol Genet, Tainan, Taiwan	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Pulses Research	Aski, MS (corresponding author), ICAR Indian Agr Res Inst, Div Genet, New Delhi, India.	murali2416@gmail.com	Aski, Muraleedhar S/GNM-7254-2022; Pandey, Renu/AES-7797-2022; Mishra, Gyan P./E-5980-2010; Prakash Reddy, Bana Venkata Ravi/GRX-6782-2022	Aski, Muraleedhar S/0000-0002-9021-2650; Pandey, Renu/0000-0002-9244-8579; Mishra, Gyan P./0000-0002-7023-2638; Prakash Reddy, Bana Venkata Ravi/0000-0003-2601-5350; Schafleitner, Roland/0000-0003-3637-7603; RAI, NEHA/0000-0002-4058-0076; Pratap, Aditya/0000-0001-7280-0953				Abdel-Ghani AH, 2013, EUPHYTICA, V189, P123, DOI 10.1007/s10681-012-0759-0; Abdel-Haleem H, 2011, THEOR APPL GENET, V122, P935, DOI 10.1007/s00122-010-1500-9; Andrews M, 2010, CLIMATE CHANGE AND MANAGEMENT OF COOL SEASON GRAIN LEGUME CROPS, P1, DOI 10.1007/978-90-481-3709-1_1; [Anonymous], 1997, FOREST SCI; Arif MR, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8070192; Arifuzzaman M, 2014, MOL BREEDING, V34, P1373, DOI 10.1007/s11032-014-0122-3; Armengaud P, 2009, PLANT J, V57, P945, DOI 10.1111/j.1365-313X.2008.03739.x; Ashraf R, 2007, PAK J BOT, V39, P629; Atkinson JA, 2015, J EXP BOT, V66, P2283, DOI 10.1093/jxb/erv006; BAIER AC, 1995, PLANT BREEDING, V114, P291, DOI 10.1111/j.1439-0523.1995.tb01236.x; Beebe SE, 2006, CROP SCI, V46, P413, DOI 10.2135/cropsci2005.0226; Bernier J, 2009, EUPHYTICA, V166, P207, DOI 10.1007/s10681-008-9826-y; Blum A, 2011, PLANT BREEDING FOR WATER-LIMITED ENVIRONMENTS, P1, DOI 10.1007/978-1-4419-7491-4; Bonser AM, 1996, NEW PHYTOL, V132, P281, DOI 10.1111/j.1469-8137.1996.tb01847.x; Bruck H, 2003, PLANT SOIL, V251, P175, DOI 10.1023/A:1022932815486; Burridge JD, 2017, THEOR APPL GENET, V130, P419, DOI 10.1007/s00122-016-2823-y; Chen Y.L., 2015, PHENOMICS CROP PLANT, P101, DOI [10.1007/978-81-322-2226-2_8, DOI 10.1007/978-81-322-2226-2_8]; Chen YL, 2011, FUNCT PLANT BIOL, V38, P355, DOI 10.1071/FP10241; Chen YL, 2012, PLANT SOIL, V354, P141, DOI 10.1007/s11104-011-1050-1; Chen YL, 2011, PLANT SOIL, V348, P345, DOI 10.1007/s11104-011-0939-z; Chen YL, 2017, J EXP BOT, V68, P1987, DOI 10.1093/jxb/erw368; Chen YL, 2016, J EXP BOT, V67, P3683, DOI 10.1093/jxb/erw127; Chimungu JG, 2014, PLANT PHYSIOL, V166, P1943, DOI 10.1104/pp.114.249037; Choudhary KK, 2014, ENVIRON EXP BOT, V99, P122, DOI 10.1016/j.envexpbot.2013.11.006; CLEMENTS JC, 1993, AUST J AGR RES, V44, P1367, DOI 10.1071/AR9931367; Comas LH, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00442; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; de Dorlodot S, 2007, TRENDS PLANT SCI, V12, P474, DOI 10.1016/j.tplants.2007.08.012; DHINGRA KK, 1991, INDIAN J AGRON, V36, P207; Douglas C, 2020, COMPEND PL GENOME, P81, DOI 10.1007/978-3-030-20008-4_6; Dubrovsky JG, 2006, ANN BOT-LONDON, V97, P903, DOI 10.1093/aob/mcj604; Ghanem ME, 2011, PLANT CELL REP, V30, P807, DOI 10.1007/s00299-011-1005-2; Fageria NK, 2008, J PLANT NUTR, V31, P1121, DOI 10.1080/01904160802116068; Farooq M., 2012, PLANT RESPONSES DROU, P1, DOI [10.1007/978-3-642-32653-0_1, DOI 10.1007/978-3-642-32653-0_1]; Fenta BA, 2014, AGRONOMY-BASEL, V4, P418, DOI 10.3390/agronomy4030418; Figueroa-Bustos V, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8070109; Fondevilla S, 2010, MOL BREEDING, V25, P259, DOI 10.1007/s11032-009-9330-7; Forster B. P., 2005, Aspects of Applied Biology, P199; Gahoonia TS, 2004, PLANT SOIL, V262, P55, DOI 10.1023/B:PLSO.0000037020.58002.ac; Ganesan K, 2018, FOOD SCI HUM WELL, V7, P11, DOI 10.1016/j.fshw.2017.11.002; Gaur PM, 2008, PLANT PROD SCI, V11, P3, DOI 10.1626/pps.11.3; Gregory PJ, 2009, FUNCT PLANT BIOL, V36, P922, DOI 10.1071/FP09150; Gulles AA., 2014, PHILIPP J CROP SCI, V39, P137; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Henry A, 2012, J EXP BOT, V63, P4751, DOI 10.1093/jxb/ers150; Henry A, 2013, PLANT ROOT, V7, P92, DOI 10.3117/plantroot.7.92; HOOGENBOOM G, 1987, AGRON J, V79, P598, DOI 10.2134/agronj1987.00021962007900040003x; Hund A, 2011, PLANT SOIL, V344, P143, DOI 10.1007/s11104-011-0735-9; HUTCHESON K, 1970, J THEOR BIOL, V29, P151, DOI 10.1016/0022-5193(70)90124-4; Idrissi O, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01174; Imada S, 2008, FUNCT ECOL, V22, P1018, DOI 10.1111/j.1365-2435.2008.01454.x; Itoh T, 2006, ACTA CRYSTALLOGR D, V62, P824, DOI 10.1107/S090744490601804X; Jaganathan D, 2015, MOL GENET GENOMICS, V290, P559, DOI 10.1007/s00438-014-0932-3; Kane-Potaka J, 2016, PULSES HDB, V2016, P93; Krishnapriya V, 2016, CROP PASTURE SCI, V67, P1096, DOI 10.1071/CP15329; Landi P, 2010, J EXP BOT, V61, P3553, DOI 10.1093/jxb/erq192; Le Bot J, 2010, PLANT SOIL, V326, P261, DOI 10.1007/s11104-009-0005-2; Leiser WL, 2014, PLANT SOIL, V377, P383, DOI 10.1007/s11104-013-1978-4; Li RY, 2015, BREEDING SCI, V65, P298, DOI 10.1270/jsbbs.65.298; Liao H, 2004, FUNCT PLANT BIOL, V31, P959, DOI 10.1071/FP03255; Liu LP, 2010, CROP SCI, V50, P222, DOI 10.2135/cropsci2009.03.0156; Lobet G, 2011, PLANT PHYSIOL, V157, P29, DOI 10.1104/pp.111.179895; Lynch JP, 2015, J EXP BOT, V66, P2199, DOI 10.1093/jxb/eru508; Lynch JP, 2013, ANN BOT-LONDON, V112, P347, DOI 10.1093/aob/mcs293; Manavalan LP, 2011, MAYDICA, V56, P59; Manschadi AM, 2008, PLANT SOIL, V303, P115, DOI 10.1007/s11104-007-9492-1; Manschadi AM, 2006, FUNCT PLANT BIOL, V33, P823, DOI 10.1071/FP06055; Mubarak AE, 2005, FOOD CHEM, V89, P489, DOI 10.1016/j.foodchem.2004.01.007; Nair RM, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01340; Narayanan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100317; Naz AA, 2012, PLANT BREEDING, V131, P392, DOI 10.1111/j.1439-0523.2012.01972.x; Phung NTP, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0747-y; Nielsen KL, 2001, J EXP BOT, V52, P329, DOI 10.1093/jexbot/52.355.329; Palta JA, 2007, FIELD CROP RES, V104, P52, DOI 10.1016/j.fcr.2007.03.015; Pandey R, 2014, PLANT CELL REP, V33, P919, DOI 10.1007/s00299-014-1570-2; Pandiyan M, 2012, WUDPECKER J AGR RES, V1, P294; Pantalone VR, 1996, CROP SCI, V36, P456, DOI 10.2135/cropsci1996.0011183X003600020039x; PASSIOURA JB, 1983, AGR WATER MANAGE, V7, P265, DOI 10.1016/0378-3774(83)90089-6; Passot S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00829; Paul D, 2018, INDIAN J GENET PL BR, V78, P333, DOI 10.31742/IJGPB.78.3.7; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Postel SL, 2000, ECOL APPL, V10, P941, DOI 10.1890/1051-0761(2000)010[0941:EAEOWS]2.0.CO;2; Powers SE, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01489; Prince SJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1334-6; Purushothaman R, 2017, FUNCT PLANT BIOL, V44, P235, DOI 10.1071/FP16154; Qiao S, 2019, PLANT SOIL, V439, P75, DOI 10.1007/s11104-018-3803-6; Rajkumar, 2013, PHYSIOL MOL BIOL PLA, V19, P409, DOI 10.1007/s12298-013-0188-0; Ramakrishnan M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183261; Ranawake A. L., 2011, Tropical Agricultural Research and Extension, V14, P76; Rao BH, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00957; Rathinavel K., 2017, INT J CURRENT MICROB, V6, P2407, DOI DOI 10.20546/IJCMAS.2017.608.285; Reddy VRP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0221008; Riaz M, 2013, GENET MOL RES, V12, P552, DOI 10.4238/2013.February.27.4; Richard CAI, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0055-9; Sadok W, 2011, ADV AGRON, V113, P313, DOI 10.1016/B978-0-12-386473-4.00012-9; Sanguineti MC, 2007, ANN APPL BIOL, V151, P291, DOI 10.1111/j.1744-7348.2007.00198.x; Schafleitner R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1556-7; Sehrawat N., 2013, International Journal of Agriculture and Crop Sciences (IJACS), V6, P505; Sharma L, 2016, SCI HORTIC-AMSTERDAM, V213, P379, DOI 10.1016/j.scienta.2016.10.033; Siddique KHM, 2001, EUR J AGRON, V15, P267, DOI 10.1016/S1161-0301(01)00106-X; Singh D., 2011, J FOOD LEGUMES, V24, P83; Singh S, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01143; Singh V, 2010, P 1 AUSTR SUMM GRAIN, P21; Sivasakthi K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01663; Sorin C, 2005, PLANT CELL, V17, P1343, DOI 10.1105/tpc.105.031625; SWINNEN J, 1994, AGR ECOSYST ENVIRON, V51, P115, DOI 10.1016/0167-8809(94)90038-8; Tavakkoli E, 2012, J EXP BOT, V63, P3853, DOI 10.1093/jxb/ers085; Thangavel P, 2011, AUST J CROP SCI, V5, P1767; Torres LG, 2019, EUPHYTICA, V215, DOI 10.1007/s10681-019-2373-x; Tuberosa R, 2002, PLANT MOL BIOL, V48, P697, DOI 10.1023/A:1014897607670; Uga Y, 2013, NAT GENET, V45, P1097, DOI 10.1038/ng.2725; Varma D, 2017, INTER J CHEM STUD, V5, P1558; Varshney RK, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.12.0002in; Wang LY, 2009, PLANT PHYSIOL, V149, P1632, DOI 10.1104/pp.108.134072; Wang YS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00865; Wasson AP, 2012, J EXP BOT, V63, P3485, DOI 10.1093/jxb/ers111; Wasson AP, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00282; Weiner W, 1963, MATH THEORY COMMUNIC, P117; Wiese AH, 2005, TREE PLANT NOTES, V51, P40; Wu H, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00530; Wu J, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0316-5; WU YJ, 1994, PLANT PHYSIOL, V106, P607, DOI 10.1104/pp.106.2.607; Xie Q, 2017, ANN BOT-LONDON, V119, P1115, DOI 10.1093/aob/mcx001; Xu W, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-014-1760-0; Yadav R. K., 2018, Agriculture and Food Security, V7, DOI 10.1186/s40066-018-0238-5; Ye H, 2018, J EXP BOT, V69, P3267, DOI 10.1093/jxb/ery082; Zar J. H., 1996, BIOSTATISTICAL ANAL; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zeng G, 2008, NEW PHYTOL, V177, P549, DOI 10.1111/j.1469-8137.2007.02271.x; Zhang LT, 2014, EUPHYTICA, V197, P435, DOI 10.1007/s10681-014-1079-3; Zheng HG, 2000, GENOME, V43, P53, DOI 10.1139/gen-43-1-53; Zobel RW, 2010, PLANT BIOSYST, V144, P507, DOI 10.1080/11263501003764483	132	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0247810	10.1371/journal.pone.0247810	http://dx.doi.org/10.1371/journal.pone.0247810			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33661994	Green Published, gold			2022-12-26	WOS:000626604100116
J	Guadiana, D; Kavanagh, NM; Squarize, CH				Guadiana, Denise; Kavanagh, Nolan M.; Squarize, Cristiane H.			Oral health care professionals recommending and administering the HPV vaccine: Understanding the strengths and assessing the barriers	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; UNITED-STATES; ADVISORY-COMMITTEE; PARENT PERCEPTIONS; DENTISTS; CANCER; PROVIDERS; INFECTIONS; PREVALENCE; PREVENTION	Introduction Head and neck cancer is a deadly cancer that ranks among the six most common cancers worldwide. The HPV vaccine has been used to prevent head and neck cancer of the oropharynx, and changes in health policies and state law are impacting the role of dental professionals in HPV vaccination. However, relatively little is known about dental professionals' attitudes regarding the vaccine. Objectives Our study assesses dental professionals' willingness to administer the HPV vaccine, their confidence discussing HPV with patients, beliefs about the vaccine's efficacy, perceived barriers to administering it, and sites of referral. Methods We surveyed 623 dental professionals, including dentists, hygienists, dental students, and hygiene students across Michigan. Attitudes toward the vaccine and predictive characteristics were evaluated by logistic regression, ANOVAs, and t-tests. Results The majority of the respondents (51% of dentists, 63% of hygienists, 82% of dental students, and 71% of hygiene students) were willing to administer the HPV vaccine if allowed by law. The role of dental and dental hygiene students would be one of advocacy, educating and recommending the vaccine, and the dental students administering it once licensed. Dental professionals were variably confident discussing HPV with patients and generally believed it enhanced patients' health. Stronger confidence and beliefs were associated with greater willingness to administer the vaccine. Barriers among professionals opposing the HPV vaccine included lack of knowledge on the subject, liability concerns, and personal beliefs. Conclusion Dental professionals can become leaders in preventing HPV-related cancers. Training and continuing education courses could enhance their confidence and willingness to recommend and administer the HPV vaccine. Policy implications Legislation that permits dental professionals to administer the vaccine could increase the vaccine's accessibility to patients, improve vaccination rates, and population health.	[Guadiana, Denise; Kavanagh, Nolan M.; Squarize, Cristiane H.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Kavanagh, Nolan M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Squarize, Cristiane H.] Univ Michigan, Sch Dent, Lab Epithelial Biol, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Squarize, Cristiane H.] Univ Michigan, Rogel Canc Ctr, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Squarize, CH (corresponding author), Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA.; Squarize, CH (corresponding author), Univ Michigan, Sch Dent, Lab Epithelial Biol, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA.; Squarize, CH (corresponding author), Univ Michigan, Rogel Canc Ctr, Sch Med, Ann Arbor, MI 48109 USA.	csquariz@umich.edu		Squarize, Cristiane/0000-0002-6782-3429; Kavanagh, Nolan/0000-0002-5701-0993	Horace H. Rackham School of Graduate Studies from the University of Michigan	Horace H. Rackham School of Graduate Studies from the University of Michigan	This study was supported by a Horace H. Rackham School of Graduate Studies (Graduate Student Research Grant-DG and CHS) from the University of Michigan.	Afonso NM, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3969-x; Agalliu I, 2016, JAMA ONCOL, V2, P599, DOI 10.1001/jamaoncol.2015.5504; Arnell TL, 2021, J CANCER EDUC, V36, P299, DOI 10.1007/s13187-019-01628-w; Brondani MA, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7923-6; Bruni L, 2016, LANCET GLOB HEALTH, V4, pE453, DOI 10.1016/S2214-109X(16)30099-7; Chaturvedi AK, 2018, J CLIN ONCOL, V36, P262, DOI 10.1200/JCO.2017.75.0141; Cotter JC, 2020, J DENT EDUC, V84, P88, DOI 10.21815/JDE.019.164; Cotter Jane C, 2011, J Dent Hyg, V85, P326; Cunningham-Erves J, 2019, JMIR CANCER, V5, DOI 10.2196/13832; Daley E, 2014, PUBLIC HEALTH, V128, P231, DOI 10.1016/j.puhe.2013.12.002; Daley E, 2011, J PUBLIC HEALTH DENT, V71, P136, DOI 10.1111/j.1752-7325.2011.00212.x; Daley EM, 2019, J DENT EDUC, V83, P161, DOI 10.21815/JDE.019.019; Daley EM, 2018, J CANCER EDUC, V33, P901, DOI 10.1007/s13187-016-1156-5; Dillard JP, 2011, J AM COLL HEALTH, V59, P186, DOI 10.1080/07448481.2010.493189; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Griner SB, 2019, HUM VACC IMMUNOTHER, V15, P1856, DOI 10.1080/21645515.2019.1565261; Hariri S, 2015, VACCINE, V33, P1608, DOI 10.1016/j.vaccine.2015.01.084; Harris KL, 2020, HUM VACC IMMUNOTHER, V16, P436, DOI 10.1080/21645515.2019.1649550; Herrero R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068329; Hubbers CU, 2015, VIRULENCE, V6, P244, DOI 10.1080/21505594.2014.999570; I. CDC/National Center for Health Statistics/Division of Analysis and Epidemiology, DENT VIS YEAR SEL CH; Illinois D., SECTION 1220403 DENT; International Diabetes Federation, 2019, IDF DIABETES ATLAS, VNinth; Kline N, 2018, PAPILLOMAVIRUS RES, V5, P104, DOI 10.1016/j.pvr.2018.03.002; Kornides ML, 2018, ACAD PEDIATR, V18, pS37, DOI 10.1016/j.acap.2017.06.008; L. Centers for Desase Control, HUM PAP VIR HPV HOM; Lazalde GE, 2018, VACCINE, V36, P461, DOI 10.1016/j.vaccine.2017.12.020; Leval A, 2013, JNCI-J NATL CANCER I, V105, P469, DOI 10.1093/jnci/djt032; Mayhew A, 2014, PEDIATRICS, V133, P404, DOI 10.1542/peds.2013-2822; McLeroy Toni M, 2020, J Dent Hyg, V94, P16; Meites E, 2016, MMWR-MORBID MORTAL W, V65, P1405, DOI 10.15585/mmwr.mm6549a5; National Center for Health Statistics, NATL VITAL STAT SYST; National Vaccine Advisory Committee, 2016, Public Health Rep, V131, P17; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Patel S, 2020, J PUBLIC HEALTH DENT, V80, P61, DOI 10.1111/jphd.12350; Petrosky E, 2015, MMWR-MORBID MORTAL W, V64, P300; Pullos AN, 2015, J DENT RES, V94, P1532, DOI 10.1177/0022034515605456; Rowan Stephanie D, 2015, Tex Dent J, V132, P528; Rutkoski H, 2018, J CANCER EDUC, V33, P907, DOI 10.1007/s13187-017-1165-z; Satterwhite CL, 2013, SEX TRANSM DIS, V40, P187, DOI 10.1097/OLQ.0b013e318286bb53; Shukla A, 2019, J CANCER EDUC, V34, P890, DOI 10.1007/s13187-018-1391-z; Strauss SM, 2012, AM J PUBLIC HEALTH, V102, P253, DOI 10.2105/AJPH.2011.300420; Stull C, 2020, J AM DENT ASSOC, V151, P560, DOI 10.1016/j.adaj.2020.05.004; Stull Cynthia L, 2019, J Dent Hyg, V93, P33; Thompson Erika L, 2017, J Dent Hyg, V91, P37; Van Dyne EA, 2018, MMWR-MORBID MORTAL W, V67, P918, DOI 10.15585/mmwr.mm6733a2; Vazquez-Otero C, 2018, J AM DENT ASSOC, V149, P9, DOI 10.1016/j.adaj.2017.08.021; Walker TY, 2019, MMWR-MORBID MORTAL W, V68, P718, DOI 10.15585/mmwr.mm6833a2; Ylitalo KR, 2013, AM J PUBLIC HEALTH, V103, P164, DOI 10.2105/AJPH.2011.300600	49	6	6	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0248047	10.1371/journal.pone.0248047	http://dx.doi.org/10.1371/journal.pone.0248047			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QT5BY	33662007	Green Published, gold			2022-12-26	WOS:000626604100022
J	Yavari, N; Tripathi, R; Wu, BS; MacPherson, S; Singh, J; Lefsrud, M				Yavari, Nafiseh; Tripathi, Rajiv; Wu, Bo-Sen; MacPherson, Sarah; Singh, Jaswinder; Lefsrud, Mark			The effect of light quality on plant physiology, photosynthetic, and stress response in Arabidopsis thaliana leaves	PLOS ONE			English	Article							CYCLIC ELECTRON FLOW; LEAF PHOTOSYNTHESIS; NATURAL VARIATION; GENETIC-VARIATION; GROWTH-RESPONSES; PHOTOSYSTEM-II; RED LIGHTS; BLUE-LIGHT; ACCUMULATION; CHLOROPHYLL	The impacts of wavelengths in 500-600 nm on plant response and their underlying mechanisms remain elusive and required further investigation. Here, we investigated the effect of light quality on leaf area growth, biomass, pigments content, and net photosynthetic rate (Pn) across three Arabidopsis thaliana accessions, along with changes in transcription, photosynthates content, and antioxidative enzyme activity. Eleven-leaves plants were treated with BL; 450 nm, AL; 595 nm, RL; 650 nm, and FL; 400-700 nm as control. RL significantly increased leaf area growth, biomass, and promoted Pn. BL increased leaf area growth, carotenoid and anthocyanin content. AL significantly reduced leaf area growth and biomass, while Pn remained unaffected. Petiole elongation was further observed across accessions under AL. To explore the underlying mechanisms under AL, expression of key marker genes involved in light-responsive photosynthetic reaction, enzymatic activity of antioxidants, and content of photosynthates were monitored in Col-0 under AL, RL (as contrast), and FL (as control). AL induced transcription of GSH2 and PSBA, while downregulated NPQ1 and FNR2. Photosynthates, including proteins and starches, showed lower content under AL. SOD and APX showed enhanced enzymatic activity under AL. These results provide insight into physiological and photosynthetic responses to light quality, in addition to identifying putative protective-mechanisms that may be induced to cope with lighting-stress in order to enhance plant stress tolerance.	[Yavari, Nafiseh; Wu, Bo-Sen; MacPherson, Sarah; Lefsrud, Mark] McGill Univ, Dept Bioresource Engn, Macdonald Campus, Ste Anne De Bellevue, PQ, Canada; [Tripathi, Rajiv; Singh, Jaswinder] McGill Univ, Dept Plant Sci, Macdonald Campus, Ste Anne De Bellevue, PQ, Canada	McGill University; McGill University	Yavari, N; Lefsrud, M (corresponding author), McGill Univ, Dept Bioresource Engn, Macdonald Campus, Ste Anne De Bellevue, PQ, Canada.	nafiseh.yavari@mail.mcgill.ca; mark.lefsrud@msgill.ca		Yavari, Nafiseh/0000-0003-1516-5628	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 355743-13, CRDPJ418919-11]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the "Natural Sciences and Engineering Research Council of Canada (NSERC)". The specific grant number is RGPIN 355743-13, CRDPJ418919-11. It is "all" the funding and/or financial sources of support (whether external and/or internal to our organization) that were received during this study. And there was no additional external and/or internal funding received for this study. ML is the author, who received this award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A., 2016, CURR BIOTECHNOL, V5, P28, DOI DOI 10.2174/2211550104666151006001126; ARMOND PA, 1978, PLANT PHYSIOL, V61, P411, DOI 10.1104/pp.61.3.411; Balasubramanian S, 2006, NAT GENET, V38, P711, DOI 10.1038/ng1818; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Belmont, 2018, ARXIV PREPRINT ARXIV, P1, DOI [10.1007/978-3-319-30648-3_69-1, DOI 10.1007/978-3-319-30648-3_69-1]; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Botto JF, 2002, PLANT CELL ENVIRON, V25, P53, DOI 10.1046/j.0016-8025.2001.00812.x; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; BRITZ SJ, 1990, PLANT PHYSIOL, V94, P448, DOI 10.1104/pp.94.2.448; Brodersen CR, 2010, FUNCT PLANT BIOL, V37, P403, DOI 10.1071/FP09262; Ceccarelli EA, 2004, BBA-PROTEINS PROTEOM, V1698, P155, DOI 10.1016/j.bbapap.2003.12.005; Cheng YS, 2011, LIPIDS, V46, P95, DOI 10.1007/s11745-010-3494-0; Croce R, 2014, NAT CHEM BIOL, V10, P492, DOI [10.1038/NCHEMBIO.1555, 10.1038/nchembio.1555]; D'Souza C, 2015, COMPR REV FOOD SCI F, V14, P719, DOI 10.1111/1541-4337.12155; Demotes-Mainard S, 2016, ENVIRON EXP BOT, V121, P4, DOI 10.1016/j.envexpbot.2015.05.010; Dougher TAO, 2001, PHOTOCHEM PHOTOBIOL, V73, P208, DOI 10.1562/0031-8655(2001)073&lt;0208:EFYLSO&gt;2.0.CO;2; Fila G, 2011, AGR FOREST METEOROL, V151, P575, DOI 10.1016/j.agrformet.2011.01.004; Filiault DL, 2008, P NATL ACAD SCI USA, V105, P3157, DOI 10.1073/pnas.0712174105; Flood P. J, 2015, NATURAL GENETIC VARI; CANAPERIA G. A., 1948, RIV MALARIOL, V27, P1; Hernandez R., 2016, ENVIRON EXP BOT, V121, P66, DOI [10.1016/j.envexpbot.2015.04.001, DOI 10.1016/j.envexpbot.2015.04.001, DOI 10.1016/B978-0-12-801775-3.00002-0]; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hogewoning SW, 2010, J EXP BOT, V61, P3107, DOI 10.1093/jxb/erq132; Holm G., 1954, Acta Agriculturae Scandinavica, V4, P457; Hoover W. H, 1937, DEPENDENCE CARBON DI, P1; Huang W, 2017, J PLANT PHYSIOL, V209, P76, DOI 10.1016/j.jplph.2016.11.013; Huche-Thelier L, 2016, ENVIRON EXP BOT, V121, P22, DOI 10.1016/j.envexpbot.2015.06.009; Ilk N, 2012, GENETIC BASES PLANT; INADA K, 1976, PLANT CELL PHYSIOL, V17, P355; Johkan M, 2010, HORTSCIENCE, V45, P1809, DOI 10.21273/HORTSCI.45.12.1809; Johnson GN, 2011, BBA-BIOENERGETICS, V1807, P384, DOI 10.1016/j.bbabio.2010.11.009; Kohl K, 2017, FUNCT PLANT BIOL, V44, P727, DOI 10.1071/FP17051; Krupinska K, 2013, PLANTA, V237, P653, DOI 10.1007/s00425-012-1817-5; Leister D, 1999, PLANT PHYSIOL BIOCH, V37, P671, DOI 10.1016/S0981-9428(00)80097-2; Li CX, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00078; Liu H, 2017, PHOTOSYNTHETICA, V55, P144, DOI 10.1007/s11099-016-0233-7; Ma XF, 2015, SCI HORTIC-AMSTERDAM, V190, P104, DOI 10.1016/j.scienta.2015.01.006; Maloof JN, 2001, NAT GENET, V29, P441, DOI 10.1038/ng777; MANCINELLI AL, 1975, PLANT PHYSIOL, V55, P251, DOI 10.1104/pp.55.2.251; Mawphlang OIL, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01181; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MCCREE KJ, 1972, AGR METEOROL, V9, P191, DOI 10.1016/0002-1571(71)90022-7; Murchie EH, 2017, PLANT CELL ENVIRON, V40, P1239, DOI 10.1111/pce.12965; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nandini Yadav, 2016, Journal of Chemical and Pharmaceutical Research, V8, P595; Nishiyama Y, 2011, PHYSIOL PLANTARUM, V142, P35, DOI 10.1111/j.1399-3054.2011.01457.x; Onda Y, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0964; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfannschmidt T, 2001, J BIOL CHEM, V276, P36125, DOI 10.1074/jbc.M105701200; Pigliucci M, 2002, EVOL ECOL, V16, P27, DOI 10.1023/A:1016073525567; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Rastogi A, 2014, PLANT CELL ENVIRON, V37, P392, DOI 10.1111/pce.12161; Schottler MA, 2015, J EXP BOT, V66, P2373, DOI 10.1093/jxb/eru495; Selmar D, 2013, PLANT CELL PHYSIOL, V54, P817, DOI 10.1093/pcp/pct054; Shikanai T, 2017, MOL PLANT, V10, P20, DOI 10.1016/j.molp.2016.08.004; Singer SD, 2016, PLANT SCI, V243, P1, DOI 10.1016/j.plantsci.2015.11.003; Singh S, 2017, P NATL ACAD SCI USA, V114, P7725, DOI 10.1073/pnas.1701824114; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Son KH, 2012, KOREAN J HORTIC SCI, V30, P664, DOI 10.7235/hort.2012.12063; Sugiura M, 2014, BBA-BIOENERGETICS, V1837, P1427, DOI 10.1016/j.bbabio.2013.12.011; Takahashi S, 2009, PLANT PHYSIOL, V149, P1560, DOI 10.1104/pp.108.134122; Taulavuori K, 2016, ENVIRON EXP BOT, V121, P145, DOI 10.1016/j.envexpbot.2015.04.002; Terashima I, 2009, PLANT CELL PHYSIOL, V50, P684, DOI 10.1093/pcp/pcp034; Tikkanen M, 2014, TRENDS PLANT SCI, V19, P10, DOI 10.1016/j.tplants.2013.09.003; van Rooijen R, 2015, PLANT PHYSIOL, V167, P1412, DOI 10.1104/pp.114.252239; Velez-Ramirez AI, 2011, TRENDS PLANT SCI, V16, P310, DOI 10.1016/j.tplants.2011.02.003; Venema JH, 2000, PLANT SCI, V152, P153, DOI 10.1016/S0168-9452(99)00228-9; Walters RG, 2005, J EXP BOT, V56, P435, DOI 10.1093/jxb/eri060; Wang H, 2009, J PHOTOCH PHOTOBIO B, V96, P30, DOI 10.1016/j.jphotobiol.2009.03.010; Wang YH, 2013, AM J BOT, V100, P70, DOI 10.3732/ajb.1200354; Watanabe M, 2013, PLANT PHYSIOL, V162, P1290, DOI 10.1104/pp.113.217380; Wild A, 1979, Planta, V146, P551, DOI 10.1007/BF00388831; Wu BS, 2020, ENVIRON EXP BOT, V171, DOI 10.1016/j.envexpbot.2019.103953; Wu BS, 2019, PLANT SCI, V289, DOI 10.1016/j.plantsci.2019.110272; Wu Q, 2014, ACTA PHYSIOL PLANT, V36, P1411, DOI 10.1007/s11738-014-1519-7; Yamori W, 2015, SCI REP-UK, V5, DOI 10.1038/srep13908; Yang XL, 2018, ENVIRON EXP BOT, V150, P161, DOI 10.1016/j.envexpbot.2018.03.013; Yavari N., 2019, J PROTEOM BIOINFORM, V12, P134, DOI [10.35248/0974-276X.19.12.507, DOI 10.35248/0974-276X.19.12.507]; Yu WW, 2017, J PLANT GROWTH REGUL, V36, P148, DOI 10.1007/s00344-016-9625-y; Zavafer A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16363	81	10	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0247380	10.1371/journal.pone.0247380	http://dx.doi.org/10.1371/journal.pone.0247380			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33661984	Green Published, gold			2022-12-26	WOS:000626604100077
J	Yu, ML; Wu, H; Wang, JH; Chen, XY; Pan, JQ; Liu, PH; Zhang, J; Chen, YS; Zhu, W; Tang, CX; Jin, Q; Li, CX; Lu, C; Zeng, H; Yu, CH; Sun, J				Yu, Mengli; Wu, Hao; Wang, Jinhai; Chen, Xueyang; Pan, Jiaqi; Liu, Peihao; Zhang, Jie; Chen, Yishu; Zhu, Wei; Tang, Chenxi; Jin, Qi; Li, Chunxiao; Lu, Chao; Zeng, Hang; Yu, Chaohui; Sun, Jing			Vitamin D receptor inhibits EMT via regulation of the epithelial mitochondrial function in intestinal fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; MESENCHYMAL TRANSITION; CELL; MECHANISMS; COLITIS; INDUCTION; PROMOTES; PATHWAY; FUSION	We previously showed that the vitamin D receptor (VDR) plays a crucial role in acute inflammatory bowel disease and that intestinal fibrosis is a common complication of Crohn's disease (CD). Epithelial-mesenchymal transition (EMT) is an important hallmark of fibrogenesis through which epithelial cells lose their epithelial phenotype and transform into mesenchymal cells. It is known that the VDR plays an essential role in epithelial integrity and mitochondrial function, but its role in intestinal fibrosis remains unknown. Here, we investigated whether the VDR is involved in epithelial mitochondrial dysfunction that results in EMT in intestinal fibrosis. Using human CD samples, intestine-specific VDR-KO mice, and fibroblast cellular models, we showed that the expression of the VDR was significantly lower in intestinal stenotic areas than in nonstenotic areas in patients with chronic CD. Genetic deletion of the VDR in the intestinal epithelium exacerbated intestinal fibrosis in mice administered with dextran sulfate sodium or 2,4,6-trinitrobenzene sulfonic acid, two experimental colitis inducers. In addition, we found that vitamin D dietary intervention regulated intestinal fibrosis by modulating the intestinal expression of the VDR. Mechanistically, knocking down the VDR in both CCD-18Co cells and human primary colonic fibroblasts promoted fibroblast activation, whereas VDR overexpression or VDR agonist administration inhibited fibroblast activation. Further analysis illustrated that the VDR inhibited EMT in the HT29 cell model and that mitochondrial dysfunction mediated epithelial integrity and barrier function in VDR-deficient epithelial cells. Together, our data for the first time demonstrate that VDR activation alleviates intestinal fibrosis by inhibiting fibroblast activation and epithelial mitochondria-mediated EMT.	[Yu, Mengli; Chen, Xueyang; Pan, Jiaqi; Liu, Peihao; Zhang, Jie; Chen, Yishu; Zhu, Wei; Tang, Chenxi; Jin, Qi; Lu, Chao; Zeng, Hang; Yu, Chaohui] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Gastroenterol, Hangzhou, Peoples R China; [Wu, Hao] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol & Hepatol, Shanghai, Peoples R China; [Wang, Jinhai] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Colorectal Surg, Hangzhou, Peoples R China; [Li, Chunxiao] Ningbo First Hosp, Dept Gastroenterol, Ningbo, Peoples R China; [Sun, Jing] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Gastroenterol, Sch Med, Shanghai, Peoples R China	Zhejiang University; Fudan University; Zhejiang University; Shanghai Jiao Tong University	Yu, CH (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Gastroenterol, Hangzhou, Peoples R China.; Sun, J (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Gastroenterol, Sch Med, Shanghai, Peoples R China.	zyyyych@zju.edu.cn; sunjinrj@shsmu.edu.cn		Tang, Chenxi/0000-0003-3448-8748	Natural Science Foundation of Zhejiang Province [LY20H030005]; National Natural Science Foundation of China [81770547]; Foundation of Shanghai Municipal Population and Family Planning Commission [20174Y0151]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Shanghai Municipal Population and Family Planning Commission	This work was supported and approved by Natural Science Foundation of Zhejiang Province (No. LY20H030005) and the National Natural Science Foundation of China (No. 81770547) and the Foundation of Shanghai Municipal Population and Family Planning Commission (No. 20174Y0151).	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Amodeo GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103879; Anand R, 2014, J CELL BIOL, V204, P919, DOI 10.1083/jcb.201308006; Bikle DD, 2015, J STEROID BIOCHEM, V148, P47, DOI 10.1016/j.jsbmb.2014.10.017; Breynaert C, 2016, J CROHNS COLITIS, V10, P1336, DOI 10.1093/ecco-jcc/jjw101; Camara AKS, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00460; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chang E, 2019, MOLECULES, V24, DOI 10.3390/molecules24213903; Chen C, 2019, BIOMED PHARMACOTHER, V117, DOI 10.1016/j.biopha.2019.109170; Christakos S, 2016, PHYSIOL REV, V96, P365, DOI 10.1152/physrev.00014.2015; Consiglio M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115816; Ding N, 2013, CELL, V153, P601, DOI 10.1016/j.cell.2013.03.028; Duran A, 2016, CANCER CELL, V30, P595, DOI 10.1016/j.ccell.2016.09.004; Gisbert-Ferrandiz L, 2020, NUTRIENTS, V12, DOI 10.3390/nu12040973; Glorevski N, 2016, NATURE, V539, P560, DOI 10.1038/nature20168; Gordon IO, 2014, INFLAMM BOWEL DIS, V20, P2198, DOI 10.1097/MIB.0000000000000080; Gracz A D, 2012, Methods Mol Biol, V879, P89, DOI 10.1007/978-1-61779-815-3_6; He L, 2018, ENDOCRINOLOGY, V159, P967, DOI 10.1210/en.2017-00748; Holvoet T, 2017, GASTROENTEROLOGY, V153, P1054, DOI 10.1053/j.gastro.2017.06.013; Honzawa Y, 2014, GUT, V63, P1902, DOI 10.1136/gutjnl-2013-305632; Huang H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.419; Jiang H, 2018, MUCOSAL IMMUNOL, V11, P294, DOI 10.1038/mi.2017.107; Johnson LA, 2013, INFLAMM BOWEL DIS, V19, P891, DOI 10.1097/MIB.0b013e3182813297; Kemmis CM, 2008, J CELL BIOCHEM, V105, P980, DOI 10.1002/jcb.21896; Lee CT, 2019, J STEROID BIOCHEM, V185, P200, DOI 10.1016/j.jsbmb.2018.09.002; Lenti MV, 2019, MOL ASPECTS MED, V65, P100, DOI 10.1016/j.mam.2018.10.003; Li CX, 2020, J CROHNS COLITIS, V14, P1103, DOI 10.1093/ecco-jcc/jjaa016; Lisse TS, 2014, MOL ENDOCRINOL, V28, P1698, DOI 10.1210/me.2014-1043; Liu D, 2019, BIOMATERIALS, V211, P57, DOI 10.1016/j.biomaterials.2019.04.034; Liu WC, 2013, J CLIN INVEST, V123, P3983, DOI 10.1172/JCI65842; Lu XW, 2019, EXP EYE RES, V187, DOI 10.1016/j.exer.2019.107776; Marchi S, 2014, J PHYSIOL-LONDON, V592, P829, DOI 10.1113/jphysiol.2013.268235; Margolis RN, 2010, ANN NY ACAD SCI, V1192, P208, DOI 10.1111/j.1749-6632.2009.05227.x; Garcia IM, 2012, AM J PHYSIOL-RENAL, V302, pF1595, DOI 10.1152/ajprenal.00617.2011; Nanki K, 2020, NATURE, V577, P254, DOI 10.1038/s41586-019-1844-5; Ortiz-Masia D, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051104; Ortiz-Masia D, 2020, J CROHNS COLITIS, V14, P230, DOI 10.1093/ecco-jcc/jjz134; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Peyrin-Biroulet L, 2010, AM J GASTROENTEROL, V105, P289, DOI 10.1038/ajg.2009.579; Ricca C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061672; Rieder F, 2013, GUT, V62, P1072, DOI 10.1136/gutjnl-2012-304353; Rieder F, 2012, J CROHNS COLITIS, V6, P373, DOI 10.1016/j.crohns.2011.11.009; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Ryan ZC, 2016, J BIOL CHEM, V291, P1514, DOI 10.1074/jbc.M115.684399; Scharl M, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0046-5; Scheibe K, 2019, GASTROENTEROLOGY, V156, P1082, DOI 10.1053/j.gastro.2018.11.029; Scheibe K, 2017, GUT, V66, P823, DOI 10.1136/gutjnl-2015-310374; Schneider M, 2006, DEVELOPMENT, V133, P3805, DOI 10.1242/dev.02549; Shi YY, 2020, FASEB J, V34, P13494, DOI 10.1096/fj.202000143RRR; Speca S, 2016, INFLAMM BOWEL DIS, V22, P279, DOI 10.1097/MIB.0000000000000618; Speca S, 2012, WORLD J GASTROENTERO, V18, P3635, DOI 10.3748/wjg.v18.i28.3635; Tao QS, 2015, DIGEST DIS SCI, V60, P868, DOI 10.1007/s10620-014-3398-6; Thia KT, 2010, GASTROENTEROLOGY, V139, P1147, DOI 10.1053/j.gastro.2010.06.070; Torres J, 2017, LANCET, V389, P1741, DOI 10.1016/S0140-6736(16)31711-1; Varanita T, 2015, CELL METAB, V21, P834, DOI 10.1016/j.cmet.2015.05.007; Wang ZT, 2014, WORLD J GASTROENTERO, V20, P2397, DOI 10.3748/wjg.v20.i9.2397; Wirtz S, 2017, NAT PROTOC, V12, P1295, DOI 10.1038/nprot.2017.044; Yang L, 2017, MOL MED REP, V15, P2273, DOI 10.3892/mmr.2017.6276; Zhang H, 2020, J BIOL CHEM, V295, P3891, DOI 10.1074/jbc.RA119.011487; Zhang J, 2020, J BIOL CHEM, V295, P4237, DOI 10.1074/jbc.RA119.010143	60	11	11	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100531	10.1016/j.jbc.2021.100531	http://dx.doi.org/10.1016/j.jbc.2021.100531			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33713706	gold, Green Published			2022-12-26	WOS:000672866400505
J	Tuason, MT; Guss, CD; Boyd, L				Tuason, Ma Teresa; Guss, C. Dominik; Boyd, Lauren			Thriving during COVID-19: Predictors of psychological well-being and ways of coping	PLOS ONE			English	Article							SOCIAL LONELINESS; HEALTH OUTCOMES; MENTAL-HEALTH; SHORT SCALES; LIFE; POPULATION; PERCEPTIONS; TECHNOLOGY; DIMENSIONS; MOTIVATION	COVID-19 has led to global dramatic shifts in daily life. Following the biopsychosocial model of health, the goal of the current study was to predict people's psychological well-being (PWB) during the initial lockdown phase of the pandemic and to investigate which coping strategies were most common among people with low and high PWB. Participants were 938 volunteers in the United States who responded to an online survey during the lockdown in April 2020. The main findings were that all three groups of variables, biological, psychological, and socio-economic, significantly contributed to PWB explaining 53% variance. Social loneliness and sense of agency were the strongest predictors. PWB was significantly predicted by physical health (not gender nor age); by spirituality, emotional loneliness, social loneliness, and sense of agency; by job security (not income, nor neighborhood safety, nor hours spent on social media). Comparing the coping strategies of participants, results show more intentional coping in the high-PWB group and more passive coping in the low-PWB group. During this unprecedented pandemic, the findings highlight that ability to sustainably cope with the global shifts in daily life depends on actively and intentionally attending to PWB by being one's own agent for physical health, spiritual health, and social connection.	[Tuason, Ma Teresa] Univ North Florida, Dept Publ Hlth, Jacksonville, FL USA; [Guss, C. Dominik; Boyd, Lauren] Univ North Florida, Dept Psychol, Jacksonville, FL 32224 USA	State University System of Florida; University of North Florida; State University System of Florida; University of North Florida	Guss, CD (corresponding author), Univ North Florida, Dept Psychol, Jacksonville, FL 32224 USA.	dguess@unf.edu		Boyd, Lauren/0000-0002-1413-956X	University of North Florida's Delaney Presidential Professorship	University of North Florida's Delaney Presidential Professorship	Yes -This research was supported by a grant from the University of North Florida's Delaney Presidential Professorship to the second author.	Abdel-Khalek AM., 2016, RELIGIOSITY PSYCHOL, P47; Afhami R, 2018, MENT HEALTH RELIG CU, V20, P879, DOI 10.1080/13674676.2017.1313825; American Psychiatric Association,, NEW POLL COVID 19 IM; Baker LR, 2010, J SOC PERS RELAT, V27, P873, DOI 10.1177/0265407510375261; Bell Iris R, 2004, BMC Complement Altern Med, V4, P1, DOI 10.1186/1472-6882-4-1; Bell SL, 2014, HEALTH PLACE, V30, P287, DOI 10.1016/j.healthplace.2014.10.005; Boehm JK, 2012, PSYCHOL BULL, V138, P655, DOI 10.1037/a0027448; Booth J., 2012, J SOCIO SOC WELFARE, V39; Borrell-Carrio F, 2004, ANN FAM MED, V2, P576, DOI 10.1370/afm.245; BRICKMAN P, 1978, J PERS SOC PSYCHOL, V36, P917, DOI 10.1037/0022-3514.36.8.917; Cantarero R, 2014, INT J AGING HUM DEV, V78, P299, DOI 10.2190/AG.78.4.a; Chen Y, 2019, J POSIT PSYCHOL, V14, P649, DOI 10.1080/17439760.2018.1519591; Chew Qian Hui, 2020, Singapore Med J, V61, P350, DOI 10.11622/smedj.2020046; Choi Yeon Jin, 2018, Gerontologist, V58, P196, DOI [10.1093/geront/gny021, 10.1093/geront/gnw187]; Cohen J.E., 1988, STAT POWER ANAL BEHA; Gierveld JD, 2006, RES AGING, V28, P582, DOI 10.1177/0164027506289723; del Castillo FA, 2021, J PUBLIC HEALTH-UK, V43, pE254, DOI 10.1093/pubmed/fdaa185; Diener E, 2009, SOC INDIC RES SER, V39, P1, DOI 10.1007/978-90-481-2354-4_1; Dorner D, 2013, REV GEN PSYCHOL, V17, P297, DOI 10.1037/a0032947; Dolan P, 2008, J ECON PSYCHOL, V29, P94, DOI 10.1016/j.joep.2007.09.001; ENGEL GL, 1981, J MED PHILOS, V6, P101, DOI 10.1093/jmp/6.2.101; Eurofound, 2015, 6 EUROPEAN WORKING C; European Commission, 2009, EUR SURV POV SOC EXC; Faul F., 2014, G POWER VERSION 3192; Favieri F., 2020, SSRN J, DOI [10.2139/ssrn.3576804, DOI 10.2139/SSRN.3576804]; Fincham FD, 2019, J POSIT PSYCHOL, V14, P854, DOI 10.1080/17439760.2019.1579361; Frankel RM., 2003, BIOPSYCHOSOCIAL APPR, P21; Frasquilho D, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2720-y; Fullana MA, 2020, J AFFECT DISORDERS, V275, P80, DOI 10.1016/j.jad.2020.06.027; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Gierveld JDJ, 2010, EUR J AGEING, V7, P121, DOI 10.1007/s10433-010-0144-6; Golden J, 2009, INT J GERIATR PSYCH, V24, P694, DOI 10.1002/gps.2181; Gomez-Baya D, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071474; Greenfield EA, 2009, J HEALTH SOC BEHAV, V50, P196, DOI 10.1177/002214650905000206; Griffith DM, 2020, PREV CHRONIC DIS, V17, DOI 10.5888/pcd17.200247; Guss CD, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00851; Hawkley LC, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0114; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Hwang TJ, 2020, INT PSYCHOGERIATR, V32, P1217, DOI 10.1017/S1041610220000988; Ivtzan I., 2013, HUMANIST PSYCHOL, V41, P119, DOI [10.1080/08873267.2012.712076, DOI 10.1080/08873267.2012.712076]; Johns Hopkins University & Medicine, 2021, COR RES CTR; Kachanoff FJ, 2019, J PERS SOC PSYCHOL, V116, P141, DOI 10.1037/pspp0000177; Karasawa M, 2011, INT J AGING HUM DEV, V73, P73, DOI 10.2190/AG.73.1.d; Karunamuni N, 2021, SOC SCI MED, V272, DOI 10.1016/j.socscimed.2020.112846; Keyes CLM, 2002, J PERS SOC PSYCHOL, V82, P1007, DOI 10.1037//0022-3514.82.6.1007; Kirby SE, 2004, J GERONTOL B-PSYCHOL, V59, pP123, DOI 10.1093/geronb/59.3.P123; Klaiber P., 2020, JS GERONTOLOGY B; Knepple-Carney A., 2020, GERONTOLOGIST; Kraut R, 1998, AM PSYCHOL, V53, P1017, DOI 10.1037/0003-066X.53.9.1017; Lam J, 2014, SOC MENT HEALTH, V4, P55, DOI 10.1177/2156869313507288; Lau ALD, 2008, AGING MENT HEALTH, V12, P746, DOI 10.1080/13607860802380607; Leonardi Matilde, 2020, SN Compr Clin Med, V2, P1758, DOI 10.1007/s42399-020-00486-8; Liekefett L, 2021, BRIT J SOC PSYCHOL, V60, P924, DOI 10.1111/bjso.12439; Lim K, 2005, PREV MED, V40, P33, DOI 10.1016/j.ypmed.2004.04.046; Litt DM, 2011, PSYCHOL ADDICT BEHAV, V25, P708, DOI 10.1037/a0024226; Lopez J, 2020, INT PSYCHOGERIATR, V32, P1365, DOI 10.1017/S1041610220000964; Lopez-Bueno R, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01426; Marino Claudia, 2020, Addict Behav Rep, V11, P100250, DOI 10.1016/j.abrep.2020.100250; McDaniel BT, 2016, PSYCHOL POP MEDIA CU, V5, P85, DOI 10.1037/ppm0000065; McKee-Ryan FM, 2005, J APPL PSYCHOL, V90, P53, DOI 10.1037/0021-9010.90.1.53; Miao J, 2021, CHINESE SOCIOL REV, V53, P1, DOI 10.1080/21620555.2020.1820860; Morales-Rodriguez FM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134778; Nasim A, 2007, J DRUG EDUC, V37, P335, DOI 10.2190/DE.37.3.g; O'Connor RC, 2021, BRIT J PSYCHIAT, V218, P326, DOI 10.1192/bjp.2020.212; Oskrochi G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198638; Pargament KI, 1998, J SCI STUD RELIG, V37, P710, DOI 10.2307/1388152; Park CL, 2019, PSYCHOL TRAUMA-US, V11, P563, DOI 10.1037/tra0000426; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Perlman D., 1981, PERSONAL RELATIONSHI, P31, DOI DOI 10.1037/0003-066X.41.2.229; Perlman D, 1998, ENCY MENTAL HLTH, V2, P571; Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017; Pressman SD, 2005, PSYCHOL BULL, V131, P925, DOI 10.1037/0033-2909.131.6.925; Roothman B., 2003, S AFR J PSYCHOL, V33, P212, DOI [10.1177/008124630303300403, DOI 10.1177/008124630303300403]; Ryan AK, 2007, J AGING HEALTH, V19, P907, DOI 10.1177/0898264307308340; Ryan RM, 2017, SELF-DETERMINATION THEORY: BASIC PSYCHOLOGICAL NEEDS IN MOTIVATION, DEVELOPMENT, AND WELLNESS, P1, DOI 10.1521/978.14625/28806; Ryff CD, 2014, PSYCHOTHER PSYCHOSOM, V83, P10, DOI 10.1159/000353263; Schonlau M., 2002, CONDUCTING RES SURVE; Seale H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235112; Seybold KS, 2001, CURR DIR PSYCHOL SCI, V10, P21, DOI 10.1111/1467-8721.00106; Shechter A, 2020, GEN HOSP PSYCHIAT, V66, P1, DOI 10.1016/j.genhosppsych.2020.06.007; Smith TW, 2014, BIOPSYCHOSOCIAL INTE; Sonderskov KM, 2020, ACTA NEUROPSYCHIATR, V32, P226, DOI 10.1017/neu.2020.15; Sun VK, 2012, J GEN INTERN MED, V27, P541, DOI 10.1007/s11606-011-1943-y; Sundar SS, 2015, SENSE AGENCY SCALE M, DOI [10.1037/t38313-000, DOI 10.1037/T38313-000]; Trudel-Fitzgerald C, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-8029-x; Tuason MTG, 2012, PROF PSYCHOL-RES PR, V43, P288, DOI 10.1037/a0028054; Twenge JM, 2019, CURR DIR PSYCHOL SCI, V28, P372, DOI 10.1177/0963721419838244; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; VanderWeele TJ, 2020, EPIDEMIOLOGY, V31, P189, DOI 10.1097/EDE.0000000000001147; VIINAMAKI H, 1995, ACTA PSYCHIAT SCAND, V91, P396, DOI 10.1111/j.1600-0447.1995.tb09799.x; Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048; Vleioras G, 2005, J ADOLESCENCE, V28, P397, DOI 10.1016/j.adolescence.2004.09.001; Wallace MG, 2020, DEPRESSED CRITICAL L; Ward SJ, 2019, J POSIT PSYCHOL, V14, P312, DOI 10.1080/17439760.2017.1402075; Weden MA, 2008, SOC SCI MED, V66, P1256, DOI 10.1016/j.socscimed.2007.11.041; World Health Organization, COR DIS 2019 COVID 1; World Health Organization [WHO], 1996, WHOQOL BREF INTR ADM; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	98	13	13	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0248591	10.1371/journal.pone.0248591	http://dx.doi.org/10.1371/journal.pone.0248591			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX9NB	33720985	Green Submitted, gold, Green Published			2022-12-26	WOS:000629667400012
J	Loxton, NW; Rohlwink, UK; Tshavhungwe, M; Dlamini, L; Shey, M; Enslin, N; Figaji, A				Loxton, Nicholas W.; Rohlwink, Ursula K.; Tshavhungwe, Mvuwo; Dlamini, Lindizwe; Shey, Muki; Enslin, Nico; Figaji, Anthony			A pilot study of inflammatory mediators in brain extracellular fluid in paediatric TBM	PLOS ONE			English	Article								Tuberculous meningitis (TBM) is the most fatal form of tuberculosis and frequently occurs in children. The inflammatory process initiates secondary brain injury processes that lead to death and disability. Much remains unknown about this cerebral inflammatory process, largely because of the difficulty in studying the brain. To date, studies have typically examined samples from sites distal to the site of disease, such as spinal cerebrospinal fluid (CSF) and blood. In this pilot study, we examined the feasibility of using direct brain microdialysis (MD) to detect inflammatory mediators in brain extracellular fluid (ECF) in TBM. MD was used to help guide neurocritical care in 7 comatose children with TBM by monitoring brain chemistry for up to 4 days. Remnant ECF fluid was stored for offline analysis. Samples of ventricular CSF, lumbar CSF and blood were collected at clinically indicated procedures for comparison. Inflammatory mediators were quantified using multiplex technology. All inflammatory markers, with the exception of interleukin (IL)-10 and IL-12p40, were detected in the ECF. Cytokine concentrations were generally lower in ECF than ventricular CSF in time-linked specimens. Individual cases showed ECF cytokine increases coinciding with marked increases in ECF glycerol or decreases in ECF glucose. Cytokine levels and glycerol were generally higher in patients with more severe disease. This is the first report of inflammatory marker analysis from samples derived directly from the brain and in high temporal resolution, demonstrating feasibility of cerebral MD to explore disease progression and possibly therapy response in TBM.	[Loxton, Nicholas W.; Rohlwink, Ursula K.; Tshavhungwe, Mvuwo; Dlamini, Lindizwe; Enslin, Nico; Figaji, Anthony] Univ Cape Town, Dept Surg, Div Neurosurg, Cape Town, South Africa; [Rohlwink, Ursula K.; Enslin, Nico; Figaji, Anthony] Univ Cape Town, Neurosci Inst, Cape Town, South Africa; [Rohlwink, Ursula K.] Francis Crick Inst, London, England; [Shey, Muki] Wellcome Ctr Infect Dis Res Africa, Cape Town, South Africa; [Shey, Muki] Univ Cape Town, Dept Med, Cape Town, South Africa	University of Cape Town; University of Cape Town; Francis Crick Institute; University of Cape Town	Figaji, A (corresponding author), Univ Cape Town, Dept Surg, Div Neurosurg, Cape Town, South Africa.; Figaji, A (corresponding author), Univ Cape Town, Neurosci Inst, Cape Town, South Africa.	Anthony.Figaji@uct.ac.za	Shey, Muki/M-1273-2016; Rohlwink, Ursula K/V-8638-2018; Figaji, Anthony/ADH-9410-2022; Rohlwink, Ursula Karin/U-8917-2019; Enslin, Nico/AHE-4539-2022	Shey, Muki/0000-0002-8776-4737; Rohlwink, Ursula K/0000-0002-4469-4935; Figaji, Anthony/0000-0002-3357-6490; Rohlwink, Ursula Karin/0000-0002-4469-4935; Enslin, Nico/0000-0002-6384-7781	National Research Foundation SARChI Chair of Clinical Neurosciences; Harry Crossley Foundation; South African Medical Research Council, National Medical Students Research Training Programme	National Research Foundation SARChI Chair of Clinical Neurosciences; Harry Crossley Foundation; South African Medical Research Council, National Medical Students Research Training Programme	The study was supported by the National Research Foundation SARChI Chair of Clinical Neurosciences, Harry Crossley Foundation and South African Medical Research Council, National Medical Students Research Training Programme received by Nicholas Loxton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao XP, 2006, METHODS, V38, P331, DOI 10.1016/j.ymeth.2005.11.012; BENVENISTE H, 1987, ACTA NEUROPATHOL, V74, P234, DOI 10.1007/BF00688186; Clausen T, 2005, J NEUROSURG, V103, P233, DOI 10.3171/jns.2005.103.2.0233; Davis AG, 2019, J LEUKOCYTE BIOL, V105, P267, DOI 10.1002/JLB.MR0318-102R; Figaji AA, 2010, TUBERCULOSIS, V90, P393, DOI 10.1016/j.tube.2010.09.005; Figaji Anthony A, 2008, Pediatr Crit Care Med, V9, pe25, DOI 10.1097/PCC.0b013e318172e8b7; Folkersma H, 2008, ACTA NEUROCHIR, V150, P1277, DOI 10.1007/s00701-008-0151-y; Frykholm P, 2001, J NEUROL NEUROSUR PS, V71, P455, DOI 10.1136/jnnp.71.4.455; Giorgi-Coll S, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6513; Helmy A, 2007, CURR MED CHEM, V14, P1525, DOI 10.2174/092986707780831113; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Hillered L, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00245; Hillman J, 2007, J NEUROSURG, V106, P820, DOI 10.3171/jns.2007.106.5.820; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Marais BJ, 2017, CLIN INFECT DIS, V64, P501, DOI 10.1093/cid/ciw757; Marais S, 2010, LANCET INFECT DIS, V10, P803, DOI 10.1016/S1473-3099(10)70138-9; Mellergard P, 2011, NEUROSURGERY, V68, P12, DOI 10.1227/NEU.0b013e3181ef2a40; Mellergard P, 2010, BRIT J NEUROSURG, V24, P261, DOI 10.3109/02688690903521605; Ozates M, 2000, ACTA RADIOL, V41, P13; R Core Team, 2013, R LANG ENV STAT COMP; Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Rohlwink UK, 2017, CLIN INFECT DIS, V65, P1298, DOI 10.1093/cid/cix540; Rohlwink UK, 2016, PEDIATR INFECT DIS J, V35, pE301, DOI 10.1097/INF.0000000000001236; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Stenken JA, 2010, AAPS J, V12, P73, DOI 10.1208/s12248-009-9163-7; Tabatabaei P, 2017, J NEURO-ONCOL, V131, P83, DOI 10.1007/s11060-016-2271-1; Thelin EP, 2017, AAPS J, V19, P367, DOI 10.1208/s12248-016-0027-7; Thwaites GE, 2003, J INFECT DIS, V188, P1105, DOI 10.1086/378642; van Toorn R, 2012, INT J TUBERC LUNG D, V16, P628, DOI 10.5588/ijtld.11.0648; Wilkinson RJ, 2017, NAT REV NEUROL, V13, P581, DOI 10.1038/nrneurol.2017.120; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S	34	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0246997	10.1371/journal.pone.0246997	http://dx.doi.org/10.1371/journal.pone.0246997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711020	gold, Green Published			2022-12-26	WOS:000629591800031
J	Zhen, J; Song, Z; Su, WJ; Zeng, QC; Li, JC; Sun, Q				Zhen, Jing; Song, Zhe; Su, WenJie; Zeng, Qing-Cui; Li, JiaCen; Sun, Qin			Integrated analysis of RNA-binding proteins in thyroid cancer	PLOS ONE			English	Article							ROLES; GUIDELINES; CARCINOMA; NETWORKS; DISEASE; REVEAL; RBPS	Recently, the incidence of thyroid cancer (THCA) has been on the rise. RNA binding proteins (RBPs) and their abnormal expression are closely related to the emergence and pathogenesis of tumor diseases. In this study, we obtained gene expression data and corresponding clinical information from the TCGA database. A total of 162 aberrantly expressed RBPs were obtained, comprising 92 up-regulated and 70 down-regulated RBPs. Then, we performed a functional enrichment analysis and constructed a PPI network. Through univariate Cox regression analysis of key genes and found that NOLC1 (p = 0.036), RPS27L (p = 0.011), TDRD9 (p = 0.016), TDRD6 (p = 0.002), IFIT2 (p = 0.037), and IFIT3 (p = 0.02) were significantly related to the prognosis. Through the online website Kaplan-Meier plotter and multivariate Cox analysis, we identified 2 RBP-coding genes (RPS27L and IFIT3) to construct a predictive model in the entire TCGA dataset and then validate in two subsets. In-depth analysis revealed that the data gave by this model, the patient's high-risk score is very closely related to the overall survival rate difference (p = 0.038). Further, we investigated the correlation between the model and the clinic, and the results indicated that the high-risk was in the male group (p = 0.011) and the T3-4 group (p = 0.046) was associated with a poor prognosis. On the whole, the conclusions of our research this time can make it possible to find more insights into the research on the pathogenesis of THCA, this could be beneficial for individualized treatment and medical decision making.	[Zhen, Jing; Sun, Qin] Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Dept Geriatr Endocrinol, Chengdu, Peoples R China; [Song, Zhe] Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Med Ctr Vasc Surg & Thyroid, Chengdu, Peoples R China; [Su, WenJie; Li, JiaCen] Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Dept Anesthesiol, Chengdu, Peoples R China; [Zeng, Qing-Cui] Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Dept Geriatr Intens Care Unit, Chengdu, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Sun, Q (corresponding author), Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Dept Geriatr Endocrinol, Chengdu, Peoples R China.; Li, JC (corresponding author), Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Dept Anesthesiol, Chengdu, Peoples R China.	LiJJcd@163.com; sunqin@med.uestc.edu.cn	Wenjie, 苏文杰/HGU-4119-2022	Wenjie, 苏文杰/0000-0001-5177-7301				Ancker OV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010010; Apicco DJ, 2019, CELL REP, V29, P4377, DOI 10.1016/j.celrep.2019.11.093; Bakkar N, 2018, ACTA NEUROPATHOL, V135, P227, DOI 10.1007/s00401-017-1785-8; Blech-Hermoni Y, 2013, INT J BIOCHEM CELL B, V45, P2467, DOI 10.1016/j.biocel.2013.08.008; Cabanillas ME, 2016, LANCET, V388, P2783, DOI 10.1016/S0140-6736(16)30172-6; Cao JG, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/4217259; Chatterji P, 2018, TRENDS MOL MED, V24, P490, DOI 10.1016/j.molmed.2018.03.008; Correa BR, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0990-4; Dominguez D, 2018, MOL CELL, V70, P854, DOI 10.1016/j.molcel.2018.05.001; Ferre F, 2016, BRIEF BIOINFORM, V17, P106, DOI 10.1093/bib/bbv031; Filetti S, 2019, ANN ONCOL, V30, P1856, DOI 10.1093/annonc/mdz400; Fleeman N, 2020, HEALTH TECHNOL ASSES, V24, P1, DOI 10.3310/hta24020; Franceschini A, 2016, BIOINFORMATICS, V32, P1085, DOI 10.1093/bioinformatics/btv696; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Hartl DM, 2019, BEST PRACT RES CL EN, V33, DOI 10.1016/j.beem.2019.05.005; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hentze MW, 2018, NAT REV MOL CELL BIO, V19, P327, DOI 10.1038/nrm.2017.130; Hodson DJ, 2019, BLOOD, V133, P2365, DOI 10.1182/blood-2018-10-839985; Ignarski M, 2019, J AM SOC NEPHROL, V30, P564, DOI 10.1681/ASN.2018090914; Jin Y, 2020, DNA CELL BIOL, V39, P1789, DOI 10.1089/dna.2020.5641; Kapeli K, 2017, HUM GENET, V136, P1193, DOI 10.1007/s00439-017-1830-7; Kim J, 2020, NAT REV ENDOCRINOL, V16, P17, DOI 10.1038/s41574-019-0263-x; Lamartina L, 2020, LANCET DIABETES ENDO, V8, P81, DOI 10.1016/S2213-8587(19)30324-9; Lewinski A, 2017, POL ARCH INTERN MED, V127, P388, DOI 10.20452/pamw.4058; Li B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1028-7; Li TW, 2017, CANCER RES, V77, pE108, DOI 10.1158/0008-5472.CAN-17-0307; Li TJ, 2017, CANCER SCI, V108, P877, DOI 10.1111/cas.13209; Li W, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00185; Lian SB, 2019, PEERJ, V7, DOI 10.7717/peerj.7696; LIVOLSI VA, 1994, THYROID, V4, P333, DOI 10.1089/thy.1994.4.333; McLeod DSA, 2019, ENDOCR REV, V40, P1481, DOI 10.1210/er.2019-00085; Mohibi S, 2019, PHARMACOL THERAPEUT, V203, DOI 10.1016/j.pharmthera.2019.07.001; Moore MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.33057; Na KJ, 2018, ENDOCR-RELAT CANCER, V25, P523, DOI 10.1530/ERC-17-0532; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Nilsson M, 2017, DEVELOPMENT, V144, P2123, DOI 10.1242/dev.145615; Nyati KK, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02790; Ospina NS, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.l6670; Ostareck DH, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00031; Pearce EN, 2003, NEW ENGL J MED, V348, P2646, DOI 10.1056/NEJMra021194; Pereira B, 2017, TRENDS CANCER, V3, P506, DOI 10.1016/j.trecan.2017.05.003; Schmidbauer B, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061292; Schuschel K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103409; Seethala RR, 2018, MODERN PATHOL, V31, P39, DOI 10.1038/modpathol.2017.130; Seib CD, 2019, ENDOCRIN METAB CLIN, V48, P23, DOI 10.1016/j.ecl.2018.10.002; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; TAYLOR S, 1961, LANCET, V1, P332; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang E, 2019, CANCER CELL, V35, P369, DOI 10.1016/j.ccell.2019.01.010; Wang K, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00140; Wang ZX, 2020, CANCERS, V12, DOI 10.3390/cancers12040892; Yang CB, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01310; Yasuda K, 2016, WIRES RNA, V7, P589, DOI 10.1002/wrna.1352; Zhao HQ, 2019, SURGERY, V166, P55, DOI 10.1016/j.surg.2019.01.025; Zhao M, 2018, MOL CELLS, V41, P818, DOI 10.14348/molcells.2018.0243; Zhu SR, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082996	60	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0247836	10.1371/journal.pone.0247836	http://dx.doi.org/10.1371/journal.pone.0247836			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711033	gold, Green Published			2022-12-26	WOS:000629591800023
J	Foscari, A; Leonarduzzi, G; Incerti, G				Foscari, Alessandro; Leonarduzzi, Giulia; Incerti, Guido			N uptake, assimilation and isotopic fractioning control delta N-15 dynamics in plant DNA: A heavy labelling experiment on Brassica napus L.	PLOS ONE			English	Article							ORYZA-SATIVA L.; NITROGEN ISOTOPES; NITRATE REDUCTASE; OILSEED RAPE; DISCRIMINATION; GROWTH; SYNTHETASE; ATMOSPHERE; ABUNDANCE; AMMONIUM	In last decades, a large body of evidence clarified nitrogen isotope composition (delta N-15) patterns in plant leaves, roots and metabolites, showing isotopic fractionation along N uptake and assimilation pathways, in relation to N source and use efficiency, also suggesting N-15 depletion in plant DNA. Here we present a manipulative experiment on Brassica napus var. oleracea, where we monitored delta N-15 of purified, lyophilized DNA and source leaf and root materials, over a 60-days growth period starting at d 60 after germination, in plants initially supplied with a heavy labelled (delta N-15(Air-N2) = 2100 mUr) ammonium nitrate solution covering nutrient requirements for the whole observation period (470 mg N per plant) and controlling for the labelled N species (H-4, O-3 and both). Dynamics of Isotopic Ratio Mass Spectrometry (IRMS) data for the three treatments showed that: (1) leaf and root delta N-15 dynamics strictly depend on the labelled chemical species, with H4O3 and H4O3 plants initially showing higher, lower and intermediate values, respectively, then converging due to the progressive NH4+ depletion from the nutrient solution; (2) in H4O3, where delta N-15 was not affected by the labelled chemical species, we did not observe isotopic fractionation associated to inorganic N uptake; (3) delta N-15 values in roots compared to leaves did not fully support patterns predicted by differences in assimilation rates of NH4+ and NO3-; (4) DNA is depleted in N-15 compared to the total N pools of roots and leaves, likely due to enzymatic discrimination during purine biosynthesis. In conclusion, while our experimental setup did not allow to assess the fractionation coefficient (epsilon) associated to DNA bases biosynthesis, this is the first study specifically reporting on dynamics of specific plant molecular pools such as nucleic acids over a long observation period with a heavy labelling technique.	[Foscari, Alessandro; Leonarduzzi, Giulia] Univ Trieste, Trieste, Italy; [Foscari, Alessandro; Leonarduzzi, Giulia; Incerti, Guido] Univ Udine, Dept Agr Food Environm & Anim Sci, Udine, Italy	University of Trieste; University of Udine	Incerti, G (corresponding author), Univ Udine, Dept Agr Food Environm & Anim Sci, Udine, Italy.	guido.incerti@uniud.it		FOSCARI, ALESSANDRO/0000-0003-1022-2697	University of Udine, Di4A, PRID2017	University of Udine, Di4A, PRID2017	Financial support for this study was provided to GI by University of Udine (www.uniud.it), Di4A, PRID2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MA, 2006, BIOCHEMISTRY-US, V45, P7132, DOI 10.1021/bi0604025; BERGERSEN FJ, 1988, AUST J PLANT PHYSIOL, V15, P407, DOI 10.1071/PP9880407; Brand WA, 2012, ISOT ENVIRON HEALT S, V48, P393, DOI 10.1080/10256016.2012.666977; Brand Willi A, 2011, Isotopes Environ Health Stud, V47, P535, DOI 10.1080/10256016.2011.645702; Coplen TB, 2011, RAPID COMMUN MASS SP, V25, P2538, DOI 10.1002/rcm.5129; Craine JM, 2015, PLANT SOIL, V396, P1, DOI 10.1007/s11104-015-2542-1; Cui J, 2020, NEW PHYTOL, V226, P1696, DOI 10.1111/nph.16480; Diepenbrock W, 2000, FIELD CROP RES, V67, P35, DOI 10.1016/S0378-4290(00)00082-4; Evans RD, 1996, PLANT CELL ENVIRON, V19, P1317, DOI 10.1111/j.1365-3040.1996.tb00010.x; Evans RD, 2001, TRENDS PLANT SCI, V6, P121, DOI 10.1016/S1360-1385(01)01889-1; FARRIS JS, 1989, SYST ZOOL, V38, P406, DOI 10.2307/2992406; Freund DM, 2017, CURR OPIN BIOTECH, V43, P41, DOI 10.1016/j.copbio.2016.08.002; Gauthier PPG, 2013, PLANT CELL ENVIRON, V36, P128, DOI 10.1111/j.1365-3040.2012.02561.x; Hayes J.M., 2004, INTRO ISOTOPIC CALCU; Haynes R. J., 1986, Mineral nitrogen in the plant-soil system., P303; Hobbie EA, 2012, NEW PHYTOL, V196, P367, DOI 10.1111/j.1469-8137.2012.04300.x; Hogberg P, 1999, NEW PHYTOL, V142, P569, DOI 10.1046/j.1469-8137.1999.00404.x; Johnson JE, 2013, PLANT CELL ENVIRON, V36, P1783, DOI 10.1111/pce.12087; Kalcsits LA, 2014, PHYSIOL PLANTARUM, V151, P293, DOI 10.1111/ppl.12167; KOHL DH, 1980, PLANT PHYSIOL, V66, P51, DOI 10.1104/pp.66.1.51; Kolb KJ, 2003, PLANT CELL ENVIRON, V26, P1431, DOI 10.1046/j.1365-3040.2003.01066.x; Makarov MI, 2019, EURASIAN SOIL SCI+, V52, P193, DOI 10.1134/S1064229319020108; MARIOTTI A, 1982, PLANT PHYSIOL, V69, P880, DOI 10.1104/pp.69.4.880; MOLL RH, 1982, AGRON J, V74, P562, DOI 10.2134/agronj1982.00021962007400030037x; Ostle NJ, 1999, SOIL BIOL BIOCHEM, V31, P1751, DOI 10.1016/S0038-0717(99)00094-2; Rishavy MA, 2000, BIOCHEMISTRY-US, V39, P7309, DOI 10.1021/bi000435z; Robinson D, 1998, PLANTA, V205, P397, DOI 10.1007/s004250050336; Rossato L, 2001, J EXP BOT, V52, P1655, DOI 10.1093/jexbot/52.361.1655; Schjoerring JK, 2001, PLANT SOIL, V228, P105, DOI 10.1023/A:1004851001342; Spangenberg JE, 2020, SCI TOTAL ENVIRON, V739, DOI 10.1016/j.scitotenv.2020.140343; Spangenberg JE, 2018, SCI TOTAL ENVIRON, V635, P178, DOI 10.1016/j.scitotenv.2018.04.078; Tcherkez G, 2006, FUNCT PLANT BIOL, V33, P531, DOI 10.1071/FP05284; Tea I, 2017, METHOD ENZYMOL, V596, P113, DOI 10.1016/bs.mie.2017.07.020; Tribouillois H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122156; WALDROP GL, 1992, J AM CHEM SOC, V114, P5941, DOI 10.1021/ja00041a006; Werner RA, 2002, PHYTOCHEMISTRY, V61, P465, DOI 10.1016/S0031-9422(02)00204-2; Williams JD, 2013, J SOIL WATER CONSERV, V68, P349, DOI 10.2489/jswc.68.5.349; YONEYAMA T, 1993, PLANT CELL PHYSIOL, V34, P489; YONEYAMA T, 1991, PLANT CELL PHYSIOL, V32, P1211; YONEYAMA T, 1989, PLANT CELL PHYSIOL, V30, P957; Yoneyama T, 2001, PLANT CELL ENVIRON, V24, P133, DOI 10.1046/j.1365-3040.2001.00663.x; Yoneyama T., 1998, STABLE ISOTOPES INTE, P99; Yoneyama Tadakatsu, 2003, Phytochemistry Reviews, V2, P121, DOI 10.1023/B:PHYT.0000004198.95836.ad; Yoneyama T, 2019, PLANT PHYSIOL BIOCH, V136, P245, DOI 10.1016/j.plaphy.2018.12.011; Yoneyama T, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01151; Zanin L, 2015, PLANT CELL PHYSIOL, V56, P532, DOI 10.1093/pcp/pcu202; Zhang Y, 2009, J AM CHEM SOC, V131, P4685, DOI 10.1021/ja808346y; Zhang ZY, 2016, CHROMATOGRAPHIA, V79, P1197, DOI 10.1007/s10337-016-3126-9	48	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0247842	10.1371/journal.pone.0247842	http://dx.doi.org/10.1371/journal.pone.0247842			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705458	Green Submitted, gold, Green Published			2022-12-26	WOS:000629590400039
J	Li, WY; Qin, S; Lu, YJ; Wang, H; Xu, Z; Wu, TZ				Li, Wanying; Qin, Shan; Lu, Yijie; Wang, Hao; Xu, Zhen; Wu, Tianzhun			A facile and comprehensive algorithm for electrical response identification in mouse retinal ganglion cells	PLOS ONE			English	Article							STIMULATION; PROSTHESIS	Retinal prostheses can restore the basic visual function of patients with retinal degeneration, which relies on effective electrical stimulation to evoke the physiological activities of retinal ganglion cells (RGCs). Current electrical stimulation strategies have defects such as unstable effects and insufficient stimulation positions, therefore, it is crucial to determine the optimal pulse parameters for precise and safe electrical stimulation. Biphasic voltages (cathode-first) with a pulse width of 25 ms and different amplitudes were used to ex vivo stimulate RGCs of three wild-type (WT) mice using a commercial microelectrode array (MEA) recording system. An algorithm is developed to automatically realize both spike-sorting and electrical response identification for the spike signals recorded. Measured from three WT mouse retinas, the total numbers of RGC units and responsive RGC units were 1193 and 151, respectively. In addition, the optimal pulse amplitude range for electrical stimulation was determined to be 0.43 V-1.3 V. The processing results of the automatic algorithm we proposed shows high consistency with those using traditional manual processing. We anticipate the new algorithm can not only speed up the elaborate electrophysiological data processing, but also optimize pulse parameters for the electrical stimulation strategy of neural prostheses.	[Li, Wanying; Wang, Hao; Xu, Zhen; Wu, Tianzhun] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Li, Wanying] Univ Chinese Acad Sci, Beijing, Peoples R China; [Qin, Shan] Shenzhen Shekou Peoples Hosp, Shenzhen, Peoples R China; [Lu, Yijie] Shenzhen Aier Eye Hosp, Shenzhen, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, Z; Wu, TZ (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China.	zhen.xu@siat.ac.in; tz.wu@siat.ac.cn			National Key Research and Development Program of China [2017YFC0111202]; Shenzhen Science and Technology Research Program [JCYJ20170818152810899, JCYJ20170818154035069]; Guangdong Science and Technology Research Program [2019A050503007, 2019A1515110843]; National Natural Science Foundation of China [31800871, 31900684]; Grants of Chinese Academy of Sciences [172644KYSB20190077]; CAS Key Laboratory on Health Bioinformatics [2011DP173015]	National Key Research and Development Program of China; Shenzhen Science and Technology Research Program; Guangdong Science and Technology Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Grants of Chinese Academy of Sciences; CAS Key Laboratory on Health Bioinformatics	The research was financially supported by National Key Research and Development Program of China (2017YFC0111202), Shenzhen Science and Technology Research Program (JCYJ20170818152810899, JCYJ20170818154035069), Guangdong Science and Technology Research Program (2019A050503007, 2019A1515110843), National Natural Science Foundation of China (31800871, 31900684), Grants of Chinese Academy of Sciences (172644KYSB20190077), and CAS Key Laboratory on Health Bioinformatics (2011DP173015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2017, COMPUT BIOL MED, V85, P33, DOI 10.1016/j.compbiomed.2017.04.013; Boinagrov D, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026008; Buccino AP, 2020, ELIFE, V9, DOI 10.7554/eLife.61834; Choi JH, 2006, IEEE T BIO-MED ENG, V53, P738, DOI 10.1109/TBME.2006.870239; Chung JE, 2017, NEURON, V95, P1381, DOI 10.1016/j.neuron.2017.08.030; Goo YS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/035003; Goureau O., 2018, RETINAL PROSTHESIS, P105, DOI [10.1007/978-3-319-67260-1_7, DOI 10.1007/978-3-319-67260-1_7]; Guo TR, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00413; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hilgen G, 2017, CELL REP, V18, P2521, DOI 10.1016/j.celrep.2017.02.038; Humayun MS, 2003, VISION RES, V43, P2573, DOI 10.1016/S0042-6989(03)00457-7; Jalligampala A, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/14/2/026004; Jiang QJ, 2018, IEEE T NEUR SYS REH, V26, P969, DOI 10.1109/TNSRE.2018.2821194; Kevric J, 2017, BIOMED SIGNAL PROCES, V31, P398, DOI 10.1016/j.bspc.2016.09.007; Lefebvre Baptiste, 2016, J Physiol Paris, V110, P327, DOI 10.1016/j.jphysparis.2017.02.005; Lieb F, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa654b; Lu YJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236176; Luo YHL, 2016, PROG RETIN EYE RES, V50, P89, DOI 10.1016/j.preteyeres.2015.09.003; Mathieson K, 2012, NAT PHOTONICS, V6, P391, DOI [10.1038/NPHOTON.2012.104, 10.1038/nphoton.2012.104]; Meiseles A, 2020, IEEE ACCESS, V8, P6190, DOI 10.1109/ACCESS.2019.2963742; Pachitariu M., 2016, BIORXIV, DOI [10.1101/061481, DOI 10.1101/061481]; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Raz-Prag D, 2017, J NEUROSCI METH, V291, P20, DOI 10.1016/j.jneumeth.2017.07.028; Rountree CM, 2018, IEEE T NEUR SYS REH, V26, P1075, DOI 10.1109/TNSRE.2018.2822322; Santos A, 1997, ARCH OPHTHALMOL-CHIC, V115, P511, DOI 10.1001/archopht.1997.01100150513011; Sekhar S, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/4/046004; Shalchyan V, 2012, IEEE T BIO-MED ENG, V59, P2576, DOI 10.1109/TBME.2012.2204991; Sinaga KP, 2020, IEEE ACCESS, V8, P80716, DOI 10.1109/ACCESS.2020.2988796; Tochitsky I, 2018, CHEM REV, V118, P10748, DOI 10.1021/acs.chemrev.7b00723; Valencia D, 2019, IEEE T BIOMED CIRC S, V13, P481, DOI 10.1109/TBCAS.2019.2907882; Walston ST, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aab4ed; Weiland JD, 2016, ANNU REV VIS SCI, V2, P273, DOI 10.1146/annurev-vision-111815-114425; Xiang ZQ, 2018, NEUROPHARMACOLOGY, V139, P137, DOI 10.1016/j.neuropharm.2018.06.027; Yang JW, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082957; Yang YN, 2017, IEEE T BIO-MED ENG, V64, P826, DOI 10.1109/TBME.2016.2580319; Yger P, 2018, ELIFE, V7, DOI 10.7554/eLife.34518; Yu YY, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19081825; Yue L, 2016, PROG RETIN EYE RES, V53, P21, DOI 10.1016/j.preteyeres.2016.05.002; Zeng Q, 2019, MICROMACHINES-BASEL, V10, DOI 10.3390/mi10060419; Zhang Y, 2017, NEURAL PROCESS LETT, V45, P365, DOI 10.1007/s11063-016-9530-1; Zrenner E, 2002, SCIENCE, V295, P1022, DOI 10.1126/science.1067996	41	2	2	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0246547	10.1371/journal.pone.0246547	http://dx.doi.org/10.1371/journal.pone.0246547			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705406	gold, Green Published			2022-12-26	WOS:000629590400019
J	Barragan, RC; Oliveira, N; Khalvati, K; Brooks, R; Reinecke, K; Rao, RPN; Meltzoff, AN				Barragan, Rodolfo C.; Oliveira, Nigini; Khalvati, Koosha; Brooks, Rechele; Reinecke, Katharina; Rao, Rajesh P. N.; Meltzoff, Andrew N.			Identifying with all humanity predicts cooperative health behaviors and helpful responding during COVID-19	PLOS ONE			English	Article							IDENTIFICATION; PROSOCIALITY; PERSONALITY	In the ongoing COVID-19 pandemic, public health experts have produced guidelines to limit the spread of the coronavirus, but individuals do not always comply with experts' recommendations. Here, we tested whether a specific psychological belief-identification with all humanity-predicts cooperation with public health guidelines as well as helpful behavior during the COVID-19 pandemic. We hypothesized that peoples' endorsement of this belief-their relative perception of a connection and moral commitment to other humans-would predict their tendencies to adopt World Health Organization (WHO) guidelines and to help others. To assess this, we conducted a global online study (N = 2537 participants) of four WHO-recommended health behaviors and four pandemic-related moral dilemmas that we constructed to be relevant to helping others at a potential cost to oneself. We used generalized linear mixed models (GLMM) that included 10 predictor variables (demographic, contextual, and psychological) for each of five outcome measures (a WHO cooperative health behavior score, plus responses to each of our four moral, helping dilemmas). Identification with all humanity was the most consistent and consequential predictor of individuals' cooperative health behavior and helpful responding. Analyses showed that the identification with all humanity significantly predicted each of the five outcomes while controlling for the other variables (Prange < 10(-22) to < 0.009). The mean effect size of the identification with all humanity predictor on these outcomes was more than twice as large as the effect sizes of other predictors. Identification with all humanity is a psychological construct that, through targeted interventions, may help scientists and policymakers to better understand and promote cooperative health behavior and help-oriented concern for others during the current pandemic as well as in future humanitarian crises.	[Barragan, Rodolfo C.; Meltzoff, Andrew N.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Barragan, Rodolfo C.; Brooks, Rechele; Meltzoff, Andrew N.] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA; [Oliveira, Nigini; Khalvati, Koosha; Reinecke, Katharina; Rao, Rajesh P. N.] Univ Washington, Paul G Allen Sch Comp Sci & Engn, Seattle, WA 98195 USA; [Rao, Rajesh P. N.] Univ Washington, Ctr Neurotechnol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Barragan, RC; Meltzoff, AN (corresponding author), Univ Washington, Dept Psychol, Seattle, WA 98195 USA.	barragan@uw.edu; meltzoff@uw.edu	Meltzoff, Andrew N/GPC-8807-2022; Brooks, Rechele/A-3089-2008	Meltzoff, Andrew N/0000-0001-8683-0547; Brooks, Rechele/0000-0002-3798-3448; Rao, Rajesh P. N./0000-0003-0682-8952	Templeton World Charity Foundation [TWCF0432]; National Institute of Mental Health [5R01MH112166]; National Science Foundation Broadening Participation Postdoctoral Research Award [1807789]	Templeton World Charity Foundation(Templeton World Charity Foundation); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation Broadening Participation Postdoctoral Research Award	The research was supported by the Templeton World Charity Foundation (https://www.templetonworldcharity.org/, Grant #TWCF0432 to R.P.N.R. and A.N.M.), National Institute of Mental Health (https://www.nimh.nih.gov/index.shtml, Grant #5R01MH112166 to R.P.N.R.), a National Science Foundation Broadening Participation Postdoctoral Research Award (https://www.nsf. gov/, Grant #1807789 to R.C.B. and A.N.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad E, 2018, NATURE, V563, P59, DOI 10.1038/s41586-018-0637-6; Barragan RC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58645-9; Belmi P, 2015, PERS SOC PSYCHOL B, V41, P467, DOI 10.1177/0146167215569493; Betsch C, 2020, P NATL ACAD SCI USA, V117, P21851, DOI 10.1073/pnas.2011674117; Brady ST, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay3689; Buckee CO, 2020, SCIENCE, V368, P145, DOI 10.1126/science.abb8021; Cannito L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73599-8; Capraro V, 2020, PRIMING REASONING IN; Christner N, 2022, J HEALTH PSYCHOL, V27, P1342, DOI 10.1177/1359105320980793; Cohn Samuel Kline, 2020, Med Confl Surviv, V36, P315, DOI 10.1080/13623699.2020.1820165; Dezecache G, 2020, CURR BIOL, V30, pR417, DOI 10.1016/j.cub.2020.04.010; Diebels KJ, 2019, J POSIT PSYCHOL, V14, P463, DOI 10.1080/17439760.2018.1484939; Dweck CS, 2017, PSYCHOL REV, V124, P689, DOI 10.1037/rev0000082; Epley N, 2014, J EXP PSYCHOL GEN, V143, P1980, DOI 10.1037/a0037323; Fiske SusanT., 1991, SOCIAL COGNITION 2; Galasso V, 2020, P NATL ACAD SCI USA, V117, P27285, DOI 10.1073/pnas.2012520117; Hamer K, 2019, PERS INDIV DIFFER, V141, P258, DOI 10.1016/j.paid.2018.12.019; Holman EA, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd5390; Keltner D, 2014, ANNU REV PSYCHOL, V65, P425, DOI 10.1146/annurev-psych-010213-115054; Lockhart M, 2020, P NATL ACAD SCI USA, V117, P24640, DOI 10.1073/pnas.2008023117; McFarland S, 2019, POLIT PSYCHOL, V40, P141, DOI 10.1111/pops.12572; McFarland S, 2013, CURR DIR PSYCHOL SCI, V22, P194, DOI 10.1177/0963721412471346; McFarland S, 2012, J PERS SOC PSYCHOL, V103, P830, DOI 10.1037/a0028724; Nowak B, 2020, PERS INDIV DIFFER, V167, DOI 10.1016/j.paid.2020.110232; Oliner SP, 1988, ALTRUISTIC PERSONALI, V1st, DOI [10.1161/01.cir.77.4.745 3258193, DOI 10.1161/01.CIR.77.4.7453258193]; Pfattheicher S, 2020, PSYCHOL SCI, V31, P1363, DOI 10.1177/0956797620964422; Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Reese G, 2015, EUR J SOC PSYCHOL, V45, P426, DOI 10.1002/ejsp.2102; Reinecke K, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW'15), P1364, DOI 10.1145/2675133.2675246; Rogers JP, 2020, LANCET PSYCHIAT, V7, P611, DOI 10.1016/S2215-0366(20)30203-0; RUSHTON JP, 1981, PERS INDIV DIFFER, V2, P293; Sinha S, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20209628; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Van Bavel JJ, 2020, RES SQUARE; Xie WZ, 2020, P NATL ACAD SCI USA, V117, P17667, DOI 10.1073/pnas.2008868117; Zaki J, 2020, TRENDS COGN SCI, V24, P587, DOI 10.1016/j.tics.2020.05.006; Zmigrod L, 2018, P NATL ACAD SCI USA, V115, pE4532, DOI 10.1073/pnas.1708960115	38	15	15	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0248234	10.1371/journal.pone.0248234	http://dx.doi.org/10.1371/journal.pone.0248234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QV3DA	33690679	Green Published, gold			2022-12-26	WOS:000627854700008
J	Martinez, AL; Brea, J; Barro, M; Monroy, X; Merlos, M; Burgueno, J; Loza, MI				Martinez, Anton L.; Brea, Jose; Barro, Mateo; Monroy, Xavier; Merlos, Manuel; Burgueno, Javier; Isabel Loza, Maria			Development of a novel in vitro assay to screen for neuroprotective drugs against iatrogenic neurite shortening	PLOS ONE			English	Article							PERIPHERAL NEUROPATHY; LIPOIC ACID; MECHANISMS; RECEPTOR; VINCRISTINE; RILPIVIRINE; PACLITAXEL; RELEASE; NEURONS	This work tries to help overcome the lack of relevant translational screening assays, as a limitation for the identification of novel analgesics for neuropathic pain. Hyperexcitability and neurite shortening are common adverse effects of antiviral and antitumor drugs, leading to neuropathic pain. Now, as seen in the drug screening that we developed here, a high-content microscopy-based assay with immortalized dorsal root ganglia (DRG) neurons (differentiated F11 cells) allowed to identify drugs able to protect against the iatrogenic neurite shortening induced by the antitumor drug vincristine and the antiviral drug rilpivirine. We observed that vincristine and rilpivirine induced a significant reduction in the neurite length, which was reverted by alpha-lipoic acid. We had also evidenced protective effects of pregabalin and melatonin, acting through the alpha(2)delta-2 subunit of the voltage-dependent calcium channels and the MT1 receptor, respectively. Additionally, two hits originated from a previous primary screening aimed to detect inhibitors of hyperexcitability to inflammatory mediators in DRG neurons (nitrendipine and felodipine) also prevented neurite shortening in our model. In summary, in this work we developed a novel secondary assay for identifying hits with neuroprotective effect against iatrogenic neurite shortening, consistent with the anti-hyperexcitability action previously tested: highlighting nitrendipine and felodipine against iatrogenic damage in DRG neurons.	[Martinez, Anton L.; Brea, Jose; Barro, Mateo; Isabel Loza, Maria] Univ Santiago de Compostela, BioFarma Res Grp, Ctr Singular Invest Med Mol & Enfermedades Cron C, Santiago De Compostela, Spain; [Monroy, Xavier; Merlos, Manuel; Burgueno, Javier] WeLab Barcelona, Barcelona, Spain	Universidade de Santiago de Compostela	Loza, MI (corresponding author), Univ Santiago de Compostela, BioFarma Res Grp, Ctr Singular Invest Med Mol & Enfermedades Cron C, Santiago De Compostela, Spain.; Burgueno, J (corresponding author), WeLab Barcelona, Barcelona, Spain.	jburgueno@welab.barcelona; mabel.loza@usc.es	Martínez-Rodríguez, Antón Leandro/ABE-4141-2020	Martínez-Rodríguez, Antón Leandro/0000-0002-1595-3459; Loza Garcia, Maria Isabel/0000-0003-4730-0863; Merlos, Manuel/0000-0002-8423-3033	Joint R&D Unit Esteve-USC [IN853A-2017/6]; Galician Innovation Agency; Spanish Ministry of Economy and Competitiveness (MINECO); Phenopain project of the RETOSCOLABORACION program of the MINECO [RTC-2015-4207-1]; European Union through the European Regional Development Fund (ERDF)	Joint R&D Unit Esteve-USC; Galician Innovation Agency; Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Phenopain project of the RETOSCOLABORACION program of the MINECO; European Union through the European Regional Development Fund (ERDF)	This work was supported by the Joint R&D Unit Esteve-USC (IN853A-2017/6), co-funded by the Galician Innovation Agency and the Spanish Ministry of Economy and Competitiveness (MINECO) within the framework of the Spanish Strategy of Innovation in Galicia; by the Phenopain project (RTC-2015-4207-1) of the RETOSCOLABORACION program of the MINECO. This work was also co-funded by the European Union through the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. WeLab Barcelona provided support in the form of salaries for XM, MM and JAB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Ambrosino P, 2014, PHARMACOL RES, V87, P113, DOI 10.1016/j.phrs.2014.06.015; Bansode SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105196; Baron R, 2010, LANCET NEUROL, V9, P807, DOI 10.1016/S1474-4422(10)70143-5; Blas-Garcia A, 2014, J ANTIMICROB CHEMOTH, V69, P2995, DOI 10.1093/jac/dku262; Boateng EK, 2015, EUR J PAIN, V19, P236, DOI 10.1002/ejp.541; Broyl A, 2010, LANCET ONCOL, V11, P1057, DOI 10.1016/S1470-2045(10)70206-0; Callejo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064471; CHANTAL T, 1986, PHARMACOL RES, V18, P519, DOI 10.1016/0031-6989(86)90147-5; Chen LH, 2015, MOL CANCER THER, V14, P2206, DOI 10.1158/1535-7163.MCT-15-0268; Chew ML, 2014, CLIN DRUG INVEST, V34, P627, DOI 10.1007/s40261-014-0221-2; Desideri I, 2017, MED ONCOL, V34, DOI 10.1007/s12032-017-0907-4; Diaz-Delfin J, 2012, ANTIMICROB AGENTS CH, V56, P3369, DOI 10.1128/AAC.00104-12; Doran C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128670; Finnerup NB, 2015, LANCET NEUROL, V14, P162, DOI 10.1016/S1474-4422(14)70251-0; Fukuda Y, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00481; Galley HF, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12444; Gbahou F, 2017, BRIT J PHARMACOL, V174, P2409, DOI 10.1111/bph.13856; Hao SL, 2013, CURR NEUROPHARMACOL, V11, P499, DOI 10.2174/1570159X11311050005; Hinckley S, 2016, C RETR OPP INF BOST; Huang BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091167; Jensen TS, 2014, LANCET NEUROL, V13, P924, DOI 10.1016/S1474-4422(14)70102-4; Kaley TJ, 2009, BRIT J HAEMATOL, V145, P3, DOI 10.1111/j.1365-2141.2008.07558.x; Kaneko Y, 2011, J PINEAL RES, V50, P272, DOI 10.1111/j.1600-079X.2010.00837.x; Kaur G, 2010, J BRACHIAL PLEX PERI, V5, DOI 10.1186/1749-7221-5-3; Krukowski K, 2015, PAIN, V156, P2184, DOI 10.1097/j.pain.0000000000000290; LaPointe NE, 2013, NEUROTOXICOLOGY, V37, P231, DOI 10.1016/j.neuro.2013.05.008; Laura B, 2017, ONCOTARGET, V8, P23188, DOI 10.18632/oncotarget.15533; Li Z, 2011, EUR J PHARMACOL, V667, P80, DOI 10.1016/j.ejphar.2011.05.054; Liu HW, 2018, P NATL ACAD SCI USA, V115, P10654, DOI 10.1073/pnas.1809392115; Martinez AL, 2019, SLAS DISCOV, V24, P158, DOI 10.1177/2472555218810323; Melli G, 2008, EXP NEUROL, V214, P276, DOI 10.1016/j.expneurol.2008.08.013; PALMERO M, 1995, BIOCHEM PHARMACOL, V50, P879, DOI 10.1016/0006-2952(95)00194-5; Patel R, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.205; Robinson B, 2007, J NEUROVIROL, V13, P160, DOI 10.1080/13550280701200102; Sams-Dodd F, 2005, DRUG DISCOV TODAY, V10, P139, DOI 10.1016/S1359-6446(04)03316-1; Sudoh Y, 2003, PAIN, V103, P49, DOI 10.1016/S0304-3959(02)00375-5; Tedeschi A, 2016, NEURON, V92, P419, DOI 10.1016/j.neuron.2016.09.026; UCEDA G, 1995, EUR J PHARM-MOLEC PH, V289, P73, DOI 10.1016/0922-4106(95)90170-1; Vetter I, 2010, BIOCHEM PHARMACOL, V79, P908, DOI 10.1016/j.bcp.2009.10.020; Warchal SJ, 2016, FUTURE MED CHEM, V8, P1331, DOI 10.4155/fmc-2016-0025; Yadav V, 2010, MULT SCLER J, V16, P387, DOI 10.1177/1352458509359722; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6	42	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0248139	10.1371/journal.pone.0248139	http://dx.doi.org/10.1371/journal.pone.0248139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690613	Green Published, gold			2022-12-26	WOS:000627854700046
J	Anttila, MR; Soderlund, A; Sjogren, T				Anttila, Marjo-Riitta; Soderlund, Anne; Sjogren, Tuulikki			Patients' experiences of the complex trust-building process within digital cardiac rehabilitation	PLOS ONE			English	Article							LIFE; SUPPORT; DISEASE; CARE	The development of digital solutions is becoming increasingly important in facing global challenges. Therefore, research on this topic is important in taking into account cardiac patients' experiences of the rehabilitation process for the design of digital counseling solutions. The aim of the present qualitative study was to explore the different meanings that patients give to the rehabilitation process using a Glaserian grounded theory (GT) approach. Qualitative interviews were conducted with 30 participants from a rehabilitation center in Finland. The findings indicated a "complex trust-building process" core category comprising five categories of trust-building in rehabilitation: feeling that one has hit rock bottom, facing and coping in a crosscurrent, understanding together as a peer group, moving toward a healthier lifestyle with technology, and finding self-awareness. The complex process of trust-building involved interactions among emotion, cognition, and acceptance and support processes. Therefore, digital rehabilitation should be incorporated into counseling based on patients' psychosocial, physical and emotional needs to help patients become aware of their own feelings and thoughts during the rehabilitation process.	[Anttila, Marjo-Riitta; Sjogren, Tuulikki] Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland; [Soderlund, Anne] Malardalen Univ, Sch Hlth Care & Social Welf, Vasteras, Sweden	University of Jyvaskyla; Malardalen University	Anttila, MR (corresponding author), Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland.	marjo-riitta.m-r.anttila@jyu.fi		Anttila, Marjo-Riitta/0000-0002-6950-4261; Soderlund, Anne/0000-0002-4537-030X	University of Jyvaskyla; Social insurance institution of Finland (Kela)	University of Jyvaskyla; Social insurance institution of Finland (Kela)	University of Jyvaskyla and Social insurance institution of Finland (Kela) The University of Jyvaskyla is employer by researchers, Tuulikki Sjogren and Marjo-Riitta Anttila (salary). The authors received no specific funding for this work (article). The funders (Kela) had no role (no salary) in decision to publish, or preparation of the manuscript by any authors.	Anttila MR, 2019, J MED INTERNET RES, V21, DOI 10.2196/10985; BANDURA A, 1989, AM PSYCHOL, V44, P1175, DOI 10.1037/0003-066X.44.9.1175; Banner D, 2015, STUD HEALTH TECHNOL, V209, P9, DOI 10.3233/978-1-61499-505-0-9; BECK AT, 1970, BEHAV THER, V1, P184, DOI 10.1016/S0005-7894(70)80030-2; Buys R, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0329-9; Clark RA, 2015, EUR J PREV CARDIOL, V22, P35, DOI 10.1177/2047487313501093; Comer J. S., 2013, BERGIN GARFIELDS HDB, Vsixth, P21; Devi R, 2014, INT J THER REHABIL, V21, P434, DOI 10.12968/ijtr.2014.21.9.434; Ellis JM, 2019, J CARDIOPULM REHABIL, V39, pE13, DOI 10.1097/HCR.0000000000000429; Embuldeniya G, 2013, PATIENT EDUC COUNS, V92, P3, DOI 10.1016/j.pec.2013.02.002; Gallo LC, 2005, J BEHAV MED, V28, P433, DOI 10.1007/s10865-005-9010-y; Glaser B., 1992, BASICS GROUNDED THEO; Glaser B.G., 1968, DISCOV GROUNDED THEO; Hamalainen H, 2000, SCAND J PUBLIC HEALT, V28, P62, DOI 10.1177/140349480002800111; Hansen TB, 2018, EUR J CARDIOVASC NUR, V17, P45, DOI 10.1177/1474515117716245; Hare DL, 2014, EUR HEART J, V35, P1365, DOI 10.1093/eurheartj/eht462; Hellem E, 2020, PHYSIOTHER THEOR PR, V36, P1107, DOI 10.1080/09593985.2018.1550829; Jbilou J, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029560; Jokar F, 2017, J NURS RES, V25, P344, DOI [10.1097/jnr.0000000000000220, 10.1097/JNR.0000000000000220]; Kazantzis N, 2018, COGNITIVE THER RES, V42, P349, DOI 10.1007/s10608-018-9920-y; Knudsen MV, 2020, EUR J CARDIOVASC NUR, V19, P376, DOI 10.1177/1474515119885325; Lazarus R.S., 1984, EMOTION ADAPTATION; Livneh H, 2005, J COUNS DEV, V83, P12, DOI 10.1002/j.1556-6678.2005.tb00575.x; Melholt C, 2018, PATIENT EDUC COUNS, V101, P854, DOI 10.1016/j.pec.2017.12.017; Moos RH, 2003, J CLIN PSYCHOL, V59, P1387, DOI 10.1002/jclp.10229; Park C.L., 1997, REV GEN PSYCHOL, V1, P115, DOI [10.1037/1089-2680.1.2.115, DOI 10.1037/1089-2680.1.2.115, 10.1037//1089-2680.1.2.115, DOI 10.1037//1089-2680.1.2.115]; Partridge SR, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.8081; Pfaeffli L., 2013, HEART LUNG CIRC, V22, P567, DOI [10.1016/j.hlc.2013.04.048, DOI 10.1016/J.HLC.2013.04.048]; Rawstorn JC, 2018, ARCH PHYS MED REHAB, V99, P2373, DOI 10.1016/j.apmr.2018.06.027; Richards SH, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002902.pub4; Roy S.C., 1999, ROY ADAPTATION MODEL; Schaufel MA, 2011, INT J QUAL STUD HEAL, V6, DOI 10.3402/qhw.v6i1.5917; Schweier R, 2018, PATIENT EDUC COUNS, V101, P1283, DOI 10.1016/j.pec.2018.02.015; Smart JF, 2009, J REHABIL, V75, P3; Steinhubl SR, 2015, J AM COLL CARDIOL, V66, P1489, DOI 10.1016/j.jacc.2015.08.006; STRUTZEL E, 1968, NURS RES, V17, P364; Webb TL, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1376; Wentzer HS, 2013, INT J MED INFORM, V82, pE386, DOI 10.1016/j.ijmedinf.2013.01.008; Yates BC, 2018, J CARDIOPULM REHABIL, V38, pE6, DOI 10.1097/HCR.0000000000000317; Yehle KS, 2012, J CARDIOPULM REHABIL, V32, P203, DOI 10.1097/HCR.0b013e31825b4e6a	40	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2021	16	3							e0247982	10.1371/journal.pone.0247982	http://dx.doi.org/10.1371/journal.pone.0247982			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QV3DJ	33690681	Green Published, gold			2022-12-26	WOS:000627855600009
J	Baggett, JP; Tillett, RL; Cooper, EA; Yerka, MK				Baggett, John P.; Tillett, Richard L.; Cooper, Elizabeth A.; Yerka, Melinda K.			De novo identification and targeted sequencing of SSRs efficiently fingerprints Sorghum bicolor sub-population identity	PLOS ONE			English	Article							GENETIC DIVERSITY; GRAIN-SORGHUM; L. MOENCH; REPEATS SSRS; LINKAGE-MAP; GENOME; YIELD; PREDICTION; MARKERS; TRAITS	Recent plant breeding studies of several species have demonstrated the utility of combining molecular assessments of genetic distance into trait-linked SNP genotyping during the development of parent lines to maximize yield gains due to heterosis. SSRs (Short Sequence Repeats) are the molecular marker of choice to determine genetic diversity, but the methods historically used to sequence them have been burdensome. The ability to analyze SSRs in a higher-throughput manner independent of laboratory conditions would increase their utility in molecular ecology, germplasm curation, and plant breeding programs worldwide. This project reports simple bioinformatics methods that can be used to generate genome-wide de novo SSRs in silico followed by targeted Next Generation Sequencing (NGS) validation of those that provide the most information about sub-population identity of a breeding line, which influences heterotic group selection. While these methods were optimized in sorghum [Sorghum bicolor (L.) Moench], they were developed to be applied to any species with a reference genome and high-coverage whole-genome sequencing data of individuals from the sub-populations to be characterized. An analysis of published sorghum genomes selected to represent its five main races (bicolor, caudatum, durra, kafir, and guinea; 75 accessions total) identified 130,120 SSR motifs. Average lengths were 23.8 bp and 95% were between 10 and 92 bp, making them suitable for NGS. Validation through targeted sequencing amplified 188 of 192 assayed SSR loci. Results highlighted the distinctness of accessions from the guinea sub-group margaritiferum from all other sorghum accessions, consistent with previous studies of nuclear and mitochondrial DNA. SSRs that efficiently fingerprinted margaritiferum individuals (Xgma1-Xgma6) are presented. Developing similar fingerprints of other sub-populations (Xunr1-Xunr182) was not possible due to the extensive admixture between them in the data set analyzed. In summary, these methods were able to fingerprint specific sub-populations when rates of admixture between them are low.	[Baggett, John P.] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Tillett, Richard L.] Univ Nevada, Nevada Ctr Bioinformat, Reno, NV 89557 USA; [Cooper, Elizabeth A.] Univ North Carolina Charlotte, Dept Bioinformat & Genom, Charlotte, NC USA; [Yerka, Melinda K.] Univ Nevada, Dept Agr Vet & Rangeland Sci, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of North Carolina; University of North Carolina Charlotte; Nevada System of Higher Education (NSHE); University of Nevada Reno	Yerka, MK (corresponding author), Univ Nevada, Dept Agr Vet & Rangeland Sci, Reno, NV 89557 USA.	myerka@unr.edu		Baggett, John/0000-0002-4398-4236	United States Department of Agriculture National Institute of Food and Agriculture [2019-67014-29174, 2017-33522-27086]; University of Nevada, Reno; National Institute of General Medical Sciences from the National Institutes of Health [GM103440]	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); University of Nevada, Reno; National Institute of General Medical Sciences from the National Institutes of Health(General Electric)	The authors would like to acknowledge the funding sources used in this project: United States Department of Agriculture National Institute of Food and Agriculture (https://nifa.usda.gov/) (Award Number 2019-67014-29174 [MYK]; Award Number 2017-33522-27086 [MYK]) and University of Nevada, Reno (https://www.unr.edu/) new faculty startup funding [MYK]. This publication was also made possible by a grant from the National Institute of General Medical Sciences (https://www.nigms.nih.gov/) (GM103440 [MYK]) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amelework B, 2017, PLANT GENET RESOUR-C, V15, P335, DOI [10.1017/S1479262115000696, 10.1017/s1479262115000696]; [Anonymous], 2018, GERMPLASM RESOURCES; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Bhargava A, 2010, MOL BIOTECHNOL, V44, P250, DOI 10.1007/s12033-009-9230-4; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brown SM, 1996, THEOR APPL GENET, V93, P190, DOI 10.1007/BF00225745; Caniato FF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020830; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Crozier D, J CROP IMPROV, V19; deOliveira AC, 1996, GENOME, V39, P579, DOI 10.1139/g96-073; Deu M, 2006, GENOME, V49, P168, DOI 10.1139/G05-092; DEU M, 1995, GENOME, V38, P635, DOI 10.1139/g95-081; Dusa A., 2018, VENN DRAW VENN DIAGR; Evans J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079192; Folkertsma RT, 2005, THEOR APPL GENET, V111, P399, DOI 10.1007/s00122-005-1949-0; Ginestet C, 2011, J R STAT SOC A STAT, V174, P245, DOI 10.1111/j.1467-985X.2010.00676_9.x; Griess JK, 2010, CROP SCI, V50, P1480, DOI 10.2135/cropsci2009.08.0463; Guo L, 2020, ECOL EVOL, V10, P3055, DOI 10.1002/ece3.6121; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; HARLAN JR, 1972, CROP SCI, V12, P172, DOI 10.2135/cropsci1972.0011183X001200020005x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; Jordan DR, 2003, THEOR APPL GENET, V106, P559, DOI 10.1007/s00122-002-1144-5; Kong L, 2000, THEOR APPL GENET, V101, P438, DOI 10.1007/s001220051501; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx093; Li ML, 2009, MOL BREEDING, V24, P41, DOI 10.1007/s11032-009-9270-2; Li TT, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5800-4; Mace ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3320; Massel K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01544; Maulana F, 2013, CROP SCI, V53, P564, DOI 10.2135/cropsci2011.12.0649; McCormick RF, 2018, PLANT J, V93, P338, DOI 10.1111/tpj.13781; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mesak F, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00074; Mindaye TT, 2016, CROP J, V4, P479, DOI 10.1016/j.cj.2016.06.020; Morris GP, 2013, P NATL ACAD SCI USA, V110, P453, DOI 10.1073/pnas.1215985110; Orostica KY, 2016, BIOINFORMATICS, V32, P2366, DOI 10.1093/bioinformatics/btw137; Ott A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022306; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Paterson Andrew H, 2008, Int J Plant Genomics, V2008, P362451, DOI 10.1155/2008/362451; Prasad PVV, 2008, CROP SCI, V48, P1911, DOI 10.2135/cropsci2008.01.0036; Prasad PVV, 2006, AGR FOREST METEOROL, V139, P237, DOI 10.1016/j.agrformet.2006.07.003; R Core Team, 2020, R LANG ENV STAT COMP; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; Ramu P, 2013, THEOR APPL GENET, V126, P2051, DOI 10.1007/s00122-013-2117-6; Ramu P, 2009, THEOR APPL GENET, V119, P1193, DOI 10.1007/s00122-009-1120-4; Rhodes DH, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3403-x; RStudio Team, 2016, RSTUDIO INTEGRATED D; Sagnard F, 2011, THEOR APPL GENET, V123, P1231, DOI 10.1007/s00122-011-1662-0; Saintenac C, 2009, GENETICS, V181, P393, DOI 10.1534/genetics.108.097469; Sapkota S, 2020, CROP SCI, V60, P132; Schloss SJ, 2002, THEOR APPL GENET, V105, P912, DOI 10.1007/s00122-002-0991-4; Smith JSC, 1997, THEOR APPL GENET, V95, P163, DOI 10.1007/s001220050544; Srinivas G, 2008, THEOR APPL GENET, V117, P283, DOI 10.1007/s00122-008-0773-8; Srinivas G, 2009, THEOR APPL GENET, V118, P703, DOI 10.1007/s00122-008-0931-z; Tao YF, 2020, PLANT BIOTECHNOL J, V18, P1093, DOI 10.1111/pbi.13284; Taramino G, 1997, THEOR APPL GENET, V95, P66, DOI 10.1007/s001220050533; Tomkowiak A, 2019, LECTION PARENTAL MAT, P15; Manechini JRV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195623; Weber-Lehmann J, 2014, FORENSIC SCI INT-GEN, V9, P42, DOI 10.1016/j.fsigen.2013.10.015; WENDORF F, 1992, NATURE, V359, P721, DOI 10.1038/359721a0; Willems T, 2017, NAT METHODS, V14, P590, DOI [10.1038/NMETH.4267, 10.1038/nmeth.4267]; Yang JJ, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00531; Zhang D, 2015, G3-GENES GENOM GENET, V5, P1117, DOI 10.1534/g3.115.017590; Zhang LY, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-42; Zheng LY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r114	67	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0248213	10.1371/journal.pone.0248213	http://dx.doi.org/10.1371/journal.pone.0248213			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU3OZ	33684158	Green Published, gold			2022-12-26	WOS:000627193500032
J	Ali, MM; Di Marco, M; Mahale, S; Jachimowicz, D; Kosalai, ST; Reischl, S; Statello, L; Mishra, K; Darnfors, C; Kanduri, M; Kanduri, C				Ali, Mohamad Moustafa; Di Marco, Mirco; Mahale, Sagar; Jachimowicz, Daniel; Kosalai, Subazini Thankaswamy; Reischl, Silke; Statello, Luisa; Mishra, Kankadeb; Darnfors, Catarina; Kanduri, Meena; Kanduri, Chandrasekhar			LY6K-AS lncRNA is a lung adenocarcinoma prognostic biomarker and regulator of mitotic progression	ONCOGENE			English	Article							LONG NONCODING RNAS; 14-3-3 PROTEINS; GENE-EXPRESSION; HISTONE CODE; ORGANIZATION; PROTEOLYSIS; MECHANISMS; RESISTANCE; LANDSCAPE; IMPACT	Recent advances in genomics unraveled several actionable mutational drivers in lung cancer, leading to promising therapies such as tyrosine kinase inhibitors and immune checkpoint inhibitors. However, the tumors' acquired resistance to the newly-developed as well as existing therapies restricts life quality improvements. Therefore, we investigated the noncoding portion of the human transcriptome in search of alternative actionable targets. We identified an antisense transcript, LY6K-AS, with elevated expression in lung adenocarcinoma (LUAD) patients, and its higher expression in LUAD patients predicts poor survival outcomes. LY6K-AS abrogation interfered with the mitotic progression of lung cancer cells resulting in unfaithful chromosomal segregation. LY6K-AS interacts with and stabilizes 14-3-3 proteins to regulate the transcription of kinetochore and mitotic checkpoint proteins. We also show that LY6K-AS regulates the levels of histone H3 lysine 4 trimethylation (H3K4me3) at the promoters of kinetochore members. Cisplatin treatment and LY6K-AS silencing affect many common pathways enriched in cell cycle-related functions. LY6K-AS silencing affects the growth of xenografts derived from wildtype and cisplatin-resistant lung cancer cells. Collectively, these data indicate that LY6K-AS silencing is a promising therapeutic option for LUAD that inhibits oncogenic mitotic progression.	[Ali, Mohamad Moustafa; Di Marco, Mirco; Mahale, Sagar; Jachimowicz, Daniel; Kosalai, Subazini Thankaswamy; Reischl, Silke; Statello, Luisa; Mishra, Kankadeb; Kanduri, Chandrasekhar] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden; [Darnfors, Catarina] Sahlgrens Univ Hosp, Dept Clin Pathol & Genet, Gothenburg, Sweden; [Kanduri, Meena] Sahlgrens Univ Hosp, Dept Clin Chem & Transfus Med, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital; Sahlgrenska University Hospital	Kanduri, C (corresponding author), Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.	kanduri.chandrasekhar@gu.se	Statello, Luisa/AAU-5115-2021; Ali, Mohamad Moustafa/ABF-5464-2020	Statello, Luisa/0000-0001-8261-4214; Ali, Mohamad Moustafa/0000-0002-4902-0550; Di Marco, Amerigo Mirco/0000-0001-8890-233X; Reischl, Silke/0000-0003-4822-4137; Kanduri, Chandrasekhar/0000-0001-6271-9078	Knut and Alice Wallenberg Foundation [KAW2014.0057]; Swedish Foundation for Strategic Research [RB13-0204]; Swedish Cancer Research foundation [Cancerfonden] [CAN2018/591]; Swedish Research Council [2017-02834]; Barncancerfonden [PR2018-0090]; Ingabritt Och Arne Lundbergs forskningsstiftelse; LUA/ ALF	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Cancer Research foundation [Cancerfonden](Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Barncancerfonden; Ingabritt Och Arne Lundbergs forskningsstiftelse; LUA/ ALF	This work was supported by the grants from Knut and Alice Wallenberg Foundation [KAW2014.0057]; Swedish Foundation for Strategic Research [RB13-0204]; Swedish Cancer Research foundation [Cancerfonden: Kontrakt no. CAN2018/591]; Swedish Research Council [2017-02834]; Barncancerfonden [PR2018-0090]; Ingabritt Och Arne Lundbergs forskningsstiftelse and LUA/ ALF (to CK). The Proteomics Core Facility at Gothenburg University, performed the analysis for protein identification. We acknowledge the Centre for Cellular Imaging at the University of Gothenburg for assisting in microscopy.	Akhade VS, 2017, ADV EXP MED BIOL, V1008, P47, DOI 10.1007/978-981-10-5203-3_2; Ali M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04082-2; Balbin OA, 2015, GENOME RES, V25, P1068, DOI 10.1101/gr.180596.114; Bose A, 2019, J BIOSCIENCES, V44, DOI 10.1007/s12038-019-9867-5; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen DY, 2015, INT J ONCOL, V46, P818, DOI 10.3892/ijo.2014.2740; de Groot PM, 2018, TRANSL LUNG CANCER R, V7, P220, DOI 10.21037/tlcr.2018.05.06; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominguez-Brauer C, 2015, MOL CELL, V60, P524, DOI 10.1016/j.molcel.2015.11.006; Galluzzi L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.428; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Giannakakou P, 2001, ONCOGENE, V20, P3806, DOI 10.1038/sj.onc.1204487; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hirsch FR, 2017, LANCET, V389, P299, DOI 10.1016/S0140-6736(16)30958-8; Holland AJ, 2012, EMBO REP, V13, P501, DOI 10.1038/embor.2012.55; Hosing AS, 2008, CELL CYCLE, V7, P3171, DOI 10.4161/cc.7.20.6812; Isaka T, 2003, J HISTOCHEM CYTOCHEM, V51, P1343, DOI 10.1177/002215540305101011; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Kasahara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2879; Kasahara K, 2010, EMBO J, V29, P2802, DOI 10.1038/emboj.2010.157; Kornienko AE, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0873-8; Lara-Gonzalez P, 2019, DEV CELL, V51, P313, DOI 10.1016/j.devcel.2019.09.005; Lassmann T, 2011, BIOINFORMATICS, V27, P130, DOI 10.1093/bioinformatics/btq614; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lischetti T, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014.970484; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Mahale S, 2016, SCI REP-UK, V6, DOI 10.1038/s41598-016-0030-3; Marchese FP, 2016, MOL CELL, V63, P397, DOI 10.1016/j.molcel.2016.06.031; Montes M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7967; NISHIMURA K, 2019, NAT COMMUN, V10; Nowicki TS, 2018, CANCER J, V24, P47, DOI 10.1097/PPO.0000000000000303; Ohhata T, 2011, GENE DEV, V25, P1702, DOI 10.1101/gad.16997911; Ooi AT, 2014, CANCER PREV RES, V7, P487, DOI 10.1158/1940-6207.CAPR-13-0372; Pandey GK, 2014, CANCER CELL, V26, P722, DOI 10.1016/j.ccell.2014.09.014; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Qi WQ, 2005, INT J CANCER, V113, P359, DOI 10.1002/ijc.20492; Raungrut P, 2014, ASIAN PAC J CANCER P, V15, P3513, DOI 10.7314/APJCP.2014.15.8.3513; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roeten MSF, 2018, CANCER CHEMOTH PHARM, V81, P227, DOI 10.1007/s00280-017-3489-0; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Siemeister G, 2019, CLIN CANCER RES, V25, P1404, DOI 10.1158/1078-0432.CCR-18-0628; Subhash S, 2018, NUCLEIC ACIDS RES, V46, P9384, DOI 10.1093/nar/gky635; Subhash S, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1250-z; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Uetake Y, 2010, CURR BIOL, V20, P1666, DOI 10.1016/j.cub.2010.08.018; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Vedadi M, 2017, PROTEIN SCI, V26, P662, DOI 10.1002/pro.3129; White NM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0429-8; Winter S, 2008, EMBO J, V27, P88, DOI 10.1038/sj.emboj.7601954; Wu H, 2017, TRENDS GENET, V33, P540, DOI 10.1016/j.tig.2017.05.004; Wu SG, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0777-1; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	57	5	5	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 1	2021	40	13					2463	2478		10.1038/s41388-021-01696-7	http://dx.doi.org/10.1038/s41388-021-01696-7		MAR 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RH1BQ	33674747				2022-12-26	WOS:000625607100003
J	Wu, YT; Huang, WY; Kor, CT; Liu, KH; Chen, TY; Lin, PT; Wu, HM				Wu, Yu-Ting; Huang, Wan-Yu; Kor, Chew-Teng; Liu, Ko-Hung; Chen, Ting-Yu; Lin, Po-Te; Wu, Hung-Ming			Relationships between depression and anxiety symptoms and adipocyte-derived proteins in postmenopausal women	PLOS ONE			English	Article								Introduction Studies on the association between adiponectin and leptin and anxiety and depression among postmenopausal women are limited. Therefore, the present study specifically evaluates the mutual relationships between adiponectin and leptin and anxiety and depression in postmenopausal women. Participants and design In this cross-sectional study, a total of 190 women aged 40-65 years were enrolled. Depression symptoms were assessed using the Center for Epidemiologic Studies Depression Scale (CES-D), and anxiety symptoms were evaluated using the Hamilton Anxiety Rating Scale (HAM-A). Fasting specimens were collected to measure sex hormone, glucose, insulin, and adipokine levels. Multiple linear regression analysis was performed to evaluate the associations between depression and anxiety and adipocyte-derived hormones. Settings The study was performed in a hospital medical center. Results Among 190 enrolled postmenopausal women, Spearman's rank correlation analysis revealed significant correlations between CES-D and HAM-A (r = 0.715, P < 0.0001), between CES-D and adiponectin (p = 0.009) and leptin (p = 0.015), and between HAM-A and adiponectin (p = 0.01) and leptin (p = 0.001). The subjects with CES-D >= 16 and with HAM-A >= 18 had higher adiponectin levels than those with CES-D < 16 and HAM-A < 18, respectively. After adjusting for age, body mass index, exercise, alanine amino transferase and parameters of lipid profiles, Log adiponectin levels were found to be significantly associated with both CES-D and HAM-A, and Log leptin levels were only significantly associated with HAM-A. Conclusions The data show that adiponectin and leptin levels are significantly associated with depression and anxiety symptoms. These results suggest that higher adiponectin and lower leptin levels may serve as potential markers related to anxiety and mood in postmenopausal women. More future research that is designed to deal with the important confounders (e.g., population heterogeneity) is needed to investigate comprehensively on these associations.	[Wu, Yu-Ting] Changhua Christian Hosp, Ctr Mitochondria Med & Free Rad Res, Changhua, Taiwan; [Huang, Wan-Yu] Kung Ten Gen Hosp, Pediat, Taichung, Taiwan; [Kor, Chew-Teng] Changhua Christian Hosp, Internal Med Res Ctr, Changhua, Taiwan; [Liu, Ko-Hung; Chen, Ting-Yu; Lin, Po-Te; Wu, Hung-Ming] Changhua Christian Hosp, Inflammat Res & Drug Dev Ctr, Changhua, Taiwan; [Wu, Hung-Ming] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan; [Wu, Hung-Ming] China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan	Changhua Christian Hospital; Changhua Christian Hospital; Changhua Christian Hospital; Changhua Christian Hospital; China Medical University Taiwan	Wu, HM (corresponding author), Changhua Christian Hosp, Inflammat Res & Drug Dev Ctr, Changhua, Taiwan.; Wu, HM (corresponding author), Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan.; Wu, HM (corresponding author), China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan.	18288@cch.org.tw			Ministry of Science and Technology, Taiwan [MOST 108-2314-B-371-004-MY3]; Changhua Christian Hospital Research Foundation, Changhua City, Taiwan [107-CCH-NPI-052, 109-CCH-IRP-087]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Changhua Christian Hospital Research Foundation, Changhua City, Taiwan	This study was funded by a grant from the Ministry of Science and Technology, Taiwan (No. MOST 108-2314-B-371-004-MY3), and by grants from the Changhua Christian Hospital Research Foundation, Changhua City, Taiwan (No. 107-CCH-NPI-052, and No. 109-CCH-IRP-087). HMW was the receiver of these three grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam T, 2010, HORM BEHAV, V58, P699, DOI 10.1016/j.yhbeh.2010.05.006; Arvaniti VA, 2008, ACTA GASTRO-ENT BELG, V71, P355; Bandyopadhyay D, 2018, J LIPIDS, V2018, DOI 10.1155/2018/8598054; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Bloemer J, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/4593530; Bromberger JT, 2013, MENOPAUSE, V20, P488, DOI [10.1097/GME.0b013e3182730599, 10.1097/gme.0b013e3182730599]; Bromberger JT, 2003, AM J EPIDEMIOL, V158, P347, DOI 10.1093/aje/kwg155; Campbell Katherine E, 2015, Womens Midlife Health, V1, P3, DOI 10.1186/s40695-015-0003-x; Cao B, 2018, J AFFECT DISORDERS, V238, P101, DOI 10.1016/j.jad.2018.05.008; Carvalho AF, 2014, J PSYCHIATR RES, V59, P28, DOI 10.1016/j.jpsychires.2014.08.002; Chwastiak L, 2002, AM J PSYCHIAT, V159, P1862, DOI 10.1176/appi.ajp.159.11.1862; Ciccone M, 2001, INT J OBESITY, V25, P805, DOI 10.1038/sj.ijo.0801623; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; Du Y, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1032-4; El Khoudary SR, 2019, MENOPAUSE, V26, P1213, DOI 10.1097/GME.0000000000001424; Everson-Rose SA, 2004, DIABETES CARE, V27, P2856, DOI 10.2337/diacare.27.12.2856; Everson-Rose SA, 2018, PSYCHONEUROENDOCRINO, V97, P20, DOI 10.1016/j.psyneuen.2018.07.011; Gannage-Yared MH, 2006, EUR J ENDOCRINOL, V155, P167, DOI 10.1530/eje.1.02175; Ge TT, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1129-1; Golden SH, 2004, DIABETES CARE, V27, P429, DOI 10.2337/diacare.27.2.429; Graziottin Alessandra, 2009, Menopause Int, V15, P76, DOI 10.1258/mi.2009.009021; Guo M, 2017, MOL PSYCHIATR, V22, P1056, DOI 10.1038/mp.2016.225; Hafiane A, 2019, METABOLISM, V100, DOI 10.1016/j.metabol.2019.153953; Hu YZ, 2015, BIOMED REP, V3, P38, DOI 10.3892/br.2014.372; Huang WY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176430; Jaremka LM, 2019, PSYCHONEUROENDOCRINO, V110, DOI 10.1016/j.psyneuen.2019.104425; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kan C, 2013, DIABETES CARE, V36, P480, DOI 10.2337/dc12-1442; Laake JPS, 2014, DIABETES CARE, V37, P2186, DOI 10.2337/dc13-2522; Lermer MA, 2011, MENOPAUSE, V18, P129, DOI 10.1097/gme.0b013e3181ec58f8; Lihn AS, 2005, OBES REV, V6, P13, DOI 10.1111/j.1467-789X.2005.00159.x; Liu J, 2012, P NATL ACAD SCI USA, V109, P12248, DOI 10.1073/pnas.1202835109; Llaneza P, 2012, MATURITAS, V71, P120, DOI 10.1016/j.maturitas.2011.11.017; Lu JY, 2007, INTERN MED J, V37, P365, DOI 10.1111/j.1445-5994.2007.01364.x; Lu XY, 2006, P NATL ACAD SCI USA, V103, P1593, DOI 10.1073/pnas.0508901103; MAIER W, 1988, J AFFECT DISORDERS, V14, P61, DOI 10.1016/0165-0327(88)90072-9; Mattu HS, 2013, J ENDOCRINOL, V216, pT17, DOI 10.1530/JOE-12-0232; Moulton CD, 2015, LANCET DIABETES ENDO, V3, P461, DOI 10.1016/S2213-8587(15)00134-5; Narita K, 2008, PSYCHONEUROENDOCRINO, V33, P305, DOI 10.1016/j.psyneuen.2007.11.013; Oh DJ, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.17m11695; Peta V, 2015, WORLD J HEPATOL, V7, P23, DOI 10.4254/wjh.v7.i1.44; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rudisch B, 2003, BIOL PSYCHIAT, V54, P227, DOI 10.1016/S0006-3223(03)00587-0; Snijder MB, 2006, DIABETES CARE, V29, P2498, DOI 10.2337/dc06-0952; Sowers MR, 2008, MATURITAS, V59, P149, DOI 10.1016/j.maturitas.2007.12.006; Tang RY, 2019, FERTIL STERIL, V112, P1160, DOI 10.1016/j.fertnstert.2019.08.005; Tangen T, 2008, J PSYCHOSOM OBST GYN, V29, P125, DOI 10.1080/01674820701733945; Thompson E, 2015, OCCUP MED-OXFORD, V65, P601, DOI 10.1093/occmed/kqv054; Timur S, 2010, MENOPAUSE, V17, P545, DOI 10.1097/gme.0b013e3181cf8997; Toffol E, 2015, MENOPAUSE, V22, P564, DOI [10.1097/gme.0000000000000323, 10.1097/GME.0000000000000323]; Unsal A, 2011, CLIMACTERIC, V14, P244, DOI 10.3109/13697137.2010.510912; Vavruch C, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0208-1; Vuong E, 2020, J AFFECT DISORDERS, V260, P372, DOI 10.1016/j.jad.2019.09.050; Westling S, 2004, J AFFECT DISORDERS, V81, P41, DOI 10.1016/j.jad.2003.07.002; Yamamoto Y, 2004, J CLIN ENDOCR METAB, V89, P87, DOI 10.1210/jc.2003-031163; Yildiz G, 2017, ARCH GYNECOL OBSTET, V295, P853, DOI 10.1007/s00404-017-4313-0; Zarouna Stalo, 2015, World J Exp Med, V5, P103, DOI 10.5493/wjem.v5.i2.103; Zeng LN, 2019, J AFFECT DISORDERS, V256, P337, DOI 10.1016/j.jad.2019.06.017; Zhang TH, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1170-9	59	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0248314	10.1371/journal.pone.0248314	http://dx.doi.org/10.1371/journal.pone.0248314			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667284	Green Published, gold			2022-12-26	WOS:000626604300007
J	Ho, K; Bradshaw, N				Ho, Kristin; Bradshaw, Niels			A conserved allosteric element controls specificity and activity of functionally divergent PP2C phosphatases from Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASES; STRESS; ACTIVATION; GROWTH; TRANSCRIPTION; MECHANISM; TRANSPORT; KINASES; SYSTEM; SPOIIE	Reversible phosphorylation relies on highly regulated kinases and phosphatases that target specific substrates to control diverse cellular processes. Here, we address how protein phosphatase activity is directed to the correct substrates under the correct conditions. The serine/threonine phosphatase SpoIIE from Bacillus subtilis, a member of the widespread protein phosphatase 2C (PP2C) family of phosphatases, is activated by movement of a conserved alpha-helical element in the phosphatase domain to create the binding site for the metal cofactor. We hypothesized that this conformational switch could provide a general mechanism for control of diverse members of the PP2C family of phosphatases. The B. subtilis phosphatase RsbU responds to different signals, acts on a different substrates, and produces a more graded response than SpoIIE. Using an unbiased genetic screen, we isolated mutants in the alpha-helical switch region of RsbU that are constitutively active, indicating conservation of the switch mechanism. Using phosphatase activity assays with phosphoprotein substrates, we found that both phosphatases integrate substrate recognition with activating signals to control metal-cofactor binding and substrate dephosphorylation. This integrated control provides a mechanism for PP2C family of phosphatases to produce specific responses by acting on the correct substrates, under the appropriate conditions.	[Ho, Kristin; Bradshaw, Niels] Brandeis Univ, Dept Biochem, Waltham, MA 02254 USA	Brandeis University	Bradshaw, N (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02254 USA.	niels@brandeis.edu		Bradshaw, Niels/0000-0002-6845-4717	Brandeis University; NIH [GM18568]	Brandeis University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this work was from start-up funds from Brandeis University to N. B. and NIH Grant GM18568 to Richard Losick. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Bradshaw N, 2017, ELIFE, V6, DOI 10.7554/eLife.26111; Bradshaw N, 2015, ELIFE, V4, DOI 10.7554/eLife.08145; Bron S, 1998, J BIOTECHNOL, V64, P3, DOI 10.1016/S0168-1656(98)00099-6; Cabeen MT, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006901; Carniol K, 2004, J BACTERIOL, V186, P4390, DOI 10.1128/JB.186.13.4390-4394.2004; Carniol K, 2004, J BIOL CHEM, V279, P14860, DOI 10.1074/jbc.M314274200; Carrara M, 2017, NAT STRUCT MOL BIOL, V24, P708, DOI 10.1038/nsmb.3443; Delumeau O, 2004, J BIOL CHEM, V279, P40927, DOI 10.1074/jbc.M405464200; Dorich V, 2019, GENE DEV, V33, P718, DOI 10.1101/gad.320168.118; DUNCAN L, 1995, SCIENCE, V270, P641, DOI 10.1126/science.270.5236.641; EISENSTADT E, 1973, J BACTERIOL, V113, P1363, DOI 10.1128/JB.113.3.1363-1372.1973; Gilmartin AG, 2014, NAT CHEM BIOL, V10, P181, DOI [10.1038/NCHEMBIO.1427, 10.1038/nchembio.1427]; Gottesman S, 2019, J BIOL CHEM, V294, P11685, DOI 10.1074/jbc.REV119.005593; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hilbert DW, 2003, J BACTERIOL, V185, P1590, DOI 10.1128/JB.185.5.1590-1598.2003; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Kerk D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132863; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Levchenko I., 2009, STRUCTURE ORTHORHOMB, DOI [10.2210/pdb3F7A/pdb, DOI 10.2210/PDB3F7A/PDB]; Levdikov VM, 2012, J MOL BIOL, V415, P343, DOI 10.1016/j.jmb.2011.11.017; Locke JCW, 2011, SCIENCE, V334, P366, DOI 10.1126/science.1208144; Mazur SJ, 2017, BIOCHEMISTRY-US, V56, P2676, DOI 10.1021/acs.biochem.6b01220; Moorhead GBG, 2009, BIOCHEM J, V417, P401, DOI 10.1042/BJ20081986; Morita K, 2020, CELL, V181, P702, DOI 10.1016/j.cell.2020.03.051; Padua RAP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06814-w; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poh WH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241019; Rothstein DM, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00212-17; SCRIBNER H, 1974, J BACTERIOL, V117, P1224, DOI 10.1128/JB.117.3.1224-1230.1974; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Soon FF, 2012, SCIENCE, V335, P85, DOI 10.1126/science.1215106; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; Tagad HD, 2018, CHEMMEDCHEM, V13, P894, DOI 10.1002/cmdc.201700779; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vassylyev DG, 2007, J MOL BIOL, V370, P417, DOI 10.1016/j.jmb.2007.05.002; Vintonyak VV, 2011, BIOORGAN MED CHEM, V19, P2145, DOI 10.1016/j.bmc.2011.02.047; Yang XF, 1996, GENE DEV, V10, P2265, DOI 10.1101/gad.10.18.2265; YOUNGMAN P, 1984, PLASMID, V12, P1, DOI 10.1016/0147-619X(84)90061-1; Zhang Y, 2013, J BIOL CHEM, V288, P22058, DOI 10.1074/jbc.M113.464339	41	1	1	6	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100518	10.1016/j.jbc.2021.100518	http://dx.doi.org/10.1016/j.jbc.2021.100518			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33684446	Green Published, gold			2022-12-26	WOS:000672866400492
J	Ackun-Farmmer, MA; Soto, CA; Lesch, ML; Byun, D; Yang, LL; Calvi, LM; Benoit, DSW; Frisch, BJ				Ackun-Farmmer, Marian A.; Soto, Celia A.; Lesch, Maggie L.; Byun, Daniel; Yang, Lila; Calvi, Laura M.; Benoit, Danielle S. W.; Frisch, Benjamin J.			Reduction of leukemic burden via bone-targeted nanoparticle delivery of an inhibitor of C-chemokine (C-C motif) ligand 3 (CCL3) signaling	FASEB JOURNAL			English	Article						nanoparticles; acute myeloid leukemia; peptide; drug delivery; small molecule drug; MIP1&#8208; alpha	ACUTE MYELOID-LEUKEMIA; MESENCHYMAL STROMAL CELLS; IN-VIVO; MARROW NICHE; STEM-CELLS; FUNCTIONAL INHIBITION; DRUG-DELIVERY; MURINE MODEL; MOUSE MODEL; DISEASE	Leukemias are challenging diseases to treat due, in part, to interactions between leukemia cells and the bone marrow microenvironment (BMME) that contribute significantly to disease progression. Studies have shown that leukemic cells secrete C-chemokine (C-C motif) ligand 3 (CCL3), to disrupt the BMME resulting in loss of hematopoiesis and support of leukemic cell survival and proliferation. In this study, a murine model of blast crisis chronic myelogenous leukemia (bcCML) that expresses the translocation products BCR/ABL and Nup98/HoxA9 was used to determine the role of CCL3 in BMME regulation. Leukemic cells derived from CCL3(-/-) mice were shown to minimally engraft in a normal BMME, thereby demonstrating that CCL3 signaling was necessary to recapitulate bcCML disease. Further analysis showed disruption in hematopoiesis within the BMME in the bcCML model. To rescue the altered BMME, therapeutic inhibition of CCL3 signaling was investigated using bone-targeted nanoparticles (NP) to deliver Maraviroc, an inhibitor of C-C chemokine receptor type 5 (CCR5), a CCL3 receptor. NP-mediated Maraviroc delivery partially restored the BMME, significantly reduced leukemic burden, and improved survival. Overall, our results demonstrate that inhibiting CCL3 via CCR5 antagonism is a potential therapeutic approach to restore normal hematopoiesis as well as reduce leukemic burden within the BMME.	[Ackun-Farmmer, Marian A.; Benoit, Danielle S. W.; Frisch, Benjamin J.] Univ Rochester, Dept Biomed Engn, Rochester, NY USA; [Ackun-Farmmer, Marian A.; Byun, Daniel; Calvi, Laura M.; Benoit, Danielle S. W.; Frisch, Benjamin J.] Univ Rochester, Med Ctr, Dept Orthopaed, Rochester, NY 14642 USA; [Ackun-Farmmer, Marian A.; Byun, Daniel; Calvi, Laura M.; Benoit, Danielle S. W.; Frisch, Benjamin J.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Soto, Celia A.; Lesch, Maggie L.; Frisch, Benjamin J.] Univ Rochester, Dept Pathol & Lab Med, Rochester, NY USA; [Yang, Lila] New York Inst Technol, Coll Osteopath Med, New York, NY USA; [Calvi, Laura M.] Univ Rochester, Med Ctr, Dept Med, Div Endocrine, Rochester, NY 14642 USA; [Calvi, Laura M.; Frisch, Benjamin J.] Univ Rochester, Sch Med & Dent, Wilmot Canc Inst, Rochester, NY USA; [Benoit, Danielle S. W.] Univ Rochester, Mat Sci Program, Rochester, NY USA; [Benoit, Danielle S. W.] Univ Rochester, Dept Chem Engn, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; New York Institute Technology; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Benoit, DSW; Frisch, BJ (corresponding author), Univ Rochester, Med Ctr, Sch Med & Dent, 601 Elmwood Ave,Box 704, Rochester, NY 14642 USA.	benoit@bme.rochester.edu; benjamin_frisch2@urmc.rochester.edu		Ackun-Farmmer, Marian/0000-0003-3081-5115; Lesch, Maggie/0000-0002-7080-2020; Benoit, Danielle/0000-0001-7137-8164; Soto, Celia/0000-0003-1787-3249	HHS | NIH | National Cancer Institute (NCI) [CA180615, CA166280]; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR069655, AR064200, AR056696]; National Science Foundation (NSF) [CBET1450987]; University of Rochester (UR) [UL1 TR002001]	HHS | NIH | National Cancer Institute (NCI); HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); University of Rochester (UR)	HHS | NIH | National Cancer Institute (NCI), Grant/Award Number: CA180615; HHS | NIH | National Cancer Institute (NCI), Grant/Award Number: CA166280; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR069655; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR064200; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR056696; National Science Foundation (NSF), Grant/Award Number: CBET1450987; University of Rochester (UR), Grant/Award Number: UL1 TR002001	[Anonymous], 2017, CANC STAT FACTS AC M; Argyle D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02629; Baba T, 2013, J EXP MED, V210, P2661, DOI 10.1084/jem.20130112; Balderman SR, 2016, BLOOD, V127, P616, DOI 10.1182/blood-2015-06-653113; Baranello MP, 2014, BIOMACROMOLECULES, V15, P2629, DOI 10.1021/bm500468d; Baranello MP., 2015, CELLS-BASEL, V8, p455; Behrmann L, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00444; Bertrand N, 2014, ADV DRUG DELIVER REV, V66, P2, DOI 10.1016/j.addr.2013.11.009; Blanco E, 2015, NAT BIOTECHNOL, V33, P941, DOI 10.1038/nbt.3330; Blau O, 2011, BLOOD, V118, P5583, DOI 10.1182/blood-2011-03-343467; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chen YL, 2019, LEUKEMIA, V33, P2365, DOI 10.1038/s41375-019-0458-0; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Dairaghi DJ, 2012, BLOOD, V120, P1449, DOI 10.1182/blood-2011-10-384784; Dalela M, 2015, ACS APPL MATER INTER, V7, P26530, DOI 10.1021/acsami.5b07764; Deshantri AK, 2018, J CONTROL RELEASE, V287, P194, DOI 10.1016/j.jconrel.2018.08.034; Dong L, 2016, NATURE, V539, P304, DOI 10.1038/nature20131; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Feldman EJ, 2011, J CLIN ONCOL, V29, P979, DOI 10.1200/JCO.2010.30.5961; Frisch BJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124213; Frisch BJ, 2012, BLOOD, V119, P540, DOI 10.1182/blood-2011-04-348151; Geyh S, 2016, LEUKEMIA, V30, P683, DOI 10.1038/leu.2015.325; Hoffmann VS, 2015, LEUKEMIA, V29, P1336, DOI 10.1038/leu.2015.73; Jain P, 2017, CANCER-AM CANCER SOC, V123, P4391, DOI 10.1002/cncr.30864; Kim S, 2017, LEUKEMIA, V31, P1582, DOI 10.1038/leu.2016.354; Krevvata M, 2014, BLOOD, V124, P2834, DOI 10.1182/blood-2013-07-517219; Kumar B, 2018, LEUKEMIA, V32, P575, DOI 10.1038/leu.2017.259; Liang M, 2000, J BIOL CHEM, V275, P19000, DOI 10.1074/jbc.M001222200; Lim WS, 2010, LEUKEMIA RES, V34, P1214, DOI 10.1016/j.leukres.2010.01.015; Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010; Menu E, 2006, CLIN EXP METASTAS, V23, P291, DOI 10.1007/s10585-006-9038-6; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Neering SJ, 2007, BLOOD, V110, P2578, DOI 10.1182/blood-2007-02-073031; Newman MR, 2018, BIOMACROMOLECULES, V19, P71, DOI 10.1021/acs.biomac.7b01193; Oyajobi BO, 2001, BONE, V28, pS81; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Roboz GJ, 2012, CURR OPIN ONCOL, V24, P711, DOI 10.1097/CCO.0b013e328358f62d; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Sheu TJ, 2002, J BONE MINER RES, V17, P915, DOI 10.1359/jbmr.2002.17.5.915; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Staversky RJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32978-y; Vallet S, 2011, LEUKEMIA, V25, P1174, DOI 10.1038/leu.2011.43; Wang Y, 2016, LEUKEMIA, V30, P1897, DOI 10.1038/leu.2016.81; Wang YC, 2017, ACS NANO, V11, P9445, DOI 10.1021/acsnano.7b05103; Wu Y, 2008, J IMMUNOL, V181, P6384, DOI 10.4049/jimmunol.181.9.6384; Yazdani Z, 2020, LIFE SCI, V240, DOI 10.1016/j.lfs.2019.117071; Ye HB, 2018, CANCER CELL, V34, P659, DOI 10.1016/j.ccell.2018.08.016; Zi J, 2017, AM J CANCER RES, V7, P869; Zucchetto A, 2009, CANCER RES, V69, P4001, DOI 10.1158/0008-5472.CAN-08-4173	50	5	5	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21402	10.1096/fj.202000938RR	http://dx.doi.org/10.1096/fj.202000938RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33724567	Green Accepted			2022-12-26	WOS:000635216100040
J	Lv, HY; Li, X; Li, H; Hu, YF; Liu, HM; Wen, SJ; Li, YP; Liu, YH; Huang, HH; Yu, GW; Huang, YB; Zhang, JJ				Lv, Huayang; Li, Xiao; Li, Hui; Hu, Yufeng; Liu, Hanmei; Wen, Shengjuan; Li, Yangping; Liu, Yinghong; Huang, Huanhuan; Yu, Guowu; Huang, Yubi; Zhang, Junjie			Gibberellin induced transcription factor bZIP53 regulates CesA1 expression in maize kernels	PLOS ONE			English	Article								Proper development of the maize kernel is of great significance for high and stable maize yield to ensure national food security. Gibberellin (GA), one of the hormones regulating plant growth, is involved in modulating the development of maize kernels. Cellulose, one of the main components of plant cells, is also regulated by gibberellin. The mechanism of hormone regulation during maize grain development is highly complicated, and reports on GA-mediated modulation of cellulose synthesis during maize grain development are rare. Our study revealed that during grain growth and development, the grain length and bulk density of GA-treated corn kernels improved significantly, and the cellulose content of grains increased, while seed coat thickness decreased. The transcription factor basic region/leucine zipper motif 53 (bZIP53), which is strongly correlated with cellulose synthase gene 1 (CesA1) expression, was screened by transcriptome sequencing and the expression of the cellulose synthase gene in maize grain development after GA treatment was determined. It was found that bZIP53 expression significantly promoted the expression of CesA1. Further, analysis of the transcription factor bZIP53 determined that the gene-encoded protein was localized in the cell and nuclear membranes, but the transcription factor bZIP53 itself showed no transcriptional activation. Further studies are required to explore the interaction of bZIP53 with CesA1.	[Lv, Huayang; Li, Xiao; Liu, Hanmei; Wen, Shengjuan; Zhang, Junjie] Sichuan Agr Univ, Coll Life Sci, Yaan, Sichuan, Peoples R China; [Li, Hui; Hu, Yufeng; Li, Yangping; Huang, Huanhuan; Yu, Guowu; Huang, Yubi] Sichuan Agr Univ, Coll Agron, Key Lab Crop Genet Resources & Improvement, Chengdu, Sichuan, Peoples R China; [Liu, Yinghong] Sichuan Agr Univ, Maize Res Inst, Minist Educ, Key Lab Crop Genet Resources & Improvement, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Zhang, JJ (corresponding author), Sichuan Agr Univ, Coll Life Sci, Yaan, Sichuan, Peoples R China.	junjiezhang@sicau.edu.cn	liu, ying/GXF-4294-2022; LIU, YING/GZL-7252-2022		National Natural Science Foundation of China [31771702, 31571682]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NO: 31771702 and NO: 31571682). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso R, 2009, PLANT CELL, V21, P1747, DOI 10.1105/tpc.108.062968; Bing YZ., 2017, CHINESE J PESTIC SCI, P64; Chen J, 2016, J EXP BOT, V67, P1327, DOI 10.1093/jxb/erv527; Crowell EF, 2009, PLANT CELL, V21, P1141, DOI 10.1105/tpc.108.065334; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fagard M, 2000, PLANT CELL, V12, P2409, DOI 10.1105/tpc.12.12.2409; Hu YF, 2012, J EXP BOT, V63, P5979, DOI 10.1093/jxb/ers246; Hu YF, 2011, BIOTECHNOL LETT, V33, P1465, DOI 10.1007/s10529-011-0582-z; Huang DB, 2015, PLANT CELL, V27, P1681, DOI 10.1105/tpc.15.00015; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Johnsson C, 2019, PHYSIOL PLANTARUM, V165, P673, DOI 10.1111/ppl.12766; Li H, 2017, J PLANT PHYSIOL, V216, P11, DOI 10.1016/j.jplph.2017.04.016; Li SD, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23179; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Petti C, 2015, PLANT PHYSIOL, V169, P705, DOI 10.1104/pp.15.00928; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; Shi Y., 2018, EFFECT EXOGENOUS CHI, P43; Taylor NG, 2007, PLANT MOL BIOL, V64, P161, DOI 10.1007/s11103-007-9142-2; Taylor NG, 1999, PLANT CELL, V11, P769, DOI 10.1105/tpc.11.5.769; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Timmers J, 2009, FEBS LETT, V583, P978, DOI 10.1016/j.febslet.2009.02.035; VANSOEST PJ, 1963, J ASSOC OFF ANA CHEM, V46, P829; Wang HaoCai, 1998, Jiangsu Agricultural Sciences, P32; Wei JHJCBoB, 2002, ADV STUDIES PLANT CE; Wright WE, 2006, PLANT CELL ENVIRON, V29, P1, DOI 10.1111/j.1365-3040.2005.01394.x; Xiao GH, 2016, J INTEGR PLANT BIOL, V58, P577, DOI 10.1111/jipb.12429; Xiao QL, 2017, FEBS J, V284, P3079, DOI 10.1111/febs.14179; Xue WW., 2018, EFFECT GIBBERELLIN F, V30, P978; Yue S.J., 2012, ACTA AGRONOMICA SINI, V37, P2111, DOI [10.3724/SP.J.1006.2011.02111, DOI 10.3724/SP.J.1006.2011.02111]; Zhang S., 2016, VARIATION LAW PERICA, V17	31	4	4	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0244591	10.1371/journal.pone.0244591	http://dx.doi.org/10.1371/journal.pone.0244591			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730027	gold, Green Published			2022-12-26	WOS:000630345000003
J	Liu, W; Shi, JC; He, SM; Luo, X; Zhong, WJ; Yang, F				Liu, Wen; Shi, Jingcheng; He, Simin; Luo, Xi; Zhong, Weijun; Yang, Fang			Understanding variations and influencing factors on length of stay for T2DM patients based on a multilevel model	PLOS ONE			English	Article								Aim Shortening the length of stay (LOS) is a potential and sustainable way to relieve the pressure that type 2 diabetes mellitus (T2DM) patients placed on the public health system. Method Multi-stage random sampling was used to obtain qualified hospitals and electronic medical records for patients discharged with T2DM in 2018. A box-cox transformation was adopted to normalize LOS. Multilevel model was used to verify hospital cluster effect on LOS variations and screen potential factors for LOS variations from both individual and hospital levels. Result 50 hospitals and a total of 12,888 T2DM patients were included. Significant differences in LOS variations between hospitals, and a hospital cluster effect on LOS variations (t = 92.188, P<0.001) was detected. The results showed that female patients, patients with new rural cooperative' medical insurance, hospitals with more beds, and hospitals with faster bed turnovers had shorter LOS. Conversely, elderly patients, patients with urban workers' medical insurance, patients requiring surgery, patients with the International Classification of Diseases coded complication types E11.1, E11.2, E11.4, E11.5, and other complications cardiovascular diseases, grade III hospitals, hospitals with a lower doctor-to-nurse ratio, and hospitals with more daily visits per doctor had longer LOS. Conclusions The evidence proved that hospital cluster effect on LOS variation did exist. Complications and patients features at individual level, as well as organization and resource characteristics at hospital level, had impacted LOS variations to varying degrees. To shorten LOS and better meet the medical demand for T2DM patients, limited health resources must be allocated and utilized rationally at hospital level, and the patients with the characteristics of longer LOS risk must be identified in time. More influencing factors on LOS variations at different levels are still worth of comprehensive exploration in the future.	[Liu, Wen; Shi, Jingcheng; He, Simin; Luo, Xi; Yang, Fang] Cent South Univ, Xiangya Sch Publ Hlth, Changsha, Peoples R China; [Zhong, Weijun] Hlth Commiss Hunan Prov, Ctr Informat Stat, Changsha, Peoples R China	Central South University	Yang, F (corresponding author), Cent South Univ, Xiangya Sch Publ Hlth, Changsha, Peoples R China.	yangfang2010@csu.edu.cn						Arefnezhad Masoud, 2016, Hosp Pract (1995), V44, P28, DOI 10.1080/21548331.2016.1143781; Bader MS, 2016, AM J MED SCI, V352, P30, DOI 10.1016/j.amjms.2016.02.032; Browne WJ, 2000, COMPUTATION STAT, V15, P391, DOI 10.1007/s001800000041; Castelli A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133545; Cheng SW, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/2363292; Claudino AM, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1327-4; Coevoet V, 2013, MED CARE, V51, P548, DOI 10.1097/MLR.0b013e3182928f84; Cromarty J, 2014, INTERN MED J, V44, P1109, DOI 10.1111/imj.12538; de Jong JD, 2006, HEALTH SERV RES, V41, P374, DOI 10.1111/j.1475-6773.2005.00486.x; Drennan VM, 2019, BRIT MED BULL, V130, P25, DOI 10.1093/bmb/ldz014; Dryden M, 2015, CLIN MICROBIOL INFEC, V21, pS27, DOI 10.1016/j.cmi.2015.03.024; Gilje EA, 2017, J PERINATOL, V37, P1130, DOI 10.1038/jp.2017.107; Giorda C, 2006, DIABETIC MED, V23, P377, DOI 10.1111/j.1464-5491.2006.01851.x; Guzman JZ, 2014, SPINE, V39, P1596, DOI 10.1097/BRS.0000000000000482; Hwabejire JO, 2013, JAMA SURG, V148, P956, DOI 10.1001/jamasurg.2013.2148; International Diabetes Federation, IDF ATLAS, V9th; Lagoe R., 2016, INT J CLIN MED, V7, P530, DOI [DOI 10.4236/IJCM.2016.78058, 10.4236/ijcm.2016.78058]; Lagoe R., 2014, ADV BIOSCI BIOTECHNO, V5, P188, DOI [DOI 10.4236/ABB.2014.53024, 10.4236/abb.2014.53024]; Lee IH, 2017, J CHIN MED ASSOC, V80, P297, DOI 10.1016/j.jcma.2016.11.002; Lee J, 2014, J TRAUMA ACUTE CARE, V77, P298, DOI 10.1097/TA.0000000000000334; Lopez-de-Andres A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183796; Maas CJM, 2004, STAT NEERL, V58, P127, DOI 10.1046/j.0039-0402.2003.00252.x; Manoukian S, 2018, J HOSP INFECT, V100, P222, DOI 10.1016/j.jhin.2018.06.003; Mathew PJ, 2018, AM J SURG, V216, P881, DOI 10.1016/j.amjsurg.2018.07.044; Mehta S, 2018, J MANAG CARE SPEC PH, V24, P280, DOI 10.18553/jmcp.2018.24.3.280; Mehta V, 2017, HEAD NECK-J SCI SPEC, V39, P311, DOI 10.1002/hed.24585; Molloy IB, 2017, J BONE JOINT SURG AM, V99, P402, DOI 10.2106/JBJS.16.00019; National Health Commission, 2019, TRANSCRIPT REGULAR P; Nawata K, 2016, HEALTH-LONDON, V08, P505, DOI [10.4236/health.2016.86054, DOI 10.4236/HEALTH.2016.86054]; Nawata K, 2015, HEALTH-LONDON, V07, P256, DOI [10.4236/health.2015.72030, DOI 10.4236/HEALTH.2015.72030]; Nawata K., 2016, HEALTH-LONDON, V8, P49, DOI [10.4236/health.2016.81007, DOI 10.4236/HEALTH.2016.81007]; Organisation for Economic Co-operation and Development, HLTH CARE USE LENGTH; Paoin W, 2018, HEALTH INF MANAG J, V47, P77, DOI 10.1177/1833358317701277; Pitkaaho T, 2016, NONLINEAR RELATIONSH, P1365; Pitkaaho T, 2016, RELATIONSHIP NURSE S, P1365; Pouwels KB, 2020, CLIN INFECT DIS, V71, pE415, DOI 10.1093/cid/ciaa136; Rattanaumpawan Pinyo, 2016, Journal of the Medical Association of Thailand, V99, P368; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V2nd ed, DOI [10.2466/pms.2002.94.2.671, DOI 10.2466/PMS.2002.94.2.671]; Ruparel Mamta, 2016, ERJ Open Res, V2; SNIJDERS TAB, 1994, SOCIOL METHOD RES, V22, P342, DOI 10.1177/0049124194022003004; Sponholtz TR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201712; Stein DJ, 2016, J AFFECT DISORDERS, V190, P663, DOI 10.1016/j.jad.2015.10.061; Suzuki H, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9020096; World Health Organization, 2018, GLOBAL STRATEGY HUMA; Yang WS, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61144-6; Zhong VW, 2018, DIABETES CARE, V41, P1870, DOI 10.2337/dc17-1583; Zhu DW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227956	47	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0248157	10.1371/journal.pone.0248157	http://dx.doi.org/10.1371/journal.pone.0248157			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8KN	33711043	gold, Green Published			2022-12-26	WOS:000629591800006
J	Moorhead, L; Krakow, M; Maggio, L				Moorhead, Laura; Krakow, Melinda; Maggio, Lauren			What cancer research makes the news? A quantitative analysis of online news stories that mention cancer studies	PLOS ONE			English	Article							HEALTH NEWS; MEDIA; COVERAGE; INTERNET; HYPERTEXTUALITY; TRANSMISSION; JOURNALISM; NEWSPAPERS; TRENDS; PRESS	Journalists' health and science reporting aid the public's direct access to research through the inclusion of hyperlinks leading to original studies in peer-reviewed journals. While this effort supports the US-government mandate that research be made widely available, little is known about what research journalists share with the public. This cross-sectional exploratory study characterises US-government-funded research on cancer that appeared most frequently in news coverage and how that coverage varied by cancer type, disease incidence and mortality rates. The subject of analysis was 11436 research articles (published in 2016) on cancer funded by the US government and 642 news stories mentioning at least one of these articles. Based on Altmetric data, researchers identified articles via PubMed and characterised each based on the news media attention received online. Only 1.88% (n = 213) of research articles mentioning US government-funded cancer research included at least one mention in an online news publication. This is in contrast to previous research that found 16.8% (n = 1925) of articles received mention by online mass media publications. Of the 13 most common cancers in the US, 12 were the subject of at least one news mention; only urinary and bladder cancer received no mention. Traditional news sources included significantly more mentions of research on common cancers than digital native news sources. However, a general discrepancy exists between cancers prominent in news sources and those with the highest mortality rate. For instance, lung cancer accounted for the most deaths annually, while melanoma led to 56% less annual deaths; however, journalists cited research regarding these cancers nearly equally. Additionally, breast cancer received the greatest coverage per estimated annual death, while pancreatic cancer received the least coverage per death. Findings demonstrated a continued misalignment between prevalent cancers and cancers mentioned in online news media. Additionally, cancer control and prevention received less coverage from journalists than other cancer continuum stages, highlighting a continued underrepresentation of prevention-focused research. Results revealed a need for further scholarship regarding the role of journalists in research dissemination.	[Moorhead, Laura] San Francisco State Univ, Dept Journalism, San Francisco, CA 94132 USA; [Krakow, Melinda] Univ Mississippi, Med Ctr, John D Bower Sch Populat Hlth, Jackson, MS 39216 USA; [Maggio, Lauren] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	California State University System; San Francisco State University; University of Mississippi; University of Mississippi Medical Center; Uniformed Services University of the Health Sciences - USA	Moorhead, L (corresponding author), San Francisco State Univ, Dept Journalism, San Francisco, CA 94132 USA.	lauralm@sfsu.edu		Moorhead, Laura/0000-0001-9185-6290				Abramson J, 2010, DAEDALUS-US, V139, P39, DOI 10.1162/daed.2010.139.2.39; Americans see medicine and health,, 2017, FOOD NUTR FOC ART HE; [Anonymous], 2015, COMM CANC TYP; [Anonymous], CELEBRITY HLTH NARRA; [Anonymous], 2019, METH STAT NEWS MED; [Anonymous], 2019, LOC NEWS AM EMBR DIG; [Anonymous], 2008, **DROPPED REF**, DOI [10.1037/e458982008-005, DOI 10.1037/E458982008-005]; [Anonymous], GOOGLE BOOKS; [Anonymous], 2019, TRENDS FACTS ONL NEW; [Anonymous], What is journalism? Definition and meaning of the craft; [Anonymous], 2017, MIXED MESSAGES PUBLI; [Anonymous], 2019, DEM PEOPL INT LOC NE; [Anonymous], 2008, HLTH NEWS COV US MED; [Anonymous], 2015, NCI OV MISS; Antunovic D, 2018, JOURNALISM, V19, P632, DOI 10.1177/1464884916663625; Bach PB, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i788; Bakker P, 2012, JOURNAL PRACT, V6, P627, DOI 10.1080/17512786.2012.667266; Bakker TP, 2011, COMMUN RES, V38, P451, DOI 10.1177/0093650210381738; Barnhurst KG, 2010, JOURNALISM STUD, V11, P555, DOI 10.1080/14616701003638426; Brechman JM, 2011, J COMMUN, V61, DOI 10.1111/j.1460-2466.2011.01550.x; Brodie M, 2003, J HEALTH POLIT POLIC, V28, P927, DOI 10.1215/03616878-28-5-927; Brownson RC, 2018, J PUBLIC HEALTH MAN, V24, P102, DOI 10.1097/PHH.0000000000000673; Caburnay CA, 2008, ETHNIC DIS, V18, P488; Chen XY, 2001, J CLIN ONCOL, V19, P4291, DOI 10.1200/JCO.2001.19.23.4291; Coddington M., 2012, INT J COMMUN-US, V6, P20; Collins K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162680; Delaney KJ, 2017, QUARTZ, DOI 1069982/thank-you-readers-quartz-is-turning-five-years-old-heres-what-comes-next/; Deuze M, 2018, JOURNALISM, V19, P165, DOI 10.1177/1464884916688550; Dong JK, 2020, AFR J EMERG MED, V10, pS120, DOI 10.1016/j.afjem.2020.04.005; Dumas-Mallet E, 2020, SCIENTOMETRICS, V123, P413, DOI 10.1007/s11192-020-03380-1; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Fishman J, 2010, ARCH INTERN MED, V170, P515, DOI 10.1001/archinternmed.2010.11; Fleerackers A, 2022, HEALTH COMMUN, V37, P726, DOI 10.1080/10410236.2020.1864892; Galligan F, 2013, SERIALS REV, V39, P56, DOI 10.1016/j.serrev.2013.01.003; Gesualdo N, 2020, JOURNALISM STUD, V21, P127, DOI 10.1080/1461670X.2019.1632734; Griffiths RR, 2016, J PSYCHOPHARMACOL, V30, P1181, DOI 10.1177/0269881116675513; Hurley RJ, 2012, J BROADCAST ELECTRON, V56, P132, DOI 10.1080/08838151.2011.648681; Jensen JD, 2008, HUM COMMUN RES, V34, P347, DOI 10.1111/j.1468-2958.2008.00324.x; Jensen JD, 2010, J HEALTH COMMUN, V15, P136, DOI 10.1080/10810730903528025; Karlsson M., 2018, RETHINKING RES METHO; Kealey E, 2010, J HEALTH COMMUN, V15, P236, DOI 10.1080/10810730.2010.522693; Kua E, 2004, PUBLIC UNDERST SCI, V13, P309, DOI 10.1177/0963662504045539; Lai WYY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006856; Larsson AO, 2013, JOURNAL PRACT, V7, P738, DOI 10.1080/17512786.2012.748514; Lee AM, 2015, JMM-INT J MEDIA MANA, V17, P3, DOI 10.1080/14241277.2014.997383; Li, 2013, INTERNET NEWSPAPERS; Liskauskas S, 2019, EMBO REP, V20, DOI 10.15252/embr.201947906; Lloyd L, 2005, LECT NOTES COMPUT SC, V3772, P161; Maggio LA, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025783; Maggio LA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012846; Mahoney L Meghan, 2015, JMIR Public Health Surveill, V1, pe2, DOI 10.2196/publichealth.3310; Matthias L, FRAMING SCI OPIOID R; Molek-Kozakowska K, 2017, DISCOURSE COMMUN, V11, P69, DOI 10.1177/1750481316683294; Moorhead LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129708; Niederdeppe J, 2008, J HEALTH COMMUN, V13, P181, DOI 10.1080/10810730701854110; Peters HP, 2008, SCIENCE, V321, P204, DOI 10.1126/science.1157780; Peters HP, 2013, P NATL ACAD SCI USA, V110, P14102, DOI 10.1073/pnas.1212745110; PHILLIPS DP, 1991, NEW ENGL J MED, V325, P1180, DOI 10.1056/NEJM199110173251620; Ross S, 2016, J PSYCHOPHARMACOL, V30, P1165, DOI 10.1177/0269881116675512; Ruiz M, 2019, BUSINESS INSIDER; Sadasivam RS, 2013, INT J MED INFORM, V82, P193, DOI 10.1016/j.ijmedinf.2012.09.008; Sayers E, 2018, E UTILITIES QUICK ST; SCHUDSON M, 1989, MEDIA CULT SOC, V11, P263, DOI 10.1177/016344389011003002; Schultz SK, 2009, AM ARE GETTING NEWS, DOI [10.21236/ada539880, DOI 10.21236/ADA539880]; Schwartz LM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8164; Schwartz LM, 2002, JAMA-J AM MED ASSOC, V287, P2859, DOI 10.1001/jama.287.21.2859; Selvaraj S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085355; Singer JB, 2018, JOURNALISM STUD, V19, P209, DOI 10.1080/1461670X.2016.1186498; Slater MD, 2008, J HEALTH COMMUN, V13, P523, DOI 10.1080/10810730802279571; Smith Katherine C., 2013, Journal of the National Cancer Institute Monographs, P175, DOI 10.1093/jncimonographs/lgt023; Steensen S, 2011, JOURNALISM STUD, V12, P311, DOI 10.1080/1461670X.2010.501151; Stray J., 2010, NIEMAN JOURNALISM LA, P10; Stray J, 2010, NIEMAN JOURNALISM LA, V10; Stroobant J, 2019, INFORM COMMUN SOC, V22, P2138, DOI 10.1080/1369118X.2018.1477971; Stroobant J, 2019, J APPL JOURNAL MEDIA, V8, P367, DOI 10.1386/ajms_00007_1; Stroobant J, 2018, JOURNAL PRACT, V12, P344, DOI 10.1080/17512786.2017.1294027; Stryker JE, 2007, PREV MED, V44, P20, DOI 10.1016/j.ypmed.2006.07.012; Sumner P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7015; Tsfati Y, 2010, AM BEHAV SCI, V54, P22, DOI 10.1177/0002764210376309; Van Eperen L, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-199; Weaver DA, 2008, J MASS COMMUN Q, V85, P515, DOI 10.1177/107769900808500303; Witschge T, 2019, JOURNALISM, V20, P651, DOI 10.1177/1464884918760669; Woloshin S, 2006, PLOS MED, V3, P452, DOI 10.1371/journal.pmed.0030170; Woloshin S, 2009, ANN INTERN MED, V150, P613, DOI 10.7326/0003-4819-150-9-200905050-00007; Yerramilli Divya, 2018, AMA J Ethics, V20, pE1075, DOI 10.1001/amajethics.2018.1075	86	2	2	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0247553	10.1371/journal.pone.0247553	http://dx.doi.org/10.1371/journal.pone.0247553			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QV3DA	33690639	Green Published, gold			2022-12-26	WOS:000627854700026
J	Vieira, WA; Goren, S; McCusker, CD				Vieira, Warren A.; Goren, Shira; McCusker, Catherine D.			ECM-mediated positional cues are able to induce pattern, but not new positional information, during axolotl limb regeneration	PLOS ONE			English	Article								The Mexican Axolotl is able to regenerate missing limb structures in any position along the limb axis throughout its life and serves as an excellent model to understand the basic mechanisms of endogenous regeneration. How the new pattern of the regenerating axolotl limb is established has not been completely resolved. An accumulating body of evidence indicates that pattern formation occurs in a hierarchical fashion, which consists of two different types of positional communications. The first type (Type 1) of communication occurs between connective tissue cells, which retain memory of their original pattern information and use this memory to generate the pattern of the regenerate. The second type (Type 2) of communication occurs from connective tissue cells to other cell types in the regenerate, which don't retain positional memory themselves and arrange themselves according to these positional cues. Previous studies suggest that molecules within the extracellular matrix (ECM) participate in pattern formation in developing and regenerating limbs. However, it is unclear whether these molecules play a role in Type 1 or Type 2 positional communications. Utilizing the Accessory Limb Model, a regenerative assay, and transcriptomic analyses in regenerates that have been reprogrammed by treatment with Retinoic Acid, our data indicates that the ECM likely facilities Type-2 positional communications during limb regeneration.	[Vieira, Warren A.; Goren, Shira; McCusker, Catherine D.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA	University of Massachusetts System; University of Massachusetts Boston	McCusker, CD (corresponding author), Univ Massachusetts, Dept Biol, Boston, MA 02125 USA.	Catherine.McCusker@umb.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development of the Nation Institutes of Health [1R15HD092180-01A1]	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the Nation Institutes of Health	This work was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the Nation Institutes of Health [grant number 1R15HD092180-01A1], awarded to CDM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funder website: https://www.nichd.nih.gov/.	Al-Thani H, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024963; Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Blassberg RA, 2011, J CELL SCI, V124, P47, DOI 10.1242/jcs.076331; BRYANT SV, 1974, ROUX ARCH DEV BIOL, V174, P90, DOI 10.1007/BF00577059; BRYANT SV, 1981, SCIENCE, V212, P993, DOI 10.1126/science.212.4498.993; Campbell LJ, 2011, DEV DYNAM, V240, P1826, DOI 10.1002/dvdy.22669; CRAWFORD K, 1988, DEVELOPMENT, V102, P687; da Silva SM, 2002, DEV CELL, V3, P547, DOI 10.1016/S1534-5807(02)00288-5; Echeverri K, 2005, DEV BIOL, V279, P391, DOI 10.1016/j.ydbio.2004.12.029; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; FRENCH V, 1976, SCIENCE, V193, P969, DOI 10.1126/science.948762; Gardiner DM, 2017, REGEN ENG TRANSL MED, V3, P192, DOI 10.1007/s40883-017-0037-8; Gerber T, 2018, SCIENCE, V362, P421, DOI 10.1126/science.aaq0681; KIM WS, 1986, ROUX ARCH DEV BIOL, V195, P455, DOI 10.1007/BF00375749; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; LUDOLPH DC, 1990, DEV BIOL, V140, P41, DOI 10.1016/0012-1606(90)90051-J; MADEN M, 1983, J EMBRYOL EXP MORPH, V77, P273; MADEN M, 1983, DEV BIOL, V98, P409, DOI 10.1016/0012-1606(83)90370-6; Makanae A, 2014, DEV BIOL, V396, P57, DOI 10.1016/j.ydbio.2014.09.021; Makanae A, 2013, DEV BIOL, V381, P213, DOI 10.1016/j.ydbio.2013.05.010; Makanae A, 2012, ANAT REC, V295, P1566, DOI 10.1002/ar.22529; McCusker C, 2014, REGENERATION, V1, P27, DOI 10.1002/reg2.10; McCusker CD, 2016, DEV BIOL, V416, P26, DOI 10.1016/j.ydbio.2016.05.032; McCusker CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077064; Mckechnie PS, 2014, INJURY, V45, P1859, DOI 10.1016/j.injury.2014.09.015; MEINHARDT H, 1983, DEV BIOL, V96, P375, DOI 10.1016/0012-1606(83)90175-6; MEINHARDT H, 1983, J EMBRYOL EXP MORPH, V76, P115; MUNEOKA K, 1986, DEV BIOL, V116, P256, DOI 10.1016/0012-1606(86)90062-X; Nacu E, 2016, NATURE, V533, P407, DOI 10.1038/nature17972; NIAZI IA, 1985, ROUX ARCH DEV BIOL, V194, P355, DOI 10.1007/BF00877373; Nogami K, 2004, J BIOL CHEM, V279, P8219, DOI 10.1074/jbc.M307304200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phan AQ, 2015, REGENERATION, V2, P182, DOI 10.1002/reg2.40; Poulain FE, 2015, DEVELOPMENT, V142, P3456, DOI 10.1242/dev.098178; Rinn JL, 2008, GENE DEV, V22, P303, DOI 10.1101/gad.1610508; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Sader F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38171-5; Satoh A, 2007, DEV BIOL, V312, P231, DOI 10.1016/j.ydbio.2007.09.021; Satoh A, 2011, DEV BIOL, V355, P263, DOI 10.1016/j.ydbio.2011.04.017; Tsonis PA, 1997, DEV GROWTH DIFFER, V39, P9; Vieira WA, 2019, BIOSYSTEMS, V183, DOI 10.1016/j.biosystems.2019.103989; Vieira WA, 2019, DEV BIOL, V451, P146, DOI 10.1016/j.ydbio.2019.04.008; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Yamaguchi Y, 2004, J CELL BIOL, V165, P275, DOI 10.1083/jcb.200311122; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	48	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0248051	10.1371/journal.pone.0248051	http://dx.doi.org/10.1371/journal.pone.0248051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667253	Green Published, gold			2022-12-26	WOS:000626604300045
J	Konig, AS; Rosener, NS; Gremer, L; Tusche, M; Flender, D; Reinartz, E; Hoyer, W; Neudecker, P; Willbold, D; Heise, H				Koenig, Anna S.; Roesener, Nadine S.; Gremer, Lothar; Tusche, Markus; Flender, Daniel; Reinartz, Elke; Hoyer, Wolfgang; Neudecker, Philipp; Willbold, Dieter; Heise, Henrike			Structural details of amyloid beta oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-RESOLUTION STRUCTURE; NUCLEAR-MAGNETIC-RESONANCE; GLUTAMATE-RECEPTOR 5; ALZHEIMERS A-BETA; CELLULAR PRION; SYNAPTIC PLASTICITY; CROSS-POLARIZATION; CHEMICAL-SHIFTS; DISEASE; C-13	Human PrP (huPrP) is a high-affinity receptor for oligomeric amyloid beta (A beta) protein aggregates. Binding of A beta oligomers to membrane-anchored huPrP has been suggested to trigger neurotoxic cell signaling in Alzheimer's disease, while an N-terminal soluble fragment of huPrP can sequester A beta oligomers and reduce their toxicity. Synthetic oligomeric A beta species are known to be heterogeneous, dynamic, and transient, rendering their structural investigation particularly challenging. Here, using huPrP to preserve A beta oligomers by coprecipitating them into large heteroassemblies, we investigated the conformations of A beta(1-42) oligomers and huPrP in the complex by solid-state MAS NMR spectroscopy. The disordered N-terminal region of huPrP becomes immobilized in the complex and therefore visible in dipolar spectra without adopting chemical shifts characteristic of a regular secondary structure. Most of the well-defined C-terminal part of huPrP is part of the rigid complex, and solid-state NMR spectra suggest a loss in regular secondary structure in the two C-terminal a-helices. For A beta(1-42) oligomers in complex with huPrP, secondary chemical shifts reveal substantial beta-strand content. Importantly, not all A beta(1-42) molecules within the complex have identical conformations. Comparison with the chemical shifts of synthetic A beta fibrils suggests that the A beta oligomer preparation represents a heterogeneous mixture of beta-strand-rich assemblies, of which some have the potential to evolve and elongate into different fibril polymorphs, reflecting a general propensity of A beta to adopt variable beta-strand-rich conformers. Taken together, our results reveal structural changes in huPrP upon binding to A beta oligomers that suggest a role of the C terminus of huPrP in cell signaling. Trapping A beta(1-42) oligomers by binding to huPrP has proved to be a useful tool for studying the structure of these highly heterogeneous beta-strand-rich assemblies.	[Koenig, Anna S.; Roesener, Nadine S.; Gremer, Lothar; Tusche, Markus; Hoyer, Wolfgang; Neudecker, Philipp; Willbold, Dieter; Heise, Henrike] Forschungszentrum Julich, Inst Biol Informat Proc 181 7 Struct Biochem & Ju, Julich Ctr Struct Biol, Julich, Germany; [Koenig, Anna S.; Roesener, Nadine S.; Gremer, Lothar; Flender, Daniel; Reinartz, Elke; Hoyer, Wolfgang; Neudecker, Philipp; Willbold, Dieter; Heise, Henrike] Heinrich Heine Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany; [Gremer, Lothar; Willbold, Dieter] Moscow Inst Phys & Technol, Res Ctr Mol Mech Aging & Age Related Dis, Dolgoprudnyi, Russia; [Flender, Daniel] Univ Greifswald, Inst Mikrobiol, Greifswald, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Moscow Institute of Physics & Technology; Ernst Moritz Arndt Universitat Greifswald	Willbold, D; Heise, H (corresponding author), Forschungszentrum Julich, Inst Biol Informat Proc 181 7 Struct Biochem & Ju, Julich Ctr Struct Biol, Julich, Germany.; Willbold, D; Heise, H (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany.; Willbold, D (corresponding author), Moscow Inst Phys & Technol, Res Ctr Mol Mech Aging & Age Related Dis, Dolgoprudnyi, Russia.	d.willbold@fz-juelich.de; h.heise@fz-juelich.de	Neudecker, Philipp/AAP-9005-2020; Hoyer, Wolfgang/H-6193-2013; Neudecker, Philipp/G-5265-2013; Gremer, Lothar/H-9128-2013; Heise, Henrike/A-7703-2010; Willbold, Dieter/A-6280-2013	Neudecker, Philipp/0000-0002-0557-966X; Hoyer, Wolfgang/0000-0003-4301-5416; Neudecker, Philipp/0000-0002-0557-966X; Gremer, Lothar/0000-0001-7065-5027; Heise, Henrike/0000-0002-9081-3894; Rosener, Nadine/0000-0002-9481-6347; Willbold, Dieter/0000-0002-0065-7366	European Research Council (ERC) Consolidator Grant [726368]	European Research Council (ERC) Consolidator Grant(European Research Council (ERC))	information-Support from a European Research Council (ERC) Consolidator Grant (grant agreement no. 726368) to W. H. is acknowledged.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Alzheimer's Assoc, 2018, ALZHEIMERS DEMENT, V14, P367, DOI 10.1016/j.jalz.2018.02.001; Amin L., 2019, ABETA RECEPTORS SPEC, DOI [10.1101/822361, DOI 10.1101/822361]; Andronesi OC, 2005, J AM CHEM SOC, V127, P12965, DOI 10.1021/ja0530164; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Baldus M, 1998, MOL PHYS, V95, P1197, DOI 10.1080/00268979809483251; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bate C, 2011, J BIOL CHEM, V286, P37955, DOI 10.1074/jbc.M111.248724; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Bove-Fenderson E, 2017, J BIOL CHEM, V292, P16858, DOI 10.1074/jbc.M117.789990; Brener O, 2015, SCI REP-UK, V5, DOI 10.1038/srep13222; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Calzolai L, 2003, J BIOL CHEM, V278, P35592, DOI 10.1074/jbc.M303005200; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Ciudad S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16566-1; Colvin MT, 2016, J AM CHEM SOC, V138, P9663, DOI 10.1021/jacs.6b05129; Colvin MT, 2015, J AM CHEM SOC, V137, P7509, DOI 10.1021/jacs.5b03997; Corbett GT, 2020, ACTA NEUROPATHOL, V139, P503, DOI 10.1007/s00401-019-02114-9; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dohler F, 2014, BRAIN, V137, P873, DOI 10.1093/brain/awt375; Ferreira DG, 2017, NAT NEUROSCI, V20, P1569, DOI 10.1038/nn.4648; Findeisen M, 2007, MAGN RESON CHEM, V45, P175, DOI 10.1002/mrc.1941; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Gao Y, 2020, J MOL BIOL, V432, P4388, DOI 10.1016/j.jmb.2020.05.018; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; Glynn C, 2020, NAT STRUCT MOL BIOL, V27, P417, DOI 10.1038/s41594-020-0403-y; Gremer L, 2017, SCIENCE, V358, P116, DOI 10.1126/science.aao2825; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Guillot-Sestier MV, 2012, J BIOL CHEM, V287, P5021, DOI 10.1074/jbc.M111.323626; Haas LT, 2016, BRAIN, V139, P526, DOI 10.1093/brain/awv356; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Heise H, 2001, J MAGN RESON, V150, P198, DOI 10.1006/jmre.2001.2343; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Hohwy M, 1999, J CHEM PHYS, V110, P7983, DOI 10.1063/1.478702; Hu NW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4374; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Jaroniec CP, 2019, J MAGN RESON, V306, P42, DOI 10.1016/j.jmr.2019.07.015; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kang M, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.63; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kellett KAB, 2009, PRION, V3, P190, DOI 10.4161/pri.3.4.9980; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Kostylev MA, 2018, MOL CELL, V72, P426, DOI 10.1016/j.molcel.2018.10.009; Kostylev MA, 2015, J BIOL CHEM, V290, P17415, DOI 10.1074/jbc.M115.643577; Kovacs H, 2014, J BIOMOL NMR, V58, P101, DOI 10.1007/s10858-013-9808-9; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lendel C, 2014, ANGEW CHEM INT EDIT, V53, P12756, DOI 10.1002/anie.201406357; Li D, 2020, BIOCHEMISTRY-US, V59, P639, DOI 10.1021/acs.biochem.9b01069; Lopez del Amo JM, 2012, J MOL BIOL, V421, P517, DOI 10.1016/j.jmb.2012.01.013; Madhu P, 2020, ACS CHEM NEUROSCI, V11, P86, DOI 10.1021/acschemneuro.9b00646; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; Markley JL, 1998, PURE APPL CHEM, V70, P117, DOI 10.1351/pac199870010117; Mengel D, 2019, BRAIN RES, V1710, P125, DOI 10.1016/j.brainres.2018.12.038; Mohammadi B, 2020, MOL NEUROBIOL, V57, P2812, DOI 10.1007/s12035-020-01917-2; MORRIS GA, 1979, J AM CHEM SOC, V101, P760, DOI 10.1021/ja00497a058; Nicoll AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3416; Nieznanski K, 2012, J BIOL CHEM, V287, P33104, DOI 10.1074/jbc.C112.400614; Norstrom EM, 2005, J BIOL CHEM, V280, P27236, DOI 10.1074/jbc.M413441200; Pagano K, 2019, MOL NEUROBIOL, V56, P1957, DOI 10.1007/s12035-018-1202-x; Parthasarathy S, 2015, J AM CHEM SOC, V137, P6480, DOI 10.1021/jacs.5b03373; Peters C, 2015, NEUROBIOL AGING, V36, P1369, DOI 10.1016/j.neurobiolaging.2014.11.019; Potapov A, 2015, J AM CHEM SOC, V137, P8294, DOI 10.1021/jacs.5b04843; Ravotti F, 2016, BIOMOL NMR ASSIGN, V10, P269, DOI 10.1007/s12104-016-9682-y; Rosener NS, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-1085-z; Rosener NS, 2018, J BIOL CHEM, V293, P15748, DOI 10.1074/jbc.RA118.003116; Sahoo BR, 2020, CHEM COMMUN, V56, P4627, DOI 10.1039/d0cc01551b; Sarell C. J., 2017, OPEN BIOL, V7, DOI DOI 10.6084/m9; Scheidt HA, 2020, PHYS CHEM CHEM PHYS, V22, P16887, DOI 10.1039/d0cp02307h; Scheidt HA, 2011, ANGEW CHEM INT EDIT, V50, P2837, DOI 10.1002/anie.201007265; SCHLEUCHER J, 1993, ANGEW CHEM INT EDIT, V32, P1489, DOI 10.1002/anie.199314891; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Silvers R, 2017, BIOCHEMISTRY-US, V56, P4850, DOI 10.1021/acs.biochem.7b00729; Skinner SP, 2016, J BIOMOL NMR, V66, P111, DOI 10.1007/s10858-016-0060-y; Solyom Z, 2013, J BIOMOL NMR, V55, P311, DOI 10.1007/s10858-013-9715-0; SZEVERENYI NM, 1982, J MAGN RESON, V47, P462, DOI 10.1016/0022-2364(82)90213-X; Tay WM, 2013, J MOL BIOL, V425, P2494, DOI 10.1016/j.jmb.2013.04.003; Theint T, 2017, BIOMOL NMR ASSIGN, V11, P75, DOI 10.1007/s12104-016-9723-6; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Um JW, 2013, PRION, V7, P37, DOI 10.4161/pri.22212; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Walti MA, 2016, P NATL ACAD SCI USA, V113, pE4976, DOI 10.1073/pnas.1600749113; Wang LQ, 2020, NAT STRUCT MOL BIOL, V27, P598, DOI 10.1038/s41594-020-0441-5; Williams TL, 2015, ACS CHEM NEUROSCI, V6, P1972, DOI 10.1021/acschemneuro.5b00229; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Xiao YL, 2020, J BIOL CHEM, V295, P458, DOI 10.1074/jbc.RA119.008522; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Younan ND, 2013, FASEB J, V27, P1847, DOI 10.1096/fj.12-222588; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413; Zou WQ, 2011, J BIOL CHEM, V286, P15095, DOI 10.1074/jbc.M110.199356	99	9	9	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100499	10.1016/j.jbc.2021.100499	http://dx.doi.org/10.1016/j.jbc.2021.100499			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33667547	Green Published, Green Submitted, gold			2022-12-26	WOS:000672866400473
J	Wu, J; Chen, X; Sehgal, P; Zhang, TW; Jackson-Weaver, O; Gou, YC; Bautch, V; Frenkel, B; Sun, HC; Xu, J				Wu, Jian; Chen, Xi; Sehgal, Prerna; Zhang, Tingwei; Jackson-Weaver, Olan; Gou, Yongchao; Bautch, Victoria; Frenkel, Baruch; Sun, Hongchen; Xu, Jian			Arginine methylation of R81 in Smad6 confines BMP-induced Smad1 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION; TRANSCRIPTION; HOMEOSTASIS; MUTATIONS; GROWTH; CANCER; RUNX2	Bone morphogenetic proteins (BMPs) secreted by a variety of cell types are known to play essential roles in cell differentiation and matrix formation in the bone, cartilage, muscle, blood vessel, and neuronal tissue. BMPs activate intracellular effectors via C-terminal phosphorylation of Smad1, Smad5, and Smad9, which relay the signaling by forming a complex with Smad4 and translocate to the nucleus for transcriptional activation. Smad6 inhibits BMP signaling through diverse mechanisms operative at the membrane, cytosolic, and nuclear levels. However, the mechanistic underpinnings of Smad6 functional diversity remain unclear. Here, using a biochemical approach and cell differentiation systems, we report a cytosolic mechanism of action for Smad6 that requires arginine methylation at arginine 81 (R81) and functions through association with Smad1 and interference with the formation of Smad1-Smad4 complexes. By mutating the methylated arginine residue, R81, and by silencing the expression of protein arginine methyltransferase 1, we show that protein arginine methyltransferase 1 catalyzes R81 methylation of Smad6 upon BMP treatment, R81 methylation subsequently facilitates Smad6 interaction with the phosphorylated active Smad1, and R81 methylation facilitates Smad6-mediated interruption of Smad1-Smad4 complex formation and nuclear translocation. Furthermore, Smad6 WT but not the methylation-deficient R81A mutant inhibited BMP-responsive transcription, attenuated BMP-mediated osteogenic differentiation, and antagonized BMP-mediated inhibition of cell invasion. Taken together, our results suggest that R81 methylation plays an essential role in Smad6-mediated inhibition of BMP responses.	[Wu, Jian; Chen, Xi; Sehgal, Prerna; Zhang, Tingwei; Jackson-Weaver, Olan; Gou, Yongchao; Xu, Jian] Univ Southern Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, Los Angeles, CA 90007 USA; [Chen, Xi; Sun, Hongchen] China Med Univ, Coll Stomatol, Shenyang, Peoples R China; [Zhang, Tingwei; Gou, Yongchao] Chongqing Med Univ, Coll Stomatol, Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing Municipal Key Lab Oral Biomed Engn High, Chongqing, Peoples R China; [Bautch, Victoria] Univ Northern Carolina, Dept Biol, Chapel Hill, NC USA; [Bautch, Victoria] Univ Northern Carolina, McAllister Heart Inst, Chapel Hill, NC USA; [Frenkel, Baruch; Xu, Jian] Univ Southern Calif, Dept Biochem & Mol Med, Keck Sch Med, Los Angeles, CA 90007 USA; [Xu, Jian] Univ Southern Calif, Keck Sch Med, Norris Canc Ctr, Los Angeles, CA 90007 USA; [Wu, Jian] Louisiana State Univ, Cardiovasc Ctr Excellence, New Orleans, LA USA; [Jackson-Weaver, Olan] Tulane Univ, Tulane Sch Med, Trauma & Crit Care Educ Div, New Orleans, LA 70118 USA	University of Southern California; China Medical University; Chongqing Medical University; University of Southern California; University of Southern California; Louisiana State University System; Tulane University	Xu, J (corresponding author), Univ Southern Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, Los Angeles, CA 90007 USA.; Sun, HC (corresponding author), China Med Univ, Coll Stomatol, Shenyang, Peoples R China.; Xu, J (corresponding author), Univ Southern Calif, Dept Biochem & Mol Med, Keck Sch Med, Los Angeles, CA 90007 USA.; Xu, J (corresponding author), Univ Southern Calif, Keck Sch Med, Norris Canc Ctr, Los Angeles, CA 90007 USA.	sunhongchen@cmu.edu.cn; xujian@usc.edu		Xu, Jian/0000-0002-8162-889X; Gou, Yongchao/0000-0001-8725-3702; Jackson-Weaver, Olan/0000-0002-0545-0647; Zhang, Tingwei/0000-0003-2173-4663; Sehgal, Prerna/0000-0003-4913-896X	NIDCR, National Institutes of Health [RO1DE02468]; American Heart Association [16BGIA26540000, 11SDG5220002]; American Heart Association postdoctoral fellowship [15POST25710243]; National Natural Science Foundation of China [81800985]; Herman Ostrow School of Dentistry; University of Southern California	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); American Heart Association(American Heart Association); American Heart Association postdoctoral fellowship(American Heart Association); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Herman Ostrow School of Dentistry; University of Southern California	This research was supported by grants including the NIDCR, National Institutes of Health (RO1DE02468, to J. X.), American Heart Association (16BGIA26540000 and 11SDG5220002, to J. X.), American Heart Association postdoctoral fellowship (15POST25710243, to J. W.), National Natural Science Foundation of China (81800985, to T. Z.), Seed grant from the Herman Ostrow School of Dentistry (to J. X.), and start-up fund from the Provost at the University of Southern California (to J. X.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akiyama S, 1997, EXP CELL RES, V235, P362, DOI 10.1006/excr.1997.3680; Bai ST, 2000, J BIOL CHEM, V275, P8267, DOI 10.1074/jbc.275.12.8267; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Chaikuad A, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022111; Chen C, 2011, NAT REV MOL CELL BIO, V12, P629, DOI 10.1038/nrm3185; de Boeck M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24968; Desgrosellier JS, 2005, DEV BIOL, V280, P201, DOI 10.1016/j.ydbio.2004.12.037; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Goto K, 2007, J BIOL CHEM, V282, P20603, DOI 10.1074/jbc.M702100200; Goumans MJ, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a031989; Grgurevic L, 2016, CYTOKINE GROWTH F R, V27, P105, DOI 10.1016/j.cytogfr.2015.12.009; Guccione E, 2019, NAT REV MOL CELL BIO, V20, P642, DOI 10.1038/s41580-019-0155-x; Hanyu A, 2001, J CELL BIOL, V155, P1017, DOI 10.1083/jcb.200106023; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Inamitsu M, 2006, FEBS LETT, V580, P6603, DOI 10.1016/j.febslet.2006.11.008; Jeon HS, 2008, CANCER RES, V68, P9686, DOI 10.1158/0008-5472.CAN-08-1083; Jiao JT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04936-9; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Katagiri T, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021899; Koromila T, 2014, J CELL BIOCHEM, V115, P27, DOI 10.1002/jcb.24646; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Lin X, 2003, MOL CELL BIOL, V23, P9081, DOI 10.1128/MCB.23.24.9081-9093.2003; Macias MJ, 2015, TRENDS BIOCHEM SCI, V40, P296, DOI 10.1016/j.tibs.2015.03.012; Miyazawa K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022095; Morimoto E, 2017, J CELL PHYSIOL, V232, P145, DOI 10.1002/jcp.25399; Mouillesseaux KP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13247; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Timberlake AT, 2018, HUM GENOME VAR, V5, DOI 10.1038/s41439-018-0014-x; Timberlake AT, 2017, P NATL ACAD SCI USA, V114, pE7341, DOI 10.1073/pnas.1709255114; Timberlake AT, 2016, ELIFE, V5, DOI 10.7554/eLife.20125; Wang Y, 2016, ONCOTARGET, V7, P24383, DOI 10.18632/oncotarget.8328; Wyliea LA, 2018, DEV BIOL, V442, P199, DOI 10.1016/j.ydbio.2018.07.027; Xu J, 2013, MOL CELL, V51, P5, DOI 10.1016/j.molcel.2013.05.004; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Zhang T, 2018, J DENT RES, V97, P810, DOI 10.1177/0022034518755688	37	2	2	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100496	10.1016/j.jbc.2021.100496	http://dx.doi.org/10.1016/j.jbc.2021.100496			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33667543	Green Published, gold			2022-12-26	WOS:000672866400470
J	Feng, HP; Cheng, HY; Hsiao, TF; Lin, TW; Hsu, JW; Huang, LH; Yu, CJ				Feng, Hsiang-Pu; Cheng, Hsiao-Yun; Hsiao, Ting-Feng; Lin, Tai-Wei; Hsu, Jia-Wei; Huang, Lien-Hung; Yu, Chia-Jung			ArfGAP1 acts as a GTPase-activating protein for human ADP-ribosylation factor-like 1 protein	FASEB JOURNAL			English	Article						ADP&#8208; ribosylation factor; Arf&#8208; like protein Arl1; Golgi; GTPase&#8208; activating protein; vesicle trafficking		ADP-ribosylation factors (Arfs) and Arf-like (Arl) GTPases are key regulators of intracellular vesicle trafficking and Golgi structure. Both Arf and Arl proteins cycle between active GTP-bound and inactive GDP-bound forms, where guanine nucleotide exchange factors (GEFs) regulate the exchange of GDP for GTP, whereas GTPase-activating proteins (GAPs) promote the hydrolysis of bound GTP. Human Arl1 is located at the trans-Golgi network (TGN) and regulates the function and structure of the Golgi complex. However, neither GEFs nor GAPs for human Arl1 have been identified. Here, we report that ArfGAP1, an Arf1 GAP, can promote GTP hydrolysis of Arl1. We show that ArfGAP1 directly interacts with GTP-bound Arl1 and exhibits GAP activity toward Arl1 in vitro. Exogenous expression of ArfGAP1, but not ArfGAP2 and ArfGAP3, causes dissociation of endogenous Arl1 from the TGN. In addition, GAP activity-deficient ArfGAP1 fails to regulate the Golgi localization of Arl1. Using an activity pull-down assay, we demonstrated that ArfGAP1 regulates the levels of Arl1-GTP in cells expressing ArfGAP1-myc or with ArfGAP1 knockdown. Finally, we observed that, similar to expression of putative active Arl1 (Arl1QL), ArfGAP1 knockdown impairs endosome-to-TGN retrograde transport of the Shiga toxin B-subunit. Thus, our findings support the idea that ArfGAP1 acts as an Arl1 GAP to regulate the function of Arl1 in vesicle trafficking at the TGN.	[Feng, Hsiang-Pu; Hsiao, Ting-Feng; Lin, Tai-Wei; Huang, Lien-Hung; Yu, Chia-Jung] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan; [Cheng, Hsiao-Yun; Yu, Chia-Jung] Chang Gung Univ, Coll Med, Dept Cell & Mol Biol, 259 Wen Hwa 1st Rd, Taoyuan, Taiwan; [Hsu, Jia-Wei] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei, Taiwan; [Hsu, Jia-Wei] Natl Taiwan Univ, Coll Life Sci, Inst Biochem Sci, Taipei, Taiwan; [Huang, Lien-Hung] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Yu, Chia-Jung] Chang Gung Mem Hosp, Dept Thorac Med, Taoyuan, Taiwan; [Yu, Chia-Jung] Chang Gung Univ, Mol Med Res Ctr, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; National Taiwan University; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Yu, CJ (corresponding author), Chang Gung Univ, Coll Med, Dept Cell & Mol Biol, 259 Wen Hwa 1st Rd, Taoyuan, Taiwan.	yucj1124@mail.cgu.edu.tw		Hsiao, Ting-Feng/0000-0003-4074-9019; Huang, Lien-Hung/0000-0001-8641-9897; Yu, Chia-Jung/0000-0001-6301-7190	Ministry of Science and Technology, Taiwan [105-2320-B-182-035-MY3, 108-2320-B-182-007-MY3, MOST-109-2636-B-002-015]; Chang Gung Memorial Hospital, Taoyuan, Taiwan [CORPD1J0092, CMRPD1H0081-3, BMRP894]; Molecular Medicine Research Center, Chang Gung University, from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education, Taiwan	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taoyuan, Taiwan(Chang Gung Memorial Hospital); Molecular Medicine Research Center, Chang Gung University, from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education, Taiwan	This work was financially supported by grants from the Ministry of Science and Technology, Taiwan (105-2320-B-182-035-MY3 and 108-2320-B-182-007-MY3 to C.-J. Y., MOST-109-2636-B-002-015 to J.-W. H.); the Chang Gung Memorial Hospital, Taoyuan, Taiwan (CORPD1J0092, CMRPD1H0081-3, and BMRP894 to C.-J. Y.); and the Molecular Medicine Research Center, Chang Gung University, from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education, Taiwan.	Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; Christis C, 2012, J CELL BIOL, V196, P327, DOI 10.1083/jcb.201107115; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; D'Souza RS, 2014, CURR BIOL, V24, P1187, DOI 10.1016/j.cub.2014.04.003; Dembla M, 2014, J NEUROSCI, V34, P5245, DOI 10.1523/JNEUROSCI.3837-13.2014; Dodonova SO, 2017, ELIFE, V6, DOI 10.7554/eLife.26691; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Eiseler T, 2016, J BIOL CHEM, V291, P462, DOI 10.1074/jbc.M115.673582; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; Frigerio G, 2007, TRAFFIC, V8, P1644, DOI 10.1111/j.1600-0854.2007.00631.x; Gallegos KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030368; Gehart H, 2012, DEV CELL, V23, P756, DOI 10.1016/j.devcel.2012.07.019; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Goud Bruno, 2018, Small GTPases, V9, P66, DOI 10.1080/21541248.2017.1384087; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Huang LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118743; Huber I, 1998, J BIOL CHEM, V273, P24786, DOI 10.1074/jbc.273.38.24786; Huber I, 2001, METHOD ENZYMOL, V329, P307; Jackson CL, 2003, CURR BIOL, V13, pR174, DOI 10.1016/S0960-9822(03)00116-7; Jian XY, 2010, TRAFFIC, V11, P732, DOI 10.1111/j.1600-0854.2010.01054.x; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kjer-Nielsen L, 1999, CURR BIOL, V9, P385, DOI 10.1016/S0960-9822(99)80168-7; Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008; Lieu ZZ, 2008, P NATL ACAD SCI USA, V105, P3351, DOI 10.1073/pnas.0800137105; Liu YW, 2005, MOL BIOL CELL, V16, P4024, DOI 10.1091/mbc.E05-01-0023; Lock JG, 2005, TRAFFIC, V6, P1142, DOI 10.1111/j.1600-0854.2005.00349.x; Lowe SL, 1996, J CELL SCI, V109, P209; Lu L, 2005, METHOD ENZYMOL, V404, P432, DOI 10.1016/S0076-6879(05)04038-3; Lu L, 2003, MOL BIOL CELL, V14, P3767, DOI 10.1091/mbc.E03-01-0864; Lu L, 2004, MOL BIOL CELL, V15, P4426, DOI 10.1091/mbc.E03-12-0872; Lu L, 2001, J CELL SCI, V114, P4543; Luo RB, 2008, J BIOL CHEM, V283, P21965, DOI 10.1074/jbc.M802268200; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Man ZQ, 2011, J BIOL CHEM, V286, P11569, DOI 10.1074/jbc.M110.201442; Munro S, 2005, BIOCHEM SOC T, V33, P601, DOI 10.1042/BST0330601; Pevzner I, 2012, TRAFFIC, V13, P849, DOI 10.1111/j.1600-0854.2012.01349.x; Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555; Poon PP, 1996, P NATL ACAD SCI USA, V93, P10074, DOI 10.1073/pnas.93.19.10074; Ramirez IBR, 2009, SEMIN CELL DEV BIOL, V20, P770, DOI 10.1016/j.semcdb.2009.03.011; Saitoh A, 2009, J BIOL CHEM, V284, P13948, DOI 10.1074/jbc.M900749200; Shiba Y, 2013, CURR BIOL, V23, P1945, DOI 10.1016/j.cub.2013.07.087; Shiba Yoko, 2011, Cell Logist, V1, P139, DOI 10.4161/cl.1.4.18896; Sinka R, 2008, J CELL BIOL, V183, P607, DOI 10.1083/jcb.200808018; Siu KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018458; Stanley AC, 2012, J LEUKOCYTE BIOL, V92, P1227, DOI 10.1189/jlb.0412191; Szafer E, 2000, J BIOL CHEM, V275, P23615, DOI 10.1074/jbc.M003171200; Sztul E, 2019, MOL BIOL CELL, V30, P1249, DOI 10.1091/mbc.E18-12-0820; Tai GH, 2005, METHOD ENZYMOL, V404, P442, DOI 10.1016/S0076-6879(05)04039-5; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; Watson PJ, 2004, TRAFFIC, V5, P79, DOI 10.1111/j.1600-0854.2004.00158.x; Weimer C, 2008, J CELL BIOL, V183, P725, DOI 10.1083/jcb.200806140; Yoshino A, 2005, J CELL SCI, V118, P2279, DOI 10.1242/jcs.02358; Yu CJ, 2017, J CELL SCI, V130, P1691, DOI 10.1242/jcs.201319; Yu XC, 2012, CELL, V148, P530, DOI 10.1016/j.cell.2012.01.015	56	2	2	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21337	10.1096/fj.202000818RR	http://dx.doi.org/10.1096/fj.202000818RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715220				2022-12-26	WOS:000635216100099
J	Mirra, P; Desiderio, A; Spinelli, R; Nigro, C; Longo, M; Parrillo, L; D'Esposito, V; Carissimo, A; Hedjazifar, S; Smith, U; Formisano, P; Miele, C; Raciti, GA; Beguinot, F				Mirra, Paola; Desiderio, Antonella; Spinelli, Rosa; Nigro, Cecilia; Longo, Michele; Parrillo, Luca; D'Esposito, Vittoria; Carissimo, Annamaria; Hedjazifar, Shahram; Smith, Ulf; Formisano, Pietro; Miele, Claudia; Raciti, Gregory A.; Beguinot, Francesco			Adipocyte precursor cells from first degree relatives of type 2 diabetic patients feature changes in hsa-mir-23a-5p, -193a-5p, and -193b-5p and insulin-like growth factor 2 expression	FASEB JOURNAL			English	Article						adipocyte precursor cells; first degree relatives of type 2 diabetic patients; marks; miRNAs; type 2 diabetes	WHITE ADIPOSE-TISSUE; FAMILY-HISTORY; 1ST-DEGREE RELATIVES; IMPAIRED ADIPOGENESIS; NONOBESE INDIVIDUALS; HYPERTROPHIC OBESITY; FAT DISTRIBUTION; WNT; RESISTANCE; DIFFERENTIATION	First-degree relatives (FDRs) of type 2 diabetics (T2D) feature dysfunction of subcutaneous adipose tissue (SAT) long before T2D onset. miRNAs have a role in adipocyte precursor cells (APC) differentiation and in adipocyte identity. Thus, impaired miRNA expression may contribute to SAT dysfunction in FDRs. In the present work, we have explored changes in miRNA expression associated with T2D family history which may affect gene expression in SAT APCs from FDRs. Small RNA-seq was performed in APCs from healthy FDRs and matched controls and omics data were validated by qPCR. Integrative analyses of APC miRNome and transcriptome from FDRs revealed down-regulated hsa-miR-23a-5p, -193a-5p and -193b-5p accompanied by up-regulated Insulin-like Growth Factor 2 (IGF2) gene which proved to be their direct target. The expression changes in these marks were associated with SAT adipocyte hypertrophy in FDRs. APCs from FDRs further demonstrated reduced capability to differentiate into adipocytes. Treatment with IGF2 protein decreased APC adipogenesis, while over-expression of hsa-miR-23a-5p, -193a-5p and -193b-5p enhanced adipogenesis by IGF2 targeting. Indeed, IGF2 increased the Wnt Family Member 10B gene expression in APCs. Down-regulation of the three miRNAs and IGF2 up-regulation was also observed in Peripheral Blood Leukocytes (PBLs) from FDRs. In conclusion, APCs from FDRs feature a specific miRNA/gene profile, which associates with SAT adipocyte hypertrophy and appears to contribute to impaired adipogenesis. PBL detection of this profile may help in identifying adipocyte hypertrophy in individuals at high risk of T2D.	[Mirra, Paola; Desiderio, Antonella; Spinelli, Rosa; Nigro, Cecilia; Longo, Michele; Parrillo, Luca; D'Esposito, Vittoria; Formisano, Pietro; Miele, Claudia; Raciti, Gregory A.; Beguinot, Francesco] CNR, Inst Expt Endocrinol & Oncol, URT Genom Diabet, Via Pansini 5, I-80131 Naples, Italy; [Mirra, Paola; Desiderio, Antonella; Spinelli, Rosa; Nigro, Cecilia; Longo, Michele; Parrillo, Luca; D'Esposito, Vittoria; Formisano, Pietro; Miele, Claudia; Raciti, Gregory A.; Beguinot, Francesco] Federico II Univ Naples, Dept Translat Med, Naples, Italy; [Carissimo, Annamaria] Telethon Inst Genet & Med, Pozzuoli, Italy; [Hedjazifar, Shahram; Smith, Ulf] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Lundberg Lab Diabet Res, Gothenburg, Sweden	Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Gothenburg	Miele, C; Beguinot, F (corresponding author), CNR, Inst Expt Endocrinol & Oncol, URT Genom Diabet, Via Pansini 5, I-80131 Naples, Italy.	c.miele@ieos.cnr.it; beguino@unina.it	Parrillo, Luca/AIA-1186-2022	Parrillo, Luca/0000-0001-9801-9778; D'Esposito, Vittoria/0000-0002-3675-8062	Ministero dell'Istruzione, Universita e della Ricerca Scientifica [PRIN 2017, ARS01_01270]; Regione Campania; European Foundation for the Study of Diabetes (EFSD); Boehringer Ingelheim; Swedish Research Council; Torsten Soderberg Foundation; Novo Nordisk Foundation	Ministero dell'Istruzione, Universita e della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR)); Regione Campania(Regione Campania); European Foundation for the Study of Diabetes (EFSD); Boehringer Ingelheim(Boehringer Ingelheim); Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten Soderberg Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	Ministero dell'Istruzione, Universita e della Ricerca Scientifica, Grant/Award Number: PRIN 2017 and ARS01_01270; Regione Campania; European Foundation for the Study of Diabetes (EFSD); Boehringer Ingelheim; Swedish Research Council; Torsten Soderberg Foundation; Novo Nordisk Foundation	Acosta JR, 2016, DIABETOLOGIA, V59, P560, DOI 10.1007/s00125-015-3810-6; Alfares MN, 2018, AM J PHYSIOL-ENDOC M, V315, pE1098, DOI 10.1152/ajpendo.00409.2017; Anthanont P, 2017, INT J OBESITY, V41, P1621, DOI 10.1038/ijo.2017.171; Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Arner P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018284; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bianchi M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040840; Blake GET, 2016, CURR OPIN CHEM BIOL, V33, P101, DOI 10.1016/j.cbpa.2016.06.008; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Brandao BB, 2017, REDOX BIOL, V12, P82, DOI 10.1016/j.redox.2017.01.020; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Cederberg H, 2015, J INTERN MED, V277, P540, DOI 10.1111/joim.12289; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Collares Cristhianna V A, 2013, BMC Res Notes, V6, P491, DOI 10.1186/1756-0500-6-491; Corral-Fernandez NE, 2013, EXP CLIN ENDOCR DIAB, V121, P347, DOI 10.1055/s-0033-1341516; Corrales P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072124; Dimas AS, 2014, DIABETES, V63, P2158, DOI 10.2337/db13-0949; DUPUIS J, 2010, NAT GENET, V42; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Fei ZL, 2011, J BIOL CHEM, V286, P27761, DOI 10.1074/jbc.M111.248435; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; Forouhi Nita G, 2014, Curr Nutr Rep, V3, P355; Groop L, 1996, DIABETES, V45, P1585, DOI 10.2337/diabetes.45.11.1585; Gustafson B, 2013, DIABETES, V62, P2997, DOI 10.2337/db13-0473; Gustafson B, 2012, DIABETES, V61, P1217, DOI 10.2337/db11-1419; Hammarstedt A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34113-3; Hammarstedt A, 2018, PHYSIOL REV, V98, P1911, DOI 10.1152/physrev.00034.2017; Hammarstedt A, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-42; Hashimoto N, 2017, J HUM GENET, V62, P141, DOI 10.1038/jhg.2016.150; He YQ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030456; Henninger AMJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105262; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3467, DOI 10.1073/pnas.95.7.3467; Johanson EH, 2003, J CLIN ENDOCR METAB, V88, P4232, DOI 10.1210/jc.2002-021961; Kanherkar RR, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00049; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Kleiman A, 2013, EXP MOL PATHOL, V94, P126, DOI 10.1016/j.yexmp.2012.09.023; Knowles NG, 2002, DIABETES CARE, V25, P292, DOI 10.2337/diacare.25.2.292; Laakso M, 2008, DIABETOLOGIA, V51, P502, DOI 10.1007/s00125-007-0899-2; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee PL, 2016, MOL METAB, V5, P422, DOI 10.1016/j.molmet.2016.04.001; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Longo M, 2018, DIABETOLOGIA, V61, P369, DOI 10.1007/s00125-017-4471-4; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Mirra P, 2017, BBA-MOL BASIS DIS, V1863, P440, DOI 10.1016/j.bbadis.2016.11.018; Mitchell BD, 2004, OBES RES, V12, P831, DOI 10.1038/oby.2004.100; Mohlke KL, 2015, HUM MOL GENET, V24, pR85, DOI 10.1093/hmg/ddv264; Nyholm B, 2004, EUR J ENDOCRINOL, V150, P207, DOI 10.1530/eje.0.1500207; Panzeri I, 2018, MOL METAB, V14, P26, DOI 10.1016/j.molmet.2018.05.010; Parrillo L, 2020, EPIGENOMICS-UK, V12, P873, DOI 10.2217/epi-2019-0267; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Raciti GA, 2017, SCI REP-UK, V7, DOI 10.1038/srep43526; Raciti GA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193704; Rassoulzadegan M, 2015, SEMIN CELL DEV BIOL, V44, P47, DOI 10.1016/j.semcdb.2015.08.007; Ren G, 2018, MOL MED REP, V17, P4554, DOI 10.3892/mmr.2018.8452; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; ROSS SE, 2000, SCIENCE, V0289, P00950, DOI [DOI 10.1126/SCIENCE.289.5481.950, DOI 10.1126/science.289.5481.950, 10.1126/science.289.5481.950]; Scott RA, 2013, DIABETOLOGIA, V56, P60, DOI 10.1007/s00125-012-2715-x; Smith U, 2016, J INTERN MED, V280, P465, DOI 10.1111/joim.12540; Stancakova A, 2016, ENDOCR DEV, V31, P203, DOI 10.1159/000439418; Vassy Jason L, 2011, Diabetes Res Clin Pract, V93, pe76, DOI 10.1016/j.diabres.2011.04.013; Vertino AM, 2005, MOL BIOL CELL, V16, P2039, DOI 10.1091/mbc.E04-08-0720; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Xu L, 2015, BIOMOLECULES, V5, P1563, DOI 10.3390/biom5031563; Yang J, 2012, OBESITY, V20, P932, DOI 10.1038/oby.2011.371; Yang J, 2020, MOL MED REP, V21, P2395, DOI 10.3892/mmr.2020.11069; Yang XL, 2004, BIOCHEM BIOPH RES CO, V317, P1045, DOI 10.1016/j.bbrc.2004.03.152; Yi F, 2017, BIOCHEM BIOPH RES CO, V491, P876, DOI 10.1016/j.bbrc.2017.07.108; Zhang K, 2019, EXP THER MED, V17, P1663, DOI 10.3892/etm.2018.7132; Zhou J, 2016, J CANCER, V7, P1740, DOI 10.7150/jca.15620	74	4	4	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21357	10.1096/fj.202002156RRR	http://dx.doi.org/10.1096/fj.202002156RRR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710685				2022-12-26	WOS:000635216100005
J	Wei, XM; Li, C; Zhang, Y; Li, K; Li, JQ; Ai, KT; Li, KM; Zhang, JS; Yang, JL				Wei, Xiumei; Li, Cheng; Zhang, Yu; Li, Kang; Li, Jiaqi; Ai, Kete; Li, Kunming; Zhang, Jiansong; Yang, Jialong			Fish NF-kappa B couples TCR and IL-17 signals to regulate ancestral T-cell immune response against bacterial infection	FASEB JOURNAL			English	Article						adaptive immunity; evolution; IL&#8208; 17; NF&#8208; &#954; B; T cells; teleost	PEPTIDOGLYCAN RECOGNITION PROTEINS; EVOLUTION ANALYSIS; FAMILY CYTOKINES; HOST-DEFENSE; TH17 CELLS; RECEPTOR; GENES; ROLES; ACTIVATION; DIVERSITY	As fish constitute the first evolutionary group with primordial T cells, they are of importance for understanding the origin and evolution of adaptive immunity. Yet, the knowledge about how ancestral T cells function remains limited. Therefore, the teleost model Nile tilapia (Oreochromis niloticus) was used in this study to investigate the regulatory mechanisms of T-cell immunity in fish. We identified an evolutionarily conserved canonical NF-kappa B signaling pathway in Nile tilapia, which participates in primary adaptive immune response during Streptococcus agalactiae infection. Blockade of NF-kappa B activity severely impairs T-cell activation and expansion, rendering the animals more vulnerable to pathogen attack. Meanwhile, NF-kappa B signaling is indispensable for fish T cells to produce IL-17A during the antibacterial immune response. Moreover, IL-17A binds its receptor IL-17RA, initiates the ACT1-TRAF6-TAK1 axis, and triggers NF-kappa B-dependent T-cell activation, thus forming a positive feedback loop of T-cell immunity in Nile tilapia. Furthermore, IL-17A seems to promote innate immunity by regulating pro-inflammatory cytokines via TRAF6-NF-kappa B axis, indicating the presence of an NF-kappa B-dependent IL-17A signaling pathway for coordinating adaptive and innate immunity in fish. Our results suggest that fish NF-kappa B couples TCR and IL-17 signals to modulate ancestral T-cell immunity against bacterial infection, and the regulation of T-cell immunity by NF-kappa B and IL-17 is a strategy that existed prior to the divergence of the tetrapod lineage from teleost fish. This study, therefore, provides a new perspective on the evolution of adaptive immunity.	[Wei, Xiumei; Li, Cheng; Zhang, Yu; Li, Kang; Li, Jiaqi; Ai, Kete; Li, Kunming; Zhang, Jiansong; Yang, Jialong] East China Normal Univ, Sch Life Sci, State Key Lab Estuarine & Coastal Res, Shanghai 200241, Peoples R China; [Yang, Jialong] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China	East China Normal University; Qingdao National Laboratory for Marine Science & Technology	Yang, JL (corresponding author), East China Normal Univ, Sch Life Sci, State Key Lab Estuarine & Coastal Res, Shanghai 200241, Peoples R China.	jlyang@bio.ecnu.edu.cn	kang, li/HCH-5087-2022		National Natural Science Foundation of China (NSFC) [32022086, 31972822, 31872591]; Natural Science Foundation of Shanghai (Shanghai Natural Science Foundation) [20ZR1417500]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai (Shanghai Natural Science Foundation)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 32022086, 31972822 and 31872591; Natural Science Foundation of Shanghai (Shanghai Natural Science Foundation), Grant/Award Number: 20ZR1417500	Algood HMS, 2009, J IMMUNOL, V183, P5837, DOI 10.4049/jimmunol.0901206; Aronica MA, 1999, J IMMUNOL, V163, P5116; Bottcher J, 2015, SEMIN IMMUNOL, V27, P4, DOI 10.1016/j.smim.2015.03.001; Brenke JK, 2018, J BIOL CHEM, V293, P13191, DOI 10.1074/jbc.RA118.002649; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Guedes PMD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000604; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Ding Y, 2016, FISH SHELLFISH IMMUN, V58, P332, DOI 10.1016/j.fsi.2016.09.017; Dong CJ, 2019, GENE, V686, P68, DOI 10.1016/j.gene.2018.10.038; Ferreira V, 1999, J IMMUNOL, V162, P6442; Gilmore TD, 2012, IMMUNOL REV, V246, P14, DOI 10.1111/j.1600-065X.2012.01096.x; Gonzalez-Fernandez C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072439; Gu CF, 2013, CYTOKINE, V64, P477, DOI 10.1016/j.cyto.2013.07.022; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; Hui SP, 2017, DEV CELL, V43, P659, DOI 10.1016/j.devcel.2017.11.010; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Kim JS, 2013, CELL MOL LIFE SCI, V70, P2271, DOI 10.1007/s00018-012-1163-6; Koretzky GA, 2001, NAT REV IMMUNOL, V1, P95, DOI 10.1038/35100523; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Kurata S, 2014, DEV COMP IMMUNOL, V42, P36, DOI 10.1016/j.dci.2013.06.006; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Li C, 2020, DEV COMP IMMUNOL, V103, DOI 10.1016/j.dci.2019.103526; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li YN, 2020, FISH SHELLFISH IMMUN, V97, P474, DOI 10.1016/j.fsi.2019.11.036; Liu CN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001843; Loo TT, 2018, J LEUKOCYTE BIOL, V104, P1069, DOI 10.1002/JLB.1RI0418-152RR; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Miyazaki Y, 2010, J IMMUNOL, V185, P1150, DOI 10.4049/jimmunol.0900047; Mousallem T, 2014, BLOOD, V124, P2046, DOI 10.1182/blood-2014-04-571265; Nakanishi Teruyuki, 2015, Biology-Basel, V4, P640, DOI 10.3390/biology4040640; Ouaaz F, 1999, J EXP MED, V189, P999, DOI 10.1084/jem.189.6.999; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Reynolds JM, 2010, CYTOKINE GROWTH F R, V21, P413, DOI 10.1016/j.cytogfr.2010.10.002; Royet J, 2004, CELL MOL LIFE SCI, V61, P537, DOI 10.1007/s00018-003-3243-0; Ruan QG, 2011, J EXP MED, V208, P2321, DOI 10.1084/jem.20110462; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sumiyoshi M, 2021, J IMMUNOL, V206, P366, DOI 10.4049/jimmunol.2000971; Sun JJ, 2019, J IMMUNOL, V203, P1845, DOI 10.4049/jimmunol.1900238; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Suryawanshi A, 2011, J IMMUNOL, V187, P1919, DOI 10.4049/jimmunol.1100736; Takeuchi Y, 2020, IMMUNOL REV, V294, P164, DOI 10.1111/imr.12841; Takizawa F, 2016, J IMMUNOL, V196, P4522, DOI 10.4049/jimmunol.1600222; Takizawa F, 2011, DEV COMP IMMUNOL, V35, P752, DOI 10.1016/j.dci.2011.02.008; Thaventhiran JED, 2013, CURR OPIN IMMUNOL, V25, P321, DOI 10.1016/j.coi.2013.05.010; Tobe M, 2003, BIOORGAN MED CHEM, V11, P383, DOI 10.1016/S0968-0896(02)00440-6; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wan F, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00675; Wang L., 2020, FISH SHELLFISH IMMUN, V97, p554; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wei XM, 2020, J BIOL CHEM, V295, P3000, DOI 10.1074/jbc.RA119.012231; Wei XM, 2020, J IMMUNOL, V204, P569, DOI 10.4049/jimmunol.1901065; Wei XM, 2019, J IMMUNOL, V203, P1172, DOI 10.4049/jimmunol.1900008; Wu Z., 2019, FISH SHELLFISH IMMUN, V93, p1084; Xu S, 2010, J IMMUNOL, V185, P5879, DOI 10.4049/jimmunol.1001763; Xu TJ, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00256-18, 10.1128/iai.00256-18]; Yang Q, 2016, FISH SHELLFISH IMMUN, V49, P243, DOI 10.1016/j.fsi.2015.12.031	62	6	6	5	35	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21457	10.1096/fj.202002393RR	http://dx.doi.org/10.1096/fj.202002393RR			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33689192				2022-12-26	WOS:000635216100100
J	Ghafari, M; Clark, J; Guo, HB; Yu, RF; Sun, Y; Dang, WW; Qin, H				Ghafari, Mehran; Clark, Justin; Guo, Hao-Bo; Yu, Ruofan; Sun, Yu; Dang, Weiwei; Qin, Hong			Complementary performances of convolutional and capsule neural networks on classifying microfluidic images of dividing yeast cells	PLOS ONE			English	Article								Microfluidic-based assays have become effective high-throughput approaches to examining replicative aging of budding yeast cells. Deep learning may offer an efficient way to analyze a large number of images collected from microfluidic experiments. Here, we compare three deep learning architectures to classify microfluidic time-lapse images of dividing yeast cells into categories that represent different stages in the yeast replicative aging process. We found that convolutional neural networks outperformed capsule networks in terms of accuracy, precision, and recall. The capsule networks had the most robust performance in detecting one specific category of cell images. An ensemble of three best-fitted single-architecture models achieves the highest overall accuracy, precision, and recall due to complementary performances. In addition, extending classification classes and data augmentation of the training dataset can improve the predictions of the biological categories in our study. This work lays a useful framework for sophisticated deep-learning processing of microfluidic-based assays of yeast replicative aging.	[Ghafari, Mehran; Clark, Justin; Guo, Hao-Bo; Qin, Hong] Univ Tennessee, Dept Comp Sci & Engn, SimCtr, Chattanooga, TN 37403 USA; [Yu, Ruofan; Sun, Yu; Dang, Weiwei] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Qin, Hong] Univ Tennessee, Dept Biol Geol & Environm Sci, Dept Comp Sci & Engn, Chattanooga, TN 37403 USA	University of Tennessee System; University of Tennessee at Chattanooga; Baylor College of Medicine; University of Tennessee System; University of Tennessee at Chattanooga	Ghafari, M; Qin, H (corresponding author), Univ Tennessee, Dept Comp Sci & Engn, SimCtr, Chattanooga, TN 37403 USA.; Qin, H (corresponding author), Univ Tennessee, Dept Biol Geol & Environm Sci, Dept Comp Sci & Engn, Chattanooga, TN 37403 USA.	ryg668@mocs.utc.edu; hong-qin@utc.edu		Dang, Weiwei/0000-0002-6931-4636; Sun, Yu/0000-0001-6220-906X; Ghafari, Mehran/0000-0003-3180-2201; Qin, Hong/0000-0002-1060-6722; Guo, Hao-Bo/0000-0003-1321-1758	National Science Foundation [1453078, 1720215, 1761839]; National Institute of Health [R01AG052507, R42AG058368]; University of Tennessee at Chattanooga	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Tennessee at Chattanooga	This study was funded in part by the National Science Foundation in the form of grants (CAREER award #1453078, #1720215; and #1761839) awarded to HQ. This study was also funded by the National Institute of Health in the form of grants (Grant Nos. #R01AG052507 and #R42AG058368) awarded to WD. This study was also supported in the form of research support from University of Tennessee at Chattanooga awarded to HQ.	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Araque O, 2017, EXPERT SYST APPL, V77, P236, DOI 10.1016/j.eswa.2017.02.002; BUCKLAND M, 1994, J AM SOC INFORM SCI, V45, P12, DOI 10.1002/(SICI)1097-4571(199401)45:1<12::AID-ASI2>3.0.CO;2-L; Ching T, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0387; Ciresan DC, 2010, NEURAL COMPUT, V22, P3207, DOI 10.1162/NECO_a_00052; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Esteva A, 2019, NAT MED, V25, P24, DOI 10.1038/s41591-018-0316-z; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P882, DOI 10.1016/j.patrec.2005.10.012; Gers FA, 2000, NEURAL COMPUT, V12, P2451, DOI 10.1162/089976600300015015; Huang XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104539; Jo MC, 2015, P NATL ACAD SCI USA, V112, P9364, DOI 10.1073/pnas.1510328112; Kim TH, 2018, BIOCHIP J, V12, P294, DOI 10.1007/s13206-018-2407-9; King DB, 2015, ACS SYM SER, V1214, P1; Krizhevsky Alex, 2017, Communications of the ACM, V60, P84, DOI 10.1145/3065386; LeCun Y., 2015, DEEP LEARNING NATURE, V521, P436, DOI [DOI 10.1038/NATURE14539, 10.1038/nature14539]; Li K., 2009, CVPR09; Ma YF, 2018, INT J HOSP MANAG, V71, P120, DOI 10.1016/j.ijhm.2017.12.008; McCormick MA, 2015, CELL METAB, V22, P895, DOI 10.1016/j.cmet.2015.09.008; McLaughlin N, 2015, 2015 12TH IEEE INTERNATIONAL CONFERENCE ON ADVANCED VIDEO AND SIGNAL BASED SURVEILLANCE (AVSS); Oh KW, 2017, MICROMACHINES-BASEL, V8, DOI 10.3390/mi8120343; Opitz DW, 1996, ADV NEUR IN, V8, P535; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Perez L., 2017, ARXIV; Qin H, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3177-7; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Razavian AS, 2014, IEEE COMPUT SOC CONF, P512, DOI 10.1109/CVPRW.2014.131; Redmon J, 2016, PROC CVPR IEEE, P779, DOI 10.1109/CVPR.2016.91; Rezaeilouyeh H, 2016, J MED IMAGING, V3, DOI 10.1117/1.JMI.3.4.044501; Sabokrou M, 2016, ARXIV160806037; Sabour S, 2017, 31 C NEUR INF PROC S, P3856; Simonyan Karen, ICLR 2015; Szegedy C, 2015, PROC CVPR IEEE, P1, DOI 10.1109/CVPR.2015.7298594; Tang Y., 2013, ARXIV; Terri L Fauber., 2016, RADIOGRAPHIC IMAGING; van Dyk DA, 2001, J COMPUT GRAPH STAT, V10, P1, DOI 10.1198/10618600152418584; Wang L, 2016, PROC CVPR IEEE, P5005, DOI 10.1109/CVPR.2016.541; Zafar M., 2018, BEGINNERS GUIDE CAPS; Zhang XQ, 2019, MED BIOL ENG COMPUT, V57, P1187, DOI 10.1007/s11517-018-01946-z; Zhao TY, 2018, LECT NOTES COMPUT SC, V11073, P677, DOI 10.1007/978-3-030-00937-3_77; Zhao W., 2018, EMNLP	40	4	4	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0246988	10.1371/journal.pone.0246988	http://dx.doi.org/10.1371/journal.pone.0246988			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730031	Green Submitted, gold, Green Published			2022-12-26	WOS:000630345000020
J	Fukasawa, K; Kadota, T; Horie, T; Tokumura, K; Terada, R; Kitaguchi, Y; Park, G; Ochiai, S; Iwahashi, S; Okayama, Y; Hiraiwa, M; Yamada, T; Iezaki, T; Kaneda, K; Yamamoto, M; Kitao, T; Shirahase, H; Hazawa, M; Wong, RW; Todo, T; Hirao, A; Hinoi, E				Fukasawa, Kazuya; Kadota, Takuya; Horie, Tetsuhiro; Tokumura, Kazuya; Terada, Ryuichi; Kitaguchi, Yuka; Park, Gyujin; Ochiai, Shinsuke; Iwahashi, Sayuki; Okayama, Yasuka; Hiraiwa, Manami; Yamada, Takanori; Iezaki, Takashi; Kaneda, Katsuyuki; Yamamoto, Megumi; Kitao, Tatsuya; Shirahase, Hiroaki; Hazawa, Masaharu; Wong, Richard W.; Todo, Tomoki; Hirao, Atsushi; Hinoi, Eiichi			CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway	ONCOGENE			English	Article								Glioblastoma (GBM) is the most malignant form of glioma. Glioma stem cells (GSCs) contribute to the initiation, progression, and recurrence of GBM as a result of their self-renewal potential and tumorigenicity. Cyclin-dependent kinase 8 (CDK8) belongs to the transcription-related CDK family. Although CDK8 has been shown to be implicated in the malignancy of several types of cancer, its functional role and mechanism in gliomagenesis remain largely unknown. Here, we demonstrate how CDK8 plays an essential role in maintaining stemness and tumorigenicity in GSCs. The genetic inhibition of CDK8 by shRNA or CRISPR interference resulted in an abrogation of the self-renewal potential and tumorigenicity of patient-derived GSCs, which could be significantly rescued by the ectopic expression of c-MYC, a stem cell transcription factor. Moreover, we demonstrated that the pharmacological inhibition of CDK8 significantly attenuated the self-renewal potential and tumorigenicity of GSCs. CDK8 expression was significantly higher in human GBM tissues than in normal brain tissues, and its expression was positively correlated with stem cell markers including c-MYC and SOX2 in human GBM specimens. Additionally, CDK8 expression is associated with poor survival in GBM patients. Collectively, these findings highlight the importance of the CDK8-c-MYC axis in maintaining stemness and tumorigenicity in GSCs; these findings also identify the CDK8-c-MYC axis as a potential target for GSC-directed therapy.	[Fukasawa, Kazuya; Kadota, Takuya; Horie, Tetsuhiro; Tokumura, Kazuya; Terada, Ryuichi; Kitaguchi, Yuka; Park, Gyujin; Ochiai, Shinsuke; Iwahashi, Sayuki; Okayama, Yasuka; Hiraiwa, Manami; Yamada, Takanori; Iezaki, Takashi; Hinoi, Eiichi] Gifu Pharmaceut Univ, Dept Bioact Mol, Lab Pharmacol, Gifu, Japan; [Kadota, Takuya; Yamamoto, Megumi; Kitao, Tatsuya; Shirahase, Hiroaki] Kyoto Pharmaceut Ind Co Ltd, Drug Discovery Res Dept, Kyoto, Japan; [Kitaguchi, Yuka; Kaneda, Katsuyuki] Kanazawa Univ, Grad Sch, Div Pharmaceut Sci, Lab Mol Pharmacol, Kanazawa, Ishikawa, Japan; [Hazawa, Masaharu; Wong, Richard W.] Kanazawa Univ, Inst Frontier Sci Initiat, Cell Bion Res Unit, Kanazawa, Ishikawa, Japan; [Wong, Richard W.; Hirao, Atsushi] Kanazawa Univ, WPI Nano Life Sci Inst WPI Nano LSI, Kanazawa, Ishikawa, Japan; [Todo, Tomoki] Univ Tokyo, Inst Med Sci, Div Innovat Canc Therapy, Tokyo, Japan; [Hirao, Atsushi] Kanazawa Univ, Canc Res Inst, Div Mol Genet, Canc & Stem Cell Res Program, Kanazawa, Ishikawa, Japan; [Hinoi, Eiichi] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan	Gifu Pharmaceutical University; Kyoto Pharmaceutical Industries Co., Ltd.; Kanazawa University; Kanazawa University; Kanazawa University; University of Tokyo; Kanazawa University; Gifu University	Hinoi, E (corresponding author), Gifu Pharmaceut Univ, Dept Bioact Mol, Lab Pharmacol, Gifu, Japan.	hinoi-e@gifu-pu.ac.jp	Wong, Richard W./E-9155-2011	Wong, Richard/0000-0002-2131-6595; Fukasawa, Kazuya/0000-0002-1845-0275; Horie, Tetsuhiro/0000-0002-2095-9425	Japan Society for the Promotion of Science [20H03407]; Extramural Collaborative Research Grant of Cancer Research Institute, Kanazawa University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Extramural Collaborative Research Grant of Cancer Research Institute, Kanazawa University	We wish to thank Dr. H. Hojo (University of Tokyo) for technical training in RNA-seq data analysis. RNA-seq data and survival analysis were performed using the super-computing resource provided by Human Genome Center, the Institute of Medical Science, the University of Tokyo. This work was supported in part by the Japan Society for the Promotion of Science (20H03407 to EH), and the Extramural Collaborative Research Grant of Cancer Research Institute, Kanazawa University.	Adler AS, 2012, CANCER RES, V72, P2129, DOI 10.1158/0008-5472.CAN-11-3886; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; [Anonymous], 2018, N Engl J Med, V379, P2582, DOI 10.1056/NEJMx180043; Bancerek J, 2013, IMMUNITY, V38, P250, DOI 10.1016/j.immuni.2012.10.017; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Bragelmann J, 2017, CLIN CANCER RES, V23, P1829, DOI 10.1158/1078-0432.CCR-16-0094; Broude EV, 2015, CURR CANCER DRUG TAR, V15, P739, DOI 10.2174/156800961508151001105814; Chen MQ, 2017, P NATL ACAD SCI USA, V114, P10208, DOI 10.1073/pnas.1710467114; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Finn RS, 2016, NEW ENGL J MED, V375, P1925, DOI 10.1056/NEJMoa1607303; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Galbraith MD, 2013, CELL, V153, P1327, DOI 10.1016/j.cell.2013.04.048; Gu WT, 2013, CELL CYCLE, V12, P987, DOI 10.4161/cc.24003; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Kitao T, 2019, YAKUGAKU ZASSHI, V139, P19, DOI 10.1248/yakushi.18-00154-2; Knuesel MT, 2009, MOL CELL BIOL, V29, P650, DOI 10.1128/MCB.00993-08; Kumar SK, 2015, BLOOD, V125, P443, DOI 10.1182/blood-2014-05-573741; Laderian B, 2017, SEMIN ONCOL, V44, P395, DOI 10.1053/j.seminoncol.2018.03.006; Lathia JD, 2015, GENE DEV, V29, P1203, DOI 10.1101/gad.261982.115; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Martinez-Fabregas J, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108545; McCleland ML, 2015, J PATHOL, V237, P508, DOI 10.1002/path.4596; Meyer M, 2015, P NATL ACAD SCI USA, V112, P851, DOI 10.1073/pnas.1320611111; Ostrom QT, 2019, J NEURO-ONCOL, V142, P27, DOI 10.1007/s11060-018-03073-z; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pelish HE, 2015, NATURE, V526, P273, DOI 10.1038/nature14904; Putz EM, 2013, CELL REP, V4, P437, DOI 10.1016/j.celrep.2013.07.012; Quevedo M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10502-8; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; Rinkenbaugh AL, 2016, ONCOTARGET, V7, P69173, DOI 10.18632/oncotarget.12507; Sachdeva R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51270-1; Serrao A, 2018, ONCOGENE, V37, P4792, DOI 10.1038/s41388-018-0316-y; Shi Y, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aah6816; Sledge GW, 2017, J CLIN ONCOL, V35, P2875, DOI 10.1200/JCO.2017.73.7585; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Venere M, 2011, GLIA, V59, P1148, DOI 10.1002/glia.21185; Waghmare I, 2014, STEM CELL TRANSL MED, V3, P1262, DOI 10.5966/sctm.2014-0086; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; Wasylishen Amanda R, 2010, Genes Cancer, V1, P532, DOI 10.1177/1947601910378024; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Westerling T, 2007, MOL CELL BIOL, V27, P6177, DOI 10.1128/MCB.01302-06; Witalisz-Siepracka A, 2018, CANCER IMMUNOL RES, V6, P458, DOI 10.1158/2326-6066.CIR-17-0183; Xu DZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7641; Xu W, 2015, CANCER LETT, V356, P613, DOI 10.1016/j.canlet.2014.10.008; Zhang JF, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0694-9; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016; Zheng H, 2008, COLD SH Q B, V73, P427, DOI 10.1101/sqb.2008.73.047; Zhou WC, 2015, NAT CELL BIOL, V17, P170, DOI 10.1038/ncb3090	56	17	17	1	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 15	2021	40	15					2803	2815		10.1038/s41388-021-01745-1	http://dx.doi.org/10.1038/s41388-021-01745-1		MAR 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RN8NW	33727660				2022-12-26	WOS:000629505700001
J	Zhang, TX; Jin, WJ; Yang, S; Li, YM; Zhang, MS; Shi, MH; Guo, XB; Li, DW; Zhang, BF; Liu, SQ; Hu, DF				Zhang, Tianxiang; Jin, Weijiang; Yang, Shuang; Li, Yimeng; Zhang, Meishan; Shi, Minghui; Guo, Xiaobing; Li, Dawei; Zhang, Baofeng; Liu, Shuqiang; Hu, Defu			Study of compositions of musks in different types secreted by forest musk deer (Moschus berezovskii)	PLOS ONE			English	Article								Musk is a secretion of the forest musk deer (Moschus berezovskii). Normal musk is a brown solid secretion with a light fragrance. In this study, abnormal types of musk, namely, white and black musks, were discovered during the musk collection process. Researchers have long been concerned with the components of musk. Herein, GC-MS, headspace solid-phase microextraction (HS-SPME), and nonmetric multidimensional scaling (NMDS) were used to analyze the nonpolar organic components, volatile organic components, and sample similarities among different musks, respectively. Abundant steroid hormones and proteins were also found in the musk. The steroid hormone concentrations were detected using a radioimmunoassay (RIA). Proteins in the samples were hydrolyzed and the amino acids concentrations were detected. The steroid hormone and amino acid concentrations in white musk were significantly lower than in normal and black musks (p<0.05). The components were subjected to NMDS analysis to understand the differences in components among different types of musk, with the results suggesting that white musk was different from normal and black musks.	[Zhang, Tianxiang; Jin, Weijiang; Yang, Shuang; Li, Yimeng; Zhang, Meishan; Shi, Minghui; Guo, Xiaobing; Li, Dawei; Zhang, Baofeng; Liu, Shuqiang; Hu, Defu] Beijing Forestry Univ, Sch Ecol & Nat Conservat, Beijing, Peoples R China	Beijing Forestry University	Liu, SQ; Hu, DF (corresponding author), Beijing Forestry Univ, Sch Ecol & Nat Conservat, Beijing, Peoples R China.	liushuqiang@bjfu.edu.cn; hudf@bjfu.edu.cn		Guo, Xiaobing/0000-0002-8398-2390	Beijing Municipal Nature Science Foundation [5202016]; National key R&D program of China [2018YFD0502204]	Beijing Municipal Nature Science Foundation; National key R&D program of China	This work was supported by Beijing Municipal Nature Science Foundation (Grant No. 5202016) and National key R&D program of China (2018YFD0502204).	Ai XP, 2019, J ETHNOPHARMACOL, V241, DOI 10.1016/j.jep.2019.111992; Andersen KF, 1999, CHEM SENSES, V24, P179, DOI 10.1093/chemse/24.2.179; Archunan G, 2013, GEN COMP ENDOCR, V181, P156, DOI 10.1016/j.ygcen.2012.11.012; Ayuob NN, 2019, J ORAL SCI, V61, P95, DOI 10.2334/josnusd.17-0440; BLOMQUIST AT, 1948, J AM CHEM SOC, V70, P34, DOI 10.1021/ja01181a012; Callejo R, 2016, CHEM-EUR J, V22, P8137, DOI 10.1002/chem.201600519; Dehnhard M, 2003, J STEROID BIOCHEM, V84, P383, DOI 10.1016/S0960-0760(03)00056-6; Du YQ, 2018, AM J TRANSL RES, V10, P4235; Fan JM, 2019, G3-GENES GENOM GENET, V9, P1037, DOI 10.1534/g3.119.400001; Fang MY, 2018, ENDOCR J, V65, P1111, DOI 10.1507/endocrj.EJ18-0211; Fujimoto S, 2002, BIOSCI BIOTECH BIOCH, V66, P1389, DOI 10.1271/bbb.66.1389; Goodwin TE, 2006, J CHEM ECOL, V32, P1849, DOI 10.1007/s10886-006-9094-z; Greenwood DR, 2005, NATURE, V438, P1097, DOI 10.1038/4381097a; Gu YG, 2020, ENVIRON RES, V182, DOI 10.1016/j.envres.2020.109119; He L, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-48; He Y, 2018, J MASS SPECTROM, V53, P1078, DOI 10.1002/jms.4283; Homem V, 2016, TALANTA, V148, P84, DOI 10.1016/j.talanta.2015.10.049; Hu XL, 2018, ACTA TROP, V177, P1, DOI 10.1016/j.actatropica.2017.09.021; Hu XL, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01674; Janig S, 2019, AM J PRIMATOL, V81, DOI 10.1002/ajp.22976; Johnson BO, 2019, MOLECULES, V24, DOI 10.3390/molecules24152818; Kamalakkannan S., 2006, ACTA PHYSIOLOGICA HUNGARICA, V93, P145, DOI 10.1556/APhysiol.93.2006.2-3.5; KLEIMAN DG, 1985, SCIENCE, V228, P875, DOI 10.1126/science.228.4701.875; Leclaire S, 2019, MOL ECOL, V28, P833, DOI 10.1111/mec.14993; Leclaire S, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2466; Li DY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18975; Li Y, 2018, FRONT MICROBIOL, P9, DOI DOI 10.3389/FMICB.2018.00009; Li YM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00300; Li YM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41158; Mason GJ, 2010, TRENDS ECOL EVOL, V25, P713, DOI 10.1016/j.tree.2010.08.011; Matsuda H, 2008, CHEM BIODIVERS, V5, P1023, DOI 10.1002/cbdv.200890082; Mayer M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15540-0; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; McLean L, 2007, J CHEM ECOL, V33, P1997, DOI 10.1007/s10886-007-9354-6; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Miyazaki T, 2018, J ETHOL, V36, P99, DOI 10.1007/s10164-017-0532-x; Pan CY, 2015, ONCOTARGET, V6, P2290, DOI 10.18632/oncotarget.2959; PoddarSarkar M, 1996, J LIPID MEDIAT CELL, V15, P89, DOI 10.1016/S0929-7855(96)00547-0; Ponmanickam P, 2010, GEN COMP ENDOCR, V167, P35, DOI 10.1016/j.ygcen.2010.03.001; Regueiro J, 2009, J CHROMATOGR A, V1216, P2805, DOI 10.1016/j.chroma.2008.09.062; RISSMAN EF, 1990, NEUROENDOCRINOLOGY, V51, P468, DOI 10.1159/000125376; Rosell F, 2002, J CHEM ECOL, V28, P1697, DOI 10.1023/A:1019954020963; Rosell F, 2001, J CHEM ECOL, V27, P2471, DOI 10.1023/A:1013627515232; Serrano RA, 2008, BIOL REPROD, V79, P861, DOI 10.1095/biolreprod.108.069914; Shokry E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183538; SOKOLOV VE, 1987, J CHEM ECOL, V13, P71, DOI 10.1007/BF01020352; Song Fu-Jiang, 2018, Zhongguo Zhong Yao Za Zhi, V43, P1366, DOI 10.19540/j.cnki.cjcmm.20180115.011; Song YF, 2017, J SEP SCI, V40, P4264, DOI 10.1002/jssc.201700341; Soso SB, 2014, SENSORS-BASEL, V14, P4428, DOI 10.3390/s140304428; Strandh M, 2011, IMMUNOGENETICS, V63, P653, DOI 10.1007/s00251-011-0534-8; Suinyuy TN, 2013, PHYTOCHEMISTRY, V85, P82, DOI 10.1016/j.phytochem.2012.09.016; Sun XN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18534-0; TENNANT LE, 1987, PHYSIOL BEHAV, V39, P677, DOI 10.1016/0031-9384(87)90249-6; Vasiliauskaite V, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218664; Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12; Yamaguchi MS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216846; Zhang FG, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03241; Zhang TX, 2017, BIOL RES, V50, DOI 10.1186/s40659-017-0116-9; Zhou C, 2019, GENOME BIOL EVOL, V11, P1019, DOI 10.1093/gbe/evz055; Zhou WL, 2019, SCI CHINA LIFE SCI, V62, P648, DOI 10.1007/s11427-018-9388-9	60	3	3	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0245677	10.1371/journal.pone.0245677	http://dx.doi.org/10.1371/journal.pone.0245677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY1VJ	33725016	gold, Green Published			2022-12-26	WOS:000629833700015
J	Kawai, M; Goseki, T; Ishikawa, H; Tatsui, S; Li, HY; Ukisu, R; Shoji, N				Kawai, Manami; Goseki, Toshiaki; Ishikawa, Hitoshi; Tatsui, Sonoko; Li, Hongyang; Ukisu, Ryutaro; Shoji, Nobuyuki			Characterization of the position of the extraocular muscles and orbit in acquired esotropia both at distance and near using orbital magnetic resonance imaging	PLOS ONE			English	Article								Purpose Age-related distance esotropia (ARDE) involves acquired esotropia at distance and phoria at near. However, distance-independent esotropia (DIE) exists esotropia both at distance and near. Thus, we examined the orbital magnetic resonance imaging (MRI) findings for DIE to assess differences in its characteristics. Methods This study was a retrospective case-control study. We evaluated the efficacy of the standard coronal MRI in patients with acquired esotropia and control patients with optic neuritis. Cases with strabismus in the control group were excluded. DIE was defined as having esotropia both at distance and near, and an angle of more than 10 prism diopters at near. The condition of the lateral rectus-superior rectus band, position of rectus muscles, and the volume ratio of the globe to the whole orbit (G/WO) were examined. Results The DIE group consisted of 12 eyes of 6 patients (77.3 +/- 7.7 years); ARDE group, 38 eyes of 19 patients (73.1 +/- 6.8 years); and control group, 34 eyes of 17 patients (70.9 +/- 4.3 years). The ratio of abnormality of the lateral rectus-superior rectus bands was higher in the DIE and ARDE groups than in the control group (p<0.01). The vertical angle of the lateral rectus deviated downwards in the control (-7.5 +/- 5.1 degrees), ARDE (-12.2 +/- 9.1 degrees), and DIE groups (-18.8 +/- 5.7 degrees) (p<0.05). The tilting angle of the lateral rectus was tilted temporally in the control (-12.2 +/- 9.1 degrees), ARDE (-20.0 +/- 8.6 degrees) and DIE groups (-28.6 +/- 5.4 degrees) (p<0.01). G/WO was higher in the DIE (0.28 +/- 0.01) and ARDE groups (0.27 +/- 0.02) compared to the control (0.25 +/- 0.03) group (p<0.01). Conclusion In comparison with the ARDE and control groups, the DIE group presented with abnormalities of the lateral rectus-superior rectus band, malposition of the lateral rectus, and differences in the G/WO. The DIE group showed a more severe form of ARDE.	[Kawai, Manami; Goseki, Toshiaki; Ishikawa, Hitoshi; Tatsui, Sonoko; Li, Hongyang; Shoji, Nobuyuki] Kitasato Univ, Dept Ophthalmol, Sch Med, Sagamihara, Kanagawa, Japan; [Goseki, Toshiaki] Int Univ Hlth & Welf Atami Hosp, Dept Ophthalmol, Atami, Shizuoka, Japan; [Li, Hongyang] Capital Med Univ, Beijing Friendship Hosp, Dept Ophthalmol, Beijing, Xicheng Distric, Peoples R China; [Ukisu, Ryutaro] Kitasato Univ, Dept Diagnost Radiol, Sch Med, Sagamihara, Kanagawa, Japan	Kitasato University; International University of Health & Welfare; Capital Medical University; Kitasato University	Goseki, T (corresponding author), Kitasato Univ, Dept Ophthalmol, Sch Med, Sagamihara, Kanagawa, Japan.; Goseki, T (corresponding author), Int Univ Hlth & Welf Atami Hosp, Dept Ophthalmol, Atami, Shizuoka, Japan.	gosekikun@aol.com		Goseki, Toshiaki/0000-0001-9016-8015				Bencic G, 2009, BRIT J OPHTHALMOL, V93, P502, DOI 10.1136/bjo.2008.147868; Chaudhuri Z, 2018, STRABISMUS, V26, P6, DOI 10.1080/09273972.2017.1421676; Chaudhuri Z, 2013, JAMA OPHTHALMOL, V131, P619, DOI 10.1001/jamaophthalmol.2013.783; Clark RA, 2002, AM J OPHTHALMOL, V134, P872, DOI 10.1016/S0002-9394(02)01695-1; Demer JL, 2004, INVEST OPHTH VIS SCI, V45, P729, DOI 10.1167/iovs.03-0464; Demer JL, 2018, STRABISMUS, V26, P33, DOI 10.1080/09273972.2017.1418393; Demer JL, 2016, INVEST OPHTH VIS SCI, V57, P1826, DOI 10.1167/iovs.15-18718; Godts D, 2018, J AAPOS, V22, P97, DOI 10.1016/j.jaapos.2017.12.010; Goseki T, 2020, AM J OPHTHALMOL, V209, P55, DOI 10.1016/j.ajo.2019.09.006; Higashiyama T, 2015, JPN J OPHTHALMOL, V59, P430, DOI 10.1007/s10384-015-0410-4; Ito H, 2017, FOLIA JAPONICA OPHTH, V10, P240; Iwasa M, 2021, NEURO-OPHTHALMOLOGY, V45, P87, DOI 10.1080/01658107.2020.1767153; Kawai M, 2020, GRAEF ARCH CLIN EXP, V258, P1983, DOI 10.1007/s00417-020-04718-4; Kohmoto H, 2011, CLIN OPHTHALMOL, V5, P11, DOI 10.2147/OPTH.S14759; Kono R, 2002, INVEST OPHTH VIS SCI, V43, P2179; Kono R, 2002, INVEST OPHTH VIS SCI, V43, P2923; Kono R, 2019, GRAEF ARCH CLIN EXP, V257, P657, DOI 10.1007/s00417-019-04250-0; Li YP, 2019, AM J OPHTHALMOL, V201, P37, DOI 10.1016/j.ajo.2019.01.029; LIM L, 1995, J PEDIATR OPHTHALMOL, V32, P76; Masuda A, 2015, FOLIA JAPONICA OPHTH, V8, P419; Mendonca TM, 2016, J AAPOS, V20, P83, DOI 10.1016/j.jaapos.2015.10.015; Mittelman D, 2006, J AAPOS, V10, P212, DOI 10.1016/j.jaapos.2006.01.217; Nakao Y, 2014, JPN J OPHTHALMOL, V58, P218, DOI 10.1007/s10384-013-0296-y; Repka MX, 2014, J AAPOS, V18, P370, DOI 10.1016/j.jaapos.2014.04.001; Rutar T, 2009, J AAPOS, V13, P36, DOI 10.1016/j.jaapos.2008.07.008; Serafino M, 2020, EUR J OPHTHALMOL, V30, P676, DOI 10.1177/1120672119850684; Shin MH, 2015, J AAPOS, V19, P188, DOI 10.1016/j.jaapos.2014.10.033; Sturm V, 2008, GRAEF ARCH CLIN EXP, V246, P1323, DOI 10.1007/s00417-008-0885-5; Tan RJD, 2015, J AAPOS, V19, P500, DOI 10.1016/j.jaapos.2015.08.012; Tian S, 2000, GRAEF ARCH CLIN EXP, V238, P393, DOI 10.1007/s004170050370; Ugradar S, 2020, OPHTHAL PLAST RECONS, V36, P475, DOI 10.1097/IOP.0000000000001605; Weir CR, 2007, STRABISMUS, V15, P111, DOI 10.1080/09273970701405347; Yamaguchi M, 2010, AM J OPHTHALMOL, V149, P341, DOI 10.1016/j.ajo.2009.08.035; Yokoyama T., 2000, 26 M EUR STRAB ASS	34	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0248497	10.1371/journal.pone.0248497	http://dx.doi.org/10.1371/journal.pone.0248497			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711045	gold, Green Published			2022-12-26	WOS:000629591800036
J	Zapukhliak, O; Netsyk, O; Romanov, A; Maximyuk, O; Oz, M; Holmes, GL; Krishtal, O; Isaev, D				Zapukhliak, Olha; Netsyk, Olga; Romanov, Artur; Maximyuk, Oleksandr; Oz, Murat; Holmes, Gregory L.; Krishtal, Oleg; Isaev, Dmytro			Mecamylamine inhibits seizure-like activity in CA1-CA3 hippocampus through antagonism to nicotinic receptors	PLOS ONE			English	Article								Cholinergic modulation of hippocampal network function is implicated in multiple behavioral and cognitive states. Activation of nicotinic and muscarinic acetylcholine receptors affects neuronal excitability, synaptic transmission and rhythmic oscillations in the hippocampus. In this work, we studied the ability of the cholinergic system to sustain hippocampal epileptiform activity independently from glutamate and GABA transmission. Simultaneous CA3 and CA1 field potential recordings were obtained during the perfusion of hippocampal slices with the aCSF containing AMPA, NMDA and GABA receptor antagonists. Under these conditions, spontaneous epileptiform discharges synchronous between CA3 and CA1 were recorded. Epileptiform discharges were blocked by addition of the calcium-channel blocker Cd2+ and disappeared in CA1 after a surgical cut between CA3 and CA1. Cholinergic antagonist mecamylamine abolished CA3-CA1 synchronous epileptiform discharges, while antagonists of alpha 7 and alpha 4 beta 2 nAChRs, MLA and Dh beta E, had no effect. Our results suggest that activation of nicotinic acetylcholine receptors can sustain CA3-CA1 synchronous epileptiform activity independently from AMPA, NMDA and GABA transmission. In addition, mecamylamine, but not alpha 7 and alpha 4 beta 2 nAChRs antagonists, reduced bicuculline-induced seizure-like activity. The ability of mecamylamine to decrease hippocampal network synchronization might be associated with its therapeutic effects in a wide variety of CNS disorders including addiction, depression and anxiety.	[Zapukhliak, Olha; Netsyk, Olga; Romanov, Artur; Maximyuk, Oleksandr; Krishtal, Oleg; Isaev, Dmytro] Bogomoletz Inst Physiol, Dept Cellular Membranol, Kiev, Ukraine; [Oz, Murat] Kuwait Univ, Fac Pharm, Dept Pharmacol & Therapeut, Kuwait, Kuwait; [Holmes, Gregory L.] Univ Vermont, Larner Coll Med, Neurol Sci, Burlington, VT USA	National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology; Kuwait University; University of Vermont	Isaev, D (corresponding author), Bogomoletz Inst Physiol, Dept Cellular Membranol, Kiev, Ukraine.	dmytro.isaev@gmail.com		Netsyk, Olga/0000-0001-6869-7834	NIH [NS108765, NS108296]; National Research Foundation of Ukraine [2201/0266]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Ukraine	This work was supported by the NIH Grants NS108765 and NS108296 (GLH), National Research Foundation of Ukraine Grant 2201/0266. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Alkondon M, 2004, PROG BRAIN RES, V145, P109, DOI 10.1016/S0079-6123(03)45007-3; Bacher I, 2009, EXPERT OPIN PHARMACO, V10, P2709, DOI 10.1517/14656560903329102; Bikson M, 2002, J NEUROPHYSIOL, V87, P62, DOI 10.1152/jn.00196.2001; Cobb SR, 2005, J PHYSIOL-LONDON, V562, P81, DOI 10.1113/jphysiol.2004.076539; Cobb SR, 1999, J PHYSIOL-LONDON, V518, P131, DOI 10.1111/j.1469-7793.1999.0131r.x; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Dannenberg H, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00102; Fellous JM, 2000, HIPPOCAMPUS, V10, P187, DOI 10.1002/(SICI)1098-1063(2000)10:2<187::AID-HIPO8>3.3.CO;2-D; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Haam J, 2017, J NEUROCHEM, V142, P111, DOI 10.1111/jnc.14052; HAAS HL, 1984, J PHYSIOL-LONDON, V354, P185, DOI 10.1113/jphysiol.1984.sp015371; Hillert MH, 2014, J NEUROCHEM, V131, P42, DOI 10.1111/jnc.12787; Isaev D, 2012, J NEUROPHYSIOL, V107, P417, DOI 10.1152/jn.00574.2011; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; KONNERTH A, 1986, J NEUROPHYSIOL, V56, P409, DOI 10.1152/jn.1986.56.2.409; Kowalczyk T, 2013, EUR J NEUROSCI, V37, P679, DOI 10.1111/ejn.12091; Lancaster T, 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001009; Lee SH, 2012, NEURON, V76, P209, DOI 10.1016/j.neuron.2012.09.012; Lietsche J, 2016, NEUROSCI LETT, V611, P69, DOI 10.1016/j.neulet.2015.11.028; Loscher W, 2003, EUR J PHARMACOL, V466, P99, DOI 10.1016/S0014-2999(03)01542-5; Nickell JR, 2013, PHARMACOL BIOCHEM BE, V108, P28, DOI 10.1016/j.pbb.2013.04.005; Petrakis IL, 2018, ADDICTION, V113, P6, DOI 10.1111/add.13943; Picciotto MR, 2012, NEURON, V76, P116, DOI 10.1016/j.neuron.2012.08.036; Picciotto MR, 2000, NEUROPSYCHOPHARMACOL, V22, P451, DOI 10.1016/S0893-133X(99)00146-3; Roshan-Milani S, 2003, EPILEPSY RES, V56, P51, DOI 10.1016/j.eplepsyres.2003.08.005; SCHNECKLOTH RE, 1956, JAMA-J AM MED ASSOC, V162, P868, DOI 10.1001/jama.1956.02970260018006; Shytle RD, 2002, J HUM HYPERTENS, V16, P453, DOI 10.1038/sj.jhh.1001416; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Tatum WO, 2020, NEUROLOGY, V94, P862, DOI 10.1212/WNL.0000000000009432; Teles-Grilo Ruivo Leonor M, 2013, Front Synaptic Neurosci, V5, P2, DOI 10.3389/fnsyn.2013.00002; Volpicelli LA, 2004, PROG BRAIN RES, V145, P59, DOI 10.1016/S0079-6123(03)45003-6; Williams JH, 1997, J NEUROPHYSIOL, V78, P2631, DOI 10.1152/jn.1997.78.5.2631; Yakel JL, 2012, NICOTINE TOB RES, V14, P1249, DOI 10.1093/ntr/nts091	34	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0240074	10.1371/journal.pone.0240074	http://dx.doi.org/10.1371/journal.pone.0240074			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711021	Green Submitted, Green Published, gold			2022-12-26	WOS:000629591800003
J	Chen, L; Zheng, YL; Zhao, LL; Zhang, Y; Yin, L; He, YK; Ma, XQ; Xu, Y; Gao, ZC				Chen, Li; Zheng, Yali; Zhao, Lili; Zhang, Ying; Yin, Lu; He, Yukun; Ma, Xinqian; Xu, Yu; Gao, Zhancheng			Lipid profiles and differential lipids in serum related to severity of community-acquired pneumonia: A pilot study	PLOS ONE			English	Article								This study aimed to characterize the lipidomic responses to community-acquired pneumonia (CAP) and provide new insight into the underlying mechanisms of pathogenesis and potential avenues for diagnostic and therapeutic treatments. This study was performed from January 2017 to October 2018. Lipidomic profiles were generated using ultra high-performance liquid chromatography with tandem mass spectrometry (UHPLC-MS/MS) platform. Spearman's rank correlation test and multiple linear regression analysis were applied to explore the correlation between changes in the relative abundance of lipids and clinical parameters. Kaplan-Meier methods were used to build 30-day survival curves. From the UHPLC-MS/MS results, a total of 509 and 195 lipid species were detected in the positive and negative ionization mode respectively. Positive ionization covered six lipid classes (glycerol-phospholipids, glycerolipids, sphingolipids, sterol-lipids, prenol-lipids, and fatty acid), whilst negative ionization covered three (glycerol-phospholipids, sphingolipids, fatty acid). Four lipids were selected as targets: PC (16:0_18:1), PC (18:2_20:4), PC (36:4), and PC (38:6). The relative increase of the areas under the curves for all four lipids were superior to the pneumonia severity index and CURB-65 (confusion, urea, respiratory rate, blood pressure, and age >= 65 years old) for discriminating severe CAP from CAP. Decreasing relative levels of PC (18:2_20:4), PC (38:6), and PC (36:4) were negatively related to fraction of inspiration O-2; Changes in the relative abundance of PC (16:0_18:1) and PC (18:2_20:4) had significantly linear relationship with procalcitonin. Patients with an elevated level of PC (16:0_18:1) had significantly longer duration of hospital stays. As the relative abundance of PC (18:2_20:4), PC (36:4), and PC (38:6) decreased, the length of hospitalization days and 30-day mortality rate increased significantly (all log-rank p<0.05). Therefore, using the UHPLC-MS/MS platform's serum lipidomic approach can help reveal changes in lipid abundance during CAP and establish lipid profiles related to disease severity.	[Chen, Li; Zhao, Lili; Zhang, Ying; Yin, Lu; He, Yukun; Ma, Xinqian; Xu, Yu; Gao, Zhancheng] Peking Univ Peoples Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China; [Zheng, Yali] Xiamen Univ, Dept Resp Crit Care & Sleep Med, Xiangan Hosp, Xiamen, Peoples R China	Peking University; Xiamen University	Xu, Y; Gao, ZC (corresponding author), Peking Univ Peoples Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China.	pkuph_xuyu@163.com; zcgao@bjmu.edu.cn			National Science and Technology Major Project [2017ZX10103004-006]	National Science and Technology Major Project	Yu Xu This study was funded by National Science and Technology Major Project (2017ZX10103004-006). http://www.nmp.gov.cn/zxjs/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arshad H, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2112-z; Attia N, 2009, CLIN BIOCHEM, V42, P845, DOI 10.1016/j.clinbiochem.2008.12.008; Boccard J, 2013, ANAL CHIM ACTA, V769, P30, DOI 10.1016/j.aca.2013.01.022; Boggara MB, 2010, BIOPHYS J, V98, P586, DOI 10.1016/j.bpj.2009.10.046; Golucci APBS, 2018, NUTRITION, V55-56, P7, DOI 10.1016/j.nut.2018.04.007; Cao B, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-018-0353-x; Chalmers JD, 2015, THORAX, V70, P515, DOI 10.1136/thoraxjnl-2015-207090; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Christ-Crain M, 2010, CRIT CARE, V14, DOI 10.1186/cc8155; Cui L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002373; Drobnik W, 2003, J LIPID RES, V44, P754, DOI 10.1194/jlr.M200401-JLR200; Filippas-Ntekouan S, 2017, INFECTION, V45, P575, DOI 10.1007/s15010-017-1022-3; Guirgis FW, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1579-8; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Holcapek M, 2018, ANAL CHEM, V90, P4249, DOI 10.1021/acs.analchem.7b05395; Huang JF, 2020, DOSE-RESPONSE, V18, DOI 10.1177/1559325820914209; Iwabuchi K, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/120748; Korneev KV, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00595; Krauss RM, 2010, CIRCULATION, V122, P452, DOI 10.1161/CIRCULATIONAHA.110.966572; Langley RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005893; Luo QZ, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1943-y; Malloy JL, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-8; Manchester M, 2017, ADV VIRUS RES, V98, P57, DOI 10.1016/bs.aivir.2017.02.001; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; Ning P, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2049-2; Orchard RC, 2018, NAT MICROBIOL, V3, P1109, DOI 10.1038/s41564-018-0221-8; Park DW, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2014.05.003; Pasvogel AE, 2010, BIOL RES NURS, V11, P325, DOI 10.1177/1099800409346056; Ryan AJ, 2003, J APPL PHYSIOL, V94, P253, DOI 10.1152/japplphysiol.00184.2002; Salluh JIF, 2011, CRIT CARE, V15, DOI 10.1186/cc10099; Sharma NK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15755-1; Simon L, 2004, CLIN INFECT DIS, V39, P206, DOI 10.1086/421997; To KKW, 2015, J INFECTION, V70, P433, DOI 10.1016/j.jinf.2015.02.011; Wali S, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-0998-5; Wunderink RG, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j2471; Xu LN, 2018, TALANTA, V178, P287, DOI 10.1016/j.talanta.2017.09.046; Yamada T, 2013, J CHROMATOGR A, V1292, P211, DOI 10.1016/j.chroma.2013.01.078; Yang JL, 2019, PHYTOMEDICINE, V64, DOI 10.1016/j.phymed.2019.153059; Zheng YL, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1028-8; Zhu HW, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020710	40	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0245770	10.1371/journal.pone.0245770	http://dx.doi.org/10.1371/journal.pone.0245770			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705428	gold, Green Published			2022-12-26	WOS:000629590400071
J	Maldonado-Taipe, N; Patirange, DSR; Schmockel, SM; Jung, C; Emrani, N				Maldonado-Taipe, Nathaly; Patirange, Dilan S. R.; Schmoeckel, Sandra M.; Jung, Christian; Emrani, Nazgol			Validation of suitable genes for normalization of diurnal gene expression studies in Chenopodium quinoa	PLOS ONE			English	Article								Quinoa depicts high nutritional quality and abiotic stress resistance, attracting strong interest in the last years. To unravel the function of candidate genes for agronomically relevant traits, studying their transcriptional activities by RT-qPCR is an important experimental approach. The accuracy of such experiments strongly depends on precise data normalization. To date, validation of potential candidate genes for normalization of diurnal expression studies has not been performed in C. quinoa. We selected eight candidate genes based on transcriptome data and literature survey, including conventionally used reference genes. We used three statistical algorithms (BestKeeper, geNorm and NormFinder) to test their stability and added further validation by a simulation-based strategy. We demonstrated that using different reference genes, including those top ranked by stability, causes significant differences among the resulting diurnal expression patterns. Our results show that isocitrate dehydrogenase enzyme (IDH-A) and polypyrimidine tract-binding protein (PTB) are suitable genes to normalize diurnal expression data of two different quinoa accessions. Moreover, we validated our reference genes by normalizing two known diurnally regulated genes, BTC1 and BBX19. The validated reference genes obtained in this study will improve the accuracy of RT-qPCR data normalization and facilitate gene expression studies in quinoa.	[Maldonado-Taipe, Nathaly; Patirange, Dilan S. R.; Jung, Christian; Emrani, Nazgol] Christian Albrechts Univ Kiel, Plant Breeding Inst, Kiel, Germany; [Schmoeckel, Sandra M.] King Abdullah Univ Sci & Technol KAUST, Biol & Environm Sci & Engn Div BESE, Thuwal, Saudi Arabia; [Schmoeckel, Sandra M.] Univ Hohenheim, Inst Crop Sci, Stuttgart, Germany	University of Kiel; King Abdullah University of Science & Technology; University Hohenheim	Emrani, N (corresponding author), Christian Albrechts Univ Kiel, Plant Breeding Inst, Kiel, Germany.	n.emrani@plantbreeding.uni-kiel.de	Jung, Christian/AAN-4537-2021	Jung, Christian/0000-0001-8325-250X; Emrani, Nazgol/0000-0001-5673-3957	King Abdullah University of Science and Technology, Saudi Arabia [OSR-2016-CRG52966-02]; State of Schleswig-Holstein, Germany	King Abdullah University of Science and Technology, Saudi Arabia(King Abdullah University of Science & Technology); State of Schleswig-Holstein, Germany	This study was partially funded by the Competitive Research Grant of the King Abdullah University of Science and Technology, Saudi Arabia awarded to CJ (Grant number: OSR-2016-CRG52966-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study. The rest of the costs were covered internally by the institute budget of the Plant Breeding Institute, Kiel University. We acknowledge the financial support by State of Schleswig-Holstein, Germany within the funding program "Open Access Publikationsfonds".	Abugoch LE, 2008, J AGR FOOD CHEM, V56, P4745, DOI 10.1021/jf703689u; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Amorim LLB, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0354-z; Bazile D, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00622; Bustin S, 2017, EUR J CLIN INVEST, V47, P756, DOI 10.1111/eci.12801; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen HH, 2019, TROP PLANT BIOL, V12, P67, DOI 10.1007/s12042-019-09218-2; Dakhiya Y, 2017, PLANT PHYSIOL, V173, P1724, DOI 10.1104/pp.17.00057; David KM, 2006, FEBS LETT, V580, P1193, DOI 10.1016/j.febslet.2006.01.016; Eckel M., 2018, SCI REP-UK, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Ferrari C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08703-2; Fiallos-Jurado J, 2016, PLANT SCI, V250, P188, DOI 10.1016/j.plantsci.2016.05.015; Jacobsen SE, 2017, J AGRON CROP SCI, V203, P603, DOI 10.1111/jac.12228; Jain N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21374-1; Jarvis DE, 2017, NATURE, V542, P307, DOI 10.1038/nature21370; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Kim JA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122680; Klumb EK, 2019, SCI HORTIC-AMSTERDAM, V247, P310, DOI 10.1016/j.scienta.2018.12.036; Knopkiewicz M, 2019, ANN APPL BIOL, V174, P86, DOI 10.1111/aab.12475; Libus J, 2006, BIOTECHNIQUES, V41, P156, DOI 10.2144/000112232; LILLO C, 1993, J INTERDISCIPL CYCLE, V24, P65, DOI 10.1080/09291019309360196; Lin YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095445; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Mangelsen E, 2010, PLANT PHYSIOL, V153, P14, DOI 10.1104/pp.110.154856; Nagel DH, 2012, CURR BIOL, V22, pR648, DOI 10.1016/j.cub.2012.07.025; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sgamma T, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0121-y; Sosa-Zuniga V, 2017, ANN APPL BIOL, V171, P117, DOI 10.1111/aab.12358; Storchova H, 2019, PLANTA, V250, P2111, DOI 10.1007/s00425-019-03285-1; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Usadel B, 2008, PLANT PHYSIOL, V146, P1834, DOI 10.1104/pp.107.115592; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vogt SH, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00146; Yan HF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35883-6; Zhang LL, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0379-3	39	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0233821	10.1371/journal.pone.0233821	http://dx.doi.org/10.1371/journal.pone.0233821			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705394	Green Submitted, gold, Green Published			2022-12-26	WOS:000629590400064
J	Hoshino, I; Ishige, F; Iwatate, Y; Gunji, H; Kuwayama, N; Nabeya, Y; Yokota, H; Takeshita, N; Iida, K; Nagase, H; Matsubara, H				Hoshino, Isamu; Ishige, Fumitaka; Iwatate, Yosuke; Gunji, Hisashi; Kuwayama, Naoki; Nabeya, Yoshihiro; Yokota, Hajime; Takeshita, Nobuyoshi; Iida, Keiko; Nagase, Hiroki; Matsubara, Hisahiro			Cell-free microRNA-1246 in different body fluids as a diagnostic biomarker for esophageal squamous cell carcinoma	PLOS ONE			English	Article								Esophageal squamous cell carcinoma is a malignant tumor with unfavorable prognosis. In this study, we investigated the usefulness of microRNA (miR)-1246 detection in various body fluids as a biomarker for this disease. A total of 72 patients with esophageal squamous cell carcinoma were enrolled, and their blood, urine, and saliva samples were collected prior to treatment. Reverse transcription-polymerase chain reaction of miR-1246 was performed, and pre- and postoperative and intraday fluctuations in its expression were examined. The expression of miR-1246 in the blood and urine was significantly higher in the patients with esophageal squamous cell carcinoma than in 50 healthy control subjects. Receiver operating characteristic curves showed that the area under the curve values were 0.91 (sensitivity 91.7%, specificity 76.0%), 0.82 (sensitivity 90.3%, specificity 62.0%), and 0.80 (sensitivity 83.3%, specificity 66.0%) in the serum, urine, and saliva, respectively. A relatively high diagnostic performance of miR-1246 was observed in all samples, which was better than that of the existing biomarkers squamous cell carcinoma antigen, carcinoembryonic antigen, and cytokeratin 19 fragment. No clear correlation was observed in the levels of miR-1246 expression among the three body fluids. Postoperatively, serum samples displayed significantly decreased miR-1246 levels. Although not significant, changes in the miR-1246 levels were observed at all collection times, with large fluctuations in the saliva. Meanwhile, serum miR-1246 expression was found to be associated with the disease prognosis. The results indicate that the levels of miR-1246 in the urine, saliva, and serum are a useful biomarker for esophageal squamous cell carcinoma and support the use of urine samples instead of blood samples for noninvasive diagnosis.	[Hoshino, Isamu; Gunji, Hisashi; Kuwayama, Naoki; Nabeya, Yoshihiro] Chiba Canc Ctr, Div Gastroenterol Surg, Chiba, Japan; [Ishige, Fumitaka; Iwatate, Yosuke] Chiba Canc Ctr, Dept Hepatobiliary & Pancreat Surg, Chiba, Japan; [Yokota, Hajime] Chiba Univ, Grad Sch Med, Dept Diagnost Radiol & Radiat Oncol, Chiba, Japan; [Takeshita, Nobuyoshi] Natl Canc Ctr Hosp East, Div Surg Technol, Chiba, Japan; [Iida, Keiko; Matsubara, Hisahiro] Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chiba, Japan; [Nagase, Hiroki] Chiba Canc Ctr Res Inst, Lab Canc Genet, Chiba, Japan	Chiba Cancer Center; Chiba Cancer Center; Chiba University; National Cancer Center - Japan; Chiba University; Chiba Cancer Center	Hoshino, I (corresponding author), Chiba Canc Ctr, Div Gastroenterol Surg, Chiba, Japan.	ihoshino@chiba-cc.jp			JSPS KAKENHI [17K10616]; Cancer Research Funds for Patients and Family	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cancer Research Funds for Patients and Family	This work was supported by JSPS KAKENHI grants-in-aid for scientific research (https://www-shinsei.jsps.go.jp/kaken/english/index.html nos. 17K10616) and Cancer Research Funds for Patients and Family (http://www.medicalwel.com/research-grant.)	Ahmed EK, 2019, J MED BIOCHEM, V38, P109, DOI 10.2478/jomb-2018-0010; Alemar B, 2016, PANCREAS, V45, P84, DOI 10.1097/MPA.0000000000000383; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brown LM, 2008, J NATL CANCER I, V100, P1184, DOI 10.1093/jnci/djn211; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Gao S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/756347; Headrick JR, 2002, ANN THORAC SURG, V73, P1697, DOI 10.1016/S0003-4975(02)03496-3; Humeau M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130996; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; Ishige F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65695-6; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kao HW, 2017, ONCOTARGET, V8, P56389, DOI 10.18632/oncotarget.16916; Kim G, 2016, LUNG CANCER, V91, P15, DOI 10.1016/j.lungcan.2015.11.013; Kim J, 2017, NATURE, V541, P169, DOI 10.1038/nature20805; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Law Simon, 2007, Adv Surg, V41, P93, DOI 10.1016/j.yasu.2007.05.007; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Li F, 2018, CLIN CHEM, V64, P1513, DOI 10.1373/clinchem.2018.290569; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Machida T, 2016, ONCOL REP, V36, P2375, DOI 10.3892/or.2016.5021; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Ohashi S, 2015, GASTROENTEROLOGY, V149, P1700, DOI 10.1053/j.gastro.2015.08.054; Rapado-Gonzalez O, 2019, J CLIN MED, V8, DOI 10.3390/jcm8122029; Ritter A, 2020, INT J ONCOL, V56, P47, DOI 10.3892/ijo.2019.4920; Salazar-Ruales C, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9792730; Sanz-Rubio D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28748-5; Shi YT, 2020, INT J CLIN ONCOL, V25, P89, DOI 10.1007/s10147-019-01532-9; Srivastava A, 2018, AAPS J, V20, DOI 10.1208/s12248-018-0220-y; Streckfus CF, 2008, CANCER INVEST, V26, P159, DOI 10.1080/07357900701783883; Takeshita N, 2013, BRIT J CANCER, V108, P644, DOI 10.1038/bjc.2013.8; Todeschini P, 2017, CANCER LETT, V388, P320, DOI 10.1016/j.canlet.2016.12.017; Wei CM, 2018, BIOMARK MED, V12, P1185, DOI 10.2217/bmm-2017-0440; Xie ZJ, 2015, CANCER PREV RES, V8, P165, DOI 10.1158/1940-6207.CAPR-14-0192; Xu YF, 2017, ONCOTARGET, V8, P77028, DOI 10.18632/oncotarget.20332; Yoshizawa JM, 2013, CLIN MICROBIOL REV, V26, P781, DOI 10.1128/CMR.00021-13; Zhang WC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11702; Zhang Y, 2011, EMBO REP, V12, P811, DOI 10.1038/embor.2011.98; Zhou J, 2015, ONCOL REP, V33, P2915, DOI 10.3892/or.2015.3937	40	2	3	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0248016	10.1371/journal.pone.0248016	http://dx.doi.org/10.1371/journal.pone.0248016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690683	gold, Green Published			2022-12-26	WOS:000627854700049
J	Kawashima, Y; Li, R; Chen, SCY; Vickery, RM; Morley, JW; Tsuchiya, N				Kawashima, Yota; Li, Rannee; Chen, Spencer Chin-Yu; Vickery, Richard Martin; Morley, John W.; Tsuchiya, Naotsugu			Steady state evoked potential (SSEP) responses in the primary and secondary somatosensory cortices of anesthetized cats: Nonlinearity characterized by harmonic and intermodulation frequencies	PLOS ONE			English	Article								When presented with an oscillatory sensory input at a particular frequency, F [Hz], neural systems respond with the corresponding frequency, f [Hz], and its multiples. When the input includes two frequencies (F1 and F2) and they are nonlinearly integrated in the system, responses at intermodulation frequencies (i.e., n1*f1+n2*f2 [Hz], where n1 and n2 are non-zero integers) emerge. Utilizing these properties, the steady state evoked potential (SSEP) paradigm allows us to characterize linear and nonlinear neural computation performed in cortical neurocircuitry. Here, we analyzed the steady state evoked local field potentials (LFPs) recorded from the primary (S1) and secondary (S2) somatosensory cortex of anesthetized cats (maintained with alfaxalone) while we presented slow (F1 = 23Hz) and fast (F2 = 200Hz) somatosensory vibration to the contralateral paw pads and digits. Over 9 experimental sessions, we recorded LFPs from N = 1620 and N = 1008 bipolar-referenced sites in S1 and S2 using electrode arrays. Power spectral analyses revealed strong responses at 1) the fundamental (f1, f2), 2) its harmonic, 3) the intermodulation frequencies, and 4) broadband frequencies (50-150Hz). To compare the computational architecture in S1 and S2, we employed simple computational modeling. Our modeling results necessitate nonlinear computation to explain SSEP in S2 more than S1. Combined with our current analysis of LFPs, our paradigm offers a rare opportunity to constrain the computational architecture of hierarchical organization of S1 and S2 and to reveal how a large-scale SSEP can emerge from local neural population activities.	[Kawashima, Yota; Li, Rannee; Tsuchiya, Naotsugu] Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Melbourne, Vic, Australia; [Chen, Spencer Chin-Yu] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosurg, New Brunswick, NJ USA; [Vickery, Richard Martin] UNSW Sydney, Sch Med Sci, Sydney, NSW, Australia; [Morley, John W.] Western Sydney Univ, Sch Med, Penrith, NSW, Australia; [Tsuchiya, Naotsugu] Natl Inst Informat & Commun Technol NICT, Ctr Informat & Neural Networks CiNet, Suita, Osaka, Japan; [Tsuchiya, Naotsugu] Adv Telecommun Res Computat Neurosci Labs, Seika, Kyoto, Japan	Monash University; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of New South Wales Sydney; Western Sydney University; National Institute of Information & Communications Technology (NICT) - Japan	Tsuchiya, N (corresponding author), Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Melbourne, Vic, Australia.; Tsuchiya, N (corresponding author), Natl Inst Informat & Commun Technol NICT, Ctr Informat & Neural Networks CiNet, Suita, Osaka, Japan.; Tsuchiya, N (corresponding author), Adv Telecommun Res Computat Neurosci Labs, Seika, Kyoto, Japan.	naotsugu.tsuchiya@monash.edu		Li, Rannee/0000-0001-9291-5299; Kawashima, Yota/0000-0003-3810-5230; Morley, John/0000-0001-9246-853X	Australian Research Council [FT120100619, DP130100194, DP180104128, DP180100396]; Australian Research Council Thinking Systems [TS0669860]	Australian Research Council(Australian Research Council); Australian Research Council Thinking Systems(Australian Research Council)	This study was supported by the Australian Research Council to NT (FT120100619, DP130100194, DP180104128, and DP180100396) and the Australian Research Council Thinking Systems to JM (TS0669860).	Baker DH, 2017, CEREB CORTEX, V27, P254, DOI 10.1093/cercor/bhw395; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boremanse A, 2013, J VISION, V13, DOI 10.1167/13.11.6; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; CARR CE, 1988, P NATL ACAD SCI USA, V85, P8311, DOI 10.1073/pnas.85.21.8311; Carter AW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107617; CLYNES M, 1961, ANN NY ACAD SCI, V92, P946; Cohen D, 2020, J NEUROSCI METH, V330, DOI 10.1016/j.jneumeth.2019.108443; Cohen D, 2018, FRONT SYST NEUROSCI, V12, DOI 10.3389/fnsys.2018.00030; Cohen D, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0329-17.2018; Cohen D, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0116-16.2016; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Cunningham DGM, 2017, J VISION, V17, DOI 10.1167/17.5.10; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dhamala M, 2008, NEUROIMAGE, V41, P354, DOI 10.1016/j.neuroimage.2008.02.020; Gabbiani F, 2004, J PHYSIOLOGY-PARIS, V98, P19, DOI 10.1016/j.jphysparis.2004.03.001; Gordon N, 2019, NEUROIMAGE, V199, P480, DOI 10.1016/j.neuroimage.2019.06.008; Gordon N, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000233; Gordon N, 2017, ELIFE, V6, DOI 10.7554/eLife.22749; Gundlach C, 2013, BIOL PSYCHOL, V94, P55, DOI 10.1016/j.biopsycho.2013.04.014; Harvey MA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001558; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Kelly EF, 1996, EXP BRAIN RES, V109, P500; Kim YJ, 2017, J NEUROSCI, V37, P4942, DOI 10.1523/JNEUROSCI.2370-16.2017; Koenig-Robert R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144858; Lachaux JP, 2012, PROG NEUROBIOL, V98, P279, DOI 10.1016/j.pneurobio.2012.06.008; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Miller KJ, 2009, J NEUROSCI, V29, P3132, DOI 10.1523/JNEUROSCI.5506-08.2009; Mitra P., 2007, OBSERVED BRAIN DYNAM; MITZDORF U, 1987, INT J NEUROSCI, V33, P33, DOI 10.3109/00207458708985928; Norcia AM, 2015, J VISION, V15, DOI 10.1167/15.6.4; Pena JL, 2004, J NEUROSCI, V24, P8907, DOI 10.1523/JNEUROSCI.2924-04.2004; Rager G, 1998, EUR J NEUROSCI, V10, P1856, DOI 10.1046/j.1460-9568.1998.00197.x; Ray S, 2008, J NEUROSCI, V28, P11526, DOI 10.1523/JNEUROSCI.2848-08.2008; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; REGAN D, 1988, VISION RES, V28, P187, DOI 10.1016/S0042-6989(88)80018-X; REGAN MP, 1988, J THEOR BIOL, V133, P293, DOI 10.1016/S0022-5193(88)80323-0; Rossion B, 2014, TRENDS COGN SCI, V18, P310, DOI 10.1016/j.tics.2014.02.013; Saal HP, 2015, ELIFE, V4, DOI 10.7554/eLife.10450; Scales L., 1985, INTRO NONLINEAR OPTI; Shirhatti V, 2016, NEURAL COMPUT, V28, P882, DOI 10.1162/NECO_a_00827; Tommerdahl M, 2005, SOMATOSENS MOT RES, V22, P151, DOI 10.1080/08990220500084461; Tommerdahl M, 1999, J NEUROPHYSIOL, V82, P1982, DOI 10.1152/jn.1999.82.4.1982; Tsai JJ, 2012, J NEUROSCI, V32, P2783, DOI 10.1523/JNEUROSCI.4485-11.2012; Tsuchiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003892; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; ZEMON V, 1984, BIOL CYBERN, V50, P401, DOI 10.1007/BF00335197; Zhang P, 2011, NEURON, V71, P362, DOI 10.1016/j.neuron.2011.05.035	54	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2021	16	3							e0240147	10.1371/journal.pone.0240147	http://dx.doi.org/10.1371/journal.pone.0240147			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DJ	33690648	Green Published, gold, Green Submitted			2022-12-26	WOS:000627855600022
J	Shimada, Y; Matsubayashi, J; Saito, A; Ohira, T; Kuroda, M; Ikeda, N				Shimada, Yoshihisa; Matsubayashi, Jun; Saito, Akira; Ohira, Tatsuo; Kuroda, Masahiko; Ikeda, Norihiko			Small RNA sequencing to differentiate lung squamous cell carcinomas from metastatic lung tumors from head and neck cancers	PLOS ONE			English	Article								Distinguishing lung squamous cell carcinoma (LSQCC) from a solitary metastatic lung tumor (MSQCC) from head and neck squamous cell carcinoma (HNSQCC) presents a difficult diagnostic challenge even after detailed pathological assessment. Treatment options and estimated survival outcomes after pulmonary resection differ between patients with LSQCC and MSQCC. This study aimed to investigate whether microRNA (miRNA) profiling by RNA sequencing of HNSQCC, MSQCC, and LSQCC was useful for differential diagnosis of MSQCC and LSQCC. RNA sequencing was performed to identify bioinformatically significant miRNAs from a formalin-fixed paraffin-embedded (FFPE) block from a derivation set. MiRNA levels were confirmed by validation sets using FFPE samples and serum extracellular vesicles from patients. Step-wise discriminant analysis and canonical discriminant analysis identified 13 miRNAs by which the different expression patterns of LSQCC, MSQCC, and HNSQCC groups were demonstrated. Six miRNAs (miR-10a/28/141/320b/3120) were assessed in validation sets, and 4 miRNAs (miR-10a/28/141/3120) were significantly upregulated in LSQCCs compared with MSQCCs and HNSQCCs. Serum extracellular vesicles from LSQCC patients demonstrated significantly elevated miR-10a (p = .042), miR-28 (p = .041), and miR-3120 (p = .047) levels compared with those from MSQCC patients. RNA sequencing is useful for differential diagnosis of LSQCC and MSQCC, and the expression level of miR-10a, miR-28, and miR-3120 in serum extracellular vesicles are promising noninvasive tools for this purpose.	[Shimada, Yoshihisa; Ohira, Tatsuo; Ikeda, Norihiko] Tokyo Med Univ, Dept Thorac Surg, Tokyo, Japan; [Matsubayashi, Jun] Tokyo Med Univ, Dept Anat Pathol, Tokyo, Japan; [Saito, Akira; Kuroda, Masahiko] Tokyo Med Univ, Dept Mol Pathol, Tokyo, Japan	Tokyo Medical University; Tokyo Medical University; Tokyo Medical University	Shimada, Y (corresponding author), Tokyo Med Univ, Dept Thorac Surg, Tokyo, Japan.	zenkyu@za3.so-net.ne.jp			Ministry of Education, Culture, Sports, and Technology, Japan [18K08799]; department of thoracic surgery, Tokyo Medical University	Ministry of Education, Culture, Sports, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); department of thoracic surgery, Tokyo Medical University	This study was supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Education, Culture, Sports, and Technology, Japan (#18K08799; Y. Shimada), and internal research funding from department of thoracic surgery, Tokyo Medical University. There was no additional external funding received for this study.	Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Bao M, 2018, INT J CLIN EXP PATHO, V11, P773; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Datta A, 2019, GENES-BASEL, V10, DOI 10.3390/genes10110852; Du FC, 2019, INT J CLIN EXP PATHO, V12, P559; Ezzati M, 2005, INT J CANCER, V116, P963, DOI 10.1002/ijc.21100; Fazio S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020354; Geurts TW, 2005, CLIN CANCER RES, V11, P6608, DOI 10.1158/1078-0432.CCR-05-0257; Halvaei S, 2018, MOL THER-NUCL ACIDS, V10, P131, DOI 10.1016/j.omtn.2017.11.014; Hongdan Li, 2018, Biochem Biophys Res Commun, V496, P302, DOI 10.1016/j.bbrc.2018.01.021; Kahlert C, 2013, J MOL MED, V91, P431, DOI 10.1007/s00109-013-1020-6; Kandioler D, 1996, J THORAC CARDIOV SUR, V111, P827, DOI 10.1016/S0022-5223(96)70343-4; Leong PP, 1998, JNCI-J NATL CANCER I, V90, P972, DOI 10.1093/jnci/90.13.972; Liu YK, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.61; Long ZH, 2017, ANTICANCER RES, V37, P4345, DOI 10.21873/anticanres.11828; Lu XD, 2019, GEN PHYSIOL BIOPHYS, V38, P525, DOI 10.4149/gpb_2019041; Ma LX, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0963-2; Masoumi-Dehghi S, 2020, J CELL COMMUN SIGNAL, V14, P233, DOI 10.1007/s12079-020-00548-5; Mu HQ, 2019, J CELL BIOCHEM, V120, P4987, DOI 10.1002/jcb.27774; Munoz-Largacha JA, 2017, J THORAC CARDIOV SUR, V154, P714, DOI 10.1016/j.jtcvs.2017.02.071; Paggetti J, 2015, BLOOD, V126, P1106, DOI 10.1182/blood-2014-12-618025; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peng Y, 2016, SIGNAL TRANSDUCT TAR, V1, DOI 10.1038/sigtrans.2015.4; Rahman MA, 2016, ONCOTARGET, V7, P54852, DOI 10.18632/oncotarget.10243; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rotrnan JA, 2015, CLIN IMAG, V39, P735, DOI 10.1016/j.clinimag.2015.05.013; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tickner JA, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00127; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Whiteside TL, 2017, CLIN EXP IMMUNOL, V189, P259, DOI 10.1111/cei.12974; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001	33	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0248206	10.1371/journal.pone.0248206	http://dx.doi.org/10.1371/journal.pone.0248206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33668046	Green Published, gold			2022-12-26	WOS:000626604300016
J	Jansson, S; Malmqvist, E; Mlacha, Y; Ignell, R; Okumu, F; Killeen, G; Kirkeby, C; Brydegaard, M				Jansson, Samuel; Malmqvist, Elin; Mlacha, Yeromin; Ignell, Rickard; Okumu, Fredros; Killeen, Gerry; Kirkeby, Carsten; Brydegaard, Mikkel			Real-time dispersal of malaria vectors in rural Africa monitored with lidar	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; ANOPHELES-FUNESTUS; MOSQUITOS; MEAL; MORTALITY; WINGBEAT; BEHAVIOR; GAMBIAE	Lack of tools for detailed, real-time observation of mosquito behavior with high spatio-temporal resolution limits progress towards improved malaria vector control. We deployed a high-resolution entomological lidar to monitor a half-kilometer static transect positioned over rice fields outside a Tanzanian village. A quarter of a million in situ insect observations were classified, and several insect taxa were identified based on their modulation signatures. We observed distinct range distributions of male and female mosquitoes in relation to the village periphery, and spatio-temporal behavioral features, such as swarming. Furthermore, we observed that the spatial distributions of males and females change independently of each other during the day, and were able to estimate the daily dispersal of mosquitoes towards and away from the village. The findings of this study demonstrate how lidar-based monitoring could dramatically improve our understanding of malaria vector ecology and control options.	[Jansson, Samuel; Malmqvist, Elin; Brydegaard, Mikkel] Lund Univ, Lund Laser Ctr, Dept Phys, Lund, Sweden; [Jansson, Samuel; Malmqvist, Elin; Brydegaard, Mikkel] Lund Univ, Ctr Anim Movement Res, Dept Biol, Lund, Sweden; [Mlacha, Yeromin; Okumu, Fredros; Killeen, Gerry] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Dept, Ifakara, Tanzania; [Mlacha, Yeromin] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Mlacha, Yeromin] Univ Basel, Basel, Switzerland; [Ignell, Rickard] Swedish Univ Agr Sci, Dept Plant Protect Biol, Dis Vector Grp, Alnarp, Sweden; [Okumu, Fredros] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Okumu, Fredros] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Killeen, Gerry] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool, Merseyside, England; [Kirkeby, Carsten] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Frederiksberg, Denmark; [Kirkeby, Carsten; Brydegaard, Mikkel] FaunaPhoton APS, Copenhagen N, Denmark; [Brydegaard, Mikkel] Norsk Elektro Optikk AS, Skedsmokorset, Norway	Lund University; Lund University; Ifakara Health Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Swedish University of Agricultural Sciences; University of Witwatersrand; University of Glasgow; Liverpool School of Tropical Medicine; University of Copenhagen	Jansson, S (corresponding author), Lund Univ, Lund Laser Ctr, Dept Phys, Lund, Sweden.; Jansson, S (corresponding author), Lund Univ, Ctr Anim Movement Res, Dept Biol, Lund, Sweden.	samuel.jansson@forbrf.lth.se	Kirkeby, Carsten/GVS-8137-2022	Killeen, Gerry/0000-0002-8583-8739; Brydegaard, Mikkel/0000-0003-0586-664X; Kirkeby, Carsten/0000-0001-9292-5526	Innovationsfonden, Denmark; Swedish Research Council; Centre for Animal Movement Research; Lund University	Innovationsfonden, Denmark; Swedish Research Council(Swedish Research CouncilEuropean Commission); Centre for Animal Movement Research; Lund University	SJ and MB were supported in part by Innovationsfonden, Denmark, by the Swedish Research Council through grants to Lund Laser Centre and the Centre for Animal Movement Research. MB was further supported by Lund University and by a direct grant from the vice chancellor. CK and MB are co-founders and shareholders but not employees of FaunaPhotonics, and per written agreement FaunaPhotonics had no influence on the scientific reporting. MB is an employee of Norsk Elektro Optikk, which is a non-profit company owned by a foundation with the aim to support optics and art in Norway. Norsk Elektro Optikk provided support in the form of salary for MB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of MB are articulated in the `author contributions' section.	Alonso P, 2017, LANCET, V390, P2532, DOI 10.1016/S0140-6736(17)33080-5; Andersson A, 2018, UNBIASING ENTOMOLOGI; [Anonymous], 2005, BIOL BLOOD SUCKING I; Barreaux P, 2017, TRENDS PARASITOL, V33, P763, DOI 10.1016/j.pt.2017.06.003; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; BIDLINGMAYER WILLIAM L., 1966, MOSQUITO NEWS, V26, P139; BIDLINGMAYER WL, 1974, J MED ENTOMOL, V11, P119, DOI 10.1093/jmedent/11.2.119; Brogdon WG, 1998, J MED ENTOMOL, V35, P681, DOI 10.1093/jmedent/35.5.681; Brydegaard M., 2019, SPIE OSA EUR C BIOM; Brydegaard M., 2017, LIDAR REMOTE SENSING, P17; Brydegaard M, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay5487; Brydegaard M, 2018, LASER PHOTONICS REV, V12, DOI 10.1002/lpor.201800135; Brydegaard M, 2016, EPJ WEB CONF, V119, DOI 10.1051/epjconf/201611922004; Charlwood JD, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-9; Chen YP, 2014, J INSECT BEHAV, V27, P657, DOI 10.1007/s10905-014-9454-4; Deakin MAB, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.9601; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Gebru A, 2018, J BIOPHOTONICS, V11, DOI 10.1002/jbio.201800014; Genoud AP, 2020, ECOL INFORM, V58, DOI 10.1016/j.ecoinf.2020.101090; Genoud AP, 2019, J BIOPHOTONICS, V12, DOI 10.1002/jbio.201900123; Genoud AP, 2018, APPL PHYS B-LASERS O, V124, DOI 10.1007/s00340-018-6917-x; Gething PW, 2016, NEW ENGL J MED, V375, P2435, DOI 10.1056/NEJMoa1606701; Gillies M. T, 1991, MALARIA PRINCIPLES P, P453; Haddow A. J., 1961, Transactions of the Royal Entomological Society of London, V113, P315; Harker J.E., 1973, P189; Kaindoa EW, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2660-y; Kaindoa Emmanuel W, 2017, Wellcome Open Res, V2, P88, DOI 10.12688/wellcomeopenres.12458.1; Kessler S, 2013, J EXP BIOL, V216, P1292, DOI 10.1242/jeb.076588; Killeen GF, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000211; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-97; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Limwagu AJ, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2913-9; Malmqvist E, 2019, FAUNA FLAMES REMOTE; Malmqvist E, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.172303; Malmqvist E, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2015.2506616; Mei L, 2015, OPT EXPRESS, V23, P1613, DOI [10.1364/OE.23.01613, 10.1364/OE.23.0A1613]; Moiroux N, 2012, J INFECT DIS, V206, P1622, DOI 10.1093/infdis/jis565; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Phasomkusolsil S, 2015, ACTA TROP, V152, P220, DOI 10.1016/j.actatropica.2015.09.021; Potamitis I, 2016, APPL ACOUST, V109, P54, DOI 10.1016/j.apacoust.2016.03.005; Protopopoff N, 2018, LANCET, V391, P1577, DOI [10.1016/S0140-6736(18)30427-6, 10.1016/s0140-6736(18)30427-6]; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Silver J. B, 2008, MOSQUITO ECOLOGY FIE; Spitzen J, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2735-6; Thomas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068679; Tiono AB, 2018, LANCET, V392, P569, DOI 10.1016/S0140-6736(18)31711-2; VANHANDEL E, 1965, J PHYSIOL-LONDON, V181, P478, DOI 10.1113/jphysiol.1965.sp007776; Villarreal SM, 2017, J MED ENTOMOL, V54, P1116, DOI 10.1093/jme/tjx079; W. H. Organization, 2017, WORLD MALARIA REPORT	50	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0247803	10.1371/journal.pone.0247803	http://dx.doi.org/10.1371/journal.pone.0247803			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33662005	Green Published, Green Accepted, gold			2022-12-26	WOS:000626604100105
J	Cooke, SL; Soares, BL; Muller, CA; Nieduszynski, CA; de Oliveira, FMB; de Bruin, RAM				Cooke, Sophie L.; Soares, Barbara L.; Muller, Carolin A.; Nieduszynski, Conrad A.; Bastos de Oliveira, Francisco M.; de Bruin, Robertus A. M.			Tos4 mediates gene expression homeostasis through interaction with HDAC complexes independently of H3K56 acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; DAMAGE CHECKPOINT; CELL; TRANSCRIPTION; RPD3; REVEALS; SPECIFICITY; HISTONE-H3; PATHWAYS; DYNAMICS	Saccharomyces cerevisiae exhibits gene expression homeostasis, which is defined as the buffering of transcription levels against changes in DNA copy number during the S phase of the cell cycle. It has been suggested that S. cerevisiae employs an active mechanism to maintain gene expression homeostasis through Rtt109-Asf1-dependent acetylation of histone H3 on lysine 56 (H3K56). Here, we show that gene expression homeostasis can be achieved independently of H3K56 acetylation by Tos4 (Target of Swi6-4). Using Nanostring technology, we establish that Tos4-dependent gene expression homeostasis depends on its forkhead-associated (FHA) domain, which is a phosphopeptide recognition domain required to bind histone deacetylases (HDACs). We demonstrate that the mechanism of Tos4-dependent gene expression homeostasis requires its interaction with the Rpd3L HDAC complex. However, this is independent of Rpd3's well-established roles in both histone deacetylation and controlling the DNA replication timing program, as established by deep sequencing of Fluorescence-Activated Cell Sorted (FACS) S and G2 phase populations. Overall, our data reveals that Tos4 mediates gene expression homeostasis through its FHA domain-dependent interaction with the Rpd3L complex, which is independent of H3K56ac.	[Cooke, Sophie L.; de Bruin, Robertus A. M.] UCL, MRC Lab Mol Cell Biol, London, England; [Soares, Barbara L.; Bastos de Oliveira, Francisco M.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Muller, Carolin A.; Nieduszynski, Conrad A.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England; [Nieduszynski, Conrad A.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [de Bruin, Robertus A. M.] UCL, UCL Canc Inst, London, England	MRC Laboratory Molecular Biology; University of London; University College London; Universidade Federal do Rio de Janeiro; University of Oxford; University of Sussex; University of London; University College London	de Bruin, RAM (corresponding author), UCL, MRC Lab Mol Cell Biol, London, England.; de Bruin, RAM (corresponding author), UCL, UCL Canc Inst, London, England.	r.debruin@ucl.ac.uk	de Oliveira, Francisco Bastos/I-3540-2013	de Oliveira, Francisco Bastos/0000-0003-3314-3940; Soares, Barbara Luisa/0000-0002-7513-3399; De Bruin, Robertus/0000-0001-9957-1409; Cooke, Sophie/0000-0001-8169-8735	R. A. M. d. B.'s Cancer Research UK Programme Foundation Award; FAPERJ [E-26/010.002425/2019, E-26/26/010.002187/2019]; CAPES/PRINT [41/2017];  [MC_EX_G0800785]	R. A. M. d. B.'s Cancer Research UK Programme Foundation Award; FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES/PRINT; 	This work was supported by core funding to the MRC-UCL University Unit (Ref. MC_EX_G0800785) and funded by R. A. M. d. B.'s Cancer Research UK Programme Foundation Award, F. M. B. d. O. is funded by FAPERJ E-26/010.002425/2019, E-26/26/010.002187/2019 and B. L. S. is supported by a scholarship from CAPES/PRINT 41/2017.	Alejandro-Osorio AL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r57; Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Batrakou DG, 2020, NAT PROTOC, V15, P1255, DOI 10.1038/s41596-019-0287-7; Chen Y, 2019, GENOME RES, V29, P1929, DOI 10.1101/gr.254342.119; Claude K. -L., 2020, TRANSCRIPTION COORDI, DOI [10.1101/2020.08.28.272492, DOI 10.1101/2020.08.28.272492]; Clemente-Ruiz M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002376; de Oliveira FMB, 2012, EMBO J, V31, P1798, DOI 10.1038/emboj.2012.27; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Feng WY, 2006, NAT CELL BIOL, V8, P148, DOI 10.1038/ncb1358; Geisberg JV, 2014, CELL, V156, P812, DOI 10.1016/j.cell.2013.12.026; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gomez-Gonzalez B, 2019, GENETICS, V211, P503, DOI 10.1534/genetics.118.301817; Guillemette B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001354; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Kim T, 2012, CELL, V150, P1158, DOI 10.1016/j.cell.2012.08.016; Kishkevich A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47170-z; Knott SRV, 2009, GENE DEV, V23, P1077, DOI 10.1101/gad.1784309; Koivomagi M, 2011, MOL CELL, V42, P610, DOI 10.1016/j.molcel.2011.05.016; Landry BD, 2014, EMBO J, V33, P1044, DOI 10.1002/embj.201386877; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marguerat S, 2012, TRENDS GENET, V28, P560, DOI 10.1016/j.tig.2012.07.003; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Muller CA, 2012, GENOME RES, V22, P1953, DOI 10.1101/gr.139477.112; Muller CA, 2017, J CELL BIOL, V216, P1907, DOI 10.1083/jcb.201701061; Natsume T, 2013, MOL CELL, V50, P661, DOI 10.1016/j.molcel.2013.05.011; Ostapenko D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045895; Padovan-Merhar O, 2015, MOL CELL, V58, P339, DOI 10.1016/j.molcel.2015.03.005; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Ramey CJ, 2004, MOL CELL BIOL, V24, P10313, DOI 10.1128/MCB.24.23.10313-10327.2004; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Santos A, 2015, NUCLEIC ACIDS RES, V43, pD1140, DOI 10.1093/nar/gku1092; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Serra-Cardona A, 2018, TRENDS BIOCHEM SCI, V43, P136, DOI 10.1016/j.tibs.2017.12.003; Shevchenko A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r167; Slager J, 2016, TRENDS MICROBIOL, V24, P788, DOI 10.1016/j.tim.2016.06.003; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Sundin BA, 2004, YEAST, V21, P793, DOI 10.1002/yea.1133; Tao R, 2013, MOL CELL BIOL, V33, P4212, DOI 10.1128/MCB.00618-13; Topal S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12400-5; Vargas-Garcia Cesar A, 2018, Curr Opin Syst Biol, V8, P109, DOI 10.1016/j.coisb.2018.01.002; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Voichek Y, 2018, MOL CELL, V70, P1121, DOI 10.1016/j.molcel.2018.05.015; Voichek Y, 2016, SCIENCE, V351, P1087, DOI 10.1126/science.aad1162; Yabuki N, 2002, GENES CELLS, V7, P781, DOI 10.1046/j.1365-2443.2002.00559.x; Yeheskely-Hayon D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085088; Yoshida K, 2014, MOL CELL, V54, P691, DOI 10.1016/j.molcel.2014.04.032; Yunger S, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800086; Zhu J, 2018, DEV CELL, V44, P420, DOI 10.1016/j.devcel.2018.02.002; Ziane R., MECH DNA REPLICATION, DOI [10.1101/553669, DOI 10.1101/553669]	52	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100533	10.1016/j.jbc.2021.100533	http://dx.doi.org/10.1016/j.jbc.2021.100533			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33713703	Green Accepted, gold, Green Published			2022-12-26	WOS:000672866400507
J	Nakahara, K; Hamada, K; Tsuchida, T; Takasugi, N; Abiko, Y; Shien, K; Toyooka, S; Kumagai, Y; Uehara, T				Nakahara, Kengo; Hamada, Kyohei; Tsuchida, Tomoki; Takasugi, Nobumasa; Abiko, Yumi; Shien, Kazuhiko; Toyooka, Shinichi; Kumagai, Yoshito; Uehara, Takashi			Covalent N-arylation by the pollutant 1,2-naphthoquinone activates the EGF receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; POLYCYCLIC AROMATIC-HYDROCARBONS; TYROSINE-PHOSPHATASE 1B; LUNG-CANCER CELLS; ATMOSPHERIC ELECTROPHILE; QUINONES; PROTEIN; INHIBITION; PATHWAY; A549	The epidermal growth factor receptor (EGFR) is the most intensively investigated receptor tyrosine kinase. Several EGFR mutations and modifications have been shown to lead to abnormal self-activation, which plays a critical role in carcinogenesis. Environmental air pollutants, which are associated with cancer and respiratory diseases, can also activate EGFR. Specifically, the environmental electrophile 1,2-naphthoquinone (1,2-NQ), a component of diesel exhaust particles and particulate matter more generally, has previously been shown to impact EGFR signaling. However, the detailed mechanism of 1,2-NQ function is unknown. Here, we demonstrate that 1,2-NQ is a novel chemical activator of EGFR but not other EGFR family proteins. We found that 1,2-NQ forms a covalent bond, in a reaction referred to as N-arylation, with Lys80, which is in the ligand-binding domain. This modification activates the EGFR-Akt signaling pathway, which inhibits serum deprivation-induced cell death in a human lung adenocarcinoma cell line. Our study reveals a novel mode of EGFR pathway activation and suggests a link between abnormal EGFR activation and environmental pollutant-associated diseases such as cancer.	[Nakahara, Kengo; Hamada, Kyohei; Tsuchida, Tomoki; Takasugi, Nobumasa; Uehara, Takashi] Okayama Univ, Dept Med Pharmacol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Abiko, Yumi; Kumagai, Yoshito] Univ Tsukuba, Fac Med, Environm Biol Lab, Tsukuba, Ibaraki, Japan; [Shien, Kazuhiko; Toyooka, Shinichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Thorac Breast & Endocrinol Surg, Okayama, Japan	Okayama University; University of Tsukuba; Okayama University	Uehara, T (corresponding author), Okayama Univ, Dept Med Pharmacol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	uehara-t@okayama-u.ac.jp	; Shien, Kazuhiko/B-8560-2012	TAKASUGI, NOBUMASA/0000-0002-6059-2082; Nakahara, Kengo/0000-0003-0765-4931; Shien, Kazuhiko/0000-0002-4959-4220	Ministry of Education, Culture, Sports and Technology (MEXT) of Japan [18H02579, 19K22498, 18H05293]; Smoking Research Foundation	Ministry of Education, Culture, Sports and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation	This work was supported in part by Grants-in-Aid for Scientific Research (B) (18H02579), Challenging Exploratory Research (19K22498) (to T. U.), and Scientific Research (S) (18H05293) (to Y. K.) from the Ministry of Education, Culture, Sports and Technology (MEXT) of Japan and by the Smoking Research Foundation (to T. U.).	Abiko Y, 2017, FREE RADICAL BIO MED, V104, P118, DOI 10.1016/j.freeradbiomed.2016.12.047; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Beei C, 2013, J TOXICOL SCI, V38, P793; Cho AK, 2004, AEROSOL SCI TECH, V38, P68, DOI 10.1080/02786820390229471; Chung MY, 2006, ENVIRON SCI TECHNOL, V40, P4880, DOI 10.1021/es0515957; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Delgado-Saborit JM, 2013, ATMOS ENVIRON, V77, P974, DOI 10.1016/j.atmosenv.2013.05.080; Dienstmann R, 2014, MOL CANCER THER, V13, P1021, DOI 10.1158/1535-7163.MCT-13-0639; Eiguren-Fernandez A, 2008, AEROSOL SCI TECH, V42, P854, DOI 10.1080/02786820802339546; Endo A, 2007, BIOCHEM BIOPH RES CO, V361, P243, DOI 10.1016/j.bbrc.2007.07.024; Fraser MP, 1998, ENVIRON SCI TECHNOL, V32, P1760, DOI 10.1021/es970349v; GOLDMAN R, 1990, BIOCHEMISTRY-US, V29, P11024, DOI 10.1021/bi00502a002; Hecht SS, 2002, LANCET ONCOL, V3, P461, DOI 10.1016/S1470-2045(02)00815-X; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Huang LM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11541-1; Huang Y, 1997, APOPTOSIS, V2, P199, DOI 10.1023/A:1026420616484; Iwamoto N, 2007, J BIOL CHEM, V282, P33396, DOI 10.1074/jbc.M705224200; Izuishi K, 2000, CANCER RES, V60, P6201; Jakober CA, 2007, ENVIRON SCI TECHNOL, V41, P4548, DOI 10.1021/es062967u; Jin YF, 2017, ENVIRON TOXICOL, V32, P1121, DOI 10.1002/tox.22308; Kautzman KE, 2010, J PHYS CHEM A, V114, P913, DOI 10.1021/jp908530s; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; Kovacs E, 2015, ANNU REV BIOCHEM, V84, P739, DOI 10.1146/annurev-biochem-060614-034402; Kumagai Yoshito, 2016, J Toxicol Sci, V41, pSP37, DOI 10.2131/jts.41.SP37; Kumagai Y, 2012, ANNU REV PHARMACOL, V52, P221, DOI 10.1146/annurev-pharmtox-010611-134517; Kuzman JA, 2005, J MOL CELL CARDIOL, V39, P841, DOI 10.1016/j.yjmcc.2005.07.019; Laux I, 2006, BRIT J CANCER, V94, P85, DOI 10.1038/sj.bjc.6602875; Lee JC, 2006, PLOS MED, V3, P2264, DOI 10.1371/journal.pmed.0030485; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Madshus IH, 2009, J CELL SCI, V122, P3433, DOI 10.1242/jcs.050260; Matsui T, 2019, CHEM RES TOXICOL, V32, P1760, DOI 10.1021/acs.chemrestox.9b00088; Misaki K, 2016, MUTAGENESIS, V31, P205, DOI 10.1093/mutage/gev076; Miura T, 2011, CHEM RES TOXICOL, V24, P1836, DOI 10.1021/tx200025y; Nair S., 2020, PLOS ONE, V15, P1; Nakahara K, 2019, BIOL PHARM BULL, V42, P1044, DOI 10.1248/bpb.b19-00025; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Pan M, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006624; Parsa N, 2012, IRAN J PUBLIC HEALTH, V41, P1; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Purba ER, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6020013; Sakaguchi M, 2014, MOL BIOTECHNOL, V56, P621, DOI 10.1007/s12033-014-9738-0; Sakai K, 2007, CANCER SCI, V98, P1498, DOI 10.1111/j.1349-7006.2007.00553.x; Santos GD, 2011, ANNU REV PATHOL-MECH, V6, P49, DOI 10.1146/annurev-pathol-011110-130206; Sasaki T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/546318; Shinkai Y, 2015, CHEM RES TOXICOL, V28, P838, DOI 10.1021/tx500416y; Sickmier EA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163366; Sigismund S, 2018, MOL ONCOL, V12, P3, DOI 10.1002/1878-0261.12155; Sumi D, 2010, J TOXICOL SCI, V35, P891, DOI 10.2131/jts.35.891; Sun Y, 2006, ARCH TOXICOL, V80, P280, DOI 10.1007/s00204-005-0043-3; Takayama N, 2011, J TOXICOL SCI, V36, P817, DOI 10.2131/jts.36.817; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Toyama T, 2014, CHEM-BIOL INTERACT, V214, P41, DOI 10.1016/j.cbi.2014.02.008; Walgraeve C, 2010, ATMOS ENVIRON, V44, P1831, DOI 10.1016/j.atmosenv.2009.12.004; Wee P, 2017, CANCERS, V9, DOI 10.3390/cancers9050052; Zhou P, 2018, ONCOL LETT, V15, P5201, DOI 10.3892/ol.2018.7961	55	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100524	10.1016/j.jbc.2021.100524	http://dx.doi.org/10.1016/j.jbc.2021.100524			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33705793	Green Published, gold			2022-12-26	WOS:000672866400498
J	Ng, CY; Whitelock, JM; Williams, H; Kim, HN; Medbury, HJ; Lord, MS				Ng, Chun-yi; Whitelock, John M.; Williams, Helen; Kim, Ha Na; Medbury, Heather J.; Lord, Megan S.			Macrophages bind LDL using heparan sulfate and the perlecan protein core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEINS; SMOOTH-MUSCLE-CELLS; ARTERIAL PROTEOGLYCANS; APOLIPOPROTEIN-B; GROWTH-FACTOR; ATHEROSCLEROSIS; GLYCOSAMINOGLYCANS; RETENTION; ACCUMULATION; IDENTIFICATION	The retention of low-density lipoprotein (LDL) is a key process in the pathogenesis of atherosclerosis and largely mediated via smooth-muscle cell-derived extracellular proteoglycans including the glycosaminoglycan chains. Macrophages can also internalize lipids via complexes with proteoglycans. However, the role of polarized macrophage-derived proteoglycans in binding LDL is unknown and important to advance our understanding of the pathogenesis of atherosclerosis. We therefore examined the identity of proteoglycans, including the pendent glycosaminoglycans, produced by polarized macrophages to gain insight into the molecular basis for LDL binding. Using the quartz crystal microbalance with dissipation monitoring technique, we established that classically activated macrophage (M1)- and alternatively activated macrophage (M2)-derived proteoglycans bind LDL via both the protein core and heparan sulfate (HS) in vitro. Among the proteoglycans secreted by macrophages, we found perlecan was the major protein core that bound LDL. In addition, we identified perlecan in the necrotic core as well as the fibrous cap of advanced human atherosclerotic lesions in the same regions as HS and colocalized with M2 macrophages, suggesting a functional role in lipid retention in vivo. These findings suggest that macrophages may contribute to LDL retention in the plaque by the production of proteoglycans; however, their contribution likely depends on both their phenotype within the plaque and the presence of enzymes, such as heparanase, that alter the secreted protein structure.	[Ng, Chun-yi; Whitelock, John M.; Kim, Ha Na; Lord, Megan S.] UNSW Sydney, Grad Sch Biomed Engn, Sydney, NSW, Australia; [Ng, Chun-yi; Williams, Helen; Medbury, Heather J.] Westmead Hosp, Vasc Biol Res Ctr, Dept Surg, Westmead, NSW, Australia; [Ng, Chun-yi; Williams, Helen; Medbury, Heather J.] Univ Sydney, Westmead Clin Sch, Westmead, NSW, Australia	University of New South Wales Sydney; University of Sydney; University of Sydney	Lord, MS (corresponding author), UNSW Sydney, Grad Sch Biomed Engn, Sydney, NSW, Australia.; Medbury, HJ (corresponding author), Westmead Hosp, Vasc Biol Res Ctr, Dept Surg, Westmead, NSW, Australia.; Medbury, HJ (corresponding author), Univ Sydney, Westmead Clin Sch, Westmead, NSW, Australia.	heather.medbury@sydney.edu.au; m.lord@unsw.edu.au	Williams, Helen/AAW-9632-2021; Lord, Megan/D-4673-2013	Williams, Helen/0000-0001-8221-5766; Lord, Megan/0000-0002-0506-9811	Australian Government Research Training Program Scholarship	Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	C. Y. N. was supported by an Australian Government Research Training Program Scholarship.	Adhikara IM, 2019, BIOCHEM BIOPH RES CO, V509, P89, DOI 10.1016/j.bbrc.2018.12.068; Asplund A, 2011, ATHEROSCLEROSIS, V215, P77, DOI 10.1016/j.atherosclerosis.2010.12.017; Asplund A, 2010, GLYCOBIOLOGY, V20, P33, DOI 10.1093/glycob/cwp139; Asplund A, 2009, J LEUKOCYTE BIOL, V86, P381, DOI 10.1189/jlb.0908536; Baker AB, 2010, ATHEROSCLEROSIS, V213, P436, DOI 10.1016/j.atherosclerosis.2010.09.003; Ballinger ML, 2009, ATHEROSCLEROSIS, V205, P451, DOI 10.1016/j.atherosclerosis.2009.01.024; Barthwal MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058054; Bi Y, 2019, NEURAL PLAST, V2019, DOI 10.1155/2019/6724903; Boren J, 1998, J CLIN INVEST, V101, P2658, DOI 10.1172/JCI2265; Boren J, 2016, CURR OPIN LIPIDOL, V27, P473, DOI 10.1097/MOL.0000000000000330; BROWN MS, 1980, J SUPRAMOL STR CELL, V13, P67, DOI 10.1002/jss.400130107; CAMEJO G, 1993, J BIOL CHEM, V268, P14131; CAMEJO G, 1980, ATHEROSCLEROSIS, V35, P307, DOI 10.1016/0021-9150(80)90129-X; CAMEJO G, 1988, ARTERIOSCLEROSIS, V8, P368, DOI 10.1161/01.ATV.8.4.368; Cardilo-Reis L, 2012, EMBO MOL MED, V4, P1072, DOI 10.1002/emmm.201201374; Chang MY, 2014, MATRIX BIOL, V34, P1, DOI 10.1016/j.matbio.2014.01.011; Chang MY, 1998, J BIOL CHEM, V273, P15985, DOI 10.1074/jbc.273.26.15985; Chinetti-Gbaguidi G, 2015, NAT REV CARDIOL, V12, P10, DOI 10.1038/nrcardio.2014.173; CHRISTNER JE, 1988, ARTERIOSCLEROSIS, V8, P535, DOI 10.1161/01.ATV.8.5.535; CUSHING SD, 1990, P NATL ACAD SCI USA, V87, P5134, DOI 10.1073/pnas.87.13.5134; DALFERES ER, 1987, EXP MOL PATHOL, V47, P363, DOI 10.1016/0014-4800(87)90019-0; Davies NP, 2008, J AGR FOOD CHEM, V56, P343, DOI 10.1021/jf072624v; Evanko SP, 1998, AM J PATHOL, V152, P533; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hakamata H, 1998, J Atheroscler Thromb, V5, P66; Halvorsen B, 1998, BIOCHEM J, V331, P743, DOI 10.1042/bj3310743; Hamilton TA, 1999, PATHOBIOLOGY, V67, P241, DOI 10.1159/000028101; HOLLMANN J, 1989, ARTERIOSCLEROSIS, V9, P154, DOI 10.1161/01.ATV.9.2.154; HURT E, 1990, J LIPID RES, V31, P443; HurtCamejo E, 1997, ARTERIOSCL THROM VAS, V17, P1011, DOI 10.1161/01.ATV.17.6.1011; HURTCAMEJO E, 1992, ARTERIOSCLER THROMB, V12, P569, DOI 10.1161/01.ATV.12.5.569; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; IVERIUS PH, 1972, J BIOL CHEM, V247, P2607; Kang H., 2019, MED NOVEL TECHNOLOGY, V3, P100016; Kaplan M, 2000, ATHEROSCLEROSIS, V149, P5, DOI 10.1016/S0021-9150(99)00287-7; Kaplan M, 1997, BIOCHEM BIOPH RES CO, V237, P271, DOI 10.1006/bbrc.1997.7130; Kovanen PT, 1999, TRENDS CARDIOVAS MED, V9, P86, DOI 10.1016/S1050-1738(99)00013-4; Krisko A, 2006, BIOPHYS CHEM, V119, P234, DOI 10.1016/j.bpc.2005.09.011; Kunjathoor VV, 2002, ARTERIOSCL THROM VAS, V22, P462, DOI 10.1161/hq0302.105378; Li Yu-Zhen, 2007, Shengli Xuebao, V59, P221; Little PJ, 2008, CURR OPIN LIPIDOL, V19, P448, DOI 10.1097/MOL.0b013e32830dd7c4; Little PJ, 2002, ARTERIOSCL THROM VAS, V22, P55, DOI 10.1161/hq0102.101100; Lord MS, 2016, METAB ENG, V38, P105, DOI 10.1016/j.ymben.2016.07.006; Lord MS, 2014, MATRIX BIOL, V35, P112, DOI 10.1016/j.matbio.2014.01.016; Lord MS, 2013, J BIOL CHEM, V288, P22930, DOI 10.1074/jbc.M112.404186; MAHLEY RW, 1979, BIOCHIM BIOPHYS ACTA, V575, P81, DOI 10.1016/0005-2760(79)90133-4; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Medbury HJ, 2013, INT ANGIOL, V32, P74; Mikita T, 2001, J BIOL CHEM, V276, P45729, DOI 10.1074/jbc.M106114200; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; Olsson U, 2001, GLYCOCONJUGATE J, V18, P789, DOI 10.1023/A:1021155518464; Osman N, 2013, CARDIOVASC PATHOL, V22, P146, DOI 10.1016/j.carpath.2012.07.002; Osterud B, 2003, PHYSIOL REV, V83, P1069, DOI 10.1152/physrev.00005.2003; OWENS RT, 1991, ATHEROSCLEROSIS, V91, P229, DOI 10.1016/0021-9150(91)90170-8; PAN YT, 1978, ARCH BIOCHEM BIOPHYS, V189, P231, DOI 10.1016/0003-9861(78)90208-4; Pillarisetti S, 1997, J CLIN INVEST, V100, P867, DOI 10.1172/JCI119602; Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003; Rey-Giraud F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042656; Sluimer JC, 2008, J AM COLL CARDIOL, V51, P1258, DOI 10.1016/j.jacc.2007.12.025; SRINIVASAN SR, 1995, BBA-MOL BASIS DIS, V1272, P61, DOI 10.1016/0925-4439(95)00068-F; STEVENS RL, 1976, J CLIN INVEST, V58, P470, DOI 10.1172/JCI108491; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Swart M, 2019, J HISTOCHEM CYTOCHEM, V67, P9, DOI 10.1369/0022155418798770; Tedesco S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00071; Tran PK, 2007, ATHEROSCLEROSIS, V190, P264, DOI 10.1016/j.atherosclerosis.2006.03.010; Tran-Lundmark K, 2008, CIRC RES, V103, P43, DOI 10.1161/CIRCRESAHA.108.172833; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Vijayagopal P, 2005, ATHEROSCLEROSIS, V178, P75, DOI 10.1016/j.atherosclerosis.2004.08.028; Vikramadithyan RK, 2004, J LIPID RES, V45, P1806, DOI 10.1194/jlr.M400019-JLR200; VOLKER W, 1990, EUR HEART J, V11, P29, DOI 10.1093/eurheartj/11.suppl_E.29; WASTY F, 1993, DIABETOLOGIA, V36, P316, DOI 10.1007/BF00400234; Whitelock JM, 1999, MATRIX BIOL, V18, P163, DOI 10.1016/S0945-053X(99)00014-1; Xu YX, 2015, J LIPID RES, V56, P266, DOI 10.1194/jlr.M053017; Zhang X, 2018, J CELL MOL MED, V22, P409, DOI 10.1111/jcmm.13329	75	9	9	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100520	10.1016/j.jbc.2021.100520	http://dx.doi.org/10.1016/j.jbc.2021.100520			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33684447	gold, Green Published			2022-12-26	WOS:000672866400494
J	Teo, AKK; Nguyen, L; Gupta, MK; Lau, HH; Loo, LSW; Jackson, N; Lim, CS; Mallard, W; Gritsenko, MA; Rinn, JL; Smith, RD; Qian, WJ; Kulkarni, RN				Teo, Adrian Kee Keong; Linh Nguyen; Gupta, Manoj K.; Lau, Hwee Hui; Loo, Larry Sai Weng; Jackson, Nicholas; Lim, Chang Siang; Mallard, William; Gritsenko, Marina A.; Rinn, John L.; Smith, Richard D.; Qian, Wei-Jun; Kulkarni, Rohit N.			Defective insulin receptor signaling in hPSCs skews pluripotency and negatively perturbs neural differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; EXTRACELLULAR-MATRIX; NETWORK; FGF; NEUROECTODERM; PROLIFERATION; MAINTENANCE; STABILITY; PATHWAYS	Human embryonic stem cells are a type of pluripotent stem cells (hPSCs) that are used to investigate their differentiation into diverse mature cell types for molecular studies. The mechanisms underlying insulin receptor (IR)-mediated signaling in the maintenance of human pluripotent stem cell (hPSC) identity and cell fate specification are not fully understood. Here, we used two independent shRNAs to stably knock down IRs in two hPSC lines that represent pluripotent stem cells and explored the consequences on expression of key proteins in pathways linked to proliferation and differentiation. We consistently observed lowered pAKT in contrast to increased pERK1/2 and a concordant elevation in pluripotency gene expression. ERK2 chromatin immunoprecipitation, luciferase assays, and ERK1/2 inhibitors established direct causality between ERK1/2 and OCT4 expression. Of importance, RNA sequencing analyses indicated a dysregulation of genes involved in cell differentiation and organismal development. Mass spectrometry-based proteomic analyses further confirmed a global downregulation of extracellular matrix proteins. Subsequent differentiation toward the neural lineage reflected alterations in SOX1(+)PAX6(+) neuroectoderm and FOXG1(+) cortical neuron marker expression and protein localization. Collectively, our data underscore the role of IR-mediated signaling in maintaining pluripotency, the extracellular matrix necessary for the stem cell niche, and regulating cell fate specification including the neural lineage.	[Teo, Adrian Kee Keong; Gupta, Manoj K.; Jackson, Nicholas; Kulkarni, Rohit N.] Harvard Med Sch, Brigham & Womens Hosp, Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol,Dept Med, Boston, MA 02115 USA; [Teo, Adrian Kee Keong; Gupta, Manoj K.; Jackson, Nicholas; Kulkarni, Rohit N.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Teo, Adrian Kee Keong; Linh Nguyen; Lau, Hwee Hui; Loo, Larry Sai Weng; Lim, Chang Siang] Proteos, Stem Cells & Diabet Lab, Inst Mol & Cell Biol, Singapore, Singapore; [Teo, Adrian Kee Keong; Linh Nguyen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Teo, Adrian Kee Keong; Linh Nguyen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Lau, Hwee Hui; Loo, Larry Sai Weng] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Mallard, William; Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Mallard, William; Rinn, John L.] Broad Inst MIT, Cambridge, MA USA; [Gritsenko, Marina A.; Smith, Richard D.; Qian, Wei-Jun] Pacific Northwest Natl Lab, Biol Sci Div, Richland, WA 99352 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Teo, AKK; Kulkarni, RN (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol,Dept Med, Boston, MA 02115 USA.; Teo, AKK; Kulkarni, RN (corresponding author), Harvard Stem Cell Inst, Boston, MA 02115 USA.; Teo, AKK (corresponding author), Proteos, Stem Cells & Diabet Lab, Inst Mol & Cell Biol, Singapore, Singapore.; Teo, AKK (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.; Teo, AKK (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore.	ateo@imcb.a-star.edu.sg; rohit.kulkarni@joslin.harvard.edu	; Teo, Adrian/A-4009-2013	Jackson, Nicholas/0000-0003-4837-6624; Rinn, John/0000-0002-7231-7539; Loo, Larry Sai Weng/0000-0003-1671-2232; Nguyen, Linh/0000-0001-9850-1302; Teo, Adrian/0000-0001-5901-7075	Institute of Molecular and Cell Biology (IMCB); JCO Career Development Award (CDA) [15302FG148]; NMRC OFYIRG [OFYIRG16may014]; MRC; A*STAR ETPL Gap Funding [ETPL/18-GAP005-R20H]; Skin Innovation Grant [SIG18011]; NMRC OF-LCG/DYNAMO; Lee Foundation [SHTX/LFG/002/2018]; Precision Medicine and Personalised Therapeutics Joint Research Grant 2019; FY2019 SingHealth Duke-NUS Surgery Academic Clinical Programme Research Support Programme Grant; SingHealth Duke-NUS Transplant Centre -MultiVisceral Transplant Fund Award; Industry Alignment Fund-Industry Collaboration Project (IAF-ICP); NIH [P41 GM103493, R01 DK 67536, R01 DK103215, UC4 DK 116278]; HSCI; DOE [DE-AC05-76RLO-1830]; A*STAR	Institute of Molecular and Cell Biology (IMCB); JCO Career Development Award (CDA); NMRC OFYIRG; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); A*STAR ETPL Gap Funding(Agency for Science Technology & Research (A*STAR)); Skin Innovation Grant; NMRC OF-LCG/DYNAMO(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lee Foundation; Precision Medicine and Personalised Therapeutics Joint Research Grant 2019; FY2019 SingHealth Duke-NUS Surgery Academic Clinical Programme Research Support Programme Grant; SingHealth Duke-NUS Transplant Centre -MultiVisceral Transplant Fund Award; Industry Alignment Fund-Industry Collaboration Project (IAF-ICP); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HSCI; DOE(United States Department of Energy (DOE)); A*STAR(Agency for Science Technology & Research (A*STAR))	A. K. K. T. is supported by the Institute of Molecular and Cell Biology (IMCB), A*STAR, the JCO Career Development Award (CDA) 15302FG148, NMRC OFYIRG OFYIRG16may014, MRC Research Grant, A*STAR ETPL Gap Funding ETPL/18-GAP005-R20H, Skin Innovation Grant SIG18011, NMRC OF-LCG/DYNAMO, Lee Foundation Grant SHTX/LFG/002/2018, Precision Medicine and Personalised Therapeutics Joint Research Grant 2019, FY2019 SingHealth Duke-NUS Surgery Academic Clinical Programme Research Support Programme Grant, SingHealth Duke-NUS Transplant Centre -MultiVisceral Transplant Fund Award and the Industry Alignment FundIndustry Collaboration Project (IAF-ICP). R. D. S. is supported by NIH grant P41 GM103493. R. N. K. is supported by the HSCI and, NIH grants R01 DK 67536, R01 DK103215, and UC4 DK 116278. Pacific Northwest National Laboratory is under DOE contract DEAC05-76RLO-1830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Brumbaugh J, 2012, P NATL ACAD SCI USA, V109, P7162, DOI 10.1073/pnas.1203874109; Chen HX, 2015, P NATL ACAD SCI USA, V112, pE5936, DOI 10.1073/pnas.1516319112; Chiu SL, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-7; Chng ZZ, 2010, CELL STEM CELL, V6, P59, DOI 10.1016/j.stem.2009.11.015; Dalton S, 2013, CURR OPIN CELL BIOL, V25, P241, DOI 10.1016/j.ceb.2012.09.005; Dastidar SG, 2011, J NEUROSCI, V31, P402, DOI 10.1523/JNEUROSCI.2897-10.2011; Ding V, 2006, BIOTECHNOL LETT, V28, P491, DOI 10.1007/s10529-006-0005-8; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Goke J, 2013, MOL CELL, V50, P844, DOI 10.1016/j.molcel.2013.04.030; Gupta MK, 2018, MOL METAB, V18, P153, DOI 10.1016/j.molmet.2018.09.003; Gupta MK, 2015, STEM CELL TRANSL MED, V4, P1101, DOI 10.5966/sctm.2014-0217; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Jerabek S, 2014, BBA-GENE REGUL MECH, V1839, P138, DOI 10.1016/j.bbagrm.2013.10.001; Kim SH, 2014, STEM CELL RES, V13, P1, DOI 10.1016/j.scr.2014.04.001; Kleinridders A, 2015, P NATL ACAD SCI USA, V112, P3463, DOI 10.1073/pnas.1500877112; Kumamoto T, 2017, DEV GROWTH DIFFER, V59, P258, DOI 10.1111/dgd.12367; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Liu J, 2014, DIABETES OBES METAB, V16, P16, DOI 10.1111/dom.12337; Liu ZZ, 1997, P NATL ACAD SCI USA, V94, P6758, DOI 10.1073/pnas.94.13.6758; Ludwig T., 2007, CURR PROTOC STEM CEL; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Mitter D, 2018, GENET MED, V20, P98, DOI 10.1038/gim.2017.75; Na J, 2010, STEM CELL RES, V5, P157, DOI 10.1016/j.scr.2010.06.002; Rizzino A, 2013, STEM CELLS, V31, P1033, DOI 10.1002/stem.1352; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Suter DM, 2009, STEM CELLS, V27, P49, DOI 10.1634/stemcells.2008-0319; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Teo AKK, 2013, J BIOL CHEM, V288, P5353, DOI 10.1074/jbc.C112.428979; Teo AKK, 2010, BIOCHEM J, V428, P11, DOI 10.1042/BJ20100102; Teo AKK, 2015, STEM CELL REP, V4, P578, DOI 10.1016/j.stemcr.2015.02.015; Teo AKK, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.007; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/nmat3339, 10.1038/NMAT3339]; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744	42	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100495	10.1016/j.jbc.2021.100495	http://dx.doi.org/10.1016/j.jbc.2021.100495			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33667549	gold, Green Published			2022-12-26	WOS:000672866400469
J	Mund, JA; Park, S; Smith, AE; He, YZ; Jiang, L; Hawley, E; Roberson, MJ; Mitchell, DK; Abu-Sultanah, M; Yuan, J; Bessler, WK; Sandusky, G; Chen, S; Zhang, C; Rhodes, SD; Clapp, DW				Mund, Julie A.; Park, SuJung; Smith, Abbi E.; He, Yongzheng; Jiang, Li; Hawley, Eric; Roberson, Michelle J.; Mitchell, Dana K.; Abu-Sultanah, Mohannad; Yuan, Jin; Bessler, Waylan K.; Sandusky, George; Chen, Shi; Zhang, Chi; Rhodes, Steven D.; Clapp, D. Wade			Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						animal model; tumor cell biology; short hairpin RNA (shRNA); Ras-related C3 botulinum toxin substrate 1 (Rac1); Schwann cells; neurofibromatosis type 1; GTPase-activating protein (GAP); tumor suppressor; kinase signaling	BREAST-CANCER; RHO GTPASES; NF1; SCHWANN; EXPRESSION; GROWTH; TUMORS; CELLS; IDENTIFICATION; PATHWAYS	Neurofibromatosis type 1 (NF1) is a common cancer predisposition syndrome caused by mutations in theNF1tumor suppressor gene.NF1encodes neurofibromin, a GTPase-activating protein for RAS proto-oncogene GTPase (RAS). Plexiform neurofibromas are a hallmark of NF1 and result from loss of heterozygosity ofNF1in Schwann cells, leading to constitutively activated p21RAS. Given the inability to target p21RAS directly, here we performed an shRNA library screen of all human kinases and Rho-GTPases in a patient-derivedNF1(?/?)Schwann cell line to identify novel therapeutic targets to disrupt PN formation and progression. Rho family members, including Rac family small GTPase 1 (RAC1), were identified as candidates. Corroborating these findings, we observed that shRNA-mediated knockdown of RAC1 reduces cell proliferation and phosphorylation of extracellular signal?regulated kinase (ERK) inNF1(?/?)Schwann cells. Genetically engineeredNf1(flox/flox);PostnCre(+)mice, which develop multiple PNs, also exhibited increased RAC1-GTP and phospho-ERK levels compared withNf1(flox/flox);PostnCre(?)littermates. Notably, mice in which bothNf1andRac1loci were disrupted (Nf1(flox/flox)Rac1(flox/flox);PostnCre(+)) were completely free of tumors and had normal phospho-ERK activity compared withNf1(flox/flox);PostnCre(+)mice. We conclude that the RAC1-GTPase is a key downstream node of RAS and that genetic disruption of theRac1allele completely prevents PN tumor formationin vivoin mice.	[Mund, Julie A.; Park, SuJung; Smith, Abbi E.; He, Yongzheng; Jiang, Li; Hawley, Eric; Roberson, Michelle J.; Mitchell, Dana K.; Abu-Sultanah, Mohannad; Yuan, Jin; Bessler, Waylan K.; Chen, Shi; Rhodes, Steven D.; Clapp, D. Wade] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Mund, Julie A.; Hawley, Eric; Clapp, D. Wade] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Zhang, Chi; Clapp, D. Wade] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Sandusky, George] Indiana Univ Sch Med, Div Pediat Hematol Oncol, Indianapolis, IN 46202 USA; [Rhodes, Steven D.] Indiana Univ Sch Med, Dept Pathol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Clapp, DW (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA.; Clapp, DW (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.; Clapp, DW (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA.	dclapp@iu.edu		Mitchell, Dana/0000-0002-1022-1072; Smith, Abbi/0000-0002-4402-8959	Developmental and Hyperactive Ras Tumor SPORE through NCI, National Institutes of Health [U54-CA19651904]; NCI/NINDS, National Institutes of Health [R01NS104489-02]; Institutional National Research Service Award T32 [5T32DK007519-34]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [K12HD000850-35]	Developmental and Hyperactive Ras Tumor SPORE through NCI, National Institutes of Health; NCI/NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional National Research Service Award T32(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a Developmental and Hyperactive Ras Tumor SPORE funded through NCI, National Institutes of Health Grant U54-CA19651904 and NCI/NINDS, National Institutes of Health Grant R01NS104489-02. Julie Mund is a predoctoral fellow supported by Institutional National Research Service Award T32 through Award 5T32DK007519-34. Steven Rhodes is a fellow in the Pediatric Scientist Development Program supported by Award K12HD000850-35 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez Diego E, 2014, Small GTPases, V5, pe29038, DOI 10.4161/sgtp.29038; Birnbaum RA, 2000, MOL CELL, V5, P189, DOI 10.1016/S1097-2765(00)80415-3; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Brosseau JP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07452-y; Canavese F, 2011, J PEDIATR ORTHOPED, V31, P303, DOI 10.1097/BPO.0b013e31820cad77; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Chen ZG, 2014, CANCER CELL, V26, P695, DOI 10.1016/j.ccell.2014.09.009; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Dai Zhiyin, 2014, F1000Res, V3, P95, DOI 10.12688/f1000research.3928.2; DeClue JE, 2000, J CLIN INVEST, V105, P1233, DOI 10.1172/JCI7610; Dombi E, 2016, NEW ENGL J MED, V375, P2550, DOI 10.1056/NEJMoa1605943; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Ferguson MJ, 2016, PEDIATR BLOOD CANCER, V63, P206, DOI 10.1002/pbc.25763; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Guo L, 2012, J NEUROSCI, V32, P17251, DOI 10.1523/JNEUROSCI.2461-12.2012; Gutmann DH, 2013, EXPERT OPIN INV DRUG, V22, P443, DOI 10.1517/13543784.2013.772979; Haga Raquel B, 2016, Small GTPases, V7, P207; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hein AL, 2016, ONCOGENE, V35, P6319, DOI 10.1038/onc.2016.163; Hiatt KK, 2001, J BIOL CHEM, V276, P7240, DOI 10.1074/jbc.M009202200; Ingram DA, 2001, J EXP MED, V194, P57, DOI 10.1084/jem.194.1.57; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Li H, 2016, LAB INVEST, V96, P1105, DOI 10.1038/labinvest.2016.88; Liao CP, 2018, J CLIN INVEST, V128, P2848, DOI 10.1172/JCI99424; Lin Y, 2015, EXPERT OPIN DRUG DIS, V10, P991, DOI 10.1517/17460441.2015.1058775; Lindsley A, 2007, DEV BIOL, V307, P340, DOI 10.1016/j.ydbio.2007.04.041; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Mayes DA, 2011, CANCER RES, V71, P4675, DOI 10.1158/0008-5472.CAN-10-4558; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Rhodes SD, 2019, HUM MOL GENET, V28, P2752, DOI 10.1093/hmg/ddz095; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Robertson KA, 2012, LANCET ONCOL, V13, P1218, DOI 10.1016/S1470-2045(12)70414-X; Simanshu DK, 2017, CELL, V170, P17, DOI 10.1016/j.cell.2017.06.009; Staser K, 2012, ANNU REV PATHOL-MECH, V7, P469, DOI 10.1146/annurev-pathol-011811-132441; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; Watson AL, 2014, ONCOTARGET, V5, P1502, DOI 10.18632/oncotarget.1609; Watson IR, 2014, CANCER RES, V74, P4845, DOI 10.1158/0008-5472.CAN-14-1232-T; Wertheimer E, 2012, CELL SIGNAL, V24, P353, DOI 10.1016/j.cellsig.2011.08.011; Wu JQ, 2008, CANCER CELL, V13, P105, DOI 10.1016/j.ccr.2007.12.027; Yang FC, 2008, CELL, V135, P437, DOI 10.1016/j.cell.2008.08.041; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	51	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2020	295	29					9948	9958		10.1074/jbc.RA119.010981	http://dx.doi.org/10.1074/jbc.RA119.010981			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MR1DY	33685622	Green Published, hybrid			2022-12-26	WOS:000553333300014
J	Choi, HM; Lee, SH; Lee, MS; Park, D; Choi, SS				Choi, Hye-Mi; Lee, Sang-Hyeop; Lee, Min-Seok; Park, Donghyun; Choi, Sun Shim			Investigation of the putative role of antisense transcripts as regulators of sense transcripts by correlation analysis of sense-antisense pairs in colorectal cancers	FASEB JOURNAL			English	Article						differential gene correlation analysis (DGCA); sense&#8208; antisense gene pairs (SAGPs); significantly correlated pairs (SCPs)		Antisense transcription occurs widely more expected than when it was first identified in bacteria in the 1980s. However, the functional relevance of antisense transcripts in transcription remains controversial. Here, we investigated the putative role of antisense transcripts in regulating their corresponding sense transcripts by analyzing changes in correlative relationships between sense-antisense pairs under tumor and normal conditions. A total of 3469 sense-antisense gene pairs (SAGPs) downloaded from BioMart mapped to a list of sense and antisense genes in RNA-seq data derived from 80 paired colorectal cancer (CRC) samples were analyzed. As a result, cancer-related genes were significantly enriched in the significantly correlated SAGPs (SCPs). Differentially expressed genes estimated between normal and tumor conditions were also significantly more enriched in SCPs than in non-SCPs. Interestingly, using differential correlation analysis, we found that tumor samples had a significantly larger density of genes with higher correlation coefficients than normal samples, as verified by various cancer transcriptomes from The Cancer Genome Atlas (TCGA). Moreover, we found that the magnitude of the correlation between SAGPs could distinguish poor prognostic CRCs from good prognostic CRCs, showing that correlation coefficients between the SAGPs of CRCs with a poor prognosis were significantly stronger than CRCs with a good prognosis. Consistent with this finding, the Cox proportion hazards model showed that the survival rates were significantly different between patients with high and low expression of genes in the SCPs. All these results strongly support the idea that antisense transcripts are important regulators of their corresponding sense transcripts.	[Choi, Hye-Mi; Lee, Sang-Hyeop; Lee, Min-Seok; Choi, Sun Shim] Kangwon Natl Univ, Inst Biosci & Biotechnol, Coll Biomed Sci, Div Biomed Convergence, Chunchon 24341, South Korea; [Park, Donghyun] GENINUS Inc, Seoul, South Korea	Kangwon National University	Choi, SS (corresponding author), Kangwon Natl Univ, Inst Biosci & Biotechnol, Coll Biomed Sci, Div Biomed Convergence, Chunchon 24341, South Korea.	schoi@kangwon.ac.kr		Choi, Hye-Mi/0000-0002-6425-3563; Choi, Sun Shim/0000-0001-6289-4220	National Research Foundation of Korea (NRF) [2019R1A2C1002350, 2018M3C9A6017315, 2017M3A9G7073033]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: 2019R1A2C1002350, 2018M3C9A6017315 and 2017M3A9G7073033	Anders S., 2012, HEIDELB GER EUR MOL, V10, pf1000r; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S., 2010, FASTQC QUALITY CONTR; Avazpour N, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00170; Balbin OA, 2015, GENOME RES, V25, P1068, DOI 10.1101/gr.180596.114; Barman P, 2019, NON-CODING RNA, V5, DOI 10.3390/ncrna5010011; Beiter T, 2009, CELL MOL LIFE SCI, V66, P94, DOI 10.1007/s00018-008-8381-y; Boque-Sastre R, 2015, P NATL ACAD SCI USA, V112, P5785, DOI 10.1073/pnas.1421197112; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Camblong J, 2009, GENE DEV, V23, P1534, DOI 10.1101/gad.522509; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Chen JJ, 2005, TRENDS GENET, V21, P326, DOI 10.1016/j.tig.2005.04.006; Chiu HS, 2018, CELL REP, V23, P297, DOI 10.1016/j.celrep.2018.03.064; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Core LJ, 2012, CELL REP, V2, P1025, DOI 10.1016/j.celrep.2012.08.034; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dianatpour A, 2017, INT J MOL CELL MED, V6, P1, DOI 10.22088/acadpub.BUMS.6.1.1; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Faghihi MA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r56; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Grigoriadis A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-324; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Houseley J, 2008, MOL CELL, V32, P685, DOI 10.1016/j.molcel.2008.09.027; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Jadaliha M, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007802; Kassambara A., PACKAGE SURVMINER 20; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kawano M, 2007, MOL MICROBIOL, V64, P738, DOI 10.1111/j.1365-2958.2007.05688.x; Kornienko AE, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-59; Lasa I, 2011, P NATL ACAD SCI USA, V108, P20172, DOI 10.1073/pnas.1113521108; Latos PA, 2012, SCIENCE, V338, P1469, DOI 10.1126/science.1228110; Li C, 2018, ONCOTARGETS THER, V11, P3969, DOI 10.2147/OTT.S163883; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Liu YH, 2012, AM J CANCER RES, V2, P658; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lu XB, 2004, J VIROL, V78, P7079, DOI 10.1128/JVI.78.13.7079-7088.2004; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; Mahmoudi S, 2009, MOL CELL, V33, P462, DOI 10.1016/j.molcel.2009.01.028; Maruyama R, 2012, P NATL ACAD SCI USA, V109, P2820, DOI 10.1073/pnas.1010559107; McKenzie AT, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0349-1; Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Piatek MJ, 2016, GENOMICS, V108, P56, DOI 10.1016/j.ygeno.2016.05.004; Pontier DB, 2011, HUM GENET, V130, P223, DOI 10.1007/s00439-011-1008-7; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Su WY, 2012, CELL RES, V22, P1374, DOI 10.1038/cr.2012.57; Therneau T.M., 2014, SURVIVAL ANAL PUBLIS, V2, P3, DOI DOI 10.1038/S41525-021-00179-8; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Vanhee-Brossollet C, 1998, GENE, V211, P1, DOI 10.1016/S0378-1119(98)00093-6; WAGNER EGH, 1994, ANNU REV MICROBIOL, V48, P713, DOI 10.1146/annurev.mi.48.100194.003433; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; Zhao SR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1876-7; Zhuo YF, 2017, CLIN CHEM LAB MED, V55, P38, DOI 10.1515/cclm-2016-0056	64	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21482	10.1096/fj.202002297RRR	http://dx.doi.org/10.1096/fj.202002297RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710708				2022-12-26	WOS:000635216100024
J	Schuler, CF; Gherasim, C; O'Shea, K; Manthei, DM; Chen, J; Giacherio, D; Troost, JP; Baldwin, JL; Baker, Jr				Schuler, Charles F.; Gherasim, Carmen; O'Shea, Kelly; Manthei, David M.; Chen, Jesse; Giacherio, Don; Troost, Jonathan P.; Baldwin, James L.; Baker, James R., Jr.			Accurate point-of-care serology tests for COVID-19	PLOS ONE			English	Article								Background As COVID-19 vaccines become available, screening individuals for prior COVID-19 infection and vaccine response in point-of-care (POC) settings has renewed interest. We prospectively screened at-risk individuals for SARS-CoV-2 spike and nucleocapsid protein antibodies in a POC setting to determine if it was a feasible method to identify antibody from prior infection. Methods Three EUA-approved lateral flow antibody assays were performed on POC finger-stick blood and compared with serum and a CLIA nucleocapsid antibody immunoassay. Variables including antibody class, time since PCR, and the assay antigen used were evaluated. Results 512 subjects enrolled, of which 104 had a COVID-19 history and positive PCR. Only three PCR-positive subjects required hospitalization, with one requiring mechanical ventilation. The POC results correlated well with the immunoassay (93-97% sensitivity) and using serum did not improve the sensitivity or specificity. Conclusions Finger-stick, POC COVID-19 antibody testing was highly effective in identifying antibody resulting from prior infections in mildly symptomatic subjects. Using high-complexity serum immunoassays did not improve the screening outcome. Almost all individuals with COVID-19 infection produced detectable antibodies to the virus. POC antibody testing is useful as a screen for prior COVID-19 infection, and should be useful in assessing vaccine response.	[Schuler, Charles F.; O'Shea, Kelly; Chen, Jesse; Baldwin, James L.; Baker, James R., Jr.] Univ Michigan, Dept Internal Med, Div Allergy & Clin Immunol, Ann Arbor, MI 48109 USA; [Schuler, Charles F.; O'Shea, Kelly; Baldwin, James L.; Baker, James R., Jr.] Univ Michigan, Mary H Weiser Food Allergy Ctr, Ann Arbor, MI 48109 USA; [Gherasim, Carmen; Manthei, David M.; Giacherio, Don] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Chen, Jesse; Baker, James R., Jr.] Univ Michigan, Michigan Nanotechnol Inst Med & Biol Sci, Ann Arbor, MI 48109 USA; [Troost, Jonathan P.] Univ Michigan, Michigan Inst Clin & Hlth Res, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Schuler, CF (corresponding author), Univ Michigan, Dept Internal Med, Div Allergy & Clin Immunol, Ann Arbor, MI 48109 USA.; Schuler, CF (corresponding author), Univ Michigan, Mary H Weiser Food Allergy Ctr, Ann Arbor, MI 48109 USA.	schulerc@med.umich.edu		Schuler, Charles/0000-0001-5656-7418; Troost, Jonathan/0000-0002-1183-8330	University of Michigan; National Institutes of Health [UL1TR002240]; Healgen Scientific; Access Bio Inc	University of Michigan(University of Michigan System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Healgen Scientific; Access Bio Inc	The funders had no role in study design, data collection and interpretation, manuscript drafting, manuscript editing, or the decision to submit the work for publication. This work was supported by the University of Michigan (Institutional Funding, COVID-19 Innovation Grant), the National Institutes of Health (UL1TR002240), and through related sponsored projects from Healgen Scientific (healgen.com) and Access Bio Inc (accessbiodiagnostics.net). In addition, lateral flow assays were provided at no cost by Healgen Scientific, Access Bio Inc, and Autobio Diagnostics Co Ltd (https://www.autobio.com.cn/en/).	[Anonymous], 2021, WHO CORONAVIRUS DASH; Brigger D, 2021, ALLERGY, V76, P853, DOI 10.1111/all.14608; Dubey S, 2020, DIABETES METAB SYND, V14, P779, DOI 10.1016/j.dsx.2020.05.035; Fontanet A, 2020, NAT REV IMMUNOL, V20, P583, DOI 10.1038/s41577-020-00451-5; Garcia LF, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01441; Gov.UK, 2020, UK AUTH PFIZ BIONTEC; Guedez-Lopez GV, 2020, EUR J CLIN MICROBIOL, V39, P2289, DOI 10.1007/s10096-020-04010-7; Hinton DM., REVOCATION EUA200349; Jarrom D, 2022, BMJ EVID-BASED MED, V27, P33, DOI 10.1136/bmjebm-2020-111511; Jeyanathan M, 2020, NAT REV IMMUNOL, V20, P615, DOI 10.1038/s41577-020-00434-6; Lumley SF, 2021, NEW ENGL J MED, V384, P533, DOI 10.1056/NEJMoa2034545; Manthei DM, 2021, AM J CLIN PATHOL, V155, P267, DOI [10.1093/AJCP/AQAA200, 10.1093/ajcp/aqaa200]; Pavlova IP, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00569; Studdert DM, 2020, NEW ENGL J MED, V383, P102, DOI 10.1056/NEJMp2007637; USFDA, 2021, EUA AUTH SER TEST PE; Widge AT, 2021, NEW ENGL J MED, V384, P80, DOI 10.1056/NEJMc2032195; Wolf J, 2020, CLIN CHIM ACTA, V511, P352, DOI 10.1016/j.cca.2020.10.035; Yuen KS, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00404-4; Zhang B, 2021, J MED VIROL, V93, P1070, DOI 10.1002/jmv.26504	20	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0248729	10.1371/journal.pone.0248729	http://dx.doi.org/10.1371/journal.pone.0248729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY1VJ	33725025	Green Published, gold			2022-12-26	WOS:000629833700021
J	Chen, LH; Yan, W; Wang, T; Wang, Y; Liu, J; Yu, Z				Chen, Li-hong; Yan, Wei; Wang, Ting; Wang, Yu; Liu, Jian; Yu, Zhuo			Analysis of small and large subunit rDNA introns from several ectomycorrhizal fungi species	PLOS ONE			English	Article							GROUP-I INTRONS; ENCODED HOMING ENDONUCLEASE; RNA; SEQUENCE; GENES; NAEGLERIA; RIBOZYME; SITE; DNA; POPULATION	The small (18S) and large (28S) nuclear ribosomal DNA (rDNA) introns have been researched and sequenced in a variety of ectomycorrhizal fungal taxa in this study, it is found that both 18S and 28S rDNA would contain introns and display some degree variation in size, nucleotide sequences and insertion positions within the same fungi species (Meliniomyces). Under investigations among the tested isolates, 18S rDNA has four sites for intron insertions, 28S rDNA has two sites for intron insertions. Both 18S and 28S rDNA introns among the tested isolates belong to group I introns with a set of secondary structure elements designated P1-P10 helics and loops. We found a 12 nt nucleotide sequences TACCACAGGGAT at site 2 in the 3'-end of 28S rDNA, site 2 introns just insert the upstream or the downstream of the12 nt nucleotide sequences. Afters sequence analysis of all 18S and 28S rDNA introns from tested isolates, three high conserved regions around 30 nt nucleotides (conserved 1, conserved 2, conserved 3) and identical nucleotides can be found. Conserved 1, conserved 2 and conserved 3 regions have high GC content, GC percentage is almost more than 60%. From our results, it seems that the more convenient host sites, intron sequences and secondary structures, or isolates for 18S and 28S rDNA intron insertion and deletion, the more popular they are. No matter 18S rDNA introns or 18S rDNA introns among tested isolates, complementary base pairing at the splicing sites in P1-IGS-P10 tertiary helix around 5'-end introns and exons were weak.	[Chen, Li-hong; Wang, Ting; Wang, Yu] Inner Mongolia Agr Univ, Coll Hort & Plant Protect, Hohhot, Inner Mongolia, Peoples R China; [Yan, Wei] Inner Mongolia Agr Univ, Coll Forestry, Hohhot, Inner Mongolia, Peoples R China; [Liu, Jian] Ordos Inst Technol, Ordos, Inner Mongolia, Peoples R China; [Yu, Zhuo] Inner Mongolia Agr Univ, Coll Agron, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia Agricultural University; Inner Mongolia Agricultural University; Inner Mongolia Agricultural University	Chen, LH (corresponding author), Inner Mongolia Agr Univ, Coll Hort & Plant Protect, Hohhot, Inner Mongolia, Peoples R China.	chenlihong29891@126.com			National Natural Science Founded of China [3106112, 31260173]	National Natural Science Founded of China	This work was funded by the National Natural Science Founded of China (No. 3106112, No. 31260173).	Adams PL, 2004, RNA, V10, P1867, DOI 10.1261/rna.7140504; BAE KS, 1989, APPL ENVIRON MICROB, V55, P2511, DOI 10.1128/AEM.55.10.2511-2516.1989; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; Birgisdottir AB, 2005, NUCLEIC ACIDS RES, V33, P2042, DOI 10.1093/nar/gki341; Brundrett MC, 2009, PLANT SOIL, V320, P37, DOI 10.1007/s11104-008-9877-9; BURKE JM, 1987, NUCLEIC ACIDS RES, V15, P7217, DOI 10.1093/nar/15.18.7217; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; CECH TR, 1988, GENE, V73, P259, DOI 10.1016/0378-1119(88)90492-1; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757; Decatur WA, 2000, RNA, V6, P616, DOI 10.1017/S1355838200992203; DOUDNA JA, 1989, P NATL ACAD SCI USA, V86, P7402, DOI 10.1073/pnas.86.19.7402; Douhan GW, 2005, NEW PHYTOL, V166, P263, DOI 10.1111/j.1469-8137.2004.01305.x; Elde M, 1999, EUR J BIOCHEM, V259, P281, DOI 10.1046/j.1432-1327.1999.00035.x; Engelhardt MA, 2000, BIOCHEMISTRY-US, V39, P2639, DOI 10.1021/bi992313g; Feau N, 2007, J MOL EVOL, V64, P489, DOI 10.1007/s00239-005-0309-7; Flick KE, 1998, NATURE, V394, P96, DOI 10.1038/27952; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Gogarten JP, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-94; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/S1097-2765(04)00592-1; GUO QB, 1992, GENE DEV, V6, P1357, DOI 10.1101/gad.6.8.1357; Haselwandter K, 1996, FOREST ECOL MANAG, V81, P1, DOI 10.1016/0378-1127(95)03661-X; Haselwandter K, 2002, BIOMETALS, V15, P73, DOI 10.1023/A:1013188823076; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Haugen P, 2004, MOL BIOL EVOL, V21, P129, DOI 10.1093/molbev/msh005; Hoshina R, 2004, AIP CONF PROC, V716, P203, DOI 10.1063/1.1796618; Hoshina R, 2008, PHYCOL RES, V56, P21, DOI 10.1111/j.1440-1835.2008.00481.x; Johansen S, 2002, BIOCHIMIE, V84, P905, DOI 10.1016/S0300-9084(02)01443-8; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mavridou A, 2000, FUNGAL GENET BIOL, V31, P79, DOI 10.1006/fgbi.2000.1232; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Nielsen H, 2009, RNA BIOL, V6, P375, DOI 10.4161/rna.6.4.9334; Nikoh N, 2001, MOL BIOL EVOL, V18, P1631, DOI 10.1093/oxfordjournals.molbev.a003952; OLIVEIRA MC, 1994, MOL BIOL EVOL, V11, P195; Perotto S, 2000, MOL BIOL EVOL, V17, P44, DOI 10.1093/oxfordjournals.molbev.a026237; Rinaldi AC, 2008, FUNGAL DIVERS, V33, P1; Rogers S O., 1994, PLANT MOL BIOL MANUA, V2nd, pD1; Shinohara ML, 1996, CURR GENET, V29, P377; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; Suh SO, 1999, J MOL EVOL, V48, P493, DOI 10.1007/PL00006493; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; VANDERHORST G, 1991, P NATL ACAD SCI USA, V88, P184, DOI 10.1073/pnas.88.1.184; Wang Ting, 2012, Weishengwu Xuebao, V52, P1059; WEEKS KM, 1995, CELL, V82, P221, DOI 10.1016/0092-8674(95)90309-7; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wikmark OG, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-39; Wu B, 1999, BIOL FERT SOILS, V28, P136, DOI 10.1007/s003740050474; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	49	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0245714	10.1371/journal.pone.0245714	http://dx.doi.org/10.1371/journal.pone.0245714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720962	Green Published, gold			2022-12-26	WOS:000629667400040
J	Paul, B; Sierra, MA; Xu, FX; Crystal, YO; Li, X; Saxena, D; Ruff, RR				Paul, Bidisha; Sierra, Maria A.; Xu, Fangxi; Crystal, Yasmi O.; Li, Xin; Saxena, Deepak; Ruff, Ryan Richard			Microbial population shift and metabolic characterization of silver diamine fluoride treatment failure on dental caries	PLOS ONE			English	Article								The objective of this pilot study was to describe the microbial profiles present in the plaque and saliva of children who continued to develop new carious lesions following treatment with silver diamine fluoride ("nonresponders") compared to caries active, caries-free, and children immediately receiving SDF treatment for untreated caries in order to identify potential microbial differences that may relate to a re-incidence of caries. Saliva and plaque samples from infected and contralateral sites were obtained from twenty children who were either caries free, had active carious lesions, were caries active and received SDF treatment immediately before sampling, or had previously received SDF treatment and developed new caries. In total, 8,057,899 Illumina-generated sequence reads from 60 samples were obtained. Reads were processed using the Quantitative Insights Into Microbial Ecology pipeline. Group differences were assessed using Analysis of Variance Models and Tukey Honest Significant Differences. To identify significant taxa between treatment groups, Linear discriminant analysis Effect Size (LefSe) and Analysis of Differential Abundance Taking Sample Variation Into Account were used. Differential abundant analysis indicated that members of the Lachnospiraceae family were significantly enriched in non-responders and the genus Tannerella and species Granulicatella adiances were also highly abundant in this group. LefSe analysis between non-responders and SDF-treated groups revealed that genera Leptotrichia and Granulicatella were enriched in non-responders. We observed the highest abundance of phosphotransferase system and lowest abundance of lipopolysaccharide synthesis in non-responders. The microbiome in dental biofilms is responsible for initiation and progression of dental caries. SDF has been shown to be effective in arresting the progression carious lesions, in part due to its antimicrobial properties. Findings suggest that the differential abundance of select microbiota and specific pathway functioning in individuals that present with recurrent decay after SDF treatment may contribute to a potential failure of silver diamine fluoride to arrest dental caries. However, the short duration of sample collection following SDF application and the small sample size emphasize the need for further data and additional analysis.	[Paul, Bidisha; Sierra, Maria A.; Xu, Fangxi; Li, Xin; Saxena, Deepak] NYU, Coll Dent, Dept Mol Pathobiol, New York, NY 10003 USA; [Crystal, Yasmi O.] NYU, Dept Pediat Dent, Coll Dent, New York, NY USA; [Ruff, Ryan Richard] NYU, Dept Epidemiol & Hlth Promot, Coll Dent, New York, NY 10003 USA; [Ruff, Ryan Richard] NYU, Coll Global Publ Hlth, New York, NY 10003 USA	New York University; New York University; New York University; New York University	Saxena, D (corresponding author), NYU, Coll Dent, Dept Mol Pathobiol, New York, NY 10003 USA.; Ruff, RR (corresponding author), NYU, Dept Epidemiol & Hlth Promot, Coll Dent, New York, NY 10003 USA.; Ruff, RR (corresponding author), NYU, Coll Global Publ Hlth, New York, NY 10003 USA.	ds100@nyu.edu; ryan.ruff@nyu.edu	Paul, Bidisha/AAB-8948-2022	Paul, Bidisha/0000-0002-0101-8187; Li, Xin/0000-0002-7414-5734; Ruff, Ryan/0000-0003-0731-5614; Crystal, Yasmi O/0000-0001-9210-7726	New York University Grant Support Initiative [RA633]; National Institute of Dental and Craniofacial Research [R56DE028933]	New York University Grant Support Initiative; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was funded in part by awards from the New York University Grant Support Initiative (#RA633, Ruff PI) and the National Institute of Dental and Craniofacial Research (#R56DE028933, Ruff and Saxena, PIs). The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institutes of Health, New York University, the New York University College of Dentistry, or the New York University School of Medicine.	Alberti MO, 2016, ANTIMICROB AGENTS CH, V60, P1411, DOI 10.1128/AAC.02645-15; [Anonymous], 2016, PEDIATR DENT, V38; [Anonymous], 2018, J DENT RES, V97; Crystal YO, 2019, J AM DENT ASSOC, V150, P140, DOI 10.1016/j.adaj.2018.10.016; Deutscher J, 2014, MICROBIOL MOL BIOL R, V78, P231, DOI 10.1128/MMBR.00001-14; Duran-Pinedo AE, 2014, ISME J, V8, P1659, DOI 10.1038/ismej.2014.23; Dye Bruce A, 2015, NCHS Data Brief, P1; Dye Bruce A, 2012, NCHS Data Brief, P1; Dye BA, 2010, PUBLIC HEALTH REP, V125, P817, DOI 10.1177/003335491012500609; Dzidic M, 2018, ISME J, V12, P2292, DOI 10.1038/s41396-018-0204-z; Eribe ERK, 2017, J ORAL MICROBIOL, V9, P1, DOI 10.1080/20002297.2017.1368848; Escapa IF, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00187-18; Featherstone J D B, 2018, Adv Dent Res, V29, P9, DOI 10.1177/0022034517736500; Fernandes AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067019; Gao S S, 2016, JDR Clin Trans Res, V1, P201, DOI 10.1177/2380084416661474; Gloor GB, 2016, ANN EPIDEMIOL, V26, P322, DOI 10.1016/j.annepidem.2016.03.003; Griffin SO, 2016, MMWR-MORBID MORTAL W, V65, P1141, DOI 10.15585/mmwr.mm6541e1; Griffin Susan O, 2014, MMWR Suppl, V63, P54; Gross EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047722; Hanel AN, 2020, DENT J-BASEL, V8, DOI 10.3390/dj8020039; Jeckelmann JM, 2020, PFLUG ARCH EUR J PHY, V472, P1129, DOI 10.1007/s00424-020-02379-0; Jiang S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121978; Johansson A., 2018, PATHOGENESIS PERIODO, P31; Karched M, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0439-z; Kassebaum NJ, 2017, J DENT RES, V96, P380, DOI 10.1177/0022034517693566; Khalili H, 2018, IMMUNOPATHOL PERSA, V4, DOI 10.15171/ipp.2018.27; Le Bars P, 2017, CAN J MICROBIOL, V63, P475, DOI 10.1139/cjm-2016-0603; Li F, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00422; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; Luo AH, 2012, ORAL DIS, V18, P595, DOI 10.1111/j.1601-0825.2012.01915.x; Marcenes W, 2013, J DENT RES, V92, P592, DOI 10.1177/0022034513490168; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mei ML, 2020, J DENT, V102, DOI [10.1016/j.jjodo.2020.100016, 10.1016/j.jdent.2020.103479]; Mei ML, 2013, MED ORAL PATOL ORAL, V18, pE824, DOI 10.4317/medoral.18831; Meyer F, 2018, INT J DENT, V2018, DOI 10.1155/2018/1415873; Mira A, 2018, Adv Dent Res, V29, P71, DOI 10.1177/0022034517737024; Mohanty R, 2019, J FAM MED PRIM CARE, V8, P3480, DOI 10.4103/jfmpc.jfmpc_759_19; NK F, 2014, PEDIATR DENT, V36; P.H.S. U.S. Department of Health and Human Services Centers for Disease Control and Prevention and the National Institutes of Health National Institute of Dental and Craniofacial Research, 2003, NAT CALL ACT PROM OR; Ruff RR, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2891-1; Ruff RR, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022646; Ruff RR, 2018, BMC ORAL HEALTH, V18, DOI 10.1186/s12903-018-0514-6; Sharma A, 2010, PERIODONTOL 2000, V54, P106, DOI 10.1111/j.1600-0757.2009.00332.x; Struzycka I, 2014, POL J MICROBIOL, V63, P127; Treadwell HM, 2017, AM J PUBLIC HEALTH, V107, pS1, DOI 10.2105/AJPH.2017.303957; Zeng L, 2016, APPL ENVIRON MICROB, V82, P3671, DOI 10.1128/AEM.00637-16; Zhao IS, 2018, INT DENT J, V68, P67, DOI 10.1111/idj.12320	47	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0242396	10.1371/journal.pone.0242396	http://dx.doi.org/10.1371/journal.pone.0242396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720954	Green Published, Green Submitted, gold			2022-12-26	WOS:000629667400024
J	Chen, T; Wang, XL; Li, C; Zhang, HW; Liu, Y; Han, DW; Li, YM; Li, Z; Luo, D; Zhang, N; Zheng, MZ; Chen, B; Wang, LJ; Zhao, WJ; Yang, QF				Chen, Tong; Wang, Xiaolong; Li, Chen; Zhang, Hanwen; Liu, Ying; Han, Dianwen; Li, Yaming; Li, Zheng; Luo, Dan; Zhang, Ning; Zheng, Meizhu; Chen, Bing; Wang, Lijuan; Zhao, Wenjing; Yang, Qifeng			CircHIF1A regulated by FUS accelerates triple-negative breast cancer progression by modulating NFIB expression and translocation	ONCOGENE			English	Article							NUCLEAR FACTOR-I; CIRCULAR RNA; PROLIFERATION; BINDING; INTERACTS; ROLES	Emerging evidence has demonstrated that circular RNAs (circRNAs) play critical roles in the development and progression of human cancer. However, the biological functions and underlying mechanisms of circRNAs in triple-negative breast cancer (TNBC) remain to be investigated. In our present study, we found that the novel circRNA circHIF1A was significantly overexpressed in breast cancer tissues and that it was associated with metastasis, poor prognosis, and the TNBC subtype. Gain- and loss-of-function experiments were conducted to investigate the biological roles of circHIF1A in TNBC. Overexpression of circHIF1A significantly promoted TNBC growth and metastasis in vitro and in vivo, while knockdown of circHIF1A exerted the opposite effects. Mechanistically, circHIF1A modulated the expression and translocation of NFIB through posttranscriptional and posttranslational modifications, resulting in the activation of the AKT/STAT3 signaling pathway and inhibition of P21. The RNA binding protein FUS could regulate the biogenesis of circHIF1A by interacting with the flanking intron, and FUS was transcriptionally regulated by NFIB, thus forming the circHIF1A/NFIB/FUS positive feedback loop. Moreover, circHIF1A could be packaged into exosomes and was upregulated in the plasma of breast cancer patients. Our findings indicated that circHIF1A played a critical role in the growth and metastasis of TNBC via a positive feedback loop and that circHIF1A could be a promising biomarker for breast cancer diagnosis and a potential therapeutic target for TNBC treatment.	[Chen, Tong; Wang, Xiaolong; Li, Chen; Zhang, Hanwen; Liu, Ying; Han, Dianwen; Li, Yaming; Li, Zheng; Luo, Dan; Zhang, Ning; Yang, Qifeng] Shandong Univ, Qilu Hosp, Dept Breast Surg, Gen Surg, Jinan, Shandong, Peoples R China; [Zheng, Meizhu] Shandong First Med Univ, Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Breast Surg, Jinan, Shandong, Peoples R China; [Chen, Bing; Wang, Lijuan; Zhao, Wenjing; Yang, Qifeng] Shandong Univ, Pathol Tissue Bank, Qilu Hosp, Jinan, Shandong, Peoples R China; [Yang, Qifeng] Shandong Univ, Res Inst Breast Canc, Jinan, Shandong, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong University; Shandong University	Yang, QF (corresponding author), Shandong Univ, Qilu Hosp, Dept Breast Surg, Gen Surg, Jinan, Shandong, Peoples R China.; Yang, QF (corresponding author), Shandong Univ, Pathol Tissue Bank, Qilu Hosp, Jinan, Shandong, Peoples R China.; Yang, QF (corresponding author), Shandong Univ, Res Inst Breast Canc, Jinan, Shandong, Peoples R China.	qifengy_sdu@163.com	Zhang, Hanwen/CAG-1998-2022; Zhang, Ning/GOJ-8058-2022; yang, qiang/GYJ-0971-2022; Zhang, Ning/GNP-1966-2022	Zhang, Ning/0000-0002-6430-4236; Yang, Qifeng/0000-0003-0576-8513; Li, Chen/0000-0001-6994-1253	National Key Research and Development Program [2020YFA0712400, 2018YFC0114705]; Special Foundation for Taishan Scholars [ts20190971]; National Natural Science Foundation of China [81672613, 81874119, 82072912, 82004122]; Shandong Provincial Natural Science Foundation, China [ZR2019LZL003, ZR201911010260, ZR201911050391]; Special Support Plan for National High Level Talents (Ten Thousand Talents Program) [W01020103]; Foundation from Clinical Research Center of Shandong University [2020SDUCRCA015]; Qilu Hospital Clinical New Technology Developing Foundation [2018-7, 2019-3]	National Key Research and Development Program; Special Foundation for Taishan Scholars; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); Special Support Plan for National High Level Talents (Ten Thousand Talents Program); Foundation from Clinical Research Center of Shandong University; Qilu Hospital Clinical New Technology Developing Foundation	This work was supported by National Key Research and Development Program (No. 2020YFA0712400; No. 2018YFC0114705), Special Foundation for Taishan Scholars (No. ts20190971), National Natural Science Foundation of China (No. 81672613; No. 81874119; No. 82072912; No. 82004122), Shandong Provincial Natural Science Foundation, China (No. ZR2019LZL003, No. ZR201911010260, No. ZR201911050391), Special Support Plan for National High Level Talents (Ten Thousand Talents Program W01020103), Foundation from Clinical Research Center of Shandong University (No.2020SDUCRCA015), Qilu Hospital Clinical New Technology Developing Foundation (No. 2018-7; No. 2019-3).	Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Chan SH, 2014, ONCOGENE, V33, P4496, DOI 10.1038/onc.2014.10; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; de Rinaldis E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-643; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dong YP, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-016-0370-2; Du WW, 2017, EUR HEART J, V38, P1402, DOI 10.1093/eurheartj/ehw001; Du WW, 2016, NUCLEIC ACIDS RES, V44, P2846, DOI 10.1093/nar/gkw027; Errichelli L, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14741; Fanale D, 2018, ADV EXP MED BIOL, V1087, P109, DOI 10.1007/978-981-13-1426-1_9; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; GRONOSTAJSKI RM, 1987, NUCLEIC ACIDS RES, V15, P5545, DOI 10.1093/nar/15.14.5545; GRONOSTAJSKI RM, 1986, NUCLEIC ACIDS RES, V14, P9117, DOI 10.1093/nar/14.22.9117; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hentze MW, 2013, EMBO J, V32, P923, DOI 10.1038/emboj.2013.53; Hong HQ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2183-z; Hu YP, 2019, AGING-US, V11, P8068, DOI 10.18632/aging.102122; Ji DG, 2019, BIOCHEM BIOPH RES CO, V512, P176, DOI 10.1016/j.bbrc.2019.03.049; Jin B, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01173-x; Kobayashi H, 2016, BBA-GENE REGUL MECH, V1859, P71, DOI 10.1016/j.bbagrm.2015.08.007; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Li J, 2019, J CELL BIOCHEM, V120, P7725, DOI 10.1002/jcb.28046; Li JQ, 2015, AM J CANCER RES, V5, P472; Li ZH, 2018, CANCER LETT, V432, P237, DOI 10.1016/j.canlet.2018.04.035; Liang HF, 2017, AM J CANCER RES, V7, P1566; Liu RZ, 2019, J PATHOL, V247, P186, DOI 10.1002/path.5182; Liu ZY, 2019, CANCER SCI, V110, P86, DOI 10.1111/cas.13833; Liu ZH, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1287-1; Moon HG, 2011, MOL ONCOL, V5, P538, DOI 10.1016/j.molonc.2011.08.002; Pan B, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01096; Sang YT, 2019, MOL THER, V27, P1638, DOI 10.1016/j.ymthe.2019.05.011; Sato S, 2005, GASTROENTEROLOGY, V129, P1225, DOI 10.1053/j.gastro.2005.07.025; Shao SQ, 2020, BIOMED PHARMACOTHER, V121, DOI 10.1016/j.biopha.2019.109582; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Wang AH, 2019, EUR REV MED PHARMACO, V23, P8310, DOI 10.26355/eurrev_201910_19142; WANG S, 2019, MOL CANCER, V18; Wu CQ, 2018, ONCOL REP, V40, P1565, DOI 10.3892/or.2018.6574; Xie MY, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01208-3; Xue DW, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1072-5; Yang R, 2019, MOL CANCER, V18, DOI 10.1186/s12943-018-0933-7; Yang Z, 2020, GASTRIC CANCER, V23, P449, DOI 10.1007/s10120-019-01019-6; Yang ZG, 2017, MOL THER, V25, P2062, DOI 10.1016/j.ymthe.2017.05.022; Yasuda K, 2017, J CELL BIOL, V216, P1015, DOI 10.1083/jcb.201608022; Yu T, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0776-8; Zhang XO, 2016, GENOME RES, V26, P1277, DOI 10.1101/gr.202895.115; Zhang XN, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0959-5; Zhang ZR, 2018, EBIOMEDICINE, V34, P267, DOI 10.1016/j.ebiom.2018.07.036; Zheng XY, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01183-9	49	27	28	3	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 15	2021	40	15					2756	2771		10.1038/s41388-021-01739-z	http://dx.doi.org/10.1038/s41388-021-01739-z		MAR 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RN8NW	33714984				2022-12-26	WOS:000628485300004
J	Isherwood, SJS; Bazin, PL; Alkemade, A; Forstmann, BU				Isherwood, Scott Jie Shen; Bazin, Pierre-Louis; Alkemade, Anneke; Forstmann, Birte Uta			Quantity and quality: Normative open-access neuroimaging databases	PLOS ONE			English	Article							POWER; HEAD	The focus of this article is to compare twenty normative and open-access neuroimaging databases based on quantitative measures of image quality, namely, signal-to-noise (SNR) and contrast-to-noise ratios (CNR). We further the analysis through discussing to what extent these databases can be used for the visualization of deeper regions of the brain, such as the subcortex, as well as provide an overview of the types of inferences that can be drawn. A quantitative comparison of contrasts including T1-weighted (T1w) and T2-weighted (T2w) images are summarized, providing evidence for the benefit of ultra-high field MRI. Our analysis suggests a decline in SNR in the caudate nuclei with increasing age, in T1w, T2w, qT1 and qT2* contrasts, potentially indicative of complex structural age-dependent changes. A similar decline was found in the corpus callosum of the T1w, qT1 and qT2* contrasts, though this relationship is not as extensive as within the caudate nuclei. These declines were accompanied by a declining CNR over age in all image contrasts. A positive correlation was found between scan time and the estimated SNR as well as a negative correlation between scan time and spatial resolution. Image quality as well as the number and types of contrasts acquired by these databases are important factors to take into account when selecting structural data for reuse. This article highlights the opportunities and pitfalls associated with sampling existing databases, and provides a quantitative backing for their usage.	[Isherwood, Scott Jie Shen; Bazin, Pierre-Louis; Alkemade, Anneke; Forstmann, Birte Uta] Univ Amsterdam, Integrat Model Based Cognit Neurosci Res Unit, Amsterdam, Netherlands; [Bazin, Pierre-Louis] Max Planck Inst Human Cognit & Brain Sci, Dept Neurophys, Leipzig, Germany	University of Amsterdam; Max Planck Society	Isherwood, SJS (corresponding author), Univ Amsterdam, Integrat Model Based Cognit Neurosci Res Unit, Amsterdam, Netherlands.	scott@leeclan.net		Bazin, Pierre-Louis/0000-0002-0141-5510; Isherwood, Scott/0000-0003-2045-9268	Center for Brain Science Neuroinformatics Research Group; Athinoula A. Martinos Center for Biomedical Imaging; Center for Human Genetic Research; Human Connectome Project, WU-Minn Consortium [1U54MH091657]	Center for Brain Science Neuroinformatics Research Group; Athinoula A. Martinos Center for Biomedical Imaging; Center for Human Genetic Research; Human Connectome Project, WU-Minn Consortium	Data were provided [in part] by the Brain Genomics Superstruct Project of Harvard University and the Massachusetts General Hospital, (Principal Investigators: Randy Buckner, Joshua Roffman, and Jordan Smoller), with support from the Center for Brain Science Neuroinformatics Research Group, the Athinoula A. Martinos Center for Biomedical Imaging, and the Center for Human Genetic Research. 20 individual investigators at Harvard and MGH generously contributed data to the overall project. Data used in the preparation of this work were obtained from the CamCAN repository (available at http://www.mrc-cbu.cam.ac.uk/datasets/camcan/) [64, 65]. Data collection and sharing for this project was provided by the Cambridge Centre for Ageing and Neuroscience (CamCAN). Data were provided [in part] by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657). The Midnight Scan Club data was obtained from the OpenfMRI database. Its accession number is ds000224. The data from Leipzig Mind Brain Body was obtained from the OpenfMRI database. Its accession number is ds000221.	Alexander LM., 2017, SCI DATA; Alkemade A, 2020, NEUROIMAGE, V221, DOI 10.1016/j.neuroimage.2020.117200; Alkemade A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176130; Alkemade A, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00040; [Anonymous], 2007, RADIOLOGY; Aquino D, 2009, RADIOLOGY, V252, P165, DOI 10.1148/radiol.2522081399; Avants BB, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.3; Bellec P, 2017, NEUROIMAGE, V144, P275, DOI 10.1016/j.neuroimage.2016.06.034; Betzel RF, 2014, NEUROIMAGE, V102, P345, DOI 10.1016/j.neuroimage.2014.07.067; Bischof GN, 2015, PSYCHOSOM MED, V77, P697, DOI 10.1097/PSY.0000000000000212; Bischoff-Grethe A, 2007, HUM BRAIN MAPP, V28, P892, DOI 10.1002/hbm.20312; Blesa M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00220; BOTTOMLEY PA, 1984, MED PHYS, V11, P425, DOI 10.1118/1.595535; BROOKS DJ, 1989, J NEUROL NEUROSUR PS, V52, P108, DOI 10.1136/jnnp.52.1.108; Brown SA., 2015, J STUD ALCOHOL DRUGS; Bullitt E, 2010, NEUROBIOL AGING, V31, P290, DOI 10.1016/j.neurobiolaging.2008.03.022; Casey BJ, 2018, DEV COGN NEUROS-NETH, V32, P43, DOI 10.1016/j.dcn.2018.03.001; Chan D., 2018, NEUROBIOL AGING; Chavhan GB, 2009, RADIOGRAPHICS, V29, P1433, DOI 10.1148/rg.295095034; Cheng SQ, 2020, CEREB CORTEX, V30, P4197, DOI 10.1093/cercor/bhaa043; Cho ZH, 2011, MOVEMENT DISORD, V26, P713, DOI 10.1002/mds.23465; Collins CM, 2001, MAGN RESON MED, V45, P684, DOI 10.1002/mrm.1091; De Graaf WL., 2013, EUR RADIOL; de Hollander G, 2017, HUM BRAIN MAPP, V38, P3226, DOI 10.1002/hbm.23586; de Hollander G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120572; Deistung A, 2013, NEUROIMAGE; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Di X, 2014, PROG NEURO-PSYCHOPH, V48, P41, DOI 10.1016/j.pnpbp.2013.09.001; DuPre E, 2017, NETW NEUROSCI, V1, P302, DOI [10.1162/NETN_a_00016, 10.1162/netn_a_00016]; Eickhoff S, 2016, NEUROIMAGE, V124, P1065, DOI 10.1016/j.neuroimage.2015.10.079; Ellis KA, 2009, INT PSYCHOGERIATR, V21, P672, DOI 10.1017/S1041610209009405; Evans AC, 2012, NEUROIMAGE, V62, P911, DOI 10.1016/j.neuroimage.2012.01.024; Federau C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154974; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; Forstmann BU, 2017, TRENDS BIOTECHNOL, V35, P904, DOI 10.1016/j.tibtech.2017.06.010; Forstmann BU, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.50; Froeling M, 2017, MAGN RESON MED, V77, P1797, DOI 10.1002/mrm.26259; Gallichan D, 2016, MAGN RESON MED, V75, P1030, DOI 10.1002/mrm.25670; Geerligs L, 2015, J NEUROSCI, V35, P13949, DOI 10.1523/JNEUROSCI.1324-15.2015; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Gordon EM, 2017, NEURON, V95, P791, DOI 10.1016/j.neuron.2017.07.011; Gratton C, 2018, NEURON, V98, P439, DOI 10.1016/j.neuron.2018.03.035; Gulban OF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198335; HAACKE E M, 1986, Magnetic Resonance Imaging, V4, P359, DOI 10.1016/0730-725X(86)91046-5; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Hanke M, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.3; Havsteen I, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00232; Haxby JV, 2011, NEURON, V72, P404, DOI 10.1016/j.neuron.2011.08.026; Holmes AJ, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.31; Holmes AJ, 2012, J NEUROSCI, V32, P18087, DOI 10.1523/JNEUROSCI.2531-12.2012; Huntenburg JM, 2017, CEREB CORTEX, V27, P981, DOI 10.1093/cercor/bhx030; Jeffreys H, 1935, P CAMB PHILOS SOC, V31, P203, DOI 10.1017/S030500410001330X; Jernigan TL., 2016, NEUROIMAGE; Job DE, 2017, NEUROIMAGE, V144, P299, DOI 10.1016/j.neuroimage.2016.01.027; Johansen-Berg H, 2013, NEUROIMAGE, V80, P541, DOI 10.1016/j.neuroimage.2013.05.082; Karayanidis F, 2016, NEUROIMAGE, V124, P1137, DOI 10.1016/j.neuroimage.2015.04.047; Keator DB, 2016, NEUROIMAGE, V124, P1074, DOI 10.1016/j.neuroimage.2015.09.003; Kerl HU., 2012, ACTA NEUROCHIR WIEN; Keuken MC, 2017, BRAIN STRUCT FUNCT, V222, P2487, DOI 10.1007/s00429-016-1352-4; Keuken MC, 2015, DATA BRIEF, V4, P577, DOI 10.1016/j.dib.2015.07.028; Keuken MC., 2014, NEUROIMAGE; Klein A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00171; Landman BA, 2011, NEUROIMAGE, V54, P2854, DOI 10.1016/j.neuroimage.2010.11.047; Lee CC, 1996, MAGNET RESON MED, V36, P436, DOI 10.1002/mrm.1910360316; Levitt JJ, 2013, SCHIZOPHR RES; Lusebrink F, 2013, NEUROIMAGE, V70, P122, DOI 10.1016/j.neuroimage.2012.12.016; Lusebrink F., 2017, SCI DATA; Madan CR, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00405; Malone IB, 2013, NEUROIMAGE, V70, P33, DOI 10.1016/j.neuroimage.2012.12.044; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Marcus DS, 2010, J COGNITIVE NEUROSCI, V22, P2677, DOI 10.1162/jocn.2009.21407; Marner L, 2003, J PSYCHIATR RES, V37, P539, DOI 10.1016/S0022-3956(03)00069-4; McAuliffe MJ, 2001, COMP MED SY, P381; Mendes N., 2017, BIORXIV INTERNET; Mennes M, 2013, NEUROIMAGE, V82, P683, DOI 10.1016/j.neuroimage.2012.10.064; Mewes AUJ, 2006, PEDIATRICS, V118, P23, DOI 10.1542/peds.2005-2675; Mikhael S, 2018, NEUROIMAGE, V170, P348, DOI 10.1016/j.neuroimage.2017.02.082; Milchenko M, 2013, NEUROINFORMATICS, V11, P65, DOI 10.1007/s12021-012-9160-3; Milham MP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04976-1; Moon Hyeong Cheol, 2016, Brain Tumor Res Treat, V4, P150; Morey R. D, 2015, BAYESFACTOR COMPUT B; MORRIS CM, 1992, ACTA ANAT, V144, P235; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Mueller SG., 2005, ALZHEIMERS DEMENTIA; Noebauer-Huhmann IM, 2015, EUR RADIOL, V25, P106, DOI 10.1007/s00330-014-3351-2; Nooner KB, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00152; Oguz I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071027; Pagani E, 2008, NEUROIMAGE, V41, P657, DOI 10.1016/j.neuroimage.2008.03.021; Pagliaccio D, 2015, JAMA PSYCHIAT, V72, P994, DOI 10.1001/jamapsychiatry.2015.1054; Pardoe HR, 2016, NEUROIMAGE, V135, P177, DOI 10.1016/j.neuroimage.2016.05.005; Poldrack RA, 2014, NAT NEUROSCI, V17, P1510, DOI 10.1038/nn.3818; Poldrack RA, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00012; Priovoulos N, 2018, NEUROIMAGE, V168, P427, DOI 10.1016/j.neuroimage.2017.07.045; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Raz N, 2003, AM J NEURORADIOL, V24, P1849; Resnick SM, 2003, J NEUROSCI, V23, P3295; Satterthwaite TD, 2014, NEUROIMAGE, V86, P544, DOI 10.1016/j.neuroimage.2013.07.064; Savalia NK, 2017, HUM BRAIN MAPP, V38, P472, DOI 10.1002/hbm.23397; Schafer A, 2012, HUM BRAIN MAPP, V33, P2831, DOI 10.1002/hbm.21404; Sengupta A, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.93; Shafto MA, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0204-1; Siemonsen S, 2008, AM J NEURORADIOL, V29, P950, DOI 10.3174/ajnr.A0951; Sodickson DK, 1997, MAGNET RESON MED, V38, P591, DOI 10.1002/mrm.1910380414; Springer E, 2016, INVEST RADIOL, V51, P469, DOI 10.1097/RLI.0000000000000256; Strike LT, 2019, CEREB CORTEX, V29, P952, DOI 10.1093/cercor/bhy002; Stucht D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133921; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Tallantyre EC, 2009, INVEST RADIOL, V44, P491, DOI 10.1097/RLI.0b013e3181b4c144; Tardif CL, 2016, NEUROIMAGE, V124, P1143, DOI 10.1016/j.neuroimage.2015.08.042; Taylor JR, 2017, NEUROIMAGE, V144, P262, DOI 10.1016/j.neuroimage.2015.09.018; Team R. Core, 2019, R LANG ENV STAT COMP; Trutti AC, 2019, NEUROIMAGE, V191, P258, DOI 10.1016/j.neuroimage.2019.01.062; Tsvetanov KA., 2020, GENETIC AIGNATURE HU; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Vaughan JT, 2001, MAGN RESON MED, V46, P24, DOI 10.1002/mrm.1156; Verheij RA, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9134; Visser E, 2016, NEUROIMAGE; Walker S., **DATA OBJECT**, P1; Wang DH, 2015, NAT NEUROSCI, V18, P1853, DOI 10.1038/nn.4164; Wang L, 2016, NEUROIMAGE, V124, P1155, DOI 10.1016/j.neuroimage.2015.06.065; Wei DT, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.134; Weiner MW., 2015, ALZHEIMERS DEMENTIA; West KL, 2019, NEUROIMAGE, V188, P198, DOI 10.1016/j.neuroimage.2018.12.012; Xu J., 2012, P 20 ANN M ISMRM, V20, P2306; Zaitsev M, 2017, NEUROIMAGE, V154, P33, DOI 10.1016/j.neuroimage.2016.11.014; Zuo XN, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.49	127	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248341	10.1371/journal.pone.0248341	http://dx.doi.org/10.1371/journal.pone.0248341			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8JZ	33705468	gold, Green Published			2022-12-26	WOS:000629590400091
J	Pagliaro, S; Sacchi, S; Pacilli, MG; Brambilla, M; Lionetti, F; Bettache, K; Bianchi, M; Biella, M; Bonnot, V; Boza, M; Butera, F; Ceylan-Batur, S; Chong, K; Chopova, T; Crimston, CR; Alvarez, B; Cuadrado, I; Ellemers, N; Formanowicz, M; Graupmann, V; Gkinopoulos, T; Jeong, EHK; Jasinskaja-Lahti, I; Jetten, J; Bin, KM; Mao, YH; McCoy, C; Mehnaz, F; Minescu, A; Sirlopu, D; Simic, A; Travaglino, G; Uskul, AK; Zanetti, C; Zinn, A; Zubieta, E				Pagliaro, Stefano; Sacchi, Simona; Pacilli, Maria Giuseppina; Brambilla, Marco; Lionetti, Francesca; Bettache, Karim; Bianchi, Mauro; Biella, Marco; Bonnot, Virginie; Boza, Mihaela; Butera, Fabrizio; Ceylan-Batur, Suzan; Chong, Kristy; Chopova, Tatiana; Crimston, Charlie R.; Alvarez, Belen; Cuadrado, Isabel; Ellemers, Naomi; Formanowicz, Magdalena; Graupmann, Verena; Gkinopoulos, Theofilos; Jeong, Evelyn Hye Kyung; Jasinskaja-Lahti, Inga; Jetten, Jolanda; Bin, Kabir Muhib; Mao, Yanhui; McCoy, Christine; Mehnaz, Farah; Minescu, Anca; Sirlopu, David; Simic, Andrej; Travaglino, Giovanni; Uskul, Ayse K.; Zanetti, Cinzia; Zinn, Anna; Zubieta, Elena			Trust predicts COVID-19 prescribed and discretionary behavioral intentions in 23 countries	PLOS ONE			English	Article							PUBLIC TRUST; HUMAN-VALUES; DISEASE; MORALITY; IMMUNIZATION; TRANSMISSION; SCIENCE	The worldwide spread of a new coronavirus (SARS-CoV-2) since December 2019 has posed a severe threat to individuals' well-being. While the world at large is waiting that the released vaccines immunize most citizens, public health experts suggest that, in the meantime, it is only through behavior change that the spread of COVID-19 can be controlled. Importantly, the required behaviors are aimed not only at safeguarding one's own health. Instead, individuals are asked to adapt their behaviors to protect the community at large. This raises the question of which social concerns and moral principles make people willing to do so. We considered in 23 countries (N = 6948) individuals' willingness to engage in prescribed and discretionary behaviors, as well as country-level and individual-level factors that might drive such behavioral intentions. Results from multilevel multiple regressions, with country as the nesting variable, showed that publicized number of infections were not significantly related to individual intentions to comply with the prescribed measures and intentions to engage in discretionary prosocial behaviors. Instead, psychological differences in terms of trust in government, citizens, and in particular toward science predicted individuals' behavioral intentions across countries. The more people endorsed moral principles of fairness and care (vs. loyalty and authority), the more they were inclined to report trust in science, which, in turn, statistically predicted prescribed and discretionary behavioral intentions. Results have implications for the type of intervention and public communication strategies that should be most effective to induce the behavioral changes that are needed to control the COVID-19 outbreak.	[Pagliaro, Stefano; Lionetti, Francesca] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Sacchi, Simona; Brambilla, Marco; Simic, Andrej] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Pacilli, Maria Giuseppina] Univ Perugia, Dept Polit Sci, Perugia, Italy; [Bettache, Karim; Chong, Kristy] Monash Univ, Dept Psychol, Clayton, Vic, Australia; [Bianchi, Mauro] Univ Lusafona, Digital Human Environm Interact Lab, Lisbon, Portugal; [Biella, Marco] Eberhard Karls Univ Tubingen, Dept Psychol, Tubingen, Germany; [Bonnot, Virginie] Univ Paris, Dept Psychol, Paris, France; [Boza, Mihaela] Univ Alexandru Ioan Cuza, Dept Psychol & Educ Sci, Iasi, Romania; [Butera, Fabrizio; Zanetti, Cinzia] Univ Lausanne, Fac Social & Polit Sci, Lausanne, Switzerland; [Ceylan-Batur, Suzan] TOBB Univ Econ & Technol, Dept Psychol, Ankara, Turkey; [Chopova, Tatiana; Ellemers, Naomi] Univ Utrecht, Dept Psychol, Utrecht, Netherlands; [Crimston, Charlie R.; Alvarez, Belen; Jetten, Jolanda; McCoy, Christine] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Cuadrado, Isabel] Univ Almeria, Dept Psychol, Almeria, Spain; [Formanowicz, Magdalena] Univ Social Sci & Humanities, Ho Chi Minh City, Vietnam; [Formanowicz, Magdalena] Nicolaus Copernicus Univ, Sch Psychol, Torun, Poland; [Graupmann, Verena] Depaul Univ, Dept Psychol, Chicago, IL 60604 USA; [Gkinopoulos, Theofilos] Greenwich Univ, Fac Educ, London, England; [Jeong, Evelyn Hye Kyung; Bin, Kabir Muhib; Mehnaz, Farah; Minescu, Anca] Univ Limerick, Dept Psychol, Limerick, Ireland; [Jasinskaja-Lahti, Inga] Univ Helsinki, Fac Social Sci, Helsinki, Finland; [Mao, Yanhui] Southwest Jiaotong Univ, Chengdu, Peoples R China; [Sirlopu, David] Univ Desarrollo, Sch Humanities & Social Sci, Santiago, Chile; [Travaglino, Giovanni] Chinese Univ Honk Kong, Honk Kong, Peoples R China; [Travaglino, Giovanni; Uskul, Ayse K.] Univ Kent, Sch Psychol, Canterbury, Kent, England; [Zinn, Anna] Univ Exeter, Dept Psychol, Exeter, Devon, England; [Zubieta, Elena] Univ Buenos Aires, Fac Psychol, Buenos Aires, DF, Argentina	G d'Annunzio University of Chieti-Pescara; University of Milano-Bicocca; University of Perugia; Monash University; Eberhard Karls University of Tubingen; UDICE-French Research Universities; Universite Paris Cite; Alexandru Ioan Cuza University; University of Lausanne; TOBB Ekonomi ve Teknoloji University; Utrecht University; University of Queensland; Universidad de Almeria; Nicolaus Copernicus University; DePaul University; University of Greenwich; University of Limerick; University of Helsinki; Southwest Jiaotong University; Universidad del Desarrollo; University of Kent; University of Exeter; University of Buenos Aires	Pagliaro, S (corresponding author), Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy.; Sacchi, S (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	s.pagliaro@unich.it; simona.sacchi@unimib.it	Biella, Marco/HIR-3365-2022; Pagliaro, Stefano/AAJ-4368-2021; Sirlopú, David/GWU-8505-2022; Brambilla, Marco/I-9342-2018; Guirado, Isabel Cuadrado/B-8958-2011; Ceylan Batur, Suzan/HHS-6367-2022; Mao, Yanhui/ABG-9969-2021; Bettache, Karim/CAG-9988-2022	Biella, Marco/0000-0002-8039-0170; Pagliaro, Stefano/0000-0003-0573-0937; Brambilla, Marco/0000-0002-4774-3309; Guirado, Isabel Cuadrado/0000-0002-0946-2696; Travaglino, Giovanni Antonio/0000-0003-4091-0634; Ceylan-Batur, Suzan/0000-0003-2073-7598; Bonnot, Virginie/0000-0002-8996-2788; Butera, Fabrizio/0000-0002-8856-4374; Sirlopu, David/0000-0003-4683-1734; Crimston, Charlie/0000-0002-4529-786X; Bianchi, Mauro/0000-0003-3318-2480; Lionetti, Francesca/0000-0002-6029-0121; Simic, Andrej/0000-0002-4039-6244; Jeong, Evelyn Hye Kyung/0000-0003-3938-1317; Bettache, Karim/0000-0001-7677-6807; Zinn, Anna Kristina/0000-0002-3631-0372; /0000-0001-8160-2510; Jasinskaja-Lahti, Inga/0000-0002-6419-5324	European Association of Social Psychology; Pomilio Blumm Communication Agency	European Association of Social Psychology; Pomilio Blumm Communication Agency	This research was supported by a "Covid-19 Grant" awarded from the European Association of Social Psychology to Stefano Pagliaro and by the Pomilio Blumm Communication Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no restrictions on sharing of data and materials.	Abrams D, 2018, BRIT J SOC PSYCHOL, V57, P310, DOI 10.1111/bjso.12233; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; Balliet D, 2013, PSYCHOL BULL, V139, P1090, DOI 10.1037/a0030939; Baumgaertner B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191728; Blair RA, 2017, SOC SCI MED, V172, P89, DOI 10.1016/j.socscimed.2016.11.016; Brambilla M, 2021, ADV EXP SOC PSYCHOL, V64, P187, DOI 10.1016/bs.aesp.2021.03.001; Chuang YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122970; Collinson S., 2020, THE CNN; Collinson S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141423; Cruwys T, 2020, BRIT J SOC PSYCHOL, V59, P584, DOI 10.1111/bjso.12391; De Cremer D, 2007, J APPL PSYCHOL, V92, P639, DOI 10.1037/0021-9010.92.3.639; Devos T, 2002, BRIT J SOC PSYCHOL, V41, P481, DOI 10.1348/014466602321149849; Ellemers N, 2017, EUR MON SOC PSYCH, P1; Everett J.A., 2020, EFFECTIVENESS MORAL, DOI [10.31234/osf.io/9yqs8, DOI 10.31234/OSF.IO/9YQS8]; Faulkner J, 2004, GROUP PROCESS INTERG, V7, P333, DOI 10.1177/1368430204046142; Gauchat G, 2012, AM SOCIOL REV, V77, P167, DOI 10.1177/0003122412438225; Gelfand MJ, 2011, SCIENCE, V332, P1100, DOI 10.1126/science.1197754; Graham J, 2011, J PERS SOC PSYCHOL, V101, P366, DOI 10.1037/a0021847; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Haerlin B, 1999, NATURE, V400, P499, DOI 10.1038/22867; HAIDT J, 1993, J PERS SOC PSYCHOL, V65, P613, DOI 10.1037/0022-3514.65.4.613; Haidt J., 2010, HDB SOCIAL PSYCHOL, V2, P797, DOI 10.1002/9780470561119.socpsy002022; Haidt J., 2012, RIGHTEOUS MIND WHY G; Han Q., 2020, TRUST GOVT ITS ASS H, DOI 10.31234/osf.io/p5gns; Hornsey MJ, 2021, EUR J SOC PSYCHOL, V51, P285, DOI 10.1002/ejsp.2737; Jetten J., 2020, TOGETHER APART PSYCH; Kachanoff FJ, 2021, SOC PSYCHOL PERS SCI, V12, P603, DOI 10.1177/1948550620931634; Lalot F, 2022, GROUP PROCESS INTERG, V25, P106, DOI 10.1177/1368430220967986; Leach C.W., 2014, INTERPERSONAL RELATI, V2; Leiserowitz AA, 2013, AM BEHAV SCI, V57, P818, DOI 10.1177/0002764212458272; Levi M, 2000, ANNU REV POLIT SCI, V3, P475, DOI 10.1146/annurev.polisci.3.1.475; Levine M, 2013, EUR REV SOC PSYCHOL, V24, P225, DOI 10.1080/10463283.2014.892318; Lewandowsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075637; Li Q., 2020, NEW ENGL J MED, V382, P1199; Marcon AR, 2017, REGEN MED, V12, P765, DOI 10.2217/rme-2017-0060; Mooney C, 2007, REPUBLICAN WAR SCI; Morselli D, 2012, SURV RES METHODS-GER, V6, P49; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Nattrass Nicoli, 2012, AIDS CONSPIRACY SCI; Plohl N, 2021, PSYCHOL HEALTH MED, V26, P1, DOI 10.1080/13548506.2020.1772988; Price AM, 2016, INT SOCIOL, V31, P57, DOI 10.1177/0268580915614593; Putterman L., 1998, EC VALUES ORG, P408, DOI DOI 10.1017/CBO9781139174855.017; Ronnerstrand B, 2014, PUBLIC HEALTH, V128, P709, DOI 10.1016/j.puhe.2014.05.015; Ronnerstrand B, 2013, SCAND J PUBLIC HEALT, V41, P853, DOI 10.1177/1403494813494975; Rutjens BT, 2018, PERS SOC PSYCHOL B, V44, P384, DOI 10.1177/0146167217741314; Schaller M, 2012, ADV EXP SOC PSYCHOL, V46, P1, DOI 10.1016/B978-0-12-394281-4.00001-5; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; Simpson JA., 2007, SOCIAL PSYCHOL HDB B, P587; Snowden F.M., 2019, EPIDEMICS SOC BLACK; Solnit Rebecca, 2009, PARADISE BUILT HELL; Sun CJ, 2011, MATH BIOSCI, V230, P87, DOI 10.1016/j.mbs.2011.01.005; Tsai LL, 2020, COMP POLIT STUD, V53, P1582, DOI 10.1177/0010414019897698; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Van Lange PAM, 1998, J APPL SOC PSYCHOL, V28, P796, DOI 10.1111/j.1559-1816.1998.tb01732.x; Woelfert FS, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.572966; Wong CML, 2020, J RISK RES, V23, P1021, DOI 10.1080/13669877.2020.1756386	56	60	60	9	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0248334	10.1371/journal.pone.0248334	http://dx.doi.org/10.1371/journal.pone.0248334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QV3DA	33690672	Green Published, Green Accepted, gold			2022-12-26	WOS:000627854700048
J	Di Stazio, M; Foschi, N; Athanasakis, E; Gasparini, P; D'Adamo, AP				Di Stazio, Mariateresa; Foschi, Nicola; Athanasakis, Emmanouil; Gasparini, Paolo; D'Adamo, Adamo Pio			Systematic analysis of factors that improve homologous direct repair (HDR) efficiency in CRISPR/Cas9 technique	PLOS ONE			English	Article								The CRISPR/Cas9 bacterial system has proven to be an powerful tool for genetic manipulation in several organisms, but the efficiency of sequence replacement by homologous direct repair (HDR) is substantially lower than random indel creation. Many studies focused on improving HDR efficiency using double sgRNA, cell synchronization cycle, and the delivery of single-stranded oligo DNA nucleotides (ssODN) with a rational design. In this study, we evaluate these three methods' synergistic effects to improve HDR efficiency. For our tests, we have chosen the TNF alpha gene (NM_000594) for its crucial role in various biological processes and diseases. For the first time, our results showed how the use of two sgRNA with asymmetric donor design and triple transfection events dramatically increase the HDR efficiency from an undetectable HDR event to 39% of HDR efficiency and provide a new strategy to facilitate CRISPR/Cas9-mediated human genome editing. Besides, we demonstrated that the TNF alpha locus could be edited with CRISPR/Cas9 methodology, an opportunity to safely correct, in the future, the specific mutations of each patient.	[Di Stazio, Mariateresa; Athanasakis, Emmanouil; Gasparini, Paolo; D'Adamo, Adamo Pio] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy; [Foschi, Nicola; Gasparini, Paolo; D'Adamo, Adamo Pio] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy	IRCCS Burlo Garofolo; University of Trieste	Di Stazio, M (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.	distazio@gmail.com	d'Adamo, Adamo Pio/G-4064-2011	d'Adamo, Adamo Pio/0000-0001-9367-4909				Acosta S, 2018, GENESIS, V56, DOI 10.1002/dvg.23212; [Anonymous], TUMOR NECROSIS FACTO; Chandrasekaran AP, 2018, PROG MOL BIOL TRANSL, V159, P157, DOI 10.1016/bs.pmbts.2018.05.001; Chen XY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07581; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; El-Tahan RR, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3197-y; Fuster-Garcia C, 2017, MOL THER-NUCL ACIDS, V8, P529, DOI 10.1016/j.omtn.2017.08.003; Gupta A, 2005, J PEDIATR ENDOCR MET, V18, P75; Jiang YP, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000013813; Latella MC, 2016, MOL THER-NUCL ACIDS, V5, P1, DOI 10.1038/mtna.2016.92; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Malak CAA, 2016, INT J CLIN EXP PATHO, V9, P9786; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Takayama K, 2017, NUCLEIC ACIDS RES, V45, P5198, DOI 10.1093/nar/gkx130; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Zhang X, 2017, SAUDI J BIOL SCI, V24, P1920, DOI 10.1016/j.sjbs.2017.11.040; Zhou JK, 2014, FEBS J, V281, P1717, DOI 10.1111/febs.12735	23	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0247603	10.1371/journal.pone.0247603	http://dx.doi.org/10.1371/journal.pone.0247603			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667229	gold, Green Published			2022-12-26	WOS:000626604300032
J	Baik, R; Wyman, SK; Kabir, S; Corn, JE				Baik, Ron; Wyman, Stacia K.; Kabir, Shaheen; Corn, Jacob E.			Genome editing to model and reverse a prevalent mutation associated with myeloproliferative neoplasms	PLOS ONE			English	Article								Myeloproliferative neoplasms (MPNs) cause the over-production of blood cells such as erythrocytes (polycythemia vera) or platelets (essential thrombocytosis). JAK2 V617F is the most prevalent somatic mutation in many MPNs, but previous modeling of this mutation in mice relied on transgenic overexpression and resulted in diverse phenotypes that were in some cases attributed to expression level. CRISPR-Cas9 engineering offers new possibilities to model and potentially cure genetically encoded disorders via precise modification of the endogenous locus in primary cells. Here we develop "scarless" Cas9-based reagents to create and reverse the JAK2 V617F mutation in an immortalized human erythroid progenitor cell line (HUDEP-2), CD34+ adult human hematopoietic stem and progenitor cells (HSPCs), and immunophenotypic long-term hematopoietic stem cells (LT-HSCs). We find no overt in vitro increase in proliferation associated with an endogenous JAK2 V617F allele, but co-culture with wild type cells unmasks a competitive growth advantage provided by the mutation. Acquisition of the V617F allele also promotes terminal differentiation of erythroid progenitors, even in the absence of hematopoietic cytokine signaling. Taken together, these data are consistent with the gradually progressive manifestation of MPNs and reveals that endogenously acquired JAK2 V617F mutations may yield more subtle phenotypes as compared to transgenic overexpression models.	[Baik, Ron; Wyman, Stacia K.; Kabir, Shaheen; Corn, Jacob E.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Baik, Ron; Wyman, Stacia K.; Kabir, Shaheen; Corn, Jacob E.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Baik, Ron] NYU, Sch Med, New York, NY USA; [Kabir, Shaheen] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Corn, Jacob E.] Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland	University of California System; University of California Berkeley; University of California System; University of California Berkeley; New York University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Swiss Federal Institutes of Technology Domain; ETH Zurich	Kabir, S; Corn, JE (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Kabir, S; Corn, JE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Kabir, S (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.; Corn, JE (corresponding author), Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland.	shaheen.kabir@ucsf.edu; Jacob.corn@biol.ethz.ch		Baik, Ron/0000-0002-2458-0121	California Institute of Regenerative Medicine [DISC1-08776]; Li Ka Shing Foundation; Heritage Medical Research Institute; National Institutes of Health New Innovator Awards [DP2 HL141006]	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Li Ka Shing Foundation; Heritage Medical Research Institute; National Institutes of Health New Innovator Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the California Institute of Regenerative Medicine (DISC1-08776), the Li Ka Shing Foundation, the Heritage Medical Research Institute, and the National Institutes of Health New Innovator Awards (DP2 HL141006).	Aiuti A, 2017, EMBO MOL MED, V9, P737, DOI 10.15252/emmm.201707573; Akada H, 2010, BLOOD, V115, P3589, DOI 10.1182/blood-2009-04-215848; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Bandaranayake RM, 2012, NAT STRUCT MOL BIOL, V19, P754, DOI 10.1038/nsmb.2348; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; BROUDY VC, 1991, BLOOD, V77, P2583, DOI 10.1182/blood.V77.12.2583.2583; Canver MC, 2016, BLOOD, V127, P2536, DOI 10.1182/blood-2016-01-678128; Chang KH, 2017, MOL THER-METH CLIN D, V4, P137, DOI 10.1016/j.omtm.2016.12.009; Charlesworth CT, 2018, MOL THER-NUCL ACIDS, V12, P89, DOI 10.1016/j.omtn.2018.04.017; Constantinescu SN, 1999, TRENDS ENDOCRIN MET, V10, P18, DOI 10.1016/S1043-2760(98)00101-5; Cordua S, 2019, BLOOD, V134, P469, DOI 10.1182/blood.2019001113; Deininger M, 2015, BLOOD, V126, P1551, DOI 10.1182/blood-2015-03-635235; Delhommeau F, 2007, BLOOD, V109, P71, DOI 10.1182/blood-2006-03-007146; Dever DP, 2017, CURR OPIN HEMATOL, V24, P481, DOI 10.1097/MOH.0000000000000385; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Etheridge SL, 2014, P NATL ACAD SCI USA, V111, P2295, DOI 10.1073/pnas.1312148111; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Garcon L, 2006, BLOOD, V108, P1551, DOI 10.1182/blood-2005-10-009514; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Hasan S, 2013, BLOOD, V122, P1464, DOI 10.1182/blood-2013-04-498956; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jamieson CHM, 2006, P NATL ACAD SCI USA, V103, P6224, DOI 10.1073/pnas.0601462103; Jones Catherine, 2014, BMJ Case Rep, V2014, DOI 10.1136/bcr-2014-205663; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kuo CY, 2018, CELL REP, V23, P2606, DOI 10.1016/j.celrep.2018.04.103; Kurita R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059890; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li J, 2014, BLOOD, V123, P3139, DOI 10.1182/blood-2013-06-510222; Li JA, 2010, BLOOD, V116, P1528, DOI 10.1182/blood-2009-12-259747; Lomova A, 2019, STEM CELLS, V37, P284, DOI 10.1002/stem.2935; Lundberg P, 2014, J EXP MED, V211, P2213, DOI 10.1084/jem.20131371; Marty C, 2010, BLOOD, V116, P783, DOI 10.1182/blood-2009-12-257063; MESSINEZY M, 1995, CLIN LAB HAEMATOL, V17, P217; Messinezy M, 2002, BRIT J HAEMATOL, V117, P47, DOI 10.1046/j.1365-2141.2002.03386.x; Mossuz P, 2004, HAEMATOLOGICA, V89, P1194; Mullally A, 2013, BLOOD, V121, P3692, DOI 10.1182/blood-2012-05-432989; Mullally A, 2010, CANCER CELL, V17, P584, DOI 10.1016/j.ccr.2010.05.015; Nam AS, 2019, NATURE, V571, P355, DOI 10.1038/s41586-019-1367-0; Nielsen C, 2014, HAEMATOLOGICA, V99, P1448, DOI 10.3324/haematol.2014.107631; Ortmann CA, 2015, NEW ENGL J MED, V372, P601, DOI 10.1056/NEJMoa1412098; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Rahmig S, 2016, STEM CELL REP, V7, P591, DOI 10.1016/j.stemcr.2016.08.005; Rodriguez-Meira A, 2019, MOL CELL, V73, P1292, DOI 10.1016/j.molcel.2019.01.009; Salit RB, 2014, HEMATOL ONCOL CLIN N, V28, P1023, DOI 10.1016/j.hoc.2014.08.003; Sawyer ST, 1996, J BIOL CHEM, V271, P32430, DOI 10.1074/jbc.271.50.32430; Schiroli G, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan0820; Shan YB, 2014, NAT STRUCT MOL BIOL, V21, P579, DOI 10.1038/nsmb.2849; Shin J, 2018, COM J CONTROLLED CYC, DOI [10.1101/301176, DOI 10.1101/301176]; Tefferi A, 2008, LEUKEMIA, V22, P14, DOI 10.1038/sj.leu.2404955; Tefferi A, 2015, JAMA ONCOL, V1, P97, DOI 10.1001/jamaoncol.2015.89; Tefferi A, 2009, CANCER-AM CANCER SOC, V115, P3842, DOI 10.1002/cncr.24440; Thiele Juergen, 2009, Curr Hematol Malig Rep, V4, P33, DOI 10.1007/s11899-009-0005-6; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Vainchenker W, 2017, BLOOD, V129, P667, DOI 10.1182/blood-2016-10-695940; Vannucchi AM, 2015, ANN ONCOL, V26, pV85, DOI 10.1093/annonc/mdv203; Walz C, 2012, BLOOD, V119, P3550, DOI 10.1182/blood-2011-12-397554; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Yan DQ, 2012, BLOOD, V119, P3539, DOI 10.1182/blood-2011-03-345215; Zaleskas VM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000018; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	69	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0247858	10.1371/journal.pone.0247858	http://dx.doi.org/10.1371/journal.pone.0247858			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33661998	gold, Green Submitted, Green Published			2022-12-26	WOS:000626604100054
J	El Alam, MB; Sims, TT; Kouzy, R; Biegert, GWG; Jaoude, JABI; Karpinets, TV; Yoshida-Court, K; Wu, XG; Delgado-Medrano, AY; Mezzari, MP; Ajami, NJ; Solley, T; Ahmed-Kaddar, M; Lin, LL; Ramondetta, L; Jazaeri, A; Jhingran, A; Eifel, PJ; Schmeler, KM; Wargo, J; Klopp, AH; Colbert, LE				El Alam, Molly B.; Sims, Travis T.; Kouzy, Ramez; Biegert, Greyson W. G.; Jaoude, Joseph A. B., I; Karpinets, Tatiana, V; Yoshida-Court, Kyoko; Wu, Xiaogang; Delgado-Medrano, Andrea Y.; Mezzari, Melissa P.; Ajami, Nadim J.; Solley, Travis; Ahmed-Kaddar, Mustapha; Lin, Lilie L.; Ramondetta, Lois; Jazaeri, Amir; Jhingran, Anuja; Eifel, Patricia J.; Schmeler, Kathleen M.; Wargo, Jennifer; Klopp, Ann H.; Colbert, Lauren E.			A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers	PLOS ONE			English	Article							THERAPY	Background A diverse and abundant gut microbiome can improve cancer patients' treatment response; however, the effect of pelvic chemoradiotherapy (CRT) on gut diversity and composition is unclear. The purpose of this prospective study was to identify changes in the diversity and composition of the gut microbiome during and after pelvic CRT. Materials and methods Rectal swabs from 58 women with cervical, vaginal, or vulvar cancer from two institutions were prospectively analyzed before CRT (baseline), during CRT (weeks 1, 3, and 5), and at first follow-up (week 12) using 16Sv4 rRNA gene sequencing of the V4 hypervariable region of the bacterial 16S rRNA marker gene. 42 of these patients received antibiotics during the study period. Observed operational taxonomic units (OTUs; representative of richness) and Shannon, Simpson, Inverse Simpson, and Fisher diversity indices were used to characterize alpha (within-sample) diversity. Changes over time were assessed using a paired t-test, repeated measures ANOVA, and linear mixed modeling. Compositional changes in specific bacteria over time were evaluated using linear discriminant analysis effect size. Results Gut microbiome richness and diversity levels continually decreased throughout CRT (mean Shannon diversity index, 2.52 vs. 2.91; all P < 0.01), but were at or near baseline levels in 60% of patients by week 12. Patients with higher gut diversity at baseline had the steepest decline in gut microbiome diversity. Gut microbiome composition was significantly altered during CRT, with increases in Proteobacteria and decreases in Clostridiales, but adapted after CRT, with increases in Bacteroides species. Conclusion After CRT, the diversity of the gut microbiomes in this population tended to return to baseline levels by the 12 week follow-up period, but structure and composition remained significantly altered. These changes should be considered when designing studies to analyze the gut microbiome in patients who receive pelvic CRT for gynecologic cancers.	[El Alam, Molly B.; Kouzy, Ramez; Biegert, Greyson W. G.; Jaoude, Joseph A. B., I; Yoshida-Court, Kyoko; Delgado-Medrano, Andrea Y.; Solley, Travis; Ahmed-Kaddar, Mustapha; Lin, Lilie L.; Jhingran, Anuja; Eifel, Patricia J.; Klopp, Ann H.; Colbert, Lauren E.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Sims, Travis T.; Ramondetta, Lois; Jazaeri, Amir; Schmeler, Kathleen M.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA; [Karpinets, Tatiana, V; Wu, Xiaogang; Ajami, Nadim J.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Mezzari, Melissa P.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Wargo, Jennifer] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Colbert, LE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.	aklopp@mdanderson.org; lcolbert@mdanderson.org	Colbert, Lauren/G-5860-2016	Colbert, Lauren/0000-0001-5806-4339; Biegert, Greyson/0000-0003-1413-6630	Radiological Society of North America Resident/Fellow Award; National Institutes of Health (NIH) through MD Anderson's Cancer Center Support Grant [P30CA016672]; National Institutes of Health (NIH) through T32 grant [CA101642-14]; University of Texas MD Anderson Cancer Center HPV-related Cancers Moonshot	Radiological Society of North America Resident/Fellow Award; National Institutes of Health (NIH) through MD Anderson's Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH) through T32 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas MD Anderson Cancer Center HPV-related Cancers Moonshot	This research was supported in part by the Radiological Society of North America Resident/Fellow Award (to L.E.C.); by the National Institutes of Health (NIH) through MD Anderson's Cancer Center Support Grant P30CA016672 and through T32 grant CA101642-14 (T.T.S.); and by The University of Texas MD Anderson Cancer Center HPV-related Cancers Moonshot (L.E.C., A. K.). The funding sources were not involved in the development of the research hypothesis, study design, data analysis, or manuscript writing. Data access was limited to the authors of this manuscript.	Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; Arbyn M, 2020, LANCET GLOB HEALTH, V8, pE191, DOI 10.1016/S2214-109X(19)30482-6; Baxter NT, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-20; Chaput N, 2017, ANN ONCOL, V28, P1368, DOI 10.1093/annonc/mdx108; Chase D, 2015, GYNECOL ONCOL, V138, P190, DOI 10.1016/j.ygyno.2015.04.036; Chen DF, 2019, INT J CANCER, V145, P2021, DOI 10.1002/ijc.32003; Cohen PA, 2019, LANCET, V393, P169, DOI 10.1016/S0140-6736(18)32470-X; Ferreira MR, 2019, CLIN CANCER RES, V25, P6487, DOI 10.1158/1078-0432.CCR-19-0960; Frankel AE, 2017, NEOPLASIA, V19, P848, DOI 10.1016/j.neo.2017.08.004; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Helmink BA, 2019, NAT MED, V25, P377, DOI 10.1038/s41591-019-0377-7; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Kumagai T, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101405; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Mitra A, 2020, INT J RADIAT ONCOL, V107, P163, DOI 10.1016/j.ijrobp.2019.12.040; Monk BJ, 2007, J CLIN ONCOL, V25, P2952, DOI 10.1200/JCO.2007.10.8324; Rizzatti G, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9351507; Rstudio T, 2020, RSTUDIO INT DEV R; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sethi V, 2018, GASTROENTEROLOGY, V155, P33, DOI 10.1053/j.gastro.2018.04.001; Sims TT, 2020, J CLIN ONCOL, V38; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Song Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0081330, 10.1371/journal.pone.0075729]; Wang AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126312; Wang YH, 2018, NAT MED, V24, P1804, DOI 10.1038/s41591-018-0238-9; Weingarden A, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0070-0; Yeung AR, 2020, J CLIN ONCOL, V38, P1685, DOI 10.1200/JCO.19.02381	27	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0247905	10.1371/journal.pone.0247905	http://dx.doi.org/10.1371/journal.pone.0247905			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33662003	Green Published, gold, Green Submitted			2022-12-26	WOS:000626604100004
J	Reinsborough, CW; Ipas, H; Abell, NS; Gouws, EB; Williams, JP; Mercado, M; Van den Berg, C; Xhemalce, B				Reinsborough, Calder W.; Ipas, Helene; Abell, Nathan S.; Gouws, Ellen B.; Williams, J. Paige; Mercado, Marvin; Van den Berg, Carla; Xhemalce, Blerta			BCDIN3D RNA methyltransferase stimulates Aldolase C expression and glycolysis through let-7 microRNA in breast cancer cells	ONCOGENE			English	Article							MAMMALIAN PROTEIN; PRE-MICRORNA; URIDYLATION; IDENTIFICATION; ZCCHC11; BIOGENESIS; RECRUITS; FAMILY; TUMORS; LOCI	Type II diabetes (T2D) and specific cancers share many risk factors, however, the molecular mechanisms underlying these connections are often not well-understood. BCDIN3D is an RNA modifying enzyme that methylates specific precursor microRNAs and tRNA(His). In addition to breast cancer, BCDIN3D may also be linked to metabolism, as its gene locus is associated with obesity and T2D. In order to uncover metabolic pathways regulated by BCDIN3D in cancer, we performed an unbiased analysis of the metabolome, transcriptome, and proteome of breast cancer cells depleted for BCDIN3D. Intersection of these analyses showed that BCDIN3D-depleted cells have increased levels of Fructose 1,6 Bisphosphate (F1,6-BP), the last six-carbon glycolytic intermediate accompanied by reduced glycolytic capacity. We further show that elevated F1,6-BP is due to downregulation of Aldolase C (ALDOC), an enzyme that cleaves F1,6-BP mainly in the brain, but whose high expression/amplification is associated with poor prognosis in breast cancer. BCDIN3D regulates ALDOC through a non-canonical mechanism involving the crucial let-7 microRNA family and its target site on the 3 ' UTR of ALDOC. Overall, our results reveal an important connection between BCDIN3D, let-7 and glycolysis that may be relevant to breast cancer, obesity, and T2D.	[Reinsborough, Calder W.; Ipas, Helene; Abell, Nathan S.; Gouws, Ellen B.; Williams, J. Paige; Mercado, Marvin; Xhemalce, Blerta] Univ Texas Austin, LiveStrong Canc Inst, Dept Mol Biosci, Dell Med Sch, 2500 Speedway, Austin, TX 78712 USA; [Abell, Nathan S.] Stanford Univ, Sch Med, Dept Genet, 300 Pasteur Dr, Stanford, CA 94305 USA; [Van den Berg, Carla] Univ Texas Austin, Dell Med Sch, Coll Pharm, Div Pharmacol & Toxicol, Austin, TX 78723 USA; [Van den Berg, Carla] Univ Texas Austin, Dell Med Sch, Dept Oncol, Austin, TX 78723 USA	University of Texas System; University of Texas Austin; Stanford University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Xhemalce, B (corresponding author), Univ Texas Austin, LiveStrong Canc Inst, Dept Mol Biosci, Dell Med Sch, 2500 Speedway, Austin, TX 78712 USA.	b.xhemalce@austin.utexas.edu		Xhemalce, Blerta/0000-0002-0517-9607	NIH [R01-GM127802]; DOD-CDMRP-BCRP [W81XWH-16-1-0352]; Welch Foundation [F1859]; STORM Therapeutics; CPRIT [RR160093]; CPRIT Core Facility Support Grants [RP120348, RP170002]; DHHS/NCI Cancer Center Support Grant (CCSG) [P30 CA16672]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD-CDMRP-BCRP(United States Department of Defense); Welch Foundation(The Welch Foundation); STORM Therapeutics; CPRIT; CPRIT Core Facility Support Grants; DHHS/NCI Cancer Center Support Grant (CCSG)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	BX was supported by NIH (R01-GM127802, DOD-CDMRP-BCRP (W81XWH-16-1-0352), Welch Foundation (F1859), STORM Therapeutics, and start-up funds. CVDB was partly supported by CPRIT (RR160093). This study made use of the MD Anderson Science Park facilities supported by CPRIT Core Facility Support Grants RP120348 and RP170002 and P30 CA16672 DHHS/NCI Cancer Center Support Grant (CCSG).	Auyeung VC, 2013, CELL, V152, P844, DOI 10.1016/j.cell.2013.01.031; Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Blazer LL, 2017, SLAS DISCOV, V22, P32, DOI 10.1177/1087057116666276; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Faehnle CR, 2014, NATURE, V514, P252, DOI 10.1038/nature13553; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heo I, 2012, CELL, V151, P521, DOI 10.1016/j.cell.2012.09.022; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Huangyang PW, 2020, CELL METAB, V31, P174, DOI 10.1016/j.cmet.2019.10.012; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jenkins DE, 2005, BREAST CANCER RES, V7, pR444, DOI 10.1186/bcr1026; Jones MR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003105; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Kim B, 2015, EMBO J, V34, P1801, DOI 10.15252/embj.201590931; Kim K, 2018, RNA, V24, P892, DOI 10.1261/rna.065862.118; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li MQ, 2019, CELL METAB, V30, P508, DOI 10.1016/j.cmet.2019.05.018; Lin SC, 2020, NAT REV MOL CELL BIO, V21, P714, DOI 10.1038/s41580-020-00305-x; Lin SB, 2015, RNA BIOL, V12, P792, DOI 10.1080/15476286.2015.1058478; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Martinez A, 2017, NUCLEIC ACIDS RES, V45, P5423, DOI 10.1093/nar/gkx051; McCall MN, 2017, GENOME RES, V27, P1769, DOI 10.1101/gr.222067.117; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Reinsborough CW, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008273; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Schapira M, 2016, ACS CHEM BIOL, V11, P575, DOI 10.1021/acschembio.5b00781; Schwartz MW, 2013, NATURE, V503, P59, DOI 10.1038/nature12709; Shelton SB, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006139; Shi DS, 2015, INT J MOL SCI, V16, P13004, DOI 10.3390/ijms160613004; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Thornton JE, 2014, NUCLEIC ACIDS RES, V42, P11777, DOI 10.1093/nar/gku805; Walley AJ, 2009, NAT REV GENET, V10, P431, DOI 10.1038/nrg2594; Xhemalce B, 2012, CELL, V151, P278, DOI 10.1016/j.cell.2012.08.041; Yao L, 2016, ONCOTARGET, V7, P53895, DOI 10.18632/oncotarget.9656; Zhang CS, 2017, NATURE, V548, P112, DOI 10.1038/nature23275; Zhu L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217603; Zhu WC, 2000, GENE, V245, P329, DOI 10.1016/S0378-1119(00)00048-2	42	9	9	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 1	2021	40	13					2395	2406		10.1038/s41388-021-01702-y	http://dx.doi.org/10.1038/s41388-021-01702-y		MAR 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RH1BQ	33664453	Green Accepted			2022-12-26	WOS:000625833000004
J	Xue, BW; McMunn, A				Xue, Baowen; McMunn, Anne			Gender differences in unpaid care work and psychological distress in the UK Covid-19 lockdown	PLOS ONE			English	Article								Objective To describe how men and women divided childcare and housework demands during the height of the first Covid-19 lockdown in the UK, and whether these divisions were associated with worsening mental health during the pandemic. Background School closures and homeworking during the Covid-19 crisis have resulted in an immediate increase in unpaid care work, which draws new attention to gender inequality in divisions of unpaid care work. Methods Data come from the wave 9 (2017-19) of Understanding Society and the following April (n = 15,426) and May (n = 14,150) waves of Understanding Society Covid-19 study. Psychological distress was measured using the General Health Questionnaire (GHQ) at both before and during the lockdown, and unpaid care work was measured during the lockdown. Linear regression models were used. Results Women spent much more time on unpaid care work than men during lockdown, and it was more likely to be the mother than the father who reduced working hours or changed employment schedules due to increased time on childcare. Women who spent long hours on housework and childcare were more likely to report increased levels of psychological distress. Working parents who adapted their work patterns increased more psychological distress than those who did not. This association was much stronger if he or she was the only member in the household who adapted their work patterns, or if she was a lone mother. Fathers increased more psychological distress if they reduced work hours but she did not, compared to neither reducing work hours. Conclusion There are continued gender inequalities in divisions of unpaid care work. Juggling home working with homeschooling and childcare as well as extra housework is likely to lead to poor mental health for people with families, particularly for lone mothers.	[Xue, Baowen; McMunn, Anne] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; University College London	Xue, BW (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	baowen.xue.10@ucl.ac.uk		McMunn, Anne/0000-0003-3237-9345; Xue, Baowen/0000-0003-0180-8776	Economic and Social Research Council International Centre for Lifecourse Studies in Society and Health (ICLS) [ES/J019119/1]; ESRC [ES/R008930/1] Funding Source: UKRI	Economic and Social Research Council International Centre for Lifecourse Studies in Society and Health (ICLS); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	AM has been supported by the Economic and Social Research Council International Centre for Lifecourse Studies in Society and Health (ICLS) [grant number ES/J019119/1]. https://esrc.ukri.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto AM, 2012, PSYCHIAT RES, V197, P163, DOI 10.1016/j.psychres.2011.09.008; Andrew A, 2020, NB290 IFS; Armitage R, 2020, LANCET GLOB HEALTH, V8, pE644, DOI 10.1016/S2214-109X(20)30116-9; Bannai A, 2014, SCAND J WORK ENV HEA, V40, P5, DOI 10.5271/sjweh.3388; Bird CE, 1999, J HEALTH SOC BEHAV, V40, P32, DOI 10.2307/2676377; Blundell R, 2020, FISC STUD, V41, P291, DOI 10.1111/1475-5890.12232; Burki T, 2020, LANCET INFECT DIS, V20, P904, DOI 10.1016/S1473-3099(20)30568-5; Burstrom B, 2010, SOC SCI MED, V70, P912, DOI 10.1016/j.socscimed.2009.11.014; Burton J., 2011, UNDERSTANDING SOC EA, P129; Carlson DanielL., 2020, SOCIUS, V6, P1, DOI DOI 10.1177/2378023120924805; Elson D., 2000, PROGR WORLDS WOM 200; England P, 2005, ANNU REV SOCIOL, V31, P381, DOI 10.1146/annurev.soc.31.041304.122317; Florean D, 2020, JFR-J FAM RES, V32, P249, DOI 10.20377/jfr-372; GREENHAUS JH, 1985, ACAD MANAGE REV, V10, P76, DOI 10.5465/AMR.1985.4277352; Grzywacz J G, 2000, J Occup Health Psychol, V5, P111, DOI 10.1037/1076-8998.5.1.111; Grzywacz JG, 2002, FAM RELAT, V51, P28, DOI 10.1111/j.1741-3729.2002.00028.x; Institute for Social and Economic Research, 2020, UND SOC COVID 19 US; Kalmbach DA, 2015, SLEEP MED, V16, P1532, DOI 10.1016/j.sleep.2015.09.007; Kamo Y, 2000, SOC SCI RES, V29, P459, DOI 10.1006/ssre.2000.0674; Kinnunen U, 2006, SCAND J PSYCHOL, V47, P149, DOI 10.1111/j.1467-9450.2006.00502.x; Lacey RE, 2019, PSYCHOL MED, V49, P1652, DOI 10.1017/S0033291718002222; McMunn A, 2020, WORK EMPLOY SOC, V34, P155, DOI 10.1177/0950017019862153; PEARLIN LI, 1989, J HEALTH SOC BEHAV, V30, P241, DOI 10.2307/2136956; Ridge T, 2011, SOC POLICY ADMIN, V45, P85, DOI 10.1111/j.1467-9515.2010.00755.x; Sato K, 2020, SOC SCI MED, V246, DOI 10.1016/j.socscimed.2019.112774; Tao Wenting, 2010, Clin Pract Epidemiol Ment Health, V6, P36, DOI 10.2174/1745017901006010036; United Nations, 2020, UN SECR GEN POL BRIE; Vasileiou K, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00585; Virtanen M, 2011, PSYCHOL MED, V41, P2485, DOI 10.1017/S0033291711000171; Virtanen M, 2009, SLEEP, V32, P737, DOI 10.1093/sleep/32.6.737; Vogel M, 2012, J NEURAL TRANSM, V119, P1121, DOI 10.1007/s00702-012-0800-4; Weston G, 2019, J EPIDEMIOL COMMUN H, V73, P465, DOI 10.1136/jech-2018-211309; Women's Resource Centre, 2020, CRIS COVID 19 UK WOM; Wright L., 2020, ARE ADVERSITIES WORR, DOI 10.1101/2020.06.02.20120311; Xu X, 2020, W2016 IFS; Yucel D, 2020, SOC MENT HEALTH, V10, P35, DOI 10.1177/2156869318813006	36	64	64	8	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0247959	10.1371/journal.pone.0247959	http://dx.doi.org/10.1371/journal.pone.0247959			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33662014	Green Published, gold			2022-12-26	WOS:000626604100087
J	Ear, J; Abd El-Hafeez, AA; Roy, S; Ngo, T; Rajapakse, N; Choi, JL; Khandelwal, S; Ghassemian, M; McCaffrey, L; Kufareva, I; Sahoo, D; Ghosh, P				Ear, Jason; Abd El-Hafeez, Amer Ali; Roy, Suchismita; Ngo, Tony; Rajapakse, Navin; Choi, Julie; Khandelwal, Soni; Ghassemian, Majid; McCaffrey, Luke; Kufareva, Irina; Sahoo, Debashis; Ghosh, Pradipta			A long isoform of GIV/Girdin contains a PDZ-binding module that regulates localization and G-protein binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUILDING-BLOCKS; MET-DB; GIRDIN; ACTIN; IDENTIFICATION; ORGANIZATION; ACTIVATION; PROGNOSIS; RECEPTOR; DEPENDS	PDZ domains are one of the most abundant protein domains in eukaryotes and are frequently found on junction-localized scaffold proteins. Various signaling molecules bind to PDZ proteins via PDZ-binding motifs (PBM) and fine-tune cellular signaling. However, how such interaction affects protein function is difficult to predict and must be solved empirically. Here we describe a long isoform of the guanine nucleotide exchange factor GIV/Girdin (CCDC88A) that we named GIV-L, which is conserved throughout evolution, from invertebrates to vertebrates, and contains a PBM. Unlike GIV, which lacks PBM and is cytosolic, GIV-L localizes onto cell junctions and has a PDZ interactome (as shown through annotating Human Cell Map and BioID-proximity labeling studies), which impacts GIV-L's ability to bind and activate trimeric G-protein, G alpha i, through its guanine-nucleotide exchange modulator (GEM) module. This GEM module is found exclusively in vertebrates. We propose that the two functional modules in GIV may have evolved sequentially: the ability to bind PDZ proteins via the PBM evolved earlier in invertebrates, whereas G-protein binding and activation may have evolved later only among vertebrates. Phenotypic studies in Caco-2 cells revealed that GIV and GIV-L may have antagonistic effects on cell growth, proliferation (cell cycle), and survival. Immunohistochemical analysis in human colon tissues showed that GIV expression increases with a concomitant decrease in GIV-L during cancer initiation. Taken together, these findings reveal how regulation in GIV/CCDC88A transcript helps to achieve protein modularity, which allows the protein to play opposing roles either as a tumor suppressor (GIV-L) or as an oncogene (GIV).	[Ear, Jason; Abd El-Hafeez, Amer Ali; Rajapakse, Navin; Choi, Julie; Ghosh, Pradipta] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ear, Jason] Calif State Polytech Univ Pomona, Biol Sci Dept, Pomona, CA 91768 USA; [Abd El-Hafeez, Amer Ali] Cairo Univ, Natl Canc Inst, Canc Biol Dept, Pharmacol & Expt Oncol Unit, Cairo, Egypt; [Roy, Suchismita; Ngo, Tony; Kufareva, Irina] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Khandelwal, Soni; Sahoo, Debashis] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Ghassemian, Majid] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [McCaffrey, Luke] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada; [McCaffrey, Luke] McGill Univ, Gerald Bronfman Dept Oncol, Montreal, PQ, Canada; [Ghosh, Pradipta] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ghosh, Pradipta] Univ Calif San Diego, Rebecca & John Moore Comprehens Canc Ctr, La Jolla, CA 92093 USA; [Ghosh, Pradipta] Vet Affairs Med Ctr, La Jolla, CA 92037 USA	University of California System; University of California San Diego; California State University System; California State Polytechnic University Pomona; Egyptian Knowledge Bank (EKB); Cairo University; National Cancer Institute - Egypt; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; McGill University; McGill University; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ear, J; Ghosh, P (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Ear, J (corresponding author), Calif State Polytech Univ Pomona, Biol Sci Dept, Pomona, CA 91768 USA.; Ghosh, P (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.; Ghosh, P (corresponding author), Univ Calif San Diego, Rebecca & John Moore Comprehens Canc Ctr, La Jolla, CA 92093 USA.; Ghosh, P (corresponding author), Vet Affairs Med Ctr, La Jolla, CA 92037 USA.	jear@cpp.edu; prghosh@ucsd.edu	Roy, Suchismita/ADM-8755-2022	Ngo, Tony/0000-0002-6779-2546	NIH [CA238042, AI141630, CA100768, CA160911, UG3TR002968]; NCI/NIH [T32 CA067754, T32CA121938]; American Cancer Society [PF-18-101-01-CSM];  [R01GM138385]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); 	This paper was supported by NIH CA238042, AI141630, CA100768, and CA160911 as well as UG3TR002968 (to P. G.). J. E. was supported by an NCI/NIH-funded Cancer Biology, Informatics & Omics (CBIO) Training Program (T32 CA067754) and a Postdoctoral Fellowship from the American Cancer Society (PF-18-101-01-CSM). D. S. is supported by R01GM138385. This paper was also supported by NCI/NIHfunded CT2 Training Grant T32CA121938 (to A. A. A. E.-H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amacher JF, 2020, J STRUCT BIOL-X, V4, DOI 10.1016/j.yjsbx.2020.100022; Aznar N, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao4220; Aznar N, 2016, ELIFE, V5, DOI 10.7554/eLife.20795; Aznar N, 2015, ELIFE, V4, DOI 10.7554/eLife.07091; Biehler C, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008674; Boldt K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11491; Breton B, 2010, BIOPHYS J, V99, P4037, DOI 10.1016/j.bpj.2010.10.025; Brown NE, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.249; Choi JS, 2017, PATHOLOGY, V49, P618, DOI 10.1016/j.pathol.2017.05.010; Coleman BD, 2016, MOL BIOL EVOL, V33, P820, DOI 10.1093/molbev/msv336; Ear J, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100859; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Ezan J, 2013, NAT CELL BIOL, V15, P1107, DOI 10.1038/ncb2819; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Ghosh P, 2015, AGING-US, V7, P469, DOI 10.18632/aging.100781; Ghosh P, 2010, MOL BIOL CELL, V21, P2338, DOI 10.1091/mbc.E10-01-0028; Go C. D., 2019, PROXIMITY BIOTINYLAT, DOI [10.1101/796391v1, 10.1101/796391, DOI 10.1101/796391]; Ha A, 2015, GENETICS, V200, P1149, DOI 10.1534/genetics.115.178954; Houssin E, 2015, DEVELOPMENT, V142, P1777, DOI 10.1242/dev.122002; de Opakua AI, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15163; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Jowett T, 1999, METHOD CELL BIOL, V59, P63; Kalogriopoulos NA, 2019, P NATL ACAD SCI USA, V116, P16394, DOI 10.1073/pnas.1906658116; Kannan N, 2015, J CELL BIOL, V211, P407, DOI 10.1083/jcb.201412003; Karaman R, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028753; Ke SD, 2015, GENE DEV, V29, P2037, DOI 10.1101/gad.269415.115; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Liu H, 2018, NUCLEIC ACIDS RES, V46, pD281, DOI 10.1093/nar/gkx1080; Liu H, 2015, NUCLEIC ACIDS RES, V43, pD197, DOI 10.1093/nar/gku1024; Manjunath GP, 2018, J BIOSCIENCES, V43, P155, DOI 10.1007/s12038-017-9727-0; Marivin A, 2019, MOL BIOL CELL, V30, P1900, DOI 10.1091/mbc.E19-02-0091; McHenry MJ, 2007, J EXP BIOL, V210, P4244, DOI 10.1242/jeb.009290; METCALFE WK, 1985, J COMP NEUROL, V233, P377, DOI 10.1002/cne.902330307; Midde KK, 2015, P NATL ACAD SCI USA, V112, pE937, DOI 10.1073/pnas.1420140112; Mykytyn K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028183; Nachury MV, 2019, NAT REV MOL CELL BIO, V20, P389, DOI 10.1038/s41580-019-0116-4; Nechipurenko IV, 2016, DEV CELL, V38, P493, DOI 10.1016/j.devcel.2016.07.013; Ohara K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036681; Oshita A, 2003, GENES CELLS, V8, P1005, DOI 10.1111/j.1365-2443.2003.00692.x; Pan CQ, 2012, CELL SIGNAL, V24, P2143, DOI 10.1016/j.cellsig.2012.06.002; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Rausch V, 2020, TRENDS CELL BIOL, V30, P32, DOI 10.1016/j.tcb.2019.10.005; Rouaud F, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2020.183399; Sasaki K, 2015, J CELL SCI, V128, P2244, DOI 10.1242/jcs.160879; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siletti K, 2017, P NATL ACAD SCI USA, V114, pE11170, DOI 10.1073/pnas.1716522115; Subbaiah VK, 2011, BIOCHEM J, V439, P195, DOI 10.1042/BJ20110903; Tang VW, 2013, J CELL BIOL, V203, P815, DOI 10.1083/jcb.201304143; Teo GC, 2014, J PROTEOMICS, V100, P37, DOI 10.1016/j.jprot.2013.10.023; VERMEULEN SJ, 1995, CANCER RES, V55, P4722; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Wang S, 2018, ONCOL REP, V40, P599, DOI 10.3892/or.2018.6469; Wang WL, 2020, ONCOL REP, V44, P637, DOI 10.3892/or.2020.7615; Wang YF, 2010, J NEUROPHYSIOL, V104, P3551, DOI 10.1152/jn.00656.2010; Wong V, 1997, AM J PHYSIOL-CELL PH, V273, pC1859, DOI 10.1152/ajpcell.1997.273.6.C1859; Yang ZY, 2018, EXP THER MED, V15, P2837, DOI 10.3892/etm.2018.5773; Zaccara S, 2019, NAT REV MOL CELL BIO, V20, P608, DOI 10.1038/s41580-019-0168-5; Zhu LY, 2018, AM J CANCER RES, V8, P2346	62	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100493	10.1016/j.jbc.2021.100493	http://dx.doi.org/10.1016/j.jbc.2021.100493			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33675748	Green Published, gold			2022-12-26	WOS:000672866400467
J	Ji, KY; Kim, SM; Yee, SM; Kim, MJ; Ban, YJ; Kim, EM; Lee, EH; Choi, H; Yun, H; Lee, CW; Yun, CH; Lee, CJ; Lee, HB; Kang, HS				Ji, Kon-Young; Kim, Su-Man; Yee, Su-Min; Kim, Min-Jae; Ban, Yu-Jin; Kim, Eun-Mi; Lee, Eun-Hee; Choi, Ha-Rim; Yun, Hyosuk; Lee, Chul Won; Yun, Chul-Ho; Lee, C. Justin; Lee, Hyang Burm; Kang, Hyung-Sik			Cyclophilin A is an endogenous ligand for the triggering receptor expressed on myeloid cells-2 (TREM2)	FASEB JOURNAL			English	Article						anti&#8208; inflammation; CD147; cyclophilin A; TREM2; TREM2 ligand		Triggering receptor expressed on myeloid cells 2 (TREM2) is a cell surface receptor expressed on macrophages, microglial cells, and pre-osteoclasts, and that participates in diverse cellular function, including inflammation, bone homeostasis, neurological development, and coagulation. In spite of the indispensable role of the TREM2 protein in the maintenance of immune homeostasis and osteoclast differentiation, the exact ligand for TREM2 has not yet been identified. Here, we report a putative TREM2 ligand which is secreted from MC38 cells and identified as a cyclophilin A (CypA). A specific interaction between CypA and TREM2 was shown at both protein and cellular levels. Exogenous CypA specifically interacted and co-localized with TREM2 in RAW264.7 cells, and the physical interactions were shown to regulate TREM2 signaling transduction. The Pro(144) residue in the extracellular domain of TREM2 was found to be the specific binding site of CypA. When considered together, this provides evidence that CypA interacts specifically with TREM2 as a potent ligand.	[Ji, Kon-Young; Kim, Su-Man; Yee, Su-Min; Kim, Min-Jae; Ban, Yu-Jin; Yun, Chul-Ho; Kang, Hyung-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Gwangju, South Korea; [Kim, Eun-Mi] Korea Inst Toxicol, R&D Ctr Adv Pharmaceut & Evaluat, Daejeon, South Korea; [Lee, Eun-Hee] Deagu Gyeongbuk Med Innovat Fdn, Adv Interdisciplinary Team, Prod R&D Div, Daegu, South Korea; [Choi, Ha-Rim] Nambu Univ, Dept Nursing, Gwangju, South Korea; [Yun, Hyosuk; Lee, Chul Won] Chonnam Natl Univ, Dept Chem, Gwangju, South Korea; [Lee, C. Justin] Inst for Basic Sci Korea, Ctr Cognit & Social, Daejeon, South Korea; [Lee, Hyang Burm] Chonnam Natl Univ, Div Food Technol Biotechnol & Agrochem, Gwangju, South Korea	Chonnam National University; Korea Institute of Toxicology; Nambu University; Chonnam National University; Institute for Basic Science - Korea (IBS); Chonnam National University	Kang, HS (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Gwangju, South Korea.	kanghs@jnu.ac.kr	Ji, Kon-Young/GZB-2640-2022	Lee, C Justin/0000-0002-3555-0980; Kim, Su-Man/0000-0002-0588-8294	National Research Foundation of Korea (NRF) [NRF--2018R1A4A1023882]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2018R1A2B6005139; National Research Foundation of Korea (NRF), Grant/Award Number: NRF--2018R1A4A1023882	Atagi Y, 2015, J BIOL CHEM, V290, P26043, DOI 10.1074/jbc.M115.679043; Bailey CC, 2015, J BIOL CHEM, V290, P26033, DOI 10.1074/jbc.M115.677286; Bhagwat B, 2018, J IMMUNOL METHODS, V456, P7, DOI 10.1016/j.jim.2018.02.003; Cella M, 2003, J EXP MED, V198, P645, DOI 10.1084/jem.20022220; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Garcia JEL, 2000, MEDIAT INFLAMM, V9, P169, DOI 10.1080/09629350020008682; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Huang YWA, 2019, J NEUROSCI, V39, P7408, DOI 10.1523/JNEUROSCI.2994-18.2019; Ito H, 2012, EUR J IMMUNOL, V42, P176, DOI 10.1002/eji.201141679; Jin ZG, 2000, CIRC RES, V87, P789, DOI 10.1161/01.RES.87.9.789; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Kobayashi M, 2016, J NEUROSCI, V36, P11138, DOI 10.1523/JNEUROSCI.1238-16.2016; Molgora M, 2020, CELL, V182, P886, DOI 10.1016/j.cell.2020.07.013; Paloneva J, 2003, J EXP MED, V198, P669, DOI 10.1084/jem.20030027; Park M, 2015, DIABETES, V64, P117, DOI 10.2337/db13-1869; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; Schlegel J, 2009, J MOL BIOL, V391, P518, DOI 10.1016/j.jmb.2009.05.080; Schmid CD, 2002, J NEUROCHEM, V83, P1309, DOI 10.1046/j.1471-4159.2002.01243.x; Seizer P, 2014, CARDIOVASC RES, V102, P17, DOI 10.1093/cvr/cvu035; SHERRY B, 1992, P NATL ACAD SCI USA, V89, P3511, DOI 10.1073/pnas.89.8.3511; Song F, 2011, J BIOL CHEM, V286, P8197, DOI 10.1074/jbc.C110.181347; Suzuki J, 2006, CIRC RES, V98, P811, DOI 10.1161/01.RES.0000216405.85080.a6; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wunderlich P, 2013, J BIOL CHEM, V288, P33027, DOI 10.1074/jbc.M113.517540; Xing JJ, 2015, RES REP BIOCHEM, V5, P89, DOI 10.2147/RRBC.S58057; XU Q, 1992, J BIOL CHEM, V267, P11968; Yurchenko V, 2006, IMMUNOLOGY, V117, P301, DOI 10.1111/j.1365-2567.2005.02316.x; Yurchenko V, 2005, J BIOL CHEM, V280, P17013, DOI 10.1074/jbc.M412851200; Yurchenko V, 2010, CLIN EXP IMMUNOL, V160, P305, DOI 10.1111/j.1365-2249.2010.04115.x; Yurchenko V, 2002, J BIOL CHEM, V277, P22959, DOI 10.1074/jbc.M201593200; Zhong L, 2015, J BIOL CHEM, V290, P15866, DOI 10.1074/jbc.M115.645986	36	5	5	4	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21479	10.1096/fj.202002325RR	http://dx.doi.org/10.1096/fj.202002325RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710680				2022-12-26	WOS:000635216100030
J	Jie, QL; Sun, F; Li, Q; Zhu, J; Wei, YJ; Yang, HM; Long, P; Wang, Z; Yang, XH; Li, D; Huang, LP; Ma, YL				Jie, Qiuling; Sun, Fei; Li, Qi; Zhu, Juan; Wei, Yunjian; Yang, Huamei; Long, Ping; Wang, Zhen; Yang, Xiaohui; Li, Dan; Huang, Liping; Ma, Yanlin			Downregulated ribosomal protein L39 inhibits trophoblast cell migration and invasion by targeting E-cadherin in the placenta of patients with preeclampsia	FASEB JOURNAL			English	Article						E&#8208; cadherin; early&#8208; onset preeclampsia; invasion; migration; proliferation; ribosomal protein L39		Early-onset preeclampsia (PE) is a pregnancy complication that can lead to severe adverse maternal and fetal outcomes. However, the mechanisms underlying the development of early-onset PE are not fully understood. Ribosomal protein L39 (RPL39) is a member of the S39E family of ribosomal proteins that plays an important role in stem cell self-renewal, cancer metastasis, and chemoresistance. In this study, we aimed to explore the potential function of RPL39 in placental trophoblast cells. We analyzed the expression of RPL39 in early-onset PE and normal placental tissues using real-time PCR, western blot analysis, and immunohistochemistry. The results showed that RPL39 was markedly downregulated in early-onset PE placental tissues. RPL39 knockdown inhibited trophoblast cell proliferation, migration, and invasion, as well as placental explant outgrowth. Flow cytometry analysis suggested that knockdown of RPL39 resulted in cell cycle arrest at the G0/G1 phase, but had no significant effect on cell apoptosis. We also found that RPL39 knockdown could alter cell morphology. We then measured the expression of the epithelial cell marker E-cadherin following knockdown of RPL39 in Bewo and HTR8/SVneo cells. RPL39 knockdown increased the expression of E-cadherin. Furthermore, E-cadherin expression was upregulated in placental explant outgrowth tissues transfected with RPL39 small interfering RNA. In conclusion, RPL39 plays an essential role in proliferation, invasion, and migration of trophoblast cells by targeting E-cadherin. Our findings provide novel insight into the mechanisms underlying the occurrence of early-onset PE.	[Jie, Qiuling; Sun, Fei; Zhu, Juan; Huang, Liping] Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, 1838 Guangzhou North Ave, Guangzhou 510515, Peoples R China; [Jie, Qiuling; Sun, Fei; Li, Qi; Zhu, Juan; Wei, Yunjian; Yang, Huamei; Long, Ping; Wang, Zhen; Yang, Xiaohui; Li, Dan; Ma, Yanlin] Hainan Med Univ, Dept Hainan Prov Key Lab Human Reprod Med & Genet, Key Lab Trop Translat Med, Minist Educ,Reprod Med,Affiliated Hosp 1, 31 Longhua Rd, Haikou 570102, Hainan, Peoples R China	Southern Medical University - China; Hainan Medical University	Huang, LP (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, 1838 Guangzhou North Ave, Guangzhou 510515, Peoples R China.; Ma, YL (corresponding author), Hainan Med Univ, Dept Hainan Prov Key Lab Human Reprod Med & Genet, Key Lab Trop Translat Med, Minist Educ,Reprod Med,Affiliated Hosp 1, 31 Longhua Rd, Haikou 570102, Hainan, Peoples R China.	lphuang@126.com; mayl1990@foxmail.com	龙, 平/HIK-1699-2022; Ma, Yanlin/CAH-2185-2022	Ma, Yanlin/0000-0001-9668-0204; Jie, Qiuling/0000-0002-1338-0888	Finance science and technology project of hainan province [ZDKJ2017007]; National Natural Science Foundation of China [81960283, 82072880, 82003144, 81660433]; Natural Science Foundation of Hainan Province [2019CXTD408]; Natural Science Foundation of Guangdong Province [2019A1515010019, 2017A030313584]; Presidential Foundation of Nanfang Hospital, Southern Medical University [2018Z014, 2017C001]	Finance science and technology project of hainan province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hainan Province; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Presidential Foundation of Nanfang Hospital, Southern Medical University	Finance science and technology project of hainan province, Grant/Award Number: ZDKJ2017007; National Natural Science Foundation of China, Grant/Award Number: 81960283, 82072880, 82003144 and 81660433; Natural Science Foundation of Hainan Province, Grant/Award Number: 2019CXTD408; Natural Science Foundation of Guangdong Province, Grant/Award Number: 2019A1515010019 and 2017A030313584; Presidential Foundation of Nanfang Hospital, Southern Medical University, Grant/Award Number: 2018Z014 and 2017C001	Aiello NM, 2018, DEV CELL, V45, P681, DOI 10.1016/j.devcel.2018.05.027; [Anonymous], 2019, Obstet Gynecol, V133, P1, DOI 10.1097/AOG.0000000000003018; Beckers KF, 2020, AM J PHYSIOL-HEART C, V318, pH1, DOI 10.1152/ajpheart.00469.2019; BROSENS I, 1967, J PATHOL BACTERIOL, V93, P569, DOI 10.1002/path.1700930218; Brown MA, 2018, HYPERTENSION, V72, P24, DOI 10.1161/HYPERTENSIONAHA.117.10803; Chen XH, 2018, HYPERTENSION, V71, P481, DOI 10.1161/HYPERTENSIONAHA.117.10250; Cheng D, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/4976845; Cui JH, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01720-9; Dave B, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw292; Dave B, 2014, P NATL ACAD SCI USA, V111, P8838, DOI 10.1073/pnas.1320769111; de las Heras-Rubio A, 2014, CANCER METAST REV, V33, P115, DOI 10.1007/s10555-013-9460-6; Fedorova L, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-15; Graifer D, 2015, BIOCHIMIE, V109, P1, DOI 10.1016/j.biochi.2014.11.016; He CJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46699-3; Ji PG, 2019, J CELL BIOCHEM, V120, P3259, DOI 10.1002/jcb.27592; Kokkinos MI, 2010, PLACENTA, V31, P747, DOI 10.1016/j.placenta.2010.06.017; Kumar S, 2018, REPRODUCTION, V156, pR155, DOI 10.1530/REP-18-0278; Le YP, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.10.11; Li CD, 2014, BIOTECHNOL J, V9, P652, DOI 10.1002/biot.201300321; Li F, 2018, HYPERTENSION, V71, P894, DOI 10.1161/HYPERTENSIONAHA.117.10849; Liu HS, 2014, ASIAN PAC J CANCER P, V15, P3093, DOI 10.7314/APJCP.2014.15.7.3093; Liu J, 2020, J CELL PHYSIOL, V235, P7410, DOI 10.1002/jcp.29643; Liu ZB, 2019, BREAST CANCER RES TR, V178, P251, DOI 10.1007/s10549-019-05374-x; Loh CY, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101118; Mendonsa AM, 2018, ONCOGENE, V37, P4769, DOI 10.1038/s41388-018-0304-2; Mol BJ, 2016, LANCET, V387, P999, DOI 10.1016/S0140-6736(15)00070-7; Owusu-Akyaw A, 2019, HUM REPROD UPDATE, V25, P114, DOI 10.1093/humupd/dmy035; Peng W, 2019, FASEB J, V33, P6327, DOI 10.1096/fj.201802058RR; Phipps EA, 2019, NAT REV NEPHROL, V15, P275, DOI 10.1038/s41581-019-0119-6; Prakash V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10100-8; Raguema N, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00098; Sani HM, 2019, BIOMED PHARMACOTHER, V109, P408, DOI 10.1016/j.biopha.2018.10.082; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; Wang SL, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.166; Wang XN, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1025; Wen YW, 2019, UROL ONCOL-SEMIN ORI, V37, DOI 10.1016/j.urolonc.2019.01.011; Ye YZ, 2019, FASEB J, V33, P2732, DOI 10.1096/fj.201800934RRR; Yue XJ, 2018, PLACENTA, V62, P43, DOI 10.1016/j.placenta.2017.12.009; Zhou L, 2019, AM J PHYSIOL-ENDOC M, V316, pE773, DOI 10.1152/ajpendo.00383.2018; Zhou X, 2015, J MOL CELL BIOL, V7, P92, DOI 10.1093/jmcb/mjv014	40	1	1	4	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21322	10.1096/fj.202002061R	http://dx.doi.org/10.1096/fj.202002061R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710681				2022-12-26	WOS:000635216100062
J	Oduwole, OO; Poliandri, A; Okolo, A; Rawson, P; Doroszko, M; Chrusciel, M; Rahman, NA; de Almeida, GS; Bevan, CL; Koechling, W; Huhtaniemi, IT				Oduwole, Olayiwola O.; Poliandri, Ariel; Okolo, Anthony; Rawson, Phil; Doroszko, Milena; Chrusciel, Marcin; Rahman, Nafis A.; Serrano de Almeida, Gilberto; Bevan, Charlotte L.; Koechling, Wolfgang; Huhtaniemi, Ilpo T.			Follicle-stimulating hormone promotes growth of human prostate cancer cell line-derived tumor xenografts	FASEB JOURNAL			English	Article						follicle&#8208; stimulating hormone; follicle&#8208; stimulating hormone receptor; gonadectomy; gonadotropin&#8208; releasing hormone antagonist; prostate cancer		Chemical castration in prostate cancer can be achieved with gonadotropin-releasing hormone (GnRH) agonists or antagonists. Their effects differ by the initial flare of gonadotropin and testosterone secretion with agonists and the immediate pituitary-testicular suppression by antagonists. While both suppress luteinizing hormone (LH) and follicle-stimulating hormone (FSH) initially, a rebound in FSH levels occurs during agonist treatment. This rebound is potentially harmful, taken the expression of FSH receptors (R) in prostate cancer tissue. We herein assessed the role of FSH in promoting the growth of androgen-independent (PC-3, DU145) and androgen-dependent (VCaP) human prostate cancer cell line xenografts in nude mice. Gonadotropins were suppressed with the GnRH antagonist degarelix, and effects of add-back human recombinant FSH were assessed on tumor growth. All tumors expressed GnRHR and FSHR, and degarelix treatment suppressed their growth. FSH supplementation reversed the degarelix-evoked suppression of PC-3 tumors, both in preventive (degarelix and FSH treatment started upon cell inoculation) and therapeutic (treatments initiated 3 weeks after cell inoculation) setting. A less marked, though significant FSH effect occurred in DU145, but not in VCaP xenografts. FSHR expression in the xenografts supports direct FSH stimulation of tumor growth. Testosterone supplementation, to maintain the VCaP xenografts, apparently masked the FSH effect on their growth. Treatment with the LH analogue hCG did not affect PC-3 tumor growth despite their expression of luteinizing hormone/choriongonadotropin receptor. In conclusion, FSH, but not LH, may directly stimulate the growth of androgen-independent prostate cancer, suggesting that persistent FSH suppression upon GnRH antagonist treatment offers a therapeutic advantage over agonist.	[Oduwole, Olayiwola O.; Okolo, Anthony; Huhtaniemi, Ilpo T.] Imperial Coll London, Dept Digest Metab & Reprod, Inst Reprod & Dev Biol, London, England; [Poliandri, Ariel] St Georges Univ London, Dept Mol & Clin Sci, London, England; [Rawson, Phil] Imperial Coll London, Cent Biomed Serv, London, England; [Doroszko, Milena; Chrusciel, Marcin; Rahman, Nafis A.; Huhtaniemi, Ilpo T.] Univ Turku, Inst Biomed, Turku, Finland; [Rahman, Nafis A.] Med Univ Bialystok, Dept Reprod & Gynecol Endocrinol, Bialystok, Poland; [Serrano de Almeida, Gilberto; Bevan, Charlotte L.] Imperial Coll London, Imperial Ctr Translat & Expt Med, London, England; [Koechling, Wolfgang] Ferring Pharmaceut AS, Nonclin Dev, Copenhagen, Denmark	Imperial College London; St Georges University London; Imperial College London; University of Turku; Medical University of Bialystok; Imperial College London; Ferring Pharmaceuticals	Huhtaniemi, IT (corresponding author), Imperial Coll London, Dept Digest Metab & Reprod, Inst Reprod & Dev Biol, London, England.	ilpo.huhtaniemi@imperial.ac.uk	Bevan, Charlotte L/K-2276-2012	Bevan, Charlotte L/0000-0002-7533-0552; Oduwole, Olayiwola/0000-0003-3840-7335	Ferring Pharmaceuticals A/S (Copenhagen, Denmark)	Ferring Pharmaceuticals A/S (Copenhagen, Denmark)	Investigator Initiated Funding from Ferring Pharmaceuticals A/S (Copenhagen, Denmark)	Ben-Josef E, 1999, J UROLOGY, V161, P970, DOI 10.1016/S0022-5347(01)61831-7; Crawford ED, 2018, SCAND J UROL, V52, P349, DOI 10.1080/21681805.2018.1522372; Crawford ED, 2014, UROLOGY, V83, P1122, DOI 10.1016/j.urology.2014.01.013; Cucchiara V, 2019, MOL CANCER THER, V18, P1811, DOI 10.1158/1535-7163.MCT-18-1337; Dirnhofer S, 1998, PROSTATE, V35, P212; Dizeyi N, 2019, UROL ONCOL-SEMIN ORI, V37, DOI 10.1016/j.urolonc.2018.12.011; GARDE SV, 1993, CANCER LETT, V75, P1, DOI 10.1016/0304-3835(93)90200-S; GARDE SV, 1991, PROSTATE, V18, P271, DOI 10.1002/pros.2990180402; HAAVISTO AM, 1993, ENDOCRINOLOGY, V132, P1687, DOI 10.1210/en.132.4.1687; Heidenreich A, 2014, EUR UROL, V65, P467, DOI 10.1016/j.eururo.2013.11.002; Hoare D, 2015, CUAJ-CAN UROL ASSOC, V9, P122, DOI 10.5489/cuaj.2545; HUHTANIEMI I, 1987, J ANDROL, V8, P355; Hupe MC, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00543; HURKADLI KS, 1990, BRIT J CANCER, V61, P225, DOI 10.1038/bjc.1990.42; KEER HN, 1991, PROSTATE, V18, P201, DOI 10.1002/pros.2990180303; Kim K, 2018, CLIN CANCER RES, V24, P2408, DOI 10.1158/1078-0432.CCR-17-3474; Klotz L, 2008, BJU INT, V102, P1531, DOI 10.1111/j.1464-410X.2008.08183.x; Limonta P, 2012, ENDOCR REV, V33, P784, DOI 10.1210/er.2012-1014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mariani S, 2006, J UROLOGY, V175, P2072, DOI 10.1016/S0022-5347(06)00273-4; Oduwole OO, 2018, J CLIN INVEST, V128, P1787, DOI 10.1172/JCI96794; Owen LJ, 2012, ANN CLIN BIOCHEM, V49, P600, DOI 10.1258/acb.2012.012037; Poliandri AHB, 2011, J BIOL RHYTHM, V26, P187, DOI 10.1177/0748730411401579; Porter AT, 2001, UROL ONCOL, V6, P131, DOI 10.1016/S1078-1439(00)00124-1; Radu A, 2010, NEW ENGL J MED, V363, P1621, DOI 10.1056/NEJMoa1001283; Salciccia S, 2016, UROLOGIA J, V83, P173, DOI 10.5301/uro.5000194; Scailteux LM, 2017, EUR J CANCER, V77, P99, DOI 10.1016/j.ejca.2017.03.002; SHAH MG, 1991, PROSTATE, V18, P1, DOI 10.1002/pros.2990180102; Tao YX, 1997, BIOL REPROD, V56, P67, DOI 10.1095/biolreprod56.1.67; van Casteren JIJ, 2000, BIOL REPROD, V62, P886, DOI 10.1095/biolreprod62.4.886; Vaz CV, 2012, INT J BIOCHEM CELL B, V44, P2077, DOI 10.1016/j.biocel.2012.08.013; Vis AN, 2015, UROL ONCOL-SEMIN ORI, V33, P7, DOI 10.1016/j.urolonc.2014.04.016; Walker WH, 2005, REPRODUCTION, V130, P15, DOI 10.1530/rep.1.00358; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Weiss J, 1999, LAB ANIM, V33, P192, DOI 10.1258/002367799780578417; Xiong SG, 2015, PROSTATE, V75, P141, DOI 10.1002/pros.22899	36	6	6	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21464	10.1096/fj.202002168RR	http://dx.doi.org/10.1096/fj.202002168RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33724574				2022-12-26	WOS:000635216100089
J	Wang, LZ; Yu, C; Pei, WJ; Geng, MY; Zhang, Y; Li, ZH; Liang, FT; Tan, FB; Du, H; Gao, JL				Wang, Lizhuo; Yu, Cui; Pei, Wenjun; Geng, Mengya; Zhang, Yao; Li, Zihui; Liang, Feiteng; Tan, Fengbiao; Du, Hui; Gao, Jialin			The lysosomal membrane protein Sidt2 is a vital regulator of mitochondrial quality control in skeletal muscle	FASEB JOURNAL			English	Article						autophagy; mitochondria; myopathy; quality control; Sidt2	AUTOPHAGY; METABOLISM; FUSION; HEALTH; MITOPHAGY; FISSION	The role of Sidt2 in the process of glucose and lipid metabolism has been recently reported. However, whether Sidt2 is involved in the metabolic regulation in skeletal muscle remains unknown. In this study, for the first time, using skeletal muscle-selective Sidt2 knockout mice, we found that Sidt2 was vital for the quality control of mitochondria in mouse skeletal muscle. These mice showed significantly reduced muscle tolerance and structurally abnormal mitochondria. Deletion of the Sidt2 gene resulted in decreased expression of mitochondrial fusion protein 2 (Mfn2) and Dynamin-related protein 1 (Drp1), as well as peroxisome proliferator-activated receptor gamma coactivator-1 (PGC1-alpha). In addition, the clearance of damaged mitochondria in skeletal muscle was inhibited upon Sidt2 deletion, which was caused by blockade of autophagy flow. Mechanistically, the fusion of autophagosomes and lysosomes was compromised in Sidt2 knockout skeletal muscle cells. In summary, the deletion of the Sidt2 gene not only interfered with the quality control of mitochondria, but also inhibited the clearance of mitochondria and caused the accumulation of a large number of damaged mitochondria, ultimately leading to the abnormal structure and function of skeletal muscle.	[Wang, Lizhuo; Geng, Mengya; Du, Hui; Gao, Jialin] Wannan Med Coll, Affiliated Hosp 1, Inst Endocrine & Metab Dis, Wannan Med Coll,Yijishan Hosp, Wuhu, Peoples R China; [Wang, Lizhuo; Yu, Cui; Geng, Mengya; Du, Hui; Gao, Jialin] Wannan Med Coll, Affiliated Hosp 1, Dept Endocrinol & Genet Metab, Wannan Med Coll,Yijishan Hosp, Wuhu 241002, Peoples R China; [Wang, Lizhuo; Zhang, Yao] Wannan Med Coll, Dept Biochem & Mol Biol, Wuhu, Peoples R China; [Pei, Wenjun; Zhang, Yao; Tan, Fengbiao; Gao, Jialin] Wannan Med Coll, Anhui Prov Key Lab Biol Macromol Res, Wannan Med Coll, Wuhu, Peoples R China; [Li, Zihui; Liang, Feiteng] Wannan Med Coll, Sch Clin Med, Wuhu, Peoples R China	Wannan Medical College; Wannan Medical College; Wannan Medical College; Wannan Medical College; Wannan Medical College	Gao, JL (corresponding author), Wannan Med Coll, Affiliated Hosp 1, Dept Endocrinol & Genet Metab, Wannan Med Coll,Yijishan Hosp, Wuhu 241002, Peoples R China.	jialing.gao@yahoo.com	GAO, JIALIN/GWN-1905-2022	Pei, Wenjun/0000-0002-3106-3309	National Natural Science Foundation of China (NSFC) [81471002, 81800766]; Funding of "Climbing Peak" Training Program for Innovative Technology team of Yijishan Hospital [PF2019013]; Funding of "Peak" Training Program for Scientific Research of Yijishan Hospital [GF2019J07]; Key Program Research Fund of Wannan Medical College [WK2020Z02]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Funding of "Climbing Peak" Training Program for Innovative Technology team of Yijishan Hospital; Funding of "Peak" Training Program for Scientific Research of Yijishan Hospital; Key Program Research Fund of Wannan Medical College	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81471002 and 81800766; Funding of "Climbing Peak" Training Program for Innovative Technology team of Yijishan Hospital, Grant/Award Number: PF2019013; Funding of "Peak" Training Program for Scientific Research of Yijishan Hospital, Grant/Award Number: GF2019J07; The Key Program Research Fund of Wannan Medical College, Grant/Award Number: WK2020Z02	Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4; Argiles JM, 2016, J AM MED DIR ASSOC, V17, P789, DOI 10.1016/j.jamda.2016.04.019; Bajaj L, 2019, J NEUROCHEM, V148, P573, DOI 10.1111/jnc.14564; Boengler K, 2017, J CACHEXIA SARCOPENI, V8, P349, DOI 10.1002/jcsm.12178; Bravo-San Pedro JM, 2017, CIRC RES, V120, P1812, DOI 10.1161/CIRCRESAHA.117.311082; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Cheng ZY, 2019, TRENDS ENDOCRIN MET, V30, P658, DOI 10.1016/j.tem.2019.07.009; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Dombi E, 2018, CURR MED CHEM, V25, P5597, DOI 10.2174/0929867324666170616101741; Frontera WR, 2015, CALCIFIED TISSUE INT, V96, P183, DOI 10.1007/s00223-014-9915-y; Gao JL, 2015, INT J CLIN EXP PATHO, V8, P15622; Gao JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066139; Gao JL, 2010, BIOCHEM BIOPH RES CO, V402, P588, DOI 10.1016/j.bbrc.2010.09.133; Goodpaster BH, 2017, CELL METAB, V25, P1027, DOI 10.1016/j.cmet.2017.04.015; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Kim KH, 2014, NAT REV ENDOCRINOL, V10, P322, DOI 10.1038/nrendo.2014.35; Kim Y, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3165396; Kliosnky D, 2016, AUTOPHAGY, V12, P443, DOI 10.1080/15548627.2016.1147886; Kuma A, 2017, AUTOPHAGY, V13, P1619, DOI 10.1080/15548627.2017.1343770; Li JX, 2002, NATURE, V418, P793, DOI 10.1038/nature00936; Liang QR, 2016, J MOL CELL CARDIOL, V95, P57, DOI 10.1016/j.yjmcc.2015.12.025; Lindqvist LM, 2018, CURR OPIN GENET DEV, V48, P104, DOI 10.1016/j.gde.2017.11.003; Liu H, 2018, METABOLISM, V85, P259, DOI 10.1016/j.metabol.2018.05.004; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Man SM, 2016, AUTOPHAGY, V12, P2504, DOI 10.1080/15548627.2016.1239679; Pagliuso A, 2018, CELL MOL LIFE SCI, V75, P355, DOI 10.1007/s00018-017-2603-0; Palikaras K, 2015, AUTOPHAGY, V11, P1428, DOI 10.1080/15548627.2015.1061172; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Raben N, 2016, ANNU REV CELL DEV BI, V32, P255, DOI 10.1146/annurev-cellbio-111315-125407; Sandoval H, 2018, MITOCHONDRION, V41, P58, DOI 10.1016/j.mito.2017.11.005; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Siddiqui A, 2015, J NEUROSCI, V35, P12833, DOI 10.1523/JNEUROSCI.0109-15.2015; Simsek-Duran F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064955; Sin J, 2016, AUTOPHAGY, V12, P369, DOI 10.1080/15548627.2015.1115172; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; van der Bliek AM, 2017, GENETICS, V207, P843, DOI 10.1534/genetics.117.300262; Yamashita S, 2017, AUTOPHAGY, V13, P980, DOI 10.1080/15548627.2017.1291113; Zhao T, 2012, J BIOL CHEM, V287, P23615, DOI 10.1074/jbc.M112.379164	39	2	2	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21223	10.1096/fj.202000424R	http://dx.doi.org/10.1096/fj.202000424R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715196				2022-12-26	WOS:000635216100088
J	Mahmoodi, R; Dadpour, MR; Hassani, D; Zeinalabedini, M; Vendramin, E; Leslie, CA				Mahmoodi, Razieh; Dadpour, Mohammad Reza; Hassani, Darab; Zeinalabedini, Mehrshad; Vendramin, Elisa; Leslie, Charles A.			Composite core set construction and diversity analysis of Iranian walnut germplasm using molecular markers and phenotypic traits	PLOS ONE			English	Article							POPULATION-STRUCTURE ANALYSIS; GENETIC DIVERSITY; TECTONA-GRANDIS; LINKAGE DISEQUILIBRIUM; COLLECTIONS; AFLP; GENOTYPES; RESOURCES; IDENTIFICATION; POLYMORPHISM	Iran is a center of origin and diversity for walnuts (Juglans regia L.) with very good potential for breeding purposes. The rich germplasm available, creates an opportunity for study and selection of the diverse walnut genotypes. In this study, the population structure of 104 Persian walnut accessions was assessed using AFLP markers in combination with phenotypic variability of 17 and 18 qualitative and quantitative traits respetively. The primers E-TG/M-CAG, with high values of number of polymorphic bands, polymorphic information content, marker index and Shannon's diversity index, were the most effective in detecting genetic variation within the walnut germplasm. Multivariate analysis of variance indicated 93.98% of the genetic variability was between individuals, while 6.32% of variation was among populations. A relatively new technique, an advanced maximization strategy with a heuristic approach, was deployed to develop the core collection. Initially, three independent core collections (CC1-CC3) were created using phenotypic data and molecular markers. The three core collections (CC1-CC3) were then merged to generate a composite core collection (CC4). The mean difference percentage, variance difference percentage, variable rate of coefficient of variance percentage, coincidence rate of range percentage, Shannon's diversity index, and Nei's gene diversity were employed for comparative analysis. The CC4 with 46 accessions represented the complete range of phenotypic and genetic variability. This study is the first report describing development of a core collection in walnut using molecular marker data in combination with phenotypic values. The construction of core collection could facilitate the work for identification of genetic determinants of trait variability and aid effective utilization of diversity caused by outcrossing, in walnut breeding programs.	[Mahmoodi, Razieh; Dadpour, Mohammad Reza] Univ Tabriz, Fac Agr, Dept Hort Sci, Tabriz, Iran; [Mahmoodi, Razieh; Hassani, Darab] Agr Res Educ & Extens Org AREEO, Hort Sci Res Inst, Temperate Fruits Res Ctr, Karaj, Iran; [Zeinalabedini, Mehrshad] Educ & Extens Org AREEO, Syst Biol Dept, Agr Biotechnol Res Inst Iran, Karaj, Iran; [Vendramin, Elisa] Consiglio Ric Agr & Anal Econ Agr, Ctr Ric Olivicoltura Frutticoltura & Agrumicoltur, Rome, Italy; [Leslie, Charles A.] Univ Calif Davis, Dept Plant Sci, Davis, CA USA	University of Tabriz; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of California System; University of California Davis	Dadpour, MR (corresponding author), Univ Tabriz, Fac Agr, Dept Hort Sci, Tabriz, Iran.; Hassani, D (corresponding author), Agr Res Educ & Extens Org AREEO, Hort Sci Res Inst, Temperate Fruits Res Ctr, Karaj, Iran.	dadpour.mr@gmail.com; d.hassani@areeo.ac.ir	Zeinlabedini, Mehrshad/AAP-8051-2021; Vendramin, Elisa/AAI-8762-2020; Hassani, Darab/B-3049-2010	Zeinlabedini, Mehrshad/0000-0002-3436-4334; Hassani, Darab/0000-0002-3569-8889				Belaj A, 2012, TREE GENET GENOMES, V8, P365, DOI 10.1007/s11295-011-0447-6; Belamkar V, 2011, GENETICA, V139, P411, DOI 10.1007/s10709-011-9556-2; BROWN AHD, 1989, GENOME, V31, P818, DOI 10.1139/g89-144; Christopoulos MV, 2010, SCI HORTIC-AMSTERDAM, V125, P584, DOI 10.1016/j.scienta.2010.05.006; Dadras AR, 2014, MOL BIOL REP, V41, P3317, DOI 10.1007/s11033-014-3194-6; Dangl GS, 2005, J AM SOC HORTIC SCI, V130, P348, DOI 10.21273/JASHS.130.3.348; Dhanaraj AL, 2002, J HORTIC SCI BIOTECH, V77, P41, DOI 10.1080/14620316.2002.11511454; Ebrahimi A, 2017, PEERJ, V5, DOI 10.7717/peerj.3834; El Bakkali A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061265; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FARRIS JS, 1989, SYST ZOOL, V38, P406, DOI 10.2307/2992406; Fatahi R, 2010, HORTIC ENVIRON BIOTE, V51, P51; Foroni I, 2007, GENET RESOUR CROP EV, V54, P1081, DOI 10.1007/s10722-006-9187-0; Garcia-Lor A, 2017, ANN APPL BIOL, V171, P327, DOI 10.1111/aab.12376; Gharaghani A, 2017, GENET RESOUR CROP EV, V64, P611, DOI 10.1007/s10722-016-0485-x; Hassan D., 2013, SEED PLANT IMPROVEME, V29; Hassani D., 2004, 5 INT WALN S, V705; Hu J, 2000, THEOR APPL GENET, V101, P264, DOI 10.1007/s001220051478; Kafkas S, 2005, J AM SOC HORTIC SCI, V130, P585, DOI 10.21273/JASHS.130.4.585; Kim KW, 2007, BIOINFORMATICS, V23, P2155, DOI 10.1093/bioinformatics/btm313; Kumar S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01554; Lee HY, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0452-8; LI Y-x., 2006, J FRUIT SCI, V3, P359; Mahmoodi R, 2019, SCI HORTIC-AMSTERDAM, V249, P439, DOI 10.1016/j.scienta.2019.02.017; McGranahan Gale, 2009, P249, DOI 10.1007/978-0-387-71203-1_8; McKhann HI, 2004, PLANT J, V38, P193, DOI 10.1111/j.1365-313X.2004.02034.x; Mohammadi SA, 2011, PLANT GENET RESOUR-C, V9, P445, DOI 10.1017/S1479262111000645; Nicese FP, 1998, EUPHYTICA, V101, P199, DOI 10.1023/A:1018390120142; Odong TL, 2013, THEOR APPL GENET, V126, P289, DOI 10.1007/s00122-012-1971-y; Pop JF, 2013, SCI HORTIC-AMSTERDAM, V153, P124, DOI 10.1016/j.scienta.2013.02.013; Shamlu F, 2018, PHYSIOL MOL BIOL PLA, V24, P939, DOI 10.1007/s12298-018-0573-9; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shrestha MK, 2005, CAN J FOREST RES, V35, P1017, DOI [10.1139/x05-033, 10.1139/X05-033]; Sreekanth PM, 2012, CONSERV GENET, V13, P1409, DOI 10.1007/s10592-012-0383-5; Thies JA, 2002, HORTSCIENCE, V37, P805, DOI 10.21273/HORTSCI.37.5.805; Vaishnaw V, 2015, CAN J FOREST RES, V45, P297, DOI 10.1139/cjfr-2014-0279; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang YZ, 2011, SCI HORTIC-AMSTERDAM, V128, P311, DOI 10.1016/j.scienta.2011.01.025; Woeste K., 2009, 6 INT WALN S, V861; Xiao YJ, 2012, THEOR APPL GENET, V125, P437, DOI 10.1007/s00122-012-1843-5; Xu Zheng, 2012, Journal of Agricultural Science (Toronto), V4, P271; Yeh FC., 1999, POPGENE 132 USER FRI; Yun WH, 2015, GENET MOL RES, V14, P6453, DOI 10.4238/2015.June.11.21; Zhang ChunYu, 2009, Scientia Agricultura Sinica, V42, P597; Zhang HY, 2006, BOT STUD, V47, P223; Zhang YX, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-102; Zhu TT, 2019, HORTIC RES-ENGLAND, V6, DOI 10.1038/s41438-019-0139-1	48	7	8	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0248623	10.1371/journal.pone.0248623	http://dx.doi.org/10.1371/journal.pone.0248623			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY1VJ	33725012	gold, Green Published			2022-12-26	WOS:000629833700030
J	Adebowale, OO; Adenubi, OT; Adesokan, HK; Oloye, AA; Bankole, NO; Fadipe, OE; Ayo-Ajayi, PO; Akinloye, AK				Adebowale, Oluwawemimo Oluseun; Adenubi, Olubukola Tolulope; Adesokan, Hezekiah Kehinde; Oloye, Abimbola Adetokunbo; Bankole, Noah Olumide; Fadipe, Oladotun Ebenezer; Ayo-Ajayi, Patience Oluwatoyin; Akinloye, Adebayo Koyuum			SARS-CoV-2 (COVID-19 pandemic) in Nigeria: Multi-institutional survey of knowledge, practices and perception amongst undergraduate veterinary medical students	PLOS ONE			English	Article							ATTITUDE	The novel Coronavirus SARS-CoV-2 (COVID-19) is a global pandemic with an increasing public health concern. Due to the non-availability of a vaccine against the disease, non-pharmaceutical interventions constitute major preventive and control measures. However, inadequate knowledge about the disease and poor perception might limit compliance. This study examined COVID-19-related knowledge, practices, perceptions and associated factors amongst undergraduate veterinary medical students in Nigeria. A cross-sectional web survey was employed to collect data from 437 consenting respondents using pre-tested self-administered questionnaire (August 2020). Demographic factors associated with the knowledge and adoption of recommended preventive practices towards COVID-19 were explored using multivariate logistic regression at P <= 0.05. The respondents' mean knowledge and practice scores were 22.7 (SD +/- 3.0) and 24.1 (SD +/- 2.9), respectively with overall 63.4% and 88.8% displaying good knowledge and satisfactory practice levels. However, relatively lower proportions showed adherence to avoid touching face or nose (19.5%), face mask-wearing (58.1%), and social distancing (57.4%). Being in the 6(th) year of study (OR = 3.18, 95%CI: 1.62-6.26, P = 0.001) and female (OR = 2.22, 95% CI = 1.11-4.41, P = 0.024) were significant positive predictors of good knowledge and satisfactory practices, respectively. While only 30% of the respondents perceived the pandemic as a scam or a disease of the elites (24.0%), the respondents were worried about their academics being affected negatively (55.6%). Veterinary Medical Students in Nigeria had good knowledge and satisfactory preventive practices towards COVID-19; albeit with essential gaps in the key non-pharmaceutical preventive measures recommended by the WHO. Therefore, there is a need to step up enlightenment and targeted campaigns about COVID-19 pandemic.	[Adebowale, Oluwawemimo Oluseun] Fed Univ Agr, Coll Vet Med, Dept Vet Publ Hlth & Prevent Med, Abeokuta, Ogun State, Nigeria; [Adenubi, Olubukola Tolulope] Fed Univ Agr, Coll Vet Med, Dept Vet Pharmacol & Toxicol, Abeokuta, Ogun State, Nigeria; [Adesokan, Hezekiah Kehinde] Univ Ibadan, Dept Vet Publ Hlth & Prevent Med, Ibadan, Oyo State, Nigeria; [Oloye, Abimbola Adetokunbo] Fed Univ Agr, Coll Vet Med, Dept Vet Surg & Theriogenol, Abeokuta, Ogun State, Nigeria; [Bankole, Noah Olumide] Fed Univ Agr, Coll Vet Med, Dept Vet Microbiol, Abeokuta, Ogun State, Nigeria; [Fadipe, Oladotun Ebenezer] Vet Council Nigeria, Abuja, Nigeria; [Ayo-Ajayi, Patience Oluwatoyin] Nigerian Field Epidemiol & Lab Training Program, Lagos, Nigeria; [Akinloye, Adebayo Koyuum] Fed Univ Agr, Coll Vet Med, Dept Vet Anat, Abeokuta, Ogun State, Nigeria	University of Agriculture, Abeokuta; University of Agriculture, Abeokuta; University of Ibadan; University of Agriculture, Abeokuta; University of Agriculture, Abeokuta; University of Agriculture, Abeokuta	Adebowale, OO (corresponding author), Fed Univ Agr, Coll Vet Med, Dept Vet Publ Hlth & Prevent Med, Abeokuta, Ogun State, Nigeria.	adebowaleoluwawemimo1@gmail.com	Adenubi, Olubukola/AFU-6288-2022	Adebowale, Oluwawemimo/0000-0002-4207-7423				Adebowale Oluwawemimo O, 2020, Vet Med Int, V2020, P2780378, DOI 10.1155/2020/2780378; Adenubi O., 2020, LEVEL KNOWLEDGE ATTI, DOI [10.20944/preprints202007.0337.v1, DOI 10.20944/PREPRINTS202007.0337.V1]; Afzal MS, 2021, J COMMUN HEALTH, V46, P476, DOI 10.1007/s10900-020-00875-z; Allen C, 2016, VET REC, V178, P391, DOI 10.1136/vr.i2140; Alvin MD, 2020, RADIOLOGY, V296, P246, DOI 10.1148/radiol.2020201222; Alzoubi H, 2020, J PURE APPL MICROBIO, V14, P17, DOI 10.22207/JPAM.14.1.04; [Anonymous], 2020, WORLD HLTH ORG WHO D; Bankole NO, 2021, J PREV MED HYG, V62, pE575, DOI [10.20944/preprints202006.0185.v1, DOI 10.20944/PREPRINTS202006.0185.V1]; Begeny C., 2019, BSAVA COMPANION, V1, P26; Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934; Clements John M, 2020, JMIR Public Health Surveill, V6, pe19161, DOI 10.2196/19161; Duong V., 2020, REPRINT 2020 ARXIVOR; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Eze SC, 2018, INT J EDUC TECHNOL H, V15, DOI 10.1186/s41239-018-0116-z; Galea S, 2020, JAMA INTERN MED, V180, P817, DOI 10.1001/jamainternmed.2020.1562; Gerry S, ADDRESSING VET SHORT; Hager E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236918; Henry C., 2015, E ORG PEOPLE, V22, P34, DOI [10.1016/j.ajp.2020.102083, DOI 10.1016/J.AJP.2020.102083]; Huang L., 2020, J BIOL SCI, V16, P1745, DOI [10.7150/ijbs.45221, DOI 10.7150/IJBS.45221]; Iyer P, 2020, J DENT EDUC, V84, P718, DOI 10.1002/jdd.12163; Kaliyaperumal K., 2004, AECS ILLUMINATION, V1, P7; Kebede Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233744; Khasawneh AI, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00253; Lofstedt J, 2003, CAN VET J, V44, P533; Mahdy AA, 2020, IEEE SYST J, DOI 10.20944/preprints202006.0130.v1; Nigeria Centre for Disease Control (NCDC), 2020, 1 CASE CORONAVIRUS D; Odetokun IA, 2019, ANTIBIOTICS-BASEL, V8, DOI 10.3390/antibiotics8040243; Olaimat AN, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00254; Olapegba P.O., 2020, SSRN ELECT J, DOI [10.2139/SSRN.3584408, DOI 10.2139/SSRN.3584408]; Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181; Peng YL, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09392-z; Pragholapati A, 2020, **DATA OBJECT**, DOI [10.17605/OSF.IO/NUYJ9, DOI 10.17605/OSF.IO/NUYJ9]; Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1; Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083; Salman M, 2020, DRUGS THER PERSPECT, V36, P319, DOI 10.1007/s40267-020-00737-7; Usher K, 2020, INT J MENT HEALTH NU, V29, P315, DOI 10.1111/inm.12726; Werner EA, 2020, SEMIN PERINATOL, V44, DOI 10.1016/j.semperi.2020.151279; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	39	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0248189	10.1371/journal.pone.0248189	http://dx.doi.org/10.1371/journal.pone.0248189			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720966	gold, Green Published			2022-12-26	WOS:000629667400043
J	Bencomo-Alvarez, AE; Rubio, AJ; Olivas, IM; Gonzalez, MA; Ellwood, R; Fiol, CR; Eide, CA; Lara, JJ; Barreto-Vargas, C; Jave-Suarez, LF; Nteliopoulos, G; Reid, AG; Milojkovic, D; Druker, BJ; Apperley, J; Khorashad, JS; Eiring, AM				Bencomo-Alvarez, Alfonso E.; Rubio, Andres J.; Olivas, Idaly M.; Gonzalez, Mayra A.; Ellwood, Rebecca; Fiol, Carme Ripoll; Eide, Christopher A.; Lara, Joshua J.; Barreto-Vargas, Christian; Jave-Suarez, Luis F.; Nteliopoulos, Georgios; Reid, Alistair G.; Milojkovic, Dragana; Druker, Brian J.; Apperley, Jane; Khorashad, Jamshid S.; Eiring, Anna M.			Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B	ONCOGENE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; STEM-CELLS; CML STEM; IMATINIB; THERAPY; INHIBITION; GENE; RESISTANT; STAT3; TRANSCRIPTION	Tyrosine kinase inhibitors (TKIs) targeting BCR-ABL1 have revolutionized therapy for chronic myeloid leukemia (CML), paving the way for clinical development in other diseases. Despite success, targeting leukemic stem cells and overcoming drug resistance remain challenges for curative cancer therapy. To identify drivers of kinase-independent TKI resistance in CML, we performed genome-wide expression analyses on TKI-resistant versus sensitive CML cell lines, revealing a nuclear factor-kappa B (NF-kappa B) expression signature. Nucleocytoplasmic fractionation and luciferase reporter assays confirmed increased NF-kappa B activity in the nucleus of TKI-resistant versus sensitive CML cell lines and CD34(+) patient samples. Two genes that were upregulated in TKI-resistant CML cells were proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), both members of the 19S regulatory complex in the 26S proteasome. PSMD1 and PSMD3 were also identified as survival-critical genes in a published small hairpin RNA library screen of TKI resistance. We observed markedly higher levels of PSMD1 and PSMD3 mRNA in CML patients who had progressed to the blast phase compared with the chronic phase of the disease. Knockdown of PSMD1 or PSMD3 protein correlated with reduced survival and increased apoptosis in CML cells, but not in normal cord blood CD34(+) progenitors. Luciferase reporter assays and immunoblot analyses demonstrated that PSMD1 and PSMD3 promote NF-kappa B protein expression in CML, and that signal transducer and activator of transcription 3 (STAT3) further activates NF-kappa B in scenarios of TKI resistance. Our data identify NF-kappa B as a transcriptional driver in TKI resistance, and implicate PSMD1 and PSMD3 as plausible therapeutic targets worthy of future investigation in CML and possibly other malignancies.	[Bencomo-Alvarez, Alfonso E.; Rubio, Andres J.; Gonzalez, Mayra A.; Lara, Joshua J.; Eiring, Anna M.] Texas Tech Univ, Hlth Sci Ctr El Paso, Ctr Emphasis Canc, Dept Mol & Translat Med,Paul L Foster Sch Med, El Paso, TX 79905 USA; [Olivas, Idaly M.; Eiring, Anna M.] Texas Tech Univ, Grad Sch Biomed Sci, Hlth Sci Ctr El Paso, El Paso, TX USA; [Ellwood, Rebecca; Fiol, Carme Ripoll; Nteliopoulos, Georgios; Milojkovic, Dragana; Apperley, Jane; Khorashad, Jamshid S.] Imperial Coll London, Ctr Haematol, Dept Med, London, England; [Eide, Christopher A.; Druker, Brian J.] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol Med Oncol, Portland, OR 97201 USA; [Barreto-Vargas, Christian] Univ Guadalajara, Guadalajara, Jalisco, Mexico; [Jave-Suarez, Luis F.] Ctr Invest Biomed Occidente, Inst Mexicano Seguro Social, Guadalajara, Jalisco, Mexico; [Nteliopoulos, Georgios] Imperial Coll London, Dept Surg & Canc, London, England; [Reid, Alistair G.] Royal Liverpool Univ Hosp, Mol Pathol Unit, Liverpool Clin Labs, Liverpool, Merseyside, England	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Imperial College London; Oregon Health & Science University; Universidad de Guadalajara; Instituto Mexicano del Seguro Social; Imperial College London; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	Eiring, AM (corresponding author), Texas Tech Univ, Hlth Sci Ctr El Paso, Ctr Emphasis Canc, Dept Mol & Translat Med,Paul L Foster Sch Med, El Paso, TX 79905 USA.	anna.eiring@ttuhsc.edu	Jave-Suarez, Luis Felipe/T-7036-2018; Eiring, Anna M./ABA-8673-2020	Jave-Suarez, Luis Felipe/0000-0001-6209-5031; Eiring, Anna M./0000-0001-6533-9150; Bencomo-Alvarez, Alfonso Enrique/0000-0002-1771-8532; Apperley, Jane/0000-0002-1710-1794; Ellwood, Rebecca/0000-0002-0412-7530	Imperial BRC Genomics Facility, Imperial College London; National Institute for Health Research (NIHR); National Cancer Institute of the National Institutes of Health [K22CA216008-04, R01CA065823-21]; Consejo Nacional de Ciencia y Tecnologia (CONACyT)	Imperial BRC Genomics Facility, Imperial College London; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors would like to thank the Imperial BRC Genomics Facility, Imperial College London for providing resources and support that have contributed to the results reported within this paper. The Imperial BRC Genomics Facility is supported by the National Institute for Health Research (NIHR) to the Imperial Biomedical Research Centre. Research reported in this publication was supported in part by the National Cancer Institute of the National Institutes of Health under award numbers K22CA216008-04 (AME) and R01CA065823-21 (BJD). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. CBV is grateful for scholarship obtained through support from Consejo Nacional de Ciencia y Tecnologia (CONACyT). We also wish to thank Michael Deininger, MD, PhD, from the University of Utah Huntsman Cancer Institute, for providing the cell lines used in this study. We thank Jessica M. Hernando, MT, ASCP (CM) and her team at the University Medical Center of El Paso (El Paso, TX, USA) for graciously donating the discarded cord blood used in this study. The authors are thankful to Shrikanth Gadad, PhD and Rajkumar Lakshmanaswamy, PhD for critical review of the paper.	Aichberger KJ, 2011, AM J HEMATOL, V86, P533, DOI 10.1002/ajh.22037; Baba T, 2013, J EXP MED, V210, P2661, DOI 10.1084/jem.20130112; Bencomo-Alvarez AE, 2019, BRIT J HAEMATOL, V186, P524, DOI 10.1111/bjh.16074; Bocchia M, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00194; Braun T, 2006, CELL DEATH DIFFER, V13, P748, DOI 10.1038/sj.cdd.4401874; Breccia M, 2010, EXPERT OPIN THER TAR, V14, P1157, DOI 10.1517/14728222.2010.522570; Caocci G, 2019, HEMATOL ONCOL, V37, P296, DOI 10.1002/hon.2606; Carra G, 2016, ONCOTARGET, V7, P66287, DOI 10.18632/oncotarget.11507; Chen JQ, 2013, CURR OPIN IMMUNOL, V25, P4, DOI 10.1016/j.coi.2012.12.005; Chen YM, 2013, LEUKEMIA LYMPHOMA, V54, P1411, DOI 10.3109/10428194.2012.745525; Chiu CF, 2016, P NATL ACAD SCI USA, V113, pE2526, DOI 10.1073/pnas.1522612113; Chomel JC, 2011, BLOOD, V118, P3657, DOI 10.1182/blood-2011-02-335497; Chorzalska A, 2018, MOL ONCOL, V12, P630, DOI 10.1002/1878-0261.12186; Chu S, 2011, BLOOD, V118, P5565, DOI 10.1182/blood-2010-12-327437; Cilloni D, 2006, LEUKEMIA, V20, P61, DOI 10.1038/sj.leu.2403998; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Dai YJ, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.143; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eiring A M, 2014, Leuk Suppl, V3, pS5, DOI 10.1038/leusup.2014.3; Eiring AM, 2015, LEUKEMIA, V29, P2328, DOI 10.1038/leu.2015.196; Eiring AM, 2015, LEUKEMIA, V29, P586, DOI 10.1038/leu.2014.245; Fararjeh AS, 2019, CANCERS, V11, DOI 10.3390/cancers11040527; Fisher DAC, 2017, LEUKEMIA, V31, P1962, DOI 10.1038/leu.2016.377; Fukuoka M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201796; Gallipoli P, 2013, BLOOD, V122, P3335, DOI 10.1182/blood-2013-02-485607; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Giustacchini A, 2017, NAT MED, V23, P692, DOI 10.1038/nm.4336; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Hamilton A, 2012, BLOOD, V119, P1501, DOI 10.1182/blood-2010-12-326843; Han SH, 2017, LEUKEMIA, V31, P1659, DOI 10.1038/leu.2017.107; Han SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-97; Heaney NB, 2010, BLOOD, V115, P2241, DOI 10.1182/blood-2008-06-164582; Im E, 2016, BMB REP, V49, P459, DOI 10.5483/BMBRep.2016.49.9.094; Jain P, 2019, BLOOD ADV, V3, P851, DOI 10.1182/bloodadvances.2018025874; Janssen L, 2019, LEUKEMIA, V33, P2116, DOI 10.1038/s41375-019-0443-7; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Kagoya Y, 2014, J CLIN INVEST, V124, P528, DOI 10.1172/JCI68101; Khorashad JS, 2015, BLOOD, V125, P1772, DOI 10.1182/blood-2014-08-588855; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Lounnas N, 2009, INT J CANCER, V125, P308, DOI 10.1002/ijc.24294; Lu ZZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-112; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; McWeeney SK, 2010, BLOOD, V115, P315, DOI 10.1182/blood-2009-03-210732; Mendez-Ferrer S, 2020, NAT REV CANCER, V20, P285, DOI 10.1038/s41568-020-0245-2; Minson AG, 2019, BLOOD ADV, V3, P1084, DOI 10.1182/bloodadvances.2018028035; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; NOWELL PC, 1960, SCIENCE, V132, P1497; O'Hare T, 2012, NAT REV CANCER, V12, P513, DOI 10.1038/nrc3317; Oh B, 2013, ANTI-CANCER DRUG, V24, P20, DOI 10.1097/CAD.0b013e32835a0fbd; Okumura T, 2018, J BIOCHEM, V163, P19, DOI 10.1093/jb/mvx053; Orlova A, 2019, CANCERS, V11, DOI 10.3390/cancers11121930; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Reynaud D, 2011, CANCER CELL, V20, P661, DOI 10.1016/j.ccr.2011.10.012; Rousselot P, 2014, J CLIN ONCOL, V32, P424, DOI 10.1200/JCO.2012.48.5797; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Santos FPS, 2011, CL LYMPH MYELOM LEUK, V11, P355, DOI 10.1016/j.clml.2011.06.004; Shen N, 2019, ONCOTARGETS THER, V12, P2355, DOI 10.2147/OTT.S197535; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Styczynski J, 2012, WSPOLCZESNA ONKOL, V16, P210, DOI 10.5114/wo.2012.29286; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Traer E, 2012, LEUKEMIA, V26, P1140, DOI 10.1038/leu.2011.325; Tsvetkov P, 2017, P NATL ACAD SCI USA, V114, P382, DOI 10.1073/pnas.1619067114; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wei W, 2013, APOPTOSIS, V18, P1060, DOI 10.1007/s10495-013-0854-2; Welner RS, 2015, CANCER CELL, V27, P671, DOI 10.1016/j.ccell.2015.04.004; Yamada T, 2014, LEUKEMIA RES, V38, P210, DOI 10.1016/j.leukres.2013.10.006; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588; Zhang B, 2016, BLOOD, V128, P2671, DOI 10.1182/blood-2015-11-679928; Zhang B, 2012, CANCER CELL, V21, P577, DOI 10.1016/j.ccr.2012.02.018; Zhang TQ, 2019, CELL BIOL INT, V43, P98, DOI 10.1002/cbin.11026; Zhang XD, 2016, CANCER CELL, V29, P639, DOI 10.1016/j.ccell.2016.03.026	76	8	8	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 15	2021	40	15					2697	2710		10.1038/s41388-021-01732-6	http://dx.doi.org/10.1038/s41388-021-01732-6		MAR 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RN8NW	33712704	hybrid, Green Published			2022-12-26	WOS:000628201500001
J	Braga, MD; Fernandes, RD; de Souza, GN; da Rocha, JEC; Dolacio, CJF; Tavares, ID; Pinheiro, RR; Noronha, FN; Rodrigues, LLS; Ramos, RTJ; Carneiro, AR; de Brito, SR; Diniz, HAC; Botelho, MD; Vallinoto, ACR				Braga, Marcus de Barros; Fernandes, Rafael da Silva; de Souza, Gilberto Nerino, Jr.; Castro da Rocha, Jonas Elias; Fonseca Dolacio, Cicero Jorge; Tavares, Ivaldo da Silva, Jr.; Pinheiro, Raphael Rodrigues; Noronha, Fernando Napoleao; Silva Rodrigues, Luana Lorena; Juca Ramos, Rommel Thiago; Carneiro, Adriana Ribeiro; de Brito, Silvana Rossy; Carneiro Diniz, Hugo Alex; Botelho, Marcel do Nascimento; Rosario Vallinoto, Antonio Carlos			Artificial neural networks for short-term forecasting of cases, deaths, and hospital beds occupancy in the COVID-19 pandemic at the Brazilian Amazon	PLOS ONE			English	Article							PREDICTION; OUTCOMES; TREND; CHINA; MODEL	The first case of the novel coronavirus in Brazil was notified on February 26, 2020. After 21 days, the first case was reported in the second largest State of the Brazilian Amazon. The State of Para presented difficulties in combating the pandemic, ranging from underreporting and a low number of tests to a large territorial distance between cities with installed hospital capacity. Due to these factors, mathematical data-driven short-term forecasting models can be a promising initiative to assist government officials in more agile and reliable actions. This study presents an approach based on artificial neural networks for the daily and cumulative forecasts of cases and deaths caused by COVID-19, and the forecast of demand for hospital beds. Six scenarios with different periods were used to identify the quality of the generated forecasting and the period in which they start to deteriorate. Results indicated that the computational model adapted capably to the training period and was able to make consistent short-term forecasts, especially for the cumulative variables and for demand hospital beds.	[Braga, Marcus de Barros; de Souza, Gilberto Nerino, Jr.; Castro da Rocha, Jonas Elias] Univ Fed Rural Amazonia, Paragominas Campus, Paragominas, Para, Brazil; [Fernandes, Rafael da Silva; Noronha, Fernando Napoleao] Univ Fed Rural Amazonia, Parauapebas Campus, Parauapebas, Para, Brazil; [Fonseca Dolacio, Cicero Jorge] Univ Fed Parana, Forest Engn & Technol Dept, Curitiba, Parana, Brazil; [Tavares, Ivaldo da Silva, Jr.] Univ Fed Vicosa, Forestry Engn Dept, Vicosa, MG, Brazil; [Pinheiro, Raphael Rodrigues] Univ Fed Rural Amazonia, Belem Campus, Belem, Para, Brazil; [Silva Rodrigues, Luana Lorena] Univ Fed Oeste Para, Inst Collect Hlth, Postgrad Program Hlth Sci, Santarem, Para, Brazil; [Juca Ramos, Rommel Thiago; Carneiro, Adriana Ribeiro; Rosario Vallinoto, Antonio Carlos] Univ Fed Para, Inst Biol Sci, Belem, Para, Brazil; [de Brito, Silvana Rossy] Univ Fed Rural Amazonia, Cyberspace Inst, Belem, Para, Brazil; [Carneiro Diniz, Hugo Alex] Univ Fed Oeste Para, Inst Educ Sci, Santarem, Para, Brazil; [Botelho, Marcel do Nascimento] Univ Fed Rural Amazonia, Socioenvironm Inst Water Resources, Belem, Para, Brazil	Universidade Federal Rural da Amazonia (UFRA); Universidade Federal Rural da Amazonia (UFRA); Universidade Federal do Parana; Universidade Federal de Vicosa; Universidade Federal Rural da Amazonia (UFRA); Universidade Federal do Oeste do Para; Universidade Federal do Para; Universidade Federal Rural da Amazonia (UFRA); Universidade Federal do Oeste do Para; Universidade Federal Rural da Amazonia (UFRA)	Braga, MD (corresponding author), Univ Fed Rural Amazonia, Paragominas Campus, Paragominas, Para, Brazil.	marcus.braga@ufra.edu.br	Braga, Marcus de Barros/AGX-3391-2022; da Silva Fernandes, Rafael/AAM-2735-2021; Ramos, Rommel Thiago Juca/L-9329-2013; Rodrigues, Luana Lorena Silva/AAQ-2151-2020; Folador, Adriana R.C./H-6410-2016	Braga, Marcus de Barros/0000-0003-1621-4460; da Silva Fernandes, Rafael/0000-0002-3035-8025; Ramos, Rommel Thiago Juca/0000-0002-8032-1474; Rodrigues, Luana Lorena Silva/0000-0001-9480-7689; Folador, Adriana R.C./0000-0003-1522-9871; PINHEIRO, RAPHAEL/0000-0002-2457-7571; Fonseca Dolacio, Cicero Jorge/0000-0002-3208-3854; Tavares Junior, Ivaldo/0000-0001-5226-0638				Adiga A, 2020, J INDIAN I SCI, V100, P793, DOI 10.1007/s41745-020-00200-6; Akbar AN, 2020, SCIENCE, V369, P256, DOI 10.1126/science.abb0762; Altmann DM, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd6160; Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Anam S, 2019, IOP C SERIES MAT SCI; Anastassopoulou C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230405; Atlas of Human Development in Brazil, 2010, RANKING ATLAS DESENV; Brazilian Institute of Geography and Statistics, 2018, PROJ POP 2018 HAB PA; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Carlos Rosario Antonio, 2020, PLOS ONE, DOI [10.1101/2020.04.14.20064923, DOI 10.1371/JOURNAL.PONE.0238339]; Castro J., 2020, INT J DEV RES, V10, P35416; Chan JWM, 2003, THORAX, V58, P686, DOI 10.1136/thorax.58.8.686; Chowell Gerardo, 2017, Infect Dis Model, V2, P379, DOI 10.1016/j.idm.2017.08.001; Chowell G, 2016, PHYS LIFE REV, V18, P66, DOI 10.1016/j.plrev.2016.07.005; Chu CM, 2004, CAN MED ASSOC J, V171, P1349, DOI 10.1503/cmaj.1040398; Croda J, 2020, REV SOC BRAS MED TRO, V53, DOI 10.1590/0037-8682-0167-2020; Egrioglu E, 2014, PROCD SOC BEHV, V109, P1094, DOI 10.1016/j.sbspro.2013.12.593; Eshragh A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240153; Fernandes R, 2020, IEEE LAT AM T; Flauzin RA, 2010, REDES NEURAIS ARTIFI; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Health Surveillance Secretary of Brazil, 2020, B EPIDEMIOL GICO ESP; Hyndman R. J., 2018, FORECASTING PRINCIPL; Islam N., 2020, TEMPERATURE HUMIDITY, DOI 10.1101/2020.03.27.20045658; Juno JA., 2020, NAT MED, P1; Khan F, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110189; Kimberley A, 2021, LANDSCAPE ECOL, V36, P265, DOI 10.1007/s10980-020-01138-x; Li LQ, 2020, J MED VIROL, V92, P577, DOI 10.1002/jmv.25757; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Luengo-Oroz M, 2020, NAT MACH INTELL, V2, P295, DOI 10.1038/s42256-020-0184-3; Maleki M, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101742; Marynych T.O., 2017, COMP ANAL UNIVARIATE, V1228, P63; Mestre R, 2019, TIME FREQUENCY MULTI; Ministry of Health of Brazil, 2020, COVID 19 PAIN COR; Moftakhar L, 2020, IRAN J PUBLIC HEALTH, V49, P92; Oliveiros B., 2020, PUBLIC GLOBAL HLTH, DOI [10.1101/2020.03.05.20031872, DOI 10.1101/2020.03.05.20031872]; Paiva HM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236386; Pal R, 2020, NEURAL NETWORK BASED; Para Information and Communication Technology Company, 2020, EMPRESA TECNOLOGIA I; Para State Department for Public Health, 2020, MON COVID 19; Petropoulos F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231236; Philemon M. D., 2019, INT J EPIDEMIOL RES, V6, P132, DOI [DOI 10.15171/IJER.2019.24, 10.15171/ijer.2019.24]; Phua Jason, 2020, Lancet Respir Med, V8, P506, DOI 10.1016/S2213-2600(20)30161-2; Saba AI, 2020, PROCESS SAF ENVIRON, V141, P1, DOI 10.1016/j.psep.2020.05.029; Schmitt F, 2018, BIOCHEM ENG J, V133, P47, DOI 10.1016/j.bej.2018.02.001; Sleijpen GLG, 1996, COMPUTING, V56, P141, DOI 10.1007/BF02309342; Sujath R, 2020, STOCH ENV RES RISK A, V34, P959, DOI [10.1007/s00477-020-01827-8, 10.1007/s00477-020-01843-8]; Takemoto MLS, 2020, INT J GYNECOL OBSTET, V151, P154, DOI 10.1002/ijgo.13300; Tamang SK, 2020, GLOB J ENVIRON SCI M, V6, P53, DOI 10.22034/GJESM.2019.06.SI.06; Tavares ID, 2020, ECOL INDIC, V117, DOI 10.1016/j.ecolind.2020.106685; TIBCO Software Inc, 2018, TIBCO STAT TRIAL DOW; Torrealba-Rodriguez O, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.109946; Universidade Federal de Pelotas, 2020, COVID 19 NO BRASIL V; Wahyunggoro O, 2013, P 59 ISI WORLD STAT, P549; Wang LJ, 2020, ACM TRANS SPAT ALGOR, V6, DOI 10.1145/3380971; Wen HY, 2019, ACCIDENT ANAL PREV, V132, DOI 10.1016/j.aap.2019.07.025; World Health Organization, 2020, ARCH WHO TIM COVID 1; Wu JT, 2018, HONG KONG MED J; Yang ZF, 2020, J THORAC DIS, V12, P165, DOI 10.21037/jtd.2020.02.64; Zeng Q, 2016, ANAL METHODS ACCID R, V10, P12, DOI 10.1016/j.amar.2016.03.002	61	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248161	10.1371/journal.pone.0248161	http://dx.doi.org/10.1371/journal.pone.0248161			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705453	Green Published, gold			2022-12-26	WOS:000629590400025
J	Grooms, I; Robinson, G				Grooms, Ian; Robinson, Gregor			A hybrid particle-ensemble Kalman filter for problems with medium nonlinearity	PLOS ONE			English	Article							DATA ASSIMILATION; ANALYSIS SCHEME; IMPLEMENTATION; PERFORMANCE; PREDICTION	A hybrid particle ensemble Kalman filter is developed for problems with medium non-Gaussianity, i.e. problems where the prior is very non-Gaussian but the posterior is approximately Gaussian. Such situations arise, e.g., when nonlinear dynamics produce a non-Gaussian forecast but a tight Gaussian likelihood leads to a nearly-Gaussian posterior. The hybrid filter starts by factoring the likelihood. First the particle filter assimilates the observations with one factor of the likelihood to produce an intermediate prior that is close to Gaussian, and then the ensemble Kalman filter completes the assimilation with the remaining factor. How the likelihood gets split between the two stages is determined in such a way to ensure that the particle filter avoids collapse, and particle degeneracy is broken by a mean-preserving random orthogonal transformation. The hybrid is tested in a simple two-dimensional (2D) problem and a multiscale system of ODEs motivated by the Lorenz-'96 model. In the 2D problem it outperforms both a pure particle filter and a pure ensemble Kalman filter, and in the multiscale Lorenz-'96 model it is shown to outperform a pure ensemble Kalman filter, provided that the ensemble size is large enough.	[Grooms, Ian; Robinson, Gregor] Univ Colorado, Dept Appl Math, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Grooms, I (corresponding author), Univ Colorado, Dept Appl Math, Boulder, CO 80309 USA.	ian.grooms@colorado.edu		GROOMS, IAN/0000-0002-4678-7203	National Science Foundation [ACI-1532235, ACI-1532236]; University of Colorado Boulder; Colorado State University; US National Science Foundation [DMS1821074]	National Science Foundation(National Science Foundation (NSF)); University of Colorado Boulder; Colorado State University; US National Science Foundation(National Science Foundation (NSF))	This work utilized the Summit supercomputer, which is supported by the National Science Foundation (awards ACI-1532235 and ACI-1532236), the University of Colorado Boulder, and Colorado State University. This work was supported by the US National Science Foundation (https://www.nsf.gov) under grant no. DMS1821074 to IG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo W, 2017, SIAM J SCI COMPUT, V39, pA1834, DOI 10.1137/16M1095184; Ades M, 2015, Q J ROY METEOR SOC, V141, P484, DOI 10.1002/qj.2370; Ades M, 2013, Q J ROY METEOR SOC, V139, P820, DOI 10.1002/qj.1995; Anderson JL, 2020, MON WEATHER REV, V148, P3361, DOI 10.1175/MWR-D-19-0307.1; Anderson JL, 2019, MON WEATHER REV, V147, P2847, DOI 10.1175/MWR-D-18-0448.1; Anderson JL, 2016, MON WEATHER REV, V144, P913, DOI 10.1175/MWR-D-15-0052.1; Anderson JL, 2010, MON WEATHER REV, V138, P4186, DOI 10.1175/2010MWR3253.1; Anderson JL, 1999, MON WEATHER REV, V127, P2741, DOI 10.1175/1520-0493(1999)127<2741:AMCIOT>2.0.CO;2; [Anonymous], 2015, DATA ASSIMILATION; Bengtsson T, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002900; Bertino L, 2003, INT STAT REV, V71, P223, DOI 10.1111/j.1751-5823.2003.tb00194.x; Bickel P, 2008, COLLECTIONS, V2, P316, DOI [10.1214/193940307000000518, DOI 10.1214/193940307000000518]; Bocquet M, 2011, NONLINEAR PROC GEOPH, V18, P735, DOI 10.5194/npg-18-735-2011; Bocquet M, 2010, MON WEATHER REV, V138, P2997, DOI 10.1175/2010MWR3164.1; Brankart JM, 2012, OCEAN SCI, V8, P121, DOI 10.5194/os-8-121-2012; Burgers G, 1998, MON WEATHER REV, V126, P1719, DOI 10.1175/1520-0493(1998)126<1719:ASITEK>2.0.CO;2; Chorin A, 2010, COMM APP MATH COM SC, V5, P221, DOI 10.2140/camcos.2010.5.221; Chorin AJ, 2012, ESAIM-MATH MODEL NUM, V46, P535, DOI 10.1051/m2an/2011055; Chorin AJ, 2009, P NATL ACAD SCI USA, V106, P17249, DOI 10.1073/pnas.0909196106; Chustagulprom N, 2016, SIAM-ASA J UNCERTAIN, V4, P592, DOI 10.1137/15M1040967; Crisan D, 2002, IEEE T SIGNAL PROCES, V50, P736, DOI 10.1109/78.984773; Doucet A, 2001, STAT ENG IN, P3; El Gharamti M, 2019, MON WEATHER REV, V147, P2535, DOI 10.1175/MWR-D-18-0389.1; Evensen G, 2004, OCEAN DYNAM, V54, P539, DOI 10.1007/s10236-004-0099-2; Evensen G, 2009, DATA ASSIMILATION: THE ENSEMBLE KALMAN FILTER, SECOND EDITION, P1, DOI 10.1007/978-3-642-03711-5_1; Frei M, 2013, BIOMETRIKA, V100, P781, DOI 10.1093/biomet/ast020; Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437; Grooms I, 2015, NONLINEAR PROC GEOPH, V22, P601, DOI 10.5194/npg-22-601-2015; Grooms I., 2020, **DATA OBJECT**, DOI [10.5281/zenodo.4394312, DOI 10.5281/ZENODO.4394312]; Grooms I, 2021, Q J ROY METEOR SOC, V147, P139, DOI 10.1002/qj.3910; Hersbach H, 2000, WEATHER FORECAST, V15, P559, DOI 10.1175/1520-0434(2000)015<0559:DOTCRP>2.0.CO;2; Houtekamer PL, 1998, MON WEATHER REV, V126, P796, DOI 10.1175/1520-0493(1998)126<0796:DAUAEK>2.0.CO;2; Kitagawa G., 1996, J OF COMPUTATIONAL A, V5, P1, DOI DOI 10.2307/1390750; Leeuwenburgh O, 2005, Q J ROY METEOR SOC, V131, P3291, DOI 10.1256/qj.05.90; Lei J, 2011, MON WEATHER REV, V139, P3964, DOI 10.1175/2011MWR3553.1; Lorenz EN, 2006, PREDICTABILITY OF WEATHER AND CLIMATE, P40, DOI 10.1017/CBO9780511617652.004; Lorenz EN, 1998, J ATMOS SCI, V55, P399, DOI 10.1175/1520-0469(1998)055<0399:OSFSWO>2.0.CO;2; Metref S, 2014, NONLINEAR PROC GEOPH, V21, P869, DOI 10.5194/npg-21-869-2014; Morzfeld M, 2018, Q J ROY METEOR SOC, V144, P806, DOI 10.1002/qj.3256; Morzfeld M, 2019, TELLUS A, V71, DOI 10.1080/16000870.2019.1600344; Owen AB, 1998, J COMPLEXITY, V14, P466, DOI 10.1006/jcom.1998.0487; Palmer T, 2006, PREDICTABILITY OF WEATHER AND CLIMATE, P1, DOI 10.2277/ 0521848822; Papadakis N, 2010, TELLUS A, V62, P673, DOI 10.1111/j.1600-0870.2010.00461.x; Penny SG, 2016, NONLINEAR PROC GEOPH, V23, P391, DOI 10.5194/npg-23-391-2016; Pinheiro FR, 2019, Q J ROY METEOR SOC, V145, P2510, DOI 10.1002/qj.3576; Poterjoy J, 2016, MON WEATHER REV, V144, P59, DOI 10.1175/MWR-D-15-0163.1; Pulido M, 2019, J COMPUT PHYS, V396, P400, DOI 10.1016/j.jcp.2019.06.060; Rebeschini P, 2015, ANN APPL PROBAB, V25, P2809, DOI 10.1214/14-AAP1061; Reich S, 2013, SIAM J SCI COMPUT, V35, pA2013, DOI 10.1137/130907367; Robinson G, 2020, SIAM J SCI COMPUT, V42, pA2281, DOI 10.1137/19M1268781; Robinson G, 2018, MON WEATHER REV, V146, P2433, DOI 10.1175/MWR-D-17-0349.1; Sakov P, 2008, MON WEATHER REV, V136, P1042, DOI 10.1175/2007MWR2021.1; Simon E, 2012, J MARINE SYST, V89, P1, DOI 10.1016/j.jmarsys.2011.07.007; Skauvold J, 2019, Q J ROY METEOR SOC, V145, P1490, DOI 10.1002/qj.3506; Slivinski L, 2015, MON WEATHER REV, V143, P195, DOI 10.1175/MWR-D-14-00051.1; Snyder C, 2015, MON WEATHER REV, V143, P4750, DOI 10.1175/MWR-D-15-0144.1; Snyder C, 2008, MON WEATHER REV, V136, P4629, DOI 10.1175/2008MWR2529.1; TIERNEY L, 1986, J AM STAT ASSOC, V81, P82, DOI 10.2307/2287970; Todter J, 2015, MON WEATHER REV, V143, P1347, DOI 10.1175/MWR-D-14-00108.1; van Leeuwen PJ, 2009, MON WEATHER REV, V137, P4089, DOI 10.1175/2009MWR2835.1; Whitaker JS, 2002, MON WEATHER REV, V130, P1913, DOI 10.1175/1520-0493(2002)130<1913:EDAWPO>2.0.CO;2; Zhou HY, 2011, ADV WATER RESOUR, V34, P844, DOI 10.1016/j.advwatres.2011.04.014; Zhu MB, 2016, Q J ROY METEOR SOC, V142, P1904, DOI 10.1002/qj.2784	65	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248266	10.1371/journal.pone.0248266	http://dx.doi.org/10.1371/journal.pone.0248266			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705463	Green Published, gold, Green Submitted			2022-12-26	WOS:000629590400047
J	Muhammad, A; Ibrahim, SS; Mukhtar, MM; Irving, H; Abajue, MC; Edith, NMA; Da'u, SS; Paine, MJI; Wondji, CS				Muhammad, Abdullahi; Ibrahim, Sulaiman S.; Mukhtar, Muhammad M.; Irving, Helen; Abajue, Maduamaka C.; Edith, Noutcha M. A.; Da'u, Sabitu S.; Paine, Mark J., I; Wondji, Charles S.			High pyrethroid/DDT resistance in major malaria vector Anopheles coluzzii from Niger-Delta of Nigeria is probably driven by metabolic resistance mechanisms	PLOS ONE			English	Article							MULTIPLE INSECTICIDE RESISTANCE; GATED SODIUM-CHANNEL; MOSQUITOS; SUSCEPTIBILITY; IDENTIFICATION; MUTATION	Entomological surveillance of local malaria vector populations is an important component of vector control and resistance management. In this study, the resistance profile and its possible mechanisms was characterised in a field population of the major malaria vector Anopheles coluzzii from Port Harcourt, the capital of Rivers state, in the Niger-Delta Region of Nigeria. Larvae collected in Port-Harcourt, were reared to adulthood and used for WHO bioassays. The population exhibited high resistance to permethrin, deltamethrin and DDT with mortalities of 6.7% +/- 2.4, 37.5% +/- 3.2 and 6.3% +/- 4.1, respectively, but were fully susceptible to bendiocarb and malathion. Synergist bioassays with piperonylbutoxide (PBO) partially recovered susceptibility, with mortalities increasing to 53% +/- 4, indicating probable role of CYP450s in permethrin resistance (chi(2) = 29.48, P < 0.0001). Transcriptional profiling revealed five major resistance-associated genes overexpressed in the field samples compared to the fully susceptible laboratory colony, Ngoussou. Highest fold change (FC) was observed with GSTe2 (FC = 3.3 in permethrin exposed and 6.2 in unexposed) and CYP6Z3 (FC = 1.4 in exposed and 4.6 in unexposed). TaqMan genotyping of 32 F-0 females detected the 1014F and 1575Y knockdown resistance (kdr) mutations with frequencies of 0.84 and 0.1, respectively, while 1014S mutation was not detected. Sequencing of a fragment of the voltage-gated sodium channel, spanning exon 20 from 13 deltamethrin-resistant and 9 susceptible females revealed only 2 distinct haplotypes with a low haplotype diversity of 0.33. The findings of high pyrethroid resistance but with a significant degree of recovery after PBO synergist assay suggests the need to move to PBO-based nets. This could be complemented with carbamate- or organophosphate-based indoor residual spraying in this area.	[Muhammad, Abdullahi; Ibrahim, Sulaiman S.; Irving, Helen; Paine, Mark J., I; Wondji, Charles S.] Liverpool Sch Trop Med LSTM, Vector Biol Dept, Liverpool, Merseyside, England; [Muhammad, Abdullahi] Bayero Univ, Ctr Biotechnol Res, Kano, Nigeria; [Ibrahim, Sulaiman S.; Mukhtar, Muhammad M.] Bayero Univ, Dept Biochem, Kano, Nigeria; [Ibrahim, Sulaiman S.; Wondji, Charles S.] Ctr Res Infect Dis CRID, LSTM Res Unit, Yaounde, Cameroon; [Abajue, Maduamaka C.; Edith, Noutcha M. A.] Univ Port Harcourt, Dept Anim & Environm Biol, Port Harcourt, Nigeria; [Da'u, Sabitu S.] Bayero Univ, Sch Continuing Educ, Dept Sci, Kano, Nigeria	Liverpool School of Tropical Medicine; Bayero University; Bayero University; University of Port Harcourt; Bayero University	Muhammad, A (corresponding author), Liverpool Sch Trop Med LSTM, Vector Biol Dept, Liverpool, Merseyside, England.; Muhammad, A (corresponding author), Bayero Univ, Ctr Biotechnol Res, Kano, Nigeria.	abdullahi.muhammad@lstmed.ac.uk	Mukhtar, Muhammad M./ABI-4061-2020; Abajue, Maduamaka Cyriacus/GQP-5165-2022; Ibrahim, Sulaiman S/N-1426-2014; Paine, Mark John Ingraham/D-3360-2013	Abajue, Maduamaka Cyriacus/0000-0003-0365-7449; Ibrahim, Sulaiman S/0000-0003-0744-802X; Paine, Mark John Ingraham/0000-0003-2061-7713; Muhammad, Abdullahi/0000-0002-6438-4897	Nigerian Petroleum Technology Development Fund, through the award of scholarship [PTDF/ED/PHD/MA/1113/17]	Nigerian Petroleum Technology Development Fund, through the award of scholarship	This study was funded by Nigerian Petroleum Technology Development Fund, through the award of scholarship (PTDF/ED/PHD/MA/1113/17) to AM.	Akpan GE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204233; Antonio-Nkondjio C, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1483-3; Atting IA., 2019, J ADV MED MED RES, V29, P1; Awolola ST., 2014, PARASIT VECTORS, V7, P1; Awolola TS, 2009, T ROY SOC TROP MED H, V103, P1139, DOI 10.1016/j.trstmh.2008.08.021; Awolola TS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205230; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Bass Chris, 2010, Malar Res Treat, V2010, P190434, DOI 10.4061/2010/190434; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bruce-Chwatt L. J., 1951, Bulletin of the World Health Organization, V4, P301; Chukwuekezie O, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-04027-z; Clark BW, 2012, ECOTOXICOLOGY, V21, P465, DOI 10.1007/s10646-011-0807-x; Dimopoulos G, 1996, P NATL ACAD SCI USA, V93, P13066, DOI 10.1073/pnas.93.23.13066; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Djouaka RJ, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1615-9; Ebere N., 2019, ANN RES REV BIOL, V32, P1; Edi Ako Victorien Constant, 2017, Wellcome Open Res, V2, P71, DOI 10.12688/wellcomeopenres.12246.1; Edi CV, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004236; Fadel AN, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3523-7; Fagbohun IK, 2019, J MED ENTOMOL, V56, P817, DOI 10.1093/jme/tjz006; Feyereisen R, 2015, PEST MANAG SCI, V71, P793, DOI 10.1002/ps.3895; Gari T, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2607-8; Gillies M. T., 1987, A supplement to the Anophelinae of Africa south of the Sahara (Afrotropical Region).; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hearn J., 2020, GENES-BASEL, V11, P1; Ibrahim SS, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0605-x; Ibrahim SS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43634-4; Ibrahim SS, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-441; Irving H, 2012, HEREDITY, V109, P383, DOI 10.1038/hdy.2012.53; Irving H, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0539-x; Jones CM, 2012, P NATL ACAD SCI USA, V109, P6614, DOI 10.1073/pnas.1201475109; Kwiatkowska RM, 2013, GENE, V519, P98, DOI 10.1016/j.gene.2013.01.036; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LIVAK KJ, 1984, GENETICS, V107, P611; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Mclaughlin LA, 2008, INSECT MOL BIOL, V17, P125, DOI 10.1111/j.1365-2583.2007.00788.x; Misra JR, 2011, GENE DEV, V25, P1796, DOI 10.1101/gad.17280911; Mitchell SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092662; Mnzava AP, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0693-4; Mohammed B., 2016, ENTOMOL ORNITHOL HER, V06, P1; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Musiime AK, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-3076-4; NMCP SUMAP WHO INFORM., 2013, DESCRIPTION EPIDEMIO; Okorie PN, 2015, MED VET ENTOMOL, V29, P44, DOI 10.1111/mve.12089; Okorie PN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028347; Okwa OO, 2009, ANN AFR MED, V8, P1, DOI 10.4103/1596-3519.55756; Olatunbosun-Oduola A, 2019, J ARTHROPOD-BORNE DI, V13, P50; Olusegun A., 2012, INTECH, Vi, P38, DOI 10.1016/j.colsurfa.2011.12.014; Onyiri N, 2015, GEOSPATIAL HEALTH, V10, P163, DOI 10.4081/gh.2015.306; Opondo KO, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1203-z; Oringanje C., 2013, INT J ANTIMALARIA RE, V1, P35; Pan YO, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184521; Pinto J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001243; RAMAKRISHNA V., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P102, DOI 10.1016/0035-9203(59)90092-6; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010; Riveron JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-817; Riveron JM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r27; Salau AT., 1985, CITIES INTERNET, V2, P14; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SELF LS, 1966, B WORLD HEALTH ORGAN, V34, P960; Martins WFS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005917; Stevenson BJ, 2011, INSECT BIOCHEM MOLEC, V41, P492, DOI 10.1016/j.ibmb.2011.02.003; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tchouakui M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42015-1; Toe KH, 2018, MED VET ENTOMOL, V32, P407, DOI 10.1111/mve.12316; Toe KH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1342-6; Wang LX, 2015, MOL PHARMACOL, V87, P421, DOI 10.1124/mol.114.094730; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2016, WORLD MALARIA REPORT; WHO, 2012, GLOB PLAN INS RES MA; WHO, 2016, TECHNICAL M REPORT, VSecond, P1; Yakubu OH, 2018, ENVIRONMENTS, V5, DOI 10.3390/environments5010002; Yunta C, 2016, INSECT BIOCHEM MOLEC, V78, P50, DOI 10.1016/j.ibmb.2016.09.001	75	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0247944	10.1371/journal.pone.0247944	http://dx.doi.org/10.1371/journal.pone.0247944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705436	Green Accepted, Green Published, gold			2022-12-26	WOS:000629590400055
J	He, Q; Xiang, Z; Ren, P				He, Qiang; Xiang, Zheng; Ren, Peng			A CLSTM and transfer learning based CFDAMA strategy in satellite communication networks	PLOS ONE			English	Article							NONORTHOGONAL MULTIPLE-ACCESS	With the development of the economy and technology, people's requirement for communication is also increasing. Satellite communication networks have been paid more and more attention because of their broadband service capability and wide coverage. In this paper, we investigate the scheme of convolutional long short term memory (CLSTM) network and transfer learning (TL) based combined free/demand assignment multiple access (CFDAMA) scheme (CFDAMA-CLSTMTL), which is a new multiple access scheme in the satellite communication networks. Generally, there is a delay time T between sending a request from the user to the satellite and receiving a reply from the satellite. So far, the traditional multiple access schemes have not processed the data generated in this period. So, in order to transmit the data in time, we propose a new prediction method CLSTMTL, which can be used to predict the data generated in this period. We introduce the prediction method into the CFDAMA scheme so that it can reduce data accumulation by the way of sending the slots request which is the sum of slots requested by the user and the predicted slots generated in the delay time. A comparison with CFDAMA-PA and CFDAMA-PB is provided through simulation results, which gives the effect of the CFDAMA-CLSTMTL in a satellite communication network.	[He, Qiang; Xiang, Zheng; Ren, Peng] Xidian Univ, Sch Telecommun Engn, Xian, Peoples R China	Xidian University	He, Q (corresponding author), Xidian Univ, Sch Telecommun Engn, Xian, Peoples R China.	bchqiangu@126.com						Cao Bao, 2014, COMMUNICATIONS TECHN, V47, P1173; DING Ling-q, 2016, COMPUTER ENG SOFTWAR, V37, P130; Dongling Jiang., 2017, RES MULTIUSER ACCESS; Gharghory SM, 2020, INT J COMPUT INTELL, V19, DOI 10.1142/S1469026820500133; Gorma W., 2018, P INT C BROADB COMM, P191; Hao X, 2016, INT J SEMANT COMPUT, V10, P417, DOI 10.1142/S1793351X16500045; Jia M, 2016, IEEE WIREL COMMUN, V23, P96, DOI 10.1109/MWC.2016.1500108WC; Jia S., 2003, 14 IEEE 2003 INT S P; Kuang LL, 2017, IEEE WIREL COMMUN, V24, P81, DOI 10.1109/MWC.2017.1700043; Li W L., 2012, RADIO COMMUNICATIONS, V21, P20; Liu F, 2017, IEEE COMMUN LETT, V21, P1175, DOI 10.1109/LCOMM.2017.2657495; Ma Wenqi, 2017, MOD MANAGE, V7, P93; Meng LI, 2019, WIR OPT COMM C BEIJ; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Qu XY, 2016, ASIA-PAC POWER ENERG, P1148, DOI 10.1109/APPEEC.2016.7779672; Sharma S. K., 2018, SATELLITE COMMUNICAT; Shuang Guo., 2014, COMMUNICATIONS TECHN, V47, P1375; WM Gorma, 2017, P INT C UND NETW SYS, P1; Xin Yuanbo, 2011, 2011 3rd International Conference on Computer Research and Development (ICCRD 2011), P41, DOI 10.1109/ICCRD.2011.5763849; Xue Yusheng, 2015, Automation of Electric Power Systems, V39, P141, DOI 10.7500/AEPS20141218003; Yan XJ, 2019, IEEE ACCESS, V7, P63531, DOI 10.1109/ACCESS.2019.2917060; Yang KH, 2019, CMC-COMPUT MATER CON, V61, P155, DOI 10.32604/cmc.2019.05901; Yongsheng Zhou, 2009, PM2 5 PREDICTION BAS; [虞湘宾 Yu Xiangbin], 2017, [数据采集与处理, Journal of Data Acquisition & Processing], V32, P440; Zhang Gengxin, 2010, 2010 INT C COMP APPL; Zhang JX, 2017, J COMMUN NETW-S KOR, V19, P147, DOI 10.1109/JCN.2017.000024; Zhang Rui-fang, 2020, COMPUTER SIMULATION, V37, P469; Zhang SB, 2018, SCI CHINA INFORM SCI, V61, DOI 10.1007/s11432-017-9282-2; Zhu XM, 2017, IEEE J SEL AREA COMM, V35, P2253, DOI 10.1109/JSAC.2017.2724478	29	1	1	9	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0248271	10.1371/journal.pone.0248271	http://dx.doi.org/10.1371/journal.pone.0248271			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690712	Green Published, gold			2022-12-26	WOS:000627854700014
J	Kilic, A; Dochtermann, D; Padman, R; Miller, JK; Dubrawski, A				Kilic, Arman; Dochtermann, Daniel; Padman, Rema; Miller, James K.; Dubrawski, Artur			Using machine learning to improve risk prediction in durable left ventricular assist devices	PLOS ONE			English	Article								Risk models have historically displayed only moderate predictive performance in estimating mortality risk in left ventricular assist device therapy. This study evaluated whether machine learning can improve risk prediction for left ventricular assist devices. Primary durable left ventricular assist devices reported in the Interagency Registry for Mechanically Assisted Circulatory Support between March 1, 2006 and December 31, 2016 were included. The study cohort was randomly divided 3:1 into training and testing sets. Logistic regression and machine learning models (extreme gradient boosting) were created in the training set for 90-day and 1-year mortality and their performance was evaluated after bootstrapping with 1000 replications in the testing set. Differences in model performance were also evaluated in cases of concordance versus discordance in predicted risk between logistic regression and extreme gradient boosting as defined by equal size patient tertiles. A total of 16,120 patients were included. Calibration metrics were comparable between logistic regression and extreme gradient boosting. C-index was improved with extreme gradient boosting (90-day: 0.707 [0.683-0.730] versus 0.740 [0.717-0.762] and 1-year: 0.691 [0.673-0.710] versus 0.714 [0.695-0.734]; each p<0.001). Net reclassification index analysis similarly demonstrated an improvement of 48.8% and 36.9% for 90-day and 1-year mortality, respectively, with extreme gradient boosting (each p<0.001). Concordance in predicted risk between logistic regression and extreme gradient boosting resulted in substantially improved c-index for both logistic regression and extreme gradient boosting (90-day logistic regression 0.536 versus 0.752, 1-year logistic regression 0.555 versus 0.726, 90-day extreme gradient boosting 0.623 versus 0.772, 1-year extreme gradient boosting 0.613 versus 0.742, each p<0.001). These results demonstrate that machine learning can improve risk model performance for durable left ventricular assist devices, both independently and as an adjunct to logistic regression.	[Kilic, Arman] Univ Pittsburgh, Div Cardiac Surg, Med Ctr, Pittsburgh, PA 15261 USA; [Dochtermann, Daniel; Padman, Rema; Miller, James K.; Dubrawski, Artur] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Kilic, A (corresponding author), Univ Pittsburgh, Div Cardiac Surg, Med Ctr, Pittsburgh, PA 15261 USA.	kilica2@upmc.edu		Dochtermann, Daniel/0000-0001-9513-5124; Dubrawski, Artur/0000-0002-2372-0831				Cowger J, 2013, J AM COLL CARDIOL, V61, P313, DOI 10.1016/j.jacc.2012.09.055; Gomes B, 2021, CLIN RES CARDIOL, V110, P343, DOI 10.1007/s00392-020-01691-0; Huang CX, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002703; Kanwar MK, 2018, JACC-HEART FAIL, V6, P771, DOI 10.1016/j.jchf.2018.03.016; Kilic A, 2021, ANN THORAC SURG, V111, P503, DOI 10.1016/j.athoracsur.2020.05.107; Kilic A, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.015449; Kilic A, 2020, ANN THORAC SURG, V109, P1811, DOI 10.1016/j.athoracsur.2019.09.049; Kilic A, 2020, ANN THORAC SURG, V109, P1323, DOI 10.1016/j.athoracsur.2019.09.042; Kormos RL, 2019, ANN THORAC SURG, V107, P341, DOI 10.1016/j.athoracsur.2018.11.011; Pencina MJ, 2017, STAT MED, V36, P4455, DOI 10.1002/sim.7041; Sanaiha Y., 2020, J THORAC CARDIOVASC, DOI [10.1016/j.jtcvs.2019.12.12132249087, DOI 10.1016/J.JTCVS.2019.12.12132249087]; Seese L, 2021, ANN THORAC SURG, V111, P881, DOI 10.1016/j.athoracsur.2020.05.164; Shah N, 2016, ANN THORAC SURG, V101, P1477, DOI 10.1016/j.athoracsur.2015.09.013; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2	14	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0247866	10.1371/journal.pone.0247866	http://dx.doi.org/10.1371/journal.pone.0247866			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690687	Green Published, gold			2022-12-26	WOS:000627854700003
J	Lange, C; Weber, AM; Schmidt, R; Schroeder, C; Strowitzki, T; Germeyer, A				Lange, Carsten; Weber, Amanda Machado; Schmidt, Ronny; Schroeder, Christoph; Strowitzki, Thomas; Germeyer, Ariane			Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line	PLOS ONE			English	Article							NF-KAPPA-B; IN-VITRO; INHIBITS PROLIFERATION; PROMOTES METASTASIS; DIABETES-MELLITUS; COLORECTAL-CANCER; INCIDENT CANCER; DOWN-REGULATION; BREAST-CANCER; TUMOR-GROWTH	The incidence of endometrial cancer (EC) has increased over the past years and mainly affects women above the age of 45 years. Metabolic diseases such as obesity and type II diabetes mellitus as well as associated conditions like polycystic ovary syndrome (PCOS), insulin resistance and hyperinsulinemia lead to elevated levels of circulating estrogens. Increased estrogen concentrations, in turn, further trigger the proliferation of endometrial cells and thus promote EC development and progression, especially in the absence of progesterone as seen in postmenopausal women. Elevated blood glucose levels in diabetic patients further contribute to the risk of EC development. Metformin is an insulin-sensitizing biguanide drug, commonly used in the treatment of type II diabetes mellitus, especially in obese patients. Besides its effects on glucose metabolism, metformin displayed anti-cancer effects in various cancer types, including EC. Direct anti-cancer effects of metformin target signaling pathways that are involved in cellular growth and proliferation, e.g. the AKT/PKB/mTOR pathway. Further proteins and pathways have been suggested as potential targets, but the underlying mechanism of action of metformin's anti-cancer activity is still not completely understood. In the present study, the effects of metformin on protein expression were investigated in the human EC cell line HEC-1A using an affinity proteomic approach. Cells were treated with 0.5 mmol/L metformin over a period of 7 days and changes in the expression pattern of 1,300 different proteins were compared to the expression in untreated control cells as well as insulin-treated cells. Insulin treatment (100 ng/mL) was incorporated into the study in order to implement a model for insulin resistance and associated hyperinsulinemia, conditions that are often observed in obese and diabetic patients. Furthermore, the culture medium was supplemented with 10 nmol/L ss-estradiol (E2) during treatments to mimic increased estrogen levels, a common risk factor for EC development. Based on the most prominent and significant changes in expression, a set of 80 proteins was selected and subjected to a more detailed analysis. The data revealed that metformin and insulin targeted similar pathways in the present study and mostly acted on proteins related to proliferation, migration and tumor immune response. These pathways may be affected in a tumor-promoting as well as a tumor-suppressing way by either metformin treatment or insulin supplementation. The consequences for the cells resulting from the detected expression changes were discussed in detail for several proteins. The presented data helps identify potential targets affected by metformin treatment in EC and allows for a better understanding of the mechanism of action of the biguanide drug's anti-cancer activity. However, further investigations are necessary to confirm the observations and conclusions drawn from the presented data after metformin administration, especially for proteins that were regulated in a favorable way, i.e. AKT3, CCND2, CD63, CD81, GFAP, IL5, IL17A, IRF4, PI3, and VTCN1. Further proteins might be of interest, where metformin counteracted unfavorable effects that have been induced by hyperinsulinemia.	[Lange, Carsten; Weber, Amanda Machado; Strowitzki, Thomas; Germeyer, Ariane] Heidelberg Univ, Womens Hosp, Dept Gynecol Endocrinol & Fertil Disorders, Heidelberg, Germany; [Schmidt, Ronny; Schroeder, Christoph] Sciomics GmbH, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Lange, C (corresponding author), Heidelberg Univ, Womens Hosp, Dept Gynecol Endocrinol & Fertil Disorders, Heidelberg, Germany.	carsten.lange@med.uni-heidelberg.de	Schröder, Christoph/AAY-9656-2021	Schröder, Christoph/0000-0001-6177-1042; Lange, Carsten/0000-0003-4915-0870	Department of Gynecologic Endocrinology and Fertility Disorders (Women's Hospital, RuprechtKarls University of Heidelberg, Germany); German Research Foundation, DFG [GE 1173/3-1]; Sciomics GmbH	Department of Gynecologic Endocrinology and Fertility Disorders (Women's Hospital, RuprechtKarls University of Heidelberg, Germany); German Research Foundation, DFG(German Research Foundation (DFG)); Sciomics GmbH	"This study was financially supported by the Department of Gynecologic Endocrinology and Fertility Disorders (Women's Hospital, RuprechtKarls University of Heidelberg, Germany) and the German Research Foundation, DFG (grant: GE 1173/3-1 to A.G.). Sciomics GmbH provided funding for this study in the form of salaries for authors R.S. & C.S., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section."https://www.klinikum.uni-heidelberg.de/frauenklinik-zentrum/gynaekologischeendokrinologie-und-fertilitaetsstoerungen https://gepris.dfg.de/gepris/projekt/394654860? language=en.	Abou-Sharieha Samah, 2009, Chinese Journal of Clinical Oncology, V6, P1, DOI 10.1007/s11805-009-0001-6; Aljofan M, 2019, FUTUR SCI OA, V5, DOI 10.2144/fsoa-2019-0053; Amant F, 2018, INT J GYNECOL OBSTET, V143, P37, DOI 10.1002/ijgo.12612; American Cancer Society, 2020, KEY STAT END CANC; [Anonymous], 2019, END CANC CAUS RISK F; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bent R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082155; Bill CA, 2020, ADV EXP MED BIOL, V1131, P215, DOI 10.1007/978-3-030-12457-1_9; Byrne FL, 2014, CANCER RES, V74, P5832, DOI 10.1158/0008-5472.CAN-14-0254; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Caruso JA, 2015, ONCOGENE, V34, P3556, DOI 10.1038/onc.2014.284; Caruso JA, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0497-4; Chen K, 2017, GENE, V614, P8, DOI 10.1016/j.gene.2017.01.016; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; Clark CR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33527-3; CLARKE CL, 1990, ENDOCR REV, V11, P266, DOI 10.1210/edrv-11-2-266; Collins G, 2019, REPROD SCI, V26, P609, DOI 10.1177/1933719118779734; Currie CJ, 2012, DIABETES CARE, V35, P299, DOI 10.2337/dc11-1313; Czech MP, 2017, NAT MED, V23, P804, DOI 10.1038/nm.4350; Daugan M, 2016, PHARMACOL RES, V113, P675, DOI 10.1016/j.phrs.2016.10.006; Deng XS, 2012, CELL CYCLE, V11, P367, DOI 10.4161/cc.11.2.18813; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dewan S., 2005, CLIN OBESITY ADULTS, V2nd ed, P249, DOI [10.1002/9780470987087, DOI 10.1002/9780470987087]; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Feng S, 1999, CHINESE MED J-PEKING, V112, P854; Feng S, 1997, World J Gastroenterol, V3, P251, DOI 10.3748/wjg.v3.i4.251; Filigheddu N, 2011, CELL SIGNAL, V23, P1988, DOI 10.1016/j.cellsig.2011.07.009; Flory J, 2019, JAMA-J AM MED ASSOC, V321, P1926, DOI 10.1001/jama.2019.3805; Gallagher EJ, 2012, ONCOGENE, V31, P3213, DOI 10.1038/onc.2011.495; Gao Zhao-wei, 2014, Biomed Res Int, V2014, P460654, DOI 10.1155/2014/460654; Garg K, 2014, ARCH PATHOL LAB MED, V138, P335, DOI 10.5858/arpa.2012-0654-RA; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gilder AS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21358-1; Grottke A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146370; Guo H, 2019, AM J CANCER RES, V9, P2170; Guo N, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00546; Han X, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0054-8; Hevir-Kene N, 2015, CHEM-BIOL INTERACT, V234, P309, DOI 10.1016/j.cbi.2014.11.015; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Horst AK, 2004, HANDB EXP PHARM, V165, P283, DOI 10.1007/978-3-540-68170-0_10; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang HY, 2017, GENE, V623, P24, DOI 10.1016/j.gene.2017.04.003; Huang XJ, 2018, INT J BIOL SCI, V14, P1483, DOI 10.7150/ijbs.27173; Huang Z, 2014, ASIAN PAC J CANCER P, V15, P989, DOI 10.7314/APJCP.2014.15.2.989; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Hunter KW, 2004, TRENDS MOL MED, V10, P201, DOI 10.1016/j.molmed.2004.03.001; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Iwabuchi E, 2019, CLIN EXP METASTAS, V36, P423, DOI 10.1007/s10585-019-09981-2; Jiang H, 2014, INT J CLIN EXP PATHO, V7, P4531; Jiang T, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1163462; Joung KH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/920618; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Karnevi E, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-235; Katoh M, 2005, INT J MOL MED, V16, P1103; Ko EM, 2014, GYNECOL ONCOL, V132, P438, DOI 10.1016/j.ygyno.2013.11.021; Kourelis TV, 2012, MED ONCOL, V29, P1314, DOI 10.1007/s12032-011-9846-7; Koyama-Nasu R, 2013, ONCOGENE, V32, P3840, DOI 10.1038/onc.2012.399; Kubota T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07358-9; Kubota T, 2017, CELL METAB, V25, P797, DOI 10.1016/j.cmet.2017.03.004; Kuhn DJ, 2003, J CELL BIOCHEM, V89, P824, DOI 10.1002/jcb.10557; KURAMOTO H, 1972, AM J OBSTET GYNECOL, V114, P1012, DOI 10.1016/0002-9378(72)90861-7; Kurarmoto Hiroyuki, 2002, Hum Cell, V15, P81, DOI 10.1111/j.1749-0774.2002.tb00103.x; Kuroki M, 2001, J LEUKOCYTE BIOL, V70, P543; Lamort AS, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080815; Lee J, 2019, NATURE, V568, P254, DOI 10.1038/s41586-019-1005-x; Li JM, 2018, THER ADV MED ONCOL, V10, P1, DOI 10.1177/1758835918794622; Li Q, 2019, INT J CLIN EXP PATHO, V12, P3740; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Litmanovich A, 2018, ONCOL THER, V6, P109, DOI 10.1007/s40487-018-0089-z; Liu AQ, 2017, ONCOTARGET, V8, P7999, DOI 10.18632/oncotarget.14033; Liu J, 2018, DISCOV MED, V25, P211; Liu SC, 2002, MOL CARCINOGEN, V34, P131, DOI 10.1002/mc.10057; Liu YS, 2015, EXP THER MED, V9, P1401, DOI 10.3892/etm.2015.2220; Ma DH, 2019, ARTIF CELL NANOMED B, V47, P3786, DOI 10.1080/21691401.2019.1669616; Ma HJ, 2014, CANCER LETT, V344, P74, DOI 10.1016/j.canlet.2013.10.017; Mallik R, 2018, DIABETES RES CLIN PR, V143, P409, DOI 10.1016/j.diabres.2018.05.023; Marcucci F, 2020, TRENDS PHARMACOL SCI, V41, P162, DOI 10.1016/j.tips.2020.01.003; Markowska A, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-76; Meireles CG, 2017, GYNECOL ONCOL, V147, P167, DOI 10.1016/j.ygyno.2017.07.120; Menges CW, 2009, CELL CYCLE, V8, P2528, DOI 10.4161/cc.8.16.9280; Modesitt SC, 2012, GYNECOL ONCOL, V124, P431, DOI 10.1016/j.ygyno.2011.11.013; Morice P, 2016, LANCET, V387, P1094, DOI 10.1016/S0140-6736(15)00130-0; Nevadunsky NS, 2014, GYNECOL ONCOL, V132, P236, DOI 10.1016/j.ygyno.2013.10.026; O'Connor KA, 2009, CANCER EPIDEM BIOMAR, V18, P828, DOI 10.1158/1055-9965.EPI-08-0996; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Phung TL, 2015, CANCER RES, V75, P40, DOI 10.1158/0008-5472.CAN-13-2961; Pierotti MA, 2013, ONCOGENE, V32, P1475, DOI 10.1038/onc.2012.181; Pietila M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10275-0; Piper AJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220567; Podojil JR, 2017, IMMUNOL REV, V276, P40, DOI 10.1111/imr.12530; Pollak MN, 2012, CANCER DISCOV, V2, P778, DOI 10.1158/2159-8290.CD-12-0263; Qian YJ, 2017, MOL MED REP, V16, P6034, DOI 10.3892/mmr.2017.7319; Qiang P, 2019, EUR REV MED PHARMACO, V23, P1778, DOI 10.26355/eurrev_201902_17140; R Core Team, 2021, R LANGUAGE ENV STAT; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Saini N, 2018, ACTA BIOCH BIOPH SIN, V50, P133, DOI 10.1093/abbs/gmx106; Saito S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054881; Schimmoller F, 1998, GENE, V216, P311, DOI 10.1016/S0378-1119(98)00349-7; Schuiveling M, 2018, CURR DRUG TARGETS, V19, P945, DOI 10.2174/1389450118666170613081730; Shao RJ, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-41; Shen Y, 2018, AM J CANCER RES, V8, P916; Sill M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-556; Simson L, 2007, J IMMUNOL, V178, P4222, DOI 10.4049/jimmunol.178.7.4222; Song MX, 2014, PROTEIN CELL, V5, P851, DOI 10.1007/s13238-014-0093-5; Stanislaus A, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-30; Sui HY, 2016, ONCOTARGET, V7, P45995, DOI 10.18632/oncotarget.10276; Swiderska E., 2018, BLOOD GLUCOSE LEVELS, P1, DOI [10.5772/intechopen.80402, DOI 10.5772/INTECHOPEN.80402]; Szablewski L, 2014, DIABETES-METAB RES, V30, P543, DOI 10.1002/dmrr.2573; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tang JC, 2017, CANCER RES TREAT, V49, P778, DOI 10.4143/crt.2015.485; Tseng HW, 2019, CANCERS, V11, DOI 10.3390/cancers11020209; Tugues S, 2013, J BIOL CHEM, V288, P19060, DOI 10.1074/jbc.M113.468199; Vences-Catalan F, 2017, BIOCHEM SOC T, V45, P531, DOI 10.1042/BST20160478; Vial G, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00294; Weigelt B, 2012, CURR OPIN ONCOL, V24, P554, DOI 10.1097/CCO.0b013e328354e585; White NMA, 2014, BRIT J CANCER, V110, P1250, DOI 10.1038/bjc.2013.828; Wilhelmsson U, 2003, ONCOGENE, V22, P3407, DOI 10.1038/sj.onc.1206372; Xie Y, 2014, ONCOL LETT, V8, P1993, DOI 10.3892/ol.2014.2466; You HL, 2018, ONCOL LETT, V16, P5505, DOI 10.3892/ol.2018.9284; Yu KS, 2010, INT J CANCER, V127, P1308, DOI 10.1002/ijc.25125; Zeng B, 2018, ONCOTARGETS THER, V11, P1333, DOI 10.2147/OTT.S154215; Zeng FC, 2016, ONCOTARGETS THER, V9, P2131, DOI 10.2147/OTT.S98002; Zhang N, 2018, MED SCI MONITOR, V24, P5739, DOI 10.12659/MSM.911612; Zhang W, 2014, ONCOL REP, V31, P1334, DOI 10.3892/or.2014.2967; Zhang ZY, 2018, MOL MED REP, V17, P5037, DOI 10.3892/mmr.2018.8533	129	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2021	16	3							e0248103	10.1371/journal.pone.0248103	http://dx.doi.org/10.1371/journal.pone.0248103			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DJ	33690729	gold, Green Published			2022-12-26	WOS:000627855600031
J	Abbasi, GA; Tiew, LY; Tang, JQ; Goh, YN; Thurasamy, R; Dragan, D				Abbasi, Ghazanfar Ali; Tiew, Lee Yin; Tang, Jinquan; Goh, Yen-Nee; Thurasamy, Ramayah; Dragan, Dejan			The adoption of cryptocurrency as a disruptive force: Deep learning-based dual stage structural equation modelling and artificial neural network analysis	PLOS ONE			English	Article							EXTENDING UTAUT2; USER ACCEPTANCE; PERSONAL INNOVATIVENESS; INFORMATION-TECHNOLOGY; PLS-SEM; MOBILE; CUSTOMERS; BANKING; INTENTIONS; CHALLENGES	In recent years, the growth of cryptocurrency has undergone an enormous increase in cryptocurrency markets all around the world. Sadly, only insignificant heed has been paid to the unveiling of determinants of cryptocurrency adoption globally, particularly in emerging markets like Malaysia. The purpose of the study is to examine whether the application of deep learning-based dual-stage Partial Least Square-Structural Equation Modelling (PLS-SEM) & Artificial Neural Network (ANN) analysis enable better in-depth research results as compared to single-step PLS-SEM approach and to excavate factors which can predict behavioural intention to adopt cryptocurrency. The Unified Theory of Acceptance and Use of Technology 2 (UTAUT2) model were extended with the inclusion of trust and personnel innovativeness. The model was further validated by introducing a new path model compared to the original UTAUT2 model and the moderating role of personal innovativeness between performance expectancy and price value, with a sample of 314 respondents. Contrary to previous technology adoption studies that used PLS-SEM & ANN as single-stage analysis, this study further enhanced the analysis by applying a deep learning-based dual-stage PLS-SEM and ANN method. The application of deep learning-based dual-stage PLS-SEM & ANN analysis is a novel methodological approach, detecting both linear and non-linear associations among constructs. At the same time, it is regarded as a superior statistical approach as compared to traditional hybrid shallow SEM & ANN single-stage analysis. Also, sensitivity analysis provides normalised importance using multi-layer perceptron with the feed-forward-back-propagation algorithm. Furthermore, the deep learning-based dualstage PLS-SEM & ANN revealed that trust proved to be the strongest predictor in driving user intention. The introduction of this new methodology and the theoretical contribution opens the vistas of the extant body of knowledge in technology-adoption related literature. This study also provides theoretical, practical and methodological contributions.	[Abbasi, Ghazanfar Ali; Tiew, Lee Yin; Goh, Yen-Nee] Univ Sains Malaysia, Grad Sch Business, Usm, Penang, Malaysia; [Tang, Jinquan] Minjiang Univ, Newhuadu Business Sch, Fuzhou, Fujian, Peoples R China; [Thurasamy, Ramayah] Univ Sains Malaysia, Sch Management, Usm, Penang, Malaysia	Universiti Sains Malaysia; Minjiang University; Universiti Sains Malaysia	Abbasi, GA (corresponding author), Univ Sains Malaysia, Grad Sch Business, Usm, Penang, Malaysia.; Tang, JQ (corresponding author), Minjiang Univ, Newhuadu Business Sch, Fuzhou, Fujian, Peoples R China.	ghazanfar.abbasi@hotmail.co.uk; tangjinquan@nbs.edu.cn	ABBASI, GHAZANFER ALI/AAM-2164-2021; ABBASI, GHAZANFAR Ali/Y-9112-2018; T., Ramayah/E-4629-2010	ABBASI, GHAZANFER ALI/0000-0003-0748-8996; ABBASI, GHAZANFAR Ali/0000-0003-0748-8996; T., Ramayah/0000-0002-7580-7058				Abbasi G, 2020, INT J INTERACTIVE MO, V14, P95; Abbasi GA, 2021, TECHNOLOGY SOC, V64; Adapa A, 2018, INT J HUM-COMPUT INT, V34, P399, DOI 10.1080/10447318.2017.1357902; Agarwal R, 1998, INFORM SYST RES, V9, P204, DOI 10.1287/isre.9.2.204; Al-Amri R., 2019, INT J ADV COMPUT RES, V9, P293, DOI [10.19101/IJACR.PID43, DOI 10.19101/IJACR.PID43]; Alalwan AA, 2018, J RETAIL CONSUM SERV, V40, P125, DOI 10.1016/j.jretconser.2017.08.026; Alalwan AA, 2017, INT J INFORM MANAGE, V37, P99, DOI 10.1016/j.ijinfomgt.2017.01.002; Alam MZ, 2020, TECHNOL SOC, V61, DOI 10.1016/j.techsoc.2020.101255; Gil-Alana LA, 2020, RES INT BUS FINANC, V51, DOI 10.1016/j.ribaf.2019.101063; [Anonymous], 2019, MAL STARTS REG CRYPT; [Anonymous], 2016, INT C DET INTR MALW; Arias-Oliva M, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00475; Bagozzi R, 2003, J BEHAV DECIS MAKING, V16, P273, DOI 10.1002/bdm.446; Beh PK, BEHAV INFORM TECHNOL; Beza E, 2018, COMPUT ELECTRON AGR, V151, P295, DOI 10.1016/j.compag.2018.06.015; Bhattacherjee A., 2012, SOCIAL SCI RES PRINC, V2nd \; Bol N, 2018, INFORM SOC, V34, P183, DOI 10.1080/01972243.2018.1438550; Brick KI, 2015, J ECON BEHAV ORGAN, V118, P383, DOI 10.1016/j.jebo.2015.02.010; Chin WW, 2003, INFORM SYST RES, V14, P189, DOI 10.1287/isre.14.2.189.16018; Cong L, 2019, 63 COL BUS SCH; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; De Filippi P, 2014, INTERNET POLICY REV, V3, DOI 10.14763/2014.2.286; Deb M., 2014, MARKETING INTELLIGEN; Duarte P, 2019, J BUS RES, V102, P140, DOI 10.1016/j.jbusres.2019.05.022; Dutta DK, 2015, INT ENTREP MANAG J, V11, P529, DOI 10.1007/s11365-013-0287-y; Farooq MS, 2017, ANN KING EDWARD MED, V23; Fornell C., 1994, PARTIAL LEAST SQUARE; Glavee-Geo R, 2017, INT J BANK MARKETING; Gupta A, 2018, J HOSPITALITY TOURIS; Hair J.F., 2011, ESSENTIALS BUSINESS; Hair JF, 2014, EUR BUS REV, V26, P106, DOI 10.1108/EBR-10-2013-0128; Hair JF, 2019, EUR BUS REV, V31, P2, DOI 10.1108/EBR-11-2018-0203; Hamidi H, 2018, TELEMAT INFORM, V35, P1053, DOI 10.1016/j.tele.2017.09.016; Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8; Henseler J, 2009, ADV INT MARKETING, V20, P277, DOI 10.1108/S1474-7979(2009)0000020014; Herrero A, 2017, COMPUT HUM BEHAV, V71, P209, DOI 10.1016/j.chb.2017.02.007; Hew TS, 2016, J COMPUT INFORM SYST, V56, P352, DOI 10.1080/08874417.2016.1164497; Higueras-Castillo E, 2020, ENERG POLICY, V136, DOI 10.1016/j.enpol.2019.111076; Hileman G., 2017, CAMB CENT ALTERN FIN, V33, P33, DOI DOI 10.2139/SSRN.2965436; Ho SH, 2008, INTERNET RES, V18, P427, DOI 10.1108/10662240810897826; Hussain A, 2019, INT J INFORM MANAGE, V44, P76, DOI 10.1016/j.ijinfomgt.2018.09.016; Jonker N, 2019, ELECTRON COMMER R A, V35, DOI 10.1016/j.elerap.2019.100848; Kavanagh D, 2020, INFORM SOC, V36, P290, DOI 10.1080/01972243.2020.1795958; Kline R. B., 2016, PRINCIPLES PRACTICE, V4th, P369; Kline RB, 2013, EDUC RES EVAL, V19, P204, DOI 10.1080/13803611.2013.767624; Kock N, 2012, J ASSOC INF SYST, V13, P546, DOI 10.17705/1jais.00302; Koksal Y, 2015, J MARKETING MANAGEME, V6; Kshetri N, 2017, THIRD WORLD Q, V38, P1710, DOI 10.1080/01436597.2017.1298438; Kwateng KO, 2019, J ENTERPRISE INFORM; Lapple D, 2011, ECOL ECON, V70, P1406, DOI 10.1016/j.ecolecon.2011.03.002; Lee VH, 2020, EXPERT SYST APPL, V157, DOI 10.1016/j.eswa.2020.113477; Leong LY, 2019, EXPERT SYST APPL, V133, P296, DOI 10.1016/j.eswa.2019.05.024; Liebana-Cabanillas F, 2018, TECHNOL FORECAST SOC, V129, P117, DOI 10.1016/j.techfore.2017.12.015; Loh XM, 2019, J COMPUTER INFORM SY; Lowry PB, 2014, IEEE T PROF COMMUN, V57, P123, DOI 10.1109/TPC.2014.2312452; Lunney A, 2016, COMPUT HUM BEHAV, V65, P114, DOI 10.1016/j.chb.2016.08.007; Mazambani L., 2019, AFRICAN J EC MANAGEM; MCMC, 2019, INT US SURV; Merhi M, 2019, TECHNOL SOC, V59, DOI 10.1016/j.techsoc.2019.101151; Miraz M.H., 2018, ARXIV; Nseke P., 2018, INT J INNOV EC DEV, V3, P61, DOI DOI 10.18775/IJIED.1849-7551-7020.2015.36.2005; Oliveira T, 2016, COMPUT HUM BEHAV, V61, P404, DOI 10.1016/j.chb.2016.03.030; Omane-Adjepong M, 2020, CHAOS SOLITON FRACT, V132, DOI 10.1016/j.chaos.2019.109563; Pajo B, 2013, SAGE OPEN, V3, DOI 10.1177/2158244013512134; Patel KJ, 2018, INT J BANK MARK, V36, P147, DOI 10.1108/IJBM-08-2016-0104; Patil P, 2020, INT J INFORM MANAGE, V54, DOI 10.1016/j.ijinfomgt.2020.102144; Phonthanukitithaworn C., 2015, J INTERNET BANKING C, V20, P1; Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452; Polasik M, 2016, INT J ELECTRON COMM, V20, P9, DOI 10.1080/10864415.2016.1061413; Poongodi T., 2020, CRYPTOCURR BLOCKCHAI, P55; Nguyen QK, 2016, 2016 3RD INTERNATIONAL CONFERENCE ON GREEN TECHNOLOGY AND SUSTAINABLE DEVELOPMENT (GTSD), P51, DOI 10.1109/GTSD.2016.22; Ramayah T, 2006, INFORM DEV, V22, P123, DOI DOI 10.1177/0266666906065575; Ramayah T., 2018, PARTIAL LEAST SQUARE, V1st ed.; Riffai MMMA, 2012, INT J INFORM MANAGE, V32, P239, DOI 10.1016/j.ijinfomgt.2011.11.007; Risius M, 2017, BUS INFORM SYST ENG+, V59, P385, DOI 10.1007/s12599-017-0506-0; Rodrigues LF, 2016, COMPUT HUM BEHAV, V61, P114, DOI 10.1016/j.chb.2016.03.015; Rogers E., 2010, DIFFUSION INNOVATION, DOI [10.1097/IMI.0b013e3181cf897d, DOI 10.1097/IMI.0B013E3181CF897D]; Ronkko M, 2013, ORGAN RES METHODS, V16, P425, DOI 10.1177/1094428112474693; Safavi S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01063; Sahibzada U. F., 2019, ASLIB J INFORM MANAG; Seetharaman A., 2017, ACCOUNTING FINANCE R, V6, P230, DOI [DOI 10.5430/AFR.V6N2P230, https://doi.org/10.5430/afr.v6n2p230]; Sekaran U., 2016, RES BUSINESSA SKILL; Shahzad F, 2020, TECHNOL SOC, V62, DOI 10.1016/j.techsoc.2020.101278; Shaw N, 2019, INT J INFORM MANAGE, V45, P44, DOI 10.1016/j.ijinfomgt.2018.10.024; Shmueli G, 2019, EUROPEAN J MARKETING; Sim JJ, 2014, TELEMAT INFORM, V31, P569, DOI 10.1016/j.tele.2013.11.005; Simpson P.K., 1990, PERGAMON; Slade EL, 2015, PSYCHOL MARKET, V32, P860, DOI 10.1002/mar.20823; Sohaib O, 2020, IEEE ACCESS, V8, P13138, DOI 10.1109/ACCESS.2019.2960083; Statista, 2020, NUMBER FACEBOOK USER; Statista, 2019, SHAR HAND PHON US WH; Talukder MS, 2020, TECHNOL FORECAST SOC, V150, DOI 10.1016/j.techfore.2019.119793; Tao Zhou, 2018, International Journal of Networking and Virtual Organisations, V18, P51; van der Heijden H, 2004, MIS QUART, V28, P695, DOI 10.2307/25148660; Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540; Venkatesh V, 2012, MIS QUART, V36, P157; Wang LZ, 2017, SOFT COMPUT, V21, P213, DOI 10.1007/s00500-016-2246-3; Winter JS, 2019, INFORM SOC, V35, P36, DOI 10.1080/01972243.2018.1542648; Xu H, 2009, ELECTRON MARK, V19, P137, DOI 10.1007/s12525-009-0012-4; Yi MY, 2006, DECISION SCI, V37, P393, DOI 10.1111/j.1540-5414.2006.00132.x; Zabukovsek SS, 2019, CENT EUR J OPER RES, V27, P703, DOI 10.1007/s10100-018-0592-1	101	32	32	9	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0247582	10.1371/journal.pone.0247582	http://dx.doi.org/10.1371/journal.pone.0247582			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QU3OZ	33684120	gold, Green Published			2022-12-26	WOS:000627193500005
J	Ajibola, W; Karcagi, I; Somlyai, G; Somlyai, I; Feher, T				Ajibola, Walliyulahi; Karcagi, Ildiko; Somlyai, Gabor; Somlyai, Ildiko; Feher, Tamas			Deuterium-depletion has no significant impact on the mutation rate of Escherichia coli, deuterium abundance therefore has a probabilistic, not deterministic effect on spontaneous mutagenesis	PLOS ONE			English	Article							WATER; OXIDE; D2O; INDUCTION; ACTIVATION; PATHWAYS; BACTERIA; MUTANTS; BIOLOGY; SYSTEM	Deuterium (D), the second most abundant isotope of hydrogen is present in natural waters at an approximate concentration of 145-155 ppm (ca. 1.5E 4 atom/atom). D is known to influence various biological processes due to its physical and chemical properties, which significantly differ from those of hydrogen. For example, increasing D-concentration to >1000-fold above its natural abundance has been shown to increase the frequency of genetic mutations in several species. An interesting deterministic hypothesis, formulated with the intent of explaining the mechanism of D-mutagenicity is based on the calculation that the theoretical probability of base pairs to comprise two adjacent D-bridges instead of H-bridges is 2.3E-8, which is equal to the mutation rate of certain species. To experimentally challenge this hypothesis, and to infer the mutagenicity of D present at natural concentrations, we investigated the effect of a nearly 100-fold reduction of D concentration on the bacterial mutation rate. Using fluctuation tests, we measured the mutation rate of three Escherichia coli genes (cycA, ackA and galK) in media containing D at either <2 ppm or 150 ppm concentrations. Out of 15 pairwise fluctuation analyses, nine indicated a significant decrease, while three marked the significant increase of the mutation/culture value upon D-depletion. Overall, growth in D-depleted minimal medium led to a geometric mean of 0.663-fold (95% confidence interval: 0.483-0.911) change in the mutation rate. This falls nowhere near the expected 10,000-fold reduction, indicating that in our bacterial systems, the effect of D abundance on the formation of point mutations is not deterministic. In addition, the combined results did not display a statistically significant change in the mutation/culture value, the mutation rate or the mutant frequency upon D-depletion. The potential mutagenic effect of D present at natural concentrations on E. coli is therefore below the limit of detection using the indicated methods.	[Ajibola, Walliyulahi; Karcagi, Ildiko; Feher, Tamas] Eotvos Lorand Res Network, Inst Biochem, Synthet & Syst Biol Unit, Biol Res Ctr, Szeged, Hungary; [Ajibola, Walliyulahi] Univ Szeged, Fac Sci & Informat, Doctoral Sch Biol, Szeged, Hungary; [Somlyai, Gabor; Somlyai, Ildiko] HYD LLC Canc Res & Drug Dev, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University	Feher, T (corresponding author), Eotvos Lorand Res Network, Inst Biochem, Synthet & Syst Biol Unit, Biol Res Ctr, Szeged, Hungary.	feher.tamas@brc.hu	Feher, Tamas/AAH-4479-2019	Feher, Tamas/0000-0001-9318-3640	National Research, Development, and Innovation Office, Hungary; OTKA [K 119298]; Economic Development and Innovation Operative Program of the EU [GINOP-2.3.2-15-2016-00001]	National Research, Development, and Innovation Office, Hungary; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Economic Development and Innovation Operative Program of the EU	This work was supported by the National Research, Development, and Innovation Office, Hungary (grant No. OTKA K 119298, awarded to T. F.) (www.nkfih.gov.hu); and by the Economic Development and Innovation Operative Program of the EU (grant No. GINOP-2.3.2-15-2016-00001, awarded to T.F.) (www.ginop.hu).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERGO DD, 1981, BIOCHEMISTRY-US, V20, P1409, DOI 10.1021/bi00509a001; AMES BN, 1973, P NATL ACAD SCI USA, V70, P2281, DOI 10.1073/pnas.70.8.2281; Avila DS, 2012, TOXICOL LETT, V211, P319, DOI 10.1016/j.toxlet.2012.04.014; Billault I, 2001, CHEMBIOCHEM, V2, P425; Brovarets' OO, 2015, J BIOMOL STRUCT DYN, V33, P2716, DOI 10.1080/07391102.2015.1092886; BUTLER LO, 1984, J GEN MICROBIOL, V130, P483; Collins ML, 2003, J APPL PHYSIOL, V94, P2203, DOI 10.1152/japplphysiol.00691.2002; CRESPI HL, 1959, NATURE, V184, P729, DOI 10.1038/184729a0; Csorgo B, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-11; CZAJKA DM, 1961, AM J PHYSIOL, V201, P357, DOI 10.1152/ajplegacy.1961.201.2.357; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEGIOVANNI R, 1960, ANN NY ACAD SCI, V84, P644; Denver DR, 2004, NATURE, V430, P679, DOI 10.1038/nature02697; DOUHAL A, 1995, NATURE, V378, P260, DOI 10.1038/378260a0; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Feher T, 2006, MUTAT RES-FUND MOL M, V595, P184, DOI 10.1016/j.mrfmmm.2005.11.004; Fernandez-Silva FS, 2020, ENVIRON MOL MUTAGEN, V61, P246, DOI 10.1002/em.22335; FURUNOFUKUSHI I, 1985, RADIAT RES, V103, P466, DOI 10.2307/3576770; GIOVANNI RD, 1961, Z VEREBUNGSL, V92, P389, DOI 10.1007/BF00890060; Glantz SA., 2012, PRIMER BIOSTATISTICS, V7; Gustafsson I, 2003, J ANTIMICROB CHEMOTH, V52, P645, DOI 10.1093/jac/dkg427; Gyongyi Z, 2013, NUTR CANCER, V65, P240, DOI 10.1080/01635581.2013.756533; Hall BG, 1998, MOL BIOL EVOL, V15, P1; HUGHES AM, 1964, GENETICS, V49, P715; Jancso G, 2003, HANDBOOK OF NUCLEAR CHEMISTRY, VOL 2, P85; JONES PJH, 1991, CLIN SCI, V80, P277, DOI 10.1042/cs0800277; JUNG K, 1968, Z ALLG MIKROBIOL, V8, P1, DOI 10.1002/jobm.3630080102; JUNG K, 1963, NATURWISSENSCHAFTEN, V50, P690, DOI 10.1007/BF00631730; KASTENBAUM MA, 1970, MUTAT RES, V9, P527, DOI 10.1016/0027-5107(70)90038-2; Katz J. J., 1971, ISOTOPE EFFECTS CHEM, P286; KATZ JJ, 1962, AM J PHYSIOL, V203, P907, DOI 10.1152/ajplegacy.1962.203.5.907; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; KONRAD M, 1960, ANN NY ACAD SCI, V84, P678, DOI 10.1111/j.1749-6632.1960.tb39100.x; KOTYK A, 1990, FEBS LETT, V264, P203, DOI 10.1016/0014-5793(90)80248-H; Krasovec R, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002731; Kselikova V, 2019, FOLIA MICROBIOL, V64, P673, DOI 10.1007/s12223-019-00740-0; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; Lis G, 2008, ANAL CHEM, V80, P287, DOI 10.1021/ac701716q; LOWDIN PO, 1965, ADV QUANTUM CHEM, V2, P213, DOI DOI 10.1016/S0065-3276(08)60076-3; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Maharjan RP, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001477; Minamoto T, 2012, J BIOTECHNOL, V157, P71, DOI 10.1016/j.jbiotec.2011.09.012; Mladin C, 2014, NEUROSCI LETT, V583, P154, DOI 10.1016/j.neulet.2014.09.037; MORGAN JA, 1979, PLANT PHYSIOL, V64, P257, DOI 10.1104/pp.64.2.257; Nyerges A, 2019, SYN BIOL, V4, DOI 10.1093/synbio/ysz008; Pedersen LG, 2006, J THEOR BIOL, V238, P914, DOI 10.1016/j.jtbi.2005.07.002; POLLARD E, 1965, MUTAT RES, V2, P213, DOI 10.1016/0027-5107(65)90030-8; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; RAO DM, 1971, MUTAT RES, V12, P109, DOI 10.1016/0027-5107(71)90081-9; REINSCH J, 1980, J BIOL CHEM, V255, P9093; Reisch CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep15096; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Roubicek DA, 2020, ENVIRON MOL MUTAGEN, V61, P200, DOI 10.1002/em.22316; Rundel PW., 1989, STABLE ISOTOPES ECOL, DOI [10.1007/978-1-4612-3498-2, DOI 10.1007/978-1-4612-3498-2]; Saxena S, 2016, J FOOD SCI, V81, pH508, DOI 10.1111/1750-3841.13190; Schaaper RM, 1998, MUTAT RES-FUND MOL M, V402, P23, DOI 10.1016/S0027-5107(97)00278-9; Schleucher J, 1999, PLANT CELL ENVIRON, V22, P525, DOI 10.1046/j.1365-3040.1999.00440.x; SCHROETER D, 1992, EUR J CELL BIOL, V58, P365; Umenhoffer K, 2017, ACS SYNTH BIOL, V6, P1471, DOI 10.1021/acssynbio.6b00378; WATSON JD, 1953, NATURE, V171, P964, DOI 10.1038/171964b0; Xu P, 2012, ACS SYNTH BIOL, V1, P256, DOI 10.1021/sb300016b; Zamenthof S, 1943, AM NAT, V77, P380, DOI 10.1086/281139; ZHANG BL, 1994, PHYTOCHEM ANALYSIS, V5, P105, DOI 10.1002/pca.2800050304; Zhou YP, 2018, PHYTOCHEMISTRY, V145, P197, DOI 10.1016/j.phytochem.2017.11.004; ZIEGLER H, 1976, PLANTA, V128, P85, DOI 10.1007/BF00397183	65	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0243517	10.1371/journal.pone.0243517	http://dx.doi.org/10.1371/journal.pone.0243517			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU3OZ	33684107	gold, Green Published, Green Accepted			2022-12-26	WOS:000627193500038
J	Chang, CYY; Tseng, CC; Lai, MT; Chiang, AJ; Lo, LC; Chen, CM; Yen, MJ; Sun, L; Yang, L; Hwang, T; Tsai, FJ; Sheu, JJC				Chang, Cherry Yin-Yi; Tseng, Chung-Chen; Lai, Ming-Tsung; Chiang, An-Jen; Lo, Lun-Chien; Chen, Chih-Mei; Yen, Man-Ju; Sun, Li; Yang, Li; Hwang, Tritium; Tsai, Fuu-Jen; Sheu, Jim Jinn-Chyuan			Genetic impacts on thermostability of onco-lncRNA HOTAIR during the development and progression of endometriosis	PLOS ONE			English	Article								HOTAIR is a well-known long non-coding RNA (lncRNA) involved in various cellular signaling, whereas its functional impacts on endometriosis development are still largely unknown. To this end, six potential functional single nucleotide polymorphisms (SNPs) in HOTAIR, with minor allele frequencies more than 10% in Han population and altered net energy of RNA structures larger than 0.5 kcal/mol, were selected for genotyping study. The study included 207 endometriosis patients and 200 healthy women. Genetic substitutions at rs1838169 and rs17720428 were frequently found in endometriosis patients, and rs1838169 showed statistical significance (p = 0.0174). The G-G (rs1838169-rs17720428) haplotype showed the most significant association with endometriosis (p < 0.0001) with enhanced HOTAIR stability, and patients who harbor such haplotype tended to show higher CA125. Data mining further revealed higher mRNA HOTAIR levels in the endometria of patients with severe endometriosis which consistently showed reduced HOXD10 and HOXA5 levels. HOTAIR knockdown with specific shRNAs down-regulated cell proliferation and migration with the induction of HOXD10 and HOXA5 expression in human ovarian clear cancer cells. Our study therefore provided evidence to indicate a prominent role of HOTAIR in promoting endometriosis, which could be used as a potential target for clinical applications.	[Chang, Cherry Yin-Yi] China Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan; [Chang, Cherry Yin-Yi] China Med Univ, Sch Med, Taichung, Taiwan; [Tseng, Chung-Chen; Chiang, An-Jen; Yen, Man-Ju; Hwang, Tritium; Sheu, Jim Jinn-Chyuan] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan; [Lai, Ming-Tsung] Taichung Hosp, Dept Pathol, Minist Hlth & Welf, Taichung, Taiwan; [Chiang, An-Jen] Kaohsiung Vet Gen Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Lo, Lun-Chien; Tsai, Fuu-Jen] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Chen, Chih-Mei; Tsai, Fuu-Jen] China Med Univ Hosp, Human Genet Ctr, Taichung, Taiwan; [Sun, Li] Qingdao Univ, Qingdao Cent Hosp, Dept Gynecol Oncol, Affiliated Hosp 2,Med Coll, Qingdao, Peoples R China; [Sun, Li] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Gynecol Oncol, Jinan, Peoples R China; [Yang, Li] Zhengzhou Univ, Dept Gynecol, Affiliated Hosp 3, Zhengzhou, Peoples R China; [Sheu, Jim Jinn-Chyuan] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Sun Yat Sen University; Kaohsiung Veterans General Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Qingdao University; Shandong First Medical University & Shandong Academy of Medical Sciences; Zhengzhou University; Kaohsiung Medical University	Sheu, JJC (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan.; Tsai, FJ (corresponding author), China Med Univ, Sch Chinese Med, Taichung, Taiwan.; Tsai, FJ (corresponding author), China Med Univ Hosp, Human Genet Ctr, Taichung, Taiwan.; Sheu, JJC (corresponding author), Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan.	d0704@mail.cmuh.org.tw; jimsheu@mail.nsysu.edu.tw			Ministry of Science and Technology, Taiwan [MOST 106-2314-B-110-001-MY3]; China Medical University Hospital, Taiwan [DMR107076]; National Sun Yat-sen UniversityKaohsiung Medical University [108-P013]; National Sun Yat-sen University-Kaohsiung Veterans General Hospital [VGHNSYSU108-010, VGHKS108-122]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); China Medical University Hospital, Taiwan; National Sun Yat-sen UniversityKaohsiung Medical University; National Sun Yat-sen University-Kaohsiung Veterans General Hospital	This study was supported by grants from (JS) Ministry of Science and Technology, Taiwan (MOST 106-2314-B-110-001-MY3), (CC) China Medical University Hospital, Taiwan (DMR107076), (JS) National Sun Yat-sen UniversityKaohsiung Medical University (108-P013), and (JS) National Sun Yat-sen University-Kaohsiung Veterans General Hospital (VGHNSYSU108-010, VGHKS108-122) joint research projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2010, J HUM GENET, V55, P816, DOI 10.1038/jhg.2010.118; Anglesio MS, 2017, NEW ENGL J MED, V376, P1835, DOI 10.1056/NEJMoa1614814; Anglesio MS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072162, 10.1371/annotation/ffcaf179-872f-470b-8bb6-f06d8ba6d03a]; Bellaousov S, 2013, NUCLEIC ACIDS RES, V41, pW471, DOI 10.1093/nar/gkt290; Bhan A, 2015, BBA-REV CANCER, V1856, P151, DOI 10.1016/j.bbcan.2015.07.001; Burglin TR, 2016, CHROMOSOMA, V125, P497, DOI 10.1007/s00412-015-0543-8; Chang CYY, 2016, ONCOTARGET, V7, P76713, DOI 10.18632/oncotarget.11536; Chang CYY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080630; Chang CJ, 2017, J CANCER, V8, P1071, DOI 10.7150/jca.17295; Congrains A, 2013, INT J MOL SCI, V14, P1278, DOI 10.3390/ijms14011278; Du HL, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a023002; Du ML, 2015, ONCOTARGET, V6, P31255, DOI 10.18632/oncotarget.5158; Fernandes JCR, 2019, NON-CODING RNA, V5, DOI 10.3390/ncrna5010017; Forloni Matteo, 2018, Cold Spring Harb Protoc, V2018, DOI 10.1101/pdb.prot097758; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hajjari M, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00113; Hajjari M, 2015, CANCER BIOL MED, V12, P1, DOI 10.7497/j.issn.2095-3941.2015.0006; Hawkins SM, 2011, MOL ENDOCRINOL, V25, P821, DOI 10.1210/me.2010-0371; Herreros-Villanueva M, 2019, CLIN CHIM ACTA, V493, P63, DOI 10.1016/j.cca.2019.02.016; Khurana E, 2016, NAT REV GENET, V17, P93, DOI 10.1038/nrg.2015.17; Kurman RJ, 2016, AM J PATHOL, V186, P733, DOI 10.1016/j.ajpath.2015.11.011; Lee GH, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.07.1237; Li J, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0434-6; Liu XH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-464; Liu X, 2017, ONCOTARGET, V8, P59698, DOI 10.18632/oncotarget.19776; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Myers C, 2002, AM J PATHOL, V161, P2099, DOI 10.1016/S0002-9440(10)64488-4; Ozes AR, 2016, ONCOGENE, V35, P5350, DOI 10.1038/onc.2016.75; Pelletier J, 2018, NAT REV CANCER, V18, P51, DOI 10.1038/nrc.2017.104; Qiu HF, 2017, FUTURE ONCOL, V13, P347, DOI 10.2217/fon-2016-0290; Qiu JJ, 2014, GYNECOL ONCOL, V134, P121, DOI 10.1016/j.ygyno.2014.03.556; Quin JE, 2014, BBA-MOL BASIS DIS, V1842, P802, DOI 10.1016/j.bbadis.2013.12.009; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schenken RS, 1998, J REPROD MED, V43, P269; Sun PR, 2014, FERTIL STERIL, V101, P1038, DOI 10.1016/j.fertnstert.2013.12.035; Tang Q, 2018, CELL PHYSIOL BIOCHEM, V47, P893, DOI 10.1159/000490131; Taylor HS, 1999, HUM REPROD, V14, P1328, DOI 10.1093/humrep/14.5.1328; Teague EMCO, 2010, HUM REPROD UPDATE, V16, P142, DOI 10.1093/humupd/dmp034; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Uno S, 2010, NAT GENET, V42, P707, DOI 10.1038/ng.612; Uphoff CC, 2011, METHODS MOL BIOL, V731, P93, DOI 10.1007/978-1-61779-080-5_8; Wang WT, 2016, SCI REP-UK, V6, DOI 10.1038/srep23343; Wang WW, 2017, REPROD SCI, V24, P400, DOI 10.1177/1933719116657191; Wu HJ, 2016, ONCOTARGET, V7, P41047, DOI 10.18632/oncotarget.8535; Yang HX, 2015, ONCOL REP, V34, P1681, DOI 10.3892/or.2015.4194; Zhang XJ, 2014, CARCINOGENESIS, V35, P2062, DOI 10.1093/carcin/bgu103; Zhou YX, 2018, AM J PHYSIOL-CELL PH, V314, pC690, DOI 10.1152/ajpcell.00222.2017; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0248168	10.1371/journal.pone.0248168	http://dx.doi.org/10.1371/journal.pone.0248168			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667269	gold, Green Published			2022-12-26	WOS:000626604300021
J	Gomes, MB; Neves, MLMW; Barreto, LMG; Ferreira, MD; Monnerat, JPID; Carone, GM; de Morais, JS; Veras, ASC				Gomes, Marilea Batista; Menezes Wanderley Neves, Maria Luciana; Gomes Barreto, Ligia Maria; Ferreira, Marcelo de Andrade; Ismerio dos Santos Monnerat, Joao Paulo; Carone, Guilherme Morais; de Morais, Jasiel Santos; Chaves Veras, Antonia Sherlanea			Prediction of carcass composition through measurements in vivo and measurements of the carcass of growing Santa Ines sheep	PLOS ONE			English	Article							BODY-COMPOSITION; MEAT QUALITY; LAMBS; FAT; PLATFORM; LIVE	In vivo and carcass measurements were evaluated to predict carcass physical and chemical composition and to list the measurements that best fit the prediction of the composition of growing Santa Ines sheep carcasses. Thirty-three animals were used to measure the loin eye area by ultrasound in vivo (LEAu) and in the carcass. We used 39 animals for biometric measurement in vivo and 42 sheep for morphometric measurement in the carcass. For the physical and chemical compositions of carcasses, dissection of the half left carcass was carried out in 42 animals. The data were submitted to Pearson's correlation analysis and t test. Simple and multiple linear regressions were performed using a stepwise procedure. All correlations between in vivo measurements and the physical and chemical compositions of carcasses (in kg) were significant, except for LEAu. Biometric measurements and hot (HCW) and cold (CCW) carcass weights were considered as predictors of the carcasses' physical and chemical compositions. Slaughter body weight (SBW) was the variable that most influenced the equations in the assessment of in vivo measurements and HCW and CCW most influenced the equations for measurements on carcasses. Biometric measurements of Santa Ines sheep can be used together with the SBW to estimate the physical and chemical compositions of carcasses, with emphasis on body compactness index, breast width, wither height, and croup height. The morphometric measurements can be used together with carcass weight to estimate the physical and chemical compositions of carcasses, with emphasis on croup width, carcass compactness index, croup perimeter, external and internal carcass lengths, chest width, and leg length and perimeter. The HCW can be used to predict the physical and chemical composition of carcasses without affecting the accuracy of the prediction model.	[Gomes, Marilea Batista; Menezes Wanderley Neves, Maria Luciana; Ferreira, Marcelo de Andrade; Ismerio dos Santos Monnerat, Joao Paulo; Carone, Guilherme Morais; de Morais, Jasiel Santos; Chaves Veras, Antonia Sherlanea] Univ Fed Rural Pernambuco, Dept Anim Sci, UFRPE, Recife, PE, Brazil; [Gomes Barreto, Ligia Maria] Univ Fed Sergipe, Dept Anim Sci, Nossa Senhora Da Gloria, Sergipe, Brazil	Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal de Sergipe	Neves, MLMW; Veras, ASC (corresponding author), Univ Fed Rural Pernambuco, Dept Anim Sci, UFRPE, Recife, PE, Brazil.	luciana.veterinaria@gmail.com; antonia.veras@ufrpe.br	de Morais, Jasiel/ABA-8678-2021	Gomes Barreto, Ligia Maria/0000-0002-8011-0335	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [88882.436732/2019-01, 88882.436189/201901]; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE) [BCT-0321-5.04/17]; CAPES (Program: PNPD/CAPES) [88882.316794/2019-01]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); CAPES (Program: PNPD/CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	MBG and JSM acknowledges the support of Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Grants Nos. 88882.436732/2019-01 and 88882.436189/201901, respectively), MLMWN acknowledges the support of Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE, Grant No. BCT-0321-5.04/17) and CAPES (Program: PNPD/CAPES, process No 88882.316794/2019-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Agamy R., 2015, Asian Journal of Animal and Veterinary Advances, V10, P335; AOAC, 1990, OFFICIAL METHODS ANA; Bautista-Diaz E, 2017, SMALL RUMINANT RES, V147, P115, DOI 10.1016/j.smallrumres.2016.12.037; Berg RT., 1976, LIVEST PROD SCI, V4, P299; Pinheiro RSB, 2010, REV BRAS ZOOTECN, V39, P1161, DOI 10.1590/S1516-35982010000500030; Brasil. Ministerio da Agricultura. Pecuaria e do Abastecimento (MAPA). Secretaria da Defesa Agropecuaria (SDA). Departamento de Inspeao de Produtos de Origem Animal (DIPOA). Divisao de Normas Tecnicas, 2000, INSTR NORM N 3 7 JAN, P14; Cezar MF., 2007, CARCACAS OVINAS CAPR; Cohen J.E., 1988, STAT POWER ANAL BEHA; Constantino C, 2014, REV BRAS ZOOTECN, V43, P27, DOI 10.1590/S1516-35982014000100005; Fonseca MA, 2017, ANIM PROD SCI, V57, P378, DOI 10.1071/AN15312; Gomes MB, 2020, THESIS U FEDERAL RUR; Hammon DJ., 1965, FARM ANIMALS THEIR B, V3aed; Hopkins DL, 2008, MEAT SCI, V78, P400, DOI 10.1016/j.meatsci.2007.07.002; KEMPSTER AJ, 1982, ANIM PROD, V34, P249, DOI 10.1017/S0003356100010187; Marcondes MI, 2010, THESIS U FEDERAL VIC; Menezes BB., 2015, REV BRAS SAUDE PROD, V16, P874, DOI [10.1590/S1519-99402015000400011, DOI 10.1590/S1519-99402015000400011]; Nascimento Urias Fagner Santos, 2018, Rev. bras. saúde prod. anim., V19, P125, DOI 10.1590/s1519-99402018000100012; NRSR, 2007, NUTR REQ SMALL RUM S; Osorio JCS., 2008, PRODUCAO CARNE OVINA; Osorio JCS, 2005, TECNICAS AVALIACAO V, V2; de Sousa MAP, 2019, TROP ANIM HEALTH PRO, V51, P1903, DOI 10.1007/s11250-019-01886-2; Perez P, 2007, SMALL RUMINANT RES, V70, P124, DOI 10.1016/j.smallrumres.2006.01.013; Ramos EM Fontes PR., 2013, TECNOLOGIA ABATE TIP, V2 ed; Rodrigues DO, 2018, THESIS U FEDERAL GRA; Romero-Bernal J, 2017, CIENC RURAL, V47, DOI 10.1590/0103-8478cr20160533; Rotta PP., 2016, BR CORTE EXIG NCIAS, V5, P127; SAS Inst, 2003, SAS USERS GUIDE VERS; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Siewerdt L, 2002, QUALIDADE MORFOLOGIA; Silva SR, 2017, SMALL RUMINANT RES, V152, P144, DOI 10.1016/j.smallrumres.2016.12.020; Silva SR, 2016, SMALL RUMINANT RES, V136, P173, DOI 10.1016/j.smallrumres.2016.01.024; Souza JD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219343; Stanford K, 1998, SMALL RUMINANT RES, V29, P241, DOI 10.1016/S0921-4488(97)00143-0; Tedeschi LO, 2013, J DAIRY SCI, V96, P2448, DOI 10.3168/jds.2012-6070; TEIXEIRA A, 1989, ANIM PROD, V49, P275, DOI 10.1017/S0003356100032402; Williams AR, 2002, J ANIM SCI, V80, pE183?8, DOI DOI 10.2527/ANIMALSCI2002.80E-SUPPL%5F2E183X; Yildirim A, 2014, S AFR J ANIM SCI, V44, P90, DOI 10.4314/sajas.v44i1.13; Yildirim A., 2013, ITAL J ANIM SCI, V12, P546; Yildirim A, 2017, SAINS MALAYS, V46, P429, DOI 10.17576/jsm-2017-4603-10	40	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0247950	10.1371/journal.pone.0247950	http://dx.doi.org/10.1371/journal.pone.0247950			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667260	gold, Green Published			2022-12-26	WOS:000626604300028
J	Angbohang, A; Huang, L; Li, Y; Zhao, Y; Gong, YJ; Fu, Y; Mao, CF; Morales, J; Luo, PY; Ehteramyan, M; Gao, YT; Margariti, A; Gu, WD; Zhang, M; Smith, A; Shah, AM; Li, T; Kong, W; Zeng, LF				Angbohang, Angshumonik; Huang, Lei; Li, Yi; Zhao, Yue; Gong, Yijie; Fu, Yi; Mao, Chenfeng; Morales, Jose; Luo, Peiyi; Ehteramyan, Mazdak; Gao, Yingtang; Margariti, Andriana; Gu, Wenduo; Zhang, Min; Smith, Alberto; Shah, Ajay M.; Li, Tong; Kong, Wei; Zeng, Lingfang			X-box binding protein 1-mediated COL4A1s secretion regulates communication between vascular smooth muscle and stem/progenitor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN TYPE-IV; XBP1 MESSENGER-RNA; ENDOTHELIAL-CELLS; NONCOLLAGENOUS DOMAINS; BIDIRECTIONAL PROMOTER; ALPHA-2(IV) CHAINS; ALPHA-1(IV); ACTIVATION; MECHANISMS; STRESS	Vascular smooth muscle cells (VSMCs) contribute to the deposition of extracellular matrix proteins (ECMs), including Type IV collagen, in the vessel wall. ECMs coordinate communication among different cell types, but mechanisms underlying this communication remain unclear. Our previous studies have demonstrated that X-box binding protein 1 (XBP1) is activated and contributes to VSMC phenotypic transition in response to vascular injury. In this study, we investigated the participation of XBP1 in the communication between VSMCs and vascular progenitor cells (VPCs). Immunofluorescence and immunohistology staining revealed that Xbp1 gene was essential for type IV collagen alpha 1 (COL4A1) expression during mouse embryonic development and vessel wall ECM deposition and stem cell antigen 1-positive (Sca1(+))VPC recruitment in response to vascular injury. The Western blot analysis elucidated an Xbp1 gene dose-dependent effect on COL4A1 expression and that the spliced XBP1 protein (XBP1s) increased protease-mediated COL4A1 degradation as revealed by Zymography. RT-PCR analysis revealed that XBP1s in VSMCs not only upregulated COL4A1/2 transcription but also induced the occurrence of a novel transcript variant, soluble type IV collagen alpha 1 (COL4A1s), in which the front part of exon 4 is joined with the rear part of exon 42. Chromatinimmunoprecipitation, DNA/protein pulldown and in vitro transcription demonstrated that XBP1s binds to exon 4 and exon 42, directing the transcription from exon 4 to exon 42. This leads to transcription complex bypassing the internal sequences, producing a shortened COL4A1s protein that increased Sca1(+)-VPC migration. Taken together, these results suggest that activated VSMCs may recruit Sca1(+)-VPCs via XBP1s-mediated COL4A1s secretion, leading to vascular injury repair or neointima formation.	[Angbohang, Angshumonik; Huang, Lei; Li, Yi; Zhao, Yue; Morales, Jose; Luo, Peiyi; Ehteramyan, Mazdak; Gu, Wenduo; Zhang, Min; Smith, Alberto; Shah, Ajay M.; Zeng, Lingfang] Kings Coll London, Kings Coll London British Heart Fdn Ctr Excellenc, Fac Life Sci & Med, Sch Cardiovasc Med & Sci, London, England; [Huang, Lei; Zhao, Yue; Li, Tong] Tianjin Third Cent Hosp, Dept Heart Ctr, Tianjin, Peoples R China; [Huang, Lei; Zhao, Yue; Gao, Yingtang; Li, Tong] Tianjin Key Lab Extracorporeal Life Support Crit, Tianjin, Peoples R China; [Gong, Yijie] Tianjin Med Univ, Cent Clin Coll 3, Tianjin, Peoples R China; [Fu, Yi; Mao, Chenfeng; Kong, Wei] Peking Univ, Key Lab Mol Cardiovasc Sci, Minist Educ, Dept Physiol & Pathophysiol,Sch Basic Med Sci, Beijing, Peoples R China; [Gao, Yingtang] Nankai Univ, Affiliated Hosp 3, Tianjin Inst Hepatobiliary Dis, Tianjin, Peoples R China; [Margariti, Andriana] Queens Univ Belfast, Ctr Expt Med, Belfast, Antrim, North Ireland	University of London; King's College London; Tianjin Medical University; Peking University; Nankai University; Queens University Belfast	Zeng, LF (corresponding author), Kings Coll London, Kings Coll London British Heart Fdn Ctr Excellenc, Fac Life Sci & Med, Sch Cardiovasc Med & Sci, London, England.; Li, T (corresponding author), Tianjin Third Cent Hosp, Dept Heart Ctr, Tianjin, Peoples R China.; Li, T (corresponding author), Tianjin Key Lab Extracorporeal Life Support Crit, Tianjin, Peoples R China.; Kong, W (corresponding author), Peking Univ, Key Lab Mol Cardiovasc Sci, Minist Educ, Dept Physiol & Pathophysiol,Sch Basic Med Sci, Beijing, Peoples R China.	litong3zx@sina.com; kongw@bjmu.edu.cn; lingfang-zeng@kcl.ac.uk	Mao, Chenfeng/GYU-9882-2022; Gao, Yingtang/AGK-4112-2022; lei, huang/AFS-7785-2022; Zhang, Min/AAF-7467-2021	Zhang, Min/0000-0003-1657-1337; Zeng, Lingfang/0000-0002-0390-4561; Shah, Ajay/0000-0002-6547-0631; Gu, Wenduo/0000-0002-3859-3150	British Heart Foundation [PG16/13/32024]; Natural Science Foundation of Tianjin City [19JCYBJC26000]; Tianjin Third Central Hospital National Natural Science Foundation Incubation Project of China [2019YNR1]; Tianjin municipal health and Health Committee Science and Technology Talent Cultivation Project of China [KJ20008]; British Heart Foundation Chair [CH/1999001/11735]; Tianjin Municipal Health and Health Committee Science and Technology Self Financing Project of China [ZD20001]	British Heart Foundation(British Heart Foundation); Natural Science Foundation of Tianjin City(Natural Science Foundation of Tianjin); Tianjin Third Central Hospital National Natural Science Foundation Incubation Project of China; Tianjin municipal health and Health Committee Science and Technology Talent Cultivation Project of China; British Heart Foundation Chair(British Heart Foundation); Tianjin Municipal Health and Health Committee Science and Technology Self Financing Project of China	This study was supported by funding from British Heart Foundation project grant PG16/13/32024 (L. Z.), the Natural Science Foundation of Tianjin City No.19JCYBJC26000 (T. L.), the Tianjin Third Central Hospital National Natural Science Foundation Incubation Project of China No.2019YNR1 (L. H.), the Tianjin municipal health and Health Committee Science and Technology Talent Cultivation Project of China No.KJ20008 (L. H.), and A. M. S. is supported by a British Heart Foundation Chair (CH/1999001/11735). The Tianjin Municipal Health and Health Committee Science and Technology Self Financing Project of China (No. ZD20001).	Aikio M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051044; Allahverdian S, 2018, CARDIOVASC RES, V114, P540, DOI 10.1093/cvr/cvy022; BEJARANO PA, 1988, BIOCHEM J, V256, P413, DOI 10.1042/bj2560413; Boosani CS, 2006, PROTEIN EXPRES PURIF, V49, P211, DOI 10.1016/j.pep.2006.03.007; BURBELO PD, 1988, P NATL ACAD SCI USA, V85, P9679, DOI 10.1073/pnas.85.24.9679; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; GRIFFIN CA, 1987, P NATL ACAD SCI USA, V84, P512, DOI 10.1073/pnas.84.2.512; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Hu YH, 2004, J CLIN INVEST, V113, P1258, DOI 10.1172/JCI200419628; Kaimoto T, 2010, HYPERTENSION, V56, P247, DOI 10.1161/HYPERTENSIONAHA.110.149781; Kokkinopoulos I, 2017, STEM CELL REP, V9, P681, DOI 10.1016/j.stemcr.2017.06.011; Kuo DS, 2012, HUM MOL GENET, V21, pR97, DOI 10.1093/hmg/dds346; Lee M, 1999, BIOCHEM MOL BIOL INT, V47, P427; Mak KM, 2017, ANAT REC, V300, P1371, DOI 10.1002/ar.23567; Martin D, 2014, J BIOL CHEM, V289, P30625, DOI 10.1074/jbc.M114.571984; Mauldin G N, 2003, Vet Comp Oncol, V1, P36, DOI 10.1046/j.1476-5829.2003.00004.x; Nguyen AT, 2013, CIRC RES, V112, P17, DOI 10.1161/CIRCRESAHA.112.281048; Oikawa D, 2010, NUCLEIC ACIDS RES, V38, P6265, DOI 10.1093/nar/gkq452; Ortega N, 2002, J CELL SCI, V115, P4201, DOI 10.1242/jcs.00106; PAULSSON M, 1992, CRIT REV BIOCHEM MOL, V27, P93; Petitclerc E, 2000, J BIOL CHEM, V275, P8051, DOI 10.1074/jbc.275.11.8051; POSCHL E, 1988, EMBO J, V7, P2687, DOI 10.1002/j.1460-2075.1988.tb03122.x; Rebustini IT, 2009, DEV CELL, V17, P482, DOI 10.1016/j.devcel.2009.07.016; Reimold AM, 2000, GENE DEV, V14, P152; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sanford JR, 2004, J CELL SCI, V117, P6261, DOI 10.1242/jcs.01513; Sawhney RS, 2006, J BIOL CHEM, V281, P8497, DOI 10.1074/jbc.M600787200; Stanton AE, 2019, ACTA BIOMATER, V96, P310, DOI 10.1016/j.actbio.2019.06.048; Steffensen LB, 2018, AM J PHYSIOL-HEART C, V315, pH610, DOI 10.1152/ajpheart.00070.2018; Tang ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1867; Uemura A, 2009, J CELL SCI, V122, P2877, DOI 10.1242/jcs.040584; Wu Q, 1999, MOL CELL BIOL, V19, P3225; Xiao QZ, 2006, ARTERIOSCL THROM VAS, V26, P2244, DOI 10.1161/01.ATV.0000240251.50215.50; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, CELL STRUCT FUNCT, V31, P117, DOI 10.1247/csf.06016; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113; Zeng LF, 2015, ARTERIOSCL THROM VAS, V35, P2134, DOI 10.1161/ATVBAHA.115.305420; Zeng LF, 2013, CIRCULATION, V127, P1712, DOI 10.1161/CIRCULATIONAHA.112.001337; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106	39	4	4	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100541	10.1016/j.jbc.2021.100541	http://dx.doi.org/10.1016/j.jbc.2021.100541			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33722606	Green Published, gold			2022-12-26	WOS:000672866400514
J	Batishchev, OV; Kuzmina, NV; Mozhaev, AA; Goryashchenko, AS; Mileshina, ED; Orsa, AN; Bocharov, EV; Deyev, IE; Petrenko, AG				Batishchev, Oleg, V; Kuzmina, Natalia, V; Mozhaev, Andrey A.; Goryashchenko, Alexander S.; Mileshina, Ekaterina D.; Orsa, Alexander N.; Bocharov, Eduard, V; Deyev, Igor E.; Petrenko, Alexander G.			Activity-dependent conformational transitions of the insulin receptor-related receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERGENT MICELLES; SENSOR IRR; PROTEIN; VISUALIZATION; EXPRESSION	The insulin receptor (IR), insulin-like growth factor 1 receptor (IGF-1R), and insulin receptor-related receptor (IRR) form a mini family of predimerized receptor-like tyrosine kinases. IR and IGF-1R bind to their peptide agonists triggering metabolic and cell growth responses. In contrast, IRR, despite sharing with them a strong sequence homology, has no peptide-like agonist but can be activated by mildly alkaline media. The spatial structure and activation mechanisms of IRR have not been established yet. The present work represents the first account of a structural analysis of a predimerized receptor-like tyrosine kinase by high-resolution atomic force microscopy in their basal and activated forms. Our data suggest that in neutral media, inactive IRR has two conformations, where one is symmetrical and highly similar to the inactive Lambda/U-shape of IR and IGF-1R ectodomains, whereas the second is drop-like and asymmetrical resembling the IRR ectodomain in solution. We did not observe complexes of IRR intracellular catalytic domains of the inactive receptor forms. At pH 9.0, we detected two presumably active IRR conformations, G-shaped and T-shaped. Both of conformations demonstrated formation of the complex of their intracellular catalytic domains responsible for autophosphorylation. The existence of two active IRR forms correlates well with the previously described positive cooperativity of the IRR activation. In conclusion, our data provide structural insights into the molecular mechanisms of alkali-induced IRR activation under mild native conditions that could be valuable for interpretation of results of IR and IGF-IR structural studies.	[Batishchev, Oleg, V; Kuzmina, Natalia, V] Russian Acad Sci, AN Frumkin Inst Phys Chem & Electrochem, Moscow, Russia; [Mozhaev, Andrey A.; Goryashchenko, Alexander S.; Mileshina, Ekaterina D.; Orsa, Alexander N.; Bocharov, Eduard, V; Deyev, Igor E.; Petrenko, Alexander G.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Mozhaev, Andrey A.] Russian Acad Sci, Shubnikov Inst Crystallog Fed Sci Res Ctr Crystal, Moscow, Russia; [Bocharov, Eduard, V] Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow Region, Russia	Russian Academy of Sciences; Frumkin Institute of Physical Chemistry & Electrochemistry; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Sciences; FSRC Crystallography & Photonics RAS; Moscow Institute of Physics & Technology	Batishchev, OV (corresponding author), Russian Acad Sci, AN Frumkin Inst Phys Chem & Electrochem, Moscow, Russia.	olegbati@gmail.com	Mozhaev, Andrey A./C-6879-2014; Deyev, Igor E/L-5841-2016; Batishchev, Oleg V/L-1976-2013; Deyev, Igor E/CAJ-5868-2022	Mozhaev, Andrey A./0000-0001-5790-9926; Deyev, Igor E/0000-0002-2041-808X; Batishchev, Oleg V/0000-0002-9581-2233; Deyev, Igor E/0000-0002-2041-808X	Russian Foundation for Basic Research (RFBR) [17-00-00488-KOMFI, 17-00-00486KOMFI, 20-0400959-A, 18-04-01369-A]; Ministry of Science and Higher Education of the Russian Federation	Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Ministry of Science and Higher Education of the Russian Federation	The work was supported in part by the Russian Foundation for Basic Research (RFBR) projects No. 17-00-00488-KOMFI (O. V. B., N. V. K.), No. 17-00-00486KOMFI (A. A. M., A. S. G., E. V. B., I. E. D., A. G. P.), No. 20-0400959-A (A. A. M., A. N. O.), and No. 18-04-01369-A (A. A. M., I. E. D., A. G. P.), and by the Ministry of Science and Higher Education of the Russian Federation.	Batishchev OV, 2016, J VIROL, V90, P575, DOI 10.1128/JVI.01539-15; Chen PH, 2015, J MOL BIOL, V427, P3921, DOI 10.1016/j.jmb.2015.10.003; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; Deev I E, 2006, Dokl Biochem Biophys, V408, P184, DOI 10.1134/S1607672906030203; Delle Bovi RJ, 2017, ANAL BIOCHEM, V536, P69, DOI 10.1016/j.ab.2017.08.011; Deyev IE, 2017, BIOCHIMIE, V138, P62, DOI 10.1016/j.biochi.2017.04.002; Deyev IE, 2013, J BIOL CHEM, V288, P33884, DOI 10.1074/jbc.M113.483172; Deyev IE, 2011, CELL METAB, V13, P679, DOI 10.1016/j.cmet.2011.03.022; Deyev IE, 2010, BIOCHIMIE, V92, P418, DOI 10.1016/j.biochi.2010.01.015; Dissen GA, 2006, ENDOCRINOLOGY, V147, P155, DOI 10.1210/en.2005-0386; Ferguson KM, 2020, PROTEIN SCI, V29, P1331, DOI 10.1002/pro.3871; Goryashchenko AS, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10071060; Gutmann T, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201907210; Gutmann T, 2018, J CELL BIOL, V217, P1643, DOI 10.1083/jcb.201711047; Haruyama T, 2019, STRUCTURE, V27, P152, DOI 10.1016/j.str.2018.09.005; Kidmose RT, 2016, STRUCTURE, V24, P351, DOI 10.1016/j.str.2016.02.003; Krasnoperov V, 2009, BIOCHEMISTRY-US, V48, P3230, DOI 10.1021/bi802163p; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12564-0; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; Mi LZ, 2008, BIOCHEMISTRY-US, V47, P10314, DOI 10.1021/bi801006s; Mi LZ, 2011, NAT STRUCT MOL BIOL, V18, P984, DOI 10.1038/nsmb.2092; Mozhaev AA, 2019, RUSS J BIOORG CHEM+, V45, P179, DOI 10.1134/S1068162019020080; Mozhaev AA, 2017, RUSS J BIOORG CHEM+, V43, P653, DOI 10.1134/S1068162017060097; Oliver RC, 2017, J PHYS CHEM LETT, V8, P5041, DOI 10.1021/acs.jpclett.7b02149; Petrenko AG, 2013, BBA-PROTEINS PROTEOM, V1834, P2170, DOI 10.1016/j.bbapap.2012.11.011; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Scapin G, 2018, NATURE, V556, P122, DOI 10.1038/nature26153; Shayahmetova DM, 2016, RUSS J BIOORG CHEM+, V42, P449, DOI 10.1134/S1068162016040166; Shtykova EV, 2019, J VIROL, V93, DOI 10.1128/JVI.01450-18; Shtykova EV, 2019, J BIOL CHEM, V294, P17790, DOI 10.1074/jbc.RA119.010390; Shtykova EV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16986-y; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Weis F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06826-6; Whited AM, 2014, BBA-BIOMEMBRANES, V1838, P56, DOI 10.1016/j.bbamem.2013.04.011; Woldin CN, 1999, J BIOL CHEM, V274, P34981, DOI 10.1074/jbc.274.49.34981; Zhang X, 2020, STRUCTURE, V28, P555, DOI 10.1016/j.str.2020.03.007; Zubkov EA, 2017, ZH VYSSH NERV DEYAT+, V67, P106, DOI 10.7868/S0044467717010130	39	6	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100534	10.1016/j.jbc.2021.100534	http://dx.doi.org/10.1016/j.jbc.2021.100534			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33713705	gold, Green Published			2022-12-26	WOS:000672866400508
J	Parthibane, V; Lin, J; Acharya, D; Abimannan, T; Srideshikan, SM; Klarmann, K; Yang, AC; Soheilian, F; Nagashima, K; Fox, SD; Andresson, T; Tessarollo, L; Keller, JR; Acharya, U; Acharya, JK				Parthibane, Velayoudame; Lin, Jing; Acharya, Diwash; Abimannan, Thiruvaimozhi; Srideshikan, Sargur Madabushi; Klarmann, Kimberly; Yang, Acong; Soheilian, Ferri; Nagashima, Kunio; Fox, Stephen D.; Andresson, Thorkell; Tessarollo, Lino; Keller, Jonathan R.; Acharya, Usha; Acharya, Jairaj K.			SSSPTA is essential for serine palmitoyltransferase function during development and hematopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOVO SPHINGOLIPID BIOSYNTHESIS; LONG-CHAIN-BASE; SACCHAROMYCES-CEREVISIAE; METABOLISM; IDENTIFICATION; PHYSIOLOGY; STEM; DYSFUNCTION; DEFICIENCY; PROTEINS	Serine palmitoyltransferase complex (SPT) mediates the first and rate-limiting step in the de novo sphingolipid biosynthetic pathway. The larger subunits SPTLC1 and SPTLC2/SPTLC3 together form the catalytic core while a smaller third subunit either SSSPTA or SSSPTB has been shown to increase the catalytic efficiency and provide substrate specificity for the fatty acyl-CoA substrates. The in vivo biological significance of these smaller subunits in mammals is still unknown. Here, using two null mutants, a conditional null for ssSPTa and a null mutant for ssSPTb, we show that SSSPTA is essential for embryogenesis and mediates much of the known functions of the SPT complex in mammalian hematopoiesis. The ssSPTa null mutants are embryonic lethal at E6.5 much like the Sptlc1 and Sptlc2 null alleles. Mx1-Cre induced deletion of ssSPTa leads to lethality and myelopoietic defect. Chimeric and competitive bone marrow transplantation experiments show that the defect in myelopoiesis is accompanied by an expansion of the Lin(-)Sca1(+)c-Kit(+) stem and progenitor compartment. Progenitor cells that fail to differentiate along the myeloid lineage display evidence of endoplasmic reticulum stress. On the other hand, ssSPTb null mice are homozygous viable, and analyses of the bone marrow cells show no significant difference in the proliferation and differentiation of the adult hematopoietic compartment. SPTLC1 is an obligatory subunit for the SPT function, and because Sptlc1(-/-) and ssSPTa(-/-) mice display similar defects during development and hematopoiesis, we conclude that an SPT complex that includes SSSPTA mediates much of its developmental and hematopoietic functions in a mammalian model.	[Parthibane, Velayoudame; Lin, Jing; Acharya, Diwash; Abimannan, Thiruvaimozhi; Srideshikan, Sargur Madabushi; Acharya, Usha; Acharya, Jairaj K.] NCI, Canc & Dev Biol Lab, Frederick, MD 21702 USA; [Klarmann, Kimberly; Tessarollo, Lino; Keller, Jonathan R.] NCI, Mouse Canc Genet Program, Frederick, MD USA; [Yang, Acong] NCI, RNA Biol Lab, Ctr Canc Res, Frederick, MD USA; [Soheilian, Ferri; Nagashima, Kunio] NCI, Electron Microscopy Grp, Ctr Canc Res, Frederick, MD USA; [Fox, Stephen D.; Andresson, Thorkell] NCI, Mass Spectrometry Grp, Ctr Canc Res, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Acharya, U; Acharya, JK (corresponding author), NCI, Canc & Dev Biol Lab, Frederick, MD 21702 USA.	acharyaura@nih.gov; acharyaj@mail.nih.gov		Madabushi, Srideshikan/0000-0002-1087-6044; Acharya, Jairaj/0000-0001-7366-4228; Abimannan, Thiruvaimozhi/0000-0001-6210-8058	intramural division of the National Cancer Institute, National Institutes of Health (Division of Health and Human Services)	intramural division of the National Cancer Institute, National Institutes of Health (Division of Health and Human Services)	This study was funded by the intramural division of the National Cancer Institute, National Institutes of Health (Division of Health and Human Services). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Acharya U, 2005, CELL MOL LIFE SCI, V62, P128, DOI 10.1007/s00018-004-4254-1; Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P7276; Alexaki A, 2017, J BIOL CHEM, V292, P3929, DOI 10.1074/jbc.M116.756460; Bieberich E, 2018, CHEM PHYS LIPIDS, V216, P114, DOI 10.1016/j.chemphyslip.2018.08.003; Cartier A, 2019, SCIENCE, V366, P323, DOI 10.1126/science.aar5551; Chen M, 2006, PLANT CELL, V18, P3576, DOI 10.1105/tpc.105.040774; Dadsena S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09654-4; Dzierzak E, 2018, CELL STEM CELL, V22, P639, DOI 10.1016/j.stem.2018.04.015; Fagundez CB, 2009, CELL BIOL INT, V33, P1196, DOI 10.1016/j.cellbi.2009.08.001; Gable K, 2000, J BIOL CHEM, V275, P7597, DOI 10.1074/jbc.275.11.7597; HAKOMORI S, 1993, BIOCHEM SOC T, V21, P583, DOI 10.1042/bst0210583; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Hanada K, 2000, J BIOL CHEM, V275, P8409, DOI 10.1074/jbc.275.12.8409; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Harmon JM, 2013, J BIOL CHEM, V288, P10144, DOI 10.1074/jbc.M113.451526; Harrison PJ, 2018, NAT PROD REP, V35, P921, DOI 10.1039/c8np00019k; Heath V, 2004, BLOOD, V104, P1639, DOI 10.1182/blood-2003-11-3963; Hojjati MR, 2005, BBA-MOL CELL BIOL L, V1737, P44, DOI 10.1016/j.bbalip.2005.08.006; Kimberlin AN, 2013, PLANT CELL, V25, P4627, DOI 10.1105/tpc.113.116145; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Liu F, 2015, J CLIN INVEST, V125, P3532, DOI 10.1172/JCI81749; Loh KC, 2011, ANTI-CANCER AGENT ME, V11, P782; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Merrill AH, 1997, TOXICOL APPL PHARM, V142, P208, DOI 10.1006/taap.1996.8029; Montefusco DJ, 2018, BIOCHEM BIOPH RES CO, V504, P608, DOI 10.1016/j.bbrc.2018.05.078; Fernandes CM, 2020, EXPERT REV ANTI-INFE, V18, P1083, DOI 10.1080/14787210.2020.1792288; Mousley CJ, 2010, ADV ENZYME REGUL, V50, P339, DOI 10.1016/j.advenzreg.2009.12.004; Ogretmen B, 2018, NAT REV CANCER, V18, P33, DOI 10.1038/nrc.2017.96; Oswald MCW, 2015, HUM MOL GENET, V24, P6899, DOI 10.1093/hmg/ddv390; Parthibane V, 2019, BLOOD ADV, V3, P3635, DOI 10.1182/bloodadvances.2019000729; PINTO WJ, 1992, J BACTERIOL, V174, P2565, DOI 10.1128/jb.174.8.2565-2574.1992; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ross JS, 2014, CLIN LIPIDOL, V9, P553, DOI 10.2217/CLP.14.37; Rutti MF, 2009, J LIPID RES, V50, P1237, DOI 10.1194/jlr.D900001-JLR200; Shamu Caroline E., 1994, Trends in Cell Biology, V4, P56, DOI 10.1016/0962-8924(94)90011-6; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Singh SK, 2013, J EXP MED, V210, P987, DOI 10.1084/jem.20121608; Smith CM, 2019, NUCLEIC ACIDS RES, V47, pD774, DOI 10.1093/nar/gky922; Smith WL, 2002, J BIOL CHEM, V277, P25841, DOI 10.1074/jbc.R200011200; Tessarollo Lino, 2009, V530, P141, DOI 10.1007/978-1-59745-471-1_8; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; WELLS GB, 1983, J BIOL CHEM, V258, P200; Wigger D, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00210; Xie SZ, 2019, CELL STEM CELL, V25, P639, DOI 10.1016/j.stem.2019.09.008; Yonamine I, 2011, J CELL BIOL, V192, P557, DOI 10.1083/jcb.201004098; Zhao LH, 2015, P NATL ACAD SCI USA, V112, P12962, DOI 10.1073/pnas.1516733112	50	3	3	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100491	10.1016/j.jbc.2021.100491	http://dx.doi.org/10.1016/j.jbc.2021.100491			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33662400	gold, Green Published			2022-12-26	WOS:000672866400465
J	Campbell, GE; Bender, HR; Parker, GA; Curry, TE; Duffy, DM				Campbell, Genevieve E.; Bender, Hannah R.; Parker, Grace A.; Curry, Thomas E., Jr.; Duffy, Diane M.			Neurotensin: A novel mediator of ovulation?	FASEB JOURNAL			English	Article						angiogenesis; fertility; ovary; primate; sortilin	GROWTH-FACTOR; LUTEINIZING-HORMONE; GRANULOSA-CELLS; PROGESTERONE SYNTHESIS; NEUROENDOCRINE TUMORS; KINASE-C; RECEPTOR; OVARIAN; EXPRESSION; PROSTAGLANDIN-E2	The midcycle luteinizing hormone (LH) surge initiates a cascade of events within the ovarian follicle which culminates in ovulation. Only mural granulosa cells and theca cells express large numbers of LH receptors, and LH-stimulated paracrine mediators communicate the ovulatory signal within the follicle. Recent reports identified the neuropeptide neurotensin (NTS) as a product of granulosa cells. Here, we demonstrate that granulosa cells were the primary site of NTS expression in macaque ovulatory follicles. Granulosa cell NTS mRNA and protein increased after human chorionic gonadotropin (hCG) administration, which substitutes for the LH surge. To identify ovulatory actions of NTS, a NTS-neutralizing antibody was injected into preovulatory macaque follicles. hCG administration immediately followed, and ovaries were removed 48 hours later to evaluate ovulatory events. Follicles injected with control IgG ovulated normally. In contrast, 75% of NTS antibody-injected follicles failed to ovulate, containing oocytes trapped within unruptured, hemorrhagic follicles. Serum progesterone was unchanged. Of the three NTS receptors, SORT1 was highly expressed in follicular granulosa, theca, and endothelial cells; NTSR1 and NTSR2 were expressed at lower levels. Excessive blood cells in NTS antibody-injected follicles indicated vascular anomalies, so the response of monkey ovarian endothelial cells to NTS was evaluated in vitro. NTS stimulated endothelial cell migration and capillary sprout formation, consistent with a role for NTS in vascular remodeling associated with ovulation. In summary, we identified NTS as a possible paracrine mediator of ovulation. Further investigation of the NTS synthesis/response pathway may lead to improved treatments for infertility and novel targets for contraception.	[Campbell, Genevieve E.; Bender, Hannah R.; Parker, Grace A.; Duffy, Diane M.] Eastern Virginia Med Sch, Dept Physiol Sci, POB 1980, Norfolk, VA 23501 USA; [Curry, Thomas E., Jr.] Univ Kentucky, Dept Obstet & Gynecol, Lexington, KY USA	Eastern Virginia Medical School; University of Kentucky	Duffy, DM (corresponding author), Eastern Virginia Med Sch, Dept Physiol Sci, POB 1980, Norfolk, VA 23501 USA.	duffydm@evms.edu			HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [P01 HD071875, R01 HD097675]	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: P01 HD071875 and R01 HD097675	Akter H, 2015, TUMOR BIOL, V36, P6053, DOI 10.1007/s13277-015-3282-9; Amorino GP, 2007, ONCOGENE, V26, P745, DOI 10.1038/sj.onc.1209814; Bender HR, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00727; Bender HR, 2018, ENDOCRINOLOGY, V159, P710, DOI 10.1210/en.2017-00739; Beraud-Dufour S, 2009, INT J BIOCHEM CELL B, V41, P2398, DOI 10.1016/j.biocel.2009.04.002; Besserer-Offroy E, 2017, EUR J PHARMACOL, V805, P1, DOI 10.1016/j.ejphar.2017.03.046; BIDARD JN, 1993, BIOCHEM J, V291, P225, DOI 10.1042/bj2910225; Bishop CV, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.134981; Boules Mona, 2013, Front Endocrinol (Lausanne), V4, P36, DOI 10.3389/fendo.2013.00036; Campbell GE., 2020, FERTIL STERIL SCI, V1, p27; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; Cerny KL, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0077-1; Choi Y, 2017, J CLIN ENDOCR METAB, V102, P1971, DOI 10.1210/jc.2016-3153; Coppola T, 2008, INT J BIOCHEM CELL B, V40, P2296, DOI 10.1016/j.biocel.2008.03.015; Curry TE, 2003, ENDOCR REV, V24, P428, DOI 10.1210/er.2002-0005; DAVIES WA, 1993, ENDOCRINOLOGY, V132, P2491, DOI 10.1210/en.132.6.2491; Devader C, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00542; Di Florio A, 2013, BBA-MOL CELL RES, V1833, P573, DOI 10.1016/j.bbamcr.2012.11.021; Dissen GA, 1996, ENDOCRINOLOGY, V137, P198, DOI 10.1210/en.137.1.198; Driessen TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083098; Duffy DM, 2019, ENDOCR REV, V40, P369, DOI 10.1210/er.2018-00075; Duffy DM, 2015, HUM REPROD UPDATE, V21, P652, DOI 10.1093/humupd/dmv026; Duffy DM, 2005, HUM REPROD, V20, P1485, DOI 10.1093/humrep/deh784; Duffy DM, 2005, J CLIN ENDOCR METAB, V90, P1021, DOI 10.1210/jc.2004-1229; Dupouy S, 2014, ONCOTARGET, V5, P8235, DOI 10.18632/oncotarget.1632; Elvin JA, 2000, P NATL ACAD SCI USA, V97, P10288, DOI 10.1073/pnas.180295197; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Ghaemimanesh Fatemeh, 2014, Avicenna Journal of Medical Biotechnology, V6, P169; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Hibbert ML, 1996, P NATL ACAD SCI USA, V93, P1897, DOI 10.1073/pnas.93.5.1897; Hiradate Y, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.112789; Huber S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175842; Kalafatakis K, 2011, REGUL PEPTIDES, V170, P7, DOI 10.1016/j.regpep.2011.04.005; Kim JT, 2018, NEOPLASIA, V20, P175, DOI 10.1016/j.neo.2017.11.012; Kim SO, 2014, ENDOCRINOLOGY, V155, P1466, DOI 10.1210/en.2013-2096; Lemko HMD, 2010, AM J PHYSIOL-ENDOC M, V298, pE80, DOI 10.1152/ajpendo.00380.2009; Li J, 2016, NATURE, V533, P411, DOI 10.1038/nature17662; Luckmann M, 2016, MOL INFORM, V35, P19, DOI 10.1002/minf.201500080; Luna LG, 1968, MANUAL HISTOLOGIC ST, V3; Maati HMO, 2012, NEUROPHARMACOLOGY, V62, P278, DOI 10.1016/j.neuropharm.2011.07.019; Mazella Jean, 2012, Front Endocrinol (Lausanne), V3, P143, DOI 10.3389/fendo.2012.00143; MCALLISTER JM, 1989, ENDOCRINOLOGY, V125, P1959, DOI 10.1210/endo-125-4-1959; McAllister JM., METHODS TOXICOL, V10, P329, DOI [10.1210/endo-125-4-1959, DOI 10.1210/ENDO-125-4-1959]; Mijatovic T, 2007, CELL ONCOL, V29, P315; Muller KM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-421; Niringiyumukiza JD, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0359-5; Nykjaer A, 2012, TRENDS NEUROSCI, V35, P261, DOI 10.1016/j.tins.2012.01.003; Pelaprat D, 2006, PEPTIDES, V27, P2476, DOI 10.1016/j.peptides.2006.04.027; PENG XR, 1991, ENDOCRINOLOGY, V129, P3200, DOI 10.1210/endo-129-6-3200; REINECKE M, 1987, NEUROSCI LETT, V73, P220, DOI 10.1016/0304-3940(87)90248-5; Richard F, 2001, MOL PHARMACOL, V60, P1392, DOI 10.1124/mol.60.6.1392; Robker RL, 2018, ENDOCRINOLOGY, V159, P3209, DOI 10.1210/en.2018-00485; Rothchild I, 1981, Recent Prog Horm Res, V37, P183; Sakumoto R, 2015, J REPROD DEVELOP, V61, P297, DOI 10.1262/jrd.2015-024; Seachord CL, 2005, BIOL REPROD, V72, P1305, DOI 10.1095/biolreprod.104.037523; Sicard F, 2006, J CLIN ENDOCR METAB, V91, P3131, DOI 10.1210/jc.2006-0105; Souaze F, 2006, CANCER RES, V66, P6243, DOI 10.1158/0008-5472.CAN-06-0450; Stouffer RL, 2013, REPROD BIOL, V13, P259, DOI 10.1016/j.repbio.2013.08.002; Su ZJ, 2019, GENE, V687, P143, DOI 10.1016/j.gene.2018.10.062; Tena-Sempere M, 2017, NAT REV ENDOCRINOL, V13, P67, DOI 10.1038/nrendo.2016.216; Trau HA, 2016, HUM REPROD, V31, P436, DOI 10.1093/humrep/dev320; Trau HA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.123711; Umezu K, 2016, J REPROD DEVELOP, V62, P409, DOI 10.1262/jrd.2016-055; Ushiro S, 1997, FEBS LETT, V418, P341, DOI 10.1016/S0014-5793(97)01403-8; WEICK RF, 1973, ENDOCRINOLOGY, V93, P1140; Wissing ML, 2014, HUM REPROD, V29, P997, DOI 10.1093/humrep/deu008; Xu FH, 2005, CONTRACEPTION, V71, P239, DOI 10.1016/j.contraception.2004.12.017; Younes M, 2014, ONCOTARGET, V5, P8252, DOI 10.18632/oncotarget.1633; Yung Y, 2014, MOL HUM REPROD, V20, P844, DOI 10.1093/molehr/gau041	69	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21481	10.1096/fj.202002547RR	http://dx.doi.org/10.1096/fj.202002547RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710668	Green Accepted			2022-12-26	WOS:000635216100016
J	Mamaeva, D; Jazouli, Z; DiFrancesco, ML; Erkilic, N; Dubois, G; Hilaire, C; Meunier, I; Boukhaddaoui, H; Kalatzis, V				Mamaeva, Daria; Jazouli, Zhour; DiFrancesco, Mattia L.; Erkilic, Nejla; Dubois, Gregor; Hilaire, Cecile; Meunier, Isabelle; Boukhaddaoui, Hassan; Kalatzis, Vasiliki			Novel roles for voltage-gated T-type Ca2+ and ClC-2 channels in phagocytosis and angiogenic factor balance identified in human iPSC-derived RPE	FASEB JOURNAL			English	Article						Ca2+ and K+ channels; ClC&#8208; 2 chloride channel; iPSC&#8208; derived RPE; phagocytosis; secretion	RETINAL-PIGMENT EPITHELIUM; GROWTH-FACTOR SECRETION; PLURIPOTENT STEM-CELLS; CHLORIDE CHANNEL; ION CHANNELS; POTASSIUM CHANNELS; TRANSPORT MECHANISMS; LARGE-CONDUCTANCE; CALCIUM-CHANNELS; MESSENGER-RNA	Human-induced pluripotent stem cell (hiPSC)-derived retinal pigment epithelium (RPE) is a powerful tool for pathophysiological studies and preclinical therapeutic screening, as well as a source for clinical cell transplantation. Thus, it must be validated for maturity and functionality to ensure correct data readouts and clinical safety. Previous studies have validated hiPSC-derived RPE as morphologically characteristic of the tissue in the human eye. However, information concerning the expression and functionality of ion channels is still limited. We screened hiPSC-derived RPE for the polarized expression of a panel of L-type (Ca(V)1.1, Ca(V)1.3) and T-type (Ca(V)3.1, Ca(V)3.3) Ca2+ channels, K+ channels (Maxi-K, Kir4.1, Kir7.1), and the Cl- channel ClC-2 known to be expressed in native RPE. We also tested the roles of these channels in key RPE functions using specific inhibitors. In addition to confirming the native expression profiles and function of certain channels, such as L-type Ca2+ channels, we show for the first time that T-type Ca2+ channels play a role in both phagocytosis and vascular endothelial growth factor (VEGF) secretion. Moreover, we demonstrate that Maxi-K and Kir7.1 channels are involved in the polarized secretion of VEGF and pigment epithelium-derived factor (PEDF). Furthermore, we show a novel localization for ClC-2 channel on the apical side of hiPSC-derived RPE, with an overexpression at the level of fluid-filled domes, and demonstrate that it plays an important role in phagocytosis, as well as VEGF and PEDF secretion. Taken together, hiPSC-derived RPE is a powerful model for advancing fundamental knowledge of RPE functions.	[Mamaeva, Daria; Jazouli, Zhour; DiFrancesco, Mattia L.; Erkilic, Nejla; Dubois, Gregor; Hilaire, Cecile; Meunier, Isabelle; Boukhaddaoui, Hassan; Kalatzis, Vasiliki] Montpellier Univ, Inst Neurosci Montpellier, INSERM, Montpellier, France; [Erkilic, Nejla; Meunier, Isabelle] Montpellier Univ, CHU Montpellier, Natl Reference Ctr Inherited Sensory Dis, Montpellier, France; [DiFrancesco, Mattia L.] Italian Inst Technol, Ctr Synapt Neurosci & Technol, Genoa, Italy; [DiFrancesco, Mattia L.] IRCCS Osped Policlin San Martino, Genoa, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Istituto Italiano di Tecnologia - IIT	Mamaeva, D; Kalatzis, V (corresponding author), INSERM, Inst Neurosci Montpellier INM, U1298, 80 Ave Augustin Fliche, F-34091 Montpellier, France.	daria.mamaeva@inserm.fr; vasiliki.kalatzis@inserm.fr	DiFrancesco, Mattia Lorenzo/AAC-1029-2022; Kalatzis, Vasiliki/F-6170-2019	DiFrancesco, Mattia Lorenzo/0000-0002-7511-4438; Kalatzis, Vasiliki/0000-0002-9626-8807; BOUKHADDAOUI, HASSAN/0000-0003-1808-7901	Fondation de France [2015 00061320]	Fondation de France(Fondation de France)	Fondation de France, Grant/Award Number: 2015 00061320	Alexander SPH, 2011, BRIT J PHARMACOL, V164, pS1, DOI 10.1111/j.1476-5381.2011.01649_1.x; Bailey CS, 2019, J GEN PHYSIOL, V151, P1173, DOI 10.1085/jgp.201912457; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Bi MM, 2014, INT J MOL SCI, V15, P218, DOI 10.3390/ijms15010218; BIALEK S, 1994, J PHYSIOL-LONDON, V475, P401, DOI 10.1113/jphysiol.1994.sp020081; Bilmen JG, 2002, ARCH BIOCHEM BIOPHYS, V406, P55, DOI 10.1016/S0003-9861(02)00240-0; Blaug S, 2003, DOC OPHTHALMOL, V106, P43, DOI 10.1023/A:1022514031645; Borooah S, 2013, PROG RETIN EYE RES, V37, P163, DOI 10.1016/j.preteyeres.2013.09.002; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; Brandl C, 2014, NEUROMOL MED, V16, P551, DOI 10.1007/s12017-014-8308-8; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Calderone V, 2002, CURR MED CHEM, V9, P1385, DOI 10.2174/0929867023369871; Catalan M, 2002, AM J PHYSIOL-GASTR L, V283, pG1004, DOI 10.1152/ajpgi.00158.2002; Cereso N, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.11; Collison DJ, 2005, EXP EYE RES, V80, P465, DOI 10.1016/j.exer.2004.09.009; Cordes M, 2020, FASEB J, V34, P4055, DOI 10.1096/fj.201901202RR; Depienne C, 2013, LANCET NEUROL, V12, P659, DOI 10.1016/S1474-4422(13)70053-X; Doss MX, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050403; Duan D, 2000, CIRC RES, V86, pE63, DOI 10.1161/01.RES.86.4.e63; Ebert AD, 2012, J CARDIOVASC PHARM, V60, P408, DOI 10.1097/FJC.0b013e318247f642; EDELMAN JL, 1994, AM J PHYSIOL, V266, pC957, DOI 10.1152/ajpcell.1994.266.4.C957; Edwards MM, 2010, INVEST OPHTH VIS SCI, V51, P3264, DOI 10.1167/iovs.09-4887; Erkilic N, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091068; Gallemore RP, 1997, PROG RETIN EYE RES, V16, P509, DOI 10.1016/S1350-9462(96)00037-7; Geng YY, 2013, J GEN PHYSIOL, V141, P493, DOI 10.1085/jgp.201210955; Giblin JP, 2016, ADV PROTEIN CHEM STR, V104, P157, DOI 10.1016/bs.apcsb.2015.11.006; Gronski MA, 2009, CELL DEATH DIFFER, V16, P1323, DOI 10.1038/cdd.2009.55; GRUNDER S, 1992, NATURE, V360, P759, DOI 10.1038/360759a0; Gyomorey K, 2000, AM J PHYSIOL-CELL PH, V279, pC1787, DOI 10.1152/ajpcell.2000.279.6.C1787; Hartzell C, 2005, PHYSIOLOGY, V20, P292, DOI 10.1152/physiol.00021.2005; Hartzell HC, 2003, J PHYSIOL-LONDON, V549, P453, DOI 10.1113/jphysiol.2003.040428; He XM, 2015, CLIN SCI, V128, P805, DOI 10.1042/CS20130463; Heckmann BL, 2019, J CELL SCI, V132, DOI 10.1242/jcs.231472; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Niemeyer MI, 2009, J PHYSIOL-LONDON, V587, P1387, DOI 10.1113/jphysiol.2008.167353; Jentsch TJ, 2018, PHYSIOL REV, V98, P1493, DOI 10.1152/physrev.00047.2017; Jentsch TJ, 2015, J PHYSIOL-LONDON, V593, P4091, DOI 10.1113/JP270043; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Johnson AA, 2017, PROG RETIN EYE RES, V58, P45, DOI 10.1016/j.preteyeres.2017.01.006; Joksimovic SM, 2017, J PHYSIOL-LONDON, V595, P6327, DOI 10.1113/JP274565; Kanzaki Y, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.5.38; Karl MO, 2008, CELL SIGNAL, V20, P1159, DOI 10.1016/j.cellsig.2008.02.005; Keckeis S, 2017, EXP EYE RES, V154, P139, DOI 10.1016/j.exer.2016.12.003; Kharade SV, 2017, MOL PHARMACOL, V92, P338, DOI 10.1124/mol.117.108472; Klettner AK, 2020, RETINAL PIGMENT EPITHELIUM IN HEALTH AND DISEASE, P85, DOI 10.1007/978-3-030-28384-1_5; Kokkinaki M, 2011, STEM CELLS, V29, P825, DOI 10.1002/stem.635; Korkka I., 2017, EMBEC NBC, V65, p454; Korkka I, 2019, STEM CELL TRANSL MED, V8, P179, DOI 10.1002/sctm.18-0026; Krohne TU, 2012, STEM CELL TRANSL MED, V1, P96, DOI 10.5966/sctm.2011-0057; Kumar M, 2014, CHANNELS, V8, P488, DOI 10.4161/19336950.2014.959809; Kusaka S, 1999, J PHYSIOL-LONDON, V520, P373, DOI 10.1111/j.1469-7793.1999.00373.x; Kusaka S, 2001, J PHYSIOL-LONDON, V531, P27, DOI 10.1111/j.1469-7793.2001.0027j.x; Lakkaraju A, 2020, PROG RETIN EYE RES, V78, DOI 10.1016/j.preteyeres.2020.100846; Lipecka J, 2002, AM J PHYSIOL-CELL PH, V282, pC805, DOI 10.1152/ajpcell.00291.2001; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; Mandai M, 2017, NEW ENGL J MED, V376, P1038, DOI 10.1056/NEJMoa1608368; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097; Marneros AG, 2005, AM J PATHOL, V167, P1451, DOI 10.1016/S0002-9440(10)61231-X; Mears D, 2004, J MEMBRANE BIOL, V200, P57, DOI 10.1007/s00232-004-0692-9; Mehta A, 2005, PEDIATR PULM, V39, P292, DOI 10.1002/ppul.20147; Mergler S, 2002, EXP EYE RES, V74, P29, DOI 10.1006/exer.2001.1128; Milenkovic A, 2015, P NATL ACAD SCI USA, V112, pE2630, DOI 10.1073/pnas.1418840112; Muller C, 2014, CELL SIGNAL, V26, P968, DOI 10.1016/j.cellsig.2013.12.021; Muller C, 2020, RETINAL PIGMENT EPITHELIUM IN HEALTH AND DISEASE, P47, DOI 10.1007/978-3-030-28384-1_3; Mullin NK., 2020, PROG RETIN EYE RES, V29; Nachtigal AL, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051597; Nguyen HV, 2015, J CLIN MED, V4, P567, DOI 10.3390/jcm4040567; Peterson WM, 1997, J NEUROSCI, V17, P2324; RAYMOND SM, 1995, CURR BIOL, V5, P1286, DOI 10.1016/S0960-9822(95)00255-7; Reichhart N, 2020, RETINAL PIGMENT EPITHELIUM IN HEALTH AND DISEASE, P65, DOI 10.1007/978-3-030-28384-1_4; Reichhart N, 2015, CELL SIGNAL, V27, P2231, DOI 10.1016/j.cellsig.2015.07.023; Reichhart N, 2010, EXP EYE RES, V91, P630, DOI 10.1016/j.exer.2010.08.001; Rosenthal R, 2007, MOL VIS, V13, P443; Rossier MF, 1996, ENDOCRINOLOGY, V137, P4817, DOI 10.1210/en.137.11.4817; Ryan JS, 1999, J PHYSIOL-LONDON, V520, P745, DOI 10.1111/j.1469-7793.1999.00745.x; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Sanjurjo-Soriano C, 2020, MOL THER-METH CLIN D, V17, P156, DOI 10.1016/j.omtm.2019.11.016; Sanjurjo-Soriano C, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/5056279; Schnichels S, 2021, PROG RETIN EYE RES, V81, DOI 10.1016/j.preteyeres.2020.100880; Shahi PK, 2019, AM J HUM GENET, V104, P310, DOI 10.1016/j.ajhg.2018.12.019; Sheu SJ, 2009, KAOHSIUNG J MED SCI, V25, P381, DOI 10.1016/S1607-551X(09)70531-5; Shimura M, 2001, J PHYSIOL-LONDON, V531, P329, DOI 10.1111/j.1469-7793.2001.0329i.x; Simonin Y, 2019, EBIOMEDICINE, V39, P315, DOI 10.1016/j.ebiom.2018.12.010; Singh R, 2015, MOL THER, V23, P1700, DOI 10.1038/mt.2015.141; Singh R, 2013, INVEST OPHTH VIS SCI, V54, P6767, DOI 10.1167/iovs.13-11943; Singh R, 2013, HUM MOL GENET, V22, P593, DOI 10.1093/hmg/dds469; Sparrrow JR, 2010, CURR MOL MED, V10, P802; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strauss O, 2016, ADV EXP MED BIOL, V854, P739, DOI 10.1007/978-3-319-17121-0_98; Sullivan DM, 1997, J NEUROSCI RES, V49, P43, DOI 10.1002/(SICI)1097-4547(19970701)49:1<43::AID-JNR5>3.0.CO;2-D; Tanimoto N, 2012, J NEUROSCI, V32, P4861, DOI 10.1523/JNEUROSCI.4654-11.2012; Tao QP, 1996, CURR EYE RES, V15, P237, DOI 10.3109/02713689609007617; Thompson CH, 2009, J BIOL CHEM, V284, P26051, DOI 10.1074/jbc.M109.031724; TOMBRANTINK J, 1995, J NEUROSCI, V15, P4992; Torriano S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26481-7; Torriano S, 2017, HUM MOL GENET, V26, P3573, DOI 10.1093/hmg/ddx244; Tovell VE, 2008, INVEST OPHTH VIS SCI, V49, P350, DOI 10.1167/iovs.07-1040; Wang HW, 2017, MOL MED REP, V16, P11, DOI 10.3892/mmr.2017.6600; Weng TX, 2002, AM J PHYSIOL-CELL PH, V283, pC839, DOI 10.1152/ajpcell.00445.2001; Wills NK, 2000, INVEST OPHTH VIS SCI, V41, P4247; Wimmers S, 2008, GRAEF ARCH CLIN EXP, V246, P685, DOI 10.1007/s00417-008-0778-7; Wimmers S, 2007, PROG RETIN EYE RES, V26, P263, DOI 10.1016/j.preteyeres.2006.12.002; Wimmers S, 2008, MOL VIS, V14, P2340; Wolfensberger T., 1998, RETINAL PIGMENT EPIT, P103; Wollmann G, 2006, VISION RES, V46, P688, DOI 10.1016/j.visres.2005.08.030; Ye K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70979-y; Zhao SL, 2001, MOL VIS, V7, P277; Zhu DH, 2011, INVEST OPHTH VIS SCI, V52, P1573, DOI 10.1167/iovs.10-6413	110	2	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21406	10.1096/fj.202002754R	http://dx.doi.org/10.1096/fj.202002754R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33724552				2022-12-26	WOS:000635216100038
J	Miyashita, Y; Tsukamoto, O; Matsuoka, K; Kamikubo, K; Kuramoto, Y; Fu, HY; Tsubota, T; Hasuike, H; Takayama, T; Ito, H; Hitsumoto, T; Okamoto, C; Kioka, H; Oya, R; Shinomiya, H; Hakui, H; Shintani, Y; Kato, H; Kitakaze, M; Sakata, Y; Asano, Y; Takashima, S				Miyashita, Yohei; Tsukamoto, Osamu; Matsuoka, Ken; Kamikubo, Kenta; Kuramoto, Yuki; Ying Fu, Hai; Tsubota, Tomoya; Hasuike, Hirona; Takayama, Toshio; Ito, Hiroaki; Hitsumoto, Tatsuro; Okamoto, Chisato; Kioka, Hidetaka; Oya, Ryohei; Shinomiya, Haruki; Hakui, Hideyuki; Shintani, Yasunori; Kato, Hisakazu; Kitakaze, Masafumi; Sakata, Yasushi; Asano, Yoshihiro; Takashima, Seiji			The CR9 element is a novel mechanical load-responsive enhancer that regulates natriuretic peptide genes expression	FASEB JOURNAL			English	Article						cardiomyocyte; CR9; enhancer; mechanical loads; natriuretic peptides		Enhancers regulate gene expressions in a tissue- and pathology-specific manner by altering its activities. Plasma levels of atrial and brain natriuretic peptides, encoded by the Nppa and Nppb, respectively, and synthesized predominantly in cardiomyocytes, vary depending on the severity of heart failure. We previously identified the noncoding conserved region 9 (CR9) element as a putative Nppb enhancer at 22-kb upstream from the Nppb gene. However, its regulatory mechanism remains unknown. Here, we therefore investigated the mechanism of CR9 activation in cardiomyocytes using different kinds of drugs that induce either cardiac hypertrophy or cardiac failure accompanied by natriuretic peptides upregulation. Chronic treatment of mice with either catecholamines or doxorubicin increased CR9 activity during the progression of cardiac hypertrophy to failure, which is accompanied by proportional increases in Nppb expression. Conversely, for cultured cardiomyocytes, doxorubicin decreased CR9 activity and Nppb expression, while catecholamines increased both. However, exposing cultured cardiomyocytes to mechanical loads, such as mechanical stretch or hydrostatic pressure, upregulate CR9 activity and Nppb expression even in the presence of doxorubicin. Furthermore, the enhancement of CR9 activity and Nppa and Nppb expressions by either catecholamines or mechanical loads can be blunted by suppressing mechanosensing and mechanotransduction pathways, such as muscle LIM protein (MLP) or myosin tension. Finally, the CR9 element showed a more robust and cell-specific response to mechanical loads than the -520-bp BNP promoter. We concluded that the CR9 element is a novel enhancer that responds to mechanical loads by upregulating natriuretic peptides expression in cardiomyocytes.	[Miyashita, Yohei; Tsukamoto, Osamu; Matsuoka, Ken; Kamikubo, Kenta; Tsubota, Tomoya; Hasuike, Hirona; Hitsumoto, Tatsuro; Okamoto, Chisato; Oya, Ryohei; Kato, Hisakazu; Takashima, Seiji] Osaka Univ, Grad Sch Med Frontier Biosci, Dept Med Biochem, Suita, Osaka, Japan; [Miyashita, Yohei] Osaka Univ, Grad Sch Med, Dept Legal Med, Suita, Osaka, Japan; [Miyashita, Yohei; Kuramoto, Yuki; Kioka, Hidetaka; Shinomiya, Haruki; Hakui, Hideyuki; Sakata, Yasushi; Asano, Yoshihiro] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan; [Ying Fu, Hai] Kagawa Univ, Dept Cardiorenal & Cerebrovasc Med, Fac Med, Takamatsu, Kagawa, Japan; [Takayama, Toshio] Tokyo Inst Technol, Sch Engn, Dept Mech Engn, Tokyo, Japan; [Ito, Hiroaki] Chiba Univ, Grad Sch Sci, Dept Phys, Chiba, Japan; [Shintani, Yasunori] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pharmacol, Suita, Osaka, Japan; [Kitakaze, Masafumi] Hanwa Daini Senboku Hosp, Osaka, Japan	Osaka University; Osaka University; Osaka University; Kagawa University; Tokyo Institute of Technology; Chiba University; National Cerebral & Cardiovascular Center - Japan	Tsukamoto, O (corresponding author), Osaka Univ, Dept Med Biochem, Suita, Osaka, Japan.; Asano, Y (corresponding author), Osaka Univ, Grad Sch Med Frontier Biosci, Dept Cardiovasc Med, Suita, Osaka, Japan.	tsuka@medbio.med.osaka-u.ac.jp; asano@cardiology.med.osaka-u.ac.jp	Oya, Ryohei/I-4142-2019; Okamoto, Chisato/HGA-8881-2022	Oya, Ryohei/0000-0001-8991-0315; Okamoto, Chisato/0000-0002-0671-793X; Ito, Hiroaki/0000-0003-3769-7115; Kato, Hisakazu/0000-0003-4619-3680; Takayama, Toshio/0000-0002-0411-4764; Shintani, Yasunori/0000-0001-9579-0727; Tsukamoto, Osamu/0000-0002-9504-8001; Miyashita, Yohei/0000-0002-1739-4734; Sakata, Yasushi/0000-0002-5618-4721	MEXT | Japan Society for the Promotion of Science (JSPS) [JP17K09578, JP18H04050, JP18H06212, JP20K17151]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP17K09578; MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP18H04050; MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP18H06212; MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP20K17151	Abugessaisa I, 2017, METHODS MOL BIOL, V1611, P199, DOI 10.1007/978-1-4939-7015-5_15; Adamcova M, 2015, INT J CARDIOL, V201, P358, DOI 10.1016/j.ijcard.2015.07.103; Bruggink AH, 2006, J HEART LUNG TRANSPL, V25, P174, DOI 10.1016/j.healun.2005.09.007; Chen SC, 1999, HYPERTENSION, V34, P1223, DOI 10.1161/01.HYP.34.6.1223; Chopra A, 2018, DEV CELL, V44, P87, DOI 10.1016/j.devcel.2017.12.012; Desai VG, 2013, TOXICOL APPL PHARM, V266, P109, DOI 10.1016/j.taap.2012.10.025; Fish-Trotter H, 2020, CIRC-HEART FAIL, V13, DOI 10.1161/CIRCHEARTFAILURE.119.006570; Fukaya T, 2016, CELL, V166, P358, DOI 10.1016/j.cell.2016.05.025; Goetze JP, 2020, NAT REV CARDIOL, V17, P698, DOI 10.1038/s41569-020-0381-0; Green EM, 2016, SCIENCE, V351, P617, DOI 10.1126/science.aad3456; Grossman W, 2013, J CLIN INVEST, V123, P3701, DOI 10.1172/JCI69830; Hayakawa T, 2014, J MOL CELL CARDIOL, V77, P178, DOI 10.1016/j.yjmcc.2014.09.010; Ibrahim NE, 2018, CIRC RES, V123, P614, DOI 10.1161/CIRCRESAHA.118.312706; Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931; Ichiki T, 2013, ADV CLIN CHEM, V61, P1, DOI 10.1016/B978-0-12-407680-8.00001-4; Kawas RF, 2017, J BIOL CHEM, V292, P16571, DOI 10.1074/jbc.M117.776815; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/s0092-8674(02)01226-6; Kuhn M, 2009, J CLIN INVEST, V119, P2019, DOI 10.1172/JCI37430; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Li WB, 2016, NAT REV GENET, V17, P207, DOI 10.1038/nrg.2016.4; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Ma KK, 2004, J MOL CELL CARDIOL, V36, P505, DOI 10.1016/j.yjmcc.2004.01.001; Martinez-Rumayor A, 2008, AM J CARDIOL, V101, p3A, DOI 10.1016/j.amjcard.2007.11.012; Matsuoka K, 2014, FASEB J, V28, P1870, DOI 10.1096/fj.13-245522; Milano G, 2014, J AM SOC ECHOCARDIOG, V27, P568, DOI 10.1016/j.echo.2014.01.014; Ovchinnikova E, 2018, STEM CELL REP, V10, P794, DOI 10.1016/j.stemcr.2018.01.016; Pandey P, 2018, DEV CELL, V44, P326, DOI 10.1016/j.devcel.2017.12.024; Pikkarainen S, 2003, J BIOL CHEM, V278, P23807, DOI 10.1074/jbc.M302719200; Pitoulis FG, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00092; Raj Shashi, 2014, Curr Treat Options Cardiovasc Med, V16, P315, DOI 10.1007/s11936-014-0315-4; Romano S, 2011, BRIT J CANCER, V105, P1663, DOI 10.1038/bjc.2011.439; Russell B, 2010, J MOL CELL CARDIOL, V48, P817, DOI 10.1016/j.yjmcc.2010.02.016; Rysa J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23042-w; Saucerman JJ, 2019, NAT REV CARDIOL, V16, P361, DOI 10.1038/s41569-019-0155-8; Sergeeva IA, 2016, DEVELOPMENT, V143, P2135, DOI 10.1242/dev.132019; Sergeeva IA, 2013, BBA-MOL BASIS DIS, V1832, P2403, DOI 10.1016/j.bbadis.2013.07.003; Solis AG, 2019, NATURE, V573, P69, DOI 10.1038/s41586-019-1485-8; Stavenschi E, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1025-8; Ward M, 2020, BBA-MOL CELL RES, V1867, DOI 10.1016/j.bbamcr.2019.01.017; Yokoyama U, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00237-1; Yu NYL, 2015, NUCLEIC ACIDS RES, V43, P6787, DOI 10.1093/nar/gkv608; ZAHRINGER J, 1980, BIOCHIM BIOPHYS ACTA, V608, P315, DOI 10.1016/0005-2787(80)90177-X	43	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21495	10.1096/fj.202002111RR	http://dx.doi.org/10.1096/fj.202002111RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33689182	Green Submitted, hybrid			2022-12-26	WOS:000635216100036
J	Huang, CY; Chang, YJ; Wei, PL; Hung, CS; Wang, W				Huang, Chien-Yu; Chang, Yu-Jia; Wei, Po-Li; Hung, Chin-Sheng; Wang, Weu			Methyl gallate, gallic acid-derived compound, inhibit cell proliferation through increasing ROS production and apoptosis in hepatocellular carcinoma cells	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; ENDOPLASMIC-RETICULUM STRESS; KILKA FISH-OIL; METHYL-3-O-METHYL GALLATE; CANCER STATISTICS; NITRIC-OXIDE; AUTOPHAGY; DEATH; ANTIOXIDANT; INDUCTION	Hepatocellular carcinoma (HCC) is a global health problem. Currently, there is no effective therapeutic strategy for HCC. Methyl gallate (MG), from plant-derived phenolic gallic acid, has exhibited antitumor efficacy. However, the effect of MG on HCC is unclear. In vitro growth activity was detected by a sulforhodamine assay. A zebrafish xenotransplantation was applied to evaluate the inhibitory effect of MG. Reactive oxygen species (ROS) production, autophagy, and lysosome formation were detected by specific dyes. Finally, apoptosis was examined using annexin V-FITC/PI staining and western blot was performed to determine the molecular mechanism. It was demonstrated that MG treatment inhibited the proliferation of Hep3B, Mahlavu, and HepJ5 cells. Xenotransplantation also showed that MG inhibited the growth of Hep3B and HepJ5 cells. MG treatment increased cellular levels of superoxide and oxidative stress. Increases in autophagy and lysosome formation were found after MG treatment. The western blot analysis showed that MG activated cleavage of caspase-3 and poly (SDP ribose) polymerase (PARP), modulated levels of the Bcl2, Bax, and Bad ligands, and induced apoptosis. MG induced autophagy with notable activation of beclin-1, autophagy related 5+12 (ATG5+12), and conversion of light chain 3-I (LC3-I) to II. Our study showed that MG exposure inhibited HCC proliferation both in vitro and in vivo. And blocking autophagy enhanced MG-induced cytotoxicity in HCC cells. These findings suggested MG might serve as a powerful therapeutic supplement for human HCC patients.	[Huang, Chien-Yu; Wei, Po-Li; Hung, Chin-Sheng; Wang, Weu] Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei, Taiwan; [Huang, Chien-Yu; Hung, Chin-Sheng] Taipei Med Univ, Shuang Ho Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Huang, Chien-Yu] Taipei Med Univ, Shuang Ho Hosp, Dept Surg, Div Colorectal Surg, Taipei, Taiwan; [Huang, Chien-Yu] Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei, Taiwan; [Chang, Yu-Jia] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chang, Yu-Jia] Taipei Med Univ, Wan Fang Hosp, Cell Physiol & Mol Image Res Ctr, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Taipei Med Univ Hosp, Dept Surg, Div Colorectal Surg, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Taipei Med Univ Hosp, Translat Lab, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University	Wang, W (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Wan Fang Hosp, Cell Physiol & Mol Image Res Ctr, Taipei, Taiwan.	r5424012@tmu.edu.tw; wangweu@tmu.edu.tw			PL WEI MOST [108MOST-00-1223-1]	PL WEI MOST	PL WEI MOST grants (108MOST-00-1223-1).	Anwanwan D, 2020, BBA-REV CANCER, V1873, DOI 10.1016/j.bbcan.2019.188314; Asnaashari M, 2016, J SCI FOOD AGR, V96, P4594, DOI 10.1002/jsfa.7677; Asnaashari M, 2014, FOOD CHEM, V159, P439, DOI 10.1016/j.foodchem.2014.03.038; Brentnall M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-32; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Cabrera R, 2010, ALIMENT PHARM THER, V31, P461, DOI 10.1111/j.1365-2036.2009.04200.x; Chan AWH, 2018, J HEPATOL, V69, P1284, DOI 10.1016/j.jhep.2018.08.027; Chang YJ, 2011, ANN SURG ONCOL, V18, P2395, DOI 10.1245/s10434-011-1597-3; Chen C, 2017, NITRIC OXIDE-BIOL CH, V70, P31, DOI 10.1016/j.niox.2017.07.005; Chen CH, 2011, FOOD CHEM TOXICOL, V49, P494, DOI 10.1016/j.fct.2010.11.031; Chen XP, 2012, NEURAL REGEN RES, V7, P376, DOI 10.3969/j.issn.1673-5374.2012.05.009; Cheng P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.17; Choi JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102697; Choi JG, 2009, MOLECULES, V14, P1773, DOI 10.3390/molecules14051773; Crispo JAG, 2010, BIOCHEM BIOPH RES CO, V393, P773, DOI 10.1016/j.bbrc.2010.02.079; Eales KL, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.50; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fan HJ, 2014, TARGET ONCOL, V9, P279, DOI 10.1007/s11523-013-0286-5; Fang JP, 2012, GLYCOCONJUGATE J, V29, P365, DOI 10.1007/s10719-012-9416-z; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Habtemariam S, 2011, J MED FOOD, V14, P1412, DOI 10.1089/jmf.2010.0257; Hsieh TJ, 2004, FOOD CHEM TOXICOL, V42, P843, DOI 10.1016/j.fct.2004.01.008; Jacobi H, 1998, FREE RADICAL BIO MED, V24, P972, DOI 10.1016/S0891-5849(97)00400-0; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kamatham S, 2015, TOXICOL REP, V2, P520, DOI 10.1016/j.toxrep.2015.03.001; Kang MS, 2009, J MICROBIOL, V47, P760, DOI 10.1007/s12275-009-0097-7; Kang MS, 2008, J MICROBIOL, V46, P744, DOI 10.1007/s12275-008-0235-7; Khurana S, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/657512; Kim H, 2016, KOREAN J PHYSIOL PHA, V20, P261, DOI 10.4196/kjpp.2016.20.3.261; Kim SH, 2017, ONCOTARGET, V8, P111581, DOI 10.18632/oncotarget.22875; Lee H, 2010, J IMMUNOL, V185, P6698, DOI 10.4049/jimmunol.1001373; Lee SH, 2013, BBA-GEN SUBJECTS, V1830, P4017, DOI 10.1016/j.bbagen.2013.03.030; Liang HH, 2013, TUMOR BIOL, V34, P3209, DOI 10.1007/s13277-013-0891-z; Liu WL, 2018, INT J MOL MED, V41, P2028, DOI 10.3892/ijmm.2018.3412; Liu YX, 2018, BIOCHEM BIOPH RES CO, V498, P246, DOI 10.1016/j.bbrc.2018.01.091; Liu ZK, 2017, CELL PHYSIOL BIOCHEM, V44, P1856, DOI 10.1159/000485821; Luo KW, 2011, CHEMOTHERAPY, V57, P449, DOI 10.1159/000331641; Maheswari U, 2018, APOPTOSIS, V23, P210, DOI 10.1007/s10495-018-1449-8; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Makhov P, 2014, BRIT J CANCER, V110, P899, DOI 10.1038/bjc.2013.810; Marchi Saverio, 2012, J Signal Transduct, V2012, P329635, DOI 10.1155/2012/329635; Markkanen E, 2017, DNA REPAIR, V59, P82, DOI 10.1016/j.dnarep.2017.09.007; Monteiro HP, 2019, NITRIC OXIDE-BIOL CH, V89, P1, DOI 10.1016/j.niox.2019.04.009; Nabavi SF, 2013, CELL MOL NEUROBIOL, V33, P261, DOI 10.1007/s10571-012-9893-4; Nabavi SM, 2013, J PHARM PHARMACOL, V65, P868, DOI 10.1111/jphp.12048; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Poetsch AR, 2020, COMPUT STRUCT BIOTEC, V18, P207, DOI 10.1016/j.csbj.2019.12.013; Rahman N, 2016, BIOFACTORS, V42, P716, DOI 10.1002/biof.1310; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Reddy DB, 2009, J ETHNOPHARMACOL, V124, P506, DOI 10.1016/j.jep.2009.05.022; Shehta A, 2016, SURG ONCOL, V25, P364, DOI 10.1016/j.suronc.2016.08.002; Siegel Rebecca L, 2019, CA Cancer J Clin, V69, P7, DOI 10.3322/caac.21551; Stauffer JK, 2012, HEPATOLOGY, V56, P1567, DOI 10.1002/hep.25674; Sullivan LB, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-17; Trevisani F, 2008, CARCINOGENESIS, V29, P1299, DOI 10.1093/carcin/bgn113; Wang RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139232; Wang WL, 2015, CANCER LETT, V358, P47, DOI 10.1016/j.canlet.2014.12.025; Wang YB, 2017, EBIOMEDICINE, V17, P45, DOI 10.1016/j.ebiom.2017.02.019; Whang WK, 2005, EXP MOL MED, V37, P343, DOI 10.1038/emm.2005.44; Winter E, 2014, TOXICOL IN VITRO, V28, P769, DOI 10.1016/j.tiv.2014.02.002; Yamashita Tatsuya, 2016, Rinsho Byori, V64, P787; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	64	13	13	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0248521	10.1371/journal.pone.0248521	http://dx.doi.org/10.1371/journal.pone.0248521			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY1VJ	33725002	Green Published, gold			2022-12-26	WOS:000629833700032
J	Theobalt, N; Hofmann, I; Fiedler, S; Renner, S; Dhom, G; Feuchtinger, A; Walch, A; de Angelis, MH; Wolf, E; Wanke, R; Blutke, A				Theobalt, Natalie; Hofmann, Isabel; Fiedler, Sonja; Renner, Simone; Dhom, Georg; Feuchtinger, Annette; Walch, Axel; de Angelis, Martin Hrabe; Wolf, Eckhard; Wanke, Ruediger; Blutke, Andreas			Unbiased analysis of obesity related, fat depot specific changes of adipocyte volumes and numbers using light sheet fluorescence microscopy	PLOS ONE			English	Article								In translational obesity research, objective assessment of adipocyte sizes and numbers is essential to characterize histomorphological alterations linked to obesity, and to evaluate the efficacies of experimental medicinal or dietetic interventions. Design-based quantitative stereological techniques based on the analysis of 2D-histological sections provide unbiased estimates of relevant 3D-parameters of adipocyte morphology, but often involve complex and time-consuming tissue processing and analysis steps. Here we report the application of direct 3D light sheet fluorescence microscopy (LSFM) for effective and accurate analysis of adipocyte volumes and numbers in optically cleared adipose tissue samples from a porcine model of diet-induced obesity (DIO). Subcutaneous and visceral adipose tissue samples from DIO-minipigs and lean controls were systematically randomly sampled, optically cleared with 3DISCO (3-dimensional imaging of solvent cleared organs), stained with eosin, and subjected to LSFM for detection of adipocyte cell membrane autofluorescence. Individual adipocytes were unbiasedly sampled in digital 3D reconstructions of the adipose tissue samples, and their individual cell volumes were directly measured by automated digital image analysis. Adipocyte numbers and mean volumes obtained by LSFM analysis did not significantly differ from the corresponding values obtained by unbiased quantitative stereological analysis techniques performed on the same samples, thus proving the applicability of LSFM for efficient analysis of relevant morphological adipocyte parameters. The results of the present study demonstrate an adipose tissue depot specific plasticity of adipocyte growth responses to nutrient oversupply. This was characterized by an exclusively hypertrophic growth of visceral adipocytes, whereas adipocytes in subcutaneous fat tissue depots also displayed a marked (hyperplastic) increase in cell number. LSFM allows for accurate and efficient determination of relevant quantitative morphological adipocyte parameters. The applied stereological methods and LSFM protocols are described in detail and can serve as a guideline for unbiased quantitative morphological analyses of adipocytes in other studies and species.	[Theobalt, Natalie; Hofmann, Isabel; Fiedler, Sonja; Wanke, Ruediger] Ludwig Maximilians Univ Munchen, Ctr Clin Vet Med, Inst Vet Pathol, Munich, Germany; [Renner, Simone; Dhom, Georg; Wolf, Eckhard] Ludwig Maximilians Univ Munchen, Gene Ctr, Munich, Germany; [Renner, Simone; Dhom, Georg; Wolf, Eckhard] Ludwig Maximilians Univ Munchen, Dept Vet Sci, Chair Mol Anim Breeding & Biotechnol, Munich, Germany; [Renner, Simone; Dhom, Georg; Wolf, Eckhard] Ludwig Maximilians Univ Munchen, Ctr Innovat Med Models CiMM, Dept Vet Sci, Oberschleissheim, Germany; [Renner, Simone; de Angelis, Martin Hrabe; Wolf, Eckhard] German Ctr Diabet Res DZD, Neuherberg, Germany; [Feuchtinger, Annette; Walch, Axel; Blutke, Andreas] Helmholtz Zentrum Munchen, Res Unit Analyt Pathol, Neuherberg, Germany; [de Angelis, Martin Hrabe; Blutke, Andreas] Helmholtz Zentrum Munchen, Inst Expt Genet, Neuherberg, Germany; [Wolf, Eckhard] Ludwig Maximilians Univ Munchen, Gene Ctr, Lab Funct Genome Anal LAFUGA, Munich, Germany; [Hofmann, Isabel] Bavarian Hlth & Food Safety Author, Oberschleissheim, Germany; [Dhom, Georg] Bavarian Food Safety & Vet Control Author KBLV, Oberding, Germany	University of Munich; University of Munich; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Bavarian Health & Food Safety Authority	Blutke, A (corresponding author), Helmholtz Zentrum Munchen, Res Unit Analyt Pathol, Neuherberg, Germany.; Blutke, A (corresponding author), Helmholtz Zentrum Munchen, Inst Expt Genet, Neuherberg, Germany.	andreas.parzefall@helmholtz-muenchen.de	de Angelis, Martin Hrabe/F-5531-2012; Wolf, Eckhard/AAT-7500-2021; Walch, Axel/B-4554-2012	de Angelis, Martin Hrabe/0000-0002-7898-2353; Wolf, Eckhard/0000-0002-0430-9510; Walch, Axel/0000-0001-5578-4023				Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Albl B, 2016, TOXICOL PATHOL, V44, P414, DOI 10.1177/0192623316631023; [Anonymous], 1979, STEREOLOGICAL METHOD; arivis-AG, 2018, AR VISION4D BAS GUID, P112; Aslan H, 2006, OBES SURG, V16, P1526, DOI 10.1381/096089206778869942; Azaripour A, 2016, PROG HISTOCHEM CYTO, V51, P9, DOI 10.1016/j.proghi.2016.04.001; BADDELEY AJ, 1986, J MICROSC-OXFORD, V142, P259, DOI 10.1111/j.1365-2818.1986.tb04282.x; Bahceci M, 2007, J ENDOCRINOL INVEST, V30, P210, DOI 10.1007/BF03347427; Blutke A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71465-1; Blutke A, 2018, JOVE-J VIS EXP, DOI 10.3791/57276; Blutke A, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12709; Boyce RW, 2010, TOXICOL PATHOL, V38, P1011, DOI 10.1177/0192623310385140; Brown DL, 2017, J TOXICOL PATHOL, V30, P183, DOI 10.1293/tox.2017-0013; Cai RY, 2019, NAT NEUROSCI, V22, P317, DOI 10.1038/s41593-018-0301-3; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chi J, 2018, JOVE-J VIS EXP, DOI 10.3791/58271; Chi JY, 2018, CELL METAB, V27, P226, DOI 10.1016/j.cmet.2017.12.011; Cuellar E., 2005, IMAGE ANAL STEREOL, V24, P187; Diel EE, 2020, NAT PROTOC, V15, P2773, DOI 10.1038/s41596-020-0360-2; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Drenckhan W, 2015, ADV COLLOID INTERFAC, V224, P1, DOI 10.1016/j.cis.2015.05.004; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Feuchtinger A, 2016, HISTOCHEM CELL BIOL, V146, P781, DOI 10.1007/s00418-016-1495-7; Fiedler S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243462; Fuchs Taíse, 2018, Rev. Col. Bras. Cir., V45, pe1975, DOI 10.1590/0100-6991e-20181975; Garvalov BK, 2017, NAT BIOMED ENG, V1, P772, DOI 10.1038/s41551-017-0150-5; Gundersen HJG, 2013, HASCHEK AND ROUSSEAUX'S HANDBOOK OF TOXICOLOGIC PATHOLOGY, VOL 1-3, 3RD EDITION, P215, DOI 10.1016/B978-0-12-415759-0.00008-X; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Head GA, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0466-4; HERMANNS W, 1981, HISTOCHEMISTRY, V73, P439, DOI 10.1007/BF00495658; Hoeflich A, 2002, FASEB J, V16, P1721, DOI 10.1096/fj.02-0349com; Howard C.V., 2005, UNBIASED STEREOLOGY, V278; Huh JY, 2014, MOL CELLS, V37, P365, DOI 10.14348/molcells.2014.0074; International Diabetes Foundation, 2006, IDF CONS WORLDW DEF; JACOBSSON B, 1972, J LIPID RES, V13, P651; Johannsen DL, 2014, DIABETES CARE, V37, P2789, DOI 10.2337/dc14-0761; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kayser K, 2009, FOLIA HISTOCHEM CYTO, V47, P355, DOI 10.2478/v10042-009-0087-y; Kayser K, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-6; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kennel P, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007322; Klingberg A, 2017, J AM SOC NEPHROL, V28, P452, DOI 10.1681/ASN.2016020232; Laforest S, 2015, CRIT REV CL LAB SCI, V52, P301, DOI 10.3109/10408363.2015.1041582; Laurencikiene J, 2011, J CLIN ENDOCR METAB, V96, pE2045, DOI 10.1210/jc.2011-1702; Longo M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092358; Madsen KM, 1999, J AM SOC NEPHROL, V10, P1124; Mancuso P, 2016, IMMUNOTARGETS THER, V5, P47, DOI 10.2147/ITT.S73223; Matenaers C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192879; MATTFELDT T, 1990, J MICROSC-OXFORD, V159, P301, DOI 10.1111/j.1365-2818.1990.tb03036.x; MATTFELDT T, 1985, J MICROSC-OXFORD, V139, P279, DOI 10.1111/j.1365-2818.1985.tb02644.x; McLaugblin T, 2007, DIABETOLOGIA, V50, P1707, DOI 10.1007/s00125-007-0708-y; McLaughlin T, 2014, OBESITY, V22, P673, DOI 10.1002/oby.20209; McLaughlin T, 2010, DIABETOLOGIA, V53, P369, DOI 10.1007/s00125-009-1496-3; McLaughlin T, 2016, DIABETES, V65, P1245, DOI 10.2337/db15-1213; Model MA, 2018, CYTOM PART A, V93A, P281, DOI 10.1002/cyto.a.23152; Mzinza DT, 2018, CELL MOL IMMUNOL, V15, P875, DOI 10.1038/cmi.2017.150; Nyengaard JR, 1999, J AM SOC NEPHROL, V10, P1100; NYENGAARD JR, 1992, J MICROSC-OXFORD, V165, P427, DOI 10.1111/j.1365-2818.1992.tb01497.x; Pakkenberg B, 2019, FRONT NEUROANAT, V13, DOI 10.3389/fnana.2019.00042; Parlee SD, 2014, METHOD ENZYMOL, V537, P93, DOI 10.1016/B978-0-12-411619-1.00006-9; Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280; Renier N, 2016, CELL, V165, P1789, DOI 10.1016/j.cell.2016.05.007; Renner S, 2018, MOL METAB, V16, P180, DOI 10.1016/j.molmet.2018.06.015; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; SCHERLE W, 1970, Mikroskopie, V26, P57; Siber A, 2017, CELLULAR PATTERNS; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Slomianka L, 2021, J COMP NEUROL, V529, P694, DOI 10.1002/cne.24976; Stenkula KG, 2018, AM J PHYSIOL-REG I, V315, pR284, DOI 10.1152/ajpregu.00257.2017; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Tanaka N, 2017, NAT BIOMED ENG, V1, P796, DOI 10.1038/s41551-017-0139-0; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Tschanz S, 2014, ANN ANAT, V196, P3, DOI 10.1016/j.aanat.2013.04.011; Vigouroux RJ, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0314-y; Wanke R, 2002, EXP TOXICOL PATHOL, V54, P163, DOI 10.1078/0940-2993-00223; West Mark J, 2012, Cold Spring Harb Protoc, V2012, DOI 10.1101/pdb.top070623; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Whitehead LW, 2017, IMMUNOL CELL BIOL, V95, P520, DOI 10.1038/icb.2017.36; Williams PT, 1997, ARTERIOSCL THROM VAS, V17, P1082, DOI 10.1161/01.ATV.17.6.1082; Zagato E, 2018, MICROSC RES TECHNIQ, V81, P941, DOI 10.1002/jemt.22981; Zhao S, 2020, CELL, V180, P796, DOI 10.1016/j.cell.2020.01.030	83	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0248594	10.1371/journal.pone.0248594	http://dx.doi.org/10.1371/journal.pone.0248594			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY1VJ	33725017	Green Published, gold			2022-12-26	WOS:000629833700008
J	Li, HJ; Han, XG; Yang, SB; Wang, YJ; Dong, Y; Tang, TT				Li, Hanjun; Han, Xiuguo; Yang, Shengbing; Wang, Yongjie; Dong, Yang; Tang, Tingting			FOXP1 drives osteosarcoma development by repressing P21 and RB transcription downstream of P53	ONCOGENE			English	Article								Osteosarcoma has a poor prognosis, and the poor understanding of the genetic drivers of osteosarcoma hinders further improvement in therapeutic approaches. Transcription factor forkhead box P1 (FOXP1) is a crucial modulator in skeletal development and aging. Here, we determined the role and regulatory mechanisms of FOXP1 in osteosarcoma. Higher FOXP1 expression correlated with malignancy in both osteosarcoma cell lines and clinical biopsies. FOXP1 overexpression and knockdown in osteosarcoma cell lines revealed that FOXP1 promoted proliferation, tumor sphere formation, migration and invasion, and inhibited anoikis. Mechanistically, FOXP1 acted as a repressor of P21 and RB (retinoblastoma protein) transcription, and directly interacted with the tumor suppressor p53 to inhibit its activity. Extracellular signal-regulated kinase/c-Jun N-terminal kinase (ERK/JNK) signaling and c-JUN/c-FOS transcription factors were found to be upstream activators of FOXP1. Moreover, FOXP1 silencing via lentivirus or adeno-associated virus (AAV)-mediated delivery of shRNA suppressed osteosarcoma development and progression in cell-derived and patient-derived xenograft animal models. Taken together, we demonstrate that FOXP1, which is transactivated by ERK/JNK-c-JUN/c-FOS, drives osteosarcoma development by regulating the p53-P21/RB signaling cascade, suggesting that FOXP1 is a potential target for osteosarcoma therapy.	[Li, Hanjun; Yang, Shengbing; Tang, Tingting] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Shanghai Key Lab Orthopaed Implants, Dept Orthoped Surg,Sch Med, Shanghai, Peoples R China; [Han, Xiuguo] Shanghai Jiao Tong Univ, Xin Hua Hosp, Dept Orthoped Surg, Sch Med, Shanghai, Peoples R China; [Wang, Yongjie; Dong, Yang] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthopaed, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Tang, TT (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Shanghai Key Lab Orthopaed Implants, Dept Orthoped Surg,Sch Med, Shanghai, Peoples R China.; Dong, Y (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthopaed, Shanghai, Peoples R China.	dongyang6405@163.com; ttt@sjtu.edu.cn	Tang, Tingting/B-1361-2013	Tang, Tingting/0000-0002-1670-7452; Wang, Yongjie/0000-0001-7035-5382; Li, Hanjun/0000-0002-7017-8782	National Natural Science Foundation of China [81802679]; Shanghai Science and Technology Development Fund [18DZ2291200]; China Postdoctoral Science Foundation [2018M632136, 2019T120348]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Development Fund; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This project was supported by the National Natural Science Foundation of China (81802679), the Shanghai Science and Technology Development Fund (18DZ2291200), and China Postdoctoral Science Foundation (2018M632136 and 2019T120348) to HL.	Armesilla-Diaz A, 2009, EXP CELL RES, V315, P3598, DOI 10.1016/j.yexcr.2009.08.004; Bates GJ, 2008, BREAST CANCER RES TR, V111, P453, DOI 10.1007/s10549-007-9812-4; Behjati S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15936; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Brown PJ, 2016, LEUKEMIA, V30, P605, DOI 10.1038/leu.2015.299; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chen HJ, 2018, BIOCHEM BIOPH RES CO, V503, P1434, DOI 10.1016/j.bbrc.2018.07.060; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Chokas AL, 2010, J BIOL CHEM, V285, P13304, DOI 10.1074/jbc.M109.088468; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Coventon J, 2017, J BONE ONCOL, V8, P4, DOI 10.1016/j.jbo.2017.07.001; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dekker JD, 2016, P NATL ACAD SCI USA, V113, pE577, DOI 10.1073/pnas.1524677113; Deng Q, 2019, ELIFE, V8, DOI 10.7554/eLife.50208; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Du L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0745-0; Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; Fittall MW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04530-z; Flori M, 2016, BLOOD, V127, P1438, DOI [10.1182/blood-2015-08662635, 10.1182/blood-2015-08-662635]; Fox SB, 2004, CLIN CANCER RES, V10, P3521, DOI 10.1158/1078-0432.CCR-03-0461; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Gascoyne DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128513; Gianferante DM, 2017, NAT REV ENDOCRINOL, V13, P480, DOI 10.1038/nrendo.2017.16; Han XG, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201902246; Han YJ, 2019, J CLIN INVEST, V129, P1895, DOI 10.1172/JCI124590; HANSEN MF, 1985, P NATL ACAD SCI USA, V82, P6216, DOI 10.1073/pnas.82.18.6216; Harrison DJ, 2018, EXPERT REV ANTICANC, V18, P39, DOI 10.1080/14737140.2018.1413939; Hieronymus H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01198-9; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Kansara M, 2014, NAT REV CANCER, V14, P722, DOI 10.1038/nrc3838; Kim JH, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1110-3; Koon HB, 2007, EXPERT OPIN THER TAR, V11, P955, DOI 10.1517/14728222.11.7.955; Leishman E, 2013, DEVELOPMENT, V140, P3809, DOI 10.1242/dev.097477; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Li HJ, 2017, J CLIN INVEST, V127, P1241, DOI 10.1172/JCI89511; Li SR, 2012, DEVELOPMENT, V139, P2500, DOI 10.1242/dev.079699; Lin YH, 2017, TRENDS MOL MED, V23, P737, DOI 10.1016/j.molmed.2017.06.004; Liu P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12988-8; MALKIN D, 1994, ANNU REV GENET, V28, P443; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MILLER CW, 1990, CANCER RES, V50, P7950; Mirabello L, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv101; Mohseny AB, 2011, LAB INVEST, V91, P1195, DOI 10.1038/labinvest.2011.72; Mottok A, 2018, BLOOD, V131, P226, DOI 10.1182/blood-2017-08-799080; Naudin C, 2017, BLOOD, V129, P2493, DOI 10.1182/blood-2016-10-747436; Papachristou DJ, 2003, BONE, V32, P364, DOI 10.1016/S8756-3282(03)00026-7; Perry JA, 2014, P NATL ACAD SCI USA, V111, pE5564, DOI 10.1073/pnas.1419260111; Quist T, 2015, ONCOGENE, V34, P4278, DOI 10.1038/onc.2014.354; Sagaert X, 2006, J CLIN ONCOL, V24, P2490, DOI 10.1200/JCO.2006.05.6150; Sheng H, 2019, CANCER BIOL THER, V20, P537, DOI 10.1080/15384047.2018.1537999; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Spaeth JM, 2015, DIABETOLOGIA, V58, P1836, DOI 10.1007/s00125-015-3635-3; Streubel B, 2005, LEUKEMIA, V19, P652, DOI 10.1038/sj.leu.2403644; Takayama K, 2008, BIOCHEM BIOPH RES CO, V374, P388, DOI 10.1016/j.bbrc.2008.07.056; Tao JN, 2014, CANCER CELL, V26, P390, DOI 10.1016/j.ccr.2014.07.023; ter Huurne M, 2020, STEM CELL REP, V14, P175, DOI 10.1016/j.stemcr.2020.01.001; Usui N, 2017, GENE DEV, V31, P2039, DOI 10.1101/gad.305037.117; van Keimpema M, 2017, HAEMATOLOGICA, V102, P573, DOI 10.3324/haematol.2016.156455; van Keimpema M, 2014, BLOOD, V124, P3431, DOI 10.1182/blood-2014-01-553412; WADAYAMA B, 1994, CANCER RES, V54, P3042; Walker MP, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005654; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Wang X, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091501; WANG ZQ, 1995, CANCER RES, V55, P6244; Xu SQ, 2018, P NATL ACAD SCI USA, V115, P8799, DOI 10.1073/pnas.1721820115; Xu WT, 2009, CANCER LETT, V281, P32, DOI 10.1016/j.canlet.2009.02.022; Yang JL, 2011, CANCER-AM CANCER SOC, V117, P4925, DOI 10.1002/cncr.26116; Yin ZX, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12308; Zhang YZ, 2010, GENE DEV, V24, P1746, DOI 10.1101/gad.1929210; Zhao HX, 2015, DEV BIOL, V398, P242, DOI 10.1016/j.ydbio.2014.12.007	71	10	10	10	28	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 15	2021	40	15					2785	2802		10.1038/s41388-021-01742-4	http://dx.doi.org/10.1038/s41388-021-01742-4		MAR 2021	18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RN8NW	33716296				2022-12-26	WOS:000628816100002
J	Lee, JH; Park, YG				Lee, Ji Hye; Park, Young Gun			Microvascular changes on optical coherence tomography angiography after rhegmatogenous retinal detachment vitrectomy with silicone tamponade	PLOS ONE			English	Article								Purpose We aimed to evaluate microvascular changes on optical coherence tomography angiography (OCTA) in patients with rhegmatogenous retinal detachment (RRD) who underwent silicone oil (SO) tamponade and compare changes according to macular involvement. Methods This retrospective study included 48 patients with unilateral RRD who underwent vitrectomy and SO tamponade and were stable after SO removal. Control data were obtained from the fellow healthy eye. Ophthalmic examinations, including best corrective visual acuity (BCVA) and OCTA, were conducted. Differences in vascular density (VD) in different sections of the macula and differences in the foveal avascular zone (FAZ) were analyzed between the affected eyes and control eyes. Subgroup analyses according to macular involvement were performed. Results Baseline BCVA and duration of SO tamponade were associated with postoperative BCVA (p<0.001, p = 0.03, respectively). The average VD in the deep capillary plexus (DCP) and the VD of the nasal parafoveal area in both the superficial capillary plexus (SCP) and the DCP decreased relative to those in the control eyes (p = 0.026, p = 0.028, and p = 0.031, respectively). The FAZ area in the DCP and in the SCP also increased when compared with that in the controls (p = 0.043, p = 0.002, respectively). In addition, the macular-off RRD group had lower VD in the nasal parafoveal area of the DCP than the macular-on RRD group. Conclusion SO tamponade could cause microvascular changes, especially in the nasal parafoveal area. The macular-off RRD group were affected more than the macular-on RRD group.	[Lee, Ji Hye; Park, Young Gun] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Park, YG (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	cuteyg2000@catholic.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIT) [2019R1G1A1100084]	National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2019R1G1A1100084). The fund is involved with publication charge.	Agarwal A, 2019, RETINA-J RET VIT DIS, V39, P2167, DOI 10.1097/IAE.0000000000002276; [Anonymous], 2004, INT OPHTHALMOL, V25, P129, DOI [10.1007/s10792-003-7609-y, DOI 10.1007/S10792-003-7609-Y]; Barca F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/502143; Bonnin S, 2015, RETINA-J RET VIT DIS, V35, P2347, DOI 10.1097/IAE.0000000000000839; Coscas F, 2016, AM J OPHTHALMOL, V161, P160, DOI 10.1016/j.ajo.2015.10.008; Dogramaci M, 2013, GRAEF ARCH CLIN EXP, V251, P35, DOI 10.1007/s00417-012-2033-5; Grzybowski A, 2012, RETINA-J RET VIT DIS, V32, P645, DOI 10.1097/IAE.0B013E3182437EA4; Inan S, 2020, OPHTHALMIC RES, V63, P524, DOI 10.1159/000506382; Kampik A, 2000, Semin Ophthalmol, V15, P88; Kubicka-Trzaska Agnieszka, 2011, Klin Oczna, V113, P146; Leaver P K, 1993, Ger J Ophthalmol, V2, P20; Lee JY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59504-3; Lee SH, 2018, RETINA-J RET VIT DIS, V38, P310, DOI 10.1097/IAE.0000000000001533; Lou BS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/713828; McKay KM, 2020, CLIN OPHTHALMOL, V14, P1759, DOI 10.2147/OPTH.S214623; Morphis G, 2012, GRAEF ARCH CLIN EXP, V250, P645, DOI 10.1007/s00417-011-1873-8; Moya R, 2015, EYE, V29, P1477, DOI 10.1038/eye.2015.135; Nam SH, 2021, OPHTHALMOLOGICA, V244, P34, DOI 10.1159/000508464; Oliveira-Ferreira C, 2020, OPHTHALMOL THER, DOI 10.1007/s40123-020-00259-5; Park YG, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/6210865; Pellegrini F, 2019, NEURO-OPHTHALMOLOGY, V43, P401, DOI 10.1080/01658107.2018.1523196; Raczynska D, 2018, CURR PHARM DESIGN, V24, P3476, DOI 10.2174/1381612824666180813115438; Roohipoor R, 2020, INT OPHTHALMOL, V40, P3295, DOI 10.1007/s10792-020-01516-z; Rouhiainen P, 1996, CURR EYE RES, V15, P293, DOI 10.3109/02713689609007623; Scheerlinck LM, 2016, RETINA-J RET VIT DIS, V36, P342, DOI 10.1097/IAE.0000000000000711; Scott IU, 2005, ARCH OPHTHALMOL-CHIC, V123, P473, DOI 10.1001/archopht.123.4.473; Woo JM, 2018, CURR EYE RES, V43, P674, DOI 10.1080/02713683.2018.1437922; Yamada K, 2019, ACTA OPHTHALMOL, V97, pE742, DOI 10.1111/aos.14038; Yoshikawa Y, 2018, CLIN OPHTHALMOL, V12, P2059, DOI 10.2147/OPTH.S177933; Yu SQ, 2015, AM J OPHTHALMOL, V159, P53, DOI 10.1016/j.ajo.2014.09.027	30	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0248433	10.1371/journal.pone.0248433	http://dx.doi.org/10.1371/journal.pone.0248433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711059	Green Published, gold			2022-12-26	WOS:000629591800011
J	Lucaci, AG; Wisotsky, SR; Shank, SD; Weaver, S; Pond, SLK				Lucaci, Alexander G.; Wisotsky, Sadie R.; Shank, Stephen D.; Weaver, Steven; Pond, Sergei L. Kosakovsky			Extra base hits: Widespread empirical support for instantaneous multiple-nucleotide changes	PLOS ONE			English	Article								Despite many attempts to introduce evolutionary models that permit substitutions to instantly alter more than one nucleotide in a codon, the prevailing wisdom remains that such changes are rare and generally negligible or are reflective of non-biological artifacts, such as alignment errors. Codon models continue to posit that only single nucleotide change have non-zero rates. Here, we develop and test a simple hierarchy of codon-substitution models with non-zero evolutionary rates for only one-nucleotide (1H), one- and two-nucleotide (2H), or any (3H) codon substitutions. Using over 42, 000 empirical alignments, we find widespread statistical support for multiple hits: 61% of alignments prefer models with 2H allowed, and 23%-with 3H allowed. Analyses of simulated data suggest that these results are not likely to be due to simple artifacts such as model misspecification or alignment errors. Further modeling reveals that synonymous codon island jumping among codons encoding serine, especially along short branches, contributes significantly to this 3H signal. While serine codons were prominently involved in multiple-hit substitutions, there were other common exchanges contributing to better model fit. It appears that a small subset of sites in most alignments have unusual evolutionary dynamics not well explained by existing model formalisms, and that commonly estimated quantities, such as dN/dS ratios may be biased by model misspecification. Our findings highlight the need for continued evaluation of assumptions underlying workhorse evolutionary models and subsequent evolutionary inference techniques. We provide a software implementation for evolutionary biologists to assess the potential impact of extra base hits in their data in the HyPhy package and in the Datamonkey.org server.	[Lucaci, Alexander G.; Wisotsky, Sadie R.; Shank, Stephen D.; Weaver, Steven; Pond, Sergei L. Kosakovsky] Temple Univ, Inst Genom & Evolutionary Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Pond, SLK (corresponding author), Temple Univ, Inst Genom & Evolutionary Med, Philadelphia, PA 19122 USA.	spond@temple.edu	Pond, Sergei LK/G-9830-2012	Pond, Sergei LK/0000-0003-4817-4029; Lucaci, Alexander/0000-0002-4896-6088; Weaver, Steven/0000-0002-6931-7191	National Institutes of Health [R01 GM093939, R01 AI134384]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants R01 GM093939 and R01 AI134384 to SKP.	Averof M, 2000, SCIENCE, V287, P1283, DOI 10.1126/science.287.5456.1283; Bazykin GA, 2004, NATURE, V429, P558, DOI 10.1038/nature02601; Chen JM, 2014, HUM MUTAT, V35, P392, DOI 10.1002/humu.22501; De Maio N, 2013, MOL BIOL EVOL, V30, P725, DOI 10.1093/molbev/mss266; Doron-Faigenboim A, 2007, MOL BIOL EVOL, V24, P388, DOI 10.1093/molbev/msl175; Dunn KA, 2019, BMC EVOL BIOL, V19, DOI 10.1186/s12862-018-1326-7; Enard D, 2016, ELIFE, V5, DOI 10.7554/eLife.12469; Fletcher W, 2009, MOL BIOL EVOL, V26, P1879, DOI 10.1093/molbev/msp098; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Halpern AL, 1998, MOL BIOL EVOL, V15, P910, DOI 10.1093/oxfordjournals.molbev.a025995; Harris K, 2014, GENOME RES, V24, P1445, DOI 10.1101/gr.170696.113; Jones CT, 2020, SYST BIOL, V69, P722, DOI 10.1093/sysbio/syz075; Jones CT, 2018, MOL BIOL EVOL, V35, P1473, DOI 10.1093/molbev/msy049; Kaplanis J, 2019, GENOME RES, V29, P1047, DOI 10.1101/gr.239756.118; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kosiol C, 2007, MOL BIOL EVOL, V24, P1464, DOI 10.1093/molbev/msm064; Mannino F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229493; Miyazawa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017244; Moretti S, 2014, NUCLEIC ACIDS RES, V42, pD917, DOI 10.1093/nar/gkt1065; Murrell B, 2015, MOL BIOL EVOL, V32, P1365, DOI 10.1093/molbev/msv035; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Okada M, 2017, AMYLOID, V24, P231, DOI 10.1080/13506129.2017.1381082; Pond SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011230; Pond SLK, 2020, MOL BIOL EVOL, V37, P295, DOI 10.1093/molbev/msz197; Pupko T, 2000, MOL BIOL EVOL, V17, P890, DOI 10.1093/oxfordjournals.molbev.a026369; Rogozin IB, 2016, P NATL ACAD SCI USA, V113, P13109, DOI 10.1073/pnas.1615832113; Sakofsky CJ, 2014, CELL REP, V7, P1640, DOI 10.1016/j.celrep.2014.04.053; Schrider DR, 2011, CURR BIOL, V21, P1051, DOI 10.1016/j.cub.2011.05.013; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Shultz AJ, 2019, ELIFE, V8, DOI 10.7554/eLife.41815; Smith NGC, 1999, GENETICS, V152, P661; Venkat A, 2018, NAT ECOL EVOL, V2, P1280, DOI 10.1038/s41559-018-0584-5; Weaver S, 2018, MOL BIOL EVOL, V35, P773, DOI 10.1093/molbev/msx335; Whelan S, 2004, GENETICS, V167, P2027, DOI 10.1534/genetics.103.023226; Wisotsky SR, 2020, MOL BIOL EVOL, V37, P2430, DOI 10.1093/molbev/msaa037; WOLFE KH, 1993, J MOL EVOL, V37, P441, DOI 10.1007/BF00178874; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Zaheri M, 2014, MOL BIOL EVOL, V31, P2528, DOI 10.1093/molbev/msu196; Zoller S, 2012, MOL BIOL EVOL, V29, P271, DOI 10.1093/molbev/msr198	40	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0248337	10.1371/journal.pone.0248337	http://dx.doi.org/10.1371/journal.pone.0248337			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711070	Green Submitted, gold, Green Published			2022-12-26	WOS:000629591800040
J	Moroz, OV; Blagova, E; Taylor, E; Turkenburg, JP; Skov, LK; Gippert, GP; Schnorr, KM; Ming, L; Ye, L; Klausen, M; Cohn, MT; Schmidt, EGW; Nymand-Grarup, S; Davies, GJ; Wilson, KS				Moroz, Olga, V; Blagova, Elena; Taylor, Edward; Turkenburg, Johan P.; Skov, Lars K.; Gippert, Garry P.; Schnorr, Kirk M.; Ming, Li; Ye, Liu; Klausen, Mikkel; Cohn, Marianne T.; Schmidt, Esben G. W.; Nymand-Grarup, Soren; Davies, Gideon J.; Wilson, Keith S.			Fungal GH25 muramidases: New family members with applications in animal nutrition and a crystal structure at 0.78 angstrom resolution	PLOS ONE			English	Article							CELL-WALL; CATALYTIC DOMAIN; LYSOZYME; ENDOLYSIN; RECOGNITION; BINDING; FOLD	Muramidases/lysozymes hydrolyse the peptidoglycan component of the bacterial cell wall. They are found in many of the glycoside hydrolase (GH) families. Family GH25 contains muramidases/lysozymes, known as CH type lysozymes, as they were initially discovered in the Chalaropsis species of fungus. The characterized enzymes from GH25 exhibit both beta-1,4-N-acetyl- and beta-1,4-N,6-O-diacetylmuramidase activities, cleaving the beta-1,4-glycosidic bond between N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) moieties in the carbohydrate backbone of bacterial peptidoglycan. Here, a set of fungal GH25 muramidases were identified from a sequence search, cloned and expressed and screened for their ability to digest bacterial peptidoglycan, to be used in a commercial application in chicken feed. The screen identified the enzyme from Acremonium alcalophilum JCM 736 as a suitable candidate for this purpose and its relevant biochemical and biophysical and properties are described. We report the crystal structure of the A. alcalophilum enzyme at atomic, 0.78 angstrom resolution, together with that of its homologue from Trichobolus zukalii at 1.4 angstrom, and compare these with the structures of homologues. GH25 enzymes offer a new solution in animal feed applications such as for processing bacterial debris in the animal gut.	[Moroz, Olga, V; Blagova, Elena; Taylor, Edward; Turkenburg, Johan P.; Davies, Gideon J.; Wilson, Keith S.] Univ York, Dept Chem, Struct Biol Lab, York, N Yorkshire, England; [Skov, Lars K.; Gippert, Garry P.; Schnorr, Kirk M.; Klausen, Mikkel; Cohn, Marianne T.; Schmidt, Esben G. W.; Nymand-Grarup, Soren] Novozymes AS, Lyngby, Denmark; [Ming, Li; Ye, Liu] Novozymes Investment Co Ltd, Beijing, Peoples R China; [Taylor, Edward] Univ Lincoln, Sch Life Sci, Joseph Banks Labs, Green Lane, Lincoln, England; [Nymand-Grarup, Soren] Christian Hansen AS, Horsholm, Denmark	University of York - UK; Novozymes; University of Lincoln; Chr Hansen	Wilson, KS (corresponding author), Univ York, Dept Chem, Struct Biol Lab, York, N Yorkshire, England.	keith.wilson@york.ac.uk		Turkenburg, Johan/0000-0001-6992-6838	Royal Society [UF100116, RP150126]; Biotechnology and Biological Sciences Research Council (BBSRC) [DTA A0031002]	Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by Novozymes: the funder provided support in the form of salaries for authors [LKS, GPG, KMS, LM, LY, MK, MTC, EGWS, SN-G], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. EJT gratefully acknowledges financial support from the Royal Society (GB), UF100116 and the Biotechnology and Biological Sciences Research Council (BBSRC) DTA A0031002,. GJD is the Royal Society (GB), RP150126 "Ken Murray" Research Professor.	Abbott W, 2018, GLYCOBIOLOGY, V28, P3, DOI 10.1093/glycob/cwx089; Al-Riyami B, 2016, PROTEINS, V84, P1681, DOI 10.1002/prot.25112; [Anonymous], 1962, NUTR REV, V20, P255; BANNER DW, 1975, NATURE, V255, P609, DOI 10.1038/255609a0; Boroojeni FG, 2019, POULTRY SCI, V98, P2080, DOI 10.3382/ps/pey556; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cohn M.Y, 2018, patent wo, Patent No. [WO2018113745A1, 2018113745]; deRuyter PGGA, 1997, NAT BIOTECHNOL, V15, P976, DOI 10.1038/nbt1097-976; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; DOBSON DE, 1984, J BIOL CHEM, V259, P1607; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; FELCH JW, 1975, J BIOL CHEM, V250, P3713; Fleming A, 1922, P R SOC LOND B-CONTA, V93, P306, DOI 10.1098/rspb.1922.0023; HASH JH, 1967, J BIOL CHEM, V242, P5586; Hermoso JA, 2003, STRUCTURE, V11, P1239, DOI 10.1016/j.str.2003.09.005; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Korczynska JE, 2010, ACTA CRYSTALLOGR F, V66, P973, DOI 10.1107/S1744309110025601; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kunzler M, 2015, MOLECULES, V20, P8144, DOI 10.3390/molecules20058144; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; Lichtenberg J, 2017, REGUL TOXICOL PHARM, V89, P57, DOI 10.1016/j.yrtph.2017.07.014; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Low LY, 2011, J BIOL CHEM, V286, P34391, DOI 10.1074/jbc.M111.244160; Martinez-Fleites C, 2009, CARBOHYD RES, V344, P1753, DOI 10.1016/j.carres.2009.06.001; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Metcalf JA, 2014, ELIFE, V3, DOI 10.7554/eLife.04266; Morais S, 2016, ENVIRON MICROBIOL, V18, P5112, DOI 10.1111/1462-2920.13501; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Niu SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068647; Okada Gen, 1993, Transactions of the Mycological Society of Japan, V34, P171; PARRY RM, 1965, P SOC EXP BIOL MED, V119, P384; Perez-Dorado I, 2007, J BIOL CHEM, V282, P24990, DOI 10.1074/jbc.M704317200; Perez-Dorado I, 2010, NAT STRUCT MOL BIOL, V17, P576, DOI 10.1038/nsmb.1817; Pierce JJ, 1997, J BIOTECHNOL, V58, P1, DOI 10.1016/S0168-1656(97)00116-8; Porter CJ, 2007, J MOL BIOL, V366, P540, DOI 10.1016/j.jmb.2006.11.056; Rau A, 2001, J BIOL CHEM, V276, P31994, DOI 10.1074/jbc.M102591200; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Romero P, 2018, MOL MICROBIOL, V108, P128, DOI 10.1111/mmi.13922; Rychen G, 2018, EFSA J, V16, DOI 10.2903/j.efsa.2018.5342; Sais M, 2020, POULTRY SCI, V99, P235, DOI 10.3382/ps/pez466; SHAPIRO SK, 1949, J BACTERIOL, V58, P689, DOI 10.1128/JB.58.5.689-694.1949; SHUGAR D, 1952, BIOCHIM BIOPHYS ACTA, V8, P302, DOI 10.1016/0006-3002(52)90045-0; Tamai E, 2014, MOL MICROBIOL, V92, P326, DOI 10.1111/mmi.12559; Taylor EJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225531; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308	52	1	1	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0248190	10.1371/journal.pone.0248190	http://dx.doi.org/10.1371/journal.pone.0248190			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711051	gold, Green Published, Green Accepted			2022-12-26	WOS:000629591800013
J	Wang, L; Wang, S				Wang, Le; Wang, Shui			HUIL-TN & HUI-TN: Mining high utility itemsets based on pattern-growth	PLOS ONE			English	Article								In recent years, high utility itemsets (HUIs) mining has been an active research topic in data mining. In this study, we propose two efficient pattern-growth based HUI mining algorithms, called High Utility Itemset based on Length and Tail-Node tree (HUIL-TN) and High Utility Itemset based on Tail-Node tree (HUI-TN). These two algorithms avoid the time-consuming candidate generation stage and the need of scanning the original dataset multiple times for exact utility values. A novel tree structure, named tail-node tree (TN-tree) is proposed as a key element of our algorithms to maintain complete utililty-information of existing itemsets of a dataset. The performance of HUIL-TN and HUI-TN was evaluated against state-of-the-art reference methods on various datasets. Experimental results showed that our algorithms exceed or close to the best performance on all datasets in terms of running time, while other algorithms can only excel in certain types of dataset. Scalability tests were also performed and our algorithms obtained the flattest curves among all competitors.	[Wang, Le; Wang, Shui] Ningbo Univ Finance & Econ, Coll Digital Technol & Engn, Ningbo, Zhejiang, Peoples R China	Ningbo University of Finance & Economics	Wang, S (corresponding author), Ningbo Univ Finance & Econ, Coll Digital Technol & Engn, Ningbo, Zhejiang, Peoples R China.	seawan@163.com			Zhejiang Basic Public Welfare Research Project [2017C35014]; Zhejiang Philosophy and Social Science Project [19GXSZ49YB]; Ningbo Natural Science Foundation [2017A610122]	Zhejiang Basic Public Welfare Research Project; Zhejiang Philosophy and Social Science Project; Ningbo Natural Science Foundation	This work is partially supported by the Zhejiang Basic Public Welfare Research Project (2017C35014, Shui Wang), Zhejiang Philosophy and Social Science Project (19GXSZ49YB, Le Wang), Ningbo Natural Science Foundation (2017A610122, Le Wang). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Agrawal R., 1994, VLDB, P487, DOI DOI 10.1007/BF02948845; Ahmed CF, 2009, IEEE T KNOWL DATA EN, V21, P1708, DOI 10.1109/TKDE.2009.46; Vo B, 2020, IEEE ACCESS, V8, P85890, DOI 10.1109/ACCESS.2020.2992729; Cao B, 2021, IEEE T NANOBIOSCI, V20, P212, DOI 10.1109/TNB.2021.3056351; Chen Y, 2016, BIG DATA RES, V6, P26, DOI 10.1016/j.bdr.2016.07.001; Duong QH, 2018, APPL INTELL, V48, P1859, DOI 10.1007/s10489-017-1057-2; Fournier-Viger Philippe, 2014, Foundations of Intelligent Systems. 21st International Symposium, ISMIS 2014. Proceedings: LNCS 8502, P83, DOI 10.1007/978-3-319-08326-1_9; Fournier-Viger P, 2016, LECT NOTES ARTIF INT, V9853, P36, DOI 10.1007/978-3-319-46131-1_8; Han JW, 2004, DATA MIN KNOWL DISC, V8, P53, DOI 10.1023/B:DAMI.0000005258.31418.83; Han JW, 2000, SIGMOD RECORD, V29, P1; Han X., 2020, INFORM SCIENCES, DOI [10.1016/j.ins.2020.08.022, DOI 10.1016/J.INS.2020.08.022]; Kim J, 2020, FUTURE GENER COMP SY, V111, P143, DOI 10.1016/j.future.2020.04.027; Krishnamoorthy S, 2019, EXPERT SYST APPL, V117, P148, DOI 10.1016/j.eswa.2018.09.051; Krishnamoorthy S, 2017, EXPERT SYST APPL, V90, P168, DOI 10.1016/j.eswa.2017.08.028; Krishnamoorthy S, 2015, EXPERT SYST APPL, V42, P2371, DOI 10.1016/j.eswa.2014.11.001; Lee J, 2018, ENG APPL ARTIF INTEL, V72, P111, DOI 10.1016/j.engappai.2018.03.020; Li YC, 2008, DATA KNOWL ENG, V64, P198, DOI 10.1016/j.datak.2007.06.009; Lin CW, 2011, EXPERT SYST APPL, V38, P7419, DOI 10.1016/j.eswa.2010.12.082; Lin CW., 2013, ADV INTELLIGENT SYST, V1, P243; Liu JQ, 2012, IEEE DATA MINING, P984, DOI 10.1109/ICDM.2012.20; Liu M., 2012, P 21 ACM INT C INF K, P55, DOI 10.1145/2396761.2396773; Liu Y, 2005, LECT NOTES ARTIF INT, V3518, P689; Nam H, 2020, IEEE ACCESS, V8, P50958, DOI 10.1109/ACCESS.2020.2979289; Peng AY, 2017, LECT NOTES ARTIF INT, V10235, P196, DOI 10.1007/978-3-319-57529-2_16; Ryang H, 2017, KNOWL INF SYST, V51, P627, DOI 10.1007/s10115-016-0989-x; Srivastava G., 2020, IEEE SENS J, DOI [10.1109/JSEN.2020.2991045, DOI 10.1109/JSEN.2020.2991045]; Mai T, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20041078; Truong T, 2019, KNOWL-BASED SYST, V183, DOI 10.1016/j.knosys.2019.07.018; Tseng V.S., 2010, P 16 ACM SIGKDD INT, P253; Tseng VS, 2016, IEEE T KNOWL DATA EN, V28, P54, DOI 10.1109/TKDE.2015.2458860; Tseng VS, 2013, IEEE T KNOWL DATA EN, V25, P1772, DOI 10.1109/TKDE.2012.59; Wang ET, 2011, DATA MIN KNOWL DISC, V23, P252, DOI 10.1007/s10618-010-0204-8; Wu C., 2012, 18 ACM SIGKDD INT C, P78; Wu JMT, 2020, J INTELL FUZZY SYST; Yao H, 2004, SIAM PROC S, P482; Yao H, 2006, DATA KNOWL ENG, V59, P603, DOI 10.1016/j.datak.2005.10.004; Ye FY, 2005, PROCEEDINGS OF 2005 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-9, P1554; Zida S, 2015, LECT NOTES ARTIF INT, V9413, P530, DOI 10.1007/978-3-319-27060-9_44	38	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0248349	10.1371/journal.pone.0248349	http://dx.doi.org/10.1371/journal.pone.0248349			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711048	gold, Green Published			2022-12-26	WOS:000629591800047
J	Daunys, G; Sukiene, L; Vaitkevicius, L; Valiulis, G; Sofiev, M; Sauliene, I				Daunys, Gintautas; Sukiene, Laura; Vaitkevicius, Lukas; Valiulis, Gediminas; Sofiev, Mikhail; Sauliene, Ingrida			Clustering approach for the analysis of the fluorescent bioaerosol collected by an automatic detector	PLOS ONE			English	Article							AIRBORNE POLLEN; PINACEAE POLLEN; IDENTIFICATION; DISPERSION; SITES	Automatically operating particle detection devices generate valuable data, but their use in routine aerobiology needs to be harmonized. The growing network of researchers using automatic pollen detectors has the challenge to develop new data processing systems, best suited for identification of pollen or spore from bioaerosol data obtained near-real-time. It is challenging to recognise all the particles in the atmospheric bioaerosol due to their diversity. In this study, we aimed to find the natural groupings of pollen data by using cluster analysis, with the intent to use these groupings for further interpretation of real-time bioaerosol measurements. The scattering and fluorescence data belonging to 29 types of pollen and spores were first acquired in the laboratory using Rapid-E automatic particle detector. Neural networks were used for primary data processing, and the resulting feature vectors were clustered for scattering and fluorescence modality. Scattering clusters results showed that pollen of the same plant taxa associates with the different clusters corresponding to particle shape and size properties. According to fluorescence clusters, pollen grouping highlighted the possibility to differentiate Dactylis and Secale genera in the Poaceae family. Fluorescent clusters played a more important role than scattering for separating unidentified fluorescent particles from tested pollen. The proposed clustering method aids in reducing the number of false-positive errors.	[Daunys, Gintautas; Sukiene, Laura; Vaitkevicius, Lukas; Valiulis, Gediminas; Sofiev, Mikhail; Sauliene, Ingrida] Vilnius Univ, Siauliai Acad, Shiauliai, Lithuania; [Sofiev, Mikhail] Finish Meteorol Inst, Helsinki, Finland	Vilnius University	Sauliene, I (corresponding author), Vilnius Univ, Siauliai Acad, Shiauliai, Lithuania.	ingrida.sauliene@sa.vu.lt	Sauliene, Ingrida/J-9320-2019; Šukienė, Laura/AAJ-1261-2021; Daunys, Gintautas/F-6870-2014	Sauliene, Ingrida/0000-0003-0250-1127; Šukienė, Laura/0000-0002-8273-7182; Daunys, Gintautas/0000-0003-2295-2881	European Social Fund [09.3.3-LMT-K712-01-0066]; Research Council of Lithuania (LMTLT)	European Social Fund(European Social Fund (ESF)); Research Council of Lithuania (LMTLT)(Research Council of Lithuania (LMTLT))	This research has been supported by the European Social Fund (project no. 09.3.3-LMT-K712-01-0066) under grant agreement with the Research Council of Lithuania (LMTLT).	Alcazar P, 2019, AEROBIOLOGIA, V35, P269, DOI 10.1007/s10453-019-09558-2; Bagcioglu M, 2017, METHODS ECOL EVOL, V8, P870, DOI 10.1111/2041-210X.12697; Bogawski P, 2019, SCI TOTAL ENVIRON, V689, P109, DOI 10.1016/j.scitotenv.2019.06.348; Buters JTM, 2018, CLIN TRANSL ALLERGY, V8, DOI 10.1186/s13601-018-0197-8; Chappuis C, 2020, AEROBIOLOGIA, V36, P159, DOI 10.1007/s10453-019-09619-6; Clot B, 2020, AEROBIOLOGIA, DOI 10.1007/s10453-020-09666-4; Core Team, R LANG ENV STAT COMP; Crouzy B, 2016, ATMOS ENVIRON, V140, P202, DOI 10.1016/j.atmosenv.2016.05.062; Galan C, 2014, AEROBIOLOGIA, V30, P385, DOI 10.1007/s10453-014-9335-5; Garcia-Mozo H, 2017, ALLERGY, V72, P1849, DOI 10.1111/all.13210; Gehrig R, 2019, AEROBIOLOGIA, V35, P577, DOI 10.1007/s10453-019-09593-z; Halbritter H, 2018, ILLUSTRATED POLLEN TERMINOLOGY, 2ND EDITION, P429, DOI 10.1007/978-3-319-71365-6_12; Hernandez-Ceballos MA, 2015, INT J BIOMETEOROL, V59, P971, DOI 10.1007/s00484-014-0910-9; Huffman JA, 2020, AEROSOL SCI TECH, V54, P465, DOI 10.1080/02786826.2019.1664724; International Diabetes Federation, 2019, IDF DIABETES ATLAS, VNinth; Karatzas KD., 2013, ALLERGENIC POLLEN, P217; Kawashima S, 2007, ATMOS ENVIRON, V41, P7987, DOI 10.1016/j.atmosenv.2007.09.019; Kiselev D, 2011, OPT EXPRESS, V19, P24516, DOI 10.1364/OE.19.024516; Lind T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166887; Makra L, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014743; Murtagh F, 2012, WIRES DATA MIN KNOWL, V2, P86, DOI 10.1002/widm.53; O'Connor DJ, 2014, AEROSOL SCI TECH, V48, P341, DOI 10.1080/02786826.2013.872768; O'Connor DJ, 2011, ATMOS ENVIRON, V45, P6451, DOI 10.1016/j.atmosenv.2011.07.044; Oh JW, 2009, J KOREAN MED ASSOC, V52, P579, DOI 10.5124/jkma.2009.52.6.579; Oteros J, 2019, SCI TOTAL ENVIRON, V688, P1263, DOI 10.1016/j.scitotenv.2019.06.131; Oteros J, 2015, INT ARCH ALLERGY IMM, V167, P158, DOI 10.1159/000436968; Pfaar O, 2020, ALLERGY, V75, P1099, DOI 10.1111/all.14111; R Studio Team, R STUDIO INTEGRATED; Sauliene I., 2007, Acta Biologica Universitatis Daugavpiliensis, P61; Sauliene I, 2019, FORESTS, V10, DOI 10.3390/f10110959; Sauliene I, 2019, ATMOS MEAS TECH, V12, P3435, DOI 10.5194/amt-12-3435-2019; Sauliene Ingrida, 2015, Acta Agrobotanica, V68, P391, DOI 10.5586/aa.2015.036; Sauliene I, 2016, AEROBIOLOGIA, V32, P157, DOI 10.1007/s10453-015-9387-1; Sauvageat E, 2020, ATMOS MEAS TECH, V13, P1539, DOI 10.5194/amt-13-1539-2020; Scheifinger H., 2013, ALLERGENIC POLLEN, P71, DOI DOI 10.1007/978-94-007-4881-1_4; Siauliai municipality, GEN PLAN CITY; Slowikowski K., 2019, GGREPEL AUTOMATICALL; Smith M, 2005, AEROBIOLOGIA, V21, P85, DOI 10.1007/s10453-005-4178-8; Sofiev M, 2019, AEROBIOLOGIA, V35, P523, DOI 10.1007/s10453-019-09583-1; Statistics Lithuania, GEOGR DAT; Swanson BE, 2020, AEROSOL SCI TECH, V54, P426, DOI 10.1080/02786826.2019.1711357; Szczepanek K, 2017, AEROBIOLOGIA, V33, P109, DOI 10.1007/s10453-016-9454-2; Tesendic D, 2022, ENTERP INF SYST-UK, V16, DOI 10.1080/17517575.2020.1793391; Valiulis G., 2020, **DATA OBJECT**, DOI [10.5281/zenodo.3873205, DOI 10.5281/ZENODO.3873205]; Valiulis G., 2020, **DATA OBJECT**, DOI [10.5281/zenodo.3873204, DOI 10.5281/ZENODO.3873204]; Veriankaite L, 2010, J ENVIRON ENG LANDSC, V18, P137, DOI 10.3846/jeelm.2010.16; Voukantsis D, 2013, AEROBIOLOGIA, V29, P175, DOI 10.1007/s10453-012-9271-1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zimmermann B, 2018, PLANTA, V247, P171, DOI 10.1007/s00425-017-2774-9	49	6	6	7	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0247284	10.1371/journal.pone.0247284	http://dx.doi.org/10.1371/journal.pone.0247284			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705418	Green Published, gold			2022-12-26	WOS:000629590400041
J	Neerukonda, SN; Vassell, R; Herrup, R; Liu, SF; Wang, T; Takeda, K; Yang, Y; Lin, TL; Wang, W; Weiss, CD				Neerukonda, Sabari Nath; Vassell, Russell; Herrup, Rachel; Liu, Shufeng; Wang, Tony; Takeda, Kazuyo; Yang, Ye; Lin, Tsai-Lien; Wang, Wei; Weiss, Carol D.			Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2	PLOS ONE			English	Article								Pseudoviruses are useful surrogates for highly pathogenic viruses because of their safety, genetic stability, and scalability for screening assays. Many different pseudovirus platforms exist, each with different advantages and limitations. Here we report our efforts to optimize and characterize an HIV-based lentiviral pseudovirus assay for screening neutralizing antibodies for SARS-CoV-2 using a stable 293T cell line expressing human angiotensin converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2). We assessed different target cells, established conditions that generate readouts over at least a two-log range, and confirmed consistent neutralization titers over a range of pseudovirus input. Using reference sera and plasma panels, we evaluated assay precision and showed that our neutralization titers correlate well with results reported in other assays. Overall, our lentiviral assay is relatively simple, scalable, and suitable for a variety of SARS-CoV-2 entry and neutralization screening assays.	[Neerukonda, Sabari Nath; Vassell, Russell; Herrup, Rachel; Liu, Shufeng; Wang, Tony; Wang, Wei; Weiss, Carol D.] US FDA, Off Vaccine Res & Review, Ctr Biol Evaluat & Res & Review, Silver Spring, MD 20993 USA; [Takeda, Kazuyo] US FDA, Off Blood Res & Review, Ctr Biol Evaluat & Res & Review, Silver Spring, MD USA; [Yang, Ye; Lin, Tsai-Lien] US FDA, Off Biostat & Epidemiol, Ctr Biol Evaluat & Res & Review, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Wang, W; Weiss, CD (corresponding author), US FDA, Off Vaccine Res & Review, Ctr Biol Evaluat & Res & Review, Silver Spring, MD 20993 USA.	wei.wang@fda.hhs.gov; carol.weiss@fda.hhs.gov	Neerukonda, Sabari Nath/AAP-6229-2021	Neerukonda, Sabari Nath/0000-0002-1049-1929; Weiss, Carol D./0000-0002-9965-1289	US Food and Drug Administration	US Food and Drug Administration	This work was supported by institutional research funds from the US Food and Drug Administration to CDW.	Almusawi YA., THERAPEUTIC EFFECTIV; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1101/2020.03.17.20037713, 10.1038/s41591-020-0913-5]; Andrewes CH, 1933, BRIT J EXP PATHOL, V14, P367; Bohn MK, 2020, CLIN CHEM LAB MED, V58, P1037, DOI 10.1515/cclm-2020-0722; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Caruana G, 2020, CLIN MICROBIOL INFEC, V26, P1178, DOI 10.1016/j.cmi.2020.06.019; Chen XY, 2020, CELL MOL IMMUNOL, V17, P647, DOI 10.1038/s41423-020-0426-7; Chu H, 2020, LANCET MICROBE, V1, pE14, DOI 10.1016/S2666-5247(20)30004-5; Connor JP., HOSPITALIZED COVID 1; Coutard B, 2020, ANTIVIR RES, V176, DOI 10.1016/j.antiviral.2020.104742; Crawford KHD, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050513; De Feo CJ, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0086-8; Duan K., 2020, P NATL ACAD SCI USA, V117, P9490; Gharbharan A., CONVALESCENT PLASMA; Giroglou T, 2004, J VIROL, V78, P9007, DOI 10.1128/JVI.78.17.9007-9015.2004; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hoffmann M, 2020, NATURE, V585, P588, DOI 10.1038/s41586-020-2575-3; Hyseni I, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12091011; Johnson MC, 2020, J VIROL, V94, DOI 10.1128/JVI.01062-20; Joyner MJ, 2020, J CLIN INVEST, V130, P4791, DOI [10.1172/JCI140200, 10.1101/2020.05.12.20099879]; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Lee JM, 2018, P NATL ACAD SCI USA, V115, pEB276, DOI 10.1073/pnas.1806133115; Lei CH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16048-4; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1038/s41564-020-0688-y, 10.1101/2020.01.22.915660]; Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Liu WB, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00461-20; Manenti A, 2020, J MED VIROL, V92, P2096, DOI 10.1002/jmv.25986; Matsuyama S, 2020, P NATL ACAD SCI USA, V117, P7001, DOI 10.1073/pnas.2002589117; Miyakawa K, 2020, J MOL CELL BIOL, V12, P987, DOI 10.1093/jmcb/mjaa047; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Noy-Porat T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18159-4; Ozcurumez MK, 2020, J ALLERGY CLIN IMMUN, V146, P35, DOI 10.1016/j.jaci.2020.05.020; Oguntuyo Kasopefoluwa Y, 2021, mBio, V12, DOI [10.1101/2020.08.13.20157222, 10.1128/mBio.02492-20]; Ou TL, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009212; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Perera RAPM, 2020, EUROSURVEILLANCE, V25, P14, DOI 10.2807/1560-7917.ES.2020.25.16.2000421; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Poland GA, 2020, MAYO CLIN PROC, V95, P2172, DOI 10.1016/j.mayocp.2020.07.021; Ravichandran S, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abc3539; Rogers TF, 2020, SCIENCE, V369, P956, DOI 10.1126/science.abc7520; Salazar E, 2020, J CLIN INVEST, V130, P6728, DOI 10.1172/JCI141206; Schmidt F, 2020, J EXP MED, V217, DOI 10.1084/jem.20201181; Seydoux E, 2020, IMMUNITY, V53, P98, DOI 10.1016/j.immuni.2020.06.001; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783; Wang W, 2008, J VIROL METHODS, V153, P111, DOI 10.1016/j.jviromet.2008.07.015; Wang W, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002081; Wang W, 2010, J VIROL METHODS, V165, P305, DOI 10.1016/j.jviromet.2010.02.009; Wec AZ, 2020, SCIENCE, V369, P731, DOI 10.1126/science.abc7424; Wiggins CC., EVIDENCE FAVOURING E; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Xie XP, 2020, CELL HOST MICROBE, V27, P841, DOI 10.1016/j.chom.2020.04.004; Yurkovetskiy Leonid, 2020, Cell, V183, P739, DOI [10.1101/2020.07.04.187757, 10.1016/j.cell.2020.09.032]; Zang RC, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc3582; Zettl F, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8030386; Zheng Yue, 2020, bioRxiv, DOI 10.1101/2020.07.17.207563; Zhou H., TREATMENT 6 COVID 19; Zhou Lanlan, 2020, bioRxiv, DOI 10.1101/2020.08.02.230839; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	64	51	52	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0248348	10.1371/journal.pone.0248348	http://dx.doi.org/10.1371/journal.pone.0248348			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690649	Green Published, Green Submitted, gold			2022-12-26	WOS:000627854700070
J	Batista, JD; Ferreira, VRS; Cabette, HSR; de Castro, LA; De Marco, P; Juen, L				Batista, Joana Darc; Santos Ferreira, Victor Rennan; Ramos Cabette, Helena Soares; de Castro, Lourivaldo Amancio; De Marco, Paulo; Juen, Leandro			Sampling efficiency of a protocol to measure Odonata diversity in tropical streams	PLOS ONE			English	Article							MATO-GROSSO; INSECTA; PATTERNS; BIODIVERSITY; COMMUNITIES; ASSEMBLAGES; INDICATORS; ABUNDANCE; STATE	Odonata can be sampled following different types of protocols. In Brazil, the most used protocol is the scanning in fixed areas method, where a 100-meter transect is delimited in one of the stream margins, subdivided into 20 segments measuring 5 meters. Despite being universally used, the methodological efficiency or limitations of this protocol for Odonata has never been tested. In this scenario, our objective was to assess the efficiency of the sampling protocol to measure the richness and composition of Odonata in three fundamental aspects: the time of sampling and sampling effort over time and space. We show that the best sampling efficiency was achieved in collections performed at noon, in transects measuring 100 meters, requiring at least two samplings in the same location, supporting the procedures traditionally adopted by many studies with the group. While comparing species composition, we did not see any implication between the different treatments on the capture of the local species pool. However, we highlight and discuss some possible methodological flaws when using this protocol to sample specific Odonata groups. We believe the results obtained are fundamental in the inventory of species and to conduct future studies, as well as to aid conservative measures that use the order Odonata as a tool for environmental monitoring.	[Batista, Joana Darc; Ramos Cabette, Helena Soares; de Castro, Lourivaldo Amancio] Univ Estado Mato Grosso, Entomol Lab Nova Xavantina, Nova Xavantina, Brazil; [Santos Ferreira, Victor Rennan; Juen, Leandro] Univ Fed Para, Lab Ecol & Conservat, Posgrad Ecol, Belem, Para, Brazil; [Santos Ferreira, Victor Rennan; Juen, Leandro] Museu Paraense Emilio Goeldi, Belem, Para, Brazil; [De Marco, Paulo] Univ Fed Goias, Lab Theory Metacommun & Landscape Ecol, Goiania, Go, Brazil	Universidade do Estado de Mato Grosso; Universidade Federal do Para; Museu Paraense Emilio Goeldi; Universidade Federal de Goias	Ferreira, VRS (corresponding author), Univ Fed Para, Lab Ecol & Conservat, Posgrad Ecol, Belem, Para, Brazil.; Ferreira, VRS (corresponding author), Museu Paraense Emilio Goeldi, Belem, Para, Brazil.	victor_rennan890@hotmail.com	Juen, Leandro/R-4014-2019; De Marco, Paulo/B-2209-2009; Juen, Leandro/I-1338-2012	Juen, Leandro/0000-0002-6188-4386; De Marco, Paulo/0000-0002-3628-6405; Rennan, Victor/0000-0001-9077-8227	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [304710/2019-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [88887.469089/2019]; CNPq [403725/2012-7]; FAPEMAT [465866/2009]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMAT(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT))	We thank the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for providing fellowships to L. Juen (process 304710/2019-9) and P. De Marco and to the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for providing scholarships to V. R. S. Ferreira (process process:88887.469089/2019). Again, we are grateful to CNPq for funding the PELD project (process:403725/2012-7) and to FAPEMAT for funding the study in streams (process:465866/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRO A, 1990, Odonatologica, V19, P223; Allan J D, 2007, STREAM ECOLOGY STRUC, V2nd; Alves-Martins F, 2019, INSECT CONSERV DIVER, V12, P251, DOI 10.1111/icad.12327; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 1957, T AM GEOPHYS UNION; De Oliveira-Jr JMB, 2015, AUSTRAL ECOL, V40, P733, DOI 10.1111/aec.12242; Oliveira JMB, 2019, INSECTS, V10, DOI 10.3390/insects10100322; Brasil LS, 2018, INSECT CONSERV DIVER, V11, P174, DOI 10.1111/icad.12262; Brasil LS, 2014, INT J ODONATOL, V17, P187, DOI 10.1080/13887890.2014.963712; Buss DF, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-014-4132-8; Calvao LB, 2018, J INSECT CONSERV, V22, P675, DOI 10.1007/s10841-018-0093-5; Calvao Lenize Batista, 2014, Check List, V10, P299; Carter JL, 2001, J N AM BENTHOL SOC, V20, P658, DOI 10.2307/1468095; Cezrio RR, 2020, MEAS ARTHR BIODIVER, P223; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Cordero-Rivera Adolfo, 2008, P7; Dalzochio MS, 2011, REV BRAS ENTOMOL, V55, P88, DOI 10.1590/S0085-56262011000100014; Das Sunit Kr., 2012, Academic Journal of Entomology, V5, P54; de Carvalho FG, 2013, INTERCIENCIA, V38, P516; Carvalho Fernando Geraldo de, 2013, Acta Limnol. Bras., V25, P10, DOI 10.1590/S2179-975X2013005000013; De Marco P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123023; De Marco P, 1998, ODONATOLOGICA, V27, P239; De Marco P, 2014, HYDROBIOLOGIA, V723, P87, DOI 10.1007/s10750-013-1695-2; Ferreira-Peruquetti Patrícia Santos, 2002, Rev. Bras. Zool., V19, P317, DOI 10.1590/S0101-81752002000200002; Foote AL, 2005, ECOL ENTOMOL, V30, P273, DOI 10.1111/j.0307-6946.2005.00701.x; Garrison R.W., 2006, NONRESIDENTIAL MISSI; Giugliano L, 2012, INT J ODONATOL, V15, P13, DOI 10.1080/13887890.2012.660403; Pereira DFG, 2019, ECOL INDIC, V98, P179, DOI 10.1016/j.ecolind.2018.09.020; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Heckman CW., 2006, ENCY S AM AQUATIC IN; Hofmann TA, 2005, HYDROBIOLOGIA, V539, P137, DOI 10.1007/s10750-004-3916-1; Juen L, 2011, INSECT CONSERV DIVER, V4, P265, DOI 10.1111/j.1752-4598.2010.00130.x; Kery M, 2007, ECOL ENTOMOL, V32, P53, DOI 10.1111/j.1365-2311.2006.00841.x; Legendre P, 2018, ENCY ECOLOGY, DOI [10.1016/B978-0-12-409548-9.10595, DOI 10.1016/B978-0-12-409548-9.10595]; Lencioni FAA., 2005, DAMSELFLIES BRAZIL, V1st; Mabry Catherine, 2010, Ecological Restoration, V28, P475, DOI 10.3368/er.28.4.475; Maezono Y, 2004, ECOL RES, V19, P263, DOI 10.1111/j.1440-1703.2004.00634.x; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; May M.L., 1991, Advances in Odonatology, V5, P71; McCarthy MA, 2013, OIKOS, V122, P717, DOI 10.1111/j.1600-0706.2012.20781.x; McPeek Mark A., 2008, P51; Mendes TP, 2017, NEOTROP ENTOMOL, V46, P631, DOI 10.1007/s13744-017-0503-5; Miguel TB, 2017, ECOL INDIC, V81, P555, DOI 10.1016/j.ecolind.2017.06.010; Miguel TB, 2017, INT J ODONATOL, V20, P27, DOI 10.1080/13887890.2017.1286267; Monteiro CD, 2015, ECOL INDIC, V48, P303, DOI 10.1016/j.ecolind.2014.08.021; Monteiro CD, 2013, INT J ODONATOL, V16, P135, DOI 10.1080/13887890.2013.764798; Oksanen J., 2018, R PACKAGE VERSION, V2, P5; De Almeida MVO, 2013, REV BRAS ENTOMOL, V57, P417, DOI 10.1590/S0085-56262013005000042; Oppel Steffen, 2006, International Journal of Odonatology, V9, P81; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Plafkin JL, 1989, EPA4444 89 011; POLLARD E, 1977, BIOL CONSERV, V12, P115, DOI 10.1016/0006-3207(77)90065-9; Rodrigues ME, 2019, INSECT CONSERV DIVER, V12, P231, DOI 10.1111/icad.12319; Sahlen G., 2005, FORESTS DRAGONFLIES, P153; Valente-Neto F, 2016, ECOL INDIC, V61, P952, DOI 10.1016/j.ecolind.2015.10.052; Vilela DS, 2016, BIOSCI J, V32, P486, DOI 10.14393/BJ-v32n2a2016-30491	58	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2021	16	3							e0248216	10.1371/journal.pone.0248216	http://dx.doi.org/10.1371/journal.pone.0248216			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DJ	33690692	gold, Green Published			2022-12-26	WOS:000627855600006
J	Omaiye, EE; Williams, M; Bozhilov, KN; Talbot, P				Omaiye, Esther E.; Williams, Monique; Bozhilov, Krassimir N.; Talbot, Prue			Design features and elemental/metal analysis of the atomizers in pod-style electronic cigarettes	PLOS ONE			English	Article							RESPONSES; ELEMENTS	Background The atomizers of electronic cigarettes (ECs) contain metals that transfer to the aerosol upon heating and may present health hazards. This study analyzed 4(th)-generation EC pod atomizer design features and characterized their elemental/metal composition. Methods Eleven EC pods from six brands/manufacturers were purchased at local shops and online. Pods were dissected and imaged using a Canon EOS Rebel SL2 camera. Elemental analysis and mapping of atomizer components was done using a scanning electron microscope coupled with an energy dispersive x-ray spectrometer. Results EC pods varied in size and design. The internal atomizer components were similar across brands except for variations occurring mainly in the wicks and filaments of some products. The filaments were either Elinvar (nickel, iron, and chromium) (36.4%), nichrome (36.4%), iron-chromium (18.2%), or nickel (9%). Thick wires present in 55% of the atomizers were mainly nickel and were joined to filaments by brazing. Wire-connector joints were Elinvar. Metal air tubes were made of Elinvar (50%), nickel, zinc, copper, and tin (37.5%), and nickel and copper (12.5%). Most of the wick components were silica, except for two pods (PHIX and Mico), which were mainly ceramic. Connectors contained gold-plated nickel, iron-chromium multiple alloys of nickel, zinc, gold, iron, and copper. Wick chambers were made of Elinvar. Outer casings were either nickel, copper-tin, or nickel-copper alloys. Magnets were nickel with minor iron, copper, and sulfur. Some frequently occurring elements were high in relative abundance in atomizer components. Conclusions The atomizers of pods are similar to previous generations, with the introduction of ceramic wicks and magnets in the newer generations. The elements in EC atomizers may transfer into aerosols and adversely affect health and accumulate in the environment.	[Omaiye, Esther E.] Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA; [Omaiye, Esther E.; Williams, Monique; Talbot, Prue] Univ Calif Riverside, Dept Mol Cell & Syst Biol, Riverside, CA 92521 USA; [Bozhilov, Krassimir N.] Univ Calif Riverside, Cent Facil Adv Microscopy & Microanal, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Talbot, P (corresponding author), Univ Calif Riverside, Dept Mol Cell & Syst Biol, Riverside, CA 92521 USA.	talbot@ucr.edu	Talbot, Prue/AAY-3896-2021	Omaiye, Esther E./0000-0002-6010-4798	National Institute of Drug Addiction; FDA Centers for Tobacco Products (CTP) [R01 DA03649]; National Institute of Food and Agriculture [1022304]; Predoctoral Fellowship from the Graduate Division; Postdoctoral T32 Training Grant Award from the NIH [T32 ES018827]	National Institute of Drug Addiction; FDA Centers for Tobacco Products (CTP)(United States Department of Health & Human Services); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Predoctoral Fellowship from the Graduate Division; Postdoctoral T32 Training Grant Award from the NIH	The research reported in this publication was supported by the National Institute of Drug Addiction and FDA Centers for Tobacco Products (CTP) [Grant #R01 DA03649] to PT, National Institute of Food and Agriculture (Grant #1022304) to PT, a Predoctoral Fellowship from the Graduate Division to EO, and a Postdoctoral T32 Training Grant Award from the NIH (Grant #T32 ES018827) to MW. The funders had no role in study design, data collection analysis, decision to publish, or manuscript preparation.	[Anonymous], 2020, STATISTA; Antonini JM, 2007, J IMMUNOTOXICOL, V4, P117, DOI 10.1080/15476910701336953; Antonini JM, 1997, EXP LUNG RES, V23, P205, DOI 10.3109/01902149709087368; Bach L, 2019, JUUL YOUTH RISING E; Bach L., 2020, CAMPAIGN TOBACCO FRE; Beauval N, 2016, REGUL TOXICOL PHARM, V79, P144, DOI 10.1016/j.yrtph.2016.03.024; Behar RZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117222; Burt B, 2020, JAAPA-J AM ACAD PHYS, V33, P17, DOI 10.1097/01.JAA.0000654384.02068.99; Chowdhury R., 2018, BMJ-BRIT MED J, V362, pk3310, DOI [10.1136/bmj.k3310, DOI 10.1136/BMJ.K3310]; Duell AK, 2018, CHEM RES TOXICOL, V31, P431, DOI 10.1021/acs.chemrestox.8b00097; Dunbar ZR, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010154; Fowles J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062146; Gaur S, 2019, BIOL TRACE ELEM RES, V188, P295, DOI 10.1007/s12011-018-1423-x; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Gray N, 2022, J ANAL TOXICOL, V46, P69, DOI 10.1093/jat/bkaa185; Halstead M, 2020, J ANAL TOXICOL, V44, P149, DOI 10.1093/jat/bkz078; Herzog B, 2018, WELLS FARGO EQUITY R; Hess CA, 2017, ENVIRON RES, V152, P221, DOI 10.1016/j.envres.2016.09.026; Huang JD, 2019, TOB CONTROL, V28, P146, DOI 10.1136/tobaccocontrol-2018-054382; INT AGCY RES CANC, 1990, IARC MONOG EVAL CARC, V49, P49; Kamilari E, 2018, FOOD CHEM TOXICOL, V116, P233, DOI 10.1016/j.fct.2018.04.035; Kuo CC, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP577; Moon K, 2012, CURR ATHEROSCLER REP, V14, P542, DOI 10.1007/s11883-012-0280-x; National Academies of Sciences Engineering and Medicine, 2018, PUBL HLTH CONS CIG; National Asthma Education and Prevention Program, 2002, J ALLERGY CLIN IMM S, V110, pS141; Olmedo P, 2018, ENVIRON HEALTH PERSP, V126, DOI 10.1289/EHP2175; Omaiye EE, 2019, CHEM RES TOXICOL, V32, P1058, DOI 10.1021/acs.chemrestox.8b00381; Omaiye Esther E, 2017, Tob Regul Sci, V3, P347, DOI 10.18001/TRS.3.3.10; Palazzolo DL, 2017, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00663; Pappas RS, 2021, J ANAL TOXICOL, V45, P337, DOI 10.1093/jat/bkaa088; Pisinger C, 2014, PREV MED, V69, P248, DOI 10.1016/j.ypmed.2014.10.009; Pollard KM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00097; Sakamaki-Ching S, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2019-000452; Sankhla M. S., 2017, INT J INNOV RES SCI, V6, P7721, DOI [10.15680/ IJIRSET.2017.0605054, DOI 10.15680/IJIRSET.2017.0605054]; Sharma P, 2015, INDIAN J CLIN BIOCHE, V30, P1, DOI 10.1007/s12291-015-0480-6; Trtchounian A, 2011, TOB CONTROL, V20, P47, DOI 10.1136/tc.2010.037259; Wagner J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240613; Wang TW, 2020, MMWR-MORBID MORTAL W, V69, P1310, DOI 10.15585/mmwr.mm6937e1; Williams M, 2020, NICOTINE TOB RES, V22, pS14, DOI 10.1093/ntr/ntaa193; Williams M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50441-4; Williams M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16162904; Williams M, 2019, ENVIRON RES, V175, P156, DOI 10.1016/j.envres.2019.05.014; Williams M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175430; Williams M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138933; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987; Zhao D, 2020, ENVIRON HEALTH PERSP, V128, DOI 10.1289/EHP5686	46	5	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2021	16	3							e0248127	10.1371/journal.pone.0248127	http://dx.doi.org/10.1371/journal.pone.0248127			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DJ	33690644	Green Published, gold			2022-12-26	WOS:000627855600026
J	Olsen, KS; Holden, M; Thalabard, JC; Busund, LTR; Lund, E; Holden, L				Olsen, Karina Standahl; Holden, Marit; Thalabard, Jean-Christophe; Busund, Lill-Tove Rasmussen; Lund, Eiliv; Holden, Lars			Global blood gene expression profiles following a breast cancer diagnosis-Clinical follow-up in the NOWAC post-genome cohort	PLOS ONE			English	Article							NORWEGIAN WOMEN; EPIDEMIOLOGY	Objective This explorative study aimed to assess if there are any time-dependent blood gene expression changes during the first one to eight years after breast cancer diagnosis, which can be linked to the clinical outcome of the disease. Material and methods A random distribution of follow-up time from breast cancer diagnosis till blood sampling was obtained by a nested, matched case-control design in the Norwegian Women and Cancer Post-genome Cohort. From 2002-5, women were invited to donate blood samples, regardless of any cancer diagnosis. At end of the study period in 2015, any cancer diagnoses in the 50 000 participants were obtained via linkage to the Norwegian Cancer Registry. For each breast cancer patient (n = 415), an age- and storage time-matched control was drawn. The design gave a uniform, random length of follow-up time, independent of cancer stage. Differences in blood gene expression between breast cancer cases and controls were identified using the Bioconductor R-package limma, using a moving window in time, to handle the varying time elapsed from diagnosis to blood sample. Results The number of differentially expressed genes between cases and controls were close to 2,000 in the first year after diagnosis, but fell sharply the second year. During the next years, a transient second increase was observed, but only in women with metastatic disease who later died, both compared to invasive cases that survived (p<0,001) and to metastatic cases that survived (p = 0.024). Among the differentially expressed genes there was an overrepresentation of heme metabolism and T cell-related processes. Conclusion This explorative analysis identified changing trajectories in the years after diagnosis, depending on clinical stage. Hypothetically, this could represent the escape of the metastatic cancer from the immune system.	[Olsen, Karina Standahl; Busund, Lill-Tove Rasmussen; Lund, Eiliv] UiT Arctic Univ Norway, Tromso, Norway; [Holden, Marit; Holden, Lars] Norwegian Comp Ctr, Oslo, Norway; [Thalabard, Jean-Christophe] Univ Paris 05, USPC, MAP5, UMR CNRS 8145, Paris, France; [Busund, Lill-Tove Rasmussen] Univ Hosp North Norway, Tromso, Norway; [Lund, Eiliv] Canc Registry Norway, Oslo, Norway	UiT The Arctic University of Tromso; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Paris Cite; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Oslo	Olsen, KS (corresponding author), UiT Arctic Univ Norway, Tromso, Norway.	karina.s.olsen@uit.no	Thalabard, Jean-Christophe/CAF-0106-2022	Lund, Eiliv/0000-0002-8071-8711	European Research Council [ERC-AdG 232997 TICE]	European Research Council(European Research Council (ERC)European Commission)	This study was supported by a grant given to EL from the European Research Council (ERC-AdG 232997 TICE, https://erc.europa.eu/) and a donation from Halfdan Jacobsen og frues legat (The Norwegian Cancer Society, https://kreftforeningen.no/en/about-us/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bovelstad E, 2017, BIORXIV; Canesin G, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00066; Du P, 2016, R PACKAGE VERSION 11; Dumeaux V, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1859; Dumeaux V, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005680; Dumeaux V, 2015, INT J CANCER, V136, P656, DOI 10.1002/ijc.29030; Holden M., 2017, Advances in Genomics and Genetics, V7, P11, DOI 10.2147/AGG.S130004; Holsbo E, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.575461; Janssen LME, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0283-9; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Korotkevich G., 2016, BIORXIV, DOI [10.1101/060012, DOI 10.1101/060012, 10.1101/060012v3]; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Lund E, 2008, CANCER EPIDEM BIOMAR, V17, P2954, DOI 10.1158/1055-9965.EPI-08-0519; Lund E, 2008, INT J EPIDEMIOL, V37, P36, DOI 10.1093/ije/dym137; Lund E, 2018, CLIN EPIDEMIOL, V10, P931, DOI 10.2147/CLEP.S163208; Lund H, 2016, BMC MED RES METHODOL, V16; Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082; Pasculli B, 2018, SEMIN CANCER BIOL, V51, P22, DOI 10.1016/j.semcancer.2018.01.007; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0246650	10.1371/journal.pone.0246650	http://dx.doi.org/10.1371/journal.pone.0246650			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU3OZ	33684121	Green Published, gold			2022-12-26	WOS:000627193500004
J	Pan, ZH; Liu, CQ; Zhi, YF; Xie, ZY; Wu, L; Jiang, MH; Zhang, YJ; Zhou, R; Zhao, L				Pan, Zhihua; Liu, Chaoqun; Zhi, Yunfei; Xie, Zhiyue; Wu, Ling; Jiang, Muhong; Zhang, Yujie; Zhou, Rui; Zhao, Liang			LIMK1 nuclear translocation promotes hepatocellular carcinoma progression by increasing p-ERK nuclear shuttling and by activating c-Myc signalling upon EGF stimulation	ONCOGENE			English	Article							FACTOR RECEPTOR INHIBITION; KINASE 1; ACTIN DYNAMICS; GROWTH; CETUXIMAB; COFILIN; PHOSPHORYLATION; SENSITIVITY; THREONINE; SERINE	LIM kinase 1 (LIMK1) is a serine/threonine and tyrosine kinase that is predominantly located in the cytoplasm. In our study, nuclear translocation of LIMK1 in clinical hepatocellular carcinoma (HCC) samples was demonstrated for the first time, especially in samples from those with intravascular tumour thrombus. LIMK1 was overexpressed in HCC tissues, and nuclear LIMK1 expression was associated with poor prognosis in HCC patients. Although the effects of cytoplasmic LIMK1 on cofilin phosphorylation and actin filament dynamics have been well studied, the function of nuclear LIMK1 is still unclear. Gain- and loss-of-function experiments were performed both in vitro and in vivo and demonstrated a correlation between nuclear LIMK1 and the enhanced aggressive phenotype of HCC. EGF could drive the nuclear translocation of LIMK1 by activating the interaction of p-ERK and LIMK1 and facilitating their roles in nuclear shuttling. Moreover, nuclear LIMK1 could directly bind to the promoter region of c-Myc and stimulate c-Myc transcription. Although the EGFR monoclonal antibody cetuximab has a poor therapeutic effect on advanced HCC patients, in vivo animal study showed that cetuximab achieved a significant inhibitory effect on the progression of nuclear LIMK1-overexpressing HCC cells. In addition, recent data have demonstrated the potential of cetuximab in combination therapy for HCC patients with LIMK1 nuclear translocation.	[Pan, Zhihua; Liu, Chaoqun; Zhi, Yunfei; Xie, Zhiyue; Wu, Ling; Jiang, Muhong; Zhang, Yujie; Zhou, Rui; Zhao, Liang] Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Peoples R China; [Pan, Zhihua; Liu, Chaoqun; Zhi, Yunfei; Xie, Zhiyue; Wu, Ling; Jiang, Muhong; Zhang, Yujie; Zhou, Rui; Zhao, Liang] Southern Med Univ, Dept Pathol, Guangdong Prov Key Lab Mol Tumor Pathol, Sch Basic Med Sci, Guangzhou, Peoples R China	Southern Medical University - China; Southern Medical University - China	Zhou, R; Zhao, L (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Peoples R China.; Zhou, R; Zhao, L (corresponding author), Southern Med Univ, Dept Pathol, Guangdong Prov Key Lab Mol Tumor Pathol, Sch Basic Med Sci, Guangzhou, Peoples R China.	yaruisunny@sina.com; liangsmu@foxmail.com	Zhi, Yunfei/GQI-2937-2022	Zhi, Yunfei/0000-0002-0084-6810	National Natural Science Foundation of China [81773082, 81872423, 81972813, 81702903]; Guangdong Natural Science Foundation [2017A030310038, 2018B030311036, 2019A1515010974]; Fork Ying Tung Education Foundation [161035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Fork Ying Tung Education Foundation	This work was supported by the National Natural Science Foundation of China (Nos. 81773082, 81872423, 81972813, 81702903), Guangdong Natural Science Foundation (2017A030310038, 2018B030311036, 2019A1515010974) and Fork Ying Tung Education Foundation (161035).	Abu Dayyeh BK, 2011, GASTROENTEROLOGY, V141, P141, DOI 10.1053/j.gastro.2011.03.045; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Asnacios A, 2008, CANCER-AM CANCER SOC, V112, P2733, DOI 10.1002/cncr.23489; Bagheri-Yarmand R, 2006, INT J CANCER, V118, P2703, DOI 10.1002/ijc.21650; Bonomi PD, 2018, ANN ONCOL, V29, P1701, DOI 10.1093/annonc/mdy196; Buonaguro L, 2013, J HEPATOL, V59, P897, DOI 10.1016/j.jhep.2013.05.031; Caruso S., 2020, HEPATOLOGY, V35, P331; Chen W, 2012, LIVER INT, V32, P70, DOI 10.1111/j.1478-3231.2011.02631.x; Craig AJ, 2020, NAT REV GASTRO HEPAT, V17, P139, DOI 10.1038/s41575-019-0229-4; Davila M, 2003, J BIOL CHEM, V278, P36868, DOI 10.1074/jbc.M306196200; Ding XF, 2019, GASTROENTEROLOGY, V157, P1630, DOI 10.1053/j.gastro.2019.09.005; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; Fuchs BC, 2014, HEPATOLOGY, V59, P1577, DOI 10.1002/hep.26898; Gao QZ, 2020, ONCOGENE, V39, P3926, DOI 10.1038/s41388-020-1266-8; Ge LS, 2004, J HEPATOL, V41, P823, DOI 10.1016/j.jhep.2004.07.021; Gebbia V, 2007, ANN ONCOL, V18, P5, DOI 10.1093/annonc/mdm215; Goldberg Richard M, 2005, Nat Rev Drug Discov, VSuppl, pS10; Hamill S, 2016, MOL CELL, V62, P397, DOI 10.1016/j.molcel.2016.04.001; Hirsch FR, 2013, J THORAC ONCOL, V8, P373, DOI 10.1097/JTO.0b013e31827ed0ff; Huang JB, 2020, J CELL MOL MED, V24, P4698, DOI 10.1111/jcmm.15138; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim E, 2018, HEPATOLOGY, V67, P2287, DOI 10.1002/hep.29738; Kremer D, 2009, P NATL ACAD SCI USA, V106, P9087, DOI 10.1073/pnas.0900204106; LAGOUTTE E, 2016, INT J BIOCHEM CELL B, V6; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Li WY, 2019, LIVER INT, V39, P147, DOI 10.1111/liv.13957; Liao Q, 2017, BRIT J CANCER, V117, P563, DOI 10.1038/bjc.2017.193; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2018, NAT REV CLIN ONCOL, V15, P599, DOI 10.1038/s41571-018-0073-4; Maiello E, 2007, Ann Oncol, V18 Suppl 6, pvi8, DOI 10.1093/annonc/mdm216; Maik-Rachline G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051194; McConnell BV, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-75; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; NUNOUE K, 1995, ONCOGENE, V11, P701; Ohashi K, 2000, BIOCHEM BIOPH RES CO, V276, P1178, DOI 10.1006/bbrc.2000.3599; Okano I, 1995, J BIOL CHEM, V270, P31321, DOI 10.1074/jbc.270.52.31321; Perugorria MJ, 2019, NAT REV GASTRO HEPAT, V16, P121, DOI 10.1038/s41575-018-0075-9; Po'uha ST, 2010, ONCOGENE, V29, P597, DOI 10.1038/onc.2009.367; PROSCHEL C, 1995, ONCOGENE, V11, P1271; Schofield AV, 2013, BIOCHEM BIOPH RES CO, V436, P571, DOI 10.1016/j.bbrc.2013.05.076; Schofield AV., 2014, ADV BIOSCI BIOTECHNO, V05, P353, DOI [10.4236/abb.2014.54043, DOI 10.4236/ABB.2014.54043]; Sheng H, 2020, EUR REV MED PHARMACO, V24, P2625, DOI 10.26355/eurrev_202003_20531; Simhadri PK, 2017, ANN NEUROL, V82, P429, DOI 10.1002/ana.25028; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stanyon CA, 1999, INT J BIOCHEM CELL B, V31, P389, DOI 10.1016/S1357-2725(98)00116-2; Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yang N, 1999, BIOCHEM J, V338, P793, DOI 10.1042/0264-6021:3380793; Yang N, 1998, EXP CELL RES, V241, P242, DOI 10.1006/excr.1998.4053; Yao Z, 2001, ONCOGENE, V20, P7588, DOI 10.1038/sj.onc.1204963; Zhao CC, 2020, CANCER LETT, V493, P120, DOI 10.1016/j.canlet.2020.08.006; Zhu AX, 2007, CANCER-AM CANCER SOC, V110, P581, DOI 10.1002/cncr.22829	52	6	6	2	17	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2021	40	14					2581	2595		10.1038/s41388-021-01736-2	http://dx.doi.org/10.1038/s41388-021-01736-2		MAR 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RK3YE	33686242				2022-12-26	WOS:000626396000006
J	Giovenco, D; Gill, K; Fynn, L; Duyver, M; O'Rourke, S; van der Straten, A; Morton, JF; Celum, CL; Bekker, LG				Giovenco, Danielle; Gill, Katherine; Fynn, Lauren; Duyver, Menna; O'Rourke, Shannon; van der Straten, Ariane; Morton, Jennifer F.; Celum, Connie L.; Bekker, Linda-Gail			Experiences of oral pre-exposure prophylaxis (PrEP) use disclosure among South African adolescent girls and young women and its perceived impact on adherence	PLOS ONE			English	Article								Introduction There is limited understanding of how social dynamics impact pre-exposure prophylaxis (PrEP) adherence among adolescent girls and young women (AGYW) in generalized HIV-epidemic settings. We examined experiences of oral PrEP use disclosure to various social groups with the goal of identifying supportive relationships that can be leveraged to promote adherence. Methods We used qualitative methods to explore experiences disclosing PrEP use and the perceived impact of disclosure on adherence among 22 South African AGYW (16-25 years) taking daily oral PrEP. Serial in-depth-interviews (IDIs) were conducted 1-, 3-, and 12-months post-PrEP initiation. Respondents also self-reported their disclosures separately for various social groups and adherence was assessed using intracellular tenofovir-diphosphate levels. Results Qualitative respondents had a median age of 20.5 years and reported disclosing their PrEP use to friends (n = 36 total disclosures), partners, siblings, other family members (n = 24 disclosures each), and parents (n = 19 disclosures). IDI data revealed that parents and partners provided the most support to respondents and a lack of support from these groups was most often perceived as negatively affecting PrEP use. AGYW described difficulties explaining PrEP to their mothers, who believed PrEP was HIV treatment or would lead to HIV infection. Disclosure to household members was notably meaningful for AGYW (both positively and negatively). Respondents reported leveraging supportive relationships for pill reminders. For respondents who perceived a household member would be unsupportive, however, non-disclosure was less feasible and PrEP use was often stigmatized. To avoid stigma, several respondents hid or discontinued PrEP. Conclusions While supportive relationships may facilitate PrEP use, disclosure can also lead to stigma. Counselors should support AGYW in disclosing to key people in their social networks and provide AGYW with materials that lend credibility to explanations of PrEP. Community education is necessary to alleviate PrEP-related stigma and facilitate disclosure.	[Giovenco, Danielle] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Giovenco, Danielle; Gill, Katherine; Fynn, Lauren; Duyver, Menna; Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, Cape Town, South Africa; [O'Rourke, Shannon; van der Straten, Ariane] RTI Int, Womens Global Hlth Imperat, Berkeley, CA USA; [van der Straten, Ariane] UCSF, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA USA; [Morton, Jennifer F.; Celum, Connie L.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Celum, Connie L.] Univ Washington, Dept Med, Seattle, WA USA; [Celum, Connie L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Cape Town; Research Triangle Institute; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Giovenco, D (corresponding author), Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC 27599 USA.; Giovenco, D (corresponding author), Univ Cape Town, Desmond Tutu HIV Ctr, Cape Town, South Africa.	dgiovenco@unc.edu	Gill, Katherine/ABG-3230-2021	Gill, Katherine/0000-0002-3372-9506; BEKKER, LINDA-GAIL/0000-0002-0755-4386; van der Straten, Ariane/0000-0001-8536-648X; Giovenco, Danielle/0000-0002-2137-5309	National Institutes of Health [R01MH107251, F31MH119965]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by grants R01MH107251 (PIs: Bekker and Celum) and F31MH119965 (PI: Giovenco) of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amico KR, 2017, AIDS BEHAV, V21, P1361, DOI 10.1007/s10461-016-1458-y; Anderson PL, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01710-17; Celum CL, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25636; Corneli A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125458; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Gill K, 2020, LANCET CHILD ADOLESC, V4, P875, DOI 10.1016/S2352-4642(20)30248-0; Golub SA, 2018, CURR HIV-AIDS REP, V15, P190, DOI 10.1007/s11904-018-0385-0; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; GROTEVANT HD, 1985, CHILD DEV, V56, P415, DOI 10.2307/1129730; Hosek S, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.7.21107; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Montgomery ET, 2015, AIDS BEHAV, V19, P784, DOI 10.1007/s10461-014-0950-5; O'Rourke S, 2021, AIDS BEHAV, V25, P2154, DOI 10.1007/s10461-020-03145-0; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Shisana O, 2014, S AFRICAN NATL HIV P; Tsondai PR, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.5.21649; UNAIDS, 2016, AIDS BY THE NUMBERS; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten Ariane, 2014, J Int AIDS Soc, V17, P19146, DOI 10.7448/IAS.17.3.19146; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4	20	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0248307	10.1371/journal.pone.0248307	http://dx.doi.org/10.1371/journal.pone.0248307			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667264	Green Published, gold			2022-12-26	WOS:000626604300048
J	Portillo, JAC; Yu, JS; Hansen, S; Kern, TS; Subauste, MC; Subauste, CS				Portillo, Jose-Andres C.; Yu, Jin-Sang; Hansen, Samuel; Kern, Timothy S.; Subauste, M. Cecilia; Subauste, Carlos S.			A cell-penetrating CD40-TRAF2,3 blocking peptide diminishes inflammation and neuronal loss after ischemia/reperfusion	FASEB JOURNAL			English	Article						endothelial; muller cell; polymorphonuclear leukocyte; retina; toxoplasma	NITRIC-OXIDE SYNTHASE; TRAF BINDING-SITES; N-TERMINAL KINASE; ISCHEMIA-REPERFUSION; RETINAL ISCHEMIA; ANTIMICROBIAL ACTIVITY; LIGAND INTERACTION; IMMUNE-RESPONSE; BOWEL-DISEASE; MULLER CELLS	While the administration of anti-CD154 mAbs in mice validated the CD40-CD154 pathway as a target against inflammatory disorders, this approach caused thromboembolism in humans (unrelated to CD40 inhibition) and is expected to predispose to opportunistic infections. There is a need for alternative approaches to inhibit CD40 that avoid these complications. CD40 signals through TRAF2,3 and TRAF6-binding sites. Given that CD40-TRAF6 is the pathway that stimulates responses key for cell-mediated immunity against opportunistic pathogens, we examined the effects of pharmacologic inhibition of CD40-TRAF2,3 signaling. We used a model of ischemia/reperfusion (I/R)-induced retinopathy, a CD40-driven inflammatory disorder. Intravitreal administration of a cell-penetrating CD40-TRAF2,3 blocking peptide impaired ICAM-1 upregulation in retinal endothelial cells and CXCL1 upregulation in endothelial and Muller cells. The peptide reduced leukocyte infiltration, upregulation of NOS2/COX-2/TNF-alpha/IL-1 beta, and ameliorated neuronal loss, effects that mimic those observed after I/R in Cd40-/- mice. While a cell-penetrating CD40-TRAF6 blocking peptide also diminished I/R-induced inflammation, this peptide (but not the CD40-TRAF2,3 blocking peptide) impaired control of the opportunistic pathogen Toxoplasma gondii in the retina. Thus, inhibition of the CD40-TRAF2,3 pathway is a novel and potent approach to reduce CD40-induced inflammation, while likely diminishing the risk of opportunistic infections that would otherwise accompany CD40 inhibition.	[Portillo, Jose-Andres C.; Yu, Jin-Sang; Hansen, Samuel; Subauste, Carlos S.] Case Western Reserve Univ, Sch Med, Dept Med, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA; [Kern, Timothy S.] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Subauste, M. Cecilia] Case Western Reserve Univ, Dept Med, Div Pulm Crit Care & Sleep Med, Cleveland, OH 44106 USA; [Subauste, M. Cecilia] Vet Adm Med Ctr, Div Pulm Crit Care Allergy & Sleep Med, 10701 East Blvd, Cleveland, OH 44106 USA; [Subauste, Carlos S.] Case Western Reserve Univ, Dept Pathol, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University	Subauste, CS (corresponding author), Case Western Reserve Univ, Dept Med, Sch Med, Cleveland, OH 44106 USA.	carlos.subauste@case.edu		Hansen, Samuel/0000-0002-7678-357X	NIH [EY019250, EY018341, P30 EY11373]; Crohn's and Colitis Foundation of America (Litwin Pioneers Program) [529250]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America (Litwin Pioneers Program)	This work was supported by NIH grants EY019250 (C.S.S), EY018341 (C.S.S), P30 EY11373, and Crohn's and Colitis Foundation of America (Litwin Pioneers Program) grant 529250 (C.S.S.).	Ahonen CL, 2002, NAT IMMUNOL, V3, P451, DOI 10.1038/ni792; Andrade RM, 2005, J IMMUNOL, V175, P6014, DOI 10.4049/jimmunol.175.9.6014; Berger S, 2008, INVEST OPHTH VIS SCI, V49, P3605, DOI 10.1167/iovs.07-0817; Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Bishop GA, 2002, J LEUKOCYTE BIOL, V72, P19; Botchkina GI, 1997, MOL MED, V3, P765, DOI 10.1007/BF03401714; Boumpas DT, 2003, ARTHRITIS RHEUM-US, V48, P719, DOI 10.1002/art.10856; Butler NJ, 2013, CLIN EXP OPHTHALMOL, V41, P95, DOI 10.1111/j.1442-9071.2012.02838.x; Choi JS, 2006, NUTRITION, V22, P668, DOI 10.1016/j.nut.2005.08.011; de Ramon L, 2015, KIDNEY INT, V88, P538, DOI 10.1038/ki.2015.146; Gerhardinger C, 2005, INVEST OPHTH VIS SCI, V46, P349, DOI 10.1167/iovs.04-0860; Gold JA, 2003, INFECT IMMUN, V71, P3521, DOI 10.1128/IAI.71.6.3521-3528.2003; Guidotti G, 2017, TRENDS PHARMACOL SCI, V38, P406, DOI 10.1016/j.tips.2017.01.003; Hangai M, 1996, EXP EYE RES, V63, P501, DOI 10.1006/exer.1996.0140; Hermann DM, 2018, THER ADV NEUROL DISO, V11, DOI 10.1177/1756286418798607; Ishikawa M, 2005, CIRCULATION, V111, P1690, DOI 10.1161/01.CIR.0000160349.42665.0C; Jabara HH, 2002, IMMUNITY, V17, P265, DOI 10.1016/S1074-7613(02)00394-1; Jian ZH, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02167; Kawai T, 2000, NAT MED, V6, P114, DOI 10.1038/72162; Kobayashi M, 2000, JPN J OPHTHALMOL, V44, P235, DOI 10.1016/S0021-5155(99)00220-8; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Levy J, 1997, J PEDIATR-US, V131, P47, DOI 10.1016/S0022-3476(97)70123-9; Lu LF, 2003, J BIOL CHEM, V278, P45414, DOI 10.1074/jbc.M309601200; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; Mackey MF, 2003, EUR J IMMUNOL, V33, P779, DOI 10.1002/eji.200323729; Miura M, 2001, AM J PATHOL, V159, P2137, DOI 10.1016/S0002-9440(10)63065-9; Neufeld AH, 2002, EXP EYE RES, V75, P521, DOI 10.1006/exer.2002.2042; Oura T, 2012, AM J TRANSPLANT, V12, P1740, DOI 10.1111/j.1600-6143.2012.04014.x; Peters AL, 2009, SEMIN IMMUNOL, V21, P293, DOI 10.1016/j.smim.2009.05.012; PINKUS GS, 1991, MODERN PATHOL, V4, P733; Portillo JAC, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00868-18; Portillo JAC, 2017, DIABETES, V66, P483, DOI 10.2337/db16-0051; Portillo JAC, 2014, INVEST OPHTH VIS SCI, V55, P8590, DOI 10.1167/iovs.14-15340; Portillo JAC, 2015, IMMUNOLOGY, V144, P21, DOI 10.1111/imm.12361; Portillo JAC, 2014, DIABETOLOGIA, V57, P2222, DOI 10.1007/s00125-014-3321-x; Portillo JAC, 2012, IMMUNOLOGY, V135, P140, DOI 10.1111/j.1365-2567.2011.03519.x; Portillo JAC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014472; Portillo JAC, 2009, MOL VIS, V15, P1383; Portillo JAC, 2008, J IMMUNOL, V181, P8719, DOI 10.4049/jimmunol.181.12.8719; Prive GG, 2006, CURR OPIN GENET DEV, V16, P71, DOI 10.1016/j.gde.2005.12.010; Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; Reichmann G, 2000, INFECT IMMUN, V68, P1312, DOI 10.1128/IAI.68.3.1312-1318.2000; Roe MT, 2008, CIRCULATION, V117, P886, DOI 10.1161/CIRCULATIONAHA.107.759167; Schorderet DF, 2005, CLIN EXP OPHTHALMOL, V33, P628, DOI 10.1111/j.1442-9071.2005.01108.x; Seijkens TTP, 2018, J AM COLL CARDIOL, V71, P527, DOI 10.1016/j.jacc.2017.11.055; Song ZF, 2012, ARTERIOSCL THROM VAS, V32, P50, DOI 10.1161/ATVBAHA.111.238329; Subauste CS, 2007, AUTOPHAGY, V3, P245, DOI 10.4161/auto.3717; Subauste CS, 1999, J IMMUNOL, V162, P6690; Sutherland CL, 1999, J IMMUNOL, V162, P4720; Tejeda GS, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809950; Touchard E, 2010, INVEST OPHTH VIS SCI, V51, P4683, DOI 10.1167/iovs.09-4733; Trivedi PJ, 2018, J CROHNS COLITIS, V12, pS641, DOI 10.1093/ecco-jcc/jjx145; Tsujikawa A, 1999, INVEST OPHTH VIS SCI, V40, P1183; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; YAMAZAKI T, 1993, AM J PATHOL, V143, P410; Yasui T, 2002, INT IMMUNOL, V14, P319, DOI 10.1093/intimm/14.3.319; Yoneda S, 2001, EXP EYE RES, V73, P661, DOI 10.1006/exer.2001.1072; Zarzycka B, 2015, J CHEM INF MODEL, V55, P294, DOI 10.1021/ci500631e; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510; Zundler S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00891	61	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2021	35	3							e21412	10.1096/fj.201903203RR	http://dx.doi.org/10.1096/fj.201903203RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	QX8EV	33675257	Green Published, hybrid			2022-12-26	WOS:000629576700026
J	Bayarri-Olmos, R; Rosbjerg, A; Johnsen, LB; Helgstrand, C; Bak-Thomsen, T; Garred, P; Skjoedt, MO				Bayarri-Olmos, Rafael; Rosbjerg, Anne; Johnsen, Laust Bruun; Helgstrand, Charlotte; Bak-Thomsen, Theresa; Garred, Peter; Skjoedt, Mikkel-Ole			The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARS CORONAVIRUS; SPIKE PROTEIN	Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 from humans to animals has been reported for many domesticated species, including farmed minks. The identification of novel spike gene mutations appearing in minks has raised major concerns about potential immune evasion and challenges for the global vaccine strategy. One genetic variant, known as "cluster five," arose among farmed minks in Denmark and resulted in a complete shutdown of the world's largest mink production. However, the functional properties of this new variant are not established. Here we present functional data on the cluster-five variant, which contains a mutation resulting in a Y453F residue change in the receptor-binding domain (RBD) of the spike protein. Using an ELISA-based angiotensin-converting enzyme-2/RBD inhibition assay, we show that the Y453F variant does not decrease established humoral immunity from previously infected individuals or affect the neutralizing antibody response in a vaccine mouse model based on the original Wuhan strain RBD or spike as antigens. However, biolayer interferometry analysis demonstrates that it binds the human angiotensin-converting enzyme-2 receptor with a 4-fold higher affinity than the original strain, suggesting an enhanced transmission capacity and a possible challenge for viral control. These results also indicate that the rise in the frequency of the cluster-five variant in mink farms might be a result of the fitness advantage conferred by the receptor adaptation rather than evading immune responses.	[Bayarri-Olmos, Rafael; Rosbjerg, Anne; Garred, Peter; Skjoedt, Mikkel-Ole] Univ Hosp Copenhagen, Dept Clin Immunol, Lab Mol Med, Copenhagen, Denmark; [Rosbjerg, Anne; Skjoedt, Mikkel-Ole] Univ Copenhagen, Inst Immunol & Microbiol, Copenhagen, Denmark; [Johnsen, Laust Bruun; Helgstrand, Charlotte; Bak-Thomsen, Theresa] Novo Nordisk AS, Malov, Denmark	University of Copenhagen; University of Copenhagen; Novo Nordisk	Skjoedt, MO (corresponding author), Univ Hosp Copenhagen, Dept Clin Immunol, Lab Mol Med, Copenhagen, Denmark.; Skjoedt, MO (corresponding author), Univ Copenhagen, Inst Immunol & Microbiol, Copenhagen, Denmark.	moskjoedt@sund.ku.dk		Skjodt, Mikkel-Ole/0000-0003-1306-6482; Garred, Peter/0000-0002-2876-8586; Rosbjerg, Anne/0000-0001-6736-3138; Johnsen, Laust/0000-0003-2953-2804	Carlsberg Foundation [CF20-0045]; Novo Nordisk Foundation [NFF205A0063505, NNF20SA0064201]	Carlsberg Foundation(Carlsberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was financially supported by grants from the Carlsberg Foundation (CF20-0045 to M.-O.S., R. B.-O., and P. G.) and the Novo Nordisk Foundation (NFF205A0063505 and NNF20SA0064201 to M.-O. S., R. B.-O., and P. G.).	Bayarri-Olmos R., 2021, RES SQ, P1, DOI [10.21203/rs.3.rs-134388/v1, DOI 10.21203/RS.3.RS-134388/V1]; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Halfmann PJ, 2020, NEW ENGL J MED, V383, P592, DOI 10.1056/NEJMc2013400; Hansen CB, 2021, J IMMUNOL, V206, P109, DOI 10.4049/jimmunol.2000898; He YX, 2004, J IMMUNOL, V173, P4050, DOI 10.4049/jimmunol.173.6.4050; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Kupferschmidt K., 2020, SCIENCE DEC, DOI [10.1126/science.abg2626, DOI 10.1126/SCIENCE.ABG2626]; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Lassauniere R., 2020, PRELIMINARY REPORT, P1; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012; Mishra D, 2021, J MED VIROL, V93, P2406, DOI 10.1002/jmv.26744; Molenaar RJ, 2020, VET PATHOL, V57, P653, DOI 10.1177/0300985820943535; Newman A, 2020, MMWR-MORBID MORTAL W, V69, P710, DOI 10.15585/mmwr.mm6923e3; Oreshkova N, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.23.2001005; Oude Munnink B.B., 2020, BIORXIV, DOI 10.1101/2020.09.01.277152; Patterson EI, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20097-0; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Shi JZ, 2020, SCIENCE, V368, P1016, DOI 10.1126/science.abb7015; Sia SF, 2020, NATURE, V583, P834, DOI 10.1038/s41586-020-2342-5; Sit THC, 2020, NATURE, V586, P776, DOI 10.1038/s41586-020-2334-5; Thomson E. C., 2020, CIRCULATING SARS COV, P1, DOI [10.1101/2020.11.04, DOI 10.1101/2020.11.04]; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yoo HS, 2020, J VET SCI, V21, DOI 10.4142/jvs.2020.21.e51; Yurkovetskiy L, 2020, CELL, V183, P739, DOI 10.1016/j.cell.2020.09.032; Zhang LZ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19808-4; Zhou WY, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.697035	30	58	59	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100536	10.1016/j.jbc.2021.100536	http://dx.doi.org/10.1016/j.jbc.2021.100536			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33716040	gold, Green Submitted, Green Published			2022-12-26	WOS:000672866400510
J	Yamaguchi, K; So, M; Aguirre, C; Ikenaka, K; Mochizuki, H; Kawata, Y; Goto, Y				Yamaguchi, Keiichi; So, Masatomo; Aguirre, Cesar; Ikenaka, Kensuke; Mochizuki, Hideki; Kawata, Yasushi; Goto, Yuji			Polyphosphates induce amyloid fibril formation of alpha-synuclein in concentration-dependent distinct manners	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INORGANIC POLYPHOSPHATE; SUPERSATURATION; AGGREGATION; DISEASE; WATER; SOLUBILITY; MEDIATORS; MECHANISM; PROTEINS; HEPARIN	Polyphosphates (polyPs), chains of phosphate residues found in species across nature from bacteria to mammals, were recently reported to accelerate the amyloid fibril formation of many proteins. How polyPs facilitate this process, however, remains unknown. To gain insight into their mechanisms, we used various physicochemical approaches to examine the effects of polyPs of varying chain lengths on ultrasonication-dependent alpha-synuclein (alpha-syn) amyloid formation. Although orthophosphate and diphosphate exhibited a single optimal concentration of amyloid formation, triphosphate and longer-chain phosphates exhibited two optima, with the second at a concentration lower than that of orthophosphate or diphosphate. The second optimum decreased markedly as the polyP length increased. This suggested that although the optima at lower polyP concentrations were caused by interactions between negatively charged phosphate groups and the positive charges of alpha-syn, the optima at higher polyP concentrations were caused by the Hofmeister salting-out effects of phosphate groups, where the effects do not depend on the net charge. NMR titration experiments of alpha-syn with tetraphosphate combined with principal component analysis revealed that, at low tetraphosphate concentrations, negatively charged tetra-phosphates interacted with positively charged "KTK" segments in four KTKEGV repeats located at the N-terminal region. At high concentrations, hydrated tetraphosphates affected the surface-exposed hydrophilic groups of compact alpha-syn. Taken together, our results suggest that long-chain polyPs consisting of 60 to 70 phosphates induce amyloid formation at sub-mu M concentrations, which are comparable with the concentrations of polyPs in the blood or tissues. Thus, these findings may identify a role for polyPs in the pathogenesis of amyloid-related diseases.	[Yamaguchi, Keiichi; Goto, Yuji] Osaka Univ, Grad Sch Med, Global Ctr Med Engn & Informat, Osaka, Japan; [Yamaguchi, Keiichi; So, Masatomo; Aguirre, Cesar; Goto, Yuji] Osaka Univ, Grad Sch Med, Inst Prot Res, Osaka, Japan; [Aguirre, Cesar; Ikenaka, Kensuke; Mochizuki, Hideki] Osaka Univ, Grad Sch Med, Dept Neurol, Osaka, Japan; [Kawata, Yasushi] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori, Japan	Osaka University; Osaka University; Osaka University; Tottori University	Goto, Y (corresponding author), Osaka Univ, Grad Sch Med, Global Ctr Med Engn & Informat, Osaka, Japan.; Goto, Y (corresponding author), Osaka Univ, Grad Sch Med, Inst Prot Res, Osaka, Japan.	gtyj8126@protein.osaka-u.ac.jp	Kawata, Yasushi/ABA-9608-2021	Goto, Yuji/0000-0003-1221-1270; Kawata, Yasushi/0000-0002-2744-1506; So, Masatomo/0000-0002-4815-4995	Cooperative Research Program for the Institute for Protein Research, Osaka University [CR-18-02]; Japan Society for the Promotion of Science [20K06580]; Ministry of Education, Culture, Sports, Science and Technology [17H06352]; SENTAN from the Japan Agency for Medical Research and Development, AMED [16809242]	Cooperative Research Program for the Institute for Protein Research, Osaka University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); SENTAN from the Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This study was performed as part of the Cooperative Research Program for the Institute for Protein Research, Osaka University (CR-18-02) and was supported by the Japan Society for the Promotion of Science (20K06580) and Core-to-Core Program A (Advance Research Networks), Ministry of Education, Culture, Sports, Science and Technology (17H06352), and SENTAN from the Japan Agency for Medical Research and Development, AMED (16809242).	Abramov AY, 2007, P NATL ACAD SCI USA, V104, P18091, DOI 10.1073/pnas.0708959104; Adachi M, 2018, J BIOL CHEM, V293, P14775, DOI 10.1074/jbc.RA118.004683; Baldwin AJ, 2011, J AM CHEM SOC, V133, P14160, DOI 10.1021/ja2017703; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Ciryam P, 2013, CELL REP, V5, P781, DOI 10.1016/j.celrep.2013.09.043; Clark PL, 2004, TRENDS BIOCHEM SCI, V29, P527, DOI 10.1016/j.tibs.2004.08.008; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; COLLINS KD, 1985, Q REV BIOPHYS, V18, P323, DOI 10.1017/S0033583500005369; Cremers CM, 2016, MOL CELL, V63, P768, DOI 10.1016/j.molcel.2016.07.016; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dettmer U, 2015, P NATL ACAD SCI USA, V112, P9596, DOI 10.1073/pnas.1505953112; Fonseca-Ornelas L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6857; Furukawa K, 2020, CURR RES STRUCT BIOL, V2, P35, DOI 10.1016/j.crstbi.2020.03.001; Fusco G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4827; Giehm L, 2010, J MOL BIOL, V401, P115, DOI 10.1016/j.jmb.2010.05.060; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRAHAM JG, 1969, J NEUROL NEUROSUR PS, V32, P28, DOI 10.1136/jnnp.32.1.28; Guerrero-Ferreira R, 2018, ELIFE, V7, DOI 10.7554/eLife.36402; HSIEH PC, 1993, PROTEIN EXPRES PURIF, V4, P76, DOI 10.1006/prep.1993.1012; Iadanza MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06761-6; Ishige K, 2002, P NATL ACAD SCI USA, V99, P16684, DOI 10.1073/pnas.262655299; Ito T, 2020, J BIOL CHEM, V295, P4014, DOI 10.1074/jbc.RA119.011763; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jaumot J, 2004, ANAL BIOCHEM, V327, P1, DOI 10.1016/j.ab.2003.12.028; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAGER GA, 1973, AM MINERAL, V58, P756; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lever J, 2017, NAT METHODS, V14, P641, DOI 10.1038/nmeth.4346; Marek PJ, 2012, BIOCHEMISTRY-US, V51, P8478, DOI 10.1021/bi300574r; Melki R, 2015, J PARKINSON DIS, V5, P217, DOI 10.3233/JPD-150543; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Munishkina LA, 2004, BIOCHEMISTRY-US, V43, P3289, DOI 10.1021/bi034938r; Nihonyanagi S, 2014, J AM CHEM SOC, V136, P6155, DOI 10.1021/ja412952y; Nitani A, 2017, J BIOL CHEM, V292, P21219, DOI 10.1074/jbc.M117.813097; Noji M, 2019, J BIOL CHEM, V294, P15826, DOI 10.1074/jbc.RA119.009971; Noji M, 2018, BIOCHEMISTRY-US, V57, P5415, DOI 10.1021/acs.biochem.8b00619; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Riek R, 2016, NATURE, V539, P227, DOI 10.1038/nature20416; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Sakurai K, 2007, P NATL ACAD SCI USA, V104, P15346, DOI 10.1073/pnas.0702112104; Sasahara K, 2019, J BIOL CHEM, V294, P15318, DOI 10.1074/jbc.RA119.008662; Sawada M, 2020, LANGMUIR, V36, P4671, DOI 10.1021/acs.langmuir.0c00426; Schweighauser M, 2020, NATURE, V585, P464, DOI 10.1038/s41586-020-2317-6; Sipe JD, 2016, AMYLOID, V23, P209, DOI 10.1080/13506129.2016.1257986; So M, 2017, PROTEIN SCI, V26, P1024, DOI 10.1002/pro.3149; So M, 2016, CURR OPIN STRUC BIOL, V36, P32, DOI 10.1016/j.sbi.2015.11.009; Strohaker T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13564-w; Terakawa MS, 2018, BBA-BIOMEMBRANES, V1860, P757, DOI 10.1016/j.bbamem.2017.12.011; Theillet FX, 2016, NATURE, V530, P45, DOI 10.1038/nature16531; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Wang X, 2020, ANGEW CHEM INT EDIT, V59, P2679, DOI 10.1002/anie.201913833; WEISEMANN R, 1993, J BIOMOL NMR, V3, P113; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; Xie LH, 2019, J BIOL CHEM, V294, P2180, DOI 10.1074/jbc.REV118.002808; Yagi H, 2005, J BIOL CHEM, V280, P38609, DOI 10.1074/jbc.M508623200; Yoshimura Y, 2017, J BIOL CHEM, V292, P8269, DOI 10.1074/jbc.M116.764886; Zhang CM, 2019, P NATL ACAD SCI USA, V116, P12833, DOI 10.1073/pnas.1819813116	60	1	1	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100510	10.1016/j.jbc.2021.100510	http://dx.doi.org/10.1016/j.jbc.2021.100510			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33676889	gold, Green Published			2022-12-26	WOS:000672866400484
J	Karki, P; Cha, BY; Zhang, CO; Li, Y; Ke, YB; Promnares, K; Kaibuchi, K; Yoshimura, A; Birukov, KG; Birukova, AA				Karki, Pratap; Cha, Boyoung; Zhang, Chen-Ou; Li, Yue; Ke, Yunbo; Promnares, Kamoltip; Kaibuchi, Kozo; Yoshimura, Akihiko; Birukov, Konstantin G.; Birukova, Anna A.			Microtubule-dependent mechanism of anti-inflammatory effect of SOCS1 in endothelial dysfunction and lung injury	FASEB JOURNAL			English	Article						cytoskeleton; endothelial permeability; inflammation; lung injury; microtubules; vascular endothelium		Suppressors of cytokine signaling (SOCS) provide negative regulation of inflammatory reaction. The role and precise cellular mechanisms of SOCS1 in control of endothelial dysfunction and barrier compromise associated with acute lung injury remain unexplored. Our results show that siRNA-mediated SOCS1 knockdown augmented lipopolysaccharide (LPS)-induced pulmonary endothelial cell (EC) permeability and enhanced inflammatory response. Consistent with in vitro data, EC-specific SOCS1 knockout mice developed more severe lung vascular leak and accumulation of inflammatory cells in bronchoalveolar lavage fluid. SOCS1 overexpression exhibited protective effects against LPS-induced endothelial permeability and inflammation, which were dependent on microtubule (MT) integrity. Biochemical and image analysis of unstimulated EC showed SOCS1 association with the MT, while challenge with LPS or MT depolymerizing agent colchicine impaired this association. SOCS1 directly interacted with N2 domains of MT-associated proteins CLIP-170 and CLASP2. Furthermore, N-terminal region of SOCS1 was indispensable for these interactions and SOCS1-Delta N mutant lacking N-terminal 59 amino acids failed to rescue LPS-induced endothelial dysfunction. Depletion of endogenous CLIP-170 or CLASP2 abolished SOCS1 interaction with Toll-like receptor-4 and Janus kinase-2 leading to impairment of SOCS1 inhibitory effects on LPS-induced inflammation. Altogether, these findings suggest that endothelial barrier protective and anti-inflammatory effects of SOCS1 are critically dependent on its targeting to the MT.	[Karki, Pratap; Zhang, Chen-Ou; Li, Yue; Birukova, Anna A.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Cha, Boyoung; Ke, Yunbo; Promnares, Kamoltip; Birukov, Konstantin G.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Kaibuchi, Kozo] Nagoya Univ, Dept Cell Pharmacol, Nagoya, Aichi, Japan; [Yoshimura, Akihiko] Keio Univ, Dept Microbiol & Immunol, Tokyo, Japan	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Nagoya University; Keio University	Birukova, AA (corresponding author), Univ Maryland, Sch Med, Dept Med, UMSOM Lung Biol Program, 20 Penn St,HSF-2,Room S143, Baltimore, MD 21201 USA.	abirukova@som.umaryland.edu	Birukov, Konstantin/FJB-5755-2022		HHS, NIH, National Heart, Lung, and Blood Institute (NHLBI) [HL107920, HL130431, HL076259, HL087823]; HHS, NIH, National Institute of General Medical Sciences (NIGMS) [GM114171]; JSPS KAKENHI (S) [JP17H06175]; AMED-CREST JP [20GM1110009, JP18H05376]; Challenging Research (P) [JP18H05376]	HHS, NIH, National Heart, Lung, and Blood Institute (NHLBI); HHS, NIH, National Institute of General Medical Sciences (NIGMS); JSPS KAKENHI (S)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED-CREST JP; Challenging Research (P)	HHS, NIH, National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL107920, HL130431, HL076259 and HL087823; HHS, NIH, National Institute of General Medical Sciences (NIGMS), Grant/Award Number: GM114171; JSPS KAKENHI (S), Grant/Award Number: JP17H06175; AMED-CREST JP, Grant/Award Number: 20GM1110009; Challenging Research (P), Grant/Award Number: JP18H05376	Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Alieva IB, 2014, BIOCHEMISTRY-MOSCOW+, V79, P964, DOI 10.1134/S0006297914090119; Alieva IB, 2013, J CELL BIOCHEM, V114, P2258, DOI 10.1002/jcb.24575; Baig MS, 2015, J EXP MED, V212, P1725, DOI 10.1084/jem.20140654; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL75, DOI 10.1152/ajplung.00447.2004; Birukova AA, 2013, EUR RESPIR J, V41, P165, DOI 10.1183/09031936.00148311; Chong MMW, 2005, BLOOD, V106, P1668, DOI 10.1182/blood-2004-08-3049; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Frank PG, 2008, AM J PHYSIOL-HEART C, V295, pH926, DOI 10.1152/ajpheart.00779.2008; Fu P, 2009, EUR RESPIR J, V33, P612, DOI 10.1183/09031936.00014808; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Galam L, 2016, ONCOTARGET, V7, P29081, DOI 10.18632/oncotarget.8543; GOLDBLUM SE, 1989, INFECT IMMUN, V57, P1218, DOI 10.1128/IAI.57.4.1218-1226.1989; GRESSER I, 1981, J IMMUNOL, V127, P1569; He Y, 2006, J BIOL CHEM, V281, P5559, DOI 10.1074/jbc.M512338200; Higginbotham K, 2014, CELL SIGNAL, V26, P2306, DOI 10.1016/j.cellsig.2014.07.032; Horvath Curt M, 2004, Sci STKE, V2004, ptr9, DOI 10.1126/stke.2602004tr9; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Karki P, 2019, J BIOL CHEM, V294, P3369, DOI 10.1074/jbc.RA118.004030; Kasa A, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.974448; Kimura A, 2005, P NATL ACAD SCI USA, V102, P17089, DOI 10.1073/pnas.0508517102; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kratzer E, 2012, AM J RESP CELL MOL, V47, P688, DOI 10.1165/rcmb.2012-0161OC; Krebs DL, 2000, J CELL SCI, V113, P2813; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Liang XB, 2011, J CLIN INVEST, V121, P4362, DOI 10.1172/JCI46279; Linossi EM, 2012, IUBMB LIFE, V64, P316, DOI 10.1002/iub.1011; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Naka T, 1998, P NATL ACAD SCI USA, V95, P15577, DOI 10.1073/pnas.95.26.15577; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nakashima T, 2008, J ALLERGY CLIN IMMUN, V121, P1269, DOI 10.1016/j.jaci.2008.02.003; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Oda M, 2000, CLIN HEMORHEOL MICRO, V23, P199; Petrache I, 2003, AM J RESP CELL MOL, V28, P574, DOI 10.1165/rcmb.2002-0075OC; Piessevaux J, 2008, CYTOKINE GROWTH F R, V19, P371, DOI 10.1016/j.cytogfr.2008.08.006; Sans M, 1999, GASTROENTEROLOGY, V116, P874, DOI 10.1016/S0016-5085(99)70070-3; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Strebovsky J, 2011, FASEB J, V25, P863, DOI 10.1096/fj.10-170597; Tian XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105912; Tian XY, 2012, FASEB J, V26, P3862, DOI 10.1096/fj.12-207746; Tian YF, 2014, MOL CELL BIOL, V34, P3546, DOI 10.1128/MCB.00248-14; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Wang W, 2016, AM J PHYSIOL-LUNG C, V311, pL494, DOI 10.1152/ajplung.00001.2016; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yoshida T, 2004, J EXP MED, V199, P1701, DOI 10.1084/jem.20031675; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang JG, 2001, P NATL ACAD SCI USA, V98, P13261, DOI 10.1073/pnas.231486498; Zhang LF, 2018, INFLAMMATION, V41, P1557, DOI 10.1007/s10753-018-0802-y	61	2	2	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21388	10.1096/fj.202001477RR	http://dx.doi.org/10.1096/fj.202001477RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33724556				2022-12-26	WOS:000635216100044
J	Hajdu, G; Hajdu, T				Hajdu, Gabor; Hajdu, Tamas			The long-term impact of restricted access to abortion on children's socioeconomic outcomes	PLOS ONE			English	Article								We examine the long-term consequences of restricted access to abortion following a change in the Hungarian abortion law in 1974. Due to a change that restricted access to legal abortions, the number of induced abortions decreased from 169,650 to 102,022 between 1973 and 1974, whereas the number of live births increased from 156,224 to 186,288. We analyze the effects on the adult outcomes of the affected cohort of newborns (educational attainment, labor market participation, teen fertility). We use matched large-scale, individual-level administrative datasets of the Hungarian Central Statistical Office (population census 2011; live birth register), and we estimate the effects by comparing children born within a short timespan around the time the law change came into effect. We apply a difference-in-differences approach, building on the special rules of the new law that, despite the severe restriction, still made abortion permissible for selected groups of women. We control for the compositional change in the population of parents, rule out the effect of (unobserved) time trends and other potential behavioral responses to the law change, and draw causal inferences. We find that restricted access to abortion had, on average, a negative impact on the socioeconomic outcomes of the affected cohort of children. Children born after the law change have had worse educational outcomes, a greater likelihood of being unemployed at age 37, and a higher probability of being a teen parent.	[Hajdu, Gabor] Ctr Social Sci, Inst Sociol, Budapest, Hungary; [Hajdu, Tamas] Ctr Econ & Reg Studies, Inst Econ, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Social Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Economic & Regional Studies	Hajdu, G (corresponding author), Ctr Social Sci, Inst Sociol, Budapest, Hungary.	hajdu.gabor@tk.hu	Hajdu, Tamás/M-5315-2018; Hajdu, Gábor/S-6675-2018	Hajdu, Tamás/0000-0002-9533-7727; Hajdu, Gábor/0000-0002-7943-1668	Hungarian National Research, Development and Innovation Office - NKFIH [FK 124384]; "Lendulet" program of the Hungarian Academy of Sciences [LP2018-2/2018]	Hungarian National Research, Development and Innovation Office - NKFIH; "Lendulet" program of the Hungarian Academy of Sciences	This work was supported by the Hungarian National Research, Development and Innovation Office - NKFIH (grant no. FK 124384). TH was supported by the "Lendulet" program of the Hungarian Academy of Sciences (grant no. LP2018-2/2018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond D, 2018, J ECON LIT, V56, P1360, DOI 10.1257/jel.20171164; Amarante V, 2016, AM ECON J-ECON POLIC, V8, P1, DOI 10.1257/pol.20140344; Ananat EO, 2007, J HUM RESOUR, V42, P375; Ananat EO, 2009, REV ECON STAT, V91, P124, DOI 10.1162/rest.91.1.124; Angrist JD, 1999, RES LABOR E, V18, P75; Anton JI, 2018, HEALTH ECON, V27, P1103, DOI 10.1002/hec.3659; Bailey MJ, 2019, J HUM RESOUR, V54, P825, DOI 10.3368/jhr.54.4.1216-8401R1; Becker G. S., 1993, TREATISE FAMILY ENLA; BECKER GS, 1973, J POLIT ECON, V81, pS279, DOI 10.1086/260166; Black SE, 2007, Q J ECON, V122, P409, DOI 10.1162/qjec.122.1.409; BOGNAR Z, 1976, AM J PUBLIC HEALTH, V66, P568, DOI 10.2105/AJPH.66.6.568; Bradley EH, 2011, BMJ QUAL SAF, V20, P826, DOI 10.1136/bmjqs.2010.048363; Buckles KS, 2013, REV ECON STAT, V95, P711, DOI 10.1162/REST_a_00314; Charles KK, 2006, J LAW ECON, V49, P481, DOI 10.1086/508249; Chatterjee E, 2020, POP STUD-J DEMOG, V74, P55, DOI 10.1080/00324728.2019.1672881; Conti JA, 2016, CURR OPIN OBSTET GYN, V28, P517, DOI 10.1097/GCO.0000000000000324; Currie J, 2013, P NATL ACAD SCI USA, V110, P13228, DOI 10.1073/pnas.1307582110; Currie J, 2009, J ECON LIT, V47, P87, DOI 10.1257/jel.47.1.87; CZEIZEL A, 1984, J EPIDEMIOL COMMUN H, V38, P143, DOI 10.1136/jech.38.2.143; Czeizel E, 1983, Orv Hetil, V124, P1297; Donohue JJ, 2001, Q J ECON, V116, P379, DOI 10.1162/00335530151144050; Donohue John, 2019, 25863 NBER; Donohue JJ, 2008, Q J ECON, V123, P425, DOI 10.1162/qjec.2008.123.1.425; Donohue JJ, 2009, AM LAW ECON REV, V11, P24, DOI 10.1093/aler/ahp006; Eggleston E, 2000, SOC SCI MED, V51, P1011, DOI 10.1016/S0277-9536(00)00010-1; Fischer S, 2018, J PUBLIC ECON, V167, P43, DOI 10.1016/j.jpubeco.2018.08.009; Foote CL, 2008, Q J ECON, V123, P407, DOI 10.1162/qjec.2008.123.1.407; Foster DG, 2018, JAMA PEDIATR, V172, P1053, DOI 10.1001/jamapediatrics.2018.1785; Foster DG, 2018, AM J PUBLIC HEALTH, V108, P407, DOI [10.2105/AJPH.2017.304247, 10.2105/ajph.2017.304247]; GAL S, 1994, E EUR POLIT SOC, V8, P256, DOI 10.1177/0888325494008002003; Goldin C, 2002, J POLIT ECON, V110, P730, DOI 10.1086/340778; GROSSMAN M, 1981, DEMOGRAPHY, V18, P695, DOI 10.2307/2060956; Gruber J, 1999, Q J ECON, V114, P263, DOI 10.1162/003355399556007; Guldi M, 2008, DEMOGRAPHY, V45, P817, DOI 10.1353/dem.0.0026; Haney L, 2002, INVENTING THE NEEDY: GENDER AND THE POLITICS OF WELFARE IN HUNGARY, P1, DOI 10.1525/california/9780520225718.001.0001; Hjalmarsson R, 2019, 26024 NBER; Joyce T, 2004, J HUM RESOUR, V39, P1, DOI 10.2307/3559003; JOYCE T, 1987, DEMOGRAPHY, V24, P229, DOI 10.2307/2061631; Joyce T, 2009, REV ECON STAT, V91, P112, DOI 10.1162/rest.91.1.112; JOYCE TJ, 1990, DEMOGRAPHY, V27, P1, DOI 10.2307/2061549; Kost K, 2015, DEMOGRAPHY, V52, P83, DOI 10.1007/s13524-014-0359-9; Levine PB, 1996, J HEALTH ECON, V15, P555, DOI 10.1016/S0167-6296(96)00495-X; Levine PB, 2004, J LAW ECON, V47, P223, DOI 10.1086/380475; Levine PB, 1999, AM J PUBLIC HEALTH, V89, P199, DOI 10.2105/AJPH.89.2.199; Lin WC, 2015, J POPUL ECON, V28, P479, DOI 10.1007/s00148-014-0530-z; Lindo JM, 2020, J HUM RESOUR, V55, P1137, DOI 10.3368/jhr.55.4.1217-9254R3; Lu Y, 2019, AM J HEALTH ECON, V5, P334, DOI 10.1162/ajhe_a_00123; Makay Z, 2015, DEMOGRAFIA ENGLISH E, V58, P65, DOI [10.21543/DEE.2015.3, DOI 10.21543/DEE.2015.3]; Miller S, 2020, 26662 NBER; Mitrut A, 2011, J HEALTH ECON, V30, P1219, DOI 10.1016/j.jhealeco.2011.08.004; Molland E, 2016, LABOUR ECON, V43, P6, DOI 10.1016/j.labeco.2016.06.011; Myers CK, 2017, J POLIT ECON, V125, P2178, DOI 10.1086/694293; Oreopoulos P, 2008, J HUM RESOUR, V43, P88; Ozbeklik S, 2014, ECON INQ, V52, P100, DOI 10.1111/ecin.12017; Pop-Eleches C, 2006, J POLIT ECON, V114, P744, DOI 10.1086/506336; Pop-Eleches C, 2010, J HUM RESOUR, V45, P971; Sandor J, 1999, Med Law, V18, P389; Skirbekk V, 2004, DEMOGRAPHY, V41, P547, DOI 10.1353/dem.2004.0028; Strand LB, 2011, ENVIRON RES, V111, P451, DOI 10.1016/j.envres.2011.01.023; Szalai J., 1988, FEMINIST REV, V29, P98, DOI [10.2307/1395151, DOI 10.2307/1395151]; Venator J, 2019, 26362 NBER; Whitaker S, 2011, ECON EDUC REV, V30, P228, DOI 10.1016/j.econedurev.2010.09.001	62	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0248638	10.1371/journal.pone.0248638	http://dx.doi.org/10.1371/journal.pone.0248638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX9NB	33720972	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000629667400002
J	Hollingsworth, KA; Shively, RD; Glasscock, SN; Light, JE; Tolleson, DR; Barboza, PS				Hollingsworth, K. A.; Shively, R. D.; Glasscock, S. N.; Light, J. E.; Tolleson, D. R.; Barboza, P. S.			Trace mineral supplies for populations of little and large herbivores	PLOS ONE			English	Article							WHITE-TAILED DEER; STABLE-ISOTOPES; SOIL TEST; SELENIUM DEFICIENCY; SIGMODON-HISPIDUS; MAMMAL HERBIVORY; LIVER; MANGANESE; COPPER; ZINC	Copper (Cu), iron (Fe), and zinc (Zn) are essential trace minerals for the reproduction, growth, and immunity of mammalian herbivore populations. We examined the relationships between Cu, Fe, and Zn in soils, common plants, and hepatic stores of two wild herbivores to assess the effects of weather, sex, and population density on the transfer of trace minerals from soils to mammals during the growing season. Soils, grasses, woody browse, hispid cotton rats (Sigmodon hispidus), and white-tailed deer (Odocoileus virginianus) were sampled across 19 sites. Concentrations of Cu, Fe, and Zn in grasses and browse species were not correlated with concentrations of those minerals in soils sampled from the same areas. Leaves of woody browse were higher in Cu, lower in Fe, and similar in Zn when compared with grasses. Available concentrations of soils were positively related to liver Cu and Zn in hispid cotton rats, which was consistent with the short lives and high productivity of these small mammals that rely on grass seed heads. Interactions between soil concentrations and weather also affected liver Cu and Fe in deer, which reflected the greater complexity of trophic transfers in large, long-lived, browsing herbivores. Population density was correlated with liver concentrations of Cu, Fe, and Zn in hispid cotton rats, and concentrations of Cu and Fe in deer. Liver Cu was < 5 mg/kg wet weight in at least 5% of animals at two of eight sites for hispid cotton rats and < 3.8 mg/kg wet weight in at least 5% of animals at three of 12 sites for deer, which could indicate regional limitation of Cu for populations of mammalian herbivores. Our data indicate that supplies of trace minerals may contribute to density dependence of herbivore populations. Local population density may therefore influence the prevalence of deficiency states and disease outbreak that exacerbate population cycles in wild mammals.	[Hollingsworth, K. A.; Shively, R. D.; Tolleson, D. R.; Barboza, P. S.] Texas A&M Univ, Dept Rangeland Wildlife & Fisheries Management, College Stn, TX 77843 USA; [Glasscock, S. N.] Welder Wildlife Fdn, Sinton, TX USA; [Light, J. E.; Barboza, P. S.] Texas A&M Univ, Dept Ecol & Conservat Biol, College Stn, TX USA; [Tolleson, D. R.] Texas A&M Univ, Texas A&M AgriLife Res Stn, Sonora, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research	Hollingsworth, KA (corresponding author), Texas A&M Univ, Dept Rangeland Wildlife & Fisheries Management, College Stn, TX 77843 USA.	kayleeholli@tamu.edu			USDA National Institute of Food and Agriculture as Hatch Project [1017594]; Texas Ecological Laboratory; Rob and Bessie Welder Wildlife Foundation; Boone and Crockett Club Dr. James H. "Red" Duke Wildlife Conservation and Policy Program	USDA National Institute of Food and Agriculture as Hatch Project; Texas Ecological Laboratory; Rob and Bessie Welder Wildlife Foundation; Boone and Crockett Club Dr. James H. "Red" Duke Wildlife Conservation and Policy Program	This study was funded by the USDA National Institute of Food and Agriculture as Hatch Project #1017594 (PSB) https://nifa.usda.gov/program/hatch-act-1887-multistate-research-fund, Texas Ecological Laboratory (PSB, KAH) https://texasecolab.org/, the Rob and Bessie Welder Wildlife Foundation (KAH) http://welderwildlife.org/content/research/fellowships/, and the Boone and Crockett Club Dr. James H. "Red" Duke Wildlife Conservation and Policy Program (PSB) https://wfsc.tamu.edu/drredduke/people/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken MRE, 2014, CAN J ZOOL, V92, P637, DOI 10.1139/cjz-2013-0232; Barboza P.S., 2008, INTEGRATIVE WILDLIFE; Beier P., 1990, Wildlife Monographs; Ben-David M, 2012, J MAMMAL, V93, P312, DOI 10.1644/11-MAMM-S-166.1; Bowyer RT, 2014, CALIF FISH GAME, V100, P550; BROWN JR, 1990, OIKOS, V57, P366, DOI 10.2307/3565966; Buckland S.T., 2001, pi; Cain A., 2015, W127R20 TEX PARKS WI; Cameron G.N., 1981, Mammalian Species, P1, DOI 10.2307/3504057; CAMERON GN, 1985, OECOLOGIA, V68, P133, DOI 10.1007/BF00379485; CHANDRA RK, 1982, NUTR RES, V2, P721, DOI 10.1016/S0271-5317(82)80116-4; Davies G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52873-4; Death C, 2017, SCI TOTAL ENVIRON, V584, P1198, DOI 10.1016/j.scitotenv.2017.01.183; DeYoung CA, 2019, WILDLIFE MONOGR, V202, P1, DOI 10.1002/wmon.1040; Doak DF, 2008, ECOLOGY, V89, P952, DOI 10.1890/07-0965.1; FLEHARTY E D, 1973, Southwestern Naturalist, V18, P21, DOI 10.2307/3669907; Flueck WT, 2012, EUR J WILDLIFE RES, V58, P761, DOI 10.1007/s10344-012-0645-z; FLUECK WT, 1994, ECOLOGY, V75, P807, DOI 10.2307/1941736; Foley AM, 2015, J MAMMAL, V96, P279, DOI 10.1093/jmammal/gyv004; Fraser CM., 1991, MERCK VET MANUAL HDB, V7th; Gamberg M, 2020, SCI TOTAL ENVIRON, V724, DOI 10.1016/j.scitotenv.2020.138305; Garrott RA, 2009, TERR ECOL SER, V3, P177, DOI 10.1016/S1936-7961(08)00210-8; Gibbs E. P. J., 1988, The arboviruses: epidemiology and ecology. Volume II., P39; Gould FW., 1960, TEXAS AGR EXPT STATI, V492, P1, DOI [10.1016/j.forsciint.2005.11.021, DOI 10.1016/J.FORSCIINT.2005.11.021]; Grace ND, 2002, NEW ZEAL VET J, V50, P252, DOI 10.1080/00480169.2002.36321; GRAHAM OH, 1977, J MED ENTOMOL, V13, P629, DOI 10.1093/jmedent/13.6.629; Graham RD, 2003, J NUTR, V133, p1502S, DOI 10.1093/jn/133.5.1502S; GRAHAM TW, 1991, VET CLIN N AM-FOOD A, V7, P153, DOI 10.1016/S0749-0720(15)30816-1; Griffith G., 2007, ECOREGIONS TEXAS AUS, P125; Halls L.K., 1978, P43; Hempson GP, 2015, SCIENCE, V350, P1056, DOI 10.1126/science.aac7978; Hermenean A, 2015, ECOTOX ENVIRON SAFE, V119, P198, DOI 10.1016/j.ecoenv.2015.05.029; Herms W. B., 1961; Hnilicka P, 2003, P 13 BIENN S NO WILD, P69; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Hood WR, 2012, PHYSIOL BIOCHEM ZOOL, V85, P385, DOI 10.1086/666057; Humann-Ziehank E, 2008, SMALL RUMINANT RES, V75, P185, DOI 10.1016/j.smallrumres.2007.10.006; Jukneviius S., 2007, EKOLOGIJA, V53, P44; Kabata-Pendias Alina, 2010, P1; KAHN AM, 1967, GASTROENTEROLOGY, V53, P193; Kamei A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065732; Kie JG, 1999, J MAMMAL, V80, P1004, DOI 10.2307/1383271; Kierdorf U, 2002, ARCH ENVIRON CON TOX, V42, P99, DOI 10.1007/s002440010297; Kilmer V. J., 1979, Biogeochemical cycling of mineral-forming elements, P515; Kramm MM, 2017, J WILDLIFE DIS, V53, P788, DOI 10.7589/2016-10-232; Lawing AM, 2017, ECOGRAPHY, V40, P651, DOI 10.1111/ecog.01986; Lee K, 2018, BIOMED OPT EXPRESS, V9, P1582, DOI 10.1364/BOE.9.001582; Li W, 2013, TALANTA, V112, P43, DOI 10.1016/j.talanta.2013.03.029; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Marshall JD, 2007, ECOL METHOD CONCEPT, P22, DOI 10.1002/9780470691854.ch2; McCoy JE, 2005, J WILDLIFE MANAGE, V69, P366, DOI 10.2193/0022-541X(2005)069&lt;0366:DBYMWD&gt;2.0.CO;2; MCCULLOUGH DR, 1994, J WILDLIFE MANAGE, V58, P319, DOI 10.2307/3809397; MEHLICH A, 1984, COMMUN SOIL SCI PLAN, V15, P1409, DOI 10.1080/00103628409367568; MEHLICH A, 1978, COMMUN SOIL SCI PLAN, V9, P477, DOI 10.1080/00103627809366824; Milewski AV, 2000, J BIOGEOGR, V27, P957, DOI 10.1046/j.1365-2699.2000.00436.x; Miller DL, 2019, J STAT SOFTW, V89, P1, DOI 10.18637/jss.v089.i01; Mund M, 2010, TREE PHYSIOL, V30, P689, DOI 10.1093/treephys/tpq027; Mysterud A, 2008, J ZOOL, V275, P407, DOI 10.1111/j.1469-7998.2008.00453.x; National Research Council, 1995, NUTR REQ LAB AN; Nelson Michael E., 2015, Canadian Field-Naturalist, V129, P1; NRC, 2007, NUTR REQ SMALL RUM S, P392; Oster KW, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2160; OWEN CA, 1968, AM J PHYSIOL, V215, P334; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Quinn Joseph F, 2011, Int J Alzheimers Dis, V2011, P150916, DOI 10.4061/2011/150916; R Core Team, 2021, R LANGUAGE ENV STAT; RANDOLPH JC, 1995, J MAMMAL, V76, P1113, DOI 10.2307/1382603; RANDOLPH PA, 1977, ECOLOGY, V58, P31, DOI 10.2307/1935106; REID RL, 1980, ANIM FEED SCI TECH, V5, P95, DOI 10.1016/0377-8401(80)90002-4; Rodriguez JE, 2015, SOUTHEAST NAT, V14, P415, DOI 10.1656/058.014.0301; ROLLIN PE, 1995, J MED VIROL, V46, P35, DOI 10.1002/jmv.1890460108; Roth GA, 2009, J ARID ENVIRON, V73, P62, DOI 10.1016/j.jaridenv.2008.09.003; Roug A, 2015, J VET DIAGN INVEST, V27, P295, DOI 10.1177/1040638715577826; Sargent RA, 1995, PROCEEDINGS OF THE FORTY-NINTH ANNUAL CONFERENCE - SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P389; Schmidly D., 2004, MAMMALS TEXAS REVISE; Schmidly D.J., 2016, MAMMALS TEXAS; SCHULTZ SR, 1994, J WILDLIFE DIS, V30, P77, DOI 10.7589/0090-3558-30.1.77; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; SLADE NA, 1983, J MAMMAL, V64, P580, DOI 10.2307/1380513; StataCorp, 2015, STAT STAT SOFTW REL; Suttle N, 2010, MINERAL NUTRITION OF LIVESTOCK, 4TH EDITION, P306, DOI 10.1079/9781845934729.0306; Tekiela S., 2009, MAMMALS TEXAS FIELD, DOI [10.1007/s00280-008-0816-5, DOI 10.1007/S00280-008-0816-5]; Tome CP, 2020, ECOGRAPHY, V43, P604, DOI 10.1111/ecog.04596; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Webb SL, 2010, SOUTHWEST NAT, V55, P269, DOI 10.1894/TAL-10.1; Weber S, 2010, STATA J, V10, P331, DOI 10.1177/1536867X1001000302; Wolcott DM, 2014, J WILDLIFE MANAGE, V78, P1335, DOI 10.1002/jwmg.777; YUNICE AA, 1974, J GERONTOL, V29, P277, DOI 10.1093/geronj/29.3.277	88	0	0	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0248204	10.1371/journal.pone.0248204	http://dx.doi.org/10.1371/journal.pone.0248204			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720946	gold, Green Published			2022-12-26	WOS:000629667400022
J	Getachew, T; Abebe, SM; Yitayal, M; Persson, LA; Della Berhanu				Getachew, Theodros; Abebe, Solomon Mekonnen; Yitayal, Mezgebu; Persson, Lars Ake; Della Berhanu			Association between a complex community intervention and quality of health extension workers' performance to correctly classify common childhood illnesses in four regions of Ethiopia	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; CASE-MANAGEMENT; CARE	Background Due to low care utilization, a complex intervention was done for two years to optimize the Ethiopian Health Extension Program. Improved quality of the integrated community case management services was an intermediate outcome of this intervention through community education and mobilization, capacity building of health workers, and strengthening of district ownership and accountability of sick child services. We evaluated the association between the intervention and the health extension workers' ability to correctly classify common childhood illnesses in four regions of Ethiopia. Methods Baseline and endline assessments were done in 2016 and 2018 in intervention and comparison areas in four regions of Ethiopia. III children aged 2 to 59 months were mobilized to visit health posts for an assessment that was followed by re-examination. We analyzed sensitivity, specificity, and difference-in-difference of correct classification with multilevel mixed logistic regression in intervention and comparison areas at baseline and endline. Results Health extensions workers' consultations with ill children were observed in intervention (n = 710) and comparison areas (n = 615). At baseline, re-examination of the children showed that in intervention areas, health extension workers' sensitivity for fever or malaria was 54%, 68% for respiratory infections, 90% for diarrheal diseases, and 34% for malnutrition. At end-line, it was 40% for fever or malaria, 49% for respiratory infections, 85% for diarrheal diseases, and 48% for malnutrition. Specificity was higher (89-100%) for all childhood illnesses. Difference-in-differences was 6% for correct classification of fever or malaria [aOR = 1.45 95% CI: 0.81-2.60], 4% for respiratory tract infection [aOR = 1.49 95% CI: 0.81-2.74], and 5% for diarrheal diseases [aOR = 1.74 95% CI: 0.77-3.92]. Conclusion This study revealed that the Optimization of Health Extension Program intervention, which included training, supportive supervision, and performance reviews of health extension workers, was not associated with an improved classification of childhood illnesses by these Ethiopian primary health care workers.	[Getachew, Theodros; Persson, Lars Ake; Della Berhanu] Ethiopian Publ Hlth Inst, Hlth Syst & Reprod Hlth Res Directorate, Addis Ababa, Ethiopia; [Getachew, Theodros; Abebe, Solomon Mekonnen; Yitayal, Mezgebu] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Gondar, Ethiopia; [Persson, Lars Ake; Della Berhanu] London Sch Hyg & Trop Med, Dept Dis Control, London, England	University of Gondar; University of London; London School of Hygiene & Tropical Medicine	Getachew, T (corresponding author), Ethiopian Publ Hlth Inst, Hlth Syst & Reprod Hlth Res Directorate, Addis Ababa, Ethiopia.; Getachew, T (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Gondar, Ethiopia.	tedi.getachew@yahoo.com		Yitayal, Mezgebu/0000-0002-9206-9528; Persson, Lars Ake/0000-0003-0710-7954; Zemedu, Theodros G/0000-0002-6486-0531	Bill & Melinda Gates Foundation [OPP1132551]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This project is funded by Bill & Melinda Gates Foundation (OPP1132551). This research paper represents the views of the authors and does not represent the views of the funder. The funder had no role in the study design, data collection, analysis or interpretation of data.	Amouzou A, 2016, AM J TROP MED HYG, V94, P596, DOI 10.4269/ajtmh.15-0586; Assefa Y, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-019-0470-1; Bailey P, 2019, BMC HEALTH SERV RES, V19, P1; Ballard Madeleine, 2017, BMJ Open, V7, pe014216, DOI 10.1136/bmjopen-2016-014216; Berhanu D, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040868; Boerma T, 2018, LANCET, V391, P1538, DOI 10.1016/S0140-6736(18)30104-1; Bosch-Capblanch X, 2014, J GLOB HEALTH, V4, P66, DOI 10.7189/jogh.04.020403; Central Statistical Agency, 2007, STAT ABSTR; Cissell WB, 2004, HEALTH EDUC RES, V19, P739, DOI 10.1093/her/cyg084; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Das JK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S29; Deribew A, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0112-2; Desta FA, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2804-0; Duc D., 2016, GLOBAL HEALTH ACTION, V9, DOI [10.3402/gha.v9.30772, DOI 10.3402/GHA.V9.30772]; Edward A, 2012, INT J QUAL HEALTH C, V24, P578, DOI 10.1093/intqhc/mzs058; Feyissa GT, 2019, J MULTIDISCIP HEALTH, V12, P989, DOI 10.2147/JMDH.S228951; Getachew T, 2019, ACTA PAEDIATR, V108, P2100, DOI 10.1111/apa.14888; Hill Z, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24085; Ho AMH, 2018, ANESTH ANALG, V126, P1755, DOI 10.1213/ANE.0000000000002705; Kok MC, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0077-4; Larson E, 2020, INT J QUAL HEALTH C, V32, P54, DOI 10.1093/intqhc/mzz126; Leslie HH, 2016, HEALTH AFFAIR, V35, P1716, DOI 10.1377/hlthaff.2016.0261; Miller JS, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2241-5; Mubiru D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134767; Okwaraji YB, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165803; Rawlings Laura B, 2007, IMPACT EVALUATION PR, Vsecond, P129; Rowe AK, 2002, TROP DOCT, V32, P166, DOI 10.1177/004947550203200317; Rowe AK, 2018, LANCET GLOB HEALTH, V6, pE1163, DOI 10.1016/S2214-109X(18)30398-X; Ruelas E, 2012, INT J QUAL HEALTH C, V24, P553, DOI 10.1093/intqhc/mzs061; Shaw B, 2015, AM J TROP MED HYG, V93, P636, DOI 10.4269/ajtmh.14-0660; Tadesse Yenealem, 2014, Ethiop Med J, V52 Suppl 3, P47; Whidden C, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.020418; White EE, 2018, AM J PUBLIC HEALTH, V108, P1252, DOI 10.2105/AJPH.2018.304555; WHO, 2003, WHO TECH REP SER, V916, P1; Woldie M, 2018, HEALTH POLICY PLANN, V33, P1128, DOI 10.1093/heapol/czy094; World Health Organization, 2014, BURD DIS AMB AIR POL	36	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0247474	10.1371/journal.pone.0247474	http://dx.doi.org/10.1371/journal.pone.0247474			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8KN	33711024	Green Published, gold			2022-12-26	WOS:000629591800025
J	Bauer, C; Champagne-Langabeer, T; Bakos-Block, C; Zhang, KH; Persse, D; Langabeer, JR				Bauer, Cici; Champagne-Langabeer, Tiffany; Bakos-Block, Christine; Zhang, Kehe; Persse, David; Langabeer, James R.			Patterns and risk factors of opioid-suspected EMS overdose in Houston metropolitan area, 2015-2019: A Bayesian spatiotemporal analysis	PLOS ONE			English	Article								Background Opioid-related overdose deaths are the top accidental cause of death in the United States, and development of regional strategies to address this epidemic should begin with a better understanding of where and when overdoses are occurring. Methods and findings In this study, we relied on emergency medical services data to investigate the geographical and temporal patterns in opioid-suspected overdose incidents in one of the largest and most ethnically diverse metropolitan areas (Houston Texas). Using a cross sectional design and Bayesian spatiotemporal models, we identified zip code areas with excessive opioid-suspected incidents, and assessed how the incidence risks were associated with zip code level socioeconomic characteristics. Our analysis suggested that opioid-suspected overdose incidents were particularly high in multiple zip codes, primarily south and central within the city. Zip codes with high percentage of renters had higher overdose relative risk (RR = 1.03; 95% CI: [1.01, 1.04]), while crowded housing and larger proportion of white citizens had lower relative risks (RR = 0.9; 95% CI: [0.84, 0.96], RR = 0.97, 95% CI: [0.95, 0.99], respectively). Conclusions Our analysis illustrated the utility of Bayesian spatiotemporal models in assisting the development of targeted community strategies for local prevention and harm reduction efforts.	[Bauer, Cici; Zhang, Kehe] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat & Data Sci, Houston, TX 77030 USA; [Champagne-Langabeer, Tiffany; Bakos-Block, Christine; Langabeer, James R.] Univ Texas Hlth Sci Ctr Houston, ACE Res Lab, Sch Biomed Informat, Houston, TX 77030 USA; [Persse, David] City Houston Fire Dept, Off Emergency Med Serv, Houston, TX USA; [Langabeer, James R.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Emergency Med, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Bauer, C (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat & Data Sci, Houston, TX 77030 USA.	cici.x.bauer@uth.tmc.edu		Bakos-Block, Christine/0000-0001-9201-962X; Bauer, Cici/0000-0002-2337-7965				BESAG J, 1974, J ROY STAT SOC B MET, V36, P192; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Buchanich JM, 2018, PUBLIC HEALTH REP, V133, P423, DOI 10.1177/0033354918774330; Darke S, 2003, ADDICTION, V98, P1169, DOI 10.1046/j.1360-0443.2003.00474.x; Gelman A., BAYESIAN DATA ANAL, VThird; Gielen AC, 2013, J BURN CARE RES, V34, pE250, DOI 10.1097/BCR.0b013e3182685b3a; Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802; Kashani S, 2018, CARDIOL CLIN, V36, P343, DOI 10.1016/j.ccl.2018.03.001; Keseg DP, 2019, J EMERG MED, V57, P187, DOI 10.1016/j.jemermed.2019.04.017; Knowlton A, 2013, PREHOSP EMERG CARE, V17, P317, DOI 10.3109/10903127.2013.792888; Koester S, 2017, INT J DRUG POLICY, V48, P115, DOI 10.1016/j.drugpo.2017.06.008; Langabeer J, 2020, J SUBST ABUSE TREAT, V111, P11, DOI 10.1016/j.jsat.2019.12.008; Li ZR, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002956; Ludwig G., 2013, FIREHOUSE, V38, P46; NEMSIS, NAT EMS DAT US MAN V, V34; NIH, 2019, TEX OP SUMM; Ofstedal MB, 2011, GERONTOLOGIST, V51, pS8, DOI 10.1093/geront/gnq100; Ross EM, 2018, PREHOSP DISASTER MED, V33, P127, DOI 10.1017/S1049023X18000055; Rowe C, 2019, J URBAN HEALTH, V96, P6, DOI 10.1007/s11524-018-0250-x; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; SAMHSA, 2014, NAT SURV DRUG US MEN; SAMHSA, 2008, RES UN WORLD POP PRO; Slavova S, 2015, PUBLIC HEALTH REP, V130, P339, DOI 10.1177/003335491513000411; Stewart K, 2017, J URBAN HEALTH, V94, P572, DOI 10.1007/s11524-017-0177-7; Togia A, 2008, PREHOSPITAL DISASTER, V23, P36, DOI 10.1017/S1049023X00005537; Tracy M, 2005, DRUG ALCOHOL DEPEN, V79, P181, DOI 10.1016/j.drugalcdep.2005.01.010; US CB, 2019, QUICK FACTS; Wagner KD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223823; Wampler DA, 2011, PREHOSP EMERG CARE, V15, P320, DOI 10.3109/10903127.2011.569854; Watson DP, 2018, HARM REDUCT J, V15, DOI 10.1186/s12954-018-0226-x; Wilson N, 2020, MMWR-MORBID MORTAL W, V69, P290, DOI 10.15585/mmwr.mm6911a4	32	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0247050	10.1371/journal.pone.0247050	http://dx.doi.org/10.1371/journal.pone.0247050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8JZ	33705402	gold, Green Published			2022-12-26	WOS:000629590400053
J	Kamoshita, M; Fujiwara, K; Ito, J; Kashiwazaki, N				Kamoshita, Maki; Fujiwara, Katsuyoshi; Ito, Junya; Kashiwazaki, Naomi			Highly successful production of viable mice derived from vitrified germinal vesicle oocytes	PLOS ONE			English	Article								The vitrification of immature germinal vesicle (GV) oocytes is an important way to preserve genetic resources and female fertility. However, it is well known that cryopreserved GV oocytes have very poor developmental ability and that further improvement in this technique is needed. We previously reported the successful vitrification of matured mouse oocytes with enclosed cumulus cells using the calcium-free vitrification solution supplemented with ethylene glycol (EG) by the minimal volume cooling (MVC) method. In this study, we investigated whether our method is applicable to the vitrification of mouse oocytes at the GV stage (GV oocytes). Following maturation and fertilization in vitro, vitrified GV oocytes showed high survival (94.3 +/- 2.0%) and maturation (94.3 +/- 2.1%) rates. Although the fertilization and blastocyst rates of vitrified oocytes (fertilization: 46.6 +/- 4.9% and blastocyst: 46.6 +/- 3.0%) were significantly lower than those of fresh oocytes (fertilization: 73.0 +/- 7.1% and blastocyst: 71.6 +/- 8.0%) (P < 0.01), there were no differences in the ability to develop to term between fresh oocytes (50.0 +/- 8.4%) and vitrified oocytes (37.5 +/- 4.6%) (P > 0.05). In conclusion, we here show, for the first time, the efficient production of live mice derived from vitrified GV oocytes.	[Kamoshita, Maki; Fujiwara, Katsuyoshi; Ito, Junya; Kashiwazaki, Naomi] Azabu Univ, Grad Sch Vet Sci, Lab Anim Reprod, Sagamihara, Kanagawa, Japan; [Ito, Junya; Kashiwazaki, Naomi] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa, Japan	Azabu University; Azabu University	Ito, J (corresponding author), Azabu Univ, Grad Sch Vet Sci, Lab Anim Reprod, Sagamihara, Kanagawa, Japan.; Ito, J (corresponding author), Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa, Japan.	itoj@azabu-u.ac.jp		Ito, Junya/0000-0001-9398-7358	Japanese Society for Promotion of Science (JSPS) (KAKENHI) [15H04584, 20H05373, 14K08054]; JSPS [2410249]; MEXT-Supported Program for the Private University Research Branding Project, (2016-2019) (Ministry of Education, Culture, Sports, Science and Technology); NIBB Collaborative Research Program [18-908, 19-903]; Azabu University Research Services Division	Japanese Society for Promotion of Science (JSPS) (KAKENHI); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT-Supported Program for the Private University Research Branding Project, (2016-2019) (Ministry of Education, Culture, Sports, Science and Technology); NIBB Collaborative Research Program; Azabu University Research Services Division	This work was partially supported in part by a Grant-in-Aid for Scientific Research from the Japanese Society for Promotion of Science (JSPS) (KAKENHI, 15H04584 and 20H05373 to J.I. and 14K08054 to N.K.) and also JSPS research fellowship (2410249) to K.F. This study was supported by MEXT*-Supported Program for the Private University Research Branding Project, (2016-2019) (*Ministry of Education, Culture, Sports, Science and Technology). This work was supported by NIBB Collaborative Research Program (18-908 and 19-903) to J.I. This research was partially supported by a research project grant awarded by the Azabu University Research Services Division to J.I. and N.K. In addition, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedpour N, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.18172; Aono N, 2005, FERTIL STERIL, V84, P1078, DOI 10.1016/j.fertnstert.2005.03.077; Cha Soo Kyung, 2011, Clin Exp Reprod Med, V38, P24, DOI 10.5653/cerm.2011.38.1.24; Chian RC, 2004, J REPROD DEVELOP, V50, P685, DOI 10.1262/jrd.50.685; Ciotti PM, 2009, FERTIL STERIL, V91, P2399, DOI 10.1016/j.fertnstert.2008.03.013; Doyle JO, 2014, J ASSIST REPROD GEN, V31, P1695, DOI 10.1007/s10815-014-0336-7; Fujiwara K, 2017, ANIM SCI J, V88, P180, DOI 10.1111/asj.12666; Hirose M, 2013, ANIM SCI J, V84, P693, DOI 10.1111/asj.12061; HO YG, 1995, MOL REPROD DEV, V41, P232, DOI 10.1002/mrd.1080410214; Hochi S, 2004, THERIOGENOLOGY, V61, P267, DOI 10.1016/S0093-691X(03)00232-2; Ito J, 2010, ANIM SCI J, V81, P34, DOI 10.1111/j.1740-0929.2009.00699.x; KASAI M, 1981, J REPROD FERTIL, V63, P175, DOI 10.1530/jrf.0.0630175; Kohaya N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058063; Kohaya N, 2011, J REPROD DEVELOP, V57, P675, DOI 10.1262/jrd.11-066H; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; Larman MG, 2006, REPRODUCTION, V131, P53, DOI 10.1530/rep.1.00878; Lee D, 2020, REPROD BIOL ENDOCRIN, V18, DOI 10.1186/s12958-020-0566-8; Moawad AR, 2017, CRYOBIOLOGY, V76, P98, DOI 10.1016/j.cryobiol.2017.04.002; Nazmara Zohreh, 2014, Avicenna Journal of Medical Biotechnology, V6, P210; Shibao Y, 2014, CRYOBIOLOGY, V68, P200, DOI 10.1016/j.cryobiol.2014.01.008; Shimada M, 2008, DEVELOPMENT, V135, P2001, DOI 10.1242/dev.020461; Simopoulou M, 2018, MEDICINA-LITHUANIA, V54, DOI 10.3390/medicina54050076; Succu S, 2011, THERIOGENOLOGY, V75, P715, DOI 10.1016/j.theriogenology.2010.10.012; TAKESHIMA T, 1991, EXP ANIM TOKYO, V40, P493, DOI 10.1538/expanim1978.40.4_493; VANBLERKOM J, 1989, HUM REPROD, V4, P883, DOI 10.1093/oxfordjournals.humrep.a137006; VANDERELST JC, 1993, J ASSIST REPROD GEN, V10, P202, DOI 10.1007/BF01239222; VANDERHYDEN BC, 1989, BIOL REPROD, V40, P720, DOI 10.1095/biolreprod40.4.720; VINCENT C, 1990, J REPROD FERTIL, V89, P253, DOI 10.1530/jrf.0.0890253; Wakai T, 2019, J CELL SCI, V132, DOI 10.1242/jcs.225441; Watanabe H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083613; Whittingham D G, 1971, J Reprod Fertil Suppl, V14, P7; Wu ZZ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091009; Yoda Y., 1971, JAPANESE J ANIM REPR, V16, P147, DOI [DOI 10.1262/JRD1955.16.147, 10.1262/jrd1955.16.147]	33	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248050	10.1371/journal.pone.0248050	http://dx.doi.org/10.1371/journal.pone.0248050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705447	gold, Green Published			2022-12-26	WOS:000629590400084
J	Li, P; Chen, C; Dong, YB				Li, Ping; Chen, Chao; Dong, Yibo			A comprehensive examination of the lysine acetylation targets in paper mulberry based on proteomics analyses	PLOS ONE			English	Article							PROTEIN ACETYLATION; ACETYLOME; SUCCINYLATION; CONSERVATION; SUCCESS; STRESS; SITES; SIRT3; GENE	Rocky desertification is a bottleneck that reduces ecological and environmental security in karst areas. Paper mulberry, a unique deciduous tree, shows good performance in rocky desertification areas. Its resistance mechanisms are therefore of high interest. In this study, a lysine acetylation proteomics analysis of paper mulberry seedling leaves was conducted in combination with the purification of acetylated protein by high-precision nano LC-MS/MS. We identified a total of 7130 acetylation sites in 3179 proteins. Analysis of the modified sites showed a predominance of nine motifs. Six positively charged residues: lysine (K), arginine (R), and histidine (H), serine (S), threonine (T), and tyrosine (Y) occurred most frequently at the +1 position, phenylalanine (F) was both detected both upstream and downstream of the acetylated lysines; and the sequence logos showed a strong preference for lysine and arginine around acetylated lysines. Functional annotation revealed that the identified enzymes were mainly involved in translation, transcription, ribosomal structure and biological processes, showing that lysine acetylation can regulate various aspects of primary carbon and nitrogen metabolism and secondary metabolism. Acetylated proteins were enriched in the chloroplast, cytoplasm, and nucleus, and many stress response-related proteins were also discovered to be acetylated, including PAL, HSP70, and ERF. HSP70, an important protein involved in plant abiotic and disease stress responses, was identified in paper mulberry, although it is rarely found in woody plants. This may be further examined in research in other plants and could explain the good adaptation of paper mulberry to the karst environment. However, these hypotheses require further verification. Our data can provide a new starting point for the further analysis of the acetylation function in paper mulberry and other plants.	[Li, Ping; Chen, Chao; Dong, Yibo] Guizhou Univ, Coll Anim Sci, Guiyang, Guizhou, Peoples R China; [Li, Ping] Sichuan Acad Grassland Sci, Inst Grassland Res, Chengdu, Sichuan, Peoples R China	Guizhou University; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS	Chen, C (corresponding author), Guizhou Univ, Coll Anim Sci, Guiyang, Guizhou, Peoples R China.	gzgyxgc3852218@163.com			National Natural Science Foundation of China [31560670]; Science and Technology Program of Guizhou Province [[2018]2258]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guizhou Province	This study was supported by the National Natural Science Foundation of China, 31560670; The Science and Technology Program of Guizhou Province, [2018]2258, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The sponsor is Mr. Chen Chao.	Asai Akieda., 2010, PLOS ONE; BAKER NR, 1991, PHYSIOL PLANTARUM, V81, P563, DOI 10.1111/j.1399-3054.1991.tb05101.x; Baoyun FENG., 2020, CHIN J TROP CROPS, V41, P119; Barkla BJ, 2013, PROTEOMICS, V13, P1801, DOI 10.1002/pmic.201200401; Bharathi SS, 2013, J BIOL CHEM, V288, P33837, DOI 10.1074/jbc.M113.510354; BUCKLAND SM, 1991, NEW PHYTOL, V119, P155, DOI 10.1111/j.1469-8137.1991.tb01019.x; Chen ZJ, 2007, BBA-GENE STRUCT EXPR, V1769, P295, DOI 10.1016/j.bbaexp.2007.04.007; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; CORNIC G, 1991, PLANTA, V183, P178, DOI 10.1007/BF00197786; Denison FC, 2011, SEMIN CELL DEV BIOL, V22, P720, DOI 10.1016/j.semcdb.2011.08.006; Diaz-Vivancos P, 2006, J EXP BOT, V57, P3813, DOI 10.1093/jxb/erl138; Finkemeier I, 2011, PLANT PHYSIOL, V155, P1779, DOI 10.1104/pp.110.171595; Gibson BW, 2005, INT J BIOCHEM CELL B, V37, P927, DOI 10.1016/j.biocel.2004.11.013; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020; Hamberger B, 2007, CAN J BOT, V85, P1182, DOI 10.1139/B07-098; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; Huang H, 2015, CHEM REV, V115, P2376, DOI 10.1021/cr500491u; Huang H, 2014, CELL, V159, P458, DOI 10.1016/j.cell.2014.09.037; Huang Shang-Zhi, 2004, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V30, P189; Hui M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114187; Jiang JT, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5250-4; Jones JD, 2011, PROTEOMICS, V11, P3012, DOI 10.1002/pmic.201000812; KAISER WM, 1987, PHYSIOL PLANTARUM, V71, P142, DOI 10.1111/j.1399-3054.1987.tb04631.x; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Knee M, 2002, ECOL RES, V17, P591, DOI 10.1046/j.1440-1703.2002.00517.x; KURZIKDUMKE U, 1995, GENE, V154, P171, DOI 10.1016/0378-1119(94)00827-F; [李慧聪 Li Huicong], 2010, [河北农业大学学报, Journal of Agricultural University of Hebei], V33, P12; Li XL, 2014, J PROTEOME RES, V13, P6087, DOI 10.1021/pr500992r; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Manosalva PM, 2011, PLANT J, V68, P777, DOI 10.1111/j.1365-313X.2011.04728.x; McAllister CA, 1998, OECOLOGIA, V117, P40, DOI 10.1007/s004420050629; Mooney HA, 1972, ANNU REV ECOL SYST; Nagel JM, 2004, BIOL INVASIONS, V6, P101, DOI 10.1023/B:BINV.0000010125.93370.32; Nallamilli BRR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089283; Neilson KA, 2011, PROTEOMICS, V11, P1696, DOI 10.1002/pmic.201000727; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Pan JY, 2014, J PROTEOME RES, V13, P3294, DOI 10.1021/pr500133t; PRICE AH, 1991, PLANT CELL ENVIRON, V14, P477, DOI 10.1111/j.1365-3040.1991.tb01517.x; [齐妍 Qi Yan], 2013, [植物遗传资源学报, Journal of Plant Genetic Resources], V14, P507; Qiulin Q, 2007, FUDAN U; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; SEEL WE, 1992, J EXP BOT, V43, P1031, DOI 10.1093/jxb/43.8.1031; Song LM, 2016, NUCLEIC ACIDS RES, V44, P1979, DOI 10.1093/nar/gkw053; Still AJ, 2013, J BIOL CHEM, V288, P26209, DOI 10.1074/jbc.M113.483396; Sun JH, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5716-z; Suo SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049108; Tsai Chung-Jui., 2010, NEW PHYTOL, V172; WALTERS MB, 1993, OECOLOGIA, V96, P219, DOI 10.1007/BF00317735; Wang H, 2012, IEEE ICC; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; WILBANKS SM, 1994, J BIOL CHEM, V269, P12893; Wong JH, 2012, PLANTA, V235, P267, DOI 10.1007/s00425-011-1506-9; Xin Li, 2014, J PROTEOMICS; Xiong YH, 2016, J PROTEOMICS, V138, P20, DOI 10.1016/j.jprot.2016.01.019; Xu Chen., 2017, CENOMICS APPL BIOL, P370; Xu XiangMing, 2000, Chinese Journal of Applied and Environmental Biology, V6, P379; Xu YX, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02104; Xue B, 2013, MOL BIOSYST, V9, P645, DOI 10.1039/c3mb25517d; Yan-ping XIAO., 2010, J AGR SCI TECHNOLOGY, V12, P111; Yanqiu AN., 2011, MOL PLANT BREEDING, V009, P402; Ye XY, 2017, ONCOTARGET, V8, P6984, DOI 10.18632/oncotarget.14346; Yoo H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3833; Zhang C., 2006, J TROP SUBTROP BOT; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang Y, 2015, J PROTEOME RES, V14, P304, DOI 10.1021/pr500940s; Zhao D, 2013, CANCER CELL, V23, P464, DOI 10.1016/j.ccr.2013.02.005; Zhen SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep31576	67	2	2	9	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0240947	10.1371/journal.pone.0240947	http://dx.doi.org/10.1371/journal.pone.0240947			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705403	gold, Green Published			2022-12-26	WOS:000629590400011
J	Gosselt, HR; Vallerga, CL; Mandaviya, PR; Lubberts, E; Hazes, JMW; de Jonge, R; Heil, SG				Gosselt, Helen R.; Vallerga, Costanza L.; Mandaviya, Pooja R.; Lubberts, Erik; Hazes, Johanna M. W.; de Jonge, Robert; Heil, Sandra G.			Epigenome wide association study of response to methotrexate in early rheumatoid arthritis patients	PLOS ONE			English	Article								Aim To identify differentially methylated positions (DMPs) and regions (DMRs) that predict response to Methotrexate (MTX) in early rheumatoid arthritis (RA) patients. Materials and methods DNA from baseline peripheral blood mononuclear cells was extracted from 72 RA patients. DNA methylation, quantified using the Infinium MethylationEPIC, was assessed in relation to response to MTX (combination) therapy over the first 3 months. Results Baseline DMPs associated with response were identified; including hits previously described in RA. Additionally, 1309 DMR regions were observed. However, none of these findings were genome-wide significant. Likewise, no specific pathways were related to response, nor could we replicate associations with previously identified DMPs. Conclusion No baseline genome-wide significant differences were identified as biomarker for MTX (combination) therapy response; hence meta-analyses are required.	[Gosselt, Helen R.; Heil, Sandra G.] Erasmus MC, Dept Clin Chem, Univ Med Ctr Rotterdam, Rotterdam, Netherlands; [Gosselt, Helen R.; de Jonge, Robert] Vrije Univ Amsterdam, Amsterdam UMC, Amsterdam Gastroenterol & Metab, Dept Clin Chem, Amsterdam, Netherlands; [Vallerga, Costanza L.; Mandaviya, Pooja R.] Erasmus MC, Dept Internal Med, Univ Med Ctr Rotterdam, Rotterdam, Netherlands; [Lubberts, Erik; Hazes, Johanna M. W.] Erasmus MC, Dept Rheumatol, Univ Med Ctr Rotterdam, Rotterdam, Netherlands; [Lubberts, Erik; Hazes, Johanna M. W.; Heil, Sandra G.] Erasmus MC, Acad Ctr Excellence Inflammun, Univ Med Ctr Rotterdam, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Gosselt, HR (corresponding author), Erasmus MC, Dept Clin Chem, Univ Med Ctr Rotterdam, Rotterdam, Netherlands.; Gosselt, HR (corresponding author), Vrije Univ Amsterdam, Amsterdam UMC, Amsterdam Gastroenterol & Metab, Dept Clin Chem, Amsterdam, Netherlands.	h.gosselt@erasmusmc.nl	Vallerga, Costanza Ludovica/D-6732-2017	Vallerga, Costanza Ludovica/0000-0001-9493-6800; Gosselt, Helen Rosalie/0000-0002-9262-7411				Arandjelovic S, 2019, NAT IMMUNOL, V20, P141, DOI 10.1038/s41590-018-0293-x; Bollepalli S, 2019, EPIGENOMICS-UK, V11, P1469, DOI 10.2217/epi-2019-0206; Burgers LE, 2019, RMD OPEN, V5, DOI 10.1136/rmdopen-2018-000870; Chen YY, 2018, EUR J IMMUNOL, V48, P915, DOI 10.1002/eji.201747157; Ciechomska M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8090953; de Rotte MCFJ, 2015, ANN RHEUM DIS, V74, P408, DOI 10.1136/annrheumdis-2013-203725; den Boer E, 2013, ANAL BIOANAL CHEM, V405, P1673, DOI 10.1007/s00216-012-6581-7; Glossop JR, 2017, EPIGENOMICS-UK, V9, P419, DOI [10.2217/epi-2016-0042, 10.2217/epi-2016-0144]; Gosselt HR, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1936-5; He XJ, 2019, EBIOMEDICINE, V41, P538, DOI 10.1016/j.ebiom.2019.02.009; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Julia A, 2017, HUM MOL GENET, V26, P2803, DOI 10.1093/hmg/ddx177; Klein K, 2018, RMD OPEN, V4, DOI 10.1136/rmdopen-2018-000744; Lehne B, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0600-x; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Logue MW, 2017, EPIGENOMICS-UK, V9, P1363, DOI 10.2217/epi-2017-0078; Mansell G, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5761-7; McAllister K, 2013, ARTHRITIS RHEUM-US, V65, P3058, DOI 10.1002/art.38183; Meng HL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-227; Nair N, 2020, RHEUMATOLOGY, V59, P1364, DOI 10.1093/rheumatology/kez411; Pidsley R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1066-1; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Smolen JS, 2020, ANN RHEUM DIS, V79, P685, DOI 10.1136/annrheumdis-2019-216655; Suderman M, 2018, DMRFF IDENTIFYING DI; Yang LY, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/2609737; Zhang FT, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1718-z; Zhu H, 2019, ANN RHEUM DIS, V78, P36, DOI 10.1136/annrheumdis-2018-213970	27	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0247709	10.1371/journal.pone.0247709	http://dx.doi.org/10.1371/journal.pone.0247709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690661	Green Published, gold			2022-12-26	WOS:000627854700031
J	Littman, AJ; Young, J; Moldestad, M; Tseng, CL; Czerniecki, JR; Landry, GJ; Robbins, J; Boyko, EJ; Dillon, MP				Littman, Alyson J.; Young, Jessica; Moldestad, Megan; Tseng, Chin-Lin; Czerniecki, Joseph R.; Landry, Gregory J.; Robbins, Jeffrey; Boyko, Edward J.; Dillon, Michael P.			How patients interpret early signs of foot problems and reasons for delays in care: Findings from interviews with patients who have undergone toe amputations	PLOS ONE			English	Article							LOWER-EXTREMITY AMPUTATIONS; DIABETIC FOOT; REAMPUTATION; PERSPECTIVES; MORTALITY; WOUNDS; PEOPLE; ULCERS	Aims To describe how patients respond to early signs of foot problems and the factors that result in delays in care. Methods Semi-structured interviews were conducted with a large sample of Veterans from across the United States with diabetes mellitus who had undergone a toe amputation. Data were analyzed using inductive content analysis. Results We interviewed 61 male patients. Mean age was 66 years, 41% were married, and 37% had a high school education or less. The patient-level factors related to delayed care included: 1) not knowing something was wrong, 2) misinterpreting symptoms, 3) "sudden" and "unexpected" illness progression, and 4) competing priorities getting in the way of care-seeking. The system-level factors included: 5) asking patients to watch it, 6) difficulty getting the right type of care when needed, and 7) distance to care and other transportation barriers. Conclusion A confluence of patient factors (e.g., not examining their feet regularly or thoroughly and/or not acting quickly when they noticed something was wrong) and system factors (e.g., absence of a mechanism to support patient's appraisal of symptoms, lack of access to timely and convenient-located appointments) delayed care. Identifying patient- and system-level interventions that can shorten or eliminate care delays could help reduce rates of limb loss.	[Littman, Alyson J.; Boyko, Edward J.] Dept Vet Affairs Puget Sound Hlth Care Syst, Seattle Epidemiol Res & Informat Ctr, Seattle, WA 98108 USA; [Littman, Alyson J.; Young, Jessica; Moldestad, Megan] Dept Vet Affairs Puget Sound Hlth Care Syst, Seattle Denver Ctr Innovat Vet Ctr & Value Driven, Seattle, WA 98108 USA; [Littman, Alyson J.; Boyko, Edward J.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Tseng, Chin-Lin] Vet Affairs New Jersey Healthcare Syst, East Orange, NJ USA; [Czerniecki, Joseph R.] Dept Vet Affairs Puget Sound Hlth Care Syst, Vet Affairs Ctr Limb Loss & Mobil CLiMB, Seattle, WA USA; [Czerniecki, Joseph R.] Dept Vet Affairs Puget Sound Hlth Care Syst, Rehabil Care Serv, Seattle, WA USA; [Czerniecki, Joseph R.] Univ Washington, Sch Med, Dept Rehabil, Seattle, WA USA; [Landry, Gregory J.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Robbins, Jeffrey] Louis Stokes VA, Cleveland, OH USA; [Boyko, Edward J.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Dillon, Michael P.] La Trobe Univ, Dept Physiotherapy, Discipline Prosthet & Orthot Podiatry & Prosthet, Sch Allied Hlth Human Serv & Sports, Melbourne, Vic, Australia	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University of Washington; University of Washington Seattle; La Trobe University	Littman, AJ (corresponding author), Dept Vet Affairs Puget Sound Hlth Care Syst, Seattle Epidemiol Res & Informat Ctr, Seattle, WA 98108 USA.; Littman, AJ (corresponding author), Dept Vet Affairs Puget Sound Hlth Care Syst, Seattle Denver Ctr Innovat Vet Ctr & Value Driven, Seattle, WA 98108 USA.; Littman, AJ (corresponding author), Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA.	Alyson.littman@va.gov	; Boyko, Edward/G-2484-2017	Dillon, Michael/0000-0003-3614-7787; Boyko, Edward/0000-0002-3695-192X; Littman, Alyson/0000-0002-4247-8286	Veterans Health Administration, Office of Research and Development, Health Services Research Development [IIR 15-372]	Veterans Health Administration, Office of Research and Development, Health Services Research Development	AJL, JY, MM, CLT were supported in part by funding from Veterans Health Administration, Office of Research and Development, Health Services Research & Development (IIR 15-372). The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahakoon C, 2020, DIABETIC MED, V37, P1266, DOI 10.1111/dme.14323; ANDERSEN BL, 1995, BRIT J SOC PSYCHOL, V34, P33, DOI 10.1111/j.2044-8309.1995.tb01047.x; [Anonymous], 2017, PREVENTION AMPUTATIO, P1; Barg FK, 2017, WOUND REPAIR REGEN, V25, P864, DOI 10.1111/wrr.12593; Beattie AM, 2014, HEALTH EXPECT, V17, P429, DOI 10.1111/j.1369-7625.2012.00768.x; Bonner T, 2017, HEALTH PROMOT PRACT, V18, P806, DOI 10.1177/1524839916688867; Burnside J, 2007, DIABETIC FOOT, V10, P17; Cichosz SL, 2020, J DIABETES SCI TECHN, DOI [10.1177/1932296820942307, DOI 10.1177/193229682094230732696655]; Claessen H, 2018, CLIN EPIDEMIOL, V10, P475, DOI 10.2147/CLEP.S146484; Dillingham TR, 2005, ARCH PHYS MED REHAB, V86, P480, DOI 10.1016/j.apmr.2004.06.072; Dillon MP, 2014, PROSTHET ORTHOT INT, V38, P122, DOI 10.1177/0309364613490441; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Elo S, 2014, SAGE OPEN, V4, DOI 10.1177/2158244014522633; Feinglass J, 2012, DISABIL REHABIL, V34, P2158, DOI 10.3109/09638288.2012.677936; Fortney JC, 2011, J GEN INTERN MED, V26, pS639, DOI 10.1007/s11606-011-1806-6; Gale L, 2008, BRIT J GEN PRACT, V58, P555, DOI 10.3399/bjgp08X319657; Geiss LS, 2019, DIABETES CARE, V42, P50, DOI 10.2337/dc18-1380; Greenwell K, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019865; GUBA EG, 1981, ECTJ-EDUC COMMUN TEC, V29, P75; Littman AJ, 2020, DIABETES CARE, V43, P1033, DOI 10.2337/dc19-2337; Lombardo FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086405; Margolis DJ, 2011, DATA POINTS PUBLICAT; Morse J. M., 2002, INT J QUAL METHODS, P13, DOI 10.1177/160940690200100202; Pedlow H, 2014, J VASC NURS, V32, P88, DOI 10.1016/j.jvn.2014.01.002; Reiber GE, 2005, LANCET, V366, P1676, DOI 10.1016/S0140-6736(05)67674-X; Roulston K., 2013, REFLECTIVE INTERVIEW, DOI [10.4135/9781446288009.n2, DOI 10.4135/9781446288009.N2]; Sandelowski M., 2008, SAGE ENCY QUALITATIV, V2, P875; Searle A, 2008, J HEALTH SERV RES PO, V13, P82, DOI 10.1258/jhsrp.2008.008011; Spoden M, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-018-3759-5; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Unger-Saldana K, 2011, SOC SCI MED, V72, P1096, DOI 10.1016/j.socscimed.2011.01.022; van Netten JJ, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3270; Walter F, 2012, J HEALTH SERV RES PO, V17, P110, DOI 10.1258/jhsrp.2011.010113; Yuncken J, 2018, J FOOT ANKLE RES, V11, DOI 10.1186/s13047-018-0255-4	34	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0248310	10.1371/journal.pone.0248310	http://dx.doi.org/10.1371/journal.pone.0248310			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QV3DA	33690723	gold, Green Published			2022-12-26	WOS:000627854700007
J	Truccollo, B; Whyte, P; Burgess, C; Bolton, D				Truccollo, Brendha; Whyte, Paul; Burgess, Catherine; Bolton, Declan			Genetic characterisation of a subset of Campylobacter jejuni isolates from clinical and poultry sources in Ireland	PLOS ONE			English	Article							GENOME; PASSAGE; EPIDEMIOLOGY; VIRULENCE; EVOLUTION; STRAINS; DISEASE	Campylobacter spp. is a significant and prevalent public health hazard globally. Campylobacter jejuni is the most frequently recovered species from human cases and poultry are considered the most important reservoir for its transmission to humans. In this study, 30 Campylobacter jejuni isolates were selected from clinical (n = 15) and broiler (n = 15) sources from a larger cohort, based on source, virulence, and antimicrobial resistance profiles. The objective of this study was to further characterise the genomes of these isolates including MLST types, population structure, pan-genome, as well as virulence and antimicrobial resistance determinants. A total of 18 sequence types and 12 clonal complexes were identified. The most common clonal complex was ST-45, which was found in both clinical and broiler samples. We characterised the biological functions that were associated with the core and accessory genomes of the isolates in this study. No significant difference in the prevalence of virulence or antimicrobial resistance determinants was observed between clinical and broiler isolates, although genes associated with severe illness such as neuABC, wlaN and cstIII were only detected in clinical isolates. The ubiquity of virulence factors associated with motility, invasion and cytolethal distending toxin (CDT) synthesis in both clinical and broiler C. jejuni genomes and genetic similarities between groups of broiler and clinical C. jejuni reaffirm that C. jejuni from poultry remains a significant threat to public health.	[Truccollo, Brendha; Burgess, Catherine; Bolton, Declan] Teagasc Food Res Ctr, Food Safety Dept, Dublin, Ireland; [Truccollo, Brendha; Whyte, Paul] Univ Coll Dublin, Sch Vet Med, Dublin, Ireland	Teagasc; University College Dublin	Bolton, D (corresponding author), Teagasc Food Res Ctr, Food Safety Dept, Dublin, Ireland.	Declan.Bolton@teagasc.ie			Teagasc [0028]	Teagasc	DB received funding for this study from Teagasc, project number 0028.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Amon P, 2012, EUR J MICROBIOL IMMU, V2, P20, DOI 10.1556/EuJMI.2.2012.1.4; Avrain L, 2004, J APPL MICROBIOL, V97, P134, DOI 10.1111/j.1365-2672.2004.02306.x; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Battersby T, 2016, J APPL MICROBIOL, V120, P1108, DOI 10.1111/jam.13066; Blaser MJ, 2008, CAMPYLOBACTER, 3RD EDITION, P99; Blaser MJ, 1997, J INFECT DIS, V176, pS103, DOI 10.1086/513780; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bushnell B, 2014, LBNL7065E; Callicott KA, 2006, APPL ENVIRON MICROB, V72, P5794, DOI 10.1128/AEM.02991-05; Carraro L, 2019, MICROBIOL RESOUR ANN, V8, DOI [10.1128/MRA.00359-19, 10.1128/mra.00359-19]; Chen LH, 2016, NUCLEIC ACIDS RES, V44, pD694, DOI 10.1093/nar/gkv1239; Citterio B, 2020, FOOD CONTROL, V110, DOI 10.1016/j.foodcont.2019.107033; Cody AJ, 2012, J CLIN MICROBIOL, V50, P3193, DOI 10.1128/JCM.01086-12; Costa D, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00072-18; Crespo MD, 2012, APPL ENVIRON MICROB, V78, P8488, DOI 10.1128/AEM.02258-12; Dearlove BL, 2016, ISME J, V10, P721, DOI 10.1038/ismej.2015.149; Di Giannatale E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225957; Dingle KE, 2002, EMERG INFECT DIS, V8, P949; European Food Safety Authority, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.5926; Facciola A, 2017, J Prev Med Hyg, V58, pE79; Fernandez H, 2000, J VET MED B, V47, P635, DOI 10.1046/j.1439-0450.2000.00392.x; Fiedoruk K, 2019, GUT PATHOG, V11, DOI 10.1186/s13099-019-0313-x; Flanagan RC, 2009, INFECT IMMUN, V77, P2399, DOI 10.1128/IAI.01266-08; Flori P, 2004, J MED MICROBIOL, V53, P603, DOI 10.1099/jmm.0.45528-0; Gundogdu O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-162; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hadfield J, 2018, BIOINFORMATICS, V34, P292, DOI 10.1093/bioinformatics/btx610; Hanel I, 2009, VET MICROBIOL, V136, P121, DOI 10.1016/j.vetmic.2008.10.018; Hao HH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01605; Harvala Heli, 2016, Infection Ecology & Epidemiology, V6, P31079, DOI 10.3402/iee.v6.31079; Hastings R, 2011, J APPL MICROBIOL, V110, P266, DOI 10.1111/j.1365-2672.2010.04883.x; Hofreuter D, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00137; Huerta-Cepas J, 2017, MOL BIOL EVOL, V34, P2115, DOI 10.1093/molbev/msx148; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Jorgensen F, 2011, APPL ENVIRON MICROB, V77, P3741, DOI 10.1128/AEM.02444-10; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; Kalendar R, 2017, GENOMICS, V109, P312, DOI 10.1016/j.ygeno.2017.05.005; Kanipes MI, 2008, J BACTERIOL, V190, P1568, DOI 10.1128/JB.01696-07; Khan M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02089; Kim JS, 2012, MICROBIOL-SGM, V158, P1304, DOI 10.1099/mic.0.057158-0; Kolehmainen A, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00759-18; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Lynch CT, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9060308; Mandal RK, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4032-8; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Mourkas E, 2020, P NATL ACAD SCI USA, V117, P11018, DOI 10.1073/pnas.1917168117; Nauta M, 2009, INT J FOOD MICROBIOL, V129, P107, DOI 10.1016/j.ijfoodmicro.2008.12.001; Nielsen LN, 2010, J APPL MICROBIOL, V108, P591, DOI 10.1111/j.1365-2672.2009.04444.x; O'Mahony E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028490; Ochman H, 2005, P NATL ACAD SCI USA, V102, P11959, DOI 10.1073/pnas.0505863102; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Petrovska L, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00354; Ponciano JM, 2007, GENETICS, V176, P957, DOI 10.1534/genetics.106.061937; Qin SS, 2012, ANTIMICROB AGENTS CH, V56, P5332, DOI 10.1128/AAC.00809-12; Quainoo S, 2017, CLIN MICROBIOL REV, V30, P1015, DOI 10.1128/CMR.00016-17; Redondo N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219088; Revez J, 2012, EUR J CLIN MICROBIOL, V31, P2203, DOI 10.1007/s10096-012-1556-3; Robyn J, 2015, COMPR REV FOOD SCI F, V14, P81, DOI 10.1111/1541-4337.12124; Rouli L., 2015, New Microbes and New Infections, V7, P72, DOI 10.1016/j.nmni.2015.06.005; SANG FC, 1989, AVIAN DIS, V33, P425, DOI 10.2307/1591100; Sayers S, 2019, NUCLEIC ACIDS RES, V47, pD693, DOI 10.1093/nar/gky999; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sheppard SK, 2012, GENES-BASEL, V3, P261, DOI 10.3390/genes3020261; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Smith MA, 1998, CAN J MICROBIOL, V44, P351, DOI 10.1139/cjm-44-4-351; Stahl M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00005; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tang YZ, 2017, J ANTIMICROB CHEMOTH, V72, P1581, DOI 10.1093/jac/dkx023; Wilson DJ, 2009, MOL BIOL EVOL, V26, P385, DOI 10.1093/molbev/msn264; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Zahin M, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/340605, 10.1155/2013/263509, 10.1155/2013/605831, 10.1155/2013/510736]; Zemtsova GE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116658; Zhang Y, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00110	78	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2021	16	3							e0246843	10.1371/journal.pone.0246843	http://dx.doi.org/10.1371/journal.pone.0246843			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DJ	33690659	Green Published, gold			2022-12-26	WOS:000627855600016
J	Miyagaki, S; Yamaguchi, M; Ota, T; Kawabe, Y; Morimoto, H; Oka, Y; Mori, J				Miyagaki, Satoshi; Yamaguchi, Mihoko; Ota, Takeshi; Kawabe, Yasuhiro; Morimoto, Hidechika; Oka, Yoshinobu; Mori, Jun			Alfacalcidol improves the growth velocity in children with vitamin D deficiency/insufficiency: A single center retrospective cohort study	PLOS ONE			English	Article							D-DEFICIENCY RICKETS; D SUPPLEMENTATION; SHORT-STATURE; BONE; HEALTH; PREGNANCY; CHILDHOOD; LACTATION; PROPOSAL; JAPAN	Objectives To investigate the growth velocity-improving effects of vitamin D replacement therapy in pediatric patients diagnosed with vitamin D deficiency and insufficiency. Study design A retrospective cohort study was conducted in 34 pediatric patients diagnosed with vitamin D deficiency/insufficiency. Based on the clinical findings, the subjects were divided into two groups: a bowed leg (BL) group and a non-bowed leg (non-BL) group. After the initiation of alfacalcidol, the standard deviation score (SDS) of their heights, weights and growth velocities in each group were monitored. Results The median age at the first visit was significantly lesser in the BL group (1.58 years old [inter-quartile range (IQR): 1.33, 2.17]) than that in the non-BL group (3.00 years old [IQR: 2.33, 3.67]). On the contrary, the SDS for height was significantly lower in the non-BL group (-2.27 [IQR: -2.63, -1.94]) than that in the BL group (-1.37 [IQR: -1.91, -1.07]). One-year treatment with alfacalcidol showed significant improvements in both height SDSs and growth velocity SDSs not only in the BL group but also in the non-BL group. Conclusions The current study revealed that vitamin D replacement therapy improved the growth rate in children with vitamin D deficiency/insufficiency, regardless of the presence of BL. This study emphasizes the importance of assessing the vitamin D status in children with poor growth rates and suggests that alfacalcidol could be a valid option for the treatment of short stature.	[Miyagaki, Satoshi; Yamaguchi, Mihoko; Ota, Takeshi; Kawabe, Yasuhiro; Morimoto, Hidechika; Mori, Jun] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan; [Oka, Yoshinobu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat Orthopaed, Kyoto, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Mori, J (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan.	jun1113@koto.kpu-m.ac.jp						Aghajafari F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1169; Antonucci R, 2018, J PEDIATR ENDOCR MET, V31, P247, DOI 10.1515/jpem-2017-0391; Brannon PM, 2011, ANNU REV NUTR, V31, P89, DOI 10.1146/annurev.nutr.012809.104807; Bueno AL, 2010, EUR J CLIN NUTR, V64, P1296, DOI 10.1038/ejcn.2010.156; Callaghan AL, 2006, ARCH DIS CHILD, V91, P606, DOI 10.1136/adc.2006.095075; Caregaro L, 2001, CLIN NUTR, V20, P251, DOI 10.1054/clnu.2001.0397; Fernandez Bustillo J M, 2018, BMC Res Notes, V11, P801, DOI 10.1186/s13104-018-3903-7; Ganmaa D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175237; Harvey NC, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18450; Jawa A, 2016, PAK J MED SCI, V32, P1321, DOI 10.12669/pjms.326.11077; Kubota T, 2018, ENDOCR J, V65, P593, DOI [10.1507/endocrj.EJ18-0008, 10.1507/endocrj.ej18-0008]; Ladhani S, 2004, ARCH DIS CHILD, V89, P781, DOI 10.1136/adc.2003.031385; Matsuo K, 2009, PEDIATR INT, V51, P559, DOI 10.1111/j.1442-200X.2009.02834.x; Miyako K, 2005, PEDIATR INT, V47, P142, DOI 10.1111/j.1442-200x.2005.02041.x; Nakano S, 2018, J NUTR SCI VITAMINOL, V64, P99, DOI 10.3177/jnsv.64.99; Nishikura K, 2002, PEDIATR INT, V44, P179, DOI 10.1046/j.1328-8067.2001.01514.x; Ogata Tsutomu, 2007, Clin Pediatr Endocrinol, V16, P85, DOI 10.1297/cpe.16.85; Okazaki R, 2017, J BONE MINER METAB, V35, P1, DOI 10.1007/s00774-016-0805-4; Ozono Keiichi, 2012, Vitamins (Kyoto), V86, P28; Pettifor JM, 2011, BEST PRACT RES CL EN, V25, P573, DOI 10.1016/j.beem.2011.06.010; Rajah J, 2008, PEDIATR INT, V50, P424, DOI 10.1111/j.1442-200X.2008.02700.x; Saggese G, 2015, EUR J PEDIATR, V174, P565, DOI 10.1007/s00431-015-2524-6; Soliman A, 2012, Georgian Med News, P58; SUWA S, 1992, Acta Paediatrica Japonica, V34, P206; Taylor SN, 2008, J AM COLL NUTR, V27, P690, DOI 10.1080/07315724.2008.10719746; Ward LM, 2007, CAN MED ASSOC J, V177, P161, DOI 10.1503/cmaj.061377; Wheeler BJ, 2015, AUST NZ J PUBL HEAL, V39, P380, DOI 10.1111/1753-6405.12390; Winzenberg T, 2013, CALCIFIED TISSUE INT, V92, P140, DOI 10.1007/s00223-012-9615-4; Zerofsky M, 2016, MATERN CHILD NUTR, V12, P898, DOI 10.1111/mcn.12187	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0247886	10.1371/journal.pone.0247886	http://dx.doi.org/10.1371/journal.pone.0247886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU3OZ	33684119	gold, Green Published			2022-12-26	WOS:000627193500031
J	Dobreva, MP; Lynton-Jenkins, JG; Chaves, JA; Tokita, M; Bonneaud, C; Abzhanov, A				Dobreva, Mariya P.; Lynton-Jenkins, Joshua G.; Chaves, Jaime A.; Tokita, Masayoshi; Bonneaud, Camille; Abzhanov, Arkhat			Sex identification in embryos and adults of Darwin's finches	PLOS ONE			English	Article								Darwin's finches are an iconic example of adaptive radiation and evolution under natural selection. Comparative genetic studies using embryos of Darwin's finches have shed light on the possible evolutionary processes underlying the speciation of this clade. Molecular identification of the sex of embryonic samples is important for such studies, where this information often cannot be inferred otherwise. We tested a fast and simple chicken embryo protocol to extract DNA from Darwin's finch embryos. In addition, we applied minor modifications to two of the previously reported PCR primer sets for CHD1, a gene used for sexing adult passerine birds. The sex of all 29 tested embryos of six species of Darwin's finches was determined successfully by PCR, using both primer sets. Next to embryos, hatchlings and fledglings are also impossible to distinguish visually. This extends to juveniles of sexually dimorphic species which are yet to moult in adult-like plumage and beak colouration. Furthermore, four species of Darwin's finches are monomorphic, males and females looking alike. Therefore, sex assessment in the field can be a source of error, especially with respect to juveniles and mature monomorphic birds outside of the mating season. We caught 567 juveniles and adults belonging to six species of Darwin's finches and only 44% had unambiguous sex-specific morphology. We sexed 363 birds by PCR: individuals sexed based on marginal sex specific morphological traits; and birds which were impossible to classify in the field. PCR revealed that for birds with marginal sex specific traits, sexing in the field produced a 13% error rate. This demonstrates that PCR based sexing can improve field studies on Darwin's finches, especially when individuals with unclear sex-related morphology are involved. The protocols used here provide an easy and reliable way to sex Darwin's finches throughout ontogeny, from embryos to adults.	[Dobreva, Mariya P.; Abzhanov, Arkhat] Imperial Coll London, Dept Life Sci, Silwood Pk, Ascot, Berks, England; [Lynton-Jenkins, Joshua G.; Bonneaud, Camille] Univ Exeter, Ctr Ecol & Conservat, Penryn, England; [Chaves, Jaime A.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Chaves, Jaime A.] Univ San Francisco Quito, Colegio Ciencias Biol & Ambientales, Campus Cumbaya, Quito, Ecuador; [Tokita, Masayoshi; Abzhanov, Arkhat] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Tokita, Masayoshi] Toho Univ, Dept Biol, Funabashi, Chiba, Japan	Imperial College London; University of Exeter; California State University System; San Francisco State University; Harvard University; Toho University	Dobreva, MP (corresponding author), Imperial Coll London, Dept Life Sci, Silwood Pk, Ascot, Berks, England.; Lynton-Jenkins, JG (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn, England.	mimi.pen@gmail.com; jl462@exeter.ac.uk	Lynton-Jenkins, Joshua/AAE-4158-2022; Chaves, Jaime/AAZ-7809-2021	Chaves, Jaime/0000-0003-0679-2603; Dobreva, Mariya/0000-0002-7152-1044; Bonneaud, Camille/0000-0003-2248-3288; Lynton-Jenkins, Josh/0000-0003-1657-7843	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [702707]; Heredity Fieldwork Grant - Genetics Society; University of Exeter; Universidad San Francisco de Quito (Ecuador); Japan Society for the Promotion of Science (JSPS) [23-771]; Uehara Memorial Foundation Research Fellowship	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant(SKA South Africa); Heredity Fieldwork Grant - Genetics Society; University of Exeter; Universidad San Francisco de Quito (Ecuador); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation Research Fellowship(Uehara Memorial Foundation)	MPD has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 702707. JGLJ was supported by Heredity Fieldwork Grant awarded by The Genetics Society, and by University of Exeter Vice Chancellor's scholarship for post-graduate research. JAC and CB received a field work collaboration grant by the Universidad San Francisco de Quito (Ecuador). MT was supported by Japan Society for the Promotion of Science (JSPS) -Postdoctoral Fellowship for research abroad No 23-771, and The Uehara Memorial Foundation Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Abzhanov A, 2006, NATURE, V442, P563, DOI 10.1038/nature04843; Abzhanov Arhat, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5174; Abzhanov A, 2010, PHILOS T R SOC B, V365, P1001, DOI 10.1098/rstb.2009.0321; Adam Iris, 2014, J Vis Exp, DOI 10.3791/51429; Arnold KE, 2003, MOL ECOL, V12, P3451, DOI 10.1046/j.1365-294X.2003.02007.x; Ayers KL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r26; Cakmak E, 2017, J VET DIAGN INVEST, V29, P59, DOI 10.1177/1040638716675197; Campas O, 2010, P NATL ACAD SCI USA, V107, P3356, DOI 10.1073/pnas.0911575107; Cimadom A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107518; Clinton M, 2001, BRIT POULTRY SCI, V42, P134, DOI 10.1080/713655025; CLINTON M, 1994, ANIM GENET, V25, P361, DOI 10.1111/j.1365-2052.1994.tb00374.x; Coyne JA, 2008, EVOLUTION, V62, P214, DOI 10.1111/j.1558-5646.2007.00254.x; DIETRICH D, 2013, PLOS ONE, V8, P1, DOI DOI 10.1371/journal.pone.0077771; Ellegren H, 1996, P ROY SOC B-BIOL SCI, V263, P1635, DOI 10.1098/rspb.1996.0239; Fessl B., 2010, DARWIN INITIAT, P1, DOI [10.13140/RG.2.1.1038.1680, DOI 10.13140/RG.2.1.1038.1680]; Fessl Birgit, 2011, Cotinga, V33, P27; GALDA L, 1992, READ TEACH, V46, P236; Gilbert L, 2007, HORM BEHAV, V51, P231, DOI 10.1016/j.yhbeh.2006.10.005; GRANT BR, 1987, BIOL J LINN SOC, V32, P247, DOI 10.1111/j.1095-8312.1987.tb00432.x; Grant P.R., 2014, 40 YEARS EVOLUTION D; Grant PR, 2003, IBIS, V145, P341, DOI 10.1046/j.1474-919X.2003.00157.x; Graves JAM, 2001, J EXP ZOOL, V290, P449, DOI 10.1002/jez.1088; Griffiths R, 1996, P ROY SOC B-BIOL SCI, V263, P1251, DOI 10.1098/rspb.1996.0184; GRIFFITHS R, 1995, NATURE, V375, P454, DOI 10.1038/375454a0; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Haunshi S, 2008, J POULT SCI, V45, P75, DOI 10.2141/jpsa.45.75; JONES RE, 1971, BIOL REV, V46, P315, DOI 10.1111/j.1469-185X.1971.tb01048.x; Kleindorfer S, 2007, ANIM BEHAV, V74, P795, DOI 10.1016/j.anbehav.2007.01.020; Lack D., 1947, DARWINS FINCHES; Lee JCI, 2010, MOL CELL PROBE, V24, P27, DOI 10.1016/j.mcp.2009.08.003; Lowe R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1506-4; Mallarino R, 2012, P NATL ACAD SCI USA, V109, P16222, DOI 10.1073/pnas.1206205109; Mallarino R, 2011, P NATL ACAD SCI USA, V108, P4057, DOI 10.1073/pnas.1011480108; Morinha F, 2012, THERIOGENOLOGY, V78, P703, DOI 10.1016/j.theriogenology.2012.04.015; Murray JR, 2013, J MORPHOL, V274, P1090, DOI 10.1002/jmor.20165; Owen JC, 2011, J FIELD ORNITHOL, V82, P339, DOI 10.1111/j.1557-9263.2011.00338.x; Peters KJ, 2017, J EVOLUTION BIOL, V30, P1940, DOI 10.1111/jeb.13167; PRICE TD, 1984, EVOLUTION, V38, P327, DOI 10.1111/j.1558-5646.1984.tb00291.x; Rudbeck L, 1998, BIOTECHNIQUES, V25, P588, DOI 10.2144/98254bm09; Rutstein AN, 2004, P ROY SOC B-BIOL SCI, V271, pS286, DOI 10.1098/rsbl.2003.0154; Savalli Udo M., 1995, Current Ornithology, V12, P141; SULANDARI S, 2012, J BIOSCIENCE, V19, P183, DOI DOI 10.4308/HJB.19.4.183; Tebbich S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091718; Turkyilmaz MK, 2010, BRIT POULTRY SCI, V51, P525, DOI 10.1080/00071668.2010.502521; Vucicevic M, 2013, ZOO BIOL, V32, P269, DOI 10.1002/zoo.21010; Wolfson A., 1952, Bird-Banding, V23, P159; Zhuo Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12179-9	48	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0237687	10.1371/journal.pone.0237687	http://dx.doi.org/10.1371/journal.pone.0237687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667220	gold, Green Submitted, Green Published			2022-12-26	WOS:000626604300047
J	Jalalirad, M; Haddad, TC; Salisbury, JL; Radisky, D; Zhang, MZ; Schroeder, M; Tuma, A; Leof, E; Carter, JM; Degnim, AC; Boughey, JC; Sarkaria, J; Yu, J; Wang, LW; Liu, MC; Zammataro, L; Malatino, L; Galanis, E; Ingle, JN; Goetz, MP; D'Assoro, AB				Jalalirad, Mohammad; Haddad, Tufia C.; Salisbury, Jeffrey L.; Radisky, Derek; Zhang, Minzhi; Schroeder, Mark; Tuma, Ann; Leof, Eduard; Carter, Jodi M.; Degnim, Amy C.; Boughey, Judy C.; Sarkaria, Jann; Yu, Jia; Wang, Liewei; Liu, Minetta C.; Zammataro, Luca; Malatino, Lorenzo; Galanis, Evanthia; Ingle, James N.; Goetz, Matthew P.; D'Assoro, Antonino B.			Aurora-A kinase oncogenic signaling mediates TGF-beta-induced triple-negative breast cancer plasticity and chemoresistance	ONCOGENE			English	Article								Triple-negative breast cancer (TNBCs) account for 15-20% of all breast cancers and represent the most aggressive subtype of this malignancy. Early tumor relapse and progression are linked to the enrichment of a sub-fraction of cancer cells, termed breast tumor-initiating cells (BTICs), that undergo epithelial to mesenchymal transition (EMT) and typically exhibit a basal-like CD44(high)/CD24(low) and/or ALDH1(high) phenotype with critical cancer stem-like features such as high self-renewal capacity and intrinsic (de novo) resistance to standard of care chemotherapy. One of the major mechanisms responsible for the intrinsic drug resistance of BTICs is their high ALDH1 activity leading to inhibition of chemotherapy-induced apoptosis. In this study, we demonstrated that aurora-A kinase (AURKA) is required to mediate TGF-beta-induced expression of the SNAI1 gene, enrichment of ALDH1(high) BTICs, self-renewal capacity, and chemoresistance in TNBC experimental models. Significantly, the combination of docetaxel (DTX) with dual TGF-beta and AURKA pharmacologic targeting impaired tumor relapse and the emergence of distant metastasis. We also showed in unique chemoresistant TNBC cells isolated from patient-derived TNBC brain metastasis that dual TGF-beta and AURKA pharmacologic targeting reversed cancer plasticity and enhanced the sensitivity of TNBC cells to DTX-based-chemotherapy. Taken together, these findings reveal for the first time the critical role of AURKA oncogenic signaling in mediating TGF-beta-induced TNBC plasticity, chemoresistance, and tumor progression.	[Jalalirad, Mohammad; Haddad, Tufia C.; Zhang, Minzhi; Yu, Jia; Wang, Liewei; Liu, Minetta C.; Galanis, Evanthia; Ingle, James N.; Goetz, Matthew P.; D'Assoro, Antonino B.] Mayo Clin, Dept Oncol, Coll Med, Rochester, MN 55905 USA; [Salisbury, Jeffrey L.; Radisky, Derek; Leof, Eduard] Mayo Clin, Dept Biochem & Mol Biol, Coll Med, Rochester, MN USA; [Schroeder, Mark; Tuma, Ann; Sarkaria, Jann] Mayo Clin, Dept Radiat Oncol, Coll Med, Rochester, MN USA; [Carter, Jodi M.; Liu, Minetta C.] Mayo Clin, Dept Lab Med & Pathol, Coll Med, Rochester, MN USA; [Degnim, Amy C.; Boughey, Judy C.] Mayo Clin, Dept Surg, Coll Med, Rochester, MN USA; [Zammataro, Luca] Yale Univ, Dept Oncol, New Heaven, CT USA; [Malatino, Lorenzo] Univ Catania, Dept Clin & Expt Med, Catania, Italy; [Galanis, Evanthia] Mayo Clin, Dept Mol Med, Coll Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Yale University; University of Catania; Mayo Clinic	D'Assoro, AB (corresponding author), Mayo Clin, Dept Oncol, Coll Med, Rochester, MN 55905 USA.	dassoro.antonio@mayo.edu	Malatino, Lorenzo/I-7319-2018	Malatino, Lorenzo/0000-0003-2944-2729; Carter, Jodi/0000-0002-5973-0732	Intramural RECDA; Nan Sawyer Award; Randy Shaver Cancer Research and Community Fund; Mayo Clinic Breast Cancer Specialized Program of Research Excellence (SPORE) NIH [CA116201]; Mayo Clinic Breast Cancer SPORE NIH [CA116201]; Prospect Creek Foundation; Mayo Clinic Comprehensive Cancer Center;  [NCI-CA214893];  [NCI-CA72836]	Intramural RECDA; Nan Sawyer Award; Randy Shaver Cancer Research and Community Fund; Mayo Clinic Breast Cancer Specialized Program of Research Excellence (SPORE) NIH; Mayo Clinic Breast Cancer SPORE NIH; Prospect Creek Foundation; Mayo Clinic Comprehensive Cancer Center; ; 	This study was supported by Intramural RECDA, The Nan Sawyer Award, the Randy Shaver Cancer Research and Community Fund, the Mayo Clinic Breast Cancer Specialized Program of Research Excellence (SPORE) NIH CA116201 Developmental Research Program, and NCI-CA214893 to ABD, NCI-CA72836 to JLS, the Mayo Clinic Breast Cancer SPORE NIH CA116201 to JI and MG, the Prospect Creek Foundation to EG, and the Mayo Clinic Comprehensive Cancer Center.	Ahmad A, 2019, ADV EXP MED BIOL, V1152, P1, DOI 10.1007/978-3-030-20301-6_1; Alamgeer M, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3648; Ascolani G, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004199; Bhola NE, 2013, J CLIN INVEST, V123, P1348, DOI 10.1172/JCI65416; Bierie B, 2008, CANCER RES, V68, P1809, DOI 10.1158/0008-5472.CAN-07-5597; Boss DS, 2009, ONCOLOGIST, V14, P780, DOI 10.1634/theoncologist.2009-0019; Cammareri P, 2010, CANCER RES, V70, P4655, DOI 10.1158/0008-5472.CAN-09-3953; Chiorean R, 2013, BREAST, V22, P1026, DOI 10.1016/j.breast.2013.08.007; Connolly EC, 2011, CANCER RES, V71, P2339, DOI 10.1158/0008-5472.CAN-10-2941; D'Assoro AB, 2014, ONCOGENE, V33, P599, DOI 10.1038/onc.2012.628; D'Assoro AB, 2002, ONCOGENE, V21, P6146, DOI 10.1038/sj.onc.1205772; D'Assoro AB, 2016, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00295; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; de Carcer G, 2014, NAT CELL BIOL, V16, P504, DOI 10.1038/ncb2978; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dutertre S, 2002, ONCOGENE, V21, P6175, DOI 10.1038/sj.onc.1205775; Goepfert TM, 2007, INT J CANCER, V120, P985, DOI 10.1002/ijc.22420; Haddad TC, 2018, BREAST CANCER RES TR, V168, P639, DOI 10.1007/s10549-017-4616-7; Huddle BC, 2018, J MED CHEM, V61, P8754, DOI 10.1021/acs.jmedchem.8b00930; Hwang-Verslues WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008377; Jiang HL, 2015, ONCOTARGET, V6, P16352, DOI 10.18632/oncotarget.3877; Karicheva O, 2016, ONCOTARGET, V7, P64109, DOI 10.18632/oncotarget.11627; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Lee YY, 2012, CANCER RES, V72, DOI [10.1158/1538-7445.AM2012-4651, 10.1158/0008-5472.CAN-12-2397]; Leontovich AA, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-1020-0; Leontovich AA, 2013, ONCOL REP, V29, P1785, DOI 10.3892/or.2013.2313; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lyons TG, 2019, ADV EXP MED BIOL, V1152, P377, DOI 10.1007/978-3-030-20301-6_20; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Moreira MP, 2018, EXP CELL RES, V363, P283, DOI 10.1016/j.yexcr.2018.01.018; Motomura H, 2020, ANTICANCER RES, V40, P35, DOI 10.21873/anticanres.13924; Ohmine S, 2018, ONCOL REP, V39, P1725, DOI 10.3892/or.2018.6239; Opyrchal M, 2017, ONCOTARGET, V8, P91803, DOI 10.18632/oncotarget.20610; Opyrchal M, 2014, INT J ONCOL, V45, P1193, DOI 10.3892/ijo.2014.2523; Pandy JGP, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6253-5; Perera M., 2010, Cancer Genomics & Proteomics, V7, P217; Shionome Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055457; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Siggelkow W, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-562; Smith AL, 2012, CLIN CANCER RES, V18, P4514, DOI 10.1158/1078-0432.CCR-11-3224; Sridharan S, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01311; Staff S, 2010, ONCOL REP, V23, P307, DOI 10.3892/or_00000637; Szasz AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056707; Tan AR, 2009, BREAST CANCER RES TR, V115, P453, DOI 10.1007/s10549-008-0184-1; Taylor MA, 2011, GENE EXPRESSION, V15, P117, DOI 10.3727/105221611X13176664479322; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wahdan-Alaswad R, 2016, CELL CYCLE, V15, P1046, DOI 10.1080/15384101.2016.1152432; Yagata H, 2011, BREAST CANCER-TOKYO, V18, P165, DOI 10.1007/s12282-011-0254-9; Yang G, 2013, INT J CANCER, V133, P275, DOI 10.1002/ijc.28032; Zhang L, 2013, MOL CELL, V51, P559, DOI 10.1016/j.molcel.2013.07.014; Zheng FM, 2014, MOL CANCER THER, V13, P1991, DOI 10.1158/1535-7163.MCT-13-1029	52	15	15	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2021	40	14					2509	2523		10.1038/s41388-021-01711-x	http://dx.doi.org/10.1038/s41388-021-01711-x		MAR 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RK3YE	33674749	Green Published, hybrid			2022-12-26	WOS:000625607100005
J	Xu, Z; Wu, B; Topcu, U				Xu, Zhe; Wu, Bo; Topcu, Ufuk			Control strategies for COVID-19 epidemic with vaccination, shield immunity and quarantine: A metric temporal logic approach	PLOS ONE			English	Article								Ever since the outbreak of the COVID-19 epidemic, various public health control strategies have been proposed and tested against the coronavirus SARS-CoV-2. We study three specific COVID-19 epidemic control models: the susceptible, exposed, infectious, recovered (SEIR) model with vaccination control; the SEIR model with shield immunity control; and the susceptible, un-quarantined infected, quarantined infected, confirmed infected (SUQC) model with quarantine control. We express the control requirement in metric temporal logic (MTL) formulas (a type of formal specification languages) which can specify the expected control outcomes such as "the deaths from the infection should never exceed one thousand per day within the next three months" or "the population immune from the disease should eventually exceed 200 thousand within the next 100 to 120 days". We then develop methods for synthesizing control strategies with MTL specifications. To the best of our knowledge, this is the first paper to systematically synthesize control strategies based on the COVID-19 epidemic models with formal specifications. We provide simulation results in three different case studies: vaccination control for the COVID-19 epidemic with model parameters estimated from data in Lombardy, Italy; shield immunity control for the COVID-19 epidemic with model parameters estimated from data in Lombardy, Italy; and quarantine control for the COVID-19 epidemic with model parameters estimated from data in Wuhan, China. The results show that the proposed synthesis approach can generate control inputs such that the time-varying numbers of individuals in each category (e.g., infectious, immune) satisfy the MTL specifications. The results also show that early intervention is essential in mitigating the spread of COVID-19, and more control effort is needed for more stringent MTL specifications. For example, based on the model in Lombardy, Italy, achieving less than 100 deaths per day and 10000 total deaths within 100 days requires 441.7% more vaccination control effort than achieving less than 1000 deaths per day and 50000 total deaths within 100 days.	[Xu, Zhe] Arizona State Univ, Sch Engn Matter Transport & Energy, Tempe, AZ 85287 USA; [Wu, Bo; Topcu, Ufuk] Univ Texas Austin, Oden Inst Computat Engn & Sci, Austin, TX 78712 USA; [Topcu, Ufuk] Univ Texas Austin, Dept Aerosp Engn & Engn Mech, Austin, TX 78712 USA	Arizona State University; Arizona State University-Tempe; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Xu, Z (corresponding author), Arizona State Univ, Sch Engn Matter Transport & Energy, Tempe, AZ 85287 USA.	xzhe1@asu.edu		Topcu, Ufuk/0000-0003-0819-9985	National Science Foundation; NSF [1652113]	National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	This study was funded by the National Science Foundation (https://nsf.gov) in the form of a grant (No. NSF 1652113) awarded to all authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Houssam, 2014, 2014 American Control Conference, P2312, DOI 10.1109/ACC.2014.6859453; Alonso-Quesada S, 2012, ADV DIFFER EQU-NY, DOI 10.1186/1687-1847-2012-161; Beal LDR, 2018, PROCESSES, V6, DOI 10.3390/pr6080106; Bertozzi AL, 2020, P NATL ACAD SCI USA, V117, P16732, DOI 10.1073/pnas.2006520117; Callaway E, 2020, NATURE, V580, P576, DOI 10.1038/d41586-020-01221-y; Carcione JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00230; Chen Z., 2020, LONDON SCH EC POLITI, P105064; Coogan S, 2016, IEEE T CONTROL NETW, V3, P162, DOI 10.1109/TCNS.2015.2428471; de Pinho MD, 2015, LECT NOTES ELECTR EN, V321, P135, DOI 10.1007/978-3-319-10380-8_14; Della Rossa F, 2020, NAT COMMUN, V11, DOI [10.1038/s41467-020-16343-0, 10.1038/s41467-020-18827-5]; Donze A, 2015, EPIC SERIES COMPUTER, V34, P160; Ediriweera  DS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238340; Elie R, 2020, MATH MODEL NAT PHENO, V15, DOI 10.1051/mmnp/2020022; Fainekos GE, 2009, THEOR COMPUT SCI, V410, P4262, DOI 10.1016/j.tcs.2009.06.021; Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387; Gupte A, 2013, SIAM J OPTIMIZ, V23, P721, DOI 10.1137/110836183; Hibbard M., 2020, 21 IFAC WORLD C; Kress-Gazit H, 2009, IEEE T ROBOT, V25, P1370, DOI 10.1109/TRO.2009.2030225; Kwan-Ho Lin, 2002, 2002 7th International Conference on Control, Automation, Robotics and Vision (IEEE Cat. No.02EX649), P980; Liu FL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238280; Liu Z., 2017, 2017 IEEE 56 ANN C D, P4452; Liu Z., 2020, IEEE T CONTROL NETW; Liu ZY, 2017, P AMER CONTR CONF, P2516, DOI 10.23919/ACC.2017.7963331; MCCORMICK GP, 1976, MATH PROGRAM, V10, P147, DOI 10.1007/BF01580665; Nikou A., 2015, ABS150909137 CORR; Pappas GJ., 2006, LNCS, V4262; Raman V, 2012, IEEE INT C INT ROBOT, P251, DOI 10.1109/IROS.2012.6385935; Saha S, 2016, P AMER CONTR CONF, P1105, DOI 10.1109/ACC.2016.7525063; Schrijver A., 1998, THEORY LINEAR INTEGE; Smith S. L., 2010, 2010 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2010), P3288, DOI 10.1109/IROS.2010.5650896; Stewart G, 2020, IEEE SPECTRUM, V57, P22, DOI 10.1109/MSPEC.2020.9099929; Topcu U, 2020, P INT C AUT AG MULT; Ulusoy A, 2011, IEEE INT C INT ROBOT, P3087, DOI 10.1109/IROS.2011.6048524; Verginis CK, 2019, IEEE INT CONF ROBOT, P951, DOI 10.1109/ICRA.2019.8794000; Weitz J., 2020, NAT MED, P849; Winn AK, 2013, P AMER CONTR CONF, P4374; Wolff EM, 2013, IEEE INT C INT ROBOT, P4332, DOI 10.1109/IROS.2013.6696978; Xu Z., IEEE SYST J; Xu Z, 2019, PROCEEDINGS OF THE TWENTY-EIGHTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P4010; Xu Z, 2020, P AMER CONTR CONF, P4745, DOI 10.23919/ACC45564.2020.9147949; Xu Z, 2019, ANN ALLERTON CONF, P1015, DOI 10.1109/ALLERTON.2019.8919727; Xu Z, 2018, P AMER CONTR CONF, P1580; Xu Z, 2017, P AMER CONTR CONF, P1874, DOI 10.23919/ACC.2017.7963225; Xu ZM, 2018, INT J ADV ROBOT SYST, V15, DOI 10.1177/1729881418763458; Yang P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236857; Zhang L, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003240; Zhao SL, 2020, QUANT BIOL, V8, P11, DOI 10.1007/s40484-020-0199-0; Zheng NN, 2020, IEEE T CYBERNETICS, V50, P2891, DOI 10.1109/TCYB.2020.2990162	49	18	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0247660	10.1371/journal.pone.0247660	http://dx.doi.org/10.1371/journal.pone.0247660			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667241	Green Submitted, gold, Green Published			2022-12-26	WOS:000626604300006
J	Majam, M; Fischer, A; Phiri, J; Venter, F; Lalla-Edward, ST				Majam, Mohammed; Fischer, Alex; Phiri, Jane; Venter, Francois; Lalla-Edward, Samanta T.			International citizen project to assess early stage adherence to public health measures for COVID-19 in South Africa	PLOS ONE			English	Article								Introduction With over 500 000 infections and nearly 12 000 deaths, South Africa (SA) is the African epicenter of the current Coronavirus (COVID-19) pandemic. SA has implemented a 5-stage Risk-Adjusted Strategy which includes a phased national lockdown, requiring social distancing, frequent hand washing and wearing face masks. Strict adherence to this strategy is crucial to reducing COVID-19 transmission, flattening the curve, and preventing resurgence. As part of the 22-country International Citizens Project COVID-19 (ICPcovid), this study aimed to describe the SA adherence to the Risk-Adjusted Strategy and identify determinants of adherence. Method During 24 April-15 May 2020, people were electronically invited, through social media platforms and a text blast, to complete an online survey, accessible via www.icpcovid.com. The survey investigated COVID-19 testing and preventative adherence measures, then used logistic regression analysis to identify predictors of adherence. Results There were 951 participants, with 731(76.9%) 25 to 54 years. Most (672;70.7%) were female, and 705(74.1%) had a university degree. Since the epidemic started, 529(55.6%) and 436(45.9%) participants stated they were eating healthier and taking more vitamins, respectively. Only 82(8.6%) had been COVID-19 tested, and 1(1.2%) tested positive. In public, 905(95.2%) socially distanced, however 99(10.4%) participants had recently attended meetings with over ten people. Regular hand washing was practiced by 907 (95.4%) participants, 774(81.4%) wore face masks and 854(89.8%) stayed home when they experienced flu-like symptoms. The odds of adhering to the guidelines were lower among men versus women (AOR 0.72, 95% confidence interval [CI] = 0.528, 0.971) and those who had flu-like symptoms (AOR 0.42, 95% CI = 0.277, 0.628). In contrast, increased odds were reported for those who reported increased vitamin intake (AOR 1.37, 95% CI = 1.044,1.798), and were either cohabiting or married (AOR 1.39, 95% CI = 1.042,1.847). Conclusion Despite high reported adherence, face mask use and symptomatic individuals not self-isolating, were areas for improvement. However, these factors cannot solely account for SA's increasing COVID-19 cases. Larger general population studies are needed to identify other adherence predictors for a strengthened SA COVID-19 response. While the government must continue to educate the entire population on preventative measures, provide personal protective equipment and stress the importance of adherence, there also needs to be implementation of prioritised prevention strategies for men and single individuals to address their demonstrated lower adherence.	[Majam, Mohammed; Fischer, Alex; Phiri, Jane; Venter, Francois; Lalla-Edward, Samanta T.] Univ Witwatersrand, Fac Hlth Sci, Ezintsha, Johannesburg, South Africa	University of Witwatersrand	Fischer, A (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Ezintsha, Johannesburg, South Africa.	fischermhealth@gmail.com	Lalla-Edward, Samanta Tresha/H-9379-2019	Lalla-Edward, Samanta Tresha/0000-0003-3597-1643; Majam, Mohammed/0000-0003-0302-5353				Aloui-Zarrouk Z., 2020, AAS OPEN RES, V3, P36, DOI [10.12688/aasopenres.13079.1, DOI 10.12688/AASOPENRES.13079.1]; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], 2020, NEW ENGL J MED; Arndt C, 2020, GLOB FOOD SECUR-AGR, V26, DOI 10.1016/j.gfs.2020.100410; Baker P, 2020, LANCET, V395, P1886, DOI 10.1016/S0140-6736(20)31303-9; Briscese G, NBER WORKING PAPER S, V26916; Chirove W, 2020, MODELLING POTENTIAL, DOI 21.20074492; Villela EFD, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10222-z; European Centre for Disease Prevention and Control, 2020, ALG MAN CONT PROB CO; Geldsetzer P, 2020, J MED INTERNET RES, V22, DOI 10.2196/18790; Gershon RR, 2018, DISASTER MED PUBLIC, V12, P528, DOI 10.1017/dmp.2017.96; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Hunter JC, 2020, LANCET; International Citizens Project, 2020, INT CIT PROJ ASS ADH; Jain Ronak, 2020, LABOR MARKET POVERTY; Klein SL, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008570; Li Q., 2020, NEW ENGL J MED, V382, P1199; National Department of Health South Africa, 2020, COVID 19 ONL RES NEW; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Ramaphosa C, COMMUNICATION 0323; Saab R, 2020, CANCER-AM CANCER SOC, V126, P4235, DOI 10.1002/cncr.33075; Salari N, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00589-w; Smith J, 2020, INT J MENS SOCIAL CO, V3, P48, DOI DOI 10.22374/IJMSCH.V3I1.42; Statistics South Africa, 2018, DO WOM FAR S AFR LAB; UNAIDS, 2017, BLIND SPOT ADDR BLIN; Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2; World Medical Association, 2013, JAMA-J AM MED ASSOC; Zhao ZB, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138959; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	30	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0248055	10.1371/journal.pone.0248055	http://dx.doi.org/10.1371/journal.pone.0248055			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33662020	gold, Green Published			2022-12-26	WOS:000626604100107
J	Schineis, C; Ullrich, A; Lehmann, KS; Holmer, C; Lauscher, JC; Weixler, B; Kreis, ME; Seifarth, C				Schineis, Christian; Ullrich, Andrea; Lehmann, Kai S.; Holmer, Christoph; Lauscher, Johannes C.; Weixler, Benjamin; Kreis, Martin E.; Seifarth, Claudia			Microscopic inflammation in ileocecal specimen does not correspond to a higher anastomotic leakage rate after ileocecal resection in Crohn's disease	PLOS ONE			English	Article								Background Patients with Crohn's disease suffer from a higher rate of anastomotic leakages after ileocecal resection than patients without Crohn's disease. Our hypothesis was that microscopic inflammation at the resection margins of ileocecal resections in Crohn's disease increases the rate of anastomotic leakages. Patients and methods In a retrospective cohort study, 130 patients with Crohn's disease that underwent ileocecal resection between 2015 and 2019, were analyzed. Anastomotic leakage was the primary outcome parameter. Inflammation at the resection margin was characterized as "inflammation at proximal resection margin", "inflammation at distal resection margin" or "inflammation at both ends". Results 46 patients (35.4%) showed microscopic inflammation at the resection margins. 17 patients (13.1%) developed anastomotic leakage. No difference in the rate of anastomotic leakages was found for proximally affected resection margins (no anastomotic leakage vs. anastomotic leakage: 20.3 vs. 35.3%, p = 0.17), distally affected resection margins (2.7 vs. 5.9%, p = 0.47) or inflammation at both ends (9.7 vs. 11.8%, p = 0.80). No effect on the anastomotic leakage rate was found for preoperative hemoglobin concentration (no anastomotic leakage vs. anastomotic leakage: 12.3 vs. 13.5 g/dl, p = 0.26), perioperative immunosuppressive medication (62.8 vs. 52.9%, p = 0.30), BMI (21.8 vs. 22.4 m(2)/kg, p = 0.82), emergency operation (21.2 vs. 11.8%, p = 0.29), laparoscopic vs. open procedure (p = 0.58), diverting ileostomy (31.9 vs. 57.1%, p = 0.35) or the level of surgical training (staff surgeon: 80.5 vs. 76.5%, p = 0.45). Conclusion Microscopic inflammation at the resection margins after ileocecal resection in Crohn's disease is common. Histologically inflamed resection margins do not appear to affect the rate of anastomotic leakages. Our data suggest that there is no need for extensive resections or frozen section to achieve microscopically inflammation-free resection margins.	[Schineis, Christian; Lehmann, Kai S.; Lauscher, Johannes C.; Weixler, Benjamin; Kreis, Martin E.; Seifarth, Claudia] Charite Univ Med Berlin, Dept Surg, Berlin, Germany; [Schineis, Christian; Ullrich, Andrea; Lehmann, Kai S.; Lauscher, Johannes C.; Weixler, Benjamin; Kreis, Martin E.; Seifarth, Claudia] Free Univ Berlin, Berlin, Germany; [Schineis, Christian; Ullrich, Andrea; Lehmann, Kai S.; Lauscher, Johannes C.; Weixler, Benjamin; Kreis, Martin E.; Seifarth, Claudia] Humboldt Univ, Berlin, Germany; [Schineis, Christian; Ullrich, Andrea; Lehmann, Kai S.; Lauscher, Johannes C.; Weixler, Benjamin; Kreis, Martin E.; Seifarth, Claudia] Berlin Inst Hlth, Berlin, Germany; [Ullrich, Andrea] Charite Univ Med Berlin, Dept Pathol, Berlin, Germany; [Holmer, Christoph] St Joseph Hosp, Dept Surg, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Seifarth, C (corresponding author), Charite Univ Med Berlin, Dept Surg, Berlin, Germany.; Seifarth, C (corresponding author), Free Univ Berlin, Berlin, Germany.; Seifarth, C (corresponding author), Humboldt Univ, Berlin, Germany.; Seifarth, C (corresponding author), Berlin Inst Hlth, Berlin, Germany.	claudia.seifarth@charite.de	Lauscher, Johannes/ABF-5142-2020	Kreis, Martin E./0000-0002-9312-4840; Lehmann, Kai/0000-0003-0479-3821; Seifarth, Claudia/0000-0001-6102-4338; Schineis, Christian/0000-0001-9189-6751				Aaltonen G, 2018, SCAND J GASTROENTERO, V53, P279, DOI 10.1080/00365521.2018.1435717; Abdalla S, 2019, J CROHNS COLITIS, V13, P1510, DOI 10.1093/ecco-jcc/jjz091; Alves A, 2007, DIS COLON RECTUM, V50, P331, DOI 10.1007/s10350-006-0782-0; Coakley KM, 2018, J SURG RES, V232, P43, DOI 10.1016/j.jss.2018.04.012; Cocorullo G, 2016, G CHIR, V37, P220, DOI 10.11138/gchir/2016.37.5.220; Fumery M, 2017, AM J GASTROENTEROL, V112, P337, DOI 10.1038/ajg.2016.541; Gajendran M, 2018, DM-DIS MON, V64, P20, DOI 10.1016/j.disamonth.2017.07.001; Galata C, 2019, INT J COLORECTAL DIS, V34, P293, DOI 10.1007/s00384-018-3196-2; Galata C, 2018, INT J COLORECTAL DIS, V33, P937, DOI 10.1007/s00384-018-3072-0; Garofalo E, 2019, INT J COLORECTAL DIS, V34, P1585, DOI 10.1007/s00384-019-03358-3; Ghoneima AS, 2019, INT J COLORECTAL DIS, V34, P2185, DOI 10.1007/s00384-019-03427-7; Kuhn F, 2018, ZBL CHIR, V143, P596, DOI 10.1055/a-0645-1489; Luglio G, 2019, TECH COLOPROCTOL, V23, P1093, DOI 10.1007/s10151-019-02105-8; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; PENNINGTON L, 1980, ANN SURG, V192, P311, DOI 10.1097/00000658-198009000-00006; Ponsioen CY, 2017, LANCET GASTROENTEROL, V2, P785, DOI 10.1016/S2468-1253(17)30248-0; POST S, 1991, ANN SURG, V213, P37, DOI 10.1097/00000658-199101000-00007; Resegotti A, 2005, DIS COLON RECTUM, V48, P464, DOI 10.1007/s10350-004-0786-6; Shental O, 2012, DIS COLON RECTUM, V55, P1125, DOI 10.1097/DCR.0b013e318267c74c; Yamamoto T, 2020, COLORECTAL DIS, V22, P554, DOI 10.1111/codi.14922; Yamamoto T, 2000, DIS COLON RECTUM, V43, P1141, DOI 10.1007/BF02236563; Zurbuchen U, 2013, LANGENBECK ARCH SURG, V398, P467, DOI 10.1007/s00423-012-0904-1	22	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0247796	10.1371/journal.pone.0247796	http://dx.doi.org/10.1371/journal.pone.0247796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33661983	gold, Green Published			2022-12-26	WOS:000626604100098
J	McAndrews, KM; Che, SPY; LeBleu, VS; Kalluri, R				McAndrews, Kathleen M.; Che, Sara P. Y.; LeBleu, Valerie S.; Kalluri, Raghu			Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR VESICLES; INTERCELLULAR COMMUNICATION; CANCER; PLATFORM; ADJUVANT; PATHWAY; SYSTEM	The Stimulator of Interferon Genes (STING) pathway is implicated in the innate immune response and is important in both oncogenesis and cancer treatment. Specifically, activation of the cytosolic DNA sensor STING in antigen-presenting cells (APCs) induces a type I interferon response and cytokine production that facilitates antitumor immune therapy. However, use of STING agonists (STINGa) as a cancer therapeutic has been limited by unfavorable pharmacological properties and targeting inefficiency due to rapid clearance and limited uptake into the cytosol. Exosomes, a class of extracellular vesicles shed by all cells are under consideration for their use as effective carriers of drugs owing to their innate ability to be taken up by cells and their biocompatibility for optimal drug biodistribution. Therefore, we engineered exosomes to deliver the STING agonist cyclic GMP-AMP (iExo(STINGa)), to exploit their favorable pharmacokinetics and pharmacodynamics. Selective targeting of the STING pathway in APCs with iExo(STINGa) was associated with superior potency compared with STINGa alone in suppressing B16F10 tumor growth. Moreover, iExo(STINGa) showed superior uptake of STINGa into dendritic cells compared with STINGa alone, which led to increased accumulation of activated CD8(+) T-cells and an antitumor immune response. Our study highlights the potential of exosomes in general, and iExo(STINGa) specifically, in enhancing cancer therapy outcomes.	[McAndrews, Kathleen M.; Che, Sara P. Y.; LeBleu, Valerie S.; Kalluri, Raghu] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [LeBleu, Valerie S.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Kalluri, Raghu] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Kalluri, Raghu] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Northwestern University; Feinberg School of Medicine; Rice University; Baylor College of Medicine	Kalluri, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.; Kalluri, R (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.; Kalluri, R (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	rkalluri@mdanderson.org	Kalluri, Raghu/E-2677-2015	Kalluri, Raghu/0000-0002-2190-547X; McAndrews, Kathleen/0000-0002-4092-4991	MD Anderson Cancer Center	MD Anderson Cancer Center	This work was primarily supported by funds from MD Anderson Cancer Center to R. K.	Baird JR, 2018, CANCER RES, V78, P6308, DOI 10.1158/0008-5472.CAN-18-1652; Batrakova EV, 2015, J CONTROL RELEASE, V219, P396, DOI 10.1016/j.jconrel.2015.07.030; Diamond JM, 2018, CANCER IMMUNOL RES, V6, P910, DOI 10.1158/2326-6066.CIR-17-0581; Kugeratski FG, 2021, FEBS J, V288, P10, DOI 10.1111/febs.15558; Gentili M, 2015, SCIENCE, V349, P1232, DOI 10.1126/science.aab3628; Gonzalez H, 2018, GENE DEV, V32, P1267, DOI 10.1101/gad.314617.118; Gutierrez-Vazquez C, 2013, IMMUNOL REV, V251, P125, DOI 10.1111/imr.12013; Hoong Brandon Yi Da, 2020, Oncotarget, V11, P2930, DOI 10.18632/oncotarget.27673; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Junkins RD, 2018, J CONTROL RELEASE, V270, P1, DOI 10.1016/j.jconrel.2017.11.030; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Kamerkar S, 2017, NATURE, V546, P498, DOI 10.1038/nature22341; Koshy ST, 2017, ADV BIOSYST, V1, DOI 10.1002/adbi.201600013; Le Naour J, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1777624; LeBleu VS, 2020, TRENDS CANCER, V6, P767, DOI 10.1016/j.trecan.2020.03.007; Luan X, 2017, ACTA PHARMACOL SIN, V38, P754, DOI 10.1038/aps.2017.12; Luteijn RD, 2019, NATURE, V573, P434, DOI 10.1038/s41586-019-1553-0; Ma Z, 2015, P NATL ACAD SCI USA, V112, pE4306, DOI 10.1073/pnas.1503831112; Mendt M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99263; Miyabe H, 2014, J CONTROL RELEASE, V184, P20, DOI 10.1016/j.jconrel.2014.04.004; Aval LM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9103323; Nguyen TA, 2017, MOL IMMUNOL, V86, P16, DOI 10.1016/j.molimm.2016.10.002; Pitt JM, 2016, J CLIN INVEST, V126, P1139, DOI 10.1172/JCI87316; Reus JB, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020137; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Rutman AK, 2018, ENDOCRINOLOGY, V159, P3834, DOI 10.1210/en.2018-00649; Sharma P, 2020, NAT REV IMMUNOL, V20, P75, DOI 10.1038/s41577-020-0275-8; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Torralba D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05077-9; Vanpouille-Box C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15618; Vatner RE, 2019, MOL IMMUNOL, V110, P13, DOI 10.1016/j.molimm.2017.12.001; Watkins-Schulz R, 2019, BIOMATERIALS, V205, P94, DOI 10.1016/j.biomaterials.2019.03.011; Wilson DR, 2018, NANOMED-NANOTECHNOL, V14, P237, DOI 10.1016/j.nano.2017.10.013; Wu JJ, 2020, MED RES REV, V40, P1117, DOI 10.1002/med.21649; Zhou XN, 2020, CANCER SCI, V111, P3100, DOI 10.1111/cas.14563; Zhang YG, 2014, J IMMUNOL, V193, P2394, DOI 10.4049/jimmunol.1302718; Zhu YY, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1087-y	38	13	13	6	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100523	10.1016/j.jbc.2021.100523	http://dx.doi.org/10.1016/j.jbc.2021.100523			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33711340	Green Published, gold			2022-12-26	WOS:000672866400497
J	Peskin, AV; Meotti, FC; Kean, KM; Gobl, C; Peixoto, AS; Pace, PE; Horne, CR; Heath, SG; Crowther, JM; Dobson, RCJ; Karplus, PA; Winterbourn, CC				Peskin, Alexander, V; Meotti, Flavia C.; Kean, Kelsey M.; Gobl, Christoph; Peixoto, Albert Souza; Pace, Paul E.; Horne, Christopher R.; Heath, Sarah G.; Crowther, Jennifer M.; Dobson, Renwick C. J.; Karplus, P. Andrew; Winterbourn, Christine C.			Modifying the resolving cysteine affects the structure and hydrogen peroxide reactivity of peroxiredoxin 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATE; TRANSITION; CATALYSIS; DYNAMICS; MODEL; SUITE	Peroxiredoxin 2 (Prdx2) is a thiol peroxidase with an active site Cys (C52) that reacts rapidly with H2O2 and other peroxides. The sulfenic acid product condenses with the resolving Cys (C172) to form a disulfide which is recycled by thioredoxin or GSH via mixed disulfide intermediates or undergoes hyperoxidation to the sulfinic acid. C172 lies near the C terminus, outside the active site. It is not established whether structural changes in this region, such as mixed disulfide formation, affect H2O2 reactivity. To investigate, we designed mutants to cause minimal (C172S) or substantial (C172D and C172W) structural disruption. Stopped flow kinetics and mass spectrometry showed that mutation to Ser had minimal effect on rates of oxidation and hyperoxidation, whereas Asp and Trp decreased both by similar to 100-fold. To relate to structural changes, we solved the crystal structures of reduced WT and C172S Prdx2. The WT structure is highly similar to that of the published hyperoxidized form. C172S is closely related but more flexible and as demonstrated by size exclusion chromatography and analytical ultracentrifugation, a weaker decamer. Size exclusion chromatography and analytical ultracentrifugation showed that the C172D and C172W mutants are also weaker decamers than WT, and small-angle X-ray scattering analysis indicated greater flexibility with partially unstructured regions consistent with C-terminal unfolding. We propose that these structural changes around C172 negatively impact the active site geometry to decrease reactivity with H2O2. This is relevant for Prdx turnover as intermediate mixed disulfides with C172 would also be disruptive and could potentially react with peroxides before resolution is complete.	[Peskin, Alexander, V; Gobl, Christoph; Pace, Paul E.; Heath, Sarah G.; Winterbourn, Christine C.] Univ Otago Christchurch, Dept Pathol & Biomed Sci, Christchurch, New Zealand; [Meotti, Flavia C.; Peixoto, Albert Souza] Univ Sao Paulo, Chem Inst, Dept Biochem, Sao Paulo, SP, Brazil; [Kean, Kelsey M.; Karplus, P. Andrew] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Horne, Christopher R.; Crowther, Jennifer M.; Dobson, Renwick C. J.] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand; [Kean, Kelsey M.] Univ N Carolina, Dept Chem, Chapel Hill, NC USA	University of Otago; Universidade de Sao Paulo; Oregon State University; University of Canterbury; University of North Carolina; University of North Carolina Chapel Hill	Winterbourn, CC (corresponding author), Univ Otago Christchurch, Dept Pathol & Biomed Sci, Christchurch, New Zealand.; Karplus, PA (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.	andy.karplus@oregonstate.edu; christine.winterbourn@otago.ac.nz	Dobson, Renwick/AAZ-7020-2021; Peixoto, Álbert Souza/E-4532-2018	Dobson, Renwick/0000-0002-5506-4939; Peixoto, Álbert Souza/0000-0002-7234-7252; peskin, alexander/0000-0001-9890-6043; Gobl, Christoph/0000-0001-8614-1434; Horne, Christopher R./0000-0003-1318-514X	Marsden Fund of New Zealand; US National Institutes of Health [R01-GM119227, K12-GM000678]; Health Research Council of New Zealand; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/07937-8, 2018/14898-2, 2015/10411-3]; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]	Marsden Fund of New Zealand(Royal Society of New ZealandMarsden Fund (NZ)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Research Council of New Zealand(Health Research Council of New Zealand); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE))	This work was supported by the Marsden Fund of New Zealand (C. C. W., A. V. P., P. E. P.); by the US National Institutes of Health (grant R01-GM119227 to P. A. K. and K12-GM000678 to K. M. K.); by a Sir Charles Hercus Fellowship from the Health Research Council of New Zealand (C. G.), the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) projects: CEPID-Redoxoma 2013/07937-8, Young Investigator 2018/14898-2 and multi-user equipment 2015/10411-3 grants (Brazil, FM). The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under Contract No. DE-AC0205CH11231. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anschau V, 2020, FREE RADICAL BIO MED, V156, P207, DOI 10.1016/j.freeradbiomed.2020.06.015; Barranco-Medina S, 2008, BIOCHEMISTRY-US, V47, P7196, DOI 10.1021/bi8002956; Barranco-Medina S, 2009, FEBS LETT, V583, P1809, DOI 10.1016/j.febslet.2009.05.029; Bolduc JA, 2018, J BIOL CHEM, V293, P11901, DOI 10.1074/jbc.RA117.001690; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P405, DOI 10.1007/s00249-009-0413-5; Carvalho LAC, 2017, J BIOL CHEM, V292, P8705, DOI 10.1074/jbc.M116.767657; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; Dalla Rizza J, 2019, PROTEIN SCI, V28, P191, DOI 10.1002/pro.3520; Demeler B., 2016, ANAL UNTRACENTRIFUGA; Demeler B, 2008, COLLOID POLYM SCI, V286, P129, DOI 10.1007/s00396-007-1699-4; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kriznik A, 2020, ACS CATAL, V10, P3326, DOI 10.1021/acscatal.9b04471; Kwak MS, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101203; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Loberg MA, 2019, CHEM RES TOXICOL, V32, P474, DOI 10.1021/acs.chemrestox.8b00346; Manta B, 2009, ARCH BIOCHEM BIOPHYS, V484, P146, DOI 10.1016/j.abb.2008.11.017; Nagy P, 2011, J BIOL CHEM, V286, P18048, DOI 10.1074/jbc.M111.232355; Nelson KJ, 2018, ANTIOXID REDOX SIGN, V28, P521, DOI 10.1089/ars.2016.6922; Nelson KJ, 2013, METHOD ENZYMOL, V527, P21, DOI 10.1016/B978-0-12-405882-8.00002-7; Nelson KJ, 2008, BIOCHEMISTRY-US, V47, P12860, DOI 10.1021/bi801718d; Pace PE, 2013, BIOCHEM J, V453, P475, DOI 10.1042/BJ20130030; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Parsonage D, 2015, BIOCHEMISTRY-US, V54, P1567, DOI 10.1021/bi501515w; Pastor-Flores D, 2020, P NATL ACAD SCI USA, V117, P16313, DOI 10.1073/pnas.1915275117; Perkins A, 2016, STRUCTURE, V24, P1668, DOI 10.1016/j.str.2016.07.012; Perkins A, 2015, TRENDS BIOCHEM SCI, V40, P435, DOI 10.1016/j.tibs.2015.05.001; Perkins A, 2013, BIOCHEMISTRY-US, V52, P8708, DOI 10.1021/bi4011573; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Peskin AV, 2020, FREE RADICAL BIO MED, V158, P115, DOI 10.1016/j.freeradbiomed.2020.07.007; Peskin AV, 2016, J BIOL CHEM, V291, P3053, DOI 10.1074/jbc.M115.692798; Peskin AV, 2013, J BIOL CHEM, V288, P14170, DOI 10.1074/jbc.M113.460881; Portillo-Ledesma S, 2018, BIOCHEMISTRY-US, V57, P3416, DOI 10.1021/acs.biochem.8b00188; Reisz JA, 2013, FEBS J, V280, P6150, DOI 10.1111/febs.12535; Rhee SG, 2017, ANNU REV BIOCHEM, V86, P749, DOI 10.1146/annurev-biochem-060815-014431; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Tairum CA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33133; Trujillo M, 2007, ARCH BIOCHEM BIOPHYS, V467, P95, DOI 10.1016/j.abb.2007.08.008; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu JA, 1998, PROTEIN SCI, V7, P158, DOI 10.1002/pro.5560070117	46	6	6	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100494	10.1016/j.jbc.2021.100494	http://dx.doi.org/10.1016/j.jbc.2021.100494			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33667550	gold, Green Published, Green Submitted			2022-12-26	WOS:000672866400468
J	Menko, AS; DeDreu, J; Logan, CM; Paulson, H; Levin, AV; Walker, JL				Menko, A. Sue; DeDreu, JodiRae; Logan, Caitlin M.; Paulson, Heather; Levin, Alex V.; Walker, Janice L.			Resident immune cells of the avascular lens: Mediators of the injury and fibrotic response of the lens	FASEB JOURNAL			English	Article						fibrosis; injury; lens; resident immune cells; wound healing	POSTERIOR CAPSULE; TISSUE; PHAGOCYTOSIS; MACROPHAGES; MONOCYTES; CATARACT; ANTIGEN; REPAIR; CD14; DIFFERENTIATION	Tissues typically harbor subpopulations of resident immune cells that function as rapid responders to injury and whose activation leads to induction of an adaptive immune response, playing important roles in repair and protection. Since the lens is an avascular tissue, it was presumed that it was absent of resident immune cells. Our studies now show that resident immune cells are a shared feature of the human, mouse, and chicken lens epithelium. These resident immune cells function as immediate responders to injury and rapidly populate the wound edge following mock cataract surgery to function as leader cells. Many of these resident immune cells also express MHCII providing them with antigen presenting ability to engage an adaptive immune response. We provide evidence that during development immune cells migrate on the ciliary zonules and localize among the equatorial epithelial cells of the lens adjacent to where the ciliary zonules associate with the lens capsule. These findings suggest that the vasculature-rich ciliary body is a source of lens resident immune cells. We identified a major role for these cells as rapid responders to wounding, quickly populating each wound were they can function as leaders of lens tissue repair. Our findings also show that lens resident immune cells are progenitors of myofibroblasts, which characteristically appear in response to lens cataract surgery injury, and therefore, are likely agents of lens pathologies to impair vision like fibrosis.	[Menko, A. Sue; DeDreu, JodiRae; Logan, Caitlin M.; Paulson, Heather; Walker, Janice L.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Sidney Kimmel Med Coll, Room 571 JAH, Philadelphia, PA 19107 USA; [Menko, A. Sue; Levin, Alex V.; Walker, Janice L.] Thomas Jefferson Univ, Dept Ophthalmol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Levin, Alex V.] Wills Eye Hosp & Res Inst, Philadelphia, PA USA; [Logan, Caitlin M.] Stanford Univ, Mary M & Sash A Spencer Ctr Vision Res, Byers Eye Inst, Palo Alto, CA 94304 USA; [Levin, Alex V.] Univ Rochester, Med Ctr, Flaum Eye Inst, Rochester, NY 14642 USA; [Levin, Alex V.] Univ Rochester, Med Ctr, Golisano Childrens Hosp, Rochester, NY 14642 USA	Jefferson University; Jefferson University; Jefferson University; Stanford University; University of Rochester; University of Rochester	Walker, JL (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Sidney Kimmel Med Coll, Room 571 JAH, Philadelphia, PA 19107 USA.	Janice.Walker@jefferson.edu		Menko, A. Sue/0000-0002-7514-4696	HHS \ NIH \ National Eye Institute (NEI) [EY02615, EY021784]	HHS \ NIH \ National Eye Institute (NEI)	HHS vertical bar NIH vertical bar National Eye Institute (NEI), Grant/Award Number: EY02615 and EY021784	Ancuta P, 2000, EUR J IMMUNOL, V30, P1872, DOI 10.1002/1521-4141(200007)30:7<1872::AID-IMMU1872>3.0.CO;2-2; Arandjelovic S, 2015, NAT IMMUNOL, V16, P907, DOI 10.1038/ni.3253; Ardain A, 2020, IMMUNOLOGY, V159, P245, DOI 10.1111/imm.13143; Beebe DC, 2008, SEMIN CELL DEV BIOL, V19, P125, DOI 10.1016/j.semcdb.2007.08.014; Bleaken BM, 2016, MOL BIOL CELL, V27, P451, DOI 10.1091/mbc.E15-09-0615; Bleriot C, 2020, IMMUNITY, V52, P957, DOI 10.1016/j.immuni.2020.05.014; Blum-Hareuveni T, 2017, AM J OPHTHALMOL, V177, P139, DOI 10.1016/j.ajo.2017.02.023; Boyman O, 2007, TRENDS IMMUNOL, V28, P51, DOI 10.1016/j.it.2006.12.005; Caputa G, 2019, NAT IMMUNOL, V20, P793, DOI 10.1038/s41590-019-0407-0; Chang JL, 2019, J CELL BIOL, V218, P2456, DOI 10.1083/jcb.201903066; CUADROS MA, 1991, CELL TISSUE RES, V266, P117, DOI 10.1007/BF00678718; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Dawson CA, 2020, NAT CELL BIOL, V22, P546, DOI 10.1038/s41556-020-0505-0; De Maria A, 2017, INVEST OPHTH VIS SCI, V58, P573, DOI 10.1167/iovs.16-20866; DeDreu J, 2020, FASEB J, V34, P9316, DOI 10.1096/fj.202000289R; Eom DS, 2017, SCIENCE, V355, P1317, DOI 10.1126/science.aal2745; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Fisus AD, 2020, EYE, V34, P256, DOI 10.1038/s41433-019-0723-5; GIBSON MA, 1986, J BIOL CHEM, V261, P1429; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; GRIFFIN JD, 1981, J CLIN INVEST, V68, P932, DOI 10.1172/JCI110348; Guilliams M, 2020, IMMUNITY, V52, P434, DOI 10.1016/j.immuni.2020.02.015; HAYNES BF, 1989, IMMUNOL TODAY, V10, P423, DOI 10.1016/0167-5699(89)90040-6; Hinz B, 2020, NAT REV RHEUMATOL, V16, P11, DOI 10.1038/s41584-019-0324-5; Hinz Boris, 2010, F1000 Biol Rep, V2, P78, DOI 10.3410/B2-78; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Hu W, 2013, J LEUKOCYTE BIOL, V94, P409, DOI 10.1189/jlb.0413207; Jakubzick CV, 2017, NAT REV IMMUNOL, V17, P349, DOI 10.1038/nri.2017.28; Jancevski M, 2010, DISCOV MED, V9, P51; Jensen AA, 2002, OPHTHALMOLOGY, V109, P324, DOI 10.1016/S0161-6420(01)00950-2; Jiang J, 2018, INVEST OPHTH VIS SCI, V59, P4986, DOI 10.1167/iovs.18-25067; Jiang QQ, 2000, J IMMUNOL, V165, P3541, DOI 10.4049/jimmunol.165.7.3541; Kelley LC, 2014, J CELL BIOL, V204, P291, DOI 10.1083/jcb.201311112; Kim ND, 2015, TRENDS IMMUNOL, V36, P547, DOI 10.1016/j.it.2015.07.007; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Lang RA, 1997, CELL DEATH DIFFER, V4, P12, DOI 10.1038/sj.cdd.4400211; Lavin Y, 2015, NAT REV IMMUNOL, V15, P731, DOI 10.1038/nri3920; Lim JJ, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00191; Liu FM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16158-z; Llop SM, 2018, SEMIN OPHTHALMOL, V33, P64, DOI 10.1080/08820538.2017.1353815; Logan CM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16456-5; Lu JL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01173; Lu WL, 2020, INT J ENDOCRINOL, V2020, DOI 10.1155/2020/8160256; Masopust D, 2019, ANNU REV IMMUNOL, V37, P521, DOI 10.1146/annurev-immunol-042617-053214; Mast J, 1998, VET IMMUNOL IMMUNOP, V61, P343, DOI 10.1016/S0165-2427(97)00152-9; McLeod DS, 2012, INVEST OPHTH VIS SCI, V53, P7912, DOI 10.1167/iovs.12-10140; Menko AS, 2014, MOL BIOL CELL, V25, P776, DOI 10.1091/mbc.E12-12-0900; Minutti CM, 2017, SEMIN CELL DEV BIOL, V61, P3, DOI 10.1016/j.semcdb.2016.08.006; Negahban Kambiz, 2002, Curr Opin Ophthalmol, V13, P419, DOI 10.1097/00055735-200212000-00013; Niederkorn J Y, 1990, Adv Immunol, V48, P191, DOI 10.1016/S0065-2776(08)60755-5; Nishitani K, 2006, EXP EYE RES, V83, P223, DOI 10.1016/j.exer.2005.12.008; Obrosova IG, 2010, DIABETES-METAB RES, V26, P172, DOI 10.1002/dmrr.1075; Oishi Y, 2018, INT IMMUNOL, V30, P511, DOI 10.1093/intimm/dxy054; Pakshir P, 2020, J CELL SCI, V133, DOI 10.1242/jcs.227900; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Raj Shetal M, 2007, Int J Biomed Sci, V3, P237; Richmond JM, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015339; Roche PA, 2015, NAT REV IMMUNOL, V15, P203, DOI 10.1038/nri3818; Rocher M, 2020, EYE, V34, P232, DOI 10.1038/s41433-019-0684-8; SAIKA S, 1992, JPN J OPHTHALMOL, V36, P184; Saika S, 1997, J CATARACT REFR SURG, V23, P787, DOI 10.1016/S0886-3350(97)80292-1; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Shu DY, 2017, PROG RETIN EYE RES, V60, P44, DOI 10.1016/j.preteyeres.2017.08.001; T'Jonck W, 2018, CELL IMMUNOL, V330, P43, DOI 10.1016/j.cellimm.2018.02.005; TODD RF, 1981, J IMMUNOL, V126, P1435; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; UENOYAMA K, 1990, J CATARACT REFR SURG, V16, P465, DOI 10.1016/S0886-3350(13)80800-0; Ursell PG, 2020, EYE, V34, P960, DOI 10.1038/s41433-019-0630-9; Walker JL, 2018, MOL BIOL CELL, V29, P1555, DOI 10.1091/mbc.E17-06-0364; Walker JL, 2007, INVEST OPHTH VIS SCI, V48, P2214, DOI 10.1167/iovs.06-1059; Walker JL, 2015, JOVE-J VIS EXP, DOI 10.3791/52886; Walker JL, 2010, P NATL ACAD SCI USA, V107, P13730, DOI 10.1073/pnas.0910382107; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wu YF, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.135121; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015	76	10	10	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21341	10.1096/fj.202002200R	http://dx.doi.org/10.1096/fj.202002200R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710665	Green Published			2022-12-26	WOS:000635216100097
J	Padilla-Rodriguez, JC; Olivera, MJ; Ahumada-Franco, ML; Paredes-Medina, AE				Cesar Padilla-Rodriguez, Julio; Olivera, Mario J.; Liliana Ahumada-Franco, Martha; Elizabeth Paredes-Medina, Andrea			Malaria risk stratification in Colombia 2010 to 2019	PLOS ONE			English	Article							ANOPHELES DIPTERA-CULICIDAE; NATURAL INFECTIVITY; PLASMODIUM-VIVAX; BITING ACTIVITY; VECTORS; CLASSIFICATION; INTERVENTIONS; MUNICIPALITY; MOSQUITOS; GUAVIARE	Background Heterogeneity and focalization are the most common epidemiological characteristics of endemic countries in the Americas, where malaria transmission is moderate and low. During malaria elimination, the first step is to perform a risk stratification exercise to prioritize interventions. This study aimed to identify malaria risk strata in the ecoepidemiological regions of Colombia. Methods This was a descriptive and retrospective study using cumulative malaria cases in 1,122 municipalities of Colombia from 2010 to 2019. To identify the strata, the criteria proposed by PAHO were adapted. To classify the receptive areas (strata 2, 3, and 4) and nonreceptive areas (stratum 1), 1,600 m above sea level, ecotypes, main malaria vector presence, Plasmodium species prevalence and occurrence of malaria cases were used. The area occupied by the receptive municipalities, the cumulative burden, and the at-risk population in the regions were calculated. Results Ninety-one percent of the Colombian territory is receptive to the transmission of malaria and includes 749 municipalities with 9,734,271 (9,514,243-9,954,299) million at-risk inhabitants. Stratum 4 accounted for 96.7% of the malaria burden, and cases were concentrated primarily in the Pacific and Uraba-Bajo Cauca-Sinu-San Jorge regions. Plasmodium vivax predominates in most of the receptive municipalities, except in the municipalities of the Pacific region, where P. falciparum predominates. Anopheles albimanus, An. nuneztovari s.l., and An. darlingi were the main vectors in receptive areas. Conclusions In Colombia, 91.2% of the territory is receptive to the transmission of malaria and is characterized by being both heterogeneous and focused. Stratum 4 contains the greatest burden of disease, with a relatively greater proportion of municipalities with a predominance of P. vivax. However, there is a low proportion of municipalities with P. falciparum mainly in the Pacific region. These findings suggest that the latter be prioritized within the malaria elimination plan in Colombia.	[Cesar Padilla-Rodriguez, Julio; Elizabeth Paredes-Medina, Andrea] Minist Salud & Protecc Social, Bogota, DC, Colombia; [Olivera, Mario J.] Inst Nacl Salud, Grp Parasitol, Bogota, DC, Colombia; [Liliana Ahumada-Franco, Martha] Inst Nacl Salud, Grp Entomol, Bogota, DC, Colombia	Instituto Nacional de Salud (Colombia); Instituto Nacional de Salud (Colombia)	Olivera, MJ (corresponding author), Inst Nacl Salud, Grp Parasitol, Bogota, DC, Colombia.	molivera@ins.gov.co	Olivera, Mario/T-5486-2018	Olivera, Mario/0000-0002-6885-6353; Padilla-Rodriguez, Julio/0000-0001-7608-9863	National Institute of Health of Colombia	National Institute of Health of Colombia	This study was supported by the National Institute of Health of Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada ML, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1421-4; [Anonymous], 2017, EPIDEMIOLOGY MALARIA, DOI DOI 10.1201/9780203756621; Beales P., 1988, PLANNING MALARIA CON; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Brochero Helena, 2006, Biomed., V26, P269; Brochero HL, 2005, J AM MOSQUITO CONTR, V21, P182, DOI 10.2987/8756-971X(2005)21[182:BAABSO]2.0.CO;2; Brower V, 2001, EMBO REP, V2, P755, DOI 10.1093/embo-reports/kve193; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; DANE, 2018, CENS NAC POBL VIV 20; de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103; Escovar JE, 2014, MEM I OSWALDO CRUZ, V109, P473, DOI 10.1590/0074-0276130596; Escovar JE, 2013, MEM I OSWALDO CRUZ, V108, P1057, DOI 10.1590/0074-0276130256; Espinosa-Velez Y, 2020, TROP MED INT HEALTH, V25, P861, DOI 10.1111/tmi.13399; Grillet ME, 2009, B MALARIOL SALUD AMB, V49, P193; Gutierrez LA, 2008, ACTA TROP, V107, P99, DOI 10.1016/j.actatropica.2008.04.019; Gutierrez LA, 2009, MEM I OSWALDO CRUZ, V104, P1117, DOI 10.1590/S0074-02762009000800008; Instituto Geografico Agustin Codazzi (IGAC), 2018, FRONT LIM ENT TERR, P1; Instituto Nacional de Salud, 2017, B EP SEM SEM 52 2017; Instituto Nacional de Salud, 2017, ACCIDENTE OFIDICO; Instituto Nacional de Salud, 2018, B EP SEM SEM 52 2018; Instituto Nacional de Salud, 2019, B EP SEM SEM 52 2019; Instituto Nacional de Salud, 2019, INF EV MAL; Rodriguez JAI, 2020, REV SOC BRAS MED TRO, V53, DOI 10.1590/0037-8682-0179-2020; Jimenez IP, 2014, J MED ENTOMOL, V51, P1002, DOI 10.1603/ME13146; Jimenez IP, 2014, J AM MOSQUITO CONTR, V30, P91, DOI 10.2987/13-6382.1; Jimenez P, 2012, BIOMEDICA, V32, P13, DOI 10.1590/S0120-41572012000500003; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584; Ministerio de Salud y Proteccion Social, 2020, PLAN ESTR NAC MAL CO; Montoya-Lerma J, 2011, MEM I OSWALDO CRUZ, V106, P223, DOI 10.1590/S0074-02762011000900028; Najera J, 1992, MALARIA NEW PATTERNS; Naranjo-Diaz N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103769; Naranjo-Diaz N, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-61; Olano VA, 2001, BIOMEDICA, V21, P402; Olivera MJ, 2020, AM J TROP MED HYG, V102, P1056, DOI 10.4269/ajtmh.19-0954; Olivera MJ, 2020, INT J INFECT DIS, V91, P196, DOI 10.1016/j.ijid.2019.11.022; Olivera MJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210156; Organizacion Panamericana de la Salud, 2019, ACT EP MAL AM; Organizacion Panamericana de la Salud, 1991, ESTR EP MAL REG AM; Organizacion Panamericana de la Salud, 1981, SIT PROGR MAL AM 29; Organizacion Panamericana de la Salud, 2019, MAN ESTR SEG RIESG M; Organizacion Panamericana de la Salud. Actualizacion epidemiologica, 2018, AUM MAL AM 2018; Orjuela LI, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0764-6; Orjuela LI, 2013, BIOMEDICA, V33, P42, DOI [10.7705/biomedica.v33i1.619, 10.1590/S0120-41572013000100006]; Pabon J, 1998, MEDIO AMBIENTE COLOM, P35; Rodriguez JCP, 2011, MEM I OSWALDO CRUZ, V106, P114, DOI 10.1590/S0074-02762011000900015; Padilla-Rodriguez JC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235119; Rangel-C. J. Orlando, 1995, P25; Rangel-Ch J, 1997, COLOMBIA DIVERSIDAD, P383; Rondon S, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2910-z; Rosas-Aguirre A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0670-y; RubioPalis Y, 1997, J MED ENTOMOL, V34, P499, DOI 10.1093/jmedent/34.5.499; Schapira A, 2012, ADV PARASIT, V78, P97, DOI 10.1016/B978-0-12-394303-3.00001-3; Sociedad Venezolana de Salud Publica, 2018, AN REP MUND MAL 2018; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2015, GLOB TECHN STRAT MAL; WHO, 2015, CONTROL ELIMINATION; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; World Health Organization, 2018, M WHO EV REV GROUP A	60	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0247811	10.1371/journal.pone.0247811	http://dx.doi.org/10.1371/journal.pone.0247811			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705472	gold, Green Published			2022-12-26	WOS:000629590400089
J	Oliveira, VD; Mendes, AAV; Ferreira, LC; Calvet, TMQ; dos Santos, SA; Figueiredo, FB; Campos, MP; Rodrigues, FDD; de Oliveira, RDC; de Lemos, ERS; Rozental, T; da Silva, RG; Amendoeira, MRR; Teles-de-Freitas, R; Bruno, RV; Morgado, FN; Miranda, LDC; Menezes, RC				Oliveira, Valeria da Costa; Velho Mendes Junior, Artur Augusto; Ferreira, Luiz Claudio; Quinates Calvet, Tatiana Machado; dos Santos, Shanna Araujo; Figueiredo, Fabiano Borges; Campos, Monique Paiva; de Carvalho Rodrigues, Francisco das Chagas; Carvalhaes de Oliveira, Raquel de Vasconcellos; Sampaio de Lemos, Elba Regina; Rozental, Tatiana; da Silva, Raphael Gomes; Reis Amendoeira, Maria Regina; Teles-de-Freitas, Rayane; Bruno, Rafaela Vieira; Morgado, Fernanda Nazare; Campos Miranda, Luciana de Freitas; Menezes, Rodrigo Caldas			Frequency of co-seropositivities for certain pathogens and their relationship with clinical and histopathological changes and parasite load in dogs infected with Leishmania infantum	PLOS ONE			English	Article							RIO-DE-JANEIRO; CANINE VISCERAL LEISHMANIASIS; SEROLOGICAL CROSS-REACTIVITY; LINKED-IMMUNOSORBENT-ASSAY; VECTOR-BORNE PATHOGENS; TOXOPLASMA-GONDII; NEOSPORA-CANINUM; EHRLICHIA-CANIS; BORRELIA-BURGDORFERI; DIROFILARIA-IMMITIS	In canine leishmaniosis caused by the protozoan Leishmania infantum, little is known about how co-infections with or co-seropositivities for other pathogens can influence aggravation of this disease. Therefore, the objectives of this study were to evaluate the frequency of co-infections with or co-seropositivities for certain pathogens in dogs seropositive for L. infantum and their relationship with clinical signs, histological changes and L. infantum load. Sixty-six L. infantum-seropositive dogs were submitted to clinical examination, collection of blood and bone marrow, culling, and necropsy. Antibodies against Anaplasma spp., Borrelia burgdorferi sensu lato, Ehrlichia spp. and Toxoplasma gondii and Dirofilaria immitis antigens were investigated in serum. Samples from different tissues were submitted to histopathology and immunohistochemistry for the detection of Leishmania spp. and T. gondii. Quantitative real-time PCR was used to assess the L. infantum load in spleen samples. For detection of Coxiella burnetii, conventional PCR and nested PCR were performed using bone marrow samples. All 66 dogs tested positive for L. infantum by qPCR and/or culture. Fifty dogs (76%) were co-seropositive for at least one pathogen: T. gondii (59%), Ehrlichia spp., (41%), and Anaplasma spp. (18%). Clinical signs were observed in 15 (94%) dogs monoinfected with L. infantum and in 45 (90%) dogs co-seropositive for certain pathogens. The L. infantum load in spleen and skin did not differ significantly between monoinfected and co-seropositive dogs. The number of inflammatory cells was higher in the spleen, lung and mammary gland of co-seropositive dogs and in the mitral valve of monoinfected dogs. These results suggest that dogs infected with L. infantum and co-seropositive for certain pathogens are common in the region studied. However, co-seropositivities for certain pathogens did not aggravate clinical signs or L. infantum load, although they were associated with a more intense inflammatory reaction in some organs.	[Oliveira, Valeria da Costa; Velho Mendes Junior, Artur Augusto; Ferreira, Luiz Claudio; Quinates Calvet, Tatiana Machado; dos Santos, Shanna Araujo; de Carvalho Rodrigues, Francisco das Chagas; Carvalhaes de Oliveira, Raquel de Vasconcellos; Campos Miranda, Luciana de Freitas; Menezes, Rodrigo Caldas] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil; [Figueiredo, Fabiano Borges; Campos, Monique Paiva] Fundacao Oswaldo Cruz, Inst Carlos Chagas, Curitiba, Parana, Brazil; [Sampaio de Lemos, Elba Regina; Rozental, Tatiana; da Silva, Raphael Gomes; Reis Amendoeira, Maria Regina; Teles-de-Freitas, Rayane; Bruno, Rafaela Vieira; Morgado, Fernanda Nazare] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Bruno, Rafaela Vieira] CNPq, Inst Nacl Ciencia & Tecnol Entomol Mol INCT EM, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Menezes, RC (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.	rodrigo.menezes@ini.fiocruz.br	ERS, Lemos/B-3421-2014; Menezes, Rodrigo/O-8722-2019; Morgado, Fernanda/AAV-4435-2021; Morgado, Fernanda/O-3577-2017; Morgado, Fernanda N/K-2527-2013; Oliveira, Raquel de V C de/S-7443-2016	ERS, Lemos/0000-0003-3761-0200; Menezes, Rodrigo/0000-0003-1853-3449; Morgado, Fernanda/0000-0002-7188-251X; Morgado, Fernanda/0000-0002-7188-251X; Morgado, Fernanda N/0000-0002-7188-251X; Oliveira, Raquel de V C de/0000-0001-9387-8645; Velho Mendes Junior, Artur Augusto/0000-0002-7106-797X	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [CNE E-26/203.069/2016, TCT E-26/202.561/2017]; Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior (CAPES), Brazil [001]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the state funding agency Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (Grants: CNE E-26/203.069/2016 and TCT E-26/202.561/2017), http://www.faperj.br/, and by Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior (CAPES), Brazil (Finance Code 001), https://www.capes.gov.br/.FBF, ERSL and RCM are recipients of productivity fellowships from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil, http://www.cnpq.br/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves AS, 2012, RES VET SCI, V93, P1329, DOI 10.1016/j.rvsc.2012.07.006; Alves AD, 2004, PESQUI VET BRASIL, V24, P203, DOI 10.1590/S0100-736X2004000400006; Andrade GB, 2014, REV BRAS PARASITOL V, V23, P509, DOI [10.1590/s1984-29612014081, 10.1590/S1984-29612014081]; Aresu L, 2007, J VET DIAGN INVEST, V19, P569, DOI 10.1177/104063870701900520; Athanasiou LV, 2019, VECTOR-BORNE ZOONOT, V19, P923, DOI 10.1089/vbz.2019.2471; Attipa C, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-2083-6; Baxarias M, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2724-9; Boechat VC, 2016, PARASITOL RES, V115, P2371, DOI 10.1007/s00436-016-4987-4; Bonna I. C. F., 2006, Revista Brasileira de Ciencia Veterinaria, V13, P186; Brasil. Ministerio da Saude, CAS CONF LEISHM VISC; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia das Doencas Transmissiveis, 2016, MAN VIG PREV CONTR Z; Calero-Bernal R, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00054; Camargo M.E., 1974, REV BRASIL PATOL 150, V10, P143, DOI DOI 10.1136/JNNP.2005.075242; Campos SDE, 2017, PESQUI VET BRASIL, V37, P1307, DOI [10.1590/S0100-736X2017001100018, 10.1590/s0100-736x2017001100018]; Cardoso L, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-62; Carson F, 2015, HISTOTECHNOLOGY SELF, V4th, P183; Cavalcante ACV., 2018, J DAIRY VET ANIM RES, V7, P214; Conselho Federal de Medicina Veterinaria, 2013, GUIA BRAS BOAS PRAT; Coutinho SG., 1985, CAD SAUDE PUBLICA, V1, P432; Cringoli G, 2002, VET PARASITOL, V106, P307, DOI 10.1016/S0304-4017(02)00114-0; CUPOLILLO E, 1994, AM J TROP MED HYG, V50, P296, DOI 10.4269/ajtmh.1994.50.296; de Arruda MM, 2016, MEM I OSWALDO CRUZ, V111, P168, DOI 10.1590/0074-02760150364; de Mello CX, 2014, REV SOC BRAS MED TRO, V47, P788, DOI 10.1590/0037-8682-0042-2014; de Queiroz NMGP, 2011, VET PARASITOL, V178, P1, DOI 10.1016/j.vetpar.2010.12.033; Oliveira TMFD, 2008, REV BRAS PARASITOL V, V17, P7, DOI 10.1590/S1984-29612008000100002; De Tommasi AS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-97; Campos SDE, 2019, REV SOC BRAS MED TRO, V52, DOI 10.1590/0037-8682-0133-2018; Pimentel MIF, 2014, REV SOC BRAS MED TRO, V47, P521, DOI 10.1590/0037-8682-0213-2013; Figueredo LA, 2017, VET PARASITOL, V243, P18, DOI 10.1016/j.vetpar.2017.05.020; Sousa VRF, 2008, ACTA SCI VET, V36, P113; HOOVER TA, 1992, J BACTERIOL, V174, P5540, DOI 10.1128/JB.174.17.5540-5548.1992; Kader M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006644; Koutinas AF, 2014, VET PATHOL, V51, P527, DOI 10.1177/0300985814521248; Labarthe NV, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0493-7; Leal PDS., 2014, COCCIDIA, V2, P2; Madeira MF, 2009, RES VET SCI, V87, P260, DOI 10.1016/j.rvsc.2009.03.008; Maia C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1452-2; Mancianti F, 1996, VET PARASITOL, V65, P1, DOI 10.1016/0304-4017(96)00946-6; Mares-Guia MAMM, 2018, BRAZ J MICROBIOL, V49, P138, DOI 10.1016/j.bjm.2017.04.009; Medkour H, 2020, VET PARASITOL REG ST, V19, DOI 10.1016/j.vprsr.2019.100353; Medkour H, 2020, COMP IMMUNOL MICROB, V69, DOI 10.1016/j.cimid.2019.101412; Melo GD, 2015, J NEUROIMMUNOL, V289, P21, DOI 10.1016/j.jneuroim.2015.10.004; Mendonca C. C., 2013, Brazilian Journal of Veterinary Pathology, V6, P89; Mares-Guia MAMD, 2014, REV SOC BRAS MED TRO, V47, P231, DOI 10.1590/0037-8682-0076-2013; Morgado FN, 2016, REV BRAS PARASITOL V, V25, P450, DOI [10.1590/S1984-29612016065, 10.1590/s1984-29612016065]; Nair ADS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148239; Ntais Pantelis, 2016, Parasitology Open, V2, pe17, DOI 10.1017/pao.2016.15; Oliveira VD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175588; Oliveira VC., 2019, VET PARASITOL REG ST, V18, P1; Paulan SD, 2013, REV BRAS PARASITOL V, V22, P162, DOI 10.1590/S1984-29612013000100031; Porrozzi R, 2007, CLIN VACCINE IMMUNOL, V14, P544, DOI 10.1128/CVI.00420-06; R Core Team, 2020, R LANG ENV STAT COMP; Ratzlaff FR, 2018, ARQ BRAS MED VET ZOO, V70, P109, DOI 10.1590/1678-4162-9412; Ribeiro RR, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3296893; Rodrigues RTGA., 2019, ACTA SCI VET, V47, P1; Saldanha-Elias AM, 2019, ACTA PARASITOL, V64, P352, DOI 10.2478/s11686-019-00043-x; Schubach EYP, 2014, T ROY SOC TROP MED H, V108, P568, DOI 10.1093/trstmh/tru109; Souza CC, 2014, INT J EXP PATHOL, V95, P260, DOI 10.1111/iep.12080; Spada E, 2016, COMP IMMUNOL MICROB, V45, P53, DOI 10.1016/j.cimid.2016.03.001; Spinelli RM, 2019, AUSTRAL J VET SCI, V51, P131, DOI 10.4067/S0719-81322019000300131; da Silveira APS, 2018, REV SOC BRAS MED TRO, V51, P843, DOI [10.1590/0037-8682-0040-2018, 10.1590/0037-8682-00]; Tabar MD, 2013, J SMALL ANIM PRACT, V54, P174, DOI 10.1111/jsap.12041; Toepp AJ, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3312-3; Unver A, 2009, CLIN MICROBIOL INFEC, V15, P59, DOI 10.1111/j.1469-0691.2008.02634.x; Sobrinho LSV, 2012, VET PARASITOL, V187, P302, DOI 10.1016/j.vetpar.2012.01.010; Waner T, 2001, VET PARASITOL, V95, P1, DOI 10.1016/S0304-4017(00)00407-6; Zanette MF, 2014, REV SOC BRAS MED TRO, V47, P105, DOI 10.1590/0037-8682-1723-2013; Zulpo DL, 2012, SEMIN-CIENC AGRAR, V33, P1897, DOI 10.5433/1679-0359.2012v33n5p1897	68	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0247560	10.1371/journal.pone.0247560	http://dx.doi.org/10.1371/journal.pone.0247560			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705437	gold, Green Published			2022-12-26	WOS:000629590400035
J	Tsai, MC				Tsai, Ming-Chi			Developing a sustainability strategy for Taiwan's tourism industry after the COVID-19 pandemic	PLOS ONE			English	Article							OUTBREAK	The outbreak of COVID-19 around the world has caused great damage to the global economy. The tourism industry is among the worst-hit industries. How to focus on visitors who are most helpful to the tourism industry and develop sustainable strategy of operation is a very important question for after the epidemic is over. This study applied two-stage data envelopment analysis (DEA) and principal component analysis (PCA) to investigate past statistics from the Tourism Bureau and explore the shopping patterns of tourists who travel to Taiwan. The focus will be on tourists from major countries such as China, Japan, and Southeast Asian countries. According to the analysis of tourists from different countries, the money spent by tourists from different countries is concentrated on different items, and there are subitems that they particularly like to purchase. For the analysis of the purpose of coming to Taiwan, some tourism areas worth developing (such as medical treatment and leisure) are also presented in the research results. Based on these results, and according to the sustainable development goals, specific recommendations for the sustainability strategy of operation are made as a reference for the government and relevant industries. This research also broadens the scope of application of DEA and points out a different direction for future research.	[Tsai, Ming-Chi] I Shou Univ, Dept Business Adm, Kaohsiung, Taiwan	I Shou University	Tsai, MC (corresponding author), I Shou Univ, Dept Business Adm, Kaohsiung, Taiwan.	mct@isu.edu.tw		Tsai, Ming-Chi/0000-0002-0560-7819				Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; AN Q, 2015, EUR J LAW ECON, V235, P13, DOI DOI 10.1007/S10479-015-1987-1; [Anonymous], 2020, LIBERTY TIMES; [Anonymous], 2020, TRADING EC; BIAN Y, 2015, ANN OPER RES, V87, P348, DOI DOI 10.1016/J.JCLEPRO.2014.10.055; BONACCORSI G, 2020, CLIN INFECT DIS, V117, P15530, DOI DOI 10.1073/PNAS.2007658117; CAVALLO JJ, 2020, P NATL ACAD SCI USA, V296, pE141, DOI DOI 10.1148/RADIOL.2020201495; CHAMS N, 2019, NAT SUSTAIN, V141, P109, DOI DOI 10.1016/J.RESCONREC.2018.10.006; CHARNES A, 1978, HARVARD BUS REV, V2, P429; Chen CM, 2020, J MED INTERNET RES, V22, DOI 10.2196/19540; Chen CC, 2020, CANCER CYTOPATHOL, V128, P309, DOI 10.1002/cncy.22280; Cheng HY, 2020, J FORMOS MED ASSOC, V119, P771, DOI 10.1016/j.jfma.2020.03.007; Cheng SC, 2020, J FORMOS MED ASSOC, V119, P747, DOI 10.1016/j.jfma.2020.02.007; DANSO A, 2019, P NATL ACAD SCI USA, V28, P885, DOI DOI 10.1002/BSE.2291; DEYNELI F, 2012, MANAGE SCI, V34, P477, DOI DOI 10.1007/S10657-011-9258-3; DIMARCO M, 2020, NAT SUSTAIN, V117, P3888, DOI DOI 10.1073/PNAS.2001655117; Fatimah S., 2017, INT J ENV SCI ED, V12, P1971; Fernandes N., 2020, EC EFFECTS CORONAVIR, DOI [10.2139/ssrn.3557504, DOI 10.2139/SSRN.3557504]; Fotiadis A, 2021, ANN TOURISM RES, V87, DOI 10.1016/j.annals.2020.103117; Gregoriou GN, 2008, INFOR, V46, P177, DOI 10.3138/infor.46.3.177; Hsih WH, 2020, J MICROBIOL IMMUNOL, V53, P459, DOI 10.1016/j.jmii.2020.03.008; Huang WH, 2020, J MICROBIOL IMMUNOL, V53, P481, DOI 10.1016/j.jmii.2020.02.009; HUSNAYAIN A, 2020, RADIOLOGY, V95, P221, DOI DOI 10.1016/J.IJID.2020.03.021; Hwang S.N., 2006, INT J MANAG, V23, P699; JABBOUR ABL, 2020, J CLEAN PROD, V225, P7567, DOI DOI 10.1016/J.IJPE.2019.107567; JOLLIFFE IT, 2015, PHIL, V374, DOI DOI 10.1098/RSTA.2015.0202; KAPLAN RS, 1992, HARVARD BUS REV, V70, P71; KOCK F, 2020, TOUR RECREAT RES, V85, P3053, DOI DOI 10.1016/J.ANNALS.2020.103053; Kuo SC, 2020, EMERG INFECT DIS, V26, P1928, DOI 10.3201/eid2608.201192; Lee NY, 2020, J MICROBIOL IMMUNOL, V53, P485, DOI 10.1016/j.jmii.2020.03.003; LEE TH, 2019, J CLEAN PROD, V70, P368, DOI DOI 10.1016/J.TOURMAN.2018.09.003; Mariappan P., 2013, INT J MARK TECHNOL, V3, P52; MOROZOVA IA, 2019, RENEW ENERG, V15, P589, DOI DOI 10.1007/S11365-018-0522-7; Nerini FF, 2019, NAT SUSTAIN, V2, P674, DOI 10.1038/s41893-019-0334-y; NI X, 2019, J CLEAN PROD, V112, P90, DOI DOI 10.1016/J.SSCI.2018.10.012; NICOLA M, 2020, EMERG INFECT DIS, V78, P185, DOI DOI 10.1016/J.IJSU.2020.04.018; OSTERGAARD PA, 2020, INT J PROD ECON, V146, P2430, DOI DOI 10.1016/J.RENENE.2019.08.094; Policy Research Indicators Database, 2016, COMP DOMESTIC INT TO; Raheli H., 2017, Information Processing in Agriculture, V4, P342, DOI 10.1016/j.inpa.2017.02.004; RAMISIO PJ, 2019, BUS STRATEG ENVIRON, V222, P300, DOI DOI 10.1016/J.JCLEPRO.2019.02.257; RUGGIERO J, 1999, WIRES COMPUT STAT, V17, P321, DOI DOI 10.1111/J.1465-7287.1999.TB00685.X; SAATY TL, 1971, TOURISM MANAGE, V40, P9; SACHS JD, 2019, ANN TOURISM RES, V2, P805, DOI DOI 10.1038/S41893-019-0352-9; SALVIA AL, 2019, RESOUR CONSERV RECY, V208, P841, DOI DOI 10.1016/J.JCLEPRO.2018.09.242; Schwartz J, 2020, CRIT REV BIOCHEM MOL; SEIFORD LM, 1999, INTERFACES, V45, P1270, DOI DOI 10.1287/MNSC.45.9.1270; SILVESTRE BS, 2019, NAT SUSTAIN, V208, P325, DOI DOI 10.1016/J.JCLEPRO.2018.09.244; Teng SY, 2019, J CLEAN PROD, V225, P359, DOI 10.1016/j.jclepro.2019.03.272; THACKER S, 2019, INT ENTREP MANAG J, V2, P324, DOI DOI 10.1038/S41893-019-0256-8; Thanassoulis E, 1999, INTERFACES, V29, P1, DOI 10.1287/inte.29.3.1; Tourism Bureau, 2020, MOTC ROC TOURISM BUS; Tourism Bureau M.O.T.C. R.O.C, 2020, VISITORSEXPENDITURE; Tourism Bureau M.O.T.C. R.O.C., 2020, TOURISM POLICY WHITE; Tourism Bureau M.O.T.C. R.O.C, 2020, SURVEY CONSUMPTION T; Tsai MC, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12050712; UDDIN N, 2019, SAFETY SCI, V102, P47, DOI DOI 10.1016/J.APGEOG.2018.12.011; Ukko J, 2019, J CLEAN PROD, V236, DOI 10.1016/j.jclepro.2019.117626; UN, 2019, SUST DEV GOALS; Wang J, 2020, IND ENG CHEM RES, V59, P12487, DOI 10.1021/acs.iecr.0c01038; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; WONG WP, 2007, CONTEMP ECON POLICY, V107, P361, DOI DOI 10.1108/02635570710734271; YEH SS, 2020, INT J SURG, DOI DOI 10.1080/02508281.2020.1805933	62	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248319	10.1371/journal.pone.0248319	http://dx.doi.org/10.1371/journal.pone.0248319			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8JZ	33705479	gold, Green Published			2022-12-26	WOS:000629590400001
J	Yu, GC; Cai, QS; Xu, XD; Shen, YQ; Xu, K				Yu, Guocan; Cai, Qingshan; Xu, Xudong; Shen, Yanqin; Xu, Kan			Anlotinib-containing regimen for advanced small-cell lung cancer: A protocol of meta-analysis	PLOS ONE			English	Article								Background Small cell lung cancer (SCLC) is a highly malignant lung cancer with a very poor prognosis. Clinical treatment options for SCLC are still limited, especially for patients who have failed first or second line therapy. Anlotinib is a potentially beneficial new treatment option for SCLC. The aim of this meta-analysis is to evaluate the efficacy and safety of anlotinib-containing regimen for the treatment of SCLC. Methods We will search SinoMed, Wanfang Database, China National Knowledge Infrastructure, Embase, Cochrane Library, and PubMed for relevant articles that may meet the criteria published before March 31, 2021. We will perform a meta-analysis to evaluate the efficacy and safety of anlotinib-containing regimen for the treatment of SCLC. Clinical randomized controlled trials comparing anlotinib-containing regimens with other treatment regimens for advanced SCLC will be included in this study. The risk of bias will be evaluated for each included study using the Cochrane Handbook for Systematic Reviews of Interventions. We will use RevMan 5.3 software for statistical analysis of the data. Results The results of this study will provide evidence of anlotinib-containing regimens for advanced SCLC, and provide clinicians and patients with another convenient and effective treatment regimen for SCLC. This meta-analysis will be submitted to a peer-reviewed journal for publication. Conclusion This meta-analysis will provide clinical evidence of anlotinib-containing regimens for advanced SCLC, which may or may not be found for anlotinib use. Systematic review registration INPLASY202110034. .	[Yu, Guocan; Cai, Qingshan; Xu, Xudong; Shen, Yanqin; Xu, Kan] Zhejiang Univ, Affiliated Hangzhou Chest Hosp, Zhejiang TB Diag & Treatment Ctr, Sch Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Xu, K (corresponding author), Zhejiang Univ, Affiliated Hangzhou Chest Hosp, Zhejiang TB Diag & Treatment Ctr, Sch Med, Hangzhou, Zhejiang, Peoples R China.	xukanmed@163.com			Hangzhou Science and Technology Bureau [20201203B179]; Health Commission of Zhejiang Province [2015PYA008]	Hangzhou Science and Technology Bureau; Health Commission of Zhejiang Province	Guocan Yu, 20201203B179, Hangzhou Science and Technology Bureau, http://kj.hangzhou.gov.cn.Qingshan Cai, 2015PYA008, Health Commission of Zhejiang Province, https://wsjkw.zj.gov.cn.The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardt EB, 2016, CANCER TREAT RES, V170, P301, DOI 10.1007/978-3-319-40389-2_14; Chen HW, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017350; Chi YHBL, 2018, CLIN CANCER RES, V24, P5233, DOI 10.1158/1078-0432.CCR-17-3766; Duma N, 2019, MAYO CLIN PROC, V94, P1623, DOI 10.1016/j.mayocp.2019.01.013; Facchinetti F, 2020, CANCERS, V12, DOI 10.3390/cancers12092645; Faggion CM, 2015, J EVID-BASED DENT PR, V15, P164, DOI 10.1016/j.jebdp.2015.09.002; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Horn L, 2018, NEW ENGL J MED, V379, P2220, DOI 10.1056/NEJMoa1809064; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Moher D, 2010, INT J SURG, V8, P658, DOI 10.1016/j.ijsu.2010.07.299; Owonikoko TK, 2012, J THORAC ONCOL, V7, P866, DOI 10.1097/JTO.0b013e31824c7f4b; Paz-Ares L, 2019, LANCET, V394, P1929, DOI 10.1016/S0140-6736(19)32222-6; Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Shen YQ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243765; Shen YQ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221427; Siegel Rebecca L, 2019, CA Cancer J Clin, V69, P7, DOI 10.3322/caac.21551; Taurin S, 2018, INT J GYNECOL CANCER, V28, P152, DOI 10.1097/IGC.0000000000001129; Wang Q., 2019, J THORAC ONCOL, V14; Yu GC, 2019, MATH BIOSCI ENG, V16, P7659, DOI 10.3934/mbe.2019383; Yu GC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242982; Zhang S, 2020, THORAC CANCER, V11, P3536, DOI 10.1111/1759-7714.13698; Zimmerman S, 2019, J THORAC ONCOL, V14, P768, DOI 10.1016/j.jtho.2019.01.022	22	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0247494	10.1371/journal.pone.0247494	http://dx.doi.org/10.1371/journal.pone.0247494			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705427	gold, Green Published			2022-12-26	WOS:000629590400092
J	Vuorenlehto, L; Hinnela, K; Ayras, O; Ulander, VM; Louhiala, P; Kaijomaa, M				Vuorenlehto, Leena; Hinnela, Kaisa; Ayras, Outi; Ulander, Veli-Matti; Louhiala, Pekka; Kaijomaa, Marja			Women's experiences of counselling in cases of a screen-positive prenatal screening result	PLOS ONE			English	Article							DOWN-SYNDROME; PREGNANT-WOMEN; 1ST TRIMESTER; ANXIETY; STRESS; RISK; TRISOMY-21; KNOWLEDGE; IMPACT	Objective To study women's apprehensions, understanding and experiences of counselling concerning a screen-positive result in screening for fetal chromosomal defects. Methods A questionnaire study including different steps of the prenatal screening process was carried out in Helsinki University Hospital. Women's experiences concerning counselling immediately after a screen-positive result and during further examinations in the Fetal Medicine Unit (FMU) were analyzed. Results 143 women filled in the questionnaire. Less than half of the women considered the primary counselling after a screen-positive result to be explicit (43.9%) and sufficient (43.1%). In the FMU, 88.3% and 89.8% of women were satisfied with the explicitness and sufficiency of counselling. Most women (75%) experienced worry before further examinations but less than half (45%) had considered their personal values concerning diagnostic tests. Half (50.5%) of women expected the worry to continue even if diagnostic tests turn out normal. Most (81%) women were aware that diagnostic tests are voluntary and were confident (85.3%) with their decision to participate. Conclusions After a screen-positive result, women have unanswered questions, experience anxiety and confusion. The possibility of an abnormal screening result is not seriously considered beforehand. To enable an informed consent for prenatal screening, improvements in prescreening counselling during the first visits of antenatal care need to be made.	[Vuorenlehto, Leena; Hinnela, Kaisa; Ayras, Outi; Ulander, Veli-Matti; Kaijomaa, Marja] Helsinki Univ Hosp, Dept Obstet & Gynecol, Helsinki, Finland; [Vuorenlehto, Leena; Hinnela, Kaisa; Ayras, Outi; Ulander, Veli-Matti; Kaijomaa, Marja] Univ Helsinki, Helsinki, Finland; [Louhiala, Pekka] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki	Vuorenlehto, L (corresponding author), Helsinki Univ Hosp, Dept Obstet & Gynecol, Helsinki, Finland.; Vuorenlehto, L (corresponding author), Univ Helsinki, Helsinki, Finland.	leena.vuorenlehto@helsinki.fi		Louhiala, Pekka/0000-0003-4538-504X	Helsinki University Research fund - Helsinki University Library	Helsinki University Research fund - Helsinki University Library	Author LV received 1500 euros from the Helsinki University Research fund (https://www.helsinki.fi/en/research/research-environment/research-funding).Open access publication was funded by the Helsinki University Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aune I, 2012, MIDWIFERY, V28, P14, DOI 10.1016/j.midw.2010.10.015; Bekker HL, 2004, PRENATAL DIAG, V24, P265, DOI 10.1002/pd.851; Beta J, 2018, MINERVA GINECOL, V70, P215, DOI 10.23736/S0026-4784.17.04178-8; Boukydis CFZ, 2006, J ULTRAS MED, V25, P721, DOI 10.7863/jum.2006.25.6.721; Chen A, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1752-y; Da Silva ECP, 2012, J MATERN-FETAL NEO M, V25, P295, DOI 10.3109/14767058.2011.574299; Dahl K, 2011, ULTRASOUND OBST GYN, V38, P152, DOI 10.1002/uog.8856; Dugo Nella, 2014, J Prenat Med, V8, P31; Ekelin M, 2004, MIDWIFERY, V20, P335, DOI 10.1016/j.midw.2004.02.001; Johnston Marie, 1993, Annals of Behavioral Medicine, V15, P245; Kagan KO, 2008, ULTRASOUND OBST GYN, V31, P618, DOI 10.1002/uog.5331; Kaijomaa M., 2017, PRENATAL SCREENING A, V1st; Kohut Ruth J, 2002, J Genet Couns, V11, P265, DOI 10.1023/A:1016378415514; Lalor J, 2006, J ADV NURS, V55, P11, DOI 10.1111/j.1365-2648.2006.03884.x; Laplante DP, 2004, PEDIATR RES, V56, P400, DOI 10.1203/01.PDR.0000136281.34035.44; Lou S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1114-6; Lou S, 2015, ACTA OBSTET GYN SCAN, V94, P15, DOI 10.1111/aogs.12482; Louhiala P., 2004, PREVENTING INTELLECT; Mancuso RA, 2004, PSYCHOSOM MED, V66, P762, DOI 10.1097/01.psy.0000138284.70670.d5; Marteau T M, 2001, Health Expect, V4, P99, DOI 10.1046/j.1369-6513.2001.00140.x; Mulder EJH, 2002, EARLY HUM DEV, V70, P3, DOI 10.1016/S0378-3782(02)00075-0; Nicolaides KH, 2005, ULTRASOUND OBST GYN, V25, P221, DOI 10.1002/uog.1860; Ohman SG, 2010, SEX REPROD HEALTHC, V1, P85, DOI 10.1016/j.srhc.2010.05.002; Richmond Z, 2017, PRENATAL DIAG, V37, P975, DOI 10.1002/pd.5110; Santalahti P, 1998, PRENATAL DIAG, V18, P153, DOI 10.1002/(SICI)1097-0223(199802)18:2<153::AID-PD240>3.0.CO;2-Z; Sayakhot P, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0856-5; Sheinis M, 2018, J GENET COUNS, V27, P95, DOI 10.1007/s10897-017-0126-3; Song Y, 2015, ULTRASOUND OBST GYN, V45, P55, DOI 10.1002/uog.13460; Uitto S., 2007, THESIS; van Schendel RV, 2017, J GENET COUNS, V26, P1348, DOI 10.1007/s10897-017-0118-3; Weinans MJN, 2000, PRENATAL DIAG, V20, P705, DOI 10.1002/1097-0223(200009)20:9<705::AID-PD904>3.0.CO;2-C; WEINSTEIN ND, 1989, SCIENCE, V246, P1232, DOI 10.1126/science.2686031; Wittman AT, 2016, AJP REP, V6, pe391, DOI 10.1055/s-0036-1594243; Zhang H, 2015, ULTRASOUND OBST GYN, V45, P530, DOI 10.1002/uog.14792	34	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0247164	10.1371/journal.pone.0247164	http://dx.doi.org/10.1371/journal.pone.0247164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QV3DA	33690660	gold, Green Published			2022-12-26	WOS:000627854700042
J	Shen, Q; Tao, YT				Shen, Qian; Tao, Yating			Stance markers in English medical research articles and newspaper opinion columns: A comparative corpus-based study	PLOS ONE			English	Article							CROSS-DISCIPLINARY; METADISCOURSE; CONSTRUCTION; FEATURES; SCIENCE	Stance markers are critical linguistic devices for writers to convey their personal attitudes, judgments or assessments about the proposition of certain messages. Following Hyland's framework of stance, this study investigated the distribution of stance markers in two different genres: medical research articles (medical RA) and newspaper opinion columns (newspaper OC). The corpus constructed for the investigation includes 52 medical research articles and 175 newspaper opinion articles, which were both written in English and published from January to April in 2020 with the topic focusing on COVID-19. The findings of this study demonstrated that the occurrences of stance markers in newspaper OC were far more frequent than those in medical RA, indicating the different conventions of these two genres. Despite the significant difference in the occurrences of stance markers between the two sub-corpora, similarities of the most frequent stance markers in two genres were also highlighted. The study indicated that the topic content seems to play an important role in shaping the way of how writers construct their stance. The lack of information or evidence on the topic of COVID-19 could restrain writers from making high degree of commitment to their claims, which make them adopt a more tentative stance to qualify their statements.	[Shen, Qian; Tao, Yating] North China Elect Power Univ, English Dept, Baoding, Hebei, Peoples R China	North China Electric Power University	Shen, Q (corresponding author), North China Elect Power Univ, English Dept, Baoding, Hebei, Peoples R China.	93761556@qq.com						[Anonymous], 2011, MED WRITING EARLY MO; Anthony L., 2019, ANTCONC VERSION 358; Aull LL, 2014, WRIT COMMUN, V31, P151, DOI 10.1177/0741088314527055; Babapour M., 2018, J ENGLISH LANGUAGE P, V11, P23, DOI [10.30495/jal.2018.541064, DOI 10.30495/JAL.2018.541064]; Biber, 2006, U LANGUAGE CORPUSBAS; Biber D., 2008, CORPUS LINGUISTICS I, P1286; Biber Douglas, 1989, TET INTERDISCIPLINAR, V9, P93, DOI [10.1515/text.1.1989.9.1.93, DOI 10.1515/TEXT.1.1989.9.1.93]; Chafe Wallace, 1986, EVIDENTIALITY LINGUI, P261; Chan THT, 2015, J ENGL ACAD PURP, V20, P176, DOI 10.1016/j.jeap.2015.09.005; Charles M, 2006, APPL LINGUIST, V27, P492, DOI 10.1093/applin/aml021; Cheng FW, 2016, J ENGL ACAD PURP, V24, P43, DOI 10.1016/j.jeap.2016.09.001; Coulthard M., 1994, EVALUATION ORG SAMPL, P191; CRISMORE A, 1990, DISCOURSE PROCESS, V13, P191, DOI 10.1080/01638539009544753; Divasson L, 2006, ENCY LANGUAGE LINGUI, V2nd, P58, DOI [10.1016/B0-08-044854-2/02358-0, DOI 10.1016/B0-08-044854-2/02358-0]; Fryer DL, 2012, FUNCT LANG, V19, P5, DOI 10.1075/fol.19.1.01fry; Fu XL, 2014, ENGL TEXT CONSTR, V7, P122, DOI 10.1075/etc.7.1.05fu; Halliday M.A.K., 2004, INTRO FUNCTIONAL GRA, V3rd; HOLMES J, 1988, APPL LINGUIST, V9, P21, DOI 10.1093/applin/9.1.21; Hoye L., 2013, ADVERBS MODALITY ENG; Hyland K, 2001, WRIT COMMUN, V18, P549, DOI 10.1177/0741088301018004005; Hyland K, 1996, WRIT COMMUN, V13, P251, DOI 10.1177/0741088396013002004; Hyland K, 2001, ENGL SPECIF PURP, V20, P207, DOI 10.1016/S0889-4906(00)00012-0; Hyland K., 2000, DISCIPLINE DISCOURSE, P20; Hyland K., 2005, METADISCOURSE EXPLOR; Hyland K., 1996, SYSTEM, V24, P477, DOI DOI 10.1016/S0346-251X(96)00043-7; Hyland K., 1998, TEXT, V18, P349; Hyland K., 1998, HEDGING SCI RES ARTI; Hyland K, 2016, WRIT COMMUN, V33, P251, DOI 10.1177/0741088316650399; Hyland K, 2010, J ENGL ACAD PURP, V9, P116, DOI 10.1016/j.jeap.2010.02.003; Ivani R., 1998, WRITING IDENTITYTHE; Johansson S., 1999, LONGMAN GRAMMAR SPOK; Khabbazi-Oskouei L, 2013, J PRAGMATICS, V47, P93, DOI 10.1016/j.pragma.2012.12.003; Li LJ, 2009, ENGL SPECIF PURP, V28, P93, DOI 10.1016/j.esp.2008.12.004; Marco Maria Jose Luzon, 2000, ENGL SPECIF PURP, V19, P63, DOI DOI 10.1016/S0889-4906(98)00013-1; Marin-Arresse J.I., 2007, RAEL REV ELECT LINGU, V1, P82; Martin J.R., 2000, EVALUATION TEXT AUTH, P142, DOI [10.1177/14614456020040041104, DOI 10.1177/14614456020040041104]; Martin JR, 2007, LANGUAGE OF EVALUATION: APPRAISAL IN ENGLISH, P1, DOI 10.1057/9780230511910; McGrath L, 2012, ENGL SPECIF PURP, V31, P161, DOI 10.1016/j.esp.2011.11.002; MYERS G, 1989, APPL LINGUIST, V10, P1, DOI 10.1093/applin/10.1.1; MYERS G, 1985, SOC STUD SCI, V15, P593, DOI 10.1177/030631285015004002; Ngai SBC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205417; Nwogu K. N., 1997, ENGL SPECIF PURP, V16, P119, DOI [DOI 10.1016/S0889-4906(97)85388-4, 10.1016/S0889-4906(97)85388-4]; Ochs E., 1989, TEXT, V9, P7, DOI DOI 10.1515/TEXT.1.1989.9.1.7; Palmer Frank R., 1986, MOOD MODALITY; Palmer FrankR., 1990, MODALITY ENGLISH MOD; Peacock M, 2006, CORPORA, V1, P61, DOI 10.3366/cor.2006.1.1.61; Blanco MP, 2016, LANG CONTRAST, V16, P31, DOI 10.1075/lic.16.1.02per; Poole R, 2019, J ENGL ACAD PURP, V42, DOI 10.1016/j.jeap.2019.100784; Quirk R., 1985, COMPREHENSIVE GRAMMA; Rundblad G, 2007, WRIT COMMUN, V24, P250, DOI 10.1177/0741088307302946; Salager-Meyer F., 1994, ENGL SPECIF PURP, V13, P149, DOI DOI 10.1016/0889-4906(94)90013-2; Sharp J, 2019, PLAYF THINK, P3; Sinclair J., 1991, CONCORDANCE COLLOCAT; SKELTON J, 1994, BRIT J GEN PRACT, V44, P455; Skelton JR, 2000, BRIT MED J, V320, P1269, DOI 10.1136/bmj.320.7244.1269; Tavassoli F, 2019, DISCOURSE SOC, V30, P64, DOI 10.1177/0957926518801079; Thomas S., 1994, ENGL SPECIF PURP, V13, P129, DOI [10.1016/0889-4906(94)90012-4, DOI 10.1016/0889-4906(94)90012-4]; THOMPSON DK, 1993, WRIT COMMUN, V10, P106, DOI 10.1177/0741088393010001004; van Dijk T.A., 1988, NEWS DISCOURSE; Varttala T., 1999, ENGL SPECIF PURP, V18, P177, DOI [10.1016/S0889-4906(98)00007-6, DOI 10.1016/S0889-4906(98)00007-6]; Vihla Minna, 1999, MED WRITING MODALITY; Wang W, 2008, DISCOURSE STUD, V10, P361, DOI 10.1177/1461445608089916; Williams I. A., 1999, ENGL SPECIF PURP, V18, P347, DOI DOI 10.1016/S0889-4906(98)00003-9; Williams IA, 2012, INT J CORPUS LINGUIS, V17, P546, DOI 10.1075/ijcl.17.4.04wil; Yang A, 2015, ENGL SPECIF PURP, V38, P1, DOI 10.1016/j.esp.2014.10.005	65	0	0	8	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0247981	10.1371/journal.pone.0247981	http://dx.doi.org/10.1371/journal.pone.0247981			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QU3OZ	33684148	Green Published, gold			2022-12-26	WOS:000627193500003
J	He, YK; Jiang, JD; Li, S				He, Yakun; Jiang, Jiadong; Li, Shuo			The circulation analysis of substandard foods in China based on GIS and social network analysis	PLOS ONE			English	Article							RAW CHICKEN; SALMONELLA; RETAIL; PREVALENCE	In China, the majority of food enterprises are small-sized and medium-sized. While the supervision costs are high, food safety issues are still emerging. Food circulation is an indispensable part in the entire food chain. At present, there are few studies on the regional spread of food safety risks in the circulation field from a macro perspective. This study combines GIS and social network analysis methods to deeply explore the regional circulation characteristics of substandard foods. First, we crawl the dataset of Food Safety Sampling Inspection Result Query System. Then we obtain the geographical locations of the manufacturers and distributors by GIS. Finally, we construct the province-level and city-level substandard foods' circulation networks, and employ social network analysis to target key cities and paths. The experimental results show that the circulations of substandard foods are characterized by dense province-level network and sparse city-level network, and they are mostly local and short-distance trafficking. 361 cities are divided into 13 city clusters considering the network connection characteristics. Chongqing, Beijing, Zhengzhou, and Changsha are identified as key cities by all measurement indicators, and at least four indicators can identify Shanghai and Wuhan. These cities have the highest priority for combating substandard foods' circulation networks.	[He, Yakun; Jiang, Jiadong; Li, Shuo] SAMR, Key Lab Qual Infrastruct Efficacy Res, China Aeropolytechnol Estab, Beijing, Peoples R China	Aviation Industry Corporation of China (AVIC)	He, YK (corresponding author), SAMR, Key Lab Qual Infrastruct Efficacy Res, China Aeropolytechnol Estab, Beijing, Peoples R China.	hyk1990@whu.edu.cn			Beijing Municipal Science & Technology Commission "Product Quality Safety Risk Warning Technology and Platform Construction based on Big Data" [Z191100001419016]	Beijing Municipal Science & Technology Commission "Product Quality Safety Risk Warning Technology and Platform Construction based on Big Data"	This research was funded by Beijing Municipal Science & Technology Commission "Product Quality Safety Risk Warning Technology and Platform Construction based on Big Data", grant number Z191100001419016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian M, 2009, P INT AAAI C WEB SOC, V2009, P361, DOI 10.13140/2.1.1341.1520; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Borgatti S. P., 2006, Computational & Mathematical Organization Theory, V12, P21, DOI 10.1007/s10588-006-7084-x; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Garrido A, 2012, FOOD CONTROL, V24, P128, DOI 10.1016/j.foodcont.2011.09.015; Gu Z.H., 2009, J CHINAS FOOD HYGIEN, V4, P299; Gu ZH, 2017, FOOD SAFETY IN CHINA: SCIENCE, TECHNOLOGY, MANAGEMENT AND REGULATION, P397; He ZLL, 2005, J TRACE ELEM MED BIO, V19, P125, DOI 10.1016/j.jtemb.2005.02.010; Huang JL, 2016, FOOD CONTROL, V59, P68, DOI 10.1016/j.foodcont.2015.05.009; Jen J. J., 2017, Food safety in China: science, technology, management and regulation, P1; Lam HM, 2013, LANCET, V381, P2044, DOI 10.1016/S0140-6736(13)60776-X; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056117; Li C., 2011, REFERENCE EC RES, P2; Li H, 2007, ECG ESSENTIALS; Li Qingquan, 2014, Geomatics and Information Science of Wuhan University, V39, P641; [李晓瑜 LI Xiaoyu], 2006, [食品科学, Food Science], V27, P275; Meng SH, 2017, FOOD SAFETY IN CHINA: SCIENCE, TECHNOLOGY, MANAGEMENT AND REGULATION, P43; Miao H., 2016, FOOD FRAUD FOOD SAFE, P172; Ministry of Agriculture, 2004, 7882004 NYT MIN AGR; Office of the UN Resident Coordinator in China, 2008, UN CHIN OCC REP ADV; Peng T, 2005, DIGEST DIS SCI, V50, P525, DOI 10.1007/s10620-005-2468-1; Sheng X.D., 2011, ENTERPRISE VITALITY, V12, P59; [唐晓纯 Tang Xiaochun], 2015, [食品科学, Food Science], V36, P221; Wang C.Z., 2014, CHINA FOOD ADDIT, V1, P61, DOI 10.3969/j.issn.1006-2513.2014.01.001; Wang J.H., 2014, INTRO 2014 CHINA DEV, V83; Wang Jun, 2009, Zhonghua Yufang Yixue Zazhi, V43, P478, DOI 10.3760/cma.j.issn.0253-9624.2009.06.008; Wang L.M., 2015, REPORT FOOD IND DEV, P4; Wang X., 2017, APPL MULTIVARIATE ST; Wang Y.L., 2009, IMPLEMENTATION ISSUE; Wang Z, 2018, NAT SUSTAIN, V1, P254, DOI 10.1038/s41893-018-0065-5; Wolfe AW, 1997, AM ETHNOL, V24, P219, DOI 10.1525/ae.1997.24.1.219; Wong K, 2012, ENVIRON INT, V45, P151, DOI 10.1016/j.envint.2012.02.009; Wu W, 2014, ARCH VIROL, V159, P1995, DOI 10.1007/s00705-014-1986-6; Xie M.Q., 2013, AIAA 2013 2907; Yang BW, 2010, INT J FOOD MICROBIOL, V141, P63, DOI 10.1016/j.ijfoodmicro.2010.04.015; Yu B.W., 2017, ARXIV PREPRINT ARXIV; Zhang J.C., 2013, J HENAN FINANCE LAW, P90; Zhou P, 2008, TRENDS PARASITOL, V24, P190, DOI 10.1016/j.pt.2008.01.001; Zhu JH, 2014, FOOD CONTROL, V44, P198, DOI 10.1016/j.foodcont.2014.03.050	40	0	0	9	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0248037	10.1371/journal.pone.0248037	http://dx.doi.org/10.1371/journal.pone.0248037			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667257	gold, Green Published			2022-12-26	WOS:000626604300010
J	Roy, D; Mazumder, O; Sinha, A; Khandelwal, S				Roy, Dibyendu; Mazumder, Oishee; Sinha, Aniruddha; Khandelwal, Sundeep			Multimodal cardiovascular model for hemodynamic analysis: Simulation study on mitral valve disorders	PLOS ONE			English	Article							LEFT ATRIAL ENLARGEMENT; VALVULAR HEART-DISEASE; ECHOCARDIOGRAPHIC-ASSESSMENT; DIAGNOSIS; RECOMMENDATIONS; CIRCULATION; STENOSIS; SYSTEM; PULSE; ECG	Valvular heart diseases are a prevalent cause of cardiovascular morbidity and mortality worldwide, affecting a wide spectrum of the population. In-silico modeling of the cardiovascular system has recently gained recognition as a useful tool in cardiovascular research and clinical applications. Here, we present an in-silico cardiac computational model to analyze the effect and severity of valvular disease on general hemodynamic parameters. We propose a multimodal and multiscale cardiovascular model to simulate and understand the progression of valvular disease associated with the mitral valve. The developed model integrates cardiac electrophysiology with hemodynamic modeling, thus giving a broader and holistic understanding of the effect of disease progression on various parameters like ejection fraction, cardiac output, blood pressure, etc., to assess the severity of mitral valve disorders, naming Mitral Stenosis and Mitral Regurgitation. The model mimics an adult cardiovascular system, comprising a four-chambered heart with systemic, pulmonic circulation. The simulation of the model output comprises regulated pressure, volume, and flow for each heart chamber, valve dynamics, and Photoplethysmogram signal for normal physiological as well as pathological conditions due to mitral valve disorders. The generated physiological parameters are in agreement with published data. Additionally, we have related the simulated left atrium and ventricle dimensions, with the enlargement and hypertrophy in the cardiac chambers of patients with mitral valve disorders, using their Electrocardiogram available in Physionet PTBI dataset. The model also helps to create 'what if' scenarios and relevant analysis to study the effect in different hemodynamic parameters for stress or exercise like conditions.	[Roy, Dibyendu; Mazumder, Oishee; Sinha, Aniruddha; Khandelwal, Sundeep] Tata Consultancy Serv Ltd, TCS Res, Kolkata, India	Tata Sons; Tata Consultancy Services Limited (TCS)	Roy, D (corresponding author), Tata Consultancy Serv Ltd, TCS Res, Kolkata, India.	roy.dibyendu@tcs.com	Sinha, Aniruddha/ABB-2972-2021	Roy, Dibyendu/0000-0002-7237-0065	Tata Consultancy Services Ltd. (TCS)	Tata Consultancy Services Ltd. (TCS)	Tata Consultancy Services Ltd. (TCS) provided support in the form of salaries for all the authors and provided infrastructural support for research and development, data analysis, decision to publish and preparation of the manuscript. Authors are full time employees of TCS. The specific roles of these authors are articulated in the "authors' contributions" section.	Addison PS, 2016, IEEE T BIO-MED ENG, V63, P2441, DOI 10.1109/TBME.2016.2528507; Adjoua O, 2019, INT J NUMER METH BIO, V35, DOI 10.1002/cnm.3274; Arts T, 2005, AM J PHYSIOL-HEART C, V288, pH1943, DOI 10.1152/ajpheart.00444.2004; Avolio A, 2002, J HYPERTENS, V20, P2341, DOI 10.1097/00004872-200212000-00007; Bacharova L, 2014, CURR CARDIOL REV, V10, P257, DOI 10.2174/1573403X10666140514103220; Baillargeon B, 2014, EUR J MECH A-SOLID, V48, P38, DOI 10.1016/j.euromechsol.2014.04.001; Baumgartner H, 2009, EUR J ECHOCARDIOGR, V10, P1, DOI 10.1093/ejechocard/jen303; Beaudoin J, 2013, J AM COLL CARDIOL, V61, P1809, DOI 10.1016/j.jacc.2013.01.064; Bhattacharya S, 2020, INT CONF ACOUST SPEE, P1165, DOI 10.1109/ICASSP40776.2020.9054570; Bousseljot R., 1995, BIOMED TECH, V40, pS317, DOI [10.1515/bmte.1995.40.s1.317, DOI 10.1515/BMTE.1995.40.S1.317]; Bozkurt S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224663; Broome M, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-69; Buist M, 2010, COMPREHENSIVE ELECTR; CADY LD, 1961, CIRC RES, V9, P1078, DOI 10.1161/01.RES.9.5.1078; Chemla D, 2015, EUR RESPIR J, V46, P1178, DOI 10.1183/13993003.00741-2015; Crosetto P, 2011, COMPUT FLUIDS, V43, P46, DOI 10.1016/j.compfluid.2010.11.032; Elgendi M, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0136-7; Elgendi M, 2012, CURR CARDIOL REV, V8, P14, DOI 10.2174/157340312801215782; Enriquez-Sarano M, 2009, CONTEMP CARDIOL, P221, DOI 10.1007/978-1-59745-411-7_10; Farber HW, 2004, NEW ENGL J MED, V351, P1655, DOI 10.1056/NEJMra035488; GRODINS FS, 1959, Q REV BIOL, V34, P93, DOI 10.1086/402631; Hoppensteadt F.C., 2013, MATH MED LIFE SCI, V10; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Jansen R, 2013, NETH HEART J, V21, P487, DOI 10.1007/s12471-013-0452-5; JOSEPHSON ME, 1977, AM J CARDIOL, V39, P967, DOI 10.1016/S0002-9149(77)80209-9; Khandelwal S, 2020 EUR CONTR C ECC; Korakianitis T, 2006, MED ENG PHYS, V28, P613, DOI 10.1016/j.medengphy.2005.10.004; Lancellotti P, 2008, HEART, V94, P1497, DOI 10.1136/hrt.2007.134833; Lau KD, 2011, J BIOMECH, V44, P2409, DOI 10.1016/j.jbiomech.2011.06.030; Lemmon JD, 2000, J BIOMECH ENG-T ASME, V122, P297, DOI 10.1115/1.1286559; Lopez-Perez A, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0033-5; Maganti K, 2010, MAYO CLIN PROC, V85, P483, DOI 10.4065/mcp.2009.0706; Malossi ACI, 2013, MULTISCALE MODEL SIM, V11, P474, DOI 10.1137/120867408; Mangoni AA, 2002, EUR J CARDIO-THORAC, V22, P90, DOI 10.1016/S1010-7940(02)00218-X; Martinez-Legazpi P, 2017, HEAVY IS LOAD VENTRI; Mazumder O, 2019, IEEE ENG MED BIO, P5024, DOI 10.1109/EMBC.2019.8856691; MCCARTHY K, 2010, EUR J ECHOCARDIOGR, V11, P3, DOI DOI 10.1093/ejechocard/jeq153; Mittal R, 2016, J COMPUT PHYS, V305, P1065, DOI 10.1016/j.jcp.2015.11.022; Mynard JP, 2012, INT J NUMER METH BIO, V28, P626, DOI 10.1002/cnm.1466; Nishimura RA, 2014, CIRCULATION, V129, P2440, DOI 10.1161/CIR.0000000000000029; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Okin PM, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007564; PELESKA B, 1963, CIRC RES, V13, P21, DOI 10.1161/01.RES.13.1.21; PYERITZ RE, 1983, AM J MED, V74, P797, DOI 10.1016/0002-9343(83)91070-7; ROMHILT DW, 1968, AM HEART J, V75, P752, DOI 10.1016/0002-8703(68)90035-5; Roy D, 2020, IEEE ENG MED BIO, P918, DOI 10.1109/EMBC44109.2020.9175352; Sengupta D, 2012, BIOMECH MODEL MECHAN, V11, P915, DOI 10.1007/s10237-011-0361-8; Shim EB, 2006, PHILOS T R SOC A, V364, P1483, DOI 10.1098/rsta.2006.1782; Sinha, 2020, 2020 16 EUR SIGN PRO, P1; Sun W, 2014, ANNU REV BIOMED ENG, V16, P53, DOI 10.1146/annurev-bioeng-071813-104517; Surawicz B, 2009, CIRCULATION, V119, pE235, DOI 10.1161/CIRCULATIONAHA.108.191095; Tison GH, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.118.005289; van de Vosse FN, 2003, J ENG MATH, V47, P175, DOI 10.1023/B:ENGI.0000007986.69547.5a; van Oosterom A, 2004, HEART, V90, P165, DOI 10.1136/hrt.2003.014662; Van Slochteren F, 2007, 0742 BMTE EINDH U TE; WAGGONER AD, 1976, CIRCULATION, V54, P553, DOI 10.1161/01.CIR.54.4.553; Weinberg EJ, 2010, BIOMECH MODEL MECHAN, V9, P373, DOI 10.1007/s10237-009-0181-2; Wilkins E., 2017, EUROPEAN CARDIOVASCU; Zhang XC, 2019, COMPUT BIOL MED, V108, P200, DOI 10.1016/j.compbiomed.2019.03.021; Zhou SR, 2019, BIOMED ENG ONLINE, V18, DOI 10.1186/s12938-019-0660-3	60	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0247921	10.1371/journal.pone.0247921	http://dx.doi.org/10.1371/journal.pone.0247921			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33662019	Green Published, gold			2022-12-26	WOS:000626604100102
J	Kwon, PK; Kim, HM; Kang, B; Kim, SW; Hwang, SM; Im, SH; Roh, TY; Kim, KT				Kwon, Paul Kwangho; Kim, Hyo-Min; Kang, Byunghee; Kim, Sung Wook; Hwang, Sung-Min; Im, Sin-Hyeog; Roh, Tae-Young; Kim, Kyong-Tai			hnRNP K supports the maintenance of ROR gamma circadian rhythm through ERK signaling	FASEB JOURNAL			English	Article						circadian rhythm; hnRNP K; poly(C) motif; ROR&#947; transcription		Retinoic acid-related orphan receptor gamma (ROR gamma) maintains the circadian rhythms of its downstream genes. However, the mechanism behind the transcriptional activation of ROR gamma itself remains unclear. Here, we demonstrate that transcription of ROR gamma is activated by heterogeneous nuclear ribonucleoprotein K (hnRNP K) via the poly(C) motif within its proximal promoter. Interestingly, we confirmed the binding of endogenous hnRNP K within ROR gamma 1 and ROR gamma 2 promoter along with the recruitment of RNA polymerase 2 through chromatin immunoprecipitation (ChIP). Furthermore, an assay for transposase accessible chromatin (ATAC)-qPCR showed that hnRNP K induced higher chromatin accessibility within the ROR gamma 1 and ROR gamma 2 promoter. Then we found that the knockdown of hnRNP K lowers ROR gamma mRNA oscillation amplitude in both ROR gamma and ROR gamma-dependent metabolic genes. Moreover, we demonstrated that time-dependent extracellular signal-regulated kinase (ERK) activation controls mRNA oscillation of ROR gamma and ROR gamma-dependent metabolic genes through hnRNP K. Taken together, our results provide new insight into the regulation of ROR gamma by hnRNP K as a transcriptional activator, along with its physiological significance in metabolism.	[Kwon, Paul Kwangho; Im, Sin-Hyeog; Roh, Tae-Young; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea; [Kim, Hyo-Min; Kang, Byunghee; Kim, Sung Wook; Hwang, Sung-Min; Im, Sin-Hyeog; Roh, Tae-Young; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 37673, Gyeongbuk, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Kim, KT (corresponding author), Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 37673, Gyeongbuk, South Korea.	ktk@postech.ac.kr	Im, Sin-Hyeog/E-6811-2013	Im, Sin-Hyeog/0000-0002-3173-1856; Kim, Hyo-Min/0000-0002-2667-3719; Kim, Sung Wook/0000-0001-9572-4762; KIM, KYONG-TAI/0000-0001-7292-2627; Hwang, Sung-Min/0000-0002-4868-147X; Roh, Tae-Young/0000-0001-5833-0844	National Research Foundation (NRF) [2017M3C7A1023478, 2019R1A2C2009440]; Rural Development Administration [PJ01324801]; Ministry of Education [10Z20130012243]	National Research Foundation (NRF); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Ministry of Education	National Research Foundation (NRF), Grant/Award Number: 2017M3C7A1023478 and 2019R1A2C2009440; Rural Development Administration, Grant/Award Number: PJ01324801; Ministry of Education, Grant/Award Number: 10Z20130012243	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Banerjee K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6769; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; BENNETT MK, 1983, J BIOL CHEM, V258, P2735; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cai DM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12529-3; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Charroux B, 1999, MOL CELL BIOL, V19, P7846, DOI 10.1128/mcb.19.11.7846; Choi JH, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00371-18; Choi JH, 2018, EMBO J, V37, DOI 10.15252/embj.201695266; Coogan AN, 2003, J NEUROSCI, V23, P3085; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Fitzsimmons RL, 2012, J STEROID BIOCHEM, V130, P159, DOI 10.1016/j.jsbmb.2011.06.009; Goldsmith CS, 2013, ADV GENET, V84, P1, DOI 10.1016/B978-0-12-407703-4.00001-3; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Hovemann BT, 2000, GENE, V245, P127, DOI 10.1016/S0378-1119(00)00027-5; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kim SH, 2015, J NEUROCHEM, V132, P642, DOI 10.1111/jnc.13027; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kojima S, 2011, J CELL SCI, V124, P311, DOI 10.1242/jcs.065771; Kwon PK, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00537-19; Kwon PK, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00101-19; Lavoie H, 2020, NAT REV MOL CELL BIO, V21, P607, DOI 10.1038/s41580-020-0255-7; Lee HR, 2015, J PINEAL RES, V59, P518, DOI 10.1111/jpi.12284; Lee KH, 2014, NUCLEIC ACIDS RES, V42, P3590, DOI 10.1093/nar/gkt1379; Lee KH, 2013, MOL BIOL CELL, V24, P2248, DOI 10.1091/mbc.E12-12-0849; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Masri S, 2018, NAT MED, V24, P1795, DOI 10.1038/s41591-018-0271-8; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; Michelotti GA, 1996, MOL CELL BIOL, V16, P2656, DOI 10.1128/mcb.16.6.2656; Miyazaki M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027168; Noh JY, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.153; Rutz S, 2016, CYTOKINE GROWTH F R, V30, P1, DOI 10.1016/j.cytogfr.2016.07.004; Shnyreva M, 2000, J BIOL CHEM, V275, P15498, DOI 10.1074/jbc.275.20.15498; Takeda Y, 2014, NUCLEIC ACIDS RES, V42, P10448, DOI 10.1093/nar/gku766; Takeda Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004331; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830	42	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21507	10.1096/fj.202002076R	http://dx.doi.org/10.1096/fj.202002076R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33724572				2022-12-26	WOS:000635216100013
J	Cousins, MM; Jannausch, M; Jagsi, R; Ilgen, M				Cousins, Matthew M.; Jannausch, Mary; Jagsi, Reshma; Ilgen, Mark			Differences between cancer patients and others who use medicinal Cannabis	PLOS ONE			English	Article								Background Cancer patients have been at the forefront of policy discussions leading to legalization of medical Cannabis (marijuana). Unfortunately, Cannabis use among those with cancer is poorly understood. Methods A diverse group of patients seeking certification for medical Cannabis in the state of Michigan were surveyed at the time of their presentation to medical dispensaries. The survey assessed demographics, employment/disability, pain, physical functioning, mental health, mode of Cannabis use, and frequency/amount of Cannabis use. Chi-square and t-tests were performed to compare those who did and did not endorse cancer diagnosis. Results Analysis of data from 1485 adults pursuing medical Cannabis certification, including 72 (4.8%) reporting a cancer diagnosis, indicated that those with cancer were older [mean age 53.4 years (SD = 10.5) vs. 44.7 years (SD = 13.0); p<0.001] than those without cancer. They also differed regarding employment status (p<0.001; working: 20.8% vs. 46.2%; disabled: 44.4% vs. 26.5% for those with vs. those without cancer, respectively). Those with cancer used less Cannabis (p = 0.033 for quantity used) and used Cannabis less often (p = 0.032 for frequency of use); they less frequently endorsed smoking Cannabis (80% vs 91%; p = 0.015). There was a non-significant trend to increased edible use in those with cancer (57% vs. 44%; p = 0.052). Conclusions Patients with cancer who are seeking medical Cannabis are different from those seeking medical Cannabis without cancer, and they report using Cannabis differently. Further research to characterize the patterns and consequences of Cannabis use in cancer patients is needed.	[Cousins, Matthew M.; Jagsi, Reshma] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Jannausch, Mary; Ilgen, Mark] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Ilgen, Mark] VA Ctr Clin Management Res CCMR, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Cousins, MM (corresponding author), Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA.	cousinma@med.umich.edu		Cousins, Matthew/0000-0003-0067-9087	National Institutes of Health [4R01DA033397]; VA Health Services Research Development [RCS 19-333]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Health Services Research Development(US Department of Veterans Affairs)	This work was supported by funding from the National Institutes of Health (https://www.nih.gov) via 4R01DA033397 to MI, which supported the overall study design, conduct and data collection. MI's time was supported by Grant RCS 19-333 from VA Health Services Research & Development. The funders did not play a role in the present analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman O, 2021, EXPERT REV PHARM OUT, V21, P1025, DOI 10.1080/14737167.2021.1854735; ( ALA) ALA, 2020, MARIJUANA LUNG HLTH; Braun IM, 2021, CANCER-AM CANCER SOC, V127, P67, DOI 10.1002/cncr.33202; Campbell G, 2018, LANCET PUBLIC HEALTH, V3, pE341, DOI 10.1016/S2468-2667(18)30110-5; Caruso R, 2017, INT REV PSYCHIATR, V29, P389, DOI 10.1080/09540261.2017.1288090; Chawla D, 2018, DRUG ALCOHOL DEPEN, V193, P177, DOI 10.1016/j.drugalcdep.2018.05.035; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Ilgen MA, 2013, DRUG ALCOHOL DEPEN, V132, P654, DOI 10.1016/j.drugalcdep.2013.04.019; Kim A, 2019, J PALLIAT MED, V22, P1196, DOI 10.1089/jpm.2018.0529; Kosinski M, 1995, SF 12 SCORE SF 12 PH; Macari DM, 2020, AM J CLIN ONCOL-CANC, V43, P636, DOI 10.1097/COC.0000000000000718; Martell K, 2018, CURR ONCOL, V25, P219, DOI 10.3747/co.25.3983; National Academies of Sciences Engineering and Medicine, 2018, LONG TERM SURV CAR C, DOI 10.17226/11993; Natl Acad Sci Engn Med, 2017, HEALTH EFFECTS OF CANNABIS AND CANNABINOIDS: THE CURRENT STATE OF EVIDENCE AND RECOMMENDATIONS FOR RESEARCH, P1, DOI 10.17226/24625; Pergam SA, 2017, CANCER-AM CANCER SOC, V123, P4488, DOI 10.1002/cncr.30879; Shi SY, 2019, CUREUS, V11, DOI 10.7759/cureus.3918; Substance Abuse and Mental Health Services Administration, 2020, HHS PUBL NSDUH, VH-55; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weinberger MI, 2011, INT J GERIATR PSYCH, V26, P21, DOI 10.1002/gps.2497; Zhang H, 2018, JAMA OTOLARYNGOL, V144, P1017, DOI 10.1001/jamaoto.2018.0486	20	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0248227	10.1371/journal.pone.0248227	http://dx.doi.org/10.1371/journal.pone.0248227			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY1VJ	33725004	Green Published, gold			2022-12-26	WOS:000629833700031
J	De Vito, A; Fiore, V; Princic, E; Geremia, N; Napodano, CMP; Muredda, AA; Maida, I; Madeddu, G; Babudieri, S				De Vito, Andrea; Fiore, Vito; Princic, Elija; Geremia, Nicholas; Napodano, Catello Mario Panu; Muredda, Alberto Augusto; Maida, Ivana; Madeddu, Giordano; Babudieri, Sergio			Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes	PLOS ONE			English	Article							CORONAVIRUS DISEASE 2019; COVID-19	Introduction Since the start of the pandemic, millions of people have been infected, with thousands of deaths. Many foci worldwide have been identified in retirement nursing homes, with a high number of deaths. Our study aims were to evaluate the spread of SARS-CoV-2 in the retirement nursing homes, the predictors to develop symptoms, and death. Methods and findings We conducted a retrospective study enrolling all people living in retirement nursing homes (PLRNH), where at least one SARS-CoV-2 infected person was present. Medical and clinical data were collected. Variables were compared with Student's t-test or Pearson chi-square test as appropriate. Uni- and multivariate analyses were conducted to evaluate variables' influence on infection and symptoms development. Cox proportional-hazards model was used to evaluate 30 days mortality predictors, considering death as the dependent variable. We enrolled 382 subjects. The mean age was 81.15 +/- 10.97 years, and males were 140(36.7%). At the multivariate analysis, mental disorders, malignancies, and angiotensin II receptor blockers were predictors of SARS-CoV-2 infection while having a neurological syndrome was associated with a lower risk. Only half of the people with SARS-CoV-2 infection developed symptoms. Chronic obstructive pulmonary disease and neurological syndrome were correlated with an increased risk of developing SARS-CoV-2 related symptoms. Fifty-six (21.2%) people with SARS-CoV-2 infection died; of these, 53 died in the first 30 days after the swab's positivity. Significant factors associated with 30-days mortality were male gender, hypokinetic disease, and the presence of fever and dyspnea. Patients' autonomy and early heparin treatment were related to lower mortality risk. Conclusions We evidenced factors associated with infection's risk and death in a setting with high mortality such as retirement nursing homes, that should be carefully considered in the management of PLRNH.	[De Vito, Andrea; Fiore, Vito; Princic, Elija; Geremia, Nicholas; Napodano, Catello Mario Panu; Muredda, Alberto Augusto; Maida, Ivana; Madeddu, Giordano; Babudieri, Sergio] Univ Sassari, Dept Med Surg & Expt Sci, Unit Infect Dis, Sassari, Italy; [Madeddu, Giordano] Univ Sassari, Mediterranean Ctr Dis Control, Sassari, Italy	University of Sassari; University of Sassari	De Vito, A (corresponding author), Univ Sassari, Dept Med Surg & Expt Sci, Unit Infect Dis, Sassari, Italy.	andreadevitoaho@gmail.com	De Vito, Andrea/AAO-3014-2020	De Vito, Andrea/0000-0002-8265-5400; BABUDIERI, SERGIO/0000-0001-7291-8687; MADEDDU, Giordano/0000-0001-6099-2273; MAIDA, Ivana/0000-0003-4895-7576				Adalja AA, 2020, JAMA-J AM MED ASSOC, V323, P1343, DOI 10.1001/jama.2020.3413; [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9; [Anonymous], COVID 19 SEX DISAGGR; Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457; Bianchetti A, 2020, J NUTR HEALTH AGING, V24, P560, DOI 10.1007/s12603-020-1389-1; Bonanad C, 2020, J AM MED DIR ASSOC, V21, P915, DOI 10.1016/j.jamda.2020.05.045; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Commission WMH, 2019, REPORT CLUSTERING PN; Covino M, 2020, GERIATR GERONTOL INT, V20, P704, DOI 10.1111/ggi.13960; Daoust JF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235590; De Vito A, 2021, EUR REV MED PHARMACO, V25, P523, DOI 10.26355/eurrev_202101_24424; De Vito A, 2020, EUR REV MED PHARMACO, V24, P7861, DOI 10.26355/eurrev_202007_22291; Du RH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00524-2020; Fan HY, 2020, NEUROPSYCH DIS TREAT, V16, P1359, DOI 10.2147/NDT.S251173; Ferini-Strambi L, 2021, J NEUROL, V268, P409, DOI 10.1007/s00415-020-10070-8; Fiolet T, 2021, CLIN MICROBIOL INFEC, V27, P19, DOI 10.1016/j.cmi.2020.08.022; Fosbol EL, 2020, JAMA-J AM MED ASSOC, V324, P168, DOI 10.1001/jama.2020.11301; Geremia N, 2020, INFECT DIS CLIN PRAC, V28, pE30, DOI 10.1097/IPC.0000000000000952; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guarneri C, 2020, J EUR ACAD DERMATOL, V34, pE449, DOI 10.1111/jdv.16669; Guo T, 2020, GERONTOLOGY, V66, P467, DOI 10.1159/000508734; He JJ, 2021, J MED VIROL, V93, P820, DOI 10.1002/jmv.26326; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Johnson HD, 2003, PERCEPT MOTOR SKILL, V97, P805, DOI 10.2466/PMS.97.7.805-810; Khan SH, 2020, DRUGS THER PERSPECT, V36, P347, DOI 10.1007/s40267-020-00750-w; Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1; Kipshidze N, 2020, CLIN APPL THROMB-HEM, V26, DOI 10.1177/1076029620936776; Lee TC, 2020, INT J INFECT DIS, V98, P216, DOI 10.1016/j.ijid.2020.06.095; Leung JM, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00688-2020; Li JY, 2020, JAMA CARDIOL, V5, P825, DOI 10.1001/jamacardio.2020.1624; Liu K, 2020, J INFECTION, V80, pE14, DOI 10.1016/j.jinf.2020.03.005; Louie JK, 2021, CLIN INFECT DIS, V72, P2018, DOI 10.1093/cid/ciaa1020; Marietta M, 2020, BLOOD TRANSFUS-ITALY, V18, P167, DOI 10.2450/2020.0083-20; Million M, 2020, NEW MICROB NEW INFEC, V38, DOI 10.1016/j.nmni.2020.100709; Mishra AK, 2020, MONALDI ARCH CHEST D, V90, P333, DOI 10.4081/monaldi.2020.1341; Molina JM, 2020, MED MALADIES INFECT, V50, P384, DOI 10.1016/j.medmal.2020.03.006; Monforte AD, 2020, INT J INFECT DIS, V99, P75, DOI 10.1016/j.ijid.2020.07.056; Niu SM, 2020, ARCH GERONTOL GERIAT, V89; Paar V, 2021, J THROMB THROMBOLYS, V51, P226, DOI 10.1007/s11239-020-02212-6; Poterucha TJ, 2017, THROMB HAEMOSTASIS, V117, P437, DOI 10.1160/TH16-08-0620; Rosenberg ES, 2020, JAMA-J AM MED ASSOC, V323, P2493, DOI 10.1001/jama.2020.8630; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Seffer MT, 2021, BLOOD PURIFICAT, V50, P28, DOI 10.1159/000508647; Shelkey M, 2001, HOME HLTH NURSE, V19, P323, DOI DOI 10.1097/00004045-200105000-00020; Stoessl AJ, 2020, MOVEMENT DISORD, V35, P709, DOI 10.1002/mds.28069; Tang N, 2020, J THROMB HAEMOST, V18, P1094, DOI 10.1111/jth.14817; Vaira LA, 2020, HEAD NECK-J SCI SPEC, V42, P1560, DOI 10.1002/hed.26269; Vaira LA, 2020, HEAD NECK-J SCI SPEC, V42, P1252, DOI 10.1002/hed.26204; Wang J, 2020, ENVIRON POLLUT, V266, DOI 10.1016/j.envpol.2020.115161; Wang L, 2020, J INFECTION, V80, P639, DOI 10.1016/j.jinf.2020.03.019; Watkins J, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m810; WHO, 2020, INFECT PREVENTION CO; World Health Organization, 2020, 191 WHO; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zinellu A, 2021, EUR J CLIN INVEST, V51, DOI 10.1111/eci.13427	56	38	38	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0248009	10.1371/journal.pone.0248009	http://dx.doi.org/10.1371/journal.pone.0248009			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY1VJ	33724987	gold, Green Published			2022-12-26	WOS:000629833700018
J	Hendrix, B; Hoffer, P; Sanders, R; Schwartz, S; Zheng, W; Eads, B; Taylor, D; Deikman, J				Hendrix, Bill; Hoffer, Paul; Sanders, Rick; Schwartz, Steve; Zheng, Wei; Eads, Brian; Taylor, Danielle; Deikman, Jill			Systemic GFP silencing is associated with high transgene expression in Nicotiana benthamiana	PLOS ONE			English	Article								Gene silencing in plants using topical dsRNA is a new approach that has the potential to be a sustainable component of the agricultural production systems of the future. However, more research is needed to enable this technology as an economical and efficacious supplement to current crop protection practices. Systemic gene silencing is one key enabling aspect. The objective of this research was to better understand topically-induced, systemic transgene silencing in Nicotiana benthamiana. A previous report details sequencing of the integration site of the Green Fluorescent Protein (GFP) transgene in the well-known N. benthamiana GFP16C event. This investigation revealed an inadvertent co-integration of part of a bacterial transposase in this line. To determine the effect of this transgene configuration on systemic silencing, new GFP transgenic lines with or without the transposase sequences were produced. GFP expression levels in the 19 single-copy events and three hemizygous GFP16C lines produced for this study ranged from 50-72% of the homozygous GFP16C line. GFP expression was equivalent to GFP16C in a two-copy event. Local GFP silencing was observed in all transgenic and GFP16C hemizygous lines after topical application of carbon dot-based formulations containing a GFP targeting dsRNA. The GFP16C-like systemic silencing phenotype was only observed in the two-copy line. The partial transposase had no impact on transgene expression level, local GFP silencing, small RNA abundance and distribution, or systemic GFP silencing in the transgenic lines. We conclude that high transgene expression level is a key enabler of topically-induced, systemic transgene silencing in N. benthamiana.	[Hendrix, Bill; Hoffer, Paul; Sanders, Rick; Schwartz, Steve; Zheng, Wei; Deikman, Jill] Bayer Crop Sci, Woodland, CA 95605 USA; [Eads, Brian; Taylor, Danielle] Bayer Crop Sci, Chesterfield Pkwy, St Louis, MO USA; [Hendrix, Bill] Bayer Crop Sci, West Sacramento, CA 95605 USA; [Hoffer, Paul] Governors Off Emergency Serv, Radiol Preparedness Unit, Mather, CA USA; [Schwartz, Steve] InnerPlant, Davis, CA USA; [Zheng, Wei] Hangzhou Huadi Grp Co, Hangzhou, Peoples R China	Bayer AG; Bayer CropScience; Bayer AG; Bayer CropScience; Bayer AG; Bayer CropScience	Hendrix, B (corresponding author), Bayer Crop Sci, Woodland, CA 95605 USA.; Hendrix, B (corresponding author), Bayer Crop Sci, West Sacramento, CA 95605 USA.	bill.hendrix@bayer.com		Deikman, Jill/0000-0003-3210-8334; Hendrix, BIll/0000-0001-8799-1254	Bayer Crop Science	Bayer Crop Science(Bayer AG)	Monsanto Company (now Bayer Crop Science) provided support in the form of salaries for all authors as well as logistical support for the studies. The funder reviewed and approved the manuscript for publication but did not play a direct role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of authors are detailed in the `author contribution' section.	Alder MN, 2003, RNA, V9, P25, DOI 10.1261/rna.2650903; Bai SL, 2011, J EXP BOT, V62, P4561, DOI 10.1093/jxb/err163; Bally J, 2018, ANNU REV PHYTOPATHOL, V56, P405, DOI 10.1146/annurev-phyto-080417-050141; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Bennett M, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00816; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen WW, 2018, PLANT PHYSIOL, V176, P2700, DOI 10.1104/pp.17.01828; Clemente T, 2006, METH MOL B, V343, P143; Dadami E, 2014, RNA BIOL, V11, P934, DOI 10.4161/rna.29623; Dalakouras A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01327; Demirer GS, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz0495; Gonsalves D, 1998, ANNU REV PHYTOPATHOL, V36, P415, DOI 10.1146/annurev.phyto.36.1.415; Halterman D, 2016, AM J POTATO RES, V93, P1, DOI 10.1007/s12230-015-9485-1; Hendrix B., 2020, TOPICALLY DELIVERED, VbioRxiv 2004 2020 052076; Kalantidis K, 2006, PLANT J, V45, P1006, DOI 10.1111/j.1365-313X.2006.02664.x; Koscianska E, 2005, PLANT MOL BIOL, V59, P647, DOI 10.1007/s11103-005-0668-x; Kotakis C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-220; KRAMER MG, 1994, EUPHYTICA, V79, P293, DOI 10.1007/BF00022530; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; McHale M, 2013, PLANT J, V76, P519, DOI 10.1111/tpj.12306; Mermigka G, 2016, J INTEGR PLANT BIOL, V58, P328, DOI 10.1111/jipb.12423; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Philips JG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171311; Pyott DE, 2015, PLANT BIOTECHNOL J, V13, P306, DOI 10.1111/pbi.12353; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Schwartz SH, 2020, PLANT PHYSIOL, V184, P647, DOI 10.1104/pp.20.00733; Siegfried BD, 2005, J ECON ENTOMOL, V98, P1320, DOI 10.1603/0022-0493-98.4.1320; SMITH CJS, 1990, MOL GEN GENET, V224, P477, DOI 10.1007/BF00262443; Taochy C, 2017, PLANT PHYSIOL, V175, P1424, DOI 10.1104/pp.17.01181; Tournier B, 2006, PLANT J, V47, P383, DOI 10.1111/j.1365-313X.2006.02796.x; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Wagner N, 2011, PLANT BIOTECHNOL J, V9, P723, DOI 10.1111/j.1467-7652.2010.00573.x; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Yang SJ, 2004, P NATL ACAD SCI USA, V101, P6297, DOI 10.1073/pnas.0304346101; Zhang H, 2019, P NATL ACAD SCI USA, V116, P7543, DOI 10.1073/pnas.1818290116; Zilberman D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-249	42	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0245422	10.1371/journal.pone.0245422	http://dx.doi.org/10.1371/journal.pone.0245422			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720987	Green Published, gold, Green Submitted			2022-12-26	WOS:000629667400031
J	Kim, SB; Kim, DS; Mo, XM				Kim, Steven B.; Kim, Dong Sub; Mo, Xiaoming			An image segmentation technique with statistical strategies for pesticide efficacy assessment	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; BETA REGRESSION; UAV TECHNOLOGY; HERBICIDE	Image analysis is a useful technique to evaluate the efficacy of a treatment for weed control. In this study, we address two practical challenges in the image analysis. First, it is challenging to accurately quantify the efficacy of a treatment when an entire experimental unit is not affected by the treatment. Second, RGB codes, which can be used to identify weed growth in the image analysis, may not be stable due to various surrounding factors, human errors, and unknown reasons. To address the former challenge, the technique of image segmentation is considered. To address the latter challenge, the proportion of weed area is adjusted under a beta regression model. The beta regression is a useful statistical method when the outcome variable (proportion) ranges between zero and one. In this study, we attempt to accurately evaluate the efficacy of a 35% hydrogen peroxide (HP). The image segmentation was applied to separate two zones, where the HP was directly applied (gray zone) and its surroundings (nongray zone). The weed growth was monitored for five days after the treatment, and the beta regression was implemented to compare the weed growth between the gray zone and the control group and between the nongray zone and the control group. The estimated treatment effect was substantially different after the implementation of image segmentation and the adjustment of green area.	[Kim, Steven B.; Mo, Xiaoming] Calif State Univ Monterey Bay, Dept Math & Stat, Seaside, CA USA; [Kim, Dong Sub] Univ Calif Davis, Dept Plant Sci, Salinas, CA 93901 USA	California State University System; California State University Monterey Bay; University of California System; University of California Davis	Kim, DS (corresponding author), Univ Calif Davis, Dept Plant Sci, Salinas, CA 93901 USA.	vdskim@ucdavis.edu						ADAMS CD, 1995, OZONE-SCI ENG, V17, P149, DOI 10.1080/01919519508547543; Ahmad J, 2018, COMPUT IND, V98, P23, DOI 10.1016/j.compind.2018.02.005; Ait Skourt B, 2018, PROCEDIA COMPUT SCI, V127, P109, DOI 10.1016/j.procs.2018.01.104; Chang IS, 1997, APPL ENVIRON MICROB, V63, P1; Chen HY, 2019, OPT LASER ENG, V118, P22, DOI 10.1016/j.optlaseng.2019.01.016; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Gade R, 2014, MACH VISION APPL, V25, P245, DOI 10.1007/s00138-013-0570-5; Gee C, 2008, COMPUT ELECTRON AGR, V60, P49, DOI 10.1016/j.compag.2007.06.003; Goodrich B., 2020, RSTANARM BAYESIAN AP, V2, P1; Hess FD, 2000, WEED SCI, V48, P160, DOI 10.1614/0043-1745(2000)048[0160:LDHAO]2.0.CO;2; Huang HS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196302; KAY SH, 1983, J AQUAT PLANT MANAGE, V21, P38; Kim DS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222695; Kolodziejczyk A., 2014, J MED INFORM TECHNOL, V23, P77; Lefevre M, 2003, ELECTROCHIM ACTA, V48, P2749, DOI 10.1016/S0013-4686(03)00393-1; Lopez-Granados F, 2016, PRECIS AGRIC, V17, P183, DOI 10.1007/s11119-015-9415-8; Lu HG, 1999, PHYSIOL MOL PLANT P, V54, P131, DOI 10.1006/pmpp.1998.0195; Ma JunCheng, 2019, Information Processing in Agriculture, V6, P216; Mabrouk E, 2019, J COMPUT SCI-NETH, V31, P111, DOI 10.1016/j.jocs.2019.01.002; Mather PM., 1999, COMPUTER PROCESSING, V3; Mohan A, 2018, ALEX ENG J, V57, P787, DOI 10.1016/j.aej.2017.01.020; Onyango CM, 2001, IMAGE VISION COMPUT, V19, P523, DOI 10.1016/S0262-8856(00)00097-4; Pena JM, 2015, SENSORS-BASEL, V15, P5609, DOI 10.3390/s150305609; Qin GZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021945; QUIMBY PC, 1981, J AQUAT PLANT MANAGE, V19, P53; R Core Team, 2020, R LANG ENV STAT COMP; Sa I., 2018, REMOTE SENS-BASEL, V10, P1; Santos TT., 2020, COMPUT ELECTRON AGR, V170, P1; Sapkota B., 2020, REMOTE SENS-BASEL, V12, P1; Tang JL, 2016, COMPUT ELECTRON AGR, V122, P103, DOI 10.1016/j.compag.2015.12.016; Tucker KP, 2006, WEED TECHNOL, V20, P745, DOI 10.1614/WT-04-316R1.1; Wang AC, 2019, COMPUT ELECTRON AGR, V158, P226, DOI 10.1016/j.compag.2019.02.005; Xu YL, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18124245; Yang W, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229651; Yu JL, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01422; Zhang L, 2019, NEUROCOMPUTING, V334, P59, DOI 10.1016/j.neucom.2019.01.003; Zhang S., 2019, FRONTIERS COMPUTER S, V1, P1	38	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0248592	10.1371/journal.pone.0248592	http://dx.doi.org/10.1371/journal.pone.0248592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720980	Green Published, gold			2022-12-26	WOS:000629667400010
J	Rodriguez, J; Paton, M; Uratani, JM; Acuna, JM				Rodriguez, Jorge; Paton, Mauricio; Uratani, Joao M.; Acuna, Juan M.			Modelling the impact of interventions on the progress of the COVID-19 outbreak including age segregation	PLOS ONE			English	Article							MATHEMATICAL-MODELS; EPIDEMIC; TRANSMISSION	In this work, a SEIR-type mathematical model of the COVID-19 outbreak was developed that describes individuals in compartments by infection stage and age group. The model assumes a close well-mixed community with no migrations. Infection rates and clinical and epidemiological information govern the transitions between stages of the disease. The impact of specific interventions (including the availability of critical care) on the outbreak time course, the number of cases and the outcome of fatalities were evaluated. Data available from the COVID-19 outbreak from Spain as of mid-May 2020 was used. Key findings in our model simulation results indicate that (i) universal social isolation measures appear effective in reducing total fatalities only if they are strict and the number of daily interpersonal contacts is reduced to very low numbers; (ii) selective isolation of only the elderly (at higher fatality risk) appears almost as effective as universal isolation in reducing total fatalities but at a possible lower economic and social impact; (iii) an increase in the number of critical care capacity directly avoids fatalities; (iv) the use of personal protective equipment (PPE) appears to be effective to dramatically reduce total fatalities when adopted extensively and to a high degree; (v) extensive random testing of the population for more complete infection recognition (accompanied by subsequent self-isolation of infected aware individuals) can dramatically reduce the total fatalities only above a high percentage threshold that may not be practically feasible.	[Rodriguez, Jorge; Paton, Mauricio; Uratani, Joao M.] Khalifa Univ, Coll Engn, Dept Chem Engn, Abu Dhabi, U Arab Emirates; [Acuna, Juan M.] Khalifa Univ, Coll Med, Dept Epidemiol & Publ Hlth, Abu Dhabi, U Arab Emirates	Khalifa University of Science & Technology; Khalifa University of Science & Technology	Rodriguez, J (corresponding author), Khalifa Univ, Coll Engn, Dept Chem Engn, Abu Dhabi, U Arab Emirates.	jorge.rodriguez@ku.ac.ae	Rodriguez R., Jorge/A-9879-2008	Rodriguez R., Jorge/0000-0002-5936-9676; Paton, Mauricio/0000-0002-1869-4448; Uratani, Joao/0000-0002-3579-7297	Khalifa University [8474000317 CRPA-2020-SEHA]	Khalifa University	This study was supported by Khalifa University in the form of a grant awarded to JR (8474000317 CRPA-2020-SEHA).	Adam D, 2020, NATURE, V583, P346, DOI 10.1038/d41586-020-02009-w; Berezovsky F, 2005, MATH BIOSCI ENG, V2, P133; Chang SL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19393-6; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Chowell G, 2016, PHYS LIFE REV, V18, P66, DOI 10.1016/j.plrev.2016.07.005; Davies NG, 2020, LANCET PUBLIC HEALTH, V5, pE375, DOI 10.1016/S2468-2667(20)30133-X; De Serres G, 2000, AM J EPIDEMIOL, V151, P1039, DOI 10.1093/oxfordjournals.aje.a010145; Delamater PL, 2019, EMERG INFECT DIS, V25, P1, DOI 10.3201/eid2501.171901; Eikenberry SE, 2020, INFECT DIS MODEL, V5, P293, DOI 10.1016/j.idm.2020.04.001; Gatto M, 2020, P NATL ACAD SCI USA, V117, P10484, DOI 10.1073/pnas.2004978117; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; Gostic KM, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008409; Grassly NC, 2008, NAT REV MICROBIOL, V6, P477, DOI 10.1038/nrmicro1845; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; ISCIII, 2020, SIT COVID 19 COR ESP; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Kyrychko YN, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76710-1; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; MAY RM, 1979, NATURE, V280, P455, DOI 10.1038/280455a0; Ngonghala CN, 2020, MATH BIOSCI, V325, DOI 10.1016/j.mbs.2020.108364; Nishiura H., 2009, MATH STAT ESTIMATION, P103, DOI [DOI 10.1007/978-90-481-2313-1_5, 10.1007/978-90-481-2313-1_5]; Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020; Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Roosa K, 2020, INFECT DIS MODEL, V5, P256, DOI 10.1016/j.idm.2020.02.002; Salje H, 2020, SCIENCE, V369, P208, DOI 10.1126/science.abc3517; Sarkar K, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110049; Tang B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020462; van Zandvoort K, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01789-2; Wallis N, 2020, AM J HEALTH-SYST PH, V77, P1547, DOI 10.1093/ajhp/zxaa211; Wang L, 2020, FIGURE 1 COVID 19 CH; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zou D., 2020, EPIDEMIC MODEL GUIDE, DOI [10.1101/2020.05.24.20111989, DOI 10.1101/2020.05.24.20111989, 10.1101/2020.05.24.20111989v1]	37	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0248243	10.1371/journal.pone.0248243	http://dx.doi.org/10.1371/journal.pone.0248243			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720988	Green Published, gold, Green Submitted			2022-12-26	WOS:000629667400021
J	Birhanu, L; Bekele, T; Tesfaw, B; Demissew, S				Birhanu, Liyew; Bekele, Tamrat; Tesfaw, Binyam; Demissew, Sebsebe			Relationships between topographic factors, soil and plant communities in a dry Afromontane forest patches of Northwestern Ethiopia	PLOS ONE			English	Article								Plant community types are influenced by topographic factors, the physical and chemical properties of soil. Therefore, the study was carried out to investigate the relationships of soil and topographic factors on the distribution of species and plant community formation of the Dega Damot district in Northwestern Ethiopia. Vegetation and environmental data were collected from 86 plots (900 m(2)). Agglomerative hierarchical cluster analysis and redundancy analysis (RDA) with R software were used to identify plant communities and analyze the relationship between plant community types and environmental variables. Five plant community types were identified: Erica arborea-Osyris quadripartita, Discopodium penninervium-Echinops pappii, Olea europaea -Scolopia theifolia, Euphorbia abyssinica-Prunus africana, Dodonaea anguistifolia-Acokanthera schimperi. The RDA result showed that the variation of species distribution and plant community formation were significantly related to altitude, organic matter, moisture content, slope, sand, pH, EC, total nitrogen and phosphorus. Our results suggest that the variation of plant communities (Community 1, 2, 3, and 4) were closely related to environmental factors, including altitude, moisture content, OM, slope, sand, pH, EC, soil nitrogen, and phosphorus, among which altitude was the most important one. However, all the measured environmental variables are not correlated to Dodonaea anguistifolia-Acokanthera schimperi community type. Therefore, it can be concluded that some other environmental variables may influence the species composition, which is needed to be further investigated.	[Birhanu, Liyew] Debre Markos Univ, Coll Nat & Computat Sci, Dept Biol, Debre Markos, Ethiopia; [Bekele, Tamrat; Demissew, Sebsebe] Addis Ababa Univ, Dept Plant Biol & Biodivers Management, Addis Ababa, Ethiopia; [Tesfaw, Binyam] Addis Ababa Univ, Sch Earth Sci, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University	Birhanu, L (corresponding author), Debre Markos Univ, Coll Nat & Computat Sci, Dept Biol, Debre Markos, Ethiopia.	liyewmtu@gmail.com			Addis Ababa University	Addis Ababa University	This research was funded by Addis Ababa University. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abella SR, 2006, PLANT ECOL, V185, P255, DOI 10.1007/s11258-006-9102-y; Alelign Alemnew, 2007, Tropical Ecology, V48, P37; Amorim PK, 2007, ACTA OECOL, V32, P319, DOI 10.1016/j.actao.2007.06.003; BEKELE T, 1994, J VEG SCI, V5, P87, DOI 10.2307/3235642; Bekele T., 1993, VAXTGEOGRAFISKA SALL, P01; Berhanu A, 2017, THESIS ADDIS ABABA U; Berhanu A, 2017, J FORESTRY RES, V28, P343, DOI 10.1007/s11676-016-0329-8; Birhanu L, 2019, REMOTE SENS APPL, V16, DOI 10.1016/j.rsase.2019.100260; Burke A, 2001, J VEG SCI, V12, P53, DOI 10.1111/j.1654-1103.2001.tb02616.x; Chapin F.S.I.I.I., 2002, PRINCIPLES TERRESTRI; De C?ceres M., 2013, USE INDICSPECIES PAC; Dewan H.C., 1987, DPETH82011 NSSP; EGIZIABHER TG, 1988, MT RES DEV, V8, P211; Ensermu Kelbessa, 2008, Sinet, Ethiopian Journal of Science, V31, P121; Fadrique B, 2016, J VEG SCI, V27, P958, DOI 10.1111/jvs.12427; FAO, 1986, ETH HIGHL RECL STUD; Friis I., 1992, KEW B ADDITIONAL SER, VXV; Friis Ib, 2010, Kongelige Danske Videnskabernes Selskab Biologiske Skrifter, V58, P9; Froumsia M., 2012, Journal of Ecology and the Natural Environment, V4, P333; Haile Yineger, 2008, Sinet, Ethiopian Journal of Science, V31, P103; HEDBERG OLOV, 1964, ACTA PHYTOGEOGR SUECICA, V49, P1; Houba V.J.G, 1989, SOIL PLANT ANAL SE 5, DOI [10.1016/0378-1097%2889%2990224-3, DOI 10.1016/0378-1097%2889%2990224-3]; Jarema SI, 2009, GLOBAL CHANGE BIOL, V15, P508, DOI 10.1111/j.1365-2486.2008.01732.x; KallWar J.S., 1982, ANAL AGR CHEM; Katabuchi M, 2012, J ECOL, V100, P643, DOI [10.1111/J.1365-2745.2011.01937.x, 10.1111/j.1365-2745.2011.01937.x]; Kebede M., 2013, Biodiversity: Research and Conservation, V29, P63; Kent M., 2012, VEGETATION DESCRIPTI; Khurana E, 2001, ENVIRON CONSERV, V28, P39, DOI 10.1017/S0376892901000042; Korner C, 2000, TRENDS ECOL EVOL, V15, P513, DOI 10.1016/S0169-5347(00)02004-8; Kumelachew Yeshitela, 2002, Sinet, Ethiopian Journal of Science, V25, P155; Legendre P., 2012, NUMERICAL ECOLOGY; [刘世梁 Liu Shiliang], 2003, [植物生态学报, Acta Phytoecologica Sinica], V27, P496; Liu Y, 2007, CHINESE SCI BULL, V52, P50, DOI 10.1007/s11434-007-7006-4; Liyew Birhanu, 2018, Journal of Ecology and the Natural Environment, V10, P53, DOI 10.5897/JENE2018.0688; Lovett J.C., 1993, BIOGEOGRAPHY ECOLOGY; Lulekal E., 2014, THESIS ADDIS ABABA U; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McLaren KP, 2003, FOREST ECOL MANAG, V183, P61, DOI 10.1016/S0378-1127(03)00100-2; Naeem S., 2009, ECOSYSTEM FUNCTIONIN; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Olsen SR, 1965, METHODS SOIL ANAL, V9, P920, DOI DOI 10.2134/AGRONMONOGR9.2.C22; Poulos HM, 2007, PLANT ECOL, V193, P15, DOI 10.1007/s11258-006-9245-x; Pugnaire FI, 2011, J ARID ENVIRON, V75, P1310, DOI 10.1016/j.jaridenv.2011.01.016; R Development Core Team, 2018, PROGR ENV DAT AN GRA; Rad JE, 2010, FLORA, V205, P721, DOI 10.1016/j.flora.2010.04.015; Ryding O., 2001, BIODIVERSITY RES HOR; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schaetzl RJ, 2005, SOILS: GENESIS AND GEOMORPHOLOGY, P1, DOI 10.1017/CBO9780511815560; Senbeta Feyera, SINET ETHIOPIAN J SC, V37, P113; Solon J, 2007, CATENA, V71, P309, DOI 10.1016/j.catena.2007.01.006; Stewart BA, 2001, ASSESSMENT METHODS S; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Tadele D, 2014, J FORESTRY RES, V25, P329, DOI 10.1007/s11676-013-0420-3; Tadesse M., 2004, FLORA ETHIOPIA ERITR, V4 2; Teketay Demel, 1995, Feddes Repertorium, V106, P127; ter Braak CJF, 2015, PLANT ECOL, V216, P683, DOI 10.1007/s11258-014-0356-5; Thompson L.M., 1979, SOILS SOIL FERTILIT; Tilahun Abiyou, 2011, ETHIOPIAN J BIOL SCI, V10, P111; Toledo M, 2012, J ECOL, V100, P253, DOI 10.1111/j.1365-2745.2011.01890.x; Urban DL, 2000, LANDSCAPE ECOL, V15, P603, DOI 10.1023/A:1008183331604; van Reeuwijk L.P., 1992, PROCEDURE SOIL ANAL; VANDERMAAREL E, 1979, VEGETATIO, V39, P97, DOI 10.1007/BF00052021; Vivero J., 2005, RED LIST ENDEMIC TRE; Wale Haile Adamu, 2012, Journal of Forestry Research (Harbin), V23, P599, DOI 10.1007/s11676-012-0300-2; White F., 1983, VEGETATION AFRICA DE, P356; Whittaker Robert J., 2003, P107; Wijesinghe DK, 2005, J ECOL, V93, P99, DOI 10.1111/j.0022-0477.2004.00934.x; WOLDU Z, 1989, VEGETATIO, V81, P189, DOI 10.1007/BF00045524; Woldu Z., 2017, COMPREHENSIVE ANAL V; Yavitt JB, 2009, AUST J SOIL RES, V47, P674, DOI 10.1071/SR08258; Zegeye Haileab, 2011, Journal of Forestry Research (Harbin), V22, P315, DOI 10.1007/s11676-011-0176-6; Zhang JT, 2010, ECOL ENG, V36, P345, DOI 10.1016/j.ecoleng.2009.04.001	73	2	2	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0247966	10.1371/journal.pone.0247966	http://dx.doi.org/10.1371/journal.pone.0247966			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711027	gold, Green Published			2022-12-26	WOS:000629591800030
J	Seiron, P; Stenwall, A; Hedin, A; Granlund, L; Esguerra, JLS; Volkov, P; Renstrom, E; Korsgren, O; Lundberg, M; Skog, O				Seiron, Peter; Stenwall, Anton; Hedin, Anders; Granlund, Louise; Esguerra, Jonathan Lou S.; Volkov, Petr; Renstrom, Erik; Korsgren, Olle; Lundberg, Marcus; Skog, Oskar			Transcriptional analysis of islets of Langerhans from organ donors of different ages	PLOS ONE			English	Article							HUMAN PANCREATIC-ISLETS; ENRICHMENT ANALYSIS; BETA-CELLS; GLUCOSE; OSTEOPONTIN; SENESCENCE; REVEALS; MARKERS	Insulin secretion is impaired with increasing age. In this study, we aimed to determine whether aging induces specific transcriptional changes in human islets. Laser capture microdissection was used to extract pancreatic islet tissue from 37 deceased organ donors aged 1-81 years. The transcriptomes of the extracted islets were analysed using Ion AmpliSeq sequencing. 346 genes that co-vary significantly with age were found. There was an increased transcription of genes linked to senescence, and several aspects of the cell cycle machinery were downregulated with increasing age. We detected numerous genes not linked to aging in previous studies likely because earlier studies analysed islet cells isolated by enzymatic digestion which might affect the islet transcriptome. Among the novel genes demonstrated to correlate with age, we found an upregulation of SPP1 encoding osteopontin. In beta cells, osteopontin has been seen to be protective against both cytotoxicity and hyperglycaemia. In summary, we present a transcriptional profile of aging in human islets and identify genes that could affect disease course in diabetes.	[Seiron, Peter; Stenwall, Anton; Hedin, Anders; Granlund, Louise; Korsgren, Olle; Lundberg, Marcus; Skog, Oskar] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Esguerra, Jonathan Lou S.; Volkov, Petr; Renstrom, Erik] Lund Univ, Dept Clin Sci Malmo, Diabet Ctr, Malmo, Sweden; [Korsgren, Olle] Univ Gothenburg, Inst Med, Gothenburg, Sweden	Uppsala University; Lund University; University of Gothenburg	Seiron, P (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden.	peter.seiron@igp.uu.se	; Esguerra, Jonathan/M-2366-2014	Lundberg, Marcus/0000-0001-7916-2237; Korsgren, Olle/0000-0002-8524-9547; Granlund, Louise/0000-0002-2888-486X; Esguerra, Jonathan/0000-0001-8454-6606	Swedish Medical Research Council [2019-01415]; Novo Nordisk Foundation; Magnus Bergvall foundation; Ake Wiberg foundation; Tore Nilsson foundation; Sten A Olsson Foundation; Ernfors Family Fund; Barndiabetesfonden; Diabetesfonden; Diabetes Wellness Foundation Sweden Junior Grants [720-747 JDWG]; Juvenile Diabetes Foundation International, an EFSD/Novo Nordisk Grant; Helmsley Charitable Trust; Swedish national strategic research initiative Excellence of Diabetes Research in Sweden (EXODIAB); Juvenile Diabetes Research Foundation; RFI/VR and Science for Life Laboratory, Sweden	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Magnus Bergvall foundation; Ake Wiberg foundation; Tore Nilsson foundation; Sten A Olsson Foundation; Ernfors Family Fund; Barndiabetesfonden; Diabetesfonden; Diabetes Wellness Foundation Sweden Junior Grants; Juvenile Diabetes Foundation International, an EFSD/Novo Nordisk Grant; Helmsley Charitable Trust; Swedish national strategic research initiative Excellence of Diabetes Research in Sweden (EXODIAB); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); RFI/VR and Science for Life Laboratory, Sweden	This study was supported by grants from the Swedish Medical Research Council (2019-01415), the Novo Nordisk Foundation, the Magnus Bergvall foundation, the Ake Wiberg foundation, the Tore Nilsson foundation, the Sten A Olsson Foundation, the Ernfors Family Fund, Barndiabetesfonden, Diabetesfonden, the Diabetes Wellness Foundation Sweden Junior Grants (separately to O.S. [720-747 JDWG], as well as ML), the Juvenile Diabetes Foundation International, an EFSD/Novo Nordisk Grant, and the Helmsley Charitable Trust. Human pancreatic biopsies and isolated islets were obtained from the Nordic Network for Clinical Islet Transplantation, supported by the Swedish national strategic research initiative Excellence of Diabetes Research in Sweden (EXODIAB) and the Juvenile Diabetes Research Foundation. Work performed at the NGI/Uppsala Genome Center has been funded by RFI/VR and Science for Life Laboratory, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Mazzucato C, 2019, CELL METAB, V30, P129, DOI 10.1016/j.cmet.2019.05.006; Aguayo-Mazzucato C, 2017, CELL METAB, V25, P898, DOI 10.1016/j.cmet.2017.03.015; AMMON HPT, 1987, J PHYSIOL-LONDON, V384, P347, DOI 10.1113/jphysiol.1987.sp016458; Arafat HA, 2007, ENDOCRINOLOGY, V148, P575, DOI 10.1210/en.2006-0970; Arda HE, 2016, CELL METAB, V23, P909, DOI 10.1016/j.cmet.2016.04.002; Barker Christopher J, 2015, Adv Biol Regul, V57, P112, DOI 10.1016/j.jbior.2014.09.005; Basu R, 2003, DIABETES, V52, P1738, DOI 10.2337/diabetes.52.7.1738; Bugliani M, 2013, MOL CELL ENDOCRINOL, V367, P1, DOI 10.1016/j.mce.2012.12.001; Butler AE, 2015, DIABETES, V64, P2698, DOI 10.2337/db15-0550; Cai MY, 2018, BIOCHEM BIOPH RES CO, V495, P1426, DOI 10.1016/j.bbrc.2017.11.147; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Chang AM, 2003, AM J PHYSIOL-ENDOC M, V284, pE7, DOI 10.1152/ajpendo.00366.2002; Cnop M, 2010, DIABETOLOGIA, V53, P321, DOI 10.1007/s00125-009-1562-x; Danielsson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115421; Fadista J, 2014, P NATL ACAD SCI USA, V111, P13924, DOI 10.1073/pnas.1402665111; GUMBINER B, 1989, DIABETES, V38, P1549, DOI 10.2337/diabetes.38.12.1549; Gunasekaran U, 2011, AGING-US, V3, P565, DOI 10.18632/aging.100350; Hao W, 2016, DIABETES CARE, V39, P1664, DOI 10.2337/dc16-0360; Helman A, 2016, DIABETES OBES METAB, V18, P58, DOI 10.1111/dom.12719; Helman A, 2016, NAT MED, V22, P412, DOI 10.1038/nm.4054; Jassal B, 2020, NUCLEIC ACIDS RES, V48, pD498, DOI 10.1093/nar/gkz1031; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kushner JA, 2013, J CLIN INVEST, V123, P990, DOI 10.1172/JCI64095; Lam CJ, 2018, DIABETES, V67, P674, DOI 10.2337/db17-1114; Lawlor N, 2017, GENOME RES, V27, P208, DOI 10.1101/gr.212720.116; Maza E, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00164; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Munakata Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19765-5; Perl S, 2010, J CLIN ENDOCR METAB, V95, pE234, DOI 10.1210/jc.2010-0932; Rankin MM, 2010, ISLETS, V2, P345, DOI 10.4161/isl.2.6.13376; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Skog O, 2020, ACTA DIABETOL, V57, P503, DOI 10.1007/s00592-019-01420-8; Smeets S, 2020, DIABETES, V69, P401, DOI 10.2337/db19-0529; Solimena M, 2018, DIABETOLOGIA, V61, P641, DOI 10.1007/s00125-017-4500-3; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson PJ, 2019, CELL METAB, V29, P1045, DOI 10.1016/j.cmet.2019.01.021; Westacott MJ, 2017, DIABETES, V66, P2436, DOI 10.2337/db17-0137; Xin YR, 2016, CELL METAB, V24, P608, DOI 10.1016/j.cmet.2016.08.018; Zhao JJ, 2017, HUM MUTAT, V38, P1394, DOI 10.1002/humu.23268	45	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0247888	10.1371/journal.pone.0247888	http://dx.doi.org/10.1371/journal.pone.0247888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711030	Green Published, gold			2022-12-26	WOS:000629591800034
J	Gao, SH; Wang, F; Niran, JTW; Li, N; Yin, YX; Yu, CY; Jiao, CH; Yao, MH				Gao, Shenghua; Wang, Fei; Niran, Juntawong; Li, Ning; Yin, Yanxu; Yu, Chuying; Jiao, Chunhai; Yao, Minghua			Transcriptome analysis reveals defense-related genes and pathways against Xanthomonas campestris pv. vesicatoria in pepper (Capsicum annuum L.)	PLOS ONE			English	Article								Bacterial spot (BS), incited by Xanthomonas campestris pv. vesicatoria (Xcv), is one of the most serious diseases of pepper. For a comparative analysis of defense responses to Xcv infection, we performed a transcriptomic analysis of a susceptible cultivar, ECW, and a resistant cultivar, VI037601, using the HiSeq(TM) 2500 sequencing platform. Approximately 120.23 G clean bases were generated from 18 libraries. From the libraries generated, a total of 38,269 expressed genes containing 11,714 novel genes and 11,232 differentially expressed genes (DEGs) were identified. Functional enrichment analysis revealed that the most noticeable pathways were plant-pathogen interaction, MAPK signaling pathway-plant, plant hormone signal transduction and secondary metabolisms. 1,599 potentially defense-related genes linked to pattern recognition receptors (PRRs), mitogen-activated protein kinase (MAPK), calcium signaling, and transcription factors may regulate pepper resistance to Xcv. Moreover, after Xcv inoculation, 364 DEGs differentially expressed only in VI037601 and 852 genes in both ECW and VI037601. Many of those genes were classified as NBS-LRR genes, oxidoreductase gene, WRKY and NAC transcription factors, and they were mainly involved in metabolic process, response to stimulus and biological regulation pathways. Quantitative RT-PCR of sixteen selected DEGs further validated the RNA-seq differential gene expression analysis. Our results will provide a valuable resource for understanding the molecular mechanisms of pepper resistance to Xcv infection and improving pepper resistance cultivars against Xcv.	[Gao, Shenghua; Wang, Fei; Li, Ning; Yin, Yanxu; Yu, Chuying; Jiao, Chunhai; Yao, Minghua] Hubei Acad Agr Sci, Hubei Key Lab Vegetable Germplasm Enhancement & G, Cash Crops Res Inst, Wuhan, Hubei, Peoples R China; [Niran, Juntawong] Kasetsart Univ, Bangkok, Thailand	Hubei Academy of Agricultural Sciences; Kasetsart University	Jiao, CH; Yao, MH (corresponding author), Hubei Acad Agr Sci, Hubei Key Lab Vegetable Germplasm Enhancement & G, Cash Crops Res Inst, Wuhan, Hubei, Peoples R China.	jiaoch@hotmail.com; yaomh_2008@126.com		Gao, Shenghua/0000-0002-3832-1980	National Key R&D Program of China [2016YFE0205500, 2017YFD0101903]; earmarked fund for China Agriculture Research System [CARS-23-G28]; China Postdoctoral Science Foundation [2017M620305]; Natural Science Foundation of Hubei Province [2020CFA010]; Youth Fund of Hubei Academy of Agricultural Sciences [2021NKYJJ04]	National Key R&D Program of China; earmarked fund for China Agriculture Research System; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Youth Fund of Hubei Academy of Agricultural Sciences	This work was supported by grants of the National Key R&D Program of China (2016YFE0205500 and 2017YFD0101903), the earmarked fund for China Agriculture Research System (CARS-23-G28), the China Postdoctoral Science Foundation (2017M620305), Natural Science Foundation of Hubei Province (2020CFA010) and Youth Fund of Hubei Academy of Agricultural Sciences (2021NKYJJ04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek W, 2016, PLANT MOL BIOL, V91, P149, DOI 10.1007/s11103-016-0451-1; Balaji V, 2007, FUNCT INTEGR GENOMIC, V7, P305, DOI 10.1007/s10142-007-0050-y; Balakireva AV, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020629; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bulle M, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0451-5; Chen HX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144927; Chen YX, 2017, GIGASCIENCE, V7, DOI 10.1093/gigascience/gix120; Chi YJ, 2013, MOL PLANT, V6, P287, DOI 10.1093/mp/sst026; Chujo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098737; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Daurelio LD, 2015, FUNCT PLANT BIOL, V42, P758, DOI 10.1071/FP14307; Daurelio LD, 2013, J PLANT PHYSIOL, V170, P934, DOI 10.1016/j.jplph.2013.01.011; Du HS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01173; Ferrari S, 2008, PLANT PHYSIOL, V146, P669, DOI 10.1104/pp.107.109686; Griffin K, 2017, CROP PROT, V96, P144, DOI 10.1016/j.cropro.2017.02.008; HIBBERD AM, 1987, PHYTOPATHOLOGY, V77, P1304, DOI 10.1094/Phyto-77-1304; Hu LF, 2018, NEW PHYTOL, V219, P1097, DOI 10.1111/nph.15247; Ibrahim Y, 2012, PLANT DIS, V96, P1690, DOI 10.1094/PDIS-04-12-0354-PDN; Ishihama N, 2012, CURR OPIN PLANT BIOL, V15, P431, DOI 10.1016/j.pbi.2012.02.003; Jensen MK, 2007, PLANT MOL BIOL, V65, P137, DOI 10.1007/s11103-007-9204-5; Jibrin MO, 2014, PLANT DIS, V98, P1426, DOI 10.1094/PDIS-06-14-0586-PDN; Jin JP, 2017, NUCLEIC ACIDS RES, V45, pD1040, DOI 10.1093/nar/gkw982; Jones JB, 1998, ANNU REV PHYTOPATHOL, V36, P41, DOI 10.1146/annurev.phyto.36.1.41; Jones JB, 2002, PHYTOPATHOLOGY, V92, P273, DOI 10.1094/PHYTO.2002.92.3.273; Kaneda T, 2009, EMBO J, V28, P926, DOI 10.1038/emboj.2009.39; Lee DS, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01856; Li CW, 2011, PLANT PHYSIOL, V156, P213, DOI 10.1104/pp.111.174268; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li R, 2015, ELIFE, V4, DOI 10.7554/eLife.04805; Li T, 2015, J PLANT BIOL, V58, P411, DOI 10.1007/s12374-015-0423-z; Liu Q, 2018, PLANT MOL BIOL, V98, P289, DOI 10.1007/s11103-018-0768-z; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Matsubayashi Y, 2002, SCIENCE, V296, P1470, DOI 10.1126/science.1069607; Mishra R, 2018, PLANT SCI, V267, P135, DOI 10.1016/j.plantsci.2017.12.001; Moffat CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035995; Muthamilarasan M, 2013, J BIOSCIENCES, V38, P433, DOI 10.1007/s12038-013-9302-2; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; Olukolu BA, 2013, GENETICS, V193, P609, DOI 10.1534/genetics.112.147595; Ou LJ, 2017, PLANT GROWTH REGUL, V83, P141, DOI 10.1007/s10725-017-0290-3; Ou Y, 2016, CELL RES, V26, P686, DOI 10.1038/cr.2016.63; Petrocelli S., 2018, PLANT GENE, V15, P28, DOI DOI 10.1016/J.PLGENE.2018.05.006; Pierre M, 2000, THEOR APPL GENET, V101, P255, DOI 10.1007/s001220051477; Potnis N, 2012, MOL PLANT MICROBE IN, V25, P307, DOI 10.1094/MPMI-08-11-0205; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; Qiu ZK, 2019, J EXP BOT, V70, P5343, DOI 10.1093/jxb/erz259; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stall RE, 2009, ANNU REV PHYTOPATHOL, V47, P265, DOI 10.1146/annurev-phyto-080508-081752; Sun LJ, 2013, PLANT MOL BIOL, V81, P41, DOI 10.1007/s11103-012-9981-3; Sun XH, 2018, PLANT SCI, V274, P32, DOI 10.1016/j.plantsci.2018.05.004; Tai T, 1999, THEOR APPL GENET, V99, P1201, DOI 10.1007/s001220051325; Tai T, 2000, THEOR APPL GENET, V100, P112, DOI 10.1007/s001220050016; Tariq RW, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030717; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tripathi L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43421-1; Truong HTH, 2011, HORTIC ENVIRON BIOTE, V52, P65, DOI 10.1007/s13580-011-0142-4; Vallejos CE, 2010, THEOR APPL GENET, V121, P37, DOI 10.1007/s00122-010-1289-6; Wai KPP, 2015, PLANT PATHOLOGY J, V31, P428, DOI 10.5423/PPJ.NT.05.2015.0074; Wan HJ, 2011, BIOCHEM BIOPH RES CO, V416, P24, DOI 10.1016/j.bbrc.2011.10.105; Wang J, 2018, MOL PLANT PATHOL, V19, P2025, DOI 10.1111/mpp.12684; Zhang YP, 2019, CHIL J AGR RES, V79, P296, DOI 10.4067/S0718-58392019000200296; Zhao Y, 2012, NEW PHYTOL, V195, P450, DOI 10.1111/j.1469-8137.2012.04160.x; Zhu CH, 2018, GENE, V666, P123, DOI 10.1016/j.gene.2018.05.004; Zuo JH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072001	69	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0240279	10.1371/journal.pone.0240279	http://dx.doi.org/10.1371/journal.pone.0240279			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705404	gold, Green Published			2022-12-26	WOS:000629590400003
J	Tessema, ZT; Tamirat, KS; Teshale, AB; Tesema, GA				Tessema, Zemenu Tadesse; Tamirat, Koku Sisay; Teshale, Achamyeleh Birhanu; Tesema, Getayeneh Antehunegn			Prevalence of low birth weight and its associated factor at birth in Sub-Saharan Africa: A generalized linear mixed model	PLOS ONE			English	Article							GESTATIONAL-AGE; RISK-FACTORS; MORBIDITY; MORTALITY; DETERMINANTS; INFANTS; TRENDS; BORN	Background Low birth weight (LBW) is one of the major determinants of perinatal survival, infant morbidity, and mortality, as well as the risk of developmental disabilities and illnesses in future lives. Though studies were conducted to assess the magnitude and associated factors of low birth weight, most of the studies were at a single center and little information on the regional level. Hence, this study assessed the prevalence and associated factors of low birth weight in Sub-Saharan countries. Method This study was based on secondary data sources from 35 Sub-Saharan countries' Demography and Health Survey (DHS). For this study, we used the Kids Record (KR file) data set. In the KR file, all under-five children who were born in the last five years preceding the survey in the selected enumeration area who had birth weight data were included for the study. To identify determinants of low birth weight multivariable mixed-effect logistic regression model fitted. Adjusted Odds Ratios (AOR) with a 95% Confidence Interval (CI) and p-value <= 0.05 in the multivariable model were used to declare significant factors associated with low birth weight at birth. Result The pooled prevalence of newborn babies' low birth weight measured at birth in Sub-Saharan Africa was 9.76% with (95% CI: 9.63% to 9.89%). Female child, women not participated in healthcare decision making, and wider birth intervals, divorced/ separated women, and twin pregnancies associated with increased occurrences of low birth weight, while some level of woman and husband education, antenatal care visits, older maternal age, and multiparity associated with reduced occurrence low birth weight. Conclusion This study revealed that the magnitude of low birth weight was high in sub-Saharan Africa countries. Therefore, the finding suggests that more emphasis is important for women with a lack of support, multiples, and healthcare decision-making problems.	[Tessema, Zemenu Tadesse; Tamirat, Koku Sisay; Teshale, Achamyeleh Birhanu; Tesema, Getayeneh Antehunegn] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar	Tessema, ZT (corresponding author), Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia.	zemenut1979@gmail.com	Teshale, Achamyeleh/HHN-8416-2022; Tadesse, Zemenu/ABG-1690-2021	Tadesse, Zemenu/0000-0003-3878-7956				Agbozo F, 2016, MIDWIFERY, V40, P200, DOI 10.1016/j.midw.2016.06.016; Ameyaw Edward Kwabena, 2016, Int J Reprod Med, V2016, P6569514, DOI 10.1155/2016/6569514; Amhara E., 2018, GLOBAL J RES REV, V5, P4; Ballot DE, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0337-4; Barria RM, 2011, REV LAT-AM ENFERM, V19, P977, DOI 10.1590/S0104-11692011000400017; Barros FC, 2011, REV SAUDE PUBL, V45, P607, DOI 10.1590/S0034-89102011005000019; Bekana Kebede, 2013, Health, V5, P25; Blencowe H, 2019, LANCET GLOB HEALTH, V7, pE849, DOI 10.1016/S2214-109X(18)30565-5; Chibwesha CJ, 2016, INT J GYNECOL OBSTET, V134, P309, DOI 10.1016/j.ijgo.2016.03.021; Class QA, 2014, AM J EPIDEMIOL, V179, P550, DOI 10.1093/aje/kwt304; Croft TN, 2018, GUIDE DHS STAT DHS 7; da Silva Lopes Katharina, 2017, BMJ Glob Health, V2, pe000389, DOI 10.1136/bmjgh-2017-000389; Dahlui M, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.28822; Dasa TT., 2020, AFRICAN J HLTH SCI, V33, P49; Demelash H, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0677-y; Efevbera Y, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1279-8; He ZF, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020410; Hughes MM, 2017, MATERN CHILD HLTH J, V21, P283, DOI 10.1007/s10995-016-2131-9; Kabir A, 2020, BMC WOMENS HEALTH, V20, DOI 10.1186/s12905-020-00952-4; Kader M, 2014, N AM J MED SCI, V6, P302, DOI 10.4103/1947-2714.136902; Kandel Kamal Prasad, 2017, J Nepal Health Res Counc, V15, P169; Laelago T, 2017, AFR HEALTH SCI, V17, P681, DOI 10.4314/ahs.v17i3.10; Lema D., 2015, DETERMINANTS LOW BIR; Lira PIC, 1996, J PEDIATR-US, V128, P497, DOI 10.1016/S0022-3476(96)70360-8; Moreira AIM, 2018, EINSTEIN-SAO PAULO, V16, DOI [10.31744/einstein_journal/2018AO4251, 10.31744/einstein_journal/2018ao4251]; Mahumud Rashidul Alam, 2017, J Prev Med Public Health, V50, P18, DOI 10.3961/jpmph.16.087; Momeni M, 2017, INT J PREVENTIVE MED, V8, DOI 10.4103/ijpvm.IJPVM_112_16; Muchemi OM, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.108.4831; Organization WH, 2010, ACC PROGR HLTH REL M; Rutstein S.O., 2014, POTENTIAL BIAS SELEC; Sebayang SK, 2012, TROP MED INT HEALTH, V17, P938, DOI 10.1111/j.1365-3156.2012.03039.x; Sharifi N, 2018, INT J WOMEN HEAL REP, V6, P233, DOI 10.15296/ijwhr.2018.40; Taha TE, 2012, PEDIATR INFECT DIS J, V31, P481, DOI 10.1097/INF.0b013e31824d9bd9; Teklehaimanot N., 2014, INT J NUTR FOOD SCI, V3; Upadhyay H.P., 2019, ASIAN J MED SCI, V10, P77, DOI DOI 10.3126/AJMS.V10I1.21665; Verhoef H, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1375-9	36	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248417	10.1371/journal.pone.0248417	http://dx.doi.org/10.1371/journal.pone.0248417			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705473	Green Published, gold			2022-12-26	WOS:000629590400027
J	Drobac, G; Waheed, Q; Heidari, B; Ruoff, P				Drobac, Gorana; Waheed, Qaiser; Heidari, Behzad; Ruoff, Peter			An amplified derepression controller with multisite inhibition and positive feedback	PLOS ONE			English	Article							ROBUST PERFECT ADAPTATION; CIRCADIAN SPORULATION RHYTHM; PSEUDO-RESPONSE REGULATORS; MOLECULAR-MECHANISMS; GOODWIN MODEL; HOMEOSTASIS; CLOCK; OSCILLATIONS; DESIGN	How organisms are able to maintain robust homeostasis has in recent years received increased attention by the use of combined control engineering and kinetic concepts, which led to the discovery of robust controller motifs. While these motifs employ kinetic conditions showing integral feedback and homeostasis for step-wise perturbations, the motifs' performance differ significantly when exposing them to time dependent perturbations. One type of controller motifs which are able to handle exponentially and even hyperbolically growing perturbations are based on derepression. In these controllers the compensatory reaction, which neutralizes the perturbation, is derepressed, i.e. its reaction rate is increased by the decrease of an inhibitor acting on the compensatory flux. While controllers in this category can deal well with different time-dependent perturbations they have the disadvantage that they break down once the concentration of the regulatory inhibitor becomes too low and the compensatory flux has gained its maximum value. We wondered whether it would be possible to bypass this restriction, while still keeping the advantages of derepression kinetics. In this paper we show how the inclusion of multisite inhibition and the presence of positive feedback loops lead to an amplified controller which is still based on derepression kinetics but without showing the breakdown due to low inhibitor concentrations. By searching for the amplified feedback motif in natural systems, we found it as a part of the plant circadian clock where it is highly interlocked with other feedback loops.	[Drobac, Gorana; Waheed, Qaiser; Heidari, Behzad; Ruoff, Peter] Univ Stavanger, Dept Chem Biosci & Environm Engn, Stavanger, Norway	Universitetet i Stavanger	Ruoff, P (corresponding author), Univ Stavanger, Dept Chem Biosci & Environm Engn, Stavanger, Norway.	peter.ruoff@uis.no		Waheed, Qaiser/0000-0002-7566-2506				Ang J, 2013, BIOPHYS J, V104, P505, DOI 10.1016/j.bpj.2012.12.015; Aoki SK, 2019, NATURE, V570, P533, DOI 10.1038/s41586-019-1321-1; Ashby WR., 1961, INTRO CYBERNETICS; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bonny O, 2009, CELL CYCLE, V8, P4015, DOI 10.4161/cc.8.24.10224; Briat C, 2016, ACS SYNTH BIOL, V5, P1108, DOI 10.1021/acssynbio.6b00014; Briat C, 2016, CELL SYST, V2, P15, DOI [10.1016/j.cels.2016.02.010, 10.1016/j.cels.2016.01.004]; Bunning E., 1963, PHYSL CLOCK; Cannon W., 1939, REVISED ENLARGED EDI; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; Cariani PA, 2009, INT J GEN SYST, V38, P139, DOI 10.1080/03081070802633593; Clancy J., 2002, HOMEOSTATIC APPROACH, VSecond edition; Davis GW, 2013, NEURON, V80, P718, DOI 10.1016/j.neuron.2013.09.044; DAVIS RC, 1958, PSYCHOL REV, V65, P8, DOI 10.1037/h0045358; Drengstig T, 2012, BIOPHYS J, V103, P2000, DOI 10.1016/j.bpj.2012.09.033; Drengstig T, 2012, J PHYS CHEM B, V116, P5355, DOI 10.1021/jp3004568; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; El-Samad H, 2002, J THEOR BIOL, V214, P17, DOI 10.1006/jtbi.2001.2422; Fjeld G, 2017, J PHYS CHEM B, V121, P6097, DOI 10.1021/acs.jpcb.7b01989; Goldbeter A, 1996, BIOCH OSCILLATIONS C; Gonze D, 2021, ACTA BIOTHEOR, V69, P857, DOI 10.1007/s10441-020-09379-8; Gonze D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069573; Goodwin BC., 1963, TEMPORAL ORG CELLS; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; Huang YS, 2012, PLANT CELL ENVIRON, V35, P917, DOI 10.1111/j.1365-3040.2011.02462.x; Jacques-Silva MC, 2010, P NATL ACAD SCI USA, V107, P6465, DOI 10.1073/pnas.0908935107; Jolma IW, 2010, BIOPHYS J, V98, P743, DOI 10.1016/j.bpj.2009.11.013; Krishnan J, 2019, BMC SYST BIOL, V13, DOI 10.1186/s12918-019-0703-1; Kruse K, 2005, CURR OPIN CELL BIOL, V17, P20, DOI 10.1016/j.ceb.2004.12.007; Kurosawa G, 2002, J BIOL RHYTHM, V17, P568, DOI 10.1177/0748730402238239; Langley LL., 1973, CONTRACEPTION BENCHM; Leibiger IB, 2002, FEBS LETT, V532, P1, DOI 10.1016/S0014-5793(02)03627-X; Lewis FL., 1992, APPL OPTIMAL CONTROL; McClung CR, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8010014; Milhorn HT., 1966, APPL CONTROL THEORY; Milsum JH., 1966, BIOL CONTROL SYSTEMS; MOOREEDE MC, 1986, AM J PHYSIOL, V250, pR737, DOI 10.1152/ajpregu.1986.250.5.R737; Nakagawa H, 2010, P JPN ACAD B-PHYS, V86, P391, DOI 10.2183/pjab.86.391; Nakamichi N, 2005, PLANT CELL PHYSIOL, V46, P686, DOI 10.1093/pcp/pci086; Nakamichi N, 2010, PLANT CELL, V22, P594, DOI 10.1105/tpc.109.072892; Ni XY, 2009, BIOPHYS J, V97, P1244, DOI 10.1016/j.bpj.2009.06.030; Nohales MA, 2016, NAT STRUCT MOL BIOL, V23, P1061, DOI 10.1038/nsmb.3327; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Radhakrishnan K., 1993, UCRLID113855 LLNL; Rawat R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001350; Rosen R, 2012, IFSR INT SER SYST SC, V1, P1, DOI 10.1007/978-1-4614-1269-4; Rowland MA, 2017, BIOPHYS J, V112, P1539, DOI 10.1016/j.bpj.2017.02.044; Ruoff P, 2001, J THEOR BIOL, V209, P29, DOI 10.1006/jtbi.2000.2239; Ruoff P, 1996, J THEOR BIOL, V179, P275, DOI 10.1006/jtbi.1996.0067; Ruoff P, 2000, CHRONOBIOL INT, V17, P733, DOI 10.1081/CBI-100102109; Ruoff P., 2000, COMMENTS THEOR BIOL, V5, P361; Ruoff P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0207831; Saunders PT, 1998, J THEOR BIOL, V194, P163, DOI 10.1006/jtbi.1998.0746; Seaton D, 2011, IET SYST BIOL, V5, P81, DOI 10.1049/iet-syb.2009.0061; Segel I.H., 1975, ENZYME KINETICS BEHA; Shabala S, 2006, J EXP BOT, V57, P171, DOI 10.1093/jxb/erj022; Shoval O, 2010, P NATL ACAD SCI USA, V107, P15995, DOI 10.1073/pnas.1002352107; Solt LA, 2011, FUTURE MED CHEM, V3, P623, DOI [10.4155/FMC.11.9, 10.4155/fmc.11.9]; Thorsen K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107766; Tyson JJ, 2008, J R SOC INTERFACE, V5, pS1, DOI 10.1098/rsif.2008.0179.focus; Wiener N., 1961, CYBERNETICS CONTROL, V2nd; Wilkie J., 2002, INTRO COURSE; Xie QG, 2014, PLANT CELL, V26, P2843, DOI 10.1105/tpc.114.126573; Xing HY, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1010888; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	65	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2021	16	3							e0241654	10.1371/journal.pone.0241654	http://dx.doi.org/10.1371/journal.pone.0241654			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DJ	33690601	Green Submitted, Green Published, gold			2022-12-26	WOS:000627855600023
J	Patel, R; Marbaniang, SP; Srivastava, S; Kumar, P; Chauhan, S; Simon, DJ				Patel, Ratna; Marbaniang, Strong P.; Srivastava, Shobhit; Kumar, Pradeep; Chauhan, Shekhar; Simon, David J.			Gender differential in low psychological health and low subjective well-being among older adults in India: With special focus on childless older adults	PLOS ONE			English	Article							LIFE; WOMEN; DETERMINANTS; RETIREMENT; DISPARITY; MORTALITY; SUPPORT; CASTE; MOOD; MEN	Background Gender and health are two factors that shape the quality of life in old age. Previous available literature established an associaton between various demographic and socio-economic factors with the health and well-being of older adults in India; however, the influence of childless aged is neglected. Therefore, the study examined the gender differential in psychological health and subjective well-being among older adults, focusing on childless older adults. Methodology This study utilized data from Building a Knowledge Base on Population Aging in India (BKPAI). Psychological health and subjective well-being were examined for 9541 older adults aged 60 years & above. Descriptive statistics and bivariate analysis were used to find the preliminary results. Further, multivariate analysis has been done to fulfill the objective of the study. Results Around one-fifth (21.2%) of the men reported low psychological health, whereas around one-fourth (25.5%) of the women reported low psychological health. Further, around 24 per cent of men and 29 per cent of women reported low subjective well-being. Results found that low psychological well-being (OR = 1.87, C.I. = 1.16-3.01), as well as low subjective well-being (OR = 1.78, C.I. = 1.15-2.76), was higher in childless older women than in childless older men. Higher education, community involvement, good self-rated health, richest wealth quintile, and residing in urban areas significantly decrease the odds of low subjective well-being and low psychological well-being among older adults. Conclusion There is a need to improve older adults' psychological health and subjective well-being through expanded welfare provisions, especially for childless older adults. Moreover, there is an immediate requirement to cater to the needs of poor and uneducated older adults.	[Patel, Ratna] Int Inst Populat Sci, Dept Publ Hlth & Mortal Studies, Mumbai, Maharashtra, India; [Marbaniang, Strong P.; Srivastava, Shobhit; Kumar, Pradeep] Int Inst Populat Sci, Dept Math Demog & Stat, Mumbai, Maharashtra, India; [Chauhan, Shekhar] Int Inst Populat Sci, Dept Populat Policies & Programmes, Mumbai, Maharashtra, India; [Simon, David J.] Paris 1 Pantheon Sorbonne Univ, Paris, France	International Institute for Population Sciences; International Institute for Population Sciences; International Institute for Population Sciences	Chauhan, S (corresponding author), Int Inst Populat Sci, Dept Populat Policies & Programmes, Mumbai, Maharashtra, India.	shekhariips2486@gmail.com	Marbaniang, Strong P/AAN-9493-2021; CHAUHAN, SHEKHAR/AAH-7233-2020; Kumar, Pradeep/AAN-9128-2021; Kumar, Pradeep/GQV-5790-2022; Srivastava, Shobhit/AAI-1811-2021	Marbaniang, Strong P/0000-0001-5347-1867; CHAUHAN, SHEKHAR/0000-0002-6926-7649; Kumar, Pradeep/0000-0003-4259-820X; Srivastava, Shobhit/0000-0002-7138-4916				Agrawal J, 2011, SOC INDIC RES, V101, P419, DOI 10.1007/s11205-010-9669-5; Bahl N.K.H., 2017, OPEN J SOCIAL SCI, V5, P321, DOI [10.4236/jss.2017.57020, DOI 10.4236/JSS.2017.57020]; Barford A, 2006, BMJ-BRIT MED J, V332, P808, DOI 10.1136/bmj.332.7545.808; Bhaswati Das, 2018, Journal of Population and Social Studies, V26, P219; BKPAI, 2011, REP STAT ELD SEL STA; Bloom DE, 2011, CURR HIST, V110, P143; Carmel S, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00218; Chaurasia H, 2018, AGEING INT, V43, P207, DOI 10.1007/s12126-017-9317-3; Chou KL, 2004, INT J GERIATR PSYCH, V19, P449, DOI 10.1002/gps.1111; Das M, 2020, INDIAN J GERONTOLOGY, V34; Denton M, 2004, SOC SCI MED, V58, P2585, DOI 10.1016/j.socscimed.2003.09.008; Deshpande A, 2000, AM ECON REV, V90, P322, DOI 10.1257/aer.90.2.322; Gibney S, 2017, SOC INDIC RES, V130, P305, DOI 10.1007/s11205-015-1177-1; Gildner TE, 2019, J GERONTOL B-PSYCHOL, V74, P516, DOI 10.1093/geronb/gbw145; Hadley R.A., 2018, AGEING CHILDREN GEND, P66, DOI 10.4324/9781315226835; Hashmi JF, 2018, J PSYCHIAT NURSING, V7, P91, DOI [10.21088/jpn.2277.9035.7318.4, DOI 10.21088/JPN.2277.9035.7318.4]; Jacob K S, 1997, Indian J Psychiatry, V39, P196; Kirchengast S, 2008, ANTHROPOL ANZ, V66, P237, DOI 10.1127/aa/66/2008/237; Ko H, 2019, ARCH GERONTOL GERIAT, V83, P239, DOI 10.1016/j.archger.2019.05.009; Kumar A, 2017, INDIAN J GERONTOLOGY, V31; Kumar J., 2010, BLOCKED CASTE EC DIS; Lamb S., 2020, CARING OLD AGE PERSP, P321; Lee J, 2014, J GERONTOL B-PSYCHOL, V69, P603, DOI 10.1093/geronb/gbu017; Lieber J, 2020, SSM-POPUL HLTH, V11, DOI 10.1016/j.ssmph.2020.100572; Lukaschek K, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0513-5; Lv QC, 2017, ASIA PAC J TOUR RES, V22, P951, DOI 10.1080/10941665.2017.1345772; Meisenberg G, 2015, J HAPPINESS STUD, V16, P1539, DOI 10.1007/s10902-014-9577-5; Mhaske R., 2017, J PSYCHOSOC RES, V12, P71; Oksuzyan A, 2008, AGING CLIN EXP RES, V20, P91; Oksuzyan A, 2018, GERONTOLOGIST, V58, P1156, DOI 10.1093/geront/gnx111; Osman U. A. N., 2018, MANAGEMENT RES J, V7, P146; Patel R., 2019, INDIAN J SOC RES, V60, P279; Perkins JM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3682-9; Pinquart M, 2001, J GERONTOL B-PSYCHOL, V56, pP195, DOI 10.1093/geronb/56.4.P195; Population Reference Bureau, 2012, IND AG POP TOD RES A, V25, P1; Quashie NT, 2018, ASIAN SOC WORK POLIC, V12, P130, DOI 10.1111/aswp.12145; Rajan S.I., 2017, CROSS CULTURAL CROSS, P143, DOI [10.1007/978-981-10-1654-7_8, DOI 10.1007/978-981-10-1654-7_8]; REMPEL J, 1985, J MARRIAGE FAM, V47, P343, DOI 10.2307/352134; Rowland DT, 2007, J FAM ISSUES, V28, P1311, DOI 10.1177/0192513X07303823; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Schmid T, 2012, EUR J AGEING, V9, P39, DOI 10.1007/s10433-011-0197-1; Sharma R., 2016, INT J AGEING DEV COU, V1, P68; Shidhaye R, 2010, INT J EPIDEMIOL, V39, P1510, DOI 10.1093/ije/dyq179; Singh L, 2016, J CROSS-CULT GERONTO, V31, P173, DOI 10.1007/s10823-016-9286-0; Singh L, 2013, SAGE OPEN, V3, DOI 10.1177/2158244013487914; Singh PK, 2018, SSM-POPUL HLTH, V5, P180, DOI 10.1016/j.ssmph.2018.06.008; Singh PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031666; Singh P, 2020, PALGR COMMUN, V6, DOI 10.1057/s41599-020-0488-2; Srivastava S, 2021, AGEING INT, V46, P182, DOI 10.1007/s12126-020-09385-8; Subramanian SV, 2006, AM J PUBLIC HEALTH, V96, P818, DOI 10.2105/AJPH.2004.060103; United Nations Department of Economic and Social Affairs Population Division, 2019, WORLD POP AG 2019 WO, DOI [10.1007/978-94-007-5204-7_6, DOI 10.1007/978-94-007-5204-7_6]; Vozikaki M, 2018, J PUBLIC HEALTH-HEID, V26, P613, DOI 10.1007/s10389-018-0916-6; World Health Organization, 1992, ASS SUBJ WELLB SUBJ	53	8	9	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0247943	10.1371/journal.pone.0247943	http://dx.doi.org/10.1371/journal.pone.0247943			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QU3OZ	33684164	gold, Green Published			2022-12-26	WOS:000627193500001
J	von Buchholz, JS; Bilic, I; Aschenbach, JR; Hess, M; Mitra, T; Awad, WA				von Buchholz, J. Sophia; Bilic, Ivana; Aschenbach, Joerg R.; Hess, Michael; Mitra, Taniya; Awad, Wageha A.			Establishment of a novel probe-based RT-qPCR approach for detection and quantification of tight junctions reveals age-related changes in the gut barriers of broiler chickens	PLOS ONE			English	Article							EPITHELIAL BARRIER; INTESTINAL DEVELOPMENT; MINIMUM INFORMATION; ZONULA OCCLUDENS; EXPRESSION; CLAUDINS; PUBLICATION; PERFORMANCE; ZO-2; GENE	Tight junctions (TJs) play a dominant role in gut barrier formation, therefore, resolving the structures of TJs in any animal species is crucial but of major importance in fast growing broilers. They are regulated in molecular composition, ultrastructure and function by intracellular proteins and the cytoskeleton. TJ proteins are classified according to their function into barrier-forming, scaffolding and pore-forming types with deductible consequences for permeability. In spite of their importance for gut health and its integrity limited studies have investigated the TJs in chickens, including the comprehensive evaluation of TJs molecular composition and function in the chicken gut. In the actual study sequence-specific probes to target different TJ genes (claudin 1, 3, 5, 7, 10, 19, zonula occludens 1 (ZO1), occludin (OCLN) and tricellulin (MD2)) were designed and probe-based RT-qPCRs were newly developed. Claudin (CLDN) 1, 5, ZO1 and CLDN 3, 7, MD2 were engulfed in multiplex RT-qPCRs, minimizing the number of separate reactions and enabling robust testing of many samples. All RT-qPCRs were standardized for chicken jejunum and caecum samples, which enabled specific detection and quantification of the gene expression. Furthermore, the newly established protocols were used to investigate the age developmental changes in the TJs of broiler chickens from 1-35 days of age in the same organ samples. Results revealed a significant increase in mRNA expression between 14 and 21days of age of all tested TJs in jejunum. However, in caecum, mRNA expression of some TJs decreased after 1 day of age whereas some TJs mRNA remained constant till 35 days of age. Taken together, determining the segment-specific changes in the expression of TJ- proteins by RT-qPCR provides a deeper understanding of the molecular mechanisms underpinning pathophysiological changes in the gut of broiler chickens with various etiologies.	[von Buchholz, J. Sophia; Bilic, Ivana; Hess, Michael; Mitra, Taniya; Awad, Wageha A.] Univ Vet Med, Dept Farm Anim & Vet Publ Hlth, Clin Poultry & Fish Med, Vienna, Austria; [Aschenbach, Joerg R.] Free Univ Berlin, Inst Vet Physiol, Dept Vet Med, Berlin, Germany	University of Veterinary Medicine Vienna; Free University of Berlin	Awad, WA (corresponding author), Univ Vet Med, Dept Farm Anim & Vet Publ Hlth, Clin Poultry & Fish Med, Vienna, Austria.	wageha.awad@vetmeduni.ac.at	Awad, Wageha/R-1705-2016	Awad, Wageha/0000-0003-0843-2089; Mitra, Taniya/0000-0003-0214-0755; Bilic, Ivana/0000-0003-3296-5117; Hess, Michael/0000-0002-6991-0120	Austrian Science Fund [P30140]	Austrian Science Fund(Austrian Science Fund (FWF))	This research was financed by the Austrian Science Fund (FWF; P30140). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABI, 2004, APPL BIOS PROD GUID, P1, DOI DOI 10.3727/000000004783992206; Alexandre MD, 2005, J CELL SCI, V118, P2683, DOI 10.1242/jcs.02406; Apajalahti J, 2004, WORLD POULTRY SCI J, V60, P223, DOI 10.1079/WPS200415; Awad WA, 2017, TOXINS, V9, DOI 10.3390/toxins9020060; Barekatain R, 2019, POULTRY SCI, V98, P3662, DOI 10.3382/ps/pey563; Barekatain R, 2019, POULTRY SCI, V98, P6761, DOI 10.3382/ps/pez393; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chrzastek K, 2014, VET IMMUNOL IMMUNOP, V161, P271, DOI 10.1016/j.vetimm.2014.08.002; Collins MM, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24517; Cordenonsi M, 1999, J CELL BIOL, V147, P1569, DOI 10.1083/jcb.147.7.1569; Emami NK, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7080231; Gunzel D, 2012, COMPR PHYSIOL, V2, P1819, DOI 10.1002/cphy.c110045; Haworth KE, 2005, GENE EXPR PATTERNS, V6, P40, DOI 10.1016/j.modgep.2005.05.002; Holmes JL, 2006, GENE EXPR PATTERNS, V6, P581, DOI 10.1016/j.modgep.2005.12.001; Huggett J, 2011, ACCREDIT QUAL ASSUR, V16, P399, DOI 10.1007/s00769-011-0769-y; Hunziker W, 2009, ANN NY ACAD SCI, V1165, P28, DOI 10.1111/j.1749-6632.2009.04033.x; John LJ, 2011, ANTIOXID REDOX SIGN, V15, P1255, DOI 10.1089/ars.2011.3892; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Krug SM, 2013, BIOMATERIALS, V34, P275, DOI 10.1016/j.biomaterials.2012.09.051; Krug SM, 2009, MOL BIOL CELL, V20, P3713, DOI 10.1091/mbc.E09-01-0080; Kuang JJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196438; Lamb-Rosteski JM, 2008, INFECT IMMUN, V76, P3390, DOI 10.1128/IAI.01698-07; Lu Z, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24978; Markov AG, 2017, IUBMB LIFE, V69, P290, DOI 10.1002/iub.1622; Markov AG, 2015, IUBMB LIFE, V67, P29, DOI 10.1002/iub.1347; Milatz S, 2017, PFLUG ARCH EUR J PHY, V469, P115, DOI 10.1007/s00424-016-1921-7; Mitjans M, 1997, CELL TISSUE RES, V290, P71, DOI 10.1007/s004410050909; Mitra T, 2016, VET RES, V47, DOI 10.1186/s13567-016-0388-z; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Noah TK, 2011, EXP CELL RES, V317, P2702, DOI 10.1016/j.yexcr.2011.09.006; Osselaere A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069014; Ozden O, 2010, ANAT REC, V293, P1175, DOI 10.1002/ar.21163; Pinton P, 2009, TOXICOL APPL PHARM, V237, P41, DOI 10.1016/j.taap.2009.03.003; Proszkowiec-Weglarz M, 2020, POULTRY SCI, V99, P4714, DOI 10.1016/j.psj.2020.06.023; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P1, DOI 10.1111/j.1749-6632.2009.04925.x; Shen L, 2006, AM J PHYSIOL-GASTR L, V290, pG577, DOI 10.1152/ajpgi.00439.2005; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; Simard A, 2005, GENE EXPR PATTERNS, V5, P553, DOI 10.1016/j.modgep.2004.10.099; Sklan D, 2001, WORLD POULTRY SCI J, V57, P415, DOI 10.1079/WPS20010030; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Stratagene, 2004, METH APPL GUID INTR, P1; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Taylor SC, 2019, TRENDS BIOTECHNOL, V37, P761, DOI 10.1016/j.tibtech.2018.12.002; Taylor SC, 2014, J MOL MICROB BIOTECH, V24, P46, DOI 10.1159/000356189; Teng PY, 2020, POULTRY SCI, V99, P4203, DOI 10.1016/j.psj.2020.04.031; Thornton B, 2011, BIOCHEM MOL BIOL EDU, V39, P145, DOI 10.1002/bmb.20461; Tomita Mikio, 2004, Drug Metab Pharmacokinet, V19, P33, DOI 10.2133/dmpk.19.33; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Van Itallie CM, 2004, PHYSIOLOGY, V19, P331, DOI 10.1152/physiol.00027.2004	51	5	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0248165	10.1371/journal.pone.0248165	http://dx.doi.org/10.1371/journal.pone.0248165			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667266	gold, Green Published			2022-12-26	WOS:000626604300022
J	Lee, HC; Ou, CH; Huang, YC; Hou, PC; Creighton, CJ; Lin, YS; Hu, CY; Lin, SC				Lee, Hsiu-Chi; Ou, Chien-Hui; Huang, Yun-Chen; Hou, Pei-Chi; Creighton, Chad J.; Lin, Yi-Syuan; Hu, Che-Yuan; Lin, Shih-Chieh			YAP1 overexpression contributes to the development of enzalutamide resistance by induction of cancer stemness and lipid metabolism in prostate cancer	ONCOGENE			English	Article							HIPPO PATHWAY; INCREASED SURVIVAL; SIZE-CONTROL; MITOXANTRONE; ABIRATERONE; PREDNISONE; DOCETAXEL; GROWTH	Metastatic castration-resistant prostate cancer (mCRPC) is a malignant and lethal disease caused by relapse after androgen-deprivation (ADT) therapy. Since enzalutamide is innovated and approved by US FDA as a new treatment option for mCRPC patients, drug resistance for enzalutamide is a critical issue during clinical usage. Although several underlying mechanisms causing enzalutamide resistance were previously identified, most of them revealed that drug resistant cells are still highly addicted to androgen and AR functions. Due to the numerous physical functions of AR in men, innovated AR-independent therapy might alleviate enzalutamide resistance and prevent production of adverse side effects. Here, we have identified that yes-associated protein 1 (YAP1) is overexpressed in enzalutamide-resistant (EnzaR) cells. Furthermore, enzalutamide-induced YAP1 expression is mediated through the function of chicken ovalbumin upstream promoter transcription factor 2 (COUP-TFII) at the transcriptional and the post-transcriptional levels. Functional analyses reveal that YAP1 positively regulates numerous genes related to cancer stemness and lipid metabolism and interacts with COUP-TFII to form a transcriptional complex. More importantly, YAP1 inhibitor attenuates the growth and cancer stemness of EnzaR cells in vitro and in vivo. Finally, YAP1, COUP-TFII, and miR-21 are detected in the extracellular vesicles (EVs) isolated from EnzaR cells and sera of patients. In addition, treatment with EnzaR-EVs induces the abilities of cancer stemness, lipid metabolism and enzalutamide resistance in its parental cells. Taken together, these results suggest that YAP1 might be a crucial factor involved in the development of enzalutamide resistance and can be an alternative therapeutic target in prostate cancer.	[Lee, Hsiu-Chi; Hou, Pei-Chi; Lin, Shih-Chieh] Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan, Taiwan; [Ou, Chien-Hui; Hu, Che-Yuan] Natl Cheng Kung Univ & Hosp, Coll Med, Dept Urol, Tainan, Taiwan; [Huang, Yun-Chen; Lin, Shih-Chieh] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan, Taiwan; [Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Dept Med, Houston, TX 77030 USA; [Lin, Yi-Syuan; Lin, Shih-Chieh] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan; [Hu, Che-Yuan] Natl Cheng Kung Univ, Inst Clin Med, Coll Med, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; Baylor College of Medicine; National Cheng Kung University; National Cheng Kung University	Lee, HC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan, Taiwan.	Jaylin@mail.ncku.edu.tw	Hu, Che-Yuan/AGP-5540-2022	Hu, Che-Yuan/0000-0001-5151-4552; Hou, Pei-Chi/0000-0002-3709-5934	Ministry of Science and Technology [MOST 108-2628-B-006-003, MOST 109-2636-B-006-006]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	We thank Yen-Yu Lai and Yi-Chen Tang for technical assistance and Chu-An Wang for proofreading the manuscript. This study was supported by research grants from Ministry of Science and Technology (MOST 108-2628-B-006-003 and MOST 109-2636-B-006-006).	Abel S, 2019, J AM OSTEOPATH ASSOC, V119, P763, DOI 10.7556/jaoa.2019.126; Abudurexiti M, 2020, PROSTATE, V80, P950, DOI 10.1002/pros.24027; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Bainbridge A, 2020, NUCLEIC ACIDS RES, V48, P5366, DOI 10.1093/nar/gkaa271; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Borgmann H, 2018, EUR UROL, V73, P4, DOI 10.1016/j.eururo.2017.08.012; Brave M, 2020, CLIN CANCER RES, V26, P4717, DOI 10.1158/1078-0432.CCR-19-3835; Cerasuolo M, 2020, CANCER RES, V80, P1564, DOI 10.1158/0008-5472.CAN-18-3637; Coutinho I, 2016, ENDOCR-RELAT CANCER, V23, pT179, DOI 10.1530/ERC-16-0422; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Del Re M, 2017, EUR UROL, V71, P680, DOI 10.1016/j.eururo.2016.08.012; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Henry N, 2009, NAT CLIN PRACT UROL, V6, P164, DOI 10.1038/ncpuro1317; Hussain M, 2018, NEW ENGL J MED, V378, P2465, DOI 10.1056/NEJMoa1800536; Jiang N, 2015, ONCOGENE, V34, P2764, DOI 10.1038/onc.2014.206; Jiang N, 2017, ONCOTARGET, V8, P115054, DOI 10.18632/oncotarget.23014; Klein EA, 2009, UROL ONCOL-SEMIN ORI, V27, P67, DOI 10.1016/j.urolonc.2008.04.001; Kong YF, 2018, J BIOL CHEM, V293, P14328, DOI 10.1074/jbc.RA118.004442; Korpal M, 2013, CANCER DISCOV, V3, P1030, DOI 10.1158/2159-8290.CD-13-0142; Kuser-Abali G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9126; Li HC, 2020, THERANOSTICS, V10, P7053, DOI 10.7150/thno.41388; Lin SC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11418; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Lukka H, 2006, Curr Oncol, V13, P81; Miyazawa Y, 2019, PROSTATE, V79, P1462, DOI 10.1002/pros.23865; Nguyen LT, 2015, CANCER CELL, V27, P797, DOI 10.1016/j.ccell.2015.05.005; Ning YM, 2015, ONCOLOGIST, V20, P960, DOI 10.1634/theoncologist.2015-0166; Peak TC, 2020, MOL CARCINOGEN, V59, P62, DOI 10.1002/mc.23129; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Stoykova GE, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112626; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Tumaneng K, 2012, CURR BIOL, V22, pR368, DOI 10.1016/j.cub.2012.03.003; Wang LM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz8031; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Zadra G, 2019, P NATL ACAD SCI USA, V116, P631, DOI 10.1073/pnas.1808834116; Zhang L, 2015, MOL CELL BIOL, V35, P1350, DOI 10.1128/MCB.00102-15; Zhang ZD, 2020, CANCER CELL, V37, P584, DOI 10.1016/j.ccell.2020.03.001; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	42	14	14	1	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 1	2021	40	13					2407	2421		10.1038/s41388-021-01718-4	http://dx.doi.org/10.1038/s41388-021-01718-4		MAR 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RH1BQ	33664454	Green Published, hybrid			2022-12-26	WOS:000625833000001
J	Ge, Q; Hu, XX; Ma, N; Sun, MQ; Zhang, LY; Cai, ZL; Tan, RL; Lu, HX				Ge, Qian; Hu, Xiaoxuan; Ma, Ning; Sun, Meiqi; Zhang, Liyun; Cai, Zhenlu; Tan, Ruolan; Lu, Haixia			Maternal high-salt diet during pregnancy impairs synaptic plasticity and memory in offspring	FASEB JOURNAL			English	Article						high&#8208; salt diet; maternal; memory; offspring; synaptic plasticity	LONG-TERM-MEMORY; HIGH-FAT DIET; COGNITIVE IMPAIRMENT; INSULIN-RESISTANCE; OXIDATIVE STRESS; HIPPOCAMPAL; FETAL; MODEL; MICE; RESTRICTION	Excess salt intake harms the brain health and cognitive functions, but whether a maternal high-salt diet (HSD) affects the brain development and neural plasticity of offspring remains unclear. Here, using a range of behavioral tests, we reported that the offspring of maternal HSD subjects exhibited short- and long-term memory deficits, especially in spatial memory in adulthood. Moreover, impairments in synaptic transmission and plasticity in the hippocampus were observed in adult offspring by using in vivo electrophysiology. Consistently, the number of astrocytes but not neurons in the hippocampus of the offspring from the HSD group were significantly decreased, and ERK and AKT signaling pathways involved in neurodevelopment were highly activated only during juvenile. In addition, the expression of synaptic proteins decreased both in juvenile and adulthood, and this effect might be involved in synaptic dysfunction. Collectively, these data demonstrated that the maternal HSD might cause adult offspring synaptic dysfunction and memory loss. It is possibly due to the reduction of astrocytes in juvenile.	[Ge, Qian; Hu, Xiaoxuan; Ma, Ning; Sun, Meiqi; Zhang, Liyun; Cai, Zhenlu; Tan, Ruolan; Lu, Haixia] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Neurobiol, Xian 710061, Shannxi, Peoples R China; [Hu, Xiaoxuan; Ma, Ning; Zhang, Liyun; Tan, Ruolan] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Human Anat & Histoembryol, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Lu, HX (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Neurobiol, Xian 710061, Shannxi, Peoples R China.	hxl01@mail.xjtu.edu.cn			National Natural Science Foundation of China (NSFC) [81870981]; Fundamental Research Funds for the Central Universities [xzy012019082]; China Postdoctoral Science Foundation [2018M643674]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81870981; Fundamental Research Funds for the Central Universities, Grant/Award Number: xzy012019082; China Postdoctoral Science Foundation, Grant/Award Number: 2018M643674	Andrade-Talavera Y, 2015, NEUROBIOL DIS, V82, P516, DOI 10.1016/j.nbd.2015.09.005; Barker DJP, 2013, CLIN OBSTET GYNECOL, V56, P511, DOI 10.1097/GRF.0b013e31829cb9ca; Basu A, 2017, HORM BEHAV, V93, P18, DOI 10.1016/j.yhbeh.2017.04.001; Borge TC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016777; Buffington SA, 2014, ANNU REV NEUROSCI, V37, P17, DOI 10.1146/annurev-neuro-071013-014100; Cai ZL, 2019, MOL CELL TOXICOL, V15, P391, DOI 10.1007/s13273-019-0042-8; Cipriano AC, 2016, HORM BEHAV, V81, P59, DOI 10.1016/j.yhbeh.2016.03.002; Cordner ZA, 2019, EXP NEUROL, V318, P92, DOI 10.1016/j.expneurol.2019.04.018; Edlow AG, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01335; Faraco G, 2019, NATURE, V574, P686, DOI 10.1038/s41586-019-1688-z; Fisch J, 2019, PHYSIOL BEHAV, V204, P162, DOI 10.1016/j.physbeh.2019.02.026; Fleming TP, 2015, REPROD FERT DEVELOP, V27, P684, DOI 10.1071/RD14455; Fusco S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12793-3; Ge Q, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700134; Gould JM, 2018, P NATL ACAD SCI USA, V115, pE7398, DOI 10.1073/pnas.1721876115; Govic A, 2014, HORM BEHAV, V66, P591, DOI 10.1016/j.yhbeh.2014.08.013; Gray C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09753; Grimes CA., 2020, BRIT J NUTR, V1, P53; Grimes CA, 2013, PEDIATRICS, V131, P14, DOI 10.1542/peds.2012-1628; Janthalthin Y, 2017, PSYCHONEUROENDOCRINO, V83, P49, DOI 10.1016/j.psyneuen.2017.05.003; Jiang PF, 2015, EUR ARCH PSY CLIN N, V265, P497, DOI 10.1007/s00406-015-0588-y; Joseph A, 2017, J NEUROSCI, V37, P6778, DOI 10.1523/JNEUROSCI.0618-17.2017; Kendig MD, 2019, ASIA PAC J CLIN NUTR, V28, P6, DOI 10.6133/apjcn.201903_28(1).0002; Liu YZ, 2014, NEUROBIOL LEARN MEM, V114, P10, DOI 10.1016/j.nlm.2014.04.010; Mao CP, 2013, J ENDOCRINOL, V218, P61, DOI 10.1530/JOE-13-0139; Maruyama K, 2015, LIFE SCI, V136, P42, DOI 10.1016/j.lfs.2015.06.023; Mokler DJ, 2007, BRAIN RES, V1148, P226, DOI 10.1016/j.brainres.2007.02.031; Niculescu MD, 2009, INT J DEV NEUROSCI, V27, P627, DOI 10.1016/j.ijdevneu.2009.08.005; O'Donnell M, 2020, EUR HEART J, V41, P3363, DOI 10.1093/eurheartj/ehaa586; Ogihara T, 2002, HYPERTENSION, V40, P83, DOI 10.1161/01.HYP.0000022880.45113.C9; Otaegi G, 2006, J CELL SCI, V119, P2739, DOI 10.1242/jcs.03012; Pan B, 2011, J NEUROSCI, V31, P13420, DOI 10.1523/JNEUROSCI.2075-11.2011; Penedo LA, 2009, EXP NEUROL, V217, P108, DOI 10.1016/j.expneurol.2009.01.021; Reynolds CM, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12110; Rivera P, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061829; Robb JL, 2017, BEHAV BRAIN RES, V326, P187, DOI 10.1016/j.bbr.2017.02.049; Sah SK, 2017, BIOCHEM BIOPH RES CO, V493, P731, DOI 10.1016/j.bbrc.2017.08.122; Skaper SD, 2017, CNS NEUROL DISORD-DR, V16, P220, DOI 10.2174/1871527316666170113120853; Soleimani E, 2016, FOOD CHEM TOXICOL, V96, P263, DOI 10.1016/j.fct.2016.07.009; Stocher DP, 2018, BRIT J NUTR, V119, P1003, DOI [10.1017/S0007114518000235, 10.1017/s0007114518000235]; Stogsdill JA, 2017, NATURE, V551, P192, DOI 10.1038/nature24638; Tay SH, 2012, ANIMAL, V6, P1803, DOI 10.1017/S1751731112000584; Wang YJ, 2018, J NUTR BIOCHEM, V56, P133, DOI 10.1016/j.jnutbio.2018.01.007; Wang ZJ, 2020, NEUROSCIENCE, V424, P24, DOI 10.1016/j.neuroscience.2019.10.050; Wimmer ME, 2012, NEUROBIOL AGING, V33, P2220, DOI 10.1016/j.neurobiolaging.2011.07.007; Woodcock EA, 2019, NEUROIMAGE, V186, P437, DOI 10.1016/j.neuroimage.2018.11.017; Wu XL, 2018, NEUROPHARMACOLOGY, V131, P351, DOI 10.1016/j.neuropharm.2018.01.003; Zhang XH, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-9; Zhao FL, 2019, NEUROSCIENCE, V411, P237, DOI 10.1016/j.neuroscience.2019.05.033	49	3	3	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21244	10.1096/fj.202001890R	http://dx.doi.org/10.1096/fj.202001890R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715195				2022-12-26	WOS:000635216100019
J	Kobayashi, K; Ashina, K; Derouiche, S; Hamabata, T; Nakamura, T; Nagata, N; Takenouchi, S; Tominaga, M; Murata, T				Kobayashi, Koji; Ashina, Kohei; Derouiche, Sandra; Hamabata, Taiki; Nakamura, Tatsuro; Nagata, Nanae; Takenouchi, Shinya; Tominaga, Makoto; Murata, Takahisa			5,6-dihydroxy-8Z,11Z,14Z,17Z-eicosatetraenoic acid accelerates the healing of colitis by inhibiting transient receptor potential vanilloid 4-mediated signaling	FASEB JOURNAL			English	Article						eicosapentaenoic acid; inflammatory bowel disease; lipid mediator		5,6-dihydroxy-8Z,11Z,14Z,17Z-eicosatetraenoic acid (5,6-DiHETE) is an eicosapentaenoic acid-derived lipid metabolite, which we previously detected in inflamed mouse colon. In this study, we investigated the pathophysiological roles of 5,6-DiHETE in murine colitis and its underlying mechanisms of action, focusing on the effects on transient receptor potential vanilloid (TRPV) channel activity. Oral administration of dextran sodium sulfate (DSS, 2%, for 4 days) caused colon inflammation, which peaked on day 7 and gradually declined by day 18. 5,6-DiHETE concentration in colon tissue was significantly increased during the healing phase of colitis (days 9 to 18). In vitro study showed that pretreatment with 5,6-DiHETE (0.1-1 mu M, 30 minutes) significantly inhibited endothelial barrier disruption induced by a TRPV4 agonist (GSK1016790A, 50 nM). Intracellular Ca2+ imaging also showed that pretreatment with 5,6-DiHETE (1 mu M, 10 minutes) reduced GSK1016790A-induced intracellular Ca2+ increase in HEK293T cells overexpressing TRPV4. In vivo, intraperitoneal administration of 5,6-DiHETE (50 mu g kg(-1) day(-1)) during the healing phase accelerated the recovery from DSS-induced colitis. Pathological studies showed that the administration of 5,6-DiHETE inhibited edema formation and leukocyte infiltration in inflamed colon tissue. In conclusion, we identified 5,6-DiHETE as a novel endogenous TRPV4 antagonist, and we also demonstrated that its administration promotes the healing of colitis by inhibiting inflammatory responses.	[Kobayashi, Koji; Ashina, Kohei; Hamabata, Taiki; Nakamura, Tatsuro; Nagata, Nanae; Takenouchi, Shinya; Murata, Takahisa] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Tokyo, Japan; [Derouiche, Sandra; Tominaga, Makoto] Natl Inst Physiol Sci, Div Cell Signaling, Okazaki, Aichi, Japan	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Murata, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Bunkyo Ku, 1-1 Yayoi, Tokyo 1138657, Japan.	amurata@g.ecc.u-tokyo.ac.jp		Murata, Takahisa/0000-0002-3328-0796	Japan Society for the Promotion of Science [19K15975, 18K14603, 19K16603, 17H06252, 17H01509]; Takeda Science Foundation; Kobayashi Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kobayashi Foundation	Japan Society for the Promotion of Science, Grant/Award Number: 19K15975, 18K14603, 19K16603, 17H06252 and 17H01509; Takeda Science Foundation; Kobayashi Foundation	Almallah YZ, 1998, AM J GASTROENTEROL, V93, P804, DOI 10.1111/j.1572-0241.1998.229_a.x; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; D'Aldebert E, 2011, GASTROENTEROLOGY, V140, P275, DOI 10.1053/j.gastro.2010.09.045; Derouiche S, 2018, FASEB J, V32, P1841, DOI 10.1096/fj.201700954R; Earley S, 2015, PHYSIOL REV, V95, P645, DOI 10.1152/physrev.00026.2014; Fer M, 2008, ARCH BIOCHEM BIOPHYS, V471, P116, DOI 10.1016/j.abb.2008.01.002; Fernandes ES, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/506450; Fichna J, 2012, NEUROGASTROENT MOTIL, V24, pe557, DOI 10.1111/j.1365-2982.2012.01999.x; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Hamabata T, 2018, J LIPID RES, V59, P1864, DOI 10.1194/jlr.M085233; Hamabata T, 2018, J LIPID RES, V59, P586, DOI 10.1194/jlr.M079095; Hashimoto K, 2016, EXPERT OPIN THER TAR, V20, P1149, DOI 10.1080/14728222.2016.1226284; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Ivanov AI, 2004, FRONT BIOSCI-LANDMRK, V9, P1977, DOI 10.2741/1383; Kahn-Kirby AH, 2004, CELL, V119, P889, DOI 10.1016/j.cell.2004.11.005; Kittaka H, 2017, PFLUG ARCH EUR J PHY, V469, P1313, DOI 10.1007/s00424-017-1998-7; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Kruschewski M, 2001, DIGEST DIS SCI, V46, P2336, DOI 10.1023/A:1012334727509; Kusunoki Y, 2015, J GASTROEN HEPATOL, V30, P1618, DOI 10.1111/jgh.12966; Le Faouder P, 2013, J CHROMATOGR B, V932, P123, DOI 10.1016/j.jchromb.2013.06.014; Lee TH, 2009, J ALLERGY CLIN IMMUN, V124, P417, DOI 10.1016/j.jaci.2009.04.020; Lopez-Vicario C, 2015, P NATL ACAD SCI USA, V112, P536, DOI 10.1073/pnas.1422590112; Matsumoto K, 2018, BRIT J PHARMACOL, V175, P84, DOI 10.1111/bph.14072; Navarini L, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0586-3; Phuong TTT, 2017, J PHYSIOL-LONDON, V595, P6869, DOI 10.1113/JP275052; Proudman SM, 2015, ANN RHEUM DIS, V74, P89, DOI 10.1136/annrheumdis-2013-204145; Qiu YE, 2018, PROSTAG OTH LIPID M, V136, P9, DOI 10.1016/j.prostaglandins.2018.03.004; RACHMILEWITZ D, 1989, GASTROENTEROLOGY, V97, P326, DOI 10.1016/0016-5085(89)90068-1; Scotland RS, 2004, CIRC RES, V95, P1027, DOI 10.1161/01.RES.0000148633.93110.24; Szitter I, 2010, J MOL NEUROSCI, V42, P80, DOI 10.1007/s12031-010-9366-5; Taberner FJ, 2015, BBA-BIOMEMBRANES, V1848, P1818, DOI 10.1016/j.bbamem.2015.03.022; Teitelbaum JE, 2001, J NUTR BIOCHEM, V12, P21, DOI 10.1016/S0955-2863(00)00141-8; Thies F, 2003, LANCET, V361, P477, DOI 10.1016/S0140-6736(03)12468-3; Utsumi D, 2018, J PHARMACOL SCI, V136, P121, DOI 10.1016/j.jphs.2017.12.012; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Wang YP, 2017, ATHEROSCLEROSIS, V260, P13, DOI 10.1016/j.atherosclerosis.2017.03.016; WEISS HJ, 1979, BLOOD, V53, P244; Yin J, 2016, AM J RESP CELL MOL, V54, P370, DOI 10.1165/rcmb.2014-0225OC; Zhang GD, 2014, PROG LIPID RES, V53, P108, DOI 10.1016/j.plipres.2013.11.003	39	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21238	10.1096/fj.201903207RRR	http://dx.doi.org/10.1096/fj.201903207RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715198				2022-12-26	WOS:000635216100029
J	Li, DF; Li, FF; Meng, LL; Wei, HF; Zhang, QJ; Jiang, F; Chen, DN; Li, W; Tan, YQ; Li, JD				Li, Dengfeng; Li, Fangfang; Meng, Lanlan; Wei, Huafang; Zhang, Qianjun; Jiang, Fang; Chen, Dan-Na; Li, Wei; Tan, Yue-Qiu; Li, Jia-Da			RNF216 regulates meiosis and PKA stability in the testes	FASEB JOURNAL			English	Article						PKA; proteomics; RNF216; spermatogenesis		Spermatogenesis is a highly sophisticated process that comprises of mitosis, meiosis, and spermiogenesis. RNF216 (ring finger protein 216), an E3 ubiquitin ligase, has been reported to be essential for spermatogenesis and male fertility in mice. However, the stages affected by Rnf216 deficiency and its underlying molecular pathological mechanisms are still unknown. In this study, we generated Rnf216-deficient mice (Rnf216(-/-)) using CRISPR-Cas9 technology. Knockout of Rnf216 led to infertility in male but not female mice. Rnf216 knockout affected the prophase of meiosis I, as no genotypic difference was observed until 12 dpp (days postpartum). Rnf216(-/-) spermatocytes were incompletely arrested at the zygotene stage and underwent apoptosis at approximately the pachytene stage. The proportion of zygotene spermatocytes was significantly increased, whereas the proportion of pachytene spermatocytes was significantly decreased in Rnf216(-/-) testes. Nevertheless, there was no significantly genotypic difference in the number of diplotene spermatocytes. We further revealed that the PKA catalytic subunit beta (PRKACB) was significantly increased, which subsequently resulted in elevated PKA activity in testes from adult as well as 9 dpp Rnf216(-/-) mice. RNF216 interacts with PRKACB and promotes its degradation through the ubiquitin-lysosome pathway. Collectively, our results revealed an important role for RNF216 in regulation of meiosis and PKA stability in the testes.	[Li, Dengfeng; Li, Fangfang; Jiang, Fang; Li, Jia-Da] Cent South Univ, Sch Life Sci, Ctr Med Genet, Changsha, Peoples R China; [Li, Dengfeng; Li, Fangfang; Jiang, Fang; Li, Jia-Da] Cent South Univ, Hunan Key Lab Anim Models Human Dis, Changsha, Peoples R China; [Li, Dengfeng; Li, Fangfang; Jiang, Fang; Li, Jia-Da] Cent South Univ, Hunan Key Lab Med Genet, Changsha, Peoples R China; [Meng, Lanlan; Zhang, Qianjun; Tan, Yue-Qiu] Cent South Univ, Inst Reprod & Stem Cell Engn, Sch Basic Med Sci, Changsha, Peoples R China; [Wei, Huafang; Li, Wei] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China; [Chen, Dan-Na] Changsha Med Univ, Dept Basic Med Sci, Changsha, Peoples R China; [Li, Jia-Da] Hunan Int Sci & Technol Cooperat Base Anim Models, Changsha, Peoples R China	Central South University; Central South University; Central South University; Central South University; Chinese Academy of Sciences; Institute of Zoology, CAS; Changsha Medical University	Li, JD (corresponding author), Cent South Univ, Sch Life Sci, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China.	lijiada@sklmg.edu.cn	Chen, Dan/GRY-2691-2022	Chen, Dan/0000-0002-1570-9034; Li, Jia-Da/0000-0002-4236-3518	National Natural Science Foundation of China (NSFC) [81770780, 81728013, 31972913]; Key Research and Development Programs from Hunan Province [2018DK2010, 2018DK2013]; Guangdong Key Project in 'Development of New Tools for Diagnosis and Treatment of Autism' [2018B030335001]; Strategic Priority Research Program of Central South University [ZLXD2017004]; National Science Fund for Distinguished Young Scholars [81925015]; Key Grant of Prevention and Treatment of Birth Defect from Hunan Province [2019SK1012]; Training Program for Excellent Young Innovators of Changsha [kq1802019]; Natural Science Foundation of Hunan Province [2018JJ3573]; Foundation of Education Bureau of Hunan Province [18A493]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Research and Development Programs from Hunan Province; Guangdong Key Project in 'Development of New Tools for Diagnosis and Treatment of Autism'; Strategic Priority Research Program of Central South University; National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Key Grant of Prevention and Treatment of Birth Defect from Hunan Province; Training Program for Excellent Young Innovators of Changsha; Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Foundation of Education Bureau of Hunan Province	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81770780, 81728013 and 31972913; Key Research and Development Programs from Hunan Province, Grant/Award Number: 2018DK2010 and 2018DK2013; Guangdong Key Project in `Development of New Tools for Diagnosis and Treatment of Autism', Grant/Award Number: 2018B030335001; Strategic Priority Research Program of Central South University, Grant/Award Number: ZLXD2017004; National Science Fund for Distinguished Young Scholars, Grant/Award Number: 81925015; Key Grant of Prevention and Treatment of Birth Defect from Hunan Province, Grant/Award Number: 2019SK1012; Training Program for Excellent Young Innovators of Changsha, Grant/Award Number: kq1802019; Natural Science Foundation of Hunan Province, Grant/Award Number: 2018JJ3573; Foundation of Education Bureau of Hunan Province, Grant/Award Number: 18A493	Alavattam KG, 2016, CELL REP, V17, P1141, DOI 10.1016/j.celrep.2016.09.073; Alturki NA, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0672-0; Bianco SDC, 2009, NAT REV ENDOCRINOL, V5, P569, DOI 10.1038/nrendo.2009.177; Bonomi M, 2012, ASIAN J ANDROL, V14, P49, DOI 10.1038/aja.2011.68; Burton KA, 2007, PHYSIOLOGY, V22, P40, DOI 10.1152/physiol.00034.2006; Burton KA, 2006, MOL ENDOCRINOL, V20, P2504, DOI 10.1210/me.2006-0060; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; da Cruz I, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2618-1; Dickins RA, 2002, MOL CELL BIOL, V22, P2294, DOI 10.1128/MCB.22.7.2294-2303.2002; Dove KK, 2017, J MOL BIOL, V429, P3363, DOI 10.1016/j.jmb.2017.08.008; Evankovich J, 2020, AM J RESP CELL MOL, V62, P157, DOI 10.1165/rcmb.2018-0373OC; Griswold MD, 2016, PHYSIOL REV, V96, P1, DOI 10.1152/physrev.00013.2015; Hillers Kenneth J, 2017, WormBook, V2017, P1, DOI 10.1895/wormbook.1.178.1; Huang XY, 2011, ASIAN J ANDROL, V13, P18, DOI 10.1038/aja.2010.71; Husain N, 2017, AGING CELL, V16, P281, DOI 10.1111/acel.12551; Jan SZ, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.160614; Kim SH, 2015, ENDOCRINOL METAB, V30, P456, DOI 10.3803/EnM.2015.30.4.456; Kumazoe M, 2017, J BIOL CHEM, V292, P4077, DOI 10.1074/jbc.M116.755959; Mabb AM, 2014, NEURON, V82, P1299, DOI 10.1016/j.neuron.2014.05.016; Margolin DH, 2013, NEW ENGL J MED, V368, P1992, DOI 10.1056/NEJMoa1215993; Meehan TF, 2017, NAT GENET, V49, P1231, DOI 10.1038/ng.3901; Melnick AF, 2019, BIOL REPROD, V100, P1132, DOI 10.1093/biolre/ioz006; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Seenivasan R, 2019, HUM MOL GENET, V28, P2862, DOI 10.1093/hmg/ddz098; Skalhegg BS, 2002, MOL ENDOCRINOL, V16, P630, DOI 10.1210/me.16.3.630; Spiller C, 2017, ANNU REV GENET, V51, P265, DOI 10.1146/annurev-genet-120215-035449; Walden H, 2018, NAT STRUCT MOL BIOL, V25, P440, DOI 10.1038/s41594-018-0063-3; Walker-Gray R, 2017, P NATL ACAD SCI USA, V114, P10414, DOI 10.1073/pnas.1701782114; Ward JO, 2007, PLOS GENET, V3, P1550, DOI 10.1371/journal.pgen.0030139; Wosnitzer Matthew, 2014, Spermatogenesis, V4, pe28218; Xu CF, 2014, AUTOPHAGY, V10, P2239, DOI 10.4161/15548627.2014.981792; Xu ZL, 2016, NUCLEIC ACIDS RES, V44, P9681, DOI 10.1093/nar/gkw652; Yin Y, 2011, DEV BIOL, V356, P51, DOI 10.1016/j.ydbio.2011.05.661; Zickler D, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016626	36	3	3	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21460	10.1096/fj.202002294RR	http://dx.doi.org/10.1096/fj.202002294RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33724554				2022-12-26	WOS:000635216100094
J	Chukwudozie, OS; Gray, CM; Fagbayi, TA; Chukwuanukwu, RC; Oyebanji, VO; Bankole, TT; Adewole, RA; Daniel, EM				Chukwudozie, Onyeka S.; Gray, Clive M.; Fagbayi, Tawakalt A.; Chukwuanukwu, Rebecca C.; Oyebanji, Victor O.; Bankole, Taiwo T.; Adewole, Richard A.; Daniel, Eze M.			Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein	PLOS ONE			English	Article							PEP-FOLD; CORONAVIRUS; IDENTIFICATION; RESISTANCE; SERVER	Developing an efficacious vaccine for SARS-CoV-2 infection is critical to stemming COVID-19 fatalities and providing the global community with immune protection. We have used a bioinformatic approach to aid in designing an epitope peptide-based vaccine against the spike protein of the virus. Five antigenic B cell epitopes with viable antigenicity and a total of 27 discontinuous B cell epitopes were mapped out structurally in the spike protein for antibody recognition. We identified eight CD8+ T cell 9-mers and 12 CD4+ T cell 14-15-mer as promising candidate epitopes putatively restricted by a large number of MHC I and II alleles, respectively. We used this information to construct an in silico chimeric peptide vaccine whose translational rate was highly expressed when cloned in pET28a (+) vector. With our In silico test, the vaccine construct was predicted to elicit high antigenicity and cell-mediated immunity when given as a homologous prime-boost, triggering of toll-like receptor 5 by the adjuvant linker. The vaccine was also characterized by an increase in IgM and IgG and an array of Th1 and Th2 cytokines. Upon in silico challenge with SARS-CoV-2, there was a decrease in antigen levels using our immune simulations. We, therefore, propose that potential vaccine designs consider this approach.	[Chukwudozie, Onyeka S.; Fagbayi, Tawakalt A.; Bankole, Taiwo T.; Adewole, Richard A.] Univ Lagos, Dept Cell Biol & Genet, Lagos, Nigeria; [Gray, Clive M.] Univ Cape Town, Div Immunol, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Gray, Clive M.] Univ Cape Town, Dept Pathol, Cape Town, South Africa; [Chukwuanukwu, Rebecca C.] Nnamdi Azikiwe Univ, Med Lab Sci Dept, Immunol Unit, Nnewi, Nigeria; [Oyebanji, Victor O.] Univ Ibadan, Dept Vet Pathol, Ibadan, Nigeria; [Daniel, Eze M.] Univ Ibadan, Univ Coll Hosp, Inst Child Hlth, Publ Hlth Biotechnol Unit, Ibadan, Nigeria	University of Lagos; University of Cape Town; University of Cape Town; University of Ibadan; University of Ibadan; University College Hospital, Ibadan	Chukwudozie, OS (corresponding author), Univ Lagos, Dept Cell Biol & Genet, Lagos, Nigeria.	Solomononyeka84@gmail.com		Oyebanji, Victor/0000-0002-6681-6366; Gray, Clive/0000-0002-9293-901X; Chukwuanukwu, Rebecca/0000-0001-5023-9560; Bankole, Taiwo/0000-0002-1124-2430; chukwudozie, solomon/0000-0002-0814-6798; Fagbayi, Tawakalt/0000-0001-7496-1814				Adams S, 2019, ANN ONCOL, V30, P397, DOI 10.1093/annonc/mdy517; Almeida JD, 1968, NATURE, V220, P650; [Anonymous], 2002, Bull World Health Organ, V80, P983; Buchan DWA, 2019, NUCLEIC ACIDS RES, V47, pW402, DOI 10.1093/nar/gkz297; Cao WCC, 2007, NEW ENGL J MED, V357, P1162, DOI 10.1056/NEJMc070348; Choe PG, 2017, EMERG INFECT DIS, V23, P1079, DOI 10.3201/eid2307.170310; Chukwudozie OS, 2020, J IMMUNOL RES, V2020, DOI 10.1155/2020/2837670; Cohen J., 2020, ARXIV2020200311597V1; Dar HA, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7030088; DeLano W.L., 2002, CCP4 NEWSL PROTEIN C, V40, P82; Eschner K., 2020, POPULAR SCI, DOI [10.1126/science.367.6474.131, DOI 10.1126/SCIENCE.367.6474.131]; Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geller C, 2012, VIRUSES-BASEL, V4, P3044, DOI 10.3390/v4113044; Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Irini A., 2008, OPEN VACCINE J, V1, P22, DOI [10.2174/1875035400801010022, DOI 10.2174/1875035400801010022]; Isra K., 2018, DESIGN EPITOPE BASED, DOI [10.1101/434779, DOI 10.1101/434779]; Jeannin P, 2002, VACCINE, V20, pA23, DOI 10.1016/S0264-410X(02)00383-3; Kahn Jeffrey S, 2005, Pediatr Infect Dis J, V24, pS223, DOI 10.1097/01.inf.0000188166.17324.60; Khan MK, 2014, MOL IMMUNOL, V61, P16, DOI 10.1016/j.molimm.2014.04.009; Knight CJ, 2015, NUCLEIC ACIDS RES, V43, pW225, DOI 10.1093/nar/gkv309; Koretzky GA, 2010, J IMMUNOL, V185, P2643, DOI 10.4049/jimmunol.1090076; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Liu HP, 2015, BIOCONJUGATE CHEM, V26, P791, DOI 10.1021/acs.bioconjchem.5b00103; Malhotra A, 2009, METHOD ENZYMOL, V463, P239, DOI 10.1016/S0076-6879(09)63016-0; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; McINTOSH K., 1974, Current Topics in Microbiology and Immunology, P85; Naz A, 2015, INFECT GENET EVOL, V32, P280, DOI 10.1016/j.meegid.2015.03.027; Naz RK, 2007, FRONT BIOSCI-LANDMRK, V12, P1833, DOI 10.2741/2191; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Patronov A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120139; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Lopez-Blanco JR, 2014, NUCLEIC ACIDS RES, V42, pW271, DOI 10.1093/nar/gku339; Rapin N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009862; Robinson J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006862; Sanchez-Trincado JL, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/2680160; Sant'Angelo DB, 2002, EUR J IMMUNOL, V32, P2510, DOI 10.1002/1521-4141(200209)32:9<2510::AID-IMMU2510>3.0.CO;2-Q; Sexton NR, 2016, J VIROL, V90, P7415, DOI 10.1128/JVI.00080-16; Shen YM, 2014, J CHEM THEORY COMPUT, V10, P4745, DOI 10.1021/ct500592m; Simmons G, 2013, ANTIVIR RES, V100, P605, DOI 10.1016/j.antiviral.2013.09.028; Sormanni P, 2015, J MOL BIOL, V427, P478, DOI 10.1016/j.jmb.2014.09.026; Sun PP, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/943636; Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419; Tian W, 2018, NUCLEIC ACIDS RES, V46, pW363, DOI 10.1093/nar/gky473; Velankar S, 2013, NUCLEIC ACIDS RES, V41, pD483, DOI 10.1093/nar/gks1258; Xu Jiaquan, 2020, NCHS Data Brief, P1; Zhou P, 2018, NUCLEIC ACIDS RES, V46, pW443, DOI 10.1093/nar/gky357	50	19	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0248061	10.1371/journal.pone.0248061	http://dx.doi.org/10.1371/journal.pone.0248061			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730022	Green Submitted, Green Published, gold			2022-12-26	WOS:000630345000075
J	Kanokudom, S; Assawakongkarat, T; Akeda, Y; Ratthawongjirakul, P; Chuanchuen, R; Chaichanawongsaroj, N				Kanokudom, Sitthichai; Assawakongkarat, Thachaporn; Akeda, Yukihiro; Ratthawongjirakul, Panan; Chuanchuen, Rungtip; Chaichanawongsaroj, Nuntaree			Rapid detection of extended spectrum beta-lactamase producing Escherichia coli isolated from fresh pork meat and pig cecum samples using multiplex recombinase polymerase amplification and lateral flow strip analysis	PLOS ONE			English	Article								The emergence and dissemination of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli is a global health issue. Food-producing animals, including pigs, are significant reservoirs of antimicrobial resistance (AMR), which can be transmitted to humans. Thus, the rapid detection of ESBLs is required for efficient epidemiological control and treatment. In this study, multiplex recombinase polymerase amplification (RPA) combined with a single-stranded tag hybridization chromatographic printed-array strip (STH-PAS), as a lateral flow strip assay (LFA), was established for the rapid and simultaneous detection of multiple bla genes in a single reaction. Visible blue lines, indicating the presence of the bla(CTX-M), bla(SHV), and bla(OXA) genes, were observed within 10 min by the naked eye. The limit of detection of all three genes was 2.5 ng/25 mu L, and no cross-reactivity with seven commensal aerobic bacteria was observed. A total of 93.9% (92/98) and 96% (48/50) of the E. coli isolates from pork meat and fecal samples, respectively, expressed an ESBL-producing phenotype. Nucleotide sequencing of the PCR amplicons showed that bla(CTX-M) was the most prevalent type (91.3-95.83%), of which the main form was bla(CTX-M-55). The sensitivity and specificity of the RPA-LFA were 99.2% and 100%, respectively, and were in almost perfect agreement (kappa = 0.949-1.000) with the results from PCR sequencing. Thus, the RPA-LFA is a promising tool for rapid and equipment-free ESBL detection and may facilitate clinical diagnosis in human and veterinary medicine, as well as AMR monitoring and surveillance.	[Kanokudom, Sitthichai; Assawakongkarat, Thachaporn; Ratthawongjirakul, Panan; Chaichanawongsaroj, Nuntaree] Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Transfus Med & Clin Microbiol, Res Unit Innovat Diag Antimicrobial Resistance, Bangkok, Thailand; [Akeda, Yukihiro] Osaka Univ, Osaka Univ Hosp, Div Infect Control & Prevent, Suita, Osaka, Japan; [Akeda, Yukihiro] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka, Japan; [Chuanchuen, Rungtip] Chulalongkorn Univ, Fac Vet Sci, Dept Vet Publ Hlth, Res Unit Microbial Food Safety & Antimicrobial Re, Bangkok, Thailand	Chulalongkorn University; Osaka University; Osaka University; Chulalongkorn University	Chaichanawongsaroj, N (corresponding author), Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Transfus Med & Clin Microbiol, Res Unit Innovat Diag Antimicrobial Resistance, Bangkok, Thailand.	nuntaree@gmail.com	Tran, My/AAJ-9151-2021	Chaichanawongsaroj, Nuntaree/0000-0002-0717-5466; Kanokudom, Sitthichai/0000-0001-9482-6353	Agricultural Research Development Agency; Research Unit of Innovative Diagnosis of Antimicrobial Resistance; Second Century Fund (C2F), Chulalongkorn University; Japan Agency for Medical Research and Development (AMED); Faculty of Allied Health Sciences at Chulalongkorn University; Ratchadapisek Sompoch Endowment fund	Agricultural Research Development Agency; Research Unit of Innovative Diagnosis of Antimicrobial Resistance; Second Century Fund (C2F), Chulalongkorn University; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Faculty of Allied Health Sciences at Chulalongkorn University; Ratchadapisek Sompoch Endowment fund	This research project was granted by Agricultural Research Development Agency (Public Organization) or "ARDA" and partially supported by Research Unit of Innovative Diagnosis of Antimicrobial Resistance, Ratchadapisek Sompoch Endowment fund and the Second Century Fund (C2F), Chulalongkorn University and Japan Agency for Medical Research and Development (AMED). We would like to extend our sincerest gratitude to Graduate School as well as Faculty of Allied Health Sciences at Chulalongkorn University for providing the Overseas Research Experience Scholarship for Graduate Students. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre L, 2020, PORCINE HEALTH MANAG, V6, DOI 10.1186/s40813-020-00146-2; Bergey DH., 1994, BERGEYS MANUAL DETER, pp. 395; Boonyasiri A, 2014, PATHOG GLOB HEALTH, V108, P235, DOI 10.1179/2047773214Y.0000000148; Clinical and Laboratory Standards Institute, 2019, PERFORMANCE STANDARD, V29th; Costa D, 2006, J ANTIMICROB CHEMOTH, V58, P1311, DOI 10.1093/jac/dkl415; Daher RK, 2016, CLIN CHEM, V62, P947, DOI 10.1373/clinchem.2015.245829; Nguyen DTA, 2016, INT J FOOD MICROBIOL, V236, P115, DOI 10.1016/j.ijfoodmicro.2016.07.017; Dohmen W, 2015, CLIN MICROBIOL INFEC, V21, P917, DOI 10.1016/j.cmi.2015.05.032; Dohmen W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174094; Geser N, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-21; Ghosh DK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208530; Gundran RS, 2020, MICROB DRUG RESIST, V26, P160, DOI 10.1089/mdr.2019.0019; Hasman H, 2005, J ANTIMICROB CHEMOTH, V56, P115, DOI 10.1093/jac/dki190; Heeroma AJ, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20154182; Hu YJ, 2019, B WORLD HEALTH ORGAN, V97, P486, DOI 10.2471/BLT.18.225698; Jorgensen JH, 2000, CLIN INFECT DIS, V30, P799, DOI 10.1086/313788; Kim J, 1998, J CLIN MICROBIOL, V36, P1446, DOI 10.1128/JCM.36.5.1446-1449.1998; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lascols C, 2012, J CLIN MICROBIOL, V50, P1632, DOI 10.1128/JCM.06115-11; Lima CM, 2017, J FOOD SCI TECH MYS, V54, P3612, DOI 10.1007/s13197-017-2820-4; Lin Wenhui, 2015, Yichuan, V37, P899, DOI 10.16288/j.yczz.15-141; Liu X, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01057; Luo K, 2020, CRIT REV FOOD SCI, V60, P157, DOI 10.1080/10408398.2018.1516623; Mayboroda O, 2018, ANAL BIOCHEM, V545, P20, DOI 10.1016/j.ab.2018.01.005; Mohsin M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02476; Nadimpalli M, 2019, J ANTIMICROB CHEMOTH, V74, P342, DOI 10.1093/jac/dky451; Paivarinta M, 2020, INT J FOOD MICROBIOL, V315, DOI 10.1016/j.ijfoodmicro.2019.108361; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Peker N, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6010006; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Rasheed MU, 2014, REV INST MED TROP SP, V56, P341, DOI 10.1590/S0036-46652014000400012; Saliu EM, 2017, ANIM HEALTH RES REV, V18, P46, DOI 10.1017/S1466252317000020; Sapugahawatte DN, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00107-20; Seenama C, 2019, INFECT DRUG RESIST, V12, P2201, DOI 10.2147/IDR.S209545; Shanmugakani RK, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00149; Shanmugakani RK, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00067-17, 10.1128/aac.00067-17]; Singpanomchai N, 2019, J CLIN LAB ANAL, V33, DOI 10.1002/jcla.22655; Sturenburg E, 2004, J ANTIMICROB CHEMOTH, V54, P870, DOI 10.1093/jac/dkh449; Su M, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01405-18; Tacconelli E, GLOBAL PRIORITY LIST; Trongjit S, 2016, MICROBIOL IMMUNOL, V60, P575, DOI 10.1111/1348-0421.12407; Yano H, 2001, ANTIMICROB AGENTS CH, V45, P1343, DOI 10.1128/AAC.45.5.1343-1348.2001; Zhang CZ, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01268; Zhang J, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0659-0	45	4	4	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0248536	10.1371/journal.pone.0248536	http://dx.doi.org/10.1371/journal.pone.0248536			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720963	gold, Green Published			2022-12-26	WOS:000629667400025
J	de Lusignan, S; Hoang, U; Liyanage, H; Tripathy, M; Sherlock, J; Joy, M; Ferreira, F; Diez-Domingo, J; Clark, T				de Lusignan, Simon; Uy Hoang; Liyanage, Harshana; Tripathy, Manasa; Sherlock, Julian; Joy, Mark; Ferreira, Filipa; Diez-Domingo, Javier; Clark, Tristan			Using Point of Care Testing to estimate influenza vaccine effectiveness in the English primary care sentinel surveillance network	PLOS ONE			English	Article								Introduction Rapid Point of Care Testing (POCT) for influenza could be used to provide information on influenza vaccine effectiveness (IVE) as well as influencing clinical decision-making in primary care. Methods We undertook a test negative case control study to estimate the overall and age-specific (6 months-17 years, 18-64 years, >= 65 years old) IVE against medically attended POCT-confirmed influenza. The study took place over the winter of 2019-2020 and was nested within twelve general practices that are part of the Oxford-Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC), the English sentinel surveillance network. Results 648 POCT were conducted. 193 (29.7%) of those who were swabbed had received the seasonal influenza vaccine. The crude unadjusted overall IVE was 46.1% (95% CI: 13.9-66.3). After adjusting for confounders the overall IVE was 26.0% (95% CI: 0-65.5). In total 211 patients were prescribed an antimicrobial after swab testing. Given a positive influenza POCT result, the odds ratio (OR) of receiving an antiviral was 21.1 (95%CI: 2.4-182.2, p = <0.01) and the OR of being prescribed an antibiotic was 0.6 (95%CI: 0.4-0.9, p = <0.01). Discussion Using influenza POCT in a primary care sentinel surveillance network to estimate IVE is feasible and provides comparable results to published IVE estimates. A further advantage is that near patient testing of influenza is associated with improvements in appropriate antiviral and antibiotic use. Larger, randomised studies are needed in primary care to see if these trends are still present and to explore their impact on outcomes.	[de Lusignan, Simon; Uy Hoang; Liyanage, Harshana; Tripathy, Manasa; Sherlock, Julian; Joy, Mark; Ferreira, Filipa] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Diez-Domingo, Javier] FISABIO Publ Hlth, Vaccine Res Dept, Valencia, Spain; [Clark, Tristan] Univ Southampton, Acad Unit Clin & Expt Sci, Southampton, Hants, England	University of Oxford; University of Southampton	de Lusignan, S (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.	simon.delusignan@phc.ox.ac.uk	Liyanage, Harshana/AAN-5206-2021; Hoang, Uy/AAD-9445-2022	Liyanage, Harshana/0000-0001-9738-6349; Hoang, Uy/0000-0002-8428-5140; de Lusignan, Simon/0000-0002-8553-2641; Ferreira, Filipa/0000-0002-7717-8486; Diez-Domingo, Javier/0000-0003-1008-3922	EU [777363]	EU(European Commission)	The work described here is part of Development of Robust and Innovative Vaccine Effectiveness (DRIVE) an EU funded project, part of the Innovative Medicines Initiative (IMI) project Grant agreement number: 777363 https://www.imi.europa.eu/The funders play no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	[Anonymous], 2016, FACT SHEET INFLUENZA; [Anonymous], 2020, D7 7  BRAND SPECIFIC; [Anonymous], 2016, GUIDELINE INFLUENZA; Correa A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011092; Dawood FS, 2020, MMWR-MORBID MORTAL W, V69, P177, DOI 10.15585/mmwr.mm6907a1; de Lusignan S, 2020, BRIT J GEN PRACT, V70, pE555, DOI 10.3399/bjgp20X710897; de Lusignan S, 2020, JMIR PUBLIC HLTH SUR, V6, P126, DOI 10.2196/18606; de Lusignan S, 2019, JMIR RES PROTOC, V8, DOI 10.2196/14186; de Lusignan S, 2017, BRIT J GEN PRACT, V67, P440, DOI 10.3399/bjgp17X692645; Dziabowska K, 2018, BIOSENSORS-BASEL, V8, DOI 10.3390/bios8040094; Fitzner J, 2018, B WORLD HEALTH ORGAN, V96, P122, DOI 10.2471/BLT.17.194514; Harding AT, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6020019; Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2; Lahariya Chandrakant, 2016, J Family Med Prim Care, V5, P7, DOI 10.4103/2249-4863.184616; Lee JJ, 2019, CLIN INFECT DIS, V69, P24, DOI 10.1093/cid/ciy837; Liyanage H, 2020, STUD HEALTH TECHNOL, V270, P1339, DOI 10.3233/SHTI200431; McCartney M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6182; Merckx J, 2017, ANN INTERN MED, V167, P394, DOI 10.7326/M17-0848; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Penttinen P, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.22.21148; Ramsay LC, 2019, BMC MED, V17, DOI 10.1186/s12916-018-1239-8; Rose A, 2020, EUROSURVEILLANCE, V25, P16, DOI 10.2807/1560-7917.ES.2020.25.10.2000153; Tippu Zayd, 2017, J Innov Health Inform, V23, P920, DOI 10.14236/jhi.v23i4.920; Troeger CE, 2019, LANCET RESP MED, V7, P69, DOI [10.1016/S2213-2600(18)30496-X, 10.1016/s2213-2600(18)30496-x]; Vos LM, 2019, CLIN INFECT DIS, V69, P1243, DOI 10.1093/cid/ciz056; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	26	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248123	10.1371/journal.pone.0248123	http://dx.doi.org/10.1371/journal.pone.0248123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705452	gold, Green Published, Green Accepted			2022-12-26	WOS:000629590400067
J	McDougal, L; Singh, A; Kumar, K; Dehingia, N; Barros, AJD; Ewerling, F; Atmavilas, Y; Raj, A				McDougal, Lotus; Singh, Abhishek; Kumar, Kaushalendra; Dehingia, Nabamallika; Barros, Aluisio J. D.; Ewerling, Fernanda; Atmavilas, Yamini; Raj, Anita			Planning for work: Exploring the relationship between contraceptive use and women's sector-specific employment in India	PLOS ONE			English	Article							LABOR-FORCE PARTICIPATION; DIRECTED ACYCLIC GRAPHS; QUALITATIVE FINDINGS; CHILD MARRIAGE; FERTILITY; HEALTH; IMPACT; EDUCATION; ETHIOPIA; STERILIZATION	While the health-related benefits of contraceptive use for women are well documented, potential social benefits, including enabling women's employment, have not been well researched. We examine the relationship between contraceptive use and women's employment in India, a country where both factors have remained relatively static over the past ten years. We use data from India's 2015-16 National Family Health Survey to test the association between current contraceptive use (none, sterilization, IUD, condom, pill, rhythm method or withdrawal) and current employment status (none, professional, clerical or sales, agricultural, services or production) with multivariable, multinomial regression; variable selection was guided by a directed acyclic graph. More than three-quarters of women in this sample were currently using contraception; sterilization was most common. Women who were sterilized or chose traditional contraception, relative to those not using contraception, were more likely to be employed in the agricultural and production sectors, versus not being employed (sterilization adjusted relative risk ratio [aRRR] = 1.5, p<0.001 for both agricultural and production sectors; rhythm aRRR = 1.5, p = 0.01 for agriculture; withdrawal aRRR = 1.5, p = 0.02 for production). In contrast, women with IUDs, compared to those who not using contraception, were more likely to be employed in the professional sector versus not being employed (aRRR = 1.9, p = 0.01). The associations between current contraceptive use and employment were heterogeneous across methods and sectors, though in no case was contraceptive use significantly associated with lower relative probabilities of employment. Policies designed to support women's access to contraception should consider the sector-specific employment of the populations they target.	[McDougal, Lotus; Dehingia, Nabamallika; Raj, Anita] Univ Calif San Diego, Sch Med, Ctr Gender Equ & Hlth, La Jolla, CA 92093 USA; [Singh, Abhishek; Kumar, Kaushalendra] Int Inst Populat Sci, Mumbai, Maharashtra, India; [Barros, Aluisio J. D.; Ewerling, Fernanda] Univ Fed Pelotas, Int Ctr Equ Hlth, Pelotas, RS, Brazil; [Atmavilas, Yamini] Bill & Melinda Gates Fdn, Delhi, India	University of California System; University of California San Diego; International Institute for Population Sciences; Universidade Federal de Pelotas	McDougal, L (corresponding author), Univ Calif San Diego, Sch Med, Ctr Gender Equ & Hlth, La Jolla, CA 92093 USA.	lmcdouga@ucsd.edu	Dehingia, Nabamallika/AAY-5588-2021	Dehingia, Nabamallika/0000-0003-1787-9050; Singh, Abhishek/0000-0001-6263-4410	Bill & Melinda Gates Foundation [OPP1179208]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This work was supported by the Bill & Melinda Gates Foundation [OPP1179208] (PI: AR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Riyami Asya, 2004, Reprod Health Matters, V12, P144, DOI 10.1016/S0968-8080(04)23113-5; Almanza CH, 2018, DEMOGRAPHY, V55, P643, DOI 10.1007/s13524-018-0664-9; An P., 2019, REPROD HEALTH, V16, P1, DOI [10.1186/s12978-018-0662-9, DOI 10.1186/S12978-018-0662-9]; Arendal G, GENDER DIVISION LABO; Austin AE, 2019, CHILD ABUSE NEGLECT, V91, P78, DOI 10.1016/j.chiabu.2019.02.011; Bailey MJ, 2006, Q J ECON, V121, P289; Bhan N, 2019, J ADOLESCENT HEALTH, V65, P498, DOI 10.1016/j.jadohealth.2019.05.002; Black RE, 2016, LANCET, V388, P2811, DOI 10.1016/S0140-6736(16)00738-8; Blackstone SR, 2017, J BIOSOC SCI, V49, P423, DOI 10.1017/S0021932016000377; Bloom D., 2003, DEMOGRAPHIC DIVIDEND; Bloom DE, 2009, J ECON GROWTH, V14, P79, DOI 10.1007/s10887-009-9039-9; Blumenthal PD, 2018, CONTRACEPTION, V98, P215, DOI 10.1016/j.contraception.2018.04.019; Boyce SC, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1577-0; Bradley SEK, 2012, REVISING UNMET NEED; Chola L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130077; Chun H, 2002, APPL ECON LETT, V9, P631, DOI 10.1080/13504850110117850; Cleland J, 2012, LANCET, V380, P149, DOI 10.1016/S0140-6736(12)60609-6; Cohen SA., 2010, GUTTMACHER POLICY RE, V13, P12; Das S, 2015, 2015 14TH INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY (ICIT 2015), P221, DOI 10.1109/ICIT.2015.34; DaVanzo J, 2007, BJOG-INT J OBSTET GY, V114, P1079, DOI 10.1111/j.1471-0528.2007.01338.x; de Jong E, 2017, WORLD DEV, V90, P360, DOI 10.1016/j.worlddev.2016.10.012; de Oliveira IT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086654; Dehingia N, 2019, SSM-POPUL HLTH, V9, DOI 10.1016/j.ssmph.2019.100467; Department of Statistics ILO., 2018, DECENT WORK SUSTAINA; Directorate General of Employment Minstry of Labour and Employment., 2015, NATL CLASSIFICATION; Ewerling F, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.020434; Ferrant G., 2014, UNPAID CARE WORK MIS; Field E, 2017, CONTRACT NO WORKING; Finlay J, 2013, BIOGAS CHALLENGES EX; Finlay JE, 2021, WORLD DEV, V139, DOI 10.1016/j.worlddev.2020.105313; Finlay JE, 2018, MILBANK Q, V96, P300, DOI 10.1111/1468-0009.12326; Fletcher E, 2017, WOMEN WORK INDIA DES; Frost JJ, 2008, PERSPECT SEX REPRO H, V40, P94, DOI 10.1363/4009408; Galor O, 1996, AM ECON REV, V86, P374, DOI 10.3386/w4550; Ghule Mohan, 2015, Asian J Res Soc Sci Humanit, V5, P18, DOI 10.5958/2249-7315.2015.00132.X; Glassman A, 2016, CTR GLOBAL DEV; Government of Tamil Nadu , 2018, HLTH FAMILY WELFARE; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Gross T., 2017, ORG INVISIBLE STRATE; Hirway I, 2011, FEM ECON, V17, P67, DOI 10.1080/13545701.2011.622289; International Institute for Population Sciences,, 2017, NATL FAMILY HLTH SUR; International Institute for Population Sciences (IIPS) and Macro International, 2007, NATL FAMILY HLTH SUR, VI; International Labour Office, 2015, INSIGHTS WORKING CON; International Labour Organization, 2016, WORKPL STRESS COLL C; International Labour Organization Department of Statistics, 2013, CONTRACT NO ICLS1920; International Labour Organization (ILO), 2018, CAR WORK CAR JOBS FU; Irani L, 2021, ASIAN POPUL STUD, V17, P94, DOI 10.1080/17441730.2020.1778854; Islam Ahmed Zohirul, 2016, Int J MCH AIDS, V5, P92; James KS, 2011, SCIENCE, V333, P576, DOI 10.1126/science.1207969; Jha P, 2011, LANCET, V377, P1921, DOI 10.1016/S0140-6736(11)60649-1; John NA, 2020, FEM ECON, V26, P23, DOI 10.1080/13545701.2019.1632471; Jutting JP, 2008, J HUM DEV CAPABIL, V9, P65; Khan ME, 1980, FERTILITY CONTROL IN, pXIV; Klasen S, 2015, WORLD BANK ECON REV, V29, P449, DOI 10.1093/wber/lhv003; Lahoti R, 2016, FEM ECON, V22, P168, DOI 10.1080/13545701.2015.1066022; Liu L, 2008, POP STUD-J DEMOG, V62, P191, DOI 10.1080/00324720801897796; Mammen K, 2000, J ECON PERSPECT, V14, P141, DOI 10.1257/jep.14.4.141; McClendon KA, 2018, CULT HEALTH SEX, V20, P799, DOI 10.1080/13691058.2017.1383513; McDougal L, 2020, SSM-POPUL HLTH, V12, DOI 10.1016/j.ssmph.2020.100688; McDougal L, 2020, ECLINICALMEDICINE, V23, DOI 10.1016/j.eclinm.2020.100414; McDougal L, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0631-z; McDougal L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171002; McDougal L, 2016, ASIA-PAC J PUBLIC HE, V28, P423, DOI 10.1177/1010539516654539; McIntosh C, 2016, 7901 WORLD BANK GROU; Ministry of Statistics and Programme Implementation Government of India., 2020, TIME USE INDIA 2019; Mwaikambo L, 2011, STUD FAMILY PLANN, V42, P67, DOI 10.1111/j.1728-4465.2011.00267.x; National Health Mission MoHFW Government of India, JAN SUR YOJ; National Statistics Office Government of India., 2019, ANN REPORT PERIODIC; OCONNOR JS, 1993, BRIT J SOCIOL, V44, P501, DOI 10.2307/591814; Office IL, 2018, WOM MEN INF EC STAT; ONU, 2015, RESOLUTION ADOPTED G, DOI DOI 10.1007/S13398-014-0173-7.2; Oxfam India, 2019, MIND GAP STATE EMPLO; Pallikadavath S, 2015, J BIOSOC SCI, V47, P75, DOI 10.1017/S002193201300059X; Poduval Jayita, 2009, Mens Sana Monogr, V7, P63, DOI 10.4103/0973-1229.41799; Prakash N, 2020, J ECON BEHAV ORGAN, V180, P494, DOI 10.1016/j.jebo.2020.10.017; Raj A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-018-6340-6; Raj Anita, 2015, Int J Gynaecol Obstet, V130 Suppl 3, pE56, DOI 10.1016/j.ijgo.2015.03.013; Raj A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106210; Raj A, 2013, INT J GYNECOL OBSTET, V121, P162, DOI 10.1016/j.ijgo.2012.12.011; Raj A, 2010, ARCH DIS CHILD, V95, P931, DOI 10.1136/adc.2009.178707; Reed E, 2016, MATERN CHILD HLTH J, V20, P1203, DOI 10.1007/s10995-016-1921-4; Rowland D., 2003, DEMOGRAPHIC METHODS; Rutstein S. O., 2004, DHS WEALTH INDEX; Saavala M, 1999, STUD FAMILY PLANN, V30, P288, DOI 10.1111/j.1728-4465.1999.t01-1-.x; Shakya HB, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08759-6; SHAPIRO D, 1994, STUD FAMILY PLANN, V25, P96, DOI 10.2307/2138087; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Sundari S, 2020, INDIAN J LABOUR ECON, V63, P689, DOI 10.1007/s41027-020-00245-2; Textor J, 2016, INT J EPIDEMIOL, V45, P1887, DOI 10.1093/ije/dyw341; Thomas JJ, 2014, ECON POLIT WEEKLY, V49; Tsui AO, 2010, EPIDEMIOL REV, V32, P152, DOI 10.1093/epirev/mxq012; World Bank, 2012, INCLUSIVE GREEN GROW; World Health Organization Department of Reproductive Health and Research Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs Knowledge for Health Project, 2018, FAMILY PLANNING GLOB; Wu XG, 2014, CHINESE SOCIOL REV, V46, P3, DOI 10.2753/CSA2162-0555460301; Yeakey MP, 2009, STUD FAMILY PLANN, V40, P205, DOI 10.1111/j.1728-4465.2009.00203.x; Zimmerman LA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218157	96	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248391	10.1371/journal.pone.0248391	http://dx.doi.org/10.1371/journal.pone.0248391			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8JZ	33705471	gold, Green Published			2022-12-26	WOS:000629590400010
J	Kline, JA; Camargo, CA; Courtney, DM; Kabrhel, C; Nordenholz, KE; Aufderheide, T; Baugh, JJ; Beiser, DG; Bennett, CL; Bledsoe, J; Castillo, E; Chisolm-Straker, M; Goldberg, EM; House, H; House, S; Jang, T; Lim, SC; Madsen, TE; McCarthy, DM; Meltzer, A; Moore, S; Newgard, C; Pagenhardt, J; Pettit, KL; Pulia, MS; Puskarich, MA; Southerland, LT; Sparks, S; Turner-Lawrence, D; Vrablik, M; Wang, A; Weekes, AJ; Westafer, L; Wilburn, J				Kline, Jeffrey A.; Camargo, Carlos A., Jr.; Courtney, D. Mark; Kabrhel, Christopher; Nordenholz, Kristen E.; Aufderheide, Thomas; Baugh, Joshua J.; Beiser, David G.; Bennett, Christopher L.; Bledsoe, Joseph; Castillo, Edward; Chisolm-Straker, Makini; Goldberg, Elizabeth M.; House, Hans; House, Stacey; Jang, Timothy; Lim, Stephen C.; Madsen, Troy E.; McCarthy, Danielle M.; Meltzer, Andrew; Moore, Stephen; Newgard, Craig; Pagenhardt, Justine; Pettit, Katherine L.; Pulia, Michael S.; Puskarich, Michael A.; Southerland, Lauren T.; Sparks, Scott; Turner-Lawrence, Danielle; Vrablik, Marie; Wang, Alfred; Weekes, Anthony J.; Westafer, Lauren; Wilburn, John			Clinical prediction rule for SARS-CoV-2 infection from 116 US emergency departments 2-22-2021	PLOS ONE			English	Article							DECISION RULES; MULTICENTER; DIAGNOSIS	Objectives Accurate and reliable criteria to rapidly estimate the probability of infection with the novel coronavirus-2 that causes the severe acute respiratory syndrome (SARS-CoV-2) and associated disease (COVID-19) remain an urgent unmet need, especially in emergency care. The objective was to derive and validate a clinical prediction score for SARS-CoV-2 infection that uses simple criteria widely available at the point of care. Methods Data came from the registry data from the national REgistry of suspected COVID-19 in EmeRgency care (RECOVER network) comprising 116 hospitals from 25 states in the US. Clinical variables and 30-day outcomes were abstracted from medical records of 19,850 emergency department (ED) patients tested for SARS-CoV-2. The criterion standard for diagnosis of SARS-CoV-2 required a positive molecular test from a swabbed sample or positive antibody testing within 30 days. The prediction score was derived from a 50% random sample (n = 9,925) using unadjusted analysis of 107 candidate variables as a screening step, followed by stepwise forward logistic regression on 72 variables. Results Multivariable regression yielded a 13-variable score, which was simplified to a 13-point score: +1 point each for age>50 years, measured temperature>37.5 degrees C, oxygen saturation<95%, Black race, Hispanic or Latino ethnicity, household contact with known or suspected COVID-19, patient reported history of dry cough, anosmia/dysgeusia, myalgias or fever; and -1 point each for White race, no direct contact with infected person, or smoking. In the validation sample (n = 9,975), the probability from logistic regression score produced an area under the receiver operating characteristic curve of 0.80 (95% CI: 0.79-0.81), and this level of accuracy was retained across patients enrolled from the early spring to summer of 2020. In the simplified score, a score of zero produced a sensitivity of 95.6% (94.8-96.3%), specificity of 20.0% (19.0-21.0%), negative likelihood ratio of 0.22 (0.19-0.26). Increasing points on the simplified score predicted higher probability of infection (e.g., >75% probability with +5 or more points). Conclusion Criteria that are available at the point of care can accurately predict the probability of SARS-CoV-2 infection. These criteria could assist with decisions about isolation and testing at high throughput checkpoints.	[Kline, Jeffrey A.; Pettit, Katherine L.; Wang, Alfred] Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA; [Camargo, Carlos A., Jr.; Kabrhel, Christopher; Baugh, Joshua J.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Courtney, D. Mark] Univ Texas Southwestern, Dept Emergency Med, Dallas, TX USA; [Nordenholz, Kristen E.] Univ Colorado, Sch Med, Dept Emergency Med, Aurora, CO USA; [Aufderheide, Thomas] Med Coll Wisconsin, Dept Emergency Med, Milwaukee, WI 53226 USA; [Beiser, David G.] Univ Chicago, Sect Emergency Med, Chicago, IL 60637 USA; [Bennett, Christopher L.] Stanford Univ, Sch Med, Dept Emergency Med, Palo Alto, CA 94304 USA; [Bledsoe, Joseph] Intermt Healthcare, Healthcare Delivery Inst, Dept Emergency Med, Salt Lake City, UT USA; [Castillo, Edward] Univ Calif San Diego, Dept Emergency Med, San Diego, CA 92103 USA; [Chisolm-Straker, Makini] Mt Sinai Sch Med, Dept Emergency Med, New York, NY USA; [Goldberg, Elizabeth M.] Brown Univ, Warren Alpert Med Sch, Dept Emergency Med, Providence, RI 02912 USA; [House, Hans] Univ Iowa, Dept Emergency Med, Sch Med, Iowa City, IA USA; [House, Stacey] Washington Univ, Sch Med, Dept Emergency Med, St Louise, MO USA; [Jang, Timothy] Univ Calif Los Angeles, David Geffen Sch Med, Dept Emergency Med, Los Angeles, CA 90095 USA; [Lim, Stephen C.] Louisiana State Univ, Sch Med, Univ Med Ctr New Orleans, New Orleans, LA USA; [Madsen, Troy E.] Univ Utah, Sch Med, Dept Surg, Div Emergency Med, Salt Lake City, UT USA; [McCarthy, Danielle M.] Northwestern Univ, Feinberg Sch Med, Dept Emergency Med, Chicago, IL 60611 USA; [Meltzer, Andrew] George Washington Univ, Sch Med, Dept Emergency Med, Washington, DC USA; [Moore, Stephen] Penn State Milton S Hershey Med Ctr, Dept Emergency Med, Hershey, PA USA; [Newgard, Craig] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97201 USA; [Pagenhardt, Justine] West Virginia Univ, Dept Emergency Med, Sch Med, Morgantown, WV USA; [Pulia, Michael S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Emergency Med, Madison, WI USA; [Puskarich, Michael A.] Hennepin Cty Med Ctr, Dept Emergency Med, Minneapolis, MN 55415 USA; [Puskarich, Michael A.] Univ Minnesota, Minneapolis, MN USA; [Southerland, Lauren T.] Ohio State Univ, Med Ctr, Dept Emergency Med, Columbus, OH 43210 USA; [Sparks, Scott] Riverside Reg Med Ctr, Dept Emergency Med, Newport News, VA USA; [Turner-Lawrence, Danielle] Beaumont Hlth, Dept Emergency Med, Royal Oak, MI USA; [Vrablik, Marie] Univ Washington, Sch Med, Dept Emergency Med, Seattle, WA USA; [Weekes, Anthony J.] Atrium Hlth, Carolinas Med Ctr, Dept Emergency Med, Charlotte, NC USA; [Westafer, Lauren] Baystate Hlth, Dept Emergency Med, Springfield, MA USA; [Wilburn, John] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI USA	Indiana University System; Indiana University Bloomington; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Colorado System; University of Colorado Anschutz Medical Campus; Medical College of Wisconsin; University of Chicago; Stanford University; Intermountain Healthcare; Intermountain Medical Center; University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai; Brown University; University of Iowa; Washington University (WUSTL); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Louisiana State University System; Utah System of Higher Education; University of Utah; Northwestern University; Feinberg School of Medicine; George Washington University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Oregon Health & Science University; West Virginia University; University of Wisconsin System; University of Wisconsin Madison; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; Ohio State University; Beaumont Health; University of Washington; University of Washington Seattle; Carolinas Medical Center; Wayne State University	Kline, JA (corresponding author), Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA.	jefkline@iu.edu	Bledsoe, Joseph/GLS-8543-2022; Nordenholz, Kristen/AAC-5348-2022; Camargo, Carlos A./C-2145-2008; Puskarich, Michael/N-7849-2014	Bledsoe, Joseph/0000-0002-3005-2878; Nordenholz, Kristen/0000-0002-6319-6309; Camargo, Carlos A./0000-0002-5071-7654; Beiser, David/0000-0001-9676-087X; Westafer, Lauren/0000-0003-2292-045X; House, Hans/0000-0003-0398-1126; Puskarich, Michael/0000-0001-6358-4670; Bennett, Christopher/0000-0002-8467-6192; Southerland, Lauren/0000-0002-3561-8332				Ahmad S, 2021, J BIOMOL STRUCT DYN, V39, P4225, DOI 10.1080/07391102.2020.1775129; Brehaut JC, 2010, MED DECIS MAKING, V30, P398, DOI 10.1177/0272989X09344747; Brehaut JC, 2005, ACAD EMERG MED, V12, P948, DOI 10.1197/j.aem.2005.04.024; Bureau USC. US Department of Commerce, QUICK FACTS US WEB S; Carpenter CR, 2020, ACAD EMERG MED, V27, P653, DOI 10.1111/acem.14048; Chen JX, 2020, VIRULENCE, V11, P1557, DOI 10.1080/21505594.2020.1840122; Dinnes J, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD013705, 10.1002/14651858.CD013705.pub2]; Grassly NC, 2020, LANCET INFECT DIS, V20, P1381, DOI 10.1016/S1473-3099(20)30630-7; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Israel A., 2020, SMOKING RISK COVID 1, DOI [10.1101/2020.06.01.20118877, DOI 10.1101/2020.06.01.20118877]; Jones J, 2020, J MED INTERNET RES, V22, DOI 10.2196/20001; Kline JA, 2008, J THROMB HAEMOST, V6, P772, DOI 10.1111/j.1538-7836.2008.02944.x; Kline JA, 2020, JACEP OPEN, V1, P1341, DOI 10.1002/emp2.12313; Lee S, 2020, JAMA INTERN MED, V180, P1447, DOI 10.1001/jamainternmed.2020.3862; Lipsitch M, 2020, NEW ENGL J MED, V382, P1194, DOI 10.1056/NEJMp2002125; Luks AM, 2020, ANN AM THORAC SOC, V17, P1040, DOI 10.1513/AnnalsATS.202005-418FR; McDonald SA, 2021, ACAD EMERG MED, V28, P206, DOI 10.1111/acem.14182; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; National Hospital Ambulatory Medical Care Survey,, 2017, STAT UDOHAHSCFDCAPNC; Organization WH, 2020, CLIN CHARACTERISATIO; Pate Alexander, 2020, Diagn Progn Res, V4, P14, DOI 10.1186/s41512-020-00082-3; Peng P, 2018, ACAD EMERG MED, V25, P958, DOI 10.1111/acem.13439; Peyrony O, 2020, ANN EMERG MED, V76, P405, DOI 10.1016/j.annemergmed.2020.05.022; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Schwab P, 2020, J MED INTERNET RES, V22, DOI 10.2196/21439; Tindle HA, 2020, NICOTINE TOB RES, V22, P1669, DOI 10.1093/ntr/ntaa077; Tritschler T, 2018, JAMA-J AM MED ASSOC, V320, P1583, DOI 10.1001/jama.2018.14346; Tsigaris P, 2020, NICOTINE TOB RES, V22, P1646, DOI 10.1093/ntr/ntaa121; van Smeden M, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0267-3; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328	30	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0248438	10.1371/journal.pone.0248438	http://dx.doi.org/10.1371/journal.pone.0248438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690722	Green Submitted, gold, Green Published			2022-12-26	WOS:000627854700004
J	De Broucker, G; Salvatore, PP; Mutembo, S; Moyo, N; Mutanga, JN; Thuma, PE; Moss, WJ; Sutcliffe, CG				De Broucker, Gatien; Salvatore, Phillip P.; Mutembo, Simon; Moyo, Nkumbula; Mutanga, Jane N.; Thuma, Philip E.; Moss, William J.; Sutcliffe, Catherine G.			The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia	PLOS ONE			English	Article								Introduction Early infant diagnosis (EID) and treatment can prevent much of the HIV-related morbidity and mortality experienced by children but is challenging to implement in sub-Saharan Africa. Point-of-care (PoC) testing would decentralize testing and increase access to rapid diagnosis. The objective of this study was to determine the cost-effectiveness of PoC testing in Southern Province, Zambia. Methods A decision tree model was developed to compare health outcomes and costs between the standard of care (SoC) and PoC testing using GeneXpert and m-PIMA platforms. The primary health outcome was antiretroviral treatment (ART) initiation within 60 days of sample collection. Additional outcomes included ART initiation by 12 months of age and death prior to ART initiation. Costs included both capital and recurrent costs. Health outcomes and costs were combined to create incremental cost effectiveness ratios (ICERs). Results The proportion of children initiating ART within 60 days increased from 27.8% with SoC to 79.8-82.8% with PoC testing depending on the algorithm and platform. The proportion of children initiating ART by 12 months of age increased from 50.9% with SoC to 84.0-86.5% with PoC testing. The proportion of HIV-infected children dying prior to ART initiation decreased from 18.1% with SoC to 3.8-4.6% with PoC testing. Total program costs were similar for the SoC and GeneXpert but higher for m-PIMA. ICERs for PoC testing were favorable, ranging from $23-1,609 for ART initiation within 60 days, $37-2,491 for ART initiation by 12 months of age, and $90-6,188 for deaths prior to ART initiation. Factors impacting the costs of PoC testing, including the lifespan of the testing instruments and integrated utilization of PoC platforms, had the biggest impact on the ICERs. Integrating utilization across programs decreased costs for the EID program, such that PoC testing was cost-saving in some situations. Conclusion PoC testing has the potential to improve linkage to care and ART initiation for HIV-infected infants and should be considered for implementation within EID programs to achieve equity in access to HIV services and reduce HIV-related pediatric morbidity and mortality.	[De Broucker, Gatien; Moss, William J.; Sutcliffe, Catherine G.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Salvatore, Phillip P.; Moss, William J.; Sutcliffe, Catherine G.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Mutembo, Simon] Prov Med Off, Choma, Zambia; [Moyo, Nkumbula; Thuma, Philip E.] Macha Res Trust, Choma, Zambia; [Mutanga, Jane N.] Livingstone Cent Hosp, Livingstone, Zambia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sutcliffe, CG (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.; Sutcliffe, CG (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	csutcli1@jhu.edu		mutembo, simon/0000-0002-5389-5966; Sutcliffe, Catherine/0000-0001-8512-8326; de Broucker, Gatien/0000-0001-6603-5124	National Institutes of Allergy and Infectious Disease [R01AI116324]	National Institutes of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Allergy and Infectious Disease (https://www.niaid.nih.gov/)(WJM, grant number R01AI116324. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation in the manuscript.	[Anonymous], 2018, ZAMBIA CONSOLIDATED; Bedri A, 2008, LANCET, V372, P300, DOI 10.1016/S0140-6736(08)61114-9; Bianchi F, 2019, LANCET HIV, V6, pE373, DOI 10.1016/S2352-3018(19)30033-5; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Diallo K, 2016, MMWR-MORBID MORTAL W, V65, P1285, DOI 10.15585/mmwr.mm6546a2; Dunning L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189226; Flynn PM, 2018, JAIDS-J ACQ IMM DEF, V77, P383, DOI 10.1097/QAI.0000000000001612; Frank SC, 2019, LANCET HIV, V6, pE182, DOI 10.1016/S2352-3018(18)30328-X; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jani IV, 2018, AIDS, V32, P1453, DOI [10.1097/QAD.0000000000001846, 10.1097/qad.0000000000001846]; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Meggi B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.019834; Ministry of Health Zambia, 2019, ZAMB POP BAS HIV IMP; Mutanga J, 2019, PED HIV WORKSH 2019; Mwenda R, 2018, CLIN INFECT DIS, V67, P701, DOI 10.1093/cid/ciy169; Ndlovu Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193577; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Nuwagaba-Biribonwoha H, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-44; Seidenberg P, 2012, B WORLD HEALTH ORGAN, V90, P348, DOI 10.2471/BLT.11.100032; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Sutcliffe CG, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4947-6; Sutcliffe CG, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0822-z; Sutcliffe CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087028; Sutcliffe CG, 2016, 21 INT AIDS C 2016 J; Taha TE, 2011, JAIDS-J ACQ IMM DEF, V57, P319, DOI 10.1097/QAI.0b013e318217877a; Temgoua EMS, 2015, CURR HIV RES, V13, P286, DOI 10.2174/1570162X13666150407143525; The World Bank, CONS PRIC IND; Dinh TH, 2018, CLIN INFECT DIS, V66, P576, DOI 10.1093/cid/cix820; UNAIDS, 2020, AIDSINFO; WHO, 2020, GLOB TUB REP; WHO, 2017, INF NOT HIV DIAGN NO; WHO, 2017, WHO PREQ IN VITR DIA; World Bank, 2019, OFF EXCH RAT LCU PER; World Health Organization, 2016, 025907000 WHO PQDX; World Health Organization, 2019, WHO PREQ VITR DIAGN; World Health Organization, PREV MOTH TO CHILD T	39	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2021	16	3							e0248217	10.1371/journal.pone.0248217	http://dx.doi.org/10.1371/journal.pone.0248217			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DJ	33690733	Green Published, gold			2022-12-26	WOS:000627855600002
J	Hassett, MR; Roepe, PD				Hassett, Matthew R.; Roepe, Paul D.			In vitro growth competition experiments that suggest consequences of the substandard artemisinin epidemic that may be accelerating drug resistance in P. falciparum malaria	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; DIHYDROARTEMISININ-PIPERAQUINE; ANTIMALARIAL-DRUGS; CHLOROQUINE RESISTANCE; COMBINATION THERAPY; SOUTHEAST-ASIA; QUALITY; MUTATIONS; PHARMACOKINETICS; ARTESUNATE	Over the past decade, artemisinin (ART)-combination therapies (ACTs) have shown declining efficacy within Southeast Asia (SEA). These resistance-like phenomena manifest as a delayed clearance phenotype (DCP) in some patients treated with ACTs. ACTs are currently the recommended treatment for P. falciparum infections by the World Health Organization (WHO), and they are our last line of defense to effectively treat all strains of malaria. Acceleration of antimicrobial resistance (AMR) is often theorized to be exacerbated by the use of subtherapeutic dosages of drugs ("substandard" drug), which for ACTs has been well documented over the last decade. Troublingly, in 2017, the WHO estimated that nearly 1 in 10 medical products tested in low- and middle-income countries failed to meet quality standards. We have developed a tissue culture-based approach for testing possible connections between substandard treatment and the spread of ACT resistant blood stage forms of P. falciparum. Via sequencing of pfk13, a molecular marker that is predictive for ART resistance (ARTR), we monitor competition of sensitive vs resistant strains over time and under various conditions and define conditions that favor emergence of ARTR parasites. Our findings help to define the conditions under which substandard drug treatments might favor the proliferation of mutant PfK13-mediated drug resistant strains over drug sensitive.	[Roepe, Paul D.] Georgetown Univ, Dept Chem, MRH, PDR, Washington, DC 20057 USA; Georgetown Univ, Dept Biochem & Cellular & Mol Biol, Washington, DC USA	Georgetown University; Georgetown University	Roepe, PD (corresponding author), Georgetown Univ, Dept Chem, MRH, PDR, Washington, DC 20057 USA.	roepep@georgetown.edu			USP QI (the United States Pharmacopeia Quality Institute, Rockville MD); Foundation for the National Institutes of Health [RO1 AI 056312]	USP QI (the United States Pharmacopeia Quality Institute, Rockville MD); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded in part by USP QI (the United States Pharmacopeia Quality Institute, Rockville MD) and the Foundation for the National Institutes of Health (grant number RO1 AI 056312 to PDR).	Affum AO, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-220; Amato R, 2018, LANCET INFECT DIS, V18, P337, DOI [10.1016/S1473-3099(18)30068-9, 10.1016/s1473-3099(18)30068-9]; Amato R, 2017, LANCET INFECT DIS, V17, P164, DOI [10.1016/S1473-3099(16)30409-1, 10.1016/s1473-3099(16)30409-1]; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; BUNNAG D, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P539; Chotsiri P, 2017, BRIT J CLIN PHARMACO, V83, P2752, DOI 10.1111/bcp.13372; Das S, 2019, CLIN INFECT DIS, V69, P1144, DOI 10.1093/cid/ciy1038; Das S, 2018, NEW ENGL J MED, V379, P1962, DOI 10.1056/NEJMc1713777; Diem TLT, 2008, DRUG METAB PHARMACOK, V23, P158, DOI 10.2133/dmpk.23.158; Dondorp AM, 2004, TROP MED INT HEALTH, V9, P1241, DOI 10.1111/j.1365-3156.2004.01342.x; Dwivedi A, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2140-1; El-Duah M, 2012, J VECTOR DIS, V49, P131; Fairhurst RM, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0013-2016; Gabryszewski SJ, 2016, MOL BIOL EVOL, V33, P1554, DOI 10.1093/molbev/msw037; Green JA, 2016, ANTIMICROB AGENTS CH, V60, P7321, DOI 10.1128/AAC.01588-16; Guo SQ, 2017, AM J TROP MED HYG, V97, P1198, DOI 10.4269/ajtmh.17-0305; Hamilton WL, 2019, LANCET INFECT DIS, V19, P943, DOI 10.1016/S1473-3099(19)30392-5; Hanboonkunupakarn B, 2014, ANTIMICROB AGENTS CH, V58, P7340, DOI 10.1128/AAC.03704-14; Hassett MR, 2019, AM J TROP MED HYG, V101, P1204, DOI 10.4269/ajtmh.19-0379; Heller LE, 2019, TROP MED INFECT DIS, V4, DOI 10.3390/tropicalmed4020089; Hott A, 2015, J ANTIMICROB CHEMOTH, V70, P2787, DOI 10.1093/jac/dkv199; Imwong M, 2017, LANCET INFECT DIS, V17, P491, DOI [10.1016/S1473-3099(17)30048-8, 10.1016/s1473-3099(17)30048-8]; Izevbekhai O, 2017, T ROY SOC TROP MED H, V111, P90, DOI 10.1093/trstmh/trx019; Kaur H, 2015, AM J TROP MED HYG, V92, P75, DOI 10.4269/ajtmh.14-0544; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Lewis IA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004085; Loesbanluechai D, 2019, INT J PARASITOL-DRUG, V9, P16, DOI 10.1016/j.ijpddr.2018.11.004; Madamet M, 2017, INT J ANTIMICROB AG, V49, P754, DOI 10.1016/j.ijantimicag.2017.01.032; Mathieu LC, 2020, ELIFE, V9, DOI 10.7554/eLife.51015; Matsena-Zingoni Z., 2020, J INFECT DIS; Menard D, 2016, NEW ENGL J MED, V374, P2453, DOI 10.1056/NEJMoa1513137; Miotto O, 2015, NAT GENET, V47, P226, DOI 10.1038/ng.3189; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Mwai L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-106; Mwanza S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1637-3; Nair S, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00605-18, 10.1128/aac.00605-18]; Nettey H., 2013, PHARM PHARMACOL-RUSS, V4, P567; Newton PN, 2008, PLOS MED, V5, P209, DOI 10.1371/journal.pmed.0050032; Newton PN, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-352; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Osei-Safo Dorcas, 2014, Malar Res Treat, V2014, P806416, DOI 10.1155/2014/806416; Ouattara A, 2015, AM J TROP MED HYG, V92, P1202, DOI 10.4269/ajtmh.14-0605; Riegel B, 2020, BIOCHEMISTRY-US, V59, P2484, DOI 10.1021/acs.biochem.0c00247; Rijken MJ, 2011, ANTIMICROB AGENTS CH, V55, P5500, DOI 10.1128/AAC.05067-11; Ross LS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05652-0; Sengaloundeth S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-172; Straimer J, 2017, MBIO, V8, DOI [10.1128/mBio.00172-17, 10.1128/mbio.00172-17]; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Sutherland CJ, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02382-16, 10.1128/aac.02382-16]; Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491; Talundzic E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004789; Teuscher F, 2012, ANTIMICROB AGENTS CH, V56, P428, DOI 10.1128/AAC.05456-11; Teuscher F, 2010, J INFECT DIS, V202, P1362, DOI 10.1086/656476; Tirrell AR, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2934-4; Tivura M, 2016, BMC PHARMACOL TOXICO, V17, DOI 10.1186/s40360-016-0089-2; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van der Pluijm RW, 2019, LANCET INFECT DIS, V19, P952, DOI 10.1016/S1473-3099(19)30391-3; Visser BJ, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0795-z; WHO, 2011, SURV QUAL SEL ANT ME; Witkowski B, 2017, LANCET INFECT DIS, V17, P174, DOI [10.1016/s1473-3099(16)30415-7, 10.1016/S1473-3099(16)30415-7]; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4; Witkowski B, 2010, ANTIMICROB AGENTS CH, V54, P1872, DOI 10.1128/AAC.01636-09; World Health Organization, 2018, STAT REP ART RES ACT; World Health Organization (WHO), 2017, 1 10 MED PROD DEV CO; World Hlth Org, 2018, VACCINE, V36, P3576, DOI 10.1016/j.vaccine.2016.10.047; Yang T, 2019, CELL REP, V29, P2917, DOI 10.1016/j.celrep.2019.10.095; Ye R, 2016, SCI REP-UK, V6, DOI 10.1038/srep20100; Yeung S, 2015, AM J TROP MED HYG, V92, P39, DOI 10.4269/ajtmh.14-0391; Yeung S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-96	70	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2021	16	3							e0248057	10.1371/journal.pone.0248057	http://dx.doi.org/10.1371/journal.pone.0248057			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DJ	33690638	gold, Green Published			2022-12-26	WOS:000627855600004
J	Mersha, A; Shibiru, S; Girma, M; Ayele, G; Bante, A; Kassa, M; Abebe, S; Shewangizaw, M				Mersha, Abera; Shibiru, Shitaye; Girma, Meseret; Ayele, Gistane; Bante, Agegnehu; Kassa, Mekidim; Abebe, Sintayehu; Shewangizaw, Misgun			Health professionals practice and associated factors towards precautionary measures for COVID-19 pandemic in public health facilities of Gamo zone, southern Ethiopia: A cross-sectional study	PLOS ONE			English	Article							CARE WORKERS; KNOWLEDGE	Introduction Coronavirus disease-2019 (COVID-19) is a highly contagious acute respiratory disease, which caused by a novel coronavirus. The disease disrupts health systems and resulting in social, political, and economic crises. Health professionals are in front of this pandemic and always work in a high-risk environment. The best prevention for COVID-19 is avoiding exposure to the virus. Some studies reported health professional's practice of precautionary measures for COVID-19. Nevertheless, a few have identified factors affecting. As such, this study aimed to fill those research gaps in the study setting. Methods In this cross-sectional study, 428 health professionals involved from the public health facilities of the Gamo zone, southern Ethiopia. A simple random sampling method employed, and the data collected by the interviewer-administered Open Data Kit survey tool and observational checklist. The data analyzed in Stata version 15, and a binary logistic regression model used to identify factors. In this study, a statistically significant association declared at P< 0.05. Results In this study, 35.3% (95%CI: 30.7%, 39.8%) of health professionals' had a good practice on precautionary measures for the COVID-19 pandemic. Use hand sanitizer or wash hands continuously with soap and water (68.9%), cover nose and mouth with a tissue during sneezing or coughing (67.3%), and use facemask in crowds (56.8%) were the most common practice reported by study participants. Marital status, being married (AOR = 1.84, 95%CI: 1.06, 3.18), good knowledge on the COVID-19 pandemic (AOR = 2.02, 95%CI: 1.02, 3.18), and positive attitude towards precautionary measures for the COVID-19 were factors showed significant association with the practice. Conclusions The magnitude of good practice of precautionary measures for the COVID-19 pandemic among health professionals was low. As such, different interventions to improve the knowledge and attitude of health professionals in the health care system are highly needed to boost the practice and to advance service delivery.	[Mersha, Abera; Shibiru, Shitaye; Bante, Agegnehu] Arba Minch Univ, Coll Med & Hlth Sci, Sch Nursing, Arba Minch, Ethiopia; [Girma, Meseret; Ayele, Gistane; Kassa, Mekidim; Abebe, Sintayehu; Shewangizaw, Misgun] Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Arba Minch, Ethiopia	Arba Minch University; Arba Minch University	Mersha, A (corresponding author), Arba Minch Univ, Coll Med & Hlth Sci, Sch Nursing, Arba Minch, Ethiopia.	mershaabera@gmail.com		Bante, Agegnehu/0000-0003-0583-6635	Arba Minch University [GOV/AMU/COVID-19/PDNPI/CMHS/RCSVPO/012/2020]	Arba Minch University	Arba Minch University provided funds for the data collection and stationary materials of this research work with a project grant code of GOV/AMU/COVID-19/PDNPI/CMHS/RCSVPO/012/2020. The website of the university is www.amu.edu.et.The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x; Al-Amri S, 2019, J FAM MED PRIM CARE, V8, P455, DOI 10.4103/jfmpc.jfmpc_336_18; Alawneh SM, 2017, INT RES J MED MED SC, V3, P103; [Anonymous], EXP SAY PATH ID NOV; [Anonymous], 2019, GAMO ZONE HLTH DEP A; Asemahagn MA, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00254-3; CDC, 2020, 2019 NOV COR; CDC, 2020, INF CLIN INV THER PA; Cucinotta D, WHO DECL COVID 19 PA; Gan WH, 2020, SAF HEALTH WORK-KR, V11, P241, DOI 10.1016/j.shaw.2020.03.001; GenBank, **DATA OBJECT**; Girma S, 2020, RISK MANAG HEALTHC P, V13, P1327, DOI 10.2147/RMHP.S267261; Holmes EC, NOVEL 2019 CORONAVIR; Honarbakhsh Marzieh, 2018, J Infect Prev, V19, P29, DOI 10.1177/1757177417724880; Li T, 2020, MED J PEKING UNION M; Marsh S., DOCT NURS PORT VOL U; McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796; McMichael Tm Fau, 2020, COVID 19 LONG TERM C; National Health Commission of People's Republic of China, 2020, PREV GUID 2019 NCOV; National Health Commission of People's Republic of China, 2020, PNEUM DIAGN TREATM 2; National Health Commission of People's Republic of China [Internet], 2020, GUID PUBL PROT NOV C; National Institute for Communicable Disease, 2020, CLIN MAN SUSP CONF C; National Institute of Health (NIH), PAK COVID 19; Nemati M, 2020, ARCH CLIN INFECT DIS, V15, DOI 10.5812/archcid.102848; Olesen B, 2020, J HOSP INFECT, V105, P377, DOI 10.1016/j.jhin.2020.04.033; Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181; Picard A., 2020, GLOBE MAIL, DOI DOI 10.1352/1934-9556-58.6.486; Saqlain M., 2020, KNOWLEDGE ATTITUDE P; Shammari AM., 2019, J INFECT PUBLIC HEAL; The medical expert group of Tongji hospital, 2020, HERALD MED, Vthird; UpToDate, COR DIS 2019 COVID 1; Wang D., LID, DOI [10.1001/jama.2020.1585(1538-3598, DOI 10.1001/JAMA.2020.1585(1538]; Wei Q, 2020, CHIN J DISINFECT, V37, P59; WHO, 2020, RISK ASSESSMENT MANA; WHO, 2020, WHO URG COUNTR NOT L; WHO, 2020, WEEKLY EPIDEMIOLOGIC; WHO, 2020, WHO STAT REG CLUST P; WHO. Regional Office for Europe, 2020, HOSP READ CHECKL COV; World Health Organization, 2020, CONS ADJ PUBL HLTH S; World Health Organization, 2020, 2019 NCOV OUTBR IS E; World Health Organization, 2020, DIR GEN OP REM MED B; World Health Organization (WHO), 2020, COR DIS COVID 19 OUT, DOI DOI 10.1016/S0140-6736(20)30566-3; Zhan MK, 2020, NEW ENGL J MED, V382, P2267, DOI 10.1056/NEJMc2005696; Zhang H, 2020, 33398287 BIORXIV, DOI [10.1101/2020.01.30.927806, DOI 10.1101/2020.01.30.927806]; Zhang J., 2020, CHIN GEN PRACT NURS; Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012	46	4	4	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2021	16	3							e0248272	10.1371/journal.pone.0248272	http://dx.doi.org/10.1371/journal.pone.0248272			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DJ	33690704	gold, Green Submitted, Green Published			2022-12-26	WOS:000627855600014
J	Isidan, A; Liu, SH; Chen, AM; Zhang, WJ; Li, P; Smith, LJ; Hara, H; Cooper, DKC; Ekser, B				Isidan, Abdulkadir; Liu, Shaohui; Chen, Angela M.; Zhang, Wenjun; Li, Ping; Smith, Lester J.; Hara, Hidetaka; Cooper, David K. C.; Ekser, Burcin			Comparison of porcine corneal decellularization methods and importance of preserving corneal limbus through decellularization	PLOS ONE			English	Article								Background The aim of this study is to compare the three previously applied, conventional porcine corneal decellularization methods and to demonstrate the importance of preserving the corneal limbus through decellularization. Methods Fresh, wild-type (with or without) limbus porcine corneas were decellularized using three different methods, including (i) sodium dodecyl sulfate (SDS), (ii) hypertonic saline (HS), and (iii) N-2 gas (NG). Post-treatment evaluation was carried out using histological, residual nuclear material, and ultrastructural analyses. Glycerol was used to help reduce the adverse effects of decellularization. The corneas were preserved for two weeks in cornea storage medium. Results All three decellularization methods reduced the number of keratocytes at different rates in the stromal tissue. However, all methods, except SDS, resulted in the retention of large numbers of cells and cell fragments. The SDS method (0.1% SDS, 48h) resulted in almost 100% decellularization in corneas without limbus. Low decellularization capacity of the NG method (<50%) could make it unfavorable. Although HS method had a more balanced damage-decellularization ratio, its decellularization capacity was lower than SDS method. Preservation of the corneoscleral limbus could partially prevent structural damage and edema, but it would reduce the decellularization capacity. Conclusion Our results suggest that SDS is a very powerful decellularization method, but it damages the cornea irreversibly. Preserving the corneoscleral limbus reduces the efficiency of decellularization, but also reduces the damage.	[Isidan, Abdulkadir; Chen, Angela M.; Zhang, Wenjun; Li, Ping; Ekser, Burcin] Indiana Univ Sch Med, Transplant Div, Dept Surg, Indianapolis, IN 46202 USA; [Liu, Shaohui] Indiana Univ Sch Med, Dept Ophthalmol, Glick Eye Inst, Indianapolis, IN 46202 USA; [Smith, Lester J.] Indiana Univ Sch Med, 3D Bioprinting Core, Indianapolis, IN 46202 USA; [Smith, Lester J.] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN 46202 USA; [Hara, Hidetaka; Cooper, David K. C.] Univ Birmingham, Dept Surg, Xenotransplantat Program, Birmingham, AL USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Ekser, B (corresponding author), Indiana Univ Sch Med, Transplant Div, Dept Surg, Indianapolis, IN 46202 USA.	bekser@iupui.edu	Ekser, Burcin/I-3288-2019; Hara, Hidetaka/AEY-6794-2022	Ekser, Burcin/0000-0003-0741-8007; Hara, Hidetaka/0000-0002-4179-7365; Isidan, Abdulkadir/0000-0001-6655-1268	Department of Surgery; Board of Directors of the Indiana University Health Values Fund for Research Award [VFR-457-Ekser]; Indiana Clinical and Translational Sciences Institute; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [UL1TR001108]	Department of Surgery; Board of Directors of the Indiana University Health Values Fund for Research Award; Indiana Clinical and Translational Sciences Institute; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award	Work on xenotransplantation in the Xenotransplantation Research Laboratory at Indiana University has been supported by internal funds of the Department of Surgery, in part, with support by the Board of Directors of the Indiana University Health Values Fund for Research Award (VFR-457-Ekser), the Indiana Clinical and Translational Sciences Institute, funded in part by Grant #UL1TR001108 from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Del Barrio JLA, 2018, AM J OPHTHALMOL, V186, P47, DOI 10.1016/j.ajo.2017.10.026; del Barrio JLA, 2015, EXP EYE RES, V132, P91, DOI 10.1016/j.exer.2015.01.020; Amano S, 2008, MOL VIS, V14, P878; Bourne RRA, 2017, LANCET GLOB HEALTH, V5, pE888, DOI 10.1016/S2214-109X(17)30293-0; Choi HJ, 2019, XENOTRANSPLANTATION, V26, DOI 10.1111/xen.12446; Choi HJ, 2014, XENOTRANSPLANTATION, V21, P115, DOI [10.1111/xen.12075, 10.1111/xen.12082]; Cohen D, 2014, CORNEA, V33, P390, DOI 10.1097/ICO.0000000000000069; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Martins TMD, 2020, MAT SCI ENG C-MATER, V116, DOI 10.1016/j.msec.2020.111215; Dong MC, 2019, J TISSUE ENG, V10, DOI 10.1177/2041731419875876; Ekser B, 2012, LANCET, V379, P672, DOI 10.1016/S0140-6736(11)61091-X; Fernandez-Perez J, 2020, METHODS, V171, P86, DOI 10.1016/j.ymeth.2019.05.009; Goldberg M F, 1982, Trans Am Ophthalmol Soc, V80, P155; Gonzalez-Andrades M, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.2.13; Gueudry J, 2019, J FR OPHTALMOL, V42, pE83, DOI 10.1016/j.jfo.2019.02.001; Hashimoto Y, 2010, BIOMATERIALS, V31, P3941, DOI 10.1016/j.biomaterials.2010.01.122; Isidan A., 2019, XENOTRANSPLANTATION, V26; Isidan A, 2019, XENOTRANSPLANTATION, V26, DOI 10.1111/xen.12564; Lee W, 2014, INT J OPHTHALMOL-CHI, V7, P587, DOI 10.3980/j.issn.2222-3959.2014.04.01; Li NY, 2011, MOL VIS, V17, P1909; Lin HJ, 2019, TISSUE ENG PT A, V25, P652, DOI [10.1089/ten.tea.2018.0162, 10.1089/ten.TEA.2018.0162]; Liu J, 2019, J BIOMED MATER RES A, V107, P2547, DOI 10.1002/jbm.a.36760; Liu YS, 2017, INT J MED SCI, V14, P128, DOI 10.7150/ijms.17624; Luo HL, 2013, BIOMATERIALS, V34, P6748, DOI 10.1016/j.biomaterials.2013.05.045; Lynch AP, 2013, EXP EYE RES, V108, P42, DOI 10.1016/j.exer.2012.12.012; Mendibil U, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155447; Oliva MS, 2012, INDIAN J OPHTHALMOL, V60, P423, DOI 10.4103/0301-4738.100540; Sasaki S, 2009, MOL VIS, V15, P2022; Shafiq MA, 2012, TISSUE ENG PART C-ME, V18, P340, DOI [10.1089/ten.tec.2011.0072, 10.1089/ten.TEC.2011.0072]; Shi WY, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201902491; Shi Y, 2017, XENOTRANSPLANTATION, V24, DOI 10.1111/xen.12338; The National Agency for the prevention of Blindness (IAPB), 2017, AVOIDABLE BLINDNESS; Topuz B, 2020, METHOD CELL BIOL, V157, P49, DOI 10.1016/bs.mcb.2019.10.012; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Wolf E, 2019, ANIM FRONT, V9, P13, DOI 10.1093/af/vfz014; World Health O, 2007, GLOB IN EL AV BLINDN; Wu Z, 2009, BIOMATERIALS, V30, P3513, DOI 10.1016/j.biomaterials.2009.03.003; Zhang MC, 2015, AM J TRANSPLANT, V15, P1068, DOI 10.1111/ajt.13096	38	4	4	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0243682	10.1371/journal.pone.0243682	http://dx.doi.org/10.1371/journal.pone.0243682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667231	Green Published, gold, Green Submitted			2022-12-26	WOS:000626604300039
J	Xu, SL; Cui, MK; Chen, RJ; Qiu, QQ; Xie, JC; Fan, YX; Dai, XH; Dong, B				Xu, Shiliang; Cui, Mengke; Chen, Renjie; Qiu, Qiaoqing; Xie, Jiacai; Fan, Yuxin; Dai, Xiaohu; Dong, Bin			Design of facile technology for the efficient removal of hydroxypropyl guar gum from fracturing fluid	PLOS ONE			English	Article							ORGANIC-COMPOUNDS; WASTE-WATER; DLVO THEORY; OIL; PARTICLES; HYDROGELS; NANOPARTICLES; SEPARATION; TRANSPORT; ADHESION	With the increasing demand for energy, fracturing technology is widely used in oilfield operations over the last decades. Typically, fracturing fluids contain various additives such as cross linkers, thickeners and proppants, and so forth, which makes it possess the properties of considerably complicated components and difficult processing procedure. There are still some difficult points needing to be explored and resolved in the hydroxypropyl guar gum (HPG) removal process, e.g., high viscosity and removal of macromolecular organic compounds. Our works provided a facile and economical HPG removal technology for fracturing fluids by designing a series of processes including gel-breaking, coagulation and precipitation according to the diffusion double layer theory. After this treatment process, the fracturing fluid can meet the requirements of reinjection, and the whole process was environment friendly without secondary pollution characteristics. In this work, the fracturing fluid were characterized by scanning electron microscopy (SEM), Energy dispersive X-ray (EDX), Xray diffraction (XRD) and Fourier transformed infrared (FTIR) spectroscopy technologies, etc. Further, the micro-stabilization and destabilization mechanisms of HPG in fracturing fluid were carefully investigated. This study maybe opens up new perspective for HPG removal technologies, exhibiting a low cost and strong applicability in both fundamental research and practical applications.	[Xu, Shiliang; Cui, Mengke; Chen, Renjie; Qiu, Qiaoqing; Dai, Xiaohu; Dong, Bin] Tongji Univ, Coll Environm Sci & Engn, State Key Lab Pollut Control & Resource Reuse, Shanghai, Peoples R China; [Xu, Shiliang] Shanghai Invest Design & Res Inst Co Ltd, Shanghai, Peoples R China; [Xie, Jiacai] CNPC Res Inst Safety & Environm Technol Co Ltd, State Key Lab Petr Pollut Control, Beijing, Peoples R China; [Fan, Yuxin] PetroChina Xinjiang Oilfield Co, Karamay, Peoples R China	Tongji University; China National Petroleum Corporation	Dong, B (corresponding author), Tongji Univ, Coll Environm Sci & Engn, State Key Lab Pollut Control & Resource Reuse, Shanghai, Peoples R China.	dongbin@tongji.edu.cn			Study on Fracturing Fluid Destabilization Technology [XJYT-gcjsyjy-2018-JS-618]; Shanghai Investigation, Design & Research Institute Co. Ltd; CNPC Research Institute of Safety & Environmental Technology Co. Ltd; PetroChina Xinjiang Oilfield Company	Study on Fracturing Fluid Destabilization Technology; Shanghai Investigation, Design & Research Institute Co. Ltd; CNPC Research Institute of Safety & Environmental Technology Co. Ltd; PetroChina Xinjiang Oilfield Company	This study was funded by the Study on Fracturing Fluid Destabilization Technology (XJYT-gcjsyjy-2018-JS-618). The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. These commercial affiliations mentioned including Shanghai Investigation, Design & Research Institute Co. Ltd, CNPC Research Institute of Safety & Environmental Technology Co. Ltd and PetroChina Xinjiang Oilfield Company played a role for comments and support in our study. We confirmed that this commercial affiliation does not alter our adherence to all PLOS ONE policies on sharing data and materials.	Adamczyk Z, 1999, ADV COLLOID INTERFAC, V83, P137, DOI 10.1016/S0001-8686(99)00009-3; Adgate JL, 2014, ENVIRON SCI TECHNOL, V48, P8307, DOI 10.1021/es404621d; Alzobaidi S, 2018, J COLLOID INTERF SCI, V526, P253, DOI 10.1016/j.jcis.2018.04.056; Bahamdan A, 2007, POLYM ADVAN TECHNOL, V18, P660, DOI 10.1002/pat.875; Balachandramohan J, 2020, J HAZARD MATER, V385, DOI 10.1016/j.jhazmat.2019.121621; Cao TC, 2018, LANGMUIR, V34, P14368, DOI 10.1021/acs.langmuir.8b03191; Coyne J, 2020, J CONTROL RELEASE, V318, P185, DOI 10.1016/j.jconrel.2019.12.026; Dai CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113723; Dai L, 2017, CHEM ENG J, V330, P1044, DOI 10.1016/j.cej.2017.08.041; Dai L, 2017, ACS APPL MATER INTER, V9, P5477, DOI 10.1021/acsami.6b14471; DERJAGUIN B, 1993, PROG SURF SCI, V43, P30, DOI 10.1016/0079-6816(93)90013-L; Gao SJ, 2015, J MATER CHEM A, V3, P2895, DOI 10.1039/c4ta05624h; Gao SJ, 2016, ADV MATER, V28, P5307, DOI 10.1002/adma.201600417; Gastone F, 2014, J COLLOID INTERF SCI, V421, P33, DOI 10.1016/j.jcis.2014.01.021; Gong HH, 2012, CARBOHYD POLYM, V88, P1015, DOI 10.1016/j.carbpol.2012.01.057; Hasan A.M.A., 2018, EGYPT J PET, V27, P1043, DOI [10.1016/j.ejpe.2018.03.005, DOI 10.1016/J.EJPE.2018.03.005]; Hickenbottom KL, 2013, DESALINATION, V312, P60, DOI 10.1016/j.desal.2012.05.037; Hurnaus T, 2015, ENERG FUEL, V29, P3601, DOI 10.1021/acs.energyfuels.5b00430; Jafry HR, 2011, IND ENG CHEM RES, V50, P3259, DOI 10.1021/ie101836z; Kaith BS, 2014, RSC ADV, V4, P40339, DOI 10.1039/c4ra05300a; Kekacs D, 2015, BIODEGRADATION, V26, P271, DOI 10.1007/s10532-015-9733-6; Kuhnen F, 2000, J COLLOID INTERF SCI, V231, P32, DOI 10.1006/jcis.2000.7097; Lester Y, 2014, ENVIRON SCI TECH LET, V1, P133, DOI 10.1021/ez4000115; Lester Y, 2015, SCI TOTAL ENVIRON, V512, P637, DOI 10.1016/j.scitotenv.2015.01.043; Liu SW, 2017, APPL CATAL B-ENVIRON, V211, P1, DOI 10.1016/j.apcatb.2017.04.009; Lu XT, 2019, COLLOID SURFACE A, V561, P325, DOI 10.1016/j.colsurfa.2018.10.071; Mohan AM, 2013, ENVIRON SCI TECHNOL, V47, P13141, DOI 10.1021/es402928b; Munirasu S, 2016, PROCESS SAF ENVIRON, V100, P183, DOI 10.1016/j.psep.2016.01.010; Nikoo AH, 2020, CHEM ENG SCI, V215, DOI 10.1016/j.ces.2019.115461; Pan XF, 2018, ACS BIOMATER SCI ENG, V4, P3397, DOI 10.1021/acsbiomaterials.8b00657; Patra AS, 2016, J HAZARD MATER, V301, P127, DOI 10.1016/j.jhazmat.2015.08.042; Pu WF, 2018, J PETROL SCI ENG, V167, P568, DOI 10.1016/j.petrol.2018.04.032; Quosay AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236726; Rogers JD, 2015, ENVIRON SCI TECH LET, V2, P158, DOI 10.1021/acs.estlett.5b00090; Sanaei A, 2019, COLLOID SURFACE A, V574, P131, DOI 10.1016/j.colsurfa.2019.04.075; Sari MA, 2015, J COLLOID INTERF SCI, V458, P103, DOI 10.1016/j.jcis.2015.07.035; Shang XS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144449; Shen CY, 2017, LANGMUIR, V33, P10455, DOI 10.1021/acs.langmuir.7b02383; Sun YB, 2016, ENVIRON SCI TECHNOL, V50, P4459, DOI 10.1021/acs.est.6b00058; Szopinski D, 2015, CARBOHYD POLYM, V119, P159, DOI 10.1016/j.carbpol.2014.11.050; Thomas L, 2019, J PETROL SCI ENG, V173, P793, DOI 10.1016/j.petrol.2018.09.056; Thombare N, 2018, CARBOHYD POLYM, V185, P169, DOI 10.1016/j.carbpol.2018.01.018; Tosco T, 2012, ENVIRON SCI TECHNOL, V46, P4008, DOI 10.1021/es202643c; VERWEY EJW, 1947, J PHYS COLLOID CHEM, V51, P631, DOI 10.1021/j150453a001; Vidic RD, 2013, SCIENCE, V340, DOI 10.1126/science.1235009; Yan ZH, 2016, J IND ENG CHEM, V37, P115, DOI 10.1016/j.jiec.2016.03.012; Yuan RQ, 2020, COLLOID SURFACE A, V586, DOI 10.1016/j.colsurfa.2019.124285; Zhang F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195363; Zhang WF, 2015, ADV MATER, V27, P7349, DOI 10.1002/adma.201502695	49	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0247948	10.1371/journal.pone.0247948	http://dx.doi.org/10.1371/journal.pone.0247948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33661981	Green Published, gold			2022-12-26	WOS:000626604100070
J	Islam, S; Dutta, P; Sahay, O; Santra, MK				Islam, Sehbanul; Dutta, Parul; Sahay, Osheen; Santra, Manas Kumar			beta-TrCP1 facilitates cell cycle checkpoint activation, DNA repair, and cell survival through ablation of beta-TrCP2 in response to genotoxic stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BOX PROTEINS; KAPPA-B-ALPHA; BETA-TRCP; MEDIATED DEGRADATION; DEPENDENT DEGRADATION; TUMOR SUPPRESSION; DAMAGE; ATM; UBIQUITINATION; PROMOTES	F-box proteins beta-TrCP1 and beta-TrCP2 are paralogs present in the human genome. They control several cellular processes including cell cycle and DNA damage signaling. Moreover, it is reported that they facilitate DNA damage-induced accumulation of p53 by directing proteasomal degradation of MDM2, a protein that promotes p53 degradation. However, the individual roles of beta-TrCP1 and beta-TrCP2 in the genotoxic stress-induced activation of cell cycle checkpoints and DNA damage repair remain largely unknown. Here, using biochemical, molecular biology, flow cytometric, and immunofluorescence techniques, we show that beta-TrCP1 and beta-TrCP2 communicate during genotoxic stress. We found that expression levels of beta-TrCP1 are significantly increased while levels of beta-TrCP2 are markedly decreased upon induction of genotoxic stress. Further, our results revealed that DNA damage-induced activation of ATM kinase plays an important role in maintaining the reciprocal expression levels of beta-TrCP1 and beta-TrCP2 via the phosphorylation of beta-TrCP1 at Ser158. Phosphorylated beta-TrCP1 potently promotes the proteasomal degradation of beta-TrCP2 and MDM2, resulting in the activation of p53. Additionally, beta-TrCP1 impedes MDM2 accumulation via abrogation of its lysine 63-linked polyubiquitination by beta-TrCP2. Thus, beta-TrCP1 helps to arrest cells at the G2/M phase of the cell cycle and promotes DNA repair upon DNA damage through attenuation of beta-TrCP2. Collectively, our findings elucidate an intriguing posttranslational regulatory mechanism of these two paralogs under genotoxic stress and revealed beta-TrCP1 as a key player in maintaining the genome integrity through the attenuation of beta-TrCP2 levels in response to genotoxic stress.	[Islam, Sehbanul; Dutta, Parul; Sahay, Osheen; Santra, Manas Kumar] Natl Ctr Cell Sci, Mol Oncol Lab, Pune, Maharashtra, India; [Islam, Sehbanul; Dutta, Parul; Sahay, Osheen] Savitribai Phule Pune Univ, Dept Biotechnol, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Savitribai Phule Pune University	Santra, MK (corresponding author), Natl Ctr Cell Sci, Mol Oncol Lab, Pune, Maharashtra, India.	manas@nccs.res.in		Dutta, Parul/0000-0003-1082-2617; Sahay, Osheen/0000-0001-5972-7632; Islam, Sehbanul/0000-0003-2686-2787	National Centre for Cell Science; Department of Biotechnology, Government of India [BT/HRD/NBA/39/01/2018-19]	National Centre for Cell Science; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	We thank Prof. Michael R. Green (University of Massachusetts Medical School, USA) for providing cell lines and shRNAs used in this study. We would like to thank Prof. Edward Yeh (University of California, USA), Dr Wuhan Xiao (Chinese Academy of Science, China), and Prof. Jae U. Jung (University of Southern California, USA) for providing cDNA constructs. We thank Dr Jayati Mullick for editorial assistance. This work was partly supported by National Centre for Cell Science and partly by Department of Biotechnology, Government of India (BT/HRD/NBA/39/01/2018-19). S. I. is senior DBT research fellow and P. D., O. S. are Senior UGC research fellows.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Beuria TK, 2003, J BIOL CHEM, V278, P3735, DOI 10.1074/jbc.M205760200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Bufalieri F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11093-0; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Cui DR, 2020, CELL DEATH DIFFER, V27, P1119, DOI 10.1038/s41418-019-0402-x; Dasika GK, 1999, ONCOGENE, V18, P7883, DOI 10.1038/sj.onc.1203283; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; He NG, 2005, MOL CARCINOGEN, V42, P18, DOI 10.1002/mc.20063; Helt CE, 2005, CELL CYCLE, V4, P529, DOI 10.4161/cc.4.4.1598; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Janic A, 2018, NAT MED, V24, P947, DOI 10.1038/s41591-018-0043-5; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Khanna KK, 2001, CELL DEATH DIFFER, V8, P1052, DOI 10.1038/sj.cdd.4400874; Kim SE, 2009, J CELL SCI, V122, P842, DOI 10.1242/jcs.040493; Kuo LJ, 2008, IN VIVO, V22, P305; Li JM, 2012, FRONT ONCOL, V2, P1, DOI [10.3389/fonc.2012.00079, 10.3389/fonc.2012.00029]; Liang J, 2017, ONCOL LETT, V14, P3131, DOI 10.3892/ol.2017.6533; Loveless TB, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005292; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Nakagawa T, 2015, MOL CELL BIOL, V35, P3517, DOI 10.1128/MCB.00343-15; Nishikawa H, 2004, J BIOL CHEM, V279, P3916, DOI 10.1074/jbc.M308540200; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; OConnor PM, 1997, CANCER RES, V57, P4285; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Pereg Y, 2005, P NATL ACAD SCI USA, V102, P5056, DOI 10.1073/pnas.0408595102; Ray D, 2005, MOL CELL BIOL, V25, P3338, DOI 10.1128/MCB.25.8.3338-3347.2005; Santra MK, 2009, NATURE, V459, P722, DOI 10.1038/nature08011; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; Suzuki H, 1999, BIOCHEM BIOPH RES CO, V256, P127, DOI 10.1006/bbrc.1999.0289; Tan MJ, 2006, NEOPLASIA, V8, P1042, DOI 10.1593/neo.06568; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Wang LN, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0440-1; Wang ZW, 2014, NAT REV CANCER, V14, P233, DOI 10.1038/nrc3700; Wang ZW, 2012, ONCOTARGET, V3, P1026; Wang ZW, 2012, AM J PHYSIOL-ENDOC M, V303, pE163, DOI 10.1152/ajpendo.00105.2012; Wu JX, 2010, PROTEIN CELL, V1, P117, DOI 10.1007/s13238-010-0010-5; Yang QZ, 2020, MOL THER-NUCL ACIDS, V19, P974, DOI 10.1016/j.omtn.2019.11.035; Zhang Q, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-1030-8; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng NN, 2016, INT J BIOCHEM CELL B, V73, P99, DOI 10.1016/j.biocel.2016.02.005	54	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100511	10.1016/j.jbc.2021.100511	http://dx.doi.org/10.1016/j.jbc.2021.100511			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33676897	Green Published, gold			2022-12-26	WOS:000672866400485
J	Rosenfeld, G; Gabrielian, A; Wang, QL; Gu, JW; Hurt, DE; Long, A; Rosenthal, A				Rosenfeld, Gabriel; Gabrielian, Andrei; Wang, Qinlu; Gu, Jingwen; Hurt, Darrell E.; Long, Alyssa; Rosenthal, Alex			Radiologist observations of computed tomography (CT) images predict treatment outcome in TB Portals, a real-world database of tuberculosis (TB) cases	PLOS ONE			English	Article								The TB Portals program provides a publicly accessible repository of TB case data containing multi-modal information such as case clinical characteristics, pathogen genomics, and radiomics. The real-world resource contains over 3400 TB cases, primarily drug resistant cases, and CT images with radiologist annotations are available for many of these cases. The breadth of data collected offers a patient-centric view into the etiology of the disease including the temporal context of the available imaging information. Here, we analyze a cohort of new TB cases with available radiologist observations of CTs taken around the time of initial registration of the case into the database and with available follow up to treatment outcome of cured or died. Follow up ranged from 5 weeks to a little over 2 years consistent with the longest treatment regimens for drug resistant TB and cases were registered within the years 2008 to 2019. The radiologist observations were incorporated into machine learning pipelines to test various class balancing strategies on the performance of predictive models. The modeling results support that the radiologist observations are predictive of treatment outcome. Moreover, inferential statistical analysis identifies markers of TB disease spread as having an association with poor treatment outcome including presence of radiologist observations in both lungs, swollen lymph nodes, multiple cavities, and large cavities. While the initial results are promising, further data collection is needed to incorporate methods to mitigate potential confounding such as including additional model covariates or matching cohorts on covariates of interest (e.g. demographics, BMI, comorbidity, TB subtype, etc.). Nonetheless, the preliminary results highlight the utility of the resource for hypothesis generation and exploration of potential biomarkers of TB disease severity and support these additional data collection efforts.	[Rosenfeld, Gabriel; Gabrielian, Andrei; Wang, Qinlu; Gu, Jingwen; Hurt, Darrell E.] NIAID, Bioinformat & Computat Biosci Branch, Off Cyber Infrastruct & Computat Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Long, Alyssa] NIAID, Software Engn Branch, Off Cyber Infrastruct & Computat Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Rosenthal, Alex] NIAID, Off Cyber Infrastruct & Computat Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Rosenfeld, G (corresponding author), NIAID, Bioinformat & Computat Biosci Branch, Off Cyber Infrastruct & Computat Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	gabriel.rosenfeld@nih.gov	Rosenfeld, Gabriel/AAJ-9243-2021	Rosenfeld, Gabriel/0000-0002-9858-634X; Gu, Jingwen/0000-0003-2258-3131; Meyer, Alyssa (Long)/0000-0001-7700-549X	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services [HHSN316201300006W/HHSN27200002, HHSN316201200018W/75N98119F00012]; US Civilian Research and Development Foundation (CDRF) [BOB1-31120-MK-13]; Office of Science Management and Operations of NIAID at the NIH	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services; US Civilian Research and Development Foundation (CDRF); Office of Science Management and Operations of NIAID at the NIH	This project has been funded in part with Federal funds from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services under contract HHSN316201300006W/HHSN27200002 to Medical Science & Computing, LLC, Inc and under contract HHSN316201200018W/75N98119F00012 to Deloitte Consulting LLP and under the US Civilian Research and Development Foundation (CDRF) Agreement No. BOB1-31120-MK-13. This research was supported in part by the Office of Science Management and Operations of NIAID at the NIH. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asad M, 2020, TUBERCULOSIS, V123, DOI 10.1016/j.tube.2020.101944; Chen RY, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009501; Dheda K, 2017, LANCET RESP MED, V5, P291, DOI [10.1016/S2213-2600(17)30079-6, 10.1016/s2213-2600(17)30079-6]; Dheda K, 2016, LANCET, V387, P1211, DOI 10.1016/S0140-6736(15)00151-8; Heo EY, 2009, INT J INFECT DIS, V13, pE371, DOI 10.1016/j.ijid.2009.01.007; Heuvelings CC, 2017, LANCET INFECT DIS, V17, pE144, DOI 10.1016/S1473-3099(16)30532-1; Kim J, 2017, DIAGN INTERV RADIOL, V23, P112, DOI 10.5152/dir.2016.16157; Kim JH, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016921; Koo HK, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05350-7; Lang M., 2019, J OPEN SOURCE SOFTW, V4; Li DC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181853; Malherbe ST, 2020, EJNMMI RES, V10, DOI 10.1186/s13550-020-0591-9; Manjelievskaia J, 2016, T ROY SOC TROP MED H, V110, P186, DOI 10.1093/trstmh/trw006; Sauer CM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207491; Murthy SE, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1053-3; Ong CWM, 2014, AM J RESP CRIT CARE, V190, P9, DOI 10.1164/rccm.201311-2106PP; Perrin FMR, 2010, INT J TUBERC LUNG D, V14, P1596; Ravimohan S, 2018, EUR RESPIR REV, V27, DOI 10.1183/16000617.0077-2017; Rosenthal A, 2017, J CLIN MICROBIOL, V55, P3267, DOI 10.1128/JCM.01013-17; Rubin DL, 2019, J AM COLL RADIOL, V16, P1309, DOI 10.1016/j.jacr.2019.05.036; Skoura E, 2015, INT J INFECT DIS, V32, P87, DOI 10.1016/j.ijid.2014.12.007; WHO, 2018, GLOBAL TUBERCULOSIS	22	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0247906	10.1371/journal.pone.0247906	http://dx.doi.org/10.1371/journal.pone.0247906			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730021	Green Published, gold			2022-12-26	WOS:000630345000035
J	Huang, LS; Li, L; Dunn, L; He, M				Huang, Li-Shan; Li, Li; Dunn, Lucia; He, Mai			Taking account of asymptomatic infections: A modeling study of the COVID-19 outbreak on the Diamond Princess cruise ship	PLOS ONE			English	Article							CORONAVIRUS COVID-19; CHINA	The COVID-19 outbreak on the Diamond Princess (DP) cruise ship has provided empirical data to study the transmission potential of COVID-19 with the presence of pre/asymptomatic cases. We studied the changes in R-0 on DP from January 21 to February 19, 2020 based on chain binomial models under two scenarios: no quarantine assuming a random mixing condition, and quarantine of passengers in cabins-passengers may get infected either by an infectious case in a shared cabin or by pre/asymptomatic crew who continued to work. Estimates of R-0 at the beginning of the epidemic were 3.27 (95% CI, 3.02-3.54) and 3.78 (95% CI, 3.49-4.09) respectively for serial intervals of 5 and 6 days; and when quarantine started, with the reported asymptomatic ratio 0.505, R-0 rose to 4.18 (95%CI, 3.86-4.52) and 4.73 (95%CI, 4.37-5.12) respectively for passengers who might be exposed to the virus due to pre/asymptomatic crew. Results confirm that the higher the asymptomatic ratio is, the more infectious contacts would happen. We find evidence to support a US CDC report that "a high proportion of asymptomatic infections could partially explain the high attack rate among cruise ship passengers and crew." Our study suggests that if the asymptomatic ratio is high, the conventional quarantine procedure may not be effective to stop the spread of virus.	[Huang, Li-Shan] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan; [Li, Li] AT&T, Bedminster, NJ USA; [Dunn, Lucia] Ohio State Univ, Dept Econ, Columbus, OH 43210 USA; [He, Mai] Washington Univ, Dept Pathol & Immunol, Sch Med St Louis, St Louis, MO 63110 USA	National Tsing Hua University; AT&T; University System of Ohio; Ohio State University; Saint Louis University; Washington University (WUSTL)	Huang, LS (corresponding author), Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan.	lhuang@stat.nthu.edu.tw		Huang, Li-Shan/0000-0001-8297-2804	Taiwan Ministry of Science and Technology [MOST 107-2118-M-007-002-MY2]	Taiwan Ministry of Science and Technology	The Taiwan Ministry of Science and Technology provided funding for this study in the form of a grant awarded to author LH (MOST 107-2118-M-007-002-MY2). Indirect support was provided through salaries/facilities use by the home institutions of LH, LD, and MH. AT&T provided support in the form of salary for author LL. The specific roles of these authors are articulated in the `author contribution' section. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Bailey N.T., 1957, MATH THEORY EPIDEMIC; Bjornstad ON., 2018, EPIDEMICS MODELS DAT; Bolker B., 2020, BBMLE TOOLS GEN MAXI; Dobrovolny HM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236976; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Du ZW, 2020, EMERG INFECT DIS, V26, P1341, DOI [10.3201/eid2606.200357, 10.1101/2020.02.19.20025452]; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Inui Shohei, 2020, Radiol Cardiothorac Imaging, V2, pe200110, DOI [10.1148/ryct.2020204002, 10.1148/ryct.2020200110]; Johansson MA, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.35057; Kakimoto K, 2020, MMWR-MORBID MORTAL W, V69, P312, DOI 10.15585/mmwr.mm6911e2; Laydon D., 2020, B MATH BIOL; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Longini IM., 1998, ENCY BIOSTATISTICS, V1, P593; Lytras T, 2018, EUROSURVEILLANCE, V23, P5, DOI 10.2807/1560-7917.ES.2018.23.17.18-00165; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Moriarty LF, 2020, MMWR-MORBID MORTAL W, V69, P347, DOI 10.15585/mmwr.mm6912e3; Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929; National Institute of Infectious Diseases`, 2020, INFECT AGENTS SURVEI, V40, P192; Nishiura H, 2020, INT J INFECT DIS, V93, P284, DOI 10.1016/j.ijid.2020.02.060; Park SW, 2020, EPIDEMICS-NETH, V31, DOI 10.1016/j.epidem.2020.100392; Plucinski MM, 2021, CLIN INFECT DIS, V72, pE448, DOI 10.1093/cid/ciaa1180; R Core Team, 2020, R LANG ENV STAT COMP; Ranjan R., 2020, PREDICTIONS COVID 19, DOI [10.1101/2020.04.02.20051466, DOI 10.1101/2020.04.02.20051466]; Rocklov J, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa030; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Zhang JJ, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2817-7; Zhang S, 2020, INT J INFECT DIS, V93, P201, DOI 10.1016/j.ijid.2020.02.033; Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	32	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0248273	10.1371/journal.pone.0248273	http://dx.doi.org/10.1371/journal.pone.0248273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY1VJ	33725000	Green Published, gold, Green Submitted			2022-12-26	WOS:000629833700014
J	Kheir, M; Saleem, F; Wang, C; Mann, A; Chua, J				Kheir, Matthew; Saleem, Farah; Wang, Christy; Mann, Amardeep; Chua, Jimmy			Higher albumin levels on admission predict better prognosis in patients with confirmed COVID-19	PLOS ONE			English	Article							SERUM-ALBUMIN; HYPOALBUMINEMIA; MANAGEMENT; DISEASE	Background Research surrounding COVID-19 (coronavirus disease 2019) is rapidly increasing, including the study of biomarkers for predicting outcomes. There is little data examining the correlation between serum albumin levels and COVID-19 disease severity. The purpose of this study is to evaluate whether admission albumin levels reliably predict outcomes in COVID-19 patients. Methods We retrospectively reviewed 181 patients from two hospitals who had COVID-19 pneumonia confirmed by polymerase chain reaction (PCR) testing and radiologic imaging, who were hospitalized between March and July 2020. We recorded demographics, COVID-19 testing techniques, and day of admission labs. The outcomes recorded included the following: venous thromboembolism (VTE), acute respiratory distress syndrome (ARDS), intensive care unit (ICU) admission, discharge with new or higher home oxygen supplementation, readmission within 90 days, in-hospital mortality, and total adverse events. A multivariate modified Poisson regression analysis was then performed to determine significant predictors for increased adverse events in patients with COVID-19 pneumonia. Results A total of 109 patients (60.2%) had hypoalbuminemia (albumin level < 3.3 g/dL). Patients with higher albumin levels on admission had a 72% decreased risk of developing venous thromboembolism (adjusted relative risk [RR]:0.28, 95% confidence interval [CI]:0.14-0.53, p<0.001) for every 1 g/dL increase of albumin. Moreover, higher albumin levels on admission were associated with a lower risk of developing ARDS (adjusted RR:0.73, 95% CI:0.55-0.98, p = 0.033), admission to the ICU (adjusted RR:0.64, 95% CI:0.45-0.93, p = 0.019), and were less likely to be readmitted within 90 days (adjusted RR:0.37, 95% CI:0.17-0.81, p = 0.012). Furthermore, higher albumin levels were associated with fewer total adverse events (adjusted RR:0.65, 95% CI:0.52-0.80, p<0.001). Conclusions Admission serum albumin levels appear to be a predictive biomarker for outcomes in COVID-19 patients. We found that higher albumin levels on admission were associated with significantly fewer adverse outcomes, including less VTE events, ARDS development, ICU admissions, and readmissions within 90 days. Screening patients may lead to early identification of patients at risk for developing in-hospital complications and improve optimization and preventative efforts in this cohort.	[Kheir, Matthew; Saleem, Farah; Wang, Christy] Trios Hlth Univ Washington Med Community Hlth Par, Dept Med, Kennewick, WA 99336 USA; [Mann, Amardeep] Lourdes Med Ctr, Dept Cardiol, Pasco, WA USA; [Chua, Jimmy] Trios Hlth Univ Washington Med Community Hlth Par, Dept Infect Dis, Kennewick, WA USA		Kheir, M (corresponding author), Trios Hlth Univ Washington Med Community Hlth Par, Dept Med, Kennewick, WA 99336 USA.	matthew.kheir@trioshealth.org		Kheir, Matthew/0000-0002-1306-7138				[Anonymous], ANN INTERN MED; [Anonymous], COVID 19 STUD WHO HL; Avula A, 2020, BRAIN BEHAV IMMUN, V87, P115, DOI 10.1016/j.bbi.2020.04.077; Aziz M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02995-3; Baral SD, 2020, ANN EPIDEMIOL, V46, P12, DOI 10.1016/j.annepidem.2020.05.001; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chen SJ, 2021, J THROMB THROMBOLYS, V51, P33, DOI 10.1007/s11239-020-02181-w; Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]; Chi G, 2019, AM J HEMATOL, V94, P21, DOI 10.1002/ajh.25296; Englert JA, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124061; Fasano M, 2005, IUBMB LIFE, V57, P787, DOI 10.1080/15216540500404093; FLECK A, 1985, LANCET, V1, P781; Folsom AR, 2010, THROMB HAEMOSTASIS, V104, P100, DOI 10.1160/TH09-12-0856; Gallis JA, 2019, ANN GLOB HEALTH, V85, DOI 10.5334/aogh.2581; Gori T, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0792-4; Gounden V., 2020, HYPOALBUMINEMIA STAT; Henry BM, 2020, CLIN CHEM LAB MED, V58, P1021, DOI 10.1515/cclm-2020-0369; Huang JF, 2020, J MED VIROL, V92, P2152, DOI 10.1002/jmv.26003; Kakodkar P, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7560; Kermali M, 2020, LIFE SCI, V254, DOI 10.1016/j.lfs.2020.117788; La Marca A, 2020, REPROD BIOMED ONLINE, V41, P483, DOI 10.1016/j.rbmo.2020.06.001; Mangalmurti NS, 2020, AM J RESP CRIT CARE, V202, P750, DOI 10.1164/rccm.202006-2598LE; Markus HS, 2020, INT J STROKE, V15, P361, DOI 10.1177/1747493020923472; Mehra MR, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMoa2007621; Mokhtari T, 2020, J MOL HISTOL, V51, P613, DOI 10.1007/s10735-020-09915-3; Moll M, 2020, CHEST, V158, P2130, DOI 10.1016/j.chest.2020.07.031; Moman RN., 2020, PHYSL ALBUMIN; Paar M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182997; Pan J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17218189; Ponti G, 2020, CRIT REV CL LAB SCI, V57, P389, DOI 10.1080/10408363.2020.1770685; Rabaan AA, 2020, HUM VACC IMMUNOTHER, V16, P3011, DOI 10.1080/21645515.2020.1825896; Shim H, 2013, WORLD J EMERG SURG, V8, DOI 10.1186/1749-7922-8-18; Soeters PB, 2019, JPEN-PARENTER ENTER, V43, P181, DOI 10.1002/jpen.1451; Su TH, 2020, J FORMOS MED ASSOC, V119, P1016, DOI 10.1016/j.jfma.2020.04.020; Sung J, 2004, AM SURGEON, V70, P1099; Tan CC, 2020, J MED VIROL, V92, P856, DOI 10.1002/jmv.25871; Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4; Taverna M, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-4; Udugama B, 2020, ACS NANO, V14, P3822, DOI 10.1021/acsnano.0c02624; Vincent JL, 2003, ANN SURG, V237, P319, DOI 10.1097/00000658-200303000-00005; Xiong TT, 2021, ENVIRON GEOCHEM HLTH, V43, P423, DOI [10.1007/s10653-020-00734-9, 10.1093/eurheartj/ehaa231]; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Yin M, 2018, J INTENSIVE CARE MED, V33, P687, DOI 10.1177/0885066616685300; Zhang C, 2020, LANCET GASTROENTEROL, V5, P428, DOI 10.1016/S2468-1253(20)30057-1; Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238; Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5; Zheng YFF, 2020, CLIN CHEM LAB MED, V58, P1106, DOI 10.1515/cclm-2020-0377	47	29	29	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0248358	10.1371/journal.pone.0248358	http://dx.doi.org/10.1371/journal.pone.0248358			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY1VJ	33725003	gold, Green Published			2022-12-26	WOS:000629833700010
J	Koester, ST; Li, NS; Lachance, DM; Morella, NM; Dey, N				Koester, Sean T.; Li, Naisi; Lachance, Daniel M.; Morella, Norma M.; Dey, Neelendu			Variability in digestive and respiratory tract Ace2 expression is associated with the microbiome	PLOS ONE			English	Article								COVID-19 (coronavirus disease 2019) patients exhibiting gastrointestinal symptoms are reported to have worse prognosis. Ace2 (angiotensin-converting enzyme 2), the gene encoding the host protein to which SARS-CoV-2 spike proteins bind, is expressed in the gut and therefore may be a target for preventing or reducing severity of COVID-19. Here we test the hypothesis that Ace2 expression in the gastrointestinal and respiratory tracts is modulated by the microbiome. We used quantitative PCR to profile Ace2 expression in germ-free mice, conventional raised specific pathogen-free mice, and gnotobiotic mice colonized with different microbiota. Intestinal Ace2 expression levels were significantly higher in germ-free mice compared to conventional mice. A similar trend was observed in the respiratory tract. Intriguingly, microbiota depletion via antibiotics partially recapitulated the germ-free phenotype, suggesting potential for microbiome-mediated regulation of Ace2 expression. Variability in intestinal Ace2 expression was observed in gnotobiotic mice colonized with different microbiota, partially attributable to differences in microbiome-encoded proteases and peptidases. Together, these data suggest that the microbiome may be one modifiable factor determining COVID-19 infection risk and disease severity.	[Koester, Sean T.; Li, Naisi; Lachance, Daniel M.; Morella, Norma M.; Dey, Neelendu] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Lachance, Daniel M.] Univ Washington, Mol Engn & Sci Inst, Seattle, WA 98195 USA; [Dey, Neelendu] Fred Hutchinson Canc Res Ctr, Microbiome Res Initiat, 1124 Columbia St, Seattle, WA 98104 USA; [Dey, Neelendu] Univ Washington, Dept Med, Div Gastroenterol, Seattle, WA 98105 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Dey, N (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.; Dey, N (corresponding author), Fred Hutchinson Canc Res Ctr, Microbiome Res Initiat, 1124 Columbia St, Seattle, WA 98104 USA.; Dey, N (corresponding author), Univ Washington, Dept Med, Div Gastroenterol, Seattle, WA 98105 USA.	ndey@fredhutch.org		Dey, Neelendu/0000-0001-8825-5689; Koester, Sean/0000-0002-0984-2752; Morella, Norma/0000-0001-8090-295X	NIH [NIDDK K08 DK111941]; NCI Cancer Center Support Grant [P30 CA015704]; Fred Hutchinson Cancer Research Center (Pathogen-Associated Malignancies Integrated Research Center, Microbiome Research Initiative); Washington Research Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fred Hutchinson Cancer Research Center (Pathogen-Associated Malignancies Integrated Research Center, Microbiome Research Initiative); Washington Research Foundation	This work was supported by grants from the NIH (NIDDK K08 DK111941 and NCI Cancer Center Support Grant P30 CA015704 to ND); institutional funds from the Fred Hutchinson Cancer Research Center (Pathogen-Associated Malignancies Integrated Research Center, Microbiome Research Initiative, and donor-sponsored COVID-19 Evergreen pilot study funds to ND); and postdoctoral fellowship support from the Washington Research Foundation (NMM).	AlGhatrif M, 2020, JAMA CARDIOL, V5, P747, DOI 10.1001/jamacardio.2020.1329; Camargo SMR, 2009, GASTROENTEROLOGY, V136, P872, DOI 10.1053/j.gastro.2008.10.055; Chen L, 2021, CELL MOL GASTROENTER, V11, P181, DOI 10.1016/j.jcmgh.2020.08.005; Dey N, 2015, CELL, V163, P95, DOI 10.1016/j.cell.2015.08.059; Garg M, 2020, GUT, V69, P841, DOI 10.1136/gutjnl-2019-318512; Hashimoto T, 2012, NATURE, V487, P477, DOI 10.1038/nature11228; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jando J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184845; Janeckova L, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071581; Li GP, 2020, J AUTOIMMUN, V112, DOI 10.1016/j.jaut.2020.102463; Li MY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00662-x; Pan L, 2020, AM J GASTROENTEROL, V115, P766, DOI 10.14309/ajg.0000000000000620; Rawlings ND, 2018, NUCLEIC ACIDS RES, V46, pD624, DOI 10.1093/nar/gkx1134; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sharif-Askari NS, 2020, MOL THER-METH CLIN D, V18, P1, DOI 10.1016/j.omtm.2020.05.013; Shulzhenko N, 2011, NAT MED, V17, P1585, DOI 10.1038/nm.2505; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Yang T, 2020, HYPERTENSION, V76, pE1, DOI 10.1161/HYPERTENSIONAHA.120.15360; Yang YW, 2015, APPL ENVIRON MICROB, V81, P6749, DOI 10.1128/AEM.01906-15; Zuo T, 2020, GASTROENTEROLOGY, V159, P944, DOI 10.1053/j.gastro.2020.05.048	20	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0248730	10.1371/journal.pone.0248730	http://dx.doi.org/10.1371/journal.pone.0248730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY1VJ	33725024	gold, Green Published			2022-12-26	WOS:000629833700011
J	Patoine, A; Mikula, L; Mejia-Romero, S; Michaels, J; Keruzore, O; Chaumillon, R; Bernardin, D; Faubert, J				Patoine, Amigale; Mikula, Laura; Mejia-Romero, Sergio; Michaels, Jesse; Keruzore, Oceane; Chaumillon, Romain; Bernardin, Delphine; Faubert, Jocelyn			Increased visual and cognitive demands emphasize the importance of meeting visual needs at all distances while driving	PLOS ONE			English	Article							INDUCED MOTION SICKNESS; DRIVEN ACCOMMODATION; PERFORMANCE; VISION; ADAPTATION; BLUR; AGE; IMPAIRMENT; TASK; ASSOCIATION	Having an optimal quality of vision as well as adequate cognitive capacities is known to be essential for driving safety. However, the interaction between vision and cognitive mechanisms while driving remains unclear. We hypothesized that, in a context of high cognitive load, reduced visual acuity would have a negative impact on driving behavior, even when the acuity corresponds to the legal threshold for obtaining a driving license in Canada, and that the impact observed on driving performance would be greater with the increase in the threshold of degradation of visual acuity. In order to investigate this relationship, we examined driving behavior in a driving simulator under optimal and reduced vision conditions through two scenarios involving different levels of cognitive demand. These were: 1. a simple rural driving scenario with some pre-programmed events and 2. a highway driving scenario accompanied by a concurrent task involving the use of a navigation device. Two groups of visual quality degradation (lower/ higher) were evaluated according to their driving behavior. The results support the hypothesis: A dual task effect was indeed observed provoking less stable driving behavior, but in addition to this, by statistically controlling the impact of cognitive load, the effect of visual load emerged in this dual task context. These results support the idea that visual quality degradation impacts driving behavior when combined with a high mental workload driving environment while specifying that this impact is not present in the context of low cognitive load driving condition.	[Patoine, Amigale; Mikula, Laura; Mejia-Romero, Sergio; Michaels, Jesse; Keruzore, Oceane; Chaumillon, Romain; Bernardin, Delphine; Faubert, Jocelyn] Univ Montreal, Sch Optometry, Faubert Lab, Montreal, PQ, Canada; [Bernardin, Delphine] Essilor Canada Ltd, Essilor Int Res & Dev, Montreal, PQ, Canada	Universite de Montreal; Essilor International	Patoine, A (corresponding author), Univ Montreal, Sch Optometry, Faubert Lab, Montreal, PQ, Canada.	amigale.patoine@umontreal.ca		Mikula, Laura/0000-0002-6964-8046	Natural Sciences and Engineering Research Council of Canada, NSERC - Essilor Industrial Research Chair [IRCPJ 305729-13]; NSERC [CRDPJ 533187 - 2018]; Road Safety Research Network (Reseau de Recherche en Securite Routiere) of Quebec	Natural Sciences and Engineering Research Council of Canada, NSERC - Essilor Industrial Research Chair; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Road Safety Research Network (Reseau de Recherche en Securite Routiere) of Quebec	This work was supported by the Natural Sciences and Engineering Research Council of Canada, NSERC - Essilor Industrial Research Chair in the form of a grant awarded to AP and LM (IRCPJ 305729-13), Research and development cooperatif NSERC in the form of an Essilor Grant awarded to JF and DB (CRDPJ 533187 -2018), Prompt (https://www.nserc-crsng.gc.ca/index_ eng.asp & https://www.essilor.ca) in the form of funds awarded to DB, the Road Safety Research Network (Reseau de Recherche en Securite Routiere) of Quebec (https://rrsr.ca/en) in the form of student awards to LM and AP, CooperVision in the form of materials used for the study, and Essilor Canada Ltd. in the form of a salary for DB. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angell L., 2006, DRIVER WORKLOAD METR; BALL K, 1993, INVEST OPHTH VIS SCI, V34, P3110; Beede KE, 2006, ACCIDENT ANAL PREV, V38, P415, DOI 10.1016/j.aap.2005.10.015; Ben-David BM, 2010, AGING NEUROPSYCHOL C, V17, P730, DOI 10.1080/13825585.2010.510553; Beran RG, 2005, INTERN MED J, V35, P364, DOI 10.1111/j.1445-5994.2005.00813.x; Boadi-Kusi Samuel Bert, 2016, J Optom, V9, P54, DOI 10.1016/j.optom.2015.06.004; Bonato F, 2015, AEROSP MED HUM PERF, V86, P440, DOI 10.3357/AMHP.4105.2015; BROOKHUIS K, 1994, ERGONOMICS, V37, P427, DOI 10.1080/00140139408963661; Brooks JX, 2009, J NEUROSCI, V29, P10499, DOI 10.1523/JNEUROSCI.1937-09.2009; Brooks JO, 2005, OPTOMETRY VISION SCI, V82, P689, DOI 10.1097/01.opx.0000174722.96171.86; Cantin V, 2009, ACCIDENT ANAL PREV, V41, P763, DOI 10.1016/j.aap.2009.03.019; Casson EJ, 2000, CAN J OPHTHALMOL, V35, P192, DOI 10.1016/S0008-4182(00)80030-7; Chaparro A, 1999, HUM FAC ERG SOC P, P1343; Colenbrander A., 2006, VISION REQUIREMENTS; Courtemanche F, 2019, ACCIDENT ANAL PREV, V127, P1, DOI 10.1016/j.aap.2019.02.022; Cox DJ, 2015, OPTOMETRY VISION SCI, V92, P404, DOI 10.1097/OPX.0000000000000554; Dawson JD, 2010, J AM GERIATR SOC, V58, P1090, DOI 10.1111/j.1532-5415.2010.02872.x; Delphine B, 2019, INVEST OPHTH VIS SCI, V60; DEMER JL, 1989, INVEST OPHTH VIS SCI, V30, P159; Desapriya E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006252.pub4; Engstrom J, 2005, TRANSPORT RES F-TRAF, V8, P97, DOI 10.1016/j.trf.2005.04.012; Farmer AD, 2014, EXP BRAIN RES, V232, P2665, DOI 10.1007/s00221-014-3964-3; Friedman C, 2013, INVEST OPHTH VIS SCI, V54, P778, DOI 10.1167/iovs.12-11249; Fylan F, 2018, TRANSPORT RES F-TRAF, V56, P123, DOI 10.1016/j.trf.2018.04.005; Gabaude C, 2012, COGNITIVE LOAD MEASU; Geringswald F, 2013, J VISION, V13, DOI 10.1167/13.3.28; GOSS DA, 1994, DOC OPHTHALMOL, V86, P349, DOI 10.1007/BF01204595; Greenberg J, 2003, TRANSPORT RES REC, P1, DOI 10.3141/1843-01; Groner R., 1983, EYE MOVEMENTS PSYCHO; Gross M, 2016, CURR BIOL, V26, pR307, DOI 10.1016/j.cub.2016.04.019; Higgins KE, 2005, OPTOMETRY VISION SCI, V82, P647, DOI 10.1097/01.opx.0000174725.32907.86; Higgins KE, 1998, HUM FACTORS, V40, P224, DOI 10.1518/001872098779480415; Hoffman DM, 2008, J VISION, V8, DOI 10.1167/8.3.33; Huisingh C, 2016, CLIN EXP OPTOM, V99, P441, DOI 10.1111/cxo.12404; International Organization of Standardization, 2002, 150071 ISO; International Standards Organization, 2001, 1500721 ISO; Jansen RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158511; Janssen CP, 2010, COGNITIVE SCI, V34, P1548, DOI 10.1111/j.1551-6709.2010.01124.x; Joubert OR, 2007, VISION RES, V47, P3286, DOI 10.1016/j.visres.2007.09.013; Kang MT, 2017, INVEST OPHTH VIS SCI, V58; Keshavarz B, 2012, PRESENCE-TELEOP VIRT, V21, P213, DOI 10.1162/PRES_a_00102; Kingery KM, 2015, J ABNORM CHILD PSYCH, V43, P1175, DOI 10.1007/s10802-014-9954-x; Kopp C., 2009, UM 13 STUD C COMP SC; Lackner JR, 2014, EXP BRAIN RES, V232, P2493, DOI 10.1007/s00221-014-4008-8; Laudate TM, 2012, AGING NEUROPSYCHOL C, V19, P102, DOI 10.1080/13825585.2011.621930; Lenne MG, 1998, SLEEP, V21, P38, DOI 10.1093/sleep/21.1.38; Levy J, 2008, APPL COGNITIVE PSYCH, V22, P507, DOI 10.1002/acp.1378; Liang YL, 2010, ACCIDENT ANAL PREV, V42, P881, DOI 10.1016/j.aap.2009.05.001; Ma JF, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00459; Mackenzie AK, 2017, J EXP PSYCHOL HUMAN, V43, P381, DOI 10.1037/xhp0000297; Maiello G, 2018, EXP EYE RES, V166, P96, DOI 10.1016/j.exer.2017.10.004; MATANZO F, 1967, HUM FACTORS, V9, P427, DOI 10.1177/001872086700900505; McGehee DV, 2004, TRANSPORT RES F-TRAF, V7, P181, DOI 10.1016/j.trf.2004.08.001; Michaels J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185909; Milleville-Pennel I, 2015, ACCIDENT ANAL PREV, V74, P192, DOI 10.1016/j.aap.2014.10.021; Molnar FJ, 2005, CAN FAM PHYSICIAN, V51, P372; Narad M., 2014, IMPACT CELL PHONE US; Owens DA, 1999, J EXP PSYCHOL-APPL, V5, P115, DOI 10.1037/1076-898X.5.2.115; OWSLEY C, 1991, PSYCHOL AGING, V6, P403, DOI 10.1037/0882-7974.6.3.403; Owsley C, 2004, TRANSPORTATION AGING, P44; Owsley C, 2010, VISION RES, V50, P2348, DOI 10.1016/j.visres.2010.05.021; Parsons B, 2016, CLIN EEG NEUROSCI, V47, P37, DOI 10.1177/1550059414563746; Peng H, 2018, IET POWER ELECTRON, V11, P2507, DOI 10.1049/iet-pel.2018.5685; Rakauskas ME, 2004, J SAFETY RES, V35, P453, DOI 10.1016/j.jsr.2004.06.003; Reason JT., 1975, MOTION SICKNESS, Vvii; Reed MP, 1999, ERGONOMICS, V42, P1015, DOI 10.1080/001401399185117; Ronen A, 2013, TRANSPORT RES F-TRAF, V18, P94, DOI 10.1016/j.trf.2012.12.007; ROSENFIELD M, 1987, OPHTHAL PHYSL OPT, V7, P225, DOI 10.1111/j.1475-1313.1987.tb00737.x; Rousselet GA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-114; Samuel S, 2016, CLIN EXP OPTOM, V99, P419, DOI 10.1111/cxo.12443; Schneider B.A., 2000, HDB AGING COGNITION, P155; STANGLERZUSCHROTT E, 1990, KLIN MONATSBL AUGENH, V196, P150, DOI 10.1055/s-2008-1046145; Vasudevan Balamurali, 2016, J Optom, V9, P196, DOI 10.1016/j.optom.2015.11.001; Vienne C, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00973; West SK, 2002, ARCH OPHTHALMOL-CHIC, V120, P774; WHO Regional Office for Europe, 2018, REP HLTH MIGR REF WH; Wong JT, 2013, ACCIDENT ANAL PREV, V58, P140, DOI 10.1016/j.aap.2013.04.033; WOOD JM, 1994, HUM FACTORS, V36, P476, DOI 10.1177/001872089403600305; Wood JM, 2006, TRANSPORT RES REC, P65; Wood JM, 2014, INVEST OPHTH VIS SCI, V55, P2284, DOI 10.1167/iovs.13-13369; Wood JM, 2012, OPTOMETRY VISION SCI, V89, P373, DOI 10.1097/OPX.0b013e31824c17ee; Yan MK, 2019, CLIN EXP OPHTHALMOL, V47, P847, DOI 10.1111/ceo.13572; Yang W-W., 2012, SID S DIGEST TECHNIC, V43, P969; Yazdan-Ashoori P, 2010, J NEURO-OPHTHALMOL, V30, P177, DOI 10.1097/WNO.0b013e3181dfa982; Young KL, 2014, SAFETY SCI, V68, P47, DOI 10.1016/j.ssci.2014.02.018; Young KL, 2010, SAFETY SCI, V48, P326, DOI 10.1016/j.ssci.2009.10.008; Young MS., 2017, SIMULATORS TRANSPORT; Zebardast N, 2015, OPHTHALMOLOGY, V122, P1102, DOI 10.1016/j.ophtha.2015.02.024; Zhang T., 2018, J VISION, V18, DOI [10.1167/18.10.485, DOI 10.1167/18.10.485]	89	2	2	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0247254	10.1371/journal.pone.0247254	http://dx.doi.org/10.1371/journal.pone.0247254			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY1VJ	33724991	gold, Green Published, Green Submitted			2022-12-26	WOS:000629833700024
J	Kumar, A; Choudhary, R; Kumar, A				Kumar, Abhinay; Choudhary, Rajan; Kumar, Ankush			Characterization of thermal storage stability of waste plastic pyrolytic char modified asphalt binders with sulfur	PLOS ONE			English	Article							COMPONENT ANALYSIS PCA; CLUSTER-ANALYSIS HCA; RHEOLOGICAL PROPERTIES; CARBON-BLACK; PERFORMANCE; IDENTIFICATION; MORPHOLOGY; RUBBER; FTIR	Pyrolysis has gained a strong interest in recent times for sustainable treatment and recovery of energy-rich products from different wastes including plastic. Waste plastic pyrolytic char (PPC) generated as a carbonaceous by-product in the pyrolysis process, is gaining attention as an asphalt binder modifier. Adequate thermal storage stability is an essential requirement for a modified asphalt binder to ensure that the composite offers integrity and homogeneous properties during its storage, handling and transportation in the field. The objective of this study was to evaluate and characterize the thermal storage stability properties of PPC modified binders. PPC modified asphalt binders were fabricated and evaluated at multiple dosages of sulfur as a cross-linking agent. In addition to the conventionally used softening point difference (SPD), characterization of thermal storage stability was attempted using rheology-based separation indices (SIs) derived through temperature sweep, frequency sweep, and multiple stress creep and recovery (MSCR) tests. These rheological SIs were based on complex modulus (G*), Superpave rutting parameter (G*/sin delta), Shenoy rutting parameter (SRP), zero shear viscosity (ZSV), and MSCR J(nr) (at three stress levels 0.1, 3.2 and 10 kPa). Two formulations of each rheology-based separation index were studied: (1) ratio, and (2) maximum-average difference formulations. The temperature and frequency dependencies of rheological SIs were also evaluated. Further, the Fourier transform infrared spectroscopy (FTIR) was used to characterize storage stability by comparing the chemical functionalities of the PPC modified binders. A 0.3% dosage of sulfur was found to produce the best results considering all SPD, rheology-based SIs and FTIR. Principal component analysis showed that the ratio and maximum-average formulations had similar contributions to the first principal component accounting for more than 99% of the variability.	[Kumar, Abhinay; Choudhary, Rajan; Kumar, Ankush] Indian Inst Technol Guwahati, Dept Civil Engn, Gauhati, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Choudhary, R (corresponding author), Indian Inst Technol Guwahati, Dept Civil Engn, Gauhati, Assam, India.	rajandce@iitg.ac.in	Kumar, Abhinay/ABF-2885-2021; Kumar, Abhinay/T-8217-2018; KUMAR, ANKUSH/AAE-8495-2022	Kumar, Abhinay/0000-0002-7740-9029; Kumar, Abhinay/0000-0002-7740-9029; KUMAR, ANKUSH/0000-0001-5323-7771				Al-Salem SM, 2009, WASTE MANAGE, V29, P2625, DOI 10.1016/j.wasman.2009.06.004; Anderson DA, 2002, TRANSPORT RES REC, P54, DOI 10.3141/1810-07; [Anonymous], 2020, STANDARD TEST METHOD; [Anonymous], 2020, D7173 ASTM ASTM INT; [Anonymous], 2019, 15462 IS BUR IND STA; [Anonymous], 2019, 17079 IS BUR IND STA; [Anonymous], 2007, J ASS ASPHALT PAVING; Arshadi A, 2013, THESIS U WISONSIN MA; Cheng L, 2020, CONSTR BUILD MATER, V240, DOI 10.1016/j.conbuildmat.2019.117908; Choudhary R, INT C INN TECHN CLEA, P337; Domingos MDI, 2016, J MATER CIVIL ENG, V28, DOI 10.1061/(ASCE)MT.1943-5533.0001364; Feng ZG, 2016, CONSTR BUILD MATER, V111, P495, DOI 10.1016/j.conbuildmat.2016.02.143; Garcia-Trave G, 2016, J MATER CIVIL ENG, V28, DOI 10.1061/(ASCE)MT.1943-5533.0001507; Golalipour A, 2011, MODIFICATION MULTIPL; Goli A, 2017, J MATER CIVIL ENG, V29, DOI 10.1061/(ASCE)MT.1943-5533.0001910; Granato D, 2018, TRENDS FOOD SCI TECH, V72, P83, DOI 10.1016/j.tifs.2017.12.006; Gupta AK., 2018, ASME POW C, P51395; Jamradloedluk J, 2014, PROCEDIA ENGINEER, V69, P1437, DOI 10.1016/j.proeng.2014.03.139; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Kaza S., 2018, WHAT WASTE 20 GLOBAL, DOI [10.1596/978-1-4648-1329-0, DOI 10.1596/978-1-4648-1329-0]; Kumar A, 2020, 3 INT C WAST MAN; Kumar A., 2020, CIV ENG CONSTR REV, V33, P22; Kumar A., 2020, INT J PAVEMENT ENG, V21, P35; Kumar A, 2018, COGENT ENG, V5, DOI 10.1080/23311916.2018.1548534; Liang M, 2017, CONSTR BUILD MATER, V150, P860, DOI 10.1016/j.conbuildmat.2017.06.069; Liang M, 2015, CONSTR BUILD MATER, V74, P124, DOI 10.1016/j.conbuildmat.2014.10.015; Liao MC, 2011, J MATER CIVIL ENG, V23, P1672, DOI 10.1061/(ASCE)MT.1943-5533.0000331; Liu HQ, 2021, CONSTR BUILD MATER, V269, DOI 10.1016/j.conbuildmat.2020.121320; Lu XH, 1999, J MATER CIVIL ENG, V11, P51, DOI 10.1061/(ASCE)0899-1561(1999)11:1(51); Mandal T, 2015, ROAD MATER PAVEMENT, V16, P349, DOI 10.1080/14680629.2015.1029683; Margaritis A, 2020, CONSTR BUILD MATER, V244, DOI 10.1016/j.conbuildmat.2020.118276; Miandad R, 2016, PROCESS SAF ENVIRON, V102, P822, DOI 10.1016/j.psep.2016.06.022; Moghadas Nejad F, 2017, PROC INST CIV ENG-CO, V170, P186, DOI 10.1680/jcoma.16.00021; Mouillet V, 2008, FUEL, V87, P2408, DOI 10.1016/j.fuel.2008.02.008; Nielsen TD, 2020, WIRES ENERGY ENVIRON, V9, DOI 10.1002/wene.360; Padhan RK, 2019, ROAD MATER PAVEMENT, V20, P1615, DOI 10.1080/14680629.2018.1467335; Polacco G, 2015, ADV COLLOID INTERFAC, V224, P72, DOI 10.1016/j.cis.2015.07.010; Qureshi MS, 2020, J ANAL APPL PYROL, V152, DOI 10.1016/j.jaap.2020.104804; Rasool RT, 2017, CONSTR BUILD MATER, V145, P126, DOI 10.1016/j.conbuildmat.2017.03.242; Ren RB, 2019, CONSTR BUILD MATER, V198, P662, DOI 10.1016/j.conbuildmat.2018.12.009; Ren ZB, 2020, NANOMATERIALS-BASEL, V10, DOI 10.3390/nano10040641; Saptoadi H, 2016, AIP CONF PROC, V1737, DOI 10.1063/1.4949286; Sharuddin SDA, 2016, ENERG CONVERS MANAGE, V115, P308, DOI 10.1016/j.enconman.2016.02.037; Shenoy A, 2001, J TRANSP ENG-ASCE, V127, P357, DOI 10.1061/(ASCE)0733-947X(2001)127:5(357); Shenoy A., 2004, APPL RHEOL, V14, P303, DOI [DOI 10.1515/ARH-2004-0017, 10.1515/arh-2004-0017]; Sigmaaldrich, 2020, IRSPECTRUM TABLE CHA; Sogancioglu M, 2020, ENVIRON SCI POLLUT R, V27, P3871, DOI 10.1007/s11356-019-07028-3; Sun DQ, 2006, PETROL SCI TECHNOL, V24, P1067, DOI 10.1081/LFT-200048186; Wahhab HIA, 2017, ROAD MATER PAVEMENT, V18, P1117, DOI 10.1080/14680629.2016.1207554; Wang HP, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11061631; Weigel S, 2017, FUEL, V208, P655, DOI 10.1016/j.fuel.2017.07.048; Xiao FP, 2022, ROAD MATER PAVEMENT, V23, P509, DOI 10.1080/14680629.2020.1830151; Xu OM, 2017, CONSTR BUILD MATER, V154, P841, DOI 10.1016/j.conbuildmat.2017.07.221; Yan CQ, 2019, FUEL, V252, P417, DOI 10.1016/j.fuel.2019.04.022; Youtcheff Jack, 2005, EVALUATION LAB ASPHA; Zani L, 2017, CONSTR BUILD MATER, V145, P326, DOI 10.1016/j.conbuildmat.2017.04.014; Zhang F, 2012, POLYM ENG SCI, V52, P71, DOI 10.1002/pen.22047; Zhang R, 2018, J MATER CIVIL ENG, V30, DOI 10.1061/(ASCE)MT.1943-5533.0002237; Zhao S, 2014, FUEL, V133, P52, DOI 10.1016/j.fuel.2014.05.002; Zou XL, 2017, ADV MATER SCI ENG, V2017, DOI 10.1155/2017/6319697	60	4	4	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0248465	10.1371/journal.pone.0248465	http://dx.doi.org/10.1371/journal.pone.0248465			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720964	Green Published, gold			2022-12-26	WOS:000629667400044
J	Londono-Burbano, A; Reis, RE				Londono-Burbano, Alejandro; Reis, Roberto E.			A combined molecular and morphological phylogeny of the Loricariinae (Siluriformes: Loricariidae), with emphasis on the Harttiini and Farlowellini	PLOS ONE			English	Article							MIRANDA-RIBEIRO; STICK CATFISH; EVOLUTION; PISCES; HYPOPTOPOMATINAE; SYSTEMATICS; TELEOSTEI; BASIN; GENUS; NEOPLECOSTOMINAE	We present a combined molecular and morphological phylogenetic analysis of the Loricariinae, with emphasis on the Harttiini (Cteniloricaria, Harttia, and Harttiella) and Farlowellini (Aposturisoma, Farlowella, Lamontichthys, Pterosturisoma, Sturisoma, and Sturisomatichthys). Character sampling comprised seven molecular markers (the mitochondrial Cytb, nd2, 12S and 16S, and the nuclear MyH6, RAG1 and RAG2) and 196 morphological characters. A total of 1,059 specimens, and 159 tissue samples were analized, representing 100 species. A Bayesian Inference analysis was performed using the concatenated data matrix, which is comprised of 6,819 characters. The Loricariinae were found to comprise the tribes (Hartiini (Loricariini, Farlowellini)), the latter two elevated from subtribes. A Maximum Parsimony analysis was also performed using the same data matrix in order to reveal phenotypical synapomorphies to diagnose each clade. Two MP trees were found with a length of 14,704 steps, consistency index of 0.29 and retention index of 0.61, which were summarized in a strict consensus tree. Harttiini includes (Harttiella (Cteniloricaria, Harttia), and Farlowellini includes (Lamontichthys (Pterosturisoma (Sturisoma (Sturisomatichthys, Farlowella)))). Aposturisoma was recovered nested within Farlowella and is synonymyzed to the latter. Sturisoma was corroborated as strictly cis-Andean, while Sturisomatichthys encompasses, besides the valid species already included in the genus, the trans-Andean species once belonging to Sturisoma sensu lato. Identification keys and phylogenetic diagnoses of family-group taxa and genera of both the Harttiini and the Farlowellini are provided.	[Londono-Burbano, Alejandro] Univ Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, Setor Ictiol, Rio De Janeiro, RJ, Brazil; [Londono-Burbano, Alejandro; Reis, Roberto E.] Pontificia Univ Catolica Rio Grande do Sul, Lab Sistemat Vertebrados, PUCRS, Porto Alegre, RS, Brazil	Universidade Federal do Rio de Janeiro; Pontificia Universidade Catolica Do Rio Grande Do Sul	Londono-Burbano, A (corresponding author), Univ Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, Setor Ictiol, Rio De Janeiro, RJ, Brazil.; Londono-Burbano, A (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Lab Sistemat Vertebrados, PUCRS, Porto Alegre, RS, Brazil.	alondonoburbano@gmail.com	Reis, Roberto/A-7030-2012	Reis, Roberto/0000-0003-3746-6894	Smithsonian Institution; CNPq [140600/2014-0]; Colciencias [529]; FAPERJ [05/2019-E-26/202.356/2019]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [306455/2014-5, 400166/2016-0]	Smithsonian Institution(Smithsonian Institution); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	L-B was partially supported by a Smithsonian Institution Short Term Visitor Academic Appointment fellowship, by CNPq through a Ph.D. scholarship (process #140600/2014-0), financial support by Colciencias (process 529), and a Postdoctoral Fellowship from FAPERJ Pos-Doutorado Nota 10 (05/2019-E-26/202.356/2019). RER is partially supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq processes #306455/2014-5 and #400166/2016-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; ALEXANDER RM, 1966, J ZOOL, V148, P88; Anderson FE, 2004, MOL PHYLOGENET EVOL, V33, P440, DOI 10.1016/j.ympev.2004.06.015; Armbruster JW, 2004, ZOOL J LINN SOC-LOND, V141, P1, DOI 10.1111/j.1096-3642.2004.00109.x; ARRATIA G, 1990, J MORPHOL, V205, P193, DOI 10.1002/jmor.1052050208; Arratia G, 1987, BONN ZOOL MONOGR, V24, P1, DOI DOI 10.1093/NAR/25.22.4692; Arroyave J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077269; Ballen GA., 2016, NEOTROP ICHTHYOL, V14, P1; Ballen GA, 2016, ICHTHYOL EXPLOR FRES, V27, P325; Ballen GA, 2014, ZOOTAXA, V 3765, P134, DOI 10.11646/zootaxa.3765.2.2; Baskin, 1973, NEOTROP ICHTHYOL, V14, pS1, DOI [10.1590/1982-0224-20150127, DOI 10.1590/1982-0224-20150127]; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; BOESEMAN M, 1976, Zoologische Mededelingen (Leiden), V50, P153; BOESEMAN M., 1971, ZOOLOGISCHE VERHANDE, V116, P1; Chiachio MC, 2008, MOL PHYLOGENET EVOL, V49, P606, DOI 10.1016/j.ympev.2008.08.013; Covain R, 2006, CYBIUM, V30, P3; Covain R, 2008, MOL PHYLOGENET EVOL, V46, P986, DOI 10.1016/j.ympev.2007.12.015; Covain R, 2007, ZOOTAXA, P1, DOI 10.11646/zootaxa.1462.1.1; Covain R, 2016, MOL PHYLOGENET EVOL, V94, P492, DOI 10.1016/j.ympev.2015.10.018; Covain R, 2012, CYBIUM, V36, P115; Covain R, 2010, MOL PHYLOGENET EVOL, V55, P751, DOI 10.1016/j.ympev.2009.10.036; Cramer CA, 2011, MOL PHYLOGENET EVOL, V59, P43, DOI 10.1016/j.ympev.2011.01.002; de Pinna M. C. C., 1993, THESIS CITY U NEW YO; De Pinna M, 2020, AM MUS NOVIT, P1; de Pinna Mario C.C., 1998, P279; Diogo R, 2009, INT J MORPHOL, V27, P333, DOI 10.4067/S0717-95022009000200008; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eigenmann C. H., 1910, Reports of the Princeton University Expeditions to Patagonia 1896-1899 Princeton NJ, V3; Ferraris CJ, 2007, ZOOTAXA, pCP1, DOI 10.11646/zootaxa.1418.1.1; FERRARIS CJ, 2003, CHECK LIST FRESHWATE, P330; Fichberg I., 2008, THESIS U SAO PAULO S; FINK SV, 1981, ZOOL J LINN SOC-LOND, V72, P297, DOI 10.1111/j.1096-3642.1981.tb01575.x; Fitzhugh Kirk, 2014, Memoirs of Museum Victoria, V71, P67; Fricke R., 2021, ESCHMEYERS CATALOG F; Ghazzi M., 2003, THESIS U SAO PAULO S; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; GOSLINE WA, 1947, ARQUIVOS MUSEU NACIO, V41, P79; Grande L., 1987, Journal of Vertebrate Paleontology, V7, P24; Grande Terry, 2004, P429; Howes G.J., 1983, Bulletin of the British Museum (Natural History) Zoology, V45, P309; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; ISBRUCKER I J H, 1978, Beaufortia, V27, P177; Isbrucker I.J.H., 1983, Revue Francaise d'Aquariologie Herpetologie, V10, P33; ISBRUCKER I.J.H., 1979, REV FRANCAISE AQUARI, V5, P86; ISBRUCKER I.J.H., 1980, VERSLAGEN TECHNISCHE, V22, P1; ISBRUCKER IJH, 1978, BIJDR DIERKD, V48, P57, DOI 10.1163/26660644-04801006; Isbrucker IJH, 1981, PROVISIONAL KEY GEN, P1; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; Kluge AG, 2006, CLADISTICS, V22, P276, DOI 10.1111/j.1096-0031.2006.00100.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; Londono-Burbano A, 2019, COPEIA, V107, P764, DOI 10.1643/CI-19-226; Londono-Burbano A, 2016, NEOTROP ICHTHYOL, V14, DOI 10.1590/1982-0224-20150120; Lujan NK, 2015, MOL PHYLOGENET EVOL, V82, P269, DOI 10.1016/j.ympev.2014.08.020; Lundberg J.G., 1982, Miscellaneous Publications Museum of Zoology University of Michigan, V163, P1; Lundberg J.G., 1969, American Museum Novitates, VNo. 2398, P1; Lundberg J. G., 1970, THESIS U MICHIGAN AN; Lundberg JG, 2000, ANN MO BOT GARD, V87, P26, DOI 10.2307/2666207; Maddison WP, 2011, MESQUITE MODULAR SYS; Miller Mark A., 2010, 2010 Gateway Computing Environments Workshop (GCE 2010), DOI 10.1109/GCE.2010.5676129; Miranda-Ribeiro P. de, 1939, Boletim Biologico Sao Paulo (NS), V4, P11; Nijssen H., 1986, REV FRANCAISE AQUARI, V13, P93; Oyakawa OT, 2013, NEOTROP ICHTHYOL, V11, P779, DOI 10.1590/S1679-62252013000400005; Oyakawa Osvaldo Takeshi, 1993, Comunicacoes do Museu de Ciencias da PUCRS Serie Zoologia, V6, P3; Paixao AC., 2012, THESIS U SAO PAULO; Paixao AD, 2009, NEOTROP ICHTHYOL, V7, P519, DOI 10.1590/S1679-62252009000400002; Pereira EHL, 2017, ZOOTAXA, V4264, P1, DOI 10.11646/zootaxa.4264.1.1; Provenzano F, 2011, THESIS U CENTRAL VEN; Provenzano R. Francisco, 2005, Neotrop. ichthyol., V3, P519, DOI 10.1590/S1679-62252005000400009; Rambaut A., 2014, TRACER VERSION 1 6 M; Rapp Py-Daniel Lucia H., 2001, Ichthyological Exploration of Freshwaters, V12, P79; RappPy-Daniel LH., 1997, THESIS U ARIZONA TUC; Regan C. T., 1913, Annals & Magazine of Natural History, V12; Regan C. T., 1904, Transactions of the Zoological Society of London, Vxvii, P191; Regan C. T., 1911, Annals & Magazine of Natural History Series 8, V8; Regan CT, 1912, P ZOOL SOC LOND, V1912, P666; Reis RE, 2016, J FISH BIOL, V89, P12, DOI 10.1111/jfb.13016; Reis RE., 2003, CLOFFSCA CHECK LIST; Retzer ME, 1997, P ACAD NAT SCI PHILA, V147, P33; Retzer ME, 2006, ZOOTAXA, P59; Rodriguez M, 2008, J FISH BIOL, V73, P1635, DOI 10.1111/j.1095-8649.2008.02037.x; Rodriguez MS, 2011, J FISH BIOL, V79, P875, DOI 10.1111/j.1095-8649.2011.03047.x; Rodriguez MS, 2015, NEOTROP ICHTHYOL, V13, P325, DOI 10.1590/1982-0224-20140129; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosen D. E, 1970, Am. Mus. Novit., VNo. 2428, P1; Roxo FF, 2019, MOL PHYLOGENET EVOL, V135, P148, DOI 10.1016/j.ympev.2019.02.017; Sanderson MJ, 2000, MOL BIOL EVOL, V17, P782, DOI 10.1093/oxfordjournals.molbev.a026357; SCHAEFER S A, 1987, Contributions in Science (Los Angeles), P1; SCHAEFER SA, 1988, J ZOOL, V214, P81, DOI 10.1111/j.1469-7998.1988.tb04988.x; SCHAEFER SA, 1990, P ACAD NAT SCI PHILA, V142, P167; Schaefer SA, 1997, P ACAD NAT SCI PHILA, V148, P1; Schaefer SA, 2003, AM MUS NOVIT, P1; SCHAEFER SA, 1991, ZOOL J LINN SOC-LOND, V102, P1, DOI 10.1111/j.1096-3642.1991.tb01535.x; Sereno PC, 2007, CLADISTICS, V23, P565, DOI 10.1111/j.1096-0031.2007.00161.x; Shelden F. F., 1937, Annals of the New York Academy of Sciences, V37, P1; Spix JBvon., COLLEGET PINGENDSO C; Sullivan JP, 2006, MOL PHYLOGENET EVOL, V41, P636, DOI 10.1016/j.ympev.2006.05.044; TAYLOR W R, 1985, Cybium, V9, P107; Teran Guillermo E., 2019, Neotropical Ichthyology, V17, P1; Thomas MR., 2011, THESIS SO ILLNOIS U; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Vari Richard P., 1998, P1; WILEY EO, 1979, SYST ZOOL, V28, P308	104	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0247747	10.1371/journal.pone.0247747	http://dx.doi.org/10.1371/journal.pone.0247747			77	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720930	Green Published, gold			2022-12-26	WOS:000629667400003
J	Han, LW; Shi, YY; Paquette, A; Wang, L; Bammler, TK; Mao, QC				Han, Lyrialle W.; Shi, Yuanyuan; Paquette, Alison; Wang, Lu; Bammler, Theo K.; Mao, Qingcheng			Key hepatic metabolic pathways are altered in germ-free mice during pregnancy	PLOS ONE			English	Article							GUT MICROBIOTA; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; GENE-EXPRESSION; ACID; GLUCOCORTICOIDS; LEUKOTOXIN; PATTERN; ENZYMES	Pregnancy is associated with metabolic changes to accommodate the mother and her growing fetus. The microbiome has been shown to modulate host metabolism of endogenous and exogenous substances. However, the combined effects of pregnancy and the microbiome on host metabolism have not been investigated. The objective of this study was to investigate how the microbiome affects overall hepatic metabolic processes during pregnancy. We assessed these changes within 4 groups of C57BL/6 mice: conventional non-pregnant, conventional pregnant, germ-free non-pregnant, and germ-free pregnant mice. We performed RNA-seq analysis on liver tissues and LC-MS/MS analysis of the plasma to assess the effects of pregnancy and the microbiome on hepatic transcriptome and untargeted plasma metabolome to describe metabolic changes as results of both pregnancy and lack of microbiome. By integrating transcriptomics and metabolomics data, we identified eight metabolic pathways that were significantly enriched for differentially expressed genes associated with pregnancy in both conventional and germ-free mice. Notably, of the eight pathways, 4 pathways (retinol metabolism, arachidonic acid metabolism, linoleic acid metabolism, and steroid hormone biosynthesis) which are all critical for normal pregnancy and fetal development were affected by the germ-free status in pregnant mice, but not at all in non-pregnant mice, indicating that the alterations in these four pathways caused by the lack of microbiome are unique for pregnancy. These results provide novel insight into the role of the microbiome in modulating host metabolic processes critical for maternal health and fetal development during pregnancy.	[Han, Lyrialle W.; Mao, Qingcheng] Univ Washington, Sch Pharm, Dept Pharmaceut, Seattle, WA 98195 USA; [Shi, Yuanyuan] Univ Washington, Sch Pharm, Dept Med Chem, Seattle, WA 98195 USA; [Paquette, Alison] Univ Washington, Ctr Dev Biol & Regenerat Med, Seattle Childrens Res Inst, Seattle, WA USA; [Paquette, Alison] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Wang, Lu; Bammler, Theo K.] Univ Washington, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Mao, QC (corresponding author), Univ Washington, Sch Pharm, Dept Pharmaceut, Seattle, WA 98195 USA.	qmao@uw.edu	; Shi, Yuanyuan/ADT-2062-2022	Wang, Lu/0000-0002-6515-1075; Mao, Qingcheng/0000-0002-0830-7627; Shi, Yuanyuan/0000-0003-1593-1767	Drug Metabolism, Transport and Pharmacogenomic Research Program (DMTPR) of the School of Pharmacy at the University of Washington; National Center for Advancing Translational Science of the National Institutes of Health [TL1TR000422]; National Institute of Environmental Health Sciences [P30ES007033]	Drug Metabolism, Transport and Pharmacogenomic Research Program (DMTPR) of the School of Pharmacy at the University of Washington; National Center for Advancing Translational Science of the National Institutes of Health; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Drug Metabolism, Transport and Pharmacogenomic Research Program (DMTPR) of the School of Pharmacy at the University of Washington (QM); the National Center for Advancing Translational Science of the National Institutes of Health under Grant [TL1TR000422] (LWH); and in part by the National Institute of Environmental Health Sciences under Grant [P30ES007033] (TKB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GD, 2005, CLIN PHARMACOKINET, V44, P989, DOI 10.2165/00003088-200544100-00001; Bobinski R, 2015, ACTA BIOCHIM POL, V62, P499, DOI 10.18388/abp.2015_1067; Borre YE, 2014, TRENDS MOL MED, V20, P509, DOI 10.1016/j.molmed.2014.05.002; Chambon Pierre, 1994, Seminars in Cell Biology, V5, P115, DOI 10.1006/scel.1994.1015; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Edwards PD, 2018, GEN COMP ENDOCR, V259, P122, DOI 10.1016/j.ygcen.2017.11.012; Edwards SM, 2017, MCN-AM J MATERN-CHIL, V42, P310, DOI 10.1097/NMC.0000000000000372; Geiger O, 2013, BBA-MOL CELL BIOL L, V1831, P503, DOI 10.1016/j.bbalip.2012.08.009; Gohir W, 2015, GUT MICROBES, V6, P310, DOI 10.1080/19490976.2015.1086056; Gu RH, 2019, J AGR FOOD CHEM, V67, P1585, DOI 10.1021/acs.jafc.8b04035; Han LW, 2020, DRUG METAB DISPOS, V48, P708, DOI 10.1124/dmd.120.000039; He Y, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0557-6; Isobe Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26325-4; Kallen CB, 2004, OBSTET GYN CLIN N AM, V31, P795, DOI 10.1016/j.ogc.2004.08.009; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; KOSAKA K, 1994, MOL CELL BIOCHEM, V139, P141, DOI 10.1007/BF01081737; Kostic AD, 2013, GENE DEV, V27, P701, DOI 10.1101/gad.212522.112; Lun ATL, 2016, METHODS MOL BIOL, V1418, P391, DOI 10.1007/978-1-4939-3578-9_19; Martinez KB, 2017, GUT MICROBES, V8, P130, DOI 10.1080/19490976.2016.1270811; Martinez-Morales F, 2003, MICROBIOL-SGM, V149, P3461, DOI 10.1099/mic.0.26522-0; McGowan PO, 2018, ENDOCRINOLOGY, V159, P69, DOI 10.1210/en.2017-00896; Mellon SH, 2007, PHARMACOL THERAPEUT, V116, P107, DOI 10.1016/j.pharmthera.2007.04.011; MorrissKay GM, 1996, FASEB J, V10, P961, DOI 10.1096/fasebj.10.9.8801178; Neuman H, 2017, NESTLE NUTR WORKS SE, V88, P1, DOI 10.1159/000455207; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nuriel-Ohayon M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01031; Oliver A, 2020, MBIO, V11, DOI 10.1128/mBio.01851-20; Renaud HJ, 2011, TOXICOL SCI, V124, P261, DOI 10.1093/toxsci/kfr240; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176; Sapin V, 2000, AM J CLIN NUTR, V71, P537; Shuster DL, 2013, DRUG METAB DISPOS, V41, P332, DOI 10.1124/dmd.112.049718; Sohlenkamp C, 2003, PROG LIPID RES, V42, P115, DOI 10.1016/S0163-7827(02)00050-4; Spanogiannopoulos P, 2016, NAT REV MICROBIOL, V14, P273, DOI 10.1038/nrmicro.2016.17; Szlapinski SK, 2021, CURR VASC PHARMACOL, V19, P141, DOI 10.2174/1570161118666200320111209; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wang H, 2004, MOL PHARMACOL, V65, P1148, DOI 10.1124/mol.65.5.1148; Wang Q, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0733-0; Xia J, 2011, CURR PROTOC BIOINFOR, DOI [10.1002/0471250953.bi1410s34, DOI 10.1002/0471250953.BI1410S34]; Zeng ZD, 2017, ANN NUTR METAB, V70, P59, DOI 10.1159/000459633; ZHANG WD, 1995, INT J LEGAL MED, V107, P174, DOI 10.1007/BF01428400	42	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0248351	10.1371/journal.pone.0248351	http://dx.doi.org/10.1371/journal.pone.0248351			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711049	Green Published, gold			2022-12-26	WOS:000629591800015
J	Singh, AR; Kumar, A; Shewade, HD; Dhingra, B				Singh, Akash Ranjan; Kumar, Amber; Shewade, Hemant Deepak; Dhingra, Bhavna			Poor adherence to TB diagnosis guidelines among under-five children with severe acute malnutrition in central India: A missed window of opportunity?	PLOS ONE			English	Article								Background In India, under-five children with Severe Acute Malnutrition (SAM) are referred to Nutritional Rehabilitation Centers (NRCs). NRCs screen the causes of SAM including tuberculosis (TB). The national TB programme recommends upfront testing with a rapid molecular test if TB is suspected in children. Objective We estimated the yield of and adherence to the TB diagnostic guidelines (clinical assessment and assessment for microbiological confirmation) among under-five children with SAM admitted at NRCs (six in district Sagar and four in district Sheopur) of Madhya Pradesh, India in 2017. We also explored the challenges in screening from the health care providers' perspective. Methods It was an explanatory mixed method study. The NRC records were reviewed This was followed by three key informant interviews and three focus group discussions among staff of NRC and TB programme. Manual descriptive thematic analysis was performed. Results Of 3230, a total of 2665(83%) children underwent Mantoux test, 2438(75%) underwent physical examination, 2277(70%) were asked about the symptoms suggestive of TB, 1220(38%) underwent chest radiograph and 485(15%) were asked for recent contact with TB. A total of 547(17%) underwent assessment for microbiological confirmation. Of 547, a total of 229 gastric aspirate specimens underwent rapid molecular test (24% positive) and 318 underwent sputum microscopy (44% positive). A total of 223 were diagnosed as TB (195 microbiologically and 28 clinically confirmed) and 209 were initiated on anti-TB treatment. The treatment outcome was favourable (cure or treatment completed) for 70(31%) and not recorded for 121(54%). The main perceived challenges in screening for TB were poor team skills, lack of diagnostic facilities and poor understanding of the guidelines due to inadequate training. Conclusion Though NRCs provided a unique window of opportunity for the screening and management of TB among under-five children with SAM, the utilization of this opportunity remained suboptimal.	[Singh, Akash Ranjan] Govt Med Coll, Shahdol, India; [Kumar, Amber; Dhingra, Bhavna] All India Inst Med Sci AIIMS, Bhopal, India; [Shewade, Hemant Deepak] Union South East Asia, New Delhi, India; [Shewade, Hemant Deepak] Int Union TB & Lung Dis Union, Paris, France	All India Institute of Medical Sciences (AIIMS) Bhopal	Dhingra, B (corresponding author), All India Inst Med Sci AIIMS, Bhopal, India.	bhavna.pediatrics@aiimsbhopal.edu.in		Shewade MBBS MD PhD, Hemant D/0000-0002-8242-1911; Dhingra, Bhavna/0000-0002-9606-5217; Kumar, Amber/0000-0003-3934-2158	National Health Mission, Government of Madhya Pradesh, India (Child) [Health-Nutrition/NHM/2017/25383]	National Health Mission, Government of Madhya Pradesh, India (Child)	This project was funded by National Health Mission, Government of Madhya Pradesh, India (Child Health-Nutrition/NHM/2017/25383).	Adejumo OA., 2016, J TROP PEDIAT, V62, P27, DOI [10.1093/TROPEJ, DOI 10.1093/TROPEJ]; Anil Kumar Jaiswal., 2018, INT J CONT PEDIAT, V5, P1497; [Anonymous], 2009, CODING MANUAL QUALIT; [Anonymous], 2017, ONA SYSTEMS MAKE DAT; Arya AK., 2017, INT J CONT MED RES, V4, P10896; Bhat PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084255; Chiang SS, 2015, INT J TUBERC LUNG D, V19, P1144, DOI 10.5588/ijtld.15.0178; Chiang SS, 2015, PAEDIATR INT CHILD H, V35, P29, DOI 10.1179/2046905514Y.0000000143; Chilld Health and Nutrition, CIRC GUID NUTR REH C; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Creswell J.W., 2007, DESIGNING CONDUCTING; De Maayer T, 2011, ARCH DIS CHILD, V96, P560, DOI 10.1136/adc.2010.205039; Delai MY, 2012, PUBLIC HEALTH ACTION, V2, P142, DOI 10.5588/pha.12.0064; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Frieze JB., 2017, BMC PUBLIC HEALTH, V17, P1, DOI [10.1186/s12889-016-3954-4, DOI 10.1186/S12889-016-3954-4]; Government of India International Institute for Population Sciences (IIPS) and ICF, 2022, NATL FAMILY HLTH SUR; Islam S, 2013, INT HEALTH, V5, P223, DOI 10.1093/inthealth/iht012; LaCourse SM, 2014, PEDIATR INFECT DIS J, V33, P1200, DOI 10.1097/INF.0000000000000384; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308; Marais BJ, 2017, INT J INFECT DIS, V56, P122, DOI 10.1016/j.ijid.2016.12.015; Marais BJ, 2004, PEDIATR ANN, V33, P695, DOI 10.3928/0090-4481-20041001-13; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Marais BJ., BURDEN CHILDHOOD TUB; Meintjes G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-72; Ministry of Women and Child Development, 2017, INT CHILD DEV SERV S; Narang P, 2005, INT J TUBERC LUNG D, V9, P188; National Rural Health Mission(NRHM) , 2011, OP GUID FAC BAS MAN, P35; National Rural Health Mission(NRHM), 2011, OP GUID FAC BAS MAN; Natrajan E., 2019, INT J SCI RES, V8, P19; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Padmapriyadarsini C, 2016, INDIAN J MED RES, V143, P11, DOI 10.4103/0971-5916.193278; Pandey R., 2018, GLOB J RES ANAL, V7, P1; Pandey R., 2018, INT ARCH BIOMED CLIN, V4, P80, DOI [10.21276/IABCR.2018.4.4.23, DOI 10.21276/IABCR.2018.4.4.23]; Pantha S., FACILITATORS BARRIER, DOI [10.21203/rs.3.rs-39360/v1, DOI 10.21203/RS.3.RS-39360/V1]; Pulmonary ZimmermanM., 1979, B NY ACAD MED, V55, P604; Raftery P., 2020, BMC HEALTH SERV RES, V20, P2; Revised National TB Control Programme (RNTCP), 2019, PED IA RNTCP UPD PED; Revised National Tuberculosis Control Programme Central TB Division, GUID PROGR MAN DRUG, P23; Satpathy DM., 2019, INDIAN J RES, V8, P223; Shanthi M., 2018, INT J CONT PEDIAT, V5, P1928; Shrivastav PS., 2015, J MED SCI CLIN RES, V03, P7970; Singh S, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0528-z; Starke JR., 2016, HDB CHILD ADOLESCENT; Sullivan BJ, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1290317; Sunguya B., 2010, DAR SALAAM MED STUDE, V14, P27, DOI [10.4314/dmsj.v14i1.51189, DOI 10.4314/DMSJ.V14I1.51189]; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Uwimana J, 2012, TROP MED INT HEALTH, V17, P488, DOI 10.1111/j.1365-3156.2011.02951.x; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wu SS, 2017, INT J INFECT DIS, V56, P105, DOI 10.1016/j.ijid.2016.11.421	52	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0248192	10.1371/journal.pone.0248192	http://dx.doi.org/10.1371/journal.pone.0248192			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711040	Green Published, gold			2022-12-26	WOS:000629591800012
J	Uysal, D; Kowalewski, KF; Kriegmair, MC; Wirtz, R; Popovic, ZV; Erben, P				Uysal, Daniel; Kowalewski, Karl-Friedrich; Kriegmair, Maximilian Christian; Wirtz, Ralph; Popovic, Zoran, V; Erben, Philipp			A comprehensive molecular characterization of the 8q22.2 region reveals the prognostic relevance of OSR2 mRNA in muscle invasive bladder cancer	PLOS ONE			English	Article								Technological advances in molecular profiling have enabled the comprehensive identification of common regions of gene amplification on chromosomes (amplicons) in muscle invasive bladder cancer (MIBC). One such region is 8q22.2, which is largely unexplored in MIBC and could harbor genes with potential for outcome prediction or targeted therapy. To investigate the prognostic role of 8q22.2 and to compare different amplicon definitions, an in-silico analysis of 357 patients from The Cancer Genome Atlas, who underwent radical cystectomy for MIBC, was performed. Amplicons were generated using the GISTIC2.0 algorithm for copy number alterations (DNA_Amplicon) and z-score normalization for mRNA gene overexpression (RNA_Amplicon). Kaplan-Meier survival analysis, univariable, and multivariable Cox proportional hazard ratios were used to relate amplicons, genes, and clinical parameters to overall (OS) and disease-free survival (DFS). Analyses of the biological functions of 8q22.2 genes and genomic events in MIBC were performed to identify potential targets. Genes with prognostic significance from the in silico analysis were validated using RT-qPCR of MIBC tumor samples (n = 46). High 8q22.2 mRNA expression (RNA-AMP) was associated with lymph node metastases. Furthermore, 8q22.2 DNA and RNA amplified patients were more likely to show a luminal subtype (DNA_Amplicon_core: p = 0.029; RNA_Amplicon_core: p = 0.01). Overexpression of the 8q22.2 gene OSR2 predicted shortened DFS in univariable (HR [CI] 1.97 [1.2; 3.22]; p = 0.01) and multivariable in silico analysis (HR [CI] 1.91 [1.15; 3.16]; p = 0.01) and decreased OS (HR [CI] 6.25 [1.37; 28.38]; p = 0.0177) in RT-qPCR data analysis. Alterations in different levels of the 8q22.2 region are associated with manifestation of different clinical characteristics in MIBC. An in-depth comprehensive molecular characterization of genomic regions involved in cancer should include multiple genetic levels, such as DNA copy number alterations and mRNA gene expression, and could lead to a better molecular understanding. In this study, OSR2 is identified as a potential biomarker for survival prognosis.	[Uysal, Daniel; Kowalewski, Karl-Friedrich; Kriegmair, Maximilian Christian; Erben, Philipp] Heidelberg Univ, Med Fac Mannheim, Dept Urol & Urosurg, Mannheim, Germany; [Wirtz, Ralph] STRATIFYER Mol Pathol GmbH, Cologne, Germany; [Popovic, Zoran, V] Heidelberg Univ, Med Fac Mannheim, Inst Pathol, Mannheim, Germany	Ruprecht Karls University Heidelberg; Stratifyer Molecular Pathology GmbH; Ruprecht Karls University Heidelberg	Erben, P (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Urol & Urosurg, Mannheim, Germany.	philipp.erben@medma-uni.heidelberg.de		Kowalewski, Karl-Friedrich/0000-0003-2931-6247				Audenet F, 2018, UROL ONCOL-SEMIN ORI, V36, P313, DOI 10.1016/j.urolonc.2018.02.017; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Breyer J, 2017, UROL INT, V98, P282, DOI 10.1159/000453670; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheng H, 2018, CELL REP, V25, P1332, DOI 10.1016/j.celrep.2018.10.007; Consortium TU., Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099 27899622; Deshpande V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08200-y; Eckstein M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113396; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goldman MJ, 2020, NAT BIOTECHNOL, V38, P675, DOI 10.1038/s41587-020-0546-8; Heidenblad M, 2005, ONCOGENE, V24, P1794, DOI 10.1038/sj.onc.1208383; Heidenblad M, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-3; Hongisto V, 2014, GENOM DATA, V2, P249, DOI 10.1016/j.gdata.2014.06.025; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Hurst CD, 2012, CLIN CANCER RES, V18, P5865, DOI 10.1158/1078-0432.CCR-12-1807; Hyman E, 2002, CANCER RES, V62, P6240; Jones RA, 2019, GENE CHROMOSOME CANC, V58, P381, DOI 10.1002/gcc.22729; Kim YH, 2006, ONCOGENE, V25, P130, DOI 10.1038/sj.onc.1208997; Knowles MA, 1999, BJU INT, V84, P412; Knowles MA, 2015, NAT REV CANCER, V15, P25, DOI 10.1038/nrc3817; Kostareli E, 2013, J CLIN INVEST, V123, P2488, DOI 10.1172/JCI67010; Kriegmair MC, 2016, ANTICANCER RES, V36, P5205, DOI 10.21873/anticanres.11091; Kuchta K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31752-4; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li WH., 2016, DIS MARKERS, V2016; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Lindquist KJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187975; Luo JQ, 2017, J MOL DIAGN, V19, P147, DOI 10.1016/j.jmoldx.2016.09.007; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Myllykangas S, 2006, CANCER LETT, V232, P79, DOI 10.1016/j.canlet.2005.07.045; Newcombe PJ, 2018, INT J EPIDEMIOL, V47, P597, DOI 10.1093/ije/dyx224; Patel AS, 2000, CURR OPIN ONCOL, V12, P62, DOI 10.1097/00001622-200001000-00011; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Riester M, 2014, CLIN CANCER RES, V20, P1873, DOI 10.1158/1078-0432.CCR-13-0759; Robertson AG, 2018, CELL, V174, P1033, DOI 10.1016/j.cell.2018.07.036; Sahlberg KK, 2013, MOL ONCOL, V7, P392, DOI 10.1016/j.molonc.2012.10.012; Savelyeva L, 2001, CANCER LETT, V167, P115, DOI 10.1016/S0304-3835(01)00472-4; Schwab M, 1999, SEMIN CANCER BIOL, V9, P319, DOI 10.1006/scbi.1999.0126; Siegel R. L., CA-CANCER J CLIN, V69, P7; Sikic D, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040994; Tamilzhalagan S, 2017, MOL CARCINOGEN, V56, P1239, DOI 10.1002/mc.22586; Tokar Tomas, 2018, Oncotarget, V9, P9137, DOI 10.18632/oncotarget.24070; Tyybakinoja A, 2006, GENE CHROMOSOME CANC, V45, P257, DOI 10.1002/gcc.20288; Veltman JA, 2003, CANCER RES, V63, P2872; Wahby S, 2021, TRANSL ONCOL, V14, DOI 10.1016/j.tranon.2020.100900; Wan TSK, 2017, METHODS MOL BIOL, V1541, P1, DOI 10.1007/978-1-4939-6703-2_1; Witjes JA, 2017, EUR UROL, V71, P462, DOI 10.1016/j.eururo.2016.06.020; Zhang CL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.285	49	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0248342	10.1371/journal.pone.0248342	http://dx.doi.org/10.1371/journal.pone.0248342			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711044	Green Published, gold			2022-12-26	WOS:000629591800052
J	Cortese, IJ; Castrillo, ML; Onetto, AL; Bich, GA; Zapata, PD; Laczeski, ME				Julieta Cortese, Iliana; Lorena Castrillo, Maria; Liliana Onetto, Andrea; Angel Bich, Gustavo; Dario Zapata, Pedro; Ester Laczeski, Margarita			De novo genome assembly of Bacillus altitudinis 19RS3 and Bacillus altitudinis T5S-T4, two plant growth-promoting bacteria isolated from Ilex paraguariensis St. Hil. (yerba mate)	PLOS ONE			English	Article								Plant growth-promoting bacteria (PGPB) are a heterogeneous group of bacteria that can exert beneficial effects on plant growth directly or indirectly by different mechanisms. PGPB-based inoculant formulation has been used to replace chemical fertilizers and pesticides. In our previous studies, two endophytic endospore-forming bacteria identified as Bacillus altitudinis were isolated from roots of Ilex paraguariensis St. Hil. seedlings and selected for their plant growth-promoting (PGP) properties shown in vitro and in vivo. The purposes of this work were to assemble the genomes of B. altitudinis 19RS3 and T5S-T4, using different assemblers available for Windows and Linux and to select the best assembly for each strain. Both genomes were also automatically annotated to detect PGP genes and compare sequences with other genomes reported. Library construction and draft genome sequencing were performed by Macrogen services. Raw reads were filtered using the Trimmomatic tool. Genomes were assembled using SPAdes, ABySS, Velvet, and SOAPdenovo2 assemblers for Linux, and Geneious and CLC Genomics Workbench assemblers for Windows. Assembly evaluation was done by the QUAST tool. The parameters evaluated were the number of contigs >= 500 bp and >= 1000 bp, the length of the longest contig, and the N50 value. For genome annotation PROKKA, RAST, and KAAS tools were used. The best assembly for both genomes was obtained using Velvet. The B. altitudinis 19RS3 genome was assembled into 15 contigs with an N50 value of 1,943,801 bp. The B. altitudinis T5S-T4 genome was assembled into 24 contigs with an N50 of 344,151 bp. Both genomes comprise several genes related to PGP mechanisms, such as those for nitrogen fixation, iron metabolism, phosphate metabolism, and auxin biosynthesis. The results obtained offer the basis for a better understanding of B. altitudinis 19RS3 and T5S-T4 and make them promissory for bioinoculant development.	[Julieta Cortese, Iliana; Lorena Castrillo, Maria; Liliana Onetto, Andrea; Angel Bich, Gustavo; Dario Zapata, Pedro; Ester Laczeski, Margarita] Univ Nacl Misiones UNaM, Fac Ciencias Exactas Quim & Nat FCEQyN, Inst Biotecnol Misiones Dra Maria Ebe Reca InBioM, CONICET,Lab Biotecnol Mol, Posadas, Misiones, Argentina; [Ester Laczeski, Margarita] Univ Nacl Misiones UNaM, Fac Ciencias Exactas Quim & Nat FCEQyN, Dept Microbiol, Catedra Bacteriol, Posadas, Misiones, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Cortese, IJ; Laczeski, ME (corresponding author), Univ Nacl Misiones UNaM, Fac Ciencias Exactas Quim & Nat FCEQyN, Inst Biotecnol Misiones Dra Maria Ebe Reca InBioM, CONICET,Lab Biotecnol Mol, Posadas, Misiones, Argentina.; Laczeski, ME (corresponding author), Univ Nacl Misiones UNaM, Fac Ciencias Exactas Quim & Nat FCEQyN, Dept Microbiol, Catedra Bacteriol, Posadas, Misiones, Argentina.	cortesejulieta@gmail.com; mlaczeski@gmail.com	Castrillo, Maria Lorena/AFV-6409-2022; Zapata, Pedro Dario/GWR-1075-2022; Bich, Gustavo/AFS-1761-2022	Zapata, Pedro Dario/0000-0001-6476-8324; Bich, Gustavo/0000-0002-3658-5157; Onetto, Andrea/0000-0002-1988-2790; Laczeski, Margarita Ester/0000-0002-8303-7874	Proyecto del Instituto Nacional de la Yerba Mate (INYM, Argentina) "Biofertilizantes: validacion a campo y estudios de trazabilidad de la utilizacion de Bacillus sp. como fertilizante para yerba mate" [274/17]	Proyecto del Instituto Nacional de la Yerba Mate (INYM, Argentina) "Biofertilizantes: validacion a campo y estudios de trazabilidad de la utilizacion de Bacillus sp. como fertilizante para yerba mate"	This study was supported by Proyecto del Instituto Nacional de la Yerba Mate (INYM, Argentina) "Biofertilizantes: validacion a campo y estudios de trazabilidad de la utilizacion de Bacillus sp. como fertilizante para yerba mate" Res. no 274/17 (INYM - PRASY) granted to ML.	Al-okaily AA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2515-7; Alexander A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222405; Alonso J., 2005, PLANTAS MED, V1st, P614; Andrews S., 2010, FASTQC QUALITY CONTR; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BASHAN Y, 1990, CAN J MICROBIOL, V36, P591, DOI 10.1139/m90-105; BERGOTTINI VM, 2013, 5 SWISS MICR EC M SM, P64; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cariaga Martinez AE, 2007, LAB BIOL MOL, Vampliada, P23; Catarina LEAL, 2020, GENOME SEQUENCE ANAL; Chakraborty A. P., 2015, Indian Phytopathology, V68, P237; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Choudhary DK, 2009, MICROBIOL RES, V164, P493, DOI 10.1016/j.micres.2008.08.007; Cortese IJ., 2021, ACTA BIOL COLOMB; Dertz EA, 2006, J AM CHEM SOC, V128, P22, DOI 10.1021/ja055898c; Dutta J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182302; Franco-Sierra ND, 2020, FUNCT INTEGR GENOMIC, V20, P575, DOI 10.1007/s10142-020-00736-x; Garkovenko AV, 2020, MICROBIOL RESOUR ANN, V9, DOI 10.1128/MRA.00450-20; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hafeez FY, 2006, AGRON SUSTAIN DEV, V26, P143, DOI 10.1051/agro:2006007; Han HS, 2006, PLANT SOIL ENVIRON, V52, P130, DOI 10.17221/3356-PSE; Hollensteiner J, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00085-17; INYM-INSTITUTO NACIONAL DE LA YERBA MATE, 2019, REL AER PLANT; Kashyap BK, 2019, PLANT HLTH BIOTIC ST, P219, DOI [10.1007/978-981-13-6040-4_11, DOI 10.1007/978-981-13-6040-4_11]; Kaymak HC., 2008, AFR J BIOTECHNOL, V7; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kenneth O.C., 2019, AM J AGRIC BIOL SCI, V14, P35, DOI [10.3844/ajabssp.2019.35.54, DOI 10.3844/AJABSSP.2019.35.54]; Khan AR, 2018, EVOL BIOINFORM, V14, DOI 10.1177/1176934318758650; Knudsen B, 2007, CLC MAIN WORKBENCH V; Kremer FS, 2017, GENET MOL BIOL, V40, P553, DOI [10.1590/1678-4685-GMB-2016-0230, 10.1590/1678-4685-gmb-2016-0230]; Kuan KB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152478; Kumar A, 2019, BIOCATAL AGR BIOTECH, V20, DOI 10.1016/j.bcab.2019.101271; Kumaravel S, 2018, GENOME ANNOUNCEMENTS, V6, DOI 10.1128/genomeA.00019-18; Laczeski ME, 2020, AN ACAD BRAS CIENC, V92, DOI 10.1590/0001-3765202020181381; Li ZY, 2012, BRIEF FUNCT GENOMICS, V11, P25, DOI 10.1093/bfgp/elr035; Liao YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08747; Liu BH, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2829-5; Liu XY, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.01305-17, 10.1128/genomea.01305-17]; Lu XX, 2017, PLANT SOIL, V416, P53, DOI 10.1007/s11104-017-3195-z; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; MARGALOT JA, 1994, GEOGRAFIA MISIONES, P110; Gamez RM, 2020, MICROB ECOL, V80, P656, DOI 10.1007/s00248-020-01571-0; Martinez-Raudales I, 2017, STAND GENOMIC SCI, V12, DOI 10.1186/s40793-017-0289-4; Medvedev P, 2011, J COMPUT BIOL, V18, P1625, DOI 10.1089/cmb.2011.0151; Mendis HC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193119; Mikheenko A, 2018, BIOINFORMATICS, V34, P142, DOI 10.1093/bioinformatics/bty266; Miller SH, 2010, ENV MICROBIOL REP, V2, P403, DOI 10.1111/j.1758-2229.2009.00105.x; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mosimann C, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02150; Nazari M, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00916; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Orhan E, 2006, SCI HORTIC-AMSTERDAM, V111, P38, DOI 10.1016/j.scienta.2006.09.002; Reddy TBK, 2015, NUCLEIC ACIDS RES, V43, pD1099, DOI 10.1093/nar/gku950; Reva ON, 2020, APPL MICROBIOL BIOT, V104, P7643, DOI 10.1007/s00253-020-10767-w; Sambrook J., 2001, MOL CLONING LAB MANU; Schmid M, 2018, NUCLEIC ACIDS RES, V46, P8953, DOI 10.1093/nar/gky726; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Singh RP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155026; Sivasakthi S., 2014, African Journal of Agricultural Research, V9, P1265; Supanjani, 2006, AGRON SUSTAIN DEV, V26, P233, DOI 10.1051/agro:2006020; THIMON L, 1992, BIOTECHNOL APPL BIOC, V16, P144; VANITTANAKOM N, 1986, J ANTIBIOT, V39, P888, DOI 10.7164/antibiotics.39.888; Wang JR, 2019, J MICROBIOL BIOTECHN, V29, P794, DOI 10.4014/jmb.1901.01040; Wang TT, 2017, J BIOTECHNOL, V260, P38, DOI 10.1016/j.jbiotec.2017.09.001; Wemheuer F, 2018, GENOME ANNOUNCEMENTS, V6, DOI [10.1128/genomeA.00011-18, 10.1128/genomea.00011-18]; Xiang N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181201; Xiong YW, 2020, ECOTOX ENVIRON SAFE, V194, DOI 10.1016/j.ecoenv.2020.110374; Yadav AN., 2017, INT J ENV SCI NAT RE, V3, P1, DOI [10.19080/IJESNR.2017.03.555601, DOI 10.19080/IJESNR.2017.03.555601]; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhu ZY, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00703	72	1	1	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248274	10.1371/journal.pone.0248274	http://dx.doi.org/10.1371/journal.pone.0248274			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705487	Green Published, gold			2022-12-26	WOS:000629590400014
J	Masciantonio, A; Bourguignon, D; Bouchat, P; Balty, M; Rime, B				Masciantonio, Alexandra; Bourguignon, David; Bouchat, Pierre; Balty, Manon; Rime, Bernard			Don't put all social network sites in one basket: Facebook, Instagram, Twitter, TikTok, and their relations with well-being during the COVID-19 pandemic	PLOS ONE			English	Article							SELF-ESTEEM; MEDIA; SATISFACTION; HEALTH	Prior studies indicated that actively using social network sites (SNSs) is positively associated with well-being by enhancing social support and feelings of connectedness. Conversely, passively using SNSs is negatively associated with well-being by fostering upward social comparison and envy. However, the majority of these studies has focused on Facebook. The present research examined the relationships between well-being-satisfaction with life, negative affect, positive affect-and using actively or passively various SNSs-Facebook, Instagram, Twitter, TikTok-during the COVID-19 pandemic. In addition, two mediators were tested: social support and upward social comparison. One thousand four persons completed an online survey during the quarantine measures; the analyses employed structural equation modeling. Results showed that passive usage of Facebook is negatively related to well-being through upward social comparison, whereas active usage of Instagram is positively related to satisfaction with life and negative affect through social support. Furthermore, active usage of Twitter was positively related to satisfaction with life through social support; while passive usage was negatively related to upward social comparison, which, in turn, was associated with more negative affect. Finally, TikTok use was not associated with well-being. Results are discussed in line with SNSs' architectures and users' motivations. Future research is required to go beyond methodological and statistical limitations and allow generalization. This study concludes that SNSs must be differentiated to truly understand how they shape human interactions.	[Masciantonio, Alexandra; Bourguignon, David; Bouchat, Pierre; Balty, Manon] Univ Lorraine, Dept Psychol, Metz, France; [Rime, Bernard] Catholic Univ Louvain, Dept Psychol, Louvain La Neuve, Belgium	Universite de Lorraine; Universite Catholique Louvain	Masciantonio, A (corresponding author), Univ Lorraine, Dept Psychol, Metz, France.	Alexandra.masciantonio@univ-lorraine.fr	MASCIANTONIO, Alexandra/GSO-3370-2022	MASCIANTONIO, Alexandra/0000-0001-5550-4976; david, Bourguignon/0000-0001-5428-422X; Bouchat, Pierre/0000-0002-6639-6453				Altena E, 2020, J SLEEP RES, V29, DOI 10.1111/jsr.13052; Apaolaza V, 2013, COMPUT HUM BEHAV, V29, P1282, DOI 10.1016/j.chb.2013.01.002; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Bossetta M, 2018, J MASS COMMUN Q, V95, P471, DOI 10.1177/1077699018763307; Brunot S, 2012, ANN PSYCHOL, V112, P197; Burke M, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1909; Casey N., 2020, VERGE 0313, DOI [1176880/covid-19-quarantine-social-distancing-isolation-loneliness-zoom-fortnite, DOI 1176880/COVID-19-QUARANTINE-SOCIAL-DISTANCING-ISOLATION-LONELINESS-ZOOM-FORTNITE]; Chae J, 2018, TELEMAT INFORM, V35, P1656, DOI 10.1016/j.tele.2018.04.011; Chamberlain J., 2020, CONVERSATION 0512; Cheung CMK, 2011, COMPUT HUM BEHAV, V27, P1337, DOI 10.1016/j.chb.2010.07.028; Clement, 2020, DISTRIBUTION INSTAGR; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 2017, CAN PSYCHOL, V58, P87, DOI 10.1037/cap0000063; Ellison N.B., 2013, OXFORD HDB INTERNET, P151, DOI DOI 10.1093/OXFORDHB/9780199589074.013.0008; Fredrickson B., 2009, POSITIVITY; Gana K., 2018, INTRO MODELISATION E; Gaudreau P, 2006, EUR J PSYCHOL ASSESS, V22, P240, DOI 10.1027/1015-5759.22.4.240; Gerson J, 2017, PERS INDIV DIFFER, V117, P81, DOI 10.1016/j.paid.2017.05.034; Haslam SA, 2009, APPL PSYCHOL-INT REV, V58, P1, DOI 10.1111/j.1464-0597.2008.00379.x; IJzerman H, 2020, PSYARXIV; JASP Team, 2022, JASP VERS 0 16 2; Johnson PR, 2009, COMMUNICATION TECHNO; Kim J, 2011, CYBERPSYCH BEH SOC N, V14, P359, DOI 10.1089/cyber.2010.0374; Lin LY, 2016, DEPRESS ANXIETY, V33, P323, DOI 10.1002/da.22466; Mohsin M., 2020, OBERLO FEB; Nadkarni A, 2012, PERS INDIV DIFFER, V52, P243, DOI 10.1016/j.paid.2011.11.007; Naveed N., 2011, P 3 INT WEB SCI C, P1, DOI [DOI 10.1145/2527031.2527052, 10.1145/ 2527031.2527052]; Nick EA, 2018, PSYCHOL ASSESSMENT, V30, P1127, DOI 10.1037/pas0000558; Omar Bahiyah, 2020, International Journal of Interactive Mobile Technologies, V14, P121, DOI 10.3991/ijim.v14i04.12429; Park CS, 2013, COMPUT HUM BEHAV, V29, P1641, DOI 10.1016/j.chb.2013.01.044; Pittman M, 2016, COMPUT HUM BEHAV, V62, P155, DOI 10.1016/j.chb.2016.03.084; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Rime B, 2020, CURR OPIN PSYCHOL, V31, P127, DOI 10.1016/j.copsyc.2019.08.024; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Sagioglou C, 2014, COMPUT HUM BEHAV, V35, P359, DOI 10.1016/j.chb.2014.03.003; Shaw AM, 2015, COMPUT HUM BEHAV, V48, P575, DOI 10.1016/j.chb.2015.02.003; Sheldon P, 2016, COMPUT HUM BEHAV, V58, P89, DOI 10.1016/j.chb.2015.12.059; Tandoc EC, 2015, COMPUT HUM BEHAV, V43, P139, DOI 10.1016/j.chb.2014.10.053; Thelwall M, 2011, J AM SOC INF SCI TEC, V62, P406, DOI 10.1002/asi.21462; Trepte S, 2017, ROUTLEDGE HANDBOOK OF MEDIA USE AND WELL-BEING: INTERNATIONAL PERSPECTIVES ON THEORY AND RESEARCH ON POSITIVE MEDIA EFFECTS, P304; Valenzuela S, 2009, J COMPUT-MEDIAT COMM, V14, P875, DOI 10.1111/j.1083-6101.2009.01474.x; Verduyn P, 2017, SOC ISS POLICY REV, V11, P274, DOI 10.1111/sipr.12033; Verduyn P, 2015, J EXP PSYCHOL GEN, V144, P480, DOI 10.1037/xge0000057; Waterloo SF, 2018, NEW MEDIA SOC, V20, P1813, DOI 10.1177/1461444817707349; Yuanyuan Shi, 2013, Online Communities and Social Computing. 5th International Conference, OCSC 2013 Held as Part of HCI International 2013. Proceedings. LNCS 8029, P94, DOI 10.1007/978-3-642-39371-6_11	45	19	19	21	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248384	10.1371/journal.pone.0248384	http://dx.doi.org/10.1371/journal.pone.0248384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8JZ	33705462	Green Published, gold			2022-12-26	WOS:000629590400051
J	Yeo, AT; Jun, HJ; Appleman, VA; Zhang, PY; Varma, H; Sarkaria, JN; Charest, A				Yeo, Alan T.; Jun, Hyun Jung; Appleman, Vicky A.; Zhang, Piyan; Varma, Hemant; Sarkaria, Jann N.; Charest, Al			EGFRvIII tumorigenicity requires PDGFRA co-signaling and reveals therapeutic vulnerabilities in glioblastoma	ONCOGENE			English	Article								Focal amplification of epidermal growth factor receptor (EGFR) and its ligand-independent, constitutively active EGFRvIII mutant form are prominent oncogenic drivers in glioblastoma (GBM). The EGFRvIII gene rearrangement is considered to be an initiating event in the etiology of GBM, however, the mechanistic details of how EGFRvIII drives cellular transformation and tumor maintenance remain unclear. Here, we report that EGFRvIII demonstrates a reliance on PDGFRA co-stimulatory signaling during the tumorigenic process in a genetically engineered autochthonous GBM model. This dependency exposes liabilities that were leveraged using kinase inhibitors treatments in EGFRvIII-expressing GBM patient-derived xenografts (PDXs), where simultaneous pharmacological inhibition of EGFRvIII and PDGFRA kinase activities is necessary for anti-tumor efficacy. Our work establishes that EGFRvIII-positive tumors have unexplored vulnerabilities to targeted agents concomitant to the EGFR kinase inhibitor repertoire.	[Yeo, Alan T.; Jun, Hyun Jung; Appleman, Vicky A.; Zhang, Piyan; Charest, Al] Harvard Med Sch, Beth Israel Deaconess Med, Dept Med, Boston, MA 02115 USA; [Yeo, Alan T.] Tufts Univ, Sch Med, Sackler Sch Grad Studies, Boston, MA 02111 USA; [Varma, Hemant] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; [Sarkaria, Jann N.] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA; [Charest, Al] Beth Israel Deaconess Med Ctr, Canc Res Inst, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Tufts University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Mayo Clinic; Harvard University; Beth Israel Deaconess Medical Center	Charest, A (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med, Dept Med, Boston, MA 02115 USA.; Charest, A (corresponding author), Beth Israel Deaconess Med Ctr, Canc Res Inst, Boston, MA 02215 USA.	acharest@bidmc.harvard.edu			NIH [R01 CA229784, R21 CA245337]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants R01 CA229784 and R21 CA245337 to AC and by internal funding to the Mayo Clinic GBM PDX National Resource to JNS.	Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bedard PL, 2015, CLIN CANCER RES, V21, P730, DOI 10.1158/1078-0432.CCR-14-1814; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Brown AP, 2007, CANCER CHEMOTH PHARM, V59, P671, DOI 10.1007/s00280-006-0323-5; Chakravarty D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08940-9; Chen PH, 2013, BBA-PROTEINS PROTEOM, V1834, P2176, DOI 10.1016/j.bbapap.2012.10.015; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Darmanis S, 2017, CELL REP, V21, P1399, DOI 10.1016/j.celrep.2017.10.030; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; deCarvalho AC, 2018, NAT GENET, V50, P708, DOI 10.1038/s41588-018-0105-0; Ebbesen SH, 2016, P NATL ACAD SCI USA, V113, P3030, DOI 10.1073/pnas.1523693113; Fan QW, 2013, CANCER CELL, V24, P438, DOI 10.1016/j.ccr.2013.09.004; Felsberg J, 2017, CLIN CANCER RES, V23, P6846, DOI 10.1158/1078-0432.CCR-17-0890; Fernandes H, 2001, J BIOL CHEM, V276, P5375, DOI 10.1074/jbc.M005599200; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Francis JM, 2014, CANCER DISCOV, V4, P956, DOI 10.1158/2159-8290.CD-13-0879; Gajadhar AS, 2012, MOL CANCER RES, V10, P428, DOI 10.1158/1541-7786.MCR-11-0531; Gan HK, 2013, FEBS J, V280, P5350, DOI 10.1111/febs.12393; Garnett J, 2013, NEOPLASIA, V15, P73, DOI 10.1593/neo.121536; Greenall SA, 2015, ONCOGENE, V34, P5277, DOI 10.1038/onc.2014.448; Grilley-Olson JE, 2016, INVEST NEW DRUG, V34, P740, DOI 10.1007/s10637-016-0377-0; Gu JG, 1998, J CELL BIOL, V143, P1375, DOI 10.1083/jcb.143.5.1375; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Hwang Y, 2011, MOL CANCER RES, V9, P1199, DOI 10.1158/1541-7786.MCR-11-0229; Jun HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05036-4; Kancha RK, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-39; Kastenhuber ER, 2014, ACTA NEUROPATHOL, V127, P747, DOI 10.1007/s00401-013-1217-3; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Luwor RB, 2004, ONCOGENE, V23, P6095, DOI 10.1038/sj.onc.1207870; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McNeill RS, 2017, NEURO-ONCOLOGY, V19, P1469, DOI 10.1093/neuonc/nox044; Meyer M, 2015, P NATL ACAD SCI USA, V112, P851, DOI 10.1073/pnas.1320611111; Montano N, 2011, NEOPLASIA, V13, P1113, DOI 10.1593/neo.111338; Nathanson DA, 2014, SCIENCE, V343, P72, DOI 10.1126/science.1241328; Nishikawa Ryo, 2004, Brain Tumor Pathol, V21, P53, DOI 10.1007/BF02484510; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Paul MD, 2019, CHEM REV, V119, P5881, DOI 10.1021/acs.chemrev.8b00467; Reardon DA, 2014, NEURO-ONCOLOGY, V16, pviii7, DOI 10.1093/neuonc/nou232; Roskoski R, 2019, PHARMACOL RES, V139, P395, DOI 10.1016/j.phrs.2018.11.014; Roskoski R, 2018, PHARMACOL RES, V129, P65, DOI 10.1016/j.phrs.2018.01.021; Rutkowska A, 2019, J ONCOL, V2019, DOI 10.1155/2019/1092587; Sarkaria JN, 2007, MOL CANCER THER, V6, P1167, DOI 10.1158/1535-7163.MCT-06-0691; Sarkaria JN, 2006, CLIN CANCER RES, V12, P2264, DOI 10.1158/1078-0432.CCR-05-2510; Schram AM, 2018, BRIT J CANCER, V119, P1471, DOI 10.1038/s41416-018-0322-4; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Shinojima N, 2003, CANCER RES, V63, P6962; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Stec W., 2018, ONCOTARGET, V9, P8560, DOI [DOI 10.18632/ONCOTARGET.24058, 10.18632/oncotarget.24058]; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Tolcher AW, 2015, CANCER CHEMOTH PHARM, V75, P183, DOI 10.1007/s00280-014-2615-5; Turner KM, 2017, NATURE, V543, P122, DOI 10.1038/nature21356; van den Bent MJ, 2015, NEURO-ONCOLOGY, V17, P935, DOI 10.1093/neuonc/nov013; Vaubel RA, 2020, CLIN CANCER RES, V26, P1094, DOI 10.1158/1078-0432.CCR-19-0909; Verhaak RGW, 2019, NAT REV CANCER, V19, P283, DOI 10.1038/s41568-019-0128-6; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wainberg ZA, 2017, TARGET ONCOL, V12, P775, DOI 10.1007/s11523-017-0530-5; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; Weng LP, 2002, HUM MOL GENET, V11, P1687, DOI 10.1093/hmg/11.15.1687; Weng LP, 2001, HUM MOL GENET, V10, P605, DOI 10.1093/hmg/10.6.605; Xing YM, 2015, DEV BIOL, V408, P56, DOI 10.1016/j.ydbio.2015.10.002; Ymer Susie I, 2011, Cancers (Basel), V3, P2032, DOI 10.3390/cancers3022032; Zhou S, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800029; Zhu H, 2009, P NATL ACAD SCI USA, V106, P2712, DOI 10.1073/pnas.0813314106	67	3	3	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 15	2021	40	15					2682	2696		10.1038/s41388-021-01721-9	http://dx.doi.org/10.1038/s41388-021-01721-9		MAR 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RN8NW	33707748	Green Accepted			2022-12-26	WOS:000627660400002
J	Grad, I; Hanes, R; Ayuda-Duran, P; Kuijjer, ML; Enserink, JM; Meza-Zepeda, LA; Myklebost, O				Grad, Iwona; Hanes, Robert; Ayuda-Duran, Pilar; Kuijjer, Marieke Lydia; Enserink, Jorrit M.; Meza-Zepeda, Leonardo A.; Myklebost, Ola			Discovery of novel candidates for anti-liposarcoma therapies by medium-scale high-throughput drug screening	PLOS ONE			English	Article							INVESTIGATIONAL PROTEASOME INHIBITOR; LYMPHOBLASTIC-LEUKEMIA CELLS; PHASE-I; ANTITUMOR-ACTIVITY; TRIPTOLIDE; APOPTOSIS; LINE; EXPRESSION; CANCER; MDM2	Sarcomas are a heterogeneous group of mesenchymal orphan cancers and new treatment alternatives beyond traditional chemotherapeutic regimes are much needed. So far, tumor mutation analysis has not led to significant treatment advances, and we have attempted to bypass this limitation by performing direct drug testing of a library of 353 anti-cancer compounds that are either FDA-approved, in clinical trial, or in advanced stages of preclinical development on a panel of 13 liposarcoma cell lines. We identified and validated six drugs, targeting different mechanisms and with good efficiency across the cell lines: MLN2238 -a proteasome inhibitor, GSK2126458 -a PI3K/mTOR inhibitor, JNJ-26481585 -a histone deacetylase inhibitor, triptolide-a multi-target drug, YM155 -a survivin inhibitor, and APO866 (FK866)-a nicotinamide phosphoribosyl transferase inhibitor. GR50s for those drugs were mostly in the nanomolar range, and in many cases below 10 nM. These drugs had long-lasting effect upon drug withdrawal, limited toxicity to normal cells and good efficacy also against tumor explants. Finally, we identified potential genomic biomarkers of their efficacy. Being approved or in clinical trials, these drugs are promising candidates for liposarcoma treatment.	[Grad, Iwona; Hanes, Robert; Meza-Zepeda, Leonardo A.; Myklebost, Ola] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway; [Hanes, Robert; Enserink, Jorrit M.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Mol Cell Biol, Oslo, Norway; [Hanes, Robert; Ayuda-Duran, Pilar; Enserink, Jorrit M.] Univ Oslo, Fac Med, Ctr Canc Cell Reprogramming, Inst Clin Med, Oslo, Norway; [Kuijjer, Marieke Lydia] Univ Oslo, Ctr Mol Med Norway NCMM, Nordic EMBL Partnership, Oslo, Norway; [Enserink, Jorrit M.] Univ Oslo, Fac Math & Nat Sci, Dept Biosci, Oslo, Norway; [Meza-Zepeda, Leonardo A.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Core Facil Genom Core Facil, Oslo, Norway; [Meza-Zepeda, Leonardo A.; Myklebost, Ola] Univ Bergen, Dept Clin Sci, Bergen, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Bergen	Myklebost, O (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway.	ola.myklebost@uib.no	Meza-Zepeda, Leonardo Andres/CAG-5229-2022; Ayuda-Durán, Pilar/AAR-6755-2021; kuijjer, marieke/AAG-5844-2019; Myklebost, Ola/E-9335-2010	Meza-Zepeda, Leonardo Andres/0000-0003-3056-212X; Ayuda-Durán, Pilar/0000-0002-9799-3680; kuijjer, marieke/0000-0001-6280-3130; Myklebost, Ola/0000-0002-2866-3223	Norwegian Cancer Society [4489653, 182524, 4487303, 208012]; Norwegian Research Council [OM/RH 221580, 294916]; Research Council of Norway through its Centres of Excellence funding scheme [262652]	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Research Council(Research Council of NorwayEuropean Commission); Research Council of Norway through its Centres of Excellence funding scheme	This work was supported by grants from the Norwegian Cancer Society to OM/IG (4489653) and JME (182524, 4487303 and 208012), and from the Norwegian Research Council to OM/RH 221580) and JME (294916). This work was also partly supported by the Research Council of Norway through its Centres of Excellence funding scheme (262652). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee S, 2013, CANCER LETT, V335, P412, DOI 10.1016/j.canlet.2013.02.050; Barone A, 2017, CLIN CANCER RES, V23, P7448, DOI 10.1158/1078-0432.CCR-17-0898; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Bolstad B, 2018, PREPROCESSCORE COLLE; Burger AM, 2014, CANCER DRUG DISCOV D, P23, DOI 10.1007/978-1-4614-9135-4_2; Clark NA, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3689-3; de Graaff MA, 2017, TRANSL ONCOL, V10, P546, DOI 10.1016/j.tranon.2017.05.007; Dickson MA, 2013, J CLIN ONCOL, V31, P2024, DOI 10.1200/JCO.2012.46.5476; Dosen-Dahl G, 2008, INT J CANCER, V123, P2759, DOI 10.1002/ijc.23833; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Gupte A, 2015, CLIN CANCER RES, V21, P3216, DOI 10.1158/1078-0432.CCR-14-3026; Hafner M, 2016, NAT METHODS, V13, P521, DOI [10.1038/NMETH.3853, 10.1038/nmeth.3853]; Hanes R, 2016, ONCOTARGET, V7, P54583, DOI 10.18632/oncotarget.10518; Heinicke U, 2015, ONCOTARGET, V6, P37836, DOI 10.18632/oncotarget.6097; Hingorani P, 2013, PEDIATR BLOOD CANCER, V60, P35, DOI 10.1002/pbc.24290; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Huang M, 2013, MOL CANCER THER, V12, P184, DOI 10.1158/1535-7163.MCT-12-0425; Huang TZ, 2017, CANCER CELL, V32, P840, DOI 10.1016/j.ccell.2017.11.005; Kitzen JJEM, 2009, EUR J CANCER, V45, P1764, DOI 10.1016/j.ejca.2009.01.026; Kwon HY, 2013, INDIAN J BIOCHEM BIO, V50, P485; Laporte AN, 2017, MOL CANCER THER, V16, P2656, DOI 10.1158/1535-7163.MCT-17-0397; Lazar AJ, 2017, CELL, V171, P950, DOI 10.1016/j.cell.2017.10.014; Lee EC, 2011, CLIN CANCER RES, V17, P7313, DOI 10.1158/1078-0432.CCR-11-0636; Lenth RV., 2021, EMMEANS ESTIMATED MA; Li XJY, 2014, J ETHNOPHARMACOL, V155, P67, DOI 10.1016/j.jep.2014.06.006; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu QY, 2011, INT IMMUNOPHARMACOL, V11, P377, DOI 10.1016/j.intimp.2011.01.012; Liu RH, 2017, CELL PHYSIOL BIOCHEM, V41, P451, DOI 10.1159/000456598; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Minoda M, 2015, INT J ONCOL, V47, P891, DOI 10.3892/ijo.2015.3077; Mitchell MA, 2010, MOL CANCER THER, V9, P682, DOI 10.1158/1535-7163.MCT-09-0705; Munster P, 2016, CLIN CANCER RES, V22, P1932, DOI 10.1158/1078-0432.CCR-15-1665; Mutz CN, 2017, ONCOTARGET, V8, P24679, DOI 10.18632/oncotarget.14976; Nakahara T, 2011, CANCER SCI, V102, P614, DOI 10.1111/j.1349-7006.2010.01834.x; Ng P, 2007, STAT MODEL, V7, P315, DOI 10.1177/1471082X0700700403; Nishio J, 2003, CANCER GENET CYTOGEN, V144, P44, DOI 10.1016/S0165-4608(02)00925-1; Noel P, 2019, TRENDS PHARMACOL SCI, V40, P327, DOI 10.1016/j.tips.2019.03.002; Ohnstad HO, 2013, CANCER-AM CANCER SOC, V119, P1013, DOI 10.1002/cncr.27837; Osgood CL, 2017, CLIN CANCER RES, V23, P6384, DOI 10.1158/1078-0432.CCR-16-2422; Pedeutour F, 1999, GENE CHROMOSOME CANC, V24, P30, DOI 10.1002/(SICI)1098-2264(199901)24:1<30::AID-GCC5>3.0.CO;2-P; Persson F, 2008, CANCER LETT, V260, P37, DOI 10.1016/j.canlet.2007.10.032; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Ray-Coquard I, 2012, LANCET ONCOL, V13, P1133, DOI 10.1016/S1470-2045(12)70474-6; Sampath D, 2015, PHARMACOL THERAPEUT, V151, P16, DOI 10.1016/j.pharmthera.2015.02.004; Shames DS, 2013, CLIN CANCER RES, V19, P6912, DOI 10.1158/1078-0432.CCR-13-1186; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Skarn M, 2014, STEM CELLS DEV, V23, P2377, DOI 10.1089/scd.2013.0599; Smith DC, 2015, INVEST NEW DRUG, V33, P652, DOI 10.1007/s10637-015-0230-x; Snyder EL, 2009, J PATHOL, V218, P292, DOI 10.1002/path.2564; Souid AK, 2010, PEDIATR BLOOD CANCER, V55, P1323, DOI 10.1002/pbc.22609; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teicher BA, 2015, MOL CANCER THER, V14, P2452, DOI 10.1158/1535-7163.MCT-15-0074; Tolcher AW, 2008, J CLIN ONCOL, V26, P5198, DOI 10.1200/JCO.2008.17.2064; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Ueno T, 2016, INT J ONCOL, V48, P1847, DOI 10.3892/ijo.2016.3438; Venugopal B, 2013, CLIN CANCER RES, V19, P4262, DOI 10.1158/1078-0432.CCR-13-0312; Wabitsch M, 2000, INT J CANCER, V88, P889, DOI 10.1002/1097-0215(20001215)88:6<889::AID-IJC8>3.0.CO;2-N; Wang SW, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0869-2; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xi C, 2017, BIOMED PHARMACOTHER, V90, P531, DOI 10.1016/j.biopha.2017.04.003; Xu LY, 2008, EUR J PHARM BIOPHARM, V70, P741, DOI 10.1016/j.ejpb.2008.07.017; Yang SB, 2011, ASIAN PAC J TROP MED, V4, P482, DOI 10.1016/S1995-7645(11)60131-4; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yao JC, 2006, BIOL PHARM BULL, V29, P1483, DOI 10.1248/bpb.29.1483; Zhang XD, 2011, OPTIMAL HIGH THROUGH	67	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0248140	10.1371/journal.pone.0248140	http://dx.doi.org/10.1371/journal.pone.0248140			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690666	gold, Green Published			2022-12-26	WOS:000627854700072
J	Prakash, MD; Stojanovska, L; Feehan, J; Nurgali, K; Donald, EL; Plebanski, M; Flavel, M; Kitchen, B; Apostolopoulos, V				Prakash, Monica D.; Stojanovska, Lily; Feehan, Jack; Nurgali, Kulmira; Donald, Elizabeth L.; Plebanski, Magdalena; Flavel, Matthew; Kitchen, Barry; Apostolopoulos, Vasso			Anti-cancer effects of polyphenol-rich sugarcane extract	PLOS ONE			English	Article							BREAST-CANCER; EXERCISE; MECHANISMS; L.; IMMUNOMODULATION; PROLIFERATION; MODULATION; EXPRESSION; SURVIVAL; INSULIN	Plant polyphenols have an array of health benefits primarily thought to be related to their high content of anti-oxidants. These are commonly undervalued and knowledge of their biological properties have grown exponentially in the last decade. Polyphenol-rich sugarcane extract (PRSE), a natural extract from sugar cane, is marketed as high in anti-oxidants and polyphenols, but its anti-cancer activity has not been reported previously. We show that, PRSE exerts anti-cancer properties on a range of cancer cells including human (LIM2045) and mouse (MC38, CT26) colon cancer cells lines; human lung cancer (A549), human ovarian cancer (SKOV-3), pro-monocytic human leukemia (U937) and to mouse melanoma (B16) cell lines; whereas no effects were noted on human breast (ZR-75-1) and human colon (HT29) cancer cell lines, as well as to human normal colon epithelial cell line (T4056). Anti-proliferative effects were shown to be mediated via alteration in cytokines, VEGF-1 and NF-kappa B expression.	[Prakash, Monica D.; Feehan, Jack; Nurgali, Kulmira; Donald, Elizabeth L.; Apostolopoulos, Vasso] Victoria Univ, Inst Hlth & Sport, Melbourne, Vic, Australia; [Prakash, Monica D.; Plebanski, Magdalena] RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia; [Stojanovska, Lily] United Arab Emirates Univ, Coll Food & Agr, Dept Nutr & Hlth, Al Ain, U Arab Emirates; [Feehan, Jack] Univ Melbourne, Dept Med Western Hlth, Melbourne, Vic, Australia; [Flavel, Matthew; Kitchen, Barry] Prod Makers, Bioact Div, Melbourne, Vic, Australia	Victoria University; Royal Melbourne Institute of Technology (RMIT); United Arab Emirates University; University of Melbourne	Apostolopoulos, V (corresponding author), Victoria Univ, Inst Hlth & Sport, Melbourne, Vic, Australia.	Vasso.Apostolopoulos@vu.edu.au	Plebanski, Magdalena/AAU-3144-2021	Nurgali, Kulmira/0000-0002-2597-6929; Prakash, Monica/0000-0002-2814-7560; Flavel, Matthew/0000-0001-7455-5162; , Magdalena/0000-0001-6889-3667; Stojanovska, Lily/0000-0001-7186-4461; Feehan, Jack/0000-0002-9627-1299	Product Makers (TPM) (Australia) Pty Ltd; Innovation Connections Grant, Department of Industry, Innovation and Science, VIC Australia	Product Makers (TPM) (Australia) Pty Ltd; Innovation Connections Grant, Department of Industry, Innovation and Science, VIC Australia	The study was supported by The Product Makers (TPM) (Australia) Pty Ltd (http://www.tpm.com.au/) and the Innovation Connections Grant, Department of Industry, Innovation and Science, VIC Australia (https://www.industry.gov.au/).The funder (TPM) provided support in the form of salaries for authors M.F and B.K but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. VA was the recipient of all funding for this study.	Ali SE, 2019, MOLECULES, V24, DOI 10.3390/molecules24050934; Alves VG, 2016, AN ACAD BRAS CIENC, V88, P1201, DOI 10.1590/0001-3765201620150349; Apostolopoulos V, 2016, MOL NUTR FOOD RES, V60, P43, DOI 10.1002/mnfr.201500272; Apostolopoulos V, 2014, IMMUNOTHERAPY-UK, V6, P1145, DOI [10.2217/IMT.14.76, 10.2217/imt.14.76]; Araujo JR, 2011, NUTR RES, V31, P77, DOI 10.1016/j.nutres.2011.01.006; Bendardaf R, 2017, LIBYAN J MED, V12, DOI 10.1080/19932820.2017.1290741; Bennani H, 2007, CANCER DETECT PREV, V31, P64, DOI 10.1016/j.cdp.2006.09.006; Bucio-Noble D, 2018, J PROTEOMICS, V177, P1, DOI 10.1016/j.jprot.2018.02.009; Chalopin M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110080; CUMMINGS JH, 1992, GASTROENTEROLOGY, V103, P1783, DOI 10.1016/0016-5085(92)91435-7; Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Deseo MA, 2020, FOOD CHEM, V314, DOI 10.1016/j.foodchem.2020.126180; Ehrke MJ, 2003, INT IMMUNOPHARMACOL, V3, P1105, DOI 10.1016/S1567-5769(03)00021-3; Ellis TP, 2016, EUR J NUTR, V55, P2365, DOI 10.1007/s00394-015-1043-6; Feng SM, 2014, FOOD CHEM, V151, P452, DOI 10.1016/j.foodchem.2013.11.057; Ghiringhelli F, 2012, ANTI-CANCER AGENT ME, V12, P852, DOI 10.2174/187152012802650048; Han DH, 2009, ANTICANCER RES, V29, P1417; Jaganathan SK, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/830616; Ji J, 2019, J AM COLL NUTR, V38, P670, DOI 10.1080/07315724.2019.1587323; Khazali AS, 2018, BRIT J CANCER, V118, P566, DOI 10.1038/bjc.2017.414; Kune S, 1987, Nutr Cancer, V9, P21; Li ZG, 2009, CELL MOL IMMUNOL, V6, P415, DOI 10.1038/cmi.2009.53; Liu LP, 2008, MOL NUTR FOOD RES, V52, P1182, DOI 10.1002/mnfr.200700499; Mahoney KM, 2015, NAT REV DRUG DISCOV, V14, P561, DOI 10.1038/nrd4591; McTiernan A, 2008, NAT REV CANCER, V8, P205, DOI 10.1038/nrc2325; Mikkelsen K, 2017, MATURITAS, V106, P48, DOI 10.1016/j.maturitas.2017.09.003; MOBUS VJ, 1993, J CANCER RES CLIN, V120, P27, DOI 10.1007/BF01200721; Moyle CWA, 2015, MOL NUTR FOOD RES, V59, P401, DOI 10.1002/mnfr.201400478; Pallavi R., 2012, International Journal of Research in Pharmacy and Chemistry, V2, P338; Prokopchuk O, 2005, BRIT J CANCER, V92, P921, DOI 10.1038/sj.bjc.6602416; Pudkasam S, 2017, MATURITAS, V105, P16, DOI 10.1016/j.maturitas.2017.04.022; Queen Brannon L, 2010, Curr Aging Sci, V3, P34; Sayin N, 2013, TURK J IMMUNOL, V1, P42, DOI 10.5606/tji.2013.213; Scalbert A, 2005, AM J CLIN NUTR, V81, p215S, DOI 10.1093/ajcn/81.1.215S; Shin KJ, 2016, CURR PHARM DESIGN, V22, P2389, DOI 10.2174/1381612822666160226144025; Stojanovska L, 2014, MATURITAS, V77, P318, DOI 10.1016/j.maturitas.2014.01.006; Stover MG, 2013, POLYPHENOLS HUMAN HL, V1, P3, DOI [10.1016/B978-0-12-398456-2.00001%26%23x2013%3B3, DOI 10.1016/B978-0-12-398456-2.00001%26%23X2013%3B3]; Wahyudi Sianne, 2007, Acta Med Indones, V39, P66; WCRF. AICR, 2018, NUTR PHYS ACT CANC G; Wright AG, 2014, PLANT FOOD HUM NUTR, V69, P310, DOI 10.1007/s11130-014-0446-5; Wu S, 2016, NATURE, V529, P43, DOI 10.1038/nature16166; Xu H, 2018, NUTR RES, V57, P1, DOI 10.1016/j.nutres.2018.04.011; Yahfoufi N, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111618; Yu MX, 2013, CANCER RES, V73, P4061, DOI 10.1158/0008-5472.CAN-12-3946; Zhao Y, 2015, FOOD CHEM, V185, P112, DOI 10.1016/j.foodchem.2015.03.120; Zhou BH, 2015, PHYTOTHER RES, V29, P415, DOI 10.1002/ptr.5267	47	6	6	8	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0247492	10.1371/journal.pone.0247492	http://dx.doi.org/10.1371/journal.pone.0247492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690618	Green Published, gold			2022-12-26	WOS:000627854700071
J	Purayil, HT; Zhang, YS; Black, JB; Gharaibeh, R; Daaka, Y				Purayil, Hamsa Thayele; Zhang, Yushan; Black, Joseph B.; Gharaibeh, Raad; Daaka, Yehia			Nuclear beta Arrestin1 regulates androgen receptor function in castration resistant prostate cancer	ONCOGENE			English	Article							BETA-ARRESTIN 1; EMERGING MECHANISMS; ADRENERGIC-RECEPTOR; LINEAGE PLASTICITY; EXPORT SIGNAL; IDENTIFICATION; PROGRESSION; EXPRESSION; PROTEIN; KINASE	Progression of prostate cancer (PC) to terminal castration-resistant PC (CRPC) involves a diverse set of intermediates, and androgen receptor (AR) is the key mediator of PC initiation and progression to CRPC. Hence, identification of factors involved in the regulation of AR expression and function is a necessary first-step to improve disease outcome. In this study, we identified ubiquitous beta Arrestin 1 (beta Arr1) as a regulator of AR function in CRPC. Unbiased gene expression analysis of public datasets revealed increased levels of ARRB1 (the gene encoding beta Arr1) in CRPC when compared to normal tissue. Further, beta Arr1 expression correlated with enhanced AR transcriptional function in these datasets. The beta Arr1 partitions to both nucleus and cytosol and mechanistic studies showed that nuclear, and not cytosolic, beta Arr1 formed a complex with AR and AR-coregulator beta Catenin and that the heterotrimeric protein complex was recruited to androgen-response elements of AR-regulated genes. Functionally, we demonstrate that depletion of beta Arr1 attenuates PC cell and tumor growth and metastasis, and rescued expression of nuclear, but not cytosolic, beta Arr1 restores the PC colony growth and invasion of Matrigel in vitro and tumor growth and metastasis in mice. The targeting of beta Arr1-regulated AR transcriptional function may be used in the development of new drugs to treat lethal CRPC.	[Purayil, Hamsa Thayele; Zhang, Yushan; Black, Joseph B.; Daaka, Yehia] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32611 USA; [Gharaibeh, Raad] Univ Florida, Coll Med, Dept Med, Gainesville, FL USA; [Zhang, Yushan] Univ Oklahoma, Hlth Sci Ctr, Stephen Canc Ctr, Norman, OK 73019 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma - Norman	Daaka, Y (corresponding author), Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32611 USA.	ydaaka@ufl.edu		THAYELE PURAYIL, HAMSA/0000-0002-7211-3659	Florida Academic Cancer Center Alliance	Florida Academic Cancer Center Alliance	This work was supported, in part, by the Florida Academic Cancer Center Alliance (to YD) and the UFHCC (to RG).	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Bao BY, 2008, PROSTATE, V68, P839, DOI 10.1002/pros.20749; Beltran H, 2019, CLIN CANCER RES, V25, P43, DOI 10.1158/1078-0432.CCR-18-1912; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Cianfrocca R, 2014, LIFE SCI, V118, P179, DOI 10.1016/j.lfs.2014.01.078; Claessens F, 2014, NAT REV UROL, V11, P712, DOI 10.1038/nrurol.2014.243; Dasgupta P, 2011, JNCI-J NATL CANCER I, V103, P317, DOI 10.1093/jnci/djq541; Dehm SM, 2011, ENDOCR-RELAT CANCER, V18, pR183, DOI 10.1530/ERC-11-0141; El-Khoury V, 2018, BRIT J CANCER, V119, P580, DOI 10.1038/s41416-018-0200-0; Fereshteha M, 2012, P NATL ACAD SCI USA, V109, P12532, DOI 10.1073/pnas.1209815109; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Ku SY, 2017, SCIENCE, V355, P78, DOI 10.1126/science.aah4199; Lakshmikanthan V, 2009, P NATL ACAD SCI USA, V106, P9379, DOI 10.1073/pnas.0900258106; Lee E, 2013, P NATL ACAD SCI USA, V110, P15710, DOI 10.1073/pnas.1218168110; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; Mu P, 2017, SCIENCE, V355, P84, DOI 10.1126/science.aah4307; Mulholland DJ, 2002, J BIOL CHEM, V277, P17933, DOI 10.1074/jbc.M200135200; Nyquist MD, 2013, P NATL ACAD SCI USA, V110, P17492, DOI 10.1073/pnas.1308587110; Purayil HT, 2015, ONCOGENE, V34, P3144, DOI 10.1038/onc.2014.252; Rosano L, 2013, ONCOGENE, V32, P5066, DOI 10.1038/onc.2012.527; Rosano L, 2009, P NATL ACAD SCI USA, V106, P2806, DOI 10.1073/pnas.0807158106; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Shenoy SK, 2012, ONCOGENE, V31, P282, DOI 10.1038/onc.2011.238; Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI 10.3322/caac.21654; Taplin ME, 2007, NAT CLIN PRACT ONCOL, V4, P236, DOI 10.1038/ncponc0765; Terada N, 2010, CANCER RES, V70, P1606, DOI 10.1158/0008-5472.CAN-09-2984; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; Tocci P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11045-8; Wang LG, 2012, ASIAN PAC J CANCER P, V13, P5671, DOI 10.7314/APJCP.2012.13.11.5671; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; Watson PA, 2015, NAT REV CANCER, V15, P701, DOI 10.1038/nrc4016; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Zecchini V, 2014, EMBO J, V33, P1365, DOI 10.15252/embj.201386874; Zhang X, 2017, NAT COMMUN, V8, P1, DOI [10.1038/s41467-017-01968-5, 10.1038/ncomms14542, 10.1038/s41467-017-00321-0]; Zhang YX, 2017, J BIOL CHEM, V292, P8933, DOI 10.1074/jbc.M116.770420; Zhang YS, 2017, CANCER LETT, V391, P50, DOI 10.1016/j.canlet.2017.01.007	42	3	3	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2021	40	14					2610	2620		10.1038/s41388-021-01730-8	http://dx.doi.org/10.1038/s41388-021-01730-8		MAR 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RK3YE	33692468				2022-12-26	WOS:000627285600001
J	Shin, YH; Baek, GH; Kim, YJ; Kim, MJ; Kim, JK				Shin, Young Ho; Baek, Goo Hyun; Kim, Ye-Jee; Kim, Min-ju; Kim, Jae Kwang			Epidemiology of congenital upper limb anomalies in Korea: A nationwide population-based study	PLOS ONE			English	Article								This study aimed to analyze the epidemiology of congenital upper limb anomalies (CULA) in Korea. We evaluated the incidence of each type of CULA, the presence of coexisting anomalies and the surgical treatment status in CULA patients. We conducted a retrospective cohort study of patients aged < 1 year between 2007 and 2016 who were registered with CULA in the Health Insurance Review and Assessment Service of Korea. In total, 10,704 patients had CULA, including 6,174 boys (57.7%) and 4,530 girls (42.3%). The mean annual incidence of CULA was 23.5 per 10,000 live births; it was significantly higher in boys than in girls (26.3 vs. 20.5, p < 0.001). Among the four categories of CULA-polydactyly, syndactyly, limb deficiency, and other anomalies-polydactyly was the most common. In total, 4,149 patients (38.8%) had other congenital anomalies and coexisting anomalies of the circulatory system (24.9%) were the most common. In total 4,776 patients (44.6%) underwent operative treatment for CULA within minimum three years of the diagnosis. The proportion of patients who underwent surgical treatment was significantly higher for polydactyly (73.4% vs. 16.8%, p < 0.001) and syndactyly (65.3% vs. 41.5%, p < 0.001), but it was significantly lower in limb deficiency (27.6% vs. 45.4%, p < 0.001) and other anomalies (10.0% vs. 69.8%, p < 0.001) than rest of CULA patients. Among the patients who had operations, 21.5% underwent multiple operations. The proportion of patients who underwent multiple operations was significantly higher in syndactyly (35.6% vs. 18.1%, p < 0.001), but it was significantly lower in polydactyly (4.0% vs. 95.5%, p < 0.001) and other anomalies (17.9% vs. 21.9%, p < 0.001) than rest of CULA patients. These results could provide a basis for estimating the national healthcare costs for CULA and the required number of CULA specialists.	[Shin, Young Ho; Kim, Jae Kwang] Univ Ulsan, Asan Med Ctr, Dept Orthopaed Surg, Coll Med, Seoul, South Korea; [Baek, Goo Hyun] Seoul Natl Univ, Dept Orthopaed Surg, Coll Med, Seoul, South Korea; [Kim, Ye-Jee; Kim, Min-ju] Univ Ulsan, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Coll Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; Seoul National University (SNU); University of Ulsan; Asan Medical Center	Shin, YH (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Orthopaed Surg, Coll Med, Seoul, South Korea.	123sinyh@gmail.com		Shin, Young Ho/0000-0002-9388-9720	Asan Medical Center Children's hospital [2020IT0003-1]	Asan Medical Center Children's hospital	Initials of the authors who received each award: YHS Grant numbers awarded to each author: 2020IT0003-1 The full name of each funder: Asan Medical Center Children's hospital URL of each funder website: http://www.amc.seoul.kr/asan/departments/deptListTypeF.do The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzug JM, 2013, J HAND SURG-AM, V38A, P1223, DOI 10.1016/j.jhsa.2013.02.002; Braun TL, 2016, SEMIN PLAST SURG, V30, P162, DOI 10.1055/s-0036-1593478; Ekblom AG, 2014, J HAND SURG-AM, V39, P237, DOI 10.1016/j.jhsa.2013.11.014; Ekblom AG, 2010, J HAND SURG-AM, V35A, P1742, DOI 10.1016/j.jhsa.2010.07.007; Ferrari BR, 2019, J HAND SURG-EUR VOL, V44, P296, DOI 10.1177/1753193418808183; Giele H, 2001, J HAND SURG-AM, V26A, P628, DOI 10.1053/jhsu.2001.26121; Goldfarb CA, 2017, J PEDIATR ORTHOPED, V37, P144, DOI 10.1097/BPO.0000000000000748; Goldfarb CA, 2015, J HAND SURG-AM, V40, P127, DOI 10.1016/j.jhsa.2014.10.038; Jo YH, 2017, J KOREAN MED SCI, V32, P357, DOI 10.3346/jkms.2017.32.2.357; Klungsoyr K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219930; KOSIS, 2020, AGE TIM OFF OFF; Koskimies E, 2011, J HAND SURG-AM, V36A, P1058, DOI 10.1016/j.jhsa.2011.03.015; Kozin SH, 2015, PLAST RECONSTR SURG, V136, p241E, DOI 10.1097/PRS.0000000000001499; LEUNG PC, 1982, J HAND SURG-AM, V7, P563, DOI 10.1016/S0363-5023(82)80102-0; MELLIN GW, 1962, NEW ENGL J MED, V267, P1238, DOI 10.1056/NEJM196212132672407; Nation Health Commission, 2020, CHIN HLTH STAT YB 20; OGINO T, 1986, J HAND SURG-BRIT EUR, V11B, P364, DOI 10.1016/0266-7681(86)90159-2; PERCIVAL NJ, 1989, J HAND SURG-BRIT EUR, V14B, P196, DOI 10.1016/0266-7681(89)90125-3; Wang AA, 2019, J HAND SURG-EUR VOL, V44, P845, DOI 10.1177/1753193419848989; Waters PM., 2012, PEDIAT HAND UPPER LI, Vx, P657; World Health Organization, 2020, INT CLASS DIS	21	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2021	16	3							e0248105	10.1371/journal.pone.0248105	http://dx.doi.org/10.1371/journal.pone.0248105			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DJ	33690710	Green Published, gold			2022-12-26	WOS:000627855600024
J	Atiba, FA; Fatokun, AA; Imosemi, IO; Malomo, AO				Atiba, Foluso A.; Fatokun, Amos A.; Imosemi, Innocent O.; Malomo, Adefolarin O.			Kola nut from Cola nitida vent. Schott administered to pregnant rats induces histological alterations in pups' cerebellum	PLOS ONE			English	Article							EXTERNAL GRANULAR LAYER; MIGRATION DEFECTS; CELL-MIGRATION; NERVOUS-SYSTEM; DEGENERATION; EXPOSURE; TOXICITY; MOUSE; OVEREXPRESSION; ACTIVATION	Kola nut (from Cola nitida) is popular in Nigeria and West Africa and is commonly consumed by pregnant women during the first trimester to alleviate morning sickness and dizziness. There is, however, a dearth of information on its effects on the developing brain. This study, therefore, investigated the potential effects of kola nut on the structure of the developing neonatal and juvenile cerebellum in the rat. Pregnant Wistar rats were administered water (as control) or crude (aqueous) kola nut extract at 400, 600, and 800 mg/kg body weight orally, from pregnancy to day 21 after birth. On postnatal days 1, 7, 14, 21 and 28, the pups were weighed, anaesthetised, sacrificed and perfused with neutral buffered formalin. Their brains were dissected out, weighed and the cerebellum preserved in 10% buffered formalin. Paraffin sections of the cerebellum were stained with haematoxylin and eosin for cerebellar cytoarchitecture, cresyl violet stain for Purkinje cell count, Glial Fibrillary Acidic Protein (GFAP) immunohistochemistry (IHC) for estimation of gliosis, and B-cell lymphoma 2 (Bcl-2) IHC for apoptosis induction. The kola nut-treated rats exhibited initial reduction in body and brain weights, persistent external granular layer, increased molecular layer thickness, and loss of Bergmann glia. Their Purkinje cells showed reduction in density, loss of dendrites and multiple layering, and their white matter showed neurodegeneration (spongiosis) and GFAP and Bcl-2 over-expression, with evidence of reactive astrogliosis. This study, therefore, demonstrates that kola nut, administered repeatedly at certain doses to pregnant dams, could disrupt normal postnatal cerebellar development in their pups. The findings suggest potential deleterious effects of excessive kola nut consumption on human brain and thus warrant further studies to understand the wider implications for human brain development.	[Atiba, Foluso A.; Imosemi, Innocent O.; Malomo, Adefolarin O.] Univ Ibadan, Coll Med, Dept Anat, Ibadan, Nigeria; [Fatokun, Amos A.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool, Merseyside, England; [Malomo, Adefolarin O.] Univ Ibadan, Coll Med, Dept Surg, Ibadan, Nigeria	University of Ibadan; Liverpool John Moores University; University of Ibadan	Atiba, FA; Malomo, AO (corresponding author), Univ Ibadan, Coll Med, Dept Anat, Ibadan, Nigeria.; Malomo, AO (corresponding author), Univ Ibadan, Coll Med, Dept Surg, Ibadan, Nigeria.	folusoatiba@gmail.com; ademalomo@yahoo.com	; Fatokun, Amos/T-7918-2017	Atiba, Foluso/0000-0003-4780-7840; Fatokun, Amos/0000-0001-5183-7589				AJAREM JS, 1994, J KING SAUD U SCIENC, V6, P41; ALTMAN J, 1972, J COMP NEUROL, V145, P399, DOI 10.1002/cne.901450402; Archibong V.B., 2017, SAUDI J MED PHARM SC, V3, P849; Atiba F. A., 2016, African Journal of Biomedical Research, V19, P65; Baloui H, 2004, EUR J NEUROSCI, V20, P2605, DOI 10.1111/j.1460-9568.2004.03728.x; Bouet V, 2005, NEUROSCI LETT, V382, P10, DOI 10.1016/j.neulet.2005.02.051; Bufalo MC, 2013, J ETHNOPHARMACOL, V149, P84, DOI 10.1016/j.jep.2013.06.004; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Burdock GA, 2005, BOCA RATON, P993; Calatrava-Ferreras L, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/135187; Casoni F, 2017, CONTEMP CLIN NEUROSC, V21, P67, DOI 10.1007/978-3-319-59749-2_4; Celec P, 2010, J PSYCHOPHARMACOL, V24, P1569, DOI 10.1177/0269881109105401; DEBLAS AL, 1984, J NEUROSCI, V4, P265; Dethy S, 1997, NEUROSCI LETT, V224, P25, DOI 10.1016/S0304-3940(97)13461-9; Ettarh RR, 2000, PHARM BIOL, V38, P281, DOI 10.1076/1388-0209(200009)3841-AFT281; Harborne JB, 1999, GEN INTRO PHYTOCHEMI; Haskell CF, 2013, NUTR RES REV, V26, P49, DOI 10.1017/S0954422413000036; Ifesanya J.U., 2013, J DENT ORAL HYGIENE, V5, P13; Ikegwuonu F I, 1981, J Appl Toxicol, V1, P292, DOI 10.1002/jat.2550010603; Imosemi IO, 2011, INT J MORPHOL, V29, P331, DOI 10.4067/S0717-95022011000200004; JENKINS T, 1978, FUNCTIONAL MAMMALIAN; Kern JK, 2006, J TOXICOL ENV HEAL B, V9, P485, DOI 10.1080/10937400600882079; Komuro H, 2003, CELL MOL LIFE SCI, V60, P1084, DOI 10.1007/s00018-003-2248-z; KOPPEL H, 1982, J ANAT, V134, P73; Kumar K, 2013, CELL MOL NEUROBIOL, V33, P731, DOI 10.1007/s10571-013-9942-7; Legradi J, 2015, ENVIRON SCI POLLUT R, V22, P16277, DOI 10.1007/s11356-014-3805-8; Liang CC, 2010, J BIOL CHEM, V285, P3499, DOI 10.1074/jbc.M109.072389; Martinez S, 2000, RES PRO CEL, V30, P91; Marzban H, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00450; McIlroy RJ., 1963, INTRO TROPICAL CASH; Miller RA, 2002, MAGICAL RITUAL USE H; National Research Council (US). National Research Council (US) Committee for the Update of the Guide for Care and Use of Laboratory Animals, 2011, NAT RES COUNC US COM; Nicolas O, 2007, FASEB J, V21, P3107, DOI 10.1096/fj.06-7827com; Nowakowska-Kotas M, 2014, CEREBELLUM, V13, P541, DOI 10.1007/s12311-014-0566-3; Nyaruhucha C N M, 2009, Tanzan J Health Res, V11, P29; Obidike I. R., 2011, Comparative Clinical Pathology, V20, P625, DOI 10.1007/s00580-010-1045-y; Obochi G O, 2007, Niger J Physiol Sci, V22, P99; Ogunwole Eunice, 2015, Niger J Physiol Sci, V30, P51; Ojo GB, 2010, REV ELECT BIOMED ELE, V2, P18; Ologe FE, 2008, J LARYNGOL OTOL, V122, P786, DOI 10.1017/S0022215107000242; Olopade Funmilayo Eniola, 2018, Journal of Caffeine and Adenosine Research, V8, P27, DOI 10.1089/caff.2017.0010; Onyiapat JLE, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-19; Opanashuk LA, 2001, EUR J NEUROSCI, V13, P48, DOI 10.1046/j.1460-9568.2001.01359.x; Priyanka S, 2012, TOXICOL ENVIRON CHEM, V94, P1422, DOI 10.1080/02772248.2012.695002; Qu Q, 2005, CEREBELLUM, V4, P261, DOI 10.1080/14734220500358351; RAKIC P, 1973, J COMP NEUROL, V152, P103, DOI 10.1002/cne.901520202; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; SMEYNE RJ, 1989, J NEUROSCI, V9, P1608; Snell RS, 2005, CLIN NEUROANATOMY; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; SPYKER JM, 1975, FED PROC, V34, P1835; Steele AD, 2007, J NEUROSCI, V27, P13022, DOI 10.1523/JNEUROSCI.3290-07.2007; Tende J. A., 2011, British Journal of Pharmacology and Toxicology, V2, P132; Tindall R, 1998, ETHNOBO LEAF, V2, P1; Umoren E. B., 2011, International Research Journal of Pharmacy and Pharmacology, V1, P93; Umoren E B, 2009, Niger J Physiol Sci, V24, P73; VanderLugt JJ, 1996, VET PATHOL, V33, P495, DOI 10.1177/030098589603300503; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Weller M, 2006, DEV NEUROSCI-BASEL, V28, P70, DOI 10.1159/000090754; Wolansky MJ, 2005, NEUROTOXICOL TERATOL, V27, P299, DOI 10.1016/j.ntt.2004.12.006; Xu HW, 2013, MOL NEUROBIOL, V47, P833, DOI 10.1007/s12035-013-8405-y	61	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0247573	10.1371/journal.pone.0247573	http://dx.doi.org/10.1371/journal.pone.0247573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU3OZ	33684143	gold, Green Published, Green Accepted			2022-12-26	WOS:000627193500040
J	Li, TF; Zhao, HB; Zhou, H; Geng, TT				Li, Tingfu; Zhao, Hongbo; Zhou, Hua; Geng, Tingting			LncRNA LINC00857 strengthens the malignancy behaviors of pancreatic adenocarcinoma cells by serving as a competing endogenous RNA for miR-340-5p to upregulate TGFA expression	PLOS ONE			English	Article								Background Pancreatic adenocarcinoma (PAAD) is a pancreatic disease with a high mortality rate in the world. This present research intends to identify the function of lncRNA LINC00857/miR-340-5p/Transforming growth factor alpha (TGFA) in the progression of PAAD. Methods Bioinformatics analysis was used to explore the differentially expressed lncRNA/miRNA/mRNA and analyze the relationship between lncRNA/miRNA/mRNA expression and prognosis of PAAD by enquiring TCGA, GEO and GTEX. KEGG pathway analysis and GO enrichment analysis were implemented to annotate the crucial genes regulated by LINC00857. The biological behaviors of PAAD cells were detected by CCK-8, colony formation and transwell assays. Interactive associations between LINC00857 and miR-340-5p, as well as miR-340-5p and TGFA were analyzed by dual luciferase assay. Results By enquiring TCGA database, we got that LINC00857 was highly expressed in patients with PAAD and positively associated with worse prognosis in PAAD patients. Moreover, LINC00857 upregulation promoted the proliferation and clone formation abilities of PAAD cells. Afterwards, the downstream miRNA and mRNA targets of LINC00857 were picked up to construct a ceRNA network. Further study revealed that TGFA expression was positively regulated by LINC00857 and negatively regulated by miR-340-5p. Besides that, the inhibitory effect of miR-340-5p on PAAD cells growth and movement can be blocked by LINC00857 upregulation. While, the malignant behavior of PAAD cells induced by TGFA overexpression can be eliminated by LINC00857 knockdown. Conclusions Upregulation of LINC00857 improved growth, invasion and migration abilities of PAAD cells by modulation of miR-340-5p/TGFA, affording potential targets and biomarkers for the clinical diagnosis and treatment.	[Li, Tingfu] Southwest Med Univ, Affiliated Tradit Chinese Hosp, Cent Lab, Luzhou, Sichuan, Peoples R China; [Zhao, Hongbo] Cent Hosp Shanxian, Digest Dept, Heze, Shandong, Peoples R China; [Zhou, Hua] Zibo Cent Hosp, West Hosp Dist, Dept Gastroenterol, Zibo, Shandong, Peoples R China; [Geng, Tingting] Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Dept Gastroenterol, Yantai, Shandong, Peoples R China	Southwest Medical University; Qingdao University	Geng, TT (corresponding author), Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Dept Gastroenterol, Yantai, Shandong, Peoples R China.	ytgengtt@163.com						Abdollahzadeh R, 2019, J CELL PHYSIOL, V234, P10080, DOI 10.1002/jcp.27941; Bi SS, 2020, CELL CYCLE, V19, P801, DOI 10.1080/15384101.2020.1731645; Bialek K, 2020, PEERJ, V8, DOI 10.7717/peerj.8676; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Cong L, 2018, BIOCHEMISTRY-MOSCOW+, V83, P1018, DOI 10.1134/S0006297918090031; Dudek AM, 2018, CANCER MED-US, V7, P3342, DOI 10.1002/cam4.1570; Egeli U, 2016, PANCREAS, V45, P1294, DOI 10.1097/MPA.0000000000000640; Fan Y, 2017, AM J CANCER RES, V7, P139; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Han SW, 2018, GENE, V645, P157, DOI 10.1016/j.gene.2017.12.036; Hao NB, 2017, ONCOTARGET, V8, P81572, DOI 10.18632/oncotarget.19197; Iorio MV, 2012, CARCINOGENESIS, V33, P1126, DOI 10.1093/carcin/bgs140; Jeong Yisun, 2019, Cell Physiol Biochem, V53, P805, DOI 10.33594/000000174; Jiao Dechao, 2018, Am J Cancer Res, V8, P748; Kanwar Jagat R, 2010, Front Biosci (Schol Ed), V2, P1113; Li LC, 2019, ONCOGENE, V38, P6241, DOI 10.1038/s41388-019-0873-8; Li Y, 2019, SAUDI J GASTROENTERO, V25, P145, DOI 10.4103/sjg.SJG_465_18; Lou CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050956; Lv YH, 2019, ONCOL LETT, V18, P3963, DOI 10.3892/ol.2019.10758; Mishra S, 2019, ONCOGENE, V38, P5817, DOI 10.1038/s41388-019-0845-z; Rosenberg A, 2018, J GASTROINTEST ONCOL, V9, P143, DOI 10.21037/jgo.2018.01.13; Su WM, 2019, AGING-US, V11, P2812, DOI 10.18632/aging.101953; Sun JW, 2020, J CANCER, V11, P2572, DOI 10.7150/jca.37959; Sun M, 2015, ENDOCR REV, V36, P25, DOI 10.1210/er.2014-1034; Ta N, 2018, CELL PHYSIOL BIOCHEM, V51, P711, DOI 10.1159/000495328; Wang L, 2020, HUM CELL, V33, P195, DOI 10.1007/s13577-019-00296-8; Wang LH, 2016, ONCOTARGET, V7, P11487, DOI 10.18632/oncotarget.7203; Wang W, 2020, MED ONCOL, V37, DOI 10.1007/s12032-020-1339-0; Wang Y, 2008, CLIN GENET, V74, P307, DOI 10.1111/j.1399-0004.2008.01075.x; Xia CF, 2019, J CELL BIOCHEM, V120, P7970, DOI 10.1002/jcb.28074; Yang L, 2018, EUR REV MED PHARMACO, V22, P4837, DOI 10.26355/eurrev_201808_15619; Yang M, 2020, J CELL PHYSIOL, DOI 10.1002/jcp.29471; Yuan QH, 2019, J CELL BIOCHEM, V120, P552, DOI 10.1002/jcb.27411; Zhang Qun-hua, 2004, Zhonghua Yi Xue Za Zhi, V84, P214; Zhang YL, 2018, J CANCER, V9, P2713, DOI 10.7150/jca.26207; Zhao P, 2018, J ENDOCRINOL INVEST, V41, P1165, DOI 10.1007/s40618-018-0848-6	36	8	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0247817	10.1371/journal.pone.0247817	http://dx.doi.org/10.1371/journal.pone.0247817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33661995	Green Published, gold			2022-12-26	WOS:000626604100118
J	Zhang, MN; Li, L; Luo, M; Liang, BH				Zhang, Manna; Li, Lin; Luo, Ma; Liang, Binhua			Genomic characterization and evolution of SARS-CoV-2 of a Canadian population	PLOS ONE			English	Article							CORONAVIRUS; BIOLOGY	COVID-19 has greatly affected public health and world economy. In this study, we analyzed 129 full-length genomes of SARS-CoV-2 viruses of a Canadian population during early phase of the pandemic. Phylogenetic analysis revealed three major paths of transmission of SARS-CoV-2 viruses into Canada. Twenty-one substitutions that have frequencies greater than 3% of viral population were identified. Analysis of these substitutions indicated that P1427I (ORF1b), Y1464C (ORF1b), and Q57H (ORF3a) might affect functions of the corresponding SARS-CoV-2 encoded proteins. Additionally, we found the evidence of positive selection on the ORF3a and codon 614 of Spike protein, suggesting the viral components responsible for host entry and activation of inflammation response were targeted by host immune responses. The study showed genomic variation and evolution of SARS-CoV-2 in a Canadian population. These information may help develop preventive strategies and be used for further study of SARS-CoV-2 pathogenesis and therapeutics development.	[Zhang, Manna] Univ Manitoba, Hlth Sci Ctr, Dept Med, Sect Hepatol, Winnipeg, MB, Canada; [Li, Lin; Luo, Ma; Liang, Binhua] Publ Hlth Agcy Canada, Natl Microbiol Lab, JC Wilt Infect Dis Res Ctr, Winnipeg, MB, Canada; [Luo, Ma] Univ Manitoba, Rudy Fac Hlth Sci, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada; [Liang, Binhua] Univ Manitoba, Rudy Fac Hlth Sci, Dept Biochem & Med Genet, Winnipeg, MB, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; Public Health Agency of Canada; University of Manitoba; University of Manitoba	Liang, BH (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, JC Wilt Infect Dis Res Ctr, Winnipeg, MB, Canada.; Liang, BH (corresponding author), Univ Manitoba, Rudy Fac Hlth Sci, Dept Biochem & Med Genet, Winnipeg, MB, Canada.	Ben.liang@canada.ca	Liang, Binhua/ABN-9806-2022	liang, binhua/0000-0002-1108-6407				Banerjee S, 2021, J MED VIROL, V93, P1428, DOI 10.1002/jmv.26417; Cagliani R, 2020, J VIROL, V94, DOI 10.1128/JVI.00411-20; Ceraolo C, 2020, J MED VIROL, V92, P522, DOI 10.1002/jmv.25700; Charlesworth B, 2012, GENETICS, V190, P5, DOI 10.1534/genetics.111.134288; Chen IY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00050; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Deng Xianding, 2020, medRxiv, DOI 10.1101/2020.03.27.20044925; Di Gioacchino Andrea, 2020, bioRxiv, DOI 10.1101/2020.05.06.074039; Di Giorgio S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb5813; Fung SY, 2020, EMERG MICROBES INFEC, V9, P558, DOI 10.1080/22221751.2020.1736644; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Kandori H, 2001, P NATL ACAD SCI USA, V98, P1571, DOI 10.1073/pnas.98.4.1571; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Korber B, 2020, SPIKE MUTATION PIPEL; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Lu GW, 2015, TRENDS MICROBIOL, V23, P468, DOI 10.1016/j.tim.2015.06.003; Minskaia E, 2006, P NATL ACAD SCI USA, V103, P5108, DOI 10.1073/pnas.0508200103; Murrell B, 2015, MOL BIOL EVOL, V32, P1365, DOI 10.1093/molbev/msv035; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Murrell B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002507; Ou J., 2020, RBD MUTATIONS CIRCUL, DOI [10.1101/2020.03.15.991844, DOI 10.1101/2020.03.15.991844]; Page AJ, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000056; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD94, DOI [10.1093/nar/gky989, DOI 10.1093/nar/gkab1112]; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Siu KL, 2019, FASEB J, V33, P8865, DOI 10.1096/fj.201802418R; Statistics Canada, 2020, TRAVEL RELATED EXPOS; Stefanelli P, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.13.2000305; Phan T, 2020, INFECT GENET EVOL, V81, DOI 10.1016/j.meegid.2020.104260; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang QD, 2016, ACS INFECT DIS, V2, P361, DOI 10.1021/acsinfecdis.6b00006; Weaver S, 2018, MOL BIOL EVOL, V35, P773, DOI 10.1093/molbev/msx335; Wei YL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244025; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	40	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0247799	10.1371/journal.pone.0247799	http://dx.doi.org/10.1371/journal.pone.0247799			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33662015	Green Published, gold			2022-12-26	WOS:000626604100083
J	Gerner, MC; Bileck, A; Janker, L; Ziegler, LS; Ohlinger, T; Raeven, P; Mullner, EW; Salzer, U; Gerner, C; Schmetterer, KG; Baron, DM				Gerner, Marlene C.; Bileck, Andrea; Janker, Lukas; Ziegler, Liesa S.; Oehlinger, Thomas; Raeven, Pierre; Muellner, Ernst W.; Salzer, Ulrich; Gerner, Christopher; Schmetterer, Klaus G.; Baron, David M.			Packed red blood cells inhibit T-cell activation via ROS-dependent signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURVIVAL BIOACTIVITIES; TRANSFUSION; GROWTH; TRANSCRIPTION; EXPRESSION; KINETICS; REVEALS	Numerous observations indicate that red blood cells (RBCs) affect T-cell activation and proliferation. We have studied effects of packed RBCs (PRBCs) on T-cell receptor (TCR) signaling and the molecular mechanisms whereby (P)RBCs modulate T-cell activation. In line with previous reports, PRBCs attenuated the expression of T-cell activation markers CD25 and CD69 upon costimulation via CD3/CD28. In addition, T-cell proliferation and cytokine expression were markedly reduced when T-cells were stimulated in the presence of PRBCs. Inhibitory activity of PRBCs required direct cell-cell contact and intact PRBCs. The production of activation-induced cellular reactive oxygen species, which act as second messengers in T-cells, was completely abrogated to levels of unstimulated T-cells in the presence of PRBCs. Phosphorylation of the TCR-related zeta chain and thus proximal TCR signal transduction was unaffected by PRBCs, ruling out mechanisms based on secreted factors and steric interaction restrictions. In large part, downstream signaling events requiring reactive oxygen species for full functionality were affected, as confirmed by an untargeted MS-based phosphoproteomics approach. PRBCs inhibited T-cell activation more efficiently than treatment with 1 mM of the antioxidant N-acetyl cysteine. Taken together, our data imply that inflammation-related radical reactions are modulated by PRBCs. These immunomodulating effects may be responsible for clinical observations associated with transfusion of PRBCs.	[Gerner, Marlene C.] Univ Appl Sci FH Campus Wien, Div Biomed Sci, Vienna, Austria; [Gerner, Marlene C.; Ziegler, Liesa S.; Schmetterer, Klaus G.] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Bileck, Andrea; Janker, Lukas; Gerner, Christopher] Univ Vienna, Fac Chem, Dept Analyt Chem, Vienna, Austria; [Bileck, Andrea; Janker, Lukas; Gerner, Christopher] Univ Vienna, Fac Chem, Joint Metabolome Facil, Vienna, Austria; [Oehlinger, Thomas; Raeven, Pierre; Baron, David M.] Med Univ Vienna, Dept Anaesthesia Intens Care Med & Pain Med, Vienna, Austria; [Muellner, Ernst W.; Salzer, Ulrich] Med Univ Vienna, Ctr Med Biochem, Max Perutz Labs MPL, Vienna, Austria	Medical University of Vienna; University of Vienna; University of Vienna; Medical University of Vienna; Medical University of Vienna	Baron, DM (corresponding author), Med Univ Vienna, Dept Anaesthesia Intens Care Med & Pain Med, Vienna, Austria.	david.baron@meduniwien.ac.at		Janker, Lukas/0000-0002-3084-2212; Schmetterer, Klaus/0000-0001-9328-4871; Salzer, Ulrich/0000-0002-3721-7225; Bileck, Andrea/0000-0002-7053-8856; Gerner, Marlene/0000-0002-4378-9254	Austrian Science Funds, Austria (FWF) [P29654-B30]; Medical-Scientific Fund of the Mayor of the City of Vienna, Austria [15070]	Austrian Science Funds, Austria (FWF)(Austrian Science Fund (FWF)); Medical-Scientific Fund of the Mayor of the City of Vienna, Austria	This work was supported by the grants from the Austrian Science Funds, Austria (FWF; project no.: P29654-B30) to K. G. S. and the Medical-Scientific Fund of the Mayor of the City of Vienna, Austria (project no.: 15070) to D. M. B.	Almasalmeh A, 2014, FEBS J, V281, P647, DOI 10.1111/febs.12653; Almizraq RJ, 2018, BLOOD ADV, V2, P2296, DOI 10.1182/bloodadvances.2018021931; Antunes RF, 2011, IMMUNOL CELL BIOL, V89, P111, DOI 10.1038/icb.2010.60; Antunes RF, 2009, CELL MOL LIFE SCI, V66, P3387, DOI 10.1007/s00018-009-0119-y; Arosa FA, 2004, CURR PHARM DESIGN, V10, P191, DOI 10.2174/1381612043453432; Asquith B, 2006, P R SOC B, V273, P1165, DOI 10.1098/rspb.2005.3432; Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419; Baker PR, 2014, MOL CELL PROTEOMICS, V13, P1392, DOI 10.1074/mcp.O113.037200; Baron DM, 2020, CURR OPIN ANESTHESIO, V33, P234, DOI 10.1097/ACO.0000000000000824; Belizaire RM, 2012, J AM COLL SURGEONS, V214, P648, DOI 10.1016/j.jamcollsurg.2011.12.032; Bernard A, 2010, J TRAUMA, V69, P320, DOI 10.1097/TA.0b013e3181e401f0; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Bileck A, 2014, J PROTEOME RES, V13, P5989, DOI 10.1021/pr5008625; Boussiotis VA, 2000, NAT MED, V6, P290, DOI 10.1038/73144; Casado P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003573; Chapman NM, 2020, NAT REV IMMUNOL, V20, P55, DOI 10.1038/s41577-019-0203-y; Closa D, 2004, IUBMB LIFE, V56, P185, DOI 10.1080/15216540410001701642; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; DAlessandro A., 2020, J PROTEOME RES; Danesh A, 2014, BLOOD, V123, P687, DOI 10.1182/blood-2013-10-530469; Ferraris VA, 2013, AM J SURG, V205, P457, DOI 10.1016/j.amjsurg.2012.07.042; Fonseca AM, 2001, BLOOD, V97, P3152, DOI 10.1182/blood.V97.10.3152; Franchina DG, 2018, TRENDS IMMUNOL, V39, P489, DOI 10.1016/j.it.2018.01.005; Francis RO, 2020, J CLIN INVEST, V130, P2270, DOI 10.1172/JCI133530; Geltink RIK, 2017, CELL, V171, P385, DOI 10.1016/j.cell.2017.08.018; Gerner MC, 2020, FASEB J, V34, P8367, DOI 10.1096/fj.201902664; Gerner MC, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00727; Groessl M, 2014, J PROTEOME RES, V13, P4773, DOI 10.1021/pr500727h; Guram K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00491; Horn H, 2014, NAT METHODS, V11, P603, DOI 10.1038/nmeth.2968; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Humphrey SJ, 2018, NAT PROTOC, V13, DOI 10.1038/s41596-018-0014-9; Le Bourgeois T, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00237; Long K, 2014, J TRAUMA ACUTE CARE, V77, P198, DOI 10.1097/TA.0000000000000330; Martins R, 2016, NAT IMMUNOL, V17, P1361, DOI 10.1038/ni.3590; Mendonca R, 2016, INFLAMM RES, V65, P665, DOI 10.1007/s00011-016-0955-9; Menocha Somaang, 2019, Transfusion, V59, P3553, DOI 10.1111/trf.15461; Metz KS, 2018, CELL SYST, V7, P347, DOI 10.1016/j.cels.2018.07.001; Minetti M, 2006, ANTIOXID REDOX SIGN, V8, P1165, DOI 10.1089/ars.2006.8.1165; Moon C, 2004, AM J HEMATOL, V75, P128, DOI 10.1002/ajh.10476; OGURA Y, 1983, J BIOCHEM-TOKYO, V94, P403, DOI 10.1093/oxfordjournals.jbchem.a134369; Prosenz J, 2019, TRANSFUSION, V59, P454, DOI 10.1111/trf.14956; Roumenina LT, 2016, TRENDS MOL MED, V22, P200, DOI 10.1016/j.molmed.2016.01.004; Schmetterer KG, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01790; Schmidt RLJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42191; Seiser S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-79378-9; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shyer JA, 2020, CELL RES, V30, P649, DOI 10.1038/s41422-020-0379-5; Torrance HDT, 2015, ANN SURG, V261, P751, DOI 10.1097/SLA.0000000000000653; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Ziegler LS, 2021, FEBS J, V288, P640, DOI 10.1111/febs.15361	55	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100487	10.1016/j.jbc.2021.100487	http://dx.doi.org/10.1016/j.jbc.2021.100487			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33676898	gold, Green Published			2022-12-26	WOS:000672866400461
J	Liang, JB; Zhou, YC; Zhang, N; Wang, DD; Cheng, XW; Li, K; Huang, R; Lu, Y; Wang, HL; Han, DQ; Wu, W; Han, M; Miao, SY; Wang, LF; Zhao, H; Song, W				Liang, Junbo; Zhou, Yanchi; Zhang, Ning; Wang, Dingding; Cheng, Xiaowen; Li, Kai; Huang, Rong; Lu, Yan; Wang, Hailong; Han, Deqiang; Wu, Wei; Han, Meng; Miao, Shiying; Wang, Linfang; Zhao, Hong; Song, Wei			The phosphorylation of the Smad2/3 linker region by nemo-like kinase regulates TGF-beta signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE ANTAGONIST; NLK; PROTEIN; IDENTIFICATION; TURNOVER; BMP	Smad2 and Smad3 (Smad2/3) are structurally similar proteins that primarily mediate the transforming growth factor-beta (TGF-beta) signaling responsible for driving cell proliferation, differentiation, and migration. The dynamics of the Smad2/3 phosphorylation provide the key mechanism for regulating the TGF-beta signaling pathway, but the details surrounding this phosphorylation remain unclear. Here, using in vitro kinase assay coupled with mass spectrometry, we identified for the first time that nemo-like kinase (NLK) regulates TGF-beta signaling via modulation of Smad2/3 phosphorylation in the linker region. TGF-beta-mediated transcriptional and cellular responses are suppressed by NLK overexpression, whereas NLK depletion exerts opposite effects. Specifically, we discovered that NLK associates with Smad3 and phosphorylates the designated serine residues located in the linker region of Smad2 and Smad3, which inhibits phosphorylation at the C terminus, thereby decreasing the duration of TGF-beta signaling. Overall, this work demonstrates that phosphorylation on the linker region of Smad2/3 by NLK counteracts the canonical phosphorylation in response to TGF-beta signals, thus providing new insight into the mechanisms governing TGF-beta signaling transduction.	[Liang, Junbo; Zhang, Ning; Wang, Dingding; Cheng, Xiaowen; Li, Kai; Huang, Rong; Lu, Yan; Wang, Hailong; Han, Deqiang; Wu, Wei; Miao, Shiying; Wang, Linfang; Song, Wei] Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, State Key Lab Med Mol Biol,Inst Basic Med Sci, Beijing, Peoples R China; [Zhou, Yanchi; Zhao, Hong] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Hepatobiliary Surg,Natl Canc Ctr, Beijing, Peoples R China; [Han, Meng] Tsinghua Univ, Prot Res Technol Ctr Prot Chem & Omics Platform, Beijing, Peoples R China; [Zhang, Ning] Univ Dundee, Wellcome Ctr Antiinfect Res WCAIR, Dundee, Scotland; [Cheng, Xiaowen] Anhui Med Univ, Affiliated Hosp 1, Dept Clin Lab, Hefei 230022, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Tsinghua University; University of Dundee; Anhui Medical University	Song, W (corresponding author), Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, State Key Lab Med Mol Biol,Inst Basic Med Sci, Beijing, Peoples R China.; Zhao, H (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Hepatobiliary Surg,Natl Canc Ctr, Beijing, Peoples R China.	zhaohong@cicams.ac.cn; songwei@ibms.pumc.edu.cn	Han, Deqiang/GXG-9968-2022; Liang, Junbo/AFN-3446-2022; HAN, Hanley/GNH-5315-2022	Liang, Junbo/0000-0001-6230-1421	National Key R&D Program of China [2018YFC1003500]; CAMS Innovation Fund for Medical Sciences [2017-I2M-3-009, 2016-I2M-1-001, 2017-I2M-4-002]; National Natural Science Foundation of China [81672472, 81672461, 81972311, 31970794, 32000586]; State Key Laboratory Special fund from the Ministry of Science [2060204]; State Key Project on Infection Diseases of China [2017ZX10201021-007-003]; Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences [2019PT310026]; Sanming Project of Medicine in Shenzhen [SZSM202011010]	National Key R&D Program of China; CAMS Innovation Fund for Medical Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory Special fund from the Ministry of Science; State Key Project on Infection Diseases of China; Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences; Sanming Project of Medicine in Shenzhen	This work was supported by grants from the National Key R&D Program of China (2018YFC1003500), CAMS Innovation Fund for Medical Sciences (2017-I2M-3-009, 2016-I2M-1-001, 2017-I2M-4-002), the National Natural Science Foundation of China (81672472, 81672461, 81972311, 31970794, 32000586), the State Key Laboratory Special fund from the Ministry of Science (2060204), the State Key Project on Infection Diseases of China (2017ZX10201021-007-003), the Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences (2019PT310026), and Sanming Project of Medicine in Shenzhen (SZSM202011010).	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Brott BK, 1998, P NATL ACAD SCI USA, V95, P963, DOI 10.1073/pnas.95.3.963; CHOI KW, 1994, CELL, V78, P125, DOI 10.1016/0092-8674(94)90579-7; Derynck R, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav5183; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Han Y, 2014, BIOMED PHARMACOTHER, V68, P497, DOI 10.1016/j.biopha.2014.05.003; Huang Y, 2015, TUMOR BIOL, V36, P9147, DOI 10.1007/s13277-015-4159-7; Ishitani T, 2013, CELL SIGNAL, V25, P190, DOI 10.1016/j.cellsig.2012.09.017; Ishitani T, 2010, NAT CELL BIOL, V12, P278, DOI 10.1038/ncb2028; Kamato D, 2020, CELL MOL LIFE SCI, V77, P243, DOI 10.1007/s00018-019-03266-3; Kamato D, 2013, CELL SIGNAL, V25, P2017, DOI 10.1016/j.cellsig.2013.06.001; Li SZ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11258-x; Li SZ, 2014, BBA-MOL CELL RES, V1843, P1365, DOI 10.1016/j.bbamcr.2014.03.028; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu XF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2762; Masoumi KC, 2017, MOL BIOL CELL, V28, P346, DOI 10.1091/mbc.E16-07-0547; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsuura I, 2005, BIOCHEMISTRY-US, V44, P12546, DOI 10.1021/bi050560g; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Millet C, 2009, J BIOL CHEM, V284, P19808, DOI 10.1074/jbc.M109.016667; Moon S, 2017, EMBO REP, V18, P61, DOI 10.15252/embr.201642683; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Moses HL, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021865; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Ota R, 2011, BIOCHEMISTRY-US, V50, P5648, DOI 10.1021/bi2002696; Ota S, 2012, EMBO J, V31, P1904, DOI 10.1038/emboj.2012.46; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Sapkota G, 2006, J BIOL CHEM, V281, P40412, DOI 10.1074/jbc.M610172200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Thorpe CJ, 2004, DEVELOPMENT, V131, P2899, DOI 10.1242/dev.01171; Wang GN, 2009, J BIOL CHEM, V284, P9663, DOI 10.1074/jbc.M809281200; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; Yoon JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8600; Yu JSL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8212; Yu Y, 2019, CURR OPIN CELL BIOL, V61, P56, DOI 10.1016/j.ceb.2019.07.007; Yuan HX, 2015, GENE DEV, V29, P2362, DOI 10.1101/gad.265116.115; Zeng YA, 2004, DEVELOPMENT, V131, P2911, DOI 10.1242/dev.01177; Zeng YA, 2007, DEVELOPMENT, V134, P2061, DOI 10.1242/dev.02853	42	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100512	10.1016/j.jbc.2021.100512	http://dx.doi.org/10.1016/j.jbc.2021.100512			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33676893	gold, Green Published			2022-12-26	WOS:000672866400486
J	Restelli, E; Capone, V; Pozzoli, M; Ortolan, D; Quaglio, E; Corbelli, A; Fiordaliso, F; Beznoussenko, GV; Artuso, V; Roiter, I; Sallese, M; Chiesa, R				Restelli, Elena; Capone, Vanessa; Pozzoli, Manuela; Ortolan, Davide; Quaglio, Elena; Corbelli, Alessandro; Fiordaliso, Fabio; Beznoussenko, Galina, V; Artuso, Vladimiro; Roiter, Ignazio; Sallese, Michele; Chiesa, Roberto			Activation of Src family kinase ameliorates secretory trafficking in mutant prion protein cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLGI; PRP; AGGREGATION; EXPRESSION; NEURONS; SURFACE; GENE; CONVERSION; MUTATIONS; DELIVERY	Fatal familial insomnia (FFI), genetic Creutzfeldt-Jakob disease (gCJD), and Gerstmann-Straussler-Scheinker (GSS) syndrome are neurodegenerative disorders linked to prion protein (PrP) mutations. The pathogenic mechanisms are not known, but increasing evidence points to mutant PrP misfolding and retention in the secretory pathway. We previously found that the D178N/M129 mutation associated with FFI accumulates in the Golgi of neuronal cells, impairing post-Golgi trafficking. In this study we further characterized the trafficking defect induced by the FFI mutation and tested the 178N/V129 variant linked to gCJD and a nine-octapeptide repeat insertion associated with GSS. We used transfected HeLa cells, embryonic fibroblasts and primary neurons from transgenic mice, and fibroblasts from carriers of the FFI mutation. In all these cell types, the mutant PrPs showed abnormal intracellular localizations, accumulating in the endoplasmic reticulum (ER) and Golgi. To test the efficiency of the membrane trafficking system, we monitored the intracellular transport of the temperature-sensitive vesicular stomatite virus glycoprotein (VSV-G), a well-established cargo reporter, and of endogenous procollagen I (PC-I). We observed marked alterations in secretory trafficking, with VSV-G accumulating mainly in the Golgi complex and PC-I in the ER and Golgi. A redacted version of mutant PrP with reduced propensity to misfold did not impair VSV-G trafficking, nor did artificial ER or Golgi retention of wild-type PrP; this indicates that both misfolding and intracellular retention were required to induce the transport defect. Pharmacological activation of Src family kinase (SFK) improved intracellular transport, suggesting that mutant PrP impairs secretory trafficking through corruption of SFK-mediated signaling.	[Restelli, Elena; Pozzoli, Manuela; Ortolan, Davide; Quaglio, Elena; Chiesa, Roberto] Dept Neurosci, Lab Prion Neurobiol, Ist Ric Farmacol Mario Negri IRCCS, Milan, Italy; [Capone, Vanessa; Sallese, Michele] Univ G DAnnunzio, Dept Innovat Technol Med & Dent, Chieti, Italy; [Capone, Vanessa; Sallese, Michele] Univ G DAnnunzio, Ctr Adv Studies & Technol CAST, Chieti, Italy; [Corbelli, Alessandro; Fiordaliso, Fabio] Ist Ric Farmacol Mario Negri IRCCS, Bioimaging Unit, Dept Cardiovasc Med, Milan, Italy; [Beznoussenko, Galina, V] IFOM FIRC Inst Mol Oncol, Milan, Italy; [Artuso, Vladimiro] ULSS 3 Serenissima, Venice, Italy; [Roiter, Ignazio] CaFoncello Hosp, ULSS 2 Marca Trevigiana, Treviso, Italy; [Ortolan, Davide] NEI, Unit Ocular & Stem Cell Translat Res, NIH, Bethesda, MD USA	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IFOM - FIRC Institute of Molecular Oncology; ULSS 3 Serenissima; Ospedale SS Giovanni Paolo Venezia; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Chiesa, R (corresponding author), Dept Neurosci, Lab Prion Neurobiol, Ist Ric Farmacol Mario Negri IRCCS, Milan, Italy.	roberto.chiesa@marionegri.it	Ortolan, Davide/AFP-8878-2022; Chiesa, Roberto/G-1561-2017	Ortolan, Davide/0000-0002-8236-9391; Chiesa, Roberto/0000-0002-3842-3733	Italian Ministry of Health [RF-2010-2314035]; Telethon Italy [TCR08005, GGP12115, GGP10208]; Fondazione Cariplo [2012-0560]	Italian Ministry of Health(Ministry of Health, Italy); Telethon Italy(Fondazione Telethon); Fondazione Cariplo(Fondazione Cariplo)	This work was supported by grants from the Italian Ministry of Health (RF-2010-2314035), Telethon Italy (TCR08005; GGP12115; GGP10208), and "Fondazione Cariplo" (2012-0560). We thank Antonella De Matteis (Telethon Institute of Genetics and Medicine) for providing anti-VSV-G and anti-GM130 antibodies for immuno-EM and Roman Polishchuk (Telethon Institute of Genetics and Medicine) for the CD59-GFP plasmid. We are grateful to members of the Italian Fatal Familial Insomnia Family Association (AFIFF; https://www.afiff.net/) for skin biopsies.	Apetri AC, 2005, BIOCHEMISTRY-US, V44, P15880, DOI 10.1021/bi051455+; Ashok A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000479; Biasini E, 2008, J NEUROCHEM, V104, P1293, DOI 10.1111/j.1471-4159.2007.05082.x; Biasini E, 2010, BIOCHEM J, V430, P477, DOI 10.1042/BJ20100615; Bouybayoune I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004796; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Capone V, 2018, BBA-MOL BASIS DIS, V1864, P3164, DOI 10.1016/j.bbadis.2018.07.003; Chiesa R, 2003, J VIROL, V77, P7611, DOI 10.1128/JVI.77.13.7611-7622.2003; Chiesa R, 2000, P NATL ACAD SCI USA, V97, P5574, DOI 10.1073/pnas.97.10.5574; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Chiesa R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004745; Chiesa R, 2009, PLOS BIOL, V7, P439, DOI 10.1371/journal.pbio.1000075; Daude N, 1997, J BIOL CHEM, V272, P11604, DOI 10.1074/jbc.272.17.11604; Dossena S, 2008, NEURON, V60, P598, DOI 10.1016/j.neuron.2008.09.008; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Fioriti L, 2005, J BIOL CHEM, V280, P11320, DOI 10.1074/jbc.M412441200; Ghirardini E, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008654; Hipp MS, 2019, NAT REV MOL CELL BIO, V20, P421, DOI 10.1038/s41580-019-0101-y; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Ivanova L, 2001, J BIOL CHEM, V276, P42409, DOI 10.1074/jbc.M106928200; Kim MO, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a033134; Kuffer A, 2016, NATURE, V536, P464, DOI 10.1038/nature19312; Lee S, 2010, EMBO J, V29, P251, DOI 10.1038/emboj.2009.333; Lehmann S, 1996, J BIOL CHEM, V271, P1633, DOI 10.1074/jbc.271.3.1633; Griffiths Gareth, 1993, Trends in Cell Biology, V3, P214, DOI 10.1016/0962-8924(93)90114-G; Malaga-Trillo E, 2016, PRION, V10, P352, DOI 10.1080/19336896.2016.1221873; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; MANSON J, 1992, DEVELOPMENT, V115, P117; Martinez-Vicente M, 2005, EXP GERONTOL, V40, P622, DOI 10.1016/j.exger.2005.07.005; Massignan T, 2010, MOL CELL PROTEOMICS, V9, P611, DOI 10.1074/mcp.M900271-MCP200; MCKINLEY MP, 1987, DEV BIOL, V121, P105, DOI 10.1016/0012-1606(87)90143-6; Minikel EV, 2019, NEUROLOGY, V93, pE125, DOI 10.1212/WNL.0000000000007745; Mironov AA, 2001, J CELL BIOL, V155, P1225, DOI 10.1083/jcb.200108073; Moore RA, 2006, PROTEIN SCI, V15, P609, DOI 10.1110/ps.051822606; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Park SY, 2015, NATURE, V521, P529, DOI 10.1038/nature14457; Polishchuk R, 2004, NAT CELL BIOL, V6, P297, DOI 10.1038/ncb1109; Priola SA, 1998, J BIOL CHEM, V273, P11980, DOI 10.1074/jbc.273.19.11980; Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751; Quaglio E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019339; Restelli E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013725; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Sallese M, 2009, SEMIN CELL DEV BIOL, V20, P801, DOI 10.1016/j.semcdb.2009.04.004; Senatore A, 2013, INT J CELL BIOL, V2013, DOI DOI 10.1155/2013/543803; Senatore A, 2012, NEURON, V74, P300, DOI 10.1016/j.neuron.2012.02.027; Singh N, 1997, J BIOL CHEM, V272, P28461, DOI 10.1074/jbc.272.45.28461; Tapella L, 2013, BIOCHEM J, V454, P417, DOI 10.1042/BJ20130563; Uchiyama K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2873; Yu SL, 2007, BIOCHEM J, V403, P343, DOI 10.1042/BJ20061592; Zavodszky E, 2019, ELIFE, V8, DOI 10.7554/eLife.46740	54	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100490	10.1016/j.jbc.2021.100490	http://dx.doi.org/10.1016/j.jbc.2021.100490			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33662396	Green Published, gold			2022-12-26	WOS:000672866400464
J	Sang, LJ; Vieira, DCO; Yue, DT; Ben-Johny, M; Dick, IE				Sang, Lingjie; Vieira, Daiana C. O.; Yue, David T.; Ben-Johny, Manu; Dick, Ivy E.			The molecular basis of the inhibition of Ca(V)1 calcium-dependent inactivation by the distal carboxy tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINUS; CA2+-DEPENDENT INACTIVATION; FLUORESCENT PROTEIN; SKELETAL-MUSCLE; CA2+ REGULATION; STAC PROTEINS; IQ DOMAIN; CHANNEL; CALMODULIN; BINDING	Ca2+/calmodulin-dependent inactivation (CDI) of Ca-V channels is a critical regulatory process that tunes the kinetics of Ca2+ entry for different cell types and physiologic responses. CDI is mediated by calmodulin (CaM), which is bound to the IQ domain of the Ca-V carboxy tail. This modulatory process is tailored by alternative splicing such that select splice variants of Ca(V)1.3 and Ca(V)1.4 contain a long distal carboxy tail (DCT). The DCT harbors an inhibitor of CDI (ICDI) module that competitively displaces CaM from the IQ domain, thereby diminishing CDI. While this overall mechanism is now well described, the detailed interactions required for ICDI binding to the IQ domain are yet to be elucidated. Here, we perform alanine-scanning mutagenesis of the IQ and ICDI domains and evaluate the contribution of neighboring regions to CDI inhibition. Through FRET binding analysis, we identify functionally relevant residues within the Ca(V)1.3 IQ domain and the Ca(V)1.4 ICDI and nearby A region, which are required for high-affinity IQ/ICDI binding. Importantly, patch-clamp recordings demonstrate that disruption of this interaction commensurately diminishes ICDI function resulting in the re-emergence of CDI in mutant channels. Furthermore, Ca(V)1.2 channels harbor a homologous DCT; however, the ICDI region of this channel does not appear to appreciably modulate Ca(V)1.2 CDI. Yet coexpression of Ca(V)1.2 ICDI with select Ca(V)1.3 splice variants significantly disrupts CDI, implicating a cross-channel modulatory scheme in cells expressing both channel subtypes. In all, these findings provide new insights into a molecular rheostat that fine-tunes Ca2+-entry and supports normal neuronal and cardiac function.	[Sang, Lingjie; Yue, David T.; Ben-Johny, Manu; Dick, Ivy E.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Vieira, Daiana C. O.; Dick, Ivy E.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Ben-Johny, Manu] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA	Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Columbia University	Dick, IE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.; Dick, IE (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	ied@som.umaryand.edu		Dick, Ivy/0000-0002-7253-6846	NIH/NINDS [5R01NS085074]; NIH/NHLBI [1R01HL149926]	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This grant was supported by an NIH/NINDS grant 5R01NS085074 and by an NIH/NHLBI grant 1R01HL149926. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PJ, 2014, CELL, V159, P608, DOI 10.1016/j.cell.2014.09.047; Alseikhan BA, 2002, P NATL ACAD SCI USA, V99, P17185, DOI 10.1073/pnas.262372999; Bazzazi H, 2013, CELL REP, V5, P367, DOI 10.1016/j.celrep.2013.09.006; Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; Bock G, 2011, J BIOL CHEM, V286, P42736, DOI 10.1074/jbc.M111.269951; Campiglio M, 2018, P NATL ACAD SCI USA, V115, P1376, DOI 10.1073/pnas.1715997115; Chaudhuri D, 2007, J GEN PHYSIOL, V129, P385, DOI 10.1085/jgp.200709749; Christel CJ, 2012, J PHYSIOL-LONDON, V590, DOI 10.1113/jphysiol.2012.239954; Doering CJ, 2005, BIOPHYS J, V89, P3042, DOI 10.1529/biophysj.105.067124; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Fuller MD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001152; Gao TY, 2000, J BIOL CHEM, V275, P25436, DOI 10.1074/jbc.M003465200; Gerhardstein BL, 2000, J BIOL CHEM, V275, P8556, DOI 10.1074/jbc.275.12.8556; Ghosh D, 2017, Adv Pharmacol, V78, P49, DOI 10.1016/bs.apha.2016.08.002; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Griessmeier K, 2009, J BIOL CHEM, V284, P29809, DOI 10.1074/jbc.M109.048082; GUTIERREZ LM, 1991, J BIOL CHEM, V266, P16387; Haeseleer F, 2016, J BIOL CHEM, V291, P15663, DOI 10.1074/jbc.M116.731737; Harvey RD, 2013, J MOL CELL CARDIOL, V58, P143, DOI 10.1016/j.yjmcc.2012.12.006; Hoda JC, 2005, J NEUROSCI, V25, P252, DOI 10.1523/JNEUROSCI.3054-04.2005; Huang H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5481; Huang H, 2012, NEURON, V73, P304, DOI 10.1016/j.neuron.2011.11.022; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Hurley MJ, 2013, BRAIN, V136, P2077, DOI 10.1093/brain/awt134; Johny MB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2727; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Lieb A, 2012, CHANNELS, V6, P197, DOI 10.4161/chan.21002; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Liu N, 2017, ELIFE, V6, DOI 10.7554/eLife.21989; Liu XD, 2010, NATURE, V463, P968, DOI 10.1038/nature08766; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; MCDONALD TF, 1994, PHYSIOL REV, V74, P365, DOI 10.1152/physrev.1994.74.2.365; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Niu J, 2018, ELIFE, V7, DOI 10.7554/eLife.35222; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Polster E, 2018, J NEUROSCI, V38, P9215, DOI 10.1523/JNEUROSCI.0695-18.2018; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Sang LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12239; Schroder E, 2009, CIRC RES, V104, P1373, DOI 10.1161/CIRCRESAHA.108.191387; Shaltiel L, 2012, J BIOL CHEM, V287, P36312, DOI 10.1074/jbc.M112.392811; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Striessnig J, 2006, BIOCHEM SOC T, V34, P903, DOI 10.1042/BST0340903; Striessnig J, 2015, CURR MOL PHARMACOL, V8, P110, DOI 10.2174/1874467208666150507105845; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Tan GMY, 2012, J BIOL CHEM, V287, P832, DOI 10.1074/jbc.M111.268722; Wahl-Schott C, 2006, P NATL ACAD SCI USA, V103, P15657, DOI 10.1073/pnas.0604621103; WEI XY, 1991, J BIOL CHEM, V266, P21943; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; Yang PS, 2014, NAT CHEM BIOL, V10, P231, DOI [10.1038/NCHEMBIO.1436, 10.1038/nchembio.1436]; Yuen SMWK, 2017, P NATL ACAD SCI USA, V114, pE9520, DOI 10.1073/pnas.1708852114; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	60	3	3	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100502	10.1016/j.jbc.2021.100502	http://dx.doi.org/10.1016/j.jbc.2021.100502			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33667546	Green Published, gold			2022-12-26	WOS:000672866400476
J	Chang, YM; Menges, S; Westhof, A; Kleinschmidt-Doerr, K; Brenneis, C; Pitsillides, AA				Chang, Yu-Mei; Menges, Stephanie; Westhof, Andreas; Kleinschmidt-Doerr, Kerstin; Brenneis, Christian; Pitsillides, Andrew A.			Systematic analysis reveals that colony housing aligns gait profiles and strengthens link between histological and micro-CT bone markers in rat models of osteoarthritis	FASEB JOURNAL			English	Article						colony housing; gait; histology; micro&#8208; CT; osteoarthritis	RODENT MODELS; PAIN; RECOMMENDATIONS; ASSESSMENTS; STRESS	Osteoarthritis (OA) etiopathogenesis is complex with strong environmental/lifestyle determinants that, in laboratory animals, extend to social context and stress levels. This study seeks to identify whether colony housing of rats exerts a social impact on locomotion behaviors to influence alignment between symptomatic (gait) and structural (bone micro-CT measures, cartilage morphometry, and histology) OA outcome measures. Rats were randomly allocated to conventional (type IV; n = 48) or rat colony cage (RCC; n = 30) housing, further randomized to OA surgical models (ACLT + tMx, MMT or DMM) or no surgery (control), and maintained for 19 weeks during which multiple gait recordings were made. Standard histological grading and bone micro-CT data were collected at necropsy. Principal component analysis was used to summarize the variation in gait, micro-CT or histology. Linear mixed effects model or two-way ANOVA was employed to evaluate the impact of the housing system, surgery and time on gait, or micro-CT and histology components Analyses reveal that RCC exaggerates trends in gait change via a combined effect of the housing system and surgery. Intriguingly, RCC-housed nonoperated control rats showed similar gait changes to rats subjected to surgery; the latter exhibited significant structural joint changes in both systems. Stronger correlation between histological and micro-CT bone changes were found in medial and lateral tibia joint compartments of rats housed in RCC system. This study has established that rat social housing exaggerates outcomes in traditional histological measures of OA, generates stronger links between histology and micro-CT bone changes and removes gait differences as a variable in their etiology.	[Chang, Yu-Mei; Pitsillides, Andrew A.] Royal Vet Coll, Dept Comparat Biomed Sci, London, England; [Menges, Stephanie; Westhof, Andreas; Kleinschmidt-Doerr, Kerstin; Brenneis, Christian] Merck Healthcare KGaA, Darmstadt, Germany	University of London; University of London Royal Veterinary College	Chang, YM (corresponding author), Royal Vet Coll, 4 Royal Coll St, London NW1 0TU, England.	ychang@rvc.ac.uk						Adebayo OO, 2017, OSTEOARTHR CARTILAGE, V25, P2108, DOI 10.1016/j.joca.2017.08.016; Bedson J, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-116; BERMAN D, 1982, PAIN, V13, P307, DOI 10.1016/0304-3959(82)90020-3; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bove SE, 2006, OSTEOARTHR CARTILAGE, V14, P1041, DOI 10.1016/j.joca.2006.05.001; Brenneis C, 2020, Osteoarthr Cartil Open, V2, P100100, DOI 10.1016/j.ocarto.2020.100100; Brenneis C, 2017, J AM ASSOC LAB ANIM, V56, P18; Burr DB, 2004, J RHEUMATOL, V31, P77; Gerwin N, 2010, OSTEOARTHR CARTILAGE, V18, pS24, DOI 10.1016/j.joca.2010.05.030; HUSKISSON EC, 1995, J RHEUMATOL, V22, P1941; Huzard D, 2015, PHYSIOL BEHAV, V151, P238, DOI 10.1016/j.physbeh.2015.07.018; Jacobs BY, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0456-x; Javaheri B, 2017, BONE, V103, P308, DOI 10.1016/j.bone.2017.07.028; Kraus VB, 2010, OSTEOARTHR CARTILAGE, V18, pS35, DOI 10.1016/j.joca.2010.04.015; Lakes EH, 2016, OSTEOARTHR CARTILAGE, V24, P1837, DOI 10.1016/j.joca.2016.03.008; Liu X, 2013, BRAIN RES, V1502, P71, DOI 10.1016/j.brainres.2013.01.044; Lorenz J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105858; Malfait AM, 2013, OSTEOARTHR CARTILAGE, V21, P1316, DOI 10.1016/j.joca.2013.06.003; Malfait AM, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0747-6; Martin Loren J, 2014, Curr Top Behav Neurosci, V20, P233, DOI 10.1007/7854_2014_287; Meakin LB, 2013, BONE, V54, P113, DOI 10.1016/j.bone.2013.01.029; Murphy L, 2008, ARTHRIT RHEUM-ARTHR, V59, P1207, DOI 10.1002/art.24021; Ohtori S, 2013, YONSEI MED J, V54, P1253, DOI 10.3349/ymj.2013.54.5.1253; Patterson-Kane EG, 2002, ANIM WELFARE, V11, P327; Poulet B, 2015, OSTEOARTHR CARTILAGE, V23, P940, DOI 10.1016/j.joca.2015.01.012; Salvarrey-Strati A, 2008, ILAR J, V49, pE23; Santangelo KS, 2014, ARTHRITIS, DOI 10.1155/2014/503519; Shu CC, 2020, ARTHRITIS RES THER, V22, DOI 10.1186/s13075-020-2117-2; Suri P, 2012, PM&R, V4, pS10, DOI 10.1016/j.pmrj.2012.01.007; TenBroek EM, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0921-5; U.S. Department of Health and Human Services Food and Drug Administration, 2018, OSTEOARTHRITIS STRUC; van der Kraan PM, 2017, OSTEOARTHR CARTILAGE, V25, P369, DOI 10.1016/j.joca.2016.09.005	32	2	2	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21451	10.1096/fj.202002009R	http://dx.doi.org/10.1096/fj.202002009R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33683776	hybrid			2022-12-26	WOS:000635216100081
J	Rohwer, N; Chiu, CY; Huang, D; Smyl, C; Rothe, M; Rund, KM; Schebb, NH; Kuhn, H; Weylandt, KH				Rohwer, Nadine; Chiu, Cheng-Ying; Huang, Dan; Smyl, Christopher; Rothe, Michael; Rund, Katharina M.; Helge Schebb, Nils; Kuhn, Hartmut; Weylandt, Karsten-Henrich			Omega-3 fatty acids protect from colitis via an Alox15-derived eicosanoid	FASEB JOURNAL			English	Article						lipid peroxidation; lipoxygenases; eicosanoids; inflammatory bowel disease		An increased omega-3 polyunsaturated fatty acid (n-3 PUFA) tissue status can lead to a significant formation of anti-inflammatory lipid mediators and effective reduction in inflammation and tissue injury in murine colitis. Arachidonic acid lipoxygenases (ALOX) have been implicated in the pathogenesis of inflammatory bowel disease as well as in the formation of pro- and anti-inflammatory lipid mediators. To explore the role of Alox15 in the protective response found in fat1 transgenic mice with endogenously increased n-3 PUFA tissue status fat1 transgenic mice were crossed with Alox15-deficient animals and challenged in the dextran sulfate sodium (DSS)- and the 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis model. Transgenic fat1 mice rich in endogenous n-3 PUFAs were protected from colitis. However, additional systemic inactivation of the Alox15 gene counteracted this protective effect. To explore the molecular basis for this effect Alox15 lipid metabolites derived from n-3 PUFA were analyzed in the different mice. Alox15 deficiency suppressed the formation of n-3 PUFA-derived 15-hydroxy eicosapentaenoic acid (15-HEPE). In contrast, treating mice with intraperitoneal injections of 15S-HEPE protected wild-type mice from DSS- and TNBS-induced colitis. These data suggest that the anti-colitis effect of increased n-3 PUFA in the transgenic fat1 mouse model is mediated in part via Alox15-derived 15-HEPE formation.	[Rohwer, Nadine; Weylandt, Karsten-Henrich] Brandenburg Med Sch Theodor Fontane, Ruppin Gen Hosp, Dept Gastroenterol Metab & Oncol, Div Med, Neuruppin, Germany; [Rohwer, Nadine; Weylandt, Karsten-Henrich] Theodor Fontane & Univ Potsdam, Brandenburg Med Sch, Joint Fac Brandenburg Univ Technol Cottbus Senfte, Fac Hlth Sci Brandenburg, Potsdam, Germany; [Rohwer, Nadine; Chiu, Cheng-Ying; Huang, Dan; Smyl, Christopher; Weylandt, Karsten-Henrich] Charite Univ Med Berlin, Dept Hepatol Gastroenterol & Metab, Div Med, Berlin, Germany; [Rohwer, Nadine; Chiu, Cheng-Ying; Huang, Dan; Smyl, Christopher; Kuhn, Hartmut; Weylandt, Karsten-Henrich] Humboldt Univ, Freie Univ Berlin, Berlin, Germany; [Rohwer, Nadine; Chiu, Cheng-Ying; Huang, Dan; Smyl, Christopher; Kuhn, Hartmut; Weylandt, Karsten-Henrich] Berlin Inst Hlth, Berlin, Germany; [Rohwer, Nadine] German Inst Human Nutr, Dept Mol Toxicol, Potsdam, Nuthetal, Germany; [Rothe, Michael] Lipidomix GmbH, Berlin, Germany; [Rund, Katharina M.; Helge Schebb, Nils] Univ Wuppertal, Fac Math & Nat Sci, Chair Food Chem, Wuppertal, Germany; [Kuhn, Hartmut] Charite Univ Med Berlin, Inst Biochem, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Wuppertal; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Weylandt, KH (corresponding author), Brandenburg Med Sch, Ruppin Gen Hosp, Dept Gastroenterol Metab & Oncol, Div Med, Neuruppin, Germany.	karsten.weylandt@mhb-fontane.de		Schebb, Nils Helge/0000-0003-1299-6629; Rohwer, Nadine/0000-0001-6170-1327	Deutsche Forschungsgemeinschaft (DFG) [WE2908/11-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: KU961/11-1; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: KU961/13-1; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: WE2908/11-1	Ackermann JA, 2017, BBA-MOL CELL BIOL L, V1862, P371, DOI 10.1016/j.bbalip.2016.07.014; Adel S, 2016, P NATL ACAD SCI USA, V113, pE4266, DOI 10.1073/pnas.1604029113; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Bento AF, 2011, J IMMUNOL, V187, P1957, DOI 10.4049/jimmunol.1101305; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Campbell EL, 2010, P NATL ACAD SCI USA, V107, P14298, DOI 10.1073/pnas.0914730107; COOPER HS, 1993, LAB INVEST, V69, P238; Coras R, 2019, METABOLOMICS, V15, DOI 10.1007/s11306-019-1527-0; FREIREMOAR J, 1995, BBA-LIPID LIPID MET, V1254, P112, DOI 10.1016/0005-2760(94)00199-9; Gil A, 2002, BIOMED PHARMACOTHER, V56, P388, DOI 10.1016/S0753-3322(02)00256-1; Gobbetti T, 2017, P NATL ACAD SCI USA, V114, P3963, DOI 10.1073/pnas.1617290114; Goto Y, 2015, CURR OPIN RHEUMATOL, V27, P388, DOI 10.1097/BOR.0000000000000192; Graham TO, 2002, GASTROENTEROL CLIN N, V31, P203, DOI 10.1016/S0889-8553(01)00022-X; Gu MQ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101351; Huang CH, 2015, CLIN NUTR, V34, P1018, DOI 10.1016/j.clnu.2014.11.008; Hudert CA, 2006, P NATL ACAD SCI USA, V103, P11276, DOI 10.1073/pnas.0601280103; Ishida T, 2010, INFLAMM BOWEL DIS, V16, P87, DOI 10.1002/ibd.21029; Jisaka M, 2000, J BIOL CHEM, V275, P1287, DOI 10.1074/jbc.275.2.1287; Jupp J, 2007, INFLAMM BOWEL DIS, V13, P537, DOI 10.1002/ibd.20094; Kang JX, 2007, PROSTAG LEUKOTR ESS, V77, P263, DOI 10.1016/j.plefa.2007.10.010; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; Kroschwald S, 2018, BBA-MOL CELL BIOL L, V1863, P866, DOI 10.1016/j.bbalip.2018.04.019; KUHN H, 1990, J BIOL CHEM, V265, P18351; Kuhn H, 2018, PROG LIPID RES, V72, P55, DOI 10.1016/j.plipres.2018.09.002; Kuhn H, 2015, BBA-MOL CELL BIOL L, V1851, P308, DOI 10.1016/j.bbalip.2014.10.002; Kutzner L, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158806; Kutzner L, 2017, BBA-MOL CELL BIOL L, V1862, P666, DOI 10.1016/j.bbalip.2017.04.001; Lewis JD, 2017, GASTROENTEROLOGY, V152, P398, DOI 10.1053/j.gastro.2016.10.019; Marcon R, 2013, J IMMUNOL, V191, P4288, DOI 10.4049/jimmunol.1202743; Mazzon E, 2006, SHOCK, V25, P377, DOI 10.1097/01.shk.0000209530.30564.22; Nguyen DH, 2011, BRIT J PHARMACOL, V162, P1119, DOI 10.1111/j.1476-5381.2010.01117.x; Ostermann AI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184470; Pergola C, 2008, P NATL ACAD SCI USA, V105, P19881, DOI 10.1073/pnas.0809120105; Pochard C, 2016, GASTROENTEROLOGY, V150, P168, DOI 10.1053/j.gastro.2015.09.038; Romano M, 2010, THESCIENTIFICWORLDJO, V10, P1048, DOI 10.1100/tsw.2010.113; Rossi A, 2019, PHARMACOL RES, V139, P182, DOI 10.1016/j.phrs.2018.11.024; Rund KM, 2018, ANAL CHIM ACTA, V1037, P63, DOI 10.1016/j.aca.2017.11.002; Serhan CN, 2013, CURR OPIN PHARMACOL, V13, P632, DOI 10.1016/j.coph.2013.05.012; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; SIGAL E, 1990, J BIOL CHEM, V265, P5113; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yum HW, 2017, BIOCHEM BIOPH RES CO, V487, P847, DOI 10.1016/j.bbrc.2017.04.140	47	2	2	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21491	10.1096/fj.202002340RR	http://dx.doi.org/10.1096/fj.202002340RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710695	Green Published			2022-12-26	WOS:000635216100033
J	Xu, LW; Gou, X; Yang, JY; Jiang, R; Jiang, X; Chen, GG; Liu, ZM				Xu, Lin-Wan; Gou, Xi; Yang, Jun-Yan; Jiang, Rong; Jiang, Xue; Chen, George G.; Liu, Zhi-Min			Methylation of ER beta 5 '-untranslated region attenuates its inhibitory effect on ER alpha gene transcription and promotes the initiation and progression of papillary thyroid cancer	FASEB JOURNAL			English	Article						5&#8242; &#8208; untranslated region; ER&#945; mRNA (A&#8208; 1); ER&#946; mRNA (0N&#8208; 1)		Normal thyroid tissue displays a prevalent expression of ER beta than ER alpha, which drastically turns upside down in the initiation and progression of papillary thyroid cancer (PTC). The underlying molecular mechanism of this phenomenon remains unclear. Here, we demonstrated that ER alpha and ER beta were coexpressed in human thyroid tissues and cells. ER alpha mRNA (A-1) and ER beta mRNA (0N-1), transcribed from Promoter A of ER alpha gene and Promoter 0N of ER beta gene, respectively, were the major mRNA isoforms which mainly contributed to total ER alpha mRNA and total ER beta mRNA in human thyroid-derived cell lines and tissues. The expression levels of ER alpha mRNA (A-1) and total ER alpha mRNA were gradually increased, and those of ER beta mRNA (0N-1) and total ER beta mRNA were decreased by degree in the initiation and progression of PTC. No aberrant DNA methylation of ER alpha 5 '-untranslated region was involved in its up-regulation; however, aberrant DNA methylation in Promoter 0N and Exon 0N of ER beta gene was found to be involved in its down-regulation in the initiation and progression of PTC. ER beta can repress ER alpha gene transcription via recruitment of NCoR and displacement of RNA polymerase II at the Sp1 site in ER alpha Promoter A-specific region in thyroid-derived cells. It is suggested that DNA methylation of CpG islands in Promoter 0N and Exon 0N of ER beta gene leads to a decreased ER beta gene expression, which attenuates its inhibitory effect on ER alpha gene transcription and results in an increased ER alpha gene expression, cell proliferation, initiation, and progression of PTC.	[Xu, Lin-Wan; Gou, Xi; Yang, Jun-Yan; Jiang, Rong; Jiang, Xue; Liu, Zhi-Min] Chongqing Med Univ, Coll Basic Med, Mol Med & Canc Res Ctr, Dept Biochem & Mol Biol, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China; [Chen, George G.] Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Dept Otorhinolaryngol Head & Neck Surg, Hong Kong, Peoples R China	Chongqing Medical University; Chinese University of Hong Kong; Prince of Wales Hospital	Liu, ZM (corresponding author), Chongqing Med Univ, Coll Basic Med, Mol Med & Canc Res Ctr, Dept Biochem & Mol Biol, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China.	liuzm9999@aliyun.com			National Natural Science Foundation of China [81272937]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81272937	Ahn HY, 2015, CLIN ENDOCRINOL, V82, P300, DOI 10.1111/cen.12486; Al-Nakhle H, 2013, INT J ONCOL, V43, P2039, DOI 10.3892/ijo.2013.2112; Barreto-Andrade JN, 2018, INT J MED SCI, V15, P1320, DOI 10.7150/ijms.26774; Bartella V, 2012, BREAST CANCER RES TR, V134, P569, DOI 10.1007/s10549-012-2090-9; Bie LH, 2018, J MOL MODEL, V24, DOI 10.1007/s00894-018-3678-8; Bossard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044787; Bouras E, 2019, GENE, V710, P333, DOI 10.1016/j.gene.2019.06.023; de Dieuleveult M, 2018, EPIGENETICS INSIGHTS, V11, DOI 10.1177/2516865718811117; deGraffenried LA, 2004, BREAST CANCER RES TR, V85, P111, DOI 10.1023/B:BREA.0000025398.93829.78; deGraffenried LA, 2002, J STEROID BIOCHEM, V82, P7, DOI 10.1016/S0960-0760(02)00151-6; Medina-Jaime AD, 2014, ASIAN PAC J CANCER P, V15, P3041, DOI 10.7314/APJCP.2014.15.7.3041; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Eliassen AH, 2008, ADV EXP MED BIOL, V630, P148; Enmark E, 1997, J CLIN ENDOCR METAB, V82, P4258, DOI 10.1210/jc.82.12.4258; Flouriot G, 1998, MOL ENDOCRINOL, V12, P1939, DOI 10.1210/me.12.12.1939; Greaves E, 2013, HUM REPROD, V28, P2490, DOI 10.1093/humrep/det235; Hervouet E, 2009, EPIGENETICS-US, V4, P487, DOI 10.4161/epi.4.7.9883; Hirata S, 2001, J STEROID BIOCHEM, V78, P33, DOI 10.1016/S0960-0760(01)00071-1; Huang YH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-383; Huang Y, 2006, J BIOL CHEM, V281, P19055, DOI 10.1074/jbc.M600910200; Inoue A, 2002, J PHARMACOL TOX MET, V47, P129, DOI 10.1016/S1056-8719(02)00221-6; Jia M, 2015, BEST PRACT RES CL EN, V29, P557, DOI 10.1016/j.beem.2015.04.008; Kohler F, 2020, J INVEST DERMATOL, V140, P38, DOI 10.1016/j.jid.2019.05.011; Kos M, 2001, MOL ENDOCRINOL, V15, P2057, DOI 10.1210/me.15.12.2057; Kurata A, 2019, MED HYPOTHESES, V122, P5, DOI 10.1016/j.mehy.2018.10.008; Lee J, 2007, ARCH BIOCHEM BIOPHYS, V461, P200, DOI 10.1016/j.abb.2006.12.030; Liu J, 2014, PATHOL RES PRACT, V210, P830, DOI 10.1016/j.prp.2014.09.002; Liyanage C, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9040148; Maekawa R, 2019, J OVARIAN RES, V12, DOI 10.1186/s13048-019-0489-1; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Matthews Jason, 2003, Mol Interv, V3, P281, DOI 10.1124/mi.3.5.281; MENASCE LP, 1993, GENOMICS, V17, P263, DOI 10.1006/geno.1993.1320; Mo XM, 2016, MOL CELL ENDOCRINOL, V431, P71, DOI 10.1016/j.mce.2016.05.010; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Nadal-Serrano M, 2012, J CELL BIOCHEM, V113, P3178, DOI 10.1002/jcb.24192; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Osborne CK, 2001, CLIN CANCER RES, V7, p4338S; Palakurthy RK, 2009, MOL CELL, V36, P219, DOI 10.1016/j.molcel.2009.10.009; Przybylik-Mazurek E, 2012, GYNECOL ENDOCRINOL, V28, P150, DOI 10.3109/09513590.2011.563909; Qiu YB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37648-7; Rahbari R, 2010, FUTURE ONCOL, V6, P1771, DOI 10.2217/FON.10.127; Reid G, 2002, CELL MOL LIFE SCI, V59, P821, DOI 10.1007/s00018-002-8470-2; Rice LW, 2010, GYNECOL ONCOL, V118, P202, DOI 10.1016/j.ygyno.2010.03.014; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Rody A, 2005, ENDOCR-RELAT CANCER, V12, P903, DOI 10.1677/erc.1.01088; Schonfeld SJ, 2011, CANCER EPIDEMIOL, V35, pE85, DOI 10.1016/j.canep.2011.05.009; Seah MKY, 2018, CURR TOP DEV BIOL, V128, P203, DOI 10.1016/bs.ctdb.2017.10.011; Shenker NS, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1335-5; Shiota K, 2002, GENES CELLS, V7, P961, DOI 10.1046/j.1365-2443.2002.00574.x; Su CW, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2016-0; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Sungwalee W, 2013, ASIAN PAC J CANCER P, V14, P5153, DOI 10.7314/APJCP.2013.14.9.5153; Suzuki A, 2010, J BIOL CHEM, V285, P13444, DOI 10.1074/jbc.M109.062430; Suzuki F, 2008, CANCER SCI, V99, P2365, DOI 10.1111/j.1349-7006.2008.00988.x; Suzuki M, 2006, ONCOGENE, V25, P2477, DOI 10.1038/sj.onc.1209272; Teneng I, 2015, ONCOGENE, V34, P621, DOI 10.1038/onc.2013.580; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Williams C, 2008, ONCOGENE, V27, P1019, DOI 10.1038/sj.onc.1210712; Yagi S, 2008, GENOME RES, V18, P1969, DOI 10.1101/gr.074070.107; Yi JW, 2017, ANN SURG ONCOL, V24, P3754, DOI 10.1245/s10434-017-5780-z; Zannoni GF, 2013, HUM PATHOL, V44, P1047, DOI 10.1016/j.humpath.2012.09.007; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	62	2	2	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21516	10.1096/fj.202001467R	http://dx.doi.org/10.1096/fj.202001467R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710697				2022-12-26	WOS:000635216100028
J	Cruz-Gonzalez, A; Munoz-Velasco, I; Cottom-Salas, W; Becerra, A; Campillo-Balderas, JA; Hernandez-Morales, R; Vazquez-Salazar, A; Jacome, R; Lazcano, A				Cruz-Gonzalez, Adrian; Munoz-Velasco, Israel; Cottom-Salas, Wolfgang; Becerra, Arturo; Campillo-Balderas, Jose A.; Hernandez-Morales, Ricardo; Vazquez-Salazar, Alberto; Jacome, Rodrigo; Lazcano, Antonio			Structural analysis of viral ExoN domains reveals polyphyletic hijacking events	PLOS ONE			English	Article							LASSA VIRUS NUCLEOPROTEIN; CRYSTAL-STRUCTURE; DNA-POLYMERASE; SARS-CORONAVIRUS; PIRNA PATHWAY; RNA VIRUS; PROTEIN; EXORIBONUCLEASE; EXONUCLEASE; MAELSTROM	Nidoviruses and arenaviruses are the only known RNA viruses encoding a 3'-5' exonuclease domain (ExoN). The proofreading activity of the ExoN domain has played a key role in the growth of nidoviral genomes, while in arenaviruses this domain partakes in the suppression of the host innate immune signaling. Sequence and structural homology analyses suggest that these proteins have been hijacked from cellular hosts many times. Analysis of the available nidoviral ExoN sequences reveals a high conservation level comparable to that of the viral RNA-dependent RNA polymerases (RdRp), which are the most conserved viral proteins. Two highly preserved zinc fingers are present in all nidoviral exonucleases, while in the arenaviral protein only one zinc finger can be identified. This is in sharp contrast with the reported lack of zinc fingers in cellular ExoNs, and opens the possibility of therapeutic strategies in the struggle against COVID-19.	[Cruz-Gonzalez, Adrian; Munoz-Velasco, Israel; Cottom-Salas, Wolfgang; Becerra, Arturo; Campillo-Balderas, Jose A.; Hernandez-Morales, Ricardo; Jacome, Rodrigo; Lazcano, Antonio] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City, DF, Mexico; [Cottom-Salas, Wolfgang] Univ Nacl Autonoma Mexico, Escuela Nacl Preparatoria, Plantel 8 Miguel E Schulz, Mexico City, DF, Mexico; [Vazquez-Salazar, Alberto] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA USA; [Lazcano, Antonio] El Colegio Nacl, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of California System; University of California Los Angeles	Jacome, R; Lazcano, A (corresponding author), Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City, DF, Mexico.; Lazcano, A (corresponding author), El Colegio Nacl, Mexico City, DF, Mexico.	alar@ciencias.unam.mx; rodrigo.jacome@ciencias.unam.mx	Campillo-Balderas, Jose Alberto/GPX-6487-2022	Vazquez-Salazar, Alberto/0000-0002-5346-1834; Munoz-Velasco, Israel/0000-0002-4712-5076; Jacome, Rodrigo/0000-0002-6367-1907; Cottom-Salas, Wolfgang/0000-0002-5143-9465	DGAPA-UNAM [PAPIIT-IN214421, PAPIME-PE204921]	DGAPA-UNAM(Universidad Nacional Autonoma de Mexico)	All the authors we would like to acknowledge financial support of DGAPA-UNAM (PAPIIT-IN214421 and PAPIME-PE204921).	Andreini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026325; Balasuriya UBR, 2013, VET MICROBIOL, V167, P93, DOI 10.1016/j.vetmic.2013.06.015; Ballou ER, 2020, MOL BIOL EVOL, DOI [10.1093/molbev/msaa324/6031919, DOI 10.1093/MOLBEV/MSAA324/6031919]; Becares M, 2016, J VIROL, V90, P5399, DOI 10.1128/JVI.03259-15; Bouvet M, 2012, P NATL ACAD SCI USA, V109, P9372, DOI 10.1073/pnas.1201130109; Burley SK, 2019, NUCLEIC ACIDS RES, V47, pD464, DOI 10.1093/nar/gky1004; Campillo-Balderas JA, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00143; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cassandri M, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.71; Cerny J, 2015, INFECT GENET EVOL, V36, P275, DOI 10.1016/j.meegid.2015.09.026; Chen KM, 2015, RNA, V21, P833, DOI 10.1261/rna.049437.114; Deng TT, 2019, NUCLEIC ACIDS RES, V47, P391, DOI 10.1093/nar/gky1019; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Duffy S, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.3000003; Durzynska I, 2018, J GEN VIROL, V99, P1253, DOI 10.1099/jgv.0.001120; Dworkin JP, 2003, J THEOR BIOL, V222, P127, DOI 10.1016/S0022-5193(03)00020-1; Eckerle LD, 2007, J VIROL, V81, P12135, DOI 10.1128/JVI.01296-07; Eckerle LD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000896; Enjuanes L, 2008, ENCYCL VIROL, P419; Eom KS, 2016, J MICROBIOL BIOTECHN, V26, P2019, DOI 10.4014/jmb.1609.09021; Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1; Felsestein J., 1993, PHYLIP PHYLOGENY INF; Ferron F, 2018, P NATL ACAD SCI USA, V115, pE162, DOI 10.1073/pnas.1718806115; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Hastie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044211; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P2396, DOI 10.1073/pnas.1016404108; Hoet A, 2008, ENCY VIROLOGY, P151, DOI DOI 10.1016/B978-012374410-4.00516-1; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hsiao YY, 2009, MOL CELL BIOL, V29, P448, DOI 10.1128/MCB.01006-08; Jacome R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139001; Jeffery CJ, 2019, BIOCHEM SOC T, V47, P371, DOI 10.1042/BST20180473; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Kamtekar S, 2006, EMBO J, V25, P1335, DOI 10.1038/sj.emboj.7601027; Lazcano A, 2014, RNA WORLD STEPPING O; Ma YY, 2015, P NATL ACAD SCI USA, V112, P9436, DOI 10.1073/pnas.1508686112; Malgieri G, 2015, FEBS J, V282, P4480, DOI 10.1111/febs.13503; Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3; Matsumoto N, 2015, CELL REP, V11, P366, DOI 10.1016/j.celrep.2015.03.030; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; Minskaia E, 2006, P NATL ACAD SCI USA, V103, P5108, DOI 10.1073/pnas.0508200103; Nakagawa K, 2016, ADV VIRUS RES, V96, P165, DOI 10.1016/bs.aivir.2016.08.001; Ogando NS, 2020, J VIROL, V94, DOI 10.1128/JVI.01246-20; Ogando NS, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01813; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pek JW, 2012, DEVELOPMENT, V139, P4505, DOI 10.1242/dev.082867; Nga PT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002215; Rambaut A., 2016, FIGTREE V143 GRAPHIC; Reynard S, 2014, J VIROL, V88, P13923, DOI 10.1128/JVI.01923-14; Rodrigues TS, 2021, J EXP MED, V218, DOI 10.1084/jem.20201707; Saberi A, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007314; Sato K, 2015, FEBS LETT, V589, P1688, DOI 10.1016/j.febslet.2015.03.023; Sittidilokratna N., 2008, ENCY VIROLOGY, P476; Snijder EJ, 2016, ADV VIRUS RES, V96, P59, DOI 10.1016/bs.aivir.2016.08.008; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003; SUBBIAH S, 1993, CURR BIOL, V3, P141, DOI 10.1016/0960-9822(93)90255-M; Vazquez-Salazar A, 2018, CURR BIOL, V28, pR220, DOI 10.1016/j.cub.2018.01.055; Velankar S, 2012, NUCLEIC ACIDS RES, V40, pD445, DOI 10.1093/nar/gkr998; Wang J, 1996, BIOCHEMISTRY-US, V35, P8110, DOI 10.1021/bi960178r; Xia SL, 2014, BIOCHEMISTRY-US, V53, P2752, DOI 10.1021/bi4014215; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Yoshimoto FK, 2020, PROTEIN J, V39, P198, DOI 10.1007/s10930-020-09901-4; Zhang DP, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-48; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	66	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0246981	10.1371/journal.pone.0246981	http://dx.doi.org/10.1371/journal.pone.0246981			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730017	Green Published, gold, Green Submitted			2022-12-26	WOS:000630345000030
J	Fiorilli, G; Grazioli, E; Buonsenso, A; Di Martino, G; Despina, T; Calcagno, G; di Cagno, A				Fiorilli, Giovanni; Grazioli, Elisa; Buonsenso, Andrea; Di Martino, Giulia; Despina, Tsopani; Calcagno, Giuseppe; di Cagno, Alessandra			A national COVID-19 quarantine survey and its impact on the Italian sports community: Implications and recommendations	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PSYCHOMETRIC PROPERTIES; PSYCHOLOGICAL IMPACT; EVENT SCALE; EXERCISE; SYMPTOMS; OUTBREAK; BEHAVIOR; PTSD	The outbreak of the 2019 coronavirus disease (COVID-19) created an international public health emergency, challenging the psychological resilience of the general population. Regarding this matter, a web-based survey was performed. Data were collected from the following 1,668 self-selected volunteers: 800 athletes (28.30 +/- 10.93 years old); 558 coaches (36.91 +/- 11.93 years old); and 310 sports managers (42.07 +/- 13.38 years old). To assess the level of psychological stress, an Impact of the Event Scale-Revised (IES-R) questionnaire was used. The results indicated that 34.4% of the participants who were interviewed were affected by subjective distress while 26.4% rated their psychological impact from the sports activity interruption as severe. Separated one-way analysis of variance (ANOVA) tests showed significant differences in the IES-R total score (TS), indicating that the level of stress in terms of gender revealed that women were more stressed than men (p = 0.000), for "sports roles" in which the manager and coaches were more stressed than the athletes (p < 0.05), and "type of sport" in which fitness and individual athletes were more stressed than team athletes (p < 0.01). The middle-level athletes showed significantly more hyperarousal levels than high-level athletes (p = 0.012). The results of this survey may raise awareness of this problem and help athletic associations to have appropriate guidelines in order to better sustain their memberships and organize an optimal resumption of their sports activities. Along these lines, social interactions, which are typical of team sports, are crucial to warrant resilience and psychological health. The athletes by managing independently the new rules and measures, thanks to a clear communication, could improve their adaptive stress reaction.	[Fiorilli, Giovanni; Buonsenso, Andrea; Calcagno, Giuseppe] Univ Molise, Dept Med & Hlth Sci, Campobasso, Italy; [Grazioli, Elisa; Di Martino, Giulia; di Cagno, Alessandra] Univ Rome Foro Italico, Dept Motor Human & Hlth Sci, Rome, Italy; [Despina, Tsopani] Natl & Kapodistrian Univ Athens, Fac Phys Educ & Sports Sci, Athens, Greece	University of Molise; Foro Italico University of Rome; National & Kapodistrian University of Athens	Calcagno, G (corresponding author), Univ Molise, Dept Med & Hlth Sci, Campobasso, Italy.	giuseppe.calcagno@unimol.it	Grazioli, Elisa/AAO-6917-2021; Calcagno, Giuseppe/AAR-4299-2020; Buonsenso, Andrea/GXZ-5091-2022	Calcagno, Giuseppe/0000-0003-4680-1535; Buonsenso, Andrea/0000-0003-2560-5789; Di Martino, Giulia/0000-0003-1468-7491				Altuzarra A, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13010367; Aron CM, 2019, BRIT J SPORT MED, V53, P779, DOI 10.1136/bjsports-2019-100695; Bonaccorsi G, 2020, P NATL ACAD SCI USA, V117, P15530, DOI 10.1073/pnas.2007658117; Bowes A, 2022, MANAG SPORT LEIS, V27, P513, DOI 10.1080/23750472.2020.1825988; Breslin N, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100118; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Chang SM, 2019, ACTA PSYCHOL SIN, V51, P1244, DOI 10.3724/SP.J.1041.2019.01244; Clarkson BG, 2022, MANAG SPORT LEIS, V27, P44, DOI 10.1080/23750472.2020.1766377; Colledge F, 2020, J EAT DISORD, V8, DOI 10.1186/s40337-020-0284-9; Conversano C, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01900; Craike MJ, 2010, J SPORT EXERCISE PSY, V32, P23, DOI 10.1123/jsep.32.1.23; Craparo G, 2013, NEUROPSYCH DIS TREAT, V9, P1427, DOI 10.2147/NDT.S51793; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; Dati ISTAT, 2016, VITA QUOTIDIANA OPIN; Deurenberg-Yap M, 2005, HEALTH PROMOT INT, V20, P320, DOI 10.1093/heapro/dai010; di Cagno A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17238867; Di Giuseppe M, 2019, PSYCHIATRY, V82, P128, DOI 10.1080/00332747.2019.1579595; Elferink-Gemser MT., 2004, SPORT MED TRAIN REHA, P25; Evans AB, 2020, EUR J SPORT SOC, V17, P85, DOI 10.1080/16138171.2020.1765100; Gualano MR, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134779; Gucciardi DF, 2015, J SCI MED SPORT, V18, P31, DOI 10.1016/j.jsams.2013.11.011; Harte CB, 2015, EVAL HEALTH PROF, V38, P42, DOI 10.1177/0163278713494774; Ho CSH, 2020, ANN ACAD MED SINGAP, V49, P155; Hoeber L, 2007, GENDER WORK ORGAN, V14, P259, DOI 10.1111/j.1468-0432.2007.00342.x; HOROWITZ MJ, 1980, ARCH GEN PSYCHIAT, V37, P85; Jukic I, 2020, SPORTS, V8, DOI 10.3390/sports8040056; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kirk CP, 2020, J BUS RES, V117, P124, DOI 10.1016/j.jbusres.2020.05.028; Kogler L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17485-w; Kumar A, 2021, J MENT HEALTH, V30, P1, DOI 10.1080/09638237.2020.1757052; KUTEROVAC G, 1994, BRIT J MED PSYCHOL, V67, P363, DOI 10.1111/j.2044-8341.1994.tb01804.x; Laborde S, 2016, SCAND J MED SCI SPOR, V26, P862, DOI 10.1111/sms.12510; Lee SM, 2018, COMPR PSYCHIAT, V87, P123, DOI 10.1016/j.comppsych.2018.10.003; Li FG, 2021, BMC PSYCHIATRY, V21, DOI 10.1186/s12888-020-03012-1; Lim MA, 2021, IRISH J MED SCI, V190, P447, DOI 10.1007/s11845-020-02300-9; Maunder RG, 2006, EMERG INFECT DIS, V12, P1924; Memish ZA, 2019, LANCET, V393, P2073, DOI 10.1016/S0140-6736(19)30501-X; Mohr M, 2022, MANAG SPORT LEIS, V27, P166, DOI 10.1080/23750472.2020.1768635; Mroczkowska H, 1997, BIOL SPORT, V14, P325; Nhamo G, 2018, SUSTAIN DEV, V26, P544, DOI 10.1002/sd.1717; Parnell D, 2022, MANAG SPORT LEIS, V27, P72, DOI 10.1080/23750472.2020.1750100; Pellecchia U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143036; Pillay L, 2020, J SCI MED SPORT, V23, P670, DOI 10.1016/j.jsams.2020.05.016; Poucher ZA, 2017, REV PSICOL DEPORTE, V26, P63; Power E, 2020, IRISH J PSYCHOL MED, V37, P301, DOI 10.1017/ipm.2020.84; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Ratten V, 2020, INT J ENTREP BEHAV R, V26, P1379, DOI 10.1108/IJEBR-06-2020-0387; Rossi R, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00790; Rowe D, 2020, J SOCIOL, V56, P704, DOI 10.1177/1440783320941284; Samuel RD, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.567966; Sanderson J, 2020, INT J SPORT COMMUN, V13, P313, DOI 10.1123/ijsc.2020-0236; Sarto F, 2020, SPORTS MED, V50, P1417, DOI 10.1007/s40279-020-01297-6; Schinke R, 2020, INT J SPORT EXERC PS, V18, P269, DOI 10.1080/1612197X.2020.1754616; Shuer ML, 1997, WESTERN J MED, V166, P104; Stapleton P, 2016, AM J MENS HEALTH, V10, P100, DOI 10.1177/1557988314556673; Steingrover C, 2016, SPORTS MED-OPEN, V2, DOI 10.1186/s40798-016-0042-3; Street AE, 2018, CLIN PSYCHOL REV, V66, P97, DOI 10.1016/j.cpr.2018.03.001; Szabo Attila, 2015, Yale Journal of Biology and Medicine, V88, P303; Taku K, 2020, J LOSS TRAUMA, V25, P623, DOI 10.1080/15325024.2020.1777762; Talbot LS, 2014, J CLIN SLEEP MED, V10, P795, DOI 10.5664/jcsm.3878; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Wang YG, 2011, GEN HOSP PSYCHIAT, V33, P75, DOI 10.1016/j.genhosppsych.2010.11.001; WASSERTHEIL S, 1970, BIOMETRICS, V26, P588, DOI 10.2307/2529115; Weiss Daniel S., 1997, P399; Wenzel T, 2013, CLINICAL SPORTS PSYCHIATRY: AN INTERNATIONAL PERSPECTIVE, P102; Whitworth JW, 2017, PSYCHOL SPORT EXERC, V33, P18, DOI 10.1016/j.psychsport.2017.07.008; Yamada M, 2019, J EPIDEMIOL, V29, P220, DOI 10.2188/jea.JE20180016	67	20	20	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0248345	10.1371/journal.pone.0248345	http://dx.doi.org/10.1371/journal.pone.0248345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX9NB	33720968	gold, Green Published			2022-12-26	WOS:000629667400052
J	Zhang, DH; Wang, HQ; Lou, S; Zhong, S				Zhang, Dehua; Wang, Haiqing; Lou, Sha; Zhong, Shen			Research on grain production efficiency in China's main grain producing areas from the perspective of financial support	PLOS ONE			English	Article							INDUSTRIALIZED COUNTRIES; TECHNICAL PROGRESS; GROWTH; SCALE	Grain production is vital to the national economy and people's livelihood, and improving grain production efficiency is of great significance to the sustainable development of China's economy and society. From the perspective of financial support, using the DEA global Malmquist productivity index model and based on the data of 13 main grain producing areas in China from 2001 to 2017, this paper discusses the evolution characteristics and regional distribution differences of the total factor productivity index of grain production in China's main grain producing areas. The results show that from 2001 to 2017, the total factor productivity index of grain production in China's main grain producing areas showed an overall fluctuation trend of gradual decline, with an average annual decline of 7.3%. From the perspective of spatial analysis, the grain production efficiency in China's main grain producing areas is characterized by uneven spatial development, which is generally manifested as the decreasing trend from the central region to the eastern and western regions. Meanwhile, it can be seen from the decomposition index that the change of total factor productivity of grain production in China's main grain producing areas mainly depends on the change of technical efficiency.	[Zhang, Dehua; Wang, Haiqing; Lou, Sha; Zhong, Shen] Harbin Univ Commerce, Inst Finance, Harbin, Peoples R China	Harbin University of Commerce	Lou, S (corresponding author), Harbin Univ Commerce, Inst Finance, Harbin, Peoples R China.	102896@hrbcu.edu.cn		Wang, Haiqing/0000-0001-7031-4601	Heilongjiang Province Philosophy and Social Science Fund Project [18JYE669]; Youth Innovative Talents Training Program in General Undergraduate Colleges and Universities in Heilongjiang Province [UNPYSCT2018125]; Special support project for postdoctoral in Heilongjiang Province [LBHZ19073]; Special plan for top young talents of Harbin University of Commerce [2020CX42]; Graduate Innovation Project of Harbin University of Commerce [YJSCX2020-643HSD]	Heilongjiang Province Philosophy and Social Science Fund Project; Youth Innovative Talents Training Program in General Undergraduate Colleges and Universities in Heilongjiang Province; Special support project for postdoctoral in Heilongjiang Province; Special plan for top young talents of Harbin University of Commerce; Graduate Innovation Project of Harbin University of Commerce	This work was supported by Heilongjiang Province Philosophy and Social Science Fund Project (18JYE669); Youth Innovative Talents Training Program in General Undergraduate Colleges and Universities in Heilongjiang Province (UNPYSCT2018125); Special support project for postdoctoral in Heilongjiang Province (LBHZ19073); Special plan for top young talents of Harbin University of Commerce (2020CX42); Graduate Innovation Project of Harbin University of Commerce (YJSCX2020-643HSD).	Alemdar T., 2006, J APPL SCI, V6, P827, DOI [10.3923/jas.2006.827.830, DOI 10.3923/JAS.2006.827.830]; Alene A. D., 2008, Journal of Developing Areas, V41, P233, DOI 10.1353/jda.2008.0010; Amos KQ., 2010, ENV DEV SUSTAIN, V12, P967; Dhungana BR, 2004, AUST J AGR RESOUR EC, V48, P347, DOI 10.1111/j.1467-8489.2004.00243.x; Ding LL, 2019, J CLEAN PROD, V241, DOI 10.1016/j.jclepro.2019.118260; Dios-Palomares R, 2015, REV CIENT-FAC CIEN V, V25, P43; Evaline C., 2014, ANAL TECHNICAL EFFIC, V5, P58; Fare R, 1997, AM ECON REV, V87, P1040; GAI Y, 2013, AGR ECON-CZECH, V59, P315, DOI DOI 10.17221/126/2012-AGRICECON; Ge DZ, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9122340; Jha R, 2000, APPL ECON LETT, V7, P1, DOI 10.1080/135048500351997; Jin Y, 2016, AGR ECON-BLACKWELL, V47, P15, DOI 10.1111/agec.12206; Li DP, 2018, PADDY WATER ENVIRON, V16, P643, DOI 10.1007/s10333-018-0652-0; Limsombunc Visit, 2005, AM J APPL SCI, V2, P1198, DOI DOI 10.3844/ajassp.2005.1198.1205; Liu XW, 2007, J CLEAN PROD, V15, P313, DOI 10.1016/j.jclepro.2005.07.003; Liu YS, 2018, LAND USE POLICY, V74, P1, DOI 10.1016/j.landusepol.2018.01.032; Mathur R., 2018, CENTRAL EUR REV EC M, V2, P79, DOI [10.29015/cerem.589, DOI 10.29015/CEREM.589]; MichUe AL, 2020, INT C AGR EC, V1, P1; Naushad Khan, 2007, Sarhad Journal of Agriculture, V23, P1285; Odeck J, 2007, APPL ECON, V39, P2617, DOI 10.1080/00036840600722224; Pastor JT, 2005, ECON LETT, V88, P266, DOI 10.1016/j.econlet.2005.02.013; Qi XY., 2020, ENERGY, V190, P1; Qiao XZ., 2020, INT J SOCIAL SCI U, V3, P3; Rahman MW, 2011, AFR J AGR RES, V6, P6440, DOI 10.5897/AJAR11.1575; Ray SC, 1997, AM ECON REV, V87, P1033; Sun MY, 2020, PHYS CHEM EARTH, V116, DOI 10.1016/j.pce.2020.102837; Tan MH, 2005, LAND USE POLICY, V22, P187, DOI 10.1016/j.landusepol.2004.03.003; THUZAR L, 2019, ASIAN J AGR DEV, V16, P1, DOI DOI 10.37801/ajad2019.16.2.1; Vardges H., 2016, J AGR ECON, V68, P386; Vasiliev N, 2008, AGR FOOD SCI, V17, P31, DOI 10.2137/145960608784182272; Wadud A, 2000, APPL ECON, V32, P1665, DOI 10.1080/000368400421011; Wang P, 2019, ECOL INDIC, V105, P563, DOI 10.1016/j.ecolind.2018.05.022; Wu TT., 2017, ADV SOCIAL SCI, V6, P970; Yao SJ, 2001, ECON PLANN, V34, P139, DOI 10.1023/A:1017599518985; Yu X, 2019, J CLEAN PROD, V212, P610, DOI 10.1016/j.jclepro.2018.12.063; Zhang DH, 2020, J CLEAN PROD, V270, DOI 10.1016/j.jclepro.2020.122194; Zhang Q, 2015, LAND USE POLICY, V49, P92, DOI 10.1016/j.landusepol.2015.07.021; Zhang QN., 2020, J CLEAN PROD; Zhang QN., 2018, PRICE THEORY PRACTIC, V9, P155	39	7	7	15	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0247610	10.1371/journal.pone.0247610	http://dx.doi.org/10.1371/journal.pone.0247610			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX9NB	33720939	gold, Green Published			2022-12-26	WOS:000629667400048
J	Grimes, DR				Grimes, David Robert			Medical disinformation and the unviable nature of COVID-19 conspiracy theories	PLOS ONE			English	Article							VACCINE HESITANCY; HPV VACCINE; BELIEFS; AVAILABILITY; MECHANISMS; CLIMATE; SPREAD; IMPACT	The coronavirus pandemic has seen a marked rise in medical disinformation across social media. A variety of claims have garnered considerable traction, including the assertion that COVID is a hoax or deliberately manufactured, that 5G frequency radiation causes coronavirus, and that the pandemic is a ruse by big pharmaceutical companies to profiteer off a vaccine. An estimated 30% of some populations subscribe some form of COVID medico-scientific conspiracy narratives, with detrimental impacts for themselves and others. Consequently, exposing the lack of veracity of these claims is of considerable importance. Previous work has demonstrated that historical medical and scientific conspiracies are highly unlikely to be sustainable. In this article, an expanded model for a hypothetical en masse COVID conspiracy is derived. Analysis suggests that even under ideal circumstances for conspirators, commonly encountered conspiratorial claims are highly unlikely to endure, and would quickly be exposed. This work also explores the spectrum of medico-scientific acceptance, motivations behind propagation of falsehoods, and the urgent need for the medical and scientific community to anticipate and counter the emergence of falsehoods.	[Grimes, David Robert] Dublin City Univ, Sch Phys Sci, Dublin, Leinster, Ireland; [Grimes, David Robert] Univ Oxford, Dept Oncol, Roosevelt Dr, Oxford, Oxon, England	Dublin City University; University of Oxford	Grimes, DR (corresponding author), Dublin City Univ, Sch Phys Sci, Dublin, Leinster, Ireland.; Grimes, DR (corresponding author), Univ Oxford, Dept Oncol, Roosevelt Dr, Oxford, Oxon, England.	davidrobert.grimes@dcu.ie	Grimes, David Robert/J-7384-2013	Grimes, David Robert/0000-0003-3140-3278	Wellcome Trust	Wellcome Trust(Wellcome Trust)	David Robert Grimes is partly funded by the Wellcome Trust. There was no additional external funding received for this study.	ALLEMANDOU S, 2020, FRANCES ANTIMASKERS; Allington D, 2021, PSYCHOL MED, V51, P1763, DOI [10.1017/S0033291721000593, 10.1017/S003329172000224X]; Apestaartjaren, 2020, APACHE SPARK; Bale JM, 2007, PATTERNS PREJUDICE, V41, P45, DOI 10.1080/00313220601118751; Brashier NM, 2020, COGNITION, V194, DOI 10.1016/j.cognition.2019.104054; Broad WJ., 2019, YOUR 5G PHONE WONT H; Cameron C., 2020, NY TIMES CO; CASSILETH BR, 1984, ANN INTERN MED, V101, P105, DOI 10.7326/0003-4819-101-1-105; Chen QY, 2020, NATURE, V579, P193, DOI 10.1038/d41586-020-00694-1; de Figueiredo A, STATE VACCINE CONFID; Douglas KM, 2017, CURR DIR PSYCHOL SCI, V26, P538, DOI 10.1177/0963721417718261; Dube E, 2013, HUM VACC IMMUNOTHER, V9, P1763, DOI 10.4161/hv.24657; European Commission, 2020, COVID 19 PROMPTS SPR; Facher L., 2020, STATNEWS; Fazio LK, 2015, J EXP PSYCHOL GEN, V144, P993, DOI 10.1037/xge0000098; FOLKES VS, 1988, J CONSUM RES, V15, P13, DOI 10.1086/209141; Freeman D, 2022, PSYCHOL MED, V52, P251, DOI 10.1017/S0033291720001890; Gargano LM, 2013, HUM VACC IMMUNOTHER, V9, P2627, DOI 10.4161/hv.25823; Goertzel T, 2010, EMBO REP, V11, P493, DOI 10.1038/embor.2010.84; Grimes DR, 2020, EMBO REP, V21, DOI 10.15252/embr.202051819; Grimes DR, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035626; Grimes DR, 2019, EMBO REP, V20, DOI 10.15252/embr.201948706; Grimes DR, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171511; Grimes DR, 2018, CHILD DEV, V89, P141, DOI 10.1111/cdev.13013; Grimes DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151003; Grimes DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147905; Grimes DR., 2019, IRRATIONAL APE WHY F, V1st; Hoeken H., 2001, ARGUMENTATION, V15, P425, DOI [10.1023/A:1012075630523, DOI 10.1023/A:1012075630523]; I Research, 2020, COMMUNITY RELATIONS; Imhoff R, 2017, EUR J SOC PSYCHOL, V47, P724, DOI 10.1002/ejsp.2265; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jacobson RA, 2007, VACCINE, V25, P3146, DOI 10.1016/j.vaccine.2007.01.046; Jarrett C, 2015, VACCINE, V33, P4180, DOI 10.1016/j.vaccine.2015.04.040; Johnson SB, 2018, JAMA ONCOL, V4, P1375, DOI 10.1001/jamaoncol.2018.2487; Jolley D, 2017, J APPL SOC PSYCHOL, V47, P459, DOI 10.1111/jasp.12453; Jolley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089177; Kahan DM, 2010, LAW HUMAN BEHAV, V34, P501, DOI 10.1007/s10979-009-9201-0; Kahan DM., 2013, BEHAV PUBLIC POLICY, V1, P54, DOI [10.1017/bpp.2016.2, DOI 10.1017/BPP.2016.2]; Kata A, 2012, VACCINE, V30, P3778, DOI 10.1016/j.vaccine.2011.11.112; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9; Lewandowsky S, 2013, PSYCHOL SCI, V24, P622, DOI 10.1177/0956797612457686; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; McCright AM, 2011, GLOBAL ENVIRON CHANG, V21, P1163, DOI 10.1016/j.gloenvcha.2011.06.003; Motta M, 2018, SOC SCI MED, V211, P274, DOI 10.1016/j.socscimed.2018.06.032; Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365; Poland GA, 2011, NEW ENGL J MED, V364, P97, DOI 10.1056/NEJMp1010594; Poortinga W, 2011, GLOBAL ENVIRON CHANG, V21, P1015, DOI 10.1016/j.gloenvcha.2011.03.001; Prue G., 2018, MED ACCESS POINT CAR, V2, DOI [10.1177/2399202618799691, DOI 10.1177/2399202618799691]; REGELSON W, 1980, JAMA-J AM MED ASSOC, V243, P337; Romer D, 2020, SOC SCI MED, V263, DOI 10.1016/j.socscimed.2020.113356; Roozenbeek J, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.201199; Rosenthal SL, 2011, VACCINE, V29, P890, DOI 10.1016/j.vaccine.2009.12.063; Shearer E., 2020, AM WHO MAINLY GET TH; Smaldino PE, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160384; Stojanov A, 2020, EUR J SOC PSYCHOL, V50, P955, DOI 10.1002/ejsp.2690; Swami V, 2013, APPL COGNITIVE PSYCH, V27, P71, DOI 10.1002/acp.2873; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; Uscinski J. E., 2020, HARVARD KENNEDY SCH, V1, P1, DOI [10.37016/mr-2020-015, DOI 10.37016/MR-2020-015]; Uscinski JE, 2016, POLIT RES QUART, V69, P57, DOI 10.1177/1065912915621621; Van Prooijen JW, 2015, APPL COGNITIVE PSYCH, V29, P753, DOI 10.1002/acp.3161; Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559; Wang WC, 2016, J COGNITIVE NEUROSCI, V28, P739, DOI 10.1162/jocn_a_00923; Wood MJ, 2012, SOC PSYCHOL PERS SCI, V3, P767, DOI 10.1177/1948550611434786; Zaller JohnR., 1992, NATURE ORIGINS MASS	65	37	37	11	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0245900	10.1371/journal.pone.0245900	http://dx.doi.org/10.1371/journal.pone.0245900			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8KN	33711025	gold, Green Published			2022-12-26	WOS:000629591800035
J	Thomas, A; Chothe, S; Byukusenge, M; Mathews, T; Pierre, T; Kariyawasam, S; Luley, E; Kuchipudi, S; Jayarao, B				Thomas, Asha; Chothe, Shubhada; Byukusenge, Maurice; Mathews, Tammy; Pierre, Traci; Kariyawasam, Subhashinie; Luley, Erin; Kuchipudi, Suresh; Jayarao, Bhushan			Prevalence and distribution of multilocus sequence types of Staphylococcus aureus isolated from bulk tank milk and cows with mastitis in Pennsylvania	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; BOVINE MASTITIS; DAIRY-COWS; METHICILLIN-RESISTANT; GENETIC DIVERSITY; MOLECULAR CHARACTERIZATION; ANTIMICROBIAL RESISTANCE; INTRAMAMMARY INFECTIONS; SUBCLINICAL MASTITIS; CLINICAL MASTITIS	A total of 163 S. aureus isolates; 113 from mastitic milk (MM) and 50 from bulk tank milk (BTM) (2008, 2013-2015) submitted for bacteriologic analysis at the Penn State Animal Diagnostic Laboratory were examined for their phenotypic and genotypic characteristics. Multi-locus sequence typing (MLST) analysis identified 16 unique sequence types (STs) which belonged to eight clonal complexes (CCs). Majority of the isolates were variants of CC97 (68.7%) and CC151 (25.1%). CC97 comprised of seven STs, of which two were new STs (ST3273, ST3274), while CC151 comprised of three STs of which ST3272 was identified for the first time. Several farms had more than one ST type that were either members of the same clonal complex or unrelated STs. On one farm, six different STs of both categories were seen over the years within the farm. It was observed that ST352 and ST151 were the two main clonal populations in cattle not only in Pennsylvania but also globally. Most isolates were susceptible to all the antibiotics evaluated. 6.7% of isolates showed resistance to vancomycin and penicillin. Two isolates of ST398 showed multidrug resistance (>3 antibiotics) against clindamycin, erythromycin, tetracycline, and penicillin. It was noted that 59 of 163 (36.2%) isolates encoded for enterotoxigenic genes. Enterotoxin genes seg/seiaccounted for similar to 85% of enterotoxin positive isolates. Toxic shock syndrome gene tsst-1 alone was positive in two isolates (ST352, ST 2187). 97.5% of CC151 isolates were enterotoxin seg/sei positive. Most isolates were positive for lukED (95%) and lukAB (96.3%) leukotoxin genes. Bovine specific bi-component leucocidin lukMF' was present in 54% of isolates. A prominent observation of this study was the explicit association of lukMF'with lineages ST151 and ST352. In conclusion, the findings of the study, suggest that small number of S. aureus STs types (ST352, ST2187, ST3028, and ST151) are associated with majority of cases of bovine mastitis in Pennsylvania dairy farms. It was observed that one ST of S. aureus predominated in the herd and this ST can coexist with several other ST types of S. aureus strains. When STs were interpreted along with virulence, leucocidin genes and antimicrobial resistance, ST-variants allowed better interpretation of the S. aureus molecular epidemiologic findings specifically for tracing recurrence or persistence of infections in cow over time, among cows in the herd, and between herds in Pennsylvania.	[Thomas, Asha; Chothe, Shubhada; Byukusenge, Maurice; Mathews, Tammy; Pierre, Traci; Kariyawasam, Subhashinie; Luley, Erin; Kuchipudi, Suresh; Jayarao, Bhushan] Penn State Univ, Dept Vet & Biomed Sci, Penn State Anim Diagnost Lab, University Pk, PA 16802 USA; [Thomas, Asha] Case Western Reserve Univ, Sch Med, Hematol Oncol, Cleveland, OH USA; [Byukusenge, Maurice] Univ Rwanda, Sch Vet Med, Nyagatare, Rwanda; [Kariyawasam, Subhashinie] Univ Florida, Dept Comparat Diagnost & Populat Med, Gainesville, FL USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Case Western Reserve University; University of Rwanda; State University System of Florida; University of Florida	Jayarao, B (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, Penn State Anim Diagnost Lab, University Pk, PA 16802 USA.	bmj3@psu.edu		Thomas, Asha/0000-0002-0293-5403; Kuchipudi, Suresh V./0000-0002-8640-254X; Byukusenge, Maurice/0000-0002-2548-1299	Pennsylvania Department of Agriculture [44166109]	Pennsylvania Department of Agriculture	BJ Award #: 44166109 The Pennsylvania Department of Agriculture https://www.agriculture.pa.gov/Animals/AHDCommission/Pages/default.aspx The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akineden O, 2001, CLIN DIAGN LAB IMMUN, V8, P959, DOI 10.1128/CDLI.8.5.959-964.2001; Akkou M, 2018, VET MICROBIOL, V223, P173, DOI 10.1016/j.vetmic.2018.08.003; Alonzo F, 2014, MICROBIOL MOL BIOL R, V78, P199, DOI 10.1128/MMBR.00055-13; Alonzo F, 2013, NATURE, V493, P51, DOI 10.1038/nature11724; [Anonymous], CLSI Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals: approved standard, V3; Antok FI, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9010001; Barkema HW, 2006, J DAIRY SCI, V89, P1877, DOI 10.3168/jds.S0022-0302(06)72256-1; Barlow JW, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-28; Bauman CA, 2018, J DAIRY SCI, V101, P2679, DOI 10.3168/jds.2017-13336; Beyene Takele, 2017, BMC Res Notes, V10, P171, DOI 10.1186/s13104-017-2487-y; Bonsaglia ECR, 2018, MICROB PATHOGENESIS, V124, P130, DOI 10.1016/j.micpath.2018.08.031; Budd KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134592; Cheng J, 2019, J DAIRY SCI, V102, P2416, DOI 10.3168/jds.2018-15135; Cremonesi P, 2015, J DAIRY SCI, V98, P6828, DOI 10.3168/jds.2014-9074; Saei HD, 2020, ARCH MICROBIOL, V202, P115, DOI 10.1007/s00203-019-01722-z; de Jong A, 2018, VET MICROBIOL, V213, P73, DOI [10.1016/j.vetmic.2017.11.021, 10.1016/j.vetm]; Delgado S, 2011, FEMS IMMUNOL MED MIC, V62, P225, DOI 10.1111/j.1574-695X.2011.00806.x; DuMont AL, 2013, P NATL ACAD SCI USA, V110, P10794, DOI 10.1073/pnas.1305121110; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Everitt RG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4956; Fijalkowski K, 2014, J MICROBIOL, V52, P366, DOI 10.1007/s12275-014-3436-2; Fueyo JM, 2005, J CLIN MICROBIOL, V43, P1278, DOI 10.1128/JCM.43.3.1278-1284.2005; Garzoni C, 2009, TRENDS MICROBIOL, V17, P59, DOI 10.1016/j.tim.2008.11.005; Gazzola A, 2020, J DAIRY SCI, V103, P2685, DOI 10.3168/jds.2019-17181; Graber HU, 2009, J DAIRY SCI, V92, P1442, DOI 10.3168/jds.2008-1430; Grumann D, 2014, INFECT GENET EVOL, V21, P583, DOI 10.1016/j.meegid.2013.03.013; Hata E, 2010, J CLIN MICROBIOL, V48, P2130, DOI 10.1128/JCM.01940-09; Haubert L, 2017, MICROB PATHOGENESIS, V113, P242, DOI 10.1016/j.micpath.2017.10.022; Haveri M, 2007, J APPL MICROBIOL, V103, P993, DOI 10.1111/j.1365-2672.2007.03356.x; Heikkila AM, 2018, J DAIRY SCI, V101, P9493, DOI 10.3168/jds.2018-14824; Jarraud S, 1999, J CLIN MICROBIOL, V37, P2446, DOI 10.1128/JCM.37.8.2446-2449.1999; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Jolley Keith A, 2018, Wellcome Open Res, V3, P124, DOI 10.12688/wellcomeopenres.14826.1; Joo YS, 2001, VET MICROBIOL, V80, P131, DOI 10.1016/S0378-1135(00)00381-3; Jorgensen HJ, 2005, APPL ENVIRON MICROB, V71, P8352, DOI 10.1128/AEM.71.12.8352-8361.2005; Kappeli N, 2019, J DAIRY SCI, V102, P3274, DOI 10.3168/jds.2018-15317; Katsuda K, 2005, VET MICROBIOL, V105, P301, DOI 10.1016/j.vetmic.2004.12.004; Keefe G, 2012, VET CLIN N AM-FOOD A, V28, P203, DOI 10.1016/j.cvfa.2012.03.010; Klibi A, 2018, MICROB DRUG RESIST, V24, P1210, DOI 10.1089/mdr.2017.0278; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Levin TP, 2005, ANTIMICROB AGENTS CH, V49, P1222, DOI 10.1128/AAC.49.3.1222-1224.2005; Li LP, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1376-5; Li LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116699; Li TM, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00127; Lundberg A, 2014, ACTA VET SCAND, V56, DOI 10.1186/1751-0147-56-2; MATSUNAGA T, 1993, J VET MED SCI, V55, P297, DOI 10.1292/jvms.55.297; McMillan K, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0789-1; Mekonnen SA, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1558-1; Melles DC, 2007, J MICROBIOL METH, V69, P371, DOI 10.1016/j.mimet.2007.01.013; Meng D, 2019, J GLOB ANTIMICROB RE, V16, P98, DOI 10.1016/j.jgar.2018.08.024; Mistry H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162256; Monecke S, 2007, VET MICROBIOL, V125, P128, DOI 10.1016/j.vetmic.2007.05.016; Moser A, 2013, SCHWEIZ ARCH TIERH, V155, P351, DOI 10.1024/0036-7281/a000470; Mugabi R., 2018, THESIS, P844; Nascimento M, 2017, BIOINFORMATICS, V33, P128, DOI 10.1093/bioinformatics/btw582; Naushad S, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00063-20; Oliveira D, 2018, TOXINS, V10, DOI 10.3390/toxins10060252; Oliver SP, 2011, FOODBORNE PATHOG DIS, V8, P337, DOI 10.1089/fpd.2010.0730; Omoe K, 2002, J CLIN MICROBIOL, V40, P857, DOI 10.1128/JCM.40.3.857-862.2002; Partridge SR, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00088-17; Peles F, 2007, INT J FOOD MICROBIOL, V118, P186, DOI 10.1016/j.ijfoodmicro.2007.07.010; Perez-Montarelo D, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00917; Pumipuntu N, 2019, PEERJ, V7, DOI 10.7717/peerj.6587; Rabello RF, 2007, J MED MICROBIOL, V56, P1505, DOI 10.1099/jmm.0.47357-0; Rainard P, 2018, TRANSBOUND EMERG DIS, V65, P149, DOI 10.1111/tbed.12698; Reyes-Robles T, 2013, CELL HOST MICROBE, V14, P453, DOI 10.1016/j.chom.2013.09.005; Rola JG, 2015, J DAIRY SCI, V98, P4273, DOI 10.3168/jds.2014-9064; Ronco T, 2018, VET MICROBIOL, V215, P35, DOI 10.1016/j.vetmic.2018.01.003; Sakwinska O, 2011, APPL ENVIRON MICROB, V77, P5908, DOI 10.1128/AEM.00238-11; Savage E, 2017, FOODBORNE PATHOG DIS, V14, P177, DOI 10.1089/fpd.2016.2222; Schabauer A, 2018, VET MICROBIOL, V227, P52, DOI 10.1016/j.vetmic.2018.10.024; Schlotter K, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-42; Schmidt T, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00511; Sheet OH, 2019, FOLIA MICROBIOL, V64, P845, DOI 10.1007/s12223-019-00698-z; Smith EM, 2005, J CLIN MICROBIOL, V43, P4737, DOI 10.1128/JCM.43.9.4737-4743.2005; Sommerhauser J, 2003, VET MICROBIOL, V96, P91, DOI 10.1016/S0378-1135(03)00204-9; Spaan AN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6438; Srinivasan V, 2006, FOODBORNE PATHOG DIS, V3, P274, DOI 10.1089/fpd.2006.3.274; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Sung JML, 2007, ANTIMICROB AGENTS CH, V51, P2189, DOI 10.1128/AAC.01442-06; Tollersrud T, 2000, APMIS, V108, P565, DOI 10.1034/j.1600-0463.2000.d01-98.x; Vrieling M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37759; Wang W, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01123; Weinert LA, 2012, BIOL LETTERS, V8, P829, DOI 10.1098/rsbl.2012.0290; Wolf C, 2011, PROTEOMICS, V11, P2491, DOI 10.1002/pmic.201000698; Yamada T, 2005, VET MICROBIOL, V110, P97, DOI 10.1016/j.vetmic.2005.07.006; Yi YY, 2018, FOODBORNE PATHOG DIS, V15, P568, DOI 10.1089/fpd.2018.2424; Zhang LL, 2016, MICROB PATHOGENESIS, V97, P103, DOI 10.1016/j.micpath.2016.06.005	88	7	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0248528	10.1371/journal.pone.0248528	http://dx.doi.org/10.1371/journal.pone.0248528			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711052	Green Published, gold			2022-12-26	WOS:000629591800019
J	Waade, J; Seibt, U; Honscha, W; Rachidi, F; Starke, A; Speck, S; Truyen, U				Waade, Jil; Seibt, Uwe; Honscha, Walther; Rachidi, Fanny; Starke, Alexander; Speck, Stephanie; Truyen, Uwe			Multidrug-resistant enterobacteria in newborn dairy calves in Germany	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; FOOD-PRODUCING ANIMALS; EXTENDED-SPECTRUM; ESCHERICHIA-COLI; RISK-FACTORS; ANTIBIOTIC USAGE; PUBLIC-HEALTH; CATTLE FARMS; CTX-M; PREVALENCE	We studied the prevalence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in dairy calves as part of a routine health check protocol. In addition, data regarding antimicrobial use (AMU), farm hygiene, and farm management were collected in order to identify possible risks for ESBL occurrence. Ten farms participated in the study with a median of 781 milking cows (319-1701). All calves investigated were younger than two weeks with an average age of 6.8 (+/- 3.9) days. The farms were visited and samples were collected twice at an interval of 7-11 months. Faecal samples diluted 1:10, were plated onto Brilliance(TM) ESBL agar in duplicates. After 24 hours at 37 degrees C, colonies were counted and total colony forming units (cfu)/ml calculated. Bacteria species were identified biochemically. ESBL-production was phenotypically confirmed using the MICRONAUT-S beta-Lactamases system. Additionally, antimicrobial susceptibility was tested using VITEK(R) 2 technology. Phylotyping of E. coli isolates and screening for bla genes was performed by PCR. ESBL-producing enterobacteria were detected on all farms and 96.5% of calves investigated shed ESBL-positive bacteria. Of all ESBL-producing isolates, the majority were E. coli (92.9%), followed by Enterobacter cloacae (5.1%) and Klebsiella pneumoniae subsp. pneumoniae (2.0%). The majority of E. coli isolates was clearly assigned to phylogroup C (25.0%), followed by phylogroups A (15.2%) and E (14.1%). CTX-M group 1 was most frequently detected (80.4%). E. cloacae contained bla(CTX-M) and bla(TEM) or bla(SHV). K. pneumoniae harboured bla(SHV) only. Besides resistance to penicillins and cephalosporins, the majority of isolates was also resistant to one or more antibiotic classes, with a high proportion being resistant against fluoroqinolones. 52.5% of isolates were further characterised as threefold multidrug resistant gram-negative bacteria (3MDR-GNB) according to the German Commission for Hospital Hygiene and Infection Prevention. None of the isolates were 4MDR-GNB, i.e. none revealed carbapenem-resistance. Penicillins were the most frequently administered antibiotics to calves on most farms and were the predominant substance class at herd level on all farms. Overall, the number of calves treated prior to sampling was rather low (11.7%). Analyses of data regarding the farm management identified weaknesses in biosecurity and cleaning and disinfection. Besides beta-lactam antibiotics being the most commonly used antibiotics no other risk factors could be identified. In summary, the prevalence of ESBL-carriers in dairy calves was exceptionally high and should be motivation to develop strategies for the reduction of multidrug-resistant bacteria in farm animals.	[Waade, Jil; Speck, Stephanie; Truyen, Uwe] Univ Leipzig, Fac Vet Med, Inst Anim Hyg & Vet Publ Hlth, Leipzig, Germany; [Seibt, Uwe; Honscha, Walther] Univ Leipzig, Fac Vet Med, Inst Pharmacol Pharm & Toxicol, Leipzig, Germany; [Rachidi, Fanny; Starke, Alexander] Univ Leipzig, Fac Vet Med, Clin Ruminants & Swine, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Truyen, U (corresponding author), Univ Leipzig, Fac Vet Med, Inst Anim Hyg & Vet Publ Hlth, Leipzig, Germany.	truyen@vetmed.uni-leipzig.de			Leipzig University for Open Access Publishing	Leipzig University for Open Access Publishing	We acknowledge support from Leipzig University for Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2015, J CLIN MICROBIOL, V53, P3515, DOI 10.1128/JCM.01915-15; [Anonymous], 2012, BUNDESGESUNDHEITSBLA, V55, P1311, DOI 10.1007/s00103-012-1549-5; Aust V, 2013, J ANIM PHYSIOL AN N, V97, P1091, DOI 10.1111/jpn.12019; Beyer A, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0578-3; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Brunton LA, 2014, PREV VET MED, V117, P403, DOI 10.1016/j.prevetmed.2014.08.005; Buchter B, 2010, THESIS FREIE U BERLI; Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Commission for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch Institute (RKI), 2019, EPID B, V9, P82, DOI [10.25646/5916, DOI 10.25646/5916]; Coque T M, 2008, Euro Surveill, V13; Coura FM, 2017, FOLIA MICROBIOL, V62, P139, DOI 10.1007/s12223-016-0480-9; Dahms C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143326; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; Eisenberger D, 2018, MICROB DRUG RESIST, V24, P505, DOI 10.1089/mdr.2017.0182; EMA/CVMP/CHM, 2019, CATEGORISATION ANTIB; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Faccone D, 2019, J GLOB ANTIMICROB RE, V18, P160, DOI 10.1016/j.jgar.2019.03.011; Geser N, 2011, J FOOD PROTECT, V74, P446, DOI 10.4315/0362-028X.JFP-10-372; Geser N, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-21; Gonggrijp MA, 2016, J DAIRY SCI, V99, P9001, DOI 10.3168/jds.2016-11134; Grobner S, 2009, J MED MICROBIOL, V58, P912, DOI 10.1099/jmm.0.005850-0; Hille K, 2018, VET MICROBIOL, V223, P93, DOI 10.1016/j.vetmic.2018.07.022; Hille K, 2014, BERL MUNCH TIERARZTL, V127, P403, DOI 10.2376/0005-9366-127-403; Hommerich K, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00244; Hooper David C, 2015, PLASMIDS BIOL IMPACT, P475; Hyde RM, 2017, VET REC, V181, DOI 10.1136/vr.104614; Ibrahim DR, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw013; Kaesbohrer A, 2019, VET MICROBIOL, V233, P52, DOI 10.1016/j.vetmic.2019.03.025; Kock R, 2018, CLIN MICROBIOL INFEC, V24, P1241, DOI 10.1016/j.cmi.2018.04.004; LEVY SB, 1982, LANCET, V2, P83; Liebana E, 2013, CLIN INFECT DIS, V56, P1030, DOI 10.1093/cid/cis1043; Merle R, 2012, BERL MUNCH TIERARZTL, V125, P52, DOI 10.2376/0005-9366-125-52; Michael GB, 2017, VET MICROBIOL, V200, P142, DOI 10.1016/j.vetmic.2016.08.023; Montso Kotsoana Peter, 2019, Biomed Res Int, V2019, P4318306, DOI 10.1155/2019/4318306; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pfeifer Y., 2013, Hygiene & Medizin, V38, P294; Reist M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071725; Santman-Berends IMGA, 2017, J DAIRY SCI, V100, P562, DOI 10.3168/jds.2016-11839; Schmid A, 2013, APPL ENVIRON MICROB, V79, P3027, DOI 10.1128/AEM.00204-13; Snow LC, 2012, PREV VET MED, V106, P225, DOI 10.1016/j.prevetmed.2012.03.009; Stoppe ND, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02512; Strauss LM, 2015, J ANTIMICROB CHEMOTH, V70, P710, DOI 10.1093/jac/dku450; Tetens JL, 2019, J DAIRY SCI, V102, P11449, DOI 10.3168/jds.2019-16659; Umair M, 2019, MICROB DRUG RESIST, V25, P1374, DOI 10.1089/mdr.2018.0450; Valat C, 2012, APPL ENVIRON MICROB, V78, P4677, DOI 10.1128/AEM.00351-12; Valentin L, 2014, INT J MED MICROBIOL, V304, P805, DOI 10.1016/j.ijmm.2014.07.015; van Rennings L, 2014, BERL MUNCH TIERARZTL, V127, P366, DOI 10.2376/0005-9366-127-366; Watson E, 2012, VET MICROBIOL, V154, P339, DOI 10.1016/j.vetmic.2011.07.020; WHO, 2017, CRITICALLY IMPORTANT; Wolfensberger A, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0614-3; World Health Organization, 2014, ANT RES GLOB REP SUR	53	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0248291	10.1371/journal.pone.0248291	http://dx.doi.org/10.1371/journal.pone.0248291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711073	gold, Green Published			2022-12-26	WOS:000629591800044
J	Mun, EY; Geng, F				Mun, Eun-Young; Geng, Feng			An epidemic model for non-first-order transmission kinetics	PLOS ONE			English	Article							COVID-19; DYNAMICS; BEHAVIOR; SPREAD; RATES	Compartmental models in epidemiology characterize the spread of an infectious disease by formulating ordinary differential equations to quantify the rate of disease progression through subpopulations defined by the Susceptible-Infectious-Removed (SIR) scheme. The classic rate law central to the SIR compartmental models assumes that the rate of transmission is first order regarding the infectious agent. The current study demonstrates that this assumption does not always hold and provides a theoretical rationale for a more general rate law, inspired by mixed-order chemical reaction kinetics, leading to a modified mathematical model for non-first-order kinetics. Using observed data from 127 countries during the initial phase of the COVID-19 pandemic, we demonstrated that the modified epidemic model is more realistic than the classic, first-order-kinetics based model. We discuss two coefficients associated with the modified epidemic model: transmission rate constant k and transmission reaction order n. While k finds utility in evaluating the effectiveness of control measures due to its responsiveness to external factors, n is more closely related to the intrinsic properties of the epidemic agent, including reproductive ability. The rate law for the modified compartmental SIR model is generally applicable to mixed-kinetics disease transmission with heterogeneous transmission mechanisms. By analyzing early-stage epidemic data, this modified epidemic model may be instrumental in providing timely insight into a new epidemic and developing control measures at the beginning of an outbreak.	[Mun, Eun-Young] Univ North Texas, Sch Publ Hlth, Dept Hlth Behav & Hlth Syst, Hlth Sci Ctr, Ft Worth, TX 76107 USA; [Geng, Feng] Northwestern Univ, Sch Profess Studies, Chicago, IL 60611 USA	University of North Texas System; University of North Texas Denton; Northwestern University	Mun, EY (corresponding author), Univ North Texas, Sch Publ Hlth, Dept Hlth Behav & Hlth Syst, Hlth Sci Ctr, Ft Worth, TX 76107 USA.	Eun-young.Mun@unthsc.edu	Mun, Eun-Young/AAA-2811-2020	Mun, Eun-Young/0000-0002-1820-615X	National Institute on Alcohol Abuse and Alcoholism (NIAAA) [R01 AA019511]	National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	EYM received funding from the National Institute on Alcohol Abuse and Alcoholism (NIAAA; Award Number R01 AA019511). https://www.niaaa.nih.gov/The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAAA or the National Institutes of Health.	Atkins P., 2006, ATKINS PHYS CHEM; Bertozzi AL, 2020, P NATL ACAD SCI USA, V117, P16732, DOI 10.1073/pnas.2006520117; Brandenburg A, 2020, INFECT DIS MODEL, V5, P681, DOI 10.1016/j.idm.2020.08.014; Brauer Fred, 2017, Infect Dis Model, V2, P113, DOI 10.1016/j.idm.2017.02.001; Breban R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000282; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Buzzi-Ferraris G, 2011, COMPUT CHEM ENG, V35, P388, DOI 10.1016/j.compchemeng.2010.11.004; Castro M, 2020, P NATL ACAD SCI USA, V117, P26190, DOI 10.1073/pnas.2007868117; Chervin S, 2002, THERMOCHIM ACTA, V392, P371, DOI 10.1016/S0040-6031(02)00122-3; Chowell G, 2007, J R SOC INTERFACE, V4, P155, DOI 10.1098/rsif.2006.0161; Corlan AD, 2015, P NATL ACAD SCI USA, V112, P14150, DOI 10.1073/pnas.1510927112; Helfferich FG., 2004, COMPREHENSIVE CHEM K, V40, P273, DOI DOI 10.1016/S0069-8040(04)80013-X; Helfferich FG., 2004, COMPREHENSIVE CHEM K, V40, P163; HOCHBERG ME, 1991, J THEOR BIOL, V153, P301, DOI 10.1016/S0022-5193(05)80572-7; Hong HG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236464; Jia ZW, 2020, LANCET INFECT DIS, V20, P757, DOI 10.1016/S1473-3099(20)30258-9; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Komarova NL, 2020, J R SOC INTERFACE, V17, DOI 10.1098/rsif.2020.0518; Kosmidis K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237304; Kumar J, 1997, CHEM ENG SCI, V52, P3455, DOI 10.1016/S0009-2509(97)00109-7; Lewis D, 2020, NATURE, V583, P510, DOI 10.1038/d41586-020-02058-1; Li M., 2020, SCALING FEATURES SPR; Li S, 2008, J APPL ELECTROCHEM, V38, P151, DOI 10.1007/s10800-007-9413-2; Liu QH, 2018, P NATL ACAD SCI USA, V115, P12680, DOI 10.1073/pnas.1811115115; LIU WM, 1986, J MATH BIOL, V23, P187, DOI 10.1007/BF00276956; LIU WM, 1987, J MATH BIOL, V25, P359, DOI 10.1007/BF00277162; Manenti F, 2020, CHEM ENG SCI, V227, DOI 10.1016/j.ces.2020.115918; Mun E-Y., 2021, **DATA OBJECT**, DOI [10.17632/yf2xkjvd4k.1, DOI 10.17632/YF2XKJVD4K.1]; Mun Eun-Young, 2019, Psychol Test Assess Model, V61, P471; Ortiz A., CHARACTERIZING 2 OUT, V2021; Park SY, 2020, EMERG INFECT DIS, V26, P1666, DOI 10.3201/eid2608.201274; Petersen E, 2020, LANCET INFECT DIS, V20, pE238, DOI 10.1016/S1473-3099(20)30484-9; Python Core Team, 2020, PYTH DYN OP SOURC PR; Sucre-Rosales E, 2020, J CHEM EDUC, V97, P2598, DOI 10.1021/acs.jchemed.0c00698; Viboud C, 2016, EPIDEMICS-NETH, V15, P27, DOI 10.1016/j.epidem.2016.01.002; Wilder-Smith A, 2020, LANCET INFECT DIS, V20, pE102, DOI 10.1016/S1473-3099(20)30129-8; WILSON EB, 1945, P NATL ACAD SCI USA, V31, P109, DOI 10.1073/pnas.31.4.109; Yang ZF, 2020, J THORAC DIS, V12, P165, DOI 10.21037/jtd.2020.02.64; Zimmer K, 2020, GENDER GAP RES OUTPU	39	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0247512	10.1371/journal.pone.0247512	http://dx.doi.org/10.1371/journal.pone.0247512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705424	gold, Green Published			2022-12-26	WOS:000629590400022
J	Bownes, LV; Williams, AP; Marayati, R; Stafman, LL; Markert, H; Quinn, CH; Wadhwani, N; Aye, JM; Stewart, JE; Yoon, KJ; Mroczek-Musulman, E; Beierle, EA				Bownes, Laura, V; Williams, Adele P.; Marayati, Raoud; Stafman, Laura L.; Markert, Hooper; Quinn, Colin H.; Wadhwani, Nikita; Aye, Jamie M.; Stewart, Jerry E.; Yoon, Karina J.; Mroczek-Musulman, Elizabeth; Beierle, Elizabeth A.			EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth	PLOS ONE			English	Article								Investigation of the mechanisms responsible for aggressive neuroblastoma and its poor prognosis is critical to identify novel therapeutic targets and improve survival. Enhancer of Zeste Homolog 2 (EZH2) is known to play a key role in supporting the malignant phenotype in several cancer types and knockdown of EZH2 has been shown to decrease tumorigenesis in neuroblastoma cells. We hypothesized that the EZH2 inhibitor, GSK343, would affect cell proliferation and viability in human neuroblastoma. We utilized four long-term passage neuroblastoma cell lines and two patient-derived xenolines (PDX) to investigate the effects of the EZH2 inhibitor, GSK343, on viability, motility, stemness and in vivo tumor growth. Immunoblotting confirmed target knockdown. Treatment with GSK343 led to significantly decreased neuroblastoma cell viability, migration and invasion, and stemness. GSK343 treatment of mice bearing SK-N-BE(2) neuroblastoma tumors resulted in a significant decrease in tumor growth compared to vehicle-treated animals. GSK343 decreased viability, and motility in long-term passage neuroblastoma cell lines and decreased stemness in neuroblastoma PDX cells. These data demonstrate that further investigation into the mechanisms responsible for the anti-tumor effects seen with EZH2 inhibitors in neuroblastoma cells is warranted.	[Bownes, Laura, V; Williams, Adele P.; Marayati, Raoud; Stafman, Laura L.; Markert, Hooper; Quinn, Colin H.; Wadhwani, Nikita; Stewart, Jerry E.; Beierle, Elizabeth A.] Univ Alabama Birmingham, Dept Surg, Div Pediat Surg, Birmingham, AL 35294 USA; [Aye, Jamie M.] Univ Alabama Birmingham, Dept Pediat, Div Hematol & Oncol, Birmingham, AL USA; [Yoon, Karina J.] Univ Alabama Birmingham, Div Pharmacol & Toxicol, Birmingham, AL USA; [Mroczek-Musulman, Elizabeth] Childrens Alabama, Dept Pathol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Beierle, EA (corresponding author), Univ Alabama Birmingham, Dept Surg, Div Pediat Surg, Birmingham, AL 35294 USA.	elizabeth.beierle@childrensal.org		Quinn, Colin/0000-0001-7853-3948; Bownes, Laura/0000-0003-3833-0657	National Cancer Institute [T32 CA229102, T32 CA183926, T32 CA091078, 5T32BM00836, P30 AR048311, P30 AI27667]; Lombardi Cancer Research Fund/Starr Children's Fund; Sid Strong Foundation; Elaine Roberts Foundation; Open Hearts Overflowing Hands	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lombardi Cancer Research Fund/Starr Children's Fund; Sid Strong Foundation; Elaine Roberts Foundation; Open Hearts Overflowing Hands	This work was partially funded by institutional grants from the National Cancer Institute including T32 CA229102 (https://grantome.com/grant/NIH/T32-CA229102-01)(LV Bownes, R Marayati), T32 CA183926 (https://grantome.com/grant/NIH/T32-CA183926-01)(AP Williams), T32 CA091078 (https://grantome.com/grant/NIH/T32-CA091078-14) (LL Stafman), 5T32BM00836 (CH Quinn), and P30 AR048311 and P30 AI27667 to the University of Alabama at Birmingham, Flow Cytometry Core (https://www.uab.edu/medicine/cfar/core-facilities/basicresearch-core/flow-cytometry-core).Funding was also provided by the Lombardi Cancer Research Fund/Starr Children's Fund (https://www.lombardifoundation.org/home-annual-report), Sid Strong Foundation (https://sidstrongfound.org/), Elaine Roberts Foundation (https://www.elainerobertsfoundation.org/), and Open Hearts Overflowing Hands (https://openhandsoverflowinghearts.org/) (EA Beierle, JM Aye). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisi A, 2013, INT J MOL SCI, V14, P24706, DOI 10.3390/ijms141224706; Amatangelo MD, 2013, CELL CYCLE, V12, P2113, DOI 10.4161/cc.25163; Anwar T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05078-8; Beierle EA, 2008, CLIN CANCER RES, V14, P3299, DOI 10.1158/1078-0432.CCR-07-1511; Beierle Elizabeth A, 2011, Front Biosci (Elite Ed), V3, P421, DOI 10.2741/e257; Beierle EA, 2010, CELL CYCLE, V9, P1005, DOI 10.4161/cc.9.5.10936; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chen LY, 2018, J CLIN INVEST, V128, P446, DOI 10.1172/JCI90793; Codd AS, 2018, IMMUNOLOGY, V153, P304, DOI 10.1111/imm.12866; Corvetta D, 2013, J BIOL CHEM, V288, P8332, DOI 10.1074/jbc.M113.454280; Ding MY, 2015, CLIN EXP PHARMACOL P, V42, P458, DOI 10.1111/1440-1681.12382; Ferraro A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115276; Gillory LA, 2015, J SURG RES, V196, P339, DOI 10.1016/j.jss.2015.03.021; Gnani D, 2017, CELL DEATH DIFFER, V24, P889, DOI 10.1038/cdd.2017.34; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jung J, 2018, CANCER RES TREAT, V50, P1, DOI 10.4143/crt.2017.307; Kaur M, 2013, CANCER RES, V73, P695, DOI 10.1158/0008-5472.CAN-12-2522; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Kratimenos P, 2017, PEDIATR HEMAT ONCOL, V34, P221, DOI 10.1080/08880018.2017.1360969; Lee S, 2012, ONCOTARGET, V3, P1576; Li CH, 2015, CURR PROTEIN PEPT SC, V16, P559, DOI 10.2174/1389203716666150409100233; Li ZH, 2018, ONCOGENE, V37, P2714, DOI 10.1038/s41388-018-0133-3; Liu HL, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00641; Liu WG, 2008, CARCINOGENESIS, V29, P1096, DOI 10.1093/carcin/bgn026; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Maris JM, 2005, CURR OPIN PEDIATR, V17, P7, DOI 10.1097/01.mop.0000150631.60571.89; Megison ML, 2013, CLIN EXP METASTAS, V30, P555, DOI 10.1007/s10585-012-9560-7; Mohammad F, 2017, NAT MED, V23, P483, DOI 10.1038/nm.4293; Newman EA, 2016, SEMIN PEDIATR SURG, V25, P257, DOI 10.1053/j.sempedsurg.2016.09.007; SCHWEIGERER L, 1990, CANCER RES, V50, P4411; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Smith HW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10681-4; Stafman LL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49853-z; Stazi G, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0763-5; Stewart JE, 2015, MOL CARCINOGEN, V54, P9, DOI 10.1002/mc.22070; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Verma SK, 2012, ACS MED CHEM LETT, V3, P1091, DOI 10.1021/ml3003346; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Xiong XF, 2016, INT J ONCOL, V49, P623, DOI 10.3892/ijo.2016.3541; Yi XQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03362-z; Ying L, 2018, CLIN EXP PHARMACOL P, V45, P58, DOI 10.1111/1440-1681.12854; Yu TF, 2017, ONCOTARGET, V8, P98348, DOI 10.18632/oncotarget.21311; Yu Y, 2019, THERANOSTICS, V9, P761, DOI 10.7150/thno.29520; Zhang Y, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1106-2; Zhao Y, 2019, EMBO J, V38, DOI 10.15252/embj.201899599; Zhou J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10176-2; Zhou J, 2013, GYNECOL ONCOL, V128, P344, DOI 10.1016/j.ygyno.2012.07.128	47	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2021	16	3							e0246244	10.1371/journal.pone.0246244	http://dx.doi.org/10.1371/journal.pone.0246244			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DJ	33690617	gold, Green Published			2022-12-26	WOS:000627855600030
J	Qiao, FF				Qiao, Fufeng			Application of deep learning in automatic detection of technical and tactical indicators of table tennis	PLOS ONE			English	Article							REAL; TRACKING; BALL	A DCNN-LSTM (Deep Convolutional Neural Network-Long Short Term Memory) model is proposed to recognize and track table tennis's real-time trajectory in complex environments, aiming to help the audiences understand competition details and provide a reference for training enthusiasts using computers. Real-time motion features are extracted via deep reinforcement networks. DCNN tracks the recognized objects, and the LSTM algorithm predicts the ball's trajectory. The model is tested on a self-built video dataset and existing systems and compared with other algorithms to verify its effectiveness. Finally, an overall tactical detection system is built to measure ball rotation and predict ball trajectory. Results demonstrate that in feature extraction, the Deep Deterministic Policy Gradient (DDPG) algorithm has the best performance, with a maximum accuracy rate of 89% and a minimum mean square error of 0.2475. The accuracy of target tracking effect and trajectory prediction is as high as 90%. Compared with traditional methods, the performance of the DCNN-LSTM model based on deep learning is improved by 23.17%. The implemented automatic detection system of table tennis tactical indicators can deal with the problems of table tennis tracking and rotation measurement. It can provide a theoretical foundation and practical value for related research in real-time dynamic detection of balls.	[Qiao, Fufeng] Qingdao Huanghai Univ, Coll Gen Educ, Qingdao, Shandong, Peoples R China		Qiao, FF (corresponding author), Qingdao Huanghai Univ, Coll Gen Educ, Qingdao, Shandong, Peoples R China.	qiaofeng1120@gmail.com			Science and Technology Project of China Railway Corporation [1341324011]	Science and Technology Project of China Railway Corporation	This work is supported by the Science and Technology Project of China Railway Corporation, Fund No. 1341324011. Moreover, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baidiuk M., 2019, INFLUENCE TABLE TENN, P365; Chen K, 2018, IEEE T CIRC SYST VID, V28, P3377, DOI 10.1109/TCSVT.2017.2757061; Fischer T, 2018, EUR J OPER RES, V270, P654, DOI 10.1016/j.ejor.2017.11.054; Fuchs M, 2018, J SPORT SCI, V36, P2653, DOI 10.1080/02640414.2018.1450073; Girija SS, 2016, SOFTWARE AVAILABLE T, V39, P2584; Han L, 2019, IEEE T ULTRASON FERR, P1; Hegazy H, 2020, PROCEDIA COMPUT SCI, V170, P555, DOI 10.1016/j.procs.2020.03.125; Hung CH, 2018, SPORTS, V6, DOI 10.3390/sports6040158; Ji YF, 2018, SYST SCI CONTROL ENG, V6, P71, DOI 10.1080/21642583.2018.1450167; Kim JU, 2020, IEEE T CIRC SYST VID, V30, P1037, DOI 10.1109/TCSVT.2019.2900709; Kratzert F, 2018, HYDROL EARTH SYST SC, V22, P6005, DOI 10.5194/hess-22-6005-2018; Li Y, 2017, ARXIV PREPRINT ARXIV, P239; Martin PE, 2020, MULTIMED TOOLS APPL, V79, P20429, DOI 10.1007/s11042-020-08917-3; Mishra A, 2017, ARXIV PREPRINT ARXIV, P364; Peng L, 2016, REV IBERICA SISTEMAS, P226; Pesa A. R., 2017, Business Excellence, V11, P121; Popoola SI, 2019, IEEE ACCESS, V7, P150462, DOI 10.1109/ACCESS.2019.2947009; Qiu CR, 2019, IEEE INTERNET THINGS, V6, P8577, DOI 10.1109/JIOT.2019.2921159; Straub G, 2017, GER J EXERC SPORT RE, V47, P95, DOI 10.1007/s12662-016-0431-2; Wang P, 2019, P I MECH ENG P-J SPO, V233, P210, DOI 10.1177/1754337118815021; Wang S, 2020, COMPUT METH PROG BIO, V187, DOI 10.1016/j.cmpb.2019.105254; Wu Y, 2018, IEEE T VIS COMPUT GR, V24, P709, DOI 10.1109/TVCG.2017.2744218; Xu SP, 2020, SIGNAL PROCESS-IMAGE, V81, DOI 10.1016/j.image.2019.115688; Zhang H, 2018, J SPORT SCI, V36, P2663, DOI 10.1080/02640414.2018.1460050; Zhang K, 2018, IEEE T INSTRUM MEAS, V67, P811, DOI 10.1109/TIM.2017.2789139	25	7	7	11	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2021	16	3							e0245259	10.1371/journal.pone.0245259	http://dx.doi.org/10.1371/journal.pone.0245259			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DJ	33690619	gold, Green Published			2022-12-26	WOS:000627855600015
J	Mangombi, JB; N'dilimabaka, N; Lekana-Douki, JB; Banga, O; Maghendji-Nzondo, S; Bourgarel, M; Leroy, E; Fenollar, F; Mediannikov, O				Mangombi, Joa Braithe; N'dilimabaka, Nadine; Lekana-Douki, Jean-Bernard; Banga, Octavie; Maghendji-Nzondo, Sydney; Bourgarel, Mathieu; Leroy, Eric; Fenollar, Florence; Mediannikov, Oleg			First investigation of pathogenic bacteria, protozoa and viruses in rodents and shrews in context of forest-savannah-urban areas interface in the city of Franceville (Gabon)	PLOS ONE			English	Article							ANAPLASMA-PHAGOCYTOPHILUM; COXIELLA-BURNETII; SEROLOGICAL EVIDENCE; INFECTIOUS-DISEASES; TRYPANOSOMA-LEWISI; TOXOPLASMA-GONDII; WILD RODENTS; PCR ASSAYS; URBANIZATION; PREVALENCE	Rodents are reservoirs of numerous zoonotic diseases caused by bacteria, protozoans, or viruses. In Gabon, the circulation and maintenance of rodent-borne zoonotic infectious agents are poorly studied and are often limited to one type of pathogen. Among the three existing studies on this topic, two are focused on a zoonotic virus, and the third is focused on rodent Plasmodium. In this study, we searched for a wide range of bacteria, protozoa and viruses in different organs of rodents from the town of Franceville in Gabon. Samples from one hundred and ninety-eight (198) small mammals captured, including two invasive rodent species, five native rodent species and 19 shrews belonging to the Soricidae family, were screened. The investigated pathogens were bacteria from the Rickettsiaceae and Anaplasmataceae families, Mycoplasma spp., Bartonella spp., Borrelia spp., Orientia spp., Occidentia spp., Leptospira spp., Streptobacillus moniliformis, Coxiella bumetii, and Yersinia pestis; parasites from class Kinetoplastida spp. (Leishmania spp., Trypanosoma spp.), Piroplasmidae spp., and Toxoplasma gondii; and viruses from Paramyxoviridae, Hantaviridae, Flaviviridae and Mammarenavirus spp. We identified the following pathogenic bacteria: Anaplasma spp. (8.1%; 16/198), Bartonella spp. (6.6%; 13/198), Coxiella spp. (5.1%; 10/198) and Leptospira spp. (3.5%; 7/198); and protozoans: Piroplasma sp. (1%; 2/198), Toxoplasma gondii (0.5%; 1/198), and Trypanosoma sp. (7%; 14/198). None of the targeted viral genes were detected. These pathogens were found in Gabonese rodents, mainly Lophuromys sp., Lemniscomys striatus and Praomys sp. We also identified new genotypes: Candidatus Bartonella gabonensis and Uncultured Anaplasma spp. This study shows that rodents in Gabon harbor some human pathogenic bacteria and protozoans. It is necessary to determine whether the identified microorganisms are capable of undergoing zoonotic transmission from rodents to humans and if they may be responsible for human cases of febrile disease of unknown etiology in Gabon.	[Mangombi, Joa Braithe; N'dilimabaka, Nadine; Lekana-Douki, Jean-Bernard; Banga, Octavie; Leroy, Eric] Ctr Interdisciplinaire Rech Med Franceville CIRMF, Franceville, Gabon; [Mangombi, Joa Braithe; Fenollar, Florence] Aix Marseille Univ, VITROME, Microbes, AP HM,IRD, Marseille, France; [Mangombi, Joa Braithe; Fenollar, Florence; Mediannikov, Oleg] IHU Mediterranee Infect, Marseille, France; [N'dilimabaka, Nadine] Univ Sci & Tech Masuku USTM, Fac Sci, Dept Biol, Franceville, Gabon; [Lekana-Douki, Jean-Bernard] Univ Sci Sante USS, Dept Parasitol, Owendo, Libreville, Gabon; [Maghendji-Nzondo, Sydney] Univ Sci Sante USS, Dept Epidemiol Biostat & Informat Med DEBIM, Owendo, Libreville, Gabon; [Bourgarel, Mathieu] UMR ASTRE, CIRAD, Harare, Zimbabwe; [Bourgarel, Mathieu] Univ Montpellier, INRA, CIRAD, ASTRE, Montpellier, France; [Leroy, Eric] UMR MIVEGEC IRD CNRS UM, IRD, Montpellier, France; [Mediannikov, Oleg] Aix Marseille Univ, MEPHI, Microbes, AP HM,IRD, Marseille, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; CIRAD; CIRAD; INRAE; Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	N'dilimabaka, N (corresponding author), Ctr Interdisciplinaire Rech Med Franceville CIRMF, Franceville, Gabon.; N'dilimabaka, N (corresponding author), Univ Sci & Tech Masuku USTM, Fac Sci, Dept Biol, Franceville, Gabon.	nadinendilimabaka@yahoo.fr	LEROY, Eric M/I-4347-2016; Bourgarel, Mathieu/F-1750-2017; Mediannikov, Oleg/H-4018-2015	LEROY, Eric M/0000-0003-0022-0890; Bourgarel, Mathieu/0000-0001-9774-7669; Mediannikov, Oleg/0000-0001-6039-2008; , Joa Braithe/0000-0003-2443-0067	Association pour la recherche en infectiologie (APRI); AUF-Agence universitaire de la Francophonie [CDMATHINBIO 17872]	Association pour la recherche en infectiologie (APRI); AUF-Agence universitaire de la Francophonie	JBM 1: AUF-Agence universitaire de la Francophonie. https://www.auf.org/afriquecentrale-grands-lacs/nouvelles/actualites/liste-beneficiaires-college-doctoral-regionalmathematiques-informatique-biosciences-geosciences-de-lenvironnement-publiee/or https://www.auf.org/wp-content/uploads/2018/09/Listedes-doctorants-MATHINBIO.pdf. Number: CDMATHINBIO 17872. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Association pour la recherche en infectiologie (APRI) for his support in finalizing this study. We thank the authorities of the city of Franceville as well as the leaders of the districts where rodent sampling took place. We also express our deep gratitude to those individuals who have kindly given us access to their homes. We also thank Mr AWOUNDJA Lauriano for assistance with the trapping of rodents and the interpretation of local languages and Randy Lyn ESSONO for his help in mapping. Finally, this acknowledgements section would be incomplete without conveying our gratitude to Dr Ce ' lia BOUMBANDA KOYO, Handi DAHMANA and Marielle BEDOTTO-BUFFET for their help with molecular biology analyses in the laboratory and Dr Serge DIBAKOU for his support in statistical analysis.	Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28; Ahmed S, 2019, ENVIRON URBAN, V31, P443, DOI 10.1177/0956247819866124; Aitichou M, 2005, J VIROL METHODS, V124, P21, DOI 10.1016/j.jviromet.2004.10.004; Alirol E, 2011, LANCET INFECT DIS, V11, P131, DOI 10.1016/S1473-3099(10)70223-1; Aliyu AA, 2017, ANN AFR MED, V16, P149, DOI 10.4103/aam.aam_1_17; Andre MR, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00293; Andre-Fontaine G, 2015, CURR MICROBIOL, V71, P136, DOI 10.1007/s00284-015-0836-4; Andrianaivoarimanana V, 2019, EMERG INFECT DIS, V25, P220, DOI 10.3201/eid2502.171974; Angelakis E, 2014, INT J INFECT DIS, V28, P107, DOI 10.1016/j.ijid.2014.05.029; Angelakis E, 2010, EMERG INFECT DIS, V16, P385, DOI [10.3201/eid1603.091685, 10.3201/eid1603.081685]; [Anonymous], 2015, J STAT SOFTW, DOI [DOI 10.18637/JSS.V067.I01, DOI 10.18637/jss.v067.i01]; Assele V, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1456-4; Auty H, 2015, REV SCI TECH OIE, V34, P587, DOI 10.20506/rst.34.2.2382; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Barton K., 2022, MULTIMODEL INFERENCE; Beck R, 2011, VECTOR-BORNE ZOONOT, V11, P81, DOI 10.1089/vbz.2009.0260; Benevenute JL, 2017, TICKS TICK-BORNE DIS, V8, P646, DOI 10.1016/j.ttbdis.2017.04.011; Billeter SA, 2014, VECTOR-BORNE ZOONOT, V14, P182, DOI 10.1089/vbz.2013.1375; Bittar F, 2014, SCI REP-UK, V4, DOI 10.1038/srep07174; Bonner PC, 2007, AM J TROP MED HYG, V77, P169, DOI 10.4269/ajtmh.2007.77.169; Borrmann S, 2002, T ROY SOC TROP MED H, V96, P660, DOI 10.1016/S0035-9203(02)90345-7; Boundenga L, 2020, SPG BIOMED; Boundenga L, 2019, INT J PARASITOL-PAR, V10, P117, DOI 10.1016/j.ijppaw.2019.07.010; Bourgarel M, 2010, Emerg Health Threats J, V3, pe7, DOI 10.3134/ehtj.10.163; Bouyou-Akotet MK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-300; Boyer N, 2010, J ANIM ECOL, V79, P538, DOI 10.1111/j.1365-2656.2010.01659.x; Brenner DJ, 1999, INT J SYST BACTERIOL, V49, P839, DOI 10.1099/00207713-49-2-839; Brouat C, 2007, PARASITOLOGY, V134, P437, DOI 10.1017/S003118200600151X; Brouat C, 2007, MOL ECOL, V16, P2985, DOI 10.1111/j.1365-294X.2007.03353.x; Brouat C, 2007, OECOLOGIA, V152, P715, DOI 10.1007/s00442-007-0680-8; Chastagner A, 2016, TICKS TICK-BORNE DIS, V7, P988, DOI 10.1016/j.ttbdis.2016.05.005; Chitanga S, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2629-7; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Cohen B, 2006, TECHNOL SOC, V28, P63, DOI 10.1016/j.techsoc.2005.10.005; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Colyn M, 2002, VARIABILITE STRUCTUR; Dahmana H, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030202; Dahmani M., 2018, New Microbes and New Infections, V25, P60, DOI 10.1016/j.nmni.2018.03.005; Dahmani M, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2233-2; Dalecky A, 2015, MAMMAL REV, V45, P176, DOI 10.1111/mam.12043; Delta S, 1994, AFRICAN SMALL MAMM; Diagne C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14880-1; Diagne C, 2016, INT J PARASITOL, V46, P857, DOI 10.1016/j.ijpara.2016.07.007; Diagne CA, 2017, VECTOR-BORNE ZOONOT, V17, P730, DOI 10.1089/vbz.2017.2135; Direction de la statistique, 2015, REC GEN POP HAB 2013; Dobigny G, 2019, INFECT GENET EVOL, V75, DOI 10.1016/j.meegid.2019.103967; Dobigny G, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004097; Dobigny G, 2011, ACTA TROP, V117, P183, DOI 10.1016/j.actatropica.2010.11.004; Dumler JS, 2005, EMERG INFECT DIS, V11, P1828, DOI 10.3201/eid1112.050898; Duplanrier J., 1982, RONGEURS MYOMORPHES; Duplantier J-M, 1987, CRITERES IDENTIFICAT; Duplantier JM, 2006, MICROMAMMALS AND MACROPARASITES: FROM EVOLUTIONARY ECOLOGY TO MANAGEMENT, P527, DOI 10.1007/978-4-431-36025-4_24; DUPLANTIER JM, 1989, REV ECOL-TERRE VIE, V44, P329; Duplantier JM, 2000, J HELMINTHOL, V74, P129; Feng AYT, 2014, URBAN ECOSYST, V17, P149, DOI 10.1007/s11252-013-0305-4; Galal L, 2019, INT J PARASITOL, V49, P267, DOI 10.1016/j.ijpara.2018.11.004; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Garba M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110666; Gharbi M, 2012, REV MED VET-TOULOUSE, V163, P563; Glazunova O, 2005, EMERG INFECT DIS, V11, P1211; Gratz N. G., 1999, Proceedings of the 3rd International Conference on Urban Pests. Czech University of Agriculture, Prague, Czech Republic, 19-22 July 1999., P51; Gratz N. G., 1994, P85; Gu W, 2019, ANNU REV PATHOL-MECH, V14, P319, DOI 10.1146/annurev-pathmechdis-012418-012751; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han BA, 2015, P NATL ACAD SCI USA, V112, P7039, DOI 10.1073/pnas.1501598112; Health Organisation World, 2019, LASS FEV NIG DIS OUT; HILTON DFJ, 1972, PARASITOLOGY, V65, P427, DOI 10.1017/S0031182000044048; Hima K, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11120238; Houemenou G, 2013, ISRN EPIDEMIOLOGY, V2013, P1; Houemenou G, 2019, URBAN SCI, V3, DOI 10.3390/urbansci3030099; Hove M, 2013, STABILITY, V2, DOI 10.5334/sta.ap; Jauregui LH, 2001, J CLIN MICROBIOL, V39, P2065, DOI 10.1128/JCM.39.6.2065-2071.2001; Jiang H, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00001; Keeling MJ, 2000, NATURE, V407, P903, DOI 10.1038/35038073; Kelly DW, 2009, ECOLOGY, V90, P2047, DOI 10.1890/08-1085.1; Klempa B, 2006, EMERG INFECT DIS, V12, P838, DOI 10.3201/eid1205.051487; Klempa B, 2010, J INFECT DIS, V201, P1031, DOI 10.1086/651169; Kosoy M, 2010, AM J TROP MED HYG, V82, P1140, DOI 10.4269/ajtmh.2010.09-0778; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kumsa B, 2015, AM J TROP MED HYG, V93, P1074, DOI 10.4269/ajtmh.14-0758; Kweka EJ, 2018, VECTOR BORNE DIS TRE; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Laporte N., 1999, GEOGRAPHIE RELATIONS, V2; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Libois BKR., 2014, INT J BIOL CHEM SCI, V8, P1202; Linardi PM, 2002, MEM I OSWALDO CRUZ, V97, P411, DOI 10.1590/S0074-02762002000300024; Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753; Mangombi JB, 2016, J ZOOL, V299, P183, DOI 10.1111/jzo.12334; Martin-Alonso A, 2016, VECTOR-BORNE ZOONOT, V16, P229, DOI 10.1089/vbz.2015.1838; Mediannikov O, 2014, MICROB PATHOGENESIS, V77, P142, DOI 10.1016/j.micpath.2014.09.008; Mediannikov O, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000654; Medkour H, 2019, NEW MICROB NEW INFEC, V32, DOI 10.1016/j.nmni.2019.100596; Medkour H, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8030356; Meerburg BG, 2009, CRIT REV MICROBIOL, V35, P221, DOI 10.1080/10408410902989837; Mercier A., 2010, APPROCHE ECOLOGIQUE; Mercier A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000876; Mills J. N., 1999, Ecologically-based management of rodent pests., P134; Mills JN, 1998, EMERG INFECT DIS, V4, P529, DOI 10.3201/eid0404.980403; Mofolorunsho KC, 2016, PAN AFR MED J, V23, DOI 10.11604/pamj.2016.23.210.8923; Mombo IM, 2019, INFECT GENET EVOL, V68, P43, DOI 10.1016/j.meegid.2018.12.003; Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206; Murphy DS, 2017, VECTOR-BORNE ZOONOT, V17, P229, DOI 10.1089/vbz.2016.2055; N'Dilimabaka N, 2015, J VIROL, V89, P1456, DOI 10.1128/JVI.01009-14; Neiderud Carl-Johan, 2015, Infection Ecology & Epidemiology, V5, P27060, DOI 10.3402/iee.v5.27060; Nicolas V, 2003, CAN J ZOOL, V81, P1034, DOI 10.1139/Z03-092; Nicolas V., 2003, REV ECOL TERRE VIE, V58; Nicolas V., 2003, REV ECOLOGIE TERRE V, V58; Nicolas V, 2008, J BIOGEOGR, V35, P2074, DOI 10.1111/j.1365-2699.2008.01950.x; Nicolas V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036586; Olayemi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25280; Olayemi A, 2016, EMERG INFECT DIS, V22, P694, DOI 10.3201/eid2204.150155; Parte AC, 2018, INT J SYST EVOL MICR, V68, P1825, DOI 10.1099/ijsem.0.002786; Passaretti T., 2017, J MICROBIOL INFECT D, V7, P88; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Picardeau M, 2017, NAT REV MICROBIOL, V15, P297, DOI 10.1038/nrmicro.2017.5; Pumhom P, 2014, EPIDEMIOL INFECT, V142, P1221, DOI 10.1017/S0950268813002161; R Development Core Team, 2007, R LANG ENV STAT COMP; Rabaan AA, 2019, J MED MICROBIOL, V68, P292, DOI 10.1099/jmm.0.000915; Reifenberg JM, 1997, VET PARASITOL, V71, P251, DOI 10.1016/S0304-4017(97)00011-3; RICHARDLENOBLE D, 1987, B SOC PATHOL EXOT, V80, P532; RICHARDLENOBLE D, 1986, B SOC PATHOL EXOT, V79, P284; Rodrigues AC, 2014, INFECT GENET EVOL, V23, P20, DOI 10.1016/j.meegid.2014.01.012; Rosso F, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2221-6; Salmon-Mulanovich G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3420-3; SALUZZO JF, 1985, T ROY SOC TROP MED H, V79, P874, DOI 10.1016/0035-9203(85)90145-2; Schwan TG, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1818-5; Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13; Socolovschi C, 2010, EMERG INFECT DIS, V16, P1140, DOI 10.3201/eid1607.100070; Sokhna C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001999; Subramanian G, 2012, TICKS TICK-BORNE DIS, V3, P405, DOI 10.1016/j.ttbdis.2012.10.001; Tatard C, 2017, ACTA TROP, V171, P151, DOI 10.1016/j.actatropica.2017.03.027; Theonest NO, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223667; Tomaso H, 2008, CLIN CHEM LAB MED, V46, P1239, DOI 10.1515/CCLM.2008.251; Tong MX, 2015, INT J ENV RES PUB HE, V12, P11025, DOI 10.3390/ijerph120911025; Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08; Truc P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002256; Vanderburg S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002787; Verma A, 2011, AM J TROP MED HYG, V85, P221, DOI 10.4269/ajtmh.2011.11-0002; Wang YL, 2008, P NATL ACAD SCI USA, V105, P6127, DOI 10.1073/pnas.0801777105; Xu YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20020; Zhan L, 2010, EMERG INFECT DIS, V16, P764, DOI [10.3201/eid1605.021293, 10.3201/eid1605.091293]	141	2	2	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0248244	10.1371/journal.pone.0248244	http://dx.doi.org/10.1371/journal.pone.0248244			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU3OZ	33684147	Green Published, gold			2022-12-26	WOS:000627193500020
J	Hunt, RD; Ashbaugh, RC; Reimers, M; Udpa, L; De Jimenez, GS; Moore, M; Gilad, AA; Pelled, G				Hunt, Ryan D.; Ashbaugh, Ryan C.; Reimers, Mark; Udpa, Lalita; De Jimenez, Gabriela Saldana; Moore, Michael; Gilad, Assaf A.; Pelled, Galit			Swimming direction of the glass catfish is responsive to magnetic stimulation	PLOS ONE			English	Article							MAGNETORECEPTION; FIELD; BEHAVIOR; ORIENTATION; NAVIGATION; LORENZINI; AMPULLAE; ORGANS; MODEL; GULF	Several marine species have developed a magnetic perception that is essential for navigation and detection of prey and predators. One of these species is the transparent glass catfish that contains an ampullary organ dedicated to sense magnetic fields. Here we examine the behavior of the glass catfish in response to static magnetic fields which will provide valuable insight on function of this magnetic response. By utilizing state of the art animal tracking software and artificial intelligence approaches, we quantified the effects of magnetic fields on the swimming direction of glass catfish. The results demonstrate that glass catfish placed in a radial arm maze, consistently swim away from magnetic fields over 20 mu T and show adaptability to changing magnetic field direction and location.	[Hunt, Ryan D.; Ashbaugh, Ryan C.; Gilad, Assaf A.; Pelled, Galit] Michigan State Univ, Dept Biomed Engn, E Lansing, MI 48824 USA; [Hunt, Ryan D.; Ashbaugh, Ryan C.; Reimers, Mark; De Jimenez, Gabriela Saldana; Moore, Michael; Pelled, Galit] Michigan State Univ, Neuroengn Div, Inst Quantitat Hlth Sci & Engn, E Lansing, MI 48824 USA; [Ashbaugh, Ryan C.; Udpa, Lalita] Michigan State Univ, Dept Elect & Comp Engn, E Lansing, MI 48824 USA; [Reimers, Mark; Moore, Michael] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Reimers, Mark; Moore, Michael] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Gilad, Assaf A.; Pelled, Galit] Michigan State Univ, Dept Radiol, E Lansing, MI 48824 USA; [Gilad, Assaf A.] Michigan State Univ, Synthet Biol Div, Inst Quantitat Hlth Sci & Engn, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; Michigan State University; Michigan State University; Michigan State University	Pelled, G (corresponding author), Michigan State Univ, Dept Biomed Engn, E Lansing, MI 48824 USA.; Pelled, G (corresponding author), Michigan State Univ, Neuroengn Div, Inst Quantitat Hlth Sci & Engn, E Lansing, MI 48824 USA.; Pelled, G (corresponding author), Michigan State Univ, Dept Radiol, E Lansing, MI 48824 USA.	Pelledga@msu.edu			National Institutes of Health NINDS [RO1NSO72171, RO1NS098231]	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health NINDS grants RO1NSO72171 to GP and RO1NS098231 to GP and AAG. The Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babineau D, 2007, PLOS COMPUT BIOL, V3, P402, DOI 10.1371/journal.pcbi.0030038; Beason RC, 1997, AUK, V114, P405, DOI 10.2307/4089242; Benhamou S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026672; BEVER MM, 1991, J COMP NEUROL, V309, P218, DOI 10.1002/cne.903090204; Brothers JR, 2015, CURR BIOL, V25, P392, DOI 10.1016/j.cub.2014.12.035; BROWN HR, 1978, J COMP PHYSIOL, V126, P333, DOI 10.1007/BF00667103; Burda H, 2009, P NATL ACAD SCI USA, V106, P5708, DOI 10.1073/pnas.0811194106; Cywiak C, 2020, BRAIN STIMUL, V13, P1774, DOI 10.1016/j.brs.2020.10.006; de Oliveira JF, 2010, J R SOC INTERFACE, V7, P143, DOI 10.1098/rsif.2009.0102; Delcourt J, 2018, BEHAV RES METHODS, V50, P1673, DOI 10.3758/s13428-018-1024-9; Eder SHK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107356; Fishelson L, 1998, ANAT RECORD, V251, P417; Fjallbrant TT, 1998, PHILOS T ROY SOC B, V353, P1211, DOI 10.1098/rstb.1998.0277; Formicki K, 2019, J FISH BIOL, V95, P73, DOI 10.1111/jfb.13998; Fritzsch B, 2014, J COMP PHYSIOL A, V200, P5, DOI 10.1007/s00359-013-0865-z; Han Jee Eun, 2011, Cell Biol Int Rep (2010), V18, pe00008, DOI 10.1042/CBR20110002; Hart V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051100; Hore PJ, 2016, ANNU REV BIOPHYS, V45, P299, DOI 10.1146/annurev-biophys-032116-094545; Hutchison ZL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60793-x; Hwang J, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10020308; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; Johnsen S, 2008, PHYS TODAY, V61, P29, DOI 10.1063/1.2897947; Krishnan V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27087-9; LISSMANN HW, 1963, NATURE, V199, P88, DOI 10.1038/199088a0; Lohmann KJ, 2010, NATURE, V464, P1140, DOI 10.1038/4641140a; London S, 2019, COMP BIOCHEM PHYS A, V228, P94, DOI 10.1016/j.cbpa.2018.11.009; MANGER PR, 1995, PHILOS T ROY SOC B, V347, P359, DOI 10.1098/rstb.1995.0030; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Mouritsen H, 2018, NATURE, V558, P50, DOI 10.1038/s41586-018-0176-1; Naisbett-Jones LC, 2017, CURR BIOL, V27, P1236, DOI 10.1016/j.cub.2017.03.015; Nath T, 2019, NAT PROTOC, V14, P2152, DOI 10.1038/s41596-019-0176-0; Ng HH, 2013, ZOOTAXA, V3630, P308, DOI 10.11646/zootaxa.3630.2.6; Nordmann GC, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003234; Osipova EA, 2016, BEHAV PROCESS, V122, P80, DOI 10.1016/j.beproc.2015.11.009; Putman NF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0542; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Rummer JL, 2014, J EXP BIOL, V217, P751, DOI 10.1242/jeb.086348; Struik ML, 2001, COMP BIOCHEM PHYS A, V130, P607, DOI 10.1016/S1095-6433(01)00436-6; Vidal-Gadea A, 2015, ELIFE, V4, DOI 10.7554/eLife.07493; WACHTEL AW, 1969, J MORPHOL, V128, P291, DOI 10.1002/jmor.1051280303; Walker MM, 2008, J THEOR BIOL, V250, P85, DOI 10.1016/j.jtbi.2007.09.030; Waranyu Khunjaroenrak SP., 2019, J ARGICULTURE RES EX, V37, P29; Wiltschko R, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2019.0295; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; Winklhofer M, 2019, CURR BIOL, V29, pR1224, DOI 10.1016/j.cub.2019.10.022; Winklhofer M, 2010, J R SOC INTERFACE, V7, pS273, DOI 10.1098/rsif.2009.0435.focus; Wynn J, 2020, CURR BIOL, V30, P2869, DOI 10.1016/j.cub.2020.05.039	47	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0248141	10.1371/journal.pone.0248141	http://dx.doi.org/10.1371/journal.pone.0248141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667278	Green Published, gold			2022-12-26	WOS:000626604300060
J	Stone, W; Louw, TM; Booysen, MJ; Wolfaardt, GM				Stone, Wendy; Louw, Tobi M.; Booysen, Marthinus J.; Wolfaardt, Gideon M.			Canary in the coliform mine: Exploring the industrial application limits of a microbial respiration alarm system	PLOS ONE			English	Article								Fundamental ecological principles of ecosystem-level respiration are extensively applied in greenhouse gas and elemental cycle studies. A laboratory system termed CEMS (Carbon Dioxide Evolution Measurement System), developed to explore microbial biofilm growth and metabolic responses, was evaluated as an early-warning system for microbial disturbances in industrial settings: in (a) potable water system contamination, and (b) bioreactor inhibition. Respiration was detected as CO2 production, rather than O-2 consumption, including aerobic and anaerobic metabolism. Design, thresholds, and benefits of the remote CO2 monitoring technology were described. Headspace CO2 correlated with contamination levels, as well as chemical (R-2 > 0.83-0.96) and microbiological water quality indicators (R-2 > 0.78-0.88). Detection thresholds were limiting factors in monitoring drinking water to national and international standards (0 CFU/100 mL fecal coliforms) in both open- (> 1500 CFU/mL) and closed-loop CO2 measuring regimes (> 100 CFU/100 mL). However, closed-loop detection thresholds allow for the detection of significant contamination events, and monitoring less stringent systems such as irrigation water (< 100 CFU/mL). Whole-system respiration was effectively harnessed as an early-warning system in bioreactor performance monitoring. Models were used to deconvolute biological CO2 fluctuations from chemical CO2 dynamics, to optimize this real-time, sustainable, low-waste technology, facilitating timeous responses to biological disturbances in bioreactors.	[Stone, Wendy; Wolfaardt, Gideon M.] Stellenbosch Univ, Water Inst, Stellenbosch, South Africa; [Stone, Wendy; Wolfaardt, Gideon M.] Stellenbosch Univ, Dept Microbiol, Stellenbosch, South Africa; [Louw, Tobi M.] Stellenbosch Univ, Dept Proc Engn, Stellenbosch, South Africa; [Booysen, Marthinus J.] Stellenbosch Univ, Dept E&E Engn, Stellenbosch, South Africa; [Wolfaardt, Gideon M.] Ryerson Univ, Dept Chem & Biol, Toronto, ON, Canada	Stellenbosch University; Stellenbosch University; Stellenbosch University; Stellenbosch University; Toronto Metropolitan University	Stone, W (corresponding author), Stellenbosch Univ, Water Inst, Stellenbosch, South Africa.; Stone, W (corresponding author), Stellenbosch Univ, Dept Microbiol, Stellenbosch, South Africa.	wstone@sun.ac.za	Booysen, MJ/AAF-6029-2019; Stone, Wendy/F-8875-2019	Booysen, MJ/0000-0003-2817-2069; Louw, Tobias/0000-0002-4166-0799; Stone, Wendy/0000-0001-9126-6362	European Union [689925]	European Union(European Commission)	GMW and WS were funded by the European Union's Horizon 2020 research and innovation program (https://ec.europa.eu/programmes/horizon2020/en), grant agreement No 689925. The study reflects only the authors' views. The EU is not responsible for any use that may be made of the information it contains. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	[Anonymous], 2004, EPA17 CLIN LAB STAND, V24, P1; [Anonymous], 1996, S AFRICAN WATER QUAL; [Anonymous], 2019, GUIDELINES CANADIAN; [Anonymous], 1996, S AFRICAN WATER QUAL; [Anonymous], 1993, GUID DRINK WAT QUAL, V1; [Anonymous], 2017, THE GUARDIAN    0130; [Anonymous], 360 ENV; Ballantyne AP, 2012, NATURE, V488, P70, DOI 10.1038/nature11299; Bester E, 2011, J APPL MICROBIOL, V110, P387, DOI 10.1111/j.1365-2672.2010.04894.x; Blackburn Brian G., 2004, Morbidity and Mortality Weekly Report, V53, P23; Boccia D, 2002, EMERG INFECT DIS, V8, P563, DOI 10.3201/eid0806.010371; Boyce JM, 2011, INFECT CONT HOSP EP, V32, P1187, DOI 10.1086/662626; Burnet JB, AUTONOMOUS ONLINE ME; Burnet JB, 2019, WATER RES, V152, P241, DOI 10.1016/j.watres.2018.12.060; Coleman DC, 2009, J APPL MICROBIOL, V106, P1424, DOI 10.1111/j.1365-2672.2008.04100.x; Dumitrache A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-175; Forootan A, BIOMOL DETECT QUANT, V1; Hanninen ML, 2003, APPL ENVIRON MICROB, V69, P1391, DOI 10.1128/AEM.69.3.1391-1396.2003; Jackson LMD, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00953; Kroukamp O, 2010, APPL ENVIRON MICROB, V76, P6025, DOI 10.1128/AEM.00070-10; Kroukamp O, 2009, APPL ENVIRON MICROB, V75, P4391, DOI 10.1128/AEM.01567-08; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Paulse AN, 2009, WATER SA, V35, P469; Ronan E, 2016, ULTRASONICS, V69, P182, DOI 10.1016/j.ultras.2016.03.017; Spanjers H, 1996, WATER SCI TECHNOL, V34, P117, DOI 10.1016/0273-1223(96)84211-9; Stone W, 2016, APPL CLAY SCI, V129, P54, DOI 10.1016/j.clay.2016.04.022	27	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0247910	10.1371/journal.pone.0247910	http://dx.doi.org/10.1371/journal.pone.0247910			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33661997	Green Published, gold			2022-12-26	WOS:000626604100018
J	Ward, J; Cheng, XH; Xiao, YY; Lapolla, P; Chandrashekar, A; Handa, A; Cleveland, RA; Lee, R				Ward, Joel; Cheng, Xinghao; Xiao, Yingyi; Lapolla, Pierfrancesco; Chandrashekar, Anirudh; Handa, Ashok; Cleveland, Robin A.; Lee, Regent			Development of a novel index to characterise arterial dynamics using ultrasound imaging	PLOS ONE			English	Article								Abdominal aortic aneurysms (AAA) are associated with systemic inflammation and endothelial dysfunction. We previously reported flow mediated dilatation (FMD) of the brachial artery as a predictor of AAA growth. We hence hypothesised that other physical characteristics of the brachial artery correlate with AAA growth. Using a prospectively cohort of AAA patients, we devised a 'brachial artery relaxation index' (BARI) and examined its role as a biomarker for AAA growth. However, no correlation between BARI and future aneurysm growth was observed (p = 0.45). Therefore, our investigations did not substantiate the hypothesis that other physical characteristics of the brachial artery predicts AAA growth.	[Ward, Joel; Lapolla, Pierfrancesco; Chandrashekar, Anirudh; Handa, Ashok; Lee, Regent] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Oxford, England; [Cheng, Xinghao; Xiao, Yingyi; Cleveland, Robin A.] Univ Oxford, Inst Biomed Engn, Oxford, England	University of Oxford; University of Oxford	Lee, R (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Oxford, England.	regent.lee@nds.ox.ac.uk	Lapolla, Pierfrancesco/AAT-8407-2021	Lapolla, Pierfrancesco/0000-0002-3088-5263; Lee, Regent/0000-0001-8621-5165; Handa, Ashok/0000-0001-7888-7180	University of Oxford, Medical Sciences Division Medical Research Fund [MRF/HT2016/2191]; University of Oxford, Nuffield Department of Surgical Sciences; John Fell Oxford University Press Research Fund [142/075]; National Institute of Health Research (NIHR) Oxford Biomedical Research Centre; Academy of Medical Science Starter Grant, UK [SGL013/1015]; EU Erasmus+ traineeship studentship	University of Oxford, Medical Sciences Division Medical Research Fund; University of Oxford, Nuffield Department of Surgical Sciences; John Fell Oxford University Press Research Fund; National Institute of Health Research (NIHR) Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Academy of Medical Science Starter Grant, UK; EU Erasmus+ traineeship studentship	The Oxford Abdominal Aortic Aneurysm Study was supported by the following: University of Oxford, Medical Sciences Division Medical Research Fund (MRF/HT2016/2191); University of Oxford, Nuffield Department of Surgical Sciences; John Fell Oxford University Press Research Fund (142/075); National Institute of Health Research (NIHR) Oxford Biomedical Research Centre; Regent Lee was supported by a Academy of Medical Science Starter Grant, UK (SGL013/1015). Pierfrancesco Lapolla was supported by an EU Erasmus+ traineeship studentship. Anirudh Chandrashekar is a Clarendon Keble Scholar, University of Oxford.	Balocco S, 2010, PHYS MED BIOL, V55, P3557, DOI 10.1088/0031-9155/55/12/019; Chaikof EL, 2018, J VASC SURG, V67, P2, DOI 10.1016/j.jvs.2017.10.044; Grondal N, 2015, BRIT J SURG, V102, P902, DOI 10.1002/bjs.9825; Klein K, 2014, COMPUT ECON, V43, P447, DOI 10.1007/s10614-013-9377-8; Knipp BS, 2002, J VASC SURG, V35, P363, DOI 10.1067/mva.2002.121069; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Lee R, 2017, EUR J VASC ENDOVASC, V53, P820, DOI 10.1016/j.ejvs.2017.03.001; Lee R, 2019, ANN SURG, V270, pE1, DOI 10.1097/SLA.0000000000003154; Li CM, 2011, IEEE T IMAGE PROCESS, V20, P2007, DOI 10.1109/TIP.2011.2146190; Medina F, 2010, ANN VASC SURG, V24, P752, DOI 10.1016/j.avsg.2009.11.011; Moxon JV, 2010, CURR PROB CARDIOLOGY, V35, P512, DOI 10.1016/j.cpcardiol.2010.08.004; Oliver-Williams C, 2018, BRIT J SURG, V105, P68, DOI 10.1002/bjs.10715; Rutherford RB, 2012, SEMIN VASC SURG, V25, P39, DOI 10.1053/j.semvascsurg.2012.03.005; Sung SH, 2013, INT J CARDIOL, V168, P1070, DOI 10.1016/j.ijcard.2012.11.002	14	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0248043	10.1371/journal.pone.0248043	http://dx.doi.org/10.1371/journal.pone.0248043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33662025	Green Published, gold, Green Submitted			2022-12-26	WOS:000626604100033
J	Stypulkowski, E; Feng, Q; Joseph, I; Farrell, V; Flores, J; Yu, SY; Sakamori, R; Sun, JX; Bandyopadhyay, S; Das, S; Dobrowolski, R; Bonder, EM; Chen, MH; Gao, N				Stypulkowski, Ewa; Feng, Qiang; Joseph, Ivor; Farrell, Victoria; Flores, Juan; Yu, Shiyan; Sakamori, Ryotaro; Sun, Jiaxin; Bandyopadhyay, Sheila; Das, Soumyashree; Dobrowolski, Radek; Bonder, Edward M.; Chen, Miao-Hsueh; Gao, Nan			Rab8 attenuates Wnt signaling and is required for mesenchymal differentiation into adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY-CILIUM; CILIARY MEMBRANE; GENE-EXPRESSION; PPAR-GAMMA; STEM-CELLS; BETA; GTPASE; PROTEINS; RECEPTOR; COMPLEX	Differentiation of mesenchymal stem cells into adipocyte requires coordination of external stimuli and depends upon the functionality of the primary cilium. The Rab8 small GTPases are regulators of intracellular transport of membrane-bound structural and signaling cargo. However, the physiological contribution of the intrinsic trafficking network controlled by Rab8 to mesenchymal tissue differentiation has not been fully defined in vivo and in primary tissue cultures. Here, we show that mouse embryonic fibroblasts (MEFs) lacking Rab8 have severely impaired adipocyte differentiation in vivo and ex vivo. Immunofluorescent localization and biochemical analyses of Rab8a-deficient, Rab8b-deficient, and Rab8a and Rab8b double-deficient MEFs revealed that Rab8 controls the Lrp6 vesicular compartment, clearance of basal signalosome, traffic of frizzled two receptor, and thereby a proper attenuation of Wnt signaling in differentiating MEFs. Upon induction of adipogenesis program, Rab8a- and Rab8b-deficient MEFs exhibited severely defective lipid-droplet formation and abnormal cilia morphology, despite overall intact cilia growth and ciliary cargo transport. Our results suggest that intracellular Rab8 traffic regulates induction of adipogenesis via proper positioning of Wnt receptors for signaling control in mesenchymal cells.	[Stypulkowski, Ewa; Feng, Qiang; Joseph, Ivor; Farrell, Victoria; Flores, Juan; Yu, Shiyan; Sakamori, Ryotaro; Sun, Jiaxin; Bandyopadhyay, Sheila; Das, Soumyashree; Dobrowolski, Radek; Bonder, Edward M.; Gao, Nan] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07103 USA; [Chen, Miao-Hsueh] Baylor Coll Med, Dept Pediat, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Gao, Nan] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08901 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Baylor College of Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Gao, N (corresponding author), Rutgers State Univ, Dept Biol Sci, Newark, NJ 07103 USA.; Chen, MH (corresponding author), Baylor Coll Med, Dept Pediat, Childrens Nutr Res Ctr, Houston, TX 77030 USA.; Gao, N (corresponding author), Rutgers Canc Inst New Jersey, New Brunswick, NJ 08901 USA.	miaohsuc@bcm.edu; ngao@rutgers.edu	Sakamori, Ryotaro/B-4406-2014	Sakamori, Ryotaro/0000-0002-1580-607X; Das, Soumyashree/0000-0003-1236-3194	National Institutes of Health [DK102934, AT010243, DK119198, DK116899, AG062475, AG061040]; National Science Foundation/BIO/IDBR [1353890, 1952823]; American Cancer Society [RSG-15-06001-TBE]; Initiative for Multidisciplinary Research Teams (IMRT) award from Rutgers University; USDA ARS grant [3092-5-001-059]; CCFA career development award [406794]; New Jersey Commission on Cancer Research (NJCCR) [DFHS16PPC045]; NIH [F31 DK121428]; NJCCR fellowship [DFHS17PPC036]; RU-N SASN Research Funds	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation/BIO/IDBR; American Cancer Society(American Cancer Society); Initiative for Multidisciplinary Research Teams (IMRT) award from Rutgers University; USDA ARS grant; CCFA career development award; New Jersey Commission on Cancer Research (NJCCR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NJCCR fellowship; RU-N SASN Research Funds	This work was supported by National Institutes of Health grants (DK102934, AT010243, and DK119198 to N. G.; DK116899 to M. -H. C.; AG062475 and AG061040 to R. D.); National Science Foundation/BIO/IDBR [1353890] and [1952823]; a Research Scholar Grant [RSG-15-06001-TBE] from the American Cancer Society to N. G.; an Initiative for Multidisciplinary Research Teams (IMRT) award from Rutgers University; an USDA ARS grant (3092-5-001-059) to M. -H. C.; a CCFA career development award (406794) to S. Y.; a postdoctoral fellowship from New Jersey Commission on Cancer Research (NJCCR) (DFHS16PPC045) to Q. F. NJCCR fellowship DFHS17PPC036 and an NIH F31 DK121428 to S. B. RU-N SASN Research Funds to E. M. B. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackers I, 2018, DIABETES VASC DIS RE, V15, P3, DOI 10.1177/1479164117738442; Ataman B, 2006, P NATL ACAD SCI USA, V103, P7841, DOI 10.1073/pnas.0600387103; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Christensen ST, 2012, J PATHOL, V226, P172, DOI 10.1002/path.3004; Chung SS, 2012, OBESITY, V20, P482, DOI 10.1038/oby.2011.212; Cortellino S, 2009, DEV BIOL, V325, P225, DOI 10.1016/j.ydbio.2008.10.020; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; D'Agostino L, 2019, CANCER RES, V79, P4099, DOI 10.1158/0008-5472.CAN-18-4075; Dalbay MT, 2015, STEM CELLS, V33, P1952, DOI 10.1002/stem.1975; Das S, 2015, DEVELOPMENT, V142, P2147, DOI 10.1242/dev.121046; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Demir K, 2013, CELL REP, V4, P1224, DOI 10.1016/j.celrep.2013.08.008; Donzelli E, 2011, J MOL CELL BIOL, V3, P123, DOI 10.1093/jmcb/mjq050; Feng Q, 2017, J CELL SCI, V130, P2491, DOI 10.1242/jcs.201897; Feng Q, 2015, J CELL PHYSIOL, V230, P1170, DOI 10.1002/jcp.24853; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Geng DH, 2016, TUMOR BIOL, V37, P7713, DOI 10.1007/s13277-015-4606-5; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Guichard A, 2014, NAT REV MICROBIOL, V12, P624, DOI 10.1038/nrmicro3325; Hausmann G, 2007, NAT REV MOL CELL BIO, V8, P331, DOI 10.1038/nrm2141; Heidrych P, 2008, HUM MOL GENET, V17, P3814, DOI 10.1093/hmg/ddn279; Hou R, 2016, TUMOR BIOL, V37, P16005, DOI 10.1007/s13277-016-5420-4; Huang Z, 2017, ONCOL RES, V25, P651, DOI 10.3727/096504016X14752792816791; Jonassen JA, 2012, J AM SOC NEPHROL, V23, P641, DOI 10.1681/ASN.2011080829; Kiral FR, 2018, CURR BIOL, V28, pR471, DOI 10.1016/j.cub.2018.02.010; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Knowles BC, 2015, J CELL SCI, V128, P1617, DOI 10.1242/jcs.163303; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Korkut C, 2009, NAT REV NEUROSCI, V10, P627, DOI 10.1038/nrn2681; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Laudes M, 2011, J MOL ENDOCRINOL, V46, pR65, DOI 10.1530/JME-10-0169; Lee H, 2015, BMB REP, V48, P647, DOI 10.5483/BMBRep.2015.48.12.229; Li CM, 2016, CELL BIOL INT, V40, P1026, DOI 10.1002/cbin.10650; Lorenowicz MJ, 2009, EXP CELL RES, V315, P2683, DOI 10.1016/j.yexcr.2009.06.015; Lu DS, 2010, EUR J PHARMACOL, V636, P198, DOI 10.1016/j.ejphar.2010.03.010; Marion V, 2009, P NATL ACAD SCI USA, V106, P1820, DOI 10.1073/pnas.0812518106; Mok CA, 2010, CLIN GENET, V77, P18, DOI 10.1111/j.1399-0004.2009.01305.x; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Mosca TJ, 2010, NAT NEUROSCI, V13, P935, DOI 10.1038/nn.2593; Murga-Zamalloa CA, 2010, HUM MOL GENET, V19, P3591, DOI 10.1093/hmg/ddq275; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nosavanh L, 2015, P NATL ACAD SCI USA, V112, P5069, DOI 10.1073/pnas.1420978112; Omori Y, 2008, NAT CELL BIOL, V10, P437, DOI 10.1038/ncb1706; Park BH, 2004, MOL CELL BIOL, V24, P8671, DOI 10.1128/MCB.24.19.8671-8680.2004; Peranen J, 2011, CYTOSKELETON, V68, P527, DOI 10.1002/cm.20529; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Qiu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015240; REED BC, 1980, P NATL ACAD SCI-BIOL, V77, P285, DOI 10.1073/pnas.77.1.285; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sakamori R, 2014, CANCER RES, V74, P5480, DOI 10.1158/0008-5472.CAN-14-0267; Sakamori R, 2012, J CLIN INVEST, V122, P1052, DOI 10.1172/JCI60282; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Sato T, 2014, J CELL SCI, V127, P422, DOI 10.1242/jcs.136903; Scott CC, 2015, EMBO REP, V16, P741, DOI 10.15252/embr.201540081; Sen Gupta P, 2009, J ENDOCRINOL, V203, P327, DOI 10.1677/JOE-09-0116; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Sun JX, 2017, J CELL SCI, V130, P2159, DOI 10.1242/jcs.200634; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Takada I, 2010, PPAR RES, V2010, DOI 10.1155/2010/341671; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Ward HH, 2011, MOL BIOL CELL, V22, P3289, DOI 10.1091/mbc.E11-01-0082; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Wilson CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005182; Wu LZ, 2014, DEV CELL, V30, P378, DOI 10.1016/j.devcel.2014.07.005; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Yu L, 2016, TUMOR BIOL, V37, P13821, DOI 10.1007/s13277-016-5172-1; Yu SY, 2015, CELL MOL LIFE SCI, V72, P3343, DOI 10.1007/s00018-015-1931-1; Yu SY, 2014, J BIOL CHEM, V289, P32030, DOI 10.1074/jbc.M113.538223; Yu SY, 2014, EMBO J, V33, P1882, DOI 10.15252/embj.201487888; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang X, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.135923; Zhang X, 2018, J CELL PHYSIOL, V233, P5908, DOI 10.1002/jcp.26400; Zhang Xiao, 2016, Small GTPases, V7, P59, DOI 10.1080/21541248.2016.1159274; Zhu D, 2009, J CELL SCI, V122, P2760, DOI 10.1242/jcs.046276; Zilber Y, 2013, MOL BIOL CELL, V24, P555, DOI 10.1091/mbc.E12-06-0437	84	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100488	10.1016/j.jbc.2021.100488	http://dx.doi.org/10.1016/j.jbc.2021.100488			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33662399	Green Published, gold			2022-12-26	WOS:000672866400462
J	Tantengco, OAG; Richardson, LS; Medina, PMB; Han, A; Menon, R				Tantengco, Ourlad Alzeus G.; Richardson, Lauren S.; Medina, Paul Mark B.; Han, Arum; Menon, Ramkumar			Organ-on-chip of the cervical epithelial layer: A platform to study normal and pathological cellular remodeling of the cervix	FASEB JOURNAL			English	Article						cervix; cervical ripening; epithelial&#8208; to&#8208; mesenchymal transition; organ&#8208; on&#8208; a&#8208; chip; pregnancy; preterm birth	TUMOR-NECROSIS-FACTOR; PRETERM; PREGNANCY; TERM; PARTURITION; INFECTION; DYNAMICS	Damage to the cervical epithelial layer due to infection and inflammation is associated with preterm birth. However, the individual and/or collective roles of cervical epithelial layers in maintaining cervical integrity remain unclear during infection/inflammation. To determine the intercellular interactions, we developed an organ-on-chip of the cervical epithelial layer (CE-OOC) composed of two co-culture chambers connected by microchannels, recapitulating the ectocervical and endocervical epithelial layers. Further, we tested the interactions between cells from each distinct region and their contributions in maintaining cervical integrity in response to LPS and TNF alpha stimulations. The co-culture of ectocervical and endocervical cells facilitated cellular migration of both epithelial cells inside the microchannels. Compared to untreated controls, both LPS and TNF alpha increased apoptosis, necrosis, and senescence as well as increased pro-inflammatory cytokine productions by cervical epithelial cells. In summary, the CE-OOC established an in vitro model that can recapitulate the ectocervical and the endocervical epithelial regions of the cervix. The established CE-OOC may become a powerful tool in obstetrics and gynecology research such as in studying cervical remodeling during pregnancy and parturition and the dynamics of cervical epithelial cells in benign and malignant pathology in the cervix.	[Tantengco, Ourlad Alzeus G.; Richardson, Lauren S.; Menon, Ramkumar] Univ Texas Med Branch Galveston, Div Maternal Fetal Med & Perinatal Res, Dept Obstet & Gynecol, 301 Univ Blvd, Galveston, TX 77555 USA; [Tantengco, Ourlad Alzeus G.; Medina, Paul Mark B.] Univ Philippines Manila, Dept Biochem & Mol Biol, Coll Med, Manila, Philippines; [Richardson, Lauren S.; Han, Arum] Texas A&M Univ, Dept Elect & Comp Engn, Dept Biomed Engn, College Stn, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of the Philippines System; University of the Philippines Manila; Texas A&M University System; Texas A&M University College Station	Menon, R (corresponding author), Univ Texas Med Branch Galveston, Div Maternal Fetal Med & Perinatal Res, Dept Obstet & Gynecol, 301 Univ Blvd, Galveston, TX 77555 USA.	ra2menon@utmb.edu	Han, Arum/C-7078-2013; Tantengco, Ourlad Alzeus/L-4740-2019	Han, Arum/0000-0002-9223-8301; Tantengco, Ourlad Alzeus/0000-0002-4535-8837; Menon, Ramkumar/0000-0001-9213-6105; Richardson, Lauren/0000-0001-8392-2833; Medina, Paul Mark/0000-0001-6116-1818	Philippine Council for Health Research and Development, Department of Science and Technology, Republic of the Philippines; National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health (NIH) of the United States [T32 ES026568]; NIH/NICHD [1R01HD100729-01]	Philippine Council for Health Research and Development, Department of Science and Technology, Republic of the Philippines; National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health (NIH) of the United States; NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	O Tantengco is an MD-PhD trainee in the MD -PhD in Molecular Medicine Program, supported by the Philippine Council for Health Research and Development, Department of Science and Technology, Republic of the Philippines, and administered through the University of the Philippines Manila. L Richardson is a postdoctoral fellow in the Regulatory Science in Environmental Health and Toxicology Training Grant (T32 ES026568), supported by the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health (NIH) of the United States, administered through Texas A&M University. This study was supported by 1R01HD100729-01 (NIH/NICHD) [R Menon and A Han]).	Anton L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02181; Anton L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03217-7; Battaglia Rachel A, 2018, F1000Res, V7, DOI 10.12688/f1000research.15967.1; Blander JM, 2016, FEBS J, V283, P2720, DOI 10.1111/febs.13771; BOEVER F, 1948, ARCH INT PHARMACOD T, V77, P1; Bonney EA, 2013, AM J REPROD IMMUNOL, V69, P567, DOI 10.1111/aji.12102; Dixon CL, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12790; Grossmann H, 2020, REPROD TOXICOL, V95, P29, DOI 10.1016/j.reprotox.2020.04.074; Herbst-Kralovetz MM, 2008, AM J REPROD IMMUNOL, V59, P212, DOI 10.1111/j.1600-0897.2007.00566.x; Huh J., 2018, US Patent App., Patent No. [15/769,387, 15769387]; Jin J, 2018, PLACENTA, V67, P15, DOI 10.1016/j.placenta.2018.05.008; Lavenus SB, 2020, J BIOL CHEM, V295, P6700, DOI 10.1074/jbc.RA119.011537; Mahendroo M, 2012, REPRODUCTION, V143, P429, DOI 10.1530/REP-11-0466; Maymon E, 1999, AM J OBSTET GYNECOL, V181, P1142, DOI 10.1016/S0002-9378(99)70097-9; Mcgee D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188645; Nallasamy S, 2017, SEMIN REPROD MED, V35, P190, DOI 10.1055/s-0037-1599091; Niepel M, 2019, CELL SYST, V9, P35, DOI 10.1016/j.cels.2019.06.005; Nold C, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.036; Nott J.P., 2016, T RES ANAT, V2, P1, DOI [10.1016/j.tria.2016.02.001, DOI 10.1016/j.tria.2016.02.001]; Pavlidis I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14089-y; Payne KJ, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101840; Potter NT., 1992, J MATERNAL FETAL MED, V1, P142; Racicot K, 2013, J IMMUNOL, V191, P934, DOI 10.4049/jimmunol.1300661; Read CP, 2007, REPRODUCTION, V134, P327, DOI 10.1530/REP-07-0032; Richardson L, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00715; Richardson L, 2020, REPROD SCI, V27, P1562, DOI 10.1007/s43032-020-00184-9; Richardson L, 2019, FASEB J, V33, P8945, DOI 10.1096/fj.201900020RR; Richardson LS, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aay1486; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; ROMERO R, 1992, AM J OBSTET GYNECOL, V166, P1576, DOI 10.1016/0002-9378(92)91636-O; ROMERO R, 1988, AM J OBSTET GYNECOL, V158, P1044, DOI 10.1016/0002-9378(88)90216-5; Ruder B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081887; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016; Sosa-Hernandez JE, 2018, MICROMACHINES-BASEL, V9, DOI 10.3390/mi9100536; Stouffer RL, 2017, ILAR J, V58, P281, DOI 10.1093/ilar/ilx027; Tantengco OAG, 2021, AM J REPROD IMMUNOL, V85, DOI 10.1111/aji.13370; Timmons B, 2010, TRENDS ENDOCRIN MET, V21, P353, DOI 10.1016/j.tem.2010.01.011; Velez DR, 2008, HUM REPROD, V23, P1902, DOI 10.1093/humrep/den170; Vink J, 2017, SEMIN PERINATOL, V41, P427, DOI 10.1053/j.semperi.2017.07.014; Vink J, 2016, SEMIN FETAL NEONAT M, V21, P106, DOI 10.1016/j.siny.2015.12.009; Word RA, 2007, SEMIN REPROD MED, V25, P69, DOI 10.1055/s-2006-956777; Yellon SM, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03156; Yellon SM, 2017, BIOL REPROD, V96, P13, DOI 10.1095/biolreprod.116.142844	43	14	14	5	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21463	10.1096/fj.202002590RRR	http://dx.doi.org/10.1096/fj.202002590RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33689188	Green Accepted			2022-12-26	WOS:000635216100095
J	Tabe, H; Kobayashi, K; Fujii, H; Watanabe, M				Tabe, Hirofumi; Kobayashi, Kazumichi; Fujii, Hiroyuki; Watanabe, Masao			Molecular dynamics study on characteristics of reflection and condensation molecules at vapor-liquid equilibrium state	PLOS ONE			English	Article								The kinetic boundary condition (KBC) represents the evaporation or condensation of molecules at the vapor-liquid interface for molecular gas dynamics (MGD). When constructing the KBC, it is necessary to classify molecular motions into evaporation, condensation, and reflection in molecular-scale simulation methods. Recently, a method that involves setting the vapor boundary and liquid boundary has been used for classifying molecules. The position of the vapor boundary is related to the position where the KBC is applied in MGD analyses, whereas that of the liquid boundary has not been uniquely determined. Therefore, in this study, we conducted molecular dynamics simulations to discuss the position of the liquid boundary for the construction of KBCs. We obtained some variables that characterize molecular motions such as the positions that the molecules reached and the time they stayed in the vicinity of the interface. Based on the characteristics of the molecules found from these variables, we investigated the valid position of the liquid boundary. We also conducted an investigation on the relationship between the condensation coefficient and the molecular incident velocity from the vapor phase to the liquid phase. The dependence of the condensation coefficient on the incident velocity of molecules was confirmed, and the value of the condensation coefficient becomes small in the low-incident-velocity range. Furthermore, we found that the condensation coefficient in the non-equilibrium state shows almost the same value as that in the equilibrium state, although the corresponding velocity distribution functions of the incident velocity significantly differ from each other.	[Tabe, Hirofumi; Kobayashi, Kazumichi; Fujii, Hiroyuki; Watanabe, Masao] Hokkaido Univ, Div Mech & Space Engn, Sapporo, Hokkaido, Japan	Hokkaido University	Tabe, H (corresponding author), Hokkaido Univ, Div Mech & Space Engn, Sapporo, Hokkaido, Japan.	azx@eis.hokudai.ac.jp		Tabe, Hirofumi/0000-0002-5864-5931; Kobayashi, Kazumichi/0000-0001-8842-469X	JSPS KAKENHI [JP20K04277]; f3 Engineering Education and Research Center, Faculty of Engineering, Hokkaido University	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); f3 Engineering Education and Research Center, Faculty of Engineering, Hokkaido University	This work was supported by JSPS KAKENHI Grant Number JP20K04277 to K.K. (https://www.jsps.go.jp/english/index.html) and f3 Engineering Education and Research Center, Faculty of Engineering, Hokkaido University to K.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M., 2017, COMPUTER SIMULATIONS, V2nd; [Anonymous], 1965, ISODATA NOVEL METHOD; Bird G.A., 1994, MOL GAS DYNAMICS DIR; Busuioc S, 2020, PHYS REV FLUIDS, V5, DOI 10.1103/PhysRevFluids.5.103401; Cercignani C., 2000, RAREFIED GAS DYNAMIC; Frezzotti A, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1824111; Frezzotti A, 2018, PHYS REV FLUIDS, V3, DOI 10.1103/PhysRevFluids.3.054001; Fujikawa S, 2011, HEAT MASS TRANSF, P1, DOI 10.1007/978-3-642-18038-5; Gu K, 2010, FLUID PHASE EQUILIBR, V297, P77, DOI 10.1016/j.fluid.2010.06.014; Ishiyama T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.084504; Ishiyama T, 2004, PHYS FLUIDS, V16, P4713, DOI 10.1063/1.1811674; Ishiyama T, 2004, PHYS FLUIDS, V16, P2899, DOI 10.1063/1.1763936; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Kobayashi K, 2018, J FLUID MECH, V856, P1045, DOI 10.1017/jfm.2018.722; Kobayashi K, 2017, MICROFLUID NANOFLUID, V21, DOI 10.1007/s10404-017-1887-6; Kobayashi K, 2016, HEAT MASS TRANSFER, V52, P1851, DOI 10.1007/s00231-015-1700-6; Kon M, 2017, EUR J MECH B-FLUID, V64, P81, DOI 10.1016/j.euromechflu.2016.12.001; Kon M, 2016, INT J HEAT MASS TRAN, V99, P317, DOI 10.1016/j.ijheatmasstransfer.2016.03.088; Kon M, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4890523; Kryukov AP, 2016, HEAT MASS TRANSFER, V52, P1393, DOI 10.1007/s00231-015-1658-4; LEKNER J, 1978, PHYSICA A, V94, P545, DOI 10.1016/0378-4371(78)90086-9; Levashov VY, 2018, INT J HEAT MASS TRAN, V127, P115, DOI 10.1016/j.ijheatmasstransfer.2018.07.069; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Louden P, 2013, FLUID PHASE EQUILIBR, V349, P83, DOI 10.1016/j.fluid.2013.04.006; Lu ZM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10209-w; MacQueen J., P 5 BERK S MATH STAT, V1, P281; Meland R, 2004, PHYS FLUIDS, V16, P223, DOI 10.1063/1.1630797; Nagata Y, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.236102; Ohashi K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64905-5; Sone Y., 2007, MOL GAS DYNAMICS THE; Tokunaga A, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0027945; Tsuruta T, 2004, J PHYS CHEM B, V108, P1736, DOI 10.1021/jp035885q; Tsuruta T, 1999, INT J HEAT MASS TRAN, V42, P4107, DOI 10.1016/S0017-9310(99)00081-2; Yamamoto K, 2019, PHYS REV FLUIDS, V4, DOI 10.1103/PhysRevFluids.4.063603; Yang TH, 2005, INT J HEAT MASS TRAN, V48, P3516, DOI 10.1016/j.ijheatmasstransfer.2005.03.015; Zhakhovsky VV, 2019, P NATL ACAD SCI USA, V116, P18209, DOI 10.1073/pnas.1714503115	36	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0248660	10.1371/journal.pone.0248660	http://dx.doi.org/10.1371/journal.pone.0248660			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY1VJ	33725026	Green Published, gold			2022-12-26	WOS:000629833700028
J	Chen, Q; Shen, P; Ge, WL; Yang, TY; Wang, WJ; Meng, LD; Huang, XM; Zhang, YH; Cao, SJ; Miao, Y; Jiang, KR; Zhang, JJ				Chen, Qun; Shen, Peng; Ge, Wan-Li; Yang, Tao-Yue; Wang, Wu-Jun; Meng, Ling-Dong; Huang, Xu-Min; Zhang, Yi-Han; Cao, Shou-Ji; Miao, Yi; Jiang, Kui-Rong; Zhang, Jing-Jing			Roundabout homolog 1 inhibits proliferation via the YY1-ROBO1-CCNA2-CDK2 axis in human pancreatic cancer	ONCOGENE			English	Article							CYCLIN A2; DUCTAL ADENOCARCINOMA; CELL-PROLIFERATION; CDK2	Pancreatic cancer (PC) is highly malignant and has a high mortality with a 5-year survival rate of less than 8%. As a member of the roundabout immunoglobulin superfamily of proteins, ROBO1 plays an important role in embryogenesis and organogenesis and also inhibits metastasis in PC. Our study was designed to explore whether ROBO1 has effects on the proliferation of PC and its specific mechanism. The expression of ROBO1 was higher in cancer tissues than in matched adjacent tissues by immunohistochemistry (IHC) and qRT-PCR. Low ROBO1 expression is associated with PC progression and poor prognosis. Overexpression of ROBO1 can inhibit the proliferation of PC cells in vitro, and the S phase fraction can also be induced. Further subcutaneous tumor formation in nude mice showed that ROBO1 overexpression can significantly inhibit tumor growth. YY1 was found to directly bind to the promoter region of ROBO1 to promote transcription by a luciferase reporter gene assay, a chromatin immunoprecipitation (ChIP) and an electrophoretic mobility shift assay (EMSA). Mechanistic studies showed that YY1 can inhibit the development of PC by directly regulating ROBO1 via the CCNA2/CDK2 axis. Taken together, our results suggest that ROBO1 may be involved in the development and progression of PC by regulating cell proliferation and shows that ROBO1 may be a novel and promising therapeutic target for PC.	[Chen, Qun; Shen, Peng; Ge, Wan-Li; Yang, Tao-Yue; Meng, Ling-Dong; Huang, Xu-Min; Zhang, Yi-Han; Cao, Shou-Ji; Miao, Yi; Jiang, Kui-Rong; Zhang, Jing-Jing] Nanjing Med Univ, Affiliated Hosp 1, Pancreas Ctr, Nanjing, Peoples R China; [Chen, Qun; Shen, Peng; Ge, Wan-Li; Yang, Tao-Yue; Meng, Ling-Dong; Huang, Xu-Min; Zhang, Yi-Han; Cao, Shou-Ji; Miao, Yi; Jiang, Kui-Rong; Zhang, Jing-Jing] Nanjing Med Univ, Pancreas Inst, Nanjing, Peoples R China; [Wang, Wu-Jun] Nanjing Univ Chinese Med, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing University of Chinese Medicine	Jiang, KR; Zhang, JJ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Pancreas Ctr, Nanjing, Peoples R China.; Jiang, KR; Zhang, JJ (corresponding author), Nanjing Med Univ, Pancreas Inst, Nanjing, Peoples R China.	jiangkuirong@njmu.edu.cn; zhangjingjing@njmu.edu.cn		chen, qun/0000-0002-9034-9825	National Natural Science Foundation of China [81871980, 81572337, 81672449]; National Science Foundation for Distinguished Young Scholars of China [81902455]; Jiangsu Key Medical Discipline [ZDXKA2016005]; Innovation Capability Development Project of Jiangsu Province [BM2015004]; Priority Academic Program AQ3 Development of Jiangsu Higher Education Institutions (PAPD) [JX10231801]; Project of Invigorating Health Care through Science, Technology and Education, Jiangsu Provincial Medical Outstanding Talent [JCRCA2016009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Jiangsu Key Medical Discipline; Innovation Capability Development Project of Jiangsu Province; Priority Academic Program AQ3 Development of Jiangsu Higher Education Institutions (PAPD); Project of Invigorating Health Care through Science, Technology and Education, Jiangsu Provincial Medical Outstanding Talent	This study was supported by the National Natural Science Foundation of China (Nos. 81871980, 81572337, 81672449); the National Science Foundation for Distinguished Young Scholars of China (No. 81902455); the Jiangsu Key Medical Discipline (General Surgery; ZDXKA2016005); the Innovation Capability Development Project of Jiangsu Province (No. BM2015004); the Priority Academic Program AQ3 Development of Jiangsu Higher Education Institutions (PAPD, JX10231801) and the Project of Invigorating Health Care through Science, Technology and Education, Jiangsu Provincial Medical Outstanding Talent (to Yi Miao, JCRCA2016009).	Chantrill LA, 2015, CLIN CANCER RES, V21, P2029, DOI 10.1158/1078-0432.CCR-15-0426; Dachineni R, 2016, MOL CANCER RES, V14, P241, DOI 10.1158/1541-7786.MCR-15-0360; Gao D, 2018, FEBS J, V285, P4229, DOI 10.1111/febs.14665; Gohrig A, 2014, CANCER RES, V74, P1529, DOI 10.1158/0008-5472.CAN-13-1012; Gopinathan L, 2014, CANCER RES, V74, P3870, DOI 10.1158/0008-5472.CAN-13-3440; Honda A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039249; Kleeff J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.22; Kong RR, 2015, J CLIN INVEST, V125, P4407, DOI 10.1172/JCI81673; Leyva-Diaz E, 2014, CURR BIOL, V24, P494, DOI 10.1016/j.cub.2014.01.042; Liu DF, 2018, INT J CANCER, V142, P1392, DOI 10.1002/ijc.31173; Liu JH, 2018, ANGIOGENESIS, V21, P237, DOI 10.1007/s10456-017-9592-3; Mitchell KA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13732-y; Moore NL, 2014, J STEROID BIOCHEM, V144, P471, DOI 10.1016/j.jsbmb.2014.09.009; Parray A, 2014, INT J CANCER, V135, P2493, DOI 10.1002/ijc.28919; Patten DK, 2018, NAT MED, V24, P1469, DOI 10.1038/s41591-018-0091-x; Peng XF, 2018, CELL BIOL INT, V42, P589, DOI 10.1002/cbin.10935; Pinho AV, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07497-z; Pommier A, 2018, SCIENCE, V360, P1202, DOI 10.1126/science.aao4908; Qin F, 2015, SCI REP-UK, V5, DOI 10.1038/srep09977; Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI 10.3322/caac.21654; Wang B, 2014, INT J RADIAT ONCOL, V90, P53, DOI 10.1016/j.ijrobp.2014.04.055; XIA Y, 2019, CELL PROLIFERAT, V52; Zhang JJ, 2017, CANCER LETT, V408, P144, DOI 10.1016/j.canlet.2017.08.032; Zhang JJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-130; Zhang QH, 2017, J CELL BIOL, V216, P3133, DOI 10.1083/jcb.201607111	25	10	10	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 15	2021	40	15					2772	2784		10.1038/s41388-021-01741-5	http://dx.doi.org/10.1038/s41388-021-01741-5		MAR 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RN8NW	33714986				2022-12-26	WOS:000628485300002
J	Loosen, SH; Castoldi, M; Jordens, MS; Roy, S; Vucur, M; Kandler, J; Hammerich, L; Mohr, R; Tacke, F; Ulmer, TF; Neumann, UP; Luedde, T; Roderburg, C				Loosen, Sven H.; Castoldi, Mirco; Joerdens, Markus S.; Roy, Sanchary; Vucur, Mihael; Kandler, Jennis; Hammerich, Linda; Mohr, Raphael; Tacke, Frank; Ulmer, Tom F.; Neumann, Ulf P.; Luedde, Tom; Roderburg, Christoph			Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC	PLOS ONE			English	Article								Background Early detection of hepatocellular carcinoma (HCC), the most common primary liver malignancy, is crucial to offer patients a potentially curative treatment strategy such as surgical resection or liver transplantation (LT). However, easily accessible biomarkers facilitating an early diagnosis of HCC as well as a reliable risk prediction are currently missing. The microRNA(miR)-107 has recently been described as a driver of HCC in both murine and human HCC but data on circulating miR-107 in HCC patients are scarce. In the present study, we evaluated a potential diagnostic and/or prognostic role of circulating miR-107 in patients undergoing tumor resection or LT for early-stage HCC. Methods The Kmplot bioinformatic tool was used to query publicly available databases (including TCGA, GEO and EGA) in order to analyse the prognostic value of tumoral miR-107 expression in HCC patients (n = 372). Serum levels of miR-107 were measured by qPCR in n = 45 HCC patients undergoing surgical tumor resection (n = 37) or LT (n = 8) as well as n = 18 healthy control samples. Results were correlated with clinical data. Results A high tumoral expression of miR-107 was associated with a significantly better overall survival compared to patients with low miR-107 expression levels (HR 0.69, 95% CI 0.48-0.99, p = 0.041). In addition, serum levels of miR-107 were significantly higher in HCC patients when compared to healthy controls. However, miR-107 serum levels in HCC patients were independent of different disease etiology, tumor stage or tumor grading. HCC patients with baseline miR-107 expression levels above a calculated ideal prognostic cut-off value (9.82) showed a clear trend towards an impaired overall survival (p = 0.119). Conclusion Tumoral miR-107 expression levels are a potential prognostic marker in early stage HCC. Furthermore, we describe a potential role of circulating miR-107 levels as a diagnostic biomarker in patients with early-stage HCC.	[Loosen, Sven H.; Castoldi, Mirco; Joerdens, Markus S.; Roy, Sanchary; Vucur, Mihael; Kandler, Jennis; Luedde, Tom; Roderburg, Christoph] Heinrich Heine Univ Dusseldorf, Univ Hosp Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, Med Fac, Dusseldorf, Germany; [Hammerich, Linda; Mohr, Raphael; Tacke, Frank; Roderburg, Christoph] Charite Univ Med Berlin, Dept Hepatol & Gastroenterol, Berlin, Germany; [Ulmer, Tom F.; Neumann, Ulf P.] Univ Hosp RWTH Aachen, Dept Visceral & Transplantat Surg, Aachen, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; RWTH Aachen University; RWTH Aachen University Hospital	Luedde, T; Roderburg, C (corresponding author), Heinrich Heine Univ Dusseldorf, Univ Hosp Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, Med Fac, Dusseldorf, Germany.; Roderburg, C (corresponding author), Charite Univ Med Berlin, Dept Hepatol & Gastroenterol, Berlin, Germany.	tom.luedde@med.uni-duesseldorf.de; christoph.roderburg@med.uni-duesseldorf.de	Loosen, Sven/AHC-5236-2022; Roderburg, Christoph/AAR-3051-2021; Luedde, Tom/AAE-9135-2022; Roderburg, Christoph/AHC-8101-2022	Loosen, Sven/0000-0002-2799-2287; Luedde, Tom/0000-0002-6288-8821; Roderburg, Christoph/0000-0002-1409-7697; Mohr, Raphael/0000-0003-2403-4275; Jordens, Markus/0000-0002-0544-1118; Tacke, Frank/0000-0001-6206-0226	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program through the ERC Consolidator Grant PhaseControl [771083]; German Cancer Aid (Deutsche Krebshilfe) [110043]; German Cancer Aid (Mildred-Scheel-Professorship); GermanResearch-Foundation [SFB-TRR57/P06, LU 1360/3-1]; Ernst-Jung-Foundation Hamburg; IZKF (interdisciplinary centre of clinical research) Aachen; medical faculty of the RWTH Aachen; GermanResearch-Foundation grant (DFG) [CA830-1/3]	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program through the ERC Consolidator Grant PhaseControl(European Research Council (ERC)); German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); German Cancer Aid (Mildred-Scheel-Professorship); GermanResearch-Foundation(German Research Foundation (DFG)); Ernst-Jung-Foundation Hamburg; IZKF (interdisciplinary centre of clinical research) Aachen; medical faculty of the RWTH Aachen; GermanResearch-Foundation grant (DFG)(German Research Foundation (DFG))	Work in the lab of T.L. was funded from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program through the ERC Consolidator Grant PhaseControl (Grant Agreement n degrees 771083). The lab of T.L. was further supported by the German Cancer Aid (Deutsche Krebshilfe 110043 and a Mildred-Scheel-Professorship), the GermanResearch-Foundation (SFB-TRR57/P06 and LU 1360/3-1), the Ernst-Jung-Foundation Hamburg, the IZKF (interdisciplinary centre of clinical research) Aachen and a grant from the medical faculty of the RWTH Aachen, and from a GermanResearch-Foundation grant (DFG, CA830-1/3) to M.C. and T.L.	Ali HEA, 2019, CLIN BIOCHEM, V65, P45, DOI 10.1016/j.clinbiochem.2019.01.002; Best J, 2020, CLIN GASTROENTEROL H, V18, P728, DOI 10.1016/j.cgh.2019.11.012; Bracken CP, 2016, NAT REV GENET, V17, P719, DOI 10.1038/nrg.2016.134; Bruix J, 2015, LANCET ONCOL, V16, P1344, DOI 10.1016/S1470-2045(15)00198-9; Chen F, 2017, CANCER BIOMARK, V18, P209, DOI 10.3233/CBM-161671; Chen L, 2015, TUMOR BIOL, V36, P7439, DOI 10.1007/s13277-015-3430-2; Corton JC, 2018, ARCH TOXICOL, V92, P83, DOI 10.1007/s00204-017-2094-7; Daimiel-Ruiz L, 2015, MOL NUTR FOOD RES, V59, P552, DOI 10.1002/mnfr.201400616; European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019; Feng M, 2020, INNOVATION-AMSTERDAM, V1, DOI 10.1016/j.xinn.2020.100032; Hester CA, 2019, MOL TRANSL MED, P145, DOI 10.1007/978-3-030-21540-8_8; Li T, 2014, ONCOL REP, V31, P1699, DOI 10.3892/or.2014.3032; Loosen SH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239386; Loosen SH, 2017, WORLD J HEPATOL, V9, P586, DOI 10.4254/wjh.v9.i12.586; Moon AM, 2018, GASTROENTEROLOGY, V155, P1128, DOI 10.1053/j.gastro.2018.06.079; Mourad L, 2018, CANCER BIOL THER, V19, P400, DOI 10.1080/15384047.2018.1423922; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Oura K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21218362; Peters JM, 2005, J MOL MED-JMM, V83, P774, DOI 10.1007/s00109-005-0678-9; Roy S, 2018, GASTROENTEROLOGY, V155, P1951, DOI 10.1053/j.gastro.2018.08.032; Schueller F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010261; Shaheen NMH, 2018, VIRUS RES, V255, P77, DOI 10.1016/j.virusres.2018.07.004; Stras W, 2020, CLIN EXP HEPATOL, V6, P170, DOI 10.5114/ceh.2020.99506; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Tsuchiya N, 2015, WORLD J GASTROENTERO, V21, P10573, DOI 10.3748/wjg.v21.i37.10573; Tzartzeva K, 2018, GASTROENTEROLOGY, V154, P1706, DOI 10.1053/j.gastro.2018.01.064; Uchida S, 2020, NON-CODING RNA, V6, DOI 10.3390/ncrna6030034; Xie RT, 2018, ONCOL LETT, V15, P4571, DOI 10.3892/ol.2018.7892; Yang HQ, 2018, ONCOL LETT, V15, P4097, DOI 10.3892/ol.2018.7879; Zhang Y, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005642	30	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0247917	10.1371/journal.pone.0247917	http://dx.doi.org/10.1371/journal.pone.0247917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711036	gold, Green Published			2022-12-26	WOS:000629591800045
J	Calice, I; Kau, S; Knecht, C; Otero, PE; Menzies, MPL				Calice, Ivana; Kau, Silvio; Knecht, Christian; Otero, Pablo E.; Menzies, M. Paula Larenza			Combined caudal retrocostal and lateral ultrasound-guided approach for transversus abdominis plane injection: A descriptive pilot study in pig cadavers	PLOS ONE			English	Article							BLOCK; ANESTHESIA; SURGERY; DOGS	Transversus abdominis plane (TAP) block is a regional anesthetic technique used to desensitize the abdominal wall in several species. This study aimed to describe the anatomical characteristics of the abdominal wall and to identify a feasible approach for an US-guided TAP injection that would result in adequate staining of the relevant nerves in the abdominal wall in pig cadavers. Fresh cadavers from five Landrace pigs (age, 12 weeks; body weight, 35.5 +/- 1.6 kg) were used. One pig (n = 1) was anatomically dissected, and four pigs (n = 4; i.e., 8 hemiabdomens) were used for TAP injections and evaluation of dye spread. The volume of 0.3 mL/kg/injection point of methylene blue was injected bilaterally. In the caudal retrocostal approach, the injection was performed ventral to the most caudal part of the costal arch. In the lateral approach, the injection was performed between the last rib and iliac crest. A needle was inserted in plane for the caudal retrocostal and the lateral approach caudocranially and craniocaudally, respectively. Successful staining was defined as presence of dye on the nerve for a length of >1 cm in its entire circumference. The TAP was found between different muscle layers in the described anatomical regions. In the caudal retrocostal approach the TAP was found between the external abdominal oblique and transversus abdominis muscle bellies. In the lateral approach the TAP was found between the internal abdominal oblique and transversus abdominis muscles. The approach combining lateral and caudal retrocostal injections at the studied volume stained a median of 5 (3-6) target nerves from the fourth-last thoracic nerve to L2 (six nerves). Combined caudal retrocostal and lateral TAP injections of 0.3 mL/kg/injection point, resulted in staining of target nerve branches which supply the periumbilical and caudal abdominal wall in pig cadavers.	[Calice, Ivana; Menzies, M. Paula Larenza] Vetmeduni Vienna, Dept Small Anim & Horses, Clin Unit Anesthesiol & Perioperat Intens Care Me, Vienna, Austria; [Kau, Silvio] Vetmeduni Vienna, Inst Topog Anat, Dept Pathobiol, Vienna, Austria; [Knecht, Christian] Univ Clin Swine, Dept Farm Anim & Vet Publ Hlth, Vetmeduni Vienna, Vienna, Austria; [Otero, Pablo E.] Univ Buenos Aires, Fac Vet Med, Dept Anesthesiol, Buenos Aires, DF, Argentina	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Buenos Aires	Calice, I (corresponding author), Vetmeduni Vienna, Dept Small Anim & Horses, Clin Unit Anesthesiol & Perioperat Intens Care Me, Vienna, Austria.	ivana.calice@vetmeduni.ac.at	Otero, Pablo Ezequiel/I-4638-2019	Otero, Pablo Ezequiel/0000-0002-0901-7269; Kau, Silvio/0000-0001-9538-9976; Calice, Ivana/0000-0002-0983-1682				[Anonymous], 2020, EUR LEX 32019R0006 E; Baldo CF, 2018, VET ANAESTH ANALG, V45, P392, DOI 10.1016/j.vaa.2018.01.009; Baum Ellenberger, 1943, HDB VERGLEICHENDEN A; Bohme G., 2004, LEHRBUCH ANATOMIE HA, V4th; Borchers N, 2004, J ANIM BREED GENET, V121, P392, DOI 10.1111/j.1439-0388.2004.00482.x; Bradbury AG, 2016, BRIT J ANAESTH, V116, P37, DOI 10.1093/bja/aev301; Carbone L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155001; Castaneda-Herrera FE, 2017, ANAT HISTOL EMBRYOL, V46, P373, DOI 10.1111/ahe.12279; Cooper DKC, 2016, TRANSPLANTATION, V100, P2039, DOI 10.1097/TP.0000000000001319; Drozdzynska M, 2017, VET ANAESTH ANALG, V44, P183, DOI 10.1111/vaa.12391; Evans H.E., 2013, MILLERS ANATOMY DOG; Garcia CD, 2020, VET ANAESTH ANALG, V47, P391, DOI 10.1016/j.vaa.2020.01.003; Jankovic ZB, 2009, ANESTH ANALG, V109, P981, DOI 10.1213/ane.0b013e3181ae0989; Kettner SC, 2011, BRIT J ANAESTH, V107, P90, DOI 10.1093/bja/aer340; Kobayashi E, 2018, EXP ANIM TOKYO, V67, P7, DOI 10.1538/expanim.17-0086; Konig H.E., 2019, ANATOMIE HAUSTIERE L; Kuls N, 2020, J EQUINE VET SCI, V90, DOI 10.1016/j.jevs.2020.102994; Marhofer P, 2005, BRIT J ANAESTH, V94, P7, DOI 10.1093/bja/aei002; Mirra A, 2018, VET ANAESTH ANALG, V45, P384, DOI 10.1016/j.vaa.2018.02.001; Portela DA, 2018, VET J, V238, P27, DOI 10.1016/j.tvjl.2018.07.003; Portela DA, 2014, VET ANAESTH ANALG, V41, P319, DOI 10.1111/vaa.12122; Rohrer GA, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0286-9; Saldanha A, 2019, J EXOT PET MED, V31, P21, DOI 10.1053/j.jepm.2019.04.001; Schroeder CA, 2010, J ZOO WILDLIFE MED, V41, P338, DOI 10.1638/2009-0113R1.1; Sisson S., 1975, SISSON GROSSMANS ANA, V5e; Skouropoulou D, 2018, VET ANAESTH ANALG, V45, P374, DOI 10.1016/j.vaa.2018.01.005; Stefanidis D, 2013, SURGERY, V154, P34, DOI 10.1016/j.surg.2013.05.001; Teixeira LG, 2018, PESQUI VET BRASIL, V38, P315, DOI [10.1590/1678-5150-PVB-5007, 10.1590/1678-5150-pvb-5007]; Tsai HC, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8284363; Walmsley R, 1937, J ANAT, V71, P404; Young MJ, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/731645	31	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0248131	10.1371/journal.pone.0248131	http://dx.doi.org/10.1371/journal.pone.0248131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690705	Green Published, gold			2022-12-26	WOS:000627854700053
J	Cherneva, Z; Valev, D; Youroukova, V; Cherneva, R				Cherneva, Zheina; Valev, Dinko; Youroukova, Vania; Cherneva, Radostina			Left ventricular diastolic dysfunction in non-severe chronic obstructive pulmonary disease - a step forward in cardiovascular comorbidome	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; HEART-FAILURE; EXERCISE; RISK; ECHOCARDIOGRAPHY; RECOMMENDATIONS; HYPERINFLATION; CAPACITY	Chronic obstructive pulmonary disease (COPD) augments the likelihood of having left ventricular diastolic dysfunction (LVDD)-precursor of heart failure with preserved ejection fraction (HFpEF). LVDD shares overlapping symptomatology (cough and dyspnea) with COPD. Stress induced LVDD is indicative of masked HFpEF. Our aim was to evaluate the predictive value of inflammatory, oxidative stress, cardio-pulmonary and echocardiographic parameters at rest for the diagnosis of stress LVDD in non-severe COPD patients, who complain of exertional dyspnea and are free of overt cardiovascular diseases. A total of 104 COPD patients (26 patients with mild and 78 with moderate COPD) underwent echocardiography before cardio-pulmonary exercise testing (CPET) and 1-2 minutes after peak exercise. Patients were divided into two groups based on peak average E/e': patients with stress induced left ventricular diastolic dysfunction (LVDD)-E/e' > 15 masked HFpEF and patients without LVDD-without masked HFpEF. CPET and echocardiographic parameters at rest were measured and their predictive value for stress E/e' was analysed. Markers for inflammation (resistin, prostaglandine E2) and oxidative stress (8-isoprostanes) were also determined. Stress induced LVDD occurred in 67/104 patients (64%). Those patients showed higher VE/VCO2 slope. None of the CPET parameters was an independent predictor for stress LVDD.Except for prostglandine E2, none of the inflammatory or oxidative stress markers correlated to stress E/e'. The best independent predictors for stress LVDD (masked HFpEF) were RAVI, right ventricular parasternal diameter and RV E/A >0.75. Their combination predicted stress LVDD with the accuracy of 91.2%. There is a high prevalence of masked HFpEF in non-severe COPD with exertional dyspnea, free of overt cardiovascular disease. RAVI, right ventricular parasternal diameter and RV E/A >0.75 were the only independent clinical predictors of masked HFpEF. 288.	[Cherneva, Zheina] Minist Internal Affairs, Med Inst, Sofia, Bulgaria; [Valev, Dinko] Univ First Multiple Clin Act Treatment, Sofia, Bulgaria; [Youroukova, Vania; Cherneva, Radostina] Univ Hosp Resp Dis St Sophia, Sofia, Bulgaria	Medical University Sofia	Cherneva, Z (corresponding author), Minist Internal Affairs, Med Inst, Sofia, Bulgaria.	jenicherneva@yahoo.com		cherneva, zheyna/0000-0002-1196-2307				Abusaid GH, 2009, POSTGRAD MED, V121, P76, DOI 10.3810/pgm.2009.07.2033; Arena R, 2008, HEART FAIL REV, V13, P245, DOI 10.1007/s10741-007-9067-5; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Barbera JA, 2003, EUR RESPIR J, V21, P892, DOI 10.1183/09031936.03.00115402; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; CARGILL RI, 1995, CLIN SCI, V89, P165, DOI 10.1042/cs0890165; Degousee N, 2008, CIRCULATION, V117, P1701, DOI 10.1161/CIRCULATIONAHA.107.749739; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Finkelstein Joseph, 2009, Int J Chron Obstruct Pulmon Dis, V4, P337; Fisk M, 2018, HYPERTENSION, V71, P499, DOI 10.1161/HYPERTENSIONAHA.117.10151; Funk GC, 2008, CHEST, V133, P1354, DOI 10.1378/chest.07-2685; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Gibby C, 2013, EUR HEART J-CARD IMG, V14, P223, DOI 10.1093/ehjci/jes078; Gould KE, 2002, AM J PHYSIOL-HEART C, V282, pH615, DOI 10.1152/ajpheart.00206.2001; Guazzi M, 2016, CIRCULATION, V133, pE694, DOI 10.1161/CIR.0000000000000406; Kaiser T, 2017, CHEST, V152, p976A, DOI 10.1016/j.chest.2017.08.1011; KLEIN JS, 2008, DIASTOLOGY CLIN APPR, P171; Kubota Y, 2016, INT J CHRONIC OBSTR, V11, P649, DOI 10.2147/COPD.S101082; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moneghetti KJ, 2018, EUR HEART J-CARD IMG, V19, P916, DOI 10.1093/ehjci/jex187; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Nedeljkovic I, 2016, EUR J PREV CARDIOL, V23, P71, DOI 10.1177/2047487315604836; O'Donnell DE, 1998, AM J RESP CRIT CARE, V158, P1557, DOI 10.1164/ajrccm.158.5.9804004; O'Donnell DE, 2001, AM J RESP CRIT CARE, V164, P770, DOI 10.1164/ajrccm.164.5.2012122; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Pocock SJ, 2013, EUR HEART J, V34, P1404, DOI 10.1093/eurheartj/ehs337; Ponikowski P, 2016, REV ESP CARDIOL, V69, P167, DOI [10.1016/j.rec.2015.11.005, DOI 10.1016/J.REC.2015.11.005]; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sallach JA, 2009, JACC-CARDIOVASC IMAG, V2, P527, DOI 10.1016/j.jcmg.2009.01.012; Sin Don D, 2005, Proc Am Thorac Soc, V2, P8, DOI 10.1513/pats.200404-032MS; STUBBING DG, 1980, J APPL PHYSIOL, V49, P506, DOI 10.1152/jappl.1980.49.3.506; Ukena C, 2010, INT J CARDIOL, V145, P172, DOI 10.1016/j.ijcard.2010.04.082; Yan S, 1997, AM J RESP CRIT CARE, V156, P55, DOI 10.1164/ajrccm.156.1.9608113; Zhyvotovska Angelina, 2019, Int J Clin Res Trials, V4, DOI 10.15344/2456-8007/2019/137	35	2	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0247940	10.1371/journal.pone.0247940	http://dx.doi.org/10.1371/journal.pone.0247940			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU3OZ	33684166	gold, Green Published			2022-12-26	WOS:000627193500007
J	Long, A; Jones, SRM				Long, Amy; Jones, Simon R. M.			Piscirickettsia salmonis shedding and tissue burden, and hematological responses during cohabitation infections in chum Oncorhynchus keta, pink O. gorbuscha and Atlantic salmon Salmo salar	PLOS ONE			English	Article							RICKETTSIA-LIKE ORGANISM; CHINOOK SALMON; COHO SALMON; RENIBACTERIUM-SALMONINARUM; FARMED ATLANTIC; DISEASE; TRANSMISSION; COLUMBIA; VIRUS; FISH	Background Salmonid rickettsial septicemia is an emergent and geographically widespread disease of marine-farmed salmonids caused by infection with the water-borne bacterium Piscirickettsia salmonis. Very little is known about the route, timing, or magnitude of bacterial shedding from infected fish. Methodology/principal findings A cohabitation challenge model was used to assess shedding from chum Oncorhynchus keta, pink O. gorbuscha and Atlantic salmon Salmo salar. Infections in donor fish were established by intraperitoneal injection of P. salmonis. Naive recipients were cohabitated with donor fish after which cumulative percent morbidity and mortality (CMM) was monitored, and bacterial burdens in kidney and in tank water were measured by qPCR. All donor fish died with mean days-to-death (MDD) among species ranging from 17.5 to 23.9. Among recipients, CMM ranged from 42.7% to 77.8% and MDD ranged from 49.7 to 56.4. In each trial, two peaks of bacterial DNA concentrations in tank water closely aligned with the MDD values of donor and recipient fish. Bacterial tissue burden and shedding rate, and plasma physiological parameters were obtained from individual donors and recipients. Statistically significant positive correlations between the shedding rate and P. salmonis kidney burden were measured in donor pink and in donor and recipient chum salmon, but not in donor or recipient Atlantic salmon. In Atlantic salmon, there was a negative correlation between kidney bacterial burden and hematocrit, plasma Ca++ and Mg++ values, whereas in infected chum salmon the correlation was positive for Na+ and Cl- and negative for glucose. Conclusions A dependency of bacterial shedding on species-specific patterns of pathogenesis was suggested. The coincidence of bacterial shedding with mortality will inform pathogen transmission models.	[Long, Amy; Jones, Simon R. M.] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC, Canada	Fisheries & Oceans Canada	Jones, SRM (corresponding author), Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC, Canada.	simon.jones@dfo-mpo.gc.ca	Jones, Simon/C-2485-2012	Jones, Simon/0000-0002-8800-9653; Long, Amy/0000-0002-9670-981X	Fisheries and Oceans Canada Program for Aquaculture Regulatory Research [2018-P-01]	Fisheries and Oceans Canada Program for Aquaculture Regulatory Research	SRMJ received funding from Fisheries and Oceans Canada Program for Aquaculture Regulatory Research (2018-P-01; https://www.dfompo.gc.ca/aquaculture/rp-pr/parr-prra/projects-projets/fhtt-etsp-2018-p-01-eng.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almendras FE, 1997, J FISH DIS, V20, P409, DOI 10.1046/j.1365-2761.1997.00315.x; BRANSON EJ, 1991, J FISH DIS, V14, P147, DOI 10.1111/j.1365-2761.1991.tb00585.x; BROCKLEBANK JR, 1993, CAN VET J, V34, P745; Brown JD, 2009, J VET DIAGN INVEST, V21, P437, DOI 10.1177/104063870902100404; BRUNO DW, 1986, J FISH DIS, V9, P205, DOI 10.1111/j.1365-2761.1986.tb01005.x; Corbeil S, 2003, BULL EUR ASSN FISH P, V23, P95; Cusack RR, 2002, CAN VET J, V43, P435; CVITANICH JD, 1991, J FISH DIS, V14, P121, DOI 10.1111/j.1365-2761.1991.tb00584.x; FRYER JL, 1992, INT J SYST BACTERIOL, V42, P120, DOI 10.1099/00207713-42-1-120; GARCES LH, 1991, DIS AQUAT ORGAN, V11, P93, DOI 10.3354/dao011093; Garver KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082296; Grant AN, 1996, VET REC, V138, P423; Groff Joseph M., 2000, Journal of Applied Aquaculture, V10, P17, DOI 10.1300/J028v10n04_02; Henriquez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071830; Henriquez P, 2016, J FISH DIS, V39, P441, DOI 10.1111/jfd.12427; Jones SRM, 2020, J FISH DIS, V43, P49, DOI 10.1111/jfd.13102; Klymus K.E., 2020, ENV DNA, V2, P271, DOI [10.1002/edn3.29, DOI 10.1002/EDN3.29]; LANNAN CN, 1984, IN VITRO CELL DEV B, V20, P671, DOI 10.1007/BF02618871; LANNAN CN, 1994, J FISH DIS, V17, P545, DOI 10.1111/j.1365-2761.1994.tb00251.x; Long A, 2021, J FISH DIS, V44, P1, DOI 10.1111/jfd.13261; Long A, 2019, J FISH DIS, V42, P869, DOI 10.1111/jfd.12989; Martin KJ, 2009, J AM SOC NEPHROL, V20, P2291, DOI 10.1681/ASN.2007111194; Mauel MJ, 2008, J VET DIAGN INVEST, V20, P213, DOI 10.1177/104063870802000211; McKibben CL, 1999, DIS AQUAT ORGAN, V38, P75, DOI 10.3354/dao038075; Olsen AB, 1997, DIS AQUAT ORGAN, V31, P35, DOI 10.3354/dao031035; Price D, 2017, AQUACULTURE, V473, P400, DOI 10.1016/j.aquaculture.2017.02.034; Purcell MK, 2016, J FISH DIS, V39, P787, DOI 10.1111/jfd.12409; REDDING JM, 1983, T AM FISH SOC, V112, P800, DOI 10.1577/1548-8659(1983)112<800:IOASOO>2.0.CO;2; Rees EE, 2014, AQUACULTURE, V428, P189, DOI 10.1016/j.aquaculture.2014.03.031; RODGER HD, 1993, J FISH DIS, V16, P361, DOI 10.1111/j.1365-2761.1993.tb00869.x; ROSE AS, 1989, J FISH DIS, V12, P573, DOI 10.1111/j.1365-2761.1989.tb00566.x; Rozas M, 2014, J FISH DIS, V37, P163, DOI 10.1111/jfd.12211; Rozas-Serri M, 2017, J FISH DIS, V40, P1451, DOI 10.1111/jfd.12671; Wargo AR, 2017, VIRUS RES, V227, P200, DOI 10.1016/j.virusres.2016.10.011	34	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0248098	10.1371/journal.pone.0248098	http://dx.doi.org/10.1371/journal.pone.0248098			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667267	gold, Green Published			2022-12-26	WOS:000626604300044
J	Gutbrod, P; Yang, WT; Grujicic, GV; Peisker, H; Gutbrod, K; Du, LF; Dormann, P				Gutbrod, Philipp; Yang, Wentao; Grujicic, Goran Vuk; Peisker, Helga; Gutbrod, Katharina; Du, Lin Fang; Doermann, Peter			Phytol derived from chlorophyll hydrolysis in plants is metabolized via phytenal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS LEAVES; PHOTOSYSTEM-I; IDENTIFICATION; BREAKDOWN; CHAIN; DEFICIENCY; SENESCENCE; OXIDATION; PATHWAY; GROWTH	Phytol is the isoprenoid alcohol bound in ester linkage to chlorophyll, the most abundant photosynthetic pigment in plants. During leaf senescence, large amounts of phytol are released by chlorophyll degradation. However, the pathway of phytol catabolism in plants is unknown. We hypothesized that phytol degradation in plants might involve its oxidation into the long-chain aldehyde phytenal. Using GC-MS for aldehyde quantification after derivatization with methylhydroxylamine, phytenal was identified in leaves, whereas other long-chain aldehydes (phytanal and pristanal) were barely detectable. We found that phytenal accumulates during chlorotic stresses, for example, salt stress, dark-induced senescence, and nitrogen deprivation. The increase in the phytenal content is mediated at least in part independently of enzyme activities, and it is independent of light. Characterization of phytenal accumulation in the pao1 mutant affected in chlorophyll degradation revealed that phytenal is an authentic phytol metabolite derived from chlorophyll breakdown. The increase in phytenal was even stronger in mutants affected in the production of other phytol metabolites including vte5-2 (tocopherol deficient) and pes1 pes2 (fatty acid phytyl ester deficient). Therefore, phytenal accumulation is controlled by competing, alternative pathways of phosphorylation (leading to tocopherol production) or esterification (fatty acid phytyl ester production). As a consequence, the content of phytenal is maintained at low levels, presumably to minimize its toxic effects caused by its highly reactive aldehyde group that can form covalent bonds with and inactivate the amino groups of proteins.	[Gutbrod, Philipp; Yang, Wentao; Grujicic, Goran Vuk; Peisker, Helga; Gutbrod, Katharina; Doermann, Peter] Univ Bonn, Inst Mol Physiol & Biotechnol Plants IMBIO, Bonn, Germany; [Yang, Wentao; Du, Lin Fang] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu, Peoples R China	University of Bonn; Sichuan University	Dormann, P (corresponding author), Univ Bonn, Inst Mol Physiol & Biotechnol Plants IMBIO, Bonn, Germany.; Du, LF (corresponding author), Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu, Peoples R China.	dulinfang@scu.edu.cn; doermann@uni-bonn.de		Dormann, Peter/0000-0002-5845-9370	University of Bonn; China Government Scholarship Council (CSC) of the P.R. China [201606240026]	University of Bonn; China Government Scholarship Council (CSC) of the P.R. China	P. G. and W. Y. were supported by University of Bonn. Furthermore, W. Y. received funding from the China Government Scholarship Council (CSC) of the P.R. China (Grant No. 201606240026).	Araujo WL, 2010, PLANT CELL, V22, P1549, DOI 10.1105/tpc.110.075630; Collakova E, 2001, PLANT PHYSIOL, V127, P1113, DOI 10.1104/pp.010421; Gaude N, 2007, PLANT J, V49, P729, DOI 10.1111/j.1365-313X.2006.02992.x; GELLERMAN JL, 1975, BIOCHIM BIOPHYS ACTA, V388, P277, DOI 10.1016/0005-2760(75)90133-2; Hortensteiner S, 2011, BBA-BIOENERGETICS, V1807, P977, DOI 10.1016/j.bbabio.2010.12.007; Ischebeck T, 2006, J BIOL CHEM, V281, P2470, DOI 10.1074/jbc.M509222200; Ishizaki K, 2005, PLANT CELL, V17, P2587, DOI 10.1105/tpc.105.035162; Lin YP, 2016, PLANT CELL, V28, P2974, DOI 10.1105/tpc.16.00478; Lippold F, 2012, PLANT CELL, V24, P2001, DOI 10.1105/tpc.112.095588; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Mishev K, 2009, PLANT GROWTH REGUL, V58, P61, DOI 10.1007/s10725-008-9352-x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAKAJIMA K, 1974, AGR BIOL CHEM TOKYO, V38, P1859, DOI 10.1080/00021369.1974.10861446; Nass R, 1998, PHYTOCHEM ANALYSIS, V9, P112, DOI 10.1002/(SICI)1099-1565(199805/06)9:3&lt;112::AID-PCA400&gt;3.0.CO;2-A; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Pruzinska A, 2005, PLANT PHYSIOL, V139, P52, DOI 10.1104/pp.105.065870; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Rontani JF, 1996, PHYTOCHEMISTRY, V42, P347, DOI 10.1016/0031-9422(95)00872-1; SAKAMOTO T, 1992, J ORG CHEM, V57, P3245, DOI 10.1021/jo00037a053; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Shimada H, 2005, PLANT J, V41, P627, DOI 10.1111/j.1365-313X.2004.02326.x; Stiti N, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00065; Valentin HE, 2006, PLANT CELL, V18, P212, DOI 10.1105/tpc.105.037077; Verhoeven NM, 1997, BIOCHEM BIOPH RES CO, V237, P33, DOI 10.1006/bbrc.1997.7066; vom Dorp K, 2015, PLANT CELL, V27, P2846, DOI 10.1105/tpc.15.00395; Wanders RJA, 2011, BBA-MOL CELL BIOL L, V1811, P498, DOI 10.1016/j.bbalip.2011.06.006; Weaver LM, 2001, PLANT PHYSIOL, V127, P876, DOI 10.1104/pp.010312; Zbierzak AM, 2010, BIOCHEM J, V425, P389, DOI 10.1042/BJ20090704	28	3	3	4	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100530	10.1016/j.jbc.2021.100530	http://dx.doi.org/10.1016/j.jbc.2021.100530			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33713704	Green Published, gold			2022-12-26	WOS:000672866400504
J	Lopez-Soldado, I; Guinovart, JJ; Duran, J				Lopez-Soldado, Iliana; Guinovart, Joan J.; Duran, Jordi			Increasing hepatic glycogen moderates the diabetic phenotype in insulin-deficient Akita mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOKINASE OVEREXPRESSION; PROTEIN PHOSPHATASE-1; LEPTIN THERAPY; MIXED MEAL; GLUCOSE; METABOLISM; LIVER; RATS; HYPERGLYCEMIA; EXPRESSION	Hepatic glycogen metabolism is impaired in diabetes. We previously demonstrated that strategies to increase liver glycogen content in a high-fat-diet mouse model of obesity and insulin resistance led to a reduction in food intake and ameliorated obesity and glucose tolerance. These effects were accompanied by a decrease in insulin levels, but whether this decrease contributed to the phenotype observed in this animal was unclear. Here we sought to evaluate this aspect directly, by examining the long-term effects of increasing liver glycogen in an animal model of insulin-deficient and monogenic diabetes, namely the Akita mouse, which is characterized by reduced insulin production. We crossed Akita mice with animals overexpressing protein targeting to glycogen (PTG) in the liver to generate Akita mice with increased liver glycogen content (Akita-PTG(OE)). Akita-PTG(OE) animals showed lower glycemia, lower food intake, and decreased water consumption and urine output compared with Akita mice. Furthermore, Akita-PTG(OE) mice showed a restoration of the hepatic energy state and a normalization of gluconeogenesis and glycolysis back to nondiabetic levels. Moreover, hepatic lipogenesis, which is reduced in Akita mice, was reverted in Akita-PTG(OE) animals. These results demonstrate that strategies to increase liver glycogen content lead to the long-term reduction of the diabetic phenotype, independently of circulating insulin.	[Lopez-Soldado, Iliana; Guinovart, Joan J.; Duran, Jordi] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Lopez-Soldado, Iliana; Guinovart, Joan J.; Duran, Jordi] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Guinovart, Joan J.] Univ Barcelona, Dept Biochem & Mol Biomed, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona	Lopez-Soldado, I (corresponding author), Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain.; Lopez-Soldado, I (corresponding author), Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain.	iliana.lopez@irbbarcelona.org	Duran, Jordi/J-7298-2017; Duran, Jordi/AGP-2068-2022	Duran, Jordi/0000-0002-8342-4882	Severo Ochoa Award of Excellence from MINECO (Government of Spain); MINECO [BFU2017-84345-P]; CIBER de Diabetes y Enfermedades Metabolicas Asociadas (ISCIII, Ministerio de Ciencia e Innovacion); "La Marato de TV3" Foundation (Barcelona, Spain) [201613-10]	Severo Ochoa Award of Excellence from MINECO (Government of Spain)(Spanish Government); MINECO(Spanish Government); CIBER de Diabetes y Enfermedades Metabolicas Asociadas (ISCIII, Ministerio de Ciencia e Innovacion); "La Marato de TV3" Foundation (Barcelona, Spain)	IRB Barcelona is the recipient of a Severo Ochoa Award of Excellence from MINECO (Government of Spain). This study was supported by a grant BFU201784345-P from MINECO to J. G. and J. D., the CIBER de Diabetes y Enfermedades Metabolicas Asociadas (ISCIII, Ministerio de Ciencia e Innovacion), and "La Marato de TV3" Foundation (Barcelona, Spain) (project 201613-10).	Berglund ED, 2009, J CLIN INVEST, V119, P2412, DOI 10.1172/JCI38650; Bischof MG, 2002, DIABETES, V51, P49, DOI 10.2337/diabetes.51.1.49; Bischof MG, 2001, DIABETES, V50, P392, DOI 10.2337/diabetes.50.2.392; BRICHARD SM, 1993, DIABETOLOGIA, V36, P292, DOI 10.1007/BF00400230; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; DULLAART RPF, 1995, NETH J MED, V46, P44, DOI 10.1016/0300-2977(94)00048-E; Ferre T, 2003, DIABETOLOGIA, V46, P1662, DOI 10.1007/s00125-003-1244-z; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fujikawa T, 2010, P NATL ACAD SCI USA, V107, P17391, DOI 10.1073/pnas.1008025107; Han HS, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.122; Hu ZX, 2019, INT J BIOL MACROMOL, V128, P665, DOI 10.1016/j.ijbiomac.2019.01.186; HWANG JH, 1995, J CLIN INVEST, V95, P783, DOI 10.1172/JCI117727; Jiang SZ, 2019, J CELL MOL MED, V23, P5794, DOI 10.1111/jcmm.14504; Kramer KL, 1999, ARCH BIOCHEM BIOPHYS, V368, P291, DOI 10.1006/abbi.1999.1299; Lin ZF, 2012, J CLIN ENDOCR METAB, V97, pE1224, DOI 10.1210/jc.2012-1132; Lopez-Soldado I, 2020, FEBS LETT, V594, P1698, DOI 10.1002/1873-3468.13770; Lopez-Soldado I, 2015, DIABETES, V64, P796, DOI 10.2337/db14-0728; Mason TM, 2000, METABOLISM, V49, P1411, DOI 10.1053/meta.2000.17731; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Mehta MB, 2017, J BIOL CHEM, V292, P10444, DOI 10.1074/jbc.M116.766329; Miyamoto A, 2008, J TOXICOL SCI, V33, P209, DOI 10.2131/jts.33.209; Naito M, 2011, DIABETES, V60, P2265, DOI 10.2337/db10-1795; Newgard CB, 2000, DIABETES, V49, P1967, DOI 10.2337/diabetes.49.12.1967; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; O'Doherty RM, 2000, J CLIN INVEST, V105, P479, DOI 10.1172/JCI8673; Owen BM, 2015, TRENDS ENDOCRIN MET, V26, P22, DOI 10.1016/j.tem.2014.10.002; PEHLING G, 1984, J CLIN INVEST, V74, P985, DOI 10.1172/JCI111519; Regnell SE, 2015, METABOLISM, V64, P872, DOI 10.1016/j.metabol.2015.04.002; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Ros S, 2011, DIABETOLOGIA, V54, P2639, DOI 10.1007/s00125-011-2238-x; Ros S, 2010, J BIOL CHEM, V285, P37170, DOI 10.1074/jbc.M110.157396; SALMON DMW, 1985, INT J OBESITY, V9, P443; Schmid AI, 2011, DIABETES CARE, V34, P448, DOI 10.2337/dc10-1076; Seoane J, 1999, J BIOL CHEM, V274, P31833, DOI 10.1074/jbc.274.45.31833; Shin DJ, 2003, J BIOL CHEM, V278, P50047, DOI 10.1074/jbc.M309736200; Sivitz WI, 1998, METABOLISM, V47, P584, DOI 10.1016/S0026-0495(98)90244-X; Szendroedi J, 2009, HEPATOLOGY, V50, P1079, DOI 10.1002/hep.23093; Taylor R, 1996, J CLIN INVEST, V97, P126, DOI 10.1172/JCI118379; Testoni G, 2017, CELL METAB, V26, P256, DOI 10.1016/j.cmet.2017.06.008; Velho G, 1996, J CLIN INVEST, V98, P1755, DOI 10.1172/JCI118974; Verges B, 2009, DIABETES METAB, V35, P353, DOI 10.1016/j.diabet.2009.04.004; Wang CJ, 2014, DIABETES, V63, P947, DOI 10.2337/db13-1096; Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107; Willecke F, 2015, ARTERIOSCL THROM VAS, V35, P102, DOI 10.1161/ATVBAHA.114.304615; Yang ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026359; Yang RJ, 2003, J BIOL CHEM, V278, P23418, DOI 10.1074/jbc.M213112200; Yechoor V, 2009, ENDOCRINOLOGY, V150, P4863, DOI 10.1210/en.2009-0527; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhang J, 2018, INT J BIOL SCI, V14, P1000, DOI 10.7150/ijbs.25026	51	4	4	3	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100498	10.1016/j.jbc.2021.100498	http://dx.doi.org/10.1016/j.jbc.2021.100498			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33667544	gold, Green Published			2022-12-26	WOS:000672866400472
J	Thakur, B; Arora, K; Gupta, A; Guptasarma, P				Thakur, Bhishem; Arora, Kanika; Gupta, Archit; Guptasarma, Purnananda			The DNA-binding protein HU is a molecular glue that attaches bacteria to extracellular DNA in biofilms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI	In biofilms, bacteria that possess a negatively charged surface are embedded within a matrix of polymers consisting mainly of negatively charged extracellular DNA (e-DNA). In all likelihood, a multivalent positively charged substance, for example, a basic protein, exists within biofilms to neutralize charge-charge repulsions and act as a 'glue' attaching negatively charged bacteria to negatively charged e-DNA; however, no protein capable of doing so has yet been identified. We decided to investigate whether a highly abundant nucleoid-associated histone-like protein (HU) happens to be the glue in question. In recent years, HU has been shown to possess qualities that could be considered desirable in the proposed glue, for example, (a) availability in association with e-DNA; (b) multivalent DNA binding; (c) non-sequence-specific DNA-binding; (d) enhancement of biofilm formation upon exogenous addition, and (e) disruption of biofilms, upon removal by HU-cognate antibodies. Geometric considerations suggest that basic residues in HU's canonical and noncanonical DNA-binding sites can interact with sugar-linked terminal phosphates in lipopolysaccharide (LPS) molecules in bacterial outer membranes. Here, using genetic, spectroscopic, biophysical-chemical, microscopy-based, and cytometry-based experiments, we demonstrate that HU's DNA-binding sites also bind to LPS, that this facilitates DNA-DNA, DNA-LPS, and LPS-LPS interactions, and that this facilitates bacterial clumping and attachment of bacteria to DNA. Exogenous addition of HU to bacteria in (nonshaken) cultures is shown to cause cells to become engulfed in a matrix of DNA, potentially arising from the lysis of bacteria with vulnerable cell walls (as they strain to grow, divide, and move away from each other, in opposition to the accreting influence of HUs).	[Thakur, Bhishem; Arora, Kanika; Gupta, Archit; Guptasarma, Purnananda] Indian Inst Sci Educ & Res IISER Mohali, Ctr Prot Sci Design & Engn CPSDE, Dept Biol Sci, Knowledge City, Punjab, India	Indian Institute of Science Education & Research (IISER) - Mohali	Guptasarma, P (corresponding author), Indian Inst Sci Educ & Res IISER Mohali, Ctr Prot Sci Design & Engn CPSDE, Dept Biol Sci, Knowledge City, Punjab, India.	guptasarma@iisermohali.ac.in	Guptasarma, Purnananda/C-3976-2009	Guptasarma, Purnananda/0000-0002-4801-3180; Thakur, Bhishem/0000-0002-2050-982X; Gupta, Archit/0000-0002-2978-3251	Council of Scientific and Industrial Research (CSIR); University Grants Commission (UGC); Department of Biotechnology (DBT), Government of India; Ministry of Human Resource Development (MHRD), Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC)(University Grants Commission, India); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Ministry of Human Resource Development (MHRD), Government of India(Ministry of Human Resource Development (MHRD), Government of India)	We thank Ms Ipsita Pani and Dr Santanu Pal of the Department of Chemical Sciences, Indian Institute of Science Education and Research Mohali, for making their liquid crystalbased assay for protein-lipopolysaccharide binding available for us to test whether highly abundant nucleoid-associated histonelike protein binds to lipopolysaccharide using their assay. We thank Ms Angel for technical assistance. B. T., K. A., and A. G., respectively, thank the Council of Scientific and Industrial Research (CSIR), the University Grants Commission (UGC), and the Department of Biotechnology (DBT), Government of India, for research fellowships. P. G. thanks the Ministry of Human Resource Development (MHRD), Government of India, for the grant of a Centre of Excellence in Frontier Areas of Science and Technology in the area of Protein Science, Design, and Engineering.	Arora K, 2015, ANAL BIOCHEM, V484, P180, DOI 10.1016/j.ab.2015.06.011; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Claret L, 1997, J MOL BIOL, V273, P93, DOI 10.1006/jmbi.1997.1310; Das D, 2015, CHEMPHYSCHEM, V16, P753, DOI 10.1002/cphc.201402739; Dengler V, 2015, J BACTERIOL, V197, P3779, DOI 10.1128/JB.00726-15; Devaraj A, 2015, MOL MICROBIOL, V96, P1119, DOI 10.1111/mmi.12994; Dorman CJ, 2013, NAT REV MICROBIOL, V11, P349, DOI 10.1038/nrmicro3007; Foulston L, 2014, MBIO, V5, DOI 10.1128/mBio.01667-14; Grove A, 2011, CURR ISSUES MOL BIOL, V13, P1; Guo FS, 2007, P NATL ACAD SCI USA, V104, P4309, DOI 10.1073/pnas.0611686104; Haji-Ghassemi O, 2016, J BIOL CHEM, V291, P10104, DOI 10.1074/jbc.M115.712448; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hammel M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600650; Hyldgaard M, 2014, APPL ENVIRON MICROB, V80, P7758, DOI 10.1128/AEM.02204-14; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Jurcisek JA, 2017, P NATL ACAD SCI USA, V114, pE6632, DOI 10.1073/pnas.1705508114; Kamashev D, 1999, EMBO J, V18, P5434, DOI 10.1093/emboj/18.19.5434; Kumar S, 2016, BIOCHEM BIOPH RES CO, V477, P575, DOI 10.1016/j.bbrc.2016.06.087; LAQUA K, 1988, PURE APPL CHEM, V60, P1449, DOI 10.1351/pac198860091449; Novotny LA, 2016, EBIOMEDICINE, V10, P33, DOI 10.1016/j.ebiom.2016.06.022; ROUVIEREYANIV J, 1979, FEBS LETT, V106, P297, DOI 10.1016/0014-5793(79)80518-9; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; TANAKA H, 1993, J BIOCHEM-TOKYO, V113, P568, DOI 10.1093/oxfordjournals.jbchem.a124084; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Turnbull L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11220; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487	26	5	5	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100532	10.1016/j.jbc.2021.100532	http://dx.doi.org/10.1016/j.jbc.2021.100532			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33713701	Green Published, gold			2022-12-26	WOS:000672866400506
J	Vohwinkel, CU; Coit, EJ; Burns, N; Elajaili, H; Hernandez-Saavedra, D; Yuan, XY; Eckle, T; Nozik, E; Tuder, RM; Eltzschig, HK				Vohwinkel, Christine U.; Coit, Ethan J.; Burns, Nana; Elajaili, Hanan; Hernandez-Saavedra, Daniel; Yuan, Xiaoyi; Eckle, Tobias; Nozik, Eva; Tuder, Rubin M.; Eltzschig, Holger K.			Targeting alveolar-specific succinate dehydrogenase A attenuates pulmonary inflammation during acute lung injury	FASEB JOURNAL			English	Article						ALI; alveolar epithelium; ARDS; HIF; inflammation; mechanical ventilation; SDHA; succinate	A2B ADENOSINE RECEPTOR; HYPOXIA; RESOLUTION; LINKS; HIF; METABOLISM; INHIBITION; PROTECTION; CONTRIBUTE; ITACONATE	Acute lung injury (ALI) is an inflammatory lung disease, which manifests itself in patients as acute respiratory distress syndrome (ARDS). Previous studies have implicated alveolar-epithelial succinate in ALI protection. Therefore, we hypothesized that targeting alveolar succinate dehydrogenase SDH A would result in elevated succinate levels and concomitant lung protection. Wild-type (WT) mice or transgenic mice with targeted alveolar-epithelial Sdha or hypoxia-inducible transcription factor Hif1a deletion were exposed to ALI induced by mechanical ventilation. Succinate metabolism was assessed in alveolar-epithelial via mass spectrometry as well as redox measurements and evaluation of lung injury. In WT mice, ALI induced by mechanical ventilation decreased SDHA activity and increased succinate in alveolar-epithelial. In vitro, cell-permeable succinate decreased epithelial inflammation during stretch injury. Mice with inducible alveolar-epithelial Sdha deletion (Sdha(loxp/loxp) SPC-CreER mice) revealed reduced lung inflammation, improved alveolar barrier function, and attenuated histologic injury. Consistent with a functional role of succinate to stabilize HIF, Sdha(loxp/loxp) SPC-CreER experienced enhanced Hif1a levels during hypoxia or ALI. Conversely, Hif1a(loxp/loxp) SPC-CreER showed increased inflammation with ALI induced by mechanical ventilation. Finally, wild-type mice treated with intra-tracheal dimethlysuccinate were protected during ALI. These data suggest that targeting alveolar-epithelial SDHA dampens ALI via succinate-mediated stabilization of HIF1A. Translational extensions of our studies implicate succinate treatment in attenuating alveolar inflammation in patients suffering from ARDS.	[Vohwinkel, Christine U.; Coit, Ethan J.; Burns, Nana; Elajaili, Hanan; Nozik, Eva] Univ Colorado, Cardiovasc Pulm Res Labs, Div Pulm Sci & Crit Care Med, Dev Lung Biol,Div Pediat Crit Care,Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA; [Vohwinkel, Christine U.; Coit, Ethan J.; Burns, Nana; Elajaili, Hanan; Nozik, Eva] Univ Colorado, Cardiovasc Pulm Res Labs, Div Pulm Sci & Crit Care Med, Dev Lung Biol,Div Pediat Crit Care,Dept Pediat, Anschutz Med Campus, Aurora, CO 80045 USA; [Hernandez-Saavedra, Daniel; Tuder, Rubin M.] Univ Colorado, Div Pulm Sci & Crit Care Med, Aurora, CO USA; [Yuan, Xiaoyi; Eltzschig, Holger K.] Univ Texas Hlth Sci Ctr Houston, Dept Anesthesiol, McGovern Med Sch, Houston, TX 77030 USA; [Eckle, Tobias] Univ Colorado, Dept Anesthesiol, Anschutz Med Campus, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Texas System; University of Texas Health Science Center Houston; University of Colorado System; University of Colorado Anschutz Medical Campus	Vohwinkel, CU (corresponding author), Univ Colorado, Cardiovasc Pulm Res Labs, Div Pulm Sci & Crit Care Med, Dev Lung Biol,Div Pediat Crit Care,Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA.; Vohwinkel, CU (corresponding author), Univ Colorado, Cardiovasc Pulm Res Labs, Div Pulm Sci & Crit Care Med, Dev Lung Biol,Div Pediat Crit Care,Dept Pediat, Anschutz Med Campus, Aurora, CO 80045 USA.	Christine.Vohwinkel@cuanschutz.edu	Hernandez-Saavedra, Daniel/AGO-1286-2022	Vohwinkel, Christine/0000-0001-8959-157X	HHS | NIH | National Institute of Child Health and Human Development (NICHD) [K12HD068372]; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [K08HL130586, R01HL133900, R01HL154720]; Parker B Francis Foundation; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK122796, R01DK109574]; DOD | Defense Advanced Research Projects Agency (DARPA) [W81XWH2110032]	HHS | NIH | National Institute of Child Health and Human Development (NICHD); HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI); Parker B Francis Foundation; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); DOD | Defense Advanced Research Projects Agency (DARPA)	HHS | NIH | National Institute of Child Health and Human Development (NICHD), Grant/Award Number: K12HD068372; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: K08HL130586; Parker B Francis Foundation, Grant/Award Number: Parker B Francis Fellowship; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R01HL133900; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: R01DK122796; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: R01DK109574; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R01HL154720; DOD | Defense Advanced Research Projects Agency (DARPA), Grant/Award Number: W81XWH2110032	Al Rasheed MRH, 2018, ARCH PATHOL LAB MED, V142, P1564, DOI 10.5858/arpa.2017-0285-RS; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Beck JM, 2009, INFECT IMMUN, V77, P1053, DOI 10.1128/IAI.00967-08; BERGMEYER HU, 1955, BIOCHEM Z, V327, P255; Bowser JL, 2017, J APPL PHYSIOL, V123, P1303, DOI 10.1152/japplphysiol.00101.2017; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Chen JN, 2021, FREE RADICAL BIO MED, V162, P582, DOI 10.1016/j.freeradbiomed.2020.11.017; Chen N, 2019, NEW ENGL J MED, V381, P1011, DOI 10.1056/NEJMoa1901713; Cordes T, 2016, J BIOL CHEM, V291, P14274, DOI 10.1074/jbc.M115.685792; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Eckle T, 2008, AM J PHYSIOL-LUNG C, V295, pL718, DOI 10.1152/ajplung.90298.2008; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Eckle T, 2014, J IMMUNOL, V192, P1249, DOI 10.4049/jimmunol.1100593; Eckle T, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001665; Eckle T, 2013, FASEB J, V27, P3078, DOI 10.1096/fj.13-228551; Ehrentraut H, 2013, FASEB J, V27, P2207, DOI 10.1096/fj.12-225201; Elajaili HB, 2019, JOVE-J VIS EXP, DOI 10.3791/58461; Eltzschig HK, 2006, METH MOL B, V341, P73; Eltzschig HK, 2014, NAT REV DRUG DISCOV, V13, P852, DOI 10.1038/nrd4422; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gudernatsch V, 2020, IMMUNOTARGETS THER, V9, P31, DOI 10.2147/ITT.S243238; Gui YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046076; Haase VH, 2019, NEPHROL DIAL TRANSPL, V34, P90, DOI 10.1093/ndt/gfy055; Hanidziar D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61489-y; Hernandez-Saavedra D, 2017, ADV EXP MED BIOL, V967, P57, DOI 10.1007/978-3-319-63245-2_5; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Hoegl S, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13648; Hoegl S, 2015, J IMMUNOL, V195, P1815, DOI 10.4049/jimmunol.1401957; Hoffman O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172116; Huang XJ, 2019, AM J PATHOL, V189, P1664, DOI 10.1016/j.ajpath.2019.04.014; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Lee JW, 2020, ANESTHESIOLOGY, V132, P763, DOI 10.1097/ALN.0000000000003037; Lee JW, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0235-1; Levy BD, 2014, ANNU REV PHYSIOL, V76, P467, DOI 10.1146/annurev-physiol-021113-170408; Li MY, 2020, SHOCK, V53, P208, DOI 10.1097/SHK.0000000000001347; Li Y, 2018, FREE RADICAL BIO MED, V126, P1, DOI 10.1016/j.freeradbiomed.2018.07.009; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maeda M, 1990, Nihon Kyobu Shikkan Gakkai Zasshi, V28, P135; Mamary AJ, 2011, CLIN MED INSIGHTS-CI, V5, P17, DOI 10.4137/CCRPM.S6649; McClendon J, 2017, AM J PATHOL, V187, P1772, DOI 10.1016/j.ajpath.2017.04.012; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mercer PF, 2009, AM J RESP CRIT CARE, V179, P414, DOI 10.1164/rccm.200712-1827OC; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; MONTANER JSG, 1986, J CLIN INVEST, V77, P1786, DOI 10.1172/JCI112503; Murphy MP, 2018, CELL, V174, P780, DOI 10.1016/j.cell.2018.07.030; Nemkov T, 2019, METHODS MOL BIOL, V1978, P13, DOI 10.1007/978-1-4939-9236-2_2; Neudecker V, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5360; Nowak-Machen M, 2013, AM J RESP CELL MOL, V48, P601, DOI 10.1165/rcmb.2012-0180OC; Nunns Geoffrey R, 2022, Ann Surg, V276, pe944, DOI 10.1097/SLA.0000000000004644; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Poth JM, 2013, J MOL MED, V91, P183, DOI 10.1007/s00109-012-0988-7; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rawlins EL, 2012, AM J RESP CELL MOL, V46, P269, DOI 10.1165/rcmb.2011-0372PS; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Shah D, 2019, FASEB J, V33, P13617, DOI 10.1096/fj.201901123R; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174; Tojo K, 2018, FASEB J, V32, P2258, DOI 10.1096/fj.201700888R; Villar J, 2011, INTENS CARE MED, V37, P1932, DOI 10.1007/s00134-011-2380-4; Vohwinkel CU, 2017, AM J RESP CELL MOL, V57, P589, DOI 10.1165/rcmb.2016-0358OC; WIENERKRONISH JP, 1991, J CLIN INVEST, V88, P864, DOI 10.1172/JCI115388; Williams GW, 2021, ANESTHESIOLOGY, V134, P270, DOI 10.1097/ALN.0000000000003571; Yuan XY, 2018, ANESTH ANALG, V126, P308, DOI 10.1213/ANE.0000000000002288; Zhang YH, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8327486; Zhao CQ, 2020, EMERG MICROBES INFEC, V9, P691, DOI 10.1080/22221751.2020.1742585	85	6	6	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21468	10.1096/fj.202002778R	http://dx.doi.org/10.1096/fj.202002778R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33687752	Green Published			2022-12-26	WOS:000635216100015
J	Li, CY; Wang, XH; Qin, MZ				Li, Cangyu; Wang, Xinhui; Qin, Mingzhou			Spatial variability of soil nutrients in seasonal rivers: A case study from the Guo River Basin, China	PLOS ONE			English	Article								Agricultural non-point source pollution refers that substance such as nitrogen and phosphorus cause water environment pollution through surface runoff and underground leakage in agricultural production activities. Water environment pollution related to agricultural non-point source pollution in the Huaihe River Basin is becoming more and more prominent. Therefore, it is necessary to analyze the characteristic of soil nutrient in cultivated land and explore the spatial variation and influencing factors of soil nutrients at the watershed scale. A total of 239 topsoil samples were collected from the Guo river basin, and the related factors of soil organic matter (SOM), total carbon (TC), total nitrogen (TN), total phosphorous (TP), total potassium (TK) and potential of hydrogen (PH) were studied by using descriptive statistics and geostatistical methods. The results showed that TK and PH were weak variation, while SOM, TC, TN and TP were medium variation. Soil pH, TP, TK, TC and SOM had moderate spatial variability, which was caused by both random factors and structural factors such as soil texture, soil type, fertilization and local ecological restoration management. Soil TN showed a strong spatial correlation, mainly due to soil texture and soil type. If the recommended fertilization amount is still given based on the average value of soil nutrients ignoring the spatial heterogeneity, it will not only affect crop production efficiency and fertilizer utilization, but may also cause greater environmental pollution. This study can provide a theoretical basis for the management of agro-ecological environments throughout the basin area.	[Li, Cangyu; Qin, Mingzhou] Henan Univ, Coll Environm & Planning, Kaifeng, Peoples R China; [Wang, Xinhui] Henan Agr Univ, Coll Plant Protect, Zhengzhou, Peoples R China	Henan University; Henan Agricultural University	Qin, MZ (corresponding author), Henan Univ, Coll Environm & Planning, Kaifeng, Peoples R China.	neighborhoo@163.com			National Natural Science Foundation of China [41601175]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under Grant no. 41601175.	Bachrudin A., 2017, MAT SCI ENG C SERIES, V332, P1; [白莹 Bai Ying], 2016, [南京大学学报. 自然科学版, Journal of Nanjing University. Natural Sciences], V52, P65; Behera SK, 2015, LAND DEGRAD DEV, V26, P71, DOI 10.1002/ldr.2306; Boakye E, 2020, SN APPL SCI, V2, DOI 10.1007/s42452-020-2129-1; Bremmer JM., 1982, AM SOCI AGRONOMY, V85, P595; [陈桂香 Chen Guixiang], 2017, [地球信息科学学报, Journal of Geo-Information Science], V19, P216; Chien YJ, 1997, SOIL SCI, V162, P291, DOI 10.1097/00010694-199704000-00007; [董琴 Dong Qin], 2019, [水土保持学报, Journal of Soil and Water Conservation], V33, P176; Fang KK, 2016, SCI HORTIC-AMSTERDAM, V207, P65, DOI 10.1016/j.scienta.2016.05.017; Fu WJ, 2014, J SOIL SEDIMENT, V14, P320, DOI 10.1007/s11368-013-0665-7; Guan FY, 2017, CATENA, V150, P161, DOI 10.1016/j.catena.2016.11.017; Guan FY, 2015, CATENA, V133, P455, DOI 10.1016/j.catena.2015.03.002; Jia YP., 2004, J SOIL WATER CONSERV, V18, P31234; Jiang Yong, 2006, Journal of Soil and Water Conservation (China), V20, P93; Kleijnen JPC, 2009, EUR J OPER RES, V192, P707, DOI 10.1016/j.ejor.2007.10.013; Laekemariam F, 2018, COMMUN SOIL SCI PLAN, V49, P124, DOI 10.1080/00103624.2017.1421656; Li LJ., 2013, GUIZHOU AGRI SCI, V41, P195; Li Q., 2014, AGR SCI TECHNOLOGY, V15, P506; Li S., 2018, ACTA PEDOLOGICA SIN, V55, P1134; [李艳 Li Yan], 2003, [水土保持学报, Journal of Soil and Water Conservation], V17, P178; [厉彦玲 Li Yanlinga], 2018, [自然资源学报, Journal of Natural Resources], V33, P489; [鲁艳红 Lu Yanhong], 2016, [中国农业科学, Scientia Agricultura Sinica], V49, P4169; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Ozgoz E, 2013, LAND DEGRAD DEV, V24, P277, DOI 10.1002/ldr.1126; Qi L., 2018, SPATIAL VARIABILITY; Qiu Y., 2001, GEOGR RES-AUST, V20, P739; [邱扬 Qiu Yang], 2002, [地理学报, Acta Geographica Sinica], V57, P587; Shi Chun-jian, 2007, Shengtaixue Zazhi, V26, P501; Shu T., 2018, GUIZHOU AGRI SCI, V46, P55; Sukhorukov VD., 2019, EUROP J GEOGRA, V10, P24; Sumfleth K, 2008, ECOL INDIC, V8, P485, DOI 10.1016/j.ecolind.2007.05.005; Sun XL, 2019, PEDOSPHERE, V29, P577, DOI 10.1016/S1002-0160(19)60801-5; Tang G.A., 2012, ARCGIS GIS SPATIAL A; Tola E, 2017, SAUDI J BIOL SCI, V24, P421, DOI 10.1016/j.sjbs.2016.04.013; WANG AC, 2001, XINJIANG AGR SCI, V38, P277; Wang CR., 2005, J NW A F U, V33, P124; Wang J., 2002, ACTA ECOL SIN, V22; [王军 Wang Jun], 2003, [地理研究, Geographical Research], V22, P373; [王军 Wang Jun], 2002, [生态学报, Acta Ecologica Sinica], V22, P1173; Wang Qiang, 2016, Journal of Anhui Agricultural University, V43, P932; WANG X D, 1997, INFORM CONTR, V26, P272; [徐剑波 XU Jianbo], 2011, [生态环境学报, Ecology and Environmental Sciences], V20, P1379; Yang Fan, 2017, Acta Pedologica Sinica, V54, P1047; Yang Qi-yong, 2011, Yingyong Shengtai Xuebao, V22, P431; Yang ZiQing, 2012, Journal of Fujian Agriculture and Forestry University (Natural Science Edition), V41, P296; Yao X, 2019, CATENA, V178, P189, DOI 10.1016/j.catena.2019.03.004; [易小波 Yi Xiaobo], 2017, [水科学进展, Advances in Water Science], V28, P373; Yin ZR., STUDY SPATIOTEMPORAL; [张玲娥 Zhang Linge], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P923; [张娜 Zhang Na], 2017, [干旱地区农业研究, Agricultural Research in the Arid Areas], V35, P157; [张智猛 Zhang Zhimeng], 2004, [土壤通报, Journal of Soil Science], V35, P38; ZHU LC, 2018, ACTA ECOL SIN, V38, P7254, DOI DOI 10.5846/stxb201710011772	52	0	0	31	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0248655	10.1371/journal.pone.0248655	http://dx.doi.org/10.1371/journal.pone.0248655			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY1VJ	33725027	gold, Green Published			2022-12-26	WOS:000629833700009
J	Takeya, R; Nakamura, S; Tanaka, M				Takeya, Ryuji; Nakamura, Shuntaro; Tanaka, Masaki			Spontaneous grouping of saccade timing in the presence of task-irrelevant objects	PLOS ONE			English	Article								Sequential movements are often grouped into several chunks, as evidenced by the modulation of the timing of each elemental movement. Even during synchronized tapping with a metronome, we sometimes feel subjective accent for every few taps. To examine whether motor segmentation emerges during synchronized movements, we trained monkeys to generate a series of predictive saccades synchronized with visual stimuli which sequentially appeared for a fixed interval (400 or 600 ms) at six circularly arranged landmark locations. We found two types of motor segmentations that featured periodic modulation of saccade timing. First, the intersaccadic interval (ISI) depended on the target location and saccade direction, indicating that particular combinations of saccades were integrated into motor chunks. Second, when a task-irrelevant rectangular contour surrounding three landmarks ("inducer") was presented, the ISI significantly modulated depending on the relative target location to the inducer. All patterns of individual differences seen in monkeys were also observed in humans. Importantly, the effects of the inducer greatly decreased or disappeared when the animals were trained to generate only reactive saccades (latency >100 ms), indicating that the motor segmentation may depend on the internal rhythms. Thus, our results demonstrate two types of motor segmentation during synchronized movements: one is related to the hierarchical organization of sequential movements and the other is related to the spontaneous grouping of rhythmic events. This experimental paradigm can be used to investigate the underlying neural mechanism of temporal grouping during rhythm production.	[Takeya, Ryuji; Nakamura, Shuntaro; Tanaka, Masaki] Hokkaido Univ, Sch Med, Dept Physiol, Sapporo, Hokkaido, Japan	Hokkaido University	Takeya, R; Tanaka, M (corresponding author), Hokkaido Univ, Sch Med, Dept Physiol, Sapporo, Hokkaido, Japan.	takeryu@med.hokudai.ac.jp; masaki@med.hokudai.ac.jp	Tanaka, Masaki/D-9199-2011	Tanaka, Masaki/0000-0002-6177-1314	Ministry of Education, Culture, Sports, Science and Technology of Japan [18H05523]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported partly by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (18H05523 to MT) and the Takeda Science Foundation (to MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis D, 2009, ANN NY ACAD SCI, V1169, P74, DOI 10.1111/j.1749-6632.2009.04766.x; Baath R, 2015, MUSIC PERCEPT, V33, P244, DOI 10.1525/MP.2015.33.2.244; Bakhurin KI, 2017, J NEUROSCI, V37, P854, DOI 10.1523/JNEUROSCI.1789-16.2016; Bartolo R, 2015, J NEUROSCI, V35, P4635, DOI 10.1523/JNEUROSCI.4570-14.2015; Bartolo R, 2014, J NEUROSCI, V34, P3910, DOI 10.1523/JNEUROSCI.2679-13.2014; Bo J, 2009, J NEUROPHYSIOL, V101, P3116, DOI 10.1152/jn.00006.2009; Boyd LA, 2009, NEUROBIOL LEARN MEM, V92, P35, DOI 10.1016/j.nlm.2009.02.009; Breska A, 2018, P NATL ACAD SCI USA, V115, P12283, DOI 10.1073/pnas.1810596115; Brochard R, 2003, PSYCHOL SCI, V14, P362, DOI 10.1111/1467-9280.24441; Cadena-Valencia J, 2018, ELIFE, V7, DOI 10.7554/eLife.38983; Coull JT, 2000, NEUROPSYCHOLOGIA, V38, P808, DOI 10.1016/S0028-3932(99)00132-3; Coull JT, 1998, J NEUROSCI, V18, P7426; Diedrichsen J, 2015, TRENDS COGN SCI, V19, P227, DOI 10.1016/j.tics.2015.02.003; Egger SW, 2019, NAT NEUROSCI, V22, P1871, DOI 10.1038/s41593-019-0500-6; Fujii N, 2005, P NATL ACAD SCI USA, V102, P9032, DOI 10.1073/pnas.0503541102; Fujioka T, 2012, J NEUROSCI, V32, P1791, DOI 10.1523/JNEUROSCI.4107-11.2012; Gamez J, 2018, ANN NY ACAD SCI, V1423, P396, DOI 10.1111/nyas.13671; Garcia-Garibay O, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01971; Hayes AE, 1998, J COGNITIVE NEUROSCI, V10, P178, DOI 10.1162/089892998562645; HIKOSAKA O, 1995, J NEUROPHYSIOL, V74, P1652, DOI 10.1152/jn.1995.74.4.1652; Iversen JR, 2009, ANN NY ACAD SCI, V1169, P58, DOI 10.1111/j.1749-6632.2009.04579.x; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; Kornysheva K, 2014, ELIFE, V3, DOI 10.7554/eLife.03043; Kunimatsu J, 2018, ELIFE, V7, DOI 10.7554/eLife.35676; Lu XF, 1998, J NEUROPHYSIOL, V79, P2245, DOI 10.1152/jn.1998.79.5.2245; Mendoza G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03482-8; Merchant H, 2015, PHILOS T R SOC B, V370, P91, DOI 10.1098/rstb.2014.0093; Merchant H, 2015, EUR J NEUROSCI, V41, P586, DOI 10.1111/ejn.12811; Miyachi S, 2002, EXP BRAIN RES, V146, P122, DOI 10.1007/s00221-002-1213-7; Nakamura T, 2017, EUR J NEUROSCI, V45, P901, DOI 10.1111/ejn.13537; Paul B. T., 2015, TIMING TIME PERCEPTI, V3, P172, DOI [10.1163/22134468-03002042, DOI 10.1163/22134468-03002042]; Penhune VB, 1998, J COGNITIVE NEUROSCI, V10, P752, DOI 10.1162/089892998563149; Sakai K, 2003, EXP BRAIN RES, V152, P229, DOI 10.1007/s00221-003-1548-8; Sakai K, 1999, J NEUROSCI, V19, P10074; Sakai K, 2004, TRENDS COGN SCI, V8, P547, DOI 10.1016/j.tics.2004.10.005; Schaefer RS, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00774; Schaefer RS, 2013, NEUROIMAGE, V70, P317, DOI 10.1016/j.neuroimage.2012.12.064; Schaefer RS, 2011, PSYCHOL RES-PSYCH FO, V75, P95, DOI 10.1007/s00426-010-0293-4; Serrien DJ, 2010, NEUROSCI LETT, V486, P215, DOI 10.1016/j.neulet.2010.09.056; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; Takeya R, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02172; Takeya R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06417-3; Tanaka M, 2005, J NEUROSCI, V25, P5866, DOI 10.1523/JNEUROSCI.0676-05.2005; Teki S, 2011, J NEUROSCI, V31, P3805, DOI 10.1523/JNEUROSCI.5561-10.2011; Tierney A, 2013, J NEUROSCI, V33, P14981, DOI 10.1523/JNEUROSCI.0612-13.2013; Verstynen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047336; Verwey WB, 2009, HUM MOVEMENT SCI, V28, P348, DOI 10.1016/j.humov.2008.10.004; Vlek RJ, 2011, CLIN NEUROPHYSIOL, V122, P1526, DOI 10.1016/j.clinph.2011.01.042; Willingham DB, 1998, PSYCHOL REV, V105, P558, DOI 10.1037/0033-295X.105.3.558; Wymbs NF, 2012, NEURON, V74, P936, DOI 10.1016/j.neuron.2012.03.038; Yokoi A, 2019, NEURON, V103, P1178, DOI 10.1016/j.neuron.2019.06.017	51	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0248530	10.1371/journal.pone.0248530	http://dx.doi.org/10.1371/journal.pone.0248530			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY1VJ	33724997	gold, Green Published			2022-12-26	WOS:000629833700004
J	Alnazly, E; Khraisat, OM; Al-Bashaireh, AM; Bryant, CL				Alnazly, Eman; Khraisat, Omar M.; Al-Bashaireh, Ahmad M.; Bryant, Christine L.			Anxiety, depression, stress, fear and social support during COVID-19 pandemic among Jordanian healthcare workers	PLOS ONE			English	Article							SYMPTOMS; SPIRITUALITY; BURNOUT; LIFE	The emergence of Coronavirus disease 2019 (COVID-19) has affected health-care workers' psychological and mental health. Few studies have been conducted examining the psychological effect of COVID-19 on health-care worker psychological health in Jordan. Therefore, the present study aims to assess the respective levels of fear, anxiety, depression, stress, social support, and the associated factors, experienced by Jordanian health-care workers during the COVID-19 Pandemic. This study adopted a cross-sectional, correlational design to collect data from 365 health-care workers in Amman, Jordan, from August 16th to 23rd, 2020. Along with collecting sociodemographic characteristics, the Fear of COVID-19 Scale, the Depression, Anxiety, Stress Scale, and the Multidimensional Scale of Perceived Social Support electronically administered to participants. The majority of the participants (69.3%) were registered nurses. The mean overall score for the Fear of COVID-19 scale was 23.64 (SD + 6.85) which again exceeded the mid-point for the total score range (21), indicating elevated level fear of the COVID-19 pandemic. Participants had displayed extremely severe depression 40%, extremely severe anxiety 60%, and 35% severely distressed. Scores for depression (21.30 +/- 10.86), anxiety (20.37 +/- 10.80), stress (23.33 +/- 10.87) were also high. Factors determined to be associated with psychological distress were being male, married, aged 40 years and older, and having more clinical experience. Assessment of social support indicated moderate-to-high levels of perceived support for all dimensions (significant other: 5.17 +/- 1.28, family: 5.03 +/- 1.30, friends: 5.05 +/- 1.30). Weak significant correlations were found between social support and the other study variables (r < 0.22), indicating a weak association with fear, depression, anxiety, and stress, respectively. Overall, Jordanian health-care workers sample reported fear, depression, anxiety, and stress. The associated factors were being male, married, aged 40 years and older, and having more clinical experience. Regarding social support, participants primarily relied on support from their families, followed by support from friends.	[Alnazly, Eman; Khraisat, Omar M.; Al-Bashaireh, Ahmad M.] Al Ahliyya Amman Univ, Fac Nursing, Dept Primary Care Nursing, Amman, Jordan; [Bryant, Christine L.] HSHS St Johns Hosp, Springfield, IL USA	Al-Ahliyya Amman University	Alnazly, E (corresponding author), Al Ahliyya Amman Univ, Fac Nursing, Dept Primary Care Nursing, Amman, Jordan.	emanalnazly@hotmail.com	Al-Bashaireh, AHMAD M/AAW-5604-2021	Al-Bashaireh, AHMAD M/0000-0002-1050-1680; Alnazly, Eman/0000-0002-9327-6756				Abufaraj MM, 2020, JORDAN TIMES; Ahorsu DK, 2022, INT J MENT HEALTH AD, V20, P1537, DOI 10.1007/s11469-020-00270-8; [Anonymous], 2012, SOC SCI QUART; Barello S, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113129; Batra K, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17239096; Bisson JI, 2010, BRIT J PSYCHIAT, V196, P69, DOI 10.1192/bjp.bp.109.066266; Centers for Disease Control and Prevention, OLDER ADULT GREATER; Chirico F, 2020, BJPSYCH INT, P1, DOI DOI 10.1192/BJI.2020.39; Chirico F, 2021, WORKPLACE HEALTH SAF, V69, P5, DOI 10.1177/2165079920950161; COBB S, 1976, PSYCHOSOM MED, V38, P300, DOI 10.1097/00006842-197609000-00003; Conti C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242538; Dall'Ora C, 2019, J NURS MANAGE, V27, P19, DOI 10.1111/jonm.12643; Erdem H, 2021, INT J INFECT DIS, V102, P239, DOI 10.1016/j.ijid.2020.10.064; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Greenberg N, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1211; Harapan H, 2020, J INFECT PUBLIC HEAL, V13, P667, DOI 10.1016/j.jiph.2020.03.019; Harrison R., 2020, EXAMINING PSYCHOL RE; Heath C, 2020, ANAESTHESIA, V75, P1364, DOI 10.1111/anae.15180; International Labour Office, ILO LIST OCCUPATIONA; Ivtzan I, 2013, J RELIG HEALTH, V52, P915, DOI 10.1007/s10943-011-9540-2; Jordanian Ministry of Health, HLTH STAT 2019; Jordanian Ministry of Health, JORDANS OFFICIAL COV; Jordanian Ministry of Health, DEP COMMUNICABLE DIS; KREJCIE RV, 1970, EDUC PSYCHOL MEAS, V30, P607, DOI 10.1177/001316447003000308; Labrague LJ, 2020, J NURS MANAGE, V28, P1653, DOI 10.1111/jonm.13121; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Li YC, 2021, PSYCHOL MED, V51, P1952, DOI 10.1017/S0033291720001555; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Luceno-Moreno L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155514; Maben J, 2020, J CLIN NURS, V29, P2742, DOI 10.1111/jocn.15307; Magnavita N, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145218; Maunder R, 2004, PHILOS T R SOC B, V359, P1117, DOI 10.1098/rstb.2004.1483; Mikkola L, 2018, MED EDUC ONLINE, V23, DOI 10.1080/10872981.2018.1435114; Mo YY, 2020, J NURS MANAGE, V28, P1002, DOI 10.1111/jonm.13014; Mostafa A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244172; Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]; Preti E, 2020, CURR PSYCHIAT REP, V22, DOI 10.1007/s11920-020-01166-z; Que JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100259; Raosoft, 2004, SAMPLE SIZE CALCULAT; Rosa William E, 2020, Nurs Manage, V51, P28, DOI 10.1097/01.NUMA.0000688940.29231.6f; Spinale J, 2008, CLIN J AM SOC NEPHRO, V3, P1620, DOI 10.2215/CJN.01790408; Williamson V, 2020, OCCUP MED-OXFORD, V70, P317, DOI 10.1093/occmed/kqaa052; Wong AH, 2020, ANN EMERG MED, V76, P379, DOI 10.1016/j.annemergmed.2020.04.041; World Health Organization, 2013, CORONAVIRUS DIS COVI; Xiao H, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.923549; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	46	93	94	9	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0247679	10.1371/journal.pone.0247679	http://dx.doi.org/10.1371/journal.pone.0247679			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8KN	33711026	gold, Green Published			2022-12-26	WOS:000629591800021
J	Doi, A; Miyazaki, T; Mihara, T; Ikeda, M; Niikura, R; Andoh, T; Goto, T				Doi, Akiko; Miyazaki, Tomoyuki; Mihara, Takahiro; Ikeda, Maiko; Niikura, Ryo; Andoh, Tomio; Goto, Takahisa			CLP290 promotes the sedative effects of midazolam in neonatal rats in a KCC2-dependent manner: A laboratory study in rats	PLOS ONE			English	Article								Immature neurons dominantly express the Na+-K+-2Cl(-) cotransporter isoform 1 (NKCC1) rather than the K+-Cl- cotransporter isoform 2 (KCC2). The intracellular chloride ion concentration ([Cl-]i) is higher in immature neurons than in mature neurons; therefore, gamma-aminobutyric acid type A (GABAA) receptor activation in immature neurons does not cause chloride ion influx and subsequent hyperpolarization. In our previous work, we found that midazolam, benzodiazepine receptor agonist, causes less sedation in neonatal rats compared to adult rats and that NKCC1 blockade by bumetanide enhances the midazolam-induced sedation in neonatal, but not in adult, rats. These results suggest that GABA receptor activation requires the predominance of KCC2 over NKCC1 to exert sedative effects. In this study, we focused on CLP290, a novel KCC2-selective activator, and found that midazolam administration at 20 mg/kg after oral CLP290 intake significantly prolonged the righting reflex latency even in neonatal rats at postnatal day 7. By contrast, CLP290 alone did not exert sedative effects. Immunohistochemistry showed that midazolam combined with CLP290 decreased the number of phosphorylated cAMP response element-binding protein-positive cells in the cerebral cortex, suggesting that CLP290 reverted the inhibitory effect of midazolam. Moreover, the sedative effect of combined CLP290 and midazolam treatment was inhibited by the administration of the KCC2-selective inhibitor VU0463271, suggesting indirectly that the sedation-promoting effect of CLP290 was mediated by KCC2 activation. To our knowledge, this study is the first report showing the sedation-promoting effect of CLP290 in neonates and providing behavioral and histological evidence that CLP290 reverted the sedative effect of GABAergic drugs through the activation of KCC2. Our data suggest that the clinical application of CLP290 may provide a breakthrough in terms of midazolam-resistant sedation.	[Doi, Akiko; Miyazaki, Tomoyuki; Mihara, Takahiro; Ikeda, Maiko; Niikura, Ryo; Goto, Takahisa] Yokohama City Univ, Dept Anesthesiol & Crit Care Med, Grad Sch Med, Yokohama, Kanagawa, Japan; [Miyazaki, Tomoyuki] Yokohama City Univ, Dept Physiol, Grad Sch Med, Yokohama, Kanagawa, Japan; [Andoh, Tomio] Teikyo Univ, Mizonokuchi Hosp, Dept Anesthesiol, Sch Med, Kawasaki, Kanagawa, Japan	Yokohama City University; Yokohama City University; Teikyo University	Miyazaki, T (corresponding author), Yokohama City Univ, Dept Anesthesiol & Crit Care Med, Grad Sch Med, Yokohama, Kanagawa, Japan.; Miyazaki, T (corresponding author), Yokohama City Univ, Dept Physiol, Grad Sch Med, Yokohama, Kanagawa, Japan.	johney@yokohama-cu.ac.jp		Miyazaki, Tomoyuki/0000-0003-3840-5436	Japan Society for the Promotion of Science [16K10945]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This project was supported by Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C)(16K10945) to TA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Cardarelli RA, 2017, NAT MED, V23, P1394, DOI 10.1038/nm.4442; Chen B, 2018, CELL, V174, P521, DOI 10.1016/j.cell.2018.06.005; Chen M, 2017, ELIFE, V6, DOI 10.7554/eLife.20142; Cleary RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057148; Delpire E, 2012, BIOORG MED CHEM LETT, V22, P4532, DOI 10.1016/j.bmcl.2012.05.126; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Ferrini F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04209-3; Flood P, 2002, ANESTHESIOLOGY, V97, P902, DOI 10.1097/00000542-200210000-00023; Friedel P, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa0354; Gagnon M, 2013, NAT MED, V19, P1524, DOI 10.1038/nm.3356; Glykys J, 2009, NEURON, V63, P657, DOI 10.1016/j.neuron.2009.08.022; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kaila K, 2014, NAT REV NEUROSCI, V15, P637, DOI 10.1038/nrn3819; Kang SK., 2015, FRONT CELL NEUROSCI, P9, DOI [10.3389/fncel.2015.00009, DOI 10.3389/FNCEL.2015.00009]; Khazipov R., 2015, FRONT NEUROANAT, P9, DOI [10.3389/fnana.2015.00009, DOI 10.3389/FNANA.2015.00009]; Kim YB, 2018, DIABETES, V67, P486, DOI 10.2337/db17-1042; Koch SC, 2008, ANESTHESIOLOGY, V108, P122, DOI 10.1097/01.anes.0000296079.45446.15; Koyama Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164125; Koyama Y, 2013, ANESTHESIOLOGY, V119, P1096, DOI 10.1097/ALN.0b013e31829e4b05; Lee HHC, 2011, NAT NEUROSCI, V14, P736, DOI 10.1038/nn.2806; Li H, 2002, EUR J NEUROSCI, V16, P2358, DOI 10.1046/j.1460-9568.2002.02419.x; Loscher W, 2013, NEUROPHARMACOLOGY, V69, P62, DOI 10.1016/j.neuropharm.2012.05.045; Medina I, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00027; Ng E, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002052.pub3; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Rakhade SN, 2012, J NEUROSCI, V32, P17800, DOI 10.1523/JNEUROSCI.6121-11.2012; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Sivakumaran S, 2015, J NEUROSCI, V35, P8291, DOI 10.1523/JNEUROSCI.5205-14.2015; Spoljaric I, 2019, CELL REP, V26, P1073, DOI 10.1016/j.celrep.2019.01.011; Stein V, 2004, J COMP NEUROL, V468, P57, DOI 10.1002/cne.10983; Sullivan BJ., 2020, BIORXIV PREPRINT, DOI [10.1101/2020.09.15.298596, DOI 10.1101/2020.09.15.298596]; Thomas AM, 2018, CELL REP, V23, P68, DOI 10.1016/j.celrep.2018.03.030; Uvarov P, 2009, J BIOL CHEM, V284, P13696, DOI 10.1074/jbc.M807366200; Wang C, 2002, DEV BRAIN RES, V139, P59, DOI 10.1016/S0165-3806(02)00536-9; Watanabe M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00371	36	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0248113	10.1371/journal.pone.0248113	http://dx.doi.org/10.1371/journal.pone.0248113			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711029	gold, Green Published			2022-12-26	WOS:000629591800007
J	Liang, SF; Liu, HL; Chen, C; Qin, CB; Yang, FC; Feng, Y; Lin, ZS				Liang, ShuFen; Liu, Huilin; Chen, Chen; Qin, Chuanbo; Yang, FangChen; Feng, Yue; Lin, Zhuosheng			Research on multi-path dense networks for MRI spinal segmentation	PLOS ONE			English	Article							INTERVERTEBRAL DISC LOCALIZATION; VERTEBRAE	Accurate and robust segmentation of anatomical structures from magnetic resonance images is valuable in many computer-aided clinical tasks. Traditional codec networks are not satisfactory because of their low accuracy of edge segmentation, the low recognition rate of the target, and loss of detailed information. To address these problems, this study proposes a series of improved models for semantic segmentation and progressively optimizes them from the three aspects of convolution module, codec unit, and feature fusion. Instead of the standard convolution structure, we apply a new type of convolution module for the feature extraction. The networks integrate a multi-path method to obtain richer-detail edge information. Finally, a dense network is utilized to strengthen the ability of the feature fusion and integrate more different-level information. The evaluation of the Accuracy, Dice coefficient, and Jaccard index led to values of 0.9855, 0.9185, and 0.8507, respectively. These metrics of the best network increased by 1.0%, 4.0%, and 6.1%, respectively. Boundary F1-Score reached 0.9124 indicating that the proposed networks can segment smaller targets to obtain smoother edges. Our methods obtain more key information than traditional methods and achieve superiority in segmentation performance.	[Liang, ShuFen; Liu, Huilin; Chen, Chen; Qin, Chuanbo; Yang, FangChen; Feng, Yue; Lin, Zhuosheng] Wuyi Univ, Fac Intelligent Mfg, Jiangmen, Guangdong, Peoples R China	Wuyi University	Chen, C; Qin, CB (corresponding author), Wuyi Univ, Fac Intelligent Mfg, Jiangmen, Guangdong, Peoples R China.	1298737629@qq.com; tenround@163.com		Qin, Chuanbo/0000-0001-7189-5196	National Natural Science Foundation of China [33518001, 61372193, 61901304]; Guangdong Natural Science Foundation [07010869]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	The study was supported by the National Natural Science Foundation of China under Grant No. 33518001, Grant No.61372193, and Grant No.61901304, and Guangdong Natural Science Foundation under Grant No.07010869. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Andrew J, 2020, INT CONF ADVAN COMPU, P945, DOI 10.1109/ICACCS48705.2020.9074218; [Anonymous], 2020, MICCAI VERTEBRAE SEG; Asari V., 2018, ARXIV180206955V5; Badrinarayanan V, 2017, IEEE T PATTERN ANAL, V39, P2481, DOI 10.1109/TPAMI.2016.2644615; Cirean D., 2012, P NEUR INF PROC SYST, P25; Csurka G, 2013, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2013, DOI 10.5244/C.27.32; Dolz J., 2018, P MICCAI 2018 IVD CH, P130, DOI DOI 10.13140/RG.2.2.23756.46724; Egger J, 2013, COMPUT METH PROG BIO, V110, P268, DOI 10.1016/j.cmpb.2012.11.010; Gawel D, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7952946; Ghosh S., 2014, COMPUT METHODS CLIN, V17, P185; Gu ZW, 2019, IEEE T MED IMAGING, V38, P2281, DOI 10.1109/TMI.2019.2903562; Guan S, 2020, IEEE J BIOMED HEALTH, V24, P568, DOI 10.1109/JBHI.2019.2912935; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Huang GL, 2017, IEEE ICC; Jadon S, 2020, 2020 IEEE CONFERENCE ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY (CIBCB), P115; Kim YJ, 2020, HEALTHC INFORM RES, V26, P61, DOI 10.4258/hir.2020.26.1.61; Kingma D., 2014, P 3 INT C LEARNING R, DOI DOI 10.1038/S41598-021-83424-5; Kolarik M, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9030404; Korez Robert, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P433, DOI 10.1007/978-3-319-46723-8_50; Korez R, 2015, IEEE T MED IMAGING, V34, P1649, DOI 10.1109/TMI.2015.2389334; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li G., 2017, ELECT DES ENG, V25, P183; Li G, 2020, IEEE ACCESS, V8, P27495, DOI 10.1109/ACCESS.2020.2971760; Li ST, 2017, INFORM FUSION, V33, P100, DOI 10.1016/j.inffus.2016.05.004; Li XM, 2018, MED IMAGE ANAL, V45, P41, DOI 10.1016/j.media.2018.01.004; Liu Z., 2020, ARXIV200709479; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Ma JX, 2019, IEEE ACCESS, V7, P36633, DOI 10.1109/ACCESS.2019.2904096; Ma YD, 2004, PROCEEDINGS OF THE 2004 INTERNATIONAL SYMPOSIUM ON INTELLIGENT MULTIMEDIA, VIDEO AND SPEECH PROCESSING, P743; Milletari F, 2016, INT CONF 3D VISION, P565, DOI 10.1109/3DV.2016.79; Minaei S, 2022, INT J SPORT NUTR EXE, V32, P16, DOI 10.1123/ijsnem.2021-0090; Niu Shengxiao, 2012, Journal of Computer Aided Design & Computer Graphics, V24, P1410; Noh S, 2016, IEEE T INTELL TRANSP, V17, P323, DOI 10.1109/TITS.2015.2466652; Norman B, 2018, RADIOLOGY, V288, P177, DOI 10.1148/radiol.2018172322; Oktay O, 2018, ARXIV180403999; QiZhi T, 2014, SCI TECHNOL ENG, V14, P222; Rak M, 2019, COMPUT METH PROG BIO, V177, P47, DOI 10.1016/j.cmpb.2019.05.003; Rehman F, 2020, J DIGIT IMAGING, V33, P191, DOI 10.1007/s10278-019-00216-0; Ronneberger O., 2015, INT C MED IM COMP CO, P234; Smorgick Y, 2021, MAGN RESON MATER PHY, V34, P421, DOI 10.1007/s10334-020-00882-0; Sun Y, 2020, IEEE ACCESS, V8, P118957, DOI 10.1109/ACCESS.2020.3005384; Tian Y, 2009, SENSOR REV, V29, P157, DOI 10.1108/02602280910936264; Wei Y., 2018, CHINA MED DEVICES, V9, P61; Wong A, 2008, IEEE ENG MED BIO, P863, DOI 10.1109/IEMBS.2008.4649290; [肖明尧 Xiao Mingyao], 2017, [吉林大学学报. 工学版, Journal of Jilin University. Engineering and Technology Edition], V47, P1591; Xie G, 2011, 30 CHIN CONTR C, P1106; Zheng GY, 2017, MED IMAGE ANAL, V35, P327, DOI 10.1016/j.media.2016.08.005; Zhongli L., 2018, COMPUT APPL SOFTW, V35; Zhu X, 2015, CHINESE J BIOMED ENG, V163, P99; Zukic D, 2014, COMPUT GRAPH FORUM, V33, P190, DOI 10.1111/cgf.12343	50	1	1	8	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0248303	10.1371/journal.pone.0248303	http://dx.doi.org/10.1371/journal.pone.0248303			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711080	Green Published, gold			2022-12-26	WOS:000629591800054
J	Ashinyo, ME; Dubik, SD; Duti, V; Amegah, KE; Ashinyo, A; Asare, BA; Ackon, AA; Akoriyea, SK; Kuma-Aboagye, P				Ashinyo, Mary Eyram; Dubik, Stephen Dajaan; Duti, Vida; Amegah, Kingsley Ebenezer; Ashinyo, Anthony; Asare, Brian Adu; Ackon, Angela Ama; Akoriyea, Samuel Kaba; Kuma-Aboagye, Patrick			Infection prevention and control compliance among exposed healthcare workers in COVID-19 treatment centers in Ghana: A descriptive cross-sectional study	PLOS ONE			English	Article							CHINESE EPICENTER	Compliance with infection prevention and control (IPC) protocols is critical in minimizing the risk of coronavirus disease (COVID-19) infection among healthcare workers. However, data on IPC compliance among healthcare workers in COVID-19 treatment centers are unknown in Ghana. This study aims to assess IPC compliance among healthcare workers in Ghana's COVID-19 treatment centers. The study was a secondary analysis of data, which was initially collected to determine the level of risk of COVID-19 virus infection among healthcare workers in Ghana. Quantitative data were conveniently collected using the WHO COVID-19 risk assessment tool. We analyzed the data using descriptive statistics and logistic regression analyses. We observed that IPC compliance during healthcare interactions was 88.4% for hand hygiene and 90.6% for Personal Protective Equipment (PPE) usage; IPC compliance while performing aerosol-generating procedures (AGPs), was 97.5% for hand hygiene and 97.5% for PPE usage. For hand hygiene during healthcare interactions, lower compliance was seen among nonclinical staff [OR (odds ratio): 0.43; 95% CI (Confidence interval): 0.21-0.89], and healthcare workers with secondary level qualification (OR: 0.24; 95% CI: 0.08-0.71). Midwives (OR: 0.29; 95% CI: 0.09-0.93) and Pharmacists (OR: 0.15; 95% CI: 0.02-0.92) compliance with hand hygiene was significantly lower than registered nurses. For PPE usage during healthcare interactions, lower compliance was seen among healthcare workers who were separated/divorced/widowed (OR: 0.08; 95% CI: 0.01-0.43), those with secondary level qualifications (OR 0.08; 95% CI 0.01-0.43), non-clinical staff (OR 0.16 95% CI 0.07-0.35), cleaners (OR: 0.16; 95% CI: 0.05-0.52), pharmacists (OR: 0.07; 95% CI: 0.01-0.49) and among healthcare workers who reported of insufficiency of PPEs (OR: 0.33; 95% CI: 0.14-0.77). Generally, healthcare workers' infection prevention and control compliance were high, but this compliance differs across the different groups of health professionals in the treatment centers. Ensuring an adequate supply of IPC logistics coupled with behavior change interventions and paying particular attention to nonclinical staff is critical in minimizing the risk of COVID-19 transmission in the treatment centers.	[Ashinyo, Mary Eyram; Akoriyea, Samuel Kaba] Ghana Hlth Serv Headquarters, Inst Care Div, Accra, Ghana; [Dubik, Stephen Dajaan] Univ Dev Studies, Sch Allied Hlth Sci, Tamale, Ghana; [Duti, Vida] IRC Ghana, Cantonments, Accra, Ghana; [Amegah, Kingsley Ebenezer] Hohoe Municipal Hosp, Dept Hlth Informat, Hohoe, Ghana; [Ashinyo, Anthony] Natl AIDS STI Control Programme, Accra, Ghana; [Asare, Brian Adu] Minist Hlth, Directorate Pharm, Accra, Ghana; [Ackon, Angela Ama] WHO, Ghana Country Off, Accra, Ghana; [Kuma-Aboagye, Patrick] Ghana Hlth Serv Headquarters, Off Director Gen, Accra, Ghana	University for Development Studies; World Health Organization	Ashinyo, ME (corresponding author), Ghana Hlth Serv Headquarters, Inst Care Div, Accra, Ghana.	mary.ashinyo@ghsmail.org	Dubik, Stephen Dajaan/AAO-3972-2021	Asare, Brian/0000-0003-2216-501X; Ashinyo, Mary Eyram/0000-0002-8493-9378; Amegah, Kingsley E./0000-0002-5251-1166; Dubik, Stephen Dajaan/0000-0001-9833-2676	IRC-Ghana	IRC-Ghana	We confirm receipt of funding from IRC-Ghana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MEA, IRC-Ghana https://www.ircwash.org/ghana	Ashinyo ME, 2020, J PRIM CARE COMMUNIT, V11, DOI 10.1177/2150132720969483; Bawazir A, 2018, J INFECT PUBLIC HEAL, V11, P89, DOI 10.1016/j.jiph.2017.05.003; Cao JL, 2020, CLIN INFECT DIS, V71, P748, DOI 10.1093/cid/ciaa243; Chatterjee P, 2020, INDIAN J MED RES, V151, P459, DOI 10.4103/ijmr.IJMR_2234_20; Chavali S, 2014, INDIAN J CRIT CARE M, V18, P689, DOI 10.4103/0972-5229.142179; Cochran William G., 2007, SAMPLING TECHNIQUES; Cooper S, 2020, PAN AFR MED J, V35, DOI [10.11604/pamj.supp.2020.35.2.23012, 10.11604/pamj.2020.35.2.23012]; Das PJ, 2022, EDUC PRIM CARE, DOI 10.1080/14739879.2022.2137856; Desta M, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3277-5; Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20; El-Sokkary RH, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245672; Ghana Health Service, 2021, SIT UPD COV 19 OUTBR; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0; Haile TG, 2017, J ENVIRON PUBLIC HEA, V2017, DOI 10.1155/2017/2050635; Houghton C, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013582; Karaaslan Ayse, 2014, Interdiscip Perspect Infect Dis, V2014, P306478, DOI 10.1155/2014/306478; Khachatryan V, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.022002; Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797; Lai XQ, 2020, ANTIMICROB RESIST IN, V9, DOI 10.1186/s13756-020-00746-1; Malik MO, 2021, PROD PLAN CONTROL, V32, P1020, DOI 10.1080/09537287.2020.1784481; Martin-Delgado J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242185; Matrajt L, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf1374; Nguyen LH, 2020, LANCET PUBLIC HEALTH, V5, pE475, DOI 10.1016/S2468-2667(20)30164-X; Powell-Jackson T, 2020, LANCET GLOB HEALTH, V8, pE780, DOI 10.1016/S2214-109X(20)30222-9; Risko N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240503; Russell D, 2018, AM J INFECT CONTROL, V46, P1211, DOI 10.1016/j.ajic.2018.05.005; Umar M, 2020, J RAWALPINDI MED COL, V24, P71, DOI DOI 10.37939/JRMC.V24ISUPP-1.1440; Verbeek JH, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011621.pub2; Wee LE, 2020, J HOSP INFECT, V106, P392, DOI 10.1016/j.jhin.2020.08.002; Wee LE, 2020, CLIN MICROBIOL INFEC, V26, P1719, DOI 10.1016/j.cmi.2020.08.040; WHO, 2019, REP WHO CHIN JOINT M; World Health Organization, 2014, BURD DIS AMB AIR POL; Xiong Y, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000021396; Zhao Y, 2020, CLIN MICROBIOL INFEC, V26, P1716, DOI 10.1016/j.cmi.2020.07.029	35	26	26	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2021	16	3							e0248282	10.1371/journal.pone.0248282	http://dx.doi.org/10.1371/journal.pone.0248282			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DJ	33690699	Green Published, gold			2022-12-26	WOS:000627855600035
J	Rana, T; Korolkova, OY; Rachakonda, G; Williams, AD; Hawkins, AT; James, SD; Sakwe, AM; Hui, N; Wang, L; Yu, C; Goodwin, JS; Izban, MG; Offodile, RS; Washington, MK; Ballard, BR; Smoot, DT; Shi, XZ; Forbes, DS; Shanker, A; M'Koma, AE				Rana, Tanu; Korolkova, Olga Y.; Rachakonda, Girish; Williams, Amanda D.; Hawkins, Alexander T.; James, Samuel D.; Sakwe, Amos M.; Hui, Nian; Wang, Li; Yu, Chang; Goodwin, Jeffrey S.; Izban, Michael G.; Offodile, Regina S.; Washington, Mary K.; Ballard, Billy R.; Smoot, Duane T.; Shi, Xuan-Zheng; Forbes, Digna S.; Shanker, Anil; M'Koma, Amosy E.			Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn's colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease	PLOS ONE			English	Article							ULCERATIVE-COLITIS; MONTREAL CLASSIFICATION; MUCOSAL FLORA; BARRIER; PREVALENCE; TRENDS; PERMEABILITY; PERFORMANCE; INFLIXIMAB; CULTURE	Evidence link bacterial enterotoxins to apparent crypt-cell like cells (CCLCs), and Alpha Defensin 5 (DEFA5) expansion in the colonic mucosa of Crohn's colitis disease (CC) patients. These areas of ectopic ileal metaplasia, positive for Paneth cell (PC) markers are consistent with diagnosis of CC. Retrospectively, we: 1. Identified 21 patients with indeterminate colitis (IC) between 2000-2007 and were reevaluation their final clinical diagnosis in 2014 after a followed-up for mean 8.7 +/- 3.7 (range, 4-14) years. Their initial biopsies were analyzed by DEFA5 bioassay. 2. Differentiated ulcer-associated cell lineage (UACL) analysis by immunohistochemistry (IHC) of the CC patients, stained for Mucin 6 (MUC6) and DEFA5. 3. Treated human immortalized colonic epithelial cells (NCM460) and colonoids with pure DEFA5 on the secretion of signatures after 24hr. The control colonoids were not treated. 4. Treated colonoids with/without enterotoxins for 14 days and the spent medium were collected and determined by quantitative expression of DEFA5, CCLCs and other biologic signatures. The experiments were repeated twice. Three statistical methods were used: (i) Univariate analysis; (ii) LASSO; and (iii) Elastic net. DEFA5 bioassay discriminated CC and ulcerative colitis (UC) in a cohort of IC patients with accuracy. A fit logistic model with group CC and UC as the outcome and the DEFA5 as independent variable differentiator with a positive predictive value of 96 percent. IHC staining of CC for MUC6 and DEFA5 stained in different locations indicating that DEFA5 is not co-expressed in UACL and is therefore NOT the genesis of CC, rather a secretagogue for specific signature(s) that underlie the distinct crypt pathobiology of CC. Notably, we observed expansion of signatures after DEFA5 treatment on NCM460 and colonoids cells expressed at different times, intervals, and intensity. These factors are key stem cell niche regulators leading to DEFA5 secreting CCLCs differentiation 'the colonic ectopy ileal metaplasia formation' conspicuously of pathogenic importance in CC.	[Rana, Tanu; Korolkova, Olga Y.; Goodwin, Jeffrey S.; Shanker, Anil; M'Koma, Amosy E.] Meharry Med Coll, Sch Med, Dept Biochem Canc Biol Neurosci & Pharmacol, Nashville, TN 37208 USA; [Rachakonda, Girish] Meharry Med Coll, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Williams, Amanda D.] Lipscomb Univ, Dept Biol, Nashville, TN USA; [Hawkins, Alexander T.; M'Koma, Amosy E.] Vanderbilt Univ, Sch Med, Div Gen Surg, Sect Colon & Rectal Surg, Nashville, TN 37212 USA; [James, Samuel D.; Izban, Michael G.; Ballard, Billy R.; Forbes, Digna S.; M'Koma, Amosy E.] Meharry Med Coll, Sch Med, Dept Pathol Anat & Cell Biol, Nashville Gen Hosp, Nashville, TN 37208 USA; [James, Samuel D.] Vanderbilt Univ, Sch Med, Tennessee Valley Hlth Syst VA Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Sakwe, Amos M.] Meharry Med Coll, Sch Grad Studies & Res, Dept Biochem Canc Biol Neurosci & Pharmacol, Nashville, TN 37208 USA; [Hui, Nian; Wang, Li; Yu, Chang] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Offodile, Regina S.] Meharry Med Coll, Sch Med, Dept Profess & Med Educ, Nashville, TN 37208 USA; [Washington, Mary K.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Smoot, Duane T.] Meharry Med Coll, Sch Med, Dept Med, Nashville Gen Hosp, Nashville, TN 37208 USA; [Shi, Xuan-Zheng] Univ Texas Med Branch UTMB Galveston, Dept Med, Galveston, TX USA	Meharry Medical College; Meharry Medical College; Vanderbilt University; Meharry Medical College; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Meharry Medical College; Vanderbilt University; Meharry Medical College; Vanderbilt University; Meharry Medical College; University of Texas System; University of Texas Medical Branch Galveston	M'Koma, AE (corresponding author), Meharry Med Coll, Sch Med, Dept Biochem Canc Biol Neurosci & Pharmacol, Nashville, TN 37208 USA.; M'Koma, AE (corresponding author), Vanderbilt Univ, Sch Med, Div Gen Surg, Sect Colon & Rectal Surg, Nashville, TN 37212 USA.; M'Koma, AE (corresponding author), Meharry Med Coll, Sch Med, Dept Pathol Anat & Cell Biol, Nashville Gen Hosp, Nashville, TN 37208 USA.	amkoma@mmc.edu			NIDDK/NIH/USA [R21DK095186]; Research Foundation, American Society of Colon and Rectal Surgeons [LPG086]; NCI/NIH/USA [3U54CA091408-09S1, 5U54RR026140-03, U54RR026140, U54CA09148-08]; NIH HHS/USA [UL1 RR024975-01, 5P30 DK58404-08/RR/NCRR]; EHDR/NIH/USA [P50CA095103, S21MD000104]; RCMI Program in Health Disparities Research/NIH/USA [5U54MD007586]; National Cancer Institute/National Institute of Health [U54 CA163069, U54 MD007593]; National Institute of Health, CA/NCI NIH HHS/United States [SC1 CA182843];  [R01 CA175370]	NIDDK/NIH/USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Research Foundation, American Society of Colon and Rectal Surgeons; NCI/NIH/USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH HHS/USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EHDR/NIH/USA; RCMI Program in Health Disparities Research/NIH/USA; National Cancer Institute/National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Health, CA/NCI NIH HHS/United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	AEM, R21DK095186, NIDDK/NIH/USA, https://grantome.com/grant/NIH/R21-DK09518602 AEM, LPG086, Research Foundation, American Society of Colon and Rectal Surgeons, https://fascrs.org/my-ascrs/research-foundation/grantsawards; SEA, 3U54CA091408-09S1, 5U54RR026140-03, U54RR026140, U54CA09148-08, 5U54MD007586, NCI/NIH/USA, https://projectreporter.nih.gov/reporter_ searchresults.cfm MKW, UL1 RR024975-01, 5P30 DK58404-08/RR/NCRR NIH HHS/USA, https://grantome.com/grant/NIH/UL1-RR024975-01 RJC, P50CA095103, S21MD000104, EHDR/NIH/USA, https://projectreporter.nih.gov/reporter_ searchresults.cfm; JEKH, 5U54MD007586, RCMI Program in Health Disparities Research/NIH/USA, https://projectreporter.nih.gov/project_info_ description.cfm?aid=9449956&icde= 36184150&ddparam=&ddvalue=&ddsub=&cr= 4&csb=default&cs=ASC&pball= AS, U54 CA163069, U54 MD007593, National Cancer Institute/National Institute of Health,/National Institute of Health SC1 CA182843, CA/NCI NIH HHS/United States https://pubmed.ncbi.nlm.nih.gov/?term=SC1+CA182843%2FCA%2FNCI+NIH +HHS%2FUnited+States%5BGrant+Number%5D and R01 CA175370, https://pubmed.ncbi.nlm.nih.gov/?term=R01+CA175370%2FCA%2FNCI+NIH +HHS%2FUnited+States%5BGrant+Number%5D The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the National Institute for Health Research (NIHR) for assisting in recruitment. The authors wish to thank Drs. Samuel E. Adunyah, Jun W. Um, and Deok-Soo Son, and James R. Goldenring for scientific and administrative support. The authors thank Institutional Research Grants from the School of Medicine (SOM) and Graduate Studies and Research (SOGRS) at Meharry Medical College, the Vanderbilt University School of Medicine (SOM), and the Vanderbilt Institute for Clinical and Translational Research (VICTR). Finally, the authors thank the Meharry Office for Scientific Editing and Publications for editing support during the manuscript submission process.	Abramson O, 2010, J PEDIATR-US, V157, P233, DOI 10.1016/j.jpeds.2010.02.024; Adamiak T, 2013, INFLAMM BOWEL DIS, V19, P1218, DOI 10.1097/MIB.0b013e318280b13e; Ananthakrishnan AN, 2016, INFLAMM BOWEL DIS, V22, P880, DOI 10.1097/MIB.0000000000000754; Ananthakrishnan AN, 2015, CLIN GASTROENTEROL H, V13, P1197, DOI 10.1016/j.cgh.2014.11.020; Andersson E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186142; Antoni L, 2014, WORLD J GASTROENTERO, V20, P1165, DOI 10.3748/wjg.v20.i5.1165; Bagheri Lankarani KGS., 2020, GOVARESH, V24, P230; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Beaurepaire C, 2009, J INTERF CYTOK RES, V29, P133, DOI 10.1089/jir.2008.0057; Benchimol EI, 2017, AM J GASTROENTEROL, V112, P1120, DOI 10.1038/ajg.2017.97; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Coburn LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082300; Dahlhamer JM, 2016, MMWR-MORBID MORTAL W, V65, P1166, DOI 10.15585/mmwr.mm6542a3; Fabregat A, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1559-2; Funderburg NT, 2013, IMMUNOLOGY, V140, P87, DOI 10.1111/imm.12114; Gmyr V, 2015, CELL TRANSPLANT, V24, P1, DOI 10.3727/096368913X667493; Goldenring JR, 2018, J PATHOL, V245, P132, DOI 10.1002/path.5066; Granlund AV, 2011, SCAND J GASTROENTERO, V46, P1316, DOI 10.3109/00365521.2011.605463; Holly MK, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050225; Holly MK, 2017, ANNU REV VIROL, V4, P369, DOI 10.1146/annurev-virology-101416-041734; James SD, 2014, WORLD J GASTROENTERO, V20, P13139, DOI 10.3748/wjg.v20.i36.13139; James SDHA, 2020, JAPENESE J GASTROENT, V3, P1; Jarde T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13207; Kappelman MD, 2013, DIGEST DIS SCI, V58, P519, DOI 10.1007/s10620-012-2371-5; Kappelman MD, 2008, GASTROENTEROLOGY, V135, P1907, DOI 10.1053/j.gastro.2008.09.012; Korolkova OY, 2015, CLIN MED INSIGHTS-GA, V8, P29, DOI 10.4137/CGast.S20612; Leung G, 2018, PHYSIOLOGY, V33, P360, DOI 10.1152/physiol.00020.2018; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Rodriguez-Peralvarez ML, 2012, INFLAMM BOWEL DIS, V18, P1864, DOI 10.1002/ibd.22865; M'Koma AE, 2019, GASTROINTEST DISORD, V1, P75, DOI 10.3390/gidisord1010007; M'Koma AE, 2013, CLIN MED INSIGHTS-GA, V6, P33, DOI 10.4137/CGast.S12731; M'Koma AE, 2011, INFLAMM BOWEL DIS, V17, P875, DOI 10.1002/ibd.21442; Mankertz J, 2007, CURR OPIN GASTROEN, V23, P379, DOI 10.1097/MOG.0b013e32816aa392; Marini M, 2003, P NATL ACAD SCI USA, V100, P8366, DOI 10.1073/pnas.1432897100; Martinez-Fierro ML, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017208; Martini E, 2017, CELL MOL GASTROENTER, V4, P33, DOI 10.1016/j.jcmgh.2017.03.007; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Myers JN, 2014, INFLAMM BOWEL DIS, V20, P1530, DOI 10.1097/MIB.0000000000000144; Nava P, 2010, IMMUNITY, V32, P392, DOI 10.1016/j.immuni.2010.03.001; Nielsen OH, 2015, EXPERT REV GASTROENT, V9, P177, DOI 10.1586/17474124.2014.945914; Nielsen OH, 2014, ANN INTERN MED, V160, P733, DOI 10.7326/M14-0605; Nielsen OH, 2013, NEW ENGL J MED, V369, P754, DOI 10.1056/NEJMct1209614; Park KT, 2020, INFLAMM BOWEL DIS, V26, P1, DOI 10.1093/ibd/izz104; Parkes GC, 2012, NEUROGASTROENT MOTIL, V24, P31, DOI 10.1111/j.1365-2982.2011.01803.x; Pedersen J, 2014, WORLD J GASTROENTERO, V20, P64, DOI 10.3748/wjg.v20.i1.64; Petryszyn PW, 2016, GASTROENTEROL REV, V11, P6, DOI 10.5114/pg.2016.57883; Sankaran-Walters S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00647; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Scharl M, 2009, J BIOL CHEM, V284, P27952, DOI 10.1074/jbc.M109.046292; Seeley EH, 2013, PROTEOM CLIN APPL, V7, P541, DOI 10.1002/prca.201200107; Spekhorst LM, 2014, WORLD J GASTROENTERO, V20, P15374, DOI 10.3748/wjg.v20.i41.15374; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Su LP, 2013, GASTROENTEROLOGY, V145, P407, DOI 10.1053/j.gastro.2013.04.011; Suenaert P, 2002, AM J GASTROENTEROL, V97, P2000; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Targan SR, 2007, CURR OPIN GASTROEN, V23, P390, DOI 10.1097/MOG.0b013e3281722271; Thorsvik S, 2019, J PATHOL, V248, P316, DOI 10.1002/path.5258; Toedter G, 2012, INFLAMM BOWEL DIS, V18, P1399, DOI 10.1002/ibd.22853; Townsend P, 2015, INFLAMM BOWEL DIS, V21, P1935, DOI 10.1097/MIB.0000000000000445; Williams AD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179710; Xu F, 2019, APPL HEALTH ECON HEA, V17, P77, DOI 10.1007/s40258-018-0432-4	62	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2021	16	3							e0246393	10.1371/journal.pone.0246393	http://dx.doi.org/10.1371/journal.pone.0246393			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DJ	33690604	Green Published, gold			2022-12-26	WOS:000627855600013
J	Ezrova, Z; Nahacka, Z; Stursa, J; Werner, L; Vlcak, E; Viziova, PK; Berridge, MV; Sedlacek, R; Zobalova, R; Rohlena, J; Boukalova, S; Neuzil, J				Ezrova, Zuzana; Nahacka, Zuzana; Stursa, Jan; Werner, Lukas; Vlcak, Erik; Kralova Viziova, Petra; Berridge, Michael V.; Sedlacek, Radislav; Zobalova, Renata; Rohlena, Jakub; Boukalova, Stepana; Neuzil, Jiri			SMAD4 loss limits the vulnerability of pancreatic cancer cells to complex I inhibition via promotion of mitophagy	ONCOGENE			English	Article								Pancreatic cancer is one of the deadliest forms of cancer, which is attributed to lack of effective treatment options and drug resistance. Mitochondrial inhibitors have emerged as a promising class of anticancer drugs, and several inhibitors of the electron transport chain (ETC) are being clinically evaluated. We hypothesized that resistance to ETC inhibitors from the biguanide class could be induced by inactivation of SMAD4, an important tumor suppressor involved in transforming growth factor beta (TGF beta) signaling, and associated with altered mitochondrial activity. Here we show that, paradoxically, both TGF beta-treatment and the loss of SMAD4, a downstream member of TGF beta signaling cascade, induce resistance to biguanides, decrease mitochondrial respiration, and fragment the mitochondrial network. Mechanistically, the resistance of SMAD4-deficient cells is mediated by increased mitophagic flux driven by MAPK/ERK signaling, whereas TGF beta-induced resistance is autophagy-independent and linked to epithelial-to-mesenchymal transition (EMT). Interestingly, mitochondria-targeted tamoxifen, a complex I inhibitor under clinical trial, overcomes resistance mediated by SMAD4-deficiency or TGF beta signaling. Our data point to differential mechanisms underlying the resistance to treatment in PDAC arising from TGF beta signaling and SMAD4 loss, respectively. The findings will help the development of mitochondria-targeted therapy for pancreatic cancer patients with SMAD4 as a plausible predictive marker.	[Ezrova, Zuzana; Nahacka, Zuzana; Stursa, Jan; Werner, Lukas; Zobalova, Renata; Rohlena, Jakub; Boukalova, Stepana; Neuzil, Jiri] Czech Acad Sci, Inst Biotechnol, Prague, Czech Republic; [Ezrova, Zuzana] Charles Univ Prague, Fac Sci, Prague, Czech Republic; [Vlcak, Erik] Czech Acad Sci, Inst Mol Genet, Prague, Czech Republic; [Kralova Viziova, Petra; Sedlacek, Radislav] Czech Acad Sci, Inst Mol Genet, Czech Ctr Phenogen, Prague, Czech Republic; [Berridge, Michael V.] Malaghan Inst Med Res, Wellington, New Zealand; [Neuzil, Jiri] Griffith Univ, Sch Med Sci, Southport, Qld, Australia	Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Charles University Prague; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Malaghan Institute; Victoria University Wellington; Griffith University	Boukalova, S; Neuzil, J (corresponding author), Czech Acad Sci, Inst Biotechnol, Prague, Czech Republic.; Neuzil, J (corresponding author), Griffith Univ, Sch Med Sci, Southport, Qld, Australia.	stepana.boukalova@ibt.cas.cz; j.neuzil@griffith.edu.au	WERNER, LUKÁŠ/AAL-7888-2021; Stursa, Jan/J-4255-2014; Rohlena, Jakub/H-6699-2014; Králová Viziová, Petra/AGJ-5763-2022; Boukalova, Stepana/H-2610-2014; Ezrova, Zuzana/W-3595-2017	Rohlena, Jakub/0000-0001-5427-6502; Boukalova, Stepana/0000-0002-6478-4604; Vlcak, Erik/0000-0003-4911-2380; Zobalova, Renata/0000-0002-9097-4700; Ezrova, Zuzana/0000-0002-4174-6066; Nahacka, Zuzana/0000-0003-0477-2764	Czech Health Research Council [NV16-31604A]; Czech Science Foundation [19-20553S, 20-18513S, 20-11724Y, 18-02550S]; Grant Agency of Charles University [GAUK1100217]; project International mobility grant of researchers of the Institute of Biotechnology CAS, v. v. i. from the ESF [CZ.02.2.69/0.0/0.0/16_027/0008353]; BIOCEV from the ERDF [CZ.1.05/1.1.00/02.0109]; Ministry of Education, Youth and Sports of the Czech Republic at the CZ-OPENSCREEN: National infrastructure for chemical biology [LO1220]; Czech-BioImaging large RI projects - (MEYS CR) [LM2015062, CZ.02.1.01/0.0/0.0/16_013/0001775]; program "Projects of Large Research, Development, and Innovations Infrastructures" [CESNET LM2015042]; Czech Academy of Sciences [RVO 68378050]; project of support program for large infrastructures for research, experimental development and innovation Czech Centre for Phenogenomics by MEYS CR [LM2018126]; MEYS; ESIF [CZ.02.1.01/0.0/0.0/16_013/0001789, CZ.02.1.01/0.0/0.0/18_046/0015861, CZ.1.05/2.1.00/19.0395];  [RVO: 86652036]	Czech Health Research Council; Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of Charles University; project International mobility grant of researchers of the Institute of Biotechnology CAS, v. v. i. from the ESF; BIOCEV from the ERDF; Ministry of Education, Youth and Sports of the Czech Republic at the CZ-OPENSCREEN: National infrastructure for chemical biology; Czech-BioImaging large RI projects - (MEYS CR); program "Projects of Large Research, Development, and Innovations Infrastructures"; Czech Academy of Sciences(Czech Academy of Sciences); project of support program for large infrastructures for research, experimental development and innovation Czech Centre for Phenogenomics by MEYS CR; MEYS; ESIF; 	This work was supported by Czech Health Research Council grants (NV16-31604A) to JN, Czech Science Foundation grants (19-20553S, 20-18513S, 20-11724Y and 18-02550S), and Grant Agency of Charles University (GAUK1100217) to ZE. SB was supported by a project International mobility grant of researchers of the Institute of Biotechnology CAS, v. v. i. (CZ.02.2.69/0.0/0.0/16_027/0008353) from the ESF. Further support was provided by BIOCEV CZ.1.05/1.1.00/02.0109 from the ERDF, RVO: 86652036 and the Ministry of Education, Youth and Sports of the Czech Republic (LO1220) at the CZ-OPENSCREEN: National infrastructure for chemical biology. We acknowledge the Imaging Methods Core Facility at BIOCEV and Microscopy Centre -Electron Microscopy Core Facility, IMG AS CR, institutions supported by the Czech-BioImaging large RI projects (LM2015062 and CZ.02.1.01/0.0/0.0/16_013/0001775, funded by MEYS CR) for their support with obtaining scientific data presented in this paper. Access to computing and storage facilities owned by parties and projects contributing to the National Grid Infrastructure MetaCentrum provided under the program "Projects of Large Research, Development, and Innovations Infrastructures" (CESNET LM2015042), is greatly appreciated. Research data were collected in cooperation with the employees of the Czech Centre for Phenogenomics supported by the Czech Academy of Sciences RVO 68378050 and by the project of support program for large infrastructures for research, experimental development and innovation LM2018126 Czech Centre for Phenogenomics provided by MEYS CR. Further support was provided by MEYS and ESIF (CZ.02.1.01/0.0/0.0/16_013/0001789, CZ.02.1.01/0.0/0.0/18_046/0015861, and CZ.1.05/2.1.00/19.0395).	Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Bajzikova M, 2019, CELL METAB, V29, P399, DOI 10.1016/j.cmet.2018.10.014; Basso D, 2017, ONCOTARGET, V8, P84928, DOI 10.18632/oncotarget.20863; Blackford A, 2009, CLIN CANCER RES, V15, P4674, DOI 10.1158/1078-0432.CCR-09-0227; Boukalova S, 2016, MOL CANCER THER, V15, P2875, DOI 10.1158/1535-7163.MCT-15-1021; Bridges HR, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0287-9; Chae YK, 2016, ONCOTARGET, V7, P40767, DOI 10.18632/oncotarget.8194; Chen YW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-181; Chen YH, 2020, J CELL PHYSIOL, V235, P1903, DOI 10.1002/jcp.29108; Cheng G, 2016, CANCER RES, V76, P3904, DOI 10.1158/0008-5472.CAN-15-2534; Colak S, 2017, TRENDS CANCER, V3, P56, DOI 10.1016/j.trecan.2016.11.008; Costanza B, 2019, INT J CANCER, V145, P1570, DOI 10.1002/ijc.32247; Cottet-Rousselle C, 2011, CYTOM PART A, V79A, P405, DOI 10.1002/cyto.a.21061; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458; David CJ, 2016, CELL, V164, P1015, DOI 10.1016/j.cell.2016.01.009; Fullerton PT, 2015, MOL ENDOCRINOL, V29, P1440, DOI 10.1210/me.2015-1102; Georgakopoulos ND, 2017, NAT CHEM BIOL, V13, P136, DOI [10.1038/NCHEMBIO.2287, 10.1038/nchembio.2287]; Hernandez G, 2013, AUTOPHAGY, V9, P1852, DOI 10.4161/auto.26501; Hubackova S, 2019, CELL DEATH DIFFER, V26, P276, DOI 10.1038/s41418-018-0118-3; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Katsuno Y, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau8544; Laker RC, 2014, J BIOL CHEM, V289, P12005, DOI 10.1074/jbc.M113.530527; Leone A, 2014, CANCER TREAT RES, V159, P355, DOI 10.1007/978-3-642-38007-5_21; Liang C, 2020, GUT, V69, P888, DOI 10.1136/gutjnl-2018-317163; Liang C, 2020, AUTOPHAGY, V16, P486, DOI 10.1080/15548627.2019.1628540; Mao L, 2017, ONCOL LETT, V14, P647, DOI 10.3892/ol.2017.6209; Molina JR, 2018, NAT MED, V24, P1036, DOI 10.1038/s41591-018-0052-4; Naguib A, 2018, CELL REP, V23, P58, DOI 10.1016/j.celrep.2018.03.032; Ozawa H, 2017, CLIN CANCER RES, V23, P5162, DOI 10.1158/1078-0432.CCR-16-1686; Papageorgis P, 2011, CANCER RES, V71, P998, DOI 10.1158/0008-5472.CAN-09-3269; Pecinova A, 2019, BIOFACTORS, V45, P703, DOI 10.1002/biof.1548; Rawla P, 2019, WORLD J ONCOL, V10, P10, DOI 10.14740/wjon1166; Rodriguez-Garcia A, 2017, FEBS J, V284, P3437, DOI 10.1111/febs.14201; Rohlenova K, 2017, ANTIOXID REDOX SIGN, V26, P84, DOI 10.1089/ars.2016.6677; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi S, 2015, CANCER LETT, V360, P227, DOI 10.1016/j.canlet.2015.02.014; Shibue T, 2017, NAT REV CLIN ONCOL, V14, P611, DOI 10.1038/nrclinonc.2017.44; Sica V, 2020, INT J CANCER, V146, P10, DOI 10.1002/ijc.32616; Springer W, 2011, AUTOPHAGY, V7, P266, DOI 10.4161/auto.7.3.14348; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003; Tauber J, 2013, INT J BIOCHEM CELL B, V45, P593, DOI 10.1016/j.biocel.2012.11.019; Um JH, 2018, JOVE-J VIS EXP, DOI 10.3791/58099; Urra FA, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00118; Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001; Wang F, 2018, CLIN CANCER RES, V24, P3176, DOI 10.1158/1078-0432.CCR-17-3435; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Wasserman I, 2019, CLIN CANCER RES, V25, P1948, DOI 10.1158/1078-0432.CCR-18-1726; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xia X, 2015, TUMOR BIOL, V36, P111, DOI 10.1007/s13277-014-2883-z; Yalcin A, 2017, BIOCHEM BIOPH RES CO, V484, P687, DOI 10.1016/j.bbrc.2017.01.178; Zhang C, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0628-8; Zhang YE, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022129; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	54	5	5	2	17	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2021	40	14					2539	2552		10.1038/s41388-021-01726-4	http://dx.doi.org/10.1038/s41388-021-01726-4		MAR 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RK3YE	33686239				2022-12-26	WOS:000626396000002
J	Li, Y; Liu, M; Yang, ST; Fuller, AM; Eisinger-Mathason, TSK; Yang, SY				Li, Yang; Liu, Min; Yang, Shuting; Fuller, Ashley M.; Karin Eisinger-Mathason, T. S.; Yang, Shuying			RGS12 is a novel tumor suppressor in osteosarcoma that inhibits YAP-TEAD1-Ezrin signaling	ONCOGENE			English	Article								Osteosarcoma (OS) is the most common primary malignancy of the bone that predominantly affects children and adolescents. Hippo pathway is a crucial regulator of organ size and tumorigenesis. However, how Hippo pathway regulates the occurrence of osteosarcoma is largely unknown. Here, we reported the regulator of G protein signaling protein 12 (RGS12) is a novel Hippo pathway regulator and tumor suppressor of osteosarcoma. Depletion of Rgs12 promotes osteosarcoma progression and lung metastasis in an orthotopic xenograft mouse model. Our data showed that the knockdown of RGS12 upregulates Ezrin expression through promoting the GNA12/13-RhoA-YAP pathway. Moreover, RGS12 negatively regulates the transcriptional activity of YAP/TEAD1 complex through its PDZ domain function to inhibit the expression and function of the osteosarcoma marker Ezrin. PDZ domain peptides of RGS12 can inhibit the development of intratibial tumor and lung metastases. Collectively, this study identifies that the RGS12 is a novel tumor suppressor in osteosarcoma through inhibiting YAP-TEAD1-Ezrin signaling pathway and provides a proof of principle that targeting RGS12 may be a therapeutic strategy for osteosarcoma.	[Li, Yang; Liu, Min; Yang, Shuting; Yang, Shuying] Univ Penn, Sch Dent Med, Dept Basic & Translat Sci, Philadelphia, PA 19104 USA; [Fuller, Ashley M.; Karin Eisinger-Mathason, T. S.] Univ Penn, Abramson Family Canc Res Inst, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Yang, Shuying] Univ Penn, Sch Dent Med, Sch Engn & Appl Sci, Ctr Innovat & Precis Dent, Philadelphia, PA 19104 USA; [Yang, Shuying] Univ Penn, Sch Med, Penn Ctr Musculoskeletal Disorders, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Yang, SY (corresponding author), Univ Penn, Sch Dent Med, Dept Basic & Translat Sci, Philadelphia, PA 19104 USA.; Yang, SY (corresponding author), Univ Penn, Sch Dent Med, Sch Engn & Appl Sci, Ctr Innovat & Precis Dent, Philadelphia, PA 19104 USA.; Yang, SY (corresponding author), Univ Penn, Sch Med, Penn Ctr Musculoskeletal Disorders, Philadelphia, PA 19104 USA.	shuyingy@upenn.edu		Li, Yang/0000-0002-7375-3025; Yang, Shuying/0000-0002-7126-6901	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR061052]; National Institute on Aging (NIA) [AG048388]	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS, AR061052), the National Institute on Aging (NIA, AG048388) awarded to SY.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Bouvier C, 2016, ONCOTARGET, V7, P64702, DOI 10.18632/oncotarget.11876; Bradley SJ, 2016, P NATL ACAD SCI USA, V113, P4524, DOI 10.1073/pnas.1521706113; Brusgard JL, 2015, ONCOTARGET, V6, P28132, DOI 10.18632/oncotarget.4654; Buckbinder L, 1997, P NATL ACAD SCI USA, V94, P7868, DOI 10.1073/pnas.94.15.7868; Chai JW, 2017, BIOCHEM BIOPH RES CO, V488, P297, DOI 10.1016/j.bbrc.2017.05.032; Chatterjee TK, 2002, MOL CELL BIOL, V22, P4334, DOI 10.1128/MCB.22.12.4334-4345.2002; Cho H., 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P107, DOI 10.2174/1568008043339938; Fromigue O, 2011, J BONE MINER RES, V26, P1533, DOI 10.1002/jbmr.343; Fukuda H, 2016, BIOCHEM BIOPH RES CO, V471, P63, DOI 10.1016/j.bbrc.2016.01.179; Gross JD, 2018, J PSYCHOPHARMACOL, V32, P191, DOI 10.1177/0269881117742100; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Holden JK, 2018, CANCERS, V10, DOI 10.3390/cancers10030081; Hurst JH, 2009, BIOCHEM PHARMACOL, V78, P1289, DOI 10.1016/j.bcp.2009.06.028; Igarashi K, 2020, CANCER LETT, V469, P332, DOI 10.1016/j.canlet.2019.10.028; Ji Q, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-266; Jules J, 2015, PROG MOL BIOL TRANSL, V133, P47, DOI 10.1016/bs.pmbts.2015.02.002; Kansara M, 2014, NAT REV CANCER, V14, P722, DOI 10.1038/nrc3838; Keinan D, 2014, FRONT BIOSCI-LANDMRK, V19, P634, DOI 10.2741/4232; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Li Y, 2017, FEBS J, V284, P948, DOI 10.1111/febs.14026; Li ZQ, 2019, J BONE MINER RES, V34, P752, DOI 10.1002/jbmr.3645; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Mao JH, 1998, P NATL ACAD SCI USA, V95, P12973, DOI 10.1073/pnas.95.22.12973; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Meyers PA, 2005, J CLIN ONCOL, V23, P2004, DOI 10.1200/JCO.2005.06.031; Mittal V, 2018, ANNU REV PATHOL-MECH, V13, P395, DOI 10.1146/annurev-pathol-020117-043854; Mohri Z, 2017, J THORAC DIS, V9, pE507, DOI 10.21037/jtd.2017.03.179; Ng AYH, 2019, ELIFE, V8, DOI 10.7554/eLife.42951; Ren L, 2014, ADV EXP MED BIOL, V804, P181, DOI 10.1007/978-3-319-04843-7_10; Rozengurt E, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-017-0005-2; Sabile AA, 2012, J BONE MINER RES, V27, P58, DOI 10.1002/jbmr.535; Stewart A, 2015, PROG MOL BIOL TRANSL, V133, P1, DOI 10.1016/bs.pmbts.2015.03.002; Tang QL, 2018, ONCOGENE, V37, P3617, DOI 10.1038/s41388-018-0231-2; Vogt S, 2003, J BIOL CHEM, V278, P28743, DOI 10.1074/jbc.M304570200; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Wang DY, 2016, CHIN J CANCER, V35, P1, DOI 10.1186/s40880-016-0109-z; Wang GY, 2005, J BONE MINER RES, V20, P1022, DOI 10.1359/JBMR.050113; Wang YQ, 2017, CANCER RES, V77, P4247, DOI 10.1158/0008-5472.CAN-17-0669; Xu MZ, 2011, ONCOGENE, V30, P1229, DOI 10.1038/onc.2010.504; Yang SY, 2013, GENESIS, V51, P201, DOI 10.1002/dvg.22373; Yang SY, 2007, J BONE MINER RES, V22, P45, DOI 10.1359/JBMR.061007; Yang Z, 2014, ONCOL REP, V32, P1265, DOI 10.3892/or.2014.3305; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yuan X, 2015, CELL DEATH DIFFER, V22, P2046, DOI 10.1038/cdd.2015.45; Yuan X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11024; Zhang L, 2009, FLY, V3, P68, DOI 10.4161/fly.3.1.7788; Zhang WQ, 2017, J CELL MOL MED, V21, P2663, DOI 10.1111/jcmm.13182; Zhang WJ, 2014, CELL RES, V24, P331, DOI 10.1038/cr.2014.10; Zhang YC, 2014, CELL SIGNAL, V26, P2504, DOI 10.1016/j.cellsig.2014.07.031; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	56	9	10	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2021	40	14					2553	2566		10.1038/s41388-020-01599-z	http://dx.doi.org/10.1038/s41388-020-01599-z		MAR 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RK3YE	33686240	Green Accepted			2022-12-26	WOS:000626396000003
J	Alam, GMM; Khatun, MN				Alam, G. M. Monirul; Khatun, Most Nilufa			Impact of COVID-19 on vegetable supply chain and food security: Empirical evidence from Bangladesh	PLOS ONE			English	Article								In Bangladesh, the COVID-19 pandemic is likely to have substantial effects on the livelihood of people, but smallholder vegetables growers will be even more affected because of the perishability nature of the product. The first case of COVID-19 was confirmed in Bangladesh on 8th March, 2020 and consequently the country went into lockdown on 26 March, 2020. This study has made a survey of vegetables farmers through a mobile phone to understand the impact of COVID-19 on vegetables supply chain, gross margin and the future production plan of the growers. In Bangladesh, the lockdown has disrupted the food supply chain and increases the likelihood of food insecurity. Lockdown has impeded vegetable farmers' access to markets, thus limiting their productive and sales capacities. The price of yield has dropped by more than half resulting in huge loss for vegetable growers. The loss incurred by the farmers for producing Brinjal, Cucumber, Pointed gourd, Yardlong beans and Bottle gourd are BDT 4900, BDT 10900, BDT 57400, BDT 52500 and BDT 18500 per acre respectively as a result of COVID-19. The decreased income increases farmers' likelihood of vulnerability and food insecurity and poses a challenge to continued produce. 'Cash support' is more important than 'food support' in order to keep vegetable farmers in farming, to ensure a ready supply of necessary low-cost resources, and to help fight against the upcoming food shortage.	[Alam, G. M. Monirul; Khatun, Most Nilufa] Bangabandhu Sheikh Mujibur Rahman Agr Univ, Gazipur, Bangladesh; [Alam, G. M. Monirul] Univ Southern Queensland, Toowoomba, Qld, Australia	Bangabandhu Sheikh Mujibur Rahman Agricultural University (BSMRAU); University of Southern Queensland	Alam, GMM (corresponding author), Bangabandhu Sheikh Mujibur Rahman Agr Univ, Gazipur, Bangladesh.; Alam, GMM (corresponding author), Univ Southern Queensland, Toowoomba, Qld, Australia.	gmmonirul79@gmail.com		Khatun, Most. Nilufa/0000-0002-4036-0073	Ministry of Science and Technology, Bangladesh	Ministry of Science and Technology, Bangladesh	Ministry of Science and Technology, Bangladesh for funding the project for data collection.	Aday S, 2020, FOOD QUAL SAF-OXFORD, V4, P167, DOI 10.1093/fqsafe/fyaa024; Alam G. M. M., 2018, South Asia Economic Journal, V19, P43, DOI 10.1177/1391561418761075; Alam GMM, 2016, ASS LIV VULN RIV ER; Alam MS., 2016, J SYLHET AGR U, V3, P253; [Anonymous], 2002, Bull World Health Organ, V80, P983; BARI, 2018, ANN REP 2017 18; BBS, 2018, BANGL STAT 2018; Carroll N, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082352; DAE, 2018, AGR EXT MAN AGR EXT; FAO, 2017, STAT YB 2017; Ferdous Z, 2017, J CROP IMPROV, V31, P261, DOI 10.1080/15427528.2017.1293578; Genova-II C., 2005, VEGETABLE PRODUCTION; Hohler J, 2021, AGRIBUSINESS, V37, P171, DOI 10.1002/agr.21678; Hortex Foundation, 2018, PROD INCR MARK EXP V, DOI [10.4060/cb1000en%0Awww.fao.org/cfs/cfs-hlpe, DOI 10.4060/CB1000EN%0AWWW.FAO.ORG/CFS/CFS-HLPE]; Hossain ST, 2020, J AGR SCI-SRI LANKA, V15, P116, DOI 10.4038/jas.v15i2.8794; IEDCR, 2020, COVID 19 STAT BANGL; Il Islam MD, 2021, POL J ENVIRON STUD, V30, P177, DOI 10.15244/pjoes/120365; Islam AMT, 2021, ENVIRON DEV SUSTAIN, V23, P9139, DOI 10.1007/s10668-020-01016-1; Mal MAS., 2004, BANGLADESH J POLIT E, V20, P139; Mottaleb KA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240709; Pu MZ, 2020, GLOB FOOD SECUR-AGR, V26, DOI 10.1016/j.gfs.2020.100409; Rahman MM, 2021, GEOJOURNAL, V86, P1957, DOI 10.1007/s10708-020-10170-y; Sajia Sharmin, 2018, Journal of the Bangladesh Agricultural University, V16, P492, DOI 10.3329/jbau.v16i3.39447; Sarker MNI, 2020, INT J ADV COMPUT SC, V11, P533; Singh S, 2021, INT J PROD RES, V59, P1993, DOI 10.1080/00207543.2020.1792000; Telukdarie A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12229331	26	19	19	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0248120	10.1371/journal.pone.0248120	http://dx.doi.org/10.1371/journal.pone.0248120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667256	gold, Green Accepted, Green Published			2022-12-26	WOS:000626604300031
J	Gebreselassie, AF; Bekele, A; Tatere, HY; Wong, R				Gebreselassie, Agazi Fitsum; Bekele, Abebe; Tatere, Heaven Yeshaneh; Wong, Rex			Assessing the knowledge, attitude and perception on workplace readiness regarding COVID-19 among health care providers in Ethiopia-An internet-based survey	PLOS ONE			English	Article							UNIVERSITY; WORKERS	Background Healthcare facilities in Ethiopia are responsible for collecting samples for testing and treating COVID-19 patients, providing COVID-19 information to staff, establishment of response teams, and provision of adequate personal protective equipment (PPE). Working at the frontlines against the pandemic, health care providers' level of knowledge about COVID-19, attitude towards their work, and confidence in the preparedness of their facilities are essential factors in mounting a successful response. Objectives This study investigated the knowledge level of HCP in Ethiopia on this novel coronavirus, and their perspectives on whether their workplaces have sufficient preparedness to handle this disease. Methods A self-administered online survey was conducted. Results The knowledge related to COVID-19 among HCPs was high, with an overall average of 91.5%. The majority of our respondents were supportive to the government's measures to minimize disease transmission, but most of them were also frustrated by how COVID affected their day to day lives. The majority of them were worried about contracting COVID at work and transmitting the infection to their families. Most respondents did not feel safe going to work (P<0.001). Apart from providing adequate information on COVID-19, most workplaces did not have sufficient PPE (P<000.1) and medical supplies (P<0.001). Close to 50% of respondents agreed and disagreed that their workplaces had clear protocols for handling COVID-19 (P = 0.144). Those who handled known COVID patients were more likely to agree their workplaces had clear protocols (OR = 2.69, P<0.001). Conclusion Improving supplies of PPEs and establishing a clear communicating protocol in handling COVID patients are highly recommended.	[Gebreselassie, Agazi Fitsum; Bekele, Abebe; Wong, Rex] Univ Global Hlth Equ, Kigali, Rwanda; [Bekele, Abebe; Tatere, Heaven Yeshaneh] Addis Ababa Univ, Addis Ababa, Ethiopia; [Wong, Rex] Yale Univ, New Haven, CT USA	Addis Ababa University; Yale University	Gebreselassie, AF (corresponding author), Univ Global Hlth Equ, Kigali, Rwanda.	agazifitsum@gmail.com		Gebreselassie, Agazi Fitsum/0000-0002-1622-2834				Africa CDC, 2020, COVID 19 SCI PUBL HL, P1; Alrubaiee GG, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09644-y; Andualem M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-534; [Anonymous], 2002, Bull World Health Organ, V80, P983; Baye, 2020, COVID 19 PREV MEAS E; Bloom BS, 1956, TAXONOMY ED OBJECTIV, V20, P24; Chustecka Z., 2020, MORE 60 DOCTORS ITAL; Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397; Ethiopian Public Health Institute, 2020, ETH HLTH CAR FAC COV; Fentie M., 2015, J PHARMASCITECH, V4, P54; Gagliardone I, 2016, STABILITY, V5, P1, DOI 10.5334/sta.344; Gurmu S., 2011, ETHIOPIAN J EC, V20, P29; Gurmu TG, 2017, CUKUROVA MED J, V42, P277, DOI 10.17826/cutf.322908; Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396; Judge G. G., 1988, THEORY PRACTICE ECON, VSecond; Kefale AT, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4087-0; Limenih Gojjam, 2020, COVID 19 ETH CHALL B; Marks S., THATS ONLY PART PROB; Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181; Oqubay A., OXFORD HDB IND POLIC; Shaban A. R. A., AFRICANEWS 0316; Szabo L., 2020, CORONAVIRUS IS KILLI; Tiruneh B. T., 2020, HOSP TOPICS, P1, DOI [10.1080/00185868, DOI 10.1080/00185868]; Waddington C., 2015, IMPROVING HLTH SYSTE, P1; Woreta SA, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-31; World Bank, 2020, GLOB EC OUTL COVID 1; Zhan MK, 2020, NEW ENGL J MED, V382, P2267, DOI 10.1056/NEJMc2005696; Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							1820578	10.1371/journal.pone.0247848	http://dx.doi.org/10.1371/journal.pone.0247848			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33661989	Green Published, gold			2022-12-26	WOS:000626604100040
J	Mojsoska, B; Ghoul, M; Perron, GG; Jenssen, H; Alatraktchi, FA				Mojsoska, Biljana; Ghoul, Melanie; Perron, Gabriel G.; Jenssen, Havard; Alatraktchi, Fatima AlZahra'a			Changes in toxin production of environmental Pseudomonas aeruginosa isolates exposed to sub-inhibitory concentrations of three common antibiotics	PLOS ONE			English	Article								Pseudomonas aeruginosa is an environmental pathogen that can cause severe infections in immunocompromised patients. P. aeruginosa infections are typically treated with multiple antibiotics including tobramycin, ciprofloxacin, and meropenem. However, antibiotics do not always entirely clear the bacteria from the infection site, where they may remain virulent. This is because the effective antibiotic concentration and diffusion in vitro may differ from the in vivo environment in patients. Therefore, it is important to understand the effect of non-lethal sub-inhibitory antibiotic concentrations on bacterial phenotype. Here, we investigate if sub-inhibitory antimicrobial concentrations cause alterations in bacterial virulence factor production using pyocyanin as a model toxin. We tested this using the aforementioned antibiotics on 10 environmental P. aeruginosa strains. Using on-the-spot electrochemical screening, we were able to directly quantify changes in production of pyocyanin in a measurement time of 17 seconds. Upon selecting 3 representative strains to further test the effects of sub-minimum inhibitory concentration (MICs), we found that pyocyanin production changed significantly when the bacteria were exposed to 10-fold MIC of the 3 antibiotics tested, and this was strain specific. A series of biologically relevant measured pyocyanin concentrations were also used to assess the effects of increased virulence on a culture of epithelial cells. We found a decreased viability of the epithelial cells when incubated with biologically relevant pyocyanin concentrations. This suggests that the antibiotic-induced virulence also is a value worth being enclosed in regular testing of pathogens.	[Mojsoska, Biljana; Jenssen, Havard; Alatraktchi, Fatima AlZahra'a] Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark; [Mojsoska, Biljana] PreDiagose, Karlslunde, Denmark; [Ghoul, Melanie] Univ Oxford, Dept Zool, Oxford, England; [Perron, Gabriel G.] Bard Coll, Dept Biol, Annandale On Hudson, NY 12504 USA	Roskilde University; University of Oxford	Alatraktchi, FA (corresponding author), Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark.	alzahraa@ruc.dk	Mojsoska, Biljana/AAL-4775-2020	Mojsoska, Biljana/0000-0001-5901-7753; Jenssen, Havard/0000-0003-0007-0335; Alatraktchi, Fatima AlZahra'a/0000-0003-3297-2560				Alatraktchi FA, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20185218; Alatraktchi FA, 2020, ANAL BIOCHEM, V593, DOI 10.1016/j.ab.2020.113586; Alatraktchi FA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194157; Alatraktchi FA, 2016, NANOMEDICINE-UK, V11, P2185, DOI 10.2217/nnm-2016-0155; Alatraktchi FA, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16030408; Bassetti Matteo, 2018, Drugs Context, V7, P212527, DOI 10.7573/dic.212527; Bellin DL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4256; Buzid A, 2016, SCI REP-UK, V6, DOI 10.1038/srep30001; Chevalier S, 2017, FEMS MICROBIOL REV, V41, P698, DOI 10.1093/femsre/fux020; FOLLATH F, 1986, EUR J CLIN MICROBIOL, V5, P236, DOI 10.1007/BF02013997; Hall S, 2016, TOXINS, V8, DOI 10.3390/toxins8080236; Hata E, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.00575-19; Hirsch EB, 2010, EXPERT REV PHARM OUT, V10, P441, DOI [10.1586/erp.10.49, 10.1586/ERP.10.49]; Kraemer SA, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7060180; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; MARLEY EF, 1995, J CLIN MICROBIOL, V33, P3191, DOI 10.1128/JCM.33.12.3191-3193.1995; Maugeri G, 2019, BIOTECHNOL J, V14, DOI 10.1002/biot.201700750; Mouritzen MV, 2018, J PEPT SCI, V24, DOI 10.1002/psc.3093; Orlandi VT, 2015, MICROBIOL-SGM, V161, P2298, DOI 10.1099/mic.0.000193; Pirnay JP, 2005, ENVIRON MICROBIOL, V7, P969, DOI 10.1111/j.1462-2920.2005.00776.x; Priyaja P, 2016, CYTOTECHNOLOGY, V68, P143, DOI 10.1007/s10616-014-9765-5; Saunders SH, 2020, CELL, V182, P919, DOI 10.1016/j.cell.2020.07.006; Sellick CA, 2010, METABOLOMICS, V6, P427, DOI 10.1007/s11306-010-0216-9; Shrestha SD, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.00804-17, 10.1128/genomea.00804-17]; Su HC, 2010, ANTIMICROB AGENTS CH, V54, P4626, DOI 10.1128/AAC.00762-10; Sun HY, 2011, CHEST, V139, P1172, DOI 10.1378/chest.10-0167; Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/s1473-3099(17)30753-3, 10.1016/S1473-3099(17)30753-3]; Ventola C Lee, 2015, P T, V40, P277; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; WILSON R, 1988, INFECT IMMUN, V56, P2515, DOI 10.1128/IAI.56.9.2515-2517.1988; Wilson VG, 2014, METHODS MOL BIOL, V1195, P33, DOI 10.1007/7651_2013_42; Zhanel G G, 1992, Can J Infect Dis, V3, P193; Zhu K, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000573	33	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0248014	10.1371/journal.pone.0248014	http://dx.doi.org/10.1371/journal.pone.0248014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33662048	Green Published, gold			2022-12-26	WOS:000626604100041
J	Cartaxo, ANS; Barbosa, FIC; Bermejo, PHD; Moreira, MF; Prata, DN				Santos Cartaxo, Adriana Nascimento; Cartaxo Barbosa, Francisco Iran; de Souza Bermejo, Paulo Henrique; Moreira, Marina Figueiredo; Prata, David Nadler			The exposure risk to COVID-19 in most affected countries: A vulnerability assessment model	PLOS ONE			English	Article								The world is facing the coronavirus pandemic (COVID-19), which began in China. By August 18, 2020, the United States, Brazil, and India were the most affected countries. Health infrastructure and socioeconomic vulnerabilities may be affecting the response capacities of these countries. We compared official indicators to identify which vulnerabilities better determined the exposure risk to COVID-19 in both the most and least affected countries. To achieve this purpose, we collected indicators from the Infectious Disease Vulnerability Index (IDVI), the World Health Organization (WHO), the World Bank, and the Brazilian Geography and Statistics Institute (IBGE). All indicators were normalized to facilitate comparisons. Speed, incidence, and population were used to identify the groups of countries with the highest and lowest risks of infection. Countries' response capacities were determined based on socioeconomic, political, and health infrastructure conditions. Vulnerabilities were identified based on the indicator sensitivity. The highest-risk group included the U.S., Brazil, and India, whereas the lowest-risk group (with the largest population by continent) consisted of China, New Zealand, and Germany. The high-sensitivity cluster had 18 indicators (50% extra IDVI), such as merchandise trade, immunization, public services, maternal mortality, life expectancy at birth, hospital beds, GINI index, adolescent fertility, governance, political stability, transparency/corruption, industry, and water supply. The greatest vulnerability of the highest-risk group was related first to economic factors (merchandise trade), followed by public health (immunization), highlighting global dependence on Chinese trade, such as protective materials, equipment, and diagnostic tests. However, domestic political factors had more indicators, beginning with high sensitivity and followed by healthcare and economic conditions, which signified a lesser capacity to guide, coordinate, and supply the population with protective measures, such as social distancing.	[Santos Cartaxo, Adriana Nascimento] Minist Hlth, Secretariat Sci Technol Innovat & Strateg Supplie, Gen Coordinat Hlth Ind Complex, Brasilia, DF, Brazil; [Cartaxo Barbosa, Francisco Iran] Brazil Hlth Surveillance Agcy ANVISA, Med Equipment Off, Brasilia, DF, Brazil; [de Souza Bermejo, Paulo Henrique] Univ Brasilia, Dept Adm, Brasilia, DF, Brazil; [Moreira, Marina Figueiredo] Univ Brasilia, Business Sch, Brasilia, DF, Brazil; [Prata, David Nadler] Fed Univ Tocantins, Inst Reg Dev, Dept Computat Modelling, Palmas, Tocantins, Brazil	Universidade de Brasilia; Universidade de Brasilia; Universidade Federal do Tocantins (UFT)	Cartaxo, ANS (corresponding author), Minist Hlth, Secretariat Sci Technol Innovat & Strateg Supplie, Gen Coordinat Hlth Ind Complex, Brasilia, DF, Brazil.	adriana.santos@saude.gov.br	De Souza Bermejo, Paulo Henrique/Y-2757-2019; PRATA, D. N./A-9925-2013	De Souza Bermejo, Paulo Henrique/0000-0003-2680-8342; PRATA, D. N./0000-0002-1414-4000; Cartaxo, Adriana/0000-0001-6518-6959	Ministry of Health [TED 43/2019]	Ministry of Health	The Ministry of Health financial support this research. Grant: Decentralized Execution Term (TED 43/2019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Adriana Cartaxo is an employee of the Ministry of Health. The authors received no specific funding for this study.	Abbey EJ, 2020, MEDRXIV 2 2020072120, DOI [10.1371/journal.pone.0239398, DOI 10.1371/JOURNAL.PONE.0239398]; Abrams EM, 2020, LANCET RESP MED, V8, P659, DOI 10.1016/S2213-2600(20)30234-4; Ahmed F, 2020, LANCET PUBLIC HEALTH, V5, pE240, DOI 10.1016/S2468-2667(20)30085-2; [Anonymous], 2020, LANCET, V395, P1461, DOI 10.1016/S0140-6736(20)31095-3; [Anonymous], 2020, LANCET, V395, P1230, DOI 10.1016/S0140-6736(20)30864-3; [Anonymous], 2020, LANCET, V395, P1011, DOI 10.1016/S0140-6736(20)30686-3; [Anonymous], 2002, Bull World Health Organ, V80, P983; Baker RE, 2020, SCIENCE, V369, P315, DOI 10.1126/science.abc2535; Barbarossa MV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238559; Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5; BRASIL I, PAISES; Chen SM, 2020, LANCET, V395, P1305, DOI 10.1016/S0140-6736(20)30744-3; Ciancio A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238341; Coelho FC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238214; Cousins S, 2020, LANCET, V395, P1474, DOI 10.1016/S0140-6736(20)31097-7; European Centre for Disease Prevention and Control (ECDC), 2020, COVID 19 GEOGR DISBT; Gilbert M, 2020, LANCET, V395, P871, DOI 10.1016/S0140-6736(20)30411-6; Ji YP, 2020, LANCET GLOB HEALTH, V8, pE480, DOI 10.1016/S2214-109X(20)30068-1; Kandel N, 2020, LANCET, V395, P1047, DOI 10.1016/S0140-6736(20)30553-5; Kiaghadi A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241166; Kucharski AJ, 2020, EFFECTIVENESS ISOLAT; Leung K, 2020, LANCET, V395, P1382, DOI 10.1016/S0140-6736(20)30746-7; Liu Q, 2020, LANCET GLOB HEALTH, V8, pE790, DOI 10.1016/S2214-109X(20)30204-7; Manning C.D., 1999, FDN STAT NATURAL LAN; Moore M, 2016, IDENTIFYING FUTURE D; Powell-Jackson T, 2020, LANCET GLOB HEALTH, V8, pE780, DOI 10.1016/S2214-109X(20)30222-9; Prata DN, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138862; Qi HC, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138778; Schwalbe N, 2020, LANCET GLOB HEALTH, V8, P974, DOI 10.1016/S2214-109X(20)30276-X; Sun ZH, 2020, HEALTH PLACE, V66, DOI 10.1016/j.healthplace.2020.102450; WHO, IHR STAT PART ANN RE; WHO, 2019, REP WHO CHIN JOINT M; World Bank, WORLD DEV IND; Yang P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236857	35	6	6	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0248075	10.1371/journal.pone.0248075	http://dx.doi.org/10.1371/journal.pone.0248075			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33662028	Green Published, gold			2022-12-26	WOS:000626604100076
J	Chen, L; Hao, M; Yan, JM; Sun, L; Tai, GH; Cheng, HR; Zhou, YF				Chen, Lei; Hao, Miao; Yan, Jingmin; Sun, Lin; Tai, Guihua; Cheng, Hairong; Zhou, Yifa			Citrus-derived DHCP inhibits mitochondrial complex II to enhance TRAIL sensitivity via ROS-induced DR5 upregulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; INDUCED APOPTOSIS; DEATH RECEPTORS; DOWN-REGULATION; TUMOR-CELLS; LIGAND; INDUCTION; PECTIN; IDENTIFICATION; SENSITIZATION	Heat-modified citrus pectin, a water-soluble indigestible polysaccharide fiber derived from citrus fruits and modified by temperature treatment, has been reported to exhibit anticancer effects. However, the bioactive fractions and their mechanisms remain unclear. In this current study, we isolated an active compound, trans-4,5-dihydroxy-2-cyclopentene-l-one (DHCP), from heat-treated citrus pectin, and found that is induces cell death in colon cancer cells via induction of mitochondrial ROS. On the molecular level, DHCP triggers ROS production by inhibiting the activity of succinate ubiquinone reductase (SQR) in mitochondrial complex II. Furthermore, cytotoxicity, apoptotic activity, and activation of caspase cascades were determined in HCT116 and HT-29 cell-based systems, the results indicated that DHCP enhances the sensitivity of cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), with DHCP-induced ROS accounting for the synergistic effect between DHCP and TRAIL. Furthermore, the combination of DHCP and TRAIL inhibits the growth of HCT116 and HT-29 xenografts synergistically. ROS significantly increases the expression of TRAIL death receptor 5 (DR5) via the p53 and C/EBP homologous protein pathways. Collectively, our findings indicate that DHCP has a favorable toxicity profile and is a new TRAIL sensitizer that shows promise in the development of pectin-based pharmaceuticals, nutraceuticals, and dietary agents aimed at combating human colon cancer.	[Chen, Lei; Hao, Miao; Yan, Jingmin; Sun, Lin; Tai, Guihua; Cheng, Hairong; Zhou, Yifa] Northeast Normal Univ, Engn Res Ctr Glycoconjugates, Sch Life Sci,Minist Educ, Jilin Prov Key Lab Chem & Biol Changbai Mt Nat Dr, Changchun, Peoples R China	Northeast Normal University - China	Cheng, HR; Zhou, YF (corresponding author), Northeast Normal Univ, Engn Res Ctr Glycoconjugates, Sch Life Sci,Minist Educ, Jilin Prov Key Lab Chem & Biol Changbai Mt Nat Dr, Changchun, Peoples R China.	chenghr893@nenu.edu.cn; zhouyf383@nenu.edu.cn		Hao, Miao/0000-0002-8386-2145	National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China [2019ZX09735-001]; National Natural Science Foundation of China [31770852, 31870796]	National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China (2019ZX09735-001) and the National Natural Science Foundation of China (31770852, 31870796). We are thankful for HCT116 variants with deletion of p53 gift from Dr Xinshan Ye, (Peking University, Beijing, China). Dr Qiang Yu (Chinese Academy of Sciences, Shanghai, China) kindly provided human lung epithelial A549 cells and A549.0 cells.	Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Bezawork-Geleta A, 2017, TRENDS BIOCHEM SCI, V42, P312, DOI 10.1016/j.tibs.2017.01.003; Chang CC, 2015, CHEM RES TOXICOL, V28, P1574, DOI 10.1021/acs.chemrestox.5b00150; Chen CY, 2010, J AGR FOOD CHEM, V58, P5604, DOI 10.1021/jf904260b; Chen L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.234; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Cheng HR, 2011, MED ONCOL, V28, P175, DOI 10.1007/s12032-010-9449-8; Dong LF, 2011, J BIOL CHEM, V286, P3717, DOI 10.1074/jbc.M110.186643; Earel JK, 2006, CANCER RES, V66, P499, DOI 10.1158/0008-5472.CAN-05-3017; Forero-Torres A, 2015, CLIN CANCER RES, V21, P2722, DOI 10.1158/1078-0432.CCR-14-2780; Gillissen B, 2017, J BIOL CHEM, V292, P6478, DOI 10.1074/jbc.M116.754184; Guan BX, 2001, J CELL PHYSIOL, V188, P98, DOI 10.1002/jcp.1101; Guan Y, 2018, J FUNCT FOODS, V48, P190, DOI 10.1016/j.jff.2018.07.001; Guo LL, 2016, J BIOL CHEM, V291, P42, DOI 10.1074/jbc.M115.697516; Hao M, 2013, FOOD FUNCT, V4, P960, DOI 10.1039/c3fo30350k; Holze C, 2018, NAT IMMUNOL, V19, P130, DOI 10.1038/s41590-017-0013-y; Hung CM, 2017, J AGR FOOD CHEM, V65, P11179, DOI 10.1021/acs.jafc.7b02358; Ishii T, 2005, CANCER RES, V65, P203; Jackson CL, 2007, GLYCOBIOLOGY, V17, P805, DOI 10.1093/glycob/cwm054; Jiang CC, 2007, CANCER RES, V67, P5880, DOI 10.1158/0008-5472.CAN-07-0213; Kim B, 2020, INT J ONCOL, V56, P821, DOI 10.3892/ijo.2020.4970; Kim JH, 2012, ANTIOXID REDOX SIGN, V16, P413, DOI 10.1089/ars.2011.3982; Kim SH, 2004, J BIOL CHEM, V279, P40044, DOI 10.1074/jbc.M404541200; Koyama N., 2000, US patent, Patent No. [US6087401, 6087401]; Kruspig B, 2016, BBA-MOL CELL RES, V1863, P2065, DOI 10.1016/j.bbamcr.2016.04.026; Lara-Espinoza C, 2018, MOLECULES, V23, DOI 10.3390/molecules23040942; Leclere L, 2016, CARBOHYD POLYM, V137, P39, DOI 10.1016/j.carbpol.2015.10.055; Leclere L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115831; Leclere L, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00128; Lee JH, 2014, J NAT PROD, V77, P2438, DOI 10.1021/np500452e; Liu Y, 2014, CANCER SCI, V105, P520, DOI 10.1111/cas.12395; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Neuzil J, 2013, MITOCHONDRION, V13, P199, DOI 10.1016/j.mito.2012.07.112; Noreen A, 2017, INT J BIOL MACROMOL, V101, P254, DOI 10.1016/j.ijbiomac.2017.03.029; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Prasad S, 2014, TRENDS PHARMACOL SCI, V35, P520, DOI 10.1016/j.tips.2014.07.004; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Ralff MD, 2018, EXPERT REV PRECIS ME, V3, P197, DOI 10.1080/23808993.2018.1476062; Ricci JE, 2003, CELL DEATH DIFFER, V10, P488, DOI 10.1038/sj.cdd.4401225; Sayers TJ, 2006, CANCER IMMUNOL IMMUN, V55, P76, DOI 10.1007/s00262-005-0676-3; Seo BR, 2017, ANTIOXID REDOX SIGN, V27, P215, DOI 10.1089/ars.2016.6749; Shankar S, 2008, CLIN CANCER RES, V14, P6855, DOI 10.1158/1078-0432.CCR-08-0903; Shi YS, 2020, BIOMATERIALS, V233, DOI 10.1016/j.biomaterials.2019.119753; Singh TR, 2005, ONCOGENE, V24, P4609, DOI 10.1038/sj.onc.1208585; Sun XX, 2013, J BIOL CHEM, V288, P8826, DOI 10.1074/jbc.M112.429316; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Takeda K, 2007, ONCOGENE, V26, P3745, DOI 10.1038/sj.onc.1210374; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02915-8; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Yadav VR, 2012, BRIT J PHARMACOL, V165, P741, DOI 10.1111/j.1476-5381.2011.01603.x; Zhang B, 2015, FREE RADICAL BIO MED, V89, P486, DOI 10.1016/j.freeradbiomed.2015.09.021; Zhang WB, 2015, TRENDS FOOD SCI TECH, V44, P258, DOI 10.1016/j.tifs.2015.04.001	55	2	2	3	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100515	10.1016/j.jbc.2021.100515	http://dx.doi.org/10.1016/j.jbc.2021.100515			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33676890	Green Published, gold			2022-12-26	WOS:000672866400489
J	Berg, NK; Li, JW; Kim, B; Mills, T; Pei, GS; Zhao, ZM; Li, XY; Zhang, X; Ruan, W; Eltzschig, HK; Yuan, XY				Berg, Nathaniel K.; Li, Jiwen; Kim, Boyun; Mills, Tingting; Pei, Guangsheng; Zhao, Zhongming; Li, Xiangyun; Zhang, Xu; Ruan, Wei; Eltzschig, Holger K.; Yuan, Xiaoyi			Hypoxia-inducible factor-dependent induction of myeloid-derived netrin-1 attenuates natural killer cell infiltration during endotoxin-induced lung injury	FASEB JOURNAL			English	Article						lung inflammation; netrin&#8208; 1; natural killer cells	NF-KAPPA-B; INHIBITS LEUKOCYTE MIGRATION; ISCHEMIA-REPERFUSION INJURY; PRO-RESOLVING MEDIATORS; NK CELLS; PULMONARY INFLAMMATION; MACROPHAGE RETENTION; INSULIN-RESISTANCE; KIDNEY INJURY; IN-VITRO	Sepsis and sepsis-associated lung inflammation significantly contribute to the morbidity and mortality of critical illness. Here, we examined the hypothesis that neuronal guidance proteins could orchestrate inflammatory events during endotoxin-induced lung injury. Through a targeted array, we identified netrin-1 as the top upregulated neuronal guidance protein in macrophages treated with lipopolysaccharide (LPS). Furthermore, we found that netrin-1 is highly enriched in infiltrating myeloid cells, particularly in macrophages during LPS-induced lung injury. Transcriptional studies implicate hypoxia-inducible factor HIF-1 alpha in the transcriptional induction of netrin-1 during LPS treatment. Subsequently, the deletion of netrin-1 in the myeloid compartment (Ntn1(loxp/loxp) LysM Cre) resulted in exaggerated mortality and lung inflammation. Surprisingly, further studies revealed enhanced natural killer cells (NK cells) infiltration in Ntn1(loxp/loxp) LysM Cre mice, and neutralization of NK cell chemoattractant chemokine (C-C motif) ligand 2 (CCL2) reversed the exaggerated lung inflammation. Together, these studies provide functional insight into myeloid cell-derived netrin-1 in controlling lung inflammation through the modulation of CCL2-dependent infiltration of NK cells.	[Berg, Nathaniel K.; Li, Jiwen; Kim, Boyun; Mills, Tingting; Li, Xiangyun; Ruan, Wei; Eltzschig, Holger K.; Yuan, Xiaoyi] Univ Texas Hlth Sci Ctr Houston, Dept Anesthesiol, McGovern Med Sch, 6431 Fannin St, Houston, TX 77030 USA; [Li, Jiwen] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Cardiac Surg, Hangzhou, Peoples R China; [Pei, Guangsheng; Zhao, Zhongming] Univ Texas Hlth Sci Ctr Houston, Ctr Precis Hlth, Sch Biomed Informat, Houston, TX 77030 USA; [Zhao, Zhongming] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Sch Publ Hlth, Houston, TX 77030 USA; [Li, Xiangyun] Tianjin Med Univ, Tianjin Nankai Hosp, Dept Anesthesiol, Tianjin, Peoples R China; [Zhang, Xu] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA; [Zhang, Xu] Univ Texas Hlth Sci Ctr Houston, Ctr Clin & Translat Sci, Houston, TX 77030 USA; [Ruan, Wei] Cent South Univ, Second Xiangya Hosp, Dept Anesthesiol, Changsha, Peoples R China	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Zhejiang University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Tianjin Medical University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Central South University	Yuan, XY (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Anesthesiol, McGovern Med Sch, 6431 Fannin St, Houston, TX 77030 USA.	lijiwen@zju.edu.cn; Holger.Eltzschig@uth.tmc.edu; Xiaoyi.Yuan@uth.tmc.edu		Pei, Guangsheng/0000-0003-1804-7598; Ruan, Wei/0000-0002-2718-7923; Mills, Tingting/0000-0002-6041-4788; Berg, Nathaniel/0000-0002-2568-2867; Li, Jiwen/0000-0002-8595-860X	HHS | National Institutes of Health (NIH) [T32GM120011]; American Thoracic Society (ATS); American Heart Association (AHA) [19CDA34660279]; American Lung Association (Lung Association) [CA622265]; UTHealth | Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston (CCTS, UTHealth) [1UL1TR003167-01]; Parker B. Francis Fellowship; Cancer Prevention and Research Institute of Texas (CPRIT) [CPRIT RP180734]; National Institutes of Health [R01HL154720, R01DK122796, R01DK109574, R01HL133900]; Department of Defense [W81XWH2110032]	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Thoracic Society (ATS); American Heart Association (AHA)(American Heart Association); American Lung Association (Lung Association); UTHealth | Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston (CCTS, UTHealth); Parker B. Francis Fellowship; Cancer Prevention and Research Institute of Texas (CPRIT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense)	HHS | National Institutes of Health (NIH), Grant/Award Number: T32GM120011; American Thoracic Society (ATS); American Heart Association (AHA), Grant/Award Number: 19CDA34660279; American Lung Association (Lung Association), Grant/Award Number: CA622265; UTHealth | Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston (CCTS, UTHealth), Grant/Award Number: 1UL1TR003167-01; Parker B. Francis Fellowship; Cancer Prevention and Research Institute of Texas (CPRIT), Grant/Award Number: CPRIT RP180734; National Institutes of Health, Grant/Award Number: R01HL154720, R01DK122796, R01DK109574 and R01HL133900; Department of Defense, Grant number: W81XWH2110032	Abdul-Careem MF, 2012, J INFECT DIS, V206, P167, DOI 10.1093/infdis/jis340; Abdulnour REE, 2018, J LEUKOCYTE BIOL, V103, P919, DOI 10.1002/JLB.3A0617-252RR; Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Afonina IS, 2017, NAT IMMUNOL, V18, P861, DOI 10.1038/ni.3772; Aherne CM, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24957; Aherne CM, 2012, GUT, V61, P695, DOI 10.1136/gutjnl-2011-300012; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arslan F, 2011, NAT REV CARDIOL, V8, P292, DOI 10.1038/nrcardio.2011.38; Beldi G, 2008, HEPATOLOGY, V48, P841, DOI 10.1002/hep.22401; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhavani S, 2015, ANN AM THORAC SOC, V12, pS164, DOI 10.1513/AnnalsATS.201503-115AW; Bin JM, 2015, CELL REP, V12, P1099, DOI 10.1016/j.celrep.2015.07.028; Brunet I, 2014, J CLIN INVEST, V124, P3230, DOI 10.1172/JCI75181; Carlin LE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00781; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Colgan SP, 2020, P NATL ACAD SCI USA, V117, P10621, DOI 10.1073/pnas.2005652117; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Dengler VL, 2014, CRIT REV BIOCHEM MOL, V49, P1, DOI 10.3109/10409238.2013.838205; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duvall MG, 2017, MOL ASPECTS MED, V58, P44, DOI 10.1016/j.mam.2017.04.003; Ehrentraut H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032416; Eltzschig HK, 2006, METH MOL B, V341, P73; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Gianchecchi E, 2018, AUTOIMMUN REV, V17, P142, DOI 10.1016/j.autrev.2017.11.018; Granja T, 2014, MUCOSAL IMMUNOL, V7, P879, DOI 10.1038/mi.2013.104; Hadi T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07495-1; Hammer Q, 2018, NAT IMMUNOL, V19, P800, DOI 10.1038/s41590-018-0163-6; Harari OA, 2010, ANN NY ACAD SCI, V1207, P32, DOI 10.1111/j.1749-6632.2010.05735.x; Hasko G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00085; Hasko G, 2009, TRENDS IMMUNOL, V30, P263, DOI 10.1016/j.it.2009.04.001; Hoegl S, 2017, J LEUKOCYTE BIOL, V101, P471, DOI 10.1189/jlb.3A0516-227R; Hong MJ, 2018, MUCOSAL IMMUNOL, V11, P894, DOI 10.1038/mi.2017.93; Jiang DH, 2004, J CLIN INVEST, V114, P291, DOI 10.1172/JCI200416861; Kabir K, 2002, SHOCK, V17, P300, DOI 10.1097/00024382-200204000-00010; Karmouty-Quintana H, 2013, J MOL MED, V91, P173, DOI 10.1007/s00109-013-0997-1; Kohler D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14958-x; Konig K, 2016, CRIT CARE MED, V44, pE625, DOI 10.1097/CCM.0000000000001609; Konig K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032145; Korner A, 2018, CELL DEATH DIFFER, V25, P421, DOI 10.1038/cdd.2017.177; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kominsky DJ, 2011, J IMMUNOL, V186, P6505, DOI 10.4049/jimmunol.1002805; Koscso B, 2013, J LEUKOCYTE BIOL, V94, P1309, DOI 10.1189/jlb.0113043; Koscso B, 2013, PURINERG SIGNAL, V9, P427, DOI 10.1007/s11302-013-9362-7; Krishnamoorthy N, 2018, PHYSIOL REV, V98, P1335, DOI 10.1152/physrev.00026.2017; Le TTT, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01633; Lee LK, 2020, ANESTH ANALG, V131, P1471, DOI 10.1213/ANE.0000000000005146; Li FA, 2012, J VIROL, V86, P2251, DOI 10.1128/JVI.06209-11; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Lu W, 2015, NAT IMMUNOL, V16, P1185, DOI 10.1038/ni.3292; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; MacManus CF, 2011, FASEB J, V25, P1856, DOI 10.1096/fj.10-170316; Maghazachi AA, 2010, CURR TOP MICROBIOL, V341, P37, DOI 10.1007/82_2010_20; Martin M., 2011, EMBNETJ, V17, p10; Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0; Mediero A, 2016, FASEB J, V30, P3835, DOI 10.1096/fj.201600615R; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Millien Valentine Ongeri, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS277, DOI 10.1513/AnnalsATS.201403-105AW; Mirakaj V, 2017, TRENDS IMMUNOL, V38, P444, DOI 10.1016/j.it.2017.03.007; Mirakaj V, 2014, J EXP MED, V211, P1037, DOI 10.1084/jem.20132103; Mirakaj V, 2012, FASEB J, V26, P1549, DOI 10.1096/fj.11-200063; Mirakaj V, 2011, P NATL ACAD SCI USA, V108, P6555, DOI 10.1073/pnas.1015605108; Mirakaj V, 2011, J IMMUNOL, V186, P549, DOI 10.4049/jimmunol.1002671; Mirakaj V, 2010, AM J RESP CRIT CARE, V181, P815, DOI 10.1164/rccm.200905-0717OC; Morrison BE, 2003, J CLIN INVEST, V112, P1862, DOI 10.1172/JCI200318125; Movassagh H, 2017, J IMMUNOL, V198, P1023, DOI 10.4049/jimmunol.1601093; Mutz C, 2010, CRIT CARE, V14, DOI 10.1186/cc9301; Nemeth ZH, 2005, J IMMUNOL, V175, P8260, DOI 10.4049/jimmunol.175.12.8260; Ngamsri KC, 2010, J IMMUNOL, V185, P4374, DOI 10.4049/jimmunol.1000433; Okamoto M, 2002, BLOOD, V99, P1289, DOI 10.1182/blood.V99.4.1289; Paradisi A, 2008, GASTROENTEROLOGY, V135, P1248, DOI 10.1053/j.gastro.2008.06.080; Poth JM, 2013, J MOL MED, V91, P183, DOI 10.1007/s00109-012-0988-7; Rabb H, 2016, J AM SOC NEPHROL, V27, P371, DOI 10.1681/ASN.2015030261; Ramkhelawon B, 2014, NAT MED, V20, P377, DOI 10.1038/nm.3467; Ramkhelawon B, 2013, ARTERIOSCL THROM VAS, V33, P1180, DOI 10.1161/ATVBAHA.112.301008; Ranganathan PV, 2013, KIDNEY INT, V83, P1087, DOI 10.1038/ki.2012.423; Ranganathan PV, 2013, AM J PHYSIOL-RENAL, V304, pF948, DOI 10.1152/ajprenal.00580.2012; Robertson MJ, 2002, J LEUKOCYTE BIOL, V71, P173; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Ryan HE, 2000, CANCER RES, V60, P4010; Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035; Schlegel M, 2019, J CLIN INVEST, V129, P2165, DOI 10.1172/JCI128681; Schlegel M, 2016, HEPATOLOGY, V63, P1689, DOI 10.1002/hep.28347; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Sham HP, 2018, J IMMUNOL, V200, P2757, DOI 10.4049/jimmunol.1602090; Shan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003041; Shen H, 2013, J IMMUNOL, V191, P2857, DOI 10.4049/jimmunol.1301539; Shi JY, 2018, METHODS MOL BIOL, V1784, P263, DOI 10.1007/978-1-4939-7837-3_24; Shimasaki N, 2020, NAT REV DRUG DISCOV, V19, P200, DOI 10.1038/s41573-019-0052-1; Shimizu I, 2013, CELL METAB, V18, P491, DOI 10.1016/j.cmet.2013.09.001; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sugimoto MA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00160; Tadagavadi RK, 2010, J IMMUNOL, V185, P3750, DOI 10.4049/jimmunol.1000435; Taylor L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160685; Thompson BT, 2017, NEW ENGL J MED, V377, P562, DOI [10.1056/NEJMra1608077, 10.1056/NEJMc1711824]; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Varadarajan SG, 2017, NEURON, V94, P790, DOI 10.1016/j.neuron.2017.03.007; Victorino F, 2015, J IMMUNOL, V195, P4973, DOI 10.4049/jimmunol.1500651; Wang J, 2014, J IMMUNOL, V193, P1133, DOI 10.4049/jimmunol.1303303; Watanabe S, 2019, J CLIN INVEST, V129, P2619, DOI 10.1172/JCI124615; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Yang YL, 2008, RESP PHYSIOL NEUROBI, V160, P99, DOI 10.1016/j.resp.2007.09.011; Yuan XY, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124317; Yuan XY, 2018, J LEUKOCYTE BIOL, V104, P515, DOI 10.1002/JLB.3MR0218-079R; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x; Zhang YY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24506-9	109	9	9	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21334	10.1096/fj.202002407R	http://dx.doi.org/10.1096/fj.202002407R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715200	hybrid, Green Published			2022-12-26	WOS:000635216100079
J	Marquant, Q; Laubreton, D; Drajac, C; Mathieu, E; Bouguyon, E; Noordine, ML; Remot, A; Riffault, S; Thomas, M; Descamps, D				Marquant, Quentin; Laubreton, Daphne; Drajac, Carole; Mathieu, Elliot; Bouguyon, Edwige; Noordine, Marie-Louise; Remot, Aude; Riffault, Sabine; Thomas, Muriel; Descamps, Delphyne			The microbiota plays a critical role in the reactivity of lung immune components to innate ligands	FASEB JOURNAL			English	Article						alveolar macrophages; germ&#8208; free; innate immune memory; lung explants; microbiota; respiratory syncytial virus		The gut microbiota contributes to shaping efficient and safe immune defenses in the gut. However, little is known about the role of the gut and/or lung microbiota in the education of pulmonary innate immune responses. Here, we tested whether the endogenous microbiota in general can modulate the reactivity of pulmonary tissue to pathogen stimuli by comparing the response of specific-pathogen-free (SPF) and germ-free (GF) mice. Thus, we observed earlier and greater inflammation in the pulmonary compartment of GF mice than that of SPF mice after intranasal instillation to lipopolysaccharide (LPS), a component of Gram-negative bacteria. Toll-like receptor 4 (TLR4) was more abundantly expressed in the lungs of GF mice than those of SPF mice at steady state, which could predispose the innate immunity of GF mice to strongly react to the environmental stimuli. Lung explants were stimulated with different TLR agonists or infected with the human airways pathogen, respiratory syncytial virus (RSV), resulting in greater inflammation under almost all conditions for the GF explants. Finally, alveolar macrophages (AM) from GF mice presented a higher innate immune response upon RSV infection than those of SPF mice. Overall, these data suggest that the presence of microbiota in SPF mice induced a process of innate immune tolerance in the lungs by a mechanism which remains to be elucidated. Our study represents a step forward to establishing the link between the microbiota and the immune reactivity of the lungs.	[Marquant, Quentin; Laubreton, Daphne; Drajac, Carole; Bouguyon, Edwige; Riffault, Sabine; Descamps, Delphyne] Univ Paris Saclay, INRAE, UVSQ, VIM, Jouy En Josas, France; [Mathieu, Elliot; Noordine, Marie-Louise; Thomas, Muriel] Univ Paris Saclay, INRAE, Micalis, Jouy En Josas, France; [Remot, Aude] Univ Tours, INRAE, ISP, Tours, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Tours	Descamps, D (corresponding author), UVSQ, INRAE, Virol & Immunol Mol, F-78350 Jouy En Josas, France.	delphyne.descamps@inrae.fr	thomas, muriel/HDO-3887-2022; Laubreton, Daphne/GRT-0001-2022	Descamps, Delphyne/0000-0002-4883-6910	Agence Nationale de la Recherche (ANR) [ANR-13-BSV3-0016]; Ile-de-France Regional Council | Domaine d'Interet Majeur OneHealth; Fondation Air Liquide	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ile-de-France Regional Council | Domaine d'Interet Majeur OneHealth; Fondation Air Liquide	Agence Nationale de la Recherche (ANR), Grant/Award Number: ANR-13-BSV3-0016; Ile-de-France Regional Council | Domaine d'Interet Majeur OneHealth; Fondation Air Liquide	Al Nabhani Z, 2020, MUCOSAL IMMUNOL, V13, P183, DOI 10.1038/s41385-020-0257-y; Dang AT, 2019, MUCOSAL IMMUNOL, V12, P843, DOI 10.1038/s41385-019-0160-6; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P1283, DOI 10.1164/rccm.201407-1240OC; Bigot J, 2020, J INFECT DIS, V221, P1000, DOI 10.1093/infdis/jiz569; Boraschi D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00799; Caballero MT, 2015, J CLIN INVEST, V125, P571, DOI 10.1172/JCI75183; Correa RO, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.17; d'Hennezel E, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00046-17; Descamps D, 2012, P NATL ACAD SCI USA, V109, P1619, DOI 10.1073/pnas.1108464109; Dickson RP, 2017, MBIO, V8, DOI 10.1128/mBio.02287-16; Didierlaurent A, 2008, J EXP MED, V205, P323, DOI 10.1084/jem.20070891; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Francois A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24687; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Goritzka M, 2015, J EXP MED, V212, P699, DOI 10.1084/jem.20140825; Hamon MA, 2016, SEMIN IMMUNOL, V28, P351, DOI 10.1016/j.smim.2016.05.003; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Huang YJ, 2015, J ALLERGY CLIN IMMUN, V136, P874, DOI 10.1016/j.jaci.2015.05.044; Huang YJ, 2013, AM J RESP CRIT CARE, V187, P1382, DOI 10.1164/rccm.201303-0488WS; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lee SK, 2005, BIOCHEM BIOPH RES CO, V337, P457, DOI 10.1016/j.bbrc.2005.09.071; Lloyd CM, 2017, IMMUNITY, V46, P549, DOI 10.1016/j.immuni.2017.04.005; Makris S, 2016, J INNATE IMMUN, V8, P452, DOI 10.1159/000446824; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; Marzec J, 2019, PHYSIOL GENOMICS, V51, P630, DOI 10.1152/physiolgenomics.00101.2019; Masui R, 2013, INFLAMM BOWEL DIS, V19, P2848, DOI 10.1097/01.MIB.0000435444.14860.ea; Mathieu E, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01168; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Ohira H, 2013, J ATHEROSCLER THROMB, V20, P425, DOI 10.5551/jat.15065; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Piters WAAD, 2016, AM J RESP CRIT CARE, V194, P1104, DOI 10.1164/rccm.201602-0220OC; Pulvirenti G, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00393; Rameix-Welti MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6104; Remot A, 2017, ISME J, V11, P1061, DOI 10.1038/ismej.2016.181; Sencio V, 2020, CELL REP, V30, P2934, DOI 10.1016/j.celrep.2020.02.013; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Takiishi T, 2017, TISSUE BARRIERS, V5, DOI 10.1080/21688370.2017.1373208; Tomas J, 2013, FASEB J, V27, P645, DOI 10.1096/fj.12-216861; Venkataraman A, 2015, MBIO, V6, DOI 10.1128/mBio.02284-14; Xiang M, 2010, MOL MED, V16, P69, DOI 10.2119/molmed.2009.00097	42	5	5	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21348	10.1096/fj.202002338R	http://dx.doi.org/10.1096/fj.202002338R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715218	Green Submitted, hybrid			2022-12-26	WOS:000635216100014
J	Vega, L; Herrera, G; Munoz, M; Patarroyo, MA; Maloney, JG; Santin, M; Ramirez, JD				Vega, Laura; Herrera, Giovanny; Munoz, Marina; Patarroyo, Manuel A.; Maloney, Jenny G.; Santin, Monica; David Ramirez, Juan			Gut microbiota profiles in diarrheic patients with co-occurrence of Clostridioides difficile and Blastocystis	PLOS ONE			English	Article							GEOGRAPHIC-DISTRIBUTION; SUBTYPES; HEALTH; DYSBIOSIS; COMMENSAL; DIET; BIOMARKERS; DIVERSITY; INFECTION	Blastocystis and Clostridioides difficile co-occurrence is considered a rare event since the colonization by Blastocystis is prevented under a decrease in beneficial bacteria in the microbiota when there is C. difficile infection (CDI). This scenario has been reported once, but no information on the gut microbiota profiling is available. The present study is motivated by knowing which members of the microbiota can be found in this rare scenario and how this co-occurrence may impact the abundance of other bacteria, eukaryotes or archaea present in the gut microbiota. This study aimed to describe the bacterial and eukaryotic communities using amplicon-based sequencing of the 16S- and 18S-rRNA regions of three patient groups: (1) Blastocystis and C. difficile infection (B+/C+, n = 31), (2) C. difficile infection only (B/C+, n = 44), and (3) without Blastocystis or C. difficile (Bn = 40). Blastocystis was subtyped using amplicon-based sequencing of the 18S-rRNA gene, revealing circulation of subtypes ST1 (43.4%), ST3 (35.85%) and ST5 (20.75%) among the study population. We found that B+/C+ patients had a higher abundance of some beneficial bacteria (such as butyrate producers or bacteria with anti-inflammatory properties) compared with non-Blastocystis-colonized patients, which may suggest a shift towards an increase in beneficial bacteria when Blastocystis colonizes patients with CDI. Regarding eukaryotic communities, statistical differences in the abundance of some eukaryotic genera between the study groups were not observed. Thus, this study provides preliminary descriptive information of a potential microbiota profiling of differential presence by Blastocystis and C. difficile.	[Vega, Laura; Herrera, Giovanny; Munoz, Marina; David Ramirez, Juan] Univ Rosario, Fac Ciencias Nat, Ctr Invest Microbiol & Biotecnol UR CIMBIUR, Bogota, Colombia; [Patarroyo, Manuel A.] Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia; [Patarroyo, Manuel A.] Univ Nacl Colombia, Fac Med, Microbiol Dept, Bogota, Colombia; [Maloney, Jenny G.; Santin, Monica] USDA ARS, Environm Microbial & F6ood Safety Lab, BARC, Beltsville, MD USA	Universidad del Rosario; Universidad Nacional de Colombia; United States Department of Agriculture (USDA)	Ramirez, JD (corresponding author), Univ Rosario, Fac Ciencias Nat, Ctr Invest Microbiol & Biotecnol UR CIMBIUR, Bogota, Colombia.	juand.ramirez@urosario.edu.co	Patarroyo, Manuel-Alfonso/I-8046-2016	Patarroyo, Manuel-Alfonso/0000-0002-4751-2500; Maloney, Jenny/0000-0002-6405-883X	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (Colciencias) [212477758147, 606-2018]	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (Colciencias)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This research was funded by the Departamento Administrativo de Ciencia, Tecnologia e Innovacion (Colciencias) within the framework of the project "Determinacion del microbioma intestinal en pacientes con diarrea asociada a la infeccion por Clostridium difficile adquirida en Unidad de Cuidados Intensivos y Comunidad"code 212477758147, contract number 606-2018, call 777 from 2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt MC, 2016, NAT REV MICROBIOL, V14, P609, DOI 10.1038/nrmicro.2016.108; Alfellani MA, 2013, ACTA TROP, V126, P11, DOI 10.1016/j.actatropica.2012.12.011; Alzate JF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72286-y; Jimenez PA, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3641-2; Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Audebert C, 2016, SCI REP-UK, V6, DOI 10.1038/srep25255; Beghini F, 2017, ISME J, V11, P2848, DOI 10.1038/ismej.2017.139; Berg G, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00875-0; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Callahan BJ., 2018, ZENODO, DOI [10.5281/zenodo.1172783, DOI 10.5281/ZENODO.1172783]; Cani PD, 2018, GUT, V67, P1716, DOI 10.1136/gutjnl-2018-316723; Chang CJ, 2018, INT J OBESITY, V42, P231, DOI 10.1038/ijo.2017.149; Chaudhary PP, 2018, APPL MICROBIOL BIOT, V102, P3095, DOI 10.1007/s00253-018-8871-2; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; Chudnovskiy A, 2016, CELL, V167, P444, DOI 10.1016/j.cell.2016.08.076; Coker OO, 2020, GASTROENTEROLOGY, V159, P1459, DOI 10.1053/j.gastro.2020.06.042; Ramirez JD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172586; Ramirez JD, 2016, INFECT GENET EVOL, V41, P32, DOI 10.1016/j.meegid.2016.03.017; Eme L, 2017, CURR BIOL, V27, P807, DOI 10.1016/j.cub.2017.02.003; Gabrielli S, 2020, PARASITE EPIDEM CONT, V9, DOI 10.1016/j.parepi.2020.e00134; Gaci N, 2014, WORLD J GASTROENTERO, V20, P16062, DOI 10.3748/wjg.v20.i43.16062; Gorvitovskaia A, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0160-7; Guillou L, 2013, NUCLEIC ACIDS RES, V41, pD597, DOI 10.1093/nar/gks1160; Hatoum R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00421; Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066019; Hooks KB, 2020, J EUKARYOT MICROBIOL, V67, P279, DOI 10.1111/jeu.12766; Hooks KB, 2017, MBIO, V8, DOI 10.1128/mBio.01492-17; Iliev ID, 2017, NAT REV IMMUNOL, V17, P635, DOI 10.1038/nri.2017.55; Koskinen K, 2017, MBIO, V8, DOI 10.1128/mBio.00824-17; Kruger W, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8020070; Kumamoto CA, 2020, CURR OPIN MICROBIOL, V56, P7, DOI 10.1016/j.mib.2020.05.006; Laforest-Lapointe I, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00201-17; Lagier J-C., 2016, HUM MICROBIOME J, V2, P10, DOI [10.1016/j.humic.2016.10.003, DOI 10.1016/J.HUMIC.2016.10.003]; Lewis JD, 2015, CELL HOST MICROBE, V18, P489, DOI 10.1016/j.chom.2015.09.008; Limon JJ, 2017, CELL HOST MICROBE, V22, P156, DOI 10.1016/j.chom.2017.07.002; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lukes J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005039; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Maloney JG, 2019, INFECT GENET EVOL, V73, P119, DOI 10.1016/j.meegid.2019.04.013; Markey L, 2018, GUT MICROBES, V9, P497, DOI 10.1080/19490976.2018.1465158; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Milani C, 2016, SCI REP-UK, V6, DOI 10.1038/srep25945; Mullany P, 2015, RES MICROBIOL, V166, P361, DOI 10.1016/j.resmic.2014.12.005; Munoz M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00074; Nakamura N, 2010, ANNU REV FOOD SCI T, V1, P363, DOI 10.1146/annurev.food.102308.124101; Nieves-Ramirez ME, 2018, MSYSTEMS, V3, DOI [10.1128/mSystems.00007-18, 10.1128/msystems.00007-18]; Nkamga VD., 2017, HUMAN MICROBIOME J, V3, P1, DOI [10.1016/j.humic.2016.11.005, DOI 10.1016/J.HUMIC.2016.11.005]; Nourrisson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111868; Oozeer R, 2010, BRIT J NUTR, V103, P1539, DOI 10.1017/S0007114509993400; Panpetch W, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210798; Parfrey LW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00298; Potes-Morales C, 2020, PARASITE EPIDEM CONT, V9, DOI 10.1016/j.parepi.2020.e00132; Rigottier-Gois L, 2013, ISME J, V7, P1256, DOI 10.1038/ismej.2013.80; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Sanchez Angie, 2017, Front Microbiol, V8, P248, DOI 10.3389/fmicb.2017.00248; Scanlan PD, 2013, TRENDS PARASITOL, V29, P523, DOI 10.1016/j.pt.2013.08.006; Sokol H, 2018, GUT MICROBES, V9, P55, DOI 10.1080/19490976.2017.1361092; Stechmann A, 2008, CURR BIOL, V18, P580, DOI 10.1016/j.cub.2008.03.037; Stensvold CR, 2007, TRENDS PARASITOL, V23, P93, DOI 10.1016/j.pt.2007.01.004; Stensvold CR, 2016, PARASITOL INT, V65, P763, DOI 10.1016/j.parint.2016.05.015; Stensvold CR, 2019, PARASITOLOGY, V146, P695, DOI 10.1017/S0031182019000039; Stensvold CR, 2018, TRENDS PARASITOL, V34, P369, DOI 10.1016/j.pt.2018.02.004; Stensvold CR, 2012, J CLIN MICROBIOL, V50, P1847, DOI 10.1128/JCM.00007-12; Stewart D, 2019, FUNGAL GENET BIOL, V129, P1, DOI 10.1016/j.fgb.2019.04.007; Tachezy J., 2019, HYDROGENOSOMES MITOS, DOI 10.1007/978-3-030-17941-0; Tito RY, 2019, GUT, V68, P1180, DOI 10.1136/gutjnl-2018-316106; Tsaousis AD, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00371; Varankovich NV, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00685; Vega L, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9040283; Yason JA, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0644-3; Yi ZW, 2020, J ETHNOPHARMACOL, V254, DOI 10.1016/j.jep.2020.112681; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347	73	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0248185	10.1371/journal.pone.0248185	http://dx.doi.org/10.1371/journal.pone.0248185			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY1VJ	33725006	Green Published, gold			2022-12-26	WOS:000629833700036
J	Ye, GH; Alim, M; Guan, P; Huang, DS; Zhou, BS; Wu, W				Ye, Guo-Hua; Alim, Mirxat; Guan, Peng; Huang, De-Sheng; Zhou, Bao-Sen; Wu, Wei			Improving the precision of modeling the incidence of hemorrhagic fever with renal syndrome in mainland China with an ensemble machine learning approach	PLOS ONE			English	Article							TRENDS	Objective Hemorrhagic fever with renal syndrome (HFRS), one of the main public health concerns in mainland China, is a group of clinically similar diseases caused by hantaviruses. Statistical approaches have always been leveraged to forecast the future incidence rates of certain infectious diseases to effectively control their prevalence and outbreak potential. Compared to the use of one base model, model stacking can often produce better forecasting results. In this study, we fitted the monthly reported cases of HFRS in mainland China with a model stacking approach and compared its forecasting performance with those of five base models. Method We fitted the monthly reported cases of HFRS ranging from January 2004 to June 2019 in mainland China with an autoregressive integrated moving average (ARIMA) model; the Holt-Winter (HW) method, seasonal decomposition of the time series by LOESS (STL); a neural network autoregressive (NNAR) model; and an exponential smoothing state space model with a Box-Cox transformation; ARMA errors; and trend and seasonal components (TBATS), and we combined the forecasting results with the inverse rank approach. The forecasting performance was estimated based on several accuracy criteria for model prediction, including the mean absolute percentage error (MAPE), root-mean-squared error (RMSE) and mean absolute error (MAE). Result There was a slight downward trend and obvious seasonal periodicity inherent in the time series data for HFRS in mainland China. The model stacking method was selected as the best approach with the best performance in terms of both fitting (RMSE 128.19, MAE 85.63, MAPE 8.18) and prediction (RMSE 151.86, MAE 118.28, MAPE 13.16). Conclusion The results showed that model stacking by using the optimal mean forecasting weight of the five abovementioned models achieved the best performance in terms of predicting HFRS one year into the future. This study has corroborated the conclusion that model stacking is an easy way to enhance prediction accuracy when modeling HFRS.	[Ye, Guo-Hua; Alim, Mirxat; Guan, Peng; Zhou, Bao-Sen; Wu, Wei] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang, Liaoning, Peoples R China; [Huang, De-Sheng] China Med Univ, Sch Fundamental Sci, Dept Math, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Wu, W (corresponding author), China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang, Liaoning, Peoples R China.	wuwei@cmu.edu.cn	Guan, Peng/GWM-9170-2022		National Natural Science Foundation of China [81202254, 71974199]; Health and Medical Big Data Research Project of China Medical University [HMB201903105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health and Medical Big Data Research Project of China Medical University	This study was supported by the National Natural Science Foundation of China (Grant No. 81202254 and 71974199) and the Health and Medical Big Data Research Project of China Medical University (Grant No. HMB201903105).	Aiolfi M, 2006, J ECONOMETRICS, V135, P31, DOI 10.1016/j.jeconom.2005.07.015; ARMSTRONG JS, 1992, INT J FORECASTING, V8, P69, DOI 10.1016/0169-2070(92)90008-W; Chae S, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081596; Choi E, 2011, ATMOS ENVIRON, V45, P7563, DOI 10.1016/j.atmosenv.2010.11.049; Clement JP, 2003, ANTIVIR RES, V57, P121, DOI 10.1016/S0166-3542(02)00205-X; Cleveland R.B., 1990, J OFF STAT, V6, P3; GARDNER ES, 1985, MANAGE SCI, V31, P1237, DOI 10.1287/mnsc.31.10.1237; Gelper S, 2010, J FORECASTING, V29, P285, DOI 10.1002/for.1125; Hansen A, 2015, INT J INFECT DIS, V33, P212, DOI 10.1016/j.ijid.2015.02.010; Holt CC, 2004, INT J FORECASTING, V20, P5, DOI [10.1016/j.ijforecast.2003.09.015, 10.1016/j.ijforecast.2004.09.015]; Hui-Yu H, 2017, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V29, P436, DOI 10.16250/j.32.1374.2017088; Joshi YP, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2506-6; Li Jian, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P1198; Li SJ, 2014, INT J ENV RES PUB HE, V11, P12129, DOI 10.3390/ijerph111212129; Liu QY, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-218; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; Qi C, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-01130-8; Rice JS, 2017, WATER RESOUR RES, V53, P4393, DOI 10.1002/2016WR020097; Sakizadeh M, 2019, ECOTOX ENVIRON SAFE, V182, DOI 10.1016/j.ecoenv.2019.109387; Sato RC, 2013, EINSTEIN-SAO PAULO, V11, P128, DOI 10.1590/S1679-45082013000100024; Song G, 1999, CHINESE MED J-PEKING, V112, P472; Sun L, 2018, EPIDEMIOL INFECT, V146, P1680, DOI [10.1017/S0950268818002030, 10.1017/s0950268818002030]; Wang LZ, 2021, SCI TOTAL ENVIRON, V765, DOI 10.1016/j.scitotenv.2020.142760; Wang T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1404-7; Wang YW, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025773; WINTERS PR, 1960, MANAGE SCI, V6, P324, DOI 10.1287/mnsc.6.3.324; Wu Wei, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P1394; Wu W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135492; Xiang JJ, 2018, SCI TOTAL ENVIRON, V636, P1249, DOI 10.1016/j.scitotenv.2018.04.407; Xiao H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061536; Yan L, 2007, EMERG INFECT DIS, V13, P1301, DOI 10.3201/eid1309.061481; Yu XJ, 2014, J INFECT DIS, V210, P1693, DOI 10.1093/infdis/jiu336; Zhai BX, 2018, SCI TOTAL ENVIRON, V635, P644, DOI 10.1016/j.scitotenv.2018.04.040; Zhao QL, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014640; Zhao YL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207518; Zou LX, 2016, INT J INFECT DIS, V43, P95, DOI 10.1016/j.ijid.2016.01.003	36	4	4	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0248597	10.1371/journal.pone.0248597	http://dx.doi.org/10.1371/journal.pone.0248597			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY1VJ	33725011	gold, Green Published			2022-12-26	WOS:000629833700007
J	Dan-Nwafor, CC; Adeoye, I; Aderemi, K; Onuoha, M; Adedire, E; Bashorun, A; Osunkwo, D; Gidado, S; Balogun, M; Idris, S; Ade-Yusuf, I; Udom, E; Nguku, P				Dan-Nwafor, Chioma Cindy; Adeoye, Ikeola; Aderemi, Kehinde; Onuoha, Martins; Adedire, Elizabeth; Bashorun, Adebobola; Osunkwo, Damaris; Gidado, Saheed; Balogun, Muhammad; Idris, Suleiman; Ade-Yusuf, Ibrahim; Udom, Ekpedeme; Nguku, Patrick			Serological markers and risk factors associated with Hepatitis B virus infection among Federal Capital Territory prison inmates, Nigeria: Should we be concerned?	PLOS ONE			English	Article							PREVALENCE; HIV; DISEASES; EPIDEMIOLOGY; TRANSMISSION; ANTIBODIES	Introduction Hepatitis B virus (HBV) infection is hyper-endemic in Nigeria. Prisons are high-risk environments for the spread of infectious diseases. Worldwide, seroprevalence of HBV infection is substantially higher among individuals in correctional facilities when compared to general population. We determined the seroprevalence and risk factors associated with HBV infection among Kuje prison inmates, Nigeria. Material and methods We conducted a prison facility based cross-sectional study. Interviewer administered questionnaires were used to obtain information on participants socio-demographic characteristics, HBV risk factors, previous HBV test and vaccination history. Blood samples collected from participants were analysed for HBsAg, HBsAb, HBcAb, HBeAg and HBeAb markers using rapid lateral chromatographic immunoassay kit. Univariate, bivariate, and multivariate analysis were performed. Results A total of 271 inmates (63 convicts and 208 awaiting trial inmates) were recruited into the study as participants. The mean age of the participants was 32.7 SD +/- 9 years. HBV seroprevalence (HBsAg) of 13.7% (95% CI: 9.8-18.3) was found. 55.4% (95% CI: 49.2-61.4) of inmates were susceptible to HBV infection, 20.7% (95%CI; 16.0-26.0) had past HBV infection while 10.3% (95% CI: 7.0-14.6) had acquired natural or artificial HBV immunity. Factors found to be associated with current HBV infection (HBsAg) include age-group <= 25years (aOR = 8.0,95% CI: 2.9-22.3), being ever married (aOR = 4.2, 95% CI: 1.7-10.4) and history of alcohol consumption (aOR = 3.4, 95% CI: 1.3-8.4). Conclusion This study reveals a high seroprevalence of HBV infection among Kuje Prison inmates, hence the need to introduce prison-focused health intervention initiatives such as HBV screening, vaccination and care to reduce the transmission of HBV infection among inmates and ultimately the general population.	[Dan-Nwafor, Chioma Cindy; Onuoha, Martins; Adedire, Elizabeth; Bashorun, Adebobola; Osunkwo, Damaris; Gidado, Saheed; Balogun, Muhammad; Nguku, Patrick] Nigeria Field Epidemiol & Lab Training Programme, Decatur, GA 30030 USA; [Adeoye, Ikeola] Univ Ibadan, Dept Epidemiol & Med Stat, Ibadan, Nigeria; [Aderemi, Kehinde] Univ Ibadan, Dept Med Microbiol & Parasitol, Coll Med, Ibadan, Nigeria; [Onuoha, Martins; Ade-Yusuf, Ibrahim; Udom, Ekpedeme] Nigerian Prisons Serv Headquarters, Abuja, Nigeria; [Idris, Suleiman] Ahmadu Bello Univ, Dept Community Med, Zaria, Nigeria	University of Ibadan; University of Ibadan; Ahmadu Bello University	Dan-Nwafor, CC (corresponding author), Nigeria Field Epidemiol & Lab Training Programme, Decatur, GA 30030 USA.	cindychomy@yahoo.com	Adedire, Elizabeth/HDM-6344-2022; Adeoye, Ikeola/HIA-0882-2022	Balogun, Muhammad Shakir/0000-0002-4846-9698; Idris Hadejia, Suleman/0000-0002-3816-3986				Adjei AA, 2006, J MED MICROBIOL, V55, P593, DOI 10.1099/jmm.0.46414-0; Adjei AA, 2007, J MED MICROBIOL, V56, P391, DOI 10.1099/jmm.0.46859-0; Adoga MP, 2009, J INFECT DEV COUNTR, V3, P539, DOI 10.3855/jidc.472; Allwright S, 2000, BRIT MED J, V321, P78, DOI 10.1136/bmj.321.7253.78; Aluede O., 2010, CURRENT RES J SOCIAL, V2, P65; AMAZIGO UO, 1990, E AFR MED J, V67, P539; Aminu M, 2013, ANN AFR MED, V12, P55, DOI 10.4103/1596-3519.108257; [Anonymous], 1982, MMWR, P327; Awopetu RG., 2014, IOSR J HUM SOC SCI, V19, P21; Babudieri S, 2005, J MED VIROL, V76, P311, DOI 10.1002/jmv.20375; Bell BP, 2012, MANUAL SURVEILLANCE; Belo AC, 2000, E AFR MED J, V77, P283; Bird S M, 2000, Commun Dis Public Health, V3, P308; Burattini MN, 2000, REV SAUDE PUBL, V34, P431, DOI 10.1590/S0034-89102000000500001; Butler TG, 1997, MED J AUSTRALIA, V166, P127, DOI 10.5694/j.1326-5377.1997.tb140041.x; Catalan-Soares B C, 2000, Rev Soc Bras Med Trop, V33, P27, DOI 10.1590/S0037-86822000000100004; Centers for Disease Control and Prevention, 2002, MMWR, V53, P678; Centers for disease control and prevention, HEP B EP PREV VACC P, V13; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Fageeh WMK, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-290; Fazel S, 2011, LANCET, V377, P956, DOI 10.1016/S0140-6736(10)61053-7; Forbi JC, 2008, REV INST MED TROP SP, V50, P219, DOI 10.1590/S0036-46652008000400006; Hunt DR, 2009, AM J GASTROENTEROL, V104, P1024, DOI 10.1038/ajg.2008.143; Hutchinson SJ, 1998, EPIDEMIOL INFECT, V121, P185, DOI 10.1017/S0950268898001022; Jaquet A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1601-4; Kakar N., 2014, BALOCHISTANGLO ADV R, P367; Kelley M., 2004, Morbidity and Mortality Weekly Report, V53, P681; Khan AJ, 2005, AM J PUBLIC HEALTH, V95, P1793, DOI 10.2105/AJPH.2004.047753; Kiire CF, 1996, GUT, V38, pS5, DOI 10.1136/gut.38.Suppl_2.S5; Kish L, 1965, SURVEY SAMPLING; Kowdley KV, 2006, MEDGENMED, P2; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Macalino GE, 2004, AM J PUBLIC HEALTH, V94, P1218, DOI 10.2105/AJPH.94.7.1218; Madhava V, 2002, LANCET INFECT DIS, V2, P293, DOI 10.1016/S1473-3099(02)00264-5; Mahfoud Z, 2010, J INFECT DEV COUNTR, V4, P144, DOI 10.3855/jidc.517; Malliori M, 1998, ADDICTION, V93, P243, DOI 10.1046/j.1360-0443.1998.9322438.x; Mbaawuaga E.M., 2014, J MED MICROBIOL, V4, P1; Mbamara SU., 2010, NIGERIAN MED J, P152; Miranda AE, 2000, SEX TRANSM DIS, V27, P491, DOI 10.1097/00007435-200010000-00001; Musa BM, 2015, NIGER J CLIN PRACT, V18, P163, DOI 10.4103/1119-3077.151035; National Programme on Immunization and Partners, 2002, 5 YEARS NAT STRAT PL, P19; Nwokediuko S., 2009, INTERNET J GASTROENT, P1; Okoli CC, 2003, NIG J PAED, P8; Olayinka AT, 2016, AM J TROP MED HYG, V95, P902, DOI 10.4269/ajtmh.15-0874; Sadoh A.E., 2013, NIGER J PAEDIAT, V40, P248; Sahajian F, 2007, EUR J PUBLIC HEALTH, V17, P263, DOI 10.1093/eurpub/ckl233; Recio RS, 2016, GAC SANIT, V30, P208, DOI 10.1016/j.gaceta.2016.01.010; Senok AC, 2006, J MED MICROBIOL, V55, P481, DOI 10.1099/jmm.0.46535-0; Sequera VG, 2015, HUM VACC IMMUNOTHER, V11, P2615, DOI 10.1080/21645515.2015.1051269; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Solomon L, 2004, J URBAN HEALTH, V81, P25, DOI 10.1093/jurban/jth085; Stark K, 1997, INT J EPIDEMIOL, V26, P1359, DOI 10.1093/ije/26.6.1359; Suckling RM, 2006, J HOSP INFECT, V64, P271, DOI 10.1016/j.jhin.2006.06.024; Terwase JM., 2015, INT J PREV TREAT, P2933; Tonetto PA, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-149; UNODC, 2006, HIV AIDS PREV CAR TR, P1; Weild A R, 2000, Commun Dis Public Health, V3, P121; White MC, 1999, WESTERN J MED, V170, P177	58	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248045	10.1371/journal.pone.0248045	http://dx.doi.org/10.1371/journal.pone.0248045			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8JZ	33705419	Green Published, Green Submitted, gold			2022-12-26	WOS:000629590400021
J	de Almeida, JR; Pachon, DMR; Franceschini, LM; dos Santos, IB; Ferrarezi, JA; de Andrade, PAM; Monteiro-Vitorello, CB; Labate, CA; Quecine, MC				de Almeida, Jaqueline Raquel; Riano Pachon, Diego Mauricio; Franceschini, Livia Maria; dos Santos, Isaneli Batista; Ferrarezi, Jessica Aparecida; Maia de Andrade, Pedro Avelino; Monteiro-Vitorello, Claudia Barros; Labate, Carlos Alberto; Quecine, Maria Carolina			Revealing the high variability on nonconserved core and mobile elements of Austropuccinia psidii and other rust mitochondrial genomes	PLOS ONE			English	Article								Mitochondrial genomes are highly conserved in many fungal groups, and they can help characterize the phylogenetic relationships and evolutionary biology of plant pathogenic fungi. Rust fungi are among the most devastating diseases for economically important crops around the world. Here, we report the complete sequence and annotation of the mitochondrial genome of Austropuccinia psidii (syn. Puccinia psidii), the causal agent of myrtle rust. We performed a phylogenomic analysis including the complete mitochondrial sequences from other rust fungi. The genome composed of 93.299 bp has 73 predicted genes, 33 of which encoded nonconserved proteins (ncORFs), representing almost 45% of all predicted genes. A. psidii mtDNA is one of the largest rust mtDNA sequenced to date, most likely due to the abundance of ncORFs. Among them, 33% were within intronic regions of diverse intron groups. Mobile genetic elements invading intron sequences may have played significant roles in size but not shaping of the rust mitochondrial genome structure. The mtDNAs from rust fungi are highly syntenic. Phylogenetic inferences with 14 concatenated mitochondrial proteins encoded by the core genes placed A. psidii according to phylogenetic analysis based on 18S rDNA. Interestingly, cox1, the gene with the greatest number of introns, provided phylogenies not congruent with the core set. For the first time, we identified the proteins encoded by three A. psidii ncORFs using proteomics analyses. Also, the orf208 encoded a transmembrane protein repressed during in vitro morphogenesis. To the best of our knowledge, we presented the first report of a complete mtDNA sequence of a member of the family Sphaerophragmiacea.	[de Almeida, Jaqueline Raquel; Franceschini, Livia Maria; dos Santos, Isaneli Batista; Ferrarezi, Jessica Aparecida; Maia de Andrade, Pedro Avelino; Monteiro-Vitorello, Claudia Barros; Labate, Carlos Alberto; Quecine, Maria Carolina] Univ Sao Paulo, Luiz de Queiroz Coll Agr ESALQ, Dept Genet, Piracicaba, SP, Brazil; [Riano Pachon, Diego Mauricio] Univ Sao Paulo, Ctr Nucl Energy Agr CENA, Piracicaba, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Quecine, MC (corresponding author), Univ Sao Paulo, Luiz de Queiroz Coll Agr ESALQ, Dept Genet, Piracicaba, SP, Brazil.	mquecine@usp.br	Labate, Carlos Alberto/L-2183-2015; Riaño-Pachón, Diego Mauricio/B-4891-2014; Monteiro-Vitorello, Claudia B/F-2436-2012	Labate, Carlos Alberto/0000-0001-7309-1300; Riaño-Pachón, Diego Mauricio/0000-0001-9803-3465; Monteiro-Vitorello, Claudia B/0000-0002-1238-9354; Verdi, Maria/0000-0002-9524-941X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP [2014/16804-4]; FAPESP [2016/16868-8, 2015/14344-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP (Grant 2014/16804-4). We thank FAPESP for the fellowship award to JRA (2016/16868-8) and LMF (2015/14344-9). We also thank Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for the fellowship award to IBS and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) to JAF and PAMA.	Aguileta G, 2014, GENOME BIOL EVOL, V6, P451, DOI 10.1093/gbe/evu028; Al-Reedy RM, 2012, FUNGAL GENET BIOL, V49, P2, DOI 10.1016/j.fgb.2011.11.008; Aliyu SR, 2019, FUNGAL GENET BIOL, V127, P23, DOI 10.1016/j.fgb.2019.02.010; Ambrosio AB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-91; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bartelli TF, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00166; Beaudet D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060768; Beck N., 2010, MFANNOT; Beenken L, 2017, PHYTOTAXA, V297, P53, DOI 10.11646/phytotaxa.297.1.5; Bini AP, 2018, EUR J PLANT PATHOL, V150, P735, DOI 10.1007/s10658-017-1321-7; Bini AP., 2016, THESIS ESCOLA SUPERI, DOI [11/11137/tde-10112016-161846/pt-br.php, DOI 11/11137/TDE-10112016-161846/PT-BR.PHP]; Borriello R, 2014, MOL PHYLOGENET EVOL, V75, P1, DOI 10.1016/j.ympev.2014.02.012; Bullerwell CE, 2005, CURR OPIN MICROBIOL, V8, P362, DOI 10.1016/j.mib.2005.06.009; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Chang AL, 2018, MBIO, V9, DOI 10.1128/mBio.01375-18; Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757; Chi SI, 2019, BMC MOL BIOL, V20, DOI 10.1186/s12867-019-0134-y; de Queiroz CB, 2018, APPL MICROBIOL BIOT, V102, P2763, DOI 10.1007/s00253-018-8812-0; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Dodds PN, 2009, NEW PHYTOL, V183, P993, DOI 10.1111/j.1469-8137.2009.02922.x; dos Santos IB, 2019, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01978; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Formighieri EF, 2008, MYCOL RES, V112, P1136, DOI 10.1016/j.mycres.2008.04.014; Gonzalez P, 1998, GENE, V220, P45, DOI 10.1016/S0378-1119(98)00421-1; Graca RN, 2013, MOL ECOL, V22, P6033, DOI 10.1111/mec.12545; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Ho Y, 1997, P NATL ACAD SCI USA, V94, P8994, DOI 10.1073/pnas.94.17.8994; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hurst GDD, 2001, NAT REV GENET, V2, P597, DOI 10.1038/35084545; James TY, 2013, CURR BIOL, V23, P1548, DOI 10.1016/j.cub.2013.06.057; Jelen V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148525; Jia WL, 2008, MOL BIOL EVOL, V25, P339, DOI 10.1093/molbev/msm259; Jimenez-Becerril MF, 2018, MITOCHONDRIAL DNA A, V29, P1, DOI 10.1080/24701394.2016.1229776; Joardar V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-698; Junghans DT, 2003, THEOR APPL GENET, V108, P175, DOI 10.1007/s00122-003-1415-9; Keren I, 2009, RNA, V15, P2299, DOI 10.1261/rna.1776409; Kim JO, 2016, MITOCHONDRIAL DNA A, V27, P4547, DOI 10.3109/19401736.2015.1101556; Kolesnikova AI, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5732-z; Kretschmer M, 2018, MOL MICROBIOL, V107, P488, DOI 10.1111/mmi.13894; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lambowitz AM, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0050-2014; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Leite TF, 2013, AUSTRALAS PLANT PATH, V42, P79, DOI 10.1007/s13313-012-0179-6; Li C, 2020, MITOCHONDRIAL DNA B, V5, P29, DOI 10.1080/23802359.2019.1674744; Li Q, 2018, APPL MICROBIOL BIOT, V102, P6143, DOI 10.1007/s00253-018-9082-6; Li Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep13892; Lopes MS, 2017, THESIS ESCOLA SUPERI, DOI [11/11137/tde-22032018-145215/pt-br.php, DOI 11/11137/TDE-22032018-145215/PT-BR.PHP]; Losada L, 2014, FEMS MICROBIOL LETT, V352, P165, DOI 10.1111/1574-6968.12387; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Machado PD, 2015, TROP PLANT PATHOL, V40, P5, DOI 10.1007/s40858-014-0002-8; Maddison W.P., 2018, MESQUITE MODULAR SYS; Makinson R., 2018, MYRTLE RUST REVIEWED; McTaggart AR, 2018, PLANT PATHOL, V67, P729, DOI 10.1111/ppa.12763; McTaggart AR, 2020, EUR J PLANT PATHOL, V156, P537, DOI 10.1007/s10658-019-01903-y; Medina R, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00978; Monteilhet C, 2000, NUCLEIC ACIDS RES, V28, P1245, DOI 10.1093/nar/28.5.1245; Nadimi M, 2016, MOL PHYLOGENET EVOL, V98, P74, DOI 10.1016/j.ympev.2016.01.009; Nylander JAA., 2004, BIOINFORMATICS; Pantou MP, 2008, GENE, V419, P7, DOI 10.1016/j.gene.2008.04.009; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quecine MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145343; Quecine MC, 2014, PLANT DIS, V98, P16, DOI 10.1094/PDIS-03-13-0332-RE; Robicheau BM, 2017, FUNGAL BIOL-UK, V121, P212, DOI 10.1016/j.funbio.2016.11.007; Salavirta H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097141; Sandhu KS, 2016, PLANT PATHOL, V65, P1084, DOI 10.1111/ppa.12501; SCHAFER B, 1994, CURR GENET, V25, P336, DOI 10.1007/BF00351487; Schuster A, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0928-9; Shen XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116466; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Song N, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00863; Tan Mui-Keng, 2014, Mycology, V5, P52; Tang GF, 2018, MOL PLANT PATHOL, V19, P1595, DOI 10.1111/mpp.12633; Tillich M, 2017, NUCLEIC ACIDS RES, V45, pW6, DOI 10.1093/nar/gkx391; Tobias PA., 2020, AUSTROPUCCINIA PSIDI, DOI [10.1101/2020.03.18.996108, DOI 10.1101/2020.03.18.996108]; Torriani SFF, 2008, FUNGAL GENET BIOL, V45, P628, DOI 10.1016/j.fgb.2007.12.005; Torriani SFF, 2014, FUNGAL GENET BIOL, V62, P34, DOI 10.1016/j.fgb.2013.11.001; VANOMMEN GJB, 1980, CELL, V20, P173, DOI 10.1016/0092-8674(80)90245-7; VAUGHN JC, 1995, J MOL EVOL, V41, P563, DOI 10.1007/BF00175814; Wang PF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01823-z; Winter G., HEDWIGIA, V23, P164; Wu BJ, 2014, G3-GENES GENOM GENET, V4, P605, DOI 10.1534/g3.113.009910; Zhang S, 2017, APPL MICROBIOL BIOT, V101, P1593, DOI 10.1007/s00253-017-8112-0; Zhang YJ, 2015, FUNGAL GENET BIOL, V77, P95, DOI 10.1016/j.fgb.2015.04.009; Zoschke R, 2010, P NATL ACAD SCI USA, V107, P3245, DOI 10.1073/pnas.0909400107; Zubaer A, 2019, MITOCHONDRIAL DNA A, V30, P835, DOI 10.1080/24701394.2019.1687691	91	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248054	10.1371/journal.pone.0248054	http://dx.doi.org/10.1371/journal.pone.0248054			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705433	gold, Green Published			2022-12-26	WOS:000629590400085
J	Rumain, B; Schneiderman, M; Geliebter, A				Rumain, Barbara; Schneiderman, Moshe; Geliebter, Allan			Prevalence of COVID-19 in adolescents and youth compared with older adults in states experiencing surges	PLOS ONE			English	Article								Purpose There has been considerable controversy regarding susceptibility of adolescents (10-19 years) and youth (15-24 years) to COVID-19. However, a number of studies have reported that adolescents are significantly less susceptible than older adults. Summer 2020 provided an opportunity to examine data on prevalence since after months of lockdowns, with the easing of restrictions, people were mingling, leading to surges in cases. Methods We examined data from Departments of Health websites in six U.S. states experiencing surges in cases to determine prevalence of COVID-19, and two prevalence-related measures, in adolescents and youth as compared to older adults. The two other measures related to prevalence were: (Percentage of cases observed in a given age group) divided by (percentage of cases expected based on population demographics); and percentage deviation, or [(% observed-% expected)/ % expected] x 100. Results Prevalence of COVID-19 for adolescents and for youth was significantly greater than for older adults (p < .00001), as was percentage observed divided by percentage expected (p < .005). The percentage deviation was significantly greater in adolescents/youth than in older adults (p < 0.00001) when there was an excess of observed cases over what was expected, and significantly less when observed cases were fewer than expected (p< 0.00001). Conclusions Our results are contrary to previous findings that adolescents are less susceptible than older adults. Possible reasons for the findings are suggested, and we note that public health messaging targeting adolescents and youth might be helpful in curbing the pandemic. Also, the findings of the potential for high transmission among adolescents and youth, should be factored into decisions regarding school reopening.	[Rumain, Barbara] New York Med Coll, Dept Pediat, New York, NY 10595 USA; [Rumain, Barbara] Touro Coll & Univ Syst, Dept Psychol, New York, NY 10001 USA; [Schneiderman, Moshe] SUNY Downstate Coll Med, Brooklyn, NY USA; [Geliebter, Allan] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA	New York Medical College; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Icahn School of Medicine at Mount Sinai	Rumain, B (corresponding author), New York Med Coll, Dept Pediat, New York, NY 10595 USA.; Rumain, B (corresponding author), Touro Coll & Univ Syst, Dept Psychol, New York, NY 10001 USA.	barbara.rumain@touro.edu						American Academy of Pediatrics, CHILDREN COVID 19 ST; [Anonymous], NEW YORK TIMES; Bi QF, 2020, LANCET INFECT DIS, V20, P911, DOI 10.1016/S1473-3099(20)30287-5; Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4; CDC, COVID 19 CASE SURVEI; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9; de Lusignan S, 2020, LANCET INFECT DIS, V20, P1034, DOI 10.1016/S1473-3099(20)30371-6; Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702; Kuchar E, 2021, EUR J CLIN MICROBIOL, V40, P541, DOI 10.1007/s10096-020-04038-9; Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Park YJ, 2020, EMERG INFECT DIS, V26, P2465, DOI 10.3201/eid2610.201315; Robert Redfield, 2020, NBC NEWS; Schneiderman M., 2020, SCIENCE; Viner RM, 2021, JAMA PEDIATR, V175, P143, DOI 10.1001/jamapediatrics.2020.4573; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zhang JJ, 2020, SCIENCE, V368, P1481, DOI 10.1126/science.abb8001	18	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0242587	10.1371/journal.pone.0242587	http://dx.doi.org/10.1371/journal.pone.0242587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690600	Green Published, Green Submitted, gold			2022-12-26	WOS:000627854700025
J	Singh, P; Singh, KK; Singh, P				Singh, Pragya; Singh, Kaushalendra Kumar; Singh, Pooja			Factors explaining the dominion status of female sterilization in India over the past two decades (1992-2016): A multilevel study	PLOS ONE			English	Article								Background Female sterilization is a permanent method of contraception practiced widely in India. Though, the important evidences of behavior of contraceptives is widespread in the literature, relatively less research has been conducted that explores particularly female sterilization method and how its behavior has remained dominant over the past two decades. The present study aims to examine how the level of women's socio-demographic and fertility related characteristics intersect to shape the behavior for the dominance of female sterilization. Methods This study was based on pooled data from 1992-93, 1998-99, 2005-06 and 2015-16 India's DHS (NFHS) surveys. The outcome variable of the study was different types of contraceptive methods used. Multinomial logistic model has been applied to examine the relationship between the dependent variable and the explanatory variables. The software STATA version14 has been used for the entire analysis. Result The result of this study clearly demonstrates the evidence of continuing sterilization dominance in the India's family planning program. The choice of different types of contraceptive methods is influenced by the longstanding heterogeneity of population associated with religion and the caste system. Reliance over female sterilization was observed in almost all parts of the country with southern India being the leading zone. Women in the lowest wealth quintile, uneducated, higher parity, and less exposed to media were more likely to use sterilization as a method of birth control. Conclusion The study was successful in identifying the factors behind the excessive dependency on female sterilization and also highlights the weakness of family planning program to promote other useful modern methods over the past two decades.	[Singh, Pragya; Singh, Kaushalendra Kumar; Singh, Pooja] Banaras Hindu Univ, Inst Sci, Dept Stat, Varanasi, Uttar Pradesh, India	Banaras Hindu University (BHU)	Singh, P (corresponding author), Banaras Hindu Univ, Inst Sci, Dept Stat, Varanasi, Uttar Pradesh, India.	statisticspragya411@gmail.com						Alfred B.C., 2014, DEATHS MASS STERILIZ; Alfred C, 2014, DEATHS MASS STERILIZ; Bairagi R, 2001, INT FAM PLAN PERSPEC, V27, P137, DOI 10.2307/2673835; Barman Subhash, 2013, Journal of Human Ecology, V42, P53; Biswas B, 2020, INDAN J COMMUNITY HE, V32, P378; Bose A, 1993, INDIAN ASIAN POPULAT; de Oliveira IT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086654; Dhar A, 2012, HINDU, P15; Dwivedi Laxmi Kant, 2007, Genus, V63, P19; Edmeades J, 2011, GLOB PUBLIC HEALTH, V6, P407, DOI 10.1080/17441692.2010.533686; Ezeh OK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006779; Harkavy O., 2007, GLOBAL FAMILY PLANNI, V301; IIPS, NATL FAMILY HLTH SUR; IIPS M., 1995, NATL FAMILY HLTH SUR; India HR, 2012, INDIA TARGET DRIVEN; International Institute for Population Sciences, 2007, NATL FAMILY HLTH SUR; International Institute for Population Sciences ORC Macro, 2000, MEASUREDHS PROGR IND; Jennings EA, 2013, STUD FAMILY PLANN, V44, P67, DOI 10.1111/j.1728-4465.2013.00344.x; Kavanaugh ML, 2018, CONTRACEPTION, V97, P14, DOI 10.1016/j.contraception.2017.10.003; Koenig MA, 2000, STUD FAMILY PLANN, V31, P1, DOI 10.1111/j.1728-4465.2000.00001.x; Leone Tiziana, 2007, Genus, V63, P77; Matthews Z, 2009, DEMOGR RES, V20, P693, DOI 10.4054/DemRes.2009.20.28; Mohanty SK, 2020, BMC WOMENS HEALTH, V20, DOI 10.1186/s12905-020-0884-1; OBERMEYER CM, 1994, STUD FAMILY PLANN, V25, P41, DOI 10.2307/2137988; Padmadas SS, 2004, INT FAM PLAN PERSPEC, V30, P12, DOI 10.1363/3001204; Perianayagam Arokiasamy, 2002, International Journal of Population Geography, V8, P49, DOI 10.1002/ijpg.236; Pradhan MR, 2019, SEX REPROD HEALTHC, V19, P56, DOI 10.1016/j.srhc.2018.12.006; Raj A, 2009, LANCET, V373, P1883, DOI 10.1016/S0140-6736(09)60246-4; RAJARETNAM T, 1994, STUD FAMILY PLANN, V25, P111, DOI 10.2307/2138088; Ram F, 2014, INDIAN J MED RES, V140, P17; Rama Baru, 2010, Economic and Political Weekly, V45, P49; Saavala M, 1999, STUD FAMILY PLANN, V30, P288, DOI 10.1111/j.1728-4465.1999.t01-1-.x; Sachedina Zulie, 1990, INT FAM PLAN PERSPEC, V16, P107, DOI 10.2307/2133308; Santhya KG, CHANGING FAMILY PLAN; Shankardass MK, **DROPPED REF**; Singh A, 2012, INT PERSPECT SEX R H, V38, P187, DOI 10.1363/3818712; Singh P, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08917-w; Srinivasan K., 2006, INT I POPULATION SCI, V47, P6; Srinivasan K., 1995, REGULATING REPROD IN; Underwood C, 2000, INT FAM PLAN PERSPEC, V26, P110, DOI 10.2307/2648299	40	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0246530	10.1371/journal.pone.0246530	http://dx.doi.org/10.1371/journal.pone.0246530			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QV3DA	33690636	gold, Green Published			2022-12-26	WOS:000627854700013
J	Rodriguez-Ramos, A; Moriana, JA; Garcia-Torres, F; Ruiz-Rubio, M				Rodriguez-Ramos, Angel; Antonio Moriana, Juan; Garcia-Torres, Francisco; Ruiz-Rubio, Manuel			Emotional stability is related to 2D:4D and social desirability in women: Possible implications on subjective well-being and psychopathology	PLOS ONE			English	Article							DIGIT RATIO 2D/4D; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; POLYCYSTIC-OVARY-SYNDROME; 5 FACTOR MODEL; GENDER-DIFFERENCES; PERSONALITY-TRAITS; DISRUPTIVE BEHAVIOR; PRENATAL ANDROGEN; SEX; DEPRESSION	Emotional stability-Neuroticism is a complex construct influenced by genetics and environmental factors. Women tend to exhibit higher neuroticism scores than men, which may be associated with an increased risk of suffering from some common mental conditions. Some authors have pointed out the influence of sex hormones, since they induce sexual differentiation of the brain that can lead to sex-specific behaviors. 2D:4D digit ratio is commonly used as a marker of prenatal sex hormones. In this study we analyzed whether there was an association between 2D:4D and personality measured through the BFQ in a homogeneous sample of 101 young women college students. We found a positive association between 2D:4D and emotional stability, as well as with its subdimensions emotion control and impulse control. This association could be quadratic and nonlinear. However, no association was found with the other four dimensions. We also measured anxiety, depression and global life satisfaction, variables related to neuroticism. We observed that emotional stability is positively associated to social desirability and global life satisfaction, and negatively related to anxiety and depression. On the other hand, we did not find any association between 2D:4D and anxiety, depression, and global life satisfaction. These results can be linked to other aspects such as subjective well-being and psychopathological symptoms. This study may help to better understand how these constructs are related and could lead to future projects to elucidated how these variables influence personality.	[Rodriguez-Ramos, Angel; Ruiz-Rubio, Manuel] Univ Cordoba, Dept Genet, Cordoba, Spain; [Rodriguez-Ramos, Angel; Antonio Moriana, Juan; Garcia-Torres, Francisco] Univ Cordoba, Dept Psychol, Cordoba, Spain; [Rodriguez-Ramos, Angel; Antonio Moriana, Juan; Garcia-Torres, Francisco; Ruiz-Rubio, Manuel] Maimonides Biomed Res Inst Cordoba IMIBIC, Cordoba, Spain; [Rodriguez-Ramos, Angel; Antonio Moriana, Juan; Garcia-Torres, Francisco; Ruiz-Rubio, Manuel] Univ Hosp Reina Sofia Cordoba, Cordoba, Spain	Universidad de Cordoba; Universidad de Cordoba	Rodriguez-Ramos, A (corresponding author), Univ Cordoba, Dept Genet, Cordoba, Spain.; Rodriguez-Ramos, A (corresponding author), Univ Cordoba, Dept Psychol, Cordoba, Spain.; Rodriguez-Ramos, A (corresponding author), Maimonides Biomed Res Inst Cordoba IMIBIC, Cordoba, Spain.; Rodriguez-Ramos, A (corresponding author), Univ Hosp Reina Sofia Cordoba, Cordoba, Spain.	angel.rguezramos@gmail.com	Garcia-Torres, Francisco/G-7095-2014; Garcia-Torres, Francisco/Q-2095-2019; Moriana, Juan Antonio/D-7718-2015	Garcia-Torres, Francisco/0000-0002-5129-6951; Garcia-Torres, Francisco/0000-0002-5129-6951; Moriana, Juan Antonio/0000-0003-0577-821X; Ruiz-Rubio, Manuel/0000-0001-8733-4377; Rodriguez Ramos, Angel/0000-0002-4461-9783	Junta de Andalucia, Spain [BIO-272]; group GC20 'Genetics and Behavioral Diseases' from the IMIBIC, Spain; University of Cordoba, Spain	Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission); group GC20 'Genetics and Behavioral Diseases' from the IMIBIC, Spain; University of Cordoba, Spain	The research work was supported by the group BIO-272, grant to Manuel Ruiz-Rubio from Junta de Andalucia, Spain (https://www.juntadeandalucia.es); group GC20 'Genetics and Behavioral Diseases' from the IMIBIC, Spain (https://www.imibic.org); and by the University of Cordoba, Spain (https://www.uco.es).	Andrejevic M, 2017, COGN AFFECT BEHAV NE, V17, P1255, DOI 10.3758/s13415-017-0548-2; Austin EJ, 2002, PERS INDIV DIFFER, V33, P1115, DOI 10.1016/S0191-8869(02)00002-8; Auyeung B, 2013, PFLUG ARCH EUR J PHY, V465, P557, DOI 10.1007/s00424-013-1268-2; Bagepally BS, 2020, AM J HUM BIOL, V32, DOI 10.1002/ajhb.23331; Bailey AA, 2005, PERS INDIV DIFFER, V39, P829, DOI 10.1016/j.paid.2004.12.017; Barel E, 2019, CURR PSYCHOL, V38, P204, DOI 10.1007/s12144-017-9598-4; Barman U, 2019, INT J PHYSL NUTR PHY, V4, P420; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Berenbaum SA, 2011, FRONT NEUROENDOCRIN, V32, P183, DOI 10.1016/j.yfrne.2011.03.001; Brajga-Zganec A, 2011, PSIHOLOGIJSKE TEME, V20, P261; Burton LA, 2013, CURR PSYCHOL, V32, P197, DOI 10.1007/s12144-013-9170-9; Caprara GV., 1993, PERS INDIVID DIF, DOI [10.1016/0191-8869%2893%2990036-3, DOI 10.1016/0191-8869%2893%2990036-3]; Caprara GV., 1995, BFQ CUESTIONARIO BIG; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Catenaccio E, 2016, BRAIN STRUCT FUNCT, V221, P3845, DOI 10.1007/s00429-016-1197-x; Cesta CE, 2017, PSYCHONEUROENDOCRINO, V85, P63, DOI 10.1016/j.psyneuen.2017.08.007; Cho Y., 2008, ENCY SURVEY RES METH, P345; Costa PT, 2001, J PERS SOC PSYCHOL, V81, P322, DOI [10.1037/0022-3514.81.2.322, 10.1037//0022-3514.81.2.322]; de Bruin EI, 2006, DEV MED CHILD NEUROL, V48, P962, DOI 10.1017/S0012162206002118; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Eaton NR, 2012, J ABNORM PSYCHOL, V121, P282, DOI 10.1037/a0024780; Evardone M, 2009, ARCH SEX BEHAV, V38, P442, DOI 10.1007/s10508-007-9260-6; Fink B, 2004, PERS INDIV DIFFER, V37, P495, DOI 10.1016/j.paid.2003.09.018; Fonseca-Pedrero E., 2012, BEHAV PSYCHOL; Goodwin RD, 2004, PSYCHIAT RES, V126, P135, DOI 10.1016/j.psychres.2003.12.024; Hampson E, 2008, ARCH SEX BEHAV, V37, P133, DOI 10.1007/s10508-007-9263-3; Hirsch O, 2018, J AFFECT DISORDERS, V232, P41, DOI 10.1016/j.jad.2018.02.007; Honekopp J, 2011, PERS INDIV DIFFER, V51, P77, DOI 10.1016/j.paid.2011.03.010; Kalichman L, 2019, AM J HUM BIOL, V31, DOI 10.1002/ajhb.23212; Kassem HS., 2009, J MED HUM GENET; Kessler RC, 2010, ARCH GEN PSYCHIAT, V67, P1168, DOI 10.1001/archgenpsychiatry.2010.146; Kim TB, 2016, J EXERC REHABIL, V12, P515, DOI 10.12965/jer.1632862.431; Knouse LE, 2013, J NERV MENT DIS, V201, P848, DOI 10.1097/NMD.0b013e3182a5bf33; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kotov R, 2010, PSYCHOL BULL, V136, P768, DOI 10.1037/a0020327; Krishnakumar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089800; Lautenbacher LM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67882-x; Lenz B, 2018, J NEURAL TRANSM, V125, P239, DOI 10.1007/s00702-017-1815-7; Lindova J, 2008, EUR J PERSONALITY, V22, P347, DOI 10.1002/per.664; Lippa RA, 2006, BIOL PSYCHOL, V71, P116, DOI 10.1016/j.biopsycho.2005.02.004; Lolli L, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0356; Luxen MF, 2005, PERS INDIV DIFFER, V39, P959, DOI 10.1016/j.paid.2005.03.016; Manning J, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00009; Manning JT, 2017, EARLY HUM DEV, V113, P73, DOI 10.1016/j.earlhumdev.2017.09.003; Manning JT, 2011, AM J HUM BIOL, V23, P527, DOI 10.1002/ajhb.21186; Manning JT, 2003, EVOL HUM BEHAV, V24, P399, DOI 10.1016/S1090-5138(03)00052-7; Martel MM, 2009, J ABNORM CHILD PSYCH, V37, P363, DOI 10.1007/s10802-008-9269-x; Martin SM, 1999, EVOL HUM BEHAV, V20, P203, DOI 10.1016/S1090-5138(99)00006-9; Massimino S, 2019, BIOMED REP, V10, P39, DOI 10.3892/br.2018.1174; Messina A, 2010, PSYCHOL REP, V107, P185, DOI 10.2466/02.07.13.15.PR0.107.4.185-192; Nye JVC, 2019, PERS INDIV DIFFER, V142, P85, DOI 10.1016/j.paid.2019.01.031; Pearce E, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0642; Peng CY, 2010, REPROD FERT DEVELOP, V22, P881, DOI 10.1071/RD09190; Quinton SJ, 2011, PERS INDIV DIFFER, V51, P402, DOI 10.1016/j.paid.2010.07.024; Rehbein E, 2021, NEUROENDOCRINOLOGY, V111, P183, DOI 10.1159/000507083; Riecher-Rossler A, 2017, LANCET PSYCHIAT, V4, P8, DOI 10.1016/S2215-0366(16)30348-0; Rinella S, 2019, PEERJ, V7, DOI 10.7717/peerj.8029; Roberts BA, 2013, PERS INDIV DIFFER, V55, P962, DOI 10.1016/j.paid.2013.08.002; Rodriguez-Ramos A, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1376; Rostovtseva V, 2019, SOC EVOL HIST, V18, P110, DOI 10.30884/seh/2019.01.06; Sanz J, 2003, 150 N SALUD; Schwarz S, 2011, ARCH SEX BEHAV, V40, P565, DOI 10.1007/s10508-010-9698-9; Schwerdtfeger A, 2010, ACCIDENT ANAL PREV, V42, P269, DOI 10.1016/j.aap.2009.08.001; Shaw AZ, 2013, PERS INDIV DIFFER, V55, P19, DOI 10.1016/j.paid.2013.01.016; Sindermann C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00811; Smedley KD, 2014, PERS INDIV DIFFER, V70, P136, DOI 10.1016/j.paid.2014.06.039; Soto CJ, 2011, J PERS SOC PSYCHOL, V100, P330, DOI 10.1037/a0021717; Sperandeo R, 2020, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00938; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Steel P, 2008, PSYCHOL BULL, V134, P138, DOI 10.1037/0033-2909.134.1.138; Tov W, 2013, SUBJECTIVE WELLBEING, P1239, DOI [10.1002/9781118339893.wbeccp518, DOI 10.1002/9781118339893.WBECCP518]; Trull Timothy J, 2013, Dialogues Clin Neurosci, V15, P135; Turano A, 2018, CURRENT TOPICS BEHAV, DOI [10.1007/7854%5F2018%5F56, DOI 10.1007/7854%5F2018%5F56]; Uziel L, 2010, PERSPECT PSYCHOL SCI, V5, P243, DOI 10.1177/1745691610369465; Van Dijk FE, 2017, PSYCHIAT RES, V258, P255, DOI 10.1016/j.psychres.2017.08.037; Vazquez C, 2013, SPAN J PSYCHOL, V16, DOI 10.1017/sjp.2013.82; Vigil P, 2016, LINACRE Q, V83, P308, DOI 10.1080/00243639.2016.1211863; Warrington NM, 2018, HUM MOL GENET, V27, P2025, DOI 10.1093/hmg/ddy121; Weisberg YJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00178; Widiger TA, 2019, WORLD PSYCHIATRY, V18, P271, DOI 10.1002/wps.20658; Wong WI, 2016, HORM BEHAV, V78, P86, DOI 10.1016/j.yhbeh.2015.10.022; Zhang KJ, 2020, J NEUROSCI RES, V98, P353, DOI 10.1002/jnr.24502	82	3	3	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2021	16	3							e0248368	10.1371/journal.pone.0248368	http://dx.doi.org/10.1371/journal.pone.0248368			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QV3DJ	33690629	Green Published, gold			2022-12-26	WOS:000627855600032
J	Saab, M; Mestivier, D; Sohrabi, M; Rodriguez, C; Khonsari, MR; Faraji, A; Sobhani, I				Saab, Massa; Mestivier, Denis; Sohrabi, Masoudreza; Rodriguez, Christophe; Khonsari, Mahmood Reza; Faraji, Amirhossein; Sobhani, Iradj			Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; BILE; POPULATION; SURVIVAL; HEALTH	Extrahepatic cholangiocarcinoma (CCA) accounts for 3% of digestive cancers. The role of biliary microbiota as an environment-related modulator has been scarcely investigated in CCA, and the putative impact of associated diseases has not been yet assessed. We characterized the biliary microbiota in CCA patients in order to identify a specific CCA-related dysbiosis. The biliary effluents were collected through an endoscopic retrograde pancreatic cholangiography (ERCP) examination involving 28 CCA and 47 patients with gallstones, herein considered as controls. The biliary effluents were submitted to bacterial DNA extraction and 16S rRNA sequencing, using Illumina technology. Overall, 32% of CCA and 22% of controls displayed another associated disease, such as diabetes, pancreatitis, inflammatory bowel disease, or primary sclerosing cholangitis. Such associated diseases were considered in the comparisons that were made. Principal coordinate analysis (PCoA) detected a significant disparity of biliary microbiota composition between CCA patients and controls without an associated disease. Amongst the most abundant phyla, Proteobacteria did not significantly differ between CCA patients and controls, whereas Firmicutes levels were lower and Bacteroidetes higher in CCAs' biliary microbiota than in the controls' microbiota. The most abundant genera were Enterococcus, Streptococcus, Bacteroides, Klebsiella, and Pyramidobacter in CCA's biliary microbiota. Additionally, levels of Bacteroides, Geobacillus, Meiothermus, and Anoxybacillus genera were significantly higher in CCA patients' biliary microbiota, without an associated disease, in comparison with controls. A specific CCA-related dysbiosis was identified as compared to controls independently from associated diseases. This suggests that a microorganism community may be involved in CCA pathogenesis.	[Saab, Massa; Mestivier, Denis; Sobhani, Iradj] Univ Paris Est Creteil UPEC, EA 7375 Team, Early Detect Colon Canc Using Mol & Microbial Mar, Creteil, France; [Mestivier, Denis; Rodriguez, Christophe; Sobhani, Iradj] UPEC, IMRB UMR 955 INSERM, Bioinformat Core Facil, Creteil, France; [Sohrabi, Masoudreza; Rodriguez, Christophe; Khonsari, Mahmood Reza; Faraji, Amirhossein; Sobhani, Iradj] Iran Univ Med Sci, Gastrointestinal & Liver Dis Res Ctr GILDRC, Tehran, Iran; [Sohrabi, Masoudreza; Rodriguez, Christophe; Khonsari, Mahmood Reza; Faraji, Amirhossein; Sobhani, Iradj] Firouzgar Hosp Prof F Zamani, Tehran, Iran; [Rodriguez, Christophe; Sobhani, Iradj] Inserm U955, Team 8, Creteil, France; [Sobhani, Iradj] CHU Henri Mondor, AP HP, Dept Gastroenterol, Creteil, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Iran University of Medical Sciences; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Saab, M; Sobhani, I (corresponding author), Univ Paris Est Creteil UPEC, EA 7375 Team, Early Detect Colon Canc Using Mol & Microbial Mar, Creteil, France.; Sobhani, I (corresponding author), UPEC, IMRB UMR 955 INSERM, Bioinformat Core Facil, Creteil, France.; Sobhani, I (corresponding author), Iran Univ Med Sci, Gastrointestinal & Liver Dis Res Ctr GILDRC, Tehran, Iran.; Sobhani, I (corresponding author), Firouzgar Hosp Prof F Zamani, Tehran, Iran.; Sobhani, I (corresponding author), Inserm U955, Team 8, Creteil, France.; Sobhani, I (corresponding author), CHU Henri Mondor, AP HP, Dept Gastroenterol, Creteil, France.	massa.saab93@gmail.com; iradj.sobhani@aphp.fr	rodriguez, christophe/B-8024-2012	rodriguez, christophe/0000-0001-8128-4030; Sohrabi, Masoudreza/0000-0001-5688-2776; saab, massa/0000-0001-5786-2056	EC2M3 Lab; UFR Sante-Paris12; UPEC Creteil-France	EC2M3 Lab; UFR Sante-Paris12; UPEC Creteil-France	Funding for DNA analyses: UFR Sante-Paris12; UPEC Creteil-France; this routine annual funding of EC2M3 Lab had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviles-Jimenez F, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.10.008; Aviles-Jimenez F, 2014, SCI REP-UK, V4, DOI 10.1038/srep04202; Bagci C, 2019, METHODS MOL BIOL, V1910, P591, DOI 10.1007/978-1-4939-9074-0_19; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bouvier AM, 2004, GASTROEN CLIN BIOL, V28, P877, DOI 10.1016/S0399-8320(04)95152-4; BROOK I, 1989, J CLIN MICROBIOL, V27, P2373, DOI 10.1128/JCM.27.10.2373-2375.1989; CALLEA F, 1993, J SURG ONCOL, P131; Chen BR, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/1092563; Chen C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00901-0; CROOK PR, 1982, ANN RHEUM DIS, V41, P645, DOI 10.1136/ard.41.6.645; Goh KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090549; Guaglianone E, 2010, FEMS IMMUNOL MED MIC, V59, P410, DOI 10.1111/j.1574-695X.2010.00686.x; Gupta A, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00438-19; Hiramatsu K, 2000, J HEPATOL, V33, P9, DOI 10.1016/S0168-8278(00)80153-1; Hosgood HD, 2014, ENVIRON MOL MUTAGEN, V55, P643, DOI 10.1002/em.21878; Hussein AH, 2015, ADV APPL MICROBIOL, V92, P1, DOI 10.1016/bs.aambs.2015.03.001; Illumina, 16S MET SEQ LIB PREP; Jia XD, 2020, HEPATOLOGY, V71, P893, DOI 10.1002/hep.30852; Jimenez E, 2014, MICROBIOLOGYOPEN, V3, P937, DOI 10.1002/mbo3.218; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; Kawarada Y, 2002, AM J SURG, V183, P679, DOI 10.1016/S0002-9610(02)00853-X; Khan SA, 2019, LIVER INT, V39, P19, DOI 10.1111/liv.14095; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Leung JW, 2001, GASTROINTEST ENDOSC, V54, P340, DOI 10.1067/mge.2001.117547; Liu F, 2019, CANCER MED-US, V8, P6904, DOI 10.1002/cam4.2419; Lu Yun, 2003, Hepatobiliary Pancreat Dis Int, V2, P431; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marschall HU, 2016, HEPATOLOGY, V63, P26, DOI 10.1002/hep.28135; Merritt ME, 2009, J MED MICROBIOL, V58, P1533, DOI 10.1099/jmm.0.014092-0; Ming H, 2015, ANTON LEEUW INT J G, V108, P897, DOI 10.1007/s10482-015-0544-x; Molinero N, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0712-8; Nanjundappa RH, 2017, CELL, V171, P655, DOI 10.1016/j.cell.2017.09.022; Nathan H, 2007, J GASTROINTEST SURG, V11, P1488, DOI 10.1007/s11605-007-0282-0; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pereira P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182924; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; SAKAGUCHI Y, 1983, J CLIN PATHOL, V36, P345, DOI 10.1136/jcp.36.3.345; Schmidt BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098741; Shah AY, 2020, AM J GASTROENTEROL, V115, P814, DOI 10.14309/ajg.0000000000000604; Shen HZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17450; Shin HR, 2010, ASIAN PAC J CANCER P, V11, P1159; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Tan J, 2014, ADV IMMUNOL, V121, P91, DOI 10.1016/B978-0-12-800100-4.00003-9; Verdier J, 2015, VISZERALMEDIZIN, V31, P156, DOI 10.1159/000431071; Vogel A, 2014, DTSCH ARZTEBL INT, V111, P748, DOI 10.3238/arztebl.2014.0748; Welzel TM, 2007, INT J CANCER, V120, P638, DOI 10.1002/ijc.22283; Wu N, 2013, MICROB ECOL, V66, P462, DOI 10.1007/s00248-013-0245-9; Wu P, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00167; Wu T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-669; Ye FQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150519; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209	53	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2021	16	3							e0247798	10.1371/journal.pone.0247798	http://dx.doi.org/10.1371/journal.pone.0247798			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DJ	33690612	Green Published, gold			2022-12-26	WOS:000627855600029
J	Schranz, M; Georgopoulos, M; Sacu, S; Reumueller, A; Reiter, GS; Mylonas, G; Schmidt-Erfurth, U; Pollreisz, A				Schranz, Markus; Georgopoulos, Michael; Sacu, Stefan; Reumueller, Adrian; Reiter, Gregor S.; Mylonas, Georgios; Schmidt-Erfurth, Ursula; Pollreisz, Andreas			Incidence and surgical care of retinal detachment during the first SARS-CoV-2 lockdown period at a tertiary referral center in Austria	PLOS ONE			English	Article								Purpose To assess the influence of the SARS-CoV-2 lockdown in spring on frequency, severity and quality of care of rhegmatogeneous retinal detachments (RRD) in a tertiary referral center in Vienna, Austria. Methods Single center, consecutive case series with historical controls. Patients presenting with primary RRD during the first Austrian SARS-CoV-2 lockdown (March 16th -May 3rd 2020) and a corresponding control group consisting of the same time period of the preceding 3 years. Results The mean number of patients with RD in the reference group (RG) was 22 (+/- 1) and in the lockdown group (LG) 15. Median total delay, defined as onset of symptoms until surgery, in the RG was 5 (lower quartile: 3.0; upper quartile: 8.0) compared to 7 (3.0; 12.0) days in the LG, (p = 0.740). During the lockdown 67% of patients were referred from an external ophthalmologist compared to 52% in the RG, (p = 0.395). 34% of patients in the RG presented with an attached macula compared to 33% in the LG (p = 0.597). PVR was present in 49% of cases in the RG compared to 73% in the LG. Single surgery success (SSS) rates were lower in the LG (73.3%) compared to the RG (85.3%), (p = 0.275). Conclusion Patients with RRD during the SARS-CoV-2 lockdown presented and were treated within acceptable time limits, showed the same macula-on ratios but a higher PVR rate and a tendency towards worse SSS rates compared to the time period of the preceding 3 years.	[Schranz, Markus; Georgopoulos, Michael; Sacu, Stefan; Reumueller, Adrian; Reiter, Gregor S.; Mylonas, Georgios; Schmidt-Erfurth, Ursula; Pollreisz, Andreas] Med Univ Vienna, Dept Ophthalmol & Optometry, Vienna, Austria; [Reiter, Gregor S.; Schmidt-Erfurth, Ursula] Med Univ Vienna, Dept Ophthalmol & Optometry, Christian Doppler Lab, OPTIMA, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Pollreisz, A (corresponding author), Med Univ Vienna, Dept Ophthalmol & Optometry, Vienna, Austria.	andreas.pollreisz@meduniwien.ac.at	Schranz, Markus/HHS-9483-2022	Schranz, Markus/0000-0002-2630-1368; Reiter, Gregor/0000-0001-7661-4015				Algvere PV, 1999, GRAEF ARCH CLIN EXP, V237, P137, DOI 10.1007/s004170050208; Ashour HM, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030186; Borowicz D, 2019, BMC OPHTHALMOL, V19, DOI 10.1186/s12886-019-1120-3; BURTON TC, 1978, OPHTHALMOLOGY, V85, P619; Echegaray JJ, 2021, OPHTHALMOL RETINA, V5, P169, DOI 10.1016/j.oret.2020.09.013; Eijk ESV, 2016, ACTA OPHTHALMOL, V94, P434, DOI 10.1111/aos.13016; GIRARD P, 1995, OPHTHALMOLOGICA, V209, P323, DOI 10.1159/000310651; Goezinne F, 2009, EYE, V23, P1393, DOI 10.1038/eye.2008.272; Heimann H, 2007, OPHTHALMOLOGY, V114, P2142, DOI 10.1016/j.ophtha.2007.09.013; Kouassi AC, 2018, J FR OPHTALMOL, V41, P744, DOI 10.1016/j.jfo.2018.01.022; Lai MM, 2011, RETINA-J RET VIT DIS, V31, P93, DOI 10.1097/IAE.0b013e3181de55f0; Mitry D, 2010, INVEST OPHTH VIS SCI, V51, P4963, DOI 10.1167/iovs.10-5400; Mowatt L, 2003, EYE, V17, P63, DOI 10.1038/sj.eye.6700245; Patel LG, 2021, OPHTHALMOLOGY, V128, P686, DOI 10.1016/j.ophtha.2020.10.009; Ross WH, 1998, OPHTHALMOLOGY, V105, P2149, DOI 10.1016/S0161-6420(98)91142-3	15	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0248010	10.1371/journal.pone.0248010	http://dx.doi.org/10.1371/journal.pone.0248010			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU3OZ	33684142	gold, Green Published			2022-12-26	WOS:000627193500037
J	Dalboni, LC; Saraiva, AMA; Konno, FTD; Perez, EC; Codeceira, JF; Spadacci-Morena, DD; Lallo, MA				Dalboni, Luciane Costa; Alvares Saraiva, Anuska Marcelino; de Camargo Konno, Fabiana Toshie; Perez, Elizabeth Cristina; Codeceira, Jessica Feliciana; Spadacci-Morena, Diva Denelle; Lallo, Maria Anete			Encephalitozoon cuniculi takes advantage of efferocytosis to evade the immune response	PLOS ONE			English	Article							CELL-DEATH; INFECTED NEUTROPHILS; APOPTOSIS; MICROSPORIDIA; PHAGOCYTOSIS; MACROPHAGE; REPLICATION; INHIBITION; FUSION; GROWTH	Microsporidia are recognized as opportunistic pathogens in individuals with immunodeficiencies, especially related to T cells. Although the activity of CD8(+) T lymphocytes is essential to eliminate these pathogens, earlier studies have shown significant participation of macrophages at the beginning of the infection. Macrophages and other innate immunity cells play a critical role in activating the acquired immunity. After programmed cell death, the cell fragments or apoptotic bodies are cleared by phagocytic cells, a phenomenon known as efferocytosis. This process has been recognized as a way of evading immunity by intracellular pathogens. The present study evaluated the impact of efferocytosis of apoptotic cells either infected or not on macrophages and subsequently challenged with Encephalitozoon cuniculi microsporidia. Macrophages were obtained from the bone marrow monocytes from C57BL mice, pre-incubated with apoptotic Jurkat cells (ACs), and were further challenged with E. cuniculi spores. The same procedures were performed using the previously infected Jurkat cells (IACs) and challenged with E. cuniculi spores before macrophage pre-incubation. The average number of spores internalized by macrophages in phagocytosis was counted. Macrophage expression of CD40, CD206, CD80, CD86, and MHCII, as well as the cytokines released in the culture supernatants, was measured by flow cytometry. The ultrastructural study was performed to analyze the multiplication types of pathogens. Macrophages pre-incubated with ACs and challenged with E. cuniculi showed a higher percentage of phagocytosis and an average number of internalized spores. Moreover, the presence of stages of multiplication of the pathogen inside the macrophages, particularly after efferocytosis of infected apoptotic bodies, was observed. In addition, pre-incubation with ACs or IACs and/or challenge with the pathogen decreased the viability of macrophages, reflected as high percentages of apoptosis. The marked expression of CD206 and the release of large amounts of IL-10 and IL-6 indicated the polarization of macrophages to an M2 profile, compatible with efferocytosis and favorable for pathogen development. We concluded that the pathogen favored efferocytosis and polarized the macrophages to an M2 profile, allowing the survival and multiplication of E. cuniculi inside the macrophages and explaining the possibility of macrophages acting as Trojan horses in microsporidiosis.	[Dalboni, Luciane Costa; de Camargo Konno, Fabiana Toshie; Perez, Elizabeth Cristina; Codeceira, Jessica Feliciana; Lallo, Maria Anete] Univ Paulista Unip, Programa Patol Ambiental & Expt, Sao Paulo, Brazil; [Alvares Saraiva, Anuska Marcelino] Univ Cruzeiro Sul, Mestrado & Doutorado Interdisciplinar Ciencias Sa, Sao Paulo, Brazil; [Alvares Saraiva, Anuska Marcelino; Spadacci-Morena, Diva Denelle] Inst Butantan, Lab Fisiopatol, Sao Paulo, Brazil	Universidade Paulista; Universidade Cruzeiro do Sul; Instituto Butantan	Lallo, MA (corresponding author), Univ Paulista Unip, Programa Patol Ambiental & Expt, Sao Paulo, Brazil.	anetelallo@hotmail.com	; Denelle Spadacci-Morena, Diva/P-6390-2015; Alvares-Saraiva, Anuska/J-1128-2016	Lallo, Maria Anete/0000-0003-3578-3087; Feliciana Codeceira, Jessica/0000-0002-2194-011X; Denelle Spadacci-Morena, Diva/0000-0003-1225-1715; Costa Dalboni, Luciane/0000-0001-8457-7656; Alvares-Saraiva, Anuska/0000-0001-8899-4182	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2015/25948-2]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This paper received a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grant number 2015/25948-2 (MAL). LCD received scholarships from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior to JFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LAH, 2000, J EXP MED, V191, P115, DOI 10.1084/jem.191.1.115; Anane S, 2010, GASTROEN CLIN BIOL, V34, P450, DOI 10.1016/j.gcb.2010.07.003; Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3; Behar SM, 2019, CURR OPIN IMMUNOL, V60, P103, DOI 10.1016/j.coi.2019.05.007; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Briken V, 2012, CELL HOST MICROBE, V12, P261, DOI 10.1016/j.chom.2012.08.008; Cabral-Piccin MP, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.135; Capella-Gutierrez S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-47; Chavez-Galan L, 2009, CELL MOL IMMUNOL, V6, P15, DOI 10.1038/cmi.2009.3; Dallenga T, 2017, CELL HOST MICROBE, V22, P519, DOI 10.1016/j.chom.2017.09.003; del Aguila C, 2006, INT J PARASITOL, V36, P869, DOI 10.1016/j.ijpara.2006.04.002; Didier ES, 2011, CURR OPIN INFECT DIS, V24, P490, DOI 10.1097/QCO.0b013e32834aa152; DIDIER ES, 1995, PARASITE IMMUNOL, V17, P405, DOI 10.1111/j.1365-3024.1995.tb00908.x; Didier ES, 2005, ACTA TROP, V94, P61, DOI 10.1016/j.actatropica.2005.01.010; DIDIER PJ, 1991, J PROTOZOOL, V38, P502, DOI 10.1111/j.1550-7408.1991.tb04824.x; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; Galimberti VE, 2019, YALE J BIOL MED, V92, P663; Ghosh K, 2012, FEMS MICROBIOL REV, V36, P748, DOI 10.1111/j.1574-6976.2011.00318.x; Grabiec AM, 2016, SEMIN IMMUNOPATHOL, V38, P409, DOI 10.1007/s00281-016-0555-3; Han B, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00172; Han B, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0018-2016; He XY, 2015, ACTA BIOCH BIOPH SIN, V47, P696, DOI 10.1093/abbs/gmv062; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Karimi K, 2020, MICROB PATHOGENESIS, V141, DOI 10.1016/j.micpath.2020.103988; Khan IA, 1999, J IMMUNOL, V162, P6086; Kim KH, 2012, P NATL ACAD SCI USA, V109, P7729, DOI 10.1073/pnas.1120251109; Krakauer T, 2018, MED HYPOTHESES, V121, P64, DOI 10.1016/j.mehy.2018.09.028; Martin CJ, 2014, CURR OPIN MICROBIOL, V17, P17, DOI 10.1016/j.mib.2013.10.007; Martin CJ, 2012, CELL HOST MICROBE, V12, P289, DOI 10.1016/j.chom.2012.06.010; Mathews A, 2009, MICROBES INFECT, V11, P905, DOI 10.1016/j.micinf.2009.06.004; Medeiros AI, 2009, J EXP MED, V206, P61, DOI 10.1084/jem.20082058; Michlewska S, 2009, FASEB J, V23, P844, DOI 10.1096/fj.08-121228; Moraco AH, 2014, SEMIN IMMUNOL, V26, P497, DOI 10.1016/j.smim.2014.10.001; Nolan A, 2008, AM J RESP CRIT CARE, V177, P301, DOI 10.1164/rccm.200703-515OC; Nolan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006600; Penteado LD, 2017, IMMUNOLOGY, V151, P304, DOI 10.1111/imm.12731; Pereira A, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007674; Plumlee CR, 2009, J BIOL CHEM, V284, P30058, DOI 10.1074/jbc.M109.018283; Rayamajhi M, 2010, VIRULENCE, V1, P418, DOI 10.4161/viru.1.5.12787; Rupp J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006020; Sak B, 2017, PARASITE IMMUNOL, V39, DOI 10.1111/pim.12496; Salina ACG, 2017, INNATE IMMUN-LONDON, V23, P219, DOI 10.1177/1753425916684934; Scanlon M, 1999, J EUKARYOT MICROBIOL, V46, p34S; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Schett G, 2018, RHEUMATOLOGY, V57, P43, DOI 10.1093/rheumatology/kex513; SHADDUCK JA, 1969, SCIENCE, V166, P516, DOI 10.1126/science.166.3904.516; Spinner JL, 2014, J LEUKOCYTE BIOL, V95, P389, DOI 10.1189/jlb.1112551; Stephenson HN, 2016, CURR OPIN IMMUNOL, V38, P59, DOI 10.1016/j.coi.2015.11.004; Texier C, 2010, CURR OPIN MICROBIOL, V13, P443, DOI 10.1016/j.mib.2010.05.005; Upadhyay S, 2018, PATHOG DIS, V76, DOI 10.1093/femspd/fty037; Van Ooij C, 1998, INFECT IMMUN, V66, P5364, DOI 10.1128/IAI.66.11.5364-5371.1998; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; van Zandbergen G, 2004, J IMMUNOL, V172, P1768, DOI 10.4049/jimmunol.172.3.1768	53	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0247658	10.1371/journal.pone.0247658	http://dx.doi.org/10.1371/journal.pone.0247658			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667240	Green Published, gold			2022-12-26	WOS:000626604300049
J	Liu, YJ; Lu, HB; Zhang, HH; Cui, YS; Xing, XT				Liu, Yujun; Lu, Haibin; Zhang, Honghua; Cui, Yusheng; Xing, Xueting			Effects of ocean eddies on the tropical storm Roanu intensity in the Bay of Bengal	PLOS ONE			English	Article								A tropical storm (TS) Roanu occurred in northern Sri Lanka in 2016, which transported northwards along the west coast of the Bay of Bengal (BoB). During the development of the TS, ocean eddies on its track had an important effect on the intensity of Roanu. The dynamic mechanism was investigated with multisource reanalysis and Argo float data in this study. The results show that ocean eddies were the main reason why Roanu first enhanced, weakened, and then enhanced again. Warm eddy W1 supports the initial development of the TS, cold eddy C1 weakens Roanu, and warm eddy W2 continues to support Roanu. On May 19, 2016, the maximum average latent heat flux over W1 was 260.85 w/m(2), while that of C1 was only 200.71 w/m(2). After the passage of Roanu, the tropical cyclone heat potential (TCHP) of eddies significantly decreased. The TCHP of W1, W2, C1 and C2 decreased by 20.95 kJ/cm(2), 11.07 kJ/cm(2), 29.82 kJ/cm(2), 9.31 kJ/cm(2), respectively. The mixed layer of warm eddies deepened much more than that of cold eddies, supporting Roanu development. In addition, changes in potential vorticity (PV) values caused by the disturbance of eddies may also reflect changes in the TS intensity. This study offers new insights on the influence of ocean eddies in regulating the development of tropical cyclone (TC) in the BoB.	[Liu, Yujun; Lu, Haibin; Cui, Yusheng; Xing, Xueting] Jiangsu Ocean Univ, Jiangsu Key Lab Marine Bioresources & Environm, Jiangsu Key Lab Marine Biotechnol, Lianyungang, Jiangsu, Peoples R China; [Lu, Haibin] Jiangsu Ocean Univ, Coinnovat Ctr Jiangsu Marine Bioind Technol, Lianyungang, Jiangsu, Peoples R China; [Lu, Haibin] Jiangsu Inst Marine Resources Dev, Lianyungang, Peoples R China; [Zhang, Honghua; Cui, Yusheng; Xing, Xueting] Lianyungang Meteorol Bur, Lianyungang, Jiangsu, Peoples R China	Jiangsu Ocean University; Jiangsu Ocean University	Lu, HB (corresponding author), Jiangsu Ocean Univ, Jiangsu Key Lab Marine Bioresources & Environm, Jiangsu Key Lab Marine Biotechnol, Lianyungang, Jiangsu, Peoples R China.; Lu, HB (corresponding author), Jiangsu Ocean Univ, Coinnovat Ctr Jiangsu Marine Bioind Technol, Lianyungang, Jiangsu, Peoples R China.; Lu, HB (corresponding author), Jiangsu Inst Marine Resources Dev, Lianyungang, Peoples R China.	haibin_lv@jou.edu.cn		LU, Haibin/0000-0002-0951-1363	Postgraduate Research & Practice Innovation Program of Jiangsu Province [SJCX19_0963, SJCX20_1244, SJCX20_1246]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Natural Science Foundation of Huai Hai Institute of Technology [Z2017006]; Key Research and Development Program of Jiangsu Province [BE2018676]; National Key Research and Development Program of China [2018YFC1405702]	Postgraduate Research & Practice Innovation Program of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Natural Science Foundation of Huai Hai Institute of Technology; Key Research and Development Program of Jiangsu Province; National Key Research and Development Program of China	This project was supported by Postgraduate Research & Practice Innovation Program of Jiangsu Province (Grant No. SJCX19_0963; SJCX20_1244; SJCX20_1246), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Natural Science Foundation of Huai Hai Institute of Technology (Grant No. Z2017006), Key Research and Development Program of Jiangsu Province (Grant No. BE2018676) and National Key Research and Development Program of China (Grant No. 2018YFC1405702).	Ali MM., 2007, EOS T AM GEOPHYS UN, V88, P93, DOI [10.1029/2007EO080001, DOI 10.1029/2007EO080001]; Anandh TS, 2018, INT J CLIMATOL, V38, P5619, DOI 10.1002/joc.5767; Anandh TS, 2020, OCEAN DYNAM, V70, P327, DOI 10.1007/s10236-019-01330-x; Balaguru K, 2016, J GEOPHYS RES-ATMOS, V121, P6954, DOI 10.1002/2016JD024936; Balaji M, 2018, INT J CLIMATOL, V38, P2819, DOI 10.1002/joc.5463; Bell MM, 2008, MON WEATHER REV, V136, P2023, DOI 10.1175/2007MWR1858.1; Bentamy A, 2017, REMOTE SENS ENVIRON, V201, P196, DOI 10.1016/j.rse.2017.08.016; Bhardwaj P, 2020, THEOR APPL CLIMATOL, V139, P615, DOI 10.1007/s00704-019-02989-4; Bosart LF, 2000, MON WEATHER REV, V128, P322, DOI 10.1175/1520-0493(2000)128<0322:EIOTRI>2.0.CO;2; Chaudhuri D, 2019, J PHYS OCEANOGR, V49, P1121, DOI 10.1175/JPO-D-18-0051.1; Chen SYS, 2006, MON WEATHER REV, V134, P3190, DOI 10.1175/MWR3245.1; Chowdhury RR, 2020, J GEOPHYS RES-OCEANS, V125, DOI 10.1029/2019JC015836; DeMaria M, 1996, J ATMOS SCI, V53, P2076, DOI 10.1175/1520-0469(1996)053<2076:TEOVSO>2.0.CO;2; EMANUEL KA, 1988, J ATMOS SCI, V45, P1143, DOI 10.1175/1520-0469(1988)045<1143:TMIOH>2.0.CO;2; EMANUEL KA, 1986, J ATMOS SCI, V43, P585, DOI 10.1175/1520-0469(1986)043<0585:AASITF>2.0.CO;2; Felton CS, 2013, J CLIMATE, V26, P9806, DOI 10.1175/JCLI-D-13-00134.1; Gaube P, 2013, J GEOPHYS RES-OCEANS, V118, P6349, DOI 10.1002/2013JC009027; Gomes HR, 2000, CONT SHELF RES, V20, P313, DOI 10.1016/S0278-4343(99)00072-2; GRAY WM, 1968, MON WEATHER REV, V96, P669, DOI 10.1175/1520-0493(1968)096<0669:GVOTOO>2.0.CO;2; Hausman SA, 2006, J ATMOS SCI, V63, P87, DOI 10.1175/JAS3601.1; Holland GJ, 1997, J ATMOS SCI, V54, P2519, DOI 10.1175/1520-0469(1997)054<2519:TMPIOT>2.0.CO;2; Jacob SD, 2003, J PHYS OCEANOGR, V33, P649, DOI 10.1175/1520-0485(2003)33<649:TROOMF>2.0.CO;2; Jayne SR, 2017, OCEANOGRAPHY, V30, P18, DOI 10.5670/oceanog.2017.213; Kumar BP, 2019, DEEP-SEA RES PT II, V168, DOI 10.1016/j.dsr2.2019.104652; Kumar B, 2011, NAT HAZARDS, V59, P1671, DOI 10.1007/s11069-011-9858-9; Kumar MRR, 1999, METEOROL ATMOS PHYS, V70, P201, DOI 10.1007/s007030050034; Leipper D. F., 1972, Journal of Physical Oceanography, V2, P218, DOI 10.1175/1520-0485(1972)002<0218:HHPOTG>2.0.CO;2; Lin II, 2005, MON WEATHER REV, V133, P2635, DOI 10.1175/MWR3005.1; Mandal S, 2018, PURE APPL GEOPHYS, V175, P4605, DOI 10.1007/s00024-018-1932-8; MERRILL RT, 1988, J ATMOS SCI, V45, P1678, DOI 10.1175/1520-0469(1988)045<1678:EIOHI>2.0.CO;2; Mohanty S, 2019, TROP CYCLONE RES REV, V8, P68, DOI 10.6057/2019TCRR02.02; Molinari J, 1998, J ATMOS SCI, V55, P2632, DOI 10.1175/1520-0469(1998)055<2632:PVAOTC>2.0.CO;2; Montgomery MT, 1998, J ATMOS SCI, V55, P3176, DOI 10.1175/1520-0469(1998)055<3176:TCVCFV>2.0.CO;2; Montgomery MT, 1997, Q J ROY METEOR SOC, V123, P435, DOI 10.1002/qj.49712353810; Park KA, 2015, J MARINE SYST, V143, P24, DOI 10.1016/j.jmarsys.2014.10.013; Peduzzi P, 2012, NAT CLIM CHANGE, V2, P289, DOI 10.1038/NCLIMATE1410; POTEMRA JT, 1991, J GEOPHYS RES-OCEANS, V96, P12667, DOI 10.1029/91JC01045; Qiu B, 2016, J PHYS OCEANOGR, V46, P947, DOI 10.1175/JPO-D-15-0188.1; Roemmich D, 2009, OCEANOGRAPHY, V22, P34, DOI 10.5670/oceanog.2009.36; Sadhuram Y, 2004, NAT HAZARDS, V32, P191, DOI 10.1023/B:NHAZ.0000031313.43492.a8; Sarangi RK, 2017, ADV SPACE RES, V59, P33, DOI 10.1016/j.asr.2016.08.038; Sarangi RK., 2019, REMOTE SENSING ASIAN, P411, DOI [10.1007/978-3-319-94067-0%5F23, DOI 10.1007/978-3-319-94067-0%5F23]; Sasaki H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6636; Sears J, 2014, TROP CYCLONE RES REV, V3, P91, DOI 10.6057/2014TCRR02.03; Shay LK, 2000, MON WEATHER REV, V128, P1366, DOI 10.1175/1520-0493(2000)128<1366:EOAWOF>2.0.CO;2; Shay LK, 2008, MON WEATHER REV, V136, P3248, DOI 10.1175/2007MWR2169.1; SHETYE SR, 1991, CONT SHELF RES, V11, P1397, DOI 10.1016/0278-4343(91)90042-5; Wada A, 2007, J OCEANOGR, V63, P427, DOI 10.1007/s10872-007-0039-0; WILLOUGHBY HE, 1982, J ATMOS SCI, V39, P395, DOI 10.1175/1520-0469(1982)039<0395:CEWSWM>2.0.CO;2; Wong MLM, 2004, J ATMOS SCI, V61, P1859, DOI 10.1175/1520-0469(2004)061<1859:TCIIVW>2.0.CO;2; Xu HB, 2019, MAR POLLUT BULL, V146, P838, DOI 10.1016/j.marpolbul.2019.07.019; Yablonsky RM, 2013, MON WEATHER REV, V141, P997, DOI 10.1175/MWR-D-12-00248.1	52	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0247521	10.1371/journal.pone.0247521	http://dx.doi.org/10.1371/journal.pone.0247521			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667249	gold, Green Published			2022-12-26	WOS:000626604300040
J	Cavus, O; Williams, J; Musa, H; El Refaey, M; Gratz, D; Shaheen, R; Schwieterman, NA; Koenig, S; Antwi-Boasiako, S; Young, LJ; Xu, XY; Han, M; Wold, LE; Hund, TJ; Mohler, PJ; Bradley, EA				Cavus, Omer; Williams, Jordan; Musa, Hassan; El Refaey, Mona; Gratz, Dan; Shaheen, Rebecca; Schwieterman, Neill A.; Koenig, Sara; Antwi-Boasiako, Steve; Young, Lindsay J.; Xu, Xianyao; Han, Mei; Wold, Loren E.; Hund, Thomas J.; Mohler, Peter J.; Bradley, Elisa A.			Giant ankyrin-G regulates cardiac function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ ENTRY; INITIAL SEGMENT; EXCITABILITY; DISEASE; ROLES; GENE	Cardiovascular disease (CVD) remains the most common cause of adult morbidity and mortality in developed nations. As a result, predisposition for CVD is increasingly important to understand. Ankyrins are intracellular proteins required for the maintenance of membrane domains. Canonical ankyrin-G (AnkG) has been shown to be vital for normal cardiac function, specifically cardiac excitability, via targeting and regulation of the cardiac voltage-gated sodium channel. Noncanonical (giant) AnkG isoforms play a key role in neuronal membrane biogenesis and excitability, with evidence for human neurologic disease when aberrant. However, the role of giant AnkG in cardiovascular tissue has yet to be explored. Here, we identify giant AnkG in the myocardium and identify that it is enriched in 1-week-old mice. Using a new mouse model lacking giant AnkG expression in myocytes, we identify that young mice displayed a dilated cardiomyopathy phenotype with aberrant electrical conduction and enhanced arrhythmogenicity. Structural and electrical dysfunction occurred at 1 week of age, when giant AnkG was highly expressed and did not appreciably change in adulthood until advanced age. At a cellular level, loss of giant AnkG results in delayed and early afterdepolarizations. However, surprisingly, giant AnkG cKO myocytes display normal I-Na, but abnormal myocyte contractility, suggesting unique roles of the large isoform in the heart. Finally, transcript analysis provided evidence for unique pathways that may contribute to the structural and electrical findings shown in giant AnkG cKO animals. In summary, we identify a critical role for giant AnkG that adds to the diversity of ankyrin function in the heart.	[Cavus, Omer; Williams, Jordan; Musa, Hassan; El Refaey, Mona; Schwieterman, Neill A.; Koenig, Sara; Young, Lindsay J.; Xu, Xianyao; Han, Mei; Wold, Loren E.; Mohler, Peter J.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Cavus, Omer; Williams, Jordan; Musa, Hassan; Gratz, Dan; Shaheen, Rebecca; Schwieterman, Neill A.; Koenig, Sara; Antwi-Boasiako, Steve; Young, Lindsay J.; Xu, Xianyao; Han, Mei; Wold, Loren E.; Hund, Thomas J.; Mohler, Peter J.; Bradley, Elisa A.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Frick Ctr Heart Failure & Arrhythmia, Columbus, OH 43210 USA; [El Refaey, Mona; Gratz, Dan; Shaheen, Rebecca; Hund, Thomas J.] Ohio State Univ, Coll Engn, Dept Biomed Engn, Columbus, OH 43210 USA; [Hund, Thomas J.; Mohler, Peter J.; Bradley, Elisa A.] Ohio State Univ, Dept Internal Med, Div Cardiovasc Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Bradley, EA (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Frick Ctr Heart Failure & Arrhythmia, Columbus, OH 43210 USA.; Bradley, EA (corresponding author), Ohio State Univ, Dept Internal Med, Div Cardiovasc Med, Columbus, OH 43210 USA.	elisa.bradley@osumc.edu		El Refaey, Mona/0000-0003-3989-0920; Shaheen, Rebecca/0000-0002-5121-8558; Koenig, Sara/0000-0002-5416-8621	NIH [HL148701, HL146969, HL135096, HL134824, HL135754, HL139348]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors are supported by NIH grants: HL148701 (E. A. B.), HL146969 (M. E. R.), HL135096 (T. J. H., P. J. M.), HL134824 (T. J. H., P. J. M.), HL135754 (P. J. M.), and HL139348 (P. J. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackers-Johnson M, 2016, CIRC RES, V119, P909, DOI 10.1161/CIRCRESAHA.116.309202; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartoli F, 2017, ADV EXP MED BIOL, V993, P523, DOI 10.1007/978-3-319-57732-6_26; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2002, CIRC RES, V90, P14, DOI 10.1161/res.90.1.14; Bondarenko VE, 2004, AM J PHYSIOL-HEART C, V287, pH1378, DOI 10.1152/ajpheart.00185.2003; Bootman MD, 2017, ADV EXP MED BIOL, V993, P363, DOI 10.1007/978-3-319-57732-6_19; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Collins HE, 2013, AM J PHYSIOL-HEART C, V305, pH446, DOI 10.1152/ajpheart.00104.2013; DOCTOR RB, 1993, AM J PHYSIOL, V264, pC1003, DOI 10.1152/ajpcell.1993.264.4.C1003; Freal A, 2016, J NEUROSCI, V36, P4421, DOI 10.1523/JNEUROSCI.3219-15.2016; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; Jenkins PM, 2015, P NATL ACAD SCI USA, V112, P957, DOI 10.1073/pnas.1416544112; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Joki Y, 2015, CIRC-HEART FAIL, V8, P342, DOI 10.1161/CIRCHEARTFAILURE.114.001647; Kong MH, 2011, J AM COLL CARDIOL, V57, P794, DOI 10.1016/j.jacc.2010.09.064; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Letunic I, 2018, NUCLEIC ACIDS RES, V46, pD493, DOI 10.1093/nar/gkx922; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Makara MA, 2018, JACC-BASIC TRANSL SC, V3, P675, DOI 10.1016/j.jacbts.2018.07.008; Makara MA, 2014, CIRC RES, V115, P929, DOI 10.1161/CIRCRESAHA.115.305154; Messa M, 2014, ELIFE, V3, DOI 10.7554/eLife.03311; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mohler PJ, 2002, J CELL SCI, V115, P1565; Mozaffarian D, 2016, CIRCULATION, V133, P447, DOI 10.1161/CIR.0000000000000366; Onal B, 2017, AM J PHYSIOL-HEART C, V313, pH1227, DOI 10.1152/ajpheart.00185.2017; Onal B, 2016, METHODSX, V3, P589, DOI 10.1016/j.mex.2016.11.002; Sato PY, 2011, CIRC RES, V109, P193, DOI 10.1161/CIRCRESAHA.111.247023; SAWADA K-I, 1991, Heart and Vessels, V6, P129, DOI 10.1007/BF02058278; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Williams JL, 2018, LIFE SCI, V196, P118, DOI 10.1016/j.lfs.2018.01.021; Yang R, 2019, P NATL ACAD SCI USA, V116, P19717, DOI 10.1073/pnas.1909989116; Yoshimura T, 2014, CURR OPIN NEUROBIOL, V27, P96, DOI 10.1016/j.conb.2014.03.004	34	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100507	10.1016/j.jbc.2021.100507	http://dx.doi.org/10.1016/j.jbc.2021.100507			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33675749	Green Published, gold			2022-12-26	WOS:000672866400481
J	Vester, SK; Beavil, RL; Lynham, S; Beavil, AJ; Graham, DSC; McDonnell, JM; Vyse, TJ				Vester, Susan K.; Beavil, Rebecca L.; Lynham, Steven; Beavil, Andrew J.; Graham, Deborah S. Cunninghame; McDonnell, James M.; Vyse, Timothy J.			Nucleolin acts as the receptor for C1QTNF4 and supports C1QTNF4-mediated innate immunity modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C1QTNF-RELATED PROTEIN 4; NF-KAPPA-B; CELL-SURFACE; FOOD-INTAKE; EXPRESSION; BINDING; C1Q; IDENTIFICATION; FAMILY; CTRP4	The C1q and TNF related 4 (C1QTNF4) protein is a structurally unique member of the C1QTNF family, a family of secreted proteins that have structural homology with both complement C1q and the tumor necrosis factor superfamily. C1QTNF4 has been linked to the autoimmune disease systemic lupus erythematosus through genetic studies; however, its role in immunity and inflammation remains poorly defined and a cell surface receptor of C1QTNF4 has yet to be identified. Here we report identification of nucleolin as a cell surface receptor of C1QTNF4 using mass spectrometric analysis. Additionally, we present evidence that the interaction between C1QTNF4 and nucleolin is mediated by the second C1q-like domain of C1QTNF4 and the C terminus of nucleolin. We show that monocytes and B cells are target cells of C1QTNF4 and observe extensive binding to dead cells. Imaging flow cytometry experiments in monocytes show that C1QTNF4 becomes actively internalized upon cell binding. Our results suggest that nucleolin may serve as a docking molecule for C1QTNF4 and act in a context-dependent manner through coreceptors. Taken together, these findings further our understanding of C1QTNF4's function in the healthy immune system and how dysfunction may contribute to the development of systemic lupus erythematosus.	[Vester, Susan K.; Graham, Deborah S. Cunninghame; Vyse, Timothy J.] Kings Coll London, Dept Med & Mol Genet, London, England; [Beavil, Rebecca L.; Beavil, Andrew J.; McDonnell, James M.] Kings Coll London, Randall Ctr Cell & Mol Biophys, London, England; [Beavil, Rebecca L.; Beavil, Andrew J.; McDonnell, James M.] Asthma UK Ctr Allerg Mech Asthma, London, England; [Lynham, Steven] Kings Coll London, Ctr Excellence Mass Spectrometry, Prote Facil, London, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London	Vyse, TJ (corresponding author), Kings Coll London, Dept Med & Mol Genet, London, England.	timothy.vyse@kcl.ac.uk		Lynham, Steven/0000-0003-3756-6430; Vester, Susan/0000-0002-4210-118X	Versus Arthritis PhD studentship [21252]; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; NIHR-funded BRC Flow Cytometry Core at Guy's and St Thomas' NHS Foundation Trust; King's College London	Versus Arthritis PhD studentship; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London(General Electric); NIHR-funded BRC Flow Cytometry Core at Guy's and St Thomas' NHS Foundation Trust; King's College London(General Electric)	This work was primarily funded by Versus Arthritis PhD studentship 21252 (to S. K. V., D. S. C. G., and T. J. V.). This research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London (to T. J. V.). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. We acknowledge financial support through the NIHR-funded BRC Flow Cytometry Core at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London.	Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Allen KL, 2012, BLOOD, V119, P884, DOI 10.1182/blood-2011-03-344671; Ando K, 2010, FEBS J, V277, P2051, DOI 10.1111/j.1742-4658.2010.07620.x; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Byerly MS, 2014, J BIOL CHEM, V289, P4055, DOI 10.1074/jbc.M113.506956; Cao LL, 2021, EUR J IMMUNOL, V51, P380, DOI 10.1002/eji.202048617; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FANG SH, 1993, EXP CELL RES, V208, P48, DOI 10.1006/excr.1993.1221; Feng SQ, 2018, PEDIATR RES, V83, P999, DOI 10.1038/pr.2018.16; Grinstein E, 2007, J BIOL CHEM, V282, P12439, DOI 10.1074/jbc.M608068200; Hirano K, 2005, J BIOL CHEM, V280, P39284, DOI 10.1074/jbc.M505275200; Hovanessian AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015787; Hu T, 2019, J CELL BIOCHEM, V120, P16206, DOI 10.1002/jcb.28902; Huang TS, 2008, STEM CELLS, V26, P1186, DOI 10.1634/stemcells.2007-0821; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Julia A, 2008, ARTHRITIS RHEUM-US, V58, P2275, DOI 10.1002/art.23623; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Korb LC, 1997, J IMMUNOL, V158, P4525; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Langefeld CD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16021; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Li Q, 2011, CANCER LETT, V308, P203, DOI 10.1016/j.canlet.2011.05.005; Li YJ, 2020, NEUROSCIENCE, V429, P1, DOI 10.1016/j.neuroscience.2019.12.039; Liu MX, 2019, J CELL PHYSIOL, V234, P18731, DOI 10.1002/jcp.28513; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Luo Y, 2016, CELL MOL IMMUNOL, V13, P688, DOI 10.1038/cmi.2016.16; Mabbott NA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-632; Mahotka C, 2018, LEUKEMIA, V32, P1865, DOI 10.1038/s41375-018-0090-4; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; Monaco G, 2019, CELL REP, V26, P1627, DOI 10.1016/j.celrep.2019.01.041; Murayama MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9483; Murayama MA, 2014, BIOCHEM BIOPH RES CO, V443, P42, DOI 10.1016/j.bbrc.2013.11.040; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Navratil JS, 2001, J IMMUNOL, V166, P3231, DOI 10.4049/jimmunol.166.5.3231; Neumeier M, 2006, J LEUKOCYTE BIOL, V79, P803, DOI 10.1189/jlb.0905521; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Okamura Y, 2015, NUCLEIC ACIDS RES, V43, pD82, DOI 10.1093/nar/gku1163; Omeka WKM, 2019, FISH SHELLFISH IMMUN, V84, P158, DOI 10.1016/j.fsi.2018.09.078; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Pakzad B, 2020, INT J RHEUM DIS, V23, P1594, DOI 10.1111/1756-185X.13981; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Phillips GN, 1997, CURR OPIN STRUC BIOL, V7, P821, DOI 10.1016/S0959-440X(97)80153-4; Pradeep A. N., 2016, J CELL SCI R, V7; Pullabhatla V, 2018, HUM MOL GENET, V27, P421, DOI 10.1093/hmg/ddx407; Said EA, 2005, FEBS J, V272, P4646, DOI 10.1111/j.1742-4658.2005.04870.x; Said EA, 2002, J BIOL CHEM, V277, P37492, DOI 10.1074/jbc.M201194200; Sarver DC, 2020, AM J PHYSIOL-ENDOC M, V319, pE1084, DOI 10.1152/ajpendo.00448.2020; Schilling D, 2002, J IMMUNOL, V169, P5874, DOI 10.4049/jimmunol.169.10.5874; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Song HJ, 2009, TRANSL RES, V154, P18, DOI 10.1016/j.trsl.2009.04.003; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TAKE M, 1994, J BIOCHEM-TOKYO, V116, P1063, DOI 10.1093/oxfordjournals.jbchem.a124628; Tayyari F, 2011, NAT MED, V17, P1132, DOI 10.1038/nm.2444; Terskikh AV, 2001, P NATL ACAD SCI USA, V98, P7934, DOI 10.1073/pnas.131200898; Tsokos GC, 2016, NAT REV RHEUMATOL, V12, P716, DOI 10.1038/nrrheum.2016.186; Wang Y, 2011, CELL BIOL INT, V35, P677, DOI 10.1042/CBI20100625; WARRENER P, 1991, BIOCHEM BIOPH RES CO, V180, P716, DOI 10.1016/S0006-291X(05)81124-6; Wise JF, 2013, BLOOD, V121, P4729, DOI 10.1182/blood-2012-12-471094; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xu WS, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.05.01; Yuan XL, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0416-6; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	67	5	5	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100513	10.1016/j.jbc.2021.100513	http://dx.doi.org/10.1016/j.jbc.2021.100513			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33676896	gold, Green Published			2022-12-26	WOS:000672866400487
J	Wei, Z; Xu, X; Fang, YQ; Khater, M; Naughton, SX; Hu, G; Terry, AV; Wu, GY				Wei, Zhe; Xu, Xin; Fang, Yinquan; Khater, Mostafa; Naughton, Sean X.; Hu, Gang; Terry, Alvin, V; Wu, Guangyu			Rab43 GTPase directs postsynaptic trafficking and neuron-specific sorting of G protein-coupled receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM EXPORT; CELL-SURFACE; ANGIOTENSIN-II; MEMBRANE TRAFFICKING; SEROTONIN RECEPTOR; TRANSPORT; GPCR; DISTINCT; MOTIF; INTERACTS	G protein-coupled receptors (GPCRs) are important modulators of synaptic functions. A fundamental but poorly addressed question in neurobiology is how targeted GPCR trafficking is achieved. Rab GTPases are the master regulators of vesicle-mediated membrane trafficking, but their functions in the synaptic presentation of newly synthesized GPCRs are virtually unknown. Here, we investigate the role of Rab43, via dominant-negative inhibition and CRISPR-Cas9-mediated KO, in the export trafficking of alpha 2-adrenergic receptor (alpha 2-AR) and muscarinic acetylcholine receptor (mAChR) in primary neurons and cells. We demonstrate that Rab43 differentially regulates the overall surface expression of endogenous alpha(2)-AR and mAChR, as well as their signaling, in primary neurons. In parallel, Rab43 exerts distinct effects on the dendritic and postsynaptic transport of specific alpha(2B)-AR and M3 mAChR subtypes. More interestingly, the selective actions of Rab43 toward alpha(2B)-AR and M3 mAChR are neuronal cell specific and dictated by direct interaction. These data reveal novel, neuronspecific functions for Rab43 in the dendritic and postsynaptic targeting and sorting of GPCRs and imply multiple forward delivery routes for different GPCRs in neurons. Overall, this study provides important insights into regulatory mechanisms of GPCR anterograde traffic to the functional destination in neurons.	[Wei, Zhe; Xu, Xin; Fang, Yinquan; Khater, Mostafa; Naughton, Sean X.; Terry, Alvin, V; Wu, Guangyu] Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Fang, Yinquan; Hu, Gang] Nanjing Med Univ, Dept Pharmacol, Nanjing, Peoples R China	University System of Georgia; Augusta University; Nanjing Medical University	Wu, GY (corresponding author), Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA.	guwu@augusta.edu		Khater, Mostafa/0000-0001-7080-6534; Terry, Alvin/0000-0003-2071-4767	NIH [R01GM118915, R35GM136397]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the NIH (R01GM118915 and R35GM136397 to G. W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al Awabdh S, 2012, J NEUROSCI, V32, P14227, DOI 10.1523/JNEUROSCI.6329-11.2012; Aridor M, 2004, J NEUROSCI, V24, P3770, DOI 10.1523/JNEUROSCI.4775-03.2004; Binotti B, 2015, ELIFE, V4, DOI 10.7554/eLife.05597; Carrel D, 2008, J NEUROSCI, V28, P8063, DOI 10.1523/JNEUROSCI.4487-07.2008; Carrel D, 2006, J CELL SCI, V119, P4276, DOI 10.1242/jcs.03189; Chan CC, 2011, CURR BIOL, V21, P1704, DOI 10.1016/j.cub.2011.08.058; Cherry S, 2013, ELIFE, V2, DOI 10.7554/eLife.01064; Choy RWY, 2014, NEURON, V82, P55, DOI 10.1016/j.neuron.2014.02.018; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cox JV, 2016, MOL BIOL CELL, V27, P1834, DOI 10.1091/mbc.E15-03-0123; Cui-Wang TT, 2012, CELL, V148, P309, DOI 10.1016/j.cell.2011.11.056; Dejgaard SY, 2008, J CELL SCI, V121, P2768, DOI 10.1242/jcs.021808; Doly S, 2016, MOL PSYCHIATR, V21, P480, DOI 10.1038/mp.2015.72; Dong C, 2008, CELL SIGNAL, V20, P1035, DOI 10.1016/j.cellsig.2008.01.014; Dong CM, 2012, TRAFFIC, V13, P857, DOI 10.1111/j.1600-0854.2012.01351.x; Dong CM, 2010, J BIOL CHEM, V285, P20369, DOI 10.1074/jbc.M109.081521; Dulubova I, 2005, EMBO J, V24, P2839, DOI 10.1038/sj.emboj.7600753; Duvernay MT, 2009, TRAFFIC, V10, P552, DOI 10.1111/j.1600-0854.2009.00890.x; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Esseltine JL, 2012, J NEUROSCI, V32, P16933, DOI 10.1523/JNEUROSCI.0625-12.2012; Filipeanu CM, 2004, J BIOL CHEM, V279, P41077, DOI 10.1074/jbc.M405988200; Foster DJ, 2017, NEURON, V94, P431, DOI 10.1016/j.neuron.2017.03.016; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Gerges NZ, 2004, J BIOL CHEM, V279, P43870, DOI 10.1074/jbc.M404982200; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Hanus C, 2008, TRAFFIC, V9, P1437, DOI 10.1111/j.1600-0854.2008.00775.x; Hilger D, 2018, NAT STRUCT MOL BIOL, V25, P4, DOI 10.1038/s41594-017-0011-7; Holmes KD, 2006, J NEUROCHEM, V96, P934, DOI 10.1111/j.1471-4159.2005.03603.x; Huang YH, 2015, FEBS LETT, V589, P1607, DOI 10.1016/j.febslet.2015.05.007; HUBER LA, 1995, MOL CELL BIOL, V15, P918; Jolimay N, 2000, J NEUROSCI, V20, P9111; Kiral FR, 2018, CURR BIOL, V28, pR471, DOI 10.1016/j.cub.2018.02.010; Kobayashi H, 2013, J CELL SCI, V126, P2424, DOI 10.1242/jcs.117846; Kretzer NM, 2016, J EXP MED, V213, P2871, DOI 10.1084/jem.20160597; Lai YC, 2015, EMBO J, V34, P2840, DOI 10.15252/embj.201591593; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Lesage S, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000009; Li CM, 2017, CELL REP, V21, P1089, DOI 10.1016/j.celrep.2017.10.011; Li CM, 2012, J BIOL CHEM, V287, P42784, DOI 10.1074/jbc.M112.410936; Liebmann T, 2012, J NEUROSCI, V32, P17998, DOI 10.1523/JNEUROSCI.1804-12.2012; Lodowski KH, 2013, J NEUROSCI, V33, P13621, DOI 10.1523/JNEUROSCI.1520-13.2013; Mignogna ML, 2018, SMALL GTPASES, V9, P145, DOI [10.1080/21541248.2016.1277001, DOI 10.1080/21541248.2016.1277001]; Mori Y, 2012, J BIOL CHEM, V287, P8963, DOI 10.1074/jbc.M111.314385; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Nakazawa H, 2012, J NEUROSCI, V32, P12712, DOI 10.1523/JNEUROSCI.0989-12.2012; Ng EL, 2008, BRAIN RES REV, V58, P236, DOI 10.1016/j.brainresrev.2008.04.006; Pavlos NJ, 2010, J NEUROSCI, V30, P13441, DOI 10.1523/JNEUROSCI.0907-10.2010; Ramirez OA, 2011, TRENDS CELL BIOL, V21, P219, DOI 10.1016/j.tcb.2010.12.003; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Seto S, 2011, TRAFFIC, V12, P407, DOI 10.1111/j.1600-0854.2011.01165.x; Shiwarski DJ, 2019, MOL BIOL CELL, V30, P680, DOI 10.1091/mbc.E18-05-0292; Shiwarski DJ, 2017, MOL BIOL CELL, V28, P2202, DOI 10.1091/mbc.E17-01-0030; Valdes V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044168; Valenzuela JI, 2014, J CELL SCI, V127, P3382, DOI 10.1242/jcs.151092; Wang GS, 2012, TRENDS PHARMACOL SCI, V33, P28, DOI 10.1016/j.tips.2011.09.002; Wei Z, 2019, CELL REP, V28, P554, DOI 10.1016/j.celrep.2019.05.033; Wei Z, 2018, MOL NEUROBIOL, V55, P6215, DOI 10.1007/s12035-017-0836-4; Wei Z, 2015, J BIOL CHEM, V290, P5105, DOI 10.1074/jbc.M114.599969; Weinberg ZY, 2019, CURR OPIN CELL BIOL, V57, P83, DOI 10.1016/j.ceb.2018.12.006; Wilson GR, 2014, AM J HUM GENET, V95, P729, DOI 10.1016/j.ajhg.2014.10.015; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Xu X, 2020, BIO-PROTOCOL, V10, DOI [10.21769/bioprotoc.3761, 10.21769/BioProtoc.3761]; Yin G, 2014, NEUROBIOL DIS, V70, P149, DOI 10.1016/j.nbd.2014.06.018; Zhang MX, 2019, TRAFFIC, V20, P110, DOI 10.1111/tra.12624; Zhang MX, 2016, SCI REP-UK, V6, DOI 10.1038/srep37921; Zhang MX, 2016, MOL CELL BIOL, V36, P1152, DOI 10.1128/MCB.00009-16	68	7	7	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100517	10.1016/j.jbc.2021.100517	http://dx.doi.org/10.1016/j.jbc.2021.100517			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33676895	gold, Green Published			2022-12-26	WOS:000672866400491
J	Sarin, HV; Pirinen, E; Pietilainen, KH; Isola, V; Hakkinen, K; Perola, M; Hulmi, JJ				Sarin, Heikki V.; Pirinen, Eija; Pietilainen, Kirsi H.; Isola, Ville; Hakkinen, Keijo; Perola, Markus; Hulmi, Juha J.			Mitochondrial bioenergetic pathways in blood leukocyte transcriptome decrease after intensive weight loss but are rescued following weight regain in female physique athletes	FASEB JOURNAL			English	Article						diet; exercise; leukocytes; oxidative phosphorylation; ribosomes		Prolonged periods of energy deficit leading to weight loss induce metabolic adaptations resulting in reduced energy expenditure, but the mechanisms for energy conservation are incompletely understood. We examined 42 healthy athletic females (age 27.5 +/- 4.0 years, body mass index 23.4 +/- 1.7 kg/m(2)) who volunteered into either a group dieting for physique competition (n = 25) or a control group (n = 17). The diet group substantially reduced their energy intake and moderately increased exercise levels to induce loss of fat mass that was regained during a voluntary weight regain period. The control group maintained their typical lifestyle habits and body mass as instructed. From the diet group, fasting blood samples were drawn at baseline (PRE), after 4- to 5-month weight loss (PRE-MID), and after 4- to 5-month weight regain (MID-POST) as well as from the control group at similar intervals. Blood was analyzed to determine leukocyte transcriptome by RNA-Sequencing and serum metabolome by nuclear magnetic resonance (NMR) platform. The intensive weight loss period induced several metabolic adaptations, including a prominent suppression of transcriptomic signature for mitochondrial OXPHOS and ribosome biogenesis. The upstream regulator analysis suggested that this reprogramming of cellular energy metabolism may be mediated via AMPK/PGC1-alpha signaling and mTOR/eIF2 signaling-dependent pathways. Our findings show for the first time that prolonged energy deprivation induced modulation of mitochondrial metabolism can be observed through minimally invasive measures of leukocyte transcriptome and serum metabolome at systemic level, suggesting that adaptation to energy deficit is broader in humans than previously thought.	[Sarin, Heikki V.; Perola, Markus] Natl Inst Hlth & Welf, Dept Publ Hlth Solut, Genom & Biobank Unit, Helsinki, Finland; [Sarin, Heikki V.; Pirinen, Eija; Perola, Markus] Univ Helsinki, Fac Med, Res Program Clin & Mol Metab, Helsinki, Finland; [Pietilainen, Kirsi H.] Univ Helsinki, Fac Med, Res Program Clin & Mol Metab, Obes Res Unit, Helsinki, Finland; [Pietilainen, Kirsi H.] Univ Helsinki, Helsinki Univ Hosp, Abdominal Ctr, Obes Ctr,Endocrinol, Helsinki, Finland; [Isola, Ville; Hakkinen, Keijo; Hulmi, Juha J.] Univ Jyvaskyla, Neuromuscular Res Ctr, Fac Sport & Hlth Sci, POB 35, FI-40014 Jyvaskyla, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Jyvaskyla	Hulmi, JJ (corresponding author), Univ Jyvaskyla, Neuromuscular Res Ctr, Fac Sport & Hlth Sci, POB 35, FI-40014 Jyvaskyla, Finland.; Sarin, HV (corresponding author), Natl Inst Hlth & Welf THL, Dept Publ Hlth Solut, Genom & Biomarkers Unit, POB 30,Mannerheimintie 166, FIN-00271 Helsinki, Finland.	heikki.sarin@thl.fi; juha.hulmi@jyu.fi			Academy of Finland (Suomen Akatemia) [269517, 286359, 275922, 314383, 266286]; Academy of Finland, Centre of Excellence in Research on Mitochondria, Metabolism and Disease [272376]; Novo Nordisk Foundation Center for Basic Metabolic Research [NNF16OC0020866, NNF17OC0027232, NNF10OC1013354]; Orionin Tutkimussaatio (Orion Research Foundation); European Union's FP7 programme [HZ2020 633589]; Yrjo Jahnsson Foundation; Suomen Laaketieteen Saatio (Finnish Medical Foundation); Finnish Diabetes Research Foundation; Signe ja Ane Gyllenbergin Saatio (Signe and Ane Gyllenberg Foundation); Sigrid Juselius Foundation; Helsinki University Hospital Research Funds; Helsingin Yliopisto ja Jyvaskylan yliopisto (University of Helsinki and Jyvaskyla); Juho Vainion Saatio	Academy of Finland (Suomen Akatemia)(Academy of Finland); Academy of Finland, Centre of Excellence in Research on Mitochondria, Metabolism and Disease(Academy of Finland); Novo Nordisk Foundation Center for Basic Metabolic Research(Novo Nordisk Foundation); Orionin Tutkimussaatio (Orion Research Foundation); European Union's FP7 programme; Yrjo Jahnsson Foundation; Suomen Laaketieteen Saatio (Finnish Medical Foundation); Finnish Diabetes Research Foundation; Signe ja Ane Gyllenbergin Saatio (Signe and Ane Gyllenberg Foundation); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University Hospital Research Funds; Helsingin Yliopisto ja Jyvaskylan yliopisto (University of Helsinki and Jyvaskyla); Juho Vainion Saatio	Academy of Finland (Suomen Akatemia), Grant/Award Number: 269517, 286359, 275922, 314383 and 266286; Academy of Finland, Centre of Excellence in Research on Mitochondria, Metabolism and Disease, Grant/Award Number: 272376; Novo Nordisk Foundation Center for Basic Metabolic Research, Grant/Award Number: NNF16OC0020866, NNF17OC0027232 and NNF10OC1013354; Juho Vainion Saatio; Orionin Tutkimussaatio (Orion Research Foundation); The European Union's FP7 programme, Grant/Award Number: HZ2020 633589 (Ageing with Elegans); Yrjo Jahnsson Foundation; Suomen Laaketieteen Saatio (Finnish Medical Foundation); Finnish Diabetes Research Foundation; Signe ja Ane Gyllenbergin Saatio (Signe and Ane Gyllenberg Foundation); Sigrid Juselius Foundation; Helsinki University Hospital Research Funds; Government Research Funds; Helsingin Yliopisto ja Jyvaskylan yliopisto (University of Helsinki and Jyvaskyla)	Ackerman KE, 2019, BRIT J SPORT MED, V53, P628, DOI 10.1136/bjsports-2017-098958; Bevilacqua L, 2004, AM J PHYSIOL-ENDOC M, V286, pE852, DOI 10.1152/ajpendo.00367.2003; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Camps SGJA, 2013, AM J CLIN NUTR, V97, P990, DOI 10.3945/ajcn.112.050310; Canto C, 2011, PHYSIOLOGY, V26, P214, DOI 10.1152/physiol.00010.2011; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; He F, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00486; Hood DA, 2019, ANNU REV PHYSIOL, V81, P19, DOI 10.1146/annurev-physiol-020518-114310; Hulmi JJ, 2017, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00689; Huovinen HT, 2015, J STRENGTH COND RES, V29, P29, DOI 10.1519/JSC.0000000000000619; Iraki J, 2019, SPORTS, V7, DOI 10.3390/sports7070154; Jokinen R, 2018, INT J OBESITY, V42, P817, DOI 10.1038/ijo.2017.299; Kitada M, 2013, BBA-GEN SUBJECTS, V1830, P4820, DOI 10.1016/j.bbagen.2013.06.014; Kohane IS, 2012, BIOINFORMATICS, V28, P538, DOI 10.1093/bioinformatics/btr713; Kramer PA, 2014, REDOX BIOL, V2, P206, DOI 10.1016/j.redox.2013.12.026; Lanza IR, 2012, CELL METAB, V16, P777, DOI 10.1016/j.cmet.2012.11.003; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Loucks AB, 2007, SPORTS MED, V37, P348, DOI 10.2165/00007256-200737040-00019; Ma EH, 2017, CURR OPIN IMMUNOL, V46, P45, DOI 10.1016/j.coi.2017.04.004; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Melin AK, 2019, INT J SPORT NUTR EXE, V29, P152, DOI 10.1123/ijsnem.2018-0201; Miller BF, 2012, AGING CELL, V11, P150, DOI 10.1111/j.1474-9726.2011.00769.x; Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177; Rabol R, 2009, METABOLISM, V58, P1145, DOI 10.1016/j.metabol.2009.03.014; Ranhotra HS, 2010, INDIAN J BIOCHEM BIO, V47, P272; Rosenbaum M, 2010, INT J OBESITY, V34, pS47, DOI 10.1038/ijo.2010.184; Sarin HV, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40107-6; Sarin HV, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00907; Simpson RJ, 2020, EXERC IMMUNOL REV, V26, P8; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Sparks LM, 2017, J CLIN ENDOCR METAB, V102, P111, DOI 10.1210/jc.2016-3211; Tarasenko TN, 2017, CELL METAB, V25, P1254, DOI 10.1016/j.cmet.2017.05.007; Topf U, 2019, J CELL SCI, V132, DOI 10.1242/jcs.226258; Trexler ET, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/1550-2783-11-7; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901; WEIGLE DS, 1988, METABOLISM, V37, P930, DOI 10.1016/0026-0495(88)90149-7; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; Weyer C, 2000, AM J CLIN NUTR, V72, P946; Wyant GA, 2018, SCIENCE, V360, P751, DOI 10.1126/science.aar2663; Zhao Y, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0648-1	46	1	1	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21484	10.1096/fj.202002029R	http://dx.doi.org/10.1096/fj.202002029R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710692	Green Published			2022-12-26	WOS:000635216100026
J	Wu, K; Tao, GQ; Xu, T; An, YY; Yu, XY; Wang, Y; Wang, SC; Guo, W; Ma, L				Wu, Kun; Tao, Guoquan; Xu, Ting; An, Yuanyuan; Yu, Xiangyou; Wang, Yi; Wang, Shaochuang; Guo, Wen; Ma, Long			Downregulation of miR-497-5p prevents liver ischemia-reperfusion injury in association with MED1/TIMP-2 axis and the NF-kappa B pathway	FASEB JOURNAL			English	Article						liver ischemia&#8208; reperfusion injury; mediator complex subunit 1; microRNA&#8208; 497&#8208; 5p; nuclear factor kappa&#8208; B; tissue inhibitor of metalloproteinases 2		Liver ischemia-reperfusion (I/R) injury is a common clinical pathological phenomenon, which is accompanied by the occurrence in liver transplantation. However, the underlying mechanism is not yet fully understood. MicroRNAs (miRNAs) play an important role in liver I/R injury. Therefore, the study of miRNAs function will contribute a new biological marker diagnosis of liver I/R injury. This study aims to evaluate effects of miR-497-5p in liver I/R injury in mice. The related regulatory factors of miR-497-5p in liver I/R injury were predicted by bioinformatics analysis. Vascular occlusion was performed to establish the liver I/R injury animal models. Hypoxia/reoxygenation (H/R) was performed to establish the in vitro models. Hematoxylin-eosin (HE) staining was conducted to assess liver injury. The inflammatory factors were evaluated by enzyme-linked immunosorbent assay (ELISA). Flow cytometry was adopted to assess the cell apoptosis. The expression of miR-497b-5p was increased in liver I/R injury. Knockdown of miR-497b-5p inhibited the production of inflammatory factors and cell apoptosis. Overexpression of mediator complex subunit 1 (MED1) and tissue inhibitor of metalloproteinase 2 (TIMP2) inhibited cell apoptosis to alleviate liver I/R injury. miR-497b-5p could activate the nuclear factor kappa-B (NF-kappa B) pathway by inhibiting the MED1/TIMP-2 axis to promote liver I/R injury. This study may provide a new strategy for the treatment of liver I/R injury.	[Wu, Kun; Tao, Guoquan] Nanjing Med Univ, Dept Gen Surg, Affiliated Huaian 1 Peoples Hosp, Huaian, Peoples R China; [Xu, Ting] Nanjing Med Univ, Affiliated Huaian 1 Peoples Hosp, Huaian, Peoples R China; [Xu, Ting] Xinjiang Med Univ, Affiliated Hosp 1, Urumqi, Peoples R China; [An, Yuanyuan] Xinjiang Med Univ, Affiliated Hosp 1, Dept VIP Med, Urumqi, Peoples R China; [Yu, Xiangyou; Wang, Yi; Guo, Wen; Ma, Long] Xinjiang Med Univ, Affiliated Hosp 1, Dept Crit Care Med, Urumqi, Peoples R China; [Wang, Shaochuang] Nanjing Med Univ, Dept Hepatobiliary Surg, Affiliated Huaian 1 Peoples Hosp, Huaian, Peoples R China	Nanjing Medical University; Nanjing Medical University; Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University; Nanjing Medical University	Ma, L (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Crit Care Med, Urumqi, Peoples R China.	malong8617@163.com	guo, wenjia/GXF-5510-2022		National Natural Science Foundation of China [81960356]; Innovative Talents Project of Huai'an First People's Hospital (The Affiliated Huai'an); Science and Technology Development Fund of Nanjing Medical University [NMUB2018155]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Talents Project of Huai'an First People's Hospital (The Affiliated Huai'an); Science and Technology Development Fund of Nanjing Medical University	This work was supported by the National Natural Science Foundation of China (No. 81960356); the Innovative Talents Project of Huai'an First People's Hospital (The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University); and Science and Technology Development Fund of Nanjing Medical University (No. NMUB2018155)	Bai LA, 2011, HEPATOLOGY, V53, P1164, DOI 10.1002/hep.24155; Balzano T, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01746-z; Bi CL, 2020, CELL SIGNAL, V70, DOI 10.1016/j.cellsig.2020.109569; Drusco A, 2017, ADV CANCER RES, V135, P1, DOI 10.1016/bs.acr.2017.06.005; Du YC, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3765898; Fan WX, 2019, CLIN CHEM LAB MED, V57, P567, DOI 10.1515/cclm-2018-0776; Feng L, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190654; Gatla HR, 2014, METHODS MOL BIOL, V1172, P271, DOI 10.1007/978-1-4939-0928-5_25; Hirao H, 2020, FREE RADICAL BIO MED, V157, P75, DOI 10.1016/j.freeradbiomed.2020.02.012; Hua SY, 2019, INT IMMUNOPHARMACOL, V68, P145, DOI 10.1016/j.intimp.2019.01.002; Jiang H, 2013, PROG NEURO-PSYCHOPH, V47, P33, DOI 10.1016/j.pnpbp.2013.07.009; Jimenez-Castro MB, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101131; Kan CY, 2018, TRANSPLANTATION, V102, P368, DOI 10.1097/TP.0000000000001999; Kim HJ, 2012, CANCER LETT, V321, P195, DOI 10.1016/j.canlet.2012.02.009; Koh WU, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235899; Lee EJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-116; Li G, 2019, J CELL BIOCHEM, V120, P10587, DOI 10.1002/jcb.28345; Li SP, 2019, INFLAMMATION, V42, P2139, DOI 10.1007/s10753-019-01078-y; Li YK, 2017, TRANSPLANTATION, V101, P1600, DOI 10.1097/TP.0000000000001765; Li YF, 2020, CARDIOVASC ENG TECHN, V11, P219, DOI 10.1007/s13239-019-00452-z; Ma JH, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgz300; Nichols TC, 2004, DRUG NEWS PERSPECT, V17, P99, DOI 10.1358/dnp.2004.17.2.829042; Padrissa-Altes S, 2010, AM J TRANSPLANT, V10, P1167, DOI 10.1111/j.1600-6143.2010.03092.x; Ramachandran S, 2012, TRANSPL IMMUNOL, V26, P201, DOI 10.1016/j.trim.2012.01.001; Wang WL, 2020, INFLAMMATION, V43, P2119, DOI 10.1007/s10753-020-01279-w; Wu YM, 2016, BIOMED PHARMACOTHER, V84, P1126, DOI 10.1016/j.biopha.2016.10.024; Xia HY, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/1079129; Yang WL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051302; Yu C, 2020, J CELL BIOCHEM, V121, P1934, DOI 10.1002/jcb.29428; Zhang Y, 2019, J CELL PHYSIOL, V234, P16367, DOI 10.1002/jcp.28305; Zhou XD, 2020, FASEB J, V34, P3224, DOI 10.1096/fj.201901718RR	31	4	4	4	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21180	10.1096/fj.202001029R	http://dx.doi.org/10.1096/fj.202001029R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715222				2022-12-26	WOS:000635216100087
J	Du, XX; Sun, YH				Du, Xiangxi; Sun, Yanhua			Performance for rotor system of hybrid electromagnetic bearing and elastic foil gas bearing with dynamic characteristics analysis under deep learning	PLOS ONE			English	Article								The bearing-rotor system is prone to faults during operation, so it is necessary to analyze the dynamic characteristics of the bearing-rotor system to discuss the optimal structure of the convolutional neural network (CNN) in system fault detection and classification. The turbo expander is undertaken as the research object. Firstly, the hybrid magnetic bearing-rotor system is modeled into the form of four stiffness coefficients and four damping coefficients, so as to analyze and explain the dynamic characteristics of the system. Secondly, the ambient pressure is introduced to analyze the dynamic characteristics of the elastic foil gas bearing-rotor system based on the changes in the dynamic stiffness and dynamic damping of the gas bearing. Finally, the CNN is introduced to be applied in the detection of faults of bearing-rotor system through determining the parameters of the constructed CNN. The results show that the displacement of the rotor increases and the stiffness decreases with the acceleration of the speed of the electromagnetic bearing. The maximum displacement of the rotor can reach 135 mu m, and the maximum stiffness can be reduced to 35x10(5)N/m. Increase of ambient pressure causes enhancement of main stiffness of the gas bearing, and the main damping decreases accordingly. Analysis of the classification accuracy and loss function based on the CNN model shows that the convolution kernel size of 7*1 and the batch size of 128 can realize the best performance of CNN in fault classification. This provides a data support and reference for studying the dynamic characteristics of the bearing-rotor system and for the optimization of CNN structure in fault classification and detection.	[Du, Xiangxi; Sun, Yanhua] Xi An Jiao Tong Univ, Sch Mech Engn, Xian, Peoples R China	Xi'an Jiaotong University	Du, XX (corresponding author), Xi An Jiao Tong Univ, Sch Mech Engn, Xian, Peoples R China.	rocket4@gmail.com						Bailey NY, 2018, J ENG MATH, V112, P17, DOI 10.1007/s10665-018-9963-9; Byun J, 2019, J ELECTR ENG TECHNOL, V14, P2409, DOI 10.1007/s42835-019-00297-5; Chen RX, 2019, COMPUT IND, V106, P48, DOI 10.1016/j.compind.2018.11.003; Chen SJ, 2018, COMPUT NETW, V143, P98, DOI 10.1016/j.comnet.2018.07.011; Cox DR, 2020, AAPG BULL, V104, P1011, DOI 10.1306/10031919011; Du GW, 2019, APPL COMPUT ELECTROM, V34, P512; Fan TP, 2019, APPL COMPUT ELECTROM, V34, P598; Fernando N, 2018, IEEE T ENERGY CONVER, V33, P49, DOI 10.1109/TEC.2017.2727960; Gong FY, 2019, ENG STRUCT, V188, P418, DOI 10.1016/j.engstruct.2019.03.036; Hoang DT, 2019, NEUROCOMPUTING, V335, P327, DOI 10.1016/j.neucom.2018.06.078; Hong J, 2020, APPL ENERG, V278, DOI 10.1016/j.apenergy.2020.115646; Huang WY, 2019, NEUROCOMPUTING, V359, P77, DOI 10.1016/j.neucom.2019.05.052; Lehn A, 2018, ARCH APPL MECH, V88, P705, DOI 10.1007/s00419-017-1337-7; Li X, 2019, RELIAB ENG SYST SAFE, V182, P208, DOI 10.1016/j.ress.2018.11.011; Lin CM, 2018, IEEE SENS J, V18, P9370, DOI 10.1109/JSEN.2018.2870957; Lin XH, 2018, TRIBOL INT, V119, P645, DOI 10.1016/j.triboint.2017.11.037; Liu G, 2018, ENERGIES, V11, DOI 10.3390/en11051236; Luznar J, 2018, APPL ACOUST, V137, P33, DOI 10.1016/j.apacoust.2018.03.005; Ma S, 2019, COMPUT IND, V105, P143, DOI 10.1016/j.compind.2018.12.012; Rezvantalab S, 2018, THEOR FOUND CHEM EN+, V52, P1045, DOI 10.1134/S004057951806009X; Samanta P, 2019, TRIBOL INT, V135, P305, DOI 10.1016/j.triboint.2019.03.021; Soni T, 2020, IEEE T IND ELECTRON, V67, P1160, DOI 10.1109/TIE.2019.2898604; Udmale SS, 2019, MEASUREMENT, V145, P665, DOI 10.1016/j.measurement.2019.05.039; Vargas JAR, 2019, NEUROCOMPUTING, V329, P86, DOI 10.1016/j.neucom.2018.10.008; Zabanbark A, 2019, OCEANOLOGY+, V59, DOI 10.1134/S0001437019040192; Zhang WY, 2020, INT J PR ENG MAN-GT, V7, P713, DOI 10.1007/s40684-019-00172-8; Zhu YW, 2018, ACTA ASTRONAUT, V152, P342, DOI 10.1016/j.actaastro.2018.08.031	27	1	1	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0244403	10.1371/journal.pone.0244403	http://dx.doi.org/10.1371/journal.pone.0244403			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720953	Green Published, gold			2022-12-26	WOS:000629667400017
J	Mortada, M; Cosby, DE; Akerele, G; Ramadan, N; Oxford, J; Shanmugasundaram, R; Ng, TT; Selvaraj, RK				Mortada, Mohamad; Cosby, Douglas E.; Akerele, Gabriel; Ramadan, Nour; Oxford, Jarred; Shanmugasundaram, Revathi; Ng, Theros T.; Selvaraj, Ramesh K.			Characterizing the immune response of chickens to Campylobacter jejuni (Strain A74C)	PLOS ONE			English	Article								Campylobacter is one of the major foodborne pathogens causing bacterial gastroenteritis worldwide. The immune response of broiler chickens to C. jejuni is under-researched. This study aimed to characterize the immune response of chickens to Campylobacter jejuni colonization. Birds were challenged orally with 0.5 mL of 2.4 x 10(8) CFU/mL of Campylobacter jejuni or with 0.5 mL of 0.85% saline. Campylobacter jejuni persisted in the ceca of challenged birds with cecal colonization reaching 4.9 log10 CFU/g on 21 dpi. Campylobacter was disseminated to the spleen and liver on 7 dpi and was cleared on 21 dpi from both internal organs. Challenged birds had a significant increase in anti-Campylobacter serum IgY (14&21 dpi) and bile IgA (14 dpi). At 3 dpi, there was a significant suppression in T-lymphocytes derived from the cecal tonsils of birds in the challenge treatment when compared to the control treatment after 72 h of ex vivo stimulation with Con A or C. jejuni. The T-cell suppression on 3 dpi was accompanied by a significant decrease in LITAF, K60, CLAU-2, IL-1 beta, iNOS, and IL-6 mRNA levels in the ceca and an increase in nitric oxide production from adherent splenocytes of challenged birds. In addition, on 3 dpi, there was a significant increase in CD4+ and CD8+ T lymphocytes in the challenge treatment. On 14 dpi, both pro and anti-inflammatory cytokines were upregulated in the spleen, and a significant increase in CD8+ T lymphocytes in Campylobacter-challenged birds' ceca was observed. The persistence of C. jejuni in the ceca of challenged birds on 21 dpi was accompanied by an increase in IL-10 and LITAF mRNA levels, an increase in MNC proliferation when stimulated ex-vivo with the diluted C. jejuni, an increase in serum specific IgY antibodies, an increase in both CD4+ and CD8+ cells, and a decrease in CD4+:CD8+ cell ratio. The balanced Th1 and Th2 immune responses against C. jejuni might explain the ceca's bacterial colonization and the absence of pathology in Campylobacter-challenged birds. Future studies on T lymphocyte subpopulations should elucidate a pivotal role in the persistence of Campylobacter in the ceca.	[Mortada, Mohamad; Akerele, Gabriel; Ramadan, Nour; Oxford, Jarred; Ng, Theros T.; Selvaraj, Ramesh K.] Univ Georgia, Dept Poultry Sci, Athens, GA 30602 USA; [Cosby, Douglas E.] USDA ARS, Poultry Microbiol Safety & Proc Res Unit, Athens, GA 30613 USA; [Shanmugasundaram, Revathi] USDA ARS, Toxicol & Mycotoxin Unit, Athens, GA 30613 USA	University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Selvaraj, RK (corresponding author), Univ Georgia, Dept Poultry Sci, Athens, GA 30602 USA.	selvaraj@uga.edu		Mortada, Mohamad/0000-0002-4936-453X; /0000-0003-0546-6902	USDA-ARS [58-6040-8-034]; USDA-NIFA [2017-05035]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA-NIFA(United States Department of Agriculture (USDA))	This work was funded partially supported by Hatch grant cooperative agreement 58-6040-8-034 from USDA-ARS and USDA-NIFA grant 2017-05035 awarded to Ramesh Selvaraj. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of authors in this manuscript is mentioned in authors contribution section.	Akerele G, 2020, VET IMMUNOL IMMUNOP, V224, DOI 10.1016/j.vetimm.2020.110059; Annamalai T, 2012, POULTRY SCI, V91, P1326, DOI 10.3382/ps.2011-02026; Awad WA, 2015, INNATE IMMUN-LONDON, V21, P151, DOI 10.1177/1753425914521648; Best EL, 2003, FEMS MICROBIOL LETT, V229, P237, DOI 10.1016/S0378-1097(03)00845-0; Bridle BW, 2006, CAN J VET RES, V70, P183; Cawthraw SA, 2010, AVIAN DIS, V54, P86, DOI 10.1637/9004-072709-Reg.1; Chen YP, 2017, POULTRY SCI, V96, P405, DOI 10.3382/ps/pew240; Conlan AJK, 2007, J R SOC INTERFACE, V4, P819, DOI 10.1098/rsif.2007.1015; Cosby D.E., 2017, J VET MED RES, V4, P1096; Cox NA, 2005, AVIAN DIS, V49, P155, DOI 10.1637/7234-070704R; Dalgaard TS, 2010, VACCINE, V28, P4506, DOI 10.1016/j.vaccine.2010.04.044; de Vries SP., 2017, SCI REP-UK, V7, P1; de Zoete MR, 2010, INFECT IMMUN, V78, P1229, DOI 10.1128/IAI.00897-09; Dhillon AS, 2006, AVIAN DIS, V50, P55, DOI 10.1637/7411-071405R.1; Dube DK, 2014, ANAT REC, V297, P1596, DOI 10.1002/ar.22964; Erf GF, 1998, POULTRY SCI, V77, P529, DOI 10.1093/ps/77.4.529; FOULAKI K, 1989, INFECT IMMUN, V57, P1399, DOI 10.1128/IAI.57.5.1399-1404.1989; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hendrixson DR, 2004, MOL MICROBIOL, V52, P471, DOI 10.1111/j.1365-2958.2004.03988.x; Hermans D, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-82; Hong YH, 2012, POULTRY SCI, V91, P1081, DOI 10.3382/ps.2011-01948; Hong YH, 2006, VET IMMUNOL IMMUNOP, V114, P209, DOI 10.1016/j.vetimm.2006.07.007; Humphrey S, 2014, MBIO, V5, DOI 10.1128/mBio.01364-14; Kannan TA., 2017, INT J CURR MICROBIOL, V6, P15, DOI [10.20546/ijcmas.2017.601.002, DOI 10.20546/IJCMAS.2017.601.002]; Kogut MH, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00071; Lacharme-Lora L, 2017, SCI REP-UK, V7, DOI 10.1038/srep45090; Lee MD, 2006, AVIAN DIS, V50, P1, DOI 10.1637/7474-111605R.1; Leshchinsky TV, 2003, POULTRY SCI, V82, P1266, DOI 10.1093/ps/82.8.1266; Li XY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011827; Maculloch B, 2015, EIB140; Markazi A, 2018, POULTRY SCI, V97, P3510, DOI 10.3382/ps/pey234; Meade KG, 2009, IMMUNOGENETICS, V61, P101, DOI 10.1007/s00251-008-0346-7; MEINERSMANN RJ, 1991, AM J VET RES, V52, P1518; Mortada M, 2020, J APPL POULTRY RES, V29, P435, DOI 10.1016/j.japr.2020.02.001; Naseri KG, 2012, J AGR SCI TECH-IRAN, V14, P1485; Oxford JH, 2019, J APPL POULTRY RES, V28, P1279, DOI 10.3382/japr/pfz095; Reid WDK, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150541; Renu S, 2020, INT J NANOMED, V15, P761, DOI 10.2147/IJN.S238445; Rothwell L, 2004, J IMMUNOL, V173, P2675, DOI 10.4049/jimmunol.173.4.2675; Sahin O, 2003, APPL ENVIRON MICROB, V69, P5372, DOI 10.1128/AEM.69.9.5372-5379.2003; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seal BS, 2007, J PROTEOME RES, V6, P4582, DOI 10.1021/pr070356a; Selvaraj RK, 2006, J NUTR, V136, P1610, DOI 10.1093/jn/136.6.1610; Selvaraj RK, 2013, DEV COMP IMMUNOL, V41, P397, DOI 10.1016/j.dci.2013.04.018; Selvaraj RK, 2010, COMP BIOCHEM PHYS A, V157, P198, DOI 10.1016/j.cbpa.2010.06.172; Shanmugasundaram R, 2012, POULTRY SCI, V91, P107, DOI 10.3382/ps.2011-01732; Shanmugasundaram R, 2019, POULTRY SCI, V98, P5840, DOI 10.3382/ps/pez188; Shanmugasundaram R, 2011, VET IMMUNOL IMMUNOP, V144, P476, DOI 10.1016/j.vetimm.2011.08.016; Sharma JM., 2008, HOST FACTORS DIS RES, Vtwelfth, P47; Shaughnessy RG, 2009, VET IMMUNOL IMMUNOP, V132, P191, DOI 10.1016/j.vetimm.2009.06.007; Skarp CPA, 2016, CLIN MICROBIOL INFEC, V22, P103, DOI 10.1016/j.cmi.2015.11.019; Smith CK, 2008, FEMS IMMUNOL MED MIC, V54, P114, DOI 10.1111/j.1574-695X.2008.00458.x; Stern NJ, 2001, J APPL POULTRY RES, V10, P315, DOI 10.1093/japr/10.4.315; STERN NJ, 1988, AVIAN DIS, V32, P330, DOI 10.2307/1590822; Stuve O, 2006, ARCH NEUROL-CHICAGO, V63, P1383, DOI 10.1001/archneur.63.10.1383; Wang ZY, 2017, BIOMED REP, V6, P120, DOI 10.3892/br.2016.817; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Zhao K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053314	59	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0247080	10.1371/journal.pone.0247080	http://dx.doi.org/10.1371/journal.pone.0247080			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720955	gold, Green Published			2022-12-26	WOS:000629667400034
J	Osibogun, A; Balogun, M; Abayomi, A; Idris, J; Kuyinu, Y; Odukoya, O; Wright, O; Adeseun, R; Mutiu, B; Saka, B; Osa, N; Lajide, D; Abdus-Salam, I; Osikomaiya, B; Onasanya, O; Adebayo, B; Oshodi, Y; Adesola, S; Adejumo, O; Erinoso, O; Abdur-Razzaq, H; Bowale, A; Akinroye, K				Osibogun, Akin; Balogun, Mobolanle; Abayomi, Akin; Idris, Jide; Kuyinu, Yetunde; Odukoya, Oluwakemi; Wright, Ololade; Adeseun, Remi; Mutiu, Bamidele; Saka, Babatunde; Osa, Nike; Lajide, Dayo; Abdus-Salam, Ismael; Osikomaiya, Bodunrin; Onasanya, Oluwatosin; Adebayo, Bisola; Oshodi, Yewande; Adesola, Sunday; Adejumo, Olu; Erinoso, Olufemi; Abdur-Razzaq, Hussein; Bowale, Abimbola; Akinroye, Kingsley			Outcomes of COVID-19 patients with comorbidities in southwest Nigeria	PLOS ONE			English	Article								Background Data on the comorbidities that result in negative outcomes for people with COVID-19 are currently scarce for African populations. This study identifies comorbidities that predict death among a large sample of COVID-19 patients from Nigeria. Methods This was a retrospective analysis of medical records for 2184 laboratory confirmed cases of COVID-19 in Lagos, southwest Nigeria. Extracted data included age, sex, severity of condition at presentation and self-reported comorbidities. The outcomes of interest were death or discharge from facility. Results Most of the cases were male (65.8%) and the median age was 43 years (IQR: 33-55). Four hundred and ninety-two patients (22.5%) had at least one comorbidity and the most common amongst them were hypertension (74.2%) and diabetes (30.3%). The mortality rate was 3.3% and a significantly higher proportion of patients with comorbidities died compared to those with none. The comorbidities that predicted death were hypertension (OR: 2.21, 95%CI: 1.22-4.01), diabetes (OR: 3.69, 95% CI: 1.99-6.85), renal disease (OR: 12.53, 95%CI: 1.97-79.56), cancer (OR: 14.12, 95% CI: 2.03-98.19) and HIV (OR: 1.77-84.15]. Conclusion Comorbidities are prevalent and the associated risk of death is high among COVID-19 patients in Lagos, Nigeria. Public enlightenment, early identification and targeted care for COVID-19 cases with comorbidities are recommended as the pandemic evolves.	[Osibogun, Akin; Abayomi, Akin; Idris, Jide; Adeseun, Remi; Osa, Nike; Lajide, Dayo; Abdus-Salam, Ismael] Lagos State COVID 19 Incident Command Syst, Emergency Operat Ctr, Lagos, Nigeria; [Osibogun, Akin; Balogun, Mobolanle; Odukoya, Oluwakemi] Univ Lagos, Dept Community Hlth & Primary Care, Coll Med, Lagos, Nigeria; [Abayomi, Akin; Abdur-Razzaq, Hussein] Lagos State Minist Hlth, Lagos, Nigeria; [Kuyinu, Yetunde; Wright, Ololade; Adebayo, Bisola] Lagos State Univ, Dept Community Hlth & Primary Hlth Care, Coll Med, Lagos, Nigeria; [Mutiu, Bamidele; Saka, Babatunde] Lagos State Biosafety & Biosecur Governing Counci, Lagos, Nigeria; [Osikomaiya, Bodunrin] Lagos State Minist Hlth, Lagos State Blood Transfus Serv, Lagos, Nigeria; [Onasanya, Oluwatosin] Lagos State Primary Hlth Care Board, Lagos, Nigeria; [Oshodi, Yewande] Univ Lagos, Dept Psychiat, Coll Med, Lagos, Nigeria; [Adesola, Sunday; Adejumo, Olu; Bowale, Abimbola] Mainland Hosp, Lagos, Nigeria; [Erinoso, Olufemi] Lagos State Univ Teaching Hosp, Dept Oral & Maxillofacial Surg, Ikeja, Nigeria; [Akinroye, Kingsley] Nigerian Heart Fdn, Lagos, Nigeria	University of Lagos; Lagos State University; University of Lagos; Lagos State University	Osibogun, A (corresponding author), Lagos State COVID 19 Incident Command Syst, Emergency Operat Ctr, Lagos, Nigeria.; Osibogun, A (corresponding author), Univ Lagos, Dept Community Hlth & Primary Care, Coll Med, Lagos, Nigeria.	akinosibogun@yahoo.co.uk	Erinoso, Olufemi/L-8583-2015	Erinoso, Olufemi/0000-0003-0733-3847; Osibogun, Akin/0000-0002-0788-9143; Saka, Babatunde Akeem/0000-0002-7185-341X; Balogun, Mobolanle/0000-0001-8147-2111; ODUKOYA, OLUWAKEMI/0000-0001-7199-3300; Adebayo, Bisola/0000-0002-7179-4157	Lagos State Government	Lagos State Government	This study was funded by the Lagos State Government as part of its COVID-19 Pandemic countermeasure. The State Government was however not involved in the design and implementation of the study, nor with its data analysis and manuscript writing. All views expressed in the manuscript are those of the authors only.	Abayomi A, 2021, INT J INFECT DIS, V102, P226, DOI 10.1016/j.ijid.2020.10.024; Adediran I., 2020, PREMIUM TIMES; Adejumo OA, 2020, SAUDI J KIDNEY DIS T, V31, P209, DOI 10.4103/1319-2442.279942; Adejumo Oluseyi A, 2016, Niger Med J, V57, P185, DOI 10.4103/0300-1652.184072; Adeloye D, 2015, J HYPERTENS, V33, P230, DOI 10.1097/HJH.0000000000000413; Africa CDC, 2020, COR DIS 2019 COVID 1; [Anonymous], 2002, Bull World Health Organ, V80, P983; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Awofeso Opeyemi, 2018, Niger Med J, V59, P74, DOI 10.4103/nmj.NMJ_112_17; Ayoade BA., 2015, J AFR CANC, V7, P178, DOI [10.1007/s12558-015-0404-7, DOI 10.1007/S12558-015-0404-7]; Blanco JL, 2020, LANCET HIV, V7, pE314, DOI 10.1016/S2352-3018(20)30111-9; Bowale A, 2020, PAN AFR MED J, V35, DOI [10.11604/pamj.supp.2020.35.2.23262, 10.11604/pamj.2020.35.2.23262]; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Du RH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00524-2020; Gervasoni C, 2020, CLIN INFECT DIS, V71, P2276, DOI 10.1093/cid/ciaa579; Giacomelli A, 2020, PHARMACOL RES, V158, DOI 10.1016/j.phrs.2020.104931; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020; Harter G, 2020, INFECTION, V48, P681, DOI 10.1007/s15010-020-01438-z; Italoye I., 2019, TOP 10 MOST POPULATE; Lagos state government ministry of health, 2020, LAG PLANS HOM BAS CA; Li LQ, 2020, J MED VIROL, V92, P577, DOI 10.1002/jmv.25757; Liang T., 2020, 1 AFFILIATED HOSP, P23; Maurano Matthew T, 2020, Genome Res, V30, P1781, DOI [10.1101/2020.04.15.20064931, 10.1101/gr.266676.120]; Mirzaei H, 2021, AIDS BEHAV, V25, P85, DOI 10.1007/s10461-020-02983-2; National Research Council, 2012, CONT EP TRANS SUBSAH; Nigeria Centre for Disease Control, 2020, COVID 19 NIG UPD; Njenga MK, 2020, AM J TROP MED HYG, V103, P564, DOI 10.4269/ajtmh.20-0474; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Ofoha CG., 2019, JAMMR, V31, P1, DOI [10.9734/JAMMR/2019/v31i530297, DOI 10.9734/JAMMR/2019/V31I530297]; Owolabi M, 2018, J CLIN HYPERTENS, V20, P47, DOI 10.1111/jch.13152; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Salvi S, 2015, LANCET GLOB HEALTH, V3, pE6, DOI 10.1016/S2214-109X(14)70359-6; Sanyaolu Adekunle, 2020, SN Compr Clin Med, V2, P1069, DOI 10.1007/s42399-020-00363-4; Shalev N, 2020, CLIN INFECT DIS, V71, P2294, DOI 10.1093/cid/ciaa635; Singhal S., 2020, RES SQUARE, DOI [10.21203/rs.3.rs-38971/v1, DOI 10.21203/RS.3.RS-38971/V1]; Ulasi II, 2010, J TROP MED-US, V2010, DOI 10.1155/2010/501957; Uloko AE, 2018, DIABETES THER, V9, P1307, DOI 10.1007/s13300-018-0441-1; Uloko Andrew E, 2012, Indian J Endocrinol Metab, V16, P558, DOI 10.4103/2230-8210.98011; Vincent-Onabajo G., 2016, INT J COMMUNITY MED, V3, P1963; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wang BL, 2020, AGING-US, V12, P6049, DOI 10.18632/aging.103000; World Health Organization, 2020, LAB TEST 2019 NOV CO, DOI [10.15585/mmwr.mm6942a5, DOI 10.15585/MMWR.MM6942A5]	42	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0248281	10.1371/journal.pone.0248281	http://dx.doi.org/10.1371/journal.pone.0248281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX9NB	33720975	Green Published, gold			2022-12-26	WOS:000629667400023
J	Demo, S; Kapinos, A; Bernardino, A; Guardino, K; Hobbs, B; Hoh, K; Lee, E; Vuong, I; Reddi, K; Freise, AC; Parker, JM				Demo, Stephanie; Kapinos, Andrew; Bernardino, Aaron; Guardino, Kristina; Hobbs, Blake; Hoh, Kimberly; Lee, Edward; Vuong, Iphen; Reddi, Krisanavane; Freise, Amanda C.; Parker, Jordan Moberg			BlueFeather, the singleton that wasn't: Shared gene content analysis supports expansion of Arthrobacter phage Cluster FE	PLOS ONE			English	Article								Bacteriophages (phages) exhibit high genetic diversity, and the mosaic nature of the shared genetic pool makes quantifying phage relatedness a shifting target. Early parameters for clustering of related Mycobacteria and Arthrobacter phage genomes relied on nucleotide identity thresholds but, more recently, clustering of Gordonia and Microbacterium phages has been performed according to shared gene content. Singleton phages lack the nucleotide identity and/or shared gene content required for clustering newly sequenced genomes with known phages. Whole genome metrics of novel Arthrobacter phage BlueFeather, originally designated a putative singleton, showed low nucleotide identity but high amino acid and gene content similarity with Arthrobacter phages originally assigned to Clusters FE and FI. Gene content similarity revealed that BlueFeather shared genes with these phages in excess of the parameter for clustering Gordonia and Microbacterium phages. Single gene analyses revealed evidence of horizontal gene transfer between BlueFeather and phages in unique clusters that infect a variety of bacterial hosts. Our findings highlight the advantage of using shared gene content to study seemingly genetically isolated phages and have resulted in the reclustering of BlueFeather, a putative singleton, as well as former Cluster FI phages, into a newly expanded Cluster FE.	[Demo, Stephanie; Kapinos, Andrew; Bernardino, Aaron; Guardino, Kristina; Hobbs, Blake; Hoh, Kimberly; Lee, Edward; Vuong, Iphen; Reddi, Krisanavane; Freise, Amanda C.; Parker, Jordan Moberg] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Parker, JM (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA.	jmobergparker@ucla.edu		Kapinos, Andrew/0000-0002-5353-5944	NIH [1S10RR23057]; CNSI at UCLA	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNSI at UCLA	We thank Rebecca A. Garlena and Daniel A. Russell at the Pittsburgh Bacteriophage Institute for genome sequence and assembly; and Travis Mavrich, Welkin Pope, Debbie Jacobs-Sera, and Graham Hatfull with the HHMI Science Education Alliance-Phage Hunters Advancing Genomics and Evolutionary Science (SEA-PHAGES) program for programmatic support. The authors acknowledge the use of instruments at the Electron Imaging Center for NanoMachines supported by NIH (1S10RR23057 to ZHZ) and CNSI at UCLA. We would like to thank the Microbiology, Immunology, and Molecular Genetics Department, and the Dean of Life Sciences Division at UCLA for programmatic support.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Bohlin J, 2019, COMPUT STRUCT BIOTEC, V17, P362, DOI 10.1016/j.csbj.2019.03.001; de Melo ACC, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1481-z; Cresawn SG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-395; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Grose JH, 2014, VIROLOGY, V468, P421, DOI 10.1016/j.virol.2014.08.024; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jacobs-Sera D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234636; Keen EC, 2015, BIOESSAYS, V37, P6, DOI 10.1002/bies.201400152; Klyczek KK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180517; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Mavrich TN, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.112; Miller-Ensminger T, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00738-17; Ngandu NK, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-160; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Pope WH, 2015, ELIFE, V4, DOI 10.7554/eLife.06416; Pope WH, 2018, METHODS MOL BIOL, V1681, P217, DOI 10.1007/978-1-4939-7343-9_16; Pope WH, 2017, MBIO, V8, DOI 10.1128/mBio.01069-17; Russell DA, 2018, METHODS MOL BIOL, V1681, P109, DOI 10.1007/978-1-4939-7343-9_9; Russell DA, 2017, BIOINFORMATICS, V33, P784, DOI 10.1093/bioinformatics/btw711; Sahoo D, 2019, MICROBIOL RESOUR ANN, V8, DOI 10.1128/MRA.01620-18; Sarkis GJ, 1998, METH MOL B, V101, P145, DOI 10.1385/0-89603-471-2:145; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SEA-PHAGES/starterator, 2020, SEA PHAGES PROGRAM; Shi YB, 2012, CURR MICROBIOL, V65, P28, DOI 10.1007/s00284-012-0119-2; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Wiles S, 2014, SCIBLOGS; Yuan YH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00403	33	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0248418	10.1371/journal.pone.0248418	http://dx.doi.org/10.1371/journal.pone.0248418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711060	gold, Green Submitted, Green Published			2022-12-26	WOS:000629591800032
J	Park, H; Yim, DH; Ochirpurev, B; Eom, SY; Choi, IA; Ju, GW; Kim, JH				Park, Hyemi; Yim, Dong-hyuk; Ochirpurev, Bolormaa; Eom, Sang-Yong; Choi, In Ah; Ju, Gawon; Kim, Ji Hyoun			Association between dementia and systemic rheumatic disease: A nationwide population-based study	PLOS ONE			English	Article								Objectives Systemic rheumatic disease is characterized by autoimmunity and systemic inflammation and affects multiple organs. Few studies have investigated whether autoimmune diseases increase the risk of dementia. Herein, we evaluate the relationship between systemic rheumatic disease and dementia through a population-based study using the Korean National Health Insurance Service (NHIS) claims database. Methods We conducted a nationwide population-based study using the Korean NHIS database, consisting of individuals who submitted medical claims from 2002-2013. Dementia was defined as having an acetylcholinesterase inhibitors (AChEIs) prescription along with symptoms satisfying the Alzhemier's disease (AD) International Classification of Diseases (ICD)-10 codes (F00 or G30), or vascular dementia (VaD; ICD-10 or F01) criteria. Control subjects were matched to the dementia patients by age and sex. The study group was limited to those diagnosed with rheumatic disease at least 6 months prior to diagnosis of dementia. Rheumatic disease was defined by the following ICD-10 codes: Rheumatoid arthritis (RA: M05), Sjogren's syndrome (SS: M35), systemic lupus erythematosus (SLE: M32), and Behcet's disease (BD: M35.2). Results Of the 6,028 dementia patients, 261 (4.3%) had RA, 108 (1.6%) had SS, 12 (0.2%) had SLE, and 6 (0.1%) had BD. SLE history was significantly higher in dementia patients (0.2%) than in controls (0.1%) and was associated with dementia (odds ratio [OR], 2.48; 95% confidence interval [CI], 1.19-5.15). In subgroup analysis, SLE significantly increased dementia risk, regardless of dementia type (AD: OR, 2.29; 95% CI, 1.06-4.91; VaD: OR, 4.54; 95% CI, 1.36-15.14). However, these associations were not sustained in the mild CCI or elderly group. Conclusion SLE was independently associated with a higher risk of dementia, including AD and VaD when compared to the control group, even after adjustment. SLE patients (<65 years old) are a high-risk group for early vascular dementia and require screening for early detection and active prevention.	[Park, Hyemi; Ju, Gawon] Chungbuk Natl Univ Hosp, Dept Psychiat, Cheongju, South Korea; [Yim, Dong-hyuk] Chungbuk Natl Univ, Ctr Environm Med, Cheongju, South Korea; [Yim, Dong-hyuk; Ochirpurev, Bolormaa; Eom, Sang-Yong] Chungbuk Natl Univ, Coll Med, Dept Prevent Med, Cheongju, South Korea; [Choi, In Ah; Kim, Ji Hyoun] Chungbuk Natl Univ Hosp, Dept Internal Med, Div Rheumatol, Cheongju, South Korea; [Choi, In Ah] Chungbuk Natl Univ, Dept Internal Med, Div Rheumatol, Coll Med, Cheongju, South Korea	Chungbuk National University; Chungbuk National University Hospital; Chungbuk National University; Chungbuk National University; Chungbuk National University; Chungbuk National University Hospital; Chungbuk National University	Kim, JH (corresponding author), Chungbuk Natl Univ Hosp, Dept Internal Med, Div Rheumatol, Cheongju, South Korea.	jeehyounee@cbnuh.or.kr		Ju, Gawon/0000-0002-5358-4578	Chungcheongbuk-do, the Chungbuktype Biohealth Industry's Big Data Platform project	Chungcheongbuk-do, the Chungbuktype Biohealth Industry's Big Data Platform project	This work was supported by the research grant from Chungcheongbuk-do, the Chungbuktype Biohealth Industry's Big Data Platform project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahtiluoto S, 2010, NEUROLOGY, V75, P1195, DOI 10.1212/WNL.0b013e3181f4d7f8; Appenzeller S, 2004, METHOD FIND EXP CLIN, V26, P339, DOI 10.1358/mf.2004.26.5.831324; Atzeni F, 2017, AUTOIMMUN REV, V16, P1265, DOI 10.1016/j.autrev.2017.10.011; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cimmino MA, 2000, RHEUMATOL INT, V19, P213, DOI 10.1007/PL00006853; Coluccia D, 2008, J NEUROSCI, V28, P3474, DOI 10.1523/JNEUROSCI.4893-07.2008; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Gomez-Puerta JA, 2005, RHEUMATOLOGY, V44, P95, DOI 10.1093/rheumatology/keh408; Guehne U, 2005, NEUROEPIDEMIOLOGY, V25, P153, DOI 10.1159/000086680; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Hou TY, 2019, ANN CLIN TRANSL NEUR, V6, P633, DOI 10.1002/acn3.737; Huang LC, 2019, NEUROTHERAPEUTICS, V16, P703, DOI 10.1007/s13311-019-00715-6; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Ishido M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09938-z; Kao LT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168106; Kapadia M, 2011, PROG NEUROBIOL, V95, P301, DOI 10.1016/j.pneurobio.2011.08.008; Katzav A, 2010, CLIN REV ALLERG IMMU, V38, P196, DOI 10.1007/s12016-009-8154-x; Korean statistical information, POPULATION PROJECTIO; Lee DM, 2001, LANCET, V358, P903, DOI 10.1016/S0140-6736(01)06075-5; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; Liliang PC, 2018, CLIN RHEUMATOL, V37, P935, DOI 10.1007/s10067-017-3940-y; Lu K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/861812; McGleenon BM, 1999, BRIT J CLIN PHARMACO, V48, P471; Meade T, 2018, ARTHRIT CARE RES, V70, P39, DOI 10.1002/acr.23243; O'Brien JT, 2015, LANCET, V386, P1698, DOI 10.1016/S0140-6736(15)00463-8; Park MiJeong, 2018, [The Journal of the Korea Contents Association, 한국콘텐츠학회 논문지], V18, P653, DOI 10.5392/JKCA.2018.18.04.653; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Rogers J, 2002, GLIA, V40, P260, DOI 10.1002/glia.10153; Sciascia S, 2013, AUTOIMMUN REV, V12, P426, DOI 10.1016/j.autrev.2012.08.014; Sumita Y, 2012, SCAND J IMMUNOL, V75, P633, DOI 10.1111/j.1365-3083.2012.02694.x; Tay SH, 2015, INT J MOL SCI, V16, P10281, DOI 10.3390/ijms160510281; Togo T, 2002, J NEUROIMMUNOL, V124, P83, DOI 10.1016/S0165-5728(01)00496-9; Vinters HV, 2000, J NEUROPATH EXP NEUR, V59, P931, DOI 10.1093/jnen/59.11.931; Vitturi BK, 2019, J CLIN NEUROSCI, V69, P81, DOI 10.1016/j.jocn.2019.08.027; Wallin K, 2012, J ALZHEIMERS DIS, V31, P669, DOI 10.3233/JAD-2012-111736; Wang IK, 2012, J RHEUMATOL, V39, P1611, DOI 10.3899/jrheum.111510; Weber A, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014355; Webster S, 1997, NEUROBIOL AGING, V18, P415, DOI 10.1016/S0197-4580(97)00042-0; Wortmann M, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt143; Yoshikawa K, 2012, J NEUROL SCI, V322, P217, DOI 10.1016/j.jns.2012.07.060; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Zoller B, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-41	44	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0248395	10.1371/journal.pone.0248395	http://dx.doi.org/10.1371/journal.pone.0248395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711047	Green Published, gold			2022-12-26	WOS:000629591800016
J	Henkhaus, ME; Hussen, SA; Brown, DN; del Rio, C; Fletcher, MR; Jones, MD; Marellapudi, A; Kalokhe, AS				Henkhaus, Michelle E.; Hussen, Sophia A.; Brown, Devon N.; del Rio, Carlos; Fletcher, Michelle R.; Jones, Marxavian D.; Marellapudi, Amulya; Kalokhe, Ameeta S.			Barriers and facilitators to use of a mobile HIV care model to re-engage and retain out-of-care people living with HIV in Atlanta, Georgia	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HEALTH CLINICS; UNITED-STATES; VAN; INTERVENTIONS; RETENTION; ADHERENCE; SERVICES; PROGRAM; IMPACT	Novel strategies to re-engage and retain people living with HIV (PLWH) who are out of care are greatly needed. While mobile clinics have been used effectively for HIV testing and linkage, evidence guiding their use in providing HIV care domestically has been limited. To guide the development of a mobile HIV clinic (MHC) model as a strategy to re-engage and retain PLWH who are out of care, we aimed to explore stakeholder perceptions of barriers and facilitators to MHC implementation and use. From June 2019-July 2020, we conducted 41 in-depth interviews with HIV clinic providers, administrators, staff, legal authorities, and community advisory board members, PLWH, AIDS service organizations and city officials in Atlanta, Georgia, and domestic and international mobile health clinics to explore barriers and facilitators to use of MHCs. Interviews were transcribed, coded and thematically analysed. Barriers raised include potential for: breach of confidentiality with resulting heightened stigmatization, fractured continuity of care, safety concerns, staffing challenges, and low community acceptance of MHC presence in their locality. Participants provided suggestions regarding appropriate exterior design, location, timing, and co-delivery of non-HIV services that could facilitate MHC acceptance and address the concerns. In identifying key barriers and facilitators to MHC use, this study informs design and implementation of an MHC as a novel strategy for re-engaging and retaining PLWH who are out of care.	[Henkhaus, Michelle E.; Hussen, Sophia A.; Brown, Devon N.; del Rio, Carlos; Fletcher, Michelle R.; Jones, Marxavian D.; Marellapudi, Amulya; Kalokhe, Ameeta S.] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA; [Hussen, Sophia A.; del Rio, Carlos; Kalokhe, Ameeta S.] Emory Univ, Dept Med, Div Infect Dis, Sch Med, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; Emory University	Kalokhe, AS (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA.; Kalokhe, AS (corresponding author), Emory Univ, Dept Med, Div Infect Dis, Sch Med, Atlanta, GA 30322 USA.	ameeta.kalokhe@emory.edu	del Rio, Carlos/B-3763-2012	del Rio, Carlos/0000-0002-0153-3517; Kalokhe, Ameeta/0000-0002-3556-1786; Jones, Marxavian/0000-0003-1468-8865; Marellapudi, Amulya/0000-0002-6969-1255; Henkhaus, Michelle/0000-0002-8525-6835	National Institutes of Health/National Institute of Allergy and Infectious Diseases through the Emory Center For AIDS Research [P30 AI050409]	National Institutes of Health/National Institute of Allergy and Infectious Diseases through the Emory Center For AIDS Research	This study was funded by the National Institutes of Health/National Institute of Allergy and Infectious Diseases through the Emory Center For AIDS Research (P30 AI050409) to ASK. http://www.cfar.emory.edu/; https://www.niaid.nih.gov/; The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Altice FL, 2005, J URBAN HEALTH, V82, P151, DOI 10.1093/jurban/jti016; Altice FL, 2004, CLIN INFECT DIS, V38, pS376, DOI 10.1086/421400; Altice FL, 2003, J URBAN HEALTH, V80, P416, DOI 10.1093/jurban/jtg053; Andersen M, 2007, J ASSOC NURSE AIDS C, V18, P33, DOI 10.1016/j.jana.2007.03.007; Barnabas R, 2018, DELIVERY OPTIMIZATIO; Bradford JB, 2007, AIDS PATIENT CARE ST, V21, pS49, DOI 10.1089/apc.2007.9987; Centers for Disease Control and Prevention, 2019, ANTIBIOTIC RESISTANC, DOI [10.15620/cdc:82532, DOI 10.15620/CDC:82532]; Clark HA, 2008, PUBLIC HEALTH REP, V123, P86, DOI 10.1177/00333549081230S311; Costelloe S, 2015, AIDS CARE, V27, P1425, DOI 10.1080/09540121.2015.1114993; Department of Health and Human Services, 2017, NATL HIVAIDS STRATEG; Duncombe C, 2015, TROP MED INT HEALTH, V20, P430, DOI 10.1111/tmi.12460; Edgerley LP, 2007, MATERN CHILD HLTH J, V11, P235, DOI 10.1007/s10995-006-0174-z; Edwards AL., 2017, STREET MED PROGRAM E; Ellen JA, 2003, JAIDS-J ACQ IMM DEF, V32, P388, DOI 10.1097/00126334-200304010-00007; Enriquez Maithe, 2019, J Int Assoc Provid AIDS Care, V18, p2325958219838858, DOI 10.1177/2325958219838858; Gardner LI, 2012, CLIN INFECT DIS, V55, P1124, DOI 10.1093/cid/cis623; Georgia Department of Public Health, 2016, STAND NURS PROT DIAB; Gorman SE, 2015, AIDS CARE, V27, P665, DOI 10.1080/09540121.2014.986053; Higa DH, 2016, AIDS BEHAV, V20, P951, DOI 10.1007/s10461-015-1204-x; Higa DH, 2012, CURR HIV-AIDS REP, V9, P313, DOI 10.1007/s11904-012-0136-6; HIV Continuum of Care U.S., 2014, OVERALL AGE RACEETHN; Kahn RH, 2003, SEX TRANSM DIS, V30, P654, DOI 10.1097/01.OLQ.0000083892.66236.7A; Kalichman SC, 2016, J BEHAV MED, V39, P1056, DOI 10.1007/s10865-016-9767-1; Kvale S., 2008, DOING INTERVIEWS; Liau A, 2013, AIDS BEHAV, V17, P1941, DOI 10.1007/s10461-013-0435-y; Liebman J, 2002, PUBLIC HEALTH NURS, V19, P345, DOI 10.1046/j.1525-1446.2002.19504.x; Maulsby C, 2018, AIDS BEHAV, V22, P819, DOI 10.1007/s10461-017-1809-3; Mercy Care, 2019, SERVICES PROGRAMS OU; Moon TD, 2014, B WORLD HEALTH ORGAN, V92, P680, DOI 10.2471/BLT.13.129478; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Okeke NL, 2014, CURR HIV-AIDS REP, V11, P376, DOI 10.1007/s11904-014-0233-9; Paris N, 1994, HEALTH PROG; Pasipamire L, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25183; Post P., 2007, MOBILE HLTH CARE HOM; Reif S, 2017, J COMMUN HEALTH, V42, P844, DOI 10.1007/s10900-017-0325-8; Schwitters A, 2015, GLOB HEALTH-SCI PRAC, V3, P109, DOI 10.9745/GHSP-D-14-00145; Spielberg F, 2011, AIDS EDUC PREV, V23, P110, DOI 10.1521/aeap.2011.23.3_supp.110; Yu SWY, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0671-2	38	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0247328	10.1371/journal.pone.0247328	http://dx.doi.org/10.1371/journal.pone.0247328			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8JZ	33705421	Green Published, gold			2022-12-26	WOS:000629590400028
J	Ma, HY				Ma, Hongyan			The role of clustering algorithm-based big data processing in information economy development	PLOS ONE			English	Article								The purposes are to evaluate the Distributed Clustering Algorithm (DCA) applicability in the power system's big data processing and find the information economic dispatch strategy suitable for new energy consumption in power systems. A two-layer DCA algorithm is proposed based on K-Means Clustering (KMC) and Affinity Propagation (AP) clustering algorithms. Then the incentive Demand Response (DR) is introduced, and the DR flexibility of the user side is analyzed. Finally, the day-ahead dispatch and real-time dispatch schemes are combined, and a multi-period information economic dispatch model is constructed. The algorithm performance is analyzed according to case analyses of new energy consumption. Results demonstrate that the two-layer DCA's calculation time is 5.23s only, the number of iterations is small, and the classification accuracy rate reaches 0.991. Case 2 corresponding to the proposed model can consume the new energy, and the income of the aggregator can be maximized. In short, the multi-period information economic dispatch model can consume the new energy and meet the DR of the user side.	[Ma, Hongyan] Xi An Jiao Tong Univ, Sch Humanities & Social Sci, Xian 710049, Shaanxi, Peoples R China; [Ma, Hongyan] Xian Fanyi Univ, Sch Business, Xian 710105, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xian Fanyi University	Ma, HY (corresponding author), Xi An Jiao Tong Univ, Sch Humanities & Social Sci, Xian 710049, Shaanxi, Peoples R China.; Ma, HY (corresponding author), Xian Fanyi Univ, Sch Business, Xian 710105, Shaanxi, Peoples R China.	maria78@stu.xjtu.edu.cn			National Social Science Foundation [18ZDA027]	National Social Science Foundation	The funder of History, Current Situation and Future of Information Philosophy is Kun Wu CHINA), a major bidding project of the 2018 National Social Science Foundation,18ZDA027. Hongyan Ma is a participant in the foundation program.	Abdalla A, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11243001; Bazydlo G, 2018, INT J ELEC POWER, V97, P174, DOI 10.1016/j.ijepes.2017.10.026; Bhatia V, 2018, EXPERT SYST APPL, V106, P217, DOI 10.1016/j.eswa.2018.04.010; Bostani H, 2017, PATTERN RECOGN, V62, P56, DOI 10.1016/j.patcog.2016.08.027; Chen JH, 2019, EXPERT SYST APPL, V127, P35, DOI 10.1016/j.eswa.2019.02.039; Choi H, 2019, J SUPERCOMPUT, V75, P5597, DOI 10.1007/s11227-019-02805-w; Chui KT., 2019, BEHAV INFORM TECHNOL, V38, P1; Lara-Jimenez JD, 2017, IET GENER TRANSM DIS, V11, P2902, DOI 10.1049/iet-gtd.2016.1951; Echoukairi H, 2017, IJAER, V12; Faerber LA, 2018, ENERG POLICY, V116, P210, DOI 10.1016/j.enpol.2018.02.010; Fernandes CM, 2014, IEEE T CYBERNETICS, V44, P843, DOI 10.1109/TCYB.2013.2273495; Gong YM, 2016, IEEE T SMART GRID, V7, P1304, DOI 10.1109/TSG.2015.2412091; Guisado-Clavero M, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0705-7; Hamidpour H, 2019, IET RENEW POWER GEN, V13, P1862, DOI 10.1049/iet-rpg.2019.0020; Hirth L, 2018, APPL ENERG, V225, P1054, DOI 10.1016/j.apenergy.2018.04.048; Jasinski M, 2019, ELECTR POW SYST RES, V166, P52, DOI 10.1016/j.epsr.2018.09.020; Kim H, 2017, IEEE T MOBILE COMPUT, V16, P2366, DOI 10.1109/TMC.2016.2618790; Ma FJ, 2019, IEEE T POWER ELECTR, V34, P1243, DOI 10.1109/TPEL.2018.2835570; Rahbari-Asr N, 2014, IEEE T SMART GRID, V5, P2836, DOI 10.1109/TSG.2014.2346511; Sen Poh G, 2017, ACM COMPUT SURV, V50, DOI 10.1145/3064005; Tang R, 2019, APPL ENERG, V250, P118, DOI 10.1016/j.apenergy.2019.04.177; Le T, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20092668; Xu HC, 2020, IEEE T SMART GRID, V11, P3438, DOI 10.1109/TSG.2020.2977088; Yang F, 2017, RENEW ENERG, V108, P132, DOI 10.1016/j.renene.2017.02.054	24	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0246718	10.1371/journal.pone.0246718	http://dx.doi.org/10.1371/journal.pone.0246718			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705391	Green Published, gold			2022-12-26	WOS:000629590400097
J	Wilski, M; Brola, W; Luniewska, M; Tomczak, M				Wilski, Maciej; Brola, Waldemar; Luniewska, Magdalena; Tomczak, Maciej			The perceived impact of multiple sclerosis and self-management: The mediating role of coping strategies	PLOS ONE			English	Article							QUALITY-OF-LIFE; PSYCHOMETRIC PROPERTIES; POLISH VERSION; SCALE MSIS-29; IMPAIRMENT; ADJUSTMENT; INTERVENTIONS; ADHERENCE; EFFICACY; FATIGUE	Low level of self-management in people with multiple sclerosis (MS) is considered to be a predominant factor that leads to poor rehabilitation efficacy. Studies focusing on the relationship between self-management and psychological variables that can be modified could contribute to expanding the knowledge needed to propose interventional programs aiming at patient activation. This study aimed to analyze whether coping strategies play a mediating role in the association between the perceived impact of MS and level of self-management in people with MS. The cross-sectional study included 382 people with MS. The participants completed the Multiple Sclerosis Self-Management Scale-Revised, Multiple Sclerosis Impact Scale-29, and Coping Inventory for Stressful Situations. The study hypothesis was evaluated using mediation analysis. The STROBE checklist specifically prepared for cross-sectional research was applied in this study for reporting. Results indicate that the emotion- and problem-focused strategies of coping can be treated as mediating the association between the MS impact and level of self-management in people with MS. A negative relationship was found between the perceived MS impact and problem-oriented coping, while a positive relationship was found between problem-oriented coping and self-management. Furthermore, a positive relationship was found between the MS impact and emotion-oriented coping, while a negative relationship was found between emotion-oriented coping and self-management. The indirect role of avoidance-oriented coping was not significant. Our study confirms the role played by coping strategies in individuals' self-management. In MS, self-management determined by perceived MS impact can be controlled by decreasing emotional-coping while increasing problem-coping strategies. Our study imparts new knowledge regarding the potential interventions for improving the level of self-management in people with MS. It indicates that recognition of individuals' illness perceptions as well as maladaptive coping strategies can help health professionals identify those who might be having lower level of self-management.	[Wilski, Maciej; Luniewska, Magdalena] Poznan Univ Phys Educ, Dept Adapted Phys Act, Poznan, Poland; [Brola, Waldemar] Jan Kochanowski Univ Humanities & Sci, Coll Med, Kielce, Poland; [Tomczak, Maciej] Poznan Univ Phys Educ, Dept Psychol, Poznan, Poland	Jan Kochanowski University	Wilski, M (corresponding author), Poznan Univ Phys Educ, Dept Adapted Phys Act, Poznan, Poland.	mwilski@wp.pl	Brola, Waldemar/D-8813-2014; Wilski, Maciej/S-6449-2018	Brola, Waldemar/0000-0002-7955-3454; Wilski, Maciej/0000-0003-4856-3016; Tomczak, Maciej/0000-0001-7323-3348; Luniewska, Magdalena/0000-0002-8168-4744				AFFLECK G, 1987, J PERS SOC PSYCHOL, V53, P273, DOI 10.1037/0022-3514.53.2.273; Bassi M, 2021, J CLIN PSYCHOL MED S, V28, P149, DOI 10.1007/s10880-019-09692-6; Bassi M, 2020, DISABIL REHABIL, V42, P3780, DOI 10.1080/09638288.2019.1610511; Berger BA, 2005, J AM PHARM ASSOC, V45, P466, DOI 10.1331/1544345054475469; Bishop M, 2011, REHABIL PSYCHOL, V56, P150, DOI 10.1037/a0023679; Bishop M, 2008, REHABIL COUNS BULL, V52, P45, DOI 10.1177/0034355208320000; Bolin JH, 2014, J EDUC MEAS, V51, P335, DOI 10.1111/jedm.12050; Bombardier CH, 2008, ARCH PHYS MED REHAB, V89, P1849, DOI 10.1016/j.apmr.2008.03.021; Calandri E, 2017, CLIN REHABIL, V31, P1386, DOI 10.1177/0269215517695374; Cameron H., 2003, SELF REGULATION HLTH; Darlington R.B., 2017, REGRESSION ANAL LINE; Dennison L, 2011, J HEALTH PSYCHOL, V16, P478, DOI 10.1177/1359105310384299; Dennison L, 2009, CLIN PSYCHOL REV, V29, P141, DOI 10.1016/j.cpr.2008.12.001; Endler NS., 1999, COPING INVENTORY STR, V2; Gedik Z, 2017, J HEALTH PSYCHOL, V22, P707, DOI 10.1177/1359105315611958; Ghahari Setareh, 2014, Int J MS Care, V16, P61, DOI 10.7224/1537-2073.2013-019; Gil KM, 1997, CLIN J PAIN, V13, P110, DOI 10.1097/00002508-199706000-00005; Grech Lisa B, 2018, Int J MS Care, V20, P109, DOI [10.7224/1537-2073.2018-029, 10.7224/1537-2073.2016-008]; Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321; Henze T, 2006, EUR NEUROL, V56, P78, DOI 10.1159/000095699; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Hoogervorst ELJ, 2004, MULT SCLER, V10, P569, DOI 10.1191/1352458504ms1078oa; Jamroz-Wisniewska A, 2007, NEUROL NEUROCHIR POL, V41, P215; Jongen PJ, 2015, MULT SCLER INT, V2015, DOI 10.1155/2015/960282; Kidd T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185931; Kralik D, 2004, J CLIN NURS, V13, P259, DOI 10.1046/j.1365-2702.2003.00826.x; Kroencke DC, 1999, MULT SCLER J, V5, P89, DOI 10.1177/135245859900500204; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Leventhal H., 2003, SELF REGULATION HLTH, P43; McAuley E, 2007, MULT SCLER, V13, P652, DOI 10.1177/1352458506072188; McCabe M, 2006, J CLIN PSYCHOL MED S, V13, P369, DOI 10.1007/s10880-006-9042-7; Mikula P, 2015, PSYCHOL HEALTH MED, V20, P653, DOI 10.1080/13548506.2015.1032310; Mohr DC, 1997, MULT SCLER J, V3, P254, DOI 10.1177/135245859700300408; Navipour H, 2006, NEUROREHABILITATION, V21, P37; Nerenz, 1980, CONTRIBUTIONS MED PS, V2, P7, DOI DOI 10.1093/GERONJ/46.4.P181; Pakenham KI, 2006, PSYCHOL HEALTH, V21, P633, DOI 10.1080/14768320500422618; Pakenham KI, 1999, HEALTH PSYCHOL, V18, P383, DOI 10.1037/0278-6133.18.4.383; Parker J.D.A., 1996, HDB COPING THEORY RE, P3; Plow MA, 2011, PM&R, V3, P251, DOI 10.1016/j.pmrj.2010.11.011; Rae-Grant AD, 2011, J REHABIL RES DEV, V48, P1087, DOI 10.1682/JRRD.2010.08.0159; Riazi A, 2003, MULT SCLER J, V9, P411, DOI 10.1191/1352458503ms929oa; Rieckmann P, 2015, MULT SCLER RELAT DIS, V4, P202, DOI 10.1016/j.msard.2015.02.005; Rucker DD, 2011, SOC PERSONAL PSYCHOL, V5, P359, DOI 10.1111/j.1751-9004.2011.00355.x; Steinberg SC, 2010, CLIN DRUG INVEST, V30, P89, DOI 10.2165/11533330-000000000-00000; Strelau J, 2007, QUESTIONNAIRE COPING; Tomczak M, 2022, DISABIL REHABIL, V44, P2113, DOI 10.1080/09638288.2020.1822933; Willemse H, 2019, J HEALTH PSYCHOL, V24, P1461, DOI 10.1177/1359105317752826; Wilski M, 2016, ACTA NEUROL SCAND, V133, P338, DOI 10.1111/ane.12465; Wilski M, 2019, RES NURS HEALTH, V42, P296, DOI 10.1002/nur.21955; Wilski M, 2015, DISABIL REHABIL, V37, P1970, DOI 10.3109/09638288.2014.993435; Zhao XS, 2010, J CONSUM RES, V37, P197, DOI 10.1086/651257	51	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248135	10.1371/journal.pone.0248135	http://dx.doi.org/10.1371/journal.pone.0248135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8JZ	33705470	Green Published, gold			2022-12-26	WOS:000629590400033
J	Bhardwaj, M; Soanes, K; Lahoz-Monfort, JJ; Lumsden, LF; van der Ree, R				Bhardwaj, Manisha; Soanes, Kylie; Lahoz-Monfort, Jose J.; Lumsden, Linda F.; van der Ree, Rodney			Insectivorous bats are less active near freeways	PLOS ONE			English	Article							ROAD-EFFECT ZONE; NOCTURNAL ACTIVITY; NYCTOPHILUS-GEOFFROYI; CHALINOLOBUS-GOULDII; TRAFFIC NOISE; HABITAT; ABUNDANCE; IMPACTS; URBANIZATION; AVAILABILITY	Traffic disturbances (i.e. pollution, light, noise, and vibrations) often extend into the area surrounding a road creating a 'road-effect zone'. Habitat within the road-effect zone is degraded or, in severe cases, completely unsuitable for wildlife, resulting in indirect habitat loss. This can have a disproportionate impact on wildlife in highly modified landscapes, where remaining habitat is scarce or occurs predominantly along roadside reserves. In this study, we investigated the road-effect zone for insectivorous bats in highly cleared agricultural landscapes by quantifying the change in call activity with proximity to three major freeways. The activity of seven out of 10 species of bat significantly decreased with proximity to the freeway. We defined the road-effect zone to be the proximity at which call activity declined by at least 20% relative to the maximum detected activity. The overall road-effect zone for bats in this region was 307 m, varying between 123 and 890 m for individual species. Given that this road-effect zone exceeds the typical width of the roadside verges (<50 m), it is possible that much of the vegetation adjacent to freeways in this and similar landscapes provides low-quality habitat for bats. Without accounting for the road-effect zone, the amount of habitat lost or degraded due to roads is underestimated, potentially resulting in the loss of wildlife, ecosystem services and key ecosystem processes (e.g. predator-prey or plant-pollinator interactions) from the landscape. We suggest all future environmental impact assessments include quantifying the road-effect zone for sensitive wildlife, in order to best plan and mitigate the impact of roads on the environment. Mitigating the effects of new and existing roads on wildlife is essential to ensure enough high-quality habitat persists to maintain wildlife populations.	[Bhardwaj, Manisha; Soanes, Kylie; Lahoz-Monfort, Jose J.; van der Ree, Rodney] Univ Melbourne, Sch BioSci, Melbourne, Vic, Australia; [Soanes, Kylie] Univ Melbourne, Sch Ecosyst & Forest Sci, Melbourne, Vic, Australia; [Lumsden, Linda F.] Arthur Rylah Inst Environm Res, Dept Environm Land Water & Planning, Heidelberg, Vic, Australia; [Bhardwaj, Manisha] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Uppsala, Sweden; [van der Ree, Rodney] WSP Australia Pty Ltd, Southbank, Vic, Australia	University of Melbourne; University of Melbourne; Arthur Rylah Institute for Environmental Research (ARI); Swedish University of Agricultural Sciences	Bhardwaj, M (corresponding author), Univ Melbourne, Sch BioSci, Melbourne, Vic, Australia.; Bhardwaj, M (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Uppsala, Sweden.	manisha.bhardwaj@live.ca	Bhardwaj, Manisha/AAC-4268-2019	Bhardwaj, Manisha/0000-0001-7769-0845; Soanes, Kylie/0000-0002-2266-9392	Baker Foundation; Earthwatch Institute; Holsworth Wildlife Research Endowment; Albert Shimmins Fund; Clean Air and Urban Landscapes Hub and Threatened Species Recovery Hub of the Australian Government's National Environmental Science Program	Baker Foundation; Earthwatch Institute; Holsworth Wildlife Research Endowment; Albert Shimmins Fund; Clean Air and Urban Landscapes Hub and Threatened Species Recovery Hub of the Australian Government's National Environmental Science Program	Funding for this study was provided by The Baker Foundation (RvdR), Earthwatch Institute (RvdR), Holsworth Wildlife Research Endowment (MB), and the Albert Shimmins Fund (MB). KS is supported by the Clean Air and Urban Landscapes Hub and Threatened Species Recovery Hub of the Australian Government's National Environmental Science Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott IM, 2012, LANDSCAPE URBAN PLAN, V106, P293, DOI 10.1016/j.landurbplan.2012.03.015; Adams MD, 2010, ACTA CHIROPTEROL, V12, P231, DOI 10.3161/150811010X504725; Agriculture Victoria, 2020, PRIM PROD LANDSC VIC; ANTHONY ELP, 1981, OECOLOGIA, V51, P151, DOI 10.1007/BF00540593; Bekker H, 2003, WILDLIFE TRAFFIC A E; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Bennett V. J, 2017, CURR LANDSC ECOL REP, DOI [10.1007/s40823-017-0020-6, DOI 10.1007/S40823-017-0020-6]; Bennett VJ, 2013, LANDSCAPE ECOL, V28, P979, DOI 10.1007/s10980-013-9874-0; Bennett VJ, 2013, J WILDLIFE MANAGE, V77, P93, DOI 10.1002/jwmg.467; Berthinussen A., 2015, WC1060 DEP ENV FOOD; Berthinussen A, 2012, J APPL ECOL, V49, P82, DOI 10.1111/j.1365-2664.2011.02068.x; Bhardwaj M, 2017, BIOL CONSERV, V212, P22, DOI 10.1016/j.biocon.2017.05.022; Bhardwaj M, 2019, ECOL EVOL, V9, P65, DOI 10.1002/ece3.4609; Boarman WI, 2006, J ARID ENVIRON, V65, P94, DOI 10.1016/j.jaridenv.2005.06.020; Bonsen G, 2015, ACTA CHIROPTEROL, V17, P347, DOI 10.3161/15081109ACC2015.17.2.010; Borkin KM, 2019, ACTA CHIROPTEROL, V21, P321, DOI 10.3161/15081109ACC2019.21.2.007; Claireau F, 2019, BIOL CONSERV, V235, P53, DOI 10.1016/j.biocon.2019.04.002; Coffin AW, 2007, J TRANSP GEOGR, V15, P396, DOI 10.1016/j.jtrangeo.2006.11.006; Costermans L., 2006, TREES VICTORIA ADJOI; Downs NC, 2006, ACTA CHIROPTEROL, V8, P169, DOI 10.3161/1733-5329(2006)8[169:TUBBOH]2.0.CO;2; Eigenbrod F, 2009, ECOL SOC, V14; Fahrig L, 2009, ECOL SOC, V14; Fensome AG, 2016, MAMMAL REV, V46, P311, DOI 10.1111/mam.12072; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2000, CONSERV BIOL, V14, P31, DOI 10.1046/j.1523-1739.2000.99299.x; Forman RTT, 2000, CONSERV BIOL, V14, P36, DOI 10.1046/j.1523-1739.2000.99088.x; Forman RTT, 2002, ENVIRON MANAGE, V29, P782, DOI 10.1007/s00267-001-0065-4; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Gibson M., 2003, AUSTRALASIAN BAT SOC, V20, P24; Hale JD, 2015, GLOBAL CHANGE BIOL, V21, P2467, DOI 10.1111/gcb.12884; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; Kitzes J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096341; Kuitunen MT, 2003, ENVIRON MANAGE, V31, P79, DOI 10.1007/s00267-002-2694-7; Lentini PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048201; Lumsden LF, 2005, BIOL CONSERV, V122, P205, DOI 10.1016/j.biocon.2004.07.006; Lumsden LF, 2002, BIOL CONSERV, V106, P237, DOI 10.1016/S0006-3207(01)00250-6; Lumsden LF, 2002, J ZOOL, V257, P207, DOI 10.1017/S095283690200081X; LUMSDEN LF, 1995, TRZS NSW, P142; Lumsden LF, 2000, BUSHC GRASS LANDSC C; Medinas D, 2019, SCI TOTAL ENVIRON, V660, P340, DOI 10.1016/j.scitotenv.2019.01.032; Medinas D, 2013, ECOL RES, V28, P227, DOI 10.1007/s11284-012-1009-6; Murray SW, 2004, J ZOOL, V262, P197, DOI 10.1017/S0952836903004503; O'Donnell CFJ, 2000, NEW ZEAL J ZOOL, V27, P207, DOI 10.1080/03014223.2000.9518228; Park KJ, 2015, MAMM BIOL, V80, P191, DOI 10.1016/j.mambio.2014.10.004; Pellet J, 2004, CONSERV BIOL, V18, P1599, DOI 10.1111/j.1523-1739.2004.0421a.x; Plummer M., 2003, P 3 INT WORKSHOP DIS; R Core Team, 2021, R LANGUAGE ENV STAT; Reside AE, 2011, BIOLOGY AND CONSERVATION OF AUSTRALASIAN BATS, P155; RICHARDS GC, 1989, AUST WILDLIFE RES, V16, P151; Riitters KH, 2003, FRONT ECOL ENVIRON, V1, P125, DOI 10.1890/1540-9295(2003)001[0125:HFTTNR]2.0.CO;2; Roberts K, 2015, HANDBOOK OF ROAD ECOLOGY, P27; Russo D, 2002, BIOL CONSERV, V107, P71, DOI 10.1016/S0006-3207(02)00047-2; Russo D, 2015, MAMM BIOL, V80, P205, DOI 10.1016/j.mambio.2014.10.003; RYDELL J, 1989, OECOLOGIA, V80, P562, DOI 10.1007/BF00380082; Rytwinski T, 2015, HANDBOOK OF ROAD ECOLOGY, P237; Schaub A, 2008, J EXP BIOL, V211, P3174, DOI 10.1242/jeb.022863; Semlitsch RD, 2007, CONSERV BIOL, V21, P159, DOI 10.1111/j.1523-1739.2006.00571.x; Shanley CS, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00093.1; Siemers BM, 2011, P ROY SOC B-BIOL SCI, V278, P1646, DOI 10.1098/rspb.2010.2262; Sih A, 2000, TRENDS ECOL EVOL, V15, P132, DOI 10.1016/S0169-5347(99)01799-1; Spellerberg IF, 1998, GLOBAL ECOL BIOGEOGR, V7, P317, DOI 10.1046/j.1466-822x.1998.00308.x; Stone EL, 2015, MAMM BIOL, V80, P213, DOI 10.1016/j.mambio.2015.02.004; Su YS., 2015, R2JAGS USING R RUNJA; Tanner D, 2007, J ENVIRON MANAGE, V85, P270, DOI 10.1016/j.jenvman.2006.08.022; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; van der Ree R, 2015, HANDBOOK OF ROAD ECOLOGY, P1; van der Ree R, 2015, HANDBOOK OF ROAD ECOLOGY, P71; Vandevelde JC, 2014, ECOL ENG, V64, P49, DOI 10.1016/j.ecoleng.2013.12.025; VicRoads, 2015, VICROADS OPEN DATA S; Zurcher AA, 2010, ACTA CHIROPTEROL, V12, P337, DOI 10.3161/150811010X537918	70	1	2	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0247400	10.1371/journal.pone.0247400	http://dx.doi.org/10.1371/journal.pone.0247400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690682	Green Published, gold			2022-12-26	WOS:000627854700050
J	Darwish, HW; Ali, NA; Naguib, IA; El Ghobashy, MR; Al-Hossaini, AM; Abdelrahman, MM				Darwish, Hany W.; Ali, Nesma A.; Naguib, Ibrahim A.; El Ghobashy, Mohamed R.; Al-Hossaini, Abdullah M.; Abdelrahman, Maha M.			Development and validation of a stability indicating RP-HPLC-DAD method for the determination of bromazepam	PLOS ONE			English	Article								A reliable, selective and sensitive stability-indicating RP-HPLC assay was established for the quantitation of bromazepam (BMZ) and one of the degradant and stated potential impurities; 2-(2-amino-5-bromobenzoyl) pyridine (ABP). The assay was accomplished on a C-18 column (250 mm x 4.6 mm i.d., 5 mu m particle size), and utilizing methanol-water (70: 30, v/v) as the mobile phase, at a flow rate of 1.0 ml min(-1). HPLC detection of elute was obtained by a photodiode array detector (DAD) which was set at 230 nm. ICH guidelines were adhered for validation of proposed method regarding specificity, sensitivity, precision, linearity, accuracy, system suitability and robustness. Calibration curves of BMZ and ABP were created in the range of 1-16 mu g mL(-1) with mean recovery percentage of 100.02 +/- 1.245 and 99.74 +/- 1.124, and detection limit of 0.20 mu g mL(-1) and 0.24 mu g mL(-1) respectively. BMZ stability was inspected under various ICH forced degradation conditions and it was found to be easily degraded in acidic and alkaline conditions. The results revealed the suitability of the described methodology for the quantitation of the impurity (ABP) in a BMZ pure sample. The determination of BMZ in pharmaceutical dosage forms was conducted with the described method and showed mean percentage recovery of 99.39 +/- 1.401 and 98.72 +/- 1.795 (n = 6), respectively. When comparing the described procedure to a reference HPLC method statistically, no significant differences between the two methods in regard to both accuracy and precision were found.	[Darwish, Hany W.; Al-Hossaini, Abdullah M.] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh, Saudi Arabia; [Darwish, Hany W.; El Ghobashy, Mohamed R.] Cairo Univ, Fac Pharm, Analyt Chem Dept, Cairo, Egypt; [Ali, Nesma A.] Justice Minist, Analyt Toxicol Lab, Forens Med Author, Cairo, Egypt; [Naguib, Ibrahim A.] Taif Univ, Coll Pharm, Dept Pharmaceut Chem, At Taif, Saudi Arabia; [El Ghobashy, Mohamed R.] October 6 Univ, Fac Pharm, Giza, Egypt; [Abdelrahman, Maha M.] Beni Suef Univ, Fac Pharm, Pharmaceut Analyt Chem Dept, Bani Suwayf, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Cairo University; Ministry of Justice - Egypt; Taif University; Egyptian Knowledge Bank (EKB); October 6 University (O6U); Egyptian Knowledge Bank (EKB); Beni Suef University	Darwish, HW (corresponding author), King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh, Saudi Arabia.; Darwish, HW (corresponding author), Cairo Univ, Fac Pharm, Analyt Chem Dept, Cairo, Egypt.	hdarwish@ksu.edu.sa	Genidy, Maha Mohamed Abdelrahman/I-1627-2019; Naguib, Ibrahim A/ABM-0813-2022	Genidy, Maha Mohamed Abdelrahman/0000-0003-3784-1332; Naguib, Ibrahim A/0000-0002-5923-1466; Elghobashy, Mohamed/0000-0003-0383-2091	Deanship of Scientific Research at King Saud University [RGP-322]; Taif University, Taif, Saudi Arabia [TURSP-2020/56]	Deanship of Scientific Research at King Saud University(King Saud University); Taif University, Taif, Saudi Arabia	The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding of this research through the Research Group Project to HD (RGP-322), and to Taif University Researchers Supporting Project, Taif University, Taif, Saudi Arabia to IN (TURSP-2020/56).	Aebi B, 2002, FORENSIC SCI INT, V128, P84, DOI 10.1016/S0379-0738(02)00165-2; Al Attas AS, 2009, INT J ELECTROCHEM SC, V4, P20; Al-Hawasli Hasan, 2012, J Pharm Anal, V2, P484, DOI 10.1016/j.jpha.2012.05.001; ALFREDSON T, 1986, J CHROMATOGR SCI, V24, P473, DOI 10.1093/chromsci/24.11.473; Ali NA, 2015, ANAL BIOANAL ELECTRO, V7, P242; Andraus MH, 2004, J MASS SPECTROM, V39, P1348, DOI 10.1002/jms.667; [Anonymous], 2009, BRIT PHARMACOPOEIA B; [Anonymous], 2000, US PHARMACOPOEIA USP; Attia MS, 2009, SPECTROCHIM ACTA A, V74, P972, DOI 10.1016/j.saa.2009.09.002; BERRUETA LA, 1992, J PHARMACEUT BIOMED, V10, P109, DOI 10.1016/0731-7085(92)80019-J; BOUKHABZA A, 1989, ANALYST, V114, P639, DOI 10.1039/an9891400639; Cheze M, 2004, FORENSIC SCI INT, V145, P123, DOI 10.1016/j.forsciint.2004.04.066; Darwish HW, 2020, SPECTROCHIM ACTA A, V238, DOI 10.1016/j.saa.2020.118433; DEBRUYNE MMA, 1982, PHARM WEEKBLAD, V4, P12, DOI 10.1007/BF02112351; ElKhateeb SZ, 1997, SPECTROSC LETT, V30, P915, DOI 10.1080/00387019708001638; Ermer J, 2005, METHOD VALIDATION IN PHARMACEUTICAL ANALYSIS: A GUIDE TO BEST PRACTICE, P1; HAEFELFINGER P, 1978, CHROMATOGRAPHIA, V11, P10, DOI 10.1007/BF02262946; Hansen SH, 2005, J PHARMACEUT BIOMED, V39, P322, DOI 10.1016/j.jpba.2005.03.017; He WD, 1998, J FORENSIC SCI, V43, P1061; HERNANDEZ L, 1987, ANALYST, V112, P1149, DOI 10.1039/an9871201149; HIRAYAMA H, 1983, J CHROMATOGR, V277, P414, DOI 10.1016/S0378-4347(00)84868-9; ICH, 2003, HARMONISED TRIPARTIT; ICH, 1996, HARMONISED TRIPARTIT; ICH Q2 (R1), 2005, VALIDATION ANALYTICA; Index Merck., 2001, MERCK RES LAB DIVISI, Vthirteenth; Laurence D.R., 1980, CLIN PHARMACOL THER, V5, P274; Laurito TL, 2004, J MASS SPECTROM, V39, P168, DOI 10.1002/jms.590; LESOLLEU H, 1993, J PHARMACEUT BIOMED, V11, P771, DOI 10.1016/0731-7085(93)80187-6; Michaud K, 2001, FORENSIC SCI INT, V124, P112, DOI 10.1016/S0379-0738(01)00584-9; Moore C., 2007, DETERMINATION BENZOD, P5989; MUSSHOFF F, 1992, INT J LEGAL MED, V105, P105, DOI 10.1007/BF02340833; Panderi I, 1998, J PHARMACEUT BIOMED, V17, P327, DOI 10.1016/S0731-7085(97)00201-X; Podilsky G, 2008, J LIQ CHROMATOGR R T, V31, P878, DOI 10.1080/10826070801893508; Rang HP., 2007, RANG DALES PHARM E B; Salem AA, 2004, SPECTROCHIM ACTA A, V60, P771, DOI 10.1016/S1386-1425(03)00300-7; Salem AA, 2003, ANAL CHIM ACTA, V498, P79, DOI 10.1016/j.aca.2003.08.070; Salem AA, 2002, ANAL LETT, V35, P1631, DOI 10.1081/AL-120013044; Salem AEA, 2002, J ELECTROANAL CHEM, V536, P1, DOI 10.1016/S0022-0728(02)01147-6; Samandiou VF, 2007, J SEP SCI, V30, P679, DOI 10.1002/jssc.200600365; Goncalves JCS, 2005, THER DRUG MONIT, V27, P601; SAWADA H, 1978, DRUG METAB DISPOS, V6, P205; Schutz H, 1982, BENZODIAZEPINES HDB; SCHWARTZ MA, 1973, J PHARM SCI, V62, P1776, DOI 10.1002/jps.2600621108; SIOUFI A, 1990, J CHROMATOGR-BIOMED, V531, P459, DOI 10.1016/S0378-4347(00)82291-4; Sweetman S.C., 2009, MARTINDALE COMPLETE, V1039; Tanaka E, 1996, J CHROMATOGR B, V682, P173, DOI 10.1016/0378-4347(96)00121-1; Trevor A.J., 2007, KATZUNG TREVORS PHAR, V8th ed.; Uddin MN, 2008, J LIQ CHROMATOGR R T, V31, P1258, DOI 10.1080/10826070802019574; VALDEON JL, 1987, ANALYST, V112, P1365, DOI 10.1039/an9871201365; Williams D.A., 2008, FOYES PRINCIPLE MED, V6th, DOI [10.2174/157340608786242089, DOI 10.2174/157340608786242089]	50	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0244951	10.1371/journal.pone.0244951	http://dx.doi.org/10.1371/journal.pone.0244951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690658	Green Published, gold			2022-12-26	WOS:000627854700001
J	Gulbay, M; Ozbay, BO; Mendi, BAR; Bastug, A; Bodur, H				Gulbay, Mutlu; Ozbay, Bahadir Orkun; Mendi, Bokebatur Ahmet Rasit; Bastug, Aliye; Bodur, Hurrem			A CT radiomics analysis of COVID-19-related ground-glass opacities and consolidation: Is it valuable in a differential diagnosis with other atypical pneumonias?	PLOS ONE			English	Article								Purpose To evaluate the discrimination of parenchymal lesions between COVID-19 and other atypical pneumonia (AP) by using only radiomics features. Methods In this retrospective study, 301 pneumonic lesions (150 ground-glass opacity [GGO], 52 crazy paving [CP], 99 consolidation) obtained from nonenhanced thorax CT scans of 74 AP (46 male and 28 female; 48.25 +/- 13.67 years) and 60 COVID-19 (39 male and 21 female; 48.01 +/- 20.38 years) patients were segmented manually by two independent radiologists, and Location, Size, Shape, and First- and Second-order radiomics features were calculated. Results Multiple parameters showed significant differences between AP and COVID-19-related GGOs and consolidations, although only the Range parameter was significantly different for CPs. Models developed by using the Bayesian information criterion (BIC) for the whole group of GGO and consolidation lesions predicted COVID-19 consolidation and AP GGO lesions with low accuracy (46.1% and 60.8%, respectively). Thus, instead of subjective classification, lesions were reclassified according to their skewness into positive skewness group (PSG, 78 AP and 71 COVID-19 lesions) and negative skewness group (NSG, 56 AP and 44 COVID-19 lesions), and group-specific models were created. The best AUC, accuracy, sensitivity, and specificity were respectively 0.774, 75.8%, 74.6%, and 76.9% among the PSG models and 0.907, 83%, 79.5%, and 85.7% for the NSG models. The best PSG model was also better at predicting NSG lesions smaller than 3 mL. Using an algorithm, 80% of COVID-19 and 81.1% of AP patients were correctly predicted. Conclusion During periods of increasing AP, radiomics parameters may provide valuable data for the differential diagnosis of COVID-19.	[Gulbay, Mutlu; Mendi, Bokebatur Ahmet Rasit] Univ Mahallesi, Ankara Numune Educ & Res Hosp, Ankara City Hosp, Dept Radiol, Ankara, Turkey; [Ozbay, Bahadir Orkun; Bastug, Aliye; Bodur, Hurrem] Univ Mahallesi, Ankara Numune Educ & Res Hosp, Ankara City Hosp, Dept Infect Dis & Clin Microbiol, Ankara, Turkey	Ankara Numune Training & Research Hospital; City Hospital Ankara; Ministry of Energy & Natural Resources - Turkey; Ankara Numune Training & Research Hospital; City Hospital Ankara; Ministry of Energy & Natural Resources - Turkey	Gulbay, M (corresponding author), Univ Mahallesi, Ankara Numune Educ & Res Hosp, Ankara City Hosp, Dept Radiol, Ankara, Turkey.	drgulbay@gmail.com	Gulbay, Mutlu/AAI-4858-2021; Bodur, Hurrem/GRO-2410-2022; Gülbay, Mutlu/ABG-9703-2021	Gulbay, Mutlu/0000-0001-5921-1652; Mendi, Bokebatur Ahmet Rasit/0000-0002-6102-2188				Agarwal PP, 2009, AM J ROENTGENOL, V193, P1488, DOI 10.2214/AJR.09.3599; Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; [Anonymous], RAPID INFLUENZA DIAG; [Anonymous], 2020, WHO CORONAVIRUS DIS; Asai N, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2677-1; Di Paolo M, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00324-2020; E LN, 2019, J COMPUT ASSIST TOMO, V43, P300, DOI 10.1097/RCT.0000000000000836; Fang X, 2020, EUR RADIOL, V30, P6888, DOI 10.1007/s00330-020-07032-z; Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432; Guan CS, 2020, DIAGN INTERV RADIOL, V26, P301, DOI 10.5152/dir.2019.20176; Homayounieh Fatemeh, 2020, Radiol Cardiothorac Imaging, V2, pe200322, DOI 10.1148/ryct.2020200322; Kim EA, 2002, RADIOGRAPHICS, V22, pS137, DOI 10.1148/radiographics.22.suppl_1.g02oc15s137; Koo HJ, 2018, RADIOGRAPHICS, V38, P719, DOI 10.1148/rg.2018170048; Kwee TC, 2020, RADIOGRAPHICS, V40, P1848, DOI 10.1148/rg.2020200159; Lee SH, 2019, CANCER IMAGING, V19, DOI 10.1186/s40644-019-0239-z; Li L, 2020, RADIOLOGY, V296, pE65, DOI 10.1148/radiol.2020200905; Mohammad Sonia, 2019, Microbiol Insights, V12, p1178636119890302, DOI 10.1177/1178636119890302; Orlhac F, 2019, RADIOLOGY, V291, P52, DOI 10.1148/radiol.2019182023; Pfoh ER, 2020, J GEN INTERN MED, V35, P2829, DOI 10.1007/s11606-020-05949-1; Pyradiomics, 2016, RAD FEAT; Simpson Scott, 2020, Radiol Cardiothorac Imaging, V2, pe200152, DOI [10.1097/RTI.0000000000000524, 10.1148/ryct.2020200152]; Talbot HK, 2010, INFECT CONT HOSP EP, V31, P683, DOI 10.1086/653202; Varghese BA, 2019, AM J ROENTGENOL, V212, P520, DOI 10.2214/AJR.18.20624; Wei W, 2020, EUR RADIOL, V30, P6788, DOI 10.1007/s00330-020-07012-3; Woloshin S, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2015897; Xie XZ, 2020, RADIOLOGY, V296, pE41, DOI 10.1148/radiol.2020200343; Zhang L, 2011, INDIAN J MED RES, V134, P270; Zhang T, 2019, CLIN RADIOL, V74, DOI 10.1016/j.crad.2018.08.014; Zhao W, 2019, EUR J RADIOL, V112, P161, DOI 10.1016/j.ejrad.2019.01.021	29	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0246582	10.1371/journal.pone.0246582	http://dx.doi.org/10.1371/journal.pone.0246582			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690730	Green Published, gold			2022-12-26	WOS:000627854700020
J	Chmura, P; Liu, HY; Andrzejewski, M; Chmura, J; Kowalczuk, E; Rokita, A; Konefal, M				Chmura, Pawel; Liu, Hongyou; Andrzejewski, Marcin; Chmura, Jan; Kowalczuk, Edward; Rokita, Andrzej; Konefal, Marek			Is there meaningful influence from situational and environmental factors on the physical and technical activity of elite football players? Evidence from the data of 5 consecutive seasons of the German Bundesliga	PLOS ONE			English	Article							FIFA WORLD CUP; MATCH RUNNING PERFORMANCE; POSSESSION STRATEGIES; SOCCER PLAYERS; ASSOCIATION; GAME; EVOLUTION; LOCATION; QUALITY; TEMPERATURE	The study aimed to identify the effects of situational (match location, match outcome and strength of team/opponent team) and environmental (ambient temperature, relative humidity, WBGT, ground and weather condition) factors on the physical and technical activity of elite football on individual playing positions. Physical and technical activity were collected from 779 football players competing in the German Bundesliga during 5 domestic seasons, from 2014/2015 to 2018/2019, totalling 1530 matches. The data on players' physical and technical activity was taken from the IMPIRE AG system. Based on the available data, 11 variables were selected to quantify the match activity profiles of players. The results showed that situational variables had major effects on the technical performance (especially number of passes performed) but minor effects on physical performance. In turn, among the analysed environmental factors, temperature is the most sensitive, which affects the Total Distance and Sprint Efforts of players in all five positions. This investigation demonstrated that, given that passing is a key technical activity in modern football, players and training staff should be particularly aware that passing maybe affected by situational variables. Professional players are able to react and adapt to various environmental conditions, modifying physical activity depending on the needs in German Bundesliga. These results could help coaches and analysts to better understand the influences of situational and environmental variables on individual playing positions during the evaluation of players' physical and technical performance.	[Chmura, Pawel; Rokita, Andrzej] Univ Sch Phys Educ, Dept Team Games, Wroclaw, Poland; [Liu, Hongyou] South China Normal Univ, Guangzhou Higher Educ Mega Ctr, Sch Phys Educ & Sports Sci, Guangzhou, Peoples R China; [Andrzejewski, Marcin] Poznan Univ Phys Educ, Dept Methodol Recreat, Poznan, Poland; [Chmura, Jan; Konefal, Marek] Univ Sch Phys Educ, Dept Biol & Motor Sport Bases, Wroclaw, Poland; [Kowalczuk, Edward] Hannover 96, Football Club, Hannover, Germany	South China Normal University	Konefal, M (corresponding author), Univ Sch Phys Educ, Dept Biol & Motor Sport Bases, Wroclaw, Poland.	marek.konefal@awf.wroc.pl	Liu, Hongyou/M-4738-2014; Chmura, Paweł/U-6645-2019; Konefal, Marek/A-1634-2019	Liu, Hongyou/0000-0003-4341-672X; Chmura, Paweł/0000-0002-4211-0393; Konefal, Marek/0000-0002-0918-1683; Andrzejewski, Marcin/0000-0002-5127-711X				Almeida C. H., 2017, HUM MOV, V18, P125, DOI 10.5114/hm.2017.73621; Andrzejewski M, 2018, J SPORT MED PHYS FIT, V58, P785, DOI 10.23736/S0022-4707.17.07352-2; Andrzejewski M, 2016, INT J PERF ANAL SPOR, V16, P817, DOI 10.1080/24748668.2016.11868930; Barnes C, 2014, INT J SPORTS MED, V35, P1095, DOI 10.1055/s-0034-1375695; Blazejczyk K, 2012, INT J BIOMETEOROL, V56, P515, DOI 10.1007/s00484-011-0453-2; Bostanci O, 2018, J HUM SPORT EXERC, V13, P319, DOI 10.14198/jhse.2018.132.07; Bradley PS, 2013, J SPORT SCI, V31, P1261, DOI 10.1080/02640414.2013.786185; Brito A, 2017, INT J PERF ANAL SPOR, V17, P902, DOI 10.1080/24748668.2017.1407207; Brito J, 2016, J STRENGTH COND RES, V30, P393, DOI 10.1519/JSC.0000000000001113; Carling C, 2015, SPORTS MED, V45, P605, DOI 10.1007/s40279-015-0313-z; Carmichael F, 1999, APPL ECON LETT, V6, P797, DOI 10.1080/135048599352196; Castellano J, 2014, SPORTS MED, V44, P701, DOI 10.1007/s40279-014-0144-3; Che Muhamed Ahmad Munir, 2016, Temperature (Austin), V3, P455, DOI 10.1080/23328940.2016.1182669; Chmura P, 2018, BIOL SPORT, V35, P197, DOI 10.5114/biolsport.2018.74196; Chmura P, 2017, INT J BIOMETEOROL, V61, P677, DOI 10.1007/s00484-016-1245-5; Clemente FM, 2020, CHAOS SOLITON FRACT, V133, DOI 10.1016/j.chaos.2020.109625; Collet C, 2013, J SPORT SCI, V31, P123, DOI 10.1080/02640414.2012.727455; Deutsche Fussball Liga (DFL), DEFINITIONSKATALOG O; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Fernandez-Navarro J, 2016, J SPORT SCI, V34, P2195, DOI 10.1080/02640414.2016.1169309; Filetti C, 2017, PERCEPT MOTOR SKILL, V124, P601, DOI 10.1177/0031512517692904; Gibson Oliver R, 2020, Temperature (Austin), V7, P3, DOI 10.1080/23328940.2019.1666624; Goes FR, 2019, BIG DATA-US, V7, P57, DOI 10.1089/big.2018.0067; Grantham J, 2010, SCAND J MED SCI SPOR, V20, P161, DOI 10.1111/j.1600-0838.2010.01216.x; Harper DJ, 2019, SPORTS MED, V49, P1923, DOI 10.1007/s40279-019-01170-1; Hebert-Losier K, 2015, MED SCI SPORT EXER, V47, P1523, DOI 10.1249/MSS.0000000000000558; Hopkins W.G., 2019, SPORTSCIENCE, V23, P5; Hopkins W.G., 2020, SPORTSCIENCE, V24, P1; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hughes M, 2012, J HUM SPORT EXERC, V7, P402, DOI 10.4100/jhse.2012.72.06; Konefal M, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01748; Konefal M, 2019, J SPORT MED PHYS FIT, V59, P752, DOI 10.23736/S0022-4707.18.08506-7; Krol M, 2017, POLISH J SPORT TOURI, V24; Lago C, 2010, EUR J SPORT SCI, V10, P103, DOI 10.1080/17461390903273994; Lago C, 2009, J SPORT SCI, V27, P1463, DOI 10.1080/02640410903131681; Lago-Penas C, 2011, J SPORT SCI MED, V10, P465; Lago-Penas C, 2010, J HUM KINET, V25, P93, DOI 10.2478/v10078-010-0036-z; Leser R, 2011, SENSORS-BASEL, V11, P9778, DOI 10.3390/s111009778; Link D, 2017, J STRENGTH COND RES, V31, P1766, DOI 10.1519/JSC.0000000000001013; Liu HY, 2016, EUR J SPORT SCI, V16, P516, DOI 10.1080/17461391.2015.1042527; Liu HY, 2016, J SPORT SCI, V34, P509, DOI 10.1080/02640414.2015.1117121; Liu HY, 2013, INT J PERF ANAL SPOR, V13, P803, DOI 10.1080/24748668.2013.11868690; Mackala K, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16173138; Mallo J, 2015, J HUM KINET, V47, P179, DOI 10.1515/hukin-2015-0073; Maughan RJ, 2010, SCAND J MED SCI SPOR, V20, P117, DOI 10.1111/j.1600-0838.2010.01221.x; Maughan RJ, 2012, EUR J APPL PHYSIOL, V112, P2313, DOI 10.1007/s00421-011-2206-7; Mekjavic IB, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00451; Memmert D, 2017, SPORTS MED, V47, P1, DOI 10.1007/s40279-016-0562-5; Nassis George P, 2017, Br J Sports Med, V51, P486, DOI 10.1136/bjsports-2016-095988; Nassis GP, 2015, BRIT J SPORT MED, V49, P609, DOI 10.1136/bjsports-2014-094449; O'Donoghue PG., 2005, J SPORT MED PHYS FIT, V45; Paul DJ, 2015, INT J SPORT PHYSIOL, V10, P516, DOI 10.1123/IJSPP.2015-0029; Phillips KE, 2017, INT J SPORT PHYSIOL, V12, P628, DOI 10.1123/ijspp.2016-0204; Poulter DR, 2009, J SPORT SCI, V27, P797, DOI 10.1080/02640410902893364; Rein R, 2017, HUM MOVEMENT SCI, V55, P172, DOI 10.1016/j.humov.2017.07.010; Russell M, 2016, J STRENGTH COND RES, V30, P2839, DOI 10.1519/JSC.0000000000000805; Sarmento H, 2018, SPORTS MED, V48, P799, DOI 10.1007/s40279-017-0836-6; Sarmento H, 2014, J SPORT SCI, V32, P1831, DOI 10.1080/02640414.2014.898852; Siegle M, 2013, J SPORT SCI, V31, P166, DOI 10.1080/02640414.2012.723131; Struzik A, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7480709; Stulp G, 2012, BIOL LETTERS, V8, P921, DOI 10.1098/rsbl.2012.0591; Taylor JB, 2008, J SPORT SCI, V26, P885, DOI 10.1080/02640410701836887; Taylor L, 2014, SPORT SCI EXCH, V27, P1; Tenga A, 2010, J SPORT SCI, V28, P245, DOI 10.1080/02640410903502766; Thornes J. E., 1977, Weather, V32, P258, DOI 10.1002/j.1477-8696.1977.tb04568.x; Tiedemann T, 2011, CENT EUR J OPER RES, V19, P571, DOI 10.1007/s10100-010-0146-7; Trewin J, 2017, SCI MED FOOTBALL, V1, P183, DOI 10.1080/24733938.2017.1329589; Varley MC, 2017, SCI MED FOOTBALL, V1, P18, DOI 10.1080/02640414.2016.1230676; Verheul J, 2019, J SCI MED SPORT, V22, P1355, DOI 10.1016/j.jsams.2019.07.006; Wallace JL, 2014, J SCI MED SPORT, V17, P223, DOI 10.1016/j.jsams.2013.03.016; Watanabe N, 2017, J SPORT MANAGE, V31, P27, DOI 10.1123/jsm.2016-0077; Zhou CJ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16214238	72	10	10	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2021	16	3							e0247771	10.1371/journal.pone.0247771	http://dx.doi.org/10.1371/journal.pone.0247771			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DJ	33690609	Green Published, gold			2022-12-26	WOS:000627855600020
J	Ma, HH; Zhang, FQ; Zhou, L; Cao, TY; Sun, DC; Wen, SX; Zhu, JP; Xiong, ZQY; Tsau, MT; Cheng, ML; Hung, LM; Zhou, YM; Li, QX				Ma, Huanhuan; Zhang, Fengqiong; Zhou, Lin; Cao, Tingyan; Sun, Dachao; Wen, Shixiong; Zhu, Jinpei; Xiong, Zhaoqianyu; Tsau, Ming-Tong; Cheng, Mei-Ling; Hung, Li-Man; Zhou, Yanming; Li, Qinxi			c-Src facilitates tumorigenesis by phosphorylating and activating G6PD	ONCOGENE			English	Article								Glucose-6-phosphate dehydrogenase (G6PD) is the first and rate-limiting enzyme in pentose phosphate pathway (PPP), excessive activation of which has been considered to be involved in tumorigenesis. Here, we show that tyrosine kinase c-Src interacts with and phosphorylates G6PD at Tyr 112. This phosphorylation enhances catalytic activity of G6PD by dramatically decreasing its K-m value and increasing its K-cat value for substrate glucose-6-phosphate. Activated G6PD therefore augments the PPP flux for NADPH and ribose-5-phosphate production which is required for detoxification of intracellular reactive oxygen species (ROS) and biosynthesis of cancer cells, and eventually contributes to tumorigenesis. Consistently, c-Src activation is closely correlated with tyrosine phosphorylation and activity of G6PD in clinical colorectal cancer samples. We thus uncover another aspect of c-Src in promoting cell proliferation and tumorigenesis, deepening our understanding of c-Src as a proto-oncogene.	[Ma, Huanhuan; Zhang, Fengqiong; Zhou, Lin; Cao, Tingyan; Sun, Dachao; Wen, Shixiong; Zhu, Jinpei; Xiong, Zhaoqianyu; Li, Qinxi] Xiamen Univ, State Key Lab Cellular Stress Biol, Innovat Ctr Cell Signaling Network, Sch Life Sci, Xiamen, Fujian, Peoples R China; [Tsau, Ming-Tong; Cheng, Mei-Ling] Chang Gung Univ, Hlth Aging Res Ctr, Metabol Core Lab, Taoyuan, Taiwan; [Cheng, Mei-Ling] Chang Gung Mem Hosp, Clin Metabol Core Lab, Taoyuan, Taiwan; [Cheng, Mei-Ling; Hung, Li-Man] Chang Gung Univ, Dept & Grad Inst Biomed Sci, Coll Med, Taoyuan, Taiwan; [Hung, Li-Man] Chang Gung Univ, Ctr Hlth & Aging Res, Taoyuan, Taiwan; [Hung, Li-Man] Chang Gung Mem Hosp, Kidney Res Ctr, Taoyuan, Taiwan; [Zhou, Yanming] Xiamen Univ, Affiliated Hosp 1, Dept Hepatobiliary & Pancreatovasc Surg, Xiamen, Fujian, Peoples R China	Xiamen University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Xiamen University	Li, QX (corresponding author), Xiamen Univ, State Key Lab Cellular Stress Biol, Innovat Ctr Cell Signaling Network, Sch Life Sci, Xiamen, Fujian, Peoples R China.	liqinxi@xmu.edu.cn	Ma, Huan-Huan/G-8768-2017	Ma, Huan-Huan/0000-0001-8029-6814	National Natural Science Foundation of China, China [U1705287, 91857102]; Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University [SKLCSB2020KF002, SKLCSB2019KF005]	National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC)); Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University	This work was supported by the National Natural Science Foundation of China, China (U1705287 and 91857102) and the Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University (SKLCSB2020KF002 and SKLCSB2019KF005).	Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; BOLEN JB, 1987, P NATL ACAD SCI USA, V84, P2251, DOI 10.1073/pnas.84.8.2251; CARTWRIGHT CA, 1989, J CLIN INVEST, V83, P2025, DOI 10.1172/JCI114113; Cho ES, 2018, BIOMOL THER, V26, P29, DOI 10.4062/biomolther.2017.179; COCCO P, 1987, J EPIDEMIOL COMMUN H, V41, P89, DOI 10.1136/jech.41.2.89; Fang ZS, 2016, BBA-MOL CELL RES, V1863, P2245, DOI 10.1016/j.bbamcr.2016.05.016; FORTELEONI G, 1988, TUMORI, V74, P665, DOI 10.1177/030089168807400608; Fury MG, 2011, ANTICANCER RES, V31, P249; Gucalp A, 2011, CLIN BREAST CANCER, V11, P306, DOI 10.1016/j.clbc.2011.03.021; Gupte RS, 2009, FREE RADICAL BIO MED, V47, P219, DOI 10.1016/j.freeradbiomed.2009.01.028; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Jiang P, 2014, PROTEIN CELL, V5, P592, DOI 10.1007/s13238-014-0082-8; Ju HQ, 2017, ONCOGENE, V36, P6282, DOI 10.1038/onc.2017.227; Li TY, 2016, MOL CELL, V62, P359, DOI 10.1016/j.molcel.2016.04.009; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Lin RT, 2015, NAT CELL BIOL, V17, P1484, DOI 10.1038/ncb3255; Liu XG, 2020, NAT CELL BIOL, V22, DOI 10.1038/s41556-020-0496-x; Ma HH, 2020, CELL REP, V30, P4235, DOI 10.1016/j.celrep.2020.03.005; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Musumeci F, 2012, FUTURE MED CHEM, V4, P799, DOI [10.4155/fmc.12.29, 10.4155/FMC.12.29]; Pan JS, 2009, WORLD J GASTROENTERO, V15, P1702, DOI 10.3748/wjg.15.1702; Pan S, 2009, ARTERIOSCL THROM VAS, V29, P895, DOI 10.1161/ATVBAHA.109.184812; Rajeshkumar NV, 2009, CLIN CANCER RES, V15, P4138, DOI 10.1158/1078-0432.CCR-08-3021; Rao XJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9468; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Stincone A, 2015, BIOL REV, V90, P927, DOI 10.1111/brv.12140; Tang HY, 2015, ANTIOXID REDOX SIGN, V22, P744, DOI 10.1089/ars.2014.6142; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tsouko E, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.18; Wang YP, 2014, EMBO J, V33, P1304, DOI 10.1002/embj.201387224; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhang CH, 2014, ANTI-CANCER AGENT ME, V14, P280, DOI 10.2174/18715206113136660337; Zhang J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13732	35	7	8	0	16	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2021	40	14					2567	2580		10.1038/s41388-021-01673-0	http://dx.doi.org/10.1038/s41388-021-01673-0		MAR 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RK3YE	33686238				2022-12-26	WOS:000626396000005
J	Sanjay, M; Gaurav, K; Gonzalez-Pabon, MJ; Fuchs, J; Mikkelsen, SR; Corton, E				Sanjay, Manoharan; Gaurav, Kumar; Jesus Gonzalez-Pabon, Maria; Fuchs, Julio; Mikkelsen, Susan R.; Corton, Eduardo			An apta-aggregation based machine learning assay for rapid quantification of lysozyme through texture parameters	PLOS ONE			English	Article							PREDICTING RNA STRUCTURE; LABEL-FREE; AGGLUTINATION ASSAY; PROTEIN-PROTEIN; GOLD NANOPARTICLES; LIGHT-SCATTERING; SENSOR ARRAYS; CLASSIFICATION; APTASENSOR; BIOSENSORS	A novel assay technique that involves quantification of lysozyme (Lys) through machine learning is put forward here. This article reports the tendency of the well- documented Ellington group anti-Lys aptamer, to produce aggregates when exposed to Lys. This property of apta-aggregation has been exploited here to develop an assay that quantifies the Lys using texture and area parameters from a photograph of the elliptical aggregate mass through machine learning. Two assay sets were made for the experimental procedure: one with high Lys concentration between 25-100 mM and another with low concentration between 1-20 mM. The high concentration set had a sample volume of 10 mu l while the low concentration set had a higher sample volume of 100 mu l, in order to obtain the statistical texture values reliably from the aggregate mass. The platform exhibited an experimental limit of detection of 1 mM and a response time of less than 10 seconds. Further, two potential operating modes for the aptamer were hypothesized for this aggregation property and the more accurate mode among the two was ascertained through bioinformatics studies.	[Sanjay, Manoharan; Jesus Gonzalez-Pabon, Maria; Fuchs, Julio; Corton, Eduardo] Univ Buenos Aires UBA, Exact & Nat Sci Fac FCEN, Biosensors & Bioanal Lab LABB, Dept Biol Chem, Buenos Aires, DF, Argentina; [Sanjay, Manoharan; Jesus Gonzalez-Pabon, Maria; Fuchs, Julio; Corton, Eduardo] Univ Buenos Aires UBA, Exact & Nat Sci Fac FCEN, IQUIBICEN CONICET, Buenos Aires, DF, Argentina; [Gaurav, Kumar] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati, Assam, India; [Mikkelsen, Susan R.] Univ Waterloo, Dept Chem, Waterloo, ON, Canada	University of Buenos Aires; University of Buenos Aires; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; University of Waterloo	Corton, E (corresponding author), Univ Buenos Aires UBA, Exact & Nat Sci Fac FCEN, Biosensors & Bioanal Lab LABB, Dept Biol Chem, Buenos Aires, DF, Argentina.; Corton, E (corresponding author), Univ Buenos Aires UBA, Exact & Nat Sci Fac FCEN, IQUIBICEN CONICET, Buenos Aires, DF, Argentina.	eduardo@qb.fcen.uba.ar		Corton, Eduardo/0000-0003-1897-4666	CONICET [PIP 2015 2017 GI]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The work was supported by CONICET [grant number PIP 2015 2017 GI, 2015].	Abdel-Nasser M, 2017, ENG APPL ARTIF INTEL, V59, P84, DOI 10.1016/j.engappai.2016.12.019; Ajiboye A.R., 2015, INT J COMP SYST SOFT, V1, P75, DOI [10.15282/ijsecs.1.2015.6.0006, DOI 10.15282/IJSECS.1.2015.6.0006]; Alejo-Cancho I, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008082; Alhabbab R.Y., 2018, PRECIPITATION AGGLUT, P23, DOI [10.1007/978-3-319-77694-1_3, DOI 10.1007/978-3-319-77694-1_3]; Alshaer W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189558; Andronescu M, 2005, J MOL BIOL, V345, P987, DOI 10.1016/j.jmb.2004.10.082; Antonio M, 2020, TALANTA, V214, DOI 10.1016/j.talanta.2020.120868; Bernhart SH, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-3; Biesiada M, 2016, METHODS MOL BIOL, V1490, P199, DOI 10.1007/978-1-4939-6433-8_13; BRAY RS, 1967, T ROY SOC TROP MED H, V61, P490, DOI 10.1016/0035-9203(67)90099-5; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Campbell GA, 2007, ENVIRON SCI TECHNOL, V41, P1668, DOI 10.1021/es061947p; Chen H, 2018, REV SCI INSTRUM, V89, DOI 10.1063/1.5022370; Chen XJ, 2016, BIOSENS BIOELECTRON, V79, P353, DOI 10.1016/j.bios.2015.12.060; Cheng AKH, 2007, ANAL CHEM, V79, P5158, DOI 10.1021/ac062214q; Delano W. L., 2004, PYMOL USERS GUIDE; Dirks RM, 2007, SIAM REV, V49, P65, DOI 10.1137/060651100; Donolato M, 2015, BIOSENS BIOELECTRON, V67, P649, DOI 10.1016/j.bios.2014.09.097; Farid S, 2015, BIOSENS BIOELECTRON, V71, P294, DOI 10.1016/j.bios.2015.04.047; Ferguson TP, 2004, ELEC COMP C, P1752, DOI 10.1109/ECTC.2004.1320355; Gibbons I, 1989, U.S. Patent No, Patent No. [4,829,011, 4829011]; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Harmening DM, 2019, MODERN BLOOD BANKING, V7th; He S, 2011, SCI CHINA PHYS MECH, V54, P1757, DOI 10.1007/s11433-011-4486-7; Hofacker IL, 2014, METHODS MOL BIOL, V1086, P1, DOI 10.1007/978-1-62703-667-2_1; Huang FWD, 2010, BIOINFORMATICS, V26, P175, DOI 10.1093/bioinformatics/btp635; Huang HP, 2009, ELECTROCHEM COMMUN, V11, P816, DOI 10.1016/j.elecom.2009.01.009; Jain P, 2016, MOL BIOTECHNOL, V58, P497, DOI 10.1007/s12033-016-9946-x; Jeddi I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01348-5; Kangas MJ, 2017, CRIT REV ANAL CHEM, V47, P138, DOI 10.1080/10408347.2016.1233805; Kawde AN, 2005, ELECTROCHEM COMMUN, V7, P537, DOI 10.1016/j.elecom.2005.03.008; Kim K, 2010, ELECTROPHORESIS, V31, P3115, DOI 10.1002/elps.201000217; Kirby R, 2004, ANAL CHEM, V76, P4066, DOI 10.1021/ac049858n; Kwak GH, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9040643; Lakhin AV, 2013, ACTA NATURAE, V5, P34, DOI 10.32607/20758251-2013-5-4-34-43; Lancefield RC, 1928, J EXP MED, V47, P469, DOI 10.1084/jem.47.3.469; Lykhovyd PV, 2018, BIOSYST DIVERSITY, V26, P11, DOI 10.15421/011802; Mahat M, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/850810; Pantic I, 2013, AN ACAD BRAS CIENC, V85, P1063, DOI 10.1590/S0001-37652013005000045; Peng YG, 2009, BIOSENS BIOELECTRON, V25, P94, DOI 10.1016/j.bios.2009.06.001; Petrusevska M, 2013, EUR J PHARM BIOPHARM, V85, P1148, DOI 10.1016/j.ejpb.2013.08.015; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pons C, 2010, PROTEINS, V78, P95, DOI 10.1002/prot.22564; Ramirez D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040525; Rodriguez MC, 2009, TALANTA, V78, P212, DOI 10.1016/j.talanta.2008.11.002; Rodriguez MC, 2005, CHEM COMMUN, P4267, DOI 10.1039/b506571b; Sanjay M., 2017, INT J APPL SCI BIOTE, V5, P261; Sanjay M, 2020, ANAL METHODS-UK, V12, P1333, DOI [10.1039/c9ay02406a, 10.1039/C9AY02406A]; Schaut RG, 2017, VET PARASITOL, V243, P188, DOI 10.1016/j.vetpar.2017.06.025; Shamir L, 2009, BIOINFORMATICS, V25, P3060, DOI 10.1093/bioinformatics/btp571; Song KM, 2012, SENSORS-BASEL, V12, P612, DOI 10.3390/s120100612; Stavitsky A.B., 1998, AGGLUTINATION ENCY I, V2nd, P56, DOI [10.1006/rwei.1999.0016, DOI 10.1006/RWEI.1999.0016]; Sukhwal A, 2015, BIOINFORM BIOL INSIG, V9, P141, DOI 10.4137/BBI.S25928; Tan J., 2019, 2019 IEEE EMBS INT C, DOI [10.1109/BHI.2019.8834585, DOI 10.1109/BHI.2019.8834585]; Thiviyanathan V, 2012, PROTEOM CLIN APPL, V6, P563, DOI 10.1002/prca.201200042; Tombelli S, 2005, BIOELECTROCHEMISTRY, V67, P135, DOI 10.1016/j.bioelechem.2004.04.011; Uddin R, 2016, BIOSENS BIOELECTRON, V85, P351, DOI 10.1016/j.bios.2016.05.023; Vidyarthi A, 2017, J INTELL FUZZY SYST, V32, P2807, DOI 10.3233/JIFS-169223; Wang RH, 2013, BIOSENS BIOELECTRON, V42, P148, DOI 10.1016/j.bios.2012.10.038; Xu XJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163454; Yan YM, 2017, NUCLEIC ACIDS RES, V45, pW365, DOI 10.1093/nar/gkx407; Yao X, 2016, MICROCHIM ACTA, V183, P2353, DOI 10.1007/s00604-016-1876-6; Zhao CH, 2017, METHODS MOL BIOL, V1654, P3, DOI 10.1007/978-1-4939-7231-9_1; Zhou ND, 2014, ANAL METHODS-UK, V6, P1569, DOI 10.1039/c3ay41816b; Zhu ZL, 2015, BIOSENS BIOELECTRON, V65, P320, DOI 10.1016/j.bios.2014.10.059	66	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0248159	10.1371/journal.pone.024815	http://dx.doi.org/10.1371/journal.pone.024815			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU3OZ	33684138				2022-12-26	WOS:000627193500012
J	Lee, CL; Park, J; Nam, S; Choi, J; Choi, Y; Lee, S; Lee, KY; Cho, M				Lee, Chang-Lae; Park, Junyoung; Nam, Sangnam; Choi, Jiyoung; Choi, Yuna; Lee, Sangmin; Lee, Kyoung-Yong; Cho, Minkook			Metal artifact reduction and tumor detection using photon-counting multi-energy computed tomography	PLOS ONE			English	Article							DUAL-ENERGY CT; BEAM HARDENING ARTIFACTS; ANGIOGRAPHY; PERFORMANCE; CONTRAST; QUALITY; SPINE; HEAD	Metal artifacts are considered a major challenge in computed tomography (CT) as these adversely affect the diagnosis and treatment of patients. Several approaches have been developed to address this problem. The present study explored the clinical potential of a novel photon-counting detector (PCD) CT system in reducing metal artifacts in head CT scans. In particular, we studied the recovery of an oral tumor region located under metal artifacts after correction. Three energy thresholds were used to group data into three bins (bin 1: low-energy, bin 2: middle-energy, and bin 3: high-energy) in the prototype PCD CT system. Three types of physical phantoms were scanned on the prototype PCD CT system. First, we assessed the accuracy of iodine quantification using iodine phantoms at varying concentrations. Second, we evaluated the performance of material decomposition (MD) and virtual monochromatic images (VMIs) using a multi-energy CT phantom. Third, we designed an ATOM phantom with metal insertions to verify the effect of the proposed metal artifact reduction. In particular, we placed an insertion-mimicking an iodine-enhanced oral tumor in the beam path of metallic objects. Normalized metal artifact reduction (NMAR) was performed for each energy bin image, followed by an image-based MD and VMI reconstruction. Image quality was analyzed quantitatively by contrast-to-noise ratio (CNR) measurements. The results of iodine quantification showed a good match between the true and measured iodine concentrations. Furthermore, as expected, the contrast between iodine and the surrounding material was higher in bin 1 image than in bin 3 image. On the other hand, the bin 3 image of the ATOM phantom showed fewer metal artifacts than the bin 1 image because of the higher photon energy. The result of quantitative assessment demonstrated that the 40-keV VMI (CNR: 20.6 +/- 1.2) with NMAR and MD remarkably increased the contrast of the iodine-enhanced region compared with that of the conventional images (CNR: 10.4 +/- 0.5) having 30 to 140 keV energy levels. The PCD-based multi-energy CT imaging has immense potential to maximize the contrast of the target tissue and reduce metal artifacts simultaneously. We believe that it would open the door to novel applications for the diagnosis and treatment of several diseases.	[Lee, Chang-Lae; Park, Junyoung; Nam, Sangnam; Choi, Jiyoung; Choi, Yuna; Lee, Sangmin; Lee, Kyoung-Yong; Cho, Minkook] Samsung Elect Co Ltd, Hlth & Med Equipment Business, CT R&D Grp, Suwon, South Korea	Samsung; Samsung Electronics	Cho, M (corresponding author), Samsung Elect Co Ltd, Hlth & Med Equipment Business, CT R&D Grp, Suwon, South Korea.	minkook.cho@samsung.com			2018 Medical Cluster R&D Support Project through Daegu Gyeongbuk Medical Innovation Foundation - Ministry of Health & Welfare, the Republic of Korea [HT18C0005]	2018 Medical Cluster R&D Support Project through Daegu Gyeongbuk Medical Innovation Foundation - Ministry of Health & Welfare, the Republic of Korea	This study was funded by 2018 Medical Cluster R&D Support Project through Daegu Gyeongbuk Medical Innovation Foundation funded by the Ministry of Health & Welfare, the Republic of Korea in the form of a grant (No. HT18C0005) awarded to CLL, YC, and MC. Samsung Electronics Co., Ltd. provided support in the form of salaries for all authors. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisogni MG, 2007, NUCL INSTRUM METH A, V581, P94, DOI 10.1016/j.nima.2007.07.036; Carrascosa P, 2015, CLIN IMAG, V39, P1000, DOI 10.1016/j.clinimag.2015.07.023; Cha J, 2017, ACTA RADIOL, V58, P1312, DOI 10.1177/0284185117692174; Clark ZE, 2015, ABDOM IMAGING, V40, P852, DOI 10.1007/s00261-014-0253-3; Douglas-Akinwande AC, 2006, RADIOGRAPHICS, V26, pS97, DOI 10.1148/rg.26si065512; Faby S, 2015, MED PHYS, V42, P4349, DOI 10.1118/1.4922654; Feldhaus F, 2019, EUR J RADIOL, V118, P153, DOI 10.1016/j.ejrad.2019.07.015; Forghani R, 2017, NEUROIMAG CLIN N AM, V27, P445, DOI 10.1016/j.nic.2017.04.001; George E, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20170411; Gong XY, 2013, DENTOMAXILLOFAC RAD, V42, DOI 10.1259/dmfr.20120105; Hokamp NG, 2018, EUR J RADIOL, V104, P136, DOI 10.1016/j.ejrad.2018.04.018; Hu RL, 2017, NEUROIMAG CLIN N AM, V27, P401, DOI 10.1016/j.nic.2017.03.004; Kaza RK, 2012, RADIOGRAPHICS, V32, P353, DOI 10.1148/rg.322115065; Kilby W, 2002, PHYS MED BIOL, V47, P1485, DOI 10.1088/0031-9155/47/9/304; Knoll GF., 2010, RAD DETECTION MEASUR, V4; Kotsenas AL, 2015, AM J NEURORADIOL, V36, P2184, DOI 10.3174/ajnr.A4416; Lee YH, 2012, EUR RADIOL, V22, P1331, DOI 10.1007/s00330-011-2370-5; Leng S, 2017, PROC SPIE, V10132, DOI 10.1117/12.2255589; Leng S, 2016, PROC SPIE, V9783, DOI 10.1117/12.2217180; Leng S, 2017, PHYS MED BIOL, V62, P7216, DOI 10.1088/1361-6560/aa8103; Liang P, 2017, AM J ROENTGENOL, V209, P1033, DOI 10.2214/AJR.16.16895; Liu X, 2009, MED PHYS, V36, P1602, DOI 10.1118/1.3097632; Marin D, 2014, RADIOLOGY, V271, P327, DOI 10.1148/radiol.14131480; Matsui K, 2015, INT J CARDIOVAS IMAG, V31, P639, DOI 10.1007/s10554-014-0574-x; Mayo J, 2014, SEMIN RESP CRIT CARE, V35, P41, DOI 10.1055/s-0033-1363450; McCollough CH, 2015, RADIOLOGY, V276, P637, DOI 10.1148/radiol.2015142631; McQueen FM, 2013, POSTGRAD MED J, V89, P87, DOI 10.1136/postgradmedj-2012-131000; Meganck JA, 2009, BONE, V45, P1104, DOI 10.1016/j.bone.2009.07.078; Megibow AJ, 2014, RADIOLOGY, V272, P618, DOI 10.1148/radiol.14141118; Meyer E, 2010, MED PHYS, V37, P5482, DOI 10.1118/1.3484090; Nagayama Y, 2018, EUR RADIOL, V28, P1719, DOI 10.1007/s00330-017-5114-3; Rajendran K, 2018, PROC SPIE, V10573, DOI 10.1117/12.2294628; ROBERTSON DD, 1988, J COMPUT ASSIST TOMO, V12, P236, DOI 10.1097/00004728-198803000-00012; Schafer ML, 2016, CLIN RADIOL, V71, P442, DOI 10.1016/j.crad.2016.01.013; Shikhaliev PM, 2005, PHYS MED BIOL, V50, P5813, DOI 10.1088/0031-9155/50/24/004; Symons R, 2017, RADIOLOGY, V285, P980, DOI 10.1148/radiol.2017162587; Tang Hao, 2014, Zhonghua Yi Xue Za Zhi, V94, P3571; Willemink MJ, 2018, RADIOLOGY, V289, P293, DOI 10.1148/radiol.2018172656; Zhang LJ, 2013, CANCER IMAGING, V13, P81, DOI 10.1102/1470-7330.2013.0009	39	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0247355	10.1371/journal.pone.0247355	http://dx.doi.org/10.1371/journal.pone.0247355			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667250	Green Published, gold			2022-12-26	WOS:000626604300027
J	Mohammed, SA; Yitafr, MG; Workneh, BD; Hailu, AD				Mohammed, Solomon Ahmed; Yitafr, Minilu Girma; Workneh, Birhanu Demeke; Hailu, Abel Demerew			Health-related quality of life and associated factors among people living with human immunodeficiency virus on highly active antiretroviral therapy in North East Ethiopia: Cross-sectional study	PLOS ONE			English	Article							HIV-INFECTED ADULTS; HIV/AIDS PATIENTS; DISCRIMINATION	Introduction HIV/AIDS remains a public health concern affecting millions of people across the world. Although the health-related quality of life (HRQoL) of patients living with HIV has significantly improved after treatment, its chronicity makes the HRQoL uncertain. This study assessed factors associated with the health-related quality of life among people living with HIV/AIDS on HAART in North-East Ethiopia. Methods An institutional-based cross-sectional study was conducted from March to April 2018, and systematic random sampling was used to select 235 participants who were on HAART. HRQoL was assessed using the Medical Outcomes Study HIV Health Survey. Descriptive and multiple linear regression analysis were computed using the statistical package for social sciences version 20. Results The study revealed one-factor structure and had good overall internal consistency (78.5). Over one-third (42.6%; 95% CI; 36.2%, 48.9%) of participants had good HRQoL. The least HRQoL mean score was found for cognitive functioning 32.21(+/- 19.78), followed by social functioning 40.58(+/- 29.8). Factors associated with the overall HRQoL were 25-45 years of age (beta = - 3.55, 95% CI;-6.54, -0.55), working in private sector (beta = -5.66, 95% CI;-9.43, -1.88), government (beta = -4.29, 95% CI;-7.83, -0.75) and self-employment (beta = -8.86, 95% CI;-13.50, -4.21), 100-200 (beta = - 4.84, 95% CI;-9.04, -0.63) and 201-350 CD4 at the time of diagnosis (beta = - 7.45, 95% CI;-11.73, -3.16), 351-500 current CD4 level (beta = 8.34, 95% CI;5.55, 11.41), 6-10 years of disease duration (beta = -8.28, 95% CI;-12.51, -4.04), WHO stage II (beta = -4.78, 95% CI;-8.52, -1.04) and III (beta = 3.42, 95% CI;0.06, 6.79) during treatment initiation and not taking of Cotrimoxazole prophylaxis (beta = -5.79, 95% CI;-8.34, -3.25). Conclusions High proportion of participants had a poor HRQoL. Routine assessment and appropriate interventions at each visit is recommended to improve HRQoL.	[Mohammed, Solomon Ahmed; Workneh, Birhanu Demeke] Wollo Univ, Coll Med & Hlth Sci, Dept Pharm, Dessie, Ethiopia; [Yitafr, Minilu Girma] Debre Berhan Univ, Coll Med & Hlth Sci, Dept Pharm, Debre Berhan, Ethiopia; [Hailu, Abel Demerew] Dessie Hlth Sci Coll, Dept Pharm, Dessie, Ethiopia	University of Gondar; University of Gondar	Mohammed, SA (corresponding author), Wollo Univ, Coll Med & Hlth Sci, Dept Pharm, Dessie, Ethiopia.	ahmedsolomon21@gmail.com		Mohammed, Solomon Ahmed/0000-0002-6498-8455				Abebe Weldsilase Y., 2018, ADV PUBLIC HLTH, V2018, DOI [10.1155/2018/1893562, DOI 10.1155/2018/1893562]; Alemayehu M, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0636-6; Arrey AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159488; Ayalew M. B., 2018, Journal of Basic and Clinical Pharmacy (JBCP), V9, P302; Ayele Mega T., 2019, OPEN PUBLIC HLTH J, V12; Tran BX, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-27; Basavaraj K H, 2010, Indian J Sex Transm Dis AIDS, V31, P75, DOI 10.4103/0253-7184.74971; Biraguma J, 2018, SAHARA J-J SOC ASP H, V15, P110, DOI 10.1080/17290376.2018.1520144; Briongos-Figuero LS, 2011, EUR REV MED PHARMACO, V15, P855; Burki TK, 2011, LANCET, V377, P286, DOI 10.1016/S0140-6736(11)60079-2; Campsmith Michael L, 2003, Health Qual Life Outcomes, V1, P12, DOI 10.1186/1477-7525-1-12; da Costa TL, 2014, REV LAT-AM ENFERM, V22, P582, DOI 10.1590/0104-1169.3350.2455; Degroote S, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-40; den Daas C, 2019, QUAL LIFE RES, V28, P2685, DOI 10.1007/s11136-019-02203-y; Deribew A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-408; Dutra BS, 2019, BRAZ J INFECT DIS, V23, P211, DOI 10.1016/j.bjid.2019.06.005; Emuren L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178953; Gakhar H, 2013, DRUGS, V73, P651, DOI 10.1007/s40265-013-0040-4; George S, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0517-4; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hidru TH, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0204-z; Imam M H, 2011, Bangladesh Med Res Counc Bull, V37, P1; Jha Nisha, 2018, J Nepal Health Res Counc, V16, P313; Kaplan B H, 1977, Med Care, V15, P47, DOI 10.1097/00005650-197705001-00006; Liu J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201177; Marashi T., 2009, Journal of Communicable Diseases, V41, P101; Mb A., 2018, J BASIC CLIN PHARM, V9; Mekuria LA, 2015, AIDS CARE, V27, P934, DOI 10.1080/09540121.2015.1020748; Melaku T, 2020, PATIENT-RELAT OUTCOM, V11, P73, DOI [10.2147/PROM.S239429, 10.17816/PED11273-84]; Miners A, 2014, LANCET HIV, V1, pE32, DOI 10.1016/S2352-3018(14)70018-9; Ndubuka NO, 2017, PALLIAT SUPPORT CARE, V15, P214, DOI 10.1017/S1478951516000638; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; Rand Health Care, 12 IT SHORT FORM SUR; Razavi P, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/849406; Rourke SB, 2012, AIDS BEHAV, V16, P2361, DOI 10.1007/s10461-012-0284-0; Sun W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064562; Surur AS, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2714-1; Suthar AB, 2012, B WORLD HEALTH ORGAN, V90, P128, DOI 10.2471/BLT.11.093260; UNAIDS, 2019, UNAIDS DAT 2019 UNAI, DOI [10.1371/journal.pone.0158767, DOI 10.1371/JOURNAL.PONE.0158767]; UNAIDS, 2019, GLOBAL HIV AIDS EPID; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; WHO, 2014, EXECUTIVE SUMMARY; Wu AW., 1999, MOS HIV HLTH SURVEY; Yahaya SS, 2016, INT J INFECT DIS, V45, P271, DOI 10.1016/j.ijid.2016.02.603; Yaya I, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4171-x	45	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0247777	10.1371/journal.pone.0247777	http://dx.doi.org/10.1371/journal.pone.0247777			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QT5CA	33667245	Green Published, gold			2022-12-26	WOS:000626604300052
J	Cohen, AA; Yang, Z; Gnanapragasam, PNP; Ou, SS; Dam, KMA; Wang, HQ; Bjorkman, PJ				Cohen, Alexander A.; Yang, Zhi; Gnanapragasam, Priyanthi N. P.; Ou, Susan; Dam, Kim-Marie A.; Wang, Haoqing; Bjorkman, Pamela J.			Construction, characterization, and immunization of nanoparticles that display a diverse array of influenza HA trimers	PLOS ONE			English	Article								Current influenza vaccines do not elicit broadly protective immune responses against multiple strains. New strategies to focus the humoral immune response to conserved regions on influenza antigens are therefore required for recognition by broadly neutralizing antibodies. It has been suggested that B-cells with receptors that recognize conserved epitopes would be preferentially stimulated through avidity effects by mosaic particles presenting multiple forms of a variable antigen. We adapted SpyCatcher-based platforms, AP205 virus-like particles (VLPs) and mi3 nanoparticles (NPs), to covalently co-display SpyTagged hemagglutinin (HA) trimers from group 1 and group 2 influenza A strains. Here we show successful homotypic and heterotypic conjugation of up to 8 different HA trimers to both VLPs and NPs. We characterized the HA-VLPs and HA-NPs by cryo-electron tomography to derive the average number of conjugated HAs and their separation distances on particles, and compared immunizations of mosaic and homotypic particles in wild-type mice. Both types of HA particles elicited strong antibody responses, but the mosaic particles did not consistently elicit broader immune responses than mixtures of homotypic particles. We conclude that covalent attachment of HAs from currently-circulating influenza strains represents a viable alternative to current annual influenza vaccine strategies, but in the absence of further modifications, is unlikely to represent a method for making a universal influenza vaccine.	[Cohen, Alexander A.; Yang, Zhi; Gnanapragasam, Priyanthi N. P.; Ou, Susan; Dam, Kim-Marie A.; Wang, Haoqing; Bjorkman, Pamela J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Wang, Haoqing] Stanford Univ, Sch Med, Dept Cellular Physiol & Med, Palo Alto, CA 94304 USA	California Institute of Technology; Stanford University	Bjorkman, PJ (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	bjorkman@caltech.edu		Dam, Kim-Marie/0000-0002-1416-4757; Bjorkman, Pamela/0000-0002-2277-3990; Yang, Zhi/0000-0001-8680-3784	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [1R01AI129784, P50 AI150464]	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health to P.J.B. (1R01AI129784 and P50 AI150464). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Air GM, 2015, CURR OPIN VIROL, V11, P113, DOI 10.1016/j.coviro.2015.03.006; Angeletti D, 2017, NAT IMMUNOL, V18, P456, DOI 10.1038/ni.3680; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Boyoglu-Barnum S, 2020, ELICITATION BROADLY; Brune KD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01432; Brune KD, 2016, SCI REP-UK, V6, DOI 10.1038/srep19234; Bruun TUJ, 2018, ACS NANO, V12, P8855, DOI 10.1021/acsnano.8b02805; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Escolano A, 2019, NATURE, V570, P468, DOI 10.1038/s41586-019-1250-z; Hagen WJH, 2017, J STRUCT BIOL, V197, P191, DOI 10.1016/j.jsb.2016.06.007; Hsia Y, 2016, NATURE, V535, P136, DOI 10.1038/nature18010; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043; Kanekiyo M, 2019, NAT IMMUNOL, V20, P362, DOI 10.1038/s41590-018-0305-x; Krammer F, 2019, NAT REV IMMUNOL, V19, P383, DOI 10.1038/s41577-019-0143-6; Krammer F, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0002-y; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lang SS, 2017, CELL REP, V20, P2935, DOI 10.1016/j.celrep.2017.08.084; Liu WC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00756; Mastronarde DN, 2017, J STRUCT BIOL, V197, P102, DOI 10.1016/j.jsb.2016.07.011; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mostafa A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090497; Nachbagauer R, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0026-4; Sautto GA, 2018, VIROL J, V15, DOI 10.1186/s12985-017-0918-y; Schmidt AG, 2015, CELL, V161, P1026, DOI 10.1016/j.cell.2015.04.028; Sheskin D., 2011, HDB PARAMETRIC NONPA, V5th; Shishovs M, 2016, J MOL BIOL, V428, P4267, DOI 10.1016/j.jmb.2016.08.025; Tan HX, 2019, J CLIN INVEST, V129, P850, DOI 10.1172/JCI123366; Temperton NJ, 2007, INFLUENZA OTHER RESP, V1, P105, DOI 10.1111/j.1750-2659.2007.00016.x; Weidenbacher PA, 2019, P NATL ACAD SCI USA, V116, P9947, DOI 10.1073/pnas.1822062116; West AP, 2013, P NATL ACAD SCI USA, V110, P10598, DOI 10.1073/pnas.1309215110; Whittle JRR, 2014, J VIROL, V88, P4047, DOI 10.1128/JVI.03422-13; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927; Zakeri B, 2012, P NATL ACAD SCI USA, V109, pE690, DOI 10.1073/pnas.1115485109	35	11	11	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0247963	10.1371/journal.pone.0247963	http://dx.doi.org/10.1371/journal.pone.0247963			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33661993	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000626604100046
J	Tao, YQ; Xie, JF; Zhong, QL; Wang, YY; Zhang, SN; Luo, F; Wen, FC; Xie, JJ; Zhao, JW; Sun, XO; Long, HF; Ma, JF; Zhang, Q; Long, JG; Fang, XY; Lu, Y; Li, D; Li, M; Zhu, JD; Sun, B; Li, GH; Diao, JJ; Liu, C				Tao, Youqi; Xie, Jingfei; Zhong, Qinglu; Wang, Yongyao; Zhang, Shengnan; Luo, Feng; Wen, Fengcai; Xie, Jingjing; Zhao, Jiawei; Sun, Xiaoou; Long, Houfang; Ma, Junfeng; Zhang, Qian; Long, Jiangang; Fang, Xianyang; Lu, Ying; Li, Dan; Li, Ming; Zhu, Jidong; Sun, Bo; Li, Guohui; Diao, Jiajie; Liu, Cong			A novel partially open state of SHP2 points to a "multiple gear" regulation mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; HELICOBACTER-PYLORI CAGA; SH2 DOMAIN; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; LEOPARD-SYNDROME; MUTATIONS; BINDING; IDENTIFICATION; ACTIVATION	The protein tyrosine phosphatase SHP2 mediates multiple signal transductions in various cellular pathways, controlled by a variety of upstream inputs. SHP2 dysregulation is causative of different types of cancers and developmental disorders, making it a promising drug target. However, how SHP2 is modulated by its different regulators remains largely unknown. Here, we use single-molecule fluorescence resonance energy transfer and molecular dynamics simulations to investigate this question. We identify a partially open, semiactive conformation of SHP2 that is intermediate between the known open and closed states. We further demonstrate a "multiple gear" regulatory mechanism, in which different activators (e.g., insulin receptor substrate-1 and CagA), oncogenic mutations (e.g., E76A), and allosteric inhibitors (e.g., SHP099) can shift the equilibrium of the three conformational states and regulate SHP2 activity to different levels. Our work reveals the essential role of the intermediate state in fine-tuning the activity of SHP2, which may provide new opportunities for drug development for relevant cancers.	[Tao, Youqi; Li, Dan] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai, Peoples R China; [Xie, Jingfei; Zhang, Shengnan; Luo, Feng; Xie, Jingjing; Long, Houfang; Zhu, Jidong; Liu, Cong] Chinese Acad Sci, Interdisciplinary Res Ctr Biol & Chem, Shanghai Inst Organ Chem, Shanghai, Peoples R China; [Xie, Jingfei; Zhong, Qinglu; Zhang, Shengnan; Luo, Feng; Xie, Jingjing; Long, Houfang; Lu, Ying; Li, Ming; Zhu, Jidong; Li, Guohui; Liu, Cong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhong, Qinglu; Li, Guohui] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Mol Modeling & Design, State Key Lab Mol React Dynam, Dalian, Peoples R China; [Wang, Yongyao; Long, Jiangang] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Ctr Mitochondrial Biol & Med,Key Lab Biomed Infor, Xian, Peoples R China; [Wang, Yongyao; Diao, Jiajie] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45221 USA; [Wen, Fengcai; Zhang, Qian; Sun, Bo] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Zhao, Jiawei; Sun, Xiaoou; Ma, Junfeng; Fang, Xianyang] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Sch Life Sci, Beijing, Peoples R China; [Lu, Ying; Li, Ming] Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Beijing, Peoples R China; [Lu, Ying; Li, Ming] Chinese Acad Sci, Inst Phys, CAS Key Lab Soft Matter Phys, Beijing, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Xi'an Jiaotong University; University System of Ohio; University of Cincinnati; ShanghaiTech University; Tsinghua University; Chinese Academy of Sciences; Institute of Physics, CAS; Chinese Academy of Sciences; Institute of Physics, CAS	Liu, C (corresponding author), Chinese Acad Sci, Interdisciplinary Res Ctr Biol & Chem, Shanghai Inst Organ Chem, Shanghai, Peoples R China.; Li, GH; Liu, C (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Li, GH (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, Lab Mol Modeling & Design, State Key Lab Mol React Dynam, Dalian, Peoples R China.; Diao, JJ (corresponding author), Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45221 USA.	ghli@dicp.ac.cn; jiajie.diao@uc.edu; liulab@sioc.ac.cn	Zhang, Qian/AAS-5468-2021; Diao, Jiajie/A-3425-2008; xie, jing/GRY-1689-2022	Zhang, Qian/0000-0002-9187-4277; Diao, Jiajie/0000-0003-4288-3203; Sun, Bo/0000-0002-4590-7795	Major State Basic Research Development Program [2016YFA0501902]; National Natural Science Foundation (NSF) of China [31872716]; Science and Technology Commission of Shanghai Municipality [18JC1420500]; Shanghai Municipal Science and Technology Major Project [2019SHZDZX02]	Major State Basic Research Development Program(National Basic Research Program of China); National Natural Science Foundation (NSF) of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Science and Technology Major Project	This work was supported by the Major State Basic Research Development Program (2016YFA0501902), the National Natural Science Foundation (NSF) of China (31872716), the Science and Technology Commission of Shanghai Municipality (18JC1420500) and The Shanghai Municipal Science and Technology Major Project (2019SHZDZX02).	Barford D, 1998, STRUCTURE, V6, P249, DOI 10.1016/S0969-2126(98)00027-6; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Bone H, 1997, J BIOL CHEM, V272, P14470, DOI 10.1074/jbc.272.22.14470; Brandao TAS, 2010, J BIOL CHEM, V285, P15874, DOI 10.1074/jbc.M109.066951; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chandradoss SD, 2014, JOVE-J VIS EXP, DOI 10.3791/50549; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Craggs TD, 2017, NAT METHODS, V14, P123, DOI 10.1038/nmeth.4159; Gavrieli M, 2003, BIOCHEM BIOPH RES CO, V312, P1236, DOI 10.1016/j.bbrc.2003.11.070; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2017, P JPN ACAD B-PHYS, V93, P196, DOI 10.2183/pjab.93.013; Hayashi T, 2017, CELL REP, V20, P2876, DOI 10.1016/j.celrep.2017.08.080; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Hong V, 2009, ANGEW CHEM INT EDIT, V48, P9879, DOI 10.1002/anie.200905087; Imhof D, 2006, J BIOL CHEM, V281, P20271, DOI 10.1074/jbc.M601047200; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; LaRochelle JR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06823-9; LaRochelle JR, 2017, BIOORGAN MED CHEM, V25, P6479, DOI 10.1016/j.bmc.2017.10.025; LaRochelle JR, 2016, BIOCHEMISTRY-US, V55, P2269, DOI 10.1021/acs.biochem.5b01287; LEE CH, 1994, STRUCTURE, V2, P423, DOI 10.1016/S0969-2126(00)00044-7; Lerner E, 2018, SCIENCE, V359, P288, DOI 10.1126/science.aan1133; Liu BA, 2012, PHILOS T R SOC B, V367, P2556, DOI 10.1098/rstb.2012.0107; Liu W, 2013, J MED CHEM, V56, P7212, DOI 10.1021/jm400474r; Mainardi S, 2018, NAT MED, V24, P961, DOI 10.1038/s41591-018-0023-9; Marchi M, 1999, J CHEM PHYS, V110, P3697, DOI 10.1063/1.478259; Martinez-Moczygemba M, 2003, J ALLERGY CLIN IMMUN, V112, P653, DOI 10.1067/mai.2003.1796; Matozaki T, 2009, CANCER SCI, V100, P1786, DOI 10.1111/j.1349-7006.2009.01257.x; Mellor P, 2012, BIOCHEM J, V441, P23, DOI 10.1042/BJ20111164; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Paci E, 1999, J MOL BIOL, V288, P441, DOI 10.1006/jmbi.1999.2670; Padua RAP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06814-w; Pamonsinlapatham P, 2009, BIOCHIMIE, V91, P320, DOI 10.1016/j.biochi.2008.10.010; Pedersen AK, 2004, ACTA CRYSTALLOGR D, V60, P1527, DOI 10.1107/S0907444904015094; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Ruess DA, 2018, NAT MED, V24, P954, DOI 10.1038/s41591-018-0024-8; Sada K, 2001, J BIOCHEM-TOKYO, V130, P177, DOI 10.1093/oxfordjournals.jbchem.a002970; Siveen KS, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0788-y; SUGIMOTO S, 1994, J BIOL CHEM, V269, P13614; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tocque B, 1997, CELL SIGNAL, V9, P153, DOI 10.1016/S0898-6568(96)00135-0; Tyagi S, 2012, METHOD CELL BIOL, V113, P169, DOI 10.1016/B978-0-12-407239-8.00009-4; Wang W, 2011, J CELL BIOCHEM, V112, P2062, DOI 10.1002/jcb.23125; WELHAM MJ, 1994, J BIOL CHEM, V269, P23764; Whittier SK, 2013, SCIENCE, V341, P899, DOI 10.1126/science.1241735; Xie JJ, 2017, J MED CHEM, V60, P10205, DOI 10.1021/acs.jmedchem.7b01520; Xu D, 2008, FRONT BIOSCI-LANDMRK, V13, P4925, DOI 10.2741/3051; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Yu ZH, 2013, J BIOL CHEM, V288, P10472, DOI 10.1074/jbc.M113.450023; Zhang YY, 2011, BIOCHEMISTRY-US, V50, P7637, DOI 10.1021/bi200439v; Zhang YL, 2018, J MOL BIOL, V430, P405, DOI 10.1016/j.jmb.2017.12.019	60	9	9	2	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100538	10.1016/j.jbc.2021.100538	http://dx.doi.org/10.1016/j.jbc.2021.100538			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33722610	gold, Green Published			2022-12-26	WOS:000672866400511
J	Yuan, MK; Zhang, JC; Gao, YP; Yuan, ZK; Zhu, ZL; Yongke, W; Wu, T; Han, J; Zhang, Y				Yuan, Mengke; Zhang, Jingcheng; Gao, Yuanpeng; Yuan, Zikun; Zhu, Zhenliang; Yongke Wei; Wu, Teng; Han, Jing; Zhang, Yong			HMEJ-based safe-harbor genome editing enables efficient generation of cattle with increased resistance to tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KNOCK-IN; TARGETED INTEGRATION; BOVINE TUBERCULOSIS; MYCOBACTERIUM-BOVIS; ROSA26 LOCUS; GENE; REPAIR; EXPRESSION; IDENTIFICATION; INSERTION	The CRISPR/Cas9 system has been used in a wide range of applications in the production of gene-edited animals and plants. Most efforts to insert genes have relied on homology-directed repair (HDR)-mediated integration, but this strategy remains inefficient for the production of gene-edited livestock, especially monotocous species such as cattle. Although efforts have been made to improve HDR efficiency, other strategies have also been proposed to circumvent these challenges. Here we demonstrate that a homology-mediated end-joining (HMEJ)-basedmethod can be used to create gene-edited cattle that displays precise integration of a functional gene at the ROSA26 locus. We found that the HMEJ-based method increased the knock-in efficiency of reporter genes by eightfold relative to the traditionalHDR-basedmethod in bovine fetal fibroblasts. Moreover, we identified the bovine homology of themouse Rosa26 locus that is an accepted genomic safe harbor and produced three live-borngene-edited cattlewith higher rates of pregnancy and birth, compared with previous work. These gene-edited cattle exhibited predictable expression of the functional gene natural resistance-associated macrophage protein-1 (NRAMP1), a metal ion transporter that should and, in our experiments does, increase resistance to bovine tuberculosis, one of the most detrimental zoonotic diseases. This research contributes to the establishment of a safe and efficient genome editing system and provides insights for gene-edited animal breeding.	[Yuan, Mengke; Zhang, Jingcheng; Gao, Yuanpeng; Yuan, Zikun; Zhu, Zhenliang; Yongke Wei; Wu, Teng; Han, Jing; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Yuan, Mengke; Zhang, Jingcheng; Gao, Yuanpeng; Yuan, Zikun; Zhu, Zhenliang; Yongke Wei; Wu, Teng; Han, Jing; Zhang, Yong] Northwest A&F Univ, Key Lab Anim Biotechnol, Minist Agr & Rural Affairs, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Zhang, Y (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.; Zhang, Y (corresponding author), Northwest A&F Univ, Key Lab Anim Biotechnol, Minist Agr & Rural Affairs, Yangling, Shaanxi, Peoples R China.	zhangyong1956@nwsuaf.edu.cn			National Major Project for Production of Transgenic Breeding [2016ZX08007003]	National Major Project for Production of Transgenic Breeding	We greatly appreciate Tong Xu and Ruizhi Deng for carefully correcting the paper and the Keyuan Cloning Company for their assistance in the gene-edited cattle production. This work was supported by the National Major Project for Production of Transgenic Breeding (No. 2016ZX08007003).	Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Bhakta MS, 2010, METHODS MOL BIOL, V649, P3, DOI 10.1007/978-1-60761-753-2_1; Bressan RB, 2017, DEVELOPMENT, V144, P635, DOI 10.1242/dev.140855; Carlson DF, 2016, NAT BIOTECHNOL, V34, P479, DOI 10.1038/nbt.3560; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gao YP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1144-4; Giel-Moloney M, 2007, GENESIS, V45, P83, DOI 10.1002/dvg.20269; Grange JM, 2001, TUBERCULOSIS, V81, P71, DOI 10.1054/tube.2000.0263; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Hedges JF, 2013, J IMMUNOL, V190, P4263, DOI 10.4049/jimmunol.1200732; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jung CJ, 2017, TRANSGENIC RES, V26, P263, DOI 10.1007/s11248-016-9998-5; Kobayashi T, 2012, STEM CELLS DEV, V21, P2981, DOI 10.1089/scd.2012.0065; Li XP, 2014, CELL RES, V24, P501, DOI 10.1038/cr.2014.15; Ma T, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12406; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Miao XY, 2013, CELL MOL LIFE SCI, V70, P815, DOI 10.1007/s00018-012-1081-7; Niu D, 2017, SCIENCE, V357, P1303, DOI 10.1126/science.aan4187; Nussenzweig A, 2007, CELL, V131, P223, DOI 10.1016/j.cell.2007.10.005; Ochiai H, 2012, P NATL ACAD SCI USA, V109, P10915, DOI 10.1073/pnas.1202768109; Papapetrou EP, 2016, MOL THER, V24, P678, DOI 10.1038/mt.2016.38; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Shanthalingam S, 2016, P NATL ACAD SCI USA, V113, P13186, DOI 10.1073/pnas.1613428113; Shi ZY, 2015, FASEB J, V29, P4914, DOI 10.1096/fj.15-273425; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Song J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10548; Thoen C, 2006, VET MICROBIOL, V112, P339, DOI 10.1016/j.vetmic.2005.11.047; Tsai SQ, 2017, NAT METHODS, V14, P607, DOI [10.1038/NMETH.4278, 10.1038/nmeth.4278]; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28502-x; Waters WR, 2012, VACCINE, V30, P2611, DOI 10.1016/j.vaccine.2012.02.018; Wu MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24360; Yang DS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25161; Yang HQ, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00360; Yao X, 2018, CELL RES, V28, P379, DOI 10.1038/cr.2018.9; Yao X, 2017, CELL RES, V27, P801, DOI 10.1038/cr.2017.76; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhang JP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1164-8	45	5	5	7	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100497	10.1016/j.jbc.2021.100497	http://dx.doi.org/10.1016/j.jbc.2021.100497			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33675752	Green Published, gold			2022-12-26	WOS:000672866400471
J	Saito, K; Mori, M; Kambara, N; Ohta, Y				Saito, Koji; Mori, Mamiko; Kambara, Norito; Ohta, Yasutaka			FilGAP, a GAP protein for Rac, regulates front-rear polarity and tumor cell migration through the ECM	FASEB JOURNAL			English	Article						Arf6; breast cancer; ECM; PIP3; Rho GTPase		Migrating tumor cells are characterized by a sustained front-rear asymmetry, with a front enriched in filamentous actin, which is induced by Rho small GTPase Rac. Regulation of Rac activity by its regulators should be required for effective motility. Here, we show that FilGAP, a GTPase-activating protein (GAP) for Rac, controls front-rear polarity and contributes to maintain effective tumor cell migration through the extracellular matrix (ECM). Overexpression of FilGAP in breast cancer cells induced polarized morphology and led to increased migration speed in collagen matrices, while depletion of FilGAP impaired the cell polarity and migration. FilGAP localizes to the cell front through its pleckstrin-homology (PH) domain in a phosphatidylinositol 3,4,5-trisphosphate (PIP3)-dependent manner and appears to inactivate Rac at its site. We found that the affinity of PH domain to PIP3 is critically involved in the maintenance of cell polarity. Moreover, small GTPase ADP-ribosylation factor 6 (Arf6), which binds to the FilGAP PH domain, also regulates FilGAP-mediated cell polarity and migration of breast cancer cells. We propose that FilGAP regulates front-rear polarity through its PIP3 and Arf6 binding in tumor cell migration through the ECM.	[Saito, Koji; Mori, Mamiko; Kambara, Norito; Ohta, Yasutaka] Kitasato Univ, Sch Sci, Dept Biosci, Div Cell Biol, Sagamihara, Kanagawa, Japan	Kitasato University	Saito, K; Ohta, Y (corresponding author), Kitasato Univ, Sch Sci, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	k-saito@kitasato-u.ac.jp; yohta@kitasato-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [22700885, 22570192]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 22700885 and 22570192	Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Campa Carlo C, 2015, Small GTPases, V6, P71, DOI 10.4161/21541248.2014.989789; Charest PG, 2007, BIOCHEM J, V401, P377, DOI 10.1042/BJ20061432; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Costa C, 2007, P NATL ACAD SCI USA, V104, P14354, DOI 10.1073/pnas.0703175104; Costa C, 2011, BLOOD, V118, P1099, DOI 10.1182/blood-2010-12-324756; Dai XP, 2018, MED SCI MONITOR, V24, P8669, DOI 10.12659/MSM.911394; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Feng M, 2014, J CLIN INVEST, V124, P5291, DOI 10.1172/JCI76711; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Fritz Rafael Dominik, 2016, F1000Res, V5, DOI 10.12688/f1000research.7370.1; Graziano BR, 2017, J CELL BIOL, V216, P2515, DOI 10.1083/jcb.201604113; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Halet G, 2005, BIOL CELL, V97, P501; Hara A, 2016, CANCER MED-US, V5, P3412, DOI 10.1002/cam4.937; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Ishihara S, 2013, FEBS LETT, V587, P732, DOI 10.1016/j.febslet.2013.01.055; Itoh RE, 2008, J CELL SCI, V121, P2635, DOI 10.1242/jcs.028647; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kardash E, 2011, NAT PROTOC, V6, P1835, DOI 10.1038/nprot.2011.395; Kawaguchi K, 2014, J BIOL CHEM, V289, P9675, DOI 10.1074/jbc.M113.546051; Koo TH, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-29; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Lien EC, 2017, CURR OPIN CELL BIOL, V45, P62, DOI 10.1016/j.ceb.2017.02.007; Lorentzen A, 2011, J CELL SCI, V124, P1256, DOI 10.1242/jcs.074849; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Morishita Y, 2015, J BIOL CHEM, V290, P26328, DOI 10.1074/jbc.M115.666875; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Nakamura F, 2013, BIOCHEM J, V453, P17, DOI 10.1042/BJ20130290; Nishi T, 2015, CANCER MED-US, V4, P808, DOI 10.1002/cam4.423; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Palacios F, 2003, J BIOL CHEM, V278, P17395, DOI 10.1074/jbc.M300998200; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pan SL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0707-6; Pandya P, 2017, MOL ONCOL, V11, P5, DOI 10.1002/1878-0261.12019; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Parrini MC, 2011, MOL CELL, V42, P650, DOI 10.1016/j.molcel.2011.03.032; Petrie RJ, 2012, J CELL SCI, V125, P5917, DOI 10.1242/jcs.093732; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Pouthas F, 2008, J CELL SCI, V121, P2406, DOI 10.1242/jcs.026849; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Reig G, 2014, DEVELOPMENT, V141, P1999, DOI 10.1242/dev.101451; Remorino A, 2017, CELL REP, V21, P1922, DOI 10.1016/j.celrep.2017.10.069; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sadok Amine, 2014, Small GTPases, V5, pe29710, DOI 10.4161/sgtp.29710; Saito K, 2015, CYTOSKELETON, V72, P146, DOI 10.1002/cm.21211; Saito K, 2012, MOL BIOL CELL, V23, P4739, DOI 10.1091/mbc.E12-04-0310; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schweitzer JK, 2011, SEMIN CELL DEV BIOL, V22, P39, DOI 10.1016/j.semcdb.2010.09.002; Seoh ML, 2003, FEBS LETT, V539, P131, DOI 10.1016/S0014-5793(03)00213-8; Sun Z, 2017, CANCER SCI, V108, P61, DOI 10.1111/cas.13118; Takagi K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030804; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Uehara S, 2017, ANTICANCER RES, V37, P4837, DOI 10.21873/anticanres.11891; van Buul JD, 2014, CELL ADHES MIGR, V8, P108, DOI 10.4161/cam.27599; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Wang L, 2017, MOL BIOSYST, V13, P2564, DOI 10.1039/c7mb00406k; Xu GS, 2016, ONCOTARGET, V7, P51829, DOI 10.18632/oncotarget.10386; Yamada H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146593; Yamazaki D, 2013, MOL BIOL CELL, V24, P3393, DOI 10.1091/mbc.E13-04-0178	68	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21508	10.1096/fj.202002155R	http://dx.doi.org/10.1096/fj.202002155R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710706				2022-12-26	WOS:000635216100012
J	Shi, FF; Feng, XZ				Shi, Feifei; Feng, Xizeng			Decabromodiphenyl ethane exposure damaged the asymmetric division of mouse oocytes by inhibiting the inactivation of cyclin-dependent kinase 1	FASEB JOURNAL			English	Article						asymmetric division; blastocyst; cyclin&#8208; dependent kinase 1; decabromodiphenyl ethane; oocyte	BROMINATED FLAME RETARDANTS; POLYBROMINATED DIPHENYL ETHERS; ADVERSE PREGNANCY OUTCOMES; SPINDLE MIGRATION; ENVIRONMENTAL EXPOSURES; DIETARY EXPOSURE; CAR DUST; LEGACY; PBDES; AIR	Decabromodiphenyl ethane (DBDPE) is a new brominated flame retardant and is widely added to flammable materials to prevent fire. Because it has been continuously detected in a variety of organisms and humans, it is important to reveal the biological toxicity of DBDPE. However, the influence of DBDPE for female reproduction is unclear. In this study, we investigated whether and how DBDPE exposure affects oocyte development. Female mice as a model were orally exposed to DBDPE by 0, 0.05, 0.5, 5, 50 mu g/kg bw/day for 30 days (0.05 mu g/kg bw/day is close to the environmental exposure concentration). We found that exposure of mice to DBDPE did not affect the first polar body extrusion (PBE) of oocytes. Strikingly, however, asymmetric division of oocytes was markedly impaired in 5 and 50 mu g/kg bw/day DBDPE exposed group, which resulted in oocytes with larger polar bodies (PBs). Then, we further explored and found that DBDPE exposure inhibited the spindle migration and membrane protrusion in oocytes during anaphase of meiosis I (anaphase I), thereby impairing asymmetric division. Additionally, we found that DBDPE exposure suppressed the inactivation of cyclin-dependent kinase 1 (Cdk1), resulting in the decrease of cytoplasmic formin2 (FMN2)-mediated F-actin polymerization in oocytes at the onset of anaphase I. Simultaneously, DBDPE exposure damaged the structural integrity of the spindle and the perpendicular relationship between spindle and cortex. These together led to the failure of spindle migration and membrane protrusion required for oocytes asymmetric division. Finally, DBDPE exposure injured the development of blastocysts, leading to blastocyst apoptosis.	[Shi, Feifei; Feng, Xizeng] Nankai Univ, Coll Life Sci, Key Lab Bioact Mat, Minist Educ,State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Nankai University	Feng, XZ (corresponding author), Nankai Univ, Coll Life Sci, Key Lab Bioact Mat, Minist Educ,State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	xzfeng@nankai.edu.cn			National Natural Science Foundation of China (NSFC) [U1613220,61633012]; National Key R&D Program of China [2019YFB1309704]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China	National Natural Science Foundation of China (NSFC), Grant/Award Number: U1613220,61633012; National Key R&D Program of China, Grant/Award Number: 2019YFB1309704	Adhikari D, 2016, CELL RES, V26, P1212, DOI 10.1038/cr.2016.119; Al-Omran LS, 2018, CHEMOSPHERE, V193, P1105, DOI 10.1016/j.chemosphere.2017.11.147; Almonacid M, 2014, J CELL SCI, V127, P477, DOI 10.1242/jcs.142711; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Bennabi I, 2016, J CELL BIOL, V215, P611, DOI 10.1083/jcb.201607062; Besis A, 2017, ENVIRON POLLUT, V230, P871, DOI 10.1016/j.envpol.2017.07.032; Bu QW, 2019, ENVIRON INT, V122, P159, DOI 10.1016/j.envint.2018.11.005; Chaigne A, 2013, NAT CELL BIOL, V15, P958, DOI 10.1038/ncb2799; Chen T, 2019, ENVIRON INT, V133, DOI 10.1016/j.envint.2019.105179; de la Torre A, 2018, SCI TOTAL ENVIRON, V630, P154, DOI 10.1016/j.scitotenv.2018.02.199; Duan X, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14068-3; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; Feng X., ECOTOX ENVIRON SAFE, V207; He MJ, 2012, SCI TOTAL ENVIRON, V419, P109, DOI 10.1016/j.scitotenv.2011.12.035; Hu GC, 2010, J ENVIRON SCI, V22, P1833, DOI 10.1016/S1001-0742(09)60328-4; Jing L, 2019, CHEMOSPHERE, V223, P675, DOI 10.1016/j.chemosphere.2019.02.115; Kalachova K, 2012, SCI TOTAL ENVIRON, V441, P182, DOI 10.1016/j.scitotenv.2012.09.061; Kramer MS, 2003, J NUTR, V133, p1592S, DOI 10.1093/jn/133.5.1592S; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; McGrath TJ, 2018, ENVIRON INT, V113, P191, DOI 10.1016/j.envint.2018.01.026; McGrath TJ, 2017, ENVIRON POLLUT, V230, P741, DOI 10.1016/j.envpol.2017.07.009; Moller A, 2011, ENVIRON POLLUT, V159, P1577, DOI 10.1016/j.envpol.2011.02.054; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; Shen KH, 2019, ENVIRON POLLUT, V250, P79, DOI 10.1016/j.envpol.2019.03.090; Shi ZX, 2016, ENVIRON INT, V96, P82, DOI 10.1016/j.envint.2016.09.005; Silbergeld EK, 2005, AM J OBSTET GYNECOL, V192, pS11, DOI 10.1016/j.ajog.2004.06.117; Stillerman KP, 2008, REPROD SCI, V15, P631, DOI 10.1177/1933719108322436; Sun RB, 2018, BIOMED ENVIRON SCI, V31, P12, DOI 10.3967/bes2018.002; Sun SC, 2012, HUM REPROD UPDATE, V18, P60, DOI 10.1093/humupd/dmr044; Sun YM, 2020, SCI TOTAL ENVIRON, V705, DOI 10.1016/j.scitotenv.2019.135783; Svitkina Tatyana, 2018, Cold Spring Harb Perspect Biol, V10, DOI 10.1101/cshperspect.a018267; Tao F, 2016, ENVIRON SCI TECHNOL, V50, P13052, DOI 10.1021/acs.est.6b02816; Tay JH, 2018, ENVIRON INT, V115, P285, DOI 10.1016/j.envint.2018.03.038; Venkatesan AK, 2014, WATER RES, V55, P133, DOI 10.1016/j.watres.2014.02.021; Wang FX, 2010, ENVIRON SCI TECHNOL, V44, P5655, DOI 10.1021/es101158e; Wang XC, 2019, ENVIRON SCI TECHNOL, V53, P8437, DOI 10.1021/acs.est.9b02831; Wei Z, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17088-6; Wei Z, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06510-9; Xie BT, 2018, CELL RES, V28, P462, DOI 10.1038/s41422-018-0009-7; Zhang K, 2015, REPROD FERT DEVELOP, V27, P880, DOI 10.1071/RD14441; Zhang SZ, 2020, CHEMOSPHERE, V245, DOI 10.1016/j.chemosphere.2019.125679; Zhou CX, 2019, J CELL SCI, V132, DOI 10.1242/jcs.233379	44	5	6	5	31	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21449	10.1096/fj.202002585R	http://dx.doi.org/10.1096/fj.202002585R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33724544				2022-12-26	WOS:000635216100084
J	Zhang, SK; Liu, BH; Wang, WJ; Lv, LY; Gao, DQ; Chai, M; Li, MS; Wu, ZH; Zhu, YP; Ma, J; Leng, L				Zhang, Shikun; Liu, Binghui; Wang, Wenjuan; Lv, Luye; Gao, Dunqin; Chai, Mi; Li, Mansheng; Wu, Zhihong; Zhu, Yunping; Ma, Jie; Leng, Ling			The "Matrisome" reveals the characterization of skin keloid microenvironment	FASEB JOURNAL			English	Article						biomatrix scaffold; extracellular matrix; keloid; matrisome; skin		Keloids are fibroproliferative dermal tumors of unknown origin that are characterized by the overabundant accumulation of extracellular matrix (ECM) components. The mechanism of keloid formation has remained unclear because of a poor understanding of its molecular basis. In this study, the dermal ECM components of keloids were identified and the pathological features of keloid formation were characterized using large-scale quantitative proteomic analyses of decellularized keloid biomatrix scaffolds. We identified a total of 267 dermal core ECM and ECM-associated proteins that were differentially expressed between patients with keloids and healthy controls. Skin mechanical properties and biological processes including protease activity, wound healing, and adhesion were disordered in keloids. The integrated network analysis of the upregulated ECM proteins revealed multiple signaling pathways involved in these processes that may lead to keloid formation. Our findings may improve the scientific basis of keloid treatment and provide new ideas for the establishment of keloid models.	[Zhang, Shikun; Gao, Dunqin; Wu, Zhihong; Leng, Ling] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Translat Med Ctr, Stem Cell & Regenerat Med Lab,Dept Med Sci,Res Ct, Beijing, Peoples R China; [Zhang, Shikun] Inst Hlth Serv & Transfus Med, Dept Stem Cell & Regenerat Med Lab, Beijing, Peoples R China; [Liu, Binghui; Li, Mansheng; Zhu, Yunping; Ma, Jie] Beijing Inst Life Om, Natl Ctr Prot Sci Beijing, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China; [Wang, Wenjuan] Chinese Peoples Liberat Army Gen Hosp, Dept Dermatol, Beijing, Peoples R China; [Lv, Luye] Inst NBC Def, Beijing, Peoples R China; [Chai, Mi] Chinese Peoples Liberat Army Gen Hosp, Dept Plast & Reconstruct Surg, Beijing, Peoples R China; [Zhu, Yunping] Anhui Med Univ, Basic Med Sch, Hefei, Anhui, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Anhui Medical University	Ma, J (corresponding author), Beijing Inst Life Om, Natl Ctr Prot Sci Beijing, 38 Life Sci Pk Rd, Beijing 102206, Peoples R China.; Leng, L (corresponding author), Peking Union Med Coll Hosp, Dept Med Sci, Res Ctr, Stem Cell & Regenerat Med Lab, 1 Shuaifuyuan Wangfujing, Beijing 100730, Peoples R China.	majie@ncpsb.org.cn; lengling@pumch.cn	leng, ling/GQH-2273-2022; Li, Mansheng/AAA-7127-2022; wu, zhi/GXH-3041-2022	Li, Mansheng/0000-0002-0778-0965; Ma, Jie/0000-0002-8934-922X; Leng, Ling/0000-0002-6519-012X	National Key Research and Development Program of China [2016YFB0201702, 2016YFC0901701]	National Key Research and Development Program of China	the National Key Research and Development Program of China, Grant/Award Number: 2016YFB0201702 and 2016YFC0901701	Al-Attar A, 2006, PLAST RECONSTR SURG, V117, P286, DOI 10.1097/01.prs.0000195073.73580.46; Amadeu TP, 2004, WOUND REPAIR REGEN, V12, P169, DOI 10.1111/j.1067-1927.2004.012209.x; Amenta PS, 2005, J HISTOCHEM CYTOCHEM, V53, P165, DOI 10.1369/jhc.4A6376.2005; Andrews JP, 2016, MATRIX BIOL, V51, P37, DOI 10.1016/j.matbio.2016.01.013; Armour A, 2007, WOUND REPAIR REGEN, V15, pS6, DOI 10.1111/j.1524-475X.2007.00219.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Badr G, 2012, J NUTR BIOCHEM, V23, P1640, DOI 10.1016/j.jnutbio.2011.11.006; Bagabir RA, 2011, J INVEST DERMATOL, V131, P2128, DOI 10.1038/jid.2011.163; Bijnen M, 2018, GUT, V67, P1317, DOI 10.1136/gutjnl-2016-313654; Birk DE, 2011, BIOL EXTRACELL MATR, P77, DOI 10.1007/978-3-642-16555-9_3; Chakrabarti S, 2005, EXP LUNG RES, V31, P599, DOI 10.1080/019021490944232; Chakravarti S, 2002, GLYCOCONJUGATE J, V19, P287, DOI 10.1023/A:1025348417078; Chua AWC, 2011, J DERMATOL SCI, V64, P199, DOI 10.1016/j.jdermsci.2011.09.008; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Farach-Carson MC, 2014, MATRIX BIOL, V34, P64, DOI 10.1016/j.matbio.2013.08.004; Fernandes RJ, 2007, MATRIX BIOL, V26, P597, DOI 10.1016/j.matbio.2007.06.007; Funderburgh JL, 1997, INVEST OPHTH VIS SCI, V38, P1159; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; Ge GX, 2004, J BIOL CHEM, V279, P41626, DOI 10.1074/jbc.M406630200; Gragnani A, 2010, ARCH DERMATOL RES, V302, P1, DOI 10.1007/s00403-009-0983-1; Hinz B, 2016, CURR RES TRANSL MED, V64, P171, DOI 10.1016/j.retram.2016.09.003; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hynes RO, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a004903; Inui S, 2011, AM J PATHOL, V179, P1951, DOI 10.1016/j.ajpath.2011.06.034; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Jiao H, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00885; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang JS, 2008, ZOOL SCI, V25, P912, DOI 10.2108/zsj.25.912; Kang N, 2006, J PLAST RECONSTR AES, V59, P693, DOI 10.1016/j.bjps.2005.11.022; Kirkness MWH, 2019, CURR OPIN CHEM BIOL, V53, P98, DOI 10.1016/j.cbpa.2019.08.001; Li HW, 2013, JAMA FACIAL PLAST SU, V15, P448, DOI 10.1001/jamafacial.2013.1211; Li Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02422; Liu CJ, 2003, SCAND J PLAST RECONS, V37, P321, DOI 10.1080/02844310310004677; Ma J, 2019, NUCLEIC ACIDS RES, V47, pD1211, DOI 10.1093/nar/gky869; Ma LJ, 2014, BURNS TRAUMA, V2, DOI 10.4103/2321-3868.130191; Maccarana M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184028; MARTIN GR, 1984, CIBA F SYMP, V108, P197; Muncie JM, 2018, CURR TOP DEV BIOL, V130, P1, DOI 10.1016/bs.ctdb.2018.02.002; Naba A, 2016, MATRIX BIOL, V49, P10, DOI 10.1016/j.matbio.2015.06.003; Naba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014647; Rasi K, 2010, CIRC RES, V107, P1241, DOI 10.1161/CIRCRESAHA.110.222133; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Sayani K, 2000, HISTOPATHOLOGY, V36, P262; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Seidler DG, 2008, IUBMB LIFE, V60, P729, DOI 10.1002/iub.115; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shih Barbara, 2010, Eplasty, V10, pe24; Shmoilov AM, 2006, J DRUG DELIV SCI TEC, V16, P285, DOI 10.1016/S1773-2247(06)50052-8; Sidgwick GP, 2012, J EUR ACAD DERMATOL, V26, P141, DOI 10.1111/j.1468-3083.2011.04200.x; Son ED, 2005, J INVEST DERMATOL, V124, P1149, DOI 10.1111/j.0022-202X.2005.23736.x; Suarez E, 2015, ARCH DERMATOL RES, V307, P115, DOI 10.1007/s00403-014-1512-4; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tan JL, 2015, BURNS TRAUMA, V3, DOI 10.1186/s41038-015-0016-6; Tredget EE, 2014, SURG CLIN N AM, V94, P793, DOI 10.1016/j.suc.2014.05.005; Ulrich D, 2010, J PLAST RECONSTR AES, V63, P1015, DOI 10.1016/j.bjps.2009.04.021; van der Veer WM, 2009, BURNS, V35, P15, DOI 10.1016/j.burns.2008.06.020; Vij N, 2005, INVEST OPHTH VIS SCI, V46, P88, DOI 10.1167/iovs.04-0833; Wang WJ, 2020, BIOCHEM BIOPH RES CO, V524, P567, DOI 10.1016/j.bbrc.2020.01.131; Wolfram D, 2009, DERMATOL SURG, V35, P171, DOI 10.1111/j.1524-4725.2008.34406.x; Wu F, 2007, J BIOL CHEM, V282, P26409, DOI 10.1074/jbc.M702402200; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xia W, 2006, AM J PHYSIOL-REG I, V290, pR501, DOI 10.1152/ajpregu.00472.2005; Xue ML, 2015, ADV WOUND CARE, V4, P119, DOI 10.1089/wound.2013.0485	65	3	3	3	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21237	10.1096/fj.202001660RR	http://dx.doi.org/10.1096/fj.202001660RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715180				2022-12-26	WOS:000635216100031
J	Pigozzi, E; Tregnago, D; Costa, L; Insolda, J; Turati, E; Rimondini, M; Donisi, V; Madera, P; Fiorica, F; Giuliani, J; Greco, F; Mercanti, A; Trolese, A; Furlani, L; Piacentini, P; Durante, E; Mandara, M; Pilotto, S; Avancini, A; Trestini, I; Zaninelli, M; Moretti, F; Milella, M; Bonetti, A				Pigozzi, Eva; Tregnago, Daniela; Costa, Lucia; Insolda, Jessica; Turati, Enrico; Rimondini, Michela; Donisi, Valeria; Madera, Pietro; Fiorica, Francesco; Giuliani, Jacopo; Greco, Filippo; Mercanti, Anna; Trolese, Annarita; Furlani, Lara; Piacentini, Paolo; Durante, Emilia; Mandara, Marta; Pilotto, Sara; Avancini, Alice; Trestini, Ilaria; Zaninelli, Marta; Moretti, Francesca; Milella, Michele; Bonetti, Andrea			Psychological impact of Covid-19 pandemic on oncological patients: A survey in Northern Italy	PLOS ONE			English	Article							CANCER	The psychological impact of the Covid 19 pandemic on cancer patients, a population at higher risk of fatal consequences if infected, has been only rarely evaluated. This study was conducted at the Departments of Oncology of four hospitals located in the Verona area in Italy to investigate the psychological consequences of the pandemic on cancer patients under active anticancer treatments. A 13-item ad hoc questionnaire to evaluate the psychological status of patients before and during the pandemic was administered to 474 consecutive subjects in the time frame between April 27(th) and June 7(th) 2020. Among the 13 questions, 7 were considered appropriate to elaborate an Emotional Vulnerability Index (EVI) that allows to separate the population in two groups (low versus high emotional vulnerability) according to observed median values. During the emergency period, the feeling of high vulnerability was found in 246 patients (53%) and was significantly associated with the following clinical variables: female gender, being under chemotherapy treatment, age <= 65 years. Compared to the pre-pandemic phase, the feeling of vulnerability was increased in 41 patients (9%), remained stably high in 196 (42%) and, surprisingly, was reduced in 10 patients (2%). Overall, in a population characterized by an high level of emotional vulnerability the pandemic had a marginal impact and only a small proportion of patients reported an increase of their emotional vulnerability.	[Pigozzi, Eva; Insolda, Jessica; Giuliani, Jacopo; Greco, Filippo; Mercanti, Anna; Trolese, Annarita; Furlani, Lara; Piacentini, Paolo; Durante, Emilia; Mandara, Marta; Zaninelli, Marta; Bonetti, Andrea] AULSS 9 Scaligera, Dept Med Oncol, Verona, Italy; [Tregnago, Daniela; Pilotto, Sara; Trestini, Ilaria; Milella, Michele] Univ Verona, Verona Univ Hosp Trust, Sect Oncol, Sch Med, Verona, Italy; [Costa, Lucia; Madera, Pietro] AULSS9 Scaligera, Clin Psicol Unit, Verona, Italy; [Turati, Enrico] Univ Ferrara, Dept Lifesci & Biotechnol, Ferrara, Italy; [Rimondini, Michela; Donisi, Valeria] Verona Univ Hosp Trust, Clin Psicol Unit, Verona, Italy; [Fiorica, Francesco] AULSS 9 Scaligera, Dept Radiat Oncol & Nucl Med, Legnago, VR, Italy; [Avancini, Alice] Univ Verona, Biomed Clin & Expt Sci, Dept Med, Verona, Italy; [Moretti, Francesca] AULSS 9 Scaligera, Med Direct, Legnago, VR, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Ferrara; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona	Pigozzi, E (corresponding author), AULSS 9 Scaligera, Dept Med Oncol, Verona, Italy.	evapigozzi@gmail.com	Bonetti, Andrea/AAL-6623-2020; Avancini, Alice/ABE-2707-2020	Avancini, Alice/0000-0003-2439-4799; GIULIANI, Jacopo/0000-0003-4096-2514				[Anonymous], LANCET, DOI [10.1016/S0140-6736%2820%2930211-7, DOI 10.1016/S0140-6736(20)30211-7]; Deckx L, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0071-7; Dinmohamed AG, 2020, LANCET ONCOL, V21, P750, DOI 10.1016/S1470-2045(20)30265-5; Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114; Giuliani J, J MED VIROL; Jones D, 2020, LANCET ONCOL, V21, P748, DOI 10.1016/S1470-2045(20)30242-4; Keller M, 1999, ACTA ONCOL, V38, P747; Kroenke CH, 2004, J CLIN ONCOL, V22, P1849, DOI 10.1200/JCO.2004.04.173; Kroenke K, 1998, PSYCHOSOM MED, V60, P150, DOI 10.1097/00006842-199803000-00006; Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6; MOR V, 1994, CANCER-AM CANCER SOC, V74, P2118, DOI 10.1002/1097-0142(19941001)74:7+<2118::AID-CNCR2820741720>3.0.CO;2-N; NATHANSON CA, 1977, SOC SCI MED, V11, P13, DOI 10.1016/0037-7856(77)90141-X; Peteet JR, 2020, J RELIG HEALTH, V59, P2203, DOI 10.1007/s10943-020-01041-4; van de Haar J, 2020, NAT MED, V26, P665, DOI [10.1038/s41591-020-0874-8, 10.1038/s41591-020-0948-7]; VERBRUGGE LM, 1985, J HEALTH SOC BEHAV, V26, P156, DOI 10.2307/2136750; Wu YC, 2020, J CHIN MED ASSOC, V83, P217, DOI 10.1097/JCMA.0000000000000270; Zhang L, 2020, ANN ONCOL, V31, P894, DOI 10.1016/j.annonc.2020.03.296; Zuliani S, 2020, EUR J CANCER, V135, P159, DOI 10.1016/j.ejca.2020.05.029	18	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0248714	10.1371/journal.pone.0248714	http://dx.doi.org/10.1371/journal.pone.0248714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY1VJ	33724999	gold, Green Published			2022-12-26	WOS:000629833700002
J	Chau, E; Rosella, LC; Mondor, L; Wodchis, WP				Chau, Edward; Rosella, Laura C.; Mondor, Luke; Wodchis, Walter P.			Association between continuity of care and subsequent diagnosis of multimorbidity in Ontario, Canada from 2001-2015: A retrospective cohort study	PLOS ONE			English	Article							ADMINISTRATIVE DATA; HEART-FAILURE; HEALTH-CARE; MEDICATION ADHERENCE; DISEASE; ADULTS; POPULATION; MANAGEMENT; EDUCATION; ACCURACY	Background Continuity of care is a well-recognized principle of the primary care discipline owing to its medical, interpersonal, and cost-saving benefits. Relationship continuity or the ongoing therapeutic relationship between a patient and their physician is a particularly desirable goal, but its role in preventing the accumulation of chronic conditions diagnoses in individuals is unknown. The objective of this study was to investigate the effect of continuity of care with physicians on the rate of incident multimorbidity diagnoses in patients with existing conditions. Methods This was a population-based, retrospective cohort study from 2001 to 2015 that focused on patients aged 18 to 105 years with at least one chronic condition (n = 166,665). Our primary exposure was relationship continuity of care with general practitioners and specialists measured using the Bice-Boxerman Continuity of Care Index (COCI). COCI was specified as a time-dependent exposure prior to the observation period. Our outcomes of interest were the time to diagnosis of a second, third, and fourth chronic condition estimated using cause-specific hazard regressions accounting for death as a competing risk. Findings We observed that patients with a single chronic condition and high continuity of care (>0.50) were diagnosed with a second chronic condition or multimorbidity at an 8% lower rate compared to individuals with low continuity (cause-specific hazard ratio (HR) 0.92 (95% Confidence Interval 0.90-0.93; p<0.0001) after adjusting for age, sex, income, place of residence, primary care enrolment, and the annual number of physician visits. Continuity remained protective as the degree of multimorbidity increased. Among patients with two conditions, the risk of diagnosis of a third chronic condition was also 8% lower for individuals with high continuity (HR 0.92; CI 0.90-0.94; p<0.0001). Patients with three conditions and high continuity had a 9% lower risk of diagnosis with a fourth condition (HR 0.91; CI 0.89-0.93; p<0.0001). Conclusions Continuity of care is a potentially modifiable health system factor that reduces the rate at which diagnoses of chronic conditions are made over time in patients with multimorbidity. Additional research is needed to explain the underlying mechanisms through which continuity is related to a protective effect and the clinical sequalae.	[Chau, Edward; Rosella, Laura C.; Wodchis, Walter P.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Rosella, Laura C.; Wodchis, Walter P.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rosella, Laura C.; Wodchis, Walter P.] Trillium Hlth Partners, Inst Better Hlth, Mississauga, ON, Canada; [Rosella, Laura C.; Mondor, Luke; Wodchis, Walter P.] ICES, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; Trillium Health Partners; University of Toronto	Wodchis, WP (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.; Wodchis, WP (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Wodchis, WP (corresponding author), Trillium Hlth Partners, Inst Better Hlth, Mississauga, ON, Canada.; Wodchis, WP (corresponding author), ICES, Toronto, ON, Canada.	walter.wodchis@utoronto.ca		wodchis, walter/0000-0003-2494-7031	Health System Performance Research Network - Ministry of Health and Long-Term Care [06034]; Ontario SPOR Support Unit; Ontario Ministry of Health; Canada Research Chair in Population Health Analytics; Trillium Health Partners Foundation	Health System Performance Research Network - Ministry of Health and Long-Term Care; Ontario SPOR Support Unit; Ontario Ministry of Health(Ministry of Health and Long-Term Care, Ontario); Canada Research Chair in Population Health Analytics; Trillium Health Partners Foundation(University of Toronto)	The funding for this manuscript was obtained through the Health System Performance Research Network funded by a grant from the Ministry of Health and Long-Term Care (#06034) and from the Ontario SPOR Support Unit. Any views expressed in this manuscript belong solely to the authors and not the funding agency. ICES receives funding from the Ontario Ministry of Health. LCR is supported by a Canada Research Chair in Population Health Analytics. LCR and WPW are supported by Research Chairs funded by the Trillium Health Partners Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alazri Mohammed, 2007, Sultan Qaboos Univ Med J, V7, P197; Allen SM, 2009, DISABIL HEALTH J, V2, P180, DOI 10.1016/j.dhjo.2009.06.004; Andersen P. K., 2012, STAT MODELS BASED CO; [Anonymous], 2019, REP CAN CHRON DIS SU; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Barker I, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j84; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bayliss EA, 2008, FAM PRACT, V25, P287, DOI 10.1093/fampra/cmn040; Bayliss EA, 2015, ANN FAM MED, V13, P123, DOI 10.1370/afm.1739; Betancourt MT, 2014, CHRON DIS INJ CAN, V34, P1; BICE TW, 1977, MED CARE, V15, P347, DOI 10.1097/00005650-197704000-00010; Boyd CM, 2014, CURR OPIN HIV AIDS, V9, P419, DOI 10.1097/COH.0000000000000073; BRESLAU N, 1975, J MED EDUC, V50, P965; Calderon-Larranaga A, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X659295; Canadian Institute for Health Information, 2015, CONT CAR FAM MED PHY; Canadian Institute for Health Information, 2011, SEN HLTH CAR SYST WH, P23; Chen CC, 2016, AM J MANAG CARE, V22, P136; Chen CC, 2013, MED CARE, V51, P231, DOI 10.1097/MLR.0b013e31827da5b9; Chen LM, 2014, JAMA INTERN MED, V174, P749, DOI 10.1001/jamainternmed.2013.14331; Cheng SH, 2014, MED CARE, V52, P149, DOI 10.1097/MLR.0000000000000042; Cowie L, 2009, J HEALTH SERV RES PO, V14, P82, DOI 10.1258/jhsrp.2009.008111; Delva D, 2011, CAN FAM PHYSICIAN, V57, P915; Dhalwani NN, 2017, J GERONTOL A-BIOL, V72, P528, DOI 10.1093/gerona/glw146; DuGoff Eva H, 2016, J Comorb, V6, P65, DOI 10.15256/joc.2016.6.76; DuGoff EH, 2014, MED CARE, V52, P688, DOI 10.1097/MLR.0000000000000166; Dumbreck S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h949; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Gershon AS., 2009, COPD J CHRONIC OBSTR, V5, P388, DOI [10.1155/2009/963098, DOI 10.1155/2009/963098]; Gilbert AL, 2011, AUSTRALAS J AGEING, V30, P32, DOI 10.1111/j.1741-6612.2011.00530.x; Glazier RH., 2012, COMP PRIMARY CARE MO; Gray DJP, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021161; Gruneir A, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1415-5; Gulliford M, 2011, J HEALTH SERV RES PO, V16, P67, DOI 10.1258/jhsrp.2010.010015; Guo JY, 2017, MED CARE, V55, P744, DOI 10.1097/MLR.0000000000000758; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Health System Performance Research Network, 2013, CAR PEOPL MULT CHRON, V2, P1; HJORTDAHL P, 1992, BRIT MED J, V304, P1287, DOI 10.1136/bmj.304.6837.1287; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Information CI for H, 2016, TRENDS INC REL HLTH, DOI [10.1080/17441692.2014.931448, DOI 10.1080/17441692.2014.931448]; Jaakkimainen RL, 2016, J ALZHEIMERS DIS, V54, P337, DOI 10.3233/JAD-160105; Johnson-Lawrence V, 2017, SSM-POPUL HLTH, V3, P366, DOI 10.1016/j.ssmph.2017.03.007; Kralj B., 2008, MEASURING RURALITY R; Lane NE, 2015, EBIOMEDICINE, V2, P2094, DOI 10.1016/j.ebiom.2015.11.018; Leijten FRM, 2018, HEALTH POLICY, V122, P12, DOI 10.1016/j.healthpol.2017.06.002; Liang HL, 2017, INQUIRY-J HEALTH CAR, V54, DOI 10.1177/0046958017724003; Melis R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103120; Mondor L, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002249; Mondor L, 2016, QUAL LIFE RES, V25, P2619, DOI 10.1007/s11136-016-1281-y; Muth C, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0223-1; Nunes BP, 2016, ARCH GERONTOL GERIAT, V67, P130, DOI 10.1016/j.archger.2016.07.008; Page RL, 2016, CIRCULATION, V134, pE32, DOI 10.1161/CIR.0000000000000426; Pefoyo AJK, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1733-2; Public Health Agency of Canada, 2014, EC BURD ILLN CAN; Reid R., 2002, DEFINING CONFUSION C; Roberts KC, 2015, HEALTH PROMOT CHRON, V35, DOI 10.24095/hpcdp.35.6.01; Ruel G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096291; Ryan A, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0355-9; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Schultz SE, 2013, CHRON DIS INJ CAN, V33, P160; Slordal L, 2006, DRUG SAFETY, V29, P567; St Sauver JL, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006413; Thavorn K, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017264; Tu Karen, 2007, Open Med, V1, pe18; Tucker-Seeley RD, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-313; van Oostrom SH, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-61; van Walraven C, 2004, J CLIN EPIDEMIOL, V57, P672, DOI 10.1016/j.jclinepi.2003.12.008; van Walraven C, 2010, J CLIN EPIDEMIOL, V63, P1000, DOI 10.1016/j.jclinepi.2010.01.023; Widdifield J, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-216; Worrall G, 2011, CAN FAM PHYSICIAN, V57, pE16	70	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0245193	10.1371/journal.pone.0245193	http://dx.doi.org/10.1371/journal.pone.0245193			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705429	Green Published, gold			2022-12-26	WOS:000629590400095
J	da Silva, RCF; Bahia, LR; da Rosa, MQM; Malhao, TA; Mendonca, ED; Rosa, RD; Araujo, DV; Moreira, LGM; Schilithz, AOC; Melo, MELD				Ferreira da Silva, Ronaldo Correa; Bahia, Luciana Ribeiro; Machado da Rosa, Michelle Quarti; Malhao, Thaina Alves; Mendonca, Eliane De Paula; Rosa, Roger dos Santos; Araujo, Denizar Vianna; Maya Moreira, Luciana Grucci; Correa Schilithz, Arthur Orlando; Diogenes Melo, Maria Eduarda Leao			Costs of cancer attributable to excess body weight in the Brazilian public health system in 2018	PLOS ONE			English	Article							MASS INDEX; BURDEN	Objectives The prevalence of excess body weight (EBW) has increased over the last decades in Brazil, where 55.4% of the adult population was overweight in 2019. EBW is a well-known risk factor for several types of cancer. We estimated the federal cost of EBW-related cancers in adults, considering the medical expenditures in the Brazilian Public Health System. Methods We calculated the costs related to 11 types of cancer considering the procedures performed in 2018 by all organizations that provide cancer care in the public health system. We obtained data from the Hospital and Ambulatory Information Systems of the Brazilian Public Health System. We calculated the fractions of cancer attributable to EBW using the relative risks from the literature and prevalence from a nationally representative survey. We converted the monetary values in Reais (R$) to international dollars (Int$), considering the purchasing power parity (PPP) of 2018. Results In Brazil, the 2018 federal cost for all types of cancers combined was Int$ 1.73 billion, of which nearly Int$ 710 million was spent on EBW-related cancer care and Int$ 30 million was attributable to EBW. Outpatient and inpatient expenditures reached Int$ 20.41 million (of which 80% was for chemotherapy) and Int$ 10.06 million (of which 82% was for surgery), respectively. Approximately 80% of EBW-attributable costs were due to breast, endometrial and colorectal cancers. Conclusion A total of 1.76% of all federal cancer-related costs could be associated with EBW, representing a substantial economic burden for the public health system. We highlight the need for integrated policies for excess body weight control and cancer prevention.	[Ferreira da Silva, Ronaldo Correa; Malhao, Thaina Alves; Mendonca, Eliane De Paula; Maya Moreira, Luciana Grucci; Correa Schilithz, Arthur Orlando; Diogenes Melo, Maria Eduarda Leao] Brazilian Natl Canc Inst Jose Alencar Gomes da Si, Rio De Janeiro, Brazil; [Bahia, Luciana Ribeiro; Machado da Rosa, Michelle Quarti] Univ Estado Rio De Janeiro, Inst Hlth Technol Assessment, Rio De Janeiro, Brazil; [Rosa, Roger dos Santos] Univ Fed Rio Grande do Sul, Inst Hlth Technol Assessment, Social Med Dept, Porto Alegre, RS, Brazil; [Araujo, Denizar Vianna] Univ Estado Rio De Janeiro, Inst Hlth Technol Assessment, Internal Med Dept, Rio De Janeiro, Brazil; [Diogenes Melo, Maria Eduarda Leao] Univ Estado Rio De Janeiro, Nutr Inst, Dept Basic & Expt Nutr, Rio De Janeiro, Brazil; [Bahia, Luciana Ribeiro; Machado da Rosa, Michelle Quarti; Araujo, Denizar Vianna; Diogenes Melo, Maria Eduarda Leao] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil; [Rosa, Roger dos Santos] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil	Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio Grande do Sul; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio Grande do Sul	da Silva, RCF (corresponding author), Brazilian Natl Canc Inst Jose Alencar Gomes da Si, Rio De Janeiro, Brazil.	rsilva@inca.gov.br	Malhão, Thainá/AFT-9923-2022; Rosa, Roger/J-1395-2016	Diogenes, Maria Eduarda Leao/0000-0002-4134-5860; Correa Ferreira da Silva, Ronaldo/0000-0002-1017-2426; Rosa, Roger/0000-0002-7315-1200; Rosa, Michelle/0000-0002-3036-3991	Brazilian National Cancer Institute Jose Alencar Gomes da Silva - INCA (Institutional Development Program Research Grant); National Institute of Science and Technology for Health Technology Assessment - IATS (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [CNPq:465518/2014-1, FAPERGS:17/2551-0000515-5]	Brazilian National Cancer Institute Jose Alencar Gomes da Silva - INCA (Institutional Development Program Research Grant); National Institute of Science and Technology for Health Technology Assessment - IATS (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	The study was supported by Brazilian National Cancer Institute Jose Alencar Gomes da Silva - INCA (Institutional Development Program Research Grant) and National Institute of Science and Technology for Health Technology Assessment - IATS (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq:465518/2014-1 and FAPERGS:17/2551-0000515-5). INCA https://www.inca.gov.br/IATS https://iats.com.br/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2017, CANC ACT NETW COSTS; Arnold M, 2016, CANCER EPIDEMIOL, V41, P8, DOI 10.1016/j.canep.2016.01.003; Arnold M, 2015, LANCET ONCOL, V16, P36, DOI 10.1016/S1470-2045(14)71123-4; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Brenner DR, 2019, PREV MED, V122, P49, DOI 10.1016/j.ypmed.2019.03.014; Brenner DR, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022378; Casagrande DS, 2014, OBES SURG, V24, P1499, DOI 10.1007/s11695-014-1276-0; Economist Intelligence Unit (EIU), 2009, EC; Fitzmaurice C, 2018, JAMA ONCOL, V4, P1553, DOI 10.1001/jamaoncol.2018.2706; Flegal KM, 2015, ANN EPIDEMIOL, V25, P201, DOI 10.1016/j.annepidem.2014.11.010; Greenland S, 2004, INT J EPIDEMIOL, V33, P1389, DOI 10.1093/ije/dyh276; Instituto Nacional de Ca^ncer Jose Alencar Gomes da Silva, 2019, EST 2020 INC CANC BR; Islami F, 2018, CA-CANCER J CLIN, V68, P31, DOI 10.3322/caac.21440; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; Luo JH, 2019, JNCI CANCER SPECT, V3, DOI 10.1093/jncics/pkz054; de Rezende LFM, 2018, CANCER EPIDEMIOL, V54, P63, DOI 10.1016/j.canep.2018.03.006; Ministerio da Saude. Divisao de Vigilancia e Analise de Situacao Instituto Nacional de Cancer Jose Alencar Gomes da Silva, 2018, REG BAS POP; Ministerio da Saude. Instituto Nacional de Cancer Jose Alencar Gomes da Silva, 2018, SIST REG HOSP CANC I; Ministerio da Saude. Portal da Saude, 2008, INF SAUD; Ministerio da Saude. Secretaria de Vigilancia em Saude, 2019, VIG BRAS 2018 VIG FA; Piola SF, 2017, TEXTO DISCUSSAO; Prager GW, 2018, ESMO OPEN, V3, DOI 10.1136/esmoopen-2017-000285; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Renehan AG, 2010, INT J CANCER, V126, P692, DOI 10.1002/ijc.24803; Shah SC, 2019, J GLOB ONCOL, V5, DOI 10.1200/JGO.18.00200; Siqueira A., 2017, HLTH SCI J, V11, DOI [10.21767/1791-809X.1000514, DOI 10.21767/1791-809X.1000514]; Steenland K, 2004, AM J EPIDEMIOL, V160, P384, DOI 10.1093/aje/kwh211; Sung H, 2019, CA-CANCER J CLIN, V69, P88, DOI 10.3322/caac.21499; The Union for International Cancer Control (UICC), 2014, WORLD CANC LEAD SUMM; Valentino L, 2022, RSF-RUS SAGE J SOC S, V8, P89, DOI [10.18311/ti/2021/v28i1/24809, 10.1097/QAD.0000000000003368, 10.1016/j.vaccine.2022.07.056, 10.7758/RSF.2022.8.7.05]; Whiteman DC, 2016, CANCER EPIDEMIOL, V44, P203, DOI 10.1016/j.canep.2016.06.013; Wild C.P., 2020, WORLD CANC REPORT 20; World Bank, 2017, INT COMP PROGR DAT G; World Cancer Research Fund/American Institute for Cancer Research, 2018, CONT UPD PROJ EXP RE; World Cancer Research Fund/American Institute for Cancer Research, 2013, SYST LIT REV ASS FOO; World Cancer Research Fund/American Institute for Cancer Research, 2014, SYST LIT REV ASS FOO; World Cancer Research Fund American Institute for Cancer Research Continuous Update Project, 2017, DIET NUTR PHYS ACT C; World Health Organization, 2004, ICD 10 INT STAT CLAS, DOI 10/2016/en#/II	40	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0247983	10.1371/journal.pone.0247983	http://dx.doi.org/10.1371/journal.pone.0247983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705455	Green Published, gold			2022-12-26	WOS:000629590400007
J	Thompson, JMD; Slykerman, RF; Wall, CR; Murphy, R; Mitchell, EA; Waldie, KE				Thompson, John M. D.; Slykerman, Rebecca F.; Wall, Clare R.; Murphy, Rinki; Mitchell, Edwin A.; Waldie, Karen E.			Factor structure of the SDQ and longitudinal associations from pre-school to pre-teen in New Zealand	PLOS ONE			English	Article								Objective The objective of this study was to assess the validity of the Strengths and Difficulties Questionnaire in a cohort of New Zealand children followed from birth to the age of eleven. The study also aimed to assess the stability of the child data in relation to behavioural outcomes during this period. Methods Children in the Auckland Birthweight Collaborative Study were assessed at approximately 31/2, 7 and 11 years of age. At all time-points parents completed the parent version of the Strengths and Difficulties Questionnaire, and the children themselves completed the self-report version at 11 years of age. The validity and internal consistency were assessed using exploratory factor analysis, Cronbach's alpha, and McDonald's Omega. Cross tabulations and Chi-square statistics were used to determine whether Total Difficulty scores, as per accepted cut-offs, remained stable over time (between normal and abnormal/borderline categories). Results The factor structure remained relatively consistent across all three time-points, though several questions did not load as per the originally published factor analysis at the earliest age. The internal consistency of the Strengths and Difficulties Questionnaire was good at all time-points and for parent- and child-completed versions. There was low agreement in the total scores between time points. Conclusions The factor analysis shows that the Strengths and Difficulties Questionnaire has a similar factor structure, particularly in older ages, to that previously published and shows good internal consistency. At the pre-school follow up, a larger than expected proportion of children were identified with high scores, particularly in the conduct sub-scale. Children's behaviour changes over time, with only poor to moderate agreement between those identified as abnormal or borderline over the longitudinal follow up.	[Thompson, John M. D.; Mitchell, Edwin A.] Univ Auckland, Fac Med & Hlth Sci, Dept Paediat Child & Youth Hlth, Auckland, New Zealand; [Thompson, John M. D.] Univ Auckland, Fac Med & Hlth Sci, Dept Obstet & Gynaecol, Auckland, New Zealand; [Slykerman, Rebecca F.] Univ Auckland, Fac Med & Hlth Sci, Dept Psychol Med, Auckland, New Zealand; [Wall, Clare R.] Univ Auckland, Fac Med & Hlth Sci, Discipline Nutr, Auckland, New Zealand; [Murphy, Rinki] Univ Auckland, Fac Med & Hlth Sci, Dept Med, Auckland, New Zealand; [Waldie, Karen E.] Univ Auckland, Fac Sci, Sch Psychol, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Auckland; University of Auckland; University of Auckland	Thompson, JMD (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Paediat Child & Youth Hlth, Auckland, New Zealand.; Thompson, JMD (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Obstet & Gynaecol, Auckland, New Zealand.	j.thompson@auckland.ac.nz		Thompson, John/0000-0001-6944-381X; Slykerman, Rebecca/0000-0003-4942-8887	Health Research Council of New Zealand; Cure Kids; Becroft Foundation; Auckland Medical Research Foundation; Hawkes Bay Medical Research Foundation; Heart Foundation; Cure Kids (New Zealand)	Health Research Council of New Zealand(Health Research Council of New Zealand); Cure Kids; Becroft Foundation; Auckland Medical Research Foundation; Hawkes Bay Medical Research Foundation; Heart Foundation; Cure Kids (New Zealand)	The initial study at birth was funded by the Health Research Council of New Zealand. The 3.5-year follow-up was funded by the Child Health Research Foundation (now Cure Kids), Becroft Foundation, and Auckland Medical Research Foundation. The 7-year follow-up was funded by the Child Health Research Foundation (now Cure Kids) and the Hawkes Bay Medical Research Foundation. The 11-year follow-up was funded by Cure Kids and the Heart Foundation. E. M. and J. T. were supported by Cure Kids (New Zealand) during the conduct of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 2008, J CHILD PSYCHOL PSYC, V49, P251, DOI 10.1111/j.1469-7610.2007.01867.x; [Anonymous], 2014, AM PSYCHOL ASS NATL; Becker A, 2015, EUR CHILD ADOLES PSY, V24, P715, DOI 10.1007/s00787-014-0640-x; Caci H, 2015, EUR CHILD ADOLES PSY, V24, P1291, DOI 10.1007/s00787-015-0679-3; Cornforth CM, 2007, BEHAVIOURAL PROBLEMS; Costa PA, 2020, CLIN CHILD PSYCHOL P, V25, P520, DOI 10.1177/1359104519891759; D'Souza S, 2017, J ABNORM CHILD PSYCH, V45, P345, DOI 10.1007/s10802-016-0176-2; Goodman A, 2009, J AM ACAD CHILD PSY, V48, P400, DOI 10.1097/CHI.0b013e3181985068; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Goodman R., 2014, ZUGRIFF AM, V17; Guo MC, 2018, ASSESSMENT, V25, P1056, DOI 10.1177/1073191116681493; Hawes DJ, 2004, AUST NZ J PSYCHIAT, V38, P644, DOI 10.1111/j.1440-1614.2004.01427.x; Hayes AF, 2020, COMMUN METHODS MEAS, V14, P1, DOI 10.1080/19312458.2020.1718629; Keilow M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220193; Kersten P., 2014, VALIDATION NORMING S; Kersten P, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021551; Klasen H, 2003, PRAX KINDERPSYCHOL K, V52, P491; Klein AM, 2013, EUR J PSYCHOL ASSESS, V29, P96, DOI 10.1027/1015-5759/a000129; Muris P, 2003, EUR CHILD ADOLES PSY, V12, P1, DOI 10.1007/s00787-003-0298-2; Obel C, 2004, EUR CHILD ADOLES PSY, V13, P32, DOI 10.1007/s00787-004-2006-2; Ortuno-Sierra J, 2018, PSYCHIAT RES, V259, P236, DOI 10.1016/j.psychres.2017.10.025; Ortuno-Sierra J, 2015, INT J CLIN HLTH PSYC, V15, P265, DOI 10.1016/j.ijchp.2015.05.005; Ruchkin V, 2007, J CLIN PSYCHOL, V63, P861, DOI 10.1002/jclp.20401; Sagatun A, 2008, SOC PSYCH PSYCH EPID, V43, P87, DOI 10.1007/s00127-007-0275-z; Smedje H, 1999, EUR CHILD ADOLES PSY, V8, P63, DOI 10.1007/s007870050086; Stone LL, 2010, CLIN CHILD FAM PSYCH, V13, P254, DOI 10.1007/s10567-010-0071-2; Thompson JMD, 2001, J PAEDIATR CHILD H, V37, P369, DOI 10.1046/j.1440-1754.2001.00684.x; van Widenfelt BM, 2003, EUR CHILD ADOLES PSY, V12, P281, DOI 10.1007/s00787-003-0341-3	29	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0247932	10.1371/journal.pone.0247932	http://dx.doi.org/10.1371/journal.pone.0247932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8JZ	33705464	gold, Green Published			2022-12-26	WOS:000629590400088
J	Al-Saleh, K; Salah, T; Arafah, M; Husain, S; Al-Rikabi, A; Abd El-Aziz, N				Al-Saleh, Khalid; Salah, Tareq; Arafah, Maria; Husain, Sufia; Al-Rikabi, Ammar; Abd El-Aziz, Nashwa			Prognostic significance of estrogen, progesterone and HER2 receptors' status conversion following neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from a tertiary Cancer Center in Saudi Arabia	PLOS ONE			English	Article								Background The prognostic impact of neoadjuvant chemotherapy (NAC) on the receptor expression status in patients with locally advanced breast cancer (LABC) is still not fully understood. We aimed to evaluate the changes in hormone (estrogen and progesterone) receptor (HR) and human epidermal growth factor receptor 2 (HER2) status post-NAC and their correlation with survival. Methods Patients with LABC who have received NAC between 2008 and 2015 and have been followed up till December 2019 at the Oncology Center, King Saud University, KSA were analyzed retrospectively. biomarker analysis of ER, PR & HER2 were done using immunohistochemistry (IHC) and Fluorescent in situ hybridization. Results Ninety-one patients fulfilled the inclusion criteria. HR status changed in 21(23.1%) patients, with a significant difference between patients with stable receptors and those with any receptor conversion; p = 0.000. Five (5.5%) initially HER2 negative tumors became HER2 positive and 10 (11%) initially HER2 positive tumors became HER2 negative after NAC. The difference in HER2 expression level before and after NAC was not statistically significant (p = 0.302). Univariate analysis relating patients' characteristics and 10-years disease-free survival (DFS) showed only significant correlations with the expressions of ER, PR, and any receptor conversion, (ER and/or PR) p< 0.001, p< 0.001, and p = 0.001; respectively. In the univariate analysis, none of the clinicopathological features showed a significant correlation with the OS except for the molecular subtypes PConclusions Patients with LABC have significant changes in the ER and PR receptor status following NAC. Post-NAC expressions change of ER and PR (ER and/or PR) are correlated to DFS. Retesting of the hormone receptors should be considered after NAC in Saudi patients with LABC.	[Al-Saleh, Khalid; Abd El-Aziz, Nashwa] King Saud Univ, Coll Med, Dept Med, Div Hematol Oncol, Riyadh, Saudi Arabia; [Salah, Tareq] King Saud Univ, Oncol Ctr, Div Radiat Oncol, Riyadh, Saudi Arabia; [Salah, Tareq] Assiut Univ, Fac Med, Dept Clin Oncol & Nucl Med, Assiut, Egypt; [Arafah, Maria; Husain, Sufia; Al-Rikabi, Ammar] King Saud Univ, Coll Med, Dept Pathol, Riyadh, Saudi Arabia; [Abd El-Aziz, Nashwa] Assiut Univ, South Egypt Canc Inst, Dept Med Oncol, Assiut, Egypt	King Saud University; King Saud University; Egyptian Knowledge Bank (EKB); Assiut University; King Saud University; Egyptian Knowledge Bank (EKB); Assiut University	Abd El-Aziz, N (corresponding author), King Saud Univ, Coll Med, Dept Med, Div Hematol Oncol, Riyadh, Saudi Arabia.; Abd El-Aziz, N (corresponding author), Assiut Univ, South Egypt Canc Inst, Dept Med Oncol, Assiut, Egypt.	nashwa.abdelaziz888@gmail.com	Husain, Sufia/GZM-5798-2022	Arafah, Maria/0000-0002-6847-5884; ABDELAZIZ, NASHWA/0000-0002-1701-9248	College of Medicine Research Center, Deanship of Scientific Research, King Saud University	College of Medicine Research Center, Deanship of Scientific Research, King Saud University	The authors would like to acknowledge the support they received from the College of Medicine Research Center, Deanship of Scientific Research, King Saud University, as well as the technician team of the Department of Pathology, College of Medicine, King Saud University.	Adams AL, 2008, BREAST J, V14, P141, DOI 10.1111/j.1524-4741.2007.00544.x; Al-Rikabi A, 2012, CROAT MED J, V53, P239, DOI 10.3325/cmj.2012.53.239; Al-Saleh K, 2017, ONCOL LETT, V14, P337, DOI 10.3892/ol.2017.6144; Alghamdi IG, 2013, BREAST CANCER-TARGET, V5, P103, DOI 10.2147/BCTT.S50750; Allison KH, 2020, ARCH PATHOL LAB MED, V144, P545, DOI 10.5858/arpa.2019-0904-SA; Arens N, 2005, VIRCHOWS ARCH, V446, P489, DOI 10.1007/s00428-005-1244-0; Bartlett JMS, 2011, J CLIN ONCOL, V29, P1531, DOI 10.1200/JCO.2010.30.3677; Bertos NR, 2011, J CLIN INVEST, V121, P3789, DOI 10.1172/JCI57100; Bines J, 1996, J CLIN ONCOL, V14, P1718, DOI 10.1200/JCO.1996.14.5.1718; Buchholz TA, 2002, CANCER J, V8, P461, DOI 10.1097/00130404-200211000-00010; Burcombe RJ, 2005, BRIT J CANCER, V92, P147, DOI 10.1038/sj.bjc.6602256; Caudle AS, 2010, J CLIN ONCOL, V28, P1821, DOI 10.1200/JCO.2009.25.3286; Chang J, 2003, CANCER-AM CANCER SOC, V97, P545, DOI 10.1002/cncr.11083; Chen S, 2012, ANN SURG ONCOL, V19, P3002, DOI 10.1245/s10434-012-2318-2; Chollet P, 2002, BRIT J CANCER, V86, P1041, DOI 10.1038/sj/bjc/6600210; Jin X, 2015, ONCOTARGET, V6, P9600, DOI 10.18632/oncotarget.3292; Kasami M, 2008, BREAST, V17, P523, DOI 10.1016/j.breast.2008.04.002; Mauri D, 2005, JNCI-J NATL CANCER I, V97, P188, DOI 10.1093/jnci/dji021; Ozmen V., 2015, CANC TREATMENT COMMU, V4, P89, DOI [10.1016/j.ctrc.2015.07.001, DOI 10.1016/J.CTRC.2015.07.001]; Parinyanitikul N, 2015, CLIN BREAST CANCER, V15, P153, DOI 10.1016/j.clbc.2014.09.006; Quddus Ruhul M, 2005, Breast Cancer, V12, P294; Razavi P, 2018, CANCER CELL, V34, P427, DOI 10.1016/j.ccell.2018.08.008; ROSE DP, 1980, CANCER RES, V40, P4043; Tacca O, 2007, ONCOLOGIST, V12, P636, DOI 10.1634/theoncologist.12-6-636; Tan MC, 2009, AM J SURG, V198, P520, DOI 10.1016/j.amjsurg.2009.06.004; Tan QX, 2014, INT J CLIN EXP PATHO, V7, P4086; van de Ven S, 2011, CANCER TREAT REV, V37, P422, DOI 10.1016/j.ctrv.2010.11.006; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yang LB, 2018, WORLD J SURG ONCOL, V16, DOI 10.1186/s12957-018-1332-7; Yoshida A, 2017, J SURG ONCOL, V116, P1021, DOI 10.1002/jso.24762; Zattarin E, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9122644; Zhang N, 2011, CANCER INVEST, V29, P594, DOI 10.3109/07357907.2011.621913	32	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0247802	10.1371/journal.pone.0247802	http://dx.doi.org/10.1371/journal.pone.0247802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667252	Green Published, gold			2022-12-26	WOS:000626604300033
J	Jansen, PM; Abdelbary, MMH; Conrads, G				Jansen, Paul Mathias; Abdelbary, Mohamed M. H.; Conrads, Georg			A concerted probiotic activity to inhibit periodontitis-associated bacteria	PLOS ONE			English	Article							REUTERI-CONTAINING TABLETS; PERI-IMPLANT MUCOSITIS; LACTOBACILLUS-REUTERI; ORAL PROBIOTICS; DOUBLE-BLIND; GLYCEROL; HEALTH; CHILDREN; PCR; M18	Periodontitis can result in tooth loss and the associated chronic inflammation can provoke several severe systemic health risks. Adjunctive to mechanical treatment of periodontitis and as alternatives to antibiotics, the use of probiotic bacteria was suggested. In this study, the inhibitory effect of the probiotic Streptococcus salivarius subsp. salivarius strains M18 and K12, Streptococcus oralis subsp. dentisani 7746, and Lactobacillus reuteri ATCC PTA 5289 on anaerobic periodontal bacteria and Aggregatibacter actinomycetemcomitans was tested. Rarely included in other studies, we also quantified the inverse effect of pathogens on probiotic growth. Probiotics and periodontal pathogens were co-incubated anaerobically in a mixture of autoclaved saliva and brain heart infusion broth. The resulting genome numbers of the pathogens and of the probiotics were measured by quantitative real-time PCR. Mixtures of the streptococcal probiotics were also used to determine their synergistic, additive, or antagonistic effects. The overall best inhibitor of the periodontal pathogens was L. reuteri ATCC PTA 5289, but the effect is coenzyme B12-, anaerobiosis-, as well as glycerol-dependent, and further modulated by L. reuteri strain DSM 17938. Notably, in absence of glycerol, the pathogen-inhibitory effect could even turn into a growth spurt. Among the streptococci tested, S. salivarius M18 had the most constant inhibitory potential against all pathogens, followed by K12 and S. dentisani 7746, with the latter still having significant inhibitory effects on P. intermedia and A. actinomycetemcomitans. Overall, mixtures of the streptococcal probiotics did inhibit the growth of the pathogens equally or-in the case of A. actinomycetemcomitans- better than the individual strains. P. gingivalis and F. nucleatum were best inhibited by pure cultures of S. salivarius K12 or S. salivarius M18, respectively. Testing inverse effects, the growth of S. salivarius M18 was enhanced when incubated with the periodontal pathogens minus/plus other probiotics. In contrast, S. oralis subsp. dentisani 7746 was not much influenced by the pathogens. Instead, it was significantly inhibited by the presence of other streptococcal probiotics. In conclusion, despite some natural limits such as persistence, the full potential for probiotic treatment is by far not utilized yet. Especially, further exploring concerted activity by combining synergistic strains, together with the application of oral prebiotics and essential supplements and conditions, is mandatory.	[Jansen, Paul Mathias; Abdelbary, Mohamed M. H.; Conrads, Georg] Rhein Westfalische TH RWTH Aachen Univ Hosp, Dept Operat Dent Periodontol & Prevent Dent, Div Oral Microbiol & Immunol, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital	Conrads, G (corresponding author), Rhein Westfalische TH RWTH Aachen Univ Hosp, Dept Operat Dent Periodontol & Prevent Dent, Div Oral Microbiol & Immunol, Aachen, Germany.	gconrads@ukaachen.de		Jansen, Paul Mathias/0000-0001-8570-2754; Abdelbary, Mohamed/0000-0001-8569-0319; Conrads, Georg/0000-0003-2577-5294				Adam E., 2011, STREPTOCOCCUS SALIVA; Badet C, 2008, Open Microbiol J, V2, P38, DOI 10.2174/1874285800802010038; Burton JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065991; Burton JP, 2013, J MED MICROBIOL, V62, P875, DOI 10.1099/jmm.0.056663-0; Caglar E, 2009, INT J PAEDIATR DENT, V19, P377, DOI 10.1111/j.1365-263X.2009.00989.x; Castiblanco GA, 2017, PROBIOTICS ANTIMICRO, V9, P278, DOI 10.1007/s12602-016-9246-6; Conrads G, 1997, J ENDODONT, V23, P433, DOI 10.1016/S0099-2399(97)80297-X; Conrads G, 1996, J PERIODONTOL, V67, P994, DOI 10.1902/jop.1996.67.10.994; Conrads G, 1999, J CLIN MICROBIOL, V37, P1621, DOI 10.1128/JCM.37.5.1621-1624.1999; Conrads G, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00110; Di Pierro F, 2015, CLIN COSMET INVESTIG, V7, P107, DOI 10.2147/CCIDE.S93066; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Esteban-Fernandez A, 2019, J PERIODONTOL, V90, P1346, DOI 10.1002/JPER.18-0751; Flichy-Fernandez AJ, 2015, J PERIODONTAL RES, V50, P775, DOI 10.1111/jre.12264; Galofre M, 2018, J PERIODONTAL RES, V53, P378, DOI 10.1111/jre.12523; Gobbi E, 2020, EUR ARCH PAEDIATR DE, V21, P673, DOI 10.1007/s40368-020-00512-2; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Hallstrom H, 2016, ACTA ODONTOL SCAND, V74, P60, DOI 10.3109/00016357.2015.1040065; He BK, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01680; Horz HP, 2007, ORAL MICROBIOL IMMUN, V22, P126, DOI 10.1111/j.1399-302X.2007.00334.x; Hou CL, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0014-3; Hyink O, 2007, APPL ENVIRON MICROB, V73, P1107, DOI 10.1128/AEM.02265-06; Ince G, 2015, J PERIODONTOL, V86, P746, DOI 10.1902/jop.2015.140612; Iniesta M, 2012, J CLIN PERIODONTOL, V39, P736, DOI 10.1111/j.1600-051X.2012.01914.x; Jiang W, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0473-6; Kinane DF, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.38; Laleman I, 2020, J CLIN PERIODONTOL, V47, P43, DOI 10.1111/jcpe.13198; Lee HJ, 2009, PROBIOTICS ANTIMICRO, V1, P113, DOI 10.1007/s12602-009-9019-6; Liu FX, 2015, APPL MICROBIOL BIOT, V99, P4659, DOI 10.1007/s00253-015-6530-4; Lopez-Lopez A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00379; Luthi-Peng Q, 2002, APPL MICROBIOL BIOT, V59, P289, DOI 10.1007/s00253-002-1002-z; Matsubara VH, 2016, EXPERT REV ANTI-INFE, V14, P643, DOI 10.1080/14787210.2016.1194198; Moon Yun-Mi, 2016, International Journal of Clinical Preventive Dentistry, V12, P209; Mu QH, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00757; Mutha NVR, 2018, MOL ORAL MICROBIOL, V33, P450, DOI 10.1111/omi.12248; ORRELL DH, 1972, J CLIN PATHOL, V25, P181, DOI 10.1136/jcp.25.2.181; Patro-Golab B, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112762; Pelekos G, 2019, J CLIN PERIODONTOL, V46, P1217, DOI 10.1111/jcpe.13191; Pena M, 2019, CLIN ORAL INVEST, V23, P1673, DOI 10.1007/s00784-018-2578-8; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Sabatini S, 2017, J BIOL REG HOMEOS AG, V31, P197; Schaefer L, 2010, MICROBIOL-SGM, V156, P1589, DOI 10.1099/mic.0.035642-0; Soares LG, 2019, AM J DENT, V32, P9; TALARICO TL, 1989, ANTIMICROB AGENTS CH, V33, P674, DOI 10.1128/AAC.33.5.674; TALARICO TL, 1990, APPL ENVIRON MICROB, V56, P943, DOI 10.1128/AEM.56.4.943-948.1990; Teughels W, 2013, J CLIN PERIODONTOL, V40, P1025, DOI 10.1111/jcpe.12155; Vestman NR, 2013, CARIES RES, V47, P338, DOI 10.1159/000347233; Vicario M, 2013, ACTA ODONTOL SCAND, V71, P813, DOI 10.3109/00016357.2012.734404; Vivekananda M R, 2010, J Oral Microbiol, V2, DOI 10.3402/jom.v2i0.5344; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wescombe PA, 2012, FUTURE MICROBIOL, V7, P1355, DOI [10.2217/FMB.12.113, 10.2217/fmb.12.113]	51	5	5	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0248308	10.1371/journal.pone.0248308	http://dx.doi.org/10.1371/journal.pone.0248308			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667279	gold, Green Published			2022-12-26	WOS:000626604300050
J	Li, JQ; Li, Y				Li, Juanqi; Li, Yang			Suitable illumination intensity is essential for preserving the quality of cucumber (Cucumis sativus L.) seedlings during storage	PLOS ONE			English	Article							LOW-TEMPERATURE STORAGE; CABBAGE PLUG SEEDLINGS; CHLOROPLAST-ULTRASTRUCTURE	Continuous darkness decreases seedling quality during storage, whereas appropriate light quality and intensity can overcome these negative effects. In this study, we determined the light intensity, storage time (ST), and storage temperature suitable for cucumber (Cucumis sativa L.) seedlings. We stored cucumber seedlings under four different photosynthetic photon flux densities (PPFDs; 0, 15, 30, and 45 mu mol center dot m(-2)center dot s(-1)) at 12 degrees C, and examined how the morphological, physiological, and photosynthetic changes in seedlings during storage affected their ability to recover after transplanting. Our results indicated that at least 15 mu mol center dot m(-2)center dot s(-1) PPFD was needed for cucumber seedlings stored in the dark for 2 or 4 d, and at least 30 mu mol center dot m(-2)center dot s(-1) PPFD was needed when the ST was extended to 6 d. Overall, our results showed that cucumber seedlings require light-emitting diode (LED) illumination during storage to maintain their quality and recovery ability.	[Li, Juanqi; Li, Yang] Henan Agr Univ, Coll Hort, Zhengzhou, Peoples R China	Henan Agricultural University	Li, Y (corresponding author), Henan Agr Univ, Coll Hort, Zhengzhou, Peoples R China.	lyrip@126.com			National Natural Science Foundation of China [31902096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (31902096).YL conceived and designed the experiments;YL wrote the manuscript.	BAKA Z A M, 1991, Beitraege zur Biologie der Pflanzen, V66, P271; Cheng L., 2010, NO HORTICULTURE, V15, P156; Duan QQ, 2014, HORTSCIENCE, V49, P881, DOI 10.21273/HORTSCI.49.7.881; FAO, 2020, FAOSTAT DOM PROD CRO; Fischer Andreas M., 2007, V26, P87; Hunt R., 1982, PLANT GROWTH ANAL, V4; Jiang W, 2012, SCI HORTIC-AMSTERDAM, V148, P23, DOI 10.1016/j.scienta.2012.09.016; KACZPERSKI MP, 1992, HORTSCIENCE, V27, P798, DOI 10.21273/HORTSCI.27.7.798; KUBOTA C, 1995, SCI HORTIC-AMSTERDAM, V61, P193, DOI 10.1016/0304-4238(94)00717-T; Kubota C, 2002, SCI HORTIC-AMSTERDAM, V94, P13, DOI 10.1016/S0304-4238(01)00382-X; KUBOTA C, 1994, HORTSCIENCE, V29, P1191, DOI 10.21273/HORTSCI.29.10.1191; Kubota C, 1997, POSTHARVEST BIOL TEC, V12, P165, DOI 10.1016/S0925-5214(97)00047-1; Kubota C, 2006, HORTSCIENCE, V41, P1640, DOI 10.21273/HORTSCI.41.7.1640; Li HS, 1998, PRINCIPLES TECHNIQUE; LICHTENTHALER HK, 1982, Z NATURFORSCH C, V37, P464; Liu XY, 2011, HORTSCIENCE, V46, P217, DOI 10.21273/HORTSCI.46.2.217; Maimaitituxun Rouzi, 2011, China Vegetables, P39; Ning Wei, 2006, China Vegetables, P12; [宁伟 NING Wei], 2006, [沈阳农业大学学报, Journal of Shenyang Agricultural University], V37, P291; ROSEN BH, 1984, J PHYCOL, V20, P173, DOI 10.1111/j.0022-3646.1984.00173.x; SARTORY DP, 1984, HYDROBIOLOGIA, V114, P177, DOI 10.1007/BF00031869; Sato F, 2004, SCI HORTIC-AMSTERDAM, V101, P349, DOI 10.1016/j.scienta.2003.11.018; Sato F, 2014, J HORTIC SCI BIOTECH, V89, P179, DOI 10.1080/14620316.2014.11513066; Toivonen PMA, 1998, J AGR FOOD CHEM, V46, P20, DOI 10.1021/jf970490n; Wang Shuai, 2016, Horticultural Plant Journal, V2, P82, DOI 10.1016/j.hpj.2016.03.001; Wang YJ., 1998, ACTA HORTIC, V02, P96; Xia HanYan, 2008, Journal of Shanghai Jiaotong University - Agricultural Science, V26, P1; Yamazaki K, 1982, YOEKI SAIBAI ZENPEN; Zhu HS., 2003, ACTA AGRIC UNIV JIAN, V25, P10; ZHUANG H, 1995, J AGR FOOD CHEM, V43, P2585, DOI 10.1021/jf00058a006	30	0	0	7	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0247882	10.1371/journal.pone.0247882	http://dx.doi.org/10.1371/journal.pone.0247882			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667261	gold, Green Published			2022-12-26	WOS:000626604300036
J	Bamford, CCG; Warwick-Evans, V; Staniland, IJ; Jackson, JA; Trathan, PN				Bamford, Connor C. G.; Warwick-Evans, Victoria; Staniland, Iain J.; Jackson, Jennifer A.; Trathan, Philip N.			Wintertime overlaps between female Antarctic fur seals (Arctocephalus gazella) and the krill fishery at South Georgia, South Atlantic	PLOS ONE			English	Article								The diet of Antarctic fur seals (Arctocephalus gazella) at South Georgia is dominated by Antarctic krill (Euphausia superba). During the breeding season, foraging trips by lactating female fur seals are constrained by their need to return to land to provision their pups. Post-breeding, seals disperse in order to feed and recover condition; estimates indicate c.70% of females remain near to South Georgia, whilst others head west towards the Patagonian Shelf or south to the ice-edge. The krill fishery at South Georgia operates only during the winter, providing the potential for fur seal: fishery interaction during these months. Here we use available winter (May to September) tracking data from Platform Terminal Transmitter (PTT) tags deployed on female fur seals at Bird Island, South Georgia. We develop habitat models describing their distribution during the winters of 1999 and 2003 with the aim of visualising and quantifying the degree of spatial overlap between female fur seals and krill harvesting in South Georgia waters. We show that spatial distribution of fur seals around South Georgia is extensive, and that the krill fishery overlaps with small, highly localised areas of available fur seal habitat. From these findings we discuss the implications for management, and future work.	[Bamford, Connor C. G.; Warwick-Evans, Victoria; Staniland, Iain J.; Jackson, Jennifer A.; Trathan, Philip N.] British Antarctic Survey, Cambridge, England; [Bamford, Connor C. G.] Univ Southampton, Southampton, Hants, England; [Staniland, Iain J.] Int Whaling Commiss, Cambridge, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Southampton	Bamford, CCG (corresponding author), British Antarctic Survey, Cambridge, England.; Bamford, CCG (corresponding author), Univ Southampton, Southampton, Hants, England.	connord48@bas.ac.uk		Bamford, Connor/0000-0002-5732-7237	SPITFIRE NERC DTP [NE/L002531/1]	SPITFIRE NERC DTP	CCGB is funded by the SPITFIRE NERC DTP (Grant number NE/L002531/1).	Aarts G, 2008, ECOGRAPHY, V31, P140, DOI 10.1111/j.2007.0906-7590.05236.x; Argos, 2016, ARGOS USERS MANUAL W; Arnould JPY, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P1079; Arthur B, 2018, ECOL INDIC, V91, P338, DOI 10.1016/j.ecolind.2018.04.019; Arthur B, 2017, DEEP-SEA RES PT II, V140, P171, DOI 10.1016/j.dsr2.2016.10.009; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Atkinson A, 2019, NAT CLIM CHANGE, V9, P142, DOI 10.1038/s41558-018-0370-z; Basberg B., 2008, 19 CENTURY ANTARCTIC; Boyd IL, 2002, MAR ECOL PROG SER, V242, P285, DOI 10.3354/meps242285; Boyd IL, 2002, J APPL ECOL, V39, P103, DOI 10.1046/j.1365-2664.2002.00697.x; BOYD IL, 1993, ANTARCT SCI, V5, P17, DOI 10.1017/S0954102093000045; Boyd IL, 1998, CAN J FISH AQUAT SCI, V55, P845, DOI 10.1139/cjfas-55-4-845; Breheny P, 2017, R J, V9, P56, DOI 10.32614/RJ-2017-046; Brierley A.S., 1999, CCAMLR Science, V6, P47; CCAMLR, 23 M SCI COMM; CCAMLR, 2018, KRILL FISH REP 2018; Chown SL, 2019, ANNU REV ENV RESOUR, V44, P1, DOI 10.1146/annurev-environ-101718-033236; Cox MJ, 2011, ICES J MAR SCI, V68, P489, DOI 10.1093/icesjms/fsq202; Croxall J.P., 1979, Polar Record, V19, P573; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Forcada J, 2005, ECOLOGY, V86, P2408, DOI 10.1890/04-1153; Forcada J., 2009, ENCY MARINE MAMMALS; Forcada J, 2008, GLOBAL CHANGE BIOL, V14, P2473, DOI 10.1111/j.1365-2486.2008.01678.x; Forcada J, 2014, NATURE, V511, P462, DOI 10.1038/nature13542; Freitas C., 2012, ARGOSFILTER ARGOS LO; Gentry R. L., 1982, EQUIPMENT TECHNIQUES; Grant SM, 2001, POPULATION INCREASE; Hays GC, 2019, TRENDS ECOL EVOL, V34, P459, DOI 10.1016/j.tree.2019.01.009; Hindell MA, 2020, NATURE, V580, P87, DOI 10.1038/s41586-020-2126-y; Hoffman JI, 2011, MOL ECOL, V20, P3989, DOI 10.1111/j.1365-294X.2011.05248.x; Hunt GL, 2016, PROG OCEANOGR, V149, P40, DOI 10.1016/j.pocean.2016.10.004; Islands GoSGaSS, 2019, S GEORG S SANDW ISL; Johnson D, 2018, ZENODO; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Jones KA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59992-3; Kawaguchi S, 2007, ANTARCT SCI, V19, P219, DOI 10.1017/S0954102007000296; Kock KH, 2007, PHILOS T R SOC B, V362, P2333, DOI 10.1098/rstb.2006.1954; Korb RE, 2005, J MARINE SYST, V57, P231, DOI 10.1016/j.jmarsys.2005.04.009; Korb RE, 2004, DEEP-SEA RES PT I, V51, P721, DOI 10.1016/j.dsr.2004.02.006; McCafferty DJ, 1998, MAR ECOL PROG SER, V166, P285, DOI 10.3354/meps166285; Mendelssohn R., RERDDAPXTRACTO EXTRA; Meredith MP, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018039; Murphy EJ, 2007, PHILOS T R SOC B, V362, P113, DOI 10.1098/rstb.2006.1957; Murphy EJ, 1998, FISH OCEANOGR, V7, P381, DOI 10.1046/j.1365-2419.1998.00081.x; Murphy EJ, 2007, P ROY SOC B-BIOL SCI, V274, P3057, DOI 10.1098/rspb.2007.1180; Naimi B, 2014, ECOGRAPHY, V37, P191, DOI 10.1111/j.1600-0587.2013.00205.x; Nicol S, 2012, FISH FISH, V13, P30, DOI 10.1111/j.1467-2979.2011.00406.x; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; PAYNE MR, 1977, PHILOS T ROY SOC B, V279, P67, DOI 10.1098/rstb.1977.0072; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Peterson RG, 1998, J GEOPHYS RES-OCEANS, V103, P24573, DOI 10.1029/98JC01947; Pirotta E, 2018, AQUAT CONSERV, V28, P713, DOI 10.1002/aqc.2892; Raymond B, 2015, ECOGRAPHY, V38, P121, DOI 10.1111/ecog.01021; Reid K, 1996, POLAR BIOL, V16, P105, DOI 10.1007/BF02390431; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; SC-CAMLR-XXXVII/03, 2018, REPORT WORKING GROUP; Siegel V, 2013, DEEP-SEA RES PT I, V77, P63, DOI 10.1016/j.dsr.2013.02.005; Staniland IJ, 2007, MAR BIOL, V152, P233, DOI 10.1007/s00227-007-0698-9; Staniland IJ, 2011, MAR ECOL PROG SER, V434, P183, DOI 10.3354/meps09201; Staniland IJ, 2012, MAR BIOL, V159, P291, DOI 10.1007/s00227-011-1807-3; Trathan P., 1998, CCAMLR SCI, V5, P9; Trathan P, 2020, ICES J MAR SCI; Trathan PN, 2006, CONSERV BIOL SER, P28, DOI 10.1017/CBO9780511541964.004; Trathan PN, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2392; Trathan PN, 2014, ADV MAR BIOL, V69, P15, DOI 10.1016/B978-0-12-800214-8.00002-5; Trathan PN, 2000, GEOPHYS RES LETT, V27, P1727, DOI 10.1029/1999GL011131; Trathan PN, 2003, FISH OCEANOGR, V12, P569, DOI 10.1046/j.1365-2419.2003.00268.x; TRATHAN PN, 1995, NATURE, V373, P201, DOI 10.1038/373201b0; Venables WN., 2002, MODERN APPL STAT S 4; Warwick-Evans V, 2018, DIVERS DISTRIB, V24, P1756, DOI 10.1111/ddi.12817; Weatherall P, 2015, EARTH SPACE SCI, V2, P331, DOI 10.1002/2015EA000107; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Young EF, 2014, J GEOPHYS RES-OCEANS, V119, P241, DOI 10.1002/2013JC009348	74	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0248071	10.1371/journal.pone.0248071	http://dx.doi.org/10.1371/journal.pone.0248071			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33662029	Green Published, gold, Green Accepted			2022-12-26	WOS:000626604100075
J	Cui, M; Alhamshari, Y; Cantwell, L; El-Haou, S; Eptaminitaki, GC; Chang, MM; Abou-Assali, O; Tan, HZ; Xu, KM; Masotti, M; Plant, LD; Thakur, GA; Noujaim, SF; Milnes, J; Logothetis, DE				Cui, Meng; Alhamshari, Yaser; Cantwell, Lucas; El-Haou, Said; Eptaminitaki, Giasemi C.; Chang, Mengmeng; Abou-Assali, Obada; Tan, Haozhou; Xu, Keman; Masotti, Meghan; Plant, Leigh D.; Thakur, Ganesh A.; Noujaim, Sami F.; Milnes, James; Logothetis, Diomedes E.			A benzopyran with antiarrhythmic activity is an inhibitor of Kir3.1-containing potassium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY INHIBITOR; K-ACH CHANNEL; ATRIAL-FIBRILLATION; NIP-142; AGENT; DRUG; TERTIAPIN; CURRENTS; BLOCKER; TARGET	Atrial fibrillation (AF) is the most commonly diagnosed cardiac arrhythmia and is associated with increased morbidity and mortality. Currently approved AF antiarrhythmic drugs have limited efficacy and/or carry the risk of ventricular proarrhythmia. The cardiac acetylcholine activated inwardly rectifying K+ current (I-KACh), composed of Kir3.1/Kir3.4 heterotetrameric and Kir3.4 homotetrameric channel subunits, is one of the best validated atrial-specific ion channels. Previous research pointed to a series of benzopyran derivatives with potential for treatment of arrhythmias, but their mechanism of action was not defined. Here, we characterize one of these compounds termed Benzopyran-G1 (BP-G1) and report that it selectively inhibits the Kir3.1 (GIRK1 or G1) subunit of the K-ACh channel. Homology modeling, molecular docking, and molecular dynamics simulations predicted that BP-G1 inhibits the IKACh channel by blocking the central cavity pore. We identified the unique F137 residue of Kir3.1 as the critical determinant for the IKACh-selective response to BP-G1. The compound interacts with Kir3.1 residues E141 and D173 through hydrogen bonds that proved critical for its inhibitory activity. BP-G1 effectively blocked the IKACh channel response to carbachol in an in vivo rodent model and displayed good selectivity and pharmacokinetic properties. Thus, BP-G1 is a potent and selective small-molecule inhibitor targeting Kir3.1-containing channels and is a useful tool for investigating the role of Kir3.1 heteromeric channels in vivo. The mechanism reported here could provide the molecular basis for future discovery of novel, selective I-KACh channel blockers to treat atrial fibrillation with minimal side effects.	[Cui, Meng; Alhamshari, Yaser; Cantwell, Lucas; Eptaminitaki, Giasemi C.; Tan, Haozhou; Xu, Keman; Masotti, Meghan; Plant, Leigh D.; Thakur, Ganesh A.; Logothetis, Diomedes E.] Northeastern Univ, Sch Pharm, Dept Pharmaceut Sci, Bouve Coll Hlth Sci, Boston, MA 02115 USA; [El-Haou, Said; Milnes, James] Xention Ltd, Dept Cardiac Biol, Cambridge, England; [Chang, Mengmeng; Abou-Assali, Obada; Noujaim, Sami F.] Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, Tampa, FL 33620 USA; [Plant, Leigh D.; Logothetis, Diomedes E.] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA; [Logothetis, Diomedes E.] Northeastern Univ, Dept Chem & Chem Biol, Coll Sci, Boston, MA 02115 USA	Northeastern University; State University System of Florida; University of South Florida; Northeastern University; Northeastern University	Cui, M; Logothetis, DE (corresponding author), Northeastern Univ, Sch Pharm, Dept Pharmaceut Sci, Bouve Coll Hlth Sci, Boston, MA 02115 USA.; Logothetis, DE (corresponding author), Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA.; Logothetis, DE (corresponding author), Northeastern Univ, Dept Chem & Chem Biol, Coll Sci, Boston, MA 02115 USA.	m.cui@northeastern.edu; d.logothetis@northeastern.edu		Eptaminitaki, Giasemi Chrysovalanti/0000-0001-9202-2183	NIH [R01 HL059949, R21 HL138064, R01 HL129136]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by NIH R01 HL059949 grant award to D. E. L., NIH R21 HL138064, and R01 HL129136 to S. N. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health (United States).	BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311; Cha TJ, 2006, CIRCULATION, V113, P1730, DOI 10.1161/CIRCULATIONAHA.105.561738; Chan KW, 1996, P NATL ACAD SCI USA, V93, P14193, DOI 10.1073/pnas.93.24.14193; Cui M., 2021, HDB EXPT PHARM; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dobrev D, 2005, CIRCULATION, V112, P3697, DOI 10.1161/circulationaha.105.575332; Dobrzynski H, 2001, J HISTOCHEM CYTOCHEM, V49, P1221, DOI 10.1177/002215540104901004; Ehrlich JR, 2008, J CARDIOVASC PHARM, V52, P129, DOI 10.1097/FJC.0b013e31816c4325; Ehrlich JR, 2008, J AM COLL CARDIOL, V51, P787, DOI 10.1016/j.jacc.2007.08.067; Ehrlich JR, 2004, J PHYSIOL-LONDON, V557, P583, DOI 10.1113/jphysiol.2004.061119; El-Haou S, 2015, J CARDIOVASC PHARM, V66, P412, DOI 10.1097/FJC.0000000000000277; Frisch M. J., 2019, GAUSSIAN 16 REVISION; Hashimoto N, 2012, ATRIAL FIBRILLATION, P321; Hashimoto N, 2008, J CARDIOVASC PHARM, V51, P162, DOI 10.1097/FJC.0b013e31815e854c; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Jin WL, 1998, BIOCHEMISTRY-US, V37, P13291, DOI 10.1021/bi981178p; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14286, DOI 10.1021/bi991205r; Kanjhan R, 2005, J PHARMACOL EXP THER, V314, P1353, DOI 10.1124/jpet.105.085928; LEALPINTO E, 1995, J MEMBRANE BIOL, V146, P123; Lee SW, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00943; Li DL, 2019, J BIOL CHEM, V294, P18934, DOI 10.1074/jbc.RA119.010047; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Machida T, 2011, CIRC-ARRHYTHMIA ELEC, V4, P94, DOI 10.1161/CIRCEP.110.951608; Matsuda T, 2005, J PHARMACOL SCI, V98, P33, DOI 10.1254/jphs.FPJ04045X; Matsuda T, 2001, LIFE SCI, V68, P2017, DOI 10.1016/S0024-3205(01)01003-7; Nagasawa H, 2002, CIRC J, V66, P185, DOI 10.1253/circj.66.185; Nattel S, 2006, NAT REV DRUG DISCOV, V5, P1034, DOI 10.1038/nrd2112; Okada T., 2008, United States, United States Patent Office, Alexandria, VA. Patent Number:, Patent No. [US20080004262A1, 20080004262]; Ravens U, 2008, EUROPACE, V10, P1133, DOI 10.1093/europace/eun193; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Torp-Pedersen C, 1999, NEW ENGL J MED, V341, P857, DOI 10.1056/NEJM199909163411201; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Voigt Niels, 2016, Card Electrophysiol Clin, V8, P411, DOI 10.1016/j.ccep.2016.02.005; Waldo AL, 1996, LANCET, V348, P7, DOI 10.1016/S0140-6736(96)02149-6; Walfridsson H, 2015, EUROPACE, V17, P473, DOI 10.1093/europace/euu192; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wydeven N, 2014, P NATL ACAD SCI USA, V111, P10755, DOI 10.1073/pnas.1405190111; Xu Y, 2020, J BIOL CHEM, V295, P3614, DOI 10.1074/jbc.RA119.011527; Yamamoto W, 2014, J CARDIOVASC PHARM, V63, P421, DOI 10.1097/FJC.0000000000000065	39	2	3	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100535	10.1016/j.jbc.2021.100535	http://dx.doi.org/10.1016/j.jbc.2021.100535			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33713702	gold, Green Published			2022-12-26	WOS:000672866400509
J	Harris, BRE; Zhang, Y; Tao, JX; Shen, RH; Zhao, XQ; Cleary, MP; Wang, T; Yang, DQ				Harris, Benjamin R. E.; Zhang, Ye; Tao, Jianxin; Shen, Renhui; Zhao, Xiaoqian; Cleary, Margot P.; Wang, Tong; Yang, Da-Qing			ATM inhibitor KU-55933 induces apoptosis and inhibits motility by blocking GLUT1-mediated glucose uptake in aggressive cancer cells with sustained activation of Akt	FASEB JOURNAL			English	Article						ATM; Akt; glucose uptake; GLUT1; KU-55933		Enhanced glucose uptake is coupled with elevated aerobic glycolysis (the Warburg effect) in cancer cells and is closely correlated with increased tumor aggressiveness and poor prognosis. We previously discovered that ATM, a protein kinase deficient in Ataxia-tclangiectasia (A-T) disease, is an insulin-responsive protein that participates in insulin-mediated glucose uptake in muscle cells by stimulating glucose transporter 4 (GLUT4) translocation. However, the role of ATM in glucose uptake and tumorigenesis of cancer cells is unclear. In the present study, we found that aggressive breast and prostate cancer cell lines with overactivated Akt activity exhibit enhanced glucose uptake and GLUT1 translocation upon insulin treatment, and KU-55933, a specific inhibitor of ATM, inhibits insulin-mediated glucose uptake by blocking translocation of GLUT1 to the cell surface. KU-55933 also inhibits aerobic glycolysis and ATP production in these cells. Moreover, KU-55933 induces apoptosis and inhibits motility of cancer cells by inhibiting glucose uptake. Our results showed that while high concentration of glucose and insulin promote the expression of a mesenchymal biomarker (vimentin) in these cancer cells, KU-55933 strongly inhibits its expression as well as epithelial to mesenchymal transition. The roles of ATM in stimulating glucose uptake, glycolysis, motility, and proliferation of cancer cells were demonstrated by knocking-down ATM in these cells. KU-55933 treatment also inhibits tumor growth and metastasis in vivo in mouse mammary tumors through inhibition of GLUT1 translocation and vimentin expression. These results suggest that ATM acts as a promoter of tumorigenesis in cancer cells with over- activated Akt, and KU-55933 induces apoptosis and inhibits motility by blocking GLUT1-mediated glucose uptake and glycolysis in these cancer cells, which may lead to the use of KU-55933 and its analogs as new preventive or therapeutic agents against cancer.	[Harris, Benjamin R. E.; Zhang, Ye; Tao, Jianxin; Shen, Renhui; Cleary, Margot P.; Yang, Da-Qing] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Zhang, Ye; Wang, Tong] Wuxi Peoples Hosp, Wuxi, Jiangsu, Peoples R China; [Tao, Jianxin; Shen, Renhui; Zhao, Xiaoqian; Wang, Tong] Nanjing Med Univ, Nanjing, Peoples R China; [Cleary, Margot P.; Yang, Da-Qing] Univ Minnesota, Mason Canc Ctr, 801 16th Ave NE, Minneapolis, MN 55455 USA	University of Minnesota System; Jiangnan University; Nanjing Medical University; University of Minnesota System; University of Minnesota Twin Cities	Yang, DQ (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.; Wang, T (corresponding author), Wuxi Peoples Hosp, Wuxi, Jiangsu, Peoples R China.; Yang, DQ (corresponding author), Univ Minnesota, Mason Canc Ctr, 801 16th Ave NE, Minneapolis, MN 55455 USA.	aanti@163.com; dyang@umn.edu		Tao, Jianxin/0000-0001-5417-213X; Harris, Benjamin/0000-0003-1459-1473	National Cancer Institute of National Institute of Health [1R01CA157012-01A1]; University of Minnesota [GIA]; National Natural Science Foundation of China;  [NSFC]	National Cancer Institute of National Institute of Health; University of Minnesota(University of Minnesota System); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	Margot P. Cleary, Grant/Award Number: 1R01CA157012-01A1; DAQING YANG, Grant/Award Number: GIA; Ye Zhang, Grant/Award Number: NSFC; National Cancer Institute of National Institute of Health, Grant/Award Number: 1R01CA157012-01A1; The University of Minnesota, Grant/Award Number: GIA; National Natural Science Foundation of China	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Andrisse S, 2014, REDOX BIOL, V2, P764, DOI 10.1016/j.redox.2014.03.004; Andrisse S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066027; Barron CC, 2016, METABOLISM, V65, P124, DOI 10.1016/j.metabol.2015.10.007; Brown KD, 1997, P NATL ACAD SCI USA, V94, P1840, DOI 10.1073/pnas.94.5.1840; Chen CT, 2012, MOL CANCER THER, V11, P2212, DOI 10.1158/1535-7163.MCT-12-0180; Chen JQ, 2012, BBA-REV CANCER, V1826, P370, DOI 10.1016/j.bbcan.2012.06.004; Ching JK, 2013, APPL PHYSIOL NUTR ME, V38, P589, DOI 10.1139/apnm-2012-0175; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Ferretti AC, 2016, ONCOTARGET, V7, P17815, DOI 10.18632/oncotarget.7404; Golding SE, 2009, MOL CANCER THER, V8, P2894, DOI 10.1158/1535-7163.MCT-09-0519; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Grossmann Michael E, 2015, Curr Pharmacol Rep, V1, P312; Halaby MJ, 2008, CELL SIGNAL, V20, P1555, DOI 10.1016/j.cellsig.2008.04.011; Halaby MJ, 2013, BIOCHEM BIOPH RES CO, V435, P708, DOI 10.1016/j.bbrc.2013.05.047; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hoffman K, 1996, CANCER CHEMOTH PHARM, V37, P254; Hu HB, 2005, CLIN CANCER RES, V11, P2379, DOI 10.1158/1078-0432.CCR-04-2084; Jang SM, 2012, J BREAST CANCER, V15, P172, DOI 10.4048/jbc.2012.15.2.172; Kang XW, 2015, CELL PHYSIOL BIOCHEM, V35, P1008, DOI 10.1159/000373928; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Krohn NG, 2014, G3-GENES GENOM GENET, V4, P49, DOI 10.1534/g3.113.008607; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Leighl NB, 2008, BREAST CANCER RES TR, V108, P87, DOI 10.1007/s10549-007-9584-x; Li DD, 2015, MOL MED REP, V12, P8148, DOI 10.3892/mmr.2015.4445; Li Y, 2010, MOL CANCER THER, V9, P113, DOI 10.1158/1535-7163.MCT-08-1189; Lin SC, 2018, CELL METAB, V27, P299, DOI 10.1016/j.cmet.2017.10.009; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Matsuura K, 2016, INT REV CEL MOL BIO, V327, P43, DOI 10.1016/bs.ircmb.2016.06.006; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Santos JM, 2020, NUTR CANCER, V72, P734, DOI 10.1080/01635581.2019.1654527; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shiloh Y, 2001, ADV CANCER RES, V83, P209, DOI 10.1016/S0065-230X(01)83007-4; Stagni V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7886; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Ueda S, 2008, JPN J CLIN ONCOL, V38, P250, DOI 10.1093/jjco/hyn019; Viniegra JG, 2005, J BIOL CHEM, V280, P4029, DOI 10.1074/jbc.M410344200; Wang Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925350; Yang DQ, 2016, FEBS LETT, V590, P3179, DOI 10.1002/1873-3468.12360; Yang DQ, 2011, DRUG DISCOV TODAY, V16, P332, DOI 10.1016/j.drudis.2011.02.001; Yang DQ, 2000, NAT CELL BIOL, V2, P893, DOI 10.1038/35046542; Zelenko Z, 2016, ENDOCR-RELAT CANCER, V23, P747, DOI 10.1530/ERC-16-0142; Zielinska HA, 2018, CANCER LETT, V419, P187, DOI 10.1016/j.canlet.2018.01.028	47	6	6	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21264	10.1096/fj.202001415RR	http://dx.doi.org/10.1096/fj.202001415RR			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715230				2022-12-26	WOS:000635216100047
J	Mayer, KA; Smole, U; Zhu, C; Derdak, S; Minervina, AA; Salnikova, M; Witzeneder, N; Christamentl, A; Boucheron, N; Waidhofer-Sollner, P; Trauner, M; Hoermann, G; Schmetterer, KG; Mamedov, IZ; Bilban, M; Ellmeier, W; Pickl, WF; Gualdoni, GA; Zlabinger, GJ				Mayer, Katharina A.; Smole, Ursula; Zhu, Ci; Derdak, Sophia; Minervina, Anastasia A.; Salnikova, Maria; Witzeneder, Nadine; Christamentl, Anna; Boucheron, Nicole; Waidhofer-Sollner, Petra; Trauner, Michael; Hoermann, Gregor; Schmetterer, Klaus G.; Mamedov, Ilgar Z.; Bilban, Martin; Ellmeier, Wilfried; Pickl, Winfried F.; Gualdoni, Guido A.; Zlabinger, Gerhard J.			The energy sensor AMPK orchestrates metabolic and translational adaptation in expanding T helper cells	FASEB JOURNAL			English	Article						AMPK; cellular metabolism; T cell; translation		The importance of cellular metabolic adaptation in inducing robust T cell responses is well established. However, the mechanism by which T cells link information regarding nutrient supply to clonal expansion and effector function is still enigmatic. Herein, we report that the metabolic sensor adenosine monophosphate-activated protein kinase (AMPK) is a critical link between cellular energy demand and translational activity and, thus, orchestrates optimal expansion of T cells in vivo. AMPK deficiency did not affect T cell fate decision, activation, or T effector cell generation; however, the magnitude of T cell responses in murine in vivo models of T cell activation was markedly reduced. This impairment was global, as all T helper cell subsets were similarly sensitive to loss of AMPK which resulted in reduced T cell accumulation in peripheral organs and reduced disease severity in pathophysiologically as diverse models as T cell transfer colitis and allergic airway inflammation. T cell receptor repertoire analysis confirmed similar clonotype frequencies in different lymphoid organs, thereby supporting the concept of a quantitative impairment in clonal expansion rather than a skewed qualitative immune response. In line with these findings, in-depth metabolic analysis revealed a decrease in T cell oxidative metabolism, and gene set enrichment analysis indicated a major reduction in ribosomal biogenesis and mRNA translation in AMPK-deficient T cells. We, thus, provide evidence that through its interference with these delicate processes, AMPK orchestrates the quantitative, but not the qualitative, manifestation of primary T cell responses in vivo.	[Mayer, Katharina A.; Smole, Ursula; Zhu, Ci; Christamentl, Anna; Boucheron, Nicole; Waidhofer-Sollner, Petra; Ellmeier, Wilfried; Pickl, Winfried F.; Zlabinger, Gerhard J.] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, Vienna, Austria; [Zhu, Ci; Trauner, Michael] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Hans Popper Lab Mol Hepatol, Vienna, Austria; [Derdak, Sophia; Bilban, Martin] Med Univ Vienna, Core Facil, Vienna, Austria; [Minervina, Anastasia A.; Salnikova, Maria; Mamedov, Ilgar Z.] Shemyakin Ovchinnikov Inst Bioorgan Chem, Dept Genom Adapt Immun, Moscow, Russia; [Witzeneder, Nadine; Hoermann, Gregor; Schmetterer, Klaus G.; Bilban, Martin] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Witzeneder, Nadine] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria; [Hoermann, Gregor] MLL Munich Leukemia Lab, Munich, Germany; [Mamedov, Ilgar Z.] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Gualdoni, Guido A.] Med Univ Vienna, Dept Internal Med 3, Div Nephrol & Dialysis, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Medical University of Vienna; Medical University of Vienna; MLL Munich Leukemia Laboratory; Masaryk University Brno; Medical University of Vienna	Zlabinger, GJ (corresponding author), Med Univ Vienna, Inst Immunol, Lazarettgasse 19, A-1090 Vienna, Austria.	gerhard.zlabinger@meduniwien.ac.at	Mamedov, Ilgar Z/H-9559-2014; Hoermann, Gregor/B-8832-2016	Mamedov, Ilgar Z/0000-0002-3992-9285; Trauner, Michael/0000-0002-1275-6425; Boucheron, Nicole/0000-0002-4979-8311; Pickl, Winfried F./0000-0003-0430-4952; Mayer, Katharina/0000-0003-2495-790X; Hoermann, Gregor/0000-0002-7374-4380	Austrian Science Fund (FWF) [DK-W1248, SFB-F4609]; Doctoral Program "Inflammation and Immunity" [DK-IAI W1212]; Russian Foundation for Basic Research (RFBR) [18-29-09132-mk]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Doctoral Program "Inflammation and Immunity"; Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR))	US and WFP were supported by grants DK-W1248 and SFB-F4609, respectively, from the Austrian Science Fund (FWF). CZ was supported by the Doctoral Program "Inflammation and Immunity" (DK-IAI W1212 to MT). IZM received funding from the Russian Foundation for Basic Research (RFBR, grant 18-29-09132-mk)	Araki K, 2017, NAT IMMUNOL, V18, P1046, DOI 10.1038/ni.3795; Bantug GR, 2018, NAT REV IMMUNOL, V18, P19, DOI 10.1038/nri.2017.99; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Bouladoux Nicolas, 2017, Curr Protoc Immunol, V119, DOI 10.1002/cpim.34; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Chiche J, 2019, CELL METAB, V29, P1243, DOI 10.1016/j.cmet.2019.02.002; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eri R, 2012, METHODS MOL BIOL, V844, P261, DOI 10.1007/978-1-61779-527-5_19; Gualdoni GA, 2018, P NATL ACAD SCI USA, V115, pE7158, DOI 10.1073/pnas.1800525115; Gualdoni GA, 2016, FASEB J, V30, P3800, DOI 10.1096/fj.201600522R; Guma M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140452; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2015, CLIN CANCER RES, V21, P3836, DOI 10.1158/1078-0432.CCR-14-3300; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Johnson MO, 2018, CELL, V175, P1780, DOI 10.1016/j.cell.2018.10.001; Kang KY, 2013, INT IMMUNOPHARMACOL, V16, P85, DOI 10.1016/j.intimp.2013.03.020; Katzman SD, 2011, CYTOKINE, V56, P116, DOI 10.1016/j.cyto.2011.07.005; Kumase F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147279; Lanna A, 2014, NAT IMMUNOL, V15, P965, DOI 10.1038/ni.2981; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lin SC, 2018, CELL METAB, V27, P299, DOI 10.1016/j.cmet.2017.10.009; Lindqvist LM, 2018, CURR OPIN GENET DEV, V48, P104, DOI 10.1016/j.gde.2017.11.003; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma EH, 2019, IMMUNITY, V51, P856, DOI 10.1016/j.immuni.2019.09.003; Ma EH, 2017, CELL METAB, V25, P345, DOI 10.1016/j.cmet.2016.12.011; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; Mayer A, 2008, EUR J IMMUNOL, V38, P948, DOI 10.1002/eji.200738045; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Nath N, 2005, J IMMUNOL, V175, P566, DOI 10.4049/jimmunol.175.1.566; Piccirillo CA, 2014, NAT IMMUNOL, V15, P503, DOI 10.1038/ni.2891; Rao EY, 2016, ONCOTARGET, V7, P33783, DOI 10.18632/oncotarget.9277; Rao EY, 2015, ONCOTARGET, V6, P7944, DOI 10.18632/oncotarget.3501; Raud B, 2018, CELL METAB, V28, P504, DOI 10.1016/j.cmet.2018.06.002; Ron-Harel N, 2019, CELL REP, V28, P3011, DOI 10.1016/j.celrep.2019.08.034; Ron-Harel N, 2016, CELL METAB, V24, P104, DOI 10.1016/j.cmet.2016.06.007; Shugay M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004503; Shugay M, 2014, NAT METHODS, V11, P653, DOI [10.1038/NMETH.2960, 10.1038/nmeth.2960]; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Smole U, 2020, NAT IMMUNOL, V21, P756, DOI 10.1038/s41590-020-0698-1; Tamas P, 2006, J EXP MED, V203, P1665, DOI 10.1084/jem.20052469; Tamas P, 2010, EUR J IMMUNOL, V40, P242, DOI 10.1002/eji.200939677; Tan HY, 2017, IMMUNITY, V46, P488, DOI 10.1016/j.immuni.2017.02.010; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vincent EE, 2015, ONCOGENE, V34, P3627, DOI 10.1038/onc.2014.301; Wei J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00247; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Yang K, 2017, NATURE, V548, P602, DOI 10.1038/nature23665; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Yin YM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0835; Yoo HS, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.45; Zeng H, 2017, CURR OPIN IMMUNOL, V46, P103, DOI 10.1016/j.coi.2017.04.005; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297	61	4	4	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21217	10.1096/fj.202001763RR	http://dx.doi.org/10.1096/fj.202001763RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715236	Green Published, hybrid			2022-12-26	WOS:000635216100102
J	Viswanathan, P; Sharma, Y; Jaber, FL; Tchaikovskaya, T; Gupta, S				Viswanathan, Preeti; Sharma, Yogeshwar; Jaber, Fadi-Luc; Tchaikovskaya, Tatyana; Gupta, Sanjeev			Transplanted hepatocytes rescue mice in acetaminophen-induced acute liver failure through paracrine signals for hepatic ATM and STAT3 pathways	FASEB JOURNAL			English	Article						cell therapy; DNA damage response; granulocyte colony&#8208; stimulating factor; inflammation; liver sinusoidal endothelial cells		Acute liver failure constitutes a devastating condition that needs novel cell and molecular therapies. To elicit synergisms in cell types of therapeutic interest, we studied hepatocytes and liver sinusoidal endothelial in mice with acetaminophen-induced acute liver failure. The context of regenerative signals was examined by transplants in peritoneal cavity because it possesses considerable capacity and allows soluble signals to enter the systemic circulation. Whereas transplanted hepatocytes and liver sinusoidal endothelial cells engrafted in peritoneal cavity, only the former could rescue mice in liver failure by improving injury outcomes, activating hepatic DNA damage repair, and inducing liver regeneration. The cytokines secreted by donor hepatocytes or liver sinusoidal endothelial cells differed and in hepatocytes from mice undergoing acetaminophen toxicity major cytokines were even rendered deficient (eg, G-CSF, VEGF, and others). Significantly, recapitulating hepatotoxicity-related DNA damage response in cultured cells identified impairments in ATM and JAK/STAT3 intersections since replacing cytokines produced less from injured hepatocytes restored these pathways to avoid acetaminophen hepatotoxicity. Similarly, hepatocyte transplantation in acute liver failure restored ATM and JAK/STAT3 pathways to advance DNA damage/repair and liver regeneration. The unexpected identification of novel hepatic G-CSF receptor expression following injury allowed paradigmatic studies of G-CSF supplementation to confirm the centrality of this paracrine ATM and STAT3 intersection. Remarkably, DNA damage/repair and hepatic regeneration directed by G-CSF concerned rebalancing of regulatory gene networks overseeing inflammation, metabolism, and cell viability. We conclude that healthy donor hepatocytes offer templates for generating specialized cell types to replace metabolic functions and regenerative factors in liver failure.	[Viswanathan, Preeti] Albert Einstein Coll Med, Dept Pediat, Childrens Hosp Montefiore, Div Pediat Gastroenterol, Bronx, NY 10467 USA; [Viswanathan, Preeti; Sharma, Yogeshwar; Jaber, Fadi-Luc; Tchaikovskaya, Tatyana; Gupta, Sanjeev] Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Ullmann Bldg,Room 625,1300 Morris Pk Ave, Bronx, NY 10461 USA; [Sharma, Yogeshwar; Jaber, Fadi-Luc; Tchaikovskaya, Tatyana; Gupta, Sanjeev] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Gupta, Sanjeev] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Gupta, Sanjeev] Albert Einstein Coll Med, Diabet Ctr, Bronx, NY 10467 USA; [Gupta, Sanjeev] Albert Einstein Coll Med, Fle Inst Diabet & Metab, Bronx, NY 10467 USA; [Gupta, Sanjeev] Albert Einstein Coll Med, Irwin S & Sylvia Chanin Inst Canc Res, Bronx, NY 10467 USA; [Gupta, Sanjeev] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Gupta, S (corresponding author), Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Ullmann Bldg,Room 625,1300 Morris Pk Ave, Bronx, NY 10461 USA.	sanjeev.gupta@einsteinmed.org	Viswanathan, Preeti/ABA-9925-2021		NIH [R01-DK071111, P30-DK41296]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH grants R01-DK071111 and P30-DK41296	Bahde R, 2014, HEPATOLOGY, V59, P1107, DOI 10.1002/hep.26766; Bandi S, 2019, DIFFERENTIATION, V105, P54, DOI 10.1016/j.diff.2019.01.005; Bandi S, 2014, ASSAY DRUG DEV TECHN, V12, P272, DOI 10.1089/adt.2014.571; Bandi S, 2012, J CELL SCI, V125, P1274, DOI 10.1242/jcs.095372; Bandi S, 2011, AM J PATHOL, V178, P161, DOI 10.1016/j.ajpath.2010.11.001; Barcena C, 2015, J HEPATOL, V63, P670, DOI 10.1016/j.jhep.2015.04.013; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Benten D, 2005, HEPATOLOGY, V42, P140, DOI 10.1002/hep.20746; Benten D, 2018, LAB INVEST, V98, P525, DOI 10.1038/s41374-017-0010-7; Cao ZW, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8710; Dold C, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2016.21; Du Z, 2015, CELL PROLIFERAT, V48, P293, DOI 10.1111/cpr.12186; Dumbuya JS, 2020, BRAIN RES, V1739, DOI 10.1016/j.brainres.2020.146817; Enami Y, 2012, HEPATOLOGY, V55, P1182, DOI 10.1002/hep.24735; Enami Y, 2009, GASTROENTEROLOGY, V136, P2356, DOI 10.1053/j.gastro.2009.03.003; Follenzi A, 2008, J CLIN INVEST, V118, P935, DOI 10.1172/JCI32748; Follenzi A, 2012, BLOOD, V119, P5532, DOI 10.1182/blood-2011-07-367680; Forbes SJ, 2015, J HEPATOL, V62, pS157, DOI 10.1016/j.jhep.2015.02.040; Freedman Deborah A, 2007, Novartis Found Symp, V283, P207; Gupta P, 2020, CYTOKINE, V127, DOI 10.1016/j.cyto.2019.154946; Gupta S, 2000, J PATHOL, V190, P203; Gupta S, 1999, HEPATOLOGY, V29, P509, DOI 10.1002/hep.510290213; Huang W, 2019, ONCOGENE, V38, P6818, DOI 10.1038/s41388-019-0925-0; Jaber FL, 2021, AM J PATHOL, V191, P79, DOI 10.1016/j.ajpath.2020.09.014; Jaber FL, 2017, METHODS MOL BIOL, V1506, P161, DOI 10.1007/978-1-4939-6506-9_11; Kakabadze Z, 2018, HEPATOLOGY, V67, P1956, DOI 10.1002/hep.29713; Komori J, 2012, NAT BIOTECHNOL, V30, P976, DOI 10.1038/nbt.2379; Lee WM, 2017, J HEPATOL, V67, P1324, DOI 10.1016/j.jhep.2017.07.005; Lu S, 2005, HUM MOL GENET, V14, P3019, DOI 10.1093/hmg/ddi333; Mehta HM, 2015, J IMMUNOL, V195, P1341, DOI 10.4049/jimmunol.1500861; Meng FY, 2012, HEPATOLOGY, V55, P209, DOI 10.1002/hep.24673; Merlin S, 2016, AM J PATHOL, V186, P539, DOI 10.1016/j.ajpath.2015.11.002; Michalopoulos GK, 2017, HEPATOLOGY, V65, P1384, DOI 10.1002/hep.28988; Mossanen JC, 2016, HEPATOLOGY, V64, P1667, DOI 10.1002/hep.28682; Olgasi C, 2018, STEM CELL REP, V11, P1391, DOI 10.1016/j.stemcr.2018.10.012; Rajvanshi P, 1996, HEPATOLOGY, V23, P482; Remot A, 2016, EUR J IMMUNOL, V46, P874, DOI 10.1002/eji.201545929; Rowell DL, 1997, AM J PHYSIOL-GASTR L, V273, pG322, DOI 10.1152/ajpgi.1997.273.2.G322; Steuerwald NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081974; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Viswanathan P, 2020, EXP MOL PATHOL, V113, DOI 10.1016/j.yexmp.2020.104369; Viswanathan P, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12445; Viswanathan P, 2016, J HEPATOL, V65, P1171, DOI 10.1016/j.jhep.2016.07.008; Viswanathan P, 2014, HEPATOLOGY, V60, P1378, DOI 10.1002/hep.27232; Woolbright BL, 2017, J HEPATOL, V66, P836, DOI 10.1016/j.jhep.2016.11.017; Wu YM, 2008, HEPATOLOGY, V47, P279, DOI 10.1002/hep.21937; Yadav N, 2019, HUM GENE THER, V30, P365, DOI 10.1089/hum.2018.166; Zhang YG, 2003, J BIOL CHEM, V278, P12650, DOI 10.1074/jbc.M210368200; Zhou WH, 2005, LAB INVEST, V85, P780, DOI 10.1038/labinvest.3700275	49	4	4	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21471	10.1096/fj.202002421R	http://dx.doi.org/10.1096/fj.202002421R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33683737				2022-12-26	WOS:000635216100008
J	Zhang, H; Wu, ZP; Yang, LJ; Zhang, Z; Chen, H; Ren, J				Zhang, Hui; Wu, Zhongping; Yang, Lijuan; Zhang, Zhen; Chen, Hao; Ren, Jun			Novel mutations in the Myo5a gene cause a dilute coat color phenotype in mice	FASEB JOURNAL			English	Article						coat color dilution; mice; microsatellite variation; molecular mechanism; Myo5a	TRANSCRIPTION FACTOR-BINDING; OPEN-ACCESS DATABASE; TANDEM REPEATS; GLOBULAR TAIL; MYOSIN V; INTRON; INSIGHTS; JASPAR; MLPH; MICROSATELLITE	C57BL/6 laboratory mice usually show black coat color. We observed a dilute (gray) coat color phenotype in progenies of two C57BL/6 mice. This phenotype is inherited in an autosomal recessive mode. To uncover the molecular mechanism underlying this naturally occurring phenotypic variation, we performed whole-genome sequencing (25x) on 10 offspring of the two founder mice. The whole-genome DNA sequencing and additional RNA-Seq data reveal that Myo5a is the gene responsible for the coat color dilution in C57BL/6 mice, and novel mutations in the Myo5a gene are likely causal. We further performed reverse transcription-quantitative PCR, and showed increased expression of truncated Myo5a transcripts encoding dysfunctional proteins and decreased expression of Myo5a full-length transcripts encoding functional proteins in mutant individuals. The decrease in full-length messenger RNA abundance was accompanied by reduced Myo5a protein level and deficient melanosome transport, a potential mechanistic link between the Myo5a mutations and the dilute color phenotype. This study not only advances our understanding of the molecular mechanisms of pigmentation in mice, but also provides a typical case of deciphering the molecular basis of phenotypic variation in mice by genomic analyses and subsequent functional work.	[Zhang, Hui; Yang, Lijuan; Ren, Jun] South China Agr Univ, Coll Anim Sci, Guangzhou 510642, Peoples R China; [Wu, Zhongping] Zhongkai Univ Agr & Engn, Coll Anim Sci & Technol, Guangzhou, Peoples R China; [Zhang, Zhen] Guilin Med Univ, Coll Biotechnol, Guilin, Peoples R China; [Chen, Hao] Jiangxi Sci & Technol Normal Univ, Coll Life Sci, Nanchang, Jiangxi, Peoples R China	South China Agricultural University; Zhongkai University of Agriculture & Engineering; Guilin Medical University; Jiangxi Science & Technology Normal University	Zhang, H; Ren, J (corresponding author), South China Agr Univ, Coll Anim Sci, Guangzhou 510642, Peoples R China.	zhanghui520627@hotmail.com; junren@scau.edu.cn	chen, hao/HGA-8980-2022	chen, hao/0000-0002-5210-8924; zhang, hui/0000-0003-0468-3526	Guangdong Provincial Promotion Project on Preservation and Utilization of Local Breed of Livestock and Poultry; National Natural Science Foundation of China [31525023]	Guangdong Provincial Promotion Project on Preservation and Utilization of Local Breed of Livestock and Poultry; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Guangdong Provincial Promotion Project on Preservation and Utilization of Local Breed of Livestock and Poultry; National Natural Science Foundation of China: 31525023.	Albanese V, 2001, HUM MOL GENET, V10, P1785, DOI 10.1093/hmg/10.17.1785; Bauer A, 2018, ANIM GENET, V49, P94, DOI 10.1111/age.12632; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cieslak M, 2011, BIOL REV, V86, P885, DOI 10.1111/j.1469-185X.2011.00177.x; Cirera S, 2013, GENE, V527, P48, DOI 10.1016/j.gene.2013.05.047; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fukuda M, 2004, J CELL SCI, V117, P583, DOI 10.1242/jcs.00891; Furutani Y, 2018, FRONT SYNAPTIC NEURO, V10, DOI 10.3389/fnsyn.2018.00027; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Haerry TE, 1996, P NATL ACAD SCI USA, V93, P13884, DOI 10.1073/pnas.93.24.13884; Harper MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053239; Hill M, 2010, PHARMACOGENOMICS J, V10, P442, DOI 10.1038/tpj.2009.66; Hofreiter M, 2010, CELL MOL LIFE SCI, V67, P2591, DOI 10.1007/s00018-010-0333-7; Hou LM, 2019, P NATL ACAD SCI USA, V116, P14583, DOI 10.1073/pnas.1904324116; Hugo H, 2006, GENE CHROMOSOME CANC, V45, P1143, DOI 10.1002/gcc.20378; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Lee TH, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.7; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liakath-Ali K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4540; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; O'Sullivan TN, 2004, P NATL ACAD SCI USA, V101, P16831, DOI 10.1073/pnas.0407339101; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Reissmann M, 2013, SEMIN CELL DEV BIOL, V24, P576, DOI 10.1016/j.semcdb.2013.03.014; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sawaya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054710; Schwartz AM, 2017, GENE, V602, P50, DOI 10.1016/j.gene.2016.11.032; Sharma VK, 2007, PHYSIOL GENOMICS, V31, P96, DOI 10.1152/physiolgenomics.00183.2006; Steingrimsson E, 2006, DEV DYNAM, V235, P2401, DOI 10.1002/dvdy.20840; Vaez M, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-7; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wilkins JM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-141; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Wu XF, 1997, J CELL SCI, V110, P847; Wu ZP, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00218; Yin ZR, 2017, NEUROBIOL AGING, V55, P115, DOI 10.1016/j.neurobiolaging.2017.03.021; Zhang WB, 2016, J BIOL CHEM, V291, P13571, DOI 10.1074/jbc.M116.724328	48	3	3	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21261	10.1096/fj.201903141RR	http://dx.doi.org/10.1096/fj.201903141RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715225				2022-12-26	WOS:000635216100042
J	Barros, OA; Viana, MSS; Viana, BC; da Silva, JH; Paschoal, AR; de Oliveira, PV				Barros, Olga Alcantara; Sales Viana, Maria Somalia; Cruz Viana, Bartolomeu; da Silva, Joao Herminio; Paschoal, Alexandre Rocha; de Oliveira, Paulo Victor			New data on Beurlenia araripensis Martins-Neto & Mezzalira, 1991, a lacustrine shrimp from Crato Formation, and its morphological variations based on the shape and the number of rostral spines	PLOS ONE			English	Article							DECAPODA	Fossil freshwater carideans are very rare worldwide. Here, we present new taxonomic remarks about Beurlenia araripensis from the Early Cretaceous laminated limestones of the Crato Formation, Araripe Basin, northeastern Brazil. We analyzed five fossil samples, testing the morphological variations such as, rostrum with 5 to 14 supra-rostral spines and 2 to 3 sub-rostral spines, which appears as serrate for Caridea. This variation demonstrates a morphologic plasticity also seen in extant species of the group, such as those of the genera Macrobrachium and Palaemon.	[Barros, Olga Alcantara] Univ Fed Ceara, Dept Geol, Posgrad Geol, Campus Pici, Fortaleza, Ceara, Brazil; [Sales Viana, Maria Somalia] Univ Estadual Vale Acarau, Lab Paleontol, Museu Dom Jose, Sobral, Ceara, Brazil; [Cruz Viana, Bartolomeu] Univ Fed Piaui, Dept Fis, Teresina, Piaui, Brazil; [da Silva, Joao Herminio] Univ Fed Cariri, Ctr Ciencias & Tecnol, Juazeiro Do Norte, Ceara, Brazil; [Paschoal, Alexandre Rocha] Univ Fed Ceara, Dept Fis, Fortaleza, Ceara, Brazil; [de Oliveira, Paulo Victor] Univ Fed Piaui, Lab Paleontol Picos, Campus Senador Helvidio Nunes de Barros, Picos, Piaui, Brazil	Universidade Federal do Ceara; Universidade Estadual Vale do Acarau; Universidade Federal do Piaui; Universidade Federal do Cariri; Universidade Federal do Ceara; Universidade Federal do Piaui	Barros, OA (corresponding author), Univ Fed Ceara, Dept Geol, Posgrad Geol, Campus Pici, Fortaleza, Ceara, Brazil.	olga.a.barros@gmail.com	Barros, Olga Alcântara/R-6693-2017; Viana, Bartolomeu C/A-3900-2019; Paschoal, Alexandre/AAX-9814-2021	Barros, Olga Alcântara/0000-0002-2671-4568; Viana, Bartolomeu C/0000-0002-5207-4269; Viana, Maria/0000-0001-5961-2667	Brazilian Federal Agency for Support and Evaluation of Graduate Education - CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	Brazilian Federal Agency for Support and Evaluation of Graduate Education - CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	The OAB is thankful to the Brazilian Federal Agency for Support and Evaluation of Graduate Education - CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), http://capes.gov.br, for the financial support for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assine M.l., 1992, BRAZ J GEOL, V22, P289, DOI DOI 10.25249/0375-7536.1992289300; Baez AM, 2009, CRETACEOUS RES, V30, P829, DOI 10.1016/j.cretres.2009.01.002; Barros OA., 2020, RES SOC DEV, V9, DOI [10.33448/rsd-v9i8.5576, DOI 10.33448/RSD-V9I8.5576]; Bravi S., 1999, PLATTENKALK VESOLE M, V140, P141; Campos Diogenes De A., 1997, Anais da Academia Brasileira de Ciencias, V69, P83; Carvalho FL, 2014, ZOOKEYS, P79, DOI 10.3897/zookeys.457.6771; Collart OO., 1993, ACTA AMAZ, V23, P227, DOI [10.1590/1809-43921993233243, DOI 10.1590/1809-43921993233243]; Correa MMG, 1977, THESIS U FEDERAL RIO; Davis SP, 1999, PALAEONTOLOGY, V42, P715, DOI 10.1111/1475-4983.00094; FELDMANN RM, 1994, NEW ZEAL J GEOL GEOP, V37, P163, DOI 10.1080/00288306.1994.9514611; Garassino A, 2003, J PALEONTOL, V77, P589, DOI 10.1666/0022-3360(2003)077<0589:PANSCD>2.0.CO;2; García-Dávila Carmen Rosa, 2005, Iheringia, Sér. Zool., V95, P327, DOI 10.1590/S0073-47212005000300013; García-Dávila Carmen Rosa, 2003, Acta Amaz., V33, P663, DOI 10.1590/S0044-59672003000400013; Holthuis LB, 1951, SUBFAMILIES EURYRHYN, V11, P332; Magalhaes C, 2003, ORDEM DECAPODA, P125; Maisey JG, 1995, AM MUS NOVIT, V3132, P1; Mantelatto F. L. M., 2005, ACTA LIMNOL BRAS, V17, P245; Martill DM., 2007, CRATO FOSSIL BEDS BR, DOI [10.1371/journal.pbio.0050204, DOI 10.1371/JOURNAL.PBIO.0050204]; Martins-Neto R., 1991, AN ACAD BRAS CIENC, V63, P361; MARTINS-NETO R G, 1991, Anais da Academia Brasileira de Ciencias, V63, P155; Martins-Neto RG., 2005, ARQ MUS NAC RIO JANE, V63, P471; Mohr BAR, 2003, REV PALAEOBOT PALYNO, V126, P279, DOI 10.1016/S0034-6667(03)00092-7; Mossolin EC, 2003, CRUSTACEANA, V76, P363, DOI 10.1163/156854003765911748; Neumann VH, 1999, B 5O S CRET BRAS, P279; Nogueira CD, 2019, IHERINGIA SER ZOOL, V109, DOI 10.1590/1678-4766e2019005; Romano Pedro S.R., 2013, P261; Saraiva AAF., 2009, J GEOSCIENCE, V5, P70, DOI [10.4013/gaea.2009.52.03, DOI 10.4013/GAEA.2009.52.03]; Simoes TR, 2012, AN ACAD BRAS CIENC, V84, P79, DOI 10.1590/S0001-37652012000100008; Valenca L. M. M., 2003, Geologica Acta, V1, P261	29	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0247497	10.1371/journal.pone.0247497	http://dx.doi.org/10.1371/journal.pone.0247497			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730028	Green Published, gold			2022-12-26	WOS:000630345000069
J	Natnael, T; Alemnew, Y; Berihun, G; Abebe, M; Andualem, A; Ademe, S; Tegegne, B; Adane, M				Natnael, Tarikuwa; Alemnew, Yeshiwork; Berihun, Gete; Abebe, Masresha; Andualem, Atsedemariam; Ademe, Sewunet; Tegegne, Belachew; Adane, Metadel			Facemask wearing to prevent COVID-19 transmission and associated factors among taxi drivers in Dessie City and Kombolcha Town, Ethiopia	PLOS ONE			English	Article							CORONAVIRUS; INFLUENZA; MASK	Background The World Health Organization (WHO) has pointed out that urban taxi drivers and their passengers are at higher risk of transmitting coronavirus disease 19 (COVID-19) due to frequent contact among many people. Facemask wearing is one of the preventive measures recommended to control the transmission of the virus. A lack of evidence of the proportion of facemask wearing among taxi drivers and associated factors in Ethiopia, including Dessie City and Kombolcha Town, hinders the design of targeted interventions to advocate for facemask use. This study was designed to address this gap. Methods A cross-sectional study was conducted among 417 taxi drivers in Dessie City and Kombolcha Town from July to August, 2020. The study participants were selected using a simple random sampling technique after proportionally allocating the sample size from the total number of taxi drivers working in Dessie City and Kombolcha Town. The data were collected by trained data collectors using a structured questionnaire and an on-the-spot observational checklist. The collected data were checked, coded and entered to EpiData version 4.6 and exported to Statistical Package for Social Sciences (SPSS) version 25.0 for data cleaning and analysis. Bivariate (Crude Odds Ratio [COR]) and multivariable (Adjusted Odds Ratio [AOR]) logistic regression analyses were employed using 95% CI (confidence interval). From bivariate logistic regression analysis, variables with p-value < 0.250 were retained into multivariable logistic regression analysis. Then, from the multivariable analysis, variables with p-value < 0.050 were declared as factors significantly associated with facemask wearing among taxi drivers in Dessie City and Kombolcha Town. Main findings The proportion of taxi drivers who wore a facemask was 54.68% [95%CI: 50.10-59.7%]. The majority (58.3%) of drivers were using cloth facemasks, followed by N95 facemasks (24.5%) and surgical facemasks (17.3%). Out of the total 417 taxi drivers, more than two-thirds (69.8%) of them had a good knowledge about COVID-19 and 67.6% of taxi drivers had a positive attitude towards taking precautions against transmission of COVID-19. Three-fourths (74.1%) of the taxi drivers believed that wearing a facemask could prevent COVID-19. More than half (52.5%) felt discomfort when wearing a facemask. Almost three-fourths (72.2%) of taxi drivers felt that the presence of local government pressure helped them to wear a facemask. We found that marital status [AOR = 3.14, 95%CI: 1.97-5.01], fear of the disease [AOR = 2.1, 95%CI: 1.28-3.47], belief in the effectiveness of a facemask [AOR = 5.6, 95%CI: 3.1-10.16] and feeling government pressure [AOR = 3.6, 95%CI: 2.16-6.13] were factors significantly associated with wearing a facemask. Conclusion We found that the proportion of facemask wearers among taxi drivers was relatively low in Dessie City and Kombolcha Town. In order to increase that number, government bodies should work aggressively to encourage more taxi drivers to wear a facemask. We also recommend that government and non-government organizations work very closely together to implement strategies that promote facemask use, including increasing the availability of inexpensive facemasks, and monitoring and controlling facemask use.	[Natnael, Tarikuwa; Berihun, Gete; Abebe, Masresha; Adane, Metadel] Wollo Univ, Coll Med & Hlth Sci, Dept Environm Hlth, Dessie, Ethiopia; [Alemnew, Yeshiwork] Wollo Univ, Coll Nat Sci, Dept Biol, Dessie, Ethiopia; [Andualem, Atsedemariam; Ademe, Sewunet; Tegegne, Belachew] Wollo Univ, Coll Med & Hlth Sci, Sch Nursing & Midwifery, Dept Nursing, Dessie, Ethiopia	University of Gondar; University of Gondar	Adane, M (corresponding author), Wollo Univ, Coll Med & Hlth Sci, Dept Environm Hlth, Dessie, Ethiopia.	metadel.adane2@gmail.com	Andualem, Atsedemariam/AAG-3882-2019; Adane, Metadel/AFQ-9478-2022	Adane, Metadel/0000-0002-7039-4768	Wollo University	Wollo University	Wollo University funded this study. The funders had no role in study design, data collection and analysis, decisions to publish, interpretation of the data and preparation of the manuscript for publication.	Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7; Ahmed A, 2020, J AMB INTEL HUM COMP; Anfinrud Philip, 2020, medRxiv, DOI 10.1101/2020.04.02.20051177; [Anonymous], 2002, Bull World Health Organ, V80, P983; Barasheed O, 2016, INT J INFECT DIS, V47, P105, DOI 10.1016/j.ijid.2016.03.023; Burgess A, 2012, SOCIOL HEALTH ILL, V34, P1184, DOI 10.1111/j.1467-9566.2012.01466.x; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chen Xuyu, 2020, Int J Environ Res Public Health, V17, DOI 10.3390/ijerph17082893; Cheng VCC, 2020, J INFECTION, V81, P107, DOI 10.1016/j.jinf.2020.04.024; Chintalapudi N, 2020, J MICROBIOL IMMUNOL, V53, P396, DOI 10.1016/j.jmii.2020.04.004; Condon BJ, 2010, HEALTH POLICY, V95, P50, DOI 10.1016/j.healthpol.2009.11.009; CSA, 2013, POPULATION PROJECTIO; Debela BK, COVID 19 PAND ETH PU; Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X; Ferng YH, 2011, PUBLIC HEALTH NURS, V28, P13, DOI 10.1111/j.1525-1446.2010.00918.x; Fouzia Hanim Binti Abdul Halim, 2020, Preprints, DOI 10.20944/preprints202005.0152; Ganyani T, 2020, EUROSURVEILLANCE, V25, P12, DOI 10.2807/1560-7917.ES.2020.25.17.2000257; Gray L, 2020, J PRIM HEALTH CARE, V12, P199, DOI 10.1071/HC20089; Gunasekaran GH., 2020, PREVALENCE FACEMASK; Haischer MH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240785; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Hosmer DW, 2013, WILEY SER PROBAB ST, P1; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jang WM, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16122161; Kelsey JL., 1996, METHODS OBSERVATIONA; Kombolcha City Administration, 2020, ANN REP KOMB CIT 202; Lan FY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233588; Lau JTF, 2008, INFECTION, V36, P434, DOI [10.1007/s15010-008-7277-y, 10.1007/s15010-008-7277-Y]; Lau JTF, 2010, AM J INFECT CONTROL, V38, P374, DOI 10.1016/j.ajic.2010.03.002; Lee M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17092977; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744; Lyu W, 2020, HEALTH AFFAIR, V39, P1419, DOI 10.1377/hlthaff.2020.00818; MOH  EPHI, 2020, MIN HLTH UG UG NAT T; Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097; Sim SW, 2014, SINGAP MED J, V55, P160; Tam VCW, 2020, ECLINICALMEDICINE, V22, DOI 10.1016/j.eclinm.2020.100356; Tang CSK, 2004, PREV MED, V39, P1187, DOI 10.1016/j.ypmed.2004.04.032; Taylor M, 2009, RISK MANAG HEALTHC P, V2, P9, DOI 10.2147/RMHP.S4810; UNECA, 2020, COVID 19 AFR PROT LI, P1; Wada K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1065; Walker PGT, 2020, SCIENCE, V369, P413, DOI 10.1126/science.abc0035; WHO, 2020, COR DIS 2019 COVID 1, P51; WHO . World Health Organisation, 2003, CONS DOC EP SEV AC R; World Health Organization, 1948, BAS DOC; Yang Y., 2020, EPIDEMIOLOGICAL CLIN, DOI [10.1111/irv.12758, DOI 10.1111/IRV.12758]; Yildirim M, 2021, PSYCHOL HEALTH MED, V26, P35, DOI 10.1080/13548506.2020.1776891; Zhang K, 2020, INT J INFECT DIS, V101, P334, DOI 10.1016/j.ijid.2020.10.002; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	52	15	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0247954	10.1371/journal.pone.0247954	http://dx.doi.org/10.1371/journal.pone.0247954			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8KN	33711038	Green Published, gold			2022-12-26	WOS:000629591800022
J	Chenouard, R; Mahieu, R; Paz, DL; Marion, E; Eveillard, M; Dubee, V				Chenouard, Rachel; Mahieu, Rafael; Paz, David Luque; Marion, Estelle; Eveillard, Matthieu; Dubee, Vincent			Impact of ceftriaxone and temocillin on fecal abundance of extended-spectrum beta-lactamase producing Escherichia coli in a mouse model	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE STRAINS; INTESTINAL COLONIZATION; DIGESTIVE COLONIZATION; ERTAPENEM; ENTEROBACTERIACEAE; ESTABLISHMENT; INFECTIONS; THERAPY; MICE	Background Gut colonization by ESBL-producing Enterobacteriaceae (ESBL-PE) is widespread and is promoted by antibiotic exposure. Higher fecal abundance of ESBL-PE promotes the dissemination of the bacteria in the environment and is associated with increased risk of infection. Ceftriaxone and temocillin are commonly used antibiotics with a different activity on gut flora. Their impact on fecal abundance of ESBL-producing Enterobacteriaceae has not been studied. The objective of this study was to compare the propensity of ceftriaxone and temocillin to modify the abundance of ESBL-producing Escherichia coli in feces of colonized mice. Methods Mice received broad-spectrum antibiotics in order to disrupt their normal gut flora. A CTX-M-type ESBL-producing E. coli clinical isolate was then administered orally, leading to durable colonization. Thirty days later, mice received either temocillin or ceftriaxone with drinking water at a concentration simulating human intestinal exposure. Third-generation-cephalosporin resistant (3GCR) E. coli were enumerated in feces on selective medium before, 2 days and 10 days after the end of antibiotic exposure. The experiment was performed with two E. coli isolates with different temocillin minimum inhibitory concentrations. Results Exposure to ceftriaxone induced an increase in the fecal abundance of 3GCR E. coli. In contrast, temocillin had no effect or transiently decreased the number of 3GCR E. coli. Results obtained with the two strains were similar. Conclusion Contrary to ceftriaxone, temocillin does not promote expansion of ESBL-producing E. coli in feces of colonized mice. Thus temocillin may be a therapeutic of choice when a temocillin-susceptible strain infection is suspected or proven to prevent the expansion of ESBL-PE in a previously colonized patient.	[Chenouard, Rachel; Eveillard, Matthieu] Angers Univ Hosp, Microbiol Lab, Angers, France; [Chenouard, Rachel; Mahieu, Rafael; Paz, David Luque; Marion, Estelle; Eveillard, Matthieu; Dubee, Vincent] Univ Angers, Univ Nantes, INSERM, Ctr Res Cancerol & Immunol Nantes Angers,UMRS1232, Angers, France; [Mahieu, Rafael; Dubee, Vincent] Angers Univ Hosp, Infect Dis Dept, Angers, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Dubee, V (corresponding author), Univ Angers, Univ Nantes, INSERM, Ctr Res Cancerol & Immunol Nantes Angers,UMRS1232, Angers, France.; Dubee, V (corresponding author), Angers Univ Hosp, Infect Dis Dept, Angers, France.	vincent.dubee@chu-angers.fr	LUQUE PAZ, David/HHC-1651-2022; Dubee, Vincent/F-8768-2018; Marion, Estelle/G-3437-2016	LUQUE PAZ, David/0000-0002-9197-7305; Dubee, Vincent/0000-0002-9982-4741; Marion, Estelle/0000-0003-4917-9665				Alexandre K, 2018, J ANTIMICROB CHEMOTH, V73, P1848, DOI 10.1093/jac/dky101; Anesi JA, 2018, INFECT CONT HOSP EP, V39, P1431, DOI 10.1017/ice.2018.254; Caron F, 2018, MED MALADIES INFECT, V48, P327, DOI 10.1016/j.medmal.2018.03.005; de Lastours V, 2016, ANTIMICROB AGENTS CH, V60, P6941, DOI 10.1128/AAC.01328-16; DiNubile MJ, 2005, EUR J CLIN MICROBIOL, V24, P443, DOI 10.1007/s10096-005-1356-0; Donskey CJ, 2000, NEW ENGL J MED, V343, P1925, DOI 10.1056/NEJM200012283432604; Ferreira-Coimbra J, 2020, EUR J CLIN MICROBIOL, V39, P1159, DOI 10.1007/s10096-020-03833-8; FUCHS PC, 1985, EUR J CLIN MICROBIOL, V4, P30, DOI 10.1007/BF02148656; Hoyen CK, 2003, ANTIMICROB AGENTS CH, V47, P3610, DOI 10.1128/AAC.47.11.3610-3612.2003; KAGER L, 1989, ANTIMICROB AGENTS CH, V33, P204, DOI 10.1128/AAC.33.2.204; Karanika S, 2016, CLIN INFECT DIS, V63, P310, DOI 10.1093/cid/ciw283; Mahieu R, 2017, INFECT CONT HOSP EP, V38, P1265, DOI 10.1017/ice.2017.173; Mahieu R, 2017, J INFECTION, V75, P75, DOI 10.1016/j.jinf.2017.04.008; Malmros K, 2019, INT J ANTIMICROB AG, V54, P478, DOI 10.1016/j.ijantimicag.2019.06.015; Melzer M, 2007, J INFECTION, V55, P254, DOI 10.1016/j.jinf.2007.04.007; Pletz MWR, 2004, ANTIMICROB AGENTS CH, V48, P3765, DOI 10.1128/AAC.48.10.3765-3772.2004; Pultz MJ, 2007, ANTIMICROB AGENTS CH, V51, P3044, DOI 10.1128/AAC.00194-07; Pultz NJ, 2005, J INFECT DIS, V191, P949, DOI 10.1086/428090; Ruppe E, 2013, ANTIMICROB AGENTS CH, V57, P4512, DOI 10.1128/AAC.00238-13; Ruppe E, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00129; Soubirou JF, 2015, J ANTIMICROB CHEMOTH, V70, P1466, DOI 10.1093/jac/dku542	21	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0248177	10.1371/journal.pone.0248177	http://dx.doi.org/10.1371/journal.pone.0248177			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QV3DA	33690674	Green Published, gold			2022-12-26	WOS:000627854700044
J	Fornili, M; Petri, D; Berrocal, C; Fiorentino, G; Ricceri, F; Macciotta, A; Bruno, A; Farinella, D; Baccini, M; Severi, G; Baglietto, L				Fornili, Marco; Petri, Davide; Berrocal, Carmen; Fiorentino, Giuseppe; Ricceri, Fulvio; Macciotta, Alessandra; Bruno, Andreina; Farinella, Domenica; Baccini, Michela; Severi, Gianluca; Baglietto, Laura			Psychological distress in the academic population and its association with socio-demographic and lifestyle characteristics during COVID-19 pandemic lockdown: Results from a large multicenter Italian study	PLOS ONE			English	Article							MENTAL-HEALTH; HOSPITAL ANXIETY; UNIVERSITY-STUDENTS; CONTROL ORIENTATION; DEPRESSION; EXERCISE; LOCUS; METAANALYSIS; QUARANTINE; SYMPTOMS	Measures implemented in many countries to contain the COVID-19 pandemic resulted in a change in lifestyle with unpredictable consequences on physical and mental health. We aimed at identifying the variables associated with psychological distress during the lockdown between April and May 2020 in the Italian academic population. We conducted a multicenter cross-sectional online survey (IO CONTO 2020) within five Italian universities. Among about 240,000 individuals invited to participate through institutional communications, 18 120 filled the questionnaire. Psychological distress was measured by the self-administered Hospital Anxiety and Depression Scale (HADS). The covariates collected included demographic and lifestyle characteristics, trust in government, doctors and scientists. Associations of covariates with influenza-like symptoms or positive COVID-19 test and with psychological distress were assessed by multiple regression models at the local level; a meta-analysis of the results was then performed. Severe levels of anxiety or depression were reported by 20% of the sample and were associated with being a student or having a lower income, irrespective of their health condition and worries about contracting the virus. The probability of being severely anxious or depressed also depended on physical activity: compared to those never exercising, the highest OR being for those who stopped during lockdown (1.53; 95% CI, 1.28 to 1.84) and the lowest for those who continued (0.78; 95% CI, 0.64 to 0.95). Up to 21% of severe cases of anxiety or depression might have been avoided if during lockdown participants had continued to exercise as before. Socioeconomic insecurity contributes to increase mental problems related to the COVID-19 pandemic and to the measures to contain it. Maintaining or introducing an adequate level of physical activity is likely to mitigate such detrimental effects. Promoting safe practice of physical activity should remain a public health priority to reduce health risks during the pandemic.	[Fornili, Marco; Petri, Davide; Baglietto, Laura] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Berrocal, Carmen] Univ Pisa, Dept Surg Med & Mol Pathol & Crit Care Med, Pisa, Italy; [Fiorentino, Giuseppe] Italian Naval Acad, Livorno, Italy; [Ricceri, Fulvio; Macciotta, Alessandra] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Bruno, Andreina] Univ Genoa, Dept Educ Sci, Genoa, Italy; [Farinella, Domenica] Univ Messina, Dept Polit Sci & Law, Messina, Italy; [Baccini, Michela; Severi, Gianluca] Univ Florence, Dept Stat Informat Applicat Giuseppe Parenti, Florence, Italy; [Severi, Gianluca] Univ Paris Saclay, Univ Paris Sud, CESP, Fac Med,UVSQ,INSERM, Villejuif, France; [Severi, Gianluca] Gustave Roussy, Villejuif, France	University of Pisa; University of Pisa; University of Turin; University of Genoa; University of Messina; University of Florence; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Baglietto, L (corresponding author), Univ Pisa, Dept Clin & Expt Med, Pisa, Italy.	laura.baglietto@unipi.it	Severi, Gianluca/Q-1824-2019	Severi, Gianluca/0000-0001-7157-419X; FARINELLA, DOMENICA/0000-0001-8796-9233				Arora T, 2020, J HEALTH PSYCHOL, V25, P1155, DOI 10.1177/1359105320937053; Barbisch D, 2015, DISASTER MED PUBLIC, V9, P547, DOI 10.1017/dmp.2015.38; BENASSI VA, 1988, J ABNORM PSYCHOL, V97, P357, DOI 10.1037/0021-843X.97.3.357; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Chekroud SR, 2018, LANCET PSYCHIAT, V5, P739, DOI 10.1016/S2215-0366(18)30227-X; Cheng C, 2013, PSYCHOL BULL, V139, P152, DOI 10.1037/a0028596; Costantini M, 1999, SUPPORT CARE CANCER, V7, P121, DOI 10.1007/s005200050241; Araujo FJD, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112977; Duncan GE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237695; Ettman CK, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19686; Ettman CK, 2020, ANN EPIDEMIOL, V43, P25, DOI 10.1016/j.annepidem.2020.02.001; Faisal RA, 2022, INT J MENT HEALTH AD, V20, P1500, DOI 10.1007/s11469-020-00458-y; Goldmann E, 2014, ANNU REV PUBL HEALTH, V35, P169, DOI 10.1146/annurev-publhealth-032013-182435; Harvey SB, 2018, AM J PSYCHIAT, V175, P28, DOI 10.1176/appi.ajp.2017.16111223; Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Iani L, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-84; Jain M., 2015, J MENTAL HLTH HUMAN, V20, P16, DOI [10.4103/0971-8990.164803, DOI 10.4103/0971-8990.164803]; Khan AH, 2020, J AFFECT DISORDERS, V277, P121, DOI 10.1016/j.jad.2020.07.135; Khumalo T, 2019, SAJP-S AFR J PSYCHI, V25, DOI 10.4102/sajpsychiatry.v25i0.1221; Kvam S, 2016, J AFFECT DISORDERS, V202, P67, DOI 10.1016/j.jad.2016.03.063; Lesser IA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113899; Mattioli AV, 2020, EUR J CLIN NUTR, V74, P852, DOI 10.1038/s41430-020-0646-z; Maugeri G, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04315; Morgan JA, 2018, J AFFECT DISORDERS, V234, P180, DOI 10.1016/j.jad.2018.02.058; Odriozola-Gonzalez P, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113108; Presson PK, 1996, J SOC BEHAV PERS, V11, P201; Rebar AL, 2015, HEALTH PSYCHOL REV, V9, P366, DOI 10.1080/17437199.2015.1022901; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; Sahu P, 2020, CUREUS, V12, DOI 10.7759/cureus.7541; Saravanan C, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.582189; Savage MJ, 2020, MENT HEALTH PHYS ACT, V19, DOI 10.1016/j.mhpa.2020.100357; Schuch FB, 2016, J PSYCHIATR RES, V77, P42, DOI 10.1016/j.jpsychires.2016.02.023; Shi L, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.14053; Stanton R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114065; Triguero-Mas M, 2017, ENVIRON RES, V159, P629, DOI 10.1016/j.envres.2017.08.048; Tully MA., 2020, MENT HLTH PHYS ACT, P19; Wathelet M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.25591; Weinstein AA, 2017, GEN HOSP PSYCHIAT, V49, P11, DOI 10.1016/j.genhosppsych.2017.06.001; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	41	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2021	16	3							e0248370	10.1371/journal.pone.0248370	http://dx.doi.org/10.1371/journal.pone.0248370			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QV3DA	33690695	Green Published, gold			2022-12-26	WOS:000627854700055
J	Zhang, J; Feng, BH; Wu, YN; Xu, PP; Ke, RM; Dong, N				Zhang, Jie; Feng, Baoheng; Wu, Yina; Xu, Pengpeng; Ke, Ruimin; Dong, Ni			The effect of human mobility and control measures on traffic safety during COVID-19 pandemic	PLOS ONE			English	Article							PARAMETERS TOBIT-MODEL; CRASH RATES; LEVEL	As mobile device location data become increasingly available, new analyses are revealing the significant changes of mobility pattern when an unplanned event happened. With different control policies from local and state government, the COVID-19 outbreak has dramatically changed mobility behavior in affected cities. This study has been investigating the impact of COVID-19 on the number of people involved in crashes accounting for the intensity of different control measures using Negative Binomial (NB) method. Based on a comprehensive dataset of people involved in crashes aggregated in New York City during January 1, 2020 to May 24, 2020, people involved in crashes with respect to travel behavior, traffic characteristics and socio-demographic characteristics are found. The results show that the average person miles traveled on the main traffic mode per person per day, percentage of work trip have positive effect on person involved in crashes. On the contrary, unemployment rate and inflation rate have negative effects on person involved in crashes. Interestingly, different level of control policies during COVID-19 outbreak are closely associated with safety awareness, driving and travel behavior, and thus has an indirect influence on the frequency of crashes. Comparing to other three control policies including emergence declare, limits on mass gatherings, and ban on all nonessential gathering, the negative relationship between stay-at-home policy implemented in New York City from March 20, 2020 and the number of people involved crashes is found in our study.	[Zhang, Jie; Feng, Baoheng; Dong, Ni] Southwest Jiaotong Univ, Sch Transportat & Logist, Chengdu, Peoples R China; [Zhang, Jie; Feng, Baoheng; Dong, Ni] Natl United Engn Lab Integrated & Intelligent Tra, Chengdu, Peoples R China; [Wu, Yina] Univ Cent Florida, Dept Civil Environm & Construct Engn, Orlando, FL 32816 USA; [Xu, Pengpeng] Univ Hong Kong, Dept Civil Engn, Hong Kong, Peoples R China; [Ke, Ruimin] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA	Southwest Jiaotong University; State University System of Florida; University of Central Florida; University of Hong Kong; University of Washington; University of Washington Seattle	Dong, N (corresponding author), Southwest Jiaotong Univ, Sch Transportat & Logist, Chengdu, Peoples R China.; Dong, N (corresponding author), Natl United Engn Lab Integrated & Intelligent Tra, Chengdu, Peoples R China.	dongni@home.swjtu.edu.cn	Xu, Pengpeng/W-7868-2019	Xu, Pengpeng/0000-0001-9826-4212	China Scholarship Council (CSC) scholarship [201807005039]; Natural Science Foundation of China [71601163]; National Key R&D Program of China [2016YFC0802208]; National Natural Science Foundation of China [61703351]	China Scholarship Council (CSC) scholarship(China Scholarship Council); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in the form of grants from China Scholarship Council (CSC) scholarship (No. 201807005039), and the Natural Science Foundation of China (No. 71601163) awarded to ND. This work was also supported in the form of grants by the National Key R&D Program of China (2016YFC0802208), and National Natural Science Foundation of China (Project No. 61703351) awarded to JZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aty MA, 2000, ACCIDENT ANAL PREV, V32, P633, DOI 10.1016/S0001-4575(99)00094-9; Cai Q, 2017, ACCIDENT ANAL PREV, V107, P11, DOI 10.1016/j.aap.2017.07.020; Cai Q, 2016, ACCIDENT ANAL PREV, V93, P14, DOI 10.1016/j.aap.2016.04.018; Cherchi E., 2014, TRAVEL BEHAV RES CUR, P517; Coruh E, 2015, ANAL METHODS ACCID R, V7, P37, DOI 10.1016/j.amar.2015.07.001; Cuebiq, 2020, COVID 19 MOB INS; De Vos Jonas, 2020, Transp Res Interdiscip Perspect, V5, P100121, DOI 10.1016/j.trip.2020.100121; Dong N, 2020, ACCIDENT ANAL PREV, V148, DOI 10.1016/j.aap.2020.105777; Dong N, 2016, ACCIDENT ANAL PREV, V92, P256, DOI 10.1016/j.aap.2016.04.001; Dong N, 2015, ACCIDENT ANAL PREV, V82, P192, DOI 10.1016/j.aap.2015.05.018; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Lee J, 2019, ACCIDENT ANAL PREV, V130, P91, DOI 10.1016/j.aap.2018.05.015; Maryland Transportation Institute, 2020, U MAR COVID 19 IMP A; Oliver N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc0764; Pakpour AH., 2020, J CONCURR DISORD, V2, P58, DOI [10.54127/WCIC8036, DOI 10.54127/WCIC8036]; Shaon MRR, 2018, ANAL METHODS ACCID R, V18, P33, DOI 10.1016/j.amar.2018.04.002; Srinivasan KK, 2000, TRANSPORT RES REC, P45, DOI 10.3141/1725-07; USA Facts, COR US MAPP COVID 19; Wen HY, 2019, ACCIDENT ANAL PREV, V132, DOI 10.1016/j.aap.2019.07.025; Xu PP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220785; Xu PP, 2019, INJURY PREV, V25, P20, DOI 10.1136/injuryprev-2017-042469; Xu PP, 2017, ACCIDENT ANAL PREV, V98, P330, DOI 10.1016/j.aap.2016.10.015; Zeng Q, 2019, TRANSPORTMETRICA A, V15, P1867, DOI 10.1080/23249935.2019.1652867; Zeng Q, 2020, J TRANSP SAF SECUR, V12, P566, DOI 10.1080/19439962.2018.1516259; Zeng Q, 2017, ACCIDENT ANAL PREV, V99, P184, DOI 10.1016/j.aap.2016.11.018; Zeng Q, 2017, ACCIDENT ANAL PREV, V100, P37, DOI 10.1016/j.aap.2016.12.023; Zhang L, 2020, INTERACTIVE COVID 19, DOI [10.1101/2020.04.29.20085472v1.full.pdf, DOI 10.1101/2020.04.29.20085472V1.FULL.PDF]; Zou YJ, 2015, ANAL METHODS ACCID R, V5-6, P1, DOI 10.1016/j.amar.2014.12.002; Zuo Fan, 2020, P URBCOMP 2020 9 SIG	29	13	13	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2021	16	3							e0243263	10.1371/journal.pone.0243263	http://dx.doi.org/10.1371/journal.pone.0243263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QU3OZ	33684104	gold, Green Published			2022-12-26	WOS:000627193500008
J	Ali, R; Alblihy, A; Miligy, IM; Alabdullah, ML; Alsaleem, M; Toss, MS; Algethami, M; Abdel-Fatah, T; Moseley, P; Chan, S; Mongan, NP; Narayan, S; Rakha, EA; Madhusudan, S				Ali, Reem; Alblihy, Adel; Miligy, Islam M.; Alabdullah, Muslim L.; Alsaleem, Mansour; Toss, Michael S.; Algethami, Mashael; Abdel-Fatah, Tarek; Moseley, Paul; Chan, Stephen; Mongan, Nigel P.; Narayan, Satya; Rakha, Emad A.; Madhusudan, Srinivasan			Molecular disruption of DNA polymerase beta for platinum sensitisation and synthetic lethality in epithelial ovarian cancers	ONCOGENE			English	Article							BASE EXCISION-REPAIR; POLY(ADP-RIBOSE) PAR POLYMER; GLYCOHYDROLASE PARG; CELLS; MECHANISMS; NAD(+); REPLICATION; DEFICIENT; PATHWAYS; DAMAGE	Targeting PARP1 [Poly(ADP-Ribose) Polymerase 1] for synthetic lethality is a new strategy for BRCA germ-line mutated or platinum sensitive ovarian cancers. However, not all patients respond due to intrinsic or acquired resistance to PARP1 inhibitor. Development of alternative synthetic lethality approaches is a high priority. DNA polymerase beta (Pol beta), a critical player in base excision repair (BER), interacts with PARP1 during DNA repair. Here we show that pol beta deficiency is a predictor of platinum sensitivity in human ovarian tumours. Pol beta depletion not only increased platinum sensitivity but also reduced invasion, migration and impaired EMT (epithelial to mesenchymal transition) of ovarian cancer cells. Pol beta small molecular inhibitors (Pamoic acid and NSC666719) were selectively toxic to BRCA2 deficient cells and associated with double-strand breaks (DSB) accumulation, cell cycle arrest and increased apoptosis. Interestingly, PARG [Poly(ADP-Ribose) Glycohydrolase] inhibitor (PDD00017273) [but not PARP1 inhibitor (Olaparib)] was synthetically lethal in pol beta deficient cells. Selective toxicity to PDD00017273 was associated with poly (ADP-ribose) accumulation, reduced nicotinamide adenine dinucleotide (NAD(+)) level, DSB accumulation, cell cycle arrest and increased apoptosis. In human tumours, pol beta-PARG co-expression adversely impacted survival in patients. Our data provide evidence that pol beta targeting is a novel strategy and warrants further pharmaceutical development in epithelial ovarian cancers.	[Ali, Reem; Alblihy, Adel; Alabdullah, Muslim L.; Algethami, Mashael; Madhusudan, Srinivasan] Univ Nottingham, Sch Med, Div Canc & Stem Cells, Translat Oncol, Nottingham, England; [Alblihy, Adel] King Fahad Secur Coll KFSC, Med Ctr, Riyadh, Saudi Arabia; [Miligy, Islam M.; Alabdullah, Muslim L.; Alsaleem, Mansour; Toss, Michael S.; Rakha, Emad A.] Univ Nottingham, Acad Pathol, Div Canc & Stem Cells, Sch Med, Nottingham, England; [Miligy, Islam M.] Menoufia Univ, Dept Pathol, Fac Med, Menoufia, Egypt; [Abdel-Fatah, Tarek; Moseley, Paul; Chan, Stephen; Madhusudan, Srinivasan] Nottingham Univ Hosp, Dept Oncol, Nottingham, England; [Mongan, Nigel P.] Univ Nottingham, Ctr Canc Sci, Fac Med & Hlth Sci, Sutton Bonington Campus, Loughborough, Leics, England; [Mongan, Nigel P.] Weill Cornell Med, Dept Pharmacol, New York, NY USA; [Narayan, Satya] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL USA	University of Nottingham; University of Nottingham; Egyptian Knowledge Bank (EKB); Menofia University; Nottingham University Hospital NHS Trust; University of Nottingham; University of Nottingham; Cornell University; State University System of Florida; University of Florida	Madhusudan, S (corresponding author), Univ Nottingham, Sch Med, Div Canc & Stem Cells, Translat Oncol, Nottingham, England.; Madhusudan, S (corresponding author), Nottingham Univ Hosp, Dept Oncol, Nottingham, England.	srinivasan.madhusudan@nottingham.ac.uk		Madhusudan, Srinivasan/0000-0002-5354-5480; Mongan, Nigel/0000-0001-5438-1126	Naaz-Coker Ovarian Cancer Fellowship, University of Nottingham, UK	Naaz-Coker Ovarian Cancer Fellowship, University of Nottingham, UK	Research in Madhusudan lab is supported by Naaz-Coker Ovarian Cancer Fellowship, University of Nottingham, UK.	Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Beaufort CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103988; Blaschuk OW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0039; Canitrot Y, 1998, P NATL ACAD SCI USA, V95, P12586, DOI 10.1073/pnas.95.21.12586; Croteau DL, 2017, CELL CYCLE, V16, P491, DOI 10.1080/15384101.2017.1285631; D'Andrea AD, 2018, DNA REPAIR, V71, P172, DOI 10.1016/j.dnarep.2018.08.021; DELFINI C, 1985, P NATL ACAD SCI USA, V82, P2220, DOI 10.1073/pnas.82.8.2220; Dianov G, 1998, J BIOL CHEM, V273, P33811, DOI 10.1074/jbc.273.50.33811; DIANOV G, 1994, CURR BIOL, V4, P1069, DOI 10.1016/S0960-9822(00)00245-1; Dianov GL, 2013, NUCLEIC ACIDS RES, V41, P3483, DOI 10.1093/nar/gkt076; Dong ZM, 2006, DIS ESOPHAGUS, V19, P172, DOI 10.1111/j.1442-2050.2006.00560.x; Farina AR, 2014, CANCERS, V6, P240, DOI 10.3390/cancers6010240; Fathers C, 2012, CELL CYCLE, V11, P990, DOI 10.4161/cc.11.5.19482; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Fouquerel E, 2014, DNA REPAIR, V23, P27, DOI 10.1016/j.dnarep.2014.09.004; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Gogola E, 2018, CANCER CELL, V33, P1078, DOI 10.1016/j.ccell.2018.05.008; Gravells P, 2017, DNA REPAIR, V52, P81, DOI 10.1016/j.dnarep.2017.02.010; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Hazan C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-22; Iwatsuki M, 2009, J SURG ONCOL, V100, P261, DOI 10.1002/jso.21275; Jaiswal AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123808; Jaiswal AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016691; Jaiswal AS, 2009, MOL CANCER RES, V7, P1973, DOI 10.1158/1541-7786.MCR-09-0309; Khanra K, 2012, CANCER BIOMARK, V11, P155, DOI 10.3233/CBM-2012-00275; Koh DW, 2005, CELL CYCLE, V4, P397, DOI 10.4161/cc.4.3.1559; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; LINDAHL T, 1990, MUTAT RES, V238, P305, DOI 10.1016/0165-1110(90)90022-4; Lombard DB, 2009, AGING-US, V1, P12, DOI 10.18632/aging.100014; Lord CJ, 2017, SCIENCE, V355, P1152, DOI 10.1126/science.aam7344; Loret N, 2019, CANCERS, V11, DOI 10.3390/cancers11060838; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Min W, 2009, FRONT BIOSCI-LANDMRK, V14, P1619, DOI 10.2741/3329; Mirza MR, 2016, NEW ENGL J MED, V375, P2154, DOI 10.1056/NEJMoa1611310; Moore K, 2018, NEW ENGL J MED, V379, P2495, DOI 10.1056/NEJMoa1810858; Moustakas A, 2016, J CLIN MED, V5, DOI 10.3390/jcm5070063; Oughtred R, 2019, NUCLEIC ACIDS RES, V47, pD529, DOI 10.1093/nar/gky1079; Parlanti E, 2007, NUCLEIC ACIDS RES, V35, P1569, DOI 10.1093/nar/gkl1159; Pascal JM, 2015, DNA REPAIR, V32, P10, DOI 10.1016/j.dnarep.2015.04.008; Pillay N, 2019, CANCER CELL, V35, P519, DOI 10.1016/j.ccell.2019.02.004; Pu H, 2014, CARCINOGENESIS, V35, P2592, DOI 10.1093/carcin/bgu183; Raudenska M., 2019, SCI REP-UK, V9, DOI [10.1038/s41598-018-38199-7, DOI 10.1038/S41598-018-38199-7]; Raudenska M, 2019, METALLOMICS, V11, P1182, DOI 10.1039/c9mt00049f; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Sobol RW, 2001, PROG NUCLEIC ACID RE, V68, P57; Srivastava DK, 1999, CARCINOGENESIS, V20, P1049, DOI 10.1093/carcin/20.6.1049; Starcevic D, 2004, CELL CYCLE, V3, P998; Sweasy JB, 2003, PROG NUCLEIC ACID RE, V73, P137, DOI 10.1016/S0079-6603(03)01005-5; Swisher EM, 2017, LANCET ONCOL, V18, P75, DOI [10.1016/S1470-2045(16)30559-9, 10.1016/s1470-2045(16)30559-9]; Weyemi U, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10711; Wong SHM, 2018, CRIT REV ONCOL HEMAT, V121, P11, DOI 10.1016/j.critrevonc.2017.11.010; Yang J, 2010, ONCOGENE, V29, P463, DOI 10.1038/onc.2009.327; Ying WH, 2005, J NEUROSCI RES, V79, P216, DOI 10.1002/jnr.20289; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103	55	6	6	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2021	40	14					2496	2508		10.1038/s41388-021-01710-y	http://dx.doi.org/10.1038/s41388-021-01710-y		MAR 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RK3YE	33674744	hybrid, Green Published			2022-12-26	WOS:000625607100004
J	Ma, RR; Zhang, H; Chen, HF; Zhang, GH; Tian, YR; Gao, P				Ma, Ran-Ran; Zhang, Hui; Chen, Hong-Fang; Zhang, Guo-Hao; Tian, Ya-Ru; Gao, Peng			MiR-19a/miR-96-mediated low expression of KIF26A suppresses metastasis by regulating FAK pathway in gastric cancer	ONCOGENE			English	Article								Gastric cancer (GC) is one of the most common malignant neoplasms. Invasion and metastasis are the main causes of GC-related deaths. Recently, kinesins were discovered to be involved in tumor development. The aim of this study was to elucidate the roles of kinesin superfamily protein 26A (KIF26A) in GC and its underlying molecular mechanism in regulating tumor invasion and metastasis. Using real-time quantitative polymerase chain reaction (qPCR) and immunohistochemistry (IHC), we showed that KIF26A expression was lower in GC tissues without lymph node metastasis (LNM) than in nontumorous gastric mucosa, and even lower in GC tissues with LNM than in GC tissues without LNM. Functional experiments showed that KIF26A inhibited migration and invasion of GC cells. We further identified focal-adhesion kinase (FAK), phosphatidylinositol 3-kinase regulatory subunit alpha (PI3KR1), VAV3, Rac1 and p21-activated kinase 2, and beta-PAK (PAK3) as downstream effectors of KIF26A in the focal-adhesion pathway, and we found that KIF26A could regulate FAK mRNA expression through inhibiting c-MYC by MAPK pathway. c-MYC could bind to the promoter of FAK and activate FAK transcription. Moreover, we found that KIF26A-mediated inactivation of the focal-adhesion pathway could reduce the occurrence of the epithelial-to-mesenchymal transition (EMT) by increasing expression of E-cadherin and reducing that of Snail. Luciferase assays and Western blotting revealed that miR-19a and miR-96 negatively regulate KIF26A. Finally, we found that decreased expression of KIF26A has been positively correlated with histological differentiation, Lauren classification, LNM, distal metastasis, and clinical stage, as well as poor survival in patients with GC. These data indicate that KIF26A could inhibit GC migration and invasion by regulating the focal-adhesion pathway and repressing the occurrence of EMT.	[Ma, Ran-Ran; Zhang, Hui; Chen, Hong-Fang; Zhang, Guo-Hao; Tian, Ya-Ru; Gao, Peng] Shandong Univ, Sch Basic Med Sci, Minist Educ, Key Lab Expt Teratol, Jinan, Peoples R China; [Ma, Ran-Ran; Zhang, Hui; Chen, Hong-Fang; Zhang, Guo-Hao; Tian, Ya-Ru; Gao, Peng] Shandong Univ, Sch Basic Med Sci, Dept Pathol, Jinan, Peoples R China; [Ma, Ran-Ran; Zhang, Hui; Gao, Peng] Shandong Univ, Qilu Hosp, Dept Pathol, Jinan, Peoples R China; [Chen, Hong-Fang] Yidu Cent Hosp Weifang, Dept Pathol, Weifang, Peoples R China	Shandong University; Shandong University; Shandong University	Gao, P (corresponding author), Shandong Univ, Sch Basic Med Sci, Minist Educ, Key Lab Expt Teratol, Jinan, Peoples R China.; Gao, P (corresponding author), Shandong Univ, Sch Basic Med Sci, Dept Pathol, Jinan, Peoples R China.; Gao, P (corresponding author), Shandong Univ, Qilu Hosp, Dept Pathol, Jinan, Peoples R China.	gaopeng@sdu.edu.cn			National Natural Science Foundation of China [81872362, 82072665]; Taishan Scholars Program of Shandong Province [ts201511096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholars Program of Shandong Province	This study was supported by the National Natural Science Foundation of China (Grant No. 81872362 and 82072665) and the Taishan Scholars Program of Shandong Province (Grant No. ts201511096).	Akhshi TK, 2014, CYTOSKELETON, V71, P1, DOI 10.1002/cm.21150; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; Bachmann A, 2015, BIOCHEM SOC T, V43, P79, DOI 10.1042/BST20140280; Baquero P, 2016, MOL CARCINOGEN, V55, P1639, DOI 10.1002/mc.22415; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Castillo A, 2007, CANCER RES, V67, P10138, DOI 10.1158/0008-5472.CAN-07-0326; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chandrasekaran G, 2015, BRIT J CANCER, V113, P693, DOI 10.1038/bjc.2015.264; Chen X, 2016, J PATHOL, V239, P459, DOI 10.1002/path.4743; Corson TW, 2006, INT J CANCER, V119, P1088, DOI 10.1002/ijc.21954; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Gao P, 2013, ONCOGENE, V32, P491, DOI 10.1038/onc.2012.61; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hippo Y, 2002, CANCER RES, V62, P233; Ho JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108248; Hung PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061664; Korb T, 2004, EXP CELL RES, V299, P236, DOI 10.1016/j.yexcr.2004.06.001; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Li PF, 2014, WORLD J GASTROENTERO, V20, P5411, DOI 10.3748/wjg.v20.i18.5411; Lin YW, 2014, CURR PHARM DESIGN, V20, P1698, DOI 10.2174/13816128113199990512; Liu XR, 2013, CANCER SCI, V104, P651, DOI 10.1111/cas.12138; Magnelli L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082893; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Muroyama A, 2017, DEVELOPMENT, V144, P3012, DOI 10.1242/dev.153171; Niwa S, 2015, ANAT SCI INT, V90, P1, DOI 10.1007/s12565-014-0259-5; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; Pharoah PDP, 2001, GASTROENTEROLOGY, V121, P1348, DOI 10.1053/gast.2001.29611; Qin S, 2013, ASIAN PAC J CANCER P, V14, P835, DOI 10.7314/APJCP.2013.14.2.835; Qu YP, 2013, CLIN CHIM ACTA, V424, P53, DOI 10.1016/j.cca.2013.05.002; Rath O, 2012, NAT REV CANCER, V12, P527, DOI 10.1038/nrc3310; Serrels A, 2011, CELL ADHES MIGR, V5, P360, DOI 10.4161/cam.5.4.17290; Stangel D, 2015, J SURG RES, V197, P91, DOI 10.1016/j.jss.2015.03.070; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Volkov V A, 2013, Ross Fiziol Zh Im I M Sechenova, V99, P153; Wang L, 2018, CELL REP, V24, P2894, DOI 10.1016/j.celrep.2018.05.075; Wang Q, 2013, CANCER EPIDEMIOL, V37, P79, DOI 10.1016/j.canep.2012.08.011; Wang TH, 2016, MOL CARCINOGEN, V55, P366, DOI 10.1002/mc.22286; Wu Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.110; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Yang T, 2013, CANCER SCI, V104, P552, DOI 10.1111/cas.12128; Yu Y, 2010, CANCER-AM CANCER SOC, V116, P5150, DOI 10.1002/cncr.25461; Zhang H, 2017, ONCOGENE, V36, P5609, DOI 10.1038/onc.2017.163; Zhang JF, 2014, ONCOL REP, V31, P1357, DOI 10.3892/or.2013.2934; Zhou RY, 2009, CELL, V139, P802, DOI 10.1016/j.cell.2009.10.023; Zhu HB, 2013, BIOCHEM BIOPH RES CO, V438, P97, DOI 10.1016/j.bbrc.2013.07.032; Zou JX, 2014, MOL CANCER RES, V12, P539, DOI 10.1158/1541-7786.MCR-13-0459	48	7	8	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2021	40	14					2524	2538		10.1038/s41388-020-01610-7	http://dx.doi.org/10.1038/s41388-020-01610-7		MAR 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RK3YE	33674746				2022-12-26	WOS:000625607100001
J	Li, GL; Wang, HQ; Zhang, XW; Wu, ZF; Yang, HQ				Li, Guoling; Wang, Haoqiang; Zhang, Xianwei; Wu, Zhenfang; Yang, Huaqiang			A Cas9-transcription factor fusion protein enhances homology-directed repair efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Precise gene insertion or replacement in cells and animals that requires incorporation of a foreign DNA template into the genome target site by homology-directed repair (HDR) remains an inefficient process. One of the limiting factors for the inefficiency of HDR lies in the limited chance for colocalization of the donor template and target in the huge genome space. We here present a strategy to enhance HDR efficiency in animal cells by spatial and temporal colocalization of the donor and Cas9 by coupling the CRISPR system with a transcription factor (TF). We first identified that THAP domain-containing 11 (THAP11) can coordinate with CRISPR/Cas9 to increase HDR stably through screening multiple TFs from different species. We next designed donor structures with different fusion patterns with TF-specific DNA-binding motifs and found that appending two copies of THAP11-specific DNA binding motifs to both ends of the double-stranded donor DNA has an optimal effect to promote HDR. The THAP11-fused CRISPR system achieved more than twofold increase in HDR-mediated knock-in efficiency for enhanced green fluorescent protein (EGFP) tagging of endogenous genes in 293T cells. We also demonstrated up to 6-fold increases of knock-in through the combinational use of the TF-fused CRISPR and valnemulin, a recently discovered small-molecule HDR enhancer. This modified CRISPR system provides a simple but highly efficient platform to facilitate CRISPR-mediated KI manipulations.	[Li, Guoling; Wang, Haoqiang; Zhang, Xianwei; Wu, Zhenfang; Yang, Huaqiang] South China Agr Univ, Coll Anim Sci, Guangzhou, Peoples R China; [Li, Guoling] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci,State Key Lab Neurosci,CAS Ctr Exce, Key Lab Primate Neurobiol,Shanghai Res Ctr Brain, Shanghai 200031, Peoples R China	South China Agricultural University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wu, ZF; Yang, HQ (corresponding author), South China Agr Univ, Coll Anim Sci, Guangzhou, Peoples R China.	wzf@scau.edu.cn; yangh@scau.edu.cn	; Wang, Haoqiang/A-6243-2019	Yang, Huaqiang/0000-0002-4287-0026; Wang, Haoqiang/0000-0003-4944-1117; Li, Guoling/0000-0003-0422-6157	National Natural Science Foundation of China [31772555]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Natural Science Foundation of China (31772555).	Aird EJ, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0054-2; Carlson-Stevermer J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01875-9; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Gu B, 2018, NAT BIOTECHNOL, V36, P632, DOI 10.1038/nbt.4166; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Lee K, 2017, ELIFE, V6, DOI 10.7554/eLife.25312; Li HL, 2016, METHODS, V101, P27, DOI 10.1016/j.ymeth.2015.10.015; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Ling XY, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz0051; Ma M, 2017, CELL RES, V27, P578, DOI 10.1038/cr.2017.29; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Riesenberg S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04609-7; Savic N, 2018, ELIFE, V7, DOI 10.7554/eLife.33761; Song J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10548; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stipkovits L, 2005, RES VET SCI, V78, P207, DOI 10.1016/j.rvsc.2004.09.005; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Yang HQ, 2014, CELL RES, V24, P464, DOI 10.1038/cr.2014.25; Zhang JP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1164-8; Zhang XW, 2018, ELIFE, V7, DOI 10.7554/eLife.34286	21	7	9	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100525	10.1016/j.jbc.2021.100525	http://dx.doi.org/10.1016/j.jbc.2021.100525			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33689695	gold, Green Published			2022-12-26	WOS:000672866400499
J	Chen, JQ; Sun, JR; Hu, YF; Wan, XL; Wang, YW; Gao, M; Liang, J; Liu, T; Sun, XD				Chen, Jieqiong; Sun, Junran; Hu, Yifan; Wan, Xiaoling; Wang, Yuwei; Gao, Min; Liang, Jian; Liu, Te; Sun, Xiaodong			MicroRNA-191-5p ameliorates amyloid-beta(1-40)-mediated retinal pigment epithelium cell injury by suppressing the NLRP3 inflammasome pathway	FASEB JOURNAL			English	Article						A beta; C/EBP beta; miR-191-5P; NLRP3; retinal pigment epithelium		Amyloid beta (A beta) is a crucial component of drusen, the hallmark of the early stage of age-related macular degeneration (AMD), and can cause retinal pigment epithelium (RPE) cell damage through activation of the inflammatory response. MicroRNAs play a critical role in inflammation. However, the mechanism underlying the effect of microRNAs on the NLRP3 inflammasome induced by A beta remains poorly understood. In the present study, we demonstrated that A beta(1-)(40) -mediated RPE damage by inducing a decrease in endogenous miR-191-5p expression. This led to the upregulation of its target gene, C/EBP beta, C/EBP beta acts as a transcription factor for NLRP3, promotes its transcription, and upregulates the downstream inflammatory factors Caspase-1 and IL-1 beta. Correspondingly, overexpression of miR-191-5p alleviated RPE cell injury by suppressing inflammation. The present study elucidates a novel transcriptional regulatory mechanism of the NLRP3 inflammasome. Our findings suggest an anti-inflammatory effect of miR-191-5p in A beta(1-40)-induced RPE impairment, shedding light on novel preventive or therapeutic approaches for AMD-associated RPE impairment.	[Chen, Jieqiong; Sun, Junran; Hu, Yifan; Wan, Xiaoling; Wang, Yuwei; Gao, Min; Liang, Jian; Sun, Xiaodong] Shanghai Gen Hosp, Dept Ophthalmol,Shanghai Engn Ctr Precise Diag &, Shanghai First Peoples Hosp,Shanghai Engn Ctr Vis, Natl Clin Res Ctr Eye Dis,Shanghai Key Lab Ocular, Shanghai, Peoples R China; [Chen, Jieqiong; Hu, Yifan; Wang, Yuwei; Gao, Min; Sun, Xiaodong] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China; [Liu, Te] Shanghai Univ Tradit Chinese Med, Shanghai Geriatr Inst Chinese Med, 365 South Xiangyang Rd, Shanghai 200031, Peoples R China	Shanghai Jiao Tong University; Shanghai University of Traditional Chinese Medicine	Liu, T (corresponding author), Shanghai Univ Tradit Chinese Med, Shanghai Geriatr Inst Chinese Med, 365 South Xiangyang Rd, Shanghai 200031, Peoples R China.; Sun, XD (corresponding author), Shanghai Gen Hosp, Natl Clin Res Ctr Eye Dis, Shanghai Key Lab Ocular Fundus Dis, Shanghai Engn Ctr Visual Sci & Photomed,Shanghai, 100 Haining Rd, Shanghai 200080, Peoples R China.	0721160004@mail.tongji.edu.cn; xdsun@sjtu.edu.cn			National Natural Science Foundation of China [81730026, 81700843]; National Key RD Program [2017YFA0105301]; Science and Technology Commission of Shanghai Municipality [17411953000]; Shanghai Sailing Program [19YF1439600, 19YF1439200, BJ-LM2018001J]; National Key R&D Program of China [2016YFC0904800, 2019YFC0840607]; National Science and Technology Major Project of China [2017ZX09304010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key RD Program; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Sailing Program; National Key R&D Program of China; National Science and Technology Major Project of China	National Natural Science Foundation of China, Grant/Award Number: 81730026 and 81700843; National Key R&D Program, Grant/Award Number: 2017YFA0105301; Science and Technology Commission of Shanghai Municipality, Grant/Award Number: 17411953000; Shanghai Sailing Program, Grant/Award Number: 19YF1439600 and 19YF1439200; Bethune-Langmu, Grant/Award Number: BJ-LM2018001J; National Key R&D Program of China, Grant/Award Number: 2016YFC0904800 and 2019YFC0840607; National Science and Technology Major Project of China, Grant/Award Number: 2017ZX09304010	Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Calvente CJ, 2019, J CLIN INVEST, V129, P4091, DOI 10.1172/JCI122258; Chen J, 2018, J GENE MED, V20, DOI 10.1002/jgm.3014; Chen M, 2008, INVEST OPHTH VIS SCI, V49, P3699, DOI 10.1167/iovs.07-1522; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Cunningham C, 2013, GLIA, V61, P71, DOI 10.1002/glia.22350; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Foster A, 2005, EYE, V19, P1133, DOI 10.1038/sj.eye.6701973; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gao JY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1062-3; Gilam A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12868; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Guduric-Fuchs J, 2012, J CELL BIOCHEM, V113, P2098, DOI 10.1002/jcb.24084; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Ha YJ, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.47; Hong Y, 2019, INT IMMUNOPHARMACOL, V74, DOI 10.1016/j.intimp.2019.05.054; HOOD DC, 1990, INVEST OPHTH VIS SCI, V31, P2070; Huang PR, 2017, INVEST OPHTH VIS SCI, V58, P1726, DOI 10.1167/iovs.16-20043; Isas JM, 2010, INVEST OPHTH VIS SCI, V51, P1304, DOI 10.1167/iovs.09-4207; Ji SY, 2014, BIOCHEM BIOPH RES CO, V451, P329, DOI 10.1016/j.bbrc.2014.07.130; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Karali M, 2016, NUCLEIC ACIDS RES, V44, P1525, DOI 10.1093/nar/gkw039; Kauppinen A, 2016, CELL MOL LIFE SCI, V73, P1765, DOI 10.1007/s00018-016-2147-8; Kauppinen A, 2012, IMMUNOL LETT, V147, P29, DOI 10.1016/j.imlet.2012.05.005; Kutty RK, 2010, MOL VIS, V16, P1475; La Rosa F, 2019, J ALZHEIMERS DIS, V72, P401, DOI 10.3233/JAD-181259; Lei CY, 2017, NEUROSCIENCE, V360, P48, DOI 10.1016/j.neuroscience.2017.07.053; Li FL, 2019, EXP THER MED, V18, P1175, DOI 10.3892/etm.2019.7668; Liu JD, 2008, CURR OPIN CELL BIOL, V20, P214, DOI 10.1016/j.ceb.2008.01.006; Liu RT, 2013, INVEST OPHTH VIS SCI, V54, P2225, DOI 10.1167/iovs.12-10849; Luciunaite A, 2020, J NEUROCHEM, V155, P650, DOI 10.1111/jnc.14945; McCulloch DL, 2019, DOC OPHTHALMOL, V138, P205, DOI 10.1007/s10633-019-09685-8; Morquette B, 2019, BRAIN, V142, P2979, DOI 10.1093/brain/awz245; Nagpal N, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00099; Nakanishi A, 2018, INFLAMM REGEN, V38, DOI 10.1186/s41232-018-0085-6; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Pulido-Salgado M, 2015, PROG NEUROBIOL, V132, P1, DOI 10.1016/j.pneurobio.2015.06.003; Rahman SM, 2012, J BIOL CHEM, V287, P34349, DOI 10.1074/jbc.M112.410613; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; Samuels IS, 2015, J NEUROPHYSIOL, V113, P1085, DOI 10.1152/jn.00761.2014; Shang P, 2018, JOVE-J VIS EXP, DOI 10.3791/56997; Sun JR, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.502; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Tejera D, 2019, EMBO J, V38, DOI 10.15252/embj.2018101064; Teodori L, 2019, MECH AGEING DEV, V182, DOI 10.1016/j.mad.2019.111127; Tseng WA, 2013, INVEST OPHTH VIS SCI, V54, P110, DOI 10.1167/iovs.12-10655; Vistbakka J, 2018, ACTA NEUROL SCAND, V138, P130, DOI 10.1111/ane.12921; Wang K, 2017, EXP CELL RES, V357, P335, DOI 10.1016/j.yexcr.2017.05.030; Wang K, 2017, J BIOCHEM MOL TOXIC, V31, DOI 10.1002/jbt.21887; Wilkins HM, 2017, BRAIN RES BULL, V133, P71, DOI 10.1016/j.brainresbull.2016.08.009; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Wu JH, 2012, OPHTHALMIC RES, V47, P195, DOI 10.1159/000331992; Yang HY, 2016, IMMUNITY, V45, P83, DOI 10.1016/j.immuni.2016.06.022; Yu SS, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1861-7; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhang XF, 2015, ONCOTARGET, V6, P4144, DOI 10.18632/oncotarget.2864; Zhao T, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0337-1	60	6	6	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21184	10.1096/fj.202000645RR	http://dx.doi.org/10.1096/fj.202000645RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33715208				2022-12-26	WOS:000635216100086
J	Shi, XY; Miao, YL; Zhang, KM; Gong, S; Xiong, B				Shi, Xiaoyan; Miao, Yilong; Zhang, Kemei; Gong, Shuai; Xiong, Bo			Ethylene glycol butyl ether deteriorates oocyte quality via impairing mitochondrial function	FASEB JOURNAL			English	Article						EGBE; fertilization ability; meiotic competency; mitochondrial function; oocyte quality		Ethylene glycol butyl ether (EGBE) is a ubiquitous environmental pollutant that is commonly used in maquillage, industrial, and household products. EGBE has been shown to cause blood toxicity, carcinogenicity, and organ malformations. However, little is known about the impact of EGBE on the female reproductive system, especially oocyte quality. Here, we reported that EGBE influenced oocyte quality by showing the disturbed oocyte meiotic capacity, fertilization potential, and early embryonic development competency. Specifically, EGBE exposure impaired spindle/chromosome structure, microtubule stability, and actin polymerization to result in the oocyte maturation arrest and aneuploidy. In addition, EGBE exposure compromised the dynamics of cortical granules and their component ovastacin, leading to the failure of sperm binding and fertilization. Last, single-cell transcriptome analysis revealed that EGBE-induced oocyte deterioration was caused by mitochondrial dysfunction, which led to the accumulation of ROS and occurrence of apoptosis. Altogether, our study illustrates that mitochondrial dysfunction and redox perturbation is the major cause of the poor quality of oocytes exposed to EGBE.	[Shi, Xiaoyan; Miao, Yilong; Xiong, Bo] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Peoples R China; [Zhang, Kemei] Ningbo First Hosp, Reprod Med Ctr, Ningbo, Peoples R China; [Gong, Shuai] Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China	Nanjing Agricultural University; Shandong Agricultural University	Xiong, B (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Peoples R China.	xiongbo@njau.edu.cn			National Key Research and Development Program of China [2018YFC1003802]; China Postdoctoral Science Foundation [2019M651849]; Medical and Health Science and Technology Plan Project [2018KY675]	National Key Research and Development Program of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Medical and Health Science and Technology Plan Project	National Key Research and Development Program of China, Grant/Award Number: 2018YFC1003802; China Postdoctoral Science Foundation, Grant/Award Number: 2019M651849; Medical and Health Science and Technology Plan Project, Grant/Award Number: 2018KY675	Adedara IA, 2010, HUM EXP TOXICOL, V29, P801, DOI 10.1177/0960327109360115; Ambroso JL, 1998, TERATOLOGY, V58, P231, DOI 10.1002/(SICI)1096-9926(199812)58:6<231::AID-TERA4>3.0.CO;2-X; Avella MA, 2013, MOL HUM REPROD, V19, P279, DOI 10.1093/molehr/gat004; Bagchi G, 2008, INT J ANDROL, V31, P269, DOI 10.1111/j.1365-2605.2007.00846.x; BARBEE SJ, 1984, ENVIRON HEALTH PERSP, V57, P157, DOI 10.2307/3429912; Beranger R, 2017, ENVIRON HEALTH PERSP, V125, P684, DOI 10.1289/EHP39; Blajszczak C, 2017, TOXICOLOGY, V391, P84, DOI 10.1016/j.tox.2017.07.013; BROWNING RG, 1994, HUM EXP TOXICOL, V13, P325, DOI 10.1177/096032719401300508; Burkart AD, 2012, J CELL BIOL, V197, P37, DOI 10.1083/jcb.201112094; Cai M, 2015, CURR EYE RES, V40, P822, DOI 10.3109/02713683.2014.959607; CHEEVER KL, 1984, ENVIRON HEALTH PERSP, V57, P241, DOI 10.2307/3429922; Cordier S, 1997, EPIDEMIOLOGY, V8, P355, DOI 10.1097/00001648-199707000-00002; Cui ZK, 2019, J CELL PHYSIOL, V234, P20111, DOI 10.1002/jcp.28611; Dai XX, 2017, HUM REPROD, V32, P598, DOI 10.1093/humrep/dew362; Dayan C, 2014, BIRTH DEFECTS RES B, V101, P254, DOI 10.1002/bdrb.21108; Fastier A, 2005, TOXICOL LETT, V156, P59, DOI 10.1016/j.toxlet.2003.09.019; Field CM, 2011, CURR BIOL, V21, pR825, DOI 10.1016/j.cub.2011.07.043; Fort DJ, 2018, J APPL TOXICOL, V38, P628, DOI 10.1002/jat.3567; GHANAYEM BI, 1987, TOXICOL APPL PHARM, V91, P222, DOI 10.1016/0041-008X(87)90103-7; Gift JS, 2005, TOXICOL LETT, V156, P163, DOI 10.1016/j.toxlet.2003.08.014; Gimenez-Abian JF, 2005, CELL CYCLE, V4, P1561, DOI 10.4161/cc.4.11.2146; Green T, 2002, TOXICOLOGY, V180, P257, DOI 10.1016/S0300-483X(02)00402-X; GROOTEGOED JA, 1984, BIOCHIM BIOPHYS ACTA, V767, P248, DOI 10.1016/0005-2728(84)90194-4; HARDIN BD, 1984, ENVIRON HEALTH PERSP, V57, P69, DOI 10.1289/ehp.845769; HEINDEL JJ, 1990, FUND APPL TOXICOL, V15, P683, DOI 10.1016/0272-0590(90)90185-M; Johanson G, 2000, CRIT REV TOXICOL, V30, P307, DOI 10.1080/10408440091159220; Kang J, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/896751; KENNEDY CH, 1993, FUND APPL TOXICOL, V21, P486, DOI 10.1006/faat.1993.1124; Kops GJPL, 2020, CURR BIOL, V30, pR589, DOI 10.1016/j.cub.2020.02.021; LAMB JC, 1984, ENVIRON HEALTH PERSP, V57, P85, DOI 10.2307/3429902; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Maldonado G, 2003, INT ARCH OCC ENV HEA, V76, P405, DOI 10.1007/s00420-003-0441-x; Miao YL, 2018, FASEB J, V32, P1328, DOI 10.1096/fj.201700908R; Miao YL, 2018, HUM REPROD, V33, P116, DOI 10.1093/humrep/dex331; Multigner L, 2005, TOXICOL LETT, V156, P29, DOI 10.1016/j.toxlet.2003.12.077; Musacchio A, 2011, PHILOS T R SOC B, V366, P3595, DOI 10.1098/rstb.2011.0072; Sehenrich N, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP2094; Sperlingova I, 2010, ANAL BIOANAL CHEM, V397, P433, DOI 10.1007/s00216-009-3148-3; Sudo H, 2010, J NEUROSCI, V30, P7215, DOI 10.1523/JNEUROSCI.0048-10.2010; TYL RW, 1984, ENVIRON HEALTH PERSP, V57, P47, DOI 10.2307/3429899; van der Bliek AM, 2017, GENETICS, V207, P843, DOI 10.1534/genetics.117.300262; Welsch F, 2005, TOXICOL LETT, V156, P13, DOI 10.1016/j.toxlet.2003.08.010; Weng SP, 2010, REPROD TOXICOL, V29, P452, DOI 10.1016/j.reprotox.2010.03.009; Xiong B, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006580; Zhang MQ, 2019, FREE RADICAL BIO MED, V143, P84, DOI 10.1016/j.freeradbiomed.2019.08.002; Zhang MQ, 2018, FASEB J, V32, P342, DOI 10.1096/fj.201700514R; Zhou CY, 2019, ENVIRON POLLUT, V255, DOI 10.1016/j.envpol.2019.113194; Zhou CY, 2019, AGING-US, V11, P4706, DOI 10.18632/aging.102084	48	2	2	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21280	10.1096/fj.202002157R	http://dx.doi.org/10.1096/fj.202002157R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33710673				2022-12-26	WOS:000635216100061
J	Kylander, ME; Holm, M; Fitchett, J; Grab, S; Cortizas, AM; Norstrom, E; Bindler, R				Kylander, Malin E.; Holm, Mikaela; Fitchett, Jennifer; Grab, Stefan; Martinez Cortizas, Antonio; Norstrom, Elin; Bindler, Richard			Late glacial (17,060-13,400 cal yr BP) sedimentary and paleoenvironmental evolution of the Sekhokong Range (Drakensberg), southern Africa	PLOS ONE			English	Article							LATE PLEISTOCENE; CLIMATE-CHANGE; HOLOCENE PALEOENVIRONMENTS; PRECIPITATION HISTORY; ISOTOPIC EVIDENCE; ORGANIC-MATTER; STABLE CARBON; WESTERN CAPE; POLLEN; LESOTHO	Southern Africa sits at the junction of tropical and temperate systems, leading to the formation of seasonal precipitation zones. Understanding late Quaternary paleoclimatic change in this vulnerable region is hampered by a lack of available, reliably-dated records. Here we present a sequence from a well-stratified sedimentary infill occupying a lower slope basin which covers 17,060 to 13,400 cal yr BP with the aim to reconstruct paleoclimatic variability in the high Drakensberg during the Late Glacial. We use a combination of pollen, total organic carbon and nitrogen, delta C-13, Fourier transform infrared spectroscopy attenuated total reflectance (FTIR-ATR) spectral and elemental data on contiguous samples with high temporal resolution (10 to 80 years per sample). Our data support a relatively humid environment with considerable cold season precipitation during what might have been the final stage of niche-glaciation on the adjoining southern aspects around 17,000 cal yr BP. Then, after an initial warmer and drier period starting similar to 15,600 cal yr BP, we identify a return to colder and drier conditions with more winter precipitation starting similar to 14,380 cal yr BP, which represents the first local evidence for the Antarctic Cold Reversal (ACR) in this region. On decadal to centennial timescales, the Late Glacial period was one marked by considerable climatic fluctuation and bi-directional environmental change, which has not been identified in previous studies for this region. Our study shows complex changes in both moisture and thermal conditions providing a more nuanced picture of the Late Glacial for the high Drakensburg.	[Kylander, Malin E.; Holm, Mikaela] Stockholm Univ, Dept Geol Sci, Stockholm, Sweden; [Kylander, Malin E.; Holm, Mikaela; Norstrom, Elin] Stockholm Univ, Bolin Ctr Climate Res, Stockholm, Sweden; [Fitchett, Jennifer; Grab, Stefan] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa; [Martinez Cortizas, Antonio] Univ Santiago Compostela, Fac Biol, EcoPast GI 1553, Santiago De Compostela, Spain; [Norstrom, Elin] Stockholm Univ, Dept Phys Geog, Stockholm, Sweden; [Bindler, Richard] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden	Stockholm University; University of Witwatersrand; Universidade de Santiago de Compostela; Stockholm University; Umea University	Kylander, ME (corresponding author), Stockholm Univ, Dept Geol Sci, Stockholm, Sweden.; Kylander, ME (corresponding author), Stockholm Univ, Bolin Ctr Climate Res, Stockholm, Sweden.	malin.kylander@geo.su.se	Fitchett, Jennifer/ABE-7179-2021; Martínez-Cortizas, Antonio/M-6196-2015	Fitchett, Jennifer/0000-0002-0854-1720; Martínez-Cortizas, Antonio/0000-0003-0430-5760; Bindler, Richard/0000-0002-7900-309X; Kylander, Malin/0000-0001-8787-5069	Bolin Centre for Climate Research; Swedish Society for Anthropology and Geography (SSAG)	Bolin Centre for Climate Research; Swedish Society for Anthropology and Geography (SSAG)	MEK and MH received funding from the Bolin Centre for Climate Research, Research Area 5 for completing fieldwork and age dating. MH was granted funding from the Swedish Society for Anthropology and Geography (SSAG) for fieldwork and a research visit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKANDE SO, 1993, J AFR EARTH SCI, V17, P445, DOI 10.1016/0899-5362(93)90003-9; Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Bamford MK, 2006, QUATERN INT, V148, P95, DOI 10.1016/j.quaint.2005.11.027; Bard E, 1997, NATURE, V385, P707, DOI 10.1038/385707a0; Barker S, 2009, NATURE, V457, P1097, DOI 10.1038/nature07770; Barrows TT, 2002, QUATERNARY SCI REV, V21, P159, DOI 10.1016/S0277-3791(01)00109-3; Battarbee R. W., 2001, TRACKING ENV CHANGE, P155, DOI DOI 10.1007/0-306-47668-1_8; Bigham J. M., 2002, P323; Birks HH, 2014, QUATERNARY SCI REV, V106, P262, DOI 10.1016/j.quascirev.2014.06.024; Blaauw M, 2011, BAYESIAN ANAL, V6, P457, DOI 10.1214/ba/1339616472; Boyle JF, 2002, DEV PALEOENVIRON RES, V2, P83; Broecker W, 2007, EARTH PLANET SC LETT, V256, P90, DOI 10.1016/j.epsl.2007.01.015; Broecker W, 2012, QUATERNARY SCI REV, V57, P17, DOI 10.1016/j.quascirev.2012.09.024; CARBUTT C., 2004, ENDINB J BOT, V60, P581; Chase BM, 2007, EARTH-SCI REV, V84, P103, DOI 10.1016/j.earscirev.2007.06.002; Chase BM, 2018, J HUM EVOL, V114, P35, DOI 10.1016/j.jhevol.2017.09.006; Chase BM, 2017, QUATERNARY SCI REV, V174, P54, DOI 10.1016/j.quascirev.2017.08.011; Chase BM, 2015, QUATERNARY SCI REV, V107, P138, DOI 10.1016/j.quascirev.2014.10.011; Chevalier M, 2015, QUATERNARY SCI REV, V125, P117, DOI 10.1016/j.quascirev.2015.07.009; Cocozza C, 2003, ORG GEOCHEM, V34, P49, DOI 10.1016/S0146-6380(02)00208-5; Coetzee JA, 1967, PALAEOECOL AFR, V2, P100; Combrink M., IN PRESS; Cook KH, 2000, J CLIMATE, V13, P3789, DOI 10.1175/1520-0442(2000)013<3789:TSICZA>2.0.CO;2; Deer W. A., 1992, INTRO ROCK FORMING M; Dill HG, 2009, SEDIMENT GEOL, V217, P95, DOI 10.1016/j.sedgeo.2009.03.014; Doner Harvey E., 2002, P199; Dyer TJG., 1979, Z GEOMORPHOL, V3, P256; Engelbrecht FA, 2019, QUATERNARY SCI REV, V226, DOI 10.1016/j.quascirev.2019.105879; Eriksson L, 1999, INTRO MULTIAND MEGA; Faith JT, 2019, QUATERNARY RES, V91, P848, DOI 10.1017/qua.2018.105; Faith JT, 2013, QUATERNARY SCI REV, V68, P191, DOI 10.1016/j.quascirev.2013.02.016; Farmer EC, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001049; Finne M, 2010, HOLOCENE, V20, P747, DOI 10.1177/0959683610362810; Fitch FJ., 1984, SPECIAL PUBLICATION, V13, P247; Fitchett JM, 2017, BIOL INVASIONS, V19, P2711, DOI 10.1007/s10530-017-1478-1; Fitchett JM, 2017, HOLOCENE, V27, P638, DOI 10.1177/0959683616670467; Fitchett JM, 2017, QUATERNARY SCI REV, V160, P85, DOI 10.1016/j.quascirev.2017.02.008; Fitchett JM, 2016, J QUATERNARY SCI, V31, P788, DOI 10.1002/jqs.2902; Fitchett JM, 2016, S AFR J SCI, V112, P24, DOI 10.17159/sajs.2016/20160045; FITCHETT JM, 2017, T ROY SOC S AFR, V72, P280, DOI DOI 10.1080/0035919X.2017.1297966; Gianoli E, 2004, ARCT ANTARCT ALP RES, V36, P484, DOI 10.1657/1523-0430(2004)036[0484:EDIMAC]2.0.CO;2; Grab S, 1999, GEOGR ANN A, V81A, P1, DOI 10.1111/j.0435-3676.1999.00045.x; Grab S, 1996, S AFR J SCI, V92, P183; Grab S, 2017, WATER SA, V43, P333, DOI 10.4314/wsa.v43i2.16; GSHHG, 2017, GLOB SELF CONS HIER; Herbert AV., 2020, QUAT RES, P1; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Holmer M, 2001, FRESHWATER BIOL, V46, P431, DOI 10.1046/j.1365-2427.2001.00687.x; Holmgren K, 2003, QUATERNARY SCI REV, V22, P2311, DOI 10.1016/S0277-3791(03)00204-X; Hooper PR., 1993, ABSTRACT EOS, P553; Iversen J, 1989, J BIOGEOGR; Jackson ST, 2012, QUATERNARY SCI REV, V49, P1, DOI 10.1016/j.quascirev.2012.05.020; Jouzel J, 2001, GEOPHYS RES LETT, V28, P3199, DOI 10.1029/2000GL012243; Juggins S., 2007, SOFTWARE ECOLOGICAL, P1, DOI [10.1890/06-1564.1, DOI 10.1890/06-1564.1]; Kalbitz K, 2000, CHEMOSPHERE, V40, P1305, DOI 10.1016/S0045-6535(99)00238-6; KAMPF N, 1983, GEODERMA, V29, P27, DOI 10.1016/0016-7061(83)90028-9; Kim JH, 2003, CLIM DYNAM, V21, P337, DOI 10.1007/s00382-003-0341-5; Kossler A, 2011, PALAEOGEOGR PALAEOCL, V306, P103, DOI 10.1016/j.palaeo.2011.04.004; LEVIEN L, 1980, AM MINERAL, V65, P920; Lodder J, 2018, QUATERN INT, V470, P119, DOI 10.1016/j.quaint.2017.08.019; Loftus E, 2015, J QUATERNARY SCI, V30, P805, DOI 10.1002/jqs.2817; Marker M., ASS BRIT CLIM SUMM M, P1993; Marker M.E., 1991, PERMAFROST PERIGLAC, V2, P21, DOI DOI 10.1002/PPP.3430020106; Marker M.E., 1971, S AFR GEOGR J, V53, P96, DOI DOI 10.1080/03736245.1971.10559490; MARKER ME, 1995, S AFR J SCI, V91, P294; Marker ME, 1994, HOLOCENE, V4, P406, DOI DOI 10.1177/095968369400400408; MEADOWS ME, 1988, CATENA, V15, P459, DOI 10.1016/0341-8162(88)90064-1; Meyer-Jacob C, 2014, CLIM PAST, V10, P209, DOI 10.5194/cp-10-209-2014; Meyers PA, 2003, ORG GEOCHEM, V34, P261, DOI 10.1016/S0146-6380(02)00168-7; Meyers PA, 1999, J PALEOLIMNOL, V21, P345, DOI 10.1023/A:1008073732192; Middleton HA, 1996, SEDIMENT GEOL, V103, P93, DOI 10.1016/0037-0738(95)00092-5; Mills SC, 2012, QUATERNARY SCI REV, V55, P145, DOI 10.1016/j.quascirev.2012.08.012; Mills SC, 2009, J QUATERNARY SCI, V24, P647, DOI 10.1002/jqs.1247; Mills SC, 2009, GEOGR ANN A, V91A, P121, DOI 10.1111/j.1468-0459.2009.00359.x; Mitchell AA, 1996, S AFR J GEOL, V99, P251; Monger H. Curtis, 2002, P611; MOZLEY PS, 1992, GEOLOGY, V20, P817, DOI 10.1130/0091-7613(1992)020<0817:ICOSAA>2.3.CO;2; Muller CM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06764; Mulholland SC., 1992, PHYTOLITH SYSTEMATIC; Neumann FH, 2011, HOLOCENE, V21, P1137, DOI 10.1177/0959683611400461; Neumann FH, 2014, VEG HIST ARCHAEOBOT, V23, P665, DOI 10.1007/s00334-014-0445-3; Neumann FH, 2010, REV PALAEOBOT PALYNO, V162, P39, DOI 10.1016/j.revpalbo.2010.05.001; Norstrom E, 2009, PALAEOGEOGR PALAEOCL, V271, P240, DOI 10.1016/j.palaeo.2008.10.018; Norstrom E, 2014, QUATERNARY SCI REV, V105, P48, DOI 10.1016/j.quascirev.2014.09.016; Norstrom E, 2018, HOLOCENE, V28, P1483, DOI 10.1177/0959683618777054; Nyakatya MJ, 2008, POLAR BIOL, V31, P139, DOI 10.1007/s00300-007-0341-8; Pargeter J, 2017, J ARCHAEOL SCI-REP, V12, P307, DOI 10.1016/j.jasrep.2017.01.027; PARTRIDGE TC, 1990, S AFR J SCI, V86, P302; Pedro JB, 2011, CLIM PAST, V7, P671, DOI 10.5194/cp-7-671-2011; Pedro JB, 2016, NAT GEOSCI, V9, P51, DOI [10.1038/ngeo2580, 10.1038/NGEO2580]; Renard F, 2017, CHEM GEOL, V449, P123, DOI 10.1016/j.chemgeo.2016.12.001; Roberts P, 2013, J QUATERNARY SCI, V28, P360, DOI 10.1002/jqs.2624; Roffe SJ, 2019, S AFR GEOGR J, V101, P158, DOI 10.1080/03736245.2019.1573151; Rout K, 2012, DALTON T, V41, P3302, DOI 10.1039/c2dt11651k; Rydberg J, 2014, J PALEOLIMNOL, V52, P265, DOI 10.1007/s10933-014-9792-4; Schefuss E, 2011, NATURE, V480, P509, DOI 10.1038/nature10685; Schwabe C, 1995, WETLANDS S AFRICA, P33; SCHWERTM.U, 1971, NATURE, V232, P624, DOI 10.1038/232624a0; Schwertmann U., 1988, Iron in soils and clay minerals . NATO ASI Series, C (Mathematical and Physical Sciences) Vol. 217., P267; Scott L, 1999, QUATERN INT, V57-8, P215, DOI 10.1016/S1040-6182(98)00062-7; Scott L, 2005, QUATERN INT, V129, P49, DOI 10.1016/j.quaint.2004.04.006; Scott L, 2012, QUATERNARY SCI REV, V32, P100, DOI 10.1016/j.quascirev.2011.11.010; Scott L, 2002, PALAEOGEOGR PALAEOCL, V177, P47, DOI 10.1016/S0031-0182(01)00351-0; Scott L, 2002, HOLOCENE, V12, P497, DOI 10.1191/0959683602hl563rr; SCOTT L, 1989, PALAEOGEOGR PALAEOCL, V70, P345, DOI 10.1016/0031-0182(89)90112-0; Sealy J, 2020, QUATERNARY SCI REV, V235, DOI 10.1016/j.quascirev.2019.105974; Sene KJ, 1998, INT J CLIMATOL, V18, P329, DOI [10.1002/(SICI)1097-0088(19980315)18:3<329::AID-JOC251>3.0.CO;2-5, 10.1002/(SICI)1097-0088(19980315)18:3&lt;329::AID-JOC251&gt;3.0.CO;2-5]; Sime LC, 2013, QUATERNARY SCI REV, V64, P104, DOI 10.1016/j.quascirev.2012.12.008; Smith DM., 2012, INTRO R NOTES R PROG; Smith JM, 2002, J QUATERNARY SCI, V17, P683, DOI 10.1002/jqs.687; Sousa PM, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aaebc7; Stewart BA, 2018, QUATERNARY SCI REV, V196, P1, DOI 10.1016/j.quascirev.2018.07.014; Taboada T, 2006, GEODERMA, V131, P218, DOI 10.1016/j.geoderma.2005.03.025; Takano Y, 2012, APPL GEOCHEM, V27, P2546, DOI 10.1016/j.apgeochem.2012.08.009; Truc L, 2013, PALAEOGEOGR PALAEOCL, V386, P575, DOI 10.1016/j.palaeo.2013.06.024; TWISS PC, 1969, SOIL SCI SOC AM PRO, V33, P109, DOI 10.2136/sssaj1969.03615995003300010030x; Tyson P.D., 2000, WEATHER CLIMATE SO A; Valsecchi V, 2013, PALAEOGEOGR PALAEOCL, V387, P6, DOI 10.1016/j.palaeo.2013.07.009; Van Zinderen Bakker E. M., 1955, ACTA GEOGR, V14, P413; Wetzel R., 2001, LIMNOLOGY, V3rd; Williams M, 2009, QUATERNARY SCI REV, V28, P2398, DOI 10.1016/j.quascirev.2009.04.020; Zech R, 2007, CLIM PAST, V3, P1, DOI 10.5194/cp-3-1-2007	122	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0246821	10.1371/journal.pone.0246821	http://dx.doi.org/10.1371/journal.pone.0246821			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730018	Green Published, gold			2022-12-26	WOS:000630345000017
J	Chan, J; Zeng, YW; Yeo, DCJ				Chan, Joleen; Zeng, Yiwen; Yeo, Darren C. J.			Invasive species trait-based risk assessment for non-native freshwater fishes in a tropical city basin in Southeast Asia	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; BIOLOGICAL INVASIONS; PROPAGULE PRESSURE; ALIEN FISHES; IMPACT; AQUARIUM; BIODIVERSITY; SUCCESS; ESTABLISHMENT; FECUNDITY	Biological invasions have created detrimental impacts in freshwater ecosystems. As non-native freshwater species include economically beneficial, but also harmful, species, trait-based risk assessments can be used to identify and prevent the import of potentially invasive species. Freshwater fishes are one of the most evaluated freshwater taxa to date. However, such assessments have mostly been done in sub-temperate to temperate regions, with a general lack of such research in the tropics. In view of this knowledge gap, this study aims to determine if a different set of traits are associated with successful establishment of non-native fishes within the tropics. In tropical Southeast Asia, Singapore represents a suitable model site to perform an invasive species trait-based risk assessment for the tropical region given its susceptibility to the introduction and establishment of non-native freshwater fishes and lack of stringent fish import regulation. A quantitative trait-based risk assessment was performed using random forest to determine the relative importance of species attributes associated with the successful establishment of introduced freshwater fishes in Singapore. Species having a match in climate, prior invasion success, lower absolute fecundity, higher trophic level, and involvement in the aquarium trade were found to have higher establishment likelihood (as opposed to native distributional range and maximum size being among the commonly identified predictors in subtropical/temperate trait-based risk assessments). To minimize invasive risk, incoming freshwater fishes could be screened in future for such traits, allowing lists of prohibited or regulated species to be updated. The findings could also potentially benefit the development of invasive species action plans and inform management decisions in the Southeast Asian region. Considering a geographical bias in terms of having relatively less documentation of biological invasions in the tropics, particularly Asia, this study highlights the need to perform more of such risk assessments in other parts of the tropics.	[Chan, Joleen; Zeng, Yiwen; Yeo, Darren C. J.] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Yeo, Darren C. J.] Natl Univ Singapore, Lee Kong Chian Nat Hist Museum, Singapore, Singapore	National University of Singapore; National University of Singapore	Yeo, DCJ (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.; Yeo, DCJ (corresponding author), Natl Univ Singapore, Lee Kong Chian Nat Hist Museum, Singapore, Singapore.	dbsyeod@nus.edu.sg		Chan, Joleen/0000-0001-7119-5392				Alcaraz C, 2005, DIVERS DISTRIB, V11, P289, DOI 10.1111/j.1366-9516.2005.00170.x; Alfred E. R., 1966, Zoologische Verhandelingen, VNo. 78, P1; [Anonymous], 2014, FISHBASE VERS 11 201; Baker N., 2012, WILD ANIMALS SINGAPO; Balon E.K., 1990, GUELPH ICHTHYOL REV, V1, P1; de Magalhaes ALB, 2013, NEOTROP ICHTHYOL, V11, P433, DOI 10.1590/S1679-62252013005000003; Barroso Magalhaes Andre Lincoln, 2019, Neotropical Biology and Conservation, V14, P329, DOI 10.3897/neotropical.14.e38058; Bellard C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0623; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Bomford M., 2004, RISK ASSESSMENT MODE; Bomford M, 2010, BIOL INVASIONS, V12, P2559, DOI 10.1007/s10530-009-9665-3; Breiman L., 2001, MACH LEARN, V45, P5; Cambray JA, 2003, HYDROBIOLOGIA, V500, P217, DOI 10.1023/A:1024648719995; Carlton JT, 2008, J GREAT LAKES RES, V34, P770, DOI 10.3394/0380-1330-34.4.770; Chan FRT, 2019, AQUAT ECOSYST HEALTH, V22, P417, DOI 10.1080/14634988.2019.1685849; Chia LS., 1991, BIOPHYSICAL ENV SING, P13; Crop Biosecurity Division  Department of Agriculture Malaysia, 2014, NAT ACT PLAN PREV ER, V1; Cuvin-Aralar Maria Lourdes A., 2016, Lakes & Reservoirs Research and Management, V21, P31, DOI 10.1111/lre.12118; Davis M. A., 2009, INVASION BIOL; Devin S, 2007, BIOL INVASIONS, V9, P13, DOI 10.1007/s10530-006-9001-0; Drake JM, 2007, FUNCT ECOL, V21, P963, DOI 10.1111/j.1365-2435.2007.01318.x; DUARTE CM, 1989, OECOLOGIA, V80, P401, DOI 10.1007/BF00379043; Dudgeon D, 2000, BIOSCIENCE, V50, P793, DOI 10.1641/0006-3568(2000)050[0793:LSHCIT]2.0.CO;2; Duggan IC, 2006, BIOL INVASIONS, V8, P377, DOI 10.1007/s10530-004-2310-2; Duggan IC., 2011, ENCY BIOL INVASIONS, P32; Emery-Butcher HE, 2020, FRESHWATER BIOL, V65, P999, DOI 10.1111/fwb.13479; Evers HG, 2019, J FISH BIOL, V94, P909, DOI 10.1111/jfb.13930; Fielding M., 2010, P 9 INT C HYDR 7 10, P2417; Fine PVA, 2002, J TROP ECOL, V18, P687, DOI [10.1017/S0266467402002456, 10.1017/S00266467402002456]; Garcia-Berthou E, 2007, J FISH BIOL, V71, P33, DOI 10.1111/j.1095-8649.2007.01668.x; Gertzen E, 2008, CAN J FISH AQUAT SCI, V65, P1265, DOI 10.1139/F08-056; Gherardi Francesca, 2007, V2, P3, DOI 10.1007/978-1-4020-6029-8_1; Gois KS, 2015, HYDROBIOLOGIA, V746, P401, DOI 10.1007/s10750-014-2061-8; Gonen M, 2006, P 31 ANN SAS R US GR; Grabowska J, 2015, REV FISH BIOL FISHER, V25, P165, DOI 10.1007/s11160-014-9375-5; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hothorn T, 2006, BIOSTATISTICS, V7, P355, DOI 10.1093/biostatistics/kxj011; Howeth JG, 2016, DIVERS DISTRIB, V22, P148, DOI 10.1111/ddi.12391; Hui TH, 2020, RAFFLES B ZOOL, V68, P150, DOI 10.26107/RBZ-2020-0016; Ishikawa T, 2014, ICHTHYOL RES, V61, P17, DOI 10.1007/s10228-013-0367-6; Jarosik V, 2011, ENCY BIOL INVASIONS, P104; Jepsen DB, 2002, OIKOS, V96, P46, DOI 10.1034/j.1600-0706.2002.960105.x; Jeschke JM, 2005, P NATL ACAD SCI USA, V102, P7198, DOI 10.1073/pnas.0501271102; Jeschke JM, 2006, GLOBAL CHANGE BIOL, V12, P1608, DOI 10.1111/j.1365-2486.2006.01213.x; Keller R.P., 2009, BIOECONOMICS INVASIV, P44; Keller RP, 2007, CONSERV BIOL, V21, P191, DOI 10.1111/j.1523-1739.2006.00563.x; Keller RP, 2011, DIVERS DISTRIB, V17, P451, DOI 10.1111/j.1472-4642.2011.00748.x; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; Kuhn M, 2021, CARET CLASSIFICATION, DOI DOI 10.1887/0750303123/B365C43; Kulhanek SA, 2011, ECOL APPL, V21, P189, DOI 10.1890/09-1452.1; Larson ER, 2010, CONSERV BIOL, V24, P1099, DOI 10.1111/j.1523-1739.2010.01462.x; Lazzaro X, 1997, INT VER THEOR ANGEW, V26, P719; Lee YN., 2013, TODAY; Leveque C, 2008, HYDROBIOLOGIA, V595, P545, DOI 10.1007/s10750-007-9034-0; Liang SH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236427; Liew JH, 2014, ENVIRON BIOL FISH, V97, P1109, DOI 10.1007/s10641-013-0201-z; Liew JH, 2012, NAT SINGAP, V5, P229; Liew JH, 2016, FRESHWATER BIOL, V61, P1421, DOI 10.1111/fwb.12781; Lim NKM, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160635; Liu CL, 2017, AQUAT CONSERV, V27, P773, DOI 10.1002/aqc.2740; Lodge DM, 2016, ANNU REV ENV RESOUR, V41, P453, DOI 10.1146/annurev-environ-110615-085532; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Lodge DM, 1998, AUST J ECOL, V23, P53, DOI 10.1111/j.1442-9993.1998.tb00705.x; Low BW, 2012, NATURE SINGAPORE, V5, P83; Lowe-McConnell RH., 1987, CAMBRIDGE TROPICAL B, P270; Lowry E, 2013, ECOL EVOL, V3, P182, DOI 10.1002/ece3.431; Magalhaes ALB, 2020, HYDROBIOLOGIA, V847, P3897, DOI 10.1007/s10750-020-04307-w; Magalhaes ALB, 2017, NEOTROP ICHTHYOL, V15, DOI 10.1590/1982-0224-20170033; Marchetti MP, 2004, ECOL APPL, V14, P587, DOI 10.1890/02-5301; Marchetti MP, 2004, FRESHWATER BIOL, V49, P646, DOI 10.1111/j.1365-2427.2004.01202.x; Meffin R, 2010, DIVERS DISTRIB, V16, P804, DOI 10.1111/j.1472-4642.2010.00684.x; Monticini P, 2010, GLOBEFISH, V102, P1; Moyle PB, 2006, BIOSCIENCE, V56, P515, DOI 10.1641/0006-3568(2006)56[515:PISFFI]2.0.CO;2; Ng H. H., 2012, NATURE SINGAPORE, V5, P73; Ng HH, 2010, COSMOS, V6, P95, DOI [10.1142/S0219607710000504, DOI 10.1142/S0219607710000504]; NG PKL, 1993, BIOL CONSERV, V64, P19, DOI 10.1016/0006-3207(93)90379-F; Nghiem LTP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071255; NORTHCOTE TG, 1988, CAN J FISH AQUAT SCI, V45, P361, DOI 10.1139/f88-044; O'Brien CE, 2017, MAR POLLUT BULL, V125, P92, DOI 10.1016/j.marpolbul.2017.07.071; O'Loughlin LS, 2017, AUSTRAL ECOL, V42, P819, DOI 10.1111/aec.12504; Padilla DK, 2004, FRONT ECOL ENVIRON, V2, P131, DOI 10.1890/1540-9295(2004)002[0131:BBWAAO]2.0.CO;2; Pallewatta N, 2003, INVASIVE ALIEN SPECI; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Peh KSH, 2010, BIODIVERS CONSERV, V19, P1083, DOI 10.1007/s10531-009-9755-7; Pelicice FM, 2017, FISH FISH, V18, P1119, DOI 10.1111/faf.12228; PRAAGMAN J, 1985, EUR J OPER RES, V19, P144, DOI 10.1016/0377-2217(85)90321-2; Pysek P, 2008, TRENDS ECOL EVOL, V23, P237, DOI 10.1016/j.tree.2008.02.002; R Core Team, 2020, R LANG ENV STAT COMP; Ribeiro F, 2008, BIOL INVASIONS, V10, P89, DOI 10.1007/s10530-007-9112-2; Ribeiro VR, 2017, PERSPECT ECOL CONSER, V15, P132, DOI 10.1016/j.pecon.2017.03.004; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Robson HLA, 2016, MOL ECOL RESOUR, V16, P922, DOI 10.1111/1755-0998.12505; Ruesink JL, 2005, CONSERV BIOL, V19, P1883, DOI 10.1111/j.1523-1739.2005.00267.x-i1; Saba AO, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74168-9; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Strecker AL, 2011, FISHERIES, V36, P74, DOI 10.1577/03632415.2011.10389070; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Sugianti B., 2014, INDONESIA KEMENTERIA, V2014; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; TAN HTW, 2010, NATURAL HERITAGE SIN; Thomaz SM, 2015, HYDROBIOLOGIA, V746, P39, DOI 10.1007/s10750-014-2044-9; Tricarico E, 2016, AQUAT CONSERV, V26, P872, DOI 10.1002/aqc.2711; Valdez-Moreno M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215505; Vila-Gispert A, 2005, BIOL INVASIONS, V7, P107, DOI 10.1007/s10530-004-9640-y; Vilizzi L, 2019, REV FISH BIOL FISHER, V29, P529, DOI 10.1007/s11160-019-09562-2; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Webb A., 2008, RISK ASSESSMENT MODE; Welcomme RL., 1988, FAO FISHERIES TECHNI; Winemiller KO, 2008, AQUAT ECOL SER, P107, DOI 10.1016/B978-012088449-0.50007-8; WINEMILLER KO, 1991, ECOL MONOGR, V61, P343, DOI 10.2307/2937046; WINEMILLER KO, 1992, CAN J FISH AQUAT SCI, V49, P2196, DOI 10.1139/f92-242; Xiong W, 2015, REV FISH BIOL FISHER, V25, P651, DOI 10.1007/s11160-015-9396-8; Yap SY, 2002, J BIOGEOGR, V29, P1187, DOI 10.1046/j.1365-2699.2002.00771.x; YEO D. C. J., 2010, COSMOS, V6, P23, DOI DOI 10.1142/S0219607710000486; Yeo D. C. J., 2011, SINGAPORE BIODIVERSI, P52; Zeng Y., 2015, BIOL INVASIONS, P1; Zeng YW, 2016, ECOL MODEL, V341, P5, DOI 10.1016/j.ecolmodel.2016.09.019	120	3	4	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2021	16	3							e0248480	10.1371/journal.pone.0248480	http://dx.doi.org/10.1371/journal.pone.0248480			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY1VJ	33724990	gold, Green Published			2022-12-26	WOS:000629833700038
J	Feyisa, ZT				Feyisa, Zelalem Tadese			Factors limiting youths' practice of preventive measures toward the outbreak of COVID-19 in Oromia special zone surrounding Finfinnee, Ethiopia	PLOS ONE			English	Article							TRANSMISSION; STUDENTS	Background Coronavirus disease 2019 (COVID-19) is a highly contagious viral infection, and it has negative effects on public health. The practice of preventive measures of the disease supports containment processes of the spread of coronavirus. However, the practice of preventive measures is affected by several associated risk factors. Objective This study aimed to investigate the associated factors that limit the youths' practice of preventive measures against COVID-19 in the study area. Methods A community-based cross-sectional study was conducted. The study used a quantitative approach for collecting data from 384 youths using a survey method. Not practicing preventive measures was measured to determine whether or not youths applied hygiene practices, kept their distance, restricted their movements, and sought self-help or support in the past two months. Descriptive statistics were used to assess the distribution of study participants, and a binary regression model was executed to examine the association factors with inability to practice preventive measures with a p-value < 0.05 statistically significant. Results Male youths (Adjusted Odds Ratio (AOR) = 0.06; 95% CI: 0.02, 0.16) were less likely to practice preventive measures. Older youth (AOR = 1.33; 95% CI: 1.13, 1.56), with higher education level (AOR = 1.03; 95% CI: 1.01, 1.06), and who had higher income (AOR = 1.34; 95% CI: 1.02, 1.78) were more likely to practice preventive measures. Further, the belief in the body's immunity to resist the disease (AOR = 0.27; 95% CI: 0.11, 0.67), lack of paying attention to the disease (AOR = 0.07; 95% CI: 0.01, 0.73), ignorance of evidence to the disease (AOR = 0.31; 95% CI: 0.13, 0.74), ease of restriction of movements (AOR = 0.29; 95% CI: 0.12, 0.72), lack of sensitization to actions in the community (AOR = 0.39; 95% CI: 0.16, 0.96), and substance use (AOR = 0.11; 95% CI: 0.05, 0.21) were other factors that were inversely related to practicing preventive measures. Conclusions The findings suggested that more intervention efforts, by either communicating to or reaching out all groups, should be employed. All segments of the population should be equipped with the facts that effectively support them practice preventive measures against the disease. Finally, the results suggested that youths should abstain from substance use, keep their distance in their pastime and avoid crowdings.	[Feyisa, Zelalem Tadese] Salale Univ, Dept Sociol, Fitche, Oromia, Ethiopia		Feyisa, ZT (corresponding author), Salale Univ, Dept Sociol, Fitche, Oromia, Ethiopia.	zetafego@gmail.com	Feyisa, Zelalem Tadese/AAQ-8597-2021	Feyisa, Zelalem Tadese/0000-0003-2391-6364				Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x; Adrian Z., 2020, KNOWLEDGE PERCEPTION, DOI [10.31234/osf.io/kr9ya, DOI 10.31234/OSF.IO/KR9YA]; Ahmed A., 2020, J COMMUN HEALTH, DOI [10.1007/s10900-020-00827-7, DOI 10.1007/S10900-020-00827-7]; Alzoubi H, 2020, J PURE APPL MICROBIO, V14, P17, DOI 10.22207/JPAM.14.1.04; [Anonymous], 2002, Bull World Health Organ, V80, P983; Bhagavathula Akshaya Srikanth, 2020, JMIR Public Health Surveill, V6, pe19160, DOI 10.2196/19160; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Cirrincione L, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093603; Cori L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093114; Di Gennaro F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082690; Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193; Hosmer D.W., 2020, APPL LOGISTIC REGRES, V2nd; Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00254-8; Kaleab B., 2020, CURRENT REALITIES PR; Kebede Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243024; Kebede Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233744; Lemeshow S., 1990, TITLE ADEQUACY SAMPL; Matthew JF., J INFECT DIS, V2020, P1, DOI [10.1002/emp2.12034/, DOI 10.1002/EMP2.12034]; Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246; Mya K.S., 2020, INT J COMMUNITY MED, V7, P1627, DOI [10.18203/2394-6040.ijcmph20201530, DOI 10.18203/2394-6040.IJCMPH20201530]; Nazli T., 2020, EPIDEM INT, V5, P10, DOI 10.24321/2455.7048.202011; Olsson G, 2020, ACTA SOCIOL, V63, P156, DOI 10.1177/0001699318820924; Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181; Parikh PA, 2020, CUREUS, V12, DOI 10.7759/cureus.8144; Rahman A, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/8223; Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007; Shah MS., 2020, KNOWLEDGE ATTITUDE P; Shereen MA, 2020, J ADV RES, V24, P91, DOI 10.1016/j.jare.2020.03.005; Singu S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00406; Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]; Terfa BK, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12031235; World Health Orgizanation, 2020, DIS BRIEFING CORONAV; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	33	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0248495	10.1371/journal.pone.0248495	http://dx.doi.org/10.1371/journal.pone.0248495			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX9NB	33720979	gold, Green Published			2022-12-26	WOS:000629667400030
J	Hoeben, EM; Bernasco, W; Liebst, LS; van Baak, C; Lindegaard, MR				Hoeben, Evelien M.; Bernasco, Wim; Liebst, Lasse Suonpera; van Baak, Carlijn; Lindegaard, Marie Rosenkrantz			Social distancing compliance: A video observational analysis	PLOS ONE			English	Article							EMERGING TECHNOLOGIES; COMPREHENSIVE SURVEY; PATIENT COMPLIANCE	Purpose Virus epidemics may be mitigated if people comply with directives to stay at home and keep their distance from strangers in public. As such, there is a public health interest in social distancing compliance. The available evidence on distancing practices in public space is limited, however, by the lack of observational data. Here, we apply video observation as a method to examine to what extent members of the public comply with social distancing directives. Data Closed Circuit Television (CCTV) footage of interactions in public was collected in inner-city Amsterdam, the Netherlands. From the footage, we observed instances of people violating the 1.5-meter distance directives in the weeks before, during, and after these directives were introduced to mitigate the COVID-19 pandemic. Results We find that people complied with the 1.5-meter distance directives when these directives were first introduced, but that the level of compliance started to decline soon after. We also find that violation of the 1.5-meter distance directives is strongly associated with the number of people observed on the street and with non-compliance to stay-at-home directives, operationalized with large-scale aggregated location data from cell phones. All three measures correlate to a varying extent with temporal patterns in the transmission of the COVID-19 virus, temperature, COVID-19 related Google search queries, and media attention to the topic. Conclusion Compliance with 1.5 meter distance directives is short-lived and coincides with the number of people on the street and with compliance to stay-at-home directives. Potential implications of these findings are that keep- distance directives may work best in combination with stay-at-home directives and place-specific crowd-control strategies, and that the number of people on the street and community-wide mobility as captured with cell phone data offer easily measurable proxies for the extent to which people keep sufficient physical distance from others at specific times and locations.	[Hoeben, Evelien M.; Bernasco, Wim; van Baak, Carlijn; Lindegaard, Marie Rosenkrantz] Netherlands Inst Study Crime & Law Enforcement NS, Amsterdam, Netherlands; [Bernasco, Wim; Lindegaard, Marie Rosenkrantz] Vrije Univ Amsterdam, Sch Business & Econ, Dept Spatial Econ, Amsterdam, Netherlands; [Liebst, Lasse Suonpera] Univ Copenhagen, Dept Sociol, Copenhagen K, Denmark; [Lindegaard, Marie Rosenkrantz] Univ Amsterdam, Fac Social & Behav Sci, Dept Sociol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Copenhagen; University of Amsterdam	Hoeben, EM (corresponding author), Netherlands Inst Study Crime & Law Enforcement NS, Amsterdam, Netherlands.	ehoeben@nscr.nl	; Bernasco, Wim/B-3639-2012	Van Baak, Carlijn/0000-0002-3823-078X; Bernasco, Wim/0000-0002-3385-0883	Netherlands Institute for the Study of Crime and Law Enforcement (NSCR); Netherlands Organisation for Health Research and Development (ZonMw) [10430022010017]	Netherlands Institute for the Study of Crime and Law Enforcement (NSCR); Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This project was supported by the Netherlands Institute for the Study of Crime and Law Enforcement (NSCR, www.nscr.nl) and by a grant from The Netherlands Organisation for Health Research and Development (ZonMw, www.zonmw.nl; project nr. 10430022010017), awarded to MRL, WB, and EH. NSCR and ZonMw had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afifi WA, 2005, SOURCEBOOK OF NONVERBAL MEASURES: GOING BEYOND WORDS, P189; Allcott H., 2020, WHAT EXPLAINS TEMPOR, DOI [10.2139/ssrn.3610422, DOI 10.2139/SSRN.3610422]; Bauch CT, 2013, SCIENCE, V342, P47, DOI 10.1126/science.1244492; BODEN D, 1994, NOWHERE SPACE TIME M, P257; Bonato P., 2020, ARXIV PREPRINT ARXIV; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Brezinski A., 202006 INET; Chetty R., 27431 NBER; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Cialdini R.B., 2006, SOC INFLUENCE, V1, p3, DOI [10.1080/15534510500181459, DOI 10.1080/15534510500181459]; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Collins R, 2004, SOCIOL THEOR, V22, P53, DOI 10.1111/j.1467-9558.2004.00204.x; Conn VS, 2015, CURR MED RES OPIN, V31, P145, DOI 10.1185/03007995.2014.978939; Courtemanche C, 2020, HEALTH AFFAIR, V39, P1237, DOI 10.1377/hlthaff.2020.00608; de Moraes RF, 2020, CIENC SAUDE COLETIVA, V25, P3393, DOI 10.1590/1413-81232020259.21892020; de Vreese CH, 2004, J MASS COMMUN Q, V81, P36, DOI 10.1177/107769900408100104; Farnum N. R., 1989, QUANTITATIVE FORECAS; Fetzer T. R., 2020, 27082 NBER, DOI DOI 10.31234/OSF; Fong MW, 2020, EMERG INFECT DIS, V26, P976, DOI 10.3201/eid2605.190995; Futing Liao T, 2004, SAGE ENCY SOCIAL SCI, P258; Gao Song, 2020, ARXIV PREPRINT ARXIV; Ghader S., 2020, ARXIV200414748V1; Gilmore RO, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0128; Goffman Erving, 1971, MICROSTUDIES PUBLIC, DOI [10.1038/229103a0 16059101, DOI 10.1038/229103A016059101]; Gollwitzer A., 2020, PSYARXIV, DOI 10.31234/osf.io/kvnwp; Google LLC, GOOGL COVID 19 COMM; Google Trends, 2020, GOOGL TRENDS; Government of the Netherlands, 2020, GOV NETH; GRIFFITH S, 1990, BRIT J GEN PRACT, V40, P114; Harper CA, 2021, INT J MENT HEALTH AD, V19, P1875, DOI 10.1007/s11469-020-00281-5; Innes M, 2004, BRIT J SOCIOL, V55, P335, DOI 10.1111/j.1468-4446.2004.00023.x; Islam N, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2743; John Hopkins University & Medicine, 2020, MAPS TRENDS FOLL GLO; Kikuzawa S, 2008, J HEALTH SOC BEHAV, V49, P385, DOI 10.1177/002214650804900402; Koninklijk Nederlands Meteorologisch Instituut, 2020, KLIM UURG VAN HET WE; Lau JTF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-18; Lindegaard MR, 2018, J RES CRIME DELINQ, V55, P155, DOI 10.1177/0022427817727830; Mauss M, 1979, SEASONAL VARIATIONS; MORRIS LS, 1992, J CLIN PHARM THER, V17, P283, DOI 10.1111/j.1365-2710.1992.tb01306.x; Nguyen CT, 2020, IEEE ACCESS, V8, P153479, DOI 10.1109/ACCESS.2020.3018140; Nguyen CT, 2020, IEEE ACCESS, V8, P154209, DOI 10.1109/ACCESS.2020.3018124; Olsen A.L., 2020, WILLINGNESS DISTANCE; Painter MO., 3569098 SSRN; Pepe E, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00575-2; Philpot R, 2019, AGGRESS VIOLENT BEH, V46, P56, DOI 10.1016/j.avb.2019.02.004; Pisano GP, 2020, HARVARD BUS REV; Pouw CAS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240963; R Core Team, 2020, R LANG ENV STAT COMP; Reiss AJ, 1971, SOCIOL METHODOL, V3, P3, DOI DOI 10.2307/270816; Reluga TC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000793; Rijksoverheid, LETT TEKST PERSC MIN; Rijksoverheid, AANV MAATR 23 MAART; Seale H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235112; Sorokowska A, 2017, J CROSS CULT PSYCHOL, V48, P577, DOI 10.1177/0022022117698039; Sun SX, 2020, J MED INTERNET RES, V22, DOI 10.2196/19992; Suvilehto JT, 2015, P NATL ACAD SCI USA, V112, P13811, DOI 10.1073/pnas.1519231112; Van Rooij B., 3582626 SSRN; Verelst F, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0820; WHO, ADHERENCE LONG TERM; World Health Organization, PAND INFL PREV MIT L	60	19	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2021	16	3							e0248221	10.1371/journal.pone.0248221	http://dx.doi.org/10.1371/journal.pone.0248221			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX9NB	33720951	gold, Green Published			2022-12-26	WOS:000629667400047
J	Zhu, B; Qian, F; Hou, YF; Yang, WC; Cai, MX; Wu, XM				Zhu, Bin; Qian, Fang; Hou, Yunfeng; Yang, Weicheng; Cai, Mengxian; Wu, Xiaoming			Complete chloroplast genome features and phylogenetic analysis of Eruca sativa (Brassicaceae)	PLOS ONE			English	Article								Eruca sativa Mill. (Brassicaceae) is an important edible vegetable and a potential medicinal plant due to the antibacterial activity of its seed oil. Here, the complete chloroplast (cp) genome of E. sativa was de novo assembled with a combination of long PacBio reads and short Illumina reads. The E. sativa cp genome had a quadripartite structure that was 153,522 bp in size, consisting of one large single-copy region of 83,320 bp and one small single-copy region of 17,786 bp which were separated by two inverted repeat (IRa and IRb) regions of 26,208 bp. This complete cp genome harbored 113 unique genes: 79 protein-coding genes, 30 tRNA genes, and four rRNA genes. Forty-nine long repetitive sequences and 69 simple sequence repeats were identified in the E. sativa cp genome. A codon usage analysis of the E. sativa cp genome showed a bias toward codons ending in A/T. The E. sativa cp genome was similar in size, gene composition, and linearity of the structural region when compared with other Brassicaceae cp genomes. Moreover, the analysis of the synonymous (Ks) and non-synonymous (Ka) substitution rates demonstrated that protein-coding genes generally underwent purifying selection pressure, expect ycf1, ycf2, and rps12. A phylogenetic analysis determined that E. sativa is evolutionarily close to important Brassica species, indicating that it may be possible to transfer favorable E. sativa alleles into other Brassica species. Our results will be helpful to advance genetic improvement and breeding of E. sativa, and will provide valuable information for utilizing E. sativa as an important resource to improve other Brassica species.	[Zhu, Bin; Qian, Fang; Hou, Yunfeng; Yang, Weicheng; Cai, Mengxian] Guizhou Normal Univ, Sch Life Sci, Guiyang, Peoples R China; [Zhu, Bin; Wu, Xiaoming] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China	Guizhou Normal University; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS	Cai, MX (corresponding author), Guizhou Normal Univ, Sch Life Sci, Guiyang, Peoples R China.; Wu, XM (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China.	caimengxian@126.com; wuxm@oilcrops.cn	Zhu, Bin/ABC-6740-2021	Cai, Mengxian/0000-0001-8330-5595	Open Project of Key Laboratory of Biology and Genetic Improvement of Oil Crops, Ministry of Agriculture and Rural Affairs, P.R. China [KF2019005]; Guizhou Provincial Science and Technology Foundation [[2020]1Y102]; Key Programs for Science, Technology and Social Development of Guizhou [QKHZC[2017] 2811]	Open Project of Key Laboratory of Biology and Genetic Improvement of Oil Crops, Ministry of Agriculture and Rural Affairs, P.R. China; Guizhou Provincial Science and Technology Foundation; Key Programs for Science, Technology and Social Development of Guizhou	This research was funded by Open Project of Key Laboratory of Biology and Genetic Improvement of Oil Crops, Ministry of Agriculture and Rural Affairs, P.R. China (KF2019005) by ZB, the Guizhou Provincial Science and Technology Foundation under Grant ([2020]1Y102) by ZB, and the Key Programs for Science, Technology and Social Development of Guizhou (QKHZC[2017] 2811) by YWC.	AGNIHOTRI A, 1990, PLANT BREEDING, V104, P281, DOI 10.1111/j.1439-0523.1990.tb00437.x; AGNIHOTRI A, 1990, CURR PLANT SCI BIOT, V9, P270; Arias T, 2012, TAXON, V61, P980, DOI 10.1002/tax.615005; Asaf S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00304; Barrett CF, 2013, CLADISTICS, V29, P65, DOI 10.1111/j.1096-0031.2012.00418.x; Beier S, 2017, BIOINFORMATICS, V33, P2583, DOI 10.1093/bioinformatics/btx198; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cai LM, 2016, J SYST EVOL, V54, P438, DOI 10.1111/jse.12204; Carbonell-Caballero J, 2015, MOL BIOL EVOL, V32, P2015, DOI 10.1093/molbev/msv082; Cavalier-Smith T, 2002, CURR BIOL, V12, pR62, DOI 10.1016/S0960-9822(01)00675-3; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; De las Rivas J, 2002, GENOME RES, V12, P567, DOI 10.1101/gr.209402; Doorduin L, 2011, DNA RES, V18, P93, DOI 10.1093/dnares/dsr002; Douglas SE, 1999, J MOL EVOL, V48, P236, DOI 10.1007/PL00006462; DOWNIE SR, 1994, SYST BOT, V19, P236, DOI 10.2307/2419599; Drescher A, 2000, PLANT J, V22, P97, DOI 10.1046/j.1365-313x.2000.00722.x; Du XY, 2020, GENE, V731, DOI 10.1016/j.gene.2020.144340; English AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047768; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gao K, 2019, TREE GENET GENOMES, V15, DOI 10.1007/s11295-019-1342-9; Gugliandolo A, 2018, MOL MED REP, V17, P6235, DOI 10.3892/mmr.2018.8695; HAMADA H, 1982, NATURE, V298, P396, DOI 10.1038/298396a0; Hebert PDN, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4611-3; Hong RL, 2003, PLANT CELL, V15, P1296, DOI 10.1105/tpc.009548; Howe CJ, 2003, PHILOS T ROY SOC B, V358, P99, DOI 10.1098/rstb.2002.1176; Hu ZY, 2011, GENET RESOUR CROP EV, V58, P875, DOI 10.1007/s10722-010-9626-9; Huang CH, 2016, MOL BIOL EVOL, V33, P394, DOI 10.1093/molbev/msv226; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jeong YM, 2014, GENE, V551, P39, DOI 10.1016/j.gene.2014.08.038; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Koubaa M., 2015, Free Radicals and Antioxidants, V5, P29, DOI 10.5530/fra.2015.1.5; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; LEW KA, 1993, J PHYCOL, V29, P500, DOI 10.1111/j.1529-8817.1993.tb00151.x; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Ma PF, 2014, SYST BIOL, V63, P933, DOI 10.1093/sysbio/syu054; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Morton BR, 1999, P NATL ACAD SCI USA, V96, P5123, DOI 10.1073/pnas.96.9.5123; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; Peden J, 1997, CODONW; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; Ren T, 2018, CONSERV GENET RESOUR, V10, P627, DOI 10.1007/s12686-017-0880-4; Seol YJ, 2017, MITOCHONDR DNA, V28, P1, DOI [10.3109/19401736.2015.1053063, DOI 10.3109/19401736.2015.1053063]; Sharma V., 2015, MILL AM J BIOL CHEM, V2, P23; Shaw J, 2014, AM J BOT, V101, P1987, DOI 10.3732/ajb.1400398; Shetty SM, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.09.0089; Torokeldiev N, 2019, TREE GENET GENOMES, V15, DOI [10.1007/s11295-018-1311-8, 1]; Wang YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105748; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yan C, 2019, GENE, V699, P24, DOI 10.1016/j.gene.2019.02.075; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Zhang X, 2018, MOLECULES, V23, DOI 10.3390/molecules23112917; Zhang Y., 2018, CONSERV GENET RESOUR, V10, P51, DOI [10.1007/s12686-017-0763-8, DOI 10.1007/s12686-017-0763-8]; Zhao B, 2010, BIOCHEM SYST ECOL, V38, P731, DOI 10.1016/j.bse.2010.06.003; Zhu B, 2019, MITOCHONDRIAL DNA B, V4, P3601, DOI 10.1080/23802359.2019.1677527	60	12	16	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2021	16	3							e0248556	10.1371/journal.pone.0248556	http://dx.doi.org/10.1371/journal.pone.0248556			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8KN	33711072	gold, Green Published			2022-12-26	WOS:000629591800009
J	Carr, KW; Perszyk, DR; Waxman, SR				Carr, Kali Woodruff; Perszyk, Danielle R.; Waxman, Sandra R.			Birdsong fails to support object categorization in human infants	PLOS ONE			English	Article							SPEECH-PERCEPTION; LANGUAGE	Recent evidence reveals a precocious link between language and cognition in human infants: listening to their native language supports infants' core cognitive processes, including object categorization, and does so in a way that other acoustic signals (e.g., time-reversed speech; sine-wave tone sequences) do not. Moreover, language is not the only signal that confers this cognitive advantage: listening to vocalizations of non-human primates also supports object categorization in 3- and 4-month-olds. Here, we move beyond primate vocalizations to clarify the breadth of acoustic signals that promote infant cognition. We ask whether listening to birdsong, another naturally produced animal vocalization, also supports object categorization in 3- and 4-month-old infants. We report that listening to zebra finch song failed to confer a cognitive advantage. This outcome brings us closer to identifying a boundary condition on the range of non-linguistic acoustic signals that initially support infant cognition.	[Carr, Kali Woodruff; Perszyk, Danielle R.; Waxman, Sandra R.] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; [Carr, Kali Woodruff] Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL USA; [Waxman, Sandra R.] Northwestern Univ, Inst Innovat Dev Sci, Evanston, IL 60208 USA; [Waxman, Sandra R.] Northwestern Univ, Inst Policy Res, Evanston, IL 60208 USA; [Perszyk, Danielle R.] Google, Mountain View, CA 94043 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University; Google Incorporated	Waxman, SR (corresponding author), Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA.; Waxman, SR (corresponding author), Northwestern Univ, Inst Innovat Dev Sci, Evanston, IL 60208 USA.; Waxman, SR (corresponding author), Northwestern Univ, Inst Policy Res, Evanston, IL 60208 USA.	s-waxman@northwestern.edu		Woodruff Carr, Kali/0000-0002-3142-0476; waxman, sandra/0000-0002-5009-2068	National Institute of Health (NIH) [R01HD083310]	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Health (NIH) Grant R01HD083310 to S.R.W. The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Google, LLC (www.google.com) provided support in the form of salary for author D.R.P. after the completion of data collection and analysis, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Aslin RN, 2007, DEVELOPMENTAL SCI, V10, P48, DOI 10.1111/j.1467-7687.2007.00563.x; Berwick RC, 2011, TRENDS COGN SCI, V15, P113, DOI 10.1016/j.tics.2011.01.002; Boersma Paul, 2002, GLOT INT, V5, P341; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; Colombo J, 2002, CURR DIR PSYCHOL SCI, V11, P196, DOI 10.1111/1467-8721.00199; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Ellis DPW, 1998, GAMMATONE LIKE SPECT; Ferguson B, 2017, J CHILD LANG, V44, P527, DOI 10.1017/S0305000916000568; Ferguson B, 2016, SCI REP-UK, V6, DOI 10.1038/srep25434; Ferry AL, 2013, P NATL ACAD SCI USA, V110, P15231, DOI 10.1073/pnas.1221166110; Ferry AL, 2010, CHILD DEV, V81, P472, DOI 10.1111/j.1467-8624.2009.01408.x; Gelman SA, 2004, TRENDS COGN SCI, V8, P404, DOI 10.1016/j.tics.2004.07.001; Gentner D, 2003, BRADFORD BOOKS, P1; GOLINKOFF RM, 1987, J CHILD LANG, V14, P23, DOI 10.1017/S030500090001271X; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hollich G., 2005, SUPERCODER PROGRAM C; Hummersone C, 2020, GAMMATONE FILTERBANK; Kuhl PK, 2008, PHILOS T R SOC B, V363, P979, DOI 10.1098/rstb.2007.2154; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9645, DOI 10.1073/pnas.1733998100; MEDIN DL, 1989, AM PSYCHOL, V44, P1469, DOI 10.1037/0003-066X.44.12.1469; Mol C, 2017, NEUROSCI BIOBEHAV R, V81, P167, DOI 10.1016/j.neubiorev.2017.02.016; Murphy G., 2004, BIG BOOK CONCEPTS; Pena M, 2010, P NATL ACAD SCI USA, V107, P3823, DOI 10.1073/pnas.0914326107; Perszyk DR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39511-9; Perszyk DR, 2018, ANNU REV PSYCHOL, V69, P231, DOI 10.1146/annurev-psych-122216-011701; Petkov Christopher I, 2012, Front Evol Neurosci, V4, P12, DOI 10.3389/fnevo.2012.00012; Prather JF, 2017, NEUROSCI BIOBEHAV R, V81, P225, DOI 10.1016/j.neubiorev.2016.12.035; Roeske TC, 2020, CURR BIOL, V30, P3544, DOI 10.1016/j.cub.2020.06.072; Santolin C, 2019, INFANCY, V24, P827, DOI 10.1111/infa.12295; Shultz S, 2010, LANG LEARN DEV, V6, P241, DOI 10.1080/15475440903507830; Slater P.J.B., 1988, Advances in the Study of Behavior, V18, P1; Smith EE, 1981, CATEGORIES CONCEPTS; Swingley D, 2012, LANG LEARN DEV, V8, P1, DOI 10.1080/15475441.2012.631852; Vouloumanos A, 2007, DEVELOPMENTAL SCI, V10, P159, DOI 10.1111/j.1467-7687.2007.00549.x; Vouloumanos A, 2010, CHILD DEV, V81, P517, DOI 10.1111/j.1467-8624.2009.01412.x; Waxman SR, 2009, TRENDS COGN SCI, V13, P258, DOI 10.1016/j.tics.2009.03.006; Werker JF, 2018, APPL PSYCHOLINGUIST, V39, P703, DOI 10.1017/S0142716418000152; WERKER JF, 1984, INFANT BEHAV DEV, V7, P49, DOI 10.1016/S0163-6383(84)80022-3	38	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0247430	10.1371/journal.pone.0247430	http://dx.doi.org/10.1371/journal.pone.0247430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8JZ	33705442	gold, Green Published			2022-12-26	WOS:000629590400066
J	Fujihara, N; Fujihara, Y; Hamada, S; Yoshida, M; Tsukushi, S				Fujihara, Nasa; Fujihara, Yuki; Hamada, Shunsuke; Yoshida, Masahiro; Tsukushi, Satoshi			Current practice patterns of osteoporosis treatment in cancer patients and effects of therapeutic interventions in a tertiary center	PLOS ONE			English	Article								Cancer and osteoporosis have high incidence rates in older populations. However, the treatment of osteoporosis among cancer patients has not been adequately described. Our purpose was to clarify the current practice patterns of osteoporosis treatment among cancer patients in an academic cancer center, and to analyze the efficacy of treatment interventions. Patient records from April 2009 to March 2018 were retrospectively reviewed, and the study included a total of 316 cancer patients with osteoporosis. After patients' data extraction, the patients were divided into two groups, with (n = 144) or without treatment (n = 172), and compared the outcomes of these groups to evaluate the medication effect. The primary outcome was new radiographic fragility fractures during the study period. The related factors associated with fracture injuries and the rate of adverse events, such as osteonecrosis in the jaw and atypical femoral fractures, were analyzed. The rate of treatment intervention was 45.6% among the patient groups. Among patients in the study group, breast cancer patients (n = 107) were mostly treated (n = 79, 73.8%) with oral bisphosphonate. A significant difference in new fracture rate was observed between the two groups (treatment group, 30.6%; non-treatment group, 54.7%), and the risk of fracture was 42% lower in the treatment group (hazard ratio, 0.58; 95% confidence interval, 0.39-0.86; p<0.05). Previous chemotherapy, steroid use, and older age were significantly associated with increased rate of new fragility fractures. The adverse event rate was 3.5% (presented in five cases). Older cancer patients who receive chemotherapy or steroids are strongly recommended undergo bone quality assessment and appropriate osteoporosis treatment to improve their prognosis.	[Fujihara, Nasa; Hamada, Shunsuke; Yoshida, Masahiro; Tsukushi, Satoshi] Aichi Canc Ctr, Sect Orthoped Surg, Nagoya, Aichi, Japan; [Fujihara, Yuki] Nagoya Ekisaikai Hosp, Sect Orthoped Surg, Nagoya, Aichi, Japan	Aichi Cancer Center	Fujihara, N (corresponding author), Aichi Canc Ctr, Sect Orthoped Surg, Nagoya, Aichi, Japan.	nfujihara@aichi-cc.jp		Fujihara, Nasa/0000-0002-4197-0586; Tsukushi, Satoshi/0000-0002-2181-0702				Andrews EB, 2012, J BONE MINER RES, V27, P2429, DOI 10.1002/jbmr.1768; Body JJ, 2016, CANCER TREAT REV, V51, P46, DOI 10.1016/j.ctrv.2016.10.004; Colzani E, 2016, BRIT J CANCER, V115, P1400, DOI 10.1038/bjc.2016.314; Cosman F, 2016, NEW ENGL J MED, V375, P1532, DOI 10.1056/NEJMoa1607948; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; Edwards BJ, 2016, J BONE MINER RES, V31, P1569, DOI 10.1002/jbmr.2818; Fardellone P, 2010, JOINT BONE SPINE, V77, P53, DOI 10.1016/j.jbspin.2009.04.009; Frieze DA, 2010, CURR PAIN HEADACHE R, V14, P256, DOI 10.1007/s11916-010-0120-z; Gilsenan A, 2021, J BONE MINER RES, V36, P244, DOI 10.1002/jbmr.4188; Hadji P, 2017, J BONE ONCOL, V7, P1, DOI 10.1016/j.jbo.2017.03.001; Hagino H, 2019, J BONE MINER METAB, V37, P273, DOI 10.1007/s00774-018-0914-3; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Hu ZS, 2018, ARCH OSTEOPOROS, V13, DOI 10.1007/s11657-018-0512-y; Iki Masayuki, 2012, Clin Calcium, V22, P797, DOI CliCa1206797803; Kataoka Y, 2020, ARCH OSTEOPOROS, V15, DOI 10.1007/s11657-020-0697-8; Khanfir A, 2013, REP PRACT ONCOL RADI, V18, P127, DOI 10.1016/j.rpor.2013.01.001; Khosla S, 2012, J CLIN ENDOCR METAB, V97, P2272, DOI 10.1210/jc.2012-1027; Koo DH, 2011, CANCER CHEMOTH PHARM, V68, P913, DOI 10.1007/s00280-011-1561-8; Lindsay BR, 2016, ARCH OSTEOPOROS, V11, DOI 10.1007/s11657-016-0272-5; Lipton A, 2012, EUR J CANCER, V48, P3082, DOI 10.1016/j.ejca.2012.08.002; Miceli TS, 2011, CLIN J ONCOL NURS, V15, P9, DOI 10.1188/11.S1.CJON.9-23; Moriwaki K, 2017, OSTEOPOROSIS INT, V28, P1939, DOI 10.1007/s00198-017-3973-8; Nawata H, 2005, J BONE MINER METAB, V23, P105, DOI 10.1007/s00774-004-0596-x; Orimo Hajime, 2012, Arch Osteoporos, V7, P3; Ottanelli S, 2015, CLIN CASES MINER BON, V12, P116, DOI 10.11138/ccmbm/2015.12.2.116; Prieto-Alhambra D, 2014, J BONE MINER RES, V29, P1737, DOI 10.1002/jbmr.2209; Reginster JY, 2006, BONE, V38, P4, DOI 10.1016/j.bone.2005.11.024; Subbiah V, 2010, OSTEOPOROSIS INT, V21, P1041, DOI 10.1007/s00198-009-1004-0; Suzuki Y, 2014, J BONE MINER METAB, V32, P337, DOI 10.1007/s00774-014-0586-6; Takamatsu H, 2015, CANCER SCI, V106, P179, DOI 10.1111/cas.12594; Winter WE, 2007, J CLIN ONCOL, V25, P3621, DOI 10.1200/JCO.2006.10.2517	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248188	10.1371/journal.pone.0248188	http://dx.doi.org/10.1371/journal.pone.0248188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705450	Green Published, gold			2022-12-26	WOS:000629590400093
J	Huang, EI; Wu, YC; Chuang, HM; Huang, TC				Huang, Ethan, I; Wu, Yu-Chieh; Chuang, Hsiu-Mei; Huang, Tzu-Chi			Bone-conduction threshold and air-bone gap may predict frequency-specific air-conduction threshold after tympanoplasty	PLOS ONE			English	Article							SENSORINEURAL HEARING-LOSS; OTITIS-MEDIA; PROGNOSTIC-FACTORS; OUTCOMES; SURGERY	Postoperative hearing improvement is one of the main expectations for patients receiving tympanoplasty. The capacity to predict postoperative hearing may help to counsel a patient properly and avoid untoward expectations. It is difficult to predict postoperative hearing without knowing the disease process in the middle ear, which can only be assessed intraoperatively. However, the duration and extent of the underlying pathologies may represent in bone-conduction threshold and air-bone gap. Here in patients undergoing tympanoplasty without ossiculoplasty, we sorted and separated the surgery dates into the first group to build the predicting models and the second group to test the predictions. There were 87 and 30 ears, respectively. No specific enrollment or exclusion criteria were based on underlying pathologies such as the perforation size of the tympanic membrane or the middle ear conditions. The results show that bone-conduction threshold and air-bone gap together predicted air-conduction threshold after the surgery, including each frequency of 0.5k, 1k, 2k, and 4k Hz. The discrepancies between the predictions and recordings did not differ among these four frequencies. Of the variance in mean postoperative air-conduction threshold, 56.7% was linearly accounted for by these two preoperative predictors in this sample. The results suggest a trend that, the higher the frequency, the larger the part was accounted for by these two preoperative predictors. These together may help a surgeon to estimate frequency-specific hearing outcome after the surgery, answer patients' questions with quantitative statistics, and counsel patients with proper expectations.	[Huang, Ethan, I] Chang Gung Mem Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Huang, Ethan, I] Chang Gung Univ, Sch Med, Taoyuan, Taiwan; [Wu, Yu-Chieh; Chuang, Hsiu-Mei; Huang, Tzu-Chi] Chang Gung Mem Hosp, Audiol & Speech Pathol Ctr, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Huang, EI (corresponding author), Chang Gung Mem Hosp, Dept Otolaryngol, Chiayi, Taiwan.; Huang, EI (corresponding author), Chang Gung Univ, Sch Med, Taoyuan, Taiwan.	ehuang@alumni.pitt.edu						Adoga A, 2010, PAN AFR MED J, V4; BELLUCCI RJ, 1989, OTOLARYNG CLIN N AM, V22, P911; BLACK B, 1992, AM J OTOL, V13, P544; Blakley BW, 1998, OTOLARYNG HEAD NECK, V119, P559, DOI 10.1016/S0194-5998(98)70011-7; Choi HG, 2011, CLIN EXP OTORHINOLAR, V4, P126, DOI 10.3342/ceo.2011.4.3.126; Ciprandi G, 2020, CURR ALLERGY ASTHM R, V20, DOI 10.1007/s11882-020-00930-8; Doyle WJ, 2002, CURR OPIN ALLERGY CL, V2, P21, DOI 10.1097/00130832-200202000-00004; DUMICH PS, 1983, LARYNGOSCOPE, V93, P583; ENGLISH GM, 1973, ARCH OTOLARYNGOL, V98, P18; Boronat-Echeverria NE, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-67; Fireman P, 1997, J ALLERGY CLIN IMMUN, V99, pS787, DOI 10.1016/S0091-6749(97)70130-1; GOYCOOLEA MV, 1980, ARCH OTOLARYNGOL, V106, P430; Higashimachi T., 2017, INT J DES NAT ECODYN, V12, P75, DOI 10.2495/dne-v12-n1-75-85; KARTUSH JM, 1994, OTOLARYNG CLIN N AM, V27, P689; Korsten-Meijer AGW, 2006, EUR ARCH OTO-RHINO-L, V263, P256, DOI 10.1007/s00405-005-0983-5; Lade H, 2014, EUR ARCH OTO-RHINO-L, V271, P1897, DOI 10.1007/s00405-013-2673-z; Merchant SN, 1998, EUR ARCH OTO-RHINO-L, V255, P221, DOI 10.1007/s004050050047; Mishiro Y, 2009, EUR ARCH OTO-RHINO-L, V266, P819, DOI 10.1007/s00405-008-0816-4; Nallapaneni LS, 2022, INDIAN J OTOLARYNGOL, V74, P26, DOI 10.1007/s12070-020-01796-y; Olusesi AD, 2011, EUR ARCH OTO-RHINO-L, V268, P367, DOI 10.1007/s00405-010-1405-x; Paparella M M, 1970, Trans Am Acad Ophthalmol Otolaryngol, V74, P108; PAPARELLA MM, 1972, ANN OTO RHINOL LARYN, V81, P632, DOI 10.1177/000348947208100503; Shakti A., 2020, INDIAN J OTOLARYNGOL; Singer AA, 2018, AM J OTOLARYNG, V39, P88, DOI 10.1016/j.amjoto.2018.01.002; Subramaniam Vijayalakshmi, 2020, Iran J Otorhinolaryngol, V32, P79, DOI 10.22038/ijorl.2019.35045.2158; Szaleniec J, 2013, COMPUT BIOL MED, V43, P16, DOI 10.1016/j.compbiomed.2012.10.003; Tuz M, 2000, OTOLARYNG HEAD NECK, V123, P775, DOI 10.1067/mhn.2000.111292; WULLSTEIN H, 1956, Laryngoscope, V66, P1076	28	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248421	10.1371/journal.pone.0248421	http://dx.doi.org/10.1371/journal.pone.0248421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705499	gold, Green Published			2022-12-26	WOS:000629590400048
J	Ono, R; Masuya, M; Inoue, N; Shinmei, M; Ishii, S; Maegawa, Y; Maharjan, BD; Katayama, N; Nosaka, T				Ono, Ryoichi; Masuya, Masahiro; Inoue, Naokazu; Shinmei, Makoto; Ishii, Satomi; Maegawa, Yuri; Maharjan, Bishnu Devi; Katayama, Naoyuki; Nosaka, Tetsuya			Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models	PLOS ONE			English	Article								The Ten Eleven Translocation 1 (TET1) gene encodes an epigenetic modifying molecule that is involved in demethylation of 5-methylcytosine. In hematological malignancies, loss-of-function mutations of TET2, which is one of the TET family genes including TET1, are frequently found, while the mutations of TET1 are not. However, clinical studies have revealed that TET1 is highly expressed in some cases of the hematological malignancies including acute myeloid leukemia. Indeed, studies by mouse models using conventional Tet1 knockout mice demonstrated that Tet1 is involved in myeloid leukemogenesis by Mixed Lineage Leukemia (MLL) fusion gene or TET2 mutant. Meanwhile, the other study showed that Tet1 is highly expressed in hematopoietic stem cells (HSCs), and that deletion of Tet1 in HSCs enhances potential self-renewal capacity, which is potentially associated with myeloid leukemogenesis. To examine the role of Tet1 in myeloid leukemogenesis more precisely, we generated novel conditional Tet1-knockout mice, which were used to generate the compound mutant mice by crossing with the inducible MLL-ENL transgenic mice that we developed previously. The leukemic immortalization in vitro was not critically affected by conditional ablation of Tet1 in HSCs with the induced expression of MLL-ENL or in hematopoietic progenitor cells retrovirally transduced with MLL-ENL. In addition, the leukemic phenotypes caused by the induced expression of MLL-ENL in vivo was not also critically affected in the compound mutant mouse model by conditional ablation of Tet1, although we found that the expression of Evi1, which is one of critical target genes of MLL fusion gene, in tumor cells was remarkably low under Tet1-ablated condition. These results revealed that Tet1 was dispensable for the myeloid leukemogenesis by MLL-ENL, suggesting that the therapeutic application of Tet1 inhibition may need careful assessment.	[Ono, Ryoichi; Shinmei, Makoto; Ishii, Satomi; Maegawa, Yuri; Maharjan, Bishnu Devi; Nosaka, Tetsuya] Mie Univ, Dept Microbiol & Mol Genet, Grad Sch Med, Tsu, Mie, Japan; [Masuya, Masahiro; Maegawa, Yuri; Katayama, Naoyuki] Mie Univ, Dept Hematol & Oncol, Grad Sch Med, Tsu, Mie, Japan; [Inoue, Naokazu] Osaka Univ, Res Inst Microbial Dis, Osaka, Japan; [Inoue, Naokazu] Fukushima Med Univ, Sch Med, Inst Biomed Sci, Dept Cell Sci, Fukushima, Japan	Mie University; Mie University; Osaka University; Fukushima Medical University	Ono, R; Nosaka, T (corresponding author), Mie Univ, Dept Microbiol & Mol Genet, Grad Sch Med, Tsu, Mie, Japan.	onor-tky@umin.net; nosaka@doc.medic.mie-u.ac.jp		Inoue, Naokazu/0000-0002-6187-8293	Ministry of Education, Culture, Sports, Science, and Technology in Japan [17H04227, 26293247, 18K08352, 15K09452]; Sanikai	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sanikai	The study was supported by Grants-inAid from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (https://www.mext.go.jp/en/; T.N.; Basic-B; 17H04227 and 26293247, and R.O.; Basic-C; 18K08352, 15K09452), and Sanikai (http://sanikai.info/; R.O. (no grant numbers awarded)). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Arai S, 2011, BLOOD, V117, P6304, DOI 10.1182/blood-2009-07-234310; Atlasi Y, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.57; Bamezai S, 2021, LEUKEMIA, V35, P389, DOI 10.1038/s41375-020-0864-3; Bindels EMJ, 2012, BLOOD, V119, P5838, DOI 10.1182/blood-2011-11-393827; Bowman RL, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026518; Cimmino L, 2015, NAT IMMUNOL, V16, P653, DOI 10.1038/ni.3148; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Flavahan WA, 2017, SCIENCE, V357, DOI 10.1126/science.aal2380; Freudenberg JM, 2012, NUCLEIC ACIDS RES, V40, P3364, DOI 10.1093/nar/gkr1253; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Garcia-Cuellar MP, 2016, CELL REP, V15, P310, DOI 10.1016/j.celrep.2016.03.018; Huang H, 2013, P NATL ACAD SCI USA, V110, P11994, DOI 10.1073/pnas.1310656110; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kitamura T, 2016, J BIOCHEM, V159, P17, DOI 10.1093/jb/mvv114; Krivtsov AV, 2013, LEUKEMIA, V27, P852, DOI 10.1038/leu.2012.363; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Kunimoto H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00273; Lio CWJ, 2019, BLOOD, V134, P1487, DOI 10.1182/blood.2019791475; Lopez-Moyado IF, 2019, P NATL ACAD SCI USA, V116, P16933, DOI 10.1073/pnas.1903059116; Lorsbach RB, 2003, LEUKEMIA, V17, P637, DOI 10.1038/sj.leu.2402834; Michalak EM, 2019, NAT REV MOL CELL BIO, V20, P573, DOI 10.1038/s41580-019-0143-1; Ono R, 2005, MOL CELL BIOL, V25, P10965, DOI 10.1128/MCB.25.24.10965-10978.2005; Ono R, 2005, J CLIN INVEST, V115, P919, DOI 10.1172/JCI200522725; Ono R, 2002, CANCER RES, V62, P4075; Ono R, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00585-16; Ono R, 2013, BLOOD, V122, P1271, DOI 10.1182/blood-2012-09-456665; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI 10.1101/gad.276568.115; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Stavropoulou V, 2016, CANCER CELL, V30, P43, DOI 10.1016/j.ccell.2016.05.011; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Vazquez I, 2011, HAEMATOL-HEMATOL J, V96, P1448, DOI 10.3324/haematol.2011.040535; Wang JH, 2018, EBIOMEDICINE, V28, P90, DOI 10.1016/j.ebiom.2018.01.031; Wu XJ, 2017, NAT REV GENET, V18, P517, DOI 10.1038/nrg.2017.33; Zhao ZG, 2015, CELL REP, V13, P1692, DOI 10.1016/j.celrep.2015.10.037	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248425	10.1371/journal.pone.0248425	http://dx.doi.org/10.1371/journal.pone.0248425			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705482	gold, Green Published			2022-12-26	WOS:000629590400049
J	Smith, LK; Babcock, IW; Minamide, LS; Shaw, AE; Bamburg, JR; Kuhn, TB				Smith, Lisa K.; Babcock, Isaac W.; Minamide, Laurie S.; Shaw, Alisa E.; Bamburg, James R.; Kuhn, Thomas B.			Direct interaction of HIV gp120 with neuronal CXCR4 and CCR5 receptors induces cofilin-actin rod pathology via a cellular prion protein- and NOX-dependent mechanism	PLOS ONE			English	Article								Nearly 50% of individuals with long-term HIV infection are affected by the onset of progressive HIV-associated neurocognitive disorders (HAND). HIV infiltrates the central nervous system (CNS) early during primary infection where it establishes persistent infection in microglia (resident macrophages) and astrocytes that in turn release inflammatory cytokines, small neurotoxic mediators, and viral proteins. While the molecular mechanisms underlying pathology in HAND remain poorly understood, synaptodendritic damage has emerged as a hallmark of HIV infection of the CNS. Here, we report that the HIV viral envelope glycoprotein gp120 induces the formation of aberrant, rod-shaped cofilin-actin inclusions (rods) in cultured mouse hippocampal neurons via a signaling pathway common to other neurodegenerative stimuli including oligomeric, soluble amyloid-beta and proinflammatory cytokines. Previous studies showed that synaptic function is impaired preferentially in the distal proximity of rods within dendrites. Our studies demonstrate gp120 binding to either chemokine co-receptor CCR5 or CXCR4 is capable of inducing rod formation, and signaling through this pathway requires active NADPH oxidase presumably through the formation of superoxide (O2-) and the expression of cellular prion protein (PrP(C)). These findings link gp120-mediated oxidative stress to the generation of rods, which may underlie early synaptic dysfunction observed in HAND.	[Smith, Lisa K.; Kuhn, Thomas B.] Univ Alaska Fairbanks, Dept Chem & Biochem, Fairbanks, AK 99775 USA; [Babcock, Isaac W.; Minamide, Laurie S.; Shaw, Alisa E.; Bamburg, James R.; Kuhn, Thomas B.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	University of Alaska System; University of Alaska Fairbanks; Colorado State University	Kuhn, TB (corresponding author), Univ Alaska Fairbanks, Dept Chem & Biochem, Fairbanks, AK 99775 USA.; Kuhn, TB (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	tbkuhn@colostate.edu			NIH [NIH-NIA 1R01AG049668, NIH 1S10OD025127, NIH-NINDS 5R01NS40371, UL1GM118991, TL4GM118992, RL5GM118990]; Alzheimer's Research Foundation of Alaska; NIH-NIGMS [P20GM103395]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Research Foundation of Alaska; NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported through NIH grants NIH-NIA 1R01AG049668 (JRB), NIH 1S10OD025127 (JRB), NIH-NINDS 5R01NS40371 (JRB) as well as the Colorado State University Microscopy Imaging Core and generous donations to the research development fund (JRB). Further support for this research was provide through NIH-NIGMS grant P20GM103395 (LKS) and NIH grants UL1GM118991, TL4GM118992, or RL5GM118990 (LKS, TBK) and the Alzheimer's Research Foundation of Alaska (TBK). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 1989, J BIOCHEM-TOKYO, V106, P696, DOI 10.1093/oxfordjournals.jbchem.a122919; Ashraf T, 2011, J NEUROSCI RES, V89, P1773, DOI 10.1002/jnr.22720; Avdoshina V, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0482-z; Avdoshina V, 2017, J NEUROCHEM, V141, P606, DOI 10.1111/jnc.14015; Ballester LY, 2012, J BIOL CHEM, V287, P3079, DOI 10.1074/jbc.M111.262543; Bamburg JR, 2016, CYTOSKELETON, V73, P477, DOI 10.1002/cm.21282; Barth BM, 2012, J NEUROSCI RES, V90, P229, DOI 10.1002/jnr.22748; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; Bell JE, 1998, REV NEUROL-FRANCE, V154, P816; Bernstein BW, 2012, J NEUROSCI, V32, P6670, DOI 10.1523/JNEUROSCI.6020-11.2012; Botto L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098344; Boutet A, 2001, NEUROSCI LETT, V311, P105, DOI 10.1016/S0304-3940(01)02149-8; BRACCI L, 1992, FEBS LETT, V311, P115, DOI 10.1016/0014-5793(92)81380-5; Canto-Noges C, 2005, J MOL NEUROSCI, V27, P79, DOI 10.1385/JMN:27:1:079; Capo-Velez CM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20271-x; Chen B, 2012, BRAIN RES, V1486, P1, DOI 10.1016/j.brainres.2012.08.054; Chen B, 2020, NEUROSCIENCE, V444, P64, DOI 10.1016/j.neuroscience.2020.07.019; Cichon J, 2012, J BIOL CHEM, V287, P3919, DOI 10.1074/jbc.M111.301911; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cox TO, 2019, ANN CLIN TRANSL NEUR, V6, P554, DOI 10.1002/acn3.730; Cremesti AE, 2002, FEBS LETT, V531, P47, DOI 10.1016/S0014-5793(02)03489-0; Davis RC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-10; Delcambre GH, 2016, PEERJ, V4, DOI 10.7717/peerj.1601; Devineni N, 1999, BRAIN RES, V823, P129, DOI 10.1016/S0006-8993(99)01147-6; Fantini J, 2003, CELL MOL LIFE SCI, V60, P1027, DOI 10.1007/s00018-003-3003-1; Fantini Jacques, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005392; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; Festa L, 2015, J NEUROSCI, V35, P10550, DOI 10.1523/JNEUROSCI.4403-14.2015; Festa LK, 2020, ELIFE, V9, DOI 10.7554/eLife.49717; Gabuzda D, 2000, J NEUROVIROL, V6, pS24; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Gavriel Y, 2020, J ALZHEIMERS DIS, V78, P653, DOI 10.3233/JAD-200506; Gerngross L, 2015, J NEUROVIROL, V21, P249, DOI 10.1007/s13365-014-0270-6; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Grassi S, 2020, J LIPID RES, V61, P636, DOI 10.1194/jlr.TR119000427; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Guo LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070565; Haigh CL, 2005, MOL CELL NEUROSCI, V30, P186, DOI 10.1016/j.mcn.2005.07.001; He SJ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aat7911; Irwin ME, 2015, ONCOTARGET, V6, P23631, DOI 10.18632/oncotarget.4604; Iskander S, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-7; Jana A, 2004, J BIOL CHEM, V279, P51451, DOI 10.1074/jbc.M404635200; Jin S, 2011, ANTIOXID REDOX SIGN, V15, P1043, DOI 10.1089/ars.2010.3619; JORDAN CA, 1991, J VIROL, V65, P736, DOI 10.1128/JVI.65.2.736-742.1991; Joy MT, 2019, CELL, V176, P1143, DOI 10.1016/j.cell.2019.01.044; Kaul M, 2007, CELL DEATH DIFFER, V14, P296, DOI 10.1038/sj.cdd.4402006; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Kawahara T, 2005, J BIOL CHEM, V280, P31859, DOI 10.1074/jbc.M501882200; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Kozak SL, 2002, J VIROL, V76, P1802, DOI 10.1128/JVI.76.4.1802-1815.2002; Legler DF, 2017, MOL PHARMACOL, V91, P331, DOI 10.1124/mol.116.107151; Lewerenz J, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00469; Li TW, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00209; LIPTON SA, 1991, NEURON, V7, P111, DOI 10.1016/0896-6273(91)90079-F; Maloney MT, 2005, J NEUROSCI, V25, P11313, DOI 10.1523/JNEUROSCI.3711-05.2005; Marchionni I, 2012, J PHYSIOL-LONDON, V590, P3185, DOI 10.1113/jphysiol.2011.224873; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; Maung R, 2014, J IMMUNOL, V193, P1895, DOI 10.4049/jimmunol.1302915; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Mi JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083609; Minamide LS, 2010, J BIOL CHEM, V285, P5450, DOI 10.1074/jbc.M109.063768; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Minamide LS, 2003, METHOD CELL BIOL, V71, P387, DOI 10.1016/S0091-679X(03)01019-7; MINAMIDE LS, 1990, ANAL BIOCHEM, V190, P66, DOI 10.1016/0003-2697(90)90134-U; Mocchetti I, 2012, NEUROTOX RES, V21, P79, DOI 10.1007/s12640-011-9279-2; MORGAN TE, 1993, J CELL BIOL, V122, P623, DOI 10.1083/jcb.122.3.623; Nguyen DH, 2002, BLOOD, V99, P4298, DOI 10.1182/blood-2001-11-0087; PARK JW, 1992, J BIOL CHEM, V267, P17327; Pelucchi S, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa086; Petito CK, 2001, J NEUROPATH EXP NEUR, V60, P377, DOI 10.1093/jnen/60.4.377; Planes R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35478-1; Purde V, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225647; Rahman T, 2014, J ALZHEIMERS DIS, V42, P1443, DOI 10.3233/JAD-140393; Ronaldson PT, 2006, MOL PHARMACOL, V70, P1087, DOI 10.1124/mol.106.025973; Rust MB, 2015, CELL MOL LIFE SCI, V72, P3521, DOI 10.1007/s00018-015-1941-z; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Sanfilippo C, 2020, BRAIN RES, V1749, DOI 10.1016/j.brainres.2020.147127; Schengrund CL, 2010, BRAIN RES BULL, V82, P7, DOI 10.1016/j.brainresbull.2010.02.013; Shah A, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-96; Shaw AE, 2004, ELECTROPHORESIS, V25, P2611, DOI 10.1002/elps.200406017; Shaw AE, 2017, PHARMACOL THERAPEUT, V175, P17, DOI 10.1016/j.pharmthera.2017.02.031; Shi Q, 2013, MED MICROBIOL IMMUN, V202, P215, DOI 10.1007/s00430-012-0284-8; Shu L, 2019, J CEREBR BLOOD F MET, V39, P2181, DOI 10.1177/0271678X18785567; Smith LK, 2018, CURR HIV RES, V16, P258, DOI 10.2174/1570162X16666181003144740; Sonnino S, 2014, MOL NEUROBIOL, V50, P130, DOI 10.1007/s12035-013-8614-4; Sorce S, 2011, PROG NEUROBIOL, V93, P297, DOI 10.1016/j.pneurobio.2010.12.003; Spear Mark, 2014, Virologica Sinica, V29, P139, DOI 10.1007/s12250-014-3476-0; Stella AO, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020063; Stradal TEB, 2018, FEBS LETT, V592, P3658, DOI 10.1002/1873-3468.13173; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Terzi A, 2020, FREE RADICAL BIO MED, V154, P33, DOI 10.1016/j.freeradbiomed.2020.04.027; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; Wallace DR, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/65741; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Walsh KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095995; Wang ZY, 2003, VIROLOGY, V312, P60, DOI 10.1016/S0042-6822(03)00181-8; Wenzel ED, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1920-7; Wenzel ED, 2019, J NEUROVIROL, V25, P301, DOI 10.1007/s13365-019-00737-y; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WIENTJES FB, 1993, BIOCHEM J, V296, P557, DOI 10.1042/bj2960557; Wiggan O, 2017, SCI REP-UK, V7, DOI 10.1038/srep40953; Wilen CB, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006866; Won SJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198709; Woo JA, 2015, CELL DEATH DIFFER, V22, P921, DOI 10.1038/cdd.2015.5; Woo JA, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.37; Wu YT, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-95; Xu HX, 2011, J NEUROSCI, V31, P17074, DOI 10.1523/JNEUROSCI.4072-11.2011; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Zhukovsky MA, 2013, PROTEINS, V81, P555, DOI 10.1002/prot.24211	111	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2021	16	3							e0248309	10.1371/journal.pone.0248309	http://dx.doi.org/10.1371/journal.pone.0248309			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8JZ	33705493	gold, Green Published			2022-12-26	WOS:000629590400045
J	Wang, XY; Tong, YX				Wang, Xuyang; Tong, Yixuan			Application of an emotional classification model in e-commerce text based on an improved transformer model	PLOS ONE			English	Article								With the rapid development of the mobile internet, people are becoming more dependent on the internet to express their comments on products or stores; meanwhile, text sentiment classification of these comments has become a research hotspot. In existing methods, it is fairly popular to apply a deep learning method to the text classification task. Aiming at solving information loss, weak context and other problems, this paper makes an improvement based on the transformer model to reduce the difficulty of model training and training time cost and achieve higher overall model recall and accuracy in text sentiment classification. The transformer model replaces the traditional convolutional neural network (CNN) and the recurrent neural network (RNN) and is fully based on the attention mechanism; therefore, the transformer model effectively improves the training speed and reduces training difficulty. This paper selects e-commerce reviews as research objects and applies deep learning theory. First, the text is preprocessed by word vectorization. Then the IN standardized method and the GELUs activation function are applied based on the original model to analyze the emotional tendencies of online users towards stores or products. The experimental results show that our method improves by 9.71%, 6.05%, 5.58% and 5.12% in terms of recall and approaches the peak level of the F1 value in the test model by comparing BiLSTM, Naive Bayesian Model, the serial BiLSTM_CNN model and BiLSTM with an attention mechanism model. Therefore, this finding proves that our method can be used to improve the text sentiment classification accuracy and effectively apply the method to text classification.	[Wang, Xuyang; Tong, Yixuan] Lanzhou Univ Technol, Sch Comp & Commun, Lanzhou, Gansu, Peoples R China	Lanzhou University of Technology	Tong, YX (corresponding author), Lanzhou Univ Technol, Sch Comp & Commun, Lanzhou, Gansu, Peoples R China.	tonyixuan2008@163.com		Yixuan, Tong/0000-0003-4922-1798	Gansu Provincial Key R&D Plan: Research on Key Technologies of Drones [18YF1GA060]	Gansu Provincial Key R&D Plan: Research on Key Technologies of Drones	This work was supported by Gansu Provincial Key R&D Plan: Research on Key Technologies of Drones, 18YF1GA060.	Ba J.L., 2016, LAYER NORMALIZATION; Feini Zhao., 2017, SAR IMAGE TARGET REC, DOI [10.1109/DSAA.2014.7058124, DOI 10.1109/DSAA.2014.7058124]; Hao Cheng., 2016, RES WORD2VEC BAESED; Hendrycks Dan, 2016, ARXIV; Li Jingmei., 2003, J HARBIN ENG U; Mikolov Tomas, 2013, ICLR 2013; Schuster M, 1997, IEEE T SIGNAL PROCES, V45, P2673, DOI 10.1109/78.650093; Vaswani A, 2017, ADV NEUR IN, V30; Victor Lempitsky., 2016, ABS160708022 CORR; Zhang Liang, 2019, DESIGN IMPLEMENTATIO; Zhang YF, 2014, SIGIR'14: PROCEEDINGS OF THE 37TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P1027, DOI 10.1145/2600428.2609501; Zhao Hong, 2019, J COMPUTER APPL	12	3	3	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2021	16	3							e0247984	10.1371/journal.pone.0247984	http://dx.doi.org/10.1371/journal.pone.0247984			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5CA	33667262	Green Published, gold			2022-12-26	WOS:000626604300008
J	Gomez, J; Gordo, O; Minias, P				Gomez, Jesus; Gordo, Oscar; Minias, Piotr			Egg recognition: The importance of quantifying multiple repeatable features as visual identity signals	PLOS ONE			English	Article							CONSPECIFIC BROOD PARASITISM; MOORHEN GALLINULA-CHLOROPUS; COOT FULICA-ATRA; AVIAN EGG; NEST PARASITISM; INDIVIDUAL EGG; ZEBRA FINCHES; COLOR; REJECTION; BIRDS	Brood parasitized and/or colonial birds use egg features as visual identity signals, which allow parents to recognize their own eggs and avoid paying fitness costs of misdirecting their care to others' offspring. However, the mechanisms of egg recognition and discrimination are poorly understood. Most studies have put their focus on individual abilities to carry out these behavioural tasks, while less attention has been paid to the egg and how its signals may evolve to enhance its identification. We used 92 clutches (460 eggs) of the Eurasian coot Fulica atra to test whether eggs could be correctly classified into their corresponding clutches based only on their external appearance. Using SpotEgg, we characterized the eggs in 27 variables of colour, spottiness, shape and size from calibrated digital images. Then, we used these variables in a supervised machine learning algorithm for multi-class egg classification, where each egg was classified to the best matched clutch out of 92 studied clutches. The best model with all 27 explanatory variables assigned correctly 53.3% (CI = 42.6-63.7%) of eggs of the test-set, greatly exceeding the probability to classify the eggs by chance (1/92, 1.1%). This finding supports the hypothesis that eggs have visual identity signals in their phenotypes. Simplified models with fewer explanatory variables (10 or 15) showed lesser classification ability than full models, suggesting that birds may use multiple traits for egg recognition. Therefore, egg phenotypes should be assessed in their full complexity, including colour, patterning, shape and size. Most important variables for classification were those with the highest intraclutch correlation, demonstrating that individual recognition traits are repeatable. Algorithm classification performance improved by each extra training egg added to the model. Thus, repetition of egg design within a clutch would reinforce signals and would help females to create an internal template for true recognition of their own eggs. In conclusion, our novel approach based on machine learning provided important insights on how signallers broadcast their specific signature cues to enhance their recognisability.	[Gordo, Oscar] Catalan Ornithol Inst, Barcelona, Spain; [Minias, Piotr] Univ Lodz, Fac Biol & Environm Protect, Dept Biodivers Studies & Bioeduc, Lodz, Poland	University of Lodz		jgm.spsc@gmail.com	Gordo, Oscar/A-4701-2013	Gordo, Oscar/0000-0003-3766-0566; Gomez, Jesus/0000-0002-2195-2129; Minias, Piotr/0000-0002-7742-6750				Amat JA, 2001, IBIS, V143, P17, DOI 10.1111/j.1474-919X.2001.tb04165.x; [Anonymous], 2017, J AVIAN BIOL, V48, P502; ARNOLD TW, 1987, CONDOR, V89, P675, DOI 10.2307/1368662; Aviles JM, 2004, J AVIAN BIOL, V35, P295, DOI 10.1111/j.0908-8857.2004.03327.x; Aviles JM, 2004, ANIM BEHAV, V67, P951, DOI 10.1016/j.anbehav.2003.08.022; BEECHER IM, 1983, Z TIERPSYCHOL, V62, P145; Beer C. G., 1970, Adv. Study Behav., V3, P27; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Brecht KF, 2020, NEUROSCI BIOBEHAV R, V116, P99, DOI 10.1016/j.neubiorev.2020.06.012; BROWN CR, 1984, SCIENCE, V224, P518, DOI 10.1126/science.224.4648.518; Brulez K, 2014, J ORNITHOL, V155, P701, DOI 10.1007/s10336-014-1053-9; Brulez K, 2014, J AVIAN BIOL, V45, P94, DOI 10.1111/j.1600-048X.2013.00236.x; BUCKLEY PA, 1972, ANIM BEHAV, V20, P457, DOI 10.1016/S0003-3472(72)80009-5; Caves EM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0598; Cheng K, 2016, WATERBIRDS, V39, P306; Dale J, 2001, AM NAT, V158, P75, DOI 10.1086/320861; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Elie JE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06394-9; Feeney WE, 2014, ANNU REV ECOL EVOL S, V45, P227, DOI 10.1146/annurev-ecolsys-120213-091603; Fleischman S, 2016, ANIM BEHAV, V120, P21, DOI 10.1016/j.anbehav.2016.07.020; GASTON AJ, 1993, ANIM BEHAV, V45, P301, DOI 10.1006/anbe.1993.1034; Gentner TQ, 1998, ANIM BEHAV, V56, P579, DOI 10.1006/anbe.1998.0810; Gomez J, 2019, J ORNITHOL, V160, P409, DOI 10.1007/s10336-018-1616-2; Gomez J, 2018, ECOL EVOL, V8, P8019, DOI 10.1002/ece3.4335; Gomez J, 2018, BEHAV ECOL SOCIOBIOL, V72, DOI 10.1007/s00265-018-2558-7; Gomez J, 2016, J AVIAN BIOL, V47, P346, DOI 10.1111/jav.00736; Gosler AG, 2000, P ROY SOC B-BIOL SCI, V267, P2469, DOI 10.1098/rspb.2000.1307; Grether GF, 2009, BIOL REV, V84, P617, DOI 10.1111/j.1469-185X.2009.00089.x; Hanley D, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2592; Hart NS, 2001, PROG RETIN EYE RES, V20, P675, DOI 10.1016/S1350-9462(01)00009-X; Hauber ME, 2019, CAN J ZOOL, V97, P385, DOI 10.1139/cjz-2018-0172; Hauber ME, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2019.0115; Hurd CR, 1996, BEHAV ECOL SOCIOBIOL, V38, P287, DOI 10.1007/s002650050244; Ishikawa S, 2010, FEBS LETT, V584, P770, DOI 10.1016/j.febslet.2009.12.041; Jamieson IG, 2000, AUK, V117, P250, DOI 10.1642/0004-8038(2000)117[0250:HROCBP]2.0.CO;2; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; KENNEDY GY, 1976, COMP BIOCHEM PHYS B, V55, P117, DOI 10.1016/0305-0491(76)90183-8; Kilner RM, 2006, BIOL REV, V81, P383, DOI 10.1017/S1464793106007044; Kiss Valentin Adrian, 2020, ORNIS HUNGARICA, V28, P176, DOI 10.2478/orhu-2020-0011; L'Herpiniere KL, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.181269; Lahti DC, 2005, P NATL ACAD SCI USA, V102, P18057, DOI 10.1073/pnas.0508930102; Lahti DC, 2002, ANIM BEHAV, V63, P1135, DOI 10.1006/anbe.2002.3009; Lambrechts Marcel M., 1995, Current Ornithology, V12, P115; Leedale AE, 2020, P NATL ACAD SCI USA, V117, P15724, DOI 10.1073/pnas.1918726117; Liu JP, 2019, BEHAV PROCESS, V168, DOI 10.1016/j.beproc.2019.103955; Lovell PG, 2013, CURR BIOL, V23, P260, DOI 10.1016/j.cub.2012.12.031; LYON BE, 1993, ANIM BEHAV, V46, P911, DOI 10.1006/anbe.1993.1273; Lyon BE, 2003, NATURE, V422, P495, DOI 10.1038/nature01505; Lyon B, 2007, BEHAV ECOL SOCIOBIOL, V61, P455, DOI 10.1007/s00265-006-0273-2; Lyon BE, 2008, ANNU REV ECOL EVOL S, V39, P343, DOI 10.1146/annurev.ecolsys.39.110707.173354; Marchetti K, 2000, ANIM BEHAV, V59, P877, DOI 10.1006/anbe.1999.1388; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; McRae SB, 2011, ECOL EVOL, V1, P317, DOI 10.1002/ece3.26; Meniaia Zeyneb, 2014, Zoology and Ecology, V24, P305, DOI 10.1080/21658005.2014.959281; Minias P, 2020, AUK, V137, DOI 10.1093/auk/ukaa054; Molina-Morales M, 2014, EVOLUTION, V68, P3020, DOI 10.1111/evo.12471; Morales J, 2006, BIOL LETTERS, V2, P334, DOI 10.1098/rsbl.2006.0471; Moreno J, 2003, ECOL LETT, V6, P803, DOI 10.1046/j.1461-0248.2003.00505.x; MUELLER HC, 1974, BEHAVIOUR, V49, P313, DOI 10.1163/156853974X00552; Nielsen BL, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00069; Oien IJ, 1998, J AVIAN BIOL, V29, P209, DOI 10.2307/3677102; Ornes AS, 2014, J FIELD ORNITHOL, V85, P397, DOI 10.1111/jofo.12079; Petrie M, 2009, NATURWISSENSCHAFTEN, V96, P405, DOI 10.1007/s00114-008-0486-5; Pike TW, 2011, AVIAN BIOL RES, V4, P231, DOI 10.3184/175815511X13228268534598; Polacek M, 2017, PEERJ, V5, DOI 10.7717/peerj.3707; Polacikova L, 2007, ANIM BEHAV, V74, P419, DOI 10.1016/j.anbehav.2006.10.023; Poysa H, 2001, J AVIAN BIOL, V32, P79, DOI 10.1034/j.1600-048X.2001.320112.x; Poysa H, 2009, J AVIAN BIOL, V40, P453, DOI 10.1111/j.1600-048X.2008.04528.x; Quach L, 2021, J EXP ZOOL PART B, V336, P595, DOI 10.1002/jez.b.22945; R Core Team, 2021, R LANGUAGE ENV STAT; Rahn K, 2020, ARDEA, V108, P83, DOI 10.5253/arde.v108i1.a5; RASA OAE, 1983, BEHAV ECOL SOCIOBIOL, V12, P181; ROHWER FC, 1989, CAN J ZOOL, V67, P239, DOI 10.1139/z89-035; ROTHSTEIN SI, 1982, AM ZOOL, V22, P547; ROTHSTEIN SI, 1975, ANIM BEHAV, V23, P268, DOI 10.1016/0003-3472(75)90075-5; Samraoui F, 2007, WATERBIRDS, V30, P133, DOI 10.1675/1524-4695(2007)030[0133:TREOTC]2.0.CO;2; Scanes PD, 2015, STURKIES AVIAN PHYSL, V6th; SCHAFFNER FC, 1990, COLON WATERBIRD, V13, P25, DOI 10.2307/1521417; Sezer M, 2009, BIOL RES, V42, P99, DOI [/S0716-97602009000100010, 10.4067/S0716-97602009000100010]; SHUGART GW, 1987, ANIM BEHAV, V35, P1563, DOI 10.1016/S0003-3472(87)80030-1; Shutler D, 2019, J AVIAN BIOL, V50, DOI 10.1111/jav.02003; Soler Manuel, 1996, Ardeola, V43, P87; Soto FA, 2012, COGN AFFECT BEHAV NE, V12, P220, DOI 10.3758/s13415-011-0070-x; Spottiswoode CN, 2012, AM NAT, V179, P633, DOI 10.1086/665031; Spottiswoode CN, 2010, P NATL ACAD SCI USA, V107, P8672, DOI 10.1073/pnas.0910486107; Steinwart I., 2008, SUPPORT VECTOR MACHI; Stevens M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3475; Stevens M, 2011, AVIAN BIOL RES, V4, P168, DOI 10.3184/175815511X13207790177958; Stoddard MC, 2017, SCIENCE, V356, P1249, DOI 10.1126/science.aaj1945; Stoddard MC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5117; Stoddard MC, 2010, P ROY SOC B-BIOL SCI, V277, P1387, DOI 10.1098/rspb.2009.2018; Stoffel MA, 2017, METHODS ECOL EVOL, V8, P1639, DOI 10.1111/2041-210X.12797; Swynnerton C.F.M., 1918, IBIS, V6, P127, DOI DOI 10.1111/J.1474-919X.1918.TB00774.X; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Vapnik V., 2013, NATURE STAT LAERNING; Veen T, 2000, P ROY SOC B-BIOL SCI, V267, P2253, DOI 10.1098/rspb.2000.1276; VICTORIA JK, 1972, IBIS, V114, P367, DOI 10.1111/j.1474-919X.1972.tb00834.x; Yom-Tov Y, 2001, IBIS, V143, P133, DOI 10.1111/j.1474-919X.2001.tb04177.x; Zeigler H. P., 1993, VISION BRAIN BEHAV B	100	6	6	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0248021	10.1371/journal.pone.0248021	http://dx.doi.org/10.1371/journal.pone.0248021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33661988	gold, Green Published			2022-12-26	WOS:000626604100066
J	Hernandez-Guillen, D; Tolsada-Velasco, C; Roig-Casasus, S; Costa-Moreno, E; Borja-de-Fuentes, I; Blasco, JM				Hernandez-Guillen, David; Tolsada-Velasco, Catalina; Roig-Casasus, Sergio; Costa-Moreno, Elena; Borja-de-Fuentes, Irene; Blasco, Jose-Maria			Association ankle function and balance in community-dwelling older adults	PLOS ONE			English	Article							AGE-RELATED DIFFERENCES; DORSIFLEXION RANGE; JOINT MOBILIZATION; MUSCLE STRENGTH; PLANTAR FLEXORS; MOTION; FOOT; ABILITY; WOMEN; FALLS	Background and purpose Ankle function declines with age. The objective of this study was to investigate the association between ankle function and balance in older adults, with a focus on range of motion (ROM) and strength. Methods This was a cross-sectional study that included 88 healthy community-dwelling older adults. Ankle mobility was measured while bearing weight (lunge test) and not bearing weight. The plantar-flexor muscle strength was assessed using a hand-held dynamometer. Balance was measured in terms of dynamic balance and mobility (timed up and go test), monopodal and bipodal static balance with open and closed eyes (single-leg stand test and platform measures), and margins of stability (functional reach test). Linear correlation and multiple regression analyses were conducted with a 95% CI. Results and discussion Most participants had limited ankle mobility (n = 75, 86%). Weight-bearing ankle dorsiflexion ROM was the strongest predictor of dynamic balance and included general mobility and stability (R-adj(2) = [0.34]; beta = [-0.50]). In contrast, plantar-flexor muscle strength was a significant predictor of static standing balance with open eyes (R-adj(2) = [0.16-0.2]; beta = [0.29-0.34]). Overall, weight-bearing ankle dorsiflexion ROM was a more representative measure of balance and functional performance; however, a non-weight-bearing mobility assessment provides complementary information. Therefore, both measures can be used in clinical practice. Conclusion This study supports the concept that ankle mobility contributes to the performance of dynamic tasks, while the plantar-flexor muscle strength helps to develop a standing static balance. Identification of alterations in ankle function is warranted and may assist in the design of tailored interventions. These interventions can be used in isolation or to augment conventional balance training in order to improve balance performance in community-dwelling older adults.	[Hernandez-Guillen, David; Roig-Casasus, Sergio; Blasco, Jose-Maria] Univ Valencia, Dept Fisioterapia, Grp Physiotherapy Ageing Proc, Valencia, Spain; [Tolsada-Velasco, Catalina; Costa-Moreno, Elena; Borja-de-Fuentes, Irene] Univ Valencia, Dept Fisioterapia, Valencia, Spain; [Roig-Casasus, Sergio] Hosp Politecn & Univ La Fe, Valencia, Spain	University of Valencia; University of Valencia	Hernandez-Guillen, D (corresponding author), Univ Valencia, Dept Fisioterapia, Grp Physiotherapy Ageing Proc, Valencia, Spain.	david.hernandez@uv.es	Blasco, Jose María/H-5495-2016	Blasco, Jose María/0000-0002-7663-9092; Hernandez-Guillen, David/0000-0002-4289-5688				An CM, 2017, J STROKE CEREBROVASC, V26, P169, DOI 10.1016/j.jstrokecerebrovasdis.2016.09.005; BASSEY EJ, 1988, CLIN SCI, V74, P85, DOI 10.1042/cs0740085; Blasco J-M., 2020, PHYS THER REHABIL J; BOEVER F, 1948, ARCH INT PHARMACOD T, V77, P1; Bok SK, 2013, ANN REHABIL MED-ARM, V37, P10, DOI 10.5535/arm.2013.37.1.10; Brito TA, 2014, PUBLIC HEALTH NURS, V31, P290, DOI 10.1111/phn.12126; Dufour M., 2006, BIOMECANICA FUNCIONA; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; Ema R, 2016, AGE, V38, P475, DOI 10.1007/s11357-016-9949-3; Gajdosik RL, 1999, PHYS THER, V79, P827, DOI 10.1093/ptj/79.9.827; Guillen-Rogel Paloma, 2017, J Phys Ther Sci, V29, P1363, DOI 10.1589/jpts.29.1363; Hernandez ME, 2010, PHYS THER, V90, P67, DOI 10.2522/ptj.20090035; Hernandez-Guillen D, 2020, PHYSIOTHER THEOR PR, V36, P1097, DOI 10.1080/09593985.2018.1563931; Hoch MC, 2012, J ORTHOP RES, V30, P1798, DOI 10.1002/jor.22150; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; HORAK FB, 1987, PHYS THER, V67, P1881, DOI 10.1093/ptj/67.12.1881; Kang MH, 2015, J PHYS THER SCI, V27, P1317, DOI 10.1589/jpts.27.1317; Kim SG, 2018, MED SCI MONITOR, V24, P3168, DOI 10.12659/MSM.908260; Konor MM, 2012, INT J SPORTS PHYS TH, V7, P279; Mackey DC, 2006, GAIT POSTURE, V23, P59, DOI 10.1016/j.gaitpost.2004.11.009; Madureira MM, 2007, OSTEOPOROSIS INT, V18, P419, DOI 10.1007/s00198-006-0252-5; Mancini M, 2010, EUR J PHYS REHAB MED, V46, P239; Maribo T., 2009, INT MUSCULOSKELETAL, V31, P4, DOI [10.1179/175361409X12472218841040, DOI 10.1179/175361409X12472218841040]; Mecagni C, 2000, PHYS THER, V80, P1004, DOI 10.1093/ptj/80.10.1004; Menz HB, 2005, J GERONTOL A-BIOL, V60, P1546, DOI 10.1093/gerona/60.12.1546; Menz HB, 2006, J GERONTOL A-BIOL, V61, P866, DOI 10.1093/gerona/61.8.866; Menz HB, 2015, GERONTOLOGY, V61, P381, DOI 10.1159/000368357; Powden CJ, 2015, MANUAL THER, V20, P524, DOI 10.1016/j.math.2015.01.004; Rabin A, 2012, J AM PODIAT MED ASSN, V102, P406, DOI 10.7547/1020406; Ribeiro F, 2009, GERIATR GERONTOL INT, V9, P75, DOI 10.1111/j.1447-0594.2008.00500.x; Runge CF, 1999, GAIT POSTURE, V10, P161, DOI 10.1016/S0966-6362(99)00032-6; Scott G, 2007, GAIT POSTURE, V26, P68, DOI 10.1016/j.gaitpost.2006.07.009; Sherrington Catherine, 2011, N S W Public Health Bull, V22, P78, DOI 10.1071/NB10056; Spink MJ, 2011, ARCH PHYS MED REHAB, V92, P68, DOI 10.1016/j.apmr.2010.09.024; Spink MJ, 2010, GERONTOLOGY, V56, P525, DOI 10.1159/000264655; Thompson W.R., 2010, ACSMS GUIDELINES EXE	36	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2021	16	3							e0247885	10.1371/journal.pone.0247885	http://dx.doi.org/10.1371/journal.pone.0247885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5BY	33661991	Green Published, gold			2022-12-26	WOS:000626604100110
J	Garza, NM; Griffin, AT; Zulkifli, M; Qiu, CX; Kaplan, CD; Gohil, VM				Garza, Natalie M.; Griffin, Aaron T.; Zulkifli, Mohammad; Qiu, Chenxi; Kaplan, Craig D.; Gohil, Vishal M.			A genome-wide copper-sensitized screen identifies novel regulators of mitochondrial cytochrome c oxidase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOL-DISULFIDE OXIDOREDUCTASE; SACCHAROMYCES-CEREVISIAE; EMERGING ROLE; H+-ATPASE; YEAST; IRON; MUTATIONS; GENES; METAL; COA6	Copper is essential for the activity and stability of cytochrome c oxidase (CcO), the terminal enzyme of the mitochondrial respiratory chain. Loss-of-function mutations in genes required for copper transport to CcO result in fatal human disorders. Despite the fundamental importance of copper in mitochondrial and organismal physiology, systematic identification of genes that regulate mitochondrial copper homeostasis is lacking. To discover these genes, we performed a genome-wide screen using a library of DNA-barcoded yeast deletion mutants grown in copper-supplemented media. Our screen recovered a number of genes known to be involved in cellular copper homeostasis as well as genes previously not linked to mitochondrial copper biology. These newly identified genes include the subunits of the adaptor protein 3 complex (AP-3) and components of the cellular pH-sensing pathway Rim20 and Rim21, both of which are known to affect vacuolar function. We find that AP-3 and Rim mutants exhibit decreased vacuolar acidity, which in turn perturbs mitochondrial copper homeostasis and CcO function. CcO activity of these mutants could be rescued by either restoring vacuolar pH or supplementing growth media with additional copper. Consistent with these genetic data, pharmacological inhibition of the vacuolar proton pump leads to decreased mitochondrial copper content and a concomitant decrease in CcO abundance and activity. Taken together, our study uncovered novel genetic regulators of mitochondrial copper homeostasis and provided a mechanism by which vacuolar pH impacts mitochondrial respiration through copper homeostasis.	[Garza, Natalie M.; Griffin, Aaron T.; Zulkifli, Mohammad; Qiu, Chenxi; Kaplan, Craig D.; Gohil, Vishal M.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Griffin, Aaron T.] Columbia Univ, Dept Syst Biol, New York, NY USA; [Qiu, Chenxi] Harvard Med Sch, Div Translat Therapeut, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Kaplan, Craig D.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Texas A&M University System; Texas A&M University College Station; Columbia University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gohil, VM (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	vgohil@tamu.edu	Kaplan, Craig/AAO-4500-2021; Zulkifli, Mohammad/V-5115-2019	Kaplan, Craig/0000-0002-7518-695X; Zulkifli, Mohammad/0000-0002-9110-9508; Garza, Natalie/0000-0002-0467-5094; Griffin, Aaron/0000-0002-8027-0822; Gohil, Vishal/0000-0002-9920-2563	National Institutes of Health [R01GM111672, R0GM1097260, 5F31GM128339]; Welch Foundation [A-1810]; National Science Foundation [HRD-1502335]; T3 grant from Texas AM University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); National Science Foundation(National Science Foundation (NSF)); T3 grant from Texas AM University	This work was supported by the National Institutes of Health awards R01GM111672 to V. M. G., R0GM1097260 to C. D. K., and 5F31GM128339 to N. M. G. and the Welch Foundation Grant (A-1810) to V. M. G. N. M. G. was also supported by National Science Foundation award HRD-1502335 in the first year of this work. This work was also supported by a T3 grant from Texas A&M University to V. M. G. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Science Foundation.	Ammann S, 2016, BLOOD, V127, P997, DOI 10.1182/blood-2015-09-671636; Baertling F, 2015, HUM MUTAT, V36, P34, DOI 10.1002/humu.22715; Bagh MB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14612; Blaby-Haas CE, 2014, J BIOL CHEM, V289, P28129, DOI 10.1074/jbc.R114.592618; Brett CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017619; Chen KL, 2020, GEROSCIENCE, V42, P749, DOI 10.1007/s11357-020-00159-3; Chun CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012503; Cobine PA, 2004, J BIOL CHEM, V279, P14447, DOI 10.1074/jbc.M312693200; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; Cobine PA, 2021, BBA-MOL CELL RES, V1868, DOI 10.1016/j.bbamcr.2020.118867; Colacurcio DJ, 2016, AGEING RES REV, V32, P75, DOI 10.1016/j.arr.2016.05.004; Corrionero A, 2018, CURR BIOL, V28, P1522, DOI 10.1016/j.cub.2018.03.063; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 2009, CURR OPIN CELL BIOL, V21, P552, DOI 10.1016/j.ceb.2009.04.014; Desai V, 2008, AM J CLIN NUTR, V88, p855S, DOI 10.1093/ajcn/88.3.855S; Diakov TT, 2013, JOVE-J VIS EXP, DOI 10.3791/50261; Diaz-Ruiz R, 2009, BBA-REV CANCER, V1796, P252, DOI 10.1016/j.bbcan.2009.07.003; Dodani SC, 2011, J AM CHEM SOC, V133, P8606, DOI 10.1021/ja2004158; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; EIDE DJ, 1993, MOL GEN GENET, V241, P447, DOI 10.1007/BF00284699; El-Chemaly S, 2016, CLIN CHEST MED, V37, P505, DOI 10.1016/j.ccm.2016.04.012; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; Foster AW, 2014, MOL MICROBIOL, V93, P317, DOI 10.1111/mmi.12661; Gaxiola RA, 1998, P NATL ACAD SCI USA, V95, P4046, DOI 10.1073/pnas.95.7.4046; Ghosh A, 2016, HUM MOL GENET, V25, P660, DOI 10.1093/hmg/ddv503; Ghosh A, 2014, HUM MOL GENET, V23, P3596, DOI 10.1093/hmg/ddu069; Giles NM, 2003, CHEM BIOL, V10, P677, DOI 10.1016/S1074-5521(03)00174-1; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Haas Albert, 1995, Methods in Cell Science, V17, P283, DOI 10.1007/BF00986234; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Horn D, 2008, MOL CELL BIOL, V28, P4354, DOI 10.1128/MCB.01920-07; Huang Z, 2013, CELL REP, V3, P577, DOI 10.1016/j.celrep.2013.01.019; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Hughes CE, 2020, CELL, V180, P296, DOI 10.1016/j.cell.2019.12.035; Ishizaki H, 2010, DIS MODEL MECH, V3, P639, DOI 10.1242/dmm.005769; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jo WJ, 2008, TOXICOL SCI, V101, P140, DOI 10.1093/toxsci/kfm226; Jo WJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-130; Kaler SG, 2013, HAND CLINIC, V113, P1745, DOI 10.1016/B978-0-444-59565-2.00045-9; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Korvatska O, 2013, HUM MOL GENET, V22, P3259, DOI 10.1093/hmg/ddt180; Lamb TM, 2001, J BIOL CHEM, V276, P1850, DOI 10.1074/jbc.M008381200; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; LIN SJ, 1995, P NATL ACAD SCI USA, V92, P3784, DOI 10.1073/pnas.92.9.3784; Little AG, 2018, COMP BIOCHEM PHYS B, V224, P170, DOI 10.1016/j.cbpb.2017.11.005; Llinares E, 2015, SCI REP-UK, V5, DOI 10.1038/srep16665; Maeda T, 2012, FEBS J, V279, P1407, DOI 10.1111/j.1742-4658.2012.08548.x; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Merz S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r95; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Nguyen M, 2019, TRENDS NEUROSCI, V42, P140, DOI 10.1016/j.tins.2018.11.001; Nguyen TQ, 2019, METALLOMICS, V11, P1298, DOI 10.1039/c9mt00104b; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; OHYA Y, 1991, J BIOL CHEM, V266, P13971; Orij R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r80; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Papadopoulou LC, 1999, NAT GENET, V23, P333; Perez-Sampietro M, 2014, FUNGAL GENET BIOL, V71, P76, DOI 10.1016/j.fgb.2014.09.001; Polishchuk EV, 2016, METALLOMICS, V8, P853, DOI [10.1039/c6mt00058d, 10.1039/C6MT00058D]; Portnoy ME, 2001, MOL GENET GENOMICS, V265, P873, DOI 10.1007/s004380100482; Read T, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005746; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Rees EM, 2007, J BIOL CHEM, V282, P21629, DOI 10.1074/jbc.M703397200; Rigo A, 2004, J INORG BIOCHEM, V98, P1495, DOI 10.1016/j.jinorgbio.2004.06.008; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Schlecht U, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-263; Smith AM, 2009, GENOME RES, V19, P1836, DOI 10.1101/gr.093955.109; Soma S, 2019, CELL REP, V29, P4114, DOI 10.1016/j.celrep.2019.11.054; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Stenger M, 2020, MICROB CELL, V7, P234, DOI 10.15698/mic2020.09.729; Stepien KM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082596; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; Timon-Gomez A, 2018, SEMIN CELL DEV BIOL, V76, P163, DOI 10.1016/j.semcdb.2017.08.055; Valnot I, 2000, AM J HUM GENET, V67, P1104; Vogtle FN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00359-0; Weber RA, 2020, MOL CELL, V77, P645, DOI 10.1016/j.molcel.2020.01.003; Wu XB, 2016, J BIOL CHEM, V291, P9796, DOI 10.1074/jbc.M115.700500; Xu WJ, 2004, MOL BIOL CELL, V15, P5528, DOI 10.1091/mbc.E04-08-0666; Yambire KF, 2019, ELIFE, V8, DOI 10.7554/eLife.51031	81	3	3	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100485	10.1016/j.jbc.2021.100485	http://dx.doi.org/10.1016/j.jbc.2021.100485			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33662401	Green Submitted, gold, Green Published			2022-12-26	WOS:000672866400459
